PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dorayappan, KDP; Wanner, R; Wallbillich, JJ; Saini, U; Zingarelli, R; Suarez, AA; Cohn, DE; Selvendiran, K				Dorayappan, Kalpana Deepa Priya; Wanner, Ross; Wallbillich, John J.; Saini, Uksha; Zingarelli, Roman; Suarez, Adrian A.; Cohn, David E.; Selvendiran, Karuppaiyah			Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins	ONCOGENE			English	Article							INTERCELLULAR-COMMUNICATION; CARCINOMA CELLS; STEM-CELLS; METASTASIS; TRAFFICKING; PROGRESSION; EXPRESSION; CISPLATIN; PATHWAY; NICHE	Hypoxia-mediated tumor progression, metastasis, and drug resistance are major clinical challenges in ovarian cancer. Exosomes released in the hypoxic tumor microenvironment may contribute to these challenges by transferring signaling proteins between cancer cells and normal cells. We observed that ovarian cancer cells exposed to hypoxia significantly increased their exosome release by upregulating Rab27a, downregulating Rab7, LAMP1/2, NEU-1, and also by promoting a more secretory lysosomal phenotype. STAT3 knockdown in ovarian cancer cells reduced exosome release by altering the Rab family proteins Rab7 and Rab27a under hypoxic conditions. We also found that exosomes from patient-derived ascites ovarian cancer cell lines cultured under hypoxic conditions carried more potent oncogenic proteins-STAT3 and FAS that are capable of significantly increasing cell migration/invasion and chemo-resistance in vitro and tumor progression/metastasis in vivo. Hypoxic ovarian cancer cells derived exosomes (HEx) are proficient in re-programming the immortalized fallopian tube secretory epithelial cells (FT) to become pro-tumorigenic in mouse fallopian tubes. In addition, cisplatin efflux via exosomes was significantly increased in ovarian cancer cells under hypoxic conditions. Co-culture of HEx with tumor cells led to significantly decreased dsDNA damage and increased cell survival in response to cisplatin treatment. Blocking exosome release by known inhibitor Amiloride or STAT3 inhibitor and treating with cisplatin resulted in a significant increase in apoptosis, decreased colony formation, and proliferation. Our results demonstrate that HEx are more potent in augmenting metastasis/chemotherapy resistance in ovarian cancer and may serve as a novel mechanism for tumor metastasis, chemo-resistance, and a point of intervention for improving clinical outcomes.	[Dorayappan, Kalpana Deepa Priya; Wanner, Ross; Saini, Uksha; Zingarelli, Roman; Cohn, David E.; Selvendiran, Karuppaiyah] Ohio State Univ, Ctr Comprehens Canc, Wexner Med Ctr, Div Gynecol Oncol, Columbus, OH 43210 USA; [Wallbillich, John J.] Augusta Univ, Div Gynecol Oncol, Dept OB GYN, Georgia Canc Ctr, Augusta, GA USA; [Suarez, Adrian A.] Ohio State Univ, Ctr Comprehens Canc, Wexner Med Ctr, Dept Pathol,Gynecol Oncol, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Georgia; Augusta University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Selvendiran, K (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Wexner Med Ctr, Div Gynecol Oncol, Columbus, OH 43210 USA.	selvendiran.karuppaiyah@osumc.edu		Wallbillich, John/0000-0001-5913-8088	NIH [S10 OD018056]; National Cancer Institute, Bethesda, MD [P30 CA016058]; Ovarian Cancer Research Fund (OCRF); NCI [RO1-CA176078]; KOH ovarian cancer foundation; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA176078] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018056] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ovarian Cancer Research Fund (OCRF); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); KOH ovarian cancer foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Zhang Liwen, PhD for proteomic analysis using Fusion Orbitrap instrument at OSU supported by NIH Award Number Grant S10 OD018056; Dr. Xiaokui Mo, Ph.D for analysis of Bioinformatics data; and Dr. Min Gao, Ph.D, Kent University for TEM analysis. Confocal images presented in this manuscript were generated using the services of the Campus Microscopy and Imaging Facility at OSU supported in part by grant P30 CA016058, National Cancer Institute, Bethesda, MD. We also thank Dr. John Olesik, Trace Element Research laboratory at OSU who helped us to quantify the Cisplatin concentration in exosomes by ICP-Mass Spectrometry; Dr. John Hays for his willingness to pre-review this manuscript and provide valuable comments and suggestions; Dr. Matthew Ringel, MD and his laboratory member Dr. Moto Saji for their invaluable help in exosome isolation protocols; and Brentley Smith, GYN/ONC fellow at OSU, Graduate students Dongju Park and Christopher Koivisto, Medical student Rashmi Madhukar, and Undergraduate student Maria Riley, for the IHC, cell culture, and basic assay help. This work was funded by Ovarian Cancer Research Fund (OCRF), NCI RO1-CA176078 grant (to KS and DEC) and KOH ovarian cancer foundation grant to KDPD.	[Anonymous], 2015, SEER STAT FACT SHEET; Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Beach A, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-14; Chacko SM, 2010, AM J PHYSIOL-CELL PH, V299, pC1562, DOI 10.1152/ajpcell.00221.2010; Chen Y, 2017, ONCOGENE, V36, P4692, DOI 10.1038/onc.2017.100; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Dorayappan KDP, 2016, GYNECOL ONCOL, V141, P66; ElNaggar AC, 2016, CANCER BIOL THER, V17, P1107, DOI 10.1080/15384047.2016.1210733; Finger EC, 2010, CANCER METAST REV, V29, P285, DOI 10.1007/s10555-010-9224-5; Gao M, 2014, MICROSC RES TECHNIQ, V77, P754, DOI 10.1002/jemt.22397; Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; Graves LE, 2004, CANCER RES, V64, P7045, DOI 10.1158/0008-5472.CAN-04-1800; Gupta S, 2007, AM J PHYSIOL-HEART C, V292, pH3052, DOI 10.1152/ajpheart.01355.2006; Holmes D, 2015, NATURE, V527, pS217, DOI 10.1038/527S217a; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Kahlert C, 2013, J MOL MED, V91, P431, DOI 10.1007/s00109-013-1020-6; Kallunki T, 2013, ONCOGENE, V32, P1995, DOI 10.1038/onc.2012.292; Kalluri R, 2016, J CLIN INVEST, V126, P1208, DOI 10.1172/JCI81135; Kanlikilicer P, 2016, CANCER RES, V76, P7194, DOI 10.1158/0008-5472.CAN-16-0714; Kirkegaard T, 2009, BBA-MOL CELL RES, V1793, P746, DOI 10.1016/j.bbamcr.2008.09.008; Kreuzaler PA, 2011, NAT CELL BIOL, V13, P303, DOI 10.1038/ncb2171; Kucharzewska P, 2013, P NATL ACAD SCI USA, V110, P7312, DOI 10.1073/pnas.1220998110; Kulbe H, 2012, CANCER RES, V72, P66, DOI 10.1158/0008-5472.CAN-11-2178; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Leca J, 2016, J CLIN INVEST, V126, P4140, DOI 10.1172/JCI87734; Liang B, 2013, J PROTEOMICS, V80, P171, DOI 10.1016/j.jprot.2012.12.029; Lobb RJ, 2017, SEMIN CELL DEV BIOL, V67, P3, DOI 10.1016/j.semcdb.2017.01.004; McCann Georgia A, 2014, Oncoscience, V1, P216; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Rath KS, 2014, CANCER RES, V74, P2316, DOI 10.1158/0008-5472.CAN-13-2433; Safaei R, 2005, MOL CANCER THER, V4, P1595, DOI 10.1158/1535-7163.MCT-05-0102; Safaei R, 2005, CLIN CANCER RES, V11, P756; Saini U, 2017, ONCOGENE, V36, P168, DOI 10.1038/onc.2016.197; Savina A, 2002, J CELL SCI, V115, P2505; Sceneay J, 2013, CANCER METAST REV, V32, P449, DOI 10.1007/s10555-013-9420-1; Selvendiran K, 2009, INT J CANCER, V125, P2198, DOI 10.1002/ijc.24601; Shender VO, 2014, MOL CELL PROTEOMICS, V13, P3558, DOI 10.1074/mcp.M114.041194; Su SA, 2017, ONCOTARGET, V8, P25700, DOI 10.18632/oncotarget.14878; Teng Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14448; Vaksman O, 2014, CARCINOGENESIS, V35, P2113, DOI 10.1093/carcin/bgu130; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Wang T, 2014, P NATL ACAD SCI USA, V111, pE3234, DOI 10.1073/pnas.1410041111; Yeung CLA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11150; Yogalingam G, 2008, DEV CELL, V15, P74, DOI 10.1016/j.devcel.2008.05.005; Zhang HG, 2014, AM J PATHOL, V184, P28, DOI 10.1016/j.ajpath.2013.09.027; Zhang W, 2016, TUMOR BIOL, V37, P4213, DOI 10.1007/s13277-015-4105-8	46	144	152	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 12	2018	37	28					3806	3821		10.1038/s41388-018-0189-0	http://dx.doi.org/10.1038/s41388-018-0189-0			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GM8HR	29636548	Green Accepted			2022-12-26	WOS:000438465600004
J	Fang, C; Li, T; Li, Y; Xu, GJ; Deng, QW; Chen, YJ; Hou, YN; Lee, HC; Zhao, YJ				Fang, Cheng; Li, Ting; Li, Ying; Xu, Guan Jie; Deng, Qi Wen; Chen, Ya Jie; Hou, Yun Nan; Lee, Hon Cheung; Zhao, Yong Juan			CD38 produces nicotinic acid adenosine dinucleotide phosphate in the lysosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nicotinic acid adenine dinucleotide phosphate (NAADP); CD38; lysosome; endocytosis; single-domain antibody (sdAb, nanobody)	CYCLIC ADP-RIBOSE; INOSITOL TRISPHOSPHATE; CA2+ MOBILIZATION; ANTIGEN CD38; CELLS; NAADP; CALCIUM; CYCLASE; INTERNALIZATION; RECEPTOR	Nicotinic acid adenosine dinucleotide phosphate (NAADP) is a Ca2+-mobilizing second messenger that regulates a wide range of biological activities. However, the mechanism of its biogenesis remains controversial. CD38 is the only enzyme known to catalyze NAADP synthesis from NADP and nicotinic acid. CD38-mediated catalysis requires an acidic pH, suggesting that NAADP may be produced in acidic endolysosomes, but this hypothesis is untested. In this study, using human cell lines, we specifically directed CD38 to the endolysosomal system and assessed cellular NAADP production. First, we found that nanobodies targeting various epitopes on the C-terminal domain of CD38 could bind to cell surface-localized CD38 and induce its endocytosis. We also found that CD38 internalization occurred via a clathrin-dependent pathway, delivered CD38 to the endolysosome, and elevated intracellular NAADP levels. We also created a CD38 variant for lysosome-specific expression, which not only withstood the degradative environment in the lysosome, but was also much more active than WT CD38 in elevating cellular NAADP levels. Supplementing CD38-expressing cells with nicotinic acid substantially increased cellular NAADP levels. These results demonstrate that endolysosomal CD38 can produce NAADP in human cells. They further suggest that CD38's compartmentalization to the lysosome may allow for its regulation via substrate access, rather than enzyme activation, thereby providing a reliable mechanism for regulating cellular NAADP production.	[Fang, Cheng; Li, Ting; Li, Ying; Xu, Guan Jie; Deng, Qi Wen; Chen, Ya Jie; Hou, Yun Nan; Lee, Hon Cheung; Zhao, Yong Juan] Peking Univ, Shenzhen Grad Sch, Lab Cytophysiol, State Key Lab Chem Oncogen,Key Lab Chem Genom, Shenzhen 518055, Peoples R China	Peking University; University Town of Shenzhen	Lee, HC; Zhao, YJ (corresponding author), Peking Univ, Shenzhen Grad Sch, Lab Cytophysiol, State Key Lab Chem Oncogen,Key Lab Chem Genom, Shenzhen 518055, Peoples R China.	leehoncheung@gmail.com; zhaoyj@pkusz.edu.cn	Zhao, Yongjuan/AAS-9919-2021; Lee, Hon Cheung/C-4329-2009	Zhao, Yong Juan/0000-0003-4564-1912; Deng, Qiwen/0000-0002-4153-1778	National Science Foundation of China [31571438, 31470815]; Shenzhen Governments [JCYJ20160608091848749, JCYJ20170412150609690]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Governments	This work was supported by National Science Foundation of China Grants 31571438 (to Y. J. Z.) and 31470815 (to H. C. L.) and Shenzhen Governments Grants JCYJ20160608091848749 (to Y. J. Z.) and JCYJ20170412150609690 (to H. C. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Antonelli A, 2001, DIABETES, V50, P985, DOI 10.2337/diabetes.50.5.985; Bahn A, 2008, J BIOL CHEM, V283, P16332, DOI 10.1074/jbc.M800737200; Bruzzone S, 2001, FASEB J, V15, P10; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Cosker F, 2010, J BIOL CHEM, V285, P38251, DOI 10.1074/jbc.M110.125864; Deaglio S, 1998, J IMMUNOL, V160, P395; Dutta Dipannita, 2012, Cell Logist, V2, P203; Elkin SR, 2016, WIEN MED WOCHENSCHR, V166, P196, DOI 10.1007/s10354-016-0432-7; Fumey W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14112-6; FUNARO A, 1990, J IMMUNOL, V145, P2390; Funaro A, 1998, J IMMUNOL, V160, P2238; Galione A, 2015, CELL CALCIUM, V58, P27, DOI 10.1016/j.ceca.2014.09.010; Gao Y, 2007, MOL CELL BIOCHEM, V295, P1, DOI 10.1007/s11010-006-9265-9; Gopal E, 2007, PHARM RES-DORDR, V24, P575, DOI 10.1007/s11095-006-9176-1; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Graeff R., 2013, MESSENGER, V2, P96; Graeff R, 2006, J BIOL CHEM, V281, P28951, DOI 10.1074/jbc.M604370200; Gul R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149125; Guse AH, 2013, CURR TOP MED CHEM, V13, P2978, DOI 10.2174/15680266113136660212; Horenstein AL, 1998, BIOCHEM J, V330, P1129; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; JACKSON DG, 1990, J IMMUNOL, V144, P2811; Kontani K, 1996, J BIOL CHEM, V271, P1534; Kubala MH, 2010, PROTEIN SCI, V19, P2389, DOI 10.1002/pro.519; KUMAGAI MA, 1995, J EXP MED, V181, P1101, DOI 10.1084/jem.181.3.1101; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Lee HC, 2012, J BIOL CHEM, V287, P31633, DOI 10.1074/jbc.R112.349464; Li T, 2016, SCI REP-UK, V6, DOI 10.1038/srep27055; Lin WK, 2017, J BIOL CHEM, V292, P13243, DOI 10.1074/jbc.M117.789347; Liu J, 2017, P NATL ACAD SCI USA, V114, P8283, DOI 10.1073/pnas.1703718114; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Mehta K, 1996, FASEB J, V10, P1408, DOI 10.1096/fasebj.10.12.8903511; Moreschi I, 2006, BIOCHEM BIOPH RES CO, V345, P573, DOI 10.1016/j.bbrc.2006.04.096; OREILLY DS, 1984, J CLIN PATHOL, V37, P1358, DOI 10.1136/jcp.37.12.1358; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Soares S, 2007, AM J PHYSIOL-CELL PH, V292, pC227, DOI 10.1152/ajpcell.00638.2005; STATES DJ, 1992, TRENDS BIOCHEM SCI, V17, P495, DOI 10.1016/0968-0004(92)90337-9; Terdoslavich Michela, 2012, Drug Metab Lett, V6, P165; WILEY HS, 1982, J BIOL CHEM, V257, P4222; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Yabuuchi H, 1998, PHARMACEUT RES, V15, P411, DOI 10.1023/A:1011920213991; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhao YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002700; Zhao YJ, 2011, J BIOL CHEM, V286, P22170, DOI 10.1074/jbc.M111.228379; Zhao YJ, 2012, ACTA BIOCH BIOPH SIN, V44, P719, DOI 10.1093/abbs/gms044; Zocchi E, 1999, FASEB J, V13, P273, DOI 10.1096/fasebj.13.2.273; Zocchi E, 1996, FEBS LETT, V396, P327, DOI 10.1016/0014-5793(96)01125-8	49	26	26	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8151	8160		10.1074/jbc.RA118.002113	http://dx.doi.org/10.1074/jbc.RA118.002113			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29632067	Green Published, hybrid			2022-12-26	WOS:000433224600020
J	Chen, X; Dai, Y; Wang, ZQ; Zhu, GY; Ding, XQ; Jin, TY				Chen, Xiao; Dai, Yan; Wang, Zhongqiu; Zhu, Guoying; Ding, Xiaoqiang; Jin, Taiyi			The association between serum vitamin D levels and renal tubular dysfunction in a general population exposed to cadmium in China	PLOS ONE			English	Article							D SUPPLEMENTATION; 25-HYDROXYVITAMIN D; D DEFICIENCY; D METABOLISM; RISK; CALCIUM	Cadmium exposure can cause renal tubular dysfunction. Recent studies show that vitamin D can play multiple roles in the body. However, the association between serum vitamin D levels and renal tubular dysfunction in a general population exposed to cadmium has not been clarified. We performed study to assess the effects of cadmium on serum 25(OH) D levels and the association between serum 25(OH) D levels and renal tubular dysfunction in a population environmentally exposed to cadmium. A total of 133 subjects living in control area and two cadmium polluted areas were included in the present study. Cadmium in urine (UCd) and blood (BCd), urinary beta 2Microglobulin (UBMG), urinary retinol binding protein (URBP) and serum 25 (OH) D were determined. Logistic regression was used to estimate the association between 25 (OH) D and prevalence of renal tubular dysfunction. No significant differences were observed in serum 25(OH) D levels among the four quartile of UCd and BCd after adjusting with cofounders. After adjusted with the confounders, the odds ratio (OR) of subjects with 25(OH) D >= 40 ng/ml were 0.20 (95%CI: 0.1-0.8) if UBMG was chosen as indicators of renal dysfunction and 0.28 (95%CI: 0.1-1.1) if URBP was chosen as indicators of renal dysfunction, compared with those with 25(OH) D < 30 ng/ml, respectively. Similar results were observed in those subjects living in cadmium polluted areas or with high level of UCd or BCd. Our data indicated that cadmium exposure did not affect serum 25 (OH) D level and high 25 (OH) D levels were associated with a decreased risk of renal tubular dysfunction induced by cadmium.	[Chen, Xiao; Dai, Yan; Ding, Xiaoqiang] Fudan Univ, Zhongshan Hosp, Dept Nephrol, Shanghai Key Lab Kidney & Dialysis, Shanghai, Peoples R China; [Chen, Xiao; Wang, Zhongqiu] Nanjing Univ Chinese Med, Affiliated Hosp, Dept Radiol, Nanjing, Jiangsu, Peoples R China; [Zhu, Guoying] Fudan Univ, Inst Radiat Med, Shanghai, Peoples R China; [Jin, Taiyi] Fudan Univ, Sch Publ Hlth, Dept Occupat Med, Shanghai, Peoples R China	Fudan University; Nanjing University of Chinese Medicine; Fudan University; Fudan University	Ding, XQ (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Nephrol, Shanghai Key Lab Kidney & Dialysis, Shanghai, Peoples R China.; Jin, TY (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Occupat Med, Shanghai, Peoples R China.	ding_xiaoqiang@zs-hospital.sh.cn; tyjin@shmu.edu.cn			National Natural Science foundation of China [81773460, 81102148]; Natural Science Foundation of Jiangsu Province [BK20161609]; Science and Technology Commission of Shanghai Municipality [14DZ2260200]	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was funded by National Natural Science foundation of China (No. 81773460, 81102148) to XC, Natural Science Foundation of Jiangsu Province (No. BK20161609) and the Science and Technology Commission of Shanghai Municipality (14DZ2260200, the project of Shanghai Key Laboratory of Kidney and Blood Purification). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2005, KIDNEY INT, V68, P2823, DOI 10.1111/j.1523-1755.2005.00755.x; Akesson AA, 2005, ENVIRON HEALTH PERSP, V113, P1627, DOI 10.1289/ehp.8033; Brzoska MM, 2005, ARCH TOXICOL, V79, P636, DOI 10.1007/s00204-005-0680-6; Chen X, 2018, BIOL TRACE ELEM RES, V186, P114, DOI 10.1007/s12011-018-1304-3; Dancer RCA, 2015, THORAX, V70, P617, DOI 10.1136/thoraxjnl-2014-206680; Engstrom A, 2009, ENVIRON RES, V109, P188, DOI 10.1016/j.envres.2008.10.008; Engstrom A, 2012, BONE, V50, P1372, DOI 10.1016/j.bone.2012.03.018; Esteve E, 2017, J SYNCHROTRON RADIAT, V24, P991, DOI 10.1107/S1600577517009572; Farhangi MA, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0597-z; Fuchs MA, 2017, ANN ONCOL, V28, P1359, DOI 10.1093/annonc/mdx109; Gobe G, 2010, TOXICOL LETT, V198, P49, DOI 10.1016/j.toxlet.2010.04.013; Goncalves JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107228; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Jha JC, 2017, DIABETES, V66, P2691, DOI 10.2337/db16-1585; Jha JC, 2016, ANTIOXID REDOX SIGN, V25, P657, DOI 10.1089/ars.2016.6664; Jin TY, 2002, BIOMETALS, V15, P397, DOI 10.1023/A:1020229923095; Jin TY, 1999, ENVIRON RES, V81, P167, DOI 10.1006/enrs.1999.3959; Johri N, 2010, BIOMETALS, V23, P783, DOI 10.1007/s10534-010-9328-y; Jung JY, 2015, RESPIROLOGY, V20, P782, DOI 10.1111/resp.12538; KAWASHIMA H, 1988, ENVIRON RES, V46, P48, DOI 10.1016/S0013-9351(88)80058-6; Kumar V, 2017, J AM SOC NEPHROL, V28, P3100, DOI 10.1681/ASN.2017010003; LEMIRE JM, 1992, AUTOIMMUNITY, V12, P143, DOI 10.3109/08916939209150321; Letavernier E, 2016, KIDNEY INT, V90, P809, DOI 10.1016/j.kint.2016.05.027; Levin Adeera, 2017, Clin J Am Soc Nephrol, V12, P1447, DOI 10.2215/CJN.10791016; Li XH, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0378-4; Lin YS, 2014, ENVIRON RES, V134, P33, DOI 10.1016/j.envres.2014.06.013; Manucha W, 2016, THER ADV CARDIOVASC; Mihajlovic M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122531; Munger KL, 2016, JAMA NEUROL, V73, P515, DOI 10.1001/jamaneurol.2015.4800; Namir Y, 2016, CLIN NEPHROL, V86, P165, DOI 10.5414/CN108796; Navaneethan SD, 2011, AM J KIDNEY DIS, V58, P536, DOI 10.1053/j.ajkd.2011.04.028; Nganvongpanit K, 2016, BIOL TRACE ELEM RES, V173, P21, DOI 10.1007/s12011-016-0625-3; Norman AW, 2008, AM J CLIN NUTR, V88, p491S, DOI 10.1093/ajcn/88.2.491S; Rani A, 2014, INT J ENVIRON HEAL R, V24, P378, DOI 10.1080/09603123.2013.835032; Ravani P, 2009, KIDNEY INT, V75, P88, DOI 10.1038/ki.2008.501; Rebholz CM, 2016, AM J KIDNEY DIS, V67, P235, DOI 10.1053/j.ajkd.2015.08.026; Satarug S, 2010, ENVIRON HEALTH PERSP, V118, P182, DOI 10.1289/ehp.0901234; Satirapoj B, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-206; Schwarz U, 1998, KIDNEY INT, V53, P1696, DOI 10.1046/j.1523-1755.1998.00951.x; Shi ZM, 2018, CLIN NUTR, V37, P276, DOI 10.1016/j.clnu.2016.12.025; Uchida H, 2010, TOXICOL PATHOL, V38, P730, DOI 10.1177/0192623310374328; Wang Y, 2006, KIDNEY INT, V70, P882, DOI 10.1038/sj.ki.5001624; WHO/ICPS, 1992, 134 WHOIPCS, P1; Wu F, 2017, ANN MED, V7, P1, DOI [10.1080/07853890.2017.1399446, DOI 10.1080/07853890]; Yin K, 2014, J INFLAMM RES, V7, P69, DOI 10.2147/JIR.S63898; Zamoiski RD, 2014, ENVIRON HEALTH PERSP, V122, P1233, DOI 10.1289/ehp.1307861	47	6	8	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195682	10.1371/journal.pone.0195682	http://dx.doi.org/10.1371/journal.pone.0195682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634781	Green Submitted, gold, Green Published			2022-12-26	WOS:000429522200048
J	Carrasco, SE; Hu, SS; Mai, DM; Kumar, R; Sandusky, GE; Yang, XF; Derbigny, WA				Carrasco, Sebastian E.; Hu, Sishun; Mai, Denise M.; Kumar, Ramesh; Sandusky, George E.; Yang, X. Frank; Derbigny, Wilbert A.			Toll-like receptor 3 (TLR3) promotes the resolution of Chlamydia muridarum genital tract infection in congenic C57BL/6N mice	PLOS ONE			English	Article							MOUSE PNEUMONITIS BIOVAR; DOUBLE-STRANDED-RNA; CD8(+) T-CELLS; GAMMA-INTERFERON; IFN-BETA; IMMUNE-RESPONSE; TRACHOMATIS; PATHOLOGY; PROTEIN; INHIBITION	Chlamydia trachomatis urogenital serovars primarily replicate in epithelial cells lining the reproductive tract. Epithelial cells recognize Chlamydia through cell surface and cytosolic receptors, and/or endosomal innate receptors such as Toll-like receptors (TLRs). Activation of these receptors triggers both innate and adaptive immune mechanisms that are required for chlamydial clearance, but are also responsible for the immunopathology in the reproductive tract. We previously demonstrated that Chlamydia muridarum (Cm) induces IFN-beta in oviduct epithelial cells (OE) in a TLR3(-/-)dependent manner, and that the synthesis of several cytokines and chemokines are diminished in Cm-challenged OE derived from TLR3-/129S1 mice. Furthermore, our in vitro studies showed that Cm replication in TLR3(-/-) OE is more efficient than in wild-type OE. Because TLR3 modulates the release inflammatory mediators involved in host defense during Cm infection, we hypothesized that TLR3 plays a protective role against Cm-induced genital tract pathology in congenic C57BU6N mice. Using the Cm mouse model for human Chlamydia genital tract infections, we demonstrated that TLR3(-/-) mice had increased Cm shedding during early and mid-stage genital infection. In early stage infection, TLR3(-/-) mice showed a diminished synthesis of IFN-beta, IL-1 beta, and IL-6, but enhanced production of IL-10, TNF-alpha, and IFN-gamma. In mid-stage infection, TLR3(-/-) mice exhibited significantly enhanced lymphocytic endometritis and salpingitis than wild-type mice. These lymphocytes were predominantly scattered along the endometrial stroma and the associated smooth muscle, and the lamina propria supporting the oviducts. Surprisingly, our data show that CD4(+) T-cells are significantly enhanced in the genital tract TLR3-/- mice during mid-stage Chlamydia/infection. In late-stage infections, both mouse strains developed hydrosalpinx; however, the extent of hydrosalpinx was more severe in TLR3(-/-) mice. Together, these data suggest that TLR3 promotes the clearance of Cm during early and mid-stages of genital tract infection, and that loss of TLR3 is detrimental in the development hydrosalpinx.	[Carrasco, Sebastian E.; Mai, Denise M.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Carrasco, Sebastian E.; Mai, Denise M.] Univ Calif Davis, Comparat Pathol Lab, Davis, CA 95616 USA; [Carrasco, Sebastian E.; Hu, Sishun; Kumar, Ramesh; Yang, X. Frank; Derbigny, Wilbert A.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Hu, Sishun] Huazhong Agr Univ, Coll Vet Med, Wuhan, Hubei, Peoples R China; [Sandusky, George E.] Indiana Univ Sch Med, Dept Pathol, Indianapolis, IN 46202 USA	University of California System; University of California Davis; University of California System; University of California Davis; Indiana University System; Indiana University Bloomington; Huazhong Agricultural University; Indiana University System; Indiana University Bloomington	Derbigny, WA (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	wderbign@iupui.edu	Kumar, Ramesh/U-8358-2019; Kumar, Ramesh/A-8258-2019		National Institutes of Health [1K22AI072072, 1R01AI104944]; National Institute of Health's, NRSA, Immunology and Infectious Disease Program at IUSM [T32 AI 060519]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104944] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health's, NRSA, Immunology and Infectious Disease Program at IUSM; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants 1K22AI072072 and 1R01AI104944 (W.A.D.). S.E.C. was supported by the National Institute of Health's, NRSA T32 AI 060519, Immunology and Infectious Disease Program at IUSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Belair C, 2009, CLIN MICROBIOL INFEC, V15, P806, DOI 10.1111/j.1469-0691.2009.02960.x; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Bsibsi M, 2010, J IMMUNOL, V184, P6929, DOI 10.4049/jimmunol.0902419; Bulut Y, 2002, J IMMUNOL, V168, P1435, DOI 10.4049/jimmunol.168.3.1435; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Carey AJ, 2009, IMMUNOL CELL BIOL, V87, P337, DOI 10.1038/icb.2009.3; Chen JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095076; Chen LL, 2010, J IMMUNOL, V184, P2602, DOI 10.4049/jimmunol.0901593; Chin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046949; Cotter TW, 1997, INFECT IMMUN, V65, P2145, DOI 10.1128/IAI.65.6.2145-2152.1997; Cunningham K, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-50; Darville T, 2000, INFECT IMMUN, V68, P5299, DOI 10.1128/IAI.68.9.5299-5305.2000; Darville T, 2003, J IMMUNOL, V171, P6187, DOI 10.4049/jimmunol.171.11.6187; Darville T, 1997, INFECT IMMUN, V65, P3065, DOI 10.1128/IAI.65.8.3065-3073.1997; Darville T, 2001, INFECT IMMUN, V69, P7419, DOI 10.1128/IAI.69.12.7419-7424.2001; Darville T, 2001, INFECT IMMUN, V69, P3556, DOI 10.1128/IAI.69.6.3556-3561.2001; Darville T, 2010, J INFECT DIS, V201, pS114, DOI 10.1086/652397; De Clercq E, 2013, INFECT IMMUN, V81, P3060, DOI 10.1128/IAI.00357-13; DELAMAZA LM, 1994, INFECT IMMUN, V62, P2094, DOI 10.1128/IAI.62.5.2094-2097.1994; Derbigny WA, 2005, J IMMUNOL, V175, P6065, DOI 10.4049/jimmunol.175.9.6065; Derbigny WA, 2012, INFECT IMMUN, V80, P254, DOI 10.1128/IAI.05549-11; Derbigny WA, 2010, J IMMUNOL, V185, P6689, DOI 10.4049/jimmunol.1001548; Elwell C, 2016, NAT REV MICROBIOL, V14, P385, DOI 10.1038/nrmicro.2016.30; Giannitti F, 2016, J VET DIAGN INVEST, V28, P184, DOI 10.1177/1040638715625729; Hakimi H, 2014, INFLAMMATION, V37, P818, DOI 10.1007/s10753-013-9801-1; Hosey KL, 2015, J INTERF CYTOK RES, V35, P901, DOI 10.1089/jir.2015.0013; Huang Y, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/297686; Igietseme Joseph U., 1993, Regional Immunology, V5, P317; Igietseme JU, 1996, IMMUNOLOGY, V88, P1, DOI 10.1046/j.1365-2567.1996.d01-655.x; Igietseme JU, 1996, J LEUKOCYTE BIOL, V59, P656, DOI 10.1002/jlb.59.5.656; Ito JI, 1999, INFECT IMMUN, V67, P5518, DOI 10.1128/IAI.67.10.5518-5521.1999; Jiang JN, 2012, JOVE-J VIS EXP, DOI 10.3791/4391; Jin HL, 2008, FEBS LETT, V582, P2679, DOI 10.1016/j.febslet.2008.06.053; Johnson RM, 2016, INFECT IMMUN, V84, P868, DOI 10.1128/IAI.01378-15; Johnson RM, 2014, IMMUNOLOGY, V142, P248, DOI 10.1111/imm.12248; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063340; Johnson RM, 2012, J IMMUNOL, V188, P1896, DOI 10.4049/jimmunol.1102764; Johnson RM, 2004, INFECT IMMUN, V72, P3951, DOI 10.1128/IAI.72.7.3951-3960.2004; Kelly KA, 1996, INFECT IMMUN, V64, P4976, DOI 10.1128/IAI.64.12.4976-4983.1996; Kelly KA, 1997, INFECT IMMUN, V65, P5198, DOI 10.1128/IAI.65.12.5198-5208.1997; Kol A, 1999, J CLIN INVEST, V103, P571, DOI 10.1172/JCI5310; Lee HY, 2010, FEMS IMMUNOL MED MIC, V59, P108, DOI 10.1111/j.1574-695X.2010.00668.x; Manam S, 2013, PATHOG DIS, V67, P221, DOI 10.1111/2049-632X.12032; Marks E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001179; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; Medoff BD, 2005, ANN NY ACAD SCI, V1062, P220, DOI 10.1196/annals.1358.026; Mori H, 2015, TOXICOL PATHOL, V43, P883, DOI 10.1177/0192623315587593; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; MORRISON RP, 1995, INFECT IMMUN, V63, P4661, DOI 10.1128/IAI.63.12.4661-4668.1995; Morrison SG, 2000, INFECT IMMUN, V68, P2870, DOI 10.1128/IAI.68.5.2870-2879.2000; Morrison SG, 2000, INFECT IMMUN, V68, P6979, DOI 10.1128/IAI.68.12.6979-6987.2000; Murthy AK, 2011, INFECT IMMUN, V79, P2928, DOI 10.1128/IAI.05022-11; Nagarajan UM, 2005, J IMMUNOL, V175, P450, DOI 10.4049/jimmunol.175.1.450; Nagarajan UM, 2011, INFECT IMMUN, V79, P486, DOI 10.1128/IAI.00843-10; O'Connell CM, 2006, J BIOL CHEM, V281, P1652, DOI 10.1074/jbc.M510182200; Perales-Linares R, 2013, IMMUNOLOGY, V140, P153, DOI 10.1111/imm.12143; Perry LL, 1997, J IMMUNOL, V158, P3344; Prantner D, 2011, INFECT IMMUN, V79, P3922, DOI 10.1128/IAI.00140-11; Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704; Prantner D, 2009, INFECT IMMUN, V77, P5334, DOI 10.1128/IAI.00883-09; Prebeck S, 2003, MICROBES INFECT, V5, P463, DOI 10.1016/S1286-4579(03)00063-7; RANK RG, 1985, INFECT IMMUN, V48, P847, DOI 10.1128/IAI.48.3.847-849.1985; RANK RG, 1992, INFECT IMMUN, V60, P4427, DOI 10.1128/IAI.60.10.4427-4429.1992; Rasmussen SJ, 1997, J CLIN INVEST, V99, P77, DOI 10.1172/JCI119136; Redgrove KA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00534; Rey-Ladino J, 2014, HUM VACC IMMUNOTHER, V10, P2664, DOI 10.4161/hv.29683; Schachter J, 1980, PSITTACOSIS LYMPHOGR; Shah AA, 2005, SEX TRANSM DIS, V32, P49, DOI 10.1097/01.olq.0000148299.14513.11; Slade JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160511; SU H, 1995, INFECT IMMUN, V63, P3302, DOI 10.1128/IAI.63.9.3302-3308.1995; Sun X, 2017, MICROBES INFECT, V19, P536, DOI 10.1016/j.micinf.2017.08.007; Tang LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060345; Taylor DR, 1999, SCIENCE, V285, P107, DOI 10.1126/science.285.5424.107; Vlcek KR, 2016, IMMUNOL CELL BIOL, V94, P208, DOI 10.1038/icb.2015.74; Welter-Stahl L, 2006, CELL MICROBIOL, V8, P1047, DOI 10.1111/j.1462-5822.2006.00686.x; WHO, 2012, REG STRAT FRAM EL KA, P20; Wilson EB, 2011, CURR TOP MICROBIOL, V350, P39, DOI 10.1007/82_2010_96; Yang CF, 2015, MBIO, V6, DOI 10.1128/mBio.01648-15; Zuniga EI, 2008, CELL HOST MICROBE, V4, P374, DOI 10.1016/j.chom.2008.08.016	83	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195165	10.1371/journal.pone.0195165	http://dx.doi.org/10.1371/journal.pone.0195165			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624589	Green Published, gold, Green Submitted			2022-12-26	WOS:000429379600016
J	Choi, HY; Oh, J; Kim, S				Choi, Hae-young; Oh, Jina; Kim, Sung			Genetic identification of eggs from four species of Ophichthidae and Congridae (Anguilliformes) in the northern East China Sea	PLOS ONE			English	Article							EEL ANGUILLA-JAPONICA; MARINE FISH EGGS; JAPANESE EEL; SPAWNING AREA; BIRTH DATE; LEPTOCEPHALI; PACIFIC; AGE; ICHTHYOPLANKTON; DISCOVERY	We report the first genetic identification of eggs of four species of Anguilliformes caught in the northern East China Sea during August 2016, where leptocephali and adults have been collected. The species were Ophisurus macrorhynchos and Echelus uropterus belonging to the Ophichthidae, and Ariosoma majus and Gnathophis heterognathos belonging to the Congridae. The eggs were identified using three molecular genetic markers (mitochondrial 12S rRNA, 16S rRNA, and cytochrome c oxidase subunit 1), sequences obtained from local adult specimens, and geographical distribution data. All eggs were in the early or middle developmental stages. For all species except A. majus, the eggs were found near the range of small leptocephali in the East China Sea and the southern Korean Peninsula, which indicates these species had spawned along the continental near these areas during the summer.	[Choi, Hae-young; Oh, Jina; Kim, Sung] Korea Inst Ocean Sci & Technol, Marine Ecosyst & Biol Res Ctr, Busan Metropolitan City, South Korea; [Choi, Hae-young; Kim, Sung] Korea Univ Sci & Technol, Marine Biol, Daejeon, South Korea	Korea Institute of Ocean Science & Technology (KIOST); University of Science & Technology (UST)	Kim, S (corresponding author), Korea Inst Ocean Sci & Technol, Marine Ecosyst & Biol Res Ctr, Busan Metropolitan City, South Korea.; Kim, S (corresponding author), Korea Univ Sci & Technol, Marine Biol, Daejeon, South Korea.	skim@kiost.ac.kr			Korea Institute of Ocean Science and Technology [PE99513, PE99663]	Korea Institute of Ocean Science and Technology	This work received support from the Korea Institute of Ocean Science and Technology (PE99513, PE99663 to SK) http://www.kiost.ac.kr/kor.do. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1989, FISHES W N ATLANTIC; Aoyama J, 2001, FISHERIES SCI, V67, P761, DOI 10.1046/j.1444-2906.2001.00288.x; Asano Hirotoshi, 1997, Memoirs of the Faculty of Agriculture of Kinki University, V30, P19; Chow S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121801; Eschmeyer W.N., 2017, CATALOG FISHES GENER; Espeland SH, 2017, ICES J MAR SCI; Fox CJ, 2008, P ROY SOC B-BIOL SCI, V275, P1543, DOI 10.1098/rspb.2008.0201; Han Song-Hun, 2015, [Korean Journal of Ichthyology, 한국어류학회지], V27, P284; Harada AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134647; Hatooka K, 2013, FISHES JAPAN PICTORI, P266; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; Ji Hwan-Sung, 2015, Bulletin of the Korean Society of Fisheries Technology, V51, P527; Ji Hwan-Sung, 2014, Korean Journal of Fisheries and Aquatic Sciences, V47, P888; Kawakami T, 2010, ENVIRON BIOL FISH, V87, P221, DOI 10.1007/s10641-010-9592-2; Kim IS, 2005, ILLUSTRATED BOOK KOR; 지환성, 2011, [Korean Journal of Ichthyology, 한국어류학회지], V23, P217; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kimura Y, 2006, FISH OCEANOGR, V15, P183, DOI 10.1111/j.1365-2419.2005.00383.x; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kurogi H, 2012, FISHERIES SCI, V78, P525, DOI 10.1007/s12562-012-0468-6; Lewis LA, 2016, FISH B-NOAA, V114, P153, DOI 10.7755/FB.114.2.3; Lie HJ, 2016, PROG OCEANOGR, V146, P121, DOI 10.1016/j.pocean.2016.06.004; Lin HY, 2016, CONT SHELF RES, V126, P64, DOI 10.1016/j.csr.2016.07.016; Ma T, 2005, J FISH BIOL, V67, P1619, DOI 10.1111/j.1095-8649.2005.00868.x; Ma T, 2008, COAST MAR SCI, V32, P48; Miller MJ, 2002, MAR ECOL PROG SER, V235, P279, DOI 10.3354/meps235279; MILLER MJ, 2004, INTRO LEPTOCEPHALI B; Minagawa G, 2007, ESTUAR COAST SHELF S, V71, P730, DOI 10.1016/j.ecss.2006.06.018; Miyazaki S, 2011, MAR BIOL, V158, P2555, DOI 10.1007/s00227-011-1756-x; Palumbi S. R., 1996, MOL SYSTEMATICS, V2, P205, DOI DOI 10.1080/17451000.2014.902536; PAULY D, 1988, ENVIRON BIOL FISH, V22, P261, DOI 10.1007/BF00004892; Qu TD, 2003, J PHYS OCEANOGR, V33, P5, DOI 10.1175/1520-0485(2003)033<0005:TBOTNE>2.0.CO;2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schlitzer R., 2021, OCEAN DATA VIEW VS 5; Shao KT, 2002, MAR FRESHWATER RES, V53, P355, DOI 10.1071/MF01141; TSUKAMOTO K, 1989, NIPPON SUISAN GAKK, V55, P1023; Tsukamoto K, 2006, NATURE, V439, P929, DOI 10.1038/439929a; TSUKAMOTO K, 1992, NATURE, V356, P789, DOI 10.1038/356789a0; Tsukamoto K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1174; UMEZAWA A, 1990, NIPPON SUISAN GAKK, V56, P1199; Valdez-Moreno M, 2010, MAR FRESHWATER RES, V61, P665, DOI 10.1071/MF09222; Yoshinaga T, 2011, FISHERIES SCI, V77, P983, DOI 10.1007/s12562-011-0418-8	43	6	6	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195382	10.1371/journal.pone.0195382	http://dx.doi.org/10.1371/journal.pone.0195382			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621326	Green Published, gold, Green Submitted			2022-12-26	WOS:000429206800073
J	Kreft, D; McGuinness, MB; Doblhammer, G; Finger, RP				Kreft, Daniel; McGuinness, Myra B.; Doblhammer, Gabriele; Finger, Robert P.			Diabetic retinopathy screening in incident diabetes mellitus type 2 in Germany between 2004 and 2013-A prospective cohort study based on health claims data	PLOS ONE			English	Article							FOLLOW-UP; CARE; PREVALENCE; GUIDELINES; OUTCOMES; ACCESS; LASER	Objective To assess factors associated with diabetic retinopathy (DR) screening uptake following a diagnosis of type 2 diabetes mellitus (type 2 diabetes) in Germany. Materials and methods A nationally representative prospective sample of individual-level health claims data for 250,000 members from Germany's largest public insurance provider in 2004-2013 was assessed. In the sample, 26,560 persons with incident type 2 diabetes were identified. Factors associated with subsequent DR screening were assessed using descriptive statistics, Kaplan-Meier estimator, and Cox regression analysis. Results On average 27.6 visits to an ophthalmologist per 100 person-years in persons with incident type 2 diabetes occurred. Half of all incident cases (Kaplan-Meier estimator) had not seen an ophthalmologist after more than two years (2.25 years) following their diabetes diagnosis. In the multivariate analysis, an older age (from hazard ratio HR(70-74) = 0.93 [95%-CI: 0.89-0.97] to HR(90+) = 0.50 [95%-CI: 0.42-0.60] compared to persons aged 50-69 years) and a higher disability level (i.e. HR(disability level 3) = 0.30 [95%-CI: 0.25-0.36]) were associated with a lower likelihood, while female sex (HR =1.12 [95%-CI: 1.08-1.15]), six or more comorbidities (HR = 1.26 [95%-CI: 1.15-1.37]), moderate (HR = 1.51 [95%-CI: 1.461.56]) or severe type 2 diabetes (HR = 1.53 [95%-CI: 1.45-1.61]) as well as being enrolled in a type 2 diabetes disease management program (HR = 1.78 [95%-CI: 1.69-1.87]) were associated with a higher likelihood of DR screening. Conclusions A high proportion of newly diagnosed persons with type 2 diabetes did not follow current German recommendations for DR screening, impeding timely detection and management of potential complications. This was more apparent among persons who were men, older or had a disability. The uptake of screening was considerably greater among those enrolled in a diseases management program. These factors need to be considered when planning DR screening services and/or referrals.	[Kreft, Daniel; Doblhammer, Gabriele] Rostock Ctr Study Demog Change, Rostock, Germany; [Kreft, Daniel; Doblhammer, Gabriele] Univ Rostock, Inst Sociol & Demog, Empir Methods Social Sci & Demog, Rostock, Germany; [McGuinness, Myra B.] Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Australia; [McGuinness, Myra B.] Univ Melbourne, Dept Surg, Ophthalmol, Melbourne, Vic, Australia; [Doblhammer, Gabriele] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Finger, Robert P.] Univ Bonn, Dept Ophthalmol, Ophthalm Epidemiol, Bonn, Germany	University of Rostock; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn	Finger, RP (corresponding author), Univ Bonn, Dept Ophthalmol, Ophthalm Epidemiol, Bonn, Germany.	Robert.finger@ukbonn.de	McGuinness, Myra/G-4900-2017	McGuinness, Myra/0000-0002-5422-040X; Finger, Robert P/0000-0003-4253-7597				[Anonymous], 1990, Arch Ophthalmol, V108, P958; [Anonymous], 2015, TYPE 2 DIABETES ADUL; Bundesarztekammer (BAK) Kassenarztliche Bundesvereinigung (KBV) Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), 2015, NAT VERSORGUNGSLEITL; Byun SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062991; Cavan D, 2017, DIABETES RES CLIN PR, V129, P16, DOI 10.1016/j.diabres.2017.03.023; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Elman MJ, 2011, OPHTHALMOLOGY, V118, P609, DOI 10.1016/j.ophtha.2010.12.033; FERRIS FL, 1993, JAMA-J AM MED ASSOC, V269, P1290, DOI 10.1001/jama.269.10.1290; Fink A, 2014, SERIES POPULATION ST, P109; Fuchs S, 2014, DTSCH ARZTEBL INT, V111, P453, DOI 10.3238/arztebl.2014.0453; Gulliford MC, 2010, DIABETIC MED, V27, P282, DOI 10.1111/j.1464-5491.2010.02946.x; Hoffmann F, 2017, GESUNDHEITSWESEN, V79, pe1, DOI 10.1055/s-0035-1564074; HURWITZ B, 1993, BRIT MED J, V306, P624, DOI 10.1136/bmj.306.6878.624; Hwang J, 2015, CAN J OPHTHALMOL, V50, P119, DOI 10.1016/j.jcjo.2014.11.014; Jani PD, 2017, JAMA OPHTHALMOL; Javitt JC, 1996, ANN INTERN MED, V124, P164, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00017; Knight K, 2005, AM J MANAG CARE, V11, P242; Kraft SK, 1997, ARCH FAM MED, V6, P29, DOI 10.1001/archfami.6.1.29; Lake AJ, 2017, J DIABETES COMPLICAT, V31, P997, DOI 10.1016/j.jdiacomp.2017.02.020; Lawrenson JG, 2016, COCHRANE DATABASE SY; Leese GP, 2008, DIABETES CARE, V31, P2131, DOI 10.2337/dc08-1098; Millett C, 2006, J MED SCREEN, V13, P152, DOI 10.1258/096914106778440608; Mitchell P., 2008, GUIDELINES MANAGEMEN; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; Mukamel D B, 1999, Ophthalmic Epidemiol, V6, P61; NAJI S, 1994, BRIT MED J, V308, P1208; Olafsdottir E, 2007, ACTA OPHTHALMOL SCAN, V85, P40, DOI 10.1111/j.1600-0420.2006.00753.x; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Piette JD, 2001, DIABETES CARE, V24, P202, DOI 10.2337/diacare.24.2.202; Ponto KA, 2016, DIABETOLOGIA, V59, P1913, DOI 10.1007/s00125-016-4013-5; Rosenberg JB, 2011, J DIABETES COMPLICAT, V25, P222, DOI 10.1016/j.jdiacomp.2010.11.001; Saadine JB, 2008, RETINA-J RET VIT DIS, V28, P195, DOI 10.1097/IAE.0b013e318115169a; Sloan FA, 2009, OPHTHALMOLOGY, V116, P1515, DOI 10.1016/j.ophtha.2009.03.010; Tikellis G, 2008, DIABETES RES CLIN PR, V80, P208, DOI 10.1016/j.diabres.2007.11.017; Wang F, 1996, OPHTHALMOLOGY, V103, P1744, DOI 10.1016/S0161-6420(96)30432-6; World Health Organization, 2005, PREV BLINDN DIAB MEL; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Ziemssen F, 2016, OPHTHALMOLOGE, V113, P623, DOI 10.1007/s00347-016-0315-8	38	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195426	10.1371/journal.pone.0195426	http://dx.doi.org/10.1371/journal.pone.0195426			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621309	Green Published, gold			2022-12-26	WOS:000429206800078
J	Ma, RD; Yuan, HL; An, J; Hao, XY; Li, HB				Ma, Rendi; Yuan, Hali; An, Jing; Hao, Xiaoyun; Li, Hongbin			A Gossypium hirsutum GDSL lipase/hydrolase gene (GhGLIP) appears to be involved in promoting seed growth in Arabidopsis	PLOS ONE			English	Article							SUCROSE SYNTHASE GENE; COTTON FIBER YIELD; LIPASE GENE; EXPRESSION ANALYSIS; CELL ELONGATION; BRASSICA-NAPUS; OVEREXPRESSION; RESISTANCE; ETHYLENE; QUALITY	GDSL lipase (GLIP) plays a pivotal role in plant cell growth as a multifunctional hydrolytic enzyme. Herein, a cotton (Gossypium hirsutum L. cv Xuzhou 142) GDSL lipase gene (GhGLIP) was obtained from developing ovules and fibers. The GhGLIP cDNA contained an open reading frame (ORF) of 1,143 base pairs (bp) and encodes a putative polypeptide of 380 amino acid residues. Sequence alignment indicated that GhGLIP includes four enzyme catalytic amino acid residue sites of Ser (S), Gly (G), Asn (N) and His (H), located in four conserved blocks. Phylogenetic tree analysis showed that GhGLIP belongs to the typical class IV lipase family with potential functions in plant secondary metabolism. Subcellular distribution analysis demonstrated that GhGLIP localized to the nucleus, cytoplasm and plasma membrane. GhGLIP was expressed predominantly at 5-15 day post anthesis (dpa) in developing ovules and elongating fibers, measured as mRNA levels and enzyme activity. Ectopic overexpression of GhGLIP in Arabidopsis plants resulted in enhanced seed development, including length and fresh weight. Meanwhile, there was increased soluble sugar and protein storage in transgenic Arabidopsis plants, coupled with the promotion of lipase activity. Moreover, the expression of cotton GhGLIP is induced by ethylene (ETH) treatment in vitro. A 1,954-bp GhGLIP promoter was isolated and expressed high activity in driving green fluorescence protein (GFP) expression in tobacco leaves. Cis-acting element analysis of the GhGLIP promoter (pGhGLIP) indicated the presence of an ethylene-responsive element (ERE), and transgenic tobacco leaves with ectopic expression of pGhGLIP::GFPGUS showed increased GUS activity after ETH treatment. In summary, these results suggest that GhGLIP is a functional enzyme involved in ovule and fiber development and performs significant roles in seed development.	[Ma, Rendi; Yuan, Hali; An, Jing; Hao, Xiaoyun; Li, Hongbin] Shihezi Univ, Coll Life Sci, Key Lab Agrobiotechnol, Shihezi, Xinjiang, Peoples R China; [Li, Hongbin] Shihezi Univ, Minist Educ, Key Lab Xinjiang Phytomed Resource Utilizat, Shihezi, Xinjiang, Peoples R China	Shihezi University; Shihezi University	Li, HB (corresponding author), Shihezi Univ, Coll Life Sci, Key Lab Agrobiotechnol, Shihezi, Xinjiang, Peoples R China.; Li, HB (corresponding author), Shihezi Univ, Minist Educ, Key Lab Xinjiang Phytomed Resource Utilizat, Shihezi, Xinjiang, Peoples R China.	lihb@shzu.edu.cn			National Natural Science Foundation of China [31660408, 31260339]; Scientific and Technological Achievement Transformation Project of Bingtuan [2016AC017]; Distinguished Youth innovation foundation of Bingtuan [2014CD003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Achievement Transformation Project of Bingtuan; Distinguished Youth innovation foundation of Bingtuan	This work was supported by grants from National Natural Science Foundation of China (Grant number 31660408, 31260339), Scientific and Technological Achievement Transformation Project of Bingtuan (Grant number 2016AC017), and Distinguished Youth innovation foundation of Bingtuan (Grant number 2014CD003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agee AE, 2010, PLANT PHYSIOL, V152, P120, DOI 10.1104/pp.109.145078; Applequist WL, 2001, EVOL DEV, V3, P3, DOI 10.1046/j.1525-142x.2001.00079.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen MX, 2012, PLANT CELL ENVIRON, V35, P2155, DOI 10.1111/j.1365-3040.2012.02546.x; Chepyshko H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-309; Clauss K, 2011, PLANT PHYSIOL, V155, P1127, DOI 10.1104/pp.110.169821; de la Torre F, 2002, PLANT PHYSIOL, V128, P247, DOI 10.1104/pp.010508; Dong X, 2016, MOL GENET GENOMICS, V291, P531, DOI 10.1007/s00438-015-1123-6; Angeles-Nunez JG, 2010, PLANTA, V232, P701, DOI 10.1007/s00425-010-1207-9; Gialvalis S., 2001, Journal of Cotton Science, V5, P252; Girard AL, 2012, PLANT CELL, V24, P3119, DOI 10.1105/tpc.112.101055; Han P, 2008, PLANT CELL, V20, P1482, DOI 10.1105/tpc.108.058867; Hong JK, 2008, PLANTA, V227, P539, DOI 10.1007/s00425-007-0637-5; Ji SJ, 2003, NUCLEIC ACIDS RES, V31, P2534, DOI 10.1093/nar/gkg358; Jiang YJ, 2012, PLANT BIOTECHNOL J, V10, P301, DOI 10.1111/j.1467-7652.2011.00662.x; Kim KJ, 2008, BIOCHEM BIOPH RES CO, V374, P693, DOI 10.1016/j.bbrc.2008.07.120; Kondou Y, 2008, PLANT PHYSIOL, V147, P1924, DOI 10.1104/pp.108.118364; Kram BW, 2008, PLANT MOL BIOL, V68, P173, DOI 10.1007/s11103-008-9361-1; Kwon SJ, 2009, PLANT J, V58, P235, DOI 10.1111/j.1365-313X.2008.03772.x; Lai CP, 2017, PLANT MOL BIOL, V95, P181, DOI 10.1007/s11103-017-0648-y; Lee DS, 2009, BIOCHEM BIOPH RES CO, V379, P1038, DOI 10.1016/j.bbrc.2009.01.006; Li HB, 2007, NEW PHYTOL, V175, P462, DOI 10.1111/j.1469-8137.2007.02120.x; Li R, 2017, INT J MOL SCI, V18; Ling H, 2006, J BIOCHEM MOL BIOL, V39, P297; Mikleusevic G, 2009, CROAT CHEM ACTA, V82, P439; Oh IS, 2005, PLANT CELL, V17, P2832, DOI 10.1105/tpc.105.034819; Park JJ, 2010, PLANT MOL BIOL, V74, P91, DOI 10.1007/s11103-010-9656-x; Procopio L, 2013, ANTON LEEUW INT J G, V103, P635, DOI 10.1007/s10482-012-9847-3; Pugh DA, 2010, MOL PLANT, V3, P1075, DOI 10.1093/mp/ssq054; Qian Zhen, 2007, Biotechnology Journal, V2, P192, DOI 10.1002/biot.200600186; Qin YM, 2005, CELL RES, V15, P465, DOI 10.1038/sj.cr.7290315; Qin YM, 2007, PLANT CELL, V19, P3692, DOI 10.1105/tpc.107.054437; Qin YM, 2007, J EXP BOT, V58, P473, DOI 10.1093/jxb/erl218; Riemann M, 2007, PLANT BIOLOGY, V9, P32, DOI 10.1055/s-2006-924561; Ruan YL, 2005, SEED SCI RES, V15, P269, DOI 10.1079/SSR2005217; Ruan YL, 2003, PLANT CELL, V15, P952, DOI 10.1105/tpc.010108; Ruan YL, 2008, FUNCT PLANT BIOL, V35, P382, DOI 10.1071/FP08017; Ruan YL, 2013, J INTEGR PLANT BIOL, V55, P572, DOI 10.1111/jipb.12074; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Sunilkumar G, 2006, P NATL ACAD SCI USA, V103, P18054, DOI 10.1073/pnas.0605389103; Tan XL, 2014, PROTEIN J, V33, P18, DOI 10.1007/s10930-013-9532-z; Tang LL, 2013, PLANT PHYSIOL BIOCH, V71, P22, DOI 10.1016/j.plaphy.2013.06.024; Updegraff EP, 2009, SEX PLANT REPROD, V22, P197, DOI 10.1007/s00497-009-0104-5; Xiao YH, 2010, J PLANT PHYSIOL, V167, P829, DOI 10.1016/j.jplph.2010.01.003; Xin S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161695; Xu SM, 2012, MOL PLANT, V5, P430, DOI 10.1093/mp/ssr090; Yadav VK, 2017, PLANT BIOTECHNOL J, V15, P1163, DOI 10.1111/pbi.12706; Zhang M, 2011, NAT BIOTECHNOL, V29, P453, DOI 10.1038/nbt.1843; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602; Zhao J, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0232-6	50	12	13	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195556	10.1371/journal.pone.0195556	http://dx.doi.org/10.1371/journal.pone.0195556			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621331	Green Published, Green Submitted, gold			2022-12-26	WOS:000429206800102
J	Philip, P; Bioulac, S; Altena, E; Morin, CM; Ghorayeb, I; Coste, O; Monteyrol, PJ; Micoulaud-Franchi, JA				Philip, Pierre; Bioulac, Stephanie; Altena, Elemarije; Morin, Charles M.; Ghorayeb, Imad; Coste, Olivier; Monteyrol, Pierre-Jean; Micoulaud-Franchi, Jean-Arthur			Specific insomnia symptoms and self-efficacy explain CPAP compliance in a sample of OSAS patients	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; OBSTRUCTIVE SLEEP-APNEA; LONG-TERM ADHERENCE; THERAPY; AGE; PREDICTORS; ASSOCIATION; VALIDATION; MEDICATION; VETERANS	This study explores the association between specific insomnia symptoms (sleep onset, sleep maintenance and early morning awakenings symptoms) and self-efficacy (perceived self-confidence in the ability to use CPAP) with CPAP compliance in French patients with obstructive sleep apnea syndrome (OSAS). We performed a retrospective, cross-sectional analysis of CPAP compliance in a cohort of 404 patients diagnosed with OSAS. Patients completed mailed questionnaires on sleepiness (ESS), insomnia (ISI) and self-efficacy in sleep apnea (SEMSA). Linear regression modeling analyses were performed to explore the impact of measured variables on the number of hours of CPAP use. Of the initial pool of 404 patients, 288 returned the questionnaires (71% response rate). Their mean age was 63.16 +/- 12.73 yrs, 31% were females, mean BMI was 30.39 6.31 kg/m(2), mean daily CPAP use was 6.19 +/- 2.03 h, mean number of years of use was 6.58 6.03 yrs, and mean initial AHI before CPAP use was 34.61 +/- 20.71 /h. Age (p<0.01), BMI (p<0.01), sleep onset insomnia symptoms (p<0.01), sleep maintenance insomnia symptoms (p<0.01) and self-efficacy (p<0.01) were significantly associated with mean daily CPAP use. We found that specific insomnia symptoms and self-efficacy were associated with CPAP compliance. Our findings underline the need to demonstrate that interventions that reduce insomnia symptoms and improve self-efficacy will increase CPAP compliance.	[Philip, Pierre; Bioulac, Stephanie; Ghorayeb, Imad; Coste, Olivier; Monteyrol, Pierre-Jean; Micoulaud-Franchi, Jean-Arthur] CHU Bordeaux, Clin Sommeil, Serv Explorat Fonct Syst Nerveux, Bordeaux, France; [Philip, Pierre; Bioulac, Stephanie; Altena, Elemarije; Micoulaud-Franchi, Jean-Arthur] Univ Bordeaux, SANPSY, Bordeaux, France; [Philip, Pierre; Bioulac, Stephanie; Altena, Elemarije; Micoulaud-Franchi, Jean-Arthur] SANPSY, CNRS, Bordeaux, France; [Morin, Charles M.] Univ Laval, 2325 Rue Univ, Quebec City, PQ G1V 0A6, Canada; [Morin, Charles M.] Inst Univ Sante Mentale Quebec, Ctr Rech CERVO, Quebec City, PQ, Canada; [Ghorayeb, Imad] Inst Neurosci Cognit & Integrat Aquitaine, CNRS, Bordeaux, France; [Ghorayeb, Imad] Univ Bordeaux, Inst Neurosci Cognit & Integrat Aquitaine, Bordeaux, France	CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Laval University; Laval University; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Philip, P (corresponding author), CHU Bordeaux, Clin Sommeil, Serv Explorat Fonct Syst Nerveux, Bordeaux, France.; Philip, P (corresponding author), Univ Bordeaux, SANPSY, Bordeaux, France.; Philip, P (corresponding author), SANPSY, CNRS, Bordeaux, France.	pr.philip@free.com	Morin, Charles M./A-4700-2008	Morin, Charles M./0000-0002-8649-8895; PHILIP, Pierre/0000-0003-3267-634X; MICOULAUD-FRANCHI, Jean-Arthur/0000-0002-5203-8444; Altena, Ellemarije/0000-0002-8882-7963; bioulac, stephanie/0000-0003-2618-4234				[Adult Obstructive Sleep Apnea Task Force of SPLF Societe francaise de recherche et de medecine du sommeil Societe francaise d'ORL Societe francaise de medecine du travail Societe de physiologie Societe francaise de cardiologie], 2010, MED SOMMEIL, V7, P161; Aloia MS, 2008, ANN BEHAV MED, V36, P44, DOI 10.1007/s12160-008-9052-9; Altena E, 2008, J SLEEP RES, V17, P335, DOI 10.1111/j.1365-2869.2008.00671.x; Bailly S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157318; Bakker JP, 2011, SLEEP, V34, P1595, DOI 10.5665/sleep.1404; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Beneto A, 2009, SLEEP MED REV, V13, P287, DOI 10.1016/j.smrv.2008.09.006; Billiard M, 2012, TROUBLES SOMMEIL; Bjornsdottir E, 2013, SLEEP, V36, P1901, DOI 10.5665/sleep.3226; Bradshaw DA, 2006, CHEST, V130, P1369, DOI 10.1378/chest.130.5.1369; Budhiraja R, 2016, J CLIN SLEEP MED, V12, P333, DOI 10.5664/jcsm.5578; Campos-Rodriguez F, 2016, SLEEP MED, V17, P1, DOI 10.1016/j.sleep.2015.07.038; Chai-Coetzer CL, 2013, SLEEP, V36, P1929, DOI 10.5665/sleep.3232; Dzierzewski JM, 2016, J CLIN SLEEP MED, V12, P169, DOI 10.5664/jcsm.5478; Gagnadoux F, 2016, CHEST, V149, P288, DOI 10.1016/j.chest.2015.09.032; Gagnadoux F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022503; Glidewell RN, 2014, SLEEP MED, V15, P899, DOI 10.1016/j.sleep.2014.05.001; GUILLEMINAULT C, 1973, SCIENCE, V181, P856, DOI 10.1126/science.181.4102.856; Jacobsen AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189614; Jaehne A, 2012, SLEEP MED, V13, P1286, DOI 10.1016/j.sleep.2012.06.026; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Krakow B, 2001, CHEST, V120, P1923, DOI 10.1378/chest.120.6.1923; Lai AYK, 2013, SLEEP MED, V14, P1192, DOI 10.1016/j.sleep.2013.04.023; Luyster FS, 2010, J CLIN SLEEP MED, V6, P196; Markov D, 2006, PSYCHIAT CLIN N AM, V29, P841, DOI 10.1016/j.psc.2006.09.008; Micoulaud-Franchi JA, 2017, MED SOMMEIL, V14, P99; Morin CM, 2009, JAMA-J AM MED ASSOC, V301, P2005, DOI 10.1001/jama.2009.682; Nguyen XL, 2013, EUR RESPIR J, V41, P593, DOI 10.1183/09031936.00080011; Nguyen XL, 2010, SLEEP MED, V11, P777, DOI 10.1016/j.sleep.2010.04.008; Olsen S, 2008, EUR RESPIR J, V32, P710, DOI 10.1183/09031936.00127507; Paine SJ, 2004, SLEEP, V27, P1163, DOI 10.1093/sleep/27.6.1163; Pieh C, 2013, SLEEP BREATH, V17, P99, DOI 10.1007/s11325-012-0655-9; Richards D, 2007, SLEEP, V30, P635, DOI 10.1093/sleep/30.5.635; Sawyer AM, 2011, SLEEP MED REV, V15, P343, DOI 10.1016/j.smrv.2011.01.003; Sawyer AM, 2011, PATIENT EDUC COUNS, V85, P85, DOI 10.1016/j.pec.2010.10.014; Smith SS, 2009, SLEEP BIOL RHYTHMS, V7, pA74; Steffen M, 2016, NEW ENGL J MED, V374, P401, DOI 10.1056/NEJMp1504547; STOOHS RA, 1993, SLEEP, V16, pS11; Suraiya S, 2006, SLEEP MED, V7, pS85, DOI DOI 10.1016/j.sleep.2006.07.203; Sweetman AM, 2017, SLEEP MED REV, V33, P28, DOI 10.1016/j.smrv.2016.04.004; Wallace DM, 2013, SLEEP BREATH, V17, P351, DOI 10.1007/s11325-012-0702-6; Wallace DM, 2013, J CLIN SLEEP MED, V9, P885, DOI 10.5664/jcsm.2988; Weaver TE, 2003, SLEEP, V26, P727, DOI 10.1093/sleep/26.6.727; Wickwire EM, 2008, CLIN CASE STUD, V7, P267; Wickwire EM, 2010, SLEEP MED, V11, P772, DOI 10.1016/j.sleep.2010.03.012; Woehrle H, 2011, SLEEP MED, V12, P1034, DOI 10.1016/j.sleep.2011.05.008; Wohlgemuth WK, 2015, SLEEP MED, V16, P336, DOI 10.1016/j.sleep.2014.08.013; Ye LC, 2012, J SLEEP RES, V21, P419, DOI 10.1111/j.1365-2869.2011.00969.x; Zhang L, 2006, AM J EPIDEMIOL, V164, P529, DOI 10.1093/aje/kwj231	49	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195343	10.1371/journal.pone.0195343	http://dx.doi.org/10.1371/journal.pone.0195343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617414	Green Submitted, Green Published, gold			2022-12-26	WOS:000429203800076
J	Rasouli, O; Vasseljen, O; Forst, EA; Loras, HW; Stensdotter, AK				Rasouli, Omid; Vasseljen, Otter; Forst, Egil A.; Loras, Havard W.; Stensdotter, Ann-Katrin			Lower regulatory frequency for postural control in patients with fibromyalgia and chronic fatigue syndrome	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; PAIN; STIMULATION; MODEL	As many similar symptoms are reported in fibromyalgia (FM) and chronic fatigue syndrome (CFS), underlying defcits may potentially also be similar. Postural disequilibrium reported in both conditions may thus be explained by similar deviations in postural control strategies. 75 females (25/group FM, CFS and control, age 19-49 years) performed 60 s of quiet standing on a force platform in each of three conditions: 1) firm surface with vision, 2) firm surface without vision and, 3) compliant surface with vision. Migration of center of pressure was decomposed into a slow and a fast component denoting postural sway and lateral forces controlling postural sway, analyzed in the time and frequency domains. Main effects of group for the antero-posterior (AP) and medio-lateral (ML) directions showed that patients displayed larger amplitudes (AP, p= 0.002; ML, p= 0.021) and lower frequencies (AP, p< 0.001; ML, p< 0.001) for the slow component, as well as for the fast component (amplitudes: AP, p = 0.010; ML, p= 0.001 and frequencies: AP, p = 0.001; ML, p= 0.029) compared to controls. Post hoc analyses showed no significant differences between patient groups. In conclusion, both the CFS- and the FM-group differed from the control group. Larger postural sway and insufficient control was found in patients compared to controls, with no significant differences between the two patient groups.	[Rasouli, Omid; Loras, Havard W.; Stensdotter, Ann-Katrin] Norwegian Univ Sci & Technol NTNU, Fac Med & Hlth Sci, Dept Neuromed & Movement Sci, Trondheim, Norway; [Rasouli, Omid; Vasseljen, Otter; Forst, Egil A.] Norwegian Univ Sci & Technol NTNU, Fac Med & Hlth Sci, Dept Publ Hlth & Nursing, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Stensdotter, AK (corresponding author), Norwegian Univ Sci & Technol NTNU, Fac Med & Hlth Sci, Dept Neuromed & Movement Sci, Trondheim, Norway.	ann-katrin.stensdotter@ntnu.no	Rasouli, Omid/S-5312-2017	Rasouli, Omid/0000-0003-2203-1839; Vasseljen, Ottar/0000-0001-6287-5871	institution Norwegian University of Science and Technology	institution Norwegian University of Science and Technology	This project was internally funded by the institution Norwegian University of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amris K, 2011, PAIN, V152, P2470, DOI 10.1016/j.pain.2011.05.027; ASHBERNAL R, 1995, ACTA OTO-LARYNGOL, V115, P9, DOI 10.3109/00016489509133339; Baratto L, 2002, MOTOR CONTROL, V6, P246, DOI 10.1123/mcj.6.3.246; Bardal EM, 2016, J ELECTROMYOGR KINES, V26, P1, DOI 10.1016/j.jelekin.2015.12.006; Bardal EM, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-186; BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728; Burgunder JM, 1998, Z RHEUMATOL, V57, P27; Casale R, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-78; Clauw DJ, 2010, PM&R, V2, P414, DOI 10.1016/j.pmrj.2010.04.010; Costa ID, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00014; Davey NJ, 2003, INT J CLIN PRACT, V57, P262; Duarte M, 2010, REV BRAS FISIOTER, V14, P183, DOI 10.1590/S1413-35552010000300003; Fraizer EV, 2008, GAIT POSTURE, V27, P271, DOI 10.1016/j.gaitpost.2007.04.002; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gay CW, 2016, BRAIN CONNECT, V6, P48, DOI 10.1089/brain.2015.0366; Gur A, 2008, CURR PHARM DESIGN, V14, P1274, DOI 10.2174/138161208799316348; Hanakawa T, 2011, NEUROSCI RES, V70, P144, DOI 10.1016/j.neures.2011.02.010; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Ingvar M, 2015, PAIN, V156, pS18, DOI 10.1097/j.pain.0000000000000093; Isableu B, 2006, EXP BRAIN RES, V174, P763, DOI 10.1007/s00221-006-0630-4; Kim J, 2015, ARTHRITIS RHEUMATOL, V67, P1395, DOI 10.1002/art.39043; Kuchinad A, 2007, J NEUROSCI, V27, P4004, DOI 10.1523/JNEUROSCI.0098-07.2007; Lopez-Sola M, 2014, ARTHRITIS RHEUMATOL, V66, P3200, DOI 10.1002/art.38781; LUND JP, 1991, CAN J PHYSIOL PHARM, V69, P683, DOI 10.1139/y91-102; Masani K, 2007, NEUROSCI LETT, V422, P202, DOI 10.1016/j.neulet.2007.06.019; Meeus M, 2014, CLIN RHEUMATOL; Miller AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098156; Milton J, 2009, CHAOS, V19, DOI 10.1063/1.3141429; Monjo F, 2015, HUM MOVEMENT SCI, V44, P225, DOI 10.1016/j.humov.2015.09.006; Morriss RK, 1998, J PSYCHOSOM RES, V45, P411, DOI 10.1016/S0022-3999(98)00022-1; Pinter IJ, 2008, J NEUROPHYSIOL, V100, P3197, DOI 10.1152/jn.01312.2007; Pujol J, 2014, PAIN, V155, P1492, DOI 10.1016/j.pain.2014.04.028; Puri BK, 2012, BRIT J RADIOL, V85, pE270, DOI 10.1259/bjr/93889091; Rasouli O, 2017, J PAIN RES IN PRESS; Rasouli O, 2016, CLIN BIOMECH, V37, P147, DOI 10.1016/j.clinbiomech.2016.07.008; Ruhe A, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-162; Sipko T, 2013, EUR J PAIN, V17, P612, DOI 10.1002/j.1532-2149.2012.00226.x; Stensdotter AK, 2013, GAIT POSTURE, V38, P918, DOI 10.1016/j.gaitpost.2013.04.017; Taylor JL, 2001, MUSCLE NERVE, V24, P18, DOI 10.1002/1097-4598(200101)24:1<18::AID-MUS2>3.3.CO;2-4; Vaillant J, 2016, ANN PHYS REHABIL M S, V59S, pe124; Vaillant J, 2016, ANN PHYS REHABIL MED, V59S, pE111; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; WOOLLACOTT MH, 1986, INT J AGING HUM DEV, V23, P97, DOI 10.2190/VXN3-N3RT-54JB-X16X; Zatsiorsky VM, 1999, MOTOR CONTROL, V3, P28, DOI 10.1123/mcj.3.1.28; Zatsiorsky VM, 2000, MOTOR CONTROL, V4, P185, DOI 10.1123/mcj.4.2.185	45	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195111	10.1371/journal.pone.0195111	http://dx.doi.org/10.1371/journal.pone.0195111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617424	Green Submitted, gold, Green Published			2022-12-26	WOS:000429203800065
J	Silva, NB; Osorio, FL				Silva, Nathiana B.; Osorio, Flavia L.			Impact of an animal-assisted therapy programme on physiological and psychosocial variables of paediatric oncology patients	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HOSPITALIZED CHILDREN; PET THERAPY; HEALTH; DOG; INTERVENTION; DEPRESSION; ANXIETY; CANCER; SCALE	The objective of this study was to propose an intervention and safety protocol for performing animal-assisted therapy (AAT) and evaluating its efficacy in children under outpatient oncological treatment based on psychological, physiological, and quality of life indicators for the children and caregivers. The sample consisted of 24 children diagnosed with leukaemia and solid tumours (58% girls with a mean age of 8.0 years) who underwent an AAT programme consisting of three 30-min sessions in an open group. Two dogs (one Labrador retriever and one golden retriever) were used, and activities such as sensory stimulation, gait training, and socialization were conducted. The exclusion criteria were severe mental problems, inability to answer the questions included in the instruments used, allergy to animals, unavailability/lack of interest, isolation precaution, surgical wound, use of invasive devices, ostomy, no current blood count for evaluation, neutropaenia, infection, fever, diarrhoea, vomiting, respiratory symptoms at the beginning of the intervention or 1 week before the intervention, hospitalization or scheduled surgery, and non-completion of the AAT programme. The variables analysed using validated self or other evaluations were stress, pain, mood, anxiety, depression, quality of life, heart rate, and blood pressure. A quasi-experimental study design was used. We observed a decrease in pain (p = 0.046, d = 0.894), irritation (p = 0.041, d = 0.917), and stress (p = 0.005; d = 1.404) and a tendency towards improvement of depressive symptoms (p = 0.069; d = 0.801). Among the caregivers, an improvement was observed in anxiety (p = 0.007, d = 1.312), mental confusion (p = 0.006, d = 1.350), and tension (p = 0.006, d = 1.361). Therefore, the selection criteria and care protocols used for the AAT programme in the oncological context were adequate, and the programme was effective.	[Silva, Nathiana B.; Osorio, Flavia L.] Barretos Canc Hosp, Pio Fdn 7, Sao Paulo, Brazil; [Osorio, Flavia L.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurosci & Behav Sci, Sao Paulo, Brazil	Hospital de Cancer de Barretos; Universidade de Sao Paulo	Osorio, FL (corresponding author), Barretos Canc Hosp, Pio Fdn 7, Sao Paulo, Brazil.; Osorio, FL (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurosci & Behav Sci, Sao Paulo, Brazil.	flaliosorio@ig.com.br	Osório, Flávia L./H-6079-2012; Osório, Flávia L./T-5001-2019	L. Osorio, Flavia/0000-0003-1396-555X	Pio XII Foundation Barretos Cancer Hospital, Barretos, Sao Paulo, Brazil; PQ-CNPq-2 [301321/2016-7]; Pio XII Foundation	Pio XII Foundation Barretos Cancer Hospital, Barretos, Sao Paulo, Brazil; PQ-CNPq-2; Pio XII Foundation	This work was supported by Pio XII Foundation Barretos Cancer Hospital, Barretos, Sao Paulo, Brazil. Prof. Osorio was supported by productivity grants (PQ-CNPq-2 -number 301321/2016-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Nucleus for Researcher Support (NAP) of the Barretos Cancer Hospital for the help with data collection and analysis, Luiz Fernando Lopes for help with the design of the AAT programme, the Hospital Infection Commission Team of the Barretos Cancer Hospital, in particular Paulo de Tarso Oliveira e Castro, for assistance with the elaboration of the intervention and safety protocol, Carla Rodrigues for the suggestions in the preparation of the final version of the manuscript, and the Pio XII Foundation for the funding provided.	Albuquerque NS, 2016, TERAPIA ASSISTIDA AN, P18; [Anonymous], 2012, FRONT PSYCHOL, DOI DOI 10.3389/FPSYG.2012.00234; Antonioli C, 2005, BMJ-BRIT MED J, V331, P1231, DOI 10.1136/bmj.331.7527.1231; Aoki J, 2012, INT J PSYCHIAT CLIN, V16, P205, DOI 10.3109/13651501.2011.644565; Arico M, 2002, BLOOD, V100, P420, DOI 10.1182/blood.V100.2.420; Assumpcao FB, 2000, ARQ NEURO-PSIQUIAT, V58, P119, DOI 10.1590/S0004-282X2000000100018; Barbeira C., 2002, REV PSIQUIATRIA CLIN, V29, P66; Barker SB, 2015, ANTHROZOOS, V28, P101, DOI 10.2752/089279315X14129350722091; Barker SB, 2005, PSYCHOL REP, V96, P713; Berget B, 2008, CLIN PRACT EPIDEMIOL, V4, P9, DOI DOI 10.1186/1745-0179-4-9; Berget B, 2011, OCCUP THER MENT HEAL, V27, P50, DOI 10.1080/0164212X.2011.543641; Bibbo J., 2013, ONCOL NURS FORUM, V40, P320; Borgi M, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00298; Borgi M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00411; Bouchard France, 2004, Can Oncol Nurs J, V14, P14; Braun Carie, 2009, Complement Ther Clin Pract, V15, P105, DOI 10.1016/j.ctcp.2009.02.008; Calcaterra V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125813; Caprilli S, 2006, EVID-BASED COMPL ALT, V3, P379, DOI 10.1093/ecam/nel029; Carine S, 2016, TERAPIA ASSISTIDA AN, P37; Cole KM, 2007, AM J CRIT CARE, V16, P575; da Silva FC, 2008, J PEDIAT-BRAZIL, V84, P344, DOI [10.1590/S0021-75572008000400010, 10.2223/JPED.1809]; da Silva WV, 2005, REV BRAS PSIQUIATR, V27, P329, DOI 10.1590/S1516-44462005000400014; DeCourcey M, 2010, DIMENS CRIT CARE NUR, V29, P211, DOI 10.1097/DCC.0b013e3181e6c71a; Eaglin Vanessa H, 2008, Hawaii Med J, V67, P45; Engelman SR, 2013, OMEGA-J DEATH DYING, V67, P63, DOI 10.2190/OM.67.1-2.g; Faraco CB, 2008, THESIS; Fleishman SB, 2015, J COMMUNITY SUPPORT, V13, P22, DOI 10.12788/jcso.0102; Gagnon Johanne, 2004, Can Oncol Nurs J, V14, P217; Goddard Anna Tielsch, 2015, Pediatr Nurs, V41, P65; Harris AD, 2006, J AM MED INFORM ASSN, V13, P16, DOI 10.1197/jamia.M1749; Havey J, 2014, ANTHROZOOS, V27, P361, DOI 10.2752/175303714X13903827487962; Hicks CL, 2001, PAIN, V93, P173, DOI 10.1016/S0304-3959(01)00314-1; Hoffmann AOM, 2009, EUR J INTEGR MED, V1, P145, DOI 10.1016/j.eujim.2009.08.002; Jegatheesan B, 2014, IAHAIO WHITE PAPER D, V1, P1; Johnson RA, 2003, AM BEHAV SCI, V47, P55, DOI 10.1177/0002764203255213; Johnson RA, 2008, ONCOL NURS FORUM, V35, P225, DOI 10.1188/08.ONF.225-232; Kaminski M, 2002, CHILD HEALTH CARE, V31, P321, DOI 10.1207/S15326888CHC3104_5; KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995; Krause-Parello CA, 2014, ANTHROZOOS, V27, P581, DOI 10.2752/089279314X14072268688005; Lefebvre SL, 2008, AM J INFECT CONTROL, V36, P78, DOI 10.1016/j.ajic.2007.09.005; Lipp M.E.N., 2002, PSICOLOGIA ESCOLAR E, V6, P51; Lipp MEN, 1998, ESCALA STRESS INFANT; Liskova S, 2013, ANTHROZOOS, V26, P27, DOI 10.2752/175303713X13534238631399; Manificat S, 1997, NEUROPSYCHIAT ENFAN, V45, P106; Marcus DA, 2014, AM J HOSP PALLIAT ME, V31, P420, DOI 10.1177/1049909113492373; Maroco J., 2007, ANALISE ESTATISTICA, V3rd; Moody WJ, 2002, J CLIN NURS, V11, P537, DOI 10.1046/j.1365-2702.2002.00618.x; Motooka M, 2006, MED J AUSTRALIA, V184, P60, DOI 10.5694/j.1326-5377.2006.tb00116.x; Lasa SM, 2015, NEUROLOGIA, V30, P1, DOI 10.1016/j.nrl.2013.01.012; Nagasawa M, 2015, SCIENCE, V348, P333, DOI 10.1126/science.1261022; Nahm N, 2012, WEST J EMERG MED, V13, P363, DOI 10.5811/westjem.2011.5.6574; Nepps P, 2014, J EVID-BASED INTEGR, V19, P211, DOI 10.1177/2156587214533570; Novotny NL, 2015, J NURS ED PRACT, V5, P123, DOI DOI 10.5430/JNEP.V5N7P123; O'Haire ME, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01121; Odendaal JSJ, 2000, J PSYCHOSOM RES, V49, P275, DOI 10.1016/S0022-3999(00)00183-5; Orlandi M, 2007, ANTICANCER RES, V27, P4301; Rohlfs ICPD, 2008, REV BRAS MED ESPORTE, V14, P176, DOI 10.1590/S1517-86922008000300003; Redd R, 2012, REV LAT-AM ENFERM, V20, P1; Rivera GK, 2014, EXPERT REV HEMATOL, V7, P649, DOI 10.1586/17474086.2014.949233; Serpell JA, 2004, ANIM WELFARE, V13, pS145; Sobo EJ, 2006, J HOLIST NURS, V24, P51, DOI 10.1177/0898010105280112; Spielberger C., 1973, STAIC PRELIMINARY MA; Stewart LA, 2014, J CREAT MENT HEALTH, V9, P332, DOI 10.1080/15401383.2014.892862; Stoffel J.M., ANIMAL ASSISTED THER; Stokes DL, 2007, HUM ECOL, V35, P361, DOI 10.1007/s10745-006-9056-7; Takashima GK, 2014, INT J ENV RES PUB HE, V11, P11110, DOI 10.3390/ijerph111111110; Terry PC, 2003, PSYCHOL SPORT EXERC, V4, P125, DOI 10.1016/S1469-0292(01)00035-8; Trembath F., 2015, HABRI CENTRAL BRIEF, P1; Tsai CC, 2010, ANTHROZOOS, V23, P245, DOI 10.2752/175303710X12750451258977; VORMBROCK JK, 1988, J BEHAV MED, V11, P509, DOI 10.1007/BF00844843; White JH, 2015, INTEGR CANCER THER, V14, P460, DOI 10.1177/1534735415580678; Willens JS, 2013, PAIN MANAG NURS, V14, P183, DOI 10.1016/j.pmn.2013.10.001; Wu Adam S, 2002, J Pediatr Nurs, V17, P354, DOI 10.1053/jpdn.2002.127173	73	35	39	7	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194731	10.1371/journal.pone.0194731	http://dx.doi.org/10.1371/journal.pone.0194731			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617398	Green Published, Green Submitted, gold			2022-12-26	WOS:000429203800045
J	Moore, TC; Messer, RJ; Hasenkrug, KJ				Moore, Tyler C.; Messer, Ronald J.; Hasenkrug, Kim J.			Regulatory T cells suppress virus-specific antibody responses to Friend retrovirus infection	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CUTTING EDGE; B-CELLS; FUNCTIONAL IMPAIRMENT; TISSUE AUTOANTIGENS; MICE; LEUKEMIA; EXPANSION; RECOVERY; DISEASE	Recent vaccine studies with experimental antigens have shown that regulatory T cells (Tregs) constrain the magnitude of B cell responses. This homeostatic Treg-mediated suppression is thought to reduce the potential of germinal center (GC) responses to generate autoreactive antibodies. However, essentially opposite results were observed in live influenza infections where Tregs promoted B cell and antibody responses. Thus, it remains unclear whether Tregs dampen or enhance B cell responses, especially during live viral infections. Here, we use mice infected with Friend retrovirus (FV), which induces a robust expansion of Tregs. Depletion of Tregs led to elevated activation, proliferation, and class switching of B cells. In addition, Treg depletion enhanced the production of virus-specific and virus-neutralizing antibodies and reduced FV viremia. Thus, in contrast to influenza infection, Tregs either directly or indirectly suppress B cells during mouse retroviral infection indicating that the ultimate effect of Tregs on B cell responses is specific to the particular infectious agent.	[Moore, Tyler C.; Messer, Ronald J.; Hasenkrug, Kim J.] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Moore, Tyler C.] Bellevue Univ, Bellevue, NE USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hasenkrug, KJ (corresponding author), NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.	khasenkrug@nih.gov			National Institute of Allergy and Infectious Diseases, Division of Intramural Research [ZA1000753]; National Institute of Allergy and Infectious Diseases, National Institute of Health, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000753] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases, National Institute of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases, Division of Intramural Research, Project #ZA1000753.; This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institute of Health, USA.	ALBERTS B, 2002, MOL BIOL CELL, pR34; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; CHESEBRO B, 1979, P NATL ACAD SCI USA, V76, P425, DOI 10.1073/pnas.76.1.425; CHESEBRO B, 1981, VIROLOGY, V112, P131, DOI 10.1016/0042-6822(81)90619-X; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Dietze KK, 2011, P NATL ACAD SCI USA, V108, P2420, DOI 10.1073/pnas.1015148108; Dittmer U, 2004, IMMUNITY, V20, P653, DOI 10.1016/S1074-7613(04)00115-3; Dittmer U, 2004, IMMUNITY, V20, P293, DOI 10.1016/S1074-7613(04)00054-8; DOIG D, 1979, J EXP MED, V150, P10, DOI 10.1084/jem.150.1.10; FRIEND C, 1957, J EXP MED, V105, P307, DOI 10.1084/jem.105.4.307; Gotot J, 2012, P NATL ACAD SCI USA, V109, P10468, DOI 10.1073/pnas.1201131109; Hasenkrug KJ, 2010, J IMMUNOL, V185, P1349, DOI 10.4049/jimmunol.1090058; Hasenkrug KJ, 1997, P NATL ACAD SCI USA, V94, P7811, DOI 10.1073/pnas.94.15.7811; Hasenkrug KJ, 1998, J VIROL, V72, P6559, DOI 10.1128/JVI.72.8.6559-6564.1998; Holmdahl R, 2014, EUR J IMMUNOL, V44, P1593, DOI 10.1002/eji.201444486; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Iwashiro M, 2001, P NATL ACAD SCI USA, V98, P9226, DOI 10.1073/pnas.151174198; Joedicke JJ, 2012, IMMUNOLOGY, V136, P8; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Leon B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4495; LI JP, 1990, NATURE, V343, P762, DOI 10.1038/343762a0; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Ludwig-Portugall I, 2008, J IMMUNOL, V181, P4447, DOI 10.4049/jimmunol.181.7.4447; Ludwig-Portugall I, 2009, EUR J IMMUNOL, V39, P225, DOI 10.1002/eji.200838699; Messer RJ, 2004, P NATL ACAD SCI USA, V101, P12260, DOI 10.1073/pnas.0404769101; Miyara M, 2005, J IMMUNOL, V175, P8392, DOI 10.4049/jimmunol.175.12.8392; Miyara M, 2011, AUTOIMMUN REV, V10, P744, DOI 10.1016/j.autrev.2011.05.004; MORRISON RP, 1987, NATURE, V329, P729, DOI 10.1038/329729a0; Myers L, 2013, J IMMUNOL, V190, P5485, DOI 10.4049/jimmunol.1202951; Nair SR, 2010, J GEN VIROL, V91, P440, DOI 10.1099/vir.0.015834-0; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Peng GP, 2008, IMMUNOLOGY, V123, P57, DOI 10.1111/j.1365-2567.2007.02691.x; Rekvig OP, 2014, SEMIN IMMUNOPATHOL, V36, P301, DOI 10.1007/s00281-014-0428-6; ROBERTSON MN, 1991, J VIROL METHODS, V34, P255, DOI 10.1016/0166-0934(91)90105-9; Robertson SJ, 2008, J VIROL, V82, P408, DOI 10.1128/JVI.01413-07; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salek-Ardakani S, 2011, J IMMUNOL, V186, P5294, DOI 10.4049/jimmunol.1100406; Super HJ, 1998, J VIROL, V72, P9400, DOI 10.1128/JVI.72.11.9400-9403.1998; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wing JB, 2014, IMMUNITY, V41, P1013, DOI 10.1016/j.immuni.2014.12.006; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Zelinskyy G, 2011, J IMMUNOL, V187, P3730, DOI 10.4049/jimmunol.1101612; Zelinskyy G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000406; Zelinskyy G, 2009, BLOOD, V114, P3199, DOI 10.1182/blood-2009-03-208736	47	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195402	10.1371/journal.pone.0195402	http://dx.doi.org/10.1371/journal.pone.0195402			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614127	gold, Green Published, Green Submitted			2022-12-26	WOS:000429081600057
J	Labgaa, I; Villacorta-Martin, C; D'Avola, D; Craig, AJ; von Felden, J; Martins, SN; Sia, D; Stueck, A; Ward, SC; Fiel, MI; Mahajan, M; Tabrizian, P; Thung, SN; Ang, C; Friedman, SL; Llovet, JM; Schwartz, M; Villanueva, A				Labgaa, Ismail; Villacorta-Martin, Carlos; D'Avola, Delia; Craig, Amanda J.; von Felden, Johann; Martins-Filho, Sebastiao N.; Sia, Daniela; Stueck, Ashley; Ward, Stephen C.; Fiel, M. Isabel; Mahajan, Milind; Tabrizian, Parissa; Thung, Swan N.; Ang, Celina; Friedman, Scott L.; Llovet, Josep M.; Schwartz, Myron; Villanueva, Augusto			A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma	ONCOGENE			English	Article							CIRCULATING TUMOR DNA; CELL-FREE DNA; DROPLET DIGITAL PCR; CLONAL EVOLUTION; LIQUID BIOPSY; LUNG-CANCER; HETEROGENEITY; PROGRESSION; RESISTANCE; LANDSCAPE	Cellular components of solid tumors including DNA are released into the bloodstream, but data on circulating-free DNA (cfDNA) in hepatocellular carcinoma (HCC) are still scarce. This study aimed at analyzing mutations in cfDNA and their correlation with tissue mutations in patients with HCC. We included 8 HCC patients treated with surgical resection for whom we collected paired tissue and plasma/serum samples. We analyzed 45 specimens, including multiregional tumor tissue sampling (n = 24), peripheral blood mononuclear cells (PMBC, n = 8), plasma (n = 8) and serum (n = 5). Ultra-deep sequencing (5500x coverage) of all exons was performed in a targeted panel of 58 genes, including frequent HCC driver genes and druggable mutations. Mutations detected in plasma included known HCC oncogenes and tumor suppressors (e.g., TERT promoter, TP53, and NTRK3) as well as a candidate druggable mutation (JAK1). This approach increased the detection rates previously reported for mutations in plasma of HCC patients. A thorough characterization of cis mutations found in plasma confirmed their tumoral origin, which provides definitive evidence of the release of HCC-derived DNA fragments into the bloodstream. This study demonstrates that ultra-deep sequencing of cfDNA is feasible and can confidently detect somatic mutations found in tissue; these data reinforce the role of plasma DNA as a promising minimally invasive tool to interrogate HCC genetics.	[Labgaa, Ismail; Villacorta-Martin, Carlos; D'Avola, Delia; Craig, Amanda J.; von Felden, Johann; Martins-Filho, Sebastiao N.; Sia, Daniela; Tabrizian, Parissa; Friedman, Scott L.; Llovet, Josep M.; Schwartz, Myron; Villanueva, Augusto] Icahn Sch Med Mt Sinai, Dept Med, Liver Canc Program, Tisch Canc Inst,Grad Sch Biomed Sci,Div Liver Dis, New York, NY 10029 USA; [Labgaa, Ismail] Lausanne Univ Hosp CHUV, Dept Visceral Surg, Lausanne, Switzerland; [D'Avola, Delia] Clin Univ Navarra, Liver Unit, Pamplona, Spain; [D'Avola, Delia] Clin Univ Navarra, CIBEREHD, Pamplona, Spain; [von Felden, Johann] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany; [Martins-Filho, Sebastiao N.] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil; [Martins-Filho, Sebastiao N.] Univ Toronto, Univ Hlth Network, Dept Pathol & Lab Med, Toronto, ON, Canada; [Stueck, Ashley; Ward, Stephen C.; Fiel, M. Isabel; Mahajan, Milind; Thung, Swan N.] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Stueck, Ashley] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Mahajan, Milind] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Tabrizian, Parissa; Schwartz, Myron] Icahn Sch Med Mt Sinai, Dept Surg, New York, NY 10029 USA; [Ang, Celina; Villanueva, Augusto] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, Dept Med, New York, NY 10029 USA; [Llovet, Josep M.] Univ Barcelona, Hosp Clin, Liver Canc Translat Res Lab, BCLC Grp,IDIBAPS,CIBEREHD, Catalonia, Spain; [Llovet, Josep M.] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Icahn School of Medicine at Mount Sinai; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Navarra; University of Hamburg; University Medical Center Hamburg-Eppendorf; Universidade de Sao Paulo; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Icahn School of Medicine at Mount Sinai; Dalhousie University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ICREA	Villanueva, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Liver Canc Program, Tisch Canc Inst,Grad Sch Biomed Sci,Div Liver Dis, New York, NY 10029 USA.; Villanueva, A (corresponding author), Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, Dept Med, New York, NY 10029 USA.	augusto.villanueva@mssm.edu	Llovet, Josep M/ABB-6264-2021; D'Avola, Delia/AAD-4289-2020; Llovet, Josep M/D-4340-2014	Llovet, Josep M/0000-0003-0547-2667; D'Avola, Delia/0000-0002-0907-6648; Llovet, Josep M/0000-0003-0547-2667; Stueck, Ashley/0000-0002-0328-6687; Sia, Daniela/0000-0002-9000-611X; Martins Filho, Sebastiao/0000-0002-6123-2601; von Felden, Johann/0000-0003-2839-5174; Labgaa, Ismail/0000-0003-4286-2170; Villanueva, Augusto/0000-0003-3585-3727; Craig, Amanda/0000-0001-8987-019X	Swiss National Science Foundation; Foundation Roberto Gianna Gonella; Foundation SICPA; Grant for Studies Broadening from the Spanish Association for the Study of the Liver (Asociacion Espanola para el Estudio del Higado, AEEH); Cancer Research Grant from Nuovo Soldati Foundation; Ruth L. Kirschstein NRSA Institutional Research Training Grant [T32 CA078207]; German Research Foundation [FE 1746/1-1]; Brazilian National Council for Scientific and Technological Development; Associacao Piauiense de Combate ao Cancer; European Commission [259744, 667273-2]; Samuel Waxman Cancer Research Foundation; Spanish National Health Institute [SAF-2016-76390]; Asociacion Espanola para el Estudio del Cancer [CA150272P1]; U.S. Department of Defense [CA150272P1, CA150272P3, W81XWH-16-1-0455]; Tisch Cancer Institute (Cancer Center Grant) [P30 CA196521]; NIH [DK56621]; American Association for the Study of Liver Diseases Foundation (AASLDF) Alan Hofmann Clinical and Translational Award; NATIONAL CANCER INSTITUTE [P30CA196521, T32CA078207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056621] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Foundation Roberto Gianna Gonella; Foundation SICPA; Grant for Studies Broadening from the Spanish Association for the Study of the Liver (Asociacion Espanola para el Estudio del Higado, AEEH); Cancer Research Grant from Nuovo Soldati Foundation; Ruth L. Kirschstein NRSA Institutional Research Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Associacao Piauiense de Combate ao Cancer; European Commission(European CommissionEuropean Commission Joint Research Centre); Samuel Waxman Cancer Research Foundation; Spanish National Health Institute(Spanish Government); Asociacion Espanola para el Estudio del Cancer; U.S. Department of Defense(United States Department of Defense); Tisch Cancer Institute (Cancer Center Grant); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association for the Study of Liver Diseases Foundation (AASLDF) Alan Hofmann Clinical and Translational Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	IL is supported by a grant from the Swiss National Science Foundation, from Foundation Roberto & Gianna Gonella and Foundation SICPA. DD is supported by the Grant for Studies Broadening from the Spanish Association for the Study of the Liver (Asociacion Espanola para el Estudio del Higado, AEEH) and the Cancer Research Grant from Nuovo Soldati Foundation. AJC is supported by a Ruth L. Kirschstein NRSA Institutional Research Training Grant (T32 CA078207). JvF is supported by a grant from the German Research Foundation (FE 1746/1-1). SNM is supported by grants from the Brazilian National Council for Scientific and Technological Development, and "Associacao Piauiense de Combate ao Cancer". JML is supported by grants from the European Commission (Heptromic, proposal number 259744; HEPCAR, proposal number 667273-2), the Samuel Waxman Cancer Research Foundation, the Spanish National Health Institute (J.M.L: SAF-2016-76390), the Asociacion Espanola para el Estudio del Cancer and the U.S. Department of Defense (CA150272P1). AV is supported by the U.S. Department of Defense (CA150272P3) and the Tisch Cancer Institute (Cancer Center Grant P30 CA196521). SLF is supported by NIH grant DK56621 and the U.S. Department of Defense (Contract No. W81XWH-16-1-0455). This study was funded by the American Association for the Study of Liver Diseases Foundation (AASLDF) Alan Hofmann Clinical and Translational Award to AV.	Abbosh C, 2017, NATURE, V545, P446, DOI 10.1038/nature22364; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Cai ZX, 2017, INT J CANCER, V141, P977, DOI 10.1002/ijc.30798; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; De Mattos-Arruda L, 2014, ANN ONCOL, V25, P1729, DOI 10.1093/annonc/mdu239; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Huang A, 2017, J HEPATOL, V67, P293, DOI 10.1016/j.jhep.2017.03.005; Huang A, 2016, J CANCER, V7, P1907, DOI 10.7150/jca.15823; Izumchenko E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9258; Jiang PY, 2015, P NATL ACAD SCI USA, V112, pE1317, DOI 10.1073/pnas.1500076112; Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Labgaa I, 2015, DISCOV MED, V19, P263; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liao WJ, 2016, ONCOTARGET, V7, P40481, DOI 10.18632/oncotarget.9629; Lin XJ, 2015, LANCET ONCOL, V16, P804, DOI 10.1016/S1470-2045(15)00048-0; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Malapelle U, 2017, BRIT J CANCER, V116, P802, DOI 10.1038/bjc.2017.8; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Newman AM, 2016, NAT BIOTECHNOL, V34, P547, DOI 10.1038/nbt.3520; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Norton ME, 2015, NEW ENGL J MED, V372, P1589, DOI 10.1056/NEJMoa1407349; Ono A, 2015, CELL MOL GASTROENTER, V1, P516, DOI 10.1016/j.jcmgh.2015.06.009; Russo M, 2016, CANCER DISCOV, V6, P147, DOI 10.1158/2159-8290.CD-15-1283; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Siravegna G, 2015, NAT MED, V21, P795, DOI 10.1038/nm.3870; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tie J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6219; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; US Food and Drug Administration, FDA APPR 1 BLOOD TES; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333; Zhai WW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14565; Zill OA, 2015, CANCER DISCOV, V5, P1040, DOI 10.1158/2159-8290.CD-15-0274	40	61	61	0	16	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 5	2018	37	27					3740	3752		10.1038/s41388-018-0206-3	http://dx.doi.org/10.1038/s41388-018-0206-3			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GM3CM	29628508	Green Accepted			2022-12-26	WOS:000437975200010
J	Badawy, SMM; Okada, T; Kajimoto, T; Hirase, M; Matovelo, SA; Nakamura, S; Yoshida, D; Ijuin, T; Nakamura, S				Badawy, Shaymaa Mohamed Mohamed; Okada, Taro; Kajimoto, Taketoshi; Hirase, Mitsuhiro; Matovelo, Shubi Ambwene; Nakamura, Shunsuke; Yoshida, Daisuke; Ijuin, Takeshi; Nakamura, Shun-ichi			Extracellular -synuclein drives sphingosine 1-phosphate receptor subtype 1 out of lipid rafts, leading to impaired inhibitory G-protein signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sphingosine-1-phosphate (S1P); lipid raft; signal transduction; -synuclein (-synuclein); ganglioside	AGGREGATED ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; GANGLIOSIDE GM1; LEWY BODIES; SPHINGOSINE-1-PHOSPHATE; EXOSOMES; MUTATION; INTERNALIZATION; TRIPLICATION; LOCALIZATION	-Synuclein (-Syn)-positive intracytoplasmic inclusions, known as Lewy bodies, are thought to be involved in the pathogenesis of Lewy body diseases, such as Parkinson's disease (PD). Although growing evidence suggests that cell-to-cell transmission of -Syn is associated with the progression of PD and that extracellular -Syn promotes formation of inclusion bodies, its precise mechanism of action in the extracellular space remains unclear. Here, as indicated by both conventional fractionation techniques and FRET-based protein-protein interaction analysis, we demonstrate that extracellular -Syn causes expulsion of sphingosine 1-phosphate receptor subtype 1 (S1P(1)R) from the lipid raft fractions. S1P(1)R regulates vesicular trafficking, and its expulsion involved -Syn binding to membrane-surface gangliosides. Consequently, the S1P(1)R became refractory to S1P stimulation required for activating inhibitory G-protein (G(i)) in the plasma membranes. Moreover, the extracellular -Syn also induced uncoupling of the S1P(1)R on internal vesicles, resulting in the reduced amount of CD63 molecule (CD63) in the lumen of multivesicular endosomes, together with a decrease in CD63 in the released exosomes from -Syn-treated cells. Furthermore, cholesterol-depleting agent-induced S1P(1)R expulsion from the rafts also resulted in S1P(1)R uncoupling. Taken together, these results suggest that extracellular -Syn-induced expulsion of S1P(1)R from lipid rafts promotes the uncoupling of S1P(1)R from G(i), thereby blocking subsequent G(i) signals, such as inhibition of cargo sorting into exosomal vesicles in multivesicular endosomes. These findings help shed additional light on PD pathogenesis.	[Badawy, Shaymaa Mohamed Mohamed; Okada, Taro; Kajimoto, Taketoshi; Hirase, Mitsuhiro; Matovelo, Shubi Ambwene; Nakamura, Shunsuke; Yoshida, Daisuke; Ijuin, Takeshi; Nakamura, Shun-ichi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Biochem, 7-5-1 Kusunoki, Kobe, Hyogo 6500017, Japan	Kobe University	Nakamura, S (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Biochem, 7-5-1 Kusunoki, Kobe, Hyogo 6500017, Japan.	snakamur@kobe-u.ac.jp		Okada, Taro/0000-0001-5183-9402; Nakamura, Shun-ichi/0000-0002-2704-6557	Ministry of Education, Culture, Sports, Science and Technology of Japan; Nakatani Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nakatani Foundation	This work was supported by a Grant-in-Aid for challenging Exploratory Research (to S.-i. N.), a Grant-in-Aid for Scientific Research (C) (to T. O.), a Grant-in-Aid for Scientific Research (C) (to T. K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a Technology Development Research Grant from the Nakatani Foundation (to T. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn KJ, 2006, J NEUROCHEM, V97, P265, DOI 10.1111/j.1471-4159.2006.03731.x; Baba M, 1998, AM J PATHOL, V152, P879; Badawy SMM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16457-4; Bae EJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5755; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fantini J, 2011, J MOL BIOL, V408, P654, DOI 10.1016/j.jmb.2011.03.009; Fuchs J, 2007, NEUROLOGY, V68, P916, DOI 10.1212/01.wnl.0000254458.17630.c5; Gaengel K, 2012, DEV CELL, V23, P587, DOI 10.1016/j.devcel.2012.08.005; Grey M, 2015, J BIOL CHEM, V290, P2969, DOI 10.1074/jbc.M114.585703; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kajimoto T, 2007, MOL CELL BIOL, V27, P3429, DOI 10.1128/MCB.01465-06; Kajimoto T, 2018, J BIOL CHEM, V293, P245, DOI 10.1074/jbc.M117.808733; Kajimoto T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3712; Klegeris A, 2006, FASEB J, V20, P2000, DOI 10.1096/fj.06-6183com; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee MJ, 2001, MOL CELL, V8, P693, DOI 10.1016/S1097-2765(01)00324-0; Maguire-Zeiss KA, 2006, BIOCHEM BIOPH RES CO, V349, P1198, DOI 10.1016/j.bbrc.2006.08.127; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; Morris DP, 2008, J BIOL CHEM, V283, P2973, DOI 10.1074/jbc.M705795200; Ohno Y, 2009, GENES CELLS, V14, P911, DOI 10.1111/j.1365-2443.2009.01319.x; Okada T, 2016, SCI REP-UK, V6, DOI 10.1038/srep37810; Park JY, 2008, GLIA, V56, P1215, DOI 10.1002/glia.20691; Park JY, 2009, J NEUROCHEM, V110, P400, DOI 10.1111/j.1471-4159.2009.06150.x; Park SM, 2002, BLOOD, V100, P2506, DOI 10.1182/blood.V100.7.2506; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; SUGANO K, 1978, FEBS LETT, V89, P321, DOI 10.1016/0014-5793(78)80246-4; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Takeda A, 1998, AM J PATHOL, V152, P367; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang LC, 2017, SECUR COMMUN NETW, DOI 10.1155/2017/4842694; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	41	28	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8208	8216		10.1074/jbc.RA118.001986	http://dx.doi.org/10.1074/jbc.RA118.001986			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29632069	Green Published, hybrid			2022-12-26	WOS:000433224600025
J	Milenkovic, VM; Bader, S; Sudria-Lopez, D; Siebert, R; Brandl, C; Nothdurfter, C; Weber, BHF; Rupprecht, R; Wetzel, CH				Milenkovic, Vladimir M.; Bader, Stefanie; Sudria-Lopez, Daniel; Siebert, Ramona; Brandl, Caroline; Nothdurfter, Caroline; Weber, Bernhard H. F.; Rupprecht, Rainer; Wetzel, Christian H.			Effects of genetic variants in the TSPO gene on protein structure and stability	PLOS ONE			English	Article							MITOCHONDRIAL TRANSLOCATOR PROTEIN; POSITRON-EMISSION-TOMOGRAPHY; AMINO-ACID SUBSTITUTIONS; 18 KDA TSPO; PERIPHERAL BENZODIAZEPINE; DELETERIOUS MUTATIONS; SYNONYMOUS VARIANTS; A147T POLYMORPH; BINDING; AFFINITY	The 18 kDa translocator protein (TSPO) is an evolutionary conserved cholesterol binding protein localized in the outer mitochondrial membrane. Expression of TSPO is upregulated in activated microglia in various neuroinflammatory, neurodegenerative, and neoplastic disorders. Therefore, TSPO radioligands are used as biomarkers in positron emission tomography (PET) studies. In particular, a common A147T polymorphism in the TSPO gene affects binding of several high affinity TSPO radioligands. Given the relevance of TSPO as a diagnostic biomarker in disease processes, we systematically searched for mutations in the human TSPO gene by a wide array of evolution and structure based bioinformatics tools and identified potentially deleterious missense mutations. The two most frequently observed missense mutations A147T and R162H were further analysed in structural models of human wildtype and mutant TSPO proteins. The effects of missense mutations were studied on the atomic level using molecular dynamics simulations. To analyse putative effects of A147T and R162H variants on protein stability we established primary dermal fibroblast cultures from wt and homozygous A147T and R162H donors. Stability of endogenous TSPO protein, which is abundantly expressed in fibroblasts, was studied using cycloheximide protein degradation assay. Our data show that the A147T mutation significantly alters the flexibility and stability of the mutant protein. Furthermore both A147T and R162H mutations decreased the half-life of the mutant proteins by about 25 percent, which could in part explain its effect on reduced pregnenolone production and susceptibility to neuropsychiatric disorders. The present study is the first comprehensive bioinformatic analysis of genetic variants in the TSPO gene, thereby extending the knowledge about the clinical relevance of TSPO nsSNPs.	[Milenkovic, Vladimir M.; Bader, Stefanie; Sudria-Lopez, Daniel; Siebert, Ramona; Nothdurfter, Caroline; Rupprecht, Rainer; Wetzel, Christian H.] Univ Regensburg, Dept Psychiat & Psychotherapy, Mol Neurosci, Regensburg, Germany; [Brandl, Caroline; Weber, Bernhard H. F.] Univ Regensburg, Inst Human Genet, Regensburg, Germany; [Brandl, Caroline] Univ Hosp Regensburg, Dept Ophthalmol, Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg	Milenkovic, VM (corresponding author), Univ Regensburg, Dept Psychiat & Psychotherapy, Mol Neurosci, Regensburg, Germany.	vladimir.milenkovic@ukr.de	Wetzel, Christian H/N-9880-2017	Wetzel, Christian H/0000-0002-5762-0003; Sudria Lopez, Daniel/0000-0002-7492-5183; Brandl, Caroline/0000-0001-8223-6137				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Albert NL, 2017, EUR J NUCL MED MOL I, V44, P2230, DOI 10.1007/s00259-017-3799-9; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Arbiza L, 2006, J MOL BIOL, V358, P1390, DOI 10.1016/j.jmb.2006.02.067; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Banati RB, 1997, J NEUROCYTOL, V26, P77, DOI 10.1023/A:1018567510105; Banati RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6452; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; Chen HL, 2005, NUCLEIC ACIDS RES, V33, P3193, DOI 10.1093/nar/gki633; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Colasanti A, 2013, PSYCHONEUROENDOCRINO, V38, P2826, DOI 10.1016/j.psyneuen.2013.07.007; Costa B, 2009, ENDOCRINOLOGY, V150, P5438, DOI 10.1210/en.2009-0752; Costa B, 2009, PSYCHIAT GENET, V19, P110, DOI 10.1097/YPG.0b013e32832080f6; Friedrich U, 2015, HUM MOL GENET, V24, P6361, DOI 10.1093/hmg/ddv346; Fuhrmann M, 2004, PLANT MOL BIOL, V55, P869, DOI 10.1007/s11103-004-2150-6; Gatliff J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.186; Gavish M, 1999, PHARMACOL REV, V51, P629; Guo YZ, 2015, SCIENCE, V347, P551, DOI 10.1126/science.aaa1534; Hecht M, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S8-S1; Jaipuria G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14893; Jaremko L, 2014, SCIENCE, V343, P1363, DOI 10.1126/science.1248725; Jaremko M, 2016, BIOMOL NMR ASSIGN, V10, P79, DOI 10.1007/s12104-015-9642-y; Jaremko M, 2015, CHEMBIOCHEM, V16, P1483, DOI 10.1002/cbic.201500217; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Kosek E, 2016, BRAIN BEHAV IMMUN, V58, P218, DOI 10.1016/j.bbi.2016.07.150; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kurumaji A, 2001, AM J MED GENET, V105, P172, DOI 10.1002/ajmg.1194; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li F, 2015, BIOCHEMISTRY-US, V54, P1441, DOI 10.1021/bi5015453; Li F, 2015, SCIENCE, V347, P555, DOI 10.1126/science.1260590; Milenkovic VM, 2015, MINI-REV MED CHEM, V15, P366, DOI 10.2174/1389557515666150324122642; Morohaku K, 2014, ENDOCRINOLOGY, V155, P89, DOI 10.1210/en.2013-1556; Nakamura K, 2006, AM J MED GENET B, V141B, P222, DOI 10.1002/ajmg.b.30211; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Owen DR, 2012, J CEREBR BLOOD F MET, V32, P1, DOI 10.1038/jcbfm.2011.147; Owen DRJ, 2011, INT REV NEUROBIOL, V101, P19, DOI 10.1016/B978-0-12-387718-5.00002-X; Owen DRJ, 2011, J NUCL MED, V52, P24, DOI 10.2967/jnumed.110.079459; Pratt CW, 2014, PSYCHIATRIC REHABILITATION, 3RD EDITION, P33, DOI 10.1016/B978-0-12-387002-5.00002-0; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Sandoval PC, 2013, J AM SOC NEPHROL, V24, P1793, DOI 10.1681/ASN.2013030279; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Setiawan E, 2015, JAMA PSYCHIAT, V72, P268, DOI 10.1001/jamapsychiatry.2014.2427; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Stocco DM, 2014, ENDOCRINOLOGY, V155, P6, DOI 10.1210/en.2013-2041; Thusberg J, 2009, HUM MUTAT, V30, P703, DOI 10.1002/humu.20938; Tu LN, 2014, J BIOL CHEM, V289, P27444, DOI 10.1074/jbc.M114.578286; Turkheimer FE, 2015, BIOCHEM SOC T, V43, P586, DOI 10.1042/BST20150058; Vomacka L, 2017, EJNMMI RES, V7, DOI 10.1186/s13550-017-0340-x	54	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195627	10.1371/journal.pone.0195627	http://dx.doi.org/10.1371/journal.pone.0195627			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641545	Green Submitted, Green Published, gold			2022-12-26	WOS:000429742900078
J	Brockman, T; Blanchard, V; Heretsch, P; Brockmann, C; Bertelmann, E				Brockman, Tobias; Blanchard, Veronique; Heretsch, Philipp; Brockmann, Claudia; Bertelmann, Eckart			Photochemical degradation of trypan blue	PLOS ONE			English	Article							INDOCYANINE GREEN; CATARACT-SURGERY; EPIRETINAL MEMBRANE; MASS-SPECTROMETRY; VITAL DYES; CELLS; LIGHT; CAROTENOIDS; VITRECTOMY; EXPOSURE	Purpose To investigate the photochemical degradation of trypan blue (TB) and to identify decomposition products. Methods Defined solution samples of TB and a mixture with lutein/zeaxanthin were exposed to blue light. Thermal degradation processes were ruled out using controls not subjected to irradiation. All samples were analyzed using optical microscopy, UVNis spectroscopy, matrix assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry and nuclear magnetic resonance (NMR) spectrometry. Degradation kinetics were determined based on changes in absorbance; intermediates were identified by analyzing mass differences of characteristic fragment ion peaks within the fragmentation patterns, and assignments were verified by NMR. Results TB demonstrated a photochemical degradation, which can be triggered by lutein/zeaxanthin. Intermediates vary depending on the presence of lutein/zeaxanthin. The self-sensitized photodegradation of TB occurs under generation of dimethyl sulfate and presumed formation of phenol. In contrast, within the presence of lutein/zeaxanthin the decomposition of TB indicates the formation of methoxyamine and sulfonyl arin. Thermal degradation processes were not observed. Conclusions TB demonstrated a photodegradation that may be triggered by lutein/zeaxanthin and results in the formation of cytotoxic decomposition products. Our findings contribute to understand degradation mechanisms of TB and may elucidate previous clinical and experimental observations of cellular toxicity after TB application.	[Brockman, Tobias; Brockmann, Claudia] Berlin Inst Hlth, Berlin, Germany; [Blanchard, Veronique; Brockmann, Claudia; Bertelmann, Eckart] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Berlin, Germany; [Blanchard, Veronique] Berlin Inst Hlth, Inst Lab Med Clin Chem & Pathobiochem, Berlin, Germany; [Heretsch, Philipp] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany; [Brockmann, Claudia; Bertelmann, Eckart] Berlin Inst Hlth, Dept Ophthalmol, Berlin, Germany	Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Berlin Institute of Health	Brockman, T (corresponding author), Berlin Inst Hlth, Berlin, Germany.; Bertelmann, E (corresponding author), Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Berlin, Germany.; Bertelmann, E (corresponding author), Berlin Inst Hlth, Dept Ophthalmol, Berlin, Germany.	tobias.brockmann@charite.de; eckart.bertelmann@charite.de	Heretsch, Philipp/AFU-6940-2022	Brockmann, Tobias/0000-0001-6939-1159; Blanchard, Veronique/0000-0002-5980-6450	Charite Universitatsmedizin Berlin; Berlin Institute of Health; German Research Foundation (DFG); Open Access Publication Fund of Charite - Universitatsmedizin Berlin	Charite Universitatsmedizin Berlin; Berlin Institute of Health; German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Fund of Charite - Universitatsmedizin Berlin	Dr. Tobias Brockmann and Dr. Claudia Brockmann are participants in the BIH Charite Clinical Scientist Program funded by the Charite Universitatsmedizin Berlin and the Berlin Institute of Health. None of the authors has a financial and proprietary interest in a product or lack thereof. We acknowledge support from the German Research Foundation (DFG) and the Open Access Publication Fund of Charite - Universitatsmedizin Berlin. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ach T, 2008, OPHTHALMOLOGE, V105, P905, DOI 10.1007/s00347-008-1795-y; [Anonymous], 2008, OPHTHALMOLOGY EXPERT; Awad D, 2011, INVEST OPHTH VIS SCI, V52, P4085, DOI 10.1167/iovs.10-6336; Bacsal KME, 2006, EYE, V20, P1310, DOI 10.1038/sj.eye.6702164; Barbazetto IA, 2004, EXP EYE RES, V78, P917, DOI 10.1016/j.exer.2004.01.003; Bernstein PS, 2001, EXP EYE RES, V72, P215, DOI 10.1006/exer.2000.0954; Brockmann T, 2014, ACTA OPHTHALMOL, V92, pe556, DOI 10.1111/aos.12419; Brockmann T, 2012, OPHTHALMOLOGICA, V228, P234, DOI 10.1159/000341605; Brockmann T, 2011, OPHTHALMOLOGICA, V226, P228, DOI 10.1159/000331218; Chang YS, 2005, J CATARACT REFR SURG, V31, P792, DOI 10.1016/j.jcrs.2004.07.020; Chou SY, 2016, RSC ADV, V6, P33478, DOI 10.1039/c5ra28024a; Creuzot-Garcher C, 2010, RETINA-J RET VIT DIS, V30, P1294, DOI 10.1097/IAE.0b013e3181d205aa; DeSesso JM, 2000, TERATOLOGY, V62, P346, DOI 10.1002/1096-9926(200011)62:5<346::AID-TERA9>3.0.CO;2-1; Ehrlich P., 1907, BERLINER KLIN WOCHEN, P320; Engel E, 2008, INVEST OPHTH VIS SCI, V49, P1777, DOI 10.1167/iovs.07-0911; Farah ME, 2009, AM J OPHTHALMOL, V148, P332, DOI 10.1016/j.ajo.2009.04.003; Feron EJ, 2002, ARCH OPHTHALMOL-CHIC, V120, P141; FORRESTER J, 1995, J CHEM SOC PERK T 1, P2289, DOI 10.1039/p19950002289; Fraser PD, 2007, PLANT J, V49, P552, DOI 10.1111/j.1365-313X.2006.02949.x; Gandorfer A, 2003, INVEST OPHTH VIS SCI, V44, P316, DOI 10.1167/iovs.02-0545; Giansanti F, 2014, J OCUL PHARMACOL TH, V30, P406, DOI 10.1089/jop.2013.0213; Gouws P, 2004, BRIT J OPHTHALMOL, V88, P1348, DOI 10.1136/bjo.2004.041756; GROSS P, 1985, CRC CR REV TOXICOL, V14, P87, DOI 10.3109/10408448509023765; Jacobs DS, 2006, OPHTHALMOLOGY, V113, P707, DOI 10.1016/j.ophtha.2006.01.024; Kaufmann R, 1996, ANAL BIOCHEM, V238, P117, DOI 10.1006/abio.1996.0264; Kodjikian L, 2005, GRAEF ARCH CLIN EXP, V243, P917, DOI 10.1007/s00417-004-1121-6; Krinsky NI, 2002, J NUTR, V132, p540S, DOI 10.1093/jn/132.3.540S; Lee YH, 2017, MOL CATAL, V432, P196, DOI 10.1016/j.mcat.2017.01.002; Li K, 2003, BRIT J OPHTHALMOL, V87, P216, DOI 10.1136/bjo.87.2.216; Liang JY, 2017, J PHOTOCH PHOTOBIO B, V174, P355, DOI 10.1016/j.jphotobiol.2017.08.018; Liu FY, 2018, CATAL TODAY, V300, P112, DOI 10.1016/j.cattod.2017.04.030; Luke M, 2013, OPHTHALMOLOGICA, V230, P21, DOI 10.1159/000353867; Maia M, 2007, CURR EYE RES, V32, P309, DOI 10.1080/02713680701199377; Mathison BH, 2004, INHAL TOXICOL, V16, P581, DOI 10.1080/08958370490464553; Melles GRJ, 1999, J CATARACT REFR SURG, V25, P7, DOI 10.1016/S0886-3350(99)80004-2; MITTAG T, 1984, EXP EYE RES, V39, P759, DOI 10.1016/0014-4835(84)90075-7; Morales MC, 2010, INVEST OPHTH VIS SCI, V51, P6018, DOI 10.1167/iovs.09-4916; Narayanan R, 2005, INVEST OPHTH VIS SCI, V46, P304, DOI 10.1167/iovs.04-0703; National Toxicology Program, 2011, Rep Carcinog, V12, P174; NORN MS, 1967, ACTA OPHTHALMOL, V45, P380; Penha FM, 2007, OPHTHALMOLOGY, V114, P899, DOI 10.1016/j.ophtha.2006.09.028; Polyakov NE, 2013, J PHYS CHEM B, V117, P10173, DOI 10.1021/jp4062708; Saeed Muhammad Usman, 2009, International Ophthalmology, V29, P239, DOI 10.1007/s10792-008-9195-5; Schutt CA, 2015, AM J OTOLARYNG, V36, P356, DOI 10.1016/j.amjoto.2014.12.009; Sinha R, 2003, BRIT J OPHTHALMOL, V87, P654, DOI 10.1136/bjo.87.5.654; Sousa- Martins D, inventor; Kemin Industries Inc, assignee. Water soluble lipophilic materials, Patent No. [WO/ 2017/ 142834, 2017142834]; Tsaousis KT, 2013, CLIN EXP OPHTHALMOL, V41, P484, DOI 10.1111/ceo.12018; Uno F, 2006, RETINA-J RET VIT DIS, V26, P237, DOI 10.1097/00006982-200602000-00026; Zsila F, 2001, J PHYS CHEM B, V105, P9413, DOI 10.1021/jp011626u	49	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195849	10.1371/journal.pone.0195849	http://dx.doi.org/10.1371/journal.pone.0195849			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634764	Green Submitted, gold, Green Published			2022-12-26	WOS:000429522200058
J	Chen, Z; Liu, LR; Pan, CL; Li, XN; Pan, L; Lan, WZ; Yang, ZK				Chen, Zhao; Liu, Luoru; Pan, Chenglin; Li, Xiaoning; Pan, Lun; Lan, Weizhong; Yang, Zhikuan			Ocular residual and corneal astigmatism in a clinical population of high school students	PLOS ONE			English	Article							ANYANG CHILDHOOD EYE; REFRACTIVE ERROR; INTERNAL ASTIGMATISM; MYOPIA DEVELOPMENT; CHINESE CHILDREN; POWER VECTORS; PREVALENCE; SCHOOLCHILDREN; LENSES; REPEATABILITY	Purpose Total refractive astigmatism is usually the first consideration that guides the selection of contact lens type (e.g., spherical or toric), while the ocular source of the astigmatism is a second, but more important consideration, for the final clinical decision. This study was conducted to provide detailed data on this topic by evaluating astigmatic components in Chinese adolescents. Methods Participants were recruited from healthy high school students undergoing an annual ocular examination at a local hospital. Total astigmatism (TA), corneal astigmatism (CA), and ocular residual astigmatism (ORA) were determined by a Hartmann-Shack wavefront analyzer system (KR-1W, Topcon) with the natural pupil. The axis relationship between CA and ORA was placed into three categories: on-axis, defined as an axis with a difference of 0 +/- 10 degrees; opposite-axis, a difference of 90 +/- 10 degrees; and the rest defined as oblique -axis. Results The study consisted of 1,466 students (57.84% girls, age: 16.49 +/- 1.05 years). ORA was present in 83.97%, 66.64%, and 45.23% of participants, according to the various criteria for astigmatism (>= 0.50 D, >= 0.75 D, and >= 1.00 D, respectively). While with-the-rule was the most common axis orientation for both TA (76.28%) and CA (89.94%), against-the-rule predominated in ORA (93.82%; chi(2) = 1688.544, p < 0.001). Opposite-axis was the major type of axis difference (90.96%) of clinical significance (i.e., >= 1.00 D) between CA and ORA, which also prevailed in all levels of TA (range: 56.25-82.26%). Conclusions ORA is common in high school students and usually demonstrates a compensation relationship with CA, which should be taken into consideration when determining the design of contact lenses to correct refractive error.	[Chen, Zhao; Pan, Chenglin; Li, Xiaoning; Pan, Lun; Lan, Weizhong; Yang, Zhikuan] Cent S Univ, Aier Sch Ophthalmol, Aier Inst Optometry & Vis Sci, Changsha, Hunan, Peoples R China; [Liu, Luoru] Anyang Eye Hosp, Anyang, Henan, Peoples R China	Central South University	Lan, WZ; Yang, ZK (corresponding author), Cent S Univ, Aier Sch Ophthalmol, Aier Inst Optometry & Vis Sci, Changsha, Hunan, Peoples R China.	13725458845@139.com; 13380071988@189.cn		Chen, Zhao/0000-0002-3970-5249; Lan, Weizhong/0000-0002-3829-7415	Science Research Foundation of Aier Eye Hospital Group [2013002]; Hunan province Foundation for Science Technology [2017WK2071]	Science Research Foundation of Aier Eye Hospital Group; Hunan province Foundation for Science Technology	This study was funded by Science Research Foundation of Aier Eye Hospital Group (Grant No. 2013002) and Hunan province Foundation for Science & Technology (Grant No. 2017WK2071). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpins N, 2001, J CATARACT REFR SURG, V27, P31, DOI 10.1016/S0886-3350(00)00798-7; Benito A, 2009, AM J OPHTHALMOL, V147, P424, DOI 10.1016/j.ajo.2008.09.027; Cowen L, 2003, INVEST OPHTH VIS SCI, V44, P4593, DOI 10.1167/iovs.02-0730; Cox DJ, 2015, OPTOMETRY VISION SCI, V92, P404, DOI 10.1097/OPX.0000000000000554; DUNNE MCM, 1994, ACTA OPHTHALMOL, V72, P483; Eom Y, 2013, AM J OPHTHALMOL, V156, P1112, DOI 10.1016/j.ajo.2013.06.039; Fan DSP, 2004, BRIT J OPHTHALMOL, V88, P938, DOI 10.1136/bjo.2003.030338; Fotouhi A, 2011, OPTOMETRY VISION SCI, V88, P1054, DOI 10.1097/OPX.0b013e318221727d; GROSVENOR T, 1988, AM J OPTOM PHYS OPT, V65, P292; Harle DE, 2006, OPTOMETRY VISION SCI, V83, P82, DOI 10.1097/01.opx.0000200680.95968.3e; Harvey EM, 2013, J AAPOS, V17, P494, DOI 10.1016/j.jaapos.2013.05.015; Hoffmann PC, 2010, J CATARACT REFR SURG, V36, P1479, DOI 10.1016/j.jcrs.2010.02.025; Huynh SC, 2006, INVEST OPHTH VIS SCI, V47, P55, DOI 10.1167/iovs.05-0182; Huynh SC, 2007, INVEST OPHTH VIS SCI, V48, P73, DOI 10.1167/iovs.06-0263; Keller PR, 1996, OPTOMETRY VISION SCI, V73, P86, DOI 10.1097/00006324-199602000-00003; Lan WZ, 2008, OPHTHAL PHYSL OPT, V28, P57, DOI 10.1111/j.1475-1313.2007.00536.x; Leung TW, 2012, OPTOMETRY VISION SCI, V89, P984, DOI 10.1097/OPX.0b013e31825da156; Li SM, 2015, INVEST OPHTH VIS SCI, V56, P4734, DOI 10.1167/iovs.14-15474; Li SM, 2015, BRIT J OPHTHALMOL, V99, P674, DOI 10.1136/bjophthalmol-2014-305322; Liu YL, 2017, JPN J OPHTHALMOL, V61, P494, DOI 10.1007/s10384-017-0532-y; Liu YC, 2011, INVEST OPHTH VIS SCI, V52, P9651, DOI 10.1167/iovs.11-7641; Manny RE, 2016, OPTOMETRY VISION SCI, V93, P1079, DOI 10.1097/OPX.0000000000000946; Maples W C, 1997, J Am Optom Assoc, V68, P87; Mashige KP, 2016, OPTOMETRY VISION SCI, V93, P243, DOI 10.1097/OPX.0000000000000771; OLSEN T, 1986, BRIT J OPHTHALMOL, V70, P152, DOI 10.1136/bjo.70.2.152; Ozdemir O, 2015, INT J OPHTHALMOL-CHI, V8, P128, DOI 10.3980/j.issn.2222-3959.2015.01.24; Pinero DP, 2011, J REFRACT SURG, V27, P509, DOI 10.3928/1081597X-20101214-01; Rajavi Zhale, 2012, J Ophthalmic Vis Res, V7, P3; Read SA, 2007, CLIN EXP OPTOM, V90, P5, DOI 10.1111/J.1444-0938.2007.00112.x; Remon L, 2009, OPTOMETRY VISION SCI, V86, P1182, DOI 10.1097/OPX.0b013e3181baac2c; Sanfilippo PG, 2015, ACTA OPHTHALMOL, V93, pE377, DOI 10.1111/aos.12644; Shankar S, 2004, OPTOMETRY VISION SCI, V81, P536, DOI 10.1097/00006324-200407000-00015; Shih YF, 2004, OPTOMETRY VISION SCI, V81, P94, DOI 10.1097/00006324-200402000-00007; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P367, DOI 10.1097/00006324-199706000-00019; Tong L, 2002, OPTOMETRY VISION SCI, V79, P606, DOI 10.1097/00006324-200209000-00012; Tong L, 2001, OPTOMETRY VISION SCI, V78, P881, DOI 10.1097/00006324-200112000-00010; Visser N, 2012, J CATARACT REFR SURG, V38, P1764, DOI 10.1016/j.jcrs.2012.05.036; Wills J, 2012, OPTOMETRY VISION SCI, V89, P271, DOI 10.1097/OPX.0b013e3182429c6b; Wolfram C, 2014, BRIT J OPHTHALMOL, V98, P857, DOI 10.1136/bjophthalmol-2013-304228; Xiao X, 2014, OPTOMETRY VISION SCI, V91, P390, DOI 10.1097/OPX.0000000000000221; Yang ZK, 2008, INVEST OPHTH VIS SCI, V49, P4779, DOI 10.1167/iovs.07-1616; Yang ZK, 2009, OPHTHAL PHYSL OPT, V29, P41, DOI 10.1111/j.1475-1313.2008.00608.x; Zhu BD, 2013, INVEST OPHTH VIS SCI, V54, P8104, DOI 10.1167/iovs.13-11958	43	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194513	10.1371/journal.pone.0194513	http://dx.doi.org/10.1371/journal.pone.0194513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630629	Green Published, Green Submitted, gold			2022-12-26	WOS:000429505000011
J	Choi, SKY; Boyle, E; Cairney, J; Grootendorst, P; Gardner, S; Collins, EJ; Kendall, C; Rourke, SB				Choi, Stephanie K. Y.; Boyle, Eleanor; Cairney, John; Grootendorst, Paul; Gardner, Sandra; Collins, Evan J.; Kendall, Claire; Rourke, Sean B.		OHTN Cohort Study	Impact of depression and recreational drug use on emergency department encounters and hospital admissions among people living with HIV in Ontario: A secondary analysis using the OHTN cohort study	PLOS ONE			English	Article							SUBSTANCE USE DISORDERS; LONG-TERM CONDITIONS; MENTAL-HEALTH; COLLABORATIVE CARE; INFECTED PATIENTS; UNSCHEDULED CARE; SERVICES; HIV/AIDS; OUTCOMES; ILLNESS	Introduction Nearly half of HIV-positive patients experience mental health and substance use problems, but many do not receive adequate or ongoing mental health or addiction care. This lack of ongoing care can result in the use of costly acute care services. Prospective evaluations of the relationship between psychiatric and substance use disorders and acute care services use are lacking, and this information is needed to understand unmet needs and improve access to appropriate services. Methods We conducted a secondary data analysis from a multicenter, longitudinal, prospective cohort study (n = 3,482 adults) between October 1, 2007 and March 31, 2013. We used explanatory extended Cox proportional hazard regression models to examine the impact of current depression and recreational drug use on acute care services use, and to explore whether current depression and recreational drug use were associated with potentially avoidable acute care services use. Results Over our 5.5 year study period, HIV-positive participants with current depression-only (aHR [95% CI]:1.2[1.1-1.4]), recreational drug use-only (1.3[1.1-1.6]), or co-occurring depression and recreational drug use (1.4[1.2-1.7]) were associated with elevated hazard of emergency department (ED) encounters compared to participants without these conditions. Over half of ED encounters were potentially avoidable. Participants with current depression-only (1.3[1.1-1.5];1.3[1.03-1.6]), recreational drug use-only (1.3[1.04-1.6];1.5[1.1-1.9]), or co-occurring depression and recreational drug use (1.3[1.04-1.7];1.4[1.06-1.9]) were associated with elevated hazard of low-acuity or repeated ED encounters respectively. Conclusions We found a significant increase in ED services use and potentially avoidable ED encounters (including low-acuity or repeated ED encounters), particularly among those with either current depression or recreational drug use. These findings emphasize the challenges in managing HIV and mental health/addiction co-morbidities in the current HIV care model. Future research should evaluate integrated and collaborative care programs for improving the coordination of care and effectively treat mental health and addiction problems among HIV-positive patients in Ontario.	[Choi, Stephanie K. Y.; Rourke, Sean B.] Ontario HIV Treatment Network, Toronto, ON, Canada; [Choi, Stephanie K. Y.] Univ New South Wales, Fac Med, Sydney, NSW, Australia; [Boyle, Eleanor; Cairney, John; Gardner, Sandra] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Boyle, Eleanor] Univ Southern Denmark, Inst Sports Sci & Clin Biomech, Odense, Denmark; [Cairney, John] McMaster Univ, Dept Family Med, Hamilton, ON, Canada; [Cairney, John; Kendall, Claire] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Cairney, John] McMaster Univ, Infant & Child Hlth Lab, Hamilton, ON, Canada; [Cairney, John] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Cairney, John] McMaster Univ, CanChild Ctr Childhood Disabil Res, Hamilton, ON, Canada; [Cairney, John] McMaster Univ, Offord Ctr Child Studies, Hamilton, ON, Canada; [Cairney, John] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Cairney, John] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Cairney, John] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Grootendorst, Paul] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Grootendorst, Paul] Univ Toronto, Sch Publ Policy & Governance, Toronto, ON, Canada; [Grootendorst, Paul] McMaster Univ, Dept Econ, Hamilton, ON, Canada; [Gardner, Sandra] Baycrest Hosp, Rotman Res Inst, Toronto, ON, Canada; [Collins, Evan J.; Rourke, Sean B.] Univ Toronto, Dept Psychiat, Fac Med, Toronto, ON, Canada; [Collins, Evan J.] Univ Hlth Network, Toronto, ON, Canada; [Kendall, Claire] Bruyere Res Inst, Ottawa, ON, Canada; [Kendall, Claire] Univ Ottawa, Ottawa, ON, Canada; [Kendall, Claire] Ottawa Hosp, Ottawa, ON, Canada; [Rourke, Sean B.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Urban Hlth Solut, Toronto, ON, Canada	University of New South Wales Sydney; University of Toronto; University of Southern Denmark; McMaster University; University of Toronto; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Toronto; McMaster University; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Rourke, SB (corresponding author), Ontario HIV Treatment Network, Toronto, ON, Canada.; Rourke, SB (corresponding author), Univ Toronto, Dept Psychiat, Fac Med, Toronto, ON, Canada.; Rourke, SB (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Urban Hlth Solut, Toronto, ON, Canada.	sean.rocrke@utoronto.ca	Cairney, John/AAQ-9703-2020; Boyle, Eleanor/G-4567-2016	Cairney, John/0000-0003-2856-3967; Boyle, Eleanor/0000-0002-9012-9128; Kendall, Claire/0000-0003-2686-1135; Choi, Stephanie Ka Yee/0000-0003-3019-5729; Grootendorst, Paul/0000-0003-1978-2834	Ontario HIV Treatment Network (OHTN); Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care (MOHLTC)	Ontario HIV Treatment Network (OHTN); Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	The study was supported by the Ontario HIV Treatment Network (OHTN) and the Institute for Clinical Evaluative Sciences, which are funded by annual grants from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Atlantis E, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004706; Bansil P, 2009, AIDS CARE, V21, P1432, DOI 10.1080/09540120902814387; Barua B, 2015, WAITING YOUR TURN; Bess KD, 2013, AIDS PATIENT CARE ST, V27, P171, DOI 10.1089/apc.2012.0406; Bing EG, 2001, ARCH GEN PSYCHIAT, V58, P721, DOI 10.1001/archpsyc.58.8.721; Brien S., 2015, TAKING STOCK REPORT; Bullard MJ, 2014, CAN J EMERG MED, V16, P485, DOI 10.2310/8000.2014.012014; Canadian Institute for Health Information [creator], 2015, DISCH ABSTR DAT; Chibanda D, 2014, JAIDS-J ACQ IMM DEF, V67, pS54, DOI 10.1097/QAI.0000000000000258; Choi BY, 2016, WEST J EMERG MED, V17, P153, DOI 10.5811/westjem.2016.1.28310; Choi SKY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165816; Choi SKY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156652; Choi SKY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142706; Christopoulos KA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001863; Chu C, 2011, J URBAN HEALTH, V88, P556, DOI 10.1007/s11524-011-9552-y; Cook JA, 2014, AIDS BEHAV, V18, P1094, DOI 10.1007/s10461-013-0679-6; Curran GM, 2011, AIDS CARE, V23, P1626, DOI 10.1080/09540121.2011.579943; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Dickens C, 2012, J PSYCHOSOM RES, V73, P334, DOI 10.1016/j.jpsychores.2012.08.018; Fairbairn N, 2012, J EMERG MED, V43, P236, DOI 10.1016/j.jemermed.2011.05.020; Ford N, 2015, LANCET HIV, V2, pE438, DOI 10.1016/S2352-3018(15)00137-X; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Himelhoch S, 2007, GEN HOSP PSYCHIAT, V29, P518, DOI 10.1016/j.genhosppsych.2007.03.008; Huang YF, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-260; Iron K., 2006, ICES REPORT HLTH DAT, V9, P24, DOI [10.12927/hcq, DOI 10.12927/HCQ]; Josephs JS, 2010, HIV MED, V11, P74, DOI 10.1111/j.1468-1293.2009.00748.x; Kaaya S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001447; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Katz MH, 1996, AIDS CARE, V8, P433, DOI 10.1080/09540129650125623; Krentz HB, 2006, HIV MED, V7, P457, DOI 10.1111/j.1468-1293.2006.00408.x; Kurdyak P, 2014, OPEN MED, V8, P99; Lam CN, 2016, WEST J EMERG MED, V17, P607, DOI 10.5811/westjem.2016.6.30690; Langer S, 2013, HEALTH SOC CARE COMM, V21, P339, DOI 10.1111/j.1365-2524.2012.01093.x; Mental Health Commission of Canada, 2012, CHANG DIR; Nanni MG, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-014-0530-4; Painter JT, 2015, JAIDS-J ACQ IMM DEF, V70, P377, DOI 10.1097/QAI.0000000000000732; Prina AM, 2015, J PSYCHOSOM RES, V78, P25, DOI 10.1016/j.jpsychores.2014.11.002; Ross LE, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0353-3; Rourke SB, 2013, INT J EPIDEMIOL, V42, P402, DOI 10.1093/ije/dyr230; Sharpe M, 2014, LANCET, V384, P1099, DOI 10.1016/S0140-6736(14)61231-9; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; StataCorp, 2013, STAT STAT SOFTW REL; Taylor SL, 2004, RELATIONSHIP TYPE ME; The Canadian Institute for Health Information, 2015, NAT AMB CAR REP SYST; Tricco AC, 2014, CAN MED ASSOC J, V186, pE568, DOI 10.1503/cmaj.140289; Uthman OA, 2014, CURR HIV-AIDS REP, V11, P291, DOI 10.1007/s11904-014-0220-1; Vittinghoff E, 2012, REGRESSION METHODS B; Weaver MR, 2008, JAIDS-J ACQ IMM DEF, V47, P449, DOI 10.1097/QAI.0b013e3181642244; Woltmann E, 2012, AM J PSYCHIAT, V169, P790, DOI 10.1176/appi.ajp.2012.11111616	50	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195185	10.1371/journal.pone.0195185	http://dx.doi.org/10.1371/journal.pone.0195185			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630615	gold, Green Published, Green Submitted			2022-12-26	WOS:000429505000029
J	Liao, SY; Schneider, NRE; Huttlin, P; Grutzner, PA; Weilbacher, F; Matschke, S; Popp, E; Kreinest, M				Liao, Shiyao; Schneider, Niko R. E.; Huettlin, Petra; Gruetzner, Paul A.; Weilbacher, Frank; Matschke, Stefan; Popp, Erik; Kreinest, Michael			Motion and dural sac compression in the upper cervical spine during the application of a cervical collar in case of unstable craniocervical junction-A study in two new cadaveric trauma models	PLOS ONE			English	Article							CRANIOVERTEBRAL JUNCTION; RIGID COLLAR; OCCIPITOVERTEBRAL RELATIONSHIPS; ATLANTOOCCIPITAL DISLOCATION; RADIOLOGIC-DIAGNOSIS; LATERAL RADIOGRAPHS; TRANSVERSE LIGAMENT; ATLANTOAXIAL JOINTS; NORMAL ANATOMY; INJURIES	Background Unstable conditions of the craniocervical junction such as atlanto-occipital dislocation (AOD) or atlanto-axial instability (AAI) are severe injuries with a high risk of tetraplegia or death. Immobilization by a cervical collar to protect the patient from secondary damage is a standard procedure in trauma patients. If the application of a cervical collar to a patient with an unstable craniocervical condition may cause segmental motion and secondary injury to the spinal cord is unknown. The aim of the current study is (i) to analyze compression on the dural sac and (ii) to determine relative motion of the cervical spine during the procedure of applying a cervical collar in case of ligamentous unstable craniocervical junction. Methods and findings Ligamentous AOD as well as AOD combined with ligamentous AAI was simulated in two newly developed cadaveric trauma models. Compression of the dural sac and segmental angulation in the upper cervical spine were measured on video fluoroscopy after myelography during the application of a cervical collar. Furthermore, overall three-dimensional motion of the cervical spine was measured by a motion tracking system. In six cadavers each, the two new trauma models on AOD and AOD combined with AAI could be implemented. Mean dural sac compression was significantly increased to-1.1 mm (-1.3 to-0.7 mm) in case of AOD and-1.2 mm (-1.6 to-0.6 mm) in the combined model of AOD and AAI. Furthermore, there is a significant increased angulation at the C0/C1 level in the AOD model. Immense three-dimensional movement up to 22.9 of cervical spine flexion was documented during the procedure. Conclusion The current study pointed out that applying a cervical collar in general will cause immense three-dimensional movement. In case of unstable craniocervical junction, this leads to a dural sac compression and thus to possible damage to the spinal cord.	[Liao, Shiyao; Huettlin, Petra; Gruetzner, Paul A.; Matschke, Stefan; Kreinest, Michael] BG Trauma Ctr Ludwigshafen, Dept Trauma Surg & Orthopaed, Ludwigshafen, Germany; [Schneider, Niko R. E.; Weilbacher, Frank; Popp, Erik] Univ Hosp Heidelberg, Dept Anesthesiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Kreinest, M (corresponding author), BG Trauma Ctr Ludwigshafen, Dept Trauma Surg & Orthopaed, Ludwigshafen, Germany.	michael.kreinest@bgu-ludwigshafen.de	Kreinest, Michael/ABI-7282-2020					ALKER GJ, 1978, ORTHOP CLIN N AM, V9, P1003; ALKER GJ, 1975, RADIOLOGY, V114, P611; Bell KM, 2009, SPINE J, V9, P225, DOI 10.1016/j.spinee.2008.03.010; Bellabarba C, 2006, J NEUROSURG-SPINE, V4, P429, DOI 10.3171/spi.2006.4.6.429; Ben-Galim P, 2010, J TRAUMA, V69, P447, DOI 10.1097/TA.0b013e3181be785a; Bisson E, 2010, SPINE, V35, pE316, DOI 10.1097/BRS.0b013e3181c41d2c; BOHLMAN HH, 1979, J BONE JOINT SURG AM, V61, P1119, DOI 10.2106/00004623-197961080-00001; Bono CM, 2007, SPINE, V32, P593, DOI 10.1097/01.brs.0000257345.21075.a7; Brown T, 2005, SPINE, V30, pE503, DOI 10.1097/01.brs.0000176245.46965.e8; BUCHOLZ RW, 1979, J TRAUMA, V19, P768, DOI 10.1097/00005373-197910000-00009; Child Z, 2016, SPINE J, V16, P1116, DOI 10.1016/j.spinee.2016.03.057; CRAIG GR, 1991, INTENS CARE MED, V17, P504, DOI 10.1007/BF01690778; CREMERS MJG, 1993, ARCH DIS CHILD, V69, P347, DOI 10.1136/adc.69.3.347; Davies G, 1996, INJURY, V27, P647, DOI 10.1016/S0020-1383(96)00115-5; Donaldson WF, 1997, SPINE, V22, P1215, DOI 10.1097/00007632-199706010-00008; EISMONT FJ, 1984, SPINE, V9, P663, DOI 10.1097/00007632-198410000-00001; FLOMAN Y, 1991, J BONE JOINT SURG BR, V73, P640, DOI 10.1302/0301-620X.73B4.2071650; Goutcher CM, 2005, BRIT J ANAESTH, V95, P344, DOI 10.1093/bja/aei190; Hall GC, 2015, WORLD J ORTHOP, V6, P236, DOI 10.5312/wjo.v6.i2.236; HARRIS JH, 1994, AM J ROENTGENOL, V162, P881, DOI 10.2214/ajr.162.4.8141012; HARRIS JH, 1994, AM J ROENTGENOL, V162, P887, DOI 10.2214/ajr.162.4.8141013; Helm M, 2013, ANAESTHESIST, V62, P973, DOI 10.1007/s00101-013-2255-x; Herrada-Pineda T, 2015, CIR CIR, V83, P135, DOI 10.1016/j.circir.2015.04.009; HINCK VC, 1960, AMER J ROENTGENOL RA, V84, P945; Hindman BJ, 2015, ANESTHESIOLOGY, V123, P1042, DOI 10.1097/ALN.0000000000000830; Holla M, 2012, EMERG MED J, V29, P104, DOI 10.1136/emj.2010.092973; Hunt K, 2001, ANAESTHESIA, V56, P511, DOI 10.1046/j.1365-2044.2001.02053.x; James CY, 2004, J ATHL TRAINING, V39, P138; KANG JD, 1994, J BONE JOINT SURG AM, V76A, P1617, DOI 10.2106/00004623-199411000-00004; Karhu JO, 2005, ACTA RADIOL, V46, P55, DOI 10.1080/02841850510012012; Kato G, 2015, SPINE J, V15, pE69, DOI 10.1016/j.spinee.2015.06.009; Kaul A, 2016, J NEUROSURG-SPINE, V25, P756, DOI 10.3171/2015.10.SPINE15337; Kleweno CP, 2008, SPINE, V33, pE659, DOI 10.1097/BRS.0b013e318182272a; Kolb JC, 1999, AM J EMERG MED, V17, P135, DOI 10.1016/S0735-6757(99)90044-X; Kornhall DK, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-016-0345-x; Kreinest M, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0267-7; Kreinest M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143409; Labler L, 2004, EUR SPINE J, V13, P172, DOI 10.1007/s00586-003-0653-5; Lador R, 2011, J TRAUMA, V70, P247, DOI 10.1097/TA.0b013e3181fd0ebf; Lennarson PJ, 2000, J NEUROSURG, V92, P201, DOI 10.3171/spi.2000.92.2.0201; Maiman D J, 1988, J Spinal Disord, V1, P134; Matschke S, 2016, TRAUMA BERUFSKRANKH, V18, P281, DOI 10.1007/s10039-016-0212-z; McCahon RA, 2015, ANAESTHESIA, V70, P452, DOI 10.1111/anae.12956; Mendenhall SK, 2015, SPINE J, V15, P2385, DOI 10.1016/j.spinee.2015.07.003; Milz S, 2001, SPINE, V26, P1765, DOI 10.1097/00007632-200108150-00007; Mobbs RJ, 2002, ANZ J SURG, V72, P389, DOI 10.1046/j.1445-2197.2002.02462.x; Nidecker AE, 2016, J NEUROL SURG PART B, V77, P388, DOI 10.1055/s-0036-1584230; Rojas CA, 2007, AM J NEURORADIOL, V28, P1819, DOI 10.3174/ajnr.A0660; Salinsky JP, 2007, PEDIATR NEUROSURG, V43, P137, DOI 10.1159/000098389; Schweigkofler U, 2013, CHIRURG, V84, P739, DOI 10.1007/s00104-013-2475-2; Shrier I, 2015, PREHOSP EMERG CARE, V19, P116, DOI 10.3109/10903127.2014.936634; Skala-Rosenbaum J, 2014, EUR SPINE J, V23, pS242, DOI 10.1007/s00586-013-3112-y; SMOKER WRK, 1994, RADIOGRAPHICS, V14, P255, DOI 10.1148/radiographics.14.2.8190952; Steinmetz MP, 2003, NEUROSURG FOCUS, V14, P1; Stone MB, 2010, ACAD EMERG MED, V17, P100, DOI 10.1111/j.1553-2712.2009.00624.x; Subcommittee A, 2013, J TRAUMA ACUTE CARE, V74, P1363; Subramanian N, 2007, SPINE, V32, P518, DOI 10.1097/01.brs.0000256449.95667.13; Sundstrom T, 2014, J NEUROTRAUM, V31, P531, DOI 10.1089/neu.2013.3094; Violas P, 2006, CLIN ORTHOP RELAT R, P286, DOI 10.1097/01.blo.0000201164.05561.e9; Walters BC, 2013, NEUROSURGERY, V60, P82, DOI 10.1227/01.neu.0000430319.32247.7f; Weinshel S, 1988, J Spinal Disord, V1, P317; Wellborn CC, 2000, J PEDIATR ORTHOPED, V20, P66, DOI 10.1097/00004694-200001000-00015; WERNE SVEN, 1957, ACTA ORTHOPAED SCAND SUPPL, V23, P1; Wolfi CG, 2008, UNFALLCHIRURG, V111, P688, DOI 10.1007/s00113-008-1466-0; Zaaroor M, 2006, MINIM INVAS NEUROSUR, V49, P220, DOI 10.1055/s-2006-948000; Zapalowicz Krzysztof, 2003, Neurol Neurochir Pol, V37, P1127	66	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195215	10.1371/journal.pone.0195215	http://dx.doi.org/10.1371/journal.pone.0195215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624623	gold, Green Published			2022-12-26	WOS:000429379600018
J	Martinez, E; Aira, Z; Buesa, I; Aizpurua, I; Rada, D; Azkue, JJ				Martinez, Endika; Aira, Zigor; Buesa, Itsaso; Aizpurua, Ibane; Rada, Diego; Azkue, Jon Jatsu			Embodied pain in fibromyalgia: Disturbed somatorepresentations and increased plasticity of the body schema	PLOS ONE			English	Article							RUBBER-HAND ILLUSION; REFLEX SYMPATHETIC DYSTROPHY; HEALTH-CARE UTILIZATION; PHANTOM LIMB PAIN; QUALITY-OF-LIFE; ANOREXIA-NERVOSA; BACK-PAIN; MENTAL REPRESENTATIONS; PERCEPTION DISTURBANCE; DIAGNOSTIC-CRITERIA	Fibromyalgia syndrome (FMS) is a highly prevalent, chronic musculoskeletal condition characterized by widespread pain and evoked pain at tender points. This study evaluated various aspects of body awareness in a sample of 14 women with FMS and 13 healthy controls, such as plasticity of the body schema, body esteem, and interoceptive awareness. To this end, the Rubber Hand Illusion (RHI), the Body Esteem Scale (BES), and the Body Perception Questionnaire (BPQ) were used, respectively. Consistent with increased plasticity of the body schema, FMS patients scored higher, with large or very large effect sizes, across all three domains evaluated in the RHI paradigm, namely proprioceptive drift and perceived ownership and motor control over the rubber hand. Scores on all items addressed by the BES were consistently lower among FMS subjects (2.52, SEM.19 vs 3.89, SEM.16, respectively, p < .01, Cohen's d = .38-.66). In the FMS sample, BES scores assigned to most painful regions also were lower than those assigned to the remaining body sites (1.58, SEM.19 vs 2.87, SEM.18, respectively, p < .01). Significantly higher scores (p < .01, Cohen's d.51-.87) were found in the FMS sample across awareness (3.57 SEM.15 vs 1.87 SEM.11), stress response (3.76 SEM.11 vs 1.78 SEM.11), autonomic nervous system reactivity (2.59 SEM.17 vs 1.35 SEM.07), and stress style 2 (2.73 SEM.27 vs 1.13 SEM.04) subscales of the BPQ. Intensity of ongoing clinical pain was found to be strongly correlated with interoceptive awareness (r = .75, p = .002). The results suggest a disturbed embodiment in FMS, characterized by instability of the body schema, negatively biased cognitions regarding one's own body, and increased vigilance to internal bodily cues. These manifestations may be interpreted as related with the inability of incoming sensory inputs to adequately update negatively biased off-line somatorepresentations stored as long-term memory.	[Martinez, Endika; Aira, Zigor; Buesa, Itsaso; Aizpurua, Ibane; Azkue, Jon Jatsu] Univ Basque Country, Dept Neurosci, Sch Med & Nursery, UPV EHU, Barrio Sarriena S-N, Leioa, Bizkaia, Spain; [Rada, Diego] Univ Basque Country, Sch Pharm, Prevent Med & Publ Hlth Dept, UPV EHU Paseo Univ, Vitoria, Araba, Spain	University of Basque Country; University of Basque Country	Buesa, I (corresponding author), Univ Basque Country, Dept Neurosci, Sch Med & Nursery, UPV EHU, Barrio Sarriena S-N, Leioa, Bizkaia, Spain.	itsaso.buesa@ehu.eus	Buesa, Itsaso/ABF-6852-2020; Aira, Zigor/ABG-4661-2020; Azkue, Jon Jatsu/H-2023-2015	Aizpurua, Ibane/0000-0001-9190-1864; Azkue, Jon Jatsu/0000-0002-8609-5500; Martinez, Endika/0000-0002-1755-2106	Basque Government (Euskal unibertsitate-sistemako ikerketa-taldeen jarduerak bultzatzeko diru-laguntzak) [GIC15/25]; University of the Basque Country UPV/EHU [PPG17/06]	Basque Government (Euskal unibertsitate-sistemako ikerketa-taldeen jarduerak bultzatzeko diru-laguntzak); University of the Basque Country UPV/EHU	This work was supported by the Basque Government (Euskal unibertsitate-sistemako ikerketa-taldeen jarduerak bultzatzeko diru-laguntzak, GIC15/25) and the University of the Basque Country UPV/EHU (PPG17/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are deeply indebted to AVAFAS (Asociacion Vasca de Fibromialgia y Astenia Cronica) for participating in this study. Supported by the Basque Government (Euskal unibertsitate-sistemako ikerketa-taldeen jarduerak bultzatzeko diru-laguntzak, GIC15/25) and the University of the Basque Country UPV/EHU (PPG17/06).	Ablin JN, 2012, CLIN EXP RHEUMATOL, V30, pS39; Akkaya N, 2012, CLIN RHEUMATOL, V31, P983, DOI 10.1007/s10067-012-1965-9; Alexander RW, 1998, ARTHRIT CARE RES, V11, P102, DOI 10.1002/art.1790110206; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Arendt-Nielsen Lars, 2003, Curr Pain Headache Rep, V7, P355, DOI 10.1007/s11916-003-0034-0; Baum C, 2011, PERCEPT MOTOR SKILL, V112, P926, DOI 10.2466/02.09.22.PMS.112.3.926-946; Bertamini M, 2011, CONSCIOUS COGN, V20, P1108, DOI 10.1016/j.concog.2011.04.006; Borg C, 2015, BRAIN COGNITION, V101, P35, DOI 10.1016/j.bandc.2015.10.002; Borsook D, 2003, ADV DRUG DELIVER REV, V55, P967, DOI 10.1016/S0169-409X(03)00099-1; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Boyington Josephine E A, 2015, Open Rheumatol J, V9, P1, DOI 10.2174/1874312901409010001; Branco JC, 2010, SEMIN ARTHRITIS RHEU, V39, P448, DOI 10.1016/j.semarthrit.2008.12.003; Bultitude JH, 2017, BRAIN, V140, P2306, DOI 10.1093/brain/awx152; Bultitude JH, 2010, EXP BRAIN RES, V204, P409, DOI 10.1007/s00221-009-2107-8; BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728; Burgess N, 2006, TRENDS COGN SCI, V10, P551, DOI 10.1016/j.tics.2006.10.005; Coslett HB, 2002, NEUROLOGY, V59, P357, DOI 10.1212/WNL.59.3.357; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Crombez G, 2004, CLIN J PAIN, V20, P98, DOI 10.1097/00002508-200403000-00006; Ares JD, 2015, PAIN PRACT, V15, P643, DOI 10.1111/papr.12219; de Vignemont F, 2005, CURR BIOL, V15, P1286, DOI 10.1016/j.cub.2005.06.067; Desmeules JA, 2003, ARTHRITIS RHEUM-US, V48, P1420, DOI 10.1002/art.10893; Dijkerman HC, 2007, BEHAV BRAIN SCI, V30, P189, DOI 10.1017/S0140525X07001392; Drossman DA, 2000, PSYCHOSOM MED, V62, P309, DOI 10.1097/00006842-200005000-00004; Dunn BD, 2010, BEHAV RES THER, V48, P1133, DOI 10.1016/j.brat.2010.07.006; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Eshkevari E, 2012, PSYCHOL MED, V42, P819, DOI 10.1017/S0033291711002091; Eubanks JR, 2006, PERCEPT MOTOR SKILL, V102, P485, DOI 10.2166/OMS.102.2.485-497; Fayed N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3072; Filbrich L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10077-8; Finestone HM, 2000, CHILD ABUSE NEGLECT, V24, P547, DOI 10.1016/S0145-2134(00)00112-5; Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991; Forderreuther S, 2004, PAIN, V110, P756, DOI 10.1016/j.pain.2004.05.019; FRANZOI SL, 1984, J PERS ASSESS, V48, P173, DOI 10.1207/s15327752jpa4802_12; GALER BS, 1995, J PAIN SYMPTOM MANAG, V10, P385, DOI 10.1016/0885-3924(95)00061-3; Gaudio S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110087; Giudice NA, 2013, EXP BRAIN RES, V224, P141, DOI 10.1007/s00221-012-3295-1; Giummarra MJ, 2007, BRAIN RES REV, V54, P219, DOI 10.1016/j.brainresrev.2007.01.009; Goldberg RT, 1999, DISABIL REHABIL, V21, P23, DOI 10.1080/096382899298061; Golding JM, 2002, J TRAUMA STRESS, V15, P187, DOI 10.1023/A:1015247110020; Green CR, 2001, CLIN J PAIN, V17, P359, DOI 10.1097/00002508-200112000-00011; Guterstam A, 2011, PLOS ONE, V6, P1; Haans A, 2008, BODY IMAGE, V5, P389, DOI 10.1016/j.bodyim.2008.04.003; Harden RN, 2007, PAIN MED, V8, P326, DOI 10.1111/j.1526-4637.2006.00169.x; Harlow BL, 2005, AM J EPIDEMIOL, V161, P871, DOI 10.1093/aje/kwi108; Herbert BM, 2011, J PERS, V79, P1149, DOI 10.1111/j.1467-6494.2011.00717.x; Herbert MS, 2014, ANN BEHAV MED, V48, P50, DOI 10.1007/s12160-013-9563-x; Hollins M, 2016, EXP BRAIN RES, V234, P1377, DOI 10.1007/s00221-015-4541-0; Horwitz EB, 2003, SCAND J CARING SCI, V17, P257, DOI 10.1046/j.1471-6712.2003.00223.x; Imbierowicz K, 2003, EUR J PAIN, V7, P113, DOI 10.1016/S1090-3801(02)00072-1; Jones KD, 2009, JCR-J CLIN RHEUMATOL, V15, P16, DOI 10.1097/RHU.0b013e318190f991; Kalckert A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00040; Kallai J, 2015, PSYCHIAT RES, V229, P410, DOI 10.1016/j.psychres.2015.05.109; Kammers MPM, 2009, NEUROPSYCHOLOGIA, V47, P204, DOI 10.1016/j.neuropsychologia.2008.07.028; Keizer A, 2012, PSYCHIAT RES, V200, P530, DOI 10.1016/j.psychres.2012.05.001; Keizer A, 2011, PSYCHIAT RES, V190, P115, DOI 10.1016/j.psychres.2011.04.031; Kendall-Tackett K, 2003, WOMEN THER, V26, P45, DOI 10.1300/J015v26n01_03; Kopec JA, 2004, CAN J PUBLIC HEALTH, V95, P361, DOI 10.1007/BF03405147; Lampe A, 2003, J PSYCHOSOM RES, V54, P361, DOI 10.1016/S0022-3999(02)00399-9; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Legrain V, 2009, PAIN, V144, P230, DOI 10.1016/j.pain.2009.03.020; Leserman J, 1996, PSYCHOSOM MED, V58, P4, DOI 10.1097/00006842-199601000-00002; Lewis JS, 2012, EUR J PAIN, V16, P1320, DOI 10.1002/j.1532-2149.2012.00120.x; Lewis JS, 2007, PAIN, V133, P111, DOI 10.1016/j.pain.2007.03.013; Lewis JS, 2010, PAIN, V149, P463, DOI 10.1016/j.pain.2010.02.007; Lotze L., 2007, CURR RHEUMATOL REP, V9, P488; Lutz J, 2008, ARTHRITIS RHEUM-US, V58, P3960, DOI 10.1002/art.24070; MacLachlan M, 2003, J REHABIL RES DEV, V40, P59, DOI 10.1682/JRRD.2003.01.0059; Maihofner C, 2007, BRAIN, V130, P2671, DOI 10.1093/brain/awm131; Martin J, 2014, PAIN PRACT, V14, P721, DOI 10.1111/papr.12134; Martin J, 2014, PAIN MED, V15, P682, DOI 10.1111/pme.12375; Mather M, 2007, PERSPECT PSYCHOL SCI, V2, P33, DOI 10.1111/j.1745-6916.2007.00028.x; McBeth J, 1999, ARTHRITIS RHEUM, V42, P1397, DOI 10.1002/1529-0131(199907)42:7<1397::AID-ANR13>3.0.CO;2-7; McDermid AJ, 1996, PAIN, V66, P133, DOI 10.1016/0304-3959(96)03059-X; Meireles SA, 2014, ACTA ORTOP BRAS, V22, P163, DOI 10.1590/1413-78522014220300386; Monterde S, 2004, REV ESP REUMATOL, V31, P507; Moseley GL, 2008, PAIN, V140, P239, DOI 10.1016/j.pain.2008.08.001; Moseley GL, 2012, NEUROSCI BIOBEHAV R, V36, P34, DOI 10.1016/j.neubiorev.2011.03.013; Moseley GL, 2009, BRAIN, V132, P3142, DOI 10.1093/brain/awp224; Moseley GL, 2009, PAIN, V144, P314, DOI 10.1016/j.pain.2009.04.030; Moseley GL, 2004, NEUROLOGY, V62, P2182, DOI 10.1212/01.WNL.0000130156.05828.43; Moseley GL, 2005, NEUROLOGY, V65, P773, DOI 10.1212/01.wnl.0000174515.07205.11; Mussap AJ, 2006, J HEALTH PSYCHOL, V11, P627, DOI 10.1177/1359105306065022; Nishigami T, 2015, MANUAL THER, V20, P63, DOI 10.1016/j.math.2014.06.010; Osborn M, 2006, SCAND J CARING SCI, V20, P216, DOI 10.1111/j.1471-6712.2006.00399.x; Osumi M, 2015, NEUROCASE, V21, P628, DOI 10.1080/13554794.2014.961482; Pain Valenzuela-Moguillansky C., 2013, CONSTRUCTIVIST FDN, V8; Peled A, 2000, BIOL PSYCHIAT, V48, P1105, DOI 10.1016/S0006-3223(00)00947-1; Pollatos O, 2009, DEPRESS ANXIETY, V26, P167, DOI 10.1002/da.20504; Porges, 1993, BODY PERCEPTION QUES; Preston C, 2013, ACTA PSYCHOL, V142, P177, DOI 10.1016/j.actpsy.2012.12.005; Ramachandran VS, 2009, BRAIN, V132, P1693, DOI 10.1093/brain/awp135; Reinersmann A, 2013, PAIN, V154, P1519, DOI 10.1016/j.pain.2013.03.039; Reinersmann A, 2012, PAIN, V153, P2174, DOI 10.1016/j.pain.2012.05.025; Reinersmann A, 2010, NEUROSCI LETT, V486, P240, DOI 10.1016/j.neulet.2010.09.062; Riva G, 2017, CONSCIOUS COGN; Riva G, 2012, MED HYPOTHESES, V79, P113, DOI 10.1016/j.mehy.2012.03.036; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Romano D, 2015, CONSCIOUS COGN, V34, P140, DOI 10.1016/j.concog.2015.04.008; Romano D, 2015, NEUROPSYCHOLOGIA, V70, P414, DOI 10.1016/j.neuropsychologia.2014.10.033; Ryan C, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-59; SCHWARTZMAN RJ, 1990, NEUROLOGY, V40, P57, DOI 10.1212/WNL.40.1.57; Schwoebel J, 2002, NEUROLOGY, V59, P775, DOI 10.1212/WNL.59.5.775; Schwoebel J, 2001, BRAIN, V124, P2098, DOI 10.1093/brain/124.10.2098; Schwoebel J, 2000, J COGNITIVE NEUROSCI, P543; Serino S, 2015, PSYCHIAT RES, V230, P732, DOI 10.1016/j.psychres.2015.10.025; Smeets MAM, 1999, J PSYCHOSOM RES, V46, P465, DOI 10.1016/S0022-3999(99)00005-7; Sorensen J, 1998, J RHEUMATOL, V25, P152; STRAUMAN TJ, 1991, J PERS SOC PSYCHOL, V61, P946, DOI 10.1037/0022-3514.61.6.946; TALLEY NJ, 1995, AM J GASTROENTEROL, V90, P366; Terhaar J, 2012, CLIN NEUROPHYSIOL, V123, P1950, DOI 10.1016/j.clinph.2012.02.086; Tiggemann Marika, 2005, Body Image, V2, P129, DOI 10.1016/j.bodyim.2005.03.006; Trapp W, 2015, J BACK MUSCULOSKELET, V28, P651, DOI 10.3233/BMR-140561; Treede RD, 2006, EXP NEUROL, V197, P1, DOI 10.1016/j.expneurol.2005.10.009; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Tsakiris M, 2008, CONSCIOUS COGN, V17, P1317, DOI 10.1016/j.concog.2008.06.012; Tsay A, 2015, NEUROSCI BIOBEHAV R, V52, P221, DOI 10.1016/j.neubiorev.2015.03.004; Vallar G, 2009, EXP BRAIN RES, V192, P533, DOI 10.1007/s00221-008-1562-y; Van Damme S, 2010, NEUROSCI BIOBEHAV R, V34, P204, DOI 10.1016/j.neubiorev.2009.01.005; van den Berg PA, 2010, J ADOLESCENT HEALTH, V47, P290, DOI 10.1016/j.jadohealth.2010.02.004; van Stralen HE, 2013, PERCEPTION, V42, P991, DOI 10.1068/p7583; Vartanian LR., 2012, ENCY BLAND HUMAN APP, V2, P711, DOI DOI 10.1016/B978-0-12-384925-0.00112-7; Walker EA, 1997, PSYCHOSOM MED, V59, P572, DOI 10.1097/00006842-199711000-00003; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wenninger K, 1998, J TRAUMA STRESS, V11, P543, DOI 10.1023/A:1024408830159; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2013, ARTHRIT CARE RES, V65, P777, DOI 10.1002/acr.21931; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Zopf R, 2010, NEUROPSYCHOLOGIA, V48, P713, DOI 10.1016/j.neuropsychologia.2009.10.028	130	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0194534	10.1371/journal.pone.0194534	http://dx.doi.org/10.1371/journal.pone.0194534			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB9FN	29624596	Green Published, Green Submitted, gold			2022-12-26	WOS:000429379600007
J	Buss, E; Grose, J				Buss, Emily; Grose, John			Auditory sensitivity to spectral modulation phase reversal as a function of modulation depth	PLOS ONE			English	Article							HEARING-IMPAIRED LISTENERS; COCHLEAR-IMPLANT USERS; SPECTROTEMPORAL MODULATION; RIPPLE DISCRIMINATION; SPEECH RECOGNITION; VOWEL IDENTIFICATION; RESOLUTION; FREQUENCY; NOISE; INTELLIGIBILITY	The present study evaluated auditory sensitivity to spectral modulation by determining the modulation depth required to detect modulation phase reversal. This approach may be preferable to spectral modulation detection with a spectrally flat standard, since listeners appear unable to perform the task based on the detection of temporal modulation. While phase reversal thresholds are often evaluated by holding modulation depth constant and adjusting modulation rate, holding rate constant and adjusting modulation depth supports rate-specific assessment of modulation processing. Stimuli were pink noise samples, filtered into seven octave-wide bands (0.125-8 kHz) and spectrally modulated in dB. Experiment 1 measured performance as a function of modulation depth to determine appropriate units for adaptive threshold estimation. Experiment 2 compared thresholds in dB for modulation detection with a flat standard and modulation phase reversal; results supported the idea that temporal cues were available at high rates for the former but not the latter. Experiment 3 evaluated spectral modulation phase reversal thresholds for modulation that was restricted to either one or two neighboring bands. Flanking bands of unmodulated noise had a larger detrimental effect on one-band than two-band targets. Thresholds for high-rate modulation improved with increasing carrier frequency up to 2 kHz, whereas low-rate modulation appeared more consistent across frequency, particularly in the two-band condition. Experiment 4 measured spectral weights for spectral modulation phase reversal detection and found higher weights for bands in the spectral center of the stimulus than for the lowest (0.125 kHz) or highest (8 kHz) band. Experiment 5 compared performance for highly practiced and relatively naive listeners, and found weak evidence of a larger practice effect at high than low spectral modulation rates. These results provide preliminary data for a task that may provide a better estimate of sensitivity to spectral modulation than spectral modulation detection with a flat standard.	[Buss, Emily; Grose, John] Univ North Carolina Chapel Hill, Dept Otolaryngol Head & Neck Surg, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Buss, E (corresponding author), Univ North Carolina Chapel Hill, Dept Otolaryngol Head & Neck Surg, Chapel Hill, NC 27599 USA.	ebuss@med.unc.edu		Buss, Emily/0000-0001-8244-3013	NIH NIDCD (National Institute on Deafness and Other Communication Disorders) [R01007391]; NIH NIDCD [R01007391]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007391] Funding Source: NIH RePORTER	NIH NIDCD (National Institute on Deafness and Other Communication Disorders)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH NIDCD (National Institute on Deafness and Other Communication Disorders) R01007391 (EB).; This work was supported by NIH NIDCD R01007391. Helpful comments on a previous version of this manuscript were provided by Joseph W. Hall III, Arne Oetjen, and an anonymous reviewer.	Anderson ES, 2012, J ACOUST SOC AM, V132, P3925, DOI 10.1121/1.4763999; ANSI, 2010, S362010 ANSI; Aronoff JM, 2013, J ACOUST SOC AM, V134, pEL217, DOI 10.1121/1.4813802; Bernstein JGW, 2013, J AM ACAD AUDIOL, V24, P293, DOI 10.3766/jaaa.24.4.5; Davies-Venn E, 2015, J ACOUST SOC AM, V138, P492, DOI 10.1121/1.4922700; Drennan WR, 2014, EAR HEARING, V35, pE92, DOI 10.1097/AUD.0000000000000009; Eddins DA, 2007, J ACOUST SOC AM, V121, P363, DOI 10.1121/1.2382347; FARRAR CL, 1987, J ACOUST SOC AM, V81, P1085, DOI 10.1121/1.394628; FORMBY C, 1985, J ACOUST SOC AM, V78, P70, DOI 10.1121/1.392456; GREEN DM, 1987, J ACOUST SOC AM, V81, P692, DOI 10.1121/1.394837; Henry BA, 2005, J ACOUST SOC AM, V118, P1111, DOI 10.1121/1.1944567; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Litvak LM, 2007, J ACOUST SOC AM, V122, P982, DOI 10.1121/1.2749413; Liu C, 2008, J ACOUST SOC AM, V124, P1704, DOI 10.1121/1.2956468; Mehraei G, 2014, J ACOUST SOC AM, V136, P301, DOI 10.1121/1.4881918; MOORE BCJ, 1987, HEARING RES, V28, P209, DOI 10.1016/0378-5955(87)90050-5; Sabin AT, 2012, J NEUROSCI, V32, P6542, DOI 10.1523/JNEUROSCI.5732-11.2012; Sabin AT, 2012, EXP BRAIN RES, V218, P567, DOI 10.1007/s00221-012-3049-0; Shrivastav MN, 2006, J ACOUST SOC AM, V119, P1131, DOI 10.1121/1.2151794; SUMMERS V, 1994, J ACOUST SOC AM, V95, P3518, DOI 10.1121/1.409969; Supin AY, 2010, HEARING RES, V260, P109, DOI 10.1016/j.heares.2009.12.018; Supin AY, 2005, HEARING RES, V204, P191, DOI 10.1016/j.heares.2005.01.010; Supin AY, 1999, J ACOUST SOC AM, V106, P2800, DOI 10.1121/1.428105; Supin AY, 2001, HEARING RES, V151, P157, DOI 10.1016/S0378-5955(00)00223-9; VANVEEN TM, 1985, J ACOUST SOC AM, V77, P628, DOI 10.1121/1.391880; VIEMEISTER NF, 1979, J ACOUST SOC AM, V66, P1364, DOI 10.1121/1.383531; Won JH, 2014, J ACOUST SOC AM, V136, P2714, DOI 10.1121/1.4895702; Won JH, 2011, J ACOUST SOC AM, V130, P2088, DOI 10.1121/1.3624820	28	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195686	10.1371/journal.pone.0195686	http://dx.doi.org/10.1371/journal.pone.0195686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621338	Green Submitted, Green Published, gold			2022-12-26	WOS:000429206800114
J	Kalzen, H; Larsson, B; Eksborg, S; Lindberg, L; Edberg, KE; Frostell, C				Kalzen, Hakan; Larsson, Bjorn; Eksborg, Staffan; Lindberg, Lars; Edberg, Karl Erik; Frostell, Claes			Survival after PICU admission: The impact of multiple admissions and complex chronic conditions	PLOS ONE			English	Article							PEDIATRIC INTENSIVE-CARE; RISK-FACTORS; CRITICAL ILLNESS; MORTALITY SCORE; OUTCOMES; CHILDREN; READMISSIONS; PREDICTION; INDEX; UNIT	Objective Factors predicting survival over time after pediatric intensive care unit (PICU) admissions are not fully understood. The primary aim of the current study was to investigate whether multiple admissions (MADM) compared to single PICU admissions (SADM) were associated with poor survival over time after being admitted to PICU facilities. Our secondary aim was to investigate if the presence of a complex chronic condition (CCC) would further impair prognosis. Design A closed cohort of all children up to 16 years of age admitted to the three PICUs in Sweden between 2008 and 2010 was prospectively collected and followed until 2012, providing survival data for at least one but up to four years of follow-up. Setting Three Swedish tertiary referral centers for pediatric intensive care and extracorporeal membrane oxygenation (ECMO) care were used. Patients In total, 3,688 Swedish children with 5,019 PICU admissions were included. Interventions No interventions were conducted. Measurements An extensive data set was recorded, including up to four-year survival information following first PICU admission. The patients were assigned to seven admission diagnostic groups, which were then divided into SADM or MADM groups. The difference in survival over time and mortality rates (MR) and mortality rate ratios (MRR) were calculated. SADM and MADM groups with and without an existing CCC were formed. The difference in survival over time between groups was calculated. Main results A highly significant difference in survival over time was noted between SADM and MADM patients (p<0.0001), which was intensified by the presence of a CCC. MADM patients with a CCC had the worst outcome, while SADM patients without a CCC had the best outcome. MADM patients with no CCC demonstrated decreased survival over time compared to SADM patients with a CCC. Survival over time was statistically worsened for patients with MADM compared to SADM for the following admission diagnostic groups: Cardiovascular, Gastrointestinal/Renal, Respiratory, Neurological, and Miscellaneous. The mortality rate (deaths/patient year of follow-up) during the time of follow-up was 0.023 for SADM and 0.062 for MADM patients. The mortality rate ratio (MRR) between these groups was 2.69. Conclusion Compared to single admissions, multiple admissions to PICU were associated with a significant decrease in survival over time in some but not all diagnostic groups. Regarding our secondary aim, we found that when the presence of a CCC is factored into the survival analysis, survival over time is further impaired.	[Kalzen, Hakan; Larsson, Bjorn] Karolinska Univ Hosp Solna, Karolinska Inst, Astrid Lindgren Childrens Hosp, Dept Paediat Anaesthesia Intens Care & ECMO Serv, Stockholm, Sweden; [Eksborg, Staffan] Karolinska Univ Hosp Solna, Astrid Lindgren Childrens Hosp, Karolinska Inst, Childhood Canc Res Unit Q6 05,Dept Womens & Child, Stockholm, Sweden; [Lindberg, Lars] Univ Hosp Lund, Paediat Intens Care Unit, Childrens Hosp, Dept Anaesthesia & Intens Care, Lund, Sweden; [Edberg, Karl Erik] Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, Dept Paediat Intens Care, Gothenburg, Sweden; [Frostell, Claes] KIDS, Danderyd Hosp, Dept Anaesthesia & Intens Care, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Lund University; Skane University Hospital; Queen Silvia Children's Hospital; Sahlgrenska University Hospital; Danderyds Hospital	Kalzen, H (corresponding author), Karolinska Univ Hosp Solna, Karolinska Inst, Astrid Lindgren Childrens Hosp, Dept Paediat Anaesthesia Intens Care & ECMO Serv, Stockholm, Sweden.	hakan.kalzen@ki.se		Kalzen, Hakan/0000-0001-5859-070X; Eksborg, Staffan/0000-0001-7326-9471; Lindberg, Lars/0000-0002-2246-2826	Stockholm County Council [20130324, 20150224]; Karolinska Institutet [20130324, 20150224]; Stockholm County Council; Research and Consulting Inc.	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Research and Consulting Inc.	Financial support from the regional agreement on medical training and clinical research (ALF), projects 20130324 and 20150224 between Stockholm County Council and Karolinska Institutet (Dr S Eksborg), additional financial support from Stockholm County Council (Hakan Kalzen 2+2 weeks of payed time for research) and C.F. Research and Consulting Inc. (computer resourse and covering costs for data extraction) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Czaja AS, 2013, PEDIATR CRIT CARE ME, V14, P571, DOI 10.1097/PCC.0b013e3182917a68; Costa GD, 2010, CLINICS, V65, P1087, DOI 10.1590/S1807-59322010001100005; Edwards JD, 2013, CRIT CARE MED, V41, P2773, DOI 10.1097/CCM.0b013e31829eb970; Edwards JD, 2012, CRIT CARE MED, V40, P2196, DOI 10.1097/CCM.0b013e31824e68cf; European Medicines Agency (EMA), MED CHINDR; Feudtner C, 2000, PEDIATRICS, V106, P205; Feudtner C, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-199; Feudtner C, 2009, J PALLIAT MED, V12, P160, DOI 10.1089/jpm.2008.0206; Gullberg N, 2008, ACTA ANAESTH SCAND, V52, P1086, DOI 10.1111/j.1399-6576.2008.01711.x; Namachivayam P, 2010, PEDIATR CRIT CARE ME, V11, P549, DOI 10.1097/PCC.0b013e3181ce7427; Namachivayam SP, 2015, CRIT CARE MED, V43, P1978, DOI 10.1097/CCM.0000000000001076; Nicholson Carol E, 2003, Pediatr Crit Care Med, V4, P196, DOI 10.1097/01.PCC.0000059728.63798.DA; O'Brien S, 2017, PEDIATR CRIT CARE ME, V18, P1, DOI 10.1097/PCC.0000000000000976; Odetola FO, 2007, PEDIATR CRIT CARE ME, V8, P343, DOI 10.1097/01.PCC.0000269400.67463.AC; Pinto NP, 2017, PEDIATR CRIT CARE ME, V18, pE122, DOI 10.1097/PCC.0000000000001070; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Pollack MM, 2015, CRIT CARE MED, V43, P1699, DOI 10.1097/CCM.0000000000001081; Rhodes A, 2012, INTENS CARE MED, V38, P598, DOI 10.1007/s00134-011-2462-3; Shann F, 1997, INTENS CARE MED, V23, P201, DOI 10.1007/s001340050317; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; Slater A, 2003, INTENS CARE MED, V29, P271, DOI 10.1007/s00134-002-1600-3; Socialstyrelsen. Dodsorsaker, 2013, DODS CAUS DEATH REG	22	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0193294	10.1371/journal.pone.0193294	http://dx.doi.org/10.1371/journal.pone.0193294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621235	gold, Green Published, Green Submitted			2022-12-26	WOS:000429206800004
J	Martin-Gonzalez, S; Navarro-Mesa, JL; Julia-Serda, G; Ramirez-Avila, GM; Ravelo-Garcia, AG				Martin-Gonzalez, Sofia; Navarro-Mesa, Juan L.; Julia-Serda, Gabriel; Marcelo Ramirez-Avila, G.; Ravelo-Garcia, Antonio G.			Improving the understanding of sleep apnea characterization using Recurrence Quantification Analysis by defining overall acceptable values for the dimensionality of the system, the delay, and the distance threshold	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; CARDIOVASCULAR-SYSTEM; EMBEDDING DIMENSION; NONLINEAR DYNAMICS; NETWORK PHYSIOLOGY; TIME; COMPLEX; ELECTROCARDIOGRAM; ALGORITHM; SELECTION	Our contribution focuses on the characterization of sleep apnea from a cardiac rate point of view, using Recurrence Quantification Analysis (RQA), based on a Heart Rate Variability (HRV) feature selection process. Three parameters are crucial in RQA: those related to the embedding process (dimension and delay) and the threshold distance. There are no overall accepted parameters for the study of HRV using RQA in sleep apnea. We focus on finding an overall acceptable combination, sweeping a range of values for each of them simultaneously. Together with the commonly used RQA measures, we include features related to recurrence times, and features originating in the complex network theory. To the best of our knowledge, no author has used them all for sleep apnea previously. The best performing feature subset is entered into a Linear Discriminant classifier. The best results in the "Apnea-ECG Physionet database" and the "HuGCDN2014 database" are, according to the area under the receiver operating characteristic curve, 0.93 (Accuracy: 86.33%) and 0.86 (Accuracy: 84.18%), respectively. Our system outperforms, using a relatively small set of features, previously existing studies in the context of sleep apnea. We conclude that working with dimensions around 7-8 and delays about 4-5, and using for the threshold distance the Fixed Amount of Nearest Neighbours (FAN) method with 5% of neighbours, yield the best results. Therefore, we would recommend these reference values for future work when applying RQA to the analysis of HRV in sleep apnea. We also conclude that, together with the commonly used vertical and diagonal RQA measures, there are newly used features that contribute valuable information for apnea minutes discrimination. Therefore, they are especially interesting for characterization purposes. Using two different databases supports that the conclusions reached are potentially generalizable, and are not limited by database variability.	[Martin-Gonzalez, Sofia; Navarro-Mesa, Juan L.; Ravelo-Garcia, Antonio G.] Univ Las Palmas Gran Canaria, Inst Technol Dev & Innovat Commun, Las Palmas Gran Canaria, Spain; [Julia-Serda, Gabriel] Hosp Univ Gran Canaria Dr Negrin, Pulm Med Dept, Las Palmas Gran Canaria, Spain; [Marcelo Ramirez-Avila, G.] Univ Mayor San Andres, Inst Invest Fis, La Paz, Bolivia	Universidad de Las Palmas de Gran Canaria; Universidad Mayor de San Andres	Martin-Gonzalez, S (corresponding author), Univ Las Palmas Gran Canaria, Inst Technol Dev & Innovat Commun, Las Palmas Gran Canaria, Spain.	sofia.martin@ulpgc.es	Martín-González, Sofía/GYD-4163-2022; Ramirez-Avila, Gonzalo Marcelo/I-3867-2019; Navarro-Mesa, Juan L./L-3633-2017	Martín-González, Sofía/0000-0002-5001-9223; Ramirez-Avila, Gonzalo Marcelo/0000-0003-4522-9012; Navarro-Mesa, Juan L./0000-0003-3860-3424; Ravelo-Garcia, Antonio G./0000-0002-8512-965X	European Regional Development Fund [MAC/1/C121]	European Regional Development Fund(European Commission)	This work was supported by European Regional Development Fund, MAC/1/C121, http://ec.europa.eu/regional_policy/es/funding/eraf/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Al-Angari HM, 2007, IEEE T BIO-MED ENG, V54, P1900, DOI 10.1109/TBME.2006.889772; [Anonymous], 2005, TUTORIALS CONT NONLI; Bartsch R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.054102; Bartsch RP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142143; Bartsch RP, 2012, P NATL ACAD SCI USA, V109, P10181, DOI 10.1073/pnas.1204568109; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bonsignore MR, 1997, SLEEP, V20, P1167; Brengelmann GL, 2003, J APPL PHYSIOL, V94, P849, DOI 10.1152/japplphysiol.00868.2002; Cao LY, 1997, PHYSICA D, V110, P43, DOI 10.1016/S0167-2789(97)00118-8; Carlson JT, 1996, AM J RESP CRIT CARE, V154, P1490, DOI 10.1164/ajrccm.154.5.8912770; Censi F, 2000, ANN BIOMED ENG, V28, P61, DOI 10.1114/1.248; Cheng CQ, 2016, COMPUT BIOL MED, V75, P10, DOI 10.1016/j.compbiomed.2016.05.006; Cruz A.A., 2007, GLOBAL SURVEILLANCE; de Chazal P, 2003, IEEE T BIO-MED ENG, V50, P686, DOI 10.1109/TBME.2003.812203; Ding H, 2008, CHAOS SOLITON FRACT, V38, P1457, DOI 10.1016/j.chaos.2006.07.059; Donner RV, 2011, INT J BIFURCAT CHAOS, V21, P1019, DOI 10.1142/S0218127411029021; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; Gao JB, 1999, PHYS REV LETT, V83, P3178, DOI 10.1103/PhysRevLett.83.3178; Giuliani A, 1998, AM J PHYSIOL-HEART C, V275, pH1455, DOI 10.1152/ajpheart.1998.275.4.H1455; Glass L, 2009, CHAOS, V19, DOI 10.1063/1.3156832; Goldberger Ary L, 2006, Proc Am Thorac Soc, V3, P467, DOI 10.1513/pats.200603-028MS; Graben PB, 2016, EPL-EUROPHYS LETT, V114, DOI 10.1209/0295-5075/114/38003; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Grassberger P, 1991, INT J BIFURCAT CHAOS, V1, P521, DOI 10.1142/S0218127491000403; GUILLEMINAULT C, 1984, LANCET, V1, P126; Gutierrez-Tobal GC, 2015, ENTROPY-SWITZ, V17, P123, DOI 10.3390/e17010123; Guzzetti S, 1996, CARDIOVASC RES, V31, P441; Hall J. E, 2006, TXB MED PHYSL; Ivanov PC, 2017, SPRINGER PROC PHYS, V191, P145, DOI 10.1007/978-3-319-47810-4_12; Ivanov PC, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/10/100201; Javorka M, 2008, PHYSIOL MEAS, V30, P29; Javorka M, 2008, CLIN PHYSIOL FUNCT I, V28, P326, DOI 10.1111/j.1475-097X.2008.00813.x; Julia-Serda Gabriel, 2018, APNEA HRV DATA SET M; Kantz H., 2004, NONLINEAR TIME SERIE, V7; Karandikar K, 2013, I IEEE EMBS C NEUR E, P1358, DOI 10.1109/NER.2013.6696194; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Klabunde RE, 2005, HYPERTROPHY CARDIOVA; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Le TQ, 2013, IEEE J TRANSL ENG HE, V1, DOI 10.1109/JTEHM.2013.2273354; Le TQ, 2013, 2013 IEEE POINT-OF-CARE HEALTHCARE TECHNOLOGIES (PHT), P152, DOI 10.1109/PHT.2013.6461307; Maier C, 2006, BIOMED TECH, V51, P224, DOI 10.1515/BMT.2006.042; Mammoliti R, 1998, COMPUT CARDIOL, V25, P145, DOI 10.1109/CIC.1998.731753; Marwan N, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026702; Marwan N, 0201062 ARXIV; Marwan N., 2015, RECURRENCE QUANTIFIC, P3, DOI [DOI 10.1007/978-3-319-07155-8, 10.1007/978-3-319-07155-8_1, DOI 10.1007/978-3-319-07155-8_1]; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Marwan N, 2011, INT J BIFURCAT CHAOS, V21, P1003, DOI 10.1142/S0218127411029008; Marwan N, 2009, PHYS LETT A, V373, P4246, DOI 10.1016/j.physleta.2009.09.042; Matassini L, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021102; Mendez MO, 2010, PHYSIOL MEAS, V31, P273, DOI 10.1088/0967-3334/31/3/001; Mendez MO, 2009, IEEE T BIO-MED ENG, V56, P2838, DOI 10.1109/TBME.2009.2029563; Mohebbi M, 2011, PHYSIOL MEAS, V32, P1147, DOI 10.1088/0967-3334/32/8/010; Narkiewicz K, 1998, CIRCULATION, V98, P1071, DOI 10.1161/01.CIR.98.11.1071; Ngamga EJ, 2016, PHYS LETT A, V380, P1419, DOI 10.1016/j.physleta.2016.02.024; Nguyen Hoa Dinh, 2014, IEEE J Biomed Health Inform, V18, P1285, DOI 10.1109/JBHI.2013.2292928; PACKARD NH, 1980, PHYS REV LETT, V45, P712, DOI 10.1103/PhysRevLett.45.712; Pamidi S, 2015, AM J RESP CRIT CARE, V192, P96, DOI 10.1164/rccm.201408-1564OC; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Penzel T, 2003, IEEE T BIO-MED ENG, V50, P1143, DOI 10.1109/TBME.2003.817636; Penzel T, 2000, COMPUT CARDIOL, V27, P255, DOI 10.1109/CIC.2000.898505; PHILLIPSON EA, 1993, NEW ENGL J MED, V328, P1271, DOI 10.1056/NEJM199304293281712; Poincare H., 1890, ACTA MATH-DJURSHOLM, V13, pA3, DOI DOI 10.1007/BF02392506; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Avila GMR, 2013, AUTON NEUROSCI-BASIC, V178, P103, DOI 10.1016/j.autneu.2013.05.003; Ravelo-Garcia AG, 2014, CHAOS, V24, DOI 10.1063/1.4869825; Ravelo-Garcia A, 2013, LECT NOTES COMPUT SC, V8112, P266; Ravelo-Garcia AG, 2015, ENTROPY-SWITZ, V17, P2932, DOI 10.3390/e17052932; Ravelo-Garcia AG, 2015, ENTROPY-SWITZ, V17, P914, DOI 10.3390/e17030914; Redline S, 2012, AM J RESP CRIT CARE, V186, P123, DOI 10.1164/rccm.201204-0657ED; Riedl M, 2010, PHILOS T R SOC A, V368, P2237, DOI 10.1098/rsta.2010.0029; SAGIE A, 1992, AM J CARDIOL, V70, P797, DOI 10.1016/0002-9149(92)90562-D; Schinkel S, 2008, EUR PHYS J-SPEC TOP, V164, P45, DOI 10.1140/epjst/e2008-00833-5; Schlenker J, 2016, BIOMED SIGNAL PROCES, V25, P1, DOI 10.1016/j.bspc.2015.10.007; Schrader M, 2000, COMPUT CARDIOL, V27, P263, DOI 10.1109/CIC.2000.898507; Schumacher Autumn, 2004, Biol Res Nurs, V5, P211, DOI 10.1177/1099800403260619; Sharma H, 2016, COMPUT BIOL MED, V77, P116, DOI 10.1016/j.compbiomed.2016.08.012; Shelhamer M, 2007, NONLINEAR DYNAMICS IN PHYSIOLOGY: A STATE-SPACE APPROACH, P1; Subramaniyam NP, 2014, PHYS LETT A, V378, P3464, DOI 10.1016/j.physleta.2014.10.005; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Tayel M.B., 2016, INT J RES ENG SCI, V4, P45; THEILER J, 1986, PHYS REV A, V34, P2427, DOI 10.1103/PhysRevA.34.2427; Thiel M, 2004, CHAOS, V14, P234, DOI 10.1063/1.1667633; Thiel M, 2002, PHYSICA D, V171, P138, DOI 10.1016/S0167-2789(02)00586-9; Tortora GJ, 2008, PRINCIPLES ANATOMY P; Trzebski A, 2001, AUTON NEUROSCI-BASIC, V90, P106, DOI 10.1016/S1566-0702(01)00275-2; Varon C, 2015, IEEE T BIO-MED ENG, V62, P2269, DOI 10.1109/TBME.2015.2422378; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; Wessel N, 2001, LECT NOTES COMPUT SC, V2199, P295; Wessel N., 2000, HERZSCHRITTMACHERTHE, V11, P159, DOI [10.1007/s003990070035, DOI 10.1007/S003990070035]; Yang H, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026214; Yildiz A, 2011, EXPERT SYST APPL, V38, P12880, DOI 10.1016/j.eswa.2011.04.080; Zbilut J., 1990, COMPUTERS CARDIO SEP, P263; Zbilut JP, 2008, PHYS LETT A, V372, P6622, DOI 10.1016/j.physleta.2008.09.027; Zbilut JP, 2002, LECT NOTES COMPUT SC, V2526, P151; Zbilut JP, 2002, MED ENG PHYS, V24, P53, DOI 10.1016/S1350-4533(01)00112-6; Zbilut JP, 1998, PHYS LETT A, V237, P131, DOI 10.1016/S0375-9601(97)00843-8; ZBILUT JP, 1992, PHYS LETT A, V171, P199, DOI 10.1016/0375-9601(92)90426-M; Zou Y, 2010, EGUGA, V20, P8226	101	11	11	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194462	10.1371/journal.pone.0194462	http://dx.doi.org/10.1371/journal.pone.0194462			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621264	Green Published, Green Submitted, gold			2022-12-26	WOS:000429206800018
J	Sinha, D; Mondal, R; Mahapa, A; Sau, K; Chattopadhyaya, R; Sau, S				Sinha, Debabrata; Mondal, Rajkrishna; Mahapa, Avisek; Sau, Keya; Chattopadhyaya, Rajagopal; Sau, Subrata			A staphylococcal anti-sigma factor possesses a single-domain, carries different denaturant-sensitive regions and unfolds via two intermediates	PLOS ONE			English	Article							CIRCULAR-DICHROISM; BACILLUS-SUBTILIS; BIOPHYSICAL CHARACTERIZATION; PROTEIN-STRUCTURE; LIGAND-BINDING; RNA-POLYMERASE; FACTOR SPOIIAB; AUREUS; UREA; STRESS	RsbW, an anti-sigma factor possessing kinase activity, is expressed by many Gram-positive bacteria including Staphylococcus aureus. To obtain clues about the domain structure and the folding-unfolding mechanism of RsbW, we have elaborately studied rRsbW, a recombinant S. aureus RsbW. Sequence analysis of the protein fragments, generated by the limited proteolysis of rRsbW, has proposed it to be a single-domain protein. The unfolding of rRsbW in the presence of GdnCl or urea was completely reversible in nature and occurred through the formation of at least two intermediates. The structure, shape, and the surface hydrophobicity of no intermediate completely matches with those of other intermediates or the native rRsbW. Interestingly, one of the intermediates, formed in the presence of less GdnCl concentrations, has a molten globule-like structure. Conversely, all of the intermediates, like native rRsbW, exist as dimers in aqueous solution. The putative molten globule and the urea-generated intermediates also have retained some kinase activity. Additionally, the putative ATP binding site/catalytic site of rRsbW shows higher denaturant sensitivity than the tentative dimerization region of this enzyme.	[Sinha, Debabrata; Chattopadhyaya, Rajagopal; Sau, Subrata] Bose Inst, Dept Biochem, Kolkata, W Bengal, India; [Mondal, Rajkrishna] Nagaland Univ, Dept Biotechnol, Dimapur, Nagaland, India; [Mahapa, Avisek; Sau, Keya] Haldia Inst Technol, Dept Biotechnol, Haldia, W Bengal, India	Department of Science & Technology (India); Bose Institute; Nagaland University; Haldia Institute of Technology	Sau, S (corresponding author), Bose Inst, Dept Biochem, Kolkata, W Bengal, India.	subratasau@gmail.com	MONDAL, RAJKRISHNA/ABH-6673-2020	MONDAL, RAJKRISHNA/0000-0001-5557-371X	University Grants Commission (India); Bose Institute (India)	University Grants Commission (India)(University Grants Commission, India); Bose Institute (India)	DS received Senior Research Fellowship from the University Grants Commission (India). SS received financial assistance for the work from Bose Institute (India). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akhtar MS, 2002, BIOCHEMISTRY-US, V41, P3819, DOI 10.1021/bi0116700; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Borges Julio C, 2016, Biophys Rev, V8, P107, DOI 10.1007/s12551-016-0194-x; Campbell EA, 2002, CELL, V108, P795, DOI 10.1016/S0092-8674(02)00662-1; Canova MJ, 2014, J BIOL CHEM, V289, P9473, DOI 10.1074/jbc.R113.529917; Chaturvedi S, 2003, J BIOL CHEM, V278, P40793, DOI 10.1074/jbc.M306192200; Chen JC, 2017, INT J MED MICROBIOL, V307, P521, DOI 10.1016/j.ijmm.2017.09.005; CONNELLY PR, 1992, P NATL ACAD SCI USA, V89, P4781, DOI 10.1073/pnas.89.11.4781; Creighton T.E., 1997, PROTEIN STRUCTURE PR; Dangel A, 2013, FASEB J, V27, P4476, DOI 10.1096/fj.13-234575; Del Vecchio P, 2002, BIOCHEMISTRY-US, V41, P1364, DOI 10.1021/bi011146t; Delumeau O, 2002, J BACTERIOL, V184, P5583, DOI 10.1128/JB.184.20.5583-5589.2002; Ekman D, 2005, J MOL BIOL, V348, P231, DOI 10.1016/j.jmb.2005.02.007; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Ganguly T, 2009, FEBS J, V276, P1975, DOI 10.1111/j.1742-4658.2009.06924.x; Gaudet M, 2010, PROTEIN SCI, V19, P1544, DOI 10.1002/pro.433; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Hughes KT, 1998, ANNU REV MICROBIOL, V52, P231, DOI 10.1146/annurev.micro.52.1.231; Jaenicke R, 2000, ADV PROTEIN CHEM, V53, P329; Jenal U, 2009, CURR OPIN MICROBIOL, V12, P152, DOI 10.1016/j.mib.2009.01.010; Julien O, 2011, BIOCHEMISTRY-US, V50, P7536, DOI 10.1021/bi200731e; Kaplan J, 2004, P NATL ACAD SCI USA, V101, P11566, DOI 10.1073/pnas.0404387101; Kazmierczak MJ, 2005, MICROBIOL MOL BIOL R, V69, P527, DOI 10.1128/MMBR.69.4.527-543.2005; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lapidus Lisa J, 2017, F1000Res, V6, P1723, DOI 10.12688/f1000research.12070.1; Mahapa A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122168; Mahendrarajah K, 2011, ANAL BIOCHEM, V411, P155, DOI 10.1016/j.ab.2010.12.001; Main ERG, 1998, BIOCHEMISTRY-US, V37, P6145, DOI 10.1021/bi973111s; Masuda S, 2004, J MOL BIOL, V340, P941, DOI 10.1016/j.jmb.2004.05.040; Miyazaki E, 1999, J BACTERIOL, V181, P2846, DOI 10.1128/JB.181.9.2846-2851.1999; Mondal R, 2010, BMB REP, V43, P176, DOI 10.5483/BMBRep.2010.43.3.176; NANDI PK, 1984, BIOCHEMISTRY-US, V23, P6661, DOI 10.1021/bi00321a058; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P137, DOI 10.1016/j.ijmm.2009.08.016; Pace CN, 2000, PROTEINS, P1; Polley S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102891; Rasheedi S, 2009, BIOPOLYMERS, V91, P574, DOI 10.1002/bip.21180; Rashid DJ, 2005, J PEPT RES, V65, P538, DOI 10.1111/j.1399-3011.2005.00255.x; Sambrook J., 2001, MOL CLONING LAB MANU; Senisterra G, 2012, ASSAY DRUG DEV TECHN, V10, P128, DOI 10.1089/adt.2011.0390; Senn MM, 2005, J BACTERIOL, V187, P8006, DOI 10.1128/JB.187.23.8006-8019.2005; Shu Q, 2004, BIOCHEMISTRY-US, V43, P1432, DOI 10.1021/bi035651x; Shukla VK, 2017, BIOPHYS J, V112, P605, DOI 10.1016/j.bpj.2016.12.020; Tuchscherr L, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6030031; Tuchscherr L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004870; Voelker U, 1996, J BACTERIOL, V178, P7020, DOI 10.1128/jb.178.23.7020-7023.1996; Waldron TT, 2003, BIOCHEMISTRY-US, V42, P5058, DOI 10.1021/bi034212v; Wang TF, 2014, J BIOL PHYS, V40, P25, DOI 10.1007/s10867-013-9332-x; Yang XF, 1996, GENE DEV, V10, P2265, DOI 10.1101/gad.10.18.2265; Yon JM, 2002, J CELL MOL MED, V6, P307, DOI 10.1111/j.1582-4934.2002.tb00511.x	52	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195416	10.1371/journal.pone.0195416	http://dx.doi.org/10.1371/journal.pone.0195416			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621342	Green Published, gold, Green Submitted			2022-12-26	WOS:000429206800076
J	Del Guidice, T; Lepetit-Stoffaes, JP; Bordeleau, LJ; Roberge, J; Theberge, V; Lauvaux, C; Barbeau, X; Trottier, J; Dave, V; Roy, DC; Gaillet, B; Garnier, A; Guay, D				Del Guidice, Thomas; Lepetit-Stoffaes, Jean-Pascal; Bordeleau, Louis-Jean; Roberge, Joannie; Theberge, Vanessa; Lauvaux, Coraline; Barbeau, Xavier; Trottier, Jessica; Dave, Vibhuti; Roy, Denis-Claude; Gaillet, Bruno; Garnier, Alain; Guay, David			Membrane permeabilizing amphiphilic peptide delivers recombinant transcription factor and CRISPR-Cas9/Cpf1 ribonucleoproteins in hard-to-modify cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; EX-VIVO EXPANSION; PENETRATING PEPTIDES; ENDOSOMAL ESCAPE; IN-VITRO; CELLULAR UPTAKE; ENGINEERED NUCLEASES; MAMMALIAN-CELLS; GENE DELIVERY; CAS9 PROTEIN	Delivery of recombinant proteins to therapeutic cells is limited by a lack of efficient methods. This hinders the use of transcription factors or Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) ribonucleoproteins to develop cell therapies. Here, we report a soluble peptide designed for the direct delivery of proteins to mammalian cells including human stem cells, hard-to-modify primary natural killer (NK) cells, and cancer cell models. This peptide is composed of a 6x histidine-rich domain fused to the endosomolytic peptide CM18 and the cell penetrating peptide PTD4. A less than two-minute co-incubation of 6His-CM18-PTD4 peptide with spCas9 and/or as Cpf1 CRISPR ribonucleoproteins achieves robust gene editing. The same procedure, co-incubating with the transcription factor HoxB4, achieves transcriptional regulation. The broad applicability and flexibility of this DNA- and chemical-free method across different cell types, particularly hard-to-transfect cells, opens the way for a direct use of proteins for biomedical research and cell therapy manufacturing.	[Del Guidice, Thomas; Lepetit-Stoffaes, Jean-Pascal; Bordeleau, Louis-Jean; Roberge, Joannie; Theberge, Vanessa; Lauvaux, Coraline; Barbeau, Xavier; Guay, David] Feldan Therapeut, Quebec City, PQ, Canada; [Lepetit-Stoffaes, Jean-Pascal; Barbeau, Xavier; Gaillet, Bruno; Garnier, Alain] Univ Laval, Dept Genie Chim, Quebec City, PQ, Canada; [Trottier, Jessica; Dave, Vibhuti; Roy, Denis-Claude] Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ, Canada	Laval University; Universite de Montreal	Del Guidice, T (corresponding author), Feldan Therapeut, Quebec City, PQ, Canada.	tdelguidice@feldan.com		Del'Guidice, Thomas/0000-0003-4969-7016	CNRC.NRC, Programme d'aide a la recherche industrielle [PARICNRC 874333]; Feldan Therapeutics Inc.	CNRC.NRC, Programme d'aide a la recherche industrielle; Feldan Therapeutics Inc.	This work was supported in part by CNRC.NRC, Programme d'aide a la recherche industrielle, PARICNRC 874333 and by Feldan Therapeutics Inc. The funders provided support in the form of salaries for authors T.D., J.-P.L.-S., L.-J.B., J.R., C.L., V.T., X.B., D.G, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are related in the author contributions section.	Amsellem S, 2003, NAT MED, V9, P1423, DOI 10.1038/nm953; Blenke EO, 2016, J CONTROL RELEASE, V244, P139, DOI 10.1016/j.jconrel.2016.08.002; Carlsten M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00266; Chanput W, 2014, INT IMMUNOPHARMACOL, V23, P37, DOI 10.1016/j.intimp.2014.08.002; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Doetschman T, 2017, CIRC RES, V120, P876, DOI 10.1161/CIRCRESAHA.116.309727; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Erazo-Oliveras A, 2014, NAT METHODS, V11, P861, DOI [10.1038/NMETH.2998, 10.1038/nmeth.2998]; Erazo-Oliveras A, 2012, PHARMACEUTICALS-BASE, V5, P1177, DOI 10.3390/ph5111177; Fasoli A, 2014, MOLECULES, V19, P9228, DOI 10.3390/molecules19079228; Feng WR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00634-0; Ferrer-Miralles N, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-101; Flynn CR, 2010, J PHARM SCI-US, V99, P3100, DOI 10.1002/jps.22087; Haas SA, 2017, HAMOSTASEOLOGIE, V37, P45, DOI 10.5482/HAMO-16-09-0035; Herrera AI, 2016, CURR PROTEIN PEPT SC, V17, P827, DOI 10.2174/1389203717666160526123821; Ho A, 2001, CANCER RES, V61, P474; Hondal RJ, 2001, J BIOL CHEM, V276, P15823, DOI 10.1074/jbc.M010405200; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Keller AA, 2013, PHARMACEUTICALS, V6, P184, DOI 10.3390/ph6020184; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kristensen M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020185; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; Lacy HM, 2002, BIOTECHNIQUES, V32, P254; LeCher Julia C., 2017, BioMolecular Concepts, V8, P131, DOI 10.1515/bmc-2017-0023; Lee J, 2013, BLOOD, V121, P4082, DOI 10.1182/blood-2012-09-455204; Lee YJ, 2011, BBA-GEN SUBJECTS, V1810, P752, DOI 10.1016/j.bbagen.2011.05.013; Lee Y, 2009, CHEMBIOCHEM, V10, P929, DOI 10.1002/cbic.200800791; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Lin Q, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-25; Lonn P, 2016, SCI REP-UK, V6, DOI 10.1038/srep32301; Luan L, 2015, J MATER CHEM B, V3, P1068, DOI 10.1039/c4tb01353k; Mager I, 2012, BBA-BIOMEMBRANES, V1818, P502, DOI 10.1016/j.bbamem.2011.11.020; Marie E, 2014, J MEMBRANE BIOL, V247, P861, DOI 10.1007/s00232-014-9679-3; Meng Z, 2017, J MATER CHEM B, V5, P74, DOI 10.1039/c6tb02862d; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Nayerossadat Nouri, 2012, Adv Biomed Res, V1, P27, DOI 10.4103/2277-9175.98152; Ng KK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154081; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Pisal DS, 2010, J PHARM SCI-US, V99, P2557, DOI 10.1002/jps.22054; Radis-Baptista G, 2017, J BIOTECHNOL, V252, P15, DOI 10.1016/j.jbiotec.2017.05.002; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Salomone F, 2012, J CONTROL RELEASE, V163, P293, DOI 10.1016/j.jconrel.2012.09.019; Sato H, 2006, BBA-BIOMEMBRANES, V1758, P1245, DOI 10.1016/j.bbamem.2006.02.021; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shao SM, 2017, INT J BIOCHEM CELL B, V92, P43, DOI 10.1016/j.biocel.2017.09.012; Shi Y, 2017, NAT REV DRUG DISCOV, V16, P115, DOI 10.1038/nrd.2016.245; Singh V, 2017, J CELL BIOCH; Stewart MP, 2016, NATURE, V538, P183, DOI 10.1038/nature19764; Suresh B, 2017, METHODS MOL BIOL, V1507, P81, DOI 10.1007/978-1-4939-6518-2_7; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ter-Avetisyan G, 2009, J BIOL CHEM, V284, P3370, DOI 10.1074/jbc.M805550200; Tung CH, 2002, BIOORGAN MED CHEM, V10, P3609, DOI 10.1016/S0968-0896(02)00248-1; Varkouhi AK, 2011, J CONTROL RELEASE, V151, P220, DOI 10.1016/j.jconrel.2010.11.004; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Wei T, 2014, METHODS MOL BIOL, V1163, P23, DOI 10.1007/978-1-4939-0799-1_3; Yin H, 2017, NAT REV DRUG DISCOV; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	58	35	36	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195558	10.1371/journal.pone.0195558	http://dx.doi.org/10.1371/journal.pone.0195558			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617431	Green Submitted, Green Published, gold			2022-12-26	WOS:000429203800093
J	Duron, S; Panjo, H; Bohet, A; Bigaillon, C; Sicard, S; Bajos, N; Meynard, JB; Merens, A; Moreau, C				Duron, Sandrine; Panjo, Henri; Bohet, Aline; Bigaillon, Christine; Sicard, Sebastien; Bajos, Nathalie; Meynard, Jean-Baptiste; Merens, Audrey; Moreau, Caroline			Prevalence and risk factors of sexually transmitted infections among French service members	PLOS ONE			English	Article							UNITED-STATES; ALCOHOL-USE; MILITARY; BEHAVIOR; HIV; PREVENTION; DEPRESSION; PERSONNEL; DISEASES; INCOME	Introduction Sexually Transmitted Infections (STIs) have always represented a public health concern in the military, yet most studies rely on self-reports among non-random samples of military populations. In addition, most of the studies exploring STI rates among the military focus on US service members. This paper assesses the prevalence and correlates of STIs in the French military using biomarkers and compares self-reported versus diagnosed STIs. Methods Data are drawn from the COSEMIL study, a national sexual health survey conducted in the French military in 2014 and 2015. A random sample of 784 men and 141 women aged 1857 years completed a self-administered questionnaire and provided biological samples for STI testing. We used logistic regression modeling to identify the correlates of STI diagnosis and self-reports. Results The prevalence of diagnosed STIs was 4.7% [3.8-5.9], mostly due to Chlamydia trachomatis. This rate was four times higher than the 12 months self-reported rate of 1.1% [0.6-2.3]. Reported STI rates were similar among men and women (1.1% versus 1.8%), but diagnosed STI rates were twice as high among females versus males (10.4% versus 4.1%, p = 0.007). There were significant differences in the determinants of reported versus diagnosed STIs. In particular, age and sexual orientation were associated with reported STIs, but not with diagnosed STIs. Conversely, STI counseling and depression were associated with STI diagnosis but not with STI reports. Conclusion This study underlines the need to use biomarkers in population-based surveys, given the differential and substantial underreporting of STIs. Results also highlight the need for programmatic adaptation to address gender inequalities in STI rates, by developing women's health services in the French military. Addressing such needs not only benefits women but could also serve as a strategy to reduce overall STI rates as most military women have military partners, increasing the risk of internal transmission.	[Duron, Sandrine; Sicard, Sebastien; Meynard, Jean-Baptiste] French Mil Ctr Epidemiol & Publ Hlth, Marseille, France; [Duron, Sandrine; Sicard, Sebastien; Meynard, Jean-Baptiste] Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France; [Panjo, Henri; Bohet, Aline; Bajos, Nathalie; Moreau, Caroline] INSERM, Gender Sexual & Reprod Hlth, Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France; [Bigaillon, Christine; Merens, Audrey] French Mil Hosp Begin, Med Biol Lab, St Mande, France; [Meynard, Jean-Baptiste; Merens, Audrey] Ecole Val de Grace, French Mil Med Acad, Paris, France; [Moreau, Caroline] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA	Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Moreau, C (corresponding author), INSERM, Gender Sexual & Reprod Hlth, Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France.; Moreau, C (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA.	cmoreau2@jhu.edu	Bajos, Nathalie/M-4170-2018; Moreau, Caroline/A-8989-2019	Bajos, Nathalie/0000-0001-8073-9056; Moreau, Caroline/0000-0002-8637-6249	"Agence Nationale de recherche sur le Sida et les hepatites virales" (ANRS); "Institut national pour la prevention et l'education pour la sante" (INPES); "Caisse nationale militaire de securite sociale" (CNMSS)	"Agence Nationale de recherche sur le Sida et les hepatites virales" (ANRS)(ANRSFrench National Research Agency (ANR)); "Institut national pour la prevention et l'education pour la sante" (INPES); "Caisse nationale militaire de securite sociale" (CNMSS)	This work was supported by the following French institutions/agencies: "Agence Nationale de recherche sur le Sida et les hepatites virales" (ANRS), "Institut national pour la prevention et l'education pour la sante" (INPES), "Caisse nationale militaire de securite sociale" (CNMSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino K., 1997, MASCULINITY SEXUALIT; Allsep LM, 2013, J HOMOSEXUAL, V60, P381, DOI 10.1080/00918369.2013.744928; Anastario MP, 2013, CULT MED PSYCHIAT, V37, P737, DOI 10.1007/s11013-013-9335-x; Anastario MP, 2010, REV PANAM SALUD PUBL, V28, P361; Anderson P, 2005, ALCOHOL PRIMARY HLTH, P172; [Anonymous], 2012, PSYCH ASP DEPL HLTH; Avery AK, 2015, MICROBIOL SPECTR, P3; Barrett Frank J., 1996, GENDER WORK ORGAN, V3, p129?142; CATES W, 1990, EPIDEMIOL REV, V12, P199, DOI 10.1093/oxfordjournals.epirev.a036054; Chai SJ, 2010, SEX TRANSM DIS, V37, P756, DOI 10.1097/OLQ.0b013e3181e3d771; Chemto D, 2017, ISR J HEALTH POLICY, V6, DOI 10.1186/s13584-017-0141-8; Cole MJ, 2015, BMC INFECT DIS, P15; Darrow WW, 1997, GENITOURIN MED, V73, P88; de Santi VP, 2009, ANN DERMATOL VENER, V136, P775, DOI 10.1016/j.annder.2009.09.007; Deiss R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167892; Essien EJ, 2006, MIL MED, V171, P1027, DOI 10.7205/MILMED.171.10.1027; Gaydos JC, 2015, SEX TRANSM INFECT, V91, P536, DOI 10.1136/sextrans-2015-052256; Goulet V, 2010, SEX TRANSM INFECT, V86, P263, DOI 10.1136/sti.2009.038752; Goyal V, 2012, J WOMENS HEALTH, V21, P1155, DOI 10.1089/jwh.2012.3605; Gual A, 2002, ALCOHOL ALCOHOLISM, V37, P591, DOI 10.1093/alcalc/37.6.591; Hakre S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-181; Harbertson J, 2013, TROP MED INT HEALTH, V18, P925, DOI 10.1111/tmi.12129; Harbertson J, 2013, AIDS BEHAV, V17, P1734, DOI 10.1007/s10461-012-0343-6; Harling G, 2014, SOC SCI MED, V102, P174, DOI 10.1016/j.socscimed.2013.11.025; Hong Y, 2011, J WOMENS HEALTH, V20, P129, DOI 10.1089/jwh.2010.2139; Jordan Nikki N, 2013, MSMR, V20, P15; Jordan NN, 2011, MIL MED, V176, P312, DOI 10.7205/MILMED-D-10-00212; Khan MR, 2009, ARCH PEDIAT ADOL MED, V163, P644, DOI 10.1001/archpediatrics.2009.95; Legleye S, 2011, REV EPIDEMIOL SANTE, V59, P223, DOI 10.1016/j.respe.2011.02.103; Lloyd J, 2014, SEX TRANSM INFECT, V90, P382, DOI 10.1136/sextrans-2013-051463; Maciosek MV, 2006, AM J PREV MED, V31, P52, DOI 10.1016/j.amepre.2006.03.012; MacQueen KM, 1996, MED ANTHROPOL Q, V10, P402, DOI 10.1525/maq.1996.10.3.02a00070; Mankayi N, 2011, AJAR-AFR J AIDS RES, V10, P43, DOI 10.2989/16085906.2011.575547; Marbac-Delon V, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14101; Marshall BDL, 2013, J TRAUMA STRESS, V26, P64, DOI 10.1002/jts.21777; Mgbere O, 2013, AIDS BEHAV, V17, P1159, DOI 10.1007/s10461-011-0126-5; O'Connell CM, 2016, MICROB CELL, V3, P390, DOI 10.15698/mic2016.09.525; Rasnake Mark S, 2005, Mil Med, V170, P61; Sanchez JL, 2013, MIL MED, V178, P1271, DOI 10.7205/MILMED-D-13-00137; Sena AC, 2000, CLIN INFECT DIS, V30, P742, DOI 10.1086/313742; Shanks GD, 2014, LANCET, V384, P1699, DOI 10.1016/S0140-6736(14)61786-4; Stahlman S, 2015, SEX HEALTH, V12, P272, DOI 10.1071/SH14211; Stahlman S, 2014, SEX TRANSM DIS, V41, P359, DOI 10.1097/OLQ.0000000000000133; Suay-Garcia B, 2017, EUR J CLIN MICROBIOL, V36, P1065, DOI 10.1007/s10096-017-2931-x; Taft AJ, 2008, BMC PUBLIC HEALTH, P8; Thompson JC, 2005, PREV MED, V41, P247, DOI 10.1016/j.ypmed.2004.11.008; Tourdot Laura E, 2016, MSMR, V23, P29; Tsevat DG, 2017, AM J OBSTET GYNECOL, V216, P1, DOI 10.1016/j.ajog.2016.08.008; US Preventive Services Task Force, 2007, ANN INTERN MED, V147, P128, DOI 10.7326/0003-4819-147-2-200707170-00172; VANDEVEN WPMM, 1981, J ECONOMETRICS, V17, P229, DOI 10.1016/0304-4076(81)90028-2; Warszawski J, 2012, SEXUALITY FRANCE, P425; Wasserheit JN, 1996, J INFECT DIS, V174, pS201, DOI 10.1093/infdis/174.Supplement_2.S201; Yavorsky RL, 2014, CLIN PEDIATR, V53, P890, DOI 10.1177/0009922814533816; Zablocka R, 2017, J COMMUN HEALTH, V42, P160, DOI 10.1007/s10900-016-0243-1; Zhang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040793	55	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195158	10.1371/journal.pone.0195158	http://dx.doi.org/10.1371/journal.pone.0195158			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB3VV	29608617	gold, Green Published, Green Submitted			2022-12-26	WOS:000428988800029
J	Pflanz, NC; Daszkowski, AW; Cornelison, GL; Trudell, JR; Mihic, SJ				Pflanz, Natasha C.; Daszkowski, Anna W.; Cornelison, Garrett L.; Trudell, James R.; Mihic, S. John			An intersubunit electrostatic interaction in the GABA(A) receptor facilitates its responses to benzodiazepines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; GABA receptor; electrostatics; electrophysiology; Xenopus; cysteine-mediated cross-linking; Cys-loop receptor; benzodiazepines; ionotropic receptor; sedative	AGONIST BINDING; ANXIOLYTIC PROPERTIES; GAMMA(2) SUBUNIT; GLYCINE RECEPTOR; A RECEPTORS; ACID; MODULATION; CHANNEL; SITE; ACTIVATION	Benzodiazepines are positive allosteric modulators of the GABA(A) receptor (GABA(A)R), acting at the - subunit interface to enhance GABA(A)R function. GABA or benzodiazepine binding induces distinct conformational changes in the GABA(A)R. The molecular rearrangements in the GABA(A)R following benzodiazepine binding remain to be fully elucidated. Using two molecular models of the GABA(A)R, we identified electrostatic interactions between specific amino acids at the - subunit interface that were broken by, or formed after, benzodiazepine binding. Using two-electrode voltage clamp electrophysiology in Xenopus laevis oocytes, we investigated these interactions by substituting one or both amino acids of each potential pair. We found that Lys(104) in the (1) subunit forms an electrostatic bond with Asp(75) of the (2) subunit after benzodiazepine binding and that this bond stabilizes the positively modified state of the receptor. Substitution of these two residues to cysteine and subsequent covalent linkage between them increased the receptor's sensitivity to low GABA concentrations and decreased its response to benzodiazepines, producing a GABA(A)R that resembles a benzodiazepine-bound WT GABA(A)R. Breaking this bond restored sensitivity to GABA to WT levels and increased the receptor's response to benzodiazepines. The (1) Lys(104) and (2) Asp(75) interaction did not play a role in ethanol or neurosteroid modulation of GABA(A)R, suggesting that different modulators induce different conformational changes in the receptor. These findings may help explain the additive or synergistic effects of modulators acting at the GABA(A)R.	[Pflanz, Natasha C.; Daszkowski, Anna W.; Cornelison, Garrett L.; Mihic, S. John] Univ Texas Austin, Inst Neurosci, Dept Neurosci, Div Pharmacol & Toxicol,Waggoner Ctr Alcohol & Ad, Austin, TX 78712 USA; [Pflanz, Natasha C.; Daszkowski, Anna W.; Cornelison, Garrett L.; Mihic, S. John] Univ Texas Austin, Inst Cell & Mol Biol, Dept Neurosci, Div Pharmacol & Toxicol,Waggoner Ctr Alcohol & Ad, Austin, TX 78712 USA; [Trudell, James R.] Stanford Univ, Sch Med, Dept Anesthesia, Stanford, CA 94305 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Stanford University	Mihic, SJ (corresponding author), Univ Texas Austin, Inst Neurosci, Dept Neurosci, Div Pharmacol & Toxicol,Waggoner Ctr Alcohol & Ad, Austin, TX 78712 USA.; Mihic, SJ (corresponding author), Univ Texas Austin, Inst Cell & Mol Biol, Dept Neurosci, Div Pharmacol & Toxicol,Waggoner Ctr Alcohol & Ad, Austin, TX 78712 USA.	mihic@austin.utexas.edu			National Institutes of Health [F31DA042564]; National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA042564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Ruth L. Kirschstein National Research Service Award F31DA042564 (to N.C.P.) from the National Institute on Drug Abuse.	Akk G, 2007, PHARMACOL THERAPEUT, V116, P35, DOI 10.1016/j.pharmthera.2007.03.004; Amato A, 1999, J PHYSIOL-LONDON, V517, P35, DOI 10.1111/j.1469-7793.1999.0035z.x; Bergmann R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052323; Boileau AJ, 2002, NEUROPHARMACOLOGY, V43, P695, DOI 10.1016/S0028-3908(02)00036-9; Bowser DN, 2002, P NATL ACAD SCI USA, V99, P15170, DOI 10.1073/pnas.212320199; Buhr A, 1997, P NATL ACAD SCI USA, V94, P8824, DOI 10.1073/pnas.94.16.8824; Campo-Soria C, 2006, BRIT J PHARMACOL, V148, P984, DOI 10.1038/sj.bjp.0706796; Ci SQ, 2008, PROTEIN J, V27, P71, DOI 10.1007/s10930-007-9109-9; Downing SS, 2005, BRIT J PHARMACOL, V145, P894, DOI 10.1038/sj.bjp.0706251; DRAGUHN A, 1990, NEURON, V5, P781, DOI 10.1016/0896-6273(90)90337-F; Gielen MC, 2012, J NEUROSCI, V32, P5707, DOI 10.1523/JNEUROSCI.5663-11.2012; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Hanson SM, 2008, J NEUROSCI, V28, P3490, DOI 10.1523/JNEUROSCI.5727-07.2008; Hanson SM, 2011, BRIT J PHARMACOL, V162, P673, DOI 10.1111/j.1476-5381.2010.01073.x; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Kash TL, 2004, J BIOL CHEM, V279, P4887, DOI 10.1074/jbc.M311441200; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Langer S.Z., 1992, EUR NEUROPSYCHOPHARM, V2, P232, DOI DOI 10.1016/0924-977X(92)90081-I; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; McCracken ML, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00045; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; MIHIC SJ, 1994, J BIOL CHEM, V269, P32768; Morris HV, 2006, EUR J NEUROSCI, V23, P2495, DOI 10.1111/j.1460-9568.2006.04775.x; NEWLAND CF, 1991, J PHYSIOL-LONDON, V432, P203, DOI 10.1113/jphysiol.1991.sp018382; ROGERS CJ, 1994, J PHYSIOL-LONDON, V475, P69, DOI 10.1113/jphysiol.1994.sp020050; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; STUDY RE, 1981, P NATL ACAD SCI-BIOL, V78, P7180, DOI 10.1073/pnas.78.11.7180; Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality, 2014, DAWN REPORT BENZODIA; Todorovic J, 2010, P NATL ACAD SCI USA, V107, P7987, DOI 10.1073/pnas.1001845107; Trudell JR, 2002, BBA-BIOMEMBRANES, V1565, P91, DOI 10.1016/S0005-2736(02)00512-6; TWYMAN RE, 1989, ANN NEUROL, V25, P213, DOI 10.1002/ana.410250302; Venkatachalan SP, 2008, P NATL ACAD SCI USA, V105, P13604, DOI 10.1073/pnas.0801854105; Venkatachalan SP, 2012, J BIOL CHEM, V287, P6714, DOI 10.1074/jbc.M111.316836; Wallner M, 2014, NEUROCHEM RES, V39, P1118, DOI 10.1007/s11064-014-1243-0; WIELAND HA, 1992, J BIOL CHEM, V267, P1426; Yoluk O, 2013, BIOPHYS J, V105, P640, DOI 10.1016/j.bpj.2013.06.037	36	8	8	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8264	8274		10.1074/jbc.RA118.002128	http://dx.doi.org/10.1074/jbc.RA118.002128			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29622679	Green Published, hybrid			2022-12-26	WOS:000433224600030
J	Bhat, A; Mishra, S; Kaul, S; Dhar, MK				Bhat, Archana; Mishra, Sonal; Kaul, Sanjana; Dhar, Manoj K.			Elucidation and functional characterization of CsPSY and CsUGT promoters in Crocus sativus L.	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; CAROTENOID METABOLISM; GENE-EXPRESSION; STRESS; SYNTHASE; IDENTIFICATION; BIOSYNTHESIS; REGULATOR	The dried stigmas of Crocus sativus constitute the saffron, which is considered to be the costliest spice of the world. Saffron is valuable for its constituents, which are mainly apocarotenoids. In order to enhance the production of apocarotenoids, it is imperative to understand the regulation of apocarotenoid biosynthetic pathway. In C. sativus, although the pathway has been elucidated, the information regarding the regulation of the pathwaygenes is scanty. During the present investigation, the characterization of promoters regulating the expression of two important genes i.e. CsPSY and CsUGT was performed. We successfully cloned the promoters of both the genes, which were functionally characterized in Crocus sativus and Nicotiana tabaccum. In silico analysis of the promoters demonstrated the presence of several important cis regulatory elements responding tolight, hormonesand interaction with transcription factors (TFs). Further analysis suggested the regulation of CsPSY promoter by Abscisic acid (ABA) and that of CsUGT by Gibberellic acid (GA). In addition, we also observed ABA and GA mediated modulation in the expression of significant TFs and CsPSY and CsUGTtranscripts. Overall, the study addresses issues related to regulation of key genes of apocarotenoid pathway in C.sativus.	[Bhat, Archana; Mishra, Sonal; Kaul, Sanjana; Dhar, Manoj K.] Univ Jammu, Sch Biotechnol, Genome Res Lab, Jammu, India	University of Jammu	Dhar, MK (corresponding author), Univ Jammu, Sch Biotechnol, Genome Res Lab, Jammu, India.	manojkdhar@rediffmail.com		Bhat, Archana/0000-0002-6054-0979; Mishra, Dr. Sonal/0000-0003-0727-6520	Department of Biotechnology, Ministry of Science and Technology [BT/PR5397/PBD/16/974/2012]	Department of Biotechnology, Ministry of Science and Technology	This work was supported by the Department of Biotechnology, Ministry of Science and Technology: BT/PR5397/PBD/16/974/2012 to MKD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ruiz-Sola MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090765; Ahrazem O, 2010, J EXP BOT, V61, P105, DOI 10.1093/jxb/erp283; Ashraf N, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0423-7; Bhattacharjee P, 2017, PLANT MOL BIOL, V93, P511, DOI 10.1007/s11103-016-0579-z; Bjorklund S, 2007, PLANT J, V52, P499, DOI 10.1111/j.1365-313X.2007.03250.x; Castillo R, 2005, PLANT PHYSIOL, V139, P674, DOI 10.1104/pp.105.067827; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; Dhar MK, 2017, PLANT PHYSIOL, V165, P277; Dong T, 2014, PLANT PHYSIOL, V165, P277, DOI 10.1104/pp.114.239210; Doyle J. J., 1991, Molecular techniques in taxonomy., P283; Feng HZ, 2006, PLANT PHYSIOL, V140, P1345, DOI 10.1104/pp.105.074138; Fujisawa M, 2013, PLANT CELL, V25, P371, DOI 10.1105/tpc.112.108118; Gomez-Gornez L, 2012, J PLANT PHYSIOL, V169, P509, DOI 10.1016/j.jplph.2011.11.021; Jain M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22456; Kumar P, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00477; Leoni C, 2011, FEBS J, V278, P3953, DOI 10.1111/j.1742-4658.2011.08307.x; Li F, 2009, PLANT PHYSIOL, V147, P1334; Li FQ, 2008, PLANT PHYSIOL, V146, P1333, DOI 10.1104/pp.107.111120; Liu LH, 2015, MOL PLANT, V8, P28, DOI 10.1016/j.molp.2014.11.006; Lu S, 2008, J INTEGR PLANT BIOL, V50, P778, DOI 10.1111/j.1744-7909.2008.00708.x; Lu SW, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01367; Mandal A, 2018, FUNCT INTEGR GENOMIC, V18, P101, DOI 10.1007/s10142-017-0578-4; Mandal A, 2015, PLANT SCI, V241, P221, DOI 10.1016/j.plantsci.2015.10.008; Mishra S, 2015, PLANT MOL BIOL, V89, P173, DOI 10.1007/s11103-015-0361-7; Moraga A, 2004, PLANTA, V219, P955, DOI 10.1007/s00425-004-1299-1; Newman LJ, 2004, PLANT J, V37, P239, DOI 10.1046/j.1365-313X.2003.01953.x; Oksman-Caldentey KM, 2004, TRENDS PLANT SCI, V9, P433, DOI 10.1016/j.tplants.2004.07.006; Ordoudi SA, 2004, PRODUCTION PRACTICES AND QUALITY ASSESSMENT OF FOOD CROPS, VOL 1: PREHARVEST PRACTICE, P209; Ramel F, 2012, P NATL ACAD SCI USA, V109, P5535, DOI 10.1073/pnas.1115982109; Renau-Morata B, 2012, IND CROP PROD, V39, P40, DOI 10.1016/j.indcrop.2012.02.009; Rubio S, 2009, PLANT PHYSIOL, V150, P1345, DOI 10.1104/pp.109.137174; Salwee Yasmin, 2013, African Journal of Agricultural Research, V8, P234; Tao NG, 2007, PLANT CELL REP, V26, P837, DOI 10.1007/s00299-006-0289-0; Toledo-Ortiz G, 2010, P NATL ACAD SCI USA, V107, P11626, DOI 10.1073/pnas.0914428107; Wang T, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01121; Welsch R, 2008, PLANT PHYSIOL, V147, P367, DOI 10.1104/pp.108.117028; Welsch R, 2007, PLANT PHYSIOL, V145, P1073, DOI 10.1104/pp.107.104828; Wu AM, 2007, CELL RES, V17, P174, DOI 10.1038/sj.cr.7310119; Yang CQ, 2012, J INTEGR PLANT BIOL, V54, P703, DOI 10.1111/j.1744-7909.2012.01161.x; Zeng WF, 2013, PLANT MOL BIOL REP, V31, P64, DOI 10.1007/s11105-012-0477-8	40	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195348	10.1371/journal.pone.0195348	http://dx.doi.org/10.1371/journal.pone.0195348			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634744	Green Published, gold, Green Submitted			2022-12-26	WOS:000429522200028
J	Velho, ALC; Menezes, E; Dinh, T; Kaya, A; Topper, E; Moura, AA; Memili, E				Velho, Ana Luiza Cazaux; Menezes, Erika; Thu Dinh; Kaya, Abdullah; Topper, Einko; Moura, Arlindo Alencar; Memili, Erdogan			Metabolomic markers of fertility in bull seminal plasma	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; PRODUCER-RECORDED DATA; BOAR SPERMATOZOA; MALE-INFERTILITY; SPERM MOTILITY; GC-MS; GENETIC SELECTION; DIFFERENT FORMS; HEALTH TRAITS; AMINO-ACIDS	Metabolites play essential roles in biological systems, but detailed identities and significance of the seminal plasma metabolome related to bull fertility are still unknown. The objectives of this study were to determine the comprehensive metabolome of seminal plasma from Holstein bulls and to ascertain the potential of metabolites as biomarkers of bull fertility. The seminal plasma metabolome from 16 Holstein bulls with two fertility rates were determined by gas chromatography-mass spectrometry (GC-MS). Multivariate and univariate analyses of the data were performed, and the pathways associated with the seminal plasma metabolome were identified using bioinformatics approaches. Sixty-three metabolites were identified in the seminal plasma of all bulls. Fructose was the most abundant metabolite in the seminal fluid, followed for citric acid, lactic acid, urea and phosphoric acid. Androstenedione, 4-ketoglucose, D-xylofuranose, 2-oxoglutaric acid and erythronic acid represented the least predominant metabolites. Partial-Least Squares Discriminant Analysis (PLSDA) revealed a distinct separation between high and low fertility bulls. The metabolites with the greatest Variable Importance in Projection score (VIP > 2) were 2-oxoglutaric acid and fructose. Heat-map analysis, based on VIP score, and univariate analysis indicated that 2-oxoglutaric acid was less (P = 0.02); whereas fructose was greater (P = 0.02) in high fertility than in low fertility bulls. The current study is the first to describe the metabolome of bull seminal plasma using GC-MS and presented metabolites such as 2-oxoglutaric acid and fructose as potential biomarkers of bull fertility.	[Velho, Ana Luiza Cazaux; Menezes, Erika; Thu Dinh; Memili, Erdogan] Mississippi State Univ, Dept Anim & Dairy Sci, Mississippi State, MS 39762 USA; [Velho, Ana Luiza Cazaux; Moura, Arlindo Alencar] Univ Fed Ceara, Dept Anim Sci, Fortaleza, Ceara, Brazil; [Kaya, Abdullah; Topper, Einko] Alta Genet Inc, Watertown, WI USA; [Kaya, Abdullah] Selcuk Univ, Dept Reprod & Artificial Inseminat, Konya, Turkey	Mississippi State University; Universidade Federal do Ceara; Selcuk University	Memili, E (corresponding author), Mississippi State Univ, Dept Anim & Dairy Sci, Mississippi State, MS 39762 USA.	em149@ads.msstate.edu	Memili, Erdogan/AAY-8726-2020; MOURA, ARLINDO A/P-6697-2018	Memili, Erdogan/0000-0002-8335-5645; MOURA, ARLINDO A/0000-0002-8271-5733; Dinh, Thu/0000-0001-5416-4949	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture (NIFA) [2017-67016-26507]; Mississippi Agricultural Experiment Station; Alta Genetics Inc.; Hatch project from the USDA NIFA [1005778]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of Brazil; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) of Brazil	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture (NIFA); Mississippi Agricultural Experiment Station; Alta Genetics Inc.; Hatch project from the USDA NIFA; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) of Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This project was supported by Agriculture and Food Research Initiative Competitive Grant no. 2017-67016-26507 from the USDA National Institute of Food and Agriculture (NIFA). Partial funding was also provided by Mississippi Agricultural Experiment Station, Alta Genetics Inc., Hatch project under accession number 1005778 from the USDA NIFA, and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of Brazil. A. Velho and E. Menezes were funded by competitive fellowships from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) of Brazil.	ALHAKIM MK, 1970, J DAIRY SCI, V53, P84, DOI 10.3168/jds.S0022-0302(70)86152-5; ANAND SR, 1973, J REPROD FERTIL, V32, P97, DOI 10.1530/jrf.0.0320097; BARONOS S, 1971, J REPROD FERTIL, V24, P303, DOI 10.1530/jrf.0.0240303; Bieniek JM, 2016, ASIAN J ANDROL, V18, P426, DOI 10.4103/1008-682X.175781; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Bromfield JJ, 2016, REPRODUCTION, V152, pR223, DOI 10.1530/REP-16-0313; Cao WL, 2009, BIOL REPROD, V80, P124, DOI 10.1095/biolreprod.108.068882; Chang YM, 2004, ANIM SCI, V79, P355, DOI 10.1017/S1357729800090226; D'Amours O, 2010, REPRODUCTION, V139, P545, DOI 10.1530/REP-09-0375; de Oliveira RV, 2013, REPRODUCTION, V146, P263, DOI 10.1530/REP-12-0399; Deepinder F, 2007, EXPERT REV MOL DIAGN, V7, P351, DOI 10.1586/14737159.7.4.351; DILLS WL, 1981, BIOL REPROD, V25, P458, DOI 10.1095/biolreprod25.3.458; Dunn WB, 2011, CHEM SOC REV, V40, P387, DOI 10.1039/b906712b; Dunn WB, 2005, ANALYST, V130, P606, DOI 10.1039/b418288j; Einarsson S, 1971, Acta Vet Scand Suppl, V36, P1; Fernandez-Gago R, 2013, THERIOGENOLOGY, V80, P400, DOI 10.1016/j.theriogenology.2013.05.003; Feugang JM, 2010, REPROD BIOMED ONLINE, V21, P312, DOI 10.1016/j.rbmo.2010.06.022; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Ford WCL, 2006, HUM REPROD UPDATE, V12, P269, DOI 10.1093/humupd/dmi053; Forero-Gonzalez RA, 2012, ANDROLOGIA, V44, P154, DOI 10.1111/j.1439-0272.2010.01154.x; Gilany K, 2017, BIOMED CHROMATOGR, V31, DOI 10.1002/bmc.3931; Gilany K, 2014, MOL REPROD DEV, V81, P84, DOI 10.1002/mrd.22284; Gonzalez-Cadavid V, 2014, THERIOGENOLOGY, V82, P697, DOI [10.1016/j.theriogenology.2014.05.024, 10.1016/j.theriogen]; Goodacre R, 2004, TRENDS BIOTECHNOL, V22, P245, DOI 10.1016/j.tibtech.2004.03.007; Goodson SG, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102673; GRAHAM EF, 1967, CRYOBIOLOGY, V4, P75, DOI 10.1016/S0011-2240(67)80214-1; Hamamah S, 1998, HUM REPROD, V13, P132, DOI 10.1093/humrep/13.1.132; HAMAMAH S, 1993, J REPROD FERTIL, V97, P51; Han Y, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0454-6; Holden SA, 2017, THERIOGENOLOGY, V87, P221, DOI 10.1016/j.theriogenology.2016.08.024; Jayaraman V, 2014, J ASSIST REPROD GEN, V31, P1195, DOI 10.1007/s10815-014-0282-4; Juyena NS, 2012, J ANDROL, V33, P536, DOI 10.2164/jandrol.110.012583; KAMP G, 1995, BBA-GEN SUBJECTS, V1243, P101, DOI 10.1016/0304-4165(94)00117-G; Karnovsky A, 2012, BIOINFORMATICS, V28, P373, DOI 10.1093/bioinformatics/btr661; KILLIAN GJ, 1993, BIOL REPROD, V49, P1202, DOI 10.1095/biolreprod49.6.1202; KING TE, 1959, PROC R SOC SER B-BIO, V151, P226, DOI 10.1098/rspb.1959.0061; Kovac JR, 2013, FERTIL STERIL, V99, P998, DOI 10.1016/j.fertnstert.2013.01.111; Kumar A, 2015, MOL REPROD DEV, V82, P123, DOI 10.1002/mrd.22450; Kwon WS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15654; Kwon WS, 2015, MOL CELL PROTEOMICS, V14, P1230, DOI 10.1074/mcp.M114.045369; Kwon WS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-897; Li YH, 2014, MOL MED REP, V9, P305, DOI 10.3892/mmr.2013.1793; Liberda J, 2001, FOLIA BIOL-PRAGUE, V47, P113; MANN T, 1946, BIOCHEM J, V40, P481, DOI 10.1042/bj0400481; Marin S, 2003, FEBS LETT, V554, P342, DOI 10.1016/S0014-5793(03)01185-2; Matsuoka T, 2006, J REPROD DEVELOP, V52, P805, DOI 10.1262/jrd.18039; MENDOZA G, 1989, THERIOGENOLOGY, V32, P455, DOI 10.1016/0093-691X(89)90012-5; Moce E, 2008, ANIM REPROD SCI, V105, P104, DOI 10.1016/j.anireprosci.2007.11.016; MOORE HDM, 1977, J REPROD FERTIL, V50, P349, DOI 10.1530/jrf.0.0500349; Moura AA, 2007, MOL REPROD DEV, V74, P214, DOI 10.1002/mrd.20590; Moura AA, 2006, J ANDROL, V27, P534, DOI 10.2164/jandrol.05201; Munoz M, 2014, METABOLOMICS, V10, P443, DOI 10.1007/s11306-013-0587-9; Newairy ASA, 2009, FOOD CHEM TOXICOL, V47, P1093, DOI 10.1016/j.fct.2009.01.032; Nielsen NI, 2004, ANIM FEED SCI TECH, V115, P191, DOI 10.1016/j.anifeedsci.2004.03.008; Oliver SG, 1998, TRENDS BIOTECHNOL, V16, P373, DOI 10.1016/S0167-7799(98)01214-1; Paiva C, 2015, ANDROLOGY-US, V3, P496, DOI 10.1111/andr.12027; Papp G, 1983, Int Urol Nephrol, V15, P195, DOI 10.1007/BF02085452; Patel AB, 1999, ANAL BIOCHEM, V266, P205, DOI 10.1006/abio.1998.2888; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Paventi G, 2015, BIOCHEM BIOPH RES CO, V462, P257, DOI 10.1016/j.bbrc.2015.04.128; Peddinti D, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-19; Petherick JC, 2005, APPL ANIM BEHAV SCI, V90, P185, DOI 10.1016/j.applanim.2004.08.021; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Qiao SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181115; Rego JPA, 2014, ANIM REPROD SCI, V148, P1, DOI 10.1016/j.anireprosci.2014.04.016; Sangeeta S, 2015, ANIM REPROD SCI, V161, P82, DOI 10.1016/j.anireprosci.2015.08.008; Shi ST, 2015, ANAL METHODS-UK, V7, P1751, DOI 10.1039/c4ay02477j; Soggiu A, 2013, MOL BIOSYST, V9, P1188, DOI 10.1039/c3mb25494a; Sorensen MB, 1999, MOL HUM REPROD, V5, P331, DOI 10.1093/molehr/5.4.331; SRIVASTAVA A, 1984, ANDROLOGIA, V16, P265; Tang B, 2017, ANDROLOGIA, V49, DOI 10.1111/and.12744; TULI RK, 1994, THERIOGENOLOGY, V42, P547, DOI 10.1016/0093-691X(94)90692-C; VANDERHORST CJ, 1970, EXPERIENTIA, V26, P249, DOI 10.1007/BF01900073; VANDERHORST CJG, 1979, TIJDSCHR DIERGENEESK, V104, P97; Vilagran I, 2015, ANDROLOGY-US, V3, P345, DOI 10.1111/andr.12009; Wennemuth G, 2001, ANDROLOGIA, V33, P43, DOI 10.1046/j.1439-0272.2001.00370.x; Westfalewicz B, 2017, J DAIRY SCI, V100, P2282, DOI 10.3168/jds.2016-11866; Williams AC, 2001, J ANDROL, V22, P680; WILLIAMS J, 1990, FUND APPL TOXICOL, V15, P651, DOI 10.1016/0272-0590(90)90182-J; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Yi YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034524; Yoon SJ, 2016, J ANIM SCI BIOTECHNO, V7, DOI 10.1186/s40104-016-0128-2; Yoon SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152690; Yousef MI, 2005, TOXICOLOGY, V215, P97, DOI 10.1016/j.tox.2005.06.025; Zhang XL, 2015, CLIN CHIM ACTA, V450, P254, DOI 10.1016/j.cca.2015.09.001; Zhou XY, 2016, TALANTA, V147, P82, DOI 10.1016/j.talanta.2015.09.040; Zwald NR, 2004, J DAIRY SCI, V87, P4295, DOI 10.3168/jds.S0022-0302(04)73574-2; Zwald NR, 2004, J DAIRY SCI, V87, P4287, DOI 10.3168/jds.S0022-0302(04)73573-0	89	56	60	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195279	10.1371/journal.pone.0195279	http://dx.doi.org/10.1371/journal.pone.0195279			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634739	Green Published, gold, Green Submitted			2022-12-26	WOS:000429522200027
J	Takeda, Y; Akiyoshi, T; Matsueda, K; Fukuoka, H; Ogura, A; Miki, H; Hiyoshi, Y; Nagasaki, T; Konishi, T; Fujimoto, Y; Fukunaga, Y; Ueno, M				Takeda, Yasuhiro; Akiyoshi, Takashi; Matsueda, Kiyoshi; Fukuoka, Hironori; Ogura, Atsushi; Miki, Hisanori; Hiyoshi, Yukiharu; Nagasaki, Toshiya; Konishi, Tsuyoshi; Fujimoto, Yoshiya; Fukunaga, Yosuke; Ueno, Masashi			Skeletal muscle loss is an independent negative prognostic factor in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy	PLOS ONE			English	Article							LONG-TERM OUTCOMES; COLORECTAL-CANCER; PANCREATIC ADENOCARCINOMA; CLINICAL-IMPLICATIONS; CURATIVE RESECTION; SARCOPENIA; CACHEXIA; IMPACT; COMPLICATIONS; PREDICTOR	Background The impact of body composition on the short- or long-term outcomes of patients with surgically treated advanced rectal cancer after neoadjuvant chemoradiotherapy remains unclear. This study examined the correlation between low skeletal muscle mass and morbidity and survival in patients with advanced lower rectal cancer. Methods We enrolled 144 clinical stage II/III patients with advanced lower rectal cancer who underwent neoadjuvant chemoradiotherapy followed by curative resection between 2004 and 2011. The cross-sectional skeletal muscle area at the third lumbar vertebra (L3) level was evaluated by computed tomography before chemoradiotherapy, and this was normalized by the square of the height to obtain the skeletal muscle index. Low skeletal muscle mass was defined as the sex-specific lowest quartile of the L3 skeletal muscle index. The association between low skeletal muscle mass and morbidity, relapse-free survival, or overall survival was assessed. Results Low skeletal muscle mass was identified in 37 (25.7%) patients. Age and body mass index were associated with low skeletal muscle mass. By multivariate analysis, we found that low skeletal muscle mass was independently associated with poor overall survival (hazard ratio = 2.93; 95%CI: 1.11-7.71; p = 0.031) and relapse-free survival (hazard ratio = 2.15; 95%CI: 1.06-4.21; p = 0.035), but was not associated with the rate of postoperative complications. Conclusions Low skeletal muscle mass is an independent negative prognostic factor for relapse-free and overall survival in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy.	[Takeda, Yasuhiro; Akiyoshi, Takashi; Fukuoka, Hironori; Ogura, Atsushi; Miki, Hisanori; Hiyoshi, Yukiharu; Nagasaki, Toshiya; Konishi, Tsuyoshi; Fujimoto, Yoshiya; Fukunaga, Yosuke; Ueno, Masashi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Surg, Gastroenterol Ctr, Tokyo, Japan; [Matsueda, Kiyoshi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Diagnost Imaging, Tokyo, Japan	Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research	Akiyoshi, T (corresponding author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Surg, Gastroenterol Ctr, Tokyo, Japan.	takashi.akiyoshi@jfcr.or.jp	Fukunaga, Yosuke/AAR-8933-2021; nagasaki, toshiya/AAE-6844-2020	Fukunaga, Yosuke/0000-0002-6397-0907; nagasaki, toshiya/0000-0001-5853-314X; Akiyoshi, Takashi/0000-0002-2321-1412	Japan Society for the Promotion of Science [15K10156]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was funded by Japan Society for the Promotion of Science grant 15K10156 to Dr. Takashi Akiyoshi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini N, 2015, J GASTROINTEST SURG, V19, P1593, DOI 10.1007/s11605-015-2835-y; Aversa Z, 2017, THER ADV MED ONCOL, V9, P369, DOI 10.1177/1758834017698643; Barberan-Garcia A, 2018, ANN SURG, V267, P50, DOI 10.1097/SLA.0000000000002293; Chemama S, 2016, ANN SURG ONCOL, V23, P3891, DOI 10.1245/s10434-016-5360-7; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Choi MH, 2018, J CACHEXIA SARCOPENI, V9, P53, DOI 10.1002/jcsm.12234; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dello SAWG, 2013, HPB, V15, P165, DOI 10.1111/j.1477-2574.2012.00517.x; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Dodson S, 2011, ANNU REV MED, V62, P265, DOI 10.1146/annurev-med-061509-131248; Dworak O, 1997, INT J COLORECTAL DIS, V12, P19, DOI 10.1007/s003840050072; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Guadagni M, 2009, CURR OPIN CLIN NUTR, V12, P617, DOI 10.1097/MCO.0b013e32833193bd; Harimoto N, 2013, BRIT J SURG, V100, P1523, DOI 10.1002/bjs.9258; Honda M, 2016, J SURG ONCOL, V114, P630, DOI 10.1002/jso.24376; Joglekar S, 2015, J SURG ONCOL, V112, P503, DOI 10.1002/jso.24025; Joglekar S, 2015, J SURG ONCOL, V111, P771, DOI 10.1002/jso.23862; Lieffers JR, 2012, BRIT J CANCER, V107, P931, DOI 10.1038/bjc.2012.350; Malietzis G, 2016, BRIT J SURG, V103, P572, DOI 10.1002/bjs.10075; Malietzis G, 2016, ANN SURG, V263, P320, DOI 10.1097/SLA.0000000000001113; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Miyamoto Y, 2016, CLIN CANCER RES, V22, P3999, DOI 10.1158/1078-0432.CCR-16-0495; Miyamoto Y, 2015, ANN SURG ONCOL, V22, P2663, DOI 10.1245/s10434-014-4281-6; Miyamoto Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129742; Nagasaki T, 2015, DIGEST SURG, V32, P496, DOI 10.1159/000441396; Ogura A, 2018, EUR J CANCER, V91, P11, DOI 10.1016/j.ejca.2017.12.005; Peeters KCMJ, 2005, J CLIN ONCOL, V23, P6199, DOI 10.1200/JCO.2005.14.779; Peng P, 2012, J GASTROINTEST SURG, V16, P1478, DOI 10.1007/s11605-012-1923-5; Peng PD, 2011, HPB, V13, P439, DOI 10.1111/j.1477-2574.2011.00301.x; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Richards CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041883; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; Sabel MS, 2013, J SURG ONCOL, V108, P169, DOI 10.1002/jso.23366; Sabel MS, 2011, ANN SURG ONCOL, V18, P3579, DOI 10.1245/s10434-011-1976-9; Watanabe T, 2018, INT J CLIN ONCOL, V23, P1, DOI 10.1007/s10147-017-1101-6	36	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195406	10.1371/journal.pone.0195406	http://dx.doi.org/10.1371/journal.pone.0195406			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630652	Green Submitted, gold, Green Published			2022-12-26	WOS:000429505000047
J	Li, HB; Dai, CG; Zhang, CR; He, YF; Ran, HY; Chen, SH				Li, Hong-Bo; Dai, Chang-Geng; Zhang, Chang-Rong; He, Yong-Fu; Ran, Hai-Yan; Chen, Shi-Hong			Screening potential reference genes for quantitative real-time PCR analysis in the oriental armyworm, Mythimna separata	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RT-PCR; HOUSEKEEPING GENES; INTERNAL CONTROL; EXPRESSION; SELECTION; VALIDATION; NORMALIZATION; WALKER; IDENTIFICATION	The oriental armyworm, Mythimna separata, is a major insect pest in China and other Asian countries. Unfortunately, suitable reference genes for quantitative real-time PCR (qRT-PCR) have not been previously identified in M. separata for normalizing target gene expression. In this study, we evaluated the expression stability of eight candidate genes (18S, ACT, EF1-alpha, GAPDH, RPS7, RPS13, RPL32 and TUB) in M. separata using the comparative Delta Ct method, BestKeeper, Normfinder geNorm and ReFinder, a comprehensive software platform. The results indicated that the appropriate reference gene varied depending on the experimental conditions. We found that ACTIN, EF1-alpha and TUB were optimal for different developmental stages; TUB, RPS13 and EF1-alpha showed the most stable expresssion in different tissues; RPS13 and 18S were the best reference genes for monitoring expression under high temperature conditions; TUB, RPS13 and RPS7 exhibited the most stable expression under larval-crowding conditions; RPS7, EF1-alpha, RPL32 and GAPDHwere the best for pesticide exposure experiments. This study provides tools for reliable normalization of qRT-PCR data and forms a foundation for functional studies of target gene expression in M. separata.	[Li, Hong-Bo; Dai, Chang-Geng; Zhang, Chang-Rong; He, Yong-Fu; Ran, Hai-Yan; Chen, Shi-Hong] Guizhou Acad Agr Sci, Inst Plant Protect, Guiyang, Guizhou, Peoples R China	Guizhou Academy of Agricultural Sciences	Li, HB; He, YF (corresponding author), Guizhou Acad Agr Sci, Inst Plant Protect, Guiyang, Guizhou, Peoples R China.	gzlhb2017@126.com; heyongfu08@163.com		Li, Hongboo/0000-0002-5860-9746	Special Fund for Agro-scientific Research in the Public Interest of China [201403031]; National Natural Science Foundation of China [31601633]; Natural Science Foundation of Guizhou province [20142121]; Talent Foundation of Guizhou Academy of Agricultural Science [201301]	Special Fund for Agro-scientific Research in the Public Interest of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guizhou province; Talent Foundation of Guizhou Academy of Agricultural Science	This research was funded by Special Fund for Agro-scientific Research in the Public Interest of China (201403031), National Natural Science Foundation of China (31601633), Natural Science Foundation of Guizhou province (20142121) and Talent Foundation of Guizhou Academy of Agricultural Science (201301).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2004, AZ QUANT PCR; Bansal R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134890; Bao WH, 2016, BIOTECHNOL LETT, V38, P1961, DOI 10.1007/s10529-016-2186-0; Baumann A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135093; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Chang XQ, 2017, COMP BIOCHEM PHYS D, V22, P120, DOI 10.1016/j.cbd.2017.03.001; Chang YW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181862; Chapman JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141853; Chapuis MP, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-7; Coker JS, 2003, BIOTECHNIQUES, V35, P740, DOI 10.2144/03354st04; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Dhar AK, 2009, MOL IMMUNOL, V46, P1688, DOI 10.1016/j.molimm.2009.02.020; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Fu W, 2013, INT J BIOL SCI, V9, P792, DOI 10.7150/ijbs.5862; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hornakova D, 2010, ANAL BIOCHEM, V397, P118, DOI 10.1016/j.ab.2009.09.019; Jiang Xing-Fu, 2014, Chinese Journal of Applied Entomology, V51, P1444, DOI 10.7679/j.issn.2095-1353.2014.168; Jiang Xing-Fu, 2014, Chinese Journal of Applied Entomology, V51, P881, DOI 10.7679/j.issn.2095-1353.2014.108; Jiang XF, 2011, ENVIRON ENTOMOL, V40, P516, DOI 10.1603/EN10199; Jiang Yu-Ying, 2014, Chinese Journal of Applied Entomology, V51, P890, DOI 10.7679/j.issn.2095-1353.2014.109; Kessler Y, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-106; Ladror DT, 2014, BIOCHEM BIOPH RES CO, V445, P535, DOI 10.1016/j.bbrc.2014.01.040; Li RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061619; Li WW, 2017, THESIS; Ling DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017762; Liu YJ, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iew079; Liu Z, 2017, SCI REP, V7; Lord JC, 2010, J MICROBIOL METH, V80, P219, DOI 10.1016/j.mimet.2009.12.007; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068059; Majerowicz D, 2011, INSECT MOL BIOL, V20, P713, DOI 10.1111/j.1365-2583.2011.01101.x; Mamidala P, 2011, J MED ENTOMOL, V48, P947, DOI 10.1603/ME10262; Morales MA, 2016, INT J BIOL SCI, V12, P1129, DOI 10.7150/ijbs.16319; Nijhof AM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-112; Pan HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125868; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Reim T, 2013, APIDOLOGIE, V44, P342, DOI 10.1007/s13592-012-0184-3; Rodrigues TB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109825; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376; Serazin-Leroy V, 1998, MOL CELL PROBE, V12, P283, DOI 10.1006/mcpr.1998.0182; Shakeel M, 2015, J ASIA-PAC ENTOMOL, V18, P123, DOI 10.1016/j.aspen.2015.01.001; Shi CH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071034; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sinha DK, 2014, SCI REP-UK, V4, DOI 10.1038/srep05059; Sun M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115979; Tang QY, 2013, INSECT SCI, V20, P254, DOI 10.1111/j.1744-7917.2012.01519.x; Teng XL, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.6001; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang GH, 2008, INSECT SCI, V15, P405, DOI 10.1111/j.1744-7917.2008.00227.x; Wang M, 2013, GENE, V530, P44, DOI 10.1016/j.gene.2013.07.084; Wang YW, 2010, IN VITRO CELL DEV-AN, V46, P595, DOI 10.1007/s11626-010-9318-y; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yang C.X, 2015, SCI REP, V5; Yang QP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098164; Yuan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086503; Zhang L, 2008, ARCH INSECT BIOCHEM, V68, P63, DOI 10.1002/arch.20255; Zhang SD, 2015, GENE, V555, P393, DOI 10.1016/j.gene.2014.11.038; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]; Zheng YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111369	65	31	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195096	10.1371/journal.pone.0195096	http://dx.doi.org/10.1371/journal.pone.0195096			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617430	gold, Green Published, Green Submitted			2022-12-26	WOS:000429203800062
J	Luengo-Gil, G; Gonzalez-Billalabeitia, E; Perez-Henarejos, SA; Manzano, EN; Chaves-Benito, A; Garcia-Martinez, E; Garcia-Garre, E; Vicente, V; de la Pena, FA				Luengo-Gil, Gines; Gonzalez-Billalabeitia, Enrique; Alejo Perez-Henarejos, Sergio; Navarro Manzano, Esther; Chaves-Benito, Asuncion; Garcia-Martinez, Elena; Garcia-Garre, Elisa; Vicente, Vicente; Ayala de la Pena, Francisco			Angiogenic role of miR-20a in breast cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR ANGIOGENESIS; NEOADJUVANT CHEMOTHERAPY; BEVACIZUMAB; MICRORNAS; CLUSTER; CELLS; EXPRESSION; DOCETAXEL; THERAPY	Background Angiogenesis is a key process for tumor progression and a target for treatment. However, the regulation of breast cancer angiogenesis and its relevance for clinical resistance to anti-angiogenic drugs is still incompletely understood. Recent developments on the contribution of microRNA to tumor angiogenesis and on the oncogenic effects of miR-17-92, a miRNA cluster, point to their potential role on breast cancer angiogenesis. The aim of this work was to establish the contribution of miR-20a, a member of miR-17-92 cluster, to tumor angiogenesis in patients with invasive breast carcinoma. Methods Tube-formation in vitro assays with conditioned medium from MCF7 and MDA-MB-231 breast cancer cell lines were performed after transfection with miR-20a and anti-miR20a. For clinical validation of the experimental findings, we performed a retrospective analysis of a series of consecutive breast cancer patients (n = 108) treated with neoadjuvant chemotherapy and with a full characterization of their vessel pattern and expression of angiogenic markers in pre-treatment biopsies. Expression of members of the cluster miR-17-92 and of angiogenic markers was determined by RT-qPCR after RNA purification from FFPE samples. Results In vitro angiogenesis assays with endothelial cells and conditioned media from breast cancer cell lines showed that transfection with anti-miR20a in MDA-MB-231 significantly decreased mean mesh size and total mesh area, while transfection with miR-20a in MCF7 cells increased mean mesh size. MiR-20a angiogenic effects were abrogated by treatment with aflibercept, a VEGF trap. These results were supported by clinical data showing that mir-20a expression was higher in tumors with no estrogen receptor or with more extensive nodal involvement (cN2-3). A higher miR-20a expression was associated with higher mean vessel size (p= 0.015) and with an angiogenic pattern consisting in larger vessels, higher VEGFA expression and presence of glomeruloid microvascular proliferations (p<0.001). This association was independent of tumor subtype and VEGFA expression. Conclusions Transfection of breast cancer cells with miR-20a induces vascular changes in endothelial tube-formation assays. Expression of miR-20a in breast invasive carcinomas is associated with a distinctive angiogenic pattern consisting in large vessels, anomalous glomeruloid microvascular proliferations and high VEGFA expression. Our results suggest a role for miR-20a in the regulation of breast cancer angiogenesis, and raise the possibility of its use as an angiogenic biomarker.	[Luengo-Gil, Gines; Gonzalez-Billalabeitia, Enrique; Alejo Perez-Henarejos, Sergio; Navarro Manzano, Esther; Garcia-Martinez, Elena; Garcia-Garre, Elisa; Vicente, Vicente; Ayala de la Pena, Francisco] Hosp Univ Morales Meseguer, Dept Hematol & Med Oncol, Murcia, Spain; [Luengo-Gil, Gines; Gonzalez-Billalabeitia, Enrique; Alejo Perez-Henarejos, Sergio; Navarro Manzano, Esther; Garcia-Martinez, Elena; Garcia-Garre, Elisa; Vicente, Vicente; Ayala de la Pena, Francisco] Ctr Reg Hemodonac, Murcia, Spain; [Luengo-Gil, Gines; Vicente, Vicente; Ayala de la Pena, Francisco] Univ Murcia, Dept Internal Med, Murcia, Spain; [Luengo-Gil, Gines; Gonzalez-Billalabeitia, Enrique; Alejo Perez-Henarejos, Sergio; Navarro Manzano, Esther; Garcia-Martinez, Elena; Garcia-Garre, Elisa; Vicente, Vicente; Ayala de la Pena, Francisco] IMIB Arrixaca, Murcia, Spain; [Gonzalez-Billalabeitia, Enrique; Garcia-Martinez, Elena] Univ Catolica San Antonio Murcia UCAM, Murcia, Spain; [Chaves-Benito, Asuncion] Hosp Univ Morales Meseguer, Dept Pathol, Murcia, Spain	Meseguer General University Hospital Morales; University of Murcia; Hospital Clinico Universitario Virgen de la Arrixaca; Universidad Catolica de Murcia; Meseguer General University Hospital Morales	de la Pena, FA (corresponding author), Hosp Univ Morales Meseguer, Dept Hematol & Med Oncol, Murcia, Spain.; de la Pena, FA (corresponding author), Ctr Reg Hemodonac, Murcia, Spain.; de la Pena, FA (corresponding author), Univ Murcia, Dept Internal Med, Murcia, Spain.; de la Pena, FA (corresponding author), IMIB Arrixaca, Murcia, Spain.	frayala@um.es	Luengo-Gil, Ginés/AAB-6780-2019; Gonzalez, Enrique/ABG-4621-2020; Vicente, Vicente/L-6185-2019; Ayala, Francisco/C-5280-2011	Luengo-Gil, Ginés/0000-0001-9940-0415; Gonzalez, Enrique/0000-0003-3143-3143; Vicente, Vicente/0000-0002-4278-3264; Ayala, Francisco/0000-0001-6311-920X; Navarro Manzano, Esther/0000-0002-0243-0085	Instituto de Salud Carlos III [PI12/02877]; FEDER funds; Fundacion Salud; Spain Ministerio de Educacion, Cultura y Deporte [FPU16/06537]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FEDER funds(European Commission); Fundacion Salud; Spain Ministerio de Educacion, Cultura y Deporte	This work was funded by Instituto de Salud Carlos III (http://www.isciii.es) (PI12/02877) (FA), including FEDER funds, and by Fundacion Salud 2000 (http://www.fundacionmercksalud.com) (Ayuda Merck Serono de Investigacion en Oncologia 2012) (FA). EN was funded by Spain Ministerio de Educacion, Cultura y Deporte (https://www.mecd.gob.es) (FPU16/06537). The funding bodies had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Avery-Kiejda KA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-51; Baar J, 2009, CLIN CANCER RES, V15, P3583, DOI 10.1158/1078-0432.CCR-08-2917; Barlow KD, 2013, CANCER MICROENVIRON, V6, P1, DOI 10.1007/s12307-012-0102-2; Bear HD, 2015, LANCET ONCOL; Beresford MJ, 2006, BRIT J CANCER, V95, P1683, DOI 10.1038/sj.bjc.6603491; Calvano CMC, 2014, TUMOR BIOL, V35, P7733, DOI 10.1007/s13277-014-2025-7; Carpentier G., 2012, ANGIOGENESIS ANAL IM; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Chamorro-Jorganes A, 2016, CIRC RES, V118, P38, DOI 10.1161/CIRCRESAHA.115.307408; Chang YY, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0301-9; Dal Bo M, 2015, ONCOTARGET, V6, P19381; de Rinaldis E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-643; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Dews M, 2010, CANCER RES, V70, P8233, DOI 10.1158/0008-5472.CAN-10-2412; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; dos Santos LV, 2015, BREAST CANCER RES TR, V151, P481, DOI 10.1007/s10549-015-3410-7; Earl HM, 2015, LANCET ONCOL, V16, P656, DOI 10.1016/S1470-2045(15)70137-3; Fan Y, 2014, RNA, V20, P765, DOI 10.1261/rna.043026.113; Freres P, 2016, ONCOTARGET, V7, P5416, DOI 10.18632/oncotarget.6786; Gasparri ML, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317695525; Ghosh S, 2008, HUM PATHOL, V39, P1835, DOI 10.1016/j.humpath.2008.06.004; Grant DS, 2003, INT J CANCER, V104, P121, DOI 10.1002/ijc.10907; Harbeck N, 2017, LANCET, V389, P1134, DOI [10.1016/s0140-6736(16)31891-8, 10.1016/S0140-6736(16)31891-8]; Jin LJ, 2014, BREAST CANCER RES TR, V146, P41, DOI 10.1007/s10549-014-2978-7; Kim K, 2012, ONCOGENE, V31, P1034, DOI 10.1038/onc.2011.296; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Luengo-Gil G, 2015, BREAST CANCER RES TR, V151, P577, DOI 10.1007/s10549-015-3421-4; Ma HB, 2016, CANCER LETT, V376, P293, DOI 10.1016/j.canlet.2016.04.011; Mikalsen LTG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075954; Miles DW, 2013, ANN ONCOL, V24, P2773, DOI 10.1093/annonc/mdt276; Nagy JA, 2009, BRIT J CANCER, V100, P865, DOI 10.1038/sj.bjc.6604929; Ouchida M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044095; Perrot-Applanat M, 2012, CELL ADHES MIGR, V6, P547, DOI 10.4161/cam.23332; Plummer PN, 2013, CANCER RES, V73, P341, DOI 10.1158/0008-5472.CAN-12-0271; Ricci V, 2015, CRIT REV ONCOL HEMAT, V96, P569, DOI 10.1016/j.critrevonc.2015.07.001; Sledge GW, 2015, J CLIN ONCOL, V33, P133, DOI 10.1200/JCO.2014.58.1298; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; van Schooneveld E, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0526-y; Vasudev NS, 2013, BRIT J CANCER, V109, P1230, DOI 10.1038/bjc.2013.429; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Wu Q, 2015, J CELL MOL MED, V19, P2874, DOI 10.1111/jcmm.12681; Wu S, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-40	42	45	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194638	10.1371/journal.pone.0194638	http://dx.doi.org/10.1371/journal.pone.0194638			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617404	Green Published, Green Submitted, gold			2022-12-26	WOS:000429203800040
J	Ribeiro, VP; Silva-Correia, J; Goncalves, C; Pina, S; Radhouani, H; Montonen, T; Hyttinen, J; Roy, A; Oliveira, AL; Reis, RL; Oliveira, JM				Ribeiro, Viviana P.; Silva-Correia, Joana; Goncalves, Cristiana; Pina, Sandra; Radhouani, Hajer; Montonen, Toni; Hyttinen, Jari; Roy, Anirban; Oliveira, Ana L.; Reis, Rui L.; Oliveira, Joaquim M.			Rapidly responsive silk fibroin hydrogels as an artificial matrix for the programmed tumor cells death	PLOS ONE			English	Article							OPTICAL PROJECTION TOMOGRAPHY; IN-VITRO; INJECTABLE HYDROGELS; FABRICATION; TRANSITION; SCAFFOLDS; PROTEINS; POLYMERS; GELATION; MODEL	Timely and spatially-regulated injectable hydrogels, able to suppress growing tumors in response to conformational transitions of proteins, are of great interest in cancer research and treatment. Herein, we report rapidly responsive silk fibroin (SF) hydrogels formed by a horseradish peroxidase (HRP) crosslinking reaction at physiological conditions, and demonstrate their use as an artificial biomimetic three-dimensional (3D) matrix. The proposed SF hydrogels presented a viscoelastic nature of injectable hydrogels and spontaneous conformational changes from random coil to beta-sheet conformation under physiological conditions. A human neuronal glioblastoma (U251) cell line was used for screening cell encapsulation and in vitro evaluation within the SF hydrogels. The transparent random coil SF hydrogels promoted cell viability and proliferation up to 10 days of culturing, while the crystalline SF hydrogels converted into beta-sheet structure induced the formation of TUNEL-positive apoptotic cells. Therefore, this work provides a powerful tool for the investigation of the microenvironment on the programed tumor cells death, by using rapidly responsive SF hydrogels as 3D in vitro tumor models.	[Ribeiro, Viviana P.; Silva-Correia, Joana; Goncalves, Cristiana; Pina, Sandra; Radhouani, Hajer; Reis, Rui L.; Oliveira, Joaquim M.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, Avepk Parque Ciencia & Tecnol,Zona Ind Gandra, Barco, Guimaraes, Portugal; [Ribeiro, Viviana P.; Silva-Correia, Joana; Goncalves, Cristiana; Pina, Sandra; Radhouani, Hajer; Reis, Rui L.; Oliveira, Joaquim M.] ICVS 3Bs PT Govt Associated Lab, Braga, Portugal; [Montonen, Toni; Hyttinen, Jari] Tampere Univ Technol, ELT Dept, Computat Biophys & Imaging Grp, Tampere, Finland; [Montonen, Toni; Hyttinen, Jari] BioMediTech Inst Biosci & Med Technol, Tampere, Finland; [Roy, Anirban] Anasys Instruments Corp Santa Barbara, Santa Barbara, CA USA; [Oliveira, Ana L.] Univ Catolica Portuguese, Escola Super Biotecnol, Lab Associado, CBQF Ctr Biotecnol & Quim Fina, Porto, Portugal; [Reis, Rui L.; Oliveira, Joaquim M.] Univ Minho, Discoveries Ctr Regenerat & Precis Med, Avepk Parque Ciencia & Tecnol,Zona Ind Gandra, Barco, Guimaraes, Portugal	Universidade do Minho; Tampere University; Universidade Catolica Portuguesa; Universidade do Minho	Ribeiro, VP (corresponding author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, Avepk Parque Ciencia & Tecnol,Zona Ind Gandra, Barco, Guimaraes, Portugal.; Ribeiro, VP (corresponding author), ICVS 3Bs PT Govt Associated Lab, Braga, Portugal.	viviana.riberiro@dep.uminho.pt	Hyttinen, Jari A/G-4280-2014; Radhouani, Hajer Radhouani H/E-1837-2011; Ribeiro, Viviana/A-3670-2019; Gonçalves, Cristiana/A-7131-2010; Reis, Rui L./A-8938-2008; Pina, Sandra/H-8133-2013; Silva-Correia, Joana/D-4980-2012; Oliveira, Ana L/J-3404-2013; Pina, Sandra/U-8428-2019; Oliveira, Joaquim Miguel/H-8636-2012	Hyttinen, Jari A/0000-0003-1850-3055; Ribeiro, Viviana/0000-0002-3679-0759; Gonçalves, Cristiana/0000-0002-3219-1310; Reis, Rui L./0000-0002-4295-6129; Pina, Sandra/0000-0002-4361-1253; Silva-Correia, Joana/0000-0003-1312-3109; Oliveira, Ana L/0000-0001-8012-4203; Pina, Sandra/0000-0002-4361-1253; Oliveira, Joaquim Miguel/0000-0001-7052-8837; Radhouani, Hajer/0000-0003-1007-4073; Montonen, Toni/0000-0003-3784-0890	Portuguese Foundation for Science and Technology (FCT) under POFC [PEst-C/SAU/ LA0026/2013]; FEDER programs; Investigator FCT program [IF/00423/2012, IF/01285/2015, IF/00411/2013, IF/00115/2015]; FCT/MCTES [PD/BD/113806/2015]; FSUPOCH [PD/59/2013]; R&D grant of Anasys Instruments Corp; Anasys Instruments Corp.;  [SFRH/BPD/94277/2013];  [SFRH/BPD/108763/2015];  [SFRH/BPD/100957/2014]; Fundação para a Ciência e a Tecnologia [PEst-C/SAU/LA0026/2013] Funding Source: FCT	Portuguese Foundation for Science and Technology (FCT) under POFC; FEDER programs; Investigator FCT program(Portuguese Foundation for Science and Technology); FCT/MCTES(Portuguese Foundation for Science and TechnologyEuropean Commission); FSUPOCH; R&D grant of Anasys Instruments Corp; Anasys Instruments Corp.; ; ; ; Fundação para a Ciência e a Tecnologia	This study was funded by the Portuguese Foundation for Science and Technology (FCT; http://www.fct.pt) project PEst (PEst-C/SAU/ LA0026/2013) under POFC and/or FEDER programs, attributed to RLR; Grants under the Investigator FCT program: IF/00423/2012 and IF/01285/2015 (JMO), IF/00411/2013 (ALO) and IF/00115/2015 (JSC); Postdoctoral fellows: SFRH/BPD/94277/2013 (CG), SFRH/BPD/108763/2015 (SP), SFRH/BPD/100957/2014 (HR); PhD scholarship PD/BD/113806/2015 attributed to VPR under the financial support from FCT/MCTES and FSUPOCH, PD/59/2013. An internal R&D grant of Anasys Instruments Corp provided support in the form of salary for author AR, but did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section. The remaining coauthors did not receive any funding from Anasys Instruments Corp.	Aho J, 2015, INT J PHARMACEUT, V494, P623, DOI 10.1016/j.ijpharm.2015.02.009; Bai S, 2013, ACTA BIOMATER, V9, P7806, DOI 10.1016/j.actbio.2013.04.033; Bastiancich C, 2016, J CONTROL RELEASE, V243, P29, DOI 10.1016/j.jconrel.2016.09.034; Bersini S, 2014, BIOMATERIALS, V35, P2454, DOI 10.1016/j.biomaterials.2013.11.050; Cai YR, 2017, MAT SCI ENG C-MATER, V70, P148, DOI 10.1016/j.msec.2016.08.070; Chen X, 2007, PROTEINS, V68, P223, DOI 10.1002/prot.21414; Cho SY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8145; Davis NE, 2012, BIOMATERIALS, V33, P6691, DOI 10.1016/j.biomaterials.2012.06.015; de Moraes MA, 2010, POLYMERS-BASEL, V2, P719, DOI 10.3390/polym2040719; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Du GY, 2017, NANOSCALE RES LETT, V12, DOI 10.1186/s11671-017-2316-1; Elisseeff J, 2008, NAT MATER, V7, P271, DOI 10.1038/nmat2147; Figueiras E, 2014, BIOMED OPT EXPRESS, V5, P3443, DOI 10.1364/BOE.5.003443; Fischbach C, 2007, BIOMATERIALS, V28, P2069, DOI 10.1016/j.biomaterials.2006.12.029; Ghosh S, 2008, ADV FUNCT MATER, V18, P1883, DOI 10.1002/adfm.200800040; Greish K, 2010, J GENE MED, V12, P572, DOI 10.1002/jgm.1469; Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hennink WE, 2012, ADV DRUG DELIVER REV, V64, P223, DOI 10.1016/j.addr.2012.09.009; Huang HZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059482, 10.1371/journal.pone.0076982, 10.1371/journal.pone.0071808]; Hutmacher DW, 2009, J CELL MOL MED, V13, P1417, DOI 10.1111/j.1582-4934.2009.00853.x; Jin R, 2010, BIOMATERIALS, V31, P3103, DOI 10.1016/j.biomaterials.2010.01.013; Kadowaki H, 2005, CELL DEATH DIFFER, V12, P19, DOI 10.1038/sj.cdd.4401528; Katt ME, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00012; Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Leisk GG, 2010, ADV MATER, V22, P711, DOI 10.1002/adma.200902643; Liu L, 2016, ASIAN J PHARM SCI, V11, P673, DOI 10.1016/j.ajps.2016.07.001; Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064; Marcott C., 2012, MICROS TODAY, V20, P16, DOI [10.1017/s1551929512000776, DOI 10.1017/S1551929512000776]; McGill M, 2017, ACTA BIOMATER, V63, P76, DOI 10.1016/j.actbio.2017.09.020; Mitropoulos AN, 2015, ACS BIOMATER SCI ENG, V1, P964, DOI 10.1021/acsbiomaterials.5b00215; Nogueira GM, 2011, MAT SCI ENG C-MATER, V31, P997, DOI 10.1016/j.msec.2011.02.019; Park KM, 2009, ACTA BIOMATER, V5, P1956, DOI 10.1016/j.actbio.2009.01.040; Partlow BP, 2014, ADV FUNCT MATER, V24, P4615, DOI 10.1002/adfm.201400526; Qin N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13079; Qiu PH, 2013, ADV MATER, V25, P2492, DOI 10.1002/adma.201204472; Reis RL, 2014, Portugal patent, Patent No. [107426, PT107426]; Ribeiro VP, 2017, BIOMATERIALS, V123, P92, DOI 10.1016/j.biomaterials.2017.01.027; Ryu S, 2016, J MATER CHEM B, V4, P4574, DOI 10.1039/c6tb00896h; Sah MK, 2011, AFR J BIOTECHNOL, V10, P7878; Sakai S, 2009, ACTA BIOMATER, V5, P554, DOI 10.1016/j.actbio.2008.10.010; Sakai S, 2009, BIOMATERIALS, V30, P3371, DOI 10.1016/j.biomaterials.2009.03.030; Seib FP, 2015, BIOMATERIALS, V51, P313, DOI 10.1016/j.biomaterials.2015.01.076; Shirmanova MV, 2017, ADV EXP MED BIOL, V1035, P143, DOI 10.1007/978-3-319-67358-5_10; Soto AM, 2016, LANGMUIR, V32, P5173, DOI 10.1021/acs.langmuir.6b00554; Sundarakrishnan A, 2016, ACTA BIOMATER, V42, P102, DOI 10.1016/j.actbio.2016.06.020; Szot CS, 2011, BIOMATERIALS, V32, P7905, DOI 10.1016/j.biomaterials.2011.07.001; Ta HT, 2008, J CONTROL RELEASE, V126, P205, DOI 10.1016/j.jconrel.2007.11.018; Teixeira LSM, 2012, BIOMATERIALS, V33, P1281, DOI 10.1016/j.biomaterials.2011.10.067; Tellado SF, 2017, TISSUE ENG PT A, V23, P859, DOI [10.1089/ten.tea.2016.0460, 10.1089/ten.TEA.2016.0460]; Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003; Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5; Xia LW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3226; Xiong G., 2013, J BIOMATER NANOBIOTE, V4, P316, DOI DOI 10.4236/JBNB.2013.44040; Yan CQ, 2010, CHEM SOC REV, V39, P3528, DOI 10.1039/b919449p; Yan LP, 2017, J TISSUE ENG REGEN M, V11, P3168, DOI 10.1002/term.2226; Yan LP, 2016, SCI REP-UK, V6, DOI 10.1038/srep31037; Yang M, 2017, ADV FUNCTIONAL MAT; Yu E, 2016, INT POLYM PROC, V31, P638, DOI 10.3139/217.3247; Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k; Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028; Zainuddin, 2008, BIOMATERIALS, V29, P4268, DOI 10.1016/j.biomaterials.2008.07.041; Zheng R, 2004, PROTEIN SCI, V13, P1288, DOI 10.1110/ps.03550404; Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078	65	39	38	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194441	10.1371/journal.pone.0194441	http://dx.doi.org/10.1371/journal.pone.0194441			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617395	Green Published, gold, Green Submitted			2022-12-26	WOS:000429203800031
J	Robson, JP; Kokhanenko, P; Marshall, JK; Phillips, AR; van der Linden, J				Robson, Jonathan P.; Kokhanenko, Pavlo; Marshall, Jean K.; Phillips, Anthony R.; van der Linden, Jan			Increased visceral tissue perfusion with heated, humidified carbon dioxide insufflation during open abdominal surgery in a rodent model	PLOS ONE			English	Article							SURGICAL SITE INFECTION; BLOOD-FLOW; LOCAL INSUFFLATION; ANASTOMOTIC LEAKS; CO2 INSUFFLATION; WOUND-INFECTION; OXYGEN-TENSION; METABOLIC-RATE; COLON SURGERY; TEMPERATURE	Tissue perfusion during surgery is important in reducing surgical site infections and promoting healing. This study aimed to determine if insufflation of the open abdomen with heated, humidified (HH) carbon dioxide (CO2) increased visceral tissue perfusion and core body temperature during open abdominal surgery in a rodent model. Using two different rodent models of open abdominal surgery, visceral perfusion and core temperature were measured. Visceral perfusion was investigated using a repeated measures crossover experiment with rodents receiving the same sequence of two alternating treatments: exposure to ambient air (no insufflation) and insufflation with HH CO2. Core body temperature was measured using an independent experimental design with three treatment groups: ambient air, HH CO2 and cold, dry (CD) CO2. Visceral perfusion was measured by laser speckle contrast analysis (LASCA) and core body temperature was measured with a rectal thermometer. Insufflation with HH CO2 into a rodent open abdominal cavity significantly increased visceral tissue perfusion (2.4 perfusion units (PU)/min (95% CI 1.23-3.58); p<0.0001) compared with ambient air, which significantly reduced visceral blood flow (-5.20 PU/min (95% CI -6.83- -3.58); p<0.0001). Insufflation of HH CO2 into the open abdominal cavity significantly increased core body temperature (+1.15 +/- 0.14 degrees C) compared with open cavities exposed to ambient air (-0.65 +/- 0.52 degrees C; p = 0.037), or cavities insufflated with CD CO2 (-0.73 +/- 0.33 degrees C; p = 0.006). Abdominal visceral temperatures also increased with HH CO2 insufflation compared with ambient air or CD CO2, as shown by infrared thermography. This study reports for the first time the use of LASCA to measure visceral perfusion in open abdominal surgery and shows that insufflation of open abdominal cavities with HH CO2 significantly increases visceral tissue perfusion and core body temperature.	[Robson, Jonathan P.; Kokhanenko, Pavlo; Marshall, Jean K.] Fisher & Paykel Healthcare, Auckland, New Zealand; [Phillips, Anthony R.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [van der Linden, Jan] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden	Haier; University of Auckland; Karolinska Institutet	Robson, JP (corresponding author), Fisher & Paykel Healthcare, Auckland, New Zealand.	Jonathan.robson@fphcare.co.nz			University of Auckland ethics board	University of Auckland ethics board	We are grateful to the VJU animal staff for all their support with the experiments and animal maintenance. We are thankful to the University of Auckland ethics board for their support and assistance in running the experiments. Special thanks to Blake Sears and Avinesh Pillai at the University of Auckland, department of statistics, who analysed the perfusion data. Thank you to Dr Callum Spence and Ali Ghalib at Fisher and Paykel Healthcare for their engineering assistance with the animal experiments.	Agaev B A, 2013, Khirurgiia (Mosk), P35; Akca O, 2013, BRIT J ANAESTH, V111, P759, DOI 10.1093/bja/aet233; [Anonymous], 2017, R LANG ENV STAT COMP; Balayssac D, 2017, SURG ENDOSC, V31, P1, DOI 10.1007/s00464-016-4866-1; Birch DW, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007821.pub3; Briers J D, 1996, J Biomed Opt, V1, P174, DOI 10.1117/12.231359; Carpinteri S, 2015, ANN SURG ONCOLOGY; Carpinteri S, 2015, ANN SURG ONCOL, V22, pS1540, DOI 10.1245/s10434-015-4508-1; Cater JE, 2015, MED ENG PHYS, V37, P121, DOI 10.1016/j.medengphy.2014.07.011; Choi B, 2004, MICROVASC RES, V68, P143, DOI 10.1016/j.mvr.2004.04.003; Davey AK, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/816283; Dickerson RN, 2005, J AM DIET ASSOC, V105, P1002, DOI 10.1016/j.jada.2005.04.022; Dickerson RN, 2005, J AM DIET ASSOC, V105, P835, DOI 10.1016/j.jada.2005.03.021; DILSAVER SC, 1992, PHARMACOL BIOCHEM BE, V42, P549, DOI 10.1016/0091-3057(92)90154-8; Draijer M, 2009, LASER MED SCI, V24, P639, DOI 10.1007/s10103-008-0626-3; EDSALL J T, 1972, Journal of the History of Biology, V5, P205, DOI 10.1007/BF00346659; Erikoglu M, 2005, J SURG RES, V125, P73, DOI 10.1016/j.jss.2004.11.029; Farley DR, 2004, ARCH SURG-CHICAGO, V139, P739, DOI 10.1001/archsurg.139.7.739; Farley DR, 2004, ARCH SURG-CHICAGO, V139, P43; Fredriksson I, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.12.126018; Freestone PP, 2002, SHOCK, V18, P465, DOI 10.1097/00024382-200211000-00014; Freestone PPE, 2000, J BACTERIOL, V182, P6091, DOI 10.1128/JB.182.21.6091-6098.2000; Frey JM, 2012, ANESTH ANALG, V115, P1204, DOI 10.1213/ANE.0b013e31826ac49f; Frey JM, 2010, WOUND REPAIR REGEN, V18, P378, DOI 10.1111/j.1524-475X.2010.00602.x; Frey JMK, 2012, WORLD J SURG, V36, P2567, DOI 10.1007/s00268-012-1735-5; Gnyawali SC, 2017, SCI REP-UK, V7, DOI 10.1038/srep41048; Greif R, 2000, NEW ENGL J MED, V342, P161, DOI 10.1056/NEJM200001203420303; HALEY RW, 1985, AM J EPIDEMIOL, V121, P206, DOI 10.1093/oxfordjournals.aje.a113991; Hamza MA, 2005, J LAPAROENDOSC ADV A, V15, P6, DOI 10.1089/lap.2005.15.6; Hayashi H, 2016, J CARDIOTHOR VASC AN, V30, P613, DOI 10.1053/j.jvca.2016.01.021; Hecht N, 2016, J CEREBR BLOOD F MET, V36, P1022, DOI 10.1177/0271678X15612487; Hecht N, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.8.FOCUS09148; Hopf HW, 1997, ARCH SURG-CHICAGO, V132, P997; Hubner M, 2011, ARCH SURG-CHICAGO, V146, P1240, DOI 10.1001/archsurg.2011.176; Hyman N, 2007, ANN SURG, V245, P254, DOI 10.1097/01.sla.0000225083.27182.85; Jafari MD, 2015, J AM COLL SURGEONS, V220, P82, DOI 10.1016/j.jamcollsurg.2014.09.015; Jenks M, 2017, EXPERT REV PHARM OUT, V17, P99, DOI 10.1080/14737167.2017.1270759; Jepsen O B, 1969, Acta Chir Scand Suppl, V396, P80; JONSSON K, 1991, ANN SURG, V214, P605, DOI 10.1097/00000658-199111000-00011; Kabon B, 2005, ANESTH ANALG, V101, P1546, DOI 10.1213/01.ANE.0000180217.57952.FE; Kabon B, 2004, ANESTHESIOLOGY, V100, P274, DOI 10.1097/00000542-200402000-00015; Klugsberger B, 2014, SURG ENDOSC, V28, P2656, DOI 10.1007/s00464-014-3522-x; Kokhanenko P, 2017, J HOSP INFECT, V95, P112, DOI 10.1016/j.jhin.2016.11.006; Kubota J, 2002, LASER MED SCI, V17, P146, DOI 10.1007/s101030200024; Levy BI, 2008, CIRCULATION, V118, P968, DOI 10.1161/CIRCULATIONAHA.107.763730; Li PC, 2006, OPT LETT, V31, P1824, DOI 10.1364/OL.31.001824; Li Y, 2013, EVID-BASED COMPL ALT, V2013; Lonsky V, 2011, PERFUSION-UK, V26, P510, DOI 10.1177/0267659111419272; Lyte M, 2003, LANCET, V361, P130, DOI 10.1016/S0140-6736(03)12231-3; Marshall J, 2014, COLORECTAL DIS S2, V16, P4; Marshall JK, 2017, J SURG RES, V220, P300, DOI 10.1016/j.jss.2017.06.057; Marshall JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122838; Milstein DMJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003875; Ott D E, 1998, JSLS, V2, P321; Park C, 2009, TRANSPLANTATION, V87, P1031, DOI 10.1097/TP.0b013e31819cc3e6; Paul JS, 2006, NEUROIMAGE, V29, P38, DOI 10.1016/j.neuroimage.2005.07.019; Rullier E, 1998, BRIT J SURG, V85, P355; Sajid MS, 2008, SURG LAPARO ENDO PER, V18, P539, DOI 10.1097/SLE.0b013e3181886ff4; Sammour T, 2008, BRIT J SURG, V95, P950, DOI 10.1002/bjs.6304; Savel RH, 2005, OBES SURG, V15, P64, DOI 10.1381/0960892052993530; SHERIDAN WG, 1987, DIS COLON RECTUM, V30, P867, DOI 10.1007/BF02555426; SONG CW, 1989, INT J RADIAT ONCOL, V17, P1041, DOI 10.1016/0360-3016(89)90153-3; STONER HB, 1991, CLIN PHYSIOL, V11, P27, DOI 10.1111/j.1475-097X.1991.tb00651.x; Volz J, 1999, CANCER, V86, P770, DOI 10.1002/(SICI)1097-0142(19990901)86:5<770::AID-CNCR11>3.0.CO;2-3; Wetterslev J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008884.pub2; Yang W, 2016, J HOSP INFECT, V93, P329, DOI 10.1016/j.jhin.2016.03.015; Zehetner J, 2015, ANN SURG, V262, P74, DOI 10.1097/SLA.0000000000000811	67	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195465	10.1371/journal.pone.0195465	http://dx.doi.org/10.1371/journal.pone.0195465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617447	gold, Green Published, Green Submitted			2022-12-26	WOS:000429203800088
J	Stager, JC; Wiltse, B; Hubeny, JB; Yankowsky, E; Nardelli, D; Primack, R				Stager, J. Curt; Wiltse, Brendan; Hubeny, J. Bradford; Yankowsky, Eric; Nardelli, David; Primack, Richard			Climate variability and cultural eutrophication at Walden Pond (Massachusetts, USA) during the last 1800 years	PLOS ONE			English	Article							NORTHEASTERN UNITED-STATES; NEW-ENGLAND; ORGANIC-MATTER; CRAWFORD LAKE; DEPTH MODELS; ICE-AGE; DROUGHT; ONTARIO; 21ST-CENTURY; SEDIMENTS	Recent shifts in the ecological condition of Walden Pond, MA, are of potentially wide interest due to the lake's importance as a cultural, historical, and recreational resource in addition to its scientific value as an indicator of local and global environmental change. Algal microfossils in six sediment cores document changes in hydroclimate and trophic status of the lake during the last 1800 years and extend two previous sediment core records of shorter length. Low percentages of planktonic diatoms in the longest cores (WAL-3, WAL-15) indicate shallowing and/or greater water clarity associated with a relatively arid interval during the Medieval Climate Anomaly, ca. A.D. 1150-1300, Cultural eutrophication of the lake since the A.D. 1920s caused diatoms in the genera Asterionella and Synedra to increase in relative abundance at the expense of Cyclotella, Discostella, and the chrysophyte alga Mallomonas allorgel. Percentages of Asterionella and Synedra have remained fairly stable since A.D. 2000 when a previous sediment core study was conducted, but scaled chrysophytes have become more numerous. These findings suggest that, although mitigation efforts have curtailed anthropogenic nutrient inputs to Walden Pond, the lake has not returned to the pre-impact condition described by Henry David Thoreau and may become increasingly vulnerable to further changes in water quality in a warmer and possibly wetter future.	[Stager, J. Curt; Wiltse, Brendan; Yankowsky, Eric; Nardelli, David] Paul Smiths Coll, Nat Sci, Paul Smiths, NY 12970 USA; [Wiltse, Brendan] Ausable River Assoc, Wilmington, NY USA; [Hubeny, J. Bradford] Salem State Univ, Dept Geol Sci, Salem, MA USA; [Primack, Richard] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA	Massachusetts System of Public Higher Education; Salem State University; Boston University	Stager, JC (corresponding author), Paul Smiths Coll, Nat Sci, Paul Smiths, NY 12970 USA.	cstager@paulsmiths.edu			U.S. National Science Foundation [1358362, 1126128]; National Science Foundation [P2C2, ATM 1358362, EAR 126128]	U.S. National Science Foundation(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	The research upon which this study is based was funded by the U.S. National Science Foundation grants #1358362 and #1126128 (www.nsf.gov).; JCS acknowledges the National Science Foundation (www.nsf.gov) for grant funding (P2C2, ATM 1358362) the Massachusetts Department of Conservation and Recreation, Jacqui Kluft, Elliott Lewis, and Rory Fraser for assistance in the field. Radiocarbon analyses for cores WAL-2, WAL-3, and WAL-15 were performed by the National Ocean Services Accelerator Mass Spectrometry laboratory, Woods Hole, MA (www.whoi.edu/nosams/home). JBH acknowledges contributions by K. Monecke, C. Knights, and R. Knudstrup, as well as funding from the National Science Foundation (EAR 126128). The funders had no direct role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barosh PJ, 1993, THOREAUS WORLD OURS, P212; Bennion H, 2000, FRESHWATER BIOL, V45, P394, DOI 10.1046/j.1365-2427.2000.00626.x; Blaauw M, 2011, BAYESIAN ANAL, V6, P457, DOI 10.1214/ba/1339616472; Booth RK, 2006, EARTH PLANET SC LETT, V242, P415, DOI 10.1016/j.epsl.2005.12.028; Burge D, 2017, DIATOMS US; Clifford MJ, 2015, HOLOCENE, V25, P1102, DOI 10.1177/0959683615580182; Colman JA, 2001, 014137 US GEOL SURV; Cook BI, 2014, J CLIMATE, V27, P383, DOI 10.1175/JCLI-D-13-00100.1; Cook ER, 2010, J QUATERNARY SCI, V25, P48, DOI 10.1002/jqs.1303; DAVIS RB, 1984, CHEM GEOL, V44, P151, DOI 10.1016/0009-2541(84)90071-8; Deevey ES, 1942, Q REV BIOL, V17, P1; Dixit SS, 1999, CAN J FISH AQUAT SCI, V56, P131, DOI 10.1139/cjfas-56-1-131; Ekdahl EJ, 2004, GEOLOGY, V32, P745, DOI 10.1130/G20496.1; Ekdahl EJ, 2007, J PALEOLIMNOL, V37, P233, DOI 10.1007/s10933-006-9016-7; Fraser AI, 1999, WATER SCI TECHNOL, V39, P41, DOI 10.1016/S0273-1223(99)00316-9; Hall Roland I., 1999, P128; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Hodgkins GA, 2002, INT J CLIMATOL, V22, P1819, DOI 10.1002/joc.857; Holtgrieve GW, 2011, SCIENCE, V334, P1545, DOI 10.1126/science.1212267; Hubeny JB, 2011, P NATL ACAD SCI USA, V108, P17895, DOI 10.1073/pnas.1019301108; JAAKKOLA T, 1983, HYDROBIOLOGIA, V103, P15, DOI 10.1007/BF00028422; Jarnefelt H, 1952, ANN ACAD SCI FENN A4, V18, P1; Jeppesen E, 2017, WATER-SUI, V9, DOI 10.3390/w9020122; Koster Dorte, 2005, Aquatic Ecosystem Health & Management, V8, P117, DOI 10.1080/14634980590953743; Krammer K, 1991, SUBETAWASSERFLORA MI; Laird KR, 2008, QUATERNARY RES, V69, P292, DOI 10.1016/j.yqres.2007.11.003; Laird KR, 2012, GLOBAL CHANGE BIOL, V18, P2869, DOI 10.1111/j.1365-2486.2012.02740.x; Laird KR, 2011, QUATERNARY SCI REV, V30, P1201, DOI 10.1016/j.quascirev.2011.02.009; Laird KR, 2010, J PALEOLIMNOL, V44, P1009, DOI 10.1007/s10933-010-9470-0; Mann ME, 2009, SCIENCE, V326, P1256, DOI 10.1126/science.1177303; Marlon JR, 2017, CLIM PAST, V13, P1355, DOI 10.5194/cp-13-1355-2017; Maynard WB, 2004, WALDEN POND HIST; Newby PE, 2014, GEOPHYS RES LETT, V41, P4300, DOI 10.1002/2014GL060183; Nurnberg GK, 2009, LAKE RESERV MANAGE, V25, P419, DOI 10.1080/00357520903458848; Oldfield, 1978, CATENA, V5, P1, DOI DOI 10.1016/S0341-8162(78)80002-2; Oswald WW, 2011, QUATERNARY RES, V76, P314, DOI 10.1016/j.yqres.2011.07.004; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Paterson AM, 2004, FRESHWATER BIOL, V49, P199, DOI 10.1046/j.1365-2427.2003.01170.x; Paterson AM, 2008, CAN J FISH AQUAT SCI, V65, P846, DOI 10.1139/F08-022; Patrick R, 1975, MONOGRAPHS ACAD NATU, V13; Patrick R.M., 1966, FRAGILARIACEAE EUNOT, V13, P1, DOI 10.2307/1351135; Pederson DC, 2005, QUATERNARY RES, V63, P238, DOI 10.1016/j.yqres.2005.01.001; Primack RB., 2014, WALDEN WARMING CLIMA; Reavie ED, 1995, CAN J FISH AQUAT SCI, V52, P2388, DOI 10.1139/f95-831; Ruhland KM, 2015, J PALEOLIMNOL, V54, P1, DOI 10.1007/s10933-015-9837-3; Saros JE, 2015, BIOL REV, V90, P522, DOI 10.1111/brv.12120; Schindler DW, 1997, BIOGEOCHEMISTRY, V36, P1, DOI 10.1023/A:1005768527751; Schwarz AM, 2002, AQUAT BOT, V72, P209, DOI 10.1016/S0304-3770(01)00201-7; Sinha E, 2017, SCIENCE, V357, P405, DOI 10.1126/science.aan2409; Sivarajah B, 2017, FUND APPL LIMNOL, V190, P13, DOI 10.1127/fal/2017/0981; Sivarajah B, 2016, J PALEOLIMNOL, V55, P357, DOI 10.1007/s10933-016-9886-2; Siver P.A, 1991, DEV HYDROBIOL, V63; Stager JC, 2016, HOLOCENE; Stone JR, 2004, LIMNOL OCEANOGR, V49, P1540; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; Sutherland RA, 1998, HYDROBIOLOGIA, V389, P153, DOI 10.1023/A:1003570219018; Thoreau H. D., 1854, WALDEN LIFE WOODS; Thoreau HD, 2009, UJMOWAC HEAD D THORE; United States Global Change Research Program, 2017, 3 NAT CLIM ASS; Wang HY, 2015, AQUAT BIOL, V24, P91, DOI 10.3354/ab00638; Winder M, 2012, HYDROBIOLOGIA, V698, P5, DOI 10.1007/s10750-012-1149-2; Winkler MG, 1993, THOREAUS WORLD OURS, P199; Woodhouse CA, 2010, P NATL ACAD SCI USA, V107, P21283, DOI 10.1073/pnas.0911197107	63	9	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0191755	10.1371/journal.pone.0191755	http://dx.doi.org/10.1371/journal.pone.0191755			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617379	Green Submitted, gold, Green Published			2022-12-26	WOS:000429203800001
J	Wang, W; Duclot, F; Groveman, BR; Carrier, N; Qiao, HF; Fang, XQ; Wang, H; Xin, WK; Jiang, XH; Salter, MW; Ding, XS; Kabbaj, M; Yu, XM				Wang, Wei; Duclot, Florian; Groveman, Bradley R.; Carrier, Nicole; Qiao, Haifa; Fang, Xiao-Qian; Wang, Hui; Xin, Wenkuan; Jiang, Xing-Hong; Salter, Michael W.; Ding, Xin-Sheng; Kabbaj, Mohamed; Yu, Xian-Min			Hippocampal protein kinase D1 is necessary for DHPG-induced learning and memory impairments in rats	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; LONG-TERM POTENTIATION; SPONTANEOUS OBJECT RECOGNITION; NMDA RECEPTORS; SYNAPTIC PLASTICITY; IN-VIVO; ASSOCIATIVE RECOGNITION; SELECTIVE IMPAIRMENT; NOVELTY ACQUISITION; CELL-SURFACE	Background Understanding molecular mechanisms underlying the induction of learning and memory impairments remains a challenge. Recent investigations have shown that the activation of group I mGluRs (mGluR1 and mGluR5) in cultured hippocampal neurons by application of (S)-3,5-Dihydroxyphenylglycine (DHPG) causes the regulated internalization of N-methylD-aspartate receptors (NMDARs), which subsequently activates protein kinase D1 (PKD1). Through phosphorylating the C-terminals of the NMDAR GluN2 subunits, PKD1 down-regulates the activity of remaining (non-internalized) surface NMDARs. The knockdown of PKD1 does not affect the DHPG-induced inhibition of AMPA receptor-mediated miniature excitatory post-synaptic currents (mEPSCs) but prevents the DHPG-induced inhibition of NMDAR-mediated mEPSCs in vitro. Thus, we investigated the in vivo effects of bilateral infusions of DHPG into the hippocampal CA1 area of rats in the Morris water maze (MWM) and the novel object discrimination (NOD) tests. Methods A total of 300 adult male Sprague Dawley rats (250-280 g) were used for behavioral tests. One hundred ninety four were used in MWM test and the other 106 rats in the NOD test. Following one week of habituation to the vivarium, rats were bilaterally implanted under deep anesthesia with cannulas aimed at the CA1 area of the hippocampus (CA1 coordinates in mm from Bregma: AP-3.14; lateral +/-2; DV-3.0). Through implanted cannulas artificial cerebrospinal fluid (ACSF), the groupl mGluR antagonist 6-Methyl-2-(phenylethynyl)pyridine (MPEP), the dynamin-dependent internalization inhibitor Dynasore, or the PKD1 inhibitor CID755673 were infused into the bilateral hippocampal CA1 areas (2 mu L per side, over 5 min). The effects of these infusions and the effects of PKD1 knockdown were examined in MWM or NOD test. Results DHPG infusion increased the latency to reach the platform in the MWM test and reduced the preference for the novel object in the NOD task. We found that the DHPG effects were dose-dependent and could be maintained for up to 2 days. Notably, these effects could be prevented by pre-infusion of the group1 mGluR antagonist MPEP, the dynamin-dependent internalization inhibitor Dynasore, the PKD1 inhibitor CID755673, or by PKD1 knockdown in the hippocampal CA1 area. Conclusion Altogether, these findings provide direct evidence that PKD1-mediated signaling may play a critical role in the induction of learning and memory impairments by DHPG infusion into the hippocampal CA1 area.	[Wang, Wei; Ding, Xin-Sheng] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Wang, Wei; Ding, Xin-Sheng; Yu, Xian-Min] Nanjing Med Univ, BenQ Affiliated Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Wei; Ding, Xin-Sheng; Yu, Xian-Min] Nanjing Med Univ, Neurol Inst, Nanjing, Jiangsu, Peoples R China; [Duclot, Florian; Groveman, Bradley R.; Carrier, Nicole; Qiao, Haifa; Fang, Xiao-Qian; Wang, Hui; Kabbaj, Mohamed; Yu, Xian-Min] Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Fang, Xiao-Qian] Univ Texas Rio Grande Valley, Sch Med, Dept Biomed Sci, Edinburg, TX USA; [Xin, Wenkuan] Southwest Univ, Coll Pharmaceut Sci, Chongqing, Peoples R China; [Jiang, Xing-Hong; Yu, Xian-Min] Soochow Univ, Med Coll, Dept Physiol & Neurobiol, Suzhou, Peoples R China; [Salter, Michael W.] Univ Toronto, Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON, Canada	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; State University System of Florida; Florida State University; University of Texas System; University of Texas Rio Grande Valley; Southwest University - China; Soochow University - China; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Ding, XS (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurol, Nanjing, Jiangsu, Peoples R China.; Ding, XS; Yu, XM (corresponding author), Nanjing Med Univ, BenQ Affiliated Hosp, Nanjing, Jiangsu, Peoples R China.; Ding, XS; Yu, XM (corresponding author), Nanjing Med Univ, Neurol Inst, Nanjing, Jiangsu, Peoples R China.; Kabbaj, M; Yu, XM (corresponding author), Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA.; Yu, XM (corresponding author), Soochow Univ, Med Coll, Dept Physiol & Neurobiol, Suzhou, Peoples R China.	ding-xs@139.com; mohamed.kabbaj@med.fsu.edu; yuxianminyu1981@hotmail.com	Duclot, Florian/E-4669-2013	Duclot, Florian/0000-0003-0121-5807	NIH [R01 NS053567]; National Natural Science Foundation of China: NSFC [30971022, 31271258, 81771187]; CIHR [MT-12682]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China: NSFC(National Natural Science Foundation of China (NSFC)); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by the NIH: R01 NS053567 to XMY, and National Natural Science Foundation of China: NSFC #30971022 to XD, NSFC #31271258 and #81771187 to XHJ. MWS is supported in part by CIHR grant MT-12682 and holds a Canada Research Chair (Tier I) in Neuroplasticity and Pain, and is the Anne and Max Tanenbaum Chair in Molecular Medicine at the Hospital for Sick Children. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE T, 1992, J BIOL CHEM, V267, P13361; Ainge JA, 2006, BEHAV BRAIN RES, V167, P183, DOI 10.1016/j.bbr.2005.09.005; Baker KB, 2002, LEARN MEMORY, V9, P58, DOI 10.1101/lm.46102; Bannerman DM, 2012, NAT NEUROSCI, V15, P1153, DOI 10.1038/nn.3166; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Barker GRI, 2015, CEREB CORTEX, V25, P472, DOI 10.1093/cercor/bht245; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; Baskys A, 2005, ANN NY ACAD SCI, V1053, P55, DOI 10.1196/annals.1344.006; BASKYS A, 1991, J PHYSIOL-LONDON, V444, P687, DOI 10.1113/jphysiol.1991.sp018901; Bear MF, 2008, NEUROPSYCHOPHARMACOL, V33, P84, DOI 10.1038/sj.npp.1301610; Bikbaev A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002155; Blaser R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00183; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Carrasquero LMG, 2010, GLIA, V58, P984, DOI 10.1002/glia.20980; Day M, 2001, SCIENCE, V293, pU1; De Leonibus E, 2009, NEUROPSYCHOPHARMACOL, V34, P729, DOI 10.1038/npp.2008.129; Di Sebastiano AR, 2016, J BIOL CHEM, V291, P17602, DOI 10.1074/jbc.M116.722355; Duclot F, 2013, J NEUROSCI, V33, P11048, DOI 10.1523/JNEUROSCI.0199-13.2013; Eales KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5701; Eichenbaum H, 2017, NEURON, V95, P1007, DOI 10.1016/j.neuron.2017.06.036; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fang XQ, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0167-1; Fitzjohn S, 2016, CURR NEUROPHARMACOL, V14, P435, DOI 10.2174/1570159X13666150615221502; Gabel LA, 2004, J NEUROSCI, V24, P10579, DOI 10.1523/JNEUROSCI.2185-04.2004; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; George Kara M, 2011, Pharmaceutics, V3, P186, DOI 10.3390/pharmaceutics3020186; Goeldner C, 2008, J NEUROSCI, V28, P2190, DOI 10.1523/JNEUROSCI.3711-07.2008; Goh JJ, 2013, HIPPOCAMPUS, V23, P129, DOI 10.1002/hipo.22072; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; Hamilton A, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-40; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Hughes EG, 2010, J NEUROSCI, V30, P5866, DOI 10.1523/JNEUROSCI.0167-10.2010; Iwamura E, 2016, BEHAV BRAIN RES, V307, P92, DOI 10.1016/j.bbr.2016.03.048; Jin DZ, 2015, BRAIN RES, V1624, P414, DOI 10.1016/j.brainres.2015.07.053; Kemp A, 2004, P NATL ACAD SCI USA, V101, P8192, DOI 10.1073/pnas.0402650101; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Krueger DD, 2010, J MOL NEUROSCI, V42, P1, DOI 10.1007/s12031-010-9338-9; Kumar A, 2014, HIPPOCAMPUS, V24, P466, DOI 10.1002/hipo.22240; Langston RF, 2010, HIPPOCAMPUS, V20, P1139, DOI 10.1002/hipo.20714; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lu YM, 1997, J NEUROSCI, V17, P5196; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mahato PK, 2015, NEUROSCIENCE, V306, P138, DOI 10.1016/j.neuroscience.2015.08.031; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Manahan-Vaughan D, 2005, CEREB CORTEX, V15, P1703, DOI 10.1093/cercor/bhi047; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Mello-Carpes PB, 2013, NEUROBIOL LEARN MEM, V100, P56, DOI 10.1016/j.nlm.2012.12.002; Menard C, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00182; Micheli F, 2000, Curr Opin Investig Drugs, V1, P355; Moldrich RX, 2003, EUR J PHARMACOL, V476, P3, DOI 10.1016/S0014-2999(03)02149-6; Montgomery JM, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-48; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Morris RGM, 2013, NEUROPHARMACOLOGY, V74, P32, DOI 10.1016/j.neuropharm.2013.04.014; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Naie K, 2004, CEREB CORTEX, V14, P189, DOI 10.1093/cercor/bhg118; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Newcomer JW, 2001, HIPPOCAMPUS, V11, P529, DOI 10.1002/hipo.1069.abs; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Nong Y, 2004, CURR OPIN NEUROBIOL, V14, P353, DOI 10.1016/j.conb.2004.05.001; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Ocampo AC, 2017, LEARN MEMORY, V24, P563, DOI 10.1101/lm.045781.117; Oh MM, 2003, J NEUROPHYSIOL, V90, P2171, DOI 10.1152/jn.01177.2002; Pandey S, 2014, J NEUROCHEM, V131, P602, DOI 10.1111/jnc.12930; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Sanderson TM, 2016, J NEUROCHEM, V139, P200, DOI 10.1111/jnc.13592; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Stemmelin J, 2008, NEUROPSYCHOPHARMACOL, V33, P574, DOI 10.1038/sj.npp.1301424; Sugita M, 2015, BRAIN RES, V1624, P370, DOI 10.1016/j.brainres.2015.08.001; Taylor AM, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0149; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Venardos K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120934; Vorhees CV, 2014, ILAR J, V55, P310, DOI 10.1093/ilar/ilu013; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Warburton EC, 2013, NEUROPHARMACOLOGY, V74, P41, DOI 10.1016/j.neuropharm.2013.04.013; Wisniewski K, 2002, CNS DRUG REV, V8, P101; Xu J, 2009, J NEUROSCI, V29, P3676, DOI 10.1523/JNEUROSCI.5716-08.2009; Yamada K, 2003, J PHARMACOL SCI, V91, P267; Yu XM, 2016, NEUROTRANSMITTER, V3, pe1192; Zalewska-Winska A, 2000, PHARMACOL RES, V42, P239, DOI 10.1006/phrs.2000.0683; Zhang SJ, 2014, HIPPOCAMPUS, V24, P1330, DOI 10.1002/hipo.22314	95	4	3	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195095	10.1371/journal.pone.0195095	http://dx.doi.org/10.1371/journal.pone.0195095			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614089	Green Submitted, gold, Green Published			2022-12-26	WOS:000429081600030
J	Dhurmeea, Z; Pethybridge, H; Appadoo, C; Bodie, N				Dhurmeea, Zahirah; Pethybridge, Heidi; Appadoo, Chandani; Bodie, Nathalie			Lipid and fatty acid dynamics in mature female albacore tuna (Thunnus alalunga) in the western Indian Ocean	PLOS ONE			English	Article							BREAM SPARUS-AURATA; FRESH-WATER FISH; REPRODUCTIVE-PERFORMANCE; BROODSTOCK DIETS; TROPHIC MARKERS; SKIPJACK TUNA; ENERGY; CAUGHT; MUSCLE; WILD	Lipid composition in the reproductive and somatic tissues were investigated for female albacore tuna, Thunnus alalunga, in the western Indian Ocean, between latitude 18-21 degrees S and longitude 56-60 degrees E, from January 2014 to March 2015. Highest total lipids (TL) were found in the gonads of spawning-capable females (SCP) (mainly phospholipids, PL, triacylglycerols, TAG and wax esters, WE) and in the liver of females in the late regressing and regenerating ovary phases (mainly TAG, PL and sterols, ST). Muscle TL was low but exhibited high inter individual variability. Correlations between gonadosomatic and hepatosomatic indices with TL and the lipid classes in albacore gonads and liver describes a pattern of reallocation of energy from the liver to the gonads during SCP. Female albacore were also observed to pursue foraging activities even during this period. Therefore, female albacore can be considered as a capital-income breeder relying mostly on stored lipids before the onset of reproduction and to a lesser extent on energy derived from concurrent feeding during the spawning season. Overall, the three examined tissues had similar general fatty acid profiles with the dominance of 22:6 omega 3 (docosahexaenoic acid, DHA), 16:0, 18:0 and 18:1 omega 9. The proportions of fatty acids varied with maturity stage and ovary lobe, with the smaller lobe having significantly higher proportions of essential fatty acids, as well as 16:0 and 18:1n9, compared to the larger one. Our results provide new information on the life-history and energy allocation strategy of albacore which will assist fisheries managers.	[Dhurmeea, Zahirah; Appadoo, Chandani] Univ Mauritius, Dept Biosci & Ocean Studies, Fac Sci, Reduit, Mauritius; [Dhurmeea, Zahirah; Bodie, Nathalie] Res Inst Sustainable Dev IRD, Marine Biodivers Exploitat & Conservat Unit, Victoria, Mahe, Seychelles; [Dhurmeea, Zahirah; Pethybridge, Heidi] CSIRO Oceans & Atmosphere, Hobart, Tas, Australia; [Bodie, Nathalie] Seychelles Fishing Author, Victoria, Mahe, Seychelles	University of Mauritius; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Dhurmeea, Z (corresponding author), Univ Mauritius, Dept Biosci & Ocean Studies, Fac Sci, Reduit, Mauritius.; Dhurmeea, Z (corresponding author), Res Inst Sustainable Dev IRD, Marine Biodivers Exploitat & Conservat Unit, Victoria, Mahe, Seychelles.; Dhurmeea, Z (corresponding author), CSIRO Oceans & Atmosphere, Hobart, Tas, Australia.	dzahirah@hotmail.com	Pethybridge, Heidi/AAI-9824-2021; Pethybridge, Heidi/AEO-8594-2022; Dhurmeea, Zahirah/AAL-4006-2021	Pethybridge, Heidi/0000-0002-7291-5766; Bodin, Nathalie/0000-0001-8464-0213	"Allocations de Recherche pour une These au Sud" (ARTS) program of the French Research Institute for the Development	"Allocations de Recherche pour une These au Sud" (ARTS) program of the French Research Institute for the Development	This work is part of the PhD research of the first author (ZD) and was supported by the "Allocations de Recherche pour une These au Sud" (ARTS) program of the French Research Institute for the Development (IRD: www.ird.fr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JRM, 1982, J FISH BIOL, V20, P409, DOI 10.1111/j.1095-8649.1982.tb03934.x; Almansa E, 2001, J FISH BIOL, V59, P267, DOI [10.1111/j.1095-8649.2001.tb00129.x, 10.1006/jfbi.2001.1650]; Alonso-Fernandez A, 2012, J EXP MAR BIOL ECOL, V416, P8, DOI 10.1016/j.jembe.2012.02.001; Aristizabal EO, 2007, MAR BIOL, V152, P713, DOI 10.1007/s00227-007-0729-6; Arukwe A, 2003, COMP HEPATOLOGY, V2; Bard FX, 1981, THESIS; BELL MV, 1995, LIPIDS, V30, P443, DOI 10.1007/BF02536303; Bivanand R, 2016, PACKAGE RGDAL; Black K.D., 1998, BIOL FARMED FISH, P114; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown-Peterson NJ, 2011, MAR COAST FISH, V3, P52, DOI 10.1080/19425120.2011.555724; Cejas JR, 2004, COMP BIOCHEM PHYS B, V138, P91, DOI 10.1016/j.cbpc.2004.03.003; Chen IC, 2005, FISH OCEANOGR, V14, P71, DOI 10.1111/j.1365-2419.2004.00322.x; Chen KS, 2010, J FISH BIOL, V77, P119, DOI 10.1111/j.1095-8649.2010.02662.x; Clarke K.R., 2006, PRIMER V6 USER MANUA; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; Dhurmeea Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168605; Dominguez-Petit R, 2010, FISH RES, V104, P73, DOI 10.1016/j.fishres.2009.05.016; Dutta H.M., 1996, FISH MORPHOLOGY; Essington TE, 2003, T AM FISH SOC, V132, P759, DOI 10.1577/T02-094; Farley JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060577; Furuita H, 2000, AQUACULTURE, V187, P387, DOI 10.1016/S0044-8486(00)00319-7; Goni N, 2010, PROG OCEANOGR, V86, P115, DOI 10.1016/j.pocean.2010.04.016; Grande M, 2016, J FISH BIOL, V89, P2434, DOI 10.1111/jfb.13125; Grigorakis K, 2002, INT J FOOD SCI TECH, V37, P477, DOI 10.1046/j.1365-2621.2002.00604.x; Henderson RJ, 1996, ARCH ANIM NUTR, V49, P5, DOI 10.1080/17450399609381859; HENDERSON RJ, 1987, PROG LIPID RES, V26, P281, DOI 10.1016/0163-7827(87)90002-6; Hiratsuka S, 2004, FISHERIES SCI, V70, P903, DOI 10.1111/j.1444-2906.2004.00885.x; Houston AI, 2007, BEHAV ECOL, V18, P241, DOI 10.1093/beheco/arl080; Intarasirisawat R, 2011, FOOD CHEM, V124, P1328, DOI 10.1016/j.foodchem.2010.07.076; Johnson RB, 2009, REV FISH SCI, V17, P78, DOI 10.1080/10641260802590004; Kiessling A, 2001, FOOD CHEM, V73, P271, DOI 10.1016/S0308-8146(00)00297-1; Kjesbu Olav S., 2009, P293, DOI 10.1002/9781444312133.ch8; KJESBU OS, 1991, CAN J FISH AQUAT SCI, V48, P2333, DOI 10.1139/f91-274; Korsmeyer KE, 1996, COMP BIOCHEM PHYS A, V113, P17, DOI 10.1016/0300-9629(95)02061-6; Kozlova TA, 2000, COMP BIOCHEM PHYS B, V126, P477, DOI 10.1016/S0305-0491(00)00207-8; Marshall CT, 1999, NATURE, V402, P288, DOI 10.1038/46272; McBride RS, 2015, FISH FISH, V16, P23, DOI 10.1111/faf.12043; MEDINA I, 1995, LIPIDS, V30, P1127, DOI 10.1007/BF02536613; Merayo CR, 1996, SCI MAR, V60, P489; Mourente G, 2001, FISH PHYSIOL BIOCHEM, V24, P351, DOI 10.1023/A:1015011609017; MOURENTE G, 1990, FISH PHYSIOL BIOCHEM, V8, P93, DOI 10.1007/BF00004436; MOURENTE G, 1991, LIPIDS, V26, P871, DOI 10.1007/BF02535970; Munschy C, 2016, ENVIRON RES, V148, P196, DOI 10.1016/j.envres.2016.03.042; Murase T, 1996, FISHERIES SCI, V62, P634, DOI 10.2331/fishsci.62.634; Nauen C. E., 1983, FAO FISH SYNOP, V2, P1; Ng WK, 2011, AQUACULTURE, V314, P122, DOI 10.1016/j.aquaculture.2011.01.034; Norton EC, 1999, J FISH BIOL, V54, P1287, DOI 10.1111/j.1095-8649.1999.tb02055.x; Ortega A, 2010, FISH PHYSIOL BIOCHEM, V36, P461, DOI 10.1007/s10695-009-9316-8; Otsu T., 1959, Fishery Bulletin United States, V59, P287; Parrish CC, 2015, DEEP-SEA RES PT II, V113, P199, DOI 10.1016/j.dsr2.2013.12.003; Parrish CC, 2015, OECOLOGIA, V177, P85, DOI 10.1007/s00442-014-3131-3; Pethybridge H, 2011, MAR BIOL, V158, P2741, DOI 10.1007/s00227-011-1773-9; Pethybridge HR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131598; R Core Team, 2021, R LANGUAGE ENV STAT; Rainuzzo JR, 1997, AQUACULTURE, V155, P103, DOI 10.1016/S0044-8486(97)00121-X; Ramon D, 1996, FISH B-NOAA, V94, P725; Ramon D, 1997, OCEANOGR LIT REV, V7, P752; Rasmussen R. S., 2006, Journal of Aquatic Food Product Technology, V15, P73, DOI 10.1300/J030v15n02_07; Rasmussen RS, 2008, J AQUAT FOOD PROD T, V17, P441, DOI 10.1080/10498850802369211; RATTY FJ, 1990, FISH B-NOAA, V88, P207; Robertson DH, 1957, FISH B WASH DC, V127, P9; Saito H, 1997, J SCI FOOD AGR, V73, P53, DOI 10.1002/(SICI)1097-0010(199701)73:1&lt;53::AID-JSFA707&gt;3.0.CO;2-5; SANWAL R, 1972, ACTA ANAT, V83, P139; Sardenne F, 2017, ECOL INDIC; Sardenne F, 2016, PROG OCEANOGR, V146, P75, DOI 10.1016/j.pocean.2016.06.001; Sargent J, 1999, AQUACULTURE, V177, P191, DOI 10.1016/S0044-8486(99)00083-6; Sargent J, 1995, BROODSTOCK MANAGEMEN, P353, DOI DOI 10.1016/S0044-8486(97)00122-1; Sargent John R., 2002, P181; Schaefer KM, 1998, B INTERAMERICAN TROP, V21, P201; Schott FA, 2001, PROG OCEANOGR, V51, P1, DOI 10.1016/S0079-6611(01)00083-0; STANSBY ME, 1976, US NMFS MAR FISH REV, V38, P1; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Ueyanagi S, 1957, REP NANKAI REG FISH, V6, P113; Underwood A.J, 1997, EXPT ECOLOGY THEIR L; WATANABE T, 1982, COMP BIOCHEM PHYS B, V73, P3, DOI 10.1016/0305-0491(82)90196-1; Wheeler S. C., 2003, Journal of Aquatic Food Product Technology, V12, P3, DOI 10.1300/J030v12n02_02; Wiegand MD, 2007, CAN J FISH AQUAT SCI, V64, P700, DOI 10.1139/F07-033; Wiegand MD, 1996, REV FISH BIOL FISHER, V6, P259, DOI 10.1007/BF00122583; Wootton RJ, 1998, REV FISH BIOL FISHER, V8, P493; Xie X, 1998, J FISH BIOL, V53, P259, DOI 10.1111/j.1095-8649.1998.tb00979.x; Zudaire I, 2014, FISH RES, V160, P50, DOI 10.1016/j.fishres.2013.12.010; Zudaire I, 2013, FISH B-NOAA, V111, P252, DOI 10.7755/FB.111.3.4	83	15	17	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0194558	10.1371/journal.pone.0194558	http://dx.doi.org/10.1371/journal.pone.0194558			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608623	Green Submitted, Green Published, gold			2022-12-26	WOS:000428988800012
J	Py, B; Gerez, C; Huguenot, A; Vidaud, C; Fontecave, M; de Choudens, SO; Barras, F				Py, Beatrice; Gerez, Catherine; Huguenot, Allison; Vidaud, Claude; Fontecave, Marc; de Choudens, Sandrine Ollagnier; Barras, Frederic			The ErpA/NfuA complex builds an oxidation-resistant Fe-S cluster delivery pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						iron-sulfur protein; Escherichia coli (E; coli); oxidative stress; isoprenoid; protein-protein interaction; metal ion-protein interaction	IRON-SULFUR CLUSTER; ESCHERICHIA-COLI; MONOTHIOL GLUTAREDOXINS; ISOPRENOID BIOSYNTHESIS; ARABIDOPSIS-THALIANA; 4FE-4S CLUSTERS; IN-VIVO; PROTEINS; MATURATION; BIOGENESIS	Fe-S cluster-containing proteins occur in most organisms, wherein they assist in myriad processes from metabolism to DNA repair via gene expression and bioenergetic processes. Here, we used both in vitro and in vivo methods to investigate the capacity of the four Fe-S carriers, NfuA, SufA, ErpA, and IscA, to fulfill their targeting role under oxidative stress. Likewise, Fe-S clusters exhibited varying half-lives, depending on the carriers they were bound to; an NfuA-bound Fe-S cluster was more stable (t(1/2) = 100 min) than those bound to SufA (t(1/2) = 55 min), ErpA (t(1/2) = 54 min), or IscA (t(1/2) = 45 min). Surprisingly, the presence of NfuA further enhanced stability of the ErpA-bound cluster to t(1/2) = 90 min. Using genetic and plasmon surface resonance analyses, we showed that NfuA and ErpA interacted directly with client proteins, whereas IscA or SufA did not. Moreover, NfuA and ErpA interacted with one another. Given all of these observations, we propose an architecture of the Fe-S delivery network in which ErpA is the last factor that delivers cluster directly to most if not all client proteins. NfuA is proposed to assist ErpA under severely unfavorable conditions. A comparison with the strategy employed in yeast and eukaryotes is discussed.	[Py, Beatrice; Huguenot, Allison; Barras, Frederic] Inst Microbiol Mediterranee, F-13009 Marseille, France; [Py, Beatrice; Huguenot, Allison; Barras, Frederic] CNRS, UMR 7283, LCB, 31 Chemin Joseph Aiguier, F-13009 Marseille, France; [Py, Beatrice; Huguenot, Allison; Barras, Frederic] Aix Marseille Univ, F-13007 Marseille, France; [Gerez, Catherine; de Choudens, Sandrine Ollagnier] Univ Grenoble Alpes, F-38400 St Martin Dheres, France; [Gerez, Catherine; de Choudens, Sandrine Ollagnier] CNRS, UMR 5249, LCBM, F-38054 Grenoble, France; [Gerez, Catherine; de Choudens, Sandrine Ollagnier] CEA, DRF, BIG, CBM,BioCat, F-38054 Grenoble, France; [Vidaud, Claude] CEA, DRF, BIAM, F-30200 Marcoule, France; [Fontecave, Marc] Paris Sci & Lettres PSL Res Univ, Univ Paris 06, UPMC, CNRS,Lab Chim Proc Biol,UMR 8229,Coll France, F-75252 Paris, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; College de France; Sorbonne Universite	Py, B (corresponding author), CNRS, UMR 7283, LCB, Inst Microbiol Mediterranee, 31 Chemin Joseph Aiguier, F-13009 Marseille, France.; Barras, F (corresponding author), Inst Pasteur, Dept Microbiol, 25-28 Rue Dr Roux, F-75015 Paris, France.	py@imm.cnrs.fr; barras@imm.cnrs.fr	VIDAUD, Claude/AGX-9878-2022	Ollagnier de Choudens, Sandrine/0000-0002-0080-6659; Barras, Frederic/0000-0003-3458-2574	CNRS; ANR (FeStress); Institut Universitaire de France; CEA; Aix-Marseille Universite; Universite Joseph Fourier	CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR (FeStress)(French National Research Agency (ANR)); Institut Universitaire de France; CEA(French Atomic Energy Commission); Aix-Marseille Universite; Universite Joseph Fourier	This work was supported by grants from CNRS, ANR (FeStress), the Institut Universitaire de France, CEA, Aix-Marseille Universite, and the Universite Joseph Fourier. The authors declare that they have no conflicts of interest with the contents of this article.	Alhebshi A, 2012, MOL BIOL CELL, V23, P3582, DOI 10.1091/mbc.E12-05-0413; Andreini C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171279; Angelini S, 2008, J BIOL CHEM, V283, P14084, DOI 10.1074/jbc.M709405200; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Balk J, 2014, ANNU REV PLANT BIOL, V65, P125, DOI 10.1146/annurev-arplant-050213-035759; Bandyopadhyay S, 2008, J BIOL CHEM, V283, P14092, DOI 10.1074/jbc.M709161200; Bandyopadhyay S, 2008, EMBO J, V27, P1122, DOI 10.1038/emboj.2008.50; Beilschmidt LK, 2014, BIOCHIMIE, V100, P48, DOI 10.1016/j.biochi.2014.01.009; Beilschmidt LK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15124; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Blanc B, 2015, BBA-MOL CELL RES, V1853, P1436, DOI 10.1016/j.bbamcr.2014.12.009; Boutigny S, 2013, J BIOL CHEM, V288, P14200, DOI 10.1074/jbc.M113.460360; Boyd ES, 2014, BIOCHEMISTRY-US, V53, P5834, DOI 10.1021/bi500488r; Boyd JM, 2008, BIOCHEMISTRY-US, V47, P8195, DOI 10.1021/bi800551y; Boyd JM, 2008, J BACTERIOL, V190, P4596, DOI 10.1128/JB.00262-08; Brancaccio D, 2014, J AM CHEM SOC, V136, P16240, DOI 10.1021/ja507822j; Braymer JJ, 2017, J BIOL CHEM, V292, P12754, DOI 10.1074/jbc.R117.787101; Bych K, 2008, EMBO J, V27, P1736, DOI 10.1038/emboj.2008.98; Ezraty B, 2013, SCIENCE, V340, P1583, DOI 10.1126/science.1238328; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; FLINT DH, 1993, J BIOL CHEM, V268, P25547; Gao HY, 2013, BIOCHEMISTRY-US, V52, P6633, DOI 10.1021/bi4007622; GARDNER PR, 1992, J BIOL CHEM, V267, P8757; Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07; Grawert T, 2004, J AM CHEM SOC, V126, P12847, DOI 10.1021/ja0471727; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HAGEN KS, 1981, J AM CHEM SOC, V103, P4054, DOI 10.1021/ja00404a013; Jordan PA, 1999, BIOCHEM J, V344, P739, DOI 10.1042/0264-6021:3440739; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kaut A, 2000, J BIOL CHEM, V275, P15955, DOI 10.1074/jbc.M909502199; Leon S, 2003, BIOCHEM J, V371, P823, DOI 10.1042/BJ20021946; Loiseau L, 2007, P NATL ACAD SCI USA, V104, P13626, DOI 10.1073/pnas.0705829104; MALKIN R, 1966, BIOCHEM BIOPH RES CO, V23, P822, DOI 10.1016/0006-291X(66)90561-4; Mashruwala AA, 2015, MOL MICROBIOL, V95, P383, DOI 10.1111/mmi.12860; Melber A, 2016, ELIFE, V5, DOI 10.7554/eLife.15991; Milner-White EJ, 2005, ORIGINS LIFE EVOL B, V35, P19, DOI 10.1007/s11084-005-4582-7; Muhlenhoff U, 2011, J BIOL CHEM, V286, P41205, DOI 10.1074/jbc.M111.296152; Navarro-Sastre A, 2011, AM J HUM GENET, V89, P656, DOI 10.1016/j.ajhg.2011.10.005; Ollagnier-de Choudens S, 2003, J BIOL CHEM, V278, P17993, DOI 10.1074/jbc.M300285200; Pelzer W, 2000, FEBS LETT, V476, P134, DOI 10.1016/S0014-5793(00)01711-7; Picciocchi A, 2007, BIOCHEMISTRY-US, V46, P15018, DOI 10.1021/bi7013272; Py B, 2012, MOL MICROBIOL, V86, P155, DOI 10.1111/j.1365-2958.2012.08181.x; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Rivasseau C, 2009, PLANT CELL ENVIRON, V32, P82, DOI 10.1111/j.1365-3040.2008.01903.x; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; SANDS RH, 1960, BIOCHEM BIOPH RES CO, V3, P47, DOI 10.1016/0006-291X(60)90101-7; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Seaver LC, 2004, J BIOL CHEM, V279, P48742, DOI 10.1074/jbc.M408754200; Sheftel AD, 2012, MOL BIOL CELL, V23, P1157, DOI 10.1091/mbc.E11-09-0772; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100; Vinella D, 2013, MOL MICROBIOL, V87, P493, DOI 10.1111/mmi.12135; Vinella D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000497; Vogel A., 2000, VOGELS TXB QUANTITAT; Wolff M, 2003, FEBS LETT, V541, P115, DOI 10.1016/S0014-5793(03)00317-X	57	19	19	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7689	7702		10.1074/jbc.RA118.002160	http://dx.doi.org/10.1074/jbc.RA118.002160			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29626095	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000437256500019
J	Friedman, A; Siewe, N				Friedman, Avner; Siewe, Nourridine			Chronic hepatitis B virus and liver fibrosis: A mathematical model	PLOS ONE			English	Article							STELLATE CELLS; COMBINATION THERAPY; ADEFOVIR DIPIVOXIL; IFN-GAMMA; INTERFERON; INFECTION; BETA; ACTIVATION; DYNAMICS; IL-13	Hepatitis B virus (HBV) infection is a liver disorder that can result in cirrhosis, liver failure and hepatocellular carcinoma. HBV infection remains a major global health problem, as it affects more 350 million people chronically and kills roughly 600,000 people annually. Drugs currently used against HBV include IFN-alpha that decreases viremia, inflammation and the growth of liver fibrosis, and adefovir that decreases the viral load. Each of these drugs can have severe side-effects. In the present paper, we consider the treatment of chronic HBV by a combination of IFN-alpha and adefovir, and raise the following question: What should be the optimal ratio between IFN-alpha and adefovir in order to achieve the best 'efficacy' under constraints on the total amount of the drugs; here the efficacy is measured by the reduction of the levels of inflammation and of fibrosis? We develop a mathematical model of HBV pathogenesis by a system of partial differential equations (PDEs) and use the model to simulate a 'synergy map' which addresses the above question.	[Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, 231 W 18th Ave, Columbus, OH 43210 USA; [Siewe, Nourridine] Univ Tennessee, Natl Inst Math & Biol Synth, Knoxville, TN 37996 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Tennessee System; University of Tennessee Knoxville	Siewe, N (corresponding author), Univ Tennessee, Natl Inst Math & Biol Synth, Knoxville, TN 37996 USA.	nourridine@aims.ac.za		Siewe, Nourridine/0000-0002-3005-8508	Mathematical Biosciences Institute of The Ohio State University; National Science Foundation through NSF Award [DBI-1300426]; University of Tennessee, Knoxville	Mathematical Biosciences Institute of The Ohio State University; National Science Foundation through NSF Award(National Science Foundation (NSF)); University of Tennessee, Knoxville	This research was supported by the Mathematical Biosciences Institute of The Ohio State University. This work was conducted while Nourridine Siewe was a Postdoctoral Fellow at the National Institute for Mathematical and Biological Synthesis, an Institute sponsored by the National Science Foundation through NSF Award #DBI-1300426, with additional support from The University of Tennessee, Knoxville.	Akdis CA, 2011, J ALLERGY CLIN IMMUN, V127, P18, DOI 10.1016/j.jaci.2010.11.030; Albeiroti S, 2015, BLOOD, V125, P1460, DOI 10.1182/blood-2014-07-590513; ALTSHULER B, 1981, ENVIRON HEALTH PERSP, V42, P23, DOI 10.2307/3429186; [Anonymous], 2000, DRUG COM KNOW MORE B; Asselah Tarik, 2007, Clin Liver Dis, V11, P839, DOI 10.1016/j.cld.2007.08.010; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bai QX, 2012, INT J MOL MED, V30, P1443, DOI 10.3892/ijmm.2012.1148; Balmasova IP, 2014, WORLD J GASTROENTERO, V20, P14156, DOI 10.3748/wjg.v20.i39.14156; Baranova A, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-91; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Biermer M, 2003, J VIROL, V77, P4033, DOI 10.1128/JVI.77.7.4033-4042.2003; Bility MT, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004032; Boltjes A, 2014, J HEPATOL, V61, P660, DOI 10.1016/j.jhep.2014.04.026; Buttner C, 1997, AM J RESP CELL MOL, V17, P315; Byrnes AA, 2007, J LEUKOCYTE BIOL, V81, P825, DOI 10.1189/jlb.1006622; Camelo A, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00173; Chen HY, 2014, GENET MOL RES, V13, P8645, DOI 10.4238/2014.October.27.4; Ciupe SM, 2007, J THEOR BIOL, V247, P23, DOI 10.1016/j.jtbi.2007.02.017; Ciupe SM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003730; Ciupe SM, 2011, MATH POPUL STUD, V18, P87, DOI 10.1080/08898480.2011.564563; Clarke DL, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-20; Colombatto P, 2006, ANTIVIR THER, V11, P197; CRUMP KS, 1976, CANCER RES, V36, P2973; d'Onofrio A, 2009, CELL PROLIFERAT, V42, P317, DOI 10.1111/j.1365-2184.2009.00595.x; d'Onofrio A, 2006, APPL MATH COMPUT, V181, P1155, DOI 10.1016/j.amc.2006.01.061; d'Onofrio A, 2010, J THEOR BIOL, V264, P253, DOI 10.1016/j.jtbi.2010.01.023; Deepak P, 2010, INT IMMUNOL, V22, P53, DOI 10.1093/intimm/dxp114; Dusheiko G, 1997, HEPATOLOGY, V26, pS112, DOI 10.1002/hep.510260720; Ebert G, 2015, P NATL ACAD SCI USA, V112, P5803, DOI 10.1073/pnas.1502400112; Ebert G, 2015, P NATL ACAD SCI USA, V112, P5797, DOI 10.1073/pnas.1502390112; Fan JM, 1999, KIDNEY INT, V56, P1455, DOI 10.1046/j.1523-1755.1999.00656.x; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Friedman A, 2017, MATH BIOSCI ENG, V14, P143, DOI [10.3034/mbe.2017010, 10.3934/mbe.2017010]; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Greco RM, 1998, J CELL PHYSIOL, V177, P465, DOI 10.1002/(SICI)1097-4652(199812)177:3<465::AID-JCP9>3.0.CO;2-5; Hao WR, 2017, P NATL ACAD SCI USA, V114, P5011, DOI 10.1073/pnas.1620264114; Hao WR, 2014, P NATL ACAD SCI USA, V111, P14193, DOI 10.1073/pnas.1413970111; Hong M, 2012, PLOS ONE, V71, P1; Huang R, 2013, HEPATOL RES, V43, P1040, DOI 10.1111/hepr.12058; Inuzuka T, 2014, PATHOGENS, V3, P377, DOI 10.3390/pathogens3020377; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Janeway CA., 2001, IMMUNOBIOLOGY IMMUNE; JANSSEN HLA, 1992, GUT, V33, P1094, DOI 10.1136/gut.33.8.1094; Jiang YF, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/143026; Kamyad AV, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/475451; Kim Y, 2009, J THEOR BIOL, V260, P359, DOI 10.1016/j.jtbi.2009.06.025; KLIMPEL GR, 1990, CELL IMMUNOL, V128, P603, DOI 10.1016/0008-8749(90)90052-S; Lai XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178479; Lau GKKK, 2000, HEPATOLOGY, V32, P394, DOI 10.1053/jhep.2000.9143; Lewin SR, 2001, HEPATOLOGY, V34, P1012, DOI 10.1053/jhep.2001.28509; Liu HY, 2015, WORLD J HEPATOL, V7, P2319, DOI 10.4254/wjh.v7.i21.2319; Liu YH, 2014, J HUAZHONG U SCI-MED, V34, P542, DOI 10.1007/s11596-014-1312-2; Loggi E, 2015, DIGEST LIVER DIS, V47, P836, DOI 10.1016/j.dld.2015.05.019; Lomas NJ, 2012, INT J CLIN EXP PATHO, V5, P58; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Manalakopoulos S, 2008, ALIMENT PHARM THER, V27, P266, DOI 10.1111/j.1365-2036.2007.03567.x; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Murray LA, 2011, INT J BIOCHEM CELL B, V43, P154, DOI 10.1016/j.biocel.2010.10.013; OSWALD IP, 1992, P NATL ACAD SCI USA, V89, P8676, DOI 10.1073/pnas.89.18.8676; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Paul Navin, 2011, Curr Hepat Rep, V10, P98, DOI 10.1007/s11901-011-0095-1; Phillips S, 2010, J IMMUNOL, V184, P287, DOI 10.4049/jimmunol.0902761; Poovorawan Kittiyod, 2013, Hepat Res Treat, V2013, P757246, DOI 10.1155/2013/757246; Pouliot P, 2005, CLIN EXP ALLERGY, V35, P804, DOI 10.1111/j.1365-2222.2005.02246.x; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Senoo Haruki, 2004, Medical Electron Microscopy, V37, P3, DOI 10.1007/s00795-003-0230-3; Siewe N, 2017, J THEOR BIOL, V412, P48, DOI 10.1016/j.jtbi.2016.10.004; Siewe N, 2016, MATH BIOSCI, V276, P28, DOI 10.1016/j.mbs.2016.02.015; Song JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110074; Terrault NA, 2015, HEPATOLOGY PRACTICE, P1, DOI DOI 10.1002/HEP.28156/SUPPINFO; Tzeng HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103008; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Venkayya R, 2002, AM J RESP CELL MOL, V26, P202, DOI 10.1165/ajrcmb.26.2.4600; Veremeyko T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081774; Vernon MA, 2010, SEMIN NEPHROL, V30, P302, DOI 10.1016/j.semnephrol.2010.03.004; Viallard JF, 1999, CLIN EXP IMMUNOL, V115, P189; Wada T, 2003, NEPHROL DIAL TRANSPL, V18, P457, DOI 10.1093/ndt/18.3.457; WebMD, 2005, DRUGS MED HEPSERA; WebMD, 2014, INT CHRON HEP B; WedMD LLC, 2017, SID EFF; WedMD LLC, 2017, SID EFF; Weng WL, 2009, HEPATHOL, V50, P230, DOI [10.1002/hep.22934, DOI 10.1002/HEP.22934]; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1; Yates A, 2004, J THEOR BIOL, V231, P181, DOI 10.1016/j.jtbi.2004.06.013; Zan YL, 2013, BIOCHEM BIOPH RES CO, V435, P391, DOI 10.1016/j.bbrc.2013.04.098; Zhao Hong, 2013, World J Nephrol, V2, P84, DOI 10.5527/wjn.v2.i3.84; Zhao SJ, 2000, INT J EPIDEMIOL, V29, P744, DOI 10.1093/ije/29.4.744	89	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195037	10.1371/journal.pone.0195037	http://dx.doi.org/10.1371/journal.pone.0195037			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634771	Green Published, Green Submitted, gold			2022-12-26	WOS:000429522200023
J	Nazir, S; Mukhtar, M; Shahnawaz, M; Farooqi, S; Fatima, N; Mehmood, R; Sheikh, N				Nazir, Sabeen; Mukhtar, Maryam; Shahnawaz, Maryam; Farooqi, Shaima; Fatima, Naz; Mehmood, Rabia; Sheikh, Nadeem			A novel single nucleotide polymorphism in exon 3 of MYOC enhances the risk of glaucoma	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OLFACTOMEDIN-HOMOLOGY DOMAIN; TRABECULAR MESHWORK; TIGR/MYOCILIN PROTEIN; MUTATION; DISEASE; MECHANISMS; SECRETION; SEVERITY; FAMILIES	Genetic polymorphisms of MYOCalter the myocilin protein,which leads to disruption of the normal regulation of intraocular pressure (IOP) that ultimately causes glaucoma. The aim of the present study was to identify the polymorphism in exon 3 of the MYOC gene of the glaucoma patients in Lahore, Pakistan. We conducted a case-control study with 100 patients and 100 controls subjects. We extracted DNA from blood samples,amplified the target DNA fragment by PCR, and identified polymorphisms through sequencing. We observed that the allelic and genotypic frequencies of rs74315341 and rs879255525 were associated with glaucoma in our patient population. The polymorphism atrs74315341 led to the substitution of serine for arginine,whereas the polymorphism at rs879255525 led to the substitution of asparagine for lysine. The haplotype TGAAGCCATTTC was associated with disease onset, whereas the haplotype GGAAGCCATTTC was protective against disease development. In conclusion, we identified MYOC gene polymorphisms in susceptible regions that were associated with glaucoma onset among the Lahore patient population. This is the first report to identify a novel mutation in rs879255525 in exon 3 of the MYOC gene that is associated with glaucoma.	[Nazir, Sabeen; Mukhtar, Maryam; Shahnawaz, Maryam; Fatima, Naz; Mehmood, Rabia; Sheikh, Nadeem] Univ Punjab, Dept Zool, Quaid E Azam Campus, Lahore, Pakistan; [Farooqi, Shaima] Univ Engn & Technol, Dept Biomed Engn Ctr, Kale Shah Kaku Campus, Lahore, Pakistan; [Sheikh, Nadeem] Univ Punjab, Ctr Appl Mol Biol, Quaid E Azam Campus, Lahore, Pakistan	University of Punjab; University of Engineering & Technology Lahore; University of Punjab	Sheikh, N (corresponding author), Univ Punjab, Dept Zool, Quaid E Azam Campus, Lahore, Pakistan.; Sheikh, N (corresponding author), Univ Punjab, Ctr Appl Mol Biol, Quaid E Azam Campus, Lahore, Pakistan.	s_nadeem77@yahoo.com	Fatima, Naz/AAG-1752-2020; Sheikh, Nadeem/A-5138-2010; Sheikh, Nadeem/GXF-4796-2022; Mukhtar, Maryam/J-7666-2016	Sheikh, Nadeem/0000-0001-9503-9538; MUKHTAR, MARYAM/0000-0003-3571-5447; Mehmood, Rabia/0000-0002-9356-2787	University of the Punjab, Lahore Pakistan	University of the Punjab, Lahore Pakistan	The authors are thankful to Vice Chancellor, University of the Punjab, Lahore Pakistan for providing full support to conduct this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; CAPRIOLI J, 1984, AM J OPHTHALMOL, V97, P730, DOI 10.1016/0002-9394(84)90505-1; Craig JE, 2001, OPHTHALMOLOGY, V108, P1607, DOI 10.1016/S0161-6420(01)00654-6; Fingert JH, 1998, GENOME RES, V8, P377, DOI 10.1101/gr.8.4.377; Gobeil S, 2004, INVEST OPHTH VIS SCI, V45, P3560, DOI 10.1167/iovs.04-0300; Gobeil S, 2006, EXP EYE RES, V82, P1017, DOI 10.1016/j.exer.2005.11.002; Hewitt AW, 2007, ARCH OPHTHALMOL-CHIC, V125, P98, DOI 10.1001/archopht.125.1.98; Ikezoe T, 2003, INT J MOL MED, V12, P259; Janssen SF, 2013, PROG RETIN EYE RES, V37, P31, DOI 10.1016/j.preteyeres.2013.09.001; Jia LY, 2009, INVEST OPHTH VIS SCI, V50, P3743, DOI 10.1167/iovs.08-3151; Khan MD, 1999, PAK J OPHTHALMOL, V5, p15 ; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Liu YH, 2004, HUM MOL GENET, V13, P1193, DOI 10.1093/hmg/ddh128; Lutjen-Drecoll E, 1998, INVEST OPHTH VIS SCI, V39, P517; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Polansky JR, 1997, OPHTHALMOLOGICA, V211, P126, DOI 10.1159/000310780; Povoa Cristine Araújo, 2006, Arq. Bras. Oftalmol., V69, P289, DOI 10.1590/S0004-27492006000300002; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Souzeau E, 2013, OPHTHALMOLOGY, V120, P1135, DOI 10.1016/j.ophtha.2012.11.029; Stoilova D, 1998, J MED GENET, V35, P989, DOI 10.1136/jmg.35.12.989; Takamoto M, 2014, JPN J OPHTHALMOL, V58, P1, DOI 10.1007/s10384-013-0286-0; Taniguchi F, 2000, JPN J OPHTHALMOL, V44, P445, DOI 10.1016/S0021-5155(00)00201-X; Vollrath D, 2006, EXP EYE RES, V82, P1030, DOI 10.1016/j.exer.2005.10.007; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Wirtz MK, 2007, AM J OPHTHALMOL, V144, P75, DOI 10.1016/j.ajo.2007.03.037; Zhou XM, 2013, INT J OPHTHALMOL-CHI, V6, P264, DOI 10.3980/j.issn.2222-3959.2013.03.02; Zhou ZH, 1999, HUM MOL GENET, V8, P2221, DOI 10.1093/hmg/8.12.2221	28	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195157	10.1371/journal.pone.0195157	http://dx.doi.org/10.1371/journal.pone.0195157			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630620	gold, Green Submitted, Green Published			2022-12-26	WOS:000429505000027
J	Sun, QQ; Wang, R; Hu, YX; Yao, LG; Guo, SL				Sun, Qiqi; Wang, Rui; Hu, Yaxian; Yao, Lunguang; Guo, Shengli			Spatial variations of soil respiration and temperature sensitivity along a steep slope of the semiarid Loess Plateau	PLOS ONE			English	Article							ORGANIC-MATTER DECOMPOSITION; NITROGEN-FERTILIZATION; MICROBIAL RESPONSES; CO2 EMISSION; LAND-USE; HETEROTROPHIC RESPIRATION; TOPOGRAPHIC POSITION; COMMUNITY STRUCTURE; TEMPORAL VARIATION; CARBON INPUTS	The spatial heterogeneity of soil respiration and its temperature sensitivity pose a great challenge to accurately estimate the carbon flux in global carbon cycling, which has primarily been researched in flatlands versus hillslope ecosystems. On an eroded slope (35) of the semiarid Loess Plateau, soil respiration, soil moisture and soil temperature were measured in situ at upper and lower slope positions in triplicate from 2014 until 2016, and the soil biochemical and microbial properties were determined. The results showed that soil respiration was significantly greater (by 44.2%) at the lower slope position (2.6 mu mol m(-2) s(-1)) than at the upper slope position, as were soil moisture, carbon, nitrogen fractions and root biomass. However, the temperature sensitivity was 13.2% greater at the upper slope position than at the lower slope position (P<0.05). The soil fungal community changed from being Basidiomycota-dominant at the upper slope position to being Zygomycota-dominant at the lower slope position, corresponding with increased P-D-glucosidase activity at the upper slope position than at the lower slope position. We concluded that soil respiration was enhanced by the greater soil moisture, root biomass, carbon and nitrogen contents at the lower slope position than at the upper slope position. Moreover, the increased soil respiration and decreased temperature sensitivity at the lower slope position were partially due to copiotrophs replacing oligotrophs. Such spatial variations along slopes must be properly accounted for when estimating the carbon budget and feedback of future climate change on hillslope ecosystems.	[Sun, Qiqi; Hu, Yaxian; Guo, Shengli] Chinese Acad Sci, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shannxi, Peoples R China; [Sun, Qiqi; Hu, Yaxian; Guo, Shengli] Minist Water Resources, Yangling, Shannxi, Peoples R China; [Sun, Qiqi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Rui; Hu, Yaxian; Guo, Shengli] Northwest A&F Univ, Coll Resources & Environm, Yangling, Shannxi, Peoples R China; [Yao, Lunguang; Guo, Shengli] Nanyang Normal Univ, Collaborat Innovat Ctr Water Secur Water Source R, Nanyang, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Northwest A&F University - China; Nanyang Normal College	Guo, SL (corresponding author), Chinese Acad Sci, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shannxi, Peoples R China.; Guo, SL (corresponding author), Minist Water Resources, Yangling, Shannxi, Peoples R China.; Guo, SL (corresponding author), Northwest A&F Univ, Coll Resources & Environm, Yangling, Shannxi, Peoples R China.; Guo, SL (corresponding author), Nanyang Normal Univ, Collaborat Innovat Ctr Water Secur Water Source R, Nanyang, Peoples R China.	slguo@ms.iswc.ac.cn			Natural Science Foundation of China [41371279, 41301322]; Chinese Universities Scientific Fund [2014116055]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Universities Scientific Fund	This work is supported by Natural Science Foundation of China (No. 41371279, No. 41301322), and Chinese Universities Scientific Fund (2014116055) to SG. The funders played important role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson LJ, 2007, NEW PHYTOL, V173, P110, DOI 10.1111/j.1469-8137.2006.01891.x; Auffret MD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165448; Bai Z, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix063; Ball BA, 2014, POLAR BIOL, V37, P573, DOI 10.1007/s00300-014-1459-0; Bastida F, 2016, MOL ECOL, V25, P4660, DOI 10.1111/mec.13783; Bell CW, 2013, JOVE-J VIS EXP, DOI 10.3791/50961; Bellamy PH, 2005, NATURE, V437, P245, DOI 10.1038/nature04038; Berhe AA, 2013, EARTH SURF PROC LAND, V38, P908, DOI 10.1002/esp.3408; Boone RD, 1998, NATURE, V396, P570, DOI 10.1038/25119; Bosatta E, 1999, SOIL BIOL BIOCHEM, V31, P1889, DOI 10.1016/S0038-0717(99)00105-4; BRIGGS JM, 1995, AM J BOT, V82, P1024, DOI 10.2307/2446232; Brindt N, 2017, MOVING BOUNDARY APPR; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chen YP, 2016, SOIL BIOL BIOCHEM, V95, P233, DOI 10.1016/j.soilbio.2016.01.004; Chigineva NI, 2009, APPL SOIL ECOL, V42, P264, DOI 10.1016/j.apsoil.2009.05.001; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; de Graaff MA, 2010, NEW PHYTOL, V188, P1055, DOI 10.1111/j.1469-8137.2010.03427.x; DeForest JL, 2009, SOIL BIOL BIOCHEM, V41, P1180, DOI 10.1016/j.soilbio.2009.02.029; Ding WX, 2007, SOIL BIOL BIOCHEM, V39, P669, DOI 10.1016/j.soilbio.2006.09.024; Ding WX, 2010, GEODERMA, V155, P381, DOI 10.1016/j.geoderma.2009.12.023; du Plessis L, 2010, APPL MICROBIOL BIOT, V86, P1503, DOI 10.1007/s00253-009-2403-z; Duan LX, 2016, J HYDROL, V537, P356, DOI 10.1016/j.jhydrol.2016.03.057; Dungait JAJ, 2013, SOIL BIOL BIOCHEM, V60, P195, DOI 10.1016/j.soilbio.2013.01.027; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fang YT, 2009, PLANT SOIL, V319, P37, DOI 10.1007/s11104-008-9847-2; Fernandez-Escobar R, 2009, EUR J AGRON, V31, P223, DOI 10.1016/j.eja.2009.08.001; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Foti S, 2016, CATENA, V143, P78, DOI 10.1016/j.catena.2016.03.034; Fujii K, 2011, GEODERMA, V163, P119, DOI 10.1016/j.geoderma.2011.04.012; German DP, 2011, SOIL BIOL BIOCHEM, V43, P1387, DOI 10.1016/j.soilbio.2011.03.017; Guo SL, 2012, GEODERMA, V189, P442, DOI 10.1016/j.geoderma.2012.06.012; Hamdi S, 2013, SOIL BIOL BIOCHEM, V58, P115, DOI 10.1016/j.soilbio.2012.11.012; Han GX, 2007, SOIL BIOL BIOCHEM, V39, P418, DOI 10.1016/j.soilbio.2006.08.009; Hu YX, 2013, AGRICULTURE-BASEL, V3, P726, DOI 10.3390/agriculture3040726; Huang JQ, 2013, ECOL ENG, V60, P67, DOI 10.1016/j.ecoleng.2013.07.040; Iqbal J, 2009, AGR ECOSYST ENVIRON, V131, P292, DOI 10.1016/j.agee.2009.02.001; Janssens IA, 2003, GLOBAL CHANGE BIOL, V9, P911, DOI 10.1046/j.1365-2486.2003.00636.x; Jiang JS, 2015, SOIL TILL RES, V150, P139, DOI 10.1016/j.still.2015.02.002; Kjoller A. H., 2002, FUNGAL COMMUNITIES S; Lal R, 2008, SCIENCE, V319, P1040, DOI 10.1126/science.319.5866.1040; Larionova AA, 2007, BIOGEOSCIENCES, V4, P1073, DOI 10.5194/bg-4-1073-2007; Li H, 2017, SOIL BIOL BIOCHEM, V104, P18, DOI 10.1016/j.soilbio.2016.10.009; Li Y, 2006, SOIL TILL RES, V86, P176, DOI 10.1016/j.still.2005.02.006; Li Y, 1991, COMPREHENSIVE STUDY; Li YC, 2017, SOIL BIOL BIOCHEM, V107, P19, DOI 10.1016/j.soilbio.2016.12.024; Li ZW, 2015, EUR J SOIL BIOL, V71, P37, DOI 10.1016/j.ejsobi.2015.10.003; Liu LL, 2016, GLOBAL CHANGE BIOL, V22, P1394, DOI 10.1111/gcb.13156; Ludley KE, 2008, SOIL BIOL BIOCHEM, V40, P11, DOI 10.1016/j.soilbio.2007.07.023; Ma G., 2003, THESIS NANJING NORMA; Moyano FE, 2013, SOIL BIOL BIOCHEM, V59, P72, DOI 10.1016/j.soilbio.2013.01.002; Nazaries L, 2015, SOIL BIOL BIOCHEM, V89, P123, DOI 10.1016/j.soilbio.2015.06.027; Pang X, 2015, BIOGEOCHEMISTRY, P1; Polyakov VO, 2008, GEODERMA, V143, P216, DOI 10.1016/j.geoderma.2007.11.005; Prolingheuer N, 2014, AGR FOREST METEOROL, V195, P24, DOI 10.1016/j.agrformet.2014.04.016; Qi Y, 2002, ECOL MODEL, V153, P131, DOI 10.1016/S0304-3800(01)00506-3; Qiu Y, 2001, J ARID ENVIRON, V49, P723, DOI 10.1006/jare.2001.0828; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Shi B, 2016, PLANT SOIL, V400, P1; Shi ZH, 2012, J HYDROL, V454, P123, DOI 10.1016/j.jhydrol.2012.06.004; Sinsabaugh RL, 2005, BIOGEOCHEMISTRY, V75, P201, DOI 10.1007/s10533-004-7112-1; Sommerkorn M, 2008, SOIL BIOL BIOCHEM, V40, P1792, DOI 10.1016/j.soilbio.2008.03.002; Stone MM, 2012, GLOBAL CHANGE BIOL, V18, P1173, DOI 10.1111/j.1365-2486.2011.02545.x; Stursova M, 2012, FEMS MICROBIOL ECOL, V80, P735, DOI 10.1111/j.1574-6941.2012.01343.x; Thomas GW, 1996, METHODS SOIL ANAL PA, P475; Tu LH, 2013, SOIL BIOL BIOCHEM, V58, P255, DOI 10.1016/j.soilbio.2012.12.005; Uchida Y, 2010, PLANT SOIL, V337, P375, DOI 10.1007/s11104-010-0533-9; van't Hoff JH, 1898, CHEM DYNAMICS 1, P224; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Venbygaart AJ, 2011, GLOBAL CHANGE BIOL, V18, P1441; Vicca S, 2010, SOIL BIOL BIOCHEM, V42, P2030, DOI 10.1016/j.soilbio.2010.07.023; Voriskova J, 2013, ISME J, V7, P477, DOI 10.1038/ismej.2012.116; Wang H, 2012, APPL ENVIRON MICROB, V78, P7652, DOI 10.1128/AEM.01602-12; Wang QK, 2014, SOIL BIOL BIOCHEM, V72, P145, DOI 10.1016/j.soilbio.2014.01.020; Wang R., 2016, ELECT J DIFFERENTIAL, V2016, P1, DOI DOI 10.1016/J.SCIT0TENV.2016.09.001; Wang R, 2018, SCI TOTAL ENVIRON, V621, P425, DOI 10.1016/j.scitotenv.2017.11.290; Wang R, 2015, NUTR CYCL AGROECOSYS, V102, P285, DOI 10.1007/s10705-015-9699-0; Wang ZQ, 2017, SOIL TILL RES, V174, P1, DOI 10.1016/j.still.2017.05.005; Wang ZQ, 2017, ECOL ENG, V105, P231, DOI 10.1016/j.ecoleng.2017.04.050; Wei SC, 2014, SOIL TILL RES, V144, P119, DOI 10.1016/j.still.2014.07.012; Xu M, 2001, GLOBAL BIOGEOCHEM CY, V15, P687, DOI 10.1029/2000GB001365; Xu WH, 2008, SOIL BIOL BIOCHEM, V40, P679, DOI 10.1016/j.soilbio.2007.10.003; Yan LM, 2011, GLOBAL CHANGE BIOL, V17, P1990, DOI 10.1111/j.1365-2486.2010.02365.x; Yuste JC, 2011, GLOBAL CHANGE BIOL, V17, P1475, DOI 10.1111/j.1365-2486.2010.02300.x; Yuste JC, 2007, GLOBAL CHANGE BIOL, V13, P2018, DOI 10.1111/j.1365-2486.2007.01415.x; Zhang JH, 2006, GLOBAL CHANGE BIOL, V12, P1834, DOI 10.1111/j.1365-2486.2006.01206.x; Zhang YJ, 2015, ECOL ENG, V74, P196, DOI 10.1016/j.ecoleng.2014.10.003; Zheng ZM, 2009, SOIL BIOL BIOCHEM, V41, P1531, DOI 10.1016/j.soilbio.2009.04.013; Zhou B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067616; Zhou JZ, 2002, APPL ENVIRON MICROB, V68, P326, DOI 10.1128/AEM.68.1.326-334.2002; Zhu HH, 2014, CATENA, V120, P64, DOI 10.1016/j.catena.2014.04.007	90	13	15	7	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195400	10.1371/journal.pone.0195400	http://dx.doi.org/10.1371/journal.pone.0195400			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624600	gold, Green Submitted, Green Published			2022-12-26	WOS:000429379600026
J	Budeli, P; Moropeng, RC; Mpenyana-Monyatsi, L; Momba, MNB				Budeli, Phumudzo; Moropeng, Resoketswe Charlotte; Mpenyana-Monyatsi, Lizzy; Momba, Maggie Ndombo Benteke			Inhibition of biofilm formation on the surface of water storage containers using biosand zeolite silver-impregnated clay granular and silver impregnated porous pot filtration systems	PLOS ONE			English	Article							HOUSEHOLD DRINKING-WATER; RURAL COMMUNITIES; QUALITY; GROUNDWATER; DIVERSITY; REMOVAL; FILTER; COLI	Development of biofilms occurring on the inner surface of storage vessels offers a suitable medium for the growth of microorganisms and consequently contributes to the deterioration of treated drinking water quality in homes. The aim of this study was to determine whether the two point-of-use technologies (biosand zeolite silver-impregnated clay granular (BSZ-SICG) filter and silver-impregnated porous pot (SIPP) filter) deployed in a rural community of South Africa could inhibit the formation of biofilm on the surface of plastic-based containers generally used by rural households for the storage of their drinking water. Culture-based methods and molecular techniques were used to detect the indicator bacteria (Total coliforms, faecal coliform, E. coli) and pathogenic bacteria (Salmonella spp., Shigella spp. and Vibrio cholerae) in intake water and on the surface of storage vessels containing treated water. Scanning electron microscopy was also used to visualize the development of biofilm. Results revealed that the surface water source used by the Makwane community was heavily contaminated and harboured unacceptably high counts of bacteria (heterotrophic plate count: 4.4-4.3 Log(10) CFU/100mL, total coliforms: 2.2 Log(10) CFU/100 mL-2.1 Log(10) CFU/100 mL, faecal coliforms: 1.9 Log(10) CFU/100 mL-1.8 Log(10) CFU/100 mL, E. coli: 1.7 Log(10) CFU/100 mL-1.6 Log(10) CFU/100 mL, Salmonella spp.: 3 Log(10) CFU/100 mL -8 CFU/100 mL; Shigella spp. and Vibrio cholerae had 1.0 Log(10) CFU/100 mL and 0.8 Log(10) CFU/100 mL respectively). Biofilm formation was apparent on the surface of the storage containers with untreated water within 24 h. The silver nanoparticles embedded in the clay of the filtration systems provided an effective barrier for the inhibition of biofilm formation on the surface of household water storage containers. Biofilm formation occurred on the surface of storage plastic vessels containing drinking water treated with the SIPP filter between 14 and 21 days, and on those containing drinking water treated with the BSZ-SICG filter between 3 and 14 days. The attachment of target bacteria on the surface of the coupons inoculated in storage containers ranged from (0.07 CFU/cm2-227.8 CFU/cm(2)). To effectively prevent the development of biofilms on the surface of container-stored water, which can lead to the recontamination of treated water, plastic storage containers should be washed within 14 days for water treated with the SIPP filter and within 3 days for water treated with the BSZ-SICG filter.	[Budeli, Phumudzo; Moropeng, Resoketswe Charlotte; Mpenyana-Monyatsi, Lizzy; Momba, Maggie Ndombo Benteke] Tshwane Univ Technol, Dept Environm Water & Earth Sci, Arcadia Campus, Pretoria, South Africa	Tshwane University of Technology	Momba, MNB (corresponding author), Tshwane Univ Technol, Dept Environm Water & Earth Sci, Arcadia Campus, Pretoria, South Africa.	mombamnb@tut.ac.za		Monyatsi, Lizzy/0000-0002-4413-5295; Budeli, Phumudzo/0000-0003-2969-3886; Momba, Maggy/0000-0003-3537-0354	National Research Foundation (NRF) of South Africa; Tshwane University of Technology (TUT)	National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa); Tshwane University of Technology (TUT)	The authors wish to express appreciation to the National Research Foundation (NRF) of South Africa and Tshwane University of Technology (TUT) for funding this research.	American_ Public_ Health_ Association (APHA), 2011, 139 ANN M EXP 2011; [Anonymous], 2001, INVESTIGATION POTTER; [Anonymous], 2002, MANAGING WATER HOME; Arvanitidou M, 2005, ENVIRON RES, V99, P278, DOI 10.1016/j.envres.2005.01.002; Cabral JPS, 2010, INT J ENV RES PUB HE, V7, P3657, DOI 10.3390/ijerph7103657; Clasen T, 2006, WATER PRACT TECHNOL, V1, DOI 10.2166/WPT.2006031; Control) C (Center for D, 2009, POW PREV CHRON DIS P; Jackson RB, 2001, ECOL APPL, V11, P1027, DOI 10.1890/1051-0761(2001)011[1027:WIACW]2.0.CO;2; Jagals P, 1997, WATER SA, V23, P373; Kim MN, 2008, J ENVIRON BIOL, V29, P543; Lantagne D., 2012, Waterlines, V31, P30, DOI 10.3362/1756-3488.2012.005; Li WJ, 2009, FEMS MICROBIOL REV, V33, P892, DOI 10.1111/j.1574-6976.2009.00182.x; Mackay WG, 1998, J APPL MICROBIOL, V85; Michen B, 2012, ENVIRON SCI TECHNOL, V46, P1170, DOI 10.1021/es2030565; Michen B, 2011, SEP PURIF TECHNOL, V81, P77, DOI 10.1016/j.seppur.2011.07.006; Momba M.N.B., 2000, P WISA 2000 BIENN C, P21; Momba MNB, 2003, J WATER SUPPLY RES T, V52, P67, DOI 10.2166/aqua.2003.0007; Momba MNB, 2002, WATER RES, V36, P3023, DOI 10.1016/S0043-1354(02)00011-8; Murcott, 2006, IMPLEMENTATION CRITI; Mwabi JK, 2013, WATER SA, P39; Mwabi JK, 2012, INT J ENV RES PUB HE, V9, P139, DOI 10.3390/ijerph9010139; Obi CL, 2006, WATER SA, V32, P323; Radhika M, 2014, BRAZ J MICROBIOL, V45, P667, DOI [10.1590/S1517-83822014005000041, 10.1590/S1517-83822014000200041]; Sarapata JS, 1994, J N ENGL WATER WORKS, V108, P277; South African Bureau of Standards (SABS), 2015, 2412015 SABS SANS; Stauber CE, 2006, WATER SCI TECHNOL, V54, P1, DOI 10.2166/wst.2006.440; Theron J, 2000, CRIT REV MICROBIOL, V26, P37, DOI 10.1080/10408410091154174; (UNESCO) United Nations Educational S and CO, 2003, WAT PEOPL WAT LIF BA; van der Merwe V, 2013, J WATER HEALTH, V11, P30, DOI 10.2166/wh.2012.014; van Halem D, 2009, PHYS CHEM EARTH, V34, P36, DOI 10.1016/j.pce.2008.01.005; WHO, 2011, WHO CHRONICLES; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x	32	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194715	10.1371/journal.pone.0194715	http://dx.doi.org/10.1371/journal.pone.0194715			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621296	gold, Green Submitted, Green Published			2022-12-26	WOS:000429206800024
J	Contreras, EG; Sierralta, J; Glavic, A				Contreras, Esteban G.; Sierralta, Jimena; Glavic, Alvaro			p53 is required for brain growth but is dispensable for resistance to nutrient restriction during Drosophila larval development	PLOS ONE			English	Article							NEURAL STEM-CELLS; DAMAGE RESPONSE; ORGAN GROWTH; SELF-RENEWAL; PROLIFERATION; METABOLISM; APOPTOSIS; COFACTOR; DIFFERENTIATION; EXPRESSION	Background Animal growth is influenced by the genetic background and the environmental circumstances. How genes promote growth and coordinate adaptation to nutrient availability is still an open question. p53 is a transcription factor that commands the cellular response to different types of stresses. In adult Drosophila melanogaster, p53 regulates the metabolic adaptation to nutrient restriction that supports fly viability. Furthermore, the larval brain is protected from nutrient restriction in a phenomenon called 'brain sparing'. Therefore, we hypothesised that p53 may regulate brain growth and show a protective role over brain development under nutrient restriction. Results Here, we studied the function of p53 during brain growth in normal conditions and in animals subjected to developmental nutrient restriction. We showed that p53 loss of function reduced animal growth and larval brain size. Endogenous p53 was expressed in larval neural stem cells, but its levels and activity were not affected by nutritional stress. Interestingly, p53 knockdown only in neural stem cells was sufficient to decrease larval brain growth. Finally, we showed that in p53 mutant larvae under nutrient restriction, the energy storage levels were not altered, and these larvae generated adults with brains of similar size than wild-type animals. Conclusions Using genetic approaches, we demonstrate that p53 is required for proper growth of the larval brain. This developmental role of p53 does not have an impact on animal resistance to nutritional stress since brain growth in p53 mutants under nutrient restriction is similar to control animals.	[Contreras, Esteban G.; Sierralta, Jimena] Univ Chile, Fac Med, Biomed Neurosci Inst, Independencia Santiago, Chile; [Contreras, Esteban G.; Sierralta, Jimena] Univ Chile, Fac Med, Dept Neurosci, Independencia Santiago, Chile; [Contreras, Esteban G.; Glavic, Alvaro] Univ Chile, Fac Sci, Dept Biol, Ctr Genome Regulat, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile	Sierralta, J (corresponding author), Univ Chile, Fac Med, Biomed Neurosci Inst, Independencia Santiago, Chile.; Sierralta, J (corresponding author), Univ Chile, Fac Med, Dept Neurosci, Independencia Santiago, Chile.; Glavic, A (corresponding author), Univ Chile, Fac Sci, Dept Biol, Ctr Genome Regulat, Santiago, Chile.	jimena@neuro.med.uchile.cl; alglavic@uchile.cl	Contreras, Esteban/Y-6512-2019; Sierralta, Jimena Alejandra/AAG-8877-2021; Glavic, Alvaro/F-5608-2013	Contreras, Esteban/0000-0002-0934-741X; Sierralta, Jimena/0000-0002-0257-146X; Glavic, Alvaro/0000-0002-7330-7623	Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT [3160412, 1140522, 1171800]; Anillo de Investigacion en Ciencia y Tecnologia DRiDANS [ACT1401]; Institute Milenio de Neurociencia Biomedica (BNI) [ICM P09015-F]; Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias (Fondap) [15090007]	Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Anillo de Investigacion en Ciencia y Tecnologia DRiDANS; Institute Milenio de Neurociencia Biomedica (BNI); Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias (Fondap)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP)	This work was supported by the following grants: Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT-Postdoctorado 3160412 (http://www.conicyt.cl/fondecyt/)to E.G.C., Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT-Regular 1140522 (http://www.conicyt.cl/fondecyt/) to A.G., Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT-Regular 1171800 (http://www.conicyt.cl/fondecyt/) to J.S., Anillo de Investigacion en Ciencia y Tecnologia DRiDANS ACT1401 (http://www.conicyt.cl/pia/sobre-piailineas-accion/anillos-de-investigacion-en-ciencial-tecnologiat)to J.S. and A.G., Institute Milenio de Neurociencia Biomedica (BNI) ICM P09015-F (http://www.bni.cl/) to J.S., Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias (Fondap) 15090007 to A.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DS, 2013, TRENDS CELL BIOL, V23, P336, DOI 10.1016/j.tcb.2013.03.005; Armesilla-Diaz A, 2009, NEUROSCIENCE, V158, P1378, DOI 10.1016/j.neuroscience.2008.10.052; ARMSTRONG JF, 1995, CURR BIOL, V5, P931, DOI 10.1016/S0960-9822(95)00183-7; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Barrio L, 2014, CELL REP, V8, P527, DOI 10.1016/j.celrep.2014.06.020; Bauer JH, 2007, P NATL ACAD SCI USA, V104, P13355, DOI 10.1073/pnas.0706121104; Berger C, 2012, CELL REP, V2, P407, DOI 10.1016/j.celrep.2012.07.008; Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019; BOULAN L, 2015, COLD SPRING HARB PER, V7; Brand AH, 1993, DEV CAMBRIDGE ENGLAN, V118, P1; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Bruno T, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00034; Cheng LY, 2011, CELL, V146, P435, DOI 10.1016/j.cell.2011.06.040; Cohen E, 2015, NEONATOLOGY, V108, P269, DOI 10.1159/000438451; de la Cova C, 2014, CELL METAB, V19, P470, DOI 10.1016/j.cmet.2014.01.012; Dichtel-Danjoy ML, 2013, CELL DEATH DIFFER, V20, P108, DOI 10.1038/cdd.2012.100; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Fischer M, 2017, ONCOGENE, V36, P3943, DOI 10.1038/onc.2016.502; Floter J, 2017, METABOLITES, V7, DOI 10.3390/metabo7020021; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Huang Q, 2014, CELL BIOL INT, V38, P1384, DOI 10.1002/cbin.10334; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jin SK, 2000, P NATL ACAD SCI USA, V97, P7301, DOI 10.1073/pnas.97.13.7301; Joruiz S. M., 2016, COLD SPRING HARB PER, V6; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kastenhuber ER, 2017, CELL, V170, P1062, DOI 10.1016/j.cell.2017.08.028; Kung CP, 2016, CELL REP, V14, P2413, DOI 10.1016/j.celrep.2016.02.037; Lanet E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00117; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liu HJ, 2013, STEM CELLS DEV, V22, P913, DOI 10.1089/scd.2012.0370; Lu WJ, 2010, SCIENCE, V328, P1278, DOI 10.1126/science.1185640; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; Maniam S, 2015, CELL DEATH DIFFER, V22, P156, DOI 10.1038/cdd.2014.135; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Merlo P, 2014, P NATL ACAD SCI USA, V111, P18055, DOI 10.1073/pnas.1419083111; Mesquita D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000566; Molchadsky A, 2013, CELL DEATH DIFFER, V20, P774, DOI 10.1038/cdd.2013.9; Mollereau B, 2014, APOPTOSIS, V19, P1421, DOI 10.1007/s10495-014-1035-7; Neumuller RA, 2011, CELL STEM CELL, V8, P580, DOI 10.1016/j.stem.2011.02.022; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; PURDIE CA, 1994, ONCOGENE, V9, P603; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; Scrable H, 2009, EXP GERONTOL, V44, P93, DOI 10.1016/j.exger.2008.05.017; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Shikama N, 1999, MOL CELL, V4, P365, DOI 10.1016/S1097-2765(00)80338-X; Simon R, 2014, APOPTOSIS, V19, P1430, DOI 10.1007/s10495-014-1000-5; Sogame N, 2003, P NATL ACAD SCI USA, V100, P4696, DOI 10.1073/pnas.0736384100; Speder P, 2011, CURR OPIN CELL BIOL, V23, P724, DOI 10.1016/j.ceb.2011.08.004; Stangl D, 2009, GENES NUTR, V4, P271, DOI 10.1007/s12263-009-0134-5; Tennessen JM, 2014, METHODS, V68, P105, DOI 10.1016/j.ymeth.2014.02.034; Thornborrow EC, 2001, J BIOL CHEM, V276, P15598, DOI 10.1074/jbc.M011643200; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wells BS, 2006, CURR BIOL, V16, P1606, DOI 10.1016/j.cub.2006.07.046; Werner H, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00159; Wylie A, 2014, ELIFE, V3, DOI 10.7554/eLife.01530; Xie HB, 2004, GENETICS, V168, P1477, DOI 10.1534/genetics.104.030882; Zhang XP, 2012, BIOPHYS J, V102, P2251, DOI 10.1016/j.bpj.2012.04.002	61	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194344	10.1371/journal.pone.0194344	http://dx.doi.org/10.1371/journal.pone.0194344			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621246	gold, Green Published, Green Submitted			2022-12-26	WOS:000429206800016
J	Gray, DW; Welsh, MD; Mansoor, F; Doherty, S; Chevallier, OP; Elliott, CT; Mooney, MH				Gray, Darren W.; Welsh, Michael D.; Mansoor, Fawad; Doherty, Simon; Chevallier, Olivier P.; Elliott, Christopher T.; Mooney, Mark H.			DIVA metabolomics: Differentiating vaccination status following viral challenge using metabolomic profiles	PLOS ONE			English	Article							BOVINE RESPIRATORY-DISEASE; PERFORMANCE LIQUID-CHROMATOGRAPHY; EXPERIMENTALLY INFECTED CALVES; VASCULAR ENDOTHELIAL-CELLS; FARNESOID-X-RECEPTOR; BENZOIC-ACID; POTENTIAL BIOMARKERS; QUADRIVALENT VACCINE; GLYCINE CONJUGATION; MASS-SPECTROMETRY	Bovine Respiratory Disease (BRD) is a major source of economic loss within the agricultural industry. Vaccination against BRD-associated viruses does not offer complete immune protection and vaccine failure animals present potential routes for disease spread. Serological differentiation of infected from vaccinated animals (DIVA) is possible using antigen-deleted vaccines, but during virus outbreaks DIVA responses are masked by wild-type virus preventing accurate serodiagnosis. Previous work by the authors has established the potential for metabolomic profiling to reveal metabolites associated with systemic immune responses to vaccination. The current study builds on this work by demonstrating for the first time the potential to use plasma metabolite profiling to differentiate between vaccinated and non vaccinated animals following infection-challenge. Male Holstein Friesian calves were intranasally vaccinated (Pfizer RISPOVAL (R) PI3-FRSV) and subsequently challenged with Bovine Parainfluenza Virus type-3 (BPI3V) via nasal inoculation. Metabolomic plasma profiling revealed that viral challenge led to a shift in acquired plasma metabolite profiles from day 2 to 20 p.i., with 26 metabolites identified whose peak intensities were significantly different following viral challenge depending on vaccination status. Elevated levels of biliverdin and bilirubin and decreased 3-indolepropionic acid in non-vaccinated animals at day 6 p.i. may be associated with increased oxidative stress and reactive oxygen scavenging at periods of peak virus titre. During latter stages of infection, increased levels of N-[3 alpha,5 beta,12 alpha)-3,12-dihydroxy-7,24-dioxocholan-24-yl]glycine and lysophosphatidycholine and decreased enterolactone in non-vaccinated animals may reflect suppression of innate immune response mechanisms and progression to adaptive immune responses. Levels of hexahydrohippurate were also shown to be significantly elevated in non-vaccinated animals from days 6 to 20 p.i. These findings demonstrate the potential of metabolomic profiling to identify plasma markers that can be employed in disease diagnostic applications to both differentially identify infected non-vaccinated animals during disease outbreaks and provide greater information on the health status of infected animals.	[Gray, Darren W.; Chevallier, Olivier P.; Elliott, Christopher T.; Mooney, Mark H.] QUB, Sch Biol Sci, IGFS, Belfast, Antrim, North Ireland; [Welsh, Michael D.; Mansoor, Fawad; Doherty, Simon] AFBI, VSD, Belfast, Antrim, North Ireland	Agri-Food & Biosciences Institute	Gray, DW (corresponding author), QUB, Sch Biol Sci, IGFS, Belfast, Antrim, North Ireland.	d.gray@qub.ac.uk	Chevallier, Olivier P/I-6550-2015	Chevallier, Olivier P/0000-0002-3786-4318; Doherty, Simon/0000-0001-5908-1050	Department of Agriculture and Rural Development (DARD) Northern Ireland postgraduate studentship	Department of Agriculture and Rural Development (DARD) Northern Ireland postgraduate studentship	This research was funded by a Department of Agriculture and Rural Development (DARD) Northern Ireland postgraduate studentship awarded to Darren Gray. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair BM, 2000, RES VET SCI, V68, P197, DOI 10.1053/rvsc.1999.0354; Aich P, 2007, OMICS, V11, P413, DOI 10.1089/omi.2007.0023; Aich P, 2009, OMICS, V13, P199, DOI 10.1089/omi.2009.0012; Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Bandhakavi S, 2009, J PROTEOME RES, V8, P5590, DOI 10.1021/pr900675w; BREWSTER D, 1977, BIOCHEM J, V164, P595, DOI 10.1042/bj1640595; Catapano AL, 2014, CARDIOVASC RES, V103, P372, DOI 10.1093/cvr/cvu150; Chamorro MF, 2014, CAN J VET RES, V78, P81; CHIBA M, 1994, J PHARMACOL EXP THER, V268, P409; Corsini E, 2010, J AGR FOOD CHEM, V58, P6678, DOI 10.1021/jf100471n; Coutant F, 2002, J IMMUNOL, V169, P1688, DOI 10.4049/jimmunol.169.4.1688; Cusack PMV, 2003, AUST VET J, V81, P480, DOI 10.1111/j.1751-0813.2003.tb13367.x; Dietmair S, 2010, ANAL BIOCHEM, V404, P155, DOI 10.1016/j.ab.2010.04.031; Dunn WB, 2008, J CHROMATOGR B, V871, P288, DOI 10.1016/j.jchromb.2008.03.021; Favre N, 1997, J IMMUNOL METHODS, V204, P57, DOI 10.1016/S0022-1759(97)00033-1; Fulton RW, 2012, CAN VET J, V53, P754; Gagnon N, 2009, J DAIRY RES, V76, P455, DOI 10.1017/S0022029909990082; Graham SF, 2013, ANAL CHEM, V85, P1803, DOI 10.1021/ac303163f; Gray DW, 2015, VET RES, V46, DOI 10.1186/s13567-014-0138-z; Griffin D, 1997, VET CLIN N AM-FOOD A, V13, P367, DOI 10.1016/S0749-0720(15)30302-9; He FT, 2006, CIRC RES, V98, P192, DOI 10.1161/01.RES.0000200400.55539.85; Hwang IK, 2009, J NEUROSCI RES, V87, P2126, DOI 10.1002/jnr.22030; JEFFERY H, 1993, PHARMACEUT RES, V10, P362, DOI 10.1023/A:1018980020506; Kahrs RF., 2001, VIRAL DIS CATTLE, V2nd Edition; Kaji H, 2013, J LIPIDS, V2013, DOI 10.1155/2013/684903; Kapil S, 1997, VET CLIN N AM-FOOD A, V13, P455, DOI 10.1016/S0749-0720(15)30308-X; KLEMPNER MS, 1978, J CLIN INVEST, V61, P1330, DOI 10.1172/JCI109050; Leifer I, 2010, J VIROL METHODS, V166, P98, DOI 10.1016/j.jviromet.2010.03.004; Leifer I, 2009, J VIROL METHODS, V158, P114, DOI 10.1016/j.jviromet.2009.02.002; Li J, 2008, CARDIOVASC RES, V77, P169, DOI 10.1093/cvr/cvm016; Lindahl G, 2011, CANCER RES, V71, P51, DOI 10.1158/0008-5472.CAN-10-2289; MARTIN AK, 1982, BRIT J NUTR, V47, P139, DOI 10.1079/BJN19820019; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Panciera RJ, 2010, VET CLIN N AM-FOOD A, V26, P191, DOI 10.1016/j.cvfa.2010.04.001; Peters AR, 2004, PREV VET MED, V66, P63, DOI 10.1016/j.prevetmed.2004.08.001; POON K, 1995, DRUG METAB DISPOS, V23, P255; Pruzanski W, 2005, BBA-MOL CELL BIOL L, V1736, P38, DOI 10.1016/j.bbalip.2005.07.005; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Salt JS, 2007, VET J, V174, P616, DOI 10.1016/j.tvjl.2006.10.007; Schwarz KB, 1996, FREE RADICAL BIO MED, V21, P641, DOI 10.1016/0891-5849(96)00131-1; Scott PR, 1994, FACTORS RESP DIS REV; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; STEINBRECHER UP, 1989, J LIPID RES, V30, P305; Tammen H, 2005, PROTEOMICS, V5, P3414, DOI 10.1002/pmic.200401219; Thompson PN, 2006, J ANIM SCI, V84, P488, DOI 10.2527/2006.842488x; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; West K, 1998, CAN J VET RES, V62, P245; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Willart MAM, 2012, ALLERGY, V67, P1501, DOI 10.1111/all.12019; Xiao JF, 2012, J PROTEOME RES, V11, P5914, DOI 10.1021/pr300673x; Yang J, 2006, J PROTEOME RES, V5, P554, DOI 10.1021/pr050364w; Zhang L, 2012, MOL ENDOCRINOLOGY, V26; Zhang T, 2013, J PROTEOME RES, V12, P505, DOI 10.1021/pr3009572	55	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194488	10.1371/journal.pone.0194488	http://dx.doi.org/10.1371/journal.pone.0194488			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621258	Green Published, gold			2022-12-26	WOS:000429206800020
J	Mccoy, VE; Soriano, C; Pegoraro, M; Luo, T; Boom, A; Foxman, B; Gabbott, SE				McCoy, Victoria E.; Soriano, Carmen; Pegoraro, Mirko; Luo, Ting; Boom, Arnoud; Foxman, Betsy; Gabbott, Sarah E.			Unlocking preservation bias in the amber insect fossil record through experimental decay	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; RESINS; INCLUSIONS; VOLATILE; PLANTS	Fossils entombed in amber are a unique resource for reconstructing forest ecosystems, and resolving relationships of modern taxa. Such fossils are famous for their perfect, life-like appearance. However, preservation quality is vast with many sites showing only cuticular preservation, or no fossils. The taphonomic processes that control this range are largely unknown; as such, we know little about potential bias in this important record. Here we employ actualistic experiments, using, fruit flies and modern tree resin to determine whether resin type, gut microbiota, and dehydration prior to entombment affects decay. We used solid phase microextraction gas chromatography-mass spectrometry (SPME GC-MS) to confirm distinct tree resin chemistry; gut microbiota of flies was modified using antibiotics and categorized though sequencing. Decay was assessed using phase contrast synchrotron tomography. Resin type demonstrates a significant control on decay rate. The composition of the gut microbiota was also influential, with minor changes in composition affecting decay rate. Dehydration prior to entombment, contrary to expectations, enhanced decay. Our analyses show that there is potential significant bias in the amber fossil record, especially between sites with different resin types where ecological completeness and preservational fidelity are likely affected.	[McCoy, Victoria E.; Boom, Arnoud; Gabbott, Sarah E.] Univ Leicester, Sch Geog Geol & Environm, Leicester, Leics, England; [McCoy, Victoria E.] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany; [Soriano, Carmen] Argonne Natl Lab, Adv Photon Source, Xray Sci Div, Argonne, IL 60439 USA; [Pegoraro, Mirko] Univ Leicester, Dept Genet & Genome Biol, Leicester, Leics, England; [Pegoraro, Mirko] John Moores Univ, Sch Nat Sci & Psychol, Liverpool, Merseyside, England; [Luo, Ting; Foxman, Betsy] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	University of Leicester; University of Bonn; United States Department of Energy (DOE); Argonne National Laboratory; University of Leicester; Liverpool John Moores University; University of Michigan System; University of Michigan	Mccoy, VE; Gabbott, SE (corresponding author), Univ Leicester, Sch Geog Geol & Environm, Leicester, Leics, England.; Mccoy, VE (corresponding author), Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany.	vmccoy@uni-bonn.de; sg21@ie.ac.uk		Boom, Arnoud/0000-0003-1299-691X; Pegoraro, Mirko/0000-0001-9381-5249; soriano, carmen/0000-0003-3963-3393	Royal Society Newton International Fellowship	Royal Society Newton International Fellowship	This research is supported by a Royal Society Newton International Fellowship (no grant number assigned) to Victoria E. McCoy; https:// royalsociety.org/grants-schemes-awards'grants/newton-international/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1972, U KANSAS PALAEONTOLO; Azar Dany, 2010, P271; Baratta M. T., 1998, Journal of Essential Oil Research, V10, P618; Beck CW, 1999, ESTUDIOS MUSEO CIENC, V14, P33; Bouzouita N, 2003, FLAVOUR FRAG J, V18, P380, DOI 10.1002/ffj.1200; Briggs DEG, 2003, ANNU REV EARTH PL SC, V31, P275, DOI 10.1146/annurev.earth.31.100901.144746; Briggs DEG, 2016, PALAEONTOLOGY, V59, P1, DOI 10.1111/pala.12219; Broderick N, 2014, DROSOPHILA MELANOGAS; Butler AD, 2015, P R SOC B; COLEMAN ML, 1993, NATURE, V361, P436, DOI 10.1038/361436a0; Coty D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104410; Delclos X, 2007, CR PALEVOL, V6, P135, DOI 10.1016/j.crpv.2006.09.003; Dorman HJD, 2000, J APPL MICROBIOL, V88, P308, DOI 10.1046/j.1365-2672.2000.00969.x; Erkosar B, 2014, FEBS LETT, V588, P4250, DOI 10.1016/j.febslet.2014.06.041; Hamm S, 2005, PHYTOCHEMISTRY, V66, P1499, DOI 10.1016/j.phytochem.2005.04.025; Hamm S, 2004, J SEP SCI, V27, P235, DOI 10.1002/jssc.200301611; Hamm S, 2003, J CHROMATOGR A, V1018, P73, DOI 10.1016/j.chroma.2003.08.027; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; HENWOOD A, 1992, Palaios, V7, P203, DOI 10.2307/3514931; HENWOOD AA, 1992, PALAEONTOLOGY, V35, P901; Henwood Alison, 1993, Modern Geology, V19, P35; Jaccard P., 1901, B SOC VAUD SCI NAT, V37, P241, DOI DOI 10.5169/SEALS-266440; Kirkman TW, STAT USE 1996; Kraemer MMS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118820; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; LABANDEIRA C.C., 2014, PALEONTOL SOC PAP, P163, DOI DOI 10.1017/S1089332600002850; Lambert JB, 2012, ARCHAEOMETRY, V54, P332, DOI 10.1111/j.1475-4754.2011.00625.x; Lambert J.B., 1995, ARCHAEOMETRY, V38, P325, DOI DOI 10.1111/j.1475-4754.1996.tb00780.x; Lambert JB, 2005, J NAT PROD, V68, P635, DOI 10.1021/np050005f; Lambert JB, 2002, ACCOUNTS CHEM RES, V35, P628, DOI 10.1021/ar0001970; Lambert JB, 2015, MAGN RESON CHEM, V53, P2, DOI 10.1002/mrc.4121; Lambert JB, 2008, ANGEW CHEM INT EDIT, V47, P9608, DOI 10.1002/anie.200705973; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Martinez-Delclos X, 2004, PALAEOGEOGR PALAEOCL, V203, P19, DOI 10.1016/S0031-0182(03)00643-6; McCoy VE, 2017, EARTH ENV S IN PRESS; McCoy VE, ORGANIC GEO IN PRESS; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Penney D, 2005, PALAEOGEOGR PALAEOCL, V223, P1, DOI 10.1016/j.palaeo.2005.03.022; Penney D, 2002, PALEOBIOLOGY, V28, P389, DOI 10.1666/0094-8373(2002)028<0389:PODAPS>2.0.CO;2; Penney D, 2006, BIOL LETTERS, V2, P266, DOI 10.1098/rsbl.2006.0442; Perrichot V., 2004, Geologica Acta, V2, P9; Perrichot Vincent, 2010, P192; Poinar G, 2004, J PETROL GEOL, V27, P207, DOI 10.1111/j.1747-5457.2004.tb00054.x; Poinar George Jr., 2007, Journal of the Botanical Research Institute of Texas, V1, P449; POINAR GO, 1985, J BALTIC STUD, V16, P222, DOI 10.1080/01629778500000141; POINAR GO, 1982, SCIENCE, V215, P1241, DOI 10.1126/science.215.4537.1241; Raff EC, 2013, EVOL DEV, V15, P243, DOI 10.1111/ede.12028; Ross Andrew, 2010, P208; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sonibare OO, 2012, ORG GEOCHEM, V51, P55, DOI 10.1016/j.orggeochem.2012.08.003; Soriano C, 2010, CR PALEVOL, V9, P361, DOI 10.1016/j.crpv.2010.07.014; Stankiewicz BA, 1998, P ROY SOC B-BIOL SCI, V265, P641, DOI 10.1098/rspb.1998.0342; Stewart J. D., 1978, U KANSAS PALEONTOLOG, P9; Wilby P.R., 1992, Historical Biology, V6, P25; Wilby Philip R., 1997, Geobios Memoire Special (Villeurbanne), V20, P493	56	5	5	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195482	10.1371/journal.pone.0195482	http://dx.doi.org/10.1371/journal.pone.0195482			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621345	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000429206800092
J	Yamaguchi, S; Horie, N; Morikawa, M; Tateishi, Y; Hiu, T; Morofuji, Y; Lzumo, T; Hayashi, K; Matsuo, T				Yamaguchi, Susumu; Horie, Nobutaka; Morikawa, Minoru; Tateishi, Yohei; Hiu, Takeshi; Morofuji, Yoichi; Lzumo, Tsuyoshi; Hayashi, Kentaro; Matsuo, Takayuki			Assessment of veins in T2*-weighted MR angiography predicts infarct growth in hyperacute ischemic stroke	PLOS ONE			English	Article							MULTIPLE HYPOINTENSE VESSELS; ENDOVASCULAR THROMBECTOMY; CEREBRAL-ISCHEMIA; PERFUSION; OCCLUSION; PENUMBRA; THROMBOLYSIS; METAANALYSIS; REPERFUSION; OUTCOMES	Background and purpose T2*-weighted magnetic resonance angiography (SWAN) detects hemodynamic insufficiency as hypointense areas in medullary or cortical veins. We therefore investigated whether SWAN can help predict ischemic penumbra-like lesions in patients with acute ischemic stroke (AIS). Materials and methods Magnetic resonance imaging (MRI) records including SWAN, diffusion-weighted imaging (DWI), and magnetic resonance angiography (MRA) of consecutive patients with major vessel occlusion within 6 h from AIS onset were analyzed. Acute recanalization was defined as an arterial occlusive lesion score of 2-3. A modified Alberta Stroke Program Early CT Score (mASPECTS) was used to evaluate ischemic areas revealed by SWAN and DWI. SWAN- and DWI-based mASPECTSs were calculated, and correlations between DWI SWAN mismatches with final infarct lesions or clinical outcomes were evaluated. Results Among the 35 patients included in this study, we confirmed cardioembolic stroke in 26, atherothrombotic stroke in 4, and unknown stroke etiology in 5. Overall, recanalization was achieved in 23 patients, who showed a higher follow-up DWI-based mASPECTS and lower modified Rankin Scale (mRS) score at 90 days than patients without recanalization. Initial SWAN- and follow-up DWI-based mASPECTSs were significantly higher for atherothrombotic stroke than for cardioembolic stroke. Of 12 patients without recanalization, DWI-SWAN mismatch was significantly correlated with infarct growth. Patients with recanalization showed no such correlation. In the assessment of clinical outcome, follow-up DWI-based mASPECTS and patient's age were significantly correlated with mRS at 90 days after stroke. A multivariate logistic regression analysis revealed that the follow-up DWI-based mASPECTS was independently associated with a favorable outcome 90 days after stroke. Conclusions For patients with AIS, DWI-SWAN mismatch might show penumbra-like lesions that would predict infarct growth without acute recanalization. Assessment of ischemic lesions from the venous side appears to be useful for considering the etiology and revascularization therapy.	[Yamaguchi, Susumu; Horie, Nobutaka; Hiu, Takeshi; Morofuji, Yoichi; Lzumo, Tsuyoshi; Hayashi, Kentaro; Matsuo, Takayuki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Neurosurg, Nagasaki, Japan; [Morikawa, Minoru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiol Sci, Nagasaki, Japan; [Tateishi, Yohei] Nagasaki Univ, Grad Sch Biomed Sci, Dept Neurol & Strokol, Nagasaki, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Yamaguchi, S (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Neurosurg, Nagasaki, Japan.	ssmymgc@gmail.com	Morofuji, Yoichi/AAB-1840-2021; Horie, Nobutaka/AAR-2778-2020; Tateishi, Yohei/X-7266-2019; Hiu, Takeshi/L-4334-2016	Morofuji, Yoichi/0000-0001-7135-2220; Tateishi, Yohei/0000-0002-7685-6396; Izumo, Tsuyoshi/0000-0001-8778-2698; Hiu, Takeshi/0000-0001-7090-1662; Horie, Nobutaka/0000-0002-0388-5188				Albers GW, 2018, N ENGL J MED; Baik SK, 2012, CEREBROVASC DIS, V34, P206, DOI 10.1159/000342148; BARON JC, 1981, STROKE, V12, P454, DOI 10.1161/01.STR.12.4.454; Chen CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131118; Chen Y, 2007, BRAIN RES, V1166, P9, DOI 10.1016/j.brainres.2007.06.043; Cheng B, 2016, J NEUROIMAGING; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Hartkamp NS, 2014, CURR OPIN NEUROL, V27, P42, DOI 10.1097/WCO.0000000000000051; Heiss WD, 1997, J CEREBR BLOOD F MET, V17, P388, DOI 10.1097/00004647-199704000-00004; Heiss WD, 2000, J CEREBR BLOOD F MET, V20, P1276, DOI 10.1097/00004647-200009000-00002; Horie N, 2016, J CLIN NEUROSCI, V32, P24, DOI 10.1016/j.jocn.2015.12.043; Kao HW, 2012, EUR RADIOL, V22, P1397, DOI 10.1007/s00330-012-2387-4; Kawano H, 2012, J NEUROL, V259, P2045, DOI 10.1007/s00415-012-6446-1; Kawano H, 2010, CEREBROVASC DIS, V30, P230, DOI 10.1159/000317183; Kaya D, 2009, AM J NEURORADIOL, V30, P1227, DOI 10.3174/ajnr.A1537; KENNAN RP, 1994, MAGNET RESON MED, V31, P9, DOI 10.1002/mrm.1910310103; Khan M, 2011, J CELL MOL MED, V15, P1515, DOI 10.1111/j.1582-4934.2009.00998.x; Langham MC, 2010, J AM COLL CARDIOL, V55, P598, DOI 10.1016/j.jacc.2009.08.068; Lansberg MG, 2008, STROKE, V39, P2491, DOI 10.1161/STROKEAHA.107.508572; Lee JM, 2003, ANN NEUROL, V53, P227, DOI 10.1002/ana.10433; Lou M, 2014, AM J NEURORADIOL, V35, P2061, DOI 10.3174/ajnr.A4017; Luo S, 2015, J NEURORADIOLOGY, V42, P255, DOI 10.1016/j.neurad.2014.07.002; MACLURE M, 1987, AM J EPIDEMIOL, V126, P161, DOI 10.1093/aje/126.2.161; Morita N, 2008, CEREBROVASC DIS, V26, P367, DOI 10.1159/000151640; Nogueira RG, 2018, NEW ENGL J MED, V378, P11, DOI 10.1056/NEJMoa1706442; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Park MG, 2014, CEREBROVASC DIS, V38, P254, DOI 10.1159/000367709; Parsons MW, 2010, J CEREBR BLOOD F MET, V30, P1214, DOI 10.1038/jcbfm.2010.3; Sanossian N, 2016, STROKE; Saver JL, 2016, JAMA-J AM MED ASSOC, V316, P1279, DOI 10.1001/jama.2016.13647; Shi ZS, 2014, STROKE, V45, P1977, DOI 10.1161/STROKEAHA.114.005603; Stampfl S, 2017, J NEUROINTERV SURG, V9, P346, DOI 10.1136/neurintsurg-2015-012208; Thijssen DHJ, 2006, AGING CELL, V5, P495, DOI 10.1111/j.1474-9726.2006.00242.x; TOYODA K, 1994, J NEUROL SCI, V121, P222, DOI 10.1016/0022-510X(94)90356-5; Xia S, 2014, MAGN RESON IMAGING, V32, P1272, DOI 10.1016/j.mri.2014.08.012; Yamaguchi S, 2017, J CEREB BLOOD FLOW M	36	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195554	10.1371/journal.pone.0195554	http://dx.doi.org/10.1371/journal.pone.0195554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617449	gold, Green Published, Green Submitted			2022-12-26	WOS:000429203800092
J	Sullivan, LL; Ballen, CJ; Cotner, S				Sullivan, Lauren L.; Ballen, Cissy J.; Cotner, Sehoya			Small group gender ratios impact biology class performance and peer evaluations	PLOS ONE			English	Article							STEREOTYPE THREAT; WOMEN; PARTICIPATION; FEMALE; MATH; PERCEPTIONS; MOTIVATION; SCIENCE; ABILITY; GAP	Women are underrepresented in science, technology, engineering, and mathematics (STEM) disciplines. Evidence suggests the microclimate of the classroom is an important factor influencing female course grades and interest, which encourages retention of women in STEM fields. Here, we test whether the gender composition of small (8-9 person) learning groups impacts course performance, sense of social belonging, and intragroup peer evaluations of intellectual contributions. Across two undergraduate active learning courses in introductory biology, we manipulated the classroom microclimate by varying the gender ratios of learning groups, ranging from 0% female to 100% female. We found that as the percent of women in groups increased, so did overall course performance for all students, regardless of gender. Additionally, women assigned higher peer- evaluations in groups with more women than groups with less women. Our work demonstrates an added benefit of the retention of women in STEM: increased performance for all, and positive peer perceptions for women.	[Sullivan, Lauren L.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Ballen, Cissy J.; Cotner, Sehoya] Univ Minnesota, Dept Biol Teaching & Learning, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sullivan, LL (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	lsulliva@umn.edu		Sullivan, Lauren L./0000-0002-4198-3483; Ballen, Cissy/0000-0002-4693-6117	Legislative Citizen Commission on Minnesota Resources (LCCMR) Environmental and Natural Resources Trust Fund (ENRTF) [186]; Department of Biology Teaching and Learning at the University of Minnesota	Legislative Citizen Commission on Minnesota Resources (LCCMR) Environmental and Natural Resources Trust Fund (ENRTF); Department of Biology Teaching and Learning at the University of Minnesota	LLS was supported by the Legislative Citizen Commission on Minnesota Resources (LCCMR) Environmental and Natural Resources Trust Fund (ENRTF) Grant (M.L. 2016, Chp. 186, Sec. 2, Subd. 08b). CJB and SH were supported by the Department of Biology Teaching and Learning at the University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon GM, 2013, J EDUC PSYCHOL, V105, P129, DOI 10.1037/a0028496; Amelink C., 2009, LIT OVERVIEW GENDER, P1; Aronson J., 1998, PREJUDICE, V40, P83, DOI [10.1016/b978-012679130-3/50039-9, DOI 10.1016/B978-012679130-3/50039-9]; Ballen CJ, PLOS ONE IN PRESS; Bartol KM, 1986, SOCIAL PSYCHOL FEMAL, P259; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baugh SG, 1997, GROUP ORGAN MANAGE, V22, P366, DOI 10.1177/1059601197223004; Beasley MA, 2012, SOC PSYCHOL EDUC, V15, P427, DOI 10.1007/s11218-012-9185-3; Beede D.N., 2011, WOMEN STEM GENDER GA, P4, DOI [DOI 10.2139/SSRN.1964782, 10.2139/ssrn.1964782]; Bian L, 2017, SCIENCE, V355, P389, DOI 10.1126/science.aah6524; Bryan RE, 2005, ANN ACAD MED SINGAP, V34, P486; Chen X., 2014, J APPL MATH, V2014, P1, DOI DOI 10.1061/(ASCE)MT.1943-5533.0000778; Cheryan S, 2009, J PERS SOC PSYCHOL, V97, P1045, DOI 10.1037/a0016239; Chichilnisky G, 2008, INT LABOUR REV, V147, P297, DOI 10.1111/j.1564-913X.2008.00038.x; Clance P.R., 1985, IMPOSTOR PHENOMENON, P20; Clark B.J., 2005, GENDER ED, V17, P369, DOI DOI 10.1080/09540250500145072; Cotner S., 2011, J COLL SCI TEACH, V40, P96; Cotner S., 2013, J COLL SCI TEACH, V42, P82, DOI DOI 10.2505/4/JCST13_042_06_82; Cotner S, 2017, CBE-LIFE SCI EDUC, V16, DOI 10.1187/cbe.16-11-0329; CRAWFORD M, 1990, SEX ROLES, V23, P101, DOI 10.1007/BF00289859; Dasgupta N, 2015, P NATL ACAD SCI USA, V112, P4988, DOI 10.1073/pnas.1422822112; De Welde K., 2011, INT J GEND SCI TECHN, V3, P571; Eddy SL, 2014, CBE-LIFE SCI EDUC, V13, P478, DOI 10.1187/cbe.13-10-0204; Espinosa LL, 2011, HARVARD EDUC REV, V81, P209, DOI 10.17763/haer.81.2.92315ww157656k3u; Gainen J, 1995, NEW DIRECTIONS TEACH, V1995, P5, DOI [10.1002/tl.37219956104, DOI 10.1002/TL.37219956104]; Good C, 2012, J PERS SOC PSYCHOL, V102, P700, DOI 10.1037/a0026659; Graham MJ, 2013, SCIENCE, V341, P1455, DOI 10.1126/science.1240487; Hall RobertaM., 1982, CLASSROOM CLIMATE CH; Heilman ME, 2001, J SOC ISSUES, V57, P657, DOI 10.1111/0022-4537.00234; Hollingshead AB, 2003, J EXP SOC PSYCHOL, V39, P355, DOI 10.1016/S0022-1031(02)00549-8; Hughes WJ, 2000, J WOMEN MINOR SCI EN, V6; Kuznetsova A, 2014, LMERTEST TESTS RANDO; Lariviere Vincent, 2013, Nature, V504, P211; Lorenzo M, 2006, AM J PHYS, V74, P118, DOI 10.1119/1.2162549; Luckenbill-Edds L, 2002, BIOSCIENCE, V52, P513, DOI 10.1641/0006-3568(2002)052[0513:TEPFWI]2.0.CO;2; MAMOLA C, 1979, SMALL GROUP BEHAV, V10, P431, DOI 10.1177/104649647901000310; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Myaskovsky L, 2005, SEX ROLES, V52, P645, DOI 10.1007/s11199-005-3732-8; Oh SS, 2011, SOC SCI J, V48, P397, DOI 10.1016/j.soscij.2010.11.008; Oncu S, 2015, EURASIA J MATH SCI T, V11, P535; President's Council of Advisors on Science and Technology, 2012, ENG EXC PROD ON MILL; R Core Team, 2021, R LANGUAGE ENV STAT; Rask K, 2008, ECON EDUC REV, V27, P676, DOI 10.1016/j.econedurev.2007.09.010; Rodriguez I, 2016, PHYS REV PHYS EDUC R, V12, DOI 10.1103/PhysRevPhysEducRes.12.020118; Schmader T, 2002, J EXP SOC PSYCHOL, V38, P194, DOI 10.1006/jesp.2001.1500; Shackelford S, 1996, SOC PSYCHOL Q, P248; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; Steele J, 2002, PSYCHOL WOMEN QUART, V26, P46, DOI 10.1111/1471-6402.00042; Stout JG, 2013, AIP CONF PROC, V1513, P402, DOI 10.1063/1.4789737; West TV, 2012, J EXP SOC PSYCHOL, V48, P1209, DOI 10.1016/j.jesp.2012.04.012; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147; Xu Y., 2015, J HIGHER ED, V86	52	8	8	7	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195129	10.1371/journal.pone.0195129	http://dx.doi.org/10.1371/journal.pone.0195129			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB5DC	29614091	Green Submitted, gold, Green Published			2022-12-26	WOS:000429081600034
J	Marinoni, DT; Valentini, N; Portis, E; Acquadro, A; Beltramo, C; Mehlenbacher, SA; Mockler, TC; Rowley, ER; Botta, R				Marinoni, Daniela Torello; Valentini, Nadia; Portis, Ezio; Acquadro, Alberto; Beltramo, Chiara; Mehlenbacher, Shawn A.; Mockler, Todd C.; Rowley, Erik R.; Botta, Roberto			High density SNP mapping and QTL analysis for time of leaf budburst in Corylus avellana L.	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENETIC-LINKAGE MAP; SINGLE NUCLEOTIDE POLYMORPHISMS; COASTAL DOUGLAS-FIR; MICROSATELLITE MARKERS; TRANSLOCATION BREAKPOINTS; ENVIRONMENTAL-CONTROL; 9-LIPOXYGENASE GENE; ADAPTIVE TRAITS; CANDIDATE GENES	The growing area of European hazelnut (Corylus avellana L.) is increasing, as well as the number of producing countries, and there is a pressing need for new improved cultivars. Hazelnut conventional breeding process is slow, due to the length of juvenile phase and the high heterozygosity level. The development of genetic linkage maps and the identification of molecular markers tightly linked to QTL (quantitative trait loci) of agronomic interest are essential tools for speeding up the selection of seedlings carrying desired traits through marker-assisted selection. The objectives of this study were to enrich a previous linkage map and confirm QTL related to time of leaf budburst, using an F1 population obtained by crossing Tonda Gentile delle Langhe with Merveille de Bollwiller. Genotyping-by-Sequencing was used to identify a total of 9,999 single nucleotide polymorphism markers. Well saturated linkage maps were constructed for each parent using the double pseudo-testcross mapping strategy. A reciprocal translocation was detected in Tonda Gentile delle Langhe between two non-homologous chromosomes. Applying a bioinformatic approach, we were able to disentangle 'pseudo-linkage' between markers, removing markers around the trans location breakpoints and obtain a linear order of the markers for the two chromosomes arms, for each linkage group involved in the translocation. Twenty-nine QTL for time of leaf budburst were identified, including a stably expressed region on LG_O2 of the Tonda Gentile delle Langhe map. The stability of these QTL and their coding sequence content indicates promise for the identification of specific chromosomal regions carrying key genes involved in leaf budburst.	[Marinoni, Daniela Torello; Valentini, Nadia; Portis, Ezio; Acquadro, Alberto; Beltramo, Chiara; Botta, Roberto] Univ Torino, Dipartimento Sci Agr Forestali & Alimentari, Turin, Italy; [Mehlenbacher, Shawn A.] Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA; [Mockler, Todd C.; Rowley, Erik R.] Donald Danforth Plant Sci Ctr, St Louis, MO USA	University of Turin; Oregon State University; Donald Danforth Plant Science Center	Portis, E (corresponding author), Univ Torino, Dipartimento Sci Agr Forestali & Alimentari, Turin, Italy.	ezio.portis@unito.it	valentini, nadia/AAY-9815-2020; Valentini, Nadia Cristina/I-5520-2013; Mockler, Todd C/L-2609-2013; Beltramo, Chiara/K-7917-2016	Valentini, Nadia Cristina/0000-0001-6412-5206; Mockler, Todd C/0000-0002-0462-5775; Beltramo, Chiara/0000-0002-7861-4171; VALENTINI, Nadia/0000-0002-8820-9006; PORTIS, Ezio/0000-0002-1548-6096; ACQUADRO, Alberto/0000-0002-5322-9701	Ferrero Hazelnut Company	Ferrero Hazelnut Company	Financial support granted by Ferrero Hazelnut Company is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball AD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-218; Batley J, 2009, METHODS MOL BIOL, V537, P303, DOI 10.1007/978-1-59745-251-9_15; Beltramo C, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0450-6; Bhattarai G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178061; Bielenberg DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139406; Boccacci P, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0195-7; BRADSHAW HD, 1995, GENETICS, V139, P963; Bregaglio S, 2016, ECOL MODEL, V329, P86, DOI 10.1016/j.ecolmodel.2016.03.006; Bushakra JM, 2015, THEOR APPL GENET, V128, P1631, DOI 10.1007/s00122-015-2541-x; Casasoli M, 2004, PLANT CELL ENVIRON, V27, P1088, DOI 10.1111/j.1365-3040.2004.01214.x; Catarino S, 2006, CHROMOSOME RES, V14, P755, DOI 10.1007/s10577-006-1089-7; Cervera MT, 2001, GENETICS, V158, P787; Charrier G, 2011, INT J BIOMETEOROL, V55, P763, DOI 10.1007/s00484-011-0470-1; CHURCHILL GA, 1994, GENETICS, V138, P963; Colburn BC, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-016-0616-2; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Cooke JEK, 2012, PLANT CELL ENVIRON, V35, P1707, DOI 10.1111/j.1365-3040.2012.02552.x; Crepinsek Z, 2012, INT J BIOMETEOROL, V56, P681, DOI 10.1007/s00484-011-0469-7; Cristofori V, 2008, J SCI FOOD AGR, V88, P1091, DOI 10.1002/jsfa.3203; Derory J, 2010, HEREDITY, V105, P401, DOI 10.1038/hdy.2009.170; Doucleff M, 2004, THEOR APPL GENET, V109, P1178, DOI 10.1007/s00122-004-1728-3; Doyle J. J., 1987, PHYTOCHEM B, P11; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Eun MH, 2016, HORTIC ENVIRON BIOTE, V57, P589, DOI 10.1007/s13580-016-0128-3; Farre A, 2011, THEOR APPL GENET, V122, P1029, DOI 10.1007/s00122-010-1507-2; Germain E, 2004, LE NOISETIER; Ghelardini L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-31; Grzeskowiak L, 2013, THEOR APPL GENET, V126, P2763, DOI 10.1007/s00122-013-2170-1; Guajardo V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127750; Gurcan K, 2010, MOL BREEDING, V26, P551, DOI 10.1007/s11032-010-9464-7; Gurcan K, 2010, TREE GENET GENOMES, V6, P513, DOI 10.1007/s11295-010-0269-y; Gurcan K, 2010, J AM SOC HORTIC SCI, V135, P159, DOI 10.21273/JASHS.135.2.159; Hassidim M, 2007, PLANT J, V51, P551, DOI 10.1111/j.1365-313X.2007.03160.x; Howe GT, 2003, CAN J BOT, V81, P1247, DOI [10.1139/b03-141, 10.1139/B03-141]; Hu TZ, 2013, PLANT MOL BIOL REP, V31, P1141, DOI 10.1007/s11105-013-0581-4; Hwang IS, 2010, PLANT PHYSIOL, V152, P948, DOI 10.1104/pp.109.147827; Jaganathan D, 2015, MOL GENET GENOMICS, V290, P559, DOI 10.1007/s00438-014-0932-3; JANSEN RC, 1994, GENETICS, V136, P1447; Jauregui B, 2001, THEOR APPL GENET, V102, P1169, DOI 10.1007/s001220000511; Jermstad KD, 2001, THEOR APPL GENET, V102, P1142, DOI 10.1007/s001220000505; Kenis K, 2005, MOL BREEDING, V15, P205, DOI 10.1007/s11032-004-5592-2; Kolomiets MV, 2001, PLANT CELL, V13, P613, DOI 10.1105/tpc.13.3.613; KONISHI T, 1988, THEOR APPL GENET, V75, P237, DOI 10.1007/BF00303959; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Lagercrantz U, 2009, J EXP BOT, V60, P2501, DOI 10.1093/jxb/erp139; LANDER ES, 1989, GENETICS, V121, P185; Larcher W, 2003, PHYSL PLANT ECOLOGY; Lehmensiek A, 2005, AUST J AGR RES, V56, P1347, DOI 10.1071/AR05126; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LI P, 1993, CAN J FOREST RES, V23, P1043, DOI 10.1139/x93-133; Li Z, 2001, THEOR APPL GENET, V103, P1167, DOI 10.1007/s001220100672; Lian QL, 2011, SCI HORTIC-AMSTERDAM, V130, P468, DOI 10.1016/j.scienta.2011.07.016; Livingstone KD, 2000, J HERED, V91, P423, DOI 10.1093/jhered/91.6.423; Longhi S, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.1; LORIEUX M, 1995, THEOR APPL GENET, V90, P81, DOI 10.1007/BF00220999; Ma BQ, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-015-0959-6; Mahama AA, 2003, CROP SCI, V43, P1602, DOI 10.2135/cropsci2003.1602; Maschietto V, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-0970-1; McCallum S, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0443-5; ME G, 1989, HORTSCIENCE, V24, P122; MEHLENBACHER SA, 1991, SCI HORTIC-AMSTERDAM, V47, P271, DOI 10.1016/0304-4238(91)90010-V; Mehlenbacher SA, 2006, GENOME, V49, P122, DOI 10.1139/G05-091; Ozturk SC, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-016-1098-4; Pilet-Nayel ML, 2002, THEOR APPL GENET, V106, P28, DOI 10.1007/s00122-002-0985-2; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pootakham W, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00367; Portis E, 2009, THEOR APPL GENET, V120, P59, DOI 10.1007/s00122-009-1159-2; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Rohlf FJ, 1998, NTSYS PC NUMERICAL T; Ros E, 2010, NUTRIENTS, V2, P652, DOI 10.3390/nu2070652; Rowley E., 2016, THESIS; Rowley ER, 2012, CROP SCI, V52, P2679, DOI 10.2135/cropsci2012.02.0065; SALESSES G, 1988, CYTOLOGIA, V53, P407, DOI 10.1508/cytologia.53.407; SALESSES G, 1973, ANN AMELIOR PLANT, V23, P59; Santino A, 2005, PLANT SCI, V168, P699, DOI 10.1016/j.plantsci.2004.10.001; SARAVITZ DM, 1995, PLANT PHYSIOL, V107, P535, DOI 10.1104/pp.107.2.535; Scotti-Saintagne C, 2004, THEOR APPL GENET, V109, P1648, DOI 10.1007/s00122-004-1789-3; Singh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084136; Talukder ZI, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2016.03.0035; *UPOV, 1979, TG713 UPOV; Van Ooijen, 2004, MAPQTL 5 SOFTWARE MA; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; VANOOIJEN JW, 1992, THEOR APPL GENET, V84, P803, DOI 10.1007/BF00227388; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; WEEDEN NF, 1994, CUR T PL M, P57; Welch D, 2007, GENE DEV, V21, P2196, DOI 10.1101/gad.440307; Xiang L, 2011, J EXP BOT, V62, P3849, DOI 10.1093/jxb/err069; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Yu HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017595	90	23	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195408	10.1371/journal.pone.0195408	http://dx.doi.org/10.1371/journal.pone.0195408			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608620	gold, Green Submitted, Green Published			2022-12-26	WOS:000428988800052
J	Alhouayek, M; Buisseret, B; Paquot, A; Guillemot-Legris, O; Muccioli, GG				Alhouayek, Mireille; Buisseret, Baptiste; Paquot, Adrien; Guillemot-Legris, Owein; Muccioli, Giulio G.			The endogenous bioactive lipid prostaglandin D-2-glycerol ester reduces murine colitis via DP1 and PPAR gamma receptors	FASEB JOURNAL			English	Article						Crohn's disease; eicosanoids; prostanoid; 15d-PGJ2-G	INFLAMMATORY BOWEL DISEASES; ULCERATIVE-COLITIS; GLYCEROL ESTERS; COX-2 INHIBITOR; SULFONIC-ACID; CANCER-CELLS; COLON-CANCER; D-2; MICE; RATS	Cyclooxygenase-2 (COX-2) has long been implicated in the pathogenesis of inflammatory bowel diseases (IBDs). COX-2 is mostly known for the production of prostaglandins (PGs) from arachidonic acid. However, it also metabolizes the endocannabinoids 2-arachidonoylglycerol (2-AG) and anandamide into the less well-studied bioactive lipids PG-glycerol esters (PG-Gs) and PG-ethanolamides (PG-EAs or prostamides). We previously showed that PGD(2)-G, a product of 2-AG oxygenation by COX-2, has anti-inflammatory effects. Therefore, we used the dextran sulfate sodium (DSS)-induced model of colitis in mice to explore the role of PGD(2)-G in murine models of IBD. Colon inflammation was assessed using macroscopic and histologic scores, myeloperoxidase activity, and expression of inflammatory mediators by real-time quantitative PCR and ELISA. We also compared the effects of PGD(2)-G with those of PGD(2) and PGD(2)-EA. Finally, we used receptor antagonists to gain mechanistic insight into the receptors responsible for the observed effects. PGD(2)-G reduced DSS-induced colitis, but PGD(2) and PGD(2)-EA did not have the same effect. Furthermore, we showed that PGD(2)-G is an agonist of the PGD(2) receptor 1 (DP1) and that some of the effects of PGD(2)-G were blocked by antagonism of peroxisome proliferator-activated receptor and DP1. Therefore, PGD(2)-G could be one of the products from the COX-2/prostaglandin D synthase axis to exert beneficial effects in colitis.Alhouayek, M., Buisseret, B., Paquot, A., Guillemot-Legris, O., Muccioli, G. G. The endogenous bioactive lipid prostaglandin D-2-glycerol ester reduces murine colitis via DP1 and PPAR receptors.	[Alhouayek, Mireille; Buisseret, Baptiste; Paquot, Adrien; Guillemot-Legris, Owein; Muccioli, Giulio G.] Catholic Univ Louvain, Louvain Drug Res Inst, Bioanal & Pharmacol Bioact Lipids Res Grp, Brussels, Belgium	Universite Catholique Louvain	Muccioli, GG (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Bioanal & Pharmacol Bioact Lipids Res Grp, Bioanal & Pharmacol Bioact Lipids Lab B1 72 01, Ave E Mounier 72, B-1200 Brussels, Belgium.	giulio.muccioli@uclouvain.be	Alhouayek, Mireille/R-5058-2018	Alhouayek, Mireille/0000-0002-9193-0718; Muccioli, Giulio/0000-0002-1600-9259; Guillemot-Legris, Owein/0000-0003-3738-3423	European Crohn's and Colitis Organisation (ECCO) [J.0071.15]; FRS-FNRS (Belgium); FRS-FNRS (Fonds National de la Recherche Scientifique), Belgium; European Crohn's and Colitis Organisation (ECCO); FRS-FNRS (Belgium) [J.0071.15]	European Crohn's and Colitis Organisation (ECCO); FRS-FNRS (Belgium)(Fonds de la Recherche Scientifique - FNRS); FRS-FNRS (Fonds National de la Recherche Scientifique), Belgium(Fonds de la Recherche Scientifique - FNRS); European Crohn's and Colitis Organisation (ECCO); FRS-FNRS (Belgium)(Fonds de la Recherche Scientifique - FNRS)	The MASSMET platform (https://uclouvain.be/en/research-institutes/ldri/massmet.html) is acknowledged for providing the access to the ultraperformance liquid chromatography-MS/MS. This work was supported by a grant from the European Crohn's and Colitis Organisation (ECCO) and Grant J.0071.15 from the FRS-FNRS (Belgium) to G.G.M. M.A. and O.G.-L. are postdoctoral researchers from the FRS-FNRS (Fonds National de la Recherche Scientifique), Belgium. The authors declare no conflicts of interest.	Ajuebor MN, 2000, AM J PHYSIOL-GASTR L, V279, pG238; Alhouayek M, 2015, FASEB J, V29, P650, DOI 10.1096/fj.14-255208; Alhouayek M, 2014, TRENDS PHARMACOL SCI, V35, P284, DOI 10.1016/j.tips.2014.03.001; Alhouayek M, 2013, P NATL ACAD SCI USA, V110, P17558, DOI 10.1073/pnas.1314017110; Alhouayek M, 2012, TRENDS MOL MED, V18, P615, DOI 10.1016/j.molmed.2012.07.009; Alhouayek M, 2011, FASEB J, V25, P2711, DOI 10.1096/fj.10-176602; Castaneda FE, 2005, GASTROENTEROLOGY, V129, P1991, DOI 10.1053/j.gastro.2005.09.017; Chicca A, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0307-7; Cuzzocrea S, 2004, CRIT CARE MED, V32, P457, DOI 10.1097/01.CCM.0000109446.38675.61; Cuzzocrea S, 2003, BRIT J PHARMACOL, V138, P678, DOI 10.1038/sj.bjp.0705077; Galvez J, 2000, BRIT J PHARMACOL, V130, P1949, DOI 10.1038/sj.bjp.0703505; Gao Q, 2005, DIGEST LIVER DIS, V37, P584, DOI 10.1016/j.dld.2005.02.011; Gatta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031111; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Guillemot-Legris O, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0666-8; Hasenoehrl C, 2016, NEUROGASTROENT MOTIL, V28, P1765, DOI 10.1111/nmo.12931; Hu SSJ, 2008, BRIT J PHARMACOL, V153, P1538, DOI 10.1038/bjp.2008.33; Iwanaga K, 2014, CANCER RES, V74, P3011, DOI 10.1158/0008-5472.CAN-13-2792; Izzo AA, 2015, HANDB EXP PHARMACOL, V231, P423, DOI 10.1007/978-3-319-20825-1_15; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kefalakes H, 2009, EUR J CLIN PHARMACOL, V65, P963, DOI 10.1007/s00228-009-0719-3; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kozak KR, 2001, J BIOL CHEM, V276, P36993, DOI 10.1074/jbc.M105854200; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Li JJ, 2017, EMBO MOL MED, V9, P571, DOI 10.15252/emmm.201606987; Ligresti A, 2016, PHYSIOL REV, V96, P1593, DOI 10.1152/physrev.00002.2016; Manna JD, 2014, J BIOL CHEM, V289, P33741, DOI 10.1074/jbc.M114.582353; Martin AR, 2005, INFLAMM RES, V54, P145, DOI 10.1007/s00011-004-1337-2; Martin AR, 2003, EUR J PHARMACOL, V481, P281, DOI 10.1016/j.ejphar.2003.09.033; Matsumoto H, 1997, BIOCHEM BIOPH RES CO, V230, P110, DOI 10.1006/bbrc.1996.5894; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; Okayama M, 2007, DIGEST DIS SCI, V52, P2095, DOI 10.1007/s10620-006-9597-z; Patsos HA, 2005, GUT, V54, P1741, DOI 10.1136/gut.2005.073403; Patsos HA, 2010, INT J ONCOL, V37, P187, DOI 10.3892/ijo_00000666; Radnai B, 2016, J CROHNS COLITIS, V10, P1087, DOI 10.1093/ecco-jcc/jjw061; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; Raman P, 2011, MOL PHARMACOL, V80, P201, DOI 10.1124/mol.110.070441; Paiotti APR, 2012, J MOL HISTOL, V43, P307, DOI 10.1007/s10735-012-9400-8; Ross RA, 2002, J PHARMACOL EXP THER, V301, P900, DOI 10.1124/jpet.301.3.900; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Savinainen JR, 2014, MOL PHARMACOL, V86, P522, DOI 10.1124/mol.114.094284; Sturino CF, 2007, J MED CHEM, V50, P794, DOI 10.1021/jm0603668; Sturm EM, 2014, J IMMUNOL, V193, P827, DOI 10.4049/jimmunol.1303484; Urquhart P, 2015, BBA-MOL CELL BIOL L, V1851, P366, DOI 10.1016/j.bbalip.2014.12.015; Valdeolivas S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.387; Vandenbroucke RE, 2014, NAT REV DRUG DISCOV, V13, P904, DOI 10.1038/nrd4390; Vong L, 2010, P NATL ACAD SCI USA, V107, P12023, DOI 10.1073/pnas.1004982107; Washida K, 2010, STROKE, V41, P1798, DOI 10.1161/STROKEAHA.110.583948; Witkamp R, 2016, EUR J PHARMACOL, V785, P96, DOI 10.1016/j.ejphar.2015.08.051; Zamuner SR, 2005, AM J PATHOL, V167, P1293, DOI 10.1016/S0002-9440(10)61216-3	50	15	16	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5000	5011		10.1096/fj.201701205R	http://dx.doi.org/10.1096/fj.201701205R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29630407				2022-12-26	WOS:000443817700031
J	Wang, LX; Liu, XH; Wang, HH; Yuan, H; Chen, SJ; Chen, Z; The, H; Zhou, J; Zhu, J				Wang, Luxiang; Liu, Xiaohui; Wang, Haihong; Yuan, Hao; Chen, Saijuan; Chen, Zhu; de The, Hugues; Zhou, Jun; Zhu, Jun			RNF4 regulates zebrafish granulopoiesis through the DNMT1-C/EBP alpha axis	FASEB JOURNAL			English	Article						SUMOylation; myelopoiesis; STUbL; neutrophil	PROTEIN 4 RNF4; DNA METHYLATION; GENE-EXPRESSION; C/EBP-ALPHA; SUMO; UBIQUITIN; HEMATOPOIESIS; SUMOYLATION; LIGASE; STEM	RING finger protein 4 (RNF4) is a multifunctional small ubiquitin-related modifier (SUMO)-targeted ubiquitin E3 ligase (STUbL) ubiquitously expressed in all tissues, and which mainly participates in DNA repair and in chromatin and transcriptional regulation. Although RNF4 has been implicated in hematopoietic disorders, its ontogenic role during hematopoietic development remains undiscovered. We generated a zebrafish rnf4 knockout line by using transcription activator-like effector nucleases technology to address the impact of rnf4 during hematopoiesis. Rnf4-deficient zebrafish embryos exhibited sharply decreased neutrophils numbers during both primitive and definitive hematopoiesis. Mechanistic studies revealed that repression of the key granulocytic activator, CCAAT/enhancer-binding protein (c/ebp), via promoter hypermethylation by SUMOylated DNA methyltransferase 1 (DNMT1) was the main cause of impaired granulopoiesis in rnf4-deficient zebrafish. In addition, for the first time, we identified DNMT1 as a potential new STUbL substrate of RNF4, with knockdown of dnmt1 largely restoring primitive and definitive granulopoiesis in rnf4-deficient zebrafish. Collectively, RNF4 is indispensable for zebrafish granulopoiesis through regulation of the DNMT1-C/EBP functional axis.Wang, L., Liu, X., Wang, H., Yuan, H., Chen, S., Chen, Z., de The, H., Zhou, J., Zhu, J. RNF4 regulates zebrafish granulopoiesis through the DNMT1-C/EBP axis.	[Wang, Luxiang; Liu, Xiaohui; Wang, Haihong; Yuan, Hao; Chen, Saijuan; Chen, Zhu; de The, Hugues; Zhou, Jun; Zhu, Jun] Shanghai Jiao Tong Univ, CNRS LIA Hematol & Canc, Sino French Res Ctr Life Sci & Genom, State Key Lab Med Genom,Rui Jin Hosp,Sch Med, 197 Rui Jin Rd 2, Shanghai 200025, Peoples R China; [de The, Hugues; Zhu, Jun] Univ Paris 07, Hop St Louis, Equipe Labellisee Ligue Natl Canc 11, INSERM,CNRS,UMR 944 7212, Paris, France	Chinese Academy of Sciences; Shanghai Jiao Tong University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Zhou, J; Zhu, J (corresponding author), Shanghai Jiao Tong Univ, CNRS LIA Hematol & Canc, Sino French Res Ctr Life Sci & Genom, State Key Lab Med Genom,Rui Jin Hosp,Sch Med, 197 Rui Jin Rd 2, Shanghai 200025, Peoples R China.	junjun_j@yahoo.com; zhuj1966@yahoo.com			National Natural Science Foundation of China [31471375]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank D. A. Jones (University of Utah, Salt Lake City) for providing the dnmt1 plasmid. The authors also thank J. Chen for cell sorting. The authors are grateful to M. Dong, M. Deng, Y. Chen, Y. Jin, and Z. Ruan (all from Shanghai Jiao Tong University School of Medicine, Shanghai, China) for technical support. This work was supported in part by research funding from the National Natural Science Foundation of China (31471375). The authors declare no conflicts of interest.	Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Bewick AJ, 2017, MOL BIOL EVOL, V34, P654, DOI 10.1093/molbev/msw264; Bojovic BB, 2008, DNA CELL BIOL, V27, P289, DOI 10.1089/dna.2007.0680; Carradice D, 2008, BLOOD, V111, P3331, DOI 10.1182/blood-2007-10-052761; Chen AT, 2009, J CELL BIOCHEM, V108, P35, DOI 10.1002/jcb.22251; Collavin L, 2004, P NATL ACAD SCI USA, V101, P8870, DOI 10.1073/pnas.0308605101; Cooper S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126385; Creton S, 2010, CELL, V143, P848, DOI 10.1016/j.cell.2010.11.026; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; Dong ZW, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-17; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Friedman AD, 2007, BLOOD CELL MOL DIS, V39, P340, DOI 10.1016/j.bcmd.2007.06.010; Friedman AD, 2015, INT J HEMATOL, V101, P330, DOI 10.1007/s12185-015-1764-6; Fryrear KA, 2012, BLOOD, V119, P1173, DOI 10.1182/blood-2011-06-358564; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Hay RT, 2013, BIOCHEM SOC T, V41, P463, DOI 10.1042/BST20130015; Hendriks IA, 2015, CELL REP, V10, P1778, DOI 10.1016/j.celrep.2015.02.033; Hirota K, 2014, GENES CELLS, V19, P743, DOI 10.1111/gtc.12173; Hu XYV, 2010, P NATL ACAD SCI USA, V107, P15087, DOI 10.1073/pnas.1009025107; Jagannathan-Bogdan M, 2013, DEVELOPMENT, V140, P2463, DOI 10.1242/dev.083147; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lallemand-Breitenbach V, 2012, TRENDS MOL MED, V18, P36, DOI 10.1016/j.molmed.2011.10.001; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; Lee B, 2009, BIOCHEM J, V421, P449, DOI 10.1042/BJ20090142; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Liu XH, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0115-7; Lyko F, 2018, NAT REV GENET, V19, P81, DOI 10.1038/nrg.2017.80; Ma O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095784; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Mizuno S, 2001, BLOOD, V97, P1172, DOI 10.1182/blood.V97.5.1172; Mukhopadhyay D, 2010, J CELL BIOL, V188, P681, DOI 10.1083/jcb.200909008; Musialik E, 2014, LEUKEMIA RES, V38, P850, DOI 10.1016/j.leukres.2014.04.013; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Ronnerblad M, 2014, BLOOD, V123, pE79, DOI 10.1182/blood-2013-02-482893; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Subramanian L, 2003, J BIOL CHEM, V278, P9134, DOI 10.1074/jbc.M210440200; Takayama K, 2014, GENE EXPR PATTERNS, V14, P105, DOI 10.1016/j.gep.2014.01.005; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Trowbridge JJ, 2012, GENE DEV, V26, P344, DOI 10.1101/gad.184341.111; Wang L, 2013, DEVELOPMENT, V140, P2755, DOI 10.1242/dev.092825; Wang Y, 2014, J BIOL CHEM, V289, P33808, DOI 10.1074/jbc.C114.611558; Warga RM, 2009, DEV CELL, V16, P744, DOI 10.1016/j.devcel.2009.04.007; Wouters BJ, 2007, BLOOD, V110, P3706, DOI 10.1182/blood-2007-02-073486; Xie J, 2015, J CLIN INVEST, V125, P1523, DOI 10.1172/JCI79325; Yuan H, 2011, BLOOD, V117, P7014, DOI 10.1182/blood-2010-12-325712	52	1	2	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4930	4940		10.1096/fj.201701450RR	http://dx.doi.org/10.1096/fj.201701450RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29634367				2022-12-26	WOS:000443817700026
J	Weinhaupl, K; Brennich, M; Kazmaier, U; Lelievre, J; Ballell, L; Goldberg, A; Schanda, P; Fraga, H				Weinhaupl, Katharina; Brennich, Martha; Kazmaier, Uli; Lelievre, Joel; Ballell, Lluis; Goldberg, Alfred; Schanda, Paul; Fraga, Hugo			The antibiotic cyclomarin blocks arginine-phosphate-induced millisecond dynamics in the N-terminal domain of ClpC1 from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear magnetic resonance (NMR); Mycobacterium tuberculosis; natural product; antibiotic action; antibiotic resistance; small-angle X-ray scattering (SAXS); protease; chaperone	SMALL-ANGLE SCATTERING; CASEINOLYTIC PROTEASE; NMR-SPECTROSCOPY; ADAPTER PROTEIN; MACROMOLECULES; STABILITY; BEAMLINE; SAXS; PLUS; BM29	Mycobacterium tuberculosis can remain dormant in the host, an ability that explains the failure of many current tuberculosis treatments. Recently, the natural products cyclomarin, ecumicin, and lassomycin have been shown to efficiently kill Mycobacterium tuberculosis persisters. Their target is the N-terminal domain of the hexameric AAA+ ATPase ClpC1, which recognizes, unfolds, and translocates protein substrates, such as proteins containing phosphorylated arginine residues, to the ClpP1P2 protease for degradation. Surprisingly, these antibiotics do not inhibit ClpC1 ATPase activity, and how they cause cell death is still unclear. Here, using NMR and small-angle X-ray scattering, we demonstrate that arginine-phosphate binding to the ClpC1 N-terminal domain induces millisecond dynamics. We show that these dynamics are caused by conformational changes and do not result from unfolding or oligomerization of this domain. Cyclomarin binding to this domain specifically blocked these N-terminal dynamics. On the basis of these results, we propose a mechanism of action involving cyclomarin-induced restriction of ClpC1 dynamics, which modulates the chaperone enzymatic activity leading eventually to cell death.	[Weinhaupl, Katharina; Schanda, Paul; Fraga, Hugo] Univ Grenoble Alpes, CEA, CNRS, IBS, 71 Ave Martyrs,CS 10090, F-38044 Grenoble 9, France; [Brennich, Martha] European Mol Biol Lab, 71 Ave Martyrs,CS 90181, F-38042 Grenoble 9, France; [Kazmaier, Uli] Saarland Univ, Inst Organ Chem, Campus C4-2, D-66123 Saarbrucken, Germany; [Lelievre, Joel; Ballell, Lluis] GlaxoSmithKline, Dis Developing World Discovery Performance Unit, Severo Ochoa 2, Madrid 28760, Spain; [Goldberg, Alfred] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Fraga, Hugo] Univ Porto, Dept Biomed, Fac Med, Alameda Prof Hernani Monteiro, P-4200319 Porto, Portugal; [Fraga, Hugo] Univ Porto, I3S, Alameda Prof Hernani Monteiro, P-4200319 Porto, Portugal	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); Saarland University; GlaxoSmithKline; Harvard University; Harvard Medical School; Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto	Schanda, P (corresponding author), Univ Grenoble Alpes, CEA, CNRS, IBS, 71 Ave Martyrs,CS 10090, F-38044 Grenoble 9, France.; Fraga, H (corresponding author), Univ Porto, Dept Biomed, Fac Med, Alameda Prof Hernani Monteiro, P-4200319 Porto, Portugal.; Fraga, H (corresponding author), Univ Porto, I3S, Alameda Prof Hernani Monteiro, P-4200319 Porto, Portugal.	paul.schanda@ibs.fr; hfraga@med.up.pt	Kazmaier, Uli/D-2947-2018; Schanda, Paul/A-5975-2010; Fraga, Hugo/X-4850-2019	Schanda, Paul/0000-0002-9350-7606; Fraga, Hugo/0000-0001-7677-4086; Weinhaupl, Katharina/0000-0002-9552-9876; Ballell, Lluis/0000-0002-3029-1860	FRISBI [ANR-10-INSB-05-02]; GRAL within the Grenoble Partnership for Structural Biology [ANR-10-LABX-4901]; Tres Cantos Open Lab Foundation; NIGMS, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER	FRISBI; GRAL within the Grenoble Partnership for Structural Biology; Tres Cantos Open Lab Foundation; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work used the platforms of the Grenoble Instruct Center (UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-4901) within the Grenoble Partnership for Structural Biology. We thank Dr. Caroline Mas for valuable advice. Dr. Goldberg's laboratory received grants from the Tres Cantos Open Lab Foundation and NIGMS, National Institutes of Health. We thank the ESRF for beam time at BM29.	Akopian T, 2012, EMBO J, V31, P1529, DOI 10.1038/emboj.2012.5; Andersson FI, 2006, J BIOL CHEM, V281, P5468, DOI 10.1074/jbc.M509661200; Ashiotis G, 2015, J APPL CRYSTALLOGR, V48, P510, DOI 10.1107/S1600576715004306; Barbie P, 2016, ORG BIOMOL CHEM, V14, P6055, DOI 10.1039/c6ob00801a; Barbie P, 2016, ORG LETT, V18, P204, DOI 10.1021/acs.orglett.5b03292; Bouvignies G, 2012, J PHYS CHEM B, V116, P14311, DOI 10.1021/jp311109u; Brennich ME, 2017, JOVE-J VIS EXP, DOI 10.3791/54861; Brennich ME, 2016, J APPL CRYSTALLOGR, V49, P203, DOI 10.1107/S1600576715024462; Carroni Marta, 2017, Elife, V6, DOI 10.7554/eLife.30120; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Favier A, 2011, J BIOMOL NMR, V49, P9, DOI 10.1007/s10858-010-9461-5; Franco R, 2017, J AM CHEM SOC, V139, P1065, DOI 10.1021/jacs.6b12089; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gao W, 2015, ANTIMICROB AGENTS CH, V59, P880, DOI 10.1128/AAC.04054-14; Gavrish E, 2014, CHEM BIOL, V21, P509, DOI 10.1016/j.chembiol.2014.01.014; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; Hart KM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12965; He LC, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601625; Ishibashi M, 2005, PROTEIN EXPRES PURIF, V42, P1, DOI 10.1016/j.pep.2005.03.028; Ishikawa T, 2004, J STRUCT BIOL, V146, P180, DOI 10.1016/j.jsb.2003.11.018; Jung IP, 2017, INT J BIOL MACROMOL, V101, P348, DOI 10.1016/j.ijbiomac.2017.03.126; Kar NP, 2008, FEBS J, V275, P6149, DOI 10.1111/j.1742-4658.2008.06738.x; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; Kirstein J, 2007, EMBO J, V26, P2061, DOI 10.1038/sj.emboj.7601655; Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012; Lo JH, 2001, PROTEIN SCI, V10, P551, DOI 10.1110/ps.41401; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Schmitt EK, 2011, ANGEW CHEM INT EDIT, V50, P5889, DOI 10.1002/anie.201101740; Schuetz AK, 2016, ELIFE, V5, DOI 10.7554/eLife.20143; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shukla D, 2010, J PHYS CHEM B, V114, P13426, DOI 10.1021/jp108399g; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05; Tamiola K, 2010, J AM CHEM SOC, V132, P18000, DOI 10.1021/ja105656t; Trentini DB, 2016, NATURE, V539, P48, DOI 10.1038/nature20122; Vagenende V, 2013, ACS CHEM BIOL, V8, P416, DOI 10.1021/cb300440x; Vasudevan D, 2013, J BIOL CHEM, V288, P30883, DOI 10.1074/jbc.M113.493767; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang F, 2011, NATURE, V471, P331, DOI 10.1038/nature09780; Yee M, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02342-16; Zhang SW, 2017, J ADV CERAM, V6, P1, DOI 10.1007/s40145-016-0209-x; Zhang Y, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0023-2013; Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001	48	20	21	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8379	8393		10.1074/jbc.RA118.002251	http://dx.doi.org/10.1074/jbc.RA118.002251			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29632076	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000434205700005
J	Weber, KS; Bridgewater, LC; Jensen, JL; Breakwell, DP; Nielsen, BL; Johnson, SM				Weber, K. Scott; Bridgewater, Laura C.; Jensen, Jamie L.; Breakwell, Donald P.; Nielsen, Brent L.; Johnson, Steven M.			Personal microbiome analysis improves student engagement and interest in Immunology, Molecular Biology, and Genomics undergraduate courses	PLOS ONE			English	Article							INSTRUCTION; HEALTH	A critical area of emphasis for science educators is the identification of effective means of teaching and engaging undergraduate students. Personal microbiome analysis is a means of identifying the microbial communities found on or in our body. We hypothesized the use of personal microbiome analysis in the classroom could improve science education by making courses more applied and engaging for undergraduate students. We determined to test this prediction in three Brigham Young University undergraduate courses: Immunology, Advanced Molecular Biology Laboratory, and Genomics. These three courses have a two-week microbiome unit and students during the 2016 semester students could submit their own personal microbiome kit or use the demo data, whereas during the 2017 semester students were given access to microbiome data from an anonymous individual. The students were surveyed before, during, and after the human microbiome unit to determine whether analyzing their own personal microbiome data, compared to analyzing demo microbiome data, impacted student engagement and interest. We found that personal microbiome analysis significantly enhanced the engagement and interest of students while completing microbiome assignments, the self-reported time students spent researching the microbiome during the two week microbiome unit, and the attitudes of students regarding the course overall. Thus, we found that integrating personal microbiome analysis in the classroom was a powerful means of improving student engagement and interest in undergraduate science courses.	[Weber, K. Scott; Bridgewater, Laura C.; Breakwell, Donald P.; Nielsen, Brent L.; Johnson, Steven M.] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA; [Jensen, Jamie L.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA	Brigham Young University; Brigham Young University	Weber, KS (corresponding author), Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA.	scott_weber@byu.edu	Johnson, Steven M/B-3940-2013; Bridgewater, Laura C/I-2999-2015; Weber, Scott/O-1022-2014	Bridgewater, Laura C/0000-0002-4664-6144; Weber, Scott/0000-0003-3688-2191; Johnson, Steven/0000-0002-7399-8153	Teaching Enhancement Grant from the College of Life Sciences at Brigham Young University; College of Life Sciences at Brigham Young University	Teaching Enhancement Grant from the College of Life Sciences at Brigham Young University; College of Life Sciences at Brigham Young University	This work was supported by a Teaching Enhancement Grant from the College of Life Sciences at Brigham Young University.; The authors would like to thank the College of Life Sciences at Brigham Young University for providing support in the form of a Teaching Enhancement Grant we received in 2015 that allowed for the purchase of the personal microbiome kits. We would also like to thank Josie Tueller for suggestions to improve the manuscript.	[Anonymous], 2006, ED PSYCHOL DEV LEARN; Ash C, 2016, SCIENCE, V352, P531, DOI 10.1126/science.352.6285.530; Blaser MJ, 2016, SCIENCE, V352, P544, DOI 10.1126/science.aad9358; Boguski MS, 2013, GENOME MED, V5, DOI 10.1186/gm426; Bransford JDBA, 2000, PEOPLE LEARN BRAIN M, P206, DOI DOI 10.17226/9853; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Callaway E, 2015, NATURE, V521, P136, DOI 10.1038/521136a; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; DEaR RM, 1985, INTRINSIC MOTIVATION; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Eccles J. S., 1983, ACHIEVEMENT ACHIEVEM, P75, DOI DOI 10.1006/CEPS.1999.1015; Eccles JS, 2002, ANNU REV PSYCHOL, V53, P109, DOI 10.1146/annurev.psych.53.100901.135153; Freeman S, 2014, P NATL ACAD SCI USA, V111, P8410, DOI 10.1073/pnas.1319030111; Frey N., 2010, J ENGLISH JOURNAL, V100, P30, DOI DOI 10.2307/20787688; Garber KB, 2016, TRENDS GENET, V32, P317, DOI 10.1016/j.tig.2016.03.008; Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378; Glasner ME, 2017, SCIENCE, V355, P577, DOI 10.1126/science.aam7446; Goodrich JK, 2016, SCIENCE, V352, P532, DOI 10.1126/science.aad9379; Hagiwara N, 2017, ADV MED EDUC PRACT, V8, P817, DOI 10.2147/AMEP.S145696; Hansen TH, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0157-z; Hartman MR, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw266; Hidi S, 2006, EDUC PSYCHOL-US, V41, P111, DOI 10.1207/s15326985ep4102_4; Houtman JHS, 2015, HUMAN MICROBIOME YOU, P1; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jensen JL, 2017, J MICROBIOL BIOL EDU, V18, DOI 10.1128/jmbe.v18i3.1367; Katsanis Sara H, 2013, N C Med J, V74, P491; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Pamer EG, 2016, SCIENCE, V352, P535, DOI 10.1126/science.aad9382; Parker L. C., 2008, IDEAS NOS UNDERGRADU, P1681, DOI [DOI 10.1175/2008BAMS2349.1, 10.1175/2008BAMS2349.1]; Plunkett-Rondeau J, 2015, GENET MED, V17, P927, DOI 10.1038/gim.2014.208; Priniski SJ, 2018, J EXP EDUC, V86, P11, DOI 10.1080/00220973.2017.1380589; Redfield RJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001356; Rhodes R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0702-7; Ryan R., 1990, LEARN INDIVID DIFFER, V2, P1, DOI [DOI 10.1016/1041-6080(90)90014-8, 10.1016/1041-6080(90)90014-8]; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Salari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068853; Salari K, 2011, ACAD MED, V86, P925, DOI 10.1097/ACM.0b013e3182223acf; Schiefele U., 1999, SCI STUD READ, V3, P257, DOI [DOI 10.1207/S1532799XSSR0303_4, 10.1207/s1532799xssr0303_4]; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Shi J, 2010, CBE-LIFE SCI EDUC, V9, P453, DOI 10.1187/cbe.10-04-0055; Singer SR, 2013, CBE-LIFE SCI EDUC, V12, P129, DOI 10.1187/cbe.13-03-0058; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Walt DR, 2011, GENET MED, V13, P63, DOI 10.1097/GIM.0b013e3181f872ac; Weber KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133486; Weitzel KW, 2016, AM J PHARM EDUC, V80; Williams K.C., 2011, RES HIGHER ED J, V12, P1, DOI [DOI 10.5430/ILTIE.V4N, DOI 10.1080/15389588.2010.515631]; Wood WB, 2009, ANNU REV CELL DEV BI, V25, P93, DOI 10.1146/annurev.cellbio.24.110707.175306; Yang XM, 2017, CBE-LIFE SCI EDUC, V16, DOI 10.1187/cbe.16-09-0281; Zhang TR, 2014, J MICROBIOL BIOL EDU, V15, P197, DOI 10.1128/jmbe.v15i2.773	51	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0193696	10.1371/journal.pone.0193696	http://dx.doi.org/10.1371/journal.pone.0193696			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641525	Green Published, gold, Green Submitted			2022-12-26	WOS:000429742900016
J	Hsiung, KM; Kimura, S; Hang, YS; Takeshige, A; Iizuka, Y				Hsiung, Kuan-Mei; Kimura, Shingo; Hang, Yu-San; Takeshige, Aigo; Iizuka, Yoshiyuki			Effect of ENSO events on larval and juvenile duration and transport of Japanese eel (Anguilla japonica)	PLOS ONE			English	Article							NORTH EQUATORIAL CURRENT; DAILY GROWTH INCREMENTS; PACIFIC-OCEAN; TROPICAL PACIFIC; WESTERN PACIFIC; SALINITY FRONT; FISH OTOLITHS; SARGASSO SEA; GLASS EELS; EL-NINO	Spawning ground of Japanese eel (Anguilla japonica) is located near the West Mariana Ridge seamount. The species travels through the North Equatorial Current (NEC) and then enters the Kuroshio Current (KC) on the migration toward East Asian growth habitats. Therefore, El Nino-Southern Oscillation (ENSO) events serve as the potentially important drivers of interannual variability across the equatorial Pacific. Because the NEC bifurcation and salinity profiles are related to ENSO events, we investigated the influence of locations of the NEC bifurcation and salinity front on the success of larval entry to the KC by numerically modeling particle transport in ocean currents from 1972 to 2013 and possible effects on the size of glass eels at continental recruitment and, via otolithometry on the duration of larval migration. Circulation and hydrography used for particle tracking were obtained from the results of the Model for Interdisciplinary Research on Climate (MIROC) high-resolution forecasting experiment. Our results demonstrated that during El Nino years, (1) the southward movement of the salinity front might cause the larvae to experience slower currents and (2) the northward movement of the NEC bifurcation might broaden the separation between their spawning ground and NEC bifurcation, thus prolonging the time needed for the larvae to enter the KC from their spawning ground, because of which the duration of entrainment in the water column and body size increase when eels reach estuarine waters. In addition, this might cause more water to flow into the Mindanao Current (MC), leading to a decline in the rate at which larvae get entrained into the KC.	[Hsiung, Kuan-Mei; Kimura, Shingo; Takeshige, Aigo] Univ Tokyo, Grad Sch Frontier Sci, Atmosphere & Ocean Res Inst, Chiba, Japan; [Hsiung, Kuan-Mei; Hang, Yu-San] Natl Taiwan Univ, Coll Life Sci, Inst Fisheries Sci, Taipei, Taiwan; [Hsiung, Kuan-Mei; Hang, Yu-San] Natl Taiwan Univ, Coll Life Sci, Dept Life Sci, Taipei, Taiwan; [Takeshige, Aigo] Fisheries Res Ctr, Natl Res Inst Far Seas Fisheries, Yokohama, Kanagawa, Japan; [Iizuka, Yoshiyuki] Acad Sinica, Inst Earth Sci, Taipei, Taiwan	University of Tokyo; National Taiwan University; National Taiwan University; Japan Fisheries Research & Education Agency (FRA); Academia Sinica - Taiwan	Hsiung, KM (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Atmosphere & Ocean Res Inst, Chiba, Japan.; Hsiung, KM (corresponding author), Natl Taiwan Univ, Coll Life Sci, Inst Fisheries Sci, Taipei, Taiwan.; Hsiung, KM (corresponding author), Natl Taiwan Univ, Coll Life Sci, Dept Life Sci, Taipei, Taiwan.	km-hsiung@s.nenv.k.u-tokyo.ac.jp	Kimura, Shingo/AAI-2209-2020	Hsiung, Kuan-Mei/0000-0002-3268-6719; Iizuka, Yoshiyuki/0000-0002-7327-7583	JSPS KAKENHI from the Japan Society for the Promotion of Science (JSPS) [JP16H04734]	JSPS KAKENHI from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grant-in-Aid for Scientific Research (JSPS KAKENHI Grant Numbers JP16H04734) from the Japan Society for the Promotion of Science (JSPS) to SK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 1997, J GEOPHYS RES-OCEANS, V102, P23063, DOI 10.1029/97JC01443; [Anonymous], 1972, BEGINNING KUROSHIO; Arai T, 2000, MAR BIOL, V137, P39, DOI 10.1007/s002270000326; Bonhommeau S, 2008, MAR ECOL PROG SER, V373, P71, DOI 10.3354/meps07696; CAMPANA SE, 1983, CAN J ZOOL, V61, P1591, DOI 10.1139/z83-214; CAMPANA SE, 1985, CAN J FISH AQUAT SCI, V42, P1014, DOI 10.1139/f85-127; CASTONGUAY M, 1987, J PLANKTON RES, V9, P195, DOI 10.1093/plankt/9.1.195; Chang YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144423; Chen JZ, 2014, ESTUAR COAST SHELF S, V151, P361, DOI 10.1016/j.ecss.2014.06.004; Cheng PW, 1996, MAR ECOL PROG SER, V131, P87, DOI 10.3354/meps131087; Friedland KD, 2007, ICES J MAR SCI, V64, P519, DOI 10.1093/icesjms/fsm022; Han YS, 2012, FISH OCEANOGR, V21, P281, DOI 10.1111/j.1365-2419.2012.00624.x; Han YS, 2009, ZOOL STUD, V48, P632; Hasumi H, 2004, K 1 COUPLED GCM MIRO; Hasumi H., 2000, CCSR REP, V13, P68; Ho M.-P, 2012, THESIS U SO QUEENSLA; Hsu AC, 2017, FISH OCEANOGR, V26, P251, DOI 10.1111/fog.12189; Ishikawa S, 2001, FISHERIES SCI, V67, P1097, DOI 10.1046/j.1444-2906.2001.00366.x; Itakura H, 2015, ENVIRON BIOL FISH, V98, P1871, DOI 10.1007/s10641-015-0404-6; Itakura H, 2015, LANDSC ECOL ENG, V11, P147, DOI 10.1007/s11355-014-0252-0; Jacoby D., 2014, IUCN RED LIST THREAT, V2, P2019; KAJIHARA T, 1988, NIPPON SUISAN GAKK, V54, P929; Kawamiya M., 2005, J EARTH SIMULATOR, V4, P18; KESSLER WS, 1987, J PHYS OCEANOGR, V17, P97, DOI 10.1175/1520-0485(1987)017<0097:DHAZGT>2.0.CO;2; Kettle AJ, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000589; Kim H, 2007, ICES J MAR SCI, V64, P1387, DOI 10.1093/icesjms/fsm091; Kim YY, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002013; Kimura S, 1999, MAR ECOL PROG SER, V186, P303, DOI 10.3354/meps186303; Kimura S, 2001, FISH OCEANOGR, V10, P51, DOI 10.1046/j.1365-2419.2001.00159.x; KIMURA S, 1994, MAR BIOL, V119, P185, DOI 10.1007/BF00349555; Kimura S, 2006, DEEP-SEA RES PT II, V53, P315, DOI 10.1016/j.dsr2.2006.01.009; Knights B, 2003, SCI TOTAL ENVIRON, V310, P237, DOI 10.1016/S0048-9697(02)00644-7; Kuroki M, 2009, J FISH BIOL, V74, P1853, DOI 10.1111/j.1095-8649.2009.02299.x; Kuroki Mari, 2005, Coastal Marine Science, V29, P154; MAILLET GL, 1990, FISH B-NOAA, V88, P155; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Masumoto Y., 2004, J EARTH SIMULATOR, V1, P35; McCleave JD, 2008, MAR BIOL, V155, P249, DOI 10.1007/s00227-008-1026-8; McCleave JD, 1987, T AM FISH SOC, V1, P138; Miller MJ, 2017, CAN J FISH AQUAT SCI, V74, P958, DOI 10.1139/cjfas-2016-0281; Miller MJ, 2009, AM FISH S S, V69, P231; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Otake T, 2003, EEL BIOLOGY, P61; PANNELLA G, 1971, SCIENCE, V173, P1124, DOI 10.1126/science.173.4002.1124; Qiu B, 2010, J PHYS OCEANOGR, V40, P2525, DOI 10.1175/2010JPO4462.1; Sakamoto TT, 2012, J METEOROL SOC JPN, V90, P325, DOI 10.2151/jmsj.2012-301; Sasaki H., 2006, J EARTH SIMULATOR, V6, P35; Shinoda A, 2004, FISHERIES SCI, V70, P339, DOI 10.1111/j.1444-2906.2003.00810.x; TABETA O, 1987, NIPPON SUISAN GAKK, V53, P1727; Tatebe H, 2012, J METEOROL SOC JPN, V90A, P275, DOI 10.2151/jmsj.2012-A14; Tatsukawa K, 2003, EEL BIOLOGY, P293; Tesch F.W., 2008, EEL; TOOLE JM, 1990, J PHYS OCEANOGR, V20, P307, DOI 10.1175/1520-0485(1990)020<0307:OOTPNE>2.0.CO;2; TOWNSEND CR, 1980, OECOLOGIA, V47, P219, DOI 10.1007/BF00346824; TSUKAMOTO K, 1989, NIPPON SUISAN GAKK, V55, P1017; TSUKAMOTO K, 1990, J FISH BIOL, V36, P659; Tsukamoto K, 2006, NATURE, V439, P929, DOI 10.1038/439929a; TSUKAMOTO K, 1992, NIPPON SUISAN GAKK, V58, P457; TSUKAMOTO K, 1992, NATURE, V356, P789, DOI 10.1038/356789a0; Tzeng WN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030805; TZENG WN, 1990, MAR BIOL, V107, P75, DOI 10.1007/BF01313244; Tzeng WN., 1985, B JAP SOC FISH OCEAN, V47, P11; UMEZAWA A, 1989, JPN J ICHTHYOL, V35, P440, DOI 10.1007/BF02905501; Wu CR, 2013, PROG OCEANOGR, V110, P49, DOI 10.1016/j.pocean.2012.12.001; Zenimoto K, 2009, J FISH BIOL, V74, P1878, DOI 10.1111/j.1095-8649.2009.02295.x	65	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195544	10.1371/journal.pone.0195544	http://dx.doi.org/10.1371/journal.pone.0195544			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634730	gold, Green Published, Green Submitted			2022-12-26	WOS:000429522200037
J	Jiang, PL; Hou, YW; Fu, WK; Tao, XF; Luo, JT; Lu, HX; Xu, YC; Han, BS; Zhang, JF				Jiang, Penglei; Hou, Yanwen; Fu, Weikang; Tao, Xiaofan; Luo, Juntao; Lu, Hanxu; Xu, Yicheng; Han, Bingshe; Zhang, Junfang			Characterization of IncRNAs involved in cold acclimation of zebrafish ZF4 cells	PLOS ONE			English	Article							NONCODING RNAS; LNCRNAS; GENE; IDENTIFICATION; EXPRESSION; TEMPERATURE; EVOLUTION; SEQ	Long non-coding RNAs (IncRNAs) are increasingly regarded as a key role in regulating diverse biological processes in various tissues and species. Although the cold responsive IncRNAs have been reported in plants, no data is available on screening and functional prediction of IncRNAs in cold acclimation in fish so far. Here we compared the expression profile of IncRNAs in cold acclimated zebrafish embryonic fibroblast cells (ZF4) cultured at 18 degrees C for 30 days with that of cells cultured at 28 degrees C as control by high-throughput sequencing. Totally 8,363 novel IncRNAs were identified. Including known and novel IncRNAs, there are 347 IncRNAs up-regulated and 342 IncRNAs down-regulated in cold acclimated cells. Among the differentially expressed IncRNAs, 74 and 61 were detected only in control cells or cold-acclimated cells, respectively. The Gene Ontology (GO) and Kyoto Encyclopaedia of Genes and Genomes (KEGG) enrichment analyses of adjacent genes to the differentially expressed IncRNAs showed that the enriched genes are involved in electron transport, cell adhesion, oxidation-reduction process, and so on. We also predicted the target genes of the differentially expressed IncRNAs by looking for interactions between IncRNAs and mRNAs, and constructed an interaction network. In summary, our genome-wide systematic identification and functional prediction of cold responsive IncRNAs in zebrafish cells suggests a crucial role of lincRNAs in cold acclimation in fish.	[Jiang, Penglei; Hou, Yanwen; Fu, Weikang; Tao, Xiaofan; Luo, Juntao; Lu, Hanxu; Xu, Yicheng; Han, Bingshe; Zhang, Junfang] Shanghai Ocean Univ, Key Lab Explorat & Utilizat Aquat Genet Resources, Minist Educ, Shanghai, Peoples R China; [Jiang, Penglei; Hou, Yanwen; Fu, Weikang; Tao, Xiaofan; Luo, Juntao; Lu, Hanxu; Xu, Yicheng; Han, Bingshe] Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China; [Zhang, Junfang] Shanghai Ocean Univ, Minist Sci & Technol, Int Res Ctr Marine Biosci, Shanghai, Peoples R China	Shanghai Ocean University; Shanghai Ocean University; Shanghai Ocean University	Han, BS; Zhang, JF (corresponding author), Shanghai Ocean Univ, Key Lab Explorat & Utilizat Aquat Genet Resources, Minist Educ, Shanghai, Peoples R China.; Han, BS (corresponding author), Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China.; Zhang, JF (corresponding author), Shanghai Ocean Univ, Minist Sci & Technol, Int Res Ctr Marine Biosci, Shanghai, Peoples R China.	bs-han@shou.edu.cn; jfzhang@shou.edu.cn	jiang, penglei/GPX-0521-2022		National Natural Science Foundation of China [31372516, 81770165]; Shanghai Municipal Education Commission	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This study was supported by grants from National Natural Science Foundation of China (grant No. 31372516 awarded to JZ and 81770165 awarded to BH), Shanghai Municipal Education Commission (Oriental scholar program awarded to JZ), Shanghai Municipal Education Commission (Project for Gaofeng Discipline of Fishery).	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blastyak A, 2006, MOL CELL BIOL, V26, P1434, DOI 10.1128/MCB.26.4.1434-1444.2006; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Chen ZZ, 2008, P NATL ACAD SCI USA, V105, P12944, DOI 10.1073/pnas.0802432105; Eddy Sean R, 2009, Genome Inform, V23, P205; Frigault JJ, 2017, J COMP PHYSIOL B, V187, P19, DOI 10.1007/s00360-016-1049-2; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Guderley H, 2004, BIOL REV, V79, P409, DOI 10.1017/S1464793103006328; Han BS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160358; Hu P, 2015, NUCLEIC ACIDS RES, V43, P9198, DOI 10.1093/nar/gkv780; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jandura A, 2017, TRENDS GENET, V33, P665, DOI 10.1016/j.tig.2017.08.002; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Le Bourg E, 2015, BIOGERONTOLOGY, V16, P411, DOI 10.1007/s10522-015-9557-0; Li SX, 2017, SCI REP-UK, V7, DOI 10.1038/srep45981; Li SM, 2017, P NATL ACAD SCI USA, V114, pE7111, DOI 10.1073/pnas.1703494114; Long Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-612; Long Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037209; Lopez-Olmeda JF, 2011, J THERM BIOL, V36, P91, DOI 10.1016/j.jtherbio.2010.12.005; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Pinto R, 2005, FEBS LETT, V579, P5553, DOI 10.1016/j.febslet.2005.09.019; Song XM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2625-2; Su S, 2016, FEBS J, V283, P1261, DOI 10.1111/febs.13660; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; Tafer H, 2008, BIOINFORMATICS, V24, P2657, DOI 10.1093/bioinformatics/btn193; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wang L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00823-3; Wang XT, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003756; Wang XD, 2017, AQUAT TOXICOL, V182, P214, DOI 10.1016/j.aquatox.2016.12.003; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Wu H, 2017, TRENDS GENET, V33, P540, DOI 10.1016/j.tig.2017.05.004; Xu B, 2005, MOL CELL ENDOCRINOL, V245, P147, DOI 10.1016/j.mce.2005.11.010; Yakovchuk P, 2009, P NATL ACAD SCI USA, V106, P5569, DOI 10.1073/pnas.0810738106; Yang RL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-605; Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhao Y, 2016, NUCLEIC ACIDS RES, V44, pD203, DOI 10.1093/nar/gkv1252	40	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195468	10.1371/journal.pone.0195468	http://dx.doi.org/10.1371/journal.pone.0195468			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634734	Green Published, gold, Green Submitted			2022-12-26	WOS:000429522200033
J	Lomax, DR; De la Sallee, P; Massare, JA; Gallois, R				Lomax, Dean R.; De la Sallee, Paul; Massare, Judy A.; Gallois, Ramues			A giant Late Triassic ichthyosaur from the UK and a reinterpretation of the Aust Cliff 'dinosaurian' bones	PLOS ONE			English	Article							JURASSIC ICHTHYOSAUR; SKULL	The largest reported ichthyosaurs lived during the Late Triassic (similar to 235-200 million years ago), and isolated, fragmentary bones could be easily mistaken for those of dinosaurs because of their size. We report the discovery of an isolated bone from the lower jaw of a giant ichthyosaur from the latest Triassic of Lilstock, Somerset, UK. It documents that giant ichthyosaurs persisted well into the Rhaetian Stage, and close to the time of the Late Triassic extinction event. This specimen has prompted the reinterpretation of several large, roughly cylindrical bones from the latest Triassic (Rhaetian Stage) Westbury Mudstone Formation from Aust Cliff, Gloucestershire, UK. We argue here that the Aust bones, previously identified as those of dinosaurs or large terrestrial archosaurs, are jaw fragments from giant ichthyosaurs. The Lilstock and Aust specimens might represent the largest ichthyosaurs currently known.	[Lomax, Dean R.] Univ Manchester, Sch Earth & Environm Sci, Oxford Rd, Manchester, Lancs, England; [De la Sallee, Paul] Etches Collect Museum Jurassic Marine Life, Kimmeridge, Dorset, England; [Massare, Judy A.] SUNY Coll Brockport, Dept Earth Sci, Brockport, NY 14420 USA; [Gallois, Ramues] Gallois Geol Consultancy, Exeter, Devon, England	University of Manchester; State University of New York (SUNY) System	Lomax, DR (corresponding author), Univ Manchester, Sch Earth & Environm Sci, Oxford Rd, Manchester, Lancs, England.	dean.lomax@manchester.ac.uk		Lomax, Dean/0000-0001-6985-3966				Bardet N, 2014, GONDWANA RES, V26, P869, DOI 10.1016/j.gr.2014.05.005; Benton M.J., 1995, FOSSIL REPTILES GREA; Buchy MC, 2003, B SOC GEOL FR, V174, P271, DOI 10.2113/174.3.271; Butler RJ, 2006, NEUES JAHRB GEOL P-M, P613; CAMP C L, 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V170, P139; Carpenter K., 2006, NEW MEXICO MUSEUM NA, V36, P131; Dal Sasso C, 1996, PALEONTOL LOMBARDA, V4, P23; Danise S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5789; Fischer V, 2016, PEERJ, V4, DOI 10.7717/peerj.2604; Fischer V, 2014, NATURWISSENSCHAFTEN, V101, P1027, DOI 10.1007/s00114-014-1242-7; Fischer V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029234; Fischer V, 2011, J VERTEBR PALEONTOL, V31, P1010, DOI 10.1080/02724634.2011.595464; Gallois R.W., 2009, GEOSCINCE S W ENGLAN, V12, P71; Galton Peter M., 2005, Revue de Paleobiologie, V24, P51; GALTON PM, 1985, GEOBIOS-LYON, V18, P671, DOI 10.1016/S0016-6995(85)80065-6; Hesselbo SP, 2004, J GEOL SOC LONDON, V161, P365, DOI 10.1144/0016-764903-033; Ibarra Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep19808; Ji C, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2015.1025956; Ji C, 2013, J VERTEBR PALEONTOL, V33, P340, DOI 10.1080/02724634.2013.723082; Jiang DY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26232; Kear BP, 2005, ZOOL J LINN SOC-LOND, V145, P583, DOI 10.1111/j.1096-3642.2005.00199.x; Kelley NP, 2014, PALAEOGEOGR PALAEOCL, V400, P9, DOI 10.1016/j.palaeo.2012.07.026; Lomax D. R., 2014, DINOSAURS BRIT ISLES; Lomax DR, 2019, GEOL J, V54, P83, DOI 10.1002/gj.3155; Macquaker J.H.S., 1999, FOSSILS RHAETIAN PEN, P39; Maidment SCR, 2008, J SYST PALAEONTOL, V6, P367, DOI 10.1017/S1477201908002459; Maisch Michael W., 1997, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V258, P1; Marek RD, 2015, PALAEONTOLOGY, V58, P723, DOI 10.1111/pala.12174; Martin JE, 2015, ACTA PALAEONTOL POL, V60, P837, DOI 10.4202/app.00062.2014; MASSARE JA, 1990, GEOL SOC AM BULL, V102, P409, DOI 10.1130/0016-7606(1990)102<0409:TAAEOT>2.3.CO;2; MCGOWAN C, 1995, CAN J EARTH SCI, V32, P292, DOI 10.1139/e95-024; McGowan C, 1999, J VERTEBR PALEONTOL, V19, P42, DOI 10.1080/02724634.1999.10011121; McGowan C, 1996, CAN J EARTH SCI, V33, P24, DOI 10.1139/e96-003; McGowan C, 1996, CAN J EARTH SCI, V33, P1011, DOI 10.1139/e96-077; McGowan C., 1973, GEOLOGY, V24, P1; McGowan C, 2003, HDB PALEOHERPETOLOGY, V8, P175; McGowan Chris, 1997, P61, DOI 10.1016/B978-012155210-7/50006-5; Moon Benjamin C., 2016, Monograph of the Palaeontographical Society, V170, P1; Motani Ryosuke, 1999, Paludicola, V2, P174; Nicholls EL, 2004, J VERTEBR PALEONTOL, V24, P838, DOI 10.1671/0272-4634(2004)024[0838:GIOTTN]2.0.CO;2; Redelstorff R, 2014, ACTA PALAEONTOL POL, V59, P607, DOI 10.4202/app.2012.0073; Reynolds S.H., 1946, COTTSWOLD NATURALIST, V29, P29; Sander PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078573; Sanders W., 1876, ANN REPORT ASS ADV S, V45, P80; Sauvage H., 1883, ANN SCI GEOL, V14, P1; Sheldon Amy, 1997, P333, DOI 10.1016/B978-012155210-7/50018-1; Sheldon M. Amy, 1999, Paludicola, V2, P190; STORRS GW, 1994, ZOOL J LINN SOC-LOND, V112, P217, DOI 10.1111/j.1096-3642.1994.tb00319.x; Stutchbury S, 1850, ANN REPORT ASS ADV S, V19, P67; Swift A., 1999, FOSSILS RHAETIAN PEN; Therrien F, 2007, J VERTEBR PALEONTOL, V27, P108, DOI 10.1671/0272-4634(2007)27[108:MTIBTY]2.0.CO;2; Thorne PM, 2011, P NATL ACAD SCI USA, V108, P8339, DOI 10.1073/pnas.1018959108; Yin Gongzheng, 2000, Geology Geochemistry, V28, P1	53	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194742	10.1371/journal.pone.0194742	http://dx.doi.org/10.1371/journal.pone.0194742			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630618	Green Submitted, Green Published, gold			2022-12-26	WOS:000429505000016
J	Jang, H; Elaish, M; Mahesh, KC; Abundo, MC; Ghorbani, A; Ngunjiri, JM; Lee, CW				Jang, Hyesun; Elaish, Mohamed; Mahesh, K. C.; Abundo, Michael C.; Ghorbani, Amir; Ngunjiri, John M.; Lee, Chang-Won			Efficacy and synergy of live-attenuated and inactivated influenza vaccines in young chickens	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSES; AVIAN INFLUENZA; VIRUS; PROTECTION; VACCINATION; H5; INFECTION; REPLICATION; INDUCTION; CHILDREN	Outbreaks of novel highly pathogenic avian influenza viruses have been reported in poultry species in the United States since 2014. These outbreaks have proven the limitations of bio-security control programs, and new tools are needed to reinforce the current avian influenza control arsenal. Some enzootic countries have implemented inactivated influenza vaccine (IIV) in their control programs, but there are serious concerns that a long-term use of IIV without eradication may result in the selection of novel antigenically divergent strains. A broadly protective vaccine is needed, such as live-attenuated influenza vaccine (LAIV). We showed in our previous studies that pc4-LAIV (a variant that encodes a C-terminally truncated NS1 protein) can provide significant protection against heterologous challenge virus in chickens vaccinated at 2-4 weeks of age through upregulation of innate and adaptive immune responses. The current study was conducted to compare the performances of pc4-LAIV and IIV in young chickens vaccinated at 1 day of age. A single dose of pc4-LAIV was able to induce stronger innate and mucosal IgA responses and protect young immunologically immature chickens better than a single dose of IIV. Most importantly, when 1-day-old chickens were intranasally primed with pc4-LAIV and subcutaneously boosted with IIV three weeks later, they showed a rapid, robust, and highly cross-reactive serum antibody response and a high level of mucosal IgA antibody response. This vaccination regimen warrants further optimization to increase its range of protection.	[Jang, Hyesun; Elaish, Mohamed; Mahesh, K. C.; Abundo, Michael C.; Ghorbani, Amir; Ngunjiri, John M.; Lee, Chang-Won] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA; [Jang, Hyesun; Mahesh, K. C.; Abundo, Michael C.; Ghorbani, Amir; Lee, Chang-Won] Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ngunjiri, JM; Lee, CW (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA.; Lee, CW (corresponding author), Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Columbus, OH 43210 USA.	ngunjiri.1@osu.edu; iee.2854@osu.edu	Ngunjiri, John/AAB-3798-2021; Jang, Hyesun/AAG-7814-2021; Elaish, Mohamed/AAT-4642-2020	Ngunjiri, John/0000-0002-2131-1698; Jang, Hyesun/0000-0002-8142-8222; Ghorbani, Amir/0000-0001-8511-1727; Elaish, Mohamed/0000-0003-3628-5856	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2013-67015-20476]; Doctoral SEEDS Grant from the Ohio Agricultural Research and Development Center [OHOA1006]	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; Doctoral SEEDS Grant from the Ohio Agricultural Research and Development Center	This work was supported by Agriculture and Food Research Initiative Competitive Grant no. 2013-67015-20476 from the USDA National Institute of Food and Agriculture; Doctoral SEEDS Grant no. OHOA1006 from the Ohio Agricultural Research and Development Center.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Ambrose CS, 2012, VACCINE, V30, P886, DOI 10.1016/j.vaccine.2011.11.104; Apanius V., 1998, AVIAN GROWTH DEV EVO; ARCHETTI I, 1950, J EXP MED, V92, P441, DOI 10.1084/jem.92.5.441; Awad F, 2016, AVIAN PATHOL, V45, P169, DOI 10.1080/03079457.2015.1137866; Barria MI, 2013, J INFECT DIS, V207, P115, DOI 10.1093/infdis/jis641; Basuno E, 2010, TRANSBOUND EMERG DIS, V57, P7, DOI 10.1111/j.1865-1682.2010.01121.x; Brown DM, 2006, J IMMUNOL, V177, P2888, DOI 10.4049/jimmunol.177.5.2888; Capua I, 2002, ACTA TROP, V83, P7, DOI 10.1016/S0001-706X(02)00057-8; Capua I, 2006, EMERG INFECT DIS, V12, P1319, DOI 10.3201/eid1209.060430; CDC, AV INFL CURR SIT SUM; Chen GL, 2011, P NATL ACAD SCI USA, V108, P1140, DOI 10.1073/pnas.1009908108; Demirjian A, 2009, EUR J IMMUNOL, V39, P36, DOI 10.1002/eji.200838620; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Elaish M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171174; *FAO, 2007, GLOB STRAT PREV CONT; Forrest BD, 2008, CLIN VACCINE IMMUNOL, V15, P1042, DOI 10.1128/CVI.00397-07; FROMMER A, 1994, AVIAN PATHOL, V23, P425, DOI 10.1080/03079459408419013; Ganapathy K, 2005, AVIAN PATHOL, V34, P248, DOI 10.1080/03079450500112344; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; GHENDON Y, 1990, ACTA VIROL, V34, P295; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; He XS, 2006, J VIROL, V80, P11756, DOI 10.1128/JVI.01460-06; Hoft DF, 2017, CLIN VACCINE IMMUNOL, V24, DOI [10.1128/cvi.00414-16, 10.1128/CVI.00414-16]; Hoft DF, 2011, J INFECT DIS, V204, P845, DOI 10.1093/infdis/jir436; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Hsu SM, 2010, AVIAN DIS, V54, P1197, DOI 10.1637/9305-031710-Reg.1; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Jang H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156603; Jang H, 2013, POULTRY SCI, V92, P2290, DOI 10.3382/ps.2013-03116; Jang YH, 2012, J VIROL, V86, P5953, DOI 10.1128/JVI.07149-11; Kapczynski DR, 2014, METHODS MOL BIOL, V1161, P217, DOI 10.1007/978-1-4939-0758-8_18; Lau YF, 2011, J VIROL, V85, P76, DOI 10.1128/JVI.01564-10; Lee Chang-Won, 2005, Animal Health Research Reviews, V6, P1, DOI 10.1079/AHR2005101; Lee CW, 2004, J VIROL METHODS, V119, P151, DOI 10.1016/j.jviromet.2004.03.014; Lee MS, 2004, EMERG INFECT DIS, V10, P1385, DOI 10.3201/eid1008.040107; Lorenzo MMG, 2013, CHEST, V143, P502, DOI 10.1378/chest.12-1711; Marcus PI, 2010, J VIROL, V84, P10974, DOI 10.1128/JVI.00502-10; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Meng SS, 2011, J INTERF CYTOK RES, V31, P533, DOI 10.1089/jir.2010.0123; Ngunjiri JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118934; OIE, 2012, MANUAL DIAGNOSTIC TE; Pawar SD, 2015, J VIROL METHODS, V222, P28, DOI 10.1016/j.jviromet.2015.05.004; Pitisuttithum P, 2017, LANCET INFECT DIS, V17, P833, DOI [10.1016/S1473-3099(17)30240-2, 10.1016/s1473-3099(17)30240-2]; RICE JT, 1979, POULTRY SCI, V58, P18, DOI 10.3382/ps.0580018; Richt JA, 2009, CURR TOP MICROBIOL, V333, P177, DOI 10.1007/978-3-540-92165-3_9; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Sridhar S, 2015, VACCINES, V3, P373, DOI 10.3390/vaccines3020373; Suarez DL, 2017, VET MICROBIOL, V206, P144, DOI 10.1016/j.vetmic.2016.11.025; Suarez David L., 2010, Animal Health Research Reviews, V11, P19, DOI 10.1017/S1466252310000095; Suarez DL, 2006, DEV BIOLOGICALS, V124, P117; Swayne DE, 2009, COMP IMMUNOL MICROB, V32, P351, DOI 10.1016/j.cimid.2008.01.006; Swayne DE, 2000, AVIAN DIS, V44, P132, DOI 10.2307/1592516; Talaat KR, 2014, J INFECT DIS, V209, P1860, DOI 10.1093/infdis/jiu123; Talon J, 2000, P NATL ACAD SCI USA, V97, P4309, DOI 10.1073/pnas.070525997; To KKW, 2012, CLIN VACCINE IMMUNOL, V19, P1012, DOI 10.1128/CVI.00081-12; Topham DJ, 1996, J VIROL, V70, P1288, DOI 10.1128/JVI.70.2.1288-1291.1996; Toro H, 2009, POULTRY SCI, V88, P867, DOI 10.3382/ps.2008-00333; Toro H, 2010, AVIAN DIS, V54, P224, DOI 10.1637/8773-033109-Reg.1; USDA, AVIAN INFLUENZA; van Ginkel FW, 2015, VACCINE, V33, P2655, DOI 10.1016/j.vaccine.2015.04.026; Vijaykrishna D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000161; Wang L, 2008, VACCINE, V26, P3580, DOI 10.1016/j.vaccine.2008.05.001; Wang LY, 2010, AVIAN DIS, V54, P297, DOI 10.1637/8623-012309-ResNote.1; Wu DL, 2015, SCI REP-UK, V5, DOI 10.1038/srep07630; Zhu W, 2017, INT J MOL SCI, V18	68	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195285	10.1371/journal.pone.0195285	http://dx.doi.org/10.1371/journal.pone.0195285			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624615	Green Published, gold, Green Submitted			2022-12-26	WOS:000429379600023
J	Vading, M; Naucler, P; Kalin, M; Giske, CG				Vading, M.; Naucler, P.; Kalin, M.; Giske, C. G.			Invasive infection caused by Klebsiella pneumoniae is a disease affecting patients with high comorbidity and associated with high long-term mortality	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; RISK-FACTORS; BACTEREMIA; COMMUNITY; EPIDEMIOLOGY; OUTCOMES; IMPACT	Klebsiella pneumoniae (KP) is after Escherichia coli (EC) the most common gram-negative species causing invasive infections. Herein, we analyzed risk factors and prognosis in invasive infections caused by KP versus EC, in an area with low antimicrobial resistance. Moreover, we compared antimicrobial resistance and relative prevalence of KP and EC (KP/ECratio) in different European countries, using EARS-Net data. Adult patients admitted to Karolinska University Hospital 2006-2012 with invasive infection caused by KP (n = 599) were matched regarding sex and age with patients infected by EC. The medical records were retrospectively reviewed. Comorbidity was adjusted for with multivariable analysis. European data were retrieved from the EARS-Net database. No differences were observed in 7- and 30-day mortality between the groups. The 90-day mortality was significantly higher in the KP cohort (26% versus 17%, p<0.001), but not after adjusting for comorbidity. Malignancy was seen in 53% of the patients with KP versus 38% with EC, OR 1.86 (1.34-2.58). A significant increase in the rate of ESBL-production was observed in EC, but not in KP. The KP/EC-ratio remained stable. In contrast, European data showed increasing percentages of isolates non-susceptible to third-generation cephalosporins in EC and KP, and increasing KP/EC-ratio. Invasive infection caused by KP is a disease affecting patients with high comorbidity and associated with high 90-d mortality. The stable KP/EC-ratio and low occurrence of anti-microbial resistance in data from Karolinska University Hospital compared to aggregate data from 20 EARS-Net countries could be related to absence of clonal spread of multidrug-resistant KP.	[Vading, M.; Giske, C. G.] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Vading, M.] Danderyd Hosp, Dept Infect Dis, Stockholm, Sweden; [Naucler, P.] Karolinska Univ Hosp Solna, Dept Infect Dis, Stockholm, Sweden; [Naucler, P.; Kalin, M.] Karolinska Inst, Infect Dis Unit, Dept Med Solna, Stockholm, Sweden; [Giske, C. G.] Karolinska Univ Hosp Solna, Dept Clin Microbiol, Stockholm, Sweden	Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Vading, M (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden.; Vading, M (corresponding author), Danderyd Hosp, Dept Infect Dis, Stockholm, Sweden.	malin.vading@sll.se		Vading, Malin/0000-0003-4221-8828	European Society for Clinical Microbiology and Infectious diseases (ESCMID)	European Society for Clinical Microbiology and Infectious diseases (ESCMID)	The study was supported by a grant from the European Society for Clinical Microbiology and Infectious diseases (ESCMID).	Anderson DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091713; Breurec S, 2013, CLIN MICROBIOL INFEC, V19, P349, DOI 10.1111/j.1469-0691.2012.03805.x; Brisse S, 2014, INT J SYSTEMATIC EVO; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; ECDC, 2015, ANN REPORT EUROPEAN; ECDC. European Center for Disease Control and Prevention, 2015, EARS NET REP PROT; EUCAST, 2013, EUCAST GUID DET RES; Hansen DS, 1998, J HOSP INFECT, V38, P119, DOI 10.1016/S0195-6701(98)90065-2; Iredell J, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6420; Jung Y, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-239; Kang CI, 2006, J KOREAN MED SCI, V21, P816, DOI 10.3346/jkms.2006.21.5.816; Kanoksil M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054714; Kjellander C, 2012, EUR J HAEMATOL, V88, P422, DOI 10.1111/j.1600-0609.2012.01768.x; Laupland KB, 2008, CLIN MICROBIOL INFEC, V14, P1041, DOI 10.1111/j.1469-0691.2008.02089.x; Maatallah M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113539; Marra AR, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-24; Meatherall BL, 2009, AM J MED, V122, P866, DOI 10.1016/j.amjmed.2009.03.034; Moon HW, 2014, J MED MICROBIOL, V63, P421, DOI 10.1099/jmm.0.069054-0; Olsson-Liljequist B, 1997, SCAND J INFECT DIS, P13; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Rodrigues C, 2014, INT J MED MICROBIOL, V304, P1100, DOI 10.1016/j.ijmm.2014.08.003; Thom KA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-116; Tsai Sung-Sheng, 2010, Chang Gung Med J, V33, P532; Tsay RW, 2002, ARCH INTERN MED, V162, P1021, DOI 10.1001/archinte.162.9.1021; Tuon FF, 2011, BRAZ J INFECT DIS, V15, P594, DOI 10.1590/S1413-86702011000600016; Wang JH, 1998, CLIN INFECT DIS, V26, P1434, DOI 10.1086/516369; Wang L S, 1990, J Formos Med Assoc, V89, P756; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Yinnon AM, 1996, QJM-MON J ASSOC PHYS, V89, P933	30	41	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195258	10.1371/journal.pone.0195258	http://dx.doi.org/10.1371/journal.pone.0195258			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624618	gold, Green Submitted, Green Published			2022-12-26	WOS:000429379600022
J	Baker, AD; Leberg, PL				Baker, Angela Darnell; Leberg, Paul L.			Impacts of human recreation on carnivores in protected areas	PLOS ONE			English	Article							HUMAN DISTURBANCE; MAMMALIAN CARNIVORES; WILDLIFE RESPONSES; EXTINCTION RISK; NORTH-AMERICA; NATIONAL-PARK; TOP PREDATORS; ROADS; CONSERVATION; FOREST	Mammalian carnivores can be particularly sensitive to human disturbance, even within protected areas (PAs). Our objective was to understand how human disturbance affects carnivore communities in southern Arizona, USA by studying habitat occupancy based on data collected using non-invasive methods in three PAs with different levels of human disturbance. Carnivore occupancy varied based on human disturbance variables (i.e., roads, trails, etc.). Common carnivore species (coyotes, gray foxes, and bobcats) had high occupancy probability in highly disturbed sites, while all other carnivore species had a higher probability of occupancy in low disturbance protected areas. Additionally, overall carnivore diversity was higher in PAs with low human disturbance. Edges of PAs appeared to negatively impact occupancy of nearly all carnivore species. We also found the presence of roads and trails, and not necessarily how much they are used, had a significant negative impact on the occupancy of most carnivore species. Furthermore, the overall level of disturbance within a PA influenced how sensitive carnivores were to human disturbance variables. Carnivores were more sensitive in PAs with higher levels of disturbance and were relatively unaffected by disturbance variables in a PA with low base levels of disturbance. Increased visitation to PAs, expected with the region's high level of population growth, is likely to cause shifts in the carnivore communities favoring species that are less sensitive to disturbance.	[Baker, Angela Darnell; Leberg, Paul L.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA; [Baker, Angela Darnell] Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA	University of Louisiana Lafayette; California State University System; California State Polytechnic University, Humboldt	Baker, AD (corresponding author), Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA.; Baker, AD (corresponding author), Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA.	ange.baker.darnell@gmail.com	Shen, Mason/ABC-9871-2020	Darnell Baker, Ange/0000-0003-1419-3248	Graduate Student Organization at the University of Louisiana at Lafayette	Graduate Student Organization at the University of Louisiana at Lafayette	Funding was provided by the Graduate Student Organization at the University of Louisiana at Lafayette and from generous donors facilitated through InstrumentI Crowdfunding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDESSI L, 1994, ECOL APPL, V4, P786, DOI 10.2307/1942008; Bidlack Allison, 2007, THESIS; Blom A, 2005, ORYX, V39, P381, DOI 10.1017/S0030605305001080; BOWERS MA, 1982, ECOLOGY, V63, P391, DOI 10.2307/1938957; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burton AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038007; Cahalane VH., 1941, J MAMMAL, V20, P418; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Carroll C, 2001, ECOL APPL, V11, P961, DOI 10.1890/1051-0761(2001)011[0961:CAFSFC]2.0.CO;2; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Cusack JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126373; Davies M. L., 2010, ANIMAL CONSERVATION, V14, P56; Dickson BG, 2002, J WILDLIFE MANAGE, V66, P1235, DOI 10.2307/3802956; Dillon A, 2007, ORYX, V41, P469, DOI 10.1017/S0030605307000518; Duchesne M, 2000, BIOL CONSERV, V96, P311, DOI 10.1016/S0006-3207(00)00082-3; Dunstan CE, 1996, J BIOGEOGR, V23, P187, DOI 10.1046/j.1365-2699.1996.d01-220.x; Farris ZJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136456; Fedriani JM, 2000, OECOLOGIA, V125, P258, DOI 10.1007/s004420000448; FERRERAS P, 1992, BIOL CONSERV, V61, P197, DOI 10.1016/0006-3207(92)91116-A; Floren A, 2001, ECOGRAPHY, V24, P547, DOI 10.1034/j.1600-0587.2001.d01-210.x; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; FREDDY DJ, 1986, WILDLIFE SOC B, V14, P63; Frid A, 2002, CONSERV ECOL, V6; Gittleman John L., 2005, P370; Gompper ME, 2006, WILDLIFE SOC B, V34, P1142, DOI 10.2193/0091-7648(2006)34[1142:ACONTT]2.0.CO;2; Gucinski H., 2001, PNWGTR509 USDA FOR S; Harmsen BJ, 2010, BIOTROPICA, V42, P126, DOI 10.1111/j.1744-7429.2009.00544.x; Hass CC, 2009, J ZOOL, V278, P174, DOI 10.1111/j.1469-7998.2009.00565.x; Hines JE, 2010, ECOL APPL, V20, P1456, DOI 10.1890/09-0321.1; Hines J.E., 2013, PRESENCE SOFTWARE ES; IUCN, PROT AR AB 2008; Karanth KK, 2009, J APPL ECOL, V46, P1189, DOI 10.1111/j.1365-2664.2009.01710.x; Kays R, 2016, J APPL ECOLOGY; Kerley LL, 2002, CONSERV BIOL, V16, P97, DOI 10.1046/j.1523-1739.2002.99290.x; KING M M, 1986, Transactions of the North American Wildlife and Natural Resources Conference, P74; Kitchen AM, 1999, CAN J ZOOL, V77, P1645, DOI 10.1139/cjz-77-10-1645; Kramer-Schadt S, 2004, J APPL ECOL, V41, P711, DOI 10.1111/j.0021-8901.2004.00933.x; Larson CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167259; Lesmeister DB, 2015, WILDLIFE MONOGR, V191, P1, DOI 10.1002/wmon.1015; Long RA, 2008, NONINVASIVE SURVEY M; MacKenzie D.I., 2005, OCCUPANCY ESTIMATION; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MacKenzie DI, PRESENCE USER MANUAL; MAEHR DS, 1995, CONSERV BIOL, V9, P1008, DOI 10.1111/j.1523-1739.2005.00286.x-i1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Martin J, 2010, CAN J ZOOL, V88, P875, DOI 10.1139/Z10-053; Miller SG, 2001, WILDLIFE SOC B, V29, P124; National Park Service [NPS], VIS US STA 2016; National Park Service [NPS], ORG PIP CACT NAT MON; National Park Service [NPS], SAG NAT PARK 2016; NEE S, 1992, J ANIM ECOL, V61, P37, DOI 10.2307/5506; Ngoprasert D, 2007, ORYX, V41, P343, DOI 10.1017/S0030605307001102; Ordenana MA, 2010, J MAMMAL, V91, P1322, DOI 10.1644/09-MAMM-A-312.1; Papouchis CM, 2001, J WILDLIFE MANAGE, V65, P573, DOI 10.2307/3803110; Paviolo A, 2009, J MAMMAL, V90, P926, DOI 10.1644/08-MAMM-A-128.1; Pirie TJ, 2016, WILDLIFE BIOL, V22, P13, DOI 10.2981/wlb.00129; Prange S, 2004, CAN J ZOOL, V82, P1804, DOI 10.1139/Z04-179; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Ray J. C., 2005, LARGE CARNIVORES CON; Reed SE, 2011, SOUTHWEST NAT, V56, P231, DOI 10.1894/F13-JKF-14.1; Reed SE, 2008, CONSERV LETT, V1, P146, DOI 10.1111/j.1755-263X.2008.00019.x; Riley SPD, 2006, J WILDLIFE MANAGE, V70, P1425, DOI 10.2193/0022-541X(2006)70[1425:SEOBAG]2.0.CO;2; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Schuette P, 2013, BIOL CONSERV, V158, P301, DOI 10.1016/j.biocon.2012.08.008; Sergio F, 2006, J APPL ECOL, V43, P1049, DOI 10.1111/j.1365-2664.2006.01218.x; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Taylor AR, 2003, ECOL APPL, V13, P951, DOI 10.1890/1051-0761(2003)13[951:WRTRAA]2.0.CO;2; Terborgh J., 1999, CONTINENTAL CONSERVA; THURBER JM, 1994, WILDLIFE SOC B, V22, P61; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; United States Forest Service [USFS], NAT VIS US MON PROGR; VANDYKE FG, 1986, J WILDLIFE MANAGE, V50, P95; Vanthomme H, 2013, CONSERV BIOL, V27, P281, DOI 10.1111/cobi.12017; Wang YW, 2015, BIOL CONSERV, V190, P23, DOI 10.1016/j.biocon.2015.05.007; Western Regional Climate Center [WRCC], AR CLIM SUMM 1981 20; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Zielinski W.J., 1995, PSWGTR157 USDA FOR S PSWGTR157 USDA FOR S; [No title captured]	82	18	19	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195436	10.1371/journal.pone.0195436	http://dx.doi.org/10.1371/journal.pone.0195436			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621335	gold, Green Submitted, Green Published			2022-12-26	WOS:000429206800081
J	Christensen, KA; Leong, JS; Sakhrani, D; Biagi, CA; Minkley, DR; Withler, RE; Rondeau, EB; Koop, BF; Devlin, RH				Christensen, Kris A.; Leong, Jong S.; Sakhrani, Dionne; Biagi, Carlo A.; Minkley, David R.; Withler, Ruth E.; Rondeau, Eric B.; Koop, Ben F.; Devlin, Robert H.			Chinook salmon (Oncorhynchus tshawytscha) genome and transcriptome	PLOS ONE			English	Article							LINKAGE MAP; SOFTWARE; PLATFORM; DATABASE	When unifying genomic resources among studies and comparing data between species, there is often no better resource than a genome sequence. Having a reference genome for the Chinook salmon (Oncorhynchus tshawytscha) will enable the extensive genomic resources available for Pacific salmon, Atlantic salmon, and rainbow trout to be leveraged when asking questions related to the Chinook salmon. The Chinook salmon's wide distribution, long cultural impact, evolutionary history, substantial hatchery production, and recent wild-population decline make it an important research species. In this study, we sequenced and assembled the genome of a Chilliwack River Hatchery female Chinook salmon (gynogenetic and homozygous at all loci). With a reference genome sequence, new questions can be asked about the nature of this species, and its role in a rapidly changing world.	[Christensen, Kris A.; Sakhrani, Dionne; Biagi, Carlo A.; Devlin, Robert H.] Fisheries & Oceans Canada, W Vancouver, BC, Canada; [Christensen, Kris A.; Leong, Jong S.; Minkley, David R.; Rondeau, Eric B.; Koop, Ben F.] Univ Victoria, Victoria, BC, Canada; [Withler, Ruth E.] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC, Canada	Fisheries & Oceans Canada; University of Victoria; Fisheries & Oceans Canada	Christensen, KA (corresponding author), Fisheries & Oceans Canada, W Vancouver, BC, Canada.; Christensen, KA (corresponding author), Univ Victoria, Victoria, BC, Canada.	kris.christensen@wsu.edu	Biagi, Carlo/AAN-2030-2020; Koop, Ben F./A-8151-2008	Biagi, Carlo/0000-0002-6345-9674; Koop, Ben F./0000-0003-0045-5200; Christensen, Kristen/0000-0003-0021-0326; Leong, Jong/0000-0001-6521-9239	Fisheries and Oceans Canada; Canadian Regulatory System for Biotechnology; DFO Salmonid Enhancement Program Chilliwack River Hatchery; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; ministere de l'Economie, de la science et de l'innovation du Quebec; Fonds de recherche du Quebec-Nature et technologies	Fisheries and Oceans Canada; Canadian Regulatory System for Biotechnology; DFO Salmonid Enhancement Program Chilliwack River Hatchery; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); ministere de l'Economie, de la science et de l'innovation du Quebec; Fonds de recherche du Quebec-Nature et technologies	The authors appreciate support from Fisheries and Oceans Canada, the Canadian Regulatory System for Biotechnology, and from the DFO Salmonid Enhancement Program Chilliwack River Hatchery. BK received funding in the form of the grant "Salmonid Genome Duplication Drives Specialization and Adaptation" from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the McGill University and Genome Quebec Innovation Centre for their services in preparing the various sequencing libraries and performing the sequencing. Thank you to Compute Canada (www.computecanada.ca), the Centre for Advanced Computing (http://cac.queensu.ca/), Calcul Quebec (MP2 server, operation of MP2 was funded by the Canada Foundation for Innovation, the ministere de l'Economie, de la science et de l'innovation du Quebec and the Fonds de recherche du Quebec-Nature et technologies) for computational resources. We would also like to thank Fisheries and Oceans Canada and the University of Victoria for the facilities and personnel. Thanks to MBD Education & Training Services for editing the manuscript. Finally, we would like to thank the two anonymous reviewers for their valuable comments.	Allendorf F.W., 1984, P1; Allendorf FW, 2015, J HERED, V106, P217, DOI 10.1093/jhered/esv015; Andrews S., 2016, BABRAHAM BIOINFORMAT; Angeloni F, 2012, EVOL APPL, V5, P130, DOI 10.1111/j.1752-4571.2011.00217.x; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2017, PACIFIC BIOSCIENCES; [Anonymous], 2013, R10 US EPA; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Barria A, 2018, G3 GENES GENOME 0213; Behnke R., 2002, TROUT SALMON N AM, P25; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; Brieuc MSO, 2014, G3-GENES GENOM GENET, V4, P447, DOI 10.1534/g3.113.009316; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chasco BE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14984-8; Ciancio JE, 2015, BIOL INVASIONS, V17, P2989, DOI 10.1007/s10530-015-0928-x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Flutre T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016526; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gutierrez AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119730; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; HEALEY MC, 1998, PACIFIC SALMON LIFE, P311; Heard William R., 2007, North Pacific Anadromous Fish Commission Bulletin, V4, P77; Hecht BC, 2015, MOL ECOL, V24, P5573, DOI 10.1111/mec.13409; Hubley R., 2013, REPEATMASKER OPEN 40; Irvine JR, 2011, ICES J MAR SCI, V68, P1122, DOI 10.1093/icesjms/fsq199; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khan S, 2016, INT J GENOMICS; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Krzywinski MI, 2009, GENOME RES; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li H., 2013, QUANT BIOL; Lien S, 2016, NATURE, V533, P200, DOI 10.1038/nature17164; Macqueen DJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2881; Mantua NJ, 2015, NAT CLIM CHANGE, V5, P613, DOI 10.1038/nclimate2670; McKinley KL, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.5; McKinney GJ, 2016, MOL ECOL RESOUR, V16, P769, DOI 10.1111/1755-0998.12479; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Qin Yuxue, 2016, North Pacific Anadromous Fish Commission Bulletin, P469, DOI 10.23849/npafcb6/469.481; QUILLET E, 1991, J EXP ZOOL, V257, P367, DOI 10.1002/jez.1402570310; Salzberg SL, 2005, BIOINFORMATICS, V21, P4320, DOI 10.1093/bioinformatics/bti769; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Smit A, 2013, REPEATMODELER OPEN 1; Soderlund C, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr123; Sutherland BJG, 2016, GENOME BIOL EVOL, V8, P3600, DOI 10.1093/gbe/evw262; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WILLSON MF, 1995, CONSERV BIOL, V9, P489, DOI 10.1046/j.1523-1739.1995.09030489.x; Yue GH, 2014, FISH FISH, V15, P376, DOI 10.1111/faf.12020; Zhang H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06780	57	50	50	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195461	10.1371/journal.pone.0195461	http://dx.doi.org/10.1371/journal.pone.0195461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621340	Green Submitted, Green Published, gold			2022-12-26	WOS:000429206800088
J	Stynes, S; Konstantinou, K; Ogollah, R; Hay, EM; Dunn, KM				Stynes, Siobhan; Konstantinou, Kika; Ogollah, Reuben; Hay, Elaine M.; Dunn, Kate M.			Clinical diagnostic model for sciatica developed in primary care patients with low back-related leg pain	PLOS ONE			English	Article							PHYSICAL-EXAMINATION; DISC HERNIATION; HISTORY; DEFINITIONS; PROGNOSIS; SYMPTOMS	Background Identification of sciatica may assist timely management but can be challenging in clinical practice. Diagnostic models to identify sciatica have mainly been developed in secondary care settings with conflicting reference standard selection. This study explores the challenges of reference standard selection and aims to ascertain which combination of clinical assessment items best identify sciatica in people seeking primary healthcare. Methods Data on 394 low back-related leg pain consulters were analysed. Potential sciatica indicators were seven clinical assessment items. Two reference standards were used: (i) high confidence sciatica clinical diagnosis; (ii) high confidence sciatica clinical diagnosis with confirmatory magnetic resonance imaging findings. Multivariable logistic regression models were produced for both reference standards. A tool predicting sciatica diagnosis in low back-related leg pain was derived. Latent class modelling explored the validity of the reference standard. Results Model (i) retained five items; model (ii) retained six items. Four items remained in both models: below knee pain, leg pain worse than back pain, positive neural tension tests and neurological deficit. Model (i) was well calibrated (p = 0.18), discrimination was area under the receiver operating characteristic curve (AUC) 0.95 (95% CI 0.93, 0.98). Model (ii) showed good discrimination (AUC 0.82; 0.78, 0.86) but poor calibration (p = 0.004). Bootstrapping revealed minimal overfitting in both models. Agreement between the two latent classes and clinical diagnosis groups defined by model (i) was substantial, and fair for model (ii). Conclusion Four clinical assessment items were common in both reference standard definitions of sciatica. A simple scoring tool for identifying sciatica was developed. These criteria could be used clinically and in research to improve accuracy of identification of this subgroup of back pain patients.	[Stynes, Siobhan; Konstantinou, Kika; Ogollah, Reuben; Hay, Elaine M.; Dunn, Kate M.] Keele Univ, Res Inst Primary Care & Hlth Sci, Arthrit Res UK Primary Care Ctr, Keele, Staffs, England	Keele University	Stynes, S (corresponding author), Keele Univ, Res Inst Primary Care & Hlth Sci, Arthrit Res UK Primary Care Ctr, Keele, Staffs, England.	s.stynes@keele.ac.uk		Ogollah, Reuben/0000-0002-5777-4117	National Institute for Health Research/Chief Nursing Officer Clinical Doctoral Research Fellowship [CDRF-2010055]; Higher Education Funding Council for England/National Institute for Health Research Senior Clinical Lectureship	National Institute for Health Research/Chief Nursing Officer Clinical Doctoral Research Fellowship; Higher Education Funding Council for England/National Institute for Health Research Senior Clinical Lectureship	SS was supported by an National Institute for Health Research/Chief Nursing Officer Clinical Doctoral Research Fellowship (CDRF-2010055). KK was supported by a Higher Education Funding Council for England/National Institute for Health Research Senior Clinical Lectureship. EMH is an National Institute for Health Research Senior Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Nezari NH, 2013, SPINE J, V13, P657, DOI 10.1016/j.spinee.2013.02.007; Austin PC, 2014, STAT MED, V33, P517, DOI 10.1002/sim.5941; Beattie PF, 2000, SPINE, V25, P819, DOI 10.1097/00007632-200004010-00010; Bogduk N, 2009, PAIN, V147, P17, DOI 10.1016/j.pain.2009.08.020; Coggon D, 2005, INT J EPIDEMIOL, V34, P949, DOI 10.1093/ije/dyi012; Coster S, 2010, J NEUROL, V257, P332, DOI 10.1007/s00415-009-5316-y; Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94; Dunn K. M., 2010, PRIM HEALTH CARE RES, V11, P93, DOI DOI 10.1017/S1463423609990296; Genevay S, 2010, SPINE, V35, P803, DOI 10.1097/BRS.0b013e3181bc9454; Hill JC, 2011, SPINE, V36, P2168, DOI 10.1097/BRS.0b013e31820712bb; HOSMER DW, 2000, WILEY PS TX, P1; Iversen T, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-206; JENSEN MC, 1994, MAGN RESON QUART, V10, P173; Karppinen J, 2001, Spine (Phila Pa 1976), V26, pE149, DOI 10.1097/00007632-200104010-00015; Knottnerus JA., 2002, EVIDENCE BASE CLIN D; Kongsted A, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-171; Konstantinou K, 2012, EUR SPINE J, V21, P2306, DOI 10.1007/s00586-012-2398-5; Konstantinou K, 2012, EUR SPINE J, V21, P1241, DOI 10.1007/s00586-011-2057-2; Konstantinou K, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-4; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lin CWC, 2014, EUR J PAIN, V18, P455, DOI 10.1002/j.1532-2149.2013.00384.x; Mathieson S, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-213; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; PATRICK DL, 1995, SPINE, V20, P1899, DOI 10.1097/00007632-199509000-00011; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Reitsma JB, 2009, J CLIN EPIDEMIOL, V62, P797, DOI 10.1016/j.jclinepi.2009.02.005; Shultz S, 2015, MANUAL THER, V20, P18, DOI 10.1016/j.math.2014.08.002; Steyerberg E., 2009, CLIN PREDICTION MODE; Stynes S, 2016, BMC MUSCULOSKEL DIS, V17, P1; Stynes S, 2016, EUR SPINE J, V25, P2734, DOI 10.1007/s00586-015-4359-2; Suarthana E, 2010, J CLIN EPIDEMIOL, V63, P1011, DOI 10.1016/j.jclinepi.2009.10.008; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; van der Windt DAWM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007431.pub2; van Smeden M, 2014, AM J EPIDEMIOL, V179, P423, DOI 10.1093/aje/kwt286; Verwoerd AJH, 2014, SPINE J, V14, P2028, DOI 10.1016/j.spinee.2013.11.049; Vroomen PCAJ, 2002, J NEUROL NEUROSUR PS, V72, P630, DOI 10.1136/jnnp.72.5.630; Vroomen PCAJ, 1999, J NEUROL, V246, P899, DOI 10.1007/s004150050480; Vucetic N, 1999, CLIN ORTHOP RELAT R, P116; Worster A, 2008, CAN J EMERG MED, V10, P174	40	19	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0191852	10.1371/journal.pone.0191852	http://dx.doi.org/10.1371/journal.pone.0191852			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621243	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000429206800001
J	Hinkley, T; Brown, H; Carson, V; Teychenne, M				Hinkley, Trina; Brown, Helen; Carson, Valerie; Teychenne, Megan			Cross sectional associations of screen time and outdoor play with social skills in preschool children	PLOS ONE			English	Article							BEHAVIOR INVENTORY ASBI; PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; EARLY-CHILDHOOD; TELEVISION EXPOSURE; SLEEP DURATION; EMOTIONAL COMPETENCE; GENDER-DIFFERENCES; COMPUTER GAME; LOW-INCOME	Screen time and physical activity behaviours develop during the crucial early childhood period (0-5 years) and impact multiple health and developmental outcomes, including psychosocial wellbeing. Social skills, one component of psychosocial wellbeing, are vital for children's school readiness and future mental health. This study investigates potential associations of screen time and outdoor play (as a proxy for physical activity) with social skills. Cross sectional data were available for 575 mothers with a child (54% boys) aged 2-5 years. Mothers reported their child's screen time, outdoor play time and social skills (Adaptive Social Behavior Inventory; ASBI). Multiple linear regression analyses assessed associations of screen and outdoor play time (Model 1) and compliance with screen time and physical activity recommendations (Model 2) with three ASBI subscales. Boys and girls spent a mean of 2.0 and 2.2 hours per day in screen time, and 3.3 and 2.9 hours per day in outdoor play, respectively. Girls scores for express and comply skills were significantly higher than boys (p<0.005). After applying the Benjamini-Hochberg Procedure to adjust for multiple associations, children's television/DVD/video viewing was inversely associated with their compliant scores (B=-0.35 95% CI-0.26,-0.14; p=0.001) and outdoor play time was positively associated with both expressive (B=0.20 95% CI 0.07, 0.34; p=0.004) and compliant (B=0.22 95% CI 0.08, 0.36; p=0.002) scores. Findings indicate that television/DVD/video viewing may be adversely, and outdoor play favourably, associated with preschool children's social skills. Future research is required to identify the direction of causation and explore potential mechanisms of association.	[Hinkley, Trina; Brown, Helen; Teychenne, Megan] Deakin Univ, Inst Phys Act & Nutr, Burwood, Vic, Australia; [Carson, Valerie] Univ Alberta, Fac Phys Educ & Recreat, Edmonton, AB, Canada	Deakin University; University of Alberta	Hinkley, T (corresponding author), Deakin Univ, Inst Phys Act & Nutr, Burwood, Vic, Australia.	think.research@outlook.com	Carson, Valerie/ABG-2853-2021; Brown, Helen/AAY-4382-2020	Carson, Valerie/0000-0002-3009-3282; Hinkley, Trina/0000-0003-2742-8579; Brown, Helen/0000-0002-5460-3654	National Health and Medical Research Council Early Career Fellowship [APP1070571]; Canadian Institutes of Health Research (CIHR) New Investigator Salary Award; School of Exercise and Nutrition Sciences, Deakin University	National Health and Medical Research Council Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research (CIHR) New Investigator Salary Award(Canadian Institutes of Health Research (CIHR)); School of Exercise and Nutrition Sciences, Deakin University	TH is supported by a National Health and Medical Research Council Early Career Fellowship (APP1070571); VC is supported by a Canadian Institutes of Health Research (CIHR) New Investigator Salary Award. The study was funded by the School of Exercise and Nutrition Sciences, Deakin University. Deakin University had no role in the study design; collection, analysis or interpretation of data; writing the report; or the decision to submit the report for publication.	Aasen W, 2009, EDUC 3-13, V37, P5, DOI 10.1080/03004270802291749; Australian Bureau of Statistics, 2015, 4442 0 FAM CHAR TRAN; Australian Bureau of Statistics, 2011, 2033 0 55 001 CENS P; Bailey R, 2009, RES PAP EDUC, V24, P1, DOI 10.1080/02671520701809817; Baker JK, 2007, AM J MENT RETARD, V112, P375, DOI 10.1352/0895-8017(2007)112[0375:POSSIY]2.0.CO;2; Barbour AC, 1999, EARLY CHILD RES Q, V14, P75, DOI 10.1016/S0885-2006(99)80007-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bingham DD, 2016, AM J PREV MED, V51, P384, DOI 10.1016/j.amepre.2016.04.022; Birch LL, 1998, PEDIATRICS, V101, P539; Brody GH, 1998, CHILD DEV, V69, P803, DOI 10.1111/j.1467-8624.1998.tb06244.x; Brody L. R., 2000, GENDER EMOTION SOCIA, V1st, P24, DOI [10.1017/CBO9780511628191.003, DOI 10.1017/CBO9780511628191.003]; Brody LR, 1997, J SOC ISSUES, V53, P369, DOI 10.1111/0022-4537.00022; Brown GL, 2015, PARENT-SCI PRACT, V15, P135, DOI 10.1080/15295192.2015.1053312; Brussoni M, 2015, INT J ENV RES PUB HE, V12, P6423, DOI 10.3390/ijerph120606423; Burdette HL, 2004, ARCH PEDIAT ADOL MED, V158, P353, DOI 10.1001/archpedi.158.4.353; Certain LK, 2002, PEDIATRICS, V109, P634, DOI 10.1542/peds.109.4.634; Cespedes EM, 2014, PEDIATRICS, V133, pE1163, DOI 10.1542/peds.2013-3998; Cheng SY, 2010, J EPIDEMIOL, V20, pS482, DOI 10.2188/jea.JE20090179; Christakis DA, 2014, JAMA PEDIATR, V168, P399, DOI 10.1001/jamapediatrics.2013.5081; Cliff DP, 2014, J SCI MED SPORT, V18; Conners-Burrow NA, 2011, EARLY EDUC DEV, V22, P256, DOI 10.1080/10409289.2011.550844; Demir M, 2012, J SOC PSYCHOL, V152, P379, DOI 10.1080/00224545.2011.591451; Denham S.A., 2006, EARLY EDUC DEV, V17, P57, DOI [10.1207/s15566935eed1701_4, DOI 10.1207/S15566935EED1701_4]; Department of Health, 2014, NAT PHYS ACT REC CHI; Diener ML, 2004, J CROSS CULT PSYCHOL, V35, P525, DOI 10.1177/0022022104268387; Durkin K, 2002, J APPL DEV PSYCHOL, V23, P373, DOI 10.1016/S0193-3973(02)00124-7; Dworak M, 2007, PEDIATRICS, V120, P978, DOI 10.1542/peds.2007-0476; Evans CA, 2011, J FAM ISSUES, V32, P1223, DOI 10.1177/0192513X11400558; Fivush R, 2000, SEX ROLES, V42, P233, DOI 10.1023/A:1007091207068; Gomes R. M., 2014, PSYCHOLOGY, V5, P99, DOI DOI 10.4236/PSYCH.2014.52015; Gray C, 2015, INT J ENV RES PUB HE, V12, P6455, DOI 10.3390/ijerph120606455; Green S, 2014, J INTELL DISABIL RES, V58, P691, DOI 10.1111/jir.12064; Greenfield DB, 1997, J PSYCHOEDUC ASSESS, V15, P322, DOI 10.1177/073428299701500404; Griswold LA, 2012, AM J OCCUP THER, V66, P709, DOI 10.5014/ajot.2012.004051; Hinkley T, 2008, AM J PREV MED, V34, P435, DOI 10.1016/j.amepre.2008.02.001; Hinkley T, 2014, PREV MED, V62, P182, DOI 10.1016/j.ypmed.2014.02.007; Hinkley T, 2014, JAMA PEDIATR, V168, P485, DOI 10.1001/jamapediatrics.2014.94; Hinkley T, 2012, J SCI MED SPORT, V15, P407, DOI 10.1016/j.jsams.2011.12.009; HOGAN AE, 1992, J PSYCHOEDUC ASSESS, V10, P230, DOI 10.1177/073428299201000303; Intusoma U, 2013, INFANT BEHAV DEV, V36, P679, DOI 10.1016/j.infbeh.2013.07.001; Jones RA, 2013, AM J PREV MED, V44, P651, DOI 10.1016/j.amepre.2013.03.001; Jones SM, 2011, CHILD DEV, V82, P533, DOI 10.1111/j.1467-8624.2010.01560.x; Keefer KV, 2013, PSYCHOL ASSESSMENT, V25, P1255, DOI 10.1037/a0033903; Kirkorian HL, 2009, CHILD DEV, V80, P1350, DOI 10.1111/j.1467-8624.2009.01337.x; Kuepper-Nybelen J, 2005, ARCH DIS CHILD, V90, P359, DOI 10.1136/adc.2004.052423; LANGLOIS JH, 1980, CHILD DEV, V51, P1217; LeBlanc AG, 2012, APPL PHYSIOL NUTR ME, V37, P753, DOI [10.1139/h2012-063, 10.1139/H2012-063]; Lewinsohn P.M., 1974, ESSENTIAL PAPERS DEP, P150; Lin LY, 2015, INFANT BEHAV DEV, V38, P20, DOI 10.1016/j.infbeh.2014.12.005; Lindsey E. W., 2002, CHILD STUDY J, V32, P145; Lotan Meir, 2005, Int J Adolesc Med Health, V17, P23; Lubans DR, 2012, CHILD ADOL MENT H-UK, V17, P2, DOI 10.1111/j.1475-3588.2011.00623.x; Magee CA, 2014, JAMA PEDIATR, V168, P465, DOI 10.1001/jamapediatrics.2013.4183; Malone, 2011, AUST J OUTDOOR ED, V15, P24, DOI DOI 10.1007/BF03400925; Marinelli M, 2014, JAMA PEDIATR, V168, P458, DOI 10.1001/jamapediatrics.2013.3861; Matsumoto D, 2012, J CROSS CULT PSYCHOL, V43, P91, DOI 10.1177/0022022111420147; McCabe PC, 2011, PSYCHOL SCHOOLS, V48, P513, DOI 10.1002/pits.20570; McWayne CM, 2012, J EDUC PSYCHOL, V104, P862, DOI 10.1037/a0028884; Meagher SM, 2009, EARLY EDUC DEV, V20, P1, DOI 10.1080/10409280801947114; Mistry KB, 2007, PEDIATRICS, V120, P762, DOI 10.1542/peds.2006-3573; Morrongiello BA, 1999, J APPL DEV PSYCHOL, V20, P227, DOI 10.1016/S0193-3973(99)00015-5; Okely AD, 2009, J PAEDIATR CHILD H, V45, P5, DOI 10.1111/j.1440-1754.2008.01445.x; Perry MA, 2010, APPL DEV SCI, V14, P1, DOI 10.1080/10888690903510281; Robinson TN, 2010, OBESITY PREVENTION: THE ROLE OF BRAIN AND SOCIETY ON INDIVIDUAL BEHAVIOR, P319, DOI 10.1016/B978-0-12-374387-9.00025-8; Saakslahti A, 1999, PEDIATR EXERC SCI, V11, P327, DOI 10.1123/pes.11.4.327; SALLIS JF, 1993, HEALTH PSYCHOL, V12, P390, DOI 10.1037/0278-6133.12.5.390; Sanchez-Villegas A, 2008, MED SCI SPORT EXER, V40, P827, DOI 10.1249/MSS.0b013e31816348b9; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Sanson A, 2009, MERRILL PALMER QUART, V55, P26; Singh A, 2012, ARCH PEDIAT ADOL MED, V166, P49, DOI 10.1001/archpediatrics.2011.716; Smith LJ, 2017, SLEEP MED, V30, P64, DOI 10.1016/j.sleep.2016.01.009; Stefan CA, 2014, EUR EARLY CHILD EDUC, V22, P14, DOI 10.1080/1350293X.2013.865359; Stone MR, 2014, PREV MED, V65, P122, DOI 10.1016/j.ypmed.2014.05.008; Sweetser P., 2012, AUST J EARLY CHILD, V37, P94, DOI DOI 10.1177/183693911203700413; Takahashi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135357; Telama R., 1999, PSYCHOL PHYS ED, P321; Teychenne M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155696; The Royal Children's Hospital Melbourne, 2015, TOP 10 CHILD HLTH PR; Timmons BW, 2012, APPL PHYSIOL NUTR ME, V37, P773, DOI [10.1139/h2012-070, 10.1139/H2012-070]; Tomporowski PD, 2008, EDUC PSYCHOL REV, V20, P111, DOI 10.1007/s10648-007-9057-0; Tomporowski PD, 2011, PREV MED, V52, pS3, DOI 10.1016/j.ypmed.2011.01.028; Toumbourou JW, 2011, AUST J PSYCHOL, V63, P214, DOI 10.1111/j.1742-9536.2011.00023.x; Tremblay MS, 2015, INT J ENV RES PUB HE, V12, P6475, DOI 10.3390/ijerph120606475; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Vanderloo LM, 2015, RES Q EXERCISE SPORT, V86, P360, DOI 10.1080/02701367.2015.1053105; Vanderloo LM, 2013, APPL PHYSIOL NUTR ME, V38, P1173, DOI 10.1139/apnm-2013-0137; Varni JW, 2013, QUAL LIFE RES; Waite S, 2013, J ADVENTURE EDUC OUT, V13, P255, DOI 10.1080/14729679.2013.798590; Wong MS, 2009, J FAM PSYCHOL, V23, P452, DOI 10.1037/a0015552; Wu CST, 2014, ITAL J PEDIATR, V40, DOI 10.1186/1824-7288-40-44; Zhai L, 2015, BRIT J SPORT MED, V49, P705, DOI 10.1136/bjsports-2014-093613	91	53	53	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0193700	10.1371/journal.pone.0193700	http://dx.doi.org/10.1371/journal.pone.0193700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617366	gold, Green Published, Green Submitted			2022-12-26	WOS:000429203800012
J	Stefanski, HE; Jonart, L; Goren, E; Mule, JJ; Blazer, BR				Stefanski, Heather E.; Jonart, Leslie; Goren, Emily; Mule, James J.; Blazer, Bruce R.			A novel approach to improve immune effector responses post transplant by restoration of CCL21 expression	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; KERATINOCYTE GROWTH-FACTOR; TERTIARY LYMPHOID STRUCTURES; NONOBESE DIABETIC MICE; TISSUE-INDUCER CELLS; VERSUS-HOST-DISEASE; T-CELLS; THYMIC REGENERATION; NODE DEVELOPMENT	Chemotherapy or chemoradiotherapy conditioning regimens required for bone marrow transplantation (BMT) cause significant morbidity and mortality as a result of insufficient immune surveillance mechanisms leading to increased risks of infection and tumor recurrence. Such conditioning causes host stromal cell injury, impairing restoration of the central (thymus) and peripheral (spleen and lymph node) T cell compartments and slow immune reconstitution. The chemokine, CCL21, produced by host stromal cells, recruits T- and B-cells that provide lymphotoxin mediated instructive signals to stromal cells for lymphoid organogenesis. Moreover, T- and B-cell recruitment into these sites is required for optimal adaptive immune responses to pathogens and tumor antigens. Previously, we reported that CCL21 was markedly reduced in secondary lymphoid organs of transplanted animals. Here, we utilized adenoviral CCL21 gene transduced dendritic cells (DC/CCL21) given by footpad injections as a novel approach to restore CCL21 expression in secondary lymphoid organs post-transplant. CCL21 expression in secondary lymphoid organs reached levels of naive controls and resulted in increased T cell trafficking to draining lymph nodes (LNs). An increase in both lymphoid tissue inducer cells and the B cell chemokine CXCL13 known to be important in LN formation was observed. Strikingly, only mice vaccinated with DC/CCL21 loaded with bacterial, viral or tumor antigens and not recipients of DC/control adenovirus loaded cells or no DCs had a marked increase in the systemic clearance of pathogens (bacteria; virus) and leukemia cells. Because DC/CCL21 vaccines have been tested in clinical trials for patients with lung cancer and melanoma, our studies provide the foundation for future trials of DC/CCL21 vaccination in patients receiving pre-transplant conditioning regimens.	[Stefanski, Heather E.; Jonart, Leslie; Goren, Emily; Blazer, Bruce R.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Mule, James J.] H Lee Moffitt Canc Ctr & Res Inst, Cutaneous Oncol Program, Tampa, FL USA	University of Minnesota System; University of Minnesota Twin Cities; H Lee Moffitt Cancer Center & Research Institute	Stefanski, HE (corresponding author), Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA.	stef0030@umn.edu		Stefanski, Heather/0000-0001-7527-9315	National Institute of Health [CA72669]; NATIONAL CANCER INSTITUTE [P01CA065493, R01CA072669] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The National Institute of Health (Grant No. CA72669 to BRB). The funders had no role in study design, data collection or analysis, decision to publish or preparation of the manuscript.	Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Alpdogan O, 2006, BLOOD, V107, P2453, DOI 10.1182/blood-2005-07-2831; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Astorri E, 2010, J IMMUNOL, V185, P3359, DOI 10.4049/jimmunol.1001836; Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065; Bajenoff M, 2008, J IMMUNOL, V181, P3947, DOI 10.4049/jimmunol.181.6.3947; Barker JN, 2005, BIOL BLOOD MARROW TR, V11, P362, DOI 10.1016/j.bbmt.2005.02.004; Bollard CM, 2016, BLOOD, V127, P3331, DOI 10.1182/blood-2016-01-628982; Burkhardt UE, 2013, J CLIN INVEST, V123, P3756, DOI [10.1172/JCI69098, 10.1172/JCI69008]; Chappaz S, 2010, J IMMUNOL, V184, P3562, DOI 10.4049/jimmunol.0901647; Chung J, 2017, J CLIN INVEST, V127, P1574, DOI 10.1172/JCI89535; Cyster JG, 2000, IMMUNOL REV, V176, P181; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Goldberg JD, 2017, LEUKEMIA LYMPHOMA, V58, P1859, DOI 10.1080/10428194.2016.1265113; Gonzalez-Rodriguez AP, 2010, LEUKEMIA LYMPHOMA, V51, P1829, DOI 10.3109/10428194.2010.503820; Guimond M, 2008, BLOOD, V111, P969, DOI 10.1182/blood-2007-09-113316; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Henry RA, 2010, J IMMUNOL, V185, P1460, DOI 10.4049/jimmunol.0903710; Hollander GA, 2010, CURR OPIN PHARMACOL, V10, P443, DOI 10.1016/j.coph.2010.04.008; Jasperson LK, 2008, BLOOD, V111, P3257, DOI 10.1182/blood-2007-06-096081; Kelly RM, 2008, BLOOD, V111, P5734, DOI 10.1182/blood-2008-01-136531; Kelly RM, 2010, BLOOD, V115, P1088, DOI 10.1182/blood-2009-05-223198; Kollmann TR, 2007, J IMMUNOL, V178, P3695, DOI 10.4049/jimmunol.178.6.3695; Krenger W, 2011, BLOOD, V117, P6768, DOI 10.1182/blood-2011-02-334623; Leen AM, 2014, IMMUNOL REV, V258, P12, DOI 10.1111/imr.12138; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Luther SA, 2003, J EXP MED, V197, P1191, DOI 10.1084/jem.20021294; Marchesi F, 2009, MUCOSAL IMMUNOL, V2, P486, DOI 10.1038/mi.2009.113; Maury S, 2001, BRIT J HAEMATOL, V115, P630, DOI 10.1046/j.1365-2141.2001.03135.x; Melero I, 2014, NAT REV CLIN ONCOL, V11, P509, DOI 10.1038/nrclinonc.2014.111; Min D, 2007, BLOOD, V109, P2529, DOI 10.1182/blood-2006-08-043794; Moyer JS, 2006, BIOL BLOOD MARROW TR, V12, P1010, DOI 10.1016/j.bbmt.2006.06.009; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Mule JJ, 2009, ANN NY ACAD SCI, V1174, P33, DOI 10.1111/j.1749-6632.2009.04936.x; Nolte MA, 2003, J EXP MED, V198, P505, DOI 10.1084/jem.20021801; Parkman R, 2006, BIOL BLOOD MARROW TR, V12, P919, DOI 10.1016/j.bbmt.2006.05.008; Perales MA, 2012, BLOOD, V120, P4882, DOI 10.1182/blood-2012-06-437236; Peske JD, 2015, NAT COMMUN, P6; Sauer MG, 2004, CANCER RES, V64, P3914, DOI 10.1158/0008-5472.CAN-03-3991; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Shields JD, 2010, SCIENCE, V328, P749, DOI 10.1126/science.1185837; Small TN, 1999, BLOOD, V93, P467, DOI 10.1182/blood.V93.2.467.402k22_467_480; Storek J, 2008, SEMIN IMMUNOPATHOL, V30, P425, DOI 10.1007/s00281-008-0132-5; Sutherland JS, 2008, CLIN CANCER RES, V14, P1138, DOI 10.1158/1078-0432.CCR-07-1784; Takamura K, 2007, J IMMUNOL, P179; Tomei AA, 2009, J IMMUNOL, V183, P4273, DOI 10.4049/jimmunol.0900835; Vezys V, 2007, LIFE SCI, V80, P2330, DOI 10.1016/j.lfs.2007.01.001; Ware CF, 2008, IMMUNOL REV, V223, P186, DOI 10.1111/j.1600-065X.2008.00629.x; Weinberg K, 2001, BLOOD, V97, P1458, DOI 10.1182/blood.V97.5.1458; Willimann K, 1998, EUR J IMMUNOL, V28, P2025, DOI 10.1002/(SICI)1521-4141(199806)28:06<2025::AID-IMMU2025>3.0.CO;2-C; Wils EJ, 2011, HAEMATOL-HEMATOL J, V96, P1846, DOI 10.3324/haematol.2011.047696; Yang CY, 2014, P NATL ACAD SCI USA, V111, pE109, DOI 10.1073/pnas.1312585111; Zeng M, 2012, BLOOD, V120, P1856, DOI 10.1182/blood-2012-03-418624; Zhang SL, 2014, BLOOD, V124, P296, DOI 10.1182/blood-2014-01-552794	57	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0193461	10.1371/journal.pone.0193461	http://dx.doi.org/10.1371/journal.pone.0193461			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617362	Green Submitted, Green Published, gold			2022-12-26	WOS:000429203800007
J	To, B; Andrechek, ER				To, Briana; Andrechek, Eran R.			Transcription factor compensation during mammary gland development in E2F knockout mice	PLOS ONE			English	Article							GENE-EXPRESSION; BRANCHING MORPHOGENESIS; PROGENITOR CELLS; EMBRYONIC STEM; BREAST-CANCER; SPECIFICITY; METASTASIS; SIGNATURES; REVEALS; ROLES	The E2F transcription factors control key elements of development, including mammary gland branching morphogenesis, with several E2Fs playing essential roles. Additional prior data has demonstrated that loss of individual E2Fs can be compensated by other E2F family members, but this has not been tested in a mammary gland developmental context. Here we have explored the role of the E2Fs and their ability to functionally compensate for each other during mammary gland development. Using gene expression from terminal end buds and chromatin immunoprecipitation data for E2F1, E2F2 and E2F3, we noted both overlapping and unique mammary development genes regulated by each of the E2Fs. Based on our computational findings and the fact that E2Fs share a common binding motif, we hypothesized that E2F transcription factors would compensate for each other during mammary development and function. To test this hypothesis, we generated RNA from E2F1(-/-), E2F2(-/-) and E2F3(+/-) mouse mammary glands. QRT-PCR on mammary glands during pregnancy demonstrated increases in E2F2 and E2F3a in the E2F1(-/-) mice and an increase in E2F2 levels in E2F3(+/-) mice. During lactation we noted that E2F3b transcript levels were increased in the E2F2(-/-) mice. Given that E2Fs have previously been noted to have the most striking effects on development during puberty, we hypothesized that loss of individual E2Fs would be compensated for at that time. Double mutant mice were generated and compared with the single knockouts. Loss of both E2F1 and E2F2 revealed a more striking phenotype than either knockout alone, indicating that E2F2 was compensating for E2F1 loss. Interestingly, while E2F2 was not able to functionally compensate for E2F3(+/-) during mammary outgrowth, increased E2F2 expression was observed in E2F3(+/-) mammary glands during pregnancy day 14.5 and lactation day 5. Together, these findings illustrate the specificity of E2F family members to compensate during development of the mammary gland.	[To, Briana; Andrechek, Eran R.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA	Michigan State University	Andrechek, ER (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.	andrech1@msu.edu			NIH; WCR grant; NIH [R01CA160514]; Worldwide Cancer Research [WCR - 14-1153]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WCR grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Worldwide Cancer Research	ERA received 2 months salary from the NIH grant that supported this study. SR student salary was supported by the WCR grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported with NIH R01CA160514 and Worldwide Cancer Research WCR - 14-1153 to E.R.A., httns://www.nih.gov/about-nih/what-we-do/nih-almanac/national-cancer-institute-nci, https://www.worldwidecancerresearch.org/.	Andrechek ER, 2015, ONCOGENE, V34, P217, DOI 10.1038/onc.2013.540; Andrechek ER, 2008, DEVELOPMENT, V135, P2403, DOI 10.1242/dev.019018; Andrechek ER, 2009, P NATL ACAD SCI USA, V106, P16387, DOI 10.1073/pnas.0901250106; Asp P, 2009, GENE DEV, V23, P37, DOI 10.1101/gad.1727309; Barker HE, 2011, CANCER RES, V71, P1561, DOI 10.1158/0008-5472.CAN-10-2868; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Black EP, 2005, P NATL ACAD SCI USA, V102, P15948, DOI 10.1073/pnas.0504300102; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chen DN, 2009, NATURE, V462, P925, DOI 10.1038/nature08544; Choi D, 2008, ONCOGENE, V27, P1716, DOI 10.1038/sj.onc.1210806; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Clarkson RWE, 2004, BREAST CANCER RES, V6, pR92, DOI 10.1186/bcr754; Danielian PS, 2008, ONCOGENE, V27, P6561, DOI 10.1038/onc.2008.253; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Freedman JA, 2009, ONCOGENE, V28, P2873, DOI 10.1038/onc.2009.153; Fujiwara K, 2011, CANCER RES, V71, P1924, DOI 10.1158/0008-5472.CAN-10-2386; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; Gaubatz S, 2000, MOL CELL, V6, P729, DOI 10.1016/S1097-2765(00)00071-X; Hatcher RJ, 2014, P NATL ACAD SCI USA, V111, P1008, DOI 10.1073/pnas.1318124111; Hennighausen L, 1998, GENE DEV, V12, P449, DOI 10.1101/gad.12.4.449; Hollern DP, 2014, MOL CELL BIOL; Huang E, 2003, NAT GENET, V34, P226, DOI 10.1038/ng1167; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Julian LM, 2016, CELL DEATH DIFFER, V23, P565, DOI 10.1038/cdd.2015.36; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kong LJ, 2007, ONCOGENE, V26, P321, DOI 10.1038/sj.onc.1209817; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Laresgoiti U, 2013, NUCLEIC ACIDS RES, V41, P10185, DOI 10.1093/nar/gkt821; Lindeman GJ, 1998, GENE DEV, V12, P1092, DOI 10.1101/gad.12.8.1092; Master SR, 2002, MOL ENDOCRINOL, V16, P1185, DOI 10.1210/me.16.6.1185; Morris JS, 2006, J CELL PHYSIOL, V206, P16, DOI 10.1002/jcp.20427; Murga M, 2001, IMMUNITY, V15, P959, DOI 10.1016/S1074-7613(01)00254-0; Rabinovich A, 2008, GENOME RES, V18, P1763, DOI 10.1101/gr.080622.108; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Sheridan JM, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1187-z; Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753; Thangaraju M, 2005, DEVELOPMENT, V132, P4675, DOI 10.1242/dev.02050; von Eyss B, 2012, EMBO J, V31, P972, DOI 10.1038/emboj.2011.451; Wang A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-268; Wang CG, 2007, J BIOL CHEM, V282, P29902, DOI 10.1074/jbc.M704757200; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yori JL, 2011, NEOPLASIA, V13, P601, DOI 10.1593/neo.11260; Yuwanita I, 2015, ONCOTARGET	44	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194937	10.1371/journal.pone.0194937	http://dx.doi.org/10.1371/journal.pone.0194937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617434	gold, Green Submitted, Green Published			2022-12-26	WOS:000429203800057
J	Costa, ASH; Costa, P; Alves, SP; Alfaia, CM; Prates, JAM; Vleck, V; Cassar-Malek, I; Hocquette, JF; Bessa, RJB				Costa, Ana S. H.; Costa, Paulo; Alves, Susana P.; Alfaia, Cristina M.; Prates, Jose A. M.; Vleck, Veronica; Cassar-Malek, Isabelle; Hocquette, Jean-Francois; Bessa, Rui J. B.			Does growth path influence beef lipid deposition and fatty acid composition?	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; GENE-EXPRESSION DATA; COMPENSATORY GROWTH; SKELETAL-MUSCLE; BELGIAN BLUE; MEAT; CHAIN; BIOHYDROGENATION; STEERS; IDENTIFICATION	Despite the recent advances in transcriptomics, gene expression studies addressing cattle's skeletal muscle adaptations in response to compensatory growth are warranted, particularly regarding lipid metabolism due to its impact in meat sensory and nutritional traits. In the present study, in comparison to ad libitum feeding, a period of feed restriction was used in order to understand the changes in bull's lipid metabolism and gene expression of the adipogenic and lipogenic pathways after re-alimentation. Thus, 40 young Alentejana bulls were either fed ad libitum (CG group) from 9 to 18 months of age or subjected to food restriction from 9 to 15 months of age, and fed ad libitum until 24 months of age (DG group). The intramuscular fat (IMF) and total fatty acids (FA) contents were similar between groups. The major FA (>2%) contents were similar (16:0, 16:1c9, 18:1c9 and 18:2n-6) between treatments with the exception of 18:0 content that was 15% lower in DG than in CG and 20:4n-6 that tended to be greater on DG bulls. Regarding minor FA (<2%), the DG group presented greater proportions (P<0.01) of 17:1c9, 18:1t9, 18:1t10 (18:1c11), 18:1c13, 18:3n-6, 22:0, 22:4n-6 and 22:6n-3 and lower (P<0.05) proportions of 20:0, 18:1t16+c14, and branched chain FA (iso-15:0, anteiso-15:0, iso-16:0 and anteiso-17:0) than the CG group. Delta-9 desaturase activity indices were consistently greater (P<0.05) in DG, when compared to the CG group. Regarding microarray analysis, differentially expressed genes between CG and DG bulls were grouped in 5 main biological functions: lipid and nucleic acid metabolisms, small molecule biochemistry, molecular transport and translational modification. Discontinuous growth down-regulated the expression of ACACB (FC (fold-change) = 1.32), FABP3 (FC = 1.45), HADHA (FC = 1.41) and SLC37A4 (FC = 1.40) genes, when compared to the CG system (FDR<0.05). In contrast, in the CG bulls, the expression of ELOVL5 (FC = 1.58) and FASN (FC = 1.71) was down-regulated when compared to DG bulls. These results were confirmed to be significant (P<0.05) in the case of ELOVL5, FASN and SLC37A4, and almost significant for FABP3 by qRT-PCR analysis. The SCD1 and SCD5 gene expressions were not found to be affected by growth path. These results contribute to the still scarce knowledge about the mechanisms involved in fatty acid metabolism during compensatory growth which have decisive role on meat quality produced in Mediterranean areas.	[Costa, Ana S. H.; Costa, Paulo; Alves, Susana P.; Alfaia, Cristina M.; Prates, Jose A. M.; Bessa, Rui J. B.] Polo Univ Alto Ajuda, Univ Lisboa, Fac Med Vet, CIISA, Ave Univ Tecn, Lisbon, Portugal; [Vleck, Veronica] Univ Lisbon, Fac Motricidade Humana, CIPER, Estr Costa, Lisbon, Portugal; [Cassar-Malek, Isabelle; Hocquette, Jean-Francois] INRA, UR 1213, URH, St Genes Champanelle, France; [Cassar-Malek, Isabelle; Hocquette, Jean-Francois] Clermont Univ, VetAgro Sup, UMR1213, Clermont Ferrand, France; [Costa, Ana S. H.] Univ Cambridge, MRC Canc Unit, Hutch MRC Res Ctr, Cambridge Biomed Campus, Cambridge, England	Universidade de Lisboa; Universidade de Lisboa; INRAE; VetAgro Sup; University of Cambridge	Costa, P (corresponding author), Polo Univ Alto Ajuda, Univ Lisboa, Fac Med Vet, CIISA, Ave Univ Tecn, Lisbon, Portugal.	paulocosta@fmv.ulisboa.pt	Alves, Susana/Q-3889-2019; Prates, José A M/K-9934-2013; Costa, Ana SH/H-2852-2012; Costa, Ana/HDL-9297-2022; Hocquette, Jean-Francois/I-1034-2019; , Cassar-Malek/AAW-6386-2020; Bessa, Rui J. B./B-8006-2008; Alves, Susana P/C-1447-2008; Alfaia, Cristina/H-4874-2013; costa, paulo/A-2556-2010; Vleck, Veronica/H-6473-2011	Alves, Susana/0000-0002-3171-9566; Prates, José A M/0000-0003-1032-5987; Costa, Ana SH/0000-0001-8932-6370; Hocquette, Jean-Francois/0000-0003-2409-3881; , Cassar-Malek/0000-0001-7407-1408; Bessa, Rui J. B./0000-0003-4109-3488; Alves, Susana P/0000-0002-3171-9566; Alfaia, Cristina/0000-0001-8648-2204; costa, paulo/0000-0003-3791-2735; Vleck, Veronica/0000-0001-8168-8633	Fundacao para a Ciencia e a Tecnologia (FCT) through Centro de Investigacao Interdisciplinar em Sanidade Animal [UID/CVT/00276/2013, PTDC/CVT/65707/2006, PTDC/CVT/111744/2009, SFRH/BPD/76836/2011, SFRH/BPD/111051/2015, SFRH/BPD/104394/2014]	Fundacao para a Ciencia e a Tecnologia (FCT) through Centro de Investigacao Interdisciplinar em Sanidade Animal	This research was supported by the Fundacao para a Ciencia e a Tecnologia (FCT) through Centro de Investigacao Interdisciplinar em Sanidade Animal (UID/CVT/00276/2013) and from Project grants (PTDC/CVT/65707/2006 and PTDC/CVT/111744/2009) and individual fellowships to: A. S.C (SFRH/BPD/76836/2011), P. C. (SFRH/BPD/111051/2015), S.P.A. (SFRH/BPD/76836/2011) and V. V. (SFRH/BPD/104394/2014). All the funding sources are presented in this submission. There was no additional external funding received for this study.	Abu-Elheiga L, 2000, P NATL ACAD SCI USA, V97, P1444, DOI 10.1073/pnas.97.4.1444; Allingham PG, 1998, MEAT SCI, V48, P65, DOI 10.1016/S0309-1740(97)00076-4; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Archibeque SL, 2005, J ANIM SCI, V83, P1153; BERGE P, 1991, LIVEST PROD SCI, V28, P203, DOI 10.1016/0301-6226(91)90143-E; Bernard C, 2009, MEAT SCI, V82, P205, DOI 10.1016/j.meatsci.2009.01.012; Bessa RJB, 2007, EUR J LIPID SCI TECH, V109, P868, DOI 10.1002/ejlt.200600311; Bessa RJB, 2015, EUR J LIPID SCI TECH, V117, P1325, DOI 10.1002/ejlt.201400468; Burczynski FJ, 1999, CAN J PHYSIOL PHARM, V77, P896, DOI 10.1139/cjpp-77-11-896; Byrne KA, 2005, J ANIM SCI, V83, P1; Carolino NR, 1997, REV PORTUGUESA ZOOTE; CARSTENS GE, 1991, J ANIM SCI, V69, P3251; Cassar-Malek I, 2008, AUST J EXP AGR, V48, P701, DOI 10.1071/EA08018; Cassar-Malek I, 2004, ANIM SCI, V79, P49, DOI 10.1017/S1357729800054527; Cassar-Malek I, 2009, J PHYSIOL PHARMACOL, V60, P83; Costa P, 2017, ANIMAL, V11, P175, DOI 10.1017/S1751731116001373; Costa P, 2015, ANIMAL, V9, P1414, DOI 10.1017/S1751731115000427; Costa P, 2012, ANIMAL, V6, P1187, DOI 10.1017/S1751731111002722; Cuvelier C, 2006, ANIM SCI, V82, P125, DOI 10.1079/ASC20057; De Smet S, 2004, ANIM RES, V53, P81, DOI 10.1051/animres:2004003; Dutta-Roy AK, 2000, CELL MOL LIFE SCI, V57, P1360, DOI 10.1007/PL00000621; Griinari JM, 1999, ADVANCES IN CONJUGATED LINOLEIC ACID RESEARCH, VOL 1, P180; Guillemin N, 2011, ANIMAL, V5, P885, DOI 10.1017/S1751731110002612; Hausman GJ, 2009, J ANIM SCI, V87, P1218, DOI 10.2527/jas.2008-1427; Hegarty RS, 2004, AUST J EXP AGR, V44, P458, DOI 10.1071/EA02148; Hiller B, 2012, BRIT J NUTR, V108, P858, DOI 10.1017/S0007114511006179; Hocquette JF, 2010, ANIMAL, V4, P303, DOI 10.1017/S1751731109991091; Hocquette JF, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-135; Hornick JL, 1998, J ANIM SCI, V76, P249; Jeong J, 2012, J ANIM SCI, V90, P2044, DOI 10.2527/jas.2011-4753; Jeronimo E, 2011, EUR J LIPID SCI TECH, V113, P924, DOI 10.1002/ejlt.201000398; Joseph SJ, 2010, BIOINFORM BIOL INSIG, V4, P19; Keogh K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149373; KIM KH, 1989, FASEB J, V3, P2250, DOI 10.1096/fasebj.3.11.2570725; Kroger J, 2012, CURR OPIN LIPIDOL, V23, P4, DOI 10.1097/MOL.0b013e32834d2dc5; Lehnert SA, 2006, J ANIM SCI, V84, P3239, DOI 10.2527/jas.2006-192; Lehnert SA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213x-7-95; Lengi AJ, 2007, LIPIDS, V42, P499, DOI 10.1007/s11745-007-3056-2; Leonard AE, 2004, PROG LIPID RES, V43, P36, DOI 10.1016/S0163-7827(03)00040-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loor JJ, 2004, J DAIRY SCI, V87, P2472, DOI 10.3168/jds.S0022-0302(04)73372-X; Maeyashiki C, 2017, BIOCHEM BIOPH RES CO, V484, P636, DOI 10.1016/j.bbrc.2017.01.159; Matsumoto H, 2012, LIVEST SCI, V144, P281, DOI 10.1016/j.livsci.2011.12.003; McLachlan GJ, 2006, BIOINFORMATICS, V22, P1608, DOI 10.1093/bioinformatics/btl148; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Pan CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023157; Park S, 2013, J MOL RECOGNIT, V26, P679, DOI 10.1002/jmr.2313; Pfaffl M, 1998, EXP CLIN ENDOCR DIAB, V106, P514, DOI 10.1055/s-0029-1212026; Picard B, 2014, J AGR FOOD CHEM, V62, P9808, DOI 10.1021/jf501528s; Reverter A, 2003, J ANIM SCI, V81, P1900; Schmid A, 2006, MEAT SCI, V73, P29, DOI 10.1016/j.meatsci.2005.10.010; Scollan ND, 2014, MEAT SCI, V97, P384, DOI 10.1016/j.meatsci.2014.02.015; Shingfield KJ, 2007, EUR J LIPID SCI TECH, V109, P799, DOI 10.1002/ejlt.200700026; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Viegas I, 2011, NEW MEDIT, V10, P17; Vlaeminck B, 2006, ANIM FEED SCI TECH, V131, P389, DOI 10.1016/j.anifeedsci.2006.06.017; Wang YH, 2009, J ANIM SCI, V87, P119, DOI 10.2527/jas.2008-1082; Zhu B, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3847-7	59	4	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0193875	10.1371/journal.pone.0193875	http://dx.doi.org/10.1371/journal.pone.0193875			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614102	Green Published, gold, Green Submitted			2022-12-26	WOS:000429081600006
J	Blain-Hartung, M; Rockwell, NC; Moreno, MV; Martin, SS; Gan, F; Bryant, DA; Lagarias, JC				Blain-Hartung, Matthew; Rockwell, Nathan C.; Moreno, Marcus V.; Martin, Shelley S.; Gan, Fei; Bryant, Donald A.; Lagarias, J. Clark			Cyanobacteriochrome-based photoswitchable adenylyl cyclases (cPACs) for broad spectrum light regulation of cAMP levels in cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adenylate cyclase (adenylyl cyclase); cyanobacteria; phototransduction; optogenetics; photoreceptor; signal transduction; biliprotein; biliverdin; cAMP; linear tetrapyrrole; photoswitch	C-DI-GMP; PHOTO-DYNAMICS; CYCLIC-AMP; SIGNAL-TRANSDUCTION; CELLULAR CAMP; RED-LIGHT; DOMAIN; PHOTOACTIVATION; PHOTORECEPTORS; BIOSYNTHESIS	Class III adenylyl cyclases generate the ubiquitous second messenger cAMP from ATP often in response to environmental or cellular cues. During evolution, soluble adenylyl cyclase catalytic domains have been repeatedly juxtaposed with signal-input domains to place cAMP synthesis under the control of a wide variety of these environmental and endogenous signals. Adenylyl cyclases with light-sensing domains have proliferated in photosynthetic species depending on light as an energy source, yet are also widespread in nonphotosynthetic species. Among such naturally occurring light sensors, several flavin-based photoactivated adenylyl cyclases (PACs) have been adopted as optogenetic tools to manipulate cellular processes with blue light. In this report, we report the discovery of a cyanobacteriochrome-based photoswitchable adenylyl cyclase (cPAC) from the cyanobacterium Microcoleus sp. PCC 7113. Unlike flavin-dependent PACs, which must thermally decay to be deactivated, cPAC exhibits a bistable photocycle whose adenylyl cyclase could be reversibly activated and inactivated by blue and green light, respectively. Through domain exchange experiments, we also document the ability to extend the wavelength-sensing specificity of cPAC into the near IR. In summary, our work has uncovered a cyanobacteriochrome-based adenylyl cyclase that holds great potential for the design of bistable photoswitchable adenylyl cyclases to fine-tune cAMP-regulated processes in cells, tissues, and whole organisms with light across the visible spectrum and into the near IR.	[Blain-Hartung, Matthew; Rockwell, Nathan C.; Moreno, Marcus V.; Martin, Shelley S.; Lagarias, J. Clark] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Gan, Fei; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Bryant, Donald A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Gan, Fei] Scripps Res Inst, 5202 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA	University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman; Scripps Research Institute	Lagarias, JC (corresponding author), 1 Shields Ave, Davis, CA 95616 USA.	jclagarias@ucdavis.edu	Lagarias, John Clark/L-3139-2013	Lagarias, John Clark/0000-0002-2093-0403; Blain-Hartung, Matthew/0000-0001-6756-0035; Gan, Fei/0000-0003-1670-5251	Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy [DOE DE-FG02-09ER16117]; National Science Foundation [MCB-1613022]; National Institutes of Health, NIGMS [T32-GM07377]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007377] Funding Source: NIH RePORTER	Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy Grant DOE DE-FG02-09ER16117 (to J. C. L.), National Science Foundation Grant MCB-1613022 (to D. A. B.), and National Institutes of Health, NIGMS Grant T32-GM07377 (to M. B.-H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x; Bhaya D, 2004, MOL MICROBIOL, V53, P745, DOI 10.1111/j.1365-2958.2004.04160.x; Blain-Hartung M, 2017, BIOCHEMISTRY-US, V56, P6145, DOI 10.1021/acs.biochem.7b00734; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; Cann MJ, 2003, J BIOL CHEM, V278, P35033, DOI 10.1074/jbc.M303025200; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Duanmu D, 2013, P NATL ACAD SCI USA, V110, P3621, DOI 10.1073/pnas.1222375110; Enomoto G, 2015, P NATL ACAD SCI USA, V112, P8082, DOI 10.1073/pnas.1504228112; Enomoto G, 2014, J BIOL CHEM, V289, P24801, DOI 10.1074/jbc.M114.583674; Freer LH, 2012, J PHYS CHEM B, V116, P10571, DOI 10.1021/jp302637u; Fushimi K, 2017, PHOTOCHEM PHOTOBIOL, V93, P903, DOI 10.1111/php.12764; Fushimi K, 2017, PHOTOCHEM PHOTOBIOL, V93, P681, DOI 10.1111/php.12732; Fushimi K, 2016, BIOCHEMISTRY-US, V55, P6981, DOI 10.1021/acs.biochem.6b00940; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Gan F, 2014, SCIENCE, V345, P1312, DOI 10.1126/science.1256963; Gasser C, 2014, P NATL ACAD SCI USA, V111, P8803, DOI 10.1073/pnas.1321600111; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gomelsky M, 2011, MOL MICROBIOL, V79, P562, DOI 10.1111/j.1365-2958.2010.07514.x; Gordillo FJL, 2004, J PLANT PHYSIOL, V161, P211, DOI 10.1078/0176-1617-00953; Hegemann P, 2008, ANNU REV PLANT BIOL, V59, P167, DOI 10.1146/annurev.arplant.59.032607.092847; Hirose Y, 2013, P NATL ACAD SCI USA, V110, P4974, DOI 10.1073/pnas.1302909110; Ho MY, 2017, CURR OPIN PLANT BIOL, V37, P24, DOI 10.1016/j.pbi.2017.03.006; Ikeuchi M, 2008, PHOTOCH PHOTOBIO SCI, V7, P1159, DOI 10.1039/b802660m; Iseki M, 2002, NATURE, V415, P1047, DOI 10.1038/4151047a; Ishizuka T, 2011, BIOCHEMISTRY-US, V50, P953, DOI 10.1021/bi101626t; JORGENSEN BB, 1986, APPL ENVIRON MICROB, V51, P408; Karsten U, 1996, SYST APPL MICROBIOL, V19, P285, DOI 10.1016/S0723-2020(96)80054-3; KLOSE KE, 1993, J MOL BIOL, V232, P67, DOI 10.1006/jmbi.1993.1370; Kobayashi M, 2004, DEV GENES EVOL, V214, P503, DOI 10.1007/s00427-004-0432-2; Kyriakakis P, 2018, ACS SYNTH BIOL, V7, P706, DOI 10.1021/acssynbio.7b00413; Lefkimmiatis K, 2014, PHARMACOL THERAPEUT, V143, P295, DOI 10.1016/j.pharmthera.2014.03.008; Li Mamie Z, 2012, Methods Mol Biol, V852, P51, DOI 10.1007/978-1-61779-564-0_5; Lim S, 2014, PHOTOCH PHOTOBIO SCI, V13, P951, DOI 10.1039/c3pp50442e; Linder JU, 2006, CELL MOL LIFE SCI, V63, P1736, DOI 10.1007/s00018-006-6072-0; Lindner R, 2017, J MOL BIOL, V429, P1336, DOI 10.1016/j.jmb.2017.03.020; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Ma Q, 2012, FEBS J, V279, P4095, DOI 10.1111/febs.12003; Muller K, 2013, MOL BIOSYST, V9, P596, DOI 10.1039/c3mb25590e; Mulder DT, 2015, MOL MICROBIOL, V95, P678, DOI 10.1111/mmi.12895; Narikawa R, 2015, BIOCHEM BIOPH RES CO, V461, P390, DOI 10.1016/j.bbrc.2015.04.045; Ohki M, 2017, P NATL ACAD SCI USA, V114, P8562, DOI 10.1073/pnas.1704391114; Ohki M, 2016, P NATL ACAD SCI USA, V113, P6659, DOI 10.1073/pnas.1517520113; OHMORI K, 1993, PLANT CELL PHYSIOL, V34, P169; Ohmori M, 2004, PHOTOCH PHOTOBIO SCI, V3, P503, DOI 10.1039/b401623h; Okamoto S, 2004, PHOTOCHEM PHOTOBIOL, V80, P429, DOI 10.1562/0031-8655(2004)080&lt;0429:APPATT&gt;2.0.CO;2; Okkotsu Y, 2013, J BACTERIOL, V195, P5499, DOI 10.1128/JB.00726-13; Oliveira MC, 2015, J MOL BIOL, V427, P415, DOI 10.1016/j.jmb.2014.11.012; Omoregie EO, 2004, APPL ENVIRON MICROB, V70, P2119, DOI 10.1128/AEM.70.4.2119-2128.2004; Ong NT, 2018, ACS SYNTH BIOL, V7, P240, DOI 10.1021/acssynbio.7b00289; Penzkofer A, 2014, J PHOTOCH PHOTOBIO A, V287, P19, DOI 10.1016/j.jphotochem.2014.04.017; Penzkofer A, 2013, CHEM PHYS, V412, P96, DOI 10.1016/j.chemphys.2012.12.015; Penzkofer A, 2011, CHEM PHYS, V387, P25, DOI 10.1016/j.chemphys.2011.05.028; Penzkofer A., 2014, TRENDS APPL SPECTROS, V11, P39; Penzkofer A, 2016, DYES PIGMENTS, V135, P102, DOI 10.1016/j.dyepig.2016.05.037; Penzkofer A, 2015, J PHOTOCH PHOTOBIO B, V153, P90, DOI 10.1016/j.jphotobiol.2015.08.027; Raffelberg S, 2013, BIOCHEM J, V455, P359, DOI 10.1042/BJ20130637; Ramakrishnan P, 2016, ACS SYNTH BIOL, V5, P733, DOI 10.1021/acssynbio.6b00068; Rockwell NC, 2008, BIOCHEMISTRY-US, V47, P7304, DOI 10.1021/bi800088t; Rockwell NC, 2017, J PLANT PHYSIOL, V217, P57, DOI 10.1016/j.jplph.2017.05.022; Rockwell NC, 2016, BIOCHEMISTRY-US, V55, P3907, DOI 10.1021/acs.biochem.6b00299; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P9667, DOI 10.1021/bi3013565; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P3576, DOI 10.1021/bi300171s; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P1449, DOI 10.1021/bi201783j; Rockwell NC, 2011, P NATL ACAD SCI USA, V108, P11854, DOI 10.1073/pnas.1107844108; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; Ryu MH, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00014-17; Ryu MH, 2014, P NATL ACAD SCI USA, V111, P10167, DOI 10.1073/pnas.1324301111; Ryu MH, 2010, J BIOL CHEM, V285, P41501, DOI 10.1074/jbc.M110.177600; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Shemetov AA, 2017, CELL CHEM BIOL, V24, P758, DOI 10.1016/j.chembiol.2017.05.018; Shenoy AR, 2004, FEBS LETT, V561, P11, DOI 10.1016/S0014-5793(04)00128-0; Shin AY, 2014, FEBS LETT, V588, P2964, DOI 10.1016/j.febslet.2014.05.050; SMITH G, 1981, FEMS MICROBIOL LETT, V11, P175; Song JY, 2011, P NATL ACAD SCI USA, V108, P10780, DOI 10.1073/pnas.1104242108; Steegborn C, 2005, NAT STRUCT MOL BIOL, V12, P32, DOI 10.1038/nsmb880; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Tabor JJ, 2011, J MOL BIOL, V405, P315, DOI 10.1016/j.jmb.2010.10.038; Terauchi K, 1999, PLANT CELL PHYSIOL, V40, P248, DOI 10.1093/oxfordjournals.pcp.a029534; Huynh TN, 2015, MICROBIOL-SGM, V161, P1504, DOI 10.1099/mic.0.000092; Uda Y, 2017, P NATL ACAD SCI USA, V114, P11962, DOI 10.1073/pnas.1707190114; YANG JK, 1983, J BIOL CHEM, V258, P3750; Yoshikawa S, 2005, PHOTOCH PHOTOBIO SCI, V4, P727, DOI 10.1039/b417212d	84	45	45	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8473	8483		10.1074/jbc.RA118.002258	http://dx.doi.org/10.1074/jbc.RA118.002258			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29632072	Green Published, hybrid			2022-12-26	WOS:000434205700012
J	Belhomme, N; Jouneau, S; Bouzille, G; Decaux, O; Lederlin, M; Guillot, S; Perlat, A; Jego, P				Belhomme, Nicolas; Jouneau, Stephane; Bouzille, Guillaume; Decaux, Olivier; Lederlin, Mathieu; Guillot, Stephanie; Perlat, Antoinette; Jego, Patrick			Role of serum immunoglobulins for predicting sarcoidosis outcome: A cohort study	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; CIRCULATING IMMUNE-COMPLEXES; FOLLOW-UP; BRONCHOALVEOLAR LAVAGE; CLINICAL-COURSE; PULMONARY; DIAGNOSIS; PROGNOSIS; CHITOTRIOSIDASE; INVOLVEMENT	Background Sarcoidosis is a systemic granulomatous disease which carries variable outcomes. Serum protein electrophoresis is an easily accessible and routinely performed examination at diagnosis, in order to search for hypergammaglobulinemia, which is frequently found, and to rule out other granulomatous diseases such as common variable immunodeficiency. We aimed to assess the impact of baseline immunoglobulin level on the outcome of sarcoidosis. Methods We conducted a retrospective cohort-study, at Rennes University Hospital, in which all newly diagnosed patients for whom a serum protein electrophoresis had been performed at baseline were enrolled, from 2006 to 2014. The main outcome was the need for corticosteroid treatment within 2 years from diagnosis, the secondary outcome was the occurrence of relapse among treated patients. Results Eighty patients were included in the study, and 41.25% of them exhibited an elevated globulins rate. In univariate analysis, an elevated ACE level > 70 U/l, Afro-Caribbean origin, and extra-pulmonary involvement, were associated with the need for corticosteroid treatment. In multivariate analysis, only ACE elevation (OR = 1.03, IC95% 1.01-1.05, p = 0.009) and extra-pulmonary involvement (OR = 5.8, IC95% 1.4-24, p = 0.015) were significant. Immunoglobulin level was not associated with the main outcome. Regarding the secondary outcome, none of the studied features were predictive of relapse among the 34 treated patients followed for two years. Conclusions There was no relation between the immunoglobulin level at diagnosis and the evolution of sarcoidosis. An elevated ACE level and the presence of initial extra-pulmonary involvement were both associated with a more severe course of the disease necessitating a corticosteroid treatment.	[Belhomme, Nicolas; Decaux, Olivier; Perlat, Antoinette; Jego, Patrick] Rennes Univ Hosp, Internal Med Dept, Rennes, France; [Belhomme, Nicolas; Jouneau, Stephane; Decaux, Olivier; Lederlin, Mathieu; Jego, Patrick] Univ Rennes 1, Rennes, France; [Jouneau, Stephane] Rennes Univ Hosp, Dept Resp Med, Rennes, France; [Jouneau, Stephane; Jego, Patrick] INSERM IRSET UMR1085, Rennes, France; [Bouzille, Guillaume; Lederlin, Mathieu] INSERM, U1099, Rennes, France; [Bouzille, Guillaume] Univ Rennes 1, LTSI, Rennes, France; [Bouzille, Guillaume] CHU Rennes, CIC Inserm 1414, Rennes, France; [Bouzille, Guillaume] CHU Rennes, Ctr Donnees Clin, Rennes, France; [Lederlin, Mathieu] Rennes Univ Hosp, Dept Radiol, Rennes, France; [Guillot, Stephanie] Rennes Univ Hosp, Dept Resp Physiol, Rennes, France	CHU Rennes; Universite de Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes; CHU Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes	Belhomme, N (corresponding author), Rennes Univ Hosp, Internal Med Dept, Rennes, France.; Belhomme, N (corresponding author), Univ Rennes 1, Rennes, France.	nicolas.belhomme@chu-rennes.fr	LEDERLIN, Mathieu/ABC-8116-2020; Jouneau, Stephane/K-9956-2015; BELHOMME, Nicolas/ABD-1850-2020	BELHOMME, Nicolas/0000-0002-9438-3350				AINSLIE GM, 1985, Q J MED, V55, P253; Bargagli E, 2013, J CLIN IMMUNOL, V33, P264, DOI 10.1007/s10875-012-9754-4; Baughman RP, 2011, SARCOIDOSIS VASC DIF, V28, P56; Baughman RP, 2014, EUR RESPIR J, V43, P337, DOI 10.1183/09031936.00138913; Baughman RP, 2011, AM J RESP CRIT CARE, V183, P573, DOI 10.1164/rccm.201006-0865CI; Baughman RP, 2001, AM J RESP CRIT CARE, V164, P1885, DOI 10.1164/ajrccm.164.10.2104046; Baughman RP, 2006, QJM-INT J MED, V99, P307, DOI 10.1093/qjmed/hcl038; BAUGHMAN RP, 1987, LUNG, V165, P371, DOI 10.1007/BF02714452; Biller H, 2006, EUR RESPIR J, V28, P1085, DOI 10.1183/09031936.00050106; Bouzille G, 2015, STUD HEALTH TECHNOL, V216, P913, DOI 10.3233/978-1-61499-564-7-913; Costabel U, 2010, SEMIN RESP CRIT CARE, V31, P404, DOI 10.1055/s-0030-1262207; EULE H, 1986, ANN NY ACAD SCI, V465, P695, DOI 10.1111/j.1749-6632.1986.tb18548.x; Gibson GJ, 1996, THORAX, V51, P238, DOI 10.1136/thx.51.3.238; Gottlieb JE, 1997, CHEST, V111, P623, DOI 10.1378/chest.111.3.623; Harlander M, 2014, RESP MED, V108, P775, DOI 10.1016/j.rmed.2014.02.002; Hunninghake GW, 1999, AM J RESP CRIT CARE, V160, P736; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Inoue Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143371; ISRAEL HL, 1986, ANN NY ACAD SCI, V465, P609, DOI 10.1111/j.1749-6632.1986.tb18537.x; Judson MA, 2014, SARCOIDOSIS VASC DIF, V31, P19; Judson MA, 2012, SARCOIDOSIS VASC DIF, V29, P119; Judson MA, 2003, SARCOIDOSIS VASC DIF, V20, P204; Judson MA, 2007, SEMIN RESP CRIT CARE, V28, P83, DOI 10.1055/s-2007-970335; Kataria YP, 1997, CLIN CHEST MED, V18, P719, DOI 10.1016/S0272-5231(05)70415-9; Mirsaeidi M, 2015, CHEST, V147, P438, DOI 10.1378/chest.14-1120; Miyoshi S, 2010, CHEST, V137, P1391, DOI 10.1378/chest.09-1975; Prasse A, 2008, AM J RESP CRIT CARE, V177, P330, DOI 10.1164/rccm.200705-742OC; Rabin DL, 2004, EUR RESPIR J, V24, P601, DOI 10.1183/09031936.04.00070503; Rizzato G, 1998, SARCOIDOSIS VASC DIF, V15, P52; ROMER FK, 1981, ACTA MED SCAND, V210, P299; SCHOENFELD N, 1994, THORAX, V49, P688, DOI 10.1136/thx.49.7.688; SILTZBACH LE, 1974, AM J MED, V57, P847, DOI 10.1016/0002-9343(74)90160-0; STUDDY PR, 1980, J CLIN PATHOL, V33, P528, DOI 10.1136/jcp.33.6.528; TAKADA K, 1993, J CLIN EPIDEMIOL, V46, P359, DOI 10.1016/0895-4356(93)90150-Y; Tukey MH, 2013, SARCOIDOSIS VASC DIF, V30, P128; Tzouvelekis A, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-78; Valeyre D, 2014, LANCET, V383, P1155, DOI 10.1016/S0140-6736(13)60680-7; WINTERBAUER RH, 1993, CHEST, V104, P352, DOI 10.1378/chest.104.2.352	38	13	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0193122	10.1371/journal.pone.0193122	http://dx.doi.org/10.1371/journal.pone.0193122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641520	Green Published, gold, Green Submitted			2022-12-26	WOS:000429742900010
J	Neaves, LE; Danks, M; Lott, MJ; Dennison, S; Frankham, GJ; King, A; Eldridge, MDB; Johnson, RN; Divljan, A				Neaves, Linda E.; Danks, Melissa; Lott, Matthew J.; Dennison, Siobhan; Frankham, Greta J.; King, Andrew; Eldridge, Mark D. B.; Johnson, Rebecca N.; Divljan, Anja			Unmasking the complexity of species identification in Australasian flying-foxes	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; LONG-DISTANCE MOVEMENTS; PTEROPUS; CHIROPTERA; GENUS; BATS; AMPLIFICATION; SEQUENCES; ISLANDS; FLIGHT	Pteropus (flying-foxes) are a speciose group of non-echolocating large bats, with five extant Australian species and 24 additional species distributed amongst the Pacific Islands. In 2015, an injured flying-fox with unusual facial markings was found in Sydney, Australia, following severe and widespread storms. Based on an initial assessment, the individual belonged to Pteropus but could not be readily identified to species. As a consequence, four hypotheses for its identification/origin were posited: the specimen represented (1) an undescribed Australian species; or (2) a morphological variant of a recognised Australian species; or (3) a hybrid individual; or (4) a vagrant from the nearby Southwest Pacific Islands. We used a combination of morphological and both mitochondrial- and nuclear DNA-based identification methods to assess these hypotheses. Based on the results, we propose that this morphologically unique Pteropus most likely represents an unusual P. alecto (black flying-fox) potentially resulting from introgression from another Pteropus species. Unexpectedly, this individual, and the addition of reference sequence data from newly vouchered specimens, revealed a previously unreported P. alecto mitochondrial DNA lineage. This lineage was distinct from currently available haplotypes. It also suggests long-term hybridisation commonly occurs between P. alecto and P. conspicillatus (spectacled flying-fox). This highlights the importance of extensive reference data, and the inclusion of multiple vouchered specimens for each species to encompass both intraspecific and interspecific variation to provide accurate and robust species identification. Moreover, our additional reference data further demonstrates the complexity of Pteropus species relationships, including hybridisation, and potential intraspecific biogeographical structure that may impact on their management and conservation.	[Neaves, Linda E.; Danks, Melissa; Lott, Matthew J.; Dennison, Siobhan; Frankham, Greta J.; King, Andrew; Johnson, Rebecca N.] Australian Museum Res Inst, Australian Ctr Wildlife Genom, Sydney, NSW, Australia; [Neaves, Linda E.] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Eldridge, Mark D. B.; Divljan, Anja] Australian Museum Res Inst, Terr Vertebrates, Sydney, NSW, Australia	Australian Museum; Australian Museum	Neaves, LE (corresponding author), Australian Museum Res Inst, Australian Ctr Wildlife Genom, Sydney, NSW, Australia.; Neaves, LE (corresponding author), Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland.	Ineaves@gmail.com	Johnson, Rebecca N/U-6514-2017; Neaves, Linda/AAY-6886-2020; Danks, Melissa A/AAC-5439-2019	Neaves, Linda/0000-0002-5626-1029; Danks, Melissa A/0000-0002-4044-6694; Johnson, Rebecca/0000-0003-3035-2827; Dennison, Siobhan/0000-0002-3308-2810; King, Andrew/0000-0003-0481-3490				Ahlers N, 2017, FORENS SCI INT-GEN S, V6, pE466, DOI 10.1016/j.fsigss.2017.09.195; Almeida FC, 2014, MOL PHYLOGENET EVOL, V77, P83, DOI 10.1016/j.ympev.2014.03.009; [Anonymous], 2014, TRACER V1 6; Australian Bureau of Meteorology, 2015, MONTHLY WEATHER REV; Australian Transport Safety Bureau, 2017, AR2016063 ATSB; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Aziz SA, 2017, PEERJ, V5, DOI 10.7717/peerj.3176; Banack SA, 2002, J WILDLIFE MANAGE, V66, P1154, DOI 10.2307/3802948; Beugin MP, 2017, CONSERV GENET RESOUR, V9, P671, DOI 10.1007/s12686-017-0738-9; Biondi KM, 2013, ACTA CHIROPTEROL, V15, P185, DOI 10.3161/150811013X667984; Breed AC, 2010, ECOHEALTH, V7, P204, DOI 10.1007/s10393-010-0332-z; Brown VA, 2011, CONSERV GENET, V12, P933, DOI 10.1007/s10592-011-0196-y; Churchill S., 2009, AUSTR BATS; Coissac E, 2016, MOL ECOL, V25, P1423, DOI 10.1111/mec.13549; Dawnay N, 2007, FORENSIC SCI INT, V173, P1, DOI 10.1016/j.forsciint.2006.09.013; Dillman CB, 2014, J APPL ICHTHYOL, V30, P1300, DOI 10.1111/jai.12568; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fox S., 2006, THESIS, V181; Fox S, 2012, TERRA AUSTRALIS, V34, P459; Hall LS, 1983, AUSTR MUSEUM COMPLET, P280; Hall lS, 2000, FLYING FOXES FRUIT B; Helgen KM, 2004, ZOOTAXA, P1; Helgen KM, 2009, AM MUS NOVIT, P1, DOI 10.1206/614.1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Korstian JM, 2016, CONSERV GENET RESOUR, V8, P27, DOI 10.1007/s12686-015-0509-4; Lee RJ, 2005, BIOL CONSERV, V123, P477, DOI 10.1016/j.biocon.2005.01.009; Martin L, 1995, SYM ZOOL S, P167; McConkey KR, 2007, BIOTROPICA, V39, P436, DOI 10.1111/j.1744-7429.2007.00269.x; Neaves LE, 2010, HEREDITY, V104, P502, DOI 10.1038/hdy.2009.137; Ng JHJ, 2013, AUST J ZOOL, V61, P48, DOI 10.1071/ZO12126; Parsons JG, 2010, ACTA CHIROPTEROL, V12, P301, DOI 10.3161/150811010X537882; Parsons JG, 2009, J WILDLIFE MANAGE, V73, P526, DOI 10.2193/2008-268; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Porter CA, 1996, MOL PHYLOGENET EVOL, V5, P89, DOI 10.1006/mpev.1996.0008; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ratcliffe F, 1932, J ANIM ECOL, V1, P32, DOI 10.2307/993; Richmond JQ, 1998, AUST J ZOOL, V46, P283, DOI 10.1071/ZO97059; Roberts BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042532; Roberts BJ, 2012, AUSTRAL ECOL, V37, P12, DOI 10.1111/j.1442-9993.2011.02243.x; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Shen YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057125; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Smith CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109522; Stephens D, 2015, MOL ECOL, V24, P5643, DOI 10.1111/mec.13416; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teeling EC, 2000, NATURE, V403, P188, DOI 10.1038/35003188; Tidemann CR, 2004, J ZOOL, V263, P141, DOI 10.1017/S0952836904004960; Walker FM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162342; Webb N. J., 1995, Australian Mammalogy, V18, P19; Webb NJ, 1996, P ROY SOC B-BIOL SCI, V263, P497, DOI 10.1098/rspb.1996.0075	52	4	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194908	10.1371/journal.pone.0194908	http://dx.doi.org/10.1371/journal.pone.0194908			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634748	Green Published, Green Submitted, gold			2022-12-26	WOS:000429522200015
J	Fix, SM; Papadopoulou, V; Velds, H; Kasoji, SK; Rivera, JN; Borden, MA; Chang, S; Dayton, PA				Fix, Samantha M.; Papadopoulou, Virginie; Velds, Hunter; Kasoji, Sandeep K.; Rivera, Judith N.; Borden, Mark A.; Chang, Sha; Dayton, Paul A.			Oxygen microbubbles improve radiotherapy tumor control in a rat fibrosarcoma model - A preliminary study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; RADIATION-THERAPY; NECK-CANCER; HYPOXIA; HEAD; DELIVERY; VOLUME; ULTRASOUND; ANEMIA; FUTURE	Cancer affects 39.6% of Americans at some point during their lifetime. Solid tumor microenvironments are characterized by a disorganized, leaky vasculature that promotes regions of low oxygenation (hypoxia). Tumor hypoxia is a key predictor of poor treatment outcome for all radiotherapy (RT), chemotherapy and surgery procedures, and is a hallmark of metastatic potential. In particular, the radiation therapy dose needed to achieve the same tumor control probability in hypoxic tissue as in normoxic tissue can be up to 3 times higher. Even very small tumors (<2-3 mm(3)) comprise 10-30% of hypoxic regions in the form of chronic and/or transient hypoxia fluctuating over the course of seconds to days. We investigate the potential of recently developed lipid-stabilized oxygen microbubbles (OMBs) to improve the therapeutic ratio of RT. OMBs, but not nitrogen microbubbles (NMBs), are shown to significantly increase dissolved oxygen content when added to water in vitro and increase tumor oxygen levels in vivo in a rat fibrosarcoma model. Tumor control is significantly improved with OMB but not NMB intra-tumoral injections immediately prior to RT treatment and effect size is shown to depend on initial tumor volume on RT treatment day, as expected.	[Fix, Samantha M.; Dayton, Paul A.] Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Papadopoulou, Virginie; Kasoji, Sandeep K.; Chang, Sha; Dayton, Paul A.] Univ North Carolina Chapel Hill, Joint Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Papadopoulou, Virginie; Kasoji, Sandeep K.; Chang, Sha; Dayton, Paul A.] NC State Univ, Chapel Hill, NC 27599 USA; [Velds, Hunter] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA; [Rivera, Judith N.; Borden, Mark A.; Chang, Sha] Univ North Carolina Chapel Hill, Dept Radiat Oncol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; North Carolina State University; University of Colorado System; University of Colorado Boulder; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Dayton, PA (corresponding author), Univ North Carolina Chapel Hill, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA.; Dayton, PA (corresponding author), Univ North Carolina Chapel Hill, Joint Dept Biomed Engn, Chapel Hill, NC 27599 USA.; Dayton, PA (corresponding author), NC State Univ, Chapel Hill, NC 27599 USA.	padayton@email.unc.edu	Papadopoulou, Virginie/E-5471-2013	Papadopoulou, Virginie/0000-0003-3395-3003; Kasoji, Sunny/0000-0002-4219-3424; Fix, Samantha/0000-0002-1608-4646	National Institutes of Health [R21 HL129144, R01 CA170665, F31CA220970]; Eshelman Institute for Innovation, University of North Carolina at Chapel Hill; Carolina Center of Cancer Nanotechnology Excellence, University of North Carolina - Chapel Hill; Office of Naval Research [11766740, N00014-15-1-2274]; Division Of Materials Research [1409972] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA170665] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL129144] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eshelman Institute for Innovation, University of North Carolina at Chapel Hill; Carolina Center of Cancer Nanotechnology Excellence, University of North Carolina - Chapel Hill; Office of Naval Research(Office of Naval Research); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health (nih.gov) R21 HL129144 (M.B.), R01 CA170665 (P.A.D.), and F31CA220970 (S.F.); Eshelman Institute for Innovation, University of North Carolina at Chapel Hill (S.C.); Carolina Center of Cancer Nanotechnology Excellence, University of North Carolina - Chapel Hill (S.C.); as well as Office of Naval Research (onr.navy.mil; Undersea Medicine) 11766740 and N00014-15-1-2274 to M.A.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society for Radiation Oncology, 2017, FAST FACTS RAD THER; Barnett GC, 2009, NAT REV CANCER, V9, P134, DOI 10.1038/nrc2587; Bradley JD, 2002, INT J RADIAT ONCOL, V52, P49, DOI 10.1016/S0360-3016(01)01772-2; Branco-Price C, 2012, CANCER CELL, V21, P52, DOI 10.1016/j.ccr.2011.11.017; BROWN JM, 1979, BRIT J RADIOL, V52, P650, DOI 10.1259/0007-1285-52-620-650; Cardenas-Navia LI, 2008, CANCER RES, V68, P5812, DOI 10.1158/0008-5472.CAN-07-6387; Cardenas-Navia LI, 2004, CANCER RES, V64, P6010, DOI 10.1158/0008-5472.CAN-03-0947; Chang JY, 2008, INT J RADIAT ONCOL, V72, P967, DOI 10.1016/j.ijrobp.2008.08.001; Chen M, 2002, AM J CLIN ONCOL-CANC, V25, P76, DOI 10.1097/00000421-200202000-00016; Curtis KK, 2016, CRIT REV ONCOL HEMAT, V103, P86, DOI 10.1016/j.critrevonc.2016.05.005; Doweck I, 2002, LARYNGOSCOPE, V112, P1742, DOI 10.1097/00005537-200210000-00006; Dubben HH, 1998, RADIOTHER ONCOL, V47, P167, DOI 10.1016/S0167-8140(97)00215-6; Dubray B, 1996, RADIOLOGY, V201, P553, DOI 10.1148/radiology.201.2.8888257; Dunn TJ, 1999, BRIT J CANCER, V80, P117, DOI 10.1038/sj.bjc.6690330; Evans SM, 2003, CANCER LETT, V195, P1, DOI 10.1016/S0304-3835(03)00012-0; Feshitan JA, 2014, BIOMATERIALS, V35, P2600, DOI 10.1016/j.biomaterials.2013.12.070; Fix SM, 2015, J CONTROL RELEASE, V209, P139, DOI 10.1016/j.jconrel.2015.04.027; Fuks Z, 2005, CANCER CELL, V8, P89, DOI 10.1016/j.ccr.2005.07.014; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Gerbaulet A, 2002, EV GEC ESTRO HDB BRA; GRAY LH, 1953, BRIT J RADIOL, V26, P638, DOI 10.1259/0007-1285-26-312-638; Harrison L, 2001, SEMIN ONCOL, V28, P54, DOI 10.1053/sonc.2001.25399; Harrison LB., 2000, ONCOLOGIST S, V5, P1, DOI [DOI 10.1634/THEONCOLOGIST.5-SUPPL_2-1, 10.1634/theoncologist.5-suppl_2-1]; HIRST DG, 1991, RADIOTHER ONCOL, V20, P29, DOI 10.1016/0167-8140(91)90183-H; HODGKISS RJ, 1987, INT J RADIAT BIOL, V52, P735, DOI 10.1080/09553008714552241; Kaanders JHAM, 2004, SEMIN RADIAT ONCOL, V14, P233, DOI 10.1016/j.semradonc.2004.04.002; KALLMAN RF, 1972, RADIOLOGY, V105, P135, DOI 10.1148/105.1.135; Kasoji SK, 2017, THERANOSTICS; Kheir JN, 2016, P NATL ACAD SCI USA, V113, pE8010, DOI 10.1073/pnas.1618152114; Krause M, 2017, ADV DRUG DELIVER REV, V109, P63, DOI 10.1016/j.addr.2016.02.002; Kwan JJ, 2012, THERANOSTICS, V2, P1174, DOI 10.7150/thno.4410; Kwok SJJ, 2013, ULTRASOUND MED BIOL, V39, P1983, DOI 10.1016/j.ultrasmedbio.2013.03.025; Legband ND, 2015, IEEE T BIO-MED ENG, V62, P1376, DOI 10.1109/TBME.2015.2388611; Liu L, 2015, CANCER LETT, V361, P147, DOI 10.1016/j.canlet.2015.02.052; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; McEwan C, 2016, BIOMATERIALS, V80, P20, DOI 10.1016/j.biomaterials.2015.11.033; McEwan C, 2015, J CONTROL RELEASE, V203, P51, DOI 10.1016/j.jconrel.2015.02.004; Mendenhall WM, 2005, CANCER-AM CANCER SOC, V104, P332, DOI 10.1002/cncr.21146; Moeller BJ, 2007, CANCER METAST REV, V26, P241, DOI 10.1007/s10555-007-9056-0; National Cancer Institute at National Institute of Health, 2017, CANC STAT; Overgaard J, 2007, J CLIN ONCOL, V25, P4066, DOI 10.1200/JCO.2007.12.7878; Pitson G, 2001, INT J RADIAT ONCOL, V51, P699, DOI 10.1016/S0360-3016(01)01662-5; Rankin EB, 2016, SCIENCE, V352, P175, DOI 10.1126/science.aaf4405; Reinhold H S, 1977, Bibl Anat, P270; Rockwell S, 2009, CURR MOL MED, V9, P442, DOI 10.2174/156652409788167087; Rwigema JCM, 2011, AM J CLIN ONCOL-CANC, V34, P372, DOI 10.1097/COC.0b013e3181e84dc0; Sangro B, 2004, J CLIN ONCOL, V22, P1389, DOI 10.1200/JCO.2004.04.059; Schroeder T, 2005, CANCER RES, V65, P5163, DOI 10.1158/0008-5472.CAN-04-3900; SEMENZA GL, 2016, BBA-MOL CELL RES, V1863, P382, DOI DOI 10.1016/J.BBAMCR.2015.05.036; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Shirley LA, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/207129; Smith BD, 2010, J CLIN ONCOL, V28, P5160, DOI 10.1200/JCO.2010.31.2520; Span PN, 2016, P NATL ACAD SCI USA, V113, pE8009, DOI 10.1073/pnas.1617279114; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Swanson EJ, 2010, LANGMUIR, V26, P15726, DOI 10.1021/la1029432; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Vishwanath K, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3251013; Walsh JC, 2014, ANTIOXID REDOX SIGN, V21, P1516, DOI 10.1089/ars.2013.5378; Yuan H, 2006, J NUCL MED, V47, P989	59	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195667	10.1371/journal.pone.0195667	http://dx.doi.org/10.1371/journal.pone.0195667			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630640	Green Published, Green Submitted, gold			2022-12-26	WOS:000429505000068
J	Khan, G; Ribeiro, PM; Bonatelli, IAS; Perez, MF; Franco, FF; Moraes, EM				Khan, Gulzar; Ribeiro, Paulianny M.; Bonatelli, Isabel A. S.; Perez, Manolo F.; Franco, Fernando F.; Moraes, Evandro M.			Weak population structure and no genetic erosion in Pilosocereus aureispinus: A microendemic and threatened cactus species from eastern Brazil	PLOS ONE			English	Article							POLYMORPHIC MICROSATELLITE LOCI; ASTROPHYTUM-ASTERIAS; CONSERVATION; SOFTWARE; MARKERS; RARE; AMPLIFICATION; CONSEQUENCES; DIVERSITY; PHYLOGEOGRAPHY	Succulent cacti (Cactaceae) are among the most threatened taxonomic groups assessed to date. Here we evaluated the genetic diversity and population structure of a narrow endemic columnar cactus Pilosocereus aureispinus. This species is only found in a small area of c. 300 km(2) of rocky savanna from eastern Brazil and it is currently classified as vulnerable (VU) on the International Union for Conservation of Nature (IUCN) red list. Eight microsatellite loci were genotyped for 91 individuals from four localities of the known P. aureispinus range. In contrast with expectations for narrow endemic species, we found relatively high levels of genetic diversity (e.g., H-E = 0.390 to 0.525; H-O = 0.394 to 0.572) and very low population structure based on the variation of six loci. All the analyzed individuals were clustered in one unique genetic group in assignment tests. We also generated the sequences of two plastid markers (trnT-trnL and psbD-trnT) and found no variation on a subsample of 39 individuals. We used Landsat 8 images and Normalized Difference Vegetation Index to estimate a potential extent of occurrence of c. 750 km(2) for this species. Our results showed that P. aureispinus is not suffering from erosion of nuclear genetic variability due to its narrow distribution. However, we advocate that because of the extremely limited extent of occurrence, the ongoing anthropogenic disturbances in its habitat, and phylogenetic distinctiveness of P. aureispinus, this species should be classified as endangered (EN) on the IUCN Red List.	[Khan, Gulzar; Ribeiro, Paulianny M.; Bonatelli, Isabel A. S.; Perez, Manolo F.; Franco, Fernando F.; Moraes, Evandro M.] Univ Fed Sao Carlos, Dept Biol, Sorocaba, SP, Brazil	Universidade Federal de Sao Carlos	Moraes, EM (corresponding author), Univ Fed Sao Carlos, Dept Biol, Sorocaba, SP, Brazil.	emarsola@ufscar.br	Perez, Manolo Fernandez/H-2243-2012; Khan, Gulzar/K-1895-2015; Moraes, Evandro M./A-4387-2009; Bonatelli, Isabel A. S./D-2361-2015; Khan, Gulzar/G-2730-2014	Perez, Manolo Fernandez/0000-0002-4642-7793; Moraes, Evandro M./0000-0003-4197-0794; Khan, Gulzar/0000-0003-0281-4270; gulzar, khan/0000-0001-6870-8935; da Silva Bonatelli, Isabel Aparecida/0000-0002-0930-1411	Sao Paulo Research Foundation (FAPESP) [2005/55200-8]; Brazilian Council of Scientific and Technological Development (CNPq) [471963/2007-0, 500903/2009-3]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported through grants from the Sao Paulo Research Foundation (FAPESP) (2005/55200-8 to EMM) and Brazilian Council of Scientific and Technological Development (CNPq) (471963/2007-0 and 500903/2009-3 to EMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakaki M, 2013, J HERED, V104, P127, DOI 10.1093/jhered/ess072; Arakaki M, 2010, AM J BOT, V97, pE17, DOI 10.3732/ajb.1000026; Bachman S, 2011, ZOOKEYS, P117, DOI 10.3897/zookeys.150.2109; Balloux F, 2003, GENETICS, V164, P1635; Bengtsson BO, 2003, J EVOLUTION BIOL, V16, P189, DOI 10.1046/j.1420-9101.2003.00523.x; Bonatelli IAS, 2013, GENET MOL RES, V12, P4579, DOI 10.4238/2013.February.28.27; Bonatelli IAS, 2014, MOL ECOL, V23, P3044, DOI 10.1111/mec.12780; Calvente A, 2017, BOT J LINN SOC, V183, P25; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Collevatti RG, 2012, ECOL EVOL, V2, P1024, DOI 10.1002/ece3.236; Barbosa NPD, 2015, ACTA BOT BRAS, V29, P299, DOI 10.1590/0102-33062014abb3731; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Figueredo CJ, 2010, J ARID ENVIRON, V74, P1392, DOI 10.1016/j.jaridenv.2010.05.020; Forrest A, 2017, BOT J LINN SOC, V183, P260, DOI 10.1093/botlinnean/bow002; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Gitzendanner MA, 2000, AM J BOT, V87, P783, DOI 10.2307/2656886; Goettsch B, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2015.142, 10.1038/NPLANTS.2015.142]; Gorostiague P, 2016, PLANT BIOLOGY, V18, P63, DOI 10.1111/plb.12297; Hamilton JA, 2007, MOL ECOL, V16, P1649, DOI 10.1111/j.1365-294X.2007.03241.x; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; Hardesty BD, 2008, MOL ECOL RESOUR, V8, P164, DOI 10.1111/j.1471-8286.2007.01913.x; He KS, 2015, REMOTE SENS ECOL CON, V1, P4, DOI 10.1002/rse2.7; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Hopper SD, 2009, PLANT SOIL, V322, P49, DOI 10.1007/s11104-009-0068-0; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Hughes SL, 2008, MOL ECOL RESOUR, V8, P1068, DOI 10.1111/j.1755-0998.2008.02157.x; Hunt D., 2006, NEW CACTUS LEXICON A; IUCN Standards and Petitions Committee, 2022, GUID US IUCN RED LIS; Jesus AA, 2014, TAXON, V63, P1150; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Jones RC, 2005, AUST J BOT, V53, P367, DOI 10.1071/BT04182; Kang U, 2000, J PLANT RES, V113, P127, DOI 10.1007/PL00013923; Leal BSS, 2016, BOT J LINN SOC, V181, P621, DOI 10.1111/boj.12437; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; MANTEL N, 1967, CANCER RES, V27, P209; Martins APV, 2012, AM J BOT, V99, pE289, DOI 10.3732/ajb.1100611; Maya-Garcia R, 2017, PLANT DIVERSITY, V39, P13, DOI 10.1016/j.pld.2016.09.005; Meirmans PG, 2015, MOL ECOL, V24, P3223, DOI 10.1111/mec.13243; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Moraes EM, 2014, GENET MOL RES, V13, P10359, DOI 10.4238/2014.December.4.31; Moraes EM, 2012, GENETICA, V140, P277, DOI 10.1007/s10709-012-9678-1; Moreira RG, 2010, CONSERV GENET, V11, P1247, DOI 10.1007/s10592-009-9953-6; Orsini L, 2013, MOL ECOL, V22, P583, DOI 10.1111/mec.12117; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perez MF, 2011, AM J BOT, V98, pE204, DOI 10.3732/ajb.1100033; Pimienta-Barrios E., 2002, CACTI BIOL USES, P163, DOI DOI 10.1525/CALIFORNIA/9780520231573.003.0005; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Prates-Clark CD, 2008, ECOL MODEL, V211, P309, DOI 10.1016/j.ecolmodel.2007.09.024; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rocha E. A., 2007, Bradleya, V25, P129; Romeiro-Brito M, 2016, APPL PLANT SCI, V4, DOI 10.3732/apps.1500074; Leal BSS, 2014, BIOCHEM SYST ECOL, V55, P305, DOI 10.1016/j.bse.2014.03.036; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Silva GAR, 2016, BIOCHEM SYST ECOL, V65, P137, DOI 10.1016/j.bse.2016.02.001; Silveira FAO, 2016, PLANT SOIL, V403, P129, DOI 10.1007/s11104-015-2637-8; Solorzano S, 2009, MOL ECOL RESOUR, V9, P156, DOI 10.1111/j.1755-0998.2008.02422.x; Solorzano S, 2015, PLANT ECOL DIVERS, V8, P559, DOI 10.1080/17550874.2015.1044581; Solorzano S, 2014, REV MEX BIODIVERS, V85, P565, DOI 10.7550/rmb.39066; Souza VC, 2005, BOT SISTEMATICA, V1st; Taylor N.P., 2004, CACTI E BRAZIL; Terry M, 2006, MOL ECOL NOTES, V6, P865, DOI 10.1111/j.1471-8286.2006.01377.x; Terry MK, 2012, SOUTHWEST NAT, V57, P182, DOI 10.1894/0038-4909-57.2.182; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Winter M, 2013, TRENDS ECOL EVOL, V28, P199, DOI 10.1016/j.tree.2012.10.015; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Zappi D, 2013, IUCN RED LIST THREAT; Zappi D.C., 1994, PILOSOCEREUS CACTACE	77	7	7	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195475	10.1371/journal.pone.0195475	http://dx.doi.org/10.1371/journal.pone.0195475			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630653	Green Published, gold, Green Submitted			2022-12-26	WOS:000429505000051
J	Kim, H; Kwak, W; Yoon, SH; Kang, DK; Kim, H				Kim, Hyaekang; Kwak, Woori; Yoon, Sook Hee; Kang, Dae-Kyung; Kim, Heebal			Horizontal gene transfer of Chlamydia: Novel insights from tree reconciliation	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; TRACHOMATIS STRAINS; IN-VITRO; EVOLUTION; BACTERIAL; GENOME; POPULATIONS; ANNOTATION; DIVERSITY; MECHANISM	Recent comparative genomics studies have suggested that horizontal gene transfer (HGT) is one of the major processes in bacterial evolution. In this study, HGT events of 64 Chlamydia strains were investigated based on the pipeline employed in HGTree database constructed in our recent study. Tree reconciliation method was applied in order to calculate feasible HGT events. Following initial detection and an evaluation procedure, evidence of the HGT was identified in 548 gene families including 42 gene families transferred from outside of Chlamydiae phylum with high reliability. The donor species of inter-phylum HGT consists of 12 different bacterial and archaeal phyla, suggesting that Chlamydia might have even more various host range than in previous reports. In addition, each species of Chlamydia showed varying preference towards HGT, and genes engaged in HGT within Chlamydia and between other species showed different functional distribution. Also, examination of individual gene flows of niche-specific genes suggested that many of such genes are transferred mainly within Chlamydia genus. Our results uncovered novel features of HGT acting on Chlamydia genome evolution, and it would be also strong evidence that HGT is an ongoing process for intracellular pathogens. We expect that the results provide more insight into lineage- and niche-specific adaptations regarding their infectivity and pathogenicity.	[Kim, Hyaekang; Yoon, Sook Hee; Kim, Heebal] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Hyaekang; Yoon, Sook Hee; Kim, Heebal] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Kwak, Woori; Kim, Heebal] Seoul Natl Univ, C&K Genom, Res Pk, Seoul, South Korea; [Kang, Dae-Kyung] Dankook Univ, Dept Anim Resources Sci, Cheonan, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Dankook University	Kim, H (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.; Kim, H (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea.; Kim, H (corresponding author), Seoul Natl Univ, C&K Genom, Res Pk, Seoul, South Korea.	heebal@snu.ac.kr	Kim, Heebal/A-8889-2016	Kim, Heebal/0000-0003-3064-1303	NextGeneration BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ01115901]	NextGeneration BioGreen 21 Program, Rural Development Administration, Republic of Korea	This work was supported by a grant from the NextGeneration BioGreen 21 Program (PJ01115901), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; BEATTY WL, 1994, INFECT IMMUN, V62, P3705, DOI 10.1128/IAI.62.9.3705-3711.1994; Bennett J., 2014, PRINCIPLES PRACTICE; Betts-Hampikian HJ, 2010, OBLIGATE INTRACELLUL, V71; Borel N, 2016, CURR CLIN MICROBIOL, V3, P10, DOI 10.1007/s40588-016-0028-4; Bose T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142102; Caro-Quintero A, 2015, ISME J, V9, P958, DOI 10.1038/ismej.2014.193; Cenci U, 2016, FRONTIERS CELLULAR I, P6; Cohen E, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.098102; Cohen O, 2011, MOL BIOL EVOL, V28, P1481, DOI 10.1093/molbev/msq333; Collingro A, 2011, MOL BIOL EVOL, V28, P3253, DOI 10.1093/molbev/msr161; Corsaro D, 2003, CRIT REV MICROBIOL, V29, P37, DOI 10.1080/713610404; Corsaro Daniele, 2002, Microbiology (Reading), V148, P343, DOI 10.1099/00221287-148-2-343; DeMars R, 2008, J BACTERIOL, V190, P1605, DOI 10.1128/JB.01592-07; Denamur E, 2000, CELL, V103, P711, DOI 10.1016/S0092-8674(00)00175-6; Fehlner-Gardiner C, 2002, J BIOL CHEM, V277, P26893, DOI 10.1074/jbc.M203937200; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Groisman EA, 1996, CELL, V87, P791, DOI 10.1016/S0092-8674(00)81985-6; Gupta RS, 2015, ANTON LEEUW INT J G, V108, P765, DOI 10.1007/s10482-015-0532-1; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Horn M, 2001, FEMS MICROBIOL LETT, V204, P71, DOI 10.1111/j.1574-6968.2001.tb10865.x; Horn M, 2008, ANNU REV MICROBIOL, V62, P113, DOI 10.1146/annurev.micro.62.081307.162818; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jeffrey BM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-142; Jelocnik M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2053-8; Jeong H, 2015, NUCLEIC ACIDS RES; Joseph SJ, 2012, MOL BIOL EVOL; Junier T, 2010, BIOINFORMATICS, V26, P1669, DOI 10.1093/bioinformatics/btq243; Kim KM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn485; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Kordi M, 2017, IEEE ACM T COMPUTATI; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lawrence JG, 2005, CURR OPIN MICROBIOL, V8, P572, DOI 10.1016/j.mib.2005.08.005; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Lind PA, 2010, EVOLUTIONARY DYNAMIC; Longbottom D, 2003, J COMP PATHOL, V128, P217, DOI 10.1053/jcpa.2002.0629; Mariotti SP, 2009, BRIT J OPHTHALMOL, V93, P563, DOI 10.1136/bjo.2008.148494; Nunes A, 2014, INFECT GENET EVOL, V23, P49, DOI 10.1016/j.meegid.2014.01.029; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; Polz MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/j.tig.2012.12.006; Raz Y, 2010, GENETICS, V185, P327, DOI 10.1534/genetics.109.113613; Read TD, 2013, MBIO, V4, DOI 10.1128/mBio.00604-12; Ribet D, 2015, MICROBES INFECT, V17, P173, DOI 10.1016/j.micinf.2015.01.004; Rosenwald A.G., 2014, BACTERIOPHAGE, V4, DOI [10.4161/21597073.2014.965076, DOI 10.4161/21597073.2014.965076]; Roulis E, 2013, TRENDS MICROBIOL, V21, P120, DOI 10.1016/j.tim.2012.10.009; Sennblad B, 2009, SYST BIOL, V58, P411, DOI 10.1093/sysbio/syp046; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soucy SM, 2015, NAT REV GENET, V16, P472, DOI 10.1038/nrg3962; Srinivasan T, 2012, J BACTERIOL, V194, P617, DOI 10.1128/JB.06268-11; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stecher B, 2013, NAT REV MICROBIOL, V11, P277, DOI 10.1038/nrmicro2989; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Suchland RJ, 2009, ANTIMICROB AGENTS CH, V53, P4604, DOI 10.1128/AAC.00477-09; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Taylor LD, 2010, INFECT IMMUN, V78, P2691, DOI 10.1128/IAI.01455-09; Yeruva L, 2013, PATHOG DIS, V68, P88, DOI 10.1111/2049-632X.12052	57	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195139	10.1371/journal.pone.0195139	http://dx.doi.org/10.1371/journal.pone.0195139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621277	Green Submitted, Green Published, gold			2022-12-26	WOS:000429206800042
J	Le Moullec, N; Fianu, A; Maillard, O; Chazelle, E; Naty, N; Schneebeli, C; Gerardin, P; Huiart, L; Charles, MA; Favier, F				Le Moullec, Nathalie; Fianu, Adrian; Maillard, Olivier; Chazelle, Emilie; Naty, Nadege; Schneebeli, Chantal; Gerardin, Patrick; Huiart, Laetitia; Charles, Marie-Aline; Favier, Francois			Sexual dimorphism in the association between gestational diabetes mellitus and overweight in offspring at 5-7 years: The OBEGEST cohort study	PLOS ONE			English	Article							IN-UTERO EXPOSURE; REUNION ISLAND; OBESITY; CHILDHOOD; PREGNANCY; RISK; PREVALENCE; HYPERGLYCEMIA; ENVIRONMENT; GLYCEMIA	Evidence from literature is mixed regarding a possible association of maternal gestational diabetes mellitus (GDM) and overweight in the offspring. Sexual dimorphism, or sex disparities in the pathogenesis linking GDM exposure to overweight, could be at play. The objective of this study was to investigate the association between GDM and child overweight at 5-7 years. Six hundred pairs (1:1) of Reunionese liveborn singletons selected from a hospital based birth registry, matched for sex, gestational age, and birth period, underwent a prospective in-home follow-up and were analyzed with respect to their exposure to GDM. The primary outcome was child overweight at 5-7 years, as defined by the International Obesity Task Force. The association between GDM exposure and child overweight was estimated by the odds ratio (OR) using conditional logistic regression models. For the subset of children exposed to GDM with available maternal glycemic data, we analyzed the relationship between maternal glycemic levels during pregnancy and child body mass index (BMI) at 5-7 years with a linear regression model. In light of the significant interaction between sex and GDM, all statistical analyses were then stratified by sex. After controlling for pre-pregnancy BMI and maternal sociodemographic characteristics, the risk of overweight increased with exposure to GDM for boys (adjusted OR: 2.34; 95% confidence interval = 1.26-4.34, P = 0.007) but not for girls (adjusted OR: 0.56; 95%Cl = 0.28-1.10, P=0.093). Consistent with this, the linear increase of boys' BMI at 5-7 years with maternal blood glucose levels during pregnancy, in the exposed group, displayed a dose-response relationship. Our findings indicate that exposure to GDM is a risk factor for childhood overweight in boys but not in girls, which adds to the growing body of evidence suggesting greater sensitivity of male offspring to intrauterine hyperglycemia.	[Le Moullec, Nathalie] CHU Reunion, Dept Endocrinol Diabetol & Nutr, St Pierre, Reunion, France; [Fianu, Adrian; Maillard, Olivier; Chazelle, Emilie; Naty, Nadege; Schneebeli, Chantal; Gerardin, Patrick; Huiart, Laetitia; Favier, Francois] Univ Reunion, CHU Reunion, INSERM CIC Clin & Epidemiol 1410, St Pierre, Reunion, France; [Fianu, Adrian] Univ Toulouse, UMR1027, UPS, INSERM, Toulouse, France; [Charles, Marie-Aline] Ctr Res Epidemiol & Populat Hlth, Paris, France; [Charles, Marie-Aline] Paris Descartes Univ, Paris, France	CHU Reunion; CHU Reunion; University of La Reunion; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; Universite Paris Cite	Fianu, A (corresponding author), Univ Reunion, CHU Reunion, INSERM CIC Clin & Epidemiol 1410, St Pierre, Reunion, France.; Fianu, A (corresponding author), Univ Toulouse, UMR1027, UPS, INSERM, Toulouse, France.	adrian.fianu@chu-reunion.fr	Charles, Marie Aline/S-1866-2019; Charles, Marie Aline/F-8567-2017	Charles, Marie Aline/0000-0003-4025-4390; Charles, Marie Aline/0000-0003-4025-4390; maillard, olivier/0000-0001-6677-3952	Centre Hospitalier Universitaire (CHU) Reunion; Groupement Interregional de Recherche Clinique et d'Innovation (GIRCI) Sud Ouest Outre Mer	Centre Hospitalier Universitaire (CHU) Reunion; Groupement Interregional de Recherche Clinique et d'Innovation (GIRCI) Sud Ouest Outre Mer	The Centre Hospitalier Universitaire (CHU) Reunion was the study sponsor. The OBEGEST cohort study was carried out with financial support from Groupement Interregional de Recherche Clinique et d'Innovation (GIRCI) Sud Ouest Outre Mer (2008 PHRC-I grant). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht SS, 2010, DIABETES CARE, V33, P768, DOI 10.2337/dc09-1801; Allirot X, 2007, DIABETES METAB, V33, P347, DOI 10.1016/j.diabet.2007.03.006; American Diabetes Association, 2004, DIABETES CARE S1, V27, pS88, DOI [10.2337/diacare.27.2007.S88, DOI 10.2337/DIACARE.27.2007.S88]; Aris IM, 2015, AM J CLIN NUTR, V102, P1104, DOI 10.3945/ajcn.115.117614; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Buchanan TA, 2007, DIABETES CARE, V30, P3154; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Coustan DR, 2013, CLIN CHEM, V59, P1310, DOI 10.1373/clinchem.2013.203331; Coustan DR, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.04.006; Dabelea D, 2007, DIABETES CARE, V30, pS169, DOI 10.2337/dc07-s211; Damm P, 2009, INT J GYNECOL OBSTET, V104, pS25, DOI 10.1016/j.ijgo.2008.11.025; Daraki V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126327; Durnwald C, 2015, SEMIN PERINATOL, V39, P254, DOI 10.1053/j.semperi.2015.05.002; Favier F, 2005, DIABETES RES CLIN PR, V67, P234, DOI 10.1016/j.diabres.2004.07.013; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; Gupta Y, 2015, INT J WOMENS HEALTH, V7, P539, DOI 10.2147/IJWH.S82046; Hall E, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0522-z; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Hillier TA, 2007, DIABETES CARE, V30, P2287, DOI 10.2337/dc06-2361; Kalisch-Smith JI, 2017, PLACENTA, V54, P10, DOI 10.1016/j.placenta.2016.12.008; Kim SY, 2011, EXP DIABETES RES, DOI 10.1155/2011/541308; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR, P377; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Lawlor DA, 2011, CIRCULATION, V123, P258, DOI 10.1161/CIRCULATIONAHA.110.980169; Li SS, 2017, INT J EPIDEMIOL, V46, P1533, DOI [10.1093/ije/dyx211, 10.1093/ije/dyx151]; Lingwood BE, 2011, DIABETES CARE, V34, P2581, DOI 10.2337/dc11-0728; Mariotti E, 2013, CORPULENCE ENFANTS C; Metzger BE, 2009, DIABETES, V58, P453, DOI 10.2337/db08-1112; Monteiro LJ, 2016, PLACENTA, V48, pS54, DOI 10.1016/j.placenta.2015.11.015; Mueller NT, 2015, INT J OBESITY, V39, P665, DOI 10.1038/ijo.2014.180; Oken E, 2016, AM J PERINAT, V33, P1273, DOI 10.1055/s-0036-1586509; Pettitt DJ, 2010, DIABETES CARE, V33, P1219, DOI 10.2337/dc09-2384; Philipps LH, 2011, DIABETOLOGIA, V54, P1957, DOI 10.1007/s00125-011-2180-y; Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603; Regnault N, 2013, DIABETES CARE, V36, P3045, DOI 10.2337/dc13-0333; Ruchat SM, 2013, NUTR REV, V71, pS88, DOI 10.1111/nure.12057; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Silverman BL, 1998, DIABETES CARE, V21, pB142; Tam WH, 2017, DIABETES CARE, V40, P679, DOI 10.2337/dc16-2397; Vivet-Lefebure A, 2007, GYNECOL OBSTET FERTI, V35, P530, DOI 10.1016/j.gyobfe.2007.04.010; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; Wilkin TJ, 2006, INT J OBESITY, V30, P1056, DOI 10.1038/sj.ijo.0803317; Yang I, 2016, NURS RES, V65, P76, DOI 10.1097/NNR.0000000000000133; Zhao YL, 2015, J DEV ORIG HLTH DIS, V6, P479, DOI 10.1017/S2040174415007205; Zhu YY, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0699-x	46	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195531	10.1371/journal.pone.0195531	http://dx.doi.org/10.1371/journal.pone.0195531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621322	Green Submitted, Green Published, gold			2022-12-26	WOS:000429206800098
J	Mizuguchi, Y; Morimoto, S; Kimura, S; Takano, N; Yamashita, K; Seki, Y; Bokuda, K; Yatabe, M; Yatabe, J; Watanabe, D; Ando, T; Ichihara, A				Mizuguchi, Yuki; Morimoto, Satoshi; Kimura, Shihori; Takano, Noriyoshi; Yamashita, Kaoru; Seki, Yasufumi; Bokuda, Kanako; Yatabe, Midori; Yatabe, Junichi; Watanabe, Daisuke; Ando, Takashi; Ichihara, Atsuhiro			Prediction of response to medical therapy by serum soluble (pro)renin receptor levels in Graves' disease	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; RENIN-ANGIOTENSIN SYSTEM; PRORENIN RECEPTOR; DRUG-THERAPY; HYPERTHYROIDISM; RATS	Antithyroid drugs are generally selected as the first-line treatment for Graves' Disease (GD); however, the existence of patients showing resistance or severe side effects to these drugs is an important issue to be solved. The (pro)renin receptor [(P)RR] is a multi-functional protein that activates the tissue renin-angiotensin system and is an essential constituent of vacuolar H+-ATPase, necessary for the autophagy-lysosome pathway. (P)RR is cleaved to soluble (s)(P)RR, which reflects the status of (P)RR expression. In this retrospective study, we aimed to investigate whether serum s(P)RR concentration can be used as a biomarker to predict the outcome of antithyroid drug treatment in GD patients. Serum s(P)RR levels were measured in 54 untreated GD patients and 47 control participants. Effects of medical treatment with antithyroid drugs on these levels were investigated in GD patients. Serum s (P)RR levels were significantly higher in patients with Graves' disease than in control subjects (P<0.005) and were significantly reduced after medical treatment for Graves' disease. High serum s(P)RR levels were associated with resistance to antithyroid drug treatment, suggesting that serum s(P)RR concentration can be used as a useful biomarker to predict the outcome of antithyroid drug treatment in these patients. Patients with Graves' disease with low body mass index showed higher levels of serum soluble (pro)renin receptor levels than those with high body mass index. In addition, in patients with Graves' disease, serum triglyceride levels were negatively correlated with serum soluble (pro)renin receptor levels. All these data indicated an association between low nutrient condition due to hyperthyroidism and increased (pro)renin receptor expression in these patients, suggesting that (pro) renin receptor expression could be increased in the process of stimulating intracellular energy production via activating autophagy function to compensate energy loss.	[Mizuguchi, Yuki; Morimoto, Satoshi; Kimura, Shihori; Takano, Noriyoshi; Yamashita, Kaoru; Seki, Yasufumi; Bokuda, Kanako; Yatabe, Midori; Yatabe, Junichi; Watanabe, Daisuke; Ando, Takashi; Ichihara, Atsuhiro] Tokyo Womens Med Univ, Dept Med Endocrinol & Hypertens 2, Tokyo, Japan	Tokyo Women's Medical University	Morimoto, S (corresponding author), Tokyo Womens Med Univ, Dept Med Endocrinol & Hypertens 2, Tokyo, Japan.	smorimoto@endm.twmu.ac.jp	Seki, Yasufumi/GXN-0888-2022	Seki, Yasufumi/0000-0002-1950-7704; Yamashita, Kaoru/0000-0001-7922-8275	Ministry of Education, Culture, Sports, Science and Technology of Japan [16K09657, 16H05316]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (number 16K09657 to S.M. and 16H05316 to A.I.) and a grant from the Institute of Science of Blood Pressure and Hormone (to Y.M.).; This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (number 16K09657 to S.M. and 16H05316 to A.I.) and a grant from the Institute of Science of Blood Pressure and Hormone (to Y.M.) In this research work, we gratefully acknowledge the technical support from Instruments of Medical Research Institute (MRI), Tokyo Women's Medical University.	Advani A, 2009, HYPERTENSION, V54, P261, DOI 10.1161/HYPERTENSIONAHA.109.128645; Amari Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158068; Andersen SL, 2016, J CLIN ENDOCR METAB, V101, P1606, DOI 10.1210/jc.2015-4274; ASHFORD TP, 1962, J CELL BIOL, V12, P198, DOI 10.1083/jcb.12.1.198; Barreto-Chaves MLM, 2010, VASC PHARMACOL, V52, P166, DOI 10.1016/j.vph.2009.10.009; Brandt F, 2012, J CLIN ENDOCR METAB, V97, P4123, DOI 10.1210/jc.2012-2268; Cooper DS, 2005, NEW ENGL J MED, V352, P905, DOI 10.1056/NEJMra042972; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; De Leo S, 2016, LANCET, V388, P906, DOI 10.1016/S0140-6736(16)00278-6; Ichihara A, 2010, HYPERTENS RES, V33, P177, DOI 10.1038/hr.2009.214; Kanda A, 2015, J BIOL CHEM, V290, P9690, DOI 10.1074/jbc.M114.626713; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Kobori H, 1997, AM J PHYSIOL-ENDOC M, V272, pE227, DOI 10.1152/ajpendo.1997.272.2.E227; Kobori H, 1997, AM J PHYSIOL-HEART C, V273, pH593, DOI 10.1152/ajpheart.1997.273.2.H593; Ludwig J, 1998, J BIOL CHEM, V273, P10939, DOI 10.1074/jbc.273.18.10939; Ma C, 2016, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/1465858.CD010094.PUB2; MARCHANT C, 1993, J CARDIOVASC PHARM, V22, P449, DOI 10.1097/00005344-199309000-00016; Maruyama Nobuhiro, 2013, Front Biosci (Elite Ed), V5, P583; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; MONTIEL M, 1984, J ENDOCRINOL INVEST, V7, P559, DOI 10.1007/BF03349486; Morimoto S, 2014, HYPERTENS RES, V37, P642, DOI 10.1038/hr.2014.46; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Oshima Y, 2011, J AM SOC NEPHROL, V22, P2203, DOI 10.1681/ASN.2011020202; Ruf J, 2006, ARCH BIOCHEM BIOPHYS, V445, P269, DOI 10.1016/j.abb.2005.06.023; SERNIA C, 1993, CARDIOVASC RES, V27, P423, DOI 10.1093/cvr/27.3.423; Sundaresh V, 2013, J CLIN ENDOCR METAB, V98, P3671, DOI 10.1210/jc.2013-1954; Vos XG, 2016, J CLIN ENDOCR METAB, V101, P1381, DOI 10.1210/jc.2015-3644; Watanabe N, 2013, J CLIN ENDOCR METAB, V98, P2528, DOI 10.1210/jc.2012-4139; Xiao FS, 2015, J CLIN ENDOCR METAB, V100, P3800, DOI 10.1210/jc.2015-1797	29	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195464	10.1371/journal.pone.0195464	http://dx.doi.org/10.1371/journal.pone.0195464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621332	Green Published, Green Submitted, gold			2022-12-26	WOS:000429206800089
J	Sommermann, L; Geistlinger, J; Wibberg, D; Deubel, A; Zwanzig, J; Babin, D; Schluter, A; Schellenberg, I				Sommermann, Loreen; Geistlinger, Joerg; Wibberg, Daniel; Deubel, Annette; Zwanzig, Jessica; Babin, Doreen; Schlueter, Andreas; Schellenberg, Ingo			Fungal community profiles in agricultural soils of a long-term field trial under different tillage, fertilization and crop rotation conditions analyzed by high-throughput ITS-amplicon sequencing	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; PIRIFORMOSPORA-INDICA; NO-TILLAGE; PLANT; TRICHODERMA; PROPAGULES; GRASSLAND; DATABASE; GENOME; BARLEY	Fungal communities in agricultural soils are assumed to be affected by soil and crop management. Our intention was to investigate the impact of different tillage and fertilization practices on fungal communities in a long-term crop rotation field trial established in 1992 in Central Germany. Two winter wheat fields in replicated strip-tillage design, comprising conventional vs. conservation tillage, intensive vs. extensive fertilization and different pre-crops (maize vs. rapeseed) were analyzed by a metabarcoding approach applying Illumina paired-end sequencing of amplicons generated by two recently developed primer pairs targeting the two fungal Internal Transcribed Spacer regions (ITS1, ITS2). Analysis of 5.1 million high-quality sequence reads uncovered a diverse fungal community in the two fields, composed of 296 fungal genera including 3,398 Operational Taxonomic Units (OTUs) at the 97% sequence similarity threshold. Both primer pairs detected the same fungal phyla (Basidio-, Asco-, Zygo-, Glomero- and Chytridiomycota), but in different relative abundances. OTU richness was higher in the ITS1 dataset, while ITS2 data were more diverse and of higher evenness. Effects of farming practice on fungal community structures were revealed. Almost two-thirds of the fungal genera were represented in all different soil treatments, whereas the remaining genera clearly responded to farming practice. Principal Component Analysis revealed four distinct clusters according to tillage practice and pre-crop. Analysis of Variance (ANOVA) substantiated the results and proved significant influences of tillage and pre-crop, while fertilization had the smallest and non-significant effect. In-depth analysis of putative phytopathogenic and plant beneficial fungal groups indicated distinct responses; for example Fusarium was significantly enriched in the intensively fertilized conservation tillage variants with the pre-crop maize, while Phoma displayed significant association with conventional tillage and pre-crop rapeseed. Many putative plant beneficial fungi also reacted differentially to farming practice with the most distinct responders identified among the Glomeromycota (arbuscular mycorrhizal fungi, AMF).	[Sommermann, Loreen; Geistlinger, Joerg; Zwanzig, Jessica; Schellenberg, Ingo] Anhalt Univ Appl Sci, Inst Bioanalyt Sci IBAS, Bernburg, Saxony Anhalt, Germany; [Wibberg, Daniel; Schlueter, Andreas] Bielefeld Univ, GRIM, Ctr Biotechnol CeBiTec, Bielefeld, North Rhine Wes, Germany; [Deubel, Annette] Anhalt Univ Appl Sci, Dept Agr Ecotrophol & Landscape Dev, Bernburg, Saxony Anhalt, Germany; [Schlueter, Andreas] JKI, Fed Res Ctr Cultivated Plants, Inst Epidemiol & Pathogen Diagnost, Braunschweig, Lower Saxony, Germany	University of Bielefeld; Julius Kuhn-Institut	Sommermann, L (corresponding author), Anhalt Univ Appl Sci, Inst Bioanalyt Sci IBAS, Bernburg, Saxony Anhalt, Germany.	loreen.sommermann@hs-anhalt.de	Babin, Doreen/J-3640-2019	Babin, Doreen/0000-0001-7144-8898; Sommermann, Loreen/0000-0002-6293-877X; Deubel, Annette/0000-0001-5504-3081; Schluter, Andreas/0000-0003-4830-310X	German Federal Ministry of Education and Research (Bundesministerium fur Bildung and Forschung, (BMBF)) [031A5606, 031A560C, 031A560D]	German Federal Ministry of Education and Research (Bundesministerium fur Bildung and Forschung, (BMBF))(Federal Ministry of Education & Research (BMBF))	The Disease Control (DiControl) project as a part of the funding initiative Soil as sustainable resource for bioeconomy (Bonares) was funded by the German Federal Ministry of Education and Research (Bundesministerium fur Bildung and Forschung, (BMBF), www.bmbf.de) to LS and JG (grant-no. 031A5606), to DB (grant-no. 031A560C) and to AS (grant-no. 031A560D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, EVOL BIOINFORM, V6, P189, DOI 10.4137/EBO.S6271; Abdelfattah A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131069; Bainard LD, 2009, WEED SCI, V57, P386, DOI 10.1614/WS-08-151.1; Balint M, 2014, ECOL EVOL, V4, P2642, DOI 10.1002/ece3.1107; Bankina B, 2013, ACTA AGR SCAND B-S P, V63, P723, DOI 10.1080/09064710.2013.861920; Bazzicalupo AL, 2013, FUNGAL ECOL, V6, P102, DOI 10.1016/j.funeco.2012.09.003; Bjonsgaard Aas A, 2016, MOL ECOL RESOUR; Blaalid R, 2013, MOL ECOL RESOUR, V13, P218, DOI 10.1111/1755-0998.12065; Borriello R., 2012, Biology and Fertility of Soils, V48, P911, DOI 10.1007/s00374-012-0683-4; Bowles T. M, 2016, J APPL ECOL; Castillo CG, 2006, BIOL FERT SOILS, V43, P83, DOI 10.1007/s00374-005-0067-0; Chaiyasen A, 2017, BIOL AGRIC HORTIC, V33, P52, DOI 10.1080/01448765.2016.1187670; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Deubel A, 2011, SOIL TILL RES, V117, P85, DOI 10.1016/j.still.2011.09.001; Dill-Macky R, 2000, PLANT DIS, V84, P71, DOI 10.1094/PDIS.2000.84.1.71; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Geiser DM, 2004, EUR J PLANT PATHOL, V110, P473, DOI 10.1023/B:EJPP.0000032386.75915.a0; Geistlinger Joerg, 2015, Diversity-Basel, V7, P360, DOI 10.3390/d7040360; Gosling P, 2014, MYCORRHIZA, V24, P1, DOI 10.1007/s00572-013-0505-z; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hannukkala AO, 2016, ANN APPL BIOL, V169, P257, DOI 10.1111/aab.12293; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Hijri I, 2006, MOL ECOL, V15, P2277, DOI 10.1111/j.1365-294X.2006.02921.x; Hu JL, 2015, CATENA, V133, P215, DOI 10.1016/j.catena.2015.05.023; Jansa J., 2006, FUNCTION SOILS HUMAN, V266, P89, DOI [DOI 10.1144/GSL.SP.2006.266.01.08, 10.1144/GSL.SP.2006.266.01.08]; Jones EE, 2014, BIOCONTROL SCI TECHN, V24, P1363, DOI 10.1080/09583157.2014.940847; Kirschner R, 2001, MYCOLOGIA, V93, P634, DOI 10.2307/3761818; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Lahlali R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094144; Laura V, 2017, AGR ECOSYST ENVIRON, V244, P32, DOI 10.1016/j.agee.2017.04.015; Lentendu G, 2014, MOL ECOL, V23, P3341, DOI 10.1111/mec.12819; Liebe S, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw004; Lopes AR, 2014, FEMS MICROBIOL ECOL, V87, P650, DOI 10.1111/1574-6941.12253; Luo X, 2016, ECOL RES, V31, P407, DOI 10.1007/s11284-016-1356-9; Madi L, 1997, PHYTOPATHOLOGY, V87, P1054, DOI 10.1094/PHYTO.1997.87.10.1054; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Maus I, 2016, J MICROBIOL BIOTECHN; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Monard C, 2013, FEMS MICROBIOL ECOL, V84, P165, DOI 10.1111/1574-6941.12046; Nagahama Takahiko, 2012, Prog Mol Subcell Biol, V53, P173, DOI 10.1007/978-3-642-23342-5_9; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Palagani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113842; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Pawluczyk M, 2015, ANAL BIOANAL CHEM, V407, P1841, DOI 10.1007/s00216-014-8435-y; Ranjard L, 2003, ENVIRON MICROBIOL, V5, P1111, DOI 10.1046/j.1462-2920.2003.00521.x; Samuels GJ, 2012, FUNGAL DIVERS, V55, P77, DOI 10.1007/s13225-012-0152-2; Santos JC, 2006, NEW PHYTOL, V172, P159, DOI 10.1111/j.1469-8137.2006.01799.x; Schalamuk S, 2010, MYCOLOGIA, V102, P261, DOI 10.3852/08-118; Schmidt PA, 2013, SOIL BIOL BIOCHEM, V65, P128, DOI 10.1016/j.soilbio.2013.05.014; Sechi V, 2017, AGR ECOSYST ENVIRON, V239, P265, DOI 10.1016/j.agee.2017.01.036; Stockinger H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107783; Tedersoo L, 2015, MYCOKEYS, P1, DOI 10.3897/mycokeys.10.4852; Theuerl S, 2015, APPL MICROBIOL BIOT, V99, P7791, DOI 10.1007/s00253-015-6627-9; Thomas E, 2006, FELDVERSUCHSWESEN; Tisserant E, 2013, P NATL ACAD SCI USA, V110, P20117, DOI 10.1073/pnas.1313452110; Tkacz A, 2015, ISME J, V9, P2349, DOI 10.1038/ismej.2015.41; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Valetti L, 2016, EUR J SOIL BIOL, V76, P103, DOI 10.1016/j.ejsobi.2016.08.005; Valyi K, 2015, NEW PHYTOL, V205, P1577, DOI 10.1111/nph.13236; Veresoglou SD, 2017, ECOL EVOL, V7, P1181, DOI 10.1002/ece3.2757; Verma S, 1998, MYCOLOGIA, V90, P896, DOI 10.2307/3761331; Vierheilig H, 2000, NEW PHYTOL, V146, P343, DOI 10.1046/j.1469-8137.2000.00642.x; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weiss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016793; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; WIBBERG D, 2016, BMC GENOMICS, V17; Williams A, 2017, NEW PHYTOL, V213, P874, DOI 10.1111/nph.14196; Xu LH, 2012, SOIL BIOL BIOCHEM, V46, P26, DOI 10.1016/j.soilbio.2011.11.010; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	73	42	44	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195345	10.1371/journal.pone.0195345	http://dx.doi.org/10.1371/journal.pone.0195345			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621291	Green Published, gold, Green Submitted			2022-12-26	WOS:000429206800069
J	Ahmed, AM; Rizaner, A; Ulusoy, AH				Ahmed, Ahmed Mohamed; Rizaner, Ahmet; Ulusoy, Ali Hakan			A novel decision tree classification based on post-pruning with Bayes minimum risk	PLOS ONE			English	Article								Pruning is applied in order to combat over-fitting problem where the tree is pruned back with the goal of identifying decision tree with the lowest error rate on previously unobserved instances, breaking ties in favour of smaller trees with high accuracy. In this paper, pruning with Bayes minimum risk is introduced for estimating the risk-rate. This method proceeds in a bottom-up fashion converting a parent node of a subtree to a leaf node if the estimated risk-rate of the parent node for that subtree is less than the risk rates of its leaf. This paper proposes a post-pruning method that considers various evaluation standards such as attribute selection, accuracy, tree complexity, and time taken to prune the tree, precision/recall scores, TP/FN rates and area under ROC. The experimental results show that the proposed method produces better classification accuracy and its complexity is not much different than the complexities of reduced-error pruning and minimum-error pruning approaches. The experiments also demonstrate that the proposed method shows satisfactory performance in terms of precision score, recall score, TP rate, FP rate and area under ROC.	[Ahmed, Ahmed Mohamed] Univ Bahri, Coll Comp Sci, Khartoum, Sudan; [Ahmed, Ahmed Mohamed] Eastern Mediterranean Univ, Dept Math, Fac Arts & Sci, Gazimagusa, North Cyprus, Turkey; [Rizaner, Ahmet; Ulusoy, Ali Hakan] Eastern Mediterranean Univ, Dept Informat Technol, Sch Comp & Technol, Gazimagusa, North Cyprus, Turkey	Eastern Mediterranean University; Eastern Mediterranean University	Ahmed, AM (corresponding author), Univ Bahri, Coll Comp Sci, Khartoum, Sudan.; Ahmed, AM (corresponding author), Eastern Mediterranean Univ, Dept Math, Fac Arts & Sci, Gazimagusa, North Cyprus, Turkey.	aymansafy76@yahoo.com	Rizaner, Ahmet/H-3568-2016; Ulusoy, Ali Hakan/D-4752-2013; Ahmed, Ahmed/HGB-0691-2022	Rizaner, Ahmet/0000-0001-8419-5308; Ulusoy, Ali Hakan/0000-0002-2992-9265; Ahmed, Ahmed/0000-0003-3019-5462				Ahmed AM, 2016, PROCEDIA COMPUT SCI, V102, P137, DOI 10.1016/j.procs.2016.09.380; Bahnsen AC, 2015, EXPERT SYST APPL, V42, P6609, DOI 10.1016/j.eswa.2015.04.042; Bahnsen AC, 2013, 2013 12TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA 2013), VOL 1, P333, DOI 10.1109/ICMLA.2013.68; Berzal F, 2003, DATA KNOWL ENG, V44, P31, DOI 10.1016/S0169-023X(02)00062-9; Bradford JP, 1998, EUR C MACH LEARN APR, P31; Breiman L., 1984, CLASSIFICATION REGRE; Buntine W., 1992, Statistics and Computing, V2, P63, DOI 10.1007/BF01889584; Dua D., 2017, MACHINE LEARNING REP; Elomaa T, 2001, J ARTIF INTELL RES, V15, P163, DOI 10.1613/jair.816; Esposito F, 1995, LECT NOTES ARTIF INT, V912, P287; Frank E, THESIS; Hall L. O., 2003, International Journal on Artificial Intelligence Tools (Architectures, Languages, Algorithms), V12, P249, DOI 10.1142/S0218213003001228; Han J, 2012, MOR KAUF D, P1; Katz G, 2014, J COMPUT SCI TECH-CH, V29, P392, DOI 10.1007/s11390-014-1438-5; Mansour Y., 1997, P 14 INT C MACH LEAR, P195; Mehta M., 1995, KDD-95 Proceedings. First International Conference on Knowledge Discovery and Data Mining, P216; Mehta S, 2015, COMP COMM CONTR IC4, P1; Mohamed WN, CONTR SYST COMP ENG; Oates T, 1997, 14 INT C MACH LEARN; QUINLAN JR, 1989, INFORM COMPUT, V80, P227, DOI 10.1016/0890-5401(89)90010-2; QUINLAN JR, 1987, INT J MAN MACH STUD, V27, P221, DOI 10.1016/S0020-7373(87)80053-6; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2	22	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194168	10.1371/journal.pone.0194168	http://dx.doi.org/10.1371/journal.pone.0194168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617369	gold, Green Published, Green Submitted			2022-12-26	WOS:000429203800021
J	D'Eath, RB; Jack, M; Futro, A; Talbott, D; Zhu, QM; Barclay, D; Baxter, EM				D'Eath, Richard B.; Jack, Mhairi; Futro, Agnieszka; Talbott, Darren; Zhu, Qiming; Barclay, David; Baxter, Emma M.			Automatic early warning of tail biting in pigs: 3D cameras can detect lowered tail posture before an outbreak	PLOS ONE			English	Article							MANAGEMENT; BEHAVIOR; CLASSIFICATION; PREVALENCE; SYSTEMS; DOCKING; LESIONS; DAMAGE	Tail biting is a major welfare and economic problem for indoor pig producers worldwide. Low tail posture is an early warning sign which could reduce tail biting unpredictability. Taking a precision livestock farming approach, we used Time-of-flight 3D cameras, processing data with machine vision algorithms, to automate the measurement of pig tail posture. Validation of the 3D algorithm found an accuracy of 73.9% at detecting low vs. not low tails (Sensitivity 88.4%, Specificity 66.8%). Twenty-three groups of 29 pigs per group were reared with intact (not docked) tails under typical commercial conditions over 8 batches. 15 groups had tail biting outbreaks, following which enrichment was added to pens and biters and/or victims were removed and treated. 3D data from outbreak groups showed the proportion of low tail detections increased pre-outbreak and declined post-outbreak. Pre-outbreak, the increase in low tails occurred at an increasing rate over time, and the proportion of low tails was higher one week pre-outbreak (-1) than 2 weeks pre-outbreak (-2). Within each batch, an outbreak and a non-outbreak control group were identified. Outbreak groups had more 3D low tail detections in weeks-1, +1 and +2 than their matched controls. Comparing 3D tail posture and tail injury scoring data, a greater proportion of low tails was associated with more injured pigs. Low tails might indicate more than just tail biting as tail posture varied between groups and over time and the proportion of low tails increased when pigs were moved to a new pen. Our findings demonstrate the potential for a 3D machine vision system to automate tail posture detection and provide early warning of tail biting on farm.	[D'Eath, Richard B.; Jack, Mhairi; Futro, Agnieszka; Baxter, Emma M.] SRUC, Edinburgh, Midlothian, Scotland; [Talbott, Darren] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland; [Zhu, Qiming; Barclay, David] Innovent Technol Ltd, Turriff, Aberdeen, Scotland	University of Edinburgh	D'Eath, RB (corresponding author), SRUC, Edinburgh, Midlothian, Scotland.	rick.death@sruc.ac.uk	Zixuan, Huang/ABI-3557-2020	D'Eath, Rick/0000-0002-1801-254X; Baxter, Emma/0000-0003-3370-7371	Innovate UK as part of the Agri-Tech Catalyst [132343]; Innovate UK scheme; Biotechnology and Biological Sciences Research Council [TS/P000541/1]; RCUK [BB/P004962/1]; Rural and Environment Science and Analytical Services Division of the Scottish Government; BBSRC [BB/P004962/1] Funding Source: UKRI	Innovate UK as part of the Agri-Tech Catalyst(UK Research & Innovation (UKRI)Innovate UK); Innovate UK scheme(UK Research & Innovation (UKRI)Innovate UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); RCUK(UK Research & Innovation (UKRI)); Rural and Environment Science and Analytical Services Division of the Scottish Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for a project titled "Early detection of tail biting in pigs using 3D video to measure tail posture (132343)" was awarded by Innovate UK (https//www.gov.uk/government/organisations/innovate-uk) to commercial partners (authors DB and QZ) as part of the Agri-Tech Catalyst. The Innovate UK funding does not cover all of the project costs, as such the commercial partner Innovent Technology (Ltd) contributed further funding by part-supporting the salaries of its employees: authors DB and QZ. As part of the Innovate UK scheme which funds academics and commercial partners to work together, the Biotechnology and Biological Sciences Research Council (https://www.bbsrc.ac.uk) provided funding to the academic partner SRUC (authors RBD, EMB, MJ, AF) BBSRC grant ref TS/P000541/1; RCUK grant ref BB/P004962/1 http://gtr.rcuk.ac.uk/projects?ref=BB%2FP004962%2F1). Additional funding to SRUC (authors RBD, EMB, MJ, AF) was awarded from the Rural and Environment Science and Analytical Services Division of the Scottish Government, http://www.gov.scot/Topcs/Research/Abouti/EBAR/StrategicResearch/strategicresearch2016-21/srp2016-21 Input from a student from the University of Edinburgh MSc Applied Animal Behaviour and Animal Welfare (DT; https://www.ed.ac.uk/vet/studying/postgrnaduate/taught-programmes/applied-animal-behaviourwelfare) was carried out on a voluntary basis. The funders provided support in the form of salaries for authors [RBD, MJ, AF, QZ, DB, EMB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Banhazi T. M., 2012, International Journal of Agricultural and Biological Engineering, V5, P1, DOI 10.3965/j.ijabe.20120503.001; Berckmans D, 2014, REV SCI TECH OIE, V33, P189, DOI 10.20506/rst.33.1.2273; Bracke MBM, 2013, J AGR ENVIRON ETHIC, V26, P847, DOI 10.1007/s10806-012-9410-2; D'Eath RB, 2016, ANIMAL, V10, P687, DOI 10.1017/S1751731115002098; D'Eath RB, 2014, ANIMAL, V8, P1479, DOI 10.1017/S1751731114001359; Di Giminiani P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05404-y; EFSA, 2007, ANNEX EFSA J, V611, P1; Fournel S, 2017, BIOSYST ENG, V155, P96, DOI 10.1016/j.biosystemseng.2016.12.005; Groffen J., 2012, 393 SLU DEP AN ENV H; Harley S, 2014, ANIM WELFARE, V23, P275, DOI 10.7120/09627286.23.3.275; Harley S, 2012, VET REC, V171, P621, DOI 10.1136/vr.100986; Keeling LJ, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-32; Kritas SK, 2004, J SWINE HEALTH PROD, V12, P17; Lahrmann HP, 2017, ANIMAL, V11, P1825, DOI 10.1017/S1751731117000490; Lahrmann HP, 2017, APPL ANIM BEHAV SCI; Larsen MLV, 2016, VET J, V209, P50, DOI 10.1016/j.tvjl.2015.12.001; Matthews SG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17451-6; Matthews SG, 2016, VET J, V217, P43, DOI 10.1016/j.tvjl.2016.09.005; McGlone J.J., 1990, T5283 TEX TECH U AGR, V283, P69; Munsterhjelm C, 2013, ANIM WELFARE, V22, P331, DOI 10.7120/09627286.22.3.331; Nasirahmadi A, 2017, LIVEST SCI, V202, P25, DOI 10.1016/j.livsci.2017.05.014; Paoli MA, 2016, ANIM WELFARE, V25, P287, DOI 10.7120/09627286.25.2.287; Reimert I, 2013, PHYSIOL BEHAV, V109, P42, DOI 10.1016/j.physbeh.2012.11.002; Schroder-Petersen DL, 2004, ACTA AGR SCAND A-AN, V54, P159, DOI 10.1080/09064700410003835; Scollo A, 2017, PREV VET MED, V146, P114, DOI 10.1016/j.prevetmed.2017.08.001; Sihvo HK, 2012, J COMP PATHOL, V146, P73, DOI 10.1016/j.jcpa.2011.11.112; SKOV A/ S, 2018, PROD MAN SYST CAM WE; Sonoda LT, 2013, BERL MUNCH TIERARZTL, V126, P104, DOI 10.2376/0005-9366-126-104; Statham P, 2009, APPL ANIM BEHAV SCI, V121, P157, DOI 10.1016/j.applanim.2009.09.011; Studnitz M, 2007, APPL ANIM BEHAV SCI, V107, P183, DOI 10.1016/j.applanim.2006.11.013; Sutherland MA, 2011, APPL ANIM BEHAV SCI, V135, P179, DOI 10.1016/j.applanim.2011.10.015; Taylor NR, 2010, VET J, V186, P137, DOI 10.1016/j.tvjl.2009.08.028; Ursinus WW, 2014, APPL ANIM BEHAV SCI, V156, P22, DOI 10.1016/j.applanim.2014.04.001; Valros A, 2015, PORCINE HEALTH MANAG, V1, DOI 10.1186/2055-5660-1-2; Van de Weerd HA, 2003, APPL ANIM BEHAV SCI, V84, P101, DOI 10.1016/S0168-1591(03)00150-3; Viazzi S, 2014, COMPUT ELECTRON AGR, V104, P57, DOI 10.1016/j.compag.2014.03.010; Zonderland JJ, 2011, ANIMAL, V5, P767, DOI 10.1017/S1751731110002326; Zonderland JJ, 2008, APPL ANIM BEHAV SCI, V110, P269, DOI 10.1016/j.applanim.2007.04.005; Zonderland JJ, 2009, APPL ANIM BEHAV SCI, V121, P165, DOI 10.1016/j.applanim.2009.09.002	39	48	49	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194524	10.1371/journal.pone.0194524	http://dx.doi.org/10.1371/journal.pone.0194524			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617403	Green Published, gold, Green Submitted			2022-12-26	WOS:000429203800033
J	Liverani, E; Mondrinos, MJ; Sun, S; Kunapuli, SP; Kilpatrick, LE				Liverani, Elisabetta; Mondrinos, Mark J.; Sun, Shuang; Kunapuli, Satya P.; Kilpatrick, Laurie E.			Role of Protein Kinase C-delta in regulating platelet activation and platelet-leukocyte interaction during sepsis	PLOS ONE			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; PKC-DELTA; ORGAN DYSFUNCTION; NEUTROPHIL; INFLAMMATION; MICE; THROMBOCYTOPENIA; BIODISTRIBUTION; PATHOGENESIS	Sepsis is characterized by an intense systemic inflammatory response activating a cascade of proinflammatory events resulting in leukocyte dysregulation and host tissue damage. The lung is particularly susceptible to systemic inflammation, leading to acute lung injury. Key to inflammation-induced lung damage is the excessive migration of neutrophils across the vascular endothelium. The mechanisms which regulate neutrophil activation and migration in sepsis are not well defined but there is growing evidence that platelets are actively involved and play a key role in microvascular permeability and neutrophil-mediated organ damage. We previously identified PKC-delta (PKC delta) as a critical regulator of the inflammatory response in sepsis and demonstrated PKC delta inhibition was lung protective. However, the role of PKC delta in sepsis-induced platelet activation and platelet-leukocyte interactions is not known. In this study, rats underwent sham surgery or cecal ligation and puncture (CLP) to induce sepsis. Following surgeries, a PKC delta inhibitor (200 mu g/kg) or vehicle (PBS) was administered intra-tracheally. At 24 hours post-surgeries, lung tissue, BAL fluid, and blood samples were collected. While sepsis caused thrombocytopenia, the remaining circulating platelets were activated as demonstrated by increased p-selectin expression, elevated plasma PF4, and enhanced platelet-leukocyte aggregate formation compared to Sham animals. Platelet activation was associated with increased platelet PKC delta activity. Inhibition of PKC delta attenuated sepsis-induced platelet activation, secretion and aggregate formation. Sepsis-induced thrombocytopenia was also significantly reduced and circulating platelet numbers were similar to sham animals. In the lung, sepsis induced significant influx of platelets and neutrophils and the development of lung injury. Administration of the PKC delta inhibitor decreased platelet and neutrophil influx, and was lung protective. Thus, PKC delta inhibition modulated platelet activity both locally and systemically, decreased neutrophil influx into the lung, and was lung protective. We demonstrate for the first time that PKC delta plays an important role in platelet activation and platelet-neutrophil interaction during sepsis.	[Liverani, Elisabetta; Mondrinos, Mark J.; Kunapuli, Satya P.; Kilpatrick, Laurie E.] Temple Univ, Sol Sherry Thrombosis Res Ctr, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Liverani, Elisabetta; Mondrinos, Mark J.; Sun, Shuang; Kilpatrick, Laurie E.] Temple Univ, Ctr Inflammat Translat & Clin Lung Res, Dept Thorac Med & Surg, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Kunapuli, Satya P.; Kilpatrick, Laurie E.] Temple Univ, Dept Physiol, Lewis Katz Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Liverani, E (corresponding author), Temple Univ, Sol Sherry Thrombosis Res Ctr, Lewis Katz Sch Med, Philadelphia, PA 19122 USA.; Liverani, E (corresponding author), Temple Univ, Ctr Inflammat Translat & Clin Lung Res, Dept Thorac Med & Surg, Lewis Katz Sch Med, Philadelphia, PA 19122 USA.	eliliverani@temple.edu	Liverani, Elisabetta/AAR-4132-2021	Liverani, Elisabetta/0000-0001-5540-0456	National Institutes of Health, National Heart, Lung, and Blood Institute [HL111552, GM114359, HL93231, HL118593]; American Heart Association [16SDG26980003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114359] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, National Heart, Lung, and Blood Institute (https://www.nhlbi.nih.gov) grant HL111552 (L.E.K.), GM114359 (L.E.K.), HL93231 (S.P.K.) and HL118593 (SPK) and the American Heart Association (www.heart.org) grant 16SDG26980003 to EL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaduzzaman M, 2009, CRIT CARE MED, V37, P1389, DOI 10.1097/CCM.0b013e31819ceb71; Bdeir K, 2017, AM J RESP CELL MOL, V56, P261, DOI 10.1165/rcmb.2015-0245OC; Begley R, 2004, BIOCHEM BIOPH RES CO, V318, P949, DOI 10.1016/j.bbrc.2004.04.121; Bhavanasi D, 2015, PLATELETS, V26, P2, DOI 10.3109/09537104.2013.868877; Bhavanasi D, 2011, BIOCHEM PHARMACOL, V82, P720, DOI 10.1016/j.bcp.2011.06.032; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Budas GR, 2007, PHARMACOL RES, V55, P523, DOI 10.1016/j.phrs.2007.04.005; Bye AP, 2016, J THROMB HAEMOST, V14, P918, DOI 10.1111/jth.13302; Cai SR, 2006, EUR J PHARM SCI, V27, P311, DOI 10.1016/j.ejps.2005.10.011; Chari R, 2009, ARTERIOSCL THROM VAS, V29, P699, DOI 10.1161/ATVBAHA.109.184010; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Danahay H, 1999, PHARMACEUT RES, V16, P1542, DOI 10.1023/A:1015048419558; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; de Stoppelaar SF, 2014, BLOOD, V124, P3781, DOI 10.1182/blood-2014-05-573915; de Stoppelaar SF, 2014, THROMB HAEMOSTASIS, V112, P666, DOI 10.1160/TH14-02-0126; Drechsler Susanne, 2015, Intensive Care Med Exp, V3, P48, DOI 10.1186/s40635-015-0048-z; Estevez B, 2017, PHYSIOLOGY, V32, P162, DOI 10.1152/physiol.00020.2016; Faraday N, 2001, ANESTHESIOLOGY, V94, P145, DOI 10.1097/00000542-200101000-00025; Gawaz M, 1997, INTENS CARE MED, V23, P379, DOI 10.1007/s001340050344; Grommes J, 2012, AM J RESP CRIT CARE, V185, P628, DOI 10.1164/rccm.201108-1533OC; Hagiwara S, 2011, SHOCK, V35, P289, DOI 10.1097/SHK.0b013e3181f48987; Harr JN, 2011, SHOCK, V36, P595, DOI 10.1097/SHK.0b013e318231ee76; Jenne CN, 2013, INT J LAB HEMATOL, V35, P254, DOI 10.1111/ijlh.12084; Kilpatrick LE, 2006, J LEUKOCYTE BIOL, V80, P1512, DOI 10.1189/jlb.0406284; Kilpatrick LE, 2011, J LEUKOCYTE BIOL, V89, P3, DOI 10.1189/jlb.0510281; Kilpatrick LE, 2010, J LEUKOCYTE BIOL, V87, P153, DOI 10.1189/jlb.0408230; Kilpatrick LE, 2002, AM J PHYSIOL-CELL PH, V283, pC48, DOI 10.1152/ajpcell.00385.2001; Kilpatrick LE, 2000, AM J PHYSIOL-CELL PH, V279, pC2011, DOI 10.1152/ajpcell.2000.279.6.C2011; Kim WY, 2016, TUBERC RESPIR DIS, V79, P53, DOI 10.4046/trd.2016.79.2.53; Kostyak JC, 2014, ARTERIOSCL THROM VAS, V34, P2579, DOI 10.1161/ATVBAHA.114.304492; Liverani E, 2016, ARTERIOSCL THROM VAS, V36, P961, DOI 10.1161/ATVBAHA.116.307401; Liverani E, 2014, J LEUKOCYTE BIOL, V95, P313, DOI 10.1189/jlb.1012518; Liverani E, 2013, J PHARMACOL EXP THER, V344, P231, DOI 10.1124/jpet.112.195883; Liverani E, 2012, BIOCHEM PHARMACOL, V83, P1364, DOI 10.1016/j.bcp.2012.02.006; Ma AC, 2008, J THROMB HAEMOST, V6, P415, DOI 10.1111/j.1538-7836.2007.02865.x; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Mavrommatis AC, 2000, CRIT CARE MED, V28, P451, DOI 10.1097/00003246-200002000-00027; Middleton EA, 2016, PHYSIOL REV, V96, P1211, DOI 10.1152/physrev.00038.2015; Mondrinos MJ, 2015, J PHARMACOL EXP THER, V355, P86, DOI 10.1124/jpet.115.224832; Mondrinos MJ, 2014, AM J PATHOL, V184, P200, DOI 10.1016/j.ajpath.2013.09.010; Pears CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003793; Russwurm S, 2002, SHOCK, V17, P263, DOI 10.1097/00024382-200204000-00004; Salter JW, 2001, AM J PHYSIOL-GASTR L, V281, pG1432, DOI 10.1152/ajpgi.2001.281.6.G1432; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Semple JW, 2010, CELL MOL LIFE SCI, V67, P499, DOI 10.1007/s00018-009-0205-1; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Slaba I, 2015, HEPATOLOGY, V62, P1593, DOI 10.1002/hep.28003; Slungaard A, 2005, INT J BIOCHEM CELL B, V37, P1162, DOI 10.1016/j.biocel.2004.12.003; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Strauss R, 2002, CRIT CARE MED, V30, P1765, DOI 10.1097/00003246-200208000-00015; Thomas MR, 2015, THROMB HAEMOSTASIS, V114, P449, DOI 10.1160/TH14-12-1067; Venkata C, 2013, J INTENSIVE CARE, V1, DOI 10.1186/2052-0492-1-9; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7; Wuescher LM, 2015, J THROMB HAEMOST, V13, P303, DOI 10.1111/jth.12795; Xiang BG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3657; Yun SH, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9060143; Zhang ZH, 2015, HEART LUNG VESSEL, V7, P64	59	24	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195379	10.1371/journal.pone.0195379	http://dx.doi.org/10.1371/journal.pone.0195379			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617417	Green Published, Green Submitted, gold			2022-12-26	WOS:000429203800079
J	Zhong, RQ; Cui, DT; Ye, ZH				Zhong, Ruiqin; Cui, Dongtao; Ye, Zheng-Hua			A group of Populus trichocarpa DUF231 proteins exhibit differential O-acetyltransferase activities toward xylan	PLOS ONE			English	Article							CELLULOSE SYNTHASE-LIKE; REDUCING END-GROUPS; WOOD FORMATION; ACETYLATED HETEROXYLAN; GLUCURONIC-ACID; ARABIDOPSIS; BIOSYNTHESIS; POPLAR; DOMAIN; GENES	Wood represents the most abundant biomass produced by plants and one of its major components is acetyl xylan. Acetylation in xylan can occur at O-2 or O-3 of a xylosyl residue, at both O-2 and O-3 of a xylosyl residue, and at O-3 of a xylosyl residue substituted at O-2 with glucuronic acid. Acetyltransferases responsible for the regiospecific acetylation of xylan in tree species have not yet been characterized. Here we report the biochemical characterization of twelve Populus trichocarpa DUF231-containing proteins, named PtrXOATs, for their roles in the regiospecific acetylation of xylan. The PtrXOAT genes were found to be differentially expressed in Populus organs and among them, PtrXOAT1, PtrXOAT2, PtrXOAT9 and PtrXOAT1 0 exhibited the highest level of expression in stems undergoing wood formation. Activity assays of recombinant proteins demonstrated that all twelve PtrXOAT proteins were able to transfer acetyl groups from acetyl CoA onto a xylohexaose acceptor with PtrXOAT1, PtrXOAT2, PtrXOAT3, PtrXOAT11 and PtrXOAT12 having the highest activity. Structural analysis of the PtrXOAT-catalyzed reaction products using H-1 NMR spectroscopy revealed that PtrXOAT1, PtrXAOT2 and PtrXOAT3 mediated 2-O- and 3-O-monoacetylation and 2,3-di-O-acetylation of xylosyl residues and PtrXOAT11 and PtrXOAT12 only catalyzed 2-O-and 3-O-monoacetylation of xylosyl residues. Of the twelve PtrXOATs, only PtrXOAT9 and PtrXOAT10 were capable of transferring acetyl groups onto the O-3 position of 2-O-glucuronic acid-substituted xylosyl residues. Furthermore, when expressed in the Arabidopsis eskimol mutant, PtrXOAT1, PtrXAOT2 and PtrXOAT3 were able to rescue the defects in xylan acetylation. Together, these results demonstrate that the twelve PtrXOATs are acetyltransferases with different roles in xylan acetylation in P. trichocarpa.	[Zhong, Ruiqin; Ye, Zheng-Hua] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Cui, Dongtao] Univ Georgia, Dept Chem, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Ye, ZH (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	yh@uga.edu			Division of Chemical Sciences, Geosciences, and Biosciences, Office of Science; US Department of Energy [DE-FG02-03ER15415]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Science; US Department of Energy(United States Department of Energy (DOE))	This work was funded by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Science, the US Department of Energy through grant DE-FG02-03ER15415 to ZHY (http://science.energy.gov/bes/csgb/researchareas/physical-biosciences/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON SI, 1983, CARBOHYD RES, V111, P283, DOI 10.1016/0008-6215(83)88312-8; Aspeborg H, 2005, PLANT PHYSIOL, V137, P983, DOI 10.1104/pp.104.055087; Bischoff V, 2010, PLANT PHYSIOL, V153, P590, DOI 10.1104/pp.110.153320; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Dharmawardhana P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-150; Evtuguin DV, 2003, CARBOHYD RES, V338, P597, DOI 10.1016/S0008-6215(02)00529-3; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Gille S, 2011, PLANT CELL, V23, P4041, DOI 10.1105/tpc.111.091728; Goncalves VMF, 2008, CARBOHYD RES, V343, P256, DOI 10.1016/j.carres.2007.11.002; Grondahl M, 2003, CARBOHYD POLYM, V52, P359, DOI 10.1016/S0144-8617(03)00014-6; Helle S, 2003, ENZYME MICROB TECH, V33, P786, DOI 10.1016/S0141-0229(03)00214-X; JOHANSSON MH, 1977, WOOD SCI TECHNOL, V11, P251, DOI 10.1007/BF00356924; Joshi CP, 2011, MOL PLANT, V4, P331, DOI 10.1093/mp/ssq081; Kabel MA, 2007, CARBOHYD POLYM, V69, P94, DOI 10.1016/j.carbpol.2006.09.006; Lee C, 2012, PLANT CELL PHYSIOL, V53, P1934, DOI 10.1093/pcp/pcs138; Lee C, 2012, PLANT SIGNAL BEHAV, V7, P332, DOI 10.4161/psb.19269; Lee CH, 2011, MOL PLANT, V4, P730, DOI 10.1093/mp/ssr035; Lee C, 2009, PLANT CELL PHYSIOL, V50, P1982, DOI 10.1093/pcp/pcp131; Lee CH, 2009, PLANT CELL PHYSIOL, V50, P1075, DOI 10.1093/pcp/pcp060; Liepman AH, 2007, PLANT PHYSIOL, V143, P1881, DOI 10.1104/pp.106.093989; Lu SF, 2013, P NATL ACAD SCI USA, V110, P10848, DOI 10.1073/pnas.1308936110; Neumuller KG, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-014-0187-6; Pawar PMA, 2017, NEW PHYTOL, V214, P1491, DOI 10.1111/nph.14489; Pfeffer JM, 2013, J BIOL CHEM, V288, P2605, DOI 10.1074/jbc.M112.436352; Selig MJ, 2009, CELLULOSE, V16, P711, DOI 10.1007/s10570-009-9322-0; Shi R, 2010, PLANT CELL PHYSIOL, V51, P144, DOI 10.1093/pcp/pcp175; Shimizu K., 1976, Mokuzai Gakkaishi (Journal of the Japan Wood Research Society), V22, P618; Suzuki S, 2006, PLANT PHYSIOL, V142, P1233, DOI 10.1104/pp.106.086678; Teleman A, 2000, CARBOHYD RES, V329, P807, DOI 10.1016/S0008-6215(00)00249-4; Teleman A, 2002, CARBOHYD RES, V337, P373, DOI 10.1016/S0008-6215(01)00327-5; Timell T. E., 1967, Wood Science and Technology, V1, P45, DOI 10.1007/BF00592255; Urbanowicz BR, 2014, PLANT J, V80, P197, DOI 10.1111/tpj.12643; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Ye ZH, 2015, J EXP BOT, V66, P4119, DOI 10.1093/jxb/erv081; Yuan YX, 2016, PLANT SCI, V243, P120, DOI 10.1016/j.plantsci.2015.12.007; Yuan YX, 2016, PLANT CELL PHYSIOL, V57, DOI 10.1093/pcp/pcv172; Yuan YX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146460; Yuan YX, 2014, PLANT SCI, V219, P42, DOI 10.1016/j.plantsci.2014.01.005; Yuan YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087370; Yuan YX, 2013, PLANT CELL PHYSIOL, V54, P1186, DOI 10.1093/pcp/pct070; Zhong RQ, 2005, PLANT CELL, V17, P3390, DOI 10.1105/tpc.105.035501; Zhong RQ, 2017, PLANT CELL PHYSIOL, V58, P2126, DOI 10.1093/pcp/pcx147; Zhong RQ, 2017, PLANT CELL PHYSIOL, V58, P156, DOI 10.1093/pcp/pcw179; Zhong RQ, 2015, PLANT CELL PHYSIOL, V56, P195, DOI 10.1093/pcp/pcu140; Zhong RQ, 2011, PLANT PHYSIOL, V157, P1452, DOI 10.1104/pp.111.181354	45	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194532	10.1371/journal.pone.0194532	http://dx.doi.org/10.1371/journal.pone.0194532			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617384	Green Submitted, Green Published, gold			2022-12-26	WOS:000429203800034
J	Gicevic, S; Gaskins, AJ; Fung, TT; Rosner, B; Tobias, DK; Isanaka, S; Willett, WC				Gicevic, Selma; Gaskins, Audrey J.; Fung, Teresa T.; Rosner, Bernard; Tobias, Deirdre K.; Isanaka, Sheila; Willett, Walter C.			Evaluating pre-pregnancy dietary diversity vs. dietary quality scores as predictors of gestational diabetes and hypertensive disorders of pregnancy	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; LOW-CARBOHYDRATE; WEIGHT-GAIN; LIFE-STYLE; RISK; MELLITUS; PREECLAMPSIA; PATTERNS; REPRODUCIBILITY; VALIDITY	Background Dietary diversity scores (DDS) are considered as metrics for monitoring the implementation of the UN's Sustainable Development Goals, but they need to be rigorously evaluated. Objective To examine two DDS, the Food Groups Index (FGI), and the Minimum Dietary Diversity Women (MDD-W), alongside two dietary quality scores, the Alternate Healthy Eating Index (AHEI-2010) and the Prime Diet Quality Score (PDQS), with risks of gestational diabetes mellitus (GDM) and hypertensive disorders of pregnancy (HDPs). Design The analysis included 21,312 (GDM) and 19,917 (HDPs) singleton births reported in the Nurses' Health Study II cohort (1991-2001), among women without major chronic disease or GDM/HDPs. Scores were derived using prepregnancy diet collected by a comprehensive food frequency questionnaire. Multivariable models were utilized to calculate relative risks (RR) and confidence intervals (95%CIs). Results Incident GDM (n = 916) and HDPs (n = 1,421) were reported. The MDD-W and FGI were not associated with risk of GDM or HDPs, but the AHEI-2010 and PDQS were associated with a lower risk of GDM and marginally lower risk of HDP. The RR's of GDM comparing the highest vs. lowest quintiles were 1.00 (95%CI: 0.79, 1.27; p-trend = 0.82) for MDD-W, 0.96 (95%CI: 0.76, 1.22; p-trend = 0.88) for FGI, 0.63 (95%CI: 0.50, 0.81; p-trend <0.0001) for the AHEI-2010 and 0.68 (95%CI: 0.54, 0.86; p-trend = 0.003) for the PDQS. Similarly, the RR's of HDPs were 0.92 (95%CI: 0.75, 1.12, p-trend = 0.94) for MDD-W, 0.97 (95%CI: 0.79, 1.17; p-trend = 0.83) for FGI, 0.84 (95%CI: 0.70, 1.02; p-trend = 0.07) for AHEI-2010 and 0.89 (95%CI: 0.74, 1.09; p-trend = 0.07) for PDQS. Conclusions MDD-W and FGI did not predict the risk of GDM and HDPs. These DDS should not be widely used as metrics for achieving dietary goals in their present form. The Prime Diet Quality Score warrants further testing as a promising measure of a sustainable and healthy diet on a global scale.	[Gicevic, Selma; Gaskins, Audrey J.; Fung, Teresa T.; Isanaka, Sheila; Willett, Walter C.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Gaskins, Audrey J.; Rosner, Bernard; Willett, Walter C.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Fung, Teresa T.] Simmons Coll, Dept Nutr, Boston, MA 02115 USA; [Rosner, Bernard] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Tobias, Deirdre K.] Brigham & Womens Hosp, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA; [Isanaka, Sheila] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Willett, Walter C.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Simmons University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Gicevic, S (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.	selma.gicevic@mail.harvard.edu	Isanaka, Sheila/AAQ-9056-2020	Kronsteiner-Gicevic, Selma/0000-0002-5414-8671	National Institutes of Health [UM1 CA176726]; NIH National Institute of Environmental Health Sciences [K99ES026648]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [K01DK103720-01]; NATIONAL CANCER INSTITUTE [UM1CA176726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK103720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K99ES026648] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by UM1 CA176726 (National Institutes of Health, https://www.nih.gov/, NHSII cohort infrastructure grant); K99ES026648 (NIH National Institute of Environmental Health Sciences, https://www.niehs.nih.gov/, AJG); K01DK103720-01 (NIH National Institute of Diabetes and Digestive and Kidney Diseases, https://www.niddk.nih.gov/, DKT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Fatima, 2014, J Ayub Med Coll Abbottabad, V26, P506; Arimond M, 2010, J NUTR, V140, p2059S, DOI 10.3945/jn.110.123414; Bao W, 2014, AM J CLIN NUTR, V99, P1378, DOI 10.3945/ajcn.113.082966; Berkey CS, 2005, ARCH PEDIAT ADOL MED, V159, P543, DOI 10.1001/archpedi.159.6.543; Bezerra IN, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-22; Brantsaeter AL, 2009, J NUTR, V139, P1162, DOI 10.3945/jn.109.104968; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Darnton-Hill I, 2004, PUBLIC HEALTH NUTR, V7, P101, DOI 10.1079/PHN2003584; EATF, 2015, INT IND SUST FOOD SY; FANTA, 2006, 360 FANTA FHI; FANTA, 2015, 360FANTA FHI; FAO U, 2006, LIV LONG SHAD; Fung TT, 2017, AM J CLIN N IN PRESS; Garnett T., 2014, WHAT IS SUSTAINABLE, P31; Gruslin A, 2011, BEST PRACT RES CL OB, V25, P491, DOI 10.1016/j.bpobgyn.2011.02.004; IAEG, 2015, COMP MET REC IND GLO; IDF, 2016, GDM RES 2015; Intapad S, 2013, CURR CARDIOVASC RISK, V7, P183, DOI 10.1007/s12170-013-0303-3; International Council for Science and International Social Science Council (ICSU and ISSC), 2015, REV TARG SUST DEV GO; Kennedy GL, 2007, J NUTR, V137, P472, DOI 10.1093/jn/137.2.472; Kernebeek H, 8 INT C LCA AGR SECT; Langer A, 2008, LANCET, V371, P705, DOI 10.1016/S0140-6736(08)60321-9; Macdiarmid JI, 2013, P NUTR SOC, V72, P13, DOI 10.1017/S0029665112002893; Mol BJ, 2016, LANCET, V387, P999, DOI 10.1016/S0140-6736(15)00070-7; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Muti M, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0110-5; Oken E, 2007, ANN EPIDEMIOL, V17, P663, DOI 10.1016/j.annepidem.2007.03.003; Otto MCD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141341; Plagemann A, 2011, EARLY HUM DEV, V87, P743, DOI 10.1016/j.earlhumdev.2011.08.018; Rah JH, 2010, EUR J CLIN NUTR, V64, P1393, DOI 10.1038/ejcn.2010.171; Rifas-Shiman SL, 2001, PUBLIC HEALTH NUTR, V4, P249, DOI 10.1079/PHN200061; Salehi-Abargouei A, 2016, EUR J CLIN NUTR, V70, P1, DOI 10.1038/ejcn.2015.118; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Schoenaker DAJM, 2016, DIABETES CARE, V39, P16, DOI 10.2337/dc15-0540; Schoenaker DAJM, 2015, AM J CLIN NUTR, V102, P94, DOI 10.3945/ajcn.114.102475; Schoenaker DAJM, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0157-7; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Solomon CG, 1997, JAMA-J AM MED ASSOC, V278, P1078, DOI 10.1001/jama.278.13.1078; Staff AC, 2013, HYPERTENSION, V61, P932, DOI 10.1161/HYPERTENSIONAHA.111.00250; Timmermans S, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.05.013; Tobias DK, 2012, AM J CLIN NUTR, V96, P289, DOI 10.3945/ajcn.111.028266; US. Department of Agriculture Agricultural Research Service, 2016, USDA NAT NUTR DAT ST; Vadiveloo M, 2014, BRIT J NUTR, V112, P1562, DOI 10.1017/S0007114514002049; WHO, 2013, COUNTD 2015 MAT NEWB; Willett W., 2012, NUTR EPIDEMIOLOGY; Willett WC, 2013, ANNU REV PUBL HEALTH, V34, P77, DOI 10.1146/annurev-publhealth-031811-124646; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Wright MJ, 2015, PUBLIC HEALTH NUTR, V18, P1762, DOI 10.1017/S1368980015000427; Yuan CZ, 2017, AM J EPIDEMIOL, V185, P570, DOI 10.1093/aje/kww104; Zhang C, 2006, DIABETOLOGIA, V49, P2604, DOI 10.1007/s00125-006-0422-1; Zhang CL, 2006, DIABETES CARE, V29, P2223, DOI 10.2337/dc06-0266; Zhang CL, 2011, AM J CLIN NUTR, V94, p1975S, DOI 10.3945/ajcn.110.001032	54	37	37	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195103	10.1371/journal.pone.0195103	http://dx.doi.org/10.1371/journal.pone.0195103			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614105	Green Published, Green Submitted, gold			2022-12-26	WOS:000429081600031
J	Zhang, LJ; Guo, CY; Jia, XD; Xu, HH; Pan, MZ; Xu, D; Shen, XB; Zhang, JH; Tan, JG; Qian, HL; Dong, CY; Shi, YW; Zhou, XD; Wu, C				Zhang, Lijun; Guo, Changyi; Jia, Xiaodong; Xu, Huihui; Pan, Meizhu; Xu, Dong; Shen, Xianbiao; Zhang, Jianghua; Tan, Jianguo; Qian, Hailei; Dong, Chunyang; Shi, Yewen; Zhou, Xiaodan; Wu, Chen			Personal exposure measurements of school-children to fine particulate matter (PM2.5) in winter of 2013, Shanghai, China	PLOS ONE			English	Article							YANGTZE-RIVER DELTA; SCHOOL CLASSROOMS; AIR-POLLUTION; GLOBAL BURDEN; CHILDREN; FILTRATION; OUTDOOR; DISEASE; QUALITY; RISKS	Objective The aim of this study was to perform an exposure assessment of PM2.5 (particulate matter less than 2.5 mu m in aerodynamic diameter) among children and to explore the potential sources of exposure from both indoor and outdoor environments. Methods In terms of real-time exposure measurements of PM2.5, we collected data from 57 children aged 8-12 years (9.64 +/- 0.93 years) in two schools in Shanghai, China. Simultaneously, questionnaire surveys and time-activity diaries were used to estimate the environment at home and daily time-activity patterns in order to estimate the exposure dose of PM2.5 in these children. Principle component regression analysis was used to explore the influence of potential sources of PM2.5 exposure. Results All the median personal exposure and microenvironment PM2.5 concentrations greatly exceeded the daily 24-h PM2.5 Ambient Air Quality Standards of China, the USA, and the World Health Organization (WHO). The median E-total (the sum of the PM2.5 exposure levels in different microenvironment and fractional time) of all students was 3014.13 (mu g.h)/m(3). The concentration of time-weighted average (TWA) exposure of all students was 137.01 mu g/m(3). The median TWA exposure level during the on-campus period (135.81 mu g/m(3)) was significantly higher than the off-campus period (115.50 mu g/m(3), P = 0.013 < 0.05). Besides ambient air pollution and meteorological conditions, storey height of the classroom and mode of transportation to school were significantly correlated with children's daily PM2.5 exposure. Conclusions Children in the two selected schools were exposed to high concentrations of PM2.5 in winter of 2013 in Shanghai. Their personal PM2.5 exposure was mainly associated with ambient air conditions, storey height of the classroom, and children's transportation mode to school.	[Zhang, Lijun; Xu, Huihui; Pan, Meizhu; Zhang, Jianghua; Qian, Hailei; Dong, Chunyang; Shi, Yewen; Zhou, Xiaodan; Wu, Chen] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai Inst Prevent Med, Div Heath Risk Factors Monitoring & Control, Environm Hlth Dept, Shanghai, Peoples R China; [Guo, Changyi] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai Inst Prevent Med, Gen Off, Shanghai, Peoples R China; [Jia, Xiaodong] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai Inst Prevent Med, Div Heath Risk Factors Monitoring & Control, Shanghai, Peoples R China; [Xu, Dong] Shanghai Xuhui Ctr Dis Control & Prevent, Environm Hlth Dept, Shanghai, Peoples R China; [Shen, Xianbiao] Shanghai Baoshan Ctr Dis Control & Prevent, Environm Hlth Dept, Shanghai, Peoples R China; [Tan, Jianguo] Shanghai Meteorol Serv, Shanghai Key Lab Meteorol & Hlth, Shanghai, Peoples R China	Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention	Xu, HH (corresponding author), Shanghai Municipal Ctr Dis Control & Prevent, Shanghai Inst Prevent Med, Div Heath Risk Factors Monitoring & Control, Environm Hlth Dept, Shanghai, Peoples R China.	xuhuihui@scdc.sh.cn			Public Health Personnel Training Program of China; United States-Fogarty Foundation [TW005741-07]; Foundation of Shanghai Municipal Family Commission of Health and Family Planning [20134289]; Public Health Key Discipline Construction of Shanghai Municipal Family Commission of Health and Family Planning-Environmental and Occupational Health [15GWZK0201]	Public Health Personnel Training Program of China; United States-Fogarty Foundation; Foundation of Shanghai Municipal Family Commission of Health and Family Planning; Public Health Key Discipline Construction of Shanghai Municipal Family Commission of Health and Family Planning-Environmental and Occupational Health	This study was funded by Public Health Personnel Training Program of China and the United States-Fogarty Foundation and through a research grant (TW005741-07) (LZ); the Foundation of Shanghai Municipal Family Commission of Health and Family Planning [grant numbers] (Grant No. 20134289) (LZ); Public Health Key Discipline Construction of Shanghai Municipal Family Commission of Health and Family Planning-Environmental and Occupational Health (Grant No. 15GWZK0201) (XJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Oliveira BFA, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-64; Anderson JO, 2012, J MED TOXICOL, V8, P166, DOI 10.1007/s13181-011-0203-1; Beko G, 2008, BUILD ENVIRON, V43, P1647, DOI 10.1016/j.buildenv.2007.10.006; Brown KW, 2008, J ENVIRON MONITOR, V10, P1041, DOI 10.1039/b805991h; Buonanno G, 2013, ATMOS ENVIRON, V79, P53, DOI 10.1016/j.atmosenv.2013.06.041; Buonanno G, 2012, SCI TOTAL ENVIRON, V438, P271, DOI 10.1016/j.scitotenv.2012.08.074; Buonanno G, 2012, ENVIRON POLLUT, V169, P183, DOI 10.1016/j.envpol.2012.03.002; Chan WR, 2016, INDOOR AIR, V26, P331, DOI 10.1111/ina.12189; Ferreira AMC, 2013, REV SAUDE PUBL, V47, P1059, DOI 10.1590/S0034-8910.2013047004810; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; DOCKERY DW, 1994, ANNU REV PUBL HEALTH, V15, P107, DOI 10.1146/annurev.pu.15.050194.000543; EPA US, 2006, AIR QUAL CRIT PART M; Fromme H, 2008, ATMOS ENVIRON, V42, P6597, DOI 10.1016/j.atmosenv.2008.04.047; GOLDMAN LR, 1995, ENVIRON HEALTH PERSP, V103, P13, DOI 10.2307/3432338; Huang FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141642; Huang J, 2012, SCI TOTAL ENVIRON, V425, P52, DOI 10.1016/j.scitotenv.2012.03.007; Huang LH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138559; Hubal EAC, 2000, ENVIRON HEALTH PERSP, V108, P475, DOI 10.2307/3454607; Jiang RT, 2011, J ENVIRON MONITOR, V13, P1695, DOI 10.1039/c0em00732c; Klepeis NE, 1999, ENVIRON HEALTH PERSP, V107, P365, DOI 10.2307/3434429; Kwon SB, 2015, J HAZARD MATER, V297, P295, DOI 10.1016/j.jhazmat.2015.05.015; Li MN, 2014, ENVIRON POLLUT, V189, P85, DOI 10.1016/j.envpol.2014.02.024; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu Q, 2017, SCI TOTAL ENVIRON, V574, P1502, DOI 10.1016/j.scitotenv.2016.08.152; MACINTOSH DL, 1995, J EXPO ANAL ENV EPID, V5, P375; MEP C, 2012, 30952012 MEPC GB; Ming LL, 2017, ENVIRON POLLUT, V223, P200, DOI 10.1016/j.envpol.2017.01.013; Montgomery JF, 2015, BUILD ENVIRON, V85, P17, DOI 10.1016/j.buildenv.2014.11.005; Morawska L, 2003, ATMOS ENVIRON, V37, P4195, DOI 10.1016/S1352-2310(03)00566-1; Osman LM, 2007, AM J RESP CRIT CARE, V176, P465, DOI 10.1164/rccm.200605-589OC; Pelucchi C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-453; ROGAN WJ, 1995, ENVIRON HEALTH PERSP, V103, P19, DOI 10.2307/3432339; Rovelli S, 2014, INT J ENV RES PUB HE, V11, P1398, DOI 10.3390/ijerph110201398; van Donkelaar A, 2010, ENVIRON HEALTH PERSP, V118, P847, DOI 10.1289/ehp.0901623; Wang F, 2016, ENVIRON POLLUT, V215, P280, DOI 10.1016/j.envpol.2016.05.023; World Health Organization, 2006, WHO AIR QUAL GUID PA; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yanosky JD, 2002, ATMOS ENVIRON, V36, P107, DOI 10.1016/S1352-2310(01)00422-8; Zanobetti A, 2009, AM J CARDIOL, V104, P665, DOI 10.1016/j.amjcard.2009.04.046; Zuraimi MS, 2015, BUILD ENVIRON, V89, P336, DOI 10.1016/j.buildenv.2015.03.010	40	21	23	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0193586	10.1371/journal.pone.0193586	http://dx.doi.org/10.1371/journal.pone.0193586			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608594	Green Published, gold, Green Submitted			2022-12-26	WOS:000428988800004
J	Sundar, IK; Rashid, K; Gerloff, J; Rangel-Moreno, J; Li, DM; Rahman, I				Sundar, Isaac K.; Rashid, Kahkashan; Gerloff, Janice; Rangel-Moreno, Javier; Li, Dongmei; Rahman, Irfan			Genetic ablation of histone deacetylase 2 leads to lung cellular senescence and lymphoid follicle formation in COPD/emphysema	FASEB JOURNAL			English	Article						cigarette smoke; HDAC2; DNA damage; inflammation	OBSTRUCTIVE PULMONARY-DISEASE; DNA-DAMAGE RESPONSE; NF-KAPPA-B; CIGARETTE-SMOKE; ACTIVATING FACTOR; HDAC2; EMPHYSEMA; CELLS; COPD; MICE	Histone deacetylase 2 (HDAC2), a critical determinant of chromatin remodeling, is reduced as a consequence of oxidative stress-mediated DNA damage and impaired repair. Cigarette smoke (CS) exposure causes DNA damage and cellular senescence. However, no information is available on the role of HDAC2 in CS-induced DNA damage, stress-induced premature senescence (SIPS), and senescence-associated secretory phenotype (SASP) during the pathogenesis of chronic obstructive pulmonary disease (COPD)/emphysema. We hypothesized that CS causes persistent DNA damage and cellular senescence via HDAC2-dependent mechanisms. We used HDAC2 global knockout (KO) and HDAC2 lung epithelial cell-specific KO [Clara cell-specific HDAC2 deletion (HDAC2 CreCC10)] mice to determine whether HDAC2 is a major player in CS-induced oxidative stress, SIPS, and SASP. HDAC2 KO mice exposed to CS show exaggerated DNA damage, inflammatory response, and decline in lung function leading to airspace enlargement. Chronic CS exposure augments lung senescence-associated -galactosidase activity in HDAC2 KO, but not in HDAC2 CreCC10 mice. HDAC2 lung epithelial cell-specific KO did not further augment CS-induced inflammatory response and airspace enlargement but instead caused an increase in lymphoid aggregate formation. Our study reveals that HDAC2 is a key player regulating CS-induced DNA damage, inflammatory response, and cellular senescence leading to COPD/emphysema.Sundar, I. K., Rashid, K., Gerloff, J., Rangel-Moreno, J., Li, D., Rahman, I. Genetic ablation of histone deacetylase 2 leads to lung cellular senescence and lymphoid follicle formation in COPD/emphysema.	[Sundar, Isaac K.; Rashid, Kahkashan; Gerloff, Janice; Rahman, Irfan] Univ Rochester, Med Ctr, Dept Environm Med, Box 850,601 Elmwood Ave, Rochester, NY 14642 USA; [Rangel-Moreno, Javier] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Li, Dongmei] Univ Rochester, Med Ctr, Dept Clin & Translat Res, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Rahman, I (corresponding author), Univ Rochester, Med Ctr, Dept Environm Med, Box 850,601 Elmwood Ave, Rochester, NY 14642 USA.	irfan_rahman@urmc.rochester.edu	Sundar, Isaac K/F-8764-2012	Sundar, Isaac K/0000-0001-6742-3460; Rangel-Moreno, Javier/0000-0002-9738-1182	U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute [2R01HL085613, 3R01HL085613-09S1]; Department of Medicine at the University of Rochester; NIH, National Institute of Allergy and Infectious Diseases (NIAID) [RO1AI111914]; University of Rochester CTSA from the NIH, National Center for Advancing Translational Sciences [UL1 TR002001]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002001] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI111914] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Medicine at the University of Rochester; NIH, National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Rochester CTSA from the NIH, National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Drs. Hongwei Yao, Tanveer Ahmad, and Chad Lerner for their technical assistance. This work was supported by the U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute Grants 2R01HL085613 and 3R01HL085613-09S1 (to I.R.); the Department of Medicine at the University of Rochester and the NIH, National Institute of Allergy and Infectious Diseases (NIAID) Grant RO1AI111914 (to J.R.-M.); and in part by the University of Rochester CTSA award number UL1 TR002001 from the NIH, National Center for Advancing Translational Sciences (to D.L.). The authors declare no conflicts of interest.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Adenuga D, 2010, BIOCHEM BIOPH RES CO, V403, P452, DOI 10.1016/j.bbrc.2010.11.054; Adenuga D, 2009, AM J RESP CELL MOL, V40, P464, DOI 10.1165/rcmb.2008-0255OC; Ahmad T, 2017, AM J RESP CELL MOL, V56, P38, DOI 10.1165/rcmb.2016-0198OC; Ahmad T, 2015, FASEB J, V29, P2912, DOI 10.1096/fj.14-268276; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bhaskara S, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-27; Bracke KR, 2013, AM J RESP CRIT CARE, V188, P343, DOI 10.1164/rccm.201211-2055OC; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen Y, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-10; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Demaria M, 2017, MOL CELL ONCOL, V4, DOI 10.1080/23723556.2017.1299666; Dovey OM, 2013, BLOOD, V121, P1335, DOI 10.1182/blood-2012-07-441949; Gary RK, 2005, ANAL BIOCHEM, V343, P329, DOI 10.1016/j.ab.2005.06.003; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Heink S, 2017, NAT IMMUNOL, V18, P474, DOI 10.1038/ni0417-474b; Hodge G, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00617; Hodge G, 2015, RESP RES, V16, DOI 10.1186/s12931-014-0161-7; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hsieh HH, 2017, J CELL SCI, V130, P3272, DOI 10.1242/jcs.204974; Huang DM, 2017, ONCOTARGET, V8, P56726, DOI 10.18632/oncotarget.18089; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Kim RY, 2017, J ALLERGY CLIN IMMUN, V139, P519, DOI 10.1016/j.jaci.2016.04.038; Kirkham PA, 2011, AM J RESP CRIT CARE, V184, P796, DOI 10.1164/rccm.201010-1605OC; Kirkland JL, 2017, J AM GERIATR SOC, V65, P2297, DOI 10.1111/jgs.14969; Laan M, 1999, J IMMUNOL, V162, P2347; Lai TW, 2018, CHEST, V153, P863, DOI 10.1016/j.chest.2017.10.031; Lehmann M, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02367-2016; Li XN, 2005, MOL CANCER THER, V4, P1912, DOI 10.1158/1535-7163.MCT-05-0184; Meja KK, 2008, AM J RESP CELL MOL, V39, P312, DOI 10.1165/rcmb.2008-0012OC; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Mizuno S, 2011, AM J PHYSIOL-LUNG C, V300, pL402, DOI 10.1152/ajplung.00207.2010; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Polverino F, 2015, AM J RESP CRIT CARE, V192, P695, DOI 10.1164/rccm.201501-0107OC; Quintana FJ, 2017, NAT IMMUNOL, V18, P8, DOI 10.1038/ni.3637; Rajendrasozhan S, 2010, AM J PHYSIOL-LUNG C, V298, pL197, DOI 10.1152/ajplung.00265.2009; Rangel-Moreno J, 2011, NAT IMMUNOL, V12, P639, DOI 10.1038/ni.2053; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Schafer MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14532; Seys LJM, 2015, AM J RESP CRIT CARE, V192, P706, DOI 10.1164/rccm.201501-0103OC; Solleti SK, 2016, FASEB J, V30, P2615, DOI 10.1096/fj.201500159R; Sundar IK, 2018, AM J RESP CELL MOL, V59, P189, DOI 10.1165/rcmb.2017-0390OC; Sundar IK, 2016, AM J PHYSIOL-LUNG C, V311, pL1245, DOI 10.1152/ajplung.00253.2016; Tan CT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147380; Tanaka T, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-26; Thurn KT, 2013, MOL CANCER THER, V12, P2078, DOI 10.1158/1535-7163.MCT-12-1242; To M, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0588-8; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Tuder RM, 2008, AM J RESP CELL MOL, V39, P1, DOI 10.1165/rcmb.2008-0117TR; van der Strate BWA, 2006, AM J RESP CRIT CARE, V173, P751, DOI 10.1164/rccm.200504-594OC; Van Pottelberge GR, 2010, EUR RESPIR J, V36, P781, DOI 10.1183/09031936.00140409; Wagner M, 2001, FEBS LETT, V499, P101, DOI 10.1016/S0014-5793(01)02524-8; Wang Y, 2013, DEV CELL, V24, P345, DOI 10.1016/j.devcel.2013.01.012; Wen LF, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00066; Winter M, 2013, EMBO J, V32, P3176, DOI 10.1038/emboj.2013.243; Xia ML, 2018, J ASTHMA, V55, P337, DOI 10.1080/02770903.2017.1337788; Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005; Yao HW, 2008, AM J RESP CELL MOL, V39, P7, DOI 10.1165/rcmb.2007-0342OC; Yao HW, 2008, AM J PHYSIOL-LUNG C, V294, pL1174, DOI 10.1152/ajplung.00439.2007; Yao HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080007; Yao HW, 2012, AM J PHYSIOL-LUNG C, V303, pL557, DOI 10.1152/ajplung.00175.2012; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Yao HW, 2010, P NATL ACAD SCI USA, V107, P15571, DOI 10.1073/pnas.1007625107; Zhou R, 2009, NUCLEIC ACIDS RES, V37, P5183, DOI 10.1093/nar/gkp533	70	14	15	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4955	4971		10.1096/fj.201701518R	http://dx.doi.org/10.1096/fj.201701518R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29630406	Green Published			2022-12-26	WOS:000443817700028
J	Mbanefo, EC; Le, L; Pennington, LF; Odegaard, JI; Jardetzky, TS; Alouffi, A; Falcone, FH; Hsieh, MH				Mbanefo, Evaristus C.; Le, Loc; Pennington, Luke F.; Odegaard, Justin I.; Jardetzky, Theodore S.; Alouffi, Abdulaziz; Falcone, Franco H.; Hsieh, Michael H.			Therapeutic exploitation of IPSE, a urogenital parasite-derived host modulatory protein, for chemotherapy-induced hemorrhagic cystitis	FASEB JOURNAL			English	Article						infiltrin; anti-inflammatory; ifosfamide; urothelial; Schistosoma	RECOMBINANT HUMAN INTERLEUKIN-4; SCHISTOSOMA-MANSONI EGGS; SOUTHWEST-ONCOLOGY-GROUP; CYCLOPHOSPHAMIDE-INDUCED CYSTITIS; MOUSE URINARY-BLADDER; RENAL-CELL CARCINOMA; PHASE-II TRIAL; MALIGNANT-MELANOMA; ADVANCED CANCER; VISCERAL PAIN	Chemotherapy-induced hemorrhagic cystitis (CHC) can be difficult to manage. Prior work suggests that IL-4 alleviates ifosfamide-induced hemorrhagic cystitis (IHC), but systemically administered IL-4 causes significant side effects. We hypothesized that the Schistosoma hematobium homolog of IL-4-inducing principle from Schistosoma mansoni eggs (H-IPSE), would reduce IHC and associated bladder pathology. IPSE binds IgE on basophils and mast cells, triggering IL-4 secretion by these cells. IPSE is also an infiltrin, translocating into the host nucleus to modulate gene transcription. Mice were administered IL-4, H-IPSE protein or its nuclear localization sequence (NLS) mutant, with or without neutralizing anti-IL-4 antibody, or 2-mercaptoethane sulfonate sodium (MESNA; a drug used to prevent IHC), followed by ifosfamide. Bladder tissue damage and hemoglobin content were measured. Spontaneous and evoked pain, urinary frequency, and bladdergene expression analysis were assessed. Pain behaviors were interpreted in a blinded fashion. One dose of H-IPSE was superior to MESNA and IL-4 in suppressing bladder hemorrhage in an IL-4-dependent fashion and comparable with MESNA in dampening ifosfamide-triggered pain behaviors in an NLS-dependent manner. H-IPSE also accelerated urothelial repair following IHC. Our work represents the first therapeutic exploitation of a uropathogen-derived host modulatory molecule in a clinically relevant bladder disease model and indicates that IPSE may be an alternative to MESNA for mitigating CHC.Mbanefo, E. C., Le, L., Pennington, L. F., Odegaard, J. I., Jardetzky, T. S., Alouffi, A., Falcone, F. H., Hsieh, M. H. Therapeutic exploitation of IPSE, a urogenital parasite-derived host modulatory protein, for chemotherapy-induced hemorrhagic cystitis.	[Mbanefo, Evaristus C.; Le, Loc; Hsieh, Michael H.] Biomed Res Inst, Bladder Immunol Grp, Rockville, MD 20852 USA; [Mbanefo, Evaristus C.; Hsieh, Michael H.] Childrens Natl Med Ctr, Div Urol, Washington, DC 20010 USA; [Pennington, Luke F.; Jardetzky, Theodore S.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Odegaard, Justin I.] OneOme, Redwood City, CA USA; [Alouffi, Abdulaziz] King Abdulaziz City Sci & Technol, Life Sci & Environm Sect, Riyadh, Saudi Arabia; [Falcone, Franco H.] Univ Nottingham, Sch Pharm, Div Mol Therapeut & Formulat, Nottingham, England; [Hsieh, Michael H.] George Washington Univ, Dept Urol, Washington, DC USA	Children's National Health System; Stanford University; King Abdulaziz City for Science & Technology; University of Nottingham; George Washington University	Hsieh, MH (corresponding author), Biomed Res Inst, 9410 Key West Ave, Rockville, MD 20850 USA.	mhsieh@afbr-bri.org	Falcone, Franco/AAE-8026-2021; Mbanefo, Evaristus/AAY-8504-2020; Alouffi, Abdulaziz/AAK-2328-2020; Falcone, Franco H/F-9210-2013	Falcone, Franco/0000-0002-1732-9932; Alouffi, Abdulaziz/0000-0001-8863-3870; Falcone, Franco H/0000-0002-1732-9932; Pennington, Luke/0000-0002-7947-8714	Margaret A. Stirewalt Endowment; U.S. National Institutes of Health; National Institute of Allergy and Infectious Diseases [R56AI119168]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK113504]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI119168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK113504] Funding Source: NIH RePORTER	Margaret A. Stirewalt Endowment; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors appreciate Jesse Nussbaum (University of California San Francisco, San Francisco, CA, USA) for helpful discussions, and gratefully acknowledge funding from the Margaret A. Stirewalt Endowment, U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases (Grant R56AI119168) and National Institute of Diabetes and Digestive and Kidney Diseases (Grant R01DK113504, both awarded to M.H.H.). The authors declare no conflicts of interest.	Abdi SAH, 2016, BASIC CLIN PHARMACOL, V119, P598, DOI 10.1111/bcpt.12627; Ackert-Bicknell Cheryl L, 2015, Curr Protoc Mouse Biol, V5, P95, DOI 10.1002/9780470942390.mo140195; Advani SH, 1998, AUST NZ J MED, V28, P410, DOI 10.1111/j.1445-5994.1998.tb01976.x; Lima MVA, 2007, CANCER CHEMOTH PHARM, V59, P643, DOI 10.1007/s00280-006-0307-5; ANDRIOLE GL, 1987, J CLIN ONCOL, V5, P799, DOI 10.1200/JCO.1987.5.5.799; ATKINS MB, 1992, J CLIN ONCOL, V10, P1802, DOI 10.1200/JCO.1992.10.11.1802; Bon K, 2003, J UROLOGY, V170, P1008, DOI 10.1097/01.ju.0000079766.49550.94; Boucher M, 2000, J UROLOGY, V164, P203, DOI 10.1016/S0022-5347(05)67495-2; Macedo FYB, 2008, EXP TOXICOL PATHOL, V59, P425, DOI 10.1016/j.etp.2007.10.010; Macedo FYB, 2012, INFLAMMATION, V35, P297, DOI 10.1007/s10753-011-9319-3; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Choi SH, 2009, J KOREAN MED SCI, V24, P684, DOI 10.3346/jkms.2009.24.4.684; Davis ID, 2000, GROWTH FACTORS, V17, P287, DOI 10.3109/08977190009028972; Delafosse L, 2016, J BIOTECHNOL, V227, P103, DOI 10.1016/j.jbiotec.2016.04.028; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Ebner F, 2014, ALLERGY, V69, P1489, DOI 10.1111/all.12496; Fu CL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002605; Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378; Furlanut M, 2003, ONCOLOGY-BASEL, V65, P2, DOI 10.1159/000073350; Giacomin P, 2015, SCI REP-UK, V5, DOI 10.1038/srep13797; Giles FJ, 1999, J INTERF CYTOK RES, V19, P1253, DOI 10.1089/107999099312911; GILLEECE MH, 1992, BRIT J CANCER, V66, P204, DOI 10.1038/bjc.1992.243; Golubeva AV, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.260; GOMES TNA, 1995, BRAZ J MED BIOL RES, V28, P1103; GRAY KJ, 1986, J UROLOGY, V136, P497, DOI 10.1016/S0022-5347(17)44929-9; HADER JE, 1993, J UROLOGY, V149, P1617, DOI 10.1016/S0022-5347(17)36462-5; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Hsieh YJ, 2014, INFECT IMMUN, V82, P2087, DOI 10.1128/IAI.01578-13; Kaur I, 2011, INFECT IMMUN, V79, P1779, DOI 10.1128/IAI.01048-10; Klastersky J, 2003, ONCOLOGY-BASEL, V65, P7, DOI 10.1159/000073351; Korkmaz A, 2007, CELL BIOL TOXICOL, V23, P303, DOI 10.1007/s10565-006-0078-0; Kyung YS, 2011, ARCH TOXICOL, V85, P51, DOI 10.1007/s00204-010-0523-y; Laird JMA, 2002, J NEUROSCI, V22, P8352; Lawson M, 2008, SCAND J UROL NEPHROL, V42, P309, DOI 10.1080/00365590701570953; Lee Gilho, 2011, Int Neurourol J, V15, P4, DOI 10.5213/inj.2011.15.1.4; Leite CAVG, 2015, J UROLOGY, V194, P1777, DOI 10.1016/j.juro.2015.07.088; Leventhal L., 2008, CURR PROTOC PHARM; Liao Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023786; Lin CH, 2014, AUTOIMMUN REV, V13, P114, DOI 10.1016/j.autrev.2013.09.011; Lukacs NW, 1996, J LEUKOCYTE BIOL, V60, P573, DOI 10.1002/jlb.60.5.573; Lv JW, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/358184; Macedo FYB, 2011, CANCER CHEMOTH PHARM, V67, P935, DOI 10.1007/s00280-010-1392-z; Majhail NS, 2004, INVEST NEW DRUG, V22, P421, DOI 10.1023/B:DRUG.0000036684.67675.fe; Manikandan R, 2010, INDIAN J UROL, V26, P159, DOI 10.4103/0970-1591.65380; MARGOLIN K, 1994, J IMMUNOTHER, V15, P147, DOI 10.1097/00002371-199402000-00009; Mathieson W, 2010, INT J PARASITOL, V40, P617, DOI 10.1016/j.ijpara.2009.10.014; Matz EL, 2017, UROLOGY, V100, P16, DOI 10.1016/j.urology.2016.07.030; Meyer NH, 2015, J BIOL CHEM, V290, P22111, DOI 10.1074/jbc.M115.675066; Meyer NH, 2011, BIOMOL NMR ASSIGN, V5, P225, DOI 10.1007/s12104-011-9305-6; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Olivar T, 1999, EUR J PAIN, V3, P141, DOI 10.1053/eujp.1998.0105; Oter S, 2004, UROL RES, V32, P185, DOI 10.1007/s00240-003-0398-y; Pedalino M, 2010, UROLOG J, V77, P38, DOI 10.1177/0391560310077017S07; Pennington LF, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00301-17; PRENDIVILLE J, 1993, EUR J CANCER, V29A, P1700, DOI 10.1016/0959-8049(93)90108-R; Ribeiro RA, 2002, J UROLOGY, V167, P2229, DOI 10.1016/S0022-5347(05)65134-8; Rogler G, 2015, PHARMACOL RES, V100, P220, DOI 10.1016/j.phrs.2015.07.005; Rosche B, 2013, PARASITE, V20, DOI 10.1051/parasite/2013056; Saito Y, 2016, JPN J CLIN ONCOL, V46, P856, DOI 10.1093/jjco/hyw093; SAKURAI M, 1986, JPN J CLIN ONCOL, V16, P153, DOI 10.1093/oxfordjournals.jjco.a039132; Schramm G, 2006, MOL BIOCHEM PARASIT, V147, P9, DOI 10.1016/j.molbiopara.2006.01.003; Schramm G, 2003, J BIOL CHEM, V278, P18384, DOI 10.1074/jbc.M300497200; Schramm G, 2007, J IMMUNOL, V178, P6023, DOI 10.4049/jimmunol.178.10.6023; SHEPHERD JD, 1991, J CLIN ONCOL, V9, P2016, DOI 10.1200/JCO.1991.9.11.2016; SHULMAN LN, 1993, HEMATOL ONCOL CLIN N, V7, P325, DOI 10.1016/S0889-8588(18)30243-0; Smith P, 2005, J EXP MED, V202, P1319, DOI 10.1084/jem.20050955; STADLER WM, 1995, CANCER, V76, P1629, DOI 10.1002/1097-0142(19951101)76:9<1629::AID-CNCR2820760920>3.0.CO;2-Q; Taylor CW, 2000, ANTI-CANCER DRUG, V11, P695, DOI 10.1097/00001813-200010000-00004; Vokes EE, 1998, CANCER J SCI AM, V4, P46; Watanabe K, 2011, J TROP PEDIATRICS, V57, P263, DOI 10.1093/tropej/fmq027; Whitehead RP, 1998, J IMMUNOTHER, V21, P440, DOI 10.1097/00002371-199811000-00006; Whitehead RP, 2002, J IMMUNOTHER, V25, P352, DOI 10.1097/00002371-200207000-00007; Wolfson W, 2013, CHEM BIOL, V20, P135, DOI 10.1016/j.chembiol.2013.02.008; Young SD, 2006, CLIN CANCER RES, V12, P3092, DOI 10.1158/1078-0432.CCR-05-2255; Yu WQ, 2014, AM J PHYSIOL-RENAL, V306, pF1296, DOI 10.1152/ajprenal.00074.2014	75	14	15	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2018	32	8					4408	4419		10.1096/fj.201701415R	http://dx.doi.org/10.1096/fj.201701415R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GN7MJ	29613835	Green Published, Green Accepted			2022-12-26	WOS:000439325400029
J	Cooke, M; Zhou, XL; Casado-Medrano, V; Lopez-Haber, C; Baker, MJ; Garg, R; Ann, J; Lee, J; Blumberg, PM; Kazanietz, MG				Cooke, Mariana; Zhou, Xiaoling; Casado-Medrano, Victoria; Lopez-Haber, Cynthia; Baker, Martin J.; Garg, Rachana; Ann, Jihyae; Lee, Jeewoo; Blumberg, Peter M.; Kazanietz, Marcelo G.			Characterization of AJH-836, a diacylglycerol-lactone with selectivity for novel PKC isozymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein kinase C (PKC); phorbol ester; diacylglycerol; lipid signaling; ligand-binding protein; C1 domain; cPKC; diacylglycerol lactone; nPKC; protein kinase activation; cell signaling; second messenger; cytoskeleton	PROTEIN-KINASE-C; PHORBOL ESTER BINDING; CONFORMATIONALLY CONSTRAINED ANALOGS; PROSTATE-CANCER CELLS; INDUCED APOPTOSIS; DOWN-REGULATION; TUMOR PROMOTION; DAG-LACTONES; MOUSE SKIN; DELTA	Diacylglycerol (DAG) is a key lipid second messenger downstream of cellular receptors that binds to the C1 domain in many regulatory proteins. Protein kinase C (PKC) isoforms constitute the most prominent family of signaling proteins with DAG-responsive C1 domains, but six other families of proteins, including the chimaerins, Ras-guanyl nucleotide-releasing proteins (RasGRPs), and Munc13 isoforms, also play important roles. Their significant involvement in cancer, immunology, and neurobiology has driven intense interest in the C1 domain as a therapeutic target. As with other classes of targets, however, a key issue is the establishment of selectivity. Here, using [H-3]phorbol 12,13-dibutyrate ([H-3]PDBu) competition binding assays, we found that a synthetic DAG-lactone, AJH-836, preferentially binds to the novel PKC isoforms PKC and PKCE relative to classical PKC and PKCII. Assessment of intracellular translocation, a hallmark for PKC activation, revealed that AJH-836 treatment stimulated a striking preferential redistribution of PKCE to the plasma membrane relative to PKC. Moreover, unlike with the prototypical phorbol ester phorbol 12-myristate 13-acetate (PMA), prolonged exposure of cells to AJH-836 selectively down-regulated PKC and PKCE without affecting PKC expression levels. Biologically, AJH-836 induced major changes in cytoskeletal reorganization in lung cancer cells, as determined by the formation of membrane ruffles, via activation of novel PKCs. We conclude that AJH-836 represents a C1 domain ligand with PKC-activating properties distinct from those of natural DAGs and phorbol esters. Our study supports the feasibility of generating selective C1 domain ligands that promote novel biological response patterns.	[Cooke, Mariana; Casado-Medrano, Victoria; Lopez-Haber, Cynthia; Baker, Martin J.; Garg, Rachana; Kazanietz, Marcelo G.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, 1256 Biomed Res Bldg 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA; [Zhou, Xiaoling; Blumberg, Peter M.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Ann, Jihyae; Lee, Jeewoo] Seoul Natl Univ, Coll Pharm, Lab Med Chem, Seoul 08826, South Korea	University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Seoul National University (SNU)	Kazanietz, MG (corresponding author), Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, 1256 Biomed Res Bldg 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	marcelog@upenn.edu	Casado-Medrano, Victoria/ABE-6429-2021; Baker, Martin/AAM-8426-2020; zhou, xuan/GZA-8157-2022; Cooke, Mariana/V-1375-2019; Cooke, Mariana/ABD-5051-2021; Baker, Martin James/AAO-1650-2020; Garg, Rachana/AAQ-9518-2020	Casado-Medrano, Victoria/0000-0002-6929-4559; Baker, Martin/0000-0002-9743-6294; Lee, Jeewoo/0000-0002-7832-6719; Ann, Jihyae/0000-0002-5043-8014; Garg, Rachana/0000-0002-7808-1053; Lopez Haber, Cynthia/0000-0001-9106-543X; Cooke, Mariana/0000-0001-9300-8447	National Institutes of Health [ES026023, CA189765, CA196232]; National Research Foundation of Korea for the Global Core Research Center [2011-0030001]; Intramural Research Program of the National Institutes of Health, Center for Cancer Research, NCI [Z1A BC 005270]; NATIONAL CANCER INSTITUTE [ZIABC005270, R01CA189765, Z01BC005270, R01CA196232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES026023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea for the Global Core Research Center(National Research Foundation of Korea); Intramural Research Program of the National Institutes of Health, Center for Cancer Research, NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants ES026023, CA189765, and CA196232 (to M.G.K.); by National Research Foundation of Korea for the Global Core Research Center Grant 2011-0030001; and in part by the Intramural Research Program of the National Institutes of Health, Center for Cancer Research, NCI Project Z1A BC 005270. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ann J, 2015, EUR J MED CHEM, V90, P332, DOI 10.1016/j.ejmech.2014.11.025; Basu A, 2007, CELL SIGNAL, V19, P1633, DOI 10.1016/j.cellsig.2007.04.008; Begley R, 2004, BIOCHEM BIOPH RES CO, V318, P949, DOI 10.1016/j.bbrc.2004.04.121; Blumberg PM, 2008, CURR DRUG TARGETS, V9, P641, DOI 10.2174/138945008785132376; Bocklandt S, 2003, ANTIVIR RES, V59, P89, DOI 10.1016/S0166-3542(03)00034-2; Bogi K, 1998, CANCER RES, V58, P1423; Caino MC, 2012, ONCOGENE, V31, P2593, DOI 10.1038/onc.2011.428; Caino MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031714; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Cooke M, 2017, MOL CARCINOGEN, V56, P1531, DOI 10.1002/mc.22617; Duan D, 2008, J MED CHEM, V51, P5198, DOI 10.1021/jm8001907; Durgan J, 2007, FEBS LETT, V581, P3377, DOI 10.1016/j.febslet.2007.06.035; Elhalem E, 2017, BIOORGAN MED CHEM, V25, P2971, DOI 10.1016/j.bmc.2017.03.022; Garcia LC, 2014, BIOORGAN MED CHEM, V22, P3123, DOI 10.1016/j.bmc.2014.04.024; Garcia-Bermejo ML, 2002, J BIOL CHEM, V277, P645, DOI 10.1074/jbc.M107639200; Garg R, 2014, ONCOGENE, V33, P5225, DOI 10.1038/onc.2013.524; Garg R, 2017, CELL REP, V19, P375, DOI 10.1016/j.celrep.2017.03.042; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; HANNUN YA, 1986, J BIOL CHEM, V261, P9341; Hayashi K, 2007, PHARMACOL RES, V55, P537, DOI 10.1016/j.phrs.2007.04.009; HENNINGS H, 1987, CARCINOGENESIS, V8, P1343, DOI 10.1093/carcin/8.9.1343; Kajimoto T, 2004, J BIOL CHEM, V279, P12668, DOI 10.1074/jbc.M312350200; Kashiwagi M, 2002, J BIOCHEM, V132, P853, DOI 10.1093/oxfordjournals.jbchem.a003297; Kazanietz MG, 2017, CANCER RES, V77, P5445, DOI 10.1158/0008-5472.CAN-17-1456; KAZANIETZ MG, 1992, J BIOL CHEM, V267, P20878; KAZANIETZ MG, 1993, MOL PHARMACOL, V44, P298; Kedei N, 2014, J MED CHEM, V57, P5356, DOI 10.1021/jm500417b; Kim H, 2016, J CELL BIOCHEM, V117, P647, DOI 10.1002/jcb.25314; Lum MA, 2013, J BIOL CHEM, V288, P13093, DOI 10.1074/jbc.M112.437061; Marquez VE, 2003, ACCOUNTS CHEM RES, V36, P434, DOI 10.1021/ar020124b; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Nacro K, 2000, J MED CHEM, V43, P921, DOI 10.1021/jm9904607; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Ohashi N, 2017, BIOCONJUGATE CHEM, V28, P2135, DOI 10.1021/acs.bioconjchem.7b00299; Okhrimenko H, 2005, J BIOL CHEM, V280, P23643, DOI 10.1074/jbc.M501374200; OLIVIER AR, 1992, J CELL PHYSIOL, V152, P240, DOI 10.1002/jcp.1041520204; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; PARKER PJ, 1995, BIOCHEM SOC T, V23, P153, DOI 10.1042/bst0230153; Pu YM, 2005, J BIOL CHEM, V280, P27329, DOI 10.1074/jbc.M414132200; Pu YM, 2009, J BIOL CHEM, V284, P1302, DOI 10.1074/jbc.M804796200; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Russo P, 2016, MAR DRUGS, V14, DOI 10.3390/md14010005; SHARKEY NA, 1984, P NATL ACAD SCI-BIOL, V81, P607, DOI 10.1073/pnas.81.2.607; SZALLASI Z, 1993, CANCER RES, V53, P2507; von Burstin VA, 2010, MOL PHARMACOL, V78, P325, DOI 10.1124/mol.110.064741; Wang HB, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227991; Wang QMJ, 1999, J BIOL CHEM, V274, P37233, DOI 10.1074/jbc.274.52.37233; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	52	9	12	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8330	8341		10.1074/jbc.RA117.000235	http://dx.doi.org/10.1074/jbc.RA117.000235			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29636415	Green Published, hybrid			2022-12-26	WOS:000434205700002
J	Litke, C; Bading, H; Mauceri, D				Litke, Christian; Bading, Hilmar; Mauceri, Daniela			Histone deacetylase 4 shapes neuronal morphology via a mechanism involving regulation of expression of vascular endothelial growth factor D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						histone deacetylase (HDAC); epigenetics; dendrite; hippocampus; calcium; neuronal morphology; nucleo-cytoplasmic shuttling; synaptic activity; VEGFD	SYNAPTIC PLASTICITY; NUCLEAR ACCUMULATION; HDAC4; PHOSPHORYLATION; SURVIVAL; BINDING; TRANSLOCATION; FAMILY; DEATH; CREB	Nucleo-cytoplasmic shuttling of class IIa histone deacetylases (i.e. HDAC4, -5, -7, and -9) is a synaptic activity- and nuclear calcium-dependent mechanism important for epigenetic regulation of signal-regulated gene expression in hippocampal neurons. HDAC4 in particular has been linked to the regulation of genes important for both synaptic structure and plasticity. Here, using a constitutively nuclear-localized, dominant-active variant of HDAC4 (HDAC4 3SA), we demonstrate that HDAC4 accumulation in the nucleus severely reduces both the length and complexity of dendrites of cultured mature hippocampal neurons, but does not affect the number of dendritic spines. This phenomenon appeared to be specific to HDAC4, as increasing the expression of HDAC3 or HDAC11, belonging to class I and class IV HDACs, respectively, did not alter dendritic architecture. We also show that HDAC4 3SA decreases the expression of vascular endothelial growth factor D (VEGFD), a key protein required for the maintenance of dendritic arbors. The expression of other members of the VEGF family and their receptors was not affected by the nuclear accumulation of HDAC4. VEGFD overexpression or administration of recombinant VEGFD, but not VEGFC, the closest VEGFD homologue, rescued the impaired dendritic architecture caused by the nuclear-localized HDAC4 variant. These results identify HDAC4 as an epigenetic regulator of neuronal morphology that controls dendritic arborization via the expression of VEGFD.	[Litke, Christian; Bading, Hilmar; Mauceri, Daniela] Heidelberg Univ, Interdisciplinary Ctr Neurosci IZN, Dept Neurobiol, INF 364, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Mauceri, D (corresponding author), Heidelberg Univ, Interdisciplinary Ctr Neurosci IZN, Dept Neurobiol, INF 364, D-69120 Heidelberg, Germany.	Mauceri@nbio.uni-heidelberg.de	Mauceri, Daniela/C-4969-2014	Mauceri, Daniela/0000-0003-1225-4633; Litke, Christian/0000-0001-9403-4233	Deutsche Forschungsgemeinschaft [SFB1158, FOR2325]; FRONTIER grant from the Heidelberg University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FRONTIER grant from the Heidelberg University	This work was supported in part by Deutsche Forschungsgemeinschaft Grants SFB1158 and FOR2325 (to D. M. and H. B.) and FRONTIER grant from the Heidelberg University (to D. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ageta-Ishihara N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3532; Akhtar MW, 2009, J NEUROSCI, V29, P8288, DOI 10.1523/JNEUROSCI.0097-09.2009; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bading H, 2017, J EXP MED, V214, P569, DOI 10.1084/jem.20161673; Bading H, 2013, NAT REV NEUROSCI, V14, P593, DOI 10.1038/nrn3531; Baloyannis SJ, 2009, J NEUROL SCI, V283, P153, DOI 10.1016/j.jns.2009.02.370; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Bryant DT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11630-1; Chan JKL, 2003, J BIOL CHEM, V278, P23515, DOI 10.1074/jbc.M301922200; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Darcy MJ, 2010, J COMP NEUROL, V518, P722, DOI 10.1002/cne.22241; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Gu X, 2018, J CELL PHYSIOL, V233, P673, DOI 10.1002/jcp.25927; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hemstedt TJ, 2017, J NEUROSCI, V37, P6946, DOI 10.1523/JNEUROSCI.2345-16.2017; Jiang Y, 2008, J NEUROSCI, V28, P11753, DOI 10.1523/JNEUROSCI.3797-08.2008; Kassis H, 2015, STROKE, V46, P1909, DOI 10.1161/STROKEAHA.115.009046; Kim HC, 2010, CELL MOL LIFE SCI, V67, P3499, DOI 10.1007/s00018-010-0388-5; Kim MS, 2012, J NEUROSCI, V32, P10879, DOI 10.1523/JNEUROSCI.2089-12.2012; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Li JL, 2012, NAT MED, V18, P783, DOI 10.1038/nm.2709; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Mauceri D, 2015, J BIOL CHEM, V290, P23039, DOI 10.1074/jbc.M115.654962; Mauceri D, 2011, NEURON, V71, P117, DOI 10.1016/j.neuron.2011.04.022; Mellstrom B, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0204-8; Oliveira AMM, 2012, NAT NEUROSCI, V15, P1111, DOI 10.1038/nn.3151; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Parsons MP, 2014, NEURON, V82, P279, DOI 10.1016/j.neuron.2014.03.030; Peserico A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/371832; Sando R, 2012, CELL, V151, P821, DOI 10.1016/j.cell.2012.09.037; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlumm F, 2013, J BIOL CHEM, V288, P8074, DOI 10.1074/jbc.M112.432773; Segal M, 2010, EUR J NEUROSCI, V31, P2178, DOI 10.1111/j.1460-9568.2010.07270.x; Shen XT, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0124-15.2016; SHOLL DA, 1953, J ANAT, V87, P387; Stephens B, 2005, NEUROSCIENCE, V132, P741, DOI 10.1016/j.neuroscience.2005.01.007; Sugo N, 2010, EUR J NEUROSCI, V31, P1521, DOI 10.1111/j.1460-9568.2010.07218.x; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Wu QM, 2017, MOL NEUROBIOL, V54, P6970, DOI 10.1007/s12035-016-0199-2; Yamazaki Y, 2006, MOL DIVERS, V10, P515, DOI 10.1007/s11030-006-9027-3; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yuan H, 2016, NEUROBIOL DIS, V91, P182, DOI 10.1016/j.nbd.2016.03.004; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200	50	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8196	8207		10.1074/jbc.RA117.001613	http://dx.doi.org/10.1074/jbc.RA117.001613			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29632070	hybrid, Green Published			2022-12-26	WOS:000433224600024
J	Kuklenyik, Z; Jones, JI; Gardner, MS; Schieltz, DM; Parks, BA; Toth, CA; Rees, JC; Andrews, ML; Carter, K; Lehtikoski, AK; McWilliams, LG; Williamson, YM; Bierbaum, KP; Pirkle, JL; Barr, JR				Kuklenyik, Zsuzsanna; Jones, Jeffery I.; Gardner, Michael S.; Schieltz, David M.; Parks, Bryan A.; Toth, Christopher A.; Rees, Jon C.; Andrews, Michael L.; Carter, Kayla; Lehtikoski, Antony K.; McWilliams, Lisa G.; Williamson, Yulanda M.; Bierbaum, Kevin P.; Pirkle, James L.; Barr, John R.			Core lipid, surface lipid and apolipoprotein composition analysis of lipoprotein particles as a function of particle size in one workflow integrating asymmetric flow field-flow fractionation and liquid chromatography-tandem mass spectrometry	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; C-III; A-I; PLASMA-LIPOPROTEIN; LC-MS/MS; LIPASE ACTIVITY; GEL-FILTRATION; LDL; HDL; CHOLESTEROL	Lipoproteins are complex molecular assemblies that are key participants in the intricate cascade of extracellular lipid metabolism with important consequences in the formation of atherosclerotic lesions and the development of cardiovascular disease. Multiplexed mass spectrometry (MS) techniques have substantially improved the ability to characterize the composition of lipoproteins. However, these advanced MS techniques are limited by traditional pre-analytical fractionation techniques that compromise the structural integrity of lipoprotein particles during separation from serum or plasma. In this work, we applied a highly effective and gentle hydrodynamic size based fractionation technique, asymmetric flow field-flow fractionation (AF4), and integrated it into a comprehensive tandem mass spectrometry based workflow that was used for the measurement of apolipoproteins (apos A-I, A-II, A-IV, B, C-I, C-II, C-III and E), free cholesterol (FC), cholesterol esters (CE), triglycerides (TG), and phospholipids (PL) (phosphatidylcholine (PC), sphingomyelin (SM), phosphatidylethanolamine (PE), phosphatidylinositol (P1) and lysophosphatidylcholine (LPC)). Hydrodynamic size in each of 40 size fractions separated by AF4 was measured by dynamic light scattering. Measuring all major lipids and apolipoproteins in each size fraction and in the whole serum, using total of 0.1 ml, allowed the volumetric calculation of lipoprotein particle numbers and expression of composition in molar analyte per particle number ratios. Measurements in 110 serum samples showed substantive differences between size fractions of HDL and LDL. Lipoprotein composition within size fractions was expressed in molar ratios of analytes (A-I/A-11, C-II/C-1, C-II/C-111. E/C-Ill, FC/PL, SM/PL, PE/PL, and PI/PL), showing differences in sample categories with combinations of normal and high levels of Total-C and/or Total-TG. The agreement with previous studies indirectly validates the AF4-LC-MS/MS approach and demonstrates the potential of this workflow for characterization of lipoprotein composition in clinical studies using small volumes of archived frozen samples.	[Kuklenyik, Zsuzsanna; Jones, Jeffery I.; Gardner, Michael S.; Schieltz, David M.; Parks, Bryan A.; Toth, Christopher A.; Rees, Jon C.; Andrews, Michael L.; Carter, Kayla; Lehtikoski, Antony K.; McWilliams, Lisa G.; Williamson, Yulanda M.; Bierbaum, Kevin P.; Pirkle, James L.; Barr, John R.] Ctr Dis Control & Prevent, Clin Chem Branch, Div Lab Sci, Atlanta, GA 30333 USA; [Jones, Jeffery I.] Univ Notre Dame, Notre Dame, IN 46556 USA; [Carter, Kayla] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA	Centers for Disease Control & Prevention - USA; University of Notre Dame; University of Michigan System; University of Michigan	Barr, JR (corresponding author), Ctr Dis Control & Prevent, Clin Chem Branch, Div Lab Sci, Atlanta, GA 30333 USA.	JBarr@cdc.gov	Carter, Kayla/GVS-9292-2022	Carter, Kayla/0000-0002-4836-0932; Andrews, Michael/0000-0003-1958-909X; Toth, Christopher/0000-0001-9294-0144; Kuklenyik, Zsuzsanna/0000-0001-9801-7705; Jones, Jeffrey/0000-0002-5940-2448	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The project is funded by the Centers for Disease Control and Prevention to ZK and JRB.	ALAUPOVI.P, 1972, BIOCHIM BIOPHYS ACTA, V260, P689, DOI 10.1016/0005-2760(72)90018-5; Alaupovic P, 1996, METHOD ENZYMOL, V263, P32; ALAUPOVIC P, 1991, PROG LIPID RES, V30, P105, DOI 10.1016/0163-7827(91)90008-S; Alaupovic Petar, 2003, Curr Atheroscler Rep, V5, P459, DOI 10.1007/s11883-003-0036-8; Arsenault BJ, 2010, CLIN CHEM, V56, P789, DOI 10.1373/clinchem.2009.140939; Asztalos BF, 2007, J LIPID RES, V48, P592, DOI 10.1194/jlr.M600403-JLR200; Chan DC, 2012, J CLIN ENDOCR METAB, V97, pE1658, DOI 10.1210/jc.2012-1522; CHARLWOOD PA, 1971, BIOCHEM J, V125, P1019, DOI 10.1042/bj1251019; Coronado-Gray A, 2005, LIPIDS, V40, P495, DOI 10.1007/s11745-005-1409-x; Ensign W, 2006, CLIN CHEM, V52, P1722, DOI 10.1373/clinchem.2005.059949; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Gao X, 2012, BIOCHEMISTRY-US, V51, P4633, DOI 10.1021/bi300555d; Gardner M., 2015, CHROMATOGRAPHY, V2, P96, DOI 10.3390/chromatography2010096; Gardner MS, 2017, J AM SOC MASS SPECTR, V28, P2319, DOI 10.1007/s13361-017-1756-2; Gautier T, 2000, J BIOL CHEM, V275, P37504, DOI 10.1074/jbc.M007210200; Holcapek M, 2015, J CHROMATOGR B, V990, P52, DOI [10.1016/j.jchromb.2015:03.010, 10.1016/j.jchromb.2015.03.010]; Holcapek M, 2015, J CHROMATOGR A, V1377, P85, DOI 10.1016/j.chroma.2014.12.023; Hoofnagle AN, 2009, J LIPID RES, V50, P1967, DOI 10.1194/jlr.R900015-JLR200; Hopkins PN, 2015, ATHEROSCLEROSIS, V243, P99, DOI 10.1016/j.atherosclerosis.2015.08.042; HUANG YD, 1994, P NATL ACAD SCI USA, V91, P1834, DOI 10.1073/pnas.91.5.1834; Hutchins PM, 2014, CLIN CHEM, V60, P1393, DOI 10.1373/clinchem.2014.228114; IBDAH JA, 1989, BIOCHEMISTRY-US, V28, P1126, DOI 10.1021/bi00429a029; Julve J, 2010, ARTERIOSCL THROM VAS, V30, P232, DOI 10.1161/ATVBAHA.109.198226; Kei AA, 2012, METABOLISM, V61, P906, DOI 10.1016/j.metabol.2011.12.002; Kuklenyik Z, 2018, INSTRUM SCI TECHNOL, V46, P102, DOI 10.1080/10739149.2017.1311912; Kwiterovich PO, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0371-5; Larsson M, 2013, J BIOL CHEM, V288, P33997, DOI 10.1074/jbc.M113.495366; Li P, 1997, J LIQ CHROMATOGR R T, V20, P2777, DOI 10.1080/10826079708005592; Martin SS, 2014, TRENDS ENDOCRIN MET, V25, P329, DOI 10.1016/j.tem.2014.05.005; Massey JB, 2009, J LIPID RES, V50, P1229, DOI 10.1194/jlr.D800044-JLR200; McNamara JR, 1996, J LIPID RES, V37, P1924; Mendivil CO, 2016, ARTERIOSCL THROM VAS, V36, P156, DOI 10.1161/ATVBAHA.115.306138; Mendivil CO, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000130; Mendivil CO, 2011, CIRCULATION, V124, P2065, DOI 10.1161/CIRCULATIONAHA.111.056986; MILNE RW, 1982, FEBS LETT, V146, P97, DOI 10.1016/0014-5793(82)80712-6; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Pan LR, 2016, BBA-BIOMEMBRANES, V1858, P2401, DOI 10.1016/j.bbamem.2016.03.010; Parks BA, 2017, PROTEOM CLIN APPL, V11, DOI 10.1002/prca.201600128; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Qureshi RN, 2009, ANAL CHIM ACTA, V654, P85, DOI 10.1016/j.aca.2009.06.060; Ramasamy I, 2014, CLIN CHEM LAB MED, V52, P1695, DOI 10.1515/cclm-2013-0358; Rambaldi DC, 2011, ANAL BIOANAL CHEM, V399, P1439, DOI 10.1007/s00216-010-4312-5; Reschiglian P, 2008, J PROTEOMICS, V71, P265, DOI 10.1016/j.jprot.2008.06.002; Santos RD, 2008, J LIPID RES, V49, P349, DOI 10.1194/jlr.M700362-JLR200; SCHLABACH MR, 1975, J BIOL CHEM, V250, P2182; Segrest JP, 2013, J LIPID RES, V54, P2733, DOI 10.1194/jlr.M039172; Segrest JP, 2002, CURR TOP MEMBR, V52, P397; Segrest JP, 2001, J LIPID RES, V42, P1346; Silva RAGD, 2008, ANN MED, V40, P5, DOI 10.1080/07853890701687201; Singh SA, 2016, J LIPID RES, V57, P714, DOI 10.1194/jlr.D061432; Sorci-Thomas MG, 2012, J LIPID RES, V53, P1890, DOI 10.1194/jlr.M026674; Tani M, 2016, ATHEROSCLEROSIS, V253, P7, DOI 10.1016/j.atherosclerosis.2016.08.014; Teerlink T, 2004, J LIPID RES, V45, P954, DOI 10.1194/jlr.M300521-JLR200; Temel RE, 2015, TRENDS PHARMACOL SCI, V36, P440, DOI 10.1016/j.tips.2015.04.002; Toth CA, 2017, J PROTEOMICS, V150, P258, DOI 10.1016/j.jprot.2016.09.011; van den Broek I, 2016, CLIN CHEM, V62, P188, DOI 10.1373/clinchem.2015.246702; vanAntwerpen R, 1997, J LIPID RES, V38, P659; Zannis VI, 2015, HANDB EXP PHARMACOL, V224, P53, DOI 10.1007/978-3-319-09665-0_2; Zheng CY, 2007, J LIPID RES, V48, P1190, DOI 10.1194/jlr.P600011-JLR200	61	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194797	10.1371/journal.pone.0194797	http://dx.doi.org/10.1371/journal.pone.0194797			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634782	gold, Green Published, Green Submitted			2022-12-26	WOS:000429522200013
J	Bataille, G; Conard, NJ				Bataille, Guido; Conard, Nicholas J.			Blade and bladelet production at Hohle Fels Cave, AH IV in the Swabian Jura and its importance for characterizing the technological variability of the Aurignacian in Central Europe	PLOS ONE			English	Article							SOUTHWESTERN GERMANY; HYPOTHESIS	Hohle Fels Cave in the Ach Valley of Southwestern Germany exhibits an Aurignacian sequence of 1 m thickness within geological horizons (GH) 6-8. The deposition of the layers took place during mild and cold phases between at least 42 ka (GI 10) and 36 ka calBP (GI 7). We present below a technological study of blade and bladelet production from AH IV (GH 7) at Hohle Fels. Our analyses show that blade manufacture is relatively constant, while bladelet production displays a high degree of variability in order to obtain different blanks. Knappers used a variety of burins as cores to produce fine bladelets. The results reveal a new variant of the Aurignacian in the Swabian Jura primarily characterized by the production of bladelets and microliths from burin-cores. The artefacts from the Swabian Aurignacian are technologically and functionally more diverse than earlier studies of the GeiBenklosterle and Vogelherd sequences have suggested. The technological analyses presented here challenge the claim that the typo-chronological system from Southwestern Europe can be applied to the Central European Aurignacian. Instead, we emphasize the impact of technological and functional variables within the Aurignacian of the Swabian Jura.	[Bataille, Guido; Conard, Nicholas J.] Eberhard Karls Univ Tubingen, Inst Ur & Fruhgeschichte & Archaol Mittelalters, Abt Urgeschichte & Quartarokol, Tubingen, Germany	Eberhard Karls University of Tubingen	Bataille, G (corresponding author), Eberhard Karls Univ Tubingen, Inst Ur & Fruhgeschichte & Archaol Mittelalters, Abt Urgeschichte & Quartarokol, Tubingen, Germany.	guido.bataille@ifu.uni-tuebingen.de		Conard, Nicholas/0000-0002-4633-0385	Baden-Wurttemberg State Office for Cultural Heritage; UNESCO foundation; State Office for Cultural Heritage, Baden Wurttemberg	Baden-Wurttemberg State Office for Cultural Heritage; UNESCO foundation; State Office for Cultural Heritage, Baden Wurttemberg	The authors thank the excavation team of Hohle Fels, especially Maria Malina, Sarah Rudolf (University of Tubingen, Heidelberg Academy of Science and Humanities) and Alexander Janas M.A. (Department of Early Prehistory and Quaternary Ecology, University of Tubingen). The authors would also like to thank Dr. Andreas Taller (Department for Early Prehistory and Quaternary Ecology, University of Tubingen) and Dr. Michael Bolus (Department for Early Prehistory and Quaternary Ecology, coordinator of the ROCEEH-project, University of Tubingen, Heidelberg Academy of Science and Humanities) for their cooperation with this research. The authors thank Dr. Claus-Joachim Kind (State Office for Cultural Heritage, Baden Wurttemberg), the Alb-Donau-Kreis, the Baden-Wurttemberg State Office for Cultural Heritage, and the UNESCO foundation for support. We thank Dr. Yvonne Tafelmaier (Department for Early Prehistory and Quaternary Ecology, University of Tubingen) for her critical review of the draft version of this paper. The authors are grateful to Diane Kerns for improving the English and to five anonymous reviewers for providing helpful improvement suggestions.	Aurignacien Hahn J., 1977, ALTERE JUNGPALAOLITH; Bataille G, 2017, 59 ANN M AUR APR 18, P16; Bataille G., 2016, MITTEILUNGEN GESELLS, V25, P27; Bataille G., 2013, THESIS; Bodu P., 2005, PRODUCTIONS LAMELLAI, V1, P297; Bolus M, 2001, QUATERN INT, V75, P29, DOI 10.1016/S1040-6182(00)00075-6; Bolus M, 2006, ARCHAOL KORRESPONDEN, V36, P1; Bolus M., 2003, TRABALHOS ARQUEOLOGI, P153; Bordes J.G., 2006, TRABALHOS ARQUEOLOGI, P147; Bordes J.-G., 2003, TRABALHOS ARQUEOLOGI, V33, P223; Brou L, 2006, BURINS PREHISTORIQUE, V2, P77; Chiotti L., 2003, GALLIA PREHISTOIRE, V45, P113, DOI DOI 10.3406/GALIP.2003.2037; Conard N., 2002, ARCHAOLOGISCHE AUSGR, V2002, P21; Conard N.J., 2015, EISZEITARCHAOLOGIE S; Conard N.J., 2004, ARCHAOLOGISCHE AUSGR, V2004, P17; Conard N.J, 2006, TRABALHOS ARQUEOLOGI, V45, P241; Conard NJ, 2009, NATURE, V459, P248, DOI 10.1038/nature07995; Conard NJ, 2009, NATURE, V460, P737, DOI 10.1038/nature08169; Conard NJ, 2008, J HUM EVOL, V55, P886, DOI 10.1016/j.jhevol.2008.08.006; Conard NJ, 2006, SCHMUCK VIELLEICHT A, V2006, P21; Conard NJ., 2006, INSTITUTO PORTUGU S, V45, P211; De Araujo Igreja M, 2006, ARCHEOLOGIQUES, V2; de Sonneville-Bordes D, 1960, PALEOLITHIQUE SUPERI; Demars P-Y., 1992, PALEO, V4, P101, DOI [10.3406/pal.1992.1197, DOI 10.3406/PAL.1992.1197]; Demars P-Y, 1989, CAHIERS QUATERNAIRE, V14; Demidenko YE, 2012, SIUREN I ROCK SHELTE, V129, P213; Dinnis R., 2011, ANTHR PRAEHISTORICA, V122, P5; Dinnis R, 2016, P PREHIST SOC, DOI [10.1017/ppr.2016.4, DOI 10.1017/PPR.2016.4]; Djindjian F., 2003, TRABALHOS ARQUEOLOGI, V33, P29; DJINDJIAN F., 1985, SIGNIFICATION CULTUR, V239, P338; Douka K, 2012, J HUM EVOL, V62, P286, DOI 10.1016/j.jhevol.2011.11.009; Driscoll K, 2014, J ARCHAEOL SCI, V47, P134, DOI 10.1016/j.jas.2014.04.008; Falcucci A, 2016, ARCHAEOL ANTHROP SCI, DOI [10.1007/s12520.016-0365-5, DOI 10.1007/S12520.016-0365-5]; Falcucci A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189241; Flakes Bataille G., 2012, FLAKES NOT BLADES WI, V5, P261; Flas D., 2006, ARCHEOLOGIQUES, V2, P55; Floss H, 2013, STEINARTEFAKTE ALTPA, P133; Hahn J., 1988, FORSCHUNGEN BERICHTE, V26; Hahn J., 1991, ERKENNEN BESTIMMEN S, V10; Higham T, 2012, J HUM EVOL, V62, P664, DOI 10.1016/j.jhevol.2012.03.003; Higham T, 2013, J HUM EVOL, V65, P806, DOI 10.1016/j.jhevol.2013.06.010; Le Brun-Ricalens F, 2005, CARINATED TOOLS NUCL, P23; Le Brun-Ricalens F, 2006, BURINS CAREENS FORMS, V2, P345; LeBrun-Ricalens F., 2005, PRODUCTIONS LAMELLAI, P157; Liolios D., 2006, AURIGNACIENS, P137; Lucas G., 2006, DEFINITION AURIGNACI, V45, P173; Miller CE, 2015, TALE 2 SWABIAN CAVES; Nigst PR, 2014, P NATL ACAD SCI USA, V111, P14394, DOI 10.1073/pnas.1412201111; Pastoors A., 2001, SALZGITTER FORSCHUNG, V3; Pelegrin J., 2000, MEMOIRES PREHISTOIRE, P73; Richter J., 1997, QUARTAR BIBLIOTHEK, V7; Riehl S, 2014, ARCHAEOL ANTHROP SCI, DOI [10.1007/s12520-014-0182, DOI 10.1007/S12520-014-0182]; Roussel M, 2009, BULL SOC PREHIST FR, V106, P219, DOI 10.3406/bspf.2009.13846; Schiegl S, 2003, GEOARCHAEOLOGY, V18, P541, DOI 10.1002/gea.10080; Schmidt R.R., 1912, DILUVIALE VORZEIT DE; Sitlivy V., 2014, MODES CONTACTES DEPL, V8, P243; Slimak L., 2005, 14 C UISPP LIEG 2 8, P75; Slimak L., 2006, BURINS PREHISTORIQUE, V2, P33; Svoboda JA, 2006, CHRONOLOGY AURIGNACI, V33, P259; Tafelmaier Y., 2017, WISSENSCHATTLICHE SC, V9; Teyssandier N., 2003, TRABALHOS ARQUEOLOGI, V33, P179; Teyssandier N., 2007, BAR INT SERIES, P1638; Tixier J., 1974, NEWSLETTER LITHIC TE, V1; Weissmuller W., 1995, QUARTAR BIBLIOTHEK, V6; Weninger G, 2016, CALPAL EDITION 2016, P3; Wolf S., TUBINGER MONOGRAPHIE; Zilhao J, 2011, VERTEBR PALEOBIOL PA, P331, DOI 10.1007/978-94-007-0492-3_25; Zotz L., QUARTER, V15, P143; Zwyns N, 2012, QUATERN INT, V259, P33, DOI 10.1016/j.quaint.2011.03.036	69	22	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194097	10.1371/journal.pone.0194097	http://dx.doi.org/10.1371/journal.pone.0194097			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630601	Green Submitted, Green Published, gold			2022-12-26	WOS:000429505000004
J	Kruger, A; Maletz, R; Ottl, P; Warkentin, M				Krueger, Joerm; Maletz, Reinhard; Ottl, Peter; Warkentin, Mareike			In vitro aging behavior of dental composites considering the influence of filler content, storage media and incubation time	PLOS ONE			English	Article							SURFACE FREE-ENERGY; RESTORATIVE MATERIALS; RESIN COMPOSITES; POSTERIOR RESTORATIONS; MECHANICAL-PROPERTIES; ALCOHOLIC BEVERAGES; ROUGHNESS; MICROHARDNESS; BIODEGRADATION; DEGRADATION	Objective Over time dental composites age due to mechanical impacts such as chewing and chemical impacts such as saliva enzymes and food ingredients. For this research, the focus was placed on chemical degradation. The objective of this study was to simulate hydrolysis by using different food simulating liquids and to assess their impact on the mechanical parameter Vickers microhardness (MHV) and the physicochemical parameter contact angle (CA). Methods Specimen of three composites (d = 6 mm, h = 2 mm; n = 435) classified with respect to their filler content (wt%), namely low-filled, medium-filled and highly-filled, were stored for 0, 14, 30, 90 and 180 days in artificial saliva (pH 7), citric acid (pH 3; pH 5), lactic acid (pH 3; pH 5) and ethanol (40%vol; 60%vol) and assessed regarding to MHV and CA. Statistics: Kruskal-Wallis test, stepwise linear regression, bivariate Spearman Rank Correlation (p < 0.05). Results While stored in artificial saliva, acid and ethanol the CA decreased especially for the low- and medium-filled composites. It was shown that rising the filler content caused less surface changes in the CA. Storage in ethanol led to a significant decrease of MHV of all composites. Regression analysis showed that the effect of in vitro aging on MHV was mainly influenced by the composite material and therefore by filler content (R-2 = 0.67; p < 0.05). In contrast, the CA is more influenced by incubation time and filler content (R-2 = 0.2; p < 0.05) leading to a higher risk of plaque accumulation over time. Significance: In vitro aging showed significant changes on the mechanical and physicochemical properties of dental composites which may shorten their long-term functionality. In conclusion, it can be stated, that the type of composite material, especially rising filler content seems to improve the materials resistance against the processes of chemical degradation.	[Krueger, Joerm; Ottl, Peter] Univ Rostock, Dept Prosthodont & Mat Sci, Fac Med, Rostock, Germany; [Maletz, Reinhard; Warkentin, Mareike] Univ Rostock, Fac Mech Engn & Marine Technol, Dept Mat Sci & Med Engn, Rostock, Germany	University of Rostock; University of Rostock	Kruger, A (corresponding author), Univ Rostock, Dept Prosthodont & Mat Sci, Fac Med, Rostock, Germany.	joem.krueger@uni-rostock.de	Rosentritt, Martin/ABI-2885-2020; Rosentritt, Martin/AAE-9020-2020	Rosentritt, Martin/0000-0002-6017-5529				Bakopoulou A, 2009, INT J MOL SCI, V10, P3861, DOI 10.3390/ijms10093861; Ben-Gal G, 2011, J DENT EDUC, V75, P1590; Bernardo M, 2007, J AM DENT ASSOC, V138, P775, DOI 10.14219/jada.archive.2007.0265; Birdi K.S., 1997, HDB SURFACE COLLOID; Bollen CML, 1997, DENT MATER, V13, P258, DOI 10.1016/S0109-5641(97)80038-3; da Silva MAB, 2016, DENT MATER J, V35, P621, DOI 10.4012/dmj.2015-383; BRAEM M, 1989, DENT MATER, V5, P346, DOI 10.1016/0109-5641(89)90128-0; Burgers R, 2009, CLIN ORAL INVEST, V13, P419, DOI 10.1007/s00784-009-0256-6; Butt H.-J., 2013, PHYS CHEM INTERFACES; Catelan A, 2010, J ESTHET RESTOR DENT, V22, P324, DOI 10.1111/j.1708-8240.2010.00360.x; CHADWICK RG, 1990, DENT MATER, V6, P123, DOI 10.1016/S0109-5641(05)80042-9; Chuenarrom C, 2009, MATER RES-IBERO-AM J, V12, P473, DOI 10.1590/S1516-14392009000400016; CHUNG KH, 1990, J DENT RES, V69, P852, DOI 10.1177/00220345900690030401; Correr GM, 2012, ACTA ODONTOL SCAND, V70, P101, DOI 10.3109/00016357.2011.600701; Craig RG, 1993, RESTORATIVE DENT MAT, V9th; Darvell B.W., 2018, MAT SCI DENT, P143, DOI DOI 10.1533/9781845696672; de Paula A B, 2014, Oper Dent, V39, pE109, DOI 10.2341/12-340; Drummond JL, 2008, J DENT RES, V87, P710, DOI 10.1177/154405910808700802; Erdemir U, 2012, DENT MATER J, V31, P729, DOI 10.4012/dmj.2012-054; Ferracane JL, 2017, DENT MATER, V33, P1171, DOI 10.1016/j.dental.2017.08.188; Ferracane JL, 2016, DENT MATER, V32, P1, DOI 10.1016/j.dental.2015.06.020; Ferracane JL, 2011, DENT MATER, V27, P29, DOI 10.1016/j.dental.2010.10.020; Ferracane JL, 2006, DENT MATER, V22, P211, DOI 10.1016/j.dental.2005.05.005; FERRACANE JL, 1994, J ORAL REHABIL, V21, P441, DOI 10.1111/j.1365-2842.1994.tb01158.x; FERRACANE JL, 1995, J DENT RES, V74, P1418, DOI 10.1177/00220345950740071501; Ferracane JL, 1998, J BIOMED MATER RES, V42, P465, DOI 10.1002/(SICI)1097-4636(19981205)42:3<465::AID-JBM17>3.0.CO;2-F; Finer Y, 2003, J BIOMAT SCI-POLYM E, V14, P837, DOI 10.1163/156856203768366558; Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3; Hahnel S, 2010, OPER DENT, V35, P412, DOI 10.2341/09-337-L; Hahnel S, 2010, J MATER SCI-MATER M, V21, P823, DOI 10.1007/s10856-009-3894-y; Hannig M, 2007, J NANOSCI NANOTECHNO, V7, P4642, DOI 10.1166/jnn.2007.005; Ilie N, 2009, CLIN ORAL INVEST, V13, P427, DOI 10.1007/s00784-009-0258-4; Kakaboura A, 2003, DENT MATER, V19, P393, DOI 10.1016/S0109-5641(02)00082-9; Korkmaz Y, 2008, OPER DENT, V33, P44, DOI 10.2341/07-28; Kruly PC, 2018, PLOS ONE, V13, P1; LARSEN IB, 1991, SCAND J DENT RES, V99, P254; Lee SY, 1998, J ORAL REHABIL, V25, P575; Leung VWH, 1997, J DENT, V25, P475, DOI 10.1016/S0300-5712(96)00068-1; Mandikos MN, 2001, J PROSTHET DENT, V85, P386, DOI 10.1067/mpr.2001.114267; MCKINNEY JE, 1985, J DENT RES, V64, P1326, DOI 10.1177/00220345850640111601; Mohamed-Tahir MA, 2005, OPER DENT, V30, P661; Münchow Eliseu A., 2014, Braz. Dent. J., V25, P321, DOI 10.1590/0103-6440201300058; Musanje L, 2004, BIOMATERIALS, V25, P4065, DOI 10.1016/j.biomaterials.2003.11.003; NASSAR U, 1995, PERIODONTOL 2000, V8, P114, DOI 10.1111/j.1600-0757.1995.tb00049.x; Nedeljkovic I, 2015, DENT MATER, V31, pE247, DOI 10.1016/j.dental.2015.09.001; Opdam NJM, 2014, J DENT RES, V93, P943, DOI 10.1177/0022034514544217; Ottenga ME, 2007, OPER DENT, V32, P524, DOI 10.2341/06-134; OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815; OYSAED H, 1986, J DENT RES, V65, P1315, DOI 10.1177/00220345860650110601; Padovani GC, 2014, OPER DENT, V39, P349, DOI 10.2341/13-089-C; Park JW, 2014, J DENT RES, V93, P195, DOI 10.1177/0022034513513905; Quirynen M, 1996, Int J Oral Maxillofac Implants, V11, P169; QUIRYNEN M, 1990, J CLIN PERIODONTOL, V17, P138, DOI 10.1111/j.1600-051X.1990.tb01077.x; Roulet J-F, 1987, DEGRADATION DENT POL, pxii; Ruttermann S, 2012, ARCH ORAL BIOL, V57, P1512, DOI 10.1016/j.archoralbio.2012.05.005; Santerre JP, 1999, J DENT RES, V78, P1459, DOI 10.1177/00220345990780081201; Sarrett DC, 2000, DENT MATER, V16, P62, DOI 10.1016/S0109-5641(99)00088-3; Sarrett DC, 2005, DENT MATER, V21, P9, DOI 10.1016/j.dental.2004.10.001; Scheie A A, 1994, Adv Dent Res, V8, P246; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; Shajii L, 1999, BIOMATERIALS, V20, P1897, DOI 10.1016/S0142-9612(99)00087-3; Sideridou ID, 2005, J BIOMED MATER RES B, V74B, P617, DOI 10.1002/jbm.b.30252; Stamm M., 2008, SPRINGER EBOOK COLLE, pXVI; Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x; Tuncer S, 2013, J ESTHET RESTOR DENT, V25, P404, DOI 10.1111/jerd.12063; Turssi CP, 2002, J ORAL REHABIL, V29, P864, DOI 10.1046/j.1365-2842.2002.00926.x; Venturini D, 2006, OPER DENT, V31, P11, DOI 10.2341/04-155; Wang RZ, 1998, CONNECT TISSUE RES, V39, P269, DOI 10.3109/03008209809021502; Warkentin M., 2014, WERKSTOFFKUNDLICHE S; WU W, 1982, J DENT RES, V61, P1180, DOI 10.1177/00220345820610101501; Yap AUJ, 2001, J ORAL REHABIL, V28, P1015, DOI 10.1046/j.1365-2842.2001.00760.x	71	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195160	10.1371/journal.pone.0195160	http://dx.doi.org/10.1371/journal.pone.0195160			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630621	Green Submitted, gold, Green Published			2022-12-26	WOS:000429505000028
J	Carvalho, FG; de Souza, CM; Hidalgo, MPL				Carvalho, Felipe Gutierrez; de Souza, Camila Morelatto; Loayza Hidalgo, Maria Paz			Work routines moderate the association between eveningness and poor psychological well-being	PLOS ONE			English	Article							QUALITY-OF-LIFE; DEPRESSIVE SYMPTOMS; CIRCADIAN TYPOLOGY; SOCIAL JETLAG; SLEEP; CHRONOTYPES; MORNINGNESS; ADOLESCENTS; PERFORMANCE; MEDIATION	Well-being is a useful screening method for the detection of mood disorders. Evidence associating psychological well-being with sleep-wake patterns exists, as well as associations with sleep-wake patterns, work-related parameters, and perceived self-efficacy. Despite the growing research regarding the relationship between these factors and mental health, there are few studies that analyze them together. OBJECTIVE: To investigate if the association between sleep-wake patterns and psychological well-being is mediated or moderated by perceived self-efficacy, work flexibility and work routines. MATERIAL AND METHODS: This cohort study was performed in southern Brazil. A sample of 987 individuals was analyzed (66.9% women; mean age = 43.9 years). Work routines parameters and work schedule flexibility were evaluated, most participants were farmers (46%) and most worked 7 days a week (69.1%). Munich Chronotype Questionnaire (MCTQ) was administered for evaluation of sleep-wake patterns, General Self-Efficacy Scale (GSE) for assessment the participants' beliefs about how they coped with daily hassles, and World Health Organization Five-item Well-being Index (WHO-5) for evaluation of psychological well-being levels. Moderation and mediation models were tested. RESULTS: The moderation model showed influences of work end time on the relationship between sleep onset time and psychological well-being (R-2 = 0.147; F = 24.16; p<0.001). The final regression model showed an association of psychological well-being with sex (Beta = -0.086; p = 0.004), sleep onset time (Beta = -0.086; p = 0.006), and self-efficacy (Beta = 0.316; p<0.001); the work end time showed association in the interaction with sleep onset time (Beta = -0.075; p = 0.016). CONCLUSION: The findings support the direct association of psychological well-being with sleep-wake patterns and self-efficacy, and show an interaction between work routines and sleep-wake patterns. Our results draw attention to the importance of the interplay between individual and social rhythms in relation to psychological well-being.	[Carvalho, Felipe Gutierrez; de Souza, Camila Morelatto; Loayza Hidalgo, Maria Paz] Hosp Clin Porto Alegre, Chronobiol & Sleep Lab, Porto Alegre, RS, Brazil; [Carvalho, Felipe Gutierrez; de Souza, Camila Morelatto; Loayza Hidalgo, Maria Paz] Univ Fed Rio Grande do Sul, Psychiat & Behav Sci Postgrad Program, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Carvalho, FG (corresponding author), Hosp Clin Porto Alegre, Chronobiol & Sleep Lab, Porto Alegre, RS, Brazil.; Carvalho, FG (corresponding author), Univ Fed Rio Grande do Sul, Psychiat & Behav Sci Postgrad Program, Porto Alegre, RS, Brazil.	labcronoesono@hcpa.edu.br	Hidalgo, Maria Paz Loayza/V-5612-2019	Hidalgo, Maria Paz Loayza/0000-0002-7886-770X	Fundo de Incentivo a Pesquisa e Eventos [FIPE/HCPA - GPPG 15-0459]	Fundo de Incentivo a Pesquisa e Eventos	The project received financial support from the "Fundo de Incentivo a Pesquisa e Eventos" (FIPE/HCPA - GPPG 15-0459). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adan A, 2012, CHRONOBIOL INT, V29, P1153, DOI 10.3109/07420528.2012.719971; Agorastos A, 2016, J PINEAL RES, V61, P3, DOI 10.1111/jpi.12330; Aiken L. S., 1991, MULTIPLE REGRESSION; Antypa N, 2016, DEPRESS ANXIETY, V33, P75, DOI 10.1002/da.22422; Bandura A, 1997, AM J HEALTH PROMOT, V12, P8, DOI 10.4278/0890-1171-12.1.8; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bech P., 2004, QUAL LIFE NEWSL, V32, P15; Benight CC, 2004, BEHAV RES THER, V42, P1129, DOI 10.1016/j.brat.2003.08.008; Brink E, 2012, PSYCHOL HEALTH MED, V17, P346, DOI 10.1080/13548506.2011.608807; Carvalho FG, 2014, CHRONOBIOL INT, V31, P442, DOI 10.3109/07420528.2013.846350; de Souza CM, 2015, CHRONOBIOL INT, V32, P341, DOI 10.3109/07420528.2014.979941; de Souza CM, 2012, EUR ARCH PSY CLIN N, V262, P239, DOI 10.1007/s00406-011-0255-x; Diaz-Morales JF, 2013, CHRONOBIOL INT, V30, P1283, DOI 10.3109/07420528.2013.840786; Goldstein D, 2007, PERS INDIV DIFFER, V42, P431, DOI 10.1016/j.paid.2006.07.008; Hasler BP, 2013, PSYCHIAT RES-NEUROIM, V214, P357, DOI 10.1016/j.pscychresns.2013.08.005; Hayes A. F., 2012, PROCESS VERSATILE CO; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Henkel V, 2003, BMJ-BRIT MED J, V326, P200; Hidalgo MP, 2009, PSYCHIAT CLIN NEUROS, V63, P283, DOI 10.1111/j.1440-1819.2009.01965.x; Hidalgo MPL, 2004, PSYCHOL REP, V95, P75, DOI 10.2466/PR0.95.5.75-85; Hoogwegt MT, 2013, EUROPACE, V15, P1468, DOI 10.1093/europace/eut072; Jankowski KS, 2016, J AFFECT DISORDERS, V196, P47, DOI 10.1016/j.jad.2016.02.015; Jeon HJ, 2017, CHRONOBIOL INT, V34, P677, DOI 10.1080/07420528.2017.1309425; KNUTSSON A, 1986, LANCET, V2, P89; Lazarus RS, 1984, STRESS APPRAISAL COP, Vxiii; Levandovski R, 2011, CHRONOBIOL INT, V28, P771, DOI 10.3109/07420528.2011.602445; Lunau T, 2014, EUR J PUBLIC HEALTH, V24, P422; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Meng X, 2016, EPIDEMIOL PSYCHIAT S, V25, P370; Ottoni GL, 2012, CHRONOBIOL INT, V29, P786, DOI 10.3109/07420528.2012.679329; Portaluppi F, 2010, CHRONOBIOL INT, V27, P1911, DOI 10.3109/07420528.2010.516381; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; Roeser K, 2012, CHRONOBIOL INT, V29, P1358, DOI 10.3109/07420528.2012.728664; Romo-Nava F, 2016, CHRONOBIOL INT, V33, P1359, DOI 10.1080/07420528.2016.1217230; Rottmann N, 2010, QUAL LIFE RES, V19, P827, DOI 10.1007/s11136-010-9653-1; Schutte S, 2014, INT ARCH OCC ENV HEA, V87, P897, DOI 10.1007/s00420-014-0930-0; Souza I., 2004, REV UNIVERSIDADE RUR, V26, P12; Stansfeld SA, 2003, J EPIDEMIOL COMMUN H, V57, P361, DOI 10.1136/jech.57.5.361; Taylor SE, 2007, ANNU REV CLIN PSYCHO, V3, P377, DOI 10.1146/annurev.clinpsy.3.022806.091520; Tuchsen F, 2006, OCCUP ENVIRON MED, V63, P451, DOI 10.1136/oem.2006.026716; Vetter C, 2015, DIABETES CARE, V38, P1707, DOI 10.2337/dc15-0302; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Wittmann M, 2010, SUBST USE MISUSE, V45, P15, DOI 10.3109/10826080903498952	45	4	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195078	10.1371/journal.pone.0195078	http://dx.doi.org/10.1371/journal.pone.0195078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB9FN	29624593	Green Published, gold, Green Submitted			2022-12-26	WOS:000429379600014
J	Shi, Q; Lie, KJ; Treuer, T; Wang, BCM; Gaich, CL; Lee, CH; Wu, WS; Furnback, W; Tang, CH				Shi, Qiang; Lie, Ko-Jen; Treuer, Tamas; Wang, Bruce C. M.; Gaich, Carol L.; Lee, Chien-Hsun; Wu, Wen-Shuo; Furnback, Wesley; Tang, Chao-Hsiun			Estimating the response and economic burden of rheumatoid arthritis patients treated with biologic disease-modifying antirheumatic drugs in Taiwan using the National Health Insurance Research Database (NHIRD)	PLOS ONE			English	Article							RISK; PREVALENCE; COMORBIDITY; MANIFESTATIONS; OSTEOPOROSIS; CONSORTIUM; MORTALITY; FREQUENCY; FRACTURE; PEOPLE	Background Previous studies in Taiwan utilizing the Taiwan's National Health Insurance Database (NHIRD) have estimated the direct healthcare costs of RA patients, but they have not focused on patients on bDMARDs, or considered patients' response to therapy. Objectives The objective of this study was to estimate the rate of inadequate response for patients newly treated with biologic disease-modifying antirheumatic drugs (bDMARDs) as well as their costs and resource use. Methods Data were from the catastrophic illness file within the NHIRD from 1/1/2009 to 12/31/2013. Patients with RA, which was categorized by the presence of a catastrophic illness card, that were previously bDMARD-naive, were included in this study if they initiated their first bDMARD during the index period. The index period included all of 2010, a pre-index period consisting of the index date 365 days, and a follow-up period including the index date to 365 days post-index, were also included. Previously biologically-naive patients were indexed into the study on the date of their first claim for a bDMARD. A validated algorithm was used to examine the rate of inadequate response (IR) in the biologically-naive cohort of patients. Inadequate responders met one or more of the following criteria during their year of follow-up: low adherence (proportion of days covered <0.80); switched to or added a second bDMARD; added a new conventional synthetic DMARD (csDMARD); received >= 1 glucocorticoid injection; or increased oral glucocorticoid dosing. All-cause mean annual direct costs and resource use were measured in the year of follow-up. Costs were converted from NT$ to USD using 1 NT$ = 0.033 USD. Results A total of 818 patients with RA initiated their first bDMARD (54% etanercept and 46% adalimumab) in 2010. After one year of follow-up, 32% (n = 258) were classified as stable, 66% (n = 540) had an IR, and 2% (n = 20) were lost to follow-up. During the follow-up period mean annual total direct costs were $16,136 for stable patients compared to $14,154 for patients with IR. Mean annual non-medication direct costs were $937 for stable patients and $1,574 for patients with IR. Mean annual hospitalizations were higher for patients with IR (0.46) compared to stable patients (0.10) during the one year follow-up period. Conclusions The majority of patients that were previously naive to bDMARDs had an IR to their first bDMARD during the year of follow-up. Patients with an IR had numerically increased all cause resource utilization and non-medication costs during the follow-up period compared to patients with stable disease. This level of IR suggests an unmet need in the RA treatment paradigm.	[Shi, Qiang] Eli Lilly & Co, Shanghai, Peoples R China; [Lie, Ko-Jen] Natl Taiwan Univ, Taipei, Taiwan; [Treuer, Tamas] Eli Lilly & Co, Budapest, Hungary; [Wang, Bruce C. M.; Furnback, Wesley] Elysia Grp Ltd, Taipei, Taiwan; [Gaich, Carol L.] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Lee, Chien-Hsun; Wu, Wen-Shuo] Eli Lilly & Co, Taipei, Taiwan; [Tang, Chao-Hsiun] Taipei Med Univ, Taipei, Taiwan	Eli Lilly; National Taiwan University; Eli Lilly; Eli Lilly; Eli Lilly; Taipei Medical University	Tang, CH (corresponding author), Taipei Med Univ, Taipei, Taiwan.	chtang@tmu.edu.tw		LI, KO-JEN/0000-0002-4544-4620	Eli Lilly and Co; Eli Lilly; Elysia Group	Eli Lilly and Co(Eli Lilly); Eli Lilly(Eli Lilly); Elysia Group	This study was funded by Eli Lilly and Co (https://www.lilly.com/). Eli Lilly provided financial support in the form of salaries for QS, TT, CG, CL, WW. Eli Lilly paid the following authors as consultants: KL, BW, WF, CT. Elysia Group provided financial support in the form of salaries for BW and WF. The specific roles of these authors are articulated in the author contributions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Bingham C, 2013, ARTHRITIS INFORM; Chang JY, 2014, VALUE HEALTH, V17, pA773, DOI 10.1016/j.jval.2014.08.328; Choy E, 2012, RHEUMATOLOGY, V51, pV3, DOI 10.1093/rheumatology/kes113; Choy EH, 2013, NAT REV RHEUMATOL, V9, P154, DOI 10.1038/nrrheum.2013.8; Coulson KA, 2009, JCR-J CLIN RHEUMATOL, V15, P155, DOI 10.1097/RHU.0b013e3181a5679d; Curtis JR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3471; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dougados M, 2014, ANN RHEUM DIS, V73, P62, DOI 10.1136/annrheumdis-2013-204223; Emery P, 2012, RHEUMATOLOGY, V51, pV22, DOI 10.1093/rheumatology/kes115; Furst DE, 2014, RHEUMATOLOGY; Gabriel SE, 2008, ANN RHEUM DIS, V67, P30, DOI 10.1136/ard.2008.098038; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; Haugeberg G, 2000, ARTHRITIS RHEUM, V43, P522, DOI 10.1002/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y; Hochberg MC, 2008, CURR MED RES OPIN, V24, P469, DOI [10.1185/030079908X261177, 10.1185/030079908X261177 ]; Hsieh CR, 2012, VALUE HEALTH, V15, pS35, DOI 10.1016/j.jval.2011.11.025; Kuo CF, 2013, RHEUMATOL INT, V33, P355, DOI 10.1007/s00296-012-2411-7; Lai CH, 2012, CLIN EXP RHEUMATOL, V30, P358; Lai NS, 2014, ARTHRIT CARE RES, V66, P371, DOI 10.1002/acr.22146; Lin YC, 2015, OSTEOPOROSIS INT, V26, P811, DOI 10.1007/s00198-014-2968-y; Lindhardsen J, 2011, ANN RHEUM DIS, V70, P929, DOI 10.1136/ard.2010.143396; Listing J, 2013, RHEUMATOLOGY, V52, P53, DOI 10.1093/rheumatology/kes305; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Moots RJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179308; Moots RJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175207; Prete M, 2011, AUTOIMMUN REV, V11, P123, DOI 10.1016/j.autrev.2011.09.001; Rudan I, 2015, J GLOB HEALTH, V5, P132, DOI 10.7189/jogh.05.010409; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Smolen JS, 2016, ANN RHEUM DIS, V75, P3, DOI 10.1136/annrheumdis-2015-207524; Smolen JS, 2014, ANN RHEUM DIS, V73, P3, DOI 10.1136/annrheumdis-2013-204317; Solomon G, 2013, BULL HOSP JT DIS, V71, P200; Strand V, 2013, ANN RHEUM DIS, V72, P71; Taiwan National Health Insurance Administration. Ministry of Health and Welfare, 2013, IMM AG REIMB GUID; Turesson C, 2013, RHEUMATOLOGY, V52, P5, DOI 10.1093/rheumatology/kes189; Wang BCM., 2016, DRUGS-REAL WOR OUTC, V3, P107, DOI [10.1007/s40801-016-0063-8, DOI 10.1007/S40801-016-0063-8]; Wotton CJ, 2012, J EPIDEMIOL COMMUN H, V66, P1177, DOI 10.1136/jech-2011-200168	36	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0193489	10.1371/journal.pone.0193489	http://dx.doi.org/10.1371/journal.pone.0193489			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624580	Green Published, gold, Green Submitted			2022-12-26	WOS:000429379600002
J	Okugn, A; Woldeyohannes, D				Okugn, Akoma; Woldeyohannes, Demelash			Food hygiene practices and its associated factors among model and non model households in Abobo district, southwestern Ethiopia: Comparative cross-sectional study	PLOS ONE			English	Article								Background In developing country most of human infectious diseases are caused by eating contaminated food. Estimated nine out ten of the diarrheal disease is attributable to the environment and associated with risk factors of poor food hygiene practice. Understanding the risk of eating unsafe food is the major concern to prevent and control food borne diseases. The main goal of this study was to assessing food hygiene practices and its associated factors among model and non model households at Abobo district. Methods This study was conducted from 18 October 2013 to 13 June 2014. A community-based comparative cross-sectional study design was used. Pretested structured questionnaire was used to collect data. A total of 1247 households (417 model and 830 non model households) were included in the study from Abobo district. Bivariate and multivariate logistic regression analysis was used to identify factors associated with outcome variable. Results The study revealed that good food hygiene practice was 51%, of which 79% were model and 36.70% were non model households. Type of household [AOR: 2.07, 95% CI: (1.32-3.39)], sex of household head [AOR: 1.63, 95% CI: (1.06-2.48)], Availability of liquid wastes disposal pit [AOR: 2.23, 95% CI: (1.39,3.63)], Knowledge of liquid waste to cause diseases [AOR: 1.95, 95% (1.23,3.08)], and availability of functional hand washing facility [AOR: 3.61, 95% CI: (1.86-7.02)] were the factors associated with food handling practices. Conclusion This study revealed that good food handling practice is low among model and non model households. While type of household (model versus non model households), sex, knowledge of solid waste to cause diseases, availability of functional hand washing facility, and availability of liquid wastes disposal pit were the factors associated with outcome variable. Health extension workers should play a great role in educating households regarding food hygiene practices to improve their knowledge and practices of the food hygiene.	[Okugn, Akoma] Gambella Coll Hlth Sci, Dept Nursing, Gambella, Ethiopia; [Woldeyohannes, Demelash] Madda Walabu Univ, Coll Med & Hlth Sci, Dept Nursing, Bale Goba, Ethiopia	University of Gondar	Woldeyohannes, D (corresponding author), Madda Walabu Univ, Coll Med & Hlth Sci, Dept Nursing, Bale Goba, Ethiopia.	woldemel@gmail.com		Handiso, Demelash Woldeyohannes/0000-0002-4071-795X				Abobo district a Health Office, 2013, AB DISTR HLTH OFF RE; Abobo district Office of Finance and Economic Development, 2010, ANN REPORT; [Anonymous], 2001, GLOBAL SURVEILLANCE; Central Statistical Agency [Ethiopia] and ORC Macro [USA], 2011, ETH DEM HLTH SURV; Gambella People National Regional State, 2011, GAMB PEOPL NAT REG S; Gambella Regional Health Bureau, 2011, ENV SAN HYG REP; Korma S, 2011, THESIS; Ministry of Health, 2007, EST BURD WAT BORN DI; MOH, 2004, FOOD HYG SAF MEAS EX; MOH, 2005, NAT HYG SAN STRAT; MOH, 2004, IMPR ACC COV RUR POO; Tadesse D, RAPID ASSESSMENT DRI; WHO, 2006, REV DIS HLTH ENV EST	13	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194391	10.1371/journal.pone.0194391	http://dx.doi.org/10.1371/journal.pone.0194391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621267	Green Published, gold, Green Submitted			2022-12-26	WOS:000429206800017
J	Pellegrini, B; Boccia, G; Zoppirolli, C; Rosa, R; Stella, F; Bortolan, L; Rainoldi, A; Schena, F				Pellegrini, Barbara; Boccia, Gennaro; Zoppirolli, Chiara; Rosa, Raffaela; Stella, Federico; Bortolan, Lorenzo; Rainoldi, Alberto; Schena, Federico			Muscular and metabolic responses to different Nordic walking techniques, when style matters	PLOS ONE			English	Article							PHYSIOLOGICAL-RESPONSES; HEALTH-BENEFITS; GAIT; POLE; REHABILITATION; EXTREMITY; TREADMILL; EXERCISE; CAPACITY; FITNESS	Due to poling action and upper body engagement, Nordic walking (NW) has additional health benefits with respect to conventional walking. The aim of this study was to evaluate the differences in muscle activation and metabolic responses between NW, performed with the technique suggested by NW instructors, and with some modifications in the way to move upper limb and poles. Ten NW instructors volunteered to walk on a treadmill at 5.5 km.h(-1) in five conditions: walking (W), Nordic walking (NW), NW with a weak poling action (NWweak), with straight-upper limbs moving the shoulders (NWshoulder) and with elbow flexion-extension pattern and shoulder freezed (NWelbow). Poling forces, body segments and poles movement, upper and lower body muscle activation, as well as metabolic parameters were measured. All modified NW techniques elicited lower muscular activation and metabolic responses with respect to the suggested NW technique (P < 0.05). All NW techniques elicited higher muscular activation and metabolic responses than W. All parameters observed with the NWweak were lower than NW. A decreased activation of shoulder extensor muscles and increased activation of anterior deltoid muscle were the main features of NWshoulder. Lower triceps brachii muscle activation and reduced propulsive poling action with respect to NW were seen for NWelbow, resulting also in shorter steps. Nordic walking instructors, sport technicians and practitioners should be aware that any deviation from the technique usually suggested might lead to lower benefits. However it is worth to note that any walking technique with poles elicits higher metabolic responses and muscular activation than walking.	[Pellegrini, Barbara; Boccia, Gennaro; Zoppirolli, Chiara; Stella, Federico; Bortolan, Lorenzo; Schena, Federico] CeRiSM Res Ctr Sport Mt & Hlth, Rovereto, TN, Italy; [Pellegrini, Barbara; Zoppirolli, Chiara; Rosa, Raffaela; Bortolan, Lorenzo; Schena, Federico] Univ Verona, Dept Neurosci Biomed & Movement, Verona, VR, Italy; [Boccia, Gennaro; Rainoldi, Alberto] Univ Turin, Sch Exercise & Sport Sci, Dept Med Sci, NeuroMuscularFunct Res Grp, Turin, TO, Italy	University of Verona; University of Turin	Pellegrini, B (corresponding author), CeRiSM Res Ctr Sport Mt & Hlth, Rovereto, TN, Italy.; Pellegrini, B (corresponding author), Univ Verona, Dept Neurosci Biomed & Movement, Verona, VR, Italy.	barbara.pellegrini@univr.it	Pellegrini, Barbara/AFV-5894-2022	PELLEGRINI, Barbara/0000-0002-9626-2632; Schena, Federico/0000-0002-2052-5117; Boccia, Gennaro/0000-0001-8706-4098; Bortolan, Lorenzo/0000-0002-1591-8565				Andersen CH, 2014, J OCCUP REHABIL, V24, P316, DOI 10.1007/s10926-013-9441-1; Burden A, 2010, J ELECTROMYOGR KINES, V20, P1023, DOI 10.1016/j.jelekin.2010.07.004; Church TS, 2002, RES Q EXERCISE SPORT, V73, P296, DOI 10.1080/02701367.2002.10609023; Encarnacion-Martinez A, 2015, RES Q EXERCISE SPORT, V86, P94, DOI 10.1080/02701367.2014.975178; Figard-Fabre H, 2011, INT J SPORTS MED, V32, P407, DOI 10.1055/s-0030-1268461; Figard-Fabre H, 2010, EUR J APPL PHYSIOL, V108, P1141, DOI 10.1007/s00421-009-1315-z; Fritschi JO, 2012, SCAND J MED SCI SPOR, V22, pe70, DOI 10.1111/j.1600-0838.2012.01495.x; Fritschi JO, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-375; Girold S, 2017, ANN PHYS REHABIL MED, V60, P223, DOI 10.1016/j.rehab.2016.12.004; Grainer A, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101235; Grimmer Karen, 1997, Aust J Physiother, V43, P7; Hansen EA, 2009, J STRENGTH COND RES, V23, P1187, DOI 10.1519/JSC.0b013e31819f1e2b; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Homma D, 2016, J PHYS THER SCI, V28, P1213, DOI 10.1589/jpts.28.1213; Jakobsen V, 2007, 4 INT C SCI SKIING S; Jurimae T, 2009, CLIN PHYSIOL FUNCT I, V29, P330, DOI 10.1111/j.1475-097X.2009.00872.x; Kocur P, 2015, J PHYS THER SCI, V27, P3733, DOI 10.1589/jpts.27.3733; Kocur P, 2009, CLIN REHABIL, V23, P995, DOI 10.1177/0269215509337464; Kuhtz-Buschbeck JP, 2012, J ELECTROMYOGR KINES, V22, P199, DOI 10.1016/j.jelekin.2011.08.014; Mathieson S, 2014, BRIT J SPORT MED, V48, P1577, DOI 10.1136/bjsports-2013-093294; Ossowski ZM, 2016, CLIN INTERV AGING, V11, P1763, DOI 10.2147/CIA.S118995; Padulo J, 2014, P NATL ACAD SCI USA, V111, pE1160, DOI 10.1073/pnas.1400112111; Parkatti T, 2012, J AGING PHYS ACTIV, V20, P93, DOI 10.1123/japa.20.1.93; Pellegrini B, 2011, SCAND J MED SCI SPOR, V21, P589, DOI 10.1111/j.1600-0838.2009.01071.x; Pellegrini B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138906; Piccoli MB, 2014, MUSCLE NERVE, V49, P413, DOI 10.1002/mus.23934; Porcari JP, 1997, RES Q EXERCISE SPORT, V68, P161, DOI 10.1080/02701367.1997.10607992; Reuter I, 2011, J AGING RES, V2011; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Saeterbakken AH, 2017, EUR J PHYS REHABIL M; Schiffer T, 2006, EUR J APPL PHYSIOL, V98, P56, DOI 10.1007/s00421-006-0242-5; Schiffer T, 2011, EUR J APPL PHYSIOL, V111, P1121, DOI 10.1007/s00421-010-1739-5; Shiavi R, 1998, MED BIOL ENG COMPUT, V36, P171, DOI 10.1007/BF02510739; Shim JM, 2013, J PHYS THER SCI, V25, P1553, DOI 10.1589/jpts.25.1553; Sugiyama K, 2013, J PHYSIOL ANTHROPOL, V32, DOI 10.1186/1880-6805-32-2; Takeshima N, 2013, J SPORT SCI MED, V12, P422; Tschentscher M, 2013, AM J PREV MED, V44, P76, DOI 10.1016/j.amepre.2012.09.043; Willson J, 2001, MED SCI SPORT EXER, V33, P142; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	39	23	23	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195438	10.1371/journal.pone.09195438	http://dx.doi.org/10.1371/journal.pone.09195438			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621317				2022-12-26	WOS:000429206800082
J	Werling, M; Fandriks, L; Olbers, T; Mala, T; Kristinsson, J; Stenlof, K; Wallenius, V; Docherty, NG; Le Roux, CW				Werling, Malin; Fandriks, Lars; Olbers, Torsten; Mala, Tom; Kristinsson, Jon; Stenlof, Kaj; Wallenius, Ville; Docherty, Neil G.; Le Roux, Carel W.			Biliopancreatic Diversion is associated with greater increases in energy expenditure than Roux-en-Y Gastric Bypass	PLOS ONE			English	Article							LAPAROSCOPIC DUODENAL SWITCH; BODY-MASS INDEX; GLUCOSE; RATS; HYPERTROPHY; METABOLISM; SURGERY	Objective The greater weight loss achieved following Biliopancreatic Diversion with Duodenal Switch (BPDS) versus Roux-en-Y Gastric Bypass (RYGB) has been attributed to the malabsorptive effects of BPDS. Increased weight loss after BPDS could also be underpinned by larger increases in energy expenditure. Hypothetically, the more radical reconfiguration of the small intestine in BPDS could result in an accentuated increase in meal associated thermogenesis (MAT). Design Female subjects (baseline mean age 40 years, mean BMI-55kg/m(2)) were assessed four years after randomization to BPDS (n = 6) or RYGB (n = 6). Energy expenditure (EE) and respiratory quotient (RQ) were measured by indirect calorimetry over 24 hours. A detailed protocol allowed for discrimination of basal metabolic rate (BMR), fasting EE and MAT as components of total energy expenditure (TEE) normalised for total and lean tissue by dual energy x-ray absorptiometry. Results Median weight loss at follow-up was 1.5-fold higher following BPDS relative to RYGB, resulting in respective median BMIs of 29.5 kg/m 2 (21.7 to 36.7) after BPDS and 37.8 kg/m(2) (34.1 to 45.7) after RYGB (p = 0.015). The BPDS group had a lower fat:lean ratio compared to the RYGB group (p = 0.009). Overall 24-hour TEE adjusted for total tissue was higher in the BPDS group, as were BMR, fasting EE and MAT (all p<0.05). Differences between RYGB and BPDS in BMR and TEE were nullified when normalised for lean mass. Postprandial RQ increased significantly but to a similar extent in both groups. Conclusion Enhanced and prolonged MAT and lower fat:lean mass ratios after BPDS may explain relative increases in total energy expenditure as compared to RYGB.	[Werling, Malin; Fandriks, Lars; Olbers, Torsten; Wallenius, Ville; Docherty, Neil G.; Le Roux, Carel W.] Univ Gothenburg, Sahlgrenska Univ Hosp Sahlgrenska, Sahlgrenska Acad, Dept Gastrosurg Res & Educ,Dept Surg, Gothenburg, Sweden; [Mala, Tom; Kristinsson, Jon] Oslo Univ Hosp, Dept Morbid Obes & Bariatr Surg, Oslo, Norway; [Mala, Tom; Kristinsson, Jon] Oslo Univ Hosp, Dept Gastrointestinal Surg, Oslo, Norway; [Stenlof, Kaj] Sahlgrens Univ Hosp, Gothia Forum, Gothenburg, Sweden; [Docherty, Neil G.; Le Roux, Carel W.] Univ Coll Dublin, Conway Inst, Diabet Complicat Res Ctr, Dublin, Ireland; [Le Roux, Carel W.] Imperial Coll London, Invest Sci, London, England	Sahlgrenska University Hospital; University of Gothenburg; University of Oslo; University of Oslo; Sahlgrenska University Hospital; University College Dublin; Imperial College London	Docherty, NG (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp Sahlgrenska, Sahlgrenska Acad, Dept Gastrosurg Res & Educ,Dept Surg, Gothenburg, Sweden.; Docherty, NG (corresponding author), Univ Coll Dublin, Conway Inst, Diabet Complicat Res Ctr, Dublin, Ireland.	neil.docherty@ucd.ie	Mala, Tom/J-5418-2019; Wallenius, Ville Raymond/C-5486-2014	Mala, Tom/0000-0003-3058-4775; Wallenius, Ville Raymond/0000-0001-8668-3196; Olbers, Torsten/0000-0002-7218-3390; Le Roux, Carel/0000-0001-5521-5445; Docherty, Neil/0000-0002-0961-2607	Vetenskapsradet [K2010-55X21432-01-2]; Science Foundation Ireland [12/Y1/ B2480]; Gothenburg Medical Association; Sahlgrenska Universitetssjukhuset; Sahlgrenska Akademin	Vetenskapsradet(Swedish Research Council); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Gothenburg Medical Association; Sahlgrenska Universitetssjukhuset; Sahlgrenska Akademin	For this study, the authors received funding from: Vetenskapsradet (K2010-55X21432-01-2), Science Foundation Ireland (12/Y1/ B2480), Gothenburg Medical Association, Sahlgrenska Universitetssjukhuset, and Sahlgrenska Akademin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraboi ED, 2015, ENDOCRINOLOGY, V156, P1316, DOI 10.1210/en.2014-1785; Baud G, 2016, CELL METAB, V23, P547, DOI 10.1016/j.cmet.2016.01.018; Borg CM, 2007, OBES SURG, V17, P1193, DOI 10.1007/s11695-007-9211-2; Branski LK, 2010, JPEN-PARENTER ENTER, V34, P55, DOI 10.1177/0148607109336601; Bueter M, 2010, GASTROENTEROLOGY, V138, P1845, DOI 10.1053/j.gastro.2009.11.012; Cavin JB, 2016, GASTROENTEROLOGY, V150, P454, DOI 10.1053/j.gastro.2015.10.009; Dirksen C, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12087; Hansen CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065696; le Roux CW, 2010, ANN SURG, V252, P50, DOI 10.1097/SLA.0b013e3181d3d21f; le Roux CW, 2006, ANN SURG, V243, P108, DOI 10.1097/01.sla.0000183349.16877.84; Li W, 2015, SURG OBES RELAT DIS, V11, P356, DOI 10.1016/j.soard.2014.07.020; Risstad H, 2016, JAMA SURG, V151, P1146, DOI 10.1001/jamasurg.2016.2798; Risstad H, 2015, JAMA SURG, V150, P352, DOI 10.1001/jamasurg.2014.3579; Saeidi N, 2013, SCIENCE, V341, P406, DOI 10.1126/science.1235103; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sovik TT, 2010, BRIT J SURG, V97, P160, DOI 10.1002/bjs.6802; Spak E, 2010, HISTOPATHOLOGY, V57, P680, DOI 10.1111/j.1365-2559.2010.03677.x; Stearns AT, 2009, AM J PHYSIOL-GASTR L, V297, pG950, DOI 10.1152/ajpgi.00253.2009; Sudan R, 2011, SURG CLIN N AM, V91, P1281, DOI 10.1016/j.suc.2011.08.015; Van Hee RHGG, 2004, WORLD J SURG, V28, P435, DOI 10.1007/s00268-004-7364-x; Vosselman MJ, 2013, AM J CLIN NUTR, V98, P57, DOI 10.3945/ajcn.113.059022; Werling M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129784; Werling M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060280	23	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194538	10.1371/journal.pone.0194538	http://dx.doi.org/10.1371/journal.pone.0194538			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617391	Green Published, Green Submitted, gold			2022-12-26	WOS:000429203800035
J	Arnould, L; Binquet, C; Guenancia, C; Alassane, S; Kawasaki, R; Daien, V; Tzourie, C; Kawasaki, Y; Bourredjem, A; Bron, A; Creuzot-Garcher, C				Arnould, Louis; Binquet, Christine; Guenancia, Charles; Alassane, Seydou; Kawasaki, Ryo; Daien, Vincent; Tzourie, Christophe; Kawasaki, Yumiko; Bourredjem, Abderrahmane; Bron, Alain; Creuzot-Garcher, Catherine			Association between the retinal vascular network with Singapore "I" Vessel Assessment (SIVA) software, cardiovascular history and risk factors in the elderly: The Montrachet study, population-based study	PLOS ONE			English	Article							ATHEROSCLEROSIS RISK; BLOOD-PRESSURE; DIAMETERS; HYPERTENSION; DISEASE; CALIBER; COMMUNITIES; MORTALITY; NUMBER; SCREE	Purpose To identify patterns summarizing the retinal vascular network in the elderly and to investigate the relationship of these vascular patterns with cardiovascular history. Methods We conducted a population-based study, the Montrachet study (Maculopathy Optic Nerve nuTRition neurovAsCular and HEarT diseases), in participants older than 75 years. The history of cardiovascular disease and a score-based estimation of their 10-year risk of cardiovascular mortality (Heart SCORE) were collected. Retinal vascular network analysis was performed by means of Singapore "I" Vessel Assessment (SIVA) software. Principal component analysis was used to condense the information contained in the high number of variables provided and to identify independent retinal vascular patterns. Results Overall, 1069 photographs (1069 participants) were reviewed with SIVA software. The mean age was 80.0 +/- 3.8 years. We extracted three vascular patterns summarizing 41.3% of the vascular information. The most clinically relevant pattern, Sparse vascular network, accounted for 17.4% of the total variance. It corresponded to a lower density in the vascular network and higher variability in vessel width. Diabetic participants with hypoglycemic treatment had a sparser vascular network pattern than subjects without such treatment (odds ratio, [OR], 1.68; 95% CI, 1.04-2.72; P=0.04). Participants with no history of cardiovascular disease who had a sparser vascular network were associated with a higher Heart SCORE (OR, 1.76; 95% CI, 1.08-2.25; P=0.02). Conclusions Three vascular patterns were identified. The Sparse vascular network pattern was associated with having a higher risk profile for cardiovascular mortality risk at 10 years.	[Arnould, Louis; Bron, Alain; Creuzot-Garcher, Catherine] Univ Hosp, Dept Ophthalmol, Dijon, France; [Arnould, Louis; Binquet, Christine; Alassane, Seydou; Bourredjem, Abderrahmane] INSERM, CIC1432, Clin Epidemiol Unit, Dijon, France; [Arnould, Louis; Binquet, Christine; Alassane, Seydou; Bourredjem, Abderrahmane] Dijon Univ Hosp, Clin Invest Ctr, Clin Epidemiol Clin Trials Unit, Dijon, France; [Guenancia, Charles] Dijon Univ Hosp, Dept Cardiol, Dijon, France; [Guenancia, Charles] Dijon Univ Hosp, INSERM, UMR866, Lab Cardiometab Physiopathol & Pharmacol, Dijon, France; [Alassane, Seydou; Bron, Alain; Creuzot-Garcher, Catherine] INRA, UMR 1324, CSGA, Eye & Nutr Res Grp, Dijon, France; [Kawasaki, Ryo; Kawasaki, Yumiko] Yamagata Univ, Dept Publ Hlth, Grad Sch Med Sci, Yamagata, Japan; [Daien, Vincent] Univ Hosp, Dept Ophthalmol, Montpellier, France; [Tzourie, Christophe] Univ Hosp, U708, INSERM, Epidemiol, Bordeaux, France	CHU Dijon Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Dijon Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Yamagata University; Universite de Montpellier; CHU de Montpellier; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)	Creuzot-Garcher, C (corresponding author), Univ Hosp, Dept Ophthalmol, Dijon, France.; Creuzot-Garcher, C (corresponding author), INRA, UMR 1324, CSGA, Eye & Nutr Res Grp, Dijon, France.	catherine.creuzot-garcher@chu-dijon.fr	Guenancia, Charles/M-5558-2013; Kawasaki, Ryo/H-9716-2019; Arnould, Louis/AAG-2207-2021; Binquet, Christine/E-8953-2018; Kawasaki, Ryo/B-7266-2009; Bron, Alain/AAP-8010-2020; DAIEN, Vincent/Z-5516-2019; Tzourio, christophe/B-4015-2009	Guenancia, Charles/0000-0002-3554-7714; Binquet, Christine/0000-0002-9417-5754; Kawasaki, Ryo/0000-0002-7492-6303; Bron, Alain/0000-0002-7265-931X; DAIEN, Vincent/0000-0001-5675-0861; Tzourio, christophe/0000-0002-6517-2984; Alassane, Seydou/0000-0001-8958-6834	Regional Council of Burgundy; Agence Nationale de la Recherche (FR)	Regional Council of Burgundy(Region Bourgogne-Franche-Comte); Agence Nationale de la Recherche (FR)(French National Research Agency (ANR))	This work was supported by Regional Council of Burgundy (Pr Catherine Creuzot-Garcher) and Agence Nationale de la Recherche (FR) (Pr Catherine Creuzot-Garcher). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Beltramo E, 2004, DIABETES-METAB RES, V20, P330, DOI 10.1002/dmrr.470; CATTELL RB, 1977, MULTIVAR BEHAV RES, V12, P289, DOI 10.1207/s15327906mbr1203_2; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Cheung CY, 2012, AM J OPHTHALMOL, V154, P663, DOI 10.1016/j.ajo.2012.04.016; Cheung CYL, 2011, OPHTHALMOLOGY, V118, P812, DOI 10.1016/j.ophtha.2010.08.045; Cheung CYL, 2010, MICROCIRCULATION, V17, P495, DOI 10.1111/j.1549-8719.2010.00048.x; Cheung N, 2007, HYPERTENSION, V50, P617, DOI 10.1161/HYPERTENSIONAHA.107.091926; Cheung N, 2007, J AM COLL CARDIOL, V50, P48, DOI 10.1016/j.jacc.2007.03.029; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Creuzot-Garcher C, 2016, ACTA OPHTHALMOL, V94, pE90, DOI 10.1111/aos.12842; Ding J, 2014, J HYPERTENS, V32, P207, DOI 10.1097/HJH.0b013e32836586f4; Feihl F, 2006, HYPERTENSION, V48, P1012, DOI 10.1161/01.HYP.0000249510.20326.72; Harman H. H., 1976, MODERN FACTOR ANAL; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kawasaki R, 2009, J HYPERTENS, V27, P2386, DOI 10.1097/HJH.0b013e3283310f7e; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Knudtson MD, 2004, BRIT J OPHTHALMOL, V88, P57, DOI 10.1136/bjo.88.1.57; Li HQ, 2005, IEEE T BIO-MED ENG, V52, P1352, DOI 10.1109/TBME.2005.847402; Liao DP, 2004, STROKE, V35, P837, DOI 10.1161/01.STR.0000120310.43457.AD; Liew G, 2008, OPHTHALMOLOGY, V115, P1951, DOI 10.1016/j.ophtha.2008.05.029; Liew G, 2011, EUR HEART J, V32, P422, DOI 10.1093/eurheartj/ehq431; Lim LS, 2011, INVEST OPHTH VIS SCI, V52, P669, DOI 10.1167/iovs.10-6184; Murray CD, 1926, J GEN PHYSIOL, V9, P835, DOI 10.1085/jgp.9.6.835; Puro DG, 2012, PROG RETIN EYE RES, V31, P258, DOI 10.1016/j.preteyeres.2012.01.001; Sasongko MB, 2012, OPHTHAL EPIDEMIOL, V19, P322, DOI 10.3109/09286586.2012.702258; Sharrett AR, 1999, AM J EPIDEMIOL, V150, P263; Tuppin P, 2009, ARCH CARDIOVASC DIS, V102, P279, DOI 10.1016/j.acvd.2009.02.005; Wang JJ, 2007, EUR HEART J, V28, P1984, DOI 10.1093/eurheartj/ehm221; WHO, 2015, NONC DIS; Wilkinson-Berka JL, 2006, INT J BIOCHEM CELL B, V38, P752, DOI 10.1016/j.biocel.2005.08.002; World Health Organization, 2012, GLOB HLTH OBS DAT RE; Zhu PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106551	35	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194694	10.1371/journal.pone.0194694	http://dx.doi.org/10.1371/journal.pone.0194694			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614075	Green Published, gold			2022-12-26	WOS:000429081600015
J	Brinkman, NE; Villegas, EN; Garland, JL; Keely, SP				Brinkman, Nichole E.; Villegas, Eric N.; Garland, Jay L.; Keely, Scott P.			Reducing inherent biases introduced during DNA viral metagenome analyses of municipal wastewater	PLOS ONE			English	Article							VIRUSES; AMPLIFICATION; AGGREGATION; SLUDGE; POLYOMAVIRUSES; IDENTIFICATION; GENERATION; DIVERSITY; DYNAMICS; QUALITY	Metagenomics is a powerful tool for characterizing viral composition within environmental samples, but sample and molecular processing steps can bias the estimation of viral community structure. The objective of this study is to understand the inherent variability introduced when conducting viral metagenomic analyses of wastewater and provide a bioinformatic strategy to accurately analyze sequences for viral community analyses. A standard approach using a combination of ultrafiltration, membrane filtration, and DNase treatment, and multiple displacement amplification (MDA) produced DNA preparations without any bacterial derived genes. Results showed recoveries in wastewater matrix ranged between 60-100%. A bias towards small single stranded DNA (ssDNA; polyomavirus) virus types vs larger double stranded DNA (dsDNA; adenovirus) viruses was also observed with a total estimated recovery of small circular viruses to be as much as 173-fold higher. Notably, ssDNA abundance decreased with sample dilution while large dsDNA genomes (e.g., Caudovirales) initially increased in abundance with dilution before gradually decreasing with further dilution in wastewater samples. The present study revealed the inherent biases associated with different components of viral metagenomic methods applied to wastewater. Overall, these results provide a well-characterized approach for effectively conducting viral metagenomics analysis of wastewater and reveal that dilution can effectively mitigate MDA bias.	[Brinkman, Nichole E.; Villegas, Eric N.; Garland, Jay L.; Keely, Scott P.] US EPA, Natl Exposure Res Lab, Cincinnati, OH 45268 USA	United States Environmental Protection Agency	Keely, SP (corresponding author), US EPA, Natl Exposure Res Lab, Cincinnati, OH 45268 USA.	keely.scott@epa.gov	Keely, Scott/W-5761-2019	Keely, Scott/0000-0002-5343-3649				American Public Health Association (APHA), 2005, STANDARD METHODS EXA; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Aw TG, 2014, J VIROL METHODS, V210, P15, DOI 10.1016/j.jviromet.2014.09.017; Bibby K, 2013, ENVIRON SCI TECHNOL, V47, P1945, DOI 10.1021/es305181x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cantalupo PG, 2011, MBIO, V2, DOI 10.1128/mBio.00180-11; Cashdollar JL, 2013, APPL ENVIRON MICROB, V79, P215, DOI 10.1128/AEM.02270-12; Colson P, 2013, INTERVIROLOGY, V56, P376, DOI 10.1159/000354558; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dutilh BE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5498; FLOYD R, 1979, APPL ENVIRON MICROB, V38, P395, DOI 10.1128/AEM.38.3.395-401.1979; Gassilloud B, 2005, APPL ENVIRON MICROB, V71, P912, DOI 10.1128/AEM.71.2.912-920.2005; Gutierrez L, 2012, ENVIRON SCI TECHNOL, V46, P8705, DOI 10.1021/es301336u; Hall RJ, 2014, J VIROL METHODS, V195, P194, DOI 10.1016/j.jviromet.2013.08.035; Hammer O., 2011, PALAEONTOL ELECTRON, V4, P9; Hurwitz BL, 2013, ENVIRON MICROBIOL, V15, P1428, DOI 10.1111/j.1462-2920.2012.02836.x; Johne R, 2006, J VIROL, V80, P3523, DOI 10.1128/JVI.80.7.3523-3531.2006; Jothikumar N, 2005, APPL ENVIRON MICROB, V71, P3131, DOI 10.1128/AEM.71.6.3131-3136.2005; Kim KH, 2008, APPL ENVIRON MICROB, V74, P5975, DOI 10.1128/AEM.01275-08; Kleiner M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1207-4; Leow A, 2017, ENVIRON SCI-WAT RES, V3, P224, DOI [10.1039/c6ew00226a, 10.1039/C6EW00226A]; Li L, 2015, J VIROL METHODS, V213, P139, DOI 10.1016/j.jviromet.2014.12.002; Marine R, 2011, APPL ENVIRON MICROB, V77, P8071, DOI 10.1128/AEM.05610-11; McCrady MH, 1915, J INFECT DIS, V17, P183, DOI 10.1093/infdis/17.1.183; McQuaig SM, 2009, APPL ENVIRON MICROB, V75, P3379, DOI 10.1128/AEM.02302-08; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Norman A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104405; NRC, 2012, WAT REUS POT EXPL NA; Otawa K, 2007, MICROB ECOL, V53, P143, DOI 10.1007/s00248-006-9150-9; Parsley LC, 2010, APPL ENVIRON MICROB, V76, P2673, DOI 10.1128/AEM.02520-09; R Core Team, 2021, R LANGUAGE ENV STAT; Reyes A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/nrmicro2853; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rosario K, 2012, ARCH VIROL, V157, P1851, DOI 10.1007/s00705-012-1391-y; Rosario K, 2011, CURR OPIN VIROL, V1, P289, DOI 10.1016/j.coviro.2011.06.004; Rosario K, 2009, ENVIRON MICROBIOL, V11, P2806, DOI 10.1111/j.1462-2920.2009.01964.x; Roux S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-76; Stachlert E, 2014, ENVIRON SCI TECH LET, V1, P405, DOI 10.1021/ez500266s; Steward GF, 2000, LIMNOL OCEANOGR, V45, P1697, DOI 10.4319/lo.2000.45.8.1697; Thatcher SA, 2015, CLIN CHEM, V61, P89, DOI 10.1373/clinchem.2014.221374; USEPA, 2010, 1615 USEPA; Vazquez-Castellanos JF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-37; Willner D, 2009, ENVIRON MICROBIOL, V11, P1752, DOI 10.1111/j.1462-2920.2009.01901.x; Wommack KE, 1999, APPL ENVIRON MICROB, V65, P231; Yilmaz S, 2010, NAT METHODS, V7, P943, DOI 10.1038/nmeth1210-943; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	47	16	16	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195350	10.1371/journal.pone.0195350	http://dx.doi.org/10.1371/journal.pone.0195350			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614100	Green Published, gold, Green Submitted			2022-12-26	WOS:000429081600052
J	Choi, MG; Kim, MJ; Kim, DG; Yu, R; Jang, YN; Oh, WJ				Choi, Mal-Gi; Kim, Mi Jin; Kim, Do-Geun; Yu, Ri; Jang, You-Na; Oh, Won-Jong			Sequestration of synaptic proteins by alpha-synuclein aggregates leading to neurotoxicity is inhibited by small peptide	PLOS ONE			English	Article							PARKINSONS-DISEASE; LEWY BODY; IN-VITRO; NACP/ALPHA-SYNUCLEIN; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; FIBRIL FORMATION; OLIGOMERS; MICE	alpha-Synuclein (alpha-syn) is a major component of Lewy bodies found in synucleinopathies including Parkinson's disease (PD) and Dementia with Lewy Bodies (DLB). Under the pathological conditions, alpha-syn tends to generate a diverse form of aggregates showing toxicity to neuronal cells and able to transmit across cells. However, mechanisms by which alpha-syn aggregates affect cytotoxicity in neurons have not been fully elucidated. Here we report that alpha-syn aggregates preferentially sequester specific synaptic proteins such as vesicle-associated membrane protein 2 (VAMP2) and synaptosomal-associated protein 25 (SNAP25) through direct binding which is resistant to SDS. The sequestration effect of alpha-syn aggregates was shown in a cell-free system, cultured primary neurons, and PD mouse model. Furthermore, we identified a specific blocking peptide derived from VAMP2 which partially inhibited the sequestration by alpha-syn aggregates and contributed to reduced neurotoxicity. These results provide a mechanism of neurotoxicity mediated by alpha-syn aggregates and suggest that the blocking peptide interfering with the pathological role of alpha-syn aggregates could be useful for designing a potential therapeutic drug for the treatment of PD.	[Choi, Mal-Gi; Kim, Mi Jin; Kim, Do-Geun; Yu, Ri; Jang, You-Na; Oh, Won-Jong] Korea Brain Res Inst, Dept Struct & Funct Neural Network, Daegu, South Korea	Korea Brain Research Institute (KBRI)	Choi, MG; Oh, WJ (corresponding author), Korea Brain Res Inst, Dept Struct & Funct Neural Network, Daegu, South Korea.	choimg@kbri.re.kr; ohwj@kbri.re.kr	Kim, Mi Jin/GXH-9639-2022	Oh, Won-Jong/0000-0001-8867-7814	KBRI basic research program through Korea Brain Research Institute - Ministry of Science and ICT [17-BR-02]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2013R1A1A3012721]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health and Welfare, South Korea [H I14C1135]	KBRI basic research program through Korea Brain Research Institute - Ministry of Science and ICT; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health and Welfare, South Korea	This research was supported by KBRI basic research program through Korea Brain Research Institute funded by the Ministry of Science and ICT (17-BR-02), Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2013R1A1A3012721), and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health and Welfare, South Korea (H I14C1135). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Agarwal R, 2008, J BIOL CHEM, V283, P25944, DOI 10.1074/jbc.M803756200; Amaral E, 2011, METHODS MOL BIOL, V689, P137, DOI 10.1007/978-1-60761-950-5_8; Betzer C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116473; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cabin DE, 2002, J NEUROSCI, V22, P8797; Cappai R, 2005, FASEB J, V19, P1377, DOI 10.1096/fj.04-3437fje; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen SW, 2015, P NATL ACAD SCI USA, V112, pE1994, DOI 10.1073/pnas.1421204112; Chen S, 2008, J BIOL CHEM, V283, P21153, DOI 10.1074/jbc.M800611200; Choi BK, 2013, P NATL ACAD SCI USA, V110, P4087, DOI 10.1073/pnas.1218424110; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; DeVos SL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0481; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Fletcher PL, 2010, J BIOL CHEM, V285, P7405, DOI 10.1074/jbc.M109.028365; George S, 2015, J PARKINSON DIS, V5, P413, DOI 10.3233/JPD-150630; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Hashimoto M, 1999, NEUROREPORT, V10, P717, DOI 10.1097/00001756-199903170-00011; Horvath I, 2012, J AM CHEM SOC, V134, P3439, DOI 10.1021/ja209829m; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Iwatsubo T, 2007, NEUROPATHOLOGY, V27, P474, DOI 10.1111/j.1440-1789.2007.00785.x; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kim HY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9997; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Kordower JH, 1998, MOVEMENT DISORD, V13, P88; Krishnan R, 2012, P NATL ACAD SCI USA, V109, P11172, DOI 10.1073/pnas.1209527109; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Mao X, 2016, SCIENCE, V353, P6307, DOI DOI 10.1126/SCIENCE.AAH3374; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Mor DE, 2017, NAT NEUROSCI, V20, P1560, DOI 10.1038/nn.4641; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nie Q, 2011, ACTA PHARMACOL SIN, V32, P545, DOI 10.1038/aps.2011.14; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Perni M, 2017, P NATL ACAD SCI USA, V114, pE1009, DOI 10.1073/pnas.1610586114; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Recasens A, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00128; Rekas A, 2010, EUR BIOPHYS J BIOPHY, V39, P1407, DOI 10.1007/s00249-010-0595-x; Relini A, 2010, BIOPHYS J, V98, P1277, DOI 10.1016/j.bpj.2009.11.052; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Scott DA, 2010, J NEUROSCI, V30, P8083, DOI 10.1523/JNEUROSCI.1091-10.2010; Shrivastava AN, 2015, EMBO J, V34, P2408, DOI 10.15252/embj.201591397; Stefani M, 2010, FEBS J, V277, P4602, DOI 10.1111/j.1742-4658.2010.07889.x; Takeda A, 1998, AM J PATHOL, V152, P367; Tran HT, 2014, CELL REP, V7, P2054, DOI 10.1016/j.celrep.2014.05.033; TRITSCHLER HJ, 1994, BIOCHEM MOL BIOL INT, V34, P169; Tsigelny IF, 2012, FEBS J, V279, P1000, DOI 10.1111/j.1742-4658.2012.08489.x; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Uversky VN, 2010, FEBS J, V277, P2940, DOI 10.1111/j.1742-4658.2010.07721.x; Volpicelli-Daley LA, 2014, NAT PROTOC, V9, P2135, DOI 10.1038/nprot.2014.143; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Wersinger C, 2005, BIOCHEMISTRY-US, V44, P13612, DOI 10.1021/bi050402p; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	61	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195339	10.1371/journal.pone.0195339	http://dx.doi.org/10.1371/journal.pone.0195339			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608598	Green Published, Green Submitted, gold			2022-12-26	WOS:000428988800046
J	Meehan, SA; Sloot, R; Draper, HR; Naidoo, P; Burger, R; Beyers, N				Meehan, Sue-Ann; Sloot, Rosa; Draper, Heather R.; Naidoo, Pren; Burger, Ronelle; Beyers, Nulda			Factors associated with linkage to HIV care and TB treatment at community-based HIV testing services in Cape Town, South Africa	PLOS ONE			English	Article							METAANALYSIS	Background Diagnosing HIV and/or TB is not sufficient; linkage to care and treatment is conditional to reduce the burden of disease. This study aimed to determine factors associated with linkage to HIV care and TB treatment at community-based services in Cape Town, South Africa. Methods This retrospective cohort study utilized routinely collected data from clients who utilized stand-alone (fixed site not attached to a health facility) and mobile HIV testing services in eight communities in the City of Cape Town Metropolitan district, between January 2008 and June 2012. Clients were included in the analysis if they were >12 years and had a known HIV status. Generalized estimating equations (GEE) logistic regression models were used to assess the association between determinants (sex, age, HIV testing service and co infection status) and self-reported linkage to HIV care and/or TB treatment. Results Linkage to HIV care was 3 738/5 929 (63.1%). Linkage to HIV care was associated with the type of HIV testing service. Clients diagnosed with HIV at mobile services had a significantly reduced odds of linking to HIV care (aOR 0.7 (CI 95%: 0.6-0.8), p<0.001. Linkage to TB treatment was 210/275 (76.4%). Linkage to TB treatment was not associated with sex and service type, but was associated with age. Clients in older age groups were less likely to link to TB treatment compared to clients in the age group 12-24 years (all, p-value<0.05). Conclusion A large proportion of clients diagnosed with HIV at mobile services did not link to care. Almost a quarter of clients diagnosed with TB did not link to treatment. Integrated community-based HIV and TB testing services are efficient in diagnosing HIV and TB, but strategies to improve linkage to care are required to control these epidemics.	[Meehan, Sue-Ann; Sloot, Rosa; Draper, Heather R.; Naidoo, Pren; Beyers, Nulda] Stellenbosch Univ, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, Fac Med & Hlth Sci, Cape Town, South Africa; [Sloot, Rosa] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Burger, Ronelle] Stellenbosch Univ, Dept Econ, Cape Town, South Africa	Stellenbosch University; Stellenbosch University	Meehan, SA (corresponding author), Stellenbosch Univ, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, Fac Med & Hlth Sci, Cape Town, South Africa.	sueannm@sun.ac.za	Burger, Ronelle/N-5203-2017	Burger, Ronelle/0000-0003-2463-5265; Meehan, Sue-Ann/0000-0002-0826-1833; Sloot, Rosa/0000-0001-7295-3247	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control (CDC) [U2GPS000739]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control (CDC)	The community-based HIV testing modalities (stand-alone centres and mobile services) described in this study was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control (CDC) under the terms of co-operative agreement number U2GPS000739. The content of this publication is solely the responsibility of the authors and do not necessarily represent the official views of PEPFAR or CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, NAT TUBERC MAN GUID; Claassens MM, 2013, INT J TUBERC LUNG D, V17, P603, DOI 10.5588/ijtld.12.0505; Daftary A, 2007, AIDS CARE, V19, P572, DOI 10.1080/09540120701203931; Dalal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027293; Ford N, 2015, LANCET HIV, V2, pE438, DOI 10.1016/S2352-3018(15)00137-X; Govindasamy D, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19032; Govindasamy D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080017; Govindasamy D, 2011, JAIDS-J ACQ IMM DEF, V58, P344, DOI 10.1097/QAI.0b013e31822e0c4c; Hood JE, 2012, AIDS BEHAV, V16, P1902, DOI 10.1007/s10461-012-0253-7; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2014, 90 90 90  AMB TREAT; Joint United Nations Programme on HIV/ AIDS (UNAIDS), AIDS INT; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Kranzer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013801; Leon N, 2010, SAMJ S AFR MED J, V100, P220, DOI 10.7196/SAMJ.4043; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Mabuto T, 2014, PLOS MED, V9; Maheswaran H, 2012, JAIDS-J ACQ IMM DEF, V59, pE43, DOI 10.1097/QAI.0b013e3182414ed7; Meehan SA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2173-8; Meehan SA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0658-2; Naik R, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19843; Nglazi M. D., 2012, JAIDS-J ACQ IMM DEF, V59, P9; Parker LA, 2015, TROP MED INT HEALTH, V20, P893, DOI 10.1111/tmi.12501; Peltzer K, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-174; Reddy P., 2014, S AFRICA NATL HLTH N; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Shisana O, 2014, S AFRICAN NATL HIV P; South African National Department of Health, 2010, S AFR ANT TREATM GUI; South African National Department of Health, 2016, NAT HIV TEST SERV PO; South African National Department of Health, 2017, LET OUR ACT COUNT S; South African National Department of Health, 2012, NAT STRAT PLAN HIV S; Statistics South Africa, 2011, INT DAT SUPERCROSS; Van Rooyen H, 2012, AIDS BEHAV; van Rooyen H, 2009, HIV/AIDS IN SOUTH AFRICA 25 YEARS ON: PSYCHOSOCIAL PERSPECTIVES, P165, DOI 10.1007/978-1-4419-0306-8_12; van Schaik N, 2010, SAMJ S AFR MED J, V100, P671, DOI 10.7196/SAMJ.4162; Western Cape Government Department of Health, 2012, PROV STRAT PLAN HIV; Western Cape Government Department of Health, 2016, W CAP CONS GUID HIV; Western Cape Government Department of Health, 2004, ANT TREATM PROT VERS; WHO, 2011, RET HIV PROGR DEF CH; WHO, 2015, CONSOLIDATED GUIDELI; Wood R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025098; World Health Organization, 2008, CAR TREATM PRIM HLTH; Wringe A, 2008, TROP MED INT HEALTH, V13, P319, DOI 10.1111/j.1365-3156.2008.02005.x	43	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195208	10.1371/journal.pone.0195208	http://dx.doi.org/10.1371/journal.pone.0195208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608616	Green Published, gold, Green Submitted			2022-12-26	WOS:000428988800037
J	Kim, KH; Kang, SY; Shin, DA; Yi, S; Ha, Y; Kim, KN; Sohn, YH; Lee, PH				Kim, Ki Hoon; Kang, Suk Yun; Shin, Dong Ah; Yi, Seong; Ha, Yoon; Kim, Keung Nyun; Sohn, Young Ho; Lee, Phil Hyu			Parkinson's disease-related non-motor features as risk factors for post-operative delirium in spinal surgery	PLOS ONE			English	Article							SLEEP BEHAVIOR DISORDER; BECK DEPRESSION INVENTORY; SCREENING QUESTIONNAIRE; DIAGNOSTIC INSTRUMENT; DAYTIME SLEEPINESS; PATHOLOGY; VALIDATION; CONFUSION; SCALE; PART	Background The clinical features of postoperative delirium are similar to the core features of alpha synuclein-related cognitive disorders, such as Parkinson's disease dementia (PDD) or dementia with Lewy bodies (DLB). Therefore, we hypothesized that the non-motor symptoms (NMSs) in Parkinson's disease (PD), which precede the cardinal motor features of PD, are likely to be risk factors for developing postoperative delirium. We investigated the association between PD related NMSs and postoperative delirium in old people undergoing elective spinal surgery. Methods This study was a prospective study. Participants were aged 65 years and older and scheduled to undergo elective spinal surgery. During the enrollment period, 338 individuals were screened, 104 participants were included in the analysis. We assessed eight easily assessed and representative PD-related NMSs 1 day before the scheduled surgery using tests or questionnaires for each symptom. The presence of delirium was determined by using the short version of the Confusion Assessment Method (CAM). Results Fifteen (14.4%) of the 104 participants (age, 71.7 +/- 4.7 years; men, 34.6%) met the CAM criteria for post-operative delirium. Multivariate logistic analysis showed that decreased olfactory function (odds ratio [OR] 0.63, 95% Cl 0.44-0.91) and exhibiting rapid eye movement sleep behavior disorder (RBD, OR 1.45, 95% Cl 1.09-1.93) were significantly independent predictors of postoperative delirium. Conclusions Our study shows that hyposmia and RBD are significantly independent risk factors for postoperative delirium in general elderly population. Considering that NMSs may represent burden of alpha synuclein deposit, we postulate that an underlying alpha synucleinopathy may correlates with postoperative delirium. Significance This study gives a novel insight for the risk factor of postoperative delirium.	[Kim, Ki Hoon; Sohn, Young Ho; Lee, Phil Hyu] Yonsei Univ, Dept Neurol, Coll Med, Seoul, South Korea; [Kang, Suk Yun] Hallym Univ, Coll Med, Dongtan Sacred Heart Hosp, Dept Neurol, Hwaseong, Gyeonggi Do, South Korea; [Shin, Dong Ah; Yi, Seong; Ha, Yoon; Kim, Keung Nyun] Yonsei Univ, Spine & Spinal Cord Inst, Dept Neurosurg, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Hallym University; Yonsei University; Yonsei University Health System	Kang, SY (corresponding author), Hallym Univ, Coll Med, Dongtan Sacred Heart Hosp, Dept Neurol, Hwaseong, Gyeonggi Do, South Korea.	sukyunkang@hanmail.net		Sohn, Young H./0000-0001-6533-2610; Lee, Phil Hyu/0000-0001-9931-8462; Shin, Dong Ah/0000-0002-5225-4083; Kim, Ki Hoon/0000-0001-6428-061X				Adogwa O, 2018, J NEUROSURG-SPINE, V28, P103, DOI 10.3171/2017.5.SPINE161244; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brown CH, 2015, J AM GERIATR SOC, V63, P16, DOI 10.1111/jgs.13198; Chaudhuri KR, 2011, PARKINSONISM RELAT D, V17, P717, DOI 10.1016/j.parkreldis.2011.02.018; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Chiu HFK, 2000, SLEEP, V23, P513; Dickson DW, 2009, PARKINSONISM RELAT D, V15, pS1, DOI 10.1016/S1353-8020(09)70769-2; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; Fineberg SJ, 2013, SPINE, V38, P1790, DOI 10.1097/BRS.0b013e3182a0d507; Freeman R, 2011, CLIN AUTON RES, V21, P69, DOI 10.1007/s10286-011-0119-5; GOLDEN WE, 1989, ANN INTERN MED, V111, P218, DOI 10.7326/0003-4819-111-3-218; Goldman JG, 2014, CURR OPIN NEUROL, V27, P434, DOI 10.1097/WCO.0000000000000112; Gore RL, 2015, J NEUROL NEUROSUR PS, V86, P50, DOI 10.1136/jnnp-2013-306389; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Iranzo A, 2013, LANCET NEUROL, V12, P443, DOI 10.1016/S1474-4422(13)70056-5; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Joo S, 2009, SLEEP MED, V10, P182, DOI 10.1016/j.sleep.2008.03.017; Kitajima Y, 2015, NEURODEGENER DIS, V15, P162, DOI 10.1159/000381522; Lee DH, 2015, NEUROLOGY, V85, P1270, DOI 10.1212/WNL.0000000000001999; Lee SA, 2015, J NEUROL SCI, V358, P328, DOI 10.1016/j.jns.2015.09.347; Leentjens AFG, 2000, MOVEMENT DISORD, V15, P1221, DOI 10.1002/1531-8257(200011)15:6<1221::AID-MDS1024>3.0.CO;2-H; Leentjens AFG, 2014, MOVEMENT DISORD, V29, P1035, DOI 10.1002/mds.25919; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Oh ES, 2016, J AM GERIATR SOC, V64, P1616, DOI 10.1111/jgs.14243; Ohayon MM, 1997, J CLIN PSYCHIAT, V58, P369; Postuma RB, 2015, NEUROLOGY, V84, P1104, DOI 10.1212/WNL.0000000000001364; Postuma RB, 2012, MOVEMENT DISORD, V27, P617, DOI 10.1002/mds.24996; Sanchez MI, 2011, CAN J SURG SB, V25, P11, DOI DOI 10.1155/2011/974573; Song JY., 1991, KOREAN J CLIN PSYCHO, V10, P93; Steiner LA, 2011, EUR J ANAESTH, V28, P628, DOI 10.1097/EJA.0b013e328349b7f5; Stiasny-Kolster K, 2007, MOVEMENT DISORD, V22, P2386, DOI 10.1002/mds.21740; Sunwoo MK, 2013, NEUROLOGY, V80, P810, DOI 10.1212/WNL.0b013e3182840782; van Eijk LT, 2007, CRIT CARE MED, V35, P1464, DOI 10.1097/01.CCM.0000266534.14262.E8; Vardy ERLC, 2015, J NEUROL, V262, P2401, DOI 10.1007/s00415-015-7760-1; Whitlock EL, 2011, MINERVA ANESTESIOL, V77, P448; Wu YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139879	38	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195749	10.1371/journal.pone.0195749	http://dx.doi.org/10.1371/journal.pone.0195749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630637	Green Published, Green Submitted, gold			2022-12-26	WOS:000429505000071
J	Wang, XH; Smith, K; Pearson, M; Hughes, A; Cosden, ML; Marcus, J; Hess, JF; Savage, MJ; Rosahl, T; Smith, SM; Schachter, JB; Uslaner, JM				Wang, Xiaohai; Smith, Karen; Pearson, Michelle; Hughes, Anna; Cosden, Mali L.; Marcus, Jacob; Hess, J. Fred; Savage, Mary J.; Rosahl, Thomas; Smith, Sean M.; Schachter, Joel B.; Uslaner, Jason M.			Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; TRANSGENIC MICE; NEUROFIBRILLARY TANGLES; O-GLCNACYLATION; POSTTRANSLATIONAL MODIFICATIONS; FRONTOTEMPORAL DEMENTIA; LOCOMOTOR-ACTIVITY; MEMORY DEFICITS; MUTANT TAU; PHOSPHORYLATION	Although tau pathology, behavioral deficits, and neuronal loss are observed in patients with tauopathies, the relationship between these endpoints has not been clearly established. Here we found that rTg4510 mice, which overexpress human mutant tau in the forebrain, develop progressive age-dependent increases in locomotor activity (LMA), which correlates with neurofibrillary tangle (NFT) pathology, hyperphosphorylated tau levels, and brain atrophy. To further clarify the relationship between these endpoints, we treated the rTg4510 mice with either doxycycline to reduce mutant tau expression or an O-GlcNAcase inhibitor Thiamet G, which has been shown to ameliorate tau pathology in animal models. We found that both doxycycline and Thiamet G treatments starting at 2 months of age prevented the progression of hyperactivity, slowed brain atrophy, and reduced brain hyperphosphorylated tau. In contrast, initiating doxycycline treatment at 4 months reduced neither brain hyperphosphorylated tau nor hyperactivity, further confirming the relationship between these measures. Collectively, our results demonstrate a unique behavioral phenotype in the rTg4510 mouse model of tauopathy that strongly correlates with disease progression, and that early interventions which reduce tau pathology ameliorate the progression of the locomotor dysfunction. These findings suggest that better understanding the relationship between locomotor deficits and tau pathology in the rTg4510 model may improve our understanding of the mechanisms underlying behavioral disturbances in patients with tauopathies.	[Wang, Xiaohai; Smith, Karen; Pearson, Michelle; Hughes, Anna; Cosden, Mali L.; Marcus, Jacob; Hess, J. Fred; Savage, Mary J.; Rosahl, Thomas; Smith, Sean M.; Schachter, Joel B.; Uslaner, Jason M.] Merck Res Labs, West Point, PA 19486 USA	Merck & Company	Wang, XH (corresponding author), Merck Res Labs, West Point, PA 19486 USA.	xiaohai_wang@merck.com	Smith, Sean/GYJ-6782-2022		Merck Co., Inc.	Merck Co., Inc.(Merck & Company)	This study was funded by Merck & Co., Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B, 2002, J NEUROSCI, V22, P9340; Bast T, 2003, PROG NEUROBIOL, V70, P319, DOI 10.1016/S0301-0082(03)00112-6; BIERER LM, 1995, ARCH NEUROL-CHICAGO, V52, P81, DOI 10.1001/archneur.1995.00540250089017; Brownlow ML, 2014, BEHAV BRAIN RES, V271, P79, DOI 10.1016/j.bbr.2014.06.001; Brownlow ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075713; Cassel JC, 1998, NEUROBIOL LEARN MEM, V69, P22, DOI 10.1006/nlme.1997.3807; Chai XY, 2011, J BIOL CHEM, V286, P34457, DOI 10.1074/jbc.M111.229633; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Cipriani G, 2014, PSYCHOGERIATRICS, V14, P135, DOI 10.1111/psyg.12044; Duyckaerts C, 1997, NEUROBIOL AGING, V18, P267, DOI 10.1016/S0197-4580(97)80306-5; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; Graham DL, 2014, NEUROPHARMACOLOGY, V79, P307, DOI 10.1016/j.neuropharm.2013.11.025; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; HOLSTEGE G, 1991, PROG BRAIN RES, V87, P307; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ikeda M, 2005, AM J PATHOL, V166, P521, DOI 10.1016/S0002-9440(10)62274-2; Jul P, 2016, J ALZHEIMERS DIS, V49, P783, DOI 10.3233/JAD-150292; Le Corre S, 2006, P NATL ACAD SCI USA, V103, P9673, DOI 10.1073/pnas.0602913103; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Leroy K, 2007, AM J PATHOL, V171, P976, DOI 10.2353/ajpath.2007.070345; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; LIPSKA BK, 1992, BRAIN RES, V585, P1, DOI 10.1016/0006-8993(92)91184-G; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Maren S, 1997, NEUROBIOL LEARN MEM, V67, P142, DOI 10.1006/nlme.1996.3752; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Meguro K, 1996, PSYCHIAT RES-NEUROIM, V67, P71, DOI 10.1016/0925-4927(96)02549-8; MOGENSON GJ, 1980, BRAIN RES, V191, P569, DOI 10.1016/0006-8993(80)91308-6; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Noble W, 2010, CNS NEUROL DISORD-DR, V9, P403, DOI 10.2174/187152710791556131; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Reynolds MR, 2006, J NEUROSCI, V26, P10636, DOI 10.1523/JNEUROSCI.2143-06.2006; Robinson L, 2007, INT J GERIATR PSYCH, V22, P9, DOI 10.1002/gps.1643; Rolland Y, 2007, ALZ DIS ASSOC DIS, V21, P31, DOI 10.1097/WAD.0b013e31802f243e; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schindowski K, 2006, AM J PATHOL, V169, P599, DOI 10.2353/ajpath.2006.060002; Song LX, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0011-1; Spillantini MG, 1998, BRAIN PATHOL, V8, P387; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/NCHEMBIO.797, 10.1038/nchembio.797]; Zhang B, 2004, J NEUROSCI, V24, P4657, DOI 10.1523/JNEUROSCI.0797-04.2004; [No title captured]	44	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195486	10.1371/journal.pone.0195486	http://dx.doi.org/10.1371/journal.pone.0195486			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624602	gold, Green Submitted, Green Published			2022-12-26	WOS:000429379600034
J	Deshayes, S; Aoubal, A; Khoy, K; Mariotte, D; Lobbedez, T; Silva, NM				Deshayes, Samuel; Aoubal, Achille; Khoy, Kathy; Mariotte, Delphine; Lobbedez, Thierry; Silva, Nicolas Martin			Hypocomplementemia is associated with worse renal survival in ANCA-positive granulomatosis with polyangiitis and microscopic polyangiitis	PLOS ONE			English	Article							ALTERNATIVE COMPLEMENT PATHWAY; FACTOR-H; VASCULITIS; ACTIVATION; GLOMERULONEPHRITIS; PROTECTS; OUTCOMES; GN; C3	Recent data suggest the existence of a complement alternative pathway activation in the pathogenesis of antineutrophilic cytoplasmic antibody (ANCA)-associated vasculitis (AAV), a condition that remains poorly understood. This study aims to assess the clinical characteristics and outcomes of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) patients with regard to their plasma complement levels at diagnosis. A retrospective monocentric study carried out at Caen University Hospital led to the identification of proteinase-3- or myeloperoxidase-ANCA-positive GPA and MPA patients from January 2000 to June 2016 and from September 2011 to June 2016, respectively. All patients with available C3 and C4 levels at diagnosis were included. Patients were categorized in the hypocomplementemia group if their C3 and/or C4 levels at diagnosis were below the lower limit of the normal range. Among the 76 AAV patients (43 GPA, 33 MPA), 4 (5%) had hypocomplementemia, and the 72 remaining patients exhibited normal plasma complement levels. All 4 hypocomplementemia patients had renal involvement. Hypocomplementemia was followed in 1 patient whose post-treatment complement level normalized within 1 month. Among all clinical and ANCA specificity, including relapse-free survival (p = 0.093), only overall and renal survival rates were significantly lower in the hypocomplementemia group (p = 0.0011 and p<0.001, respectively). Hypocomplementemia with low C3 and/or C4 levels at GPA or MPA diagnosis may be responsible for worse survival and renal prognosis. These results argue for larger and prospective studies to better determine the epidemiology of the disease and to assess complement-targeting therapy in these patients.	[Deshayes, Samuel; Aoubal, Achille; Silva, Nicolas Martin] CHU Caen, Dept Internal Med, Caen, France; [Khoy, Kathy; Mariotte, Delphine] CHU Caen, Dept Immunol, Caen, France; [Lobbedez, Thierry] CHU Caen, Dept Nephrol, Caen, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie	Silva, NM (corresponding author), CHU Caen, Dept Internal Med, Caen, France.	martinsilva-n@chu-caen.fr	DESHAYES, Samuel/H-4845-2019; Silva, Nicolas Martins da/HDO-6805-2022; LOBBEDEZ, Thierry/L-7730-2015	DESHAYES, Samuel/0000-0001-8887-3233; Silva, Nicolas Martins da/0000-0001-8288-3174; 				Augusto JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158871; Chen M, 2017, NAT REV NEPHROL, V13, DOI 10.1038/nrneph.2017.37; Chen SF, 2017, CLIN IMMUNOL, V175, P41, DOI 10.1016/j.clim.2016.11.013; Chen SF, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0656-8; Cheng L, 2017, CLIN EXP IMMUNOL; Crnogorac M, 2017, J NEPHROL; Fukui S, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004871; Gou SJ, 2013, CLIN J AM SOC NEPHRO, V8, P1884, DOI 10.2215/CJN.02790313; Gou SJ, 2013, KIDNEY INT, V83, P129, DOI 10.1038/ki.2012.313; Haas M, 2004, KIDNEY INT, V65, P2145, DOI 10.1111/j.1523-1755.2004.00632.x; Hao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038317; Hopkins J, 2003, ARTHRITIS RHEUM-US, V48, P2299, DOI 10.1002/art.11075; Huugen D, 2007, KIDNEY INT, V71, P646, DOI 10.1038/sj.ki.5002103; Jayne DRW, 2017, J AM SOC NEPHROL; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Manenti L, 2017, INTERN EMERG MED; Manenti L, 2015, CLIN J AM SOC NEPHRO, V10, P2143, DOI 10.2215/CJN.00120115; Molad Y, 2014, NEPHRON CLIN PRACT, V126, P67, DOI 10.1159/000357154; Mukhtyar C, 2009, ANN RHEUM DIS, V68, P1827, DOI 10.1136/ard.2008.101279; Schreiber A, 2017, P NATL ACAD SCI USA, V114, pE9618, DOI 10.1073/pnas.1708247114; Schreiber A, 2009, J AM SOC NEPHROL, V20, P289, DOI 10.1681/ASN.2008050497; Stone JH, 2002, CONTROL CLIN TRIALS, V23, P450; Villacorta J, 2016, CLIN RHEUMATOL, V35, P2733, DOI 10.1007/s10067-016-3384-9; Watts R, 2007, ANN RHEUM DIS, V66, P222, DOI 10.1136/ard.2006.054593; Xiao H, 2007, AM J PATHOL, V170, P52, DOI 10.2353/ajpath.2007.060573; Xiao H, 2014, J AM SOC NEPHROL, V25, P225, DOI 10.1681/ASN.2013020143; Yu F, 2007, NEPHROLOGY, V12, P74, DOI 10.1111/j.1440-1797.2006.00713.x; Yuan J, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3873	28	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195680	10.1371/journal.pone.0195680	http://dx.doi.org/10.1371/journal.pone.0195680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621352	gold, Green Published, Green Submitted			2022-12-26	WOS:000429206800113
J	Ranjard, L; Wong, TKF; Rodrigo, AG				Ranjard, Louis; Wong, Thomas K. F.; Rodrigo, Allen G.			Reassembling haplotypes in a mixture of pooled amplicons when the relative concentrations are known: A proof-of-concept study on the efficient design of next-generation sequencing strategies	PLOS ONE			English	Article							GENOME; ZIKA	Next-generation sequencing can be costly and labour intensive. Usually, the sequencing cost per sample is reduced by pooling amplified DNA = amplicons) derived from different individuals on the same sequencing lane. Barcodes unique to each amplicon permit short-read sequences to be assigned appropriately. However, the cost of the library preparation increases with the number of barcodes used. We propose an alternative to barcoding: by using different known proportions of individually-derived amplicons in a pooled sample, each is characterised a priori by an expected depth of coverage. We have developed a Hidden Markov Model that uses these expected proportions to reconstruct the input sequences. We apply this method to pools of mitochondrial DNA amplicons extracted from kangaroo meat, genus Macropus. Our experiments indicate that the sequence coverage can be efficiently used to index the short-reads and that we can reassemble the input haplotypes when secondary factors impacting the coverage are controlled. We therefore demonstrate that, by combining our approach with standard barcoding, the cost of the library preparation is reduced to a third.	[Ranjard, Louis; Wong, Thomas K. F.; Rodrigo, Allen G.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia	Australian National University	Ranjard, L (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	louis.ranjard@anu.edu.au	Rodrigo, Allen/E-8905-2015; Ranjard, Louis/M-4525-2015	Rodrigo, Allen/0000-0002-8327-7317; Ranjard, Louis/0000-0002-7622-4823	Australian Research Council [DP160103474]	Australian Research Council(Australian Research Council)	This research was supported by the Australian Research Council Discovery Project Grant #DP160103474.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; [Anonymous], MATLAB BIOINF TOOLB; Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062856; Dodt WG, 2016, MITOCHONDRIAL DNA A, V27, P1366, DOI 10.3109/19401736.2014.947583; Ferretti L, 2013, MOL ECOL, V22, P5561, DOI 10.1111/mec.12522; Futschik A, 2010, NEXT GENERATION MOLE, V218, P207; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Gautier M, 2013, MOL ECOL, V22, P3766, DOI 10.1111/mec.12360; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leguia M, 2017, J VIROL METHODS, V248, P77, DOI 10.1016/j.jviromet.2017.06.005; Mariac C, 2014, MOL ECOL RESOUR, V14, P1103, DOI 10.1111/1755-0998.12258; McComish BJ, 2010, GENOME BIOL EVOL, V2, P410, DOI 10.1093/gbe/evq029; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Nilsson MA, 2003, J MOL EVOL, V57, pS3, DOI 10.1007/s00239-003-0001-8; O'Neill EM, 2013, MOL ECOL, V22, P111, DOI 10.1111/mec.12049; Penalba JV, 2014, MOL ECOL RESOUR, V14, P1000, DOI 10.1111/1755-0998.12249; Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066; Schlotterer C, 2014, NAT REV GENET, V15, P749, DOI 10.1038/nrg3803; Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930; State of New South Wales and Office of Environment and Heritage, 2017, 2016 ANN REP; Van den Hoecke S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26314; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Wang BA, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-180, 10.1186/1471-2164-15-467]; Wu SH, 2017, BIOINFORMATICS, V266, P554; Zhou H, 2017, MATLAB MGLM TOOLBOX	26	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195090	10.1371/journal.pone.0195090	http://dx.doi.org/10.1371/journal.pone.0195090			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621260	Green Published, Green Submitted, gold			2022-12-26	WOS:000429206800036
J	Bambhroliya, A; Van Wyhe, RD; Kumar, S; Debeb, BG; Reddy, JP; Van Laere, S; El-Zein, R; Rao, A; Woodward, WA				Bambhroliya, Arvind; Van Wyhe, Renae D.; Kumar, Swaminathan; Debeb, Bisrat G.; Reddy, Jay P.; Van Laere, Steve; El-Zein, Randa; Rao, Arvind; Woodward, Wendy A.			Gene set analysis of post-lactational mammary gland involution gene signatures in inflammatory and triple-negative breast cancer	PLOS ONE			English	Article							EXPRESSION; STEM; CELLS; RECURRENCE; INVOLUCRIN; REGRESSION; FEATURES; REVEALS; MOUSE	Background Epidemiological studies have found that triple-negative breast cancer (TNBC) and TN inflammatory breast cancer (IBC) are associated with lower frequency and duration of breast-feeding compared to non-TNBC and non-TN IBC, respectively. Limited breast-feeding could reflect abrupt or premature involution and contribute to a "primed" stroma that is permissive to the migration of cancer cells typical of IBC. We hypothesized that gene expression related to abrupt mammary gland involution after forced weaning may be enriched in the tissues of IBC patients and, if so, provide a potential correlation between limited breast-feeding and the development of aggressive breast cancer. Methods We utilized the Short Time-series Expression Miner (STEM) program to cluster significant signatures from two independent studies that analyzed gene expression at multiple time points of mouse mammary gland involution. Using 10 significant signatures, we performed gene ontology analysis and gene set enrichment analysis (GSEA) on training and validation sets from human breast cancer gene expression data to identify specific genes that are enriched in IBC compared to non-IBC and in TN compared to non-TN in IBC and non-IBC groups. Results Examining the combined data, we identified 10 involution gene clusters (Inv1-10) that share time-dependent regulation after forced weaning. Inv5 was the only cluster significantly enriched in IBC in the training and validation set (nominal p-values <0.05) and only by unadjusted p-values (FDR q-values 0.26 and 0.46 respectively). Eight genes in Inv5 are upregulated in both the training and validation sets in IBC. Combining the training and validation sets, both Inv5 and Inv6 have nominal p-values <0.05 and q-values 0.39 and 0.20, respectively. The time course for both clusters includes genes that change within 12 hours after forced weaning. Conclusions Results from this in silico study suggest correlation between molecular events during abrupt involution and aggressive breast cancer. Specifically, candidate genes from Inv5 merit functional investigation regarding the role of limited breast-feeding in IBC development.	[Bambhroliya, Arvind; Kumar, Swaminathan] Univ Texas MD Anderson Canc Ctr, UTHlth Grad Sch Biomed Sci, Houston, TX 77030 USA; [Bambhroliya, Arvind; Van Wyhe, Renae D.; Kumar, Swaminathan; Debeb, Bisrat G.; Woodward, Wendy A.] Univ Texas MD Anderson Canc Ctr, Morgan Welch Inflammatory Breast Canc Res Program, Houston, TX 77030 USA; [Van Wyhe, Renae D.] Baylor Coll Med, Houston, TX 77030 USA; [Debeb, Bisrat G.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Reddy, Jay P.; Rao, Arvind; Woodward, Wendy A.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Van Laere, Steve] Univ Antwerp, Dept Oncol, Antwerp, Belgium; [El-Zein, Randa] Houston Methodist Hosp, Dept Radiol, Houston, TX USA; [Rao, Arvind] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Antwerp; The Methodist Hospital System; The Methodist Hospital - Houston; University of Texas System; UTMD Anderson Cancer Center	Woodward, WA (corresponding author), Univ Texas MD Anderson Canc Ctr, Morgan Welch Inflammatory Breast Canc Res Program, Houston, TX 77030 USA.; Woodward, WA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA.	wwoodward@mdanderson.org	Woodward, Wendy/AAX-6593-2020	Reddy, Jay Paul/0000-0001-9378-4585; Bambhroliya, Arvind/0000-0002-2584-2517; Woodward, Wendy/0000-0002-7935-739X; Kumar, Swaminathan/0000-0002-9358-787X	National Institutes of Health [R01CA180061, R01CA138239]; State of Texas Grant; State of Texas Grant for Rare and Aggressive Breast Cancer Research Program; National Center for Clinical and Translational Science [TL1-TR000369]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Texas Grant; State of Texas Grant for Rare and Aggressive Breast Cancer Research Program; National Center for Clinical and Translational Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the National Institutes of Health Grants R01CA180061 and R01CA138239 to Wendy Ann Woodward, the State of Texas Grant for Rare and Aggressive Breast Cancer Research Program to Wendy Ann Woodward, and the National Center for Clinical and Translational Science Grant TL1-TR000369 to Wendy Ann Woodward. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2017, CANC FACTS FIG 2017; Anderson WF, 2010, BREAST DIS, V22, P9, DOI DOI 10.1007/978-94-007-3907-9-2.; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Atkinson RL, 2016, CANCER CAUSE CONTROL, V27, P359, DOI 10.1007/s10552-015-0712-3; Atkinson RL, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3471; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Blanchard A, 2007, FRONT BIOSCI, V12, P2221, DOI 10.2741/2225; Clarkson RWE, 2004, BREAST CANCER RES, V6, pR92, DOI 10.1186/bcr754; Clarkson RWE, 2003, J MAMMARY GLAND BIOL, V8, P309, DOI 10.1023/B:JOMG.0000010031.53310.92; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; DJIAN P, 1993, MOL BIOL EVOL, V10, P1136; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Ernst J, 2005, BIOINFORMATICS; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; Gaudet MM, 2011, BREAST CANCER RES TR, V130, P587, DOI 10.1007/s10549-011-1616-x; Hance KW, 2005, JNCI-J NATL CANCER I, V97, P966, DOI 10.1093/jnci/dji172; Henry MD, 2004, ONCOGENE, V23, P6980, DOI 10.1038/sj.onc.1207827; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lyons TR, 2011, NAT MED, V17, P1109, DOI 10.1038/nm.2416; Macias H, 2012, WIRES DEV BIOL, V1, P533, DOI 10.1002/wdev.35; McDaniel SM, 2006, AM J PATHOL, V168, P608, DOI 10.2353/ajpath.2006.050677; Sandberg R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-48; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753; Stein T, 2009, J MAMMARY GLAND BIOL, V14, P99, DOI 10.1007/s10911-009-9120-1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsuda H, 1997, BRIT J CANCER, V75, P1519, DOI 10.1038/bjc.1997.260; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Van Laere SJ, 2013, CLIN CANCER RES, V19, P4685, DOI 10.1158/1078-0432.CCR-12-2549; Wagner KU, 2005, J MAMMARY GLAND BIOL, V10, P25, DOI 10.1007/s10911-005-2538-1; Wagner KU, 2002, DEVELOPMENT, V129, P1377; Weber A., 1949, FUNDAMENTALS HISTOLO, pIII; Weber A., 1952, SCIENCE, P116; Wolfe AR, 2016, INT J RADIAT ONCOL, V95, P791, DOI 10.1016/j.ijrobp.2016.01.025; Woodward WA, 2009, SEMIN RADIAT ONCOL, V19, P256, DOI 10.1016/j.semradonc.2009.05.008; Wu C, 2005, GCRMA BACKGROUND ADJ; Yin N, 2004, CANCER RES, V64, P5870, DOI 10.1158/0008-5472.CAN-04-0655; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335	38	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0192689	10.1371/journal.pone.0192689	http://dx.doi.org/10.1371/journal.pone.0192689			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617367	Green Submitted, gold, Green Published			2022-12-26	WOS:000429203800003
J	Kotha, S; Sun, SJ; Adams, A; Hayes, B; Phong, KT; Nagao, R; Reems, JA; Gao, DY; Torok-Storb, B; Lopez, JA; Zheng, Y				Kotha, Surya; Sun, Sijie; Adams, Arnie; Hayes, Brian; Phong, Kiet T.; Nagao, Ryan; Reems, Jo-Anna; Gao, Dayong; Torok-Storb, Beverly; Lopez, Jose A.; Zheng, Ying			Microvasculature-directed thrombopoiesis in a 3D in vitro marrow microenvironment	PLOS ONE			English	Article							VASCULAR NICHE; ENDOTHELIAL-CELLS; PLATELET PRODUCTION; STEM-CELLS; BONE; MEGAKARYOCYTES; CULTURE; DIFFERENTIATION; HEMATOPOIESIS; EXPRESSION	Vasculature is an interface between the circulation and the hematopoietic tissue providing the means for hundreds of billions of blood cells to enter the circulation every day in a regulated fashion. The precise mechanisms that control the interactions of hematopoietic cells with the vessel wall are largely undefined. Here, we report on the development of an in vitro 3D human marrow vascular microenvironment (VME) to study hematopoietic trafficking and the release of blood cells, specifically platelets. We show that mature megakaryocytes from aspirated marrow as well as megakaryocytes differentiated in culture from CD34+ cells can be embedded in a collagen matrix containing engineered microvessels to create a thrombopoietic VME. These megakaryocytes continue to mature, penetrate the vessel wall, and release platelets into the vessel lumen. This process can be blocked with the addition of antibodies specific for CXCR4, indicating that CXCR4 is required for megakaryocyte migration, though whether it is sufficient is unclear. The 3D marrow VME system shows considerable potential for mechanistic studies defining the role of marrow vasculature in thrombopoiesis. Through a stepwise addition or removal of individual marrow components, this model provides potential to define key pathways responsible for the release of platelets and other blood cells.	[Kotha, Surya; Sun, Sijie; Adams, Arnie; Phong, Kiet T.; Nagao, Ryan; Zheng, Ying] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Sun, Sijie; Reems, Jo-Anna; Lopez, Jose A.] Bloodworks Res Inst, Seattle, WA USA; [Hayes, Brian; Torok-Storb, Beverly] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Gao, Dayong] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA; [Lopez, Jose A.] Univ Washington, Dept Med Hematol, Seattle, WA 98195 USA; [Zheng, Ying] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Zheng, Ying] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Reems, Jo-Anna] Univ Utah, Div Hematol & Hematol Malignancies, Salt Lake City, UT USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah	Zheng, Y (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.; Zheng, Y (corresponding author), Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98195 USA.; Zheng, Y (corresponding author), Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA.	yingzy@uw.edu		Hayes, Brian J/0000-0002-0930-0160; Kotha, Surya/0000-0003-1385-4630	Lynn and Mike Garvey Imaging Laboratory at the Institute of Stem Cell and Regenerative Medicine, Flow Cytometry core; Nanotech User Facility at the University of Washington; Electron Microscope facility; Co-operative Center for Excellence in Hematology-Hematopoietic Cell Processing and Repository at the Fred Hutchinson Cancer Research Institute [DK56465, DK106829]; National Institutes of Health [DP2DK102258]; NIH [HL099993, UH2/UH3 TR000504]; BloodWorks Northwest Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102258, U54DK106829] Funding Source: NIH RePORTER	Lynn and Mike Garvey Imaging Laboratory at the Institute of Stem Cell and Regenerative Medicine, Flow Cytometry core; Nanotech User Facility at the University of Washington; Electron Microscope facility; Co-operative Center for Excellence in Hematology-Hematopoietic Cell Processing and Repository at the Fred Hutchinson Cancer Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BloodWorks Northwest Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge the Lynn and Mike Garvey Imaging Laboratory at the Institute of Stem Cell and Regenerative Medicine, Flow Cytometry core, and the Nanotech User Facility at the University of Washington. We acknowledge Electron Microscope facility and the Co-operative Center for Excellence in Hematology-Hematopoietic Cell Processing and Repository at the Fred Hutchinson Cancer Research Institute (DK56465 and DK106829). We acknowledge Dr. Mortimer Poncz for helpful discussions and Dr. Xiaoping Wu for assistance in flow cytometry. We acknowledge the financial support of National Institutes of Health New Innovator Award (DP2DK102258) (YZ), NIH HL099993 (BTS), NIH UH2/UH3 TR000504 and BloodWorks Northwest Research Institute.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Baudin B, 2007, NAT PROTOC, V2, P481, DOI 10.1038/nprot.2007.54; BECKER RP, 1976, AM J ANAT, V145, P183, DOI 10.1002/aja.1001450204; BRANEMARK P I, 1959, Scand J Clin Lab Invest, V11 Supp 38, P1; Brookes M., 1998, BLOOD SUPPLY BONE SC; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Choi JS, 2015, BIOTECHNOL J, V10, P1529, DOI 10.1002/biot.201400758; Di Buduo CA, 2015, BLOOD, V125, P2254, DOI 10.1182/blood-2014-08-595561; Di Maggio N, 2011, BIOMATERIALS, V32, P321, DOI 10.1016/j.biomaterials.2010.09.041; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Doan PL, 2013, STEM CELLS, V31, P327, DOI 10.1002/stem.1275; Dominietto A, 2001, BRIT J HAEMATOL, V112, P219, DOI 10.1046/j.1365-2141.2001.02468.x; Dutting S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15838; Fliedner TM, 2002, CANCER BIOTHER RADIO, V17, P405, DOI 10.1089/108497802760363204; French DL, 2013, BLOOD, V121, P2379, DOI 10.1182/blood-2013-02-479022; GARTNER S, 1980, P NATL ACAD SCI-BIOL, V77, P4756, DOI 10.1073/pnas.77.8.4756; Gori JL, 2015, J CLIN INVEST, V125, P1243, DOI 10.1172/JCI79328; Hagiwara T, 1996, EXP HEMATOL, V24, P690; Hamada T, 1998, J EXP MED, V188, P539, DOI 10.1084/jem.188.3.539; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Huang H, 2009, J CELL BIOCHEM, V107, P857, DOI 10.1002/jcb.22184; Italiano JE, 2007, J THROMB HAEMOST, V5, P18, DOI 10.1111/j.1538-7836.2007.02487.x; Itkin T, 2016, NATURE, V532, P323, DOI 10.1038/nature17624; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; KAUSHANSKY K, 1995, P NATL ACAD SCI USA, V92, P3234, DOI 10.1073/pnas.92.8.3234; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Kufrin D, 2003, BLOOD, V102, P926, DOI 10.1182/blood-2003-01-0054; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Kuter DJ, 2007, BLOOD, V109, P4607, DOI 10.1182/blood-2006-10-019315; Machlus KR, 2013, J CELL BIOL, V201, P785, DOI 10.1083/jcb.201304054; Malara A, 2014, STEM CELLS, V32, P926, DOI 10.1002/stem.1626; Malara A, 2011, BLOOD, V118, P4449, DOI 10.1182/blood-2011-04-345876; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Nishimura S, 2015, J CELL BIOL, V209, P453, DOI 10.1083/jcb.201410052; Nolan DJ, 2013, DEV CELL, V26, P204, DOI 10.1016/j.devcel.2013.06.017; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pallotta I, 2011, TISSUE ENG PART C-ME, V17, P1223, DOI 10.1089/ten.tec.2011.0134; Pang LY, 2005, J CLIN INVEST, V115, P3332, DOI 10.1172/JCI26720; RAFII S, 1995, BLOOD, V86, P3353, DOI 10.1182/blood.V86.9.3353.bloodjournal8693353; Ramirez P, 2011, BONE MARROW TRANSPL, V46, P981, DOI 10.1038/bmt.2010.218; Roberts MA, 2016, JOVE-J VIS EXP, DOI 10.3791/54457; Sabri S, 2006, BLOOD, V108, P134, DOI 10.1182/blood-2005-03-1219; Schachtner H, 2013, BLOOD, V121, P2542, DOI 10.1182/blood-2012-07-443457; SCHWEITZER CM, 1995, EXP HEMATOL, V23, P41; Seandel M, 2008, P NATL ACAD SCI USA, V105, P19288, DOI 10.1073/pnas.0805980105; Stegner D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00201-7; Sun SJ, 2013, PHYSIOL GENOMICS, V45, P217, DOI 10.1152/physiolgenomics.00056.2012; Thon JN, 2017, PLATELETS, V28, P472, DOI 10.1080/09537104.2016.1265922; Thon JN, 2014, BLOOD, V124, P1857, DOI 10.1182/blood-2014-05-574913; Thon JN, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1838; Torisawa YS, 2014, NAT METHODS, V11, P663, DOI [10.1038/NMETH.2938, 10.1038/nmeth.2938]; Uchida N, 1998, J CLIN INVEST, V101, P961, DOI 10.1172/JCI1681; Vinet L, 2010, J EXP MED, V209, P2165; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Zhang L, 2013, BLOOD, V122, P791, DOI 10.1182/blood-2012-12-473884; Zheng Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8858; Zheng Y, 2012, P NATL ACAD SCI USA, V109, P9342, DOI 10.1073/pnas.1201240109; Zijlmans JMJM, 1998, P NATL ACAD SCI USA, V95, P725, DOI 10.1073/pnas.95.2.725	61	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195082	10.1371/journal.pone.0195082	http://dx.doi.org/10.1371/journal.pone.0195082			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617409	gold, Green Published, Green Submitted			2022-12-26	WOS:000429203800061
J	Li, CY; Xue, JG; Quan, C; Yue, JW; Zhang, CG				Li, Chunyong; Xue, Jiguo; Quan, Cheng; Yue, Jingwei; Zhang, Chenggang			Biometric recognition via texture features of eye movement trajectories in a visual searching task	PLOS ONE			English	Article							DISCRIMINANT-ANALYSIS; IDENTIFICATION	Biometric recognition technology based on eye-movement dynamics has been in development for more than ten years. Different visual tasks, feature extraction and feature recognition methods are proposed to improve the performance of eye movement biometric system. However, the correct identification and verification rates, especially in long-term experiments, as well as the effects of visual tasks and eye trackers' temporal and spatial resolution are still the foremost considerations in eye movement biometrics. With a focus on these issues, we proposed a new visual searching task for eye movement data collection and a new class of eye movement features for biometric recognition. In order to demonstrate the improvement of this visual searching task being used in eye movement biometrics, three other eye movement feature extraction methods were also tested on our eye movement datasets. Compared with the original results, all three methods yielded better results as expected. In addition, the biometric performance of these four feature extraction methods was also compared using the equal error rate (EER) and Rank-1 identification rate (Rank-1 IR), and the texture features introduced in this paper were ultimately shown to offer some advantages with regard to long-term stability and robustness over time and spatial precision. Finally, the results of different combinations of these methods with a score-level fusion method indicated that multi-biometric methods perform better in most cases.	[Li, Chunyong; Xue, Jiguo; Quan, Cheng; Yue, Jingwei; Zhang, Chenggang] Beijing Inst Radiat Med, State Key Lab Prote, Cognit & Mental Hlth Res Ctr, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Yue, JW; Zhang, CG (corresponding author), Beijing Inst Radiat Med, State Key Lab Prote, Cognit & Mental Hlth Res Ctr, Beijing, Peoples R China.	jwyuecn@gmail.com; zhangcg@bmi.ac.cn	Zhang, Chenggang/B-1480-2009	Zhang, Chenggang/0000-0002-4521-3304; Quan, Cheng/0000-0003-1859-9683				Balamurugan V, 2012, INT J COMPUT APPL, V49, P38; Bayat A, 2018, ADV INTELL SYST, V591, P583, DOI 10.1007/978-3-319-60591-3_53; Bednarik R, 2005, LECT NOTES COMPUT SC, V3540, P780; Burge M. J., 2013, HDB IRIS RECOGNITION; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Camlikaya E, 2008, MULTIBIOMETRIC TEMPL; Cantoni V, 2015, PATTERN RECOGN, V48, P1027, DOI 10.1016/j.patcog.2014.02.017; Carol JJ, 2016, BRAZ ARCH BIOL TECHN, V59, DOI 10.1590/1678-4324-2016161074; Cherepovskaya EN, 2017, 2017 IEEE 15 INT S A; Duchowski A.T, 2007, EYE TRACKING METHODO, DOI DOI 10.1007/978-3-319-57883-5; George A, 2016, PATTERN RECOGN LETT, V82, P207, DOI 10.1016/j.patrec.2015.11.020; Haghighat Mohammad, 2013, Computer Analysis of Images and Patterns. 15th International Conference, CAIP 2013. Proceedings: LNCS 8048, P440, DOI 10.1007/978-3-642-40246-3_55; Hamamoto Y, 1995, P 3 INT C DOC AN REC; He ZY, 2004, P 2004 INT C MACH LE; Hill R. B., 2002, BIOMETRICS, P123; Holland C, 2011, 2011 INT JOINT C BIO; Holland CD, 2013, INT CONF BIOMETR; Holland CD, 2013, IEEE T INF FOREN SEC, V8, P2115, DOI 10.1109/TIFS.2013.2285884; Jain A. K., 2005, HDB FACE RECOGNITION; Jain Anil K., 2007, HDB BIOMETRICS; Javal E., 1905, PHYSL LECTURE ECRITU, Vxv; Josephson S, 2002, P 2002 S EYE TRACK R; Karnan M, 2011, APPL SOFT COMPUT, V11, P1565, DOI 10.1016/j.asoc.2010.08.003; Kasprowski P, 2005, P SOC PHOTO OPT INS; Kasprowski P, 2004, LECT NOTES COMPUT SC; Kasprowski P, 2012, 2012 IEEE 5 INT C BI; Kasprowski P, 2014, 2014 IEEE/IAPR INTERNATIONAL JOINT CONFERENCE ON BIOMETRICS (IJCB 2014); Kinnunen T., 2010, P 2010 S EYE TRACK R, P187, DOI DOI 10.1145/1743666.1743712; Kinnunen T, 2010, SPEECH COMMUN, V52, P12, DOI 10.1016/j.specom.2009.08.009; Komogortsev O.V., 2010, P 2010 S EYE TRACKIN, P57; Komogortsev OV, 2015, 2015 IEEE 7 INT C BO; Kumar A, 2006, IEEE T IMAGE PROCESS, V15, P2454, DOI 10.1109/TIP.2006.875214; Leigh R.J., 2015, NEUROLOGY EYE MOVEME, Vfifth; Liu CJ, 2002, IEEE T IMAGE PROCESS, V11, P467, DOI 10.1109/TIP.2002.999679; Lyamin AV, 2017, IEEE T INF FOREN SEC, V12, P881, DOI 10.1109/TIFS.2016.2639342; Maltoni D., 2009, HDB FINGERPRINT RECO, DOI DOI 10.1007/978-1-84882-254-2; Meshgini S, 2013, COMPUT ELECTR ENG, V39, P727, DOI 10.1016/j.compeleceng.2012.12.011; NOTON D, 1971, SCIENCE, V171, P308, DOI 10.1126/science.171.3968.308; Rigas I, 2014, BIOMETRIC RECOGNITIO; Rigas I, 2014, IEEE T INF FOREN SEC, V9, P1743, DOI 10.1109/TIFS.2014.2350960; Rigas I, 2012, PATTERN RECOGN LETT, V33, P786, DOI 10.1016/j.patrec.2012.01.003; Rodrigues RN, 2010, 2010 4 IEEE INT C BI, DOI 10.1109/BTAS.2010.5634531; Said HES, 2000, PATTERN RECOGN, V33, P149, DOI 10.1016/S0031-3203(99)00006-0; Said HES, 1998, 14 INT C PATT REC 19; Sangeetha K., 2015, INT J APPL ENG RES, V10, P30438; Sarkar S, 2005, IEEE T PATTERN ANAL, V27, P162, DOI 10.1109/TPAMI.2005.39; Shen L, 2007, IMAGE VISION COMPUT, V25, P553, DOI 10.1016/j.imavis.2006.05.002; Tan TN, 1992, 11 IAPR INT C PATT R; Van Der Maaten L., 2009, J MACH LEARN RES, V10, P13, DOI [10.1080/ 135062804440 0 0102, DOI 10.1080/13506280444000102]; Vapnik V., 2013, NATURE STAT LAERNING; Venugopalan S, 2011, IEEE T INF FOREN SEC, V6, P385, DOI 10.1109/TIFS.2011.2108288; Weston J, 1998, CSDTR9804 U LOND; Yong Z, 2000, 15 INT C PATT REC 20; Zhang D, 2012, ACM COMPUT SURV, V44, DOI 10.1145/2071389.2071391; Zhen L, 2012, 2012 IEEE INT C SIGN	55	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194475	10.1371/journal.pone.0194475	http://dx.doi.org/10.1371/journal.pone.0194475			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617383	gold, Green Submitted, Green Published			2022-12-26	WOS:000429203800032
J	Maas, ET; Koehoorn, M; McLeod, CB				Maas, Esther T.; Koehoorn, Mieke; McLeod, Christopher B.			Return-to-work for multiple jobholders with a work-related musculoskeletal disorder: A population-based, matched cohort in British Columbia	PLOS ONE			English	Article							JOB TENURE; INJURY; DISABILITY; EMPLOYMENT; IMPACT; MODEL	Introduction Multiple jobholders (MJHs) have a higher risk of injury compared to single jobholders (SJHs), but it is unknown if return-to-work (RTW) after a work injury is affected by multiple jobholding. This study examined the association between multiple versus single jobholding and time to RTW for workers with a work-related musculoskeletal disorder (MSD). Methods We used administrative workers' compensation data to identify injured workers with an accepted MSD lost-time claim between 2010-2014 in British Columbia, Canada (n = 125,639 SJHs and 9,029 MJHs). The outcome was days until RTW during twelve months after the first day of time-loss. The MJH and SJH cohorts were balanced using coarsened exact matching that yielded a final matched cohort of 8,389 MJHs and 8,389 SJHs. The outcome was estimated with Cox regression, using piecewise models, and the hazard ratios were stratified by type of MSD, a serious injury indicator, gender, weekly workdays preceding MSD, and wage categories. Results MJHs were less likely to RTW compared to SJHs within the first six months after the first time-loss day, with greater and longer lasting effects for males, workers with a serious injury, and a higher wage. No difference between MJHs and SJHs was found for workers who had a six-or seven-day work week preceding MSD, for workers with dislocations, and for workers who were still off work after six months. Conclusions Overall, MJHs with a workweek of maximum five days are disadvantaged compared to SJHs in terms of RTW following a work-related MSD within the first six months after the first time-loss day. This difference might be caused by more precarious job contracts for MJHs that challenges RTW because of lack of support for modified work, higher workload, and reduced likelihood that MJHs file a workers' compensation claim. Despite adjusting for type of MSD, severity of injury and occupation, the differences persisted for the vast majority of the study sample.	[Maas, Esther T.; Koehoorn, Mieke; McLeod, Christopher B.] Univ British Columbia, Sch Populat & Publ Hlth, Partnership Work Hlth & Safety, Vancouver, BC, Canada	University of British Columbia	Maas, ET (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Partnership Work Hlth & Safety, Vancouver, BC, Canada.	esther.maas@ubc.ca		McLeod, Christopher/0000-0001-9268-3694; Maas, Esther/0000-0002-2290-9552	Canadian Institutes for Health Research (CIHR) postdoctoral fellowship; CIHR Chair in Gender, Work and Health; CIHR New Investigator Award; Michael Smith Foundation for Health Research Scholar Award; WorkSafeBC through the Partnership for Work, Health and Safety	Canadian Institutes for Health Research (CIHR) postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); CIHR Chair in Gender, Work and Health(Canadian Institutes of Health Research (CIHR)); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research Scholar Award(Michael Smith Foundation for Health Research); WorkSafeBC through the Partnership for Work, Health and Safety	Esther Maas is supported by a Canadian Institutes for Health Research (CIHR) postdoctoral fellowship. Mieke Koehoorn is supported by a CIHR Chair in Gender, Work and Health. Christopher McLeod is supported by a CIHR New Investigator Award and a Michael Smith Foundation for Health Research Scholar Award. All authors are supported with funds from WorkSafeBC through the Partnership for Work, Health and Safety. All inferences, opinions, and conclusions drawn in this manuscript are those of the authors, and do not reflect the opinions or policies of the Data Steward(s).	Baines J, 2005, TRENDS NZ LABOUR MAR; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Blackwell M, 2009, STATA J, V9, P524, DOI 10.1177/1536867X0900900402; Bohle P, 2004, REV SAUDE PUBL, V38, P19, DOI 10.1590/S0034-89102004000700004; Breslin FC, 2008, ACCIDENT ANAL PREV, V40, P368, DOI 10.1016/j.aap.2007.07.007; Bureau of Labor Statistics, DAT RETR LAB FORC ST; Bush AM, 2013, AM J IND MED, V56, P881, DOI 10.1002/ajim.22156; Dickey H, 2015, ECONOMICS, P15; Hipple SF, 2010, MON LABOR REV, V133, P21; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Hoy D, 2014, BEST PRACT RES CL RH, V28, P377, DOI 10.1016/j.berh.2014.07.006; Iacus SM, 2012, POLIT ANAL, V20, P1, DOI 10.1093/pan/mpr013; Kimmel J, 1999, CAN PUBLIC POL, V25, P207, DOI 10.2307/3551889; Lilley R, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000400; Locke SJ, 2014, OCCUP ENVIRON MED, V71, P855, DOI 10.1136/oemed-2013-101801; Marucci-Wellman HR, 2014, AM J PUBLIC HEALTH, V104, P134, DOI 10.2105/AJPH.2013.301431; McLeod C, 2017, SCANDINAVIAN J WORK; Rouault S., 2002, MULTIPLE JOBHOLDING; Schultz IZ, 2002, SPINE, V27, P2720, DOI 10.1097/00007632-200212010-00012; Statistics Canada, 2016, EMPL IND SEX; Statistics Canada, 1991, STAND OCC CLASS SOC; Statistics Canada, 2016, MULT JOB HOLD PERC T; Statistics Canada, 2016, LAB FORC SURV EST LF; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; The PLOS Medicine Editors, 2014, PLOS MED, V11; Tompa E, 2008, OCCUP ENVIRON MED, V65, P801, DOI 10.1136/oem.2007.037259; Tompa E., 2010, INVESTIGATION TEMPOR, P6; Tompa E, 2010, WORK, V37, P251, DOI 10.3233/WOR-2010-1077; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wells AR, 2013, POPUL HEALTH MANAG, V16, P35, DOI 10.1089/pop.2011.0104; WorksafeBC, 2016, IND HLTH SAF IND; WorkSafeBC, 2014, WORKSAFEBC CLAIM LEV; Zierold KM, 2011, OCCUP ENVIRON MED, V68, P818, DOI 10.1136/oem.2010.059170	33	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0193618	10.1371/journal.pone.0193618	http://dx.doi.org/10.1371/journal.pone.0193618			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB5DC	29614128	Green Published, Green Submitted, gold			2022-12-26	WOS:000429081600005
J	Philbin, MM; Hirsch, JS; Wilson, PA; Ly, T; Giang, LM; Parker, RG				Philbin, Morgan M.; Hirsch, Jennifer S.; Wilson, Patrick A.; An Thanh Ly; Le Minh Giang; Parker, Richard G.			Structural barriers to HIV prevention among men who have sex with men (MSM) in Vietnam: Diversity, stigma, and healthcare access	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; TRANSGENDER WOMEN; YOUNG MEN; RISK BEHAVIORS; PACIFIC REGION; SUBSTANCE USE; BLACK-MEN; ASIA; INFECTION; THAILAND	Men who have sex with men (MSM) in Vietnam experience disproportionate rates of HIV infection. To advance understanding of how structural barriers may shape their engagement with HIV prevention services, we draw on 32 in-depth interviews and four focus groups (n = 31) conducted with MSM in Hanoi between October 2015-March 2016. Three primary factors emerged: (1) Diversity, both in relation to identity and income; Vietnamese MSM described themselves as segregated into Bong kin (hidden, often heterosexually-identified MSM) and Bong IO ('out,' transgender, or effeminate MSM). Lower-income, 'hidden' MSM from rural areas were reluctant to access MSM-targeted services; (2) Stigma: MSM reported being stigmatized by the healthcare system, family, and other MSM; and (3) Healthcare access: this was limited due to economic barriers and lack of MSM-friendly services. Our research suggests the need for multiple strategies to reach diverse types of MSM as well as to address barriers in access to health services such as stigma and costs. While a great deal has been written about the diversity of MSM in relation to gender performance and sexual identities, our research points to the substantial structural-level barriers that must be addressed in order to achieve meaningful and effective HIV prevention for MSM worldwide.	[Philbin, Morgan M.; Hirsch, Jennifer S.; Wilson, Patrick A.; Parker, Richard G.] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY 10032 USA; [An Thanh Ly; Le Minh Giang] Hanoi Med Univ, Ctr Res & Training HIV AIDS CREATA, Hanoi, Vietnam	Columbia University; Hanoi Medical University	Philbin, MM (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY 10032 USA.	mp3243@columbia.edu	/AET-2949-2022; /AAF-4450-2021; Le, Giang/P-2309-2019	Giang, Le Minh/0000-0003-3370-4453	National Institute of Child Health and Human Development [R24 HD056691]; Department of Sociomedical Sciences; Center for the Study of Culture, Politics and Health; Columbia Population Research Center [P2-CHD058486]; NIDA [K01DA039804A]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD056691, P2CHD058486] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Department of Sociomedical Sciences; Center for the Study of Culture, Politics and Health; Columbia Population Research Center; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by a grant from the National Institute of Child Health and Human Development (R24 HD056691; PIs Hirsch and Parker). Support was also provided by the Department of Sociomedical Sciences and the Center for the Study of Culture, Politics and Health. Dr. Hirsch was partially supported by the Columbia Population Research Center (P2-CHD058486). Dr. Philbin is supported by a NIDA-funded K01 (K01DA039804A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMFAR, 2016, WILL IMP CUTS PEPFAR; [Anonymous], 2013, HEALTH; Ayala G, 2013, J SEXUALLY TRANSMITT, V2013; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Barlow J, 2010, J ROY SOC MED, V103, P51, DOI 10.1258/jrsm.2009.090296; Bauermeister JA, 2014, CURR HIV RES, V11, P520, DOI 10.2174/1570162X12666140129100411; Berry MC, 2013, AIDS CARE, V25, P38, DOI 10.1080/09540121.2012.687808; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Boellstorff T., 2005, GAY ARCHIPELAGO SEXU; Boellstorff T, 2011, CULT ANTHROPOL, V26, P287, DOI 10.1111/j.1548-1360.2011.01100.x; Calabrese SK, 2015, AM J PUBLIC HEALTH, V105, P1960, DOI 10.2105/AJPH.2015.302816; Center for Applied Research on Men and Community Health (CARMAH), 2015, STUD TRANSG WOM HLTH; Colby D, 2004, AIDS EDUC PREV, V16, P45, DOI 10.1521/aeap.16.1.45.27722; Colby D, 2016, AIDS BEHAV, V20, pS379, DOI 10.1007/s10461-016-1485-8; Dao A, 2013, GLOB PUBLIC HEALTH, V8, pS7, DOI 10.1080/17441692.2013.811532; de Loenzien Myriam, 2009, Sante, V19, P141, DOI 10.1684/san.2009.0169; de Oliveira DL, 2011, CIENC SAUDE COLETIVA, V16, P3093, DOI 10.1590/S1413-81232011000800030; Ekman B, 2008, HEALTH POLICY PLANN, V23, P252, DOI 10.1093/heapol/czn009; Epstein S., 1998, IMPURE SCI AIDS ACTI, V7; Gangcuangco Louie Mar A, 2013, Southeast Asian J Trop Med Public Health, V44, P810; Garcia J, 2016, GLOB PUBLIC HEALTH, P1; Garcia MC, 2014, GLOB PUBLIC HEALTH, V9, P1225, DOI 10.1080/17441692.2014.948481; Garcia Macarena C, 2012, BMJ Open, V2, DOI 10.1136/bmjopen-2012-001511; Golub SA, 2017, AIDS BEHAV, V21, P1229, DOI 10.1007/s10461-015-1129-4; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P248, DOI 10.1089/apc.2012.0419; Hirsch JS, 2015, J HEALTH POLIT POLIC, V40, P13, DOI 10.1215/03616878-2854447; HIV pre-exposure prophylaxis and health and community systems in the Global South, 2015, J INT AIDS SOC; Holt M, 2014, SEX HEALTH, V11, P166, DOI 10.1071/SH13060; Horton P, 2014, CULT HEALTH SEX, V16, P960, DOI 10.1080/13691058.2014.924556; Giang LM, 2013, J FOOD DRUG ANAL, V21, pS42, DOI 10.1016/j.jfda.2013.09.032; Giang LM, 2013, GLOB PUBLIC HEALTH, V8, pS1, DOI 10.1080/17441692.2013.797484; Lo Y-R, 2014, SEXUAL HLTH; Lo YR, 2014, SEX HEALTH, V11, P126, DOI 10.1071/SH13094; Logie CH, 2016, AIDS PATIENT CARE ST, V30, P92, DOI 10.1089/apc.2015.0197; Maher L, 2007, INT J DRUG POLICY, V18, P296, DOI 10.1016/j.drugpo.2006.12.006; Malebranche DJ, 2009, MEN MASC, V12, P90, DOI 10.1177/1097184X07309504; Ministry of Health (MOH) & Health Partnership Group (HPG), 2013, JOINT ANN HLTH REV 2; Newman P.A., 2017, NEW ERA FOCUS GROUP, P83; Newman PA, 2012, PREV SCI, V13, P483, DOI 10.1007/s11121-012-0275-4; Ngo DA, 2009, AIDS EDUC PREV, V21, P251, DOI 10.1521/aeap.2009.21.3.251; Oldenburg CE, 2016, AIDS BEHAV, V20, pS365, DOI 10.1007/s10461-016-1483-x; Oosterhoff P, NEGOTIATING PUBLIC L; Parker RG, 2000, AIDS, V14, pS22, DOI 10.1097/00002030-200006001-00004; Parker Richard G., 2000, GLOBAL HLTH POLICY L; Philbin MM, 2016, AIDS PATIENT CARE ST, V30, P282, DOI 10.1089/apc.2016.0037; Pham QD, 2015, SEX TRANSM INFECT, V91, P178, DOI 10.1136/sextrans-2014-051574; Ramesh M, 2008, PAC REV, V21, P171, DOI 10.1080/09512740801990238; Solomon SS, 2015, AIDS, V29, P723, DOI 10.1097/QAD.0000000000000602; Nguyen TV, 2016, AIDS BEHAV, V20, P2357, DOI 10.1007/s10461-015-1265-x; Underhill K, 2016, AIDS BEHAV, V20, P1514, DOI 10.1007/s10461-015-1088-9; Underhill K, 2015, J URBAN HEALTH, V92, P667, DOI 10.1007/s11524-015-9961-4; van Griensven F, 2013, AIDS, V27, P825, DOI 10.1097/QAD.0b013e32835c546e; van Griensven F, 2010, AIDS, V24, pS30, DOI 10.1097/01.aids.0000390087.22565.b4; Vietnam Authority of AIDS Control, 2016, RES HIV SENT SURV IN; Vietnam Authority of AIDS Control, 2012, VIETN HIV AIDS EST P; Vu BN, 2008, SEX HEALTH, V5, P83, DOI 10.1071/SH07064; Vu VT, 2011, AIDS CARE, V23, P139, DOI 10.1080/09540121.2010.507741; Wilson P, CATEGORICAL IN PRESS; World Bank, 2006, VIETN DEV REP 2007 A; World Health Organization, 2009, ASS COMP TREATM PEOP; World Health Organization, 2012, HLTH SERV DEL PROF V; Zablotska I, 2016, J INT AIDS SOC, P19	62	30	31	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195000	10.1371/journal.pone.0195000	http://dx.doi.org/10.1371/journal.pone.0195000			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB5DC	29614104	Green Published, Green Submitted, gold			2022-12-26	WOS:000429081600023
J	Ross, J; Edmonds, A; Hoover, DR; Shi, QH; Anastos, K; Lelo, P; Behets, F; Yotebieng, M				Ross, Jonathan; Edmonds, Andrew; Hoover, Donald R.; Shi, Qiuhu; Anastos, Kathryn; Lelo, Patricia; Behets, Frieda; Yotebieng, Marcel			Association between pregnancy at enrollment into HIV care and loss to care among women in the Democratic Republic of Congo, 2006-2013	PLOS ONE			English	Article							OPTION B PLUS; RANDOMIZED CONTROLLED-TRIAL; CONDITIONAL CASH TRANSFERS; TO-CHILD TRANSMISSION; FOLLOW-UP; ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; RISK-FACTORS; RETROSPECTIVE COHORT; POSTPARTUM WOMEN	Background Loss to care is high among asymptomatic HIV-infected women initiated on antiretroviral therapy (ART) during pregnancy or in the postpartum period. However, whether pregnancy itself plays a role in the high loss to care rate is uncertain. We compared loss to care over seven years between pregnant and non-pregnant women at enrollment into HIV care in the Democratic Republic of Congo (DRC). Methods We conducted a retrospective analysis of all ART-naive women aged 15-45 initiating HIV care at two large clinics in Kinshasa, DRC, from 2007-2013. Pregnancy status was recorded at care enrollment. Patients were classified as having no follow-up if they did not return to care after the initial enrollment visit. Among those with at least one follow-up visit after enrollment, we classified patients as lost to care if more than 365 days had passed since their last clinic visit. We used logistic regression to model the association between pregnancy status and no follow-up, and Cox proportional hazards regression to model the association between pregnancy status and time to loss to care. Results Of 2175 women included in the analysis, 1497 (68.8%) were pregnant at enrollment. Compared to non-pregnant women, pregnant women were less likely to be over 35 years of age (19.1% vs. 31.9%, p<0.0001) and less likely to be in WHO stage III or IV (9.0% vs. 26.3%, p<0.0001). Among pregnant women, 106 (7.1%) were not seen after enrollment, versus 25 (3.7%) non-pregnant women (adjusted odds ratio 2.01, 95% CI 1.24-3.24). Of the 2,044 women with at least one follow-up visit, 46.5% of pregnant women and 46.7% of non-pregnant women were lost to care by 5 years; hazards of loss to care were similar for pregnant and non-pregnant women (adjusted hazard ratio 1.08, 95% CI 0.93-1.26). Conclusions In this large cohort of HIV-infected women, patients pregnant at care enrollment were more likely to never return for follow-up. Among those who attended at least one follow-up visit, loss to care was not different between pregnant and non-pregnant women, suggesting that pregnancy itself may not be the main driver of the high attrition observed in this cohort.	[Ross, Jonathan; Anastos, Kathryn] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Gen Internal Med, Bronx, NY 10467 USA; [Edmonds, Andrew; Behets, Frieda] Univ North Carolina Chapel Hill, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Hoover, Donald R.] Rutgers State Univ, Dept Stat & Biostat, New Brunswick, NJ USA; [Shi, Qiuhu] New York Med Coll, Dept Epidemiol & Community Hlth, Valhalla, NY 10595 USA; [Lelo, Patricia] Kalembelembe Pediat Hosp, Kinshasa, DEM REP CONGO; [Yotebieng, Marcel] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Rutgers State University New Brunswick; New York Medical College; University System of Ohio; Ohio State University	Ross, J (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Gen Internal Med, Bronx, NY 10467 USA.	joross@montefiore.org	Ross, Jonathan/AAV-2402-2020; Yotebieng, Marcel/L-2083-2013	Ross, Jonathan/0000-0001-6126-3048; Yotebieng, Marcel/0000-0003-2110-2631; Edmonds, Andrew/0000-0001-6768-0096	National Institute of Allergy and Infectious Diseases [U01 AI096299]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01 HD087993]; National Institute of Mental Health [K23 MH114752]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD087993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI096299, P30AI124414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH114752] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was conducted as part of the Central Africa International Epidemiologic Databases to Evaluate AIDS (CA-IeDEA) consortium, which is funded by the National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov, grant number U01 AI096299 to KA), and received additional support from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (https://www.nichd.nih.gov, grant number R01 HD087993) and National Institute of Mental Health grant K23 MH114752 to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, GLOB PLAN COUNTR FAC; [Anonymous], 2013, CONSOLIDATED GUIDELI; [Anonymous], 2016, FAST TRACK AIDS FREE; Boyles TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019201; Clouse K, 2014, JAIDS-J ACQ IMM DEF, V67, pE12, DOI 10.1097/QAI.0000000000000263; Clouse K, 2013, TROP MED INT HEALTH, V18, P451, DOI 10.1111/tmi.12072; Clouse K, 2013, JAIDS-J ACQ IMM DEF, V62, pE39, DOI 10.1097/QAI.0b013e318273ac48; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Dzangare J, 2016, TROP MED INT HEALTH, V21, P202, DOI 10.1111/tmi.12637; Edmonds A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001044; Edmonds A, 2009, INT J EPIDEMIOL, V38, P1612, DOI 10.1093/ije/dyp208; Fowler MG, 2016, NEW ENGL J MED, V375, P1726, DOI 10.1056/NEJMoa1511691; Grimsrud A, 2016, J EPIDEMIOL COMMUN H, V70, P549, DOI 10.1136/jech-2015-206629; Gwynn RC, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0898-9; Haas AD, 2016, LANCET HIV, V3, pE175, DOI 10.1016/S2352-3018(16)00008-4; Joint United Nations Programmes on HIV/AIDS, 2011, COUNTD ZER GLOB PLAN; Kaplan R, 2008, AIDS, V22, P1679, DOI 10.1097/QAD.0b013e32830ebcee; Kim MH, PLOS ONE, V11; Koole O, 2014, TROP MED INT HEALTH, V19, P1397, DOI 10.1111/tmi.12386; Landes M, 2016, BMC Public Health, V15, P713, DOI 10.1186/s12889-016-3380-7; Layer EH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104961; Llenas-Garcia J, 2016, TROP MED INT HEALTH, V21, P1003, DOI 10.1111/tmi.12728; Ministere du Plan et Suivi de la Mise en oeuvre de la Re A volution de la Modernite A et Ministere de la Sante A Publique, 2014, MIN PLAN SUIV MIS OE; Mitiku I, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20662; Mutasa-Apollo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086305; OKOBOI S, 2016, J INT AIDS SOC S4, V19; Pati R, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18490; Phillips T, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19242; Rawizza HE, 2015, CURR HIV RES, V13, P201, DOI 10.2174/1570162X1303150506183256; Schnippel K, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0778-2; Stinson K, 2012, AJAR-AFR J AIDS RES, V11, P65, DOI 10.2989/16085906.2012.671263; Sturt AS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008440; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Tweya H, 2014, TROP MED INT HEALTH, V19, P1360, DOI 10.1111/tmi.12369; Vuylsteke B, 2015, JAIDS-J ACQ IMM DEF, V68, pS99, DOI 10.1097/QAI.0000000000000442; Wang BX, 2011, SAMJ S AFR MED J, V101, P253, DOI 10.7196/SAMJ.4078; WHO, 2006, ANT DRUGS TREAT PREG; WHO, 2022, ANT DRUGS TREAT PREG; World Health Organization, 2021, ANT DRUGS TREAT PREG; Yotebieng M, 2017, JAIDS-J ACQ IMM DEF, V74, P150, DOI 10.1097/QAI.0000000000001219; Yotebieng M, 2016, LANCET HIV, V3, pE85, DOI 10.1016/S2352-3018(15)00247-7; Yotebieng M, 2015, LANCET GLOB HEALTH, V3, pE546, DOI 10.1016/S2214-109X(15)00012-1; Yotebieng M, 2013, INT BREASTFEED J, V8, DOI 10.1186/1746-4358-8-11	44	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195231	10.1371/journal.pone.0195231	http://dx.doi.org/10.1371/journal.pone.0195231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608618	Green Published, gold			2022-12-26	WOS:000428988800040
J	Sun, LX; Xu, XH; Chen, YJ; Zhou, YX; Tan, R; Qiu, HT; Jin, LT; Zhang, WY; Fan, R; Hong, WJ; Wang, TL				Sun, Lixiang; Xu, Xiaohui; Chen, Yongjun; Zhou, Yuxia; Tan, Ran; Qiu, Hantian; Jin, Liting; Zhang, Wenyi; Fan, Rong; Hong, Wanjin; Wang, Tuanlao			Rab34 regulates adhesion, migration, and invasion of breast cancer cells	ONCOGENE			English	Article							VESICLE TRAFFICKING; ALPHA-5-BETA-1 INTEGRIN; 3D MICROENVIRONMENTS; SRC KINASE; ENDOCYTOSIS; GTPASES; MACROPINOCYTOSIS; PATHWAY; DISEASE; PROTEIN	The small GTPase Rab34 regulates spatial distribution of the lysosomes, secretion, and macropinocytosis. In this study, we found that Rab34 is over-expressed in aggressive breast cancer cells, implying a potential role of Rab34 in breast cancer. Silencing Rab34 by shRNA inhibits cell migration, invasion, and adhesion of breast cancer cells. Rab34 specifically binds to the cytoplasmic tail of integrin beta 3, and depletion of Rab34 promotes the degradation of integrin beta 3. Interestingly, EGF induces the translocation of Rab34 to the membrane ruffle, which is greatly enhanced by the expression of Src kinase. Accordingly, Rab34 is tyrosine phosphorylated by Src at Y247 residue. A mutant mimicking phosphorylated form of Rab34 (Rab34Y247D) promotes cell migration and invasion. Importantly, the tyrosine phosphorylation of Rab34 is inhibited in cells in suspension, and increased with the cells re-adhesion. In addition, Rab34Y247D promotes cell adhesion, and enhances integrin beta 3 endocytosis and recycling. The results uncover a role of Rab34 in migration and invasion of breast cancer cells and its involvement in cancer metastasis, and provide a novel mechanism of tyrosine phosphorylation of Rab34 in regulating cell migration, invasion, and adhesion through modulating the endocytosis, stability, and recycling of integrin beta 3.	[Sun, Lixiang; Xu, Xiaohui; Chen, Yongjun; Zhou, Yuxia; Qiu, Hantian; Jin, Liting; Zhang, Wenyi; Fan, Rong; Hong, Wanjin; Wang, Tuanlao] Xiamen Univ, Sch Pharmaceut Sci, State Key Lab Cellular Stress Biol, Fujian Prov Key Lab Innovat Drug Target Res, Xiamen 361005, Peoples R China; [Tan, Ran] State Ocean Adm, Inst Oceanog 3, Xiamen 361005, Peoples R China; [Hong, Wanjin] ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore	Xiamen University; State Oceanic Administration; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Hong, WJ; Wang, TL (corresponding author), Xiamen Univ, Sch Pharmaceut Sci, State Key Lab Cellular Stress Biol, Fujian Prov Key Lab Innovat Drug Target Res, Xiamen 361005, Peoples R China.; Hong, WJ (corresponding author), ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	mcbhwj@imcb.a-star.edu.sg; xmuibrwtl@xmu.edu.cn		Sun, Lixiang/0000-0002-0287-4831	National Natural Science Foundation of China [31371353, 31671478]; International Science & Technology Cooperation Program of China [2013DFG32730]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China	This work was supported by National Natural Science Foundation of China (No. 31371353 and No. 31671478) and International Science & Technology Cooperation Program of China (No. 2013DFG32730). The cDNA of integrin beta 1 and integrin beta 3 were kindly provided by Dr. Jiahuai Han (State Key Laboratory of Cellular Stress Biology, Xiamen University, China).	Agola JO, 2011, CLIN GENET, V80, P305, DOI 10.1111/j.1399-0004.2011.01724.x; Alanko J, 2016, TRENDS CELL BIOL, V26, P391, DOI 10.1016/j.tcb.2016.02.001; Alanko J, 2015, NAT CELL BIOL, V17, P1412, DOI 10.1038/ncb3250; Amyere M, 2002, INT J MED MICROBIOL, V291, P487; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Balzac F, 2005, J CELL SCI, V118, P4765, DOI 10.1242/jcs.02584; Bhuin T, 2014, EXP CELL RES, V328, P1, DOI 10.1016/j.yexcr.2014.07.027; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Chavez Kathryn J, 2010, Breast Dis, V32, P35, DOI 10.3233/BD-2010-0307; Cheng KW, 2005, CANCER RES, V65, P2516, DOI 10.1158/0008-5472.CAN-05-0573; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Chodniewicz D, 2004, EXP CELL RES, V301, P31, DOI 10.1016/j.yexcr.2004.08.006; Coyne CB, 2007, CELL HOST MICROBE, V2, P181, DOI 10.1016/j.chom.2007.07.003; Di Florio A, 2007, ENDOCR-RELAT CANCER, V14, P111, DOI 10.1677/erc.1.01318; Edinger AL, 2003, DEV CELL, V5, P571, DOI 10.1016/S1534-5807(03)00291-0; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Goldenberg NM, 2007, MOL BIOL CELL, V18, P4762, DOI 10.1091/mbc.E06-11-0991; Gu ZZ, 2011, J CELL BIOL, V193, P61, DOI 10.1083/jcb.201007003; Harris KP, 2011, CURR BIOL, V21, pR841, DOI 10.1016/j.cub.2011.08.061; Hawes CR, 1999, CURR OPIN PLANT BIOL, V2, P454, DOI 10.1016/S1369-5266(99)00023-0; Igarashi T, 2017, ONCOTARGET, V8, P12290, DOI 10.18632/oncotarget.14703; Ihemelandu CU, 2008, AM J SURG, V195, P153, DOI 10.1016/j.amjsurg.2007.09.033; Iwamoto DV, 2015, CURR OPIN CELL BIOL, V36, P41, DOI 10.1016/j.ceb.2015.06.009; Lee U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082125; Lin XS, 2017, CELL SIGNAL, V35, P84, DOI 10.1016/j.cellsig.2017.03.006; Luo HC, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-82; Mettlen M, 2006, TRAFFIC, V7, P589, DOI 10.1111/j.1600-0854.2006.00412.x; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; Porther N, 2015, Small GTPases, V6, P135, DOI 10.1080/21541248.2015.1050152; Redig AJ, 2013, J INTERN MED, V274, P113, DOI 10.1111/joim.12084; SALISBURY JL, 1983, INT REV EXP PATHOL, V24, P1; Spang A, 2008, CELL MOL LIFE SCI, V65, P2781, DOI 10.1007/s00018-008-8349-y; Speight P, 2005, TRAFFIC, V6, P858, DOI 10.1111/j.1600-0854.2005.00321.x; Starling GP, 2016, EMBO REP, V17, P823, DOI 10.15252/embr.201541382; Stein MP, 2003, ADV DRUG DELIVER REV, V55, P1421, DOI 10.1016/j.addr.2003.07.009; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Subramani D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-312; Sun P, 2003, J BIOL CHEM, V278, P4063, DOI 10.1074/jbc.M208699200; Tang BL, 2009, CELL MOTIL CYTOSKEL, V66, P365, DOI 10.1002/cm.20376; Valdembri D, 2012, CURR OPIN CELL BIOL, V24, P582, DOI 10.1016/j.ceb.2012.08.004; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wang HJ, 2015, TUMOR BIOL, V36, P1573, DOI 10.1007/s13277-014-2732-0; Wang TL, 2004, MOL BIOL CELL, V15, P815, DOI 10.1091/mbc.E03-06-0413; Wang TL, 2002, MOL BIOL CELL, V13, P4317, DOI 10.1091/mbc.E02-05-0280; Wang TL, 2012, J CELL PHYSIOL, V227, P2788, DOI 10.1002/jcp.23023; Wright PK, 2008, RECENT PAT ANTI-CANC, V3, P137, DOI 10.2174/157489208784638730; Xiao R, 2013, BLOOD, V121, P700, DOI 10.1182/blood-2012-07-440644; Zhang B, 2015, GENET TEST MOL BIOMA, V19, P69, DOI 10.1089/gtmb.2014.0210; Zhang JX, 2016, THERANOSTICS, V6, P2099, DOI 10.7150/thno.16587; Zhang XD, 2017, NANOSCALE, V9, P150, DOI 10.1039/c6nr07866d	55	20	20	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 5	2018	37	27					3698	3714		10.1038/s41388-018-0202-7	http://dx.doi.org/10.1038/s41388-018-0202-7			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GM3CM	29622794				2022-12-26	WOS:000437975200007
J	Dahl, EF; Wu, SC; Healy, CL; Harsch, BA; Shearer, GC; O'Connell, TD				Dahl, Erika F.; Wu, Steven C.; Healy, Chastity L.; Harsch, Brian A.; Shearer, Gregory C.; O'Connell, Timothy D.			Subcellular compartmentalization of proximal G(q)-receptor signaling produces unique hypertrophic phenotypes in adult cardiac myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiac hypertrophy; cell compartmentalization; cell signaling; G protein-coupled receptor (GPCR); adrenergic receptor; angiotensin II; signaling mechanism; myocardial biology; intracellular compartmentalization; G protein signaling; angiotensin receptor	B-SPLICE VARIANT; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; ENDOTHELIN RECEPTORS; BETA; LOCALIZATION; OVEREXPRESSION; FAILURE; CARDIOMYOCYTES; ACTIVATION; PATHWAY	G protein-coupled receptors that signal through G(q) (G(q) receptors), such as (1)-adrenergic receptors ((1)-ARs) or angiotensin receptors, share a common proximal signaling pathway that activates phospholipase C1 (PLC1), which cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) to produce inositol 1,4,5-trisphosphate (IP3) and diacylglycerol. Despite these common proximal signaling mechanisms, G(q) receptors produce distinct physiological responses, yet the mechanistic basis for this remains unclear. In the heart, G(q) receptors are thought to induce myocyte hypertrophy through a mechanism termed excitation-transcription coupling, which provides a mechanistic basis for compartmentalization of calcium required for contraction versus IP3-dependent intranuclear calcium required for hypertrophy. Here, we identified subcellular compartmentalization of G(q)-receptor signaling as a mechanistic basis for unique G(q) receptor-induced hypertrophic phenotypes in cardiac myocytes. We show that (1)-ARs co-localize with PLC1 and PIP2 at the nuclear membrane. Further, nuclear (1)-ARs induced intranuclear PLC1 activity, leading to histone deacetylase 5 (HDAC5) export and a robust transcriptional response (i.e. significant up- or down-regulation of 806 genes). Conversely, we found that angiotensin receptors localize to the sarcolemma and induce sarcolemmal PLC1 activity, but fail to promote HDAC5 nuclear export, while producing a transcriptional response that is mostly a subset of (1)-AR-induced transcription. In summary, these results link G(q)-receptor compartmentalization in cardiac myocytes to unique hypertrophic transcription. They suggest a new model of excitation-transcription coupling in adult cardiac myocytes that accounts for differential G(q)-receptor localization and better explains distinct physiological functions of G(q) receptors.	[Dahl, Erika F.] Univ Minnesota, Dept Pharmacol, 3-249 Millard Hall, Minneapolis, MN 55455 USA; [Wu, Steven C.; Healy, Chastity L.; O'Connell, Timothy D.] Univ Minnesota, Dept Integrat Biol & Physiol, 2231 6th St SE,Canc & Cardiovasc Res Bldg,3-141, Minneapolis, MN 55455 USA; [Harsch, Brian A.; Shearer, Gregory C.] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	O'Connell, TD (corresponding author), Univ Minnesota, Dept Integrat Biol & Physiol, 2231 6th St SE,Canc & Cardiovasc Res Bldg,3-141, Minneapolis, MN 55455 USA.	tdoconne@umn.edu			University of Minnesota (Minneapolis, MN); Pennsylvania State University (University Park, PA)	University of Minnesota (Minneapolis, MN)(University of Minnesota System); Pennsylvania State University (University Park, PA)	This work was supported by start-up funds from the University of Minnesota (Minneapolis, MN) (to T.D.O.) and start-up funds from Pennsylvania State University (University Park, PA) (to G.C.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Bendall JK, 2002, CIRCULATION, V105, P293, DOI 10.1161/hc0302.103712; BOHELER KR, 1992, J BIOL CHEM, V267, P12979; Boivin B, 2003, J BIOL CHEM, V278, P29153, DOI 10.1074/jbc.M301738200; Bossuyt J, 2011, J BIOL CHEM, V286, P33390, DOI 10.1074/jbc.M111.246447; Braz JC, 2003, J CLIN INVEST, V111, P1475, DOI 10.1172/JCI200317295; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P4586, DOI 10.1073/pnas.072647999; Cajka T, 2014, TRAC-TREND ANAL CHEM, V61, P192, DOI 10.1016/j.trac.2014.04.017; Chang CWJ, 2013, J BIOL CHEM, V288, P192, DOI 10.1074/jbc.M112.382358; Chrysant SG, 2008, CLIN THER, V30, P2181, DOI 10.1016/j.clinthera.2008.12.002; COHN JN, 1993, CIRCULATION, V87, P1; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; Dorn GW, 1999, TRENDS CARDIOVAS MED, V9, P26, DOI 10.1016/S1050-1738(99)00004-3; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Grubb DR, 2008, FASEB J, V22, P2768, DOI 10.1096/fj.07-102558; Grubb DR, 2015, J MOL CELL CARDIOL, V84, P95, DOI 10.1016/j.yjmcc.2015.04.016; Hein L, 1997, P NATL ACAD SCI USA, V94, P6391, DOI 10.1073/pnas.94.12.6391; Higazi DR, 2009, MOL CELL, V33, P472, DOI 10.1016/j.molcel.2009.02.005; Huang Y, 2007, CIRCULATION, V115, P763, DOI 10.1161/CIRCULATIONAHA.106.664862; Ibarra C, 2013, CIRC RES, V112, P236, DOI 10.1161/CIRCRESAHA.112.273839; Jalili T, 1999, AM J PHYSIOL-HEART C, V277, pH2298, DOI 10.1152/ajpheart.1999.277.6.H2298; Jensen BC, 2009, N-S ARCH PHARMACOL, V379, P409, DOI 10.1007/s00210-008-0368-6; Kamato D, 2017, CELL MOL LIFE SCI, V74, P1379, DOI 10.1007/s00018-016-2405-9; Kawada N, 2002, J AM SOC NEPHROL, V13, P2860, DOI 10.1097/01.ASN.0000035087.11758.ED; Kim D, 1997, NATURE, V389, P290, DOI 10.1038/38508; Liu PS, 1996, J BIOL CHEM, V271, P10299, DOI 10.1074/jbc.271.17.10299; Luo DL, 2008, CELL CALCIUM, V43, P165, DOI 10.1016/j.ceca.2007.04.017; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Mesaeli N, 2000, ARCH BIOCHEM BIOPHYS, V382, P48, DOI 10.1006/abbi.2000.2012; Nikolaev VO, 2010, SCIENCE, V327, P1653, DOI 10.1126/science.1185988; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; O'Connell TD, 2014, PHARMACOL REV, V66, P308, DOI 10.1124/pr.112.007203; Paradis P, 2000, P NATL ACAD SCI USA, V97, P931, DOI 10.1073/pnas.97.2.931; Ponicke K, 1998, CIRCULATION, V97, P744, DOI 10.1161/01.CIR.97.8.744; Ramazzotti G, 2011, J CELL PHYSIOL, V226, P14, DOI 10.1002/jcp.22334; Robu VG, 2003, J BIOL CHEM, V278, P48154, DOI 10.1074/jbc.M304396200; Sekerkova G, 2014, BRAIN STRUCT FUNCT, V219, P719, DOI 10.1007/s00429-013-0531-9; Shcherbakova OG, 2007, J CELL BIOL, V176, P521, DOI 10.1083/jcb.200604167; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Tadevosyan A, 2010, J BIOL CHEM, V285, P22338, DOI 10.1074/jbc.M110.121749; Vaniotis G, 2013, J MOL CELL CARDIOL, V62, P58, DOI 10.1016/j.yjmcc.2013.05.003; Wenk MR, 2003, NAT BIOTECHNOL, V21, P813, DOI 10.1038/nbt837; Wright CD, 2008, CIRC RES, V103, P992, DOI 10.1161/CIRCRESAHA.108.176024; Wright CD, 2012, CELL SIGNAL, V24, P794, DOI 10.1016/j.cellsig.2011.11.014; Wu SC, 2015, J CARDIOVASC PHARM, V65, P91, DOI 10.1097/FJC.0000000000000165; Wu SC, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000145; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Zaccolo M, 2009, BRIT J PHARMACOL, V158, P50, DOI 10.1111/j.1476-5381.2009.00185.x; Zhang LH, 2013, CELL, V153, P216, DOI 10.1016/j.cell.2013.02.047; Zhou GH, 2011, BIOORG MED CHEM LETT, V21, P5905, DOI 10.1016/j.bmcl.2011.07.122; Ziegelhoffer A, 2001, CARDIOVASC RES, V49, P118, DOI 10.1016/S0008-6363(00)00209-1; Zwart R, 2001, MOL CELL BIOL, V21, P4188, DOI 10.1128/MCB.21.13.4188-4196.2001	52	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8734	8749		10.1074/jbc.RA118.002283	http://dx.doi.org/10.1074/jbc.RA118.002283			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29610273	Green Published, hybrid			2022-12-26	WOS:000434941900002
J	Mygind, KJ; Storiko, T; Freiberg, ML; Samsoe-Petersen, J; Schwarz, J; Andersen, OM; Kveiborg, M				Mygind, Kasper J.; Stoeriko, Theresa; Freiberg, Marie L.; Samsoe-Petersen, Jacob; Schwarz, Jeanette; Andersen, Olav M.; Kveiborg, Marie			Sorting nexin 9 (SNX9) regulates levels of the transmembrane ADAM9 at the cell surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM; sorting nexin (SNX); endocytosis; trafficking; shedding	ALPHA CONVERTING-ENZYME; INDUCED DOWN-REGULATION; METALLOPROTEASE-DISINTEGRIN; PROSTATE-CANCER; BREAST-CANCER; SECRETED FORM; ENDOCYTOSIS; CLATHRIN; RECEPTOR; INTEGRIN	ADAM9 is an active member of the family of transmembrane ADAMs (a disintegrin and metalloproteases). It plays a role in processes such as bone formation and retinal neovascularization, and importantly, its expression in human cancers correlates with disease stage and poor prognosis. Functionally, ADAM9 can cleave several transmembrane proteins, thereby shedding their ectodomains from the cell surface. Moreover, ADAM9 regulates cell behavior by binding cell-surface receptors such as integrin and membrane-type matrix metalloproteases. Because these functions are mainly restricted to the cell surface, understanding the mechanisms regulating ADAM9 localization and activity at this site is highly important. To this end, we here investigated how intracellular trafficking regulates ADAM9 availability at the cell surface. We found that ADAM9 undergoes constitutive clathrin-dependent internalization and subsequent degradation or recycling to the plasma membrane. We confirmed previous findings of an interaction between ADAM9 and the intracellular sorting protein, sorting nexin 9 (SNX9), as well as its close homolog SNX18. Knockdown of either SNX9 or SNX18 had no apparent effects on ADAM9 internalization or recycling. However, double knockdown of SNX9 and SNX18 decreased ADAM9 internalization significantly, demonstrating a redundant role in this process. Moreover, SNX9 knockdown revealed a nonredundant effect on overall ADAM9 protein levels, resulting in increased ADAM9 levels at the cell surface, and a corresponding increase in the shedding of Ephrin receptor B4, a well-known ADAM9 substrate. Together, our findings demonstrate that intracellular SNX9-mediated trafficking constitutes an important ADAM9 regulatory pathway.	[Mygind, Kasper J.; Stoeriko, Theresa; Freiberg, Marie L.; Samsoe-Petersen, Jacob; Schwarz, Jeanette; Kveiborg, Marie] Univ Copenhagen, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark; [Andersen, Olav M.] Aarhus Univ, Danish Res Inst Translat Neurosci DANDRITE Nord E, Dept Biomed, Ole Worms Alle 3, DK-8000 Aarhus C, Denmark; [Mygind, Kasper J.] PSL Res Univ, Inst Curie, CNRS, UMR144, 26 Rue Ulm, F-75005 Paris, France; [Stoeriko, Theresa] Humboldt Univ, Dept Biol, Fac Life Sci, Mol Parasitol, Philippstr 13,Haus 14, D-10115 Berlin, Germany; [Schwarz, Jeanette] Univ Hosp Schleswig Holstein, Inst Clin Chem, Campus Kiel,Arnold Heller Str 3, D-24105 Kiel, Germany; [Schwarz, Jeanette] Univ Hosp Schleswig Holstein, Inst Clin Mol Biol, Campus Kiel,Arnold Heller Str 3, D-24105 Kiel, Germany	University of Copenhagen; Aarhus University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Humboldt University of Berlin; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Kveiborg, M (corresponding author), Univ Copenhagen, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	marie.kveiborg@sund.ku.dk	Kveiborg, Marie/AAM-3019-2020; Andersen, Olav/N-2777-2017	Kveiborg, Marie/0000-0002-1293-1019; Samsoe-Petersen, Jacob/0000-0001-9763-2175; Andersen, Olav/0000-0003-4226-3354; Storiko, Theresa/0000-0001-6253-5738	Danish Cancer Society; Lundbeck Foundation; Kobenhavns Universitets Fond for Kraeftforskning; Faculty of Health and Medical Sciences, University of Copenhagen	Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Kobenhavns Universitets Fond for Kraeftforskning; Faculty of Health and Medical Sciences, University of Copenhagen	The work was supported in part by The Danish Cancer Society, Lundbeck Foundation, and Kobenhavns Universitets Fond for Kraeftforskning. The authors declare that they have no conflicts of interest with the contents of this article. K. J. M. was supported by a Ph.D. fellowship from the Faculty of Health and Medical Sciences, University of Copenhagen.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Amour A, 2002, FEBS LETT, V524, P154, DOI 10.1016/S0014-5793(02)03047-8; Bendris N., 2016, MOL BIOL CELL, DOI [10.1019/mbc.E16-02-0101, DOI 10.1019/MBC.E16-02-0101]; Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; Carl-McGrath S, 2005, INT J ONCOL, V26, P17; Chan KM, 2012, DEV CELL, V22, P1176, DOI 10.1016/j.devcel.2012.04.014; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Doedens JR, 2000, J BIOL CHEM, V275, P14598, DOI 10.1074/jbc.275.19.14598; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dombernowsky SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8518; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Endres K, 2003, EUR J BIOCHEM, V270, P2386, DOI 10.1046/j.1432-1033.2003.03606.x; English WR, 2012, BIOCHEM BIOPH RES CO, V421, P70, DOI 10.1016/j.bbrc.2012.03.113; Fritzsche FR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-179; Fry JL, 2010, CANCER RES, V70, P8187, DOI 10.1158/0008-5472.CAN-09-4231; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Grutzmann R, 2004, BRIT J CANCER, V90, P1053, DOI 10.1038/sj.bjc.6601645; Guaiquil V, 2009, MOL CELL BIOL, V29, P2694, DOI 10.1128/MCB.01460-08; Guo S, 2015, BBA-BIOMEMBRANES, V1848, P2101, DOI 10.1016/j.bbamem.2015.05.024; Haining EJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416503; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; Horazdovsky BF, 1997, MOL BIOL CELL, V8, P1529, DOI 10.1091/mbc.8.8.1529; Hotoda N, 2002, BIOCHEM BIOPH RES CO, V293, P800, DOI 10.1016/S0006-291X(02)00302-9; Howard L, 1999, J BIOL CHEM, V274, P31693, DOI 10.1074/jbc.274.44.31693; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Jeffers M, 1997, MOL CELL BIOL, V17, P799, DOI 10.1128/MCB.17.2.799; Karadag A, 2006, BLOOD, V107, P3271, DOI 10.1182/blood-2005-09-3830; Linford A, 2012, DEV CELL, V22, P952, DOI 10.1016/j.devcel.2012.04.010; Lorenzen I, 2016, SCI REP-UK, V6, DOI 10.1038/srep35067; Lundmark R, 2009, J CELL SCI, V122, P5, DOI 10.1242/jcs.037135; Mao XY, 2011, AM J CANCER RES, V1, P604; Marcello E, 2013, J CLIN INVEST, V123, P2523, DOI 10.1172/JCI65401; Maretzky T, 2017, BIOCHEM J, V474, P1467, DOI 10.1042/BCJ20170075; Matthews AL, 2017, PLATELETS, V28, P333, DOI 10.1080/09537104.2016.1184751; Mazzocca A, 2005, CANCER RES, V65, P4728, DOI 10.1158/0008-5472.CAN-04-4449; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Monoranu CM, 2008, CANCER GENET CYTOGEN, V182, P18, DOI 10.1016/j.cancergencyto.2007.12.008; Nath D, 2000, J CELL SCI, V113, P2319; O'Shea C, 2003, INT J CANCER, V105, P754, DOI 10.1002/ijc.11161; Park J, 2010, J CELL SCI, V123, P1742, DOI 10.1242/jcs.064170; Peduto L, 2005, CANCER RES, V65, P9312, DOI 10.1158/0008-5472.CAN-05-1063; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Shin N, 2007, J BIOL CHEM, V282, P28939, DOI 10.1074/jbc.M700283200; Shintani Y, 2004, CANCER RES, V64, P4190, DOI 10.1158/0008-5472.CAN-03-3235; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Stautz D, 2012, TRAFFIC, V13, P1532, DOI 10.1111/j.1600-0854.2012.01405.x; Sun HS, 2003, BRIT J HAEMATOL, V122, P590, DOI 10.1046/j.1365-2141.2003.04419.x; Tao KS, 2010, JPN J CLIN ONCOL, V40, P645, DOI 10.1093/jjco/hyq030; Tseng HY, 2014, J MOL BIOL, V426, P3180, DOI 10.1016/j.jmb.2014.07.003; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Weskamp G, 1996, J CELL BIOL, V132, P717, DOI 10.1083/jcb.132.4.717; Wong GE, 2001, J BIOL CHEM, V276, P24937, DOI 10.1074/jbc.M101637200; Wu G, 2016, MODERN PATHOL, V29, P359, DOI 10.1038/modpathol.2016.37; Zhou M, 2001, BIOCHEM BIOPH RES CO, V280, P574, DOI 10.1006/bbrc.2000.4155; Zigrino P, 2007, J BIOL CHEM, V282, P30785, DOI 10.1074/jbc.M701658200; Zigrino P, 2011, J BIOL CHEM, V286, P6801, DOI 10.1074/jbc.M110.168617; Zubel A, 2009, GYNECOL ONCOL, V114, P332, DOI 10.1016/j.ygyno.2009.05.005	61	6	6	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8077	8088		10.1074/jbc.RA117.001077	http://dx.doi.org/10.1074/jbc.RA117.001077			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29622675	Green Published, hybrid			2022-12-26	WOS:000433224600014
J	Suarez, J; Cividini, F; Scott, BT; Lehmann, K; Diaz-Juarez, J; Diemer, T; Dai, A; Suarez, JA; Jain, M; Dillmann, WH				Suarez, Jorge; Cividini, Federico; Scott, Brian T.; Lehmann, Kim; Diaz-Juarez, Julieta; Diemer, Tanja; Dai, Anzhi; Suarez, Jorge A.; Jain, Mohit; Dillmann, Wolfgang H.			Restoring mitochondrial calcium uniporter expression in diabetic mouse heart improves mitochondrial calcium handling and cardiac function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondrial metabolism; calcium; diabetes; pyruvate dehydrogenase complex (PDC); metabolomics; cardiomyocyte; mitochondrial calcium handling; mitochondrial calcium uniporter (MCU)	PERMEABILITY TRANSITION PORE; SENSITIVE K+ CHANNELS; SARCOPLASMIC-RETICULUM; REPERFUSION INJURY; O-GLCNACYLATION; ESSENTIAL COMPONENT; RODENT MODELS; GENE-TRANSFER; CA2+ RELEASE; RAT-HEART	Diabetes mellitus is a growing health care problem, resulting in significant cardiovascular morbidity and mortality. Diabetes also increases the risk for heart failure (HF) and decreased cardiac myocyte function, which are linked to changes in cardiac mitochondrial energy metabolism. The free mitochondrial calcium level ([Ca2+](m)) is fundamental in activating the mitochondrial respiratory chain complexes and ATP production and is also known to regulate pyruvate dehydrogenase complex (PDC) activity. The mitochondrial calcium uniporter (MCU) complex (MCUC) plays a major role in mediating mitochondrial Ca2+ import, and its expression and function therefore have a marked impact on cardiac myocyte metabolism and function. Here, we investigated MCU's role in mitochondrial Ca2+ handling, mitochondrial function, glucose oxidation, and cardiac function in the heart of diabetic mice. We found that diabetic mouse hearts exhibit altered expression of MCU and MCUC members and a resulting decrease in [Ca2+](m), mitochondrial Ca2+ uptake, mitochondrial energetic function, and cardiac function. Adeno-associated virus-based normalization of MCU levels in these hearts restored mitochondrial Ca2+ handling, reduced PDC phosphorylation levels, and increased PDC activity. These changes were associated with cardiac metabolic reprogramming toward normal physiological glucose oxidation. This reprogramming likely contributed to the restoration of both cardiac myocyte and heart function to nondiabetic levels without any observed detrimental effects. These findings support the hypothesis that abnormal mitochondrial Ca2+ handling and its negative consequences can be ameliorated in diabetes by restoring MCU levels via adeno-associated virus-based MCU transgene expression.	[Suarez, Jorge; Cividini, Federico; Scott, Brian T.; Diaz-Juarez, Julieta; Diemer, Tanja; Dai, Anzhi; Suarez, Jorge A.; Dillmann, Wolfgang H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Lehmann, Kim; Jain, Mohit] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Lehmann, Kim; Jain, Mohit] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Diaz-Juarez, Julieta] Inst Nacl Cardiol, Dept Pharmacol, Juan Badiano 41, Tlalpan 14080, DF, Mexico	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Dillmann, WH (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	wdillmann@ucsd.edu	Suarez, Jorge/AAS-7873-2021	Suarez, Jorge/0000-0002-2294-6329; Scott, Brian/0000-0002-1321-7204; Cividini, Federico/0000-0001-6312-6514	National Institutes of Health [HL066941]; Department of Veterans Affairs [BX001121]; P. Robert Majumder Charitable Foundation; University of California Institute for Mexico; United States (UC MEXUS)-Consejo Nacional de Ciencia y Tecnologia (CONACYT) [CN 15-1489]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066941] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); P. Robert Majumder Charitable Foundation; University of California Institute for Mexico; United States (UC MEXUS)-Consejo Nacional de Ciencia y Tecnologia (CONACYT); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grant HL066941, Merit Review Award BX001121 from the Department of Veterans Affairs, the P. Robert Majumder Charitable Foundation, University of California Institute for Mexico and the United States (UC MEXUS)-Consejo Nacional de Ciencia y Tecnologia (CONACYT) Grant CN 15-1489 (to W. H. D. and J. D. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allison MB, 2014, J ENDOCRINOL, V223, pT25, DOI 10.1530/JOE-14-0404; Andrienko TN, 2009, J MOL CELL CARDIOL, V46, P1027, DOI 10.1016/j.yjmcc.2009.03.015; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Belke DD, 2007, AM J PHYSIOL-HEART C, V292, pH1755, DOI 10.1152/ajpheart.00884.2006; Belke DD, 2004, DIABETES, V53, P3201, DOI 10.2337/diabetes.53.12.3201; Bernardi P, 2012, CELL CALCIUM, V52, P22, DOI 10.1016/j.ceca.2012.03.004; Beutner G, 2001, J BIOL CHEM, V276, P21482, DOI 10.1074/jbc.M101486200; Bugger H, 2009, DIS MODEL MECH, V2, P454, DOI 10.1242/dmm.001941; Cividini F, 2016, J BIOL CHEM, V291, P26515, DOI 10.1074/jbc.M116.754481; Das A, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0486-5; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Diaz-Juarez J, 2016, AM J PHYSIOL-CELL PH, V311, pC1005, DOI 10.1152/ajpcell.00236.2016; ENTMAN ML, 1977, J MOL CELL CARDIOL, V9, P515, DOI 10.1016/S0022-2828(77)80367-2; Fang HF, 2012, HUM GENE THER METHOD, V23, P234, DOI 10.1089/hgtb.2012.105; Flarsheim CE, 1996, AM J PHYSIOL-HEART C, V271, pH192, DOI 10.1152/ajpheart.1996.271.1.H192; Fricovsky ES, 2012, AM J PHYSIOL-REG I, V303, pR689, DOI 10.1152/ajpregu.00548.2011; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Gottlieb E, 2002, P NATL ACAD SCI USA, V99, P12801, DOI 10.1073/pnas.202477599; Granatiero V, 2017, ADV EXP MED BIOL, V982, P25, DOI 10.1007/978-3-319-55330-6_2; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Griffin TM, 2016, BIOCHIMIE, V124, P74, DOI 10.1016/j.biochi.2015.10.013; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Hu Y, 2005, CIRC RES, V96, P1006, DOI 10.1161/01.RES.0000165478.06813.58; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Ji LL, 2017, DIABETES, V66, P1586, DOI 10.2337/db16-1237; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Liu JC, 2016, CELL REP, V16, P1561, DOI 10.1016/j.celrep.2016.07.011; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Lu XY, 2013, CIRC RES, V112, P424, DOI 10.1161/CIRCRESAHA.111.300501; Luongo TS, 2015, CELL REP, V12, P23, DOI 10.1016/j.celrep.2015.06.017; Makino A, 2011, AM J PHYSIOL-REG I, V300, pR1296, DOI 10.1152/ajpregu.00437.2010; Mor I, 2011, COLD SH Q B, V76, P211, DOI 10.1101/sqb.2011.76.010868; NEELY J R, 1972, Progress in Cardiovascular Diseases, V15, P289, DOI 10.1016/0033-0620(72)90029-1; Ong SB, 2015, J MOL CELL CARDIOL, V78, P23, DOI 10.1016/j.yjmcc.2014.11.005; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Pendin D, 2014, CELL CALCIUM, V55, P139, DOI 10.1016/j.ceca.2014.02.008; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Pulicherla N, 2011, MOL THER, V19, P1070, DOI 10.1038/mt.2011.22; Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157; RANDLE PJ, 1963, LANCET, V1, P785; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RUTTER GA, 1989, BIOCHIM BIOPHYS ACTA, V1014, P263, DOI 10.1016/0167-4889(89)90222-X; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Schilling JD, 2015, ANTIOXID REDOX SIGN, V22, P1515, DOI 10.1089/ars.2015.6294; Sloan RC, 2012, J MOL CELL CARDIOL, V52, P1009, DOI 10.1016/j.yjmcc.2012.02.009; Suarez J, 2004, AM J PHYSIOL-HEART C, V286, pH68, DOI 10.1152/ajpheart.00245.2003; Suarez J, 2013, AM J PHYSIOL-CELL PH, V304, pC248, DOI 10.1152/ajpcell.00039.2012; TANAKA Y, 1992, CARDIOVASC RES, V26, P409, DOI 10.1093/cvr/26.4.409; Tomar D, 2016, CELL REP, V15, P1673, DOI 10.1016/j.celrep.2016.04.050; Trost SU, 2000, ENDOCRINOLOGY, V141, P3057, DOI 10.1210/en.141.9.3057; Trost SU, 2002, DIABETES, V51, P1166, DOI 10.2337/diabetes.51.4.1166; Wahlquist C, 2014, NATURE, V508, P531, DOI 10.1038/nature13073; Wang BX, 2014, CURR DIABETES REV, V10, P131, DOI 10.2174/1573399810666140508121012; WEISS JN, 1989, J GEN PHYSIOL, V94, P911, DOI 10.1085/jgp.94.5.911; WEISS JN, 1987, SCIENCE, V238, P67, DOI 10.1126/science.2443972; Williams GSB, 2013, P NATL ACAD SCI USA, V110, P10479, DOI 10.1073/pnas.1300410110; Yu LP, 2013, DIABETES, V62, P1833, DOI 10.2337/db12-1152; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	61	42	44	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8182	8195		10.1074/jbc.RA118.002066	http://dx.doi.org/10.1074/jbc.RA118.002066			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29626093	hybrid, Green Published			2022-12-26	WOS:000433224600023
J	Perdue, BM; Evans, TA; Beran, MJ				Perdue, Bonnie M.; Evans, Theodore A.; Beran, Michael J.			Chimpanzees show some evidence of selectively acquiring information by using tools, making inferences, and evaluating possible outcomes	PLOS ONE			English	Article							MONKEYS CEBUS-APELLA; MACAQUES MACACA-MULATTA; LION-TAILED MACAQUES; RHESUS-MONKEYS; UNCERTAINTY RESPONSES; ANIMAL-METACOGNITION; MEMORY AWARENESS; PAN-TROGLODYTES; PAPIO-HAMADRYAS; META-COGNITION	Metacognition refers to thinking about one's thinking or knowing what one knows. Research suggests that this ability is not unique to humans and may be shared with nonhuman animals. In particular, great apes have shown behaviors on a variety of tasks that are suggestive of metacognitive ability. Here we combine a metacognitive task, the information-seeking task, with tool use and variable forms of initial information provided to chimpanzees to explore how informational states impact behavioral responses in these apes. Three chimpanzees were presented with an apparatus that contained five locations where food could be hidden. If they pointed to the correct location, they received the reward, but otherwise they did not. We first replicated several existing findings using this method, and then tested novel hypotheses. The chimpanzees were given different types of information across the experiments. Sometimes, they were shown the location of the food reward. Other times, they were shown only one empty location, which was not useful information. The chimpanzees also could use a tool to search any of those locations before making a selection. Chimpanzees typically used the tool to search out the location of the reward when they could not already know where it was, but they did not use the tool when they already had been given that information. One chimpanzee made inferences about the location of hidden food, even when that food was never shown in that location. The final experiment involved hiding foods of differing preference values, and then presenting the chimpanzees with different initial knowledge states (i.e., where the best food was located, where the less-preferred food was located, or where no food was located). All chimpanzees used the tool when they needed to use it to find the best possible item on that trial, but responded by choosing a location immediately when they did not need the tool. This finding highlights that their behavior was not the result of a simple rule following such as pointing to where any food had been seen.	[Perdue, Bonnie M.] Agnes Scott Coll, Dept Psychol, Decatur, GA 30030 USA; [Evans, Theodore A.; Beran, Michael J.] Georgia State Univ, Language Res Ctr, Decatur, GA USA; [Beran, Michael J.] Georgia State Univ, Dept Psychol, Univ Plaza, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Perdue, BM (corresponding author), Agnes Scott Coll, Dept Psychol, Decatur, GA 30030 USA.	bonnie.m.perdue@gmail.com	Beran, Michael J./ABY-1786-2022; Beran, Michael J./M-8743-2016	Beran, Michael J./0000-0002-2504-0338; Beran, Michael J./0000-0002-2504-0338	National Institutes of Health [HD-060563]; National Science Foundation [BCS 1552405]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Institutes of Health (HD-060563) and the National Science Foundation - (BCS 1552405) to B.P. and M. B. - Confidence judgements and metacognition in comparative and developmental perspective.	Adams A, 2011, LEARN BEHAV, V39, P1, DOI 10.1007/s13420-010-0001-7; Basile BM, 2015, J EXP PSYCHOL GEN, V144, P85, DOI 10.1037/xge0000031; Basile BM, 2014, J COMP PSYCHOL, V128, P135, DOI 10.1037/a0034412; Basile BM, 2013, COGNITION, V126, P391, DOI 10.1016/j.cognition.2012.10.012; Basile BM, 2009, ANIM COGN, V12, P169, DOI 10.1007/s10071-008-0180-1; Beran MJ, 2015, COGNITION, V142, P236, DOI 10.1016/j.cognition.2015.05.023; Beran MJ, 2013, PSYCHOL SCI, V24, P660, DOI 10.1177/0956797612458936; Beran MJ, 2011, COGNITION, V120, P90, DOI 10.1016/j.cognition.2011.02.016; Brown EK, 2017, BEHAV PROCESS, V135, P132, DOI 10.1016/j.beproc.2016.12.004; Call J, 2004, J COMP PSYCHOL, V118, P232, DOI 10.1037/0735-7036.118.2.232; Call J., 2001, ANIM COGN, V3, P207, DOI [10.1007/s100710100078, DOI 10.1007/S100710100078]; Call J, 2006, ANIM COGN, V9, P393, DOI 10.1007/s10071-006-0037-4; Call J, 2010, ANIM COGN, V13, P689, DOI 10.1007/s10071-010-0317-x; Call J, 2000, ANIM COGN, V3, P23, DOI 10.1007/s100710050047; Carruthers P, 2008, MIND LANG, V23, P58, DOI 10.1111/j.1468-0017.2007.00329.x; Carruthers P, 2009, BEHAV BRAIN SCI, V32, P121, DOI 10.1017/S0140525X09000545; Castro L, 2013, ANIM COGN, V16, P241, DOI 10.1007/s10071-012-0569-8; Crystal JD, 2014, J COMP PSYCHOL, V128, P152, DOI 10.1037/a0034427; Crystal JD, 2009, COMP COGN BEHAV REV, V4, P54, DOI 10.3819/ccbr.2009.40005; Crystal JD, 2011, CURR ZOOL, V57, P531, DOI 10.1093/czoolo/57.4.531; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Foote AL, 2012, ANIM COGN, V15, P187, DOI 10.1007/s10071-011-0445-y; Fujita K, 2009, ANIM COGN, V12, P575, DOI 10.1007/s10071-009-0217-0; Hampton RR, 2009, COMP COGN BEHAV REV, V4, P17, DOI 10.3819/ccbr.2009.40002; Hampton RR, 2006, BEHAV PROCESS, V72, P184, DOI 10.1016/j.beproc.2006.01.007; Hampton RR, 2004, ANIM COGN, V7, P239, DOI 10.1007/s10071-004-0215-1; Hampton RR, 2001, P NATL ACAD SCI USA, V98, P5359, DOI 10.1073/pnas.071600998; Heimbauer LA, 2012, ANIM COGN, V15, P45, DOI 10.1007/s10071-011-0430-5; Hill A, 2011, J COMP PSYCHOL, V125, P91, DOI 10.1037/a0020867; Iwasaki S, 2013, ANIM COGN, V16, P211, DOI 10.1007/s10071-012-0566-y; Jozefowiez J, 2009, COMP COGN BEHAV REV, V4, P29, DOI 10.3819/ccbr.2009.40003; Kirk CR, 2014, J EXP PSYCHOL-ANIM L, V40, P249, DOI 10.1037/xan0000018; KORIAT A, 1993, PSYCHOL REV, V100, P609, DOI 10.1037/0033-295X.100.4.609; Kornell N, 2007, PSYCHOL SCI, V18, P64, DOI 10.1111/j.1467-9280.2007.01850.x; Kornell N, 2014, J COMP PSYCHOL, V128, P143, DOI 10.1037/a0033444; Kornell N, 2009, CURR DIR PSYCHOL SCI, V18, P11, DOI 10.1111/j.1467-8721.2009.01597.x; Le Pelley ME, 2012, J EXP PSYCHOL LEARN, V38, P686, DOI 10.1037/a0026478; Le Pelley ME, 2014, J COMP PSYCHOL, V128, P132, DOI 10.1037/a0034227; Maille A, 2012, ANIM COGN, V15, P1075, DOI 10.1007/s10071-012-0531-9; Malassis R, 2015, ANIM COGN, V18, P1347, DOI 10.1007/s10071-015-0907-8; Marsh HL, 2015, J COMP PSYCHOL, V129, P256, DOI 10.1037/a0039316; Marsh HL, 2014, ANIM COGN, V17, P1313, DOI 10.1007/s10071-014-0767-7; Marsh HL, 2012, J COMP PSYCHOL, V126, P263, DOI 10.1037/a0025906; Marsh HL, 2012, ANIM COGN, V15, P293, DOI 10.1007/s10071-011-0453-y; Metcalfe J., 1994, METACOGNITION KNOWIN; Morgan G, 2014, ANIM COGN, V17, P249, DOI 10.1007/s10071-013-0657-4; Mulcahy NJ, 2016, J COMP PSYCHOL, V130, P391, DOI 10.1037/com0000046; Mulcahy NJ, 2006, SCIENCE, V312, P1038, DOI 10.1126/science.1125456; Nakao H, 2015, JPN J ANIM PSYCHOL, V65, P45, DOI DOI 10.2502/JANIP.65.1.1; Nelson T.O., 1992, METACOGNITION CORE R; Nelson T.O., 1990, PSYCHOL LEARNING MOT, V26, P125, DOI [10.1016/S0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5, 10.1016/s0079-7421(08)60053-5]; Osvath M, 2008, ANIM COGN, V11, P661, DOI 10.1007/s10071-008-0157-0; Paukner A, 2006, ANIM COGN, V9, P110, DOI 10.1007/s10071-005-0007-2; Paukner A, 2009, J COMP PSYCHOL, V123, P26, DOI 10.1037/a0013128; Perner J, 2012, FDN METACOGNITION; Rosati AG, 2016, PSYCHOL SCI, V27, P1181, DOI 10.1177/0956797616653737; Sabbatini G, 2008, J COMP PSYCHOL, V122, P156, DOI 10.1037/0735-7036.122.2.156; Schmitt V, 2009, J COMP PSYCHOL, V123, P316, DOI 10.1037/a0016218; SCHWARTZ BL, 1994, PSYCHON B REV, V1, P357, DOI 10.3758/BF03213977; Shumaker R. W., 2011, ANIMAL TOOL BEHAV US; Smith JD, 2008, PSYCHON B REV, V15, P679, DOI 10.3758/PBR.15.4.679; Smith JD, 2006, J EXP PSYCHOL GEN, V135, P282, DOI 10.1037/0096-3445.135.2.282; Smith JD, 2013, J EXP PSYCHOL GEN, V142, P458, DOI 10.1037/a0029601; Smith JD, 2012, PHILOS T R SOC B, V367, P1297, DOI 10.1098/rstb.2011.0366; Smith JD, 2010, ANIM COGN, V13, P93, DOI 10.1007/s10071-009-0249-5; Smith JD, 2009, TRENDS COGN SCI, V13, P389, DOI 10.1016/j.tics.2009.06.009; SMITH JD, 1995, J EXP PSYCHOL GEN, V124, P391, DOI 10.1037/0096-3445.124.4.391; Smith JD, J COMP PSYCH, V128, P115, DOI [10.1007/s10071-004-0215-1, DOI 10.1007/S10071-004-0215-1]; Suda-King C, 2008, ANIM COGN, V11, P21, DOI 10.1007/s10071-007-0082-7; Suda-King C, 2013, ANIM COGN, V16, P65, DOI 10.1007/s10071-012-0551-5; Templer VL, 2017, ANIM COGN, V20, P891, DOI 10.1007/s10071-017-1109-3; Templer VL, 2012, ANIM COGN, V15, P409, DOI 10.1007/s10071-011-0468-4; Tu HW, 2015, J COMP PSYCHOL, V129, P347, DOI 10.1037/a0039595; Vining AQ, 2015, ANIM COGN, V18, P667, DOI 10.1007/s10071-015-0835-7; Yuki S, 2017, J EXP PSYCHOL-ANIM L, V43, P109, DOI 10.1037/xan0000130; Zakrzewski AC, 2014, J EXP PSYCHOL-ANIM L, V40, P490, DOI 10.1037/xan0000041	76	7	7	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0193229	10.1371/journal.pone.0193229	http://dx.doi.org/10.1371/journal.pone.0193229			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641519	Green Submitted, Green Published, gold			2022-12-26	WOS:000429742900011
J	Gebhard, C; Gebhard, CE; Stahli, BE; Maafi, F; Bertrand, MJ; Wildi, K; Fortier, A; Onandia, ZG; Toma, A; Zhang, ZW; Smith, DC; Spagnoli, V; Ly, HQ				Gebhard, Catherine; Gebhard, Caroline E.; Stahli, Barbara E.; Maafi, Foued; Bertrand, Marie-Jeanne; Wildi, Karin; Fortier, Annik; Onandia, Zurine Galvan; Toma, Aurel; Zhang, Zheng W.; Smith, David C.; Spagnoli, Vincent; Ly, Hung Q.			Weather and risk of ST-elevation myocardial infarction revisited: Impact on young women	PLOS ONE			English	Article							DAILY HOSPITAL ADMISSIONS; TEMPERATURE; STRESS; MORTALITY	Background During the last decade, the incidence and mortality rates of ST-elevation myocardial infarction (STEMI) has been steadily increasing in young women but not in men. Environmental variables that contribute to cardiovascular events in women remain ill-defined. Methods and results A total of 2199 consecutive patients presenting with acute ST-elevation myocardial infarction (STEMI, 25.8% women, mean age 62.6 +/- 12.4 years) were admitted at the Montreal Heart Institute between June 2010 and December 2014. Snow fall exceeding 2cm/day was identified as a positive predictor for STEMI admission rates in the overall population (RR 1.28, 95% Cl 1.07-1.48, p = 0.005), with a significant effect being seen in men (RR 1.30, 95% Cl 1.06-1.53, p = 0.01) but not in women (p = NS). An age-specific analysis revealed a significant increase in hospital admission rates for STEMI in younger women <= 55 years, (n = 104) during days with higher outside temperature (p = 0.004 vs men <= 55 years) and longer daylight hours (p = 0.0009 vs men <= 55 years). Accordingly, summer season, increased outside temperature and sunshine hours were identified as strong positive predictors for STEMI occurrence in women <= 55 years (RR 1.66, 95% Cl 1.1-2.5, p = 0.012, RR 1.70, 95% Cl 1.2-2.5, p = 0.007, and RR 1.67, 95% Cl 1.2-2.5, p = 0.011, respectively), while an opposite trend was observed in men <= 55 years (RR for outside temperature 0.8, 95% Cl 0.73-0.95, p = 0.01). Conclusion The impact of environmental variables on STEMI is age-and sex-dependent. Higher temperature may play an important role in triggering such acute events in young women.	[Gebhard, Catherine; Gebhard, Caroline E.; Stahli, Barbara E.; Maafi, Foued; Bertrand, Marie-Jeanne; Onandia, Zurine Galvan; Zhang, Zheng W.; Smith, David C.; Spagnoli, Vincent; Ly, Hung Q.] Montreal Heart Inst, Montreal, PQ, Canada; [Gebhard, Catherine] Univ Hosp Zurich, Dept Nucl Med, Zurich, Switzerland; [Gebhard, Catherine; Toma, Aurel] Univ Heart Ctr, Freiburg, Bad Krozingen, Germany; [Gebhard, Caroline E.; Wildi, Karin] Univ Hosp Basel, Dept Anaesthesiol, Basel, Switzerland; [Fortier, Annik] Montreal Hlth Innovat Coordinating Ctr, Montreal, PQ, Canada; [Ly, Hung Q.] Univ Montreal, Dept Med, Montreal, PQ, Canada	Universite de Montreal; University of Zurich; University Zurich Hospital; Universitats Herzzentrum Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Basel; Universite de Montreal; Universite de Montreal	Gebhard, C (corresponding author), Montreal Heart Inst, Montreal, PQ, Canada.; Gebhard, C (corresponding author), Univ Hosp Zurich, Dept Nucl Med, Zurich, Switzerland.; Gebhard, C (corresponding author), Univ Heart Ctr, Freiburg, Bad Krozingen, Germany.	catherine.gebhard@usz.ch	Gebhard, Catherine/AAT-7060-2020; Smith, David/GQQ-8257-2022; Wildi, Karin/AAN-3644-2020	Gebhard, Catherine/0000-0001-7240-5822; Wildi, Karin/0000-0002-6520-2696	Swiss National Science Foundation (SNSF) [P3SMP3_151740, 1142741]; Novartis Foundation for Medical-Biological Research, Switzerland; Gottfried und Julia Bangerter-Rhyner-Foundation, Switzerland	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Novartis Foundation for Medical-Biological Research, Switzerland; Gottfried und Julia Bangerter-Rhyner-Foundation, Switzerland	This work was supported by the Swiss National Science Foundation (SNSF, grants P3SMP3_151740 and 1142741 to BES and CG), the Novartis Foundation for Medical-Biological Research, Switzerland (to BES and CG) and the Gottfried and Julia Bangerter-Rhyner-Foundation, Switzerland (to BES).	Auger N, 2017, CAN MED ASSOC J, V189, pE235, DOI 10.1503/cmaj.161064; Banerjee A, 2009, CIRC-CARDIOVASC GENE, V2, P98, DOI 10.1161/CIRCGENETICS.108.806562; Barnett AG, 2005, J EPIDEMIOL COMMUN H, V59, P551, DOI 10.1136/jech.2004.028514; Dreyer RP, 2016, EUR HEART J-ACUTE CA, V5, P43, DOI 10.1177/2048872615568967; ENQUSELASSIE F, 1993, INT J EPIDEMIOL, V22, P632, DOI 10.1093/ije/22.4.632; Gabet A, 2017, EUR HEART J, V38, P1060, DOI 10.1093/eurheartj/ehx097; Gerber Y, 2006, J AM COLL CARDIOL, V48, P287, DOI 10.1016/j.jacc.2006.02.065; Kloner RA, 2001, AM J CARDIOL, V88, P1021, DOI 10.1016/S0002-9149(01)01981-6; KUNST AE, 1993, AM J EPIDEMIOL, V137, P331, DOI 10.1093/oxfordjournals.aje.a116680; Lee JH, 2010, INT J CARDIOL, V144, P16, DOI 10.1016/j.ijcard.2009.03.122; Morabito M, 2005, INT J CARDIOL, V105, P288, DOI 10.1016/j.ijcard.2004.12.047; Nichols RB, 2012, CLIN RES CARDIOL, V101, P11, DOI 10.1007/s00392-011-0356-6; Osler M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086758; PAN WH, 1995, LANCET, V345, P353, DOI 10.1016/S0140-6736(95)90341-0; Panagiotakos DB, 2004, INT J CARDIOL, V94, P229, DOI 10.1016/j.ijcard.2003.04.050; Phung D, 2016, SCI TOTAL ENVIRON, V550, P1084, DOI 10.1016/j.scitotenv.2016.01.154; Rooks CR, 2016, BRAIN BEHAV IMMUN, V51, P92, DOI 10.1016/j.bbi.2015.08.008; Shah Amit J, 2014, J Am Heart Assoc, V3, pe000741, DOI 10.1161/JAHA.113.000741; Templin C, 2015, NEW ENGL J MED, V373, P929, DOI 10.1056/NEJMoa1406761; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Townsend N, 2016, EUR HEART J, V37, P3232, DOI [10.1093/eurheartj/ehw334, 10.1093/eurheartj/ehy342]; Vaccarino V, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003630; van der Meer MG, 2015, EUR J CLIN INVEST, V45, P226, DOI 10.1111/eci.12399; Women Gebhard C., 2017, EUR HEART J, V38, P1066, DOI [10.1093/eurheartj/ehx109, DOI 10.1093/EURHEARTJ/EHX109]; Xu X, 2015, CIRCULATION, V131, P614, DOI 10.1161/CIRCULATIONAHA.114.012826	25	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195602	10.1371/journal.pone.0195602	http://dx.doi.org/10.1371/journal.pone.0195602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630673	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000429505000063
J	Ramnath, U; Rauch, L; Lambert, EV; Kolbe-Alexander, TL				Ramnath, U.; Rauch, L.; Lambert, E. V.; Kolbe-Alexander, T. L.			The relationship between functional status, physical fitness and cognitive performance in physically active older adults: A pilot study	PLOS ONE			English	Article							MEXICAN-AMERICANS; HANDGRIP STRENGTH; MOBILITY; EXERCISE	Objective Ageing is associated with a progressive decline in physical function and cognitive performance which could result in a shift from an independent to a more dependent lifestyle. The aim of this research study was to assess the fitness, functional performance and cognitive ability in independently living older South Africans and to determine which fitness parameters and functional performance tests best explain the variance in cognitive function. Design Descriptive observational study. Participants Older adults with a mean age 71 +/- 4.7 years (n = 70; 28 men and 42 women) were recruited. Sixty percent of the sample completed at least secondary schooling and more than two-thirds were taking medication for a chronic medical condition. Measurements Self-reported physical activity was assessed using the Yale Physical Activity Survey. Fitness tests included the 6-minute walk test and Bicep Curls. The functional performance tests were; Static and Dynamic balance, Timed Up and Go, Sit to Stand, Grip strength and Functional Reach. The Stroop Task and 6-Item cognitive impairment test were used to measure cognitive performance. Bivariate and multivariate analyses were conducted between performance on the novel cognitive Stroop Task and functional and cognitive tests. Results We found significant relationships between the number of correct responses on the Stroop Task and scores on the 6-Item Cognitive Impairment test (-0.520, p < 0.01) and grip strength (r = 0.42, p< 0.01). The number of incorrect responses was inversely associated with functional reach (r = -0.445, p< 0.01). The final regression model included: age, dynamic balance, right arm grip strength and the score on the 6-item cognitive impairment test, and explained 44% of the variance in performance of the Stroop Task. Conclusions The results of this study showed that measures of physical function were associated with cognitive performance even in highly functioning older South African adults. Further research is needed to determine the extent to which exercise training can improve functional capacity and the effect on cognitive performance.	[Ramnath, U.; Rauch, L.; Lambert, E. V.; Kolbe-Alexander, T. L.] Univ Cape Town, Fac Hlth Sci, Div Exercise Sci & Sports Med, Dept Human Biol, Cape Town, South Africa; [Kolbe-Alexander, T. L.] Univ Southern Queensland, Sch Hlth & Wellbeing, Ipswich, Australia	University of Cape Town; University of Southern Queensland	Ramnath, U (corresponding author), Univ Cape Town, Fac Hlth Sci, Div Exercise Sci & Sports Med, Dept Human Biol, Cape Town, South Africa.	rmnudh001@myuct.ac.ma	Lambert, Estelle/ABF-1268-2020; Rauch, Henri GL/HCI-8272-2022; Kolbe-Alexander, Tracy/C-1333-2014	Lambert, Estelle/0000-0003-4315-9153; Rauch, Henri GL/0000-0002-7709-3407; Ramnath, Udhir/0000-0002-9705-0789; Kolbe-Alexander, Tracy/0000-0002-5025-3204				Al Snih S, 2002, J AM GERIATR SOC, V50, P1250, DOI 10.1046/j.1532-5415.2002.50312.x; Alfaro-Acha A, 2006, J GERONTOL A-BIOL, V61, P859, DOI 10.1093/gerona/61.8.859; Arnett SW, 2008, AGE AGEING, V37, P384, DOI 10.1093/ageing/afn022; Barnes ED, 2003, LONGITUDINAL STUDY C; BRODERICK K, 2002, S AFR J OCCUP THER, V32, P8; Brooke P, 1999, INT J GERIATR PSYCH, V14, P936, DOI 10.1002/(SICI)1099-1166(199911)14:11<936::AID-GPS39>3.3.CO;2-T; Buchman AS, 2009, ARCH INTERN MED, V169, P1139, DOI 10.1001/archinternmed.2009.135; Buchman SA, 2007, PHYS ACTIVITY MOTOR; Bucks RS, 1996, AGE AGEING, V25, P113, DOI 10.1093/ageing/25.2.113; Cigolle CT, 2007, ANN INTERN MED, V147, P156, DOI 10.7326/0003-4819-147-3-200708070-00004; Daley MJ, 2000, SPORTS MED, V29, P1, DOI 10.2165/00007256-200029010-00001; DIPIETRO L, 1993, MED SCI SPORT EXER, V25, P628; DURNIN JVG, 1969, J PHYSIOL-LONDON, V200, pP105; Eggermont HL, 2010, LOWER EXTREMITY FUNC; Ferreira NV, 2015, ASS FUNCTIONAL PERFO; Fleg JL, 2005, CIRCULATION, V112, P674, DOI 10.1161/CIRCULATIONAHA.105.545459; Forstmann BU, 2008, STRIATUM PRESMA FACI; Geal Rauch H, 2005, 7 PHYS SOC SO AFR; Goodpaster BH, 2008, J APPL PHYSIOL, V105, P1498, DOI 10.1152/japplphysiol.90425.2008; Grigsby J, 1998, EXECUTIVE COGNITIVE; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; Hoeymans N, 1996, J CLIN EPIDEMIOL, V49, P1103, DOI 10.1016/0895-4356(96)00210-7; Holtzer R, 2007, RELATIONSHIP SPECIFI; Jones CJ, 2005, PHYS ACTIVITY INSTRU; Kinsell K, 1997, AGEING TRENDS S AFRI; Kolbe-Alexander TL, 2006, J AGING PHYS ACTIV, V14, P98, DOI 10.1123/japa.14.1.98; Kolbe-Alexander TL, 2006, EFFECTIVENESS COMMUN; Konopack JE, 2008, INT J BEHAV MED, V15, P311, DOI 10.1080/10705500802365557; Kramer FA, 2005, FITNESS AGING NEUROC; Kramer FA, 2006, EXERCISE COGNITION A; Lehohla PJ, 2010, STAT S AFRICA MIDYEA; Liu-Ambrose T, 2007, EXECUTIVE FUNCTION I; Liu-Ambrose T, 2008, OTAGO HOME BASED STR; Martins AR, 2010, LA ESCLAVITUD NEGROA, P9; Mayson JD, 2008, LEG STRENGTH VELOCIT; McGough EL, 2011, ASS PHYS PERFORMANCE; Medicine A. C. of S, 2009, ACSMS GUIDELINES EXE, P60; Misic MM, 2009, IMPACT TRAINING MODA; Miyake A, 2000, UNITY DIVERSITY EXEC; de Castro KCM, 2008, ARQ NEURO-PSIQUIAT, V66, P809, DOI 10.1590/S0004-282X2008000600006; Park D C, 2001, Dialogues Clin Neurosci, V3, P151; Peavy GM, 2009, AM J PSYCHIAT, V166, P1384, DOI 10.1176/appi.ajp.2009.09040461; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Renaud P, 1997, INT J PSYCHOPHYSIOL, V27, P87, DOI 10.1016/S0167-8760(97)00049-4; Rikli E., 2001, SENIOR FITNESS TEST; Spieler DH, 1996, J EXP PSYCHOL HUMAN, V22, P461, DOI 10.1037/0096-1523.22.2.461; Taylor WA, 2008, PHYSL EXERCISE HLTH; Voelcker-Rahage C, 2010, PHYS MOTOR FITNESS A; WEINER DK, 1992, J AM GERIATR SOC, V40, P203, DOI 10.1111/j.1532-5415.1992.tb02068.x; Whaley HM, 2006, ACSMS GUIDELINES EXE; Williamson JD, 2009, J GERONTOL A-BIOL, V64, P688, DOI 10.1093/gerona/glp014; Wilmore HJ, 2008, PHYSL SPORT EXERCISE; WINOGRAD CH, 1994, J AM GERIATR SOC, V42, P743, DOI 10.1111/j.1532-5415.1994.tb06535.x; Yaffe K, 2001, PROSPECTIVE STUDY PH	55	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194918	10.1371/journal.pone.0194918	http://dx.doi.org/10.1371/journal.pone.0194918			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630625	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000429505000020
J	Castelucci, BG; Consonni, SR; Rosa, VS; Sensiate, LA; Delatti, PCR; Alvares, LE; Joazeiro, PP				Castelucci, Bianca Gazieri; Consonni, Silvio Roberto; Rosa, Viviane Souza; Sensiate, Lucimara Aparecida; Rugno Delatti, Paula Cristina; Alvares, Lucia Elvira; Joazeiro, Paulo Pinto			Time-dependent regulation of morphological changes and cartilage differentiation markers in the mouse pubic symphysis during pregnancy and postpartum recovery	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; GENE-EXPRESSION; ARTICULAR CHONDROCYTES; REPAIR TISSUE; II COLLAGEN; CELLS; RELAXIN; BONE; MICE; RELAXATION	Animal models commonly serve as a bridge between in vitro experiments and clinical applications; however, few physiological processes in adult animals are sufficient to serve as proof-of-concept models for cartilage regeneration. Intriguingly, some rodents, such as young adult mice, undergo physiological connective tissue modifications to birth canal elements such as the pubic symphysis during pregnancy; therefore, we investigated whether the differential expression of cartilage differentiation markers is associated with cartilaginous tissue morphological modifications during these changes. Our results showed that osteochondral progenitor cells expressing Runx2, Sox9, Col2a1 and Dcx at the non-pregnant pubic symphysis proliferated and differentiated throughout pregnancy, giving rise to a complex osteoligamentous junction that attached the interpubic ligament to the pubic bones until labour occurred. After delivery, the recovery of pubic symphysis cartilaginous tissues was improved by the time-dependent expression of these chondrocytic lineage markers at the osteoligamentous junction. This process potentially recapitulates embryologic chondrocytic differentiation to successfully recover hyaline cartilaginous pads at 10 days postpartum. Therefore, we propose that this physiological phenomenon represents a proof-of-concept model for investigating the mechanisms involved in cartilage restoration in adult animals.	[Castelucci, Bianca Gazieri; Consonni, Silvio Roberto; Rosa, Viviane Souza; Sensiate, Lucimara Aparecida; Rugno Delatti, Paula Cristina; Alvares, Lucia Elvira; Joazeiro, Paulo Pinto] State Univ Campinas UNICAMP, Inst Biol, Dept Biochem & Tissue Biol, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas	Castelucci, BG; Consonni, SR; Joazeiro, PP (corresponding author), State Univ Campinas UNICAMP, Inst Biol, Dept Biochem & Tissue Biol, Campinas, SP, Brazil.	biancastelucci@gmail.com; consonni@unicamp.br; pjoaz@unicamp.br	Consonni, Sílvio Roberto/R-9281-2019; Castelucci, Bianca/V-4055-2019	Castelucci, Bianca/0000-0003-1534-305X; Consonni, Silvio Roberto/0000-0003-3149-021X	FAPESP-Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/25038-8, 2015/23616-2]; CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [302590/2013-7, 140714/2016-2]; FAPESP [2012/25038-8, 2015/23616-2]; CNPq [302590/2013-7, 140714/2016-2]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [08/57906-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [573913/2008-0]	FAPESP-Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPESP-Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, grant no. 2012/25038-8 (http://www.fapesp.br/) to BGC and 2015/23616-2 to PPJ and CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico grant no. 302590/2013-7 (http://www.cnpq.br/) to PPJ and 140714/2016-2 to BGC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul Y, 2012, ENDOCRINOLOGY, V153, P3493, DOI 10.1210/en.2011-1950; An BS, 2003, MOL CELL ENDOCRINOL, V205, P79, DOI 10.1016/S0303-7207(03)00203-X; Becker I, 2010, J ANAT, V217, P475, DOI 10.1111/j.1469-7580.2010.01300.x; Benjamin M, 1998, J ANAT, V193, P481, DOI 10.1046/j.1469-7580.1998.19340481.x; Benjamin M, 2006, J ANAT, V208, P471, DOI 10.1111/j.1469-7580.2006.00540.x; Bernhard JC, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0314-3; Borjesson AE, 2013, CELL MOL LIFE SCI, V70, P4023, DOI 10.1007/s00018-013-1317-1; Carroll SH, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.2; Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]; Consonni SR, 2012, HISTOL HISTOPATHOL, V27, P885, DOI 10.14670/HH-27.885; Consonni SR, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095653; CORWIN JA, 1971, ANAT RECORD, V171, P509, DOI 10.1002/ar.1091710407; CRELIN ES, 1969, T NEW YORK ACAD SCI, V31, P1049, DOI 10.1111/j.2164-0947.1969.tb02024.x; Dyment NA, 2015, DEV BIOL, V405, P96, DOI 10.1016/j.ydbio.2015.06.020; Foldager CB, 2015, CARTILAGE, V6, P123, DOI 10.1177/1947603514560655; Garcia EA, 2008, CELL BIOL INT, V32, P913, DOI 10.1016/j.cellbi.2008.04.006; Gardener WU, 1936, AM J ANAT, V59, P459, DOI 10.1002/aja.1000590307; Ge DX, 2014, INT J MOL SCI, V15, P6941, DOI 10.3390/ijms15046941; HALL K, 1954, J ENDOCRINOL, V11, P210, DOI 10.1677/joe.0.0110210; HALL K, 1956, J ENDOCRINOL, V13, P384, DOI 10.1677/joe.0.0130384; Hashem G, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1978; Joazeiro P. P., 2014, GUIDE INVESTIGATION, P403; Kamat AA, 2004, ENDOCRINOLOGY, V145, P4712, DOI 10.1210/en.2004-0515; Koelling S, 2009, CELL STEM CELL, V4, P324, DOI 10.1016/j.stem.2009.01.015; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Makris EA, 2015, NAT REV RHEUMATOL, V11, P21, DOI 10.1038/nrrheum.2014.157; Maneix L, 2014, J MOL MED, V92, P1179, DOI 10.1007/s00109-014-1195-5; Matsumaru D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016260; Mays S, 2015, ANN HUM BIOL, V42, P332, DOI 10.3109/03014460.2015.1044470; McGonagle D, 2017, NAT REV RHEUMATOL, V13, P719, DOI 10.1038/nrrheum.2017.182; Moraes Suzana Guimaraes, 2003, Brazilian Journal of Morphological Sciences, V20, P85; Moran Conor J, 2016, J Exp Orthop, V3, P1, DOI 10.1186/s40634-015-0037-x; Moro CF, 2012, MOL REPROD DEV, V79, P272, DOI 10.1002/mrd.22020; Ortega HH, 2003, CELLS TISSUES ORGANS, V173, P105, DOI 10.1159/000068947; Pinheiro MC, 2005, CELL BIOL INT, V29, P458, DOI 10.1016/j.cellbi.2004.11.025; Pinheiro MC, 2004, MICRON, V35, P685, DOI 10.1016/j.micron.2004.04.007; Pinheiro MC, 2003, CELL BIOL INT, V27, P647, DOI 10.1016/S1065-6995(03)00121-5; Rosa RG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105170; Rosa RG, 2011, REPROD SCI, V18, P963, DOI 10.1177/1933719111401657; Rosa RG, 2008, MICROSC RES TECHNIQ, V71, P169, DOI 10.1002/jemt.20549; Rosa RG, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.093229; Sensiate LA, 2014, DEV DYNAM, V243, P428, DOI 10.1002/dvdy.23948; Sherwood O. David, 1994, P861; Shintaku Y, 2011, CELLS TISSUES ORGANS, V194, P38, DOI 10.1159/000322557; Solem RC, 2011, DEV BIOL, V356, P28, DOI 10.1016/j.ydbio.2011.05.003; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; STOREY E, 1957, J PATHOL BACTERIOL, V74, P147, DOI 10.1002/path.1700740117; Takahashi I, 1998, J CELL SCI, V111, P2067; Thomopoulos S, 2010, J MUSCULOSKEL NEURON, V10, P35; Timmons B, 2010, TRENDS ENDOCRIN MET, V21, P353, DOI 10.1016/j.tem.2010.01.011; Wang T, 2017, J CELL PHYSIOL, V232, P913, DOI 10.1002/jcp.25641; Wang W, 2009, OSTEOARTHR CARTILAGE, V17, P646, DOI 10.1016/j.joca.2008.09.015; Yang J, 2015, INT J ORAL SCI, V7, P73, DOI 10.1038/ijos.2015.14; Yao LJ, 2008, ENDOCRINOLOGY, V149, P2072, DOI 10.1210/en.2007-1176; Yoon BS, 2004, J CELL BIOCHEM, V93, P93, DOI 10.1002/jcb.20211; Yu XD, 2017, J ORTHOP RES, V35, P1671, DOI 10.1002/jor.23463; Zhang QY, 2011, GENESIS, V49, P75, DOI 10.1002/dvg.20702; Zhang Y, 2007, BIOCHEM BIOPH RES CO, V363, P694, DOI 10.1016/j.bbrc.2007.09.030; Zhao L, 2000, BIOL REPROD, V63, P697, DOI 10.1095/biolreprod63.3.697; Zhao L, 1999, ENDOCRINOLOGY, V140, P445, DOI 10.1210/en.140.1.445; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103	61	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195304	10.1371/journal.pone.0195304	http://dx.doi.org/10.1371/journal.pone.0195304			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621303	Green Submitted, Green Published, gold			2022-12-26	WOS:000429206800057
J	Hector, J; Davies, MA; Dekker-Boersema, J; Aly, MM; Abdalad, CCA; Langa, EBR; Ehmer, J; Hobbins, MA; Jefferys, LF				Hector, Jonas; Davies, Mary-Ann; Dekker-Boersema, Johanna; Aly, Mussa Manuel; Abdalad, Cassimo Charifo A.; Langa, Ernesto Belario Rafael; Ehmer, Jochen; Hobbins, Michael Andre; Jefferys, Laura Frances			Acceptability and performance of a directly assisted oral HIV self-testing intervention in adolescents in rural Mozambique	PLOS ONE			English	Article							LINKAGE; AFRICA	Introduction Whereas progress in HIV testing and treatment has been made globally, the UNAIDS goal of "90 90 90" is still out of sight in rural northern Mozambique. New strategies that promote testing in hard to reach groups will aid Mozambique's response to the HIV epidemic. HIV self-testing (HIVST) is recommended by the WHO as an additional approach to augment the HIV testing services available to adolescents. This study evaluates acceptability and performance of a directly assisted oral HIVST intervention for adolescents in rural Mozambique. Methods Adolescents aged 16-20 years were included at schools and invited to attend the local hospital's youth friendly service for directly assisted oral HIVST. Baseline and post-test questionnaires were obtained. OraQuick Rapid HIV-1/2 Anti body test (R) was used. Results were read by the participant and by a nurse. Results were confirmed by finger prick HIV test (Determine (R) HIV 1/2 Alere and Unigold (TM) HIV Trinity Biotech) according to the Mozambican national standard. Results Between September and November 2016, 496 adolescents were included, of which 299 performed an oral HIV self-test. 70% were first time testers. The positivity rate was 1.7%. The inter-rater agreement between adolescent and nurse was 99.6% (kappa 0.93); there were no false negative or false positive results of the oral HIV self-test. Five tests were invalid. 7.1% found the test difficult to use. Over 80% preferred directly assisted HIVST compared to the standard finger prick testing. While 20% thought it would be good to do HIVST at home, 76% preferred to do HIVST at the health centre, for reasons including increased security, privacy, and the presence of a counsellor. Conclusions Directly assisted oral HIVST is a feasible intervention for adolescents in rural Mozambique and showed encouraging results for first time HIV testers.	[Hector, Jonas; Dekker-Boersema, Johanna; Jefferys, Laura Frances] SolidarMed, Pemba, Mozambique; [Davies, Mary-Ann] Univ Cape Town, Sch Publ Hlth & Family Med, Cape Town, South Africa; [Aly, Mussa Manuel] Operat Res Unit Pemba, Pemba, Cabo Delgado, Mozambique; [Abdalad, Cassimo Charifo A.] Dist Hlth Directorate, Ancuabe, Cabo Delgado, Mozambique; [Langa, Ernesto Belario Rafael] Prov Hlth Directorate, Cabo Delgado, Pemba, Mozambique; [Ehmer, Jochen; Hobbins, Michael Andre] SolidarMed, Luzern, Switzerland	University of Cape Town	Hector, J (corresponding author), SolidarMed, Pemba, Mozambique.	j.hector@solidarmed.ch						Agha S, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-20; Asaolu IO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164052; Baltazar CS, 2014, J CLIN MICROBIOL, V52, P3544, DOI 10.1128/JCM.01098-14; Bandason T, 2013, AIDS CARE, V25, P1520, DOI 10.1080/09540121.2013.780120; Beksinska ME, 2012, SEX HEALTH, V9, P51, DOI 10.1071/SH11011; Cambiano V, 2015, J INFECT DIS, V212, P570, DOI 10.1093/infdis/jiv040; Choko AT, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001873; Clark S, 2004, STUD FAMILY PLANN, V35, P149, DOI 10.1111/j.1728-4465.2004.00019.x; Dittus PJ, 2014, J ADOLESCENT HEALTH, V55, P528, DOI 10.1016/j.jadohealth.2014.04.005; Govindasamy D, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20182; Hiltabiddle S J, 1996, J Obstet Gynecol Neonatal Nurs, V25, P61, DOI 10.1111/j.1552-6909.1996.tb02514.x; Institute Nacional de SaUde e Institute Nacional de Estatistica. Inquerito de Indicadores de lmunizacao Malaria e HIV/SIDA em Mocambique (IMASIDA, 2015, INQ IND IM MAL HIV S; Instituto Nacional de Estatistica, 2013, EST DISTR ANC; Kelvin EA, 2016, AJAR-AFR J AIDS RES, V15, P99, DOI 10.2989/16085906.2016.1189442; Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735; Kurth AE, 2016, AIDS BEHAV, V20, P870, DOI 10.1007/s10461-015-1213-9; Madiba S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1746-x; Marlin RW, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1226; Minesterio de Saude e Institute Nacional de Estatistica, 2016, INQ IND IM MAL HIV S; Ministerio da Saude, TRAT ANT INF OP AD A; Mugo PM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170868; Naik R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-824; Ng OT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045168; Njau B, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0230-8; Njau B, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-838; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Peck RB, 2014, AIDS BEHAV, V18, pS422, DOI 10.1007/s10461-014-0818-8; Sarkar A, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20993; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Sisay Solomon, 2014, BMC Res Notes, V7, P518, DOI 10.1186/1756-0500-7-518; Tarkang EE, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.259.2772; UNAIDS, 90 90 90 AMB TREATM; UNAIDS, END AIDS EP AD AD; UNAIDS, HIV AIDS EST; Unicef, CHILD MARR AD PREGN; Wagenaar BH, 2014, TROP MED INT HEALTH, V19, P791, DOI 10.1111/tmi.12314; Wong HTH, 2015, AIDS BEHAV, V19, P505, DOI 10.1007/s10461-014-0881-1; World Health Organisation, HIV AD GUID HIV TEST; World Health Organisation, CONS GUID HIV TEST S; World Health Organziation, GUID HIV SELF TEST P	40	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195391	10.1371/journal.pone.0195391	http://dx.doi.org/10.1371/journal.pone.0195391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621308	Green Published, gold, Green Submitted			2022-12-26	WOS:000429206800074
J	Conley, D; Johnson, R; Domingue, B; Dawes, C; Boardman, J; Siegal, M				Conley, Dalton; Johnson, Rebecca; Domingue, Ben; Dawes, Christopher; Boardman, Jason; Siegal, Mark			A sibling method for identifying vQTLs	PLOS ONE			English	Article							FTO GENE; NICHE-CONSTRUCTION; PHENOTYPIC VARIABILITY; EXPRESSION VARIABILITY; HSP90; ROBUSTNESS; VARIANCE; TWIN; IDENTIFICATION; HERITABILITY	The propensity of a trait to vary within a population may have evolutionary, ecological, or clinical significance. In the present study we deploy sibling models to offer a novel and unbiased way to ascertain loci associated with the extent to which phenotypes vary (variance controlling quantitative trait loci, or vQTLs). Previous methods for vQTL-mapping either exclude genetically related individuals or treat genetic relatedness among individuals as a complicating factor addressed by adjusting estimates for non-independence in phenotypes. The present method uses genetic relatedness as a tool to obtain unbiased estimates of variance effects rather than as a nuisance. The family-based approach, which utilizes random variation between siblings in minor allele counts at a locus, also allows controls for parental genotype, mean effects, and non-linear (dominance) effects that may spuriously appear to generate variation. Simulations show that the approach performs equally well as two existing methods (squared Z-score and DGLM) in controlling type I error rates when there is no unobserved confounding, and performs significantly better than these methods in the presence of small degrees of confounding. Using height and BMI as empirical applications, we investigate SNPs that alter within-family variation in height and BMI, as well as pathways that appear to be enriched. One significant SNP for BMI variability, in the MAST4 gene, replicated. Pathway analysis revealed one gene set, encoding members of several signaling pathways related to gap junction function, which appears significantly enriched for associations with within-family height variation in both datasets (while not enriched in analysis of mean levels). We recommend approximating laboratory random assignment of genotype using family data and more careful attention to the possible conflation of mean and variance effects.	[Conley, Dalton; Johnson, Rebecca] Princeton Univ, Dept Sociol, Princeton, NJ 08544 USA; [Domingue, Ben] Stanford Univ, Grad Sch Educ, Stanford, CA 94305 USA; [Dawes, Christopher] NYU, Wilff Family Dept Polit, New York, NY USA; [Boardman, Jason] Univ Colorado, Inst Behav Sci, Boulder, CO 80309 USA; [Siegal, Mark] NYU, Ctr Genom & Syst Biol, New York, NY USA	Princeton University; Stanford University; New York University; University of Colorado System; University of Colorado Boulder; New York University	Conley, D (corresponding author), Princeton Univ, Dept Sociol, Princeton, NJ 08544 USA.	dconley@princeton.edu		Johnson, Rebecca/0000-0003-2475-6622; Siegal, Mark/0000-0001-6930-2988	National Institutes of Health [R35GM118170]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R35GM118170 (MS). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003607; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; [Anonymous], 2012, NATURE, V490; Ansel J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000049; Aschard H, 2013, GENET EPIDEMIOL, V37, P323, DOI 10.1002/gepi.21716; Ayroles JF, 2015, P NATL ACAD SCI USA, V112, P6706, DOI 10.1073/pnas.1503830112; Bauer CR, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145264; Berger D, 2011, EVOLUTION, V65, P2830, DOI 10.1111/j.1558-5646.2011.01392.x; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; Cameron AC, 2015, J HUM RESOUR, V50, P317, DOI 10.3368/jhr.50.2.317; Cao Y, 2015, ANN HUM GENET, V79, P46, DOI 10.1111/ahg.12089; Cao Y, 2014, GENET EPIDEMIOL, V38, P51, DOI 10.1002/gepi.21778; Caplin A, GENES ADDICTION EC; Cha SW, 2008, OBESITY, V16, P2185, DOI 10.1038/oby.2008.314; Champely S., 2009, PWR BASIC FUNCTIONS; Chang YC, 2008, DIABETES, V57, P2245, DOI 10.2337/db08-0377; Chen B, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-25; Conley D, 2013, BEHAV GENET, V43, P415, DOI 10.1007/s10519-013-9602-1; Day RL, 2003, PERSPECT BIOL MED, V46, P80, DOI 10.1353/pbm.2003.0003; Dieleman JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110257; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dongen SV, 2006, J EVOLUTION BIOL, V19, P1727, DOI 10.1111/j.1420-9101.2006.01175.x; Dumitrascu B, 2015, ARXIV151201616QBIOST; Fehrmann S, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.53; Fraser HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008635; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Geiler-Samerotte KA, 2013, CURR OPIN BIOTECH, V24, P752, DOI 10.1016/j.copbio.2013.03.010; Geiler-Samerotte KA, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000465; Gelman A., 2007, DATA ANAL USING REGR, V1; Gibson G, 2009, NATURE REV GENETICS, V10; Gibson G, 2004, NATURE REV GENETICS, V5; Gibson G, 2008, CURR BIOL, V18, pR989, DOI 10.1016/j.cub.2008.08.011; Hall MC, 2007, P NATL ACAD SCI USA, V104, P13717, DOI 10.1073/pnas.0701936104; Hamer D, 2000, MOL PSYCHIATR, V5, P11, DOI 10.1038/sj.mp.4000662; Haworth CMA, 2008, OBESITY, V16, P2663, DOI 10.1038/oby.2008.434; Hong C, 2017, BIOMETRICS, V73, P571, DOI 10.1111/biom.12612; Hsieh YY, 2013, MOL CELL, V50, P82, DOI 10.1016/j.molcel.2013.01.026; Hulse AM, 2013, GENETICS, V193, P95, DOI 10.1534/genetics.112.146779; Hunt SC, 2008, OBESITY, V16, P902, DOI 10.1038/oby.2007.126; Iacono WG, 2002, TWIN RES, V5, P482, DOI 10.1375/twin.5.5.482; Imbens GW, 2016, REV ECON STAT, V98, P701, DOI 10.1162/REST_a_00552; Janhunen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038766; Jarosz DF, 2010, SCIENCE, V330, P1820, DOI 10.1126/science.1195487; Jimenez-Gomez JM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002295; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Laland KN, 2006, EVOL ANTHROPOL, V15, P95, DOI 10.1002/evan.20093; Laland KN, 1999, P NATL ACAD SCI USA, V96, P10242, DOI 10.1073/pnas.96.18.10242; Lamparter D, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004714; Levy SF, 2012, ADV EXP MED BIOL, V751, P431, DOI 10.1007/978-1-4614-3567-9_20; Levy SF, 2008, PLOS BIOL, V6, P2588, DOI 10.1371/journal.pbio.0060264; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Masel J, 2009, TRENDS GENET, V25, P395, DOI 10.1016/j.tig.2009.07.005; Miller MB, 2012, TWIN RES HUM GENET, V15, P767, DOI 10.1017/thg.2012.62; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; OdlingSmee FJ, 1996, AM NAT, V147, P641, DOI 10.1086/285870; Pare G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000981; Perry GML, 2012, GENETICS, V191, P1003, DOI 10.1534/genetics.112.138909; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Richardson JB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003733; Ronnegard L, 2011, GENETICS, V188, P435, DOI 10.1534/genetics.111.127068; Ronnegard L, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-63; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sangster TA, 2008, P NATL ACAD SCI USA, V105, P2963, DOI 10.1073/pnas.0712200105; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Sgro CM, 2010, P ROY SOC B-BIOL SCI, V277, P2049, DOI 10.1098/rspb.2010.0008; Shen X, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002839; Siegal ML, 2014, ANNU REV ECOL EVOL S, V45, P495, DOI 10.1146/annurev-ecolsys-120213-091705; Siegal ML, 2013, MOL ECOL, V22, P1187, DOI 10.1111/mec.12195; Siegal ML, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-14; Soave D, 2015, AM J HUM GENET, V97, P125, DOI 10.1016/j.ajhg.2015.05.015; Stinchcombe JR, 2005, AM J BOT, V92, P1701, DOI 10.3732/ajb.92.10.1701; Struchalin MV, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-92; Sun XQ, 2013, AM J HUM GENET, V93, P390, DOI 10.1016/j.ajhg.2013.06.017; Takahashi KH, 2012, EVOLUTION, V66, P2878, DOI 10.1111/j.1558-5646.2012.01636.x; Takahashi KH, 2011, J HERED, V102, P448, DOI 10.1093/jhered/esr026; Tonjes A, 2009, EUROPEAN J HUMAN GEN, V18; Tonsor SJ, 2013, EVOLUTION, V67, P2923, DOI 10.1111/evo.12175; Wagner A, 2008, P ROY SOC B-BIOL SCI, V275, P91, DOI 10.1098/rspb.2007.1137; Wang G, 2014, GENETICS, V196, P413, DOI 10.1534/genetics.113.157503; Wei WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep25014; Yeyati PL, 2007, PLOS GENET, V3, P431, DOI 10.1371/journal.pgen.0030043; Zhang KL, 2010, NUCLEIC ACIDS RES, V38, pW90, DOI 10.1093/nar/gkq324	84	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194541	10.1371/journal.pone.0194541	http://dx.doi.org/10.1371/journal.pone.0194541			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617452	Green Published, gold			2022-12-26	WOS:000429203800036
J	Murdaugh, LB; Mendoza-Romero, HN; Fish, EW; Parnell, SE				Murdaugh, Laura B.; Mendoza-Romero, Haley N.; Fish, Eric W.; Parnell, Scott E.			A novel method for determining sex in late term gestational mice based on the external genitalia	PLOS ONE			English	Article							MOUSE EMBRYOS; EXPOSURE	In many experiments using fetal mice, it is necessary to determine the sex of the individual fetus. However, other than genotyping for sex-specific genes, there is no convenient, reliable method of sexing mice between gestational day (GD) 16.5 and GD 18.0. We designed a rapid, relatively simple visual method to determine the sex of mouse fetuses in the GD 16.5-GD 18.0 range that can be performed as part of a routine morphological assessment. By examining the genitalia for the presence or absence of key features, raters with minimal experience with the method were able to correctly identify the sex of embryos with 99% accuracy, while raters with no experience were 95% accurate. The critical genital features include: the presence or absence of urethral seam or proximal urethral meatus; the shape of the genitalia, and the presence or absence of an area related to the urethral plate. By comparing these morphological features of the external genitalia, we show a simple, accurate, and fast way to determine the sex of late stage mouse fetuses. Integrating this method into regular morphological assessments will facilitate the determination of sex differences in fetuses between GD 16.5 and GD 18.0.	[Murdaugh, Laura B.; Mendoza-Romero, Haley N.; Fish, Eric W.; Parnell, Scott E.] Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA; [Parnell, Scott E.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Parnell, Scott E.] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Parnell, SE (corresponding author), Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA.; Parnell, SE (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.; Parnell, SE (corresponding author), Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA.	sparnell@med.unc.edu		Murdaugh, Laura/0000-0002-3282-3576; Mendoza-Romero, Haley/0000-0001-7290-9246	National Institute on Alcohol Abuse and Alcoholism (NIAAA); NIAAA [U01-M021651, P60-M011605]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA021651] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	All or part of this work was done in conjunction with the Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), which is funded by grants from the National Institute on Alcohol Abuse and Alcoholism (NIAAA). Additional information about CIFASD can be found at www.cifasd.org. Support was provided by grant nos. U01-M021651 and P60-M011605 from the NIAAA to SEP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Deeney S, 2016, LAB ANIMAL, V45, P380, DOI 10.1038/laban.1105; Dipietro JA, 2017, NEUROSCIENCE, V342, P4, DOI 10.1016/j.neuroscience.2015.07.068; Fish EW, 2016, BEHAV BRAIN RES, V311, P70, DOI 10.1016/j.bbr.2016.05.004; Georgas KM, 2015, DEVELOPMENT, V142, P1893, DOI 10.1242/dev.117903; GOTO T, 1985, TERATOLOGY, V31, P425, DOI 10.1002/tera.1420310313; GREENHAM L W, 1977, Laboratory Animals (London), V11, P181, DOI 10.1258/002367777780936620; Hubbard AC, 2013, COMPARATIVE MED, V63, P127; McClive PJ, 2001, MOL REPROD DEV, V60, P225, DOI 10.1002/mrd.1081; Murphy SK, 2012, GENE, V494, P36, DOI 10.1016/j.gene.2011.11.062; Prakash R, 2008, SINGAP MED J, V49, P47; Song J, 2015, BIOTECH HISTOCHEM, V90, P309, DOI 10.3109/10520295.2015.1004557; Suzuki H, 2015, DEV GROWTH DIFFER, V57, P639, DOI 10.1111/dgd.12247; Suzuki K, 2002, EVOL DEV, V4, P133, DOI 10.1046/j.1525-142X.2002.01061.x; Wolterink-Donselaar IG, 2009, LAB ANIMAL, V38, P35, DOI 10.1038/laban0109-35	15	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194767	10.1371/journal.pone.0194767	http://dx.doi.org/10.1371/journal.pone.0194767			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617407	Green Published, gold, Green Submitted			2022-12-26	WOS:000429203800048
J	Szabo, R; Bugge, TH				Szabo, Roman; Bugge, Thomas H.			Loss of HAI-2 in mice with decreased prostasin activity leads to an early-onset intestinal failure resembling congenital tufting enteropathy	PLOS ONE			English	Article							AUTOSOMAL RECESSIVE ICHTHYOSIS; FACTOR ACTIVATOR INHIBITOR-1; SERINE-PROTEASE CAP1/PRSS8; EPIDERMAL BARRIER FUNCTION; EPITHELIAL DEVELOPMENT; HYPOTRICHOSIS SYNDROME; MATRIPTASE-ACTIVATION; PLACENTAL DEVELOPMENT; PROTEOLYTIC CASCADE; EPCAM	Prostasin (CAP1/PRSS8) is a glycosylphosphatidylinositol (GPI)-anchored serine protease that is essential for epithelial development and overall survival in mice. Prostasin is regulated primarily by the transmembrane serine protease inhibitor, hepatocyte growth factor activator inhibitor (HAI)-2, and loss of HAI-2 function leads to early embryonic lethality in mice due to an unregulated prostasin activity. We have recently reported that critical in vivo functions of prostasin can be performed by proteolytically-inactive or zymogen-locked variants of the protease. Here we show that the zymogen form of prostasin does not bind to HAI-2 and, as a result, loss of HAI-2 does not affect prenatal development and survival of mice expressing only zymogen-locked variant of prostasin (Prss8 R44Q). Indeed, HAI-2-deficient mice homozygous for R44Q mutation (Spint2(-/-) prss8(R44Q/R44Q)) are born in the expected numbers and do not exhibit any obvious developmental abnormality at birth. However, postnatal growth in these mice is severely impaired and they all die within 4 to 7 days after birth due to a critical failure in the development of small and large intestines, characterized by a widespread villous atrophy, tufted villi, near-complete loss of mucin-producing goblet cells, loss of colonic crypt structure, and bleeding into the intestinal lumen. Intestines of Spint2(-/-);Prss8(R44Q/R44Q) mice showed altered expression of epithelial junctional proteins, including reduced levels of EpCAM, E-cadherin, occludin, claudin-1 and -7, as well as an increased level of claudin-4, indicating that the loss of HAI-2 compromises intestinal epithelial barrier function. Our data indicate that the loss of HAI-2 in Prss8(R44Q/R44Q) mice leads to development of progressive intestinal failure that at both histological and molecular level bears a striking resemblance to human congenital tufting enteropathy, and may provide important clues for understanding and treating this debilitating human disease.	[Szabo, Roman; Bugge, Thomas H.] Natl Inst Dent & Craniofacial Res, Proteases & Tissue Remodeling Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Szabo, R (corresponding author), Natl Inst Dent & Craniofacial Res, Proteases & Tissue Remodeling Sect, NIH, Bethesda, MD 20892 USA.	rszabo@nidcr.nih.gov; tbugge@mail.nih.gov			National Institute of Dental and Craniofacial Research Intramural Research Program; NIDCR Gene Targeting and Veterinary Resources Cores; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR Gene Targeting and Veterinary Resources Cores; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by National Institute of Dental and Craniofacial Research Intramural Research Program to TB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Mary Jo Danton for critically reviewing this manuscript. This research was supported by the NIDCR Gene Targeting and Veterinary Resources Cores.	Alef T, 2009, J INVEST DERMATOL, V129, P862, DOI 10.1038/jid.2008.311; Avrahami L, 2008, CLIN GENET, V74, P47, DOI 10.1111/j.1399-0004.2008.01006.x; Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Bauer A, 2017, G3-GENES GENOM GENET, V7, P1315, DOI 10.1534/g3.117.039511; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Chen LM, 2004, PROSTATE, V59, P1, DOI 10.1002/pros.10346; Choi WS, 2017, EXP CELL RES, V358, P71, DOI 10.1016/j.yexcr.2017.03.036; Coombs GS, 1998, CHEM BIOL, V5, P475, DOI 10.1016/S1074-5521(98)90004-7; DAVIDSON GP, 1978, GASTROENTEROLOGY, V75, P783; FALCONER DS, 1952, J HERED, V43, P53, DOI 10.1093/oxfordjournals.jhered.a106262; Fan B, 2007, DEV BIOL, V303, P222, DOI 10.1016/j.ydbio.2006.11.005; Frateschi S, 2012, AM J PATHOL, V181, P605, DOI 10.1016/j.ajpath.2012.05.007; Friis S, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0384-4; Friis S, 2016, J BIOL CHEM, V291, P2577, DOI 10.1074/jbc.C115.706721; Friis S, 2014, J BIOL CHEM, V289, P22319, DOI 10.1074/jbc.M114.574400; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Hummler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055796; Keppner A, 2016, INFLAMM BOWEL DIS, V22, P2824, DOI 10.1097/MIB.0000000000000940; Kozan PA, 2015, J MOL MED, V93, P535, DOI 10.1007/s00109-014-1239-x; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; List K, 2007, J BIOL CHEM, V282, P36714, DOI 10.1074/jbc.M705521200; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Maghzal N, 2013, DEV CELL, V27, P263, DOI 10.1016/j.devcel.2013.10.003; Malsure S, 2014, J AM SOC NEPHROL, V25, P1453, DOI 10.1681/ASN.2013090936; Mehta S, 2015, CELL TISSUE RES, V360, P749, DOI 10.1007/s00441-014-1994-6; Miller GS, 2013, CELL TISSUE RES, V351, P245, DOI 10.1007/s00441-012-1348-1; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Nagaike K, 2008, AM J PATHOL, V173, P1464, DOI 10.2353/ajpath.2008.071142; Neri I, 2016, J DERMATOL SCI, V81, P63, DOI 10.1016/j.jdermsci.2015.10.012; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Oshima T, 2016, J GASTROENTEROL, V51, P768, DOI 10.1007/s00535-016-1207-z; Peters DE, 2014, J BIOL CHEM, V289, P14740, DOI 10.1074/jbc.M113.541318; Planes C, 2010, EMBO MOL MED, V2, P26, DOI 10.1002/emmm.200900050; Salomon J, 2014, HUM GENET, V133, P299, DOI 10.1007/s00439-013-1380-6; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2016, DEVELOPMENT, V143, P2818, DOI 10.1242/dev.137968; Szabo R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004470; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Tanaka H, 2005, MOL CELL BIOL, V25, P5687, DOI 10.1128/MCB.25.13.5687-5698.2005; Wakida N, 2006, KIDNEY INT, V70, P1432, DOI 10.1038/sj.ki.5001787; Wu CJ, 2017, J CLIN INVEST, V127, P623, DOI 10.1172/JCI88428	47	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194660	10.1371/journal.pone.0194660	http://dx.doi.org/10.1371/journal.pone.0194660			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617460	Green Submitted, Green Published, gold			2022-12-26	WOS:000429203800042
J	Yamazaki, T; Joshita, S; Umemura, T; Usami, Y; Sugiura, A; Fujimori, N; Kimura, T; Matsumoto, A; Igarashi, K; Ota, M; Tanaka, E				Yamazaki, Tomoo; Joshita, Satoru; Umemura, Takeji; Usami, Yoko; Sugiura, Ayumi; Fujimori, Naoyuki; Kimura, Takefumi; Matsumoto, Akihiro; Igarashi, Koji; Ota, Masao; Tanaka, Eiji			Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C	PLOS ONE			English	Article							PLASMA LYSOPHOSPHATIDIC ACID; SIMPLE NONINVASIVE INDEX; LIVER FIBROSIS; HEPATOCELLULAR-CARCINOMA; CIRRHOSIS; DACLATASVIR; ASUNAPREVIR; REGRESSION; MARKERS; PREDICT	Sustained virological response (SVR) rates have increased remarkably since the introduction of direct-acting antiviral agents (DAAs) for chronic hepatitis C. Autotaxin (ATX) is a secreted enzyme converting lysophosphatidylcholine to lysophosphatidic acid and a newly established biomarker for liver fibrosis. Interferon-free DAA regimens for chronic hepatitis C could improve liver stiffness in SVR patients according to several non-invasive evaluation methods, but the clinical response and significance of ATX in this context have not yet been defined. We therefore investigated sequential serum ATX levels at baseline, 4 weeks after the start of treatment, and 24 weeks after treatment in 159 hepatitis C virus (HCV)-infected patients who received DAA therapy. Other non-invasive fibrosis markers (aspartate aminotransferase-to-platelet ratio and FIB-4 index) were examined as well. Baseline median ATX levels were comparable between the 144 patients who achieved a SVR and the 15 who did not (1.54 vs. 1.62 mg/L), but median ATX levels became significantly decreased during and after DAA therapy in the SVR group only (from 1.54 to 1.40 and 1.31 mg/L, respectively; P < 0.001). ATX was significantly decreased between baseline and 4 weeks of treatment in overall, male, and female SVR patients (all P < 0.001). In subjects with low necro-inflammatory activity in the liver (i.e., alanine aminotransferase < 30 U/L), ATX levels were significantly reduced from baseline to 4 weeks of treatment and remained low (P < 0.001) in patients with a SVR. Thus, interferon-free DAA therapy was associated with a significant decrease in serum ATX levels in patients achieving a SVR, suggesting early regression of liver fibrosis in addition to inflammation treatment.	[Yamazaki, Tomoo; Joshita, Satoru; Umemura, Takeji; Sugiura, Ayumi; Fujimori, Naoyuki; Kimura, Takefumi; Matsumoto, Akihiro; Ota, Masao; Tanaka, Eiji] Shinshu Univ, Sch Med, Div Hepatol & Gastroenterol, Dept Med, Matsumoto, Nagano, Japan; [Joshita, Satoru; Umemura, Takeji] Shinshu Univ, Res Ctr Next Generat Med, Matsumoto, Nagano, Japan; [Usami, Yoko] Shinshu Univ Hosp, Dept Lab Med, Matsumoto, Nagano, Japan; [Igarashi, Koji] TOSOH Corp, Biosci Div, Ayase, Kanagawa, Japan	Shinshu University; Shinshu University; Shinshu University; Tosoh Corporation	Umemura, T (corresponding author), Shinshu Univ, Res Ctr Next Generat Med, Matsumoto, Nagano, Japan.	tumemura@shinshu-u.ac.jp	Igarashi, Koji/AAC-5332-2020; Joshita, Satoru/K-5679-2019	Igarashi, Koji/0000-0002-5007-7079; Joshita, Satoru/0000-0002-6364-9654; Umemura, Takeji/0000-0001-7985-919X				Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691; Bachofner JA, 2017, LIVER INT, V37, P369, DOI 10.1111/liv.13256; Chan J, 2017, DIG DIS SCI; Farquhar MJ, 2017, J HEPATOL, V66, P919, DOI 10.1016/j.jhep.2017.01.009; Ichikawa Y, 2016, HEPATOL RES; Ikeda H, 2012, CLIN CHIM ACTA, V413, P1817, DOI 10.1016/j.cca.2012.07.014; Jansen S, 2009, CANCER LETT, V284, P216, DOI 10.1016/j.canlet.2009.04.029; Joshita S, 2017, HEPATOL RES; Kaffe E, 2017, HEPATOLOGY, V65, P1369, DOI 10.1002/hep.28973; Keune WJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11248; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; Knop V, 2016, J VIRAL HEPATITIS, V23, P994, DOI 10.1111/jvh.12578; Kostadinova L, 2016, J INFECT DIS, V214, P1438, DOI 10.1093/infdis/jiw372; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Masuda A, 2008, BRIT J HAEMATOL, V143, P60, DOI 10.1111/j.1365-2141.2008.07325.x; Masuda A, 2011, CLIN CHIM ACTA, V412, P1944, DOI 10.1016/j.cca.2011.06.039; Miyaki E, 2016, HEPATOL RES, V46, P758, DOI 10.1111/hepr.12621; Mizokami M, 2015, LANCET INFECT DIS, V15, P645, DOI 10.1016/S1473-3099(15)70099-X; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Moolenaar WH, 2002, J CELL BIOL, V158, P197, DOI 10.1083/jcb.200206094; Nakagawa H, 2011, CLIN CHIM ACTA, V412, P1201, DOI 10.1016/j.cca.2011.03.014; Nakagawa S, 2016, CANCER CELL, V30, P879, DOI 10.1016/j.ccell.2016.11.004; Nakamura K, 2008, CLIN CHIM ACTA, V388, P51, DOI 10.1016/j.cca.2007.10.005; Naz S, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02322-2016; Ogasawara N, 2018, J MED VIROL, V90, P313, DOI 10.1002/jmv.24950; Omata M, 2014, J VIRAL HEPATITIS, V21, P762, DOI 10.1111/jvh.12312; Pleli T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103532; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Tada T, 2017, J GASTROEN HEPATOL, V32, P1982, DOI 10.1111/jgh.13788; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Umemura T, 2006, HEPATOLOGY, V43, P91, DOI 10.1002/hep.20917; Umemura T, 2009, J GASTROENTEROL, V44, P102, DOI 10.1007/s00535-008-2251-0; Umemura T, 2015, AM J GASTROENTEROL, V110, P857, DOI 10.1038/ajg.2015.118; Umemura T, 2011, ANTIVIR THER, V16, P1073, DOI 10.3851/IMP1869; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Watanabe N, 2007, LIFE SCI, V81, P1009, DOI 10.1016/j.lfs.2007.08.013; Watanabe N, 2007, J CLIN GASTROENTEROL, V41, P616, DOI 10.1097/01.mcg.0000225642.90898.0e; Yamazaki T, 2017, SCI REP-UK, V7, DOI 10.1038/srep46705	38	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195632	10.1371/journal.pone.0195632	http://dx.doi.org/10.1371/journal.pone.0195632			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617443	Green Submitted, Green Published, gold			2022-12-26	WOS:000429203800095
J	Kurvers, RHJM; de Zoete, A; Bachman, SL; Algra, PR; Ostelo, R				Kurvers, Ralf H. J. M.; de Zoete, Annemarie; Bachman, Shelby L.; Algra, Paul R.; Ostelo, Raymond			Combining independent decisions increases diagnostic accuracy of reading lumbosacral radiographs and magnetic resonance imaging	PLOS ONE			English	Article							LOW-BACK-PAIN; COLLECTIVE INTELLIGENCE; CHIROPRACTIC RADIOLOGISTS; GROUP-PERFORMANCE; 2 HEADS; RELIABILITY; EXPENDITURES; MAMMOGRAMS; PHYSICIANS; PATTERNS	Diagnosing the causes of low back pain is a challenging task, prone to errors. A novel approach to increase diagnostic accuracy in medical decision making is collective intelligence, which refers to the ability of groups to outperform individual decision makers in solving problems. We investigated whether combining the independent ratings of chiropractors, chiropractic radiologists and medical radiologists can improve diagnostic accuracy when interpreting diagnostic images of the lumbosacral spine. Evaluations were obtained from two previously published studies: study 1 consisted of 13 raters independently rating 300 lumbosacral radiographs; study 2 consisted of 14 raters independently rating 100 lumbosacral magnetic resonance images. In both studies, raters evaluated the presence of "abnormalities", which are indicators of a serious health risk and warrant immediate further examination. We combined independent decisions of raters using a majority rule which takes as final diagnosis the decision of the majority of the group. We compared the performance of the majority rule to the performance of single raters. Our results show that with increasing group size (i.e., increasing the number of independent decisions) both sensitivity and specificity increased in both data-sets, with groups consistently outperforming single raters. These results were found for radiographs and MR image reading alike. Our findings suggest that combining independent ratings can improve the accuracy of lumbosacral diagnostic image reading.	[Kurvers, Ralf H. J. M.; Bachman, Shelby L.] Max Planck Inst Human Dev, Ctr Adapt Rat, Berlin, Germany; [de Zoete, Annemarie; Ostelo, Raymond] Vrije Univ, Amsterdam Publ Hlth Res Inst, Dept Hlth Sci, Amsterdam, Netherlands; [Algra, Paul R.] Med Ctr Alkmaar, Dept Radiol, Alkmaar, Netherlands	Max Planck Society; Vrije Universiteit Amsterdam; Medical Center Of Alkmaar	Kurvers, RHJM (corresponding author), Max Planck Inst Human Dev, Ctr Adapt Rat, Berlin, Germany.	kurvers@mpib-berlin.mpg.de	de Zoete, Annemarie/J-3865-2014; Ostelo, Raymond/GSE-2602-2022	Bachman, Shelby/0000-0002-4460-4661; Ostelo, Raymond/0000-0001-7679-7210; de Zoete, Annemarie/0000-0002-1421-3862	Netherlands Organisation for Health Research and Development (ZonMW); Netherlands Organisation for Scientific Research (NWO); Scientific College of Physiotherapy (WCF); EUROSPINE	Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Scientific College of Physiotherapy (WCF); EUROSPINE	R. Ostelo acknowledges funding of the Netherlands Organisation for Health Research and Development (ZonMW), the Netherlands Organisation for Scientific Research (NWO), the Scientific College of Physiotherapy (WCF) and EUROSPINE. The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Bahrami B, 2010, SCIENCE, V329, P1081, DOI 10.1126/science.1185718; Bang D, 2014, CONSCIOUS COGN, V26, P13, DOI 10.1016/j.concog.2014.02.002; Baras JD, 2009, HEALTH AFFAIR, V28, pW1133, DOI 10.1377/hlthaff.28.6.w1133; Blass T, 1999, J APPL SOC PSYCHOL, V29, P955, DOI 10.1111/j.1559-1816.1999.tb00134.x; BOLAND PJ, 1989, STATISTICIAN, V38, P181, DOI 10.2307/2348873; Bonabeau E, 1999, SWARM INTELLIGENCE N, DOI DOI 10.1093/OSO/9780195131581.001.0001; Carrino JA, 2009, RADIOLOGY, V250, P161, DOI 10.1148/radiol.2493071999; CHERKIN DC, 1994, ARTHRITIS RHEUM, V37, P15, DOI 10.1002/art.1780370104; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chou R, 2012, RADIOL CLIN N AM, V50, P569, DOI 10.1016/j.rcl.2012.04.005; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; Clement RJG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077943; de Zoete A, 2002, SPINE, V27, P1926, DOI 10.1097/00007632-200209010-00021; de Zoete A, 2015, SPINE, V40, pE653, DOI 10.1097/BRS.0000000000000896; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; Deyo RA, 2016, NEW ENGL J MED, V374, P1763, DOI 10.1056/NEJMcp1512658; Deyo RA, 2009, J AM BOARD FAM MED, V22, P62, DOI 10.3122/jabfm.2009.01.080102; Dinnes J, 2001, BREAST, V10, P455, DOI 10.1054/brst.2001.0350; GROFMAN B, 1983, THEOR DECIS, V15, P261, DOI 10.1007/BF00125672; Gromet M, 2008, AM J ROENTGENOL, V190, P854, DOI 10.2214/AJR.07.2812; Hackman J. R, 1975, ADV EXPT SOCIAL PSYC, P1, DOI DOI 10.1016/S0065-2601(08)60248-8; HART LG, 1995, SPINE, V20, P11, DOI 10.1097/00007632-199501000-00003; Harvey SC, 2003, AM J ROENTGENOL, V180, P1461, DOI 10.2214/ajr.180.5.1801461; Hastie R, 2005, PSYCHOL REV, V112, P494, DOI 10.1037/0033-295X.112.2.494; Hilden J, 1996, STAT MED, V15, P969, DOI 10.1002/(SICI)1097-0258(19960530)15:10<969::AID-SIM211>3.0.CO;2-9; Kammer JE, 2017, MED DECIS MAKING, V37, P715, DOI 10.1177/0272989X17696998; Kattan MW, 2016, MED DECIS MAKING, V36, P536, DOI 10.1177/0272989X15581615; Kerr NL, 2004, ANNU REV PSYCHOL, V55, P623, DOI 10.1146/annurev.psych.55.090902.142009; King AJ, 2013, CANCER EPIDEMIOL, V37, P979, DOI 10.1016/j.canep.2013.09.004; Klein N, 2015, P NATL ACAD SCI USA, V112, P7460, DOI 10.1073/pnas.1504048112; Koriat A, 2015, J EXP PSYCHOL GEN, V144, P934, DOI 10.1037/xge0000092; Koriat A, 2012, SCIENCE, V336, P360, DOI 10.1126/science.1216549; Krause J, 2010, TRENDS ECOL EVOL, V25, P28, DOI 10.1016/j.tree.2009.06.016; Kurvers RHJM, 2016, P NATL ACAD SCI USA, V113, P8777, DOI 10.1073/pnas.1601827113; Kurvers RHJM, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150222; Kurvers RHJM, 2015, JAMA DERMATOL, V151, P1346, DOI 10.1001/jamadermatol.2015.3149; Luo XM, 2004, SPINE, V29, P79, DOI 10.1097/01.BRS.0000105527.13866.0F; Lurie JD, 2008, SPINE, V33, P1605, DOI 10.1097/BRS.0b013e3181791af3; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; McGrath J. E., 1984, GROUPS INTERACTION P; Moussaid M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167223; Sorkin RD, 1998, PSYCHOL SCI, V9, P456, DOI 10.1111/1467-9280.00085; Surowiecki James, 2004, WISDOM CROWDS WHY MA; Tan AL, 2016, J GEN INTERN MED, V31, P156, DOI 10.1007/s11606-015-3475-3; Turner ME, 1998, ORGAN BEHAV HUM DEC, V73, P105, DOI 10.1006/obhd.1998.2756; Wassenaar M, 2012, EUR SPINE J, V21, P220, DOI 10.1007/s00586-011-2019-8; Wolf M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134269; Wolf M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2777; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	51	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194128	10.1371/journal.pone.0194128	http://dx.doi.org/10.1371/journal.pone.0194128			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614070	Green Published, Green Submitted, gold			2022-12-26	WOS:000429081600008
J	Mahmoud, M; Zeng, Y; Shirali, M; Yin, T; Brugemann, K; Konig, S; Haley, C				Mahmoud, M.; Zeng, Y.; Shirali, M.; Yin, T.; Bruegemann, K.; Koenig, S.; Haley, C.			Genome-wide pleiotropy and shared biological pathways for resistance to bovine pathogens	PLOS ONE			English	Article							HOLSTEIN CATTLE; DAIRY-CATTLE; GASTROINTESTINAL NEMATODES; GENETIC SUSCEPTIBILITY; MASTITIS RESISTANCE; DISEASE RESISTANCE; ASSOCIATION; INFECTION; TRAITS; STRATIFICATION	Host genetic architecture is a major factor in resistance to pathogens and parasites. The collection and analysis of sufficient data on both disease resistance and host genetics has, however, been a major obstacle to dissection the genetics of resistance to single or multiple pathogens. A severe challenge in the estimation of heritabilities and genetic correlations from pedigree-based studies has been the confounding effects of the common environment shared among relatives which are difficult to model in pedigree analyses, especially for health traits with low incidence rates. To circumvent this problem we used genome-wide single-nucleotide polymorphism data and implemented the Genomic-Restricted Maximum Likelihood (G-REML) method to estimate the heritabilities and genetic correlations for resistance to 23 different infectious pathogens in calves and cows in populations undergoing natural pathogen challenge. Furthermore, we conducted gene-based analysis and generalized gene-set analysis to understand the biological background of resistance to infectious diseases. The results showed relatively higher heritabilities of resistance in calves than in cows and significant pleiotropy (both positive and negative) among some calf and cow resistance traits. We also found significant pleiotropy between resistance and performance in both calves and cows. Finally, we confirmed the role of the B-lymphocyte pathway as one of the most important biological pathways associated with resistance to all pathogens. These results both illustrate the potential power of these approaches to illuminate the genetics of pathogen resistance in cattle and provide foundational information for future genomic selection aimed at improving the overall production fitness of cattle.	[Mahmoud, M.; Yin, T.; Bruegemann, K.; Koenig, S.] Justus Liebig Univ Giessen, Inst Anim Breeding & Genet, Giessen, Germany; [Mahmoud, M.; Zeng, Y.; Haley, C.] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Shirali, M.] Univ Edinburgh, Ctr Clin Brain Sci, Royal Edinburgh Hosp, Kennedy Tower, Edinburgh, Midlothian, Scotland; [Haley, C.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Haley, C.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland	Justus Liebig University Giessen; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Konig, S (corresponding author), Justus Liebig Univ Giessen, Inst Anim Breeding & Genet, Giessen, Germany.; Haley, C (corresponding author), Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland.; Haley, C (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland.; Haley, C (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland.	Sven.Koenig@agrar.uni-giessen.de; Chris.Haley@igmm.ed.ac.uk	Shirali, Masoud/AAZ-5633-2020; Shirali, Masoud/GYH-0339-2022	Shirali, Masoud/0000-0002-5401-0541; Shirali, Masoud/0000-0002-5401-0541	German Federal Ministry of Education and Research (BMBF); Forderverein Biookonomieforschung e.V. (FBV) / German Holstein Association (DHV) [031A416C]; Biotechnology and Biological Sciences Research Council in the UK [BB/P013759/1]; Medical Research Council in the UK [MC_PC_U127592696]; Biotechnology and Biological Sciences Research Council [BBS/E/D/30002275, BBS/E/D/20211554, BBS/E/D/20211553, BBS/E/D/20211550] Funding Source: researchfish; Medical Research Council [MC_PC_U127592696] Funding Source: researchfish; BBSRC [BBS/E/D/20211554, BBS/E/D/20211550, BBS/E/D/20211553] Funding Source: UKRI; MRC [MC_PC_U127592696] Funding Source: UKRI	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Forderverein Biookonomieforschung e.V. (FBV) / German Holstein Association (DHV); Biotechnology and Biological Sciences Research Council in the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council in the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research funded by the German Federal Ministry of Education and Research (BMBF), the Forderverein Biookonomieforschung e.V. (FBV) / German Holstein Association (DHV) and through the collaborative project "KMU-innovativ-10: Kuh-L - cow calibration groups for the implementation of selection strategies based on high-density genotyping in dairy cattle" (grant no. 031A416C). CSH was supported by the Biotechnology and Biological Sciences Research Council in the UK (Grant BB/P013759/1). CSH and YZ were supported by the Medical Research Council in the UK (Grant MC_PC_U127592696). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the invaluable contributions of Pau Navarro, Carmen Amador and Charley Xia at the MRC Human Genetics Unit, University of Edinburgh and thank Andrea Wilson of The Roslin Institute, University of Edinburgh, for additional valuable comments on the manuscript. This research funded by the German Federal Ministry of Education and Research (BMBF), the Forderverein Biookonomieforschung e.V. (FBV) / German Holstein Association (DHV) and through the collaborative project "KMU-innovativ-10: Kuh-L-cow calibration groups for the implementation of selection strategies based on high-density genotyping in dairy cattle" (grant no. 031A416C).	Alberts B, 2002, INTRO PATHOGENS; Allen AR, 2010, P ROY SOC B-BIOL SCI, V277, P2737, DOI 10.1098/rspb.2010.0830; Alpay F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111704; [Anonymous], 2001, BERGEYS MANUAL SYSTE; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bermingham ML, 2014, HEREDITY, V112, P543, DOI 10.1038/hdy.2013.137; Berry DP, 2011, IRISH VET J, V64, DOI 10.1186/2046-0481-64-5; Bishop SC, 2007, SMALL RUMINANT RES, V70, P48, DOI 10.1016/j.smallrumres.2007.01.006; Bishop SC, 2014, LIVEST SCI, V166, P190, DOI 10.1016/j.livsci.2014.04.034; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Cad Leeuw, 2015, PLOS COMPUT BIOL, V11; Casas E, 2015, ANIM GENET, V46, P8, DOI 10.1111/age.12239; Chen GB, 2014, HUM MOL GENET, V23, P4710, DOI 10.1093/hmg/ddu174; Coppieters W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-96; DAVIS GP, 1993, AUST J AGR RES, V44, P179, DOI 10.1071/AR9930179; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Feucker W, ZENTRALER DIAGNOSESC; Finlay EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030545; Frodsham AJ, 2004, HUM MOL GENET, V13, pR187, DOI 10.1093/hmg/ddh225; Gernand E, 2012, J DAIRY SCI, V95, P2144, DOI 10.3168/jds.2011-4812; Hamzic E, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0170-0; Heringstad B, 2008, J DAIRY SCI, V91, P367, DOI 10.3168/jds.2007-0365; Heringstad B, 2000, LIVEST PROD SCI, V64, P95, DOI 10.1016/S0301-6226(99)00128-1; Kiser JN, 2017, J ANIMAL SCI; Lee BY, 2015, ASIAN AUSTRAL J ANIM, V28, P166, DOI 10.5713/ajas.14.0383; Mahmoud M, 2017, J DAIRY SCI, V100, P2017, DOI 10.3168/jds.2016-11767; Pan Y, 2004, J DAIRY SCI, V87, P3967, DOI 10.3168/jds.S0022-0302(04)73537-7; Passafaro TL, 2015, VET PARASITOL, V210, P224, DOI 10.1016/j.vetpar.2015.03.017; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Raszek MM, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00030; Richardson IW, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0197-x; Rupp R, 2009, J DAIRY SCI, V92, P1203, DOI 10.3168/jds.2008-1435; Segelke D, 2012, J DAIRY SCI, V95, P5403, DOI 10.3168/jds.2012-5466; Settles M, 2009, ANIM GENET, V40, P655, DOI 10.1111/j.1365-2052.2009.01896.x; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; STEAR MJ, 1994, VET PARASITOL, V54, P161, DOI 10.1016/0304-4017(94)90089-2; Stock K.F., 2013, ICAR TECHNICAL SERIE, V17, P75; Swalve HH, 2015, GERMAN PROJECTS GENO; Templeton J, 1990, P 4 WORLD C GEN APPL; Thompson-Crispi KA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-559; Tsairidou S, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0264-3; Tsairidou S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096728; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zanella R, 2011, ANIM GENET, V42, P28, DOI 10.1111/j.1365-2052.2010.02076.x; Zare Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088380	50	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0194374	10.1371/journal.pone.0194374	http://dx.doi.org/10.1371/journal.pone.0194374			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608619	Green Published, Green Submitted, gold			2022-12-26	WOS:000428988800010
J	Moser, O; Eckstein, ML; McCarthy, O; Deere, R; Bain, SC; Haahr, HL; Zijlstra, E; Heise, T; Bracken, RM				Moser, Othmar; Eckstein, Max L.; McCarthy, Olivia; Deere, Rachel; Bain, Stephen C.; Haahr, Hanne L.; Zijlstra, Eric; Heise, Tim; Bracken, Richard M.			Heart rate dynamics during cardio-pulmonary exercise testing are associated with glycemic control in individuals with type 1 diabetes	PLOS ONE			English	Article							RATE PERFORMANCE CURVE; AEROBIC CAPACITY; ADOLESCENTS; THRESHOLD; MORTALITY; STATEMENT; POINT	Introduction This study investigated the degree and direction (k(HR)) of the heart rate to performance curve (HRPC) during cardio-pulmonary exercise (CPX) testing and explored the relationship with diabetes markers, anthropometry and exercise physiological markers in type 1 diabetes (T1DM). Material and methods Sixty-four people with T1DM (13 females; age: 34 +/- 8 years; HbA(1c): 7.8 +/- 1% (62 +/- 13 mmol.mol(-1)) performed a CPX test until maximum exhaustion. kHR was calculated by a second-degree polynomial representation between post-warm up and maximum power output. Adjusted stepwise linear regression analysis was performed to investigate k(HR) and its associations. Receiver operating characteristic (ROC) curve was performed based on k(HR) for groups k(HR) < 0.20 vs. > 0.20 in relation to HbA(1c). Results We found significant relationships between k(HR) and HbA(1c) (beta = -0.70, P < 0.0001), age beta = -0.23, P = 0.03) and duration of diabetes beta = 0.20, P = 0.04). Stepwise linear regression resulted in an overall adjusted R-2 of 0.57 (R = 0.79, P < 0.0001). Our data revealed also significant associations between k(HR) and percentage of heart rate at heart rate turn point from maximum heart rate beta = 0.43, P < 0.0001) and maximum power output relativized to body-weight beta = 0.44, P = 0.001) (overall adjusted R-2 of 0.44 (R = 0.53, P < 0.0001)). ROC curve analysis based on k(HR) resulted in a HbA(1c) threshold of 7.9% (62 mmol.mol(-1)). Conclusion Our data demonstrate atypical HRPC during CPX testing that were mainly related to glycemic control in people with T1DM.	[Moser, Othmar; Eckstein, Max L.; McCarthy, Olivia; Deere, Rachel; Bain, Stephen C.; Bracken, Richard M.] Swansea Univ, Med Sch, Diabet Res Grp, Swansea, W Glam, Wales; [Moser, Othmar; Eckstein, Max L.; McCarthy, Olivia; Deere, Rachel; Bracken, Richard M.] Swansea Univ, Coll Engn, Appl Sport Technol Exercise & Med Res Ctr A STEM, Swansea, W Glam, Wales; [Haahr, Hanne L.] Novo Nordisk AS, Soborg, Denmark; [Zijlstra, Eric; Heise, Tim] Profil, Neuss, Germany	Swansea University; Swansea University; Novo Nordisk; Profil	Moser, O (corresponding author), Swansea Univ, Med Sch, Diabet Res Grp, Swansea, W Glam, Wales.; Moser, O (corresponding author), Swansea Univ, Coll Engn, Appl Sport Technol Exercise & Med Res Ctr A STEM, Swansea, W Glam, Wales.	othmar.moser@swansea.ac.uk	Bracken, Rich/AAC-2586-2021	Bracken, Rich/0000-0002-6986-6449; McCarthy, Olivia/0000-0001-6971-611X; Deere, Rachel/0000-0001-6925-7865; Haahr, Hanne Lis/0000-0002-6980-8230	Novo Nordisk A/S [NN1250-3999]; Medtronic; Novo Nordisk A/S; Ser Cymru II COFUND fellowship/European Union; KESS2/European Social Fund scholarship; Abbott; Astra Zeneca; Boehringer Ingelheim; BMS; Diartis; Eli Lily and Company; GlaxoSmithKline; Johnson Johnson; Merck Sharp Dohme; Novartis; Novo Nordisk; Pfizer; Roche; Sanofi-Aventis; ScheringPlough; Servier; Takeda; Adocia; BD; Biocon; Dance Pharmaceuticals; Grunenthal; Sanofi; Senseonics; Mylan	Novo Nordisk A/S(Novo Nordisk); Medtronic(Medtronic); Novo Nordisk A/S(Novo Nordisk); Ser Cymru II COFUND fellowship/European Union; KESS2/European Social Fund scholarship; Abbott(Abbott Laboratories); Astra Zeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); BMS(Bristol-Myers Squibb); Diartis; Eli Lily and Company; GlaxoSmithKline(GlaxoSmithKline); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Merck Sharp Dohme(Merck & Company); Novartis(Novartis); Novo Nordisk(Novo Nordisk); Pfizer(Pfizer); Roche(Roche Holding); Sanofi-Aventis(Sanofi-Aventis); ScheringPlough(Merck & CompanySchering Plough Corporation); Servier(Servier); Takeda(Takeda Pharmaceutical Company Ltd); Adocia; BD; Biocon(AblynxAkvaplan-nivaCentre National de la Recherche Scientifique (CNRS)); Dance Pharmaceuticals; Grunenthal(HAL Allergy Group); Sanofi; Senseonics; Mylan	This study was supported by Novo Nordisk A/S (NN1250-3999 to Tim Heise).; O. Moser has received lecture fees from Medtronic, a travel grant from Novo Nordisk A/S and research grants from Ser Cymru II COFUND fellowship/European Union and Novo Nordisk A/S. M. L. Eckstein has received a KESS2/European Social Fund scholarship. S. C. Bain reports having received honoraria, teaching and research grants from the Abbott, Astra Zeneca, Boehringer Ingelheim, BMS, Diartis, Eli Lily and Company, GlaxoSmithKline, Johnson & Johnson, Merck Sharp & Dohme, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi-Aventis, ScheringPlough, Servier and Takeda. T. Heise reports having received research funds from Adocia, Astra Zeneca, BD, Biocon, Boehringer Ingelheim, Dance Pharmaceuticals, Grunenthal, Eli Lily and Company, Medtronic, Novo Nordisk, Novartis, Sanofi and Senseonics and having received speaker honoraria and travel grants from Eli Lily and Company, Mylan and Novo Nordisk. R. M. Bracken reports having received honoraria, travel and educational grant support from, Boehringer-Ingelheim, Eli Lily and Company, Novo Nordisk, Sanofi-Aventis. E. Zijlstra, R. Deere and O. McCarthy have no disclosures to report. H. L. Haahr is employee and shareholder in Novo Nordisk A/S. This does not alter our adherence to PLOS ONE policies on sharing data and materials.; This study was funded by Novo Nordisk A/S. Data were extracted from a clinical trial (NCT01704417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69; Baldi JC, 2010, EXERC SPORT SCI REV, V38, P161, DOI 10.1097/JES.0b013e3181f4501e; Baldi JC, 2010, MED SCI SPORT EXER, V42, P1454, DOI 10.1249/MSS.0b013e3181d1fdb3; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Brahma MK, 2017, DIABETES METAB J, V41, P1, DOI 10.4093/dmj.2017.41.1.1; BUNC V, 1995, EUR J APPL PHYSIOL O, V70, P263, DOI 10.1007/BF00238574; Chiang JL, 2014, DIABETES CARE, V37, P2034, DOI 10.2337/dc14-1140; COLUCCI WS, 1986, NEW ENGL J MED, V314, P349, DOI 10.1056/NEJM198602063140605; CONCONI F, 1982, J APPL PHYSIOL, V52, P869, DOI 10.1152/jappl.1982.52.4.869; Dresing TJ, 2000, AM J CARDIOL, V86, P602, DOI 10.1016/S0002-9149(00)01036-5; Gusso S, 2008, DIABETOLOGIA, V51, P1317, DOI 10.1007/s00125-008-1012-1; Heise T, 2016, DIABETES OBES METAB, V18, P196, DOI 10.1111/dom.12588; Heyman E, 2007, DIABETES METAB, V33, P422, DOI 10.1016/j.diabet.2007.10.003; Hofmann P, 2005, MED SCI SPORT EXER, V37, P1704, DOI 10.1249/01.mss.0000176308.70316.cc; Hofmann P, 1997, MED SCI SPORT EXER, V29, P762, DOI 10.1097/00005768-199706000-00005; HOFMANN P, 1994, EUR J APPL PHYSIOL O, V69, P132, DOI 10.1007/BF00609405; Hofmann P, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/209302; Hofmann P, 2010, INT J SPORT PHYSIOL, V5, P437, DOI 10.1123/ijspp.5.4.437; Keytsman C, 2015, SPORTS MED, V45, P985, DOI 10.1007/s40279-015-0328-5; Kodama S, 2013, DIABETES CARE, V36, P471, DOI 10.2337/dc12-0783; Livingstone SJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001321; Lymperopoulos A, 2008, CIRC RES, V6, P2166; McKnight JA, 2015, DIABETIC MED, V32, P1036, DOI 10.1111/dme.12676; McNeilly AD, 2017, DIABETES, V66, P1696, DOI 10.2337/db16-1533; Moser O, 2017, ASIAN J SPORTS MED, P8; Nadeau KJ, 2010, J CLIN ENDOCR METAB, V95, P513, DOI 10.1210/jc.2009-1756; Niranjan V, 1997, AM J MED, V103, P504, DOI 10.1016/S0002-9343(97)00251-9; Peltonen JE, 2012, RESP PHYSIOL NEUROBI, V181, P267, DOI 10.1016/j.resp.2012.04.002; RIBEIRO JP, 1985, INT J SPORTS MED, V6, P220, DOI 10.1055/s-2008-1025844; Sastre Julia, 2012, Endocrinol Nutr, V59, P539, DOI 10.1016/j.endonu.2012.07.003; Wallymahmed M., 2005, PRACTICAL DIABETES I, V22, P81; Wilson LC, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13248; Wonisch M, 2003, EUR J CARDIOV PREV R, V10, P296, DOI 10.1097/00149831-200308000-00013	33	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0194750	10.1371/journal.pone.0194750	http://dx.doi.org/10.1371/journal.pone.0194750			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608593	Green Published, Green Submitted, gold			2022-12-26	WOS:000428988800016
J	Sarangi, PP; Chakraborty, P; Dash, SP; Ikeuchi, T; de Vega, S; Ambatipudi, K; Wahl, L; Yamada, Y				Sarangi, Pranita P.; Chakraborty, Papiya; Dash, Shiba Prasad; Ikeuchi, Tomoko; de Vega, Susana; Ambatipudi, Kiran; Wahl, Larry; Yamada, Yoshihiko			Cell adhesion protein fibulin-7 and its C-terminal fragment negatively regulate monocyte and macrophage migration and functions in vitro and in vivo	FASEB JOURNAL			English	Article						extracellular matrix; immunomodulation; inflammation	EXTRACELLULAR-MATRIX PROTEINS; FIBRONECTIN; INTEGRIN; INFLAMMATION; TISSUE; OSTEOARTHRITIS; MOLECULES; INTERACTS; FAMILY; ALPHA	Fibulin-7 (Fbln7) has been identified as the latest member of the fibulin family of secreted glycoproteins in developing teeth, functioning as a cell adhesion molecule and interacting with other matrix proteins, receptors, and growth factors. More recently, we have shown that the C-terminal Fbln7 fragment (Fbln7-C) has antiangiogenic activity in vitro. Fbln7 is also expressed in immune-privileged tissues, such as eye and placenta, but its functional significance is unknown. In the current study, we show that human monocytes adhere to both full-length Fbln7 (Fbln7-FL) and Fbln7-C, in part, via integrins (51) and (21). Morphologic studies and surface expression analyses of CD14, mannose receptor (CD206), major histocompatibility complex II, and CD11b receptors revealed that both Fbln7-FL and Fbln7-C inhibit M-CSF-induced monocyte differentiation. Fbln7-C had significantly greater negative effects on cell spreading and stress fiber formation, including the production of IL-6 and metalloproteinase-1/-9 compared with Fbln7-FL. Furthermore, in an LPS-induced systemic inflammation model, Fbln7-C and Fbln7-FL reduced the infiltration of immune cells, such as neutrophils and macrophages, to the inflamed peritoneum. Thus, these results suggest that Fbln7 and Fbln7-C could modulate the activity of immune cells and have therapeutic potential for inflammatory diseases.Sarangi, P. P., Chakraborty, P., Dash, S. P., Ikeuchi, T., de Vega, S., Ambatipudi, K., Wahl, L., Yamada, Y. Cell adhesion protein fibulin-7 and its C-terminal fragment negatively regulate monocyte and macrophage migration and functions in vitro and in vivo.	[Sarangi, Pranita P.; Ikeuchi, Tomoko; de Vega, Susana; Yamada, Yoshihiko] Natl Inst Dent & Craniofacial Res, Mol Biol Sect, NIH, Bethesda, MD USA; [Ambatipudi, Kiran] Natl Inst Dent & Craniofacial Res, Secretory Mech & Dysfunct Sect, NIH, Bethesda, MD USA; [Wahl, Larry] Natl Inst Dent & Craniofacial Res, Immunopathol Sect, NIH, Bethesda, MD USA; [Sarangi, Pranita P.; Chakraborty, Papiya; Dash, Shiba Prasad; Ambatipudi, Kiran] Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee 247667, Uttarakhand, India; [de Vega, Susana] Juntendo Univ, Sch Med, Res Inst Dis Old Age, Tokyo, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Juntendo University	Sarangi, PP (corresponding author), Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee 247667, Uttarakhand, India.; Yamada, Y (corresponding author), Natl Inst Dent & Craniofacial Res, NIH, 30 Convent Dr,Bldg 30,Room 430, Bethesda, MD 20892 USA.	psarafbt@iitr.ac.in; yoshi.yamada@nih.gov	Ikeuchi, Tomoko/AAE-6417-2019; de Vega, Susana/AAH-4775-2020		Intramural Research Program of National Institute of Dental and Craniofacial Research [DE000485-26]; Department of Science and Technology, Government of India [YSS/2015/000451]; Department of Biotechnology, Government of India [102/IFD/SAN/1671/2014-2015]; Japan Society of Promotion of Science for Young Investigator [714175]; University Grants Commission, Government of India [2061430670]; Ministry of Human Resource Development, Government of India [MHR 02-23-200-429]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000485] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [17K08770] Funding Source: KAKEN	Intramural Research Program of National Institute of Dental and Craniofacial Research; Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Japan Society of Promotion of Science for Young Investigator(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); University Grants Commission, Government of India(University Grants Commission, India); Ministry of Human Resource Development, Government of India(Ministry of Human Resource Development (MHRD), Government of India); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Dr. James Melvin, Dr. Marjan Gucek, and Dr. Steve Swatkoski [all of the U.S. National Institutes of Health (NIH)] for granting access to the NIH, National Heart, Lung, and Blood Institute Proteomics Core Facility. This work was supported by the Intramural Research Program of National Institute of Dental and Craniofacial Research (DE000485-26; to Y.Y.) and funds from the Department of Science and Technology, Government of India (YSS/2015/000451; to P.P.S.), the Department of Biotechnology, Government of India (102/IFD/SAN/1671/2014-2015; to P.P.S.), a Japan Society of Promotion of Science for Young Investigator (714175; to T.I. and S.d.V.), University Grants Commission, Government of India (Sr. No-2061430670; to S.P.D.), and the Ministry of Human Resource Development, Government of India (MHR 02-23-200-429; to P.C.). The authors declare no conflicts of interest.	Adair-Kirk TL, 2008, INT J BIOCHEM CELL B, V40, P1101, DOI 10.1016/j.biocel.2007.12.005; Cassol E, 2009, J IMMUNOL, V182, P6237, DOI 10.4049/jimmunol.0803447; Coito AJ, 2000, AM J PATHOL, V157, P1207, DOI 10.1016/S0002-9440(10)64636-6; DAVIS LS, 1990, J IMMUNOL, V145, P785; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; de Vega S, 2007, J BIOL CHEM, V282, P30878, DOI 10.1074/jbc.M705847200; de Vega S, 2014, ARCH BIOCHEM BIOPHYS, V545, P148, DOI 10.1016/j.abb.2014.01.013; Gonzalez A, 2008, FEMS IMMUNOL MED MIC, V53, P114, DOI 10.1111/j.1574-695X.2008.00411.x; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Hozumi K, 2006, J BIOL CHEM, V281, P32929, DOI 10.1074/jbc.M605708200; Kitamura N, 2000, CLIN EXP IMMUNOL, V120, P66, DOI 10.1046/j.1365-2249.2000.01162.x; KLUFTINGER JL, 1989, INFECT IMMUN, V57, P817, DOI 10.1128/IAI.57.3.817-822.1989; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Lisi S, 2009, SCAND J RHEUMATOL, V38, P198, DOI 10.1080/03009740802520722; Madsen DH, 2013, J CELL BIOL, V202, P951, DOI 10.1083/jcb.201301081; REDLINE RW, 1990, J CLIN INVEST, V85, P1951, DOI 10.1172/JCI114658; RUEGG CR, 1989, P NATL ACAD SCI USA, V86, P7437, DOI 10.1073/pnas.86.19.7437; Sarangi PP, 2017, J IMMUNOL, V199, P2930, DOI 10.4049/jimmunol.1700541; Sarangi PP, 2012, SHOCK, V38, P281, DOI 10.1097/SHK.0b013e31826136f8; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; WAHL SM, 1984, CELL IMMUNOL, V85, P384, DOI 10.1016/0008-8749(84)90252-1; Weber C, 1996, J CELL BIOL, V134, P1063, DOI 10.1083/jcb.134.4.1063; Wu J, 2007, ARTHRITIS RHEUM-US, V56, P3675, DOI 10.1002/art.22876; Xiang Y, 2006, J IMMUNOL, V176, P3196, DOI 10.4049/jimmunol.176.5.3196; Zamiri P, 2005, INVEST OPHTH VIS SCI, V46, P908, DOI 10.1167/iovs.04-0362; Zhou M, 2003, J BIOL CHEM, V278, P45406, DOI 10.1074/jbc.M309075200	28	13	13	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4889	4898		10.1096/fj.201700686RRR	http://dx.doi.org/10.1096/fj.201700686RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29634368	Green Published			2022-12-26	WOS:000443817700023
J	Crossland, DL; Denning, WL; Ang, S; Olivares, S; Mi, TJ; Switzer, K; Singh, H; Huls, H; Gold, KS; Glisson, BS; Cooper, LJ; Heymach, JV				Crossland, Denise L.; Denning, Warren L.; Ang, Sonny; Olivares, Simon; Mi, Tiejuan; Switzer, Kirsten; Singh, Harjeet; Huls, Helen; Gold, Kate S.; Glisson, Bonnie S.; Cooper, Laurence J.; Heymach, John V.			Antitumor activity of CD56-chimeric antigen receptor T cells in neuroblastoma and SCLC models	ONCOGENE			English	Article							ANTIBODY-DRUG CONJUGATE; LUNG-CANCER; LORVOTUZUMAB MERTANSINE; IMPROVED SURVIVAL; HU ANTIBODIES; PHASE 1/2; EXPRESSION; SYSTEM; TRANSACTIVATOR; PEMBROLIZUMAB	The CD56 antigen (NCAM-1) is highly expressed on several malignancies with neuronal or neuroendocrine differentiation, including small-cell lung cancer and neuroblastoma, tumor types for which new therapeutic options are needed. We hypothesized that CD56-specific chimeric antigen receptor (CAR) T cells could target and eliminate CD56-positive malignancies. Sleeping Beauty transposon-generated CD56R-CAR T cells exhibited a beta T-cell receptors, released antitumor cytokines upon co-culture with CD56(+) tumor targets, demonstrated a lack of fratricide, and expression of cytolytic function in the presence of CD56(+) stimulation. The CD56R-CAR(+) T cells are capable of killing CD56(+) neuroblastoma, glioma, and SCLC tumor cells in in vitro co-cultures and when tested against CD56(+) human xenograft neuroblastoma models and SCLC models, CD56R-CAR(+) T cells were able to inhibit tumor growth in vivo. These results indicate that CD56-CARs merit further investigation as a potential treatment for CD56(+) malignancies.	[Crossland, Denise L.; Olivares, Simon; Mi, Tiejuan; Switzer, Kirsten; Singh, Harjeet; Huls, Helen; Cooper, Laurence J.] UT MD Anderson Canc Ctr, Div Pediat, Houston, TX USA; [Denning, Warren L.; Glisson, Bonnie S.; Heymach, John V.] UT MD Anderson Canc Ctr, Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Ang, Sonny] UT MD Anderson Canc Ctr, Stem Cell Transplantat, Houston, TX USA; [Huls, Helen] Intrexon, Germantown, MD USA; [Gold, Kate S.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Cooper, Laurence J.] ZIOPHARM Oncol Inc, Boston, MA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Diego	Heymach, JV (corresponding author), UT MD Anderson Canc Ctr, Thorac Head & Neck Med Oncol, Houston, TX 77030 USA.	jheymach@mdanderson.org	Heymach, John/AAG-2361-2019	Heymach, John/0000-0001-9068-8942; Denning, Warren/0000-0003-0781-4288	Cancer Center Core Grant [CA16672]; RO1 [CA124782, CA120956, CA141303]; P01 [CA148600]; SPORES [CA100632, CA136411, CA00632]; Albert J Ward Foundation; Alex's Lemonade Stand Foundation; Burroughs Wellcome Fund; Cancer Prevention and Research Institute of Texas; Charles B. Goddard Foundation of Texas; CLL Global Research Foundation; Energy Transfer Partners; Estate of Noelan L. Bibler; Gillson Longenbaugh Foundation; Harry T. Mangurian, Jr., Fund for Leukemia Immunotherapy; Khalifa Bin Zayed Al Nahyan Foundation; Kleberg Foundation; Leukemia and Lymphoma Society; Lung Cancer Research Foundation; Lung Cancer Moon Shot; Lymphoma Research Foundation; Miller Foundation; National Foundation for Cancer Research; NIH Cancer Center Support Grant Pediatric Cancer Research Foundation [CA016672]; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy; University of Texas MD Anderson Cancer Center Sister Institution Network Fund; University of Texas Moon Shot Fund; University of Texas Southwestern Medical Center [5 P50 CA070907]; University of Texas MD Anderson Cancer Center NIH Lung SPORE Grant [5 P50 CA070907]; William Lawrence and Blanche Hughes Children's Foundation	Cancer Center Core Grant; RO1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); P01; SPORES; Albert J Ward Foundation; Alex's Lemonade Stand Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Cancer Prevention and Research Institute of Texas; Charles B. Goddard Foundation of Texas; CLL Global Research Foundation; Energy Transfer Partners; Estate of Noelan L. Bibler; Gillson Longenbaugh Foundation; Harry T. Mangurian, Jr., Fund for Leukemia Immunotherapy; Khalifa Bin Zayed Al Nahyan Foundation; Kleberg Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Lung Cancer Research Foundation; Lung Cancer Moon Shot; Lymphoma Research Foundation; Miller Foundation; National Foundation for Cancer Research; NIH Cancer Center Support Grant Pediatric Cancer Research Foundation; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy; University of Texas MD Anderson Cancer Center Sister Institution Network Fund; University of Texas Moon Shot Fund; University of Texas Southwestern Medical Center; University of Texas MD Anderson Cancer Center NIH Lung SPORE Grant; William Lawrence and Blanche Hughes Children's Foundation	We thank the flow cytometry and cellular imaging core facilities at MD Anderson. This study was funded by Cancer Center Core Grant (CA16672); RO1 (CA124782, CA120956, CA141303, CA141303); P01 (CA148600); SPORES (CA100632, CA136411, CA00632); Albert J Ward Foundation; Alex's Lemonade Stand Foundation; Burroughs Wellcome Fund; Cancer Prevention and Research Institute of Texas; Charles B. Goddard Foundation of Texas; CLL Global Research Foundation; Energy Transfer Partners; Estate of Noelan L. Bibler; Gillson Longenbaugh Foundation; Harry T. Mangurian, Jr., Fund for Leukemia Immunotherapy; Khalifa Bin Zayed Al Nahyan Foundation; Kleberg Foundation; Leukemia and Lymphoma Society; Lung Cancer Research Foundation; Lung Cancer Moon Shot; Lymphoma Research Foundation; Miller Foundation; Mr. Herb Simons; Mr. and Mrs. Joe H. Scales; Mr. Thomas Scott; National Foundation for Cancer Research; NIH Cancer Center Support Grant (CA016672) Pediatric Cancer Research Foundation; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy; University of Texas MD Anderson Cancer Center Sister Institution Network Fund and Moon Shot Fund; The University of Texas Southwestern Medical Center and The University of Texas MD Anderson Cancer Center NIH Lung SPORE Grant (5 P50 CA070907); William Lawrence and Blanche Hughes Children's Foundation. Publication under the Creative Commons CC-BY license is not required.	Antonia SJ, 2016, LANCET ONCOL, V17, P883, DOI 10.1016/S1470-2045(16)30098-5; Bruns M, 2016, ONCOTARGET, V7, P64543, DOI 10.18632/oncotarget.11620; Chen HL, 1996, NAT GENET, V13, P210, DOI 10.1038/ng0696-210; DALMAU J, 1995, CANCER, V75, P99, DOI 10.1002/1097-0142(19950101)75:1<99::AID-CNCR2820750117>3.0.CO;2-I; de Braud F., 2015, J IMMUNOTHER CANCER, V3, pP376, DOI DOI 10.1186/2051-1426-3-S2-P376; DOYLE A, 1985, J EXP MED, V161, P1135, DOI 10.1084/jem.161.5.1135; Fedorov VD, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006597; Feng Y, 2016, MABS-AUSTIN, V8, P799, DOI 10.1080/19420862.2016.1155014; FISK B, 1994, LYMPHOKINE CYTOK RES, V13, P125; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Graus F, 1997, J CLIN ONCOL, V15, P2866, DOI 10.1200/JCO.1997.15.8.2866; Jena B, 2010, BLOOD, V116, P1035, DOI 10.1182/blood-2010-01-043737; Kazarian M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-33; Kelly-Rogers J, 2006, HUM IMMUNOL, V67, P863, DOI 10.1016/j.humimm.2006.08.292; Michielsen AJ, 2012, MOL CANCER THER, V11, P1829, DOI 10.1158/1535-7163.MCT-12-0162; Morsut L, 2016, CELL, V164, P780, DOI 10.1016/j.cell.2016.01.012; Noble A, 2006, BLOOD, V107, P4475, DOI 10.1182/blood-2005-10-3994; Ohkawa T, 2001, IMMUNOLOGY, V103, P281, DOI 10.1046/j.1365-2567.2001.01248.x; Ott PA, 2017, J CLIN ONCOL, V35, P3823, DOI 10.1200/JCO.2017.72.5069; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Pittet MJ, 2000, J IMMUNOL, V164, P1148, DOI 10.4049/jimmunol.164.3.1148; Roellecke K, 2016, GENE THER, V23, P615, DOI 10.1038/gt.2016.38; Ryan SO, 2010, CANCER RES, V70, P5788, DOI 10.1158/0008-5472.CAN-09-4519; Sakemura R, 2016, CANCER IMMUNOL RES, V4, P658, DOI 10.1158/2326-6066.CIR-16-0043; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shah MH, 2016, INVEST NEW DRUG, V34, P290, DOI 10.1007/s10637-016-0336-9; Singh H, 2008, CANCER RES, V68, P2961, DOI 10.1158/0008-5472.CAN-07-5600; Singh H, 2011, CANCER RES, V71, P3516, DOI 10.1158/0008-5472.CAN-10-3843; Socinski MA, 2017, CLIN LUNG CANCER, V18, P68, DOI 10.1016/j.cllc.2016.09.002; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Whiteman KR, 2014, MABS-AUSTIN, V6, P556, DOI 10.4161/mabs.27756; WINTER SF, 1993, J NATL CANCER I, V85, P2012, DOI 10.1093/jnci/85.24.2012; Yazawa T, 2002, AM J PATHOL, V161, P291, DOI 10.1016/S0002-9440(10)64181-8; Yoshihama S, 2016, P NATL ACAD SCI USA, V113, P5999, DOI 10.1073/pnas.1602069113; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	36	31	33	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 5	2018	37	27					3686	3697		10.1038/s41388-018-0187-2	http://dx.doi.org/10.1038/s41388-018-0187-2			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GM3CM	29622795				2022-12-26	WOS:000437975200006
J	McCarthy, RC; Sosa, JC; Gardeck, AM; Baez, AS; Lee, CH; Wessling-Resnick, M				McCarthy, Ryan C.; Sosa, Jose Carlo; Gardeck, Andrew M.; Baez, Andrew S.; Lee, Chih-Hao; Wessling-Resnick, Marianne			Inflammation-induced iron transport and metabolism by brain microglia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSIVE ELEMENTS; ACCUMULATION; CHAPERONE; HEPCIDIN; EXPRESSION; CELLS	Microglia are immune cells of the central nervous system and are implicated in brain inflammation. However, how brain microglia modulate transport and metabolism of the essential metal iron in response to pro- and anti-inflammatory environmental cues is unclear. Here, we characterized uptake of transferrin (Tf)-bound iron (TBI) and non-Tf-bound iron (NTBI) by immortalized microglial (IMG) cells. We found that these cells preferentially take up NTBI in response to the proinflammatory stimulus lipopolysaccharide (LPS) or -amyloid (A). In contrast, the anti-inflammatory cytokine interleukin 4 (IL-4) promoted TBI uptake. Concordant with these functional data, levels of the Tf receptor (TfR) in IMG cells were up-regulated in response to IL-4, whereas divalent metal transporter-1 (DMT1) and ferritin levels increased in response to LPS or A. Similar changes in expression were confirmed in isolated primary adult mouse microglia treated with pro- or anti-inflammatory inducers. LPS-induced changes in IMG cell iron metabolism were accompanied by notable metabolic changes, including increased glycolysis and decreased oxidative respiration. Under these conditions, the extracellular acidification rate was increased, compatible with changes in the cellular microenvironment that would support the pH-dependent function of DMT1. Moreover, LPS increased heme oxygenase-1 (HO1) expression in IMG cells, and iron released because of HO1 activity increased the intracellular labile free-iron pool. Together, this evidence indicates that brain microglia preferentially acquire iron from Tf or from non-Tf sources, depending on their polarization state; that NTBI uptake is enhanced by the proinflammatory response; and that under these conditions microglia sequester both extra- and intracellular iron.	[McCarthy, Ryan C.; Sosa, Jose Carlo; Gardeck, Andrew M.; Baez, Andrew S.; Lee, Chih-Hao; Wessling-Resnick, Marianne] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Wessling-Resnick, M (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	wessling@hsph.harvard.edu			National Institutes of Health [NIDDK R01 DK064750, NIAID R21 AI131659, NIEHS T32 ES016645]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI131659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES016645] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants NIDDK R01 DK064750 (to M.W.-R), NIAID R21 AI131659 (to C.-H.L.), and NIEHS T32 ES016645 (to R.C.M). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Barichello T, 2011, J NEUROIMMUNOL, V233, P12, DOI 10.1016/j.jneuroim.2010.10.035; CASEY JL, 1988, SCIENCE, V240, P924, DOI 10.1126/science.2452485; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Erlitzki R, 2002, J BIOL CHEM, V277, P42579, DOI 10.1074/jbc.M207918200; Fan Y, 2017, MOL CELLS, V40, P163, DOI 10.14348/molcells.2017.0011; Gaasch JA, 2007, NEUROCHEM RES, V32, P1196, DOI 10.1007/s11064-007-9290-4; Greter M, 2013, GLIA, V61, P121, DOI 10.1002/glia.22408; GUTTERIDGE JMC, 1992, CLIN SCI, V82, P315, DOI 10.1042/cs0820315; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Jenkitkasemwong S, 2012, BIOMETALS, V25, P643, DOI 10.1007/s10534-012-9526-x; Kaur C, 1999, NEUROSCI LETT, V262, P183, DOI 10.1016/S0304-3940(99)00075-0; Madsen E, 2007, ANNU REV NEUROSCI, V30, P317, DOI 10.1146/annurev.neuro.30.051606.094232; McCarthy RC, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0484-z; McCarthy RC, 2015, CELL MOL LIFE SCI, V72, P709, DOI 10.1007/s00018-014-1771-4; McCarthy RC, 2012, BIOMETALS, V25, P665, DOI 10.1007/s10534-012-9538-6; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Rouault Tracey A, 2006, Semin Pediatr Neurol, V13, P142, DOI 10.1016/j.spen.2006.08.002; Salvador GA, 2010, BIOFACTORS, V36, P103, DOI 10.1002/biof.80; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Stefanova D, 2017, BLOOD, V130, P245, DOI 10.1182/blood-2017-03-772715; Thomsen MS, 2015, NEUROBIOL DIS, V81, P108, DOI 10.1016/j.nbd.2015.03.013; Urrutia P, 2013, J NEUROCHEM, V126, P541, DOI 10.1111/jnc.12244; Wessling-Resnick M, 2015, J BIOL CHEM, V290, P18984, DOI 10.1074/jbc.R115.643973; Wessling-Resnick M, 2010, ANNU REV NUTR, V30, P105, DOI 10.1146/annurev.nutr.012809.104804; Wetli HA, 2006, CHEM BIOL, V13, P965, DOI 10.1016/j.chembiol.2006.08.005; Yanatori I, 2017, J BIOL CHEM, V292, P13205, DOI 10.1074/jbc.M117.776021; Yanatori I, 2014, BIOCHEM J, V462, P25, DOI 10.1042/BJ20140225; Zechel S, 2006, J NEUROSCI RES, V84, P790, DOI 10.1002/jnr.20991; Zeineh MM, 2015, NEUROBIOL AGING, V36, P2483, DOI 10.1016/j.neurobiolaging.2015.05.022	33	78	79	5	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7853	7863		10.1074/jbc.RA118.001949	http://dx.doi.org/10.1074/jbc.RA118.001949			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29610275	hybrid, Green Published			2022-12-26	WOS:000437256500032
J	Bell, KJL; Azizi, L; Nilsson, PM; Hayen, A; Irwig, L; Ostgren, CJ; Sundrom, J				Bell, Katy J. L.; Azizi, Lamiae; Nilsson, Peter M.; Hayen, Andrew; Irwig, Les; Ostgren, Carl J.; Sundrom, Johan			Prognostic impact of systolic blood pressure variability in people with diabetes	PLOS ONE			English	Article							TO-VISIT VARIABILITY; ALL-CAUSE MORTALITY; PRIMARY-CARE; CARDIOVASCULAR-DISEASE; MICROVASCULAR COMPLICATIONS; EPISODIC HYPERTENSION; RISK; PREDICTION; EVENTS; COHORT	Objective Blood pressure variability (BPV) has been associated with risk of cardiovascular events in observational studies, independently of mean BP levels. In states with higher autonomic imbalance, such as in diabetes, the importance of BP variability may theoretically be even greater. We aimed to investigate the incremental value of BPV for prediction of cardiovascular and all-cause mortality in patients with type 2 diabetes. Methods We identified 9,855 patients without pre-existing cardiovascular disease who did not change BP-lowering treatment during the observation period from a Swedish primary health care cohort of patients with type 2 diabetes. BPV was summarized as the standard deviation (SD), coefficient of variation (CV), or variation independent of mean (VIM). Patients were followed for a median of 4 years and associations with cardiovascular and all-cause mortality were investigated using Cox proportional hazards models. Results BPV was not associated with cardiovascular specific or all-cause mortality in the total sample. In patients who were not on BP-lowering drugs during the observation period (n = 2,949), variability measures were associated with all-cause mortality: hazard ratios were 1.05, 1.04 and 1.05 for 50% increases in SD, CV and VIM, respectively, adjusted for Framingham risk score risk factors, including mean BP. However, the addition of the variability measures in this subgroup only led to very minimal improvement in discrimination, indicating they may have limited clinical usefulness (change in C-statistic ranged from 0.000-0.003 in all models). Conclusions Although BPV was independently associated with all-cause mortality in diabetes patients in primary care who did not have pre-existing cardiovascular disease or BP-lowering drugs, it may be of minimal clinical usefulness above and beyond that of other routinely measured predictors, including mean BP.	[Bell, Katy J. L.; Irwig, Les] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Azizi, Lamiae] Univ Sydney, Sch Math & Stat, Sydney, NSW, Australia; [Nilsson, Peter M.] Lund Univ, Dept Clin Sci, Univ Hosp, Malmo, Sweden; [Hayen, Andrew] UTS, Australian Ctr Publ & Populat Hlth Res, Sydney, NSW, Australia; [Ostgren, Carl J.] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Sundrom, Johan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	University of Sydney; University of Sydney; Lund University; Skane University Hospital; University of Technology Sydney; Linkoping University; Uppsala University	Bell, KJL (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia.	katy.bell@sydney.edu.au	Stefanadis, Christodoulos/ABH-2232-2020; Bell, Katy/B-9650-2013	Stefanadis, Christodoulos/0000-0001-5974-6454; Bell, Katy/0000-0002-0137-3218; Hayen, Andrew/0000-0003-4046-8030	Australian National Health and Medical Research Council [1013390, 633003]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The work was supported by the Australian National Health and Medical Research Council (Early Career Fellowship No. 1013390 and Program Grant No 633003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Bell K, 2012, EUR J PREV CARDIOL, V19, P1474, DOI 10.1177/1741826711424494; Bell KJL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006044; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Hata J, 2013, CIRCULATION, V128, P1325, DOI 10.1161/CIRCULATIONAHA.113.002717; Hsieh YT, 2012, EUR J CLIN INVEST, V42, P245, DOI 10.1111/j.1365-2362.2011.02574.x; Lau KK, 2014, ATHEROSCLEROSIS, V235, P230, DOI 10.1016/j.atherosclerosis.2014.04.015; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; MCKINLAY S, 1994, J HUM HYPERTENS, V8, P887; Moons KGM, 2012, HEART, V98, P683, DOI 10.1136/heartjnl-2011-301246; Ostgren CJ, 2013, DIABETIC MED, V30, pE170, DOI 10.1111/dme.12145; Parati G, 2013, DIABETES CARE, V36, pS312, DOI 10.2337/dcS13-2043; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Sohn MW, 2017, J DIABETES COMPLICAT, V31, P195, DOI 10.1016/j.jdiacomp.2016.09.003; Stevens SL, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4098; Sundstrom J, 2013, J HYPERTENS, V31, P1603, DOI 10.1097/HJH.0b013e32836123aa; Takao T, 2015, J DIABETES COMPLICAT, V29, P699, DOI 10.1016/j.jdiacomp.2015.03.010; Vinik AI, 2007, CIRCULATION, V115, P387, DOI 10.1161/CIRCULATIONAHA.106.634949; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wan EYF, 2017, DIABETES CARE, V40, P270, DOI 10.2337/dc16-1617	21	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194084	10.1371/journal.pone.0194084	http://dx.doi.org/10.1371/journal.pone.0194084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641538	Green Published, gold, Green Submitted			2022-12-26	WOS:000429742900023
J	Gommer, R; Bom, RA; Fijen, TPM; van Gils, JA				Gommer, Roy; Bom, Roeland A.; Fijen, Thijs P. M.; van Gils, Jan A.			Stomach fullness shapes prey choice decisions in crab plovers (Dromas ardeola)	PLOS ONE			English	Article							FORAGING DECISIONS; SIZE SELECTION; DIGESTIVE RATE; RED KNOTS; CONSTRAINTS; MECHANISMS; SHOREBIRD; CAPACITY; BEHAVIOR; MODEL	Foragers whose energy intake rate is constrained by search and handling time should, according to the contingency model (CM), select prey items whose profitability exceeds or equals the forager's long-term average energy intake rate. This rule does not apply when prey items are found and ingested at a higher rate than the digestive system can process them. According to the digestive rate model (DRM), foragers in such situations should prefer prey with the highest digestive quality, instead of the highest profitability. As the digestive system fills up, the limiting constraint switches from ingestion rate to digestion rate, and prey choice is expected to change accordingly for foragers making decisions over a relative short time window. We use these models to understand prey choice in crab plovers (Dromas ardeola), preying on either small burrowing crabs that are swallowed whole (high profitability, but potentially inducing a digestive constraint) or on larger swimming crabs that are opened to consume only the flesh (low profitability, but easier to digest). To parameterize the CM and DRM, we measured energy content, ballast mass and handling times for different sized prey, and the birds' digestive capacity in three captive individuals. Subsequently, these birds were used in ad libitum experiments to test if they obeyed the rules of the CM or DRM. We found that crab plovers with an empty stomach mainly chose the most profitable prey, matching the CM. When stomach fullness increased, the birds switched their preference from the most profitable prey to the highest-quality prey, matching the predictions of the DRM. This shows that prey choice is context dependent, affected by the stomach fullness of an animal. Our results suggest that prey choice experiments should be carefully interpreted, especially under captive conditions as foragers often 'fill up' in the course of feeding trials.	[Gommer, Roy; Bom, Roeland A.; Fijen, Thijs P. M.; van Gils, Jan A.] NIOZ Royal Netherlands Inst Sea Res, Dept Coastal Syst, Den Burg, Texel, Netherlands; [Gommer, Roy; Bom, Roeland A.; Fijen, Thijs P. M.; van Gils, Jan A.] Univ Utrecht, Den Burg, Texel, Netherlands; [Gommer, Roy] Univ Groningen, Groningen Inst Evolutionary Life Sci GELIFES, Conservat Ecol Grp, Groningen, Netherlands; [Bom, Roeland A.] Sultan Qaboos Univ, Remote Sensing & GIS Ctr, Al Khoud, Oman; [Fijen, Thijs P. M.] Wageningen Univ & Res, Plant Ecol & Nat Conservat, Wageningen, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; University of Groningen; Sultan Qaboos University; Wageningen University & Research	Gommer, R (corresponding author), NIOZ Royal Netherlands Inst Sea Res, Dept Coastal Syst, Den Burg, Texel, Netherlands.; Gommer, R (corresponding author), Univ Utrecht, Den Burg, Texel, Netherlands.; Gommer, R (corresponding author), Univ Groningen, Groningen Inst Evolutionary Life Sci GELIFES, Conservat Ecol Grp, Groningen, Netherlands.	roygommer@hotmail.com	Fijen, Thijs/O-9864-2019	Fijen, Thijs/0000-0002-4371-2708	Research Council (TRC) of the Sultanate of Oman [ORG/EBR/12/002]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) in the Netherlands [821.01.001]	Research Council (TRC) of the Sultanate of Oman(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) in the Netherlands(Netherlands Organization for Scientific Research (NWO))	This study was financed by The Research Council (TRC) of the Sultanate of Oman (ORG/EBR/12/002 grant awarded to Andy Kwarteng) and by Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) in the Netherlands (ALW Open Programme grant 821.01.001 awarded to Jan A. van Gils).	[Anonymous], FORAGING THEORY; Aspinall S.J., 1996, ARABIAN WILDLIFE, V3, P32; BALL JP, 1994, OIKOS, V70, P233, DOI 10.2307/3545634; BENCE JR, 1986, ECOLOGY, V67, P324, DOI 10.2307/1938576; Bergman CM, 2001, J ANIM ECOL, V70, P289, DOI 10.1046/j.1365-2656.2001.00496.x; Bom Roeland A., 2015, Wader Study, V122, P212; CHARNOV EL, 1976, AM NAT, V110, P141, DOI 10.1086/283054; de Fouw Jimmy, 2017, Wader Study, V124, P10, DOI 10.18194/ws.00060; De Marchi G, 2006, IBIS, V148, P753, DOI 10.1111/j.1474-919X.2006.00572.x; De Sanctis A, 2005, IBIS, V147, P490, DOI 10.1111/j.1474-919x.2005.00419.x; Delany S., 2009, ATLAS WADER POPULATI; Farnsworth KD, 1998, FUNCT ECOL, V12, P74, DOI 10.1046/j.1365-2435.1998.00163.x; Fortin D, 2002, ECOLOGY, V83, P970, DOI 10.1890/0012-9658(2002)083[0970:TTSOFD]2.0.CO;2; Gill AB, 1998, J FISH BIOL, V53, P897, DOI 10.1111/j.1095-8649.1998.tb01844.x; Hewson-Hughes AK, 2011, J EXP BIOL, V214, P1039, DOI 10.1242/jeb.049429; Hirakawa H, 1997, EVOL ECOL, V11, P249; Hockey PAR, 1996, OSTRICH, V67, P33, DOI 10.1080/00306525.1996.9633778; HOUSTON A, 1985, BEHAV ECOL SOCIOBIOL, V17, P135; Illius AW, 2002, J ANIM ECOL, V71, P723, DOI 10.1046/j.1365-2656.2002.00643.x; Jeschke JM, 2002, ECOL MONOGR, V72, P95, DOI 10.1890/0012-9615(2002)072[0095:PFRDBH]2.0.CO;2; Kacelnik A, 1996, AM ZOOL, V36, P402; KREBS JR, 1977, ANIM BEHAV, V25, P30, DOI 10.1016/0003-3472(77)90064-1; LABINGER Z, 1991, ANIM BEHAV, V42, P969, DOI 10.1016/S0003-3472(05)80149-6; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Machovsky-Capuska GE, 2016, ETHOLOGY, V122, P703, DOI 10.1111/eth.12523; Machovsky-Capuska GE, 2016, TRENDS ECOL EVOL, V31, P355, DOI 10.1016/j.tree.2016.02.009; Mayntz D, 2009, ANIM BEHAV, V77, P349, DOI 10.1016/j.anbehav.2008.09.036; Molokwu MN, 2011, BEHAV ECOL, V22, P639, DOI 10.1093/beheco/arr025; Oudman T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136144; Oudman T, 2014, AM NAT, V183, P650, DOI 10.1086/675759; Quaintenne G, 2010, J ANIM ECOL, V79, P53, DOI 10.1111/j.1365-2656.2009.01608.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RECHTEN C, 1983, ANIM BEHAV, V31, P576, DOI 10.1016/S0003-3472(83)80081-5; Sih A, 2001, ANIM BEHAV, V61, P379, DOI 10.1006/anbe.2000.1592; Simpson SJ, 2011, AUST J ZOOL, V59, P350, DOI 10.1071/ZO11068; SUTHERLAND WJ, 1982, ANIM BEHAV, V30, P857, DOI 10.1016/S0003-3472(82)80159-0; Vahl WK, 2005, BEHAV ECOL, V16, P845, DOI 10.1093/beheco/ari073; Van Gils JA, 2005, J ANIM ECOL, V74, P105, DOI 10.1111/j.1365-2656.2004.00903.x; van Gils JA, 2003, J EXP BIOL, V206, P3369, DOI 10.1242/jeb.00546; VANDERMEER J, 1992, ANIM BEHAV, V44, P1101, DOI 10.1016/S0003-3472(05)80322-7; Verkuil Yvonne, 2006, Wader Study Group Bulletin, V110, P15; VERLINDEN C, 1989, EVOL ECOL, V3, P264, DOI 10.1007/BF02270727; Wetzel M. A., 2008, HELGOLAND MARINE RES, V59, P206; Whelan CJ, 2005, OIKOS, V110, P481, DOI 10.1111/j.0030-1299.2005.13387.x; ZWARTS L, 1993, NETH J SEA RES, V31, P441, DOI 10.1016/0077-7579(93)90059-2; Zwarts L, 1996, ARDEA, V84A, P269; ZWARTS L, 1990, ARDEA, V78, P193; Zwarts L, 1996, ARDEA, V84A, P229	48	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194824	10.1371/journal.pone.0194824	http://dx.doi.org/10.1371/journal.pone.0194824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641542	Green Published, Green Submitted, gold			2022-12-26	WOS:000429742900048
J	Fernandez, I; Sycz, G; Goldbaum, FA; Carrica, MD				Fernandez, Ignacio; Sycz, Gabriela; Alberto Goldbaum, Fernando; del Carmen Carrica, Mariela			Acidic pH triggers the phosphorylation of the response regulator NtrX in alphaproteobacteria	PLOS ONE			English	Article							CAULOBACTER-CRESCENTUS; 2-COMPONENT SYSTEM; RHODOBACTER-CAPSULATUS; ESCHERICHIA-COLI; BRUCELLA-SUIS; EXPRESSION; SENSOR; MACROPHAGES; ADAPTATION; METABOLISM	Many signaling pathways that control cellular development, cell-cycle progression and nutritional versatility have been studied in Caulobacter crescentus. For example, it was suggested that the response regulator NtrX is conditionally essential for this bacterium and that it might be necessary for responding to a signal produced in phosphate-replete minimal medium. However, such signal has not been identified yet and the role of NtrX in C. crescentus biology remains elusive. Here, using wild-type C. crescentus and a strain with a chromosomally myc-tagged ntrX gene, we demonstrate that high concentrations of phosphate (10 mM) regulate ntrX transcription and the abundance of the protein. We also show that the pH of the medium acts as a switch able to regulate the phosphorylation status of NtrX, promoting its phosphorylation under mildly acidic conditions and its dephosphorylation at neutral pH. Moreover, we demonstrate that the ntrX gene is required for survival in environments with low pH and under acidic stress. Finally, we prove that NtrX phosphorylation is also triggered by low pH in Brucella abortus, a pathogenic alphaproteobacterium. Overall, our work contributes to deepen the general knowledge of this system and provides tools to elucidate the NtrX regulon.	[Fernandez, Ignacio; Sycz, Gabriela; Alberto Goldbaum, Fernando; del Carmen Carrica, Mariela] Fdn Inst Leloir, CONICET, IIBBA, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Carrica, MD (corresponding author), Fdn Inst Leloir, CONICET, IIBBA, Buenos Aires, DF, Argentina.	mcarrica@leloir.org.ar		Fernandez, Ignacio/0000-0003-2632-8111; Goldbaum, Fernando/0000-0001-6235-3002	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT-2013-1629]; CONICET	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, PICT-2013-1629) to Dr. Mariela del Carmen Carrica.; We thank Michael Laub for kindly providing us the C. crescentus CB15N and Delta ntrX strains. F.A.G and M.C.C are researchers from CONICET. I.F. received a fellowship from CONICET and G.S. is a fellow from this institution.	Atack JM, 2013, J BACTERIOL, V195, P2632, DOI 10.1128/JB.02062-12; Bonato P, 2016, FEBS J, V283, P3919, DOI 10.1111/febs.13897; Boschiroli ML, 2002, P NATL ACAD SCI USA, V99, P1544, DOI 10.1073/pnas.032514299; Calatrava-Morales N, 2017, MOL PLANT MICROBE IN, V30, P566, DOI 10.1094/MPMI-01-17-0021-R; Capra EJ, 2012, CELL, V150, P222, DOI 10.1016/j.cell.2012.05.033; Chakraborty S, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002116; Cheng ZH, 2014, MBIO, V5, DOI 10.1128/mBio.02141-14; Cheung J, 2008, J BIOL CHEM, V283, P13762, DOI 10.1074/jbc.M710592200; Choi J, 2016, MOL MICROBIOL, V101, P1024, DOI 10.1111/mmi.13439; Carrica MD, 2013, MOL MICROBIOL, V88, P222, DOI 10.1111/mmi.12181; Carrica MD, 2012, MOL MICROBIOL, V85, P39, DOI 10.1111/j.1365-2958.2012.08095.x; Drepper T, 2006, FEMS MICROBIOL LETT, V258, P250, DOI 10.1111/j.1574-6968.2006.00228.x; Eguchi Y, 2014, J BACTERIOL, V196, P3140, DOI 10.1128/JB.01742-14; ELY B, 1991, BACT GEN SYST, V204, P372, DOI DOI 10.1016/0076-6879(91)04019-K; Fernandez I, 2017, J MOL BIOL, V429, P1192, DOI 10.1016/j.jmb.2016.12.022; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gregor J, 2007, J MOL MICROB BIOTECH, V13, P126, DOI 10.1159/000103604; Hsieh YJ, 2010, CURR OPIN MICROBIOL, V13, P198, DOI 10.1016/j.mib.2010.01.014; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Kulakov YK, 1997, RES MICROBIOL, V148, P145, DOI 10.1016/S0923-2508(97)87645-0; Lubin EA, 2016, J BACTERIOL, V198, P187, DOI 10.1128/JB.00658-15; Lund P, 2014, FEMS MICROBIOL REV, V38, P1091, DOI 10.1111/1574-6976.12076; PAWLOWSKI K, 1991, MOL GEN GENET, V231, P124, DOI 10.1007/BF00293830; Perez JC, 2007, MOL MICROBIOL, V63, P283, DOI 10.1111/j.1365-2958.2006.05512.x; Porte F, 1999, INFECT IMMUN, V67, P4041, DOI 10.1128/IAI.67.8.4041-4047.1999; Prost LR, 2007, MOL CELL, V26, P165, DOI 10.1016/j.molcel.2007.03.008; Purcell EB, 2008, ADV EXP MED BIOL, V631, P122, DOI 10.1007/978-0-387-78885-2_8; RILEY RG, 1976, MICROBIOS, V16, P219; Roop RM, 2009, MED MICROBIOL IMMUN, V198, P221, DOI 10.1007/s00430-009-0123-8; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Unger T, 2010, J STRUCT BIOL, V172, P34, DOI 10.1016/j.jsb.2010.06.016; Wang D, 2013, APPL ENVIRON MICROB, V79, P7150, DOI 10.1128/AEM.02225-13; Wen Y, 2007, J BACTERIOL, V189, P2426, DOI 10.1128/JB.01492-06; Wortinger MA, 1998, MOL MICROBIOL, V29, P963, DOI 10.1046/j.1365-2958.1998.00959.x	36	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194486	10.1371/journal.pone.0194486	http://dx.doi.org/10.1371/journal.pone.0194486			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634773	Green Published, gold, Green Submitted			2022-12-26	WOS:000429522200010
J	Jansen, C; Al-Kassou, B; Lehmann, J; Pohlmann, A; Chang, J; Praktiknjo, M; Nickenig, G; Strassburg, CP; Schrickel, JW; Andrie, R; Linhart, M; Trebicka, J				Jansen, Christian; Al-Kassou, Baravan; Lehmann, Jennifer; Pohlmann, Alessandra; Chang, Johannes; Praktiknjo, Michael; Nickenig, Georg; Strassburg, Christian P.; Schrickel, Jan W.; Andrie, Rene; Linhart, Markus; Trebicka, Jonel			Severe abnormal Heart Rate Turbulence Onset is associated with deterioration of liver cirrhosis	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; RATE-VARIABILITY; AUTONOMIC NEUROPATHY; FAILURE; DECOMPENSATION; PROGNOSIS; INTERVAL	Background In patients with liver cirrhosis, cardiac dysfunction is frequent and is associated with increased morbidity and mortality. Cardiac dysfunction in cirrhosis seems to be linked to autonomic dysfunction. This study investigates the role of autonomic dysfunction assessed by Heart Rate Turbulence (HRT) analyses in patients with liver cirrhosis. Methods and patients Inclusion criteria was (1) diagnosis of cirrhosis by clinical, imaging or biopsy and (2) evaluation by standard 12-lead-ECG and 24h holter monitoring and (3) at least 3 premature ventricular contractions. The exclusion criterion was presence of cardiac diseases, independent of liver cirrhosis. Biochemical parameters were analysed using standard methods. HRT was assessed using Turbulence onset (TO) and slope (TS). The endpoint was deterioration of liver cirrhosis defined as increased MELD and readmission for complications of liver cirrhosis. Results Out of 122 cirrhotic patients, 82 patients (63% male) with median Child score of 6 (range 5-12) and median MELD score of 10 (range 6-32) were included. Increasing Child score, INR and decreasing albumin were correlated with TO. In addition, decompensated patients with ascites showed more abnormal TO and TS. During the observation period, patients with more abnormal TO showed significantly higher rate of rising MELD Score at 6 months (p = 0.03). Nevertheless, at least in our collective HRT-parameters were not independent predictors of deterioration of cirrhosis. Conclusion Parameters of HRT are closely associated with deterioration of cirrhosis and might be helpful in its prediction.	[Jansen, Christian; Al-Kassou, Baravan; Lehmann, Jennifer; Pohlmann, Alessandra; Chang, Johannes; Praktiknjo, Michael; Strassburg, Christian P.; Trebicka, Jonel] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Nickenig, Georg; Schrickel, Jan W.; Andrie, Rene; Linhart, Markus] Univ Bonn, Dept Internal Med 2, Bonn, Germany; [Linhart, Markus] Hosp Clin Barcelona, Dept Cardiol, Barcelona, Spain; [Trebicka, Jonel] European Fdn Study Chron Liver Failure, Barcelona, Spain; [Trebicka, Jonel] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark; [Trebicka, Jonel] Inst Bioengn Catalonia, Barcelona, Spain	University of Bonn; University of Bonn; University of Barcelona; Hospital Clinic de Barcelona; University of Southern Denmark; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona	Trebicka, J (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.; Trebicka, J (corresponding author), European Fdn Study Chron Liver Failure, Barcelona, Spain.; Trebicka, J (corresponding author), Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark.; Trebicka, J (corresponding author), Inst Bioengn Catalonia, Barcelona, Spain.	jonel.trebicka@ukbonn.de	Al-Kassou, Baravan/GPW-7910-2022		Deutsche Forschungsgemeinschaft [SFB TRR57]; Cellex Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cellex Foundation	The authors were supported by grants from the Deutsche Forschungsgemeinschaft (SFB TRR57) and Cellex Foundation. The funders had no influence on study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ates F, 2006, DIGEST DIS SCI, V51, P1614, DOI 10.1007/s10620-006-9073-9; Balcioglu S, 2007, AM J CARDIOL, V100, P890, DOI 10.1016/j.amjcard.2007.03.106; Barthel P, 2003, CIRCULATION, V108, P1221, DOI 10.1161/01.CIR.0000088783.34082.89; Bazett H. C., 1997, ANN NONINVAS ELECTRO, V2, P177, DOI DOI 10.1111/J.1542-474X.1997.TB00325.X; EWING DJ, 1986, CLIN ENDOCRINOL META, V15, P855, DOI 10.1016/S0300-595X(86)80078-0; Garcia-Martinez R, 2013, HEPATOLOGY, V58, P1836, DOI 10.1002/hep.26338; Genovesi S, 2009, CLIN SCI, V116, P851, DOI 10.1042/CS20080325; GERBES AL, 1986, LANCET, V1, P1409; Gunduz H, 2006, EUROPACE, V8, P515, DOI 10.1093/europace/eul059; KURTHS J, 1995, CHAOS, V5, P88, DOI 10.1063/1.166090; Laffi G, 1997, GASTROENTEROLOGY, V113, P891, DOI 10.1016/S0016-5085(97)70184-7; LEE SS, 1990, HEPATOLOGY, V12, P481, DOI 10.1002/hep.1840120306; Mani AR, 2009, AM J PHYSIOL-GASTR L, V296, pG330, DOI 10.1152/ajpgi.90488.2008; Moller S, 2007, AM J PHYSIOL-HEART C, V292, pH2966, DOI 10.1152/ajpheart.01227.2006; Moller S, 2013, EUR HEART J, V34, P2804, DOI 10.1093/eurheartj/eht246; Moore RKG, 2006, EUR J HEART FAIL, V8, P585, DOI 10.1016/j.ejheart.2005.11.012; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Osman F, 2004, AM J CARDIOL, V94, P465, DOI 10.1016/j.amjcard.2004.04.061; Piano S, 2017, J HEPATOL, V67, P1177, DOI 10.1016/j.jhep.2017.07.008; Poliwczak AR, 2011, MED SCI MONITOR, V17, pPR5, DOI 10.12659/MSM.881788; Ramirez J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186152; Schmidt G, 1999, LANCET, V353, P1390, DOI 10.1016/S0140-6736(98)08428-1; Stockigt F, 2014, EUROPACE, V16, P1092, DOI 10.1093/europace/eut357; Tuomainen P, 2005, LIFE SCI, V77, P2723, DOI 10.1016/j.lfs.2005.05.023; Watanabe MA, 2004, HEART RHYTHM, V1, P732, DOI 10.1016/j.hrthm.2004.09.003	25	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195631	10.1371/journal.pone.0195631	http://dx.doi.org/10.1371/journal.pone.0195631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634776	Green Published, gold, Green Submitted			2022-12-26	WOS:000429522200042
J	Ramula, S; Ost, M; Linden, A; Karell, P; Kilpi, M				Ramula, Satu; Ost, Markus; Linden, Andreas; Karell, Patrik; Kilpi, Mikael			Increased male bias in eider ducks can be explained by sex-specific survival of prime-age breeders	PLOS ONE			English	Article							SOMATERIA-MOLLISSIMA; COMMON EIDERS; RATIO; POPULATION; DYNAMICS; SYSTEM; COST; CONSEQUENCES; DISPERSAL; MOVEMENTS	In contrast to theoretical predictions of even adult sex ratios, males are dominating in many bird populations. Such bias among adults may be critical to population growth and viability. Nevertheless, demographic mechanisms for biased adult sex ratios are still poorly understood. Here, we examined potential demographic mechanisms for the recent dramatic shift from a slight female bias among adult eider ducks (Somateria mollissima) to a male bias (about 65% males) in the Baltic Sea, where the species is currently declining. We analysed a nine-year dataset on offspring sex ratio at hatching based on molecularly sexed ducklings of individually known mothers. Moreover, using demographic data from long-term individual-based capture-recapture records, we investigated how sex-specific survival at different ages after fledgling can modify the adult sex ratio. More specifically, we constructed a stochastic two-sex matrix population model and simulated scenarios of different survival probabilities for males and females. We found that sex ratio at hatching was slightly female-biased (52.8%) and therefore unlikely to explain the observed male bias among adult birds. Our stochastic simulations with higher survival for males than for females revealed that despite a slight female bias at hatching, study populations shifted to a male-biased adult sex ratio (> 60% males) in a few decades. This shift was driven by prime reproductive-age individuals(>5-year-old), with sex-specific survival of younger age classes playing a minor role. Hence, different age classes contributed disproportion ally to population dynamics. We argue that an alternative explanation for the observed male dominance among adults sex-biased dispersal can be considered redundant and is unlikely, given the ecology of the species. The present study highlights the importance of considering population structure and age-specific vital rates when assessing population dynamics and management targets.	[Ramula, Satu] Univ Turku, Dept Biol, Turku, Finland; [Ost, Markus; Linden, Andreas; Karell, Patrik; Kilpi, Mikael] Novia Univ Appl Sci, Bioecon Res Team, Ekenas, Finland; [Ost, Markus] Abo Akad Univ, Environm & Marine Biol, Fac Sci & Engn, Turku, Finland	University of Turku; Novia University of Applied Sciences; Abo Akademi University	Ramula, S (corresponding author), Univ Turku, Dept Biol, Turku, Finland.	satu.ramula@utu.fi	Öst, Markus/C-7376-2008; Linden, Andreas/D-9315-2017	Öst, Markus/0000-0002-2205-1437; Karell, Patrik/0000-0003-0297-125X; Linden, Andreas/0000-0002-5548-2671	Academy of Finland [285746, 309992]; Swedish Cultural Foundation in Finland; Walter and Andree de Nottbeck Foundation	Academy of Finland(Academy of Finland); Swedish Cultural Foundation in Finland; Walter and Andree de Nottbeck Foundation	This work was supported by the Academy of Finland (#285746 to SR, #309992 to PK), the Swedish Cultural Foundation in Finland (to MO) and the Walter and Andree de Nottbeck Foundation (to MK).	Alisauskas RT, 2015, STUDIES AVIAN BIOL, P46; Ancona S, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0313; BAILLIE SR, 1982, BIRD STUDY, V29, P55, DOI 10.1080/00063658209476738; BAILLIE SR, 1989, IBIS, V131, P321, DOI 10.1111/j.1474-919X.1989.tb02782.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bensch S, 1999, J EVOLUTION BIOL, V12, P1104; BirdLife International, 2015, EUR RED LIST BIRDS; Blums P, 1996, AUK, V113, P505, DOI 10.2307/4088920; Carmona-Isunza MC, 2017, BEHAV ECOL, V28, P523, DOI 10.1093/beheco/arw183; Caswell, 2000, MATRIX POPULATION MO; COULSON JC, 1984, IBIS, V126, P525, DOI 10.1111/j.1474-919X.1984.tb02078.x; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; Eberhart-Phillips LJ, 2017, P NATL ACAD SCI USA, V114, pE5474, DOI 10.1073/pnas.1620043114; Ekroos J, 2012, OECOLOGIA, V170, P979, DOI 10.1007/s00442-012-2378-9; Fisher, 1930, GENETICAL THEORY NAT; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Gerber LR, 2014, J APPL ECOL, V51, P270, DOI 10.1111/1365-2664.12177; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Hario M, 2009, ORNIS FENNICA, V86, P81; Hario M, 2009, OECOLOGIA, V159, P747, DOI 10.1007/s00442-008-1265-x; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Jaatinen K, 2011, ANIM BEHAV, V81, P1289, DOI 10.1016/j.anbehav.2011.03.020; Jaatinen K, 2011, J ANIM ECOL, V80, P49, DOI 10.1111/j.1365-2656.2010.01757.x; Kilpi M, 1997, OECOLOGIA, V111, P297, DOI 10.1007/s004420050238; Kilpi M, 2003, ORNIS FENNICA, V80, P137; Kokko H, 2008, J EVOLUTION BIOL, V21, P919, DOI 10.1111/j.1420-9101.2008.01540.x; Kosztolanyi A, 2011, J EVOLUTION BIOL, V24, P1842, DOI 10.1111/j.1420-9101.2011.02305.x; Kurvinen L, 2016, ORNIS FENNICA, V93, P55; Lee AM, 2011, AM NAT, V177, P301, DOI 10.1086/658344; Lehikoinen A, 2008, CONDOR, V110, P574, DOI 10.1525/cond.2008.8574; Lehikoinen A, 2008, WILDLIFE BIOL, V14, P288, DOI 10.2981/0909-6396(2008)14[288:LCITSR]2.0.CO;2; McNamara JM, 2000, J THEOR BIOL, V205, P605, DOI 10.1006/jtbi.2000.2093; Milton GR, 2016, J WILDLIFE MANAGE, V80, P1427, DOI 10.1002/jwmg.21135; Morrison CA, 2016, J ANIM ECOL, V85, P1298, DOI 10.1111/1365-2656.12556; Nevoux M, 2013, ECOL LETT, V16, P438, DOI 10.1111/ele.12060; Oppel S, 2010, CONDOR, V112, P323, DOI 10.1525/cond.2010.090199; Ost M, 2016, POPUL ECOL, V58, P121, DOI 10.1007/s10144-015-0517-y; Ost M, 2010, OECOLOGIA, V162, P59, DOI 10.1007/s00442-009-1444-4; Pettersson LB, 2004, BEHAV ECOL SOCIOBIOL, V55, P461, DOI 10.1007/s00265-003-0727-8; Pipoly I, 2015, NATURE, V527, P91, DOI 10.1038/nature15380; Proaktor G, 2007, BIOLOGY LETT, V3, P674, DOI 10.1098/rsbl.2007.0376; R Core Team, 2021, R LANGUAGE ENV STAT; Saino N, 2008, EVOL ECOL, V22, P659, DOI 10.1007/s10682-007-9189-1; Shyu E, 2016, ECOL EVOL, V6, P1470, DOI 10.1002/ece3.1902; Steele BB, 2007, ORNIS FENNICA, V84, P49; SWENNEN C, 1990, ORNIS SCAND, V21, P17, DOI 10.2307/3676374; Szekely T, 2014, J EVOLUTION BIOL, V27, P1500, DOI 10.1111/jeb.12415; Szekely T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0342; Veran S, 2009, ECOL LETT, V12, P129, DOI 10.1111/j.1461-0248.2008.01268.x	49	16	18	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195415	10.1371/journal.pone.0195415	http://dx.doi.org/10.1371/journal.pone.0195415			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634733	Green Published, gold			2022-12-26	WOS:000429522200030
J	Arkun, Y; Yasemi, M				Arkun, Yaman; Yasemi, Mohammadreza			Dynamics and control of the ERK signaling pathway: Sensitivity, bistability, and oscillations	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; EPIDERMAL-GROWTH-FACTOR; NEGATIVE-FEEDBACK; COMPUTATIONAL ANALYSIS; MAPK; RAS; PHOSPHORYLATION; SWITCH; EGF; ULTRASENSITIVITY	Cell signaling is the process by which extracellular information is transmitted into the cell to perform useful biological functions. The ERK (extracellular-signal-regulated kinase) signaling controls several cellular processes such as cell growth, proliferation, differentiation and apoptosis. The ERK signaling pathway considered in this work starts with an extracellular stimulus and ends with activated (double phosphorylated) ERK which gets translocated into the nucleus. We model and analyze this complex pathway by decomposing it into three functional subsystems. The first subsystem spans the initial part of the pathway from the extracellular growth factor to the formation of the SOS complex, ShC-Grb2-SOS. The second subsystem includes the activation of Ras which is mediated by the SOS complex. This is followed by the MAPK subsystem (or the Raf-MEK-ERK pathway) which produces the double phosphorylated ERK upon being activated by Ras. Although separate models exist in the literature at the subsystems level, a comprehensive model for the complete system including the important regulatory feedback loops is missing. Our dynamic model combines the existing subsystem models and studies their steady-state and dynamic interactions under feedback. We establish conditions under which bistability and oscillations exist for this important pathway. In particular, we show how the negative and positive feedback loops affect the dynamic characteristics that determine the cellular outcome.	[Arkun, Yaman; Yasemi, Mohammadreza] Koc Univ, Dept Chem & Biol Engn, Rumeli Feneri Yolu, Istanbul, Turkey	Koc University	Arkun, Y (corresponding author), Koc Univ, Dept Chem & Biol Engn, Rumeli Feneri Yolu, Istanbul, Turkey.	yarkun@ku.edu.tr		Arkun, Yaman/0000-0002-3740-379X; Yasemi, Mohammadreza/0000-0003-0226-7748	TUBITAK; Scientific and Technological Research Council of Turkey; Koc University	TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Koc University(Koc University)	The authors received funding from TUBITAK, The Scientific and Technological Research Council of Turkey and Koc University for this work.	Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Brightman FA, 2000, FEBS LETT, V482, P169, DOI 10.1016/S0014-5793(00)02037-8; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Chen D, 1996, J BIOL CHEM, V271, P6328, DOI 10.1074/jbc.271.11.6328; Choi S., 2007, INTRO SYSTEMS BIOL; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Doyle FJ, 2004, CELL, V118, P675, DOI [10.1016/j.cell.2004.09.008, DOI 10.1016/J.CELL.2004.09.008]; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; Ferrell JE, 2013, CURR OPIN CELL BIOL, V25, P676, DOI 10.1016/j.ceb.2013.07.007; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Fey D, 2016, SEMIN CELL DEV BIOL, V58, P96, DOI 10.1016/j.semcdb.2016.06.011; Gille H, 1999, J BIOL CHEM, V274, P22033, DOI 10.1074/jbc.274.31.22033; Goldstein B, 1999, J MOL RECOGNIT, V12, P293, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<293::AID-JMR472>3.0.CO;2-M; Golembo M, 1996, DEVELOPMENT, V122, P223; Hatakeyama M, 2003, BIOCHEM J, V373, P451, DOI 10.1042/BJ20021824; Hornberg JJ, 2005, ONCOGENE, V24, P5533, DOI 10.1038/sj.onc.1208817; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Ingalls B. P, 2014, J CHEM INF MODEL, V53, P1; Ingolia NT, 2004, CURR BIOL, V14, pR771, DOI 10.1016/j.cub.2004.09.018; Kawashima N, 2010, CHEM-EUR J, V16, P1186, DOI 10.1002/chem.200902963; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Klein DE, 2004, NATURE, V430, P1040, DOI 10.1038/nature02840; Kochanczyk M, 2017, SCI REP-UK, V7, DOI 10.1038/srep38244; LANGLOIS WJ, 1995, J BIOL CHEM, V270, P25320, DOI 10.1074/jbc.270.43.25320; Lauffenberger DA, 1993, RECEPTORS MODELS BIN; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; Nakayama K, 2008, CURRENT BIOL; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Ortega F, 2006, FEBS J, V273, P3915, DOI 10.1111/j.1742-4658.2006.05394.x; Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908; Pfeuty B, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046013; Pribyl M, 2003, BIOPHYS J, V84, P883; Qiao L, 2007, PLOS COMPUT BIOL, V3, P1819, DOI 10.1371/journal.pcbi.0030184; Reeves GT, 2005, DEV BIOL, V284, P523, DOI 10.1016/j.ydbio.2005.05.013; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Ryu H, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156458; Santarpia L, 2012, EXPERT OPIN THER TAR, V16, P103, DOI 10.1517/14728222.2011.645805; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Seborg D.E., 2011, PROCESS DYNAMICS CON; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Shin SY, 2009, J CELL SCI, V122, P425, DOI 10.1242/jcs.036319; Shurki A, 2004, PROTEINS, V55, P1, DOI 10.1002/prot.20004; Shvartsman SY, 2002, DEVELOPMENT, V129, P2577; Shvartsman SY, 2001, BIOPHYS J, V81, P1854, DOI 10.1016/S0006-3495(01)75837-7; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; SPORN MB, 1992, ANN INTERN MED, V117, P408, DOI 10.7326/0003-4819-117-5-408; Tian XJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011926; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Waters KM, 2014, CHEM RES TOXICOL, V27, P1496, DOI 10.1021/tx500085u; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; WILEY HS, 1988, J CELL BIOL, V107, P801, DOI 10.1083/jcb.107.2.801; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	62	38	38	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195513	10.1371/journal.pone.0195513	http://dx.doi.org/10.1371/journal.pone.0195513			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630631	gold, Green Published, Green Submitted			2022-12-26	WOS:000429505000054
J	Onishi, S; Ishino, M; Kitazawa, H; Yoto, A; Shimba, Y; Mochizuki, Y; Unno, K; Meguro, S; Tokimitsu, I; Miura, S				Onishi, Shintaro; Ishino, Mayu; Kitazawa, Hidefumi; Yoto, Ai; Shimba, Yuki; Mochizuki, Yusuke; Unno, Keiko; Meguro, Shinichi; Tokimitsu, Ichiro; Miura, Shinji			Green tea extracts ameliorate high-fat diet induced muscle atrophy in senescence-accelerated mouse prone-8 mice	PLOS ONE			English	Article							AMINO-ACID SUPPLEMENTATION; RANDOMIZED CONTROLLED-TRIAL; ACTIVATED PROTEIN-KINASE; INSULIN-RESISTANCE; METABOLIC SYNDROME; PHYSICAL FUNCTION; SELENOPROTEIN P; CHEMOTAXIN 2; RISK-FACTORS; OLDER WOMEN	Muscle atrophy (loss of skeletal muscle mass) causes progressive deterioration of skeletal function. Recently, excessive intake of fats was suggested to induce insulin resistance, followed by muscle atrophy. Green tea extracts (GTEs), which contain polyphenols such as epigallocatechin gallate, have beneficial effects on obesity, hyperglycemia, and insulin resistance, but their effects against muscle atrophy are still unclear. Here, we found that GTEs prevented high-fat (HF) diet induced muscle weight loss in senescence-accelerated mouse prone-8 (SAMP8), a murine model of senescence. SAMP8 mice were fed a control diet, an HF diet, or HF with 0.5% GTEs (HFGT) diet for 4 months. The HF diet induced muscle weight loss with aging (measured as quadriceps muscle weight), whereas GTEs prevented this loss. In HF diet fed mice, blood glucose and plasma insulin concentrations increased in comparison with the control group, and these mice had insulin resistance as determined by homeostasis model assessment of insulin resistance (HOMA-IR). In these mice, serum concentrations of leukocyte cell derived chemotaxin 2 (LECT2), which is known to induce insulin resistance in skeletal muscle, were elevated, and insulin signaling in muscle, as determined by the phosphorylation levels of Akt and p70 S6 kinases, tended to be decreased. In HFGT diet fed mice, these signs of insulin resistance and elevation of serum LECT2 were not observed. Although our study did not directly show the effect of serum LECT2 on muscle weight, insulin resistance examined using HOMA-IR indicated an intervention effect of serum LECT2 on muscle weight, as revealed by partial correlation analysis. Accordingly, GTEs might have beneficial effects on age-related and HF diet induced muscle weight loss, which correlates with insulin resistance and is accompanied by a change in serum LECT2.	[Onishi, Shintaro; Kitazawa, Hidefumi; Yoto, Ai; Meguro, Shinichi; Tokimitsu, Ichiro] Univ Shizuoka, Ind Acad Collaborat Res Lab, Shizuoka, Japan; [Onishi, Shintaro; Kitazawa, Hidefumi; Yoto, Ai; Meguro, Shinichi; Tokimitsu, Ichiro] Univ Shizuoka, Kao Corp, Shizuoka, Japan; [Ishino, Mayu; Shimba, Yuki; Mochizuki, Yusuke; Miura, Shinji] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Lab Nutr Biochem, Shizuoka, Japan; [Unno, Keiko] Univ Shizuoka, Sch Pharmaceut Sci, Dept Neurophysiol, Shizuoka, Japan; [Onishi, Shintaro; Kitazawa, Hidefumi; Meguro, Shinichi] Kao Corp, Biol Sci Res, Haga Gun, Tochigi, Japan; [Tokimitsu, Ichiro] Univ Human Arts & Sci, Dept Hlth & Food Sci, Saitama, Japan	University of Shizuoka; KAO Corporation; University of Shizuoka; University of Shizuoka; University of Shizuoka; KAO Corporation	Meguro, S (corresponding author), Univ Shizuoka, Ind Acad Collaborat Res Lab, Shizuoka, Japan.; Meguro, S (corresponding author), Univ Shizuoka, Kao Corp, Shizuoka, Japan.; Meguro, S (corresponding author), Kao Corp, Biol Sci Res, Haga Gun, Tochigi, Japan.	meguro.shinichi@kao.com	Miura, Shinji/K-6516-2013	Miura, Shinji/0000-0001-8806-9763; Meguro, Shinichi/0000-0002-3072-2632; SHIMBA, Yuki/0000-0001-7995-2220	University of Shizuoka; Kao Corporation	University of Shizuoka; Kao Corporation	This work was supported by industry academia collaboration between the University of Shizuoka and Kao Corporation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee S, 2012, NUTR RES, V32, P985, DOI 10.1016/j.nutres.2012.10.005; Biolo G, 1999, DIABETES, V48, P949, DOI 10.2337/diabetes.48.5.949; Bodine SC, 2013, INT J BIOCHEM CELL B, V45, P2200, DOI 10.1016/j.biocel.2013.06.011; Borsheim E, 2008, CLIN NUTR, V27, P189, DOI 10.1016/j.clnu.2008.01.001; Bosaeus I, 2016, P NUTR SOC, V75, P174, DOI 10.1017/S002966511500422X; Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; Brady AO, 2014, J SPORT HEALTH SCI, V3, P179, DOI 10.1016/j.jshs.2014.04.002; Brown AL, 2009, BRIT J NUTR, V101, P886, DOI 10.1017/S0007114508047727; Chen S, 2015, BIOCHEM BIOPH RES CO, V461, P1, DOI 10.1016/j.bbrc.2015.03.158; Derave W, 2005, EXP GERONTOL, V40, P562, DOI 10.1016/j.exger.2005.05.005; Derave W, 2005, AM J PHYSIOL-ENDOC M, V289, pE272, DOI 10.1152/ajpendo.00039.2005; Dillon EL, 2009, J CLIN ENDOCR METAB, V94, P1630, DOI 10.1210/jc.2008-1564; Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291; Ferrando AA, 2010, CLIN NUTR, V29, P18, DOI 10.1016/j.clnu.2009.03.009; Ferreira MA, 2016, OBES REV, V17, P1316, DOI 10.1111/obr.12452; Fujita S, 2004, NUTR RES REV, V17, P69, DOI 10.1079/NRR200481; Gordon BS, 2013, INT J BIOCHEM CELL B, V45, P2147, DOI 10.1016/j.biocel.2013.05.039; Greenlund LJS, 2003, MECH AGEING DEV, V124, P287, DOI 10.1016/S0047-6374(02)00196-3; Guo AY, 2015, EXP ANIM TOKYO, V64, P425, DOI 10.1538/expanim.15-0025; Hairi NN, 2010, J AM GERIATR SOC, V58, P2055, DOI 10.1111/j.1532-5415.2010.03145.x; Hamrick MW, 2006, BONE, V39, P845, DOI 10.1016/j.bone.2006.04.011; Kalyani RR, 2014, LANCET DIABETES ENDO, V2, P819, DOI 10.1016/S2213-8587(14)70034-8; Keller Karsten, 2013, Muscles Ligaments Tendons J, V3, P346; Kim HK, 2012, J AM GERIATR SOC, V60, P16, DOI 10.1111/j.1532-5415.2011.03776.x; Lan F, 2014, DIABETES, V63, P1649, DOI 10.2337/db13-0728; Legeay S, 2015, NUTRIENTS, V7, P5443, DOI 10.3390/nu7075230; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Liu HW, 2015, J AGR FOOD CHEM, V63, P8407, DOI 10.1021/acs.jafc.5b02501; McGregor Robin A, 2014, Longev Healthspan, V3, P9, DOI 10.1186/2046-2395-3-9; Misu H, 2017, NAT MED, V23, P508, DOI 10.1038/nm.4295; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Murase T, 2005, AM J PHYSIOL-REG I, V288, pR708, DOI 10.1152/ajpregu.00693.2004; Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505; Teixeira VDN, 2013, EXP BIOL MED, V238, P1421, DOI 10.1177/1535370213505961; Okumura A, 2016, CLIN CHIM ACTA, V463, P145, DOI 10.1016/j.cca.2016.10.031; Okumura A, 2013, BIOSCI TRENDS, V7, P276, DOI 10.5582/bst.2013.v7.6.276; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Rasmussen BB, 2006, FASEB J, V20, P768, DOI 10.1096/fj.05-4607fje; Santamarina AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141227; Takeda T, 1997, EXP GERONTOL, V32, P105, DOI 10.1016/S0531-5565(96)00036-8; Thomas DR, 2007, CLIN NUTR, V26, P389, DOI 10.1016/j.clnu.2007.03.008; Tieland M, 2012, J AM MED DIR ASSOC, V13, P720, DOI 10.1016/j.jamda.2012.07.005; Verdijk LB, 2009, AM J CLIN NUTR, V89, P608, DOI 10.3945/ajcn.2008.26626; Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428	45	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195753	10.1371/journal.pone.0195753	http://dx.doi.org/10.1371/journal.pone.0195753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630667	Green Published, gold, Green Submitted			2022-12-26	WOS:000429505000072
J	Nyunt, KKK; Han, WW; Satyanarayana, S; Isaakidis, P; Hone, S; Khaing, AA; Binh, HN; Oo, HN				Nyunt, Kay Khaing Kaung; Han, Wai Wai; Satyanarayana, Srinath; Isaakidis, Petros; Hone, San; Khaing, Aye Aye; Hoa Nguyen Binh; Oo, Htun Nyunt			Factors associated with death and loss to follow-up in children on antiretroviral care in Mingalardon Specialist Hospital, Myanmar, 2006-2016	PLOS ONE			English	Article								Background Myanmar National AIDS programme's priority is to improve the survival of all people living with HIV by providing anti-retroviral therapy (ART) care. More than 7200 children (aged <15 years) have been enrolled into ART care from 2005 to 2016. A previous study showed that similar to 11% children on ART care had either died or were lost to follow-up by 60 months. Factors associated with death and lost-to follow-up (adverse outcomes) have not been previously studied. Objectives To describe the association between demographic and clinical characteristics at enrollment into ART care with adverse outcomes. Methods Cohort study using records of children enrolled for ART care at Mingalardon Specialist Hospital (main Paediatric ART center in Myanmar) from 2006-2016. We used multivariable Cox proportional hazards regression models for analysis. Results 1,159 children were enrolled for ART care and they contributed a total of 1.45 million person-days of follow-up period. 112 (10%) had an adverse outcome during the follow-up time period (55 deaths, 57 lost to follow-up). Enrollment into the ART care through in-patient care department of the hospital, CD4 Cell count <50/mm(3), enrollment during changing ART guidelines (different ART eligibility criteria and preferred ART regimen) were independently associated with higher hazards of adverse outcome. Receiving protease inhibitor-based ART regimen at enrollment was independently associated with lower hazards of adverse outcome. Age, sex, residing in urban or rural areas, WHO clinical stage, having TB at the time of enrollment, receiving cotrimoxazole prophylaxis were not statistically associated with adverse outcomes. Conclusion Our analysis reconfirms good survival of children on ART care (including those with TB). The characteristics associated with adverse outcomes (other than CD4 cell count<50) are surrogates of some unmeasured underlying health system/patient related factors that needs further exploration to improve the survival of children on ART care.	[Nyunt, Kay Khaing Kaung; Hone, San; Oo, Htun Nyunt] Minist Hlth & Sports, Dept Publ Hlth, Natl AIDS Programme, Nay Pyi Taw, Myanmar; [Han, Wai Wai] Minist Hlth & Sports, Dept Med Res, Yangon, Myanmar; [Satyanarayana, Srinath; Hoa Nguyen Binh] Int Union TB & Lung Dis, Ctr Operat Res, Paris, France; [Isaakidis, Petros] Med Sans Frontieres MSF Doctors Borders, Bombay, Maharashtra, India; [Isaakidis, Petros] Med Sans Frontieres MSF Doctors Borders, Operat Res Unit, Luxembourg, Luxembourg; [Khaing, Aye Aye] Mingaladon Specialist Hosp, Dept Med Care, Minist Hlth & Sports, Yangon, Myanmar; [Hoa Nguyen Binh] Natl TB Program Vietnam, Hanoi, Vietnam		Nyunt, KKK (corresponding author), Minist Hlth & Sports, Dept Publ Hlth, Natl AIDS Programme, Nay Pyi Taw, Myanmar.	kaykhaingoo132@gmail.com	B, Hoa/AAF-4933-2020	Satyanarayana, Srinath/0000-0002-5420-2551; Isaakidis, Petros/0000-0002-7881-1554				Isaakidis P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-11; Kabue MM, 2012, PEDIATRICS, V130, pE591, DOI 10.1542/peds.2011-1187; Mon KL, 2016, MYANMAR HLTH SCI RES, V28, P1; Myanmar Government, 2015, 2014 MYANM POP HOUS; National AIDS Program, 2011, GUID CLIN MAN HIV IN; National AIDS Program, 2005, GUID CLIN MAN HIV IN; National AIDS Program, 2014, GUID CLIN MAN HIV IN; National AIDS Program, 2016, MYANM NAT STRAT PLAN; National AIDS Program, 2007, GUID CLIN MAN HIV IN; Ph D, 2010, EARLY ANTIRETROVIR T, V359, P2233; Raguenaud ME, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-54; Survey PB, 2014, GARPR ONLINE REPORTI; UNAIDS, 2016, HIV AIDS FACT SHEET	13	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195435	10.1371/journal.pone.0195435	http://dx.doi.org/10.1371/journal.pone.0195435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621302	Green Published, Green Submitted, gold			2022-12-26	WOS:000429206800080
J	Peoples, LM; Donaldson, S; Osuntokun, O; Xia, Q; Nelson, A; Blanton, J; Allen, EE; Church, MJ; Bartlett, DH				Peoples, Logan M.; Donaldson, Sierra; Osuntokun, Oladayo; Xia, Qing; Nelson, Alex; Blanton, Jessica; Allen, Eric E.; Church, Matthew J.; Bartlett, Douglas H.			Vertically distinct microbial communities in the Mariana and Kermadec trenches	PLOS ONE			English	Article							DEEP-SEA; HYDROSTATIC-PRESSURE; SP-NOV.; CHALLENGER DEEP; HADAL TRENCHES; JAPAN TRENCH; BACTERIOPLANKTON DISTRIBUTION; PHYLOGENETIC ANALYSIS; BAROPHILIC BACTERIUM; BATHYPELAGIC OCEAN	Hadal trenches, oceanic locations deeper than 6,000 m, are thought to have distinct microbial communities compared to those at shallower depths due to high hydrostatic pressures, topographical funneling of organic matter, and biogeographical isolation. Here we evaluate the hypothesis that hadal trenches contain unique microbial biodiversity through analyses of the communities present in the bottom waters of the Kermadec and Mariana trenches. Estimates of microbial protein production indicate active populations under in situ hydrostatic pressures and increasing adaptation to pressure with depth. Depth, trench of collection, and size fraction are important drivers of microbial community structure. Many putative hadal bathytypes, such as members related to the Marinimicrobia, Rhodobacteraceae, Rhodospirilliceae, and Aquibacter, are similar to members identified in other trenches. Most of the differences between the two trench microbiomes consists of taxa belonging to the Gammaproteobacteria whose distributions extend throughout the water column. Growth and survival estimates of representative isolates of these taxa under deep-sea conditions suggest that some members may descend from shallower depths and exist as a potentially inactive fraction of the hadal zone. We conclude that the distinct pelagic communities residing in these two trenches, and perhaps by extension other trenches, reflect both cosmopolitan hadal bathytypes and ubiquitous genera found throughout the water column.	[Peoples, Logan M.; Donaldson, Sierra; Osuntokun, Oladayo; Xia, Qing; Blanton, Jessica; Allen, Eric E.; Bartlett, Douglas H.] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; [Xia, Qing] North Carolina State Univ, Dept Soil Sci, Raleigh, NC 27695 USA; [Nelson, Alex; Church, Matthew J.] Univ Hawaii Manoa, Ctr Microbial Oceanog Res & Educ, CMORE Hale, Honolulu, HI 96822 USA; [Church, Matthew J.] Univ Montana, Flathead Lake Biol Stn, Poison, MT USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of North Carolina; North Carolina State University; University of Hawaii System; University of Hawaii Manoa; University of Montana System; University of Montana	Bartlett, DH (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.	dbartlett@ucsd.edu		Xia, Qing/0000-0002-6316-9941	National Science Foundation [0801973, 0827051, 1536776]; National Aeronautics and Space Administration [NNX11AG10G, NNX14AP13H]; Prince Albert II Foundation [1265]; Simons Foundation via the Simons Collaboration on Ocean Processes and Ecology (SCOPE) [329108]	National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Prince Albert II Foundation; Simons Foundation via the Simons Collaboration on Ocean Processes and Ecology (SCOPE)	LMP and DHB were supported by the National Science Foundation (0801973, 0827051, 1536776), National Aeronautics and Space Administration (NNX11AG10G, NNX14AP13H), the Prince Albert II Foundation (Project 1265), and a gift from Earthship Productions. MJC and AN were supported by the Simons Foundation via the Simons Collaboration on Ocean Processes and Ecology (SCOPE; grant ID 329108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8608; Amante C., 2009, PSYCHOLOGIST, DOI [10.7289/V5C8276M, DOI 10.7289/V5C8276M]; Angel M.V., 1982, ENVIRONMENTALIST, V2, P1, DOI DOI 10.1007/BF02340472; Belyaev GM, 1989, DEEP SEA OCEAN TRENC; Bidle KD, 2001, LIMNOL OCEANOGR, V46, P1606, DOI 10.4319/lo.2001.46.7.1606; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brown CT, 2015, NATURE, V523, P208, DOI 10.1038/nature14486; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; Cao Y, 2014, APPL ENVIRON MICROB, V80, P54, DOI 10.1128/AEM.02288-13; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Danovaro R, 2003, DEEP-SEA RES PT I, V50, P1411, DOI 10.1016/j.dsr.2003.07.001; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Eloe EA, 2011, APPL ENVIRON MICROB, V77, P8145, DOI 10.1128/AEM.05204-11; Eloe EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020388; Eloe EA, 2011, ENV MICROBIOL REP, V3, P449, DOI 10.1111/j.1758-2229.2010.00223.x; Fletcher B, 2009, MAR TECHNOL SOC J, V43, P65, DOI 10.4031/MTSJ.43.5.26; Fontanez KM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00469; Fryer P, 2003, EARTH PLANET SC LETT, V211, P259, DOI 10.1016/S0012-821X(03)00202-4; FUHRMAN JA, 1988, APPL ENVIRON MICROB, V54, P1426, DOI 10.1128/AEM.54.6.1426-1429.1988; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Galand PE, 2010, ISME J, V4, P564, DOI 10.1038/ismej.2009.134; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Gardner JV, 2014, MAR GEOD, V37, P1, DOI 10.1080/01490419.2013.837849; Glud RN, 2013, NAT GEOSCI, V6, P284, DOI [10.1038/NGEO1773, 10.1038/ngeo1773]; Hansell DA, 2003, LIMNOL OCEANOGR, V48, P150, DOI 10.4319/lo.2003.48.1.0150; Hatzenpichler R, 2016, P NATL ACAD SCI USA, V113, pE4069, DOI 10.1073/pnas.1603757113; Herndl GJ, 2013, NAT GEOSCI, V6, P718, DOI [10.1038/ngeo1921, 10.1038/NGEO1921]; Hwang CY, 2009, INT J SYST EVOL MICR, V59, P3019, DOI 10.1099/ijs.0.008102-0; Ichino MC, 2015, DEEP-SEA RES PT I, V100, P21, DOI 10.1016/j.dsr.2015.01.010; Ivanova EP, 2015, ANTON LEEUW INT J G, V107, P119, DOI 10.1007/s10482-014-0309-y; Ivars-Martinez E, 2008, ISME J, V2, P1194, DOI 10.1038/ismej.2008.74; Jamieson A, 2015, HADAL ZONE: LIFE IN THE DEEPEST OCEANS, P1, DOI 10.1017/CBO9781139061384; Jamieson AJ, 2013, DEEP-SEA RES PT II, V92, P107, DOI 10.1016/j.dsr2.2012.12.002; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Kaneko H, 2000, BIOSCI BIOTECH BIOCH, V64, P72, DOI 10.1271/bbb.64.72; Kato C, 1997, EXTREMOPHILES, V1, P117, DOI 10.1007/s007920050024; Kato C, 1998, APPL ENVIRON MICROB, V64, P1510; Kawagucci S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00270; Kaye JZ, 2011, FEMS MICROBIOL ECOL, V75, P123, DOI 10.1111/j.1574-6941.2010.00984.x; Kaye JZ, 2004, APPL ENVIRON MICROB, V70, P6220, DOI 10.1128/AEM.70.10.6220-6229.2004; Kusube M, 2017, INT J SYST EVOL MICR, V67, P824, DOI 10.1099/ijsem.0.001671; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Li L, 1999, MAR BIOTECHNOL, V1, P391, DOI 10.1007/PL00011793; Linley TD, 2017, DEEP-SEA RES PT I, V121, P38, DOI 10.1016/j.dsr.2016.12.009; Linley TD, 2016, DEEP-SEA RES PT I, V114, P99, DOI 10.1016/j.dsr.2016.05.003; LONGHURST A, 1995, J PLANKTON RES, V17, P1245, DOI 10.1093/plankt/17.6.1245; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Luef B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7372; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Maruyama A, 2000, INT J SYST EVOL MICR, V50, P835, DOI 10.1099/00207713-50-2-835; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Nagata T, 2000, LIMNOL OCEANOGR, V45, P426, DOI 10.4319/lo.2000.45.2.0426; Nagata T, 2010, DEEP-SEA RES PT II, V57, P1519, DOI 10.1016/j.dsr2.2010.02.019; Nakayama A, 2005, J GEN APPL MICROBIOL, V51, P385, DOI 10.2323/jgam.51.385; Nogi Y, 2004, INT J SYST EVOL MICR, V54, P1627, DOI 10.1099/ijs.0.03049-0; Nogi Y, 1998, ARCH MICROBIOL, V170, P331, DOI 10.1007/s002030050650; Nogi Y, 2002, INT J SYST EVOL MICR, V52, P1527, DOI 10.1099/00207713-52-5-1527; Nunnally CC, 2016, DEEP-SEA RES PT I, V118, P30, DOI 10.1016/j.dsr.2016.10.009; Nunoura T, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01261; Nunoura T, 2015, P NATL ACAD SCI USA, V112, pE1230, DOI 10.1073/pnas.1421816112; Nunoura T, 2013, ENVIRON MICROBIOL, V15, P3087, DOI 10.1111/1462-2920.12152; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Pante E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073051; Parada AE, 2016, ENVIRON MICROBIOL, V18, P1403, DOI 10.1111/1462-2920.13023; Pedler BE, 2014, P NATL ACAD SCI USA, V111, P7202, DOI 10.1073/pnas.1401887111; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Ritchie H, 2017, DEEP-SEA RES PT I, V119, P50, DOI 10.1016/j.dsr.2016.11.006; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Salazar G, 2016, ISME J, V10, P596, DOI 10.1038/ismej.2015.137; Salazar G, 2015, MOL ECOL, V24, P5692, DOI 10.1111/mec.13419; Samo TJ, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00048; SCHWARZ JR, 1976, APPL ENVIRON MICROB, V31, P46, DOI 10.1128/AEM.31.1.46-48.1976; Seki H, 1976, J OCEANOGR SOC JAPAN, V23, P182; Siedler G, 2004, J PHYS OCEANOGR, V34, P566, DOI 10.1175/2511.1; Sintes E, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00077; Sintes E, 2013, ENVIRON MICROBIOL, V15, P1647, DOI 10.1111/j.1462-2920.2012.02801.x; Smedile F, 2013, ENVIRON MICROBIOL, V15, P167, DOI 10.1111/j.1462-2920.2012.02827.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Tamburini C, 2013, ENVIRON MICROBIOL, V15, P1262, DOI 10.1111/1462-2920.12084; Tamburini C, 2009, DEEP-SEA RES PT II, V56, P1533, DOI 10.1016/j.dsr2.2008.12.035; Tamegai H, 1997, EXTREMOPHILES, V1, P207, DOI 10.1007/s007920050035; Tamegai H, 2006, EXTREMOPHILES, V5, P27; Tarn J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00665; Turley C, 2000, FEMS MICROBIOL ECOL, V33, P89, DOI 10.1111/j.1574-6941.2000.tb00731.x; Vinogradova NG, 1997, ADV MAR BIOL, V32, P325; Wenzhofer F, 2016, DEEP-SEA RES PT I, V116, P276, DOI 10.1016/j.dsr.2016.08.013; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Yanagibayashi M, 1999, FEMS MICROBIOL LETT, V170, P271, DOI 10.1016/S0378-1097(98)00556-4; Yayanos AA, 2001, METHOD MICROBIOL, V30, P615; YAYANOS AA, 1982, APPL ENVIRON MICROB, V43, P1481, DOI 10.1128/AEM.43.6.1481-1489.1982; YAYANOS AA, 1981, P NATL ACAD SCI-BIOL, V78, P5212, DOI 10.1073/pnas.78.8.5212; Yoon JH, 2005, INT J SYST EVOL MICR, V55, P1007, DOI 10.1099/ijs.0.63464-0; Yoshida M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057271	98	45	47	6	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195102	10.1371/journal.pone.0195102	http://dx.doi.org/10.1371/journal.pone.0195102			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621268	Green Published, gold, Green Submitted			2022-12-26	WOS:000429206800038
J	Thishya, K; Vattam, KK; Naushad, SM; Raju, SB; Kutalal, VK				Thishya, Kalluri; Vattam, Kiran Kumar; Naushad, Shaik Mohammad; Raju, Shree Bhushan; Kutalal, Vijay Kumar			Artificial neural network model for predicting the bioavailability of tacrolimus in patients with renal transplantation	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; MDR1 ABCB1 POLYMORPHISMS; DOSE REQUIREMENTS; ACUTE REJECTION; CLINICAL FACTORS; CYP3A5 GENOTYPE; CALCINEURIN INHIBITORS; ORGAN-TRANSPLANTATION; BLOOD-CONCENTRATIONS; GENE POLYMORPHISMS	The objective of the current study was to explore the role of ABCB1 and CYP3A5 genetic polymorphisms in predicting the bioavailability of tacrolimus and the risk for post-transplant diabetes. Artificial neural network (ANN) and logistic regression (LR) models were used to predict the bioavailability of tacrolimus and risk for post-transplant diabetes, respectively. The five-fold cross-validation of ANN model showed good correlation with the experimental data of bioavailability (r(2) = 0.93-0.96). Younger age, male gender, optimal body mass index were shown to exhibit lower bioavailability of tacrolimus. ABCB1 1236 C>T and 2677G>T/A showed inverse association while CYP3A5*3 showed a positive association with the bioavailability of tacrolimus. Gender bias was observed in the association with ABCB1 3435 C>T polymorphism. CYP3A5*3 was shown to interact synergistically in increasing the bioavailability in combination with ABCB1 1236 TT or 2677GG genotypes. LR model showed an independent association of ABCB1 2677 G>T/A with post transplant diabetes (OR: 4.83, 95% CI: 1.22-19.03). Multifactor dimensionality reduction analysis (MDR) revealed that synergistic interactions between CYP3A5*3 and ABCB1 2677 G>T/A as the determinants of risk for post-transplant diabetes. To conclude, the ANN and MDR models explore both individual and synergistic effects of variables in modulating the bioavailability of tacrolimus and risk for post-transplant diabetes.	[Thishya, Kalluri; Kutalal, Vijay Kumar] Nizams Inst Med Sci, Dept Clin Pharmacol, Hyderabad, Telangana, India; [Thishya, Kalluri; Kutalal, Vijay Kumar] Nizams Inst Med Sci, Dept Therapeut, Hyderabad, Telangana, India; [Vattam, Kiran Kumar; Naushad, Shaik Mohammad] Sandor Lifesci Pvt Ltd, Hyderabad, Telangana, India; [Raju, Shree Bhushan] Nizams Inst Med Sci, Dept Nephrol, Hyderabad, Telanagana, India	Nizam's Institute of Medical Sciences; Nizam's Institute of Medical Sciences; Nizam's Institute of Medical Sciences	Kutalal, VK (corresponding author), Nizams Inst Med Sci, Dept Clin Pharmacol, Hyderabad, Telangana, India.; Kutalal, VK (corresponding author), Nizams Inst Med Sci, Dept Therapeut, Hyderabad, Telangana, India.	vijaykutala@gmail.com	Naushad, Mohammad/C-3094-2012; Shanmugam, Raju/N-8120-2013; Raju, Sree Bhushan/ABD-1880-2020	Naushad, Mohammad/0000-0001-8952-9581; Shanmugam, Raju/0000-0002-8613-9518; Raju, Sree Bhushan/0000-0001-9409-3874; Kutala, Vijay Kumar/0000-0002-7253-8999	Department of Biotechnology, Government of India [BT/PR7964/MED/12/606/2013]; Sandor Lifesciences Pvt Ltd	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Sandor Lifesciences Pvt Ltd	This work was supported by a grant from Department of Biotechnology, Government of India No. BT/PR7964/MED/12/606/2013 to VKK. Sandor Lifesciences Pvt Ltd only provided salary support to KKV and SMN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions'.	Anglicheau D, 2003, J AM SOC NEPHROL, V14, P1889, DOI 10.1097/01.ASN.0000073901.94759.36; Aouam K, 2015, PHARMACOGENOMICS, V16, P2045, DOI 10.2217/pgs.15.138; Borobia AM, 2009, THER DRUG MONIT, V31, P436, DOI 10.1097/FTD.0b013e3181a8f02a; Chandel N, 2009, PHARMACOGENET GENOM, V19, P458, DOI 10.1097/FPC.0b013e32832bd085; Chitnis SD, 2013, XENOBIOTICA, V43, P641, DOI 10.3109/00498254.2012.752118; Cho JH, 2012, TRANSPL P, V44, P109, DOI 10.1016/j.transproceed.2011.11.004; Cusinato DAC, 2014, BRIT J CLIN PHARMACO, V78, P364, DOI 10.1111/bcp.12345; de Jonge H, 2012, CLIN PHARMACOL THER, V92, P366, DOI 10.1038/clpt.2012.109; Fukudo M, 2008, PHARMACOGENET GENOM, V18, P413, DOI 10.1097/FPC.0b013e3282f9ac01; Gerard C, 2014, AAPS J, V16, P379, DOI 10.1208/s12248-014-9577-8; Goto M, 2004, PHARMACOGENETICS, V14, P471, DOI 10.1097/01.fpc.0000114747.08559.49; Haufroid V, 2004, PHARMACOGENETICS, V14, P147, DOI 10.1097/00008571-200403000-00002; Hesselink DA, 2008, PHARMACOGENET GENOM, V18, P339, DOI 10.1097/FPC.0b013e3282f75f88; Kidokoro K, 2012, KIDNEY BLOOD PRESS R, V35, P549, DOI 10.1159/000339494; Kim I-W, 2011, EUROPEAN J CLIN PHAR, V68, P657; Kim IW, 2012, BASIC CLIN PHARMACOL, V111, P217, DOI 10.1111/j.1742-7843.2012.00892.x; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Kuypers DRJ, 2007, CLIN PHARMACOL THER, V82, P711, DOI 10.1038/sj.clpt.6100216; Li JL, 2011, PHARMACOGENOMICS J, V11, P300, DOI 10.1038/tpj.2010.42; Li L, 2011, EUR J CLIN PHARMACOL, V67, P787, DOI 10.1007/s00228-011-1010-y; Soria MALM, 2010, TRANSPL P, V42, P3031, DOI 10.1016/j.transproceed.2010.08.001; MacPhee IAM, 2005, TRANSPLANTATION, V79, P499, DOI 10.1097/01.TP.0000151766.73249.12; Omar MS., 2013, INT J PHARM PHARM SC, V5, P470; Passey C, 2012, PHARMACOGENOMICS, V13, P1141, DOI [10.2217/PGS.12.98, 10.2217/pgs.12.98]; Passey C, 2011, BRIT J CLIN PHARMACO, V72, P948, DOI 10.1111/j.1365-2125.2011.04039.x; Pavani A, 2012, PHARMACOGENOMICS J, V12, P306, DOI 10.1038/tpj.2011.4; Pavani A, 2016, PHARMACOGENOMICS, V17, P121, DOI 10.2217/pgs.15.161; Plosker GL, 2000, DRUGS, V59, P323, DOI 10.2165/00003495-200059020-00021; Provenzani A, 2011, INT J MOL MED, V28, P1093, DOI 10.3892/ijmm.2011.794; Provenzani A, 2009, ANN TRANSPL, V14, P23; Renders L, 2007, CLIN PHARMACOL THER, V81, P228, DOI 10.1038/sj.clpt.6100039; Rodriguez-Peralvarez M, 2012, Am J Transplant, V12, P2797; Shi YY, 2013, GENE, V512, P226, DOI 10.1016/j.gene.2012.10.048; Singh R, 2011, J CLIN PHARMACOL, V51, P603, DOI 10.1177/0091270010370704; Singh R, 2009, N-S ARCH PHARMACOL, V380, P169, DOI 10.1007/s00210-009-0415-y; Staatz C, 2001, NEPHROL DIAL TRANSPL, V16, P1905, DOI 10.1093/ndt/16.9.1905; Staatz CE, 2010, CLIN PHARMACOKINET, V49, P141, DOI 10.2165/11317350-000000000-00000; Tahara T, 2011, DIGEST DIS SCI, V56, P103, DOI 10.1007/s10620-010-1251-0; Tang J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42192; Tang K, 2002, PHARMACOGENETICS, V12, P437, DOI 10.1097/00008571-200208000-00004; Thervet E, 2010, CLIN PHARMACOL THER, V87, P721, DOI 10.1038/clpt.2010.17; Tsuchiya N, 2004, TRANSPLANTATION, V78, P1182, DOI 10.1097/01.TP.0000137789.58694.B4; Undre NA, 1999, TRANSPLANT P, V31, P296, DOI 10.1016/S0041-1345(98)01633-9; Wallemacq P, 2009, THER DRUG MONIT, V31, P139, DOI 10.1097/FTD.0b013e318198d092; Wang P, 2010, PHARMACOGENOMICS, V11, P1389, DOI 10.2217/PGS.10.105; Zuo XC, 2013, PHARMACOGENET GENOM, V23, P251, DOI 10.1097/FPC.0b013e32835fcbb6	46	27	28	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0191921	10.1371/journal.pone.0191921	http://dx.doi.org/10.1371/journal.pone.0191921			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621269	Green Submitted, Green Published, gold			2022-12-26	WOS:000429206800003
J	Cirillo, E; Kutmon, M; Hernandez, MG; Hooimeijer, T; Adriaens, ME; Eijssen, LMT; Parnell, LD; Coort, SL; Evelo, CT				Cirillo, Elisa; Kutmon, Martina; Hernandez, Manuel Gonzalez; Hooimeijer, Tom; Adriaens, Michiel E.; Eijssen, Lars M. T.; Parnell, Laurence D.; Coort, Susan L.; Evelo, Chris T.			From SNPs to pathways: Biological interpretation of type 2 diabetes (T2DM) genome wide association study (GWAS) results	PLOS ONE			English	Article							RISK LOCI; COMPLEX TRAITS; IDENTIFICATION; VARIANTS; ONTOLOGY; DISEASE; GENES; TOOL; UNIFICATION; NETWORKS	Genome-wide association studies (GWAS) have become a common method for discovery of gene-disease relationships, in particular for complex diseases like Type 2 Diabetes Mellitus (T2DM). The experience with GWAS analysis has revealed that the genetic risk for complex diseases involves cumulative, small effects of many genes and only some genes with a moderate effect. In order to explore the complexity of the relationships between T2DM genes and their potential function at the process level as effected by polymorphism effects, a secondary analysis of a GWAS meta-analysis is presented. Network analysis, pathway information and integration of different types of biological information such as eQTLs and gene-environment interactions are used to elucidate the biological context of the genetic variants and to perform an analysis based on data visualization. We selected a T2DM data set from a GWAS meta-analysis, and extracted 1,971 SNPs associated with T2DM. We mapped 580 SNPs to 360 genes, and then selected 460 pathways containing these genes from the curated collection of WikiPathways. We then created and analyzed SNP-gene and SNP-gene-pathway network modules in Cytoscape. A focus on genes with robust connections to pathways permitted identification of many T2DM pertinent pathways. However, numerous genes lack literature evidence of association with T2DM. We also speculate on the genes in specific network structures obtained in the SNP-gene network, such as gene SNP-gene modules. Finally, we selected genes relevant to T2DM from our SNP-gene-pathway network, using different sources that reveal gene-environment interactions and eQTLs. We confirmed functions relevant to T2DM for many genes and have identified some LPL and APOB that require further validation to clarify their involvement in T2DM.	[Cirillo, Elisa; Kutmon, Martina; Hernandez, Manuel Gonzalez; Hooimeijer, Tom; Eijssen, Lars M. T.; Coort, Susan L.; Evelo, Chris T.] Maastricht Univ, Dept Bioinformat BiGCaT, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands; [Kutmon, Martina; Adriaens, Michiel E.; Evelo, Chris T.] Maastricht Univ, Maastricht Ctr Syst Biol MaCSBio, Maastricht, Netherlands; [Parnell, Laurence D.] Tufts Univ, USDA, Human Nutr Res Ctr Aging, ARS,Jean Mayer USDA, Boston, MA 02111 USA	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Tufts University; United States Department of Agriculture (USDA)	Cirillo, E (corresponding author), Maastricht Univ, Dept Bioinformat BiGCaT, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands.	elisa.cirillo@maastrichtuniversity.nl	Coort, Susan/ABF-1021-2021; Kutmon, Martina/AAT-2718-2021	Kutmon, Martina/0000-0002-7699-8191; Eijssen, Lars/0000-0002-6473-2839; Coort, Susan/0000-0003-1224-9690; Evelo, Chris/0000-0002-5301-3142; Cirillo, Elisa/0000-0002-0241-7833; Adriaens, Michiel/0000-0002-4472-7119	Dutch Province of Limburg	Dutch Province of Limburg	This project/research has been made possible with support of the Dutch Province of Limburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguet F, 2016, BIORXIV, V1; Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Cauchi S, 2008, J MOL MED, V86, P341, DOI 10.1007/s00109-007-0295-x; Cho YS, 2008, EXP MOL MED, V40, P523, DOI 10.3858/emm.2008.40.5.523; Eilbeck K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r44; Erdos MR, 2015, THESIS; FAUSTINELLA F, 1991, J BIOL CHEM, V266, P14418; Flannick J, 2016, NAT REV GENET, V17, P535, DOI 10.1038/nrg.2016.56; Florez JC, 2007, DIABETES, V56, P3063, DOI 10.2337/db07-0451; Garcia-Campos MA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00383; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hanson RL, 2007, DIABETES, V56, P3045, DOI 10.2337/db07-0462; Hara K, 2016, EXPERT OPIN THER TAR, V20, P255, DOI 10.1517/14728222.2016.1098618; Hayes MG, 2007, DIABETES, V56, P3033, DOI 10.2337/db07-0482; Jager J, 2010, DIABETES, V59, P61, DOI 10.2337/db09-0470; Jo B, 2016, BIORXIV, V1; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kao PYP, 2017, BBA-GEN SUBJECTS, V1861, P335, DOI 10.1016/j.bbagen.2016.11.030; Kimchi-Sarfaty C, 2007, SCIENCE, V318, P1382; KOBAYASHI J, 1992, BIOCHEM BIOPH RES CO, V182, P70, DOI 10.1016/S0006-291X(05)80113-5; Kutmon M, 2016, NUCLEIC ACIDS RES, V44, pD488, DOI 10.1093/nar/gkv1024; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Niel C, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00280; Oliveros J. C., INTERACTIVE TOOL COM; Parnell LD, 2014, BIODATA MIN, V7, DOI 10.1186/1756-0381-7-21; Perry JRB, 2009, DIABETES, V58, P1463, DOI 10.2337/db08-1378; Pinero J, 2016, NUCLEIC ACIDS RES, V19; Rampersaud E, 2007, DIABETES, V56, P3053, DOI 10.2337/db07-0457; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siddiqa A, 2017, GENOMICS; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5; Thomas PPM, 2016, PERS MED, V13, P381, DOI 10.2217/pme-2016-0029; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Xu X, 2014, CURR MED CHEM, V21, P3244, DOI 10.2174/0929867321666140716092052; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yazdanpanah M, 2013, ANN HUM GENET, V77, P472, DOI 10.1111/ahg.12035; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366; Zambonelli P, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-99; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126082	51	25	26	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0193515	10.1371/journal.pone.0193515	http://dx.doi.org/10.1371/journal.pone.0193515			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617380	Green Submitted, gold, Green Published			2022-12-26	WOS:000429203800008
J	Gertz, H; Fiehler, K; Voudouris, D				Gertz, Hanna; Fiehler, Katja; Voudouris, Dimitris			The role of visual processing on tactile suppression	PLOS ONE			English	Article							REACHING MOVEMENTS; TIME-COURSE; SIGNALS; ENHANCEMENT; ATTENUATION; VISION; HUMANS; LIMB	It has been suggested that tactile signals are suppressed on a moving limb to free capacities for processing other relevant sensory signals. In line with this notion, we recently showed that tactile suppression is indeed stronger in the presence of reach-relevant somatosensory signals. Here we examined whether this effect also generalizes to the processing of additional visual signals during reaching. Brief vibrotactile stimuli were presented on the participants' right index finger either during right-hand reaching to a previously illuminated target LED, or during rest. Participants had to indicate whether they detected the vibrotactile stimulus or not. The target LED remained off (tactile), or was briefly illuminated (tactile & vis) during reaching, providing additional reach-relevant visual information about the target position. If tactile suppression frees capacities for reach-relevantvisual information, suppression should be stronger in the tactile & vis compared to the tactile condition. In an additional visual-discrimination condition (tactile & visDis), the target LED flashed once or twice during reaching and participants had to also report the number of flashes. If tactile suppression occurs to free additional capacities for perception-relevant visual signals, tactile suppression should be even stronger in the tactile & visDis compared to the tactile & vis condition. We found that additional visual signals improved reach endpoint accuracy and precision. In all conditions, reaching led to tactile suppression as indicated by higher detection thresholds compared to rest, confirming previous findings. However, tactile suppression was comparable between conditions arguing against the hypothesis that it frees capacities for processing other relevant visual signals.	[Gertz, Hanna; Fiehler, Katja; Voudouris, Dimitris] Justus Liebig Univ Giessen, Expt Psychol, Giessen, Germany	Justus Liebig University Giessen	Voudouris, D (corresponding author), Justus Liebig Univ Giessen, Expt Psychol, Giessen, Germany.	dimitris.voudouris@psychol.uni-giessen.de	Voudouris, Dimitris/H-7704-2018	Voudouris, Dimitris/0000-0001-9110-0928	German Research Foundation (DFG) [TRR 135]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) TRR 135. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the German Research Foundation (DFG) TRR 135. Additional materials related to this manuscript (kinematic data and participants' responses from the detection tasks) may be found at http://dx.doi.org/10.5281/zenodo.1207321	Alais D, 2006, P R SOC B, V273, P1339, DOI 10.1098/rspb.2005.3420; Bays PM, 2006, PLOS BIOL, V4, P281, DOI 10.1371/journal.pbio.0040028; Berkinblit MB, 1995, EXP BRAIN RES, V107, P326; Berman RA, 2002, COGNITIVE BRAIN RES, V14, P64, DOI 10.1016/S0926-6410(02)00061-7; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 2000, NEUROREPORT, V11, pR11, DOI 10.1097/00001756-200008030-00002; Buckingham G, 2010, EXP BRAIN RES, V201, P411, DOI 10.1007/s00221-009-2050-8; CASTIELLO U, 1992, BEHAV BRAIN RES, V50, P7, DOI 10.1016/S0166-4328(05)80283-9; CHAPMAN CE, 1987, EXP BRAIN RES, V68, P516; Colino FL, 2016, J MOTOR BEHAV, V48, P390, DOI 10.1080/00222895.2015.1113917; Duncan J, 1997, NATURE, V387, P808, DOI 10.1038/42947; GENTILUCCI M, 1991, NEUROPSYCHOLOGIA, V29, P361, DOI 10.1016/0028-3932(91)90025-4; Gertz H, 2017, J NEUROPHYSIOL, V117, P2262, DOI 10.1152/jn.00052.2017; GHEZ C, 1995, J NEUROPHYSIOL, V73, P361, DOI 10.1152/jn.1995.73.1.361; Gold JI, 2010, J NEUROPHYSIOL, V103, P140, DOI 10.1152/jn.00744.2009; Haggard P, 2004, COGNITIVE BRAIN RES, V19, P52, DOI 10.1016/j.cogbrainres.2003.10.018; Jackson SR, 2011, Q J EXP PSYCHOL, V64, P839, DOI 10.1080/17470218.2010.529580; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Jones SAH, 2012, J NEUROPHYSIOL, V107, P3316, DOI 10.1152/jn.00901.2011; Jones SAH, 2010, NEUROPSYCHOLOGIA, V48, P3782, DOI 10.1016/j.neuropsychologia.2010.10.001; Manson G., 2012, SEEING PERCEIVING, V25, P106, DOI [10.1163/187847612X647388, DOI 10.1163/187847612X647388]; McIsaac TL, 2015, EXP BRAIN RES, V233, P2607, DOI 10.1007/s00221-015-4333-6; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parkinson A, 2011, COGN NEUROSCI-UK, V2, P47, DOI 10.1080/17588928.2010.525627; PRABLANC C, 1986, EXP BRAIN RES, V62, P293; Sarlegna FR, 2006, BRAIN RES BULL, V69, P404, DOI 10.1016/j.brainresbull.2006.02.005; Schot WD, 2010, J NEUROSCI METH, V187, P147, DOI 10.1016/j.jneumeth.2010.01.004; Shergill SS, 2003, SCIENCE, V301, P187, DOI 10.1126/science.1085327; Shergill SS, 2013, NEUROIMAGE, V70, P356, DOI 10.1016/j.neuroimage.2012.12.043; Soto-Faraco S., 2004, HDB MULTISENSORY PRO, P49; Tremblay L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008952; Voss M, 2006, NAT NEUROSCI, V9, P26, DOI 10.1038/nn1592; Voss M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002866; Voudouris D, 2012, J MOTOR BEHAV, V44, P295, DOI 10.1080/00222895.2012.703975; Voudouris D, 2017, ATTEN PERCEPT PSYCHO, V79, P2424, DOI 10.3758/s13414-017-1385-7; Voudouris D, 2017, J EXP PSYCHOL HUMAN, V43, P1238, DOI 10.1037/xhp0000373; WEISKRANTZ L, 1971, NATURE, V230, P598, DOI 10.1038/230598a0; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Williams SR, 2002, J NEUROPHYSIOL, V88, P1968, DOI 10.1152/jn.2002.88.4.1968; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8	40	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195396	10.1371/journal.pone.0195396	http://dx.doi.org/10.1371/journal.pone.0195396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617416	Green Published, gold, Green Submitted			2022-12-26	WOS:000429203800082
J	Martin-Torrijos, L; Kawai, T; Makkonen, J; Jussila, J; Kokko, H; Dieguez-Uribeondo, J				Martin-Torrijos, Laura; Kawai, Tadashi; Makkonen, Jenny; Jussila, Japo; Kokko, Harri; Dieguez-Uribeondo, Javier			Crayfish plague in Japan: A real threat to the endemic Cambaroides japonicus	PLOS ONE			English	Article							SPECIES PACIFASTACUS-LENIUSCULUS; PATHOGEN APHANOMYCES-ASTACI; FRESH-WATER CRAYFISH; GENETIC DIVERSITY; ALIEN CRAYFISH; FUNGUS; BIODIVERSITY; IMPACT	Global introductions of aquatic species and their associated pathogens are threatening worldwide biodiversity. The introduction of two North American crayfish species, Procambarus clarkiiand Pacifastacus leniusculus, into Japan in 1927 seems to have negatively affected native Japanese crayfish populations of Cambaroides japonicus. Several studies have shown the decline of these native populations due to competition, predation and habitat colonization by the two invasive North American crayfish species. Here, we identify an additional factor contributing to this decline. We report the first crayfish plague outbreaks in C. japonicus populations in Japan, which were diagnosed using both histological and molecular approaches (analyses of the internal transcribed spacer region). Subsequent analyses of the mitochondrial ribosomal rnnS and rnnL regions of diseased specimens indicate that these outbreaks originated from a P. clarkii population and identify a novel haplotype of Aphanomyces astaci, d3-haplotype, hosted by P. clarkii. Overall, our findings demonstrate the first two cases of crayfish plague in Japan, and the first case in a non-European native crayfish species, which originated from the red swamp crayfish P. clarkii. This finding is a matter of concern for the conservation of the native freshwater species of Japan and also highlights the risk of introducing crayfish carrier species into biogeographic regions harboring species susceptible to the crayfish plague.	[Martin-Torrijos, Laura; Dieguez-Uribeondo, Javier] CSIC, Dept Mycol, RJB, Madrid, Spain; [Kawai, Tadashi] Wakanai Fisheries Res Inst, Wakkanai, Hokkaido, Japan; [Makkonen, Jenny; Jussila, Japo; Kokko, Harri] Univ Eastern Finland, Dept Environm & Biol Sci, Kuopio, Finland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; University of Eastern Finland	Dieguez-Uribeondo, J (corresponding author), CSIC, Dept Mycol, RJB, Madrid, Spain.	dieguez@rjb.csic.es	MARTIN-TORRIJOS, LAURA/AAH-8654-2019; Diéguez-Uribeondo, Javier/ABF-1130-2021; dieguez-uribeondo, javier/I-2178-2015	MARTIN-TORRIJOS, LAURA/0000-0002-2850-2737; Diéguez-Uribeondo, Javier/0000-0002-4488-0658; dieguez-uribeondo, javier/0000-0002-4488-0658; Kokko, Hanna/0000-0002-5772-4881	Spanish Ministry of Economy and Competitiveness [CGL2016-80526-R]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This research was partially supported by a grant from the Spanish Ministry of Economy and Competitiveness (CGL2016-80526-R). There was no additional external funding received for this study. We also like to thank Emilio Cano and Marta Higuera, RJB-CSIC, for the technical assistance.r This research was partially supported by a grant from the Spanish Ministry of Economy and Competitiveness (CGL2016-80526-R). There was no additional external funding received for this study.	Alderman D.J., 1993, Freshwater Crayfish, V9, P266; Alderman DJ, 1997, SCI TECHNICAL REV, V15, P15; Almerao MP, 2015, AQUAT CONSERV, V25, P288, DOI 10.1002/aqc.2488; Aquiloni L, 2011, BIOL INVASIONS, V13, P359, DOI 10.1007/s10530-010-9828-2; BARAN I, 1989, J FISH DIS, V12, P193, DOI 10.1111/j.1365-2761.1989.tb00292.x; Bentley AI, 2010, FRESHWATER BIOL, V55, P1861, DOI 10.1111/j.1365-2427.2010.02420.x; Cerenius L., 1988, P131; Cornalia E., 1960, ATTI SOC ITAL SCI NA, V2, P334; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dieguez-Uribeondo J, 2006, B FR PECHE PISCIC, P1303, DOI 10.1051/kmae:2006036; Dieguez-Uribeondo J, 2003, PHYTOPATHOLOGY, V93, P923, DOI 10.1094/PHYTO.2003.93.8.923; Dieguez-Uribeondo J., 1993, Aquaculture and Fisheries Management, V24, P761, DOI 10.1111/j.1365-2109.1993.tb00655.x; Dieguez-Uribeondo J, 1997, B FR PECHE PISCIC, P753, DOI 10.1051/kmae/1997051; Dieguez-Uribeondo J, 2010, B FRANC E AIS PISCIC, P625; DIEGUEZURIBEONDO J, 1995, MYCOL RES, V99, P574, DOI 10.1016/S0953-7562(09)80716-8; Duggan IC, 2010, BIOL INVASIONS, V12, P3757, DOI 10.1007/s10530-010-9768-x; Faulkes Zen, 2012, Aquat Biosyst, V8, P13; Filipova L, 2011, J N AM BENTHOL SOC, V30, P871, DOI 10.1899/10-130.1; Grandjean F, 2014, VET MICROBIOL, V170, P317, DOI 10.1016/j.vetmic.2014.02.020; Hsieh CY, 2016, J INVERTEBR PATHOL, V136, P117, DOI 10.1016/j.jip.2016.03.015; HUANG TS, 1994, AQUACULTURE, V126, P1, DOI 10.1016/0044-8486(94)90243-7; Jones JPG, 2009, BIOL INVASIONS, V11, P1475, DOI 10.1007/s10530-008-9334-y; Kawai T, 2005, CRUSTACEANA, V78, P1143, DOI 10.1163/156854005775361034; Kawai T, 2004, CRUSTACEANA, V77, P861, DOI 10.1163/156854004774248735; Kawai T, 2004, P BIOL SOC WASH, V117, P23; Kawai T, 2003, J NAT HIST AOMORI, V8, P1; Kawai T, 2011, ORIGIN RED SWAMP CRA; Kawai Tadashi, 2002, Freshwater Crayfish, V13, P198; Kawai T, 2009, J CRUSTACEAN BIOL, V29, P562, DOI 10.1651/08-3125.1; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kozubikova E, 2011, J INVERTEBR PATHOL, V108, P214, DOI 10.1016/j.jip.2011.08.002; Lodge DM, 2012, ANNU REV ECOL EVOL S, V43, P449, DOI 10.1146/annurev-ecolsys-111511-103919; Lowe S., 100 WORLDS WORST INV; Makkonen J, 2018, PARASITOLOGY; Makkonen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36089; MATTHEWS M, 1992, HYDROBIOLOGIA, V234, P1, DOI 10.1007/BF00010773; Mrugala A, 2017, AQUAT CONSERV, V27, P103, DOI 10.1002/aqc.2674; Nakata K, 2005, CRUSTACEANA, V78, P1389, DOI 10.1163/156854005776759771; Nakata K, 2003, J CRUSTACEAN BIOL, V23, P897, DOI 10.1651/C-2411; Nakata K, 2002, FISHERIES SCI, V68, P763, DOI 10.1046/j.1444-2906.2002.00491.x; Nakata K, 2006, J CRUSTACEAN BIOL, V26, P134, DOI 10.1651/S-2652.1; Ohtaka A, 2005, BIOL INVASIONS, V7, P149, DOI 10.1007/s10530-004-8146-y; Oidtmann B, 2004, VET MICROBIOL, V100, P269, DOI 10.1016/j.vetmic.2004.01.019; Oidtmann B, 2006, DIS AQUAT ORGAN, V72, P53, DOI 10.3354/dao072053; Rocha SCO, 2016, PHYTOTAXA, V270, P286, DOI 10.11646/phytotaxa.270.4.5; Patoka J, 2016, BIOL INVASIONS, V18, P457, DOI 10.1007/s10530-015-1018-9; Peiro DF, 2016, HYDROBIOLOGIA, V781, P181, DOI 10.1007/s10750-016-2841-4; Rezinciuc S., 2015, Freshwater crayfish: a global overview, P182; Rezinciuc S, 2014, FUNGAL BIOL-UK, V118, P612, DOI 10.1016/j.funbio.2013.10.007; SODERHALL K, 1979, J INVERTEBR PATHOL, V34, P285, DOI 10.1016/0022-2011(79)90075-2; Unestam T., 1972, Report lnst Freshwat Res Drottningholm, VNo. 52, P192; UNESTAM T, 1970, J GEN MICROBIOL, V60, P77, DOI 10.1099/00221287-60-1-77; Unestam T., 1969, RESISTANCE CRAYFISH; Usio Nisikawa, 2001, Biological Invasions, V3, P179, DOI 10.1023/A:1014573915464; Viljamaa-Dirks S., 2008, CRAYFISH DIS DIAGNOS, P32; Walker PJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010022	56	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195353	10.1371/journal.pone.0195353	http://dx.doi.org/10.1371/journal.pone.0195353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617418	Green Published, Green Submitted, gold			2022-12-26	WOS:000429203800078
J	Kawata, M; Sasabuchi, Y; Taketomi, S; Inui, H; Matsui, H; Fushimi, K; Chikuda, H; Yasunaga, H; Tanaka, S				Kawata, Manabu; Sasabuchi, Yusuke; Taketomi, Shuji; Inui, Hiroshi; Matsui, Hiroki; Fushimi, Kiyohide; Chikuda, Hirotaka; Yasunaga, Hideo; Tanaka, Sakae			Annual trends in arthroscopic meniscus surgery: Analysis of a national database in Japan	PLOS ONE			English	Article							PARTIAL MENISCECTOMY; AMERICAN BOARD; UNITED-STATES; REPAIR; TEARS; OSTEOARTHRITIS; DIAGNOSIS; KNEE; INCREASE; INJURY	Background The importance of meniscus preservation is widely recognized. There have been a few studies describing trends in meniscectomy and meniscus repair in the United States; however, they presented differing results. We reported annual trends in meniscus surgery, using a national database in Japan. Methods We interrogated the Diagnosis Procedure Combination database, which represents approximately half of all hospital admissions in Japan. We included the patients who underwent meniscectomy and meniscus repair between July 2007 and March 2015. The diagnosis, age and sex of each patient were recorded. Results We identified 83,105 patients: 69,310 underwent meniscectomy; 13,416 underwent meniscus repair and 379 underwent both in a single admission. The proportion of patients undergoing meniscus repair rose from 7.0% in 2007 to 25.9% in 2014 (p < 0.001), while the proportion undergoing meniscectomy fell from 92.8% in 2007 to 73.3% in 2014 (p < 0.001). Among patients under 30 years old, the proportions undergoing meniscus repair or meniscectomy in 2014 were 50.3% versus 48.3%, respectively. A bimodal age distribution was observed for meniscectomy, with peaks at 10-19 years of age and 60-69 years of age, whereas most patients undergoing meniscus repair were 10-19 years of age. Conclusions We found characteristic trends where the popularity of meniscus repair increased rapidly at the expense of meniscectomy in Japan during the study period. In the last survey year, the proportion of meniscus repair exceeded that of meniscectomy in those younger than 30 years. Meniscectomy was undertaken most often in adolescents and early old age, while meniscus repair was undertaken most often in adolescents.	[Kawata, Manabu; Taketomi, Shuji; Inui, Hiroshi; Tanaka, Sakae] Univ Tokyo, Dept Orthopaed Surg, Fac Med, Bunkyo Ku, Tokyo, Japan; [Sasabuchi, Yusuke; Matsui, Hiroki; Yasunaga, Hideo] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Bunkyo Ku, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Informat & Policy, Bunkyo Ku, Tokyo, Japan; [Chikuda, Hirotaka] Gunma Univ, Dept Orthopaed Surg, Grad Sch Med, Maebashi, Gunma, Japan	University of Tokyo; University of Tokyo; Tokyo Medical & Dental University (TMDU); Gunma University	Taketomi, S (corresponding author), Univ Tokyo, Dept Orthopaed Surg, Fac Med, Bunkyo Ku, Tokyo, Japan.	takeos-tky@umin.ac.jp	Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414; Yasunaga, Hideo/0000-0002-6017-469X; Sasabuchi, Yusuke/0000-0001-7828-0549	Ministry of Health, Labour and Welfare, Japan [H29-Policy-Designated-009, H29-ICT-Genral-004]; Ministry of Education, Culture, Sports, Science and Technology, Japan [17H04141]; Japan Agency for Medical Research and Development (AMED)	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by grants from the Ministry of Health, Labour and Welfare, Japan (H29-Policy-Designated-009 and H29-ICT-Genral-004); Ministry of Education, Culture, Sports, Science and Technology, Japan (17H04141); and the Japan Agency for Medical Research and Development (AMED). The sponsor had no role in the study design, data collection, data analysis, data interpretation or writing of the manuscript.	Abrams GD, 2013, AM J SPORT MED, V41, P2333, DOI 10.1177/0363546513495641; Akiyama T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002412; Andersson-Molina H, 2002, ARTHROSCOPY, V18, P183, DOI 10.1053/jars.2002.30435; Aune KT, 2014, AM J SPORT MED, V42, P1865, DOI 10.1177/0363546514535069; BAKER BE, 1985, AM J SPORT MED, V13, P1, DOI 10.1177/036354658501300101; Baratz ME, 1986, AM J SPORTS MED, V14; Bureau of Statistics Ministry of Internal Affairs and Communications of Japan, 2011, SUMM RES POP CENS JA; Campbell SE, 2001, AM J ROENTGENOL, V177, P409, DOI 10.2214/ajr.177.2.1770409; Chikuda H, 2014, SPINE J, V14, P2275, DOI 10.1016/j.spinee.2014.01.024; Chikuda H, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-173; DICKASON JM, 1982, CLIN ORTHOP RELAT R, P75; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Englund M, 2012, NAT REV RHEUMATOL, V8, P412, DOI 10.1038/nrrheum.2012.69; Feeley BT, 2016, KNEE, V23, P674, DOI 10.1016/j.knee.2016.03.006; FUKUBAYASHI T, 1980, ACTA ORTHOP SCAND, V51, P871, DOI 10.3109/17453678008990887; Garrett WE, 2006, J BONE JOINT SURG AM, V88A, P660, DOI 10.2106/JBJS.E.01208; Haas AL, 2005, ARTHROSCOPY, V21, P167, DOI 10.1016/j.arthro.2004.10.012; Hare KB, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-71; HEDE A, 1992, J BONE JOINT SURG BR, V74, P118, DOI 10.1302/0301-620X.74B1.1732238; HEDE A, 1992, INT ORTHOP, V16, P122, DOI 10.1007/BF00180200; Herrlin SV, 2013, KNEE SURG SPORT TR A, V21, P358, DOI 10.1007/s00167-012-1960-3; IKEUCHI H, 1982, CLIN ORTHOP RELAT R, P19; JACKSON R W, 1972, Journal of Bone and Joint Surgery British Volume, V54, P310; Jordan, 1996, J Am Acad Orthop Surg, V4, P191; Katz JN, 2013, NEW ENGL J MED, V368, P1675, DOI 10.1056/NEJMoa1301408; Kim S, 2011, J BONE JOINT SURG AM, V93A, P994, DOI 10.2106/JBJS.I.01618; Kirkley A, 2008, NEW ENGL J MED, V359, P1097, DOI 10.1056/NEJMoa0708333; Koenig JH, 2009, ARTHROSCOPY, V25, P1025, DOI 10.1016/j.arthro.2009.03.015; Kramer DE, 2009, J AM ACAD ORTHOP SUR, V17, P698, DOI 10.5435/00124635-200911000-00004; Kurzweil PR, 2014, ARTHROSCOPY, V30, P1513, DOI 10.1016/j.arthro.2014.05.038; Lubowitz JH, 2011, ARTHROSCOPY, V27, P301, DOI 10.1016/j.arthro.2010.12.006; Maak TG, 2012, CLIN SPORT MED, V31, P1, DOI 10.1016/j.csm.2011.08.012; McDermott ID, 2006, J BONE JOINT SURG BR, V88B, P1549, DOI 10.1302/0301-620X.88B12.18140; Montgomery SR, 2013, ORTHOPEDICS, V36, pE1007, DOI 10.3928/01477447-20130724-15; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Parker BR, 2016, AM J SPORT MED, V44, P1717, DOI 10.1177/0363546516638082; Paxton ES, 2011, ARTHROSCOPY, V27, P1275, DOI 10.1016/j.arthro.2011.03.088; Sgaglione NA, 2003, ARTHROSCOPY, V19, P161, DOI 10.1016/j.arthro.2003.10.032; Sihvonen R, 2013, NEW ENGL J MED, V369, P2515, DOI 10.1056/NEJMoa1305189; Stein T, 2010, AM J SPORT MED, V38, P1542, DOI 10.1177/0363546510364052; Thorlund JB, 2014, ACTA ORTHOP, V85, P287, DOI 10.3109/17453674.2014.919558; Vaquero J, 2016, MLTJ-MUSCLE LIGAMENT, V6, P71, DOI 10.11138/mltj/2016.6.1.071; Vidal Armando F, 2012, J Bone Joint Surg Am, V94, pe186, DOI 10.2106/JBJS.L.01243; VOLOSHIN AS, 1983, J BIOMED ENG, V5, P157, DOI 10.1016/0141-5425(83)90036-5; Xu CQ, 2015, KNEE SURG SPORT TR A, V23, P164, DOI 10.1007/s00167-013-2528-6; Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8	46	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194854	10.1371/journal.pone.0194854	http://dx.doi.org/10.1371/journal.pone.0194854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614071	Green Published, Green Submitted, gold			2022-12-26	WOS:000429081600020
J	Kawata, T; Tokunaga, S; Murai, M; Masuda, N; Haruyama, W; Shoukei, Y; Hisada, Y; Yanagida, T; Miyazaki, H; Wada, M; Akizawa, T; Fukagawa, M				Kawata, Takehisa; Tokunaga, Shin; Murai, Miki; Masuda, Nami; Haruyama, Waka; Shoukei, Youji; Hisada, Yutaka; Yanagida, Tetsuya; Miyazaki, Hiroshi; Wada, Michihito; Akizawa, Tadao; Fukagawa, Masafumi			A novel calcimimetic agent, evocalcet (MT-4580/KHK7580), suppresses the parathyroid cell function with little effect on the gastrointestinal tract or CYP isozymes in vivo and in vitro	PLOS ONE			English	Article							PATIENTS RECEIVING HEMODIALYSIS; SECONDARY HYPERPARATHYROIDISM; CINACALCET HYDROCHLORIDE; CARDIOVASCULAR-DISEASE; PRACTICE PATTERNS; DIALYSIS PATIENTS; VITAMIN-D; CALCIUM; HCL; PTH	Cinacalcet hydrochloride (cinacalcet), an oral calcimimetic agent has been widely used for the management of secondary hyperparathyroidism (SHPT) in chronic kidney disease (CKD). In sharp contrast to vitamin D receptor activators, cinacalcet suppresses SHPT without inducing hypercalcemia or hyperphosphatemia. Nevertheless, some patients remain refractory to SHPT with this agent, as the dose cannot be sufficiently increased due to gastrointestinal symptoms. In order to resolve this issue, we have developed a newly synthesized calcimimetic agent, evocalcet (MT-4580/KHK7580). In a rat model of CKD induced by 5/6 nephrectomy, oral administration of evocalcet efficiently suppressed the secretion of parathyroid hormone (PTH). With regard to the gastro-intestinal effects, cinacalcet induced a significant delay in gastric emptying in rats, while evocalcet did no marked effects on it. Evocalcet also demonstrated the less induction of emesis compared to cinacalcet in common marmosets. The pharmacological effects of evocalcet were observed at lower doses because of its higher bioavailability than cinacalcet, which may have contributed to the reduced GI tract symptoms. In addition, evocalcet showed no substantial direct inhibition of any CYP isozymes in in vitro liver microsome assay, suggesting a better profile in drug interactions than cinacalcet that inhibits cytochrome P450 (CYP) 2D6. These findings suggest that evocalcet can be a better alternative to cinacalcet, an oral calcimimetic agent, with a wider safety margin.	[Kawata, Takehisa; Tokunaga, Shin; Haruyama, Waka] Kyowa Hakko Kirin Co Ltd, R&D Div, Nephrol R&D Unit, Nephrol Res Labs, Shizuoka, Japan; [Murai, Miki; Shoukei, Youji] Kyowa Hakko Kirin Co Ltd, R&D Div, Res Core Funct Labs, Res Funct Unit, Shizuoka, Japan; [Masuda, Nami] Kyowa Hakko Kirin Co Ltd, Prod Div, Takasaki Plant, Gunma, Japan; [Hisada, Yutaka; Yanagida, Tetsuya; Miyazaki, Hiroshi] Mitsubishi Tanabe Pharma Corp, Res Unit, Innovat Res Div, Yokohama, Kanagawa, Japan; [Wada, Michihito] Kyowa Hakko Kirin Co Ltd, Med Affairs Dept, Tokyo, Japan; [Akizawa, Tadao] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo, Japan; [Fukagawa, Masafumi] Tokai Univ, Sch Med, Div Nephrol Endocrinol & Metab, Hiratsuka, Kanagawa, Japan	Kyowa Kirin Ltd; Kyowa Kirin Ltd; Kyowa Kirin Ltd; Mitsubishi Tanabe Pharma Corporation; Kyowa Kirin Ltd; Showa University; Tokai University	Fukagawa, M (corresponding author), Tokai Univ, Sch Med, Div Nephrol Endocrinol & Metab, Hiratsuka, Kanagawa, Japan.	fukagawa@tokai-u.jp		Fukagawa, Misato/0000-0003-1117-9213; Fukagawa, Masafumi/0000-0002-7832-2339	Mitsubishi Tanabe Pharma Corporation; Kyowa-Hakko Kirin Co., Ltd.; Kyowa Hakko Kirin Co., Ltd	Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation); Kyowa-Hakko Kirin Co., Ltd.(Kyowa Kirin Ltd); Kyowa Hakko Kirin Co., Ltd(Kyowa Kirin Ltd)	Mitsubishi Tanabe Pharma Corporation provided KHK7580 compound. The studies of rat PK study and CYP inhibition assay were performed and all the cost of these studies were supported by Mitsubishi Tanabe Pharma Corporation. Other studies were performed and the cost of them were supported by Kyowa-Hakko Kirin Co., Ltd. Takehisa Kawata, Shin Tokunaga, Miki Murai, Nami Masuda, Waka Haruyama, Youji Shoukei, and Michihito Wada are employees of Kyowa Hakko Kirin Co., Ltd. Kyowa Hakko Kirin Co., Ltd provided support in the form of salaries for authors, TK, ST, MM, NM, WH, YS and MW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.; This study was supported by Mitsubishi Tanabe Pharma Corporation under a collaboration agreement. We thank Ayako Kannami (Mitsubishi Tanabe Pharma Corporation) for providing data of PK and CYP studies, and Hikaru Yoneda (Mitsubishi Tanabe Pharma Corporation) for his helpful discussion and reviewing this manuscript. We also wish to thank Misaki Kobayashi, Eri Okita, Akiko Katsumata, Miho Araki, and Mika Kawai for their assistance in the in vivo studies.	Akizawa T, 2011, CLIN J AM SOC NEPHRO, V6, P2280, DOI 10.2215/CJN.11501210; Badary OA, 2006, WORLD J GASTROENTERO, V12, P5363, DOI 10.3748/wjg.v12.i33.5363; Block GA, 2004, NEW ENGL J MED, V350, P1516, DOI 10.1056/NEJMoa031633; Block GA, 2017, JAMA-J AM MED ASSOC, V317, P156, DOI 10.1001/jama.2016.19468; Boussios S, 2012, ANN GASTROENTEROL, V25, P106; Chertow GM, 2012, NEW ENGL J MED, V367, P2482, DOI 10.1056/NEJMoa1205624; Cunningham J, 2005, KIDNEY INT, V68, P1793, DOI 10.1111/j.1523-1755.2005.00596.x; Cunningham J, 2011, CLIN J AM SOC NEPHRO, V6, P913, DOI 10.2215/CJN.06040710; Fukagawa M, 2008, NEPHROL DIAL TRANSPL, V23, P328, DOI 10.1093/ndt/gfm534; Fukagawa M, 2012, CLIN J AM SOC NEPHRO, V7, P1473, DOI 10.2215/CJN.13081211; Fukuma S, 2013, KIDNEY INT SUPPL, V3, P436, DOI 10.1038/kisup.2013.91; Fukumoto K., 2010, J JPN SOC DIAL THER, V43, P309; Gincherman Y, 2010, HEMODIAL INT, V14, P68, DOI 10.1111/j.1542-4758.2009.00397.x; Hamano N, 2017, EXPERT OPIN PHARMACO, V18, P529, DOI 10.1080/14656566.2017.1303482; Harris RZ, 2007, CLIN PHARMACOKINET, V46, P495, DOI 10.2165/00003088-200746060-00003; Kawata T, 2006, J BONE MINER METAB, V24, P300, DOI 10.1007/s00774-006-0687-y; Kiefer L, 2011, EXPERT OPIN THER PAT, V21, P681, DOI 10.1517/13543776.2011.568479; Nagano N, 2006, PHARMACOL THERAPEUT, V109, P339, DOI 10.1016/j.pharmthera.2005.06.019; Nakashima D, 2007, J CLIN PHARMACOL, V47, P1311, DOI 10.1177/0091270007304103; Nemeth EF, 2004, J PHARMACOL EXP THER, V308, P627, DOI 10.1124/jpet.103.057273; Padhi D, 2009, CLIN PHARMACOKINET, V48, P303, DOI 10.2165/00003088-200948050-00002; Palmer SC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001436; Raggi P, 2002, J AM COLL CARDIOL, V39, P695, DOI 10.1016/S0735-1097(01)01781-8; Raggi P, 2011, NEPHROL DIAL TRANSPL, V26, P1327, DOI 10.1093/ndt/gfq725; Rutter AR, 2014, J PHARMACOL EXP THER, V350, P153, DOI 10.1124/jpet.114.214155; Sassi Graziella, 2005, J Oncol Pharm Pract, V11, P63, DOI 10.1191/1078155205jp154oa; Taniguchi M, 2013, THER APHER DIAL, V17, P221, DOI 10.1111/1744-9987.12030; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Tentori F, 2014, KIDNEY INT, V85, P166, DOI 10.1038/ki.2013.279; Tominaga Y, 2016, THER APHER DIAL, V20, P6, DOI 10.1111/1744-9987.12352; Wetmore JB, 2015, CLIN J AM SOC NEPHRO, V10, P1031, DOI 10.2215/CJN.07050714	31	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195316	10.1371/journal.pone.0195316	http://dx.doi.org/10.1371/journal.pone.0195316			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614098	Green Submitted, Green Published, gold			2022-12-26	WOS:000429081600044
J	Shakeel, T; Gupta, M; Fatma, Z; Kumar, R; Kumar, R; Singh, R; Sharma, M; Jade, D; Gupta, D; Fatma, T; Yazdani, SS				Shakeel, Tabinda; Gupta, Mayank; Fatma, Zia; Kumar, Rakesh; Kumar, Raubins; Singh, Rahul; Sharma, Medha; Jade, Dhananjay; Gupta, Dinesh; Fatma, Tasneem; Yazdani, Syed Shams			A consensus-guided approach yields a heat-stable alkane-producing enzyme and identifies residues promoting thermostability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein engineering; structure-function; enzyme mechanism; enzyme mutation; molecular modeling; molecular dynamics; biofuel; aldehyde deformylating oxygenase; long-chain alkane; thermostable enzyme	CYANOBACTERIAL ALDEHYDE DECARBONYLASE; DEFORMYLATING OXYGENASE; SALT BRIDGES; ACID; BIOSYNTHESIS; SIMULATION; CONVERSION; STABILITY; INSIGHTS; DYNAMICS	Aldehyde-deformylating oxygenase (ADO) is an essential enzyme for production of long-chain alkanes as drop-in biofuels, which are compatible with existing fuel systems. The most active ADOs are present in mesophilic cyanobacteria, especially Nostoc punctiforme. Given the potential applications of thermostable enzymes in biorefineries, here we generated a thermostable (Cts)-ADO based on a consensus of ADO sequences from several thermophilic cyanobacterial strains. Using an in silico design pipeline and a metagenome library containing 41 hot-spring microbial communities, we created Cts-ADO. Cts-ADO displayed a 3.8-fold increase in pentadecane production on raising the temperature from 30 to 42 degrees C, whereas ADO from N. punctiforme (Np-ADO) exhibited a 1.7-fold decline. 3D structure modeling and molecular dynamics simulations of Cts- and Np-ADO at different temperatures revealed differences between the two enzymes in residues clustered on exposed loops of these variants, which affected the conformation of helices involved in forming the ADO catalytic core. In Cts-ADO, this conformational change promoted ligand binding to its preferred iron, Fe2, in the di-iron cluster at higher temperature, but the reverse was observed in Np-ADO. Detailed mapping of residues conferring Cts-ADO thermostability identified four amino acids, which we substituted individually and together in Np-ADO. Among these substitution variants, A161E was remarkably similar to Cts-ADO in terms of activity optima, kinetic parameters, and structure at higher temperature. A161E was located in loop L6, which connects helices H5 and H6, and supported ligand binding to Fe2 at higher temperatures, thereby promoting optimal activity at these temperatures and explaining the increased thermostability of Cts-ADO.	[Shakeel, Tabinda; Gupta, Mayank; Fatma, Zia; Kumar, Raubins; Singh, Rahul; Sharma, Medha; Yazdani, Syed Shams] Int Ctr Genet Engn & Biotechnol, Microbial Engn Grp, New Delhi 110067, India; [Kumar, Rakesh; Jade, Dhananjay; Gupta, Dinesh] Int Ctr Genet Engn & Biotechnol, Translat Bioinformat Grp, New Delhi 110067, India; [Shakeel, Tabinda; Gupta, Mayank; Fatma, Zia; Singh, Rahul; Sharma, Medha; Yazdani, Syed Shams] Int Ctr Genet Engn & Biotechnol, DBT ICGEB Ctr Adv Bioenergy Res, New Delhi 110067, India; [Fatma, Tasneem] Jamia Millia Islamia, Dept Biosci, New Delhi 110025, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; DBT-ICGEB Centre for Advanced Bioenergy Research, New Delhi; Jamia Millia Islamia	Yazdani, SS (corresponding author), Int Ctr Genet Engn & Biotechnol, Microbial Engn Grp, New Delhi 110067, India.; Yazdani, SS (corresponding author), Int Ctr Genet Engn & Biotechnol, DBT ICGEB Ctr Adv Bioenergy Res, New Delhi 110067, India.	shams@icgeb.res.in	Singh, Rahul/AAT-2337-2021; Gupta, Dinesh/C-1079-2009	Gupta, Dinesh/0000-0002-7548-8835; Jade, Dhananjay/0000-0002-3009-5915	Department of Biotechnology, Government of India [BT/PB/Center/03/2011, BT/IN/INDO-UK/SuBB/21/SSY/2013, BT/BI/25/066/2012]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by Department of Biotechnology, Government of India, Grants BT/PB/Center/03/2011 and BT/IN/INDO-UK/SuBB/21/SSY/2013 (to S. S. Y.) and Grant BT/BI/25/066/2012 (to D. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Akhtar MK, 2013, P NATL ACAD SCI USA, V110, P87, DOI 10.1073/pnas.1216516110; Andre C, 2013, P NATL ACAD SCI USA, V110, P3191, DOI 10.1073/pnas.1218769110; Artimo Panu, 2012, Nucleic Acids Res, V40, pW597, DOI 10.1093/nar/gks400; Bao LY, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0596-9; Buer BC, 2014, ACS CHEM BIOL, V9, P2584, DOI 10.1021/cb500343j; Buist PH, 2007, NAT PROD REP, V24, P1110, DOI 10.1039/b508584p; Case D. A., 2014, AMBER 14; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chan CH, 2015, WORLD J EMERG MED, V6, P16, DOI 10.5847/wjem.j.1920-8642.2015.01.003; Damnjanovic J, 2014, BIOTECHNOL BIOENG, V111, P674, DOI 10.1002/bit.25149; Das D, 2014, ACS CHEM BIOL, V9, P570, DOI 10.1021/cb400772q; Das D, 2011, ANGEW CHEM INT EDIT, V50, P7148, DOI 10.1002/anie.201101552; DeLano W.L., 2002, PYMOL MOL GRAPH SYST; Dembitsky VM, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1276, DOI 10.1023/A:1021309623541; DENNIS M, 1992, P NATL ACAD SCI USA, V89, P5306, DOI 10.1073/pnas.89.12.5306; Eser BE, 2011, BIOCHEMISTRY-US, V50, P10743, DOI 10.1021/bi2012417; Fatma Z, 2018, METAB ENG, V46, P1, DOI 10.1016/j.ymben.2018.01.002; Fatma Z, 2016, METAB ENG, V37, P35, DOI 10.1016/j.ymben.2016.04.003; GELPI E, 1968, SCIENCE, V161, P700, DOI 10.1126/science.161.3842.700; Gribenko AV, 2009, P NATL ACAD SCI USA, V106, P2601, DOI 10.1073/pnas.0808220106; Gunasekaran K, 2003, J MOL BIOL, V332, P143, DOI 10.1016/S0022-2836(03)00893-3; Hayashi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122217; Howard TP, 2013, P NATL ACAD SCI USA, V110, P7636, DOI 10.1073/pnas.1215966110; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; Idicula-Thomas S, 2005, PROTEIN SCI, V14, P582, DOI 10.1110/ps.041009005; Jia CJ, 2015, PROTEIN CELL, V6, P55, DOI 10.1007/s13238-014-0108-2; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; JONES JG, 1969, J GEN MICROBIOL, V59, P145, DOI 10.1099/00221287-59-2-145; Khara B, 2013, CHEMBIOCHEM, V14, P1204, DOI 10.1002/cbic.201300307; Knothe G, 2010, PROG ENERG COMBUST, V36, P364, DOI 10.1016/j.pecs.2009.11.004; Krebs C, 2011, CURR OPIN CHEM BIOL, V15, P291, DOI 10.1016/j.cbpa.2011.02.019; Kurtz DM, 1997, J BIOL INORG CHEM, V2, P159, DOI 10.1007/s007750050120; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Li N, 2012, BIOCHEMISTRY-US, V51, P7908, DOI 10.1021/bi300912n; Li N, 2011, J AM CHEM SOC, V133, P6158, DOI 10.1021/ja2013517; Liao H H, 1991, Protein Expr Purif, V2, P43, DOI 10.1016/1046-5928(91)90008-7; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Lu XF, 2010, BIOTECHNOL ADV, V28, P742, DOI 10.1016/j.biotechadv.2010.05.021; Makhatadze GI, 2003, J MOL BIOL, V327, P1135, DOI 10.1016/S0022-2836(03)00233-X; Malabanan MM, 2010, CURR OPIN STRUC BIOL, V20, P702, DOI 10.1016/j.sbi.2010.09.005; Mamonova TB, 2013, BBA-PROTEINS PROTEOM, V1834, P854, DOI 10.1016/j.bbapap.2013.02.011; MCINNES AG, 1980, LIPIDS, V15, P609, DOI 10.1007/BF02534009; MERDINGER E, 1966, J BACTERIOL, V91, P1831, DOI 10.1128/JB.91.5.1831-1833.1966; Merkx M, 2001, ANGEW CHEM INT EDIT, V40, P2782, DOI 10.1002/1521-3773(20010803)40:15<2782::AID-ANIE2782>3.0.CO;2-P; Olson DG, 2012, CURR OPIN BIOTECH, V23, P396, DOI 10.1016/j.copbio.2011.11.026; ORO J, 1966, SCIENCE, V154, P399, DOI 10.1126/science.154.3747.399; Pace CN, 2011, J MOL BIOL, V408, P514, DOI 10.1016/j.jmb.2011.02.053; Papaleo E, 2007, J MOL GRAPH MODEL, V26, P93, DOI 10.1016/j.jmgm.2006.09.012; Paul B, 2013, J AM CHEM SOC, V135, P5234, DOI 10.1021/ja3115949; Paul M, 2014, J BIOMOL STRUCT DYN, V32, P928, DOI 10.1080/07391102.2013.799438; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Sazinsky MH, 2006, ACCOUNTS CHEM RES, V39, P558, DOI 10.1021/ar030204v; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Shakeel T, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00034; Shanklin J, 2009, J BIOL CHEM, V284, P18559, DOI 10.1074/jbc.R900009200; SHIEA J, 1990, ORG GEOCHEM, V15, P223, DOI 10.1016/0146-6380(90)90001-G; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Speight J. G., 2016, HDB PETROLEUM REFINI; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan XM, 2011, METAB ENG, V13, P169, DOI 10.1016/j.ymben.2011.01.001; Thomas AS, 2004, J AM CHEM SOC, V126, P2208, DOI 10.1021/ja039159c; Timilsina GR, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2012.0323; Turner P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-9; Vinther JM, 2011, J AM CHEM SOC, V133, P271, DOI 10.1021/ja105388k; Wang Q, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0351-8; Wang Q, 2014, CHEM COMMUN, V50, P4299, DOI 10.1039/c4cc00591k; Warui DM, 2011, J AM CHEM SOC, V133, P3316, DOI 10.1021/ja111607x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Waugh MW, 2014, BIOCHEMISTRY-US, V53, P5537, DOI 10.1021/bi5005766; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Westerlund-Karlsson A, 2002, BIOCHEM BIOPH RES CO, V296, P1072, DOI 10.1016/S0006-291X(02)02052-1; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P193, DOI 10.1111/j.1574-6968.1998.tb13045.x; WINTERS K, 1969, SCIENCE, V163, P467, DOI 10.1126/science.163.3866.467; Wintrode PL, 2003, J MOL BIOL, V327, P745, DOI 10.1016/S0022-2836(03)00147-5; Yu HR, 2017, SCI REP-UK, V7, DOI 10.1038/srep41212; Zhang Jingjing, 2013, Biotechnol Biofuels, V6, P86, DOI 10.1186/1754-6834-6-86	83	13	13	1	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9148	9161		10.1074/jbc.RA117.000639	http://dx.doi.org/10.1074/jbc.RA117.000639			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29632075	hybrid, Green Published			2022-12-26	WOS:000435441400002
J	Thines, L; Deschamps, A; Sengottaiyan, P; Savel, O; Stribny, J; Morsomme, P				Thines, Louise; Deschamps, Antoine; Sengottaiyan, Palanivelu; Savel, Oksana; Stribny, Jiri; Morsomme, Pierre			The yeast protein Gdt1p transports Mn2+ ions and thereby regulates manganese homeostasis in the Golgi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						yeast; Golgi; calcium transport; manganese; membrane transport; transporter; Congenital Disorder of Glycosylation; GDT1; UPF0016	SACCHAROMYCES-CEREVISIAE; SUPEROXIDE-DISMUTASE; PLASMA-MEMBRANE; PH HOMEOSTASIS; CALCIUM; GLYCOSYLATION; TMEM165; PMR1; IDENTIFICATION; BIOSYNTHESIS	The uncharacterized protein family 0016 (UPF0016) is a family of secondary ion transporters implicated in calcium homeostasis and some diseases. More precisely, genetic variants of the human UPF0016 ortholog transmembrane protein 165 (TMEM165) have been linked to congenital disorders of glycosylation (CDG). The Saccharomyces cerevisiae ortholog Gdt1p has been shown to be involved in calcium homeostasis and protein glycosylation. Moreover, plant and bacterial UPF0016 members appear to have putative roles in Mn2+ homeostasis. Here, we produced the yeast UPF0016 member Gdt1p in the bacterial host Lactococcus lactis. Using Mn2+-induced quenching of Fura-2-emitted fluorescence, we observed that Gdt1p mediates Mn2+ influx, in addition to its previously reported regulation of Ca2+ influx. The estimated K-m values of Gdt1p of 15.6 +/- 2.6 m for Ca2+ and 83.2 +/- 9.8 m for Mn2+ indicated that Gdt1p has a higher affinity for Ca2+ than for Mn2+. In yeast cells, we found that Gdt1p is involved in the resistance to high Mn2+ concentration and controls total Mn2+ stores. Lastly, we demonstrated that GDT1 deletion affects the activity of the yeast Mn2+-dependent Sod2p superoxide dismutase, most likely by modulating cytosolic Mn2+ concentrations. Taken together, we obtained first evidence that Gdt1p from yeast directly transports manganese, which strongly reinforces the suggested link between the UPF0016 family and Mn2+ homeostasis and provides new insights into the molecular causes of human TMEM165-associated CDGs. Our results also shed light on how yeast cells may regulate Golgi intraluminal concentrations of manganese, a key cofactor of many enzymes involved in protein glycosylation.	[Thines, Louise; Deschamps, Antoine; Sengottaiyan, Palanivelu; Savel, Oksana; Stribny, Jiri; Morsomme, Pierre] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain La Neuve, Belgium; [Thines, Louise] Fonds Format Rech Ind & Agr FRIA, Brussels, Belgium	Universite Catholique Louvain	Morsomme, P (corresponding author), Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain La Neuve, Belgium.	pierre.morsomme@uclouvain.be	Morsomme, Pierre/AAD-9600-2019	Morsomme, Pierre/0000-0001-7780-7230; Stribny, Jiri/0000-0002-2449-3167	Fonds National de la Recherche Scientifique-FNRS [PDR-T.0206.16]; Communaute Francaise de Belgique-Actions de Recherches Concertees	Fonds National de la Recherche Scientifique-FNRS(Fonds de la Recherche Scientifique - FNRS); Communaute Francaise de Belgique-Actions de Recherches Concertees	This work was supported by grants from Fonds National de la Recherche Scientifique-FNRS Grant PDR-T.0206.16 and the Communaute Francaise de Belgique-Actions de Recherches Concertees. The authors declare that they have no conflicts of interest with the contents of this article.	ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Brandenburg F, 2017, PLANT PHYSIOL, V173, P1798, DOI 10.1104/pp.16.01895; Chen JL, 2002, J BIOL CHEM, V277, P35682, DOI 10.1074/jbc.M204157200; Colinet AS, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12729; Colinet AS, 2016, SCI REP-UK, V6, DOI 10.1038/srep24282; Demaegd D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100851; Demaegd D, 2013, P NATL ACAD SCI USA, V110, P6859, DOI 10.1073/pnas.1219871110; Dulary E, 2018, BBA-GEN SUBJECTS, V1862, P394, DOI 10.1016/j.bbagen.2017.11.006; Fisher CR, 2016, J BACTERIOL, V198, P2810, DOI 10.1128/JB.00215-16; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; Gandini C, 2017, NEW PHYTOL, V215, P256, DOI 10.1111/nph.14526; Luk EEC, 2001, J BIOL CHEM, V276, P47556, DOI 10.1074/jbc.M108923200; Mandal D, 2000, J BIOL CHEM, V275, P23933, DOI 10.1074/jbc.M002619200; OHSUMI Y, 1983, J BIOL CHEM, V258, P5614; Page MM, 2010, J COMP PHYSIOL B, V180, P361, DOI 10.1007/s00360-009-0416-7; Portnoy ME, 2000, MOL CELL BIOL, V20, P7893, DOI 10.1128/MCB.20.21.7893-7902.2000; Potelle S, 2017, BIOCHEM J, V474, P1481, DOI 10.1042/BCJ20160910; Potelle S, 2016, HUM MOL GENET, V25, P1489, DOI 10.1093/hmg/ddw026; Rayner JC, 1998, J BIOL CHEM, V273, P26836, DOI 10.1074/jbc.273.41.26836; ROMERO PA, 1989, J BIOL CHEM, V264, P1946; Schneider A, 2016, PLANT CELL, V28, P892, DOI 10.1105/tpc.15.00812; Snyder NA, 2017, G3-GENES GENOM GENET, V7, P3913, DOI 10.1534/g3.117.300339; Sorin A, 1997, J BIOL CHEM, V272, P9895; Striebeck A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130022; Vallee F, 2000, EMBO J, V19, P581, DOI 10.1093/emboj/19.4.581; VANLOON APGM, 1986, P NATL ACAD SCI USA, V83, P3820; Wang C, 2016, MOL PLANT, V9, P1183, DOI 10.1016/j.molp.2016.05.015; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945	29	21	21	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8048	8055		10.1074/jbc.RA118.002324	http://dx.doi.org/10.1074/jbc.RA118.002324			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29632074	hybrid, Green Published			2022-12-26	WOS:000433224600011
J	Mundy, C; Yang, E; Takano, H; Billings, PC; Pacifici, M				Mundy, Christina; Yang, Evan; Takano, Hajime; Billings, Paul C.; Pacifici, Maurizio			Heparan sulfate antagonism alters bone morphogenetic protein signaling and receptor dynamics, suggesting a mechanism in hereditary multiple exostoses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone morphogenetic protein (BMP); heparan sulfate; cell-surface receptor; signaling; cell biology; hereditary multiple exostoses	TGF-BETA; SKELETAL DEVELOPMENT; PROXIMITY LIGATION; NATURAL-HISTORY; MOUSE MODEL; LONG BONES; IN-SITU; EXT1; BMP; COMPLEXES	Hereditary multiple exostoses (HME) is a pediatric disorder caused by heparan sulfate (HS) deficiency and is characterized by growth plate-associated osteochondromas. Previously, we found that osteochondroma formation in mouse models is preceded by ectopic bone morphogenetic protein (BMP) signaling in the perichondrium, but the mechanistic relationships between BMP signaling and HS deficiency remain unclear. Therefore, we used an HS antagonist (surfen) to investigate the effects of this HS interference on BMP signaling, ligand availability, cell-surface BMP receptor (BMPR) dynamics, and BMPR interactions in Ad-293 and C3H/10T1/2 cells. As observed previously, the HS interference rapidly increased phosphorylated SMAD family member 1/5/8 levels. FACS analysis and immunoblots revealed that the cells possessed appreciable levels of endogenous cell-surface BMP2/4 that were unaffected by the HS antagonist, suggesting that BMP2/4 proteins remained surface-bound but became engaged in BMPR interactions and SMAD signaling. Indeed, surface mobility of SNAP-tagged BMPRII, measured by fluorescence recovery after photobleaching (FRAP), was modulated during the drug treatment. This suggested that the receptors had transitioned to lipid rafts acting as signaling centers, confirmed for BMPRII via ultracentrifugation to separate membrane subdomains. In situ proximity ligation assays disclosed that the HS interference rapidly stimulates BMPRI-BMPRII interactions, measured by oligonucleotide-driven amplification signals. Our in vitro studies reveal that cell-associated HS controls BMP ligand availability and BMPR dynamics, interactions, and signaling, and largely restrains these processes. We propose that HS deficiency in HME may lead to extensive local BMP signaling and altered BMPR dynamics, triggering excessive cellular responses and osteochondroma formation.	[Mundy, Christina; Yang, Evan; Billings, Paul C.; Pacifici, Maurizio] Childrens Hosp Philadelphia, Div Orthopaed Surg, Translat Res Program Pediat Orthopaed, Philadelphia, PA 19104 USA; [Takano, Hajime] Childrens Hosp Philadelphia, Dept Pediat, Div Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Mundy, C (corresponding author), Translat Res Program Pediat Orthopaed, ARC 904,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	matticolac@email.chop.edu	Takano, Hajime/AAD-4589-2019		NIAMS, National Institutes of Health [R01AR061758, AR071946]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD086984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061758, R01AR071946] Funding Source: NIH RePORTER	NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIAMS, National Institutes of Health, Grants R01AR061758 and AR071946 (to M. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AHN J, 1995, NAT GENET, V11, P137, DOI 10.1038/ng1095-137; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Anower-E-Khuda MF, 2013, GLYCOBIOLOGY, V23, P865, DOI 10.1093/glycob/cwt024; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Bandyopadhyay A, 2008, DEV BIOL, V321, P162, DOI 10.1016/j.ydbio.2008.06.012; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Bellucci A, 2014, METHODS MOL BIOL, V1174, P397, DOI 10.1007/978-1-4939-0944-5_27; Billings PC, 2015, CONNECT TISSUE RES, V56, P272, DOI 10.3109/03008207.2015.1045066; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brown A, 2013, BIOPHYS J, V104, P1720, DOI 10.1016/j.bpj.2013.02.051; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Chen S, 2008, KIDNEY INT, V74, P289, DOI 10.1038/ki.2008.159; Cheung PK, 2001, AM J HUM GENET, V69, P55, DOI 10.1086/321278; Dormans J. P., 2005, PEDIAT ORTHOPAEDICS, P382; Doumazane E, 2011, FASEB J, V25, P66, DOI 10.1096/fj.10-163147; Ehrlich M, 2012, FEBS LETT, V586, P1885, DOI 10.1016/j.febslet.2012.01.040; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Guzman A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.387639; Haas AR, 1999, DIFFERENTIATION, V64, P77, DOI 10.1046/j.1432-0436.1999.6420077.x; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; Hatsell SJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4358; HECHT JT, 1995, AM J HUM GENET, V56, P1125; Hojo H, 2013, J BIOL CHEM, V288, P9924, DOI 10.1074/jbc.M112.409342; Huegel J, 2015, AM J PATHOL, V185, P1676, DOI 10.1016/j.ajpath.2015.02.014; Huegel J, 2013, DEV DYNAM, V242, P1021, DOI 10.1002/dvdy.24010; Huegel J, 2013, DEV BIOL, V377, P100, DOI 10.1016/j.ydbio.2013.02.008; Ibrahimi OA, 2004, BIOCHEMISTRY-US, V43, P4724, DOI 10.1021/bi0352320; Inubushi T, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90049; Jiao XY, 2007, J BIOL CHEM, V282, P1080, DOI 10.1074/jbc.M513414200; Jones KB, 2010, P NATL ACAD SCI USA, V107, P2054, DOI 10.1073/pnas.0910875107; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Knudson AG, 1996, J CANCER RES CLIN, V122, P135, DOI 10.1007/BF01366952; Kuo WJ, 2010, MOL BIOL CELL, V21, P4028, DOI 10.1091/mbc.E10-04-0348; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Manton KJ, 2007, STEM CELLS, V25, P2845, DOI 10.1634/stemcells.2007-0065; Marom B, 2011, J BIOL CHEM, V286, P19287, DOI 10.1074/jbc.M110.210377; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matsumoto K, 2010, P NATL ACAD SCI USA, V107, P10932, DOI 10.1073/pnas.0914642107; Matsushita T, 2009, MOL CELL BIOL, V29, P5843, DOI 10.1128/MCB.01549-08; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Minina E, 2005, GENE EXPR PATTERNS, V6, P102, DOI 10.1016/j.modgep.2005.04.012; Mooij HL, 2015, J LIPID RES, V56, P665, DOI 10.1194/jlr.M053504; Mundy C, 2016, J CELL PHYSIOL, V231, P1033, DOI 10.1002/jcp.25192; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; Pohl TLM, 2012, ACTA BIOMATER, V8, P772, DOI 10.1016/j.actbio.2011.10.019; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; Salazar VS, 2016, NAT REV ENDOCRINOL, V12, P203, DOI 10.1038/nrendo.2016.12; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; SCHMALE GA, 1994, J BONE JOINT SURG AM, V76A, P986, DOI 10.2106/00004623-199407000-00005; Schuksz M, 2008, P NATL ACAD SCI USA, V105, P13075, DOI 10.1073/pnas.0805862105; Sgariglia F, 2013, BONE, V57, P220, DOI 10.1016/j.bone.2013.08.012; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sinha S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006742; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; SOLOMON L, 1963, J BONE JOINT SURG BR, V45, P292, DOI 10.1302/0301-620X.45B2.292; THOMAS P, 2006, FRON NEUROS, P155; Uchida K, 1997, EUR RESPIR J, V10, P735; Weiss A, 2013, WIRES DEV BIOL, V2, P47, DOI 10.1002/wdev.86; Whiteford JR, 2011, MOL BIOL CELL, V22, P3609, DOI 10.1091/mbc.E11-02-0099; WICKLUND CL, 1995, AM J MED GENET, V55, P43, DOI 10.1002/ajmg.1320550113; Wuyts W, 2000, HUM MUTAT, V15, P220, DOI 10.1002/(SICI)1098-1004(200003)15:3<220::AID-HUMU2>3.0.CO;2-K; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Zak BM, 2011, BONE, V48, P979, DOI 10.1016/j.bone.2011.02.001	67	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7703	7716		10.1074/jbc.RA117.000264	http://dx.doi.org/10.1074/jbc.RA117.000264			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29622677	Green Published, hybrid			2022-12-26	WOS:000437256500020
J	Fechner, S; Grant, K; von der Emde, G; Engelmann, J				Fechner, Sylvia; Grant, Kirsty; von der Emde, Gerhard; Engelmann, Jacob			Physiological evidence of sensory integration in the electrosensory lateral line lobe of Gnathonemus petersii	PLOS ONE			English	Article							WEAKLY ELECTRIC FISH; MORMYRID FISH; COROLLARY DISCHARGE; TOPOGRAPHIC MAPS; AUDITORY-CORTEX; RESPONSES; NEURONS; ELECTRORECEPTOR; ORGANIZATION; CONNECTIONS	Mormyrid fish rely on reafferent input for active electrolocation. Their electrosensory input consists of phase and amplitude information. These are encoded by differently tuned receptor cells within the Mormyromasts, A- and B-cells, respectively, which are distributed over the animal's body. These convey their information to two topographically ordered medullary zones in the electrosensory lateral line lobe (ELL). The so-called medial zone receives only amplitude information, while the dorsolateral zone receives amplitude and phase information. Using both sources of information, Mormyrid fish can disambiguate electrical impedances. Where and how this disambiguation takes place is presently unclear. We here investigate phase-sensitivity downstream from the electroreceptors. We provide first evidence of phase-sensitivity in the medial zone of ELL. In this zone I-cells consistently decreased their rate to positive phase-shifts (6 of 20 cells) and increased their rate to negative shifts (11/20), while E-cells of the medial zone (3/9) responded oppositely to I-cells. In the dorsolateral zone the responses of E-and I-cells were opposite to those found in the medial zone. Tracer injections revealed interzonal projections that interconnect the dorsolateral and medial zones in a somatotopic manner. In summary, we show that phase information is processed differently in the dorsolateral and the medial zones. This is the first evidence for a mechanism that enhances the contrast between two parallel sensory channels in Mormyrid fish. This could be beneficial for impedance discrimination that ultimately must rely on a subtractive merging of these two sensory streams.	[Fechner, Sylvia; von der Emde, Gerhard; Engelmann, Jacob] Univ Bonn, Inst Zool, Bonn, Germany; [Grant, Kirsty] UNIC, CNRS, 1 Ave Terrasse, Gif Sur Yvette, France; [Engelmann, Jacob] Univ Bielefeld, Biol AG Act Sensing, Bielefeld, Germany; [Fechner, Sylvia] Stanford Sch Med, Dept Mol & Cellular Physiol, Stanford, CA USA	University of Bonn; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Bielefeld; Stanford University	Engelmann, J (corresponding author), Univ Bonn, Inst Zool, Bonn, Germany.; Engelmann, J (corresponding author), Univ Bielefeld, Biol AG Act Sensing, Bielefeld, Germany.	Jacob.Engelmann@uni-bielefeld.de		Engelmann, Jacob/0000-0002-1054-0938; Fechner, Sylvia/0000-0003-4440-6611	Deutsche Forschungsgemeinschaft [EN 826/4-1]; Deutscher Akademischer Austauschdienst (DAAD)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by Grant EN 826/4-1 from the Deutsche Forschungsgemeinschaft, http//www.dfg.de/; and a travel grant by the Deutscher Akademischer Austauschdienst (DAAD), https://www.daad.de/de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacelo J, 2008, J COMP NEUROL, V511, P342, DOI 10.1002/cne.21843; BARLOW HB, 1986, VISION RES, V26, P81, DOI 10.1016/0042-6989(86)90072-6; Bell C.C., 1986, P375; Bell CC, 2005, SPR HDB AUD, V21, P68; BELL CC, 1992, J NEUROPHYSIOL, V68, P843, DOI 10.1152/jn.1992.68.3.843; Bell CC, 1997, J NEUROSCI, V17, P6409; BELL CC, 1978, J COMP NEUROL, V182, P367, DOI 10.1002/cne.901820302; BELL CC, 1981, EXP BRAIN RES, V42, P9; BELL CC, 1990, J NEUROPHYSIOL, V63, P319, DOI 10.1152/jn.1990.63.2.319; Braford M. R. Jr., 1993, Journal of Comparative Physiology A Sensory Neural and Behavioral Physiology, V173, P704; Brown WM, 2006, NEURAL COMPUT, V18, P1511, DOI 10.1162/neco.2006.18.7.1511; Engelmann J, 2006, J NEUROPHYSIOL, V95, P1231, DOI 10.1152/jn.00405.2005; FINGER TE, 1981, EXP BRAIN RES, V42, P23; Goenechea L, 2004, J COMP PHYSIOL A, V190, P907, DOI 10.1007/s00359-004-0548-x; Graziano MSA, 2007, NEUROSCIENTIST, V13, P138, DOI 10.1177/1073858406295918; HEILIGENBERG W, 1978, SCIENCE, V199, P1001, DOI 10.1126/science.622577; Hitschfeld EM, 2009, ILAR J, V50, P361, DOI 10.1093/ilar.50.4.361; HOPKINS CD, 1981, SCIENCE, V212, P85, DOI 10.1126/science.7209524; Kaas J., 1982, CONTRIBUTIONS SENSOR, P200; Kaas J H, 1989, J Cogn Neurosci, V1, P121, DOI 10.1162/jocn.1989.1.2.121; Kaas JH, 1997, BRAIN RES BULL, V44, P107, DOI 10.1016/S0361-9230(97)00094-4; Khosravi-Hashemi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040339; Krahe R, 2014, CURR OPIN NEUROBIOL, V24, P13, DOI 10.1016/j.conb.2013.08.013; Lee CC, 2004, NEUROSCIENCE, V128, P871, DOI 10.1016/j.neuroscience.2004.06.062; LISSMANN HW, 1958, J EXP BIOL, V35, P451; McGillivray P, 2012, J NEUROSCI, V32, P5510, DOI 10.1523/JNEUROSCI.0478-12.2012; Meek J, 1999, J EXP BIOL, V202, P1291; Meek J, 2004, J COMP NEUROL, V468, P151, DOI 10.1002/cne.10951; Meek J, 2001, J COMP NEUROL, V431, P255, DOI 10.1002/1096-9861(20010312)431:3<255::AID-CNE1069>3.0.CO;2-9; Metzen MG, 2008, J COMP PHYSIOL A, V194, P1063, DOI 10.1007/s00359-008-0377-4; Metzner W, 1997, P NATL ACAD SCI USA, V94, P14798, DOI 10.1073/pnas.94.26.14798; Mohr C, 2003, J NEUROPHYSIOL, V90, P1193, DOI 10.1152/jn.00211.2003; Sawtell NB, 2005, CURR OPIN NEUROBIOL, V15, P437, DOI 10.1016/j.conb.2005.06.006; Schreiner CE, 2007, NEURON, V56, P356, DOI 10.1016/j.neuron.2007.10.013; SHUMWAY CA, 1989, J NEUROSCI, V9, P4388; SZABO T, 1967, PHYSIOL BEHAV, V2, P331, DOI 10.1016/0031-9384(67)90047-9; SZABO T, 1970, J ULTRA MOL STRUCT R, V30, P473, DOI 10.1016/S0022-5320(70)90048-1; van Hemmen JL, 2002, CHEMPHYSCHEM, V3, P291, DOI 10.1002/1439-7641(20020315)3:3<291::AID-CPHC291>3.0.CO;2-M; VonderEmde G, 1996, J NEUROPHYSIOL, V76, P1581, DOI 10.1152/jn.1996.76.3.1581; VONDEREMDE G, 1992, J COMP PHYSIOL A, V171, P683, DOI 10.1007/BF00194116; VONDEREMDE G, 1994, J COMP PHYSIOL A, V175, P801, DOI 10.1007/BF00191852; vonderEmde G, 1997, J COMP PHYSIOL A, V181, P511, DOI 10.1007/s003590050135; VONDEREMDE G, 1992, NATURWISSENSCHAFTEN, V79, P131, DOI 10.1007/BF01131542; VONDEREMDE G, 1994, J COMP PHYSIOL A, V175, P83, DOI 10.1007/BF00217439; VONDEREMDE G, 1993, J EXP BIOL, V181, P157; VONDEREMDE G, 1990, J COMP PHYSIOL A, V167, P413, DOI 10.1007/BF00192576; Vonderschen K, 2011, SPARSE DENSE CODING, P3102; Weinberg RJ, 1997, BRAIN RES BULL, V44, P113, DOI 10.1016/S0361-9230(97)00095-6; Winer JA, 2005, TRENDS NEUROSCI, V28, P255, DOI 10.1016/j.tins.2005.03.009	49	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194347	10.1371/journal.pone.0194347	http://dx.doi.org/10.1371/journal.pone.0194347			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641541	Green Published, Green Submitted, gold			2022-12-26	WOS:000429742900030
J	Ghorbani, A; Izadpanah, K; Dietzgen, RG				Ghorbani, Abozar; Izadpanah, Keramatollah; Dietzgen, Ralf G.			Changes in maize transcriptome in response to maize Iranian mosaic virus infection	PLOS ONE			English	Article							PLANT DEFENSE; GENE-EXPRESSION; PROTEIN; RESISTANCE; TOMATO; RHABDOVIRUS; MECHANISMS; IMMUNITY; GENOMICS; BIOLOGY	Background Maize Iranian mosaic virus (MIMV, genus Nucleorhabdovirus, family Rhabdoviridae) causes an economically important disease in maize and other gramineous crops in Iran. MIMV negative-sense RNA genome sequence of 12,426 nucleotides has recently been completed. Maize Genetics and Genomics database shows that 39,498 coding genes and 4,976 non-coding genes of maize have been determined, but still some transcripts could not be annotated. The molecular host cell responses of maize to MIMV infection including differential gene expression have so far not been elucidated. Methodology/Principal findings Complementary DNA libraries were prepared from total RNA of MIMV-infected and mock inoculated maize leaves and sequenced using Illumina HiSeq 2500. Cleaned raw transcript reads from MIMV-infected maize were mapped to reads from uninfected maize and to a maize reference genome. Differentially expressed transcripts were characterized by gene ontology and biochemical pathway analyses. Transcriptome data for selected genes were validated by real-time quantitative PCR. Conclusion/Significance Approximately 42 million clean reads for each treatment were obtained. In MIMV-infected maize compared to uninfected plants, 1689 transcripts were up-regulated and 213 transcripts were down-regulated. In response to MIMV infection, several pathways were activated in maize including immune receptor signaling, metabolic pathways, RNA silencing, hormone-mediated pathways, protein degradation, protein kinase and ATP binding activity, and fatty acid metabolism. Also, several transcripts including those encoding hydrophobic protein RCI2B, adenosylmethionine decarboxylase NAC transcription factor and nucleic acid binding, leucine-rich repeat, heat shock protein, 26S proteasome, oxidoreductases and endonuclease activity protein were up-regulated. These data will contribute to the identification of genes and pathways involved in plant-virus interactions that may serve as future targets for improved disease control.	[Ghorbani, Abozar; Izadpanah, Keramatollah] Shiraz Univ, Coll Agr, Plant Virol Res Ctr, Shiraz, Iran; [Ghorbani, Abozar; Dietzgen, Ralf G.] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia	Shiraz University; University of Queensland	Dietzgen, RG (corresponding author), Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia.	r.dietzgen@uq.edu.au	Ghorbani, Abozar/ABB-5025-2021; Dietzgen, Ralf Georg/A-5565-2010	Ghorbani, Abozar/0000-0002-2183-0033; Dietzgen, Ralf Georg/0000-0002-7772-2250	Queensland Department of Agriculture and Fisheries; University of Queensland through the Queensland Alliance for Agriculture and Food Innovation; Plant Virology Research Center, Shiraz University; Shiraz University, Iran	Queensland Department of Agriculture and Fisheries; University of Queensland through the Queensland Alliance for Agriculture and Food Innovation; Plant Virology Research Center, Shiraz University; Shiraz University, Iran	The research was jointly supported by the Queensland Department of Agriculture and Fisheries and the University of Queensland through the Queensland Alliance for Agriculture and Food Innovation. Plant Virology Research Center, Shiraz University provided funds for part of this research. AG was supported by a scholarship from Shiraz University, Iran.	Agudelo-Romero P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-92; Alazem M, 2015, MOL PLANT PATHOL, V16, P529, DOI 10.1111/mpp.12204; Amarasinghe GK, 2017, ARCH VIROL, V162, P2493, DOI 10.1007/s00705-017-3311-7; Asters MC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04815; Bolwell GP, 1999, CURR OPIN PLANT BIOL, V2, P287, DOI 10.1016/S1369-5266(99)80051-X; Brininstool G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-58; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Calil IP, 2017, ANN BOT-LONDON, V119, P711, DOI 10.1093/aob/mcw200; Carmo LST, 2017, J PROTEOMICS, V151, P284, DOI 10.1016/j.jprot.2016.07.018; Cassone BJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-133; Chen J, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0584-5; Chen TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080816; Choi H, 2015, PLANT MOL BIOL, V88, P233, DOI 10.1007/s11103-015-0317-y; Converse R., 1990, LAB MANUAL, P179; Czosnek H, 2013, VIRUSES-BASEL, V5, P998, DOI 10.3390/v5030998; de la Torre F, 2013, PLANT CELL, V25, P2748, DOI 10.1105/tpc.113.113530; Dietzgen R. G., 2012, RHABDOVIRUSES MOL TA; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; DOMS RW, 1988, J CELL BIOL, V107, P89, DOI 10.1083/jcb.107.1.89; Dubey NK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-241; Escaler M, 2000, VIROLOGY, V267, P318, DOI 10.1006/viro.1999.0119; Estakhr A, 2015, ANN RES REV BIOL, V8, P1; Fan HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132277; Fan HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085284; Gamage SMKW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159085; Goyer A, 2010, PHYTOCHEMISTRY, V71, P1615, DOI 10.1016/j.phytochem.2010.06.022; Hazarika Pranjal, 2011, Physiology and Molecular Biology of Plants, V17, P115, DOI 10.1007/s12298-011-0053-y; IZADPANAH K, 1983, PHYTOPATHOL Z, V107, P283; IZADPANAH K, 1989, J PHYTOPATHOL, V126, P43, DOI 10.1111/j.1439-0434.1989.tb01088.x; Jackson AO, 2005, ANNU REV PHYTOPATHOL, V43, P623, DOI 10.1146/annurev.phyto.43.011205.141136; Jeevalatha A, 2017, VIRUS RES, V232, P22, DOI 10.1016/j.virusres.2017.01.015; Jensen PJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-261; Kachroo A, 2009, ANNU REV PHYTOPATHOL, V47, P153, DOI 10.1146/annurev-phyto-080508-081820; Kidd Parris, 2003, Altern Med Rev, V8, P223; Liu J, 2014, J INTEGR PLANT BIOL, V56, P122, DOI 10.1111/jipb.12133; Liu M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119858; Liu YJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2780-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043447; Maldonado AFS, 2015, TRENDS FOOD SCI TECH, V46, P49, DOI 10.1016/j.tifs.2015.07.013; Massah A, 2008, ARCH VIROL, V153, P1041, DOI 10.1007/s00705-008-0085-y; Massah A., 2005, Iranian Journal of Plant Pathology, V41, P151; Medina J, 2001, PLANT PHYSIOL, V125, P1655, DOI 10.1104/pp.125.4.1655; Min BE, 2010, MOL PLANT MICROBE IN, V23, P1420, DOI 10.1094/MPMI-04-10-0097; Oksman-Caldentey KM, 2005, CURR OPIN BIOTECH, V16, P174, DOI 10.1016/j.copbio.2005.02.007; Pazhouhandeh M, 2006, P NATL ACAD SCI USA, V103, P1994, DOI 10.1073/pnas.0510784103; Pedley KF, 2005, CURR OPIN PLANT BIOL, V8, P541, DOI 10.1016/j.pbi.2005.07.006; Plat J, 2015, J AOAC INT, V98, P697, DOI 10.5740/jaoacint.SGEPlat; Rojas-Rivera D, 2012, CELL DEATH DIFFER, V19, P1013, DOI 10.1038/cdd.2011.189; Satoh K, 2010, J GEN VIROL, V91, P294, DOI 10.1099/vir.0.015990-0; Sood A, 2017, BIOENERG RES, V10, P129, DOI 10.1007/s12155-016-9783-6; Stobbe AH, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00150; Strable J, 2009, COLD SPRING HARBOR P, V2009; Thiel H, 2012, MOL PLANT MICROBE IN, V25, P1058, DOI 10.1094/MPMI-03-12-0057-R; Tzin V, 2015, PLANT PHYSIOL, V169, P1727, DOI 10.1104/pp.15.01039; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Wang H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177739; Wang JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058274; Wang X, 2009, J VIROL, V83, P9720, DOI 10.1128/JVI.00941-09; Wu WQ, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-118; Zhang ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121222	61	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194592	10.1371/journal.pone.0194592	http://dx.doi.org/10.1371/journal.pone.0194592			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634778	Green Submitted, gold, Green Published			2022-12-26	WOS:000429522200012
J	Reeves, AB; Hall, JS; Poulson, RL; Donnelly, T; Stallknecht, DE; Ramey, AM				Reeves, Andrew B.; Hall, Jeffrey S.; Poulson, Rebecca L.; Donnelly, Tyrone; Stallknecht, David E.; Ramey, Andrew M.			Influenza A virus recovery, diversity, and intercontinental exchange: A multi-year assessment of wild bird sampling at Izembek National Wildlife Refuge, Alaska	PLOS ONE			English	Article							PINTAILS ANAS-ACUTA; AVIAN INFLUENZA; NORTHERN PINTAILS; HEMAGGLUTININ SUBTYPE; SPRING MIGRATION; REASSORTMENT; ALIGNMENT; AMERICA; ROUTES; LAGOON	Western Alaska is a potential point-of-entry for foreign-origin influenza A viruses (IAVs) into North America via migratory birds. We sampled waterfowl and gulls for IAVs at Izembek National Wildlife Refuge (NWR) in western Alaska, USA, during late summer and autumn months of 2011-2015, to evaluate the abundance and diversity of viruses at this site. We collected 4842 samples across five years from 25 species of wild birds resulting in the recovery, isolation, and sequencing of 172 IAVs. With the intent of optimizing sampling efficiencies, we used information derived from this multi-year effort to: 1) evaluate from which species we consistently recover viruses, 2) describe viral subtypes of isolates by host species and year, 3) characterize viral gene segment sequence diversity with respect to host species, and assess potential differences in the viral lineages among the host groups, and 4) examine how evidence of intercontinental exchange of IAVs relates to host species. We consistently recovered viruses from dabbling ducks (Anas spp.), emperor geese (Chen canagica) and glaucous-winged gulls (Larus glaucescens). There was little evidence for differences in viral subtypes and diversity from different waterfowl hosts, however subtypes and viral diversity varied between waterfowl host groups and glaucous-winged gulls. Furthermore, higher proportions of viral sequences from northern pintails (Anas acute), emperor geese and glaucous-winged gulls were grouped in phylogenetic clades that included IAV sequences originating from wild birds sampled in Asia as compared to non-pintail dabbling ducks, a difference that may be related to intercontinental migratory tendencies of host species. Our summary of research and surveillance efforts at Izembek NWR will assist in future prioritization of which hosts to sample and swab types to collect in Alaska and elsewhere in order to maximize isolate recovery, subtype and sequence diversity for resultant viruses, and detection of evidence for intercontinental viral exchange.	[Reeves, Andrew B.; Donnelly, Tyrone; Ramey, Andrew M.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [Hall, Jeffrey S.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA; [Poulson, Rebecca L.; Stallknecht, David E.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, Southeastern Cooperat Wildlife Dis Study, Athens, GA USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University System of Georgia; University of Georgia	Reeves, AB; Ramey, AM (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA.	areeves@usgs.gov; aramey@usgs.gov	Poulson, Rebecca/K-4014-2019; Poulson, Rebecca/AAD-2231-2021	Poulson, Rebecca/0000-0002-8087-3295; Reeves, Andrew/0000-0002-7526-0726	U.S. Geological Survey through the Wildlife Program of the Ecosystems Mission; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272201400006C]	U.S. Geological Survey through the Wildlife Program of the Ecosystems Mission; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded, in part, by the U.S. Geological Survey through the Wildlife Program of the Ecosystems Mission area and by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract HHSN272201400006C. The contents of this product are the responsibility of the authors and do not necessarily represent the official views of the NIH.	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bao Y, 2007, NUCLEIC ACIDS RES, V35, pW280, DOI 10.1093/nar/gkm354; Bevins SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104360; Dusek RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092075; EASTERDAY BC, 1968, NATURE, V219, P523, DOI 10.1038/219523a0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ely CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057614; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Hall JS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-179; Hatch SA, 2011, CONDOR, V113, P340, DOI 10.1525/cond.2011.090224; HINSHAW VS, 1982, J VIROL, V42, P865, DOI 10.1128/JVI.42.3.865-872.1982; Huang YY, 2014, VIROLOGY, V456, P353, DOI 10.1016/j.virol.2014.04.009; Hupp JW, 2007, J AVIAN BIOL, V38, P462, DOI 10.1111/j.0908-8857.2007.03969.x; Hupp JW, 2011, J AVIAN BIOL, V42, P289, DOI 10.1111/j.1600-048X.2011.05320.x; Ip HS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-71; KAWAOKA Y, 1988, VIROLOGY, V163, P247, DOI 10.1016/0042-6822(88)90260-7; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Miller MR, 2005, CAN J ZOOL, V83, P1314, DOI 10.1139/Z05-125; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pearce JM, 2011, MOL ECOL, V20, P1015, DOI 10.1111/j.1365-294X.2010.04908.x; Pearce JM, 2009, EVOL APPL, V2, P457, DOI 10.1111/j.1752-4571.2009.00071.x; Peters JL, 2014, MOL ECOL, V23, P2961, DOI 10.1111/mec.12799; Ramey AM, 2014, J WILDL DIS; Ramey AM, 2016, INFECT GENET EVOL, V40, P176, DOI 10.1016/j.meegid.2016.02.035; Ramey AM, 2015, VIROLOGY, V482, P79, DOI 10.1016/j.virol.2015.03.028; Ramey AM, 2010, VIROLOGY, V406, P352, DOI 10.1016/j.virol.2010.07.031; Ramey AM, 2010, VIROLOGY, V401, P179, DOI 10.1016/j.virol.2010.02.006; REED A, 1989, J WILDLIFE MANAGE, V53, P720, DOI 10.2307/3809203; Reeves AB, 2018, INFLUENZA A VIRUS DA; Reeves AB, 2013, J WILDLIFE DIS, V49, P600, DOI 10.7589/2012-04-108; SHARP GB, 1993, EPIDEMIOL INFECT, V110, P161, DOI 10.1017/S0950268800050780; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Toennessen R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-21; Tonnessen R, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-112; Ward DH, 1997, AQUAT BOT, V58, P229, DOI 10.1016/S0304-3770(97)00037-5; WARD DH, 1989, RESPONSE BRANT OTHER; Wilcox BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024010; Wille M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020664; Wille M, 2011, ARCH VIROL, V156, P107, DOI 10.1007/s00705-010-0839-1; Winker K, 2010, AVIAN DIS, V54, P477, DOI 10.1637/8741-032509-Reg.1; Woolcock PR, 2008, AVIAN DIS, V52, P209, DOI 10.1637/8106-090607-Reg.1; Yamnikova SS, 2003, AVIAN DIS, V47, P1164, DOI 10.1637/0005-2086-47.s3.1164	46	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195327	10.1371/journal.pone.0195327	http://dx.doi.org/10.1371/journal.pone.0195327			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621333	Green Published, Green Submitted, gold			2022-12-26	WOS:000429206800063
J	van Knippenberg, RJM; de Vugt, ME; Ponds, RW; Verhey, FRJ; Myin-Germeys, I				van Knippenberg, Rosalia J. M.; de Vugt, Marjolein E.; Ponds, Rudolf W.; Verhey, Frans R. J.; Myin-Germeys, Inez			Emotional reactivity to daily life stress in spousal caregivers of people with dementia: An experience sampling study	PLOS ONE			English	Article							ECOLOGICAL MOMENTARY ASSESSMENT; RANDOMIZED CONTROLLED-TRIAL; INFORMAL CAREGIVERS; ELDER RELATIVES; SOCIAL SUPPORT; DEPRESSION; DISTRESS; BURDEN; MOOD; SCHIZOPHRENIA	Introduction Caregivers differ in their emotional response when facing difficult situations during the care giving process. Individual differences in vulnerabilities and resources could play an exacerbating or buffering role in caregivers' reactivity to daily life stress. This study examines which caregiver characteristics modify emotional stress reactivity in dementia caregivers. Methods Thirty caregivers collected momentary data, as based on the experience sampling methodology, to assess (1) appraised subjective stress related to events and minor disturbances in daily life, and (2) emotional reactivity to these daily life stressors, conceptualized as changes in negative affect. Caregiver characteristics (i.e. vulnerabilities and resources) were administered retrospectively. Results Caregivers who more frequently used the coping strategies 'seeking distraction', 'seeking social support', and 'fostering reassuring thoughts' experienced less emotional reactivity towards stressful daily events. A higher educational level and a higher sense of competence and mastery lowered emotional reactivity towards minor disturbances in daily life. No effects were found for age, gender, and hours of care and contact with the person with dementia. Discussion Caregiver resources can impact emotional reactivity to daily life stress. Interventions aimed at empowerment of caregiver resources, such as sense of competence, mastery, and coping, could help to reduce stress reactivity in dementia caregivers.	[van Knippenberg, Rosalia J. M.; de Vugt, Marjolein E.; Ponds, Rudolf W.; Verhey, Frans R. J.] Maastricht Univ, Dept Psychiat & Neuropsychol, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [van Knippenberg, Rosalia J. M.; de Vugt, Marjolein E.; Ponds, Rudolf W.; Verhey, Frans R. J.] Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Myin-Germeys, Inez] Katholieke Univ Leuven, Ctr Contextual Psychiat, Dept Neurosci, Leuven, Belgium	Maastricht University; Maastricht University; KU Leuven	de Vugt, ME (corresponding author), Maastricht Univ, Dept Psychiat & Neuropsychol, Sch Mental Hlth & Neurosci, Maastricht, Netherlands.; de Vugt, ME (corresponding author), Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Maastricht, Netherlands.	mdevugt@maastrichtuniversity.nl	Myin Germeys, Inez/HIR-3364-2022	Myin Germeys, Inez/0000-0002-3731-4930; ponds, rudolf/0000-0002-9748-4659	Dutch Alzheimer Society [WE03-2011-06]	Dutch Alzheimer Society	This study is supported by a grant of the Dutch Alzheimer Society (Grant no. WE03-2011-06; https.//www.alzheimer-nederland.nl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afram B, 2014, J AM MED DIR ASSOC, V15, P108, DOI 10.1016/j.jamda.2013.09.012; Allen AP, 2017, NEUROSCI BIOBEHAV R, V73, P123, DOI 10.1016/j.neubiorev.2016.12.006; Andersson G, 2005, BRIT J PSYCHIAT, V187, P456, DOI 10.1192/bjp.187.5.456; Antonucci TC, 1900, HDB AGING SOCIAL SCI, P205; Cheng ST, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0818-2; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; Dam AEH, 2016, MATURITAS, V85, P117, DOI 10.1016/j.maturitas.2015.12.008; de Vugt ME, 2013, PROG NEUROBIOL, V110, P54, DOI 10.1016/j.pneurobio.2013.04.005; de Vugt ME, 2004, INT J GERIATR PSYCH, V19, P85, DOI 10.1002/gps.1044; Delespaul PAEG, 1995, ASS SCHIZ DAIL LIF E; Ebner-Priemer UW, 2009, PSYCHOL ASSESSMENT, V21, P463, DOI 10.1037/a0017075; Feast A, 2017, INT J GERIATR PSYCH, V32, P76, DOI 10.1002/gps.4447; FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617; Gilhooly KJ, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0280-8; Haines KJ, 2015, CRIT CARE MED, V43, P1112, DOI 10.1097/CCM.0000000000000865; Hektner JM, 2007, EXPERIENCE SAMPLING; Hilgeman MM, 2009, GERONTOLOGIST, V49, P248, DOI 10.1093/geront/gnp015; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; Kat M G, 2002, Tijdschr Gerontol Geriatr, V33, P150; Koerner SS, 2007, FAM RELAT, V56, P1, DOI 10.1111/j.1741-3729.2007.00435.x; Koerner SS, 2010, J GERONTOL B-PSYCHOL, V65, P561, DOI 10.1093/geronb/gbq045; Kramer I, 2014, WORLD PSYCHIATRY, V13, P68, DOI 10.1002/wps.20090; Lazarus R.S., 1984, EMOTION ADAPTATION; Lazarus RS, 2000, AM PSYCHOL, V55, P665, DOI 10.1037//0003-066X.55.6.665; Martin-Carrasco Manuel, 2013, Rev Esp Geriatr Gerontol, V48, P276, DOI 10.1016/j.regg.2013.06.002; Mechanic D., 1967, APPLETON CENTURY CRO, P123; Morris J C, 1997, Int Psychogeriatr, V9 Suppl 1, P173, DOI 10.1017/S1041610297004870; Mroczek DK, 2004, J PERS, V72, P355, DOI 10.1111/j.0022-3506.2004.00265.x; Myin-Germeys I, 2002, AM J PSYCHIAT, V159, P443, DOI 10.1176/appi.ajp.159.3.443; Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947; Myin-Germeys I, 2011, SCHIZOPHRENIA BULL, V37, P244, DOI 10.1093/schbul/sbq164; Oorschot M, 2012, SCHIZOPHRENIA BULL, V38, P405, DOI 10.1093/schbul/sbr166; Palmier-Claus JE, 2011, ACTA PSYCHIAT SCAND, V123, P12, DOI 10.1111/j.1600-0447.2010.01596.x; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Prince M., 2016, WORLD ALZHEIMER REPO; Roepke SK, 2008, AM J GERIAT PSYCHIAT, V16, P310, DOI 10.1097/JGP.0b013e3181662a80; Sato H, 2011, ANXIETY STRESS COPIN, V24, P359, DOI 10.1080/10615806.2010.543132; Schreurs P.J.G., 1993, UTRECHT COPING LIST; Schwartz JE, 1998, HEALTH PSYCHOL, V17, P6, DOI 10.1037/0278-6133.17.1.6; Serido J, 2004, J HEALTH SOC BEHAV, V45, P17, DOI 10.1177/002214650404500102; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Sonnenschein M, 2007, BIOL PSYCHOL, V75, P176, DOI 10.1016/j.biopsycho.2007.02.001; STONE AA, 1995, HEALTH PSYCHOL, V14, P341, DOI 10.1037/0278-6133.14.4.341; Taylor SE, 1997, ANNU REV PSYCHOL, V48, P411, DOI 10.1146/annurev.psych.48.1.411; Trull TJ, 2013, ANNU REV CLIN PSYCHO, V9, P151, DOI 10.1146/annurev-clinpsy-050212-185510; van der Lee J, 2017, AGING MENT HEALTH, V21, P232, DOI 10.1080/13607863.2015.1102196; van der Steen Y, 2017, ACTA PSYCHIAT SCAND, V136, P63, DOI 10.1111/acps.12714; van Knippenberg R., 2017, THESIS; van Knippenberg RJM, 2017, INT J GERIATR PSYCH, V32, P949, DOI 10.1002/gps.4552; van Knippenberg RJM, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0834-5; van Winkel M, 2015, EUR PSYCHIAT, V30, P441, DOI 10.1016/j.eurpsy.2015.02.011; Vernooij-Dassen MJFJ, 1999, J AM GERIATR SOC, V47, P256, DOI 10.1111/j.1532-5415.1999.tb04588.x; VITALIANO PP, 1990, J PERS SOC PSYCHOL, V59, P582, DOI 10.1037/0022-3514.59.3.582; Vitaliano PP, 2003, PSYCHOL BULL, V129, P946, DOI 10.1037/0033-2909.129.6.946	56	10	10	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194118	10.1371/journal.pone.0194118	http://dx.doi.org/10.1371/journal.pone.0194118			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617373	Green Published, gold, Green Submitted			2022-12-26	WOS:000429203800017
J	Wilkinson, J; Bors, C; Burgis, F; Lorke, A; Bodmer, P				Wilkinson, Jeremy; Bors, Christoph; Burgis, Florian; Lorke, Andreas; Bodmer, Pascal			Measuring CO2 and CH4 with a portable gas analyzer: Closed-loop operation, optimization and assessment	PLOS ONE			English	Article							CAVITY OUTPUT SPECTROSCOPY; CARBON-DIOXIDE; DISSOLVED METHANE; WATER; ECOSYSTEMS; FLUXES; CHROMATOGRAPHY; ATMOSPHERE; EMISSIONS; CHAMBER	The use of cavity ring-down spectrometer (CRDS) based portable greenhouse gas analyzers (PGAs) in closed-loop configuration to measure small sample volumes (<1 l) for CH4 and CO2 concentrations is increasing and offers certain advantages over conventional measurement methods in terms of speed as well as the ability to measure directly in field locations. This first systematic assessment of the uncertainties, problems and issues associated with achieving reliable and repeatable measurement with this technique presents the adaptation, measurement range, calibration and maintenance, accuracy and issues of efficient operation, for one example instrument. Regular open-loop calibration, a precise loop volume estimate, leak free system, and a high standard of injection practices are necessary for accurate results. For 100 mu l injections, measured values ranging from 4.5 to 9 x10(4) ppm (CH4), and 1000 ppm to 1 x10(6) ppm (CO2) are possible with uncertainties 5.9% and 3.0%, respectively, beyond 100 ppm CH4 correction may be necessary. Uncertainty arising from variations water vapour content and atmospheric pressure are small (0.24% and -0.9% to +0.5%, respectively). With good practice, individual operator repeatability of 1.9% (CH4) and 2.48% (CO2) can be achieved. Between operator injection error was around 3% for both gases for four operators. Slow syringe plunger operation (>1s) is recommended; generally delivered more (ca. 3-4%) sample into the closed instrument loop than did rapid operation. Automated value retrieval is recommended; we achieved a 3 to 5-fold time reduction for each injection cycle (ca. <2 min), and operator reading, recording, and digitization errors are eliminated.	[Wilkinson, Jeremy; Bors, Christoph; Burgis, Florian; Lorke, Andreas; Bodmer, Pascal] Univ Koblenz Landau, Inst Environm Sci, Landau, Germany	University of Koblenz & Landau	Wilkinson, J (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Landau, Germany.	wilkinson@uni-landau.de	Bodmer, Pascal/M-6902-2019; Lorke, Andreas/B-9195-2008	Lorke, Andreas/0000-0001-5533-1817; Wilkinson, Jeremy/0000-0001-6019-0297	German Research Foundation [L01150/5-2, L01150/9-1]	German Research Foundation(German Research Foundation (DFG))	This study was undertaken within a German Research Foundation funded project (grants L01150/5-2 and L01150/9-1; http//gam.dfg.de/en) that studied greenhouse gas emissions from impounded rivers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshboul Z, 2016, ENVIRON SCI TECHNOL, V50, P5555, DOI 10.1021/acs.est.5b04923; Attermeyer K, 2016, SCI REPORTS; Baird AJ, 2010, ECOHYDROLOGY, V3, P360, DOI 10.1002/eco.109; Baldocchi D, 2014, GLOBAL CHANGE BIOL, V20, P3600, DOI 10.1111/gcb.12649; Bodmer P, 2016, SCI TOTAL ENVIRON, V553, P574, DOI 10.1016/j.scitotenv.2016.02.095; Brandt AR, 2014, SCIENCE, V343, P733, DOI 10.1126/science.1247045; Eapi GR, 2014, J AIR WASTE MANAGE, V64, P927, DOI 10.1080/10962247.2014.907098; Flores E, 2015, ANAL CHEM, V87, P3272, DOI 10.1021/ac5043076; Gonzalez-Valencia R, 2014, ENVIRON SCI TECHNOL, V48, P11421, DOI 10.1021/es500987j; Gulzow W, 2011, LIMNOL OCEANOGR-METH, V9, P176, DOI 10.4319/lom.2011.9.176; Hamilton Company Inc, 2017, SYR CAR US GUID COMP; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; KAMPBELL DH, 1989, INT J ENVIRON AN CH, V36, P249, DOI 10.1080/03067318908026878; Kittler F, 2017, GLOBAL BIOGEOCHEM CY, V31, P1704, DOI 10.1002/2017GB005774; KLING GW, 1991, SCIENCE, V251, P298, DOI 10.1126/science.251.4991.298; Kriesel JM, 2017, VERSATILE ULTRALOW S; Kwok CEY, 2015, ATMOS MEAS TECH, V8, P2853, DOI 10.5194/amt-8-2853-2015; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Liu L, 2018, ENV SCI TECHNOLOGY; Lorke A, 2015, BIOGEOSCIENCES, V12, P7013, DOI 10.5194/bg-12-7013-2015; Los Gatos Inc, 2014, ULTR GAS AN MIRR CLE; Mbaka JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111392; Murdiyarso D., 2017, MITIGATION ADAPTATIO, P1; Nickerson N, 2017, LOW POWER ANAL AUTOM, P10423; Olefeldt D, 2017, GLOBAL CHANGE BIOL, V23, P2428, DOI 10.1111/gcb.13612; Oliveira ES, 2018, AQUAT BOT, V145, P1, DOI 10.1016/j.aquabot.2017.11.005; Pirk N, 2016, BIOGEOSCIENCES, V13, P903, DOI 10.5194/bg-13-903-2016; Saunois M, 2016, EARTH SYST SCI DATA, V8, P697, DOI 10.5194/essd-8-697-2016; SGE Analytical Science, 2017, IMPR PREC CUST SYR T; Smith PA, 2015, PORTABLE GAS CHROMAT; Sparda A, 2017, COMMUN SOIL SCI PLAN, V48, P214, DOI 10.1080/00103624.2016.1254235; Wang C., 2010, SIMULTANEOUS ANAL GR; WEISS RF, 1981, J CHROMATOGR SCI, V19, P611, DOI 10.1093/chromsci/19.12.611; Wilkinson J, 2015, ENVIRON SCI TECHNOL, V49, P13121, DOI 10.1021/acs.est.5b01525; Zellweger C, 2016, ATMOS MEAS TECH, V9, P4737, DOI 10.5194/amt-9-4737-2016; Zhao J, 2017, GLOBAL CHANGE BIOL, V23, P3139, DOI 10.1111/gcb.13621	36	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0193973	10.1371/journal.pone.0193973	http://dx.doi.org/10.1371/journal.pone.0193973			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617382	gold, Green Published, Green Submitted			2022-12-26	WOS:000429203800016
J	Nitzschke, A; Bettenbrock, K				Nitzschke, Annika; Bettenbrock, Katja			All three quinone species play distinct roles in ensuring optimal growth under aerobic and fermentative conditions in E. coli K12	PLOS ONE			English	Article							ARCB SENSOR KINASE; SIGNAL-TRANSDUCTION SYSTEM; TRIMETHYLAMINE N-OXIDE; ESCHERICHIA-COLI; 2-COMPONENT SYSTEM; REDOX STATE; IN-VITRO; DIHYDROOROTATE DEHYDROGENASE; TRANSCRIPTIONAL REGULATION; OXIDATIVE STRESS	The electron transport chain of E. coli contains three different quinone species, ubiquinone (UQ), menaquinone (MK) and demethylmenaquinone (DMK). The content and ratio of the different quinone species vary depending on the external conditions. To study the function of the different quinone species in more detail, strains with deletions preventing UQ synthesis, as well as MK and/or DMK synthesis were cultured under aerobic and anaerobic conditions. The strains were characterized with respect to growth and product synthesis. As quinones are also involved in the control of ArcB/A activity, we analyzed the phosphorylation state of the response regulator as well as the expression of selected genes. The data show reduced aerobic growth coupled to lactate production in the mutants defective in ubiquinone synthesis. This confirms the current assumption that ubiquinone is the main quinone under aerobic growth conditions. In the UQ mutant strains the amount of MK and DMK is significantly elevated. The strain synthesizing only DMK is less affected in growth than the strain synthesizing MK as well as DMK. An inhibitory effect of MK on aerobic growth due to increased oxidative stress is postulated. Under fermentative growth conditions the mutant synthesizing only UQ is severely impaired in growth. Obviously, UQ is not able to replace MK and DMK during anaerobic growth. Mutations affecting quinone synthesis have an impact on ArcA phosphorylation only under anaerobic conditions. ArcA phosphorylation is reduced in strains synthesizing only MK or MK plus DMK.	[Nitzschke, Annika; Bettenbrock, Katja] Max Planck Inst Dynam Complex Tech Syst, Sandtorstr, Magdeburg, Germany	Max Planck Society	Bettenbrock, K (corresponding author), Max Planck Inst Dynam Complex Tech Syst, Sandtorstr, Magdeburg, Germany.	bettenbrock@mpi-magdeburg.mpg.de	Bettenbrock, Katja/AAN-5812-2020	Bettenbrock, Katja/0000-0002-2444-7777	German Federal Ministery of Education and Research [FKZ 031A127B]; German Federal Ministry of Education and Research (BMBF) [FKZ 031A127B]	German Federal Ministery of Education and Research; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	Funded by German Federal Ministery of Education and Research FKZ 031A127B.; This work was supported by grant FKZ 031A127B of the German Federal Ministry of Education and Research (BMBF). We thank Prof. Hellingwerf (University of Amsterdam) for kindly supplying ArcA antiserum. We thank Andrea Schutze and Helga Tietgens for technical support.	Alvarez AF, 2013, J BACTERIOL, V195, P3054, DOI 10.1128/JB.00406-13; ANDREWS S, 1977, BIOCHIM BIOPHYS ACTA, V462, P153, DOI 10.1016/0005-2728(77)90197-9; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; Bekker M, 2007, MICROBIOL-SGM, V153, P1974, DOI 10.1099/mic.0.2007/006098-0; Bekker M, 2010, J BACTERIOL, V192, P746, DOI 10.1128/JB.01156-09; Bjornberg O, 1999, BIOCHEMISTRY-US, V38, P2899, DOI 10.1021/bi982352c; Brondijk THC, 2004, BIOCHEM J, V379, P47, DOI 10.1042/BJ20031115; CARTER K, 1985, J BIOL CHEM, V260, P986; CLARK DP, 1989, FEMS MICROBIOL LETT, V63, P223, DOI 10.1111/j.1574-6968.1989.tb03398.x; COX GB, 1970, BIOCHEM J, V117, P551, DOI 10.1042/bj1170551; Crack J, 2004, J BIOL CHEM, V279, P9278, DOI 10.1074/jbc.M309878200; de Graef MR, 1999, J BACTERIOL, V181, P2351, DOI 10.1128/JB.181.8.2351-2357.1999; Evans C. G. T., 1970, METHODS MICROBIOLOGY, V2, DOI [10.1016/S0580-9517(08)70227-7, DOI 10.1016/S0580-9517(08)70227-7]; Georgellis D, 1999, J BIOL CHEM, V274, P35950, DOI 10.1074/jbc.274.50.35950; Georgellis D, 1998, J BIOL CHEM, V273, P32864, DOI 10.1074/jbc.273.49.32864; Georgellis D, 1997, J BACTERIOL, V179, P5429, DOI 10.1128/jb.179.17.5429-5435.1997; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Green J, 2009, CURR OPIN MICROBIOL, V12, P145, DOI 10.1016/j.mib.2009.01.008; GUNSALUS RP, 1994, RES MICROBIOL, V145, P437, DOI 10.1016/0923-2508(94)90092-2; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; IUCHI S, 1993, J BIOL CHEM, V268, P23972; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Levanon SS, 2005, BIOTECHNOL BIOENG, V89, P556; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malpica R, 2004, P NATL ACAD SCI USA, V101, P13318, DOI 10.1073/pnas.0403064101; McBee ME, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00459; NEWTON NA, 1972, J BACTERIOL, V109, P69, DOI 10.1128/JB.109.1.69-73.1972; Palfey BA, 2001, BIOCHEMISTRY-US, V40, P4381, DOI 10.1021/bi0025666; Perrenoud A, 2005, J BACTERIOL, V187, P3171, DOI 10.1128/JB.187.9.3171-3179.2005; Pinske C, 2016, ECOSAL PLUS; Rodriguez C, 2004, J BACTERIOL, V186, P2085, DOI 10.1128/JB.186.7.2085-2090.2004; Rolfe MD, 2011, J BIOL CHEM, V286, P10147, DOI 10.1074/jbc.M110.211144; Salmon KA, 2005, J BIOL CHEM, V280, P15084, DOI 10.1074/jbc.M414030200; SAUTER M, 1990, MOL MICROBIOL, V4, P355, DOI 10.1111/j.1365-2958.1990.tb00603.x; Sawers RG, 2004, ECOSAL PLUS; Schoepp-Cothenet B, 2009, P NATL ACAD SCI USA, V106, P8549, DOI 10.1073/pnas.0813173106; Shalel-Levanon S, 2005, BIOTECHNOL BIOENG, V92, P147, DOI 10.1002/bit.20583; Shalel-Levanon S, 2005, METAB ENG, V7, P364, DOI 10.1016/j.ymben.2005.07.001; Sharma P, 2012, FEBS J, V279, P3952, DOI 10.1111/j.1742-4658.2012.08755.x; Sharma P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075412; Shestopalov AI, 1997, FEBS LETT, V404, P272, DOI 10.1016/S0014-5793(97)00143-9; Soballe B, 1999, MICROBIOL-SGM, V145, P1817, DOI 10.1099/13500872-145-8-1817; Soballe B, 2000, MICROBIOL-SGM, V146, P787, DOI 10.1099/00221287-146-4-787; SPIRO S, 1991, TRENDS BIOCHEM SCI, V16, P310, DOI 10.1016/0968-0004(91)90125-F; Steinsiek S, 2011, J BIOTECHNOL, V154, P35, DOI 10.1016/j.jbiotec.2011.03.015; Steinsiek S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087307; Sutton VR, 2004, J BACTERIOL, V186, P8018, DOI 10.1128/JB.186.23.8018-8025.2004; Tyson K, 1997, ARCH MICROBIOL, V168, P403, DOI 10.1007/s002030050515; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; Unden G., 2014, ECOSAL PLUS; Utrilla J, 2009, J IND MICROBIOL BIOT, V36, P1057, DOI 10.1007/s10295-009-0589-9; Valgepea K, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-106; van Beilen JWA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01339; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P84, DOI 10.1016/0005-2728(77)90071-8; Wang QZ, 2010, APPL ENVIRON MICROB, V76, P2107, DOI 10.1128/AEM.02545-09; WISSENBACH U, 1990, ARCH MICROBIOL, V154, P60; WISSENBACH U, 1992, ARCH MICROBIOL, V158, P68, DOI 10.1007/BF00249068; Zhou S, 2008, BIOTECHNOL LETT, V30, P335, DOI 10.1007/s10529-007-9544-x	60	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194699	10.1371/journal.pone.0194699	http://dx.doi.org/10.1371/journal.pone.0194699			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614086	gold, Green Submitted, Green Published			2022-12-26	WOS:000429081600016
J	Mondragon-Rodriguez, S; Salas-Gallardo, A; Gonzalez-Pereyra, P; Macias, M; Ordaz, B; Pena-Ortega, F; Aguilar-Vazquez, A; Orta-Salazar, E; Diaz-Cintra, S; Perry, G; Williams, S				Mondragon-Rodriguez, Siddhartha; Salas-Gallardo, Anahi; Gonzalez-Pereyra, Perla; Macias, Martin; Ordaz, Benito; Pena-Ortega, Fernando; Aguilar-Vazquez, Azucena; Orta-Salazar, Erika; Diaz-Cintra, Sofia; Perry, George; Williams, Sylvain			Phosphorylation of Tau protein correlates with changes in hippocampal theta oscillations and reduces hippocampal excitability in Alzheimer's model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; Tau protein (Tau); tauopathy; biomarker; genetics; compensatory mechanism; epileptiform activity; hyperphosphorylation; Tau; theta activity	TRIPLE-TRANSGENIC MODEL; AMYLOID-BETA TOXICITY; A-BETA; MOUSE MODEL; DISEASE; DEPOSITION; OLIGOMERS; CURRENTS; MICE; EEG	Tau hyperphosphorylation at several sites, including those close to the microtubule domain region (MDr), is considered a key pathological event in the development of Alzheimer's disease (AD). Recent studies indicate that at the very early stage of this disease, increased phosphorylation in Tau's MDr domain correlates with reduced levels of neuronal excitability. Mechanistically, we show that pyramidal neurons and some parvalbumin-positive interneurons in 1-month-old triple-transgenic AD mice accumulate hyperphosphorylated Tau protein and that this accumulation correlates with changes in theta oscillations in hippocampal neurons. Pyramidal neurons from young triple-transgenic AD mice exhibited less spike accommodation and power increase in subthreshold membrane oscillations. Furthermore, triple-transgenic AD mice challenged with the potassium channel blocker 4-aminopyridine had reduced theta amplitude compared with 4-aminopyridine-treated control mice and, unlike these controls, displayed no seizure-like activity after this challenge. Collectively, our results provide new insights into AD pathogenesis and suggest that increases in Tau phosphorylation at the initial stages of the disease represent neuronal responses that compensate for brain circuit overexcitation.	[Mondragon-Rodriguez, Siddhartha] CONACYT Natl Council Sci & Technol, Mexico City 03940, DF, Mexico; [Mondragon-Rodriguez, Siddhartha; Salas-Gallardo, Anahi; Gonzalez-Pereyra, Perla; Macias, Martin; Ordaz, Benito; Pena-Ortega, Fernando; Aguilar-Vazquez, Azucena; Orta-Salazar, Erika; Diaz-Cintra, Sofia] Univ Nacl Autonoma Mexico, Inst Neurobiol, UNAM Dev Neurobiol & Neurophysiol, Queretaro 76230, Mexico; [Perry, George] Univ Texas San Antonio, Coll Sci, UTSA Neurosci Inst, San Antonio, TX 78284 USA; [Perry, George] Univ Texas San Antonio, Coll Sci, Dept Biol, San Antonio, TX 78284 USA; [Williams, Sylvain] McGill Univ, Douglas Mental Hlth Univ Inst, Dept Psychiat, Quebec City, PQ H4H 1R3, Canada	Universidad Nacional Autonoma de Mexico; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); McGill University	Mondragon-Rodriguez, S (corresponding author), CONACYT Natl Council Sci & Technol, Mexico City 03940, DF, Mexico.	sidmonrod@gmail.com	Miranda, Sofía/AAS-8499-2021; Mondragon-Rodriguez, Siddhartha/AAA-2452-2019; Perry, George/A-8611-2009	Perry, George/0000-0002-6547-0172; diaz cintra, sofia/0000-0002-3354-2717; Pena-Ortega, Fernando/0000-0002-0348-4392	CONACYT [612271, 770620, 269021, 117-235789]; DGAPA-UNAM [IN202018]; Fundacion Marcos Moshinsky; National Institute of Minority Health and Health Disparities from the National Institutes of Health [G12MD007591]; Semmes Foundation; National Institute on Minority Health and Health Disparities [G12MD007591] Funding Source: NIH RePORTER	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); Fundacion Marcos Moshinsky; National Institute of Minority Health and Health Disparities from the National Institutes of Health; Semmes Foundation; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported CONACYT Grants 612271 and 770620 (to P. G.-P. and A. S.-G.), CONACYT Grants 269021 and 117-235789, DGAPA-UNAM Grant IN202018, fund from the Fundacion Marcos Moshinsky, and National Institute of Minority Health and Health Disparities Grant G12MD007591 from the National Institutes of Health and by the Semmes Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amilhon B, 2015, NEURON, V86, P1277, DOI 10.1016/j.neuron.2015.05.027; Barry C, 2012, FRONT NEURAL CIRCUIT, V6, DOI [10.3389/fncir.2012.00030, 10.3389/fncir.2012.00005]; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Cayzac S, 2015, NEUROBIOL AGING, V36, P3200, DOI 10.1016/j.neurobiolaging.2015.08.023; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Colgin LL, 2016, NAT REV NEUROSCI, V17, P239, DOI 10.1038/nrn.2016.21; Deacon RMJ, 2003, BEHAV BRAIN RES, V139, P139, DOI 10.1016/S0166-4328(02)00225-5; Deacon RMJ, 2002, BEHAV BRAIN RES, V132, P203, DOI 10.1016/S0166-4328(01)00401-6; Deacon RMJ, 2001, NEUROREPORT, V12, P2053, DOI 10.1097/00001756-200107030-00052; Deacon R, 2012, JOVE-J VIS EXP, DOI 10.3791/2607; Deacon RMJ, 2006, NAT PROTOC, V1, P118, DOI 10.1038/nprot.2006.19; Engels MMA, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00238; García-Méndez K.M., 2017, Rev. mex. ing. bioméd, V38, P217, DOI 10.17488/rmib.38.1.16; Goedert M, 1999, NATURE, V399, P739, DOI 10.1038/21550; Goutagny R, 2013, EUR J NEUROSCI, V37, P1896, DOI 10.1111/ejn.12233; Goutagny R, 2009, NAT NEUROSCI, V12, P1491, DOI 10.1038/nn.2440; Gouw AA, 2017, NEUROBIOL AGING, V57, P133, DOI 10.1016/j.neurobiolaging.2017.05.017; Ittner A, 2016, SCIENCE, V354, P904, DOI 10.1126/science.aah6205; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Kaniyappan S, 2017, ALZHEIMERS DEMENT, V13, P1270, DOI 10.1016/j.jalz.2017.04.002; Kazim SF, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00071; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lei M, 2016, NEUROBIOL DIS, V85, P111, DOI 10.1016/j.nbd.2015.10.019; Mahar I, 2017, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00327; Mondragon-Rodriguez S, 2014, NEUROPATH APPL NEURO, V40, P121, DOI 10.1111/nan.12084; Mondragon-Rodriguez S, 2012, INT J ALZHEIMERS DIS, V2012; Mondragon-Rodriguez S, 2017, CURR ALZHEIMER RES, V14, P40, DOI 10.2174/1567205013666160819131336; Mondragon-Rodriguez S, 2012, J BIOL CHEM, V287, P32040, DOI 10.1074/jbc.M112.401240; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Palop JJ, 2016, NAT REV NEUROSCI, V17, P777, DOI 10.1038/nrn.2016.141; Patel J, 2012, NEURON, V75, P410, DOI 10.1016/j.neuron.2012.07.015; Salgado-Puga K, 2017, J ALZHEIMERS DIS, V57, P205, DOI 10.3233/JAD-160543; Shiri Z, 2017, J NEUROSCI, V37, P2999, DOI 10.1523/JNEUROSCI.2244-16.2017; Soler H, 2017, NEUROBIOL AGING, V49, P40, DOI 10.1016/j.neurobiolaging.2016.09.006; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Wang Y, 2014, NEUROBIOL AGING, V35, P88, DOI 10.1016/j.neurobiolaging.2013.07.007	38	42	42	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8462	8472		10.1074/jbc.RA117.001187	http://dx.doi.org/10.1074/jbc.RA117.001187			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29632073	Green Published, hybrid			2022-12-26	WOS:000434205700011
J	Ramachandran, B; Stabley, JN; Cheng, SL; Behrmann, AS; Gay, A; Li, L; Mead, M; Kozlitina, J; Lemoff, A; Mirzaei, H; Chen, ZJ; Towler, DA				Ramachandran, Bindu; Stabley, John N.; Cheng, Su-Li; Behrmann, Abraham S.; Gay, Austin; Li, Li; Mead, Megan; Kozlitina, Julia; Lemoff, Andrew; Mirzaei, Hamid; Chen, Zhijian; Towler, Dwight A.			A GTPase-activating protein-binding protein (G3BP1)/antiviral protein relay conveys arteriosclerotic Wnt signals in aortic smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Wnt signaling; calcification; atherosclerosis; protein methylation; cardiovascular disease; vascular biology; vascular smooth muscle cells; Type 2 diabetes; metabolic syndrome; arteriosclerosis	TRANSCRIPTION FACTOR RUNX2; VASCULAR CALCIFICATION; CARDIOVASCULAR-DISEASE; ARGININE METHYLATION; BONE BIOLOGY; IN-VIVO; KAPPA-B; RIG-I; MINERALIZATION; EXPRESSION	In aortic vascular smooth muscle (VSM), the canonical Wnt receptor LRP6 inhibits protein arginine (Arg) methylation, a new component of noncanonical Wnt signaling that stimulates nuclear factor of activated T cells (viz. NFATc4). To better understand how methylation mediates these actions, MS was performed on VSM cell extracts from control and LRP6-deficient mice. LRP6-dependent Arg methylation was regulated on >500 proteins; only 21 exhibited increased monomethylation (MMA) with concomitant reductions in dimethylation. G3BP1, a known regulator of arteriosclerosis, exhibited a >30-fold increase in MMA in its C-terminal domain. Co-transfection studies confirm that G3BP1 (G3BP is Ras-GAP SH3 domain-binding protein) methylation is inhibited by LRP6 and that G3BP1 stimulates NFATc4 transcription. NFATc4 association with VSM osteopontin (OPN) and alkaline phosphatase (TNAP) chromatin was increased with LRP6 deficiency and reduced with G3BP1 deficiency. G3BP1 activation of NFATc4 mapped to G3BP1 domains supporting interactions with RIG-I (retinoic acid inducible gene I), a stimulus for mitochondrial antiviral signaling (MAVS) that drives cardiovascular calcification in humans when mutated in Singleton-Merten syndrome (SGMRT2). Gain-of-function SGMRT2/RIG-I mutants increased G3BP1 methylation and synergized with osteogenic transcription factors (Runx2 and NFATc4). A chemical antagonist of G3BP, C108 (C108 is 2-hydroxybenzoic acid, 2-[1-(2-hydroxyphenyl)ethylidene]hydrazide CAS 15533-09-2), down-regulated RIG-I-stimulated G3BP1 methylation, Wnt/NFAT signaling, VSM TNAP activity, and calcification. G3BP1 deficiency reduced RIG-I protein levels and VSM osteogenic programs. Like G3BP1 and RIG-I deficiency, MAVS deficiency reduced VSM osteogenic signals, including TNAP activity and Wnt5-dependent nuclear NFATc4 levels. Aortic calcium accumulation is decreased in MAVS-deficient LDLR-/- mice fed arteriosclerotic diets. The G3BP1/RIG-I/MAVS relay is a component of Wnt signaling. Targeting this relay may help mitigate arteriosclerosis.	[Ramachandran, Bindu; Stabley, John N.; Cheng, Su-Li; Behrmann, Abraham S.; Gay, Austin; Li, Li; Mead, Megan; Towler, Dwight A.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Kozlitina, Julia] Univ Texas Southwestern Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Lemoff, Andrew; Mirzaei, Hamid] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chen, Zhijian] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Towler, DA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Internal Med Endocrine Div, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	dwight.towler@utsouthwestern.edu	Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251; Lemoff, Andrew/0000-0002-4943-0170; Towler, Dwight/0000-0003-2107-7923; /0000-0002-1825-7846; Kozlitina, Julia/0000-0001-7720-2290	National Institutes of Health [HL114806, HL069229]; J. D. and Maggie E. Wilson Endowed Chair in Biomedical Research; Louis V. Avioli Professorship in Mineral Metabolism Research; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114806, R01HL069229] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J. D. and Maggie E. Wilson Endowed Chair in Biomedical Research; Louis V. Avioli Professorship in Mineral Metabolism Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL114806 (to D. A. T.) and HL069229 (to D. A. T.), the J. D. and Maggie E. Wilson Endowed Chair in Biomedical Research (to D. A. T.), the Louis V. Avioli Professorship in Mineral Metabolism Research (to D. A. T.), and the Howard Hughes Medical Institute (to Z. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Aly Z, 2007, ARTERIOSCL THROM VAS, V27, P2589, DOI 10.1161/ATVBAHA.107.153668; Albanese I, 2017, ARTERIOSCL THROM VAS, V37, P543, DOI 10.1161/ATVBAHA.116.308394; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Asl HF, 2015, CIRC-CARDIOVASC GENE, V8, P305, DOI 10.1161/CIRCGENETICS.114.000640; Berglund ED, 2008, DIABETES, V57, P1790, DOI 10.2337/db07-1615; Bidder M, 2002, J BIOL CHEM, V277, P44485, DOI 10.1074/jbc.M206235200; Bikkavilli RK, 2012, J CELL SCI, V125, P2446, DOI 10.1242/jcs.100933; Bikkavilli RK, 2011, J CELL SCI, V124, P2310, DOI 10.1242/jcs.084046; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Bostrom K, 2000, CRIT REV EUKAR GENE, V10, P151; Byon CH, 2011, ARTERIOSCL THROM VAS, V31, P1387, DOI 10.1161/ATVBAHA.110.222547; Cai X, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a023580; Cai ZJ, 2016, CIRC RES, V119, P422, DOI 10.1161/CIRCRESAHA.116.308301; Can U, 2016, J PEDIATR ENDOCR MET, V29, P1277, DOI 10.1515/jpem-2016-0136; Cassola A, 2010, RNA BIOL, V7, P339, DOI 10.4161/rna.7.3.12087; Cheng SL, 2015, CIRC RES, V117, P142, DOI 10.1161/CIRCRESAHA.117.306712; Cheng SL, 2014, DIABETES, V63, P4326, DOI 10.2337/db14-0326; Cheng SL, 2010, CIRC RES, V107, P271, DOI 10.1161/CIRCRESAHA.110.219899; Cohen MM, 2006, AM J MED GENET A, V140A, P2646, DOI 10.1002/ajmg.a.31368; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Demer LL, 2014, ARTERIOSCL THROM VAS, V34, P715, DOI 10.1161/ATVBAHA.113.302070; Dhar S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01311; Duan PP, 2016, INT J BIOCHEM CELL B, V77, P23, DOI 10.1016/j.biocel.2016.05.015; Fakhry M, 2017, BBA-MOL BASIS DIS, V1863, P643, DOI 10.1016/j.bbadis.2016.12.003; Gay A, 2017, CURR OPIN LIPIDOL, V28, P387, DOI 10.1097/MOL.0000000000000445; Glantz S. A., 2005, PRIMER BIOSTATISTICS, P64; Greenblatt MB, 2013, ANNU REV CELL DEV BI, V29, P63, DOI 10.1146/annurev-cellbio-101512-122347; Greenwald SE, 2007, J PATHOL, V211, P157, DOI 10.1002/path.2101; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Gupta N, 2017, P NATL ACAD SCI USA, V114, P1033, DOI 10.1073/pnas.1525387114; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; He MZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145112; Heath JM, 2014, CIRC RES, V114, P1094, DOI 10.1161/CIRCRESAHA.114.302968; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Horner SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117963; Ibarra A, 2015, GENE DEV, V29, P337, DOI 10.1101/gad.256495.114; Irvine K, 2004, INT J DEV BIOL, V48, P1065, DOI 10.1387/ijdb.041893ki; Jang MA, 2015, AM J HUM GENET, V96, P266, DOI 10.1016/j.ajhg.2014.11.019; Janssens S, 2014, NAT IMMUNOL, V15, P910, DOI 10.1038/ni.2991; Karmali KN, 2016, JAMA CARDIOL, V1, P341, DOI 10.1001/jamacardio.2016.0218; Kedersha N, 2016, J CELL BIOL, V212, P845, DOI 10.1083/jcb.201508028; Kelynack KJ, 2016, METHODS MOL BIOL, V1397, P209, DOI 10.1007/978-1-4939-3353-2_14; Komura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071271; Kong L, 2009, CELL HOST MICROBE, V6, P150, DOI 10.1016/j.chom.2009.06.008; Lai CF, 2012, ENDOCRINOLOGY, V153, P3897, DOI 10.1210/en.2012-1216; Lawson MA, 2010, J BIOMED MATER RES B, V92B, P149, DOI 10.1002/jbm.b.31500; Lin ME, 2016, CARDIOVASC RES, V112, P606, DOI 10.1093/cvr/cvw205; Liu F, 2011, PROTEIN CELL, V2, P351, DOI 10.1007/s13238-011-1045-y; Lundgren Deborah H, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1303s28; Mackenzie NCW, 2011, INT J MOL MED, V27, P663, DOI 10.3892/ijmm.2011.631; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Martin S, 2016, J NEUROCHEM, V139, P349, DOI 10.1111/jnc.13768; Masuda M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000238; Milewicz DM, 2017, ARTERIOSCL THROM VAS, V37, P26, DOI 10.1161/ATVBAHA.116.303229; Morony S, 2012, CALCIFIED TISSUE INT, V91, P379, DOI 10.1007/s00223-012-9655-9; Morony S, 2008, CIRCULATION, V117, P411, DOI 10.1161/CIRCULATIONAHA.107.707380; Muhammad IF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181718; Narisawa S, 2013, J BONE MINER RES, V28, P1587, DOI 10.1002/jbmr.1901; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; New SEP, 2013, ARTERIOSCL THROM VAS, V33, P1753, DOI 10.1161/ATVBAHA.112.300128; New SEP, 2013, CIRC RES, V113, P72, DOI 10.1161/CIRCRESAHA.113.301036; Pazman C, 2000, DEVELOPMENT, V127, P1715; Pockwinse SM, 2011, J CELL PHYSIOL, V226, P1383, DOI 10.1002/jcp.22465; Ptak C, 2017, ADV EXP MED BIOL, V963, P111, DOI 10.1007/978-3-319-50044-7_7; Raaz U, 2015, CIRC RES, V117, P513, DOI 10.1161/CIRCRESAHA.115.306341; Rademaker J, 2008, AM J ROENTGENOL, V191, P32, DOI 10.2214/AJR.07.3112; Ranoa DRE, 2016, ONCOTARGET, V7, P26496, DOI 10.18632/oncotarget.8420; Ritchey M.D., 2017, J AM HEART ASS, V6, DOI [DOI 10.1161/JAHA.117.006021, 10.1161/jaha.117.006021]; Rutsch F, 2015, AM J HUM GENET, V96, P275, DOI 10.1016/j.ajhg.2014.12.014; Sahoo PK, 2012, BIOL OPEN, V1, P109, DOI 10.1242/bio.2011023; Saito Y, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080858; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shafer SL, 2009, J MOL CELL CARDIOL, V46, P621, DOI 10.1016/j.yjmcc.2009.01.005; Shao JS, 2011, ARTERIOSCL THROM VAS, V31, P1821, DOI 10.1161/ATVBAHA.111.230011; Shao JS, 2010, HYPERTENSION, V55, P579, DOI 10.1161/HYPERTENSIONAHA.109.134205; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Shen Q, 2005, J BIOL CHEM, V280, P40589, DOI 10.1074/jbc.M504166200; Siddique A, 2018, CAN J PHYSIOL PHARM, V96, P208, DOI 10.1139/cjpp-2017-0577; Sidney S, 2016, JAMA CARDIOL, V1, P594, DOI 10.1001/jamacardio.2016.1326; Sierra OL, 2004, J BIOL CHEM, V279, P32913, DOI 10.1074/jbc.M314098200; Sierra OL, 2010, MOL ENDOCRINOL, V24, P1478, DOI 10.1210/me.2010-0029; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Srivastava R, 2015, CELL REP, V13, P746, DOI 10.1016/j.celrep.2015.09.028; Stabley JN, 2017, ARTERIOSCL THROM VAS, V37, P205, DOI 10.1161/ATVBAHA.116.306258; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Sun ST, 2016, BIOCONJUGATE CHEM, V27, P329, DOI 10.1021/acs.bioconjchem.5b00369; Sun Y, 2012, CIRC RES, V111, P543, DOI 10.1161/CIRCRESAHA.112.267237; Tintut Y, 2006, J INVEST MED, V54, P395, DOI 10.2310/6650.2006.06019; Tourriere H, 2001, MOL CELL BIOL, V21, P7747, DOI 10.1128/MCB.21.22.7747-7760.2001; Tsai WC, 2017, J BIOL CHEM, V292, P18886, DOI 10.1074/jbc.M117.800706; Tsai WC, 2016, J BIOL CHEM, V291, P22671, DOI 10.1074/jbc.M116.739573; Tsaousi A, 2011, CIRC RES, V108, P427, DOI 10.1161/CIRCRESAHA.110.233999; Valiente-Echeverria F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5819; Vognsen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080947; Westerhof N, 2009, MED BIOL ENG COMPUT, V47, P131, DOI 10.1007/s11517-008-0359-2; Whelton SP, 2015, JACC-CARDIOVASC IMAG, V8, P1393, DOI 10.1016/j.jcmg.2015.06.019; Williams H, 2016, ARTERIOSCL THROM VAS, V36, P1417, DOI 10.1161/ATVBAHA.116.307626; Woldt E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2087; Wu XS, 2017, INT J BIOL SCI, V13, P1082, DOI 10.7150/ijbs.20905; Zhang H, 2013, CANCER GENE THER, V20, P622, DOI 10.1038/cgt.2013.62; Zhang H, 2015, ONCOTARGET, V6, P17039, DOI 10.18632/oncotarget.3636; Zhong ZD, 2012, J CELL BIOCHEM, V113, P31, DOI 10.1002/jcb.23324	106	18	18	1	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					7942	7968		10.1074/jbc.RA118.002046	http://dx.doi.org/10.1074/jbc.RA118.002046			27	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29626090	Green Published, hybrid			2022-12-26	WOS:000433224600004
J	Ku, BM; Choi, MK; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ				Ku, Bo Mi; Choi, Moon Ki; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Park, Keunchil; Ahn, Myung-Ju			Acquired resistance to AZD9291 as an upfront treatment is dependent on ERK signaling in a preclinical model	PLOS ONE			English	Article							CELL LUNG-CANCER; EGFR; INHIBITOR; OSIMERTINIB; MECHANISMS; MASPIN; 1ST	AZD9291 (osimertinib) is approved for standard care in patients with EGFR T790M-positive non-small cell lung cancer (NSCLC) after prior EGFR TKI progression. Furthermore, AZD9291 is now being evaluated as a first-line treatment for NSCLC patients with activation EGFR mutations. Based on previous experiments, resistance to AZD9291 as a first-line treatment may also emerge. Thus, identification and understanding of resistance mechanisms to AZD9291 as a first-line treatment can help direct development of future therapies. AZD9291-resistant cells (PC9/AZDR) were established using EGFR inhibitor-naive PC9 cells. Resistance mechanisms were analyzed using next-generation sequencing (NGS) and a proteome profiler array. Resistance to AZD9291 developed through aberrant activation of ERK signaling by an EGFR-independent mechanism. The combination of a MEK inhibitor with AZD9291 restored the sensitivity of PC9/AZDR cells in vitro and in vivo. PC9/AZDR cells also showed increased MET expression and an HRAS G13R mutation. In addition, maspin expression was higher after AZD9291 treatment in PC9/AZDR cells. Sustained ERK activation confers resistance to AZD9291 as a first-line therapy. Thus, co-targeting EGFR and MEK may be an effective strategy to overcome resistance to AZD9291.	[Ku, Bo Mi] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Biomed Res Inst, Seoul, South Korea; [Choi, Moon Ki] Natl Canc Ctr, Res Inst & Hosp, Ctr Colorectal Canc, Goyang, South Korea; [Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Park, Keunchil; Ahn, Myung-Ju] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; National Cancer Center - Korea (NCC); Sungkyunkwan University (SKKU); Samsung Medical Center	Ahn, MJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea.	silk.ahn@samsung.com	sun, jm/O-5938-2014; Park, Keunchil/ABD-5852-2021; Park, Keunchil/ABD-7072-2021	Park, Keunchil/0000-0002-4846-7449; 	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C1984]; Collaborative Genome Program for Fostering New Post-Genome Industry of the National Research Foundation (NRF) - Ministry of Science and ICT (MSIT) [NRF-2017M3C9A6044632]; Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MSIT) [2017M3A9G5060252]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Collaborative Genome Program for Fostering New Post-Genome Industry of the National Research Foundation (NRF) - Ministry of Science and ICT (MSIT); Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MSIT)	This work was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI16C1984) (MJA), by the Collaborative Genome Program for Fostering New Post-Genome Industry of the National Research Foundation (NRF) funded by the Ministry of Science and ICT (MSIT) (No. NRF-2017M3C9A6044632) and by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (No. 2017M3A9G5060252) (JMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berardi R, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-8; Boidot R, 2016, INT J COLORECTAL DIS, V31, P1245, DOI 10.1007/s00384-015-2448-7; Cathcart-Rake E, 2014, J THORAC ONCOL, V9, pE75, DOI 10.1097/JTO.0000000000000315; Chabon JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11815; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Eberlein CA, 2015, CANCER RES, V75, P2489, DOI 10.1158/0008-5472.CAN-14-3167; Ercan D, 2015, CLIN CANCER RES, V21, P3913, DOI 10.1158/1078-0432.CCR-14-2789; Ercan D, 2012, CANCER DISCOV, V2, P934, DOI 10.1158/2159-8290.CD-12-0103; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Juchum M, 2015, DRUG RESIST UPDATE, V20, P12, DOI 10.1016/j.drup.2015.05.002; Khalkhali-Ellis Z, 2004, CLIN CANCER RES, V10, P449, DOI 10.1158/1078-0432.CCR-1002-03; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee DH, 2017, PHARMACOL THERAPEUT, V174, P1, DOI 10.1016/j.pharmthera.2017.02.001; Longhi MT, 2012, FEBS OPEN BIO, V2, P93, DOI 10.1016/j.fob.2012.04.006; Martinez-Garcia M, 2012, CLIN CANCER RES, V18, P4806, DOI 10.1158/1078-0432.CCR-12-0742; Mazza V, 2017, APPL CLIN GENET, V10, P49, DOI 10.2147/TACG.S103471; Meador CB, 2015, MOL CANCER THER, V14, P542, DOI 10.1158/1535-7163.MCT-14-0723; Mok TS, 2017, NEW ENGL J MED, V376, P629, DOI 10.1056/NEJMoa1612674; Moniz S, 2010, CELL MOL LIFE SCI, V67, P1265, DOI 10.1007/s00018-010-0261-6; Planchard D, 2015, ANN ONCOL, V26, P2073, DOI 10.1093/annonc/mdv319; Ramalignam S, 2017, J THORACIC ONCOLO S5, V28, pv605; Ramalingam SS, 2018, J CLIN ONCOL, V36, P841, DOI 10.1200/JCO.2017.74.7576; Sequist LV, 2015, NEW ENGL J MED, V372, P1700, DOI 10.1056/NEJMoa1413654; Shi PY, 2017, CLIN CANCER RES, V23, P6567, DOI 10.1158/1078-0432.CCR-17-1574; Shi PY, 2016, CANCER LETT, V380, P494, DOI 10.1016/j.canlet.2016.07.021; Sullivan I, 2017, FRONT MED-LAUSANNE, V3, DOI 10.3389/fmed.2016.00076; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Tricker EM, 2015, CANCER DISCOV, V5, P960, DOI 10.1158/2159-8290.CD-15-0063; Yang JCH, 2017, J CLIN ONCOL, V35, P1288, DOI 10.1200/JCO.2016.70.3223	29	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194730	10.1371/journal.pone.0194730	http://dx.doi.org/10.1371/journal.pone.0194730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641535	Green Submitted, gold, Green Published			2022-12-26	WOS:000429742900043
J	Giffard, PM; Andersson, P; Wilson, J; Buckley, C; Lilliebridge, R; Harris, TM; Kleinecke, M; O'Grady, KAF; Huston, WM; Lambert, SB; Whiley, DM; Holt, DC				Giffard, Philip M.; Andersson, Patiyan; Wilson, Judith; Buckley, Cameron; Lilliebridge, Rachael; Harris, Tegan M.; Kleinecke, Mariana; O'Grady, Kerry-Ann F.; Huston, Wilhelmina M.; Lambert, Stephen B.; Whiley, David M.; Holt, Deborah C.			CtGEM typing: Discrimination of Chlamydia trachomatis ocular and urogenital strains and major evolutionary lineages by high resolution melting analysis of two amplified DNA fragments	PLOS ONE			English	Article							SEQUENCE-ANALYSIS; PCR; IDENTIFICATION; RECOMBINATION; ASSAY	Chlamydia trachomatis infects the urogenital tract (UGT) and eyes. Anatomical tropism is correlated with variation in the major outer membrane protein encoded by ompA. Strains possessing the ocular ompA variants A, B, Ba and C are typically found within the phylogenetically coherent "classical ocular lineage". However, variants B, Ba and C have also been found within three distinct strains in Australia, all associated with ocular disease in children and outside the classical ocular lineage. CtGEM genotyping is a method for detecting and discriminating ocular strains and also the major phylogenetic lineages. The rationale was facilitation of surveillance to inform responses to C. trachomatis detection in UGT specimens from young children. CtGEM typing is based on high resolution melting analysis (HRMA) of two PCR amplified fragments with high combinatorial resolving power, as defined by computerised comparison of 65 whole genomes. One fragment is from the hypothetical gene defined by Jali-1891 in the C. trachomatis B_Jali20 genome, while the other is from ompA. Twenty combinatorial CtGEM types have been shown to exist, and these encompass unique genotypes for all known ocular strains, and also delineate the TI and T2 major phylogenetic lineages, identify LGV strains and provide additional resolution beyond this. CtGEM typing and Sanger sequencing were compared with 42 C. trachomatis positive clinical specimens, and there were no disjunctions. CtGEM typing is a highly efficient method designed and tested using large scale comparative genomics. It divides C. trachomatis into clinically and biologically meaningful groups, and may have broad application in surveillance.	[Giffard, Philip M.; Andersson, Patiyan; Wilson, Judith; Kleinecke, Mariana; Holt, Deborah C.] Charles Darwin Univ, Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Giffard, Philip M.; Holt, Deborah C.] Charles Darwin Univ, Sch Psychol & Clin Sci, Darwin, NT, Australia; [Buckley, Cameron; Lilliebridge, Rachael; Whiley, David M.] Univ Queensland, Clin Res Ctr, Fac Med, Herston, Qld, Australia; [Harris, Tegan M.] Charles Darwin Univ, Menzies Sch Hlth Res, Child Hlth Div, Darwin, NT, Australia; [O'Grady, Kerry-Ann F.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Ctr Childrens Hlth Res, Brisbane, Qld, Australia; [Huston, Wilhelmina M.] Univ Technol, Sch Life Sci, Sydney, NSW, Australia; [Lambert, Stephen B.; Whiley, David M.] Univ Queensland, Child Hlth Res Ctr, Brisbane, Qld, Australia; [Whiley, David M.] Pathol Queensland Cent Lab, Brisbane, Qld, Australia	Charles Darwin University; Menzies School of Health Research; Charles Darwin University; University of Queensland; Charles Darwin University; Menzies School of Health Research; Queensland University of Technology (QUT); University of Technology Sydney; University of Queensland	Giffard, PM (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia.; Giffard, PM (corresponding author), Charles Darwin Univ, Sch Psychol & Clin Sci, Darwin, NT, Australia.	phil.giffard@menzies.edu.au	Huston, Wilhelmina/S-7269-2019; O'Grady, Kerry-Ann F/F-2529-2010; Whiley, David M/E-8955-2011; Lambert, Stephen/B-8348-2008; Harris, Tegan/A-5964-2016; Huston, Wilhelmina/B-9984-2008	O'Grady, Kerry-Ann F/0000-0002-8159-2620; Whiley, David M/0000-0001-5969-3161; Lambert, Stephen/0000-0002-2709-193X; Harris, Tegan/0000-0002-9312-7451; Giffard, Phil/0000-0002-3030-9127; Holt, Deborah/0000-0003-4951-1891; Huston, Wilhelmina/0000-0002-0879-1287	Australian National Health and Medical Research Council [1060768]; Children's Hospital Foundation, Brisbane; Queensland University of Technology	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Children's Hospital Foundation, Brisbane; Queensland University of Technology	This work was funded from the Australian National Health and Medical Research Council (https://www.nhmrc.gov.au/) project grant 1060768 to Philip Giffard and an un-numbered seeding grant from the Children's Hospital Foundation, Brisbane (https://www.childrens.org.au/), and the Queensland University of Technology (https://www.qut.edu.au/) to Stephen Lambert.	Andersson P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10688; Andersson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033530; Asche VL., 1990, P 7 INT S HUM CHLAM, P555; Brown A, 2007, MED J AUSTRALIA, V187, P621, DOI 10.5694/j.1326-5377.2007.tb01446.x; Brunelle Brian W, 2012, BMC Res Notes, V5, P53, DOI 10.1186/1756-0500-5-53; BRUNHAM RC, 1993, INFECT IMMUN, V61, P2273, DOI 10.1128/IAI.61.6.2273-2276.1993; Cai L, 2010, INT J STD AIDS, V21, P101, DOI 10.1258/ijsa.2009.009013; CALDWELL HD, 1982, INFECT IMMUN, V35, P1024, DOI 10.1128/IAI.35.3.1024-1031.1982; Dean D, 2009, EMERG INFECT DIS, V15, P1385, DOI 10.3201/eid1509.090272; Douglas FP, 1986, P 6 INT S HUM CHLAM, P237; Dwight Z, 2011, BIOINFORMATICS, V27, P1019, DOI 10.1093/bioinformatics/btr065; Erali M, 2008, EXP MOL PATHOL, V85, P50, DOI 10.1016/j.yexmp.2008.03.012; Giffard PM, 2017, SEX TRANSM INFECT, V93, P236, DOI 10.1136/sextrans-2015-052473; Giffard PM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009624; Gundry CN, 2003, CLIN CHEM, V49, P396, DOI 10.1373/49.3.396; Hadfield J, 2017, GENOME RES, V27, P1220, DOI 10.1101/gr.212647.116; Hammerschlag MR, 2011, CLIN INFECT DIS, V53, pS103, DOI 10.1093/cid/cir700; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Herrmann B, 2015, J CLIN MICROBIOL, V53, P2172, DOI 10.1128/JCM.00249-15; Hunt Martin, 2017, Microb Genom, V3, pe000131, DOI 10.1099/mgen.0.000131; Jeffrey BM, 2010, INFECT IMMUN, V78, P2544, DOI 10.1128/IAI.01324-09; Joseph SJ, 2012, MOL BIOL EVOL, V29, P3933, DOI 10.1093/molbev/mss198; Labiran C, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00068; Lilliebridge RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019749; Lysen M, 2004, J CLIN MICROBIOL, V42, P1641, DOI 10.1128/JCM.42.4.1641-1647.2004; Millman K, 2004, J BACTERIOL, V186, P2457, DOI 10.1128/JB.186.8.2457-2465.2004; Millman KL, 2001, J BACTERIOL, V183, P5997, DOI 10.1128/JB.183.20.5997-6008.2001; Pedersen LN, 2008, CLIN MICROBIOL INFEC, V14, P644, DOI 10.1111/j.1469-0691.2008.02011.x; Price EP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-278; Richardson LJ, 2011, CLIN MICROBIOL INFEC, V17, P1426, DOI 10.1111/j.1469-0691.2010.03433.x; Robertson GA, 2004, J MED MICROBIOL, V53, P35, DOI 10.1099/jmm.0.05365-0; Rogstad K., 2010, UK NATL GUIDELINE MA; Schaeffer A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-56; Seth-Smith HMB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-239; STEPHENS RS, 1982, J IMMUNOL, V128, P1083; Stevens MP, 2010, J CLIN MICROBIOL, V48, P2060, DOI 10.1128/JCM.02308-09; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108; Tong SYC, 2012, J CLIN MICROBIOL, V50, P3418, DOI 10.1128/JCM.01709-12; Tong SYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029189; Versteeg B, 2015, SEX TRANSM INFECT, V91, P510, DOI 10.1136/sextrans-2014-051998; WANG SP, 1985, J INFECT DIS, V152, P791, DOI 10.1093/infdis/152.4.791; Wang YG, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023495, 10.1371/journal.pone.0020422]; Wild Rex, 2007, AMPE AKELYERNEMANE M; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; Xiong LK, 2006, J CLIN MICROBIOL, V44, P1413, DOI 10.1128/JCM.44.4.1413-1418.2006	45	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195454	10.1371/journal.pone.0195454	http://dx.doi.org/10.1371/journal.pone.0195454			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634761	Green Published, gold			2022-12-26	WOS:000429522200032
J	Neyt, M; Vlayen, J; Devriese, S; Camberlin, C				Neyt, Mattias; Vlayen, Joan; Devriese, Stephan; Camberlin, Cecile			First- and second-line bevacizumab in ovarian cancer: A Belgian cost-utility analysis	PLOS ONE			English	Article							PHASE-3 RANDOMIZED-TRIAL; STANDARD CHEMOTHERAPY; EPITHELIAL OVARIAN; END-POINTS; ICON7; SURVIVAL; ONCOLOGY	Background Currently, in Belgium, bevacizumab is reimbursed for ovarian cancer patients, based on a contract between the Minister and the manufacturer including confidential agreements. This reimbursement will be re-evaluated in 2018. Objective To support the reimbursement reassessment by calculating the cost-effectiveness of bevacizumab: (1) in addition to first-line chemotherapy; (2) in the treatment of recurrent ovarian cancer (platinum-sensitive or platinum-resistant). Methods A health economic model has been developed for the Belgian situation according to the Belgian guidelines for economic evaluations. The lifetime Markov model was set up from the perspective of the health care payer (government and patient), including direct healthcare related costs. Results are expressed as the extra costs per quality-adjusted life year (QALY). Calculations were based on results of four international trials. Both probabilistic and one-way sensitivity analyses were performed. Results Incremental cost-effectiveness ratios (ICERs) of first-line bevacizumab are on average 158 000/QALY (GOG-0218 trial) and 443 000/QALY (ICON7 trial). The most favourable scenario is based on the stage IV subgroup of the GOG-0218 trial (epsilon 52 000/QALY). Since subgroup findings are often exploratory and require confirmatory studies, results of the economic evaluation based on this subgroup analysis should be considered with caution. For second-line bevacizumab, ICERs are on average epsilon 587 000/QALY (OCEANS trial) and epsilon 172 000/QALY (AURELIA trial). Sensitivity analysis shows that results are most sensitive to the price of bevacizumab. Conclusion From a health economic perspective, ICERs of bevacizumab are relatively high. The most favourable results are found for first-line treatment of stage IV ovarian cancer patients. Price reductions have a major impact on the estimated ICERs. It is recommended to take these findings into account when re-evaluating the reimbursement of bevacizumab in ovarian cancer.	[Neyt, Mattias; Vlayen, Joan; Devriese, Stephan; Camberlin, Cecile] Belgian Hlth Care Knowledge Ctr KCE, Brussels, Belgium		Neyt, M (corresponding author), Belgian Hlth Care Knowledge Ctr KCE, Brussels, Belgium.	mattias.neyt@kce.fgov.be		Camberlin, Cecile/0000-0003-3473-876X				Aghajanian C, 2012, J CLIN ONCOL, V30, P2039, DOI 10.1200/JCO.2012.42.0505; Barnett JC, 2013, CANCER-AM CANCER SOC, V119, P3653, DOI 10.1002/cncr.28283; Belgian Cancer Registry, 2016, INC FACT SHEET OV CA; Belgian Cancer Registry, 2015, CANC BURD BELG 2004; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Chan JK, 2014, ONCOLOGIST, V19, P523, DOI 10.1634/theoncologist.2013-0322; Chappell NP, 2016, J ONCOL PRACT, V12, P689, DOI 10.1200/JOP.2015.010470; Cleemput I, 2012, HLTH TECHNOLOGY ASSE; Cohn DE, 2015, GYNECOL ONCOL, V136, P293, DOI 10.1016/j.ygyno.2014.10.020; Cohn DE, 2011, J CLIN ONCOL, V29, P1247, DOI 10.1200/JCO.2010.32.1075; Coleman R. L., 2015, ANN M WOM CANC CHIC; Cooper K, 2012, SINGLE TECHNOLOGY AP; Duong M, 2016, CURR ONCOL, V23, pE461, DOI 10.3747/co.23.3139; Edwards S, 2012, BEVACIZUMAB TREATMEN; EUnetHTA, 2015, METH HLTH EC EV GUID; European network for Health Technology Assessment (EUnetHTA), 2015, ENDP US REL EFF ASS; European Network for Health Technology Assessment (EUnetHTA) guideline, 2013, ENDP US REL EFF ASS; Gerkens S, 2017, KCE REPORTS; Havrilesky LJ, 2014, CANCER-AM CANCER SOC, V120, P3651, DOI 10.1002/cncr.28940; Hinde S, 2016, VALUE HEALTH, V19, P431, DOI 10.1016/j.jval.2016.01.013; Husereau D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-80; Kim C, 2015, JAMA INTERN MED, V175, P1992, DOI 10.1001/jamainternmed.2015.5868; Lesnock JL, 2011, GYNECOL ONCOL, V122, P473, DOI 10.1016/j.ygyno.2011.05.014; Ludwig Boltzmann Institute for Health Technology Assessment, 2014, BEV AV PLAT RES REC; Mehta DA, 2014, GYNECOL ONCOL, V132, P677, DOI 10.1016/j.ygyno.2014.01.021; Minion LE, 2016, GYNECOL ONCOL, V140, P193, DOI 10.1016/j.ygyno.2015.11.030; National Institute for Health and Care Excellence, 2016, GUID EX GE REV TA284; National Institute for Health and Care Excellence (NICE), 2005, PACL PEG LIP DOX HYD; National Institute for Health and Care Excellence (NICE), 2012, BEV TREATM REC ADV O; National Institute for Health and Care Excellence (NICE), 2012, BEV COMB CARB PACL T; Neyt M, 2017, KCE REPORTS; Oza AM, 2015, LANCET ONCOL, V16, P928, DOI 10.1016/S1470-2045(15)00086-8; Prasad V, 2015, JAMA INTERN MED, V175, P1389, DOI 10.1001/jamainternmed.2015.2829; Protocol. ICON7, 2009, ICON7 RAND 2 ARM MUL; Pujade-Lauraine E, 2014, J CLIN ONCOL, V32, P1302, DOI 10.1200/JCO.2013.51.4489; Randall LM, 2013, GYNECOL ONCOL; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Scottish Intercollegiate Guidelines Network, 2013, 135 SIGN; Stark D, 2013, LANCET ONCOL, V14, P236, DOI 10.1016/S1470-2045(12)70567-3; Vergote I, 2016, OVARIAN CANC DIAGNOS	40	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195134	10.1371/journal.pone.0195134	http://dx.doi.org/10.1371/journal.pone.0195134			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630612	Green Published, gold, Green Submitted			2022-12-26	WOS:000429505000026
J	Schneider, KA				Schneider, Kristan Alexander			Large and finite sample properties of a maximum-likelihood estimator for multiplicity of infection	PLOS ONE			English	Article							ARTEMISININ RESISTANCE; EVOLUTION; VIRULENCE; MALARIA; CHILDREN; MODEL; AREA	Reliable measures of transmission intensities can be incorporated into metrics for monitoring disease-control interventions. Genetic (molecular) measures like multiplicity of infection (MOI) have several advantages compared with traditional measures, e.g., R-0. Here, we investigate the properties of a maximum-likelihood approach to estimate MOI and pathogen-lineage frequencies. By verifying regulatory conditions, we prove asymptotical unbiasedness, consistency and efficiency of the estimator. Finite sample properties concerning bias and variance are evaluated over a comprehensive parameter range by a systematic simulation study. Moreover, the estimator's sensitivity to model violations is studied. The estimator performs well for realistic sample sizes and parameter ranges. In particular, the lineage-frequency estimates are almost unbiased independently of sample size. The MOI estimate's bias vanishes with increasing sample size, but might be substantial if sample size is too small. The estimator's variance matrix agrees well with the Cramer-Rao lower bound, even for small sample size. The numerical and analytical results of this study can be used for study design. This is exemplified by a malaria data set from Venezuela. It is shown how the results can be used to determine the necessary sample size to achieve certain performance goals. An implementation of the likelihood method and a simulation algorithm for study design, implemented as an R script, is available as Si File alongside a documentation(S2 File) and example data (S3 File).	[Schneider, Kristan Alexander] Univ Appl Sci Mittweida, Dept CB, Mittweida, Germany		Schneider, KA (corresponding author), Univ Appl Sci Mittweida, Dept CB, Mittweida, Germany.	kristan.schneider@hs-mittweida.de		Schneider, Kristan/0000-0003-4138-1180	SMWK-SAB project "Innovationsvorhaben zur Profilscharfung an Hochschulen fur angewandte Wissenschaften" [100257255]	SMWK-SAB project "Innovationsvorhaben zur Profilscharfung an Hochschulen fur angewandte Wissenschaften"	This work was funded by the SMWK-SAB project "Innovationsvorhaben zur Profilscharfung an Hochschulen fur angewandte Wissenschaften" (Project number 100257255).	Abd Razak MRM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152415; Alizon S, 2013, ECOL LETT, V16, P556, DOI 10.1111/ele.12076; Amoah LE, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2338-7; [Anonymous], 2014, R LANG ENV STAT COMP; Assefa SA, 2014, BIOINFORMATICS, V30, P1292, DOI 10.1093/bioinformatics/btu005; Awaga KL, 2012, TROP MED INT HEALTH, V17, P153, DOI 10.1111/j.1365-3156.2011.02913.x; Balmer O, 2011, LANCET INFECT DIS, V11, P868, DOI 10.1016/S1473-3099(11)70241-9; Ben-Ami F, 2008, EVOLUTION, V62, P1700, DOI 10.1111/j.1558-5646.2008.00391.x; Ben-Ami F, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-97; Brown CM, 2014, VIROLOGY, V466, P71, DOI 10.1016/j.virol.2014.07.023; Chang HH, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005348; Cohen T, 2012, CLIN MICROBIOL REV, V25, P708, DOI 10.1128/CMR.00021-12; Davison A., 2003, STAT MODELS; FRANK SA, 1992, P ROY SOC B-BIOL SCI, V250, P195, DOI 10.1098/rspb.1992.0149; Friedrich LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004526; Galinsky K, 2015, MALARIA J, V14, DOI 10.1186/1475-2875-14-4; Hamid MMA, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1641-z; Hastings IM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-130; Hawkes M, 2014, NEW ENGL J MED, V371, P1944, DOI 10.1056/NEJMc1410735; Hill William G., 1995, Proceedings of the Royal Society of London Series B Biological Sciences, V262, P249, DOI 10.1098/rspb.1995.0203; Kateera F, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1287-5; Ken-Dror G, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1473-5; Kilama M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-111; Klein EY, 2012, P ROY SOC B-BIOL SCI, V279, P3834, DOI 10.1098/rspb.2012.1064; Kobbe R, 2006, TROP MED INT HEALTH, V11, P613, DOI 10.1111/j.1365-3156.2006.01618.x; Kuk AYC, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-82; Li XH, 2007, STAT APPL GENET MOL, V6; Lindstrom I, 2008, PARASITOLOGY, V135, P39, DOI 10.1017/S0031182007003654; Lively CM, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-64; Marasini S, 2017, MOL CELLS, V40, P598, DOI 10.14348/molcells.2017.0095; Matussek A, 2011, J CLIN MICROBIOL, V49, P3647, DOI 10.1128/JCM.00389-11; McCollum AM, 2007, ANTIMICROB AGENTS CH, V51, P2085, DOI 10.1128/AAC.01228-06; McCollum AM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-77; Mueller I, 2012, P NATL ACAD SCI USA, V109, P10030, DOI 10.1073/pnas.1200841109; Nabet C, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1397-0; NEI M, 1978, GENETICS, V89, P583; Nishimura T, 2017, J INFECT CHEMOTHER, V23, P703, DOI 10.1016/j.jiac.2017.07.015; Pinkevych M, 2015, J INFECT DIS, V211, P1121, DOI 10.1093/infdis/jiu561; Poon AFY, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002753; Ross A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042496; Schjorring S, 2003, P ROY SOC B-BIOL SCI, V270, P189, DOI 10.1098/rspb.2002.2233; Schneider KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097899; Schneider KA, 2010, THEOR POPUL BIOL, V78, P93, DOI 10.1016/j.tpb.2010.06.005; Sisya TJ, 2015, ACTA TROP, V142, P108, DOI 10.1016/j.actatropica.2014.11.008; Smith DL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-87; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; TAKALA SL, 2006, MALARIA J, V5, DOI DOI 10.1186/1475-2875-5-31; Taylor AR, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-102; Thanapongpichat S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-275; Theron A, 2004, PARASITOLOGY, V129, P571, DOI 10.1017/S0031182004005943; Tognazzo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049137; Tusting LS, 2014, ADV PARASIT, V84, P151, DOI 10.1016/B978-0-12-800099-1.00003-X; Vu-Thien H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-24; Wacker MA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-180; Weir W, 2011, INT J PARASITOL, V41, P193, DOI 10.1016/j.ijpara.2010.08.004; Wigger L, 2013, STAT MED, V32, P3737, DOI 10.1002/sim.5792; Winzeler EA, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0544-6	57	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194148	10.1371/journal.pone.0194148	http://dx.doi.org/10.1371/journal.pone.0194148			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630605	gold, Green Published, Green Submitted			2022-12-26	WOS:000429505000006
J	Lu, BC; Maharbiz, MM				Lu, Bochao; Maharbiz, Michel M.			Germanium as a scalable sacrificial layer for nanoscale protein patterning	PLOS ONE			English	Article							SILICON; DISSOLUTION; BIOCOMPATIBILITY	We demonstrate the use of germanium (Ge) films as water-soluble features that allow the patterning of proteins onto surfaces with commonly used organic solvents. This technique is scalable for manufacturing and is compatible with nano-and microfabrication processes, including standard lithography. We use Ge as a sacrificial layer to mask and protect areas of the substrate during surface functionalization. Since Ge dissolves in 0.35% hydrogen peroxide (H202) in water but not in organic solvents, Ge can be removed after patterning without significantly affecting protein activities. In this paper, we present examples of protein patterning with two different techniques. We show that 50 nm thick Ge layers can be completely removed in 10 min without residues and, importantly, nanoscale resolution and misalignment can be achieved with conventional photolithography equipment. Both biotin and streptavidin maintain-80% and >50% activity after 10 min and 360 min incubation in 0.35% H2O2, respectively. Lastly, the process can be used to functionalize sidewalls with proteins, a capability of recent interest for cell-cell adhesion studies.	[Lu, Bochao; Maharbiz, Michel M.] Univ Calif Berkeley, UC Berkeley UCSF Grad Program Bioengn, Berkeley, CA 94720 USA; [Maharbiz, Michel M.] Univ Calif Berkeley, Elect Engn & Comp Sci Dept, Berkeley, CA 94720 USA; [Maharbiz, Michel M.] Chan Zuckerberg Biohub, San Francisco, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Lu, BC (corresponding author), Univ Calif Berkeley, UC Berkeley UCSF Grad Program Bioengn, Berkeley, CA 94720 USA.	steven_lu@berkeley.edu			Defense Advanced Research Project Agency Advanced Study [HR0011- 16-C-0023]; Berkeley Sensor and Actuator Center; Chan Zuckerberg Biohub; Berkeley Sensor and Actuator Center (BSAC) funds; DARPA Advanced Study [HR0011- 16-C-0023]	Defense Advanced Research Project Agency Advanced Study; Berkeley Sensor and Actuator Center; Chan Zuckerberg Biohub; Berkeley Sensor and Actuator Center (BSAC) funds; DARPA Advanced Study	This work was supported by the Defense Advanced Research Project Agency Advanced Study HR0011- 16-C-0023 (https://www.darpa.mil/); the Berkeley Sensor and Actuator Center (https://www-bsac.eecs.berkeley.edu) and Chan Zuckerberg Biohub (https://www.czbiohub.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by Berkeley Sensor and Actuator Center (BSAC) funds and DARPA Advanced Study HR0011- 16-C-0023. Michel M. Maharbiz is a Chan Zuckerberg Biohub investigator.	Bernard A, 2000, ADV MATER, V12, P1067, DOI 10.1002/1521-4095(200007)12:14<1067::AID-ADMA1067>3.3.CO;2-D; Bernard A, 1998, LANGMUIR, V14, P2225, DOI 10.1021/la980037l; CERNIGLIA N, 1962, J ELECTROCHEM SOC, V109, P508, DOI 10.1149/1.2425457; Chen JR, 2004, BIOTECHNOL ADV, V22, P505, DOI 10.1016/j.biotechadv.2004.03.004; Cohen DJ, 2016, P NATL ACAD SCI USA, V113, P14698, DOI 10.1073/pnas.1612208113; Filipponi L, 2016, BIOMED MICRODEVICES, V18, DOI 10.1007/s10544-016-0036-4; Frasconi M, 2010, ANAL BIOANAL CHEM, V398, P1545, DOI 10.1007/s00216-010-3708-6; Haes AJ, 2002, J AM CHEM SOC, V124, P10596, DOI 10.1021/ja020393x; Han SW, 2013, BIOSENS BIOELECTRON, V45, P129, DOI 10.1016/j.bios.2013.01.062; HARVEY WW, 1958, J ELECTROCHEM SOC, V105, P654, DOI 10.1149/1.2428685; Heck J. M., 2001, POLYCRYSTALLINE SILI; Kang SK, 2015, ACS APPL MATER INTER, V7, P9297, DOI 10.1021/acsami.5b02526; Lan S, 2005, BIOSENS BIOELECTRON, V20, P1697, DOI 10.1016/j.bios.2004.06.025; Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172; Lee SH, 2004, SENSOR ACTUAT B-CHEM, V99, P623, DOI 10.1016/j.snb.2003.11.040; Lu BC, 2017, IEEE ENG MED BIO, P1865, DOI 10.1109/EMBC.2017.8037210; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; Salaita K, 2007, NAT NANOTECHNOL, V2, P145, DOI 10.1038/nnano.2007.39; Sorribas H, 2002, BIOMATERIALS, V23, P893, DOI 10.1016/S0142-9612(01)00199-5; Veiseh M, 2002, LANGMUIR, V18, P6671, DOI 10.1021/la025529j; Yin L, 2014, ADV FUNCT MATER, V24, P645, DOI 10.1002/adfm.201301847; Zhou G., 2013, 2013 Transducers & Eurosensors XXVII: 17th International Conference on Solid-State Sensors, Actuators and Microsystems (TRANSDUCERS & EUROSENSORS XXVII), P2783, DOI 10.1109/Transducers.2013.6627383; Zhou GN, 2015, J PROTEOME RES, V14, P1872, DOI 10.1021/pr501259e; Zoller FA, 2008, MICROELECTRON ENG, V85, P1370, DOI 10.1016/j.mee.2007.12.061	24	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195062	10.1371/journal.pone.0195062	http://dx.doi.org/10.1371/journal.pone.0195062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624587	Green Published, Green Submitted, gold			2022-12-26	WOS:000429379600013
J	Michel, ES; Jenks, JA; Kaskie, KD; Klaver, RW; Jensen, WF				Michel, Eric S.; Jenks, Jonathan A.; Kaskie, Kyle D.; Klaver, Robert W.; Jensen, William F.			Weather and landscape factors affect white-tailed deer neonate survival at ecologically important life stages in the Northern Great Plains	PLOS ONE			English	Article							CONTERMINOUS UNITED-STATES; CAUSE-SPECIFIC MORTALITY; BED-SITE SELECTION; POPULATION-DYNAMICS; SOUTHERN ILLINOIS; COHORT VARIATION; PLANT PHENOLOGY; FAWNS; CLIMATE; PREDATOR	Offspring survival is generally more variable than adult survival and may limit population growth. Although white-tailed deer neonate survival has been intensively investigated, recent work has emphasized how specific cover types influence neonate survival at local scales (single study area). These localized investigations have often led to inconsistences within the literature. Developing specific hypotheses describing the relationships among environmental, habitat, and landscape factors influencing white-tailed deer neonate survival at regional scales may allow for detection of generalized patterns. Therefore, we developed 11 hypotheses representing the various effects of environmental (e.g., winter and spring weather), habitat (e.g., hiding and escape cover types), and landscape factors (e.g., landscape configuration regardless of specific cover type available) on white-tailed deer neonate survival up to one-month and from one-to three-months of age. At one-month, surviving fawns experienced a warmer lowest recorded June temperature and more June precipitation than those that perished. At three-months, patch connectance (percent of patches of the corresponding patch type that are connected within a predefined distance) positively influenced survival. Our results are consistent with white-tailed deer neonate ecology: increased spring temperature and precipitation are likely associated with a flush of nutritional resources available to the mother, promoting increased lactation efficiency and neonate growth early in life. In contrast, reduced spring temperature with increased precipitation place neonates at risk to hypothermia. Increased patch connectance likely reflects increased escape cover available within a neonate's home range after they are able to flee from predators. If suitable escape cover is available on the landscape, then managers could focus efforts towards manipulating landscape configuration (patch connectance) to promote increased neonate survival while monitoring spring weather to assess potential influences on current year survival.	[Michel, Eric S.; Jenks, Jonathan A.; Kaskie, Kyle D.] South Dakota State Univ, Dept Nat Resource Management, Brookings, SD 57007 USA; [Klaver, Robert W.] Iowa State Univ, Iowa Cooperat Fish & Wildlife Res Unit, US Geol Survey, Ames, IA USA; [Jensen, William F.] North Dakota Game & Fish Dept, Bismarck, ND USA	South Dakota State University; Iowa State University; United States Department of the Interior; United States Geological Survey	Michel, ES (corresponding author), South Dakota State Univ, Dept Nat Resource Management, Brookings, SD 57007 USA.	eric.michel@sdstate.edu	Jenks, Jonathan A/B-7321-2009		Federal Aid to Wildlife Restoration [W-67-R-57, W-67-R57]	Federal Aid to Wildlife Restoration	This project was funded by Federal Aid to Wildlife Restoration administered through North Dakota Game and Fish Department (Project W-67-R-57, Study No. C-VIII to WFJ and W-67-R57 to JAJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the North Dakota Game and Fish Department, South Dakota Department of Game, Fish and Parks, the Minnesota Department of Natural Resources, the Department of Natural Resource Management at South Dakota State University, and numerous private landowners, graduate students, and technicians for their help and cooperation with this project. We also thank M. Apollonio, B. Pokorny, and an anonymous reviewer for their helpful comments. This project was funded by Federal Aid to Wildlife Restoration administered through North Dakota Game and Fish Department (Project W-67-R-57, Study No. C-VIII). Any mention of trade, product, or firm names is for descriptive purposes only, and does not imply endorsement by the U.S. Government.	Adams KP, 2011, BIOL MANAGEMENT WHIT; ARMSTRONG RA, 1950, AM MIDL NAT, V43, P650, DOI 10.2307/2421857; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Barton K., 2016, MUMIN MULTIMODEL INF; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; Brinkman TJ, 2005, J WILDLIFE MANAGE, V69, P1099, DOI 10.2193/0022-541X(2005)069[1099:MOFWDE]2.0.CO;2; Brinkman TJ, 2004, WILDLIFE SOC B, V32, P726, DOI 10.2193/0091-7648(2004)032[0726:SOWDIA]2.0.CO;2; Brinkman TJ, 2002, WILDLIFE SOC B, V30, P258; Bryce SA., 1996, ECOREGIONS N DAKOTA; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CARL GR, 1988, CAN J ZOOL, V66, P239, DOI 10.1139/z88-034; Carstensen M, 2009, J WILDLIFE MANAGE, V73, P175, DOI 10.2193/2006-107; Chitwood MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119070; Chitwood MC, 2015, J WILDLIFE MANAGE, V79, P211, DOI 10.1002/jwmg.835; Ciuti S, 2015, J WILDLIFE MANAGE, V79, P1226, DOI 10.1002/jwmg.956; Conner LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137169; Cooch E, 2016, USING MARK GENTLE IN; Cook JG, 2004, WILDLIFE MONOGR, P1; Coulson T, 2000, P ROY SOC B-BIOL SCI, V267, P1771, DOI 10.1098/rspb.2000.1209; Coulson T, 2004, ECOLOGY, V85, P411, DOI 10.1890/03-0009; DOWNING RL, 1969, J WILDLIFE MANAGE, V33, P711, DOI 10.2307/3799399; Eacker DR, 2016, J WILDLIFE MANAGE, V80, P1345, DOI 10.1002/jwmg.21133; Edwards SL, 2004, WILDLIFE SOC B, V32, P739, DOI 10.2193/0091-7648(2004)032[0739:WDFPIM]2.0.CO;2; Forchhammer MC, 2001, J ANIM ECOL, V70, P721, DOI 10.1046/j.0021-8790.2001.00532.x; Forchhammer MC, 2002, POPUL ECOL, V44, P113, DOI 10.1007/s101440200013; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gaillard JM, 1997, OECOLOGIA, V112, P502, DOI 10.1007/s004420050338; Griffin KA, 2011, J ANIM ECOL, V80, P1246, DOI 10.1111/j.1365-2656.2011.01856.x; Grovenburg TW, 2012, J WILDLIFE MANAGE, V76, P944, DOI 10.1002/jwmg.339; Grovenburg TW, 2012, ANIM BEHAV, V84, P59, DOI 10.1016/j.anbehav.2012.04.005; Grovenburg TW, 2012, J WILDLIFE MANAGE, V76, P632, DOI 10.1002/jwmg.288; Grovenburg TW, 2011, J WILDLIFE MANAGE, V75, P213, DOI 10.1002/jwmg.20; Grovenburg TW, 2010, J WILDLIFE MANAGE, V74, P1250, DOI 10.2193/2009-399; Gulsby WD, 2017, J WILDLIFE MANAGE, V81, P601, DOI 10.1002/jwmg.21240; Hao FH, 2012, ENVIRON MODEL ASSESS, V17, P389, DOI 10.1007/s10666-011-9297-8; Haskell SP, 2007, J MAMMAL, V88, P1482, DOI 10.1644/07-MAMM-A-004R.1; Hegel TM, 2010, J ANIM ECOL, V79, P471, DOI 10.1111/j.1365-2656.2009.01647.x; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Hosmer D. W., 2013, APPL LOGISTIC REGRES; HUEGEL CN, 1985, WILDLIFE SOC B, V13, P287; Hurley MA, 2017, J WILDLIFE MANAGE, V81, P364, DOI 10.1002/jwmg.21211; Jacques CN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144026; Johnson JR, 2007, AGR EXPT STATION B; Kilgo JC, 2014, J WILDLIFE MANAGE, V78, P1261, DOI 10.1002/jwmg.764; Kilgo JC, 2012, J WILDLIFE MANAGE, V76, P1420, DOI 10.1002/jwmg.393; Landete-Castillejos T, 2005, BEHAV ECOL SOCIOBIOL, V57, P267, DOI 10.1007/s00265-004-0848-8; Lent P.C., 1974, IUCN Publs (New Series), VNo. 24, P14; Linnell JDC, 1995, WILDLIFE BIOL, V1, P209, DOI 10.2981/wlb.1995.0026; Mcart SH, 2009, ECOLOGY, V90, P1400, DOI 10.1890/08-1435.1; McGarigal K., 2012, TECH REP; Michel ES, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136034; Moratz K. L, 2016, THESIS; NELSON TA, 1987, J WILDLIFE MANAGE, V51, P326, DOI 10.2307/3801010; NOAA: National Centers for Environmental Information, 2016, DAT TOOLS DAIL WEATH; North Dakota Office of Climatology, 2016, N DAK CLIM WEATH; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Pekins PJ, 1998, CAN J ZOOL, V76, P1091, DOI 10.1139/cjz-76-6-1091; Pettorelli N, 2005, BIOL LETT-UK, V1, P24, DOI 10.1098/rsbl.2004.0262; Pettorelli N, 2007, ECOLOGY, V88, P381, DOI 10.1890/06-0875; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; Burroughs JP, 2006, J WILDLIFE MANAGE, V70, P743, DOI 10.2193/0022-541X(2006)70[743:CMASOW]2.0.CO;2; R Core Team, 2013, R LANG ENV STAT COMP; Rohm JH, 2007, J WILDLIFE MANAGE, V71, P851, DOI 10.2193/2006-027; Schaffer Brian A., 2014, Prairie Naturalist, V46, P34; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; Smith BL, 1998, J WILDLIFE MANAGE, V62, P1036, DOI 10.2307/3802556; Sternhagen K. M., 2015, THESIS; Swanson CC, 2008, WILDLIFE BIOL, V14, P272, DOI 10.2981/0909-6396(2008)14[272:DTUOVT]2.0.CO;2; Therrien JF, 2008, ANIM BEHAV, V75, P235, DOI 10.1016/j.anbehav.2007.04.030; Vreeland JK, 2004, WILDLIFE SOC B, V32, P542, DOI 10.2193/0091-7648(2004)32[542:SRMCAH]2.0.CO;2; WHITE M, 1972, J WILDLIFE MANAGE, V36, P897, DOI 10.2307/3799446; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110	74	12	12	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195247	10.1371/journal.pone.0195247	http://dx.doi.org/10.1371/journal.pone.0195247			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621287	gold, Green Submitted, Green Published			2022-12-26	WOS:000429206800052
J	Wang, CH; Li, NN; Wang, H; Yin, HY; Zhao, YW				Wang, Cunhui; Li, Niannian; Wang, Heng; Yin, Hongyan; Zhao, Yunwu			Study on essential drug use status and its influencing factors among cerebral infarction inpatients in county level hospitals of Anhui Province, China	PLOS ONE			English	Article							ESSENTIAL MEDICINES POLICY; LENGTH-OF-STAY; CARE FACILITIES; COST; MORTALITY; STROKE; IMPACT	Background and purpose Drug costs is one of the main components of hospitalization expenditure for cerebral infarction inpatients. In China, the National Essential Medicine System (NEMS) was created to relieve the heavy drug-cost burden for patients. The objective of this study was to investigate essential drug-use status and its influencing factors among cerebral infarction inpatients in county-level hospitals of Anhui province, China. Methods Three county-level hospitals were selected through a multi-stage cluster random sampling method. The hospitalization cost data of cerebral infarction inpatients in the three hospitals were extracted from the Anhui provincial information platform of the New Rural Cooperative Insurance System (NCMS), and whether the proportion of essential drug cost in the total drug cost reached the median value of 33.05% which was set as the evaluation index for essential drug-use status. Questionnaires for hospitals and physicians were designed and given to them to assess influencing factors. Results We retrieved the cost data of 2,189 inpatients from the NCMS platform and investigated 51 corresponding physicians in total. The drug costs accounted for 52.6% of the total hospitalization cost, and essential drug costs alone accounted for 37.0% of the total drug costs. The essential drug-cost proportion was high among physicians with a higher recognition degree on NEMS, older age, lower final academic degree, longer work experience and lower professional title. Married physicians and those with tight organizational affiliation also prescribed more essential drugs. Conclusions Increasing the proportion of essential drugs was an effective way to reduce the disease burden for cerebral infarction patients. Perfecting the NEMS, increasing government investment, reinforcing education and propaganda, and formulating relevant incentive and restrictive mechanisms were all effective ways to promote and increase the number of essential drug prescriptions written by physicians.	[Wang, Cunhui; Wang, Heng; Yin, Hongyan] Anhui Med Univ, Social Sci & Hlth Management Sch, Hefei, Anhui, Peoples R China; [Li, Niannian] Anhui Med Univ, Affiliated Hosp 1, Dept Res Adm, Hefei, Anhui, Peoples R China; [Wang, Heng] Anhui Med Univ, Affiliated Hosp 1, Dept Deams Off, Hefei, Anhui, Peoples R China; [Zhao, Yunwu] Anhui Med Univ, Affiliated Hosp 1, Dept Human Resources, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University	Wang, H (corresponding author), Anhui Med Univ, Social Sci & Hlth Management Sch, Hefei, Anhui, Peoples R China.; Wang, H (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Deams Off, Hefei, Anhui, Peoples R China.	wanghengteam@163.com	Yin, Hong/AAC-5784-2020		National Science Foundation of China [71473003, 71774001]; Young's Culture Plan of the First Affiliated Hospital of Anhui Medical University [2015kj10]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young's Culture Plan of the First Affiliated Hospital of Anhui Medical University	This research was supported by grants from the National Science Foundation of China (No. 71473003; No. 71774001 Received by HW) and Young's Culture Plan of the First Affiliated Hospital of Anhui Medical University (No. 2015kj10; Received by NL). The URL of the National Science Foundation of China is http://www.nsfc.gov.cni The URL of the latter funder is http://www.ayfy.com/menhuweb/show.php?itemid=7555. Neither of the above two funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anhui Provincial Statistics Bureau, 2016, STAT B NAT EC SOC DE; [Anonymous], 2017, AV AG STROK CHIN IS; Bian C, PLOSONE, V10; Chen W, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-211; Eriksen J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014345; Fang Y, 2013, LANCET GLOB HEALTH, V1, pE227, DOI 10.1016/S2214-109X(13)70072-X; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Guan XD, 2011, J PUBLIC HEALTH POL, V32, P305, DOI 10.1057/jphp.2011.34; Gustafsson LL, 2011, BASIC CLIN PHARMACOL, V108, P224, DOI 10.1111/j.1742-7843.2011.00682.x; Kitagawa KT, 2009, STROKE DATA BANK 200, P23; Lee H, 2015, PREV MED, V70, P19, DOI 10.1016/j.ypmed.2014.11.007; Li L, 2008, CHINESE HLTH EC, V27, P79; [李林蔚 Li Linwei], 2015, [中国全科医学, Chinese General Practice], V18, P4239; Ma C., 2015, MOL CELL PROBE, V29, P1; Ma Y, 2010, EUR J NEUROL, V17, P1270, DOI 10.1111/j.1468-1331.2010.03007.x; National Health and Family Planning Commission of China, 2015, CHIN STAT YB HLTH FA; Norman C, 2009, INT J CLIN PRACT, V63, P1320, DOI 10.1111/j.1742-1241.2009.02129.x; Orzella L, 2010, HEALTH POLICY, V95, P236, DOI 10.1016/j.healthpol.2009.12.005; Peltola M, 2015, HEALTH ECON, V24, P38, DOI 10.1002/hec.3264; Rao ML, 2007, GUIDELINES PREVENTIO; Research group of the development research center of the State Council, 2005, CHINA DEV REV CHIN A, VA01, P1; Samsa GP, 1999, STROKE, V30, P338, DOI 10.1161/01.STR.30.2.338; Sekimoto M, 2008, HEALTH POLICY, V88, P100, DOI 10.1016/j.healthpol.2008.01.013; Song Y, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0507-3; Tu F, 2002, HEALTH POLICY, V59, P243, DOI 10.1016/S0168-8510(01)00182-8; Turk AS, 2014, J NEUROINTERV SURG, P1; Wang H, 2012, CHINESE J HLTH POLIC, V5, P30; Wang H, 2012, CHIN J HOSP ADM, V2012, P544; Wang H. Y., 2013, J CONTROL SCI ENG, V2013, P8, DOI DOI 10.1371/J0URNAL.P0NE.0056800; Wang LD., 2016, STROKE PREVENTION CO; Wettermark Bjorn, 2009, Qual Prim Care, V17, P179; WHO, 2002, WHO POL PERSP MED 4, V4; WHO, 2010, INT STAT CLASS DIS R; Xi XY, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1008-8; Xu SM, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1073-z; Yang L, 2013, B WORLD HEALTH ORGAN, V91, P184, DOI 10.2471/BLT.11.097998; Yang LP, 2013, HEALTH POLICY PLANN, V28, P750, DOI 10.1093/heapol/czs116; Yoneda Y, 2003, STROKE, V34, P718, DOI 10.1161/01.STR.0000056171.55342.FF; [于倩倩 Yu Qianqian], 2014, [中国全科医学, Chinese General Practice], V17, P2277; Zhang QY, 2011, PRACTICAL PREVENTIVE, V18, P1593; Zhao YW, 2015, CHINESE MED J-PEKING, V128, P2887, DOI 10.4103/0366-6999.168046; Zou SN, 2015, CHINESE HLTH EC, V34, P72; Zu XL, 2014, CHINESE J HLTH STAT, V26, p[515, 518]; 胡丹, 2014, [中国卫生统计, Chinese Journal of Health Statistics], V31, P707	44	3	3	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0193513	10.1371/journal.pone.0193513	http://dx.doi.org/10.1371/journal.pone.0193513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621245	gold, Green Submitted, Green Published			2022-12-26	WOS:000429206800006
J	Wang, YH; Wu, JY; Kong, SC; Chiang, MH; Ho, ML; Yeh, ML; Chen, CH				Wang, Yan-Hsiung; Wu, Jyun-Yi; Kong, Su Chii; Chiang, Min-Hsuan; Ho, Mei-Ling; Yeh, Ming-Long; Chen, Chia-Hsin			Low power laser irradiation and human adipose-derived stem cell treatments promote bone regeneration in critical-sized calvarial defects in rats	PLOS ONE			English	Article							ENERGY DIODE-LASER; IN-VITRO; THERAPY; TISSUE; PROLIFERATION; REPAIR; DIFFERENTIATION; VIVO	Both stem cell therapy and physical treatments have been shown to be beneficial in accelerating bone healing. However, the efficacy of combined treatment with stem cells and physical stimuli for large bone defects remains uncertain. The aim of this study was to evaluate the bone regeneration effects of low-power laser irradiation (LPLI) and human adipose derived stem cell (ADSC) treatments during fracture repair using a comparative rat calvarial defect model. We evaluated the viability of human ADSCs, which were cultured on a porous PLGA scaffold using an MTS assay. The critical-sized calvarial bone defect rats were divided into 4 groups: control group, LPLI group, ADSC group, and ADSC+LPLI group. Bone formation was evaluated using micro-CT. New bone formation areas and osteogenic factor expression levels were then examined by histomorphological analysis and immunohistochemical staining. Our data showed that PLGA had no cytotoxic effect on human ADSCs. Micro-CT analyses revealed that both the LPLI and ADSC groups showed improved calvarial bone defect healing compared to the control group. In addition, the ADSC+LPLI group showed significantly increased bone volume at 16 weeks after surgery. The area of new bone formation ranked as follows: control group < LPLI group < ADSC group < ADSC+LPLI group. There were significant differences between the groups. In addition, both ADSC and ADSC+LPLI groups showed strong signals of vWF expression. ADSC and LPLI treatments improved fracture repair in critical-sized calvarial defects in rats. Importantly, the combined treatment of ADSCs and LPLI further enhances the bone healing process.	[Wang, Yan-Hsiung; Chiang, Min-Hsuan] Kaohsiung Med Univ, Sch Dent, Coll Dent Med, Kaohsiung, Taiwan; [Wang, Yan-Hsiung; Wu, Jyun-Yi; Kong, Su Chii; Chiang, Min-Hsuan; Ho, Mei-Ling; Chen, Chia-Hsin] Kaohsiung Med Univ, Coll Med, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Wang, Yan-Hsiung; Ho, Mei-Ling] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Wu, Jyun-Yi] Fresenius Kabi Taiwan Ltd, Taipei, Taiwan; [Ho, Mei-Ling] Kaohsiung Med Univ, Dept Physiol, Coll Med, Kaohsiung, Taiwan; [Ho, Mei-Ling] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan; [Yeh, Ming-Long] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan; [Yeh, Ming-Long] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ, Coll Med, Dept Phys Med & Rehabil, Sch Med, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Sun Yat Sen University; National Cheng Kung University; National Cheng Kung University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chen, CH (corresponding author), Kaohsiung Med Univ, Coll Med, Orthopaed Res Ctr, Kaohsiung, Taiwan.; Chen, CH (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Phys Med & Rehabil, Sch Med, Kaohsiung, Taiwan.; Chen, CH (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan.	chchen@kmu.edu.tw	Wang, Yan-Hsiung/ABD-4004-2020	Wang, Yan-Hsiung/0000-0001-8161-7472; Ho, Mei-Ling/0000-0001-8064-8488	Ministry of Economic Affairs, Ministry of Science and Technology [102-EC-17-A-19-S1-176]; ITRI Southern Taiwan Industry Joint Service Center [MOST-104-2314-6-037-059, MOST -105-2314-B-037-012]; Kaohsiung Medical University [KMUTP103808, KMU-TP104811, KMU-TP105611]	Ministry of Economic Affairs, Ministry of Science and Technology; ITRI Southern Taiwan Industry Joint Service Center; Kaohsiung Medical University	We gratefully acknowledge support for this research provided by the Ministry of Economic Affairs, Ministry of Science and Technology, ITRI Southern Taiwan Industry Joint Service Center and Kaohsiung Medical University Aim for the Top Universities Grant under grant numbers 102-EC-17-A-19-S1-176, MOST-104-2314-6-037-059, MOST -105-2314-B-037-012, ST105007, KMUTP103808, KMU-TP104811 and KMU-TP105611, respectively. The funder, Fresenius Kabi Taiwan Ltd., provided support in the form of salaries for J Y Wu, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Ahn TY, 2016, INT J BIOL MACROMOL, V93, P1488, DOI 10.1016/j.ijbiomac.2016.07.027; Amid R, 2014, J LASERS MED SCI, V5, P163; Arinzeh TL, 2003, J BONE JOINT SURG AM, V85A, P1927, DOI 10.2106/00004623-200310000-00010; Asumda FZ, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-44; Barba M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/416391; Barbosa D, 2013, LASER MED SCI, V28, P651, DOI 10.1007/s10103-012-1125-0; Barboza CAG, 2017, INT J EXP PATHOL; Beane OS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115963; Behr B, 2011, STEM CELLS, V29, P286, DOI 10.1002/stem.581; Burastero G, 2010, BONE, V47, P117, DOI 10.1016/j.bone.2010.03.023; Chen HT, 2012, J CELL MOL MED, V16, DOI 10.1111/j.1582-4934.2011.01335.x; Colnot C, 2005, J CELL BIOCHEM, V95, P688, DOI 10.1002/jcb.20449; Costa-Almeida R, 2014, EUR CELLS MATER, V28, P51, DOI 10.22203/eCM.v028a05; David R, 1996, LASER SURG MED, V19, P458, DOI 10.1002/(SICI)1096-9101(1996)19:4<458::AID-LSM12>3.0.CO;2-Z; De Francesco F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006537; de Oliveira FA, 2017, J PHOTOCH PHOTOBIO B, V169, P35, DOI 10.1016/j.jphotobiol.2017.02.020; Desiderio V, 2013, J CELL PHYSIOL, V228, P1762, DOI 10.1002/jcp.24336; Dmitrieva RI, 2012, CELL CYCLE, V11, P377, DOI 10.4161/cc.11.2.18858; Ducy P, 2011, DIABETOLOGIA, V54, P1291, DOI 10.1007/s00125-011-2155-z; El-Maghraby EMF, 2013, ARCH ORAL BIOL, V58, P796, DOI 10.1016/j.archoralbio.2012.10.003; Fujihara NA, 2006, LASER SURG MED, V38, P332, DOI 10.1002/lsm.20298; Gao XJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-4; Geuze RE, 2012, TISSUE ENG PT A, V18, P2052, DOI [10.1089/ten.tea.2011.0560, 10.1089/ten.TEA.2011.0560]; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Kazancioglu HO, 2013, J CRANIOFAC SURG, V24, P2141, DOI 10.1097/SCS.0b013e3182a244ae; Khadra M, 2004, CLIN ORAL IMPLAN RES, V15, P325, DOI 10.1111/j.1600-0501.2004.00994.x; Kim H, 2012, J DERMATOL SCI, V68, P149, DOI 10.1016/j.jdermsci.2012.09.013; Knight MN, 2013, ADV WOUND CARE, V2, P306, DOI 10.1089/wound.2012.0420; Liu YC, 2015, J TISSUE ENG REGEN M, V9, P85, DOI 10.1002/term.1617; Huertas RM, 2014, BIOL RES NURS, V16, P191, DOI 10.1177/1099800413482695; Renno ACM, 2010, PHOTOMED LASER SURG, V28, P131, DOI 10.1089/pho.2009.2487; Nakao N, 2010, AM J PATHOL, V177, P547, DOI 10.2353/ajpath.2010.091042; Nascimento SB, 2010, PHOTOMED LASER SURG, V28, P45, DOI 10.1089/pho.2008.2396; Nauth A, 2012, INDIAN J ORTHOP, V46, P19, DOI 10.4103/0019-5413.91630; Ninomiya T, 2003, J BONE MINER METAB, V21, P67, DOI 10.1007/s007740300011; Nurkovic J, 2017, LASER MED SCI, V32, P151, DOI 10.1007/s10103-016-2097-2; Paino F, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.308; Pretel H, 2007, LASER SURG MED, V39, P788, DOI 10.1002/lsm.20585; Reid IR, 2008, OSTEOPOROSIS INT, V19, P595, DOI 10.1007/s00198-007-0492-z; Rosland GV, 2009, CANCER RES, V69, P5331, DOI 10.1158/0008-5472.CAN-08-4630; Schindl A, 1999, DERMATOLOGY, V198, P314, DOI 10.1159/000018140; SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299, DOI 10.1097/00003086-198604000-00036; Shao J, 2015, BIOL RES, V48, DOI [10.1186/S40659-015-0053-4, 10.1186/s40659-015-0053-4]; Stein A, 2005, PHOTOMED LASER SURG, V23, P161, DOI 10.1089/pho.2005.23.161; Taniguchi D, 2009, LASER SURG MED, V41, P232, DOI 10.1002/lsm.20750; Torricelli P, 2001, BIOMED PHARMACOTHER, V55, P117, DOI 10.1016/S0753-3322(00)00025-1; Wu J., 2013, ADV MATER SCI ENG, V2013, P10, DOI [DOI 10.1016/J.DYEPIG.2013.12.023, DOI 10.1016/J.CARBP0L.2013.10.093]; Wu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054067, 10.1371/journal.pone.0067644]; Wu JY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046393, 10.1371/journal.pone.0044027]; Wu SC, 2010, BIOMATERIALS, V31, P631, DOI 10.1016/j.biomaterials.2009.09.089; Yamada K, 1991, Nihon Seikeigeka Gakkai Zasshi, V65, P787; Zuk, 2013, ISRN STEM CELLS, DOI [10.1155/2013/713959, DOI 10.1155/2013/713959]; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	53	27	27	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195337	10.1371/journal.pone.0195337	http://dx.doi.org/10.1371/journal.pone.0195337			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621288	Green Published, gold, Green Submitted			2022-12-26	WOS:000429206800066
J	Fiore, E; Artuso, F; Gianesella, M; Vecchio, D; Morgante, M; Mazzotta, E; Badon, T; Rossi, P; Bedin, S; Piccione, G				Fiore, Enrico; Artuso, Francesca; Gianesella, Matteo; Vecchio, Domenico; Morgante, Massimo; Mazzotta, Elisa; Badon, Tamara; Rossi, Pasquale; Bedin, Silvia; Piccione, Giuseppe			Metabolic and hormonal adaptation in Bubalus bubalis around calving and early lactation	PLOS ONE			English	Article							NORTHEASTERN UNITED-STATES; NONESTERIFIED FATTY-ACIDS; TRANSITION DAIRY-CATTLE; BETA-HYDROXYBUTYRATE; BLOOD PARAMETERS; MILK-COMPOSITION; BODY CONDITION; COWS; BUFFALOS; PERIOD	Pregnancy and lactation are physiological periods that result in an increased metabolic demand that, if not satisfied, could provoke a threat to homeostasis. In this study changes in the values of Non-Esterified Fatty Acids (NEFA) and p-hydroxybutyrate (BHB), glucose, insulin, thyroid hormones, milk composition and yield were investigated in buffaloes during the late pregnancy and early lactation. From a total of 50 buffaloes, blood samples were collected -7 +/- 5 days before expected calving; +7 +/- 5; +30 +/- 5 and +50 +/- 5 days post-partum; milk samples were collected at the same post-partum time points. On serum samples, the values of Non-Esterified Fatty Acids (NEFA), beta-hydroxybutyrate (BHB), glucose, insulin, Triiodothy-ronine (T3), Thyroxine (T4) and Thyroid-stimulating hormone (TSH) were evaluated. On milk, fat %, protein %, lactose %, somatic cells score (SCS), milk yield and daily milk production (DMP) were assessed. Peripartum period significantly influenced all studied parameters (P<0.05). Milk constituents and productivity statistically changed throughout monitoring period (P<0.005). Milk yield resulted positively correlated with insulin and TSH values, negatively correlated with NEFA and BHB. Insulin was negatively correlated with lactose % and positively correlated with SCS. The obtained results showed that the peripartum period and lactation are accompanied by marked changes in some biochemical variables and in the thyroid hormones values in Italian Mediterranean Buffaloes. Moreover, the relationship found between TSH values and milk yield seems to suggest a possible role of thyroid gland on the maintenance of lactogenesis. This study underlines the importance of monitoring the hormonal status of buffalo during the transition period in order to understand when adjustments of regulatory mechanisms break through physiological limits predisposing the buffalo to metabolic problems.	[Fiore, Enrico; Gianesella, Matteo; Morgante, Massimo; Mazzotta, Elisa; Badon, Tamara; Bedin, Silvia] Univ Padua, Dept Anim Med Prod & Hlth MAPS, Padua, Italy; [Artuso, Francesca; Piccione, Giuseppe] Univ Messina, Polo Univ Annunziata, Dept Vet Sci, Messina, Italy; [Vecchio, Domenico] Ist Zooprofilatt Sperimentale Mezzogiorno, Natl Reference Ctr Water Buffalo Farming & Prod H, Salerno, Italy; [Rossi, Pasquale] Sud Rienergy, Corigliano Calabro, Italy	University of Padua; University of Messina; IZS del Mezzogiorno	Gianesella, M (corresponding author), Univ Padua, Dept Anim Med Prod & Hlth MAPS, Padua, Italy.	matteo.gianesella@unipd.it	FIORE, ENRICO/AAI-9467-2020; Mazzotta, Elisa/AAB-9668-2022; Vecchio, Domenico/I-4102-2013; Fiore, Enrico/CAF-7137-2022	Mazzotta, Elisa/0000-0003-2369-8467; Vecchio, Domenico/0000-0002-8766-7224; Fiore, Enrico/0000-0002-0377-9553; , Matteo/0000-0001-8117-5969				Abdulkareem T.A., 2013, AL ANBAR J VET SCI, V6, P143; Abdulkareem T.A., 2013, J BUFFALO SCI INDIA, V2, P78; Abdulkareem TA, 2012, PAK VET J, V32, P345; Accorsi PA, 2005, REPROD DOMEST ANIM, V40, P217, DOI 10.1111/j.1439-0531.2005.00581.x; AKASHA M, 1984, P SOC EXP BIOL MED, V177, P360, DOI 10.3181/00379727-177-41957; [Anonymous], 2004, ITAL J ANIM SCI, V3, P275; Arfuso F, 2016, ARCH ANIM BREED, V59, P429, DOI 10.5194/aab-59-429-2016; Ashmawy N. A., 2015, Asian Journal of Animal and Veterinary Advances, V10, P271; Ashmawy N.A., 2015, INT J ADV RES, V3, P1377; BAUMAN DE, 1980, J DAIRY SCI, V63, P1514, DOI 10.3168/jds.S0022-0302(80)83111-0; BERTONI G, 1993, EAAP PUBLIC, V62, P270; Bertoni G, 1994, AGRICOLTURA RICERCA, V16, P87; Campanile G., 1997, Bubalus Bubalis, P236; Campanile G, 1995, P 11 NAT C ASPA 19 2, P77; Deka RS, 2014, BIOL TRACE ELEM RES, V161, P57, DOI 10.1007/s12011-014-0069-6; EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0; Fiore E, 2015, ANIMAL PRODUCTION SC, V57, P74; Fiore E, 2017, ANIM SCI J, V88, P2025, DOI 10.1111/asj.12872; Fiore E, 2015, ANIM SCI PAP REP, V33, P129; Hogan J. S., 1999, LAB HDB BOVINE MASTI, Vrev; Holtorf K., 2014, J RESTOR MED, V3, P53, DOI [10.14200/jrm.2014.3.0104, DOI 10.14200/JRM.2014.3.0104]; Huszenicza G, 2002, VET MED-CZECH, V47, P199, DOI 10.17221/5824-VETMED; Medhammar E, 2012, J SCI FOOD AGR, V92, P445, DOI 10.1002/jsfa.4690; Nikolic JA, 1997, ACTA VET-BEOGRAD, V47, P3; Nozad Shahram, 2012, Vet Res Forum, V3, P55; Ospina PA, 2010, J DAIRY SCI, V93, P1596, DOI 10.3168/jds.2009-2852; Ospina PA, 2010, J DAIRY SCI, V93, P546, DOI 10.3168/jds.2009-2277; PETHES G, 1985, J DAIRY SCI, V68, P1148, DOI 10.3168/jds.S0022-0302(85)80941-3; Rosati A, 2002, LIVEST PROD SCI, V74, P185, DOI 10.1016/S0301-6226(01)00293-7; RUCKEBUSCH Y, 1991, PHYSL SMALL LARGE AN; Tsuda T., 1991, PHYSL ASPECTS DIGEST; TYRRELL HF, 1965, J DAIRY SCI, V48, P1215, DOI 10.3168/jds.S0022-0302(65)88430-2; WIGGANS GR, 1987, J DAIRY SCI, V70, P2666, DOI 10.3168/jds.S0022-0302(87)80337-5; WILSON DB, 1980, BIOCHEM BIOPH RES CO, V95, P807, DOI 10.1016/0006-291X(80)90859-1; Youssef MA, 2010, TROP ANIM HEALTH PRO, V42, P1771, DOI 10.1007/s11250-010-9636-9	35	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0193803	10.1371/journal.pone.0193803	http://dx.doi.org/10.1371/journal.pone.0193803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617370	Green Published, Green Submitted, gold			2022-12-26	WOS:000429203800013
J	Prochazka, M; Otero, L; Konda, KA; Gonzalez-Lagos, E; Echevarria, J; Gotuzzo, E				Prochazka, Mateo; Otero, Larissa; Konda, Kelika A.; Gonzalez-Lagos, Elsa; Echevarria, Juan; Gotuzzo, Eduardo			Patient-nominated supporters as facilitators for engagement in HIV care in a referral hospital in Peru: A retrospective cohort study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; COMMUNITY SUPPORT; PEER SUPPORT; FOLLOW-UP; ADHERENCE; RETENTION; DISCLOSURE; HEALTH; IMPACT; STIGMA	Patient-nominated supporters can potentially improve the continuum of HIV care. We retrospectively determined factors associated with having a patient-nominated supporter among people living with HIV (PLWH), and its association with retention in care and viral suppression. We analysed registries of adults evaluated by social workers (n = 1345) at a referral hospital in Peru between 2011-2014. Nondisclosure of HIV status was associated with lacking supporters (aPR: 5.41, 95% CI: 3.83-7.64). Retention in care was 76.4% and 34.2% after one and two years of enrolment, respectively. PLWH with supporters were more likely to be retained in care after two years (aRR = 1.36, 95% CI: 1.02-1.81), but not after one year (aRR = 1.10, 95% CI: 0.98-1.23) compared to PLWH without supporters. Having supporters who were parents or friends was associated with an increased probability of being retained in care after one and two years of enrolment. Viral suppression after one year of enrolment was 58.7%. Having a supporter was not associated with viral suppression (aRR = 1.18, 95% CI: 0.99-1.41), but PLWH with supporters were more likely to have viral load measurements (p = 0.005). Patient-nominated supporters appear beneficial for engagement in HIV care; these benefits may be related to the nature of their relationship with PLWH.	[Prochazka, Mateo; Otero, Larissa; Gonzalez-Lagos, Elsa; Echevarria, Juan; Gotuzzo, Eduardo] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Prochazka, Mateo; Konda, Kelika A.] Univ Peruana Cayetano Heredia, Carlos Vidal Layseca Sch Publ Hlth & Management, Lima, Peru; [Otero, Larissa; Gonzalez-Lagos, Elsa; Echevarria, Juan; Gotuzzo, Eduardo] Univ Peruana Cayetano Heredia, Alberto Hurtado Sch Med, Lima, Peru; [Konda, Kelika A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Konda, Kelika A.] Univ Calif Los Angeles, David Geffen Sch Med, Ctr World Hlth, Los Angeles, CA 90095 USA; [Echevarria, Juan; Gotuzzo, Eduardo] Minist Hlth, Dept Infect Trop & Dermatol Dis, Hosp Cayetano Heredia, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Prochazka, M (corresponding author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru.; Prochazka, M (corresponding author), Univ Peruana Cayetano Heredia, Carlos Vidal Layseca Sch Publ Hlth & Management, Lima, Peru.	mateo.prochazka@upch.pe		Otero, Larissa/0000-0002-8348-4340	Fogarty International Center at the U.S. National Institutes of Health (NIH) through the Program for Advanced Research Capacities for AIDS in Peru (PARACAS) [D43TW00976301]; NIH [U01AI069923]; FOGARTY INTERNATIONAL CENTER [D43TW009763] Funding Source: NIH RePORTER	Fogarty International Center at the U.S. National Institutes of Health (NIH) through the Program for Advanced Research Capacities for AIDS in Peru (PARACAS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was funded by Fogarty International Center at the U.S. National Institutes of Health (NIH) through the Program for Advanced Research Capacities for AIDS in Peru (PARACAS) [grant number D43TW00976301]. Additional data management support was granted by the NIH-funded Caribbean, Central and South America network for HIV epidemiology (CCASAnet), a member cohort of the International Epidemiologic Databases to Evaluate AIDS (leDEA) [grant number U01AI069923]. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer AM, 2017, J HIV AIDS, V3; Bekele T, 2013, AIDS CARE, V25, P337, DOI 10.1080/09540121.2012.701716; Bezabhe WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097353; Bofill LM, 2014, AIDS CARE, V26, P602, DOI 10.1080/09540121.2013.844767; Bradford JB, 2007, AIDS PATIENT CARE ST, V21, pS85, DOI 10.1089/apc.2007.9983; Cakeres CF, 2008, AIDS, V22, pS45, DOI 10.1097/01.aids.0000327436.36161.80; Chang LW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010923; Clark JL, 2015, AIDS BEHAV, V19, P2245, DOI 10.1007/s10461-015-1049-3; Cohen SM, 2014, JAIDS-J ACQ IMM DEF, V67, P519, DOI 10.1097/QAI.0000000000000349; Curioso WH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-13; deSalud M, 2014, NORMA TECNICA SALUD; Duwell MM, 2013, AIDS PATIENT CARE ST, V27, P96, DOI 10.1089/apc.2012.0348; Earnshaw VA, 2015, AIDS BEHAV, V19, P41, DOI 10.1007/s10461-014-0758-3; Ford MA, 2012, MONITORING HIV CARE; Foster SD, 2010, AIDS CARE, V22, P35, DOI 10.1080/09540120903500027; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Frieden TR, 2017, NEW ENGL J MED, V377, P465, DOI 10.1056/NEJMra1614394; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Granich R, 2017, LANCET, V390, P341, DOI 10.1016/S0140-6736(17)31872-X; Greenland S, 2016, INT J EPIDEMIOL, V45, P565, DOI 10.1093/ije/dyw040; Greenland S, 2015, ANNU REV PUBL HEALTH, V36, P89, DOI 10.1146/annurev-publhealth-031914-122559; Hoces D., 2015, OPEN FORUM INFECT DI, V2, DOI [10.1093/ofid/ofv133.282, DOI 10.1093/OFID/OFV133.282]; Karwa R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002355; Lanoy E, 2006, J CLIN EPIDEMIOL, V59, P829, DOI 10.1016/j.jclinepi.2005.11.024; de Mola CL, 2012, SOC PSYCH PSYCH EPID, V47, P967, DOI 10.1007/s00127-011-0404-6; Maher D, 2011, TROP MED INT HEAL; Masquillier C, 2015, AIDS BEHAV, V19, P214, DOI 10.1007/s10461-014-0865-1; Mocroft A, 2008, HIV MED, V9, P261, DOI 10.1111/j.1468-1293.2008.00557.x; Mugavero MJ, 2014, CLIN INFECT DIS, V59, P1471, DOI 10.1093/cid/ciu603; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, pS127, DOI 10.1097/01.qai.0000248349.25630.3d; Nakigozi G, 2015, JAIDS-J ACQ IMM DEF, V70, P75, DOI 10.1097/QAI.0000000000000710; O'Laughlin KN, 2012, AIDS BEHAV, V16, P1308, DOI 10.1007/s10461-011-0038-4; Parsons JT, 2004, AIDS EDUC PREV, V16, P459, DOI 10.1521/aeap.16.5.459.48741; Peltzer K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-111; Pineirua A, 2015, LANCET INFECT DIS, V15, P833, DOI 10.1016/S1473-3099(15)00108-5; Ramirez Durand G., 2008, MANUAL USUARIO EQUIP; Rebeiro PF, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20636; Ruiz I, ENFERM INFECC MICROB, V28, P409; Simoni J. M., 2000, AIDS BEHAV, V4, P147, DOI [10.1023/A:1009508406855, DOI 10.1023/A:1009508406855]; Simoni JM, 2007, HEALTH PSYCHOL, V26, P488, DOI 10.1037/0278-6133.26.4.488; Simoni JM, 2009, JAIDS-J ACQ IMM DEF, V52, P465, DOI 10.1097/QAI.0b013e3181b9300c; Smith R, 2008, AIDS CARE, V20, P1266, DOI 10.1080/09540120801926977; Taylor SE, 2011, OXFORD HDB HLTH PSYC, P936; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; Thompson ML, 1998, OCCUP ENVIRON MED, V55, P272, DOI 10.1136/oem.55.4.272; UNAIDS, 2014, 90 90 90 AMB TREATM; Valdiserri RO, 2013, ASS SCH PUBLIC HLTH, V128, P354; Valenzuela C, 2015, AIDS BEHAV, V19, P235, DOI 10.1007/s10461-014-0908-7; Verre MC, 2014, AIDS BEHAV, V18, P2030, DOI 10.1007/s10461-014-0787-y; Wills TA., 1991, PROSOCIAL BEHAV, P265; World Health Organisation, 2007, WHO CAS DEF HIV SURV; Wouters E, 2009, AIDS CARE, V21, P411, DOI 10.1080/09540120802242077; Wouters E, 2008, AIDS, V22, P2545, DOI 10.1097/QAD.0b013e32831c5562; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	55	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195389	10.1371/journal.pone.0195389	http://dx.doi.org/10.1371/journal.pone.0195389			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617437	gold, Green Submitted, Green Published			2022-12-26	WOS:000429203800080
J	Hani, YMI; Marchand, A; Turies, C; Kerambrun, E; Palluel, O; Bado-Nilles, A; Beaudouin, R; Porcher, JM; Geffard, A; Dedourge-Geffard, O				Hani, Younes Mohamed Ismail; Marchand, Adrien; Turies, Cyril; Kerambrun, Elodie; Palluel, Olivier; Bado-Nilles, Anne; Beaudouin, Remy; Porcher, Jean-Marc; Geffard, Alain; Dedourge-Geffard, Odile			Digestive enzymes and gut morphometric parameters of threespine stickleback (Gasterosteus aculeatus): Influence of body size and temperature	PLOS ONE			English	Article							RUDD SCARDINIUS-ERYTHROPHTHALMUS; PRICKLEBACK FISHES TELEOSTEI; 3-SPINED STICKLEBACK; INTESTINAL-MUCOSA; AMYLOLYTIC ACTIVITY; AMYLASE ACTIVITIES; FOOD-CONSUMPTION; RUTILUS-RUTILUS; ATLANTIC COD; MARINE FISH	Determining digestive enzyme activity is of potential interest to obtain and understand valuable information about fish digestive physiology, since digestion is an elementary process of fish metabolism. We described for the first time (i) three digestive enzymes: amylase, trypsin and intestinal alkaline phosphatase (IAP), and (ii) three gut morphometric parameters: relative gut length (RGL), relative gut mass (RGM) and Zihler's index (ZI) in threespine stickleback (Gasterosteus aculeatus), and we studied the effect of temperature and body size on these parameters. When mimicking seasonal variation in temperature, body size had no effect on digestive enzyme activity. The highest levels of amylase and trypsin activity were observed at 18 degrees C, while the highest IAP activity was recorded at 20 degrees C. When sticklebacks were exposed to three constant temperatures (16, 18 and 21 degrees C), a temporal effect correlated to fish growth was observed with inverse evolution patterns between amylase activity and the activities of trypsin and IAP. Temperature (in both experiments) had no effect on morphometric parameters. However, a temporal variation was recorded for both RGM (in the second experiment) and ZI (in both experiments), and the later was correlated to fish body mass.	[Hani, Younes Mohamed Ismail; Marchand, Adrien; Turies, Cyril; Kerambrun, Elodie; Palluel, Olivier; Bado-Nilles, Anne; Porcher, Jean-Marc; Geffard, Alain; Dedourge-Geffard, Odile] Unite Mixte Rech Stress Environm & Biosurveillanc, Reims, France; [Hani, Younes Mohamed Ismail; Marchand, Adrien; Turies, Cyril; Palluel, Olivier; Bado-Nilles, Anne; Porcher, Jean-Marc] Inst Natl Environm Ind & Risques INERIS, Unite Ecotoxicol Vitro & Vivo ECOT, Verneuil En Halatte, France; [Hani, Younes Mohamed Ismail; Kerambrun, Elodie; Geffard, Alain; Dedourge-Geffard, Odile] URCA, Moulin Housse, Reims, France; [Beaudouin, Remy] Inst Natl Environm Ind & Risques INERIS, Unite Modeles Ecotoxicol & Toxicol METO, Verneuil En Halatte, France	Universite de Reims Champagne-Ardenne; Institut National de l'Environnement Industriel et des Risques (INERIS); Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne; Institut National de l'Environnement Industriel et des Risques (INERIS); Universite de Reims Champagne-Ardenne	Dedourge-Geffard, O (corresponding author), Unite Mixte Rech Stress Environm & Biosurveillanc, Reims, France.; Dedourge-Geffard, O (corresponding author), URCA, Moulin Housse, Reims, France.	odile.dedourge@univ-reims.fr	PALLUEL, Olivier/R-3225-2018; Beaudouin, Rémy/H-1491-2012; HANI, Younes/H-7802-2018; Porcher, Jean-Marc/S-7342-2018; Bado-Nilles, Anne/Q-8563-2018	PALLUEL, Olivier/0000-0001-5372-4852; Beaudouin, Rémy/0000-0002-2855-1571; HANI, Younes/0000-0002-9892-0715; Porcher, Jean-Marc/0000-0002-4135-3078; Bado-Nilles, Anne/0000-0002-4776-9592; Geffard, Alain/0000-0001-9236-2890; Dedourge-Geffard, Odile/0000-0001-6308-2080; TURIES, Cyril/0000-0002-6238-4885	University of Reims Champagne-Ardenne; P190 Ecotoxicology Program of the French Ministry for Ecology and Sustainable Development	University of Reims Champagne-Ardenne; P190 Ecotoxicology Program of the French Ministry for Ecology and Sustainable Development	This work was partly supported by the University of Reims Champagne-Ardenne and the financial support of the P190 Ecotoxicology Program of the French Ministry for Ecology and Sustainable Development.	Ahmad T, 2014, AQUACULT NUTR, V20, P265, DOI 10.1111/anu.12072; AL-HUSSAINI A. H., 1949, QUART JOUR MICROSC SCI, V90, P109; ALLEN JRM, 1984, FRESHWATER BIOL, V14, P335, DOI 10.1111/j.1365-2427.1984.tb00158.x; [Anonymous], [No title captured]; Bado-Nilles A, 2014, ENVIRON TOXICOL PHAR, V38, P672, DOI 10.1016/j.etap.2014.08.002; Barlow GW, 2002, FISH FISH, V3, P197, DOI 10.1046/j.1467-2979.2002.00083.x; Blier PU, 2002, AQUACULTURE, V209, P379, DOI 10.1016/S0044-8486(01)00807-9; Bone Q., 2008, BIOL FISHES, DOI [10.1201/9781134186310, DOI 10.1201/9781134186310]; Bowyer JN, 2014, AQUAC RES, V45, P2010, DOI 10.1111/are.12146; Cahu C, 2007, CYBIUM, V31, P217; Caruso G, 2014, FISH PHYSIOL BIOCHEM, V40, P1373, DOI 10.1007/s10695-014-9931-x; Debnath D, 2007, COMP BIOCHEM PHYS B, V146, P107, DOI 10.1016/j.cbpb.2006.09.008; Dedourge O, 2008, ORIGINE PERTURBATION, p[243, 94]; Dedourge-Geffard O, 2009, CHEMOSPHERE, V77, P1569, DOI 10.1016/j.chemosphere.2009.09.042; ENRE (Equipe nationale de retablissement des paires d'especes d'epinoches), 2007, SER PROGR RET LOI ES; GARCIACARRENO FL, 1993, J FOOD BIOCHEM, V17, P97, DOI 10.1111/j.1745-4514.1993.tb00864.x; Gelman Alexander, 2008, P155; German DP, 2006, MAR BIOL, V148, P1123, DOI 10.1007/s00227-005-0149-4; German DP, 2004, PHYSIOL BIOCHEM ZOOL, V77, P789, DOI 10.1086/422228; German DP, 2003, DIGESTIVE ENZYME ACT; Golovanova IL, 2013, FISH PHYSIOL BIOCHEM, V39, P1497, DOI 10.1007/s10695-013-9803-9; Guderley Helga E., 1994, P85; Hidalgo MC, 1999, AQUACULTURE, V170, P267, DOI 10.1016/S0044-8486(98)00413-X; HOFER R, 1979, J FISH BIOL, V15, P373, DOI 10.1111/j.1095-8649.1979.tb03619.x; HOFER R, 1979, J FISH BIOL, V14, P565, DOI 10.1111/j.1095-8649.1979.tb03556.x; Hovel RA, 2015, T AM FISH SOC, V144, P1311, DOI 10.1080/00028487.2015.1079554; HTUNHAN M, 1978, J FISH BIOL, V13, P369, DOI 10.1111/j.1095-8649.1978.tb03445.x; Imsland AK, 2002, FISH FISH, V3, P36, DOI 10.1046/j.1467-2979.2002.00070.x; Infante JLZ, 2007, AQUACULTURE, V268, P98, DOI 10.1016/j.aquaculture.2007.04.032; INFANTE JLZ, 1994, COMP BIOCHEM PHYS A, V109, P209, DOI 10.1016/0300-9629(94)90122-8; IPCC, 2013, CLIM CHANG PHYS SCI; Jolles JW, 2016, J FISH BIOL, V88, P1661, DOI 10.1111/jfb.12934; JORDAN CM, 1972, CAN J ZOOLOG, V50, P1405, DOI 10.1139/z72-189; Junge W, 2001, CLIN BIOCHEM, V34, P607, DOI 10.1016/S0009-9120(01)00278-8; Karachle PK, 2010, MARINE BIODIVERSITY, P3; Karasov HW, 2013, COMP DIGESTIVE PHYSL; Klepsatel P, 2016, SCI REPORTS, P6; Kofuji PYM, 2005, AQUAC RES, V36, P696, DOI 10.1111/j.1365-2109.2005.01276.x; KRAMER DL, 1995, ENVIRON BIOL FISH, V42, P129, DOI 10.1007/BF00001991; Kuz'mina V, 2003, COMP BIOCHEM PHYS B, V134, P529, DOI 10.1016/S1096-4959(03)00005-8; Kuzmina VV, 1996, AQUACULTURE, V148, P25, DOI 10.1016/S0044-8486(96)01370-1; Kuzmina VV, 1996, COMP BIOCHEM PHYS B, V113, P255, DOI 10.1016/0305-0491(95)02019-5; Langeland T.L.M., 2013, J AQUAC RES DEV, V5, P1, DOI [10.4172/2155-9546.1000208, DOI 10.4172/2155-9546.1000208]; Le Guernic A, 2016, FISH PHYSIOL BIOCHEM, V42, P643, DOI 10.1007/s10695-015-0166-2; Lefebure R, 2014, J EXP MAR BIOL ECOL, V451, P82, DOI 10.1016/j.jembe.2013.11.008; Leloutre C, 2016, ECOLOGY FRESHWATER F; Lemieux H, 1999, FISH PHYSIOL BIOCHEM, V20, P293, DOI 10.1023/A:1007791019523; Pujante IM, 2017, AQUAC RES, V48, P367, DOI 10.1111/are.13038; Miegel RP, 2010, AQUACULTURE, V308, P145, DOI 10.1016/j.aquaculture.2010.07.036; MITCHELL MA, 1992, COMP BIOCHEM PHYS A, V101, P137, DOI 10.1016/0300-9629(92)90641-3; Nespolo RF, 2002, J EXP BIOL, V205, P2697; Pantegini M, 2008, TIETZ FUNDAMENTALS C, P317; Rungruangsak-Torrissen K, 2006, FISH PHYSIOL BIOCHEM, V32, P7, DOI 10.1007/s10695-005-0630-5; Sanchez W, 2008, ENVIRON INT, V34, P490, DOI 10.1016/j.envint.2007.11.003; Shan XJ, 2008, AQUACULTURE, V281, P70, DOI 10.1016/j.aquaculture.2008.05.034; Smith C., 2009, FISH FISH, V10, P354; Solovyev M, 2016, FISH PHYSIOL BIOCHEM, V42, P1383, DOI 10.1007/s10695-016-0226-2; Wagner CE, 2009, FUNCT ECOL, V23, P1122, DOI 10.1111/j.1365-2435.2009.01589.x; Wootton R.J., 1994, P114; Wootton R. J., 1984, FUNCTIONAL BIOL STIC; Wootton R.J., 1976, BIOL STICKLEBACKS; Zeyl JN, 2014, J GREAT LAKES RES, V40, P164, DOI 10.1016/j.jglr.2013.12.004; Zihler F., 1981, NETHERLANDS J ZOOLOG, V32, P544, DOI [10.1163/002829682X00210, DOI 10.1163/002829682X00210]	63	20	21	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194932	10.1371/journal.pone.0194932	http://dx.doi.org/10.1371/journal.pone.0194932			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614133	Green Submitted, Green Published, gold			2022-12-26	WOS:000429081600021
J	Ludecke, D; Bien, B; McKee, K; Krevers, B; Mestheneos, E; Di Rose, M; von dem Knesebeckl, O; Kofahl, C				Luedecke, Daniel; Bien, Barbara; McKee, Kevin; Krevers, Barbro; Mestheneos, Elizabeth; Di Rose, Mirko; von dem Knesebeckl, Olaf; Kofahl, Christopher			For better or worse: Factors predicting outcomes of family care of older people over a one-year period. A six-country European study	PLOS ONE			English	Article							CAREGIVER BURDEN; INFORMAL CAREGIVERS; SUPPORT SERVICES; ELDERLY PARENTS; HOME-CARE; DEMENTIA; QUALITY	Objectives Demographic change has led to an increase of older people in need of long-term care in nearly all European countries. Informal carers primarily provide the care and support needed by dependent people. The supply and willingness of individuals to act as carers are critical to sustain informal care resources as part of the home health care provision. This paper describes a longitudinal study of informal care in six European countries and reports analyses that determine those factors predicting the outcomes of family care over a one-year period. Methods Analyses are based on data from the EUROFAMCARE project, a longitudinal survey study of family carers of older people with baseline data collection in 2004 and follow-up data collection a year later in six European countries (Germany, Greece, Italy, Poland, Sweden, and the United Kingdom), N = 3,348. Descriptive statistics of the sample characteristics are reported. Binary logistic random-intercept regressions were computed, predicting the outcome of change of the care dyad's status at follow-up. Results Where care is provided by a more distant family member or by a friend or neighbour, the care-recipient is significantly more likely to be cared for by someone else (OR 1.62) or to be in residential care (OR 3.37) after one year. The same holds true if the care-recipient has memory problems with a dementia diagnosis (OR 1.79/OR 1.84). Higher dependency (OR 1.22) and behavioural problems (OR 1.76) in the care-recipient also lead to a change of care dyad status. Country of residence explained a relatively small amount of variance (8%) in whether a care-recipient was cared for by someone else after one year, but explained a substantial amount of variance (52%) in whether a care-recipient was in residential care. Particularly in Sweden, care-recipients are much more likely to be cared for by another family or professional carer or to be in residential care, whereas in Greece the status of the care dyad is much less likely to change. Discussion The majority of family carers continued to provide care to their respective older relatives over a one-year period, despite often high levels of functional, cognitive and behavioural problems in the care-recipient. Those family carers could benefit most from appropriate support. The carer/care-recipient relationship plays an important role in whether or not a family care dyad remains intact over a one-year period. The support of health and social care services should be particularly targeted toward those care dyads where there is no partner or spouse acting as carer, or no extended family network that might absorb the caring role when required. Distant relatives, friends or acquaintances who are acting as carers might need substantial intervention if their caregiving role is to be maintained.	[Luedecke, Daniel; von dem Knesebeckl, Olaf; Kofahl, Christopher] Univ Med Ctr Hamburg Eppendorf, Dept Med Sociol, Martinistr, Hamburg, Germany; [Bien, Barbara] Med Univ Bialystok, Dept Geriatr, Bialystok, Poland; [McKee, Kevin] Dalarna Univ, Sch Educ Hlth & Social Studies, Falun, Sweden; [Krevers, Barbro] Linkoping Univ, Div Hlth Care Anal, Dept Med & Hlth Sci, Linkoping, Sweden; [Mestheneos, Elizabeth] 50 Hellas, Ammohostou 6, Halandri Attiki, Greece; [Di Rose, Mirko] Natl Inst Hlth & Sci Aging, Ancona, Italy	University of Hamburg; University Medical Center Hamburg-Eppendorf; Medical University of Bialystok; Dalarna University; Linkoping University	Ludecke, D (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Sociol, Martinistr, Hamburg, Germany.	d.luedecke@uke.de	Kofahl, Christopher/AGZ-7071-2022; Di Rosa, Mirko/J-5974-2016	Di Rosa, Mirko/0000-0002-1862-4159; Bien, Barbara/0000-0002-2953-989X; Kofahl, Christopher/0000-0002-0503-3077; von dem Knesebeck, Olaf/0000-0001-6310-5879; Ludecke, Daniel/0000-0002-8895-3206	EU [QLK6-CT-2002-02647]	EU(European Commission)	The EUROFAMCARE project was funded by the EU (contract no.: QLK6-CT-2002-02647), FP5. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsson M, 2016, HOUS THEORY SOC, V33, P217, DOI 10.1080/14036096.2015.1104385; Alber J, 2004, HLTH CARE ENLARGED E; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bien B, 2008, FAMILY CARERS OLDER, P233; Bien B, 2013, EUR J PUBLIC HEALTH, V23, P1032, DOI 10.1093/eurpub/cks190; Bonsang E, 2009, J HEALTH ECON, V28, P143, DOI 10.1016/j.jhealeco.2008.09.002; Bouget D, 2016, WORK LIFE BALANCE ME, P74; Brodaty H, 2014, J ALZHEIMERS DIS, V40, P221, DOI 10.3233/JAD-131850; Carretero S, 2009, ARCH GERONTOL GERIAT, V49, P74, DOI 10.1016/j.archger.2008.05.004; Chen QX, 2015, STAT MED, V34, P3637, DOI 10.1002/sim.6618; Chiao CY, 2015, INT NURS REV, V62, P340, DOI 10.1111/inr.12194; Crespo L, 2014, REV ECON STAT, V96, P693, DOI 10.1162/REST_a_00426; Delalibera M, 2015, CIENC SAUDE COLETIVA, V20, P2731, DOI 10.1590/1413-81232015209.09562014; Dilworth-Anderson P, 2007, J APPL GERONTOL, V26, P355, DOI 10.1177/0733464807302669; Epps F, 2015, J RELIG SPIRITUAL A, V27, P166, DOI 10.1080/15528030.2014.971141; Farre M, 2016, INT J NURS STUD, V55, P39, DOI 10.1016/j.ijnurstu.2015.10.012; Frericks P, 2014, J AGING STUD, V29, P66, DOI 10.1016/j.jaging.2013.12.002; Fulmer T, 2005, GERONTOLOGIST, V45, P525, DOI 10.1093/geront/45.4.525; Genet N, 2013, HEALTH POLICY, V110, P84, DOI 10.1016/j.healthpol.2013.01.009; Genet N, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-207; Hajek A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148916; Hajek A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144203; Hochgraeber I, 2015, DEMENTIA; Hodge DR, 2012, AGING MENT HEALTH, V16, P689, DOI 10.1080/13607863.2012.678481; Jeong YG, 2015, J PHYS THER SCI, V27, P1543, DOI 10.1589/jpts.27.1543; Kalwij A, 2014, REV ECON HOUSEHOLD, V12, P379, DOI 10.1007/s11150-012-9159-4; Keady J, 1996, J Psychiatr Ment Health Nurs, V3, P163, DOI 10.1111/j.1365-2850.1996.tb00083.x; Keating NC, 2014, J ECON AGEING, V3, P11, DOI 10.1016/j.jeoa.2014.03.002; Kehusmaa S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-317; Kofahl C, 2009, PFLEGE GESELLSCHAFT, V3, P236; Kofahl C., 2008, EUROPAISCHE PERSPEKT, P130; Kohler S, 2012, QUALITATIVE UNTERSUC, p293 ; Kommission Europaische, 2007, LIV COND EUR DAT 200; Lamura G, 2006, Z GERONTOL GERIATR, V39, P429, DOI 10.1007/s00391-006-0416-0; Lamura G, 2008, GERONTOLOGIST, V48, P752, DOI 10.1093/geront/48.6.752; Lamura Giovanni, 2008, FAMILY CARERS OLDER; Ldecke D., 2014, HLTH CARE UTILIZATIO, P171, DOI [10.1007/978-1-4614-9191-0_10, DOI 10.1007/978-1-4614-9191-0_10]; Conde-Sala JL, 2010, INT J NURS STUD, V47, P1262, DOI 10.1016/j.ijnurstu.2010.03.001; Ludecke D., 2018, SJPLOT DATA VISUALIZ; McKee K, 2008, FAMILY CARERS OLDER, P49; McKee KJ, 2003, AGING MENT HEALTH, V7, P39, DOI 10.1080/1360786021000006956; Mestheneos E, 2005, SUPPORTING FAMILY CA, V1; Mortazavi Hamed, 2015, Int J Community Based Nurs Midwifery, V3, P187; Oberg B, 2008, FAMILY CARERS OLDER, P75; Park M, 2015, INT PSYCHOGERIATR, V27, P1355, DOI 10.1017/S1041610215000460; R Core Team, 2021, R LANGUAGE ENV STAT; Romero-Moreno R, 2011, INT PSYCHOGERIATR, V23, P573, DOI 10.1017/S1041610210001821; Shahly V., 2012, PSYCHOL MED, V9, P1; Stones D, 2016, AGEING SOC, V36, P449, DOI 10.1017/S0144686X14001214; Sutcliffe CL, 2015, INT J GERIATR PSYCHI; Wang YN, 2011, J ADV NURS, V67, P829, DOI 10.1111/j.1365-2648.2010.05505.x; Wu S, 2012, CONTEMP CLIN TRIALS, V33, P869, DOI 10.1016/j.cct.2012.05.004; Wun LM, 2007, STAT MED, V26, P1875, DOI 10.1002/sim.2809	53	17	17	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195294	10.1371/journal.pone.0195294	http://dx.doi.org/10.1371/journal.pone.0195294			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB5DC	29614108	Green Submitted, gold, Green Published			2022-12-26	WOS:000429081600041
J	Otim, MH; Tay, WT; Walsh, TK; Kanyesigye, D; Adumo, S; Abongosi, J; Ochen, S; Sserumaga, J; Alibu, S; Abalo, G; Asea, G; Agona, A				Otim, Michael H.; Tay, Wee Tek; Walsh, Thomas K.; Kanyesigye, Dalton; Adumo, Stella; Abongosi, Joseph; Ochen, Stephen; Sserumaga, Julius; Alibu, Simon; Abalo, Grace; Asea, Godfrey; Agona, Ambrose			Detection of sister-species in invasive populations of the fall armyworm Spodoptera frugiperda (Lepidoptera: Noctuidae) from Uganda	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA LEPIDOPTERA; FIELD-EVOLVED RESISTANCE; BT MAIZE; INSECTICIDE RESISTANCE; REPRODUCTIVE ISOLATION; HUBNER LEPIDOPTERA; HOST STRAINS; PEST; DNA; PATTERNS	The fall armyworm (FAW) Spodoptera frugiperda (J. E. Smith) is a species native to the Americas. This polyphagous lepidopteran pest was first reported in Nigeria and the Democratic Republic of Sao Tome and Principe in 2016, but its presence in eastern Africa has not been confirmed via molecular characterisation. In this study, FAW specimens from western and central Uganda were identified based on the partial mtDNA COI gene sequences, with mtDNA COI haplotypes matching those identified in Nigeria and Sao Tome. In this study, we sequence an additional partial mtDNA Cyt b gene and also the partial mtDNA COIII gene in Ugandan FAW samples. We detected identical mitochondrial DNA haplotypes for both the mtDNA Cyt b and COI partial genes, while combining the mtDNA COI/Cyt b haplotypes and mtDNA COIII haplotypes enabled a new maternal lineage in the Ugandan corn-preferred FAW samples to be identified. Our results suggested that the African incursions of S. frugiperda involved at least three maternal lineages. Recent full genome, phylogenetic and microsatellite analyses provided evidence to support S. frugiperda as likely consisted of two sympatric sister species known as the corn-preferred and rice-preferred strains. In our Ugandan FAW populations, we identified the presence of mtDNA haplotypes representative of both sister species. It is not known if both FAW sister species were originally introduced together or separately, and whether they have since spread as a single population. Further analyses of additional specimens originally collected from Sao Tome, Nigeria and throughout Africa would be required to clarify this issue. Importantly, our finding showed that the genetic diversity of the African corn-preferred FAW species is higher than previously reported. This potentially contributed to the success of FAW establishment in Africa. Furthermore, with the additional maternal lineages detected, there is likely an increase in paternal lineages, thereby increasing the diversity of the African FAW population. Knowledge of the FAW genetic diversity will be needed to assess the risks of introducing Bt-resistance traits and to understand the FAW incursion pathways into the Old World and its potential onward spread. The agricultural implications of the presence of two evolutionary divergent FAW lineages (the corn and the rice lineage) in the African continent are further considered and discussed.	[Otim, Michael H.; Kanyesigye, Dalton; Adumo, Stella; Abongosi, Joseph; Ochen, Stephen; Sserumaga, Julius; Alibu, Simon; Abalo, Grace; Asea, Godfrey] Natl Crops Resources Res Inst, Kampala, Uganda; [Tay, Wee Tek; Walsh, Thomas K.] CSIRO, Canberra, ACT, Australia; [Agona, Ambrose] Natl Agr Res Org, Entebbe, Uganda	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Otim, MH (corresponding author), Natl Crops Resources Res Inst, Kampala, Uganda.	motim9405@gmail.com	Walsh, Thomas K/C-1263-2009; Tay, Wee Tek/GPF-6142-2022; Sserumaga, Julius Pyton/AAN-7162-2020; Kanyesigye, Dalton/CAH-6903-2022; Otim, Michael/ABF-9389-2021; Tay, Wee Tek/C-1818-2008	Walsh, Thomas K/0000-0001-8425-0135; Tay, Wee Tek/0000-0002-8451-0811; Sserumaga, Julius Pyton/0000-0001-5152-2835; Otim, Michael/0000-0001-5406-012X; Tay, Wee Tek/0000-0002-8451-0811; Kanyesigye, Dalton/0000-0003-3035-2835; Alibu, Simon/0000-0003-2708-0293	Agricultural Technology and Agribusiness Advisory Services Project - World Bank [P109224]; CSIRO Health and Biosecurity [R-8681-1]; CSIRO Land and Water	Agricultural Technology and Agribusiness Advisory Services Project - World Bank; CSIRO Health and Biosecurity; CSIRO Land and Water(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	MHO acknowledges funding from the Agricultural Technology and Agribusiness Advisory Services Project (Project ID No.: P109224) funded by the World Bank. WTT and TKW acknowledged funding support from CSIRO Health and Biosecurity (R-8681-1) and CSIRO Land and Water.	Abo-Elghar GE, 2004, INSECT BIOCHEM MOLEC, V34, P743, DOI 10.1016/j.ibmb.2004.03.009; Adamczyk JJ, 1999, FLA ENTOMOL, V82, P230, DOI 10.2307/3496574; Anderson CJ, 2016, MOL ECOL, V25, P5296, DOI 10.1111/mec.13841; Arnemann JA, 2016, GENET MOL RES, V15; Arneodo JD, 2015, J ECON ENTOMOL, V108, P2505, DOI 10.1093/jee/tov254; Ascunce MS, 2011, SCIENCE, V331, P1066, DOI 10.1126/science.1198734; Behere GT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-117; Bowden J., 1976, P97; Carvalho RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062268; Chown SL, 2015, EVOL APPL, V8, P23, DOI 10.1111/eva.12234; Cock MJW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04238-y; Czepak Cecília, 2013, Pesqui. Agropecu. Trop., V43, P110, DOI 10.1590/S1983-40632013000100015; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Diez-Rodriguez Gabriela I., 2001, Neotropical Entomology, V30, P311, DOI 10.1590/S1519-566X2001000200016; Downes S, 2016, CURR OPIN INSECT SCI, V15, P78, DOI 10.1016/j.cois.2016.04.002; Dumas P, 2015, GENETICA, V143, P305, DOI 10.1007/s10709-015-9829-2; Dumas P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122407; European Union, 2017, EUR INT EUR UN NOT S; European Union, 2016, EUR INT EUR UN NOT S; European Union, 2016, EUR UN ANN REP 2015; European Union, 2015, EUR INT EUR UN NOT S; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Feng HQ, 2009, J ECON ENTOMOL, V102, P95, DOI 10.1603/029.102.0114; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FRENCH RA, 1969, J ANIM ECOL, V38, P199, DOI 10.2307/2746; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Murua MG, 2014, FLA ENTOMOL, V97, P854, DOI 10.1653/024.097.0279; Goergen G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165632; Gouin A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10461-4; Groot AT, 2010, ECOL ENTOMOL, V35, P105, DOI 10.1111/j.1365-2311.2009.01138.x; Groot AT, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-20; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harper GA, 2015, GLOB ECOL CONSERV, V3, P607, DOI 10.1016/j.gecco.2015.02.010; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hayden J. E, 2015, FDACS02039 DIV PLANT; Hess Jon E., 2009, Aquatic Invasions, V4, P299, DOI 10.3391/ai.2009.4.2.1; Huang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112958; Jakka SRK, 2014, J INVERTEBR PATHOL, V122, P52, DOI 10.1016/j.jip.2014.08.009; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kergoat GJ, 2012, MOL PHYLOGENET EVOL, V65, P855, DOI 10.1016/j.ympev.2012.08.006; Kriticos DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119618; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Ledezma LA, 2016, J ECON ENTOMOL, V109, P1957, DOI 10.1093/jee/tow111; Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149; Leite NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113286; Liu QN, 2016, GENES GENOM, V38, P205, DOI 10.1007/s13258-015-0346-6; MARTIN JA, 1989, ANN ENTOMOL SOC AM, V82, P177, DOI 10.1093/aesa/82.2.177; Mastrangelo T, 2014, J ECON ENTOMOL, V107, P970, DOI 10.1603/EC13403; MCCORD E, 1987, PESTIC BIOCHEM PHYS, V27, P114, DOI 10.1016/0048-3575(87)90103-9; Meagher RL, 2004, FLA ENTOMOL, V87, P454, DOI 10.1653/0015-4040(2004)087[0454:LDOFAL]2.0.CO;2; Nagoshi RN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181982; Nagoshi RN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171743; Niu Y., 2014, RESISTANCE FALL ARMY; OOI BG, 1988, VIROLOGY, V166, P515, DOI 10.1016/0042-6822(88)90522-3; Os JDR, 2011, J ECON ENTOMOL, V104, P1698; Paini DR, 2016, P NATL ACAD SCI USA, V113, P7575, DOI 10.1073/pnas.1602205113; PASHLEY DP, 1987, ANN ENTOMOL SOC AM, V80, P731, DOI 10.1093/aesa/80.6.731; PASHLEY DP, 1986, ANN ENTOMOL SOC AM, V79, P898, DOI 10.1093/aesa/79.6.898; PASHLEY DP, 1985, ANN ENTOMOL SOC AM, V78, P756, DOI 10.1093/aesa/78.6.756; Pea Abrahams, FALL ARMYWORM STATUS; Pearce SL, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0413-3; Pearce SL, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0402-6; PHA Ltd, 2007, IND BIOS PLAN VEG IN; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; QUISENBERRY SS, 1991, FLA ENTOMOL, V74, P194, DOI 10.2307/3495297; Schofl G, 2011, AM NAT, V177, P470, DOI 10.1086/658904; Seymour PR, 1985, INSECTS OTHER INVERT; Sosa-Gomez DR, 2016, REV BRAS ENTOMOL, V60, P101, DOI 10.1016/j.rbe.2015.09.008; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Staden R, 2000, Methods Mol Biol, V132, P115; Storer NP, 2012, J INVERTEBR PATHOL, V110, P294, DOI 10.1016/j.jip.2012.04.007; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tay WT, 2008, B ENTOMOL RES, V98, P509, DOI 10.1017/S000748530800583X; Tay WT, 2017, SCI REP-UK, V7, DOI 10.1038/srep45302; Tay WT, 2016, PEST MANAG SCI, V72, P1250, DOI 10.1002/ps.3805; Tay WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080134; URQUHART FA, 1978, CAN J ZOOL, V56, P1759, DOI 10.1139/z78-240; Vassal Jean-Michel, 2008, Commun Agric Appl Biol Sci, V73, P433; Velasquez-Velez MI, 2011, ANN ENTOMOL SOC AM, V104, P826, DOI 10.1603/AN10164; Venette R. C., 2003, MINIRISK ASSESSMENT; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wan XL, 2013, MOL BIOL REP, V40, P6333, DOI 10.1007/s11033-013-2748-3; Wild S, 2017, NATURE, V543, P13, DOI 10.1038/nature.2017.21527; Wu QL, 2013, MITOCHONDR DNA, V24, P31, DOI 10.3109/19401736.2012.716052; Yano E., 2016, SCIENCES, VX, P4; YOUNG JR, 1979, J ECON ENTOMOL, V72, P202, DOI 10.1093/jee/72.2.202; YU SJ, 1992, J ECON ENTOMOL, V85, P675, DOI 10.1093/jee/85.3.675; YU SJ, 1991, PESTIC BIOCHEM PHYS, V39, P84, DOI 10.1016/0048-3575(91)90216-9; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zhu YC, 2015, PESTIC BIOCHEM PHYS, V122, P15, DOI 10.1016/j.pestbp.2015.01.007	91	44	50	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194571	10.1371/journal.pone.0194571	http://dx.doi.org/10.1371/journal.pone.0194571			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614067	gold, Green Published, Green Submitted			2022-12-26	WOS:000429081600013
J	Pokholkova, GV; Demakov, SA; Andreenkov, OV; Andreenkova, NG; Volkova, EI; Belyaeva, ES; Zhimulev, IF				Pokholkova, Galina V.; Demakov, Sergei A.; Andreenkov, Oleg V.; Andreenkova, Natalia G.; Volkova, Elena I.; Belyaeva, Elena S.; Zhimulev, Igor F.			Tethering of CHROMATOR and dCTCF proteins results in decompaction of condensed bands in the Drosophila melanogaster polytene chromosomes but does not affect their transcription and replication timing	PLOS ONE			English	Article							INTERCALARY HETEROCHROMATIN; CHROMODOMAIN PROTEIN; INSULATOR PROTEINS; GENE-EXPRESSION; DNA-REPLICATION; GENOME; DOMAINS; UNDERREPLICATION; ORGANIZATION; DECONDENSATION	Instulator proteins are central to domain organization and gene regulation in the genome. We used ectopic tethering of CHROMATOR (CHRIZ/CHRO) and dCTCF to pre-defined regions of the genome to dissect the influence of these proteins on local chromatin organization, to analyze their interaction with other key chromatin proteins and to evaluate the effects on transcription and replication. Specifically, using UAS-GAL4DBD system, CHRO and dCTCF were artificially recruited into highly compacted polytene chromosome bands that share the features of silent chromatin type known as intercalary heterochromatin (IH). This led to local chromatin decondensation, formation of novel DHSes and recruitment of several "open chromatin" proteins. CHRO tethering resulted in the recruitment of CP190 and Z4 (PZG), whereas dCTCF tethering attracted CHRO, CP190, and Z4. Importantly, formation of a local stretch of open chromatin did not result in the reactivation of silent marker genes yellow and mini-white immediately adjacent to the targeting region (UAS), nor did RNA polll become recruited into this chromatin. The decompacted region retained late replicated, similarly to the wild-type untargeted region.	[Pokholkova, Galina V.; Demakov, Sergei A.; Andreenkov, Oleg V.; Andreenkova, Natalia G.; Volkova, Elena I.; Belyaeva, Elena S.; Zhimulev, Igor F.] Russian Acad Sci, Siberian Branch, Inst Mol & Cellular Biol, Novosibirsk, Russia; [Demakov, Sergei A.; Zhimulev, Igor F.] Novosibirsk State Univ, Novosibirsk, Russia	Russian Academy of Sciences; Novosibirsk State University	Zhimulev, IF (corresponding author), Russian Acad Sci, Siberian Branch, Inst Mol & Cellular Biol, Novosibirsk, Russia.; Zhimulev, IF (corresponding author), Novosibirsk State Univ, Novosibirsk, Russia.	zhimulev@mcb.nsc.ru	Elena, Volkova/N-7468-2015; Demakov, Sergey A/N-6543-2015; Andreyenkova, Natalya G/N-4003-2015; Andreenkov, Oleg/N-4070-2015; Zhimulev, Igor F/N-7978-2015	Andreyenkova, Natalya G/0000-0002-5981-8857; Andreyenkov, Oleg/0000-0001-8231-8984; Zhimulev, Igor/0000-0002-6220-3028; Demakov, Sergey/0000-0002-5526-6784	Russian Science Foundation [14-14-00934]; Russian Foundation for Basic Research [15-04-03898]; program of support and development of bioresurce collections [0310-2016-0001];  [0310-2018-0010]; Russian Science Foundation [17-14-00038] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); program of support and development of bioresurce collections; ; Russian Science Foundation(Russian Science Foundation (RSF))	FISH experiments were supported by the Russian Science Foundation project 14-14-00934 IFZ; genetic analysis was supported by the Russian Foundation for Basic Research 15-04-03898 IFZ; budget grants 0310-2018-0010 IFZ; program of support and development of bioresurce collections ? 0310-2016-0001 SAD. The resources provided by the "Molecular and Cellular Biology core facility of the IMCB SB RAS, Sergei A. Demakov.; FISH experiments were supported by the Russian Science Foundation project 14-14-00934, genetic analysis was supported by the Russian Fund of Basic Research 15-04-03898, budget grants 0310-2018-0010 and program of support and development of bioresurce collections (No 0310-2016-0001). The authors are very grateful to colleagues supplying us with antibodies: I.V. Makunin, K. McKim, P.G. Georgiev, H. Saumweber, S. Elgin, A. Gorchakov as well as V. A. Khoroshko, T.Yu. Zykova, T.D. Kolesnikova and O.V. Antonenko for help in of the manuscript. We thank the Bloomington Drosophila Stock Center for kind providing the EY flystocks. The authors gratefully acknowledge the resources provided by the "Molecular and Cellular Biology" core facility of the IMCB SB RASpreparation	Ahanger SH, 2014, SCI REP-UK, V4, DOI 10.1038/srep03917; Ali T, 2016, CURR OPIN GENET DEV, V37, P17, DOI 10.1016/j.gde.2015.11.009; Andreenkov O V, 2016, Tsitologiia, V58, P493; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Belyaeva ES, 2012, PLOS ONE, V7, P352, DOI 10.1371/journal.pone.0030035; Belyaeva ES, 1998, P NATL ACAD SCI USA, V95, P7532, DOI 10.1073/pnas.95.13.7532; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; Chesnokov IN, 2007, INT REV CYTOL, V256, P69, DOI 10.1016/S0074-7696(07)56003-1; Demakov SA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-566; Deng H, 2008, DEVELOPMENT, V135, P699, DOI 10.1242/dev.015362; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Eagen KP, 2015, CELL, V163, P934, DOI 10.1016/j.cell.2015.10.026; Eaton ML, 2011, GENOME RES, V21, P164, DOI 10.1101/gr.116038.110; Eggert H, 2004, J CELL SCI, V117, P4253, DOI 10.1242/jcs.01292; Feng SH, 2014, MOL CELL, V55, P694, DOI 10.1016/j.molcel.2014.07.008; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Gortchakov AA, 2005, CHROMOSOMA, V114, P54, DOI 10.1007/s00412-005-0339-3; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Khoroshko VA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157147; Kolesnikova TD, 2013, CHROMOSOMA, V122, P55, DOI 10.1007/s00412-012-0390-9; Kolesnikova TD, 2011, FLY, V5, P181, DOI 10.4161/fly.5.3.16729; Koryakov DE, 2012, CHROMOSOMA, V121, P573, DOI 10.1007/s00412-012-0382-9; Kwon SY, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005969; Lubelsky Y, 2014, GENOME RES, V24, P1102, DOI 10.1101/gr.160010.113; MacAlpine D, 2005, CHROMOSOME RES, V13, P309, DOI 10.1007/s10577-005-1508-1; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; Maksimenko O, 2015, GENOME RES, V25, P89, DOI 10.1101/gr.174169.114; Makunin IV, 2002, GENETICS, V160, P1023; MEYEROWITZ EM, 1985, COLD SPRING HARB SYM, V50, P347, DOI 10.1101/SQB.1985.050.01.044; Milon B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-988; Moon H, 2005, EMBO REP, V6, P165, DOI 10.1038/sj.embor.7400334; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Nordman J, 2011, GENOME RES, V21, P175, DOI 10.1101/gr.114611.110; Pokholkova GV, 2015, CHROMOSOMA, V124, P209, DOI 10.1007/s00412-014-0491-8; Rath U, 2006, J CELL SCI, V119, P2332, DOI 10.1242/jcs.02960; Regnard C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001327; Sambrook J., 2004, MOL CLONING LAB MANU; Schwaiger M, 2009, GENE DEV, V23, P589, DOI 10.1101/gad.511809; Schwartz YB, 2012, GENOME RES, V22, P2188, DOI 10.1101/gr.138156.112; Seum C, 2000, CHROMOSOMA, V109, P453, DOI 10.1007/s004120000101; Sexton T, 2015, CELL, V160, P1049, DOI 10.1016/j.cell.2015.02.040; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; SHAFFER CD, 1994, METHOD CELL BIOL, V44, P185, DOI 10.1016/S0091-679X(08)60913-9; Sher N, 2012, GENOME RES, V22, P64, DOI 10.1101/gr.126003.111; Stadler MR, 2017, CHROMATIN EXTENSION; Therizols P, 2014, SCIENCE, V346, P1238, DOI 10.1126/science.1259587; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Ulianov SV, 2016, GENOME RES, V26, P70, DOI 10.1101/gr.196006.115; Van Bortle K, 2013, CURR OPIN GENET DEV, V23, P212, DOI 10.1016/j.gde.2012.11.003; Van Bortle K, 2012, GENOME RES, V22, P2176, DOI 10.1101/gr.136788.111; Vatolina TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025960; Vogelmann J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004544; Wang C, 2011, J CELL SCI, V124, P4309, DOI 10.1242/jcs.092585; White R, 2012, BRIEF FUNCT GENOMICS, V11, P347, DOI 10.1093/bfgp/els020; Wood AM, 2011, MOL CELL, V44, P29, DOI 10.1016/j.molcel.2011.07.035; Yarosh W, 2014, GENE DEV, V28, P1840, DOI 10.1101/gad.245811.114; ZHAO K, 1995, CELL, V81, P879, DOI 10.1016/0092-8674(95)90008-X; Zhimolev IF, 1996, ADV GENET, V34, P1; ZHIMULEV IF, 1982, CHROMOSOMA, V87, P197, DOI 10.1007/BF00338489; Zhimulev IF, 2003, J CELL SCI, V116, P169, DOI 10.1242/jcs.00196; Zhimulev IF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101631	65	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0192634	10.1371/journal.pone.0192634	http://dx.doi.org/10.1371/journal.pone.0192634			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608600	Green Submitted, Green Published, gold			2022-12-26	WOS:000428988800001
J	Si, WX; Xie, W; Deng, WB; Xiao, Y; Karnik, SS; Xu, CQ; Chen, QY; Wang, QK				Si, Wenxia; Xie, Wen; Deng, Wenbing; Xiao, Yi; Karnik, Sadashiva S.; Xu, Chengqi; Chen, Qiuyun; Wang, Qing Kenneth			Angiotensin II increases angiogenesis by NF-kappa B-mediated transcriptional activation of angiogenic factor AGGF1	FASEB JOURNAL			English	Article						AT1R; AT2R; p65	KLIPPEL-TRENAUNAY-SYNDROME; ENDOTHELIAL GROWTH-FACTOR; IN-VIVO; SIGNALING PATHWAY; TYPE-2 RECEPTOR; GENE-EXPRESSION; DOWN-REGULATION; CELLS; CARCINOMA; SYSTEM	Angiogenic factor with G-patch and FHA domains 1 (AGGF1) is involved in vascular development, angiogenesis, specification of hemangioblasts, and differentiation of veins. When mutated, however, it causes Klippel-Trenaunay syndrome, a vascular disorder. In this study, we show that angiotensin II (AngII)the major effector of the renin-angiotensin system and one of the most important regulators of the cardiovascular systeminduces the expression of AGGF1 through NF-B, and that AGGF1 plays a key role in AngII-induced angiogenesis. AngII significantly up-regulated the levels of AGGF1 mRNA and protein in HUVECs at concentrations of 10-40 g/ml but not >60 g/ml. AngII type 1 receptor (AT1R) inhibitor losartan inhibited AngII-induced up-regulation of AGGF1, whereas AT2R inhibitor PD123319 further increased AngII-induced up-regulation of AGGF1. Up-regulation of AGGF1 by AngII was blocked by NF-B inhibitors, and p65 binds directly to a binding site at the promoter/regulatory region of AGGF1 and transcriptionally activates AGGF1 expression. AngII-induced endothelial tube formation was blocked by small interfering RNAs (siRNAs) for RELA (RELA proto-oncogene, NF-B subunit)/p65 or AGGF1, and the effect of RELA siRNA was rescued by AGGF1. AngII-induced angiogenesis from aortic rings was severely impaired in Aggf1(+/-) mice, and the effect was restored by AGGF1. These data suggest that AngII acts as a critical regulator of AGGF1 expression through NF-B, and that AGGF1 plays a key role in AngII-induced angiogenesis.Si, W., Xie, W., Deng, W., Xiao, Y., Karnik, S. S., Xu, C., Chen, Q., Wang, Q. K. Angiotensin II increases angiogenesis by NF-B-mediated transcriptional activation of angiogenic factor AGGF1.	[Si, Wenxia; Xie, Wen; Deng, Wenbing; Xu, Chengqi; Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Ctr Human Genome Res, Key Lab Mol Biophys,Minist Educ,CardioX Inst, Wuhan, Hubei, Peoples R China; [Xiao, Yi; Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Coll Phys, Wuhan, Hubei, Peoples R China; [Si, Wenxia] Hubei Polytech Univ, Huangshi Cent Hosp, Hubei Key Lab Kidney Dis Pathogenesis & Intervent, Edong Healthcare Grp,Sch Med, Huangshi, Peoples R China; [Karnik, Sadashiva S.; Chen, Qiuyun; Wang, Qing Kenneth] Cleveland Clin, Ctr Cardiovasc Genet, Cleveland, OH 44106 USA; [Karnik, Sadashiva S.; Chen, Qiuyun; Wang, Qing Kenneth] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Karnik, Sadashiva S.; Chen, Qiuyun; Wang, Qing Kenneth] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA; [Karnik, Sadashiva S.; Chen, Qiuyun; Wang, Qing Kenneth] Case Western Reserve Univ, Learner Coll Med, Cleveland Clin, Dept Mol Med, Cleveland, OH 44106 USA; [Wang, Qing Kenneth] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Hubei Polytechnic University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University	Chen, QY (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, 9500 Euclid Ave, Cleveland, OH 44195 USA.; Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Ctr Human Genome Res, 1037 Luoyu Rd, Wuhan 430074, Peoples R China.; Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, 1037 Luoyu Rd, Wuhan 430074, Peoples R China.	chenq3@ccf.org; qkwang@mail.hust.edu.cn	Karnik, Sadashiva/Y-2477-2019	Karnik, Sadashiva/0000-0003-0746-2753; Xu, Chengqi/0000-0002-4269-6830; Wang, Qing/0000-0002-5639-8519	China National Natural Science Foundation [81630002, 91439129, 31430047, 81600263]; Innovative Team Grant from Hubei Province [2017CFA014]; 2016 Top-Notch Innovative Talent Development Project Award from the Bureau of Human Resources and Social Security of Wuhan City; Chinese National Basic Research Program (973 Project) [2013CB531101]; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [R01 HL121358, R01 HL126729]; Hubei Province Natural Science Programs [2016CFB224, 2014CFA074]; Outstanding Medical Academic Leader Program of Hubei Province; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121358, R01HL126729, R01HL132351] Funding Source: NIH RePORTER	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Innovative Team Grant from Hubei Province; 2016 Top-Notch Innovative Talent Development Project Award from the Bureau of Human Resources and Social Security of Wuhan City; Chinese National Basic Research Program (973 Project)(National Basic Research Program of China); U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Hubei Province Natural Science Programs; Outstanding Medical Academic Leader Program of Hubei Province; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. George Stalk (Cleveland Clinic) for quinacrine. This study was supported by China National Natural Science Foundation Grants 81630002, 91439129, 31430047, and 81600263; Innovative Team Grant 2017CFA014 from Hubei Province; a 2016 Top-Notch Innovative Talent Development Project Award from the Bureau of Human Resources and Social Security of Wuhan City; the Chinese National Basic Research Program (973 Project 2013CB531101); U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants R01 HL121358 and R01 HL126729; Hubei Province Natural Science Programs (2016CFB224 and 2014CFA074); and the Outstanding Medical Academic Leader Program of Hubei Province. The authors declare no conflicts of interest.	Buharalioglu CK, 2011, AM J PHYSIOL-HEART C, V301, pH1043, DOI 10.1152/ajpheart.01018.2010; Chen D, 2013, HUM MOL GENET, V22, P963, DOI 10.1093/hmg/dds501; Chua CC, 1998, BBA-MOL CELL RES, V1401, P187, DOI 10.1016/S0167-4889(97)00129-8; Daugherty A, 2004, TRENDS CARDIOVAS MED, V14, P117, DOI 10.1016/j.tcm.2004.01.002; Escobar Elizabeth, 2004, Current Vascular Pharmacology, V2, P385, DOI 10.2174/1570161043385556; Fan C, 2009, J BIOL CHEM, V284, P23331, DOI 10.1074/jbc.M109.036079; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Han CJ, 2010, ATHEROSCLEROSIS, V212, P206, DOI 10.1016/j.atherosclerosis.2010.05.020; Harada M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122603; Horiuchi M, 1999, HYPERTENSION, V33, P613, DOI 10.1161/01.HYP.33.2.613; HSUEH WA, 1995, ADV EXP MED BIOL, V377, P217; Hu FY, 2013, CELL SIGNAL, V25, P1645, DOI 10.1016/j.cellsig.2013.04.007; Jani TS, 2010, J BIOL CHEM, V285, P19162, DOI 10.1074/jbc.M109.091645; Jing T, 2009, INT J MOL MED, V24, P103, DOI 10.3892/ijmm_00000213; JOHNSTON CI, 1992, J HYPERTENS, V10, pS13; Kaschina E, 2003, BLOOD PRESSURE, V12, P70, DOI 10.1080/08037050310001057; Kashiwada T, 2015, DEVELOPMENT, V142, P497, DOI 10.1242/dev.115576; Kim S, 2000, ARTERIOSCL THROM VAS, V20, P2539, DOI 10.1161/01.ATV.20.12.2539; LENOBLE FAC, 1993, AM J PHYSIOL, V264, pR460, DOI 10.1152/ajpregu.1993.264.2.R460; Li L, 2014, BLOOD, V123, P501, DOI 10.1182/blood-2013-07-514612; Lu QB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052073; Lu QL, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002529; Munk VC, 2007, HYPERTENSION, V49, P1178, DOI 10.1161/HYPERTENSIONAHA.106.080242; Munzenmaier DH, 1996, HYPERTENSION, V27, P760, DOI 10.1161/01.HYP.27.3.760; Pei NN, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0542-0; Peng H, 2001, MOL BIOL CELL, V12, P449, DOI 10.1091/mbc.12.2.449; Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265; Scheidegger KJ, 1999, J BIOL CHEM, V274, P3522, DOI 10.1074/jbc.274.6.3522; STACHOWIAK MK, 1994, J CELL BIOL, V127, P203, DOI 10.1083/jcb.127.1.203; Tamarat R, 2002, LAB INVEST, V82, P747, DOI 10.1097/01.LAB.0000017372.76297.EB; Tian XL, 2004, NATURE, V427, P640, DOI 10.1038/nature02320; VISWANATHAN M, 1992, PEPTIDES, V13, P783, DOI 10.1016/0196-9781(92)90187-8; Walther T, 2003, FASEB J, V17, P2061, DOI 10.1096/fj.03-0129com; Wolf G, 2002, LAB INVEST, V82, P1305, DOI 10.1097/01.LAB.0000029207.92039.2F; Xu Y, 2014, BBA-MOL BASIS DIS, V1842, P712, DOI 10.1016/j.bbadis.2014.01.007; Yamamoto Y, 2008, HYPERTENS RES, V31, P1241, DOI 10.1291/hypres.31.1241; Yao YF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00171-w; Yao YF, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005889; Zhang T, 2016, HUM MOL GENET, V25, P5094, DOI 10.1093/hmg/ddw273; Zhang XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107634; Zhou BS, 2013, CANCER LETT, V333, P159, DOI 10.1016/j.canlet.2013.01.028	41	17	20	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5051	5062		10.1096/fj.201701543RR	http://dx.doi.org/10.1096/fj.201701543RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29641288	Green Published			2022-12-26	WOS:000443817700035
J	Cao, L; Wang, SY; Zhang, YQ; Wong, KC; Nakatsu, G; Wang, XH; Wong, S; Ji, JF; Yu, J				Cao, Lei; Wang, Shiyan; Zhang, Yanquan; Wong, Ka-Chun; Nakatsu, Geicho; Wang, Xiaohong; Wong, Sunny; Ji, Jiafu; Yu, Jun			Zinc-finger protein 471 suppresses gastric cancer through transcriptionally repressing downstream oncogenic PLS3 and TFAP2A	ONCOGENE			English	Article							FUNCTIONAL DIVERSITY; METHYLATION; EXPRESSION; PROGNOSIS; PROMOTER; SURVIVAL; HYPERMETHYLATION; PROGRESSION; PREDICTION; CARCINOMA	Zinc-finger protein 471 (ZNF471) was preferentially methylated in gastric cancer using promoter methylation array. The role of ZNF471 in human cancer is unclear. Here we elucidated the functional significance, molecular mechanisms and clinical impact of ZNF471 in gastric cancer. ZNF471 mRNA was silenced in 15 out of 16 gastric cancer cell lines due to promoter hypermethylation. Significantly higher ZNF471 promoter methylation was also observed in primary gastric cancers compared to their adjacent normal tissues (P < 0.001). ZNF471 promoter CpG-site hypermethylation correlated with poor survival of gastric cancer patients (n = 120, P = 0.001). Ectopic expression of ZNF471 in gastric cancer cell lines (AGS, BGC823, and MKN74) significantly suppressed cell proliferation, migration, and invasion, while it induced apoptosis in vitro and inhibited xenograft tumorigenesis in nude mice. Transcription factor AP-2 Alpha (TFAP2A) and plastin3 (PLS3) were two crucial downstream targets of ZNF471 demonstrated by bioinformatics modeling and ChIP-PCR assays. ZNF471 directly bound to the promoter of TFAP2A and PLS3 and transcriptionally inhibited their expression. TFAP2A and PLS3 showed oncogenic functions in gastric cancer cell lines. Moreover, ZNF471 recruited KAP1 to the promoter of the target genes, thereby inducing H3K9me3 enrichment for transcriptional repression and inhibition of oncogenic TFAP2A and PLS3. In conclusion, ZNF471 acts as a tumor suppressor in gastric cancer by transcriptionally inhibiting downstream targets TFAP2A and PLS3. KAP1 is a co-repressor of ZNF471 at the promoter of the target genes. The promoter CpG-site methylation is an independent prognostic factor for overall survival of gastric cancer patients.	[Cao, Lei; Wang, Shiyan; Zhang, Yanquan; Nakatsu, Geicho; Wong, Sunny; Yu, Jun] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Cao, Lei; Wang, Shiyan; Zhang, Yanquan; Nakatsu, Geicho; Wong, Sunny; Yu, Jun] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Dept Med & Therapeut, State Key Lab Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Wong, Ka-Chun] City Univ Hong Kong Kowloon Tong, Dept Comp Sci, Kowloon Tong, Hong Kong, Peoples R China; [Wang, Xiaohong; Ji, Jiafu] Beijing Canc Hosp & Inst, Dept Gastrointestinal Surg, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Yu, J (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China.; Yu, J (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Dept Med & Therapeut, State Key Lab Digest Dis, Hong Kong, Hong Kong, Peoples R China.	junyu@cuhk.edu.hk	Wong, Ka-Chun/L-7160-2019; Wong, Sunny H/N-3754-2015; Nakatsu, Geicho/AAU-3089-2021; Yu, Jun/D-8569-2015; Zhang, Yanquan/D-5615-2017	Wong, Ka-Chun/0000-0001-6062-733X; Wong, Sunny H/0000-0002-3354-9310; Yu, Jun/0000-0001-5008-2153; Zhang, Yanquan/0000-0003-3527-9972	RGC-GRF Hong Kong [766613, 14106415, 14111216]; HMRF Hong Kong [1195728]; 135 program project China [2016YFC1303200]; Shenzhen Virtual University Park Support Scheme; CUHK direct grant	RGC-GRF Hong Kong(Hong Kong Research Grants Council); HMRF Hong Kong; 135 program project China; Shenzhen Virtual University Park Support Scheme; CUHK direct grant(Chinese University of Hong Kong)	This project was supported by RGC-GRF Hong Kong (766613, 14106415, 14111216), HMRF Hong Kong (1195728), 135 program project China (2016YFC1303200), Shenzhen Virtual University Park Support Scheme to CUHK Shenzhen Research Institute and CUHK direct grant (J. Yu).	Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bennett KL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006931; Berlato C, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2838; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bhat S, 2017, VIRCHOWS ARCH, V470, P445, DOI 10.1007/s00428-017-2094-2; Choi IS, 2005, CELL RES, V15, P247, DOI 10.1038/sj.cr.7290293; Claus R, 2012, J CLIN ONCOL, V30, P2483, DOI 10.1200/JCO.2011.39.3090; Deng JY, 2014, ONCOTARGET, V5, P7420, DOI 10.18632/oncotarget.1973; Deng JY, 2014, AM J CANCER RES, V4, P518; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Huang L, 2015, AM J TRANSL RES, V7, P2141; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Jen JY, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0269-9; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Liu ZJ, 2014, CLIN CANCER RES, V20, P4598, DOI 10.1158/1078-0432.CCR-13-3380; Lupo A, 2013, CURR GENOMICS, V14, P268, DOI 10.2174/13892029113149990002; Mitchell SM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-54; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Najafabadi HS, 2015, NAT BIOTECHNOL, V33, P555, DOI 10.1038/nbt.3128; Peille AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080741; Qu YP, 2013, CLIN CHIM ACTA, V424, P53, DOI 10.1016/j.cca.2013.05.002; Schmitges FW, 2016, GENOME RES, V26, P1742, DOI 10.1101/gr.209643.116; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shi DB, 2014, CANCER PREV RES, V7, P266, DOI 10.1158/1940-6207.CAPR-13-0271; Sigova AA, 2015, SCIENCE, V350, P978, DOI 10.1126/science.aad3346; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ueda M, 2014, ANN SURG ONCOL, V21, P3680; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Wang N, 2016, ARCH MED RES, V47, P285, DOI 10.1016/j.arcmed.2016.07.011; Wang SY, 2013, GUT, V62, P833, DOI 10.1136/gutjnl-2011-301776; Wong CC, 2016, GASTROENTEROLOGY, V151, P945, DOI 10.1053/j.gastro.2016.07.011; Zouridis H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004504	39	26	27	3	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2018	37	26					3601	3616		10.1038/s41388-018-0220-5	http://dx.doi.org/10.1038/s41388-018-0220-5			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GK7TM	29610526	hybrid, Green Published			2022-12-26	WOS:000436412500010
J	Huang, S; Jaffe, PR				Huang, Shan; Jaffe, Peter R.			Isolation and characterization of an ammonium-oxidizing iron reducer: Acidimicrobiaceae sp A6	PLOS ONE			English	Article							SP NOV.; HUMIC SUBSTANCES; WETLAND SOILS; FE(III) OXIDE; NITROGEN LOSS; GEN. NOV.; REDUCTION; OXIDATION; MICROORGANISMS; HETEROGENEITY	Acidimicrobiaceae sp. A6 (ATCC, PTA-122488), a strain that has been previously reported to play a key role in the oxidation of ammonium (NH4+) under iron reducing conditions, has now been isolated from riparian wetland soils in New Jersey, USA. Incubations of this strain in a medium containing ferrihydrite as the ferric iron [Fe(III)] source, CO2 as the carbon source, under room temperature, and a pH of 4.5, resulted in 52% of NH4+ removal over a 20-day incubation period, while reducing Fe(III) in the expected stoichiometric ratio when NH4+ was oxidized to nitrite with Fe(III) as the electron acceptor. This study demonstrates that this new isolated strain is capable of oxidizing NH4+ while reducing iron under anaerobic conditions.	[Huang, Shan; Jaffe, Peter R.] Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA	Princeton University	Jaffe, PR (corresponding author), Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA.	jaffe@princeton.edu		Jaffe, Peter/0000-0002-8531-8549	Princeton University; NSF [CBET-1433101]	Princeton University(Princeton University); NSF(National Science Foundation (NSF))	Funding for this work was provided by Project X from Princeton University, and NSF Project No. CBET-1433101. (PRJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blothe M, 2008, APPL ENVIRON MICROB, V74, P1019, DOI 10.1128/AEM.01194-07; Bridge TAM, 1998, APPL ENVIRON MICROB, V64, P2181; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Clark DA, 1996, MICROBIOL-UK, V142, P785, DOI 10.1099/00221287-142-4-785; Cleaver AA, 2007, APPL ENVIRON MICROB, V73, P4294, DOI 10.1128/AEM.02658-06; Clement JC, 2005, SOIL BIOL BIOCHEM, V37, P2323, DOI 10.1016/j.soilbio.2005.03.027; Cornell RM, 2003, IRON OXIDES STRUCTUR, DOI [10.1002/3527602097.ins, DOI 10.1002/]; Ding LJ, 2014, ENVIRON SCI TECHNOL, V48, P10641, DOI 10.1021/es503113s; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; Hacherl EL, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001312; Heylen K, 2006, ENVIRON MICROBIOL, V8, P2012, DOI 10.1111/j.1462-2920.2006.01081.x; Huang S, 2015, BIOGEOSCIENCES, V12, P769, DOI 10.5194/bg-12-769-2015; Huang S, 2016, SOIL BIOL BIOCHEM, V98, P148, DOI 10.1016/j.soilbio.2016.04.012; Itoh T, 2011, INT J SYST EVOL MICR, V61, P1281, DOI 10.1099/ijs.0.023044-0; Johnson DB, 2008, EXTREMOPHILES, V12, P789, DOI 10.1007/s00792-008-0184-4; Johnson DB, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00096; Johnson DB, 2009, INT J SYST EVOL MICR, V59, P1082, DOI 10.1099/ijs.0.65409-0; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li M, 2011, APPL MICROBIOL BIOT, V89, P1243, DOI 10.1007/s00253-010-2929-0; Lloyd JR, 1999, J BACTERIOL, V181, P7647, DOI 10.1128/JB.181.24.7647-7649.1999; Lonergan DJ, 1996, J BACTERIOL, V178, P2402, DOI 10.1128/jb.178.8.2402-2408.1996; MacDonald LH, 2011, WATER RES, V45, P1049, DOI 10.1016/j.watres.2010.10.017; Nevin KP, 2002, APPL ENVIRON MICROB, V68, P2294, DOI 10.1128/AEM.68.5.2294-2299.2002; Sawayama S, 2006, J BIOSCI BIOENG, V101, P70, DOI 10.1263/jbb.101.70; Scott DT, 1998, ENVIRON SCI TECHNOL, V32, P2984, DOI 10.1021/es980272q; Shrestha J, 2009, SOIL SCI, V174, P156, DOI 10.1097/SS.0b013e3181988fbf; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Ward BB, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00553; Weber KA, 2006, NAT REV MICROBIOL, V4, P752, DOI 10.1038/nrmicro1490; Wolf M, 2009, ENVIRON SCI TECHNOL, V43, P5679, DOI 10.1021/es803647r; Yang WH, 2012, NAT GEOSCI, V5, P538, DOI [10.1038/ngeo1530, 10.1038/NGEO1530]	32	55	59	27	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194007	10.1371/journal.pone.0194007	http://dx.doi.org/10.1371/journal.pone.0194007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641534	Green Published, Green Submitted, gold			2022-12-26	WOS:000429742900021
J	Bongomin, F; Harris, C; Hayes, G; Kosmidis, C; Denning, DW				Bongomin, Felix; Harris, Chris; Hayes, Gemma; Kosmidis, Chris; Denning, David W.			Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis	PLOS ONE			English	Article							GEORGES RESPIRATORY QUESTIONNAIRE; QUALITY-OF-LIFE; AZOLE RESISTANCE; HEALTH-STATUS; MULTICENTER TRIAL; CHRONIC CAVITARY; GUIDELINES; MICAFUNGIN; FUMIGATUS; DIAGNOSIS	There is a paucity of evidence surrounding the optimal antifungal therapy for use in chronic pulmonary aspergillosis (CPA) and the duration of therapy remains unclear. We retrospectively evaluated treatment outcomes, including change in quality of life scores (St George's Respiratory Questionnaire (QoL)), weight and Aspergillus IgG at 6 and 12 months following initiation of therapy in a cohort of 206 CPA patients referred to the UK National Aspergillosis Centre (NAC), Manchester between April 2013 and March 2015. One hundred and forty-two patients (69%) were azole naive at presentation and 105 (74%) (Group A) were commenced on itraconazole, 27 (19%) on voriconazole, and 10 (7%) were not treated medically. The remainder (64 patients, 31%) had previously trialled, or remained on, azole therapy at inclusion (Group B) of whom 46 (72%) received itraconazole, 16 (25%) voriconazole, and 2 (3%) posaconazole. Initial therapy was continued for 12 months in 78 patients (48%) of those treated; the azole was changed in 62 (32%) patients and discontinued in 56 (29%) patients for adverse reactions (32, 57%), azole resistance (11, 20%), clinical failure (8, 14%) or clinical stability (5, 9%). Azole discontinuation rates were higher in Group B than in Group A (42% vs. 22%, p = 0.003). For all patients who survived, weight increased (median of 62.2Kg at baseline, to 64.8 at 12 months), mean Aspergillus IgG declined from 260 (baseline) to 154 (12 months) and QoL improved from 62.2/100 (baseline) to 57.2/100 (12 months). At 12 months, there was no difference in median survival between Groups A and B (95% vs. 91%, p = 0.173). The rate of emergence of resistance during therapy was 13% for itraconazole compared to 5% for voriconazole. Bronchial artery embolization was done in 9 (4.4%) patients and lobectomy in 7 (3.2%). The optimal duration of azole therapy in CPA is undetermined due to the absence of evidenced based endpoints allowing clinical trials to be undertaken. However we have demonstrated itraconazole and voriconazole are modestly effective for CPA, especially if given for 12 months, but fewer than 50% of patients manage this duration. This suggests extended therapy may be required for demonstrable clinical improvement.	[Bongomin, Felix; Harris, Chris; Hayes, Gemma; Kosmidis, Chris; Denning, David W.] Manchester Univ NHS Fdn Trust, Wythenshawe Hosp, Natl Aspergillosis Ctr, Manchester, Lancs, England; [Bongomin, Felix; Hayes, Gemma; Kosmidis, Chris; Denning, David W.] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Infect Immun & Resp Med, Manchester, Lancs, England; [Kosmidis, Chris; Denning, David W.] Manchester Acad Hlth Serv Ctr, Manchester, Lancs, England; [Hayes, Gemma] Northern Devon Healthcare Trust, North Devon Dist Hosp, Raleigh Pk, Barnstaple, Devon, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester	Denning, DW (corresponding author), Manchester Univ NHS Fdn Trust, Wythenshawe Hosp, Natl Aspergillosis Ctr, Manchester, Lancs, England.; Denning, DW (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Div Infect Immun & Resp Med, Manchester, Lancs, England.; Denning, DW (corresponding author), Manchester Acad Hlth Serv Ctr, Manchester, Lancs, England.	ddenning@manchester.ac.uk	Denning, David/AAC-6931-2019; Kosmidis, Chris/AAS-8700-2020; Bongomin, Felix/I-4626-2019	Denning, David/0000-0001-5626-2251; Kosmidis, Chris/0000-0003-0662-1265; Bongomin, Felix/0000-0003-4515-8517	UK National Health Service Highly Specialised Commissioning team; Cidara Therapeutics; Global Action Fund for Fungal Disease	UK National Health Service Highly Specialised Commissioning team; Cidara Therapeutics; Global Action Fund for Fungal Disease	This work was primarily funded by the UK National Health Service Highly Specialised Commissioning team and also supported by an educational grant from Cidara Therapeutics to the University Hospital of South Manchester and by a grant from the Global Action Fund for Fungal Disease to the University of Manchester on behalf of Dr. Felix Bongomin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was in part supported by an educational grant from Cidara Therapeutics. We would like to thank Mr. Philip Foden of the department of medical statistics and Mr. Paul Somerset of the department of medical illustrations both of the Manchester University NHS Foundation Trust (Wythenshawe Hospital) for sacrificing their to time to help with statistics and illustrations respectively. This work was presented in part as an abstract at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID, 2017) held in Vienna, Austria.	Agarwal R, 2013, MYCOSES, V56, P559, DOI 10.1111/myc.12075; Al-shair K, 2013, CLIN INFECT DIS, V57, P828, DOI 10.1093/cid/cit411; Al-Shair K, 2013, CHEST, V144, P623, DOI 10.1378/chest.12-0014; Albarrag AM, 2011, ANTIMICROB AGENTS CH, V55, P5113, DOI 10.1128/AAC.00517-11; Ashbee HR, 2014, J ANTIMICROB CHEMOTH, V69, P1162, DOI 10.1093/jac/dkt508; Cadranel J, 2012, EUR J CLIN MICROBIOL, V31, P3231, DOI 10.1007/s10096-012-1690-y; CAMPBELL JH, 1991, THORAX, V46, P839, DOI 10.1136/thx.46.11.839; Camuset J, 2007, CHEST, V131, P1435, DOI 10.1378/chest.06-2441; Denning DW, 2016, EUR RESPIR J, V47, P45, DOI 10.1183/13993003.00583-2015; Denning DW, 2011, CLIN INFECT DIS, V52, P1123, DOI 10.1093/cid/cir179; Denning DW, 2003, CLIN INFECT DIS, V37, pS265, DOI 10.1086/376526; Felton TW, 2010, CLIN INFECT DIS, V51, P1383, DOI 10.1086/657306; Godet C, 2016, CHEST, V150, P139, DOI 10.1016/j.chest.2016.02.640; Howard SJ, 2010, CLIN MICROBIOL INFEC, V16, P683, DOI 10.1111/j.1469-0691.2009.02911.x; Howard SJ, 2011, ANTIMICROB AGENTS CH, V55, P4802, DOI 10.1128/AAC.00304-11; Howard SJ, 2009, EMERG INFECT DIS, V15, P1068, DOI 10.3201/eid1507.090043; Izumikawa K, 2007, MED MYCOL, V45, P273, DOI 10.1080/13693780701278386; Jain Lakshmi R, 2006, J Infect, V52, pe133, DOI 10.1016/j.jinf.2005.08.022; Jewkes J., 1983, ANN THORAC SURG, V53, P621; Jhun BW, 2013, MED MYCOL, V51, P811, DOI 10.3109/13693786.2013.806826; Jones PW, 1997, AM J RESP CRIT CARE, V155, P1283, DOI 10.1164/ajrccm.155.4.9105068; JONES PW, 1994, EUR RESPIR J, V7, P55, DOI 10.1183/09031936.94.07010055; Jones PW, 2002, EUR RESPIR J, V19, P398, DOI 10.1183/09031936.02.00063702; Jones PW, 2008, STRUCTURE, V44, P1; Kawamura S, 2000, INTERNAL MED, V39, P209, DOI 10.2169/internalmedicine.39.209; Kohno S, 2004, SCAND J INFECT DIS, V36, P372, DOI 10.1080/00365540410020406; Kohno S, 2013, EUR J CLIN MICROBIOL, V32, P387, DOI 10.1007/s10096-012-1754-z; Kohno S, 2011, MED MYCOL, V49, P688, DOI 10.3109/13693786.2011.561369; Kosmidis C, 2015, THORAX, V70, P270, DOI 10.1136/thoraxjnl-2014-206291; Lowes D, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01062-2016; Muldoon EG, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0276-3; Newton PJ, 2016, J INFECTION, V73, P485, DOI 10.1016/j.jinf.2016.06.001; Ohba H, 2012, RESP MED, V106, P724, DOI 10.1016/j.rmed.2012.01.014; Page ID, 2016, J INFECTION, V72, P240, DOI 10.1016/j.jinf.2015.11.003; Patterson TF, 2016, CLIN INFECT DIS, V63, pE1, DOI 10.1093/cid/ciw326; Sambatakou H, 2006, AM J MED, V119; Stenton C, 2008, OCCUP MED-OXFORD, V58, P226, DOI 10.1093/occmed/kqm162; TOMLINSON JR, 1987, CHEST, V92, P505, DOI 10.1378/chest.92.3.505; Wilson CB, 1997, AM J RESP CRIT CARE, V156, P536, DOI 10.1164/ajrccm.156.2.9607083; Yoshida K, 2012, J INFECT CHEMOTHER, V18, P378, DOI 10.1007/s10156-012-0414-7	40	47	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0193732	10.1371/journal.pone.0193732	http://dx.doi.org/10.1371/journal.pone.0193732			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634721	Green Published, gold, Green Submitted			2022-12-26	WOS:000429522200002
J	Koziarska, D; Krol, J; Nocon, D; Kubaszewski, P; Rzepa, T; Nowacki, P				Koziarska, Dorota; Krol, Joanna; Nocon, Danuta; Kubaszewski, Przemyslaw; Rzepa, Teresa; Nowacki, Przemyslaw			Prevalence and factors leading to unemployment in MS (multiple sclerosis) patients undergoing immunomodulatory treatment in Poland	PLOS ONE			English	Article							QUALITY-OF-LIFE; EMPLOYMENT STATUS; DISABILITY; PERSONALITY; FATIGUE; DISEASE; PEOPLE; SCALE; WORK; HOPE	Multiple Sclerosis (MS) is the most common, primary neurogenic cause of disability among young adults. We investigated demographic and clinical factors associated with unemployment on the example of 150 MS patients receiving immunomodulatory treatment in Poland. This study was based on clinical evaluation and collection of self-reported questionnaires, with an attention to self-motivation, severe fatigue and moderate disability. Patients who were unemployed (40% of all patients) had a mean disease duration of almost 5 years. Older (p<0.001), less educated (p = 0.007) and more severely disabled patients (p<0,001) were most likely to be unemployed. Moderate disability (OR = 11.089 95% CI: 4.11-34.201, p<0,001), severe fatigue (OR = 2.625 95% CI: 1.02-6.901, p = 0,046) and lower level of self-motivation (KNS) (OR = 0.947, 95% CI: 0.896-0.006, p = 0.042) were independently associated with unemployment.	[Koziarska, Dorota; Nocon, Danuta; Nowacki, Przemyslaw] Pomeranian Med Univ, Dept Neurol, Szczecin, Poland; [Krol, Joanna] Univ Szczecin, Inst Psychol, Szczecin, Poland; [Kubaszewski, Przemyslaw; Rzepa, Teresa] Univ Social Sci & Humanities Poznan, Poznan, Poland	Pomeranian Medical University; University of Szczecin	Koziarska, D (corresponding author), Pomeranian Med Univ, Dept Neurol, Szczecin, Poland.	dorkoz@pum.edu.pl		Nowacki, Przemyslaw/0000-0002-6536-2905; Rzepa, Teresa/0000-0002-2128-8416				Affleck G, 1996, J PERS, V64, P899, DOI 10.1111/j.1467-6494.1996.tb00948.x; Amato MP, 2010, NEUROL SCI, V31, P211, DOI 10.1007/s10072-010-0376-4; Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; [Anonymous], MSQL MULT SCLER QUAL; Barnum DD, 1998, CHILD HEALTH CARE, V27, P15, DOI 10.1207/s15326888chc2701_2; Beatty WW, 1995, J NEUROL REHABIL, V9, P167; Benedict RHB, 2005, J NEUROL SCI, V231, P29, DOI 10.1016/j.jns.2004.12.009; Bevan S, 2011, M EMPL CAR ASP PEOPL; Bruce JM, 2010, J BEHAV MED, V33, P219, DOI 10.1007/s10865-010-9247-y; Carrieri L, 2014, WORK, V47, P509, DOI 10.3233/WOR-131623; Edan G, 2014, J NEUROL NEUROSUR PS, V85, P1183, DOI 10.1136/jnnp-2013-306222; Edan G, 2015, 67 AAN 18 25 APR; Flachenecker P, 2008, DTSCH ARZTEBL INT, V105, P113, DOI 10.3238/arztebl.2008.0113; FREAL JE, 1984, ARCH PHYS MED REHAB, V65, P135; GRONNING M, 1990, J NEUROL NEUROSUR PS, V53, P388, DOI 10.1136/jnnp.53.5.388; Kappos L, 2015, J NEUROL NEUROSUR PS, V86, P1202, DOI 10.1136/jnnp-2014-310024; Krause I, 2013, MULT SCLER J, V19, P1792, DOI 10.1177/1352458513485655; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Laguna M., 2005, KWESTIONARIUSZ NADZI; LINN MW, 1985, AM J PUBLIC HEALTH, V75, P502, DOI 10.2105/AJPH.75.5.502; Miller A, 2006, QUAL LIFE RES, V15, P259, DOI 10.1007/s11136-005-0891-6; Moore P, 2013, MULT SCLER J, V19, P1647, DOI 10.1177/1352458513481396; Multiple Sclerosis International Federation, MSIF SURV EMPL MS; O'Connor R, 2005, J NEUROL, V252, P892, DOI 10.1007/s00415-005-0765-4; Orlewska E, 2005, EUR J NEUROL, V12, P31, DOI 10.1111/j.1468-1331.2004.00950.x; Patti F, 2007, MULT SCLER J, V13, P783, DOI 10.1177/1352458506073511; Pfleger CCH, 2010, EUR J NEUROL, V17, P1346, DOI 10.1111/j.1468-1331.2010.03020.x; Polman CH, 2005, MULT SCLER, V11, P5, DOI 10.1191/1352458505ms1135oa; Pompeii LA, 2005, J OCCUP REHABIL, V15, P69, DOI 10.1007/s10926-005-0875-y; Ratsep T, 2000, MULT SCLER, V6, P397, DOI 10.1177/135245850000600607; Simmons RD, 2010, J NEUROL, V257, P926, DOI 10.1007/s00415-009-5441-7; Snyder C.R., 1997, GROUP DYN-THEOR RES, V1, P107, DOI [DOI 10.1037/1089-2699.1.2.107, 10.1037/1089-2699.1.2.107]; Snyder CR, 1997, J PEDIATR PSYCHOL, V22, P399, DOI 10.1093/jpepsy/22.3.399; Snyder CR, 2002, PSYCHOL INQ, V13, P249, DOI 10.1207/S15327965PLI1304_01; Snyder CR, 2001, COPING STRESS, P3, DOI [DOI 10.1093/MED:PSYCH/9780195130447.001.0001, DOI 10.1093/MED:PSYCH/9780195130447.003.0001]; Strober LB, 2012, MULT SCLER J, V18, P647, DOI 10.1177/1352458511426735; Trisolini M, 2010, MULT SCLER INT FED, P1, DOI [10.18632/oncotarget.21284, DOI 10.18632/ONCOTARGET.21284]; Uccelli MM, 2009, J NEUROL, V256, P1989, DOI 10.1007/s00415-009-5225-0; Wickstrom A, MULT SCLER	40	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194117	10.1371/journal.pone.0194117	http://dx.doi.org/10.1371/journal.pone.0194117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC1EM	29634737	Green Published, Green Submitted, gold			2022-12-26	WOS:000429522200007
J	Ding, JF; Huang, ZJ; Zhu, M; Li, CY; Zhu, XK; Guo, WS				Ding, Jinfeng; Huang, Zhengjin; Zhu, Min; Li, Chunyan; Zhu, Xinkai; Guo, Wenshan			Does cyclic water stress damage wheat yield more than a single stress?	PLOS ONE			English	Article							WINTER-WHEAT; WATERLOGGING TOLERANCE; DRY-MATTER; DROUGHT STRESS; SPRING WHEAT; GRAIN-YIELD; GROWTH; SOIL; MECHANISMS; BARLEY	The occurrence of water stress during wheat growth is more frequent due to climate change. Three experiments (cyclic drought, cyclic waterlogging, and cyclic drought plus waterlogging) were conducted to investigate the effects of mild and severe cyclic/single water stress at elongation and heading stages on winter wheat (Triticum aestivum L.) yield. The effect of either mild drought at elongation or mild waterlogging at heading on wheat yield was not significant; however, significance did occur under other single water stresses. As the stress becomes more severe, the yield loss significantly increases. Extreme drought/waterlogging treatment at elongation caused a greater yield penalty than stress at heading stage. Except the combination of mild drought and mild waterlogging treatment, cyclic water stress significantly decreased wheat yields. The decrease in wheat yield under cyclic severe drought and waterlogging was significantly higher than any other treatment, with percentage decreases of 71.52 and 73.51%, respectively. In general, a yield reduction from mild cyclic water stress did not indicate more severe damage than single treatments; in contrast, grain yield suffered more when water stress occurred again after severe drought and waterlogging. Drought during elongation significantly decreased kernel number, whereas drought at heading/waterlogging during elongation and heading decreased the spike weight, which might be the main reason for the yield penalty. Furthermore, water stress caused variation in the decrease of total biomass and/or harvest index. The present study indicates comprehensive understanding of the types, degree, and stages of water stress are essential for assessing the impact of multiple water stresses on wheat yield.	[Ding, Jinfeng; Zhu, Min; Li, Chunyan; Zhu, Xinkai; Guo, Wenshan] Yangzhou Univ, Jiangsu Key Lab Crop Genet & Physiol, Yangzhou, Jiangsu, Peoples R China; [Ding, Jinfeng; Zhu, Min; Li, Chunyan; Zhu, Xinkai; Guo, Wenshan] Yangzhou Univ, Coinnovat Ctr Modern Prod Technol Grain Crops, Yangzhou, Jiangsu, Peoples R China; [Ding, Jinfeng; Zhu, Min; Li, Chunyan; Zhu, Xinkai; Guo, Wenshan] Yangzhou Univ, Wheat Res Inst, Yangzhou, Jiangsu, Peoples R China; [Huang, Zhengjin] Jiangsu Prov & Chinese Acad Sci, Nanjing Bot Garden Mem Sun Yat Sen, Inst Bot, Nanjing, Jiangsu, Peoples R China; [Guo, Wenshan] Yangzhou Univ, Inst Agr Sci, Yangzhou, Jiangsu, Peoples R China; [Guo, Wenshan] Yangzhou Univ, Inst Technol Dev, Yangzhou, Jiangsu, Peoples R China; [Guo, Wenshan] Yangzhou Univ, Minist Educ China, Joint Int Res Lab Agr & Agriprod Safety, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University; Yangzhou University; Chinese Academy of Sciences; Yangzhou University; Yangzhou University; Ministry of Education, China; Yangzhou University	Guo, WS (corresponding author), Yangzhou Univ, Jiangsu Key Lab Crop Genet & Physiol, Yangzhou, Jiangsu, Peoples R China.; Guo, WS (corresponding author), Yangzhou Univ, Coinnovat Ctr Modern Prod Technol Grain Crops, Yangzhou, Jiangsu, Peoples R China.; Guo, WS (corresponding author), Yangzhou Univ, Wheat Res Inst, Yangzhou, Jiangsu, Peoples R China.; Guo, WS (corresponding author), Yangzhou Univ, Inst Agr Sci, Yangzhou, Jiangsu, Peoples R China.; Guo, WS (corresponding author), Yangzhou Univ, Inst Technol Dev, Yangzhou, Jiangsu, Peoples R China.; Guo, WS (corresponding author), Yangzhou Univ, Minist Educ China, Joint Int Res Lab Agr & Agriprod Safety, Yangzhou, Jiangsu, Peoples R China.	guows@yu.edu.cn		Ding, Jinfeng/0000-0002-3845-9429	National Natural Science Foundation of China [31401317]; National Key Research and Development Program of China [2016YFD0300405]; Special Scientific Research Fund of the Ministry of Agriculture [201503130]; Jiangsu Agricultural Industry Technology System [SXGC[2017]295]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Science and Technology Innovation Team of Yangzhou University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Special Scientific Research Fund of the Ministry of Agriculture; Jiangsu Agricultural Industry Technology System; Priority Academic Program Development of Jiangsu Higher Education Institutions; Science and Technology Innovation Team of Yangzhou University	This work was supported by the grants from the National Natural Science Foundation of China (31401317), the National Key Research and Development Program of China (2016YFD0300405), the Special Scientific Research Fund of the Ministry of Agriculture (201503130), Jiangsu Agricultural Industry Technology System (SXGC[2017]295), the Priority Academic Program Development of Jiangsu Higher Education Institutions and Science and Technology Innovation Team of Yangzhou University.	Ali M, 1999, FIELD CROP RES, V62, P35, DOI 10.1016/S0378-4290(99)00003-9; Araki H, 2012, FIELD CROP RES, V137, P27, DOI 10.1016/j.fcr.2012.09.006; Cheng S., 2012, WHEAT S CHINA; de San Celedonio RP, 2014, PLANT SOIL, V378, P265, DOI 10.1007/s11104-014-2028-6; Dickin E, 2009, J AGR SCI-CAMBRIDGE, V147, P127, DOI 10.1017/S0021859608008289; Dickin E, 2008, EUR J AGRON, V28, P234, DOI 10.1016/j.eja.2007.07.010; Eck HV, 1998, AGRON J, V80, P902; Ercoli L, 2008, EUR J AGRON, V28, P138, DOI 10.1016/j.eja.2007.06.002; Farooq M, 2014, CRIT REV PLANT SCI, V33, P331, DOI 10.1080/07352689.2014.875291; Foulkes MJ, 2007, FIELD CROP RES, V103, P11, DOI 10.1016/j.fcr.2007.04.007; GALES K, 1984, PLANT SOIL, V80, P67, DOI 10.1007/BF02232940; Hague ME, 2012, PLANT PROD SCI, V15, P164, DOI 10.1626/pps.15.164; Herzog M, 2016, PLANT CELL ENVIRON, V39, P1068, DOI 10.1111/pce.12676; Hossain MA, 2011, AUST J CROP SCI, V5, P1094; Izanloo A, 2008, J EXP BOT, V59, P3327, DOI 10.1093/jxb/ern199; Jager K, 2014, J PLANT PHYSIOL, V171, P1256, DOI 10.1016/j.jplph.2014.04.013; Li P, 2011, AGRON J, V103, P1619, DOI 10.2134/agronj2011.0013; Liu CL, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034002; Liu EK, 2016, AGR WATER MANAGE, V167, P75, DOI 10.1016/j.agwat.2015.12.026; Ma J, 2014, CROP SCI, V54, P331, DOI 10.2135/cropsci2013.03.0141; Nezhadahmadi A, 2013, SCI WORLD J, DOI 10.1155/2013/610721; Sayre K., 1994, ANN WHEAT NEWSL, V40, P165; Semenov MA, 2014, J CEREAL SCI, V59, P245, DOI 10.1016/j.jcs.2014.01.006; Setter TL, 2003, PLANT SOIL, V253, P1, DOI 10.1023/A:1024573305997; Setter TL, 2000, DAW292 GRDC, P68; Shao GC, 2013, PHOTOSYNTHETICA, V51, P429, DOI 10.1007/s11099-013-0039-9; SOJKA RE, 1975, AGRON J, V67, P591, DOI 10.2134/agronj1975.00021962006700050001x; Tan W, 2008, PHOTOSYNTHETICA, V46, P21, DOI 10.1007/s11099-008-0005-0; Vicente-Serrano SM, 2010, AGR FOREST METEOROL, V150, P614, DOI 10.1016/j.agrformet.2010.02.002; WATSON ER, 1976, AUST J EXP AGR, V16, P114, DOI 10.1071/EA9760114; Wollenweber B, 2003, J AGRON CROP SCI, V189, P142, DOI 10.1046/j.1439-037X.2003.00025.x; Wu JD, 2014, ACTA PHYSIOL PLANT, V36, P207, DOI 10.1007/s11738-013-1401-z; Yang JC, 2000, CROP SCI, V40, P1645, DOI 10.2135/cropsci2000.4061645x; Zhang H, 1999, IRRIGATION SCI, V19, P37, DOI 10.1007/s002710050069	34	25	25	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195535	10.1371/journal.pone.0195535	http://dx.doi.org/10.1371/journal.pone.0195535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630647	Green Published, Green Submitted, gold			2022-12-26	WOS:000429505000057
J	Lee, SE; Sung, JM; Cho, IJ; Kim, HC; Chang, HJ				Lee, Sang-Eun; Sung, Ji Min; Cho, In-Jeong; Kim, Hyeon Chang; Chang, Hyuk-Jae			Risk of new-onset diabetes among patients treated with statins according to hypertension and gender: Results from a nationwide health-screening cohort	PLOS ONE			English	Article							PRIMARY PREVENTION; THERAPY; INTERVENTION; METAANALYSIS; MORTALITY; MELLITUS; JUPITER; TRIAL; WOMEN	Background Statins have been known to increase the risk of incident type 2 diabetes mellitus (DM); however, other factors, especially hypertension, are also associated with DM development. Objective We investigated whether statin use increases the risk of DM and further analyzed whether the relation between statin use and incident DM differs according to the presence of hypertension and gender. Methods From a nationwide health-screening cohort, 40,164 participants with total cholesterol levels >= eve mg/dL and without pre-diagnosed DM, cardiovascular disease, or cancer, who underwent a series of regular health check-ups, were enrolled. Statin users were defined as participants who were prescribed statins more than twice during 6 months. Results There were 17,798 statin non-users and 22,366 statin users. During 7.66 +/- 3.21 years of follow-up, incident DM developed in 5.68% of statin non-users and 7.64% of statin users. Among the entire study population, statin use was associated with new-onset DM after adjusting for clinical risk factors. In sub-analysis according to hypertension, statin use significantly increased the risk of incident DM only in normotensive patients [hazard ratio (HR) 1.31, 95% confidence interval (CI) 1.09 to 1.58, p = 0.004], and not in hypertensive patients (p>0.05). Furthermore, continuous statin use was strongly associated with new-onset DM in women, regardless of hypertension presence (all p<0.05). However, in men, statin was associated with new-onset DM only in normotensive males (HR 1.61, 95% CI 1.35 to 1.92, p<0.001) and not in hypertensive males (p>0.05). Conclusions Statin use increased the risk of new-onset DM only in normotensive patients and hypertensive women, suggesting that these groups should be more carefully monitored for the development of DM during the course of follow-up.	[Lee, Sang-Eun; Sung, Ji Min; Cho, In-Jeong; Kim, Hyeon Chang; Chang, Hyuk-Jae] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, Dept Internal Med, Seoul, South Korea; [Lee, Sang-Eun; Sung, Ji Min; Cho, In-Jeong; Chang, Hyuk-Jae] Yonsei Univ, Yonsei Univ Hlth Syst, Integrat Cardiovasc Imaging Res Ctr, Coll Med, Seoul, South Korea; [Kim, Hyeon Chang] Yonsei Univ, Yonsei Univ Hlth Syst, Dept Prevent Med, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Chang, HJ (corresponding author), Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, Dept Internal Med, Seoul, South Korea.; Chang, HJ (corresponding author), Yonsei Univ, Yonsei Univ Hlth Syst, Integrat Cardiovasc Imaging Res Ctr, Coll Med, Seoul, South Korea.	hjchang@yuhs.ac	Kim, Hyeon Chang/F-8796-2019	Kim, Hyeon Chang/0000-0001-7867-1240; Lee, Sang-Eun/0000-0001-6645-4038; Chang, Hyuk-Jae/0000-0002-6139-7545	Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT (MSIT) [2012027176]	Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT (MSIT)	This research was supported by Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (MSIT), (No. 2012027176) (HJC). The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. HJC had full access to all of the data in the study and had final responsibility for the decision to submit for publication.	Baker WL, 2010, DIABETES RES CLIN PR, V87, P98, DOI 10.1016/j.diabres.2009.10.008; Culver AL, 2012, ARCH INTERN MED, V172, P144, DOI 10.1001/archinternmed.2011.625; Food U Administration D, 2015, FDA EXP ADV STAT RIS; Fulcher J, 2015, LANCET, V385, P1397, DOI 10.1016/S0140-6736(14)61368-4; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Ha KH, 2015, ENDOCRINOL METAB, V30, P142, DOI 10.3803/EnM.2015.30.2.142; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Koh KK, 2012, INT J CARDIOL, V154, P97, DOI 10.1016/j.ijcard.2011.09.002; Koo BK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110650; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Macedo AF, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-51; Mancia G, 2003, HYPERTENSION, V41, P431, DOI 10.1161/01.HYP.0000057420.27692.AD; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Mancia G, 2009, J HYPERTENS, V27, P1672, DOI 10.1097/HJH.0b013e32832be5f9; Mason JM, 2005, J HYPERTENS, V23, P1777, DOI 10.1097/01.hjh.0000177537.91527.09; Mora S, 2010, CIRCULATION, V121, P1069, DOI 10.1161/CIRCULATIONAHA.109.906479; Navarese EP, 2013, AM J CARDIOL, V111, P1123, DOI 10.1016/j.amjcard.2012.12.037; Park IB, 2013, DIABETES METAB J, V37, P233, DOI 10.4093/dmj.2013.37.4.233; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Rajpathak SN, 2009, DIABETES CARE, V32, P1924, DOI 10.2337/dc09-0738; Ridker PM, 2012, LANCET, V380, P565, DOI 10.1016/S0140-6736(12)61190-8; Sattar N, 2012, ATHEROSCLEROSIS SUPP, V13, P1, DOI 10.1016/j.atherosclerosissup.2012.06.001; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Sowers JR, 2000, NEW ENGL J MED, V342, P969, DOI 10.1056/NEJM200003303421310; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Waters DD, 2011, J AM COLL CARDIOL, V57, P1535, DOI 10.1016/j.jacc.2010.10.047; White J, 2016, JAMA CARDIOL, V1, P692, DOI 10.1001/jamacardio.2016.1884	28	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195459	10.1371/journal.pone.0195459	http://dx.doi.org/10.1371/journal.pone.0195459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630642	Green Published, gold			2022-12-26	WOS:000429505000050
J	Orysiak, J; Mazur-Rozycka, J; Fitzgerald, J; Starczewski, M; Malczewska-Lenczowska, J; Busko, K				Orysiak, Joanna; Mazur-Rozycka, Joanna; Fitzgerald, John; Starczewski, Michal; Malczewska-Lenczowska, Jadwiga; Busko, Krzysztof			Vitamin D status and its relation to exercise performance and iron status in young ice hockey players	PLOS ONE			English	Article							PROFESSIONAL FOOTBALL PLAYERS; ATHLETIC PERFORMANCE; COMPETITIVE SEASON; D SUPPLEMENTATION; D INSUFFICIENCY; HIGH PREVALENCE; MUSCLE FUNCTION; WINTER MONTHS; STRENGTH; ASSOCIATION	Objectives The aim was to examine the association between serum vitamin D concentration and isometric strength of various muscle groups, vertical jump performance, and repeated sprint ability in young ice hockey players. The secondary aim was to determine the association between vitamin D deficiency and indices of iron status. Methods Fifty male ice hockey players (17.2 +/- 0.9 years) participated in this cross-sectional study. Exercise performance was evaluated using isometric strength measures of upper and lower extremities, vertical jump performance and repeated sprint ability (RSA). Blood samples were collected for the determination of serum 25-hydroxyvitamin D (25(OH)D) and multiple indicies of iron status. Results The mean serum 25(OH)D concentration was 30.4 ng.ml(-1) and ranged from 12.5 to 91.4 ng.ml(-1). Eleven participants (22%) had vitamin D deficiency and 20 athletes (40%) had vitamin D insufficiency. Serum 25(OH)D concentration was not positively correlated with isometric muscle strength, vertical jump performance, or RSA after adjusting for age, training experience, fat mass, fat free mass and height. Serum 25(OH)D concentration was not associated with indices of iron status. Conclusion Vitamin D insufficiency is highly prevalent in ice hockey players, but 25(OH)D concentration but it is not associated with exercise performance or indices of iron status.	[Orysiak, Joanna; Malczewska-Lenczowska, Jadwiga] Natl Res Inst, Dept Nutr Physiol & Dietet, Inst Sport, Warsaw, Poland; [Mazur-Rozycka, Joanna] Natl Res Inst CIOP PIB, Cent Inst Labour Protect, Dept Ergon, Warsaw, Poland; [Fitzgerald, John] Univ North Dakota, Dept Kinesiol & Publ Hlth Educ, Grand Forks, ND USA; [Starczewski, Michal] Natl Res Inst, Dept Physiol, Inst Sport, Warsaw, Poland; [Busko, Krzysztof] Kazimierz Wielki Univ, Dept Anat & Biomech, Bydgoszcz, Poland	Institute of Sport - National Research Institute; Central Institute for Labour Protection - National Research Institute; University of North Dakota Grand Forks; Institute of Sport - National Research Institute; Kazimierz Wielki University	Busko, K (corresponding author), Kazimierz Wielki Univ, Dept Anat & Biomech, Bydgoszcz, Poland.	krzysztof.busko@ukw.edu.pl	Starczewski, Michal/AAS-9392-2021; Malczewska-Lenczowska, Jadwiga/O-4417-2018; Starczewski, Michal/ABH-1873-2021; Buśko, Krzysztof/ABE-7456-2020	Starczewski, Michal/0000-0001-7419-8943; Malczewska-Lenczowska, Jadwiga/0000-0001-9574-8158; Starczewski, Michal/0000-0001-7419-8943; Buśko, Krzysztof/0000-0002-6456-3502; Mazur-Rozycka, Joanna/0000-0002-3905-9291; Orysiak, Joanna/0000-0002-4998-2274	Fund for the Development of Physical Culture from the Ministry of Sport and Tourism, Republic of Poland [2016/0005/0223/SubB/DSW]; Institute of Sport National Research Institute [102.05]	Fund for the Development of Physical Culture from the Ministry of Sport and Tourism, Republic of Poland; Institute of Sport National Research Institute	This work was co-supported by the Fund for the Development of Physical Culture from the Ministry of Sport and Tourism, Republic of Poland (grant number 2016/0005/0223/SubB/DSW) and Institute of Sport National Research Institute (grant number 102.05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AM, 1997, J CLIN ENDOCR METAB, V82, P3976, DOI 10.1210/jc.82.12.3976; Bacchetta J, 2014, J AM SOC NEPHROL, V25, P564, DOI 10.1681/ASN.2013040355; Biesalski HK, 2011, NUTRITION, V27, pS1, DOI 10.1016/j.nut.2011.04.002; Bishop D, 2003, J SCI MED SPORT, V6, P199, DOI 10.1016/S1440-2440(03)80255-4; Brocherie F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144446; Cannell JJ, 2009, MED SCI SPORT EXER, V41, P1102, DOI 10.1249/MSS.0b013e3181930c2b; Close GL, 2013, J SPORT SCI, V31, P344, DOI 10.1080/02640414.2012.733822; Close GL, 2013, BRIT J SPORT MED, V47, P692, DOI 10.1136/bjsports-2012-091735; Constantini NW, 2010, CLIN J SPORT MED, V20, P368, DOI 10.1097/JSM.0b013e3181f207f2; Crowe FL, 2011, PUBLIC HEALTH NUTR, V14, P340, DOI 10.1017/S1368980010002454; Dahlquist DT, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0093-8; Deakin V, 2010, CLIN SPORTS NUTR, P222; Dellavalle DM, 2014, MED SCI SPORT EXER, V46, P1204, DOI 10.1249/MSS.0000000000000208; DeLuca HF, 2016, VITAM HORM, V100, P1, DOI 10.1016/bs.vh.2015.11.001; Dubnov-Raz G, 2015, PEDIATR EXERC SCI, V27, P113, DOI 10.1123/pes.2014-0030; Dzedzej A, 2016, BIOL SPORT, V33, P223, DOI 10.5604/20831862.1201811; Fallon KE, 2008, J SCI MED SPORT, V11, P329, DOI 10.1016/j.jsams.2007.02.017; Farlinger CM, 2007, J STRENGTH COND RES, V21, P915; Farrokhyar F, 2015, SPORTS MED, V45, P365, DOI 10.1007/s40279-014-0267-6; Fitzgerald JS, 2015, J STRENGTH COND RES, V29, P2513, DOI 10.1519/JSC.0000000000000887; Fitzgerald JS, 2014, J STRENGTH COND RES, V28, P3200, DOI 10.1519/JSC.0000000000000523; Gajewski J, 2011, BIOL SPORT, V28, P239, DOI 10.5604/965479; Gajewski J, 2018, ACTA BIOENGINEERING, V20; Gibson R.S., 2005, PRINCIPLES NUTR ASSE, V2nd ed., P443; Hamilton B, 2014, J SCI MED SPORT, V17, P139, DOI 10.1016/j.jsams.2013.03.006; Heaney RP, 2011, J BONE MINER RES, V26, P455, DOI 10.1002/jbmr.328; Hinton PS, 2014, APPL PHYSIOL NUTR ME, V39, P1012, DOI 10.1139/apnm-2014-0147; Jastrzebska M, 2016, J STRENGTH COND RES, V30, P2648, DOI 10.1519/JSC.0000000000001337; Koundourakis NE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101659; Malczewska-Lenczowska J, 2009, BIOMED HUM KINET, V1, P36, DOI 10.2478/v10101-009-0010-1; Mielgo-Ayuso J, 2015, APPL PHYSIOL NUTR ME, V40, P615, DOI 10.1139/apnm-2014-0500; Monlezun DJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001799; Orysiak J, 2015, J STRENGTH COND RES, V29, P2333, DOI 10.1519/JSC.0000000000000880; Owens DJ, 2018, SPORTS MED, V48, pS3, DOI 10.1007/s40279-017-0841-9; Peeling P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093002; Peterson BJ, 2015, J STRENGTH COND RES, V29, P1465, DOI 10.1519/JSC.0000000000000786; Pludowski P, 2013, ENDOKRYNOL POL, V64, P319, DOI 10.5603/EP.2013.0012; Sghaier-Ayadi A, 2015, BIOL SPORT, V32, P281, DOI 10.5604/20831862.1163690; Solarz K, 2014, PHYSIOL RES, V63, P237, DOI 10.33549/physiolres.932586; Valtuena J, 2014, NUTR HOSP, V30, P124, DOI 10.3305/nh.2014.30.1.7539; Weaver CM, 2004, AM J CLIN NUTR, V80, p1735S, DOI 10.1093/ajcn/80.6.1735S; Wyon MA, 2016, CLIN J SPORT MED, V26, P279, DOI 10.1097/JSM.0000000000000264; Wyon MA, 2014, J SCI MED SPORT, V17, P8, DOI 10.1016/j.jsams.2013.03.007	43	9	10	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195284	10.1371/journal.pone.0195284	http://dx.doi.org/10.1371/journal.pone.0195284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630669	Green Published, gold, Green Submitted			2022-12-26	WOS:000429505000035
J	Wozniak-Knopp, G; Stadlmayr, G; Perthold, JW; Stadlbauer, K; Gotsmy, M; Becker, S; Ruker, F				Wozniak-Knopp, Gordana; Stadlmayr, Gerhard; Perthold, Jan Walther; Stadlbauer, Katharina; Gotsmy, Mathias; Becker, Stefan; Rueker, Florian			An antibody with Fab-constant domains exchanged for a pair of C(H)3 domains	PLOS ONE			English	Article							NEONATAL FC-RECEPTOR; HUMAN IGG1; EFFECTOR FUNCTION; STRUCTURAL CLASSIFICATION; DIRECTED EVOLUTION; VARIABLE DOMAINS; IMMUNOGLOBULIN-G; BISPECIFIC IGG; DISULFIDE BOND; STABILITY	We have designed a complete antibody-like construct where the C(H)1 and C-K domains are exchanged for a pair of the C(H)3 domains and efficient pairing of the heavy and light variable domain is achieved using "Knobs-into-Holes" strategy. This construct, composed of only naturally occurring immunoglobulin sequences without artificial linkers, expressed at a high level in mammalian cells, however exhibited low solubility. Rational mutagenesis aimed at the amino acid residues located at the interface of the variable domains and the exchanged CH3 domains was applied to improve the biophysical properties of the molecule. The domain -exchanged construct, including variable domains of the HER2/neu specific antibody trastuzumab, was able to bind to the surface of the strongly HER2/neu positive cell line SKBR3 4-fold weaker than trastuzumab, but could nevertheless incite a more potent response in an antibody-dependent cell cytotoxicity (ADCC) reporter assay with Fc gamma RIlla-overexpressing T-cells. This could be explained with a stronger binding to the Fc gamma RIlla. Importantly, the novel construct could mediate a specific ADCC effect with natural killer cells similar to the parental antibody.	[Wozniak-Knopp, Gordana; Stadlmayr, Gerhard; Stadlbauer, Katharina; Gotsmy, Mathias; Rueker, Florian] Univ Nat Resources & Life Sci BOKU, Dept Biotechnol, Christian Doppler Lab Innovat Immunotherapeut, Vienna, Austria; [Perthold, Jan Walther] Univ Nat Resources & Life Sci BOKU, Inst Mol Modeling & Simulat, Dept Mat Sci, Vienna, Austria; [Becker, Stefan] Merck KGaA, Prot Engn & Antibody Technol, Darmstadt, Germany	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; Merck KGaA	Wozniak-Knopp, G (corresponding author), Univ Nat Resources & Life Sci BOKU, Dept Biotechnol, Christian Doppler Lab Innovat Immunotherapeut, Vienna, Austria.	gordana.wozniak@boku.ac.at	Wozniak-Knopp, Gordana/AAL-5148-2021; Perthold, Jan Walther/I-3359-2019	Wozniak-Knopp, Gordana/0000-0002-4069-070X; Perthold, Jan Walther/0000-0002-8575-0278; Stadlbauer, Katharina/0000-0002-0724-5874; Gotsmy, Mathias/0000-0003-1333-4870; Rueker, Florian/0000-0001-7639-2686	Christian Doppler Research Society (Christian Doppler Gesellschaft, CDG, Austria); F-star; Merck KGaA	Christian Doppler Research Society (Christian Doppler Gesellschaft, CDG, Austria); F-star; Merck KGaA(Merck & Company)	This study was funded by Christian Doppler Research Society (Christian Doppler Gesellschaft, CDG, Austria) to GWK, (CD Laboratory for Innovative Immunotherapeutics) and F-star (www.f-star.com). These funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Merck KGaA provided support in the form of salary for author SB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; Cheng ZJ, 2014, J IMMUNOL METHODS, V414, P69, DOI 10.1016/j.jim.2014.07.010; Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P9266, DOI 10.1021/bi980270i; Dimitrov DS, 2009, MABS, V1, P26, DOI 10.4161/mabs.1.1.7480; Gong R, 2009, J BIOL CHEM, V284, P14203, DOI 10.1074/jbc.M900769200; Grevys A, 2015, J IMMUNOL, V194, P5497, DOI 10.4049/jimmunol.1401218; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; Hu SZ, 1996, CANCER RES, V56, P3055; Ionescu RM, 2008, J PHARM SCI-US, V97, P1414, DOI 10.1002/jps.21104; Kiyoshi M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7866; Krah S, 2017, PROTEIN ENG DES SEL, V30, P291, DOI 10.1093/protein/gzw077; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Lefranc MP, 2009, IMGT INT IMMUNOGENET; LESK AM, 1988, NATURE, V335, P188, DOI 10.1038/335188a0; Leung KM, 2015, MOL THER, V23, P1722, DOI 10.1038/mt.2015.127; Liu Z, 2015, J BIOL CHEM, V290, P7535, DOI 10.1074/jbc.M114.620260; Matsumiya S, 2007, J MOL BIOL, V368, P767, DOI 10.1016/j.jmb.2007.02.034; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Moore PA, 2011, BLOOD, V117, P4542, DOI 10.1182/blood-2010-09-306449; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Rothlisberger D, 2005, J MOL BIOL, V347, P773, DOI 10.1016/j.jmb.2005.01.053; Saxena A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00580; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shen Y, 2013, MABS-AUSTIN, V5, P418, DOI 10.4161/mabs.24291; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Skegro D, 2017, J BIOL CHEM; Teerinen T, 2006, J MOL BIOL, V361, P687, DOI 10.1016/j.jmb.2006.06.073; Teplyakov A, 2013, MOL IMMUNOL, V56, P131, DOI 10.1016/j.molimm.2013.03.018; TISCHENKO VM, 1982, EUR J BIOCHEM, V126, P517, DOI 10.1111/j.1432-1033.1982.tb06811.x; Tischenko VM, 1998, BIOCHEMISTRY-US, V37, P5576, DOI 10.1021/bi972647a; Traxlmayr MW, 2012, J MOL BIOL, V423, P397, DOI 10.1016/j.jmb.2012.07.017; Traxlmayr MW, 2012, BBA-PROTEINS PROTEOM, V1824, P542, DOI 10.1016/j.bbapap.2012.01.006; Vaughn DE, 1998, STRUCTURE, V6, P63, DOI 10.1016/S0969-2126(98)00008-2; Vermeer AWP, 2000, BIOPHYS J, V78, P394, DOI 10.1016/S0006-3495(00)76602-1; Von Kreudenstein TS, 2013, MABS-AUSTIN, V5, P646, DOI 10.4161/mabs.25632; Wozniak-Knopp G, 2010, PROTEIN ENG DES SEL, V23, P289, DOI 10.1093/protein/gzq005; Wozniak-Knopp G, 2012, ARCH BIOCHEM BIOPHYS, V526, P181, DOI 10.1016/j.abb.2012.03.024; Wozniak-Knopp G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030083; Yan BX, 2012, J BIOL CHEM, V287, P5891, DOI 10.1074/jbc.M111.311811	43	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195442	10.1371/journal.pone.0195442	http://dx.doi.org/10.1371/journal.pone.0195442			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630643	gold, Green Published, Green Submitted			2022-12-26	WOS:000429505000049
J	Heinrichs, V; Dieluweit, S; Stellbrink, J; Pyckhout-Hintzen, W; Hersch, N; Richter, D; Merkel, R				Heinrichs, Viktor; Dieluweit, Sabine; Stellbrink, Jorg; Pyckhout-Hintzen, Wim; Hersch, Nils; Richter, Dieter; Merkel, Rudolf			Chemically defined, ultrasoft PDMS elastomers with selectable elasticity for mechanobiology	PLOS ONE			English	Article							LINEAR VISCOELASTICITY; MECHANICAL-PROPERTIES; CURE KINETICS; CELL; STIFFNESS; RIGIDITY; SIZE; POLYMER	Living animal cells are strongly influenced by the mechanical properties of their environment. To model physiological conditions ultrasoft cell culture substrates, in some instances with elasticity (Young's modulus) of only 1 kPa, are mandatory. Due to their long shelf life PDMS-based elastomers are a popular choice. However, uncertainty about additives in commercial formulations and difficulties to reach very soft materials limit their use. Here, we produced silicone elastomers from few, chemically defined and commercially available substances. Elastomers exhibited elasticities in the range from 1 kPa to 55 kPa. In detail, a high molecular weight (155 kg/mol), vinyl-terminated linear silicone was crosslinked with a multifunctional (f = 51) crosslinker (a copolymer of dimethyl siloxane and hydrosilane) by a platinum catalyst. The following different strategies towards ultrasoft materials were explored: sparse crosslinking, swelling with inert silicone polymers, and, finally, deliberate introduction of dangling ends into the network (inhibition). Rheological experiments with very low frequencies led to precise viscoelastic characterizations. All strategies enabled tuning of stiffness with the lowest stiffness of-1 kPa reached by inhibition. This system was also most practical to use. Biocompatibility of materials was tested using primary cortical neurons from rats. Even after several days of cultivation no adverse effects were found.	[Heinrichs, Viktor; Dieluweit, Sabine; Hersch, Nils; Merkel, Rudolf] Forschungszentrum Julich, Inst Complex Syst 7, Julich, Germany; [Heinrichs, Viktor; Stellbrink, Jorg; Pyckhout-Hintzen, Wim; Richter, Dieter] Forschungszentrum Julich, Juelich Ctr Neutron Sci 1, Julich, Germany; [Heinrichs, Viktor; Stellbrink, Jorg; Pyckhout-Hintzen, Wim; Richter, Dieter] Forschungszentrum Julich, Inst Complex Syst 1, Julich, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich	Merkel, R (corresponding author), Forschungszentrum Julich, Inst Complex Syst 7, Julich, Germany.	r.merkel@fz-juelich.de	pyckhout-hintzen, wim/J-9461-2013; Stellbrink, Jorg/K-3351-2013; Richter, Dieter/H-3701-2013; Merkel, Rudolf/G-3647-2013	pyckhout-hintzen, wim/0000-0002-1142-359X; Stellbrink, Jorg/0000-0001-6183-3901; Richter, Dieter/0000-0003-0719-8470; Merkel, Rudolf/0000-0003-3178-3282; Hersch, Nils/0000-0003-4717-8984				[Anonymous], 1980, VISCOELASTIC PROPERT; Bejenariu A.G., 2009, COMP STUDY INFLUENCE, V17, P269; Brands D W, 2000, Stapp Car Crash J, V44, P249; Cai LH, 2015, ADV MATER, V27, P5132, DOI 10.1002/adma.201502771; Carraher CE, 2000, APPL POLYM SCI 21 CE; CHAMBON F, 1987, J RHEOL, V31, P683, DOI 10.1122/1.549955; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Colby R.H., 2003, POLYM PHYS; DAVIDSON DW, 1950, J CHEM PHYS, V18, P1417, DOI 10.1063/1.1747496; DAVIDSON DW, 1951, J CHEM PHYS, V19, P1484, DOI 10.1063/1.1748105; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Doi M., 1988, THEORY POLYM DYNAMIC; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Eyckmans J, 2011, DEV CELL, V21, P35, DOI 10.1016/j.devcel.2011.06.015; FALLENSTEIN GT, 1969, J BIOMECH, V2, P217, DOI 10.1016/0021-9290(69)90079-7; Flory PJ, 1941, J AM CHEM SOC, V63, P3083, DOI 10.1021/ja01856a061; Frankr SMG, 2012, RHEOL ACTA, V51, P559, DOI 10.1007/s00397-012-0624-z; Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Guan DB, 2016, CHINESE J POLYM SCI, V34, P1290, DOI 10.1007/s10118-016-1847-8; HAVRILIAK S, 1966, J POLYM SCI POL SYM, P99; Hong IK, 2013, J IND ENG CHEM, V19, P42, DOI 10.1016/j.jiec.2012.05.006; Jensen MK, 2009, INT J ADHES ADHES, V29, P687, DOI 10.1016/j.ijadhadh.2008.10.005; Larsen AL, 2004, E-POLYMERS; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Moreira R, 2014, TISSUE ENG PART C-ME, V20, P741, DOI 10.1089/ten.tec.2013.0426; Mrozek RA, 2011, POLYMER, V52, P3422, DOI 10.1016/j.polymer.2011.05.021; Nejad SP, 2016, ADV DRUG DELIVER REV, V96, P161, DOI 10.1016/j.addr.2015.11.003; PATEL SK, 1992, MACROMOLECULES, V25, P5241, DOI 10.1021/ma00046a021; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274; Santoro F, 2014, NANO LETT, V14, P6906, DOI 10.1021/nl502922b; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; STAUFFER D, 1994, INTRO PERCOLATION TH; Tee SY, 2011, BIOPHYS J, V100, pL25, DOI 10.1016/j.bpj.2010.12.3744; TOLL JS, 1956, PHYS REV, V104, P1760, DOI 10.1103/PhysRev.104.1760; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Vlahos C, 2003, POLYMER, V44, P503, DOI 10.1016/S0032-3861(02)00511-6; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zorn R, 2002, J CHEM PHYS, V116, P3204, DOI 10.1063/1.1446035	45	14	14	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195180	10.1371/journal.pone.0195180	http://dx.doi.org/10.1371/journal.pone.0195180			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624610	Green Published, gold, Green Submitted			2022-12-26	WOS:000429379600017
J	Nogueira, BMF; Rolla, VC; Akrami, KM; Kiene, SM				Nogueira, Betania M. F.; Rolla, Valeria C.; Akrami, Kevan M.; Kiene, Susan M.			Factors associated with tuberculosis treatment delay in patients co-infected with HIV in a high prevalence area in Brazil	PLOS ONE			English	Article							RIO-DE-JANEIRO; DIAGNOSIS	Background Worldwide, about 11% of Tuberculosis (TB) cases occur in people living with HIV (PLHIV) and it is the leading cause of death in this population. An important step towards reducing the incidence and mortality of TB in PLHIV is to reduce the time from onset of symptoms to treatment. Factors related to TB treatment delay therefore need to be understood. Methods Using data from a prospective cohort study of patients diagnosed with TB at the National Institute of Infectious Disease, at the Oswaldo Cruz Foundation, Rio de Janeiro, Brazil we conducted a survival analysis to identify factors associated with patient and health care treatment delay. In our analysis we included patients who were co-infected with TB and HIV (n = 201). Patients were followed during the course of their TB treatment and information regarding duration of symptoms, sociodemographics and clinical characteristics were collected at the baseline visit. Results The median time from onset of initial symptoms to prescription of TB treatment (total delay) was 82 days. From initiation of symptoms to first visit at INI clinic (patient delay), the median was 51 days. From first visit to initiation of treatment (health care delay) the median was 16 days. Illiteracy was associated with greater patient delay [Hazard Ratio (HR) = 2.25, CI 95% 1.29-3.94]. Having had a previous episode of TB (HR = 0.53, CI 95% 0.37-0.74) and being married (HR = 0.71, CI 95% 0.54-0.94) were inversely related to patient delay. Illiteracy was also associated with greater health care delay (HR = 2.83, CI 95% 1.25-5.47) in contrast to high viral load (HR = 0.37, CI 95% 0.24-0.54) and weight loss greater than 10% (HR = 0.54, CI 95% 0.37-0.8), both of which were inversely related to health care delay. Conclusions This study highlights the existence of factors that lead to greater risk of delayed treatment of TB among patients co-infected with HIV and TB. These include factors that can be assessed through targeted interventions which have implications for improving treatment outcomes and, through reduced duration of infectiousness, reduce the incidence of TB in Brazil.	[Nogueira, Betania M. F.; Kiene, Susan M.] San Diego State Univ, Div Epidemiol & Biostat, San Diego, CA 92182 USA; [Rolla, Valeria C.] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [Akrami, Kevan M.] Univ Calif San Diego, Div Infect Dis, La Jolla, CA 92093 USA	California State University System; San Diego State University; Fundacao Oswaldo Cruz; University of California System; University of California San Diego	Nogueira, BMF (corresponding author), San Diego State Univ, Div Epidemiol & Biostat, San Diego, CA 92182 USA.	betaniafnogueira@gmail.com	Rolla, Valeria Cavalcanti/AAI-6078-2021	Rolla, Valeria Cavalcanti/0000-0002-0841-1408; Kiene, Susan/0000-0001-8922-5289	Rotary Foundation [GG1745722]; J. Keith Behner and Catherine M. Stiefel Program (SDSU) on Brazil; UNODC; Clinical Research Laboratory on Mycobacteria of INI, FIOCRUZ [01/2013]	Rotary Foundation; J. Keith Behner and Catherine M. Stiefel Program (SDSU) on Brazil; UNODC; Clinical Research Laboratory on Mycobacteria of INI, FIOCRUZ	This work was supported by the Rotary Foundation grant GG1745722 and J. Keith Behner and Catherine M. Stiefel Program (SDSU) on Brazil to BMFN and the Brazilian Program of STD-AIDS and Viral Hepatitis, in partnership with the UNODC and the Clinical Research Laboratory on Mycobacteria of INI, FIOCRUZ, edital modalidade pesquisas no 01/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coimbra I, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-208; dos Santos MAPS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-25; Durovni B, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001766; Golub JE, 2006, INT J TUBERC LUNG D, V10, P24; Hudson CP, 2000, INT J TUBERC LUNG D, V4, P240; [Institut Brasileiro de Geogratia e Estatistica (IBGE) Pesquisa Nacional por Amostra de Domicilios (PNAD)], 2009, PESQ NAC AM DOM; Instituto Brasileiro de Geografia e Estatistica ( IBGE), 2016, 36 IBGE; Instituto Paulo Montenegro, 2011, IND ALF FUNC BRAS 20; Lienhardt C, 2001, INT J TUBERC LUNG D, V5, P233; Madebo T., 1999, MED GEN MED, pE6; Ministerio da Saude, 2015, B EP TUB, V46; Ministerio da Saude do Brasil, 2015, B EP HIV AIDS; Saldana L, 2013, PUBLIC HEALTH, V127, P171, DOI 10.1016/j.puhe.2012.11.010; Saraceni V, 2008, INT J TUBERC LUNG D, V12, P769; Saraceni V, 2014, JAIDS-J ACQ IMM DEF, V67, P98, DOI 10.1097/QAI.0000000000000247; Scatena Lúcia Marina, 2009, Rev. Saúde Pública, V43, P389, DOI 10.1590/S0034-89102009005000022; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Schmaltz CAS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045704; Statistics Canada OECD, 2013, OECD SKILLS OUTL 201; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Sunnetcioglu A, 2015, ANN CLIN MICROB ANTI; Sunnetcioglu A, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0092-2; UNAIDS, 2016, PREV GAP REP; Virenfeldt J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004818; Whitehorn J, 2010, INT J TUBERC LUNG D, V14, P741; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2014, THE END TB STRAT; World Health Organization, 2016, GLOB HLTH SECT STRAT; World Health Organization, TUB PROF 2016; Wysocki AD, 2013, REV ESC ENFERM USP, V47, P434; Ponce MAZ, 2016, EPIDEMIOL SERV SAUDE, V25, P553, DOI [10.5123/s1679-49742016000300011, 10.5123/S1679-49742016000300011]	31	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195409	10.1371/journal.pone.0195409	http://dx.doi.org/10.1371/journal.pone.0195409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624603	Green Published, gold, Green Submitted			2022-12-26	WOS:000429379600027
J	Balakrishnan, S; Mironov, SL				Balakrishnan, Saju; Mironov, Sergej L.			Rescue of hyperexcitability in hippocampal CA1 neurons from Mecp2 ((-/y)) mouse through surface potential neutralization	PLOS ONE			English	Article							HCN1 CHANNELS; RETT-SYNDROME; BRAIN-STEM; CALCIUM-CHANNELS; EXTRACELLULAR PH; I-H; MODEL; HYPERVENTILATION; DYSFUNCTION; MAGNESIUM	Hyperventilation is a known feature of Rett syndrome (RTT). However, how hyperventilation is related to other RTT symptoms such as hyperexcitability is unknown. Intense breathing during hyperventilation induces hypocapnia and culminates in respiratory alkalosis. Alkalinization of extracellular milieu can trigger epilepsy in patients who already have neuronal hyperexcitability. By combining patch-clamp electrophysiology and quantitative glutamate imaging, we compared excitability of CA1 neurons of WT and Mecp2 ((-/y)) mice, and analyzed the biophysical properties of subthreshold membrane channels. The results show that Mecp2 ((-/y)) CA1 neurons are hyperexcitable in normal pH (7.4) and are increasingly vulnerable to alkaline extracellular pH (8.4), during which their excitability increased further. Under normal pH conditions, an abnormal negative shift in the voltage-dependencies of HCN (hyperpolarization-activated cyclic nucleotide-gated) and calcium channels in the CA1 neurons of Mecp2 ((-/y)) mice was observed. Alkaline pH also enhanced excitability in wild-type (WT) CA1 neurons through modulation of the voltage dependencies of HCN- and calcium channels. Additionally alkaline pH augmented spontaneous glutamate release and burst firing in WT CA1 neurons. Conversely, acidic pH (6.4) and 8 mM Mg2+ exerted the opposite effect, and diminished hyperexcitability in Mecp2 ((-/y)) CA1 neurons. We propose that the observed effects of pH and Mg2+ are mediated by changes in the neuronal membrane surface potential, which consecutively modulates the gating of HCN and calcium channels. The results provide insight to pivotal cellular mechanisms that can regulate neuronal excitability and help to devise treatment strategies for hyperexcitability induced symptoms of Rett syndrome.	[Balakrishnan, Saju; Mironov, Sergej L.] Georg August Univ, Inst Neuro & Sensory Physiol, CNMPB Ctr Nanoscale Microscopy & Mol Physiol, DFG Res Ctr 103,Cluster Excellence 171, Gottingen, Germany	University of Gottingen	Balakrishnan, S (corresponding author), Georg August Univ, Inst Neuro & Sensory Physiol, CNMPB Ctr Nanoscale Microscopy & Mol Physiol, DFG Res Ctr 103,Cluster Excellence 171, Gottingen, Germany.	saju.balakrishnan@med.uni-goettingen.de			Deutsche Forschungsgemeinschaft through Centre for Nanoscale Microscopy and Molecular Physiology of the Brain, Cluster of Excellence [171]; Cluster of Excellence; DFG Research Centre for Nano scale Microscopy and Molecular Physiology of the Brain [EXC 171, FZT 103]	Deutsche Forschungsgemeinschaft through Centre for Nanoscale Microscopy and Molecular Physiology of the Brain, Cluster of Excellence; Cluster of Excellence; DFG Research Centre for Nano scale Microscopy and Molecular Physiology of the Brain	This project was funded by The Deutsche Forschungsgemeinschaft through Centre for Nanoscale Microscopy and Molecular Physiology of the Brain, Cluster of Excellence 171.	Avery RB, 1996, J NEUROSCI, V16, P5567; Balakrishnan S, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00015; Bender RA, 2007, J NEUROSCI, V27, P4697, DOI 10.1523/JNEUROSCI.4699-06.2007; Bodda C, 2013, AM J PATHOL, V183, P195, DOI 10.1016/j.ajpath.2013.03.019; Calfa G, 2011, J NEUROPHYSIOL, V105, P1768, DOI 10.1152/jn.00800.2010; Chapleau CA, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/976164; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Cichy A, 2015, J NEUROSCI, V35, P4025, DOI 10.1523/JNEUROSCI.2593-14.2015; CIRIGNOTTA F, 1986, AM J MED GENET, V24, P167; De Filippis B, 2010, GENES BRAIN BEHAV, V9, P213, DOI 10.1111/j.1601-183X.2009.00551.x; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; Doering CJ, 2007, NEUROSCIENCE, V146, P1032, DOI 10.1016/j.neuroscience.2007.02.049; Durante P, 2004, J NEUROPHYSIOL, V91, P1450, DOI 10.1152/jn.01015.2003; EGGER J, 1992, LANCET, V340, P621, DOI 10.1016/0140-6736(92)92166-D; Ermolyuk YS, 2013, NAT NEUROSCI, V16, P1754, DOI 10.1038/nn.3563; Fedorovich SV, 2003, NEUROCHEM RES, V28, P715, DOI 10.1023/A:1022809716834; Galland L, 1991, Magnes Trace Elem, V10, P287; Gantz SC, 2011, J NEUROSCI, V31, P12629, DOI 10.1523/JNEUROSCI.0684-11.2011; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Herrmann S, 2015, INT J MOL SCI, V16, P1429, DOI 10.3390/ijms16011429; HILLE B, 1975, PHILOS T R SOC B, V270, P301, DOI 10.1098/rstb.1975.0011; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Holmes MD, 2004, EPILEPSIA, V45, P618, DOI 10.1111/j.0013-9580.2004.63803.x; Huang Z, 2011, NAT NEUROSCI, V14, P478, DOI 10.1038/nn.2757; Isaev D, 2012, J NEUROPHYSIOL, V107, P417, DOI 10.1152/jn.00574.2011; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; Janc OA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00056; Jin XR, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00316; Julu POO, 2001, ARCH DIS CHILD, V85, P29, DOI 10.1136/adc.85.1.29; Kalmbach BE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0114-15.2015; Kase D, 2012, J SIGNAL TRANSDUCT; KERR A, 1990, BRAIN DEV-JPN, V12, P61, DOI 10.1016/S0387-7604(12)80179-3; Khurana I, 2015, TXB MED PHYSL; KOSTYUK PG, 1982, J MEMBRANE BIOL, V70, P171, DOI 10.1007/BF01870560; Kumandas S, 2001, BRAIN DEV-JPN, V23, P240, DOI 10.1016/S0387-7604(01)00191-7; Kuwana S, 1998, BRAIN RES, V786, P194, DOI 10.1016/S0006-8993(97)01476-5; Lei SB, 2001, J NEUROPHYSIOL, V85, P2030, DOI 10.1152/jn.2001.85.5.2030; Lewis AS, 2011, MOL CELL NEUROSCI, V46, P357, DOI 10.1016/j.mcn.2010.11.007; MA J, 1988, SCIENCE, V242, P99, DOI 10.1126/science.2459777; Mackay J, 2017, J NEURODEV DISORD, V9, DOI 10.1186/s11689-017-9196-7; Makani S, 2007, J NEUROSCI, V27, P7438, DOI 10.1523/JNEUROSCI.2304-07.2007; Malcolm AT, 2003, BBA-BIOMEMBRANES, V1609, P183, DOI 10.1016/S0005-2736(02)00687-9; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; Medrihan L, 2008, J NEUROPHYSIOL, V99, P112, DOI 10.1152/jn.00826.2007; Mironov SL, 2011, NEUROPHARMACOLOGY, V60, P869, DOI 10.1016/j.neuropharm.2011.01.002; Mironov SL, 2009, J PHYSIOL-LONDON, V587, P2473, DOI 10.1113/jphysiol.2009.169805; Mironov SL, 2000, EUR J NEUROSCI, V12, P520, DOI 10.1046/j.1460-9568.2000.00928.x; Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009; Noam Y, 2011, CURR OPIN NEUROBIOL, V21, P873, DOI 10.1016/j.conb.2011.06.013; Oginsky MF, 2017, J CELL PHYSIOL, V232, P1151, DOI 10.1002/jcp.25589; Okamoto K, 2014, J PHYSIOL SCI, V64, P421, DOI 10.1007/s12576-014-0337-4; Postea O, 2011, NAT REV DRUG DISCOV, V10, P903, DOI 10.1038/nrd3576; Ren J, 2012, J NEUROSCI, V32, P17230, DOI 10.1523/JNEUROSCI.2951-12.2012; Ricciardi S, 2011, HUM MOL GENET, V20, P1182, DOI 10.1093/hmg/ddq563; Rusakov DA, 1999, TRENDS NEUROSCI, V22, P382, DOI 10.1016/S0166-2236(99)01425-3; Schneider D, 2009, NEUROLOGICAL B, V1, P11; Shah MJ, 2001, J NEUROPHYSIOL, V85, P1051, DOI 10.1152/jn.2001.85.3.1051; Sinning A, 2013, FEBS LETT, V587, P1923, DOI 10.1016/j.febslet.2013.04.045; Somjen GG, 2002, NEUROSCIENTIST, V8, P254, DOI 10.1177/1073858402008003011; SOUTHALL DP, 1988, ARCH DIS CHILD, V63, P1039, DOI 10.1136/adc.63.9.1039; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; Toloe J, 2014, MOL CELL NEUROSCI, V59, P47, DOI 10.1016/j.mcn.2013.12.008; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; Tsay D, 2007, NEURON, V56, P1076, DOI 10.1016/j.neuron.2007.11.015; TSUKIOKA M, 1994, J PHYSIOL-LONDON, V475, P369, DOI 10.1113/jphysiol.1994.sp020078; Vaidya SP, 2013, NAT NEUROSCI, V16, P1812, DOI 10.1038/nn.3562; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Zemankovics R, 2010, J PHYSIOL-LONDON, V588, P2109, DOI 10.1113/jphysiol.2009.185975; Zhang L, 2008, HIPPOCAMPUS, V18, P294, DOI 10.1002/hipo.20389; Zhang W, 2014, J NEUROSCI, V34, P2754, DOI 10.1523/JNEUROSCI.4900-12.2014	71	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195094	10.1371/journal.pone.0195094	http://dx.doi.org/10.1371/journal.pone.0195094			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621262	Green Published, gold, Green Submitted			2022-12-26	WOS:000429206800037
J	Zheng, TY; Lanahan, AA; Lynd, LR; Olson, DG				Zheng, Tianyong; Lanahan, Anthony A.; Lynd, Lee R.; Olson, Daniel G.			The redox-sensing protein Rex modulates ethanol production in Thermoanaerobacterium saccharolyticum	PLOS ONE			English	Article							STRESS-RESPONSE; CLOSTRIDIUM-THERMOCELLUM; REPRESSOR REX; WILD-TYPE; TOLERANCE; BACTERIUM; ALCOHOL	Thermoanaerobacterium saccharolyticum is a thermophilic anaerobe that has been engineered to produce high amounts of ethanol, reaching similar to 90% theoretical yield at a titer of 70 g/L. Here we report the physiological changes that occur upon deleting the redox-sensing transcriptional regulator Rex in wild type T. saccharolyticum: a single deletion of rex resulted in a two-fold increase in ethanol yield (from 40% to 91% theoretical yield), but the resulting strains grew only about a third as fast as the wild type strain. Deletion of the rex gene also had the effect of increasing expression of alcohol dehydrogenase genes, adhE and adhA. After several serial transfers, the ethanol yield decreased from an average of 91% to 55%, and the growth rates had increased. We performed whole-genome resequencing to identify secondary mutations in the Delta rex strains adapted for faster growth. In several cases, secondary mutations had appeared in the adhE gene. Furthermore, in these strains the NADH-linked alcohol dehydrogenase activity was greatly reduced. Complementation studies were done to reintroduce rex into the Delta rex strains: reintroducing rex decreased ethanol yield to below wild type levels in the Delta rex strain without adhE mutations, but did not change the ethanol yield in the Delta rex strain where an adhE mutation occurred.	[Zheng, Tianyong; Lynd, Lee R.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Zheng, Tianyong; Lanahan, Anthony A.; Lynd, Lee R.; Olson, Daniel G.] BioEnergy Sci Ctr, Oak Ridge, TN 37831 USA; [Lanahan, Anthony A.; Lynd, Lee R.; Olson, Daniel G.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Lanahan, Anthony A.; Lynd, Lee R.; Olson, Daniel G.] Ctr Bioenergy Innovat, Oak Ridge, TN 37831 USA	Dartmouth College; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); Dartmouth College	Lynd, LR (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.; Lynd, LR; Olson, DG (corresponding author), BioEnergy Sci Ctr, Oak Ridge, TN 37831 USA.; Lynd, LR; Olson, DG (corresponding author), Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.; Lynd, LR; Olson, DG (corresponding author), Ctr Bioenergy Innovat, Oak Ridge, TN 37831 USA.	Lee.R.Lynd@Dartmouth.edu; Daniel.G.Olson@darlmouth.edu	Lynd, Lee R/N-1260-2013; Zheng, Tianyong/T-3554-2019; Olson, Daniel/F-2058-2011	Lynd, Lee R/0000-0002-5642-668X; Olson, Daniel/0000-0001-5393-6302; Zheng, Tianyong/0000-0001-6127-4492	Office of Biological and Environmental Research in the DOE Office of Science;  [DE-AC05-00OR22725]	Office of Biological and Environmental Research in the DOE Office of Science(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); 	The BioEnergy Science Center and Center for Bioenergy Innovation are U.S. Department of Energy Bioenergy Research Centers supported by the Office of Biological and Environmental Research in the DOE Office of Science. Grant number DE-AC05-00OR22725 was awarded to LL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyros DA, 2011, APPL ENVIRON MICROB, V77, P8288, DOI 10.1128/AEM.00646-11; Bitoun JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044766; Bitoun JP, 2011, FEMS MICROBIOL LETT, V320, P110, DOI 10.1111/j.1574-6968.2011.02293.x; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; CARTWRIGHT CP, 1986, J GEN MICROBIOL, V132, P369; Chandler M, 2004, ANN MICROBIOL, V54, P427; Christensen GA, 2015, J BACTERIOL, V197, P29, DOI 10.1128/JB.02083-14; Currie DH, 2014, APPL ENVIRON MICROB, V80, P5001, DOI 10.1128/AEM.00998-14; Currie DH, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0159-x; Ding JM, 2009, APPL MICROBIOL BIOT, V85, P253, DOI 10.1007/s00253-009-2223-1; Gyan S, 2006, J BACTERIOL, V188, P7062, DOI 10.1128/JB.00601-06; Herring CD, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0536-8; Hon S, 2017, METAB ENG, V42, P175, DOI 10.1016/j.ymben.2017.06.011; Hu LJ, 2016, J BIOTECHNOL, V233, P17, DOI 10.1016/j.jbiotec.2016.06.024; Hu XH, 2007, GENETICS, V175, P1479, DOI 10.1534/genetics.106.065292; INGRAM LO, 1990, CRIT REV BIOTECHNOL, V9, P305; Kuehl J V, 2014, DESULFOVIBRIO ALASKE, V5, P1; LEAO C, 1984, BIOTECHNOL BIOENG, V26, P403, DOI 10.1002/bit.260260422; Lo J, 2015, J BACTERIOL, V197, P2920, DOI 10.1128/JB.00347-15; Madden T., 2002, NCBI HDB, V2002; Mai V, 1997, FEMS MICROBIOL LETT, V148, P163, DOI 10.1016/S0378-1097(97)00028-1; McLaughlin KJ, 2010, MOL CELL, V38, P563, DOI 10.1016/j.molcel.2010.05.006; Mrazek J, 2006, BIOINFORMATICS, V22, P3099, DOI 10.1093/bioinformatics/btl551; Mulder DW, 2011, STRUCTURE, V19, P1038, DOI 10.1016/j.str.2011.06.008; Olson D.G., 2012, METHODS ENZYMOLOGY; Pagels M, 2010, MOL MICROBIOL, V76, P1142, DOI 10.1111/j.1365-2958.2010.07105.x; Pei JJ, 2011, METAB ENG, V13, P186, DOI 10.1016/j.ymben.2010.12.006; Ravcheev DA, 2012, J BACTERIOL, V194, P1145, DOI 10.1128/JB.06412-11; Shaw AJ, 2008, P NATL ACAD SCI USA, V105, P13769, DOI 10.1073/pnas.0801266105; Shaw AJ, 2008, ENZYME MICROB TECH, V42, P453, DOI 10.1016/j.enzmictec.2009.01.005; Shaw AJ, 2010, APPL ENVIRON MICROB, V76, P4713, DOI 10.1128/AEM.00402-10; Stanley D, 2010, J APPL MICROBIOL, V109, P13, DOI 10.1111/j.1365-2672.2009.04657.x; Tian L, 2016, APPL ENV MICROBIOL, V82; Timmons MD, 2009, APPL MICROBIOL BIOT, V82, P929, DOI 10.1007/s00253-009-1891-1; Vesic D, 2013, J BACTERIOL, V195, P1815, DOI 10.1128/JB.02135-12; Wietzke M, 2012, APPL MICROBIOL BIOT, V96, P749, DOI 10.1007/s00253-012-4112-2; Zhang L, 2014, J BACTERIOL, V196, P3949, DOI 10.1128/JB.02037-14; Zheng TY, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00542-16; Zheng TY, 2015, J BACTERIOL, V197, P2610, DOI 10.1128/JB.00232-15; Zhou JL, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0304-1	40	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195143	10.1371/journal.pone.0195143	http://dx.doi.org/10.1371/journal.pone.0195143			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621294	Green Submitted, gold, Green Published			2022-12-26	WOS:000429206800043
J	Walston, LJ; Hartmann, HM				Walston, Leroy J.; Hartmann, Heidi M.			Development of a landscape integrity model framework to support regional conservation planning	PLOS ONE			English	Article							HUMAN FOOTPRINT; UNITED-STATES; ECOLOGICAL INTEGRITY; BIODIVERSITY; ELK; CLIMATE; SCALE; ROADS	Land managers increasingly rely upon landscape assessments to understand the status of natural resources and identify conservation priorities. Many of these landscape planning efforts rely on geospatial models that characterize the ecological integrity of the landscape. These general models utilize measures of habitat disturbance and human activity to map indices of ecological integrity. We built upon these modeling frameworks by developing a Landscape Integrity Index (LII) model using geospatial datasets of the human footprint, as well as incorporation of other indicators of ecological integrity such as biodiversity and vegetation departure. Our LII model serves as a general indicator of ecological integrity in a regional context of human activity, biodiversity, and change in habitat composition. We also discuss the application of the LII framework in two related coarse-filter landscape conservation approaches to expand the size and connectedness of protected areas as regional mitigation for anticipated land-use changes.	[Walston, Leroy J.; Hartmann, Heidi M.] Argonne Natl Lab, Environm Sci Div, Lemont, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory	Walston, LJ (corresponding author), Argonne Natl Lab, Environm Sci Div, Lemont, IL 60439 USA.	lwalston@anl.gov	Hartmann, Heidi/AAT-6481-2021	Walston, Leroy/0000-0002-6569-1223	U.S. Department of the Interior, Bureau of Land Management	U.S. Department of the Interior, Bureau of Land Management	Funding was provided by the U.S. Department of the Interior, Bureau of Land Management.	[Anonymous], 2017, PARTN; Auguie B, 2017, GRIDEXTRA MISCELLANE; Belote RT, 2017, BIOSCIENCE, V67, P494, DOI 10.1093/biosci/bix028; Belote RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154223; BLM, 2016, REG MIT STRAT AR SOL; BLM, 2014, 444 BLM SO NEV DISTR; BLM and Argonne National Laboratory, 2017, REG MIT STRAT COL SO; Bryce S., 2012, COLORADO PLATEAU RAP; Burdett CL, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00005.1; Bureau of Land Management (BLM), 2016, 2017021 BLM; Burgi M, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9081371; Carr NB, 2015, 20151155 US GEOL SUR; Carter S. K., 2017, 20161207 US GEOL SUR; Decker KL, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1775; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Freeman OE, 2015, ECOL SOC, V20, DOI 10.5751/ES-07175-200124; Hak JC, 2017, ECOL INDIC, V82, P206, DOI 10.1016/j.ecolind.2017.06.049; Hann W., 2004, INTERAGENCY FIRE REG; Kavanagh D.M., 2011, LINKAGE MAPPER CONNE; Krosby M, 2015, LANDSCAPE ECOL, V30, P2121, DOI 10.1007/s10980-015-0235-z; Leu M, 2008, ECOL APPL, V18, P1119, DOI 10.1890/07-0480.1; Montgomery RA, 2013, J WILDLIFE MANAGE, V77, P313, DOI 10.1002/jwmg.462; National Park Service (NPS), 2014, SCAL UP COLL APPR LA; Naylor LM, 2009, J WILDLIFE MANAGE, V73, P328, DOI 10.2193/2008-102; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; NOSS RF, 1995, 28 NAT BIOL SERV; Nunez TA, 2013, CONSERV BIOL, V27, P407, DOI 10.1111/cobi.12014; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; Parrish JD, 2003, BIOSCIENCE, V53, P851, DOI 10.1641/0006-3568(2003)053[0851:AWCWWS]2.0.CO;2; Rowland MM, 2000, J WILDLIFE MANAGE, V64, P672, DOI 10.2307/3802737; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Sayer J, 2013, P NATL ACAD SCI USA, V110, P8349, DOI 10.1073/pnas.1210595110; Scott JH, 2014, RMRSRN71 USDA FOR SE; Theobald DM, 2013, LANDSCAPE ECOL, V28, P1859, DOI 10.1007/s10980-013-9941-6; Theobald DM, 2012, CONSERV LETT, V5, P123, DOI 10.1111/j.1755-263X.2011.00218.x; Theobald DM, 2004, FRONT ECOL ENVIRON, V2, P139, DOI 10.1890/1540-9295(2004)002[0139:PELCIA]2.0.CO;2; Torres A, 2016, P NATL ACAD SCI USA, V113, P8472, DOI 10.1073/pnas.1522488113; U. S. Geological Survey (USGS), 2007, SW REG GAP AN PROJ F; USGS, 2016, LANDFIRE V 1 1 VEG D; USGS, 2016, GAP AN PROGR GAP PRO; USGS, 2010, LANDFIRE BIOPH SETT; Vimal R, 2012, J ENVIRON MANAGE, V95, P9, DOI 10.1016/j.jenvman.2011.09.018; Walker BL, 2007, J WILDLIFE MANAGE, V71, P2644, DOI 10.2193/2006-529; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Woolmer G, 2008, LANDSCAPE URBAN PLAN, V87, P42, DOI 10.1016/j.landurbplan.2008.04.005; Wu JG, 2013, LANDSCAPE ECOL, V28, P999, DOI 10.1007/s10980-013-9894-9; Wurtzebach Z, 2016, BIOSCIENCE, V66, P446, DOI 10.1093/biosci/biw037	47	13	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195115	10.1371/journal.pone.0195115	http://dx.doi.org/10.1371/journal.pone.0195115			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614093	Green Submitted, Green Published, gold			2022-12-26	WOS:000429081600033
J	Yoon, JS; So, CH; Lee, HS; Lim, JS; Hwang, JS				Yoon, Jong Seo; So, Cheol Hwan; Lee, Hae Sang; Lim, Jung Sub; Hwang, Jin Soon			The prevalence of brain abnormalities in boys with central precocious puberty may be overestimated	PLOS ONE			English	Article							CLEFT CYSTS; CHILDREN; ETIOLOGY; GIRLS	Brain magnetic resonance imaging (MRI) is routinely performed to identify brain lesions in boys with central precocious puberty (CPP). We investigated the prevalence of CPP in Korean boys and the necessity for routine brain MRI examinations. This retrospective cross-sectional study was conducted from April 2003 to December 2016 at a Korean university hospital. Among 151 boys who were diagnosed with CPP, the data of 138 boys who underwent sellar MRI were evaluated. The mean age of the study subjects was 9.51 +/- 0.56 years (<8 years [n = 4] and >= 8 years [n = 134]). We excluded patients who had been previously diagnosed with brain tumors and those who did not undergo a sellar MRI because of refusal or the decision of the pediatric endocrinologist. The main outcome measure was the prevalence of intracranial lesions among boys with CPP. Normal sellar MRI findings were observed in 128 of the 138 boys (93%). Mild brain abnormalities were found in 10 boys (7%), while none of the patients had pathological brain lesions. The prevalence (7%) of intracranial lesions among boys who were healthy, did not have neurological symptoms, and were diagnosed with CPP was different from that previously reported. None of the identified lesions necessitated treatment. Although this was a single country study, we found that the previously reported prevalence of brain lesions in boys with CPP is much higher than the prevalence observed in Korea. This study suggests the need to globally reevaluate the prevalence of pathological brain lesions among male pediatric patients with CPP.	[Yoon, Jong Seo; Lee, Hae Sang; Hwang, Jin Soon] Ajou Univ, Ajou Univ Hosp, Sch Med, Dept Pediat, Suwon, South Korea; [So, Cheol Hwan] Wonkwang Univ, Wonkwang Univ Hosp, Sch Med, Dept Pediat, Jeonbuk, South Korea; [Lim, Jung Sub] Korea Canc Ctr Hosp, Dept Pediat, Seoul, South Korea	Ajou University; Ajou University Hospital; Wonkwang University; National Cancer Center - Korea (NCC)	Hwang, JS (corresponding author), Ajou Univ, Ajou Univ Hosp, Sch Med, Dept Pediat, Suwon, South Korea.	pedhwang@ajou.ac.kr	LIM, JUNG SUB/GLU-0130-2022; lee, Hae Sang/AFL-6833-2022; lee, haesang/AAG-6951-2022	lee, Hae Sang/0000-0002-9684-4042; Yoon, Jong Seo/0000-0003-2331-1680; So, Cheol Hwan/0000-0003-1759-0003				Aksglaede L, 2009, PEDIATRICS, V123, pE932, DOI 10.1542/peds.2008-2491; Al-Gahtany Mubarak, 2003, Hormones (Athens), V2, P149; Al-Holou WN, 2009, J NEUROSURG-PEDIATR, V4, P230, DOI 10.3171/2009.4.PEDS0951; Biro FM, 2010, PEDIATRICS, V126, pE583, DOI 10.1542/peds.2009-3079; BRIDGES NA, 1994, ARCH DIS CHILD, V70, P116, DOI 10.1136/adc.70.2.116; Carel JC, 2004, HUM REPROD UPDATE, V10, P135, DOI 10.1093/humupd/dmh012; Carel JC, 2008, NEW ENGL J MED, V358, P2366, DOI 10.1056/NEJMcp0800459; Carel JC, 2009, PEDIATRICS, V123, pE752, DOI 10.1542/peds.2008-1783; Choi Keun Hee, 2013, Ann Pediatr Endocrinol Metab, V18, P183, DOI 10.6065/apem.2013.18.4.183; De Sanctis V, 2000, J PEDIATR ENDOCR MET, V13, P687; ELSTER AD, 1990, RADIOLOGY, V174, P681, DOI 10.1148/radiology.174.3.2305049; Greulich W.W., 1971, RADIOGRAPHIC ATLAS S; Kim SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141844; Kliegman RM, NELSON TXB PEDIAT, P2656; Lim Han Hyuk, 2010, Korean J Pediatr, V53, P759, DOI 10.3345/kjp.2010.53.7.759; NEELY EK, 1995, J PEDIATR-US, V127, P47, DOI 10.1016/S0022-3476(95)70255-5; Talma H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060056; Teilmann G, 2005, PEDIATRICS, V116, P1323, DOI 10.1542/peds.2005-0012; Trifanescu R, 2012, CLIN ENDOCRINOL, V76, P151, DOI 10.1111/j.1365-2265.2011.04235.x; Trivin C, 2006, CLIN ENDOCRINOL, V65, P239, DOI 10.1111/j.1365-2265.2006.02582.x; XhrouetHeinrichs D, 1997, ACTA PAEDIATR, V86, P808; Zada G, 2009, NEUROSURGERY, V64; Zada G, 2009, NEUROSURGERY, V64, P1132, DOI 10.1227/01.NEU.0000341873.20737.56; 문진수, 2008, Clinical and Experimental Pediatrics, V51, P1	24	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195209	10.1371/journal.pone.0195209	http://dx.doi.org/10.1371/journal.pone.0195209			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614125	Green Submitted, Green Published, gold			2022-12-26	WOS:000429081600036
J	Zhou, J; An, XH; Dong, JJ; Wang, YC; Zhong, H; Duan, LL; Ling, JJ; Ping, FF; Shang, J				Zhou, Jia; An, Xiaohong; Dong, Jinjin; Wang, Yichuan; Zhong, Hui; Duan, Lanlan; Ling, Jingjing; Ping, Fengfeng; Shang, Jing			IL-17 induces cellular stress microenvironment of melanocytes to promote autophagic cell apoptosis in vitiligo	FASEB JOURNAL			English	Article						interleukin-17; autophagy; mitochondria; oxidative stress; depigmentary disorder	REGULATORY T-CELLS; OXIDATIVE STRESS; SKIN; INTERLEUKIN-17; FAMILY; KERATINOCYTES; PIGMENTATION; RECEPTOR; INFLAMMASOME; NEUTROPHILS	Vitiligo is a depigmentary disorder that develops as a result of the progressive disappearance of epidermal melanocytes. Stress can precipitate or exacerbate a skin disease through psychosomatic mechanisms. Stress exposure induces vitiligo-like symptoms in mice, as cellular damage to melanocytes causes synthetic pigment loss. Stress also increases IL-17, IL-1, and antimelanocyte IgG in model mouse serum. Up-regulation of the IL-1 transcript in patients suggests its possible role in autoimmune pathogenesis of vitiligo. We demonstrate that IL-17 promoted IL-1 secretion from keratinocytes. Mitochondrial dysfunction, which can induce the excessive production of reactive oxygen species (ROS), is emerging as a mechanism that underlies various inflammatory and autoimmune diseases. In this study, we demonstrate that IL-17 inhibits melanogenesis of zebrafish, normal human epidermal melanocytes, and B16F10 cells. IL-17 increased mitochondrial dysfunction and ROS accumulation, which was related to autophagy induction. Autophagy is needed for autophagic apoptosis of B16F10 cells induced by IL-17. To inhibit ROS generation, B16F10 cells were pretreated with N-acetyl-l-cysteine (NAC), which inhibited autophagy. 3-Methyladenine (3-MA) also had an inhibiting effect on autophagy. NAC or 3-MA pretreatments inhibited IL-17-mediated cell apoptosis. In summary, IL-17 induces the cellular stress microenvironment in melanocytes to promote autophagic cell apoptosis in vitiligo.Zhou, J., An, X., Dong, J., Wang, Y., Zhong, H., Duan, L., Ling, J., Ping, F., Shang, J. IL-17 induces cellular stress microenvironment of melanocytes to promote autophagic cell apoptosis in vitiligo.	[Zhou, Jia; An, Xiaohong; Dong, Jinjin; Wang, Yichuan; Zhong, Hui; Duan, Lanlan; Ling, Jingjing; Shang, Jing] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Zhou, Jia; An, Xiaohong; Dong, Jinjin; Wang, Yichuan; Zhong, Hui; Duan, Lanlan; Ling, Jingjing; Shang, Jing] China Pharmaceut Univ, Jiangsu Key Lab Tradit Chinese Med TCM Evaluat &, Nanjing, Jiangsu, Peoples R China; [Ping, Fengfeng] Nanjing Med Univ, Wuxi Peoples Hosp, Wuxi, Peoples R China	China Pharmaceutical University; China Pharmaceutical University; Jiangnan University; Nanjing Medical University	Ping, FF (corresponding author), Nanjing Med Univ, Wuxi Peoples Hosp, Wuxi, Peoples R China.; Shang, J (corresponding author), Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.	pffzjtg2015@163.com; shangjing21cn@cpu.edu.cn		ping, fengfeng/0000-0003-4444-4976; ling, jingjing/0000-0002-8028-6891	National Natural Science Foundation of China [81503176]; Jiangsu Youth Medical Talents [QNRC2016194, QNRC2016195]; Medical Innovation Team of Jiangsu Province [CXTDB2017016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Youth Medical Talents; Medical Innovation Team of Jiangsu Province	This work was supported by the National Natural Science Foundation of China (Grant 81503176), Jiangsu Youth Medical Talents (Grants QNRC2016194 and QNRC2016195), and the Medical Innovation Team of Jiangsu Province (Grant CXTDB2017016). The authors declare no conflicts of interest.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Arck PC, 2006, J INVEST DERMATOL, V126, P1697, DOI 10.1038/sj.jid.5700104; Basak PY, 2009, J AM ACAD DERMATOL, V60, P256, DOI 10.1016/j.jaad.2008.09.048; Bassiouny DA, 2011, CLIN EXP DERMATOL, V36, P292, DOI 10.1111/j.1365-2230.2010.03972.x; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Chua CEL, 2011, CELL MOL LIFE SCI, V68, P3349, DOI 10.1007/s00018-011-0748-9; de Koning HD, 2015, BRIT J DERMATOL, V173, P448, DOI 10.1111/bjd.13857; Denat L, 2014, J INVEST DERMATOL, V134, P1512, DOI 10.1038/jid.2014.65; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Dyring-Andersen B, 2017, BRIT J DERMATOL, V177, pE321, DOI 10.1111/bjd.15533; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Guerra L, 2010, CURR DRUG METAB, V11, P451, DOI 10.2174/138920010791526105; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Jin W, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.58; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kotobuki Y, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2011.00945.x; Laddha NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107020; Lima AL, 2016, BRIT J DERMATOL, V174, P514, DOI 10.1111/bjd.14214; Matsuzaki G, 2007, MICROBIOL IMMUNOL, V51, P1139, DOI 10.1111/j.1348-0421.2007.tb04008.x; Murase D, 2013, J INVEST DERMATOL, V133, P2416, DOI 10.1038/jid.2013.165; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Ongenae K, 2006, J EUR ACAD DERMATOL, V20, P1, DOI 10.1111/j.1468-3083.2005.01369.x; Ono S, 2014, ACTA DERM-VENEREOL, V94, P329, DOI 10.2340/00015555-1713; Ping FF, 2012, NEUROSCI LETT, V514, P173, DOI 10.1016/j.neulet.2012.02.087; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Richmond JM, 2013, CURR OPIN IMMUNOL, V25, P676, DOI 10.1016/j.coi.2013.10.010; Rodriguez-Vallecillo E, 2014, PSYCHIAT CLIN N AM, V37, P625, DOI 10.1016/j.psc.2014.08.009; Schaaf MBE, 2016, FASEB J, V30, P3961, DOI 10.1096/fj.201600698R; Silverberg JI, 2015, CUTIS, V95, P255; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2009, EXP DERMATOL, V18, P760, DOI 10.1111/j.1600-0625.2009.00892.x; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Speeckaert R, 2015, AUTOIMMUN REV, V14, P332, DOI 10.1016/j.autrev.2014.12.003; van Beelen AJ, 2007, CURR OPIN ALLERGY CL, V7, P374, DOI 10.1097/ACI.0b013e3282ef869e; Van den Bossche K, 2006, TRAFFIC, V7, P769, DOI 10.1111/j.1600-0854.2006.00425.x; Wang CQF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025832, 10.1371/journal.pone.0018907]; Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819; Weiner L, 2014, PIGM CELL MELANOMA R, V27, P1014, DOI 10.1111/pcmr.12301; Wu H, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086085, 10.1371/journal.pone.0091856]; Xie H, 2016, J DERMATOL SCI, V81, P3, DOI 10.1016/j.jdermsci.2015.09.003; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhou J, 2014, J DERMATOL SCI, V73, P110, DOI 10.1016/j.jdermsci.2013.09.005	48	41	41	2	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4899	4916		10.1096/fj.201701242RR	http://dx.doi.org/10.1096/fj.201701242RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29613836				2022-12-26	WOS:000443817700024
J	Gauthier-Kemper, A; Alonso, MS; Sundermann, F; Niewidok, B; Fernandez, MP; Bakota, L; Heinisch, JJ; Brandt, R				Gauthier-Kemper, Anne; Suarez Alonso, Maria; Suendermann, Frederik; Niewidok, Benedikt; Fernandez, Maria-Pilar; Bakota, Lidia; Heinisch, Juergen Josef; Brandt, Roland			Annexins A2 and A6 interact with the extreme N terminus of tau and thereby contribute to tau's axonal localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microtubule-associated protein (MAP); annexin; tau protein; axon; neuron; polarity	CENTRAL-NERVOUS-SYSTEM; COLI SHUTTLE VECTORS; ALZHEIMERS-DISEASE; INITIAL SEGMENT; SACCHAROMYCES-CEREVISIAE; FRONTOTEMPORAL DEMENTIA; KLUYVEROMYCES-LACTIS; HIPPOCAMPAL-NEURONS; RESTRICTION SITES; AMYLOID-BETA	During neuronal development, the microtubule-associated protein tau becomes enriched in the axon, where it remains concentrated in the healthy brain. In tauopathies such as Alzheimer's disease, tau redistributes from the axon to the somatodendritic compartment. However, the cellular mechanism that regulates tau's localization remains unclear. We report here that tau interacts with the Ca2+-regulated plasma membrane-binding protein annexin A2 (AnxA2) via tau's extreme N terminus encoded by the first exon (E1). Bioinformatics analysis identified two conserved eight-amino-acids-long motifs within E1 in mammals. Using a heterologous yeast system, we found that disease-related mutations and pseudophosphorylation of Tyr-18, located within E1 but outside of the two conserved regions, do not influence tau's interaction with AnxA2. We further observed that tau interacts with the core domain of AnxA2 in a Ca2+-induced open conformation and interacts also with AnxA6. Moreover, lack of E1 moderately increased tau's association rate to microtubules, consistent with the supposition that the presence of the tau-annexin interaction reduces the availability of tau to interact with microtubules. Of note, intracellular competition through overexpression of E1-containing constructs reduced tau's axonal enrichment in primary neurons. Our results suggest that the E1-mediated tau-annexin interaction contributes to the enrichment of tau in the axon and is involved in its redistribution in pathological conditions.	[Gauthier-Kemper, Anne; Suendermann, Frederik; Niewidok, Benedikt; Bakota, Lidia; Brandt, Roland] Univ Osnabruck, Dept Neurobiol, Barbarastr 11, D-49076 Osnabruck, Germany; [Heinisch, Juergen Josef] Univ Osnabruck, Dept Genet, D-49076 Osnabruck, Germany; [Suarez Alonso, Maria; Fernandez, Maria-Pilar] Univ Oviedo, Dept Biochem & Mol Biol, Fac Med, E-33006 Oviedo, Spain; [Suarez Alonso, Maria] Univ Fribourg, Dept Physiol Med, Chemin Musee 5, CH-1700 Fribourg, Switzerland	University Osnabruck; University Osnabruck; University of Oviedo; University of Fribourg	Brandt, R (corresponding author), Univ Osnabruck, Dept Neurobiol, Barbarastr 11, D-49076 Osnabruck, Germany.	brandt@biologie.uni-osnabrueck.de	Heinisch, Juergen J./G-3801-2017	Bakota, Lidia/0000-0002-8777-5006; Brandt, Roland/0000-0003-0101-1257	DAAD ("Deutscher Akademischer Austauschdienst"); University of Osnabruck [SFB 944]	DAAD ("Deutscher Akademischer Austauschdienst")(Deutscher Akademischer Austausch Dienst (DAAD)); University of Osnabruck	This work was supported by the DAAD ("Deutscher Akademischer Austauschdienst") and performed as part of the IPID ("International Promovieren in Deutschland") doctoral student exchange program from the University of Osnabruck and the University of Oviedo, the FICYT ("Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia"), by computing time by the HLRN ("Norddeutscher Verbund fur Hoch-und Hochstleistungsrechnen"), the UV2000/GPU cluster at the computing center of the University of Osnabruck, and the Z-project of the SFB 944, University of Osnabruck. The authors declare that they have no conflicts of interest with the contents of this article.	Bakota L, 2012, MOL GENET GENOMICS, V287, P313, DOI 10.1007/s00438-012-0680-1; Bharadwaj A, 2013, INT J MOL SCI, V14, P6259, DOI 10.3390/ijms14036259; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; CHAPIN SJ, 1992, CELL MOTIL CYTOSKEL, V23, P236, DOI 10.1002/cm.970230403; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; DOTTI CG, 1988, J NEUROSCI, V8, P1454; EBERHARD DA, 1994, AM J PATHOL, V145, P640; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Fath T, 2002, J NEUROSCI, V22, P9733; Gauthier-Kemper A, 2011, J CELL BIOL, V192, P647, DOI 10.1083/jcb.201007161; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gunawardana CG, 2015, MOL CELL PROTEOMICS, V14, P3000, DOI 10.1074/mcp.M115.050724; Hall GF, 1997, P NATL ACAD SCI USA, V94, P4733, DOI 10.1073/pnas.94.9.4733; HAMRE KM, 1995, J COMP NEUROL, V352, P421, DOI 10.1002/cne.903520308; Hatch RJ, 2017, ACTA NEUROPATHOL, V133, P717, DOI 10.1007/s00401-017-1674-1; Hayashi S, 2002, ANN NEUROL, V51, P525, DOI 10.1002/ana.10163; HEINISCH J, 1991, CURR GENET, V20, P167, DOI 10.1007/BF00312781; Heinisch JJ, 2016, MICROB CELL, V3, DOI 10.15698/mic2016.04.489; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HIROKAWA N, 1988, J CELL BIOL, V107, P1449, DOI 10.1083/jcb.107.4.1449; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Igaev M, 2014, BIOPHYS J, V107, P2567, DOI 10.1016/j.bpj.2014.09.016; Janning D, 2014, MOL BIOL CELL, V25, P3541, DOI 10.1091/mbc.E14-06-1099; Jha AK, 2005, P NATL ACAD SCI USA, V102, P13099, DOI 10.1073/pnas.0506078102; Kempf M, 1996, J NEUROSCI, V16, P5583; Kirchrath L, 2000, J MOL BIOL, V300, P743, DOI 10.1006/jmbi.2000.3916; Kneynsberg A, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0043-17.2017; Konzack S, 2007, J NEUROSCI, V27, P9916, DOI 10.1523/JNEUROSCI.0927-07.2007; Lang AE, 2014, NEUROSCIENCE, V275, P322, DOI 10.1016/j.neuroscience.2014.06.017; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; Leschik J, 2007, J NEUROCHEM, V101, P1303, DOI 10.1111/j.1471-4159.2006.04435.x; Liu C, 2016, J BIOL CHEM, V291, P8173, DOI 10.1074/jbc.M115.641902; Lorberg A, 2001, MOL GENET GENOMICS, V266, P514; Maas T, 2000, J BIOL CHEM, V275, P15733, DOI 10.1074/jbc.M000389200; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Mandell JW, 1996, J NEUROSCI, V16, P5727; Marin MA, 2016, EXP NEUROL, V281, P93, DOI 10.1016/j.expneurol.2016.04.018; MERCKEN M, 1995, FEBS LETT, V368, P10, DOI 10.1016/0014-5793(95)00590-6; Niewidok B, 2016, MOL BIOL CELL, V27, P3537, DOI 10.1091/mbc.E16-06-0402; Orr ME, 2015, NEUROBIOL AGING, V36, P1496, DOI 10.1016/j.neurobiolaging.2014.12.004; Paquet D, 2009, J CLIN INVEST, V119, P1382, DOI 10.1172/JCI37537; Park SY, 2005, J NEUROSCI, V25, P5365, DOI 10.1523/JNEUROSCI.1125-05.2005; Pchitskaya E, 2018, CELL CALCIUM, V70, P87, DOI 10.1016/j.ceca.2017.06.008; Poorkaj P, 2002, ANN NEUROL, V52, P511, DOI 10.1002/ana.10340; Porzig R, 2007, BIOCHEM BIOPH RES CO, V358, P644, DOI 10.1016/j.bbrc.2007.04.187; RABEN N, 1995, AM J HUM GENET, V56, P131; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rodicio R, 2006, MICROBIOL-SGM, V152, P2635, DOI 10.1099/mic.0.29105-0; Sanchez-Ponce D, 2011, MOL CELL NEUROSCI, V48, P104, DOI 10.1016/j.mcn.2011.06.010; Sohn PD, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0109-0; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Stern JL, 2017, MOL BIOL CELL, V28, P1079, DOI 10.1091/mbc.E16-10-0728; Sundermann F, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2590-9; Sun XQ, 2014, P NATL ACAD SCI USA, V111, P14271, DOI 10.1073/pnas.1411837111; Uversky VN, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00018; Weissmann C, 2009, TRAFFIC, V10, P1655, DOI 10.1111/j.1600-0854.2009.00977.x; Wheeler TJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-7; Xia D, 2016, SCI REP-UK, V6, DOI 10.1038/srep29074; Yamatani H, 2010, DEV NEUROBIOL, V70, P523, DOI 10.1002/dneu.20794; Zhao WQ, 2007, J NEUROCHEM, V100, P1211, DOI 10.1111/j.1471-4159.2006.04311.x	64	34	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8065	8076		10.1074/jbc.RA117.000490	http://dx.doi.org/10.1074/jbc.RA117.000490			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29636414	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000433224600013
J	Niehaus, TD; Folz, J; McCarty, DR; Cooper, AJL; Amador, DM; Fiehn, O; Hanson, AD				Niehaus, Thomas D.; Folz, Jacob; McCarty, Donald R.; Cooper, Arthur J. L.; Amador, David Moraga; Fiehn, Oliver; Hanson, Andrew D.			Identification of a metabolic disposal route for the oncometabolite S-(2-succino)cysteine in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metabolism; energy metabolism; respiration; metabolic disease; microbiology; cysteine; fumarate; N-acetylation; oncometabolite; protein succination; sulfhydryl group; protein modification	SMOOTH-MUSCLE TUMORS; MITOCHONDRIAL STRESS; ESCHERICHIA-COLI; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; MYCOBACTERIUM-TUBERCULOSIS; CHEMICAL-MODIFICATION; TISSUE PROTEINS; SUCCINATION; FUMARATE; INACTIVATION	Cellular thiols such as cysteine spontaneously and readily react with the respiratory intermediate fumarate, resulting in the formation of stable S-(2-succino)-adducts. Fumarate-mediated succination of thiols increases in certain tumors and in response to glucotoxicity associated with diabetes. Therefore, S-(2-succino)-adducts such as S-(2-succino)cysteine (2SC) are considered oncometabolites and biomarkers for human disease. No disposal routes for S-(2-succino)-compounds have been reported prior to this study. Here, we show that Bacillus subtilis metabolizes 2SC to cysteine using a pathway encoded by the yxe operon. The first step is N-acetylation of 2SC followed by an oxygenation that we propose results in the release of oxaloacetate and N-acetylcysteine, which is deacetylated to give cysteine. Knockouts of the genes predicted to mediate each step in the pathway lose the ability to grow on 2SC as the sulfur source and accumulate the expected upstream metabolite(s). We further show that N-acetylation of 2SC relieves toxicity. This is the first demonstration of a metabolic disposal route for any S-(2-succino)-compound, paving the way toward the identification of corresponding pathways in other species.	[Niehaus, Thomas D.; McCarty, Donald R.; Hanson, Andrew D.] Univ Florida, Dept Hort Sci, 1301 Fifield Hall,2550 Hull Rd, Gainesville, FL 32611 USA; [Amador, David Moraga] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL 32611 USA; [Folz, Jacob; Fiehn, Oliver] Univ Calif Davis, West Coast Metabol Ctr, Davis, CA 95616 USA; [Cooper, Arthur J. L.] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California Davis; New York Medical College	Niehaus, TD; Hanson, AD (corresponding author), Univ Florida, Dept Hort Sci, 1301 Fifield Hall,2550 Hull Rd, Gainesville, FL 32611 USA.	tomniehaus@ufl.edu; adha@ufl.edu	Folz, Jacob/HHN-6906-2022	Niehaus, Thomas/0000-0002-3575-8001	National Science Foundation [MCB-1153413]; C.V. Griffin Sr. Foundation; Div Of Molecular and Cellular Bioscience [1611711] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); C.V. Griffin Sr. Foundation; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant MCB-1153413 and by an endowment from the C.V. Griffin Sr. Foundation.	Adam J, 2017, CELL REP, V20, P3135, DOI 10.1016/j.celrep.2017.08.093; Adam J, 2011, CANCER CELL, V20, P524, DOI 10.1016/j.ccr.2011.09.006; Alderson NL, 2006, ARCH BIOCHEM BIOPHYS, V450, P1, DOI 10.1016/j.abb.2006.03.005; Bardella C, 2011, J PATHOL, V225, P4, DOI 10.1002/path.2932; Biatnik M, 2008, ANN NY ACAD SCI, V1126, P272, DOI 10.1196/annals.1433.047; Blatnik M, 2008, DIABETES, V57, P41, DOI 10.2337/db07-0838; BRAND B, 1991, J BIOL CHEM, V266, P14113; Burguiere P, 2005, J BACTERIOL, V187, P6019, DOI 10.1128/JB.187.17.6019-6030.2005; Chan CM, 2014, ENVIRON MICROBIOL, V16, P101, DOI 10.1111/1462-2920.12210; Danchin A, 2009, BIOESSAYS, V31, P769, DOI 10.1002/bies.200900024; Dippel R, 2005, J BACTERIOL, V187, P8322, DOI 10.1128/JB.187.24.8322-8331.2005; Frizzell N, 2012, BIOCHEM J, V445, P247, DOI 10.1042/BJ20112142; Frizzell N, 2011, FREE RADICAL RES, V45, P101, DOI 10.3109/10715762.2010.524643; Frizzell N, 2009, J BIOL CHEM, V284, P25772, DOI 10.1074/jbc.M109.019257; Gladyshev VN, 2014, ANTIOXID REDOX SIGN, V20, P727, DOI 10.1089/ars.2013.5228; Higashitsuji Y, 2007, FEMS MICROBIOL LETT, V274, P48, DOI 10.1111/j.1574-6968.2007.00817.x; Hoekstra AS, 2015, ONCOTARGET, V6, P38777, DOI 10.18632/oncotarget.6091; Hullo MF, 2007, J BACTERIOL, V189, P187, DOI 10.1128/JB.01273-06; Johnson CM, 2014, MOL MICROBIOL, V93, P1284, DOI 10.1111/mmi.12736; Koo BM, 2017, CELL SYST, V4, P291, DOI 10.1016/j.cels.2016.12.013; Lazinski D. W., 2015, CURR PROTOC MICROBIO, V36, P1, DOI DOI 10.1002/9780471729259.MC01E03S36; Limsuwun K, 2000, J BACTERIOL, V182, P5373, DOI 10.1128/JB.182.19.5373-5380.2000; Lin HJ, 2010, ANAL BIOCHEM, V407, P226, DOI 10.1016/j.ab.2010.07.036; Linster CL, 2013, NAT CHEM BIOL, V9, P72, DOI [10.1038/NCHEMBIO.1141, 10.1038/nchembio.1141]; Manuel AM, 2017, ANTIOXID REDOX SIGN, V27, P1281, DOI 10.1089/ars.2016.6853; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Merkley ED, 2014, MASS SPECTROM REV, V33, P98, DOI 10.1002/mas.21382; Miglio G, 2016, BBA-PROTEINS PROTEOM, V1864, P211, DOI 10.1016/j.bbapap.2015.11.003; Nagai R, 2007, J BIOL CHEM, V282, P34219, DOI 10.1074/jbc.M703551200; Niehaus TD, 2017, J BIOL CHEM, V292, P16360, DOI 10.1074/jbc.M117.805028; Oda K, 2013, J BACTERIOL, V195, P1741, DOI 10.1128/JB.02085-12; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Piroli GG, 2016, MOL CELL PROTEOMICS, V15, P445, DOI 10.1074/mcp.M115.051516; Piroli GG, 2014, BIOCHEM J, V462, P231, DOI 10.1042/BJ20131581; Qiu JJ, 2013, INT J MOL MED, V31, P1229, DOI 10.3892/ijmm.2013.1298; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; Reyes C, 2014, MODERN PATHOL, V27, P1020, DOI 10.1038/modpathol.2013.215; Ruecker N, 2017, CELL CHEM BIOL, V24, P306, DOI 10.1016/j.chembiol.2017.01.005; Schmidt TJ, 2007, BIOORGAN MED CHEM, V15, P333, DOI 10.1016/j.bmc.2006.09.053; Sekowska A, 2001, GENOME BIOL, V2; Sullivan LB, 2013, MOL CELL, V51, P236, DOI 10.1016/j.molcel.2013.05.003; Ternette N, 2013, CELL REP, V3, P689, DOI 10.1016/j.celrep.2013.02.013; Thomas SA, 2012, OBESITY, V20, P263, DOI 10.1038/oby.2011.340; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Thorpe SR, 2003, AMINO ACIDS, V25, P275, DOI 10.1007/s00726-003-0017-9; Tsugawa H, 2015, NAT METHODS, V12, P523, DOI 10.1038/nmeth.3393; van der Ploeg JR, 1998, MICROBIOL-SGM, V144, P2555, DOI 10.1099/00221287-144-9-2555; Wright GD, 2005, ADV DRUG DELIVER REV, V57, P1451, DOI 10.1016/j.addr.2005.04.002; Yang M, 2013, J CLIN INVEST, V123, P3652, DOI 10.1172/JCI67228; Yu ACS, 2014, APPL MICROBIOL BIOT, V98, P855, DOI 10.1007/s00253-013-5377-9; Zheng L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7001	51	11	11	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8255	8263		10.1074/jbc.RA118.002925	http://dx.doi.org/10.1074/jbc.RA118.002925			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29626092	Green Published, hybrid			2022-12-26	WOS:000433224600029
J	Li, W; Tam, KMV; Chan, WWR; Koon, AC; Ngo, JCK; Chan, HYE; Lau, KF				Li, Wen; Tam, Ka Ming Vincent; Chan, Wai Wa Ray; Koon, Alex Chun; Ngo, Jacky Chi Ki; Chan, Ho Yin Edwin; Lau, Kwok-Fai			Neuronal adaptor FE65 stimulates Rac1-mediated neurite outgrowth by recruiting and activating ELMO1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP-ribosylation factor (ARF); amyloid precursor protein (APP); guanine nucleotide exchange factor (GEF); neurite outgrowth; Ras-related C3 botulinum toxin substrate 1 (Rac1); amyloid A4 precursor protein-binding family B member 1; ELMO1; FE65	AMYLOID PRECURSOR PROTEIN; DOWNSTREAM ACTIVATION; ALZHEIMERS-DISEASE; RHO GTPASES; FAMILY; COMPLEX; INTERACTS; CELLS; RAC1; ARF6	Neurite outgrowth is a crucial process in developing neurons for neural network formation. Understanding the regulatory mechanisms of neurite outgrowth is essential for developing strategies to stimulate neurite regeneration after nerve injury and in neurodegenerative disorders. FE65 is a brain-enriched adaptor that stimulates Rac1-mediated neurite elongation. However, the precise mechanism by which FE65 promotes the process remains elusive. Here, we show that ELMO1, a subunit of ELMO1-DOCK180 bipartite Rac1 guanine nucleotide exchange factor (GEF), interacts with the FE65 N-terminal region. Overexpression of FE65 and/or ELMO1 enhances, whereas knockdown of FE65 or ELMO1 inhibits, neurite outgrowth and Rac1 activation. The effect of FE65 alone or together with ELMO1 is attenuated by an FE65 double mutation that disrupts FE65-ELMO1 interaction. Notably, FE65 is found to activate ELMO1 by diminishing ELMO1 intramolecular autoinhibitory interaction and to promote the targeting of ELMO1 to the plasma membrane, where Rac1 is activated. We also show that FE65, ELMO1, and DOCK180 form a tripartite complex. Knockdown of DOCK180 reduces the stimulatory effect of FE65-ELMO1 on Rac1 activation and neurite outgrowth. Thus, we identify a novel mechanism by which FE65 stimulates Rac1-mediated neurite outgrowth by recruiting and activating ELMO1.	[Li, Wen; Tam, Ka Ming Vincent; Chan, Wai Wa Ray; Koon, Alex Chun; Ngo, Jacky Chi Ki; Chan, Ho Yin Edwin; Lau, Kwok-Fai] Chinese Univ Hong Kong, Fac Sci, Sch Life Sci, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Lau, KF (corresponding author), Chinese Univ Hong Kong, Fac Sci, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	kflau@cuhk.edu.hk	Ngo, Jacky C/O-8093-2017; Chan, Edwin/A-9478-2011; LI, WEN/Y-6659-2018	Ngo, Jacky C/0000-0002-6004-7041; Chan, Edwin/0000-0003-4307-474X; Lau, Kwok-Fai/0000-0002-0193-1152; Chan, Wai Wa/0000-0002-3735-1985	Research Grants Council Hong Kong; Health and Medical Research Fund (Hong Kong); CUHK direct grant scheme; United College endowment fund; TUYF Charitable Trust	Research Grants Council Hong Kong(Hong Kong Research Grants Council); Health and Medical Research Fund (Hong Kong); CUHK direct grant scheme; United College endowment fund; TUYF Charitable Trust	This work was supported by funds from the Research Grants Council Hong Kong, Health and Medical Research Fund (Hong Kong), CUHK direct grant scheme, the United College endowment fund, and the TUYF Charitable Trust. The authors declare that they have no conflicts of interest with the contents of this article.	Anitei M, 2010, NAT CELL BIOL, V12, P330, DOI 10.1038/ncb2034; Bryan B, 2004, J BIOL CHEM, V279, P45824, DOI 10.1074/jbc.M406216200; Bustelo Xose R, 2012, Small GTPases, V3, P60, DOI 10.4161/sgtp.19111; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cheung HNM, 2014, FASEB J, V28, P337, DOI 10.1096/fj.13-232694; Chow WNV, 2015, BIOCHEM J, V470, P303, DOI 10.1042/BJ20141485; Chow WNV, 2015, CELL MOL BIOL LETT, V20, P66, DOI 10.1515/cmble-2015-0002; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gomez-Pinedo U, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00195; Guenette S, 2006, EMBO J, V25, P420, DOI 10.1038/sj.emboj.7600926; Hao CY, 2011, BIOCHEM J, V436, P631, DOI 10.1042/BJ20110145; Hernandez-Deviez DJ, 2004, MOL BIOL CELL, V15, P111, DOI 10.1091/mbc.E03-06-0410; Hu QB, 2005, J BIOL CHEM, V280, P12548, DOI 10.1074/jbc.M411855200; Jaworski J, 2007, EUR J CELL BIOL, V86, P513, DOI 10.1016/j.ejcb.2007.04.007; Kajiwara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005071; Kasri NN, 2008, PFLUG ARCH EUR J PHY, V455, P787, DOI 10.1007/s00424-007-0385-1; Kim JY, 2011, J BIOL CHEM, V286, P37615, DOI 10.1074/jbc.M111.268029; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Krause K, 2008, J ENDOCRINOL, V198, P291, DOI 10.1677/JOE-08-0005; Lau KF, 2000, NEUROREPORT, V11, P3607, DOI 10.1097/00001756-200011090-00041; Lau KF, 2008, J BIOL CHEM, V283, P34728, DOI 10.1074/jbc.M801874200; Laurin M, 2014, GENE DEV, V28, P533, DOI 10.1101/gad.236349.113; Lee YS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12334-2; Li HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2680; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lundquist EA, 2003, CURR OPIN NEUROBIOL, V13, P384, DOI 10.1016/s0959-4388(03)00071-0; Marei Hadir, 2017, Small GTPases, V8, P139, DOI 10.1080/21541248.2016.1211398; Margaron Y, 2013, J BIOL CHEM, V288, P1184, DOI 10.1074/jbc.M112.431825; Martinez LA, 2011, NEUROPHARMACOLOGY, V61, P305, DOI 10.1016/j.neuropharm.2011.04.017; Masin M, 2006, J BIOL CHEM, V281, P4100, DOI 10.1074/jbc.M507735200; Mauldin JP, 2013, CURR BIOL, V23, P162, DOI 10.1016/j.cub.2012.11.049; McLoughlin DM, 2008, J NEUROSCI RES, V86, P744, DOI 10.1002/jnr.21532; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Minopoli G, 2012, IUBMB LIFE, V64, P936, DOI 10.1002/iub.1094; Nensa FM, 2014, MOL CELL PROTEOMICS, V13, P475, DOI 10.1074/mcp.M113.029280; Nikolic M, 2002, INT J BIOCHEM CELL B, V34, P731, DOI 10.1016/S1357-2725(01)00167-4; Nishihara H, 1999, BBA-MOL CELL RES, V1452, P179, DOI 10.1016/S0167-4889(99)00133-0; Patel Manishha, 2011, Small GTPases, V2, P268; Patel M, 2010, CURR BIOL, V20, P2021, DOI 10.1016/j.cub.2010.10.028; Perkinton MS, 2004, J BIOL CHEM, V279, P22084, DOI 10.1074/jbc.M311479200; Pietrzik CU, 1998, P NATL ACAD SCI USA, V95, P1770, DOI 10.1073/pnas.95.4.1770; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Sabo SL, 2003, J NEUROSCI, V23, P5407; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Stankiewicz TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00314; Stevenson C, 2014, J IMMUNOL, V192, P6062, DOI 10.4049/jimmunol.1303348; Stoops EH, 2016, TRAFFIC, V17, P1272, DOI 10.1111/tra.12449; Strecker P, 2016, SCI REP-UK, V6, DOI 10.1038/srep25652; Sun YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11529; Sun YF, 2014, J BIOL CHEM, V289, P12217, DOI 10.1074/jbc.M113.526194; Tudor EL, 2005, J BIOL CHEM, V280, P34735, DOI 10.1074/jbc.M506216200; Wang BP, 2004, J NEUROSCI RES, V75, P12, DOI 10.1002/jnr.10834; Ward HH, 2011, MOL BIOL CELL, V22, P3289, DOI 10.1091/mbc.E11-01-0082; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630	55	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7674	7688		10.1074/jbc.RA117.000505	http://dx.doi.org/10.1074/jbc.RA117.000505			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29615491	Green Published, hybrid			2022-12-26	WOS:000437256500018
J	Ko, FC; Pan, WL; Cheng, JO; Chen, TH; Kuo, FW; Kao, SJ; Chang, CW; Ho, HC; Wang, WH; Fang, LS				Ko, Fung-Chi; Pan, Wei-Ling; Cheng, Jing-O; Chen, Te-Hao; Kuo, Fu-Wen; Kao, Shu-Ji; Chang, Chih-Wei; Ho, Hsuan-Ching; Wang, Wei-Hsien; Fang, Li -Sing			Persistent organic pollutants in Antarctic notothenioid fish and invertebrates associated with trophic levels	PLOS ONE			English	Article							MARINE FOOD-WEB; DIPHENYL ETHERS PBDES; ORGANOCHLORINE PESTICIDES; BALTIC SEA; BIOACCUMULATION; CONTAMINANTS; PATTERNS; P,P'-DDE; TISSUES; TAIWAN	Notothenioid fish and invertebrate samples from Antarctica were collected in the austral summer of 2009, and analyzed for persistent organic pollutants (POPs), including polycyclic aromatic hydrocarbons (PAHs), organochlorine pesticides (OCPs), and polybrominated diphenylethers (PBDEs), as well as delta C-13 and delta N-15 stable isotopes for trophic level determination. In this study, the POP levels in the Antarctic biota samples were found to be ranked in the following order: OCPs > PAHs >> PBDEs. The POP levels in notothenioid fish and krill correlate to trophic levels; however, the POP concentrations in intertidal benthic invertebrates are higher than in notothenioid fish implying that specific biogeochemical factors may affect bioaccumulation in the Antarctica ecosystem. Biomagnification of POPs may have a smaller role than bioconcentration in Antarctica environment. In addition to the source, transport, exposure, and absorption for each group of POPs in the short food chain in Antarctica, the biological variation among species, interaction habitats, diet and metabolism are also factors for future studies on contaminant bioaccumulation.	[Ko, Fung-Chi; Cheng, Jing-O; Chen, Te-Hao; Kuo, Fu-Wen; Chang, Chih-Wei; Ho, Hsuan-Ching] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Ko, Fung-Chi; Pan, Wei-Ling; Chen, Te-Hao; Chang, Chih-Wei; Ho, Hsuan-Ching] Natl Dong Hwa Univ, Inst Marine Biol, Pingtung, Taiwan; [Kao, Shu-Ji] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Wang, Wei-Hsien] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan; [Fang, Li -Sing] Cheng Shiu Univ, Dept Leisure & Sport Management, Kaohsiung, Taiwan	National Museum of Marine Biology & Aquarium; National Dong Hwa University; Xiamen University; National Sun Yat Sen University; Cheng Shiu University	Ko, FC (corresponding author), Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan.; Ko, FC (corresponding author), Natl Dong Hwa Univ, Inst Marine Biol, Pingtung, Taiwan.	ko@nmmba.gov.tw		Ko, Fung-Chi/0000-0002-8276-2353	National Museum Marine Biology and Aquarium [NMMBA981014]; National Dong-Hwa University; National Museum Marine Biology and Aquarium	National Museum Marine Biology and Aquarium; National Dong-Hwa University; National Museum Marine Biology and Aquarium	This work was funded by the National Museum Marine Biology and Aquarium (Grant No. NMMBA981014 to FCK) (URL: http://www.nmmba.gov.tw/En/cp.aspx?n=77EE24DA4467A777&s=CAD4BFFA9CD4C5C7), and the National Dong-Hwa University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the National Museum Marine Biology and Aquarium, and the National Dong-Hwa University. Special thanks are extended to the crew of the Snow Dragon (Xue Long icebreaker and research vessel) on its 26th cruise to the Antarctic in November 2009. Their cordial and valuable assistance and support in sampling were vital to the success of the study. We also highly appreciate Professor Jiang-Shiou Hwang, the Academic Editor, and three anonymous reviewers who gave constructive comments to improve the quality of this manuscript.	Alegria HA, 2000, ENVIRON SCI TECHNOL, V34, P1953, DOI 10.1021/es990982b; Bargagli R, 2005, ANTARCTIC ECOSYSTEMS; Barrera-Oro E, 2002, ANTARCT SCI, V14, P293, DOI 10.1017/S0954102002000111; Borga K, 2004, ENVIRON TOXICOL CHEM, V23, P2367, DOI 10.1897/03-518; Borghesi N, 2008, CHEMOSPHERE, V73, P155, DOI 10.1016/j.chemosphere.2008.06.031; Cipro CVZ, 2010, CHEMOSPHERE, V78, P767, DOI 10.1016/j.chemosphere.2009.10.006; Corsolini S, 2006, ENVIRON POLLUT, V140, P371, DOI 10.1016/j.envpol.2005.04.039; Corsolini S, 2009, J CHROMATOGR A, V1216, P598, DOI 10.1016/j.chroma.2008.08.012; Darnerud PO, 2003, ENVIRON INT, V29, P841, DOI 10.1016/S0160-4120(03)00107-7; Eastman JT, 2000, ARCH FISH MAR RES, V48, P11; Fisk AT, 2001, ENVIRON SCI TECHNOL, V35, P732, DOI 10.1021/es001459w; GEORGE J. L., 1966, Pesticides in the Antarctic., P155, DOI 10.2307/2401454; Goutte A, 2013, MAR POLLUT BULL, V77, P82, DOI 10.1016/j.marpolbul.2013.10.027; Ko FC, 2014, J HAZARD MATER, V277, P127, DOI 10.1016/j.jhazmat.2013.12.057; Ko FC, 2014, ENVIRON POLLUT, V185, P35, DOI 10.1016/j.envpol.2013.10.025; KOCK KH, 1991, ANTARCT SCI, V3, P125, DOI 10.1017/S0954102091000172; Mormede S, 2003, CHEMOSPHERE, V50, P563, DOI 10.1016/S0045-6535(02)00493-9; Nash SB, 2011, J ENVIRON MONITOR, V13, P497, DOI 10.1039/c0em00230e; Nfon E, 2008, SCI TOTAL ENVIRON, V397, P190, DOI 10.1016/j.scitotenv.2008.02.029; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Poulsen AH, 2013, ENVIRON POLLUT, V175, P92, DOI 10.1016/j.envpol.2012.12.026; Poulsen AH, 2012, ENVIRON POLLUT, V160, P185, DOI 10.1016/j.envpol.2011.09.022; RISEBROUGH RW, 1968, NATURE, V220, P1098, DOI 10.1038/2201098a0; Schiavone A, 2009, CHEMOSPHERE, V76, P264, DOI 10.1016/j.chemosphere.2009.03.007; SIMONICH SL, 1995, SCIENCE, V269, P1851, DOI 10.1126/science.7569923; SLADEN WJL, 1966, NATURE, V210, P670, DOI 10.1038/210670a0; Sobek A, 2010, SCI TOTAL ENVIRON, V408, P2753, DOI 10.1016/j.scitotenv.2010.03.013; Stephansen DA, 2012, MAR ENVIRON RES, V73, P17, DOI 10.1016/j.marenvres.2011.10.006; Storelli MM, 2009, ENVIRON RES, V109, P851, DOI 10.1016/j.envres.2009.07.008; Storm EG, 2006, ENV TXICOL CHEM, V25, P2502; Strobel A, 2016, CHEMOSPHERE, V161, P555, DOI 10.1016/j.chemosphere.2016.01.089; Tartu S, 2015, SCI TOTAL ENVIRON, V505, P180, DOI 10.1016/j.scitotenv.2014.10.008; TATTON JO, 1967, NATURE, V215, P346, DOI 10.1038/215346a0; Tomy GT, 2008, ENVIRON SCI TECHNOL, V42, P3634, DOI 10.1021/es703083z; WANIA F, 1993, AMBIO, V22, P10; Weber K, 2003, CHEMOSPHERE, V53, P667, DOI 10.1016/S0045-6535(03)00551-4	36	9	10	7	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194147	10.1371/journal.pone.0194147	http://dx.doi.org/10.1371/journal.pone.0194147			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641526	gold, Green Submitted, Green Published			2022-12-26	WOS:000429742900026
J	Pritchard, AL; Johansson, PA; Nathan, V; Howlie, M; Symmons, J; Palmer, JM; Hayward, NK				Pritchard, Antonia L.; Johansson, Peter A.; Nathan, Vaishnavi; Howlie, Madeleine; Symmons, Judith; Palmer, Jane M.; Hayward, Nicholas K.			Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers	PLOS ONE			English	Article							BREAST-CANCER; PHENOTYPIC SPECTRUM; SOMATIC MUTATIONS; VARIANTS; BRCA2; IDENTIFICATION; FAMILIES; DATABASE; MSH6; QUEENSLAND	Background While a number of autosomal dominant and autosomal recessive cancer syndromes have an associated spectrum of cancers, the prevalence and variety of cancer predisposition mutations in patients with multiple primary cancers have not been extensively investigated. An understanding of the variants predisposing to more than one cancer type could improve patient care, including screening and genetic counselling, as well as advancing the understanding of tumour development. Methods A cohort of 57 patients ascertained due to their cutaneous melanoma (CM) diagnosis and with a history of two or more additional non-cutaneous independent primary cancer types were recruited for this study. Patient blood samples were assessed by whole exome or whole genome sequencing. We focussed on variants in 525 pre-selected genes, including 65 autosomal dominant and 31 autosomal recessive cancer predisposition genes, 116 genes involved in the DNA repair pathway, and 313 commonly somatically mutated in cancer. The same genes were analysed in exome sequence data from 1358 control individuals collected as part of non-cancer studies (UK10K). The identified variants were classified for pathogenicity using online databases, literature and in silico prediction tools. Results No known pathogenic autosomal dominant or previously described compound heterozygous mutations in autosomal recessive genes were observed in the multiple cancer cohort. Variants typically found somatically in haematological malignancies (in JAK1, JAK2, SF3B1, SRSF2, TET2 and TYK2) were present in lymphocyte DNA of patients with multiple primary cancers, all of whom had a history of haematological malignancy and cutaneous melanoma, as well as colorectal cancer and/or prostate cancer. Other potentially pathogenic variants were discovered in BUB1B, POLE2, ROS1 and DNMT3A. Compared to controls, multiple cancer cases had significantly more likely damaging mutations (nonsense, frameshift ins/del) in tumour suppressor and tyrosine kinase genes and higher overall burden of mutations in all cancer genes. Conclusions We identified several pathogenic variants that likely predispose to at least one of the tumours in patients with multiple cancers. We additionally present evidence that there may be a higher burden of variants of unknown significance in 'cancer genes' in patients with multiple cancer types. Further screens of this nature need to be carried out to build evidence to show if the cancers observed in these patients form part of a cancer spectrum associated with single germline variants in these genes, whether multiple layers of susceptibility exist (oligogenic or polygenic), or if the occurrence of multiple different cancers is due to random chance.	[Pritchard, Antonia L.; Johansson, Peter A.; Nathan, Vaishnavi; Howlie, Madeleine; Symmons, Judith; Palmer, Jane M.; Hayward, Nicholas K.] QIMR Berghofer Med Res Inst, Oncogenom Grp, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute	Pritchard, AL (corresponding author), QIMR Berghofer Med Res Inst, Oncogenom Grp, Brisbane, Qld, Australia.	antonia.pritchard@qimrberghofer.edu.au	hayward, nick/AAV-8802-2020; Pritchard, Antonia/F-4288-2010; hayward, nicholas/C-1367-2015	Pritchard, Antonia/0000-0001-5336-0454; Nathan, Vaishnavi/0000-0001-7201-6819; hayward, nicholas/0000-0003-4760-1033	National Health and Medical Research Council [APP1093017, APP1026112]; Townsville Central Rotary Club	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Townsville Central Rotary Club	This work was supported by the National Health and Medical Research Council: APP1093017 and APP1026112 to Nicholas K Hayward. Additional funding was provided to Nicholas K Hayward from Jack and Rae Cowie and the Townsville Central Rotary Club. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Aitken J, 1999, JNCI-J NATL CANCER I, V91, P446, DOI 10.1093/jnci/91.5.446; Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Aoude LG, 2015, FAM CANCER, V14, P621, DOI 10.1007/s10689-015-9826-8; Aoude LG, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju408; Aoude LG, 2015, PIGM CELL MELANOMA R, V28, P148, DOI 10.1111/pcmr.12333; Aoude LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072144; Baglietto L, 2010, JNCI-J NATL CANCER I, V102, P193, DOI 10.1093/jnci/djp473; Balmana J, 2011, ANN ONCOL, V22, pvi31, DOI 10.1093/annonc/mdr373; BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; Baxter AJ, 2008, TWIN RES HUM GENET, V11, P183, DOI 10.1375/twin.11.2.183; Beroud C, 2005, HUM MUTAT, V26, P184, DOI 10.1002/humu.20210; Bodian DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094554; Bouaoun L, 2016, HUM MUTAT, V37, P865, DOI 10.1002/humu.23035; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chubb D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11883; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Couts KL, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.16.00013; Curiel-Lewandrowski C, 2011, ARCH DERMATOL, V147, P248, DOI 10.1001/archdermatol.2010.428; Demeester R, 2001, Hum Mutat, V17, P354, DOI 10.1002/humu.42; Easton DF, 1997, AM J HUM GENET, V61, P120, DOI 10.1086/513891; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Glusman G, 2011, BIOINFORMATICS, V27, P3216, DOI 10.1093/bioinformatics/btr540; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Hearle N, 2003, INVEST OPHTH VIS SCI, V44, P458, DOI 10.1167/iovs.02-0026; Kilpivaara O, 2009, NAT GENET, V41, P455, DOI 10.1038/ng.342; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Law MH, 2015, NAT GENET, V47, P987, DOI 10.1038/ng.3373; Lee J, 2013, CANCER-AM CANCER SOC, V119, P1627, DOI 10.1002/cncr.27967; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Margraf RL, 2009, HUM MUTAT, V30, P548, DOI 10.1002/humu.20928; Martinelli S, 2015, HUM MUTAT, V36, P787, DOI 10.1002/humu.22809; Masica DL, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004725; McKerrell T, 2015, CELL REP, V10, P1239, DOI 10.1016/j.celrep.2015.02.005; McKusick-Nathans Institute of Genetic Medicine JHUB MD), 2016, ONL MEND INH MAN OMI; Mersch J, 2015, CANCER-AM CANCER SOC, V121, P269, DOI 10.1002/cncr.29041; Miyaki M, 1997, NAT GENET, V17, P271, DOI 10.1038/ng1197-271; Monnerat C, 2007, FAM CANCER, V6, P453, DOI 10.1007/s10689-007-9143-y; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Myrie KA, 2000, CANCER LETT, V152, P193, DOI 10.1016/S0304-3835(00)00340-2; Passamonti F, 2009, HAEMATOL-HEMATOL J, V94, P7, DOI 10.3324/haematol.2008.001271; Podlevsky JD, 2008, NUCLEIC ACIDS RES, V36, pD339, DOI 10.1093/nar/gkm700; Pritchard CC, 2016, NEW ENGL J MED, V375, P443, DOI 10.1056/NEJMoa1603144; Read J, 2016, J MED GENET, V53, P1, DOI 10.1136/jmedgenet-2015-103150; Robles-Espinoza CD, 2014, NAT GENET, V46, P478, DOI 10.1038/ng.2947; Roe OD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006554; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; Shiffman D, 2005, AM J HUM GENET, V77, P596, DOI 10.1086/491674; Spier I, 2015, INT J CANCER, V137, P320, DOI 10.1002/ijc.29396; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Wadt KAW, 2015, CLIN GENET, V88, P267, DOI 10.1111/cge.12501; Wadt K, 2012, PIGM CELL MELANOMA R, V25, P815, DOI 10.1111/pcmr.12006; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wiesner T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4116; Wijnen J, 1999, NAT GENET, V23, P142, DOI 10.1038/13773; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yokoyama S, 2011, NATURE, V480, P99, DOI 10.1038/nature10630; Zhang JH, 2015, NEW ENGL J MED, V373, P2336, DOI 10.1056/NEJMoa1508054	61	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194098	10.1371/journal.pone.0194098	http://dx.doi.org/10.1371/journal.pone.0194098			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641532	Green Published, gold			2022-12-26	WOS:000429742900025
J	Joelsson, K; Hjalten, J; Gibb, H				Joelsson, Klara; Hjaelten, Joakim; Gibb, Heloise			Forest management strategy affects saproxylic beetle assemblages: A comparison of even and uneven-aged silviculture using direct and indirect sampling	PLOS ONE			English	Article							BOREAL SPRUCE FORESTS; DEAD WOOD; FUNCTIONAL-GROUPS; SPECIES RICHNESS; SWEDISH FORESTS; HIGH STUMPS; OLD-GROWTH; LOGS; HETEROGENEITY; DECOMPOSITION	Management of forest for wood production has altered ecosystem structures and processes and led to habitat loss and species extinctions, worldwide. Deadwood is a key resource supporting forest biodiversity, and commonly declines following forest management. However, different forest management methods affect dead wood differently. For example, uneven aged silviculture maintains an age-stratified forest with ongoing dead wood production, while even-aged silviculture breaks forest continuity, leading to long periods without large trees. We asked how deadwood-dependent beetles respond to different silvicultural practices and if their responses depend on deadwood volume, and beetles preference for decay stages of deadwood. We compared beetle assemblages in five boreal forest types with different management strategies: clearcutting and thinning (both representing even-aged silviculture), selective felling (representing uneven-aged silviculture), reference and old growth forest (both uneven-aged controls without a recent history [similar to 50 years] of management, but the latter with high conservation values). We collected beetles using window traps and by sieving the bark from experimental logs (bolts). Beetle assemblages on clear-cuts differed from all other stand types, regardless of trapping method or decay stage preference. Thinning differed from reference stands, indicating incomplete recovery after clear-cutting, while selective felling differed only from clear-cuts. In contrast to our predictions, early and late successional species responded similarly to different silvicultural practices. However, there were indications of marginal assemblage differences both between thinned stands and selective felling and between thinned and old growth stands (p = 0.10). The stand volume of early decay stage wood influenced assemblage composition of early, but not late successional species. Uneven-aged silviculture maintained species assemblages similar to those of the reference and old growth stands and might therefore be a better management option when considering biodiversity conservation.	[Joelsson, Klara; Hjaelten, Joakim] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, Umea, Sweden; [Gibb, Heloise] La Trobe Univ, Dept Ecol Evolut & Environm, Melbourne, Vic, Australia	Swedish University of Agricultural Sciences; La Trobe University	Joelsson, K (corresponding author), Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, Umea, Sweden.	klara.joelsson@slu.se	Gibb, Heloise/B-8338-2013	Hjalten, Joakim/0000-0002-8279-6633; Gibb, Heloise/0000-0001-7194-0620	Formas [215 - 2012-748]; Stiftelsen Oscar och Lili Lamms Minne [D02012-0056]	Formas(Swedish Research Council Formas); Stiftelsen Oscar och Lili Lamms Minne	This work was funded by Formas [grant number 215 - 2012-748] and Stiftelsen Oscar och Lili Lamms Minne [grant number D02012-0056] to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinvi O, 2007, J INSECT CONSERV, V11, P99, DOI 10.1007/s10841-006-9012-2; Aussenac G, 2000, ANN FOR SCI, V57, P287; BERG A, 1994, CONSERV BIOL, V8, P718, DOI 10.1046/j.1523-1739.1994.08030718.x; Bernes C., 2011, BIODIVERSITY SWEDEN; Birkemoe T, 2015, J INSECT CONSERV, V19, P163, DOI 10.1007/s10841-015-9757-6; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cabin RJ., 2000, B ECOL SOC AM, V81, P246, DOI [DOI 10.2307/20168454, 10.2307/20168454]; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Drever CR, 2006, CAN J FOREST RES, V36, P2285, DOI 10.1139/X06-132; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fridman J, 2001, SCAND J FOREST RES, V16, P455, DOI 10.1080/02827580152632856; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Gibb H, 2006, BIOL CONSERV, V132, P250, DOI 10.1016/j.biocon.2006.04.017; Gibb H, 2006, BIOL CONSERV, V129, P437, DOI 10.1016/j.biocon.2005.11.010; Gibb H, 2006, ECOGRAPHY, V29, P191, DOI 10.1111/j.2006.0906-7590.04372.x; Grove SJ, 2002, ANNU REV ECOL SYST, V33, P1, DOI 10.1146/annurev.ecolsys.33.010802.150507; Hansen AJ, 2001, BIOSCIENCE, V51, P765, DOI 10.1641/0006-3568(2001)051[0765:GCIFRO]2.0.CO;2; Hautala H, 2004, BIODIVERS CONSERV, V13, P1541, DOI 10.1023/B:BIOC.0000021327.43783.a9; Heikkala O, 2016, FOREST ECOL MANAG, V359, P51, DOI 10.1016/j.foreco.2015.09.043; Hjalten J, 2017, FOREST ECOL MANAG, V402, P37, DOI 10.1016/j.foreco.2017.06.064; Hjalten J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041100; Hjalten J, 2010, FOREST ECOL MANAG, V260, P1149, DOI 10.1016/j.foreco.2010.07.003; HOUGHTON RA, 1994, BIOSCIENCE, V44, P305, DOI 10.2307/1312380; Hyvarinen E, 2006, EUR J ENTOMOL, V103, P397, DOI 10.14411/eje.2006.054; Joelsson K, 2018, J ENVIRON MANAGE, V205, P1, DOI 10.1016/j.jenvman.2017.09.054; Joelsson K, 2017, FOREST ECOL MANAG, V391, P436, DOI 10.1016/j.foreco.2017.02.006; Johansson T, 2007, FOREST ECOL MANAG, V242, P496, DOI 10.1016/j.foreco.2007.01.062; Jonsell M, 2003, FOREST ECOL MANAG, V175, P425, DOI 10.1016/S0378-1127(02)00143-3; Jonsson BG, 2016, FOREST ECOL MANAG, V376, P174, DOI 10.1016/j.foreco.2016.06.017; Kassambara A., 2016, FACTOEXTRA EXTRACT V, V1; Kebli H, 2012, FOREST ECOL MANAG, V279, P45, DOI 10.1016/j.foreco.2012.05.028; Koch K., 1989, KAFER MITTELEUROPAS; Kouki J, 2012, DIVERS DISTRIB, V18, P348, DOI 10.1111/j.1472-4642.2011.00839.x; Kuuluvainen T, 2002, SILVA FENN, V36, P97, DOI 10.14214/sf.552; Kuuluvainen T, 2012, AMBIO, V41, P720, DOI 10.1007/s13280-012-0289-y; Kuuluvainen T, 2012, CAN J FOREST RES, V42, P1185, DOI [10.1139/X2012-064, 10.1139/x2012-064]; Kuuluvainen T, 2011, SILVA FENN, V45, P823, DOI 10.14214/sf.73; Kuuluvainen T, 2009, AMBIO, V38, P309, DOI 10.1579/08-A-490.1; Lee SI, 2014, AGR FOREST ENTOMOL, V16, P391, DOI 10.1111/afe.12069; Martikainen P, 2003, BIODIVERS CONSERV, V12, P1815, DOI 10.1023/A:1024132829581; Muller J, 2015, ECOGRAPHY, V38, P499, DOI 10.1111/ecog.00908; Nilsson SG, 1997, ECOGRAPHY, V20, P491, DOI 10.1111/j.1600-0587.1997.tb00417.x; Oksanen J, 2007, THE VEGAN PACKAGE, P10; Ostlund L, 1997, CAN J FOREST RES, V27, P1198, DOI 10.1139/x97-070; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Palm T., 1959, OPUSC ENT S, VXVI, P269; Puettmann KJ, 2015, FOR ECOSYST, V2, DOI 10.1186/s40663-015-0031-x; Saint-Germain M, 2007, ECOGRAPHY, V30, P737, DOI 10.1111/j.2007.0906-7590.05080.x; Schall P, 2017, J APPL ECOL, DOI [10.1111/1365-2664.12950, DOI 10.1111/1365-2664.12950]; Seibold S, 2016, J APPL ECOL, V53, P934, DOI 10.1111/1365-2664.12607; SIITONEN J, 1994, SCAND J FOREST RES, V9, P185, DOI 10.1080/02827589409382830; Siitonen Juha, 2001, Ecological Bulletins, V49, P11; SLU, FOR STAT 2016 OFF ST; Speight M.C.D., 1989, Council of Europe Nature and Environment Series, P1; Stenbacka F, 2010, ECOL APPL, V20, P2310, DOI 10.1890/09-0815.1; Stokland JN, 2012, ECOL BIODIVERS CONS, P248; Storaunet K, 2002, CAN J FOREST RES, V32, P1801, DOI 10.1139/X02-105; Sverdrup-Thygeson A, 2009, J INSECT CONSERV, V13, P183, DOI 10.1007/s10841-008-9141-x; Thorn S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101757; Tikkanen O- P, 2006, ANN ZOOLOGICI FENNIC; Tikkanen OP, 2006, ANN ZOOL FENN, V43, P373; Ulyshen MD, 2016, APPL SOIL ECOL, V105, P25, DOI 10.1016/j.apsoil.2016.03.017; Vanderwel MC, 2006, FOREST ECOL MANAG, V225, P190, DOI 10.1016/j.foreco.2005.12.051; Wang Y, 2016, PACKAGE MVABUND; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Wikars LO, 2005, CAN ENTOMOL, V137, P304, DOI 10.4039/N04-104; ZACKRISSON O, 1977, OIKOS, V29, P22, DOI 10.2307/3543289	68	11	11	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194905	10.1371/journal.pone.0194905	http://dx.doi.org/10.1371/journal.pone.0194905			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634728	Green Submitted, Green Published, gold			2022-12-26	WOS:000429522200014
J	Shin, J; Park, JY; Choi, J				Shin, Jinyoung; Park, Jin Young; Choi, Jaekyung			Long-term exposure to ambient air pollutants and mental health status: A nationwide population-based cross-sectional study	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT VISITS; DEPRESSIVE SYMPTOMS; RISK-FACTOR; POLLUTION; ASSOCIATION	There is a suspected but unproven association between long-term exposure to ambient air pollution and mental health. The aim of this study is to investigate the association between long-term exposure to ambient air pollution and subjective stress, depressive disorders, health-related quality of life (QoL) and suicide. We selected 124,205 adults from the Korean Community Health Survey in 2013 who were at least 19 years old and who had lived in their current domiciles for > five years. Based on the computer-assisted personal interviews to measure subjective stress in daily life, EuroQoL-5 dimensions, depression diagnosis by a doctor, suicidal ideation, and suicidal attempts, we evaluated the risk of mental disorders using multiple logistic regression analysis according to the quartiles of air pollutants, such as particulate matter <10 mu m (PM10), nitrogen dioxide (NO2), carbon monoxide (CO), and sulfur dioxide, using yearly average concentration between August 2012 and July 2013. The prevalence of high stress, poor QoL, depressiveness, diagnosis of depression, and suicide ideation was positively associated with high concentrations of PM10, NO2, and CO after adjusting for confounding factors. Men were at increased risk of stress, poor QoL, and depressiveness from air pollution exposure than were women. The risk of higher stress or poor QoL in subjects < age 65 increased with air pollution more than did that in subjects >= age 65. Long-term exposure to ambient air pollution may be an independent risk factor for mental health disorders ranging from subjective stress to suicide ideation.	[Shin, Jinyoung; Choi, Jaekyung] Konkuk Univ, Sch Med, Res Inst Med Sci, Dept Family Med,Med Ctr, Seoul, South Korea; [Park, Jin Young] Yonsei Univ, Gangnam Severance Hosp, Dept Psychiat, Coll Med, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Yonsei University; Yonsei University Health System	Choi, J (corresponding author), Konkuk Univ, Sch Med, Res Inst Med Sci, Dept Family Med,Med Ctr, Seoul, South Korea.	cjk@kuh.ac.kr		Shin, Jinyoung/0000-0001-9558-1853; Choi, Jaekyung/0000-0002-0875-7505				Ayanlade A, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3553-y; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Cho J, 2014, J AFFECT DISORDERS, V157, P45, DOI 10.1016/j.jad.2014.01.002; Choi Y, 2017, J ENVIRON SCI, V53, P151, DOI 10.1016/j.jes.2016.02.020; Fonken LK, 2011, MOL PSYCHIATR, V16, P987, DOI 10.1038/mp.2011.76; Greenberg N, 2017, J TOXICOL ENV HEAL A, V80, P326, DOI 10.1080/15287394.2017.1313800; Hong JX, 2016, SCI REP-UK, V6, DOI 10.1038/srep23858; Kim C, 2010, AM J PSYCHIAT, V167, P1100, DOI 10.1176/appi.ajp.2010.09050706; Kim J, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040431; Kim KN, 2016, ENVIRON HEALTH PERSP, V124, P1547, DOI 10.1289/EHP192; Kim Sun Taek, 2015, QUALITY CONTROL AIR; Kim YG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137044; Kioumourtzoglou MA, 2017, AM J EPIDEMIOL, V185, P801, DOI 10.1093/aje/kww163; Lee YK, 2009, VALUE HEALTH, V12, P1187, DOI 10.1111/j.1524-4733.2009.00579.x; Lim YH, 2012, ENVIRON HEALTH PERSP, V120, P1023, DOI 10.1289/ehp.1104100; Maes M, 2011, NEUROENDOCRINOL LETT, V32, P7; Mannucci Pier Mannuccio, 2017, Int J Environ Res Public Health, V14, DOI 10.3390/ijerph14091048; Oh DH, 2013, J KOREAN MED SCI, V28, P128, DOI 10.3346/jkms.2013.28.1.128; Oudin A, 2018, ENVIRON HEALTH-GLOB, V17, DOI 10.1186/s12940-017-0348-8; Patten SB, 2015, CAN J PSYCHIAT, V60, P23, DOI 10.1177/070674371506000106; Pun VC, 2017, ENVIRON HEALTH PERSP, V125, P342, DOI 10.1289/EHP494; Seidler ZE, 2016, CLIN PSYCHOL REV, V49, P106, DOI 10.1016/j.cpr.2016.09.002; Seo J, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4798-2; Sun QH, 2010, CIRCULATION, V121, P2755, DOI 10.1161/CIRCULATIONAHA.109.893461; Szyszkowicz M, 2010, ENVIRON HEALTH INSIG, V4, P79, DOI 10.4137/EHI.S5662; Szyszkowicz M, 2009, INT J OCCUP MED ENV, V22, P355, DOI 10.2478/v10001-009-0031-6; Wang Y, 2014, ENVIRON HEALTH PERSP, V122, P553, DOI 10.1289/ehp.1205909; Zijlema WL, 2016, INT J HYG ENVIR HEAL, V219, P212, DOI 10.1016/j.ijheh.2015.11.006	28	54	54	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195607	10.1371/journal.pone.0195607	http://dx.doi.org/10.1371/journal.pone.0195607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630645	gold, Green Submitted, Green Published			2022-12-26	WOS:000429505000064
J	Uutela, TI; Kautiainen, HJ; Hakkinen, AH				Uutela, Toini I.; Kautiainen, Hannu J.; Hakkinen, Arja H.			Decreasing muscle performance associated with increasing disease activity in patients with rheumatoid arthritis	PLOS ONE			English	Article							BONE-MINERAL DENSITY; PHYSICAL-ACTIVITY; ENERGY-EXPENDITURE; STRENGTH; WOMEN; INACTIVITY; INDEX; ONSET; MASS	Objectives Increasing evidence suggests that inflammation has a detrimental effect on muscle strength. Our objective was to analyse the association between muscle performance and different disease activity levels in patients with rheumatoid arthritis (RA). Method A total of 199 consecutive outpatients were subject to cross-sectional assessment. Measurements of grip strength, endurance of the upper and lower limbs and trunk strength were combined as a muscle performance composite score (MPCS), using a standardised method. The disease activity for 28 joints (DAS28), radiographs of small joints (Larsen score), rheumatoid factor, body mass index (BMI), comorbidities and anti-rheumatic drugs were verified. Patients questionnaires included sociodemographic information, pain level, global disease activity, the Beck Depression Inventory, the mental and physical component scores of Short Form-36 and physical activity level. Results Of the 199 patients, 36%, 17% and 47% patients had remission, low/moderate and high DAS28, respectively. The patients in remission had significantly shorter disease duration, better parameters in terms of pain, physicians assessment, Larsen, Beck or physical component score of Short Form-36, and they were more physically active than other patients. After adjustments for age, sex, RA duration, radiographs and BMI, the decreasing MPCS associated linearly with the increasing DAS28 activity levels (linearity, P <0.001). Conclusion Poorer MPCS is clearly associated with higher disease activity in patients with RA. Muscle performance is a modifiable risk factor. The findings suggest evaluating muscle performance in clinical practice as a part of patient care.	[Uutela, Toini I.] Cent Hosp Lapland, Dept Med, Rovaniemi, Finland; [Uutela, Toini I.] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Kautiainen, Hannu J.] Helsinki Univ Hosp, Unit Primary Hlth Care, Helsinki, Finland; [Kautiainen, Hannu J.] Kuopio Univ Hosp, Unit Primary Hlth Care, Kuopio, Finland; [Hakkinen, Arja H.] Cent Hosp Jyvaskyla, Dept Phys & Rehabil Med, Jyvaskyla, Finland; [Hakkinen, Arja H.] Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland	University of Oulu; University of Helsinki; Helsinki University Central Hospital; Kuopio University Hospital; University of Eastern Finland; Central Finland Central Hospital; University of Jyvaskyla	Uutela, TI (corresponding author), Cent Hosp Lapland, Dept Med, Rovaniemi, Finland.; Uutela, TI (corresponding author), Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland.	toini.uutela@fimnet.fi			EVO-funding from central Hospital of Lapland; Oulu University Hospital	EVO-funding from central Hospital of Lapland; Oulu University Hospital	This work was supported by the EVO-funding from central Hospital of Lapland and Oulu University Hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALARANTA H, 1994, SCAND J REHABIL MED, V26, P211; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baker JF, 2014, ARTHRIT CARE RES, V66, P1612, DOI 10.1002/acr.22328; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beenakker KGM, 2010, AGEING RES REV, V9, P431, DOI 10.1016/j.arr.2010.05.005; Biolo G, 2014, CLIN NUTR, V33, P737, DOI 10.1016/j.clnu.2014.03.007; Bruunsgard H, 2005, J LEUKOCYTE BIOL, V78, P19; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen L, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-74; Cooney Jennifer K, 2011, J Aging Res, V2011, P681640, DOI 10.4061/2011/681640; Fransen J, 2004, RHEUMATOLOGY, V43, P1252, DOI 10.1093/rheumatology/keh297; Fransen J, 2003, ARTHRIT RHEUM-ARTHR, V49, pS214, DOI [DOI 10.1002/ART.11407, 10.1002/art.11407]; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hakala Markku, 2009, Duodecim, V125, P2131; Hakkinen A, 2006, ANN RHEUM DIS, V65, P30, DOI 10.1136/ard.2004.034769; Hakkinen A, 2005, CLIN EXP RHEUMATOL, V23, P505; Hakkinen A, 2004, ANN RHEUM DIS, V63, P910, DOI 10.1136/ard.2003.013003; Hakkinen A, 1999, SCAND J RHEUMATOL, V28, P145; Henchoz Y, 2012, RHEUMATOLOGY, V51, P1500, DOI 10.1093/rheumatology/kes067; Heyward VH, 1996, APPL BODY COMPOSITIO, P112; Hueber AJ, 2009, RHEUMATOID ARTHRITIS, P200; International Physical Activity Questionnaires (IPAQ), 2015, GUID DAT PROC AN INT; Iversen Maura D, 2012, Int J Clin Rheumtol, V7, P489; LARSEN A, 1977, ACTA RADIOL DIAGN, V18, P481, DOI 10.1177/028418517701800415; Matschke V, 2010, MED SCI SPORTS EXERC; Metsios GS, 2009, EUR J CARDIOV PREV R, V16, P188, DOI 10.1097/HJR.0b013e3283271ceb; Rall LC, 1996, ARTHRITIS RHEUM, V39, P1115, DOI 10.1002/art.1780390707; Roubenoff R, 2002, AM J CLIN NUTR, V76, P774, DOI 10.1093/ajcn/76.4.774; Sandberg MEC, 2014, ANN RHEUM DIS, V73, P1541, DOI 10.1136/annrheumdis-2014-205180; Schaap LA, 2009, J GERONTOL A-BIOL, V64, P1183, DOI 10.1093/gerona/glp097; Sharif S, 2011, CASE REP MED, V2011, DOI 10.1155/2011/205691; Sheehy C, 2013, SCAND J RHEUMATOL, V42, P289, DOI 10.3109/03009742.2012.747624; Sherbourne CD, 1992, MED CARE, V30; Sokka T, 2008, ARTHRIT RHEUM-ARTHR, V59, P42, DOI 10.1002/art.23255; Sternang O, 2015, AGE AGEING, V44, P269, DOI 10.1093/ageing/afu170; STUCKI G, 1994, J RHEUMATOL, V21, P2200; Summers GD, 2010, NAT REV RHEUMATOL, V6, P445, DOI 10.1038/nrrheum.2010.105; van den Ende CHM, 2000, ANN RHEUM DIS, V59, P615, DOI 10.1136/ard.59.8.615	38	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194917	10.1371/journal.pone.0194917	http://dx.doi.org/10.1371/journal.pone.0194917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630626	Green Published, Green Submitted, gold			2022-12-26	WOS:000429505000019
J	Zhou, N; Katz, M; Knecht, W; Compagno, C; Piskur, J				Zhou, Nerve; Katz, Michael; Knecht, Wolfgang; Compagno, Concetta; Piskur, Jure			Genome dynamics and evolution in yeasts: A long-term yeast-bacteria competition experiment	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; SACCHAROMYCES-CEREVISIAE; CLONAL INTERFERENCE; POPULATIONS; INHIBITION; STRAINS; ECOLOGY; DEATH	There is an enormous genetic diversity evident in modern yeasts, but our understanding of the ecological basis of such diversifications in nature remains at best fragmented so far. Here we report a long-term experiment mimicking a primordial competitive environment, in which yeast and bacteria co-exist and compete against each other. Eighteen yeasts covering a wide phylogenetic background spanning approximately 250 million years of evolutionary history were used to establish independent evolution lines for at most 130 passages. Our collection of hundreds of modified strains generated through such a rare two-species cross-kingdom competition experiment re-created the appearance of large-scale genomic rearrangements and altered phenotypes important in the diversification history of yeasts. At the same time, the methodology employed in this evolutionary study would also be a non gene-technological method of reprogramming yeast genomes and then selecting yeast strains with desired traits. Cross-kingdom competition may therefore be a method of significant value to generate industrially useful yeast strains with new metabolic traits.	[Zhou, Nerve; Katz, Michael; Knecht, Wolfgang; Piskur, Jure] Lund Univ, Dept Biol, Lund, Sweden; [Zhou, Nerve] Botswana Int Univ Sci & Technol, Dept Biol Sci & Biotechnol, Private Bag 16, Palapye, Botswana; [Katz, Michael] Carlsberg Labs, Gamle Carlsberg Vej 10, Copenhagen V, Denmark; [Knecht, Wolfgang] Lund Univ, Lund Prot Prod Platform, Lund, Sweden; [Compagno, Concetta] Univ Milan, Dept Food Environm & Nutr Sci, Milan, Italy	Lund University; Lund University; University of Milan	Zhou, N (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.; Zhou, N (corresponding author), Botswana Int Univ Sci & Technol, Dept Biol Sci & Biotechnol, Private Bag 16, Palapye, Botswana.	zhoun@biust.ac.bw		Zhou, Nerve/0000-0002-8822-1347	Marie Curie, Cornucopia Project [264717]; Fysiografen Foundation; Lindstrom Foundation; Carlsberg Laboratories, Copenhagen, Denmark under Cornucopia Project [264717]	Marie Curie, Cornucopia Project; Fysiografen Foundation; Lindstrom Foundation; Carlsberg Laboratories, Copenhagen, Denmark under Cornucopia Project	This work was funded by the Marie Curie, Cornucopia Project (264717) to JP, Fysiografen and Lindstrom Foundations to NZ. Part of this work involving use of a Bioscreen C was done at Carlsberg Laboratories, Copenhagen, Denmark as a consortium partner under the same Cornucopia Project (264717). The funder provided support in the form of salaries for authors [MK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS J, 1985, GENETICS, V110, P173; Ahmad KM, 2013, ANTON LEEUW INT J G, V104, P111, DOI 10.1007/s10482-013-9931-3; Arneborg N, 2000, ARCH MICROBIOL, V174, P125, DOI 10.1007/s002030000185; Bae S, 2006, J APPL MICROBIOL, V100, P712, DOI 10.1111/j.1365-2672.2006.02890.x; Barata A, 2012, INT J FOOD MICROBIOL, V153, P243, DOI 10.1016/j.ijfoodmicro.2011.11.025; Barrick JE, 2009, COLD SH Q B, V74, P119, DOI 10.1101/sqb.2009.74.018; Batista M, 2011, BIOCONTROL SCI TECHN, V21, P797, DOI 10.1080/09583157.2011.580837; Beckner M, 2011, LETT APPL MICROBIOL, V53, P387, DOI 10.1111/j.1472-765X.2011.03124.x; BENNETT AF, 1990, NATURE, V346, P79, DOI 10.1038/346079a0; Chang SL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003232; Charton C, 2004, BIOCHEM BIOPH RES CO, V318, P67, DOI 10.1016/j.bbrc.2004.03.185; Chernin LS, 1997, APPL ENVIRON MICROB, V63, P834, DOI 10.1128/AEM.63.3.834-839.1997; Conrad TM, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.42; Cowen LE, 2000, J BACTERIOL, V182, P1515, DOI 10.1128/JB.182.6.1515-1522.2000; Cray JA, 2013, MICROB BIOTECHNOL, V6, P453, DOI 10.1111/1751-7915.12027; Crowley S, 2013, TRENDS FOOD SCI TECH, V33, P93, DOI 10.1016/j.tifs.2013.07.004; Darwin C, 1859, ORIGIN SPECIES MEANS; Dashko S, 2014, FEMS YEAST RES, V14, P826, DOI 10.1111/1567-1364.12161; Dragosits M, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-64; Dudley R, 2002, ADDICTION, V97, P381, DOI 10.1046/j.1360-0443.2002.00002.x; Dunham MJ, 2010, METHOD ENZYMOL, V470, P487, DOI 10.1016/S0076-6879(10)70019-7; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Gleeson O, 2010, ANTON LEEUW INT J G, V97, P261, DOI 10.1007/s10482-009-9407-7; Goddard MR, 2008, ECOLOGY, V89, P2077, DOI 10.1890/07-2060.1; Hagman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068734; Hallsworth JE, 1998, J FERMENT BIOENG, V86, P451, DOI 10.1016/S0922-338X(98)80150-5; Hellborg L, 2009, EUKARYOT CELL, V8, P1739, DOI 10.1128/EC.00115-09; Humphry DR, 2003, INT J SYST EVOL MICR, V53, P393, DOI 10.1099/ijs.0.02271-0; Kao KC, 2008, NAT GENET, V40, P1499, DOI 10.1038/ng.280; Kurtzman CP, 2003, FEMS YEAST RES, V4, P233, DOI 10.1016/S1567-1356(03)00175-2; Lambert RJ, 1999, J APPL MICROBIOL, V86, P157, DOI 10.1046/j.1365-2672.1999.00646.x; Lang GI, 2013, NATURE, V500, P571, DOI 10.1038/nature12344; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Moktaduzzaman M, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fou009; Morales L, 2012, MICROBIOL MOL BIOL R, V76, P721, DOI 10.1128/MMBR.00022-12; MORTIMER RK, 1994, YEAST, V10, P1543, DOI 10.1002/yea.320101203; Mustonen V, 2010, P NATL ACAD SCI USA, V107, P4248, DOI 10.1073/pnas.0907953107; Paquin CE, 1983, RELATIVE FITNESS CAN; Passoth V, 2006, FEMS YEAST RES, V6, P3, DOI 10.1111/j.1567-1364.2005.00004.x; Petersen RF, 1999, INT J SYST BACTERIOL, V49, P1925, DOI 10.1099/00207713-49-4-1925; Piskur J, 2006, TRENDS GENET, V22, P183, DOI 10.1016/j.tig.2006.02.002; Piskur J, 2012, INT J FOOD MICROBIOL, V157, P202, DOI 10.1016/j.ijfoodmicro.2012.05.008; RICHARDS M, 1966, NATURE, V209, P536, DOI 10.1038/209536a0; Roach DR, 2015, MICROB BIOTECHNOL, V8, P510, DOI 10.1111/1751-7915.12253; Rozen DE, 2009, ECOL LETT, V12, P34, DOI 10.1111/j.1461-0248.2008.01257.x; Rozpedowska E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1305; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Steensels J, 2014, APPL ENVIRON MICROB, V80, P6965, DOI 10.1128/AEM.02235-14; Steensels J, 2014, FEMS MICROBIOL REV, V38, P947, DOI 10.1111/1574-6976.12073; Sun G, 2002, SCIENCE, V296, P899, DOI 10.1126/science.1069439; Thompson JN, 1999, SCIENCE, V284, P2116, DOI 10.1126/science.284.5423.2116; Thomson JM, 2005, NAT GENET, V37, P630, DOI 10.1038/ng1553; Ueda KI, 1952, J AGR CHEM SOC JAPAN, V26, P35, DOI DOI 10.1271/NOGEIKAGAKU1924.26.35; Verstrepen KJ, 2006, YEAST HANDB, V2, P399; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Woolfit M, 2007, EUKARYOT CELL, V6, P721, DOI 10.1128/EC.00338-06; Zeyl C, 2006, FEMS YEAST RES, V6, P685, DOI 10.1111/j.1567-1364.2006.00061.x; Zhou N, 2015, THESIS; Zhou N, 2017, COEVOLUTION BACTERIA, V12, DOI [10.1371/journal.pone.0173318, DOI 10.1371/JOURNAL.PONE.0173318]; Zhou N, 2017, FEMS YEAST RES, V17, DOI 10.1093/femsyr/fox060	61	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0194911	10.1371/journal.pone.0194911	http://dx.doi.org/10.1371/journal.pone.0194911			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624585	gold, Green Published, Green Submitted			2022-12-26	WOS:000429379600010
J	Adamovicz, L; Allender, MC; Archer, G; Rzadkowska, M; Boers, K; Phillips, C; Driskell, E; Kinsel, MJ; Chu, C				Adamovicz, Laura; Allender, Matthew C.; Archer, Grace; Rzadkowska, Marta; Boers, Kayla; Phillips, Chris; Driskell, Elizabeth; Kinsel, Michael J.; Chu, Caroline			Investigation of multiple mortality events in eastern box turtles (Terrapene carolina carolina)	PLOS ONE			English	Article							VIRUS 3-LIKE VIRUS; RANAVIRUS INFECTION; QUANTITATIVE PCR; DISEASE; MYCOPLASMA; MANAGEMENT; TORTOISES; CHYTRIDIOMYCOSIS; HERPESVIRUS-1; SURVEILLANCE	Wildlife mortality investigations are important for conservation, food safety, and public health; but they are infrequently reported for cryptic chelonian species. Eastern box turtles (Terrapene carolina carolina) are declining due to anthropogenic factors and disease, and while mortality investigations have been reported for captive and translocated individuals, few descriptions exist for free-living populations. We report the results of four natural mortality event investigations conducted during routine health surveillance of three Illinois box turtle populations in 2011, 2013, 2014, and 2015. In April 2011, over 50 box turtles were found dead and a polymicrobial necrotizing bacterial infection was diagnosed in five survivors using histopathology and aerobic/anaerobic culture. This represents the first reported occurrence of necrotizing bacterial infection in box turtles. In August 2013, paired histopathology and qPCR ranavirus detection in nine turtles was significantly associated with occupation of moist microhabitats, identification of oral plaques and nasal discharge on physical exam, and increases in the heterophil count and heterophil to lymphocyte ratio (p < 0.05). In July 2014 and 2015, ranavirus outbreaks reoccurred within a 0.2km radius of highly-disturbed habitat containing ephemeral ponds used by amphibians for breeding. qPCR ranavirus detection in five individuals each year was significantly associated with use of moist microhabitats (p < 0.05). Detection of single and co-pathogens (Terrapene herpesvirus 1, adenovirus, and Mycoplasma sp.) was common before, during, and after mortality events, but improved sample size would be necessary to determine the impacts of these pathogens on the occurrence and outcome of mortality events. This study provides novel information about the causes and predictors of natural box turtle mortality events. Continued investigation of health, disease, and death in free-living box turtles will improve baseline knowledge of morbidity and mortality, identify threats to survival, and promote the formation of effective conservation strategies.	[Adamovicz, Laura; Allender, Matthew C.; Archer, Grace; Rzadkowska, Marta; Boers, Kayla] Univ Illinois, Coll Vet Med, Wildlife Epidemiol Lab, Urbana, IL 61801 USA; [Phillips, Chris] Illinois Nat Hist Survey, Prairie Res Inst, Champaign, IL 61820 USA; [Driskell, Elizabeth; Kinsel, Michael J.] Univ Illinois, Coll Vet Med, Dept Pathobiol, Urbana, IL 61801 USA; [Chu, Caroline] Univ Illinois, Coll Vet Med, Zool Pathol Program, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Allender, MC (corresponding author), Univ Illinois, Coll Vet Med, Wildlife Epidemiol Lab, Urbana, IL 61801 USA.	mcallend@illinois.edu		Adamovicz, Laura/0000-0002-5696-2327				Agha M, 2017, DIS AQUAT ORGAN, V124, P91, DOI 10.3354/dao03122; Allender MC, 2006, J WILDLIFE DIS, V42, P677, DOI 10.7589/0090-3558-42.3.677; Allender Matthew C., 2013, Journal of Herpetological Medicine and Surgery, V23, P25, DOI 10.5818/1529-9651-23.1.25; Allender MC, 2013, J VIROL METHODS, V188, P121, DOI 10.1016/j.jviromet.2012.12.012; Artois Marc, 2009, P187, DOI 10.1007/978-4-431-77134-0_10; Belzer William R., 2011, Turtle and Tortoise Newsletter, V15, P18; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bishop EJ, 2007, EPIDEMIOL INFECT, V135, P1248, DOI 10.1017/S0950268807008515; Black Y, 2017, J WILDLIFE DIS, V53, P509, DOI 10.7589/2016-08-176; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Blum SA, 2014, P ASREPTILIAN AMPH, P17; Boers K, 2017, HERPETOL REV, V48, P300; Brand CJ, 2013, ECOHEALTH, V10, P446, DOI 10.1007/s10393-013-0897-4; Brenes R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092476; BROWN MB, 1994, INFECT IMMUN, V62, P4580, DOI 10.1128/IAI.62.10.4580-4586.1994; Brunner J.L., 2015, RANAVIRUSES LETHAL P, P71, DOI [10.1007/978-3-319-13755-1_4, DOI 10.1007/978-3-319-13755-1_4]; Butkus CE, 2017, J ZOO WILDLIFE MED, V48, P1210, DOI 10.1638/2017-0098.1; CAGLE FRED R., 1939, COPEIA, V1939, P170, DOI 10.2307/1436818; Clark RW, 2011, BIOL CONSERV, V144, P886, DOI 10.1016/j.biocon.2010.12.001; Crane M, 2011, VIRUSES-BASEL, V3, P2025, DOI 10.3390/v3112025; Currylow AF, 2014, J HERPETOL, V48, P117, DOI 10.1670/12-235; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; De Voe R, 2004, J ZOO WILDLIFE MED, V35, P534, DOI 10.1638/03-037; DODD CK, 2001, N AM BOX TURTLES NAT; Doszpoly A, 2013, INFECT GENET EVOL, V17, P106, DOI 10.1016/j.meegid.2013.03.049; Edlich RF, 2010, J EMERG MED, V39, P261, DOI 10.1016/j.jemermed.2008.06.024; Farkas SL, 2009, VET MICROBIOL, V138, P169, DOI 10.1016/j.vetmic.2009.03.016; Farnsworth SD, 2013, TRANSPORT RES REC, P1, DOI 10.3141/2362-01; Feldman SH, 2006, J WILDLIFE DIS, V42, P279, DOI 10.7589/0090-3558-42.2.279; Heppell SS, 1998, COPEIA, P367, DOI 10.2307/1447430; Homan HJ, 2001, WILDLIFE SOC B, V29, P292; Hyatt AD, 2000, ARCH VIROL, V145, P301, DOI 10.1007/s007050050025; Johnson AJ, 2007, VET PATHOL, V44, P285, DOI 10.1354/vp.44-3-285; Johnson AJ, 2008, J WILDLIFE DIS, V44, P851, DOI 10.7589/0090-3558-44.4.851; Johnson AJ, 2010, VET MICROBIOL, V142, P160, DOI 10.1016/j.vetmic.2009.09.059; Jousimies-Somer H., 2003, WADSWORTH KTL ANAERO, V6th ed; Kane LP, 2017, J WILDLIFE DIS, V53, P285, DOI 10.7589/2016-06-138; Kane LP, 2016, J VIROL METHODS, V232, P57, DOI 10.1016/j.jviromet.2016.02.002; Kimble SJA, 2017, ECOHEALTH; Kimble SJA, 2015, ECOHEALTH, V12, P334, DOI 10.1007/s10393-014-0974-3; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; Morner T, 2002, REV SCI TECH OIE, V21, P67, DOI 10.20506/rst.21.1.1321; Ossiboff RJ, 2015, J WILDLIFE DIS, V51, P466, DOI 10.7589/2014-04-086; Phan HH, 2010, CRIT CARE MED, V38, pS460, DOI 10.1097/CCM.0b013e3181ec667f; R Core Team, 2021, R LANGUAGE ENV STAT; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Ruder MG, 2010, JAVMA-J AM VET MED A, V237, P783, DOI 10.2460/javma.237.7.783; Ryser-Degiorgis MP, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-223; Sarani B, 2009, J AM COLL SURGEONS, V208, P279, DOI 10.1016/j.jamcollsurg.2008.10.032; Sartelli M, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-57; Schloegel LM, 2006, ECOHEALTH, V3, P35, DOI 10.1007/s10393-005-0012-6; SCHUMACHER IM, 1993, J CLIN MICROBIOL, V31, P1454, DOI 10.1128/JCM.31.6.1454-1460.1993; Sim RR, 2016, J ZOO WILDLIFE MED, V47, P256, DOI 10.1638/2015-0048.1; Sim RR, 2015, VET MICROBIOL, V175, P218, DOI 10.1016/j.vetmic.2014.11.029; Sleeman J., 2012, NEW DIRECTIONS CONSE, P539; Stacy BA, 2014, J WILDLIFE DIS, V50, P906, DOI 10.7589/2013-10-271; Stallknecht DE, 2007, CURR TOP MICROBIOL, V315, P445; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Teacher AGF, 2010, ANIM CONSERV, V13, P514, DOI 10.1111/j.1469-1795.2010.00373.x; Turtle Taxonomy Working Group, 2017, Chelonian Research Monographs, V7, P1; Wobeser G.A, 2006, ESSENTIALS DIS WILD; Wuerthner VP, 2017, J ANIM ECOL, V86, P921, DOI 10.1111/1365-2656.12665	64	23	23	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195617	10.1371/journal.pone.0195617	http://dx.doi.org/10.1371/journal.pone.0195617			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621347	Green Published, Green Submitted, gold			2022-12-26	WOS:000429206800107
J	Mobley, CB; Haun, CT; Roberson, PA; Mumford, PW; Kephart, WC; Romero, MA; Osburn, SC; Vann, CG; Young, KC; Beck, DT; Martin, JS; Lockwood, CM; Roberts, MD				Mobley, Christopher B.; Haun, Cody T.; Roberson, Paul A.; Mumford, Petey W.; Kephart, Wesley C.; Romero, Matthew A.; Osburn, Shelby C.; Vann, Christopher G.; Young, Kaelin C.; Beck, Darren T.; Martin, Jeffrey S.; Lockwood, Christopher M.; Roberts, Michael D.			Biomarkers associated with low, moderate, and high vastus lateralis muscle hypertrophy following 12 weeks of resistance training	PLOS ONE			English	Article							SKELETAL-MUSCLE; MYOFIBER HYPERTROPHY; RIBOSOME BIOGENESIS; PROTEIN-SYNTHESIS; GENE-EXPRESSION; MYONUCLEAR ADDITION; EXERCISE; MYOSTATIN; TESTOSTERONE; HUMANS	We sought to identify biomarkers which delineated individual hypertrophic responses to resistance training. Untrained, college-aged males engaged in full-body resistance training (3 d/wk) for 12 weeks. Body composition via dual x-ray absorptiometry (DXA), vastus lateralis (VL) thickness via ultrasound, blood, VL muscle biopsies, and three-repetition maximum (3-RM) squat strength were obtained prior to (PRE) and following (POST) 12 weeks of training. K-means cluster analysis based on VL thickness changes identified LOW [n = 17; change (mean +/- SD) = +0.11 +/- 0.14 cm], modest (MOD; n = 29, +0.40 +/- 0.06 cm), and high (HI; n = 21, +0.69 +/- 0.14 cm) responders. Biomarkers related to histology, ribosome biogenesis, proteolysis, inflammation, and androgen signaling were analyzed between clusters. There were main effects of time (POST>PRE, p<0.05) but no cluster x time interactions for increases in DXA lean body mass, type I and II muscle fiber cross sectional area and myonuclear number, satellite cell number, and macronutrients consumed. Interestingly, PRE VL thickness was similar to 12% greater in LOW versus HI (p = 0.021), despite POST values being similar to 12% greater in HI versus LOW (p = 0.006). However there was only a weak correlation between PRE VL thickness scores and change in VL thickness (r(2) = 0.114, p = 0.005). Forced post hoc analysis indicated that muscle total RNA levels (i.e., ribosome density) did not significantly increase in the LOW cluster (351 +/- 70 ng/mg to 380 +/- 62, p = 0.253), but increased in the MOD (369 +/- 115 to 429 +/- 92, p = 0.009) and HI clusters (356 +/- 77 to 470 +/- 134, p<0.001; POST HI>POST LOW, p = 0.013). Nonetheless, there was only a weak association between change in muscle total RNA and VL thickness (r(2) = 0.079, p = 0.026). IL-1 beta mRNA levels decreased in the MOD and HI clusters following training (p<0.05), although associations between this marker and VL thickness changes were not significant (r(2) = 0.0002, p = 0.919). In conclusion, individuals with lower pre-training VL thickness values and greater increases muscle total RNA levels following 12 weeks of resistance training experienced greater VL muscle growth, although these biomarkers individually explained only similar to 8-11% of the variance in hypertrophy.	[Mobley, Christopher B.; Haun, Cody T.; Roberson, Paul A.; Mumford, Petey W.; Kephart, Wesley C.; Romero, Matthew A.; Osburn, Shelby C.; Vann, Christopher G.; Young, Kaelin C.; Beck, Darren T.; Martin, Jeffrey S.; Roberts, Michael D.] Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA; [Young, Kaelin C.; Beck, Darren T.; Martin, Jeffrey S.; Roberts, Michael D.] Edward Via Coll Osteopath Med, Dept Cell Biol & Physiol, Auburn Campus, Auburn, AL 36832 USA; [Lockwood, Christopher M.] Lockwood LLC, Draper, UT USA	Auburn University System; Auburn University	Roberts, MD (corresponding author), Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA.; Roberts, MD (corresponding author), Edward Via Coll Osteopath Med, Dept Cell Biol & Physiol, Auburn Campus, Auburn, AL 36832 USA.	mdr0024@auburn.edu	Mobley, Christopher/AAC-2123-2020; Lockwood, Chris/A-8136-2018; Mumford, Petey/GLS-9565-2022	Lockwood, Chris/0000-0002-4002-4301; Mumford, Petey/0000-0002-4946-9702; Mobley, C. Brooks/0000-0002-4045-9962				Ahmed M, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030200; Antonio J, 2015, J INT SOC SPORT NUTR, V12, DOI 10.1186/s12970-015-0100-0; Antonio J, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/1550-2783-11-19; Bamman MM, 2007, J APPL PHYSIOL, V102, P2232, DOI 10.1152/japplphysiol.00024.2007; Ben-Nissan G, 2014, BIOMOLECULES, V4, P862, DOI 10.3390/biom4030862; Chaillou T, 2014, J CELL PHYSIOL, V229, P1584, DOI 10.1002/jcp.24604; Dalbo VJ, 2013, EUR J NUTR, V52, P477, DOI 10.1007/s00394-012-0349-x; De Larichaudy J, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-2; Ferrando AA, 1998, AM J PHYSIOL-ENDOC M, V275, pE864; Figueiredo VC, 2015, AM J PHYSIOL-ENDOC M, V309, pE72, DOI 10.1152/ajpendo.00050.2015; Greiwe JS, 2001, FASEB J, V15, P475, DOI 10.1096/fj.00-0274com; GRIGGS RC, 1989, J APPL PHYSIOL, V66, P498, DOI 10.1152/jappl.1989.66.1.498; Haddad F, 2005, J APPL PHYSIOL, V98, P911, DOI 10.1152/japplphysiol.01026.2004; Haff G., 2016, ESSENTIALS STRENGTH; HAMMOND HK, 1992, AM J PHYSIOL, V263, pH1675, DOI 10.1152/ajpheart.1992.263.6.H1675; Hikim IS, 2002, AM J PHYSIOL-ENDOC M, V283, pE154, DOI 10.1152/ajpendo.00502.2001; Hulmi JJ, 2009, AMINO ACIDS, V37, P297, DOI 10.1007/s00726-008-0150-6; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Kim JS, 2007, J APPL PHYSIOL, V103, P1488, DOI 10.1152/japplphysiol.01194.2006; Lambert CP, 2008, J APPL PHYSIOL, V105, P473, DOI 10.1152/japplphysiol.00006.2008; LEXELL J, 1983, MUSCLE NERVE, V6, P588, DOI 10.1002/mus.880060809; Louis E, 2007, J APPL PHYSIOL, V103, P1744, DOI 10.1152/japplphysiol.00679.2007; Mayhew DL, 2009, J APPL PHYSIOL, V107, P1655, DOI 10.1152/japplphysiol.91234.2008; McFarlane C, 2008, EXP CELL RES, V314, P317, DOI 10.1016/j.yexcr.2007.09.012; McGlory C, 2017, J APPL PHYSIOL, V122, P541, DOI 10.1152/japplphysiol.00613.2016; Menon MK, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-119; Mitchell CJ, 2015, J APPL PHYSIOL, V118, P495, DOI 10.1152/japplphysiol.00609.2014; Mitchell CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078636; Mobley CB, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090972; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Murton AJ, 2013, INT J BIOCHEM CELL B, V45, P2209, DOI 10.1016/j.biocel.2013.07.005; Nader GA, 2014, J PHYSIOL-LONDON, V592, P5143, DOI 10.1113/jphysiol.2014.284828; Pasiakos SM, 2014, IUBMB LIFE, V66, P478, DOI 10.1002/iub.1291; Percipalle P, 2006, EMBO REP, V7, P525, DOI 10.1038/sj.embor.7400657; Petrella JK, 2008, J APPL PHYSIOL, V104, P1736, DOI 10.1152/japplphysiol.01215.2007; Petrella JK, 2006, AM J PHYSIOL-ENDOC M, V291, pE937, DOI 10.1152/ajpendo.00190.2006; Raj DSC, 2008, KIDNEY INT, V73, P1054, DOI 10.1038/ki.2008.21; Rhea MR, 2002, J STRENGTH COND RES, V16, P250, DOI 10.1519/00124278-200205000-00013; Schoenfeld BJ, 2013, J STRENGTH COND RES, V27, P1720, DOI 10.1519/JSC.0b013e31828ddd53; Sinha-Hikim I, 2003, AM J PHYSIOL-ENDOC M, V285, pE197, DOI 10.1152/ajpendo.00370.2002; Snijders T, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00283; Stec MJ, 2016, AM J PHYSIOL-ENDOC M, V310, pE652, DOI 10.1152/ajpendo.00486.2015; Taylor WE, 2001, AM J PHYSIOL-ENDOC M, V280, pE221, DOI 10.1152/ajpendo.2001.280.2.E221; Terzis G, 2008, EUR J APPL PHYSIOL, V102, P145, DOI 10.1007/s00421-007-0564-y; Thalacker-Mercer A, 2013, PHYSIOL GENOMICS, V45, P499, DOI 10.1152/physiolgenomics.00167.2012; Wang DT, 2014, INT IMMUNOPHARMACOL, V19, P206, DOI 10.1016/j.intimp.2014.02.002; Wen Y, 2016, EXERC SPORT SCI REV, V44, P110, DOI 10.1249/JES.0000000000000082; White JP, 2009, ACTA PHYSIOL, V197, P321, DOI 10.1111/j.1748-1716.2009.02029.x; Yang LX, 2013, MOL CELL BIOL, V33, P3835, DOI 10.1128/MCB.00476-13; Zamir O, 1992, Mediators Inflamm, V1, P247, DOI 10.1155/S0962935192000371	50	50	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195203	10.1371/journal.pone.0195203	http://dx.doi.org/10.1371/journal.pone.0195203			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621305	Green Published, Green Submitted, gold			2022-12-26	WOS:000429206800049
J	Fick, SE; Evett, RR				Fick, Stephen E.; Evett, Rand R.			Distribution modelling of pre-Columbian California grasslands with soil phytoliths: New insights for prehistoric grassland ecology and restoration	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; COMPETITION; VEGETATION	Historical reconstructions of plant community distributions are useful for biogeographic studies and restoration planning, but the quality of insights gained depends on the depth and reliability of historical information available. For the Central Valley of California, one of the most altered terrestrial ecosystems on the planet, this task is particularly difficult given poor historical documentation and sparse relict assemblages of pre-invasion plant species. Coastal and interior prairies were long assumed to have been dominated by perennial bunchgrasses, but this hypothesis has recently been challenged. We evaluated this hypothesis by creating species distribution models (SDMs) using a novel approach based on the abundance of soil phytoliths (microscopic particles of biogenic silica used as a proxy for long-term grass presence) extracted from soil samples at locations statewide. Modeled historical grass abundance was consistently high along the coast and to a lesser extent in higher elevation foothills surrounding the Central Valley. SDMs found strong associations with mean temperature, temperature variability, and precipitation variability, with higher predicted abundance in regions with cooler, equable temperatures and moderated rainfall, mirroring the pattern for modern perennial grass distribution across the state. The results of this study strongly suggest that the pre-Columbian Central Valley of California was not dominated by grasses. Using soil phytolith data as input for SDMs is a promising new method for predicting the extent of prehistoric grass distributions where alternative historical datasets are lacking.	[Fick, Stephen E.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Evett, Rand R.] Univ Calif Berkeley, Dept ESPM, Berkeley, CA 94720 USA	University of California System; University of California Davis; University of California System; University of California Berkeley	Fick, SE (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	sfick@ucdavis.edu		Fick, Stephen/0000-0002-3548-6966	UC Davis Ecology Fellowship; Ben A. Madson scholarship	UC Davis Ecology Fellowship; Ben A. Madson scholarship	This work was supported by internal funding from the UC Davis Ecology Fellowship and the Ben A. Madson scholarship, http://ecology.ucdavis.edu/funding/, http://financialaid.ucdavis.edu/scholarships/campus/awards/caes.html.	Aleman JC, 2013, QUATERNARY RES, V80, P341, DOI 10.1016/j.yqres.2013.05.008; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Bartolome JW, THE ECOLOGICAL STATU; Bivand R, 2015, COMPARING IMPLEMENTA; Blecker SW, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002690; Booth TH, 2014, DIVERS DISTRIB, V20, P1, DOI 10.1111/ddi.12144; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burcham L. T., 1957, CALIFORNIA RANGE LAN; Cabanes D, 2011, J ARCHAEOL SCI, V38, P2480, DOI 10.1016/j.jas.2011.05.020; Clary J, 2008, PLANT ECOL, V195, P13, DOI 10.1007/s11258-007-9294-9; Clary J, 2012, PLANT ECOL, V213, P1203, DOI 10.1007/s11258-012-0076-7; Clements FE, 1934, J ECOL, V22, P39, DOI 10.2307/2256095; Corbin JD, 2004, ECOLOGY, V85, P1273, DOI 10.1890/02-0744; Dyer AR, 1999, ECOLOGY, V80, P2697, DOI 10.1890/0012-9658(1999)080[2697:EOCORA]2.0.CO;2; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Evett Rand R., 2006, Madrono, V53, P351, DOI 10.3120/0024-9637(2006)53[351:PEFTLO]2.0.CO;2; Evett RR, 2013, HOLOCENE, V23, P1644, DOI 10.1177/0959683613499056; Evett RR, 2013, RESTOR ECOL, V21, P464, DOI 10.1111/j.1526-100X.2012.00912.x; Fishkis O, 2010, GEODERMA, V157, P27, DOI 10.1016/j.geoderma.2010.03.012; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Geology Holstein G., 2011, FREMONTIA, V39, P22; Hamilton JG, 1997, CHANGING PERCEPTIONS, P311; Heady H.F., 1977, TERRESTRIAL VEGETATI, P491; Hengl T, 2014, SOILGRIDS1KM D GLOBA; Higgs E, 2014, FRONT ECOL ENVIRON, V12, P499, DOI 10.1890/110267; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holland V. I., 1995, CALIFORNIA VEGETATIO; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Hyland E, 2013, PALAEOGEOGR PALAEOCL, V374, P338, DOI 10.1016/j.palaeo.2013.01.026; JACKSON LE, 1990, AGR ECOSYST ENVIRON, V32, P89, DOI 10.1016/0167-8809(90)90126-X; Kuchler AW, 1977, THE MAP OF THE NATUR; Lulow ME, 2011, FREMONTIA, V39, P6; Minnich RA, 2008, CALIFORNIA S FADING; Nevada California, 2006, MADRONO, V53, P351; San Francisco Estuary Institute (SFEI), 2015, CALIFORNIA AQUATIC R; Seabloom EW, 2003, ECOL APPL, V13, P575, DOI 10.1890/1051-0761(2003)013[0575:CSLDAR]2.0.CO;2; White AF, 2012, GEOCHIM COSMOCHIM AC, V94, P72, DOI 10.1016/j.gca.2012.06.009; Wigand PE., 2007, CALIFORNIA GRASSLAND, P37; Young DJN, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00303.1	43	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194315	10.1371/journal.pone.0194315	http://dx.doi.org/10.1371/journal.pone.0194315			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617400	Green Published, Green Submitted, gold			2022-12-26	WOS:000429203800026
J	Linares, I; Farrokhi, K; Echeverri, J; Kaths, JM; Kollmann, D; Hamar, M; Urbanellis, P; Ganesh, S; Adeyi, OA; Yip, P; Seizner, M; Seizner, N				Linares, Ivan; Farrokhi, Kaveh; Echeverri, Juan; Kaths, Johan Moritz; Kollmann, Dagmar; Hamar, Matyas; Urbanellis, Peter; Ganesh, Sujani; Adeyi, Oyedele A.; Yip, Paul; Seizner, Markus; Seizner, Nazia			PPAR-gamma activation is associated with reduced liver ischemia-reperfusion injury and altered tissue-resident macrophages polarization in a mouse model	PLOS ONE			English	Article							HEPATIC ISCHEMIA/REPERFUSION INJURY; RECEPTOR-GAMMA; INFLAMMATORY RESPONSE; GENE-EXPRESSION; AGONIST; CELLS; MICE; APOPTOSIS; PIOGLITAZONE; HOMEOSTASIS	Background PPAR-gamma (gamma) is highly expressed in macrophages and its activation affects their polarization. The effect of PPAR-gamma activation on Kupffer cells (KCs) and liver ischemia-reperfusion injury (IRI) has not yet been evaluated. We investigated the effect of PPAR-gamma activation on KC-polarization and IRI. Materials and methods Seventy percent (70%) liver ischemia was induced for 60mins. PPAR-gamma-agonist or vehicle was administrated before reperfusion. PPAR-gamma-antagonist was used to block PPAR-gamma activation. Liver injury, necrosis, and apoptosis were assessed post-reperfusion. Flow-cytometry determined KC-phenotypes (pro-inflammatory Nitric Oxide +, anti-inflammatory CD206+ and anti-inflammatory IL-10+). Results Liver injury assessed by serum AST was significantly decreased in PPAR-gamma-agonist versus control group at all time points post reperfusion (1hr: 3092 +/- 105 vs 4469 +/- 551; p = 0.042; 6hr: 7041 +/- 1160 vs 12193 +/- 1143; p = 0.015; 12hr: 5746 +/- 328 vs 8608 +/- 1259; p = 0.049). Furthermore, liver apoptosis measured by TUNEL-staining was significantly reduced in PPAR-gamma-agonist versus control group post reperfusion (1hr:2.46 +/- 0.49 vs 6.90 +/- 0.85%;p = 0.001; 6hr:26.40 +/- 2.93 vs 50.13 +/- 8.29%; p = 0.048). H&E staining demonstrated less necrosis in PPAR-gamma-agonist versus control group (24hr:26.66 +/- 4.78 vs 45.62 +/- 4.57%; p = 0.032). The percentage of pro-inflammatory NO+KCs was significantly lower at all post reperfusion time points in the PPAR-gamma-agonist versus control group (1hr:28.49 +/- 4.99 vs 53.54 +/- 9.15%; p = 0.040; 6hr5.51 +/- 0.54 vs 31.12 +/- 9.58%; p = 0.009; 24hr4.15 +/- 1.50 vs 17.10 +/- 4.77%; p = 0.043). In contrast, percentage of anti-inflammatory CD206+ KCs was significantly higher in PPAR-gamma-agonist versus control group prior to IRI (8.62 +/- 0.96 vs 4.88 +/- 0.50%; p = 0.04). Administration of PPAR-gamma-antagonist reversed the beneficial effects on AST, apoptosis, and pro-inflammatory NO+KCs. Conclusion PPAR-gamma activation reduces IRI and decreases the pro-inflammatory NO+ Kupffer cells. PPAR-gamma activation can become an important tool to improve outcomes in liver surgery through decreasing the pro-inflammatory phenotype of KCs and IRI.	[Linares, Ivan; Farrokhi, Kaveh; Echeverri, Juan; Kaths, Johan Moritz; Kollmann, Dagmar; Hamar, Matyas; Urbanellis, Peter; Ganesh, Sujani; Seizner, Markus; Seizner, Nazia] Toronto Gen Hosp, Multi Organ Transplant Program, Toronto, ON, Canada; [Linares, Ivan] Consejo Nacl Ciencia & Technol, Mexico City, DF, Mexico; [Linares, Ivan; Kaths, Johan Moritz; Urbanellis, Peter] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Farrokhi, Kaveh] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Adeyi, Oyedele A.] Toronto Gen Hosp, Dept Pathol, Toronto, ON, Canada; [Yip, Paul] Toronto Gen Hosp, Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Seizner, N (corresponding author), Toronto Gen Hosp, Multi Organ Transplant Program, Toronto, ON, Canada.	nseizner@gmail.com	Linares-Cervantes, Ivan/AAA-1484-2021; Selzner, Nazia/AAI-1469-2020	Linares-Cervantes, Ivan/0000-0001-5124-9883; Selzner, Nazia/0000-0002-9435-2597; Selzner, Markus/0000-0002-4326-0887; Adeyi, Oyedele/0000-0003-4272-1095	Mexican National Council of Science and Technology (CONACyT, Mexico City, Mexico)	Mexican National Council of Science and Technology (CONACyT, Mexico City, Mexico)	IL expresses his gratitude to the Mexican National Council of Science and Technology (CONACyT, Mexico City, Mexico) for its support for the Graduate program at University of Toronto.	Agrawal YO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111212; Akahori T, 2007, J HEPATOL, V47, P784, DOI 10.1016/j.jhep.2007.07.030; Bendinelli P, 1996, FEBS LETT, V398, P193, DOI 10.1016/S0014-5793(96)01228-8; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Cheng F, 2008, TRANSPL P, V40, P2163, DOI 10.1016/j.transproceed.2008.07.082; Clavien PA, 2001, HEPATOLOGY, V33, P1555, DOI 10.1053/jhep.2001.25448; DECKER K, 1990, EUR J BIOCHEM, V192, P245, DOI 10.1111/j.1432-1033.1990.tb19222.x; Duan SZ, 2008, CIRC RES, V102, P283, DOI 10.1161/CIRCRESAHA.107.164384; Fondevilla C, 2003, EXP MOL PATHOL, V74, P86, DOI 10.1016/S0014-4800(03)00008-X; Fouraschen SMG, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/202975; Ghose R, 2007, J HEPATOL, V46, P115, DOI 10.1016/j.jhep.2006.09.008; Giaginis C, 2008, CURR MOL MED, V8, P562, DOI 10.2174/156652408785748022; Han LJ, 2015, STROKE, V46, P2628, DOI 10.1161/STROKEAHA.115.010091; Hochhauser E, 2015, CELL PHYSIOL BIOCHEM, V36, P1971, DOI 10.1159/000430165; Hu Q, 2014, ASIAN PAC J TROP MED, V7, P271, DOI 10.1016/S1995-7645(14)60036-5; Huang LH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/864509; JAESCHKE H, 1991, AM J PHYSIOL, V260, pG355, DOI 10.1152/ajpgi.1991.260.3.G355; Jaeschke H, 2003, AM J PHYSIOL-GASTR L, V284, pG15, DOI 10.1152/ajpgi.00342.2002; Kakiuchi-Kiyota S, 2011, TOXICOL PATHOL, V39, P1032, DOI 10.1177/0192623311422080; Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11; Kuboki S, 2008, HEPATOLOGY, V47, P215, DOI 10.1002/hep.21963; Lee VG, 2001, SHOCK, V16, P355, DOI 10.1097/00024382-200116050-00006; Lim JE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09639-7; Lin HH, 2005, J EXP MED, V201, P1615, DOI 10.1084/jem.20042307; Liu HX, 2014, BIOCHEM PHARMACOL, V91, P256, DOI 10.1016/j.bcp.2014.07.003; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Majdalawieh Amin, 2010, Nucl Recept Signal, V8, pe004, DOI 10.1621/nrs.08004; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Morrison A, 2011, AM J PHYSIOL-HEART C, V301, pH895, DOI 10.1152/ajpheart.00137.2011; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Palumbo T, 2017, TRANSPLANTATION, V101, P322, DOI 10.1097/TP.0000000000001552; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Prasad K, 2012, J MED SYST, V36, P2621, DOI 10.1007/s10916-011-9737-7; Ranganathan PV, 2013, AM J PHYSIOL-RENAL, V304, pF948, DOI 10.1152/ajprenal.00580.2012; Reel B, 2013, J SURG RES, V182, P176, DOI 10.1016/j.jss.2012.08.020; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rong YP, 2017, TRANSPL P, V49, P1455, DOI 10.1016/j.transproceed.2017.02.063; Sahu SK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006410; Selzner N, 2003, GASTROENTEROLOGY, V125, P917, DOI 10.1016/S0016-5085(03)01048-5; Stewart RK, 2014, J HEPATOL, V60, P298, DOI 10.1016/j.jhep.2013.09.013; Sun CK, 2017, AM J TRANSL RES, V9, P1543; Sun L, 2016, CELL PHYSIOL BIOCHEM, V38, P1831, DOI 10.1159/000443121; Tsung A, 2005, J IMMUNOL, V175, P7661, DOI 10.4049/jimmunol.175.11.7661; Wang Q, 2017, MOL MED REP, V15, P798, DOI 10.3892/mmr.2016.6074; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wang W, 2017, HEPATOLOGY, V66, P108, DOI 10.1002/hep.29129; WIJSMAN JH, 1993, J HISTOCHEM CYTOCHEM, V41, P7, DOI 10.1177/41.1.7678025; Yanagida H, 2006, SHOCK, V26, P162, DOI 10.1097/01.shk.0000223130.87382.73; Yang Y, 2014, TRANSPL P, V46, P1573, DOI 10.1016/j.transproceed.2014.01.018; Yao L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176106; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhai Y, 2004, J IMMUNOL, V173, P7115, DOI 10.4049/jimmunol.173.12.7115	52	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195212	10.1371/journal.pone.0195212	http://dx.doi.org/10.1371/journal.pone.0195212			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617419	Green Published, gold, Green Submitted			2022-12-26	WOS:000429203800069
J	Sharma, S; Chunduri, V; Kumar, A; Kumar, R; Khare, P; Kondepudi, KK; Bishnoi, M; Garg, M				Sharma, Saloni; Chunduri, Venkatesh; Kumar, Aman; Kumar, Rohit; Khare, Pragyanshu; Kondepudi, Kanthi Kiran; Bishnoi, Mahendra; Garg, Monika			Anthocyanin bio-fortified colored wheat: Nutritional and functional characterization	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; BLUE ALEURONE; PURPLE; BREAD; GRAIN; CORN	Colored wheat, rich in anthocyanins, has created interest among the breeders and baking industry. This study was aimed at understanding the nutritional and product making potential of our advanced, high yielding and regionally adapted colored wheat lines. Our results indicated that our advanced colored wheat lines exhibited higher anthocyanin content and antioxidant activity than donor wheat lines and it varied in the order of white<purple<blue<black wheat. UPLC chromatogram revealed that anthocyanin composition and peak pattern is not only dependent on donor genotype but also background of recipient genotype. Interestingly, the purple wheat extract showed highest anti-inflammatory effect and followed the trend of white<blue<black<purple. Nutritional (carbohydrates, sugar, protein, ash, dietary fibre and vitamins) and processing parameters in relation to end-use quality (SDS sedimentation, gluten content, alveograph) of advanced colored lines were similar to high yielding white wheat cultivar. Colored wheat lines showed high iron and zinc content compared to white wheat indicating double bio-fortification. Therefore, our advanced colored wheat lines with high anthocyanin, iron and zinc contents showed antioxidant and anti-inflammatory activity and possessed desirable features for product making and commercial utilization.	[Sharma, Saloni; Chunduri, Venkatesh; Kumar, Aman; Kumar, Rohit; Khare, Pragyanshu; Kondepudi, Kanthi Kiran; Bishnoi, Mahendra; Garg, Monika] Natl Agri Food Biotechnol Inst, Mohali, Punjab, India	Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI)	Garg, M (corresponding author), Natl Agri Food Biotechnol Inst, Mohali, Punjab, India.	mgarg100@yahoo.com	Kondepudi, Kanthi Kiran/P-8336-2014; Bishnoi, Mahendra/CAG-3229-2022; Khare, Pragyanshu/T-6469-2019; Kumar, Aman/AAY-3202-2020	Kondepudi, Kanthi Kiran/0000-0001-8036-7555; Bishnoi, Mahendra/0000-0002-7785-1204	Institutional (NABI) Core Fund for the project "Improvement of nutritional and processing quality in wheat"	Institutional (NABI) Core Fund for the project "Improvement of nutritional and processing quality in wheat"	Institutional (NABI) Core Fund for the project "Improvement of nutritional and processing quality in wheat" was utilized for this study.	Abdel-Aal ESM, 2006, J AGR FOOD CHEM, V54, P4696, DOI 10.1021/jf0606609; Abdel-Aal ESM, 2008, J AGR FOOD CHEM, V56, P11171, DOI 10.1021/jf802168c; Abdel-Aal ESM, 1999, CEREAL CHEM, V76, P350, DOI 10.1094/CCHEM.1999.76.3.350; American Association of Cereal Chemists [AACC], 1990, APPR METH AM ASS CER; AOAC, 1990, INT OFF METH AN, Vfifteenth; Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Boeing JS, 2014, CHEM CENT J, V8, DOI 10.1186/s13065-014-0048-1; Boligon A. A., 2014, MED CHEM, V4, P517, DOI [10.4172/2161-0444.1000188, DOI 10.4172/2161-0444.1000188]; Chen CD, 2013, J NEUROSCI, V33, P1927, DOI 10.1523/JNEUROSCI.2080-12.2013; Ficco DBM, 2014, J AGR FOOD CHEM, V62, P8686, DOI 10.1021/jf5003683; Garg M, 2016, J CEREAL SCI, V71, P138, DOI 10.1016/j.jcs.2016.08.004; Garg M, 2009, J CEREAL SCI, V50, P358, DOI 10.1016/j.jcs.2009.06.012; Hosseinian FS, 2008, FOOD CHEM, V109, P916, DOI 10.1016/j.foodchem.2007.12.083; Hu C, 2000, J AGR FOOD CHEM, V48, P1466, DOI 10.1021/jf990677+; Jaafar SNS, 2013, PLANT BREEDING, V132, P546, DOI 10.1111/pbr.12090; Knievel DC, 2009, J CEREAL SCI, V50, P113, DOI 10.1016/j.jcs.2009.03.007; Kris-Etherton PM, 2004, ANNU REV NUTR, V24, P511, DOI 10.1146/annurev.nutr.23.011702.073237; Lachman J, 2017, J CEREAL SCI, V74, P145, DOI 10.1016/j.jcs.2017.02.007; Li YG, 2015, CROP J, V3, P328, DOI 10.1016/j.cj.2015.04.004; Liu Q, 2010, J AGR FOOD CHEM, V58, P9235, DOI 10.1021/jf101700s; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Martinek P, 2013, TAG 64 JAHR VER PFLA, V1, P75; Montilla EC, 2011, J AGR FOOD CHEM, V59, P3385, DOI 10.1021/jf104724k; Mota FL, 2008, IND ENG CHEM RES, V47, P5182, DOI 10.1021/ie071452o; Patel K, 2013, J ACUTE DIS, V2, P169, DOI 10.1016/S2221-6189(13)60123-7; Petroni K, 2014, PLANTA, V240, P901, DOI 10.1007/s00425-014-2131-1; Prasanna BM, 2011, CURR SCI, V81, P1308; Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698; Shipp J., 2010, Open Food Science Journal, V4, P7, DOI 10.2174/1874256401004010007; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Tsuda T, 2003, J NUTR, V133, P2125, DOI 10.1093/jn/133.7.2125	31	31	31	10	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194367	10.1371/journal.pone.0194367	http://dx.doi.org/10.1371/journal.pone.0194367			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617385	Green Published, Green Submitted, gold			2022-12-26	WOS:000429203800029
J	Honda, F; Hiramatsu, A; Hyogo, H; Aikata, H; Daijo, K; Teraoka, Y; Inagaki, Y; Morio, K; Kobayashi, T; Nakahara, T; Nagaoki, Y; Kawaoka, T; Yoneda, M; Tsuge, M; Imamura, M; Kawakami, Y; Ochi, H; Chayama, K				Honda, Fumi; Hiramatsu, Akira; Hyogo, Hideyuki; Aikata, Hiroshi; Daijo, Kana; Teraoka, Yuji; Inagaki, Yuki; Morio, Kei; Kobayashi, Tomoki; Nakahara, Takashi; Nagaoki, Yuko; Kawaoka, Tomokazu; Yoneda, Masayasu; Tsuge, Masataka; Imamura, Michio; Kawakami, Yoshiiku; Ochi, Hidenori; Chayama, Kazuaki			Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring	PLOS ONE			English	Article							HEPATIC CIRRHOSIS; HEMOGLOBIN; INSULIN; HYPERINSULINISM; DEGRADATION; RISK	Background and aims The feature of blood glucose dynamics in patients with chronic liver disease (CLD) is marked blood glucose fluctuations. However, the detail of blood glucose dynamics is not well known. The aim of the present study was to evaluate glycemic fluctuations by continuous glucose monitoring (CGM). Materials and methods A total of 105 CLD patients with type 2 diabetes mellitus (T2DM) were enrolled in this study. Various parameters of glycemic variability were evaluated. The association of these parameters with liver functional reserve was examined. The parameters were also evaluated according to glycated hemoglobin A1c (HbA1c) levels. Results and discussion Data of all patients showed that mean blood glucose (MBG) levels and the difference between highest and lowest blood glucose (Delta BG) increased significantly with worsening of liver functional reserve (P < 0.001 and P = 0.005, respectively). Although many of the cases were being treated for diabetes, postprandial hyperglycemia was seen in 92% of patients. Nocturnal hypoglycemia was seen in 22% of patients. In non-anemic patients with HbA1c levels of < 7.0%, the percentage of patients with mean amplitude of glycemic excursion (MAGE) of >= 77.4 mg/dL and that of MBG levels of > 145 mg/dL were higher in liver cirrhosis (LC) patients than in chronic hepatitis (CH) patients. In them, homeostasis model assessment for insulin resistance (HOMA-IR) of > 2.5 and LC were significantly associated with the increase in MAGE. LC was also significantly associated with increased MBG levels. Conclusion The CGM systems were useful in finding hidden abnormalities of blood glucose fluctuations in CLD patients with T2DM, especially in non-anemic CLD patients with HbA1c levels of <7.0%.	[Honda, Fumi; Hiramatsu, Akira; Aikata, Hiroshi; Daijo, Kana; Teraoka, Yuji; Inagaki, Yuki; Morio, Kei; Kobayashi, Tomoki; Nakahara, Takashi; Nagaoki, Yuko; Kawaoka, Tomokazu; Tsuge, Masataka; Imamura, Michio; Kawakami, Yoshiiku; Ochi, Hidenori; Chayama, Kazuaki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Appl Life Sci, Hiroshima, Japan; [Hyogo, Hideyuki] JA Hiroshima Gen Hosp, Dept Gastroenterol & Hepatol, Hiroshima, Japan; [Yoneda, Masayasu] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol & Internal Med, Hiroshima, Japan	Hiroshima University; Hiroshima University	Hiramatsu, A (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Appl Life Sci, Hiroshima, Japan.	akirah@hiroshima-u.ac.jp	Tsuge, Masataka/G-5246-2019; chayama, Kazuaki/G-2917-2019; Nakahara, Takashi/H-2320-2019; Hiramatsu, Akira/G-9594-2019	Tsuge, Masataka/0000-0001-7591-8287; Chayama, Kazuaki/0000-0002-5530-5341				BALKAU B, 1991, J CLIN EPIDEMIOL, V44, P465, DOI 10.1016/0895-4356(91)90209-R; Bando Yukihiro, 1997, Journal of the Japan Diabetes Society, V40, P17; BIANCHI G, 1994, HEPATOLOGY, V20, P119, DOI 10.1016/0270-9139(94)90143-0; BOSCH J, 1984, AM J PHYSIOL, V247, pG206, DOI 10.1152/ajpgi.1984.247.3.G206; BUNN HF, 1978, SCIENCE, V200, P21, DOI 10.1126/science.635569; Chen T, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-38; de Marco R, 1999, DIABETES CARE, V22, P756, DOI 10.2337/diacare.22.5.756; Del Prato S, 2002, INT J OBESITY, V26, pS9, DOI 10.1038/sj.ijo.0802172; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065; IWASAKI Y, 1978, J CLIN ENDOCR METAB, V47, P774, DOI 10.1210/jcem-47-4-774; JOHNSTON DG, 1977, LANCET, V1, P10; Kawaguchi T, 2004, AM J PATHOL, V165, P1499, DOI 10.1016/S0002-9440(10)63408-6; KOENIG RJ, 1976, NEW ENGL J MED, V295, P417, DOI 10.1056/NEJM197608192950804; Koga M, 2008, DIABETES RES CLIN PR, V81, P258, DOI 10.1016/j.diabres.2008.04.012; Koga M, 2010, ENDOCR J, V57, P751, DOI 10.1507/endocrj.K10E-138; Marling Cynthia R, 2011, J Diabetes Sci Technol, V5, P871; NOMURA Y, 1989, DIABETES RES CLIN EX, V11, P177; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; OWEN OE, 1983, J CLIN INVEST, V72, P1821, DOI 10.1172/JCI111142; PETRIDES AS, 1994, DIABETES REV, V2, P2; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; SERVICE FJ, 1970, DIABETES, V19, P644, DOI 10.2337/diab.19.9.644; TRENTI T, 1990, RES CLIN LAB, V20, P261; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346	24	17	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195028	10.1371/journal.pone.0195028	http://dx.doi.org/10.1371/journal.pone.0195028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614124	Green Published, Green Submitted, gold			2022-12-26	WOS:000429081600025
J	Zheng, XJ; Zhou, KJ; Zhang, YJ; Han, XL; Zhao, AH; Liu, JJ; Qu, C; Ge, K; Huang, FJ; Hernandez, B; Yu, H; Panee, J; Chen, TL; Jia, WP; Jia, W				Zheng, Xiaojiao; Zhou, Kejun; Zhang, Yunjing; Han, Xiaolong; Zhao, Aihua; Liu, Jiajian; Qu, Chun; Ge, Kun; Huang, Fengjie; Hernandez, Brenda; Yu, Herbert; Panee, Jun; Chen, Tianlu; Jia, Weiping; Jia, Wei			Food withdrawal alters the gut microbiota and metabolome in mice	FASEB JOURNAL			English	Article						fasting; microbiome; metabolomics	SATURATED FATTY-ACIDS; AKKERMANSIA-MUCINIPHILA; CALORIC RESTRICTION; INSULIN-RESISTANCE; BRANCHED-CHAIN; ADIPOSE-TISSUE; AMINO-ACIDS; STARVATION; OBESITY; DIET	Food withdrawal as a health-enhancing measure has beneficial effects on aging, disease prevention, and treatment. However, the cellular and molecular mechanisms involving gut microbial changes and metabolic consequences resulting from food withdrawal have yet to be elucidated. In this study, we subjected lean and obese mice to a dietary intervention that consisted of a 4-d complete food withdrawal and an 8-d 50% food withdrawal, and we studied changes in cecal microbiome and host serum metabolome. The abundance of potentially pathogenic Proteobacteria was decreased and Akkermansia muciniphila was elevated by food withdrawal in mice fed a high-fat diet (HFD). Meanwhile, food withdrawal decreased the abundance of metabolites in branched chain amino acid, lipid, and free fatty acid metabolisms in host serum, more so in HFD mice than in normal mice. Microbial predicted function also showed that food withdrawal decreased the abundance of microbes associated with predicted diseases in the HFD group but not in the normal chow group. Correlation between the microbiome data and metabolomics data revealed a strong association between gut microbial and host metabolic changes in response to food withdrawal. In summary, our results showed that food withdrawal was safer and more metabolically beneficial to HFD-induced obese mice than to normal lean mice, and the beneficial effects were primarily derived from the changes in gut microbiota, which were closely associated with the host metabolome.Zheng, X., Zhou, K., Zhang, Y., Han, X., Zhao, A., Liu, J., Qu, C., Ge, K., Huang, F., Hernandez, B., Yu, H., Panee, J., Chen, T., Jia, W., Jia, W. Food withdrawal alters the gut microbiota and metabolome in mice.	[Zheng, Xiaojiao; Zhang, Yunjing; Han, Xiaolong; Zhao, Aihua; Liu, Jiajian; Qu, Chun; Ge, Kun; Huang, Fengjie; Chen, Tianlu; Jia, Weiping; Jia, Wei] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Lab Diabet Mellitus, 600 Yishan Rd, Shanghai 200233, Peoples R China; [Zheng, Xiaojiao; Zhang, Yunjing; Han, Xiaolong; Zhao, Aihua; Liu, Jiajian; Qu, Chun; Ge, Kun; Huang, Fengjie; Chen, Tianlu; Jia, Weiping; Jia, Wei] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Ctr Translat Med, 600 Yishan Rd, Shanghai 200233, Peoples R China; [Zhou, Kejun; Hernandez, Brenda; Yu, Herbert; Panee, Jun; Jia, Wei] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Cancer Research Center of Hawaii; University of Hawaii System	Zheng, XJ; Jia, W (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Lab Diabet Mellitus, 600 Yishan Rd, Shanghai 200233, Peoples R China.; Zheng, XJ; Jia, W (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Ctr Translat Med, 600 Yishan Rd, Shanghai 200233, Peoples R China.	joyzheng99@sjtu.edu.cn; wjia@cc.hawaii.edu	Jia, Wei/AAN-5102-2020	Jia, Wei/0000-0002-3739-8994	National Natural Science Foundation of China [31500954, 31501079, 81772530]; International Science and Technology Cooperation Program of China [2014DFA31870]; NATIONAL CANCER INSTITUTE [P30CA071789] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation Program of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Natural Science Foundation of China (31500954, 31501079, and 81772530) and the International Science and Technology Cooperation Program of China (2014DFA31870). The authors declare no conflicts of interest.	Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Chen TL, 2016, SCI REP-UK, V6, DOI 10.1038/srep20594; CHENG M, 1971, J COMP PHYSIOL PSYCH, V76, P206, DOI 10.1037/h0031374; Choi IY, 2016, CELL REP, V15, P2136, DOI 10.1016/j.celrep.2016.05.009; Connor WE, 1996, J LIPID RES, V37, P290; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Eisen M., CHINESE BIGU YANG SH; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Esposito E, 2009, J NUTR, V139, P905, DOI 10.3945/jn.108.101808; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Funaki M, 2009, J MED INVESTIG, V56, P88, DOI 10.2152/jmi.56.88; Greer RL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13329; Kennedy A, 2009, J NUTR, V139, P1, DOI 10.3945/jn.108.098269; Kobayashi T, 2015, BENEF MICROBES, V6, P735, DOI 10.3920/BM2014.0147; Kohl KD, 2014, FEMS MICROBIOL ECOL, V90, P883, DOI 10.1111/1574-6941.12442; LAESSLE RG, 1988, BIOL PSYCHIAT, V23, P719, DOI 10.1016/0006-3223(88)90056-X; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lecomte V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126931; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Lee CH, 2010, CANCER RES, V70, P1564, DOI 10.1158/0008-5472.CAN-09-3228; Li GL, 2017, CELL METAB, V26, P801, DOI 10.1016/j.cmet.2017.10.007; Li GL, 2017, CELL METAB, V26, P672, DOI 10.1016/j.cmet.2017.08.019; Li J, 2016, CIRCULATION, V133, P2434, DOI 10.1161/CIRCULATIONAHA.115.019645; Lippert K, 2017, BENEF MICROBES, V8, P545, DOI 10.3920/BM2016.0184; Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171; Madigan M.T., 2005, BROCK BIOL MICROORGA, V11; Mattison JA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14063; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Ni Y, 2015, EBIOMEDICINE, V2, P1513, DOI 10.1016/j.ebiom.2015.09.004; Park DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059470; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Perreault M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088539; Placanica JL, 2002, INT J EAT DISORDER, V32, P79, DOI 10.1002/eat.10066; Pregadio Fabrizio, 2008, ENCY TAOISM, Vi, P233; Raffaghello L, 2008, P NATL ACAD SCI USA, V105, P8215, DOI 10.1073/pnas.0708100105; Richards SE, 2008, ANAL CHEM, V80, P4876, DOI 10.1021/ac702584g; Safdie FM, 2009, AGING-US, V1, P988, DOI 10.18632/aging.100114; Schneeberger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16643; Selman C, 2006, PHYSIOL GENOMICS, V27, P187, DOI 10.1152/physiolgenomics.00084.2006; Steffen BT, 2012, INT J OBESITY, V36, P797, DOI 10.1038/ijo.2011.157; Stice E, 2008, J ABNORM PSYCHOL, V117, P941, DOI 10.1037/a0013644; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wei M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8700	47	25	27	2	38	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4878	4888		10.1096/fj.201700614R	http://dx.doi.org/10.1096/fj.201700614R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29620942	Green Published			2022-12-26	WOS:000443817700022
J	Feng, ZZ; Jiang, AJ; Mao, AW; Feng, YH; Wang, WN; Li, JJ; Zhang, XY; Xing, K; Peng, X				Feng, Zhao-Zhong; Jiang, An-Jie; Mao, An-Wen; Feng, Yuhan; Wang, Weinan; Li, Jingjing; Zhang, Xiaoyan; Xing, Ke; Peng, Xue			The Salmonella effectors SseF and SseG inhibit Rab1A-mediated autophagy to facilitate intracellular bacterial survival and replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; host-pathogen interaction; Rab; Salmonella enterica; virulence factor	III SECRETION SYSTEM; TRANSLOCATED EFFECTORS; ENDOPLASMIC-RETICULUM; CONTAINING VACUOLE; ULK1 COMPLEX; RAB GTPASES; HOST-CELLS; IMMUNITY; PROTEIN; TYPHIMURIUM	In mammalian cells, autophagy plays crucial roles in restricting further spread of invading bacterial pathogens. Previous studies have established that the Salmonella virulence factors SseF and SseG are required for intracellular bacterial survival and replication. However, the underlying mechanism by which these two effectors facilitate bacterial infection remains elusive. Here, we report that SseF and SseG secreted by Salmonella Typhimurium (S. Typhimurium) inhibit autophagy in host cells and thereby establish a replicative niche for the bacteria in the cytosol. Mechanistically, SseF and SseG impaired autophagy initiation by directly interacting with the small GTPase Rab1A in the host cell. This interaction abolished Rab1A activation by disrupting the interaction with its guanine nucleotide exchange factor (GEF), the TRAPPIII (transport protein particle III) complex. This disruption of Rab1A signaling blocked the recruitment and activation of Unc-51-like autophagy-activating kinase 1 (ULK1) and decreased phosphatidylinositol 3-phosphate biogenesis, which ultimately impeded autophagosome formation. Furthermore, SseF- or SseG-deficient bacterial strains exhibited reduced survival and growth in both mammalian cell lines and mouse infection models, and Rab1A depletion could rescue these defects. These results reveal that virulence factor-dependent inactivation of the small GTPase Rab1A represents a previously unrecognized strategy of S. Typhimurium to evade autophagy and the host defense system.	[Feng, Zhao-Zhong; Jiang, An-Jie; Mao, An-Wen; Feng, Yuhan; Wang, Weinan; Li, Jingjing; Zhang, Xiaoyan; Xing, Ke; Peng, Xue] Jiangsu Normal Univ, Sch Life Sci, Xuzhou 221116, Jiangsu, Peoples R China	Jiangsu Normal University	Peng, X (corresponding author), Jiangsu Normal Univ, Sch Life Sci, Xuzhou 221116, Jiangsu, Peoples R China.	6020100065@jsnu.edu.cn			National Natural Science Foundation of China [31400099, 31570028]; Jiangsu Natural Science Foundation Grant [BK20140235]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation Grant; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by National Natural Science Foundation of China Grants 31400099 and 31570028, Jiangsu Natural Science Foundation Grant BK20140235, and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The authors declare that they have no conflicts of interest with the contents of this article. This article contains Fig. S1.	Abrahams GL, 2006, TRAFFIC, V7, P950, DOI 10.1111/j.1600-0854.2006.00454.x; Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Ao X, 2014, CELL DEATH DIFFER, V21, P348, DOI 10.1038/cdd.2013.187; Bakowski MA, 2008, TRAFFIC, V9, P2022, DOI 10.1111/j.1600-0854.2008.00827.x; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Cadwell K, 2016, NAT REV IMMUNOL, V16, P661, DOI 10.1038/nri.2016.100; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Chu YY, 2016, ONCOTARGET, V7, P8295, DOI 10.18632/oncotarget.6989; Cortes C, 2007, INFECT IMMUN, V75, P5586, DOI 10.1128/IAI.01020-07; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deiwick J, 2006, INFECT IMMUN, V74, P6965, DOI 10.1128/IAI.00648-06; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Deretic V, 2012, CURR OPIN IMMUNOL, V24, P21, DOI 10.1016/j.coi.2011.10.006; Escoll P, 2016, NAT REV MICROBIOL, V14, P5, DOI 10.1038/nrmicro.2015.1; Galluzzi L, 2011, EMBO J, V30, P3213, DOI 10.1038/emboj.2011.244; Ganesan R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006227; Garcia Iris A, 2011, Cell Logist, V1, P159; Gomes LC, 2014, MOL CELL, V54, P224, DOI 10.1016/j.molcel.2014.03.009; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hansen-Wester I, 2002, INFECT IMMUN, V70, P1403, DOI 10.1128/IAI.70.3.1403-1409.2002; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Huang J, 2011, AUTOPHAGY, V7, P17, DOI 10.4161/auto.7.1.13840; Huang J, 2009, CURR TOP MICROBIOL, V335, P189, DOI 10.1007/978-3-642-00302-8_9; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; Jo EK, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00097; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; Kern A, 2015, AUTOPHAGY, V11, P2393, DOI 10.1080/15548627.2015.1110668; Kuhle V, 2002, CELL MICROBIOL, V4, P813, DOI 10.1046/j.1462-5822.2002.00234.x; Lee CH, 2014, GENE THER, V21, P309, DOI 10.1038/gt.2013.86; McQuate SE, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12641; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; Muller P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035004; Park JM, 2016, AUTOPHAGY, V12, P547, DOI 10.1080/15548627.2016.1140293; Rubinsztein DC, 2015, J EXP MED, V212, P979, DOI 10.1084/jem.20150956; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517; Castrejon-Jimenez NS, 2015, BIOSCI TRENDS, V9, P149, DOI 10.5582/bst.2015.01035; Sherwood RK, 2013, CELL HOST MICROBE, V14, P256, DOI 10.1016/j.chom.2013.08.010; Slavin I, 2011, EUR J CELL BIOL, V90, P301, DOI 10.1016/j.ejcb.2010.10.001; Spano S, 2016, CELL HOST MICROBE, V19, P216, DOI 10.1016/j.chom.2016.01.004; Spano S, 2014, CELL MICROBIOL, V16, P1321, DOI 10.1111/cmi.12327; Szatmari Z, 2014, AUTOPHAGY, V10, P1154, DOI 10.4161/auto.29395; Tan YH, 2011, P NATL ACAD SCI USA, V108, P21212, DOI 10.1073/pnas.1114023109; Tattoli I, 2013, EMBO J, V32, P3066, DOI 10.1038/emboj.2013.234; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wang J, 2013, P NATL ACAD SCI USA, V110, P9800, DOI 10.1073/pnas.1302337110; Webster CP, 2016, EMBO J, V35, P1656, DOI 10.15252/embj.201694401; Yamasaki A, 2009, MOL BIOL CELL, V20, P4205, DOI 10.1091/mbc.E09-05-0387; Yu XJ, 2016, MBIO, V7, DOI 10.1128/mBio.00474-16; Zhang XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep29774	52	31	32	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9662	9673		10.1074/jbc.M117.811737	http://dx.doi.org/10.1074/jbc.M117.811737			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29610274	hybrid, Green Published			2022-12-26	WOS:000436102300011
J	Griffin, C; Eter, L; Lanzetta, N; Abrishami, S; Varghese, M; McKernan, K; Muir, L; Lane, J; Lumeng, CN; Singer, K				Griffin, Cameron; Eter, Leila; Lanzetta, Nico; Abrishami, Simin; Varghese, Mita; McKernan, Kaitlin; Muir, Lindsey; Lane, Jamie; Lumeng, Carey N.; Singer, Kanakadurga			TLR4, TRIF, and MyD88 are essential for myelopoiesis and CD11c(+) adipose tissue macrophage production in obese mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						obesity; Toll-like receptor 4 (TLR4); metabolism; myeloid cell; macrophage; TIR domain-containing adapter-inducing interferon-B (TRIF); myeloid differentiation primary response gene 88 (MyD88); metabolic syndrome; insulin resistance; myelopoiesis; glucose intolerance	HEMATOPOIETIC STEM-CELLS; INSULIN-RESISTANCE; PROLIFERATION; INFLAMMATION; ACTIVATION; CONTRIBUTE; PHENOTYPE; MUTATION; LEPTIN	Obesity-induced chronic inflammation is associated with metabolic disease. Results from mouse models utilizing a high-fat diet (HFD) have indicated that an increase in activated macrophages, including CD11c(+) adipose tissue macrophages (ATMs), contributes to insulin resistance. Obesity primes myeloid cell production from hematopoietic stem cells (HSCs) and Toll-like receptor 4 (TLR4), and the downstream TIR domain-containing adapter protein-inducing interferon- (TRIF)- and MyD88-mediated pathways regulate production of similar myeloid cells after lipopolysaccharide stimulation. However, the role of these pathways in HFD-induced myelopoiesis is unknown. We hypothesized that saturated fatty acids and HFD alter myelopoiesis by activating TLR4 pathways in HSCs, differentially producing pro-inflammatory CD11c(+) myeloid cells that contribute to obesity-induced metabolic disease. Results from reciprocal bone marrow transplants (BMTs) with Tlr4(-/-) and WT mice indicated that TLR4 is required for HFD-induced myelopoiesis and production of CD11c(+) ATMs. Experiments with homozygous knockouts of Irakm (encoding a suppressor of MyD88 inactivation) and Trif in competitive BMTs revealed that MyD88 is required for HFD expansion of granulocyte macrophage progenitors and that Trif is required for pregranulocyte macrophage progenitor expansion. A comparison of WT, Tlr4(-/-), Myd88(-/-), and Trif(-/-) mice on HFD demonstrated that TLR4 plays a role in the production of CD11c(+) ATMs, and both Myd88(-/-) and Trif(-/-) mice produced fewer ATMs than WT mice. Moreover, HFD-induced TLR4 activation inhibited macrophage proliferation, leading to greater accumulation of recruited CD11c(+) ATMs. Our results indicate that HFD potentiates TLR4 and both its MyD88- and TRIF-mediated downstream pathways within progenitors and adipose tissue and leads to macrophage polarization.	[Griffin, Cameron; Eter, Leila; Lanzetta, Nico; Abrishami, Simin; Varghese, Mita; McKernan, Kaitlin; Muir, Lindsey; Lane, Jamie; Lumeng, Carey N.; Singer, Kanakadurga] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Singer, K (corresponding author), Dept Pediat & Communicable Dis, Div Pediat Endocrinol, D1205 MPB,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	ksinger@umich.edu	Muir, Lindsey/AAJ-9256-2021; Varghese, Mita/O-5860-2019	Varghese, Mita/0000-0003-4627-9396; Singer, Kanakadurga/0000-0001-8278-3800; McKernan, Kaitlin/0000-0003-3171-7218	University of Michigan Department of Pediatrics Janette Ferrantino Investigator Award; NIDDK, National Institutes of Health [K08DK101755]; Edith Briskin/SKS Foundation Taubman Emerging Scholar; National Institutes of Health [DK090262, F32DK105676]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, K08DK101755, P30DK020572, R01DK090262, F32DK105676, R01DK115190] Funding Source: NIH RePORTER	University of Michigan Department of Pediatrics Janette Ferrantino Investigator Award(University of Michigan System); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Edith Briskin/SKS Foundation Taubman Emerging Scholar; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the University of Michigan Department of Pediatrics Janette Ferrantino Investigator Award; NIDDK, National Institutes of Health, Grant K08DK101755; and Edith Briskin/SKS Foundation Taubman Emerging Scholar support (to K.S.); National Institutes of Health Grants DK090262 (to C. N. L.); and National Institutes of Health Grant F32DK105676 (to L. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Boettcher S, 2012, J IMMUNOL, V188, P5824, DOI 10.4049/jimmunol.1103253; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Carvalheira JBC, 2013, BLOOD, V122, P3263, DOI 10.1182/blood-2013-04-459446; Chen J, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal3336; Cho KW, 2016, J IMMUNOL, V197, P3650, DOI 10.4049/jimmunol.1600820; Coats BR, 2017, CELL REP, V20, P3149, DOI 10.1016/j.celrep.2017.08.096; Crewe C, 2017, J CLIN INVEST, V127, P74, DOI 10.1172/JCI88883; Davis JE, 2011, J NUTR BIOCHEM, V22, P136, DOI 10.1016/j.jnutbio.2009.12.008; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; Deng ZB, 2009, DIABETES, V58, P2498, DOI 10.2337/db09-0216; Deng ZB, 2009, HEPATOLOGY, V50, P1412, DOI 10.1002/hep.23148; Ehses JA, 2010, DIABETOLOGIA, V53, P1795, DOI 10.1007/s00125-010-1747-3; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hosoi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012537; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Li L, 2011, HEPATOLOGY, V54, P1620, DOI 10.1002/hep.24552; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Liu AL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03145-8; Liu AL, 2015, J IMMUNOL, V195, P2524, DOI 10.4049/jimmunol.1501231; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Morris DL, 2012, OBESITY, V20, P1189, DOI 10.1038/oby.2012.7; Morris MC, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00680; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Norseen J, 2012, MOL CELL BIOL, V32, P2010, DOI 10.1128/MCB.06193-11; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Orr JS, 2012, DIABETES, V61, P2718, DOI 10.2337/db11-1595; Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Razolli DS, 2015, ENDOCRINOLOGY, V156, P103, DOI 10.1210/en.2014-1552; Richards MR, 2013, INNATE IMMUN-LONDON, V19, P20, DOI 10.1177/1753425912447130; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Schuettpelz LG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00204; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shindou H, 2005, J IMMUNOL, V175, P1177, DOI 10.4049/jimmunol.175.2.1177; Singer K, 2015, J BIOL CHEM, V290, P13250, DOI 10.1074/jbc.M114.634568; Singer K, 2014, MOL METAB, V3, P664, DOI 10.1016/j.molmet.2014.06.005; Sodhi CP, 2010, GASTROENTEROLOGY, V138, P185, DOI 10.1053/j.gastro.2009.09.045; Takizawa H, 2017, CELL STEM CELL, V21, P225, DOI 10.1016/j.stem.2017.06.013; Tao C, 2017, ENDOCRINOLOGY, V158, P1260, DOI 10.1210/en.2017-00024; Vila IK, 2014, CELL REP, V7, P1116, DOI 10.1016/j.celrep.2014.03.062; Wang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013951; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Westcott DJ, 2009, J EXP MED, V206, P3143, DOI 10.1084/jem.20091333; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001; Yang L, 2017, CELL MOL GASTROENTER, V3, P469, DOI 10.1016/j.jcmgh.2016.12.004; Yu MJ, 2014, J EXP MED, V211, P887, DOI 10.1084/jem.20131314	58	43	44	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8775	8786		10.1074/jbc.RA117.001526	http://dx.doi.org/10.1074/jbc.RA117.001526			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29636416	hybrid, Green Published			2022-12-26	WOS:000434941900005
J	Edwards, MJ; White, GF; Lockwood, CW; Lawes, MC; Martel, A; Harris, G; Scott, DJ; Richardson, DJ; Butt, JN; Clarke, TA				Edwards, Marcus J.; White, Gaye F.; Lockwood, Colin W.; Lawes, Matthew C.; Martel, Anne; Harris, Gemma; Scott, David J.; Richardson, David J.; Butt, Julea N.; Clarke, Thomas A.			Structural modeling of an outer membrane electron conduit from a metal-reducing bacterium suggests electron transfer via periplasmic redox partners	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome; membrane protein; protein complex; electron transfer complex; liposome; shewanella; outer membrane; small-angle neutron scattering; MtrCAB	SHEWANELLA-ONEIDENSIS MR-1; SMALL-ANGLE SCATTERING; RESPIRATORY FLEXIBILITY; CYTOCHROME; RESOLUTION; PATHWAYS; PROTEINS; EXCHANGE; REVEALS; NETWORK	Many subsurface microorganisms couple their metabolism to the reduction or oxidation of extracellular substrates. For example, anaerobic mineral-respiring bacteria can use external metal oxides as terminal electron acceptors during respiration. Porin-cytochrome complexes facilitate the movement of electrons generated through intracellular catabolic processes across the bacterial outer membrane to these terminal electron acceptors. In the mineral-reducing model bacterium Shewanella oneidensis MR-1, this complex is composed of two decaheme cytochromes (MtrA and MtrC) and an outer-membrane -barrel (MtrB). However, the structures and mechanisms by which porin-cytochrome complexes transfer electrons are unknown. Here, we used small-angle neutron scattering (SANS) to study the molecular structure of the transmembrane complexes MtrAB and MtrCAB. Ab initio modeling of the scattering data yielded a molecular envelope with dimensions of approximate to 105 x 60 x 35 for MtrAB and approximate to 170 x 60 x 45 for MtrCAB. The shapes of these molecular envelopes suggested that MtrC interacts with the surface of MtrAB, extending approximate to 70 from the membrane surface and allowing the terminal hemes to interact with both MtrAB and an extracellular acceptor. The data also reveal that MtrA fully extends through the length of MtrB, with approximate to 30 being exposed into the periplasm. Proteoliposome models containing membrane-associated MtrCAB and internalized small tetraheme cytochrome (STC) indicate that MtrCAB could reduce Fe(III) citrate with STC as an electron donor, disclosing a direct interaction between MtrCAB and STC. Taken together, both structural and proteoliposome experiments support porin-cytochrome-mediated electron transfer via periplasmic cytochromes such as STC.	[Edwards, Marcus J.; White, Gaye F.; Lockwood, Colin W.; Lawes, Matthew C.; Richardson, David J.; Butt, Julea N.; Clarke, Thomas A.] Univ East Anglia, Ctr Mol & Struct Biochem, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Edwards, Marcus J.; White, Gaye F.; Lockwood, Colin W.; Lawes, Matthew C.; Richardson, David J.; Butt, Julea N.; Clarke, Thomas A.] Univ East Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England; [Martel, Anne] Inst Laue Langevin, F-38042 Grenoble, France; [Harris, Gemma; Scott, David J.] Rutherford Appleton Lab, Res Complex Harwell, Didcot OX11 0FA, Oxon, England; [Scott, David J.] Rutherford Appleton Lab, ISIS Spallat Neutron & Muon Source, Didcot OX11 0QX, Oxon, England; [Scott, David J.] Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Nottingham LE12 5RD, Leics, England	University of East Anglia; University of East Anglia; Institut Laue-Langevin (ILL); UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Nottingham	Clarke, TA (corresponding author), Univ East Anglia, Ctr Mol & Struct Biochem, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.; Clarke, TA (corresponding author), Univ East Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England.	tom.clarke@uea.ac.uk	clarke, tom/D-1837-2009; Butt, Julea/E-2133-2011	clarke, tom/0000-0002-6234-1914; Butt, Julea/0000-0002-9624-5226; Harris, Gemma/0000-0002-4587-4620; Scott, David/0000-0002-6726-2078; Martel, Anne/0000-0002-1232-8519; Lawes, Matt/0000-0003-1963-994X; Edwards, Marcus/0000-0002-0243-3788	Beamtime award at ISIS (Oxfordshire, UK) [RB1410125]; Beamtime award at ILL (Grenoble, France) [8-03-882]; Biotechnology and Biological Sciences Research Council [BB/K009885/1, BB/L023733/1, BB/K00929X/1]; BBSRC DTP studentship; BBSRC [BB/R013411/1, BB/K00929X/1, BB/K009885/1, BB/L023733/1, BB/P01819X/1] Funding Source: UKRI	Beamtime award at ISIS (Oxfordshire, UK); Beamtime award at ILL (Grenoble, France); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC DTP studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Beamtime awards RB1410125 at ISIS (Oxfordshire, UK) and 8-03-882 at the ILL (Grenoble, France) (to T.A.C.). This research was supported by the Biotechnology and Biological Sciences Research Council Grants BB/K009885/1, BB/L023733/1, and BB/K00929X/1 and a BBSRC DTP studentship (to M. C. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Alves MN, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00665; Breyton C, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13071-6; Compton ELR, 2011, J BIOL CHEM, V286, P27058, DOI 10.1074/jbc.M111.244533; Coursolle D, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00056; Coursolle D, 2010, MOL MICROBIOL, V77, P995, DOI 10.1111/j.1365-2958.2010.07266.x; Coursolle D, 2010, J BACTERIOL, V192, P467, DOI 10.1128/JB.00925-09; Dohnalkova AC, 2011, APPL ENVIRON MICROB, V77, P1254, DOI 10.1128/AEM.02001-10; Edwards MJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11677; Feigin L.A., 1987, STRUCTURE ANAL SMALL; Firer-Sherwood MA, 2011, J PHYS CHEM B, V115, P11208, DOI 10.1021/jp203603r; Fonseca BM, 2013, BIOCHEM J, V449, P101, DOI 10.1042/BJ20121467; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Hartshorne RS, 2009, P NATL ACAD SCI USA, V106, P22169, DOI 10.1073/pnas.0900086106; Jiao Y, 2007, J BACTERIOL, V189, P1765, DOI 10.1128/JB.00776-06; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Le Roy A, 2015, METHOD ENZYMOL, V562, P257, DOI 10.1016/bs.mie.2015.06.010; Liu J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00037; Liu YM, 2014, ENV MICROBIOL REP, V6, P776, DOI 10.1111/1758-2229.12204; Lower BH, 2009, APPL ENVIRON MICROB, V75, P2931, DOI 10.1128/AEM.02108-08; Marritt SJ, 2012, BIOCHEM SOC T, V40, P1217, DOI 10.1042/BST20120150; Okamoto A, 2011, ELECTROCHIM ACTA, V56, P5526, DOI 10.1016/j.electacta.2011.03.076; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Paquete CM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00318; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Richardson DJ, 2012, MOL MICROBIOL, V85, P201, DOI 10.1111/j.1365-2958.2012.08088.x; Rodrigues ML, 2006, EMBO J, V25, P5951, DOI 10.1038/sj.emboj.7601439; Ross DE, 2007, APPL ENVIRON MICROB, V73, P5797, DOI 10.1128/AEM.00146-07; Schicklberger M, 2011, APPL ENVIRON MICROB, V77, P1520, DOI 10.1128/AEM.01201-10; Shi L, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00050; Sturm G, 2015, ISME J, V9, P1802, DOI 10.1038/ismej.2014.264; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; White GF, 2016, ADV MICROB PHYSIOL, V68, P87, DOI 10.1016/bs.ampbs.2016.02.002; White GF, 2013, P NATL ACAD SCI USA, V110, P6346, DOI 10.1073/pnas.1220074110; White GF, 2012, BIOCHEM SOC T, V40, P1257, DOI 10.1042/BST20120116	37	32	31	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8103	8112		10.1074/jbc.RA118.001850	http://dx.doi.org/10.1074/jbc.RA118.001850			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29636412	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000433224600016
J	Zhang, HM; Yokom, AL; Cheng, S; Su, M; Hollenberg, PF; Southworth, DR; Osawa, Y				Zhang, Haoming; Yokom, Adam L.; Cheng, Shen; Su, Min; Hollenberg, Paul F.; Southworth, Daniel R.; Osawa, Yoichi			The full-length cytochrome P450 enzyme CYP102A1 dimerizes at its reductase domains and has flexible heme domains for efficient catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; dimerization; electron transfer; protein structure; electron microscopy (EM); cytochrome P450; cytochrome P450 BM3; fatty acid hydroxylase; heme domain; reductase domain	FLAVOCYTOCHROME P450 BM3; FATTY-ACID HYDROXYLASE; ELECTRON-TRANSFER; BACILLUS-MEGATERIUM; FUNCTIONAL DOMAINS; FMN; METABOLITES; MICROSCOPY; BINDING; NADPH	The cytochrome P450 enzyme CYP102A1 from Bacillus megaterium is a highly efficient hydroxylase of fatty acids, and there is a significant interest in using CYP102A1 for biotechnological applications. Here, we used size-exclusion chromatography-multiangle light scattering (SEC-MALS) analysis and negative-stain EM to investigate the molecular architecture of CYP102A1. The SEC-MALS analysis yielded a homogeneous peak with an average molecular mass of 235 +/- 5 kDa, consistent with homodimeric CYP102A1. The negative-stain EM of dimeric CYP102A1 revealed four distinct lobes, representing the two heme and two reductase domains. Two of the lobes were in close contact, whereas the other two were often observed apart and at the ends of a U-shaped configuration. The overall dimension of the dimer was approximate to 130 . To determine the identity of the lobes, we FLAG-tagged the N or C terminus of CYP102A1 to visualize additional densities in EM and found that anti-FLAG Fab could bind only the N-tagged P450. Single-particle analysis of this anti-Flag Fab-CYP102A1 complex revealed additional density in the N-terminally tagged heme domains, indicating that the heme domains appear flexible, whereas the reductase domains remain tightly associated. The effects of truncation on CYP102A1 dimerization, identification of cross-linked sites by peptide mapping, and molecular modeling results all were consistent with the dimerization of the reductase domain. We conclude that functional CYP102A1 is a compact globular protein dimerized at its reductase domains, with its heme domains exhibiting multiple conformations that likely contribute to the highly efficient catalysis of CYP102A1.	[Zhang, Haoming; Cheng, Shen; Hollenberg, Paul F.; Osawa, Yoichi] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Yokom, Adam L.; Southworth, Daniel R.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Su, Min] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Zhang, HM; Osawa, Y (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, 1150 West Med Ctr Dr, Ann Arbor, MI 48109 USA.	haom@umich.edu; osawa@umich.edu	Cheng, Shen/GWQ-6903-2022; Hollenberg, Paul F/A-7538-2009; Zhang, Haoming/AAE-3749-2020	Cheng, Shen/0000-0002-7493-4784; Zhang, Haoming/0000-0002-8765-4394	National Institutes of Health [GM077430, GM110001A]; University of Michigan Protein Folding Diseases Initiative; University of Michigan Mcubed fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077430, R01GM110001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Protein Folding Diseases Initiative; University of Michigan Mcubed fund(University of Michigan System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM077430 and GM110001A, the University of Michigan Protein Folding Diseases Initiative, and the University of Michigan Mcubed fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AXELSSON I, 1978, J CHROMATOGR, V152, P21, DOI 10.1016/S0021-9673(00)85330-3; BLACK SD, 1994, BIOCHEMISTRY-US, V33, P12056, DOI 10.1021/bi00206a007; Bukharina N. S., 2015, Biofizika, V60, P80; Butler CF, 2013, J BIOL CHEM, V288, P25387, DOI 10.1074/jbc.M113.479717; Carmichael AB, 2001, EUR J BIOCHEM, V268, P3117, DOI 10.1046/j.1432-1327.2001.02212.x; Chen MMY, 2012, PROTEIN ENG DES SEL, V25, P171, DOI 10.1093/protein/gzs004; Dai Y, 2017, J BIOL CHEM, V292, P6753, DOI 10.1074/jbc.M117.777219; Damsten MC, 2008, CHEM-BIOL INTERACT, V171, P96, DOI 10.1016/j.cbi.2007.09.007; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Girvan HM, 2011, ARCH BIOCHEM BIOPHYS, V507, P75, DOI 10.1016/j.abb.2010.09.014; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Jiang JS, 2013, NATURE, V496, P187, DOI 10.1038/nature12062; Joyce MG, 2012, FEBS J, V279, P1694, DOI 10.1111/j.1742-4658.2012.08544.x; Kim KH, 2011, DRUG METAB DISPOS, V39, P140, DOI 10.1124/dmd.110.036392; Kitazume T, 2007, BIOCHEMISTRY-US, V46, P11892, DOI 10.1021/bi701031r; Leitner A, 2014, NAT PROTOC, V9, P120, DOI 10.1038/nprot.2013.168; Lin HL, 2011, DRUG METAB DISPOS, V39, P345, DOI 10.1124/dmd.110.034074; Meinhold P, 2005, CHEMBIOCHEM, V6, P1765, DOI 10.1002/cbic.200500261; NARHI LO, 1986, J BIOL CHEM, V261, P7160; NARHI LO, 1987, J BIOL CHEM, V262, P6683; Neeli R, 2005, FEBS LETT, V579, P5582, DOI 10.1016/j.febslet.2005.09.023; Noble MA, 1999, BIOCHEM J, V339, P371, DOI 10.1042/0264-6021:3390371; OMURA T, 1964, J BIOL CHEM, V239, P2379; OPRIAN DD, 1982, J BIOL CHEM, V257, P8935; Otey CR, 2006, BIOTECHNOL BIOENG, V93, P494, DOI 10.1002/bit.20744; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sevrioukova I, 1997, ARCH BIOCHEM BIOPHYS, V340, P231, DOI 10.1006/abbi.1997.9895; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Truan G, 1998, ARCH BIOCHEM BIOPHYS, V349, P53, DOI 10.1006/abbi.1997.0400; Venkataraman H, 2015, APPL MICROBIOL BIOT, V99, P4713, DOI 10.1007/s00253-014-6281-7; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wu SP, 2012, STRUCTURE, V20, P582, DOI 10.1016/j.str.2012.02.017; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; Yokom AL, 2014, J BIOL CHEM, V289, P16855, DOI 10.1074/jbc.M114.564005; Zhang HM, 2008, J BIOL CHEM, V283, P5217, DOI 10.1074/jbc.M709094200; Zhang HM, 2013, BIOCHEMISTRY-US, V52, P355, DOI 10.1021/bi301567z; Zhang HM, 2003, BIOCHEMISTRY-US, V42, P6804, DOI 10.1021/bi030081m	39	23	24	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7727	7736		10.1074/jbc.RA117.000600	http://dx.doi.org/10.1074/jbc.RA117.000600			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29618513	Green Published, hybrid			2022-12-26	WOS:000437256500022
J	Feodorova, VA; Konnova, SS; Saltykov, YV; Zaitsev, SS; Subbotina, IA; Polyanina, TI; Ulyanov, SS; Lamers, SL; Gaydos, CA; Quinn, TC; Motin, VL				Feodorova, Valentina A.; Konnova, Svetlana S.; Saltykov, Yury V.; Zaitsev, Sergey S.; Subbotina, Irina A.; Polyanina, Tatiana I.; Ulyanov, Sergey S.; Lamers, Susanna L.; Gaydos, Charlotte A.; Quinn, Thomas C.; Motin, Vladimir L.			Urogenital Chlamydia trachomatis multilocus sequence types and genovar distribution in chlamydia infected patients in a multi-ethnic region of Saratov, Russia	PLOS ONE			English	Article							LYMPHOGRANULOMA-VENEREUM; STRAINS; IDENTIFICATION; EPIDEMIOLOGY; PREVALENCE; GENOTYPES; SWEDISH; ASSAY; MEN; DNA	Background This is the first report to characterize the prevalence and genovar distribution of genital chlamydial infections among random heterosexual patients in the multi-ethnic Saratov Region, located in Southeast Russia. Methods Sixty-one clinical samples (cervical or urethral swabs) collected from a random cohort of 856 patients (7.1%) were C. trachomatis (CT) positive in commercial nucleic acid amplification tests (NAATs) and duplex TaqMan PCRs. Results Sequence analysis of the VDII region of the ompA gene revealed seven genovars of C. trachomatis in PCR-positive patients. The overall genovars were distributed as E (41.9%), G (21.6%), F (13.5%), K (9.5%), D (6.8%), J (4.1%), and H (2.7%). CT-positive samples were from males (n = 12, 19.7%), females (n = 42, 68.8%), and anonymous (n = 7, 11.5%) patients, with an age range of 19 to 45 years (average 26.4), including 12 different ethnic groups representative of this region. Most patients were infected with a single genovar (82%), while 18% were co-infected with either two or three genovars. The 1156 bp-fragment of the ompA gene was sequenced in 46 samples to determine single nucleotide polymorphisms (SNP) among isolates. SNP-based subtyping and phylogenetic reconstruction revealed the presence of 13 variants of the ompA gene, such as E (E1, E2, E6), G (G1, G2, G3, G5), F1, K, D (D1, Da2), J1, and H2. Differing genovar distribution was identified among urban (E>G>F) and rural (E>K) populations, and in Slavic (E>G>D) and non-Slavic (E>G>K) ethnic groups. Multilocus sequence typing (MLST) determined five sequences types (STs), such as ST4 (56%, 95% confidence interval, CI, 70.0 to 41.3), ST6 (10%, 95% CI 21.8 to 3.3), ST9 (22%, 95% CI 35.9 to 11.5), ST10 (2%, 95% CI 10.7 to 0.05) and ST38 (10%, 95% CI 21.8 to 3.3). Thus, the most common STs were ST4 and ST9. Conclusion C. trachomatis is a significant cause of morbidity among random heterosexual patients with genital chlamydial infections in the Saratov Region. Further studies should extend this investigation by describing trends in a larger population, both inside and outside of the Saratov Region to clarify some aspects for the actual application of C. trachomatis genotype analysis for disease control.	[Feodorova, Valentina A.; Konnova, Svetlana S.; Saltykov, Yury V.; Zaitsev, Sergey S.; Subbotina, Irina A.; Polyanina, Tatiana I.; Ulyanov, Sergey S.] Fed Res Ctr Virol & Microbiol FRCViM, Lab Mol Biol Chlamydia, Pokrov, Vladimir Region, Russia; [Feodorova, Valentina A.; Saltykov, Yury V.; Zaitsev, Sergey S.; Subbotina, Irina A.; Polyanina, Tatiana I.; Ulyanov, Sergey S.] Fed Res Ctr Virol & Microbiol FRCViM, Lab Mol Biol & NanoBiotechnol, Branch Saratov, Saratov, Russia; [Feodorova, Valentina A.; Saltykov, Yury V.; Subbotina, Irina A.] SSAU, Dept Microbiol Biotechnol & Chem, Saratov, Russia; [Ulyanov, Sergey S.] SSU, Dept Med Phys, Saratov, Russia; [Lamers, Susanna L.] Bioinfoexperts LLC, Thibodaux, Los Angeles, CA USA; [Gaydos, Charlotte A.; Quinn, Thomas C.] Johns Hopkins Univ, Div Infect Dis, Sch Med JHUScM, Baltimore, MD USA; [Quinn, Thomas C.] NIAID, Div Intramural Res, Baltimore, MD USA; [Motin, Vladimir L.] UTMB, Dept Microbiol & Immunol, Dept Pathol, Galveston, TX 77555 USA	Saratov State University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Texas System; University of Texas Medical Branch Galveston	Feodorova, VA (corresponding author), Fed Res Ctr Virol & Microbiol FRCViM, Lab Mol Biol Chlamydia, Pokrov, Vladimir Region, Russia.; Feodorova, VA (corresponding author), Fed Res Ctr Virol & Microbiol FRCViM, Lab Mol Biol & NanoBiotechnol, Branch Saratov, Saratov, Russia.; Feodorova, VA (corresponding author), SSAU, Dept Microbiol Biotechnol & Chem, Saratov, Russia.; Motin, VL (corresponding author), UTMB, Dept Microbiol & Immunol, Dept Pathol, Galveston, TX 77555 USA.	feodorovav@mail.ru; vlmotin@utmb.edu	Zaitsev, Sergey/G-8735-2018; Saltykov, Yury/O-6816-2017; Motin, Vladimir L/O-1535-2013; Feodorova, Valentina A/F-7545-2014; Konnova, Svetlana/D-3799-2016; Gaydos, Charlotte A./E-9937-2010; Subbotina, Irina/AHD-7481-2022; Polyanina, Tatiana/N-7068-2016	Zaitsev, Sergey/0000-0002-1373-8229; Saltykov, Yury/0000-0001-8163-1979; Feodorova, Valentina A/0000-0002-3827-407X; Konnova, Svetlana/0000-0003-1282-7980; Motin, Vladimir/0000-0002-4762-457X; Polyanina, Tatiana/0000-0003-1448-5785	Russian Science Foundation [17-16-01099]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Baltimore, MD, USA; BioInfoExperts LLC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000358, ZIAAI000361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB007958] Funding Source: NIH RePORTER	Russian Science Foundation(Russian Science Foundation (RSF)); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Baltimore, MD, USA; BioInfoExperts LLC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Russian Science Foundation, Project No. 17-16-01099 (for Prof. V.A. Feodorova) and the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Baltimore, MD, 21205, USA (for Prof. T.C. Quinn). BioInfoExperts LLC provided financial support in the form of a salary for S.L. Lamers. The specific role of this author is articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsamed H, 2013, FUTURE MICROBIOL, V8, P1129, DOI 10.2217/fmb.13.80; Bax CJ, 2011, SEX TRANSM INFECT, V87, P503, DOI 10.1136/sti.2010.048173; Bilozorova OA, 2010, J VN KARAZIN KHARK B, V11, P55; Brunham RC, 1996, J INFECT DIS, V173, P950, DOI 10.1093/infdis/173.4.950; Byrne GI, 2010, J INFECT DIS, V201, pS126, DOI 10.1086/652398; Chiaradonna C, 2008, J PEDIATR ADOL GYNEC, V21, P233, DOI 10.1016/j.jpag.2007.10.005; Dahlberg J, 2018, SEX TRANSM INFECT, V94, P100, DOI 10.1136/sextrans-2016-052992; DEAN D, 1995, J INFECT DIS, V172, P1013, DOI 10.1093/infdis/172.4.1013; EFREMENKO A A, 1956, Vestn Oftalmol, V69, P94; Emmadi R, 2011, J MOL DIAGN, V13, P583, DOI 10.1016/j.jmoldx.2011.05.011; Fedorova V. A., 2010, Klinicheskaya Laboratornaya Diagnostika, P45; Gharsallah H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-333; Giffard PM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009624; Gravningen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034452; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Herrmann B, 2015, J CLIN MICROBIOL, V53, P2172, DOI 10.1128/JCM.00249-15; HIV/AIDS/STI UWG on G, 2012, STRAT LAB METH STREN; IBRAGIMOV NG, 1978, VESTN OFTALMOL, P77; Ikryannikova LN, 2010, FEMS IMMUNOL MED MIC, V59, P188, DOI 10.1111/j.1574-695X.2010.00678.x; Jurstrand M, 2001, J CLIN MICROBIOL, V39, P3915, DOI 10.1128/JCM.39.11.3915-3919.2001; Kapil R, 2015, J CLIN MICROBIOL, V53, P546, DOI 10.1128/JCM.02483-14; Kese D, 2011, FEMS IMMUNOL MED MIC, V63, P210, DOI 10.1111/j.1574-695X.2011.00843.x; Klint M, 2007, J CLIN MICROBIOL, V45, P1410, DOI 10.1128/JCM.02301-06; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lysen M, 2004, J CLIN MICROBIOL, V42, P1641, DOI 10.1128/JCM.42.4.1641-1647.2004; Morre SA, 2000, J CLIN MICROBIOL, V38, P2292; Nunes A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013171; Nunes A, 2009, J BACTERIOL, V191, P7182, DOI 10.1128/JB.00895-09; Pannekoek Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-42; Papadogeorgakis H, 2010, J CLIN MICROBIOL, V48, P2231, DOI 10.1128/JCM.00586-10; Quint KD, 2007, J MOL DIAGN, V9, P631, DOI 10.2353/jmoldx.2007.070011; Sharkeev VI, 2005, B EXP BIOL MED+, V140, P222, DOI 10.1007/s10517-005-0451-7; Shipitsyna E, 2012, ACTA DERM-VENEREOL, V92, P330, DOI 10.2340/00015555-1269; Smelov V, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02195; Stevens MP, 2010, J CLIN MICROBIOL, V48, P2060, DOI 10.1128/JCM.02308-09; Tikhomirov AL, 2007, UROGENITAL CHLAMYDIO, P55; WANG SP, 1970, AM J OPHTHALMOL, V70, P367, DOI 10.1016/0002-9394(70)90096-6; Ward H, 2009, SEX TRANSM INFECT, V85, P173, DOI 10.1136/sti.2008.035311	38	5	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195386	10.1371/journal.pone.0195386	http://dx.doi.org/10.1371/journal.pone.0195386			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641543	Green Submitted, gold, Green Published			2022-12-26	WOS:000429742900068
J	Wang, J; Hilchey, SP; DeDiego, M; Perry, S; Hyrien, O; Nogales, A; Garigen, J; Amanat, F; Huertas, N; Krammer, F; Martinez-Sobrido, L; Topham, DJ; Treanor, JJ; Sangster, MY; Zand, MS				Wang, Jiong; Hilchey, Shannon P.; DeDiego, Marta; Perry, Sheldon; Hyrien, Ollivier; Nogales, Aitor; Garigen, Jessica; Amanat, Fatima; Huertas, Nelson; Krammer, Florian; Martinez-Sobrido, Luis; Topham, David J.; Treanor, John J.; Sangster, Mark Y.; Zand, Martin S.			Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice	PLOS ONE			English	Article							A VIRUS-INFECTION; HETEROSUBTYPIC IMMUNITY; CONSTRUCTS PROTECT; MF59 ADJUVANT; B-CELLS; ANTIBODY; MEMORY; NEUTRALIZATION; INDUCTION; A(H3N2)	Annual immunization against influenza virus is a large international public health effort. Accumulating evidence suggests that antibody mediated cross-reactive immunity against influenza hemagglutinin (HA) strongly correlates with long-lasting cross-protection against influenza virus strains that differ from the primary infection or vaccination strain. However, the optimal strategies for achieving highly cross-reactive antibodies to the influenza virus HA have not yet to be defined. In the current study, using Luminex-based mPlex-Flu assay, developed by our laboratory, to quantitatively measure influenza specific IgG antibody mediated cross-reactivity, we found that prime-boost-boost vaccination of ferrets with rHA proteins admixed with adjuvant elicited higher magnitude and broader cross-reactive antibody responses than that induced by actual influenza viral infection, and this cross-reactive response likely correlated with increased anti-stalk reactive antibodies. We observed a similar phenomenon in mice receiving three sequential vaccinations with rHA proteins from either A/California/07/2009 (H1N1) or A/Hong Kong/1/1968 (H3N2) viruses admixed with Addavax, an MF59-like adjuvant. Using this same mouse vaccination model, we determined that Addavax plays a more significant role in the initial priming event than in subsequent boosts. We also characterized the generation of cross-reactive antibody secreting cells (ASCs) and memory B cells (MBCs) when comparing vaccination to viral infection. We have also found that adjuvant plays a critical role in the generation of long-lived ASCs and MBCs cross-reactive to influenza viruses as a result of vaccination with rHA of influenza virus, and the observed increase in stalk-reactive antibodies likely contributes to this IgG mediated broad cross-reactivity.	[Wang, Jiong; Hilchey, Shannon P.; Perry, Sheldon; Garigen, Jessica; Zand, Martin S.] Univ Rochester, Med Ctr, Dept Med, Div Nephrol, Rochester, NY 14642 USA; [DeDiego, Marta] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Hyrien, Ollivier; Nogales, Aitor; Martinez-Sobrido, Luis; Topham, David J.; Sangster, Mark Y.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Biostat Bioinformat & Epidemiol Program, 1124 Columbia St, Seattle, WA 98104 USA; [Amanat, Fatima; Huertas, Nelson] Univ Rochester, Med Ctr, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Treanor, John J.] Univ Rochester, Med Ctr, Div Infect Dis, Rochester, NY 14642 USA; [Zand, Martin S.] Univ Rochester, Med Ctr, Rochester Ctr Hlth Informat, Rochester, NY 14642 USA	University of Rochester; University of Rochester; Fred Hutchinson Cancer Center; University of Rochester; Icahn School of Medicine at Mount Sinai; University of Rochester; University of Rochester	Zand, MS (corresponding author), Univ Rochester, Med Ctr, Dept Med, Div Nephrol, Rochester, NY 14642 USA.; Zand, MS (corresponding author), Univ Rochester, Med Ctr, Rochester Ctr Hlth Informat, Rochester, NY 14642 USA.	Martin_zand@urmc.rochester.edu	Krammer, Florian/H-3237-2019; NOGALES, AITOR/AAY-1590-2020; DeDiego, Marta L./B-2307-2017	Krammer, Florian/0000-0003-4121-776X; NOGALES, AITOR/0000-0002-2424-7900; Sangster, Mark/0000-0002-1599-5894; Wang, Jiong/0000-0002-4938-5074; DeDiego, Marta L./0000-0002-7888-7372; Martinez-Sobrido, Luis/0000-0001-7084-0804	National Institutes of Health, National Institutes of Allergy and Infectious Diseases [HHSN272201000055C, AI098112, AI069351, R21AI138500, HHSN272201400008C, AI109946]; University of Rochester CTSA award from the National Center for Advancing Translational Sciences of the National Institutes of Health [UL1 TR002001]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI129518, R21AI138500, U19AI109946] Funding Source: NIH RePORTER	National Institutes of Health, National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Rochester CTSA award from the National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health, National Institutes of Allergy and Infectious Diseases, including: HHSN272201000055C, AI098112, and AI069351 (MZ, JW, SH, OH, SP, JG, NH), R21AI138500 (MZ, JW, JG), HHSN272201400008C and AI109946(FC, FA). The project described in this publication was also supported by the University of Rochester CTSA award UL1 TR002001 from the National Center for Advancing Translational Sciences of the National Institutes of Health (MZ). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. None of the above funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by grants from the National Institutes of Health, National Institutes of Allergy and Infectious Diseases, including: HHSN272201000055C, AI098112, and A1069351 (MZ, JW, SH, OH, SP, JG, NH), R21AI138500 (MZ, JW, JG), HHSN272201400008C and AI109946(FC, FA). The project described in this publication was also supported by the University of Rochester CTSA award UL1 TR002001 from the National Center for Advancing Translational Sciences of the National Institutes of Health (MZ). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. None of the above funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Ansaldi F, 2008, VACCINE, V26, P1525, DOI 10.1016/j.vaccine.2008.01.019; Banzhoff A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004384; Carr K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009550; Clark AM, 2017, J VIROL, V91, DOI 10.1128/JVI.00721-17; Cobey S, 2017, CURR OPIN VIROL, V22, P105, DOI 10.1016/j.coviro.2016.12.004; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Cortina-Ceballos B, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0239-y; DeDiego ML, 2016, IMMUNOLOGY, V148, P160, DOI 10.1111/imm.12594; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Epstein SL, 1997, J IMMUNOL, V158, P1222; Faenzi E, 2012, VACCINE, V30, P4086, DOI 10.1016/j.vaccine.2012.04.020; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Fragapane E, 2010, CLIN VACCINE IMMUNOL, V17, P1817, DOI 10.1128/CVI.00461-09; Galli G, 2009, P NATL ACAD SCI USA, V106, P7962, DOI 10.1073/pnas.0903181106; Gavillet BM, 2015, J IMMUNOL, V194, P4836, DOI 10.4049/jimmunol.1402071; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Goff PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079194; Guo HL, 2014, J VIROL, V88, P12006, DOI 10.1128/JVI.01847-14; Hai R, 2012, J VIROL, V86, P5774, DOI 10.1128/JVI.00137-12; He XS, 2011, J IMMUNOL METHODS, V365, P67, DOI 10.1016/j.jim.2010.12.008; Heaton NS, 2013, P NATL ACAD SCI USA, V110, P20248, DOI 10.1073/pnas.1320524110; Heaton NS, 2013, J VIROL, V87, P8272, DOI 10.1128/JVI.00969-13; Henn AD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02327; Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Jayasundara K, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0670-5; Joo HM, 2010, VACCINE, V28, P2186, DOI 10.1016/j.vaccine.2009.12.058; Khurana S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095496; King C, 2009, NAT REV IMMUNOL, V9, P757, DOI 10.1038/nri2644; Krammer F, 2016, CURR OPIN VIROL, V17, P95, DOI 10.1016/j.coviro.2016.02.002; Krammer F, 2014, J VIROL, V88, P2340, DOI 10.1128/JVI.03183-13; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; Krammer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043603; Krammer F, 2012, J VIROL, V86, P10302, DOI 10.1128/JVI.01336-12; Laurie KL, 2015, CLIN VACCINE IMMUNOL, V22, P957, DOI 10.1128/CVI.00278-15; Linderman SL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005806; Margine I, 2013, J VIROL, V87, P10435, DOI 10.1128/JVI.01715-13; Molenberghs G, 2000, LINEAR MIXED MODELS; Mulligan MJ, 2014, JAMA-J AM MED ASSOC, V312, P1409, DOI 10.1001/jama.2014.12854; Nduati EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015007; Nguyen HH, 2001, J INFECT DIS, V183, P368, DOI 10.1086/318084; O'Hagan DT, 2011, EXPERT REV VACCINES, V10, P447, DOI [10.1586/erv.11.23, 10.1586/ERV.11.23]; Park MS, 2016, IMMUNE NETW, V16, P261, DOI 10.4110/in.2016.16.5.261; Pica N, 2012, J VIROL, V86, P10293, DOI 10.1128/JVI.01131-12; Quataert SA, 2004, CLIN DIAGN LAB IMMUN, V11, P1064, DOI 10.1128/CDLI.11.6.1064-1069.2004; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sliepen K, 2015, J BIOL CHEM, V290, P7436, DOI 10.1074/jbc.M114.620534; Stephenson I, 2008, NEW ENGL J MED, V359, P1631, DOI 10.1056/NEJMc0805274; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; Wack A, 2008, VACCINE, V26, P552, DOI 10.1016/j.vaccine.2007.11.054; Wang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129858; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927; Zand Martin S, 2015, Math J, V17	56	18	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0193680	10.1371/journal.pone.0193680	http://dx.doi.org/10.1371/journal.pone.0193680			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641537	Green Published, gold			2022-12-26	WOS:000429742900015
J	Abu-Lafi, S; Makhamra, S; Rayan, I; Barriah, W; Nasser, A; Abu Farkh, B; Rayan, A				Abu-Lafi, Saleh; Makhamra, Sadam; Rayan, Ibrahim; Barriah, Waseim; Nasser, Ahmed; Abu Farkh, Basheer; Rayan, Anwar			Sesamin from Cuscuta palaestina natural plant extracts: Directions for new prospective applications	PLOS ONE			English	Article							CANCER-CELLS; RECEPTOR; LIGNAN; L.	The aim of this study is to disclose the potential bioactive components of Cuscuta palaestina, a native parasitic natural plant of flora palaestina and to open direction towards new prospective application. GC-MS analysis identified 18 components in the methanolic extract of C. palaestina for the first time. The most appealing among them are Sesamin and two other phytosterols (Campesterol and Stigmasterol), all of which are documented in the scientific literature for their anticancer activity. Quantitation of Sesamin extracted from C. palaestina by HPLC-PDA with the use of three organic solvents showed that the Sesamin content in the methanolic extract was the highest. Following the disclosure of Sesamin presence in C. palaestina, we raised the question of whether it is produced naturally in C. palaestina or acquired from the host plant. The quantitation of Sesamin in C. palaestina was performed while being with five different host plants, and was compared with the amount of Sesamin in C. palaestina grown alone. The findings reveal that Sesamin is an endogenous secondary metabolite in C. palaestina. Thus, further studies are required to prove if C. palaestina can be used as an alternative source of anticancer phytochemicals, mainly Sesamin, and if proteins in the Sesamin production pathway could be valid biological targets for the development of novel and selective pesticides for control/eradication of C. palaestina and maybe some other Cuscuta species. As well, the findings from this study raise a big question of whether inferring Sesamin production in C. palaestina could reduce its attack ability to host plants.	[Abu-Lafi, Saleh] Al Quds Univ, Fac Pharm, Abu Dies, Palestine; [Makhamra, Sadam] Al Quds Univ, Fac Sci & Technol, Chem Dept, Abu Dies, Palestine; [Rayan, Ibrahim; Rayan, Anwar] Inst Appl Res Galilee Soc, Shefa Amr, Israel; [Barriah, Waseim; Rayan, Anwar] Al Qasemi Coll Engn & Sci, Baka El Garbiah, Israel; [Nasser, Ahmed] ARO, Volcani Ctr, Interinst Analyt Instrumentat Unit, Rishon Leziyyon, Israel; [Abu Farkh, Basheer; Rayan, Anwar] Al Qasemi Acad Coll, QRC, Drug Discovery Informat Lab, Baka El Garbiah, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Rayan, A (corresponding author), Inst Appl Res Galilee Soc, Shefa Amr, Israel.; Rayan, A (corresponding author), Al Qasemi Coll Engn & Sci, Baka El Garbiah, Israel.; Rayan, A (corresponding author), Al Qasemi Acad Coll, QRC, Drug Discovery Informat Lab, Baka El Garbiah, Israel.	a_rayan@qsm.ac.il		Rayan, Anwar/0000-0001-8255-5947	Al-Qasemi Academic College; Institute of Applied Research Galilee Society	Al-Qasemi Academic College; Institute of Applied Research Galilee Society	This study was supported by unrestricted grants from Al-Qasemi Academic College and the Institute of Applied Research Galilee Society. The authors acknowledge the Ministry of Science, Space and Technology. The authors declare that the funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 2015, DRUG DES DEV THER, V9, P2793, DOI 10.2147/DDDT.S83514; Aswad M, 2018, INFLAMM RES, V67, P67, DOI 10.1007/s00011-017-1096-5; Choi JM, 2007, PHYTOTHER RES, V21, P954, DOI 10.1002/ptr.2189; FARNSWORTH NR, 1985, B WORLD HEALTH ORGAN, V63, P965; Frank A, 2017, INFLAMM RES, V66, P923, DOI 10.1007/s00011-017-1075-x; Ide T, 2013, EUR J NUTR, V52, P1015, DOI 10.1007/s00394-012-0408-3; Kacergius T, 2017, MOL MED REP, V16, P949, DOI 10.3892/mmr.2017.6674; Khosravi-Boroujeni H, 2017, J SCI FOOD AGR, V97, P3087, DOI 10.1002/jsfa.8361; Lee CC, 2011, INFLAMMATION, V34, P209, DOI 10.1007/s10753-010-9226-z; Pappalardo M, 2017, MOL INFORM, V36, DOI 10.1002/minf.201700014; Pappalardo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109340; Qadir A, 2018, DRUG RES, V68, P344, DOI 10.1055/s-0043-123466; Rayan A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187925; Saeed M, 2014, PHYTOMEDICINE, V21, P689, DOI 10.1016/j.phymed.2014.01.006; Shahaf N, 2016, MOL INFORM, V35, P414, DOI 10.1002/minf.201501029; Stefanovic S, 2004, SYST BIOL, V53, P384, DOI 10.1080/10635150490445896; Verpoorte R, 2000, J PHARM PHARMACOL, V52, P253, DOI 10.1211/0022357001773931; Xu PY, 2015, ONCOL REP, V33, P3117, DOI 10.3892/or.2015.3888; Yokota T, 2007, CANCER SCI, V98, P1447, DOI 10.1111/j.1349-7006.2007.00560.x; Zaid H, 2016, FRONT BIOSCI-LANDMRK, V21, P597, DOI 10.2741/4409; Zeidan M, 2017, MOLECULES, V22, DOI 10.3390/molecules22091563	21	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195707	10.1371/journal.pone.0195707	http://dx.doi.org/10.1371/journal.pone.0195707			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634770	Green Published, Green Submitted, gold			2022-12-26	WOS:000429522200049
J	Brown, WE; Huey, DJ; Hu, JC; Athanasiou, KA				Brown, Wendy E.; Huey, Daniel J.; Hu, Jerry C.; Athanasiou, Kyriacos A.			Functional self-assembled neocartilage as part of a biphasic osteochondral construct	PLOS ONE			English	Article							CALCIUM-PHOSPHATE CERAMICS; MARROW STROMAL CELLS; INTERFACIAL SHEAR-STRENGTH; IN-VITRO GENERATION; BIOMECHANICAL PROPERTIES; ARTICULAR-CARTILAGE; BONE; REPAIR; TISSUE; SCAFFOLDS	Bone-to-bone integration can be obtained by osteoconductive ceramics such as hydroxyapatite (HAp) and beta-tricalcium phosphate ((beta-TCP), but cartilage-to-cartilage integration is notoriously difficult. Many cartilage repair therapies, including microfracture and mosaicplasty, capitalize on the reparative aspects of subchondral bone due to its resident population of stem cells and vascularity. A strategy of incorporating tissue engineered neocartilage into a ceramic to form an osteochondral construct may serve as a suitable alternative to achieve cartilage graft fixation. The use of a tissue engineered osteochondral construct to repair cartilage defects may also benefit from the ceramic's proximity to underlying bone and abundant supply of progenitor cells and nutrients. The objective of the first study was to compare HAp and beta-TCP ceramics, two widely used ceramics in bone regeneration, in terms of their ability to influence neocartilage interdigitation at an engineered osteochondral interface. Additional assays quantified ceramic pore size, porosity, and compressive strength. The compressive strength of HAp was six times higher than that of beta-TCP due to differences in porosity and pore size, and HAp was thus carried forward in the second study as the composition with which to engineer an osteochondral construct. Importantly, it was shown that incorporation of the HAp ceramic in conjunction with the self-assembling process resulted in functionally viable neocartilage. For example, only collagen/dry weight and ultimate tensile strength of the chondral control constructs remained significantly greater than the neocartilage cut off the osteochondral constructs. By demonstrating that the functional properties of engineered neocartilage are not negatively affected by the inclusion of an HAp ceramic in culture, neocartilage engineering strategies may be directly applied to the formation of an osteochondral construct.	[Brown, Wendy E.; Hu, Jerry C.; Athanasiou, Kyriacos A.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA; [Huey, Daniel J.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Huey, Daniel J.] Genentech Inc, Vacaville, CA USA	University of California System; University of California Irvine; University of California System; University of California Davis; Roche Holding; Genentech	Athanasiou, KA (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA.	athens@uci.edu			National Institutes of Health [R01 AR067821]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health R01 AR067821 (https://www.nih.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2009, TISSUE ENG PT A, V15, P2595, DOI [10.1089/ten.tea.2008.0511, 10.1089/ten.TEA.2008.0511]; Arzi B, 2015, ACTA BIOMATER, V23, P72, DOI 10.1016/j.actbio.2015.05.025; ATHANASIOU KA, 1995, CLIN ORTHOP RELAT R, P254; Athanasiou KA., 2017, ARTICULAR CARTILAGE; Athanasiou KA, 2013, ANNU REV BIOMED ENG, V15, P115, DOI [10.1146/annurev-bioeng-071812-152423, 10.1146/annurev-bioeng-071812-15242]; Bae WC, 2008, OSTEOARTHR CARTILAGE, V16, P841, DOI 10.1016/j.joca.2007.11.015; Blokhuis TJ, 2000, J TRAUMA, V48, P179, DOI 10.1097/00005373-200001000-00037; Bodde EWH, 2007, J BIOMED MATER RES A, V82A, P711, DOI 10.1002/jbm.a.30990; Bohner M, 2000, INJURY, V31, pS37; Brand Richard A, 2005, Iowa Orthop J, V25, P82; Buckwalter J A, 2003, Iowa Orthop J, V23, P66; BUCKWALTER JA, 1990, BRIS MYER Z, P19; Chen KL, 2016, J TISSUE ENG REGEN M, V10, P294, DOI 10.1002/term.1716; Chen KL, 2016, J TISSUE ENG REGEN M, V10, P284, DOI 10.1002/term.1708; Cissell DD, 2017, TISSUE ENG PART C-ME, V23, P243, DOI 10.1089/ten.tec.2017.0018; Davies LC, 2008, OSTEOARTHR CARTILAGE, V16, P855, DOI 10.1016/j.joca.2007.12.005; Frenkel SR, 2005, OSTEOARTHR CARTILAGE, V13, P798, DOI 10.1016/j.joca.2005.04.018; Fu Q, 2008, J BIOMED MATER RES B, V86B, P125, DOI 10.1002/jbm.b.30997; GOLDSTEIN SA, 1987, J BIOMECH, V20, P1055, DOI 10.1016/0021-9290(87)90023-6; Guo XM, 2004, TISSUE ENG, V10, P1830, DOI 10.1089/ten.2004.10.1830; Hamilton DJ, 2006, BIOMATERIALS, V27, P397, DOI 10.1016/j.biomaterials.2005.07.007; Hu JC, 2006, CONNECT TISSUE RES, V47, P133, DOI 10.1080/03008200600685392; Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Khan IM, 2008, EUR CELLS MATER, V16, P26, DOI 10.22203/eCM.v016a04; Lee JK, 2016, TISSUE ENG PT A, V22, P318, DOI [10.1089/ten.tea.2015.0491, 10.1089/ten.TEA.2015.0491]; Lee JK, NATURE MAT IN PRESS; Lee WD, 2015, OSTEOARTHR CARTILAGE, V23, P1307, DOI 10.1016/j.joca.2015.04.010; MacBarb RE, 2013, BIOMATERIALS, V34, P9980, DOI 10.1016/j.biomaterials.2013.09.026; Makris EA, 2013, FASEB J, V27, P2421, DOI 10.1096/fj.12-224030; Mayr HO, 2013, ACTA BIOMATER, V9, P4845, DOI 10.1016/j.actbio.2012.07.040; Murphy MK, 2015, CELL TRANSPLANT, V24, P235, DOI 10.3727/096368913X676204; Murphy MK, 2013, INT J ORAL MAX IMPL, V28, pE393, DOI 10.11607/jomi.te20; Nehrer S, 1999, CLIN ORTHOP RELAT R, P149, DOI 10.1097/00003086-199908000-00020; Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1; Rodrigues MT, 2012, ACTA BIOMATER, V8, P2795, DOI 10.1016/j.actbio.2012.04.013; Schaefer D, 2002, ARTHRITIS RHEUM-US, V46, P2524, DOI 10.1002/art.10493; St-Pierre JP, 2012, ACTA BIOMATER, V8, P1603, DOI 10.1016/j.actbio.2011.12.022; Wang YC, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-80; Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7; Zhang WJ, 2015, MAT SCI ENG C-MATER, V46, P10, DOI 10.1016/j.msec.2014.09.042	41	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195261	10.1371/journal.pone.0195261	http://dx.doi.org/10.1371/journal.pone.0195261			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634740	gold, Green Published			2022-12-26	WOS:000429522200026
J	Torstensson, A; Fransson, A; Currie, K; Wulff, A; Chierici, M				Torstensson, Anders; Fransson, Agneta; Currie, Kim; Wulff, Angela; Chierici, Melissa			Microalgal photophysiology and macronutrient distribution in summer sea ice in the Amundsen and Ross Seas, Antarctica	PLOS ONE			English	Article							PHOTOSYNTHESIS-IRRADIANCE RELATIONSHIPS; M-CRESOL PURPLE; MICROBIAL COMMUNITIES; PACK ICE; MCMURDO SOUND; CARBONIC-ACID; ALGAE; SEAWATER; GROWTH; LIGHT	Our study addresses how environmental variables, such as macronutrients concentrations, snow cover, carbonate chemistry and salinity affect the photophysiology and biomass of Antarctic sea-ice algae. We have measured vertical profiles of inorganic macronutrients (phosphate, nitrite + nitrate and silicic acid) in summer sea ice and photophysiology of ice algal assemblages in the poorly studied Amundsen and Ross Seas sectors of the Southern Ocean. Brine-scaled bacterial abundance, chl a and macronutrient concentrations were often high in the ice and positively correlated with each other. Analysis of photosystem II rapid light curves showed that microalgal cells in samples with high phosphate and nitrite + nitrate concentrations had reduced maximum relative electron transport rate and photosynthetic efficiency. We also observed strong couplings of PSII parameters to snow depth, ice thickness and brine salinity, which highlights a wide range of photoacclimation in Antarctic pack-ice algae. It is likely that the pack ice was in a post-bloom situation during the late sea ice season, with low photosynthetic efficiency and a high degree of nutrient accumulation occurring in the ice. In order to predict how key biogeochemical processes are affected by future changes in sea ice cover, such as in situ photosynthesis and nutrient cycling, we need to understand how physicochemical properties of sea ice affect the microbial community. Our results support existing hypothesis about sea-ice algal photophysiology, and provide additional observations on high nutrient concentrations in sea ice that could influence the planktonic communities as the ice is retreating.	[Torstensson, Anders; Wulff, Angela] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Fransson, Agneta] Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway; [Fransson, Agneta] Univ Gothenburg, Dept Earth Sci, Gothenburg, Sweden; [Currie, Kim] Univ Otago, Res Ctr Oceanog, Natl Inst Water & Atmospher Res Ltd NIWA, Dunedin, New Zealand; [Chierici, Melissa] Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden; [Chierici, Melissa] Inst Marine Res, Tromso, Norway; [Torstensson, Anders] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Gothenburg; Norwegian Polar Institute; University of Gothenburg; University of Otago; University of Gothenburg; Institute of Marine Research - Norway; University of Washington; University of Washington Seattle	Torstensson, A (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.; Torstensson, A (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	andtor@uw.edu		Torstensson, Anders/0000-0002-8283-656X	Swedish Research Council [2007-8365, 2008-6228, 2009-2994]; Flagship program "Ocean Acidification and ecosystem effects in Northern waters" at the FRAM High North Research Centre for Climate and the Environment	Swedish Research Council(Swedish Research CouncilEuropean Commission); Flagship program "Ocean Acidification and ecosystem effects in Northern waters" at the FRAM High North Research Centre for Climate and the Environment	This project was funded by the Swedish Research Council (www.vr.se), grant numbers 2007-8365 (MC), 2008-6228 (AF) and 2009-2994 (MC). The study was partly financed by the Flagship program "Ocean Acidification and ecosystem effects in Northern waters" at the FRAM High North Research Centre for Climate and the Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin SA, 2012, MICROBIOL MOL BIOL R, V76, P667, DOI 10.1128/MMBR.00007-12; [Anonymous], 2021, LANG ENV STAT COMP; Arrigo Kevin R., 2014, Elementa-Science of the Anthropocene, V2, P000028, DOI 10.12952/journal.elementa.000028; Arrigo KR, 2014, ANNU REV MAR SCI, V6, P439, DOI 10.1146/annurev-marine-010213-135103; Arrigo KR, 2004, ANTARCT SCI, V16, P471, DOI 10.1017/S0954102004002263; Arrigo KR., 2017, SEA ICE, V3rd, P352, DOI DOI 10.1002/9781118778371.CH14; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Beardall J, 2001, AQUAT SCI, V63, P44, DOI 10.1007/PL00001344; Bidle KD, 1999, NATURE, V397, P508, DOI 10.1038/17351; Bjork MM, 2014, BIOGEOSCIENCES, V11, P57, DOI 10.5194/bg-11-57-2014; Boetius A, 2013, SCIENCE, V339, P1430, DOI 10.1126/science.1231346; Brierley AS, 2002, SCIENCE, V295, P1890, DOI 10.1126/science.1068574; Chierici M, 1999, MAR CHEM, V65, P281, DOI 10.1016/S0304-4203(99)00020-1; CLAYTON TD, 1993, DEEP-SEA RES PT I, V40, P2115, DOI 10.1016/0967-0637(93)90048-8; Conover RJ, 1999, MAR ECOL PROG SER, V179, P55, DOI 10.3354/meps179055; COTA GF, 1990, J PHYCOL, V26, P399, DOI 10.1111/j.0022-3646.1990.00399.x; Cowie ROM, 2014, AQUAT MICROB ECOL, V73, P123, DOI 10.3354/ame01710; COX GFN, 1983, J GLACIOL, V29, P306, DOI 10.3189/S0022143000008364; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; EICKEN H, 1992, J GEOPHYS RES-OCEANS, V97, P15545, DOI 10.1029/92JC01588; Firth E, 2016, ELEMENTA-SCI ANTHROP, V4, DOI 10.12952/journal.elementa.000120; Frankenstein G, 1967, J GLACIOL, V6, P943, DOI 10.1017/s0022143000020244; Fransson A, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006844; Fripiat F, 2017, ELEMENTA-SCI ANTHROP, V5, DOI 10.1525/elementa.217; Galindo V, 2014, J GEOPHYS RES-OCEANS, V119, P3746, DOI 10.1002/2013JC009497; Golden KM, 1998, SCIENCE, V282, P2238, DOI 10.1126/science.282.5397.2238; Gowing MM, 2003, MAR BIOL, V142, P1029, DOI 10.1007/s00227-003-1015-x; Grasshoff K, 1999, METHODS SEAWATER ANA; HANSEN PJ, 1991, MAR ECOL PROG SER, V73, P253, DOI 10.3354/meps073253; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540, DOI 10.4319/lo.1976.21.4.0540; Kohlbach D, 2016, LIMNOL OCEANOGR, V61, P2027, DOI 10.1002/lno.10351; Lannuzel D, 2013, POLAR BIOL, V36, P1483, DOI 10.1007/s00300-013-1368-7; Lannuzel D, 2016, DEEP-SEA RES PT II, V131, P111, DOI 10.1016/j.dsr2.2014.12.003; Lannuzel D, 2011, MAR CHEM, V124, P134, DOI 10.1016/j.marchem.2011.01.004; Lazzara L, 2007, ANTARCT SCI, V19, P83, DOI 10.1017/S0954102007000119; Malkin, 2015, PHYTOTOOLS PHYTOPLAN; MARANGER R, 1994, MAR ECOL PROG SER, V111, P121, DOI 10.3354/meps111121; Martin A, 2012, ANTARCT SCI, V24, P547, DOI 10.1017/S0954102012000491; McMinn A, 2008, POLAR BIOL, V31, P1011, DOI 10.1007/s00300-008-0433-0; McMinn A, 2010, POLAR BIOL, V33, P1547, DOI 10.1007/s00300-010-0844-6; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Meiners KM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053478; Miller LA, 2015, ELEMENTA-SCI ANTHROP, V3, DOI 10.12952/journal.elementa.000038; Mock T, 2002, PHYTOCHEMISTRY, V61, P53, DOI 10.1016/S0031-9422(02)00215-7; PALMISANO AC, 1985, J PHYCOL, V21, P341; PALMISANO AC, 1987, MAR BIOL, V94, P299, DOI 10.1007/BF00392944; Petrich C, 2017, SEA ICE, P1, DOI [10.1002/9781118778371.ch1, DOI 10.1002/9781118778371.CH1]; Petrou K, 2010, LIMNOL OCEANOGR, V55, P1400, DOI 10.4319/lo.2010.55.3.1400; Ralph PJ, 2007, J PHYCOL, V43, P948, DOI 10.1111/j.1529-8817.2007.00382.x; Ralph PJ, 2005, J PHYCOL, V41, P763, DOI 10.1111/j.1529-8817.2005.00106.x; Riaux-Gobin C, 2011, POLAR RES, V30, DOI 10.3402/polar.v30i0.5910; Ryan KG, 2012, J PHYCOL, V48, P74, DOI 10.1111/j.1529-8817.2011.01104.x; Ryan KG, 2004, POLAR BIOL, V27, P679, DOI 10.1007/s00300-004-0636-y; Saenz BT, 2014, J GEOPHYS RES-OCEANS, V119, P3645, DOI 10.1002/2013JC009677; Saenz BT, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007544; Schmoker C, 2013, J PLANKTON RES, V35, P691, DOI 10.1093/plankt/fbt023; Sogaard DH, 2011, POLAR BIOL, V34, P1157, DOI 10.1007/s00300-011-0976-3; Stammerjohn SE, 2015, ELEMENTA-SCI ANTHROP, V3, DOI 10.12952/journal.elementa.000055; Stewart FJ, 2004, ANTARCT SCI, V16, P143, DOI 10.1017/S0954102004001889; SULLIVAN CW, 1984, APPL ENVIRON MICROB, V47, P788, DOI 10.1128/AEM.47.4.788-795.1984; Thomas DN, 2001, ANN GLACIOL, V33, P297, DOI 10.3189/172756401781818338; Thomas DN, 2002, SCIENCE, V295, P641, DOI 10.1126/science.1063391; Thomas DN, 1998, ANTARCT RES SER, V73, P161; Tiselius P, 1996, J PLANKTON RES, V18, P133, DOI 10.1093/plankt/18.2.133; Torstensson A, 2013, BIOGEOSCIENCES, V10, P6391, DOI 10.5194/bg-10-6391-2013; Torstensson A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1513; Torstensson A, 2015, ENVIRON MICROBIOL, V17, P3869, DOI 10.1111/1462-2920.12865; Torstensson A, 2012, POLAR BIOL, V35, P205, DOI 10.1007/s00300-011-1056-4; Vancoppenolle M, 2013, QUATERNARY SCI REV, V79, P207, DOI 10.1016/j.quascirev.2013.04.011; Vancoppenolle M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005369; Wallace D, 2006, MS EXCEL PROGRAM DEV; Wright S., 1997, PHYTOPLANKTON PIGMEN, P327; Zhang Qing, 1999, Boreal Environment Research, V4, P1	75	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195587	10.1371/journal.pone.0195587	http://dx.doi.org/10.1371/journal.pone.0195587			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634756	Green Published, Green Submitted, gold			2022-12-26	WOS:000429522200039
J	Komura, T; Ando, H; Horikoshi, K; Suzuki, H; Isagi, Y				Komura, Taketo; Ando, Haruko; Horikoshi, Kazuo; Suzuki, Hajime; Isagi, Yuji			DNA barcoding reveals seasonal shifts in diet and consumption of deep-sea fishes in wedge-tailed shearwaters	PLOS ONE			English	Article							EASTERN TROPICAL PACIFIC; SOUTHEASTERN BERING-SEA; WESTERN INDIAN-OCEAN; CALONECTRIS-DIOMEDEA; MARINE ECOSYSTEMS; STABLE-ISOTOPES; FEEDING ECOLOGY; YELLOWFIN TUNA; PREY SELECTION; BULWERS PETREL	The foraging ecology of pelagic seabirds is difficult to characterize because of their large foraging areas. In the face of this difficulty, DNA metabarcoding may be a useful approach to analyze diet compositions and foraging behaviors. Using this approach, we investigated the diet composition and its seasonal variation of a common seabird species on the Ogasawara Islands, Japan: the wedge-tailed shearwater Ardenna pacifica. We collected fecal samples during the prebreeding (N= 73) and rearing (N= 96) periods. The diet composition of wedge-tailed shearwater was analyzed by Ion Torrent sequencing using two universal polymerase chain reaction primers for the 12S and 16S mitochondrial DNA regions that targeted vertebrates and mollusks, respectively. The results of a BLAST search of obtained sequences detected 31 and 1 vertebrate and mollusk taxa, respectively. The results of the diet composition analysis showed that wedge-tailed shearwaters frequently consumed deep-sea fishes throughout the sampling season, indicating the importance of these fishes as a stable food resource. However, there was a marked seasonal shift in diet, which may reflect seasonal changes in food resource availability and wedge-tailed shearwater foraging behavior. The collected data regarding the shearwater diet may be useful for in situ conservation efforts. Future research that combines DNA metabarcoding with other tools, such as data logging, may provide further insight into the foraging ecology of pelagic seabirds.	[Komura, Taketo; Isagi, Yuji] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto, Japan; [Ando, Haruko] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan; [Horikoshi, Kazuo; Suzuki, Hajime] Inst Boninol, Nishi Machi, Tokyo, Japan	Kyoto University; National Institute for Environmental Studies - Japan	Komura, T (corresponding author), Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto, Japan.	little.village.health.man@gmail.com	Isagi, Yuji/ABA-8678-2020	Isagi, Yuji/0000-0002-9777-076X; Komura, Taketo/0000-0001-7491-5594	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [4-1402]; Grants-in-Aid for Scientific Research [16K18484] Funding Source: KAKEN	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan(Ministry of the Environment, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Environment Research and Technology Development Fund (4-1402) of the Ministry of the Environment, Japan (http://www.env.go.jp/policy/kenkyu/suishin/gaiyou/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso H, 2014, MOL ECOL, V23, P3719, DOI 10.1111/mec.12785; Ando K., 2004, REP TOKYO METROP FIS, V213, P23; Baduini CL, 2006, MAR ECOL PROG SER, V320, P279, DOI 10.3354/meps320279; Barrett RT, 2007, ICES J MAR SCI, V64, P1675, DOI 10.1093/icesjms/fsm152; Bartumeus F, 2010, CURR BIOL, V20, P215, DOI 10.1016/j.cub.2009.11.073; Berry TE, 2017, DNA METABARCODING DI; Bicknell AWJ, 2013, J APPL ECOL, V50, P649, DOI 10.1111/1365-2664.12072; BirdLife International, 2017, IUCN RED LIST THREAT; BLACKBURN M, 1970, MAR BIOL, V7, P14, DOI 10.1007/BF00346804; Bond AL, 2010, WATERBIRDS, V33, P50, DOI 10.1675/063.033.0106; BOST CA, 1993, ACTA OECOL, V14, P463; Bourgeois K, 2011, J ORNITHOL, V152, P947, DOI 10.1007/s10336-011-0677-2; Bowles E, 2011, MOL ECOL RESOUR, V11, P530, DOI 10.1111/j.1755-0998.2010.02974.x; Boyd IL, 2001, J ANIM ECOL, V70, P747, DOI 10.1046/j.0021-8790.2001.00534.x; Brazil M., 2009, BIRDS E AS E CHIN TA; Brodeur RD, 2006, GEOPHYS RES LETT, P33, DOI [10.1029/2006GL027800, DOI 10.1029/2006GL027800]; Brooke M, 2004, ALBATROSSES PETRELS; Buglione M, 2018, MAMM BIOL, V88, P31, DOI 10.1016/j.mambio.2017.10.010; Catry T, 2009, MAR ECOL PROG SER, V391, P231, DOI 10.3354/meps07717; Catry T, 2009, MAR ECOL PROG SER, V374, P259, DOI 10.3354/meps07713; Cecere JG, 2013, WATERBIRDS, V36, P432, DOI 10.1675/063.036.0414; Chiba Hayato, 2007, Journal of the Yamashina Institute for Ornithology, V39, P1; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Connell SC, 2014, NEW ZEAL J MAR FRESH, V48, P416, DOI 10.1080/00288330.2014.914042; Craine JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161511; Davoren GK, 1999, ANIM BEHAV, V58, P853, DOI 10.1006/anbe.1999.1209; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Deagle BE, 2007, CONSERV GENET, V8, P743, DOI 10.1007/s10592-006-9197-7; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Diamond AW, 2003, ENVIRON MONIT ASSESS, V88, P153, DOI 10.1023/A:1025560805788; Dolganova NT, 2004, PROG OCEANOGR, V61, P227, DOI 10.1016/j.pocean.2004.06.008; Einoder LD, 2009, FISH RES, V95, P6, DOI 10.1016/j.fishres.2008.09.024; Giusti A, 2017, J AGR FOOD CHEM, V65, P2902, DOI 10.1021/acs.jafc.6b05802; Gould P, 1997, EMU, V97, P168, DOI 10.1071/MU97020; GOULD PJ, 1967, CONDOR, V69, P529, DOI 10.2307/1366157; Granadeiro JP, 1998, MAR ECOL PROG SER, V166, P267, DOI 10.3354/meps166267; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HARRISON CS, 1983, WILDLIFE MONOGR, P1; Hedd A, 1997, IBIS, V139, P452, DOI 10.1111/j.1474-919X.1997.tb04658.x; HOBSON KA, 1994, J ANIM ECOL, V63, P786, DOI 10.2307/5256; Hunt GL, 2002, DEEP-SEA RES PT II, V49, P6147, DOI 10.1016/S0967-0645(02)00338-7; Jansen JK, 2002, OECOLOGIA, V131, P306, DOI 10.1007/s00442-002-0880-1; Jarman SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082227; Kato K., 2011, TOKYO METROP RES FIS, V5, P17; Kato K., 2008, TOKYO METROP RES FIS, P1; Kawakami K, 2012, CONDOR, V114, P507, DOI 10.1525/cond.2012.110196; Kress WJ, 2015, TRENDS ECOL EVOL, V30, P25, DOI 10.1016/j.tree.2014.10.008; Louzao M, 2006, MAR ECOL PROG SER, V318, P247, DOI 10.3354/meps318247; Maeda H., 2006, TOKYO METROP RES FIS, V1, P31; Matsumoto K, 2012, ORNITHOL SCI, V11, P9, DOI 10.2326/osj.11.9; MCduie Fiona, 2015, Marine Ornithology, V43, P123; McInnes J. C., 2017, MOL ECOL; McInnes JC, 2017, METHODS ECOL EVOL, V8, P192, DOI 10.1111/2041-210X.12677; Ministry of the Environment, 2015, JAP BIRD RED LIST; Nakabou T., 2013, FISHES JAPAN PICTORI; Nakahara F., 2015, DNA BARCODES, DOI [10.1515/dna-2015-0021, DOI 10.1515/DNA-2015-0021]; Navarro J, 2007, MAR ECOL PROG SER, V351, P261, DOI 10.3354/meps07115; Neves VC, 2011, WATERBIRDS, V34, P357, DOI 10.1675/063.034.0310; Oehm J, 2017, ECOL EVOL, V7, P1984, DOI 10.1002/ece3.2790; Oksanen J, 2013, PACKAGE VEGAN COMMUN, P2; Olson RJ, 2014, MAR ECOL PROG SER, V497, P157, DOI 10.3354/meps10609; Peters KJ, 2015, MAR ECOL-EVOL PERSP, V36, P347, DOI 10.1111/maec.12145; Polovina J. J., 2008, GEOPHYS RES LETT, P35, DOI DOI 10.1029/2008GL035090; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Potier M, 2007, FISH RES, V83, P60, DOI 10.1016/j.fishres.2006.08.020; R_Core_Team, 2015, R LANG ENV STAT COMP; Ramos JA, 2018, CONDOR, V120, P283, DOI 10.1650/CONDOR-17-220.1; Raymond B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010960; Riaz T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr732; Shehzad W, 2012, MOL ECOL, V21, P1951, DOI 10.1111/j.1365-294X.2011.05424.x; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Stamoulis KA, 2017, SCI REP-UK, V7, DOI 10.1038/srep43819; Suryan RM, 2002, MAR ECOL PROG SER, V236, P273, DOI 10.3354/meps236273; Tanabe AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076910; The Ornithological Society of Japan, 2012, CHECK LIST JAPANESE; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Waap S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01312-3; Waap S., 2015, TROPHIC RELATIONSHIP; Willerslev E, 2014, NATURE, V506, P47, DOI 10.1038/nature12921; Yamamoto T, 2011, MAR ECOL PROG SER, V424, P191, DOI 10.3354/meps08973	80	10	10	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195385	10.1371/journal.pone.0195385	http://dx.doi.org/10.1371/journal.pone.0195385			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630670	Green Submitted, gold, Green Published			2022-12-26	WOS:000429505000046
J	Zahin, M; Dean, WL; Ghim, SJ; Joh, J; Gray, RD; Khanal, S; Bossart, GD; Mignucci-Giannoni, AA; Rouchka, EC; Jenson, AB; Trent, JO; Chaires, JB; Chariker, JH				Zahin, Maryam; Dean, William L.; Ghim, Shin-Je; Joh, Joongho; Gray, Robert D.; Khanal, Sujita; Bossart, Gregory D.; Mignucci-Giannoni, Antonio A.; Rouchka, Eric C.; Jenson, Alfred B.; Trent, John O.; Chaires, Jonathan B.; Chariker, Julia H.			Identification of G-quadruplex forming sequences in three manatee papillomaviruses	PLOS ONE			English	Article							FLORIDA MANATEE; MUCOSOTROPIC PAPILLOMAVIRUSES; PARALLEL QUADRUPLEXES; HUMAN TELOMERE; DNA APTAMER; K+ SOLUTION; G-TETRAD; RNA; BINDING; HIV-1	The Florida manatee (Trichechus manatus latirotris) is a threatened aquatic mammal in United States coastal waters. Over the past decade, the appearance of papillomavirus-induced lesions and viral papillomatosis in manatees has been a concern for those involved in the management and rehabilitation of this species. To date, three manatee papillomaviruses (TmPVs) have been identified in Florida manatees, one forming cutaneous lesions (TmPV1) and two forming genital lesions (TmPV3 and TmPV4). We identified DNA sequences with the potential to form G-quadruplex structures (G4) across the three genomes. G4 were located on both DNA strands and across coding and non-coding regions on all TmPVs, offering multiple targets for viral control. Although G4 have been identified in several viral genomes, including human PVs, most research has focused on canonical structures comprised of three G tetrads. In contrast, the vast majority of sequences we identified would allow the formation of non-canonical structures with only two G-tetrads. Our biophysical analysis confirmed the formation of G4 with parallel topology in three such sequences from the E2 region. Two of the structures appear comprised of multiple stacked two G-tetrad structures, perhaps serving to increase structural stability. Computational analysis demonstrated enrichment of G4 sequences on all TmPVs on the reverse strand in the E2/E4 region and on both strands in the L2 region. Several G4 sequences occurred at similar regional locations on all PVs, most notably on the reverse strand in the E2 region. In other cases, G4 were identified at similar regional locations only on PVs forming genital lesions. On all TmPVs, G4 sequences were located in the non-coding region near putative E2 binding sites. Together, these findings suggest that G4 are possible regulatory elements in TmPVs.	[Zahin, Maryam; Dean, William L.; Ghim, Shin-Je; Joh, Joongho; Gray, Robert D.; Khanal, Sujita; Jenson, Alfred B.; Trent, John O.; Chaires, Jonathan B.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Joh, Joongho; Trent, John O.; Chaires, Jonathan B.] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [Khanal, Sujita; Trent, John O.; Chaires, Jonathan B.] Univ Louisville, Dept Biochem & Mol Genet, Louisville, KY 40292 USA; [Bossart, Gregory D.] Georgia Aquarium, Atlanta, GA USA; [Bossart, Gregory D.] Univ Miami, Miller Sch Med, Dept Pathol, Div Comparat Pathol, Miami, FL 33136 USA; [Mignucci-Giannoni, Antonio A.] Inter Amer Univ Puerto Rico, Puerto Rico Manatee Conservat Ctr, Bayamon, PR USA; [Rouchka, Eric C.] Univ Louisville, Dept Comp Engn & Comp Sci, Duthie Ctr Engn, Louisville, KY 40292 USA; [Rouchka, Eric C.; Chariker, Julia H.] Univ Louisville, KBRIN Bioinformat Core, Louisville, KY 40292 USA; [Chariker, Julia H.] Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Miami; Inter American University of Puerto Rico-San German; University of Louisville; University of Louisville; University of Louisville	Chariker, JH (corresponding author), Univ Louisville, KBRIN Bioinformat Core, Louisville, KY 40292 USA.; Chariker, JH (corresponding author), Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40292 USA.	julia.chariker@louisville.edu		trent, John/0000-0002-7346-4231	Helmsley Trust Foundation [G2585-20162014]; James Graham Brown Cancer Center, School of Medicine, University of Louisville; National Institutes of Health (NIH) [R01GM077422]; National Institutes of Health [P20GM103436]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077422] Funding Source: NIH RePORTER	Helmsley Trust Foundation; James Graham Brown Cancer Center, School of Medicine, University of Louisville; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Helmsley Trust Foundation (www.helmsleytrust.org) grant G2585-20162014 (Alfred Jenson, PI) and the James Graham Brown Cancer Center, School of Medicine, University of Louisville (http://browncancercenter.louisville.edu/). Support for JBC was provided by the National Institutes of Health (NIH, www.nih.gov) grant R01GM077422 (Jonathan. B. Chaires, PI). Support for JHC and ECR was provided by the National Institutes of Health grant P20GM103436 (Nigel Cooper, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrane S, 2014, J AM CHEM SOC, V136, P5249, DOI 10.1021/ja501500c; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Beaudoin JD, 2013, NUCLEIC ACIDS RES, V41, P5898, DOI 10.1093/nar/gkt265; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Besnard E, 2012, NAT STRUCT MOL BIOL, V19, P837, DOI 10.1038/nsmb.2339; Blaum BS, 2012, NUCLEIC ACIDS RES, V40, P3042, DOI 10.1093/nar/gkr1152; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Brazda V, 2014, INT J MOL SCI, V15, P17493, DOI 10.3390/ijms151017493; Broxson C, 2011, BIOCHEMISTRY-US, V50, P4162, DOI 10.1021/bi2002136; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Cahoon LA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003074; Callegaro S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02667-3; Case D. A., 2017, AMBER 2017; Cayrou C, 2012, CELL CYCLE, V11, P658, DOI 10.4161/cc.11.4.19097; Chaires JB, 2015, METHOD ENZYMOL, V562, P287, DOI 10.1016/bs.mie.2015.04.011; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; Chariker JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165101; Davison AC, 1997, BOOTSTRAP METHODS TH; de la Faverie AR, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku111; Del Villar-Guerra R., 2017, CURR PROTOC NUCL ACI, V68, P17, DOI DOI 10.1002/CPNC.23; Deng B, 2014, ANAL CHIM ACTA, V837, P1, DOI 10.1016/j.aca.2014.04.055; Dona MG, 2011, J WILDLIFE DIS, V47, P673, DOI 10.7589/0090-3558-47.3.673; Fisette JF, 2012, J NEUROCHEM, V121, P763, DOI 10.1111/j.1471-4159.2012.07680.x; Fleming AM, 2016, ACS INFECT DIS, V2, P674, DOI 10.1021/acsinfecdis.6b00109; Ghim SJ, 2014, AQUAT MAMM, V40, P195, DOI 10.1578/AM.40.2.2014.195; Harris LM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004562; Hazel P, 2004, J AM CHEM SOC, V126, P16405, DOI 10.1021/ja045154j; Holm AIS, 2010, BIOPOLYMERS, V93, P429, DOI 10.1002/bip.21354; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Johansson C, 2013, NAT REV MICROBIOL, V11, P239, DOI 10.1038/nrmicro2984; Kang HJ, 2009, BIOCHEMISTRY-US, V48, P7392, DOI 10.1021/bi9006836; Karsisiotis A. I., 2011, ANGEW CHEM, V123, P10833, DOI DOI 10.1002/ANGE.201105193; Koepf EK, 1999, PROTEIN SCI, V8, P841, DOI 10.1110/ps.8.4.841; Kruisselbrink E, 2008, CURR BIOL, V18, P900, DOI 10.1016/j.cub.2008.05.013; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Kwok CK, 2016, NAT METHODS, V13, P841, DOI 10.1038/nmeth.3965; Lahaye X, 2013, IMMUNITY, V39, P1132, DOI 10.1016/j.immuni.2013.11.002; Le HT, 2014, J PHYS CHEM B, V118, P5390, DOI 10.1021/jp502213y; Lemmens B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9909; Lim KW, 2009, J AM CHEM SOC, V131, P4301, DOI 10.1021/ja807503g; LU JZJ, 1993, J VIROL, V67, P7131, DOI 10.1128/JVI.67.12.7131-7139.1993; MACAYA RF, 1993, P NATL ACAD SCI USA, V90, P3745, DOI 10.1073/pnas.90.8.3745; Matsugami A, 2003, J BIOL CHEM, V278, P28147, DOI 10.1074/jbc.M303694200; Matsugami A, 2001, Nucleic Acids Res Suppl, P271; Matsugami A, 2001, J MOL BIOL, V313, P255, DOI 10.1006/jmbi.2001.5047; Mendoza O, 2016, NUCLEIC ACIDS RES, V44, P1989, DOI 10.1093/nar/gkw079; Metifiot M, 2014, NUCLEIC ACIDS RES, V42, P12352, DOI 10.1093/nar/gku999; Millevoi S, 2012, WIRES RNA, V3, P495, DOI 10.1002/wrna.1113; Murat P, 2014, NAT CHEM BIOL, V10, P358, DOI [10.1038/nchembio.1479, 10.1038/NCHEMBIO.1479]; Norseen J, 2009, J VIROL, V83, P10336, DOI 10.1128/JVI.00747-09; North BV, 2002, AM J HUM GENET, V71, P439, DOI 10.1086/341527; Ou TM, 2007, J MED CHEM, V50, P1465, DOI 10.1021/jm0610088; Pagano B, 2008, BIOPHYS J, V94, P562, DOI 10.1529/biophysj.107.117382; Palumbo SL, 2008, NUCLEIC ACIDS RES, V36, P1755, DOI 10.1093/nar/gkm1069; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Perrone R, 2015, J MED CHEM, V58, P9639, DOI 10.1021/acs.jmedchem.5b01283; Perrone R, 2014, J ANTIMICROB CHEMOTH, V69, P3248, DOI 10.1093/jac/dku280; Perrone R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073121; Perrone R, 2013, J MED CHEM, V56, P6521, DOI 10.1021/jm400914r; Tran PLT, 2011, NUCLEIC ACIDS RES, V39, P3282, DOI 10.1093/nar/gkq1292; Piekna-Przybylska D, 2014, BIOCHEMISTRY-US, V53, P2581, DOI 10.1021/bi4016692; Qin MY, 2015, J PHYS CHEM B, V119, P3706, DOI 10.1021/jp512914t; Rector A, 2004, J VIROL, V78, P12698, DOI 10.1128/JVI.78.22.12698-12702.2004; Rector A, 2013, VIROLOGY, V445, P213, DOI 10.1016/j.virol.2013.05.007; Ribeiro MM, 2015, HUM GENET, V134, P37, DOI 10.1007/s00439-014-1485-6; Rogers A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-379; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Shiyong Wang, 2016, International Journal of Distributed Sensor Networks, V2016, DOI 10.1155/2016/3159805; Shum KT, 2008, CHEMBIOCHEM, V9, P3037, DOI 10.1002/cbic.200800491; Sobczak K, 2010, J BIOL CHEM, V285, P12755, DOI 10.1074/jbc.M109.078790; Stoddart CA, 1998, ANTIMICROB AGENTS CH, V42, P2113, DOI 10.1128/AAC.42.8.2113; Sun DY, 1997, J MED CHEM, V40, P2113, DOI 10.1021/jm970199z; Tan SH, 1992, NUCLEIC ACIDS RES, P20; Tluckova K, 2013, BIOCHEMISTRY-US, V52, P7207, DOI 10.1021/bi400897g; Tosoni E, 2015, NUCLEIC ACIDS RES, V43, P8884, DOI 10.1093/nar/gkv897; Tothova P, 2014, BIOCHEMISTRY-US, V53, P7013, DOI 10.1021/bi500773c; Valton AL, 2014, EMBO J, V33, P732, DOI 10.1002/embj.201387506; Viglasky V, 2010, BIOCHEMISTRY-US, V49, P2110, DOI 10.1021/bi902099u; von Hacht A, 2014, NUCLEIC ACIDS RES, V42, P6630, DOI 10.1093/nar/gku290; Vorlickova M, 2012, METHODS, V57, P64, DOI 10.1016/j.ymeth.2012.03.011; Wang SR, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501535; Wieland M, 2009, NAT PROTOC, V4, P1632, DOI 10.1038/nprot.2009.111; Woo HM, 2013, ANTIVIR RES, V100, P337, DOI 10.1016/j.antiviral.2013.09.004; Yang DZ, 2010, FUTURE MED CHEM, V2, P619, DOI 10.4155/FMC.09.172; Zahin M, 2015, J GEN VIROL, V96, P3545, DOI 10.1099/jgv.0.000293; Zhang ZJ, 2010, NUCLEIC ACIDS RES, V38, P1009, DOI 10.1093/nar/gkp1029	87	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195625	10.1371/journal.pone.0195625	http://dx.doi.org/10.1371/journal.pone.0195625			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630682	Green Published, Green Submitted, gold			2022-12-26	WOS:000429505000066
J	Zahradnik, J; Kolenko, P; Palyzova, A; Cerny, J; Kolarova, L; Kyslikova, E; Maresova, H; Grulich, M; Nunvar, J; Sulc, M; Kyslik, P; Schneider, B				Zahradnik, Jiri; Kolenko, Petr; Palyzova, Andrea; Cerny, Jiri; Kolarova, Lucie; Kyslikova, Eva; Maresova, Helena; Grulich, Michel; Nunvar, Jaroslav; Sulc, Miroslav; Kyslik, Pavel; Schneider, Bohdan			The crystal structure of XdpB, the bacterial old yellow enzyme, in an FMN-free form	PLOS ONE			English	Article							GLYCEROL TRINITRATE REDUCTASE; ACTIVE-SITE; OXIDATIVE STRESS; MORPHINONE REDUCTASE; NEMA GENE; EXPRESSION; PROTEIN; SEQUENCE; FAMILY; PURIFICATION	Old Yellow Enzymes (OYES) are NAD(P)H dehydrogenases of not fully resolved physiological roles that are widespread among bacteria, plants, and fungi and have a great potential for biotechnological applications. We determined the apo form crystal structure of a member of the OYE class, glycerol trinitrate reductase XdpB, from Agrobacterium bohemicum R89-1 at 2.1 A resolution. In agreement with the structures of the related bacterial OYEs, the structure revealed the TIM barrel fold with an N-terminal beta-hairpin lid, but surprisingly, the structure did not contain its cofactor FMN. Its putative binding site was occupied by a pentapeptide TTSDN from the C-terminus of a symmetry related molecule. Biochemical experiments confirmed a specific concentration-dependent oligomerization and a low FMN content. The blocking of the FMN binding site can exist in vivo and regulates enzyme activity. Our bioinformatic analysis indicated that a similar self-inhibition could be expected in more OYEs which we designated as subgroup OYE C1. This subgroup is widespread among G-bacteria and can be recognized by the conserved sequence GxxDYP in proximity of the C termini. In proteobacteria, the C1 subgroup OYEs are typically coded in one operon with short-chain dehydrogenase. This operon is controlled by the tetR-like transcriptional regulator. OYEs coded in these operons are unlikely to be involved in the oxidative stress response as the other known members of the OYE family because no upregulation of XdpB was observed after exposing A. bohemicum R89-1 to oxidative stress.	[Zahradnik, Jiri; Kolenko, Petr; Cerny, Jiri; Kolarova, Lucie; Nunvar, Jaroslav; Schneider, Bohdan] BIOCEV, Inst Biotechnol CAS, Vvi, Vestec, Prague West, Czech Republic; [Zahradnik, Jiri; Sulc, Miroslav] Charles Univ Prague, Dept Biochem, Fac Sci, Prague, Czech Republic; [Zahradnik, Jiri; Palyzova, Andrea; Kyslikova, Eva; Maresova, Helena; Grulich, Michel; Kyslik, Pavel] Inst Microbiol CAS, Vvi, Prague, Czech Republic; [Kolenko, Petr] FNSPE Czech Tech Univ, Dept Solid State Engn, Prague, Czech Republic	Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Charles University Prague; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Technical University Prague	Zahradnik, J; Schneider, B (corresponding author), BIOCEV, Inst Biotechnol CAS, Vvi, Vestec, Prague West, Czech Republic.; Zahradnik, J (corresponding author), Charles Univ Prague, Dept Biochem, Fac Sci, Prague, Czech Republic.; Zahradnik, J (corresponding author), Inst Microbiol CAS, Vvi, Prague, Czech Republic.	zahradj@ibt.cas.cz; bohdan.schneider@gmail.com	Černý, Jiří/I-4733-2012; Sulc, Miroslav/K-1029-2014; Schneider, Bohdan/D-2565-2009; Kolenko, Petr/G-5732-2014; Marešová, Helena/H-4646-2014; Palyzova, Andrea/H-2628-2014; Kolarova, Lucie/M-6228-2017	Černý, Jiří/0000-0002-1969-9304; Sulc, Miroslav/0000-0002-2659-0489; Kolenko, Petr/0000-0002-4619-9276; Kolarova, Lucie/0000-0002-6491-3568; Zahradnik, Jiri/0000-0002-8698-4236	Grant Agency of Charles University [720414]; long-term research development project from the ERDF [RVO 61388971, 86 652 036, CZ.1.05/2.1.00/19.0390]; MEYS; Grant Agency of the Czech Technical University in Prague [SGS16/246/OHK4/3T/14]	Grant Agency of Charles University; long-term research development project from the ERDF; MEYS; Grant Agency of the Czech Technical University in Prague	The study was supported by grant No. 720414 of the Grant Agency of Charles University, the long-term research development project RVO 61388971 to the Institute of Microbiology CAS, v. v. i. and 86 652 036 to the Institute of Biotechnology CAS, v. v. i. and to project Introduction of new research methods to BIOCEV CZ.1.05/2.1.00/19.0390 from the ERDF and MEYS and in part by the Grant Agency of the Czech Technical University in Prague, grant No. SGS16/246/OHK4/3T/14. We thank the Helmholz Zentrum Berlin for the allocation of synchrotron radiation beamtime.	Adalbjornsson BV, 2010, CHEMBIOCHEM, V11, P197, DOI 10.1002/cbic.200900570; Alexandre H, 2001, FEBS LETT, V498, P98, DOI 10.1016/S0014-5793(01)02503-0; Amato ED, 2015, BIOTECHNOL ADV, V33, P624, DOI 10.1016/j.biotechadv.2015.04.011; Barna T, 2002, J BIOL CHEM, V277, P30976, DOI 10.1074/jbc.M202846200; Barna TM, 2001, J MOL BIOL, V310, P433, DOI 10.1006/jmbi.2001.4779; Blehert DS, 1997, J BACTERIOL, V179, P6912, DOI 10.1128/jb.179.22.6912-6920.1997; Bohm G., 1997, CDNN D CD SPECTRA DE; Breithaupt C, 2006, P NATL ACAD SCI USA, V103, P14337, DOI 10.1073/pnas.0606603103; Brige A, 2006, BIOCHEM J, V394, P335, DOI 10.1042/BJ20050979; Brown BJ, 1998, J BIOL CHEM, V273, P32753, DOI 10.1074/jbc.273.49.32753; Brown BJ, 2002, J BIOL CHEM, V277, P2138, DOI 10.1074/jbc.M108453200; Chilton AS, 2014, ACTA CRYSTALLOGR F, V70, P1328, DOI 10.1107/S2053230X14018962; Deng WY, 2013, CELL SIGNAL, V25, P1608, DOI 10.1016/j.cellsig.2013.04.003; Ehira S, 2010, MICROBIOL-SGM, V156, P1335, DOI 10.1099/mic.0.036913-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fitzpatrick TB, 2003, J BIOL CHEM, V278, P19891, DOI 10.1074/jbc.M211778200; FRENCH CE, 1994, BIOCHEM J, V301, P97, DOI 10.1042/bj3010097; Garadnay S, 2013, CENT EUR J CHEM, V11, P430, DOI 10.2478/s11532-012-0181-4; Gutierrez-Preciado A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126124; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanekar P.P., 2014, BIOL REMEDIATION EXP, P67, DOI DOI 10.1007/978-3-319-01083-0_4; Kitzing K, 2005, J BIOL CHEM, V280, P27904, DOI 10.1074/jbc.M502587200; Koerkamp MG, 2002, MOL BIOL CELL, V13, P2783, DOI 10.1091/mbc.E02-02-0075; Kohli RM, 1998, J BIOL CHEM, V273, P32763, DOI 10.1074/jbc.273.49.32763; Kubata BK, 2002, J EXP MED, V196, P1241, DOI 10.1084/jem.20020885; Kyslikova E, 2013, J MOL CATAL B-ENZYM, V87, P1, DOI 10.1016/j.molcatb.2012.10.004; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; MacLellan SR, 2006, MICROBIOL-SGM, V152, P1751, DOI 10.1099/mic.0.28743-0; Malone TE, 2005, PROTEINS, V58, P243, DOI 10.1002/prot.20162; Marshall SJ, 2004, J BACTERIOL, V186, P1802, DOI 10.1128/JB.186.6.1802-1810.2004; Messiha HL, 2005, J BIOL CHEM, V280, P27103, DOI 10.1074/jbc.M502293200; Miura K, 1997, BIOL PHARM BULL, V20, P110; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murta SMF, 2006, MOL BIOCHEM PARASIT, V146, P151, DOI 10.1016/j.molbiopara.2005.12.001; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nizam S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04013; Oberdorfer G, 2013, CHEMBIOCHEM, V14, P836, DOI 10.1002/cbic.201300136; Odat O, 2007, J BIOL CHEM, V282, P36010, DOI 10.1074/jbc.M704058200; Okamoto N, 2011, J BIOCHEM, V150, P563, DOI 10.1093/jb/mvr096; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Persson B, 2008, CELL MOL LIFE SCI, V65, P3879, DOI 10.1007/s00018-008-8587-z; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reich S, 2012, CHEMBIOCHEM, V13, P2400, DOI 10.1002/cbic.201200404; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schaller F, 2000, PLANTA, V210, P979, DOI 10.1007/s004250050706; Schittmayer M, 2011, ADV SYNTH CATAL, V353, P268, DOI 10.1002/adsc.201000862; Schneider B, 2014, ACTA CRYSTALLOGR D, V70, P2413, DOI 10.1107/S1399004714014631; Snape JR, 1997, J BACTERIOL, V179, P7796, DOI 10.1128/jb.179.24.7796-7802.1997; Solovjev V, 2011, METAGENOMICITAPP, P61; Spiegelhauer O, 2010, J MOL BIOL, V403, P286, DOI 10.1016/j.jmb.2010.08.047; Spiegelhauer O, 2010, J MOL BIOL, V398, P66, DOI 10.1016/j.jmb.2010.02.044; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Umezawa Y, 2008, J BACTERIOL, V190, P5890, DOI 10.1128/JB.00459-08; van den Hemel D, 2006, J BIOL CHEM, V281, P28152, DOI 10.1074/jbc.M603946200; Warburg O, 1933, BIOCHEM Z, V266, P377; Wick A, 2011, ENVIRON SCI TECHNOL, V45, P3374, DOI 10.1021/es103489x; WILLEY DL, 1993, BIOCHEM J, V290, P539, DOI 10.1042/bj2900539; Williams RE, 2004, APPL ENVIRON MICROB, V70, P3566, DOI 10.1128/AEM.70.6.3566-3574.2004; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu D, 1999, P NATL ACAD SCI USA, V96, P3556, DOI 10.1073/pnas.96.7.3556; Zahradnik J, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00196-16; Zahradnik J, 2018, SYST APPL MICROBIOL, V41, P184, DOI 10.1016/j.syapm.2018.01.003	67	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195299	10.1371/journal.pone.0195299	http://dx.doi.org/10.1371/journal.pone.0195299			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630677	Green Published, Green Submitted, gold			2022-12-26	WOS:000429505000037
J	Fassbinder-Orth, CA; Killpack, TL; Goto, DS; Rainwater, EL; Shearn-Bochsler, VI				Fassbinder-Orth, Carol A.; Killpack, Tess L.; Goto, Dylan S.; Rainwater, Ellecia L.; Shearn-Bochsler, Valerie I.			High costs of infection: Alphavirus infection reduces digestive function and bone and feather growth in nestling house sparrows (Passer domesticus)	PLOS ONE			English	Article							BUGGY-CREEK-VIRUS; EASTERN EQUINE ENCEPHALITIS; POOR DEVELOPMENTAL CONDITIONS; GALLUS-GALLUS-DOMESTICUS; WEST-NILE-VIRUS; FOOD RESTRICTION; TRADE-OFFS; OECIACUS-VICARIUS; AMERICAN KESTRELS; MOURNING DOVES	Increasingly, ecoimmunology studies aim to use relevant pathogen exposure to examine the impacts of infection on physiological processes in wild animals. Alphaviruses are arthropod-borne, single-stranded RNA (ssRNA) viruses ("arboviruses") responsible for millions of cases of human illnesses each year. Buggy Creek virus (BCRV) is a unique alphavirus that is transmitted by a cimicid insect, the swallow bug, and is amplified in two avian species: the house sparrow (Passer domesticus) and the cliff swallow (Petrochelidon pyrrhonota). BCRV, like many alphaviruses, exhibits age-dependent susceptibility where the young are most susceptible to developing disease and exhibit a high mortality rate. However, alpha virus disease etiology in nestling birds is unknown. In this study, we infected nestling house sparrows with Buggy Creek virus and measured virological, pathological, growth, and digestive parameters following infection. Buggy Creek virus caused severe encephalitis in all infected nestlings, and the peak viral concentration in brain tissue was over 34 times greater than any other tissue. Growth, tissue development, and digestive function were all significantly impaired during BCRV infection. However, based on histopathological analysis performed, this impairment does not appear to be the result of direct tissue damage by the virus, but likely caused by encephalitis and neuronal invasion and impairment of the central nervous system. This is the first study to examine the course of alphavirus diseases in nestling birds and these results will improve our understanding of age-dependent infections of alphaviruses in vertebrate hosts.	[Fassbinder-Orth, Carol A.] Creighton Univ, Dept Biol, Omaha, NE 68178 USA; [Killpack, Tess L.] Salem State Univ, Dept Biol, Salem, MA USA; [Goto, Dylan S.; Rainwater, Ellecia L.] Creighton Univ, Sch Med, Omaha, NE USA; [Shearn-Bochsler, Valerie I.] USGS Natl Wildlife Hlth Ctr, Madison, WI USA	Creighton University; Massachusetts System of Public Higher Education; Salem State University; Creighton University; United States Department of the Interior; United States Geological Survey	Fassbinder-Orth, CA (corresponding author), Creighton Univ, Dept Biol, Omaha, NE 68178 USA.	carolfassbinder-orth@creighton.edu		Fassbinder-Orth, Carol/0000-0001-5286-5266	National Institute for General Medical Science (NIGMS), a component of the Institutes of Health (NIH) [5P20GM103427]; Creighton's Center for Undergraduate Research and Scholarship; Dr. George F. Haddix President's Faculty Research Fund; Creighton Center for Undergraduate Research and Scholarship	National Institute for General Medical Science (NIGMS), a component of the Institutes of Health (NIH); Creighton's Center for Undergraduate Research and Scholarship; Dr. George F. Haddix President's Faculty Research Fund; Creighton Center for Undergraduate Research and Scholarship	This publication was made possible by grants from the National Institute for General Medical Science (NIGMS) (5P20GM103427), a component of the Institutes of Health (NIH), and its contents are the sole responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH. Additional funding was provided by a research fellowship to CFO and MJW from Creighton's Center for Undergraduate Research and Scholarship, Dr. George F. Haddix President's Faculty Research Fund to CFO, and a summer research fellowship from Randolph Ferlic and the Creighton Center for Undergraduate Research and Scholarship to ELR and DSG.	Adelman JS, 2017, J AVIAN BIOL, V48, P519, DOI 10.1111/jav.01058; Adelman ZN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003462; Bize P, 2003, J ANIM ECOL, V72, P633, DOI 10.1046/j.1365-2656.2003.00734.x; Bosman DS, 2016, J FIELD ORNITHOL, V87, P391, DOI 10.1111/jofo.12177; Boughton RK, 2011, FUNCT ECOL, V25, P81, DOI 10.1111/j.1365-2435.2010.01817.x; CALISHER CH, 1994, CLIN MICROBIOL REV, V7, P89, DOI 10.1128/CMR.7.1.89-116.1994; Caviedes-Vidal E, 2001, PHYSIOL BIOCHEM ZOOL, V74, P769, DOI 10.1086/322966; Chin EH, 2009, P ROY SOC B-BIOL SCI, V276, P499, DOI 10.1098/rspb.2008.1294; Dahdul WM, 2003, AUK, V120, P1069, DOI 10.1642/0004-8038(2003)120[1069:EAAPGI]2.0.CO;2; DAHLQVIST A, 1984, SCAND J CLIN LAB INV, V44, P169, DOI 10.3109/00365518409161400; Deguchi T, 2004, AUK, V121, P452, DOI 10.1642/0004-8038(2004)121[0452:PFDAAM]2.0.CO;2; DELRIO CM, 1995, PHYSIOL ZOOL, V68, P490, DOI 10.1086/physzool.68.3.30163781; Demas GE, 2011, J ANIM ECOL, V80, P710, DOI 10.1111/j.1365-2656.2011.01813.x; Deresiewicz RL, 1997, NEW ENGL J MED, V336, P1867, DOI 10.1056/NEJM199706263362604; Ezenwa VO, 2010, AM NAT, V176, P613, DOI 10.1086/656496; Fassbinder-Orth CA, 2006, POULTRY SCI, V85, P1449, DOI 10.1093/ps/85.8.1449; Fassbinder-Orth CA, 2014, INTEGR COMP BIOL, V54, P396, DOI 10.1093/icb/icu023; Fassbinder-Orth CA, 2014, VECTOR-BORNE ZOONOT, V14, P439, DOI 10.1089/vbz.2013.1531; Fassbinder-Orth CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058045; Go YY, 2014, CLIN EXP VACCINE RES, V3, P58, DOI 10.7774/cevr.2014.3.1.58; Graham AL, 2005, ANNU REV ECOL EVOL S, V36, P373, DOI 10.1146/annurev.ecolsys.36.102003.152622; Hawley DM, 2011, FUNCT ECOL, V25, P48, DOI 10.1111/j.1365-2435.2010.01753.x; HAYES RO, 1977, J MED ENTOMOL, V14, P257, DOI 10.1093/jmedent/14.3.257; Huyvaert KP, 2008, J WILDLIFE DIS, V44, P331, DOI 10.7589/0090-3558-44.2.331; Iseri VJ, 2013, DEV COMP IMMUNOL, V40, P248, DOI 10.1016/j.dci.2013.02.005; Killpack TL, 2013, J AVIAN BIOL, V44, P513, DOI 10.1111/j.1600-048X.2013.00239.x; Killpack TL, 2012, J EXP BIOL, V215, P1806, DOI 10.1242/jeb.066316; Killpack TL, 2012, PLOS ONE, V7, DOI .0047294; Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010; LACOMBE D, 1994, CAN J ZOOL, V72, P2084, DOI 10.1139/z94-279; Lennette EH, 1944, J IMMUNOL, V49, P175; Lepczyk CA, 1998, PHYSIOL ZOOL, V71, P561, DOI 10.1086/515965; Lepczyk CA, 2000, AUK, V117, P164, DOI 10.1642/0004-8038(2000)117[0164:EOEFRO]2.0.CO;2; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3; Luers AJ, 2005, COMP FUNCT GENOM, V6, P217, DOI 10.1002/cfg.478; MCLEAN RG, 1995, J WILDLIFE DIS, V31, P502, DOI 10.7589/0090-3558-31.4.502; Miller DA, 2011, J AVIAN BIOL, V42, P151, DOI 10.1111/j.1600-048X.2010.05124.x; Miller DA, 2010, P ROY SOC B-BIOL SCI, V277, P1659, DOI 10.1098/rspb.2010.0022; MILLER MR, 1984, CONDOR, V86, P396, DOI 10.2307/1366814; Mireles AJ, 2005, POULTRY SCI, V84, P553, DOI 10.1093/ps/84.4.553; Moe B, 2004, J EXP BIOL, V207, P4067, DOI 10.1242/jeb.01226; Moore AT, 2007, J MED ENTOMOL, V44, P42, DOI 10.1603/0022-2585(2007)44[42:ECOBCV]2.0.CO;2; Moreno-Garcia M, 2013, B ENTOMOL RES, V103, P127, DOI 10.1017/S000748531200048X; Naef-Daenzer B, 2016, J FIELD ORNITHOL, V87, P227, DOI 10.1111/jofo.12157; National Research Council, 1981, NATL ACAD SCI; NEGRO JJ, 1994, CONDOR, V96, P749, DOI 10.2307/1369478; Nemeth NM, 2007, AM J TROP MED HYG, V76, P310, DOI 10.4269/ajtmh.2007.76.310; O'Brien VA, 2012, AUK, V129, P707, DOI 10.1525/auk.2012.12036; O'Brien VA, 2012, J WILDLIFE DIS, V48, P138, DOI 10.7589/0090-3558-48.1.138; O'Brien VA, 2010, AM J TROP MED HYG, V82, P937, DOI 10.4269/ajtmh.2010.09-0515; O'Brien VA, 2010, J WILDLIFE DIS, V46, P23, DOI 10.7589/0090-3558-46.1.23; Owen JP, 2010, TRENDS PARASITOL, V26, P530, DOI 10.1016/j.pt.2010.06.005; Passoni G, 2017, DIS MODEL MECH, V10, P847, DOI 10.1242/dmm.029231; Reid K, 2000, IBIS, V142, P188, DOI 10.1111/j.1474-919X.2000.tb04858.x; Reisen WK, 2006, VECTOR-BORNE ZOONOT, V6, P248, DOI 10.1089/vbz.2006.6.248; Reisen WK, 2003, J MED ENTOMOL, V40, P968, DOI 10.1603/0022-2585-40.6.968; Scott T.W., 1988, Miscellaneous Publications of the Entomological Society of America, P9; SCOTT TW, 1984, AM J TROP MED HYG, V33, P981, DOI 10.4269/ajtmh.1984.33.981; Searcy WA, 2004, J AVIAN BIOL, V35, P269, DOI 10.1111/j.0908-8857.2004.03247.x; Sears BF, 2011, TRENDS PARASITOL, V27, P382, DOI 10.1016/j.pt.2011.05.004; SEEL DC, 1969, IBIS, V111, P36, DOI 10.1111/j.1474-919X.1969.tb01603.x; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64; Swayne DE, 2001, EMERG INFECT DIS, V7, P751; Takenaka M, 2005, CAN J ZOOL, V83, P1476, DOI 10.1139/Z05-145; Tkachev S, 2011, NONFLAVIVIRUS ENCEPH, DOI 10.5772/24175; TUCKER PC, 1993, J VIROL, V67, P4605, DOI 10.1128/JVI.67.8.4605-4610.1993; Unnasch RS, 2006, ECOL MODEL, V192, P425, DOI 10.1016/j.ecolmodel.2005.07.011; Valero N, 2001, Invest Clin, V42, P161; Viney ME, 2005, TRENDS ECOL EVOL, V20, P665, DOI 10.1016/j.tree.2005.10.003	71	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195467	10.1371/journal.pone.0195467	http://dx.doi.org/10.1371/journal.pone.0195467			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624598	gold, Green Published, Green Submitted			2022-12-26	WOS:000429379600032
J	Islam, M; Ercumen, A; Ashraf, S; Rahman, M; Shoab, AK; Luby, SP; Unicomb, L				Islam, Mahfuza; Ercumen, Ayse; Ashraf, Sania; Rahman, Mahbubur; Shoab, Abul K.; Luby, Stephen P.; Unicomb, Leanne			Unsafe disposal of feces of children < 3 years among households with latrine access in rural Bangladesh: Association with household characteristics, fly presence and child diarrhea	PLOS ONE			English	Article							YOUNG-CHILDREN; BURKINA-FASO; HYGIENE; BEHAVIOR; RISK; MANAGEMENT; SANITATION; POTTIES	Background Young children frequently defecate in the living environment in low-income countries. Unsafe child feces disposal has been associated with risk of diarrhea. Additionally, reported practices can underestimate socially undesirable unhygienic behaviors. This analysis aimed to assess (1) the sensitivity of reported child feces disposal practices as an indicator for observed presence of human feces in the domestic environment, (2) household characteristics associated with reported unsafe feces disposal and (3) whether unsafe feces disposal is associated with fly presence and diarrhea among children <3 years. Methods We recorded caregiver-reported feces disposal practices for children <3 years; unsafe disposal was defined as feces put/rinsed into a drain, ditch, bush or garbage heap or left on the ground and safe disposal as feces put/rinsed into latrine or specific pit or buried. We conducted spot checks for human feces, counted flies in the compound and recorded caregiver-reported child diarrhea prevalence among 803 rural Bangladeshi households. We assessed associations using generalized estimating equations (GEE) and generalized linear models (GLM) with robust standard errors. Results Unsafe disposal of child feces was reported by 80% of households. Reported disposal practices had high sensitivity (91%) but low positive predictive value (15%) as an indicator of observed feces in the compound. Unsafe disposal was more common among households that reported daily adult open defecation (PR: 1.13, 1.02-1.24) and had children defecating in a nappy or on the ground versus in a potty (PR: 2.92, 1.98-4.32), and less common in households where adults reported always defecating in latrines (PR: 0.91, 0.84-0.98). The presence of observed human feces was similarly associated with these household characteristics. Reported unsafe feces disposal or observed human feces were not associated with fly detection or child diarrhea. Conclusion Despite access to on-site sanitation, unsafe child feces disposal was reported by the majority of households. However, this practices was not associated with diarrhea; suggesting that child feces may not be the most important fecal exposure. Before resources are invested to improve child feces management practices, studies should explore whether these contribute meaningfully to risk of enteric disease.	[Islam, Mahfuza; Rahman, Mahbubur; Shoab, Abul K.; Unicomb, Leanne] Int Ctr Diarrheal Dis Res Bangladesh, Enter & Resp Infect Program, Environm Intervent Unit, Infect Dis Div, Dhaka, Bangladesh; [Ercumen, Ayse] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Ashraf, Sania] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Luby, Stephen P.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA	International Centre for Diarrhoeal Disease Research (ICDDR); University of California System; University of California Berkeley; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Stanford University	Islam, M (corresponding author), Int Ctr Diarrheal Dis Res Bangladesh, Enter & Resp Infect Program, Environm Intervent Unit, Infect Dis Div, Dhaka, Bangladesh.	mi_sheuli@icddrb.org	Unicomb, Leanne Elizabeth/AAW-4900-2021	Unicomb, Leanne Elizabeth/0000-0002-7757-5641; Ashraf, Sania/0000-0001-7305-8922; Ercumen, Ayse/0000-0001-6002-1514	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The authors would like to thank the participants for donating their time, field team for collecting the data. We also thank all the collaborators engaged in the WASH Benefits study and Bill and Melinda Gates Foundation for funding.; This research protocol was funded by Bill and Melinda Gates Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2014, BANGLADESH NATL HYGI; ALAM N, 1989, INT J EPIDEMIOL, V18, P242, DOI 10.1093/ije/18.1.242; ALAM N, 1991, J DIARRHOEAL DIS RES, V9, P104; Arnold BF, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003476; AULIA H, 1994, J DIARRHOEAL DIS RES, V12, P42; Azage M, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0090-z; AZIZ KMA, 1990, T ROY SOC TROP MED H, V84, P433, DOI 10.1016/0035-9203(90)90353-G; BALTAZAR JC, 1989, INT J EPIDEMIOL, V18, pS16, DOI 10.1093/ije/18.Supplement_2.S16; Brown J, 2013, ARCH DIS CHILD, V98, P629, DOI 10.1136/archdischild-2011-301528; Cirillo VJ, 2006, PERSPECT BIOL MED, V49, P52, DOI 10.1353/pbm.2006.0005; CURTIS V, 1993, B WORLD HEALTH ORGAN, V71, P23; CURTIS V, 1995, SOC SCI MED, V41, P383, DOI 10.1016/0277-9536(94)00341-P; Ercumen A, 2017, TROP MED INT HEALTH, V22, P2, DOI 10.1111/tmi.12803; Freeman MC, 2016, T ROY SOC TROP MED H, V110, P386, DOI 10.1093/trstmh/trw043; George CM, 2016, J PEDIATR-US, V176, P43, DOI 10.1016/j.jpeds.2016.05.035; Gil A, 2004, 11 BUR GLOB HLTH; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; Hussain F, 2017, AM J TROP MED HYG, V97, P469, DOI 10.4269/ajtmh.15-0932; HUTTLY SRA, 1994, J DIARRHOEAL DIS RES, V12, P14; Jinadu MK, 2007, HEALTH EDUC J, V66, P222, DOI 10.1177/0017896907080120; Kwong LH, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060563; Majorin F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089551; MERTENS TE, 1992, INT J EPIDEMIOL, V21, P1157, DOI 10.1093/ije/21.6.1157; Miller-Petrie MK, 2016, AM J TROP MED HYG, V94, P456, DOI 10.4269/ajtmh.15-0423; Morita T, 2016, TROP MED INT HEALTH, V21, P1403, DOI 10.1111/tmi.12773; Mwambete K D, 2010, Tanzan J Health Res, V12, P47; Roy E, 2011, S AFR J CHILD HEALTH, V5, P78; Sultana R, 2013, TROP MED INT HEALTH, V18, P854, DOI 10.1111/tmi.12103; TRAORE E, 1994, J EPIDEMIOL COMMUN H, V48, P270, DOI 10.1136/jech.48.3.270; UNICEF/MICS/DHS, LAT AV MICS DHS SURV; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO/UNICEF, COR QUEST DRINK WAT; WHO/UNICEF Joint Water Supply and Sanitation Monitoring Programme, 2014, PROGR DRINK WAT SAN; Wilunda C, 2009, J HEALTH RES, V23, P17; World Health Organization, PROGR SAN DRINK WAT; Yeager BAC, 1999, SOC SCI MED, V49, P531, DOI 10.1016/S0277-9536(99)00119-7	36	29	29	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195218	10.1371/journal.pone.0195218	http://dx.doi.org/10.1371/journal.pone.0195218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621289	Green Published, gold, Green Submitted			2022-12-26	WOS:000429206800050
J	Jabbari, H; Wark, I; Montemagno, C				Jabbari, Hosna; Wark, Ian; Montemagno, Carlo			RNA secondary structure prediction with pseudoknots: Contribution of algorithm versus energy model	PLOS ONE			English	Article							PARTITION-FUNCTION	Motivation RNA is a biopolymer with various applications inside the cell and in biotechnology. Structure of an RNA molecule mainly determines its function and is essential to guide nanostructure design. Since experimental structure determination is time-consuming and expensive, accurate computational prediction of RNA structure is of great importance. Prediction of RNA secondary structure is relatively simpler than its tertiary structure and provides information about its tertiary structure, therefore, RNA secondary structure prediction has received attention in the past decades. Numerous methods with different folding approaches have been developed for RNA secondary structure prediction. While methods for prediction of RNA pseudoknot-free structure (structures with no crossing base pairs) have greatly improved in terms of their accuracy, methods for prediction of RNA pseudoknotted secondary structure (structures with crossing base pairs) still have room for improvement. A long-standing question for improving the prediction accuracy of RNA pseudoknotted secondary structure is whether to focus on the prediction algorithm or the underlying energy model, as there is a trade-off on computational cost of the prediction algorithm versus the generality of the method. Results The aim of this work is to argue when comparing different methods for RNA pseudoknotted structure prediction, the combination of algorithm and energy model should be considered and a method should not be considered superior or inferior to others if they do not use the same scoring model. We demonstrate that while the folding approach is important in structure prediction, it is not the only important factor in prediction accuracy of a given method as the underlying energy model is also as of great value. Therefore we encourage researchers to pay particular attention in comparing methods with different energy models.	[Jabbari, Hosna] Univ Vermont, Dept Comp Sci, Burlington, VT 05405 USA; [Wark, Ian] Univ Alberta, Dept Chem & Mat Engn, Ingenu Lab, Edmonton, AB, Canada; [Montemagno, Carlo] Southern Illinois Univ Carbondale, Carbondale, IL USA	University of Vermont; University of Alberta; Southern Illinois University System; Southern Illinois University	Jabbari, H (corresponding author), Univ Vermont, Dept Comp Sci, Burlington, VT 05405 USA.	jabbari@ualberta.ca		Jabbari, Hosna/0000-0002-7155-2297				Akutsu T, 2000, DISCRETE APPL MATH, V104, P45, DOI 10.1016/S0166-218X(00)00186-4; Andronescu M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-340; Andronescu MS, 2010, RNA, V16, P26, DOI 10.1261/rna.1689910; Bellaousov S, 2010, RNA, V16, P1870, DOI 10.1261/rna.2125310; Chen HL, 2009, J COMPUT BIOL, V16, P803, DOI 10.1089/cmb.2008.0219; Ding F, 2008, RNA, V14, P1164, DOI 10.1261/rna.894608; Dirks RM, 2003, J COMPUT CHEM, V24, P1664, DOI 10.1002/jcc.10296; Do CB, 2006, BIOINFORMATICS, V22, pE90, DOI 10.1093/bioinformatics/btl246; Hajiaghayi M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-22; Hesterberg T, 2005, BOOTSTRAP METHODS PE; Huang CH, 2005, BIOINFORMATICS, V21, P3501, DOI 10.1093/bioinformatics/bti568; Huang XL, 2007, NUCLEIC ACIDS RES, V35, P656, DOI 10.1093/nar/gkl943; Jabbari H, 2008, J COMPUT BIOL, V15, P139, DOI 10.1089/cmb.2007.0198; Jabbari H, 2015, ACS COMB SCI, V17, P535, DOI 10.1021/acscombsci.5b00079; Jabbari H, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-147; Lange SJ, 2012, NUCLEIC ACIDS RES, V40, P5215, DOI 10.1093/nar/gks181; Lu ZJ, 2009, RNA, V15, P1805, DOI 10.1261/rna.1643609; Lyngso RB, 2004, LECT NOTES COMPUT SC, V3142, P919; Lyngso RB, 2000, J COMPUT BIOL, V7, P409, DOI 10.1089/106652700750050862; Mathews DH, 2004, RNA, V10, P1178, DOI 10.1261/rna.7650904; Mathews DH, 2006, THEOR CHEM ACC THEOR, P1; NUSSINOV R, 1980, P NATL ACAD SCI-BIOL, V77, P6309, DOI 10.1073/pnas.77.11.6309; Puton T, 2013, NUCLEIC ACIDS RES, V41, P4307, DOI 10.1093/nar/gkt101; Rastegari B, 2007, J COMPUT BIOL, V14, P16, DOI 10.1089/cmb.2006.0108; Reeder J, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-104; Ren JH, 2005, RNA, V11, P1494, DOI 10.1261/rna.7284905; Rivas E, 1999, J MOL BIOL, V285, P2053, DOI 10.1006/jmbi.1998.2436; Ruan JH, 2004, BIOINFORMATICS, V20, P58, DOI 10.1093/bioinformatics/btg373; Sato K, 2011, BIOINFORMATICS, V27, pI85, DOI 10.1093/bioinformatics/btr215; Sperschneider J, 2008, RNA, V14, P630, DOI 10.1261/rna.968808; Sperschneider J, 2012, BIOINFORMATICS, V28, P3058, DOI 10.1093/bioinformatics/bts575; Sperschneider J, 2011, RNA, V17, P27, DOI 10.1261/rna.2394511; Sperschneider J, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq021; Team RDC, 2011, R PROJ STAT COMP, P309; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; Uemura Y, 1999, THEOR COMPUT SCI, V210, P277, DOI 10.1016/S0304-3975(98)00090-5; Varian H., 2005, Mathematica Journal, V9, P768; Weinberg Z, 2008, RNA, V14, P822, DOI 10.1261/rna.988608; Wilkinson KA, 2005, J AM CHEM SOC, V127, P4659, DOI 10.1021/ja0436749; Wu M, 1998, P NATL ACAD SCI USA, V95, P11555, DOI 10.1073/pnas.95.20.11555	40	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194583	10.1371/journal.pone.0194583	http://dx.doi.org/10.1371/journal.pone.0194583			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621250	Green Published, gold, Green Submitted			2022-12-26	WOS:000429206800022
J	Koike, Y; Sumida, I; Mizuno, H; Shiomi, H; Kurosu, K; Ota, S; Yoshioka, Y; Suzuki, O; Tamari, K; Ogawa, K				Koike, Yuhei; Sumida, Iori; Mizuno, Hirokazu; Shiomi, Hiroya; Kurosu, Keita; Ota, Seiichi; Yoshioka, Yasuo; Suzuki, Osamu; Tamari, Keisuke; Ogawa, Kazuhiko			Dosimetric impact of intra-fraction prostate motion under a tumour-tracking system in hypofractionated robotic radiosurgery	PLOS ONE			English	Article							RADIATION-THERAPY; SEMINAL-VESICLES; FIDUCIAL MARKERS; PATIENT MOTION; CINE-MRI; INTRAFRACTION; RADIOTHERAPY; LOCALIZATION; DEFORMATION; ACCURACY	For CyberKnife-mediated prostate cancer treatment, a tumour-tracking approach is applied to correct the target location by acquiring X-ray images of implanted fiducial markers intermittently. This study investigated the dosimetric impact of intra-fraction prostate motion during CyberKnife treatment. We retrospectively analyzed 16 patients treated using the CyberKnife (35 Gy delivered in five fractions). Using log files of recorded prostate motion, the intra-fraction prostate motion was simulated. We defined the worst-case intra-fraction prostate motion as the difference between pre- and post-deviation on log files and shifted structure sets according to the corresponding offsets for each beam. The dose-volume indices were calculated and compared with the original plan in terms of clinical target volume (CTV), planning target volume (CTV plus a 2-mm margin), rectum, bladder, and urethra. Prostate motions of >3, >5, and >10 mm were observed for 31.3, 9.1, and 0.5% of the 1929 timestamps, respectively. Relative differences between the simulated and original plans were mostly less than 1%. Although significant decreases were observed in D-50% and D-98% of the target, absolute dose differences were <0.1 Gy compared with the planned dose. The dosimetric impact of intra-fraction prostate motion may be small even with longer treatment durations, indicating that the tumour tracking using the CyberKnife could be a robust system for examining prostate motion.	[Koike, Yuhei; Sumida, Iori; Mizuno, Hirokazu; Shiomi, Hiroya; Kurosu, Keita; Yoshioka, Yasuo; Tamari, Keisuke; Ogawa, Kazuhiko] Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Suita, Osaka, Japan; [Shiomi, Hiroya] Miyakojima IGRT Clin, Miyakojima Ku, Osaka, Japan; [Kurosu, Keita; Ota, Seiichi] Osaka Univ Hosp, Dept Radiol, Suita, Osaka, Japan; [Suzuki, Osamu] Osaka Univ, Grad Sch Med, Dept Carbon Ion Radiotherapy, Suita, Osaka, Japan; [Yoshioka, Yasuo] Canc Inst Hosp, Japanese Fdn Canc Res, Dept Radiat Oncol, Koto Ku, Tokyo, Japan	Osaka University; Osaka University; Osaka University; Japanese Foundation for Cancer Research	Sumida, I (corresponding author), Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Suita, Osaka, Japan.	sumida@radonc.med.osaka-u.ac.jp	Koike, Yuhei/GQP-9918-2022	Koike, Yuhei/0000-0003-3963-4257; Sumida, Iori/0000-0001-7669-0325				[Anonymous], 2010, J ICRU, V10, P27, DOI 10.1093/jicru/ndq008; Baker M, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2533-5; Beltran C, 2008, INT J RADIAT ONCOL, V70, P289, DOI 10.1016/j.ijrobp.2007.08.040; Brenner DJ, 2002, INT J RADIAT ONCOL, V52, P6; Detti B, 2015, CANCER INVEST, V33, P329, DOI 10.3109/07357907.2015.1060063; Deurloo KEI, 2005, INT J RADIAT ONCOL, V61, P228, DOI 10.1016/j.ijrobp.2004.09.023; Ghilezan MJ, 2005, INT J RADIAT ONCOL, V62, P406, DOI 10.1016/j.ijrobp.2003.10.017; Gill S, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-174; Hoogeman MS, 2008, INT J RADIAT ONCOL, V70, P609, DOI 10.1016/j.ijrobp.2007.08.066; Inoue M, 2014, JPN J RADIOL, V32, P461, DOI 10.1007/s11604-014-0330-0; Iwata H, 2016, TECHNOL CANCER RES T, V15, P101, DOI 10.1177/1533034614563443; Kotte ANTJ, 2007, INT J RADIAT ONCOL, V69, P419, DOI 10.1016/j.ijrobp.2007.03.029; Langen KM, 2008, INT J RADIAT ONCOL, V71, P1084, DOI 10.1016/j.ijrobp.2007.11.054; Langen KM, 2003, INT J RADIAT ONCOL, V57, P635, DOI 10.1016/S0360-3016(03)00633-3; Langen KM, 2001, INT J RADIAT ONCOL, V50, P265, DOI 10.1016/S0360-3016(01)01453-5; Li HS, 2008, INT J RADIAT ONCOL, V71, P801, DOI 10.1016/j.ijrobp.2007.10.049; Mah D, 2002, INT J RADIAT ONCOL, V54, P568, DOI 10.1016/S0360-3016(02)03008-0; Malinowski K, 2012, MED PHYS, V39, P2042, DOI 10.1118/1.3676690; Muren LP, 2004, RADIOTHER ONCOL, V70, P11, DOI 10.1016/j.radonc.2003.11.013; Nichol AM, 2007, INT J RADIAT ONCOL, V67, P48, DOI 10.1016/j.ijrobp.2006.08.021; Oehler C, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0229-z; Ogino I, 2011, J RADIAT RES, V52, P199, DOI 10.1269/jrr.10126; Padhani AR, 1999, INT J RADIAT ONCOL, V44, P525, DOI 10.1016/S0360-3016(99)00040-1; Sheng Y, 2017, INT J RADIAT ONCOL, V98, P473, DOI 10.1016/j.ijrobp.2017.02.089; Shiomi H, 2000, Radiat Med, V18, P107; Smeenk RJ, 2012, INT J RADIAT ONCOL, V83, P661, DOI 10.1016/j.ijrobp.2011.07.028; Sumida I, 2016, J APPL CLIN MED PHYS, V17, P74, DOI 10.1120/jacmp.v17i2.5914; Suzuki Osamu, 2007, Radiat Med, V25, P31, DOI 10.1007/s11604-006-0092-4; van de Water S, 2014, INT J RADIAT ONCOL, V88, P1154, DOI 10.1016/j.ijrobp.2013.12.045; van der Wielen GJ, 2008, INT J RADIAT ONCOL, V72, P1604, DOI 10.1016/j.ijrobp.2008.07.023; Wang JZ, 2003, INT J RADIAT ONCOL, V55, P194, DOI 10.1016/S0360-3016(02)03828-2; Xie YQ, 2008, INT J RADIAT ONCOL, V72, P236, DOI 10.1016/j.ijrobp.2008.04.051; Yamazaki H, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-10	33	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195296	10.1371/journal.pone.0195296	http://dx.doi.org/10.1371/journal.pone.0195296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621319	gold, Green Published, Green Submitted			2022-12-26	WOS:000429206800056
J	Chassaing, B; Gewirtzl, AT				Chassaing, Benoit; Gewirtzl, Andrew T.			Mice harboring pathobiont-free microbiota do not develop intestinal inflammation that normally results from an innate immune deficiency	PLOS ONE			English	Article							ALTERED SCHAEDLER FLORA; GERM-FREE MICE; METABOLIC SYNDROME; GUT MICROBIOTA; RECEPTOR 5; TLR5-DEFICIENT MICE; COLITIS; COLONIZATION; DISEASE; SUSCEPTIBILITY	Background Inability to maintain a stable and beneficial microbiota is associated with chronic gut inflammation, which classically manifests as colitis but may more commonly exist as low-grade inflammation that promotes metabolic syndrome. Alterations in microbiota, and associated inflammation, can originate from dysfunction in host proteins that manage the microbiota, such as the flagellin receptor TLR5. That the complete absence of a microbiota (i.e. germ free conditions) eliminates all evidence of inflammation in TLR5-deficient mice demonstrates that this model of gut inflammation is microbiota-dependent. We hypothesize that such microbiota dependency reflects an inability to manage pathobionts, such as Adherent Invasive E. coli (AIEC). Herein, we examined the extent to which microbiota mismanagement and associated inflammation in TLR5-deficient mice would manifest in a limited and pathobiont-free microbiota. For this purpose, WT and TLR5-deficient mice were generated and maintained with the 8-member consortium of bacteria referred to as "Altered Schaedler Flora" (ASF). Such ASF animals were subsequently inoculated with AIEC reference strain LF82. Feces were assayed for bacterial loads, fecal lipopolysaccharide and flagellin loads, fecal inflammatory marker lipocalin-2 and microbiota composition. Results Relative to similarly maintained WT mice, mice lacking TLR5 (T5KO) did not display low-grade intestinal inflammation nor metabolic syndrome under ASF conditions. Concomitantly, the ASF microbial community was similar between WT and T5KO mice, while inoculation with AIEC strain LF82 resulted in alteration of the ASF community in T5KO mice compared to WT control animals. AIEC LF82 inoculation in ASF T5KO mice resulted in microbiota components having elevated levels of bioactive lipopolysaccharide and flagellin, a modest level of low-grade inflammation and increased adiposity. Conclusions In a limited-complexity pathobiont-free microbiota, loss of the flagellin receptor TLR5 does not impact microbiota composition nor its ability to promote inflammation. Addition of AIEC to this ecosystem perturbs microbiota composition, increases levels of lipopolysaccharide and flagellin, but only modestly promotes gut inflammation and adiposity, suggesting that the phenotypes previously associated with loss of this innate immune receptor require disruption of complex microbiota.	[Chassaing, Benoit; Gewirtzl, Andrew T.] Georgia State Univ, Ctr Inflammat Immun & Infect, Inst Biomed Sci, Atlanta, GA 30303 USA; [Chassaing, Benoit] Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Chassaing, B (corresponding author), Georgia State Univ, Ctr Inflammat Immun & Infect, Inst Biomed Sci, Atlanta, GA 30303 USA.; Chassaing, B (corresponding author), Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA.	bchassaing@gsu.edu			NIH [DK099071, DK083890]; Crohn's and Colitis Foundation of America (CCFA); Kenneth Rainin Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America (CCFA); Kenneth Rainin Foundation	This work was supported by NIH grant DK099071 (A.T.G.) and DK083890 (A.T.G.). B.C. is a recipient of the Career Development Award from the Crohns and Colitis Foundation of America (CCFA). B.C. is a recipient of the Innovator Award from Kenneth Rainin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand MW, 2015, ILAR J, V56, P169, DOI 10.1093/ilar/ilv012; Brugiroux S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.215; Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004; Carvalho FA, 2012, GUT, V61, P373, DOI 10.1136/gut.2011.240556; Chassaing B, 2017, GUT, V66, P1414, DOI 10.1136/gutjnl-2016-313099; Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232; Chassaing B, 2014, GASTROENTEROLOGY, V147, P1363, DOI 10.1053/j.gastro.2014.08.033; Chassaing B, 2014, GUT, V63, P1069, DOI 10.1136/gutjnl-2013-304909; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Chassaing B, 2011, GASTROENTEROLOGY, V140, P1720, DOI 10.1053/j.gastro.2011.01.054; Cho JH, 2011, GASTROENTEROLOGY, V140, P1704, DOI 10.1053/j.gastro.2011.02.046; Chow J, 2010, CELL HOST MICROBE, V7, P265, DOI 10.1016/j.chom.2010.03.004; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Everard A, 2013, BEST PRACT RES CL GA, V27, P73, DOI 10.1016/j.bpg.2013.03.007; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Gomes-Neta JC, 2016, EVALUATION NEW REAL; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Hecht G, 2014, LAB ANIM-UK, V48, P292, DOI 10.1177/0023677214544728; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Lu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep18379; Mirpuri J, 2013, GUT MICROBES, V5; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Norio E, 2010, ANAEROBE, V16, P311, DOI 10.1016/j.anaerobe.2009.10.006; Paik J, 2015, GUT MICROBES, V6, P255, DOI 10.1080/19490976.2015.1064576; Sarma-Rupavtarm RB, 2004, APPL ENVIRON MICROB, V70, P2791, DOI 10.1128/AEM.70.5.2791-2800.2004; Singh V, 2015, CELL METAB, V22, P983, DOI 10.1016/j.cmet.2015.09.028; Singh V, 2015, GUT MICROBES, V6, P279, DOI 10.1080/19490976.2015.1060390; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wannemuehler MJ, 2014, GENOME ANNOUNC, V2; Zechner EL, 2017, CURR OPIN MICROBIOL, V35, P64, DOI 10.1016/j.mib.2017.01.011	37	16	16	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195310	10.1371/journal.pone.0195310	http://dx.doi.org/10.1371/journal.pone.0195310			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617463	Green Published, gold, Green Submitted			2022-12-26	WOS:000429203800074
J	Rajendran, M; Sun, WN; Cornella, P; Nachbagauer, R; Wohlbold, TJ; Amanat, F; Kirkpatrick, E; Palese, P; Krammer, F				Rajendran, Madhusudan; Sun, Weina; Cornella, Phillip; Nachbagauer, Raffael; Wohlbold, Teddy John; Amanat, Fatima; Kirkpatrick, Ericka; Palese, Peter; Krammer, Florian			An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations	PLOS ONE			English	Article							SINGLE-RADIAL-IMMUNODIFFUSION; A VIRUS; NEUTRALIZING EPITOPE; ANTIBODY RECOGNITION; PANDEMIC H1N1; POTENCY; ASSAY; STABILITY; IMMUNITY; ANTIGEN	The standard method to quantify the hemagglutinin content of influenza virus vaccines is the single radial immunodiffusion assay. This assay primarily relies on polyclonal antibodies against the head domain of the influenza virus hemagglutinin, which is the main target antigen of influenza virus vaccines. Novel influenza virus vaccine candidates that redirect the immune response towards the evolutionary more conserved hemagglutinin stalk, including chimeric hemagglutinin and headless hemagglutinin constructs, are highly dependent on the structural integrity of the protein to present conformational epitopes for neutralizing antibodies. In this study, we describe a novel enzyme-linked immunosorbent assay that allows quantifying the amount of hemagglutinin with correctly folded stalk domains and which could be further developed into a potency assay for stalk-based influenza virus vaccines.	[Rajendran, Madhusudan; Sun, Weina; Cornella, Phillip; Nachbagauer, Raffael; Wohlbold, Teddy John; Amanat, Fatima; Kirkpatrick, Ericka; Palese, Peter; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Rajendran, Madhusudan; Cornella, Phillip; Wohlbold, Teddy John; Kirkpatrick, Ericka] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Palese, Peter] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Krammer, F (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.	florian.krammer@mssm.edu	Krammer, Florian/H-3237-2019; Nachbagauer, Raffael/H-7798-2019	Krammer, Florian/0000-0003-4121-776X; Nachbagauer, Raffael/0000-0001-5568-5420; Roubidoux, Ericka/0000-0001-8878-744X; Rajendran, Madhusudan/0000-0003-4451-9608	Centers of Influenza Virus Research and Surveillance (CEIRS) [HHSN272201400008C]; GlaxoSmithKline; Biomedical Advanced Research and Development Authority (BARDA) [HHS0100201500010C];  [P01 AI097092];  [U19 AI109946]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109946] Funding Source: NIH RePORTER	Centers of Influenza Virus Research and Surveillance (CEIRS); GlaxoSmithKline(GlaxoSmithKline); Biomedical Advanced Research and Development Authority (BARDA); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially funded by the Centers of Influenza Virus Research and Surveillance (CEIRS) contract HHSN272201400008C (Option 22), GlaxoSmithKline, the Biomedical Advanced Research and Development Authority (BARDA, HHS0100201500010C), P01 AI097092 and U19 AI109946. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen CJ, 2016, J VIROL; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Cotter CR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003831; Desbien AL, 2013, BIOTECHNIQUES, V54, P345, DOI 10.2144/000114041; Dinca Luminita, 1993, Viral Immunology, V6, P75, DOI 10.1089/vim.1993.6.75; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Duehr J, 2017, J VIROL, V91, DOI 10.1128/JVI.00652-17; Ekiert DC, 2012, CURR OPIN VIROL, V2, P134, DOI 10.1016/j.coviro.2012.02.005; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Epand RM, 2002, BIOCHEM J, V365, P841, DOI 10.1042/BJ20020290; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Hai R, 2012, J VIROL, V86, P5774, DOI 10.1128/JVI.00137-12; Heaton NS, 2013, J VIROL, V87, P8272, DOI 10.1128/JVI.00969-13; Hirst GK, 1942, J EXP MED, V75, P49, DOI 10.1084/jem.75.1.49; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Hong MS, 2013, J VIROL, V87, P12471, DOI 10.1128/JVI.01388-13; Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Krammer F, 2015, CELL HOST MICROBE, V18, P395, DOI 10.1016/j.chom.2015.10.003; Krammer F, 2014, J VIROL, V88, P3432, DOI 10.1128/JVI.03004-13; Krammer F, 2013, CURR OPIN VIROL, V3, P521, DOI 10.1016/j.coviro.2013.07.007; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; Krammer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043603; LAVER WG, 1969, VIROLOGY, V38, P105, DOI 10.1016/0042-6822(69)90132-9; Margine I, 2013, JOVE-J VIS EXP, DOI 10.3791/51112; Minor PD, 2015, VACCINES-BASEL, V3, P90, DOI 10.3390/vaccines3010090; Nachbagauer R, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0026-4; Nachbagauer R, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.15; Ohmit SE, 2011, J INFECT DIS, V204, P1879, DOI 10.1093/infdis/jir661; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Pavlovic B, 2016, J AOAC INT, V99, P396, DOI 10.5740/jaoacint.15-0201; SCHILD GC, 1975, B WORLD HEALTH ORGAN, V52, P223; SCHOLTISSEK C, 1985, VACCINE, V3, P215, DOI 10.1016/0264-410X(85)90109-4; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tan GS, 2012, J VIROL, V86, P6179, DOI 10.1128/JVI.00469-12; Thomson CA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00087; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wan HQ, 2013, J VIROL, V87, P9290, DOI 10.1128/JVI.01203-13; WILLIAMS MS, 1993, VET MICROBIOL, V37, P253, DOI 10.1016/0378-1135(93)90027-5; Wohlbold TJ, 2017, NAT MICROBIOL, V2, P1415, DOI 10.1038/s41564-017-0011-8; Wohlbold TJ, 2016, J VIROL, V90, P851, DOI 10.1128/JVI.02275-15; WOOD JM, 1977, J BIOL STAND, V5, P237, DOI 10.1016/S0092-1157(77)80008-5; Xu R, 2012, J VIROL, V86, P982, DOI 10.1128/JVI.06322-11; Yang H, 2014, J VIROL, V88, P4828, DOI 10.1128/JVI.02278-13; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927; Zhang W, 2010, PROTEIN CELL, V1, P459, DOI 10.1007/s13238-010-0059-1	47	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194830	10.1371/journal.pone.0194830	http://dx.doi.org/10.1371/journal.pone.0194830			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617394	gold, Green Submitted, Green Published			2022-12-26	WOS:000429203800050
J	de Lima, FF; Lescano, CH; Arrigo, JD; Cardoso, CAL; Coutinho, JP; Moslaves, ISB; Ximenes, TVD; Kadri, MCT; Webers, SS; Perdomo, RT; Kassuya, CAL; Vieira, MD; Sanjinez-Argandona, EJ				de Lima, Fernando Freitas; Lescano, Caroline Honaiser; Arrigo, Jucicleia da Silva; Lima Cardoso, Claudia Andrea; Coutinho, Janclei Pereira; Bonfa Moslaves, Iluska Senna; do Nascimento Ximenes, Thalita Vieira; Toffoli Kadri, Monica Cristina; Webers, Simone Schneider; Perdomo, Renata Trentin; Leite Kassuya, Candida Aparecida; Vieira, Maria do Carmo; Sanjinez-Argandona, Eliana Janet			Anti-inflammatory, antiproliferative and cytoprotective potential of the Attalea phalerata Mart. ex Spreng. pulp oil	PLOS ONE			English	Article							INDUCED PAW EDEMA; BETA-CAROTENE; INFLAMMATORY RESPONSE; PHENOLIC-COMPOUNDS; NITRIC-OXIDE; CARRAGEENAN; CYTOKINES; FRUITS; ASSAY; RATS	The anti-inflammatory, antiproliferative and cytoprotective activity of the Attalea phalerata Mart. ex Spreng pulp oil was evaluated by in vitro and in vivo methods. As for the chemical profile, the antioxidant activity was performed by spectrophotometry, and the profile of carotenoids and amino acids by chromatography. Our data demonstrated that A. phalerata oil has high carotenoid content, antioxidant activity and the presence of 5 essential amino acids. In the in vitro models of inflammation, the oil demonstrated the capacity to inhibit COX1 and COX2 enzymes, the production of nitric oxide and also induces macrophages to spreading. In the in vivo models of inflammation, the oil inhibited edema and leukocyte migration in the Wistar rats. In the in vitro model of antiproliferative and cytoprotective activity, the oil was shown inactive against the kidney carcinoma and prostate carcinoma lineage cells and with cytoprotective capacity in murine fibroblast cells, inhibiting the cytotoxic action of doxorubicin. Therefore, it is concluded that A. phalerata pulp oil has anti-inflammatory effects with nutraceutical properties potential due to the rich composition. Moreover, the oil also has cytoprotective activity probably because of its ability to inhibit the action of free radicals.	[de Lima, Fernando Freitas; Arrigo, Jucicleia da Silva; Leite Kassuya, Candida Aparecida] Fed Univ Grande Dourados, Fac Hlth Sci, Dourados, MS, Brazil; [Lescano, Caroline Honaiser] Univ Estadual Campinas, Fac Med Sci, Campinas, SP, Brazil; [Lima Cardoso, Claudia Andrea] Univ Estadual Mato Grosso do Sul, Course Chem, Dourados, MS, Brazil; [Coutinho, Janclei Pereira] Univ Estadual Campinas, Fac Food Engn, Campinas, SP, Brazil; [Bonfa Moslaves, Iluska Senna; do Nascimento Ximenes, Thalita Vieira; Toffoli Kadri, Monica Cristina; Webers, Simone Schneider; Perdomo, Renata Trentin] Univ Fed Mato Grosso do Sul, Ctr Biol & Hlth Sci, Campo Grande, MS, Brazil; [Vieira, Maria do Carmo] Fed Univ Grande Dourados, Fac Agr Sci, Dourados, MS, Brazil; [Sanjinez-Argandona, Eliana Janet] Fed Univ Grande Dourados, Fac Engn, Dourados, MS, Brazil	Universidade Federal da Grande Dourados; Universidade Estadual de Campinas; Universidade Estadual de Mato Grosso do Sul; Universidade Estadual de Campinas; Universidade Federal de Mato Grosso do Sul; Universidade Federal da Grande Dourados; Universidade Federal da Grande Dourados	de Lima, FF (corresponding author), Fed Univ Grande Dourados, Fac Hlth Sci, Dourados, MS, Brazil.	flfernando_@hotmail.com	de Lima, Fernando Freitas/E-6661-2017; Kassuya, Candida A. L./G-8329-2011; Argandoña, Eliana Janet EJSA Sanjinez/J-6524-2012; Kadri, Mônica/AAH-4495-2021; Toffoli-Kadri, Mônica C/D-4972-2014; Lescano, Caroline C.H.L Honaiser/I-2108-2017; Vieira, Maria do Carmo MCV/D-4860-2016; Cardoso, Claudia Andrea Lima/AAK-5578-2020	de Lima, Fernando Freitas/0000-0001-5889-8165; Argandoña, Eliana Janet EJSA Sanjinez/0000-0001-9377-8839; Kadri, Mônica/0000-0003-4160-4444; Toffoli-Kadri, Mônica C/0000-0003-4160-4444; Lescano, Caroline C.H.L Honaiser/0000-0003-4193-7361; Cardoso, Claudia Andrea Lima/0000-0002-4907-0056; Weber, Simone/0000-0002-4181-142X; Perdomo, Renata Trentin/0000-0003-2747-7039; Kassuya, Candida/0000-0002-8998-9219	Fundacao de Apoio ao Desenvolvimento do Ensino; Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Apoio ao Desenvolvimento do Ensino; Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	We thank the development agencies Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) (FFL), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (FFL) and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (FFL).	Balslev H, 1989, AAU REPORTS, P1; Batista J.S., 2010, Arq. Inst. Biol., V77, P441, DOI 10.1590/1808-1657v77p4412010; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Negrelle RRB, 2015, CIENC FLOREST, V25, P1061, DOI 10.5902/1980509820669; Calbet JAL, 2002, J NUTR, V132, P2174, DOI 10.1093/jn/132.8.2174; Carey AN, 2017, NUTR NEUROSCI, V20, P238, DOI [10.1080/1028415X.2015.1115213, 10.1080/1028415x.2015.1115213]; CASSATELLA MA, 1995, IMMUNOL TODAY, V16, P21, DOI 10.1016/0167-5699(95)80066-2; Choo J, 2010, AM J BOT, V97, pE105, DOI 10.3732/ajb.1000281; Cintra DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030571; da Silva NA, 2014, J AGR FOOD CHEM, V62, P5072, DOI 10.1021/jf501211p; De Lima FF, 2017, FOOD RES INT, V91, P11, DOI 10.1016/j.foodres.2016.11.019; de Lima FF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165258; Sousa AGD, 2011, FOOD RES INT, V44, P2319, DOI 10.1016/j.foodres.2011.02.013; DING AH, 1988, J IMMUNOL, V141, P2407; DIROSA M, 1971, J PATHOL, V104, P15, DOI 10.1002/path.1711040103; During A, 2004, ARCH BIOCHEM BIOPHYS, V430, P77, DOI 10.1016/j.abb.2004.03.024; Formagio ASN, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-14; Freshney R.I., 2005, CULTURE ANIMAL CELLS, P375, DOI 10.1002/0471747599.cac023; Galler KM, 2006, EUR J ORAL SCI, V114, P138, DOI 10.1111/j.1600-0722.2006.00327.x; Guay J, 2004, J BIOL CHEM, V279, P24866, DOI 10.1074/jbc.M403106200; dos Santos MDG, 2015, ANTIOXIDANTS-BASEL, V4, P591, DOI 10.3390/antiox4030591; Hadad N, 2012, FREE RADICAL BIO MED, V53, P1381, DOI 10.1016/j.freeradbiomed.2012.07.078; Haraguchi Fabiano Kenji, 2006, Rev. Nutr., V19, P479, DOI 10.1590/S1415-52732006000400007; Hiane Priscila Aiko, 2003, Food Sci. Technol, V23, P206; Itariu BK, 2012, AM J CLIN NUTR, V96, P1137, DOI 10.3945/ajcn.112.037432; Ivy JL, 2002, J APPL PHYSIOL, V93, P1337, DOI 10.1152/japplphysiol.00394.2002; Jantz MA, 2008, RESPIRATION, V75, P121, DOI 10.1159/000113629; Klein A, 2010, PHARMACEUTICALS, V3, P1084, DOI 10.3390/ph3041084; Kudo Y, 2002, BONE, V30, P712, DOI 10.1016/S8756-3282(02)00689-0; Kassuya CAL, 2009, J ETHNOPHARMACOL, V124, P369, DOI 10.1016/j.jep.2009.06.003; Lescano CH, 2015, J MED FOOD, V18, P656, DOI 10.1089/jmf.2014.0077; e Silva MCBE, 2014, FOOD SCI TECH-BRAZIL, V34, P55, DOI 10.1590/S0101-20612014000100008; Lin HW, 2012, FOOD CHEM, V134, P2169, DOI 10.1016/j.foodchem.2012.04.024; de Oliveira MLM, 2010, J ETHNOPHARMACOL, V129, P214, DOI 10.1016/j.jep.2010.03.014; MARCO GJ, 1968, J AM OIL CHEM SOC, V45, P594, DOI 10.1007/BF02668958; Moraes M, 1996, ECON BOT, V50, P423, DOI 10.1007/BF02866525; Morris Christopher J, 2003, Methods Mol Biol, V225, P115; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Othman A, 2016, J FUNCT FOODS, V21, P263, DOI 10.1016/j.jff.2015.12.014; Padhi EMT, 2017, J FUNCT FOODS, V38, P602, DOI 10.1016/j.jff.2016.11.006; Pereira DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088341; RABINOVITCH M, 1973, EXP CELL RES, V77, P323, DOI 10.1016/0014-4827(73)90584-3; Ribeiro JC, 2010, AVALIACAO POTENCIAL, DOI [10.3732/AJB.1000281, DOI 10.3732/AJB.1000281]; Rodriguez-Amaya DB., 1997, CAROTENOIDS FOOD PRE, P1; Rodriguez-Amaya DB, 2010, J FOOD COMPOS ANAL, V23, P726, DOI 10.1016/j.jfca.2010.03.008; RUSSO M, 1989, PARASITE IMMUNOL, V11, P385, DOI 10.1111/j.1365-3024.1989.tb00675.x; Sarada SKS, 2002, J ETHNOPHARMACOL, V79, P149, DOI 10.1016/S0378-8741(01)00360-9; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; SHAY JW, 1991, BIOCHIM BIOPHYS ACTA, V1072, P1, DOI 10.1016/0304-419X(91)90003-4; Silva CRM, 2001, REV NUTR, V14, P135, DOI DOI 10.1590/S1415-52732001000200007; Silva FRF, 2010, CARBOHYD POLYM, V79, P26, DOI 10.1016/j.carbpol.2009.07.010; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Skulas-Ray AC, 2015, PROSTAG OTH LIPID M, V116, P104, DOI 10.1016/j.prostaglandins.2015.02.001; Soontornchaiboon W, 2012, BIOL PHARM BULL, V35, P1137, DOI 10.1248/bpb.b12-00187; Stahl W, 2007, MOL BIOTECHNOL, V37, P26, DOI 10.1007/s12033-007-0051-z; Wink DA, 1998, CARCINOGENESIS, V19, P711, DOI 10.1093/carcin/19.5.711; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544; Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01; Yoshihisa Y, 2014, EXP DERMATOL, V23, P178, DOI 10.1111/exd.12347	59	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195678	10.1371/journal.pone.0195678	http://dx.doi.org/10.1371/journal.pone.0195678			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634766	Green Submitted, Green Published, gold			2022-12-26	WOS:000429522200047
J	Hacker, GM; Brown, RN; Fedorova, N; Girard, YA; Higley, M; Clueit, B; Lane, RS				Hacker, Gregory M.; Brown, Richard N.; Fedorova, Natalia; Girard, Yvette A.; Higley, Mark; Clueit, Bernadette; Lane, Robert S.			Spatial clustering of Borrelia burgdorferi sensu lato within populations of Allen's chipmunks and dusky-footed woodrats in northwestern California	PLOS ONE			English	Article							IXODES-PACIFICUS ACARI; MULTILOCUS SEQUENCE-ANALYSIS; LYME-DISEASE SPIROCHETE; BLACK-LEGGED TICK; NORTHERN CALIFORNIA; VECTOR COMPETENCE; SEASONAL ACTIVITY; SMALL MAMMALS; SP NOV.; DIVERSITY	The ecology of Lyme borreliosis is complex in northwestern California, with several potential reservoir hosts, tick vectors, and genospecies of Borrelia burgdorferisensu lato. The primary objective of this study was to determine the fine-scale spatial distribution of different genospecies in four rodent species, the California ground squirrel (Otospermophilus bee-cheyi), northern flying squirrel (Glaucomys sabrinus), dusky-footed woodrat (Neotoma fuscipes), and Allen's chipmunk (Neotamias senex). Rodents were live-trapped between June 2004 and May 2005 at the Hoopa Valley Tribal Reservation (HVTR) in Humboldt County, California. Ear-punch biopsies obtained from each rodent were tested by polymerase chain reaction (PCR) and sequencing analysis. The programs ArcGIS and SaTScan were used to examine the spatial distribution of genospecies. Multinomial log-linear models were used to model habitat and host-specific characteristics and their effect on the presence of each bor-relial genospecies. The Akaike information criterion (AICc) was used to compare models and determine model fit. Borrelia burgdorferisensu stricto was primarily associated with chipmunks and B. bissettiae largely with woodrats. The top model included the variables "host species", "month", and "elevation" (weight = 0.84). Spatial clustering of B. bissettiae was detected in the northwestern section of the HVTR, whereas B. burgdorferisensu stricto was clustered in the southeastern section. We conclude that the spatial distribution of these borreliae are driven at least in part by host species, time-of-year, and elevation.	[Hacker, Gregory M.; Brown, Richard N.; Clueit, Bernadette] Humboldt State Univ, Dept Nat Resources, Arcata, CA 95521 USA; [Fedorova, Natalia; Girard, Yvette A.; Lane, Robert S.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Higley, Mark] Hoopa Valley Tribal Reservat, Hoopa Tribal Forestry, Hoopa, CA USA; [Hacker, Gregory M.] Calif Dept Publ Hlth, Vector Borne Dis Sect, Elk Grove, CA 95624 USA	California State University System; California State Polytechnic University, Humboldt; University of California System; University of California Berkeley; California Department of Public Health	Hacker, GM (corresponding author), Humboldt State Univ, Dept Nat Resources, Arcata, CA 95521 USA.; Hacker, GM (corresponding author), Calif Dept Publ Hlth, Vector Borne Dis Sect, Elk Grove, CA 95624 USA.	Greg.Hacker@cdph.ca.gov		Higley, Mark/0000-0002-7722-3785	National Institutes of Health [AI22501]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by a National Institutes of Health grant AI22501 to Robert Lane. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Alekseev AN, 2000, J MED ENTOMOL, V37, P9, DOI 10.1603/0022-2585-37.1.9; Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Brown RN, 2006, J MED ENTOMOL, V43, P743, DOI 10.1603/0022-2585(2006)43[743:SMOBBS]2.0.CO;2; Brown RN, 1996, AM J TROP MED HYG, V54, P84, DOI 10.4269/ajtmh.1996.54.84; BROWN RN, 1992, SCIENCE, V256, P1439, DOI 10.1126/science.1604318; Bunikis J, 2004, J INFECT DIS, V189, P1515, DOI 10.1086/382594; BURGDORFER W, 1985, AM J TROP MED HYG, V34, P925, DOI 10.4269/ajtmh.1985.34.925; Burkot TR, 2001, AM J TROP MED HYG, V65, P293, DOI 10.4269/ajtmh.2001.65.293; Carraway L.N., 1991, Mammalian Species, P1; Casher L, 2002, EXP APPL ACAROL, V26, P127, DOI 10.1023/A:1020911306291; Clark KL, 2014, J MED MICROBIOL, V63, P674, DOI 10.1099/jmm.0.073122-0; Clark KL, 2013, INT J MED SCI, V10, P915, DOI 10.7150/ijms.6273; CLOVER JR, 1995, AM J TROP MED HYG, V53, P237, DOI 10.4269/ajtmh.1995.53.237; Dolan MC, 1997, J MED ENTOMOL, V34, P128, DOI 10.1093/jmedent/34.2.128; Eisen L, 2009, J VECTOR ECOL, V34, P81, DOI [10.1111/j.1948-7134.2009.00010.x, 10.3376/038.034.0110]; Eisen RJ, 2010, TICKS TICK-BORNE DIS, V1, P35, DOI 10.1016/j.ttbdis.2009.12.002; Eisen RJ, 2003, ENVIRON ENTOMOL, V32, P1010, DOI 10.1603/0046-225X-32.5.1010; Fedorova N, 2014, TICKS TICK-BORNE DIS, V5, P951, DOI 10.1016/j.ttbdis.2014.07.015; Foley JE, 2008, VECTOR-BORNE ZOONOT, V8, P49, DOI 10.1089/vbz.2007.0175; Furman D.P., 1984, Bulletin of the California Insect Survey, V25, P1; Gannon William L., 1995, Mammalian Species, V502, P1; Girard YA, 2011, J CLIN MICROBIOL, V49, P945, DOI 10.1128/JCM.01689-10; Hall E. R., 1981, MAMMALS N AM; Hamm KA, 1995, THESIS; Hughes KD., 2006, THESIS; Klenner W, 2009, FOREST ECOL MANAG, V257, P1078, DOI 10.1016/j.foreco.2008.11.012; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Lane RS, 2005, J MED ENTOMOL, V42, P388, DOI 10.1603/0022-2585(2005)042[0388:WGSRSA]2.0.CO;2; Lane RS, 2004, J MED ENTOMOL, V41, P239, DOI 10.1603/0022-2585-41.2.239; LANE RS, 1991, ANNU REV ENTOMOL, V36, P587, DOI 10.1146/annurev.en.36.010191.003103; Lane RS, 1999, J MED ENTOMOL, V36, P329, DOI 10.1093/jmedent/36.3.329; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Margos G, 2017, INT J SYST EVOL MICR, V67, P3872, DOI 10.1099/ijsem.0.002214; Margos G, 2016, INT J SYST EVOL MICR, V66, P1447, DOI 10.1099/ijsem.0.000897; Margos G, 2014, INT J SYST EVOL MICR, V64, P128, DOI 10.1099/ijs.0.054593-0; Margos G, 2010, TICKS TICK-BORNE DIS, V1, P151, DOI 10.1016/j.ttbdis.2010.09.002; Marsot M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055377; Mather TN, 1989, J EPIDEMIOL, P130; Mayer K.E., 1988, GUIDE WILDLIFE HABIT; O'hara KL, W J APPL FOREST, V11, P97; Peavey CA, 1997, EXP APPL ACAROL, V21, P569, DOI 10.1023/A:1018448416618; Postic D, 1998, J CLIN MICROBIOL, V36, P3497, DOI 10.1128/JCM.36.12.3497-3504.1998; POSTIC D, 1994, INT J SYST BACTERIOL, V44, P743, DOI 10.1099/00207713-44-4-743; Postic D, 2007, INT J MED MICROBIOL, V297, P263, DOI 10.1016/j.ijmm.2007.01.006; Pritt BS, 2016, LANCET INFECT DIS, V16, P556, DOI 10.1016/S1473-3099(15)00464-8; Roy AN, 2017, VECTOR-BORNE ZOONOT, V17, P735, DOI 10.1089/vbz.2017.2134; Rudenko N, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.11.009; Rudenko N, 2009, FEMS MICROBIOL LETT, V292, P274, DOI 10.1111/j.1574-6968.2009.01498.x; Rudenko N, 2011, TICKS TICK-BORNE DIS, V2, P123, DOI 10.1016/j.ttbdis.2011.04.002; Rudenko N, 2009, J CLIN MICROBIOL, V47, P3875, DOI 10.1128/JCM.01050-09; Rudenko N, 2009, J CLIN MICROBIOL, V47, P134, DOI 10.1128/JCM.01183-08; Salkeld DJ, 2008, AM J TROP MED HYG, V79, P535, DOI 10.4269/ajtmh.2008.79.535; Salkeld DJ, 2014, TICKS TICK-BORNE DIS, V5, P790, DOI 10.1016/j.ttbdis.2014.05.002; Salkeld DJ, 2010, ECOLOGY, V91, P293, DOI 10.1890/08-2106.1; Schwartz AM, 2017, SURVEILLANCE LYME DI; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; Sholty KE, 2015, THESIS; Slajchert T, 1997, J WILDLIFE DIS, V33, P40, DOI 10.7589/0090-3558-33.1.40; Swei A, 2011, J MED ENTOMOL, V48, P20, DOI 10.1603/ME10131; Swei A, 2015, TICKS TICK-BORNE DIS, V6, P414, DOI 10.1016/j.ttbdis.2015.03.011; Swei A, 2012, VECTOR-BORNE ZOONOT, V12, P623, DOI 10.1089/vbz.2011.0783; Swofford D., 1998, PAUP 4 0 PHYLOGENETI; Talleklint-Eisen L, 1999, J PARASITOL, V85, P824, DOI 10.2307/3285817; Talleklint-Eisen L, 2000, ENVIRON ENTOMOL, V29, P272, DOI 10.1603/0046-225X(2000)029[0272:SATVIT]2.0.CO;2; Urban NA, 2011, FOREST ECOL MANAG, V261, P353, DOI 10.1016/j.foreco.2010.10.015; Vredevoe LK, 2004, J MED ENTOMOL, V41, P736, DOI 10.1603/0022-2585-41.4.736; Waldien DL, 2006, J MAMMAL, V87, P454, DOI 10.1644/05-MAMM-A-136R1.1; Waters JR, 1998, J MAMMAL, V79, P1244, DOI 10.2307/1383015; Whitaker DA, 2008, THESIS	69	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195586	10.1371/journal.pone.0195586	http://dx.doi.org/10.1371/journal.pone.0195586			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634745	Green Submitted, Green Published, gold			2022-12-26	WOS:000429522200038
J	Hao, ZJ; Fu, DG; Ming, Y; Yang, JL; Huang, Q; Lin, WL; Zhang, H; Zhang, B; Zhou, AF; Hu, XJ; Yao, C; Dong, YP; Ring, HJZ; Ring, BZ				Hao, Zongjie; Fu, Denggang; Ming, Yang; Yang, Jinlong; Huang, Qi; Lin, Weilong; Zhang, Huan; Zhang, Bin; Zhou, Aifen; Hu, Xijiang; Yao, Cong; Dong, Yunping; Ring, Huijun Z.; Ring, Brian Z.			Large scale newborn deafness genetic screening of 142,417 neonates in Wuhan, China	PLOS ONE			English	Article							SYNDROMIC HEARING-LOSS; RIBOSOMAL-RNA GENE; VESTIBULAR AQUEDUCT; SLC26A4 MUTATIONS; GJB2 CONNEXIN-26; IMPAIRMENT; HETEROPLASMY; FREQUENCY; SPECTRUM; PROGRAM	Almost one third of the three million people in China suffering severe deafness are children, and 50% of these cases are believed to have genetic components to their etiology. Newborn hearing genetic screening can complement Universal Neonatal Hearing Screening for the diagnosis of congenital hearing loss as well as identifying children at risk for late-onset and progressive hearing impairment. The aim of this joint academic and Ministry of Health project was to prototype a cost effective newborn genetic screen in a community health setting on a city-wide level, and to ascertain the prevalence of variation at loci that have been associated with non-syndromic hearing loss. With the participation of 143 local hospitals in the city of Wuhan, China we screened 142,417 neonates born between May 2014 and Dec. 2015. The variants GJB2 c.235delC, SLC26A4 c.919-2A>G, and mitochondrial variants m.1555A>G and m.1494C>T were assayed using real time PCR. Newborns found to carry a variant were re-assayed by sequencing in duplicate. Within a subset of 707 newborns we assayed using real-time PCR and ARMS-PCR to compare cost, sensitivity and operating procedure. The most frequent hearing loss associated allele detected in this population was the 235deIC variant in GJB2 gene. In total, 4289 (3.01%) newborns were found to carry at least one allele of either GJB2 c.235delC, SLC26A4 c.919-2A>G or two assayed MT-RNR1 variants. There was complete accordance between the real-time PCR and the ARMS PCR, though the real-time PCR had a much lower failure rate. Real-time PCR had a lower cost and operating time than ARMS PCR. Ongoing collaboration with the participating hospitals will determine the specificity and sensitivity of the association of the variants with hearing loss at birth and arising in early childhood, allowing an estimation of the benefits of newborn hearing genetic screening in a large-scale community setting.	[Hao, Zongjie; Fu, Denggang; Ming, Yang; Yang, Jinlong; Huang, Qi; Lin, Weilong; Zhang, Huan; Ring, Huijun Z.; Ring, Brian Z.] Huazhong Univ Sci & Technol, Coll Life Sci, Inst Genom & Personalized Med, Wuhan, Hubei, Peoples R China; [Zhang, Bin; Zhou, Aifen; Hu, Xijiang; Yao, Cong] Wuhan Women & Children Hosp, Wuhan, Hubei, Peoples R China; [Dong, Yunping] Hlth & Family Planning Commiss Wuhan Municipal, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Ring, HJZ; Ring, BZ (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci, Inst Genom & Personalized Med, Wuhan, Hubei, Peoples R China.	hzring@gmail.com; bzring@hust.edu.cn	付, 刚/ACC-5964-2022	Fu, Denggang/0000-0001-7274-033X				Hernandez-Juarez AA, 2014, INT J PEDIATR OTORHI, V78, P2107, DOI 10.1016/j.ijporl.2014.09.016; Angeli S, 2012, ANAT REC, V295, P1812, DOI 10.1002/ar.22579; Bindu LH, 2008, INT J AUDIOL, V47, P702, DOI 10.1080/14992020802215862; Bitner-Glindzicz M, 2002, BRIT MED BULL, V63, P73, DOI 10.1093/bmb/63.1.73; Caijuan L, 2015, MATERN CHILD HLTH J, V30, P6007; Chen Y, 2015, CLIN GENET, V87, P467, DOI 10.1111/cge.12452; Choi SY, 2009, CLIN EXP OTORHINOLAR, V2, P44, DOI 10.3342/ceo.2009.2.1.44; Chu J., 2016, MATERN CHILD HLTH J, V31, P525; Svidnicki MCCM, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0232-8; Dai P, 2008, GENET MED, V10, P586, DOI [10.1097/GIM.0b013e31817d2ef1, 10.1097GIM.0b013e31817d2ef1]; del Castillo FJ, 2003, J MED GENET, V40, P632, DOI 10.1136/jmg.40.8.632; Du J., 2015, SHAN DONG YI YAO, V55, P17; Du W, 2013, INT J PEDIATR OTORHI, V77, P1670, DOI 10.1016/j.ijporl.2013.07.023; ElSchahawi M, 1997, NEUROLOGY, V48, P453, DOI 10.1212/WNL.48.2.453; Feng JZ., 2015, HE BEI YI KE XUE XUE, V36, P1271; Fortnum HM, 2001, BRIT MED J, V323, P536, DOI 10.1136/bmj.323.7312.536; Gao H, 2014, J NANTONG U MED SCI, P577; [韩冰 Han Bing], 2013, [中华耳科学杂志, Chinese Journal of Otology], V11, P380; Han B, 2013, INT J PEDIATR OTORHI, V77, P1440, DOI 10.1016/j.ijporl.2013.05.040; Han P, 2015, CHINESE J WOMEN CHIL, V6, P62; Hessel Franz, 2003, Ger Med Sci, V1, pDoc09; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; [胡书君 Hu Shujun], 2010, [听力学及言语疾病杂志, Journal of Audiology and Speech Pathology], V18, P222; Huang LH, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-97; Kezirian EJ, 2001, OTOLARYNG HEAD NECK, V124, P359, DOI 10.1067/mhn.2001.113945; Kim SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125416; Korres S, 2008, LARYNGOSCOPE, V118, P1253, DOI 10.1097/MLG.0b013e31816d726c; Lan Peiji, 2016, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V30, P150; Li SX, 2015, CLIN EXP OTORHINOLAR, V8, P211, DOI 10.3342/ceo.2015.8.3.211; [李晓泽 Li Xiaoze], 2015, [中华耳科学杂志, Chinese Journal of Otology], V13, P654; Li Z, 2014, J AUDIOLOGY SPEECH P; Lu JX, 2010, MITOCHONDRION, V10, P380, DOI 10.1016/j.mito.2010.01.007; Lu YJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002248; Lu JR, 2011, INT J PEDIATR OTORHI, V75, P1045, DOI 10.1016/j.ijporl.2011.05.022; Lyu Kangmo, 2014, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V31, P547, DOI 10.3760/cma.j.issn.1003-9406.2014.05.001; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Ou QS, 2011, CHINESE MED J-PEKING, V124, P3347, DOI 10.3760/cma.j.issn.0366-6999.2011.20.025; Pandya A, 2003, GENET MED, V5, P295, DOI 10.1097/01.GIM.0000078026.01140.68; Propst EJ, 2006, INT J PEDIATR OTORHI, V70, P435, DOI 10.1016/j.ijporl.2005.07.013; Pryor SP, 2005, J MED GENET, V42, P159, DOI 10.1136/jmg.2004.024208; Putcha GV, 2007, GENET MED, V9, P413, DOI 10.1097/GIM.0b013e3180a03276; Sarafraz M., 2011, DETERMINATION HEARIN; Schimmenti LA, 2008, GENET MED, V10, P517, DOI [10.1097/GIM.0b013e31817708fa, 10.1097GIM.0b013e31817708fa]; Schimmenti LA, 2011, GENET MED, V13, P1006, DOI 10.1097/GIM.0b013e318226fc2e; Sun Xuejing, 2015, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V32, P766, DOI 10.3760/cma.j.issn.1003-9406.2015.06.002; Tang Junxiang, 2015, SHANDONG MED J, P76; Tranebjaerg L, 2000, Ugeskr Laeger, V162, P3044; Tsukada K, 2015, ANN OTO RHINOL LARYN, V124, p61S, DOI 10.1177/0003489415575060; Uus K, 2006, J MED SCREEN, V13, P14, DOI 10.1258/096914106776179764; van der Ploeg CPB, 2012, INT J AUDIOL, V51, P584, DOI 10.3109/14992027.2012.684402; Wang QJ, 2007, CLIN GENET, V72, P245, DOI 10.1111/j.1399-0004.2007.00862.x; [王莹 Wang Ying], 2015, [听力学及言语疾病杂志, Journal of Audiology and Speech Pathology], V23, P248; Wu CC, 2017, GENET MED, V19, P6, DOI 10.1038/gim.2016.66; Wu J, 2015, J MED GENET, V52, P95, DOI 10.1136/jmedgenet-2014-102753; Xiangjun LI, 2017, J MED THEORY PRACTIC; Xin F, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-312; Yan B, BMC MED GENETICS, V11, P1; Yang T, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-85; Yao J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-136; Ye KX, 2014, P NATL ACAD SCI USA, V111, P10654, DOI 10.1073/pnas.1403521111; Yongjun P, 2015, CHINESE J BIRTH HLTH, P66; Yoshinaga-Itano C, 1998, AM ANN DEAF, V143, P380, DOI 10.1353/aad.2012.0151; Yoshinaga-Itano C, 1998, AM ANN DEAF, V143, P416, DOI 10.1353/aad.2012.0118; Yoshinaga-Itano C, 2003, MENT RETARD DEV D R, V9, P252, DOI 10.1002/mrdd.10088; Yu H, 2014, CHINESE J BIRTH HLTH, P34; Yu Hong, 2015, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V32, P335, DOI 10.3760/cma.j.issn.1003-9406.2015.03.007; Yuan YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037557; Yuan Y, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-79; Zhang J, 2013, CHIN MED ASS NAT OT; Zhang JQ, 2013, INT J PEDIATR OTORHI, V77, P1929, DOI 10.1016/j.ijporl.2013.08.038; Zhang ZW, 2012, INT J PEDIATR OTORHI, V76, P984, DOI 10.1016/j.ijporl.2012.03.016; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133; Zheng J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128691	73	15	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195740	10.1371/journal.pone.0195740	http://dx.doi.org/10.1371/journal.pone.0195740			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634755	Green Published, gold, Green Submitted			2022-12-26	WOS:000429522200053
J	Bafoil, M; Jemmat, A; Martinez, Y; Merbahi, N; Eichwald, O; Dunand, C; Yousfi, M				Bafoil, Maxime; Jemmat, Achraf; Martinez, Yves; Merbahi, Nofel; Eichwald, Olivier; Dunand, Christophe; Yousfi, Mohammed			Effects of low temperature plasmas and plasma activated waters on Arabidopsis thaliana germination and growth	PLOS ONE			English	Article							SEED-GERMINATION; AIR PLASMA	Two plasma devices at atmospheric pressure (air dielectric barrier discharge and helium plasma jet) have been used to study the early germination of Arabidopsis thaliana seeds during the first days. Then, plasma activated waters are used during the later stage of plant development and growth until 42 days. The effects on both testa and endospserm ruptures during the germination stage are significant in the case of air plasma due to its higher energy and efficiency of producing reactive oxygen species than the case of helium plasma. The latter has shown distinct effects only for testa rupture. Analysis of germination stimulations are based on specific stainings for reactive oxygen species production, peroxidase activity and also membrane permeability tests. Furthermore, scanning electron microscopy (SEM) has shown a smoother seed surface for air plasma treated seeds that can explain the plasma induced-germination. During the growth stage, plants were watered using 4 kinds of water (tap and deionized waters activated or not by the low temperature plasma jet). With regards to other water kinds, the characterization of the tap water has shown a larger conductivity, acidity and concentration of reactive nitrogen and oxygen species. Only the tap water activated by the plasma jet has shown a significant effect on the plant growth. This effect could be correlated to reactive nitrogen species such as nitrite/nitrate species present in plasma activated tap water.	[Bafoil, Maxime; Jemmat, Achraf; Merbahi, Nofel; Eichwald, Olivier; Yousfi, Mohammed] Univ Paul Sabatier, UMR CNRS 5213, LAPLACE, Toulouse, France; [Bafoil, Maxime; Jemmat, Achraf; Dunand, Christophe] Univ Toulouse, CNRS, UPS, Lab Rech Sci Vegetales, Castanet Tolosan, France; [Martinez, Yves] Federat Rech 3450, Plateforme Imagerie, Pole Biotechnol Vegetale, Castanet Tolosan, France; [Jemmat, Achraf] Rhein Westfal TH Aachen, Inst Bot & Mol Genet, Bioecon Sci Ctr, Aachen, Germany	Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; RWTH Aachen University	Yousfi, M (corresponding author), Univ Paul Sabatier, UMR CNRS 5213, LAPLACE, Toulouse, France.; Dunand, C (corresponding author), Univ Toulouse, CNRS, UPS, Lab Rech Sci Vegetales, Castanet Tolosan, France.	dunand@lrsv.ups-tlse.fr; yousfi@laplace.univ-tlse.fr	Dunand, Christophe/I-6424-2012	Dunand, Christophe/0000-0003-1637-4042	University Paul Sabatier Toulouse CNRS	University Paul Sabatier Toulouse CNRS	University Paul Sabatier Toulouse CNRS	Abramzon N, 2006, IEEE T PLASMA SCI, V34, P1304, DOI 10.1109/TPS.2006.877515; Bailly C, 2008, CR BIOL, V331, P806, DOI 10.1016/j.crvi.2008.07.022; Choudhury SR, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.23000, 10.4161/psb.23681]; De Giorgi J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005708; Dekkers BJW, 2013, PLANT PHYSIOL, V163, P205, DOI 10.1104/pp.113.223511; Dhayal M, 2006, VACUUM, V80, P499, DOI 10.1016/j.vacuum.2005.06.008; Dubinov AE, 2000, IEEE T PLASMA SCI, V28, P180, DOI 10.1109/27.842898; Dubinov AE, 2017, IEEE T PLASMA SCI, V45, P294, DOI 10.1109/TPS.2017.2649604; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Heinlin J, 2010, J DTSCH DERMATOL GES, V8, P968, DOI 10.1111/j.1610-0387.2010.07495.x; Jemmat A, 2015, EFFECTS 3 LOW TEMP P; Jiang JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097753; Krapivina S.A., 1994, U.S. Patent, Patent No. [5281315A, 5281315]; Lariguet P, 2013, PLANTA, V238, P381, DOI 10.1007/s00425-013-1901-5; Laroussi M, 2002, IEEE T PLASMA SCI, V30, P1409, DOI 10.1109/TPS.2002.804220; Leymarie J, 2012, PLANT CELL PHYSIOL, V53, P96, DOI 10.1093/pcp/pcr129; Marchal F, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/34/345202; Mildaziene V, 2016, BIOELECTROMAGNETICS, DOI 10.1002/bem.22003; Mittler R, 2017, TRENDS PLANT SCI, V22, P11, DOI 10.1016/j.tplants.2016.08.002; Molina I, 2008, PLANT J, V53, P437, DOI 10.1111/j.1365-313X.2007.03348.x; Muller K, 2006, PLANT CELL PHYSIOL, V47, P864, DOI 10.1093/pcp/pcj059; Ogawa Y, 2005, BIOTECHNOL BIOENG, V92, P865, DOI 10.1002/bit.20659; Passardi F, 2004, TRENDS PLANT SCI, V9, P534, DOI 10.1016/j.tplants.2004.09.002; Plewa JM, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/4/043027; Puac N, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4880360; Samouillan V, 2012, IEEE T PLASMA SCI, V40, P1688, DOI 10.1109/TPS.2012.2190303; Sardella E, 2008, PLASMA PROCESS POLYM, V5, P540, DOI 10.1002/ppap.200800005; Sarin NB., 2014, BIO-PROTOCOL, V4, DOI [10.21769/BioProtoc.1108, DOI 10.21769/BIOPROTOC.1108]; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Sivachandiran L, 2017, RSC ADV, V7, P1822, DOI 10.1039/c6ra24762h; Stolarik T, 2015, PLASMA CHEM PLASMA P, V35, P659, DOI 10.1007/s11090-015-9627-8; Villeger S, 2005, PLASMA PROCESS POLYM, V2, P709, DOI 10.1002/ppap.200500040; Vishwanath SJ, 2013, PLANT PHYSIOL, V163, P1118, DOI 10.1104/pp.113.224410; Volin JC, 2000, CROP SCI, V40, P1706, DOI 10.2135/cropsci2000.4061706x; Yousfi M, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/4/045003; Yousfi M, 2014, FUND CLIN PHARMACOL, V28, P123, DOI 10.1111/fcp.12018; Zerrouki A, 2016, PLASMA PROCESS POLYM, V13, P633, DOI 10.1002/ppap.201500144	37	54	55	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195512	10.1371/journal.pone.0195512	http://dx.doi.org/10.1371/journal.pone.0195512			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630641	Green Published, Green Submitted, gold			2022-12-26	WOS:000429505000053
J	Holm, M; Saraswat, M; Joenvaara, S; Ristimaki, A; Haglund, C; Renkonen, R				Holm, Matilda; Saraswat, Mayank; Joenvaara, Sakari; Ristimaki, Ari; Haglund, Caj; Renkonen, Risto			Colorectal cancer patients with different C reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics	PLOS ONE			English	Article							BINDING PROTEIN-2; COLON-CANCER; AMYLOID-A; PANCREATIC-CANCER; POOR-PROGNOSIS; BIOMARKER; INSULIN; ANTIGEN; IDENTIFICATION; CHOLESTEROL	Over 1.4 million people are diagnosed with colorectal cancer (CRC) each year, making it the third most common cancer in the world. Increased screening and therapeutic modalities including improved combination treatments have reduced CRC mortality, although incidence and mortality rates are still increasing in some areas. Serum-based biomarkers are mainly used for follow-up of cancer, and are ideal due to the ease and minimally invasive nature of sample collection. Unfortunately, CEA and other serum markers have too low sensitivity for screening and preoperative diagnostic purposes. Increasing interest is focused on the possible use of biomarkers for predicting treatment response and prognosis in cancer. In this study, we have performed mass spectrometry analysis (UPLC-UDMSE) of serum samples from 19 CRC patients. Increased levels of C-reactive protein (CRP), which occur during local inflammation and the presence of a systemic inflammatory response, have been linked to poor prognosis in CRC patients. We chose to analyze samples according to CRP values by dividing them into the categories CRP <30 and >30, and, separately, according to short and long 5-year survival. The aim was to discover differentially expressed proteins associated with poor prognosis and shorter survival. We quantified 256 proteins and performed detailed statistical analyses and pathway analysis. We discovered multiple proteins that are up- or downregulated in patients with CRP >30 as compared to CRP <30 and in patients with short as compared to long 5-year survival. Pathways that were enriched include LXR/RXR activation, FXR/RXR activation, complement and coagulation cascades and acute phase signaling response, with some of the proteins we identified having roles in these pathways. In this study, we have identified multiple proteins, of which a few have been previously identified as potential biomarkers, and others that have been identified as potential biomarkers for CRC for the first time, to the best of our knowledge. While these proteins still need to be validated in larger patient series, this pilot study will pave the way for future studies aiming to provide better biomarkers for patients with CRC.	[Holm, Matilda; Ristimaki, Ari] Univ Helsinki, Dept Pathol, Helsinki, Finland; [Holm, Matilda; Ristimaki, Ari; Haglund, Caj] Helsinki Univ Hosp, Helsinki, Finland; [Holm, Matilda; Haglund, Caj] Univ Helsinki, Dept Surg, Helsinki, Finland; [Holm, Matilda; Ristimaki, Ari] Univ Helsinki, Res Programs Unit, Genome Scale Biol Res Program, Helsinki, Finland; [Holm, Matilda; Haglund, Caj] Univ Helsinki, Translat Canc Biol Res Program, Res Programs Unit, Helsinki, Finland; [Saraswat, Mayank; Joenvaara, Sakari; Renkonen, Risto] Univ Helsinki, Haartman Inst, Transplantat Lab, Helsinki, Finland; [Saraswat, Mayank; Joenvaara, Sakari; Ristimaki, Ari; Haglund, Caj; Renkonen, Risto] Helsinki Univ Hosp, HUSLAB, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Holm, M (corresponding author), Univ Helsinki, Dept Pathol, Helsinki, Finland.; Holm, M (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.; Holm, M (corresponding author), Univ Helsinki, Dept Surg, Helsinki, Finland.; Holm, M (corresponding author), Univ Helsinki, Res Programs Unit, Genome Scale Biol Res Program, Helsinki, Finland.; Holm, M (corresponding author), Univ Helsinki, Translat Canc Biol Res Program, Res Programs Unit, Helsinki, Finland.	matilda.holm@helsinki.fi	Haglund, Caj/N-1240-2019; Saraswat, Mayank/F-2985-2015	Saraswat, Mayank/0000-0002-5021-8150	Sigrid Juselius Foundation; Finnish Cancer Foundation; Helsinki University Hospital; University of Helsinki	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Foundation; Helsinki University Hospital; University of Helsinki	CH and AR received funding in the form of grants from the Sigrid Juselius Foundation and the Finnish Cancer Foundation. CH and RR also received funding from Helsinki University Hospital and RR also received funding from the University of Helsinki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belting M, 2005, ARTERIOSCL THROM VAS, V25, P1545, DOI 10.1161/01.ATV.0000171155.05809.bf; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Blakesley RE, 2009, NEUROPSYCHOLOGY, V23, P255, DOI 10.1037/a0012850; Busund LT, 2005, J CLIN PATHOL, V58, P361, DOI 10.1136/jcp.2004.020834; Chan DC, 2007, ANN SURG ONCOL, V14, P84, DOI 10.1245/s10434-006-9091-z; Cho WCS, 2010, BRIT J CANCER, V102, P1731, DOI 10.1038/sj.bjc.6605700; Cho WCS, 2004, CLIN CANCER RES, V10, P43, DOI 10.1158/1078-0432.CCR-0413-3; Chuu CP, 2011, MED HYPOTHESES, V76, P697, DOI 10.1016/j.mehy.2011.01.037; Cocco E, 2010, CANCER-AM CANCER SOC, V116, P843, DOI 10.1002/cncr.24838; Dayon L., 2013, EUPA OPEN PROTEOM, V1, P8, DOI [10.1016/j.euprot.2013.08.001, DOI 10.1016/J.EUPROT.2013.08.001]; Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936; Di Luca A, 2015, DARU, V23, DOI 10.1186/s40199-015-0120-y; Duffy MJ, 2001, CLIN CHEM, V47, P624; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Flyvbjerg A, 1997, J CLIN ENDOCR METAB, V82, P2308, DOI 10.1210/jc.82.7.2308; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Glojnaric I, 2001, CLIN CHEM LAB MED, V39, P129, DOI 10.1515/CCLM.2001.022; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Inamura K., 2018, CANCERS BASEL, V10; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; KANETY H, 1993, J CLIN ENDOCR METAB, V77, P229, DOI 10.1210/jc.77.1.229; Kassam A, 2003, J BIOL CHEM, V278, P10028, DOI 10.1074/jbc.M208312200; Kersten C, 2013, ACTA ONCOL, V52, P1691, DOI 10.3109/0284186X.2013.835494; Khaidakov M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020277; Kim HJ, 2008, BMB REP, V41, P685, DOI 10.5483/BMBRep.2008.41.10.685; Kimura M, 2001, CANCER, V92, P2072, DOI 10.1002/1097-0142(20011015)92:8<2072::AID-CNCR1547>3.0.CO;2-P; Kocarnik JM, 2015, GASTROENTEROL REP, V3, P269, DOI 10.1093/gastro/gov046; Lin MS, 2012, HEPATO-GASTROENTEROL, V59, P1687, DOI 10.5754/hge12277; Liou JM, 2010, J CLIN ENDOCR METAB, V95, P1717, DOI 10.1210/jc.2009-2668; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; McArdle CS, 2002, BRIT J CANCER, V86, P331, DOI 10.1038/sj.bjc.6600120; Murthy S, 2002, J LIPID RES, V43, P1054, DOI 10.1194/jlr.M100358-JLR200; Nash GF, 2002, LANCET ONCOL, V3, P425, DOI 10.1016/S1470-2045(02)00789-1; Renehan AG, 2000, BRIT J CANCER, V83, P1344, DOI 10.1054/bjoc.2000.1462; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Saraswat M, 2017, CANCER MED-US, V6, P1738, DOI 10.1002/cam4.1107; Saraswat M, 2017, MOL CELL PROTEOMICS, V16, P57, DOI 10.1074/mcp.M116.061028; Serang O, 2012, J PROTEOME RES, V11, P5586, DOI 10.1021/pr300426s; SHEPHERD FA, 2009, J CLIN ONCOL S, V27; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Srinivas PR, 2001, LANCET ONCOL, V2, P698, DOI 10.1016/S1470-2045(01)00560-5; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Stewart B, 2014, WORLD CANC REPORT 20; Takano S, 2008, ONCOGENE, V27, P2810, DOI 10.1038/sj.onc.1210951; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; VANDUIJNHOVEN EM, 1993, HAEMOSTASIS, V23, P168; Ward DG, 2006, BRIT J CANCER, V94, P1898, DOI 10.1038/sj.bjc.6603188; Wroblewski MS, 2006, FEBS J, V273, P4707, DOI 10.1111/j.1742-4658.2006.05473.x; Zhang Feng, 2012, World J Biol Chem, V3, P167, DOI 10.4331/wjbc.v3.i8.167	51	23	23	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195354	10.1371/journal.pone.0195354	http://dx.doi.org/10.1371/journal.pone.0195354			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630649	Green Published, Green Submitted, gold			2022-12-26	WOS:000429505000041
J	Urrestarazu, J; Errea, P; Miranda, C; Santesteban, LG; Pina, A				Urrestarazu, Jorge; Errea, Pilar; Miranda, Carlos; Santesteban, Luis G.; Pina, Ana			Genetic diversity of Spanish Prunus domestica L. germplasm reveals a complex genetic structure underlying	PLOS ONE			English	Article							CHLOROPLAST DNA VARIATION; MICROSATELLITE MARKERS; PLUM GERMPLASM; PERSICA L.; PEACH; IDENTIFICATION; CULTIVARS; HYBRIDIZATION; AMPLIFICATION; MITOCHONDRIAL	European plum (Prunus domestica L.) is an ancient domesticated species cultivated in temperate areas worldwide whose genetic structure has been scarcely analyzed to date. In this study, a broad representation of Spanish European plum germplasm collected in Northeastern Spain and a representative set of reference cultivars were compared using nuclear and chloroplast markers. The number of alleles per locus detected with the SSR markers ranged from 8 to 39, with an average of 23.4 alleles, and 8 haplotypes were identified. Bayesian model-based clustering, minimum spanning networks, and the analysis of molecular variance showed the existence of a hierarchical structure. At the first level, two genetic groups were found, one containing 'Reine Claude' type reference cultivars altogether with ca. 25% of local genotypes, and a second one much more diverse. This latter group split in two groups, one containing most (ca. 70%) local genotypes and some old Spanish and French reference cultivars, whereas the other included 24 reference cultivars and only six local genotypes. A third partition level allowed a significant finer delineation into five groups. As a whole, the genetic structure of European plum from Northeastern Spain was shown to be complex and conditioned by a geographical proximity factor. This study not only contributes to genetic conservation and breeding for this species at the national level, but also supports the relevance of undertaking similar tasks of collection and characterization in other unexplored areas. Moreover, this kind of research could lead to future coordinated actions for the examination of the whole European plum diversity, to define conservation strategies, and could be used to better understand the genetic control of traits of horticultural interest through association mapping.	[Urrestarazu, Jorge; Errea, Pilar; Pina, Ana] Univ Zaragoza, Ctr Invest & Tecnol Agroalimentaria Aragon CITA, IA2, Unidad Hortofruticultura,CITA, Avda Montanana, Zaragoza, Spain; [Urrestarazu, Jorge; Miranda, Carlos; Santesteban, Luis G.] Univ Publ Navarra, Dept Prod Agr, Campus Arrosadia S-N, Pamplona, Spain	University of Zaragoza; Universidad Publica de Navarra	Pina, A (corresponding author), Univ Zaragoza, Ctr Invest & Tecnol Agroalimentaria Aragon CITA, IA2, Unidad Hortofruticultura,CITA, Avda Montanana, Zaragoza, Spain.	apina@aragon.es	Miranda, Carlos/B-4293-2010; Santesteban, Luis Gonzaga/B-2408-2009; Errea, Pilar/ABE-1635-2020	Miranda, Carlos/0000-0001-7217-0859; Santesteban, Luis Gonzaga/0000-0001-6924-6744; Errea, Pilar/0000-0002-2889-1728; Pina, Ana/0000-0002-4988-9467	Institute Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) [RF2009 -00015-00-00]; Research Group of Aragon, Spain [A12]	Institute Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)(Instituto de Investigacion Agropecuaria (INIA)); Research Group of Aragon, Spain	This research was supported by the grant RF2009-00015-00-00 from the Institute Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) and the Research Group A12 of Aragon, Spain.	Aranzana MJ, 2002, THEOR APPL GENET, V106, P321; BADENES ML, 1995, THEOR APPL GENET, V90, P1035, DOI 10.1007/BF00222918; Becher SA, 2000, THEOR APPL GENET, V101, P643, DOI 10.1007/s001220051526; Biswajit Das, 2011, International Journal of Biodiversity and Conservation, V3, P721; Bouhadida M, 2007, J AM SOC HORTIC SCI, V132, P670, DOI 10.21273/JASHS.132.5.670; Bourguiba H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-49; Breton C, 2008, PLANT SCI, V175, P524, DOI 10.1016/j.plantsci.2008.05.025; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; Cherry Watkins R., 1976, EVOLUTION CROP PLANT, P242; Cipriani G, 1999, THEOR APPL GENET, V99, P65, DOI 10.1007/s001220051209; Clark LV, 2011, MOL ECOL RESOUR, V11, P562, DOI 10.1111/j.1755-0998.2011.02985.x; Crane MB, 1952, GENETICS GARDEN PLAN, P301; Cullinan FP, 1937, USDA YB AGR, P605; De Riek J, 2007, CROP SCI, V47, P1964, DOI 10.2135/cropsci2006.04.0265; DEMESURE B, 1995, MOL ECOL, V4, P129, DOI 10.1111/j.1365-294X.1995.tb00201.x; Dirlewanger E, 2002, THEOR APPL GENET, V105, P127, DOI 10.1007/s00122-002-0867-7; Dufresne F, 2014, MOL ECOL, V23, P40, DOI 10.1111/mec.12581; DumolinLapegue S, 1997, MOL ECOL, V6, P393, DOI 10.1046/j.1365-294X.1997.00193.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; El Bakkali A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061265; Esselink GD, 2003, THEOR APPL GENET, V106, P277, DOI 10.1007/s00122-002-1122-y; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Faust M., 1999, Horticultural Reviews, V23, P179, DOI 10.1002/9780470650752.ch4; GarciaRuiz JM, 1996, LANDSCAPE ECOL, V11, P267, DOI 10.1007/BF02059854; Gharbi O, 2014, SCI HORTIC-AMSTERDAM, V169, P57, DOI 10.1016/j.scienta.2014.02.018; Han QX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135132; Hartmann HT, 2002, PRINCIPLES AND PRACT; Hedrich UP, 1911, PLUMS NEW YORK; Herrero J, 1964, CARTOGRAFIA FRUTALES, V5; Herrero J, 1971, PLUM CULTIVARS SPAIN, V11, P165; Hormaza JI, 2002, THEOR APPL GENET, V104, P321, DOI 10.1007/s001220100684; Horvath A, 2011, SCI HORTIC-AMSTERDAM, V129, P283, DOI 10.1016/j.scienta.2011.03.049; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Aranzana MJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-69; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Kazija DH, 2014, TREE GENET GENOMES, V10, P761, DOI 10.1007/s11295-014-0721-5; Lepais O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075029; Lespinasse J, 2005, GROWING FRUIT TREES; Leterme E, 2008, FRUITS RETROUVES PAT; Li XW, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-84; Liorzou M, 2016, J EXP BOT, V67, P4711, DOI 10.1093/jxb/erw269; Lv J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046919; Mariette S, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-77; Miranda C, 2010, J AM SOC HORTIC SCI, V135, P428, DOI 10.21273/JASHS.135.5.428; Mnejja M, 2004, MOL ECOL NOTES, V4, P163, DOI 10.1111/j.1471-8286.2004.00603.x; Mnejja M, 2010, TREE GENET GENOMES, V6, P689, DOI 10.1007/s11295-010-0284-z; Mohanty A, 2003, ANN BOT-LONDON, V92, P749, DOI 10.1093/aob/mcg198; Mudge K., 2009, Horticultural Reviews, V35, P437; Obbard DJ, 2006, HEREDITY, V97, P296, DOI 10.1038/sj.hdy.6800862; Palme AE, 2002, MOL ECOL, V11, P1769, DOI 10.1046/j.1365-294X.2002.01581.x; Panda S, 2003, PLANT BREEDING, V122, P92, DOI 10.1046/j.1439-0523.2003.00768.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pina A, 2014, SCI HORTIC-AMSTERDAM, V174, P1, DOI 10.1016/j.scienta.2014.04.037; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2016, R LANG ENV STAT COMP; Reales A, 2010, TREE GENET GENOMES, V6, P37, DOI 10.1007/s11295-009-0226-9; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rouger R, 2014, MOL ECOL, V23, P3158, DOI 10.1111/mec.12802; Sampson JF, 2012, BIOL J LINN SOC, V105, P218, DOI 10.1111/j.1095-8312.2011.01787.x; Sehic J, 2015, SCI HORTIC-AMSTERDAM, V190, P195, DOI 10.1016/j.scienta.2015.03.034; Sosinski B, 2000, THEOR APPL GENET, V101, P421, DOI 10.1007/s001220051499; Stock M, 2010, EVOLUTION, V64, P944, DOI 10.1111/j.1558-5646.2009.00876.x; Tabuenca M. C., 1991, Anales de la Estacion Experimental de Aula Dei, V20, P119; Tabuenca M.C., 1991, REINA CLAUDIA VERDE, V20, P153; Tabuenca MC, 1991, REINA CLAUDIA BAVAY, V20, P177; Tabuenca MC, 1991, REINA CLAUDIA OULLIN, V20, P165; Topp BL, 2012, HANDB PLANT BREED, V8, P571, DOI 10.1007/978-1-4419-0763-9_15; Urrestarazu J, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0818-0; Urrestarazu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138417; Urrestarazu J, 2012, TREE GENET GENOMES, V8, P1163, DOI 10.1007/s11295-012-0502-y; Vallejo-Marin M, 2013, HEREDITY, V110, P111, DOI 10.1038/hdy.2012.91; WATKINS R, 1981, OXFORD ENCY TREES WO, P196; Wunsch A, 2009, SCI HORTIC-AMSTERDAM, V120, P348, DOI 10.1016/j.scienta.2008.11.012; Zhang X, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00583; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	78	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195591	10.1371/journal.pone.0195591	http://dx.doi.org/10.1371/journal.pone.0195591			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630655	Green Published, gold, Green Submitted			2022-12-26	WOS:000429505000062
J	Gong, EJ; Lee, JY; Bae, SE; Park, YS; Choi, KD; Song, HJ; Lee, GH; Jung, HY; Jeong, WJ; Cheon, GJ; Yook, JH; Kim, BS				Gong, Eun Jeong; Lee, Ji Young; Bae, Suh Eun; Park, Young Soo; Choi, Kee Don; Song, Ho June; Lee, Gin Hyug; Jung, Hwoon-Yong; Jeong, Woo Jin; Cheon, Gab Jin; Yook, Jeong Hwan; Kim, Byung Sik			Characteristics of non-cardia gastric cancer with a high serum anti-Helicobacter pylori IgG titer and its association with diffuse-type histology	PLOS ONE			English	Article							PEPSINOGEN; INFECTION; CARCINOGENESIS; CLASSIFICATION; SUBTYPE; STOMACH; SMOKING; KOREA	Background Data on implications of a high positive titer of serum anti-Helicobacter pyloriantibody on gastric cancer (GC) is limited. This study aimed to investigate the characteristics of GC with a high serum anti-H. pylori IgG (Hp-IgG) titer, and its association with diffuse-type GC. Methods We analyzed clinical and histological characteristics of 917 non-cardia GC patients who underwent gastrectomy. H. pylori infection was determined serologically by measuring Hp-IgG titer with immunoassay. Seropositive patients were divided into three groups (low-positive, mid-positive, and high-positive) according to the Hp-IgG titer value. Tumors were classified according to the Lauren criteria as diffuse or intestinal types. Results The median age of the patients was 59.0 years, and 33.8% were female. The patents were grouped as follows: seronegative, 188 (20.5%); low-positive, 288 (31.4%); mid-positive, 290 (31.6%); and high-positive 151 (16.5%). The high-positive group was significantly younger (median age, 55.0 years), with a higher proportion of female (45.0%) and nonsmokers (58.9%). The proportion of diffuse-type GC increased in the order low-, mid-, and high-positive groups (p<0.001). In univariate analysis, the factors associated with diffuse type GC were younger age, female sex, non-smokers, and a high-positive Hp-IgG titer. Younger age, female sex, and non-smokers remained significant on multivariate analysis whereas the high-positive Hp-IgG titer showed only a tendency toward the association (p = 0.078). Conclusions Non-cardia GC patients with a high Hp-IgG titer have distinct clinicopathologic characteristics. A high-positive Hp-IgG titer should be interpreted together with patients' age, sex, and smoking status.	[Gong, Eun Jeong; Jeong, Woo Jin; Cheon, Gab Jin] Univ Ulsan, Gangneung Asan Hosp, Coll Med, Dept Internal Med, Kangnung, South Korea; [Lee, Ji Young; Bae, Suh Eun] Asan Med Ctr, Hlth Screening & Promot Ctr, Seoul, South Korea; [Park, Young Soo] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol, Seoul, South Korea; [Choi, Kee Don; Song, Ho June; Lee, Gin Hyug; Jung, Hwoon-Yong] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Yook, Jeong Hwan; Kim, Byung Sik] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea	University of Ulsan; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Song, HJ (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea.	hjsong@amc.seoul.kr		SONG, HO JUNE/0000-0002-3195-8794				[Anonymous], 2010, WHO CLASSIFICATION T; BIASCO G, 1993, J CLIN PATHOL, V46, P826, DOI 10.1136/jcp.46.9.826; Burucoa C, 2013, HELICOBACTER, V18, P169, DOI 10.1111/hel.12030; Chen YC, 2016, PATHOL ONCOL RES, V22, P197, DOI 10.1007/s12253-015-9996-6; Cho SJ, 2010, GUT LIVER, V4, P466, DOI 10.5009/gnl.2010.4.4.466; CORREA P, 1992, CANCER RES, V52, P6735; Edge SB, 2010, AJCC CANC STAGING MA, P117, DOI DOI 10.1007/978-0-387-88441-7; Hsu PI, 1997, J CLIN GASTROENTEROL, V25, P587, DOI 10.1097/00004836-199712000-00007; Inoue M, 1999, INT J CANCER, V81, P39; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kim HJ, 2016, GUT LIVER, V10, P212, DOI 10.5009/gnl14416; Kishikawa H, 2015, DIS MARKERS, V2015; Korea Ministry of Food and Drug Safety, 2000, SAF EFF IMM 1000 200; Kwak HW, 2014, J GASTROEN HEPATOL, V29, P1671, DOI 10.1111/jgh.12605; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee JY, 2017, GUT LIVER, V11, P807, DOI 10.5009/gnl17033; LEE WJ, 1995, BRIT J SURG, V82, P802, DOI 10.1002/bjs.1800820627; Miki Kazumasa, 2006, Gastric Cancer, V9, P245, DOI 10.1007/s10120-006-0397-0; Plebani M, 1996, AM J GASTROENTEROL, V91, P954; Sasazuki S, 2002, INT J CANCER, V101, P560, DOI 10.1002/ijc.10649; Tatemichi M, 2008, ACTA ONCOL, V47, P360, DOI 10.1080/02841860701843035; Tatemichi M, 2009, HELICOBACTER, V14, P231, DOI 10.1111/j.1523-5378.2009.00681.x; Tu HK, 2014, SCAND J GASTROENTERO, V49, P259, DOI 10.3109/00365521.2013.869352; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Waldum HL, 2016, THER ADV GASTROENTER, V9, P836, DOI 10.1177/1756283X16663395; Waldum HL, 2015, DIGEST DIS SCI, V60, P1522, DOI 10.1007/s10620-014-3468-9; Watabe H, 2005, GUT, V54, P764, DOI 10.1136/gut.2004.055400; Watanabe M, 2012, INT J CANCER, V131, P2632, DOI 10.1002/ijc.27514; Yoon H, 2011, HELICOBACTER, V16, P382, DOI 10.1111/j.1523-5378.2011.00859.x	29	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195264	10.1371/journal.pone.0195264	http://dx.doi.org/10.1371/journal.pone.0195264			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621300	Green Published, Green Submitted, gold			2022-12-26	WOS:000429206800053
J	Jang, SH; Yang, DK				Jang, Seung Hee; Yang, Dong Kwon			The combination of Cassia obtusifolia L. and Foeniculum vulgare M. exhibits a laxative effect on loperamide-induced constipation of rats	PLOS ONE			English	Article							OPIOID-INDUCED CONSTIPATION; MUSCARINIC RECEPTORS; ESSENTIAL OILS; SMOOTH-MUSCLE; FENNEL; ANTIOXIDANT; EXTRACT; SEEDS; CONSTITUENTS; SECRETION	Chronic constipation is a functional gastrointestinal disease that is detrimental to the quality of patient life. Cassia obtusifolia L. (CO) and Foeniculum vulgare M. (FV) are commonly used as medicinal foods in many countries. We aimed to examine the laxative effect and their underlying mechanism of CO and FV mixture on loperamide (lop)-induced constipated rats. To determine the laxative effects of these compounds, Sprague-Dawley rats were divided into six groups: the control, lop -induced constipated (2mg/kg), and three doses (100, 300, and 500mg/kg) of CO and FV mixture-, and Bisacodyl (bis, 3.3mg/kg)-treated groups. The mixture of CO and FV and bis were orally administered once a day for 4 weeks. For induction of constipation, the lop were treated with a dose of 2 mg/kg twice a day on the 3rd week after treatments of CO and FV extracts and bis. The results were revealed that the CO and FV mixture has the laxative effects more than those in CO and FV-alone treatments on constipated rats by determining the stool parameters, including stool number and weight. Indeed, stool parameters, such as, stool number, weight, and water contents and colonic peristalsis from the intestinal transit length and ratio were dramatically improved by CO and FV mixture treatment. Histological study also revealed that CO and FV mixture enhanced the thicknesses of mucosa and muscular layers of the colon in constipated rats. For their underlying mechanism, the mRNAs and proteins expression of muscarinic acetylcholine receptors (mAchR) M2 and M3 and their downstream signaling were preserved by CO and FV mixture treatment in constipated rats. Therefore, this study suggests that treatment with CO and FV mixture has beneficial effects against constipation. We further suggest that CO and FV mixture may be utilized as an alternative therapeutic strategy for constipation.	[Jang, Seung Hee] Res & Dev TEAZEN Inc, Anyang Si, Gyeonggi Do, South Korea; [Yang, Dong Kwon] Chonbuk Natl Univ, Coll Vet Med, Dept Vet Pharmacol & Toxicol, Iksan Si, Jeollabuk Do, South Korea	Jeonbuk National University	Yang, DK (corresponding author), Chonbuk Natl Univ, Coll Vet Med, Dept Vet Pharmacol & Toxicol, Iksan Si, Jeollabuk Do, South Korea.	dkyang0502@gmail.com			Ministry of Trade, Industry & Energy (MOTIE), Korea Institute for Advancement of Technology (KIAT) through the Encouragement Program for The Industries of Economic Cooperation Region; TEAZEN Inc.	Ministry of Trade, Industry & Energy (MOTIE), Korea Institute for Advancement of Technology (KIAT) through the Encouragement Program for The Industries of Economic Cooperation Region; TEAZEN Inc.	This research was supported by the Ministry of Trade, Industry & Energy (MOTIE), Korea Institute for Advancement of Technology (KIAT) through the Encouragement Program for The Industries of Economic Cooperation Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study. TEAZEN Inc. provided support in the form of salaries for author SHJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	ABDULGHANI AS, 1988, J ETHNOPHARMACOL, V24, P213, DOI 10.1016/0378-8741(88)90154-7; Al-Amoudi WM, 2017, SAUDI J BIOL SCI, V24, P915, DOI 10.1016/j.sjbs.2016.10.021; Al-Huniti N, 2017, CLIN PHARMACOL THER, V102, P741, DOI 10.1002/cpt.719; Arantes S, 2017, NAT PROD RES, V31, P2183, DOI 10.1080/14786419.2017.1278598; Badgujar SB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/842674; Castro J, 2013, GASTROENTEROLOGY, V145, P1334, DOI 10.1053/j.gastro.2013.08.017; Choi EM, 2004, FITOTERAPIA, V75, P557, DOI 10.1016/j.fitote.2004.05.005; Choi J, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/457620; Chokhavatia S, 2016, DRUG AGING, V33, P557, DOI 10.1007/s40266-016-0381-2; Cirillo C, 2015, PHYTOTHER RES, V29, P1488, DOI 10.1002/ptr.5410; Dadalioglu I, 2004, J AGR FOOD CHEM, V52, P8255, DOI 10.1021/jf049033e; Eglen RM, 2001, LIFE SCI, V68, P2573, DOI 10.1016/S0024-3205(01)01054-2; Ehlert FJ, 1999, LIFE SCI, V64, P387, DOI 10.1016/S0024-3205(98)00584-0; Fei GJ, 2010, J PHARMACOL EXP THER, V334, P333, DOI 10.1124/jpet.110.166116; Fukudo S, 2011, NEUROGASTROENT MOTIL, V23, P544, DOI 10.1111/j.1365-2982.2011.01668.x; Harada Y, 2017, J PHARMACOL EXP THER, V362, P78, DOI 10.1124/jpet.117.240630; Harrington AM, 2010, NEUROGASTROENT MOTIL, V22, P999, DOI 10.1111/j.1365-2982.2009.01456.x; Harrington AM, 2010, NEUROGASTROENT MOTIL, V22, pe1262; Hatano T, 1999, CHEM PHARM BULL, V47, P1121, DOI 10.1248/cpb.47.1121; Ip FCF, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1417-1; Jabri MA, 2017, BIOMED PHARMACOTHER, V89, P29, DOI 10.1016/j.biopha.2017.02.020; Jeon JR, 2010, J MED FOOD, V13, P950, DOI 10.1089/jmf.2009.1307; Johanson JF, 2007, ALIMENT PHARM THER, V25, P599, DOI 10.1111/j.1365-2036.2006.03238.x; Ju MS, 2010, FOOD CHEM TOXICOL, V48, P2037, DOI 10.1016/j.fct.2010.05.002; Kim JE, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-017-0576-y; Kim Ji Eun, 2016, Lab Anim Res, V32, P231, DOI 10.5625/lar.2016.32.4.231; Kim JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161144; Kim SJ, 2011, AM J CHINESE MED, V39, P565, DOI 10.1142/S0192415X11009032; KITANAKA S, 1986, YAKUGAKU ZASSHI, V106, P302, DOI 10.1248/yakushi1947.106.4_302; Kojima R, 2009, PHARMACOLOGY, V84, P227, DOI 10.1159/000236524; Kurniawan Indra, 2011, Acta Med Indones, V43, P195; Leung FW, 2007, DIGEST DIS SCI, V52, P313, DOI 10.1007/s10620-006-9298-7; McCallum IJD, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b831; Mohamad RH, 2011, J MED FOOD, V14, P986, DOI 10.1089/jmf.2008.0255; Parejo I, 2004, J AGR FOOD CHEM, V52, P3679, DOI 10.1021/jf030813h; Patil UK, 2004, J ETHNOPHARMACOL, V90, P249, DOI 10.1016/j.jep.2003.10.007; Pradeep K, 2007, CHEM-BIOL INTERACT, V167, P12, DOI 10.1016/j.cbi.2006.12.011; Ramkumar D, 2005, AM J GASTROENTEROL, V100, P936, DOI 10.1111/j.1572-0241.2005.40925.x; Sabiu S, 2016, PHARM BIOL, V54, P2901, DOI 10.1080/13880209.2016.1193885; Seo Y, 2017, FOOD RES INT, V97, P340, DOI 10.1016/j.foodres.2017.04.032; Song XD, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0668-6; Soylu S, 2007, J APPL MICROBIOL, V103, P1021, DOI 10.1111/j.1365-2672.2007.03310.x; Talley NJ, 1999, GUT, V45, P37; Tripathi VR, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-56; Walia R, 2009, CURR OPIN PEDIATR, V21, P661, DOI 10.1097/MOP.0b013e32832ff241; Wintola OA, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-95; Yang ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003348	47	12	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195624	10.1371/journal.pone.0195624	http://dx.doi.org/10.1371/journal.pone.0195624			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621360	Green Submitted, Green Published, gold			2022-12-26	WOS:000429206800109
J	Wang, J; Li, XY; Li, X; Wang, HH; Su, ZC; Wang, XJ; Zhang, HW				Wang, Jian; Li, Xinyu; Li, Xu; Wang, Huanhuan; Su, Zhencheng; Wang, Xiujuan; Zhang, Huiwen			Dynamic changes in microbial communities during the bioremediation of herbicide (chlorimuron-ethyl and atrazine) contaminated soils by combined degrading bacteria	PLOS ONE			English	Article							PHOSPHOLIPID FATTY-ACID; DEGRADATION; BIOMASS; BIOAUGMENTATION; FERTILIZATION; MANAGEMENT; PESTICIDE; IMPACTS; PLANT	Chlorimuron-ethyl and atrazine are two herbicides with long half-lives in soil; their long-term and excessive application has led to a series of environmental problems. In this study, the strains Chenggangzhangella methanolivorans CHL1 and Arthrobactersp. ART1 were combined and used for the remediation of chlorimuron-ethyl, atrazine and combined contaminated soils in a microcosm experiment. Changes in chlorimuron-ethyl and atrazine concentrations in soils were monitored, and variations in the soil microbial community were studied by phospholipid fatty acid (PLFA) analysis. The two inoculated degrading strains accelerated the degradation of chlorimuron-ethyl and atrazine in soil, especially in the combined contaminated soil. Addition of the two herbicides and their combination generally decreased the concentrations of total PLFAs, total bacterial PLFAs, Gram-negative and Gram-positive bacterial PLFAs and Shannon-Wiener indices, and changed microbial community composition, whilst stimulating fungal PLFA concentrations. In addition, the combined herbicide treatment had more impact on microbial biomass than the single herbicide treatments. Inoculation treatments significantly relieved the effects of herbicides on soil microbial biomass, diversity and community structure. This study demonstrated that strains CHL1 and ATR1 have the potential to remediate chlorimuron-ethyl, atrazine and combined contaminated soils, and provided valuable information for remediation of chlorimuron-ethyl, atrazine and combined contaminated soils in situ.	[Wang, Jian; Li, Xinyu; Li, Xu; Wang, Huanhuan; Su, Zhencheng; Wang, Xiujuan; Zhang, Huiwen] Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang, Liaoning, Peoples R China; [Wang, Jian; Wang, Huanhuan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, HW (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang, Liaoning, Peoples R China.	hwzhang@iae.ac.cn	li, xin/HHS-9461-2022; zhang, hui/GXH-6098-2022; Zhang, Hui/HHN-8494-2022; Li, Lambert LL/F-7146-2015		National Key R&D Program of China [2017YFD0800702]; National Natural Science Foundation of China [31670515]; Derivative Bank of Chinese Biological Resources [ZSYS-007]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Derivative Bank of Chinese Biological Resources	This work was supported by the National Key R&D Program of China (2017YFD0800702 to HZ), the National Natural Science Foundation of China (31670515 to HZ) and Derivative Bank of Chinese Biological Resources (ZSYS-007).	Acosta EJ, 2004, J AGR FOOD CHEM, V52, P545, DOI 10.1021/jf0349331; Aguilera P, 2009, CHEMOSPHERE, V77, P785, DOI 10.1016/j.chemosphere.2009.08.020; Fernandez LA, 2013, ANN MICROBIOL, V63, P207, DOI 10.1007/s13213-012-0463-2; ARMSTRONG DE, 1967, SOIL SCI SOC AM PRO, V31, P61, DOI 10.2136/sssaj1967.03615995003100010019x; Arthur EL, 2000, WATER AIR SOIL POLL, V119, P75, DOI 10.1023/A:1005165603963; Bach EM, 2010, SOIL BIOL BIOCHEM, V42, P2182, DOI 10.1016/j.soilbio.2010.08.014; Baluch HU, 2008, J ENV SCI HLTH B, V28, P127; Banks ML, 2014, APPL SOIL ECOL, V74, P12, DOI 10.1016/j.apsoil.2013.08.018; Bardgett RD, 1999, SOIL BIOL BIOCHEM, V31, P1021, DOI 10.1016/S0038-0717(99)00016-4; Bardgett RD, 1999, BIOL FERT SOILS, V29, P282, DOI 10.1007/s003740050554; Bohme L, 2005, AGR ECOSYST ENVIRON, V109, P141, DOI 10.1016/j.agee.2005.01.017; Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087; Burges A, 2015, CHEMOSPHERE, V120, P8, DOI 10.1016/j.chemosphere.2014.05.037; Byss M, 2008, CHEMOSPHERE, V73, P1518, DOI 10.1016/j.chemosphere.2008.07.030; Choudhury PP, 1996, J AGR FOOD CHEM, V44, P3379, DOI 10.1021/jf950556j; Cycon M, 2013, APPL SOIL ECOL, V66, P8, DOI 10.1016/j.apsoil.2013.01.014; dos Santos KC, 2014, ECOTOX ENVIRON SAFE, V100, P7, DOI 10.1016/j.ecoenv.2013.11.014; Drigo B, 2010, P NATL ACAD SCI USA, V107, P10938, DOI 10.1073/pnas.0912421107; Dua M, 2002, APPL MICROBIOL BIOT, V59, P143, DOI 10.1007/s00253-002-1024-6; FRANK R, 1985, B ENVIRON CONTAM TOX, V34, P541, DOI 10.1007/BF01609773; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; FROSTEGARD A, 1991, J MICROBIOL METH, V14, P151, DOI 10.1016/0167-7012(91)90018-L; Garcia-Orenes F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080522; Herrmann RF, 1997, MICROB ECOL, V33, P78, DOI 10.1007/s002489900010; Huang HL, 2009, SOIL BIOL BIOCHEM, V41, P726, DOI 10.1016/j.soilbio.2009.01.009; Hunter LD., 2006, REV HUMAN EXPOSURE E; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; Kaur A, 2005, CURR SCI INDIA, V89, P1103; Mahia J, 2011, BIOL FERT SOILS, V47, P577, DOI 10.1007/s00374-011-0569-x; Mcelroy JA, 2007, J EXPO SCI ENV EPID, V17, P207, DOI 10.1038/sj.jes.7500511; Monard C, 2008, SOIL BIOL BIOCHEM, V40, P2253, DOI 10.1016/j.soilbio.2008.04.022; NAIR DR, 1993, J ENVIRON ENG, V119, P842, DOI 10.1061/(ASCE)0733-9372(1993)119:5(842); OLSSON PA, 1995, MYCOL RES, V99, P623, DOI 10.1016/S0953-7562(09)80723-5; Papadakis EN, 2006, INT J ENVIRON AN CH, V86, P573, DOI 10.1080/03067310500249187; Ratcliff AW, 2006, APPL SOIL ECOL, V34, P114, DOI 10.1016/j.apsoil.2006.03.002; Seghers D, 2003, FEMS MICROBIOL ECOL, V46, P139, DOI 10.1016/S0168-6496(03)00205-8; Sharma S, 2012, FEMS MICROBIOL LETT, V337, P18, DOI 10.1111/1574-6968.12006; Silva E, 2004, ENVIRON SCI TECHNOL, V38, P632, DOI 10.1021/es0300822; Sullivan TP, 1998, CAN J FOREST RES, V28, P168, DOI 10.1139/cjfr-28-2-168; Tan HB, 2013, J HAZARD MATER, V260, P368, DOI 10.1016/j.jhazmat.2013.05.043; USEPA, 2004, CHLOR ETH HUM HLTH R; vanVeen JA, 1997, MICROBIOL MOL BIOL R, V61, P121, DOI 10.1128/.61.2.121-135.1997; VESTAL JR, 1989, BIOSCIENCE, V39, P535, DOI 10.2307/1310976; Wallsten S, 2005, PUBLIC PRIVATE DRINK; Wang MC, 2008, SOIL BIOL BIOCHEM, V40, P778, DOI 10.1016/j.soilbio.2007.10.012; Xiong MH, 2013, J HAZARD MATER, V252, P347, DOI 10.1016/j.jhazmat.2013.02.054; Yale RL, 2017, ENVIRON SCI POLLUT R, V24, P7359, DOI 10.1007/s11356-017-8377-y; Yang LQ, 2016, INT J SYST EVOL MICR, V66, P2825, DOI 10.1099/ijsem.0.001062; Yang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117943; Yang LQ, 2014, J HAZARD MATER, V274, P314, DOI 10.1016/j.jhazmat.2014.04.011; Ye GB, 2006, CHINESE J ANAL CHEM, V34, P1207, DOI 10.1016/S1872-2040(07)60001-2; Zhang XL, 2011, ENVIRON SCI POLLUT R, V18, P407, DOI 10.1007/s11356-010-0381-4	52	5	7	6	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194753	10.1371/journal.pone.0194753	http://dx.doi.org/10.1371/journal.pone.0194753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621247	Green Submitted, Green Published, gold			2022-12-26	WOS:000429206800026
J	Lopez-Espuela, F; Gonzalez-GiI, T; Amarilla-Donoso, J; Cordovilla-Guardia, S; Portilla-Cuenca, JC; Casado-Naranjo, I				Lopez-Espuela, Fidel; Gonzalez-Gi, Teresa, I; Amarilla-Donoso, Javier; Cordovilla-Guardia, Sergio; Carlos Portilla-Cuenca, Juan; Casado-Naranjo, Ignacio			Critical points in the experience of spouse caregivers of patients who have suffered a stroke. A phenomenological interpretive study	PLOS ONE			English	Article							QUALITY-OF-LIFE; FAMILY CAREGIVERS; EVERYDAY LIFE; 1ST YEAR; SURVIVORS; CARE; OUTCOMES; PARTNER; REHABILITATION; TRANSITIONS	Aims To explore and document the experiences and values of spouse caregivers of stroke survivors. To gain more in-depth knowledge of how the act of caring and the adaption process affects caregiving spouses. Materials and methods Phenomenological, qualitative study. This study included spouses of stroke survivors who also served as primary caregivers. Individual, semi-structured, in-depth interviews were conducted, transcribed, and analysed using a thematic content analysis as proposed by Giorgi. Data was analysed and managed using Atlas-ti (version 7.0). This study was approved by our institution's Complejo Hospitalario de Caceres Ethics and Research Committee. Results Spouse caregivers of stroke survivors undergo a process of disruption in their private lives and relationships, marked by their caregiving duties. The experiences of spouses caring for stroke survivors is condensed into topics and subtopics: "Caregiving and that's all" summarizes the sense of having no life horizons and also caregiver impossibility of moving away from caring role. Otherwise, "Breaking the couple's life together" enlightens the further consequences of stroke in couples shared live biography, which needs to be understood and rebuilt. Finally, "Going through the (non) loss alone" alludes to how spouses reinterpret meaning of loss, which is not appreciated by others and that refers to the balance between stroke survival and any acquired global disability. Conclusions A comprehensive approach to the couple (family), from a psycho-socio-emotional and relational perspective, is essential for ensuring adequate quality of life for people who suffered a stroke as well as their caregivers. Spouses-caregivers must be considered as individuals living a transition process due to their unexpected disrupting change, which nurses should address through a comprehensive and integrated approach focused on transition care. Care resources must be adapted to the interpretation that the spouses have of their caregiving role and their relationship with the different components of the caregiving process.	[Lopez-Espuela, Fidel; Cordovilla-Guardia, Sergio] Univ Extremadura, Dept Nursing, Fac Enfermeria & Terapia Ocupac, Caceres, Spain; [Gonzalez-Gi, Teresa, I] Univ Autonoma Madrid, Nursing Sect Dept, Fac Med, Madrid, Spain; [Amarilla-Donoso, Javier] Hosp Campo Aranuelo, Dept Nursing, Navalmoral De La Mata, Caceres, Spain; [Carlos Portilla-Cuenca, Juan; Casado-Naranjo, Ignacio] Hosp San Pedro Alcantara, Stroke Unit, Caceres, Spain	Universidad de Extremadura; Autonomous University of Madrid	Lopez-Espuela, F (corresponding author), Univ Extremadura, Dept Nursing, Fac Enfermeria & Terapia Ocupac, Caceres, Spain.	fidel.lopez.es@gmail.com	Espuela, Fidel Lopez/R-1843-2017; Cuenca, Juan Carlos Portilla/R-6151-2019; Sergio, Cordovilla-Guardia/I-7268-2019	Espuela, Fidel Lopez/0000-0002-7509-1192; Cuenca, Juan Carlos Portilla/0000-0002-0796-0990; Sergio, Cordovilla-Guardia/0000-0001-7651-5017	Institute Carlos III: Grants for investigation of the Health Research [PI11/001756]	Institute Carlos III: Grants for investigation of the Health Research	This work was funded by Institute Carlos III: Grants for investigation of the Health Research of 2011 (PI11/001756). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backstrom B, 2010, NURS INQ, V17, P257, DOI 10.1111/j.1440-1800.2010.00490.x; Backstrom B, 2009, INT J NURS STUD, V46, P1475, DOI 10.1016/j.ijnurstu.2009.04.009; Bakas T, 2014, STROKE, V45, P2836, DOI 10.1161/STR.0000000000000033; Bergstrom AL, 2015, J REHABIL MED, V47, P508, DOI 10.2340/16501977-1964; Bridges J, 2010, INT J NURS STUD, V47, P89, DOI 10.1016/j.ijnurstu.2009.09.009; Bulley C, 2010, DISABIL REHABIL, V32, P1406, DOI 10.3109/09638280903531238; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Charmaz K, 1983, Sociol Health Illn, V5, P168, DOI 10.1111/1467-9566.ep10491512; Cheung J, 2004, J ADV NURS, V47, P475, DOI 10.1111/j.1365-2648.2004.03126.x; Coombs Ursula Eileen, 2007, J Neurosci Nurs, V39, P112; de la Cuesta-Benjumea C, 2011, ENFERM CLIN, V21, P163, DOI 10.1016/j.enfcli.2011.02.005; Eriksson M, 2006, J CLIN NURS, V15, P324, DOI 10.1111/j.1365-2702.2006.01290.x; Fonarow GC, 2014, STROKE, V45, P1589, DOI 10.1161/STR.0000000000000014; Forster A, 2013, LANCET, V382, P2069, DOI 10.1016/S0140-6736(13)61603-7; Gillespie David, 2011, Nurs Stand, V26, P39; Giorgi A, 2000, SCAND J CARING SCI, V14, P3, DOI 10.1111/j.1471-6712.2000.tb00554.x; Gosman-Hedstrom G, 2012, SCAND J CARING SCI, V26, P587, DOI 10.1111/j.1471-6712.2012.00975.x; Green TL, 2010, J STROKE CEREBROVASC, V19, P10, DOI 10.1016/j.jstrokecerebrovasdis.2009.02.005; Guba EG, 1981, EFFECTIVE EVALUATION, P1; Hunt D, 2004, DISABIL REHABIL, V26, P1000, DOI 10.1080/09638280410001702423; Jenkins C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006384; Kitson AL, 2013, INT J NURS STUD, V50, P392, DOI 10.1016/j.ijnurstu.2012.09.017; KRAMER BJ, 1993, FAM RELAT, V42, P367, DOI 10.2307/585336; Kruithof WJ, 2012, J STROKE CEREBROVASC, V21, P801, DOI 10.1016/j.jstrokecerebrovasdis.2011.04.011; Kvale S., 2009, INTERVIEWS LEARNING; Larson J, 2008, INT J NURS STUD, V45, P257, DOI 10.1016/j.ijnurstu.2006.08.021; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Levine C, 2011, AM J NURS, V111, P47, DOI 10.1097/01.NAJ.0000406420.35084.a1; Levine C, 2010, HEALTH AFFAIR, V29, P116, DOI 10.1377/hlthaff.2009.0520; Luker J, 2017, ARCH PHYS MED REHAB, V98, P1852, DOI 10.1016/j.apmr.2017.02.024; Lutz BJ, 2010, REHABIL NURS, V35, P152, DOI 10.1002/j.2048-7940.2010.tb00041.x; MacDougall C, 2001, QUAL HEALTH RES, V11, P117, DOI 10.1177/104973201129118975; MAHONEY F I, 1965, Md State Med J, V14, P61; McPherson CJ, 2010, REHABIL PSYCHOL, V55, P194, DOI 10.1037/a0019359; Meleis AI, 2000, ADV NURS SCI, V23, P12, DOI 10.1097/00012272-200009000-00006; MELEIS AI, 1994, NURS OUTLOOK, V42, P255, DOI 10.1016/0029-6554(94)90045-0; Messias DKH, 1995, FAM SYSTEMS MED, V3, P367; Morrissey MB, 2015, GERONTOLOGIST, V55, P245, DOI 10.1093/geront/gnu178; MUNHALL PL, 2001, NURSING RES; National Alliance for Caregiving AARP, 2015, CAR US 2015 EX SUMM; Persson J, 2015, STROKE, V46, P2584, DOI 10.1161/STROKEAHA.115.009791; Quinn K, 2014, DISABIL REHABIL, V36, P185, DOI 10.3109/09638288.2013.783630; Reinhard SC, HOME ALONE FAMILY CA; Saban KL, 2012, J NEUROSCI NURS, V44, P2, DOI 10.1097/JNN.0b013e31823ae4f9; Satink T, 2017, DISABIL REHABIL, V23, P1; Schumacher KL, 1996, RES NURS HEALTH, V19, P261, DOI 10.1002/(SICI)1098-240X(199608)19:4<261::AID-NUR1>3.0.CO;2-G; Skolarus LE, 2014, STROKE, V45, P224, DOI 10.1161/STROKEAHA.113.002874; Smith J, 2009, CLIN REHABIL, V23, P195, DOI 10.1177/0269215508092820; Strauss A., 2016, BASES INVESTIGACION; Tseng CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131911; Van Durme T, 2012, INT J NURS STUD, V49, P490, DOI 10.1016/j.ijnurstu.2011.10.011; Visser-Meily A, 2008, PATIENT EDUC COUNS, V73, P153, DOI 10.1016/j.pec.2008.03.011; Wright L, 2012, NURSES FAMILIES GUID; Young ME, 2014, DISABIL REHABIL, V36, P1892, DOI 10.3109/09638288.2014.881565; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	55	18	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195190	10.1371/journal.pone.0195190	http://dx.doi.org/10.1371/journal.pone.0195190			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617425	Green Submitted, Green Published, gold			2022-12-26	WOS:000429203800067
J	Sciarretta, A; Tabilio, MR; Lampazzi, E; Ceccaroli, C; Colacci, M; Trematerra, P				Sciarretta, Andrea; Tabilio, Maria Rosaria; Lampazzi, Elena; Ceccaroli, Claudio; Colacci, Marco; Trematerra, Pasquale			Analysis of the Mediterranean fruit fly [Ceratitis capitata (Wiedemann)] spatio-temporal distribution in relation to sex and female mating status for precision IPM	PLOS ONE			English	Article							DIPTERA TEPHRITIDAE; INTEGRATED MANAGEMENT; DISTRIBUTION PATTERNS; FIELD-EVALUATION; POPULATION; FLIES; RANGE; ATTRACTANTS; PHEROMONE; ORCHARD	The Mediterranean fruit fly (medfly), Ceratitis capitata (Wiedemann), is a key pest of fruit crops in many tropical, subtropical and mild temperate areas worldwide. The economic importance of this fruit fly is increasing due to its invasion of new geographical areas. Efficient control and eradication efforts require adequate information regarding C. capitata adults in relation to environmental and physiological cues. This would allow effective characterisation of the population spatio-temporal dynamic of the C. capitata population at both the orchard level and the area-wide landscape. The aim of this study was to analyse population patterns of adult medflies caught using two trapping systems in a peach orchard located in central Italy. They were differentiated by adult sex (males or females) and mating status of females (unmated or mated females) to determine the spatio-temporal dynamic and evaluate the effect of cultivar and chemical treatments on trap catches. Female mating status was assessed by spermathecal dissection and a blind test was carried out to evaluate the reliability of the technique. Geostatistical methods, variogram and kriging, were used to produce distributional maps. Results showed a strong correlation between the distribution of males and unmated females, whereas males versus mated females and unmated females versus mated females showed a lower correlation. Both cultivar and chemical treatments had significant effects on trap catches, showing associations with sex and female mating status. Medfly adults showed aggregated distributions in the experimental field, but hot spots locations varied. The spatial pattern of unmated females reflected that of males, whereas mated females were largely distributed around ripening or ripe fruit. The results give relevant insights into pest management. Mated females may be distributed differently to unmated females and the identification of male hot spots through monitoring would allow localisation of virgin female populations. Based on our results, a more precise IPM strategy, coupled with effective sanitation practices, could represent a more effective approach to medfly control.	[Sciarretta, Andrea; Colacci, Marco; Trematerra, Pasquale] Univ Molise, Dept Agr Environm & Food Sci, Campobasso, Italy; [Tabilio, Maria Rosaria; Ceccaroli, Claudio] Res Ctr Olive Citrus & Tree Fruit, CREA, Consiglio Ric Agr & Anal Econ Agr, Rome, Italy; [Lampazzi, Elena] Italian Natl Agcy New Technol Energy & Sustainabl, ENEA, Casaccia Res Ctr, Rome, Italy	University of Molise; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Italian National Agency New Technical Energy & Sustainable Economics Development	Sciarretta, A (corresponding author), Univ Molise, Dept Agr Environm & Food Sci, Campobasso, Italy.	sciarretta@unimol.it	Sciarretta, Andrea/C-5307-2008	Sciarretta, Andrea/0000-0002-9443-4816; Colacci, Marco/0000-0002-9068-3049				Alemany A, 2008, J APPL ENTOMOL, V132, P746, DOI 10.1111/j.1439-0418.2008.01376.x; Alemany A., 2004, BOLET N SANIDAD VEGE, V30, P255; BAKER R, 1985, J CHEM SOC CHEM COMM, P824, DOI 10.1039/c39850000824; BATEMAN MA, 1972, ANNU REV ENTOMOL, V17, P493, DOI 10.1146/annurev.en.17.010172.002425; Broughton S, 2002, J ECON ENTOMOL, V95, P507, DOI 10.1603/0022-0493-95.2.507; CABI, 2017, INV SPEC COMP; CDFA, 2003, PREV BIOL POLL MED F; CDFA (California Department of Food and Agriculture), 2017, MEDFL INT QUAR REG; Chapman T, 1998, P ROY SOC B-BIOL SCI, V265, P1879, DOI 10.1098/rspb.1998.0516; Copeland RS, 2002, ANN ENTOMOL SOC AM, V95, P672, DOI 10.1603/0013-8746(2002)095[0672:IHOCCD]2.0.CO;2; De Meyer M, 2008, J BIOGEOGR, V35, P270, DOI 10.1111/j.1365-2699.2007.01769.x; Delrio G., 1986, P135; Enkerlin W, 2015, FLA ENTOMOL, V98, P665, DOI 10.1653/024.098.0242; EPPO, 2016, EPPO GLOB DAT; Epsky ND, 2010, J ECON ENTOMOL, V103, P1886, DOI 10.1603/EC09286; Flores S, 2013, BIOCONTROL SCI TECHN, V23, P1186, DOI 10.1080/09583157.2013.822473; Gutierrez AP, 2011, BIOL INVASIONS, V13, P2661, DOI 10.1007/s10530-011-9937-6; Hancock D.L., 2000, DISTRIBUTION HOST PL; HENDRICHS J, 1991, OECOLOGIA, V86, P223, DOI 10.1007/BF00317534; IAEA (International Atomic Energy Agency), 2013, TRAPP MAN AR WID FRU; Israely N, 2005, ANN ENTOMOL SOC AM, V98, P302, DOI 10.1603/0013-8746(2005)098[0302:MSDPOM]2.0.CO;2; Israely N, 2005, ANN ENTOMOL SOC AM, V98, P77, DOI 10.1603/0013-8746(2005)098[0077:SDPOMF]2.0.CO;2; JANG EB, 1995, J INSECT PHYSIOL, V41, P705, DOI 10.1016/0022-1910(95)00015-M; Journel A. G., 1978, MINING GEOSTATISTICS; Juan-Blasco M, 2014, B ENTOMOL RES, V104, P233, DOI 10.1017/S0007485313000692; Kaspi R, 1999, FUNCT ECOL, V13, P539, DOI 10.1046/j.1365-2435.1999.00344.x; Katsoyannos BI, 1999, J ECON ENTOMOL, V92, P583, DOI 10.1093/jee/92.3.583; Klassen K, STERILE INSECT TECHN; LANDOLT PJ, 1992, ENTOMOL EXP APPL, V65, P259, DOI 10.1007/BF02343859; Leza MM, 2008, J APPL ENTOMOL, V132, P753, DOI 10.1111/j.1439-0418.2008.01370.x; Liquido N.J., 1991, MISCELLANEOUS PUBLIC, V77, P1; Manoukis NC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149869; Manrakhan A, 2017, J APPL ENTOMOL, V141, P825, DOI 10.1111/jen.12373; Meats A, 2007, J APPL ENTOMOL, V131, P518, DOI 10.1111/j.1439-0418.2007.01168.x; Meixner MD, 2002, MOL ECOL, V11, P891, DOI 10.1046/j.1365-294X.2002.01488.x; Midgarden D, TRAPPING DETECTION C; Morales Pedro, 2004, Entomotropica, V19, P51; Nansen C, 2003, J ECON ENTOMOL, V96, P1617, DOI 10.1603/0022-0493-96.6.1617; Navarro-Llopis V, 2008, J ECON ENTOMOL, V101, P126, DOI 10.1603/0022-0493(2008)101[126:EOTALF]2.0.CO;2; Navarro-Llopis V, 2010, PEST MANAG SCI, V66, P511, DOI 10.1002/ps.1901; Papadopoulos NT, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1466; Papadopoulos NT, 1996, ANN ENTOMOL SOC AM, V89, P526, DOI 10.1093/aesa/89.4.526; Papadopoulos NT, 2003, ENVIRON ENTOMOL, V32, P319, DOI 10.1603/0046-225X-32.2.319; Pimentel R, 2017, J INSECT SCI, V17, DOI 10.1093/jisesa/iew097; Pimentel R, 2017, INT J PEST MANAGE, V63, P172, DOI 10.1080/09670874.2016.1256512; Pinero J.C., 2014, TRAPPING DETECTION C, P457, DOI DOI 10.1007/978-94-017-9193-9_13; Reyes-Flores J., 2014, TRAPPING DETECTION C, pix; Rossler Y., 1994, Bulletin OEPP, V24, P813, DOI 10.1111/j.1365-2338.1994.tb01102.x; Sciarretta A, 2014, PLANT PROTECT SCI, V50, P97, DOI 10.17221/40/2013-PPS; Sciarretta A, 2011, J APPL ENTOMOL, V135, P241, DOI 10.1111/j.1439-0418.2010.01515.x; Shelly TE, 2004, ANIM BEHAV, V68, P417, DOI 10.1016/j.anbehav.2003.08.029; Shelly TE, 2007, J INSECT BEHAV, V20, P453, DOI 10.1007/s10905-007-9091-2; Siciliano P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085523; Szyniszewska AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111582; Tan K.H., 2014, TRAPPING DETECTION C, P15, DOI DOI 10.1007/978-94-017-9193-9_2; The University of Arizona, 2021, MED FRUIT FLY CER CA; Vargas RI, 2001, J ECON ENTOMOL, V94, P817, DOI 10.1603/0022-0493-94.4.817; Vreysen M. J. B., 2007, P723, DOI 10.1007/978-1-4020-6059-5_66; White IM, 1992, FRUIT FLIES EC SIGNI, DOI DOI 10.1017/S0007485300041237; Zanoni S., 2017, IOBC/WPRS Bulletin, V123, P43	62	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195097	10.1371/journal.pone.0195097	http://dx.doi.org/10.1371/journal.pone.0195097			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617420	Green Published, gold, Green Submitted			2022-12-26	WOS:000429203800063
J	Yekwayo, I; Pryke, JS; Gaigher, R; Samways, MJ				Yekwayo, Inam; Pryke, James S.; Gaigher, Rene; Samways, Michael J.			Only multi-taxon studies show the full range of arthropod responses to fire	PLOS ONE			English	Article							SOUTH-AFRICA; CONSERVATION; INVERTEBRATES; GRASSLAND; DIVERSITY; FOREST; MOUNTAIN; HABITAT; BIODIVERSITY; COMMUNITIES	Fire is a major driver in many ecosystems. Yet, little is known about how different ground-living arthropods survive fire. Using three sampling methods, and time-since-fire (last fire event: 3 months, 1 year, and 7 years), we investigate how ground-living arthropod diversity responds to fire, and how species richness, diversity, abundance, and composition of the four dominant taxa: ants, beetles, cockroaches and mites, respond. We did this in the naturally fire-prone Mediterranean-type scrubland vegetation (fynbos) of the Cape Floristic Region. Surprisingly, overall species richness and diversity was the same for all time-since fire categories. However, when each dominant taxon was analysed separately, effect of fire on species richness and abundance varied among taxa. This emphasizes that many taxa must be investigated to really understand fire-driven events. We also highlight the importance of using different diversity measures, as fire did not influence species richness and abundance of particular taxa, while it affected others, overall greatly affecting assemblages of all taxa. Rockiness affected species richness, abundance and composition of a few taxa. We found that all time-since-fire categories supported distinctive assemblages. Some indicator species occurred across all time-since-fire categories, while others were restricted to a single time-since-fire category, showing that there is a wide range of responses to fire between taxa. Details of local landscape structure, abiotic and biotic, and frequency and intensity of fire add complexity to the fire-arthropod interaction. Overall, we show that the relationship between fire and arthropods is phylogenetically constrained, having been honed by many millennia of fire events, and highly complex. Present-day species manifest a variety of adaptations for surviving the great natural selective force of fire.	[Yekwayo, Inam] Univ Mpumalanga, Sch Biol & Environm Sci, Nelspruit, South Africa; [Yekwayo, Inam; Pryke, James S.; Gaigher, Rene; Samways, Michael J.] Stellenbosch Univ, Dept Conservat Ecol & Entomol, Matieland, South Africa	Stellenbosch University	Yekwayo, I (corresponding author), Univ Mpumalanga, Sch Biol & Environm Sci, Nelspruit, South Africa.; Yekwayo, I (corresponding author), Stellenbosch Univ, Dept Conservat Ecol & Entomol, Matieland, South Africa.	Inam.Yekwayo@ump.ac.za	Gaigher, Rene/X-3635-2018; Pryke, James/A-6644-2008	Gaigher, Rene/0000-0003-4100-8634; Pryke, James/0000-0003-3148-5744; Yekwayo, Inam/0000-0002-7671-3643; Yekwayo, Inam/0000-0002-9722-6545	National Research Foundation	National Research Foundation	Funded by National Research Foundation (freestanding postdoctoral fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation o the manuscript.; We thank Rustenburg, Boschendal, and Montagne farms for access, and D. Ngadze, P. Tshililo, Z. Tyeku, F. Becker, B. Dlamini, M. Mukundamago, S. Mensah, R. Agrela, L. Sikhutshwa, M. Pheme, S. Adu-Acheampong, and A. Katumanyane for field assistance. Thanks also to F. Roets and T. Mwabvu for arthropod identification. Funding was from the National Research Foundation (freestanding postdoctoral fellowship), and the work was carried out under Cape Nature collection permit no. AAA007-00196-0056.	Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Barratt BIP, 2006, RANGELAND ECOL MANAG, V59, P383, DOI 10.2111/05-190R1.1; Bates D., 2005, R R NEWS, V5, P27, DOI DOI 10.18637/JSS.V067.I01; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Braschler B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031463; Cardoso P, 2011, BIOL CONSERV, V144, P2647, DOI 10.1016/j.biocon.2011.07.024; Coddington JA, 2009, J ANIM ECOL, V78, P573, DOI 10.1111/j.1365-2656.2009.01525.x; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Crous CJ, 2013, J APPL ECOL, V50, P205, DOI 10.1111/1365-2664.12012; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; Forsyth Greg G., 2008, Koedoe, V50, P3; Gerlach J, 2013, J INSECT CONSERV, V17, P831, DOI 10.1007/s10841-013-9565-9; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; Hortal J, 2006, J ANIM ECOL, V75, P274, DOI 10.1111/j.1365-2656.2006.01048.x; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hugo-Coetzee EA, 2011, ZOOSYMPOSIA, V6, P210, DOI 10.11646/zoosymposia.6.1.31; Joubert L, 2014, S AFR J BOT, V92, P126, DOI 10.1016/j.sajb.2014.02.009; Kamczyc J, 2017, EXP APPL ACAROL, V72, P145, DOI 10.1007/s10493-017-0148-4; Kraaij T, 2013, KOEDOE, V55, DOI 10.4102/koedoe.v55i1.1104; Kwon TS, 2013, J ASIA-PAC ENTOMOL, V16, P321, DOI 10.1016/j.aspen.2013.04.008; Lawes MJ, 2005, BIOTROPICA, V37, P109, DOI 10.1111/j.1744-7429.2005.04054.x; Linder R, 1992, ECOLOGY FYNBOS; Luke SH, 2014, BIODIVERS CONSERV, V23, P2817, DOI 10.1007/s10531-014-0750-2; Masse Mbenoun P.S., 2017, Journal of Biodiversity and Environmental Sciences, V10, P181; Mucina L., 2011, VEGETATION S AFRICA; Munyai TC, 2012, J INSECT CONSERV, V16, P677, DOI 10.1007/s10841-011-9449-9; Murvanidze M., 2008, INTEGRATIVE ACAROLOG, P216; Mustart P., 2000, VELD FLORA, V86, P73; Mwabvu T, 1997, ENTOMOL SCAND, P287; New TM, 2014, INS FIR CONS; Parr CL, 2004, J APPL ECOL, V41, P630, DOI 10.1111/j.0021-8901.2004.00920.x; Proches S, 2006, GLOBAL ECOL BIOGEOGR, V15, P445, DOI 10.1111/j.1566-822x.2006.00239.x; Pryke JS, 2008, BIODIVERS CONSERV, V17, P3027, DOI 10.1007/s10531-008-9414-4; Pryke JS, 2010, J INSECT CONSERV, V14, P247, DOI 10.1007/s10841-009-9253-y; Pryke JS, 2012, AUSTRAL ECOL, V37, P460, DOI 10.1111/j.1442-9993.2011.02307.x; Pryke JS, 2012, J INSECT CONSERV, V16, P177, DOI 10.1007/s10841-011-9404-9; Richardson DM., 1992, ECOL STUD, P273, DOI [10.1007/978-3-642-76174-4_15, DOI 10.1007/978-3-642-76174-4_15]; Sackmann P, 2006, ECOSCIENCE, V13, P360, DOI 10.2980/i1195-6860-13-3-360.1; SAMWAYS MJ, 1990, CONSERV BIOL, V4, P375, DOI 10.1111/j.1523-1739.1990.tb00311.x; Samways MJ, 2010, INSECT CONSERVATION; Sasal Y, 2015, ECOL RES, V30, P1015, DOI 10.1007/s11284-015-1302-2; SCHLETTWEIN C H G, 1987, Annale Universiteit van Stellenbosch Serie A 3 (Landbouwetenskappe), V2, P1; Silveira JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012877; STEWART AJA, 1995, ECOL ENTOMOL, V20, P98, DOI 10.1111/j.1365-2311.1995.tb00434.x; Swart RC, 2017, AFR ENTOMOL, V25, P164, DOI 10.4001/003.025.0164; Swengel AB, 2001, BIODIVERS CONSERV, V10, P1141, DOI 10.1023/A:1016683807033; Thom MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126755; Uys C, 2009, AFR J ECOL, V47, P341, DOI 10.1111/j.1365-2028.2008.00968.x	50	12	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195414	10.1371/journal.pone.0195414	http://dx.doi.org/10.1371/journal.pone.0195414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614132	Green Published, gold, Green Submitted			2022-12-26	WOS:000429081600058
J	Newman, JH; Augeri, DJ; NeMoyer, R; Malhotra, J; Langenfeld, E; Chesson, CB; Dobias, NS; Lee, MJ; Tarabichi, S; Jhawar, SR; Bommareddy, PK; Marshall, S; Sadimin, ET; Kerrigan, JE; Goedken, M; Minerowicz, C; Jabbour, SK; Li, SG; Carayannopolous, MO; Zloza, A; Langenfeld, J				Newman, Jenna H.; Augeri, David J.; NeMoyer, Rachel; Malhotra, Jyoti; Langenfeld, Elaine; Chesson, Charles B.; Dobias, Natalie S.; Lee, Michael J.; Tarabichi, Saeed; Jhawar, Sachin R.; Bommareddy, Praveen K.; Marshall, Sh'Rae; Sadimin, Evita T.; Kerrigan, John E.; Goedken, Michael; Minerowicz, Christine; Jabbour, Salma K.; Li, Shengguo; Carayannopolous, Mary O.; Zloza, Andrew; Langenfeld, John			Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer	ONCOGENE			English	Article							IN-VIVO; APOPTOSIS PROTEIN; BMP; ACTIVATION; DEATH; EXPRESSION; GROWTH; RESPONSES; THERAPY; XIAP	BMP receptor inhibitors induce death of cancer cells through the downregulation of antiapoptotic proteins XIAP, pTAK1, and Id1-Id3. However, the current most potent BMP receptor inhibitor, DMH2, does not downregulate BMP signaling in vivo because of metabolic instability and poor pharmacokinetics. Here we identified the site of metabolic instability of DMH2 and designed a novel BMP receptor inhibitor, JL5. We show that JL5 has a greater volume of distribution and suppresses the expression of Id1 and pTak1 in tumor xenografts. Moreover, we demonstrate JL5-induced tumor cell death and tumor regression in xenograft mouse models without immune cells and humanized with adoptively transferred human immune cells. In humanized mice, JL5 additionally induces the infiltration of immune cells within the tumor microenvironment. Our studies show that the BMP signaling pathway is targetable in vivo and BMP receptor inhibitors can be developed as a therapeutic to treat cancer patients.	[Newman, Jenna H.; Chesson, Charles B.; Dobias, Natalie S.; Bommareddy, Praveen K.; Marshall, Sh'Rae; Li, Shengguo; Zloza, Andrew] Rutgers Canc Inst New Jersey, Sect Surg Oncol Res, Div Surg Oncol, New Brunswick, NJ 08903 USA; [Augeri, David J.] Rutgers State Univ, Off Translat Sci Mol Design & Synth, Piscataway, NJ 08854 USA; [NeMoyer, Rachel; Lee, Michael J.; Tarabichi, Saeed; Zloza, Andrew] Rutgers State Univ, Dept Surg, Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ 08903 USA; [Malhotra, Jyoti] Rutgers Canc Inst New Jersey, Div Med Oncol, New Brunswick, NJ 08903 USA; [Langenfeld, Elaine; Langenfeld, John] Rutgers Canc Inst New Jersey, Dept Surg, Div Surg Oncol & Thorac Surg, New Brunswick, NJ 08903 USA; [Jhawar, Sachin R.; Jabbour, Salma K.] Rutgers Robert Wood Johnson Med Sch, Dept Radiat Oncol, New Brunswick, NJ 08903 USA; [Sadimin, Evita T.; Minerowicz, Christine; Carayannopolous, Mary O.] Rutgers Robert Wood Johnson Med Sch, Dept Pathol & Lab Sci, New Brunswick, NJ 08903 USA; [Kerrigan, John E.] Rutgers State Univ, Dept Bioinformat, Rutgers Biomed Hlth Sci, Piscataway, NJ 08854 USA; [Goedken, Michael] Rutgers State Univ, Off Translat Sci, Res Pathol Serv, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Zloza, A (corresponding author), Rutgers Canc Inst New Jersey, Sect Surg Oncol Res, Div Surg Oncol, New Brunswick, NJ 08903 USA.; Zloza, A (corresponding author), Rutgers State Univ, Dept Surg, Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ 08903 USA.; Langenfeld, J (corresponding author), Rutgers Canc Inst New Jersey, Dept Surg, Div Surg Oncol & Thorac Surg, New Brunswick, NJ 08903 USA.	andrew.zloza@rutgers.edu; langenje@cinj.rutgers.edu	Jhawar, Sachin R/M-1587-2017; Bommareddy, Praveen/L-1173-2019	Jhawar, Sachin R/0000-0001-8604-4757; Bommareddy, Praveen/0000-0003-0089-8693; Kerrigan, John/0000-0001-6562-4533; Zloza, Andrew/0000-0001-8844-6493	NCI [P30CA72720]	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work utilized shared resources at Rutgers Cancer Institute of New Jersey, which are supported by NCI P30CA72720.	Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Augeri DJ, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0511-9; Balboni AL, 2013, CANCER RES, V73, P1020, DOI 10.1158/0008-5472.CAN-12-2862; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bobbio A, 2015, PHARMACOL RES, V99, P217, DOI 10.1016/j.phrs.2015.06.011; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Clement JH, 2005, INT J ONCOL, V27, P401; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; de Bruin EC, 2008, CANCER TREAT REV, V34, P737, DOI 10.1016/j.ctrv.2008.07.001; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Galban S, 2009, BIOCHEM J, V417, P765, DOI 10.1042/BJ20081677; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hahm E, 2017, NAT MED, V23, P100, DOI 10.1038/nm.4242; Hao JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090748; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Kleeff J, 1999, GASTROENTEROLOGY, V116, P1202, DOI 10.1016/S0016-5085(99)70024-7; Kohlhapp FJ, 2016, CELL REP, V17, P957, DOI 10.1016/j.celrep.2016.09.068; Kohlhapp FJ, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0063-3; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kurooka H, 2012, BIOCHEM BIOPH RES CO, V420, P281, DOI 10.1016/j.bbrc.2012.02.150; Lai TH, 2008, PROSTATE, V68, P1341, DOI 10.1002/pros.20799; Langenfeld E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061256; Langenfeld EM, 2006, ONCOGENE, V25, P685, DOI 10.1038/sj.onc.1209110; Langenfeld EM, 2005, MOL CANCER RES, V3, P679, DOI 10.1158/1541-7786.MCR-05-0124; Langenfeld EM, 2005, ANN THORAC SURG, V80, P1028, DOI 10.1016/j.athoracsur.2005.03.094; Langenfeld EM, 2004, MOL CANCER RES, V2, P141; Langenfeld EM, 2003, CARCINOGENESIS, V24, P1445, DOI 10.1093/carcin/bgg100; Le Page C, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-4; Liu ZP, 2009, BBA-MOL CELL RES, V1793, P1819, DOI 10.1016/j.bbamcr.2009.09.012; Lu R, 2014, AIDS RES HUM RETROV, V30, P677, DOI [10.1089/AID.2013.0289, 10.1089/aid.2013.0289]; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Martinez CG, 2011, IMMUNOL CELL BIOL, V89, P610, DOI 10.1038/icb.2010.135; Martinez VG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131453; Martinez VG, 2014, EUR J IMMUNOL, V44, P1031, DOI 10.1002/eji.201343693; Mihaly SR, 2014, CELL DEATH DIFFER, V21, P1667, DOI 10.1038/cdd.2014.123; Nguyen A, 2014, INT ORTHOP, V38, P2313, DOI 10.1007/s00264-014-2512-x; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; Obexer P, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00197; Owens P, 2015, ONCOGENE, V34, P2437, DOI 10.1038/onc.2014.189; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Robson NC, 2014, CANCER RES, V74, P5019, DOI 10.1158/0008-5472.CAN-13-2845; Rothhammer T, 2005, CANCER RES, V65, P448; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Sountoulidis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041460; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Weaver M, 1999, DEVELOPMENT, V126, P4005; Yamaguchi K, 1999, EMBO J, V18, P179, DOI 10.1093/emboj/18.1.179; Ye L, 2011, FRONT BIOSCI-LANDMRK, V16, P865, DOI 10.2741/3725; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang YG, 2015, AIDS RES HUM RETROV, V31, P774, DOI 10.1089/aid.2014.0341; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622; Zloza A, 2012, NAT MED, V18, P422, DOI 10.1038/nm.2683; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	58	12	12	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 5	2018	37	27					3672	3685		10.1038/s41388-018-0156-9	http://dx.doi.org/10.1038/s41388-018-0156-9			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GM3CM	29622797				2022-12-26	WOS:000437975200005
J	Cook, AA; Deng, W; Ren, JQ; Li, RH; Sondek, J; Bergmeier, W				Cook, Aaron A.; Deng, Wei; Ren, Jinqi; Li, Renhao; Sondek, John; Bergmeier, Wolfgang			Calcium-induced structural rearrangements release autoinhibition in the Rap-GEF CalDAG-GEFI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; guanine nucleotide exchange factor (GEF); GTPase; platelet; structural model; autoinhibition; conformational dynamics; EF hand	PLATELET DYSFUNCTION; ACTIVATION; DOMAIN; AFFINITY; RASGRP2; PARVALBUMIN; MUTATIONS; PROTEINS	Platelets are recruited to sites of vascular injury, where they are activated and aggregate to form a hemostatic plug. This process requires the activation of the small GTPase Rap1B by its cognate guanine nucleotide exchange factor CalDAG-GEFI. Studies on platelet function suggest that CalDAG-GEFI activity is regulated by changes in cytosolic calcium, but the exact molecular mechanism is poorly understood. Here we show that purified CalDAG-GEFI is autoinhibited and directly regulated by calcium. Substitutions of putative calcium-binding residues within the canonical EF hands of CalDAG-GEFI diminish its capacity to activate Rap1B. Structural differences between active (WT) and inactive (EF hand variant) CalDAG-GEFI protein were determined by hydrogen-deuterium exchange MS. The highest differential rates of deuterium uptake in WT over EF hand variant CalDAG-GEFI were observed in regions within the catalytic Cdc25 domain and a putative autoinhibitory linker connecting the Cdc25 and EF hand domains. Exchange activity in the EF hand variant was fully restored by an additional substitution, valine 406 to glutamate, which is thought to disrupt the interface between the autoinhibitory linker and the Cdc25 domain. Overall, our results suggest a model for how CalDAG-GEFI remains in an autoinhibited state when levels of cytosolic calcium in resting platelets are low. In response to cellular stimulation, calcium mobilization and binding to the EF hands causes conformational rearrangements within CalDAG-GEFI, including the autoinhibitory linker that frees the catalytic surface of CalDAG-GEFI to engage and activate Rap1B. The data from this study are the first evidence linking CalDAG-GEFI activity directly to calcium.	[Cook, Aaron A.; Sondek, John; Bergmeier, Wolfgang] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Ren, Jinqi; Sondek, John] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Deng, Wei; Sondek, John] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Deng, Wei; Li, Renhao] Emory Univ, Sch Med, Aflac Canc & Blood Disorders Ctr, Dept Pediat, Atlanta, GA 30322 USA; [Bergmeier, Wolfgang] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27516 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Emory University; University of North Carolina; University of North Carolina Chapel Hill	Bergmeier, W (corresponding author), 120 Mason Farm Rd,3113 Genet Med Bldg, Chapel Hill, NC 27599 USA.	bergmeie@email.unc.edu	Li, Renhao/B-1257-2012; Ren, Jinqi/D-5545-2015	Li, Renhao/0000-0002-5806-5080; Ren, Jinqi/0000-0001-7461-0491	NHLBI, National Institutes of Health [R01 HL130404, R01 HL121650]; NIGMS, National Institutes of Health [P01GM103723]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121650, R01HL130404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM103723] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NHLBI, National Institutes of Health Grants R01 HL130404 and R01 HL121650 and NIGMS, National Institutes of Health Grant P01GM103723. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boudreaux MK, 2007, TRANSL RES, V150, P81, DOI 10.1016/j.trsl.2007.03.006; Busch E, 2000, J BIOL CHEM, V275, P25508, DOI 10.1074/jbc.M001770200; Cates MS, 1999, STRUCTURE, V7, P1269, DOI 10.1016/S0969-2126(00)80060-X; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; Czikora A, 2016, J BIOL CHEM, V291, P11133, DOI 10.1074/jbc.M116.725333; Declercq JP, 1999, PROTEIN SCI, V8, P2194, DOI 10.1110/ps.8.10.2194; Deng W, 2017, J THROMB HAEMOST, V15, P1867, DOI 10.1111/jth.13775; Iwig JS, 2013, ELIFE, V2, DOI 10.7554/eLife.00813; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Kumar S, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-15; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Lozano ML, 2016, BLOOD, V128, P1282, DOI 10.1182/blood-2015-11-683102; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Morgan Christopher R, 2009, Curr Protoc Protein Sci, VChapter 17, DOI 10.1002/0471140864.ps1706s58; Ren J, 2016, BIOCHEM BIOPH RES CO, V474, P193, DOI 10.1016/j.bbrc.2016.04.100; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Stefanini L, 2016, J MOL MED, V94, P13, DOI 10.1007/s00109-015-1346-3; Stefanini L, 2015, J CLIN INVEST, V125, P1419, DOI 10.1172/JCI77993; Stefanini L, 2009, BLOOD, V114, P2506, DOI 10.1182/blood-2009-04-218768; Stolla M, 2011, BLOOD, V117, P1005, DOI 10.1182/blood-2010-07-297713; Stone James C, 2011, Genes Cancer, V2, P320, DOI 10.1177/1947601911408082; Westbury SK, 2017, BLOOD, V130, P1026, DOI 10.1182/blood-2017-03-776773	23	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8521	8529		10.1074/jbc.RA118.002712	http://dx.doi.org/10.1074/jbc.RA118.002712			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29622678	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000434205700016
J	Weijers, D; Hemerik, L; Heitkonig, IMA				Weijers, Debby; Hemerik, Lia; Heitkonig, Ignas M. A.			An experimental approach in revisiting the magnetic orientation of cattle	PLOS ONE			English	Article							COMPASS ORIENTATION; ONCORHYNCHUS-KETA; CHUM SALMON; ALIGNMENT; FIELD; NAVIGATION; PIGEONS; SALAMANDRIDAE; PREFERENCE; DIRECTION	In response to the increasing number of observational studies on an apparent south-north orientation in non-homing, non-migrating terrestrial mammals, we experimentally tested the alignment hypothesis using strong neodymium magnets on the resting orientation of individual cattle in Portugal. Contrary to the hypothesis, the 34 cows in the experiment showed no directional preference, neither with, nor without a strong neodymium magnet fixed to their collar. The concurrently performed 2,428 daytime observations +/- excluding the hottest part of the day +/- of 659 resting individual cattle did not show a south-north alignment when at rest either. The preferred compass orientation of these cows was on average 130 degrees from the magnetic north (i.e., south east). Cow compass orientation correlated significantly with sun direction, but not with wind direction. In as far as we can determine, this is the first experimental test on magnetic orientation in larger, non-homing, non-migrating mammals. These experimental and observational findings do not support previously published suggestions on the magnetic south-north alignment in these mammals.	[Weijers, Debby; Heitkonig, Ignas M. A.] Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands; [Hemerik, Lia] Wageningen Univ & Res, Biometris, Dept Math & Stat Methods, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Heitkonig, IMA (corresponding author), Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands.	ignas.heitkonig@wur.nl		Hemerik, Lia/0000-0002-6892-2840; Heitkonig, Ignas/0000-0001-7771-3111				[Anonymous], 2010, R LANG ENV STAT COMP; Batschelet E, 1981, CIRCULAR STAT BIOL; Begall S, 2011, J COMP PHYSIOL A, V197, P1127, DOI 10.1007/s00359-011-0674-1; Begall S, 2008, P NATL ACAD SCI USA, V105, P13451, DOI 10.1073/pnas.0803650105; Begall S, 2013, MAMM BIOL, V78, P10, DOI 10.1016/j.mambio.2012.05.005; BURDA H, 1990, EXPERIENTIA, V46, P528, DOI 10.1007/BF01954256; Burda H, 2009, P NATL ACAD SCI USA, V106, P5708, DOI 10.1073/pnas.0811194106; Cerveny J, 2016, MAMMAL REV, DOI [10.1111/mam., DOI 10.1111/MAM]; Cerveny J, 2011, BIOL LETTERS, V7, P355, DOI 10.1098/rsbl.2010.1145; Dennis TE, 2007, P ROY SOC B-BIOL SCI, V274, P1153, DOI 10.1098/rspb.2007.3768; Deutschlander ME, 2003, ANIM BEHAV, V65, P779, DOI 10.1006/anbe.2003.2111; Edelman NB, 2015, P NATL ACAD SCI USA, V112, P262, DOI 10.1073/pnas.1407915112; Guerra PA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5164; Hart V, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-80; Hart V, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-38; Hert J, 2011, J COMP PHYSIOL A, V197, P1135, DOI 10.1007/s00359-011-0688-8; Hert J, 2011, J COMP PHYSIOL A, V197, P677, DOI 10.1007/s00359-011-0628-7; HOFMEYR MD, 1987, J ARID ENVIRON, V13, P137; Holland RA, 2006, NATURE, V444, P702, DOI 10.1038/444702b; Holland RA, 2010, P NATL ACAD SCI USA, V107, P6941, DOI 10.1073/pnas.0912477107; Horton TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114557; Keary N, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-25; Kimchi T, 2001, J EXP BIOL, V204, P751; Landler L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124728; Lease HM, 2014, J THERM BIOL, V45, P150, DOI 10.1016/j.jtherbio.2014.08.008; Lohmann KJ, 2008, J EXP BIOL, V211, P1719, DOI 10.1242/jeb.015792; Luschi P, 2007, CURR BIOL, V17, P126, DOI 10.1016/j.cub.2006.11.062; Malkemper EP, 2016, J THEOR BIOL, V399, P141, DOI 10.1016/j.jtbi.2016.03.040; Mora CV, 2012, ANIM BEHAV, V84, P377, DOI 10.1016/j.anbehav.2012.05.005; Muheim R, 2006, LEARN BEHAV, V34, P366, DOI 10.3758/BF03193201; Nishi T, 2004, J EXP BIOL, V207, P2965, DOI 10.1242/jeb.01131; Papi F, 2000, J EXP BIOL, V203, P3435; Perez SM, 1999, NATURWISSENSCHAFTEN, V86, P140, DOI 10.1007/s001140050587; Phillips JB, 2002, J EXP BIOL, V205, P3903; QUINN TP, 1983, CAN J FISH AQUAT SCI, V40, P1598, DOI 10.1139/f83-185; Rao JS., 2001, TOPICS CIRCULAR STAT; Schlegel PA, 2007, J ETHOL, V25, P177, DOI 10.1007/s10164-006-0016-x; Schlegel PA, 2007, J ETHOL, V25, P185, DOI 10.1007/s10164-006-0017-9; Shcherbakov D, 2005, CURR BIOL, V15, pR161, DOI 10.1016/j.cub.2005.02.039; Slaby P, 2013, J COMP PHYSIOL A, V199, P695, DOI 10.1007/s00359-013-0827-5; Tian LX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123205; Treiber CD, 2012, NATURE, V484, P367, DOI 10.1038/nature11046; Vacha M, 2010, BEHAVIOUR, V147, P425, DOI 10.1163/000579509X12580965484148; Voss J, 2007, NEUROREPORT, V18, P1053, DOI 10.1097/WNR.0b013e32818b2a21; Walker MM, 2002, CURR OPIN NEUROBIOL, V12, P735, DOI 10.1016/S0959-4388(02)00389-6; Wang YN, 2007, P R SOC B, V274, P2901, DOI 10.1098/rspb.2007.0904; Wegner RE, 2006, J EXP BIOL, V209, P4747, DOI 10.1242/jeb.02573; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko R, 2013, J COMP PHYSIOL A, V199, P89, DOI 10.1007/s00359-012-0769-3; Yano A, 1997, MAR BIOL, V129, P523, DOI 10.1007/s002270050193	50	2	2	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0187848	10.1371/journal.pone.0187848	http://dx.doi.org/10.1371/journal.pone.0187848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641517	Green Submitted, Green Published, gold			2022-12-26	WOS:000429742900003
J	Guan, C; Li, XR; Zhang, P; Chen, YL				Guan, Chao; Li, Xinrong; Zhang, Peng; Chen, Yongle			Diel hysteresis between soil respiration and soil temperature in a biological soil crust covered desert ecosystem	PLOS ONE			English	Article							CARBON-DIOXIDE FLUX; TENGGER-DESERT; SEASONAL-VARIATION; CO2 EFFLUX; VEGETATION; PHOTOSYNTHESIS; DEPENDENCE; PULSES; FOREST	Soil respiration induced by biological soil crusts (BSCs) is an important process in the carbon (C) cycle in arid and semi-arid ecosystems, where vascular plants are restricted by the harsh environment, particularly the limited soil moisture. However, the interaction between temperature and soil respiration remains uncertain because of the number of factors that control soil respiration, including temperature and soil moisture, especially in BSC-dominated areas. In this study, the soil respiration in moss-dominated crusts and lichen-dominated crusts was continuously measured using an automated soil respiration system over a one-year period from November 2015 to October 2016 in the Shapotou region of the Tengger Desert, northern China. The results indicated that over daily cycles, the half-hourly soil respiration rates in both types of BSC-covered areas were commonly related to the soil temperature. The observed diel hysteresis between the half-hourly soil respiration rates and soil temperature in the BSC-covered areas was limited by nonlinearity loops with semielliptical shapes, and soil temperature often peaked later than the half-hourly soil respiration rates in the BSC-covered areas. The average lag times between the half-hourly soil respiration rates and soil temperature for both types of BSC-covered areas were two hours over the diel cycles, and they were negatively and linearly related to the volumetric soil water content. Our results highlight the diel hysteresis phenomenon that occurs between soil respiration rates and soil temperatures in BSC-covered areas and the negative response of this phenomenon to soil moisture, which may influence total C budget evaluations. Therefore, the interactive effects of soil temperature and moisture on soil respiration in BSC-covered areas should be considered in global carbon cycle models of desert ecosystems.	[Guan, Chao; Li, Xinrong; Zhang, Peng; Chen, Yongle] Chinese Acad Sci, Shapotou Desert Res & Expt Stn, NW Inst Ecoenvironm & Resources, Lanzhou, Gansu, Peoples R China; [Guan, Chao; Chen, Yongle] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Guan, C (corresponding author), Chinese Acad Sci, Shapotou Desert Res & Expt Stn, NW Inst Ecoenvironm & Resources, Lanzhou, Gansu, Peoples R China.; Guan, C (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	guanchao880421@163.com	Li, Xinrong/GNW-6025-2022		National Natural Science Foundation of China [41621001, 41530746]; West Light Program for Talent Cultivation of Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); West Light Program for Talent Cultivation of Chinese Academy of Sciences	This work was supported by National Natural Science Foundation of China (grant No. 41621001, 41530746) and the West Light Program for Talent Cultivation of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belnap J, 1994, RESTORATION MANAGEME, V12, P85; Belnap J., 2003, BIOL SOIL CRUSTS STR, DOI 10.1007/978-3-642-56475-8_21; Cable JM, 2004, OECOLOGIA, V141, P317, DOI 10.1007/s00442-003-1461-7; Carbone MS, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000611; Castillo-Monroy AP, 2011, ECOSYSTEMS, V14, P835, DOI 10.1007/s10021-011-9449-3; Darrouzet-Nardi A, 2015, BIOGEOCHEMISTRY, V126, P363, DOI 10.1007/s10533-015-0163-7; Feng W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102954; Gaumont-Guay D, 2006, AGR FOREST METEOROL, V140, P220, DOI 10.1016/j.agrformet.2006.08.003; Grote EE, 2010, GLOBAL CHANGE BIOL, V16, P2763, DOI 10.1111/j.1365-2486.2010.02201.x; Housman DC, 2006, J ARID ENVIRON, V66, P620, DOI 10.1016/j.jaridenv.2005.11.014; Hu R, 2015, CATENA, V127, P9, DOI 10.1016/j.catena.2014.12.012; Jia RL, 2012, SOIL BIOL BIOCHEM, V45, P31, DOI 10.1016/j.soilbio.2011.09.021; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Kuzyakov Y, 2010, GLOBAL CHANGE BIOL, V16, P3386, DOI 10.1111/j.1365-2486.2010.02179.x; Lai Z, 2016, J FOREST RES, V21, P1; Lal R, 2004, ENVIRON MANAGE, V33, P528, DOI 10.1007/s00267-003-9110-9; Li XR, 2005, PLANT SOIL, V277, P375, DOI 10.1007/s11104-005-8162-4; Li XR, 2003, PLANT SOIL, V251, P237, DOI 10.1023/A:1023023702248; Li XR, 2004, RESTOR ECOL, V12, P376, DOI 10.1111/j.1061-2971.2004.00313.x; Li XR, 2000, ACTA BOT SIN, V42, P965; Liu Q, 2006, GLOBAL CHANGE BIOL, V12, P2136, DOI 10.1111/j.1365-2486.2006.01245.x; Liu Z, 2017, CATENA, V155, P147, DOI 10.1016/j.catena.2017.03.011; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Parkin TB, 2003, SOIL SCI SOC AM J, V67, P1763, DOI 10.2136/sssaj2003.1763; Phillips CL, 2011, GLOBAL CHANGE BIOL, V17, P515, DOI 10.1111/j.1365-2486.2010.02250.x; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Raich JW, 2002, GLOBAL CHANGE BIOL, V8, P800, DOI 10.1046/j.1365-2486.2002.00511.x; Riveros-Iregui DA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030938; Scharlemann JPW, 2014, CARBON MANAG, V5, P81, DOI 10.4155/CMT.13.77; Subke JA, 2003, SOIL BIOL BIOCHEM, V35, P1467, DOI 10.1016/S0038-0717(03)00241-4; Tang JW, 2005, GLOBAL CHANGE BIOL, V11, P1298, DOI 10.1111/j.1365-2486.2005.00978.x; Tucker CL, 2017, BIOGEOCHEMISTRY, V135, P239, DOI 10.1007/s10533-017-0372-3; van Asperen H, 2017, AGR FOREST METEOROL, V234, P95, DOI 10.1016/j.agrformet.2016.12.014; Vargas R, 2008, NEW PHYTOL, V179, P460, DOI 10.1111/j.1469-8137.2008.02481.x; Vargas R, 2010, ECOL APPL, V20, P1569, DOI 10.1890/09-0693.1; Wang B, 2014, BIOGEOSCIENCES, V11, P259, DOI 10.5194/bg-11-259-2014; Welsch DL, 2004, BIOGEOCHEMISTRY, V71, P415, DOI 10.1023/B:BIOG.0000049350.24911.e9; Winkler JP, 1996, SOIL BIOL BIOCHEM, V28, P1067, DOI 10.1016/0038-0717(96)00076-4; Wohlfahrt G, 2008, GLOBAL CHANGE BIOL, V14, P1475, DOI 10.1111/j.1365-2486.2008.01593.x; Xu M, 2001, GLOBAL CHANGE BIOL, V7, P667, DOI 10.1046/j.1354-1013.2001.00435.x; Zhang ZS, 2013, PLANT SOIL, V367, P449, DOI 10.1007/s11104-012-1465-3; Zhong YQW, 2016, FIELD CROP RES, V199, P1, DOI 10.1016/j.fcr.2016.09.014	42	4	4	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195606	10.1371/journal.pone.0195606	http://dx.doi.org/10.1371/journal.pone.0195606			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624606	Green Submitted, Green Published, gold			2022-12-26	WOS:000429379600040
J	Vandepitte, L; Vanhoorne, B; Decock, W; Vranken, S; Lanssens, T; Dekeyzer, S; Verfaille, K; Horton, T; Kroh, A; Hernandez, F; Mees, J				Vandepitte, Leen; Vanhoorne, Bart; Decock, Wim; Vranken, Sofie; Lanssens, Thomas; Dekeyzer, Stefanie; Verfaille, Kevin; Horton, Tammy; Kroh, Andreas; Hernandez, Francisco; Mees, Jan			A decade of the World Register of Marine Species - General insights and experiences from the Data Management Team: Where are we, what have we learned and how can we continue?	PLOS ONE			English	Review								The World Register of Marine Species (WoRMS) celebrated its 10th anniversary in 2017. WoRMS is a unique database: there is no comparable global database for marine species, which is driven by a large, global expert community, is supported by a Data Management Team and can rely on a permanent host institute, dedicated to keeping WoRMS online. Over the past ten years, the content of WoRMS has grown steadily, and the system currently contains more than 242,000 accepted marine species. WoRMS has not yet reached completeness: approximately 2,000 newly described species per year are added, and editors also enter the remaining missing older names both accepted and unaccepted an effort amounting to approximately 20,000 taxon name additions per year. WoRMS is used extensively, through different channels, indicating that it is recognized as a high-quality database on marine species information. It is updated on a daily basis by its Editorial Board, which currently consists of 490 taxonomic and thematic experts located around the world. Owing to its unique qualities, WoRMS has become a partner in many large-scale initiatives including OBIS, LifeWatch and the Catalogue of Life, where it is recognized as a high-quality and reliable source of information for marine taxonomy.	[Vandepitte, Leen; Vanhoorne, Bart; Decock, Wim; Lanssens, Thomas; Dekeyzer, Stefanie; Verfaille, Kevin; Hernandez, Francisco; Mees, Jan] Flanders Marine Inst VLIZ, Wandelaarkaai 7, Oostende, Belgium; [Vranken, Sofie] UWA Oceans Inst, Sch Biol Sci, Perth, WA, Australia; [Horton, Tammy] Natl Oceanog Ctr, Southampton, Hants, England; [Kroh, Andreas] Nat Hist Museum, Vienna, Austria; [Mees, Jan] Univ Ghent, Ghent, Belgium	NERC National Oceanography Centre; Ghent University	Vandepitte, L (corresponding author), Flanders Marine Inst VLIZ, Wandelaarkaai 7, Oostende, Belgium.	leen.vandepitte@vliz.be	Kroh, Andreas/AAI-3650-2020; Vandepitte, Leen/N-9764-2014; Horton, Tammy/G-3590-2010; Mees, Jan/HDN-5048-2022	Kroh, Andreas/0000-0002-8566-8848; Vandepitte, Leen/0000-0002-8160-7941; Horton, Tammy/0000-0003-4250-1068; Vranken, Sofie/0000-0002-8459-041X	Flanders Marine Institute; MarBEF Network of Excellence 'Marine Biodiversity Ecosystem Functioning' (EU FP6) [GOCE-CT-2003-505446]; Pan European Species directories Infrastructure (PESI, EU-FP7) [RI-223806]; EMODnet Biology I [MARE/2008/03-Lot 4 Biology, SI2.531562]; 4D4Life [INFRA-2008-1.2.2, 238988]; EMODnet Biology 11 [MARE/2012/10 - Lot 5 Biology, SI2.657705]; EMODnet Biology III [EASME/EMFF/2016/1.3.1.2 - Lot 5/S121750022]; AquaRES [BR/132/A6/AQUARES]; LifeWatch; Alfred P. Sloan Foundation (through the Census of Marine Life, Memorial University, Canada); Global Biodiversity Information Facility (GBIF); Department of Fisheries and Oceans (DFO, Canada); Marine Environmental Data and Information Network (MEDIN, UK); CORONA project of the National Science Foundation (NSF, USA); Natural Environment Research Council [noc010009] Funding Source: researchfish; NERC [noc010009] Funding Source: UKRI	Flanders Marine Institute; MarBEF Network of Excellence 'Marine Biodiversity Ecosystem Functioning' (EU FP6); Pan European Species directories Infrastructure (PESI, EU-FP7); EMODnet Biology I; 4D4Life; EMODnet Biology 11; EMODnet Biology III; AquaRES; LifeWatch; Alfred P. Sloan Foundation (through the Census of Marine Life, Memorial University, Canada)(Alfred P. Sloan Foundation); Global Biodiversity Information Facility (GBIF); Department of Fisheries and Oceans (DFO, Canada); Marine Environmental Data and Information Network (MEDIN, UK); CORONA project of the National Science Foundation (NSF, USA)(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The continuous work on WoRMS is currently made possible through LifeWatch Belgium, part of the E-Science European LifeWatch Infrastructure for Biodiversity and Ecosystem Research. In addition, funding is available through the Flanders Marine Institute. Over the last 10 years, WoRMS and many of its sub-registers have been able to grow by funding received through several projects: MarBEF Network of Excellence 'Marine Biodiversity Ecosystem Functioning' (EU FP6, GOCE-CT-2003-505446; 2004-2009), Pan European Species directories Infrastructure (PESI, EU-FP7, RI-223806; 2009-2011), EMODnet Biology I (MARE/2008/03-Lot 4 Biology Contract nr SI2.531562; 2009-2011), 4D4Life (INFRA-2008-1.2.2 Scientific Data Infrastructures Grant Agreement 238988; 2009-2012), EMODnet Biology 11 (MARE/2012/10 - Lot 5 Biology - Contract nr SI2.657705; 2012-2016), EMODnet Biology III (EASME/EMFF/2016/1.3.1.2 - Lot 5/S121750022), AquaRES (BR/132/A6/AQUARES; 2014-2016) and LifeWatch (2012-2017). Next to structured project funding, a number of ad-hoc funds have also contributed to the further development of WoRMS: Alfred P. Sloan Foundation (through the Census of Marine Life, Memorial University, Canada), the Global Biodiversity Information Facility (GBIF), the Department of Fisheries and Oceans (DFO, Canada), the Marine Environmental Data and Information Network (MEDIN, UK), and the CORONA project of the National Science Foundation (NSF, USA).	[Anonymous], 2017, MYS; [Anonymous], 2010, MANY FISH OTHER SPEC; [Anonymous], 2012, ALC ECH; ASHWORTH JH, 1912, CATALOGUE CHAETOPO 1; Barber A.D., 2014, Bulletin of the British Myriapod and Isopod Group, V27, P43; Costello MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051629; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Costello MJ, 2008, MAR BEF NEWSLETTER, V8, P36; De Broyer C., 2017, REGISTER ANTARCTIC M; Ellis J, 1786, NATURAL HIST MANY CU; Esper EJC, 1788, PFLANZENTHIERE ABBIL; FLEMING J., 1828, HIST BRIT ANIMALS EX; Gerovasileiou V, 2017, WORLD REGISTER MARIN; Guiry MD, 2017, ALGAEBASE; Hartmeyer R., 1916, Mitteilungen aus dem Zoologischen Museum in Berlin, V8; Horton T, 2017, EUR J TAXON, V389, P1, DOI 10.5852/ejt.2017.389; Lamarck JBP, 1815, MEMOIRES MUSEUM HIST, V1, p[69, 162, 331]; Leveque C, 2005, HYDROBIOLOGIA, V542, P39, DOI 10.1007/s10750-004-5522-7; Linnaeus C, 1766, SYSTEMA NATURAE REGN; O'Dor R, 2004, BIOSCIENCE, V54, P92, DOI 10.1641/0006-3568(2004)054[0092:ACOML]2.0.CO;2; Pagad S, 2017, WORLD REGISTER INTRO; Parr Cynthia S, 2014, Biodivers Data J, pe1079, DOI 10.3897/BDJ.2.e1079; Read G., 2017, SCOLOPENDRA LINNAEUS; Read G., 2017, COLOPENDRA MARINA LI; Rees T., 2008, P TDWG, P72; Rees T., 2008, P C OC BIOD INF 2 4, P11; Rees T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107510; Roskov Y., 2017, SPECIES 2000 ITIS CA; Sanamyan K., 2007, ASCIDIACEA WORLD DAT; Sanamyan K., 2007, ASCIDIACEA WORLD DAT; Schlosser JA, 1755, FRS PHILOS T, V49, P449; Slabber M., 1781, PHYS BELUSTIGUNGEN M; Thompson DA, 1910, WORKS ARISTOTLE HIST; Turton W., 1807, BRIT FAUNA CONTAININ; van Soest R, 1758, ALCYONIUM LINNAEUS; Van Soest RWM, 2016, WORLD PORIFERA DATAB; Vandepitte L, 2015, J MAR SCI ENG, V3, P1448, DOI 10.3390/jmse3041448; Vanhoorne B, 2008, INT MARINE DATA INFO, P145; Xu K, 2017, CHINESE REGISTER MAR	39	15	15	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0194599	10.1371/journal.pone.0194599	http://dx.doi.org/10.1371/journal.pone.0194599			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624577	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000429379600008
J	Churchward, CP; Calder, A; Snyder, LAS				Churchward, Colin P.; Calder, Alan; Snyder, Lori A. S.			Mutations in Neisseria gonorrhoeae grown in sub-lethal concentrations of monocaprin do not confer resistance	PLOS ONE			English	Article							ENCODED EFFLUX PUMP; FACTOR DKSA; STRAINS; REGIONS; GENE; PARC; GYRA	Neisseria gonorrhoeae, due to its short lipooligosaccharide structure, is generally more sensitive to the antimicrobial effects of some fatty acids than most other Gram negative bacteria. This supports recent development of a fatty acid-based potential treatment for gonococcal infections, particularly ophthalmia neonatorum. The N. gonorrhoeae genome contains genes for fatty acid resistance. In this study, the potential for genomic mutations that could lead to resistance to this potential new treatment were investigated. N. gonorrhoeae strain NCCP11945 was repeatedly passaged on growth media containing a sub-lethal concentration of fatty acid myristic acid and monoglyceride monocaprin. Cultures were re-sequenced and assessed for changes in minimum inhibitory concentration. Of note, monocaprin grown cultures developed a mutation in transcription factor gene dksA, which suppresses molecular chaperone DnaK and may be involved in the stress response. The minimum inhibitory concentration after exposure to monocaprin showed a modest two-fold change. The results of this study suggest that N. gonorrhoeae cannot readily evolve resistance that will impact treatment of ophthalmia neonatorum with monocaprin.	[Churchward, Colin P.; Calder, Alan; Snyder, Lori A. S.] Kingston Univ, Sch Life Sci Pharm & Chem, Kingston Upon Thames, Surrey, England; [Churchward, Colin P.] Imperial Coll London, Natl Heart & Lung Inst, London, England	Kingston University; Imperial College London	Snyder, LAS (corresponding author), Kingston Univ, Sch Life Sci Pharm & Chem, Kingston Upon Thames, Surrey, England.	Lsnyder@kingston.ac.uk	Churchward, Colin/AAB-2736-2020	Snyder, Lori/0000-0003-3172-3984; Calder, Alan/0000-0001-5012-048X; Churchward, Colin/0000-0002-7590-5504	Sparks Children's Medical Research charity [11KIN01, 13KIN01]	Sparks Children's Medical Research charity	This work was supported by the Sparks Children's Medical Research charity (www.sparks.org.uk), which has provided for this work with Project Grants 11KIN01 and 13KIN01 to support Colin Churchward and this research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen VG, 2011, ANTIMICROB AGENTS CH, V55, P703, DOI 10.1128/AAC.00788-10; BELLAND RJ, 1994, MOL MICROBIOL, V14, P371, DOI 10.1111/j.1365-2958.1994.tb01297.x; Bergsson G, 1999, ANTIMICROB AGENTS CH, V43, P2790, DOI 10.1128/AAC.43.11.2790; Blaby-Haas CE, 2011, MOL MICROBIOL, V79, P700, DOI 10.1111/j.1365-2958.2010.07475.x; Centers for Disease Control and Prevention, 2006, MMWR Recomm Rep, V55, P1; Chen PL, 2010, J FORMOS MED ASSOC, V109, P120, DOI 10.1016/S0929-6646(10)60032-0; Chung GT, 2008, J BACTERIOL, V190, P6035, DOI 10.1128/JB.00566-08; Churchward CP, 2017, MBIO, V8, DOI 10.1128/mBio.00534-17; Deguchi T, 1996, ANTIMICROB AGENTS CH, V40, P1020, DOI 10.1128/AAC.40.4.1020; Furman R, 2012, NUCLEIC ACIDS RES, V40, P3392, DOI 10.1093/nar/gkr1273; Golosova O, 2014, PEERJ, V2, DOI 10.7717/peerj.644; HAGMAN KE, 1995, J BACTERIOL, V177, P4162, DOI 10.1128/jb.177.14.4162-4165.1995; Hecht M, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S8-S1; Johnson PJT, 2011, ANTIMICROB AGENTS CH, V55, P2559, DOI 10.1128/AAC.00010-11; KANG PJ, 1990, J BACTERIOL, V172, P2055, DOI 10.1128/jb.172.4.2055-2064.1990; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee EH, 2003, J BACTERIOL, V185, P7145, DOI 10.1128/JB.185.24.7145-7152.2003; Lee EH, 1999, MOL MICROBIOL, V33, P839, DOI 10.1046/j.1365-2958.1999.01530.x; Lee EH, 2006, MOL MICROBIOL, V60, P1381, DOI 10.1111/j.1365-2958.2006.05185.x; Lee JH, 2012, J MOL BIOL, V416, P503, DOI 10.1016/j.jmb.2011.12.028; Long A, 2015, NAT REV GENET, V16, P567, DOI 10.1038/nrg3937; Mallik P, 2006, J BACTERIOL, V188, P5775, DOI 10.1128/JB.00276-06; Meddows TR, 2005, MOL MICROBIOL, V57, P97, DOI 10.1111/j.1365-2958.2005.04677.x; MORSE SA, 1982, INFECT IMMUN, V37, P432, DOI 10.1128/IAI.37.2.432-438.1982; Mueller EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120280; Ohneck EA, 2011, MBIO, V2, DOI 10.1128/mBio.00187-11; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Schielke S, 2011, INT J MED MICROBIOL, V301, P325, DOI 10.1016/j.ijmm.2010.11.007; Schlievert PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040350; Schlotterer C, 2015, HEREDITY, V114, P431, DOI 10.1038/hdy.2014.86; Su XH, 2001, ANTIMICROB AGENTS CH, V45, P117, DOI 10.1128/AAC.45.1.117-123.2001	33	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195453	10.1371/journal.pone.0195453	http://dx.doi.org/10.1371/journal.pone.0195453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621310	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000429206800086
J	Jella, KK; Moriarty, R; McClean, B; Byrne, HJ; Lyng, FM				Jella, Kishore Kumar; Moriarty, Roisin; McClean, Brendan; Byrne, Hugh J.; Lyng, Fiona M.			Reactive oxygen species and nitric oxide signaling in bystander cells	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; MEDIATED INTERCELLULAR COMMUNICATION; TARGETED CYTOPLASMIC IRRADIATION; SISTER-CHROMATID EXCHANGES; ALPHA-PARTICLE IRRADIATION; VERY-LOW FLUENCES; IONIZING-RADIATION; GLIOMA-CELLS; NONIRRADIATED CELLS; HUMAN FIBROBLASTS	It is now well accepted that radiation induced bystander effects can occur in cells exposed to media from irradiated cells. The aim of this study was to follow the bystander cells in real time following addition of media from irradiated cells and to determine the effect of inhibiting these signals. A human keratinocyte cell line, HaCaT cells, was irradiated (0.005, 0.05 and 0.5 Gy) with Y irradiation, conditioned medium was harvested after one hour and added to recipient bystander cells. Reactive oxygen species, nitric oxide, Glutathione levels, caspase activation, cytotoxicity and cell viability was measured after the addition of irradiated cell conditioned media to bystander cells. Reactive oxygen species and nitric oxide levels in bystander cells treated with 0.5Gy ICCM were analysed in real time using time lapse fluorescence microscopy. The levels of reactive oxygen species were also measured in real time after the addition of extracellular signal-regulated kinase and c-Jun amino-terminal kinase pathway inhibitors. ROS and glutathione levels were observed to increase after the addition of irradiated cell conditioned media (0.005, 0.05 and 0.5 Gy ICCM). Caspase activation was found to increase 4 hours after irradiated cell conditioned media treatment (0.005, 0.05 and 0.5 Gy ICCM) and this increase was observed up to 8 hours and there after a reduction in caspase activation was observed. A decrease in cell viability was observed but no major change in cytotoxicity was found in HaCaT cells after treatment with irradiated cell conditioned media (0.005, 0.05 and 0.5 Gy ICCM). This study involved the identification of key signaling molecules such as reactive oxygen species, nitric oxide, glutathione and caspases generated in bystander cells. These results suggest a clear connection between reactive oxygen species and cell survival pathways with persistent production of reactive oxygen species and nitric oxide in bystander cells following exposure to irradiated cell conditioned media.	[Jella, Kishore Kumar] Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Moriarty, Roisin; Lyng, Fiona M.] Dublin Inst Technol, Radiat & Environm Sci Ctr, Focas Inst, Dublin, Ireland; [McClean, Brendan] St Lukes Hosp, Dublin, Ireland; [Byrne, Hugh J.] Dublin Inst Technol, Focas Inst, Dublin, Ireland; [Lyng, Fiona M.] Dublin Inst Technol, Sch Phys, Dublin, Ireland	Emory University; Technological University Dublin; Trinity College Dublin; Technological University Dublin; Technological University Dublin	Jella, KK (corresponding author), Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA.	kjella@emory.edu	Lyng, Fiona/AAD-2842-2020; Byrne, Hugh James/AAD-9713-2020; Jella, Kishore Kumar/N-9875-2018	Lyng, Fiona/0000-0002-9876-963X; Byrne, Hugh James/0000-0002-1735-8610; Jella, Kishore Kumar/0000-0001-9707-795X; Moriarty, Roisin/0000-0001-9167-2328	Irish Government's Programme for Research in Third Level Institutions, Cycle 4	Irish Government's Programme for Research in Third Level Institutions, Cycle 4	The work was conducted as part of the National Biophotonics and Imaging Platform of Ireland (NBIPI), funded by the Irish Governments Programme for Research in Third Level Institutions, Cycle 4 (2007-2013).	Al-Mayah A, 2015, MUTAT RES-FUND MOL M, V772, P38, DOI 10.1016/j.mrfmmm.2014.12.007; Al-Mayah AHJ, 2012, RADIAT RES, V177, P539, DOI 10.1667/RR2868.1; Aloy MT, 2008, INT J RADIAT ONCOL, V70, P543, DOI 10.1016/j.ijrobp.2007.08.061; Azzam EI, 2002, CANCER RES, V62, P5436; Azzam EI, 2003, CANCER RES, V63, P7128; Azzam EI, 1998, RADIAT RES, V150, P497, DOI 10.2307/3579865; Azzam EI, 2001, P NATL ACAD SCI USA, V98, P473, DOI 10.1073/pnas.011417098; Burdak-Rothkamm S, 2007, ONCOGENE, V26, P993, DOI 10.1038/sj.onc.1209863; Burdak-Rothkamm S, 2015, CANCER LETT, V356, P454, DOI 10.1016/j.canlet.2014.09.043; Chen S, 2008, BRIT J CANCER, V98, P1839, DOI 10.1038/sj.bjc.6604358; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Facoetti A, 2006, RADIAT PROT DOSIM, V122, P271, DOI 10.1093/rpd/ncl431; Facoetti A, 2009, INT J RADIAT BIOL, V85, P690, DOI 10.1080/09553000903020016; Furlong H, 2013, MUTAT RES-FUND MOL M, V741, P35, DOI 10.1016/j.mrfmmm.2013.02.001; Ghandhi SA, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-63; Hamada N, 2007, J RADIAT RES, V48, P87, DOI 10.1269/jrr.06084; Han W, 2007, ONCOGENE, V26, P2330, DOI 10.1038/sj.onc.1210024; Hanot M, 2009, INT J RADIAT ONCOL, V75, P1247, DOI 10.1016/j.ijrobp.2009.07.014; Harada T, 2008, INT J RADIAT BIOL, V84, P809, DOI 10.1080/09553000802360844; Hei TK, 2008, J PHARM PHARMACOL, V60, P943, DOI 10.1211/jpp.60.8.0001; Huo LH, 2001, RADIAT RES, V156, P521, DOI 10.1667/0033-7587(2001)156[0521:HMIIBC]2.0.CO;2; Iyer R, 2000, CANCER RES, V60, P1290; Jella KK, 2014, RADIAT RES, V181, P138, DOI 10.1667/RR13337.1; Jella KK, 2013, INT J RADIAT BIOL, V89, P182, DOI 10.3109/09553002.2013.734942; Jiang Y, 2014, BRIT J CANCER, V111, P772, DOI 10.1038/bjc.2014.368; Klokov D, 2004, MUTAT RES-FUND MOL M, V568, P97, DOI 10.1016/j.mrfmmm.2004.06.049; Koturbash I, 2006, ONCOGENE, V25, P4267, DOI 10.1038/sj.onc.1209467; Koturbash I, 2006, INT J RADIAT ONCOL, V66, P327, DOI 10.1016/j.ijrobp.2006.06.012; Le M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173685; Leach JK, 2001, CANCER RES, V61, P3894; Lee CF, 2005, ANN NY ACAD SCI, V1042, P246, DOI 10.1196/annals.1338.027; Lehnert BE, 1997, CANCER RES, V57, P2164; Lewis DA, 2001, RADIAT RES, V156, P251, DOI 10.1667/0033-7587(2001)156[0251:PODDAN]2.0.CO;2; Li ZT, 2015, RADIAT RES, V184, P249, DOI 10.1667/RR14092.1; Li ZT, 2014, RADIAT RES, V182, P573, DOI 10.1667/RR13723.1; Li ZT, 2013, RADIAT RES, V180, P17, DOI 10.1667/RR3332.1; Liu ZF, 2006, RADIAT RES, V166, P19, DOI 10.1667/RR3580.1; Lopez-Sanchez N, 2007, MOL CANCER RES, V5, P47, DOI 10.1158/1541-7786.MCR-06-0233; Lorimore SA, 1998, P NATL ACAD SCI USA, V95, P5730, DOI 10.1073/pnas.95.10.5730; Luce A, 2009, CARCINOGENESIS, V30, P432, DOI 10.1093/carcin/bgp008; Lyng FM, 2012, INT J RADIAT BIOL, V88, P770, DOI 10.3109/09553002.2012.705222; Lyng FM, 2011, INT J RADIAT BIOL, V87, P683, DOI 10.3109/09553002.2010.549533; Lyng FM, 2000, BRIT J CANCER, V83, P1223, DOI 10.1054/bjoc.2000.1433; Lyng FM, 2006, RADIAT RES, V165, P400, DOI 10.1667/RR3527.1; Lyng FM, 2002, RADIAT PROT DOSIM, V99, P169, DOI 10.1093/oxfordjournals.rpd.a006753; Lyng FM, 2002, RADIAT RES, V157, P365, DOI 10.1667/0033-7587(2002)157[0365:IOAICE]2.0.CO;2; Lyng FM, 2011, INT J RAD BIOL; Maguire P, 2005, RADIAT RES, V163, P384, DOI 10.1667/RR3325; Matsumoto H, 2001, RADIAT RES, V155, P387, DOI 10.1667/0033-7587(2001)155[0387:IORBAN]2.0.CO;2; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; MOREL F, 1991, EUR J BIOCHEM, V201, P523, DOI 10.1111/j.1432-1033.1991.tb16312.x; Morgan WF, 2009, HEALTH PHYS, V97, P426, DOI 10.1097/HP.0b013e3181ab98c7; Mothersill C, 1997, INT J RADIAT BIOL, V71, P421, DOI 10.1080/095530097144030; Mothersill C, 2006, MUTAT RES-FUND MOL M, V597, P5, DOI 10.1016/j.mrfmmm.2005.10.011; Murphy JEJ, 2005, MUTAT RES-GEN TOX EN, V585, P127, DOI 10.1016/j.mrgentox.2005.04.011; Nagasawa H, 2002, CANCER RES, V62, P2531; NAGASAWA H, 1992, CANCER RES, V52, P6394; Narayanan PK, 1997, CANCER RES, V57, P3963; Niles Andrew L, 2009, Curr Chem Genomics, V3, P33, DOI 10.2174/1875397300903010033; Osterreicher J, 2003, ACTA HISTOCHEM, V105, P223, DOI 10.1078/0065-1281-00710; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Prise KM, 1998, INT J RADIAT BIOL, V74, P793, DOI 10.1080/095530098141087; Seymour CB, 2000, RADIAT RES, V153, P508, DOI 10.1667/0033-7587(2000)153[0508:RCOBAT]2.0.CO;2; Shao C, 2008, ONCOGENE, V27, P434, DOI 10.1038/sj.onc.1210653; Shao C, 2003, CANCER RES, V63, P8437; Shao C, 2002, INT J RADIAT BIOL, V78, P837, DOI 10.1080/09553000210149786; Shao C, 2008, MUTAT RES-FUND MOL M, V638, P139, DOI 10.1016/j.mrfmmm.2007.09.007; Shao CL, 2006, RADIAT RES, V166, P479, DOI 10.1667/RR3600.1; Shao CL, 2004, P NATL ACAD SCI USA, V101, P13495, DOI 10.1073/pnas.0404930101; Shareef MM, 2007, CANCER RES, V67, P11811, DOI 10.1158/0008-5472.CAN-07-0722; Spitz DR, 2004, CANCER METAST REV, V23, P311, DOI 10.1023/B:CANC.0000031769.14728.bc; Tartier L, 2007, CANCER RES, V67, P5872, DOI 10.1158/0008-5472.CAN-07-0188; Temme J, 2013, RADIAT RES, V179, P422, DOI 10.1667/RR3161.2; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Wang XD, 2015, INT J RADIAT BIOL, V91, P452, DOI 10.3109/09553002.2015.1012308; Wright EG, 2006, MUTAT RES-FUND MOL M, V597, P119, DOI 10.1016/j.mrfmmm.2005.03.035; Wu LJ, 1999, P NATL ACAD SCI USA, V96, P4959, DOI 10.1073/pnas.96.9.4959; Xie YX, 2015, MUTAT RES-FUND MOL M, V772, P23, DOI 10.1016/j.mrfmmm.2014.12.010; Yang HY, 2005, ONCOGENE, V24, P2096, DOI 10.1038/sj.onc.1208439; Zhuang SG, 2008, J PHARMACOL EXP THER, V325, P732, DOI 10.1124/jpet.108.136358	80	20	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195371	10.1371/journal.pone.0195371	http://dx.doi.org/10.1371/journal.pone.0195371			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621312	Green Published, Green Submitted, gold			2022-12-26	WOS:000429206800072
J	Kleven, MD; Gomes, MM; Wortham, AM; Enns, CA; Kahl, CA				Kleven, Mark D.; Gomes, Michelle M.; Wortham, Aaron M.; Enns, Caroline A.; Kahl, Christoph A.			Ultrafiltered recombinant AAV8 vector can be safely administered in vivo and efficiently transduces liver	PLOS ONE			English	Article							ADENOASSOCIATED VIRAL VECTORS; GENE-TRANSFER; HEPCIDIN EXPRESSION; VIRUS; PURIFICATION; SEROTYPE; STOCKS; CONTAMINANTS; TROPISM; MUSCLE	Viral vectors are extensively purified for use in biomedical research, in order to separate biologically active virus particles and to eliminate production related impurities that are assumed to be detrimental to the host. For recombinant adeno-associated virus (rAAV) vectors this is typically accomplished using density gradient-based methods, which are tedious and require specialized ultracentrifugation equipment. In order to streamline the preparation of rAAV vectors for pilot and small animal studies, we recently devised a simple ultrafiltration approach that permits rapid virus concentration and partial removal of production-related impurities. Here we show that systemic administration of such rapidly prepared (RP) rAAV8 vectors in mice is safe and efficiently transduces the liver. Across a range of doses, delivery of RP rAAV8-CMV-eGFP vector induced enhanced green fluorescent protein (eGFP) expression in liver that was comparable to that obtained from a conventional iodixanol gradient-purified (IP) vector. Surprisingly, no liver inflammation or systemic cytokine induction was detected in RP rAAV injected animals, revealing that residual impurities in the viral vector preparation are not deleterious to the host. Together, these data demonstrate that partially purified rAAV vector can be safely and effectively administered in vivo. The speed and versatility of the RP method and lack of need for cumbersome density gradients or expensive ultracentrifuge equipment will enable more widespread use of RP prepared rAAV vectors, such as for pilot liver gene transfer studies.	[Kleven, Mark D.; Wortham, Aaron M.; Enns, Caroline A.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA; [Gomes, Michelle M.; Kahl, Christoph A.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center	Kahl, CA (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Portland, OR 97201 USA.	kahl@ohsu.edu		Gomes, Michelle/0000-0003-4809-2664	National Institutes of Health [P510D011092]; National Institute of Diabetes and Digestive and Kidney Diseases [R0172166, R37054488, T32 A1007472]; NIH NIDDK [R0172166, R37054488, T32 A1007472]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK054488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All rAAV productions and neutralizing assays were supported in part by National Institutes of Health grant P510D011092 (support for the Oregon National Primate Research Center). Research support for the mouse liver studies came from National Institute of Diabetes and Digestive and Kidney Diseases R0172166 and R37054488 (to C.A.E.) and T32 A1007472 (to M.D.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All rAAV productions and neutralizing assays were supported in part by National Institutes of Health grant P510D011092 (support for the Oregon National Primate Research Center). Research support for the mouse liver studies came from NIH NIDDK R0172166 and R37054488 (to C.A.E.) and T32 A1007472 (to M.D.K.). We are thankful to Jim Wilson and the University of Pennsylvania Vector Core for providing AAV plasmids, to Byung Park and Lina Gao for biostatistics advice, to Barbra Mason (ONPRC Histopathology-Morphology Core) and Sathya Srinivasan (ONPRC Imaging and Morphology Support Core) for help with preparation and imaging of liver immunofluorescence slides, and to Anupriya Agarwal at OHSU for the cytokine panel studies.	Ai JZ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40336; Alexander IE, 1997, HUM GENE THER, V8, P1911, DOI 10.1089/hum.1997.8.16-1911; [Anonymous], 2015, PUB THERMOFISHER SCI, VMAN0004015; Arden Erik, 2016, J Biol Methods, V3; Aurnhammer C, 2012, HUM GENE THER METHOD, V23, P18, DOI 10.1089/hgtb.2011.034; Ayuso E, 2010, GENE THER, V17, P503, DOI 10.1038/gt.2009.157; Ayuso E, 2010, CURR GENE THER, V10, P423, DOI 10.2174/156652310793797685; Burova E, 2005, GENE THER, V12, pS5, DOI 10.1038/sj.gt.3302611; Clement N, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.2; D'Costa S, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.19; Doria M, 2013, HUM GENE THER METHOD, V24, P392, DOI 10.1089/hgtb.2013.155; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Gao JW, 2010, BLOOD, V115, P3374, DOI 10.1182/blood-2009-09-245209; Gao K, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2013.9; Geering B, 2011, J IMMUNOL METHODS, V373, P209, DOI 10.1016/j.jim.2011.08.024; Gomes MM, 2016, METHODS MOL BIOL, V1427, P43, DOI 10.1007/978-1-4939-3615-1_3; Goncalves MAFV, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-43; Guo P, 2012, J VIROL METHODS, V183, P139, DOI 10.1016/j.jviromet.2012.04.004; Halbert CL, 1998, J VIROL, V72, P9795, DOI 10.1128/JVI.72.12.9795-9805.1998; Hosel M, 2012, HEPATOLOGY, V55, P287, DOI 10.1002/hep.24625; Klein RL, 2008, MOL THER, V16, P89, DOI 10.1038/sj.mt.6300331; Li LN, 2005, J GENE MED, V7, P420, DOI 10.1002/jgm.681; Mingozzi F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005795; Miyake K, 2012, J NIPPON MED SCH, V79, P394, DOI 10.1272/jnms.79.394; Moss B, 2013, FIELDS VIROLOGY, V2, P2129; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Pien GC, 2009, J CLIN INVEST, V119, P1688, DOI 10.1172/JCI36891; Strobel B, 2015, HUM GENE THER METHOD, V26, P147, DOI 10.1089/hgtb.2015.051; Tenenbaum L, 1999, GENE THER, V6, P1045, DOI 10.1038/sj.gt.3300904; Urabe M, 2006, MOL THER, V13, P823, DOI 10.1016/j.ymthe.2005.11.024; Wahedi M, 2017, J BIOL CHEM, V292, P18354, DOI 10.1074/jbc.M117.801795; Wang LL, 2015, MOL THER, V23, P1877, DOI 10.1038/mt.2015.179; Wright JF, 2014, BIOMEDICINES, V2, P80, DOI 10.3390/biomedicines2010080; Zhu JG, 2009, J CLIN INVEST, V119, P2388, DOI 10.1172/JCI37607; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	36	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194728	10.1371/journal.pone.0194728	http://dx.doi.org/10.1371/journal.pone.0194728			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621273	gold, Green Published			2022-12-26	WOS:000429206800025
J	Wang, JN; Sun, W; Wells, GA; Li, ZB; Li, TY; Wu, JD; Zhang, YY; Liu, YY; Li, LB; Yu, YP; Liu, YH; Qi, C; Lu, Y; Liu, N; Yan, YY; Liu, LL; Hui, G; Liu, B				Wang, Junnan; Sun, Wei; Wells, George A.; Li, Zhibo; Li, Tianyi; Wu, Junduo; Zhang, Yangyu; Liu, Yingyu; Li, Longbo; Yu, Yunpeng; Liu, Yihang; Qi, Chao; Lu, Yang; Liu, Ning; Yan, Youyou; Liu, Lulu; Hui, Gang; Liu, Bin			Differences in prevalence of hypertension and associated risk factors in urban and rural residents of the northeastern region of the People's Republic of China: A cross-sectional study	PLOS ONE			English	Article							BLOOD-PRESSURE; AWARENESS; MANAGEMENT; ADULTS; GUIDELINES; DIETARY; OBESITY; TRENDS	Background Hypertension is a significant global public health problem and recognized as an important risk factor for cardiovascular diseases. This study was designed to assess the current prevalence of hypertension and to explore risk factors associated with hypertension by urban and rural status to guide the prevention and control of hypertension in Jilin province. Methods A multi-stage stratified random cluster sampling method was used to obtain data on hypertension, which was investigated by physical examination and face-to-face questionnaire in July 2014-December 2015. Sample data were analyzed by complex weighted statistical analysis to estimate blood pressure levels and prevalence of hypertension in the province. Multivariable logistic regression analysis was used to identify factors influencing hypertension rates. Results The prevalence of hypertension was significantly higher in rural areas than urban areas (25.93% versus 22.73%, respectively). The rates of hypertension known (46.7% versus 38.1%, respectively), control (13.7% versus 5.0%, respectively), and controlled among treated subjects (38.3% versus 17.5%, respectively) were higher in urban areas than in rural areas (all p < 0.001), while the treatment rate was not statistically significantly different between urban and rural areas (35.9% versus 28.4%, respectively). After adjusting for demographic covariates, hypertension prevalence in rural areas was still significantly greater than in urban areas (adjusted OR = 1.22; 95%Cl: 1.10, 1.36; p < 0.001). Common risk factors for hypertension among urban and rural residents included older age; male; married; employed; less education; overweight/obese; greater abdominal waist circumference; family history of hypertension, stroke, or coronary heart disease; current smoker; alcohol consumption; higher visceral adiposity index; and higher body fat percentage. Conclusions This study identified an increased risk for hypertension in rural regions of Jilin province, suggesting that rural hypertension screening and treatment guidelines should receive greater attention.	[Wang, Junnan; Sun, Wei; Li, Zhibo; Li, Tianyi; Wu, Junduo; Li, Longbo; Yu, Yunpeng; Liu, Yihang; Qi, Chao; Lu, Yang; Liu, Ning; Yan, Youyou; Liu, Lulu; Hui, Gang; Liu, Bin] Jilin Univ, Hosp 2, Dept Cardiol, Changchun, Jilin, Peoples R China; [Wells, George A.] Univ Ottawa, Heart Inst, Dept Cardiovasc, Res Methods Ctr, Ottawa, ON, Canada; [Zhang, Yangyu; Liu, Yingyu] Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Changchun, Jilin, Peoples R China	Jilin University; University of Ottawa; University of Ottawa Heart Institute; Jilin University	Liu, B (corresponding author), Jilin Univ, Hosp 2, Dept Cardiol, Changchun, Jilin, Peoples R China.	liubin3333@vip.sina.com			National Key RAMP;D Program from the Chinese Ministry of Science and Technology [2011BA111601]; National Clinical Key Specialty Project	National Key RAMP;D Program from the Chinese Ministry of Science and Technology; National Clinical Key Specialty Project	This study was supported by the National Key R&D Program in the Twelfth Five-year Plan (No. 2011BA111601) from the Chinese Ministry of Science and Technology and the National Clinical Key Specialty Project.	Abdul-Razak S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3008-y; Abu-Saad K, 2014, AM J HYPERTENS, V27, P1511, DOI 10.1093/ajh/hpu081; Akinlua JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140021; Anchala R, 2014, J HYPERTENS, V32, P1170, DOI 10.1097/HJH.0000000000000146; [Anonymous], 2011, CHIN J HYPERTENS; Bi ZQ, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130423; Booth JN, 2017, HYPERTENSION, V70, P275, DOI 10.1161/HYPERTENSIONAHA.116.09004; Bursztyn M, 2014, J HYPERTENS, V32, P1351, DOI [10.1097/HJH.0000000000000171, 10.1097/HJH.0000000000000170]; Chang G, 2006, CHINESE J PREVENTION, V14, P101; Chen XF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091830, 10.1371/journal.pone.0085716, 10.1371/journal.pone.0115462, 10.1371/journal.pone.0103330, 10.1371/journal.pone.0091809, 10.1371/journal.pone.0087752]; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Dastan I, 2017, ANATOL J CARDIOL, V18, P39, DOI 10.14744/AnatolJCardiol.2017.7452; De Buyzere M, 2015, J HYPERTENS, V33, P2200, DOI 10.1097/HJH.0000000000000718; Diederichs C, 2014, J HYPERTENS, V32, P1405, DOI 10.1097/HJH.0000000000000211; Gao KY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04552-5; Guan X, 2008, CHIN PREV MED, V9, P197; Guo FJ, 2012, J AM COLL CARDIOL, V60, P599, DOI 10.1016/j.jacc.2012.04.026; Halanych JH, 2010, AM J EPIDEMIOL, V171, P532, DOI 10.1093/aje/kwp417; Hay SI, 2017, LANCET, V389, pE1; Hu LH, 2017, PLOS ONE, V12; Hu MQ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004709; Huang JS, 1960, NAT S HEART VASC DIS; Kogure M, 2016, HYPERTENS RES, V39, P670, DOI 10.1038/hr.2016.46; Lee S, 2005, INT J EPIDEMIOL, V34, P69, DOI 10.1093/ije/dyh258; Lei XY, 2012, CHINA ECON REV, V23, P105, DOI 10.1016/j.chieco.2011.08.004; Leung AA, 2016, CAN J CARDIOL, V32, P569, DOI 10.1016/j.cjca.2016.02.066; Li J, 2014, J ZHENGZHOU U, V49, P744; Li JJ, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0545-7; Lim SS, 2013, LANCET, V381, P1276; Lv SR, 2011, CHINESE J HLTH ED, V27, P52; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Markovic BB, 2011, CROAT MED J, V52, P566, DOI [10.3325/cmj.2011.52.566, 10.3325/cmj.2011.52.556]; Meng XY, 2009, J APPL PREVENTIVE ME, V15, P207; Mittal BV, 2010, AM J KIDNEY DIS, V55, P590, DOI 10.1053/j.ajkd.2009.06.044; Nagai M, 2015, HYPERTENS RES, V38, P790, DOI 10.1038/hr.2015.81; National Health Commission for Disease Control and Prevention, 2015, CHIN RES NUTR CHRON; Olsen MH, 2016, LANCET, V388, P2665, DOI 10.1016/S0140-6736(16)31134-5; Ratovoson R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137408; Rumball-Smith J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-536; Su M, 2017, LANCET, V390, P2559, DOI 10.1016/S0140-6736(17)32476-5; Suliburska J, 2012, ANN AGR ENV MED, V19, P339; The sixth census leading group office of Jilin Province Jilin Provincial Bureau of Statistics, 2012, JIL PROV 2010 CENS D; Tian S, 2011, HYPERTENS RES, V34, P1087, DOI 10.1038/hr.2011.99; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062469; Wang JW, 2014, AM J HYPERTENS, V27, P1355, DOI 10.1093/ajh/hpu053; [王诗镔 Wang Shibin], 2014, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V40, P183; Wei Q, 2015, J HUM HYPERTENS, V29, P64, DOI 10.1038/jhh.2014.32; Wu L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132814; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Wu Y, 2009, J HYPERTENS, V27, P190, DOI 10.1097/HJH.0b013e328317c8c3; Yang G, 2016, INT J ENV RES PUB HE, V13; Yang L, 2016, PLOS ONE, V11; Zhang G, 2013, CHIN J HLTH ED, V29, P499; [章蓉 Zhang Rong], 2014, [南京医科大学学报. 自然科学版, Journal of Nanjing Medical University. Natural Sciences Edition], V34, P84; 陈伟伟, 2017, [中国循环杂志, Chinese Circulation Journal], V32, P521	55	42	43	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195340	10.1371/journal.pone.0195340	http://dx.doi.org/10.1371/journal.pone.0195340			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621328	Green Published, gold, Green Submitted			2022-12-26	WOS:000429206800067
J	Crego, RD; Jimenez, JE; Rozzi, R				Crego, Ramiro D.; Jimenez, Jaime E.; Rozzi, Ricardo			Potential niche expansion of the American mink invading a remote island free of native-predatory mammals	PLOS ONE			English	Article							HORN BIOSPHERE RESERVE; ACTIVITY PATTERNS; NEOVISON-VISON; MUSTELA-VISON; HABITAT SELECTION; NAVARINO ISLAND; RELEASE; IMPACT; CONSERVATION; COEXISTENCE	The success of an invasive species depends in part on its niche and the new niche opportunities that such species may find in the invaded habitat. Niche opportunities can be understood as the potential provided by a community to an invasive species to expand its niche by changes in habitat use, behavior, or diet, that favors population growth, reflected in the species occupying more habitat. This may occur under a favorable combination of access to resources that can be further favored by a lack of competitors and a release from natural enemies. The American mink (Neovison vison) is a crepuscular/nocturnal and semi-aquatic mustelid native to North America that generally concentrates activities at <100 m from the water. It has recently established an invasive population on Navarino Island in southern Chile. Here, the mink is now the top terrestrial predator free of predators or competitors. We hypothesized that this lack of potential predators and competitors, together with a more diurnal and terrestrial prey, have resulted in the mink expanding its spatial and temporal niche on Navarino Island as compared to that in its native habitats, expressed in occupancy of sites away from water and diurnal activity. We evaluated this by using 93 randomly-chosen camera-trap stations, occupancy models and mink daily activity patterns. Models showed a dynamic occupancy with the area occupied by mink being highest during summers and lowest in spring with seasonal changes in occupancy related to distance to water sources. Mink occupied and were active at sites up to 880 m from water sources during summers. Occupancy decreased at shorter distances from water during spring, but mink were still active at up to 300 m from water. Mink were active daylong during summers, and nocturnal and crepuscular during winter and spring. These results show that compared to the native and other invaded habitats, on Navarino Island mink use more terrestrial habitats and are more diurnal during summers, suggesting a niche expansion under new niche opportunities that may enhance the negative impacts of this predator on a myriad of small native vertebrates.	[Crego, Ramiro D.; Jimenez, Jaime E.] Univ North Texas, Dept Biol Sci, Denton, TX 76203 USA; [Crego, Ramiro D.; Jimenez, Jaime E.; Rozzi, Ricardo] Univ Magallanes, Inst Ecol & Biodivers, Puerto Williams, Chile; [Crego, Ramiro D.; Jimenez, Jaime E.; Rozzi, Ricardo] Univ North Texas, Subantarctic Biocultural Conservat Program, Denton, TX 76203 USA; [Jimenez, Jaime E.; Rozzi, Ricardo] Univ North Texas, Dept Philosophy & Relig, Denton, TX USA	University of North Texas System; University of North Texas Denton; Universidad de Magallanes; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton	Crego, RD (corresponding author), Univ North Texas, Dept Biol Sci, Denton, TX 76203 USA.; Crego, RD (corresponding author), Univ Magallanes, Inst Ecol & Biodivers, Puerto Williams, Chile.; Crego, RD (corresponding author), Univ North Texas, Subantarctic Biocultural Conservat Program, Denton, TX 76203 USA.	ramirocrego84@gmail.com	Crego, Ramiro Daniel/I-3964-2019; Jimenez, Jaime E./AAO-7531-2020; Rozzi, Ricardo/G-1047-2012	Crego, Ramiro Daniel/0000-0001-8583-5936; Rozzi, Ricardo/0000-0001-5265-8726	Rufford Foundation [14986-1]; Conservation Research and Education Opportunities International (CREOi); Institute of Ecology and Biodiversity of Chile (IEB) [ICM P05-002]; Institute of Ecology and Biodiversity of Chile (Basal-CONICYT) [PFB-23]	Rufford Foundation; Conservation Research and Education Opportunities International (CREOi); Institute of Ecology and Biodiversity of Chile (IEB); Institute of Ecology and Biodiversity of Chile (Basal-CONICYT)	This study was funded by the Rufford Foundation (https://www.rufford.org/proiects/ramiro_daniel_crego) (14986-1 to RDC), the Conservation Research and Education Opportunities International (CREOi; http://creoi.org/predatory-impacts-and-variables-deterrnining-the-spatiotemporal-occupancy-of-the-invasive-american-mink-neovison-vison-on-a-pristine-island-ecosystem-in-southern-chile-2/) (RDC), and the Institute of Ecology and Biodiversity of Chile (IEB; grants ICM P05-002 and Basal-CONICYT PFB-23 to RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlers AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135036; Anderson CB, 2006, BIODIVERS CONSERV, V15, P3295, DOI 10.1007/s10531-005-0605-y; Bellard C, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0623; Bled F, 2011, ECOL APPL, V21, P290, DOI 10.1890/09-1877.1; Bodey TW, 2010, J APPL ECOL, V47, P114, DOI 10.1111/j.1365-2664.2009.01739.x; Bonesi L, 2004, OIKOS, V106, P509, DOI 10.1111/j.0030-1299.2004.13034.x; Brzezinski M, 2010, FOLIA ZOOL, V59, P183; Carlsson NOL, 2010, BIOL INVASIONS, V12, P633, DOI 10.1007/s10530-009-9470-z; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Costa GC, 2008, AM NAT, V172, P868, DOI 10.1086/592998; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; Crego RD, 2016, BIOL INVASIONS, V18, P1923, DOI 10.1007/s10530-016-1135-0; Dunstone N, 1983, ACTA ZOO FENN, V174, P189; Dunstone N., 1993, MINK; Fasola L, 2018, BIOL CONSERV, V218, P217, DOI 10.1016/j.biocon.2017.12.031; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Fritts TH, 1998, ANNU REV ECOL SYST, V29, P113, DOI 10.1146/annurev.ecolsys.29.1.113; Fuller AK, 2016, ECOL APPL, V26, P1125, DOI 10.1890/15-0315; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gerber BD, 2012, POPUL ECOL, V54, P43, DOI 10.1007/s10144-011-0276-3; Harrington LA, 2008, J MAMMAL, V89, P991, DOI 10.1644/07-MAMM-A-292.1; Harrington LA, 2009, ECOLOGY, V90, P1207, DOI 10.1890/08-0302.1; Holt RD, 2009, P NATL ACAD SCI USA, V106, P19659, DOI 10.1073/pnas.0905137106; Ibarra JT, 2009, ORYX, V43, P87, DOI 10.1017/S0030605308099997; Ippi S, 2009, ORNITOL NEOTROP, V20, P231; Jaksic Fabian M., 2002, Biological Invasions, V4, P157, DOI 10.1023/A:1020576709964; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Lesmeister DB, 2015, WILDLIFE MONOGR, V191, P1, DOI 10.1002/wmon.1015; MACARTHUR RH, 1972, ECOLOGY, V53, P330, DOI 10.2307/1934090; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Manly B.F.J., 2002, RESOURCE SELECTION A; Medina-Vogel G, 2013, J ZOOL, V290, P27, DOI 10.1111/jzo.12010; Melero Y, 2011, FOLIA ZOOL, V60, P47; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Moorman MC, 2009, T AM FISH SOC, V138, P306, DOI 10.1577/T08-081.1; Moran EV, 2014, ECOL LETT, V17, P637, DOI 10.1111/ele.12262; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; Plummer M, 2016, JAGS PROGRAM ANAL BA; Previtali A, 1998, J ZOOL, V246, P482, DOI 10.1111/j.1469-7998.1998.tb00187.x; R Development Core Team, 2016, R LANG ENV STAT COMP; Ridout MS, 2009, J AGR BIOL ENVIR ST, V14, P322, DOI 10.1198/jabes.2009.08038; Rogers HS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14557; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; Royle J. A., 2008, HIERARCHICAL MODELIN; Rozzi R., 2006, CAPE HORN BIOSPHERE; Rozzi R., 2014, SUBANTARCTIC MAGELLA; Rozzi R, 2006, ECOL SOC, V11; Rozzi Ricardo, 2003, Anales del Instituto de la Patagonia Serie Ciencias Naturales, V31, P97; Ruete A, 2016, ECOL APPL, V26, P1475, DOI 10.1890/15-1271; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Schuttler E, 2018, PEERJ, V6, DOI 10.7717/peerj.4124; Schuttler E, 2010, BIODIVERS CONSERV, V19, P725, DOI 10.1007/s10531-009-9730-3; Schuttler E, 2009, BIOL CONSERV, V142, P1450, DOI 10.1016/j.biocon.2009.02.013; Schuttler E, 2008, REV CHIL HIST NAT, V81, P585; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Valenzuela AEJ, 2013, BIOL INVASIONS, V15, P645, DOI 10.1007/s10530-012-0315-9; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Wellman ST, 2009, CAN FIELD NAT, V123, P368, DOI 10.22621/cfn.v123i4.1005; Yamaguchi N, 2003, J MAMMAL, V84, P1356, DOI 10.1644/1545-1542(2003)084<1356:HPOFAM>2.0.CO;2; Zuberogoitia I, 2006, MAMMALIA, V70, P310, DOI 10.1515/MAMM.2006.046	64	10	12	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194745	10.1371/journal.pone.0194745	http://dx.doi.org/10.1371/journal.pone.0194745			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617392	Green Published, Green Submitted, gold			2022-12-26	WOS:000429203800047
J	Xu, MQ; Jiang, H; Zhang, LQ; Sun, XL; Luo, D; Fu, Y; Gao, Y; Yuan, B; Zhang, JB				Xu, Ming-Qiang; Jiang, Hao; Zhang, Li-Qun; Sun, Xu-Lei; Luo, Dan; Fu, Yao; Gao, Yan; Yuan, Bao; Zhang, Jia-Bao			MiR-29b affects the secretion of PROG and promotes the proliferation of bovine corpus luteum cells	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE 2; PROGESTERONE; EXPRESSION; OXYTOCIN; METASTASIS; EVOLUTION; PREGNANCY; SURVIVAL; LEUKEMIA; PROTEIN	The regulatory role of miRNAs has been explored in ovarian cells, and their effects on gonadal development, apoptosis, ovulation, steroid production and corpus luteum (CL) development have been revealed. In this study, we analyzed the expression of miR-29b at different stages of bovine CL development and predicted the target genes of miR-29b. We confirmed that miR-29b reduces the expression of the oxytocin receptor (OXTR), affects progesterone (PROG) secretion and regulates the function of the CL. RT-PCR showed that the expression of miR-29b was significantly higher in functional CL phases than in the regressed CL phase. Immunohistochemistry showed that OXTR was expressed in both large and small CL cells and was mainly located in the cell membrane and cytoplasm of these cells. We analyzed the expression levels of OXTR and found that transfection with a miR-29b mimic decreased OXTR expression, but transfection with the inhibitor had a limited effect on the expression of the OXTR protein. At the same time, the secretion of PROG was significantly increased in the miR-29b mimic-transfected group. We also analyzed the effect of miR-29b on the apoptosis of CL cells. Finally, we found that miR-29b could promote the proliferation of bovine CL cells. In conclusion, we found that miR-29b reduces the expression of OXTR and can promote PROG secretion and the proliferation of CL cells via OXTR.	[Xu, Ming-Qiang; Jiang, Hao; Sun, Xu-Lei; Luo, Dan; Fu, Yao; Gao, Yan; Yuan, Bao; Zhang, Jia-Bao] Jilin Univ, Coll Anim Sci, Dept Lab Anim, Changchun, Jilin, Peoples R China; [Zhang, Li-Qun] Jilin Univ, Hosp 1, Dept Obstet & Gynecol, Changchun, Jilin, Peoples R China	Jilin University; Jilin University	Yuan, B; Zhang, JB (corresponding author), Jilin Univ, Coll Anim Sci, Dept Lab Anim, Changchun, Jilin, Peoples R China.	yuan_bao@jlu.edu.cn; zhangjiabaojlu@163.com		Jiang, Hao/0000-0003-2008-6166	National Natural Science Foundation of China [31572400, 31601940]; Modern Agricultural Industry Technology System [CARS-37]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Modern Agricultural Industry Technology System	This work was supported by the National Natural Science Foundation of China (31572400 to JZ and 31601940 to HJ) and the Modern Agricultural Industry Technology System (CARS-37) to JZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2008, NAT MED, V14, P1036, DOI 10.1038/nm1008-1036; Azhar S, 2002, MOL CELL ENDOCRINOL, V195, P1, DOI 10.1016/S0303-7207(02)00222-8; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chouhan VS, 2014, ANIM REPROD SCI, V148, P251, DOI 10.1016/j.anireprosci.2014.06.009; Daya S, 2009, MATURITAS, V65, pS29, DOI 10.1016/j.maturitas.2009.09.012; Fang JH, 2011, HEPATOLOGY, V54, P1729, DOI 10.1002/hep.24577; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Duong HT, 2012, J REPROD DEVELOP, V58, P223, DOI 10.1262/jrd.11-122T; Hassan MQ, 2012, J BIOL CHEM, V287, P42084, DOI 10.1074/jbc.M112.377515; Huang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070023; JABLONKASHARIFF A, 1993, ENDOCRINOLOGY, V133, P1871, DOI 10.1210/en.133.4.1871; KHANDAWOOD FS, 1988, AM J OBSTET GYNECOL, V158, P882, DOI 10.1016/0002-9378(88)90089-0; Khanna S, 2013, J CEREBR BLOOD F MET, V33, P1197, DOI 10.1038/jcbfm.2013.68; Kim PJ, 2003, LANCET, V362, P205, DOI 10.1016/S0140-6736(03)13910-4; Kubota Y, 1996, MOL CELL ENDOCRINOL, V124, P25, DOI 10.1016/S0303-7207(96)03923-8; Kuo TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031587; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; LIU Y, 2017, ONCOTARGET; Ma TH, 2011, J APPL GENET, V52, P481, DOI 10.1007/s13353-011-0055-z; Mesen TB, 2015, OBSTET GYN CLIN N AM, V42, P135, DOI 10.1016/j.ogc.2014.10.003; Miyado M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14705; Mohammed BT, 2017, J CLIN ENDOCR METAB, V102, P2188, DOI 10.1210/jc.2017-00259; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Niswender GD, 2000, PHYSIOL REV, V80, P1, DOI 10.1152/physrev.2000.80.1.1; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Sakumoto R, 2011, J ANIM SCI, V89, P3040, DOI 10.2527/jas.2010-3479; Sirotkin AV, 2009, J CELL PHYSIOL, V219, P415, DOI 10.1002/jcp.21689; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Stormshak Fredrick, 2003, Reprod Biol Endocrinol, V1, P92, DOI 10.1186/1477-7827-1-92; Vecchio D, 2012, THERIOGENOLOGY, V77, P1811, DOI 10.1016/j.theriogenology.2011.12.025; Wang HY, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0169-y; Wiltbank MC, 2014, ANIMAL, V8, P70, DOI 10.1017/S1751731114000585; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Zhao XM, 2016, PEERJ, V4, DOI 10.7717/peerj.1635; Zhou KS, 2014, LEUKEMIA LYMPHOMA, V55, P1544, DOI 10.3109/10428194.2013.855308	41	8	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195562	10.1371/journal.pone.0195562	http://dx.doi.org/10.1371/journal.pone.0195562			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617446	Green Submitted, Green Published, gold			2022-12-26	WOS:000429203800094
J	Arruda, AG; Vilalta, C; Puig, P; Perez, A; Alba, A				Arruda, Andreia Goncalves; Vilalta, Caries; Puig, Pere; Perez, Andres; Alba, Anna			Time-series analysis for porcine reproductive and respiratory syndrome in the United States	PLOS ONE			English	Article							SYNDROME VIRUS; TRANSMISSION; EPIDEMIOLOGY; TRANSPORT; VEHICLES; FOMITES; HERDS	Industry-driven voluntary disease control programs for swine diseases emerged in North America in the early 2000's, and, since then, those programs have been used for monitoring diseases of economic importance to swine producers. One example of such initiatives is Dr. Morrison's Swine Health Monitoring Project, a nation-wide monitoring program for swine diseases including the porcine reproductive and respiratory syndrome (PRRS). PRRS has been extensively reported as a seasonal disease in the U.S., with predictable peaks that start in fall and are extended through the winter season. However, formal time series analysis stratified by geographic region has never been conducted for this important disease across the U.S. The main objective of this study was to use approximately seven years of PRRS incidence data in breeding swine herds to conduct time-series analysis in order to describe the temporal patterns of PRRS outbreaks at the farm level for five major swine producing states across the U.S. including the states of Minnesota, Iowa, North Carolina, Nebraska and Illinois. Data was aggregated retrospectively at the week level for the number of herds containing animals actively shedding PRRS virus. Basic descriptive statistics were conducted followed by autoregressive integrated moving average (ARIMA) modelling, conducted separately for each of the above-mentioned states. Results showed that there was a difference in the nature of PRRS seasonality among states. Of note, when comparing states, the typical seasonal pattern previously described for PRRS could only be detected for farms located in the states of Minnesota, North Carolina and Nebraska. For the other two states, seasonal peaks every six months were detected within a year. In conclusion, we showed that epidemic patterns are not homogeneous across the U.S, with major peaks of disease occurring through the year. These findings highlight the importance of coordinating alternative control strategies in different regions considering the prevailing epidemiological patterns.	[Arruda, Andreia Goncalves] Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA; [Vilalta, Caries; Perez, Andres; Alba, Anna] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA; [Puig, Pere] Autonomous Univ Barcelona, Dept Math, Barcelona, Spain	University System of Ohio; Ohio State University; University of Minnesota System; University of Minnesota Twin Cities; Autonomous University of Barcelona	Arruda, AG (corresponding author), Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA.	goncalvesarruda.1@osu.edu	Puig, Pedro/K-4414-2014; Perez, Andres/HGD-8377-2022	Puig, Pedro/0000-0002-6607-9642; Arruda, Andreia/0000-0001-7040-9686; Vilalta, Carles/0000-0002-9220-8620	Swine Health Information Center; National Pork Board; MN Drive Program; Spanish Ministry of Economy and Competitiveness [MTM2015-69493-R, MDM-2014-0445]	Swine Health Information Center; National Pork Board; MN Drive Program; Spanish Ministry of Economy and Competitiveness(Spanish Government)	Funding for the MSHMP and this study was provided by the Swine Health Information Center, the National Pork Board, and the MN Drive Program to AP. The third author (PP) was partially funded by the grant MTM2015-69493-R and by the "Maria de Maeztu" Programme for Units of Excellence in R&D (MDM-2014-0445) from the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122547; Alkamis MA, 2017, SURVEILLANCE PORCINE; Anatia A, 2016, SORT-STAT OPER RES T, V40, P267; Arruda AG, 2016, PREV VET MED, V128, P41, DOI 10.1016/j.prevetmed.2016.03.010; Arruda AG, 2017, FRONT VET SCI; Arruda AG, 2015, CAN J VET RES, V79, P268; Arruda AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172638; Bowman AS, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.5; Corzo CA, 2010, VIRUS RES, V154, P185, DOI 10.1016/j.virusres.2010.08.016; Dee SA, 2004, CAN J VET RES, V68, P128; Dunsmuir WTM, 2015, J STAT SOFTW, V67, P1; Fernandez-Fontelo A, 2017, STAT MODEL, V17, P172, DOI 10.1177/1471082X16683113; Hermann J, 2007, VET RES, V38, P81, DOI 10.1051/vetres:2006044; Holtkamp DJ, 2011, J SWINE HEALTH PROD, V19, P44; National Pork Board, 2016, HOGSPIGS 06 24 2016; Otake S, 2002, J SWINE HEALTH PROD, V10, P59; Perez AM, FRONT VET SCI; Perez AM, 2015, JAVMA-J AM VET MED A, V246, P1304, DOI 10.2460/javma.246.12.1304; Pitkin A, 2009, CAN J VET RES, V73, P298; Tousignant SJP, 2015, CAN VET J, V56, P1087; Tousignant SJP, 2015, AM J VET RES, V76, P70, DOI 10.2460/ajvr.76.1.70; U. S. Department of Agriculture, 2015, OV US HOG IND; Valdes-Donoso P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149498	23	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195282	10.1371/journal.pone.0195282	http://dx.doi.org/10.1371/journal.pone.0195282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614099	Green Submitted, gold, Green Published			2022-12-26	WOS:000429081600040
J	Benadiba, J; Ansari, M; Krajinovic, M; Vachon, MF; Duval, M; Teira, P; Cellot, S; Bittencourt, H				Benadiba, Joy; Ansari, Marc; Krajinovic, Maja; Vachon, Marie-France; Duval, Michel; Teira, Pierre; Cellot, Sonia; Bittencourt, Henrique			Pharmacokinetics-adapted Busulfan-based myeloablative conditioning before unrelated umbilical cord blood transplantation for myeloid malignancies in children	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; RECEIVING INTRAVENOUS BUSULFAN; BONE-MARROW-TRANSPLANTATION; VENOOCCLUSIVE DISEASE; PEDIATRIC-PATIENTS; GRAFT-REJECTION; ORAL BUSULFAN; HOST DISEASE; IV BUSULFAN; LEUKEMIA	Unrelated umbilical cord blood transplantation (UCBT) is an alternative to provide transplants in children with acute leukemia or myelodysplastic syndrome who lack a related donor. Intravenous Busulfan (Bu) combined with therapeutic drug monitoring-guided dosing has been increasingly used, with more predictable bioavailability and better outcomes comparing to oral Bu. There is still an important variation in Bu pharmacokinetic between patients that is associated with an increased risk of toxicity and graft failure. The objective of the study was to analyze the impact of first-dose pharmacokinetic adapted myeloablative conditioning regimen of intravenous Bu on the different outcomes after transplantation. Data of 36 children who underwent allogeneic HSCT with Bu plus a second alkylating agent at Sainte Justine Hospital in Montreal, Canada, between December 2000 and April 2012 were analyzed. For children with high risk myeloid malignancies receiving an UCBT, first dose Bu pharmacokinetic seems to be a significant prognostic factor, influencing neutrophil (100% vs 67.9%) and platelet recovery (95.5% vs 70.5%), non-relapse mortality (0% vs 18.6%), EFS (64% vs 28.6%) and OS (81.3% vs 37.5%) for a first-dose steady-state concentration (Css) <600ng/mL vs >600ng/mL, respectively. These data reinforce the importance of Busulfan therapeutic drug monitoring-guided dosing in pediatric HSCT patients, particularly in the context of UCBT.	[Benadiba, Joy] Nice Univ Hosp, Dept Hematooncol Pediat, Nice, France; [Ansari, Marc] Geneva Univ Hosp, Dept Pediat, Geneva, Switzerland; [Ansari, Marc] Geneva Univ Med Sch, Cansearch Res Lab, Geneva, Switzerland; [Krajinovic, Maja; Vachon, Marie-France; Duval, Michel; Teira, Pierre; Cellot, Sonia; Bittencourt, Henrique] Ste Justine Hosp, Ctr Cancerol Charles Bruneau, Hematol Oncol Div, Montreal, PQ, Canada; [Krajinovic, Maja] Ste Justine Hosp, Clin Pharmacol Unit, Montreal, PQ, Canada; [Krajinovic, Maja; Duval, Michel; Teira, Pierre; Cellot, Sonia; Bittencourt, Henrique] Univ Montreal, Fac Med, Dept Pediat, Montreal, PQ, Canada	CHU Nice; University of Geneva; Universite de Montreal; Universite de Montreal; Universite de Montreal	Benadiba, J (corresponding author), Nice Univ Hosp, Dept Hematooncol Pediat, Nice, France.	benadiba.j@chu-nice.fr		ansari, marc/0000-0002-9649-6498				Andersson BS, 2002, BIOL BLOOD MARROW TR, V8, P477, DOI 10.1053/bbmt.2002.v8.pm12374452; Ansari M, 2013, BONE MARROW TRANSPL, V48, P939, DOI 10.1038/bmt.2012.265; Ansari M, 2010, BONE MARROW TRANSPL, V45, P261, DOI 10.1038/bmt.2009.143; Ansari M, 2014, THER DRUG MONIT, V36, P93, DOI 10.1097/FTD.0b013e3182a04fc7; Ansari M, 2012, RAPID COMMUN MASS SP, V26, P1437, DOI 10.1002/rcm.6241; Baker KS, 2000, BONE MARROW TRANSPL, V26, P607, DOI 10.1038/sj.bmt.1702590; Bartelink IH, 2008, BIOL BLOOD MARROW TR, V14, P88, DOI 10.1016/j.bbmt.2007.09.015; Bartelink IH, 2009, BIOL BLOOD MARROW TR, V15, P231, DOI 10.1016/j.bbmt.2008.11.022; Bleyzac N, 2001, BONE MARROW TRANSPL, V28, P743, DOI 10.1038/sj.bmt.1703207; Copelan EA, 2001, BONE MARROW TRANSPL, V27, P1121, DOI 10.1038/sj.bmt.1703047; Dalle JH, 2003, BONE MARROW TRANSPL, V32, P647, DOI 10.1038/sj.bmt.1704209; Dix SP, 1996, BONE MARROW TRANSPL, V17, P225; Dupuis LL, 2008, BIOL BLOOD MARROW TR, V14, P576, DOI 10.1016/j.bbmt.2008.03.002; Gibbs JP, 1997, CANCER RES, V57, P5509; HASSAN M, 1994, BLOOD, V84, P2144; Huezo-Diaz P, 2014, CURR DRUG METAB, V15, P251, DOI 10.2174/1389200215666140202214012; Johnson L, 2008, J CLIN PHARMACOL, V48, P1052, DOI 10.1177/0091270008321940; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kim I, 2007, CLIN TRANSPLANT, V21, P207, DOI 10.1111/j.1399-0012.2006.00624.x; Madureira ABM, 2011, LEUKEMIA, V25, P449, DOI 10.1038/leu.2010.285; McCune JS, 2007, BIOL BLOOD MARROW TR, V13, P853, DOI 10.1016/j.bbmt.2007.03.012; McCune JS, 2002, BONE MARROW TRANSPL, V30, P167, DOI 10.1038/sj.bmt.1703612; MCDONALD GB, 1993, ANN INTERN MED, V118, P255, DOI 10.7326/0003-4819-118-4-199302150-00003; Michel G, 2016, LEUKEMIA, V30, P1180, DOI 10.1038/leu.2015.243; Michel G, 2003, BLOOD, V102, P4290, DOI 10.1182/blood-2003-04-1288; Nguyen L, 2004, BONE MARROW TRANSPL, V33, P979, DOI 10.1038/sj.bmt.1704446; Paci A, 2012, THER DRUG MONIT, V34, P198, DOI 10.1097/FTD.0b013e31824c2f60; Perkins J, 2011, BONE MARROW TRANSPL, V46, P1418, DOI 10.1038/bmt.2010.315; Pidala J, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-36; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Rifai N, 1997, THER DRUG MONIT, V19, P169, DOI 10.1097/00007691-199704000-00009; SANTOS GW, 1983, NEW ENGL J MED, V309, P1347, DOI 10.1056/NEJM198312013092202; Sisler IY, 2009, BIOL BLOOD MARROW TR, V15, P1620, DOI 10.1016/j.bbmt.2009.08.014; SLATTERY JT, 1995, BONE MARROW TRANSPL, V16, P31; Slattery JT, 1997, BLOOD, V89, P3055, DOI 10.1182/blood.V89.8.3055; Tse WT, 2009, BONE MARROW TRANSPL, V44, P145, DOI 10.1038/bmt.2008.437; Zwaveling J, 2005, BONE MARROW TRANSPL, V35, P17, DOI 10.1038/sj.bmt.1704707	37	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0193862	10.1371/journal.pone.0193862	http://dx.doi.org/10.1371/journal.pone.0193862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608607	Green Published, Green Submitted, gold			2022-12-26	WOS:000428988800005
J	Zhang, JW; Dulak, AM; Hattersley, MM; Willis, BS; Nikkila, J; Wang, A; Lau, A; Reimer, C; Zinda, M; Fawell, SE; Mills, GB; Chen, HW				Zhang, Jingwen; Dulak, Austin M.; Hattersley, Maureen M.; Willis, Brandon S.; Nikkila, Jenni; Wang, Anderson; Lau, Alan; Reimer, Corinne; Zinda, Michael; Fawell, Stephen E.; Mills, Gordon B.; Chen, Huawei			BRD4 facilitates replication stress-induced DNA damage response	ONCOGENE			English	Article							BROMODOMAIN PROTEIN BRD4; ACUTE MYELOID-LEUKEMIA; DOUBLE-STRAND BREAKS; THERAPEUTIC TARGET; OVARIAN-CARCINOMA; ATR KINASE; IN-VIVO; S-PHASE; INHIBITOR; CANCER	Previous reports have demonstrated that select cancers depend on BRD4 to regulate oncogenic gene transcriptional programs. Here we describe a novel role for BRD4 in DNA damage response (DDR). BRD4 associates with and regulates the function of pre-replication factor CDC6 and plays an indispensable part in DNA replication checkpoint signaling. Inhibition of BRD4 by JQ1 or AZD5153 resulted in a rapid, time-dependent reduction in CHK1 phosphorylation and aberrant DNA replication re-initiation. Furthermore, BRD4 inhibition sensitized cancer cells to various replication stress-inducing agents, and synergized with ATR inhibitor AZD6738 to induce cell killing across a number of cancer cell lines. The synergistic interaction between AZD5153 and AZD6738 is translatable to in vivo ovarian cell-line and patient-derived xenograft models. Taken together, our study uncovers a new biological function of BRD4 and provides mechanistic rationale for combining BET inhibitors with DDR-targeted agents for cancer therapy.	[Zhang, Jingwen; Dulak, Austin M.; Hattersley, Maureen M.; Willis, Brandon S.; Reimer, Corinne; Zinda, Michael; Fawell, Stephen E.; Chen, Huawei] AstraZeneca R&D, IMED Biotech Unit, Oncol, Boston, MA 02298 USA; [Nikkila, Jenni; Wang, Anderson; Lau, Alan] AstraZeneca, IMED Biotech Unit, Oncol, Cambridge, England; [Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	AstraZeneca; AstraZeneca; University of Texas System; UTMD Anderson Cancer Center	Chen, HW (corresponding author), AstraZeneca R&D, IMED Biotech Unit, Oncol, Boston, MA 02298 USA.	raymond.chen@astrazeneca.com	Zhang, Jing/GWZ-7332-2022; Zhang, Jing/HII-4294-2022	Wang, Anderson/0000-0002-3571-5095; Lau, Alan/0000-0003-1055-9812; Mills, Gordon/0000-0002-0144-9614	NATIONAL CANCER INSTITUTE [U01CA217842] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA217842] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amorim S, 2016, LANCET HAEMATOL, V3, pE196, DOI 10.1016/S2352-3026(16)00021-1; Baker A, 2016, CANCER RES, V76, P1158, DOI 10.1158/0008-5472.CAN-15-1070; Baratta MG, 2015, P NATL ACAD SCI USA, V112, P232, DOI 10.1073/pnas.1422165112; Berthon C, 2016, LANCET HAEMATOL, V3, pE186, DOI 10.1016/S2352-3026(15)00247-1; Borlado LR, 2008, CARCINOGENESIS, V29, P237, DOI 10.1093/carcin/bgm268; Bradbury RH, 2016, J MED CHEM, V59, P7801, DOI 10.1021/acs.jmedchem.6b00070; Chen R, 2005, BLOOD, V106, P2513, DOI 10.1182/blood-2005-04-1678; Chen YH, 2009, J BIOL CHEM, V284, P182, DOI 10.1074/jbc.M806530200; Chiang CM, 2009, BIOL REP, V1, P98, DOI DOI 10.3410/B1-98; Crafter C, 2015, INT J ONCOL, V47, P446, DOI 10.3892/ijo.2015.3062; Degorce SL, 2016, J MED CHEM, V59, P6281, DOI 10.1021/acs.jmedchem.6b00519; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dobbelstein M, 2015, NAT REV DRUG DISCOV, V14, P405, DOI 10.1038/nrd4553; Duursma AM, 2005, CELL CYCLE, V4, P1725, DOI 10.4161/cc.4.12.2193; Elsasser S, 1999, MOL BIOL CELL, V10, P3263, DOI 10.1091/mbc.10.10.3263; Etemadmoghadam D, 2013, CLIN CANCER RES, V19, P5960, DOI 10.1158/1078-0432.CCR-13-1337; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Floyd SR, 2013, NATURE, V498, P246, DOI 10.1038/nature12147; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Foote KM, 2015, FUTURE MED CHEM, V7, P873, DOI [10.4155/FMC.15.33, 10.4155/fmc.15.33]; Gelot C, 2015, GENES-BASEL, V6, P267, DOI 10.3390/genes6020267; Gong FD, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006272; Goundiam O, 2015, INT J CANCER, V137, P1890, DOI 10.1002/ijc.29568; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jiang W, 1999, P NATL ACAD SCI USA, V96, P6193, DOI 10.1073/pnas.96.11.6193; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; Koltun ES, 2012, BIOORG MED CHEM LETT, V22, P3727, DOI 10.1016/j.bmcl.2012.04.024; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Maruyama T, 2002, MOL CELL BIOL, V22, P6509, DOI 10.1128/MCB.22.18.6509-6520.2002; Montagnoli A, 2008, NAT CHEM BIOL, V4, P357, DOI 10.1038/nchembio.90; Montecucco A, 2007, CANCER LETT, V252, P9, DOI 10.1016/j.canlet.2006.11.005; Nam EA, 2011, J BIOL CHEM, V286, P28707, DOI 10.1074/jbc.M111.248914; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; Oehlmann M, 2004, J CELL BIOL, V165, P181, DOI 10.1083/jcb.200311044; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Puigvert JC, 2016, FEBS J, V283, P232, DOI 10.1111/febs.13574; Rhyasen GW, 2016, MOL CANCER THER, V15, P2563, DOI 10.1158/1535-7163.MCT-16-0141; Rodriguez-Bravo V, 2006, CANCER RES, V66, P8672, DOI 10.1158/0008-5472.CAN-05-4443; Shi JW, 2014, MOL CELL, V54, P728, DOI 10.1016/j.molcel.2014.05.016; Stanlie A, 2014, MOL CELL, V55, P97, DOI 10.1016/j.molcel.2014.05.018; Stathis A, 2016, CANCER DISCOV, V6, P492, DOI 10.1158/2159-8290.CD-15-1335; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Vendetti FP, 2015, ONCOTARGET, V6, P44289, DOI 10.18632/oncotarget.6247; Walter D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10530; Waring MJ, 2016, NAT CHEM BIOL, V12, P1097, DOI [10.1038/NCHEMBIO.2210, 10.1038/nchembio.2210]; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	54	48	49	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 12	2018	37	28					3763	3777		10.1038/s41388-018-0194-3	http://dx.doi.org/10.1038/s41388-018-0194-3			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GM8HR	29636547	Green Accepted			2022-12-26	WOS:000438465600001
J	Jung, JH; Jung, DB; Kim, H; Lee, H; Kang, SE; Srivastava, SK; Yun, MY; Kim, SH				Jung, Ji Hoon; Jung, Deok-Beom; Kim, Hyunseok; Lee, Hyemin; Kang, Shi-Eun; Srivastava, Sanjay K.; Yun, Miyong; Kim, Sung-Hoon			Zinc finger protein 746 promotes colorectal cancer progression via c-Myc stability mediated by glycogen synthase kinase 3 beta and F-box and WD repeat domain-containing 7	ONCOGENE			English	Article							PARKINSONS-DISEASE; CELLS; EXPRESSION; TARGET; APOPTOSIS; ONCOGENE; PATHWAY; PHOSPHORYLATION; IDENTIFICATION; PROLIFERATION	To elucidate the underlying oncogenic mechanism of zinc finger protein 746 (ZNF746), current study was conducted in colorectal cancers (CRCs). Herein, ZNF746 was overexpressed in HCT116, SW620, and SW480 cells, which was supported by CRC tissue microarray and TCGA analysis. Also, DNA microarray revealed the differentially expressed gene profile particularly related to cell cycle genes and c-Myc in ZNF746 depleted HCT116 cells. Furthermore, ZNF746 enhanced the stability of c-Myc via their direct binding through nuclear colocalization by immunoprecipitation and immunofluorescence, while ZNF746 and c-Myc exist mainly in nucleoplasm. Conversely, ZNF746 depletion attenuated phosphorylation of c-Myc (S62) and glycogen synthase kinase 3 beta (GSK3 beta) (S9) and also activated p-c-Myc (T58), which was reversed by GSK3 inhibitors such as SB-216763 and Enza. Also, c-Myc degradation by ZNF746 depletion was blocked by knockdown of F-box/WD repeat-containing protein 7 (FBW7) ubiquitin ligase or proteosomal inhibitor MG132. Additionally, the growth of ZNF746 depleted HCT116 cancer cells was retarded with decreased expression of ZNF746 and c-Myc. Overall, these findings suggest that ZNF746 promotes CRC progression via c-Myc stability mediated by GSK3 and FBW7.	[Jung, Ji Hoon; Jung, Deok-Beom; Lee, Hyemin; Kim, Sung-Hoon] Kyung Hee Univ, Coll Korean Med, Korean Med Tumor Ecosyst Regulat Res Ctr, Seoul, South Korea; [Kang, Shi-Eun; Yun, Miyong] Kyung Hee Univ, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Seoul, South Korea; [Kim, Hyunseok] NJ Univ Hosp, Univ Hosp Newark, 150 Bergen St, Newark, NJ 07103 USA; [Srivastava, Sanjay K.] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Amarillo, TX 79106 USA; [Srivastava, Sanjay K.] Texas Tech Univ, Canc Biol Ctr, Hlth Sci Ctr, Amarillo, TX 79106 USA	Kyung Hee University; Kyung Hee University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Kim, SH (corresponding author), Kyung Hee Univ, Coll Korean Med, Korean Med Tumor Ecosyst Regulat Res Ctr, Seoul, South Korea.; Yun, MY (corresponding author), Kyung Hee Univ, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Seoul, South Korea.	myyun91@khu.ac.kr; sungkim7@khu.ac.kr	Srivastava, Sanjay K./AAE-7635-2020; YUN, MIYONG/S-9433-2019	kim, sunghoon/0000-0003-2423-1973	National Research Foundation of Korea (NRF) grant [2017R1A2A1A17069297]	National Research Foundation of Korea (NRF) grant	This work was supported by the National Research Foundation of Korea (NRF) grant (no. 2017R1A2A1A17069297) and also we appreciate Dr. Han YH in KIRMAS for pcDNA3 reporter, 5'-V5-Myc, HA-FBW7, HA-Myc (S62A), and HA-Myc(T58A) and Dr. Lee ES for c-Myc mutant plasmids used in this project.	Aslan JE, 2009, MOL CELL, V34, P497, DOI 10.1016/j.molcel.2009.04.011; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Bommer GT, 2007, CANCER CELL, V11, P391, DOI 10.1016/j.ccr.2007.04.015; Center MM, 2009, CANCER EPIDEM BIOMAR, V18, P1688, DOI 10.1158/1055-9965.EPI-09-0090; Chen BJ, 2014, INT J BIOL SCI, V10, P1084, DOI 10.7150/ijbs.10190; Chen TC, 2016, TOXICOL IN VITRO, V31, P1, DOI 10.1016/j.tiv.2015.11.002; Choi SH, 2010, GENE DEV, V24, P1236, DOI 10.1101/gad.1920310; Conrad T, 2017, METHODS MOL BIOL, V1468, P1, DOI 10.1007/978-1-4939-4035-6_1; de Mello RA, 2013, WORLD J GASTROENTERO, V19, P6315, DOI 10.3748/wjg.v19.i38.6315; Farrell AS, 2013, MOL CELL BIOL, V33, P2930, DOI 10.1128/MCB.01455-12; Gao SP, 2016, TUMOR BIOL, V37, P1279, DOI 10.1007/s13277-015-3878-0; GARTE SJ, 1993, CRIT REV ONCOGENESIS, V4, P435; Geng JH, 2016, J ALZHEIMERS DIS, V49, P1161, DOI 10.3233/JAD-150423; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huang HL, 2014, CURR PHARM DESIGN, V20, P6543, DOI 10.2174/1381612820666140826153203; Ji LL, 2014, INT J CLIN EXP PATHO, V7, P1124; Karuppagounder SS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04874; KELLY K, 1986, ANNU REV IMMUNOL, V4, P317, DOI 10.1146/annurev.immunol.4.1.317; Kim B, 2014, ONCOL REP, V31, P73, DOI 10.3892/or.2013.2801; Koch HB, 2007, CELL CYCLE, V6, P205, DOI 10.4161/cc.6.2.3742; Koukourakis GV, 2011, CLIN TRANSL ONCOL, V13, P710, DOI 10.1007/s12094-011-0720-z; Kumar Manoj, 2012, Acta Biomed, V83, P220; Li M, 2017, ONCOL REP, V37, P1627, DOI 10.3892/or.2017.5432; Liu PY, 2013, CELL DEATH DIFFER, V20, P503, DOI 10.1038/cdd.2012.147; Mansi L, 2011, B CANCER, V98, P1019, DOI 10.1684/bdc.2011.1380; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; MORELLO D, 1989, ONCOGENE, V4, P955; NEPVEU A, 1987, GENE DEV, V1, P938, DOI 10.1101/gad.1.9.938; Paul I, 2013, ONCOGENE, V32, P1284, DOI 10.1038/onc.2012.144; Popov N, 2010, NAT CELL BIOL, V12, P973, DOI 10.1038/ncb2104; Poulogiannis G, 2010, P NATL ACAD SCI USA, V107, P15145, DOI 10.1073/pnas.1009941107; Prochownik Edward V, 2004, Expert Rev Anticancer Ther, V4, P289, DOI 10.1586/14737140.4.2.289; Robson S, 2006, RECENT PAT ANTI-CANC, V1, P305, DOI 10.2174/157489206778776934; ROTHBERG PG, 1987, SEMIN SURG ONCOL, V3, P152, DOI 10.1002/ssu.2980030305; Roy UKB, 2008, MOL CARCINOGEN, V47, P947, DOI 10.1002/mc.20451; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Schweiger T, 2014, ANN SURG ONCOL, V21, P946, DOI 10.1245/s10434-013-3386-7; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; SPENCER CA, 1991, ADV CANCER RES, V56, P1; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Wang XH, 2016, GASTRIC CANCER, V19, P116, DOI 10.1007/s10120-015-0467-2; Welcker M, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-7; Won SH, 2012, PHYTOTHER RES, V26, P669, DOI 10.1002/ptr.3616; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yuge R, 2015, AM J PATHOL, V185, P399, DOI 10.1016/j.ajpath.2014.10.014	47	27	27	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 5	2018	37	27					3715	3728		10.1038/s41388-018-0225-0	http://dx.doi.org/10.1038/s41388-018-0225-0			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GM3CM	29628506				2022-12-26	WOS:000437975200008
J	Zauner, FB; Elsasser, B; Dall, E; Cabrele, C; Brandstetter, H				Zauner, Florian B.; Elsaesser, Brigitta; Dall, Elfriede; Cabrele, Chiara; Brandstetter, Hans			Structural analyses of Arabidopsis thaliana legumain gamma reveal differential recognition and processing of proteolysis and ligation substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; CASPASE-LIKE ACTIVITY; CIRCULAR PROTEINS; CRYSTAL-STRUCTURE; ASPARAGINYL ENDOPEPTIDASE; PEPTIDE MACROCYCLIZATION; DRUG DISCOVERY; CYCLOTIDES; BIOSYNTHESIS; SUNFLOWER	Legumain is a dual-function protease-peptide ligase whose activities are of great interest to researchers studying plant physiology and to biotechnological applications. However, the molecular mechanisms determining the specificities for proteolysis and ligation are unclear because structural information on the substrate recognition by a fully activated plant legumain is unavailable. Here, we present the X-ray structure of Arabidopsis thaliana legumain isoform gamma (AtLEG gamma) in complex with the covalent peptidic Ac-YVAD chloromethyl ketone (CMK) inhibitor targeting the catalytic cysteine. Mapping of the specificity pockets preceding the substrate-cleavage site explained the known substrate preference. The comparison of inhibited and free AtLEG gamma structures disclosed a substrate-induced disorder-order transition with synergistic rearrangements in the substrate-recognition sites. Docking and in vitro studies with an AtLEG gamma ligase substrate, sunflower trypsin inhibitor (SFTI), revealed a canonical, protease substrate-like binding to the active site-binding pockets preceding and following the cleavage site. We found the interaction of the second residue after the scissile bond, P2'-S2', to be critical for deciding on proteolysis versus cyclization. cis-trans-Isomerization of the cyclic peptide product triggered its release from the AtLEG gamma active site and prevented inadvertent cleavage. The presented integrative mechanisms of proteolysis and ligation (transpeptidation) explain the interdependence of legumain and its preferred substrates and provide a rational framework for engineering optimized proteases, ligases, and substrates.	[Zauner, Florian B.; Elsaesser, Brigitta; Dall, Elfriede; Cabrele, Chiara; Brandstetter, Hans] Univ Salzburg, Dept Biosci, A-5020 Salzburg, Austria	Salzburg University	Brandstetter, H (corresponding author), Univ Salzburg, Dept Mol Biol, A-5020 Salzburg, Austria.	hans.brandstetter@sbg.ac.at	Cabrele, Chiara/B-8790-2015; Brandstetter, Hans/E-6754-2011; Dall, Elfriede/F-1711-2017	Cabrele, Chiara/0000-0002-7550-6896; Brandstetter, Hans/0000-0002-6089-3045; Dall, Elfriede/0000-0002-0823-8983	Austrian Science Fund (FWF) [W_01213, M1901]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund (FWF) Projects W_01213 and M1901. The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernath-Levin K, 2015, CHEM BIOL, V22, P571, DOI 10.1016/j.chembiol.2015.04.010; Bonneau L, 2008, J EXP BOT, V59, P491, DOI 10.1093/jxb/erm352; Bosch M, 2010, PLANT MOL BIOL, V74, P381, DOI 10.1007/s11103-010-9681-9; Bozhkov PV, 2004, CELL DEATH DIFFER, V11, P175, DOI 10.1038/sj.cdd.4401330; Breitling R, 2002, PROTEIN EXPRES PURIF, V25, P209, DOI 10.1016/S1046-5928(02)00001-3; Chemical Computing Group Inc, 2017, MOL OPERATING ENV; Christoff AP, 2014, PLANT SCI, V215, P100, DOI 10.1016/j.plantsci.2013.11.005; Conlan BF, 2012, J BIOL CHEM, V287, P28037, DOI 10.1074/jbc.M112.347823; Conlan BF, 2011, AM J BOT, V98, P2018, DOI 10.3732/ajb.1100382; Conlan BF, 2010, BIOPOLYMERS, V94, P573, DOI 10.1002/bip.21422; Craik DJ, 2013, CURR OPIN CHEM BIOL, V17, P546, DOI 10.1016/j.cbpa.2013.05.033; Craik DJ, 2012, TOXINS, V4, P139, DOI 10.3390/toxins4020139; Dall E, 2016, BIOCHIMIE, V122, P126, DOI 10.1016/j.biochi.2015.09.022; Dall E, 2015, ANGEW CHEM INT EDIT, V54, P2917, DOI 10.1002/anie.201409135; Dall E, 2013, P NATL ACAD SCI USA, V110, P10940, DOI 10.1073/pnas.1300686110; Daly NL, 2006, J BIOL CHEM, V281, P23668, DOI 10.1074/jbc.M601426200; Elsasser B, 2017, ACS CATAL, V7, P5585, DOI 10.1021/acscatal.7b01505; Gillon AD, 2008, PLANT J, V53, P505, DOI 10.1111/j.1365-313X.2007.03357.x; Gould A, 2011, CURR PHARM DESIGN, V17, P4294, DOI 10.2174/138161211798999438; HARANISHIMURA I, 1991, FEBS LETT, V294, P89, DOI 10.1016/0014-5793(91)81349-D; Harris KS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10199; Hatsugai N, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00234; James AM, 2018, NEW PHYTOL, V218, P923, DOI 10.1111/nph.14511; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kintzing JR, 2016, CURR OPIN CHEM BIOL, V34, P143, DOI 10.1016/j.cbpa.2016.08.022; Koehnke J, 2012, NAT STRUCT MOL BIOL, V19, P767, DOI 10.1038/nsmb.2340; Korsinczky MLJ, 2001, J MOL BIOL, V311, P579, DOI 10.1006/jmbi.2001.4887; Kroemer RT, 2004, J CHEM INF COMP SCI, V44, P871, DOI 10.1021/ci049970m; Kuroyanagi M, 2005, J BIOL CHEM, V280, P32914, DOI 10.1074/jbc.M504476200; Lesner A, 2011, CURR PHARM DESIGN, V17, P4308, DOI 10.2174/138161211798999393; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Molecular Operating Environment (MOE), 2018, MOL OP ENV MOE VERS; Mulvenna JP, 2005, J BIOL CHEM, V280, P32245, DOI 10.1074/jbc.M506060200; Muntz K, 2002, TRENDS PLANT SCI, V7, P340, DOI 10.1016/S1360-1385(02)02298-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mylne JS, 2011, NAT CHEM BIOL, V7, P257, DOI 10.1038/nchembio.542; Nguyen GKT, 2015, J AM CHEM SOC, V137, P15398, DOI 10.1021/jacs.5b11014; Nguyen GKT, 2014, NAT CHEM BIOL, V10, P732, DOI [10.1038/NCHEMBIO.1586, 10.1038/nchembio.1586]; Pelegrini PB, 2007, PEPTIDES, V28, P1475, DOI 10.1016/j.peptides.2007.04.025; Powell HR, 2017, NAT PROTOC, V12, P1310, DOI 10.1038/nprot.2017.037; Rojo E, 2004, CURR BIOL, V14, P1897, DOI 10.1016/j.cub.2004.09.056; Rotari VI, 2001, BIOL CHEM, V382, P953, DOI 10.1515/BC.2001.119; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Sheldon PS, 1996, BIOCHEM J, V320, P865, DOI 10.1042/bj3200865; Valiev M, 2010, COMPUT PHYS COMMUN, V181, P1477, DOI 10.1016/j.cpc.2010.04.018; Vidmar R, 2017, EMBO J, V36, P2455, DOI 10.15252/embj.201796750; Weidmann J, 2016, J EXP BOT, V67, P4801, DOI 10.1093/jxb/erw210; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu GZ, 2001, NATURE, V410, P494, DOI 10.1038/35068604; Zauner FB, 2018, PLANT CELL, V30, P686, DOI 10.1105/tpc.17.00963; Zhao LX, 2014, CELL RES, V24, P344, DOI 10.1038/cr.2014.4	54	31	31	4	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8934	8946		10.1074/jbc.M117.817031	http://dx.doi.org/10.1074/jbc.M117.817031			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29628443	hybrid, Green Published			2022-12-26	WOS:000434941900017
J	Zhang, XF; Cao, SF; Barila, G; Edreira, MM; Wankhede, M; Naim, N; Buck, M; Altschuler, DL				Zhang, Xuefeng; Cao, Shufen; Barila, Guillermo; Edreira, Martin M.; Wankhede, Mamta; Naim, Nyla; Buck, Matthias; Altschuler, Daniel L.			Cyclase-associated protein 1 (CAP1) is a prenyl-binding partner of Rap1 GTPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE-CYCLASE; FORCE-FIELD; NUCLEOTIDE EXCHANGE; SRV2/CAP COMPLEX; KINASE PKA; A-FACTOR; F-ACTIN; RAS; ACTIVATION; COFILIN	Rap1 proteins are members of the Ras subfamily of small GTPases involved in many biological responses, including adhesion, cell proliferation, and differentiation. Like all small GTPases, they work as molecular allosteric units that are active in signaling only when associated with the proper membrane compartment. Prenylation, occurring in the cytosol, is an enzymatic posttranslational event that anchors small GTPases at the membrane, and prenyl-binding proteins are needed to mask the cytoplasm-exposed lipid during transit to the target membrane. However, several of these proteins still await discovery. In this study, we report that cyclase-associated protein 1 (CAP1) binds Rap1. We found that this binding is GTP-independent, does not involve Rap1's effector domain, and is fully contained in its C-terminal hypervariable region (HVR). Furthermore, Rap1 prenylation was required for high-affinity interactions with CAP1 in a geranylgeranyl-specific manner. The prenyl binding specifically involved CAP1's C-terminal hydrophobic -sheet domain. We present a combination of experimental and computational approaches, yielding a model whereby the high-affinity binding between Rap1 and CAP1 involves electrostatic and nonpolar side-chain interactions between Rap1's HVR residues, lipid, and CAP1 -sheet domain. The binding was stabilized by the lipid insertion into the -solenoid whose interior was occupied by nonpolar side chains. This model was reminiscent of the recently solved structure of the PDE-K-Ras complex; accordingly, disruptors of this complex, e.g. deltarasin, blocked the Rap1-CAP1 interaction. These findings indicate that CAP1 is a geranylgeranyl-binding partner of Rap1.	[Zhang, Xuefeng; Barila, Guillermo; Edreira, Martin M.; Wankhede, Mamta; Naim, Nyla; Altschuler, Daniel L.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, W1346 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA; [Cao, Shufen; Buck, Matthias] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44116 USA; [Barila, Guillermo] Univ Penn Hlth Syst, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA; [Edreira, Martin M.] Univ Buenos Aires, CONICET, Consejo Nacl Invest Cient & Tecn, IQUIBICEN,Inst Dept Quim Biol,Fac Ciencias Exacta, C1428EGA, Buenos Aires, DF, Argentina	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Case Western Reserve University; University of Pennsylvania; Pennsylvania Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Altschuler, DL (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, W1346 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	altschul@pitt.edu	Edreira, Martin/AAE-7816-2020	Edreira, Martin/0000-0002-9120-2649	National Institutes of Health [R01 GM099775]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099775, R01GM112491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM099775 (to D. L. A. and partially to M. B). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALTSCHULER D, 1993, J BIOL CHEM, V268, P7527; ALTSCHULER DL, 1995, J BIOL CHEM, V270, P10373, DOI 10.1074/jbc.270.18.10373; Altschuler DL, 1998, P NATL ACAD SCI USA, V95, P7475, DOI 10.1073/pnas.95.13.7475; Balcer HI, 2003, CURR BIOL, V13, P2159, DOI 10.1016/S0960-9822(03)00907-2; Banerjee A, 2016, CURR OPIN STRUC BIOL, V36, P10, DOI 10.1016/j.sbi.2015.11.010; Bao Z, 2016, PATHOL RES PRACT, V212, P264, DOI 10.1016/j.prp.2015.12.017; Berg TJ, 2010, J BIOL CHEM, V285, P35255, DOI 10.1074/jbc.M110.129916; Bertling E, 2004, MOL BIOL CELL, V15, P2324, DOI 10.1091/mbc.E04-01-0048; Bertling E, 2007, J CELL SCI, V120, P1225, DOI 10.1242/jcs.000158; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Brunsveld L, 2009, BBA-BIOMEMBRANES, V1788, P273, DOI 10.1016/j.bbamem.2008.08.006; Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154; Chaudhry F, 2013, MOL BIOL CELL, V24, P31, DOI 10.1091/mbc.E12-08-0589; Chung J, 2008, J IMMUNOL, V181, P5501, DOI 10.4049/jimmunol.181.8.5501; Dharmaiah S, 2016, P NATL ACAD SCI USA, V113, pE6766, DOI 10.1073/pnas.1615316113; Dodatko T, 2004, BIOCHEMISTRY-US, V43, P10628, DOI 10.1021/bi049071r; Dursina B, 2006, J AM CHEM SOC, V128, P2822, DOI 10.1021/ja052196e; Edreira MM, 2009, J BIOL CHEM, V284, P27480, DOI 10.1074/jbc.M109.011312; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fan YC, 2016, ONCOL REP, V36, P1619, DOI 10.3892/or.2016.4936; FEDORCHAIKEN M, 1990, CELL, V61, P329, DOI 10.1016/0092-8674(90)90813-T; FIELD J, 1990, CELL, V61, P319, DOI 10.1016/0092-8674(90)90812-S; Figueroa C, 2001, J BIOL CHEM, V276, P28219, DOI 10.1074/jbc.M101763200; Flacke JP, 2013, J BIOL CHEM, V288, P3126, DOI 10.1074/jbc.M112.403279; Freeman NL, 2000, CELL MOTIL CYTOSKEL, V45, P106, DOI 10.1002/(SICI)1097-0169(200002)45:2<106::AID-CM3>3.0.CO;2-3; Freeman SN, 2011, J IMMUNOL, V187, P5887, DOI 10.4049/jimmunol.1102233; Goitre L, 2014, METHODS MOL BIOL, V1120, P197, DOI 10.1007/978-1-62703-791-4_13; Guo XX, 2016, CELL PHYSIOL BIOCHEM, V39, P137, DOI 10.1159/000445612; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; Hochbaum D, 2008, J BIOL CHEM, V283, P4464, DOI 10.1074/jbc.C700171200; Hochbaum D, 2011, J BIOL CHEM, V286, P859, DOI 10.1074/jbc.M110.163816; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Hoshino T, 2005, J BIOL CHEM, V280, P24095, DOI 10.1074/jbc.M414447200; HRYCYNA CA, 1991, EMBO J, V10, P1699, DOI 10.1002/j.1460-2075.1991.tb07694.x; Hua MH, 2015, INT J MOL MED, V35, P941, DOI 10.3892/ijmm.2015.2089; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Hubberstey AV, 2002, FASEB J, V16, P487, DOI 10.1096/fj.01-0659rev; Insel PA, 2012, ACTA PHYSIOL, V204, P277, DOI 10.1111/j.1748-1716.2011.02273.x; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Iwase S, 2017, CYTOSKELETON, V74, P343, DOI 10.1002/cm.21385; Iwase S, 2016, BIOCHEM J, V473, P4427, DOI 10.1042/BCJ20160329; Jansen S, 2014, J BIOL CHEM, V289, P30732, DOI 10.1074/jbc.M114.601765; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kakurina GV, 2016, B EXP BIOL MED+, V160, P695, DOI 10.1007/s10517-016-3252-2; Khan I, 2017, CARDIOVASC THER, V35, DOI 10.1111/1755-5922.12248; Lagarrigue F, 2016, BLOOD, V128, P479, DOI 10.1182/blood-2015-12-638700; Lin KBL, 2008, IMMUNITY, V28, P75, DOI 10.1016/j.immuni.2007.11.019; Liu XC, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0878-7; Liu YH, 2014, PATHOL RES PRACT, V210, P169, DOI 10.1016/j.prp.2013.11.011; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Makkonen M, 2013, J BIOL CHEM, V288, P984, DOI 10.1074/jbc.M112.435719; Mangmool S, 2015, MOL ENDOCRINOL, V29, P583, DOI 10.1210/me.2014-1346; Marada S, 2016, DEV BIOL, V409, P84, DOI 10.1016/j.ydbio.2015.10.020; Masugi Y, 2015, PATHOL INT, V65, P627, DOI 10.1111/pin.12351; Misra UK, 2009, J CELL BIOCHEM, V108, P998, DOI 10.1002/jcb.22333; Moriyama K, 2002, J CELL SCI, V115, P1591; Normoyle KPM, 2012, J BIOL CHEM, V287, P35722, DOI 10.1074/jbc.M112.396051; Ono S, 2013, J CELL SCI, V126, P3249, DOI 10.1242/jcs.128231; Otto JC, 1999, J BIOL CHEM, V274, P8379, DOI 10.1074/jbc.274.13.8379; Pannekoek WJ, 2009, BBA-BIOMEMBRANES, V1788, P790, DOI 10.1016/j.bbamem.2008.12.010; Papke B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11360; Pedro MP, 2017, MOL BIOL CELL, V28, P962, DOI 10.1091/mbc.E16-08-0603; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PILLINGER MH, 1994, J BIOL CHEM, V269, P1486; Prior IA, 2012, SEMIN CELL DEV BIOL, V23, P145, DOI 10.1016/j.semcdb.2011.09.002; Quintero-Monzon O, 2009, J BIOL CHEM, V284, P10923, DOI 10.1074/jbc.M808760200; Ribeiro-Neto F, 2004, J BIOL CHEM, V279, P46868, DOI 10.1074/jbc.M406858200; Ribeiro-Neto F, 2002, P NATL ACAD SCI USA, V99, P5418, DOI 10.1073/pnas.082122499; Riou P, 2013, CELL, V153, P640, DOI 10.1016/j.cell.2013.03.044; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Rotblat B, 2004, CANCER RES, V64, P3112, DOI 10.1158/0008-5472.CAN-04-0026; Schuld NJ, 2014, J BIOL CHEM, V289, P6862, DOI 10.1074/jbc.M113.527192; Shah B, 2017, CEREB CORTEX, V27, P1253, DOI 10.1093/cercor/bhv341; Sun W, 2017, BIOCHEM BIOPH RES CO, V485, P355, DOI 10.1016/j.bbrc.2017.02.075; Suzuki S, 2010, J BIOL CHEM, V285, P24248, DOI 10.1074/jbc.M109.094581; Takahashi M, 2017, J BIOL CHEM, V292, P1449, DOI 10.1074/jbc.M116.768986; Tan M, 2013, ONCOL REP, V30, P1639, DOI 10.3892/or.2013.2607; Taylor JS, 2003, EMBO J, V22, P5963, DOI 10.1093/emboj/cdg571; Tnimov Z, 2012, J BIOL CHEM, V287, P26549, DOI 10.1074/jbc.M112.371294; van Hooren KWEM, 2012, J BIOL CHEM, V287, P24713, DOI 10.1074/jbc.M111.321976; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3155, DOI 10.1021/ci3003649; Wang JC, 2017, J CELL SCI, V130, P1094, DOI 10.1242/jcs.191858; Wang M, 2016, NAT REV MOL CELL BIO, V17, P110, DOI 10.1038/nrm.2015.11; Wilson JM, 2016, J MOL BIOL, V428, P4929, DOI 10.1016/j.jmb.2016.10.016; Wilson JM, 2015, CANCER BIOL THER, V16, P1364, DOI 10.1080/15384047.2015.1070988; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Wu LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021929; Wu YW, 2007, P NATL ACAD SCI USA, V104, P12294, DOI 10.1073/pnas.0701817104; Wu YG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143777; Xie SS, 2015, ONCOL REP, V33, P363, DOI 10.3892/or.2014.3577; Xie SS, 2017, ONCOTARGET, V8, P27216, DOI 10.18632/oncotarget.16111; Yamazaki K, 2009, LAB INVEST, V89, P425, DOI 10.1038/labinvest.2009.5; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; Yu XF, 2014, EXP MOL PATHOL, V96, P188, DOI 10.1016/j.yexmp.2014.02.002; Zelicof A, 1996, J BIOL CHEM, V271, P18243, DOI 10.1074/jbc.271.30.18243; Zhang HB, 2012, VISION RES, V75, P19, DOI 10.1016/j.visres.2012.08.013; Zhang HouJiang, 2016, Journal of Forestry Engineering, V1, P1; Zhang YL, 2017, CANCER BIOL MED, V14, P90, DOI 10.20892/j.issn.2095-3941.2016.0086; Zhou GL, 2014, J CELL SCI, V127, P5052, DOI 10.1242/jcs.156059; Zhou M, 2016, J CELL BIOL, V214, P445, DOI 10.1083/jcb.201604061; Zhou Y, 2017, CELL, V168, P239, DOI 10.1016/j.cell.2016.11.059; Zhu L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01822-8; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	107	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7659	7673		10.1074/jbc.RA118.001779	http://dx.doi.org/10.1074/jbc.RA118.001779			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29618512	Green Published, hybrid			2022-12-26	WOS:000437256500017
J	He, Q; Hao, YP; Liu, H; Liu, WY				He, Qing; Hao, Yinping; Liu, Hui; Liu, Wenyi			Analysis of exergy efficiency of a super-critical compressed carbon dioxide energy-storage system based on the orthogonal method	PLOS ONE			English	Article							THERMODYNAMIC ANALYSIS; CYCLES	Super-critical carbon dioxide energy-storage (SC-CCES) technology is a new type of gas energy-storage technology. This paper used orthogonal method and variance analysis to make significant analysis on the factors which would affect the thermodynamics characteristics of the SC-CCES system and obtained the significant factors and interactions in the energy-storage process, the energy-release process and the whole energy-storage system. Results have shown that the interactions in the components have little influence on the energy-storage process, the energy-release process and the whole energy-storage process of the SC-CCES system, the significant factors are mainly on the characteristics of the system component itself, which will provide reference for the optimization of the thermal properties of the energy-storage system.	[He, Qing; Hao, Yinping; Liu, Wenyi] North China Elect Power Univ, Sch Energy Power & Mech Engn, Beijing, Peoples R China; [Liu, Hui] Elect Power Res Inst CO LTD, Shenhua Guohua Beijing, Beijing, Peoples R China	North China Electric Power University	Hao, YP (corresponding author), North China Elect Power Univ, Sch Energy Power & Mech Engn, Beijing, Peoples R China.	lbabo0824@163.com			National Key Research and Development Program of China [2017YFB0903601]	National Key Research and Development Program of China	This paper is supported by the National Key Research and Development Program of China (No. 2017YFB0903601).	Ahmadi P, 2011, ENERGY, V36, P5886, DOI 10.1016/j.energy.2011.08.034; Bai Z, 2010, APPL ORTHOGONAL EXPT, P142; Cayer E, 2009, APPL ENERG, V86, P1055, DOI 10.1016/j.apenergy.2008.09.018; Gordon Rogers, 1992, ENG THERMODYNAMICS W; [何青 He Qing], 2016, [动力工程学报, Journal of Chinese Society of Power Engineering], V36, P313; Kim YM, 2011, ENERGY, V36, P6220, DOI 10.1016/j.energy.2011.07.040; Liu H, 2016, ENERG CONVERS MANAGE, V127, P149, DOI 10.1016/j.enconman.2016.08.096; Moran M.J., 2006, FUNDAMENTALS ENG THE; Morandin M, 2012, ENERGY, V45, P375, DOI 10.1016/j.energy.2012.03.031; Padilla RV, 2015, APPL ENERG, V148, P348, DOI 10.1016/j.apenergy.2015.03.090; Peking University Mathematics Department, 1976, MATH METH SCHED MULT; Reistad GM, 1980, ACS SYM SER, V122, P143; Tian HL, APPL ORTHOGONAL EXPT, P917; Wang MK, 2015, APPL THERM ENG, V91, P812, DOI 10.1016/j.applthermaleng.2015.08.081; Wang ZW, 2016, APPL ENERG, V180, P810, DOI 10.1016/j.apenergy.2016.08.014; Weng J, 2014, OPTIMAL DESIGN PACKA, P409; [杨俊兰 Yang Junlan], 2013, [流体机械, Fluid Machinery], V41, P66; Zhang XR, 2017, INT J ENERGY RES, V41; Zhang Y., 2014, STUDY SYSTEM INTEGTA; Zhang Y, 2016, RENEW ENERG, V99, P682, DOI 10.1016/j.renene.2016.07.048	20	0	0	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195614	10.1371/journal.pone.0195614	http://dx.doi.org/10.1371/journal.pone.0195614			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634742	Green Published, gold, Green Submitted			2022-12-26	WOS:000429522200040
J	Hefti, MM; Farrell, K; Kim, S; Bowles, KR; Fowkes, ME; Raj, T; Crary, JF				Hefti, Marco M.; Farrell, Kurt; Kim, SoongHo; Bowles, Kathryn R.; Fowkes, Mary E.; Raj, Towfique; Crary, John F.			High-resolution temporal and regional mapping of MAPT expression and splicing in human brain development	PLOS ONE			English	Article							GENE-EXPRESSION; FETAL-TAU; PROTEIN; ISOFORMS; PHOSPHORYLATION; MUTATIONS; 3-REPEAT; DISTINCT	The microtubule associated protein tau plays a critical role in the pathogenesis of neurode-generative disease. Recent studies suggest that tau also plays a role in disorders of neuronal connectivity, including epilepsy and post-traumatic stress disorder. Animal studies have shown that the MAPT gene, which codes for the tau protein, undergoes complex pre-mRNA alternative splicing to produce multiple isoforms during brain development. Human data, particularly on temporal and regional variation in tau splicing during development are however lacking. In this study, we present the first detailed examination of the temporal and regional sequence of MAPT alternative splicing in the developing human brain. We used a novel computational analysis of large transcriptomic datasets (total n = 502 patients), quantitative polymerase chain reaction (qPCR) and western blotting to examine tau expression and splicing in post-mortem human fetal, pediatric and adult brains. We found that MAPT exons 2 and 10 undergo abrupt shifts in expression during the perinatal period that are unique in the canonical human microtubule-associated protein family, while exon 3 showed small but significant temporal variation. Tau isoform expression may be a marker of neuronal maturation, temporally correlated with the onset of axonal growth. Immature brain regions such as the ganglionic eminence and rhombic lip had very low tau expression, but within more mature regions, there was little variation in tau expression or splicing. We thus demonstrate an abrupt, evolutionarily conserved shift in tau isoform expression during the human perinatal period that may be due to tau expression in maturing neurons. Alternative splicing of the MAPT pre-mRNA may play a vital role in normal brain development across multiple species and provides a basis for future investigations into the developmental and pathological functions of the tau protein.	[Hefti, Marco M.; Kim, SoongHo; Fowkes, Mary E.; Crary, John F.] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Hefti, Marco M.; Farrell, Kurt; Bowles, Kathryn R.; Raj, Towfique; Crary, John F.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Hefti, Marco M.; Bowles, Kathryn R.; Crary, John F.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Hefti, Marco M.; Farrell, Kurt; Kim, SoongHo; Bowles, Kathryn R.; Raj, Towfique; Crary, John F.] Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, New York, NY 10029 USA; [Bowles, Kathryn R.; Raj, Towfique] Icahn Sch Med Mt Sinai, Dept Genet & Genome Sci, New York, NY 10029 USA; [Hefti, Marco M.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Iowa	Hefti, MM; Crary, JF (corresponding author), Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA.; Hefti, MM; Crary, JF (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.; Hefti, MM; Crary, JF (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA.; Hefti, MM; Crary, JF (corresponding author), Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, New York, NY 10029 USA.; Hefti, MM (corresponding author), Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA.	marco-hefti@uiowa.edu; john.crary@mountsinai.org	Raj, Towfique/ABD-7620-2021	Hefti, Marco/0000-0002-3127-4528; Farrell, Kurt/0000-0001-6955-7278	National Institutes of Health [National Institute on Aging] [F32AG056098, R01AG054008]; National Institutes of Health [National Institute of Neurological Disorders and Stroke] [R01NS095252]; Alzheimer's Association [NIRG-15-363188]; United States Department of Defense [13267017]; Tau Consortium; Alexander Saint-Amand Scholarship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS095252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005136, R01AG054008, F32AG056098] Funding Source: NIH RePORTER	National Institutes of Health [National Institute on Aging](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health [National Institute of Neurological Disorders and Stroke](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alzheimer's Association(Alzheimer's Association); United States Department of Defense(United States Department of Defense); Tau Consortium; Alexander Saint-Amand Scholarship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (http://www.nih.gov) [National Institute on Aging grant numbers F32AG056098 to K.F. and R01AG054008 to J.F.C.] and [National Institute of Neurological Disorders and Stroke grant no. R01NS095252 to J.F.C.], the Alzheimer's Association (http://www.alz.org) [NIRG-15-363188 to J.F.C.], the United States Department of Defense (http://www.defense.gov) [13267017 to J.F.C.], the Tau Consortium (http://www.tauconsortium.org) [to J.F.C.], and an Alexander Saint-Amand Scholarship (https://glg.it) [to J.F.C.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Andreadis A, 2012, J CELL PHYSIOL, V227, P1220, DOI 10.1002/jcp.22842; Arendt T, 2016, BRAIN RES B; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Barnes M, 2005, NUCLEIC ACIDS RES, V33, P5914, DOI 10.1093/nar/gki890; Bearce EA, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00241; BrainSpan, 2011, BRAINSPAN ATL DEV HU; BRION JP, 1993, J NEUROCHEM, V61, P2071, DOI 10.1111/j.1471-4159.1993.tb07444.x; Bullmann T, 2009, INT J DEV NEUROSCI, V27, P591, DOI 10.1016/j.ijdevneu.2009.06.001; Caillet-Boudin ML, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0025-8; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Gehman LT, 2011, NAT GENET, V43, P706, DOI 10.1038/ng.841; Grover A, 1999, J BIOL CHEM, V274, P15134, DOI 10.1074/jbc.274.21.15134; Gumucio A, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-148; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iijima T, 2011, CELL, V147, P1601, DOI 10.1016/j.cell.2011.11.028; Ingelsson M, 2007, ACTA NEUROPATHOL, V114, P471, DOI 10.1007/s00401-007-0280-z; IOVINO M, 2015, BRAIN 11, V138, DOI DOI 10.1093/BRAIN/AWV222; Jovanov-Milosevic N, 2012, INT J BIOCHEM CELL B, V44, P1290, DOI 10.1016/j.biocel.2012.05.001; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Lacovich V, 2017, J NEUROSCI, V37, P58, DOI 10.1523/JNEUROSCI.2305-16.2016; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; Luciani P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071716; Lunn MR, 2008, LANCET, V371, P2120, DOI 10.1016/S0140-6736(08)60921-6; Mattsson N, 2010, NEUROSCI RES, V66, P330, DOI 10.1016/j.neures.2009.11.012; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Perfetti A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093983; Pierce MJ, 2012, AM J MED GENET A, V158A, P606, DOI 10.1002/ajmg.a.33958; Raj B, 2014, MOL CELL, V56, P90, DOI 10.1016/j.molcel.2014.08.011; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Ruggiu M, 2009, P NATL ACAD SCI USA, V106, P3513, DOI 10.1073/pnas.0813112106; Sealey MA, 2017, NEUROBIOL DIS, V105, P74, DOI 10.1016/j.nbd.2017.05.003; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stoothoff W, 2009, J NEUROCHEM, V111, P417, DOI 10.1111/j.1471-4159.2009.06316.x; Sundermann F, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2590-9; Suh J, 2010, J NEUROCHEM, V114, P160, DOI 10.1111/j.1471-4159.2010.06732.x; Takuma H, 2003, DEV BRAIN RES, V142, P121, DOI 10.1016/S0165-3806(03)00056-7; Trabzuni D, 2012, HUM MOL GENET, V21, P4094, DOI 10.1093/hmg/dds238; Verheyen A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146127; Vuong CK, 2016, NAT REV NEUROSCI, V17, P265, DOI 10.1038/nrn.2016.27; Xu X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S9-S1; Yano M, 2010, NEURON, V66, P848, DOI 10.1016/j.neuron.2010.05.007; Yoshida H, 2002, BIOCHEMISTRY-US, V41, P15203, DOI 10.1021/bi026464m; YOSHIDA H, 1993, J NEUROCHEM, V61, P1183, DOI 10.1111/j.1471-4159.1993.tb03642.x; Yu Y, 2009, J NEUROCHEM, V108, P1480, DOI 10.1111/j.1471-4159.2009.05882.x	47	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195771	10.1371/journal.pone.0195771	http://dx.doi.org/10.1371/journal.pone.0195771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634760	Green Submitted, gold, Green Published			2022-12-26	WOS:000429522200057
J	Pike, A; Dimopoulos, G				Pike, Andrew; Dimopoulos, George			Genetic modification of Anopheles stephensi for resistance to multiple Plasmodium falciparum strains does not influence susceptibility to o'nyong'nyong virus or insecticides, or Wolbachia-mediated resistance to the malaria parasite	PLOS ONE			English	Article							CYTOPLASMIC INCOMPATIBILITY; POPULATIONS; MOSQUITOS; DENSITY	Mosquitoes that have been genetically engineered for resistance to human pathogens are a potential new tool for controlling vector-borne disease. However, genetic modification may have unintended off-target effects that could affect the mosquitoes' utility for disease control. We measured the resistance of five genetically modified Plasmodium-suppressing Anopheles stephensi lines to o'nyong'nyong virus, four classes of insecticides, and diverse Plasmodium falciparum field isolates and characterized the interactions between our genetic modifications and infection with the bacterium Wolbachia. The genetic modifications did not alter the mosquitoes' resistance to either o'nyong'nyong virus or insecticides, and the mosquitoes were equally resistant to all tested P. falciparum strains, regardless of Wolbachia infection status. These results indicate that mosquitoes can be genetically modified for resistance to malaria parasite infection and remain compatible with other vector-control measures without becoming better vectors for other pathogens.	[Pike, Andrew; Dimopoulos, George] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Dimopoulos, G (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	gdimopo1@jhu.edu		Pike, Andrew/0000-0003-3155-9969	National Institutes of Health / National Institute of Allergy and Infectious Disease [RO1A1061576]; Bloomberg Philanthropies	National Institutes of Health / National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bloomberg Philanthropies	This work was supported by National Institutes of Health / National Institute of Allergy and Infectious Disease RO1A1061576 (to George Dimopoulos) and Bloomberg Philanthropies (to Andrew Pike).	[Anonymous], 1998, WHOCDCMAL98; Baldini F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4985; Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Dong YM, 2012, CELL HOST MICROBE, V12, P521, DOI 10.1016/j.chom.2012.09.004; Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458; Duron O, 2007, HEREDITY, V98, P368, DOI 10.1038/sj.hdy.6800948; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Jupatanakul N, 2014, DEV COMP IMMUNOL, V43, P1, DOI 10.1016/j.dci.2013.10.002; Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754; Molina-Cruz A, 2014, MEM I OSWALDO CRUZ, V109, P662, DOI 10.1590/0074-0276130553; Mouton L, 2006, PARASITOLOGY, V132, P49, DOI 10.1017/S0031182005008723; Pike A, 2017, SCIENCE, V357, P1396, DOI 10.1126/science.aak9691; Pike A, 2014, INSECT BIOCHEM MOLEC, V52, P82, DOI 10.1016/j.ibmb.2014.06.005; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Sim C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-231; Sinkins SP, 2004, P ROY SOC B-BIOL SCI, V271, P1421, DOI 10.1098/rspb.2004.2740; Sinkins SP, 2004, INSECT BIOCHEM MOLEC, V34, P723, DOI 10.1016/j.ibmb.2004.03.025; van Schalkwyk DA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-320; WHO, 2016, WORLD MAL REP 2016; WHO, 2013, TEST PROC INREMO, V2	27	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195720	10.1371/journal.pone.0195720	http://dx.doi.org/10.1371/journal.pone.0195720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634777	gold, Green Submitted, Green Published			2022-12-26	WOS:000429522200051
J	Zhang, X; Xiao, WX; Hu, XH				Zhang, Xue; Xiao, Wangxin; Hu, Xihao			Predicting essential proteins by integrating orthology, gene expressions, and PPI networks	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; CENTRALITY; GENOMICS; DATABASE	Identifying essential proteins is very important for understanding the minimal requirements of cellular life and finding human disease genes as well as potential drug targets. Experimental methods for identifying essential proteins are often costly, time-consuming, and laborious. Many computational methods for such task have been proposed based on the topological properties of protein-protein interaction networks (PINs). However, most of these methods have limited prediction accuracy due to the noisy and incomplete natures of PINs and the fact that protein essentiality may relate to multiple biological factors. In this work, we proposed a new centrality measure, OGN, by integrating orthologous information, gene expressions, and PINs together. OGN determines a protein's essentiality by capturing its co-clustering and co-expression properties, as well as its conservation in the evolution process. The performance of OGN was tested on the species of Saccharomyces cerevisiae. Compared with several published centrality measures, OGN achieves higher prediction accuracy in both working alone and ensemble.	[Zhang, Xue] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Xiao, Wangxin] Huaiyin Inst Technol, Sch Comp & Software Engn, Huaian, Jiangsu, Peoples R China; [Hu, Xihao] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Hu, Xihao] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Tufts University; Huaiyin Institute of Technology; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Zhang, X (corresponding author), Tufts Univ, Sch Med, Boston, MA 02111 USA.; Xiao, WX (corresponding author), Huaiyin Inst Technol, Sch Comp & Software Engn, Huaian, Jiangsu, Peoples R China.	lindajja03@gmail.com; wangxinxiao19750329@gmail.com			National Natural Science Foundation of China [61402423, 51678282, 51378243]; Guizhou Provincial Science and Technology Fund [[2015]2135]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guizhou Provincial Science and Technology Fund	This work was funded by National Natural Science Foundation of China, No. 61402423, XZ; National Natural Science Foundation of China, No. 51678282, WX; National Natural Science Foundation of China, No. 51378243, WX; Guizhou Provincial Science and Technology Fund with grant No. [2015]2135, XZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Rocha CG, 2013, TRENDS GENET, V29, P273, DOI 10.1016/j.tig.2012.11.001; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Estrada E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056103; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Li GS, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1115-5; Li M, 2016, TSINGHUA SCI TECHNOL, V21, P668, DOI 10.1109/TST.2016.7787009; Li M, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-15; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Qin C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161042; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Wang JX, 2013, PROTEOM CLIN APPL, V7, P181, DOI 10.1002/prca.201200068; Wei W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072343; WERNERWASHBURNE M, 1987, MOL CELL BIOL, V7, P2568, DOI 10.1128/MCB.7.7.2568; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wuchty S, 2003, J THEOR BIOL, V223, P45, DOI 10.1016/S0022-5193(03)00071-7; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Zhang R, 2004, NUCLEIC ACIDS RES, V32, pD271, DOI 10.1093/nar/gkh024; Zhang X, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1166-7; Zhang X, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00075; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058763; Zhang X, 2012, COMPUT SCI INF SYST, V9, P1627, DOI 10.2298/CSIS120130044Z; Zhang X, 2012, COMPUT SCI INF SYST, V9, P1513, DOI 10.2298/CSIS120202045Z; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	30	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195410	10.1371/journal.pone.0195410	http://dx.doi.org/10.1371/journal.pone.0195410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634727	gold, Green Published, Green Submitted			2022-12-26	WOS:000429522200029
J	Kisler, LB; Gurion, I; Granovsky, Y; Sinai, A; Sprecher, E; Shamay-Tsoory, S; Weissman-Fogel, I				Kisler, Lee-Bareket; Gurion, Ilan; Granovsky, Yelena; Sinai, Alon; Sprecher, Elliot; Shamay-Tsoory, Simone; Weissman-Fogel, Irit			Can a single pulse transcranial magnetic stimulation targeted to the motor cortex interrupt pain processing?	PLOS ONE			English	Article							EVOKED-POTENTIALS; NEUROPATHIC PAIN; SENSORIMOTOR CORTEX; BRAIN; TMS; PERCEPTION; SUPPRESSION; ACTIVATION; RTMS; REPRESENTATIONS	The modulatory role of the primary motor cortex (M1), reflected by an inhibitory effect of Ml-stimulation on clinical pain, motivated us to deepen our understanding of M1's role in pain modulation. We used Transcranial Magnetic Stimulation (TMS)-induced virtual lesion (VL) to interrupt with M1 activity during noxious heat pain. We hypothesized that TMS-VL will effect experimental pain ratings. Three VL protocols were applied consisting of single-pulse TMS to transiently interfere with right M1 activity: (1) VLM1-TMS applied to 11 subjects, 20 msec before the individual's first pain-related M1 peak activation, as determined by source analysis (sLORETA), (2) VL-50 (N = 16; TMS applied 50 ms prior to noxious stimulus onset), and (3) VL+150 (N = 16; TMS applied 150 ms after noxious stimulus onset). Each protocol included 3 conditions ('pain -alone', ' TMS-VL', and `SHAM-VL'), each consisted of 30 noxious heat stimuli. Pain ratings were compared, in each protocol, for TMS-VL vs. SHAM-VL and vs. pain-alone conditions. Repeated measures analysis of variance, corrected for multiple comparisons revealed no significant differences in the pain ratings between the different conditions within each protocol. Therefore, our results from this exploratory study suggest that a single pulse TMS-induced VL that is targeted to M1 failed to interrupt experimental pain processing in the specific three stimulation timing examined here.	[Kisler, Lee-Bareket; Gurion, Ilan; Shamay-Tsoory, Simone] Univ Haifa, Dept Psychol, Haifa, Israel; [Kisler, Lee-Bareket; Granovsky, Yelena] Technion Fac Med, Lab Clin Neurophysiol, Haifa, Israel; [Granovsky, Yelena; Sinai, Alon; Sprecher, Elliot] Rambam Hlth Care Campus, Dept Neurol, Haifa, Israel; [Sinai, Alon] Rambam Hlth Care Campus, Dept Neurosurg, Haifa, Israel; [Weissman-Fogel, Irit] Univ Haifa, Fac Social Welf & Hlth Sci, Haifa, Israel	University of Haifa; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Rambam Health Care Campus; University of Haifa	Weissman-Fogel, I (corresponding author), Univ Haifa, Fac Social Welf & Hlth Sci, Haifa, Israel.	ifogel@univ.haifa.ac.il			Israel Science Foundation [518/12]; IWF	Israel Science Foundation(Israel Science Foundation); IWF	This work was supported by the Israel Science Foundation grant #518/12 (https://www.isf.org.il/#/) to AS, YG and IWF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMASSIAN VE, 1989, ELECTROEN CLIN NEURO, V74, P458, DOI 10.1016/0168-5597(89)90036-1; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; BECKERS G, 1995, BRAIN, V118, P49, DOI 10.1093/brain/118.1.49; Bestmann S, 2004, EUR J NEUROSCI, V19, P1950, DOI 10.1111/j.1460-9568.2004.03277.x; Bingel U, 2002, PAIN, V99, P313, DOI 10.1016/S0304-3959(02)00157-4; Borckardt JJ, 2011, CLIN J PAIN, V27, P486, DOI 10.1097/AJP.0b013e31820d2733; Bradley C, 2016, BRAIN STIMUL, V9, P48, DOI 10.1016/j.brs.2015.08.015; BRASILNETO JP, 1992, ELECTROEN CLIN NEURO, V85, P9, DOI 10.1016/0168-5597(92)90095-S; Burns E, 2016, EUR J PAIN, V20, P1203, DOI 10.1002/ejp.859; Cohen NR, 2009, EXP BRAIN RES, V196, P303, DOI 10.1007/s00221-009-1838-x; Cohen NR, 2009, NEUROPSYCHOLOGIA, V47, P1553, DOI 10.1016/j.neuropsychologia.2008.12.034; Dambeck N, 2006, BRAIN RES, V1072, P194, DOI 10.1016/j.brainres.2005.05.075; Di Lazzaro V, 2004, CLIN NEUROPHYSIOL, V115, P255, DOI 10.1016/j.clinph.2003.10.009; DosSantos MF, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00018; Epstein CM, 1999, CLIN NEUROPHYSIOL, V110, P1073, DOI 10.1016/S1388-2457(99)00047-4; Franca NRM, 2013, BEHAV BRAIN RES, V250, P211, DOI 10.1016/j.bbr.2013.05.019; Frot M, 2013, HUM BRAIN MAPP, V34, P2655, DOI 10.1002/hbm.22097; Garcia-Larrea L, 2003, NEUROPHYSIOL CLIN, V33, P279, DOI 10.1016/j.neucli.2003.10.008; Garcia-Larrea L, 1999, PAIN, V83, P259, DOI 10.1016/S0304-3959(99)00114-1; Garcia-Larrea L, 1997, STEREOT FUNCT NEUROS, V68, P141, DOI 10.1159/000099915; Garcia-Larrea L, 2007, NEUROIMAGE, V37, pS71, DOI 10.1016/j.neuroimage.2007.05.062; Gelnar PA, 1999, NEUROIMAGE, V10, P460, DOI 10.1006/nimg.1999.0482; Gerloff C, 1997, BRAIN, V120, P1587, DOI 10.1093/brain/120.9.1587; Granovsky Y, 2005, PAIN, V115, P238, DOI 10.1016/j.pain.2005.02.017; Granovsky Y, 2016, EUR J PAIN, V20, P241, DOI 10.1002/ejp.715; Granovsky Y, 2008, J PAIN, V9, P53, DOI 10.1016/j.jpain.2007.08.010; Hamilton RH, 1998, TRENDS COGN SCI, V2, P168, DOI 10.1016/S1364-6613(98)01172-3; Harris JA, 2008, J COGNITIVE NEUROSCI, V20, P734, DOI 10.1162/jocn.2008.20048; Jahanshahi M, 2000, EXP BRAIN RES, V131, P1, DOI 10.1007/s002219900224; Kanda M, 2003, CLIN NEUROPHYSIOL, V114, P860, DOI 10.1016/S1388-2457(03)00034-8; Kisler LB, 2017, BEHAV BRAIN RES, V328, P209, DOI 10.1016/j.bbr.2017.04.006; Kisler LB, 2016, EXP BRAIN RES, V234, P3119, DOI 10.1007/s00221-016-4710-9; Kramer JLK, 2012, CLIN NEUROPHYSIOL, V123, P582, DOI 10.1016/j.clinph.2011.08.013; Kramer JLK, 2013, PAIN, V154, P235, DOI 10.1016/j.pain.2012.10.027; Lee MC, 2009, J NEUROSCI, V29, P7909, DOI 10.1523/JNEUROSCI.0014-09.2009; Lefaucheur JP, 2006, NEUROLOGY, V67, P1568, DOI 10.1212/01.wnl.0000242731.10074.3c; Lin KP, 2012, CHINESE J PHYSIOL, V55, P163, DOI 10.4077/CJP.2012.AMM117; Lisanby SH, 2001, BIOL PSYCHIAT, V49, P460, DOI 10.1016/S0006-3223(00)01110-0; Lockwood PL, 2013, CORTEX, V49, P2201, DOI 10.1016/j.cortex.2012.10.006; Loo CK, 2000, BIOL PSYCHIAT, V47, P325, DOI 10.1016/S0006-3223(99)00285-1; Meister IG, 2006, NEUROSCIENCE, V142, P119, DOI 10.1016/j.neuroscience.2006.06.023; Moont R, 2011, PAIN, V152, P1469, DOI 10.1016/j.pain.2011.01.036; Mull BR, 2001, CLIN NEUROPHYSIOL, V112, P1672, DOI 10.1016/S1388-2457(01)00606-X; Mylius V, 2007, NEUROSCI LETT, V415, P49, DOI 10.1016/j.neulet.2006.12.042; Nguyen JP, 1999, PAIN, V82, P245, DOI 10.1016/S0304-3959(99)00062-7; Nizard J, 2012, DISCOV MED, V14, P237; Ohara PT, 2005, CELL MOL LIFE SCI, V62, P44, DOI 10.1007/s00018-004-4283-9; Osaka N, 2007, NEUROSCI LETT, V418, P232, DOI 10.1016/j.neulet.2007.01.087; Pagano RL, 2012, PAIN, V153, P2359, DOI 10.1016/j.pain.2012.08.002; Pascual-Leone A, 1999, PHILOS T R SOC B, V354, P1229, DOI 10.1098/rstb.1999.0476; Pascual-Marqui R.D., 2007, ARXIV07103341; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Peyron R, 2007, NEUROIMAGE, V34, P310, DOI 10.1016/j.neuroimage.2006.08.037; Pleger B, 2004, NEUROSCI LETT, V356, P87, DOI 10.1016/j.neulet.2003.11.037; Porro CA, 2007, BEHAV BRAIN RES, V178, P183, DOI 10.1016/j.bbr.2006.11.011; PRICE DD, 1977, PAIN, V3, P57, DOI 10.1016/0304-3959(77)90035-5; Reichenbach A, 2011, NEUROIMAGE, V54, P1375, DOI 10.1016/j.neuroimage.2010.08.047; Rice NJ, 2006, J NEUROSCI, V26, P8176, DOI 10.1523/JNEUROSCI.1641-06.2006; ROTHWELL JC, 1987, BRAIN, V110, P1173, DOI 10.1093/brain/110.5.1173; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125, DOI 10.1152/jn.2001.86.5.2125; Shitara H, 2011, NEUROIMAGE, V56, P1469, DOI 10.1016/j.neuroimage.2011.03.011; Siebner HR, 2009, CORTEX, V45, P1035, DOI 10.1016/j.cortex.2009.02.007; Siebner HR, 2003, EXP BRAIN RES, V148, P1, DOI 10.1007/s00221-002-1234-2; Siebner HR, 2001, HUM BRAIN MAPP, V12, P157, DOI 10.1002/1097-0193(200103)12:3<157::AID-HBM1012>3.0.CO;2-V; Soto D, 2009, NEUROSCI LETT, V451, P261, DOI 10.1016/j.neulet.2008.12.052; Thut G, 2003, CLIN NEUROPHYSIOL, V114, P2071, DOI 10.1016/S1388-2457(03)00205-0; TSUBOKAWA T, 1991, PACE, V14, P131, DOI 10.1111/j.1540-8159.1991.tb04058.x; Tunik E, 2005, NAT NEUROSCI, V8, P505, DOI 10.1038/nn1430; Valeriani M, 2007, CLIN NEUROPHYSIOL, V118, P1097, DOI 10.1016/j.clinph.2007.01.015; Walsh V, 1998, P ROY SOC B-BIOL SCI, V265, P537, DOI 10.1098/rspb.1998.0328; Walsh V, 1999, NEUROPSYCHOLOGIA, V37, P125; WASSERMANN EM, 1992, ELECTROEN CLIN NEURO, V85, P1, DOI 10.1016/0168-5597(92)90094-R; Ziemann U, 2010, CORTEX, V46, P124, DOI 10.1016/j.cortex.2009.02.020	73	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195739	10.1371/journal.pone.0195739	http://dx.doi.org/10.1371/journal.pone.0195739			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630681	gold, Green Published, Green Submitted			2022-12-26	WOS:000429505000069
J	Thanel, K; Garfinkel, D; Riley, C; Esch, K; Girma, W; Kebede, T; Kasongo, G; Afolabi, K; Kalamar, A; Thurston, S; Longfield, K; Bertrand, J; Shaw, B				Thanel, Katherine; Garfinkel, Danielle; Riley, Christina; Esch, Keith; Girma, Woldemariam; Kebede, Tadele; Kasongo, Gaby; Afolabi, Kayode; Kalamar, Amanda; Thurston, Sarah; Longfield, Kim; Bertrand, Jane; Shaw, Bryan		FPwatch Grp	Leveraging long acting reversible contraceptives to achieve FP2020 commitments in sub-Saharan Africa: The potential of implants	PLOS ONE			English	Article								Background In developing regions, an estimated 214 million women have an unmet need for family planning. Reaching Family Planning 2020 (FP2020) commitments will require a shift in modern contraceptive promotion, including improved access to long-acting reversible contraceptives (LARCs). Until now, a lack of market data limited understanding of the potential of LARCs to increase contraceptive access and choice. Methods From 2015, the FPwatch Project conducted representative surveys in Ethiopia, Nigeria, and Democratic Republic of Congo (DRC) using a full census approach in selected administrative areas. In these areas, every public and private sector outlet with the potential to sell or distribute modern contraceptives was approached. In outlets with modern contraceptives, product audits and provider interviews assessed contraceptive market composition, market share, availability, price, and outlet readiness to perform services. Results Fifty-four percent of outlets in Ethiopia had LARC commodities or services available at the time of the survey, versus 7% and 8% of outlets in Nigeria and DRC, respectively. When present, LARCs were usually available with at least two other methods (99%, 39%, and 84% of public health facilities in Ethiopia, Nigeria and DRC, respectively). Many public facilities had both implants and IUDs in stock (76%, 47%, and 53%, respectively). Lack of readiness to provide LARCs was mostly due to a lack of equipment, private room, or the commodity itself. Market share for implants in the public sector was 60%, 53%, and 37% of Couple Years of Protection (CYP) in Ethiopia, Nigeria, and DRC. Discussion Limited availability of LARCs in Nigeria and DRC restricts contraceptive choice and makes it difficult for women to adopt and use modern contraception consistently. Brand-specific subsidies, task shifting, and promotion of methods that require less equipment and training are promising strategies for increasing uptake. Substantial government investment is required to improve availability and affordability. Investment in implants should be prioritized to make progress towards FP2020 commitments.	[Thanel, Katherine; Garfinkel, Danielle; Riley, Christina; Esch, Keith; Kalamar, Amanda; Thurston, Sarah; FPwatch Grp] Populat Serv Int, Washington, DC 20036 USA; [Girma, Woldemariam] Populat Serv Int Ethiopia, Addis Ababa, Ethiopia; [Kebede, Tadele] Fed Minist Hlth, Addis Ababa, Ethiopia; [Kasongo, Gaby] Assoc Sante Familiale, Kinshasa, DEM REP CONGO; [Afolabi, Kayode] Fed Minist Hlth, Ibadan, Nigeria; [Bertrand, Jane] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA USA; [Shaw, Bryan] Georgetown Univ, Inst Reprod Hlth, Washington, DC USA	Federal Ministry of Health - Ethiopia (FMOH); Tulane University; Georgetown University	Thanel, K (corresponding author), Populat Serv Int, Washington, DC 20036 USA.	kthanel@gmail.com			Bill and Melinda Gates Foundation [OPP1112709]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	FPwatch was funded by the Bill and Melinda Gates Foundation, https://www.gatesfoundation.org/, through grant number OPP1112709. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, GLOB HEALTH-SCI PRAC, V4, pS1, DOI 10.9745/GHSP-D-16-00241; Asnake Mengistu, 2013, Int J Gynaecol Obstet, V123 Suppl 1, pe29, DOI 10.1016/j.ijgo.2013.07.003; Bertrand J, COMMUNICATION; Charyeva Z, 2015, GLOB HEALTH-SCI PRAC, V3, P382, DOI 10.9745/GHSP-D-15-00129; Christofield M, 2016, LACOSTE ACCESSIBLE C; Contraceptive Security, 2011, FACTC 3 UND DEM SUPP; Duvall S, 2014, GLOB HEALTH-SCI PRAC, V2, P72, DOI 10.9745/GHSP-D-13-00116; FP2020, 2016, FP2020 MOM MIDP; High Impact Practices in Family Planning (HIP), SOC MARK LEV PRIV SE; Jacobstein R, 2013, GLOB HEALTH-SCI PRAC, V1, P11, DOI 10.9745/GHSP-D-12-00003; Migiro K., 2013, FACTBOX WOMEN KENYAN; Ministry of Health, 2016, COST IMPL PLAN FAM P; Olson DJ, 2013, STUD FAMILY PLANN, V44, P445, DOI 10.1111/j.1728-4465.2013.00369.x; Tsui AO, 2010, EPIDEMIOL REV, V32, P152, DOI 10.1093/epirev/mxq012; World Health Organization (WHO), 2012, EV POL EXP ACC FAM P	15	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195228	10.1371/journal.pone.0195228	http://dx.doi.org/10.1371/journal.pone.0195228			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630607	Green Published, gold, Green Submitted			2022-12-26	WOS:000429505000033
J	Evans, SM; Griffin, KJ; Blick, RAJ; Poore, AGB; Verges, A				Evans, Suzanna M.; Griffin, Kingsley J.; Blick, Ray A. J.; Poore, Alistair G. B.; Verges, Adriana			Seagrass on the brink: Decline of threatened seagrass Posidonia australis continues following protection	PLOS ONE			English	Article							ZOSTERA-CAPRICORNI; WESTERN-AUSTRALIA; COCKBURN SOUND; IMAGE-ANALYSIS; WATER-QUALITY; BOTANY-BAY; RECOVERY; DEGRADATION; MEADOWS; IMPACT	Seagrasses are in decline globally due to sustained pressure from coastal development, water quality declines and the ongoing threat from climate change. The result of this decline has been a change in coastal productivity, a reduction in critical fisheries habitat and increased erosion. Attempts to slow this decline have included legislative protection of habitat and direct restoration efforts. Monitoring the success of these approaches requires tracking changes in the abundance of seagrasses, but such monitoring is frequently conducted at either too coarse a spatial scale, or too infrequently to adequately detect changes within individual meadows. Here, we used high resolution aerial imagery to quantify the change in meadows dominated by Posidonia australis over five years at 14 sites in five estuaries in south-eastern Australia. Australia has some of the world's most diverse and extensive sea grass meadows, but the widely distributed P. australis has a slow growth rate, recovers poorly after disturbance, and suffers runaway attrition if the conditions for recovery are not met. In 2010, after declines of 12-57% between the 1940s and 1980s, P. australis was listed as a threatened ecological community in New South Wales. We quantified changes in area at fine spatial scales and, where loss was observed, describe the general patterns of temporal decline within each meadow. Our results demonstrate that seagrass meadows dominated by P. australis underwent declines of similar to 2-40% total area at 11 out of 14 study sites between 2009 and 2014. In the iconic Sydney Harbour, our analyses suggest that P. australis meadows are declining at an average rate greater than 10% yr(-1), exceeding the global rate of seagrass decline. Highlighting these alarming declines across the study region should serve as means to prioritise management action and review the effectiveness of legislative listing as a method to limit impacts at an ecosystem level.	[Evans, Suzanna M.; Griffin, Kingsley J.; Blick, Ray A. J.; Poore, Alistair G. B.; Verges, Adriana] Univ New South Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Evans, Suzanna M.; Verges, Adriana] UNSW Australia, Sch Biol Earth & Environm Sci, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [Evans, Suzanna M.; Poore, Alistair G. B.; Verges, Adriana] Sydney Inst Marine Sci, Mosman, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Sydney Institute of Marine Science	Griffin, KJ (corresponding author), Univ New South Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	k.griffin@unsw.edu.au	Poore, Alistair/C-2934-2008; Blick, Ray/AAB-5604-2020; Verges, Adriana/B-8288-2013	Poore, Alistair/0000-0002-3560-3659; Verges, Adriana/0000-0002-3507-1234	Australian Postgraduate Awards; Australian Research Council [LP160100836]; Sea Life Trust Conservation Fund; Evolution & Ecology Research Centre (UNSW)	Australian Postgraduate Awards(Australian Government); Australian Research Council(Australian Research Council); Sea Life Trust Conservation Fund; Evolution & Ecology Research Centre (UNSW)	SE, RB and KG were supported by Australian Postgraduate Awards. This project was partly funded by project LP160100836 from the Australian Research Council, by the Sea Life Trust Conservation Fund (http//www.sealifetrustorg.au/) and the Evolution & Ecology Research Centre (UNSW) (http://www.eerc.unsw.edu.au/). The research was made possible by Nearmap Australia Photomaps (http:/www.nearmap.com.au/) accessed through the University of Queensland, St. Lucia.	Albani AD., 2013, PORT HACKING PRESENT; [Anonymous], [No title captured]; Arnaud-Haond S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030454; Beijbom O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130312; Blandon A, 2014, ESTUAR COAST SHELF S, V141, P1, DOI 10.1016/j.ecss.2014.01.009; CAMBRIDGE ML, 1986, AQUAT BOT, V24, P269, DOI 10.1016/0304-3770(86)90062-8; Creese RG, 2009, MAPPING HABITATS NSW; Cullen-Unsworth LC, 2016, J APPL ECOL, V53, P967, DOI 10.1111/1365-2664.12637; Cunha AH, 2012, RESTOR ECOL, V20, P427, DOI 10.1111/j.1526-100X.2012.00878.x; Demers MCA, 2013, MAR ENVIRON RES, V83, P54, DOI 10.1016/j.marenvres.2012.10.010; DPI N, 2012, END POP NSW POS AUST; Duarte CM, 2008, ESTUAR COAST, V31, P233, DOI 10.1007/s12237-008-9038-7; Duarte CM, 2002, ENVIRON CONSERV, V29, P192, DOI 10.1017/S0376892902000127; ESRI, 2014, ARCGIS VERS 10 2 2; Evans SM, 2017, RESTORATION ECOLOGY; Glasby TM., 2015, FISHERIES FINAL REPO, V147; Greening H, 2006, ENVIRON MANAGE, V38, P163, DOI 10.1007/s00267-005-0079-4; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hamada Y, 2013, ENVIRON MONIT ASSESS, V185, P3173, DOI 10.1007/s10661-012-2781-z; Heenkenda MK, 2014, REMOTE SENS-BASEL, V6, P6064, DOI 10.3390/rs6076064; Kendrick GA, 2002, AQUAT BOT, V73, P75, DOI 10.1016/S0304-3770(02)00005-0; KIRKMAN H, 1978, AQUAT BOT, V5, P63, DOI 10.1016/0304-3770(78)90047-5; Kirkman H., 1997, SEAGRASSES AUSTR; Larkum A, 1976, MARINE FRESHWATER RE, V27, P117, DOI DOI 10.1071/MF9760117; LARKUM AWD, 1990, AQUAT BOT, V37, P55, DOI 10.1016/0304-3770(90)90064-R; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lukatelich R, 1987, ENV PROTECTION AUTHO, V16; Manly, 2009, MANL COV COAST ZON M; Marion SR, 2010, RESTOR ECOL, V18, P549, DOI 10.1111/j.1526-100X.2010.00695.x; Meehan AJ, 2000, AQUAT BOT, V67, P161, DOI 10.1016/S0304-3770(99)00097-2; Meehan AJ, 2004, AQUAT BOT, V79, P1, DOI 10.1016/j.aquabot.2003.11.009; MIDDLETON MJ, 1984, AQUAT BOT, V18, P89, DOI 10.1016/0304-3770(84)90082-2; Mumby PJ, 1999, J ENVIRON MANAGE, V55, P157, DOI 10.1006/jema.1998.0255; Nearmap, 2009, NEARM PHOT AER IM; NSW D, 2011, BOT BAY CABL PROJ SE; Orth RJ, 2017, ESTUAR COAST, P1; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Owers CJ, 2016, INT J REMOTE SENS, V37, P4296, DOI 10.1080/01431161.2016.1211349; Preen A, 1993, WIDESPREAD LOSS SEAG; Rasheed MA, 2004, J EXP MAR BIOL ECOL, V310, P13, DOI 10.1016/j.jembe.2004.03.022; Rasheed MA, 1999, J EXP MAR BIOL ECOL, V235, P183, DOI 10.1016/S0022-0981(98)00158-0; Roca G, 2015, ECOL INDIC, V54, P161, DOI 10.1016/j.ecolind.2015.02.031; Roelfsema CM, 2014, REMOTE SENS ENVIRON, V150, P172, DOI 10.1016/j.rse.2014.05.001; Shepherd S, 1989, DECLINE SEAGRASSES; Short FT, 2011, BIOL CONSERV, V144, P1961, DOI 10.1016/j.biocon.2011.04.010; Spalding M, 2003, DISTRIBUTION STATUS, P5; Thomas M, 1999, SEAGRASS AUSTR STRAT, V98, P223; WALKER DI, 1992, MAR POLLUT BULL, V25, P191, DOI 10.1016/0025-326X(92)90224-T; Walker DI, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P551; Watford FA, 1998, INVENTORY ESTUARINE; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; West R, 1989, REGIONAL STUDIES SEA, P230; West RJ, 2012, WETLANDS AUSTR J, V26, P3; Wood SN, 2017, MGCV MIXED GAM COMPU; Wright A, 2013, POSIDONIA AUSTRALIS	55	28	28	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0190370	10.1371/journal.pone.0190370	http://dx.doi.org/10.1371/journal.pone.0190370			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624579	gold, Green Submitted, Green Published			2022-12-26	WOS:000429379600001
J	Alvarez-Ponce, D; Torres-Sanchez, M; Feyertag, F; Kulkarni, A; Nappi, T				Alvarez-Ponce, David; Torres-Sanchez, Maria; Feyertag, Felix; Kulkarni, Asmita; Nappi, Taylen			Molecular evolution of DNMT1 in vertebrates: Duplications in marsupials followed by positive selection	PLOS ONE			English	Article							CPG-RICH ISLANDS; DNA METHYLTRANSFERASE; NUCLEOTIDE SUBSTITUTIONS; MONODELPHIS-DOMESTICA; SEQUENCE SPECIFICITY; X-CHROMOSOMES; GC-CONTENT; METHYLATION; GENOME; EXPRESSION	DNA methylation is mediated by a conserved family of DNA methyltransferases (Dnmts). The human genome encodes three active Dnmts (Dnmt1, Dnmt3a and Dnmt3b), the tRNA methyltransferase Dnmt2, and the regulatory protein Dnmt3L. Despite their high degree of conservation among different species, genes encoding Dnmts have been duplicated and/or lost in multiple lineages throughout evolution, indicating that the DNA methylation machinery has some potential to undergo evolutionary change. However, little is known about the extent to which this machinery, or the methylome, varies among vertebrates. Here, we study the molecular evolution of Dnmt1, the enzyme responsible for maintenance of DNA methylation patterns after replication, in 79 vertebrate species. Our analyses show that all studied species exhibit a single copy of the DNMT1 gene, with the exception of tilapia and marsupials (tammar wallaby, koala, Tasmanian devil and opossum), each of which displays two apparently functional DNMT1 copies. Our phylogenetic analyses indicate that DNMT1 duplicated before the radiation of major marsupial groups (i.e., at least similar to 75 million years ago), thus giving rise to two DNMT1 copies in marsupials (copy 1 and copy 2). In the opossum lineage, copy 2 was lost, and copy 1 recently duplicated again, generating three DNMT1 copies: two putatively functional genes (copy la and 1b) and one pseudogene (copy 1 Psi). Both marsupial copies (DNMT1 copies 1 and 2) are under purifying selection, and copy 2 exhibits elevated rates of evolution and signatures of positive selection, suggesting a scenario of neofunctionalization. This gene duplication might have resulted in modifications in marsupial methylomes and their dynamics.	[Alvarez-Ponce, David; Torres-Sanchez, Maria; Feyertag, Felix; Kulkarni, Asmita; Nappi, Taylen] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [Torres-Sanchez, Maria] Univ Complutense Madrid, Dept Biodivers Ecol & Evolut, Madrid, Spain	Nevada System of Higher Education (NSHE); University of Nevada Reno; Complutense University of Madrid	Alvarez-Ponce, D (corresponding author), Univ Nevada, Dept Biol, Reno, NV 89557 USA.	dap@unr.edu	Torres-Sánchez, María/AAC-9387-2019	Torres-Sánchez, María/0000-0001-8484-9279; Alvarez-Ponce, David/0000-0002-8729-1036; Nappi, Taylen/0000-0002-1145-8362	Smooth Muscle Plasticity COBRE of the University of Nevada, Reno - National Institutes of Health [5P30GM110767-04]; FPI predoctoral fellowship [BES-2013- 062723]; Ministry of Economy and Competitiveness of Spain [EEBB-I-16-11395]	Smooth Muscle Plasticity COBRE of the University of Nevada, Reno - National Institutes of Health; FPI predoctoral fellowship(National Health and Medical Research Council (NHMRC) of Australia); Ministry of Economy and Competitiveness of Spain(Spanish Government)	This work was supported by a Pilot Grant from the Smooth Muscle Plasticity COBRE of the University of Nevada, Reno, funded by the National Institutes of Health (grant 5P30GM110767-04). MTS was supported by a FPI predoctoral fellowship (BES-2013- 062723) and a travel grant (EEBB-I-16-11395) from the Ministry of Economy and Competitiveness of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aken BL, 2017, NUCLEIC ACIDS RES, V45, pD635, DOI 10.1093/nar/gkw1104; Barau J, 2016, SCIENCE, V354, P909, DOI 10.1126/science.aah5143; BESTOR TH, 1983, P NATL ACAD SCI-BIOL, V80, P5559, DOI 10.1073/pnas.80.18.5559; Bewick AJ, 2017, MOL BIOL EVOL, V34, P654, DOI 10.1093/molbev/msw264; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Campos C, 2012, GENE, V500, P93, DOI 10.1016/j.gene.2012.03.041; Cortez D, 2014, NATURE, V508, P488, DOI 10.1038/nature13151; Ding F, 2003, GENESIS, V36, P209, DOI 10.1002/gene.10215; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Duchene DA, 2017, SYST BIOL; Dunwell TL, 2014, EPIGENOMICS-UK, V6, P459, DOI [10.2217/EPI.14.46, 10.2217/epi.14.46]; ELDEIRY WS, 1991, P NATL ACAD SCI USA, V88, P3470, DOI 10.1073/pnas.88.8.3470; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Gremme G, 2013, IEEE ACM T COMPUT BI, V10, P645, DOI 10.1109/TCBB.2013.68; GRUENBAUM Y, 1982, NATURE, V295, P620, DOI 10.1038/295620a0; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Hobbs M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-786; Hodges E, 2009, GENOME RES, V19, P1593, DOI 10.1101/gr.095190.109; Jeltsch A, 2006, TRENDS BIOCHEM SCI, V31, P306, DOI 10.1016/j.tibs.2006.04.005; Jeltsch A, 2010, SCIENCE, V328, P837, DOI 10.1126/science.1190738; Johnson Rebecca N., 2014, Technical Reports of the Australian Museum Online, V24, DOI 10.3853/j.1835-4211.24.2014.1624; JUKES T H, 1969, P21; Jurkowski TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028104; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee JT, 2003, CURR BIOL, V13, pR242, DOI 10.1016/S0960-9822(03)00162-3; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9; Meredith RW, 2008, J MAMM EVOL, V15, P1, DOI 10.1007/s10914-007-9062-6; Meredith RW, 2009, MOL PHYLOGENET EVOL, V51, P554, DOI 10.1016/j.ympev.2009.02.009; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Mugal CF, 2015, G3-GENES GENOM GENET, V5, P441, DOI 10.1534/g3.114.015545; Murchison EP, 2012, CELL, V148, P780, DOI 10.1016/j.cell.2011.11.065; Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943; NEI M, 1986, MOL BIOL EVOL, V3, P418; NORRIS DP, 1991, MAMM GENOME, V1, P78, DOI 10.1007/BF02443782; Oh BK, 2007, INT J MOL MED, V20, P65; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Peat Julian R, 2017, F1000Res, V6, P526, DOI 10.12688/f1000research.11281.1; Ponger L, 2005, MOL BIOL EVOL, V22, P1119, DOI 10.1093/molbev/msi098; Qin WH, 2011, NUCLEUS-PHILA, V2, P392, DOI 10.4161/nucl.2.5.17928; Renfree MB, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r81; Rens W, 2010, P NATL ACAD SCI USA, V107, P17657, DOI 10.1073/pnas.0910322107; Richardson B, 2003, AGEING RES REV, V2, P245, DOI 10.1016/S1568-1637(03)00010-2; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Romiguier J, 2010, GENOME RES, V20, P1001, DOI 10.1101/gr.104372.109; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Waters SA, 2018, MOL BIOL EVOL, V35, P431, DOI 10.1093/molbev/msx297; Whelan S, 1999, MOL BIOL EVOL, V16, P1292, DOI 10.1093/oxfordjournals.molbev.a026219; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yokomine T, 2006, CYTOGENET GENOME RES, V113, P75, DOI 10.1159/000090817; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang Z, 2015, BIORXIV	65	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195162	10.1371/journal.pone.0195162	http://dx.doi.org/10.1371/journal.pone.0195162			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621315	Green Submitted, Green Published, gold			2022-12-26	WOS:000429206800044
J	Du, ZQ; Dong, J; Bi, JB; Bai, RH; Zhang, J; Wu, Z; Lv, Y; Zhang, XF; Wu, RQ				Du, Zhaoqing; Dong, Jian; Bi, Jianbin; Bai, Ruhai; Zhang, Jia; Wu, Zheng; Lv, Yi; Zhang, Xufeng; Wu, Rongqian			Predictive value of the preoperative neutrophil-to-lymphocyte ratio for the development of hepatocellular carcinoma in HBV-associated cirrhotic patients after splenectomy	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; NEUTROPHIL/LYMPHOCYTE RATIO; LIVER-TRANSPLANTATION; PROGNOSTIC-FACTOR; SURVIVAL; RISK; CHEMOTHERAPY; RECURRENCE; DISEASE; MARKER	The neutrophil to lymphocyte ratio (NLR), a simple marker of inflammation, has recently been showed to predict tumor recurrence in hepatocellular carcinoma (HCC) patients after hepatic resection or liver transplantation. However, whether it can be used to predict HCC development in cirrhotic patients remained unknown. The aim of this study was to evaluate the predictive value of the preoperative NLR for the development of HCC in cirrhotic patients who underwent splenectomy. A total of 230 HBV-associated cirrhotic patients who underwent splenectomy in our hospital from January 2000 to December 2012 were included in this study. Detailed clinical data included patients' general characteristics, laboratory tests and imaging studies, surgical procedures and complications. Information on patients' follow-up data was also obtained. We found that 38 (16.52%) patients developed HCC after splenectomy during the follow-up period. An elevated preoperative NLR was associated with increased risk of developing HCC in cirrhotic patients after splenectomy. The optimal cutoff value of NLR for HCC development was 2.27. In patients who developed HCC during the follow-up period, NLR scores showed no predictive value in overall survival after splenectomy. However, NLR scores appeared to have a much better predictive value in overall survival in patients who did not develop HCC. In conclusion, cirrhotic patients who underwent splenectomy remain at a relatively high risk of developing HCC, and an elevated preoperative NLR is associated with HCC development in cirrhotic patients who underwent splenectomy for hypersplenism.	[Du, Zhaoqing; Dong, Jian; Bi, Jianbin; Zhang, Jia; Lv, Yi; Zhang, Xufeng; Wu, Rongqian] Xi An Jiao Tong Univ, Affiliated Hosp 1, Shaanxi Prov Ctr Regenerat Med & Surg Engn, Xian, Shaanxi, Peoples R China; [Du, Zhaoqing; Dong, Jian; Bi, Jianbin; Zhang, Jia; Lv, Yi; Zhang, Xufeng; Wu, Rongqian] Xi An Jiao Tong Univ, Affiliated Hosp 1, Inst Adv Surg Technol & Engn, Xian, Shaanxi, Peoples R China; [Du, Zhaoqing; Dong, Jian; Bi, Jianbin; Zhang, Jia; Wu, Zheng; Lv, Yi; Zhang, Xufeng] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian, Shaanxi, Peoples R China; [Bai, Ruhai] Xi An Jiao Tong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Zhang, XF; Wu, RQ (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Shaanxi Prov Ctr Regenerat Med & Surg Engn, Xian, Shaanxi, Peoples R China.; Zhang, XF; Wu, RQ (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Inst Adv Surg Technol & Engn, Xian, Shaanxi, Peoples R China.; Zhang, XF (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian, Shaanxi, Peoples R China.	xfzhang125@126.com; rwu001_@mail.xjtu.edu.cn	Zhang, xiaoyu/GXA-3206-2022; zhang, xu/GYE-3558-2022; zhang, xu/GRX-9733-2022; zhang, xian/GYA-0290-2022; Bai, Ruhai/AAV-2762-2020; Wu, Rongqian/I-3614-2012	Wu, Rongqian/0000-0003-0993-4531; ruhai, bai/0000-0001-5426-6291	Ministry of Education Innovation Team Development Program of China [IRT16R57]; Young Talent Recruiting Plans of Xi'an Jiaotong University	Ministry of Education Innovation Team Development Program of China; Young Talent Recruiting Plans of Xi'an Jiaotong University	This work was supported by a grant from the Ministry of Education Innovation Team Development Program of China (No. IRT16R57, YL) and a research fund for Young Talent Recruiting Plans of Xi'an Jiaotong University (RW).	Aino H, 2016, MOL CLIN ONCOL, V5, P83, DOI 10.3892/mco.2016.879; Aizawa M, 2011, WORLD J SURG, V35, P2717, DOI 10.1007/s00268-011-1269-2; Azab B, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0432-4; Basyigit S, 2015, EUR J GASTROEN HEPAT, V27, P1230, DOI 10.1097/MEG.0000000000000426; BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; Capece D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/187204; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chen TM, 2012, J GASTROEN HEPATOL, V27, P553, DOI 10.1111/j.1440-1746.2011.06910.x; Chua W, 2011, BRIT J CANCER, V104, P1288, DOI 10.1038/bjc.2011.100; Coffin CS, 2014, ALIMENT PHARM THER, V40, P1262, DOI 10.1111/apt.12990; Do AL, 2014, J CLIN GASTROENTEROL, V48, P644, DOI 10.1097/MCG.0000000000000015; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Gomez D, 2008, WORLD J SURG, V32, P1757, DOI 10.1007/s00268-008-9552-6; Halazun KJ, 2009, ANN SURG, V250, P141, DOI 10.1097/SLA.0b013e3181a77e59; Harimoto N, 2013, TRANSPLANTATION, V96, P1008, DOI 10.1097/TP.0b013e3182a53f2b; Hiramatsu N, 2016, J GASTROEN HEPATOL, V31, P546, DOI 10.1111/jgh.13229; Ho MC, 2016, LIVER CANCER, V5, P245, DOI 10.1159/000449336; Huang ZL, 2011, J VASC INTERV RADIOL, V22, P702, DOI 10.1016/j.jvir.2010.12.041; Liao WJ, 2014, TRANSL ONCOL, V7, P248, DOI 10.1016/j.tranon.2014.02.011; LIAW YF, 1989, LIVER, V9, P235; Lv X, 2016, TUMOR BIOL, V37, P8889, DOI 10.1007/s13277-015-4764-5; Mano Y, 2013, ANN SURG, V258, P301, DOI 10.1097/SLA.0b013e318297ad6b; Motomura T, 2013, J HEPATOL, V58, P58, DOI 10.1016/j.jhep.2012.08.017; Seretis C, 2013, AM J SURG, V205, P691, DOI 10.1016/j.amjsurg.2012.08.006; Triolo M, 2014, LIVER INT, V34, P139, DOI 10.1111/liv.12394; van Kessel KEM, 2016, BLADDER CANCER, V2, P351, DOI 10.3233/BLC-160055; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Yang H.D, 2016, ONCOTARGET; Yang T, 2017, J SURG ONCOL; Yavuzcan A, 2013, J TURK-GER GYNECOL A, V14, P210, DOI 10.5152/jtgga.2013.55452	33	13	13	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195336	10.1371/journal.pone.0195336	http://dx.doi.org/10.1371/journal.pone.0195336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621282	Green Published, gold, Green Submitted			2022-12-26	WOS:000429206800065
J	Imai, Y; Kariya, T; Iwakiri, M; Yamada, Y; Takimoto, E				Imai, Yousuke; Kariya, Taro; Iwakiri, Masaki; Yamada, Yoshitsugu; Takimoto, Eiki			Sildenafil ameliorates right ventricular early molecular derangement during left ventricular pressure overload	PLOS ONE			English	Article							SYSTOLIC HEART-FAILURE; CHRONIC INHIBITION; PHOSPHODIESTERASE 5; EJECTION FRACTION; PDE5 INHIBITION; DYSFUNCTION; MECHANISMS; EXPRESSION; HYPERTENSION; HYPERTROPHY	Right ventricular (RV) dysfunction following left ventricular (LV) failure is associated with poor prognosis. RV remodeling is thought initiated by the increase in the afterload of RV due to secondary pulmonary hypertension (PH) to impaired LV function; however, RV molecular changes might occur in earlier stages of the disease. cGMP (cyclic guanosine monophosphate)-phosphodiesterase 5 (PDE5) inhibitors, widely used to treat PH through their pulmonary vasorelaxation properties, have shown direct cardiac benefits, but their impacts on the RV in LV diseases are not fully determined. Here we show that RV molecular alterations occur early in the absence of RV hemodynamic changes during LV pressure-overload and are ameliorated by PDE5 inhibition. Two-day moderate LV pressure-overload (transverse aortic constriction) neither altered RV pressure/function nor RV weight in mice, while it induced only mild LV hypertrophy. Importantly, pathological molecular features were already induced in the RV free wall myocardium, including up-regulation of gene markers for hypertrophy and inflammation, and activation of extracellular signal-regulated kinase (ERK) and calcineurin. Concomitant PDE5 inhibition (sildenafil) prevented induction of such pathological genes and activation of ERK and calcineurin in the RV as well as in the LV. Importantly, dexamethasone also prevented these RV molecular changes, similarly to sildenafil treatment. These results suggest the contributory role of inflammation to the early pathological interventricular interaction between RV and LV. The current study provides the first evidence for the novel early molecular cross-talk between RV and LV, preceding RV hemodynamic changes in LV disease, and supports the therapeutic strategy of enhancing cGMP signaling pathway to treat heart diseases.	[Imai, Yousuke; Kariya, Taro; Iwakiri, Masaki; Yamada, Yoshitsugu] Univ Tokyo, Grad Sch Med, Dept Anesthesiol, Bunkyo Ku, Tokyo, Japan; [Takimoto, Eiki] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo, Japan; [Takimoto, Eiki] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA	University of Tokyo; University of Tokyo; Johns Hopkins University	Takimoto, E (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo, Japan.; Takimoto, E (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA.	etakimo1@jhmi.edu	Kariya, Taro/AAF-4551-2021; Takimoto, Eiki/AAC-5100-2021	Kariya, Taro/0000-0001-7678-3652; Takimoto, Eiki/0000-0001-7767-0094	National Institute of Health [R01 HL-093432]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institute of Health Grants R01 HL-093432 (ET).	Bueno OF, 2002, CIRC RES, V91, P776, DOI 10.1161/01.RES.0000038488.38975.1A; De Vecchis Renato, 2017, J Clin Med Res, V9, P488, DOI 10.14740/jocmr3008w; Di Luigi L, 2016, INFLAMMATION, V39, P1238, DOI 10.1007/s10753-016-0359-6; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Fiore D, 2016, J CLIN ENDOCR METAB, V101, P1525, DOI 10.1210/jc.2015-4252; Giannetta E, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0185-3; Giannetta E, 2012, CIRCULATION, V125, P2323, DOI 10.1161/CIRCULATIONAHA.111.063412; Guazzi M, 2011, CIRC-HEART FAIL, V4, P8, DOI 10.1161/CIRCHEARTFAILURE.110.944694; Guimaraes FD, 2017, MOL CELL BIOCHEM, V424, P87, DOI 10.1007/s11010-016-2846-3; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; Haddad F, 2008, CIRCULATION, V117, P1717, DOI 10.1161/CIRCULATIONAHA.107.653584; Jang HS, 2014, BBA-MOL BASIS DIS, V1842, P1733, DOI 10.1016/j.bbadis.2014.06.022; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Koka S, 2014, AM J PHYSIOL-HEART C, V306, pH1558, DOI 10.1152/ajpheart.00865.2013; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Lourenco AP, 2006, AM J PHYSIOL-HEART C, V291, pH1587, DOI 10.1152/ajpheart.01004.2005; Maillet M, 2013, NAT REV MOL CELL BIO, V14, P38, DOI 10.1038/nrm3495; Mandosi E, 2015, EXPERT OPIN THER TAR, V19, P1617, DOI 10.1517/14728222.2015.1066337; Melenovsky V, 2014, EUR HEART J, V35, P3452, DOI 10.1093/eurheartj/ehu193; Meyer P, 2010, CIRCULATION, V121, P252, DOI 10.1161/CIRCULATIONAHA.109.887570; Mohammed SF, 2014, CIRCULATION, V130, P2310, DOI 10.1161/CIRCULATIONAHA.113.008461; Poels EM, 2015, AM J PHYSIOL-HEART C, V308, pH803, DOI 10.1152/ajpheart.00573.2014; Puzzo D, 2009, J NEUROSCI, V29, P8075, DOI 10.1523/JNEUROSCI.0864-09.2009; Reddy S, 2015, CIRCULATION, V132, P1734, DOI 10.1161/CIRCULATIONAHA.114.012975; Sachan N, 2011, CIRC RES, V108, P437, DOI 10.1161/CIRCRESAHA.110.235309; Nunes AKS, 2015, BRAIN RES, V1627, P119, DOI 10.1016/j.brainres.2015.09.008; Santi D, 2015, EUR J ENDOCRINOL, V172, pR103, DOI 10.1530/EJE-14-0700; Schinner E, 2015, INT J MOL SCI, V16, P2320, DOI 10.3390/ijms16022320; Seo K, 2014, P NATL ACAD SCI USA, V111, P1551, DOI 10.1073/pnas.1308963111; Sergeeva IA, 2013, BBA-MOL BASIS DIS, V1832, P2403, DOI 10.1016/j.bbadis.2013.07.003; Shah AM, 2011, LANCET, V378, P704, DOI 10.1016/S0140-6736(11)60894-5; Sharma S, 2004, AM J PHYSIOL-HEART C, V286, pH1185, DOI 10.1152/ajpheart.00916.2003; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Takimoto E, 2012, CIRC J, V76, P1819, DOI 10.1253/circj.CJ-12-0664; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Venneri MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126580; Voelkel NF, 2006, CIRCULATION, V114, P1883, DOI 10.1161/CIRCULATIONAHA.106.632208; Walker DK, 1999, XENOBIOTICA, V29, P297, DOI 10.1080/004982599238687; Wang RC, 2014, RESP MED, V108, P531, DOI 10.1016/j.rmed.2014.01.003; Williams JW, 2013, AM J PHYSIOL-LUNG C, V305, pL693, DOI 10.1152/ajplung.00214.2013; WILSON DW, 1989, MICROVASC RES, V38, P57; Wu XJ, 2014, EUR J HEART FAIL, V16, P444, DOI 10.1002/ejhf.47; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Zhao SG, 2015, INT J CARDIOL, V198, P178, DOI 10.1016/j.ijcard.2015.06.183	45	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195528	10.1371/journal.pone.0195528	http://dx.doi.org/10.1371/journal.pone.0195528			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621314	gold, Green Published, Green Submitted			2022-12-26	WOS:000429206800097
J	Moreau, J; Khalil, T; Dupic, G; Chautard, E; Lemaire, JJ; Magnier, F; Dedieu, V; Lapeyre, M; Verrelle, P; Biau, J				Moreau, Juliette; Khalil, Toufic; Dupic, Guillaume; Chautard, Emmanuel; Lemaire, Jean-Jacques; Magnier, Florian; Dedieu, Veronique; Lapeyre, Michel; Verrelle, Pierre; Biau, Julian			Second course of stereotactic radiosurgery for locally recurrent brain metastases: Safety and efficacy	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINE; SURGICAL RESECTION; SALVAGE THERAPY; BREAST-CANCER; SURVIVAL; MANAGEMENT; RADIONECROSIS; RADIOTHERAPY; TUMORS; SRS	In the present study, we have evaluated the efficacy and toxicity of repeated brain metastases (BM) stereotactic radiosurgery (SRS2) following local failure of a prior radiosurgical procedure (SRS1). Between December 1996 and August 2015, 30 patients with 36 BM underwent SRS2 with a median dose of 18Gy. All BM were located outside critical structures. Following SRS2, local control at 6 months and one year were respectively 82.9% (IC 95%: 67.6-91.9) and 67.8% (IC 95%: 51-81). On multivariate analysis, planning target volume (PTV) < 3cc (HR: 0.19 (0.1-0.52)) and whole brain radiotherapy (WBRT) prior to SRS2 (HR: 0.25 (0.1-0.64)) were significantly associated with a better local control. One- and two-year overall survival rates after SRS2 were respectively 65.5% (IC 95%: 47.3-80%) and 27.6% (IC 95%: 14.7-45.7). Median overall survival following SRS2 was 14.2 months (range 1-106). Nineteen (63%) patients died from progressive systemic disease. Three (10%) patients died from out-field progressive brain disease and 8 (27%) in-field. Concerning toxicities, edema, radionecrosis, and hemorrhages were identified in 5 (12.8%), 4 (10.2%), and 5 (12.8%) patients respectively. No toxicity resulted in a neurological deficit. On univariate analysis, toxicities were significantly associated with PTV > 7cc (p = 0.02) and all patients had a WBRT before SRS2. A second course of SRS for locally recurrent brain metastases showed encouraging rates of local control. This treatment led to acceptable toxicities, especially for brain metastases smaller than 7cc, in our selected cohort of patients with BM located outside critical structures. Further studies are needed.	[Moreau, Juliette; Dupic, Guillaume; Chautard, Emmanuel; Lapeyre, Michel; Verrelle, Pierre; Biau, Julian] Univ Clermont Auvergne, Radiotherapy Dept, Ctr Jean Perrin, Clermont Ferrand, France; [Khalil, Toufic; Lemaire, Jean-Jacques] Clermont Ferrand Hosp, Neurosurg Dept, Clermont Ferrand, France; [Chautard, Emmanuel; Dedieu, Veronique; Biau, Julian] Univ Clermont Auvergne, INSERM, U1240 IMoST, Clermont Ferrand, France; [Lemaire, Jean-Jacques] Univ Clermont Auvergne, CNRS, Inst Pascal, UMR 6602, Clermont Ferrand, France; [Magnier, Florian; Dedieu, Veronique] Ctr Jean Perrin, Med Phys Dept, Clermont Ferrand, France; [Verrelle, Pierre] Inst Curie, Radiat Oncol Dept, Paris, France	UNICANCER; Centre Jean Perrin; Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite Clermont Auvergne (UCA); UNICANCER; Centre Jean Perrin; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Biau, J (corresponding author), Univ Clermont Auvergne, Radiotherapy Dept, Ctr Jean Perrin, Clermont Ferrand, France.; Biau, J (corresponding author), Univ Clermont Auvergne, INSERM, U1240 IMoST, Clermont Ferrand, France.	Julian.biau@clermont.unicancer.fr	CHAUTARD, Emmanuel/X-8946-2019; Biau, Julian/X-9035-2019; dedieu, veronique/X-8551-2019	CHAUTARD, Emmanuel/0000-0003-2655-7803; Biau, Julian/0000-0002-1570-4487; MAGNIER, Florian/0000-0001-9403-9923; Lemaire, Jean-Jacques/0000-0003-4395-5328				Ahmed KA, 2015, ANN ONCOL; Ammirati M, 2010, J NEURO-ONCOL, V96, P85, DOI 10.1007/s11060-009-0055-6; Aoyama H, 2006, JAMA-J AM MED ASSOC, V295, P2483, DOI 10.1001/jama.295.21.2483; Bartsch R, 2007, J NEURO-ONCOL, V85, P311, DOI 10.1007/s11060-007-9420-5; Blonigen BJ, 2010, INT J RADIAT ONCOL, V77, P996, DOI 10.1016/j.ijrobp.2009.06.006; Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Chen JCT, 2000, NEUROSURGERY, V46, P860, DOI 10.1097/00006123-200004000-00017; Cicone F, 2015, EUR J NUCL MED MOL I, V42, P103, DOI 10.1007/s00259-014-2886-4; Hanna A, 2016, J NEURO-ONCOL, V127, P303, DOI 10.1007/s11060-015-2034-4; Holt DE, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00084; Jayachandran P, 2014, INT J RADIAT ONCOL, V90, pS320, DOI 10.1016/j.ijrobp.2014.05.1063; Kim DH, 2012, INT J RADIAT ONCOL, V84, pS286, DOI 10.1016/j.ijrobp.2012.07.746; Kirsch DG, 2005, J CLIN ONCOL, V23, P2114, DOI 10.1200/JCO.2005.05.249; Kocher M, 2011, J CLIN ONCOL, V29, P134, DOI 10.1200/JCO.2010.30.1655; Kohutek ZA, 2015, J NEURO-ONCOL, V125, P149, DOI 10.1007/s11060-015-1881-3; Kwon KY, 2007, CLIN NEUROL NEUROSUR, V109, P132, DOI 10.1016/j.clineuro.2006.06.007; Lin NU, 2015, LANCET ONCOL, V16, pE270, DOI 10.1016/S1470-2045(15)70057-4; Lin XL, 2015, J CLIN ONCOL, V33, P3475, DOI 10.1200/JCO.2015.60.9503; Linskey ME, 2010, J NEURO-ONCOL, V96, P45, DOI 10.1007/s11060-009-0073-4; Mckay WH, 2017, J NEUROSURG, V127, P148, DOI 10.3171/2016.5.JNS153051; Milano MT, 2009, INT J RADIAT ONCOL, V73, P832, DOI 10.1016/j.ijrobp.2008.04.073; Minniti G, 2016, J NEURO-ONCOL, V126, P91, DOI 10.1007/s11060-015-1937-4; Minniti G, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-48; Miyakawa A, 2016, INT J CLIN ONCOL, P1; Noel G, 2001, RADIOTHER ONCOL, V60, P61, DOI 10.1016/S0167-8140(01)00359-0; Patchell RA, 2003, CANCER TREAT REV, V29, P533, DOI 10.1016/S0305-7372(03)00105-1; Redmond AJ, 2008, J NEUROSURG, V109, P99, DOI 10.3171/JNS/2008/109/12/S16; Shaw E, 2000, INT J RADIAT ONCOL, V47, P291, DOI 10.1016/S0360-3016(99)00507-6; Song CW, 2014, INT J CLIN ONCOL, V19, P570, DOI 10.1007/s10147-014-0717-z; Sperduto PW, 2012, J CLIN ONCOL, V30, P419, DOI 10.1200/JCO.2011.38.0527; Trifiletti DM, 2015, INT J RADIAT ONCOL, V93, pE73, DOI 10.1016/j.ijrobp.2015.07.729; Truong MT, 2006, NEUROSURGERY, V59, P86, DOI 10.1227/01.NEU.0000219858.80351.38; Vecil GG, 2005, J NEUROSURG, V102, P209, DOI 10.3171/jns.2005.102.2.0209	33	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195608	10.1371/journal.pone.0195608	http://dx.doi.org/10.1371/journal.pone.0195608			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621341	Green Published, gold, Green Submitted			2022-12-26	WOS:000429206800106
J	Bogoni, JA; Graipel, ME; Peroni, N				Bogoni, Juliano Andre; Graipel, Mauricio Eduardo; Peroni, Nivaldo			The ecological footprint of Acca sellowiana domestication maintains the residual vertebrate diversity in threatened highlands of Atlantic Forest	PLOS ONE			English	Article							LARGE-BODIED MAMMALS; SEED-DISPERSAL; COMMUNITY STRUCTURE; ARAUCARIA-ANGUSTIFOLIA; DIDELPHIS-ALBIVENTRIS; TROPICAL FOREST; FOOD WEBS; TOP-DOWN; PLANT; PATTERNS	Past and contemporary human actions are causing numerous changes in patterns and processes at various ecosystem scales and trophic levels, including unintended downstream changes, such as species interactions. In its native range Acca sellowiana (Feijoa) combines some characteristics of human interactions: incipient domestication, restricted to subtropical Atlantic Forest highlands, associated with the threatened conifer Araucaria angustifolia (Araucaria), within a domesticated landscape with anthropogenic forest patches, and provides fruit at a time of resource shortage (Araucaria seeds-pinhao). We quantify the trophic relationships between Feijoa and vertebrates, and evaluate the influences on interactions caused by environmental variations, Feijoa domestication evidences, spatial distance and fruit availability. In four sites within protected areas, we selected 28 focal individuals of Feijoa (seven/site) and collected three temporal replicas between 2015 and 2016, when we measured productivity and frugivory via 45-second videos taken with camera traps. Using ecological network, rarefaction curves and variation partitioning analyses, we evaluate the frugivory network topology, the spatiotemporal structure of communities in relation to fruit availability and the influence of predictive variables on frugivory. We found a large spatiotemporal variation in productivity of Feijoa and that 20 species consumed Feijoa fruits, with a species degree of 2.8 (+/- 5.7) and average Feijoa degree of 14.4 (+/- 10.1), in a modular network with intermediary connectance. Rarefaction curves showed that richness and the independent records are congruent with the fruit amount. Variation partitioning showed that, for the focal individuals, canopy area, green coverage, patch size and distance to water influenced frugivory, and the Feijoa domestication influenced significantly the mammalian frugivory. Feijoa is an important resource that provides food during the time of year when Pinhao is absent, and attracts frugivores, maintain the residual diversity of vertebrates contributing to the structure of communities in highlands. Our insights allowed us to evaluate the magnitude of the interactions between vertebrates and an incipient domesticated tree, in a cultural landscape and highly threatened environment, under a basal foodweb approach with implications for bottom-up and top-down forces. The results contribute to understanding animal-plant relationships, including concepts that can be replicated for other sessile prey and mobile predators in any region or habitat under different gradients of management. Thus, this work shows how human actions can change not only patterns of distribution and abundance but also the diversity and direction of interspecific interactions among species.	[Bogoni, Juliano Andre; Peroni, Nivaldo] Univ Fed Santa Catarina, Programa Posgrad Ecol, Dept Ecol & Zool, Florianopolis, SC, Brazil; [Graipel, Mauricio Eduardo] Univ Fed Santa Catarina, Dept Ecol & Zool, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC)	Bogoni, JA (corresponding author), Univ Fed Santa Catarina, Programa Posgrad Ecol, Dept Ecol & Zool, Florianopolis, SC, Brazil.	bogoni.ja@gmail.com	Peroni, Nivaldo/ABA-2663-2021; Graipel, Maurício/T-3443-2019; Peroni, Nivaldo/AAU-4701-2020	Peroni, Nivaldo/0000-0002-6770-5377; Peroni, Nivaldo/0000-0002-6770-5377; Bogoni, Juliano Andre/0000-0002-8541-0556	Brazilian Ministry of Education (CAPES); CNPq; Brazilian Ministry of Education (MEC-CAPES)	Brazilian Ministry of Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Ministry of Education (MEC-CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Brazilian Ministry of Education (CAPES), Ph.D. scholarship (JAB) and (CNPq) productivity fellowship (NP).; JAB thanks the Brazilian Ministry of Education (MEC-CAPES) for a Ph.D. scholarship. NP thanks CNPq for a productivity fellowship. We thank Patricia Puechagut and Rafael B. Suhs for field support and for the photography contained in S2 Fig., and Laboratorio de Ecologia Terrestre Animal (LECOTA-UFSC) for loaned camera-traps. We thank the PPBio and ICM-Bio for field support. We thank Mauricio Sedrez dos Reis, Tania T. Castellani, Luiz Gustavo R. Oliveira-Santos, Mauricio Cantor, Fabio Daura-Jorge, and Adriano Paglia for comments on the manuscript. We thank Fernanda Michalski and other two anonymous reviewers for their important contribution to this manuscript.	Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Almeida-Neto M, 2008, GLOBAL ECOL BIOGEOGR, V17, P503, DOI 10.1111/j.1466-8238.2008.00386.x; Amarante CVT, 2011, REV BRAS FRUTIC, V33, P1; [Anonymous], 1912, POMONA COLL J BOT; [Anonymous], THESIS; [Anonymous], THESIS; [Anonymous], 2013, PACKFOR FORWARD SELE; [Anonymous], RODRIGUESIA; [Anonymous], 2008, QUANT GIS VERS 3 4 4; Bartuszevige AM, 2008, J ARID ENVIRON, V72, P904, DOI 10.1016/j.jaridenv.2007.11.007; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bitencourt Ana Luisa Vietti, 2006, REVISTA BRASILEIRA DE PALEONTOLOGIA, V9, P109; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Bogoni JA, 2016, MAMMALIA; Bogoni JA, 2017, BIOL CONSERV, V211, P85, DOI 10.1016/j.biocon.2017.05.012; Bogoni JA, 2016, BIODIVERS CONSERV, V25, P1661, DOI 10.1007/s10531-016-1147-1; Bogoni JA, 2016, J MAMMAL, V97, P713, DOI 10.1093/jmammal/gyv215; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brocardo CR, 2013, BIOL CONSERV, V163, P107, DOI 10.1016/j.biocon.2013.04.024; Brower J.E., 1998, FIELD LAB METHODS GE; Bueno RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056252; Caceres NC, 2002, STUD NEOTROP FAUNA E, V37, P97, DOI 10.1076/snfe.37.2.97.8582; Canale GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041671; Cantor M, 2010, BIOTA NEOTROP, V10, P45, DOI 10.1590/S1676-06032010000200004; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Ceotto P, 2009, DIET VARIATION MARSU; Clark CJ, 2005, ECOLOGY, V86, P2684, DOI 10.1890/04-1325; Clement CR, 1999, ECON BOT, V53, P188, DOI 10.1007/BF02866498; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Neto EMDL, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-33; de Jesus Costa Elizabete Marques, 2008, Neotropical Biology and Conservation, V3, P66; de Lima RAF, 2015, BIODIVERS CONSERV, V24, P2135, DOI 10.1007/s10531-015-0953-1; de Souza JG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158127; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Donatti CI, 2011, ECOL LETT, V14, P773, DOI 10.1111/j.1461-0248.2011.01639.x; Dormann C.F., 2008, R NEWS, V8, P8; dos Reis MS, 2014, ECOL SOC, V19, DOI 10.5751/ES-06163-190243; dos Santos KL, 2009, ECON BOT, V63, P204, DOI 10.1007/s12231-009-9076-5; Ducroquet JPHJ, 1997, ACTA HORTIC, P37, DOI 10.17660/ActaHortic.1997.452.5; Dupont YL, 2011, OIKOS, V120, P170, DOI 10.1111/j.1600-0706.2010.18699.x; Fortuna MA, 2010, J ANIM ECOL, V79, P811, DOI 10.1111/j.1365-2656.2010.01688.x; FOX J, 1992, J AM STAT ASSOC, V87, P178, DOI 10.2307/2290467; Galetti M, 2015, GLOB ECOL CONSERV, V3, P824, DOI 10.1016/j.gecco.2015.04.008; Galetti M, 2013, BIOL CONSERV, V163, P1, DOI 10.1016/j.biocon.2013.04.020; Galetti M, 2013, SCIENCE, V340, P1086, DOI 10.1126/science.1233774; Gressler Eliana, 2006, Braz. J. Bot., V29, P509, DOI 10.1590/S0100-84042006000400002; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Hickel E. R., 2000, Revista Brasileira de Fruticultura, V22, P96; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Instituto Brasileiro de Geografia e Estatistica (IBGE), 1992, MAN TECN VEG TAM REC; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jorge MLSP, 2013, BIOL CONSERV, V163, P49, DOI 10.1016/j.biocon.2013.04.018; Karubian J, 2011, WILSON J ORNITHOL, V123, P137, DOI 10.1676/10-029.1; Kissui BM, 2004, P ROY SOC B-BIOL SCI, V271, P1867, DOI 10.1098/rspb.2004.2797; Kurten EL, 2013, BIOL CONSERV, V163, P22, DOI 10.1016/j.biocon.2013.04.025; Lacerda AEB, 2016, BIOTROPICA, P1; Landrum LR, 1997, BRITTONIA, V49, P508, DOI 10.2307/2807742; Lessa LG, 2013, ACTA BOT BRAS, V27, P519, DOI 10.1590/S0102-33062013000300009; Levis C, 2017, SCIENCE, V355, P925, DOI 10.1126/science.aal0157; Mello AJM, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/s13002-015-0039-x; Magurran A.E., 2004, MEASURING BIOL DIVER; Markl JS, 2012, CONSERV BIOL, V26, P1072, DOI 10.1111/j.1523-1739.2012.01927.x; MAY RM, 1973, ECOLOGY, V54, P638, DOI 10.2307/1935352; May RM, 1976, NATURE, V260, P471, DOI DOI 10.1038/260471A0; Mckey D, 2010, P NATL ACAD SCI USA, V107, P7823, DOI 10.1073/pnas.0908925107; Meyer RS, 2012, NEW PHYTOL, V196, P29, DOI 10.1111/j.1469-8137.2012.04253.x; Miller AJ, 2011, AM J BOT, V98, P1389, DOI 10.3732/ajb.1000522; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nogales M, 2005, FUNCT ECOL, V19, P429, DOI 10.1111/j.0269-8463.2005.00975.x; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Oliveira-Santos LGR, 2008, J TROP ECOL, V24, P563, DOI 10.1017/S0266467408005324; Olsen KM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00290; PAINE RT, 1980, J ANIM ECOL, V49, P667; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Pires MM, 2011, J ANIM ECOL, V80, P896, DOI 10.1111/j.1365-2656.2011.01818.x; Pires MM, 2014, OECOLOGIA, V175, P1247, DOI 10.1007/s00442-014-2971-1; Pizo Marco Aurelio, 1996, Ornitologia Neotropical, V6, P87; POWER ME, 1992, ECOLOGY, V73, P733, DOI 10.2307/1940153; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Purves DW, 2005, J ECOL, V93, P658, DOI 10.1111/j.1365-2745.2005.00988.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rambo B., 1951, ANAIS BOT HERBARIO B, V3, P7; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Redondo B, 2012, BRENESIA, V77, P357; Rocha LEC, 2005, THESIS; Santos K. L. dos, 2011, Biotemas, V24, P75; Santos KL, 2017, AGROECOLOGY SUSTAINA; Souza AF, 2007, AUSTRAL ECOL, V32, P524, DOI 10.1111/j.1442-9993.2007.01724.x; Sunquist M.E., 1989, P197; Tabarelli M., 1999, Revista Brasileira de Biologia, V59, P239, DOI 10.1590/S0034-71081999000200008; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Traveset A., 2007, Seed dispersal: theory and its application in a changing world, P78, DOI 10.1079/9781845931650.0078; Traveset Anna, 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P151, DOI 10.1078/1433-8319-00057; Uowolo AL, 2008, PAC SCI, V62, P129, DOI 10.2984/1534-6188(2008)62[129:COTPCM]2.0.CO;2; van der Pijl L., 1992, PRINCIPLES DISPERSAL; Vasconcellos-Neto J, 2009, ACTA BOT BRAS, V23, P1171, DOI 10.1590/S0102-33062009000400027; Vidal MM, 2014, ECOLOGY, V95, P3440, DOI 10.1890/13-1584.1; Vidal MM, 2013, BIOL CONSERV, V163, P42, DOI 10.1016/j.biocon.2013.03.025; Vieira MV, 2009, BIOL CONSERV, V142, P1191, DOI 10.1016/j.biocon.2009.02.006; Wang BC, 2002, TRENDS ECOL EVOL, V17, P379, DOI 10.1016/S0169-5347(02)02541-7; Will H, 2008, J ECOL, V96, P1011, DOI 10.1111/j.1365-2745.2007.01341.x; Yumoto T, 1999, BIOTROPICA, V31, P654, DOI 10.1111/j.1744-7429.1999.tb00414.x; Zhang XueYong, 2013, African Journal of Agricultural Research, V8, P3967	109	7	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195199	10.1371/journal.pone.0195199	http://dx.doi.org/10.1371/journal.pone.0195199			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617455	gold, Green Published			2022-12-26	WOS:000429203800068
J	Stojanova, B; Surinova, M; Klapste, J; Kolarikova, V; Hadincova, V; Munzbergova, Z				Stojanova, Bojana; Surinova, Maria; Klapste, Jaroslav; Kolarikova, Veronika; Hadincova, Veroslava; Munzbergova, Zuzana			Adaptive differentiation of Festuca rubra along a climate gradient revealed by molecular markers and quantitative traits	PLOS ONE			English	Article							SPATIAL GENETIC-STRUCTURE; CO-INERTIA ANALYSIS; PHENOTYPIC PLASTICITY; LOCAL ADAPTATION; Q(ST)-F-ST COMPARISONS; POPULATION DIVERGENCE; ALTITUDINAL GRADIENT; NATURAL-SELECTION; STOMATAL DENSITY; EVOLUTIONARY	Species response to climate change is influenced by predictable (selective) and unpredictable (random) evolutionary processes. To understand how climate change will affect present-day species, it is necessary to assess their adaptive potential and distinguish it from the effects of random processes. This will allow predicting how different genotypes will respond to forecasted environmental change. Space for time substitution experiments are an elegant way to test the response of present day populations to climate variation in real time. Here we assess neutral and putatively adaptive variation in 11 populations of Festuca rubra situated along crossed gradients of temperature and moisture using molecular markers and phenotypic measurements, respectively. By comparing population differentiation in putatively neutral molecular markers and phenotypic traits (Q(ST)-F(ST)comparisons), we show the existence of adaptive differentiation in phenotypic traits and their plasticity across the climatic gradient. The observed patterns of differentiation are due to the high genotypic and phenotypic differentiation of the populations from the coldest (and wettest) environment. Finally, we observe statistically significant covariation between markers and phenotypic traits, which is likely caused by isolation by adaptation. These results contribute to a better understanding of the current adaptation and evolutionary potential to face climate change of a widespread species. They can also be extrapolated to understand how the studied populations will adjust to upcoming climate change without going through the lengthy process of phenotyping.	[Stojanova, Bojana] Univ Ostrava, Dept Biol & Ecol, Fac Sci, Ostrava, Czech Republic; [Stojanova, Bojana; Surinova, Maria; Kolarikova, Veronika; Munzbergova, Zuzana] Charles Univ Prague, Dept Bot, Fac Sci, Prague, Czech Republic; [Surinova, Maria; Hadincova, Veroslava; Munzbergova, Zuzana] Acad Sci Czech Republ, Inst Bot, Pruhonice, Czech Republic; [Klapste, Jaroslav] Scion New Zealand Forest Res Inst Ltd, Rotorua, New Zealand	University of Ostrava; Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Scion	Stojanova, B (corresponding author), Univ Ostrava, Dept Biol & Ecol, Fac Sci, Ostrava, Czech Republic.; Stojanova, B (corresponding author), Charles Univ Prague, Dept Bot, Fac Sci, Prague, Czech Republic.	bojana.stojanova@gmail.com	Šurinová, Mária/F-5239-2015; Klapste, Jaroslav/B-6668-2016; Stojanova, Bojana/AAL-9784-2021; Hadincova, Veroslava/D-4572-2013; Münzbergová, Zuzana/F-6321-2013	Klapste, Jaroslav/0000-0001-5504-3735; Hadincova, Veroslava/0000-0002-3825-1919; Münzbergová, Zuzana/0000-0002-4026-6220; Stojanova, Bojana/0000-0002-6761-7756	Czech Grant Agency [GACR 15-07795S]; Academy of Sciences of the Czech Republic; Charles University of Prague; Scion (New Zealand Forest Research Institute Ltd.), a commerial company; University of Ostrava; Norwegian Research Council [NORKLIMA 184912, KLIMAFORSK 244525];  [RVO 67985939]	Czech Grant Agency(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Charles University of Prague; Scion (New Zealand Forest Research Institute Ltd.), a commerial company; University of Ostrava; Norwegian Research Council(Research Council of NorwayEuropean Commission); 	The study was supported by project GACR 15-07795S of the Czech Grant Agency, which provided funding for field trips and all experimental work, and parts of the salaries of ZM, VH, and BS, through the Academy of Sciences of the Czech Republic and Charles University of Prague. JK salary was funded by Scion (New Zealand Forest Research Institute Ltd.), a commerial company. BS salary was partly funded by the University of Ostrava. The study was also partly supported institutional research projects RVO 67985939 and MSMT. The plant material upon which this research was based was collected from within the SEEDCLIM Climate Grid field sites in western Norway, PI Vigdis Vandvik, funded by the Norwegian Research Council projects NORKLIMA 184912 and KLIMAFORSK 244525. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.; The study was supported by project GACR 15-07795S and partly by institutional research projects RVO 67985939 and MSMT. The plant material upon which this research was based was collected from within the SEEDCLIM Climate Grid field sites in western Norway, PI Vigdis Vandvik, funded by the Norwegian Research Council projects NORKLIMA 184912 and KLIMAFORSK 244525. The SEEDCLIM project team granted access to the field sites and provided the associated climatic and environmental data.	[Anonymous], 2014, R LANG ENV STAT COMP; Aykanat T, 2015, MOL ECOL, V24, P5158, DOI 10.1111/mec.13383; Barton NH, 2000, PHILOS T R SOC B, V355, P1553, DOI 10.1098/rstb.2000.0716; BEERLING DJ, 1993, P ROY SOC B-BIOL SCI, V251, P133, DOI 10.1098/rspb.1993.0019; Blois JL, 2013, P NATL ACAD SCI USA, V110, P9374, DOI 10.1073/pnas.1220228110; Brommer JE, 2011, J EVOLUTION BIOL, V24, P1160, DOI 10.1111/j.1420-9101.2011.02268.x; Brommer JE, 2005, EVOLUTION, V59, P1362; Butler DG, 2018, ASREML R REFERENCE M; Castro S, 2011, EVOL ECOL, V25, P795, DOI 10.1007/s10682-010-9439-5; Chandna R, 2012, ABIOTIC STRESS RESPONSES IN PLANTS: METABOLISM, PRODUCTIVITY AND SUSTAINABILITY, P181, DOI 10.1007/978-1-4614-0634-1_10; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Clark LV, 2011, MOL ECOL RESOUR, V11, P562, DOI 10.1111/j.1755-0998.2011.02985.x; Davis MB, 2005, ECOLOGY, V86, P1704, DOI 10.1890/03-0788; de Jong G, 2005, NEW PHYTOL, V166, P101, DOI 10.1111/j.1469-8137.2005.01322.x; De Kort H, 2016, J EVOLUTION BIOL, V29, P253, DOI 10.1111/jeb.12777; de Witte LC, 2010, ANN BOT-LONDON, V106, P859, DOI 10.1093/aob/mcq191; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; DOLEDEC S, 1994, FRESHWATER BIOL, V31, P277, DOI 10.1111/j.1365-2427.1994.tb01741.x; Drake JM, 2005, P ROY SOC B-BIOL SCI, V272, P1823, DOI 10.1098/rspb.2005.3148; Dray S, 2003, ECOLOGY, V84, P3078, DOI 10.1890/03-0178; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Dufresne F, 2014, MOL ECOL, V23, P40, DOI 10.1111/mec.12581; Edelaar P, 2011, MOL ECOL, V20, P4830, DOI 10.1111/j.1365-294X.2011.05333.x; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; ELLSTRAND NC, 1987, AM J BOT, V74, P123, DOI 10.2307/2444338; Esselink GD, 2004, THEOR APPL GENET, V109, P402, DOI 10.1007/s00122-004-1645-5; Franks SJ, 2014, EVOL APPL, V7, P123, DOI 10.1111/eva.12112; Fu YB, 2006, MOL ECOL NOTES, V6, P894, DOI 10.1111/j.1471-8286.2006.01390.x; Garcia-Navas V, 2014, J EVOLUTION BIOL, V27, P1590, DOI 10.1111/jeb.12412; Gomory D, 2015, EUR J FOREST RES, V134, P1075, DOI 10.1007/s10342-015-0910-2; Gonzalo-Turpin H, 2009, J ECOL, V97, P742, DOI 10.1111/j.1365-2745.2009.01509.x; Govindjee SA, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI DOI 10.1016/J.JPH0T0BI0L.2010.12.010; Hanssen-Bauer I, 2005, CLIM RES, V29, P255, DOI 10.3354/cr029255; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Henderson C. R, 1984, APPL LINEAR MODELS A; Herben T, 2001, OIKOS, V95, P43, DOI 10.1034/j.1600-0706.2001.950105.x; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Karhunen M, 2014, EVOLUTION, V68, P559, DOI 10.1111/evo.12268; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kim Y, 2000, GENETICS, V155, P1415; Klanderud K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130205; KORNER C, 1989, FLORA, V182, P353; Lauvergeat V, 2005, MOL ECOL NOTES, V5, P401, DOI 10.1111/j.1471-8286.2005.00941.x; Leinonen T, 2006, J EVOLUTION BIOL, V19, P1803, DOI 10.1111/j.1420-9101.2006.01182.x; Leinonen T, 2013, NAT REV GENET, V14, P179, DOI 10.1038/nrg3395; Lester RE, 2014, GLOBAL CHANGE BIOL, V20, P3471, DOI 10.1111/gcb.12634; LEWONTIN RC, 1973, GENETICS, V74, P175; Li S-L, 2015, ANN BOT; Lind MI, 2011, EVOLUTION, V65, P684, DOI 10.1111/j.1558-5646.2010.01122.x; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Luo Y, 2015, HEREDITY, V114, P220, DOI 10.1038/hdy.2014.89; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; Meerhoff M., 2012, ENV WARMING SHALLOW; Meineri E, 2014, J VEG SCI, V25, P275, DOI 10.1111/jvs.12062; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; Merila J, 2014, EVOL APPL, V7, P1, DOI 10.1111/eva.12137; Michalakis Y, 1996, GENETICS, V142, P1061; Michalski SG, 2015, ECOL EVOL, V5, P2172, DOI 10.1002/ece3.1481; Mosca E, 2012, MOL ECOL, V21, P5530, DOI 10.1111/mec.12043; MOTRO U, 1982, EVOLUTION, V36, P1059, DOI 10.1111/j.1558-5646.1982.tb05474.x; Munzbergova A Z, 2017, J ECOL; Munzbergova A Z, 2017, ECOL EVOL; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Nicotra AB, 2015, ECOL EVOL, V5, P634, DOI 10.1002/ece3.1329; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; PICKETT S T A, 1989, P110; Pons O, 1996, GENETICS, V144, P1237; Porth I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142864; Pujol B, 2008, MOL ECOL, V17, P4782, DOI 10.1111/j.1365-294X.2008.03958.x; Raven JA, 2002, NEW PHYTOL, V153, P371, DOI 10.1046/j.0028-646X.2001.00334.x; Rogell B, 2012, MOL ECOL, V21, P2963, DOI 10.1111/j.1365-294X.2012.05590.x; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Skalova H, 1997, J EVOLUTION BIOL, V10, P383, DOI 10.1007/s000360050031; Springate DA, 2011, J EVOLUTION BIOL, V24, P2280, DOI 10.1111/j.1420-9101.2011.02360.x; Stenstrom A, 2002, AM J BOT, V89, P1410, DOI 10.3732/ajb.89.9.1410; Sultan SE, 1995, ACTA BOT NEERL, V44, P363; Valladares F, 2000, NEW PHYTOL, V148, P79, DOI 10.1046/j.1469-8137.2000.00737.x; Valladares F, 2006, J ECOL, V94, P1103, DOI 10.1111/j.1365-2745.2006.01176.x; VIA S, 1993, AM NAT, V142, P352, DOI 10.1086/285542; Whitlock MC, 2009, GENETICS, V183, P1055, DOI 10.1534/genetics.108.099812; Zhang LR, 2012, ECOL EVOL, V2, P1065, DOI 10.1002/ece3.233	88	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194670	10.1371/journal.pone.0194670	http://dx.doi.org/10.1371/journal.pone.0194670			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617461	Green Submitted, gold, Green Published			2022-12-26	WOS:000429203800043
J	Araujo, IJD; de Paula, AB; Alonso, RCB; Taparelli, JR; Mei, LHI; Stipp, RN; Puppin-Rontani, RM				de Souza Araujo, Isaac Jordao; de Paula, Andreia Bolzan; Bruschi Alonso, Roberta Caroline; Taparelli, Jesus Roberto; Innocentini Mei, Lucia Helena; Stipp, Rafael Nobrega; Puppin-Rontani, Regina Maria			A novel Triclosan Methacrylate-based composite reduces the virulence of Streptococcus mutans biofilm	PLOS ONE			English	Article							DENTAL RESTORATIVE MATERIALS; MOLECULAR-GENETICS; CALCIUM-PHOSPHATE; EXPRESSION; BIODEGRADATION; ANTIBACTERIAL; CHLORHEXIDINE; COMPONENTS; RESINS; GLUCOSYLTRANSFERASE	The use of antimicrobial monomers, linked to the polymer chain of resin composites, is an interesting approach to circumvent the effects of bacteria on the dental and material surfaces. In addition, it can likely reduce the incidence of recurrent caries lesions. The aim of this study was to evaluate the effects of a novel Triclosan Methacrylate (TM) monomer, which was developed and incorporated into an experimental resin composite, on Streptococcus mutans (S. mutans) biofilms, focusing on the analyses of vicR, gtfD, gtfC, covR, and gbpB gene expression, cell viability and biofilm characteristics. The contact time between TM-composite and S. mutans down-regulated the gbpB and covR and up-regulated the gtfC gene expression, reduced cell viability and significantly decreased parameters of the structure and characteristics of S. mutans biofilm virulence. The presence of Triclosan Methacrylate monomer causes harmful effects at molecular and cellular levels in S. mutans, implying a reduction in the virulence of those microorganisms.	[de Souza Araujo, Isaac Jordao; de Paula, Andreia Bolzan] Univ Estadual Campinas, Piracicaba Dent Sch, Dent Mat Div, Operat Dent Dept, Piracicaba, SP, Brazil; [Bruschi Alonso, Roberta Caroline] Metropolitan Univ Santos UNIMES, Sch Dent, Dept Dent, Santos, SP, Brazil; [Bruschi Alonso, Roberta Caroline] Univ Mogi das Cruzes, Sch Dent, Technol Res Ctr, Mogi das Cruzes, Brazil; [Taparelli, Jesus Roberto; Innocentini Mei, Lucia Helena] Univ Estadual Campinas, Chem Engn Sch, Dept Mat Engn & Bioproc, Campinas, SP, Brazil; [Stipp, Rafael Nobrega] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Oral Diag, Piracicaba, SP, Brazil; [Puppin-Rontani, Regina Maria] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Pediat Dent, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade de Mogi das Cruzes; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Puppin-Rontani, RM (corresponding author), Univ Estadual Campinas, Piracicaba Dent Sch, Dept Pediat Dent, Sao Paulo, Brazil.	rmpuppin@fop.unicamp.br	PUPPIN-RONTANI, regina/AAM-9962-2020; Stipp, Rafael Nobrega/D-4518-2011; PUPPIN-RONTANI, REGINA/GVS-2045-2022; PUPPIN-RONTANI, regina/C-3994-2012; de Souza Araújo, Isaac Jordao/P-6068-2017	PUPPIN-RONTANI, regina/0000-0002-1218-5159; Stipp, Rafael Nobrega/0000-0001-5305-1299; PUPPIN-RONTANI, regina/0000-0002-1218-5159; de Souza Araújo, Isaac Jordao/0000-0002-1795-8640	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [AUXPE/CAPES/PROEX - 1777/2014]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/10750-4]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors received funding only for research project development from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (AUXPE/CAPES/PROEX - 1777/2014) and from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - (#2012/10750-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.capes.gov.br/. http://www.fapesp.br/; Authors thank FAPESP (#2012/10750-4) and CAPES/PROEX/AUXPE-1777/2014 for financial support, and also thank Jeremy Matis for language revision and editing.	Anusavice KJ, 2006, J DENT RES, V85, P950, DOI 10.1177/154405910608501016; Anusavice KJ, 2005, J DENT RES, V84, P440, DOI 10.1177/154405910508400508; Biswas S, 2006, J BACTERIOL, V188, P988, DOI 10.1128/JB.188.3.988-998.2006; Cheng L, 2012, DENT MATER, V28, P853, DOI 10.1016/j.dental.2012.04.024; Cheng L, 2012, DENT MATER, V28, P573, DOI 10.1016/j.dental.2012.01.006; Chong P, 2008, J BACTERIOL, V190, P4478, DOI 10.1128/JB.01961-07; Rodolpho PAD, 2011, DENT MATER, V27, P955, DOI 10.1016/j.dental.2011.06.001; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Duque C, 2011, INFECT IMMUN, V79, P786, DOI 10.1128/IAI.00725-10; Eick S, 2004, J ORAL REHABIL, V31, P278, DOI 10.1046/j.0305-182X.2003.01233.x; Gharechahi M., 2012, J BIOMATER NANOBIOTE, V03, P541, DOI DOI 10.4236/JBNB.2012.324056; Imazato S, 2014, DENT MATER, V30, P97, DOI 10.1016/j.dental.2013.06.003; Junker LM, 2004, J ANTIMICROB CHEMOTH, V53, P989, DOI 10.1093/jac/dkh196; Kawai K, 2001, OPER DENT, V26, P396; Kawai K, 2000, J BIOMED MATER RES, V51, P123, DOI 10.1002/(SICI)1097-4636(200007)51:1<123::AID-JBM16>3.0.CO;2-7; Khalichi P, 2004, BIOMATERIALS, V25, P5467, DOI 10.1016/j.biomaterials.2003.12.056; Khalichi P, 2009, BIOMATERIALS, V30, P452, DOI 10.1016/j.biomaterials.2008.09.053; KURAMITSU HK, 1993, CRIT REV ORAL BIOL M, V4, P159, DOI 10.1177/10454411930040020201; Leung D, 2005, BIOMATERIALS, V26, P7145, DOI 10.1016/j.biomaterials.2005.05.014; Mattos-Graner RO, 2001, INFECT IMMUN, V69, P6931, DOI 10.1128/IAI.69.11.6931-6941.2001; Meereis CTW, 2014, DENT MATER, V30, P945, DOI 10.1016/j.dental.2014.05.020; Mjor IA, 2000, INT DENT J, V50, P361; Opdam NJM, 2010, J DENT RES, V89, P1063, DOI 10.1177/0022034510376071; Padovani GC, 2014, OPER DENT, V39, P349, DOI 10.2341/13-089-C; Padovani GC, 2015, AM J DENT, V28, P3; Petersen RC, 2016, AIMS MOL SCI, V3, P88, DOI 10.3934/molsci.2016.1.88; Phan TN, 2006, CAN J MICROBIOL, V52, P977, DOI 10.1139/W06-055; Polydorou O, 2007, DENT MATER, V23, P1535, DOI 10.1016/j.dental.2006.12.011; de Fucio SBP, 2009, AM J DENT, V22, P131; Santerre JP, 1999, J DENT RES, V78, P1459, DOI 10.1177/00220345990780081201; Senadheera MD, 2005, J BACTERIOL, V187, P4064, DOI 10.1128/JB.187.12.4064-4076.2005; Singh J, 2009, J BIOMED MATER RES A, V88A, P551, DOI 10.1002/jbm.a.31879; Song F, 2015, J DENT RES, V94, P1027, DOI 10.1177/0022034515587690; Spencer Paulette, 2012, Braz Dent Sci, V15, P4; Steinberg D, 2002, J DENT, V30, P47, DOI 10.1016/S0300-5712(01)00058-6; Stipp RN, 2013, PLOS ONE, P8; Villalain J, 2001, ARCH BIOCHEM BIOPHYS, V390, P128, DOI 10.1006/abbi.2001.2356; Whillerhausen B, 1999, INT DENT J, P231; Zhang JF, 2014, J DENT RES, V93, P1283, DOI 10.1177/0022034514555143	39	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195244	10.1371/journal.pone.0195244	http://dx.doi.org/10.1371/journal.pone.0195244			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608622	Green Submitted, Green Published, gold			2022-12-26	WOS:000428988800042
J	Menotta, M; Orazi, S; Gioacchini, AM; Spapperi, C; Ricci, A; Chessa, L; Magnani, M				Menotta, Michele; Orazi, Sara; Gioacchini, Anna Maria; Spapperi, Chiara; Ricci, Anastasia; Chessa, Luciana; Magnani, Mauro			Proteomics and transcriptomics analyses of ataxia telangiectasia cells treated with Dexamethasone	PLOS ONE			English	Article							DOUBLE-STRAND BREAK; GENE-EXPRESSION; DNA-DAMAGE; NEUROLOGICAL SYMPTOMS; IONIZING-RADIATION; SIGNALING PATHWAYS; ATM PROTEIN; MUTATED ATM; SURVIVAL; AKT	Ataxia telangiectasia (A-T) is an incurable and rare hereditary syndrome. In recent times, treatment with glucocorticoid analogues has been shown to improve the neurological symptoms that characterize this condition, but the molecular mechanism of action of these analogues remains unknown. Hence, the aim of this study was to gain insight into the molecular mechanism of action of glucocorticoid analogues in the treatment of A-T by investigating the role of Dexamethasone (Dexa) in A-T lymphoblastoid cell lines. We used 2DE and tandem MS to identify proteins that were influenced by the drug in A-T cells but not in healthy cells. Thirty-four proteins were defined out of a total of 746 63. Transcriptome analysis was performed by microarray and showed the differential expression of 599 A-T and 362 wild type (WT) genes and a healthy un-matching between protein abundance and the corresponding gene expression variation. The proteomic and transcriptomic profiles allowed the network pathway analysis to pinpoint the biological and molecular functions affected by Dexamethasone in Dexa-treated cells. The present integrated study provides evidence of the molecular mechanism of action of Dexamethasone in an A-T cellular model but also the broader effects of the drug in other tested cell lines.	[Menotta, Michele; Orazi, Sara; Gioacchini, Anna Maria; Spapperi, Chiara; Ricci, Anastasia; Magnani, Mauro] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy; [Chessa, Luciana] Sapienza Univ, Dept Clin & Mol Med, Rome, Italy	University of Urbino; Sapienza University Rome	Menotta, M (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy.	michele.menotta@uniurb.it	Magnani, Mauro/A-1919-2008	Magnani, Mauro/0000-0001-6456-6626; Menotta, Michele/0000-0001-5206-6296	Sparks, A-T Society; Action for A-T [14SAP01]	Sparks, A-T Society; Action for A-T	This study was supported by Sparks, A-T Society and Action for A-T (grant ref. 14SAP01), https://www.sparks.org.uk/.; The study was supported by Sparks, A-T Society and Action for A-T (Grant ref. 14SAP01).	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Barlow C, 2000, P NATL ACAD SCI USA, V97, P871, DOI 10.1073/pnas.97.2.871; Biagiotti S, 2016, FEBS J, V283, P3962, DOI 10.1111/febs.13901; Biagiotti S, 2014, MOL CELL BIOCHEM, V392, P13, DOI 10.1007/s11010-014-2013-7; Boehrs JK, 2007, J NEUROCHEM, V100, P337, DOI 10.1111/j.1471-4159.2006.04254.x; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Broccoletti T, 2008, EUR J NEUROL, V15, P223, DOI 10.1111/j.1468-1331.2008.02060.x; Buoni S, 2006, ARCH NEUROL-CHICAGO, V63, P1479, DOI 10.1001/archneur.63.10.1479; Burns K, 1994, Trends Cell Biol, V4, P152; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; Chaudhary MW, 2014, APPL CLIN GENET, V7, P159, DOI 10.2147/TACG.S35759; Cheema AK, 2013, RADIAT RES, V179, P674, DOI 10.1667/RR3198.1; Cheema AK, 2011, J PROTEOME RES, V10, P2651, DOI 10.1021/pr101243j; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Chessa L, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-5; Colella AD, 2012, ANAL BIOCHEM, V430, P108, DOI 10.1016/j.ab.2012.08.015; D'Assante R, 2017, CLIN IMMUNOL, V175, P16, DOI 10.1016/j.clim.2016.11.015; Dote H, 2006, CANCER RES, V66, P9211, DOI 10.1158/0008-5472.CAN-06-2181; Fraser M, 2011, CELL CYCLE, V10, P2218, DOI 10.4161/cc.10.13.16305; Galat A, 2014, BIOCHEM BIOPH RES CO, V450, P1255, DOI 10.1016/j.bbrc.2014.06.105; Gudavicius G, 2013, BIOCHEM SOC T, V41, P761, DOI 10.1042/BST20130013; Gurtler A, 2013, ANAL BIOCHEM, V433, P105, DOI 10.1016/j.ab.2012.10.010; Holaska JM, 2002, MOL CELL BIOL, V22, P6286, DOI 10.1128/MCB.22.17.6286-6297.2002; Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930; Jiang LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep35671; Koike M, 2015, J VET MED SCI, V77, P1137, DOI 10.1292/jvms.14-0651; Leuzzi V, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000098; Li Y, 2012, CHIN J CANCER, V31, P364, DOI 10.5732/cjc.012.10086; Lopez-Carballo G, 2002, J BIOL CHEM, V277, P25297, DOI 10.1074/jbc.M201869200; Menotta M, 2018, MOL CELL BIOCHEM, V438, P153, DOI 10.1007/s11010-017-3122-x; Menotta M, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0669-2; Menotta M, 2017, CELL BIOCHEM BIOPHYS, V75, P95, DOI 10.1007/s12013-016-0775-0; Menotta M, 2012, J BIOL CHEM, V287, P41352, DOI 10.1074/jbc.M112.344473; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Oka A, 1998, NEUROSCI LETT, V252, P195, DOI 10.1016/S0304-3940(98)00576-X; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SAVITSKY K, 1995, HUM MOL GENET, V4, P2025, DOI 10.1093/hmg/4.11.2025; Schwanhausser B, 2013, NATURE, V495, P126, DOI 10.1038/nature11848; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Tomimatsu N, 2007, J BIOL CHEM, V282, P10138, DOI 10.1074/jbc.M611880200; Toulany M, 2012, MOL CANCER RES, V10, P945, DOI 10.1158/1541-7786.MCR-11-0592; Toulany M, 2011, RADIOTHER ONCOL, V101, P140, DOI 10.1016/j.radonc.2011.06.004; Valentin-Vega YA, 2012, BLOOD, V119, P1490, DOI 10.1182/blood-2011-08-373639; Wang ZY, 2013, AUTOPHAGY, V9, P925, DOI 10.4161/auto.24229; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Zannolli R, 2012, MOVEMENT DISORD, V27, P1312, DOI 10.1002/mds.25126; Zuiderweg ERP, 2017, CELL STRESS CHAPERON, V22, P173, DOI 10.1007/s12192-017-0776-y	54	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195388	10.1371/journal.pone.0195388	http://dx.doi.org/10.1371/journal.pone.0195388			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608596	Green Published, Green Submitted, gold			2022-12-26	WOS:000428988800049
J	Zeng, JM; Jin, Y; Liu, ZC				Zeng, Jumei; Jin, Yun; Liu, Zhongchuan			Solution scattering study of the Bacillus subtilis PgdS enzyme involved in poly-gamma-glutamic acids degradation	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; SEQUENCE ALIGNMENT; POLYGLUTAMIC ACID; PROTEIN; RECOGNITION; PRODUCT; GENE; LYTF	The PgdS enzyme is a poly-gamma-glutamic (gamma-PGA) hydrolase, which has potential application for a controllable degradation of gamma-PGA by enzymatic depolymerization; however, the structure of PgdS is still unknown. Here, to study in detail the full-length PgdS structure, we analyze the low-resolution architecture of PgdS hydrolase from Bacillus subtilis in solution using small angle X-ray scattering (SAXS) method. Combining with other methods, like dynamic light scattering and mutagenesis analyses, a model for the full length structure and the possible substrate delivery route of PgdS are proposed. The results will provide useful hints for future investigations into the mechanisms of gamma-PGA degradation by the PgdS hydrolase and may provide valuable practical information.	[Zeng, Jumei; Jin, Yun; Liu, Zhongchuan] Chinese Acad Sci, Chengdu Inst Biol, Key Lab Environm & Appl Microbiol, Chengdu, Sichuan, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Liu, ZC (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Key Lab Environm & Appl Microbiol, Chengdu, Sichuan, Peoples R China.	liuzhangch07@mails.ucas.ac.cn	jin, yun/GQZ-6618-2022	Liu, Zhongchuan/0000-0003-0806-4319	National Natural Science Foundation of China (NSFC) [31400040, 31700664]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the Grants from National Natural Science Foundation of China (NSFC) (NO.31400040, NO.31700664). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Arai R, 2012, J BIOL CHEM, V287, P44736, DOI 10.1074/jbc.M112.414763; Aramini JM, 2008, BIOCHEMISTRY-US, V47, P9715, DOI 10.1021/bi8010779; Bajaj I, 2011, BIORESOURCE TECHNOL, V102, P5551, DOI 10.1016/j.biortech.2011.02.047; Bhat AR, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-36; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cao MF, 2011, BIORESOURCE TECHNOL, V102, P4251, DOI 10.1016/j.biortech.2010.12.065; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fujimoto Z, 2012, PROTEINS, V80, P722, DOI 10.1002/prot.23229; Fukushima T, 2006, J BACTERIOL, V188, P5541, DOI 10.1128/JB.00188-06; Huang J, 2011, ENG LIFE SCI, V11, P291, DOI 10.1002/elsc.201000133; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levy-Assaraf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056138; Li L, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-9; Li N, 2016, J APPL CRYSTALLOGR, V49, P1428, DOI 10.1107/S160057671601195X; Peng YY, 2015, PROCESS BIOCHEM, V50, P329, DOI 10.1016/j.procbio.2014.12.024; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Shih IL, 2001, BIORESOURCE TECHNOL, V79, P207, DOI 10.1016/S0960-8524(01)00074-8; Smith TJ, 2000, MICROBIOL-UK, V146, P249, DOI 10.1099/00221287-146-2-249; Suzuki T, 2003, J BACTERIOL, V185, P2379, DOI 10.1128/JB.185.7.2379-2382.2003; Tanimoto H, 2007, J AM COLL NUTR, V26, P645, DOI 10.1080/07315724.2007.10719642; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wong JEMM, 2015, ACTA CRYSTALLOGR D, V71, P592, DOI 10.1107/S139900471402793X; Xu QP, 2014, J MOL BIOL, V426, P169, DOI 10.1016/j.jmb.2013.09.011; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1354, DOI 10.1107/S1744309110021214; Xu QP, 2009, STRUCTURE, V17, P303, DOI 10.1016/j.str.2008.12.008; Yamamoto H, 2003, J BACTERIOL, V185, P6666, DOI 10.1128/JB.185.22.6666-6677.2003; Yan S, 2015, BIOTECHNOL PROGR, V31, P1287, DOI 10.1002/btpr.2118; Yao J, 2009, J MOL CATAL B-ENZYM, V56, P158, DOI 10.1016/j.molcatb.2007.12.027; Yu YY, 2016, FRONT MICROBIOL, V7; Zhao CF, 2013, APPL BIOCHEM BIOTECH, V170, P562, DOI 10.1007/s12010-013-0214-2	40	0	0	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e195355	10.1371/journal.pone.0195355	http://dx.doi.org/10.1371/journal.pone.0195355			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608608	Green Submitted, Green Published, gold			2022-12-26	WOS:000428988800048
J	Tidhar, R; Zelnik, ID; Volpert, G; Ben-Dor, S; Kelly, S; Merrill, AH; Futerman, AH				Tidhar, Rotem; Zelnik, Iris D.; Volpert, Giora; Ben-Dor, Shifra; Kelly, Samuel; Merrill, Alfred H., Jr.; Futerman, Anthony H.			Eleven residues determine the acyl chain specificity of ceramide synthases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ceramide; ceramide synthase; sphingolipid; membrane; lipid	TRANSMEMBRANE PROTEIN TOPOLOGY; LONGEVITY ASSURANCE GENES; ENDOPLASMIC-RETICULUM; METABOLIC-PATHWAYS; FAMILY-MEMBERS; WEB SERVER; PREDICTION; SPHINGANINE; LAG1; DOMAINS	Lipids display large structural complexity, with approximate to 40,000 different lipids identified to date, approximate to 4000 of which are sphingolipids. A critical factor determining the biological activities of the sphingolipid, ceramide, and of more complex sphingolipids is their N-acyl chain length, which in mammals is determined by a family of six ceramide synthases (CerS). Little information is available about the CerS regions that determine specificity toward different acyl-CoA substrates. We previously demonstrated that substrate specificity resides in a region of approximate to 150 residues in the Tram-Lag-CLN8 domain. Using site-directed mutagenesis and biochemical analyses, we now narrow specificity down to an 11-residue sequence in a loop located between the last two putative transmembrane domains (TMDs) of the CerS. The specificity of a chimeric protein, CerS5((299-309CerS2)), based on the backbone of CerS5 (which generates C16-ceramide), but containing 11 residues from CerS2 (which generates C22-C24-ceramides), was altered such that it generated C22-C24 and other ceramides. Moreover, a chimeric protein, CerS4((291-301CerS2)), based on CerS4 (which normally generates C18-C22 ceramides) displayed significant activity toward C24:1-CoA. Additional data supported the notion that substitutions of these 11 residues alter the specificities of the CerS toward their cognate acyl-CoAs. Our findings may suggest that this short loop may restrict adjacent TMDs, leading to a more open conformation in the membrane, and that the CerS acting on shorter acyl-CoAs may have a longer, more flexible loop, permitting TMD flexibility. In summary, we have identified an 11-residue region that determines the acyl-CoA specificity of CerS.	[Tidhar, Rotem; Zelnik, Iris D.; Volpert, Giora; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel; [Ben-Dor, Shifra] Weizmann Inst Sci, Life Sci Core Facil, IL-76100 Rehovot, Israel; [Kelly, Samuel; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Kelly, Samuel; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Tidhar, Rotem] 3PLW, IL-4250408 Netanya, Israel; [Volpert, Giora] Vens Med, IL-4250704 Netanya, Israel; [Futerman, Anthony H.] Weizmann Inst Sci, Biochem, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Weizmann Institute of Science	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel.	tony.futerman@weizmann.ac.il	BEN-DOR, SHIFRA/M-6718-2019	BEN-DOR, SHIFRA/0000-0001-9604-1939; Futerman, Anthony/0000-0003-0013-0115	National Institutes of Health [GM076217]; Israel Science Foundation [1728/15]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM076217 and Israel Science Foundation Grant 1728/15. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Breitling J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013359; Cserzo M, 2002, PROTEIN ENG, V15, P745, DOI 10.1093/protein/15.9.745; Ekroos K., 2012, LIPIDOMICS TECHNOLOG, V1st, P1; Futerman A. H., 2015, BIOCH LIPIDS LIPOPRO, P297; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; Ikeda M, 2003, NUCLEIC ACIDS RES, V31, P406, DOI 10.1093/nar/gkg020; Jiang JC, 1998, GENOME RES, V8, P1259, DOI 10.1101/gr.8.12.1259; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kageyama-Yahara N, 2006, BIOCHEM J, V398, P585, DOI 10.1042/BJ20060697; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lahiri S, 2005, J BIOL CHEM, V280, P33735, DOI 10.1074/jbc.M506485200; Lahiri S, 2007, FEBS LETT, V581, P5289, DOI 10.1016/j.febslet.2007.10.018; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; MANDON EC, 1992, J BIOL CHEM, V267, P11144; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Mesika A, 2007, J BIOL CHEM, V282, P27366, DOI 10.1074/jbc.M703487200; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Pasquier C, 1999, PROTEIN ENG, V12, P631, DOI 10.1093/protein/12.8.631; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Rost B, 1996, METHOD ENZYMOL, V266, P525; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Tidhar R, 2015, J LIPID RES, V56, P193, DOI 10.1194/jlr.D052001; Tidhar R, 2013, BBA-MOL CELL RES, V1833, P2511, DOI 10.1016/j.bbamcr.2013.04.010; Tidhar R, 2012, J BIOL CHEM, V287, P3197, DOI 10.1074/jbc.M111.280271; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Venkataraman K, 2002, FEBS LETT, V528, P3, DOI 10.1016/S0014-5793(02)03248-9; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Volpert G, 2017, J CELL SCI, V130, P1486, DOI 10.1242/jcs.199968; Winter E, 2002, TRENDS BIOCHEM SCI, V27, P381, DOI 10.1016/S0968-0004(02)02154-0; Yuan Z, 2004, J COMPUT CHEM, V25, P632, DOI 10.1002/jcc.10411	47	27	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9912	9921		10.1074/jbc.RA118.001936	http://dx.doi.org/10.1074/jbc.RA118.001936			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29632068	Green Published, hybrid			2022-12-26	WOS:000436102300032
J	Maklashina, E; Rajagukguk, S; Iverson, TM; Cecchini, G				Maklashina, Elena; Rajagukguk, Sany; Iverson, T. M.; Cecchini, Gary			The unassembled flavoprotein subunits of human and bacterial complex II have impaired catalytic activity and generate only minor amounts of ROS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						structure-function; electron transfer complex; flavoprotein; mitochondrial respiratory chain complex; protein assembly; protein domain; protein evolution	SOLUBLE FUMARATE REDUCTASE; MITOCHONDRIAL SUCCINATE-DEHYDROGENASE; FLAVINYLATION FACTOR SDH5; L-ASPARTATE OXIDASE; ESCHERICHIA-COLI; RESPIRATORY COMPLEX; SHEWANELLA-FRIGIDIMARINA; QUINOLFUMARATE REDUCTASE; DIHYDROFOLATE-REDUCTASE; CRYSTAL-STRUCTURE	Complex II (SdhABCD) is a membrane-bound component of mitochondrial and bacterial electron transport chains, as well as of the TCA cycle. In this capacity, it catalyzes the reversible oxidation of succinate. SdhABCD contains the SDHA protein harboring a covalently bound FAD redox center and the iron-sulfur protein SDHB, containing three distinct iron-sulfur centers. When assembly of this complex is compromised, the flavoprotein SDHA may accumulate in the mitochondrial matrix or bacterial cytoplasm. Whether the unassembled SDHA has any catalytic activity, for example in succinate oxidation, fumarate reduction, reactive oxygen species (ROS) generation, or other off-pathway reactions, is not known. Therefore, here we investigated whether unassembled Escherichia coli SdhA flavoprotein, its homolog fumarate reductase (FrdA), and the human SDHA protein have succinate oxidase or fumarate reductase activity and can produce ROS. Using recombinant expression in E. coli, we found that the free flavoproteins from these divergent biological sources have inherently low catalytic activity and generate little ROS. These results suggest that the iron-sulfur protein SDHB in complex II is necessary for robust catalytic activity. Our findings are consistent with those reported for single-subunit flavoprotein homologs that are not associated with iron-sulfur or heme partner proteins.	[Maklashina, Elena; Rajagukguk, Sany; Iverson, T. M.; Cecchini, Gary] San Francisco Vet Affairs Hlth Care Syst, Div Mol Biol, San Francisco, CA 94121 USA; [Maklashina, Elena; Cecchini, Gary] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Iverson, T. M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Iverson, T. M.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Iverson, T. M.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Iverson, T. M.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA	University of California System; University of California San Francisco; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Cecchini, G (corresponding author), San Francisco Vet Affairs Healthcare Syst, Mol Biol Div 151 S, 4150 Clement St, San Francisco, CA 94121 USA.	Gary.Cecchini@ucsf.edu		Cecchini, Gary/0000-0002-0571-1747	National Institutes of Health [GM61606]; Department of Veterans Affairs Grant [BX001077]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061606] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Grant(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grant GM61606 (to G. C. and T. M. I.) and Department of Veterans Affairs Grant BX001077 (to G. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ACKRELL BAC, 1993, FEBS LETT, V326, P92, DOI 10.1016/0014-5793(93)81768-U; ACKRELL BAC, 1989, ARCH BIOCHEM BIOPHYS, V268, P26, DOI 10.1016/0003-9861(89)90561-4; ACKRELL BAC, 1975, J BIOL CHEM, V250, P7114; Arora K, 2013, TOP CURR CHEM, V337, P165, DOI 10.1007/128_2012_408; Bamford V, 1999, NAT STRUCT BIOL, V6, P1104; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Baysal BE, 2002, J MED GENET, V39, P617, DOI 10.1136/jmg.39.9.617; Bezawork-Geleta A, 2017, TRENDS BIOCHEM SCI, V42, P312, DOI 10.1016/j.tibs.2017.01.003; Bezawork-Geleta A, 2014, FASEB J, V28, P1794, DOI 10.1096/fj.13-242420; Boehr DD, 2008, BIOCHEMISTRY-US, V47, P9227, DOI 10.1021/bi801102e; BONOMI F, 1983, EUR J BIOCHEM, V134, P439, DOI 10.1111/j.1432-1033.1983.tb07586.x; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Cecchini G, 2002, BBA-BIOENERGETICS, V1553, P140, DOI 10.1016/S0005-2728(01)00238-9; CECCHINI G, 1986, J BIOL CHEM, V261, P1808; Cheng VWT, 2015, BIOCHEMISTRY-US, V54, P1043, DOI 10.1021/bi501350j; DERVARTANIAN DV, 1964, BIOCHIM BIOPHYS ACTA, V92, P233, DOI 10.1016/0926-6569(64)90182-8; Efimov I, 2014, FEBS LETT, V588, P701, DOI 10.1016/j.febslet.2013.12.030; Eletsky A, 2012, BIOCHEMISTRY-US, V51, P8475, DOI 10.1021/bi301171u; Gill AJ, 2012, PATHOLOGY, V44, P285, DOI 10.1097/PAT.0b013e3283539932; GRIVENNIKOVA VG, 1993, BIOCHIM BIOPHYS ACTA, V1140, P282, DOI 10.1016/0005-2728(93)90067-P; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Hanoian P, 2015, ACCOUNTS CHEM RES, V48, P482, DOI 10.1021/ar500390e; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Harms MJ, 2011, P NATL ACAD SCI USA, V108, P18954, DOI 10.1073/pnas.1104808108; Hirst J, 1997, J AM CHEM SOC, V119, P7434, DOI 10.1021/ja9631413; Huang LS, 2006, BBA-BIOENERGETICS, V1757, P1073, DOI 10.1016/j.bbabio.2006.06.015; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; IMLAY JA, 1995, J BIOL CHEM, V270, P19767; Inaoka DK, 2008, BIOCHEMISTRY-US, V47, P10881, DOI 10.1021/bi800413r; Ishii T, 2005, CANCER RES, V65, P203; Iverson TM, 2012, J BIOL CHEM, V287, P35430, DOI 10.1074/jbc.R112.408419; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; Iverson TM, 2000, CURR OPIN STRUC BIOL, V10, P448, DOI 10.1016/S0959-440X(00)00113-5; KACZOROWSKI GJ, 1977, BIOCHEMISTRY-US, V16, P2619, DOI 10.1021/bi00631a007; Kareyeva AV, 2011, FEBS LETT, V585, P385, DOI 10.1016/j.febslet.2010.12.019; King KS, 2014, MOL CELL ENDOCRINOL, V386, P92, DOI 10.1016/j.mce.2013.07.032; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; KOTLYAR AB, 1984, BIOCHIM BIOPHYS ACTA, V784, P24, DOI 10.1016/0167-4838(84)90168-7; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; Leger C, 2001, BIOCHEMISTRY-US, V40, P11234, DOI 10.1021/bi010889b; Leys D, 1999, NAT STRUCT BIOL, V6, P1113; Lim K, 2005, PROTEINS, V58, P759, DOI 10.1002/prot.20337; Maher MJ, 2018, P NATL ACAD SCI USA, V115, P2982, DOI 10.1073/pnas.1800195115; Maklashina E, 2006, J BIOL CHEM, V281, P11357, DOI 10.1074/jbc.M512544200; Maklashina E, 2016, J BIOL CHEM, V291, P2904, DOI 10.1074/jbc.M115.690396; Martucci VL, 2014, CURR PROB CANCER, V38, P7, DOI 10.1016/j.currproblcancer.2014.01.001; MASSEY V, 1991, FLAVINS AND FLAVOPROTEINS 1990, P59; Mattevi A, 1999, STRUCTURE, V7, P745, DOI 10.1016/S0969-2126(99)80099-9; McNeil MB, 2014, FEBS LETT, V588, P414, DOI 10.1016/j.febslet.2013.12.019; Mcneil MB, 2012, J BIOL CHEM, V287, P18418, DOI 10.1074/jbc.M111.293803; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Mowat CG, 2002, BIOCHEMISTRY-US, V41, P11990, DOI 10.1021/bi0203177; Mowat CG, 2001, BIOCHEMISTRY-US, V40, P12292, DOI 10.1021/bi011360h; Na U, 2014, CELL METAB, V20, P253, DOI 10.1016/j.cmet.2014.05.014; OHNISHI T, 1981, J BIOL CHEM, V256, P5577; Ozluk Y, 2015, HUM PATHOL, V46, P1951, DOI 10.1016/j.humpath.2015.07.027; Pankhurst KL, 2006, J BIOL CHEM, V281, P20589, DOI 10.1074/jbc.M603077200; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Reid GA, 2000, BBA-BIOENERGETICS, V1459, P310, DOI 10.1016/S0005-2728(00)00166-3; Rothery EL, 2003, BIOCHEMISTRY-US, V42, P13160, DOI 10.1021/bi030159z; Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001; Sharma P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02713-8; Shen AL, 1999, J BIOL CHEM, V274, P5391, DOI 10.1074/jbc.274.9.5391; Starbird CA, 2018, J STRUCT BIOL, V202, P100, DOI 10.1016/j.jsb.2017.11.004; Starbird CA, 2017, J BIOL CHEM, V292, P12921, DOI 10.1074/jbc.M117.795120; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Tedeschi G, 2001, BIOCHEMISTRY-US, V40, P4738, DOI 10.1021/bi002406u; Tedeschi G, 2010, BIOCHIMIE, V92, P1335, DOI 10.1016/j.biochi.2010.06.015; Tomasiak TM, 2008, J BIOL CHEM, V283, P15460, DOI 10.1074/jbc.M801372200; Van Vranken JG, 2015, CRIT REV BIOCHEM MOL, V50, P168, DOI 10.3109/10409238.2014.990556; Van Vranken JG, 2014, CELL METAB, V20, P241, DOI 10.1016/j.cmet.2014.05.012; Yamamoto H, 2015, PATHOL INT, V65, P9, DOI 10.1111/pin.12230; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Zafreen L, 2016, ARCH BIOCHEM BIOPHYS, V604, P47, DOI 10.1016/j.abb.2016.06.006	74	18	18	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7754	7765		10.1074/jbc.RA118.001977	http://dx.doi.org/10.1074/jbc.RA118.001977			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29610278	Green Published, hybrid			2022-12-26	WOS:000437256500024
J	Motani, K; Kosako, H				Motani, Kou; Kosako, Hidetaka			Activation of stimulator of interferon genes (STING) induces ADAM17-mediated shedding of the immune semaphorin SEMA4D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM; cell surface protein; inflammation; proteomics; post-translational modification (PTM); SEMA4D; STING	CYCLIC GMP-AMP; CYTOSOLIC-DNA; INNATE IMMUNITY; MAMMALIAN DNA; TACE; IRHOM2; DEGRADATION; TRAFFICKING; SYNTHASE; PHOSPHORYLATION	Stimulator of interferon genes (STING) is an endoplasmic reticulum-resident membrane protein that mediates cytosolic pathogen DNA-induced innate immunity and inflammatory responses in host defenses. STING is activated by cyclic di-nucleotides and is then translocated to the Golgi apparatus, an event that triggers STING assembly with the downstream enzyme TANK-binding kinase 1 (TBK1). This assembly leads to the phosphorylation of the transcription factor interferon regulatory factor 3 (IRF3), which in turn induces expression of type-I interferon (IFN) and chemokine genes. STING also mediates inflammatory responses independently of IRF3, but these molecular pathways are largely unexplored. Here, we analyzed the RAW264.7 macrophage secretome to comprehensively identify proinflammatory factors released into the extracellular medium upon STING activation. In total, we identified 1299 proteins in macrophage culture supernatants, of which 23 were significantly increased after STING activation. These proteins included IRF3-dependent cytokines, as well as previously unknown targets of STING, such as the immune semaphorin SEMA4D/CD100, which possesses proinflammatory cytokine-like activities. Unlike for canonical cytokines, the expression of the SEMA4D gene was not up-regulated. Instead, upon STING activation, membrane-bound SEMA4D was cleaved into a soluble form, suggesting the presence of a post-translational shedding machinery. Importantly, the SEMA4D shedding was blocked by TMI-1, an inhibitor of the sheddase ADAM metallopeptidase domain 17 (ADAM17) but not by the TBK1 inhibitor BX795. These results suggest that STING activates ADAM17 and that this activation produces soluble proinflammatory SEMA4D independently of the TBK1/IRF3-mediated transcriptional pathway.	[Motani, Kou; Kosako, Hidetaka] Tokushima Univ, Fujii Mem Inst Med Sci, Div Cell Signaling, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan	Tokushima University	Motani, K (corresponding author), Tokushima Univ, Fujii Mem Inst Med Sci, Div Cell Signaling, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	motani@tokushima-u.ac.jp			KAKENHI from the Japan Society for the Promotion of Science (JSPS) [15K19024, 17K08661]; Takeda Science Foundation; KAKENHI from the JSPS [17K08635]; Japan Foundation for Applied Enzymology	KAKENHI from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); KAKENHI from the JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Foundation for Applied Enzymology	This work was supported by KAKENHI Grants-in-aid for Scientific Research characterized by interstitial lung disease, skin lesions, and 15K19024 and 17K08661 from the Japan Society for the Promotion of Science (JSPS) and by the Takeda Science Foundation (to K.M.). This work also was supported by KAKENHI Grant-in-aid for Scientific Research 17K08635 from the JSPS and by the Japan Foundation for Applied Enzymology (to H.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe T, 2014, J VIROL, V88, P5328, DOI 10.1128/JVI.00037-14; Ablasser A, 2013, CLIN IMMUNOL, V147, P207, DOI 10.1016/j.clim.2013.01.003; Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Brifault C, 2017, J BIOL CHEM, V292, P18699, DOI 10.1074/jbc.M117.798413; Brooke MA, 2014, HUM MOL GENET, V23, P4064, DOI 10.1093/hmg/ddu120; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; Cavadas M, 2017, CELL REP, V21, P745, DOI 10.1016/j.celrep.2017.09.074; Chasis JA, 2008, BLOOD, V112, P470, DOI 10.1182/blood-2008-03-077883; Dreymueller D, 2012, EUR J CELL BIOL, V91, P472, DOI 10.1016/j.ejcb.2011.09.003; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Grieve AG, 2017, ELIFE, V6, DOI 10.7554/eLife.23968; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jeremiah N, 2014, J CLIN INVEST, V124, P5516, DOI 10.1172/JCI79100; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kawane K, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016394; Kawane K, 2010, P NATL ACAD SCI USA, V107, P19432, DOI 10.1073/pnas.1010603107; Liu C, 2009, MOL CELL, V35, P26, DOI 10.1016/j.molcel.2009.06.018; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Luo WW, 2016, NAT IMMUNOL, V17, P1057, DOI 10.1038/ni.3510; Maleki KT, 2016, CLIN IMMUNOL, V163, P52, DOI 10.1016/j.clim.2015.12.012; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Moss ML, 2007, ANAL BIOCHEM, V366, P144, DOI 10.1016/j.ab.2007.04.043; Motani K, 2015, J IMMUNOL, V194, P4914, DOI 10.4049/jimmunol.1402705; Mukai K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11932; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Okabe Y, 2008, EUR J IMMUNOL, V38, P3150, DOI 10.1002/eji.200838559; Prantner D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.382986; Rauniyar N, 2015, INT J MOL SCI, V16, P28566, DOI 10.3390/ijms161226120; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Rodero MP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01932-3; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Stone RC, 2016, CELL TISSUE RES, V365, P495, DOI 10.1007/s00441-016-2464-0; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Tsukamoto S, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.161; Waerner T, 2006, CANCER CELL, V10, P227, DOI 10.1016/j.ccr.2006.07.020; Warner JD, 2017, J EXP MED, V214, P3279, DOI 10.1084/jem.20171351; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xu PL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002689; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; Yoshida Y, 2015, ARTHRITIS RHEUMATOL, V67, P1481, DOI 10.1002/art.39086	47	16	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7717	7726		10.1074/jbc.RA118.002175	http://dx.doi.org/10.1074/jbc.RA118.002175			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29618514	hybrid, Green Published			2022-12-26	WOS:000437256500021
J	Lee, HS; Thiem, VD; Anh, DD; Duong, TN; Lee, M; Grace, D; Nguyen-Viet, H				Lee, Hu Suk; Vu Dinh Thiem; Dang Duc Anh; Tran Nhu Duong; Lee, Mihye; Grace, Delia; Hung Nguyen-Viet			Geographical and temporal patterns of rabies post exposure prophylaxis (PEP) incidence in humans in the Mekong River Delta and Southeast Central Coast regions in Vietnam from 2005 to 2015	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; NORTHERN VIETNAM; UNITED-STATES; BAT; VIRUS; ENCEPHALITIS; CHINA; ASIA	Background In Vietnam, rabies has been a notifiable disease for more than 40 years. Over the last five years, on average, more than 350,000 people per year have been bitten by dogs and cats while more than 80 human deaths have been reported yearly. No studies have been conducted to evaluate the geographical and temporal patterns of rabies in humans in Vietnam. Therefore, the main objective of this study was to assess the geographical and temporal distributions of rabies post exposure prophylaxis (PEP) incidence in humans in Vietnam from 2005 to 2015. Methods Average incidence rabies (AIR) PEP rates for every 3 or 4 years (2005-2008, 2009-2012 and 2013-2015) were calculated to describe the spatial distribution of rabies PEP. Hotspot analysis was implemented to identify patterns of spatial significance using the Getis-Ord Gi statistic. For temporal pattern analysis, two regions [Mekong River Delta (MRD) and Southeast Central Coast (SCC)], with the highest incidence rates, and the seasonal-decomposition procedure based on loess (STL), were compared to assess their temporal patterns of rabies PEP. Findings We found hotspots in southern Vietnam and coldspots in northern Vietnam during the study period. Rabies cases were limited to specific areas. In addition, the hotspot analysis showed that new risk areas were identified in each period which were not observed in incidence rate maps. The seasonal plots showed seasonal patterns with a strong peak in February/July and a minor peak in October/December in the MRD region. However, in the SCC, a small peak was detected at the early part of each year and a strong peak in the middle of each year. Conclusion Our findings provide insight into understanding the geographical and seasonal patterns of rabies PEP in Vietnam. This study provides evidence to aid policy makers when making decisions and investing resources. Such information may also be utilized to raise public awareness to prevent rabies exposures and reduce unnecessary PEP.	[Lee, Hu Suk; Hung Nguyen-Viet] Int Livestock Res Inst, Hanoi, Vietnam; [Vu Dinh Thiem; Dang Duc Anh; Tran Nhu Duong] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Lee, Mihye] Royal Bournemouth Hosp, Med Microbiol Dept, Bournemouth, Dorset, England; [Grace, Delia] Int Livestock Res Inst, Nairobi, Kenya	National Institute of Hygiene & Epidemiology (NIHE); CGIAR; International Livestock Research Institute (ILRI)	Lee, HS (corresponding author), Int Livestock Res Inst, Hanoi, Vietnam.	h.s.Iee@cgiar.org	Nguyen-Viet, Hung/F-6498-2012; Nguyen-Viet, Hung/AHH-2981-2022	Nguyen-Viet, Hung/0000-0001-9877-0596; Nguyen-Viet, Hung/0000-0003-1549-2733; Vu, Thiem/0000-0001-6168-4555; Grace, Delia/0000-0002-0195-9489; Lee, Hu Suk/0000-0002-8731-9836	CGIAR Research Program on Agriculture for Nutrition and Health (A4NH), Livestock CRP; Climate Change, Agriculture and Food Security (CCAFS)	CGIAR Research Program on Agriculture for Nutrition and Health (A4NH), Livestock CRP; Climate Change, Agriculture and Food Security (CCAFS)	This study was funded through the CGIAR Research Program on Agriculture for Nutrition and Health (A4NH), Livestock CRP and Climate Change, Agriculture and Food Security (CCAFS) to Hu Suk Lee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work received support from the CGIAR Research Program on Agriculture for Nutrition and Health (A4NH), led by the International Food Policy Research Institute (IFPRI). We also acknowledge the CGIAR Fund Donors (https://www.cgianorg/funders/). The authors thank the National Institute of Hygiene and Epidemiology (NIHE) under the Ministry of Health for providing information on human rabies PEP cases. We thank Ms. Minh for data management.	Nguyen ATK, 2014, EMERG INFECT DIS, V20, P161, DOI 10.3201/eid2001.130813; ASEAN, ASEAN RAB EL STRAT 2; Bixler A, 2000, J ZOOL, V251, P525, DOI 10.1111/j.1469-7998.2000.tb00808.x; Cleveland R.B., 1990, J OFF STAT, V6, P3; Courtin F, 2000, PREV VET MED, V43, P13, DOI 10.1016/S0167-5877(99)00083-5; FAO, DEV STEPW APPR RAB P; Feldhamer G.A., 2003, WILD MAMMALS N AM BI; Fooks AR, 2003, J MED VIROL, V71, P281, DOI 10.1002/jmv.10481; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gongal G, 2011, ADV PREV MED; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; Lee HS, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2326-8; Hung DM, 2008, BMC P, P1; Kim CH, 2006, J VET MED B, V53, P111, DOI 10.1111/j.1439-0450.2006.00928.x; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Lee HS, 2014, J VET INTERN MED, V28, P779, DOI 10.1111/jvim.12335; LUMIO J, 1986, LANCET, V1, P378; MALAGA H, 1979, INT J EPIDEMIOL, V8, P243, DOI 10.1093/ije/8.3.243; Meslin F X, 1994, Curr Top Microbiol Immunol, V187, P1; Messenger SL, 2002, CLIN INFECT DIS, V35, P738, DOI 10.1086/342387; Mitmoonpitak C, 1998, EPIDEMIOL INFECT, V120, P165, DOI 10.1017/S0950268897008601; Morimoto K, 1996, P NATL ACAD SCI USA, V93, P5653, DOI 10.1073/pnas.93.11.5653; Nadin-Davis SA, 2012, VIRUS RES, V163, P352, DOI 10.1016/j.virusres.2011.10.026; Nguyen AKT, 2015, PUBLIC HEALTH, V129, P1591, DOI 10.1016/j.puhe.2015.07.019; Nguyen AKT, 2011, JPN J INFECT DIS, V64, P391; Nguyen TTH, 2013, J PREV MED WILMINGTO, V7, P29; Piyaphanee W, 2010, AM J TROP MED HYG, V82, P1168, DOI 10.4269/ajtmh.2010.09-0699; Samaratunga H, 1998, NEUROPATH APPL NEURO, V24, P331, DOI 10.1046/j.1365-2990.1998.00129.x; Tao XY, 2009, EMERG INFECT DIS, V15, P1192, DOI 10.3201/eid1508.081551; Tenzin, 2011, ZOONOSES PUBLIC HLTH, V58, P463, DOI 10.1111/j.1863-2378.2011.01393.x; Thao T Dinh, 2004, MAIZE VIETNAM PRODUC; WARRELL DA, 1995, SCHWEIZ MED WSCHR, V125, P879; Wertheim HFL, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000044; WHO Expert Consultation on rabies, 2015, WHO TECH REP SER, V931, P1; World Health Organization, HUM RAB 2017; Yamagata J, 2007, MICROBIOL IMMUNOL, V51, P833, DOI 10.1111/j.1348-0421.2007.tb03979.x; Yin Cui-ping, 2012, Virologica Sinica, V27, P132, DOI 10.1007/s12250-012-3244-y; Zienius Dainius, 2007, Ekologija, V53, P59	38	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194943	10.1371/journal.pone.0194943	http://dx.doi.org/10.1371/journal.pone.0194943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634746	Green Published, gold, Green Submitted			2022-12-26	WOS:000429522200018
J	Wei, LS; Yan, TJ; Wu, YF; Chen, H; Zhang, BS				Wei, Lusha; Yan, Tongjing; Wu, Yifei; Chen, Hui; Zhang, Baoshan			Optimization of alkaline extraction of hemicellulose from sweet sorghum bagasse and its direct application for the production of acidic xylooligosaccharides by Bacillus subtilis strain MR44	PLOS ONE			English	Article							ENZYMATIC-HYDROLYSIS; GLUCURONOXYLAN XYLANOHYDROLASE; STRUCTURAL-CHARACTERIZATION; ETHANOL-PRODUCTION; OLIGOSACCHARIDES; DEPOLYMERIZATION; POLYSACCHARIDES; XYLANASE	As predominant components of hemicelluloses in grasses, methylglucuroarabinoxylans (MeGAX(n)) are sources for the production of acidic xylooligosaccharides (U-XOS). Bacillus subtilis MR44, an engineered biocatalyst to secrete only the XynC xylanase and Axh43 arabinoxylan hydrolase is capable of processing MeGAX(n) to exclusively U-XOS. The present studies are directed at the explosion on direct alkaline extraction serving for production of U-XOS. Response Surface Methodology was used to optimize xylan extraction conditions on the sweet sorghum bagasse to achieve maximum hemicelluloses yield. The optimized condition was as follows: extraction time of 3.91 h, extraction temperature of 86.1 degrees C, and NaOH concentration (w/w) of 12.33%. Crude xylan extracted with NaOH revealed a compositional analysis of xylose (79.0%), arabinose (5.3%), glucose (1.7%), lignin and ash (5.6%). After neutralization this xylan preparation supported growth of MR44, processing MeGAX(n) from sweet sorghum and accumulating U-XOS. The quality of U-XOS produ ced by MR44 using alkaline-treated sweet sorghum bagasse was comparable to that obtained from purified MeGAX(n). Overall, the present study demonstrates that direct alkaline treatment of sweet sorghum bagasse is useful to improve the bioavailability of MeGAX(n) for MR44-mediated conversion to U-XOS with average degrees of polymerization of 11-12, providing alternative resources with applications in nutrition and human and veterinary medicine.	[Wei, Lusha; Yan, Tongjing; Zhang, Baoshan] Shaanxi Normal Univ, Coll Food Engn & Nutrit Sci, Xian, Shaanxi, Peoples R China; [Wu, Yifei] Northwest Univ, Dept Life Sci, Xian, Shaanxi, Peoples R China; [Chen, Hui] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China	Shaanxi Normal University; Northwest University Xi'an; Northwest A&F University - China	Zhang, BS (corresponding author), Shaanxi Normal Univ, Coll Food Engn & Nutrit Sci, Xian, Shaanxi, Peoples R China.	baoshan2@snnu.edu.cn			Shaanxi Normal University [GK 201601007, GK 20170306]; Science and Technology Co-ordination Innovation Project from Shaanxi province [2016KTCL02-33]; Science and Technology Project from Xi'an city [NC1504(4)]; Agricultural Science and Technology Innovation Project from Shaanxi province [2015NY009]	Shaanxi Normal University; Science and Technology Co-ordination Innovation Project from Shaanxi province; Science and Technology Project from Xi'an city; Agricultural Science and Technology Innovation Project from Shaanxi province	This project was supported by the Shaanxi Normal University with funding from central universities No. GK 201601007 and GK 20170306, Science and Technology Co-ordination Innovation Project from Shaanxi province No. 2016KTCL02-33, Science and Technology Project from Xi'an city No. NC1504(4) and Agricultural Science and Technology Innovation Project from Shaanxi province No. 2015NY009.	Avci A, 2013, BIORESOURCE TECHNOL, V130, P603, DOI 10.1016/j.biortech.2012.12.104; Balint S, 2009, APPL BIOCHEM BIOTECH, V153, P151, DOI 10.1007/s12010-008-8423-9; Cai WR, 2008, CARBOHYD POLYM, V71, P403, DOI 10.1016/j.carbpol.2007.06.008; Cunningham R. L., 1986, BIOTECHNOL BIOENG S, V17, P159, DOI DOI 10.1385/ABAB:124:1-3:1119; Don TM, 2006, CARBOHYD POLYM, V63, P331, DOI 10.1016/j.carbpol.2005.08.023; Furtado GP, 2011, PROCESS BIOCHEM, V46, P1202, DOI 10.1016/j.procbio.2011.01.037; Gokhale DV, 1998, BIORESOURCE TECHNOL, V63, P187, DOI 10.1016/S0960-8524(97)00062-X; Gomez B, 2016, J CHEM TECHNOL BIOT, V91, P234, DOI 10.1002/jctb.4569; John FJS, 2006, J BACTERIOL, V188, P8617, DOI 10.1128/JB.01283-06; Kardosova A, 1998, CARBOHYD RES, V308, P99, DOI 10.1016/S0008-6215(98)00072-X; Lawther JM, 1996, J APPL POLYM SCI, V60, P1827, DOI 10.1002/(SICI)1097-4628(19960613)60:11<1827::AID-APP6>3.0.CO;2-N; Lu P, 2006, FEMS MICROBIOL LETT, V261, P224, DOI 10.1111/j.1574-6968.2006.00367.x; Preston JF, 2003, ACS SYM SER, V855, P191, DOI 10.1021/bk-2003-0855.ch012; Ravikumar K, 2006, DYES PIGMENTS, V70, P18, DOI 10.1016/j.dyepig.2005.02.004; Reis A, 2003, CARBOHYD POLYM, V53, P101, DOI 10.1016/S0144-8617(03)00007-9; Rhee MS, 2016, APPL MICROBIOL BIOT, V100, P1501, DOI 10.1007/s00253-015-7124-x; Rhee MS, 2014, APPL ENVIRON MICROB, V80, P917, DOI 10.1128/AEM.03246-13; Shi ZJ, 2011, BIORESOURCES, V6, P5151; Sluiter A., 2006, DETERMINATION SUGARS; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; St John FJ, 2011, J MOL BIOL, V407, P92, DOI 10.1016/j.jmb.2011.01.010; Sun SL, 2013, CARBOHYD POLYM, V92, P2224, DOI 10.1016/j.carbpol.2012.11.098; Vrsanska M, 2007, FEBS J, V274, P1666, DOI 10.1111/j.1742-4658.2007.05710.x; Wei LS, 2016, J CHEM TECHNOL BIOT, V91, P2056, DOI 10.1002/jctb.4800; Yat SC, 2008, BIORESOURCE TECHNOL, V99, P3855, DOI 10.1016/j.biortech.2007.06.046; Yu Q, 2012, BIORESOURCE TECHNOL, V116, P220, DOI 10.1016/j.biortech.2012.04.031	26	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195616	10.1371/journal.pone.0195616	http://dx.doi.org/10.1371/journal.pone.0195616			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634785	Green Published, Green Submitted, gold			2022-12-26	WOS:000429522200041
J	Benson, FG; Levin, J; Rispel, LC				Benson, Frew Gerald; Levin, Jonathan; Rispel, Laetitia Charmaine			Health care providers' compliance with the notifiable diseases surveillance system in South Africa	PLOS ONE			English	Article							CAPTURE-RECAPTURE ANALYSIS; INFECTIOUS-DISEASES; COMPLETENESS; NOTIFICATION; HOSPITALIZATIONS; TUBERCULOSIS; NETHERLANDS; PERFORMANCE; PHYSICIANS; COUNTRIES	Background The optimal performance of a notifiable disease surveillance system (NDSS) is dependent on health care provider (HCP) compliance with communicable disease notification. HCP compliance ensures appropriate investigation and control measures by relevant health care authorities. This study examines the compliance of HCPs with the NDSS in South Africa and factors associated with their compliance. Methods A cross-sectional survey was carried out in three randomly selected provinces. We stratified by type of facility, and recruited clusters of HCPs on survey day to participate. All consenting HCPs in the randomly selected health care facilities on the day of the survey, completed a questionnaire that elicited information on socio-demographic characteristics and notification practices. The data were analysed using STATA (R) 14, using the identifiers for stratum and cluster as well as the calculated sampling weights. Results The study found that 58% of 919 HCPs diagnosed a notifiable disease in the year preceding the survey. The majority of these professionals (92%) indicated that they had reported the disease, but only 51% of those notified the disease/s correctly to the Department of Health. Paediatricians were less likely to notify correctly (OR 0.01, 95% CI 0.00-0.12, p = 0.001). The factors that influenced notification were HCPs perceptions of workload (OR 0.84, 95% CI 0.70-0.99, p = 0.043) and that notification data are not useful (OR 0.84, 95% CI 0.71-0.99, p = 0.040). The study found no association between correct notification and HCPs willingness to notify, experience or training on the NDSS, understanding of the purpose of the NDSS, knowledge of what to notify, or perception of feedback given. Conclusions The compliance of HCPs in South Africa with the NDSS is suboptimal. In light of the important role of HCPs in the effective functioning of the NDSS, information on NDSS usefulness and guidelines on correct notification procedures are needed to increase their compliance.	[Benson, Frew Gerald] Rahima Moosa Hosp, Gauteng Dept Hlth, Johannesburg, South Africa; [Benson, Frew Gerald; Levin, Jonathan] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Rispel, Laetitia Charmaine] Univ Witwatersrand, Sch Publ Hlth, Dept Sci & Technol,Fac Hlth Sci, Ctr Hlth Policy,Natl Res Fdn,SARChI Chair Hlth Wo, Johannesburg, South Africa	University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand	Benson, FG (corresponding author), Rahima Moosa Hosp, Gauteng Dept Hlth, Johannesburg, South Africa.; Benson, FG (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa.	frewbenson@gmail.com			Global Disease Detection Center of the Centers for Disease Control and Prevention, United States of America [5U19 GH000571-05]; National Health Laboratory Services, South Africa	Global Disease Detection Center of the Centers for Disease Control and Prevention, United States of America; National Health Laboratory Services, South Africa	This and the overall research study were funded by the Global Disease Detection Center of the Centers for Disease Control and Prevention, United States of America, through co-operative agreement no. 5U19 GH000571-05 with the National Health Laboratory Services, South Africa. The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention, Department of Health and Human Services, or the US government.	Ahmadi A, 2015, INT J PREVENTIVE MED, V6, DOI 10.4103/2008-7802.172545; Al-Laham H, 2001, East Mediterr Health J, V7, P590; Allen CJ, 2000, MED J AUSTRALIA, V172, P325; Bawa S B, 2003, Afr J Med Med Sci, V32, P49; Benson FG, 2017, INT J INFECT DIS, V59, P141, DOI 10.1016/j.ijid.2017.03.007; Benson FG, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3781-7; Brabazon ED, 2008, EPIDEMIOL INFECT, V136, P241, DOI 10.1017/S0950268807008230; Brabazon ED, 2015, EPIDEMIOL INFECT, V143, P1166, DOI 10.1017/S0950268814001733; Chorba T L, 1990, MMWR Recomm Rep, V39, P1; Coovadia H, 2009, LANCET, V374, P817, DOI 10.1016/S0140-6736(09)60951-X; Dinis J, 2000, Acta Med Port, V13, P33; Doyle TJ, 2002, AM J EPIDEMIOL, V155, P866, DOI 10.1093/aje/155.9.866; Esler D, 2007, AUST FAM PHYSICIAN, V36, P337; Figueiras A, 2004, PUBLIC HEALTH, V118, P521, DOI 10.1016/j.puhe.2003.12.015; Gauci C, 2007, Euro Surveill, V12, pE5; Hafiz MY, 2016, INFECT DRUG RESIST, V9, DOI 10.2147/IDR.S108057; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Ibarz-Pavon AB, 2016, INT J TUBERC LUNG D, V20, P920, DOI 10.5588/ijtld.15.0907; Isere Elvis E, 2015, Niger Med J, V56, P161, DOI 10.4103/0300-1652.160347; Jansson A, 2005, EPIDEMIOL INFECT, V133, P401, DOI 10.1017/S0950268804003632; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Karim SSA, 1996, S AFR MED J, V86, P834; KARIM SSA, 1991, S AFR MED J, V79, P242; Lafond KE, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0568-3; Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0; National Department of Health (South Africa), 2017, NOT MED COND REP S A; Nkgudi B, 2006, SAMJ S AFR MED J, V96, pA206; Overhage JM, 2008, AM J PUBLIC HEALTH, V98, P344, DOI 10.2105/AJPH.2006.092700; Parneix P, 2015, J HOSP INFECT, V89, P328, DOI 10.1016/j.jhin.2014.12.009; Parrella A, 2009, AUST FAM PHYSICIAN, V38, P932; Philip S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123286; Prato R, 2004, Ann Ig, V16, P449; Quan V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-151; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; Robinson P, 1999, Commun Dis Intell, V23, P97; Roush S, 1999, JAMA-J AM MED ASSOC, V282, P164, DOI 10.1001/jama.282.2.164; Sahal N, 2009, SCAND J PUBLIC HEALT, V37, P187, DOI 10.1177/1403494808101179; Sarti E, 2016, INT J INFECT DIS, V44, P44, DOI 10.1016/j.ijid.2016.01.015; Sekimoto M, 2009, AM J INFECT CONTROL, V37, P136, DOI 10.1016/j.ajic.2008.03.005; South Africa. National Department of Health, 2011, HUM RES HLTH S AFR H; Tan HF, 2007, VACCINE, V25, P2630, DOI 10.1016/j.vaccine.2006.12.016; Tan HF, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-11; Thomas BE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147579; United Nations, 2016, WORK HLTH GROWTH INV; van Hest N A, 2001, Ned Tijdschr Geneeskd, V145, P175; van Hest NAH, 2007, EPIDEMIOL INFECT, V135, P1021, DOI 10.1017/S0950268806007540; Weber IB, 2007, EVALUATION NOTIFIABL; 2016, LANCET, V387, P1348, DOI DOI 10.1016/S0140-6736(16)30116-7	48	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195194	10.1371/journal.pone.0195194	http://dx.doi.org/10.1371/journal.pone.0195194			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630627	Green Published, gold, Green Submitted			2022-12-26	WOS:000429505000030
J	Lee, N; Khalenkov, AM; Lugovtsev, VY; Ireland, DD; Samsonova, AP; Bovin, NV; Donnelly, RP; Ilyushina, NA				Lee, Nicolette; Khalenkov, Alexey M.; Lugovtsev, Vladimir Y.; Ireland, Derek D.; Samsonova, Anastasia P.; Bovin, Nicolai V.; Donnelly, Raymond P.; Ilyushina, Natalia A.			The use of plant lectins to regulate H1 N1 influenza A virus receptor binding activity	PLOS ONE			English	Article							NEURAMINIDASE ACTIVITIES; FUNCTIONAL BALANCE; HEMAGGLUTININ; MICE; HA; ACID; COMBINATIONS; REASSORTANTS; REPLICATION; INFECTIONS	We applied an in vitro selection approach using two different plant lectins that bind to alpha 2,3- or alpha 2,6-linked sialic acids to determine which genetic changes of the A/California/04/09 (H1 N1) virus alter hemagglutinin (HA) receptor binding toward alpha 2,3- or alpha 2,6-linked glycans. Consecutive passages of the A/California/04/09 virus with or without lectins in human lung epithelial Calu-3 cells led to development of three HA1 amino acid substitutions, N129D, G155E, and S183P, and one mutation in the neuraminidase (NA), G201E. The S183P mutation significantly increased binding to several a2,6 SA-linked glycans, including YDS, 6'SL(N), and 6-Su-6'SLN, compared to the wild-type virus (up arrow 3.6-fold, P < 0.05). Two other HA1 mutations, N129D and G155E, were sufficient to significantly increase binding to a2,6 linked glycans, 6'SLN and 6-Su-6'SLN, compared to S183P (up arrow 4.1-fold, P < 0.05). These HA1 mutations also increased binding affinity for 3'SLN glycan compared to the wild-type virus as measured by Biacore surface plasmon resonance method. In addition, the HA1 N129D and HA1 G155E substitutions were identified as antigenic mutations. Furthermore, the G201E mutation in NA reduced the NA enzyme activity (down arrow 2.3-fold). These findings demonstrate that the A/California/04/09 (H1N1) virus can acquire enhanced receptor affinity for both alpha 2,3- and alpha 2,6-linked sialic receptors under lectin-induced selective pressure. Such changes in binding affinity are conferred by selection of beneficial HA1 mutations that affect receptor specificity, antigenicity, and/or functional compatibility with the NA protein.	[Lee, Nicolette; Ireland, Derek D.; Donnelly, Raymond P.; Ilyushina, Natalia A.] US FDA, Div Biotechnol Res & Review 2, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Khalenkov, Alexey M.] US FDA, Div Plasma Prot Therapeut, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Lugovtsev, Vladimir Y.; Samsonova, Anastasia P.] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Bovin, Nicolai V.] Russian Acad Sci, Shemyakin Inst Bioorgan Chem, Carbohydrate Chem Lab, Moscow, Russia	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Donnelly, RP; Ilyushina, NA (corresponding author), US FDA, Div Biotechnol Res & Review 2, Ctr Drug Evaluat & Res, Silver Spring, MD USA.	Raymond.Donnelly@fda.hhs.gov; Natalia.llyushina@fda.hhs.gov	Bovin, Nicolai/P-2948-2017; Donnelly, Raymond P./AFT-8600-2022	Bovin, Nicolai/0000-0001-8669-4477; Donnelly, Raymond P./0000-0002-0695-5276; Ireland, Derek/0000-0001-5829-4206; Lugovtsev, Vladimir/0000-0003-0573-1497	intramural funds from the FDA Center for Drug Evaluation and Research; FDA Medical Countermeasures (MCM) Program [2011094]; Russian Science Foundation [14-50-00131]	intramural funds from the FDA Center for Drug Evaluation and Research; FDA Medical Countermeasures (MCM) Program; Russian Science Foundation(Russian Science Foundation (RSF))	This research project was supported in part by intramural funds from the FDA Center for Drug Evaluation and Research and by Grant No. 2011094 from the FDA Medical Countermeasures (MCM) Program to Dr. Raymond P. Donnelly. Dr. N.V. Bovin was supported by the Russian Science Foundation grant # 14-50-00131.	Al Hajjar S, 2010, ANN SAUDI MED, V30, P1, DOI 10.4103/0256-4947.59365; Chan RWY, 2013, VIRUS RES, V178, P133, DOI 10.1016/j.virusres.2013.03.003; COLMAN PM, 1994, PROTEIN SCI, V3, P1687, DOI 10.1002/pro.5560031007; Connaris H, 2014, P NATL ACAD SCI USA, V111, P6401, DOI 10.1073/pnas.1404205111; Geisler C, 2011, GLYCOBIOLOGY, V21, P988, DOI 10.1093/glycob/cwr080; Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235; Govorkova EA, 2015, ANTIMICROB AGENTS CH, V59, P1495, DOI 10.1128/AAC.04431-14; HAYDEN FG, 1980, ANTIMICROB AGENTS CH, V17, P865, DOI 10.1128/AAC.17.5.865; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hughes MT, 2000, J VIROL, V74, P5206, DOI 10.1128/JVI.74.11.5206-5212.2000; Ilyushina N, 2004, VIROLOGY, V329, P33, DOI 10.1016/j.virol.2004.08.002; Ilyushina NA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181999; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Kaverin NV, 1998, VIROLOGY, V244, P315, DOI 10.1006/viro.1998.9119; Kaverin NV, 2000, VIRUS RES, V66, P123, DOI 10.1016/S0168-1702(99)00131-8; Lyon JB, 2010, PEDIATR RADIOL, V40, P200, DOI 10.1007/s00247-009-1487-z; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Marathe BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071401; Mitnaul LJ, 2000, J VIROL, V74, P6015, DOI 10.1128/JVI.74.13.6015-6020.2000; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; O'Donnell CD, 2012, MBIO, V3, DOI 10.1128/mBio.00120-12; Palmer DF, 1975, IMMUNOLOGY SERIES, V6; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rudneva IA, 1996, ARCH VIROL, V141, P1091, DOI 10.1007/BF01718612; RUDNEVA IA, 1993, ARCH VIROL, V133, P437, DOI 10.1007/BF01313781; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; WANG WC, 1988, J BIOL CHEM, V263, P4576; Wang X, 2017, J VIROL, V91; Xu R, 2012, J VIROL, V86, P9221, DOI 10.1128/JVI.00697-12; Ye JQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001145; Zanin M, 2015, J VIROL, V89, P5935, DOI 10.1128/JVI.02537-14	33	7	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195525	10.1371/journal.pone.0195525	http://dx.doi.org/10.1371/journal.pone.0195525			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630683	Green Published, Green Submitted, gold			2022-12-26	WOS:000429505000056
J	Pawlat, J; Starek, A; Sujak, A; Terebun, P; Kwiatkowski, M; Budzen, M; Andrejko, D				Pawlat, Joanna; Starek, Agnieszka; Sujak, Agnieszka; Terebun, Piotr; Kwiatkowski, Michal; Budzen, Malgorzata; Andrejko, Dariusz			Effects of atmospheric pressure plasma jet operating with DBD on Lavatera thuringiaca L. seeds' germination	PLOS ONE			English	Article							DIELECTRIC BARRIER DISCHARGE; PLANT-GROWTH; SURFACE MODIFICATION; DEGRADATION; WATER; MICROORGANISMS; STERILIZATION; POSTDISCHARGE; INACTIVATION; COATINGS	The paper presents the results of an experiment on the effect of pre-sowing stimulation of seeds with atmospheric pressure plasma jet operating with dielectric barrier discharge (DBD plasma jet) on the process of germination of Thuringian Mallow (Lavatera thuringiaca L.). Five groups of seeds characterized by a different exposure times (1, 2, 5, 10 and 15 minutes) as well as untreated seeds control were used. Pre-sowing plasma stimulation of seeds improved germination parameters such as: germination capacity and germination energy for all tested groups relative to control. The highest germination parameters were obtained for seeds stimulated with plasma for the exposure times of 2 and 5 min. The analysis of the contact surface angle indicated the decrease of its' mean values upon seed stimulation while no statistical effects were observed. Analysis of the SEM scans revealed the increase in seed pattern intensity which could be attributed to removing of the surface parts of cuticle possibly covered with wax upon short time-2 and 5 min plasma treatment. Such a phenomenon can act similarly to mechanical scarification of seeds. Longer exposure of seeds to plasma resulted in affecting the deeper zone of cuticle and damage or fracture of some parts of the cuticle. Lower germination parameters of seeds upon longer exposure times to plasma may indicate mechanical damage of the seeds.	[Pawlat, Joanna; Terebun, Piotr; Kwiatkowski, Michal] Lublin Univ Technol, Inst Elect Engn & Electrotechnol, Lublin, Poland; [Starek, Agnieszka; Andrejko, Dariusz] Univ Life Sci Lublin, Dept Biol Bases Food & Feed Technol, Lublin, Poland; [Sujak, Agnieszka; Budzen, Malgorzata] Univ Life Sci Lublin, Dept Biophys, Lublin, Poland	Lublin University of Technology; University of Life Sciences in Lublin; University of Life Sciences in Lublin	Pawlat, J (corresponding author), Lublin Univ Technol, Inst Elect Engn & Electrotechnol, Lublin, Poland.; Starek, A (corresponding author), Univ Life Sci Lublin, Dept Biol Bases Food & Feed Technol, Lublin, Poland.	askmik@hotmail.com; agnieszka.starek@up.lublin.pl	Starek, Agnieszka/V-5985-2018; Kwiatkowski, Michał/D-4855-2017; Pawlat, Joanna/B-3998-2013; Sujak, Sujak/U-5538-2018; Terebun, Piotr/D-4825-2017	Starek, Agnieszka/0000-0002-9387-5900; Kwiatkowski, Michał/0000-0001-5697-3176; Pawlat, Joanna/0000-0001-8224-0355; Sujak, Sujak/0000-0001-5616-3827; Terebun, Piotr/0000-0002-3947-9552; Budzen, Malgorzata/0000-0001-7872-3362; Andrejko, Dariusz/0000-0001-9345-7795	LUT research found; Inkubator Innowacyjnosci+ found; networking actions: KONNECT project; COST Action [TD1208]; CEEPUS [CIII-AT-0063]	LUT research found; Inkubator Innowacyjnosci+ found; networking actions: KONNECT project; COST Action(European Cooperation in Science and Technology (COST)); CEEPUS	This study has been supported by LUT research found, Inkubator Innowacyjnosci+ found, networking actions: KONNECT project, COST TD1208 Action and CEEPUS CIII-AT-0063.; This study has been supported by LUT research found, Inkubator Innowacyjnoki+found, networking actions: KONNECT project, COST TD1208 Action and CEEPUS CIII-AT-0063.	Adamovich I, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa76f5; Bayliss DL, 2012, PLASMA PROCESS POLYM, V9, P597, DOI 10.1002/ppap.201100104; Brisset JL, 2016, PLASMA CHEM PLASMA P, V36, P355, DOI 10.1007/s11090-015-9653-6; Bruggeman PJ, 2016, PLASMA SOURCES SCI T, V25, DOI 10.1088/0963-0252/25/5/053002; Canal C, 2009, INT J PHARM, V367, P155, DOI 10.1016/j.ijpharm.2008.09.038; Connor M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41814; Dobrin D, 2015, INNOV FOOD SCI EMERG, V29, P255, DOI 10.1016/j.ifset.2015.02.006; Dvorakova H., 2015, COMPOSITES, V2, P3; Favia P, 2001, SURF COAT TECH, V142, P1, DOI 10.1016/S0257-8972(01)01191-4; Favia P, 2012, SURF COAT TECH, V211, P50, DOI 10.1016/j.surfcoat.2012.01.032; Fridman G, 2006, PLASMA CHEM PLASMA P, V26, P425, DOI 10.1007/s11090-006-9024-4; Graves DB, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/26/263001; Hensel K, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4919559; Henselova M, 2012, BIOLOGIA, V67, P490, DOI 10.2478/s11756-012-0046-5; Iriondo JM, 1996, SOMACLONAL VARIATION, P280, DOI [10.1007/978-3-642-61081-3_19, DOI 10.1007/978-3-642-61081-3_19]; ISTA, 2012, INT RUL SEED TEST; Janca J, 1998, SURF COAT TECH, V98, P1112, DOI 10.1016/S0257-8972(97)00213-2; Janda M, 2016, J PHYS CONF SER, V768, DOI 10.1088/1742-6596/768/1/012009; Janda M, 2016, PLASMA CHEM PLASMA P, V36, P767, DOI 10.1007/s11090-016-9694-5; Ji SH, 2016, ARCH BIOCHEM BIOPHYS, V605, P117, DOI 10.1016/j.abb.2016.02.028; KITAZAKI S, 2012, JPN J APPL PHYS 2, V51; Kitazaki S, 2014, CURR APPL PHYS, V14, pS149, DOI 10.1016/j.cap.2013.11.056; Kolacinski Z, 2013, EUR PHYS J-APPL PHYS, V61, DOI 10.1051/epjap/2012120393; Kornarzynski K, 2015, ACTA SCI POL TECH AG, V14, P23; Kovalova Z, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/22/224014; Krcma F, 2014, J PHYS CONF SER, V565, DOI 10.1088/1742-6596/565/1/012012; Krishna S, 2016, CHEM ENG J, V292, P35, DOI 10.1016/j.cej.2016.01.108; Krumpolec R, 2012, CHEM LISTY, V106, pS1450; Kubota Y, 2009, J PLASMA FUSION RES, V8, P740; Kutasi K, 2008, PLASMA PROCESS POLYM, V5, P840, DOI 10.1002/ppap.200800085; Laghetti G, 1998, ECON BOT, V52, P107, DOI 10.1007/BF02861301; Liguori A, 2016, PLASMA PROCESS POLYM, V13, P623, DOI 10.1002/ppap.201500143; Liguori A, 2015, PLASMA PROCESS POLYM, V12, P1195, DOI 10.1002/ppap.201500054; Lukes P, 2005, IND ENG CHEM RES, V44, P2921, DOI 10.1021/ie0491342; Lukes P, 2014, PLASMA SOURCES SCI T, P23; Machala Z, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/22/222001; Mizeraczyk J, 2013, EUR PHYS J-APPL PHYS, V61, DOI 10.1051/epjap/2012120405; Mozetic M, 2010, MATER TEHNOL, V44, P165; Ono R, 2017, VACUUM, V136, P214, DOI 10.1016/j.vacuum.2016.07.017; Park DP, 2013, CURR APPL PHYS, V13, pS19, DOI 10.1016/j.cap.2012.12.019; Pawlat J, 2004, J ADV OXID TECHNOL, V7, P59; PAWLAT J, 2013, EUR PHYS J D APPL, V61; Pawlat J, 2007, PLASMA PROCESS POLYM, V4, P753, DOI 10.1002/ppap.200700028; Pawlat J, 2018, PLASMA PROCESS POLYM, V15, DOI 10.1002/ppap.201700064; Pawlat J, 2016, J PHYS D APPL PHYS, V49, DOI 10.1088/0022-3727/49/37/374001; Pawlat J, 2016, IEEE T PLASMA SCI, V44, P314, DOI 10.1109/TPS.2015.2436061; Prysiazhnyi V, 2012, APPL SURF SCI, V258, P5467, DOI 10.1016/j.apsusc.2012.02.040; Puac N, 2006, J PHYS D APPL PHYS, V39, P3514, DOI 10.1088/0022-3727/39/16/S09; Puac N, 2005, MATER SCI FORUM, V494, P291, DOI 10.4028/www.scientific.net/MSF.494.291; Puac N, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4880360; Puligundla P, 2017, FOOD CONTROL, V71, P376, DOI 10.1016/j.foodcont.2016.07.021; Reuter S, 2015, IEEE T PLASMA SCI, V43, P3185, DOI 10.1109/TPS.2014.2361921; Rognli O.A., 1994, BREED FODD CROP MARG, P93; Sahni M, 2005, J ADV OXID TECHNOL, V8, P105; Schmidt-Bleker A, 2015, PLASMA SOURCES SCI T, V24, DOI 10.1088/0963-0252/24/3/035022; Sera B, 2010, IEEE T PLASMA SCI, V38, P2963, DOI 10.1109/TPS.2010.2060728; Shiratani M, 2016, MRS ADV, V1, P1265, DOI 10.1557/adv.2016.37; Sivachandiran L, 2017, RSC ADV, V7, P1822, DOI 10.1039/c6ra24762h; Skoro N, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/47/475206; Sulborska A, 2017, APICULTURAL VALUE TH, P76; Terebun P, 2014, EUR J MED TECHNOL, P38; Vesel A, 2008, SURF INTERFACE ANAL, V40, P1444, DOI 10.1002/sia.2923; von Woedtke T, 2013, PHYS REP, V530, P291, DOI 10.1016/j.physrep.2013.05.005; Young T, 2013, J ADV OXID TECHNOL, V16, P89; Zahoranova A, 2016, PLASMA CHEM PLASMA P, V36, P397, DOI 10.1007/s11090-015-9684-z; Zivkovic S, 2004, SEED SCI TECHNOL, V32, P693	66	41	42	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194349	10.1371/journal.pone.0194349	http://dx.doi.org/10.1371/journal.pone.0194349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630623	Green Published, Green Submitted, gold			2022-12-26	WOS:000429505000010
J	Hebberecht, L; Vancoillie, L; Schauvliege, M; Staelens, D; Dauwe, K; Mortier, V; Verhofstede, C				Hebberecht, Laura; Vancoillie, Leen; Schauvliege, Marlies; Staelens, Delfien; Dauwe, Kenny; Mortier, Virginie; Verhofstede, Chris			Frequency of occurrence of HIV-1 dual infection in a Belgian MSM population	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DISEASE PROGRESSION; SEX WORKERS; SUPERINFECTION; SUBTYPE; MEN; RECOMBINATION; SEROCONVERTERS; DIVERSITY; REGION	Introduction HIV-1 dual infection is a condition that results from infection with at least two HIV-1 variants from different sources. The scarceness of information on this condition is partly due to the fact that its detection is technically challenging. Using next-generation sequencing we defined the extent of HIV-1 dual infection in a cohort of men who have sex with men (MSM). Material & methods Eighty-six MSM, diagnosed with HIV-1 subtype B infection between 2008 and 2013 were selected for next-generation sequencing of the HIV-1 envelope V3. Sequencing was performed on 2 plasma samples collected with an interval of > 6 months before the initiation of antiretroviral therapy. Maximum likelihood phylogenetic trees were inspected for dual infection, defined as the presence of two or more monophyletic clusters with >= 90% bootstrap support and a mean between-cluster genetic distance of >= 10%. To confirm dual infection, deep V3 sequencing of intermediate samples was performed as well as clonal sequencing of the HIV-1 protease-reverse transcriptase gene. Results Five of the 74 patients (6.8%) for whom deep sequencing was successful, showed clear evidence of dual infection. In 4 of them, the second strain was absent in the first sample but occurred in subsequent samples. This was highly suggestive for superinfection. In 3 patients both virus variants were of subtype B, in 2 patients at least one of the variants was a subtype B/non-B recombinant virus. Conclusions Dual infection was confirmed in 6.8% of MSM diagnosed with HIV-1 in Belgium. This prevalence is probably an underestimation, because stringent criteria were used to classify viral variants as originating from a new infection event.	[Hebberecht, Laura; Vancoillie, Leen; Schauvliege, Marlies; Staelens, Delfien; Dauwe, Kenny; Mortier, Virginie; Verhofstede, Chris] Univ Ghent, Aids Reference Lab, Dept Clin Chem Microbiol & Immunol, Ghent, Belgium	Ghent University	Verhofstede, C (corresponding author), Univ Ghent, Aids Reference Lab, Dept Clin Chem Microbiol & Immunol, Ghent, Belgium.	chris.verhofstede@ugent.be			Belgian Ministery of Social Affairs through Health Insurance System	Belgian Ministery of Social Affairs through Health Insurance System	The AIDS Reference Laboratory of Ghent is supported by the Belgian Ministery of Social Affairs through a fund within the Health Insurance System. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreani G, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-392; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Berghe W Vanden, 2011, EURO SURVEILL, V16; Chaillon A, 2013, J VIROL, V87, P12737, DOI 10.1128/JVI.02260-13; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; Chohan B, 2005, J VIROL, V79, P10701, DOI 10.1128/JVI.79.16.10701-10708.2005; Cornelissen M, 2012, CLIN INFECT DIS, V54, P539, DOI 10.1093/cid/cir849; Fang GW, 2004, AIDS, V18, P153, DOI 10.1097/00002030-200401230-00003; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Herbinger KH, 2006, AIDS RES HUM RETROV, V22, P599, DOI 10.1089/aid.2006.22.599; Jost S, 2002, NEW ENGL J MED, V347, P731, DOI 10.1056/NEJMoa020263; Kiwelu IE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071131; Kiwelu IE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047605; Koelsch KK, 2003, AIDS, V17, pF11, DOI 10.1097/00002030-200305020-00001; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Luan H, 2017, JAIDS-J ACQ IMM DEF, V75, P480, DOI 10.1097/QAI.0000000000001420; Manigart O, 2004, AIDS, V18, P1645, DOI 10.1097/01.aids.0000131333.30548.db; Novitsky V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166746; Pacold M, 2010, AIDS RES HUM RETROV, V26, P1291, DOI 10.1089/aid.2010.0042; Pacold ME, 2012, AIDS, V26, P157, DOI 10.1097/QAD.0b013e32834dcd26; Pernas M, 2006, JAIDS-J ACQ IMM DEF, V42, P12, DOI 10.1097/01.qai.0000214810.65292.73; Piantadosi A, 2008, AIDS RES HUM RETROV, V24, P1221, DOI 10.1089/aid.2008.0100; Rachinger A, 2010, J VIROL METHODS, V165, P311, DOI 10.1016/j.jviromet.2010.02.016; Redd AD, 2014, AIDS, V28, P2147, DOI 10.1097/QAD.0000000000000365; Redd AD, 2014, J CLIN MICROBIOL, V52, P844, DOI 10.1128/JCM.03143-13; Redd AD, 2013, LANCET INFECT DIS, V13, P622, DOI 10.1016/S1473-3099(13)70066-5; Redd AD, 2012, J INFECT DIS, V206, P267, DOI 10.1093/infdis/jis325; Ronen K, 2014, AIDS, V28, P2281, DOI 10.1097/QAD.0000000000000422; Sheward DJ, 2015, J INFECT DIS, V212, P904, DOI 10.1093/infdis/jiv136; Smyth RP, 2012, VIRUS RES, V169, P415, DOI 10.1016/j.virusres.2012.06.015; de Oliveira ACS, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-223; Ssemwanga D, 2011, VIROLOGY, V411, P113, DOI 10.1016/j.virol.2010.12.025; Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739; van der Kuyl AC, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-67; Vancoillie L, 2015, ANTIVIR THER, V20, P789, DOI 10.3851/IMP2966; Verhofstede C, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2850-6; Vidal N, 2013, INFECT GENET EVOL, V14, P73, DOI 10.1016/j.meegid.2012.11.017; Wagner GA, 2017, J VIROL, V91, DOI 10.1128/JVI.00475-17; Wagner GA, 2014, J INFECT DIS, V209, P1032, DOI 10.1093/infdis/jit633; Waters L, 2012, CURR OPIN INFECT DIS, V25, P42, DOI 10.1097/QCO.0b013e32834ef5af	41	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195679	10.1371/journal.pone.0195679	http://dx.doi.org/10.1371/journal.pone.0195679			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624605	gold, Green Submitted, Green Published			2022-12-26	WOS:000429379600043
J	Kim, CR; Jeon, YJ; Kim, MC; Jeong, T; Koo, WR				Kim, Chung Reen; Jeon, Young-Jee; Kim, Moon Chan; Jeong, Taeheum; Koo, Woo Ram			Reference values for hand grip strength in the South Korean population	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; LEAN MASS; SARCOPENIA; WOMEN; HEALTH; ADULTS; ASSOCIATION; MORTALITY; MEN; INTERVENTIONS	Objective To establish reference values for hand grip strength (HGS) in a healthy Korean population and to identify the dependent anthropometric variables that affect HGS. Methods Based on the sixth Korea National Health and Nutrition Examination Survey from 2014 to 2015, we analyzed the HGS data of 7,969 South Koreans. Individuals with specific chronic diseases and who reported poor subjective health status were excluded to ensure a healthy population sample. Means with standard deviations (SDs) and 95% confidence intervals were calculated for each 5-year interval starting from 10 years of age. To determine the relationship between HGS and anthropometric variables, we performed correlation analyses between HGS and height, weight, and body mass index (BMI). Additionally, based on these findings, the cut-off value for low HGS was presented by deriving-2SD values of healthy young adults as recommended by the European Working Group on Sarcopenia in Older People. Results The mean age and BMI of men and women were 38.3 and 38.2 years and 23.8 and 22.4 kg/m(2), respectively. Mean HGS of the dominant hand in men and women was 39.5 and 24.2 kg, respectively. The peak in HGS was at 35-39 years of age, after which HGS decreased in both sexes. HGS was significantly correlated with height, weight, and BMI. The cut-off values for weak HGS were < 28.9 and < 16.8 kg in men and women, respectively. Conclusion These results provide useful reference values to assess HGS in patients who undergo hand surgery or who have various diseases that affect HGS. Moreover, a cut-off value for low HGS may help in defining sarcopenia among the Korean population.	[Kim, Chung Reen; Koo, Woo Ram] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Phys Med & Rehabil, Ulsan, South Korea; [Jeon, Young-Jee; Kim, Moon Chan; Jeong, Taeheum] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Family Med, Ulsan, South Korea	University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital	Jeon, YJ (corresponding author), Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Family Med, Ulsan, South Korea.	yjjeon@uuh.ulsan.kr						Barreto SM, 2009, REV SAUDE PUBL, V43, P38, DOI 10.1590/S0034-89102009000900006; Bohannon RW, 2015, CURR OPIN CLIN NUTR, V18, P465, DOI 10.1097/MCO.0000000000000202; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3; Cesari M, 2009, J GERONTOL A-BIOL, V64, P377, DOI 10.1093/gerona/gln031; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cheung CL, 2013, AGE, V35, P929, DOI 10.1007/s11357-012-9385-y; Chong Choon-Khim, 1994, Journal of the Formosan Medical Association, V93, P616; Cruz-Jentoft AJ, 2014, AGE AGEING, V43, P748, DOI 10.1093/ageing/afu115; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Denison HJ, 2015, CLIN INTERV AGING, V10, P859, DOI 10.2147/CIA.S55842; Dodds RM, 2016, AGE AGEING, V45, P209, DOI 10.1093/ageing/afv192; Dodds RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113637; Doherty TJ, 2001, CURR OPIN CLIN NUTR, V4, P503, DOI 10.1097/00075197-200111000-00007; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Gunther CM, 2008, J HAND SURG-AM, V33A, P558, DOI 10.1016/j.jhsa.2008.01.008; Han DS, 2016, SCI REP-UK, V6, DOI 10.1038/srep19457; Heimburger O, 2000, AM J KIDNEY DIS, V36, P1213, DOI 10.1053/ajkd.2000.19837; HUNT SM, 1980, J EPIDEMIOL COMMUN H, V34, P281, DOI 10.1136/jech.34.4.281; Janssen I, 2004, AM J EPIDEMIOL, V159, P413, DOI 10.1093/aje/kwh058; Jurca R, 2004, MED SCI SPORT EXER, V36, P1301, DOI 10.1249/01.MSS.0000135780.88930.A9; Karkkainen M, 2009, BONE, V44, P660, DOI 10.1016/j.bone.2008.12.010; Kim KM, 2016, KOREAN J INTERN MED, V31, P643, DOI 10.3904/kjim.2016.015; Kim YS, 2007, J KOREAN SOC PEDIAT, V12, P142; Koley S, 2009, ANTHROPOL ANZ, V67, P21, DOI 10.1127/0003-5548/2009/0003; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lawman HG, 2016, AM J PREV MED, V50, P677, DOI 10.1016/j.amepre.2015.10.022; Lee WJ, 2013, J AM MED DIR ASSOC, V14, P528, DOI 10.1016/j.jamda.2013.03.019; Little MA, 2017, AM J HUM BIOL, V29, DOI 10.1002/ajhb.22922; Maltais ML, 2009, J MUSCULOSKEL NEURON, V9, P186; Massy-Westropp Nicola M, 2011, BMC Res Notes, V4, P127, DOI 10.1186/1756-0500-4-127; Mathiowetz Virgil, 2002, Occup Ther Int, V9, P201, DOI 10.1002/oti.165; McLean RR, 2014, J GERONTOL A-BIOL, V69, P576, DOI 10.1093/gerona/glu012; Messier V, 2011, MATURITAS, V68, P331, DOI 10.1016/j.maturitas.2011.01.014; Nascimento DD, 2015, AGING CLIN EXP RES, V27, P791, DOI 10.1007/s40520-015-0349-9; Newman AB, 2005, AM J CLIN NUTR, V82, P872, DOI 10.1093/ajcn/82.4.872; Newman AB, 2005, AM J CLIN NUTR, V82, P915, DOI DOI 10.1093/AJCN/82.4.872; PHILLIPS SK, 1993, CLIN SCI, V84, P95, DOI 10.1042/cs0840095; Rantanen T, 2003, J AM GERIATR SOC, V51, P636, DOI 10.1034/j.1600-0579.2003.00207.x; Rosen B, 1996, J Hand Ther, V9, P315; Roubenoff R, 2000, J GERONTOL A-BIOL, V55, pM716, DOI 10.1093/gerona/55.12.M716; Schlussel MM, 2008, CLIN NUTR, V27, P601, DOI 10.1016/j.clnu.2008.04.004; Shafiee G, 2017, J DIABETES METAB DIS, V16, DOI 10.1186/s40200-017-0302-x; Shim JH, 2013, ARCH PLAST SURG-APS, V40, P52, DOI 10.5999/aps.2013.40.1.52; Smidt N, 2002, ARCH PHYS MED REHAB, V83, P1145, DOI 10.1053/apmr.2002.33728; Steiber N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163917; Tanimoto Y, 2012, ARCH GERONTOL GERIAT, V55, pE9, DOI 10.1016/j.archger.2012.06.015; United Nations Economic and Social Affairs Population Division, 2015, WORLD POP AG 2015; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Wong SL, 2016, HEALTH REP, V27, P3; Wu SW, 2009, APPL ERGON, V40, P811, DOI 10.1016/j.apergo.2008.08.006; Yoo JI, 2017, J KOREAN MED SCI, V32, P868, DOI 10.3346/jkms.2017.32.5.868; Yoshida D, 2014, GERIATR GERONTOL INT, V14, P46, DOI 10.1111/ggi.12210; Yu RB, 2014, GERIATR GERONTOL INT, V14, P15, DOI 10.1111/ggi.12220	53	36	36	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195485	10.1371/journal.pone.0195485	http://dx.doi.org/10.1371/journal.pone.0195485			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB9FN	29624617	gold, Green Published, Green Submitted			2022-12-26	WOS:000429379600033
J	Schuelke, J; Meyers, N; Reitmaier, S; Klose, S; Ignatius, A; Claes, L				Schuelke, Julian; Meyers, Nicholaus; Reitmaier, Sandra; Klose, Svenja; Ignatius, Anita; Claes, Lutz			Intramembranous bone formation after callus distraction is augmented by increasing axial compressive strain	PLOS ONE			English	Article							EXPERIMENTAL TIBIAL FRACTURES; SEGMENTAL TRANSPORT; EXTERNAL FIXATORS; GENE-EXPRESSION; OSTEOGENESIS; FIXATION; REGENERATION; MICROMOVEMENT; MATURATION; STABILITY	The mechanical environment is a primary factor in the success of distraction osteogenesis. It is known that the interfragmentary movement during the distraction and maturation phase effects the callus formation. In addition to cyclic compression, other movements like shear and bending influence the bone formation process as shown in previous callus distraction studies. Reports of cartilage presence and endochondral ossification in the regenerative zone have been associated with a lack of fixation stability and delayed healing. So far the effects of the direction of interfragmentary movements could not be studied separately. By means of a unique lateral callus distraction model, we investigated the effects of small (0.1 mm) and moderate (0.6 mm), purely axial compression on ossification during callus maturation in sheep. A distraction device incorporating a mobile titanium plate was mounted on the tibia. Following lateral callus distraction, electromechanically controlled movements allowed purely axial cyclic compression of the tissue regenerate. Seven weeks post-operatively, the tissue regenerates were investigated using pCT, histology and immunohistochemistry. The larger amplitude significantly increased bone formation (Fractional bone volume: 19.4% vs. 5.2%, p = 0.03; trabecular thickness: 0.1 mm vs. 0.06 mm, p = 0.006; mean spicule height: 2.6 mm vs. 1.1 mm, p = 0.02) however, no endochondral ossification occurred. The elimination of shear movement, unimpaired neovascularization as well as the tensile strain stimuli during the distraction phase suppressing chondrogenic differentiation may all contribute to the absence of cartilage. In clinical application of distraction osteogenesis, moderate axial interfragmentary movement augments intramembranous ossification provided shear strain is minimized.	[Schuelke, Julian; Meyers, Nicholaus; Reitmaier, Sandra; Klose, Svenja; Ignatius, Anita; Claes, Lutz] Univ Hosp Ulm, Ctr Musculoskeletal Res Ulm, Inst Orthoped Res & Biomech, Baden Wurttemberg, Germany	Ulm University	Claes, L (corresponding author), Univ Hosp Ulm, Ctr Musculoskeletal Res Ulm, Inst Orthoped Res & Biomech, Baden Wurttemberg, Germany.	lutz.claes@uni-ulm.de	Claes, Lutz/O-4697-2014; Ignatius, Anita/M-6012-2013	Ignatius, Anita/0000-0002-4782-1979; Schuelke, Julian/0000-0002-9532-4205	German Research Foundation [DFG 77/22-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG 77/22-1). All authors state that they have no conflict of interests.	Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Amir LR, 2007, J HISTOCHEM CYTOCHEM, V55, P1095, DOI 10.1369/jhc.6A7162.2007; Amir LR, 2009, ODONTOLOGY, V97, P63, DOI 10.1007/s10266-009-0101-z; ARONSON J, 1989, CLIN ORTHOP RELAT R, P106; Augat P, 2003, J ORTHOP RES, V21, P1011, DOI 10.1016/S0736-0266(03)00098-6; Augat P, 2001, J ORTHOP TRAUMA, V15, P54, DOI 10.1097/00005131-200101000-00010; Carter DR, 1998, CLIN ORTHOP RELAT R, pS41; Claes L, 2000, J BONE JOINT SURG BR, V82B, P142, DOI 10.1302/0301-620X.82B1.9332; Claes L, 2005, CLIN ORTHOP RELAT R, P189, DOI 10.1097/01.blo.0000150456.39608.bc; Claes L, 2010, BONE, V47, P712, DOI 10.1016/j.bone.2010.07.010; CLAES LE, 1995, CLIN BIOMECH, V10, P227, DOI 10.1016/0268-0033(95)99799-8; Claes L, 2008, J ORTHOP RES, V26, P772, DOI 10.1002/jor.20588; Colnot C, 2009, J BONE MINER RES, V24, P274, DOI 10.1359/JBMR.081003; Duda GN, 2002, CLIN ORTHOP RELAT R, P163; FRIERSON M, 1994, CLIN ORTHOP RELAT R, P19; GOODSHIP AE, 1985, J BONE JOINT SURG BR, V67, P650, DOI 10.1302/0301-620X.67B4.4030869; Haudenschild AK, 2009, ANN BIOMED ENG, V37, P492, DOI 10.1007/s10439-008-9629-2; Hente R, 2004, J ORTHOP RES, V22, P709, DOI 10.1016/j.orthres.2003.11.007; ILIZAROV GA, 1989, CLIN ORTHOP RELAT R, P249, DOI 10.1097/00003086-198901000-00038; Jazrawi LM, 1998, J ORTHOP TRAUMA, V12, P111, DOI 10.1097/00005131-199802000-00008; Kaspar D, 2002, J BIOMECH, V35, P873, DOI 10.1016/S0021-9290(02)00058-1; Kassis B, 1996, J PEDIATR ORTHOPED, V16, P480, DOI 10.1097/01241398-199607000-00011; Leung KS, 2004, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000111889.64238.6a; Lopez-Pliego EM, 2016, INJURY, V47, pS7, DOI 10.1016/S0020-1383(16)30600-3; Meyers N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189432; Morgan EF, 2010, J BIOMECH, V43, P2418, DOI 10.1016/j.jbiomech.2010.04.019; Percival CJ, 2013, DEV DYNAM, V242, P909, DOI 10.1002/dvdy.23992; Rath B, 2008, J BIOMECH, V41, P1095, DOI 10.1016/j.jbiomech.2007.11.024; Schell H, 2005, J ORTHOP RES, V23, P1022, DOI 10.1016/j.orthres.2005.03.005; Tuohy JL, 2014, VET SURG, V43, P903, DOI 10.1111/j.1532-950X.2014.12189.x; WEIBEL ER, 1963, LAB INVEST, V12, P131; Yang L, 2003, CLIN BIOMECH, V18, P166, DOI 10.1016/S0268-0033(02)00175-4	32	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195466	10.1371/journal.pone.0195466	http://dx.doi.org/10.1371/journal.pone.0195466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624608	Green Submitted, gold, Green Published			2022-12-26	WOS:000429379600031
J	Skowron, PM; Kropinski, AM; Zebrowska, J; Janus, L; Szemiako, K; Czajkowska, E; Maciejewska, N; Skowron, M; Los, J; Los, M; Zylicz-Stachula, A				Skowron, Piotr M.; Kropinski, Andrew M.; Zebrowska, Joanna; Janus, Lukasz; Szemiako, Kasjan; Czajkowska, Edyta; Maciejewska, Natalia; Skowron, Malgorzata; Los, Joanna; Los, Marcin; Zylicz-Stachula, Agnieszka			Sequence, genome organization, annotation and proteomics of the thermophilic, 47.7-kb Geobacillus stearothermophilus bacteriophage TP-84 and its classification in the new Tp84virus genus	PLOS ONE			English	Article							DATABASE; PREDICTION; VIRUSES	Bacteriophage TP-84 is a well-characterized bacteriophage of historical interest. It is a member of the Siphoviridae, and infects a number of thermophilic Geobacillus (Bacillus) stearothermophilus strains. Its' 47.7-kbp double-stranded DNA genome revealed the presence of 81 coding sequences (CDSs) coding for polypeptides of 4 kDa or larger. Interestingly, all CDSs are oriented in the same direction, pointing to a dominant transcription direction of one DNA strand. Based on a homology search, a hypothetical function could be assigned to 31 CDSs. No RNA or DNA polymerase-coding genes were found on the bacteriophage genome indicating that TP-84 relies on the host's transcriptional and replication enzymes. The TP84 genome is tightly packed with CDSs, typically spaced by several-to tens of bp or often overlapping. The genome contains five putative promoter-like sequences showing similarity to the host promoter consensus sequence and allowing for a 2-bp mismatch. In addition, ten putative rho-independent terminators were detected. Because the genome sequence shows essentially no similarity to any previously characterised bacteriophage, TP-84 should be considered a new species in an undefined genus within the Siphoviridae family. Thus a taxonomic proposal of a new Tp84virus genus has been accepted by the International Committee on Taxonomy of Viruses. The bioinformatics genome analysis was verified by confirmation of 33 TP-84 proteins, which included: a) cloning of a selected CDS in Escherichia coli, coding for a DNA single-stranded binding protein (SSB; gene TP84_63), b) purification and functional assays of the recombinant TP-84 SSB, which has been shown to improve PCR reactions, c) mass spectrometric (MS) analysis of TP-84 bacteriophage capsid proteins, d) purification of TP-84 endolysin activity, e) MS analysis of the host cells from infection time course.	[Skowron, Piotr M.; Zebrowska, Joanna; Janus, Lukasz; Czajkowska, Edyta; Maciejewska, Natalia; Zylicz-Stachula, Agnieszka] Univ Gdansk, Dept Mol Biotechnol, Fac Chem, Gdansk, Poland; [Skowron, Piotr M.; Janus, Lukasz; Maciejewska, Natalia; Skowron, Malgorzata; Zylicz-Stachula, Agnieszka] BioVentures Inst Ltd, Poznan, Poland; [Kropinski, Andrew M.] Univ Guelph, Dept Food Sci Mol & Cellular Biol, Guelph, ON, Canada; [Kropinski, Andrew M.] Univ Guelph, Dept Pathobiol, Guelph, ON, Canada; [Szemiako, Kasjan] Gdansk Univ Technol, Dept Mol Biotechnol & Microbiol, Fac Chem, Gdansk, Poland; [Los, Joanna; Los, Marcin] Phage Consultants, Gdansk, Poland; [Los, Joanna; Los, Marcin] Univ Gdansk, Fac Biol, Dept Bacterial Mol Genet, Gdansk, Poland	Fahrenheit Universities; University of Gdansk; University of Guelph; University of Guelph; Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; University of Gdansk	Skowron, PM (corresponding author), Univ Gdansk, Dept Mol Biotechnol, Fac Chem, Gdansk, Poland.; Skowron, PM (corresponding author), BioVentures Inst Ltd, Poznan, Poland.	piotr.skowron@ug.edu.plp	Kropinski, Andrew M/H-7130-2016; Zylicz-Stachula, Agnieszka/G-8000-2011	Kropinski, Andrew M/0000-0002-6871-6799; Zylicz-Stachula, Agnieszka/0000-0003-2479-3634; Zebrowska, Joanna/0000-0003-2637-6439; Szemiako, Kasjan/0000-0002-3265-4717; Skowron, Piotr/0000-0003-1345-3271; Los, Marcin/0000-0001-9732-8376; Maciejewska, Natalia/0000-0001-7728-0598; Czajkowska, Edyta/0000-0002-1571-2356	National Center for Development (Poland) [POIG.01.04.00-22-140/12]; BioVentures Institute Ltd.	National Center for Development (Poland); BioVentures Institute Ltd.	The project has been sponsored in part by the National Center for Development (Poland) grant no POIG.01.04.00-22-140/12 issued to BioVentures Institute Ltd., in which the University of Gdansk has been a scientific partner. The BioVentures Institute Ltd. provided support in the form of salaries for the following authors: Piotr M. Skowron, Joanna Zebrowska, Lukasz Janus, Kasjan Szemiako, Edyta Czajkowska, Natalia Maciejewska, Malgorzata Skowron and Agnieszka Zylicz-Stachula. These authors are (or have been) also University of Gdansk employees or students. The specific roles of these authors are articulated in the 'author contributions' section. During the grant realisation, BioVentures Institute Ltd. also provided materials, reagents and equipment. BioVentures Institute Ltd. has played a predominant role in this study during all of its stages: the concept development, experiments design and realisation, as well as the decision to publish and the manuscript preparation.	Adriaenssens EM, 2018, ARCH VIROL, V163, P1125, DOI 10.1007/s00705-018-3723-z; BASSEL A, 1971, J VIROL, V7, P663, DOI 10.1128/JVI.7.5.663-672.1971; Black LW, 2012, ADV EXP MED BIOL, V726, P469, DOI 10.1007/978-1-4614-0980-9_21; Blanc M, 1997, INT J SYST BACTERIOL, V47, P1246, DOI 10.1099/00207713-47-4-1246; Chaudhry WN, 2014, J BASIC MICROB, V54, P531, DOI 10.1002/jobm.201200710; Chen X, 2016, J DAIRY SCI, V99, P6995, DOI 10.3168/jds.2016-11332; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; EGBERT LARRE N., 1967, J VIROL, V1, P610; EPSTEIN I, 1975, APPL MICROBIOL, V29, P219, DOI 10.1128/AEM.29.2.219-223.1975; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; HOLMES D, 1981, J GEN VIROL, V52, P141, DOI 10.1099/0022-1317-52-1-141; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; KIZER PE, 1972, BIOCHEMISTRY-US, V11, P1562, DOI 10.1021/bi00759a003; Liu B, 2009, RES MICROBIOL, V160, P166, DOI 10.1016/j.resmic.2008.12.005; Liu B, 2006, CURR MICROBIOL, V53, P163, DOI 10.1007/s00284-005-0509-9; Madden T, 2002, NCBI HDB; MARK KK, 1970, ANAL BIOCHEM, V37, P447, DOI 10.1016/0003-2697(70)90071-0; Marks TJ, 2014, ARCH VIROL, V159, P2771, DOI 10.1007/s00705-014-2101-8; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Naville M, 2011, RNA BIOL, V8, P11, DOI 10.4161/rna.8.1.13346; Nowak M, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-91; Olszewski M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126563; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Rose PW, 2015, NUCLEIC ACIDS RES, V43, pD345, DOI 10.1093/nar/gku1214; Rossmann MG, 2013, Q REV BIOPHYS, V46, P133, DOI 10.1017/S0033583513000012; SAUNDERS GF, 1966, J BACTERIOL, V91, P340, DOI 10.1128/JB.91.1.340-348.1966; SAUNDERS GF, 1965, BIOCHEMISTRY-US, V4, P2836, DOI 10.1021/bi00888a039; Saunders GF, 1964, 148 M AM CHEM SOC C, p36C; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; SHARP RJ, 1986, J GEN MICROBIOL, V132, P1709; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Skowron P, 2016, METHOD USE NUCLEOTID; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Wang YQ, 2010, APPL ENVIRON MICROB, V76, P7861, DOI 10.1128/AEM.01270-10; WARREN RAJ, 1980, ANNU REV MICROBIOL, V34, P137, DOI 10.1146/annurev.mi.34.100180.001033	38	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195449	10.1371/journal.pone.0195449	http://dx.doi.org/10.1371/journal.pone.0195449			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624616	Green Published, Green Submitted, gold			2022-12-26	WOS:000429379600030
J	Gombos, RB; Gonzalez, A; Manrique, M; Chand, D; Savitsky, D; Morin, B; Breous-Nystrom, E; Dupont, C; Ward, RA; Mande, C; Duckless, B; Tango, H; Findeis, MA; Schuster, A; Weight, JD; Underwood, D; Clarke, C; Ritter, G; Merghoub, T; Scheer, D; Wolchok, JD; van Dijk, M; Buell, JS; Cuillerot, JM; Stein, R; Drouin, EE; Wilson, NS				Gombos, Randi B.; Gonzalez, Ana; Manrique, Mariana; Chand, Dhan; Savitsky, David; Morin, Benjamin; Breous-Nystrom, Ekaterina; Dupont, Christopher; Ward, Rebecca A.; Mande, Cornelia; Duckless, Benjamin; Tango, Hao; Findeis, Mark A.; Schuster, Andrea; Weight, Jeremy D.; Underwood, Dennis; Clarke, Christopher; Ritter, Gerd; Merghoub, Taha; Scheer, David; Wolchok, Jedd D.; van Dijk, Marc; Buell, Jennifer S.; Cuillerot, Jean-Marie; Stein, Robert; Drouin, Elise E.; Wilson, Nicholas S.			Toxicological and pharmacological assessment of AGEN1884, a novel human IgG1 anti-CTLA-4 antibody	PLOS ONE			English	Article							REGULATORY T-CELLS; NIVOLUMAB PLUS IPILIMUMAB; CYTOKINE RELEASE ASSAYS; IN-VITRO; MEDIATED CYTOTOXICITY; ANTITUMOR ACTIVITIES; UNTREATED MELANOMA; CRYSTAL-STRUCTURE; LUNG-CANCER; CTLA-4	CTLA-4 and CD28 exemplify a co-inhibitory and co-stimulatory signaling axis that dynamically sculpts the interaction of antigen-specific T cells with antigen-presenting cells. Anti-CTLA-4 antibodies enhance tumor-specific immunity through a variety of mechanisms including: blockade of CD80 or CD86 binding to CTLA-4, repressing regulatory T cell function and selective elimination of intratumoral regulatory T cells via an Fcy receptor-dependent mechanism. AGEN1884 is a novel IgG1 antibody targeting CTLA-4. It potently enhanced antigen-specific T cell responsiveness that could be potentiated in combination with other immunomodulatory antibodies. AGEN1884 was well-tolerated in non-human primates and enhanced vaccine-mediated antigen-specific immunity. AGEN1884 combined effectively with PD-1 blockade to elicit a T cell proliferative response in the periphery. Interestingly, an IgG2 variant of AGEN1884 revealed distinct functional differences that may have implications for optimal dosing regimens in patients. Taken together, the pharmacological properties of AGEN1884 support its clinical investigation as a single therapeutic and combination agent.	[Gombos, Randi B.; Gonzalez, Ana; Manrique, Mariana; Chand, Dhan; Savitsky, David; Ward, Rebecca A.; Weight, Jeremy D.; Wilson, Nicholas S.] Agenus Inc, Immunomodulatory Drug Discovery, Lexington, MA 02421 USA; [Morin, Benjamin; Findeis, Mark A.] Agenus Inc, Res Biochem, Lexington, MA USA; [Breous-Nystrom, Ekaterina; Mande, Cornelia; Schuster, Andrea] Agenus Switzerland Inc, Basel, Switzerland; [Dupont, Christopher; Duckless, Benjamin; Tango, Hao] Agenus Inc, Translat Biomarkers, Lexington, MA USA; [Clarke, Christopher] Agenus Inc, Safety Pharmacol & Toxicol, Lexington, MA USA; [Ritter, Gerd] Ludwig Inst Canc Res, New York, NY USA; [Merghoub, Taha; Scheer, David; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [van Dijk, Marc] Agenus United Kingdom Ltd, Cambridge, England; [Buell, Jennifer S.; Cuillerot, Jean-Marie] Agenus Inc, Res & Dev Management, Lexington, MA USA; [Stein, Robert] Agenus Inc, Res & Dev Consultant, Lexington, MA USA	Agenus Inc; Agenus Inc; Agenus Inc; Agenus Inc; Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center; Agenus Inc; Agenus Inc	Wilson, NS (corresponding author), Agenus Inc, Immunomodulatory Drug Discovery, Lexington, MA 02421 USA.	nwnicholas@gmail.com	Merghoub, Taha/ABD-8362-2021		Agenus Inc.; Agenus Switzerland Inc.; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Agenus Inc.; Agenus Switzerland Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The licensed antibodies, AGEN1884, AGEN2041 and AGEN2034, were developed under a Collaborative Research and Development Agreement between Ludwig Cancer Research, 4 Antibody AG (now Agenus Switzerland Inc.) and Recepta Biopharma S.A. Funding of this work was provided by Agenus Inc. or Agenus Switzerland Inc. The funder provided support in the form of salaries for authors RBG, AG, MM, DC, DS, BM, EB-N, CD, RAW, CM, BD, HT, MAF, AS, JDW, DU, CC, MvD, JSB, JC, RS, EED and NSW, and was also involved in the study design, data collection and analysis, decision to publish and preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Antonia S, 2016, LANCET ONCOL, V17, P299, DOI 10.1016/S1470-2045(15)00544-6; AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; Boutros C, 2016, NAT REV CLIN ONCOL, V13, P473, DOI 10.1038/nrclinonc.2016.58; Breous-Nystrom E, 2014, METHODS, V65, P57, DOI 10.1016/j.ymeth.2013.09.003; Brezski RJ, 2011, MABS-AUSTIN, V3, P558, DOI 10.4161/mabs.3.6.18119; Buchbinder EI, 2016, AM J CLIN ONCOL-CANC, V39, P98, DOI 10.1097/COC.0000000000000239; Bulliard Y, 2014, IMMUNOL CELL BIOL, V92, P475, DOI 10.1038/icb.2014.26; Bulliard Y, 2013, J EXP MED, V210, P1685, DOI 10.1084/jem.20130573; Callahan MK, 2015, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00385; Chung S, 2014, J IMMUNOL METHODS, V407, P63, DOI 10.1016/j.jim.2014.03.021; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Curti BD, 2013, CANCER RES, V73, P7189, DOI 10.1158/0008-5472.CAN-12-4174; Das R, 2015, J IMMUNOL, V194, P950, DOI 10.4049/jimmunol.1401686; Eagar TN, 2002, EUR J IMMUNOL, V32, P972, DOI 10.1002/1521-4141(200204)32:4<972::AID-IMMU972>3.0.CO;2-M; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Finco D, 2014, CYTOKINE, V66, P143, DOI 10.1016/j.cyto.2013.12.009; FREEDMAN AS, 1991, CELL IMMUNOL, V137, P429, DOI 10.1016/0008-8749(91)90091-O; Funt SA, 2014, ONCOLOGY-NY, V28, P6; GarciaSanz JA, 1996, J EXP MED, V184, P159, DOI 10.1084/jem.184.1.159; Grawunder U, 2016, United States Patent, Patent No. 9346874; Grosso Joseph F, 2013, Cancer Immun, V13, P5; Guntermann C, 2002, J IMMUNOL, V168, P4420, DOI 10.4049/jimmunol.168.9.4420; HATHCOCK KS, 1993, SCIENCE, V262, P905, DOI 10.1126/science.7694361; Hellmann MD, 2017, LANCET ONCOL, V18, P31, DOI [10.1016/S1470-2045(16)30624-6, 10.1016/s1470-2045(16)30624-6]; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Jure-Kunkel M, 2007, US patent, Patent No. [US7288638B2, 7288638]; Kim JM, 2013, J EXP MED, V210, P1647, DOI 10.1084/jem.20131625; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Kvistborg P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008918; Le Mercier I, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00418; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Levy R, 2016, P NATL ACAD SCI USA, V113, pE6437, DOI 10.1073/pnas.1603321113; Marabelle A, 2013, J CLIN INVEST, V123, P2447, DOI 10.1172/JCI64859; Montler R, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.16; Moreau T, 1996, BRAIN, V119, P225, DOI 10.1093/brain/119.1.225; Oflazoglu E, 2009, BRIT J CANCER, V100, P113, DOI 10.1038/sj.bjc.6604812; Petersson K, 2002, STRUCTURE, V10, P1619, DOI 10.1016/S0969-2126(02)00895-X; Piccotti Joseph R, 2005, J Immunotoxicol, V2, P191, DOI 10.1080/15476910500362838; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Ribas A, 2012, NEW ENGL J MED, V366, P2517, DOI 10.1056/NEJMe1205943; Robert L, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.29244; Romano E, 2015, P NATL ACAD SCI USA, V112, P6140, DOI 10.1073/pnas.1417320112; Schadendorf D, 2014, J CLIN ONCOL, V56, P2736, DOI DOI 10.1200/JC0.2014.56.2736; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Spindler N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004377; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Sznol M, 2008, J CLIN ONCOL, V26; Tai XG, 2012, BLOOD, V119, P5155, DOI 10.1182/blood-2011-11-388918; Thudium K. B., 2011, US Patent Application Publication No, Patent No. [US 2011/0150892 Al, 20110150892]; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Trist HM, 2014, J IMMUNOL, V192, P792, DOI 10.4049/jimmunol.1301554; Valk E, 2006, IMMUNITY, V25, P807, DOI 10.1016/j.immuni.2006.08.024; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Van Dijk MA, 2016, Anti-ctla-4 antibodies and methods of use thereof. United States Patent Application Publication No. 20160368989, Patent No. 20160368989; Van Dijk MA, 2017, Anti-pd-1 antibodies and methods of use thereof. United States Patent Application Publication No. 20170081409, Patent No. 20170081409; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Vessillier S, 2015, J IMMUNOL METHODS, V424, P43, DOI 10.1016/j.jim.2015.04.020; Warncke M, 2012, J IMMUNOL, V188, P4405, DOI 10.4049/jimmunol.1200090; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wilson NS, 2011, CANCER CELL, V19, P101, DOI 10.1016/j.ccr.2010.11.012; Wilson NS, 2005, ADV IMMUNOL, V86, P241, DOI 10.1016/S0065-2776(04)86007-3; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Xu ZH, 2012, J IMMUNOL, V189, P4470, DOI 10.4049/jimmunol.1201813	71	13	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0191926	10.1371/journal.pone.0191926	http://dx.doi.org/10.1371/journal.pone.0191926			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617360	Green Published, gold, Green Submitted			2022-12-26	WOS:000429203800002
J	Shaheen, AA; Kaplan, GG; Almishri, W; Vallerand, I; Frolkis, AD; Patten, S; Swain, MG				Shaheen, Abdel-Aziz; Kaplan, Gilaad G.; Almishri, Wagdi; Vallerand, Isabelle; Frolkis, Alexandra D.; Patten, Scott; Swain, Mark G.			The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes	PLOS ONE			English	Article							PLATELET-DERIVED SEROTONIN; PRIMARY SCLEROSING CHOLANGITIS; QUALITY-OF-LIFE; LIVER-TRANSPLANTATION; MAJOR DEPRESSION; CIRRHOSIS; FATIGUE; DISEASE; POPULATION; PREVALENCE	Background Depression is prevalent in primary biliary cholangitis (PBC) patients. Our aims were to examine the effects of depression and antidepressants on hepatic outcomes of PBC patients. Methods We used the UK Health Improvement Network database to identify PBC patients between 1974 and 2007. Our primary outcome was one of three clinical events: decompensated cirrhosis, liver transplantation and death. We assessed depression and each class of antidepressant medication in adjusted multivariate Cox proportional hazards models to identify independent predictors of outcomes. In a sensitivity analysis, the study population was restricted to PBC patients using ursodeoxycholic acid (UDCA). Results We identified 1,177 PBC patients during our study period. In our cohort, 86 patients (7.3%) had a depression diagnosis prior to PBC diagnosis, while 79 patients (6.7%) had a depression diagnosis after PBC diagnosis. Ten-year incidence of mortality, decompensated cirrhosis, and liver transplantation were 13.4%, 6.6%, and 2.0%, respectively. In our adjusted models, depression status was not a predictor of poor outcomes. After studying all classes of antidepressants, using the atypical antidepressant mirtazapine after PBC diagnosis was significantly protective (Adjusted HR 0.23: 95% CI 0.07-0.72) against poor liver outcomes (decompensation, liver transplant, mortality), which remained statistically significant in patients using UCDA (HR 0.21: 95% CI 0.05-0.83). Conclusions In our study, depression was not associated with poor clinical outcomes. However, using the antidepressant mirtazapine was associated with decreased mortality, decompensated cirrhosis and liver transplantation in PBC patients. These findings support further assessment of mirtazapine as a potential treatment for PBC patients.	[Shaheen, Abdel-Aziz; Kaplan, Gilaad G.; Frolkis, Alexandra D.; Swain, Mark G.] Univ Calgary, Dept Med, Div Gastroenterol & Hepatol, Calgary, AB, Canada; [Almishri, Wagdi; Swain, Mark G.] Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Calgary, AB, Canada; [Vallerand, Isabelle; Frolkis, Alexandra D.; Patten, Scott] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Vallerand, Isabelle; Frolkis, Alexandra D.; Patten, Scott] Univ Calgary, Dept Psychiat, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Shaheen, AA (corresponding author), Univ Calgary, Dept Med, Div Gastroenterol & Hepatol, Calgary, AB, Canada.	az.shaheen@ucalgary.ca	Patten, Scott/B-4434-2011; Shaheen, Abdel Aziz/AAX-3773-2021; Kaplan, Gil/AAH-2335-2021	Patten, Scott/0000-0001-9871-4041; Shaheen, Abdel Aziz/0000-0002-2940-897X; Kaplan, Gil/0000-0003-2719-0556	Canadian Institutes of Health Research Team Grant [THC - 135231]; Alberta Innovates [201300174] Funding Source: researchfish	Canadian Institutes of Health Research Team Grant(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	This work was funded through a Canadian Institutes of Health Research Team Grant (M. Swain as PI). Grant title: Health Challenges in Chronic Inflammation Initiative. Grant ID: THC - 135231.	Al-Harthy N, 2010, HEPATOLOGY, V52, P562, DOI 10.1002/hep.23683; Alam A, 2013, PRIMARY CARE COMPANI, V15; Andersson NW, 2015, PSYCHOL MED, V45, P3559, DOI 10.1017/S0033291715001488; [Anonymous], 2010, THIN DATA GUIDE RES, P106; Bhayat F, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-252; Biagini MR, 2008, EUR J GASTROEN HEPAT, V20, P122, DOI 10.1097/MEG.0b013e3282f1cbda; Blak BT, 2009, VALUE HEALTH, V12, pA253, DOI 10.1016/S1098-3015(10)74240-6; BRADLEY P, 1995, BRIT MED J, V311, P951; Carta MG, 2002, J PSYCHOSOM RES, V53, P789, DOI 10.1016/S0022-3999(02)00328-8; Cauch-Dudek K, 1998, GUT, V43, P705, DOI 10.1136/gut.43.5.705; Croon KF, 2009, CNS DRUGS, V23, P427, DOI 10.2165/00023210-200923050-00006; de las Casas-Engel M, 2013, J IMMUNOL, V190, P2301, DOI 10.4049/jimmunol.1201133; Eyre HA, 2016, PHARMACOPSYCHIATRY, V49, P85, DOI 10.1055/s-0042-103159; Hohenester S, 2009, SEMIN IMMUNOPATHOL, V31, P283, DOI 10.1007/s00281-009-0164-5; Huet PM, 2000, AM J GASTROENTEROL, V95, P760; Josephson CB, 2017, JAMA NEUROL, V74, P533, DOI 10.1001/jamaneurol.2016.5042; Kronman MP, 2012, PEDIATRICS, V130, pE794, DOI 10.1542/peds.2011-3886; Lalor PF, 2013, AM J PHYSIOL-GASTR L, V304, pG469, DOI 10.1152/ajpgi.00407.2012; Lammers WJ, 2014, GASTROENTEROLOGY, V147, P1338, DOI 10.1053/j.gastro.2014.08.029; Lang PA, 2008, NAT MED, V14, P756, DOI 10.1038/nm1780; Lawrance IC, 2003, GASTROENTEROLOGY, V125, P1750, DOI 10.1053/j.gastro.2003.08.027; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; Lesurtel M, 2012, CLIN RES HEPATOL GAS, V36, P319, DOI 10.1016/j.clinre.2012.05.005; Lewinson RT, 2017, J INVEST DERMATOL, V137, P828, DOI 10.1016/j.jid.2016.11.032; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Marzioni M, 2005, GASTROENTEROLOGY, V128, P121, DOI 10.1053/j.gastro.2004.10.002; Mells GF, 2013, HEPATOLOGY, V58, P273, DOI 10.1002/hep.26365; Mojtabai R, 2004, PSYCHOL MED, V34, P623, DOI 10.1017/S0033291703001764; Mullish BH, 2014, ALIMENT PHARM THER, V40, P880, DOI 10.1111/apt.12925; Myers RP, 2009, HEPATOLOGY, V50, P1884, DOI 10.1002/hep.23210; Nery FG, 2007, COMPR PSYCHIAT, V48, P14, DOI 10.1016/j.comppsych.2006.04.002; Nocito A, 2007, HEPATOLOGY, V45, P369, DOI 10.1002/hep.21516; O'Connell PJ, 2006, BLOOD, V107, P1010, DOI 10.1182/blood-2005-07-2903; Pares A, 2006, GASTROENTEROLOGY, V130, P715, DOI 10.1053/j.gastro.2005.12.029; PAYNE C, 1995, BRIT MED J, V311, P951; Penninx BWJH, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-129; Rogal SS, 2011, LIVER TRANSPLANT, V17, P251, DOI 10.1002/lt.22231; Frick LR, 2013, LIFE SCI, V92, P525, DOI 10.1016/j.lfs.2013.01.020; Ruddell RG, 2008, J HEPATOL, V48, P666, DOI 10.1016/j.jhep.2008.01.006; Shajib MS, 2015, ACTA PHYSIOL, V213, P561, DOI 10.1111/apha.12430; Singh N, 1997, DIGEST DIS SCI, V42, P1421, DOI 10.1023/A:1018898106656; ter Borg PCJ, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-13; Valtysdottir ST, 2000, CLIN EXP RHEUMATOL, V18, P597; van Os E, 2007, J HEPATOL, V46, P1099, DOI 10.1016/j.jhep.2007.01.036; Wallace H, 1998, LANCET, V352, P1970, DOI 10.1016/S0140-6736(98)04512-7; Zyrianova Y, 2006, IRISH J MED SCI, V175, P32, DOI 10.1007/BF03167946	46	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194839	10.1371/journal.pone.0194839	http://dx.doi.org/10.1371/journal.pone.0194839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617396	gold, Green Published, Green Submitted			2022-12-26	WOS:000429203800051
J	Araujo, F; van Oosterhout, F; Becker, V; Attayde, JL; Lurling, M				Araujo, Fabiana; van Oosterhout, Frank; Becker, Vanessa; Attayde, Jose Luiz; Lurling, Miquel			Effects of polyaluminum chloride and lanthanum-modified bentonite on the growth rates of three Cylindrospermopsis raciborskii strains	PLOS ONE			English	Article							PRYMNESIUM-PARVUM HAPTOPHYCEAE; PHOSPHORUS BINDING CLAY; OF-THE-ART; MICROCYSTIS-AERUGINOSA; RARE-EARTH; CYANOBACTERIAL BLOOMS; GENETIC DIVERSITY; LAKE RESTORATION; LOCAL SOILS; RED-TIDE	In tropical and subtropical lakes, eutrophication often leads to nuisance blooms of Cylindrospermopsis raciborskii. In laboratory experiments, we tested the combined effects of flocculant polyaluminum chloride (PAC) and lanthanum-modified bentonite (LMB) on the sinking and growth rates of three C. raciborskii strains. We tested the hypothesis that the combination of PAC and LMB would (1) effectively sink C. raciborskii in a test tube experiment and (2) impair C. raciborskii growth, irrespective of the biomass of the inoculum (bloom) and the strain in the growth experiment. We tested the recommended (LMB1) and a three-times higher dose of LMB (LMB3). The combined addition of PAC and LMB enhanced the sedimentation of all C. raciborskii strains. Moreover, both the PAC and LMB doses decreased the phosphate concentration. PAC and LMB1 decreased the growth rate of all strains, but the efficacy depended on the biomass and strain. The combined addition of PAC and LMB3 inhibited the growth of all strains independently of the biomass and strain. We conclude that a low dose of PAC in combination with the recommended dose of LMB decreases C. raciborskii blooms and that the efficiency of the technique depends on the biomass of the bloom. A higher dose of LMB is needed to obtain a more efficient control of C. raciborskii blooms.	[Araujo, Fabiana] Univ Fed Rio Grande do Norte, Programa Posgrad Ecol, Natal, RN, Brazil; [Araujo, Fabiana; Becker, Vanessa] Univ Fed Rio Grande do Norte, Ctr Technol, Dept Engn Civil, Lab Recursos Hidricos & Saneamento Ambiental, Natal, RN, Brazil; [van Oosterhout, Frank; Lurling, Miquel] Wageningen Univ, Dept Environm Sci, Aquat Ecol & Water Qual Management Grp, Wageningen, Netherlands; [Attayde, Jose Luiz] Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Ecol, Natal, RN, Brazil; [Lurling, Miquel] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Wageningen University & Research; Universidade Federal do Rio Grande do Norte; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Araujo, F (corresponding author), Univ Fed Rio Grande do Norte, Programa Posgrad Ecol, Natal, RN, Brazil.; Araujo, F (corresponding author), Univ Fed Rio Grande do Norte, Ctr Technol, Dept Engn Civil, Lab Recursos Hidricos & Saneamento Ambiental, Natal, RN, Brazil.	fabianabio@gmail.com	Becker, Vanessa/G-6189-2015; KNAW, NIOO-KNAW/A-4320-2012	Becker, Vanessa/0000-0002-7326-4328; KNAW, NIOO-KNAW/0000-0002-3835-159X; Araujo, Fabiana/0000-0001-5803-2601; Attayde, Jose/0000-0002-8372-4172	CAPES (Foundation for the Coordination of Higher Education and Graduate Training, Brazil) [BEX 5135/11-7]; CAPES (Brazil)/Wageningen University (The Netherlands): CAPES-WUR [004/2008]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [407783/2016-4]	CAPES (Foundation for the Coordination of Higher Education and Graduate Training, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES (Brazil)/Wageningen University (The Netherlands): CAPES-WUR; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank W. Beekman-Lukassen for her assistance during the lab work. F.A. was supported by a Sandwich Ph.D. fellowship from CAPES (Foundation for the Coordination of Higher Education and Graduate Training, Brazil-BEX 5135/11-7). This study was conducted under the flag of the CAPES (Brazil)/Wageningen University (The Netherlands): CAPES-WUR project 004/2008. Preparation of the manuscript was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Process Number: Universal 407783/2016-4. The funders had no role in study design, data colletion and analysis, decision to publish, or preparation of the manuscript.; We thank W. Beekman-Lukassen for her assistance during the lab work. F.A. was supported by a Sandwich Ph.D. fellowship from CAPES (Foundation for the Coordination of Higher Education and Graduate Training, Brazil-BEX 5135/11-7). This study was conducted under the flag of the CAPES (Brazil)/Wageningen University (The Netherlands): CAPES-WUR project 004/2008. This work also was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Process Number: Universal 407783/2016-4.	Anderson DM, 1997, NATURE, V388, P513, DOI 10.1038/41415; Bouvy M, 1999, AQUAT MICROB ECOL, V20, P285, DOI 10.3354/ame020285; Bouvy M, 2000, AQUAT MICROB ECOL, V23, P13, DOI 10.3354/ame023013; Briand E, 2009, ISME J, V3, P419, DOI 10.1038/ismej.2008.121; Briand JF, 2004, J PHYCOL, V40, P231, DOI 10.1111/j.1529-8817.2004.03118.x; Chonudomkul D, 2004, FEMS MICROBIOL ECOL, V48, P345, DOI 10.1016/j.femsec.2004.02.014; Cooke G.D., 2005, RESTORATION MANAGEME, Vthird, DOI DOI 10.1002/RRR.3450090207; Costa I., 2009, OECOLOGIA BRASILIENS, V13, P382, DOI 10.4257/oeco.2009.1302.11; Costa I. A. S., 2006, Braz. J. Biol., V66, P211, DOI 10.1590/S1519-69842006000200005; Douglas G. B., 2004, PHOSPHORUS ENV TECHN, P291; Douglas G. B., 1999, INT ASS WAT QUAL C D, P517; Gibbs MM, 2011, HYDROBIOLOGIA, V658, P253, DOI 10.1007/s10750-010-0477-3; Gulati RD, 2002, HYDROBIOLOGIA, V478, P73, DOI 10.1023/A:1021092427559; Haghseresht F, 2009, APPL CLAY SCI, V46, P369, DOI 10.1016/j.clay.2009.09.009; Haghseresht F., 2005, REVOLUTION PHOSPHORO, P21; Hagstrom JA, 2005, HARMFUL ALGAE, V4, P249, DOI 10.1016/j.hal.2004.03.004; Hilt S, 2006, LIMNOLOGICA, V36, P155, DOI 10.1016/j.limno.2006.06.001; Huszar VLM, 2000, HYDROBIOLOGIA, V424, P67, DOI 10.1023/A:1003996710416; Istvanovics V, 2000, FRESHWATER BIOL, V43, P257, DOI 10.1046/j.1365-2427.2000.00549.x; JOHANNESSON KH, 1994, LIMNOL OCEANOGR, V39, P1141, DOI 10.4319/lo.1994.39.5.1141; Kardinaal WEA, 2007, APPL ENVIRON MICROB, V73, P2939, DOI 10.1128/AEM.02892-06; Lazzaro X, 2003, FRESHWATER BIOL, V48, P649, DOI 10.1046/j.1365-2427.2003.01037.x; LEE JH, 1992, GEOCHIM COSMOCHIM AC, V56, P1127, DOI 10.1016/0016-7037(92)90050-S; LEE JH, 1993, GEOCHIM COSMOCHIM AC, V57, P295; Liu XW, 1997, GEOCHIM COSMOCHIM AC, V61, P1625, DOI 10.1016/S0016-7037(97)00037-9; Lurling M, 1999, PHYCOLOGIA, V38, P368, DOI 10.2216/i0031-8884-38-5-368.1; Lurling M, 2013, WATER RES, V47, P6527, DOI 10.1016/j.watres.2013.08.019; Marinho MM, 2013, MICROB ECOL, V66, P479, DOI 10.1007/s00248-013-0232-1; McGregor Glenn B., 2000, Lakes and Reservoirs Research and Management, V5, P195, DOI 10.1046/j.1440-1770.2000.00115.x; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Noyma NP, 2015, WATER RES; Padisak J., 1997, ARCH HYDROBIOL, V107, P563; Paerl HW, 2011, WATER RES, V45, P1973, DOI 10.1016/j.watres.2010.09.018; Pan G, 2006, ENVIRON POLLUT, V141, P206, DOI 10.1016/j.envpol.2005.08.047; Pan G, 2006, ENVIRON POLLUT, V141, P195, DOI 10.1016/j.envpol.2005.08.041; Panosso R., 2007, OECOL BRAS, V11, P433, DOI [10.4257/oeco.2007.1103.12, DOI 10.4257/0EC0.2007.1103.12]; PETERSON SA, 1982, WATER RESOUR BULL, V18, P423; Piccini C, 2011, HARMFUL ALGAE, V10, P644, DOI 10.1016/j.hal.2011.04.016; Posselt AJ, 2009, J PHYCOL, V45, P540, DOI 10.1111/j.1529-8817.2009.00675.x; Reitzel K, 2003, HYDROBIOLOGIA, V506, P781, DOI 10.1023/B:HYDR.0000008624.54844.2d; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Robb M, 2003, HYDROBIOLOGIA, V494, P237, DOI 10.1023/A:1025478618611; Ross G, 2008, HARMFUL ALGAE, V7, P545, DOI 10.1016/j.hal.2007.12.007; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Sengco MR, 2005, HARMFUL ALGAE, V4, P261, DOI 10.1016/j.hal.2004.05.001; Sengco MR, 2004, J EUKARYOT MICROBIOL, V51, P169, DOI 10.1111/j.1550-7408.2004.tb00541.x; Sengco MR, 2001, MAR ECOL PROG SER, V210, P41, DOI 10.3354/meps210041; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Soares MCS, 2013, HYDROBIOLOGIA, V717, P1, DOI 10.1007/s10750-013-1562-1; Sondergaard M, 2001, ScientificWorldJournal, V1, P427; Sondergaard M, 1999, INTERNAL PHOSPHORUS, P145; Spears BM, 2013, WATER RES, V47, P5930, DOI 10.1016/j.watres.2013.07.016; van Oosterhout F, 2013, HYDROBIOLOGIA, V710, P265, DOI 10.1007/s10750-012-1206-x; Verspagen JMH, 2006, AQUAT MICROB ECOL, V44, P165, DOI 10.3354/ame044165; Waajen G, 2016, WATER RES, V97, P83, DOI 10.1016/j.watres.2015.11.034; WALSBY AE, 1994, MICROBIOL REV, V58, P94, DOI 10.1128/MMBR.58.1.94-144.1994; Welch EB, 2005, LAKE RESERV MANAGE, V21, P209, DOI 10.1080/07438140509354430; Wilson AE, 2005, APPL ENVIRON MICROB, V71, P6126, DOI 10.1128/AEM.71.10.6126-6133.2005; Wu ZX, 2012, HARMFUL ALGAE, V15, P53, DOI 10.1016/j.hal.2011.11.005; Wu ZX, 2009, HARMFUL ALGAE, V8, P910, DOI 10.1016/j.hal.2009.05.002; Yunes JS, 2009, J PHYCOL, V45, P585, DOI 10.1111/j.1529-8817.2009.00673.x; Zamparas M, 2012, APPL CLAY SCI, V62-63, P101, DOI 10.1016/j.clay.2012.04.020	63	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195359	10.1371/journal.pone.0195359	http://dx.doi.org/10.1371/journal.pone.0195359			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614118	gold, Green Submitted, Green Published			2022-12-26	WOS:000429081600054
J	Graves, GR; Newsome, SD; Fogel, ML				Graves, Gary R.; Newsome, Seth D.; Fogel, Marilyn L.			Stable hydrogen isotope variability within and among plumage tracts (delta H-2(F)) of a migratory wood warbler	PLOS ONE			English	Article							THROATED BLUE WARBLERS; NEOTROPICAL MIGRANT; DELTA-D; NONEXCHANGEABLE HYDROGEN; BREEDING POPULATIONS; WINTERING GROUNDS; DRINKING-WATER; RATIOS; DISPERSAL; BIRDS	Hydrogen isotope analysis of feather keratin (delta H-2(F)) has become an essential tool for tracking movements between breeding and wintering populations of migratory birds. In particular, delta H-2(F) has been used to create delta H-2(F) isoscapes that can be used to assign the geographic origins of molt. The majority of past studies have sampled a portion of a single feather as an isotopic proxy for the entire plumage although surprisingly little is known about variation of stable isotopes within and between feather tracts of individuals in local populations. Here we examine delta H-2(F) variation in 24 pterylographic variables (9 primaries, 6 secondaries, 6 rectrices, and 3 patches of ventral contour feathers) in individual specimens of black-throated blue warbler (Setophaga caerulescens) breeding in the Big Santeetlah Creek watershed (5350 ha), southern Appalachian Mountains. By restricting our study to territorial ASY males (after second year) inhabiting a small watershed, we could focus on delta H-2(F) variation generated during the complete prebasic annual molt in a circumscribed population while factoring out age and sexual differences in foraging behavior, isotopic incorporation, and post-breeding dispersal. Summed within-individual variation (delta H-2(F)) across 24 pterylographic variables ranged from 12 to 60 parts per thousand (= 21.8 9.4 parts per thousand), with 81% of the individuals exhibiting variation >= 16 parts per thousand (reproducibility of analyses was <= 4 parts per thousand). Adjacent feathers in feather tracts tend to have more similar delta H-2(F) values than feathers grown weeks apart, consistent with the stepwise replacement of flight feathers. The pooled population sample exhibited significant delta H-2(F) variation in primaries (-78 to-21 parts per thousand), secondaries (-80 to-17 parts per thousand), rectrices (-78 to-23 parts per thousand), and ventral contour feathers (-92 to-32 parts per thousand). Strong year effects in delta H-2(F) variation were observed in each of the 24 pterylographic variables. Altitudinal effects were observed only in ventral contour feathers. The current findings demonstrate that within-individual variation (delta H-2(F)) may be much greater than previously thought in migratory species that molt on or near breeding territories. Our study also highlights the need for greater pterylographic precision in research design of isotope-based studies of avian movement. Within-individual and within-population delta H-2(F) variation should be incorporated in geographic assignment models. In a broader context, the staggered Staffelmauser pattern of molt in wood warblers provides an exceptional view of the seasonal variation of hydrogen isotopes circulating in blood plasma during the six-week period of annual molt.	[Graves, Gary R.] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, MRC-116, Washington, DC 20560 USA; [Graves, Gary R.] Univ Copenhagen, Natl Museum Denmark, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Newsome, Seth D.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Fogel, Marilyn L.] Univ Calif Riverside, Environm Dynam & Geoecol Inst, Riverside, CA 92521 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University of Copenhagen; University of New Mexico; University of California System; University of California Riverside	Graves, GR (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, MRC-116, Washington, DC 20560 USA.; Graves, GR (corresponding author), Univ Copenhagen, Natl Museum Denmark, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark.	gravesg@si.edu	Graves, Gary R/P-1003-2017	Graves, Gary R/0000-0003-1406-5246	Alexander Wetmore Fund; Smithsonian Institution; Smoketree Trust; National Science Foundation (NSF) [DEB-1343015, DEB-1437845]	Alexander Wetmore Fund; Smithsonian Institution(Smithsonian Institution); Smoketree Trust; National Science Foundation (NSF)(National Science Foundation (NSF))	This study was supported by Alexander Wetmore Fund, Smithsonian Institution, to GRG; Smoketree Trust (private financial support), to GRG; National Science Foundation (NSF) grant DEB-1343015, to SDN; National Science Foundation (NSF) grant DEB-1437845, to MLF.	Bent A. C., 1953, Bulletin United States National Museum, VNo. 203, P1; Betts MG, 2008, P ROY SOC B-BIOL SCI, V275, P2257, DOI 10.1098/rspb.2008.0217; Biasiolli TG, 2008, THESIS; Blum JD, 2001, OECOLOGIA, V126, P569, DOI 10.1007/s004420000550; Boulet Marylene, 2006, Ornithological Monographs, V61, P29, DOI 10.1642/0078-6594(2006)61[29:IAOGSI]2.0.CO;2; Bowen GJ, 2005, RAPID COMMUN MASS SP, V19, P2371, DOI 10.1002/rcm.2069; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Braun E.L, 1950, SOIL SCI, V71, P155, DOI [10.1097/00010694-195102000-00012, DOI 10.1097/00010694-195102000-00012]; Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; Clegg SM, 2003, MOL ECOL, V12, P819, DOI 10.1046/j.1365-294X.2003.01757.x; Dugger KM, 2004, CONDOR, V106, P744, DOI 10.1650/7632; ESTEP MF, 1980, SCIENCE, V209, P1537, DOI 10.1126/science.209.4464.1537; Fallon SM, 2006, BIOL LETTERS, V2, P213, DOI 10.1098/rsbl.2005.0429; Farmer A, 2008, OECOLOGIA, V158, P183, DOI 10.1007/s00442-008-1143-6; Graves GR, 2009, ECOL APPL, V19, P1264, DOI 10.1890/08-0934.1; Graves GR, 2004, AUK, V121, P473, DOI 10.1642/0004-8038(2004)121[0473:TVAAAA]2.0.CO;2; Graves GR, 2002, P NATL ACAD SCI USA, V99, P8096, DOI 10.1073/pnas.082240899; Graves GR, 1997, J FIELD ORNITHOL, V68, P443; Graves GR, 1997, ECOLOGY, V78, P2524; Grus WE, 2009, AUK, V126, P198, DOI 10.1525/auk.2009.07159; Hache S, 2012, CANADIAN J ZOOLOGY; Haney JC, 2001, CONDOR, V103, P268, DOI 10.1650/0010-5422(2001)103[0268:AHCCOB]2.0.CO;2; Hobson KA, 2004, CONDOR, V106, P732, DOI 10.1650/7631; Hobson KA, 2008, TERR ECOL SER, V2, P1; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Hobson KA, 1999, P NATL ACAD SCI USA, V96, P8003, DOI 10.1073/pnas.96.14.8003; Hobson KA, 2015, AVIAN CONSERV ECOL, V10, DOI 10.5751/ACE-00719-100103; Hobson KA, 2014, J FIELD ORNITHOL, V85, P237, DOI 10.1111/jofo.12065; Hobson KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035137; Holberton RL, 2015, J FIELD ORNITHOL, V86, P213, DOI 10.1111/jofo.12112; HOLMES RT, 2005, BLACK THROATED BLUE; Jr Dwight J, 1900, ANN NEW YORK ACAD SC, V13, P73; Kelly JF, 2008, ECOL APPL, V18, P568, DOI 10.1890/07-0027.1; Kelly JF, 2006, AUK, V123, P431, DOI 10.1642/0004-8038(2006)123[431:SIELBG]2.0.CO;2; Langin KM, 2007, OECOLOGIA, V152, P449, DOI 10.1007/s00442-007-0669-3; LORIMER CG, 1980, ECOLOGY, V61, P1169, DOI 10.2307/1936836; Meehan TD, 2003, CONDOR, V105, P567, DOI 10.1650/7283; Meehan TD, 2001, CONDOR, V103, P11, DOI 10.1650/0010-5422(2001)103[0011:UHIGTE]2.0.CO;2; Nolan V., 1978, ORNITHOL MONOGR, V26, P1; Nordell CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163957; Norris DR, 2004, SCIENCE, V306, P2249, DOI 10.1126/science.1103542; Paxton KL, 2007, AUK, V124, P162, DOI 10.1642/0004-8038(2007)124[162:SATMPO]2.0.CO;2; Perez GE, 2006, CONDOR, V108, P877, DOI 10.1650/0010-5422(2006)108[877:IEOIMI]2.0.CO;2; Poage MA, 2001, AM J SCI, V301, P1, DOI 10.2475/ajs.301.1.1; Podlesak DW, 2005, OECOLOGIA, V142, P501, DOI 10.1007/s00442-004-1737-6; Pyle P, 1997, IDENTIFICATION GUIDE; Reudink MW, 2008, AUK, V125, P742; Royle JA, 2004, ECOL APPL, V14, P1780; Rubenstein DR, 2002, SCIENCE, V295, P1062, DOI 10.1126/science.1067124; Sauer PE, 2009, RAPID COMMUN MASS SP, V23, P949, DOI 10.1002/rcm.3954; Sellick MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004735; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; STRESEMANN ERWIN, 1966, J ORNITHOL, V107, P1; Studds CE, 2008, P NATL ACAD SCI USA, V105, P2929, DOI 10.1073/pnas.0710732105; van Dijk JGB, 2014, J AVIAN BIOL, V45, P103, DOI 10.1111/j.1600-048X.2013.00232.x; Van Wilgenburg Steven L., 2012, Endangered Species Research, V16, P17, DOI 10.3354/esr00383; Wassenaar LI, 2006, RAPID COMMUN MASS SP, V20, P2505, DOI 10.1002/rcm.2626; Wassenaar LI, 2000, ECOL APPL, V10, P911, DOI 10.1890/1051-0761(2000)010[0911:SCAHIR]2.0.CO;2; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Wassenaar LI, 2000, ENVIRON SCI TECHNOL, V34, P2354, DOI 10.1021/es990804i; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; West JB, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P1, DOI 10.1007/978-90-481-3354-3; Wetmore A., 1936, Auk, V53, P159; WILCOVE DS, 1988, WILSON BULL, V100, P256; Wiley AE, 2010, CONDOR, V112, P337, DOI 10.1525/cond.2010.090186; Wolf BO, 2000, OECOLOGIA, V124, P536, DOI 10.1007/s004420000406; Wolf N, 2012, J EXP BIOL, V215, P1915, DOI 10.1242/jeb.065219; Wolf N, 2011, J EXP BIOL, V214, P98, DOI 10.1242/jeb.050211; Wunder MB, 2008, ECOL APPL, V18, P549, DOI 10.1890/07-0058.1	69	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0193486	10.1371/journal.pone.0193486	http://dx.doi.org/10.1371/journal.pone.0193486			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614120	Green Published, gold, Green Submitted			2022-12-26	WOS:000429081600004
J	Tzotzos, G; Iley, JN; Moore, EA				Tzotzos, George; Iley, Jim N.; Moore, Elaine A.			New insights on repellent recognition by Anopheles gambiae odorant-binding protein 1	PLOS ONE			English	Article							PHEROMONE-SENSITIVE NEURONS; BOLTZMANN SURFACE-AREA; LIGAND-BINDING; CONFORMATIONAL-CHANGES; MOLECULAR-DYNAMICS; LYMANTRIA-DISPAR; FORCE-FIELD; GYPSY-MOTH; RAS-RAF; MECHANISM	It is generally recognized that insect odorant binding proteins (OBPs) mediate the solubilisation and transport of hydrophobic odorant molecules and contribute to the sensitivity of the insect olfactory system. However, the exact mechanism by which OBPs deliver odorants to olfactory receptors and their role, if any, as selectivity filters for specific odorants, are still a matter of debate. In the case of Anopheles gambiae, recent studies indicate that ligand discrimination is effected through the formation of heterodimers such as AgamOBP1 and AgamOBP4 (odorant binding proteins 1 and 4 from Anopheles gambiae). Furthermore, AgamOBPs have been reported to be promiscuous in binding more than one ligand simultaneously and repellents such as DEET (N,N-diethyl-3-toluamide) and 6-MH (6-methyl-5-hepten-2-one) interact directly with mosquito OBPs and/or compete for the binding of attractive odorants thus disrupting OBP heterodimerisation. In this paper, we propose mechanisms of action of DEET and 6-MH. We also predict that ligand binding can occur in several locations of AgamOBP1 with partial occupancies and propose structural features appropriate for repellent pharmacophores.	[Tzotzos, George] Ferrogasse, Vienna, Austria; [Iley, Jim N.; Moore, Elaine A.] Open Univ, Sch Life Hlth & Chem Sci, Milton Keynes, Bucks, England	Open University - UK	Tzotzos, G (corresponding author), Ferrogasse, Vienna, Austria.	gtzotzos@me.com		Tzotzos, George/0000-0001-9258-4338; Moore, Elaine/0000-0003-4418-0536				Andronopoulou E, 2006, INSECT MOL BIOL, V15, P797, DOI 10.1111/j.1365-2583.2006.00685.x; Anjana R, 2012, BIOINFORMATION, V8, P1220, DOI 10.6026/97320630081220; [Anonymous], HYDR BONDS PI PI STA; [Anonymous], LANCET, V386, P31; Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; Cao LH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01185-0; Case D. A., 2010, AMBER 11 AMBERTOOLS; David CC, 2014, METHODS MOL BIOL, V1084, P193, DOI 10.1007/978-1-62703-658-0_11; Davrazou F, 2011, J BIOL CHEM, V286, P34175, DOI 10.1074/jbc.M111.274712; Drakou CE, 2017, CELL MOL LIFE SCI, V74, P319, DOI 10.1007/s00018-016-2335-6; Fuglebakk E, 2012, BIOINFORMATICS, V28, P2431, DOI 10.1093/bioinformatics/bts445; Gohlke H, 2004, J COMPUT CHEM, V25, P238, DOI 10.1022/jcc.10379; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Guimaraes Affonso RdS, 2013, J BRAZILIAN CHEM SOC, V24; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Honson N, 2003, CHEM SENSES, V28, P479, DOI 10.1093/chemse/28.6.479; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hou TJ, 2011, J COMPUT CHEM, V32, P866, DOI 10.1002/jcc.21666; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Krieger J, 1999, SCIENCE, V286, P720, DOI 10.1126/science.286.5440.720; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Ladbury JE, 1996, CHEM BIOL, V3, P973, DOI 10.1016/S1074-5521(96)90164-7; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Lautenschlager C, 2007, STRUCTURE, V15, P1148, DOI 10.1016/j.str.2007.07.013; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003045; Leite NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008006; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; Manoharan M, 2014, J BIOMOL STRUCT DYN, V32, P1742, DOI 10.1080/07391102.2013.834118; Mao Y, 2010, P NATL ACAD SCI USA, V107, P19102, DOI 10.1073/pnas.1012274107; Mbengue A, 2015, NATURE, V520, P683, DOI 10.1038/nature14412; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murphy EJ, 2013, J BIOL CHEM, V288, P4475, DOI 10.1074/jbc.M112.436386; Oliferenko PV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064547; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Pelletier J, 2010, J CHEM ECOL, V36, P245, DOI 10.1007/s10886-010-9762-x; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 1996, J NEUROBIOL, V30, P3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plettner E, 2000, BIOCHEMISTRY-US, V39, P8953, DOI 10.1021/bi000461x; Qiao HL, 2011, CELL MOL LIFE SCI, V68, P1799, DOI 10.1007/s00018-010-0539-8; Rusconi B, 2012, BBA-PROTEINS PROTEOM, V1824, P947, DOI 10.1016/j.bbapap.2012.04.011; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Skjrven L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0399-6; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; Tsitsanou KE, 2012, CELL MOL LIFE SCI, V69, P283, DOI 10.1007/s00018-011-0745-z; Tzotzos G., 2012, STRUCTURE FUNCTION P; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; Wang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084795; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Yin J, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00056; Ziemba BP, 2013, PROTEIN SCI, V22, P11, DOI 10.1002/pro.2179	59	6	7	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194724	10.1371/journal.pone.0194724	http://dx.doi.org/10.1371/journal.pone.0194724			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614080	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000429081600017
J	Bruinsma, S; James, DJ; Serrano, M; Esquibel, J; Woo, SS; Kielar-Grevstad, E; Crummy, E; Qurashi, R; Kowalchyk, JA; Martin, TFJ				Bruinsma, Stephen; James, Declan J.; Serrano, Melanie Quintana; Esquibel, Joseph; Woo, Sang Su; Kielar-Grevstad, Elle; Crummy, Ellen; Qurashi, Rehan; Kowalchyk, Judy A.; Martin, Thomas F. J.			Small molecules that inhibit the late stage of Munc13-4-dependent secretory granule exocytosis in mast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane fusion; mast cell; exocytosis; small molecule; secretion; inhibitor; intracellular trafficking; Munc13-4	MEMBRANE-FUSION; SNARE COMPLEXES; REGULATED EXOCYTOSIS; VESICLE EXOCYTOSIS; PC12 CELLS; MUNC13-4; SYNAPTOTAGMIN; IDENTIFICATION; DEGRANULATION; ENDOCYTOSIS	Ca2+-dependent secretory granule fusion with the plasma membrane is the final step for the exocytic release of inflammatory mediators, neuropeptides, and peptide hormones. Secretory cells use a similar protein machinery at late steps in the regulated secretory pathway, employing protein isoforms from the Rab, Sec1/Munc18, Munc13/CAPS, SNARE, and synaptotagmin protein families. However, no small-molecule inhibitors of secretory granule exocytosis that target these proteins are currently available but could have clinical utility. Here we utilized a high-throughput screen of a 25,000-compound library that identified 129 small-molecule inhibitors of Ca2+-triggered secretory granule exocytosis in RBL-2H3 mast cells. These inhibitors broadly fell into six different chemical classes, and follow-up permeable cell and liposome fusion assays identified the target for one class of these inhibitors. A family of 2-aminobenzothiazoles (termed benzothiazole exocytosis inhibitors or bexins) was found to inhibit mast cell secretory granule fusion by acting on a Ca2+-dependent, C2 domain-containing priming factor, Munc13-4. Our findings further indicated that bexins interfere with Munc13-4-membrane interactions and thereby inhibit Munc13-4-dependent membrane fusion. We conclude that bexins represent a class of specific secretory pathway inhibitors with potential as therapeutic agents.	[Bruinsma, Stephen; James, Declan J.; Serrano, Melanie Quintana; Esquibel, Joseph; Woo, Sang Su; Kielar-Grevstad, Elle; Crummy, Ellen; Qurashi, Rehan; Kowalchyk, Judy A.; Martin, Thomas F. J.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Bruinsma, Stephen] Illumina Inc, 5602 Res Pk Blvd, Madison, WI 53719 USA; [Serrano, Melanie Quintana] Univ Puerto Rico, Sch Med, San Juan, PR 00936 USA; [Esquibel, Joseph] Lansing Community Coll, 309 N Washington Sq, Lansing, MI 48933 USA; [Woo, Sang Su] NINDS, NIH, 35 Convent Dr, Bethesda, MD 20892 USA; [Qurashi, Rehan] Univ Chicago, Graham Sch, 1427 E 60th St, Chicago, IL 60637 USA	University of Wisconsin System; University of Wisconsin Madison; Illumina; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Chicago	Martin, TFJ (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	tfmartin@wisc.edu	; Martin, Thomas F/A-6962-2009	Woo, Sang Su/0000-0002-8712-9530; Martin, Thomas F/0000-0002-5204-0202	NIH [R01 DK025861, R21 NS064833]; American Heart Association [0825742G]; National Science Foundation [DBI 1063085]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS064833] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH Grants R01 DK025861 and R21 NS064833 (to T. F. J. M.), American Heart Association Grant 0825742G (to S. B.), and National Science Foundation Grant DBI 1063085 (to M. Q. S.) for summer fellowship support.	Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Blank U, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00453; Boswell KL, 2012, J CELL BIOL, V197, P301, DOI 10.1083/jcb.201109132; Catz SD, 2013, J LEUKOCYTE BIOL, V94, P613, DOI 10.1189/jlb.1112600; Chicka MC, 2016, BIOCHEM J, V473, P627, DOI 10.1042/BJ20151150; Cukalevski R, 2012, ACS CHEM NEUROSCI, V3, P1008, DOI 10.1021/cn300073s; D'Angelo ND, 2011, J MED CHEM, V54, P1789, DOI 10.1021/jm1014605; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Harvima IT, 2014, J ALLERGY CLIN IMMUN, V134, P530, DOI 10.1016/j.jaci.2014.03.007; He J, 2016, MOL BIOL CELL, V27, P572, DOI 10.1091/mbc.E15-05-0283; Henry EP, 2006, NAT CHEM BIOL, V2, P39, DOI 10.1038/nchembio751; Hong WJ, 2014, TRENDS CELL BIOL, V24, P35, DOI 10.1016/j.tcb.2013.09.006; HOWELL TW, 1987, J CELL BIOL, V105, P191, DOI 10.1083/jcb.105.1.191; Ivanov AI, 2014, METHODS MOL BIOL, V1174, P3, DOI 10.1007/978-1-4939-0944-5_1; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; James Declan J, 2013, Front Endocrinol (Lausanne), V4, P187, DOI 10.3389/fendo.2013.00187; James DJ, 2009, P NATL ACAD SCI USA, V106, P17308, DOI 10.1073/pnas.0900755106; Johnson JL, 2016, J BIOL CHEM, V291, P25965, DOI 10.1074/jbc.M116.741884; Keri RS, 2015, EUR J MED CHEM, V89, P207, DOI 10.1016/j.ejmech.2014.10.059; Klenchin VA, 1998, METHODS, V16, P204, DOI 10.1006/meth.1998.0668; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Lynch KL, 2007, MOL BIOL CELL, V18, P4957, DOI 10.1091/mbc.E07-04-0368; Lynch KL, 2007, J CELL SCI, V120, P617, DOI 10.1242/jcs.03375; MARTIN TFJ, 1989, METHOD ENZYMOL, V168, P225; Matsuda H, 2016, CHEM PHARM BULL, V64, P96, DOI 10.1248/cpb.c15-00781; McShane MP, 2015, J BIOMOL SCREEN, V20, P720, DOI 10.1177/1087057115579613; Milovanovic D, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00089; Mishev K, 2013, CHEM BIOL, V20, P475, DOI 10.1016/j.chembiol.2013.03.009; Moon TC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00569; Noel S, 2013, CHEM SOC REV, V42, P7747, DOI 10.1039/c3cs60086f; Pinheiro PS, 2016, J NEUROCHEM, V139, P943, DOI 10.1111/jnc.13865; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Ren JQ, 2012, DEV CELL, V22, P967, DOI 10.1016/j.devcel.2012.03.005; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Rizo J, 2015, ANNU REV BIOPHYS, V44, P339, DOI 10.1146/annurev-biophys-060414-034057; Rossi AB, 2006, J ALLERGY CLIN IMMUN, V118, P749, DOI 10.1016/j.jaci.2006.05.023; Sagi-Eisenberg R, 2007, IMMUNOL REV, V217, P292, DOI 10.1111/j.1600-065X.2007.00516.x; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shirakawa R, 2004, J BIOL CHEM, V279, P10730, DOI 10.1074/jbc.M309426200; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Vennekate W, 2012, P NATL ACAD SCI USA, V109, P11037, DOI 10.1073/pnas.1116326109; Vukman K. V., 2014, BIOPROTOCOL, V4, pe1053; Wang CX, 2012, NANOSCALE, V4, P1895, DOI 10.1039/c2nr11508e; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Woo SS, 2017, MOL BIOL CELL, V28, P792, DOI 10.1091/mbc.E16-08-0617; Yang Y, 2013, BIOCHEM J, V450, P537, DOI 10.1042/BJ20121256; Yang Y, 2010, P NATL ACAD SCI USA, V107, P22145, DOI 10.1073/pnas.1006899108; Zhang CH, 2016, P NATL ACAD SCI USA, V113, pE41, DOI 10.1073/pnas.1521248112; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	53	4	4	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8217	8229		10.1074/jbc.RA117.001547	http://dx.doi.org/10.1074/jbc.RA117.001547			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29615494	hybrid, Green Published			2022-12-26	WOS:000433224600026
J	Engelke, AD; Gonsberg, A; Thapa, S; Jung, S; Ulbrich, S; Seidel, R; Basu, S; Multhaup, G; Baier, M; Engelhard, M; Schatzl, HM; Winklhofer, KF; Tatzelt, J				Engelke, Anna D.; Gonsberg, Anika; Thapa, Simrika; Jung, Sebastian; Ulbrich, Sarah; Seidel, Ralf; Basu, Shaon; Multhaup, Gerd; Baier, Michael; Engelhard, Martin; Schaetzl, Hermann M.; Winklhofer, Konstanze F.; Tatzelt, Joerg			Dimerization of the cellular prion protein inhibits propagation of scrapie prions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurodegenerative disease; prion disease; glycosylphosphatidylinositol; GPI anchor; dimerization; trafficking; neurological disease; amyloid; Creutzfeldt-Jakob disease; scrapie; PrPC; amyloid plaque	NEUROBLASTOMA-CELLS; TRANSMEMBRANE FORM; TRANSGENIC MICE; PRP; DISEASE; GLYCOSYLATION; REPLICATION; IMPAIRMENT; RESISTANT; PRECURSOR	A central step in the pathogenesis of prion diseases is the conformational transition of the cellular prion protein (PrPC) into the scrapie isoform, denoted PrPSc. Studies in transgenic mice have indicated that this conversion requires a direct interaction between PrPC and PrPSc; however, insights into the underlying mechanisms are still missing. Interestingly, only a subfraction of PrPC is converted in scrapie-infected cells, suggesting that not all PrPC species are suitable substrates for the conversion. On the basis of the observation that PrPC can form homodimers under physiological conditions with the internal hydrophobic domain (HD) serving as a putative dimerization domain, we wondered whether PrP dimerization is involved in the formation of neurotoxic and/or infectious PrP conformers. Here, we analyzed the possible impact on dimerization of pathogenic mutations in the HD that induce a spontaneous neurodegenerative disease in transgenic mice. Similarly to wildtype (WT) PrPC, the neurotoxic variant PrP(AV3) formed homodimers as well as heterodimers with WTPrPC. Notably, forced PrP dimerization via an intermolecular disulfide bond did not interfere with its maturation and intracellular trafficking. Covalently linked PrP dimers were complex glycosylated, GPI-anchored, and sorted to the outer leaflet of the plasma membrane. However, forced PrPC dimerization completely blocked its conversion into PrPSc in chronically scrapie-infected mouse neuroblastoma cells. Moreover, PrPC dimers had a dominant-negative inhibition effect on the conversion of monomeric PrPC. Our findings suggest that PrPC monomers are the major substrates for PrPSc propagation and that it may be possible to halt prion formation by stabilizing PrPC dimers.	[Engelke, Anna D.; Gonsberg, Anika; Jung, Sebastian; Ulbrich, Sarah; Tatzelt, Joerg] Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Dept Biochem Neurodegenerat Dis, D-44801 Bochum, Germany; [Winklhofer, Konstanze F.] Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Dept Mol Cell Biol, D-44801 Bochum, Germany; [Thapa, Simrika; Schaetzl, Hermann M.] Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB T2N 4Z6, Canada; [Thapa, Simrika; Schaetzl, Hermann M.] Univ Calgary, Calgary Prion Res Unit, Calgary, AB T2N 4Z6, Canada; [Seidel, Ralf; Engelhard, Martin] Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany; [Basu, Shaon; Multhaup, Gerd] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Baier, Michael] Robert Koch Inst, Ctr Biol Threats & Special Pathogens ZBS6, Res Grp Proteinopathies Neurodegenerat Dis, D-13353 Berlin, Germany; [Engelke, Anna D.] Heinrich Heine Univ, Med Fac, Dept Neurol, D-40225 Dusseldorf, Germany	Ruhr University Bochum; Ruhr University Bochum; University of Calgary; University of Calgary; Max Planck Society; McGill University; Robert Koch Institute; Heinrich Heine University Dusseldorf	Tatzelt, J (corresponding author), Ruhr Univ Bochum, Univ Str 150, D-44801 Bochum, Germany.	Joerg.Tatzelt@rub.de		Winklhofer, Konstanze/0000-0002-7256-8231; Jung, Sebastian/0000-0002-0365-5710; Tatzelt, Jorg/0000-0001-5017-5528; Basu, Shaon/0000-0003-2648-4827; Schatzl, Hermann/0000-0003-4972-8740	Deutsche Forschungsgemeinschaft [TA167/6]; Ministerium fur Kultur und Wissenschaft des Landes Nordrhein-Westfalen [Az 233-1.08.03.03-031.68079]; National Institutes of Health [R01 NS076853-01A1]; Calgary Prion Research Unit, Alberta Prion Research Institute [201600010]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076853] Funding Source: NIH RePORTER; Alberta Innovates [201610675] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministerium fur Kultur und Wissenschaft des Landes Nordrhein-Westfalen; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Calgary Prion Research Unit, Alberta Prion Research Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alberta Innovates	This work was supported in part by Deutsche Forschungsgemeinschaft Grant TA167/6 (to J.T.), Ministerium fur Kultur und Wissenschaft des Landes Nordrhein-Westfalen Grant Az 233-1.08.03.03-031.68079, National Institutes of Health Grant R01 NS076853-01A1 (to H.M.S.), and Calgary Prion Research Unit, Alberta Prion Research Institute Grant 201600010 (to H.M.S.).	Bach C, 2009, J BIOL CHEM, V284, P31260, DOI 10.1074/jbc.M109.004382; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; CAO HN, 1992, J BIOL CHEM, V267, P20489; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Chesebro B, 2003, BRIT MED BULL, V66, P1, DOI 10.1093/bmb/66.1.1; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chiarini LB, 2002, EMBO J, V21, P3317, DOI 10.1093/emboj/cdf324; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Ferreira DG, 2017, NAT NEUROSCI, V20, P1569, DOI 10.1038/nn.4648; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; HARAGUCHI T, 1989, ARCH BIOCHEM BIOPHYS, V274, P1, DOI 10.1016/0003-9861(89)90409-8; HARDY J, 1991, TRENDS NEUROSCI, V14, P423, DOI 10.1016/0166-2236(91)90038-V; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Meier P, 2003, CELL, V113, P49, DOI 10.1016/S0092-8674(03)00201-0; Meyer RK, 2000, J BIOL CHEM, V275, P38081, DOI 10.1074/jbc.M007114200; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Neuendorf E, 2004, J BIOL CHEM, V279, P53306, DOI 10.1074/jbc.M410796200; PRIOLA SA, 1995, J BIOL CHEM, V270, P3299, DOI 10.1074/jbc.270.7.3299; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; RACE RE, 1987, J GEN VIROL, V68, P1391, DOI 10.1099/0022-1317-68-5-1391; Rambold AS, 2008, EMBO J, V27, P1974, DOI 10.1038/emboj.2008.122; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Sakthivelu V, 2011, J BIOL CHEM, V286, P8901, DOI 10.1074/jbc.M110.185470; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; STAHL N, 1990, BIOCHEMISTRY-US, V29, P5405, DOI 10.1021/bi00474a028; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Stewart RS, 2001, MOL BIOL CELL, V12, P881, DOI 10.1091/mbc.12.4.881; Stohr J, 2011, P NATL ACAD SCI USA, V108, P21223, DOI 10.1073/pnas.1117827108; Taguchi Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003466; Tatzelt A, 2004, AMYLOID, V11, P162, DOI 10.1080/1350-612040000723; Warwicker J, 2000, BIOCHEM BIOPH RES CO, V278, P646, DOI 10.1006/bbrc.2000.3829; Weissmann C, 1996, COLD SPRING HARB SYM, V61, P511; Winklhofer KF, 2003, TRAFFIC, V4, P313, DOI 10.1034/j.1600-0854.2003.00088.x; Wu B, 2017, ELIFE, V6, DOI 10.7554/eLife.23473	43	11	11	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8020	8031		10.1074/jbc.RA117.000990	http://dx.doi.org/10.1074/jbc.RA117.000990			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29636413	Green Published, hybrid			2022-12-26	WOS:000433224600009
J	Ke, HJ; Dass, S; Morrisey, JM; Mather, MW; Vaidya, AB				Ke, Hangjun; Dass, Swati; Morrisey, Joanne M.; Mather, Michael W.; Vaidya, Akhil B.			The mitochondrial ribosomal protein L13 is critical for the structural and functional integrity of the mitochondrion in Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						malaria; mitochondria; ribosome; plasmodium; parasitology; mitochondrial DNA (mtDNA); apicomplexan; mitochondrial ribosome; mitoribosome; mRPL13; ribosomal protein; mitochondrion; mitochondrial genome	MALARIA PARASITES; ELECTRON-TRANSPORT; COMPLEX; RNA; DNA; TRANSLATION; RESISTANCE; GENES; APICOMPLEXA; ATOVAQUONE	The phylum Apicomplexa contains a group of protozoa causing diseases in humans and livestock. Plasmodium spp., the causative agent of malaria, contains a mitochondrion that is very divergent from that of their hosts. The malarial mitochondrion is a clinically validated target for the antimalarial drug atovaquone, which specifically blocks the electron transfer activity of the bc(1) complex of the mitochondrial electron transport chain (mtETC). Most mtETC proteins are nuclear-encoded and imported from the cytosol, but three key protein subunits are encoded in the Plasmodium mitochondrial genome: cyt b, COXI, and COXIII. They are translated inside the mitochondrion by mitochondrial ribosomes (mitoribosomes). Here, we characterize the function of one large mitoribosomal protein in Plasmodium falciparum, PfmRPL13. We found that PfmRPL13 localizes to the parasite mitochondrion and is refractory to genetic knockout. Ablation of PfmRPL13 using a conditional knockdown system (TetR-DOZI-aptamer) caused a series of adverse events in the parasite, including mtETC deficiency, loss of mitochondrial membrane potential ((m)), and death. The PfmRPL13 knockdown parasite also became hypersensitive to proguanil, a drug proposed to target an alternative process for maintaining (m). Surprisingly, transmission EM revealed that PfmRPL13 disruption also resulted in an unusually elongated and branched mitochondrion. The growth arrest of the knockdown parasite could be rescued with a second copy of PfmRPL13, but not by supplementation with decylubiquinone or addition of a yeast dihydroorotate dehydrogenase gene. In summary, we provide first and direct evidence that mitoribosomes are essential for malaria parasites to maintain the structural and functional integrity of the mitochondrion.	[Ke, Hangjun; Dass, Swati; Morrisey, Joanne M.; Mather, Michael W.; Vaidya, Akhil B.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Ctr Mol Parasitol, Philadelphia, PA 19129 USA	Drexel University	Ke, HJ (corresponding author), 2900 Queen Lane, Philadelphia, PA 19129 USA.	hk84@drexel.edu		Mather, Michael/0000-0002-1062-0137; Dass, Swati/0000-0002-0696-3209	National Institutes of Health Career Transition Award K22 [K22AI127702]; National Institutes of Health [R01 AI028398]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI127702, R01AI028398] Funding Source: NIH RePORTER	National Institutes of Health Career Transition Award K22(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Career Transition Award K22, K22AI127702 (to H. K.) and National Institutes of Health Award R01 AI028398 (to A. B. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AIKAWA M, 1966, AM J TROP MED HYG, V15, P449, DOI 10.4269/ajtmh.1966.15.449; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Burger G, 2013, GENOME BIOL EVOL, V5, P418, DOI 10.1093/gbe/evt008; Bushell E, 2017, CELL, V170, P260, DOI 10.1016/j.cell.2017.06.030; Camps M, 2002, MOL MICROBIOL, V43, P1309, DOI 10.1046/j.1365-2958.2002.02825.x; Chaubey S, 2005, MOL MICROBIOL, V56, P81, DOI 10.1111/j.1365-2958.2005.04538.x; Dahl EL, 2007, ANTIMICROB AGENTS CH, V51, P3485, DOI 10.1128/AAC.00527-07; Das S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005647; FEAGIN JE, 1992, MOL BIOCHEM PARASIT, V52, P145, DOI 10.1016/0166-6851(92)90046-M; FEAGIN JE, 1992, NUCLEIC ACIDS RES, V20, P879, DOI 10.1093/nar/20.4.879; Feagin JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038320; FRY M, 1992, BIOCHEM PHARMACOL, V43, P1545, DOI 10.1016/0006-2952(92)90213-3; Ganesan SM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10727; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Goodman CD, 2016, TRENDS PARASITOL, V32, P953, DOI 10.1016/j.pt.2016.09.011; Goodman CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091178; Gray MW, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016097; Gupta A, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140045; Hikosaka K, 2013, MOL BIOCHEM PARASIT, V188, P26, DOI 10.1016/j.molbiopara.2013.02.006; Hunte C, 2003, FEBS LETT, V545, P39, DOI 10.1016/S0014-5793(03)00391-0; Ke H, 2017, CURR CLIN MICROBIOL, V4, P175, DOI 10.1007/s40588-017-0075-5; Ke HJ, 2011, EUKARYOT CELL, V10, P1053, DOI 10.1128/EC.05049-11; Khaitovich P, 1999, P NATL ACAD SCI USA, V96, P85, DOI 10.1073/pnas.96.1.85; Lill R, 2014, CURR OPIN MICROBIOL, V22, P111, DOI 10.1016/j.mib.2014.09.015; Mather MW, 2010, MOL BIOCHEM PARASIT, V174, P150, DOI 10.1016/j.molbiopara.2010.07.006; Nina PB, 2011, J BIOL CHEM, V286, P41312, DOI 10.1074/jbc.M111.290973; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Puiu D, 2004, NUCLEIC ACIDS RES, V32, pD329, DOI 10.1093/nar/gkh050; Sharma A, 2015, BIOCHEM J, V465, P459, DOI 10.1042/BJ20140998; Smits P, 2007, NUCLEIC ACIDS RES, V35, P4686, DOI 10.1093/nar/gkm441; Spillman NJ, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12719; Srivastava IK, 1997, J BIOL CHEM, V272, P3961, DOI 10.1074/jbc.272.7.3961; Sun M, 2015, NUCLEIC ACIDS RES, V43, P10515, DOI 10.1093/nar/gkv991; SUPLICK K, 1988, MOL BIOCHEM PARASIT, V30, P289, DOI 10.1016/0166-6851(88)90098-9; SUPLICK K, 1990, MOL CELL BIOL, V10, P6381, DOI 10.1128/MCB.10.12.6381; Timsit Y, 2009, INT J MOL SCI, V10, P817, DOI 10.3390/ijms10030817; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; VAIDYA AB, 1989, MOL BIOCHEM PARASIT, V35, P97, DOI 10.1016/0166-6851(89)90112-6; Vaidya AB, 2000, DRUG RESIST UPDATE, V3, P283, DOI 10.1054/drup.2000.0157; Vaidya AB, 2009, ANNU REV MICROBIOL, V63, P249, DOI 10.1146/annurev.micro.091208.073424; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449; Wong W, 2014, ELIFE, V3, DOI 10.7554/eLife.03080; World Health Organization, 2017, DEPRESSION	47	24	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8128	8137		10.1074/jbc.RA118.002552	http://dx.doi.org/10.1074/jbc.RA118.002552			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29626096	Green Published, hybrid			2022-12-26	WOS:000433224600018
J	Crespillo-Casado, A; Claes, Z; Choy, MS; Peti, W; Bollen, M; Ron, D				Crespillo-Casado, Ana; Claes, Zander; Choy, Meng S.; Peti, Wolfgang; Bollen, Mathieu; Ron, David			A Sephin1-insensitive tripartite holophosphatase dephosphorylates translation initiation factor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphoprotein phosphatase 1 (PP1); eukaryotic initiation factor 2 (eIF2); enzyme inhibitor; G-actin; proteostasis; guanabenz; integrated stress response; protein synthesis; Sephin1	INTEGRATED STRESS-RESPONSE; PROTEIN PHOSPHATASE 1; ENDOPLASMIC-RETICULUM; REGULATORY SUBUNIT; SELECTIVE-INHIBITION; GROWTH ARREST; EIF2-ALPHA; PHOSPHORYLATION; MUSCLE; CELLS	The integrated stress response (ISR) is regulated by kinases that phosphorylate the subunit of translation initiation factor 2 and phosphatases that dephosphorylate it. Genetic and biochemical observations indicate that the eIF2(P)-directed holophosphatase, a therapeutic target in diseases of protein misfolding, is comprised of a regulatory subunit, PPP1R15, and a catalytic subunit, protein phosphatase 1 (PP1). In mammals, there are two isoforms of the regulatory subunit, PPP1R15A and PPP1R15B, with overlapping roles in the essential function of eIF2(P) dephosphorylation. However, conflicting reports have appeared regarding the requirement for an additional co-factor, G-actin, in enabling substrate-specific dephosphorylation by PPP1R15-containing PP1 holoenzymes. An additional concern relates to the sensitivity of the holoenzyme to the [(o-chlorobenzylidene)amino]guanidines Sephin1 or guanabenz, putative small-molecule proteostasis modulators. It has been suggested that the source and method of purification of the PP1 catalytic subunit and the presence or absence of an N-terminal repeat-containing region in the PPP1R15A regulatory subunit might influence the requirement for G-actin and sensitivity of the holoenzyme to inhibitors. We found that eIF2(P) dephosphorylation by PP1 was moderately stimulated by repeat-containing PPP1R15A in an unphysiological low ionic strength buffer, whereas stimulation imparted by the co-presence of PPP1R15A and G-actin was observed under a broad range of conditions, low and physiological ionic strength, regardless of whether the PPP1R15A regulatory subunit had or lacked the N-terminal repeat-containing region and whether it was paired with native PP1 purified from rabbit muscle or recombinant PP1 purified from bacteria. Furthermore, none of the PPP1R15A-containing holophosphatases tested were inhibited by Sephin1 or guanabenz.	[Crespillo-Casado, Ana; Ron, David] Univ Cambridge, Cambridge Inst Med Res, Cambridge Biomed Campus,Wellcome Trust MRC Bldg, Cambridge CB2 0XY, England; [Claes, Zander; Bollen, Mathieu] Katholieke Univ Leuven, Dept Cellular & Mol Med, B-3000 Leuven, Belgium; [Choy, Meng S.; Peti, Wolfgang] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA	University of Cambridge; KU Leuven; University of Arizona	Crespillo-Casado, A; Ron, D (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Cambridge Biomed Campus,Wellcome Trust MRC Bldg, Cambridge CB2 0XY, England.	ac880@cam.ac.uk; dr360@medschl.cam.ac.uk		Ron, David/0000-0002-3014-5636	Wellcome Trust principal research fellowship [Wellcome 200848/Z/16/Z]; Wellcome Trust strategic award [Wellcome 100140]; National Institute of Health [R01NS091336]; American Diabetes Association Pathway to Stop Diabetes [1-14-ACN-31]; Flemish Concerted Research Action [GOA15/016]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091336] Funding Source: NIH RePORTER	Wellcome Trust principal research fellowship(Wellcome Trust); Wellcome Trust strategic award(Wellcome Trust); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Pathway to Stop Diabetes; Flemish Concerted Research Action; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Wellcome Trust principal research fellowship (Wellcome 200848/Z/16/Z) to D. R. and a Wellcome Trust strategic award to the Cambridge Institute for Medical Research (Wellcome 100140). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institute of Health Grant R01NS091336 and American Diabetes Association Pathway to Stop Diabetes Grant 1-14-ACN-31.; Supported by a Flemish Concerted Research Action (GOA15/016).	Brush MH, 2008, MOL CELL BIOL, V28, P6989, DOI 10.1128/MCB.00724-08; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Carrara M, 2017, NAT STRUCT MOL BIOL, V24, P708, DOI 10.1038/nsmb.3443; Chambers JE, 2015, ELIFE, V4, DOI 10.7554/eLife.04872; Chen RM, 2015, ELIFE, V4, DOI 10.7554/eLife.04871; Choy MS, 2015, CELL REP, V11, P1885, DOI 10.1016/j.celrep.2015.05.043; Choy MS, 2014, P NATL ACAD SCI USA, V111, P4097, DOI 10.1073/pnas.1317395111; Connor JH, 2001, MOL CELL BIOL, V21, P6841, DOI 10.1128/MCB.21.20.6841-6850.2001; Crespillo-Casado A, 2017, ELIFE, V6, DOI 10.7554/eLife.26109; D'Antonio M, 2013, J EXP MED, V210, P821, DOI 10.1084/jem.20122005; Das I, 2015, SCIENCE, V348, P239, DOI 10.1126/science.aaa4484; DEGUZMAN A, 1988, METHOD ENZYMOL, V159, P356; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; He B, 1998, J BIOL CHEM, V273, P20737, DOI 10.1074/jbc.273.33.20737; HUBBARD MJ, 1989, EUR J BIOCHEM, V186, P711, DOI 10.1111/j.1432-1033.1989.tb15264.x; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Kelker MS, 2009, J MOL BIOL, V385, P11, DOI 10.1016/j.jmb.2008.10.053; Lin WS, 2008, AM J PATHOL, V173, P1508, DOI 10.2353/ajpath.2008.080449; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Malzer E, 2013, J CELL SCI, V126, P1406, DOI 10.1242/jcs.117614; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mikami S, 2010, BIOTECHNOL LETT, V32, P897, DOI 10.1007/s10529-010-0251-7; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Perego J, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aam8104; Peti W, 2013, FEBS J, V280, P596, DOI 10.1111/j.1742-4658.2012.08509.x; Schneider K, 2015, J CELL SCI, V128, P3861, DOI 10.1242/jcs.173047; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Verbinnen I, 2017, BIOCHEM SOC T, V45, P89, DOI 10.1042/BST20160154; Vulsteke V, 1997, J BIOL CHEM, V272, P32972, DOI 10.1074/jbc.272.52.32972; Wang LJ, 2014, HUM MOL GENET, V23, P2629, DOI 10.1093/hmg/ddt658; Zhou W, 2011, J BIOL CHEM, V286, P21687, DOI 10.1074/jbc.M110.212787	35	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7766	7776		10.1074/jbc.RA118.002325	http://dx.doi.org/10.1074/jbc.RA118.002325			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29618508	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000437256500025
J	Zhu, YS; Sun, HJ; He, SD; Lou, QY; Yu, M; Tang, MM; Tu, LJ				Zhu, Yongsheng; Sun, Hanju; He, Shudong; Lou, Qiuyan; Yu, Min; Tang, Mingming; Tu, Lijun			Metabolism and prebiotics activity of anthocyanins from black rice (Oryza sativa L.) in vitro	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; VANILLIC ACID; IDENTIFICATION; BIOTRANSFORMATION; QUANTIFICATION; BIFIDOBACTERIA; POLYPHENOLS; PIGMENTS	Anthocyanins are naturally active substances. In this study, anthocyanins from black rice were obtained by membrane filtration and column chromatography separation. Five anthocyanin monomers in black rice extract were identified by HPLC-MS/MS, and the major anthocyanin monomer (cyanidin-3-glucoside, C3G) was purified by preparative HPLC (Pre-HPLC). The proliferative effects of the anthocyanins on Bifidobacteria and Lactobacillus were investigated by determining the media pH, bacterial populations and metabolic products. After anaerobic incubation at 37 degrees C for 48 h, not only the pH of the media containing C3G was lower than that of the extract of black rice anthocyanin (BRAE), but the numbers of both Bifidobacteria and Lactobacillus were also significantly increased. Furthermore, hydroxyphenylpropionic, hydroxyphenylacetic, and hydroxybenzoic acids and other metabolites were detected by GC-MS in vitro. Our results revealed that the anthocyanins and anthocyanin monomers from black rice had prebiotic activity and they were metabolized into several small molecules by Bifidobacteria and Lactobacillus.	[Zhu, Yongsheng; Sun, Hanju; He, Shudong; Lou, Qiuyan; Yu, Min; Tang, Mingming; Tu, Lijun] Hefei Univ Technol, Sch Food Sci & Engn, Hefei, Anhui, Peoples R China; [He, Shudong] Dalian Polytech Univ, Sch Food Sci & Technol, Natl Engn Res Ctr Seafood, Dalian, Liaoning, Peoples R China	Hefei University of Technology; Dalian Polytechnic University	Sun, HJ (corresponding author), Hefei Univ Technol, Sch Food Sci & Engn, Hefei, Anhui, Peoples R China.	sunhanjv@163.com	He, Shudong/ABF-4582-2021; He, Shudong/H-4396-2014	He, Shudong/0000-0002-1155-4928; Sun, Hanju/0000-0002-3886-4088	National Natural Science Foundation of China [31771974, 31701524]; Anhui Provincial Natural Science Foundation [1708085MC70]; Autumn Project of Hefei University of Technology [JZ2015QSJH0217]; China Postdoctoral Science Foundation [2017M611208]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Autumn Project of Hefei University of Technology; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The authors are grateful for the financial support from the National Natural Science Foundation of China (No. 31771974, No. 31701524), the Anhui Provincial Natural Science Foundation (No. 1708085MC70), the Autumn Project of Hefei University of Technology (No. JZ2015QSJH0217), and the 61th Financial Grant from China Postdoctoral Science Foundation (No. 2017M611208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila M, 2009, FOOD RES INT, V42, P1453, DOI 10.1016/j.foodres.2009.07.026; Bowen-Forbes CS, 2010, J FOOD COMPOS ANAL, V23, P554, DOI 10.1016/j.jfca.2009.08.012; Cao YG, 2009, BIOCHEM PHARMACOL, V77, P1096, DOI 10.1016/j.bcp.2008.11.029; Castaneda-Ovando A, 2009, FOOD CHEM, V113, P859, DOI 10.1016/j.foodchem.2008.09.001; Chen XQ, 2012, FOOD CHEM, V135, P2783, DOI 10.1016/j.foodchem.2012.06.098; Chen Y, 2017, FOOD CHEM, V237, P887, DOI 10.1016/j.foodchem.2017.06.054; Cheng JR, 2016, FOOD CHEM, V213, P721, DOI 10.1016/j.foodchem.2016.07.032; Cueva C, 2010, RES MICROBIOL, V161, P372, DOI 10.1016/j.resmic.2010.04.006; Duthie GG, 2000, NUTR RES REV, V13, P79, DOI 10.1079/095442200108729016; Hao J, 2015, J CEREAL SCI, V64, P92, DOI 10.1016/j.jcs.2015.05.003; He SD, 2017, J FOOD PROCESS PRES, V41, DOI 10.1111/jfpp.13091; Hou ZH, 2013, FOOD RES INT, V50, P691, DOI 10.1016/j.foodres.2011.07.037; Ichikawa Haruyo, 2001, J Med Food, V4, P211, DOI 10.1089/10966200152744481; Itoh A, 2010, BIOL PHARM BULL, V33, P983, DOI 10.1248/bpb.33.983; Kahkonen MP, 2003, J AGR FOOD CHEM, V51, P628, DOI 10.1021/jf025551i; Keppler K, 2005, BIOORGAN MED CHEM, V13, P5195, DOI 10.1016/j.bmc.2005.05.003; Kim HJ, 2009, J AGR FOOD CHEM, V57, P7529, DOI 10.1021/jf900788c; Kong JM, 2003, PHYTOCHEMISTRY, V64, P923, DOI 10.1016/S0031-9422(03)00438-2; Kumar S, 2014, EUR J PHARMACOL, V743, P117, DOI 10.1016/j.ejphar.2014.09.010; Lee HC, 2006, RES MICROBIOL, V157, P876, DOI 10.1016/j.resmic.2006.07.004; Lee JH, 2010, FOOD SCI BIOTECHNOL, V19, P391, DOI 10.1007/s10068-010-0055-5; Mapari SAS, 2005, CURR OPIN BIOTECH, V16, P231, DOI 10.1016/j.copbio.2005.03.004; Pitija K, 2013, INT J FOOD SCI TECH, V48, P300, DOI 10.1111/j.1365-2621.2012.03187.x; Sanchez-Patan F, 2012, FOOD CHEM, V131, P337, DOI 10.1016/j.foodchem.2011.08.011; Serra A, 2011, FOOD CHEM, V126, P1127, DOI 10.1016/j.foodchem.2010.11.145; Sghir A, 1998, J APPL MICROBIOL, V85, P769, DOI 10.1111/j.1365-2672.1998.00590.x; Tabasco R, 2011, FOOD MICROBIOL, V28, P1345, DOI 10.1016/j.fm.2011.06.005; Wang JP, 2010, POULTRY SCI, V89, P1549, DOI 10.3382/ps.2009-00235; Zhang X, 2016, J AGR FOOD CHEM, V64, P2582, DOI 10.1021/acs.jafc.6b00586	29	52	53	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195754	10.1371/journal.pone.0195754	http://dx.doi.org/10.1371/journal.pone.0195754			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630662	Green Published, gold, Green Submitted			2022-12-26	WOS:000429505000073
J	Ghaderi, AH; Moradkhani, S; Haghighattard, A; Akrami, F; Khayyer, Z; Balci, F				Ghaderi, Amir Hossein; Moradkhani, Shadi; Haghighattard, Arvin; Akrami, Fatemeh; Khayyer, Zahra; Balci, Fuat			Time estimation and beta segregation: An EEG study and graph theoretical approach	PLOS ONE			English	Article							MULTI CHANNEL EEG; INTERNAL CLOCK; FUNCTIONAL SEGREGATION; PARKINSONS-DISEASE; PERCEPTION; OSCILLATIONS; FREQUENCY; COHERENCE; SYNCHRONIZATION; CONNECTIVITY	Elucidation of the neural correlates of time perception constitutes an important research topic in cognitive neuroscience. The focus to date has been on durations in the millisecond to seconds range, but here we used electroencephalography (EEG) to examine brain functional connectivity during much longer durations (i.e., 15 min). For this purpose, we conducted an initial exploratory experiment followed by a confirmatory experiment. Our results showed that those participants who overestimated time exhibited lower activity of beta (1830 Hz) at several electrode sites. Furthermore, graph theoretical analysis indicated significant differences in the beta range (15-30 Hz) between those that overestimated and underestimated time. Participants who underestimated time showed higher clustering coefficient compared to those that overestimated time. We discuss our results in terms of two aspects. FFT results, as a linear approach, are discussed within localized/dedicated models (i.e., scalar timing model). Second, non-localized properties of psychological interval timing (as emphasized by intrinsic models) are addressed and discussed based on results derived from graph theory. Results suggested that although beta amplitude in central regions (related to activity of BG-thalamocortical pathway as a dedicated module) is important in relation to timing mechanisms, the properties of functional activity of brain networks; such as the segregation of beta network, are also crucial for time perception. These results may suggest subjective time may be created by vector units instead of scalar ticks.	[Ghaderi, Amir Hossein] Univ Tabriz, Dept Psychol, Cognit Neurosci Lab, Tabriz, Iran; [Ghaderi, Amir Hossein; Moradkhani, Shadi; Haghighattard, Arvin; Akrami, Fatemeh] Iranian Neurowave Lab, Esfahan, Iran; [Moradkhani, Shadi] Amirkabir Univ Technol, Dept Phys, Tehran, Iran; [Haghighattard, Arvin] Islamic Azad Univ, North Tehran Branch, Dept Biol, Tehran, Iran; [Haghighattard, Arvin] Islamic Azad Univ, Tehran Med Sci Branch, Dept Genet, Tehran, Iran; [Akrami, Fatemeh] Iran Univ Med Sci, Fac Hlth Management & Informat, Tehran, Iran; [Khayyer, Zahra] Univ Isfahan, Dept Psychol, Esfahan, Iran; [Balci, Fuat] Koc Univ, Dept Psychol, Istanbul, Turkey	University of Tabriz; Amirkabir University of Technology; Islamic Azad University; Islamic Azad University; Iran University of Medical Sciences; University of Isfahan; Koc University	Ghaderi, AH (corresponding author), Univ Tabriz, Dept Psychol, Cognit Neurosci Lab, Tabriz, Iran.; Ghaderi, AH (corresponding author), Iranian Neurowave Lab, Esfahan, Iran.	a_ghaderi@tabrizu.ac.ir	Balci, Fuat/Y-9061-2018; Haghighatfard, Arvin/ACF-6171-2022; Ghaderi, Amirhossein/AAB-9680-2021	Balci, Fuat/0000-0003-3390-9352; Ghaderi, Amirhossein/0000-0001-5497-3025; Haghighatfard, Arvin/0000-0002-2179-9822; Moradkhani, Shadi/0000-0002-7093-7646				Allman MJ, 2014, ANNU REV PSYCHOL, V65, P743, DOI 10.1146/annurev-psych-010213-115117; Arnal LH, 2015, CEREB CORTEX, V25, P3077, DOI 10.1093/cercor/bhu103; Arns M, 2013, J ATTEN DISORD, V17, P374, DOI 10.1177/1087054712460087; Babiloni C, 2011, INT J PSYCHOPHYSIOL, V82, P260, DOI 10.1016/j.ijpsycho.2011.09.008; Bar-Haim Y, 2010, COGNITION EMOTION, V24, P255, DOI 10.1080/02699930903387603; Berkovich-Ohana A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00912; Berlin HA, 2004, J PERS DISORD, V18, P358, DOI 10.1521/pedi.18.4.358.40349; Boccara N, 2010, GRAD TEXTS PHYS, P1, DOI 10.1007/978-1-4419-6562-2; Brown P, 1999, MOVEMENT DISORD, V14, P423, DOI 10.1002/1531-8257(199905)14:3<423::AID-MDS1006>3.0.CO;2-V; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cha M, P 18 INT C WORLD WID, P721, DOI DOI 10.1145/1526709.1526806; CHURCH RM, 1994, J EXP PSYCHOL ANIM B, V20, P135, DOI 10.1037/0097-7403.20.2.135; Cravo AM, 2011, J NEUROPHYSIOL, V106, P2964, DOI 10.1152/jn.00157.2011; Droit-Volet S, 2013, J PHYSIOL-PARIS, V107, P255, DOI 10.1016/j.jphysparis.2013.03.005; Eagleman DM, 2009, PHILOS T R SOC B, V364, P1841, DOI 10.1098/rstb.2009.0026; Eddington A, 1927, NATURE PHYS WORLD GI; Egner T, 2004, CLIN NEUROPHYSIOL, V115, P131, DOI 10.1016/S1388-2457(03)00353-5; Einstein A., 1950, MEANING RELATIVITY; Etchell AC, 2016, NEUROIMAGE, V125, P953, DOI 10.1016/j.neuroimage.2015.10.086; Etchell AC, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01036; Fraschini M, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/3/036015; Ghaderi A, 2016, INTERVAL TIMING ADUL, P6173; Ghaderi AH, 2017, BASIC CLIN NEUROSCI, V8, P267, DOI 10.18869/nirp.bcn.8.4.267; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Goel A, 2016, NEURON, V91, P320, DOI 10.1016/j.neuron.2016.05.042; Graber S, 2002, BRAIN LANG, V82, P65, DOI 10.1016/S0093-934X(02)00002-0; Grondin S, 2014, ADV EXP MED BIOL, V829, P17, DOI 10.1007/978-1-4939-1782-2_2; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Kabat-Zinn J, 2003, CLIN PSYCHOL-SCI PR, V10, P144, DOI 10.1093/clipsy/bpg016; Karmarkar UR, 2007, NEURON, V53, P427, DOI 10.1016/j.neuron.2007.01.006; Klostermann F, 2007, EUR J NEUROSCI, V25, P1604, DOI 10.1111/j.1460-9568.2007.05417.x; Kononowicz TW, 2015, NEUROPSYCHOLOGIA, V75, P381, DOI 10.1016/j.neuropsychologia.2015.06.014; Kramer RSS, 2013, CONSCIOUS COGN, V22, P846, DOI 10.1016/j.concog.2013.05.008; Krause D, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01993; Kulashekhar S, 2016, HUM BRAIN MAPP, V37, P3262, DOI 10.1002/hbm.23239; Lage-Castellanos A, 2010, STAT MED, V29, P63, DOI 10.1002/sim.3784; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Matthews WJ, 2014, WIRES COGN SCI, V5, P429, DOI 10.1002/wcs.1298; McFarland DJ, 2000, BRAIN TOPOGR, V12, P177, DOI 10.1023/A:1023437823106; Meck WH, 2006, BRAIN RES, V1109, P93, DOI 10.1016/j.brainres.2006.06.031; Meck WH, 2002, BRAIN COGNITION, V48, P195, DOI 10.1006/brcg.2001.1313; Merchant H, 2015, PHIL T R SOC B, V370, DOI 10.1098/rstb.2014.0093; Merchant H, 2018, J NEURAL TRANSM, V125, P461, DOI 10.1007/s00702-017-1716-9; Micheloyannis S, 2006, NEUROSCI LETT, V402, P273, DOI 10.1016/j.neulet.2006.04.006; Moazami-Goudarzi M, 2008, NEUROIMAGE, V41, P985, DOI 10.1016/j.neuroimage.2008.03.032; Ng KK, 2014, ADV EXP MED BIOL, V829, P187, DOI 10.1007/978-1-4939-1782-2_11; Porjesz B, 2002, P NATL ACAD SCI USA, V99, P3729, DOI 10.1073/pnas.052716399; Reichert JL, 2015, CLIN NEUROPHYSIOL, V126, P2068, DOI 10.1016/j.clinph.2014.09.032; Ritter P, 2009, HUM BRAIN MAPP, V30, P1168, DOI 10.1002/hbm.20585; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sanei S., 2013, EEG SIGNAL PROCESSIN; Schank T., 2005, J GRAPH ALGORITHMS A, V9, P265, DOI DOI 10.7155/JGAA.00108; Shi ZH, 2013, TRENDS COGN SCI, V17, P556, DOI 10.1016/j.tics.2013.09.009; Simen P, 2011, J NEUROSCI, V31, P9238, DOI 10.1523/JNEUROSCI.3121-10.2011; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Stefanics G, 2010, J NEUROSCI, V30, P13578, DOI 10.1523/JNEUROSCI.0703-10.2010; Thatcher R.W., 2003, J NEUROTHER, V7, P87, DOI [10.1300/j184v07n03_05, DOI 10.1300/J184V07N03_05]; Thatcher RW, 2012, DEV NEUROPSYCHOL, V37, P476, DOI 10.1080/87565641.2011.619241; Thatcher RW, 2005, CLIN NEUROPHYSIOL, V116, P2129, DOI 10.1016/j.clinph.2005.04.026; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Utianski RL, 2016, CLIN NEUROPHYSIOL, V127, P2228, DOI 10.1016/j.clinph.2016.02.017; van Rijn H, 2014, ADV EXP MED BIOL, V829, P75, DOI 10.1007/978-1-4939-1782-2_5; WEARDEN JH, 1991, LEARN MOTIV, V22, P59, DOI 10.1016/0023-9690(91)90017-3; Weinberger M, 2006, J NEUROPHYSIOL, V96, P3248, DOI 10.1152/jn.00697.2006	66	20	20	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195380	10.1371/journal.pone.0195380	http://dx.doi.org/10.1371/journal.pone.0195380			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624619	Green Published, gold, Green Submitted			2022-12-26	WOS:000429379600025
J	Nay-Htoon, B; Xue, W; Lindner, S; Cuntz, M; Ko, J; Tenhunen, J; Werner, C; Dubbert, M				Nay-Htoon, Bhone; Xue, Wei; Lindner, Steve; Cuntz, Matthias; Ko, Jonghan; Tenhunen, John; Werner, Christiane; Dubbert, Maren			Quantifying differences in water and carbon cycling between paddy and rainfed rice (Oryza sativa L.) by flux partitioning	PLOS ONE			English	Article							SUBSTRATE WEIGHT-LOSS; DRY-SEEDED RICE; MICROBIAL RESPIRATION; HERBACEOUS VEGETATION; OXYGEN-ISOTOPE; CLIMATE-CHANGE; ECOSYSTEM CO2; AEROBIC RICE; EVAPOTRANSPIRATION; EXCHANGE	Agricultural crops play an important role in the global carbon and water cycle. Global climate change scenarios predict enhanced water scarcity and altered precipitation pattern in many parts of the world. Hence, a mechanistic understanding of water fluxes, productivity and water use efficiency of cultivated crops is of major importance, i.e. to adapt management practices. We compared water and carbon fluxes of paddy and rainfed rice by canopy scale gas exchange measurements, crop growth, daily evapotranspiration, transpiration and carbon flux modeling. Throughout a monsoon rice growing season, soil evaporation in paddy rice contributed strongly to evapotranspiration (96.6% to 43.3% from initial growth to fully developed canopy and amounted to 57.9% of total water losses over the growing seasons. Evaporation of rainfed rice was significantly lower (by 65% on average) particularly before canopy closure. Water use efficiency (WUE) was significantly higher in rainfed rice both from an agronomic (WUEagro, i.e. grain yield per evapotranspiration) and ecosystem (WUEeco, i.e. gross primary production per evapotranspiration) perspective. However, our results also show that higher WUE in rainfed rice comes at the expense of higher respiration losses compared to paddy rice (26% higher on average). Hence, suggestions on water management depend on the regional water availability (i.e. Mediterranean vs. Monsoon climate) and the balance between higher respiratory losses versus a potential reduction in CH4 and other greenhouse gas emissions. Our results suggest that a shift from rainfed/unsaturated soil to waterlogged paddy conditions after closure of the rice canopy might be a good compromise towards a sustainable use of water while preserving grain yield, particularly for water-limited production areas.	[Nay-Htoon, Bhone] Minist Agr Livestock & Irrigat, Dept Rural Dev, LIFT UNOPS Tech Assistant Team, Nay Pyi Taw, Myanmar; [Xue, Wei; Lindner, Steve; Tenhunen, John] Univ Bayreuth, Dept Plant Ecol, Bayreuth, Germany; [Cuntz, Matthias] INRA, Tree & Ecosyst Level Integrat Ecol & Ecophysiol, Nantes, France; [Ko, Jonghan] Chonnam Natl Univ, Dept Appl Plant Sci, Gwangju, South Korea; [Werner, Christiane; Dubbert, Maren] Univ Freiburg, Dept Ecosyst Physiol, Freiburg, Germany	University of Bayreuth; INRAE; Chonnam National University; University of Freiburg	Dubbert, M (corresponding author), Univ Freiburg, Dept Ecosyst Physiol, Freiburg, Germany.	maren.dubbert@cep.uni-freiburg.de	Dubbert, Maren/K-4204-2019; Werner, Christiane/B-2948-2009; Ko, Jonghan/AAP-5709-2021; Xue, Wei/K-2455-2017	Werner, Christiane/0000-0002-7676-9057; Dubbert, Maren/0000-0002-2352-8516; Xue, Wei/0000-0003-3257-7755	Deutsche Forschungsgemeinschaft (DFG) as part of the International Research and Training Group: TERRECO at the University of Bayreuth, Germany [GRK 1565/1]; Korean Research Foundation (KRF) at Kangwon National University, Chuncheon, S. Korea; German Research Foundation (DFG); University of Freiburg	Deutsche Forschungsgemeinschaft (DFG) as part of the International Research and Training Group: TERRECO at the University of Bayreuth, Germany(German Research Foundation (DFG)); Korean Research Foundation (KRF) at Kangwon National University, Chuncheon, S. Korea; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	This study was funded by the Deutsche Forschungsgemeinschaft (DFG) as part of the International Research and Training Group: TERRECO (GRK 1565/1) at the University of Bayreuth, Germany and Korean Research Foundation (KRF) at Kangwon National University, Chuncheon, S. Korea. The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing.	Adekoya M. A., 2014, Journal of Agricultural Science (Toronto), V6, P110; Alberto MCR, 2014, AGR WATER MANAGE, V136, P1, DOI 10.1016/j.agwat.2014.01.005; Alberto MCR, 2013, FIELD CROP RES, V146, P51, DOI 10.1016/j.fcr.2013.03.006; Alberto MCR, 2011, AGR WATER MANAGE, V98, P1417, DOI 10.1016/j.agwat.2011.04.011; Alberto MCR, 2009, AGR FOREST METEOROL, V149, P1737, DOI 10.1016/j.agrformet.2009.06.003; Allen R. G., 1998, FAO Irrigation and Drainage Paper; [Anonymous], 2012, 1203 ESA; [Anonymous], 2012, CROPS FEED WORLD 7 R; Arnell NW, 2014, CLIMATIC CHANGE, V122, P127, DOI 10.1007/s10584-013-0948-4; Balwinder-Singh, 2014, AGR WATER MANAGE, V135, P19, DOI 10.1016/j.agwat.2013.12.008; Beer C, 2009, GLOBAL BIGEOCHEMICAL; Berger S, 2013, BIOGEOCHEMISTRY, V115, P317, DOI 10.1007/s10533-013-9837-1; Bhattacharyya P, 2014, AGR ECOSYST ENVIRON, V189, P127, DOI 10.1016/j.agee.2014.03.013; Bouman B.A.M, 2002, P INT WORKSHOP WATER, P356; Bouman BAM, 2005, AGR WATER MANAGE, V74, P87, DOI 10.1016/j.agwat.2004.11.007; Bouman BAM, 2001, AGR WATER MANAGE, V49, P11, DOI 10.1016/S0378-3774(00)00128-1; BUNNELL FL, 1977, SOIL BIOL BIOCHEM, V9, P41, DOI 10.1016/0038-0717(77)90059-1; BUNNELL FL, 1977, SOIL BIOL BIOCHEM, V9, P33, DOI 10.1016/0038-0717(77)90058-X; Dubbert M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00530; Dubbert M, 2013, J HYDROL, V496, P142, DOI 10.1016/j.jhydrol.2013.05.033; Duchemin B, 2006, AGR WATER MANAGE, V79, P1, DOI 10.1016/j.agwat.2005.02.013; Fitzjarrald DR, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000596; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Gavilan P, 2007, AGR WATER MANAGE, V89, P275, DOI 10.1016/j.agwat.2007.01.014; Glenn EP, 2008, SENSORS-BASEL, V8, P2136, DOI 10.3390/s8042136; Hejazi MI, 2014, HYDROL EARTH SYST SC, V18, P2859, DOI 10.5194/hess-18-2859-2014; Hu ZM, 2008, GLOBAL CHANGE BIOL, V14, P1609, DOI 10.1111/j.1365-2486.2008.01582.x; Istanbulluoglu E, 2012, ECOHYDROLOGY, V5, P121, DOI 10.1002/eco.211; KELLIHER FM, 1995, AGR FOREST METEOROL, V73, P1, DOI 10.1016/0168-1923(94)02178-M; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; Kudo Y, 2014, AGR ECOSYST ENVIRON, V186, P77, DOI 10.1016/j.agee.2014.01.015; LEUNING R, 1994, AGR FOREST METEOROL, V67, P221, DOI 10.1016/0168-1923(94)90004-3; Li YL, 2008, AGR FOREST METEOROL, V148, P1318, DOI 10.1016/j.agrformet.2008.03.013; Lindner S, 2016, AGR FOREST METEOROL, V228, P229, DOI 10.1016/j.agrformet.2016.07.014; Lindner S, 2015, AGR ECOSYST ENVIRON, V199, P132, DOI 10.1016/j.agee.2014.09.005; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Miyata A, 2000, AGR FOREST METEOROL, V102, P287, DOI 10.1016/S0168-1923(00)00092-7; Mo XG, 2004, J HYDROL, V285, P125, DOI 10.1016/j.jhydrol.2003.08.013; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; MONTEITH JL, 1981, Q J ROY METEOR SOC, V107, P1, DOI 10.1256/smsqj.45101; Multsch S, 2015, GEOSCI MODEL DEV, V8, P1233, DOI 10.5194/gmd-8-1233-2015; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Nay-Htoon B, 2013, J NATURAL RES DEV, V03, P58, DOI 10.5027/jnrd.v3i0.05; NIE LX, 2012, REV CITE THIS VERSIO, V32, P411, DOI DOI 10.1007/S13593-011-0055-8; Nishimura S, 2015, J GEOPHYS RES-BIOGEO, V120, P63, DOI 10.1002/2014JG002746; Otieno D, 2012, WETLANDS, V32, P895, DOI 10.1007/s13157-012-0322-8; Pape L, 2009, BIOGEOSCIENCES, V6, P405, DOI 10.5194/bg-6-405-2009; Payero JO, 2013, AGR WATER MANAGE, V129, P31, DOI 10.1016/j.agwat.2013.06.018; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Reichstein M, 2002, GLOBAL CHANGE BIOL, V8, P999, DOI 10.1046/j.1365-2486.2002.00530.x; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Sakai RK, 2004, GLOBAL CHANGE BIOL, V10, P895, DOI 10.1111/j.1529-8817.2003.00773.x; SELLERS PJ, 1985, INT J REMOTE SENS, V6, P1335, DOI 10.1080/01431168508948283; Seo J, 2014, WETLANDS, V34, P213, DOI 10.1007/s13157-013-0477-y; Smith P, 2007, CLIMATE CHANGE 2007; Team RC, 2014, R LANG ENV STAT COMP; Thanawong K, 2014, J CLEAN PROD, V73, P204, DOI 10.1016/j.jclepro.2013.12.067; Tuong TP, 2003, COMP ASSESS WAT MAN, V1, P53, DOI 10.1079/9780851996691.0053; Wassmann R, 2000, NUTR CYCL AGROECOSYS, V58, P1, DOI 10.1023/A:1009848813994; Weller S, 2014, NUTR CYCLING AGROECO, DOI 10.1007/s10705-014-9658-1; Xiao Y, 2005, AGR ECOSYST ENVIRON, V109, P273, DOI 10.1016/j.agee.2005.03.016; Yan XY, 2003, GLOBAL CHANGE BIOL, V9, P237, DOI 10.1046/j.1365-2486.2003.00564.x; Zhao XS, 2008, J HYDROL, V355, P181, DOI 10.1016/j.jhydrol.2008.03.019; Zhou MC, 2006, J HYDROL, V327, P151, DOI 10.1016/j.jhydrol.2005.11.013	64	12	12	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195238	10.1371/journal.pone.0195238	http://dx.doi.org/10.1371/journal.pone.0195238			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624613	Green Published, gold, Green Submitted			2022-12-26	WOS:000429379600019
J	Fu, M; Travier, N; Martin-Sanchez, JC; Martinez-Sanchez, JM; Vidal, C; Garcia, M				Fu, Marcela; Travier, Noemie; Martin-Sanchez, Juan Carlos; Martinez-Sanchez, Jose M.; Vidal, Carmen; Garcia, Montse		LUCAPREV Res Grp	Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria	PLOS ONE			English	Article							LOW-DOSE CT; SELECTION CRITERIA; POPULATION; TRIAL; SURVIVAL	Background There are two main types of strategies to identify target population for lung cancer screening: 1) strategies based on age and cumulative smoking criteria, 2) risk prediction models allowing the calculation of an individual risk. The objective of this study was to compare different strategies to identify the proportion of the Spanish population at high risk of developing lung cancer, susceptible to be included in a lung cancer screening programme. Methods Cross-sectional study. We used the data of the Spanish National Interview Health Survey (ENSE) of 2011-2012 (21,006 individuals) to estimate the proportion of participants at high risk of developing lung cancer. This estimation was performed using the U.S. national lung screening trial (NLST) criteria and a 6-year prediction model (PLCOm2012), both independently and in combination. Results The prevalence of individuals at high risk of developing lung cancer according to the NLST criteria was 4.9% (7.9% for men, 2.4% for women). Among the 1,034 subjects who met the NLST criteria, 533 (427 men and 106 women) had a 6-year lung cancer risk >= 2.0%. The combination of these two selection strategies showed that 2.5% of the Spanish population had a high risk of developing lung cancer. However, this selection process did not take into account different groups of subjects <75 years old having an individual risk of lung cancer >= 2%, such as heavy smokers <55 years old who were long-time former smokers, and ever smokers having smoked <30 pack-years with other risk factors. Conclusions Further research is needed to determine which selection strategy achieves a higher benefit/harm ratio and to assess other prevention strategies for individuals with elevated risk for lung cancer but who do not meet the screening eligibility criteria.	[Fu, Marcela; Martinez-Sanchez, Jose M.] Catalan Inst Oncol IDIBELL, Tobacco Control Unit, Canc Prevent & Control Programme, Lhospitalet De Llobregat, Llobregat, Spain; [Travier, Noemie; Vidal, Carmen; Garcia, Montse] Catalan Inst Oncol IDIBELL, Canc Screening Unit, Canc Prevent & Control Programme, Lhospitalet De Llobregat, Llobregat, Spain; [Martin-Sanchez, Juan Carlos; Martinez-Sanchez, Jose M.] Univ Int Catalunya, Grp Evaluat Hlth Determinants & Hlth Policies, Sant Cugat Del Valles, Spain	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Universitat Internacional de Catalunya (UIC)	Vidal, C; Garcia, M (corresponding author), Catalan Inst Oncol IDIBELL, Canc Screening Unit, Canc Prevent & Control Programme, Lhospitalet De Llobregat, Llobregat, Spain.	cvidal@iconcologia.net; moarcia@iconcologia.net	Díaz-Sanchis, Mireia/H-1593-2015; Garcia, Montse/B-8832-2014; Martín, JuanCarlos/AAB-5440-2019; Martínez-Sánchez, Jose/AAA-6343-2019; Martínez-Sánchez, Jose M/ABH-3093-2020; Sanchez, Juan Carlos Martin/G-5650-2019; Vidal, Carmen/H-4029-2016; Trapero-Bertran, Marta/D-7437-2014	Díaz-Sanchis, Mireia/0000-0001-9360-4548; Garcia, Montse/0000-0002-3437-3185; Martín, JuanCarlos/0000-0002-1045-4802; Martínez-Sánchez, Jose M/0000-0002-9632-5701; Sanchez, Juan Carlos Martin/0000-0002-1045-4802; Vidal, Carmen/0000-0003-2768-2710; Trapero-Bertran, Marta/0000-0002-9233-1776; Travier, Noemie/0000-0001-5228-7769	Asociacion Espanola Contra el Cancer de Barcelona [PROYBAR16909FU]	Asociacion Espanola Contra el Cancer de Barcelona	This study has been funded by the Asociacion Espanola Contra el Cancer de Barcelona in the Call for proposals of Research in Oncology of 2016 (grant PROYBAR16909FU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Berto J, 2016, GAC SANIT, V30, P386, DOI 10.1016/j.gaceta.2016.07.001; Callol L, 2007, LUNG CANCER, V56, P217, DOI 10.1016/j.lungcan.2007.01.010; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; Domingo-Salvany A, 2013, GAC SANIT, V27, P263, DOI 10.1016/j.gaceta.2012.12.009; Ferlay J, 2014, IARC CANCERBASE; Garrido P, 2017, ARCH BRONCONEUMOL; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Katki HA, 2016, JAMA-J AM MED ASSOC, V315, P2300, DOI 10.1001/jama.2016.6255; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; Marcus MW, 2015, J THORAC DIS, V7, pS156, DOI 10.3978/j.issn.2072-1439.2015.04.19; McRonald FE, 2014, CANCER PREV RES, V7, P362, DOI 10.1158/1940-6207.CAPR-13-0206; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Ruano-Ravina A, 2016, GAC SANIT, V30, P383, DOI 10.1016/j.gaceta.2016.03.003; Saghir Z, 2012, THORAX, V67, P296, DOI 10.1136/thoraxjnl-2011-200736; Sanchez-Salcedo P, 2015, AM J RESP CRIT CARE, V191, P924, DOI 10.1164/rccm.201410-1848OC; Spanish Statistical Office, 2017, CIFR POBL 1 EN 2017 CIFR POBL 1 EN 2017; Tammemagi MC, 2015, J THORAC IMAG, V30, P88, DOI 10.1097/RTI.0000000000000142; Tammemagi MC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001764; ten Haaf K, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002277; ten Haaf K, 2015, J THORAC ONCOL, V10, P1285, DOI 10.1097/JTO.0000000000000593; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; Viguier J, 2015, EUR J CANCER PREV, V24, pS87, DOI 10.1097/CEJ.0000000000000142; Weber M, 2017, INT J CANCER, V141, P242, DOI 10.1002/ijc.30673	26	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195441	10.1371/journal.pone.0195441	http://dx.doi.org/10.1371/journal.pone.0195441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621354	Green Published, gold, Green Submitted			2022-12-26	WOS:000429206800084
J	Charifi, M; Miserazzi, A; Sow, M; Perrigault, M; Gonzalez, P; Ciret, P; Benomar, S; Massabuau, JC				Charifi, Mohcine; Miserazzi, Alison; Sow, Mohamedou; Perrigault, Mickael; Gonzalez, Patrice; Ciret, Pierre; Benomar, Soumaya; Massabuau, Jean-Charles			Noise pollution limits metal bioaccumulation and growth rate in a filter feeder, the Pacific oyster Magallana gigas	PLOS ONE			English	Article							CRASSOSTREA-GIGAS; GENE-EXPRESSION; CORBICULA-FLUMINEA; CADMIUM; ACCUMULATION; TOXICITY; EXPOSURE; BEHAVIOR; STRESS; SOUND	Shipping has increased dramatically in recent decades and oysters can hear them. We studied the interaction between noise pollution and trace metal contamination in the oyster Magallana gigas. Four oyster-groups were studied during a 14-day exposure period. Two were exposed to cadmium in the presence of cargo ship-noise ([Cd++]w approximate to 0.5 mu g-L-1; maximum sound pressure level 150 dBrms re 1 mu Pa), and 2 were exposed only to cadmium. The Cd concentration in the gills ([Cd]g) and the digestive gland ([Cd]dg), the valve closure duration, number of valve closures and circadian distribution of opening and closure, the daily shell growth-rate and the expression of 19 genes in the gills were studied. Oysters exposed to Cd in the presence of cargo ship-noise accumulated 2.5 times less Cd in their gills than did the controls without ship noise and their growth rate was 2.6 times slower. In the presence of ship noise, oysters were closed more during the daytime, and their daily valve activity was reduced. Changes in gene activity in the gills were observed in 7 genes when the Cd was associated with the ship noise. In the absence of ship noise, a change in expression was measured in 4 genes. We conclude that chronic exposure to cargo ship noise has a depressant effect on the activity in oysters, including on the volume of the water flowing over their gills (Vw). In turn, a decrease in the Vw and valve-opening duration limited metal exposure and uptake by the gills but also limited food uptake. This latter conclusion would explain the slowing observed in the fat metabolism and growth rate. Thus, we propose that cargo ship noise exposure could protect against metal bioaccumulation and affect the growth rate. This latter conclusion points towards a potential risk in terms of ecosystem productivity.	[Charifi, Mohcine; Miserazzi, Alison; Sow, Mohamedou; Perrigault, Mickael; Gonzalez, Patrice; Ciret, Pierre; Massabuau, Jean-Charles] Univ Bordeaux, EPOC, Arcachon, France; [Charifi, Mohcine; Miserazzi, Alison; Sow, Mohamedou; Perrigault, Mickael; Gonzalez, Patrice; Ciret, Pierre; Massabuau, Jean-Charles] CNRS, EPOC, Talence, France; [Charifi, Mohcine; Benomar, Soumaya] Mohammed V Agdal Univ, Fac Sci, Unit Res Biol Rhythms Neurosci & Environm, Rabat, Morocco	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Mohammed V University in Rabat	Massabuau, JC (corresponding author), Univ Bordeaux, EPOC, Arcachon, France.; Massabuau, JC (corresponding author), CNRS, EPOC, Talence, France.	jean-charles.massabuau@u-bordeaux.fr	Perrigault, Mickael/P-2887-2017	Perrigault, Mickael/0000-0002-7271-100X; Gonzalez, Patrice/0000-0003-2628-2993; Massabuau, Jean-Charles/0000-0003-1302-1719	Campus France; ANR [ANR-15-CE04-0002-02]; NEUROMED; Institut National de la Sante et de la Recherche Medical (INSERM); GDRI de Neurosciences, n 198, Embassy of France, Institut Francais in Morocco; MoIIuSCAN Eye Project; Centre National pour la Recherche Scientifique et Technique (CNRST); TOTAL RD [FR00008208]	Campus France; ANR(French National Research Agency (ANR)); NEUROMED; Institut National de la Sante et de la Recherche Medical (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); GDRI de Neurosciences, n 198, Embassy of France, Institut Francais in Morocco; MoIIuSCAN Eye Project; Centre National pour la Recherche Scientifique et Technique (CNRST); TOTAL RD	This study was supported by grants from Campus France, ANR (ANR-15-CE04-0002-02 WAQMOS), NEUROMED, the Institut National de la Sante et de la Recherche Medical (INSERM), the GDRI de Neurosciences, n 198, Embassy of France, Institut Francais in Morocco, the MoIIuSCAN Eye Project, and the Centre National pour la Recherche Scientifique et Technique (CNRST) to M.C.. TOTAL R&D provided a grant (no. FR00008208) to A.M.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams W, 2002, COMP BIOCHEM PHYS C, V133, P1, DOI 10.1016/S1532-0456(02)00113-8; Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; Amorim MCP, 2008, BEHAVIOUR, V145, P1065, DOI 10.1163/156853908784474498; Andrade H, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00187; Andre M, 2011, FRONT ECOL ENVIRON, V9, P489, DOI 10.1890/100124; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], [No title captured]; Bijoux H., 2014, THESIS; Bruintjes R, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150686; Burtin B., 1986, THESIS; Campbell P., 2003, P 7 INT S FISH PHYS, P125; CAMPBELL PGC, 1985, CAN J FISH AQUAT SCI, V42, P2034, DOI 10.1139/f85-251; Charifi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185353; Cheng L, 2011, PHYSIOL BEHAV, V104, P981, DOI 10.1016/j.physbeh.2011.06.018; Cuypers A, 2010, BIOMETALS, V23, P927, DOI 10.1007/s10534-010-9329-x; Di Toro DM, 2001, ENVIRON TOXICOL CHEM, V20, P2383, DOI 10.1002/etc.5620201034; ELLERS O, 1995, BIOL BULL-US, V189, P128, DOI 10.2307/1542463; Espinosa EP, 2016, J PROTEOMICS, V132, P63, DOI 10.1016/j.jprot.2015.11.018; Fewtrell JL, 2012, MAR POLLUT BULL, V64, P984, DOI 10.1016/j.marpolbul.2012.02.009; Fournier E, 2006, ENVIRON TOXICOL CHEM, V25, P2692, DOI 10.1897/05-386R1.1; Frisk GV, 2012, SCI REP-UK, V2, DOI 10.1038/srep00437; Gamain P., 2016, THESIS; Gannon DP, 2005, ANIM BEHAV, V69, P709, DOI 10.1016/j.anbehav.2004.06.020; Gonzalez P, 2006, BIOMETALS, V19, P225, DOI 10.1007/s10534-005-5670-x; Guerra A, 2011, BIOL CONSERV, V144, P1989, DOI 10.1016/j.biocon.2011.04.021; Haberkorn H, 2011, MAR POLLUT BULL, V62, P1191, DOI 10.1016/j.marpolbul.2011.03.034; Hawkins AD, 2015, REV FISH BIOL FISHER, V25, P39, DOI 10.1007/s11160-014-9369-3; Huvet A, 2004, GENE, V343, P211, DOI 10.1016/j.gene.2004.09.008; Fernandez-Reiriz MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148245; Klaassen CD, 1999, ANNU REV PHARMACOL, V39, P267, DOI 10.1146/annurev.pharmtox.39.1.267; LAGARDERE JP, 1982, MAR BIOL, V71, P177, DOI 10.1007/BF00394627; Lassus P, 2007, AQUAT LIVING RESOUR, V20, P59, DOI 10.1051/alr:2007016; Lillis A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079337; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LLOYD R, 1961, J EXP BIOL, V38, P447; Lloyd R, 1962, I PUBL HLTH ENGRS J, V61, P132; Mai H, 2014, AQUAT TOXICOL, V147, P48, DOI 10.1016/j.aquatox.2013.11.024; Marie V, 2006, ENVIRON TOXICOL CHEM, V25, P412, DOI 10.1897/05-114R.1; Massabuau JC, 2001, RESP PHYSIOL, V128, P249, DOI 10.1016/S0034-5687(01)00305-X; McDonald MA, 2006, J ACOUST SOC AM, V120, P711, DOI 10.1121/1.2216565; MOSHER J I, 1972, Proceedings of the Malacological Society of London, V40, P125; MYRBERG AA, 1986, ANIM BEHAV, V34, P913, DOI 10.1016/S0003-3472(86)80077-X; PALACE VP, 1993, CAN J FISH AQUAT SCI, V50, P156, DOI 10.1139/f93-018; Pan K, 2008, AQUAT TOXICOL, V90, P253, DOI 10.1016/j.aquatox.2008.09.010; Payton L, 2017, MAR BIOTECHNOL, V19, P361, DOI 10.1007/s10126-017-9761-9; Peng C, 2016, SCI REP-UK, V6, DOI 10.1038/srep24266; Peng C, 2015, INT J ENV RES PUB HE, V12, P12304, DOI 10.3390/ijerph121012304; Pierron F, 2007, ENVIRON TOXICOL CHEM, V26, P1010, DOI 10.1897/06-490R.1; Radford AN, 2016, GLOBAL CHANGE BIOL, V22, P3349, DOI 10.1111/gcb.13352; RANDALL D, 1991, PHYSIOL ZOOL, V64, P26; Roberts L, 2015, MAR ECOL PROG SER, V538, P185, DOI 10.3354/meps11468; Rogers P.H., 1988, P131; Rogers PH, 2016, ADV EXP MED BIOL, V875, P933, DOI 10.1007/978-1-4939-2981-8_115; Romeo M, 2000, AQUAT TOXICOL, V48, P185, DOI 10.1016/S0166-445X(99)00039-9; Ross D, 2005, IEEE J OCEANIC ENG, V30, P257, DOI 10.1109/JOE.2005.850879; Ross D., 1993, Acoustics Bulletin, V18, P5; Samson J, 2005, ENVIRON TOXICOL PHAR, V20, P142, DOI 10.1016/j.etap.2004.12.059; Schwartzmann C, 2011, LIMNOL OCEANOGR, V56, P1940, DOI 10.4319/lo.2011.56.5.1940; Shi QL, 2011, J NEUROCHEM, V118, P440, DOI 10.1111/j.1471-4159.2011.07333.x; Solan M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20540; Thevenod F, 2009, TOXICOL APPL PHARM, V238, P221, DOI 10.1016/j.taap.2009.01.013; Tran D, 2002, ENVIRON TOXICOL CHEM, V21, P327, DOI 10.1897/1551-5028(2002)021<0327:RBFIVA>2.0.CO;2; Tran D, 2001, ENVIRON TOXICOL CHEM, V20, P2073, DOI 10.1002/etc.5620200929; Wale MA, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1194	64	8	8	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194174	10.1371/journal.pone.0194174	http://dx.doi.org/10.1371/journal.pone.0194174			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617387	Green Published, gold, Green Submitted			2022-12-26	WOS:000429203800022
J	Horibata, S; Rice, EJ; Zheng, H; Mukai, C; Chu, TY; Marks, BA; Coonrod, SA; Danko, CG				Horibata, Sachi; Rice, Edward J.; Zheng, Hui; Mukai, Chinatsu; Chu, Tinyi; Marks, Brooke A.; Coonrod, Scott A.; Danko, Charles G.			A bi-stable feedback loop between GDNF, EGR1, and ER alpha contribute to endocrine resistant breast cancer	PLOS ONE			English	Article							CELL VARIABILITY; TRANSCRIPTION; RET; INITIATION; REVEALS; KINASE; MECHANISMS; EXPRESSION; ENHANCERS; GROWTH	Discovering regulatory interactions between genes that specify the behavioral properties of cells remains an important challenge. We used the dynamics of transcriptional changes resolved by PRO-seq to identify a regulatory network responsible for endocrine resistance in breast cancer. We show that GDNF leads to endocrine resistance by switching the active state in a bi-stable feedback loop between GDNF, EGR1, and the master transcription factor ER alpha. GDNF stimulates MAP kinase, activating the transcription factors SRF and AP-1. SRF initiates an immediate transcriptional response, activating EGR1 and suppressing ER alpha. Newly translated EGR1 protein activates endogenous GDNF, leading to constitutive GDNF and EGR1 up-regulation, and the sustained down-regulation of ER alpha. Endocrine resistant MCF-7 cells are constitutively in the GDNF-high/ER alpha-low state, suggesting that the state in the bi-stable feedback loop may provide a 'memory' of endocrine resistance. Thus, we identified a regulatory network switch that contributes to drug resistance in breast cancer.	[Horibata, Sachi; Rice, Edward J.; Zheng, Hui; Mukai, Chinatsu; Chu, Tinyi; Marks, Brooke A.; Coonrod, Scott A.; Danko, Charles G.] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Horibata, Sachi] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Chu, Tinyi] Cornell Univ, Grad Field Computat Biol, Ithaca, NY USA; [Coonrod, Scott A.; Danko, Charles G.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Cornell University	Coonrod, SA; Danko, CG (corresponding author), Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA.; Coonrod, SA; Danko, CG (corresponding author), Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA.	sac269@cornell.edu; dankoc@gmail.com	Horibata, Sachi/AAC-3204-2020	Horibata, Sachi/0000-0002-2629-7821	NIH [R01 HG009309-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009309] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This project was supported by the NIH grants R01 HG009309-01 to C.G.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6336; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Andreucci E, 2016, ONCOTARGET, V7, P80543, DOI 10.18632/oncotarget.11826; Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Boulay A, 2008, CANCER RES, V68, P3743, DOI 10.1158/0008-5472.CAN-07-5100; Chu T, 2017, CHROMATIN RUN ON REV; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Core LJ, 2014, NAT GENET; Danko CG, 2015, NAT METHODS, V12, P433, DOI [10.1038/NMETH.3329, 10.1038/nmeth.3329]; Danko CG, 2013, MOL CELL, V50, P212, DOI 10.1016/j.molcel.2013.02.015; Duarte FM, 2016, GENE DEV, V30, P1731, DOI 10.1101/gad.284430.116; Fang FQ, 2016, CELL REP, V14, P1218, DOI 10.1016/j.celrep.2016.01.002; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gattelli A, 2013, EMBO MOL MED, V5, P1335, DOI 10.1002/emmm.201302625; Gonzalez-Malerva L, 2011, P NATL ACAD SCI USA, V108, P2058, DOI 10.1073/pnas.1018157108; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hah N, 2013, GENOME RES; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Horibata S, 2017, ER POSITIVE BREAST C; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; KIM TK, 2010, ALL RIGHTS RESERVED, V465, P182; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma CX, 2009, ONCOLOGY-NY, V23, P133; Magnani L, 2013, P NATL ACAD SCI USA, V110, pE1490, DOI 10.1073/pnas.1219992110; Mahat DB, 2016, MOL CELL, V62, P63, DOI 10.1016/j.molcel.2016.02.025; Mahat DB, 2016, NAT PROTOC, V11, P1455, DOI 10.1038/nprot.2016.086; Miller WR, 2012, PHARMACOGENOMICS J, V12, P10, DOI 10.1038/tpj.2010.67; Morandi A, 2010, RET BREAST CANC FUNC; Morandi A, 2013, CANCER RES, V73, P3783, DOI 10.1158/0008-5472.CAN-12-4265; Nojima T, 2015, CELL, V161, P526, DOI 10.1016/j.cell.2015.03.027; Pisco AO, 2016, CONCEPTUAL CONFUSION; PlanasSilva MD, 1997, MOL CELL BIOL, V17, P4059, DOI 10.1128/MCB.17.7.4059; Plaza-Menacho I, 2010, ONCOGENE, V29, P4648, DOI 10.1038/onc.2010.209; Prall OWJ, 1998, J STEROID BIOCHEM, V65, P169, DOI 10.1016/S0960-0760(98)00021-1; Schwalb B, 2016, SCIENCE, V352, P1225, DOI 10.1126/science.aad9841; Scruggs BS, 2015, MOL CELL, V58, P1101, DOI 10.1016/j.molcel.2015.04.006; Shaffer SM, 2017, NATURE, V546, P431, DOI 10.1038/nature22794; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Thomas C, 2015, TRENDS ENDOCRIN MET, V26, P467, DOI 10.1016/j.tem.2015.06.007; Waddington C. H., 1939, INTRO MODERN GENETIC; WADDINGTON CH, 1968, NATURE, V218, P525, DOI 10.1038/218525a0; Wang Z, 2016, BIOINFORMATICS	46	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194522	10.1371/journal.pone.0194522	http://dx.doi.org/10.1371/journal.pone.0194522			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614078	Green Submitted, gold, Green Published			2022-12-26	WOS:000429081600012
J	Liu, HB; Zhu, BH; Qiu, SF; Xia, YD; Liang, BB; Yang, CJ; Dong, NA; Li, YR; Xiang, Y; Wang, S; Xie, J; Mahe, M; Sun, YS; Song, HB				Liu, Hongbo; Zhu, Binghua; Qiu, Shaofu; Xia, Yidan; Liang, Beibei; Yang, Chaojie; Dong, Nian; Li, Yongrui; Xiang, Ying; Wang, Shan; Xie, Jing; Mahe, Muti; Sun, Yansong; Song, Hongbin			Dominant serotype distribution and antimicrobial resistance profile of Shigella spp. in Xinjiang, China	PLOS ONE			English	Article							EMPIRIC ANTIBIOTIC-THERAPY; INTENSIVE-CARE-UNIT; GENETIC-CHARACTERIZATION; MULTIDRUG-RESISTANCE; 2 INTEGRONS; SONNEI; FLEXNERI; ENTEROBACTERIACEAE; MUTATIONS; PATTERNS	Shigella represents one of the major diarrhea-inducing pathogens threatening public health, but its prevalence and antimicrobial resistance profile in Xinjiang Uygur Autonomous region, China, remains unclear. We conducted comprehensive investigation of Shigella serotype distribution and antimicrobial resistance pattern in Xinjiang, identifying 458 Shigella isolates between 2008 to 2014. Shigella flexneri was identified as predominant species, and several S. flexneri serotypes were isolated, including atypical serotypes 1 c, 2c, and 4s. Dominant S. flexneri serotypes were 2a, 1b, 2b, and Xv, different from those generally dominant in China. A hybrid serotype pattern was observed, which included the major Chinese serotypes (2a, Xv) and those predominant in Pakistan (1 b, 2b). Shigella sonnei was shown to have a lower frequency compared with that generally observed in China, but an increasing trend of infections associated with this pathogen was observed. Furthermore, a high frequency of drug resistance and different Shigella antimicrobial resistance patterns were demonstrated as well, including very severe resistance phenotypes, such as multidrug resistance and resistance to frontline antibiotics. Seventy-five cephalosporin-resistant Shigella isolates were frequently identified with the resistance determinants that can undergo horizontal transfer, such as bla(OXA), bla(TEM), bla(CTX-M), and integrons, facilitating the development of cephalosporin resistance among Shigella subtypes. Additionally, genetic analyses demonstrated that all 86 quinolone-resistant S. flexneri isolates possess 3-4 mutation sites in quinolone resistance-determining regions, primarily contributing to their resistance to quinolone. However, S. sonnei isolates were not shown to be quinolone resistant. Co-resistance to cephalosporins and quinolones was detected in 17 S. flexneri isolates, and these isolates were additionally multi drug resistant and carried beta-lactamase genes and quinolone-resistance determinants. As is demonstrated in this study, dominant serotypes of Shigella were distributed in unique trend with dangerous drug resistance patterns. Novel strategies are urgently required to prevent the development of drug resistance among diarrhea-inducing pathogens.	[Liu, Hongbo; Zhu, Binghua; Liang, Beibei; Dong, Nian; Xiang, Ying; Wang, Shan; Sun, Yansong] Acad Mil Med Sci, Acad Mil Med Sci, Beijing, Peoples R China; [Liu, Hongbo; Zhu, Binghua; Qiu, Shaofu; Liang, Beibei; Yang, Chaojie; Dong, Nian; Li, Yongrui; Xiang, Ying; Wang, Shan; Xie, Jing; Song, Hongbin] PLA, Inst Dis Control & Prevent, Beijing, Peoples R China; [Xia, Yidan; Mahe, Muti] Ctr Dis Control & Prevent Xinjiang Uygur Autonomo, Urumqi, Peoples R China	Academy of Military Medical Sciences - China	Sun, YS (corresponding author), Acad Mil Med Sci, Acad Mil Med Sci, Beijing, Peoples R China.; Song, HB (corresponding author), PLA, Inst Dis Control & Prevent, Beijing, Peoples R China.; Mahe, M (corresponding author), Ctr Dis Control & Prevent Xinjiang Uygur Autonomo, Urumqi, Peoples R China.	mahefyk@163.com; sunys1964@hotmail.com; hongbinsong@263.net	Qiu, Shaofu/CAJ-0602-2022		National Key R&D Program of China [2017YFC1600105]; National Nature Science Foundation of China [81673237, 81473023]	National Key R&D Program of China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key R&D Program of China (no. 2017YFC1600105) and the National Nature Science Foundation of China (nos. 81673237 and 81473023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2006, J MED MICROBIOL, V55, P1685, DOI 10.1099/jmm.0.46725-0; Ahmed SF, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-9; Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Anderson M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00045; AOKI YOSHIO, 1968, ARCH IMMUNOL THER EXP, V16, P303; Bhattacharya D, 2015, EPIDEMIOL INFECT, V143, P470, DOI 10.1017/S0950268814000958; Bodhidatta L, 2012, VACCINE, V30, P7040, DOI 10.1016/j.vaccine.2012.09.061; Chung H., 2016, PLOS MED, V13; Collatz E, 2008, CLIN MICROBIOL INFEC, V14, P1, DOI 10.1111/j.1469-0691.2008.02127.x; Cristea Daniela, 2009, Roum Arch Microbiol Immunol, V68, P44; Cui XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129009; Cui XY, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00435; English BK, 2010, ADV EXP MED BIOL, V659, P73, DOI 10.1007/978-1-4419-0981-7_6; Flores-Carrero A, 2016, J GLOB ANTIMICROB RE, V7, P114, DOI 10.1016/j.jgar.2016.08.006; Folster JP, 2011, ANTIMICROB AGENTS CH, V55, P1758, DOI 10.1128/AAC.01463-10; Galani I, 2010, INT J ANTIMICROB AG, V36, P252, DOI 10.1016/j.ijantimicag.2010.05.004; Gassama-Sow A, 2010, J INFECT DEV COUNTR, V4, P207, DOI 10.3855/jidc.583; Gu B, 2017, J GLOB ANTIMICROB RE, V10, P29, DOI 10.1016/j.jgar.2017.03.009; Guarino A, 2008, J PEDIATR GASTR NUTR, V46, pS81, DOI 10.1097/MPG.0b013e31816f7b16; Hoffmann C, 2013, INFECTION, V41, P999, DOI 10.1007/s15010-013-0501-4; Hu LF, 2007, J MICROBIOL, V45, P168; Institute. CaLS, 2018, M100 CLSI I CALS; Kahsay Atsebaha Gebrekidan, 2016, BMC Res Notes, V9, P422, DOI 10.1186/s13104-016-2236-7; Ke X, 2011, ARCH MICROBIOL, V193, P767, DOI 10.1007/s00203-011-0744-3; Klontz KC, 2015, EXPERT REV ANTI-INFE, V13, P69, DOI 10.1586/14787210.2015.983902; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Kuo HW, 2009, WIEN KLIN WOCHENSCHR, V121, P157, DOI 10.1007/s00508-008-1141-7; Li RC, 2017, J ANTIMICROB CHEMOTH, V72, P696, DOI 10.1093/jac/dkw509; Lindsey RL, 2017, GENOME ANNOUNCEMENTS, V5; Livio S, 2014, CLIN INFECT DIS, V59, P933, DOI 10.1093/cid/ciu468; Madiyarov RS, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-18; Mahemuti Wupuer, 2015, Zhonghua Yu Fang Yi Xue Za Zhi, V49, P447; Matar GM, 2007, ANN TROP MED PARASIT, V101, P511, DOI 10.1179/136485907X193860; Mathers CD, 2009, BRIT MED BULL, V92, P7, DOI 10.1093/bmb/ldp028; MITSUHASHI S, 1961, JPN J EXP MED, V31, P47; Moore John E, 2010, Ulster Med J, V79, P85; Nandy S, 2011, EMERG INFECT DIS, V17, P2072, DOI 10.3201/eid1711.110403; Nguyen TKN, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000702; Oduro-Mensah D, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0144-2; Pan JC, 2006, J ANTIMICROB CHEMOTH, V58, P288, DOI 10.1093/jac/dkl228; Parsot C, 2005, FEMS MICROBIOL LETT, V252, P11, DOI 10.1016/j.femsle.2005.08.046; Pazhani GP, 2005, EPIDEMIOL INFECT, V133, P1089, DOI 10.1017/S0950268805004498; Pouwels KB, 2017, J HOSP INFECT, V96, P23, DOI 10.1016/j.jhin.2017.03.016; Puzari M, 2017, J INFECT PUBLIC HLTH; Qin T, 2016, EUR J CLIN MICROBIOL, V35, P2037, DOI 10.1007/s10096-016-2761-2; Qiu S, 2015, CLIN MICROBIOL INFEC, V21, P252; Qiu SF, 2013, EMERG INFECT DIS, V19, P1147, DOI 10.3201/eid1907.111221; Qiu SF, 2011, J CLIN MICROBIOL, V49, P1148, DOI 10.1128/JCM.01946-10; Qu F, 2012, DIAGN MICR INFEC DIS, V74, P166, DOI 10.1016/j.diagmicrobio.2012.06.026; Smet A, 2009, J ANTIMICROB CHEMOTH, V63, P1286, DOI 10.1093/jac/dkp101; Solgi H, 2018, J ANTIMICROBIAL CHEM; Tariq A, 2012, CAN J MICROBIOL, V58, P1047, DOI [10.1139/w2012-085, 10.1139/W2012-085]; Tatay-Dualde J, 2017, VET MICROBIOL, V207, P63, DOI 10.1016/j.vetmic.2017.06.003; Tong PP, 2015, FOODBORNE PATHOG DIS, V12, P345, DOI 10.1089/fpd.2014.1857; Ud-Din AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082601; Wang J, 2015, DIAGN MICR INFEC DIS, V83, P338, DOI 10.1016/j.diagmicrobio.2015.08.010; Wang X, 2015, BIOESSAYS, V37, P1045, DOI 10.1002/bies.201500071; Wang XY, 2006, B WORLD HEALTH ORGAN, V84, P561, DOI 10.2471/BLT.05.023853; Wang Z, 2017, INFECT CONT HOSP EP, V38, P758, DOI 10.1017/ice.2017.60; Ye CY, 2010, J CLIN MICROBIOL, V48, P419, DOI 10.1128/JCM.00614-09; Zafar A, 2009, INT J INFECT DIS, V13, P668, DOI 10.1016/j.ijid.2008.10.005; Zhang CL, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-260; Zhang J, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P1526, DOI 10.3760/cma.j.issn.0254-6450.2016.11.018; Zhu JY, 2011, CURR MICROBIOL, V62, P802, DOI 10.1007/s00284-010-9790-3	64	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195259	10.1371/journal.pone.0195259	http://dx.doi.org/10.1371/journal.pone.0195259			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614121	gold, Green Published, Green Submitted			2022-12-26	WOS:000429081600039
J	Novakova, L; Axelsson, M; Malmestrom, C; Imberg, H; Elias, O; Zetterberg, H; Nerman, O; Lycke, J				Novakova, Lenka; Axelsson, Markus; Malmestrom, Clas; Imberg, Henrik; Elias, Olle; Zetterberg, Henrik; Nerman, Olle; Lycke, Jan			Searching for neurodegeneration in multiple sclerosis at clinical onset: Diagnostic value of biomarkers	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; BRAIN PARENCHYMAL FRACTION; NERVE-FIBER LAYER; CEREBROSPINAL-FLUID; DISABILITY PROGRESSION; OLIGOCLONAL BANDS; MATTER ATROPHY; NEUROFILAMENT; SEGMENTATION; GUIDELINES	Background Neurodegeneration occurs during the early stages of multiple sclerosis. It is an essential, devastating part of the pathophysiology. Tools for measuring the degree of neurodegeneration could improve diagnostics and patient characterization. Objective This study aimed to determine the diagnostic value of biomarkers of degeneration in patients with recent clinical onset of suspected multiple sclerosis, and to evaluate these biomarkers for characterizing disease course. Methods This cross-sectional study included 271 patients with clinical features of suspected multiple sclerosis onset and was the baseline of a prospective study. After diagnostic investigations, the patients were classified into the following disease groups: patients with clinically isolated syndrome (n = 4) or early relapsing remitting multiple sclerosis (early RRMS; n = 93); patients with relapsing remitting multiple sclerosis with disease durations >= 2 years (established RRMS; n = 39); patients without multiple sclerosis, but showing symptoms (symptomatic controls; n = 89); and patients diagnosed with other diseases (n = 46). In addition, we included healthy controls (n = 51) and patients with progressive multiple sclerosis (n = 23). We analyzed six biomarkers of neurodegeneration: cerebrospinal fluid neurofilament light chain levels; cerebral spinal fluid glial fibrillary acidic protein; cerebral spinal fluid tau; retinal nerve fiber layer thickness; macula volume; and the brain parenchymal fraction. Results Except for increased cerebral spinal fluid neurofilament light chain levels, median 670 ng/L (IQR 400-2110), we could not find signs of early degeneration in the early disease group with recent clinical onset. However, the intrathecal immunoglobin G production and cerebral spinal fluid neurofilament light chain levels showed diagnostic value. Moreover, elevated levels of cerebral spinal fluid glial fibrillary acidic protein, thin retinal nerve fiber layers, and low brain parenchymal fractions were associated with progressive disease, but not with the other phenotypes. Thin retinal nerve fiber layers and low brain parenchymal fractions, which indicated neurodegeneration, were associated with longer disease duration. Conclusions In clinically suspected multiple sclerosis, intrathecal immunoglobin G production and neurofilament light chain levels had diagnostic value. Therefore, these biomarkers could be included in diagnostic work-ups for multiple sclerosis. We found that the thickness of the retinal nerve fiber layer and the brain parenchymal fraction were not different between individuals that were healthy, symptomatic, or newly diagnosed with multiple sclerosis. This finding suggested that neurodegeneration had not reached a significant magnitude in patients with a recent clinical onset of multiple sclerosis.	[Novakova, Lenka; Axelsson, Markus; Malmestrom, Clas; Lycke, Jan] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden; [Imberg, Henrik; Elias, Olle; Nerman, Olle] Chalmers Univ Technol, Math Sci, Gothenburg, Sweden; [Imberg, Henrik; Elias, Olle; Nerman, Olle] Univ Gothenburg, Gothenburg, Sweden; [Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden; [Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Mol Neurosci, Queen Sq, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England	University of Gothenburg; Chalmers University of Technology; University of Gothenburg; University of Gothenburg; Sahlgrenska University Hospital; University of London; University College London; University of London; University College London	Novakova, L (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden.	lenka.novakova@vgregion.se	Malmeström, Clas/A-8749-2012; Novakova, Lenka/ABF-5492-2020; Imberg, Henrik/ABC-5503-2021	Malmeström, Clas/0000-0003-2477-0088; Novakova, Lenka/0000-0001-7899-6395; Imberg, Henrik/0000-0001-9447-663X; Hallqvist Elias, Olof/0000-0002-4998-8561	Swedish Research Council; European Research Council; Swedish State Support for Clinical Research (ALFGBG); Knut and Alice Wallenberg Foundation; Frimurarestiftelsen; NEURO Sweden; Research Foundation of the Multiple Sclerosis Society of Gothenburg; Edith Jacobsons Foundation; Helena Ahlin's Foundation; Novartis; Biogen; TEVA	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Swedish State Support for Clinical Research (ALFGBG); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Frimurarestiftelsen; NEURO Sweden; Research Foundation of the Multiple Sclerosis Society of Gothenburg; Edith Jacobsons Foundation; Helena Ahlin's Foundation; Novartis(Novartis); Biogen(Biogen); TEVA(Teva Pharmaceutical Industries)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was supported by grants from the Swedish and European Research Councils (HZ), Swedish State Support for Clinical Research (ALFGBG; HZ, JL), the Knut and Alice Wallenberg Foundation (HZ), Frimurarestiftelsen (HZ), NEURO Sweden (LN, JL), the Research Foundation of the Multiple Sclerosis Society of Gothenburg (LN, JL), the Edith Jacobsons Foundation (LN, JL), Helena Ahlin's Foundation (LN), Novartis (JL), Biogen and TEVA (unconditional grants) (LN, JL).	[Anonymous], 2017, R LANG ENV STAT COMP; Axelsson M, 2011, J NEUROL, V258, P882, DOI 10.1007/s00415-010-5863-2; Balcer LJ, 2015, BRAIN, V138, P11, DOI 10.1093/brain/awu335; Behbehani R, 2015, J NEUROL SCI, V359, P305, DOI 10.1016/j.jns.2015.11.017; Bergsland N, 2012, AM J NEURORADIOL, V33, P1573, DOI 10.3174/ajnr.A3086; Bermel RA, 2006, LANCET NEUROL, V5, P158, DOI 10.1016/S1474-4422(06)70349-0; Chard DT, 2002, BRAIN, V125, P327, DOI 10.1093/brain/awf025; Charil A, 2007, J NEUROL SCI, V259, P7, DOI 10.1016/j.jns.2006.08.017; Coles AJ, 2017, NEUROLOGY, V89, P1117, DOI 10.1212/WNL.0000000000004354; Dorr J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018132; Giovannoni G, 2015, MULT SCLER RELAT DIS, V4, P329, DOI 10.1016/j.msard.2015.04.006; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; Granberg T, 2016, AM J NEURORADIOL, V37, P1023, DOI 10.3174/ajnr.A4665; Havrdova E, 2017, NEUROLOGY, V89, P1107, DOI 10.1212/WNL.0000000000004313; Henry RG, 2008, J NEUROL NEUROSUR PS, V79, P1236, DOI 10.1136/jnnp.2007.134825; Jacobsen C, 2014, J NEUROL NEUROSUR PS, V85, P1109, DOI 10.1136/jnnp-2013-306906; Kalincik T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050101; Kuhle J, 2017, NEUROLOGY, V88, P826, DOI 10.1212/WNL.0000000000003653; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Link H, 2006, J NEUROIMMUNOL, V180, P17, DOI 10.1016/j.jneuroim.2006.07.006; Lourenco P, 2013, MULT SCLER J, V19, P577, DOI 10.1177/1352458512459684; Martinez MAM, 2015, MULT SCLER J, V21, P550, DOI 10.1177/1352458514549397; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Paolillo A, 2000, J NEUROL SCI, V174, P85, DOI 10.1016/S0022-510X(00)00259-8; Perez-Miralles F, 2013, MULT SCLER J, V19, P1878, DOI 10.1177/1352458513488231; Petzold A, 2017, LANCET NEUROL, V16, P797, DOI 10.1016/S1474-4422(17)30278-8; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Pietroboni AM, 2019, MULT SCLER J, V25, P31, DOI 10.1177/1352458517740214; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Popescu Bogdan F Gh, 2013, Continuum (Minneap Minn), V19, P901, DOI 10.1212/01.CON.0000433291.23091.65; ROSENGREN LE, 1994, J NEUROSCI METH, V51, P197, DOI 10.1016/0165-0270(94)90011-6; Salzer J, 2010, MULT SCLER J, V16, P287, DOI 10.1177/1352458509359725; Teunissen CE, 2009, NEUROLOGY, V73, P1914, DOI 10.1212/WNL.0b013e3181c47cc2; Therneau Terry., 2017, RPART RECURSIVE PART; Thompson AJ, 2018, LANCET NEUROL, V17, P162, DOI 10.1016/S1474-4422(17)30470-2; Vagberg M, 2017, ACTA NEUROL SCAND, V135, P17, DOI 10.1111/ane.12667; Vagberg M, 2013, AM J NEURORADIOL, V34, P498, DOI 10.3174/ajnr.A3262; Vagberg M, 2016, J NEURORADIOLOGY, V43, P384, DOI 10.1016/j.neurad.2016.08.002; Zimmermann H, 2013, MULT SCLER J, V19, P443, DOI 10.1177/1352458512457844; Zivadinov R, 2013, AM J NEURORADIOL, V34, P1931, DOI 10.3174/ajnr.A3503	40	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194828	10.1371/journal.pone.0194828	http://dx.doi.org/10.1371/journal.pone.0194828			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614113	Green Published, gold, Green Submitted			2022-12-26	WOS:000429081600019
J	Kaplan, Z; Fehrer, J; Bambasova, V; Hellquist, CB				Kaplan, Zdenek; Fehrer, Judith; Bambasova, Veronika; Hellquist, C. Barre			The endangered Florida pondweed (Potamogeton floridanus) is a hybrid: Why we need to understand biodiversity thoroughly	PLOS ONE			English	Article							X-P.-NATANS; ISOZYME EVIDENCE; SEQUENCE DATA; PHYLOGENETIC-RELATIONSHIPS; BRITISH POPULATIONS; MOLECULAR ANALYSIS; BARCODING MARKERS; HYBRIDIZATION; TAXONOMY; EUROPE	Thorough understanding of biodiversity is a fundamental prerequisite for biological research. A lack of taxonomic knowledge and species misidentifications are particularly critical for conservation. Here we present an example of Potamogeton floridanus, the Florida Pond weed, an endangered taxon endemic to a small area in the Florida panhandle, whose taxonomic status remained controversial for more than a century, and all previous attempts to elucidate its identity have failed. We applied molecular approaches to tackle the origin of the mysterious taxon and supplemented them with morphological and anatomical investigations of both historical herbarium collections and plants recently collected in the type area for a comprehensive taxonomic reassessment. Sequencing of two nuclear ribosomal markers and one chloroplast non-coding spacer resulted in the surprising discovery that P. floridanus is a hybrid of P. pulcherand P. oakesianus, with the former being the maternal parent. The hybrid colony is currently geographically isolated from the distribution range of P. oakesianus. We show that previous molecular analyses have failed to reveal its hybrid identity due to inadequate nuclear DNA sequence editing. This is an example how the uncritical use of automized sequence reads can hamper molecular species identifications and also affect phylogenetic tree construction and interpretation. This unique hybrid taxon, P. xfloridanus, adds another case study to the debate on hybrid protection; consequences for its conservation are discussed.	[Kaplan, Zdenek; Fehrer, Judith; Bambasova, Veronika] Czech Acad Sci, Inst Bot, Pruhonice, Czech Republic; [Kaplan, Zdenek] Charles Univ Prague, Dept Bot, Fac Sci, Prague, Czech Republic; [Hellquist, C. Barre] Massachusetts Coll Liberal Arts, Dept Biol, North Adams, MA USA	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Charles University Prague; Massachusetts System of Public Higher Education; Massachusetts College Liberal Arts	Kaplan, Z (corresponding author), Czech Acad Sci, Inst Bot, Pruhonice, Czech Republic.; Kaplan, Z (corresponding author), Charles Univ Prague, Dept Bot, Fac Sci, Prague, Czech Republic.	kaplan@ibot.cas.cz	Kaplan, Zdenek/A-3751-2012; Fehrer, Judith/B-9296-2013	Kaplan, Zdenek/0000-0003-1707-7461; Fehrer, Judith/0000-0002-0337-5444	Czech Science Foundation [17-06825S]; Czech Academy of Sciences [RVO 67985939]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Academy of Sciences(Czech Academy of Sciences)	The research was supported by grant no. 17-06825S from the Czech Science Foundation and by the long-term research development project no. RVO 67985939 from The Czech Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso C, 2013, AN JARDIN BOT MADRID, V70, P72, DOI 10.3989/ajbm.2326; Becker M, 2013, NAT CLIM CHANGE, V3, P1039, DOI 10.1038/NCLIMATE2027; Bennett A, 1887, J BOT LONDON, V25, P177; Bennett A., 1903, J LINN SOC BOT, V36, P193; Bennett A., 1907, J BOT LONDON, V45, P373; Bennett A., 1914, PHILIPP J SCI C, V9, P339; Bennett A., 1896, B HERB BOISSIER, V4, P545; Bobrov AA, 2013, PHYTOTAXA, V149, P31, DOI 10.11646/phytotaxa.149.1.5; BORCHSENIUS F, 2009, FASTGAP 1 2; Borsch T, 2015, PERSPECT PLANT ECOL, V17, P284, DOI 10.1016/j.ppees.2015.05.003; Brochet AL, 2010, FRESHWATER BIOL, V55, P1262, DOI 10.1111/j.1365-2427.2009.02350.x; Brochet AL, 2009, ECOGRAPHY, V32, P919, DOI 10.1111/j.1600-0587.2009.05757.x; Chrtek J, 2009, ANN BOT-LONDON, V104, P161, DOI 10.1093/aob/mcp107; Clausen P, 2002, ACTA OECOL, V23, P191, DOI 10.1016/S1146-609X(02)01150-5; DANDY JE, 1975, HYBRIDIZATION FLORA, P444; DANDY JE, 1980, FLORA EUROPAEA, V5, P7; Du ZY, 2011, J SYST EVOL, V49, P246, DOI 10.1111/j.1759-6831.2011.00131.x; Du ZY, 2010, PLANT SYST EVOL, V287, P57, DOI 10.1007/s00606-010-0289-y; Ennos RA, 2005, TRENDS ECOL EVOL, V20, P164, DOI 10.1016/j.tree.2005.01.012; Fant JB, 2004, BOT J LINN SOC, V144, P99, DOI 10.1111/j.0024-4074.2004.00236.x; Fehrer J, 2008, CLADISTICS, V24, P443, DOI 10.1111/j.1096-0031.2008.00216.x; Fehrer J, 2007, MOL PHYLOGENET EVOL, V42, P347, DOI 10.1016/j.ympev.2006.07.004; Fehrer J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-239; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Figuerola J, 2002, ARCH HYDROBIOL, V155, P557; Figuerola J, 2002, J ECOL, V90, P989, DOI 10.1046/j.1365-2745.2002.00734.x; FISCHER G, 1907, BER BAYER BOT GES, V11, P20; Fish US and Service Wildlife, 2013, FED THREAT END OTH S; Florida Natural Areas Inventory, 2014, FNAI EL TRACK SUMM; Gonzalez MEG, 2011, ACTA BOT GALLICA, V158, P577, DOI 10.1080/12538078.2011.10516296; Graebner P., 1907, PFLANZENREICH REGNI, P39; Green AJ, 2002, ACTA OECOL, V23, P177, DOI 10.1016/S1146-609X(02)01149-9; Guo Y.H., 2010, FLORA CHINA, P108; Hagstrom JO, 1906, KUNGL SVENSKA VETENS, V55, P1; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Haynes R.R., 2000, FLORA N AM N MEXICO, V22, P47; Haynes R.R, 2003, FLORA NEOTROPICA MON, V85, P1; Hettiarachchi P., 1991, OPERA BOT BELG, V4, P87; HOLLINGSWORTH PM, 1995, PLANT SYST EVOL, V197, P71, DOI 10.1007/BF00984633; Hollingsworth PM, 1996, PLANT SYST EVOL, V202, P219, DOI 10.1007/BF00983384; Hollingsworth PM, 1998, AQUAT BOT, V60, P433, DOI 10.1016/S0304-3770(97)00063-6; HOLLINGSWORTH PM, 1995, BOT J LINN SOC, V117, P59, DOI 10.1006/bojl.1995.0006; Iida S, 2004, AQUAT BOT, V80, P115, DOI 10.1016/j.aquabot.2004.08.005; Ito Yu, 2016, Bulletin of the National Museum of Nature and Science Series B-Botany, V42, P131; Kaplan Z, 2007, PLANT BIOSYST, V141, P344, DOI 10.1080/11263500701626408; Kaplan Z, 2005, PRESLIA, V77, P419; Kaplan Z, 2005, TAXON, V54, P822, DOI 10.2307/25065445; Kaplan Z, 2005, BOT J LINN SOC, V148, P329, DOI 10.1111/j.1095-8339.2005.00410.x; Kaplan Z, 2004, TAXON, V53, P1033, DOI 10.2307/4135570; Kaplan Z, 2004, FOLIA GEOBOT, V39, P431, DOI 10.1007/BF02803212; Kaplan Z, 2004, PRESLIA, V76, P141; Kaplan Z, 2003, PLANT SYST EVOL, V239, P95, DOI 10.1007/s00606-002-0252-7; Kaplan Z, 2002, FOLIA GEOBOT, V37, P141, DOI 10.1007/BF02804229; Kaplan Z., 1995, SIBERIANT NAT, V1, P73; Kaplan Z, 2007, ANN BOT-LONDON, V99, P1213, DOI 10.1093/aob/mcm072; Kaplan Zdenek, 2002, Preslia (Prague), V74, P187; Kaplan Z, 2006, PRESLIA, V78, P303; Kaplan Z, 2014, AQUAT BOT, V119, P91, DOI 10.1016/j.aquabot.2014.08.005; Kaplan Z, 2013, PRESLIA, V85, P421; Kaplan Z, 2013, BRITTONIA, V65, P452, DOI 10.1007/s12228-012-9299-0; Kaplan Z, 2013, AQUAT BOT, V105, P34, DOI 10.1016/j.aquabot.2012.11.002; Kaplan Z, 2012, BOT J LINN SOC, V170, P112, DOI 10.1111/j.1095-8339.2012.01270.x; Kaplan Z, 2011, NORD J BOT, V29, P477, DOI 10.1111/j.1756-1051.2011.01240.x; Kaplan Z, 2011, TAXON, V60, P758, DOI 10.1002/tax.603011; Kaplan Z, 2011, TELOPEA, V13, P245; Kaplan Z, 2010, ANN BOT FENN, V47, P373, DOI 10.5735/085.047.0508; Kaplan Z, 2010, PRESLIA, V82, P261; Kaplan Z, 2009, PRESLIA, V81, P387; Kaplan Z, 2009, SYST BOT, V34, P625, DOI 10.1600/036364409790139745; Kaplan Zdenek, 2001, Preslia (Prague), V73, P333; Kashina LI, 2000, FLORA SIBERIA, V1, P85; Kirschner J, 2002, TAXON, V51, P155, DOI 10.2307/1554973; Kolar F, 2015, PRESLIA, V87, P363; Les DH, 2009, SYST BOT, V34, P643, DOI 10.1600/036364409790139727; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Lindqvist C, 2006, CLADISTICS, V22, P568, DOI 10.1111/j.1096-0031.2006.00124.x; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; Morong T., 1886, B TORREY BOT CLUB, V13, P145; Oakley CG, 2015, INT J PLANT SCI, V176, P11, DOI 10.1086/677946; OBRIEN SJ, 1991, SCIENCE, V251, P1187, DOI 10.1126/science.251.4998.1187; Ogden E., 1943, RHODORA, V45, P171; Ogden E.C., 1943, RHODORA, V45, P119; OGDEN EC, 1943, RHODORA, V45, P57; Papassotiriou S.E., 2011, FLORA OF AUSTR, V39, P84; Piett S, 2015, BIODIVERS CONSERV, V24, P1931, DOI 10.1007/s10531-015-0919-3; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Preston C. D., 1998, Watsonia, V22, P61; Preston C. D., 2015, HYBRID FLORA BRIT IS, P319; Preston CD., 1995, PONDWEEDS GREAT BRIT; Raduski AR, 2010, INT J MOL SCI, V11, P492, DOI 10.3390/ijms11020492; RAUNKIAER C, 1903, BOT TIDSSKR, V25, P253; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santamaria L, 2002, ARCH HYDROBIOL, V156, P11, DOI 10.1127/0003-9136/2002/0156-0011; Sedlacek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047415; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Small J. K., 1903, FLORA SE US; Smith GF, 2008, S AFR J SCI, V104, P254; Soltis DE, 2008, SYST BOT, V33, P7, DOI 10.1600/036364408783887401; Storchova H, 2000, TAXON, V49, P79, DOI 10.2307/1223934; Swofford DL, 2002, PAUP PHYLOGENETIC AN; SYMOENS JJ, 1979, B SOC ROY BOT BELG, V112, P79; Taylor N, 1909, N AM FLORA, V17, P13; USDI-FWS, 1993, FED REGISTER, V58, P51144; von Staden L, 2013, S AFR J SCI, V109, P48, DOI 10.1590/sajs.2013/1182; vonHoldt BM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501714; Walter KS, 1998, 1997 IUCN RED LIST T; Wang B, 2016, ORYX, V50, P446, DOI 10.1017/S0030605315000435; Wang QD, 2007, PLANT SYST EVOL, V267, P65, DOI 10.1007/s00606-006-0499-5; Wiegleb G, 1998, FOLIA GEOBOT, V33, P241, DOI 10.1007/BF03216205; WIEGLEB G, 1990, PLANT SYST EVOL, V169, P245, DOI 10.1007/BF00937678; WIEGLEB G, 1990, FLORA, V184, P197; WIEGLEB G, 1990, PLANT SYST EVOL, V170, P53, DOI 10.1007/BF00937849; Wiegleb G, 2002, FLORA MALESIANA 1, V16, P174; Wiegleb G., 1988, REPERTORIUM SPECIERU, V99, P249; WILHELM G S, 1986, SIDA Contributions to Botany, V11, P340; Yang T, 2017, AQUAT BOT, V137, P56, DOI 10.1016/j.aquabot.2016.11.009; Zalewska-Galosz J, 2011, PRESLIA, V83, P259; Zalewska-Galosz J, 2010, TAXON, V59, P559, DOI 10.1002/tax.592020; Zalewska-Galosz J, 2009, PRESLIA, V81, P281; Zaya DN, 2017, CONSERV GENET, V18, P171, DOI 10.1007/s10592-016-0891-9; Zhang T, 2008, AQUAT BOT, V89, P34, DOI 10.1016/j.aquabot.2008.02.002	122	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195241	10.1371/journal.pone.0195241	http://dx.doi.org/10.1371/journal.pone.0195241			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608584	Green Submitted, Green Published, gold			2022-12-26	WOS:000428988800041
J	Hur, J; Mateo, V; Amalric, N; Babiak, M; Bereziat, G; Kanony-Truc, C; Clerc, T; Blaise, R; Limon, I				Hur, Justine; Mateo, Veronique; Amalric, Nicolas; Babiak, Megane; Bereziat, Gilbert; Kanony-Truc, Claire; Clerc, Thierry; Blaise, Regis; Limon, Isabelle			Cerebrovascular beta-amyloid deposition and associated microhemorrhages in a Tg2576 Alzheimer mouse model are reduced with a DHA-enriched diet	FASEB JOURNAL			English	Article						docosahexaenoic acid; cerebral amyloid angiopathy; vascular smooth muscle cells; 12-HETE	POLYUNSATURATED FATTY-ACID; PROTECTS CORTICAL-NEURONS; BLOOD MONONUCLEAR-CELLS; DOCOSAHEXAENOIC ACID; SPONTANEOUS HEMORRHAGE; POSSIBLE INVOLVEMENT; ANGIOPATHY; DISEASE; CHOLESTEROL; BRAIN	Cerebral amyloid angiopathy (CAA) is a major contributor to Alzheimer's disease (AD) pathogenesis. Like AD, CAA is often accompanied by marked inflammation, aggravating associated vasculopathies. No evidence-based prevention or treatment strategies are available. Here, we evaluate the possible beneficial effect of a diet enriched with docosahexaenoic acid (DHA), which is known to attenuate inflammation in CAA. Tg2576 mice, a transgenic model of AD/CAA, were fed a DHA-enriched diet starting at 2 mo of age and ending at 10, 14, or 18 mo of age. -Amyloid (A)-peptide deposition and bleeding were visualized by immunohistochemistry or histochemistry on coronal sections of the brain. DHA, arachidonic acid, and eicosanoid levels were measured by liquid chromatography/mass spectrometry or GC-MS. DHA-enriched diet throughout aging limits the accumulation of vascular A peptide deposits as well as the likelihood of microhemorrhages. There is a strong correlation between systemic 12-hydroxyeicosatetraenoic acid (HETE) levels and the size of the area affected by both vascular amyloid deposits and hemorrhages. The lowest levels of 12-HETE, a lipid-derived proinflammatory product of 12-lipoxygenase (LOX), were found in DHA-fed mice. In vitro experiments performed on amyloid vascular smooth muscle cells showed that a 12-LOX inhibitor almost completely blocked the A(1-40) peptide-induced apoptosis of these cells. This study yet again highlights the important role of inflammation in CAA pathogenesis and identifies potential new targets for preventive care.Hur, J., Mateo, V., Amalric, N., Babiak, M., Bereziat, G., Kanony-Truc, C., Clerc, T., Blaise, R., Limon, I. Cerebrovascular -amyloid deposition and associated microhemorrhages in a Tg2576 Alzheimer mouse model are reduced with a DHA-enriched diet.	[Hur, Justine; Babiak, Megane; Bereziat, Gilbert; Blaise, Regis; Limon, Isabelle] Sorbonne Univ, IBPS, CNRS, Unite Mixte Rech UMR Biol Adaptat & Aging 8256, Paris, France; [Mateo, Veronique] Sorbonne Univ, Ctr Immunol & Infect Dis Immune Intervent & Bioth, INSERM, UMR Sci CR7,Unite 1135, Paris, France; [Amalric, Nicolas] Synelvia, Labege, France; [Kanony-Truc, Claire; Clerc, Thierry] Pierre Fabre Res Inst, Pierre Fabre Ctr Res & Dev, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Limon, I (corresponding author), Sorbonne Univ, IBPS, CNRS, Unite Mixte Rech UMR Biol Adaptat & Aging 8256, Paris, France.	isabelle.limon@upmc.fr	Mateo, Véronique/AAD-1379-2019; Mateo, Véronique/O-9738-2017	Mateo, Véronique/0000-0002-9327-1277; Mateo, Véronique/0000-0002-9327-1277; Blaise, Regis/0000-0001-7759-3244	Pierre Fabre Research Institute (a subsidiary of the pharmaceutical company, Pierre Fabre)	Pierre Fabre Research Institute (a subsidiary of the pharmaceutical company, Pierre Fabre)	The authors thank Stephane Fouquet and David Godefroy (Imaging Core Facility, Institut de la Vision, Paris, France) for slide scanning. The authors also thank Jean-Francois Gilles (Imaging Facility, Biological Institute of Paris-Seine) for helping to construct the macro for plaque quantification. This work was supported by the Pierre Fabre Research Institute (a subsidiary of the pharmaceutical company, Pierre Fabre). The authors declare no conflicts of interest.	Aisen PS, 2002, NEUROLOGY, V58, P1050, DOI 10.1212/WNL.58.7.1050; Andrieu S, 2017, LANCET NEUROL, V16, P377, DOI 10.1016/S1474-4422(17)30040-6; Blaise R, 2012, AGING CELL, V11, P384, DOI 10.1111/j.1474-9726.2012.00797.x; Cole GM, 2009, PROSTAG LEUKOTR ESS, V81, P213, DOI 10.1016/j.plefa.2009.05.015; de la Torre JC, 2010, AGEING RES REV, V9, P218, DOI 10.1016/j.arr.2010.04.002; Farooqui AA, 2007, J NEUROCHEM, V101, P577, DOI 10.1111/j.1471-4159.2006.04371.x; Fryer JD, 2003, J NEUROSCI, V23, P7889; Ghiso Jorge, 2010, Hirosaki Igaku, V61, pS111; Greenberg SM, 2002, NEUROLOGY, V58, P1587, DOI 10.1212/WNL.58.11.1587; Gupta S, 2016, J PHYS CHEM B, V120, P8346, DOI 10.1021/acs.jpcb.6b02036; Hashimoto M, 2008, J NEUROCHEM, V107, P1634, DOI 10.1111/j.1471-4159.2008.05731.x; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Hooijmans CR, 2007, NEUROBIOL DIS, V28, P16, DOI 10.1016/j.nbd.2007.06.007; Hooijmans CR, 2009, NEUROBIOL DIS, V33, P482, DOI 10.1016/j.nbd.2008.12.002; Jellinger KA, 2010, NEURODEGENER DIS, V7, P112, DOI 10.1159/000285518; Jicha GA, 2010, CLIN INTERV AGING, V5, P45; Kalaria RN, 2010, NUTR REV, V68, pS74, DOI 10.1111/j.1753-4887.2010.00352.x; Kim TK, 2012, EXP MOL MED, V44, P492, DOI 10.3858/emm.2012.44.8.056; Kloppenborg RP, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-18; Kondreddy VKR, 2016, IMMUNOPHARM IMMUNOT, V38, P153, DOI 10.3109/08923973.2016.1147578; Lebeau A, 2004, CELL DEATH DIFFER, V11, P875, DOI 10.1038/sj.cdd.4401395; Lebeau A, 2001, NEUROREPORT, V12, P2199, DOI 10.1097/00001756-200107200-00031; Marottoli FM, 2017, ASN NEURO, V9, DOI 10.1177/1759091417719201; Mateo V, 2007, BLOOD, V110, P4285, DOI 10.1182/blood-2007-05-088286; Miguel-Alvarez M, 2015, DRUG AGING, V32, P139, DOI 10.1007/s40266-015-0239-z; Nagasawa K, 2007, NEUROSCI LETT, V429, P120, DOI 10.1016/j.neulet.2007.09.073; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Norris PC, 2012, P NATL ACAD SCI USA, V109, P8517, DOI 10.1073/pnas.1200189109; Oksman M, 2006, NEUROBIOL DIS, V23, P563, DOI 10.1016/j.nbd.2006.04.013; Pratico D, 2004, AM J PATHOL, V164, P1655, DOI 10.1016/S0002-9440(10)63724-8; Reynolds MR, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0073-8; Robbins EM, 2006, J NEUROSCI, V26, P365, DOI 10.1523/JNEUROSCI.3854-05.2006; Serini S, 2012, CURR ALZHEIMER RES, V9, P913, DOI 10.2174/156720512803251147; Shaikh SR, 2013, PROSTAG LEUKOTR ESS, V88, P21, DOI 10.1016/j.plefa.2012.03.004; Shin HK, 2007, BRAIN, V130, P2310, DOI 10.1093/brain/awm156; Simonyi A, 2010, MOL NEUROBIOL, V41, P73, DOI 10.1007/s12035-010-8107-7; Somjen D, 2016, J STEROID BIOCHEM, V163, P28, DOI 10.1016/j.jsbmb.2016.03.032; Sutcliffe JG, 2011, J NEUROSCI RES, V89, P808, DOI 10.1002/jnr.22603; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Vromman A, 2013, AGING CELL, V12, P358, DOI 10.1111/acel.12056; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Wang XZ, 2015, J LIPID RES, V56, P674, DOI 10.1194/jlr.P055418; Wilcock DM, 2006, NAT PROTOC, V1, P1591, DOI 10.1038/nprot.2006.277; Winkler DT, 2001, J NEUROSCI, V21, P1619, DOI 10.1523/JNEUROSCI.21-05-01619.2001; Wojtas AM, 2017, P NATL ACAD SCI USA, V114, pE6962, DOI 10.1073/pnas.1701137114; Yamada M, 2015, J STROKE, V17, P17, DOI 10.5853/jos.2015.17.1.17; Yan P, 2015, STROKE, V46, P1633, DOI 10.1161/STROKEAHA.115.008582; Yaqoob P, 2003, EUR J MED RES, V8, P337; Yassine HN, 2016, JAMA NEUROL, V73, P1208, DOI 10.1001/jamaneurol.2016.1924	49	14	14	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4972	4983		10.1096/fj.201800200R	http://dx.doi.org/10.1096/fj.201800200R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29620941	Bronze			2022-12-26	WOS:000443817700029
J	Castejon-Grinan, M; Herraiz, C; Olivares, C; Jimenez-Cervantes, C; Garcia-Borron, JC				Castejon-Grinan, Maria; Herraiz, Cecilia; Olivares, Conchi; Jimenez-Cervantes, Celia; Carlos Garcia-Borron, Jose			cAMP-independent non-pigmentary actions of variant melanocortin 1 receptor: AKT-mediated activation of protective responses to oxidative DNA damage	ONCOGENE			English	Article							DOUBLE-STRAND BREAK; NUCLEOTIDE EXCISION-REPAIR; RED HAIR; HUMAN MELANOCYTES; ULTRAVIOLET-RADIATION; FUNCTIONAL-ANALYSIS; CUTANEOUS MELANOMA; FUNCTION MUTATIONS; SIGNALING PATHWAY; CANCER-THERAPY	The melanocortin 1 receptor gene (MC1R), a well-established melanoma susceptibility gene, regulates the amount and type of melanin pigments formed within epidermal melanocytes. MC1R variants associated with increased melanoma risk promote the production of photosensitizing pheomelanins as opposed to photoprotective eumelanins. Wild-type (WT) MC1R activates DNA repair and antioxidant defenses in a cAMP-dependent fashion. Since melanoma-associated MC1R variants are hypomorphic in cAMP signaling, these non-pigmentary actions are thought to be defective in MC1R-variant human melanoma cells and epidermal melanocytes, consistent with a higher mutation load in MC1R-variant melanomas. We compared induction of antioxidant enzymes and DNA damage responses in melanocytic cells of defined MC1R genotype. Increased expression of catalase (CAT) and superoxide dismutase (SOD) genes following MC1R activation was cAMP-dependent and required a WT MC1R genotype. Conversely, pretreatment of melanocytic cells with an MC1R agonist before an oxidative challenge with Luperox decreased (i) accumulation of 8-oxo-7,8-dihydro-2'-deoxyguanine, a major product of oxidative DNA damage, (ii) phosphorylation of histone H2AX, a marker of DNA double-strand breaks, and (iii) formation of DNA breaks. These responses were comparable in cells WT for MC1R or harboring hypomorphic MC1R variants without detectable cAMP signaling. In MC1R-variant melanocytic cells, the DNA-protective responses were mediated by AKT. Conversely, in MC1R-WT melanocytic cells, high cAMP production downstream of MC1R blocked AKT activation and was responsible for inducing DNA repair. Accordingly, MC1R activation could promote repair of oxidative DNA damage by a cAMP-dependent pathway downstream of WT receptor, or via AKT in cells of variant MC1R genotype.	[Castejon-Grinan, Maria; Herraiz, Cecilia; Olivares, Conchi; Jimenez-Cervantes, Celia; Carlos Garcia-Borron, Jose] Univ Murcia, Dept Biochem Mol Biol & Immunol, Sch Med, Murcia, Spain; [Castejon-Grinan, Maria; Herraiz, Cecilia; Olivares, Conchi; Jimenez-Cervantes, Celia; Carlos Garcia-Borron, Jose] IMIB, Murcia, Spain	University of Murcia	Herraiz, C (corresponding author), Univ Murcia, Dept Biochem Mol Biol & Immunol, Sch Med, Murcia, Spain.; Herraiz, C (corresponding author), IMIB, Murcia, Spain.	ceciliahs@um.es	Garcia-Borron, Jose Carlos/H-2247-2015; Castejón Griñán, María/AAC-8557-2022; Serrano, Cecilia Herraiz/H-2550-2015; Jimenez-Cervantes, Celia/H-1953-2015; Olivares, Conchi/H-2794-2015	Garcia-Borron, Jose Carlos/0000-0002-9192-588X; Castejón Griñán, María/0000-0003-4494-3986; Serrano, Cecilia Herraiz/0000-0001-6912-0738; Jimenez-Cervantes, Celia/0000-0002-5821-9510; Olivares, Conchi/0000-0001-7518-3858	MINECO (Spain) [SAF2015-67092-R]; FEDER (European Community); Fundacion Seneca, Comunidad Autonoma de la Region de Murcia (CARM) [19875/GERM/15]; Fundacion Seneca	MINECO (Spain); FEDER (European Community)(European Commission); Fundacion Seneca, Comunidad Autonoma de la Region de Murcia (CARM); Fundacion Seneca(Fundacion Seneca)	Supported by grants SAF2015-67092-R from MINECO (Spain) and FEDER (European Community) and 19875/GERM/15 from Fundacion Seneca, Comunidad Autonoma de la Region de Murcia (CARM). M Castejon holds a pre-doctoral fellowship from the Fundacion Seneca. Cecilia Herraiz was a Juan de la Cierva-Incorporacion fellow of MINECO. We thank Prof. G Ghanem, from the Free University of Brussels for gift of human melanoma cell lines and Prof. Neptuno Rodriguez (University of Murcia) for Hermes melanocytes. We also thank Prof. JL Castejon for help with the statistical analysis of data, Dr. M Abrisqueta for assistance in cell cycle analysis and Dr. A Lopez-Contreras for suggestions and critical reading of the manuscript.	Abdel-Malek ZA, 2014, ARCH BIOCHEM BIOPHYS, V563, P4, DOI 10.1016/j.abb.2014.07.002; ABDELMALEK Z, 1995, P NATL ACAD SCI USA, V92, P1789, DOI 10.1073/pnas.92.5.1789; Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Altieri F, 2008, ANTIOXID REDOX SIGN, V10, P891, DOI 10.1089/ars.2007.1830; Bastiaens MT, 2001, AM J HUM GENET, V68, P884, DOI 10.1086/319500; Beaumont KA, 2007, HUM MOL GENET, V16, P2249, DOI 10.1093/hmg/ddm177; Bohm M, 2005, J BIOL CHEM, V280, P5795, DOI 10.1074/jbc.M406334200; Box NF, 1997, HUM MOL GENET, V6, P1891, DOI 10.1093/hmg/6.11.1891; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Cadet J, 2015, PHOTOCHEM PHOTOBIOL, V91, P140, DOI 10.1111/php.12368; Cao JX, 2013, MOL CELL, V51, P409, DOI 10.1016/j.molcel.2013.08.010; Garcia-Borron JC, 2014, EXP DERMATOL, V23, P387, DOI 10.1111/exd.12310; CHEDEKEL MR, 1978, P NATL ACAD SCI USA, V75, P5395, DOI 10.1073/pnas.75.11.5395; Cho EA, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-36; Cohen-Armon M, 2007, TRENDS PHARMACOL SCI, V28, P556, DOI 10.1016/j.tips.2007.08.005; d'Ischia M, 2015, PIGM CELL MELANOMA R, V28, P520, DOI 10.1111/pcmr.12393; Robles-Espinoza CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12064; Davies JR, 2012, PIGM CELL MELANOMA R, V25, P384, DOI 10.1111/j.1755-148X.2012.00982.x; Dessinioti C, 2011, PHOTOCHEM PHOTOBIOL, V87, P978, DOI 10.1111/j.1751-1097.2011.00970.x; Fajuyigbe D, 2016, PIGM CELL MELANOMA R, V29, P607, DOI 10.1111/pcmr.12511; FELIX CC, 1978, BIOCHEM BIOPH RES CO, V84, P335, DOI 10.1016/0006-291X(78)90175-4; Frandberg PA, 1998, BIOCHEM BIOPH RES CO, V245, P490, DOI 10.1006/bbrc.1998.8459; Garcia-Borron JC, 2014, PIGM CELL MELANOMA R, V27, P699, DOI 10.1111/pcmr.12257; Gerstenblith MR, 2007, HUM MUTAT, V28, P495, DOI 10.1002/humu.20476; Gharbi SI, 2007, BIOCHEM J, V404, P15, DOI 10.1042/BJ20061489; Habib SL, 2016, CELL CYCLE, V15, P3048, DOI 10.1080/15384101.2016.1231259; Hawkins AJ, 2011, RADIOTHER ONCOL, V101, P13, DOI 10.1016/j.radonc.2011.05.074; Hein AL, 2014, INT J ONCOL, V45, P1813, DOI 10.3892/ijo.2014.2614; Herraiz C, 2017, BBA-MOL BASIS DIS, V1863, P2448, DOI 10.1016/j.bbadis.2017.02.027; Herraiz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144757; Herraiz C, 2012, INT J BIOCHEM CELL B, V44, P2244, DOI 10.1016/j.biocel.2012.09.008; Herraiz C, 2011, MOL ENDOCRINOL, V25, P138, DOI 10.1210/me.2010-0217; Herraiz C, 2009, FEBS LETT, V583, P3269, DOI 10.1016/j.febslet.2009.09.023; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Horrell EMW, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00095; Hustedt N, 2017, NAT CELL BIOL, V19, P1, DOI 10.1038/ncb3452; Ito S, 2003, PIGM CELL RES, V16, P523, DOI 10.1034/j.1600-0749.2003.00072.x; Janjetovic Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01305-2; Jarrett SG, 2016, NUCLEIC ACIDS RES, V44, P10711, DOI 10.1093/nar/gkw871; Jarrett SG, 2017, PIGM CELL MELANOMA R, V30, P284, DOI 10.1111/pcmr.12582; Jo H, 2012, P NATL ACAD SCI USA, V109, P10581, DOI 10.1073/pnas.1202810109; Johansson PA, 2017, PIGM CELL MELANOMA R, V30, P255, DOI 10.1111/pcmr.12571; Kadekaro AL, 2005, CANCER RES, V65, P4292, DOI 10.1158/0008-5472.CAN-04-4535; Kadekaro AL, 2012, MOL CANCER RES, V10, P778, DOI 10.1158/1541-7786.MCR-11-0436; Kadekaro AL, 2010, FASEB J, V24, P3850, DOI 10.1096/fj.10-158485; Khaled M, 2002, J BIOL CHEM, V277, P33690, DOI 10.1074/jbc.M202939200; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Liu Q, 2014, NEURO-ONCOLOGY, V16, P1313, DOI 10.1093/neuonc/nou058; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Luo Z, 2009, BRIT J PHARMACOL, V157, P935, DOI 10.1111/j.1476-5381.2009.00259.x; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Maresca V, 2010, PIGM CELL MELANOMA R, V23, P263, DOI 10.1111/j.1755-148X.2010.00673.x; MEDRANO EE, 1995, CANCER RES, V55, P4047; Merlino G, 2016, PIGM CELL MELANOMA R, V29, P404, DOI 10.1111/pcmr.12475; Mitra D, 2012, NATURE, V491, P449, DOI 10.1038/nature11624; Monaghan RM, 2015, NAT CELL BIOL, V17, P782, DOI 10.1038/ncb3170; Musante V, 2017, ELIFE, V6, DOI 10.7554/eLife.24998; Nakayama K, 2006, HUM GENET, V119, P322, DOI 10.1007/s00439-006-0141-1; Napolitano A, 2014, PIGM CELL MELANOMA R, V27, P721, DOI 10.1111/pcmr.12262; Newton RA, 2005, PEPTIDES, V26, P1818, DOI 10.1016/j.peptides.2004.11.031; O'Hayre M, 2014, CURR OPIN CELL BIOL, V27, P126, DOI 10.1016/j.ceb.2014.01.005; Pan YD, 2018, EXP NEUROL, V300, P149, DOI 10.1016/j.expneurol.2017.10.030; Panzella L, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12199; Oliva ABP, 2009, HUM MUTAT, V30, P811, DOI 10.1002/humu.20971; Piao MJ, 2011, TOXICOL LETT, V207, P143, DOI 10.1016/j.toxlet.2011.09.002; Podhorecka M., 2010, J NUCL ACIDS, V2010, P1, DOI DOI 10.4061/2010/920161; Ringholm A, 2004, J INVEST DERMATOL, V123, P917, DOI 10.1111/j.0022-202X.2004.23444.x; Roberts DW, 2008, J CELL PHYSIOL, V215, P344, DOI 10.1002/jcp.21318; Rodriguez-Escudero I, 2011, HUM MOL GENET, V20, P4132, DOI 10.1093/hmg/ddr337; Sanchez-Laorden BL, 2006, J INVEST DERMATOL, V126, P172, DOI 10.1038/sj.jid.5700036; Scherer D, 2010, MUTAT RES-REV MUTAT, V705, P141, DOI 10.1016/j.mrrev.2010.06.002; Schioth HB, 1999, BIOCHEM BIOPH RES CO, V260, P488, DOI 10.1006/bbrc.1999.0935; Scott MC, 2002, J CELL SCI, V115, P2349; Shahzad M, 2015, PIGM CELL MELANOMA R, V28, P730, DOI 10.1111/pcmr.12400; Simon JD, 2010, ACCOUNTS CHEM RES, V43, P1452, DOI 10.1021/ar100079y; Singh P, 2016, FEBS LETT, V590, P3071, DOI 10.1002/1873-3468.12377; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Smith R, 1998, J INVEST DERMATOL, V111, P119, DOI 10.1046/j.1523-1747.1998.00252.x; Song XZ, 2009, PIGM CELL MELANOMA R, V22, P809, DOI 10.1111/j.1755-148X.2009.00615.x; Toulany M, 2008, MOL CANCER THER, V7, P1772, DOI 10.1158/1535-7163.MCT-07-2200; Toulany M, 2015, SEMIN CANCER BIOL, V35, P180, DOI 10.1016/j.semcancer.2015.07.003; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Wei F, 2011, CURR MED CHEM, V18, P5476, DOI 10.2174/092986711798194388; Xu NH, 2012, J ONCOL, V2012, DOI 10.1155/2012/951724; Yang JL, 2016, THERANOSTICS, V6, P2015, DOI 10.7150/thno.15993; Zanna PT, 2008, BIOCHEM BIOPH RES CO, V368, P211, DOI 10.1016/j.bbrc.2008.01.060; Zhang TW, 2016, PIGM CELL MELANOMA R, V29, P266, DOI 10.1111/pcmr.12459	87	19	19	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 5	2018	37	27					3631	3646		10.1038/s41388-018-0216-1	http://dx.doi.org/10.1038/s41388-018-0216-1			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GM3CM	29622793				2022-12-26	WOS:000437975200002
J	Willis, WL; Wang, LA; Wada, TT; Gardner, M; Abdouni, O; Hampton, J; Valiente, G; Young, N; Ardoin, S; Agarwal, S; Freitas, MA; Wu, LC; Jarjour, WN				Willis, William L.; Wang, Linan; Wada, Takuma Tsuzuki; Gardner, Mark; Abdouni, Omar; Hampton, Jeffrey; Valiente, Giancarlo; Young, Nicholas; Ardoin, Stacy; Agarwal, Sudha; Freitas, Michael A.; Wu, Lai-Chu; Jarjour, Wael N.			The proinflammatory protein HMGB1 is a substrate of transglutaminase-2 and forms high-molecular weight complexes with autoantigens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein cross-linking; transglutaminase; lipopolysaccharide (LPS); calcium; autoimmune disease; autoimmunity; high-mobility group box 1; systemic lupus erythematosus	SYSTEMIC-LUPUS-ERYTHEMATOSUS; TANDEM MASS-SPECTROMETRY; FACTOR-KAPPA-B; TISSUE TRANSGLUTAMINASE; IMMUNE-RESPONSES; ALPHA PRODUCTION; CROSS-LINKING; CELLS; PEPTIDES; IDENTIFICATION	High-mobility group box 1 (HMGB1) is a chromatin-associated protein that, in response to stress or injury, translocates from the nucleus to the extracellular milieu, where it functions as an alarmin. HMGB1's function is in part determined by the complexes (HMGB1c) it forms with other molecules. However, structural modifications in the HMGB1 polypeptide that may regulate HMGB1c formation have not been previously described. In this report, we observed high-molecular weight, denaturing-resistant HMGB1c in the plasma and peripheral blood mononuclear cells of individuals with systemic lupus erythematosus (SLE) and, to a much lesser extent, in healthy subjects. Differential HMGB1c levels were also detected in mouse tissues and cultured cells, in which these complexes were induced by endotoxin or the immunological adjuvant alum. Of note, we found that HMGB1c formation is catalyzed by the protein-cross-linking enzyme transglutaminase-2 (TG2). Cross-link site mapping and MS analysis revealed that HMGB1 can be cross-linked to TG2 as well as a number of additional proteins, including human autoantigens. These findings have significant functional implications for studies of cellular stress responses and innate immunity in SLE and other autoimmune disease.	[Willis, William L.; Wada, Takuma Tsuzuki; Gardner, Mark; Abdouni, Omar; Hampton, Jeffrey; Valiente, Giancarlo; Young, Nicholas; Ardoin, Stacy; Wu, Lai-Chu; Jarjour, Wael N.] Ohio State Univ, Coll Dent, Dept Internal Med, Columbus, OH 43210 USA; [Wang, Linan; Freitas, Michael A.] Ohio State Univ, Coll Dent, Dept Canc Biol & Genet, Columbus, OH 43210 USA; [Wu, Lai-Chu] Ohio State Univ, Coll Dent, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA; [Agarwal, Sudha] Ohio State Univ, Coll Dent, Div Biosci, Columbus, OH 43210 USA; [Agarwal, Sudha] Ohio State Univ, Coll Dent, Dept Orthoped, Columbus, OH 43210 USA; [Willis, William L.; Wang, Linan; Wada, Takuma Tsuzuki; Gardner, Mark; Abdouni, Omar; Hampton, Jeffrey; Valiente, Giancarlo; Young, Nicholas; Ardoin, Stacy; Freitas, Michael A.; Jarjour, Wael N.] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Willis, WL; Jarjour, WN (corresponding author), Ohio State Univ, Coll Dent, Dept Internal Med, Columbus, OH 43210 USA.; Willis, WL; Jarjour, WN (corresponding author), Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA.	william.willis@osumc.edu; wael.jarjour@osumc.edu	wang, lina/HGC-1592-2022; wang, lin/HHM-2225-2022; Wu, Lai-Chu/E-4328-2011; Freitas, Michael/C-8953-2009	Wu, Lai-Chu/0000-0002-1348-269X; Freitas, Michael/0000-0002-3103-8410; Young, Nicholas/0000-0002-9323-9437	OSUWMC; CCTS from the National Center for Advancing Translational Science [UL1TR001070]; Lupus Research Alliance; NATIONAL CANCER INSTITUTE [T32CA090223, P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122436] Funding Source: NIH RePORTER	OSUWMC; CCTS from the National Center for Advancing Translational Science; Lupus Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful for the participation of our patient and healthy volunteers as well as the Clinical Research Center and the Research Match Program through CCTS at OSUWMC. Funding is provided through OSUWMC and the CCTS is supported by UL1TR001070 from the National Center for Advancing Translational Science. The lupus research program at The Ohio State University is supported in part by a grant from the Lupus Research Alliance.	Abdulahad DA, 2010, AUTOIMMUN REV, V9, P661, DOI 10.1016/j.autrev.2010.05.015; Bagriantsev SN, 2006, METHOD ENZYMOL, V412, P33, DOI 10.1016/S0076-6879(06)12003-0; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Bowness JM, 1997, MOL CELL BIOCHEM, V169, P157, DOI 10.1023/A:1006846400478; Bronner DN, 2015, IMMUNITY, V43, P451, DOI 10.1016/j.immuni.2015.08.008; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Evankovich J, 2010, J BIOL CHEM, V285, P39888, DOI 10.1074/jbc.M110.128348; Fagone P, 2011, GENE THER, V18, P1070, DOI 10.1038/gt.2011.59; Falasca L, 2008, J IMMUNOL, V180, P2616, DOI 10.4049/jimmunol.180.4.2616; FESUS L, 1989, FEBS LETT, V245, P150, DOI 10.1016/0014-5793(89)80210-8; Fleckenstein B, 2004, J BIOL CHEM, V279, P17607, DOI 10.1074/jbc.M310198200; Folk J E, 1977, Adv Protein Chem, V31, P1, DOI 10.1016/S0065-3233(08)60217-X; Gandhirajan RK, 2013, J CLIN INVEST, V123, P887, DOI 10.1172/JCI65647; Gilbert D, 1996, J AUTOIMMUN, V9, P247, DOI 10.1006/jaut.1996.0031; Gundemir S, 2012, BBA-MOL CELL RES, V1823, P406, DOI 10.1016/j.bbamcr.2011.09.012; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hreggvidsdottir HS, 2012, MOL MED, V18, P224, DOI 10.2119/molmed.2011.00327; Jiang W, 2008, ANN RHEUM DIS, V67, P727, DOI 10.1136/ard.2007.074484; Kim YH, 2016, BRIT J NEUROSURG, V2016, P1, DOI DOI 10.1155/2016/1489692; Kuo TF, 2011, FEBS J, V278, P4756, DOI 10.1111/j.1742-4658.2011.08409.x; Li J, 2010, J RHEUMATOL, V37, P766, DOI 10.3899/jrheum.090663; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Ma CY, 2012, RHEUMATOL INT, V32, P395, DOI 10.1007/s00296-010-1636-6; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Muthumani G, 2009, IMMUNOLOGY, V128, pe612, DOI 10.1111/j.1365-2567.2009.03044.x; Piredda L, 1997, CELL DEATH DIFFER, V4, P463, DOI 10.1038/sj.cdd.4400267; Plotz PH, 2003, NAT REV IMMUNOL, V3, P73, DOI 10.1038/nri976; Routsias JG, 2006, ANN NY ACAD SCI, V1088, P52, DOI 10.1196/annals.1366.029; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Ruoppolo M, 2003, PROTEIN SCI, V12, P1290, DOI 10.1110/ps.0239103; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; Shrivastav M, 2002, CLIN RHEUMATOL, V21, P505, DOI 10.1007/s100670200124; Stamnaes J, 2008, BBA-PROTEINS PROTEOM, V1784, P1804, DOI 10.1016/j.bbapap.2008.08.011; Stamnaes J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134922; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; Szondy Z, 2003, P NATL ACAD SCI USA, V100, P7812, DOI 10.1073/pnas.0832466100; Tanaka M, 2007, CURR MED CHEM, V14, P2892, DOI 10.2174/092986707782360006; Tang DL, 2007, J LEUKOCYTE BIOL, V81, P741, DOI 10.1189/jlb.0806540; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Ueda T, 2010, BBA-GENE REGUL MECH, V1799, P114, DOI 10.1016/j.bbagrm.2009.11.005; Urbonaviciute V, 2007, J LEUKOCYTE BIOL, V81, P67, DOI 10.1189/jlb.0306196; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; Wahamaa H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3450; Watanabe N, 1996, J BIOCHEM-TOKYO, V120, P1190; Willis WL, 2013, J CELL BIOCHEM, V114, P2753, DOI 10.1002/jcb.24624; Wu LC, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-4; Xu H, 2010, J PROTEOME RES, V9, P3384, DOI 10.1021/pr100369y; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662; Youn JH, 2008, J IMMUNOL, V180, P5067, DOI 10.4049/jimmunol.180.7.5067; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889; Young NA, 2013, MOL IMMUNOL, V54, P23, DOI 10.1016/j.molimm.2012.10.026	60	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8394	8409		10.1074/jbc.RA117.001078	http://dx.doi.org/10.1074/jbc.RA117.001078			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29618516	hybrid, Green Published			2022-12-26	WOS:000434205700006
J	Huang, HY; Wang, P; Bian, L; Osawa, M; Erickson, HP; Chen, YD				Huang, Haiyan; Wang, Ping; Bian, Li; Osawa, Masaki; Erickson, Harold P.; Chen, Yaodong			The cell division protein MinD from Pseudomonas aeruginosa dominates the assembly of the MinC-MinD copolymers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; cell division; electron microscopy (EM); protein dynamic; cytoskeleton; FtsZ; min system; MinC-MinD copolymer; MinCDE proteins; Z-ring	ESCHERICHIA-COLI; POLE OSCILLATION; INHIBITOR MINC; RAPID POLE; FTSZ; MEMBRANE; CYTOKINESIS; REGULATORS; FILAMENTS; SEQUENCE	Cell division of rod-shaped bacteria requires the Z ring, a ring of FtsZ filaments associated with the inner-membrane wall. The MinCDE proteins help localize the Z ring to the center of the Escherichia coli cell. MinC, which inhibits Z-ring assembly, is a passenger on MinD. Previous studies have shown that MinC-MinD from E. coli and Aquifex aeolicus assemble in vitro into extended filaments with a 1:1 stoichiometry. However, a recent study has raised questions about the function of the MinC-MinD copolymer in vivo, because its assembly appears to require a high concentration of these two proteins and has a long lag time, and its blockade does not affect in vivo activities. Here, we found that MinC and MinD from Pseudomonas aeruginosa coassemble into filaments with a 1:1 stoichiometry. We also found that the minimal concentration of approximate to 4 m required for assembly applies only to MinD because above 4 m MinD, even very low MinC concentrations sustained coassembly. As previously reported, the MinC-MinD coassembly exhibited a long lag of approximate to 100 s when initiated by ATP. Premixing MinD with ATP eliminated this lag, suggesting that it may be due to slow MinD dimerization following ATP activation. We also discovered that MinC-MinD copolymers quickly bound FtsZ filaments and formed huge bundles. Our results resolve previous questions about the low concentration of MinC and the lag time, insights that may inform future investigations into the exact role of the MinC-MinD copolymer in vivo.	[Huang, Haiyan; Bian, Li; Chen, Yaodong] Northwest Univ, Coll Life Sci, Key Lab Resources Biol & Biotechnol Western China, Minist Educ, Xian 710069, Shaanxi, Peoples R China; [Wang, Ping] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Osawa, Masaki; Erickson, Harold P.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Northwest University Xi'an; Duke University; Duke University	Erickson, HP (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.; Chen, YD (corresponding author), Northwest Univ, Coll Life Sci, Xian 710069, Shaanxi, Peoples R China.	h.erickson@cellbio.duke.edu; ydchen@nwu.edu.cn	Chen, Yaodong/X-8923-2019	Chen, Yaodong/0000-0002-3751-0923	NIGMS NIH HHS [R01 GM066014] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066014] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bailey MW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004504; Chen YD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03983-4; Chen YD, 2017, J BIOL CHEM, V292, P5207, DOI 10.1074/jbc.M116.767715; Conti J, 2015, FEBS LETT, V589, P201, DOI 10.1016/j.febslet.2014.11.047; Cordell SC, 2001, EMBO J, V20, P2454, DOI 10.1093/emboj/20.10.2454; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; Du SS, 2017, MOL MICROBIOL, V105, P177, DOI 10.1111/mmi.13696; Erickson HP, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700045; Erickson HP, 2017, SUBCELL BIOCHEM, V84, P139, DOI 10.1007/978-3-319-53047-5_5; Ghosal D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6341; Guberman JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000233; Haeusser DP, 2016, NAT REV MICROBIOL, V14, P305, DOI 10.1038/nrmicro.2016.26; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Hu ZL, 2003, MOL MICROBIOL, V47, P345, DOI 10.1046/j.1365-2958.2003.03321.x; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Hu ZL, 2000, J BACTERIOL, V182, P3965, DOI 10.1128/JB.182.14.3965-3971.2000; Kretschmer S, 2016, CURR OPIN CELL BIOL, V38, P52, DOI 10.1016/j.ceb.2016.02.005; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Loose M, 2011, NAT STRUCT MOL BIOL, V18, P577, DOI 10.1038/nsmb.2037; Lutkenhaus J, 2017, SUBCELL BIOCHEM, V84, P27, DOI 10.1007/978-3-319-53047-5_2; Park KT, 2015, MOL MICROBIOL, V98, P895, DOI 10.1111/mmi.13164; Park KT, 2011, CELL, V146, P396, DOI 10.1016/j.cell.2011.06.042; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Schumacher MA, 2017, SUBCELL BIOCHEM, V84, P267, DOI 10.1007/978-3-319-53047-5_9; Szeto TH, 2003, J BIOL CHEM, V278, P40050, DOI 10.1074/jbc.M306876200; Szwedziak P, 2017, SUBCELL BIOCHEM, V84, P213, DOI 10.1007/978-3-319-53047-5_7; Vecchiarelli AG, 2016, P NATL ACAD SCI USA, V113, pE1479, DOI 10.1073/pnas.1600644113	30	9	9	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7786	7795		10.1074/jbc.RA117.001513	http://dx.doi.org/10.1074/jbc.RA117.001513			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29610277	Green Published, hybrid			2022-12-26	WOS:000437256500027
J	Kustiawan, I; Derksen, NIL; Guhr, T; Kruithof, S; Jiskoot, W; Vidarsson, G; Rispens, T				Kustiawan, Iwan; Derksen, Ninotska I. L.; Guhr, Theresa; Kruithof, Simone; Jiskoot, Wim; Vidarsson, Gestur; Rispens, Theo			Dimeric IgG complexes from IVIg are incapable of inducing in vitro neutrophil degranulation or complement activation	PLOS ONE			English	Article							INTRAVENOUS IMMUNOGLOBULIN PREPARATIONS; IMMUNE-COMPLEXES; FC-GAMMA; THROMBOCYTOPENIC PURPURA; THERAPEUTIC-EFFICACY; STIMULATION; GLOBULIN; ANTIBODIES	Purpose Intravenous immunoglobulin (IVIg) products contain various amounts of dimeric IgG complexes. Current insights into the possible biological activities of these dimers remain controversial, and both immunemodulating and immune-activating effects have been reported. Here, we analyzed the putative immune-activating effects of dimers isolated from IVIg. Methods Dimers isolated from IVIg were purified by high-performance size-exclusion chromatography (HP-SEC) and tested for the ability to induce neutrophil degranulation in vitro. Results Dimers isolated from IVIg were found to be incapable of inducing in vitro neutrophil degranulation or complement activation, even at concentrations exceeding those expected to be reached upon administration in patients. These results depend on the removal of artefactual activation by using 0.1 micron filtration and the use of poloxamer to prevent adsorption of IgG onto the solid phase. Conclusions The data suggest dimeric IgG found in IVIg may bind to Fc-receptors without causing activation.	[Kustiawan, Iwan; Derksen, Ninotska I. L.; Guhr, Theresa; Kruithof, Simone; Rispens, Theo] Univ Amsterdam, Sanquin Blood Supply & Landsteiner Lab, Amsterdam Med Ctr, Dept Immunopathol, Amsterdam, Netherlands; [Jiskoot, Wim] Leiden Acedem Ctr Drug Res, Cluster BioTherapeut, Div Drug Delivery Technol, Leiden, Netherlands; [Vidarsson, Gestur] Univ Amsterdam, Sanquin Blood Supply & Landsteiner Lab, Amsterdam Med Ctr, Dept Immune Heamatol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Rispens, T (corresponding author), Univ Amsterdam, Sanquin Blood Supply & Landsteiner Lab, Amsterdam Med Ctr, Dept Immunopathol, Amsterdam, Netherlands.	t.rispens@Sanquin.nl	Jiskoot, Wim/A-6877-2016; Vidarsson, Gestur/A-9909-2009	Jiskoot, Wim/0000-0002-1012-3456; Vidarsson, Gestur/0000-0001-5621-003X				Ballow Mark, 2002, J Am Pharm Assoc (Wash), V42, P449, DOI 10.1331/108658002763316888; Bleeker WK, 2000, BLOOD, V95, P1856, DOI 10.1182/blood.V95.5.1856.005k03_1856_1861; Bolli R, 2010, BIOLOGICALS, V38, P150, DOI 10.1016/j.biologicals.2009.09.002; BRUTON OC, 1952, PEDIATRICS, V9, P722; Casulli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026469; CROCKETTTORABI E, 1990, J IMMUNOL, V145, P3026; FURUSHO K, 1984, LANCET, V2, P1055; HAMADA F, 1993, P NATL ACAD SCI USA, V90, P6305, DOI 10.1073/pnas.90.13.6305; Higurashi S, 2012, BIOCHEM BIOPH RES CO, V417, P794, DOI 10.1016/j.bbrc.2011.12.038; HUIZINGA TWJ, 1989, J IMMUNOL, V142, P2359; IMBACH P, 1981, LANCET, V1, P1228; Jarius S, 2007, BLOOD, V109, P4376, DOI 10.1182/blood-2005-12-019604; Knezevic-Maramica I, 2003, TRANSFUSION, V43, P1460, DOI 10.1046/j.1537-2995.2003.00519.x; Kustiawan I, 2013, J IMMUNOL METHODS, V392, P49, DOI 10.1016/j.jim.2013.03.009; Lutz HU, 2008, AUTOIMMUN REV, V7, P405, DOI 10.1016/j.autrev.2008.03.005; Machino Y, 2012, BIOCHEM BIOPH RES CO, V418, P748, DOI 10.1016/j.bbrc.2012.01.092; Mollnes TE, 1998, SCAND J IMMUNOL, V48, P312; Nagelkerke SQ, 2013, EUR J CLIN INVEST, V43, P36; Nemes E, 2000, PEDIATR RES, V47, P357, DOI 10.1203/00006450-200003000-00012; Ortiz DF, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9418; Prezzo A, 2016, CELL IMMUNOL, P306; Radosevich M, 2010, VOX SANG, V98, P12, DOI 10.1111/j.1423-0410.2009.01226.x; Ritter C, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0361-1; ROBINSON JJ, 1994, FEMS IMMUNOL MED MIC, V8, P249; ROUX KH, 1990, J IMMUNOL, V144, P1387; Roux KH, 1999, INT ARCH ALLERGY IMM, V120, P85, DOI 10.1159/000024226; Schaub A, 2011, ALLERGY, V66, P1030, DOI 10.1111/j.1398-9995.2011.02579.x; Singh-Joy SD, 2008, INT J TOXICOL, V27, P93, DOI 10.1080/10915810802244595; TANKERSLEY DL, 1988, MOL IMMUNOL, V25, P41, DOI 10.1016/0161-5890(88)90088-0; Teeling JL, 2001, BRIT J HAEMATOL, V112, P1031, DOI 10.1046/j.1365-2141.2001.02674.x; Teeling JL, 2001, BLOOD, V98, P1095, DOI 10.1182/blood.V98.4.1095; Teeling JL, 1998, CLIN EXP IMMUNOL, V114, P264; Tremblay T, 2013, TRANSFUSION, V53, P261, DOI 10.1111/j.1537-2995.2012.03725.x; UEMURA Y, 1983, TOHOKU J EXP MED, V141, P337, DOI 10.1620/tjem.141.337; VERHOEVEN AJ, 1988, BLOOD, V71, P505; Voice JK, 1997, EUR J IMMUNOL, V27, P2514, DOI 10.1002/eji.1830271008; Watson F, 1997, J BIOL CHEM, V272, P17944, DOI 10.1074/jbc.272.29.17944; WOLBINK GJ, 1993, J IMMUNOL METHODS, V163, P67, DOI 10.1016/0022-1759(93)90240-8; Wymann S, 2008, MOL IMMUNOL, V45, P2621, DOI 10.1016/j.molimm.2007.12.020	39	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195729	10.1371/journal.pone.0195729	http://dx.doi.org/10.1371/journal.pone.0195729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634774	Green Published, gold			2022-12-26	WOS:000429522200052
J	Kwon, S; Park, JH; Kim, WS; Hang, K; Lee, Y; Paik, NJ				Kwon, SuYeon; Park, Ji-Hong; Kim, Won-Seok; Hang, Kyungdo; Lee, Yookyung; Paik, Nam-Jong			Health-related quality of life and related factors in stroke survivors: Data from Korea National Health and Nutrition Examination Survey (KNHANES) 2008 to 2014	PLOS ONE			English	Article							POSTSTROKE DEPRESSION; FUNCTIONAL OUTCOMES; 1ST-EVER STROKE; IMPACT; PREDICTORS; RECOVERY; DISEASE	As persons with stroke are surviving longer, monitoring and managing their quality of life is becoming important. We reviewed the Korea National Health and Nutrition Examination Survey (KNHANES) in order to evaluate the health-related quality of life (HRQoL) in stroke survivors as measured by the Euro Quality of Life-5D (EQ-5D), and to find out influencing factors. A total of 42,500 subjects were enrolled in the KNHANES, and 575 of them were persons with stroke. The EQ-5D index was lower in persons with stroke than those without stroke, when adjusted for age and sex (with stroke: 0.757 +/- 0.012, without stroke: 0.948 +/- 0.001, p < .0001). Dimension-specific influencing factors of HRQoL were observed in persons with stroke; mobility problems increased with old age; self-care problems increased with old age and depression; usual activity problems increased with old age, low income, absence of economic activity, and depression; pain/discomfort problems increased with low income. The EQ-5D index was lower in stroke survivors with older age, hypertension, diabetes mellitus, and lack of regular exercise. This is the first study to utilize nationally representative data of the Korean population to investigate the effect of stroke on HRQoL and explore the dimension-specific influencing factors. Further development of rehabilitative interventions for post-stroke depression, vocational rehabilitation, and tailored programs for encouraging physical activity may be needed to improve the HRQoL in Korean stroke survivors.	[Kwon, SuYeon; Park, Ji-Hong; Kim, Won-Seok; Lee, Yookyung; Paik, Nam-Jong] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Rehabil Med, Seongnam Si, Gyeonggi Do, South Korea; [Hang, Kyungdo] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea	Seoul National University (SNU); Catholic University of Korea	Kim, WS (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Rehabil Med, Seongnam Si, Gyeonggi Do, South Korea.	wondol77@gmail.com	Paik, Nam-Jong/D-5798-2012; , 김원석/AAJ-2334-2020	Paik, Nam-Jong/0000-0002-5193-8678; , 김원석/0000-0002-1199-5707; Lee, Yookyung/0000-0003-4282-9848				Abubakar S A, 2012, Int J Biomed Sci, V8, P183; Aidar FJ, 2007, REV NEUROLOGIA, V45, P518, DOI 10.33588/rn.4509.2006366; Alguren B, 2012, NEUROREHAB NEURAL RE, V26, P266, DOI 10.1177/1545968311414204; Ashe MC, 2009, GERONTOLOGY, V55, P64, DOI 10.1159/000141518; Bagg S, 2002, STROKE, V33, P179, DOI 10.1161/hs0102.101224; Barker-Collo S, 2010, NEUROLOGY, V75, P1608, DOI 10.1212/WNL.0b013e3181fb44c8; Baumann M, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-92; Chang WH, 2016, J NEUROL, V263, P1166, DOI 10.1007/s00415-016-8119-y; Chau JPC, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-49; Chen CM, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0314-5; Corr S., 2003, BRIT J OCCUPATIONAL, V66, P186, DOI DOI 10.1177/030802260306600502; Cox AM, 2006, LANCET NEUROL, V5, P181, DOI 10.1016/S1474-4422(06)70351-9; De Wit L, 2016, DISABIL REHABIL, P1; Gokkaya NKO, 2005, INT J REHABIL RES, V28, P229, DOI 10.1097/00004356-200509000-00005; Gurcay E, 2009, ANN SAUDI MED, V29, P36, DOI 10.4103/0256-4947.51814; HEWER RL, 1990, Q J MED, V76, P659; Horner RD, 2003, STROKE, V34, P1027, DOI 10.1161/01.STR.0000060028.60365.5D; Jaracz K, 2003, ACTA NEUROL SCAND, V107, P324, DOI 10.1034/j.1600-0404.2003.02078.x; Kang Y, 2009, NURS HEALTH SCI, V11, P301, DOI 10.1111/j.1442-2018.2009.00460.x; Kelly-Hayes Margaret, 2003, J Stroke Cerebrovasc Dis, V12, P119, DOI 10.1016/S1052-3057(03)00042-9; Kim JS, 2014, J STROKE, V16, P55, DOI 10.5853/jos.2014.16.2.55; King RB, 1996, STROKE, V27, P1467, DOI 10.1161/01.STR.27.9.1467; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lai SM, 2002, STROKE, V33, P1840, DOI 10.1161/01.STR.0000019289.15440.F2; Lee HT, 2015, ANGIOLOGY, V66, P326, DOI 10.1177/0003319714533182; Lee YK, 2009, VALUE HEALTH, V12, P1187, DOI 10.1111/j.1524-4733.2009.00579.x; Lynch EB, 2008, J REHABIL MED, V40, P518, DOI 10.2340/16501977-0203; Nichols-Larsen DS, 2005, STROKE, V36, P1480, DOI 10.1161/01.STR.0000170706.13595.4f; Oh SW, 2011, DIABETES METAB J, V35, P561, DOI 10.4093/dmj.2011.35.6.561; Oppe M, 2015, EQ 5D 3L USER GUIDE; PARIKH RM, 1990, ARCH NEUROL-CHICAGO, V47, P785, DOI 10.1001/archneur.1990.00530070083014; Rand D, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-80; Rastenyte D, 2007, MEDICINA-LITHUANIA, V43, P1, DOI 10.3390/medicina43010001; Rimmer James H, 2005, Top Stroke Rehabil, V12, P17; Tengs TO, 2001, STROKE, V32, P964, DOI 10.1161/01.STR.32.4.964; Tennant A, 1997, DISABIL REHABIL, V19, P278, DOI 10.3109/09638289709166539; Tseng Mei-Chiun, 2007, Acta Neurol Taiwan, V16, P7; van de Weg FB, 1999, CLIN REHABIL, V13, P268, DOI 10.1191/026921599672495022; Whyte EM, 2002, BIOL PSYCHIAT, V52, P253, DOI 10.1016/S0006-3223(02)01424-5; Xie JP, 2006, STROKE, V37, P2567, DOI 10.1161/01.STR.0000240506.34616.10	40	34	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195713	10.1371/journal.pone.0195713	http://dx.doi.org/10.1371/journal.pone.0195713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC1EM	29634768	Green Published, gold, Green Submitted			2022-12-26	WOS:000429522200050
J	Reed, JL; D'Ambrosio, E; Marenco, S; Ursini, G; Zheutlin, AB; Blasi, G; Spencer, BE; Romano, R; Hochheiser, J; Reifman, A; Sturm, J; Berman, KF; Bertolino, A; Weinberger, DR; Callicott, JH				Reed, Jessica L.; D'Ambrosio, Enrico; Marenco, Stefano; Ursini, Gianluca; Zheutlin, Amanda B.; Blasi, Giuseppe; Spencer, Barbara E.; Romano, Raffaella; Hochheiser, Jesse; Reifman, Ann; Sturm, Justin; Berman, Karen F.; Bertolino, Alessandro; Weinberger, Daniel R.; Callicott, Joseph H.			Interaction of childhood urbanicity and variation in dopamine genes alters adult prefrontal function as measured by functional magnetic resonance imaging (fMRI)	PLOS ONE			English	Article							WORKING-MEMORY; OBSTETRIC COMPLICATIONS; PSYCHIATRIC-DISORDERS; PSYCHOLOGICAL STRESS; EMISSION-TOMOGRAPHY; SCHIZOPHRENIA RISK; PSYCHOTIC DISORDER; RECEPTOR; ASSOCIATION; METAANALYSIS	Brain phenotypes showing environmental influence may help clarify unexplained associations between urban exposure and psychiatric risk. Heritable prefrontal fMRI activation during working memory (WM) is such a phenotype. We hypothesized that urban upbringing (childhood urbanicity) would alter this phenotype and interact with dopamine genes that regulate prefrontal function during WM. Further, dopamine has been hypothesized to mediate urban-associated factors like social stress. WM-related prefrontal function was tested for main effects of urbanicity, main effects of three dopamine genes catechol-O-methyltransferase (COM7), dopamine receptor D1 (DRD1), and dopamine receptor D2 (DRD2)-and, importantly, dopamine gene-by-urbanicity interactions. For COMT, three independent human samples were recruited (total n = 487). We also studied 253 subjects genotyped for DRD1 and DRD2. 3T fMRI activation during the N-back WM task was the dependent variable, while childhood urbanicity, dopamine genotype, and urbanicity-dopamine interactions were independent variables. Main effects of dopamine genes and of urbanicity were found. Individuals raised in an urban environment showed altered prefrontal activation relative to those raised in rural or town settings. For each gene, dopamine genotype-by-urbanicity interactions were shown in prefrontal cortex COMTreplicated twice in two independent samples. An urban childhood upbringing altered prefrontal function and interacted with each gene to alter genotype-phenotype relationships. Gene-environment interactions between multiple dopamine genes and urban upbringing suggest that neural effects of developmental environmental exposure could mediate, at least partially, increased risk for psychiatric illness in urban environments via dopamine genes expressed into adulthood.	[Reed, Jessica L.; Marenco, Stefano; Zheutlin, Amanda B.; Spencer, Barbara E.; Hochheiser, Jesse; Reifman, Ann; Sturm, Justin; Berman, Karen F.; Weinberger, Daniel R.; Callicott, Joseph H.] NIMH, Clin & Translat Neurosci Branch, Div Intramural Programs, NIH, Bethesda, MD 20892 USA; [Reed, Jessica L.] Georgetown Univ, Med Ctr, Interdisciplinary Program Neurosci, Washington, DC 20007 USA; [Reed, Jessica L.] NIMH, Expt Therapeut & Pathophysiol Branch, Div Intramural Programs, NIH, Bethesda, MD 20892 USA; [D'Ambrosio, Enrico; Ursini, Gianluca; Weinberger, Daniel R.] Lieber Inst Brain Dev, Johns Hopkins Med Campus, Baltimore, MD USA; [D'Ambrosio, Enrico; Ursini, Gianluca; Blasi, Giuseppe; Romano, Raffaella; Bertolino, Alessandro] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Psychiat Neurosci Grp, Bari, Italy; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Georgetown University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Johns Hopkins University; Johns Hopkins Medicine; Universita degli Studi di Bari Aldo Moro; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Callicott, JH (corresponding author), NIMH, Clin & Translat Neurosci Branch, Div Intramural Programs, NIH, Bethesda, MD 20892 USA.	callicottj@mail.nih.gov	Ursini, Gianluca/AAA-8242-2019; Callicott, Joseph H/AAE-7243-2022; Blasi, Giuseppe/HHS-5404-2022; D'Ambrosio, Enrico/K-1942-2015; Marenco, Stefano/A-2409-2008; Callicott, Joseph/C-9102-2009	D'Ambrosio, Enrico/0000-0001-9774-3860; Marenco, Stefano/0000-0002-2488-2365; Ursini, Gianluca/0000-0002-4733-5196; Reed, Jessica/0000-0003-0550-7284; Callicott, Joseph/0000-0003-1298-3334; Blasi, Giuseppe/0000-0003-0878-1131	Division of Intramural Research Program of the National Institute of Mental Health; Psychiatric Neuroscience Group, Department of Basic Medical Science, Neuroscience and Sense Organs of University of Bad Aldo Moro; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002942, ZIAMH002652] Funding Source: NIH RePORTER	Division of Intramural Research Program of the National Institute of Mental Health; Psychiatric Neuroscience Group, Department of Basic Medical Science, Neuroscience and Sense Organs of University of Bad Aldo Moro; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded as part of the Division of Intramural Research Program of the National Institute of Mental Health and the Psychiatric Neuroscience Group, Department of Basic Medical Science, Neuroscience and Sense Organs of University of Bad Aldo Moro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 2002, J NEUROSCI, V22, P3708, DOI 10.1523/jneurosci.22-09-03708.2002; Agerbo E, 2001, SCHIZOPHR RES, V47, P243, DOI 10.1016/S0920-9964(00)00133-X; Arnsten AFT, 1997, J PSYCHOPHARMACOL, V11, P151, DOI 10.1177/026988119701100208; Ashburner J, 2009, SPM5 MANUAL; Barnett JH, 2007, AM J PSYCHIAT, V164, P142, DOI 10.1176/appi.ajp.164.1.142; Bertolino A, 2009, BRAIN, V132, P417, DOI 10.1093/brain/awn248; Blasi G, 2015, NEUROPSYCHOPHARMACOL, V40, P1600, DOI 10.1038/npp.2015.5; Blokland GAM, 2008, BIOL PSYCHOL, V79, P70, DOI 10.1016/j.biopsycho.2008.03.006; Bobb AJ, 2005, AM J MED GENET B, V134B, P67, DOI 10.1002/ajmg.b.30142; Boileau I, 2006, ARCH GEN PSYCHIAT, V63, P1386, DOI 10.1001/archpsyc.63.12.1386; Booij L, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.6; Boonstra N, 2012, EUR PSYCHIAT, V27, P500, DOI 10.1016/j.eurpsy.2011.05.001; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Callicott JH, 2003, AM J PSYCHIAT, V160, P709, DOI 10.1176/appi.ajp.160.4.709; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cosentino M, 2015, HUM IMMUNOL, V76, P747, DOI 10.1016/j.humimm.2015.09.032; Dreher JC, 2012, BIOL PSYCHIAT, V71, P890, DOI 10.1016/j.biopsych.2012.01.002; Durstewitz D, 2008, BIOL PSYCHIAT, V64, P739, DOI 10.1016/j.biopsych.2008.05.015; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Freeman D, 2015, SCHIZOPHRENIA BULL, V41, P971, DOI 10.1093/schbul/sbu173; Frissen A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0166651; Frissen A, 2015, SOC PSYCH PSYCH EPID, V50, P1481, DOI 10.1007/s00127-015-1049-7; GARDNER EB, 1975, PHYSIOL BEHAV, V14, P321, DOI 10.1016/0031-9384(75)90040-2; George MS, 2007, SCHIZOPHR RES, V93, P42, DOI 10.1016/j.schres.2007.03.011; Glaeser E, 2011, SCIENCE, V333, P592, DOI 10.1126/science.1209264; Goldman-Rakic PS, 2004, PSYCHOPHARMACOLOGY, V174, P3, DOI 10.1007/s00213-004-1793-y; Haddad L, 2015, SCHIZOPHRENIA BULL, V41, P115, DOI 10.1093/schbul/sbu072; Harpending H, 2002, P NATL ACAD SCI USA, V99, P10, DOI 10.1073/pnas.012612799; Harrison G, 2003, PSYCHOL MED, V33, P723, DOI 10.1017/S0033291703007591; HEBB DO, 1955, AM J PSYCHIAT, V111, P826, DOI 10.1176/ajp.111.11.826; HENDERSO.ND, 1970, SCIENCE, V169, P768, DOI 10.1126/science.169.3947.776; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Kates WR, 2006, AM J MED GENET B, V141B, P274, DOI 10.1002/ajmg.b.30284; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Krabbendam L, 2005, SCHIZOPHRENIA BULL, V31, P795, DOI 10.1093/schbul/sbi060; KRECH D, 1962, J COMP PHYSIOL PSYCH, V55, P801, DOI 10.1037/h0044220; Lai IC, 2011, EUR J CLIN PHARMACOL, V67, P383, DOI 10.1007/s00228-010-0967-2; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Levy F, 2013, J CHILD ADOL PSYCHOP, V23, P423, DOI 10.1089/cap.2013.0006; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Malhotra AK, 2004, NEUROTOX RES, V6, P51, DOI 10.1007/BF03033296; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Meyer-Lindenberg A, 2012, NAT NEUROSCI, V15, P663, DOI 10.1038/nn.3083; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; Miller P, 2013, DEV PSYCHOL, V49, P1452, DOI 10.1037/a0030244; Mizrahi R, 2016, NEUROPSYCHOPHARMACOL, V41, P666, DOI 10.1038/npp.2015.274; Mortensen PB, 1999, NEW ENGL J MED, V340, P603, DOI 10.1056/NEJM199902253400803; Nee DE, 2013, CEREB CORTEX, V23, P264, DOI 10.1093/cercor/bhs007; Neilson E, 2017, SCHIZOPHR RES, V184, P128, DOI 10.1016/j.schres.2016.12.011; Newbury J, 2016, SCHIZOPHRENIA BULL, V42, P1372, DOI 10.1093/schbul/sbw052; Newman AEM, 2015, AM J PHYSIOL-REG I, V308, pR449, DOI 10.1152/ajpregu.00328.2014; Nicodemus KK, 2008, MOL PSYCHIATR, V13, P873, DOI 10.1038/sj.mp.4002153; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oswald LM, 2014, PSYCHOPHARMACOLOGY, V231, P2417, DOI 10.1007/s00213-013-3407-z; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pani L, 2000, MOL PSYCHIATR, V5, P14, DOI 10.1038/sj.mp.4000589; Pedersen CB, 2001, ARCH GEN PSYCHIAT, V58, P1039, DOI 10.1001/archpsyc.58.11.1039; Peen J, 2010, ACTA PSYCHIAT SCAND, V121, P84, DOI 10.1111/j.1600-0447.2009.01438.x; Peeters SCT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120030; Potkin SG, 2014, CNS SPECTRUMS, V19, P176, DOI 10.1017/S109285291300059X; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Pruessner JC, 2004, J NEUROSCI, V24, P2825, DOI 10.1523/JNEUROSCI.3422-03.2004; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rasetti R, 2011, ARCH GEN PSYCHIAT, V68, P1207, DOI 10.1001/archgenpsychiatry.2011.103; Rieckmann A, 2011, J NEUROSCI, V31, P14284, DOI 10.1523/JNEUROSCI.3114-11.2011; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rypma B, 2015, J NEUROSCI, V35, P14702, DOI 10.1523/JNEUROSCI.1298-15.2015; Slifstein M, 2008, MOL PSYCHIATR, V13, P821, DOI 10.1038/mp.2008.19; Slifstein M, 2015, JAMA PSYCHIAT, V72, P316, DOI 10.1001/jamapsychiatry.2014.2414; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Streit F, 2014, STRESS, V17, P352, DOI 10.3109/10253890.2014.921903; Tura E, 2008, NEUROREPORT, V19, P603, DOI 10.1097/WNR.0b013e3282fa6d8d; Turner KM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00097; Ursini G, 2011, J NEUROSCI, V31, P6692, DOI 10.1523/JNEUROSCI.6631-10.2011; Vaessen T, 2015, NEUROSCI BIOBEHAV R, V56, P241, DOI 10.1016/j.neubiorev.2015.07.008; van Os J, 2005, CURR OPIN PSYCHIATR, V18, P141, DOI 10.1097/00001504-200503000-00006; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Vassos E, 2012, SCHIZOPHRENIA BULL, V38, P1118, DOI 10.1093/schbul/sbs096; Villanueva K, 2016, ACAD PEDIATR, V16, P10, DOI 10.1016/j.acap.2015.09.006; Wand GS, 2007, NEUROPSYCHOPHARMACOL, V32, P2310, DOI 10.1038/sj.npp.1301373; Westergaard T, 1999, ARCH GEN PSYCHIAT, V56, P993, DOI 10.1001/archpsyc.56.11.993; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; World Health Organization, 2010, WHO CTR HLTH DEV; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Zhang RB, 2016, SCHIZOPHRENIA BULL, V42, P1068, DOI 10.1093/schbul/sbv221; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P20552, DOI 10.1073/pnas.0707106104	90	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195189	10.1371/journal.pone.0195189	http://dx.doi.org/10.1371/journal.pone.0195189			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634738	Green Published, gold, Green Submitted			2022-12-26	WOS:000429522200025
J	Anasa, VV; Manickam, M; Talwar, P; Ravanan, P				Anasa, Vivek Vishnu; Manickam, Madhumathi; Talwar, Priti; Ravanan, Palaniyandi			Identification of ASB7 as ER stress responsive gene through a genome wide in silico screening for genes with ERSE	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; CCAAT REGULATORY ELEMENT; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; ANKYRIN REPEAT; TRANSCRIPTION FACTORS; GRP78/BIP PROMOTER; UBIQUITIN LIGASE; DEGRADATION	The endoplasmic reticulum (ER) not only performs its basic function of regulating calcium homeostasis, lipid biosynthesis, folding, modifying and transporting proteins but also plays a decisive role in regulating multiple cellular processes ranging from cell growth and differentiation to apoptosis and autophagy. Disturbances in ER homeostasis initiate the unfolded protein response (UPR) implicated in the pathogenesis of many human diseases. Drugging the UPR components for therapeutic interventions has received considerable attention. The purpose of this study is to identify genes that are previously unsuspected to be regulated under ER stress. Because ER stress-inducible gene expression is majorly regulated under ERSE elements, we screened human genome by adopting an in silico approach using ERSE elements (I, II, III) as probes and identified 337 candidate genes. Having knowledge of the importance of E3 ubiquitin ligase in the ERAD machinery; we validated our preliminary search by focusing on one of the hits i.e. ASB7 gene that encodes E3 ubiquitin ligase. In HeLa cells, we found that pharmacological induction of ER stress led to an increase in the expression of ASB7 with simultaneous activation of UPR pathways. Although knockdown of ASB7 expression leads to significant reduction in GRP78 and CHOP mRNA levels, it did not protect cells from ER stress-induced cell death. Also, an up-regulation in the expression of pro-inflammatory genes like TNF-alpha and IL-1 beta in ASB7 knockdown cells was observed under ER stress. Collectively, our findings suggest that ASB7 is regulated under ER stress and this study also identifies several other genes that could apparently be regulated under ER stress.	[Anasa, Vivek Vishnu; Manickam, Madhumathi; Talwar, Priti; Ravanan, Palaniyandi] VIT Univ, Sch Biosci & Technol, Dept Biosci, Apoptosis & Cell Survival Res Lab, Vellore, Tamil Nadu, India	Vellore Institute of Technology	Talwar, P; Ravanan, P (corresponding author), VIT Univ, Sch Biosci & Technol, Dept Biosci, Apoptosis & Cell Survival Res Lab, Vellore, Tamil Nadu, India.	priti.t@vit.ac.in; ravanan.p@vitac.in	Talwar, Priti/AAA-1126-2021	Palaniyandi, Ravanan/0000-0003-0665-5801; Talwar, Priti/0000-0002-6826-581X	Department of Science and Technology (DST, Govt. of India) Young Scientist Scheme grants [YSS/2014/000915, SB/FT/LS-419/2012]	Department of Science and Technology (DST, Govt. of India) Young Scientist Scheme grants	PT and PR wish to acknowledge Department of Science and Technology (DST, Govt. of India) Young Scientist Scheme grants (YSS/2014/000915 and SB/FT/LS-419/2012 respectively) for supporting this work.; The authors wish to greatly acknowledge VIT University for providing research facilities to carry out this work. We would also like to acknowledge Namrata Chaudhari for reviewing the manuscript. Additionally, PT and PR wish to acknowledge Department of Science and Technology (DST, Govt. of India) Young Scientist Scheme grants (YSS/2014/000915 and SB/FT/LS-419/2012 respectively), for supporting this work.	Andresen CA, 2014, J BIOL CHEM, V289, P2043, DOI 10.1074/jbc.M113.534602; BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; Barbosa-Tessmann IP, 2000, J BIOL CHEM, V275, P26976; Bassi S, 2007, PLOS COMPUT BIOL, V3, P2052, DOI 10.1371/journal.pcbi.0030199; Bode M, 2011, CELL BIOCHEM FUNCT, V29, P334, DOI 10.1002/cbf.1755; Boengler K, 2003, BIOCHEM BIOPH RES CO, V302, P17, DOI 10.1016/S0006-291X(03)00095-0; BORNSTEIN P, 1987, P NATL ACAD SCI USA, V84, P8869, DOI 10.1073/pnas.84.24.8869; Boulpaep E.L., 2009, SIGNAL TRANSDUCT, V48, P27; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Chaudhari N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00213; Chung AS, 2005, MOL CELL BIOL, V25, P4716, DOI 10.1128/MCB.25.11.4716-4726.2005; Church DM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001091; Debrincat MA, 2007, J BIOL CHEM, V282, P4728, DOI 10.1074/jbc.M609164200; Dery MA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3398; Eder J, 1997, TRENDS PHARMACOL SCI, V18, P319, DOI 10.1016/S0165-6147(97)01097-3; FERRARI M, 1990, J IMMUNOL METHODS, V131, P165, DOI 10.1016/0022-1759(90)90187-Z; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hasnain SZ, 2012, IMMUNOL CELL BIOL, V90, P260, DOI 10.1038/icb.2011.112; Helenius Ari, 1992, Trends in Cell Biology, V2, P227, DOI 10.1016/0962-8924(92)90309-B; Heuze ML, 2005, J BIOL CHEM, V280, P5468, DOI 10.1074/jbc.M413040200; Jousse C, 1999, FEBS LETT, V448, P211, DOI 10.1016/S0014-5793(99)00373-7; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Kohroki J, 2005, FEBS LETT, V579, P6796, DOI 10.1016/j.febslet.2005.11.016; Kokame K, 2001, J BIOL CHEM, V276, P9199, DOI 10.1074/jbc.M010486200; Kondoh H, 2004, INT J DEV BIOL, V48, P819, DOI 10.1387/ijdb.041868hk; Kwon S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-23; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AS, 2006, CANCER BIOL THER, V5, P721, DOI 10.4161/cbt.5.7.3120; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee MR, 2008, MOL CELLS, V26, P621; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Malhotra JD, 2007, SEM CELL DEV BIOL; McDaneld TG, 2008, J ANIM SCI, V86, P2897, DOI 10.2527/jas.2008-1076; Misiewicz M, 2013, J BIOL CHEM, V288, P20378, DOI 10.1074/jbc.M113.457242; Mruk Dolores D, 2011, Spermatogenesis, V1, P121; Najwer I, 2005, AM J PHYSIOL-CELL PH, V289, pC785, DOI 10.1152/ajpcell.00098.2005; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nayak RR, 2014, NUCLEIC ACIDS RES, V42, P1757, DOI 10.1093/nar/gkt999; Nishitoh H, 2012, J BIOCHEM, V151, P217, DOI 10.1093/jb/mvr143; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; ROY B, 1995, MOL CELL BIOL, V15, P2263; Roy B, 1996, J BIOL CHEM, V271, P28995, DOI 10.1074/jbc.271.46.28995; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Surinya KH, 1998, J BIOL CHEM, V273, P16798, DOI 10.1074/jbc.273.27.16798; Tam AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045078; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Uematsu K, 2016, J CELL BIOL, V215, P95, DOI 10.1083/jcb.201603062; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wingender E, 2013, NUCLEIC ACIDS RES, V41, pD165, DOI 10.1093/nar/gks1123; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 1999, J BIOL CHEM, V274, P2592; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zabel MD, 2001, INT IMMUNOPHARMACOL, V1, P483, DOI 10.1016/S1567-5769(00)00046-1; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200; Zheng X, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.66	70	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194310	10.1371/journal.pone.0194310	http://dx.doi.org/10.1371/journal.pone.0194310			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630609	Green Published, gold, Green Submitted			2022-12-26	WOS:000429505000009
J	Han, BG; Song, SH; Yoo, JS; Park, H; Kim, J; Choi, E				Han, Byoung-Geun; Song, Shin Han; Yoo, Jin Sae; Park, Hyeoncheol; Kim, Juwon; Choi, Eunhee			Association between OH/ECW and echocardiographic parameters in CKD5 patients not undergoing dialysis	PLOS ONE			English	Article							FLUID STATUS; CARDIOVASCULAR OUTCOMES; HEMODIALYSIS-PATIENTS; STANDARDS COMMITTEE; DIASTOLIC FUNCTION; VOLUME OVERLOAD; NT-PROBNP; RECOMMENDATIONS; MORTALITY; QUANTIFICATION	Background Echocardiography is the most valuable tool for assessing cardiac abnormalities of chronic kidney disease (CKD) patients even though it has its limitations, including high equipment cost and the need for specialized personnel. Assessment of volume status is important not only for volume management, but also for prevention of cardiovascular disease of the CKD patients. Recently, bioimpedance is gaining acceptance as a way to quantitatively assess patient hydration status at bedside. Methods 127 patients who were admitted for planning their first dialysis treatment were enrolled. The echocardiography and bioimpedance spectroscopy (BIS) were performed. The association between echocardiographic data and clinical values such as NT-proBNP and OH/ECW was examined. Results OH/ECW, which indicates relative fluid overload, was positively associated with LA dimension (r = 0.25, P = 0.007), LAVI (r = 0.32, P < 0.001), and E/e' ratio (r = 0.38, P < 0.001). While OH/ECW was not significantly associated with echocardiographic values such as LVEDD, LVEDV, LVMI, and LVEF, NT-proBNP were significantly associated with all echocardiographic parameters. Multivariate logistic regression analysis showed E/e' ratio (odds ratio, 1.14 [95% confidence interval (CI), 1.01 to 1.29]; P = 0.031), NT-proBNP (odds ratio, 4.78 [95% CI, 1.51 to 15.11]; P = 0.008), and albumin (odds ratio, 0.22 [95% CI, 0.08 to 0.66]; P = 0.007) were significantly associated with OH/ECW. Conclusions Since OH/ECW measured by BIS is associated with echocardiographic parameters related to diastolic dysfunction, preliminary screening through laboratory findings, including serum albumin in conjunction with OH/ECW and NT-proBNP, may find patient with risk of diastolic dysfunction. Our study suggests that a timely detection of fluid overload in patients with CKD as well as their proper treatment may help reduce diastolic dysfunction. Further research may be needed to validate the consistency of this association across other stages of CKD.	[Han, Byoung-Geun; Song, Shin Han; Yoo, Jin Sae; Park, Hyeoncheol] Yonsei Univ, Dept Nephrol, Wonju Coll Med, Wonju, Kang Won, South Korea; [Kim, Juwon] Yonsei Univ, Dept Lab Med, Wonju Coll Med, Wonju, Kang Won, South Korea; [Choi, Eunhee] Yonsei Univ, Inst Lifestyle Med, Wonju Coll Med, Wonju, Kang Won, South Korea; [Choi, Eunhee] Beth Israel Deaconess Med Ctr, Smith Ctr Outcomes Res Cardiol, Boston, MA 02215 USA	Yonsei University; Yonsei University; Yonsei University; Harvard University; Beth Israel Deaconess Medical Center	Han, BG (corresponding author), Yonsei Univ, Dept Nephrol, Wonju Coll Med, Wonju, Kang Won, South Korea.	neptune@yonsei.ac.kr		Choi, Eunhee/0000-0002-3449-0672				Bansal N, 2015, J AM SOC NEPHROL, V26, P946, DOI 10.1681/ASN.2014010108; Bolton K, 2005, AM J KIDNEY DIS, V45, pS7, DOI 10.1053/j.ajkd.2005.01.016; Booth J, 2010, CLIN J AM SOC NEPHRO, V5, P1036, DOI 10.2215/CJN.09001209; Chazot C, 2012, NEPHROL DIAL TRANSPL, V27, P2404, DOI 10.1093/ndt/gfr678; Chiu DYY, 2014, AM J KIDNEY DIS, V64, P804, DOI 10.1053/j.ajkd.2014.01.450; di Gioia MC, 2017, NEFROLOGIA, V37, P47, DOI 10.1016/j.nefro.2016.06.003; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Drepper VJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158741; Farshid A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-280; Hung SC, 2014, KIDNEY INT, V85, P703, DOI 10.1038/ki.2013.336; Juan-Garcia I, 2012, NEFROLOGIA, V32, P94, DOI 10.3265/Nefrologia.pre2011.Nov.10867; Kim SJ, 2011, NEPHROL DIAL TRANSPL, V26, P3732, DOI 10.1093/ndt/gfr118; Kraemer M, 2006, KIDNEY INT, V69, P1609, DOI 10.1038/sj.ki.5000286; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Little WC, 2009, CIRCULATION, V120, P802, DOI 10.1161/CIRCULATIONAHA.109.869602; Machek P, 2010, NEPHROL DIAL TRANSPL, V25, P538, DOI 10.1093/ndt/gfp487; Moissl UM, 2006, PHYSIOL MEAS, V27, P921, DOI 10.1088/0967-3334/27/9/012; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Nakanishi K, 2017, EUR J PREV CARDIOL, V24, P392, DOI 10.1177/2047487316679903; Onofriescu M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135691; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Tsai YC, 2015, CLIN J AM SOC NEPHRO, V10, P39, DOI 10.2215/CJN.03610414; Tsang TSM, 2006, J AM COLL CARDIOL, V47, P1018, DOI 10.1016/j.jacc.2005.08.077; Untersteller K, 2016, CLIN J AM SOC NEPHRO, V11, P1978, DOI 10.2215/CJN.01660216; Vega A, 2014, NEFROLOGIA, V34, P579, DOI 10.3265/Nefrologia.pre2014.Jun.12422; Wizemann V, 2009, NEPHROL DIAL TRANSPL, V24, P1574, DOI 10.1093/ndt/gfn707; Yilmaz Z, 2014, Clin Ter, V165, pe52, DOI 10.7417/CT.2014.1672; Yilmaz Z, 2014, MEDICINA-LITHUANIA, V50, P269, DOI 10.1016/j.medici.2014.10.007; Yilmaz Z, 2014, RENAL FAILURE, V36, P495, DOI 10.3109/0886022X.2013.875815	29	6	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195202	10.1371/journal.pone.0195202	http://dx.doi.org/10.1371/journal.pone.0195202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630661	Green Submitted, Green Published, gold			2022-12-26	WOS:000429505000031
J	Hessels, AC; Rutgers, A; Sanders, JSF; Stegeman, CA				Hessels, Arno C.; Rutgers, Abraham; Sanders, Jan Stephan F.; Stegeman, Coen A.			Thiopurine methyltransferase genotype and activity cannot predict outcomes of azathioprine maintenance therapy for antineutrophil cytoplasmic antibody associated vasculitis: A retrospective cohort study	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ANCA-ASSOCIATED VASCULITIS; TPMT ACTIVITY; MYELOSUPPRESSION; PHARMACOGENETICS; TRIAL	Objective Azathioprine is a widely used immunosuppressive drug. Genetic polymorphisms and activity of the enzyme thiopurine methyltransferase (TPMT) have been associated with azathioprine efficacy and toxicity in several populations. We investigated whether these associations also exist for ANCA associated vasculitis (AAV) patients, who receive azathioprine maintenance therapy after remission induction with cyclophosphamide. Methods 207 AAV patients treated with cyclophosphamide induction and azathioprine maintenance therapy were included and followed for 60 months. TPMT genotype and tertiles of TPMT activity were compared to relapse free survival and occurrence of adverse events, particularly leukopenia. Multivariable regression was performed to account for confounders. Results In univariable analysis, relapse free survival was not significantly associated with TPMT genotype (P = 0.41) or TPMT activity (P = 0.07), although it tended to be longer in lower tertiles of TPMT activity. There was no significant association of TPMT genotype and activity with occurrence of any adverse event. In multiple regression, leukocyte counts at the end of cyclophosphamide induction were related to risk of leukopenia during azathioprine therapy [P<0.001; OR 0.54 (95% Cl 0.43-0.68)] and risk of relapse during follow-up [P = 0.001; HR 1.17 (95% Cl 1.07-1.29)] irrespective of TMPT genotype or activity. Conclusion TPMT genotype and activity were not independent predictors of relapse, and could not predict leukopenia or other adverse effects from azathioprine. Leukocyte counts after cyclophosphamide induction were related to both outcomes, implying a greater influence of cyclophosphamide response compared to azathioprine and TPMT in AAV patients.	[Hessels, Arno C.; Sanders, Jan Stephan F.; Stegeman, Coen A.] Univ Groningen, Univ Med Ctr Groningen, Div Nephrol, Dept Internal Med, Groningen, Netherlands; [Rutgers, Abraham] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands	University of Groningen; University of Groningen	Hessels, AC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Div Nephrol, Dept Internal Med, Groningen, Netherlands.	a.c.hessels@umng.nl	Sanders, Jan-Stephan/ABC-6782-2021	Sanders, Jan-Stephan/0000-0002-0904-3969; Stegeman, Coen/0000-0002-0224-0927				Ansari A, 2002, ALIMENT PHARM THER, V16, P1743, DOI 10.1046/j.1365-2036.2002.01353.x; Bellera CA, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-20; Coenen MJH, 2015, GASTROENTEROLOGY, V149, P907, DOI 10.1053/j.gastro.2015.06.002; Coulthard SA, 2002, MOL PHARMACOL, V62, P102, DOI 10.1124/mol.62.1.102; Cuffari C, 2004, CLIN GASTROENTEROL H, V2, P410, DOI 10.1016/S1542-3565(04)00127-2; Dong XW, 2010, WORLD J GASTROENTERO, V16, P3187, DOI 10.3748/wjg.v16.i25.3187; Gisbert JP, 2008, AM J GASTROENTEROL, V103, P1783, DOI 10.1111/j.1572-0241.2008.01848.x; Gisbert JP, 2006, HEPATO-GASTROENTEROL, V53, P399; Higgs JE, 2010, PHARMACOGENOMICS, V11, P177, DOI 10.2217/PGS.09.155; Jayne D, 2003, NEW ENGL J MED, V349, P36, DOI 10.1056/NEJMoa020286; Jennette JC, 2013, CLIN EXP NEPHROL, V17, P603, DOI 10.1007/s10157-013-0869-6; Kallenberg CGM, 2015, CLIN EXP RHEUMATOL, V33, pS11; Kroplin T, 1998, EUR J CLIN PHARMACOL, V54, P265, DOI 10.1007/s002280050457; Little MA, 2010, ANN RHEUM DIS, V69, P1036, DOI 10.1136/ard.2009.109389; Liu YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144234; LUQMANI RA, 1994, Q J MED, V87, P671; Moon W, 2016, ALIMENT PHARM THER; Newman WG, 2011, PHARMACOGENOMICS, V12, P815, DOI [10.2217/PGS.11.32, 10.2217/pgs.11.32]; Pagnoux C, 2008, NEW ENGL J MED, V359, P2790, DOI 10.1056/NEJMoa0802311; Roberts RL, 2012, J GASTROEN HEPATOL, V27, P1546, DOI 10.1111/j.1440-1746.2012.07220.x; Stassen PM, 2009, ANN RHEUM DIS, V68, P758, DOI 10.1136/ard.2008.097667; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905; Wall N, 2012, NAT REV NEPHROL, V8, P523, DOI 10.1038/nrneph.2012.107; WEINSHILBOUM RM, 1980, AM J HUM GENET, V32, P651; Yates CR, 1997, ANN INTERN MED, V126, P608, DOI 10.7326/0003-4819-126-8-199704150-00003	25	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195524	10.1371/journal.pone.0195524	http://dx.doi.org/10.1371/journal.pone.0195524			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630648	Green Published, Green Submitted, gold			2022-12-26	WOS:000429505000055
J	Jia, JJ; Ahmed, I; Liu, LX; Liu, Y; Xu, ZQ; Duan, XH; Li, QH; Dou, TF; Gu, DH; Rong, H; Wang, K; Li, ZT; Talpur, MZ; Huang, Y; Wang, SR; Yan, SX; Tong, HQ; Zhao, SM; Zhao, GP; te Pas, MFW; Su, ZC; Ge, CR				Jia, Junjing; Ahmed, Irfan; Liu, Lixian; Liu, Yong; Xu, Zhiqiang; Duan, Xiaohua; Li, Qihua; Dou, Tengfei; Gu, Dahai; Rong, Hua; Wang, Kun; Li, Zhengtian; Talpur, Mir Zulqarnain; Huang, Ying; Wang, Shanrong; Yan, Shixiong; Tong, Huiquan; Zhao, Sumei; Zhao, Guiping; te Pas, Marinus F. W.; Su, Zhengchang; Ge, Changrong			Selection for growth rate and body size have altered the expression profiles of somatotropic axis genes in chickens	PLOS ONE			English	Article							HORMONE RECEPTOR-BINDING; MESSENGER-RNA; FACTOR-I; SKELETAL-MUSCLE; TRANSGENIC MICE; GH RECEPTOR; DWARF; WEIGHT; PITUITARY; ONTOGENY	The growth hormone / insulin-like growth factor-1 (GH/IG F-1) pathway of the somatotropic axis is the major controller for growth rate and body size in vertebrates, but the effect of selection on the expression of GH/IGF-1 somatotropic axis genes and their association with body size and growth performance in farm animals is not fully understood. We analyzed a time series of expression profiles of GH/IGF-1 somatotropic axis genes in two chicken breeds, the Daweishan mini chickens and Wuding chickens, and the commercial Avian broilers hybrid exhibiting markedly different body sizes and growth rates. We found that growth rate and feed conversion efficiency in Daweishan mini chickens were significantly lower than those in Wuding chickens and Avian broilers. The Wuding and Daweishan mini chickens showed higher levels of plasma GH, pituitary GH mRNA but lower levels of hepatic growth hormone receptor (GHR) mRNA than in Avian broilers. Daweishan mini chickens showed significantly lower levels of plasma IGF-1, thigh muscle and hepatic IGF-1 mRNA than did Avian broilers and Wuding chickens. These results suggest that the GH part of the somatotropic axis is the main regulator of growth rate, while IGF-1 may regulate both growth rate and body weight. Selection for growth performance and body size have altered the expression profiles of somatotropic axis genes in a breed-, age-, and tissue-specific manner, and manner, and alteration of regulatory mechanisms of these genes might play an important role in the developmental characteristics of chickens.	[Jia, Junjing; Ahmed, Irfan; Liu, Lixian; Liu, Yong; Xu, Zhiqiang; Duan, Xiaohua; Li, Qihua; Dou, Tengfei; Rong, Hua; Wang, Kun; Li, Zhengtian; Talpur, Mir Zulqarnain; Huang, Ying; Wang, Shanrong; Yan, Shixiong; Tong, Huiquan; Zhao, Sumei; te Pas, Marinus F. W.; Ge, Changrong] Yunnan Agr Univ, Yunnan Prov Key Lab Anim Nutr & Feed, Kunming, Yunnan, Peoples R China; [Gu, Dahai] Yunnan Agr Univ, Dept Food Sci, Kunming, Yunnan, Peoples R China; [Zhao, Guiping] Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China; [te Pas, Marinus F. W.] Wageningen UR Livestock Sci, Anim Breeding & Genet, Wageningen, Netherlands; [te Pas, Marinus F. W.] Dali Univ, Dali, Yunnan, Peoples R China; [Su, Zhengchang] Univ North Carolina Charlotte, Dept Bioinformat & Genom, Coll Comp & Informat, Charlotte, NC 28223 USA	Yunnan Agricultural University; Yunnan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Dali University; University of North Carolina; University of North Carolina Charlotte	te Pas, MFW; Ge, CR (corresponding author), Yunnan Agr Univ, Yunnan Prov Key Lab Anim Nutr & Feed, Kunming, Yunnan, Peoples R China.; te Pas, MFW (corresponding author), Wageningen UR Livestock Sci, Anim Breeding & Genet, Wageningen, Netherlands.; te Pas, MFW (corresponding author), Dali Univ, Dali, Yunnan, Peoples R China.; Su, ZC (corresponding author), Univ North Carolina Charlotte, Dept Bioinformat & Genom, Coll Comp & Informat, Charlotte, NC 28223 USA.	marinus.tepas@wur.nl; zcsu@uncc.edu; gcrzal@126.com	Ahmed, Irfan/HHD-1948-2022; AHMED, IRFAN/AFW-6944-2022	, hua/0000-0003-0049-5202; Zhao, Guiping/0000-0002-1510-6903	National Natural Science Foundation of China [31260532, 31560618, 31572359]; Yunnan Provincial Natural Science Foundation [2011FA015, 2016FA046]; National Science and Technology Program in the 13th Five-Year Plan [2015BAD03B03-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Natural Science Foundation(Natural Science Foundation of Yunnan Province); National Science and Technology Program in the 13th Five-Year Plan	This work was partially funded by National Natural Science Foundation of China (31260532, 31560618, 31572359) (JJ), Yunnan Provincial Natural Science Foundation (2011FA015, 2016FA046) (JJ), and National Science and Technology Program in the 13th Five-Year Plan (2015BAD03B03-4) (CG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit T, 2000, J CLIN ENDOCR METAB, V85, P927, DOI 10.1210/jc.85.3.927; [Anonymous], 2004, CHIN CHICK FEED STAN; Bernard C, 2009, MEAT SCI, V82, P205, DOI 10.1016/j.meatsci.2009.01.012; Brown-Borg HM, 2009, MOL CELL ENDOCRINOL, V299, P64, DOI 10.1016/j.mce.2008.07.001; BRUMBY P. J., 1959, NEW ZEALAND JOUR AGRIC RES, V2, P683; BURNSIDE J, 1992, MOL CELL ENDOCRINOL, V89, P91, DOI 10.1016/0303-7207(92)90214-Q; BURNSIDE J, 1992, GEN COMP ENDOCR, V88, P20, DOI 10.1016/0016-6480(92)90190-U; Campion B, 2009, LIVEST SCI, V126, P100, DOI 10.1016/j.livsci.2009.06.003; Carter-Su C, 2016, GROWTH HORM IGF RES, V28, P11, DOI 10.1016/j.ghir.2015.09.002; Castigliego L, 2010, DOMEST ANIM ENDOCRIN, V39, P40, DOI 10.1016/j.domaniend.2010.02.001; Chen RJ, 2011, LIVEST SCI, V136, P72, DOI 10.1016/j.livsci.2010.08.001; Clemmons DR, 2009, TRENDS ENDOCRIN MET, V20, P349, DOI 10.1016/j.tem.2009.04.002; CLUTTER AC, 1995, J ANIM SCI, V73, P1776; DAUNCEY MJ, 1994, FASEB J, V8, P81, DOI 10.1096/fasebj.8.1.7507871; Dou TF, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3845-9; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Frystyk Jan, 2008, J Clin Endocrinol Metab, V93, P3008, DOI 10.1210/jc.2008-0375; HUYBRECHTS LM, 1989, REPROD NUTR DEV, V29, P219, DOI 10.1051/rnd:19890209; HUYBRECHTS LM, 1985, HORM METAB RES, V17, P690, DOI 10.1055/s-2007-1013646; HUYBRECHTS LM, 1987, REPROD NUTR DEV, V27, P547, DOI 10.1051/rnd:19870413; Katsumata M, 2000, J NUTR, V130, P2482, DOI 10.1093/jn/130.10.2482; Keady SM, 2011, J ANIM SCI, V89, P4007, DOI 10.2527/jas.2011-4032; Kim JW, 2010, ASIAN AUSTRAL J ANIM, V23, P1668, DOI 10.5713/ajas.2010.10329; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; LEUNG FC, 1987, P SOC EXP BIOL MED, V184, P234, DOI 10.3181/00379727-184-42473; Li QH, 2013, MOL BIOL REP, V40, P2769, DOI 10.1007/s11033-012-2030-0; Li ZC, 2013, MOL BIOL REP, V40, P3569, DOI 10.1007/s11033-012-2430-1; Lu FZ, 2008, POULTRY SCI, V87, P2087, DOI 10.3382/ps.2007-00493; Mao JNC, 1998, J ENDOCRINOL, V156, P67, DOI 10.1677/joe.0.1560067; MATHEWS LS, 1988, ENDOCRINOLOGY, V123, P2827, DOI 10.1210/endo-123-6-2827; MCCANNLEVORSE LM, 1993, P SOC EXP BIOL MED, V202, P109, DOI 10.3181/00379727-202-43519; Mukherjee A, 2008, MOL ENDOCRINOL, V22, P206, DOI 10.1210/me.2007-0336; National Research Council, 1994, NUTR REQ POULTR; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A, V8th, DOI [10.1258/la.2010.010031, DOI 10.1258/LA.2010.010031]; Anh NTL, 2015, ASIAN AUSTRAL J ANIM, V28, P1686, DOI 10.5713/ajas.15.0028; Oksbjerg N, 2004, DOMEST ANIM ENDOCRIN, V27, P219, DOI 10.1016/j.domaniend.2004.06.007; Pas MFWT, 2003, J ANIM BREED GENET, V120, P346, DOI 10.1046/j.1439-0388.2003.00404.x; Pas MFWT, 2001, DOMEST ANIM ENDOCRIN, V20, P165, DOI 10.1016/S0739-7240(01)00094-7; Rahimi G., 2005, International Journal of Poultry Science, V4, P476; REIPRICH K, 1995, J ENDOCRINOL, V145, P343, DOI 10.1677/joe.0.1450343; Shavlakadze T, 2005, GROWTH HORM IGF RES, V15, P4, DOI 10.1016/j.ghir.2004.11.001; Slifierz MJ, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-247; Spurlock DM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-320; te Pas MFW, 2004, DOMEST ANIM ENDOCRIN, V27, P287, DOI 10.1016/j.domaniend.2004.06.003; Te Pas MFW, 2001, J ANIM SCI S1, V79, P30; Tuggle CK, 1996, DOMEST ANIM ENDOCRIN, V13, P1, DOI 10.1016/0739-7240(95)00059-3; VANDERPOOTEN A, 1993, DOMEST ANIM ENDOCRIN, V10, P199, DOI 10.1016/0739-7240(93)90024-6; VANDERPOOTEN A, 1991, REPROD NUTR DEV, V31, P47, DOI 10.1051/rnd:19910104; Vasilatos-Younken R, 1999, DOMEST ANIM ENDOCRIN, V17, P181, DOI 10.1016/S0739-7240(99)00035-1; Wit JM, 2002, BEST PRACT RES CL EN, V16, P483, DOI 10.1053/beem.2002.0206; Wu Gui-Qin, 2007, Yichuan, V29, P989, DOI 10.1360/yc-007-0989; Zhao RQ, 2004, GEN COMP ENDOCR, V136, P2, DOI 10.1016/j.ygcen.2003.11.009	52	19	20	6	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195378	10.1371/journal.pone.0195378	http://dx.doi.org/10.1371/journal.pone.0195378			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630644	Green Published, Green Submitted, gold			2022-12-26	WOS:000429505000045
J	Chalazan, B; Mol, D; Sridhar, A; Alzahrani, Z; Darner, SD; Ornelas-Loredo, A; Farooqui, A; Argos, M; Daviglus, ML; Konda, S; Rehman, J; Darbar, D				Chalazan, Brandon; Mol, Denise; Sridhar, Arvind; Alzahrani, Zain; Darner, Sara D.; Ornelas-Loredo, Aylin; Farooqui, Abdullah; Argos, Maria; Daviglus, Martha L.; Konda, Sreenivas; Rehman, Jalees; Darbar, Dawood			Genetic modulation of atrial fibrillation risk in a Hispanic/Latino cohort	PLOS ONE			English	Article							CHROMOSOME 4Q25; PREVALENCE; VARIANTS; CHANNELS; CARDIOMYOPATHY; EPIDEMIOLOGY; MUTATION; MARKERS; IMPACT; COMMON	Atrial fibrillation (AF) is the most prevalent cardiac rhythm disorder worldwide but the underlying genetic and molecular mechanisms and the response to therapies is not fully understood. Despite a greater burden of AF risk factors in Hispanics/Latinos the prevalence of AF remains low. Over the last decade, genome-wide association studies have identified numerous AF susceptibility loci in mostly whites of European descent. The goal of this study was to determine if the top 9 single nucleotide polymorphisms (SNPs) associated with AF in patients of European descent also increase susceptibility to AF in Hispanics/Latinos. AF cases were prospectively enrolled in the University of Illinois at Chicago (UIC) AF Registry and control subjects were identified from the UIC Cohort of Patients, Family and Friends. AF cases and controls were genotyped for 9 AF risk SNPs at chromosome 1q21: rs13376333, rs6666258; chr1q24: rs3903239; chr4q25: rs2200733; rs10033464; chr10q22: rs10824026; chr14q23: rs1152591; chr16q22: rs2106261 and rs7193343. The study sample consisted of 713 Hispanic/Latino subjects including 103 AF cases and 610 controls. Among the 8 AF risk SNPs genotyped, only rs10033464 SNP at chromosome (chr) 4q25 (near PITX2) was significantly associated with development of AF after multiple risk factor adjustment and multiple testing (adj. odds ratio [OR] 2.27, 95% confidence interval [CI] 1.31-3.94; P = 3.3 x 10-3). Furthermore, the association remained significant when the analysis was restricted to Hispanics of Mexican descent (adj. OR 2.32, 95% CI 1.35-3.99; P = 0.002. We confirm for the first time the association between a chromosome 4q25 SNP and increased susceptibility to AF in Hispanics/Latinos. While the underlying molecular mechanisms by which the chr4q25 SNP modulates AF risk remains unclear, this study supports a genetic basis for non-familial AF in patients of Hispanic descent.	[Chalazan, Brandon; Mol, Denise; Sridhar, Arvind; Alzahrani, Zain; Darner, Sara D.; Ornelas-Loredo, Aylin; Farooqui, Abdullah; Daviglus, Martha L.; Rehman, Jalees; Darbar, Dawood] Univ Illinois, Dept Med, Chicago, IL 60607 USA; [Argos, Maria; Konda, Sreenivas] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA; [Daviglus, Martha L.] Univ Illinois, Inst Minor Hlth Res, Chicago, IL USA; [Rehman, Jalees; Darbar, Dawood] Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Darbar, D (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60607 USA.; Darbar, D (corresponding author), Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA.	darbar@uic.edu	Rehman, Jalees/GVU-1981-2022; Rehman, Jalees/J-8258-2012	Rehman, Jalees/0000-0002-2787-9292; Rehman, Jalees/0000-0002-2787-9292	self-determined research funds of CCNU from the colleges' basic research and operation of MOE [CCNU17SJ004]; American Heart Association [17MCPRP33420153]; National Institutes of Health [R01 HL092217, HL138737]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL138737] Funding Source: NIH RePORTER	self-determined research funds of CCNU from the colleges' basic research and operation of MOE; American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association grant 17MCPRP33420153 (Brandon Chalazan) and National Institutes of Health grants R01 HL092217 and HL138737 (Dawood Darbar).	Body SC, 2009, CIRC-CARDIOVASC GENE, V2, P499, DOI 10.1161/CIRCGENETICS.109.849075; Christophersen IE, 2017, NAT GENET, V49, P946, DOI 10.1038/ng.3843; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Darbar D, 2013, NAT REV CARDIOL, V10, P317, DOI 10.1038/nrcardio.2013.53; Darghosian L, 2015, AM J CARDIOL, V115, P196, DOI 10.1016/j.amjcard.2014.10.022; Delaney JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032338; Dewland TA, 2013, CIRCULATION, V128, P2470, DOI 10.1161/CIRCULATIONAHA.113.002449; Diness JG, 2015, J CARDIOVASC PHARM, V66, P441, DOI 10.1097/FJC.0000000000000249; Diness JG, 2010, CIRC-ARRHYTHMIA ELEC, V3, P380, DOI 10.1161/CIRCEP.110.957407; Disertori M, 2013, CIRC-CARDIOVASC GENE, V6, P27, DOI 10.1161/CIRCGENETICS.112.963520; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Fatkin D, 2017, HEART LUNG CIRC, V26, P894, DOI 10.1016/j.hlc.2017.04.008; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P2851, DOI 10.1001/jama.291.23.2851; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gbadebo TD, 2011, AM HEART J, V162, P31, DOI 10.1016/j.ahj.2011.03.030; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Huang H, 2017, EUR HEART J, V38, P2595, DOI 10.1093/eurheartj/ehx289; Inoue H, 2009, INT J CARDIOL, V137, P102, DOI 10.1016/j.ijcard.2008.06.029; Keenan Nora L., 2011, Morbidity and Mortality Weekly Report, V60, P94; Kilpelainen TO, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10494; Kirchhof P, 2011, CIRC-CARDIOVASC GENE, V4, P123, DOI 10.1161/CIRCGENETICS.110.958058; Li N, 2009, J PHYSIOL-LONDON, V587, P1087, DOI 10.1113/jphysiol.2008.167718; Liu YW, 2015, PACE, V38, P164, DOI 10.1111/pace.12494; Lubitz SA, 2014, J AM COLL CARDIOL, V63, P1200, DOI 10.1016/j.jacc.2013.12.015; Lubitz SA, 2010, CIRCULATION, V122, P976, DOI 10.1161/CIRCULATIONAHA.109.886440; Mommersteeg MTM, 2007, CIRC RES, V101, P902, DOI 10.1161/CIRCRESAHA.107.161182; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Olivotto I, 2008, MAYO CLIN PROC, V83, P630, DOI 10.4065/83.6.630; Ozgen N, 2007, CARDIOVASC RES, V75, P758, DOI 10.1016/j.cardiores.2007.05.008; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Rice TK, 2008, ADV GENET, V60, P293, DOI 10.1016/S0065-2660(07)00412-9; Ruo B, 2004, J AM COLL CARDIOL, V43, P429, DOI 10.1016/j.jacc.2003.09.035; Sinner MF, 2014, CIRCULATION, V130, P1225, DOI 10.1161/CIRCULATIONAHA.114.009892; Stamos TD, 2016, JAMA CARDIOL, V1, P377, DOI 10.1001/jamacardio.2016.1259	38	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0194480	10.1371/journal.pone.0194480	http://dx.doi.org/10.1371/journal.pone.0194480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624624	Green Published, gold, Green Submitted			2022-12-26	WOS:000429379600006
J	Al-Mawali, A; Pinto, AD; Al-Busaidi, R; Al-Lawati, RH; Morsi, M				Al-Mawali, Adhra; Pinto, Avinash Daniel; Al-Busaidi, Raiya; Al-Lawati, Rabab H.; Morsi, Magdi			Comprehensive haematological indices reference intervals for a healthy Omani population: First comprehensive study in Gulf Cooperation Council (GCC) and Middle Eastern countries based on age, gender and ABO blood group comparison	PLOS ONE			English	Article							MOLECULAR-SPECTRUM	Background Reference intervals for venous blood parameters differs with age, gender, geographic region, and ethnic groups. Hence local laboratory reference intervals are important to improve the diagnostic accuracy of health assessments and diseases. However, there have been no comprehensive published reference intervals established in Oman, the Gulf Cooperation Council or Middle Eastern countries. Hence, the aim of this study was to establish reference intervals for full blood count in healthy Omani adults. Methods Venous blood specimens were collected from 2202 healthy individuals aged 18 to 69 years from January 2012 to April 2017, and analysed by Sysmex XS-1000i and Cell-Dyn Sapphire automated haematology analysers. Results were statistically analysed and compared by gender, age, and ABO blood group. The lower and upper reference limits of the haematology reference intervals were established at the 2.5th and 97.5th percentiles respectively. Results Reference intervals were calculated for 17 haematology parameters which included red blood cell, white blood cell, and platelet parameters. Red blood cell (RBC), haemoglobin (HGB), haematocrit (HCT), platelet and platelet haematocrit counts of the healthy donors were significantly different between males and females at all ages (p < 0.05), with males having higher mean values of RBC, HGB and HCT than females. Other complete blood count parameters showed no significant differences between genders, age groups, instruments, or blood groups. Our study showed a lower haemoglobin limit for the normal reference interval in males and females than the currently used in Oman. Conclusions Data from this study established specific reference intervals which could be considered for general use in Oman. The differences in haematology reference intervals highlights the necessity to establish reference intervals for venous blood parameters among the healthy population in each country or at least in each region.	[Al-Mawali, Adhra; Pinto, Avinash Daniel; Morsi, Magdi] Minist Hlth, Ctr Studies & Res, Muscat, Oman; [Al-Busaidi, Raiya; Al-Lawati, Rabab H.] Royal Hosp, Muscat, Oman	The Royal Hospital, Sultanate of Oman	Al-Mawali, A (corresponding author), Minist Hlth, Ctr Studies & Res, Muscat, Oman.	adhra.almawali@gmail.com		Al-Mawali, Adhra/0000-0002-5344-4591	Research Council Oman [47]	Research Council Oman(Ministry of Higher Education, Research & Innovation, OmanThe Research Council Oman)	This work was supported by The Research Council Oman (47) to Adhra Al-Mawali (https://www.tr.gov.om/trcweb/). The funding body had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbassi-Ghanavati M, 2009, OBSTET GYNECOL, V114, P1326, DOI 10.1097/AOG.0b013e3181c2bde8; Al Riyami Asya, 2012, Oman Med J, V27, P425; Al-Ankoodi Y, 2004, SAUDI MED J, V25, P1507; Al-Jafar H., 2016, J HEMATOL THROMB, V2, P04; Al-Mawali A., 2013, J STEM CELL RES THER, V3, P01; Al-Mawali A, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0292-z; Al-Mawali Adhra, 2015, Oman Med J, V30, P227, DOI 10.5001/omj.2015.47; Al-Mawali Adhra, 2013, Oman Med J, V28, P432, DOI 10.5001/omj.2013.121; Al-Mawali A, 2013, CYTOM PART A, V83A, P739, DOI 10.1002/cyto.a.22322; Ambayya A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091968; Biino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054289; Cheng C, 2003, LAB HEMATOLOGY OFFIC, V10, P42; Dasgupta A, 2013, ACCURATE RESULTS IN THE CLINICAL LABORATORY: A GUIDE TO ERROR DETECTION AND CORRECTION, P1; Denic Srdjan, 2009, BMC Blood Disord, V9, P3, DOI 10.1186/1471-2326-9-3; Gari M, 2015, BMC P; GRASBECK R, 1990, SCAND J CLIN LAB INV, V50, P45, DOI 10.3109/00365519009085800; Hassan SM, 2014, HEMOGLOBIN, V38, P422, DOI 10.3109/03630269.2014.976414; Hassan SM, 2010, HEMOGLOBIN, V34, P127, DOI 10.3109/03630261003673147; Horn PS, 2001, CLIN CHEM, V47, P2137; Horowitz GL, 2010, CLIN LAB STAND I; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Katayev A, 2010, AM J CLIN PATHOL, V133, P180, DOI 10.1309/AJCPN5BMTSF1CDYP; Kobayashi Y, 2015, EXCLI J, V14, P220, DOI 10.17179/excli2015-102; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Ozarda Y, 2016, BIOCHEM MEDICA, V26, P5, DOI 10.11613/BM.2016.001; Pekelharing J.M.P., 2010, SYSMEX J INT, V20, P1; Rajab A, 2014, J COMMUN GENET, V5, P283, DOI 10.1007/s12687-014-0182-4; Samaneka WP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165821; SAXENA S, 1990, ARCH PATHOL LAB MED, V114, P715; Segal JB, 2006, ANN EPIDEMIOL, V16, P123, DOI 10.1016/j.annepidem.2005.06.052; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Troussard X, 2013, J CLIN PATHOL; WHO, 2011, WHONMHNHDMNM111; World Health Organization, 2008, WHO GLOBAL DATABASE; World Health Organization, 2012, BLOOD DON SEL GUID A; Wu XZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119669; Yadav D., 2015, BIOCH ANALYT BIOCH, V4, P01	38	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194497	10.1371/journal.pone.0194497	http://dx.doi.org/10.1371/journal.pone.0194497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621271	Green Published, gold, Green Submitted			2022-12-26	WOS:000429206800021
J	Grzesiuk, M; Mielecki, D; Pilzys, T; Garbicz, D; Marcinkowski, M; Grzesiuk, E				Grzesiuk, Malgorzata; Mielecki, Damian; Pilzys, Tomasz; Garbicz, Damian; Marcinkowski, Michel; Grzesiuk, Elzbieta			How cyclophosphamide at environmentally relevant concentration influences Daphnia magna life history and its proteome	PLOS ONE			English	Article							AQUATIC ENVIRONMENT; INDUCED APOPTOSIS; PHARMACEUTICALS; VITELLOGENIN; DRUGS; FATE; ECOTOXICOLOGY; RESISTANCE; CRUSTACEAN; TOLERANCE	The waste of commonly used medicines is known to contaminate freshwater ecosystems. Pharmaceuticals can be toxic, mutagenic, or modifying to freshwater organisms even at low concentrations if consider their permanent presence in the environment. Chemotherapeutics used to treat cancer, and in particular alkylating agents, contribute significantly to this form of pollution, the latter introducing cytotoxic and/or mutagenic lesions to the DNA and RNA of organisms which can be disruptive to their cells. The aim of the present study was to investigate the influence of the alkylating anticancer agent cyclophosphamide (CP) on Daphnia magna clones. We evaluated the life history parameters and protein profiles of this crustacean following exposure to environmentally relevant CP concentration of 10 ng L-1 Even at this low concentration, the alkylating agent caused modification of the life history parameters and proteome profile of the Daphnia. These changes were clone-specific and involved growth rate, age at first reproduction, neonate number, and proteins related to cell cycle and redox state regulation. The disturbance caused by pharmaceuticals contaminating freshwater ecosystem is probably weaker and unlikely to be cytotoxic in character due to the high dilution of these substances in the water. However, our results indicate that prolonged exposure of organisms to these toxins may lead to modifications on the organismal and molecular levels with unpredictable significance for the entire ecosystem.	[Grzesiuk, Malgorzata] Univ Warsaw, Fac Biol, Biol & Chem Res Ctr, Dept Hydrobiol, Warsaw, Poland; [Grzesiuk, Malgorzata; Mielecki, Damian; Pilzys, Tomasz; Garbicz, Damian; Marcinkowski, Michel; Grzesiuk, Elzbieta] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland	University of Warsaw; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Grzesiuk, M (corresponding author), Univ Warsaw, Fac Biol, Biol & Chem Res Ctr, Dept Hydrobiol, Warsaw, Poland.; Grzesiuk, M (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	m.grzesiuk@uw.edu.pl	Grzesiuk-Bieniek, Małgorzata/ACF-1924-2022	Marcinkowski, Michal/0000-0002-4001-9609; Grzesiuk, Elzbieta/0000-0002-7833-7602; Grzesiuk, Malgorzata/0000-0002-9331-7183; Pilzys, Tomas/0000-0003-1294-1222; Garbicz, Damian/0000-0001-5417-8531; Mielecki, Damian/0000-0003-2929-4500	National Science Centre, NCN Poland [UMO-2016/21/B/NZ8/01542, 2015/21/B/NZ8/01542]	National Science Centre, NCN Poland	This work was supported by the National Science Centre, NCN Poland, UMO-2016/21/B/NZ8/01542 to EG and 2015/21/B/NZ8/01542. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DAPHNIA DEV MODEL OR; [Anonymous], ADV PURE APPL CHEM; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Arnold KE, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0492; Booker V, 2014, SCI TOTAL ENVIRON, V473, P159, DOI 10.1016/j.scitotenv.2013.11.145; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brooks BW, 2003, TOXICOL LETT, V142, P169, DOI 10.1016/S0378-4274(03)00066-3; Chen S, 2011, BIOL REPROD, V85, P31, DOI 10.1095/biolreprod.110.090340; DAWIDOWICZ P, 1992, LIMNOL OCEANOGR, V37, P1589, DOI 10.4319/lo.1992.37.8.1589; Fent K, 2006, AQUAT TOXICOL, V76, P122, DOI 10.1016/j.aquatox.2005.09.009; Geerts AN, 2015, NAT CLIM CHANGE, V5, P665, DOI 10.1038/NCLIMATE2628; Grung M, 2007, CHEMOSPHERE, V67, P108, DOI 10.1016/j.chemosphere.2006.09.021; Grzesiuk M, 2018, ECOTOX ENVIRON SAFE, V156, P271, DOI 10.1016/j.ecoenv.2018.03.019; Halling-Sorensen B, 1998, CHEMOSPHERE, V36, P357, DOI 10.1016/S0045-6535(97)00354-8; Heberer T, 2002, TOXICOL LETT, V131, P5, DOI 10.1016/S0378-4274(02)00041-3; HEBERT PDN, 1987, HYDROBIOLOGIA, V145, P183, DOI 10.1007/BF02530279; Hughes SR, 2013, ENVIRON SCI TECHNOL, V47, P661, DOI 10.1021/es3030148; Kato Y, 2004, GENE, V334, P157, DOI 10.1016/j.gene.2004.03.030; Kosjek T, 2011, TRAC-TREND ANAL CHEM, V30, P1065, DOI 10.1016/j.trac.2011.04.007; la Farre M, 2008, TRAC-TREND ANAL CHEM, V27, P991, DOI 10.1016/j.trac.2008.09.010; Lampert W, 1996, FUNCT ECOL, V10, P631, DOI 10.2307/2390173; Lampert W, 1987, FEEDING NUTR DAPHNIA; Messiaen M, 2013, AQUAT TOXICOL, V144, P322, DOI 10.1016/j.aquatox.2013.10.016; Ohtani T, 2006, FEBS LETT, V580, P1597, DOI 10.1016/j.febslet.2006.01.092; Osorio V, 2016, SCI TOTAL ENVIRON, V540, P267, DOI 10.1016/j.scitotenv.2015.06.143; Radzikowski J, 2013, J PLANKTON RES, V35, P707, DOI 10.1093/plankt/fbt032; Rosi EJ, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2041; Togola A, 2008, J CHROMATOGR A, V1177, P150, DOI 10.1016/j.chroma.2007.10.105; Tokishita S, 2006, BIOCHEM BIOPH RES CO, V345, P362, DOI 10.1016/j.bbrc.2006.04.102; Tsai-Turton M, 2007, TOXICOL SCI, V98, P216, DOI 10.1093/toxsci/kfm087; Van Donk E, 2016, REV ENVIRON CONTAM T, V238, P91, DOI 10.1007/398_2015_5002; Villegas-Navarro A, 2003, COMP BIOCHEM PHYS C, V136, P127, DOI 10.1016/S1532-0456(03)00172-8; Warne Michael St J., 2008, Australasian Journal of Ecotoxicology, V14, P1; Yang XS, 2011, J CELL BIOCHEM, V112, P1376, DOI 10.1002/jcb.23054; Zhang JF, 2013, SCI TOTAL ENVIRON, V445, P281, DOI 10.1016/j.scitotenv.2012.12.061; [No title captured]	36	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195366	10.1371/journal.pone.0195366	http://dx.doi.org/10.1371/journal.pone.0195366			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621334	Green Published, gold, Green Submitted			2022-12-26	WOS:000429206800071
J	Halvarsson, A; Hagman, I; Tegern, M; Broman, L; Larsson, H				Halvarsson, Alexandra; Hagman, Ingela; Tegern, Matthias; Broman, Lisbet; Larsson, Helena			Self-reported musculoskeletal complaints and injuries and exposure of physical workload in Swedish soldiers serving in Afghanistan	PLOS ONE			English	Article							BRIGADE COMBAT TEAM; MILITARY PERSONNEL; PREMATURE DISCHARGE; RISK-FACTORS; PAIN; INTERVENTION; THERAPIST	Background Musculoskeletal complaints and injuries (MSCI) are common in military populations. However, only a limited number of studies have followed soldiers during international deployments and investigated the prevalence of MSCI during and at the end of their deployment. The aim was to describe the prevalence of MSCI in different military occupational specialties and categorise their most common tasks in terms of exposures to physical workloads during a six-month long international deployment in Afghanistan. Methods Cross-sectional survey, including 325 soldiers (300 men), aged 20-62 participating in an international deployment in Afghanistan during the spring of 2012. Soldiers were clustered into different military occupational specialties: Infantry, Administration, Logistics, Logistics/Camp, Medical and Other. Data were collected through the use of the Musculoskeletal Screening Protocol at the end of the international mission. Results Forty-seven percent reported MSCI during deployment, with 28% at the end. The most common locations of MSCI during the mission were lower back, knee, shoulders, upper back, neck and foot, while the knee and lower back prevailed at the end of the mission. Almost half of the soldiers who had MSCI reported affected work ability. The most common duties during the mission were vehicle patrolling, staff duties, guard/security duties, foot patrols and transportation. Soldiers reported that vehicle patrolling, staff duties and transportation were demanding with respect to endurance strength, guard/security duties challenged both maximum and endurance strength while foot patrolling challenged maximum and endurance strength, aerobic and anaerobic endurance and speed. Conclusions MSCI during international deployment are common among Swedish soldiers. The results indicate the need to further develop strategies focusing on matching the soldiers' capacity to the job requirements, with relevant and fair physical selection-tests during the recruitment process and proactive interventions targeting MSCI before and during deployment, in order to enhance soldiers' readiness and promote operational readiness.	[Halvarsson, Alexandra; Hagman, Ingela; Tegern, Matthias; Broman, Lisbet; Larsson, Helena] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Physiotherapy, Huddinge, Sweden; [Halvarsson, Alexandra] Karolinska Univ Hosp, Allied Hlth Profess Funct, Stockholm, Sweden; [Tegern, Matthias] Umea Univ, Dept Community Med & Rehabil Physiotherapy, Umea, Sweden; [Larsson, Helena] Swedish Armed Forces, Med Serv, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Umea University	Halvarsson, A (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Physiotherapy, Huddinge, Sweden.; Halvarsson, A (corresponding author), Karolinska Univ Hosp, Allied Hlth Profess Funct, Stockholm, Sweden.	alexandra.halvarsson@ki.se		Halvarsson, Alexandra/0000-0002-0893-7653; Tegern, Matthias/0000-0001-6871-1341				Campbell DJ, 2009, MIL PSYCHOL, V21, pS47, DOI 10.1080/08995600903249149; George SZ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-128; Glad D, 2012, EUR SPINE J, V21, P739, DOI 10.1007/s00586-011-2142-6; Goff BJ, 2011, PM&R, V3, P183, DOI 10.1016/j.pmrj.2010.10.024; Hauret KG, 2010, AM J PREV MED, V38, pS61, DOI 10.1016/j.amepre.2009.10.021; Kaufman KR, 2000, AM J PREV MED, V18, P54, DOI 10.1016/S0749-3797(00)00114-8; Knapik JJ, 2004, MIL MED, V169, P45, DOI 10.7205/MILMED.169.1.45; Konitzer LN, 2008, J HAND THER, V21, P143, DOI 10.1197/j.jht.2007.10.017; Larsson H., 2009, THESIS; Larsson H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132185; Larsson H, 2012, WORK, V42, P241, DOI 10.3233/WOR-2012-1347; Larsson H, 2009, MIL MED, V174, P9, DOI 10.7205/MILMED-D-03-7407; LINTON SJ, 1993, PAIN, V54, P353, DOI 10.1016/0304-3959(93)90037-P; Rhon DI, 2010, MIL MED, V175, P442, DOI 10.7205/MILMED-D-09-00097; Rosendal L, 2003, CLIN J SPORT MED, V13, P157, DOI 10.1097/00042752-200305000-00006; Roy TC, 2012, AVIAT SPACE ENVIR MD, V83, P1060, DOI 10.3357/ASEM.3341.2012; Roy TC, 2011, MIL MED, V176, P903, DOI 10.7205/MILMED-D-11-00006; Sharma S, 2015, IIMB MANAG REV, V27, P185, DOI 10.1016/j.iimb.2015.06.002; Taanila H, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-89; Yancosek KE, 2012, CURR OPIN RHEUMATOL, V24, P232, DOI 10.1097/BOR.0b013e3283503406; Zambraski Edward J, 2012, J Strength Cond Res, V26 Suppl 2, pS101, DOI 10.1097/JSC.0b013e31825cf03b	21	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195548	10.1371/journal.pone.0195548	http://dx.doi.org/10.1371/journal.pone.0195548			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621324	Green Submitted, Green Published, gold			2022-12-26	WOS:000429206800100
J	Simon, EG; Calle, S; Perrotin, F; Remenieras, JP				Simon, Emmanuel G.; Calle, Samuel; Perrotin, Franck; Remenieras, Jean-Pierre			Measurement of shear wave speed dispersion in the placenta by transient elastography: A preliminary ex vivo study	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; HUMAN FETOPLACENTAL VASCULOGENESIS; FORCE IMPULSE ELASTOGRAPHY; 1 BASIC PRINCIPLES; RADIATION FORCE; CLINICAL-USE; COMPLICATED PREGNANCIES; WFUMB GUIDELINES; 2ND TRIMESTER; LIVER-DISEASE	Background Placental elasticity may be modified in women with placental insufficiency. Shear wave elastography (SWE) can measure this, using acoustic radiation force, but the safety of its use in pregnant women has not yet been demonstrated. Transient elastography (TE) is a safer alternative, but has not yet been applied to the placenta. Moreover, the dispersion of shear wave speed (SWS) as a function of frequency has received relatively little study for placental tissue, although it might improve the accuracy of biomechanical assessment. Objective To explore the feasibility and reproducibility of TE for placental analysis, to compare the values of SWS and Young's modulus (YM) from TE and SWE, and to analyze SWS dispersion as a function of frequency ex vivo in normal placentas. Materials and methods Ten normal placentas were analyzed ex vivo by an Aixplorer ultrasound system as shear waves were generated by a vibrating plate and by using an Aixplorer system. The frequency analysis provided the value of the exponent n from a fractional rheological model applied to the TE method. We calculated intra- and interobserver agreement for SWS and YM with 95% prediction intervals, created Bland-Altman plots with 95% limits of agreement, and estimated the intraclass correlation coefficient (ICC). Main results The mean SWS was 1.80 m/s +/- 0.28 (standard deviation) with the TE method at 50 Hz and 1.82 m/s +/-0.13 with SWE (P = 0.912). No differences were observed between the central and peripheral regions of placentas with either TE or SWE. With TE, the intraobserver ICC for SWS was 0.68 (0.50-0.82), and the interobserver ICC for SWS 0.65 (0.37-0.85). The mean parameter n obtained from the fractional rheological model was 1.21 +/- 0.12, with variable values of n for any given SWS. Conclusions TE is feasible and reproducible on placentas ex vivo. The frequency analysis of SWS provides additional information about placental elasticity and appears to be able to distinguish differences between placental structures.	[Simon, Emmanuel G.; Calle, Samuel; Perrotin, Franck; Remenieras, Jean-Pierre] Univ Tours, INSERM, UMR 1253, iBrain, Tours, France; [Simon, Emmanuel G.; Perrotin, Franck] Univ Hosp Ctr Tours, Dept Obstet Gynecol & Fetal Med, Tours, France; [Calle, Samuel] Univ Tours, CNRS, UMR 7347, GREMAN, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Tours	Simon, EG (corresponding author), Univ Tours, INSERM, UMR 1253, iBrain, Tours, France.; Simon, EG (corresponding author), Univ Hosp Ctr Tours, Dept Obstet Gynecol & Fetal Med, Tours, France.	emmanuel.g.simon@gmail.com	REMENIERAS, Jean-pierre/AAB-4105-2021; Perrotin, Franck/AAL-8833-2021	REMENIERAS, Jean-pierre/0000-0001-8440-5184; Perrotin, Franck/0000-0001-9694-6658; Simon, Emmanuel/0000-0001-6442-1013				Abeysekera JM, 2017, ULTRASOUND MED BIOL, V43, P1112, DOI 10.1016/j.ultrasmedbio.2017.01.014; Alan B, 2016, INT J GYNECOL OBSTET, V135, P43, DOI 10.1016/j.ijgo.2016.03.037; Alan B, 2016, KOREAN J RADIOL, V17, P218, DOI 10.3348/kjr.2016.17.2.218; Albayrak E, 2016, CLIN IMAG, V40, P926, DOI 10.1016/j.clinimag.2016.04.006; Bamber J, 2013, ULTRASCHALL MED, V34, P169, DOI 10.1055/s-0033-1335205; Barr RG, 2015, ULTRASOUND MED BIOL, V41, P1148, DOI 10.1016/j.ultrasmedbio.2015.03.008; Barry CT, 2014, ULTRASOUND MED BIOL, V40, P704, DOI 10.1016/j.ultrasmedbio.2013.10.016; Catheline S, 2004, J ACOUST SOC AM, V116, P3734, DOI 10.1121/1.1815075; Cimsit C, 2015, ARCH GYNECOL OBSTET, V291, P811, DOI 10.1007/s00404-014-3479-y; Cimsit C, 2015, J ULTRAS MED, V34, P151, DOI 10.7863/ultra.34.1.151; Correas J-M, 2013, Diagn Interv Imaging, V94, P551, DOI 10.1016/j.diii.2013.01.017; Dasgeb B, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150344; Di Ieva A, 2010, NEUROSURG REV, V33, P137, DOI 10.1007/s10143-010-0249-6; Durhan G, 2017, ULTRASOUND MED BIOL, V43, P111, DOI 10.1016/j.ultrasmedbio.2016.08.037; Falco ML, 2017, ULTRASOUND OBST GYN, V50, P295, DOI 10.1002/uog.17494; Fink M, 2013, Diagn Interv Imaging, V94, P485, DOI 10.1016/j.diii.2013.02.007; Frulio N, 2013, Diagn Interv Imaging, V94, P515, DOI 10.1016/j.diii.2013.02.005; Gennisson J-L, 2013, Diagn Interv Imaging, V94, P487, DOI 10.1016/j.diii.2013.01.022; Grenier N, 2013, Diagn Interv Imaging, V94, P545, DOI 10.1016/j.diii.2013.02.003; Habibi HA, 2017, EUR J RADIOL, V97, P16, DOI 10.1016/j.ejrad.2017.10.007; HOEKS APG, 1994, ULTRASOUND MED BIOL, V20, P953, DOI 10.1016/0301-5629(94)90054-X; Holm S, 2010, J ACOUST SOC AM, V127, P542, DOI 10.1121/1.3268508; Karaman E, 2016, J OBSTET GYNAECOL RE, V42, P1464, DOI 10.1111/jog.13078; KASAI C, 1985, IEEE T SON ULTRASON, V32, P458, DOI 10.1109/T-SU.1985.31615; Kaufmann P, 2004, PLACENTA, V25, P114, DOI 10.1016/j.placenta.2003.10.009; Kilic F, 2015, DIAGN INTERV RADIOL, V21, P202, DOI 10.5152/dir.2014.14338; Kingdom J, 2000, EUR J OBSTET GYN R B, V92, P35, DOI 10.1016/S0301-2115(00)00423-1; Li WJ, 2012, CLIN EXP OBSTET GYN, V39, P470; Lupsor-Platon M, 2015, WORLD J GASTROENTERO, V21, P11914, DOI 10.3748/wjg.v21.i42.11914; Macara L, 1996, PLACENTA, V17, P37, DOI 10.1016/S0143-4004(05)80642-3; Mastrolia SA, 2016, J MATERN-FETAL NEO M, V29, P921, DOI 10.3109/14767058.2015.1023709; Mayhew TM, 2004, PLACENTA, V25, P127, DOI 10.1016/j.placenta.2003.10.010; Mayhew TM, 2004, PLACENTA, V25, P829, DOI 10.1016/j.placenta.2004.04.011; Mayhew TM, 2003, PLACENTA, V24, P191, DOI 10.1053/plac.2002.0895; McAleavey SA, 2016, ULTRASOUND MED BIOL, V42, P1282, DOI 10.1016/j.ultrasmedbio.2016.01.009; McCarthy R, 2016, EUR J OBSTET GYN R B, V197, P130, DOI 10.1016/j.ejogrb.2015.12.015; Messas E, 2013, Diagn Interv Imaging, V94, P561, DOI 10.1016/j.diii.2013.01.025; Monpeyssen H, 2013, Diagn Interv Imaging, V94, P535, DOI 10.1016/j.diii.2013.01.023; Nicolas E, 2018, ULTRASONICS, V84, P119, DOI 10.1016/j.ultras.2017.10.009; Nicolle S, 2010, J BIOMECH, V43, P927, DOI 10.1016/j.jbiomech.2009.11.002; Ohmaru T, 2015, PLACENTA, V36, P915, DOI 10.1016/j.placenta.2015.06.008; Pavlov CS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010542.pub2; Quarello E, 2015, GYNECOL OBSTET FERTI, V43, P200, DOI 10.1016/j.gyobfe.2015.01.004; Quarello E, 2015, PRENATAL DIAG, V35, P1112, DOI 10.1002/pd.4655; Quibel T, 2015, PRENATAL DIAG, V35, P1106, DOI 10.1002/pd.4654; Roland CS, 2016, CELL MOL LIFE SCI, V73, P365, DOI 10.1007/s00018-015-2069-x; Ronot M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094679; Scifres CM, 2009, J PHYSIOL-LONDON, V587, P3453, DOI 10.1113/jphysiol.2009.173252; Shiina T, 2015, ULTRASOUND MED BIOL, V41, P1126, DOI 10.1016/j.ultrasmedbio.2015.03.009; Simon EG, 2017, J OBSTET GYNAECOL RE, V43, P1509, DOI 10.1111/jog.13383; Sinkus R, 2007, MAGN RESON MED, V58, P1135, DOI 10.1002/mrm.21404; Sugitani M, 2013, PLACENTA, V34, P1009, DOI 10.1016/j.placenta.2013.08.014; Torricelli M, 2015, PLACENTA, V36, P463, DOI 10.1016/j.placenta.2014.12.018; Vedmedovska N, 2011, EUR J OBSTET GYN R B, V155, P36, DOI 10.1016/j.ejogrb.2010.11.017; Wu SZ, 2016, ULTRASONOGRAPHY, V35, P253, DOI 10.14366/usg.16002; Yuksel MA, 2016, J OBSTET GYNAECOL, V36, P585, DOI 10.3109/01443615.2015.1110120	56	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194309	10.1371/journal.pone.0194309	http://dx.doi.org/10.1371/journal.pone.0194309			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621270	Green Published, gold, Green Submitted			2022-12-26	WOS:000429206800015
J	Yurchenko, KS; Zhou, PP; Kovner, AV; Zavjalov, EL; Shestopalova, LV; Shestopalov, AM				Yurchenko, Kseniya S.; Zhou, Peipei; Kovner, Anna V.; Zavjalov, Evgenii L.; Shestopalova, Lidiya V.; Shestopalov, Alexander M.			Oncolytic effect of wild-type Newcastle disease virus isolates in cancer cell lines in vitro and in vivo on xenograft model	PLOS ONE			English	Article							PANCREATIC ADENOCARCINOMA; INFECTION; APOPTOSIS; REPLICATION; VIROTHERAPY; RESPONSES; MTH-68/H; GLIOMA; DEATH; TRIAL	Oncolyic virotherapy is one of the modern experimental techniques to treat human cancers. Here we studied the antitumor activity of wild-type Newcastle disease virus (NDV) isolates from Russian migratory birds. We showed that NDV could selectively kill malignant cells without affecting healthy cells. We evaluated the oncolytic effect of 44 NDV isolates in 4 histogenetically different human cell lines (HCT116, HeLa, A549, MCF7). The safety of the isolates was also tested in normal peripheral blood mononuclear (PBMC) cells. The viability of tumor cell lines after incubation with NDV isolates was evaluated by MTT. All cell lines, except for normal PBMC primary cells, had different degrees of susceptibility to NDV infection. Seven NDV strains had the highest oncolytic activity, and some NDV strains demonstrated oncolytic selectivity for different cell lines. In vivo, we described the intratumoral activity of NDV/Altai/pigeon/770/2011 against subcutaneous non-small cell lung carcinoma using xenograft SCID mice model. All animals were responsive to therapy. Histology confirmed therapy-induced destructive changes and growing necrotic bulk density in tumor tissue. Our findings indicate that wild-type NDV strains selectively kill tumor cells with no effect on healthy PBMC cells, and intratumoral virotherapy with NDV suppresses the subcutaneous tumor growth in SCID mice.	[Yurchenko, Kseniya S.; Kovner, Anna V.; Shestopalov, Alexander M.] Res Inst Expt & Clin Med, Subdiv FRC FTM, Novosibirsk, Novosibirsk Reg, Russia; [Zhou, Peipei; Shestopalova, Lidiya V.] Novosibirsk State Univ, Novosibirsk, Novosibirsk Reg, Russia; [Zhou, Peipei] Heilongjiang Univ, Harbin, Heilongjiang, Peoples R China; [Zavjalov, Evgenii L.] Russian Acad Sci, Ctr Genet Resources Lab Anim, Inst Cytol & Genet, Siberian Branch, Novosibirsk, Novosibirsk Reg, Russia	Novosibirsk State University; Heilongjiang University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Yurchenko, KS (corresponding author), Res Inst Expt & Clin Med, Subdiv FRC FTM, Novosibirsk, Novosibirsk Reg, Russia.	xenia7yurchenko@gmail.com	Zavjalov, Evgenii/X-2415-2019; Shestopalov, Alexander/AAO-5569-2020; Yurchenko, Kseniya/S-2821-2019; Shestopalova, Lidiya V/E-4056-2014; kovner, anna/L-9133-2015	Shestopalova, Lidiya V/0000-0002-6619-2135; kovner, anna/0000-0001-9543-9005; Yurchenko, Kseniya/0000-0002-0679-8493	Russian Scientific Foundation [17-44-07001]; small grant of the mayoralty of the city of Novosibirsk for young scientists; Ministry of Education and Science of Russia [RFMEFI62117X0015]; Russian Science Foundation [17-44-07001] Funding Source: Russian Science Foundation	Russian Scientific Foundation(Russian Science Foundation (RSF)); small grant of the mayoralty of the city of Novosibirsk for young scientists; Ministry of Education and Science of Russia(Ministry of Education and Science, Russian Federation); Russian Science Foundation(Russian Science Foundation (RSF))	The study was supported partially by a grant of Russian Scientific Foundation (project No. 17-44-07001) in the part of monitoring and analysis of viral samples isolated from migratory birds in the framework of monitoring of influenza virus. The animal study was financed by a small grant of the mayoralty of the city of Novosibirsk for young scientists. The animal study was carried out in the Center for Genetic Resources of Laboratory Animals at the Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences, supported by the Ministry of Education and Science of Russia (RFMEFI62117X0015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D. J., 2008, DIS POULTRY, P74; Altomonte J, 2010, MOL THER, V18, P275, DOI 10.1038/mt.2009.231; An Y, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0273-0; Apostolidis L, 2007, INT J ONCOL, V31, P1009; Arifin MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/586363; Bai FL, 2014, CANCER BIOL THER, V15, P1226, DOI 10.4161/cbt.29686; Bian JC, 2011, ARCH VIROL, V156, P1335, DOI 10.1007/s00705-011-0987-y; Buijs PRA, 2014, CANCER GENE THER, V21, P24, DOI 10.1038/cgt.2013.78; Buijs P, 2015, VIRUSES-BASEL, V7, P2980, DOI 10.3390/v7062756; Cox RM, 2017, CURR OPIN VIROL, V24, P105, DOI 10.1016/j.coviro.2017.05.004; Csatary LK, 2004, J NEURO-ONCOL, V67, P83, DOI 10.1023/B:NEON.0000021735.85511.05; Elankumaran S, 2006, J VIROL, V80, P7522, DOI 10.1128/JVI.00241-06; Elankumaran S, 2010, J VIROL, V84, P3835, DOI 10.1128/JVI.01553-09; Fournier P, 2012, METHODS MOL BIOL, V797, P177, DOI 10.1007/978-1-61779-340-0_13; Freeman AI, 2006, MOL THER, V13, P221, DOI 10.1016/j.ymthe.2005.08.016; Ghrici M, 2013, INT J MOL MED, V31, P525, DOI 10.3892/ijmm.2013.1244; Grimes S.E., 2002, BASIC LAB MANUAL SMA; Kabilov M. R., 2016, GENOME ANNOUNC, V4; Koks CA, 2015, INT J CANCER, V136, pE313, DOI 10.1002/ijc.29202; Krishnamurthy S, 2006, J VIROL, V80, P5145, DOI 10.1128/JVI.02618-05; Lam HY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/718710; Laurie SA, 2006, CLIN CANCER RES, V12, P2555, DOI 10.1158/1078-0432.CCR-05-2038; Lazar I, 2010, J VIROL, V84, P639, DOI 10.1128/JVI.00401-09; Li PD, 2011, HEAD NECK-J SCI SPEC, V33, P1394, DOI 10.1002/hed.21609; Mayo MA, 2002, ARCH VIROL, V147, P1655, DOI 10.1007/s007050200039; Meng CC, 2012, ARCH VIROL, V157, P1011, DOI 10.1007/s00705-012-1270-6; Miller P., 2013, DIS POULTRY, P89, DOI DOI 10.1002/9781119421481.CH3.(HTTPS://D0I.0RG/); Miller PJ, 2010, INFECT GENET EVOL, V10, P26, DOI 10.1016/j.meegid.2009.09.012; Molouki A, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-179; Molouki A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-385; MOORE AE, 1952, P SOC EXP BIOL MED, V81, P498; NIH National Cancer Institute, TOP INT ALT COMPL TH; Pecora AL, 2002, J CLIN ONCOL, V20, P2251, DOI 10.1200/JCO.2002.08.042; Puhlmann J, 2010, ONCOGENE, V29, P2205, DOI 10.1038/onc.2009.507; Ravindra PV, 2009, VIRUS RES, V141, P13, DOI 10.1016/j.virusres.2008.12.008; REICHARD KW, 1992, J SURG RES, V52, P448, DOI 10.1016/0022-4804(92)90310-V; Schirrmacher V, 1999, GENE THER, V6, P63, DOI 10.1038/sj.gt.3300787; Schirrmacher V, 2016, BIOMEDICINES, V4, DOI 10.3390/biomedicines4030016; Song KY, 2010, J MOL MED, V88, P589, DOI 10.1007/s00109-010-0605-6; Wagner S, 2006, APMIS, V114, P731, DOI 10.1111/j.1600-0463.2006.apm_516.x; Walter RJ, 2012, J PANCREAS, V13, P45; Yaacov B, 2012, J GEN VIROL, V93, P1664, DOI 10.1099/vir.0.043281-0; Yurchenko K. S, 2015, GENOME ANNOUNC, V3, P1514, DOI DOI 10.1128/GEN0MEA.01514-14; Yurchenko KS, 2015, GENOME ANNOUNC, V3; Zamarin D, 2009, MOL THER, V17, P697, DOI 10.1038/mt.2008.286	46	23	28	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195425	10.1371/journal.pone.0195425	http://dx.doi.org/10.1371/journal.pone.0195425			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621357	Green Published, Green Submitted, gold			2022-12-26	WOS:000429206800077
J	Dojat, M; Pizzagalli, F; Hupe, JM				Dojat, Michel; Pizzagalli, Fabrizio; Hupe, Jean-Michel			Magnetic resonance imaging does not reveal structural alterations in the brain of grapheme-color synesthetes	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; INDIVIDUAL-DIFFERENCES; CEREBRAL-CORTEX; MR-IMAGES; VOLUME; FALSE; SEGMENTATION; CONNECTIVITY; SENSITIVITY; STATISTICS	Several publications have reported structural changes in the brain of synesthetes compared to controls, either local differences or differences in connectivity. In the present study, we pursued this quest for structural brain differences that might support the subjective experience of synesthesia. In particular, for the first time in this field, we investigated brain folding in comparing 45 sulcal shapes in each hemisphere of control and grapheme-color synesthete populations. To overcome flaws relative to data interpretation based only on p-values, common in the synesthesia literature, we report confidence intervals of effect sizes. Moreover, our statistical maps are displayed without introducing the classical, but misleading, p value level threshold. We adopt such a methodological procedure to facilitate appropriate data interpretation and promote the "New Statistics" approach. Based on structural or diffusion magnetic resonance imaging data, we did not find any strong cerebral anomaly, in sulci, tissue volume, tissue density or fiber organization that could support synesthetic color experience. Finally, by sharing our complete datasets, we strongly support the multi-center construction of a sufficient large dataset repository for detecting, if any, subtle brain differences that may help understanding how a subjective experience, such as synesthesia, is mentally constructed.	[Dojat, Michel; Pizzagalli, Fabrizio] Univ Grenoble Alpes, Grenoble Inst Neurosci, Inst Natl Sante & Rech Med, Grenoble, France; [Dojat, Michel; Pizzagalli, Fabrizio] Ctr Hosp Univ Grenoble Alpes, Grenoble, France; [Hupe, Jean-Michel] Univ Toulouse Paul Sabatier, Ctr Rech Cerveau & Cognit, Toulouse, France; [Hupe, Jean-Michel] CNRS, Toulouse, France; [Pizzagalli, Fabrizio] Univ Southern Calif, Mark & Mary Stevens Neuroimaging & Informat Inst, Los Angeles, CA USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); University of Southern California	Dojat, M (corresponding author), Univ Grenoble Alpes, Grenoble Inst Neurosci, Inst Natl Sante & Rech Med, Grenoble, France.; Dojat, M (corresponding author), Ctr Hosp Univ Grenoble Alpes, Grenoble, France.	Michel.Dojat@univ-grenoble-alpes.fr	Pizzagalli, Fabrizio/AAE-4990-2022; Dojat, Michel/G-7758-2011	Dojat, Michel/0000-0003-2747-6845; Pizzagalli, Fabrizio/0000-0003-4582-0224	Agence Nationale de Recherche [ANR-11-BSH2-010]; French program "Investissement d'avenir" run by the Agence Nationale pour la Recherche grant "Infrastructure d'Avenir en Biologie Sante" [ANR11-INBS-0006]; NIH Big Data [U54 EB020403]	Agence Nationale de Recherche(French National Research Agency (ANR)); French program "Investissement d'avenir" run by the Agence Nationale pour la Recherche grant "Infrastructure d'Avenir en Biologie Sante"(French National Research Agency (ANR)); NIH Big Data	Research funded by Agence Nationale de Recherche ANR-11-BSH2-010. Grenoble MRI facility IRMaGe was partly funded by the French program "Investissement d'avenir" run by the Agence Nationale pour la Recherche grant "Infrastructure d'Avenir en Biologie Sante" ANR11-INBS-0006. We thank the technical staff at the 3T scanner facility from IRMaGe unit. F. Pizzagalli is also presently funded by the NIH Big Data to Knowledge (BD2K) Center of Excellence grant U54 EB020403 (to Prof. Paul M. Thompson).	Abe O, 2010, NEURORADIOLOGY, V52, P699, DOI 10.1007/s00234-010-0716-3; Aleman-Gomez Y, 2013, J NEUROSCI, V33, P15004, DOI 10.1523/JNEUROSCI.1459-13.2013; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Auzias G, 2014, NEUROIMAGE-CLIN, V4, P593, DOI 10.1016/j.nicl.2014.03.008; Banissy MJ, 2012, COGN NEUROSCI-UK, V3, P29, DOI 10.1080/17588928.2011.594499; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Callaert DV, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00124; Chun CA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00776; COHEN J, 1994, AM PSYCHOL, V49, P997, DOI 10.1037/0003-066X.50.12.1103; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; de Boer R, 2010, NEUROIMAGE, V51, P1047, DOI 10.1016/j.neuroimage.2010.03.012; Eagleman DM, 2007, J NEUROSCI METH, V159, P139, DOI 10.1016/j.jneumeth.2006.07.012; Eagleman DM, 2009, TRENDS COGN SCI, V13, P288, DOI 10.1016/j.tics.2009.03.009; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Fiedler K, 2012, PERSPECT PSYCHOL SCI, V7, P661, DOI 10.1177/1745691612462587; Focke NK, 2011, NEUROIMAGE, V56, P1164, DOI 10.1016/j.neuroimage.2011.02.029; Fusar-Poli P, 2014, HUM BRAIN MAPP, V35, P3052, DOI 10.1002/hbm.22384; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gregory MD, 2016, CURR BIOL, V26, P1301, DOI 10.1016/j.cub.2016.03.021; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; Hanggi J, 2011, J NEUROSCI, V31, P5816, DOI 10.1523/JNEUROSCI.0964-10.2011; Hubbard EM, 2005, NEURON, V45, P975, DOI 10.1016/j.neuron.2005.02.008; Hupe JM, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00103; Hupe JM, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00018; Hupe JM, 2012, CEREB CORTEX, V22, P1622, DOI 10.1093/cercor/bhr236; Im K, 2008, NEUROIMAGE, V43, P103, DOI 10.1016/j.neuroimage.2008.07.016; Ioannidis JPA, 2011, ARCH GEN PSYCHIAT, V68, P773, DOI 10.1001/archgenpsychiatry.2011.28; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jancke L, 2009, EUR J NEUROSCI, V29, P1287, DOI 10.1111/j.1460-9568.2009.06673.x; Kurth F, 2015, NAT PROTOC, V10, P293, DOI 10.1038/nprot.2015.014; Liu T, 2011, NEUROIMAGE, V56, P865, DOI 10.1016/j.neuroimage.2011.03.015; Luders E, 2008, CEREB CORTEX, V18, P2019, DOI 10.1093/cercor/bhm227; Mangin JF, 2004, IEEE T MED IMAGING, V23, P968, DOI 10.1109/TMI.2004.831204; Manjon JV, 2015, MED IMAGE ANAL, V22, P35, DOI 10.1016/j.media.2015.01.004; Manjon JV, 2010, J MAGN RESON IMAGING, V31, P192, DOI 10.1002/jmri.22003; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; Melero H, 2013, EXP BRAIN RES, V227, P343, DOI 10.1007/s00221-013-3514-4; Nichols TE, 2017, NAT NEUROSCI, V20, P299, DOI 10.1038/nn.4500; Nunn JA, 2002, NAT NEUROSCI, V5, P371, DOI 10.1038/nn818; O'Hanlon E, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00755; Perrot M, 2011, MED IMAGE ANAL, V15, P529, DOI 10.1016/j.media.2011.02.008; Pizzagalli F, GENETIC ANAL CORTICA; Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663; Ridgway GR, 2008, NEUROIMAGE, V40, P1429, DOI 10.1016/j.neuroimage.2008.01.003; Rouw R, 2007, NAT NEUROSCI, V10, P792, DOI 10.1038/nn1906; Rouw R, 2011, J NEUROPSYCHOL, V5, P214, DOI 10.1111/j.1748-6653.2011.02006.x; Rouw R, 2010, J NEUROSCI, V30, P6205, DOI 10.1523/JNEUROSCI.3444-09.2010; Ruiz MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119377; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Scarpazza C, 2015, NEUROSCI BIOBEHAV R, V52, P49, DOI 10.1016/j.neubiorev.2015.02.008; Senjem ML, 2005, NEUROIMAGE, V26, P600, DOI 10.1016/j.neuroimage.2005.02.005; Silver M, 2011, NEUROIMAGE, V54, P992, DOI 10.1016/j.neuroimage.2010.08.049; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sowell ER, 2002, CEREB CORTEX, V12, P17, DOI 10.1093/cercor/12.1.17; Stiers P, 2006, NEUROIMAGE, V29, P74, DOI 10.1016/j.neuroimage.2005.07.033; Takao H, 2014, NEUROIMAGE, V84, P133, DOI 10.1016/j.neuroimage.2013.08.046; Tardif CL, 2009, NEUROIMAGE, V44, P827, DOI 10.1016/j.neuroimage.2008.09.053; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; Van Hecke W, 2010, HUM BRAIN MAPP, V31, P98, DOI 10.1002/hbm.20848; Weiss PH, 2009, BRAIN, V132, P65, DOI 10.1093/brain/awn304; Whitaker KJ, 2014, NEUROIMAGE, V90, P52, DOI 10.1016/j.neuroimage.2013.12.054; Whitwell JL, 2009, J NEUROSCI, V29, P9661, DOI 10.1523/JNEUROSCI.2160-09.2009; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Witthoft N, 2013, PSYCHOL SCI, V24, P258, DOI 10.1177/0956797612452573; Zamm A, 2013, NEUROIMAGE, V74, P359, DOI 10.1016/j.neuroimage.2013.02.024	70	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194422	10.1371/journal.pone.0194422	http://dx.doi.org/10.1371/journal.pone.0194422			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617401	Green Published, gold, Green Submitted			2022-12-26	WOS:000429203800030
J	Han, Q; Chen, R; Wang, FJ; Chen, S; Sun, XS; Guan, X; Yang, Y; Peng, BJ; Pan, XD; Li, JF; Yi, WJ; Li, P; Zhang, HW; Feng, DF; Chen, A; Li, XH; Li, SH; Yin, ZM				Han, Qi; Chen, Rui; Wang, Fangjie; Chen, Sha; Sun, Xiongshan; Guan, Xiao; Yang, Yao; Peng, Bingjie; Pan, Xiaodong; Li, Jinfang; Yi, Weijing; Li, Peng; Zhang, Hongwei; Feng, Dongfang; Chen, An; Li, Xiaohui; Li, Shuhui; Yin, Zuoming			Pre-exposure to 50 Hz-electromagnetic fields enhanced the antiproliferative efficacy of 5-fluorouracil in breast cancer MCF-7 cells	PLOS ONE			English	Article							MULTICENTER RANDOMIZED-TRIAL; METASTATIC COLORECTAL-CANCER; ALTERNATING ELECTRIC-FIELDS; 1ST-LINE TREATMENT; DRUG-RESISTANCE; MAGNETIC-FIELDS; EXPOSURE; PROLIFERATION; CYCLE; COMMUNICATION	Resistance to 5-fluorouracil (5-FU) and its induced immune suppression have prevented its extensive application in the clinical treatment of breast cancer. In this study, the combined effect of 50 Hz-EMFs and 5-FU in the treatment of breast cancer was explored. MCF-7 and MCF10A cells were pre-exposed to 50 Hz-EMFs for 0, 2, 4, 8 and 12 h and then treated with different concentrations of 5-FU for 24 h; cell viability was analyzed by MTT assay and flow cytometry. After pre-exposure to 50 Hz-EMFs for 12 h, apoptosis and cell cycle distribution in MCF-7 and MCF10A cells were detected via flow cytometry and DNA synthesis was measured by EdU incorporation assay. Apoptosis-related and cell cycle-related gene and protein expression levels were monitored by qPCR and western blotting. Pre-exposure to 50 Hz-EMFs for 12 h enhanced the antiproliferative effect of 5-FU in breast cancer cell line MCF-7 in a dose-dependent manner but not in normal human breast epithelial cell line MCF10A. Exposure to 50 Hz-EMFs had no effect on apoptosis and P53 expression of MCF-7 and MCF10A cells, whereas it promoted DNA synthesis, induced entry of MCF-7 cells into the S phase of cell cycle, and upregulated the expression levels of cell cycle-related proteins Cyclin D1 and Cyclin E. Considering the pharmacological mechanisms of 5-FU in specifically disrupting DNA synthesis, this enhanced inhibitory effect might have resulted from the specific sensitivity of MCF7 cells in active S phase to 5-FU. Our findings demonstrate the enhanced cytotoxic activity of 5-FU on MCF7 cells through promoting entry into the S phase of the cell cycle via exposure to 50 Hz-EMFs, which provides a novel method of cancer treatment based on the combinatorial use of 50 Hz-EMFs and chemotherapy.	[Han, Qi; Zhang, Hongwei; Feng, Dongfang; Yin, Zuoming] Gen Hosp Tibet Area Mil Command, Lhasa, Peoples R China; [Han, Qi; Chen, Sha; Peng, Bingjie; Li, Jinfang; Yi, Weijing; Chen, An; Li, Shuhui] Third Mil Med Univ, Southwest Hosp, Fac Med Lab Sci, Dept Clin Biochem, Chongqing, Peoples R China; [Han, Qi; Wang, Fangjie; Sun, Xiongshan; Guan, Xiao; Yang, Yao; Pan, Xiaodong; Li, Xiaohui] Third Mil Med Univ, Inst Mat Med, Coll Pharm, Chongqing, Peoples R China; [Chen, Rui] Tibetan Tradit Med Coll, Lhasa, Peoples R China; [Li, Peng] 201th Hosp Peoples Liberat Army, Urol, Liaoyang, Peoples R China	Army Medical University; Army Medical University; University of Tibetan Medicine	Yin, ZM (corresponding author), Gen Hosp Tibet Area Mil Command, Lhasa, Peoples R China.; Li, SH (corresponding author), Third Mil Med Univ, Southwest Hosp, Fac Med Lab Sci, Dept Clin Biochem, Chongqing, Peoples R China.; Li, XH (corresponding author), Third Mil Med Univ, Inst Mat Med, Coll Pharm, Chongqing, Peoples R China.	lpsh008@aliyun.com; lishuhui316@yeah.net; yinzuoming@163.com		Xiongshan, Sun/0000-0002-7958-0620	National Natural Science Foundation of China [81472481, 81272909, 81402513]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81472481 to SL, 81272909 to SL, and 81402513 to SC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Natural Science Foundation of China (81472481, 81272909 and 81402513). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali FM, 2011, TECHNOL HEALTH CARE, V19, P455, DOI 10.3233/THC-2011-0649; Barbault A, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-51; Berg H, 2010, ELECTROMAGN BIOL MED, V29, P132, DOI 10.3109/15368371003776725; Bourthoumieu S, 2013, BIOELECTROMAGNETICS, V34, P52, DOI 10.1002/bem.21744; Chen S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.380; Crocetti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072944; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Destefanis M, 2015, INT J RADIAT BIOL, V91, P964, DOI 10.3109/09553002.2015.1101648; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Giacchetti S, 2000, J CLIN ONCOL, V18, P136, DOI 10.1200/JCO.2000.18.1.136; Gomez MJR, 2001, BIOELECTROCHEMISTRY, V53, P137, DOI 10.1016/S0302-4598(00)00119-7; Griffin GD, 2000, BIOELECTROCHEMISTRY, V51, P117, DOI 10.1016/S0302-4598(99)00085-9; Hirata M, 2001, ANTICANCER RES, V21, P317; Hirose H, 2006, BIOELECTROMAGNETICS, V27, P494, DOI 10.1002/bem.20238; Hu CMJ, 2012, BIOCHEM PHARMACOL, V83, P1104, DOI 10.1016/j.bcp.2012.01.008; Jin ZD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046102; Jordan VC, 2016, CANCER RES, V76, P767, DOI 10.1158/0008-5472.CAN-16-0150; Kang L, 2015, ACTA PHARM SIN B, V5, P169, DOI 10.1016/j.apsb.2015.03.001; Kheifets L, 2010, BRIT J CANCER, V103, P1128, DOI 10.1038/sj.bjc.6605838; Kirson ED, 2004, CANCER RES, V64, P3288, DOI 10.1158/0008-5472.CAN-04-0083; Kirson ED, 2007, P NATL ACAD SCI USA, V104, P10152, DOI 10.1073/pnas.0702916104; Kirson ED, 2009, CLIN EXP METASTAS, V26, P633, DOI 10.1007/s10585-009-9262-y; Li JR, 1999, RADIAT RES, V151, P710, DOI 10.2307/3580210; Lim S, 2015, BIOMED ENVIRON SCI, V28, P231, DOI 10.3967/bes2015.032; Liu YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042332; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Moreno-Layseca P, 2014, MATRIX BIOL, V34, P144, DOI 10.1016/j.matbio.2013.10.011; Jimenez-Garcia MN, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-159; Ouyang L, 2012, CELL PROLIFERAT, V45, P487, DOI 10.1111/j.1365-2184.2012.00845.x; Percherancier Y, 2015, BIOELECTROMAGNETICS, V36, P287, DOI 10.1002/bem.21908; Schuz J, 2011, PROG BIOPHYS MOL BIO, V107, P339, DOI 10.1016/j.pbiomolbio.2011.09.008; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; STEVENS RG, 1987, AM J EPIDEMIOL, V125, P556, DOI 10.1093/oxfordjournals.aje.a114569; Taghi M, 2013, RECENT PATENTS ENDOC, V7, P252, DOI 10.2174/18722148113079990007; Taghi M, 2012, RECENT PATENTS ENDOC, V6, P251, DOI 10.2174/187221412802481757; Visweswaran M, 2018, INT J BIOCHEM CELL B, V95, P63, DOI 10.1016/j.biocel.2017.12.013; Wolf FI, 2005, BBA-MOL CELL RES, V1743, P120, DOI 10.1016/j.bbamcr.2004.09.005; Yan Y, 2012, ACS NANO, V6, P3663, DOI 10.1021/nn3016162; Yang Min-li, 2015, Zhejiang Da Xue Xue Bao Yi Xue Ban, V44, P323; Zhao G, 2014, EUR J GYNAECOL ONCOL, V35, P264; Zimmerman JW, 2012, BRIT J CANCER, V106, P307, DOI 10.1038/bjc.2011.523	42	15	16	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0192888	10.1371/journal.pone.0192888	http://dx.doi.org/10.1371/journal.pone.0192888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617363	gold, Green Published, Green Submitted			2022-12-26	WOS:000429203800005
J	Kuret, T; Lakota, K; Mali, P; Cucnik, S; Praprotnik, S; Tomsic, M; Sodin-Semrl, S				Kuret, Tadeja; Lakota, Katja; Mali, Polonca; Cucnik, Sasa; Praprotnik, Sonja; Tomsic, Matija; Sodin-Semrl, Snezna			Naturally occurring antibodies against serum amyloid A reduce IL-6 release from peripheral blood mononuclear cells	PLOS ONE			English	Article							ACUTE-PHASE PROTEINS; NECROSIS-FACTOR-ALPHA; C-REACTIVE PROTEIN; MESSENGER-RNA EXPRESSION; INTRAVENOUS IMMUNOGLOBULIN; AA AMYLOIDOSIS; RHEUMATOID-ARTHRITIS; RECEPTOR ANTIBODY; DISEASE; AUTOANTIBODIES	Serum amyloid A (SAA) is a sensitive inflammatory marker rapidly increased in response to infection, injury or trauma during the acute phase. Resolution of the acute phase and SAA reduction are well documented, however the exact mechanism remains elusive. Two inducible SAA proteins, SAA1 and SAA2, with their variants could contribute to systemic inflammation. While unconjugated human variant SAA1 alpha is already commercially available, the variants of SAA2 are not. Antibodies against SAA have been identified in apparently healthy blood donors (HBDs) in smaller, preliminary studies. So, our objective was to detect antiSAA and anti-SAA1 alpha autoantibodies in the sera of 300 HBDs using ELISA, characterize their specificity and avidity. Additionally, we aimed to determine the presence of anti-SAA and anti-SAA1 alpha autoantibodies in intravenous immunoglobulin (IVIg) preparations and examine their effects on released IL-6 from SAA/SAA1 alpha-treated peripheral blood mononuclear cells (PBMCs). Autoantibodies against SAA and SAA1 alpha had a median (IQR) absorbance OD (A(450)) of 0.655 (0.262-1.293) and 0.493 (0.284-0.713), respectively. Both antiSAA and anti-SAA1 alpha exhibited heterogeneous to high avidity and reached peak levels between 41-50 years, then diminished with age in the oldest group (51-67 years). Women consistently exhibited significantly higher levels than men. Good positive correlation was observed between anti-SAA and anti-SAA1 alpha. Both anti-SAA and anti-SAA1 alpha were detected in IVIg, their fractions subsequently isolated, and shown to decrease IL-6 protein levels released from SAA/SAA1 alpha-treated PBMCs. In conclusion, naturally occurring antibodies against SAA and anti-SAA1 alpha could play a physiological role in down-regulating their antigen and proinflammatory cytokines leading to the resolution of the acute phase and could be an important therapeutic option in patients with chronic inflammatory diseases.	[Kuret, Tadeja; Lakota, Katja; Cucnik, Sasa; Praprotnik, Sonja; Tomsic, Matija; Sodin-Semrl, Snezna] Univ Med Ctr Ljubljana, Dept Rheumatol, Ljubljana, Slovenia; [Lakota, Katja; Sodin-Semrl, Snezna] Univ Primorska, Fac Math Nat Sci & Informat Technol, Koper, Slovenia; [Mali, Polonca] Blood Transfus Ctr Slovenia, Ljubljana, Slovenia; [Cucnik, Sasa] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia; [Tomsic, Matija] Univ Ljubljana, Fac Med, Ljubljana, Slovenia	University Medical Centre Ljubljana; University of Primorska; University of Ljubljana; University of Ljubljana	Sodin-Semrl, S (corresponding author), Univ Med Ctr Ljubljana, Dept Rheumatol, Ljubljana, Slovenia.; Sodin-Semrl, S (corresponding author), Univ Primorska, Fac Math Nat Sci & Informat Technol, Koper, Slovenia.	ssodin1@yahoo.com	Lakota, Katja/AAH-8033-2020; Sodin-Semrl, Snezna/AAJ-8954-2020; Kuret, Tadeja/AAJ-8170-2020	Lakota, Katja/0000-0002-8062-7908; Kuret, Tadeja/0000-0002-4749-594X	Slovenian Research Agency (ARRS) [P3-0314]; Slovenian Research Agency (ARRS), National Research Program [P3-0314]	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia); Slovenian Research Agency (ARRS), National Research Program	The authors would like to acknowledge funding from the Slovenian Research Agency (ARRS) for the National Research Program P3-0314.; This work was supported by the Slovenian Research Agency (ARRS), National Research Program P3-0314.	ALGIMAN M, 1992, P NATL ACAD SCI USA, V89, P3795, DOI 10.1073/pnas.89.9.3795; Rodriguez JA, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0055; Ather JL, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.327; AUKRUST P, 1994, BLOOD, V84, P2136; AVRAMEAS S, 1991, IMMUNOL TODAY, V12, P154; Avrameas S, 2007, J AUTOIMMUN, V29, P213, DOI 10.1016/j.jaut.2007.07.010; Afonso AFB, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010015; BOYDEN STEPHEN V., 1966, ADVANCE IMMUNOL, V5, P1, DOI 10.1016/S0065-2776(08)60271-0; Bozinovski S, 2012, P NATL ACAD SCI USA, V109, P935, DOI 10.1073/pnas.1109382109; Chen ES, 2010, AM J RESP CRIT CARE, V181, P360, DOI 10.1164/rccm.200905-0696OC; Connolly M, 2012, ARTHRITIS RHEUM-US, V64, P1035, DOI 10.1002/art.33455; Cucnik S, 2004, ANN RHEUM DIS, V63, P1478, DOI 10.1136/ard.2003.017939; De Buck M, 2016, CYTOKINE GROWTH F R, V30, P55, DOI 10.1016/j.cytogfr.2015.12.010; De Buck M, 2016, CURR MED CHEM, V23, P1725, DOI 10.2174/0929867323666160418114600; De Buck M, 2015, J LEUKOCYTE BIOL, V98, P1049, DOI 10.1189/jlb.3A0315-085R; de Seny D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066769; Eklund KK, 2012, CRIT REV IMMUNOL, V32, P335; Furlaneto CJ, 2000, BIOCHEM BIOPH RES CO, V268, P405, DOI 10.1006/bbrc.2000.2143; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gouwy M, 2015, EUR J IMMUNOL, V45, P101, DOI 10.1002/eji.201444818; GUILBERT B, 1982, J IMMUNOL, V128, P2779; Hatanaka E, 2004, IMMUNOL LETT, V91, P33, DOI 10.1016/j.imlet.2003.09.011; HAZENBERG BPC, 1994, BAILLIERE CLIN RHEUM, V8, P661, DOI 10.1016/S0950-3579(05)80121-9; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; Hocevar A, 2013, AMYLOID, V20, P275, DOI 10.3109/13506129.2013.838947; Jensen LE, 1998, BIOCHEM J, V334, P489, DOI 10.1042/bj3340489; Jura J, 2011, ACUTE PHASE PROTEINS - REGULATION AND FUNCTIONS OF ACUTE PHASE PROTEINS, P61; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaveri S, 1996, J CLIN INVEST, V97, P865, DOI 10.1172/JCI118488; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; King VL, 2011, CURR OPIN LIPIDOL, V22, P302, DOI 10.1097/MOL.0b013e3283488c39; Kurtenkov O, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6097647; Lakota K, AUTOANTIBODIES; Lakota K, 2011, AUTOIMMUN REV, V10, P779, DOI 10.1016/j.autrev.2011.06.001; Lakota K, 2011, AUTOIMMUNITY, V44, P149, DOI 10.3109/08916934.2010.487504; Lane T, 2015, CLIN EXP RHEUMATOL, V33, pS46; Lavie M, 2006, HEPATOLOGY, V44, P1626, DOI 10.1002/hep.21406; Le Pottier L, 2007, J CLIN IMMUNOL, V27, P257, DOI 10.1007/s10875-007-9082-2; Lee HY, 2005, BIOCHEM BIOPH RES CO, V330, P989, DOI 10.1016/j.bbrc.2005.03.069; LING ZD, 1993, J CLIN IMMUNOL, V13, P302, DOI 10.1007/BF00920238; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Lutz HU, 2007, J AUTOIMMUN, V29, P287, DOI 10.1016/j.jaut.2007.07.007; Malle E, 2009, CELL MOL LIFE SCI, V66, P9, DOI 10.1007/s00018-008-8321-x; Miyagawa I, 2014, MOD RHEUMATOL, V24, P405, DOI 10.3109/14397595.2013.844294; Nagele EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060726; Noskova L, 2017, BIOMED PAP, V161, P179, DOI 10.5507/bp.2017.017; O'Hara R, 2004, ARTHRITIS RHEUM-US, V50, P1788, DOI 10.1002/art.20301; O'Nuallain B, 2006, J IMMUNOL, V176, P7071, DOI 10.4049/jimmunol.176.11.7071; Okuda Y, 2006, ARTHRITIS RHEUM-US, V54, P2997, DOI 10.1002/art.22118; Patel H, 1998, SCAND J IMMUNOL, V48, P410; Patil V, 2014, AUTOANTIBODIES, P305; de Asua DR, 2014, CLIN EPIDEMIOL, V6, P369, DOI 10.2147/CLEP.S39981; Ribeiro FP, 2003, MEDIAT INFLAMM, V12, P173, DOI 10.1080/0962935031000134897; Rieper CD, 2009, CYTOKINE GROWTH F R, V20, P61, DOI 10.1016/j.cytogfr.2009.01.003; Rosenau BJ, 2006, ANN RHEUM DIS, V65, P674, DOI 10.1136/ard.2005.037895; Rosenau BJ, 2004, J AUTOIMMUN, V23, P179, DOI 10.1016/j.jaut.2004.05.005; Scarpioni Roberto, 2016, World J Nephrol, V5, P66, DOI 10.5527/wjn.v5.i1.66; Schrodl W, 2016, PROTEOM CLIN APPL, V10, P1077, DOI 10.1002/prca.201600028; SCHULTZ DR, 1990, SEMIN ARTHRITIS RHEU, V20, P129, DOI 10.1016/0049-0172(90)90055-K; SELLAR GC, 1994, GENOMICS, V19, P221, DOI 10.1006/geno.1994.1051; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Sewell WAC, 2002, IMMUNOLOGY, V107, P387, DOI 10.1046/j.1365-2567.2002.01545.x; Simell B, 2008, CLIN VACCINE IMMUNOL, V15, P1391, DOI 10.1128/CVI.00110-08; Sjowall C, 2004, ARTHRITIS RES THER, V6, pR87, DOI 10.1186/ar1032; Sjowall C, 2002, J AUTOIMMUN, V19, P155, DOI 10.1006/jaut.2002.0608; Sjowall C, 2011, J RHEUMATOL, V38, P215, DOI 10.3899/jrheum.100690; Song CJ, 2009, ATHEROSCLEROSIS, V207, P374, DOI 10.1016/j.atherosclerosis.2009.05.007; STRACHAN AF, 1989, J BIOL CHEM, V264, P18368; Su Q, 2017, PHARM RES; Sugimoto MA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00160; Sun L, 2016, GENE, V583, P48, DOI 10.1016/j.gene.2016.02.044; Sung HJ, 2011, J PROTEOME RES, V10, P1383, DOI 10.1021/pr101154j; Takeshita S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176957; Thompson JC, 2015, J LIPID RES, V56, P286, DOI 10.1194/jlr.M054015; Tremoulet AH, 2008, J PEDIATR-US, V153, P117, DOI 10.1016/j.jpeds.2007.12.021; Ugurlu S, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0642-0; UHLAR CM, 1994, GENOMICS, V19, P228, DOI 10.1006/geno.1994.1052; van den Brand B, 2013, ARTHRITIS RHEUM-US, V65, P283, DOI 10.1002/art.37737; van der Westhuyzen DR, 2005, J BIOL CHEM, V280, P35890, DOI 10.1074/jbc.M505685200; von Stemann JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179981; Westermark GT, 2015, ANNU REV PATHOL-MECH, V10, P321, DOI 10.1146/annurev-pathol-020712-163913; Wu KH, 2006, PEDIAT ALLERG IMM-UK, V17, P60, DOI 10.1111/j.1399-3038.2005.00344.x; Xu YY, 2006, CLIN CHEM LAB MED, V44, P59, DOI 10.1515/CCLM.2006.012; Ye RD, 2015, J LEUKOCYTE BIOL, V98, P923, DOI 10.1189/jlb.3VMR0315-080R; Yu N, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12320; Zavdy O, AUTOANTIBODIES	87	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195346	10.1371/journal.pone.0195346	http://dx.doi.org/10.1371/journal.pone.0195346			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617422	Green Submitted, Green Published, gold			2022-12-26	WOS:000429203800077
J	Ronning, SB; Pedersen, ME; Berg, RS; Kirkhus, B; Rodbotten, R				Ronning, Sissel Beate; Pedersen, Mona Elisabeth; Berg, Ragnhild Stenberg; Kirkhus, Bente; Rodbotten, Rune			Vitamin K2 improves proliferation and migration of bovine skeletal muscle cells in vitro	PLOS ONE			English	Article							SATELLITE CELL; BONE; DIFFERENTIATION; LIPOPROTEINS; EXPRESSION; MECHANISM; TRANSPORT; RANKL	Skeletal muscle function is highly dependent on the ability to regenerate, however, during ageing or disease, the proliferative capacity is reduced, leading to loss of muscle function. We have previously demonstrated the presence of vitamin K2 in bovine skeletal muscles, but whether vitamin K has a role in muscle regulation and function is unknown. In this study, we used primary bovine skeletal muscle cells, cultured in monolayers in vitro, to assess a potential effect of vitamin K2 (MK-4) during myogenesis of muscle cells. Cell viability experiments demonstrate that the amount of ATP produced by the cells was unchanged when MK-4 was added, indicating viable cells. Cytotoxicity analysis show that MK-4 reduced the lactate dehydrogenase (LDH) released into the media, suggesting that MK-4 was beneficial to the muscle cells. Cell migration, proliferation and differentiation was characterised after MK-4 incubation using wound scratch analysis, immunocytochemistry and real-time PCR analysis. Adding MK-4 to the cells led to an increased muscle proliferation, increased gene expression of the myogenic transcription factor myod as well as increased cell migration. In addition, we observed a reduction in the fusion index and relative gene expression of muscle differentiation markers, with fewer complex myotubes formed in MK-4 stimulated cells compared to control cells, indicating that the MK-4 plays a significant role during the early phases of muscle proliferation. Likewise, we see the same pattern for the relative gene expression of collagen 1A, showing increased gene expression in proliferating cells, and reduced expression in differentiating cells. Our results also suggest that MK-4 incubation affect low density lipoprotein receptor-related protein 1 (LRP1) and the low-density lipoprotein receptor (LDLR) with a peak in gene expression after 45 min of MK-4 incubation. Altogether, our experiments show that MK-4 has a positive effect on muscle cell migration and proliferation, which are two important steps during early myogenesis.	[Ronning, Sissel Beate; Pedersen, Mona Elisabeth; Berg, Ragnhild Stenberg; Kirkhus, Bente; Rodbotten, Rune] Nofima AS, Norwegian Inst Food Fisheries & Aquaculture Res, As, Norway	Nofima	Ronning, SB (corresponding author), Nofima AS, Norwegian Inst Food Fisheries & Aquaculture Res, As, Norway.	sissel.ronning@nofima.no		Ronning, Sissel Beate/0000-0002-2255-0172; Kirkhus, Bente/0000-0003-2396-8906; Rodbotten, Rune/0000-0003-4775-8954	Fund for Research Levy on Agricultural Products in Norway; Norwegian Research Council [262300/F40]	Fund for Research Levy on Agricultural Products in Norway; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by grants from the Fund for Research Levy on Agricultural Products in Norway and the Norwegian Research Council, 262300/F40 (https://www.landbruksdirektoratet.no/no/fou-midler/jordbruks-og-matforskning). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexakis C, 2007, AM J PHYSIOL-CELL PH, V293, pC661, DOI 10.1152/ajpcell.00061.2007; Beulens JWJ, 2013, BRIT J NUTR, V110, P1357, DOI 10.1017/S0007114513001013; Boengler K, 2017, J CACHEXIA SARCOPENI, V8, P349, DOI 10.1002/jcsm.12178; Boldrin L, 2010, J HISTOCHEM CYTOCHEM, V58, P941, DOI 10.1369/jhc.2010.956201; Booth SL, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.5505; Braga M, 2017, ENDOCR CONNECT, V6, P139, DOI 10.1530/EC-17-0008; Brancaccio P, 2010, BIOCH MARKERS MUSCUL; Brotto M, 2015, BONE, V80, P109, DOI 10.1016/j.bone.2015.02.010; Bugel S, 2008, VITAM HORM, V78, P393, DOI 10.1016/S0083-6729(07)00016-7; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Capkovic KL, 2008, EXP CELL RES, V314, P1553, DOI 10.1016/j.yexcr.2008.01.021; Dhakshinamoorthy S, 2015, MOL BIOSYST, V11, P2406, DOI 10.1039/c5mb00237k; Gijsbers BLM, 1996, BRIT J NUTR, V76, P223, DOI 10.1079/BJN19960027; Griffin CA, 2010, J CELL SCI, V123, P3052, DOI 10.1242/jcs.066241; Grober U, 2014, DERM-ENDOCRINOL, V6, DOI 10.4161/19381972.2014.968490; Ichikawa T, 2006, J BIOL CHEM, V281, P16927, DOI 10.1074/jbc.M600896200; Kaji H, 2016, BONEKEY REP, V5, DOI 10.1038/bonekey.2016.48; Katsuyama H, 2005, INT J MOL MED, V15, P231; Kohlmeier M, 1996, J NUTR, V126, pS1192, DOI 10.1093/jn/126.suppl_4.1192S; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Matheson S, 2005, J PERIODONTAL RES, V40, P312, DOI 10.1111/j.1600-0765.2005.00800.x; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Mochida Y, 2009, MATRIX BIOL, V28, P44, DOI 10.1016/j.matbio.2008.11.003; Niemeier A, 2005, J BONE MINER RES, V20, P283, DOI 10.1359/JBMR.041102; Niemeier A, 2008, BONE, V43, P230, DOI 10.1016/j.bone.2008.03.022; Palermo A, 2017, METABOLISM, V70, P57, DOI 10.1016/j.metabol.2017.01.032; Rodbotten R, 2014, MEAT SCI, V97, P49, DOI 10.1016/j.meatsci.2014.01.005; Ronning SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129288; Ronning SB, 2013, DIFFERENTIATION, V86, P13, DOI 10.1016/j.diff.2013.06.006; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schurgers LJ, 2007, BLOOD, V109, P3279, DOI 10.1182/blood-2006-08-040709; Schurgers LJ, 2002, BBA-GEN SUBJECTS, V1570, P27, DOI 10.1016/S0304-4165(02)00147-2; Tellam RL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-193; Tsivitse S, 2010, INT J BIOL SCI, V6, P268; van Ballegooijen AJ, 2017, INT J ENDOCRINOL, V2017, DOI 10.1155/2017/7454376; van der Meijden K, 2016, J CELL PHYSIOL, V231, P2517, DOI 10.1002/jcp.25388; Vermeer G, 2000, HEMATOL ONCOL CLIN N, V14, P339, DOI 10.1016/S0889-8588(05)70137-4; Vos M, 2012, SCIENCE, V336, P1306, DOI 10.1126/science.1218632; Wu WJ, 2015, FOOD FUNCT, V6, P3351, DOI 10.1039/c5fo00544b; Xia JH, 2015, WORLD J CLIN CASES, V3, P757, DOI 10.12998/wjcc.v3.i9.757; Yamaguchi M, 2011, INT J MOL MED, V27, P3, DOI 10.3892/ijmm.2010.562	41	8	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195432	10.1371/journal.pone.0195432	http://dx.doi.org/10.1371/journal.pone.0195432			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617432	Green Published, gold, Green Submitted			2022-12-26	WOS:000429203800086
J	Zhang, XY; Matziari, M; Xie, YX; Fernig, D; Rong, R; Meng, J; Lu, ZL				Zhang, Xiaoyang; Matziari, Magdalini; Xie, Yixin; Fernig, David; Rong, Rong; Meng, Jia; Lu, Zhi-Liang			Functional examination of novel kisspeptin phosphinic peptides	PLOS ONE			English	Article							METASTASIS-SUPPRESSOR GENE; PROTEIN-COUPLED RECEPTOR; HYPOGONADOTROPIC HYPOGONADISM; MATRIX METALLOPROTEINASES; POTENT INHIBITORS; HORMONE NEURONS; GPR54; KISS-1; EXPRESSION; CARCINOMA	Kisspeptins acting on their cognate G protein-coupled receptor, kisspeptin receptor, play important roles in the suppression of cancer cell metastasis and regulation of the reproductive system, and therefore are important for therapeutic intervention. All native functional human kisspeptins (kisspeptin-54, kisspsptin-14 and kisspeptin-13) share the 10 amino acids of kisspeptin-10 at their C-terminus (45-54). However, they are inactivated rapidly by matrix metalloproteinases (MMPs) through the cleavage of the peptide bond between glycine(51) and leucine(52), which limits their clinical applications. Development of MMP-resistant analogues of kisspeptins may provide better therapeutic outputs. In the present study, two kisspeptin phosphinic peptides were designed and synthesized, and their ability to induce phosphorylation of ERK1/2 through kisspeptin receptor and their inhibition on MMP-2 and MMP-9 whose activity correlates with cancer metastasis were assessed. The results showed that one analogue, phosphinic kisspeptin R isomer (PKPR), exhibited kisspeptin receptor-agonistic activity and also inhibitory activity on MMP-2, indicating that PKPR may serve as a lead for the further development of kisspeptin analogues for therapeutic purpose.	[Zhang, Xiaoyang; Rong, Rong; Meng, Jia; Lu, Zhi-Liang] Xian Jiaotong Liverpool Univ, Dept Biol Sci, Suzhou, Jiangsu, Peoples R China; [Matziari, Magdalini; Xie, Yixin] Xian Jiaotong Liverpool Univ, Dept Chem, Suzhou, Jiangsu, Peoples R China; [Fernig, David] Univ Liverpool, Inst Integrat Biol, Dept Biochem, Liverpool, Merseyside, England	Xi'an Jiaotong-Liverpool University; Xi'an Jiaotong-Liverpool University; University of Liverpool	Lu, ZL (corresponding author), Xian Jiaotong Liverpool Univ, Dept Biol Sci, Suzhou, Jiangsu, Peoples R China.	zhiliang.lu@xjtiu.edu.cn	Fernig, David G/A-3590-2008; Meng, Jia/H-8796-2019	Fernig, David G/0000-0003-4875-4293; Meng, Jia/0000-0003-3455-205X; Lu, Zhiliang/0000-0002-3442-1415; Xie, Yixin/0000-0002-7274-7731	National Natural Science Foundation of China [81373469]; Research Development Fund of Xi'an Jiaotong-Liverpool University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Development Fund of Xi'an Jiaotong-Liverpool University	This work was supported by the National Natural Science Foundation of China (81373469) (http://www.nsfc.gov.cn/) and the Research Development Fund of Xi'an Jiaotong-Liverpool University (http://www.xjtlu.edu.cn./en/) to ZL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglund K, 2004, GYNECOL ONCOL, V94, P699, DOI 10.1016/j.ygyno.2004.06.028; Arttamangkul S, 2000, MOL PHARMACOL, V58, P1570, DOI 10.1124/mol.58.6.1570; Asami T, 2012, BIOORG MED CHEM LETT, V22, P6328, DOI 10.1016/j.bmcl.2012.08.087; Asami T, 2012, BIOORG MED CHEM LETT, V22, P6391, DOI 10.1016/j.bmcl.2012.08.069; Camerino MA, 2016, J PEPT SCI, V22, P406, DOI 10.1002/psc.2883; Chevrier L, 2013, MOL ENDOCRINOL, V27, P1004, DOI 10.1210/me.2012-1386; Daniel JA, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0021-4; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Desmeules P, 2015, HUM PATHOL, V46, P739, DOI 10.1016/j.humpath.2015.01.014; Dhillo WS, 2007, J CLIN ENDOCR METAB, V92, P3958, DOI 10.1210/jc.2007-1116; Dhillo WS, 2005, J CLIN ENDOCR METAB, V90, P6609, DOI 10.1210/jc.2005-1468; Di Nezza LA, 2002, CANCER, V94, P1466, DOI 10.1002/cncr.10355; Dive V, 2004, CELL MOL LIFE SCI, V61, P2010, DOI 10.1007/s00018-004-4050-y; Georgiadis D, 2015, TOP CURR CHEM, V360, P1, DOI 10.1007/128_2014_571; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Hu XX, 2012, ARCH GYNECOL OBSTET, V286, P1537, DOI 10.1007/s00404-012-2456-6; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Jiang Y, 2005, CLIN EXP METASTAS, V22, P369, DOI 10.1007/s10585-005-8186-4; Kaneda M, 2014, BIOORGAN MED CHEM, V22, P3325, DOI 10.1016/j.bmc.2014.04.052; Kang HS, 2011, MOL CANCER THER, V10, P580, DOI 10.1158/1535-7163.MCT-10-0763; Kirby HR, 2010, PHARMACOL REV, V62, P565, DOI 10.1124/pr.110.002774; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Lee DK, 1999, FEBS LETT, V446, P103, DOI 10.1016/S0014-5793(99)00009-5; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Li N, 2012, WORLD J GASTROENTERO, V18, P1827, DOI 10.3748/wjg.v18.i15.1827; Makaritis A, 2003, CHEM-EUR J, V9, P2079, DOI 10.1002/chem.200204456; Matziari M, 2005, ORG LETT, V7, P4049, DOI 10.1021/ol051622y; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Niida A, 2006, BIOORG MED CHEM LETT, V16, P134, DOI 10.1016/j.bmcl.2005.09.054; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Pasquier J, 2014, J MOL ENDOCRINOL, V52, pT101, DOI 10.1530/JME-13-0224; Ren FH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135544; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Semple RK, 2005, J CLIN ENDOCR METAB, V90, P1849, DOI 10.1210/jc.2004-1418; Sullu Y, 2011, PATHOL RES PRACT, V207, P747, DOI 10.1016/j.prp.2011.09.010; Takino T, 2003, ONCOGENE, V22, P4617, DOI 10.1038/sj.onc.1206542; Tan K, 2014, CURR MOL MED, V14, P652, DOI 10.2174/1566524014666140603115314; Tomita K, 2008, J MED CHEM, V51, P7645, DOI 10.1021/jm800930w; Vassiliou S, 1999, J MED CHEM, V42, P2610, DOI 10.1021/jm9900164; Yi TF, 2010, J BIOL CHEM, V285, P17811, DOI 10.1074/jbc.M110.130740; Yiotakis A, 1996, J ORG CHEM, V61, P6601, DOI 10.1021/jo9603439; Ziegler E, 2013, ONCOL REP, V29, P549, DOI 10.3892/or.2012.2135	43	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195089	10.1371/journal.pone.0195089	http://dx.doi.org/10.1371/journal.pone.0195089			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614094	Green Published, gold, Green Submitted			2022-12-26	WOS:000429081600029
J	Baquero, OS; Santana, LMR; Chiaravalloti-Neto, F				Baquero, Oswaldo Santos; Reis Santana, Lidia Maria; Chiaravalloti-Neto, Francisco			Dengue forecasting in Sao Paulo city with generalized additive models, artificial neural networks and seasonal autoregressive integrated moving average models	PLOS ONE			English	Article							RIO-DE-JANEIRO; BRAZIL	Globally, the number of dengue cases has been on the increase since 1990 and this trend has also been found in Brazil and its most populated city-Sao Paulo. Surveillance systems based on predictions allow for timely decision making processes, and in turn, timely and efficient interventions to reduce the burden of the disease. We conducted a comparative study of dengue predictions in Sao Paulo city to test the performance of trained seasonal autoregressive integrated moving average models, generalized additive models and artificial neural networks. We also used a naive model as a benchmark. A generalized additive model with lags of the number of cases and meteorological variables had the best performance, predicted epidemics of unprecedented magnitude and its performance was 3.16 times higher than the benchmark and 1.47 higher that the next best performing model. The predictive models captured the seasonal patterns but differed in their capacity to anticipate large epidemics and all outperformed the benchmark. In addition to be able to predict epidemics of unprecedented magnitude, the best model had computational advantages, since its training and tuning was straightforward and required seconds or at most few minutes. These are desired characteristics to provide timely results for decision makers. However, it should be noted that predictions are made just one month ahead and this is a limitation that future studies could try to reduce.	[Baquero, Oswaldo Santos] Univ Sao Paulo, Dept Prevent Vet Med & Anim Hlth, Sch Vet Med, Sao Paulo, Brazil; [Baquero, Oswaldo Santos; Chiaravalloti-Neto, Francisco] Univ Sao Paulo, Dept Epidemiol, Sch Publ Hlth, Sao Paulo, Brazil; [Reis Santana, Lidia Maria] Sao Paulo State, Epidemiol Surveillance Ctr, Dept Hlth, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Baquero, OS (corresponding author), Univ Sao Paulo, Dept Prevent Vet Med & Anim Hlth, Sch Vet Med, Sao Paulo, Brazil.; Baquero, OS (corresponding author), Univ Sao Paulo, Dept Epidemiol, Sch Publ Hlth, Sao Paulo, Brazil.	baquero@usp.br	Neto, Francisco Chiaravalloti/F-8006-2012; Baquero, Oswaldo/R-4265-2016	Neto, Francisco Chiaravalloti/0000-0003-2686-8740; Baquero, Oswaldo/0000-0003-2695-7946; , Lidia Maria/0000-0001-9993-8530	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [1573079]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	OSB received funding from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, number: 1573079. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburas HM, 2010, EXPERT SYST APPL, V37, P4256, DOI 10.1016/j.eswa.2009.11.077; Althouse BM, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0054-0; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Centro de Vigilancia Epidemiologica do Estado de Sao Paulo. Dengue, 2015, DISTR CAS DENG NOT C; Chien LC, 2014, ENVIRON INT, V73, P46, DOI 10.1016/j.envint.2014.06.018; Gamboa JC., 2017, DEEP LEARNING TIME S; Glorot X., 2011, P 14 INT C ART INT S; Gomes AF, 2012, CAD SAUDE PUBLICA, V28, P2189, DOI 10.1590/S0102-311X2012001100018; Google.org, 2009, GOOGL FLU TRENDS; Greff K, 2017, IEEE T NEUR NET LEAR, V28, P2222, DOI 10.1109/TNNLS.2016.2582924; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Hastie T., 2016, ELEMENTS STAT LEARNI; Hyndman RJ, 2014, FORECASTING PRINCIPL; Johansson MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33707; Kingma D. P., 2015, 3 INT C LEARNING REP; Kuhn M., 2013, APPL PREDICTIVE MODE, DOI 10.1007/978-1-4614-6849-3; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Lowe R, 2016, ELIFE, V5, DOI 10.7554/eLife.11285; Lowe R, 2014, LANCET INFECT DIS, V14, P619, DOI 10.1016/S1473-3099(14)70781-9; Lowe R, 2013, STAT MED, V32, P864, DOI 10.1002/sim.5549; Luz PM, 2008, AM J TROP MED HYG, V79, P933, DOI 10.4269/ajtmh.2008.79.933; Ministerio da Saudede Vigilancia em Saude, 2005, GUIA VIGILANCIA EPID; Morin CW, 2013, ENV HLTH PERSPECT; Pan American Health Organization, 2016, NUMB REP CAS DENG SE; Racloz V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001648; Ramadona AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152688; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Sousa LB, 2015, REGULARIZED LINEAR N, P121; Yuan QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064323	30	25	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195065	10.1371/journal.pone.0195065	http://dx.doi.org/10.1371/journal.pone.0195065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608586	Green Published, gold, Green Submitted			2022-12-26	WOS:000428988800024
J	Arao, Y; Korach, KS				Arao, Yukitomo; Korach, Kenneth S.			The F domain of estrogen receptor is involved in species-specific, tamoxifen-mediated transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						estrogen receptor; estrogen; ligand-binding protein; mouse; human; nuclear receptor superfamily; selective estrogen receptor modulator (SERM); tamoxifen; F domain; estrogen signaling; receptor transactivation; domain swapping; estradiol	ALPHA; ANTAGONISTS; GENE; 4-HYDROXYTAMOXIFEN; IDENTIFICATION; DIMERIZATION; RESISTANCE; INHIBITOR; MUTATION; AGONISTS	Estrogen receptor (ER) is a major transducer of estrogen-mediated physiological signals. ER is a member of the nuclear receptor superfamily, which encompasses ligand-dependent transcription factors. The C terminus of nuclear receptors, termed the F domain, is the least homologous region among the members of this family. The ER F domain possesses 45 amino acids; however, its function remains unclear. We noticed that the homology of the F domains between mouse and human ERs is remarkably lower (75.6% similarity) than that between the entire proteins (94.7% similarity). To assess the functionality of the ER F domains, here we generated chimeric ER expression constructs with mouse-human-exchanged F domains. Using cell-based in vitro assays, we analyzed the transcriptional coactivator interaction and ligand-binding domain dimerization activities of these mouse-human F domain-swapped ERs. We found that the transcriptional activity of the mouse WT ER is more potent than that of the human WT ER in the human hepatoma cell line HepG2. 4-Hydroxytamoxifen (4OHT)-mediated transcriptional activity of mouse-human F domain-swapped ERs was the inverse of the WT ER activities but not estradiol-mediated transcriptional activities. Further experiments with constructs containing deletion or point mutations of a predicted -strand region within the F domain suggested that this region governs the species-specific 4OHT-mediated transcriptional activity of ER. We conclude that the ER F domain has a species-specific function in 4OHT-mediated receptor transactivation and that mouse-human F domain-swapped ER mutants enable key insights into ER F domain structure and function.	[Arao, Yukitomo; Korach, Kenneth S.] NIEHS, Receptor Biol Sect, Reprod & Dev Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Arao, Y; Korach, KS (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	araoy@niehs.nih.gov; korach@niehs.nih.gov	Arao, Yukitomo/AAL-1665-2021	Arao, Yukitomo/0000-0003-1560-351X	National Institutes of Health from the Division of Intramural Research of the NIEHS [1ZIAES070065]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES070065] Funding Source: NIH RePORTER	National Institutes of Health from the Division of Intramural Research of the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grant 1ZIAES070065 (to K. S. K.) from the Division of Intramural Research of the NIEHS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arao Y, 2015, J BIOL CHEM, V290, P17611, DOI 10.1074/jbc.M115.638650; Arao Y, 2013, J BIOL CHEM, V288, P21105, DOI 10.1074/jbc.M113.463455; Bernard V, 2017, J CLIN ENDOCR METAB, V102, P93, DOI 10.1210/jc.2016-2749; BERRY M, 1989, P NATL ACAD SCI USA, V86, P1218, DOI 10.1073/pnas.86.4.1218; BERRY M, 1990, EMBO J, V9, P2811, DOI 10.1002/j.1460-2075.1990.tb07469.x; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Chatagnon A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009665; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Hamilton KJ, 2014, REPROD BIOL, V14, P3, DOI 10.1016/j.repbio.2013.12.002; HART JE, 1990, PHARMACOL THERAPEUT, V47, P203, DOI 10.1016/0163-7258(90)90087-I; Jiang X, 2007, ONCOGENE, V26, P4106, DOI 10.1038/sj.onc.1210197; Kanamori H, 2000, J BIOL CHEM, V275, P5867, DOI 10.1074/jbc.275.8.5867; Koide A, 2007, MOL ENDOCRINOL, V21, P829, DOI 10.1210/me.2006-0203; MONTANO MM, 1995, MOL ENDOCRINOL, V9, P814, DOI 10.1210/me.9.7.814; Nichols M, 1998, EMBO J, V17, P765, DOI 10.1093/emboj/17.3.765; Norris JD, 1996, MOL ENDOCRINOL, V10, P1605, DOI 10.1210/mend.10.12.8961270; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quaynor SD, 2013, NEW ENGL J MED, V369, P164, DOI 10.1056/NEJMoa1303611; Schwartz JA, 2002, J BIOL CHEM, V277, P13202, DOI 10.1074/jbc.M112215200; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Sumida K, 2003, J STEROID BIOCHEM, V84, P33, DOI 10.1016/S0960-0760(03)00003-7; Yang J, 2008, MOL CELL ENDOCRINOL, V295, P94, DOI 10.1016/j.mce.2008.08.001	22	10	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8495	8507		10.1074/jbc.RA117.001212	http://dx.doi.org/10.1074/jbc.RA117.001212			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29632071	Green Published, hybrid			2022-12-26	WOS:000434205700014
J	Armstrong, JA; Cash, NJ; Ouyang, Y; Morton, JC; Chvanov, M; Latawiec, D; Awais, M; Tepikin, AV; Sutton, R; Criddle, DN				Armstrong, Jane A.; Cash, Nicole J.; Ouyang, Yulin; Morton, Jack C.; Chvanov, Michael; Latawiec, Diane; Awais, Muhammad; Tepikin, Alexei V.; Sutton, Robert; Criddle, David N.			Oxidative stress alters mitochondrial bioenergetics and modifies pancreatic cell death independently of cyclophilin D, resulting in an apoptosis-to-necrosis shift	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pancreas; oxidative stress; mitochondrial permeability transition (MPT); cyclophilin D; bioenergetics; reactive oxygen species (ROS); apoptosis; necrosis (necrotic death); antioxidant; Acute Pancreatitis; Seahorse	PERMEABILITY TRANSITION PORE; ACINAR-CELLS; ATP SYNTHASE; UNCOUPLING PROTEIN-2; INHIBITION; PROTECT; MODELS; LIVER; DYSFUNCTION; INDUCTION	Mitochondrial dysfunction lies at the core of acute pancreatitis (AP). Diverse AP stimuli induce Ca2+-dependent formation of the mitochondrial permeability transition pore (MPTP), a solute channel modulated by cyclophilin D (CypD), the formation of which causes ATP depletion and necrosis. Oxidative stress reportedly triggers MPTP formation and is elevated in clinical AP, but how reactive oxygen species influence cell death is unclear. Here, we assessed potential MPTP involvement in oxidant-induced effects on pancreatic acinar cell bioenergetics and fate. H2O2 application promoted acinar cell apoptosis at low concentrations (1-10 m), whereas higher levels (0.5-1 mm) elicited rapid necrosis. H2O2 also decreased the mitochondrial NADH/FAD(+) redox ratio and (m) in a concentration-dependent manner (10 m to 1 mm H2O2), with maximal effects at 500 m H2O2. H2O2 decreased the basal O-2 consumption rate of acinar cells, with no alteration of ATP turnover at <50 m H2O2. However, higher H2O2 levels (50 m) diminished spare respiratory capacity and ATP turnover, and bioenergetic collapse, ATP depletion, and cell death ensued. Menadione exerted detrimental bioenergetic effects similar to those of H2O2, which were inhibited by the antioxidant N-acetylcysteine. Oxidant-induced bioenergetic changes, loss of (m), and cell death were not ameliorated by genetic deletion of CypD or by its acute inhibition with cyclosporine A. These results indicate that oxidative stress alters mitochondrial bioenergetics and modifies pancreatic acinar cell death. A shift from apoptosis to necrosis appears to be associated with decreased mitochondrial spare respiratory capacity and ATP production, effects that are independent of CypD-sensitive MPTP formation.	[Cash, Nicole J.; Ouyang, Yulin; Morton, Jack C.; Chvanov, Michael; Tepikin, Alexei V.; Criddle, David N.] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England; [Armstrong, Jane A.; Latawiec, Diane; Awais, Muhammad; Sutton, Robert] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Canc Med, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Criddle, DN (corresponding author), Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England.	criddle@liv.ac.uk		Tepikin, Alexei/0000-0002-8172-7513; Morton, Jack/0000-0002-6571-1191	Wellcome Trust [102381/Z/13/Z]; Medical Research Council; China Scholarship Council; National Institute for Health; MRC [MR/K012967/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); China Scholarship Council(China Scholarship Council); National Institute for Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grant 102381/Z/13/Z (to (J.C.M.), by funds from the Medical Research Council, China Scholarship Council (to Y.O.), and by a National Institute for Health Research grant to the NIHR Liverpool Pancreas Biomedical Research Unit.	Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; Armstrong JA, 2013, FREE RADICAL RES, V47, P917, DOI 10.3109/10715762.2013.835046; Armstrong JS, 2004, J BIOL CHEM, V279, P50420, DOI 10.1074/jbc.M408882200; Baggaley EM, 2008, AM J PHYSIOL-CELL PH, V295, pC1247, DOI 10.1152/ajpcell.00083.2008; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Beger HG, 2007, WORLD J GASTROENTERO, V13, P5043, DOI 10.3748/wjg.v13.i38.5043; Bernardi P, 2015, PHYSIOL REV, V95, P1111, DOI 10.1152/physrev.00001.2015; Bernardi P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00095; Bhatia M, 1998, BIOCHEM BIOPH RES CO, V246, P476, DOI 10.1006/bbrc.1998.8519; Bonora M, 2015, ONCOGENE, V34, P1475, DOI 10.1038/onc.2014.96; Booth DM, 2011, GASTROENTEROLOGY, V140, P2116, DOI 10.1053/j.gastro.2011.02.054; Bruce JIE, 2007, AM J PHYSIOL-CELL PH, V293, pC938, DOI 10.1152/ajpcell.00582.2006; CHANCE B, 1979, J BIOL CHEM, V254, P4764; Criddle DN, 2016, CELL CALCIUM, V60, P180, DOI 10.1016/j.ceca.2016.04.007; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Criddle DN, 2004, P NATL ACAD SCI USA, V101, P10738, DOI 10.1073/pnas.0403431101; Curran FJM, 2000, BRIT J SURG, V87, P301, DOI 10.1046/j.1365-2168.2000.01375.x; De Marchi U, 2006, MOL MEMBR BIOL, V23, P521, DOI 10.1080/09687860600907644; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Elrod JW, 2013, CIRC J, V77, P1111, DOI 10.1253/circj.CJ-13-0321; Gerasimenko JV, 2002, J CELL SCI, V115, P485; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Gukovsky I, 2011, ANTIOXID REDOX SIGN, V15, P2699, DOI 10.1089/ars.2011.4068; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; He JY, 2017, P NATL ACAD SCI USA, V114, P9086, DOI 10.1073/pnas.1711201114; He JY, 2017, P NATL ACAD SCI USA, V114, P3409, DOI 10.1073/pnas.1702357114; He LH, 2003, J BIOL CHEM, V278, P16755, DOI 10.1074/jbc.M300153200; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; Huang W, 2014, GUT, V63, P1313, DOI 10.1136/gutjnl-2012-304058; Johnson PR, 2003, CELL TISSUE RES, V313, P37, DOI 10.1007/s00441-003-0741-1; Juhaszova M, 2008, ANN NY ACAD SCI, V1123, P197, DOI 10.1196/annals.1420.023; KAISER AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1295, DOI 10.1152/ajpcell.1995.269.5.C1295; Kim MS, 2009, GASTROENTEROLOGY, V137, P1509, DOI 10.1053/j.gastro.2009.07.042; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kramer PA, 2015, BIOMED J, V38, P294, DOI 10.4103/2319-4170.155591; Lerch MM, 2013, GASTROENTEROLOGY, V144, P1180, DOI 10.1053/j.gastro.2012.12.043; Linard D, 2009, ARCH BIOCHEM BIOPHYS, V491, P39, DOI 10.1016/j.abb.2009.09.002; Mareninova OA, 2006, J BIOL CHEM, V281, P3370, DOI 10.1074/jbc.M511276200; Mari M, 2010, ANTIOXID REDOX SIGN, V12, P1295, DOI 10.1089/ars.2009.2634; Mukherjee R, 2016, GUT, V65, P1333, DOI 10.1136/gutjnl-2014-308553; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nicotera P, 1998, TOXICOL LETT, V103, P139; Ostrander JH, 2010, CANCER RES, V70, P4759, DOI 10.1158/0008-5472.CAN-09-2572; Pandol SJ, 2007, GASTROENTEROLOGY, V133, P1056; Peery AF, 2015, GASTROENTEROLOGY, V149, P1731, DOI 10.1053/j.gastro.2015.08.045; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; Saito Y, 2006, FREE RADICAL RES, V40, P619, DOI 10.1080/10715760600632552; Sansbury BE, 2011, CHEM-BIOL INTERACT, V191, P288, DOI 10.1016/j.cbi.2010.12.002; Sata N, 1997, FREE RADICAL BIO MED, V23, P844, DOI 10.1016/S0891-5849(97)00064-6; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Segersvard R, 2005, CELL TISSUE RES, V320, P251, DOI 10.1007/s00441-004-1024-1; Shalbueva N, 2013, GASTROENTEROLOGY, V144, P437, DOI 10.1053/j.gastro.2012.10.037; Shore ER, 2016, J MED CHEM, V59, P2596, DOI 10.1021/acs.jmedchem.5b01801; Tsai K, 1998, GUT, V42, P850, DOI 10.1136/gut.42.6.850; Voronina SG, 2010, GASTROENTEROLOGY, V138, P1976, DOI 10.1053/j.gastro.2010.01.037; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; Zhou WC, 2017, ELIFE, V6, DOI 10.7554/eLife.23781; Zhu X, 2016, AM J PHYSIOL-GASTR L, V310, pG609, DOI 10.1152/ajpgi.00389.2015; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	60	55	56	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8032	8047		10.1074/jbc.RA118.003200	http://dx.doi.org/10.1074/jbc.RA118.003200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29626097	hybrid, Green Published			2022-12-26	WOS:000433224600010
J	Nowicki, JP; O'Connell, LA; Cowman, PF; Walker, SPW; Coker, DJ; Pratchett, MS				Nowicki, Jessica P.; O'Connell, Lauren A.; Cowman, Peter F.; Walker, Stefan P. W.; Coker, Darren J.; Pratchett, Morgan S.			Variation in social systems within Chaetodon butterflyfishes, with special reference to pair bonding	PLOS ONE			English	Article							CORAL-REEF FISHES; GROWTH-RATE ADVANTAGE; PRAIRIE VOLE; MATING SYSTEM; SEX-CHANGE; CORALLIVOROUS BUTTERFLYFISH; MONOGAMOUS BUTTERFLYFISH; MICROTUS-OCHROGASTER; GENE-EXPRESSION; BEHAVIOR	For many animals, affiliative relationships such as pair bonds form the foundation of society and are highly adaptive. Animal systems amenable for comparatively studying pair bonding are important for identifying underlying biological mechanisms, but mostly exist in mammals. Better establishing fish systems will enable comparison of pair bonding mechanisms across taxonomically distant lineages that may reveal general underlying mechanistic principles. We examined the utility of wild butterflyfishes (f: Chaetodontidae; g: Chaetodon) for comparatively studying pair bonding. Using stochastic character mapping, we provide the first analysis of the evolutionary history of butterflyfish sociality, revealing that pairing is ancestral, with at least seven independent transitions to gregarious grouping and solitary behavior since the late Miocene. We then formally verified social systems in six sympatric and widespread species representing a clade with one ancestrally reconstructed transition from paired to solitary grouping at Lizard Island, Australia. In situ observations of the size, selective affiliation and aggression, fidelity, and sex composition of social groups confirmed that Chaetodon baronessa, C. lunulatus, and C. vagabundus are predominantly pair bonding, whereas C. rainfordi, C. plebeius, and C. trifascialis are predominantly solitary. Even in the predominantly pair bonding species, C. lunulatus, a proportion of adults (15%) are solitary. Importantly, inter-and intra-specific differences in social systems do not co-vary with other previously established attributes, including parental care. Hence, the proposed butterflyfish populations are promising for inter-and intra-species comparative analyses of pair bonding and its mechanistic underpinnings. Avenues for further developing the system are proposed, including determining whether the aforementioned utility of these species applies across their geographic disruptions.	[Nowicki, Jessica P.; Cowman, Peter F.; Walker, Stefan P. W.; Coker, Darren J.; Pratchett, Morgan S.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld, Australia; [Nowicki, Jessica P.; O'Connell, Lauren A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Coker, Darren J.] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia	James Cook University; Stanford University; King Abdullah University of Science & Technology	Nowicki, JP; Pratchett, MS (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld, Australia.; Nowicki, JP (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	jnowicki@stanford.edu; Morgan.pratchett@jcu.edu.au	Cowman, Peter Francis/G-9998-2017; Pratchett, Morgan/AAW-5179-2020; Nowicki, Jessica Ploetz/AAY-2349-2021	Cowman, Peter Francis/0000-0001-5977-5327; Pratchett, Morgan/0000-0002-1862-8459; Nowicki, Jessica Ploetz/0000-0002-6373-8761; O'Connell, Lauren/0000-0002-2706-4077	Australian Research Centre; James Cook University Postgraduate Research Grant	Australian Research Centre; James Cook University Postgraduate Research Grant	This work was supported by an Australian Research Centre grant to SPWW and MSP, as well as a James Cook University Postgraduate Research Grant to JPN. The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155877; Allen G.R., 1998, GUIDE ANGELFISHES BU; Aragona BJ, 2004, ILAR J, V45, P35, DOI 10.1093/ilar.45.1.35; Bellwood DR, 2010, J EVOLUTION BIOL, V23, P335, DOI 10.1111/j.1420-9101.2009.01904.x; Bellwood DR, 2014, Biology of Butterflyfishes, P1; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Berumen ML, 2009, ENVIRON BIOL FISH, V86, P447, DOI 10.1007/s10641-009-9545-9; Berumen ML, 2005, ENVIRON BIOL FISH, V72, P409, DOI 10.1007/s10641-004-2595-0; Berumen ML, 2005, MAR ECOL PROG SER, V287, P217, DOI 10.3354/meps287217; Berumen ML, 10 INT COR REEF S 20; Blowes SA, 2013, AM NAT, V182, P157, DOI 10.1086/670821; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Bonaldo R. M., 2005, Braz. J. Biol., V65, P211, DOI 10.1590/S1519-69842005000200004; BOUCHONNAVARO Y, 1981, J EXP MAR BIOL ECOL, V55, P145, DOI 10.1016/0022-0981(81)90108-8; BRADLEY JS, 1990, J ANIM ECOL, V59, P487, DOI 10.2307/4876; Brandl SJ, 2014, OCEANOGR MAR BIOL, V52, P1; Bull CM, 2000, BEHAV PROCESS, V51, P7, DOI 10.1016/S0376-6357(00)00115-7; Buxton CD, 1990, ALTERNATIVE LIFE HIS, P113; Caldwell JP, 1997, NATURE, V385, P211, DOI 10.1038/385211a0; CARTER CS, 1995, NEUROSCI BIOBEHAV R, V19, P303; Choat J, 1991, ECOLOGY FISHES CORAL, V39; Cockburn A, 2006, P ROY SOC B-BIOL SCI, V273, P1375, DOI 10.1098/rspb.2005.3458; Cole A.J., 2014, BIOL BUTTERFLYFISHES; Cole KS, 2001, ENVIRON BIOL FISH, V61, P161, DOI 10.1023/A:1011032228716; Cowman PF, 2011, J EVOLUTION BIOL, V24, P2543, DOI 10.1111/j.1420-9101.2011.02391.x; Cowman PF, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00394; Cowman PF, 2013, J BIOGEOGR, V40, P209, DOI 10.1111/jbi.12003; Cowman PF, 2013, P R SOC B; CREWS D, 1986, SCIENCE, V231, P121, DOI 10.1126/science.3941893; Delbeek J, 2006, ADVANCEMENTS MARINE, P2; Delbeek JC, 2014, BIOL BUTTERFLYFISHES; DeVries AC, 1997, CAN J ZOOL, V75, P295, DOI 10.1139/z97-037; Dewan AK, 2011, HORM BEHAV, V59, P56, DOI 10.1016/j.yhbeh.2010.10.002; DRISCOLL JW, 1988, ENVIRON BIOL FISH, V22, P29, DOI 10.1007/BF00000542; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EHRLICH PR, 1977, J ZOOL, V183, P213; Fessler JL, 2007, MOL PHYLOGENET EVOL, V45, P50, DOI 10.1016/j.ympev.2007.05.018; Freeman SM, 2013, OXYTOCIN, VASOPRESSIN AND RELATED PEPTIDES IN THE REGULATION OF BEHAVIOR, P128; FRICKE HW, 1986, ETHOLOGY, V73, P307; FROESE R., 2012, FISHBASE; Fuentes A, 2000, YEARB PHYS ANTHROPOL, V43, P33; GETZ LL, 1986, BEHAV ECOL SOCIOBIOL, V18, P275, DOI 10.1007/BF00300004; GETZ LL, 1981, BEHAV ECOL SOCIOBIOL, V8, P189, DOI 10.1007/BF00299829; Gobrogge K, 2016, CURR OPIN NEUROBIOL, V38, P80, DOI 10.1016/j.conb.2016.04.011; Godin, 1997, BEHAV ECOLOGY TELEOS; Goodson JL, 2006, HORM BEHAV, V50, P223, DOI 10.1016/j.yhbeh.2006.03.005; Goodson JL, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00013; Gregson MA, 2008, CORAL REEFS, V27, P583, DOI 10.1007/s00338-008-0366-7; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Gubernick David J., 1994, Ettore Majorana International Life Sciences Series, V13, P427; Harding JA, 2003, ANIM BEHAV, V65, P865, DOI 10.1006/anbe.2003.2144; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hinde RA, 1982, ETHOLOGY ITS NATURE; Hofmann HA, 2014, TRENDS ECOL EVOL, V29, P581, DOI 10.1016/j.tree.2014.07.008; HOURIGAN TF, 1989, ENVIRON BIOL FISH, V25, P61, DOI 10.1007/BF00002201; Hourigan TF, 1987, THESIS; Hourigan TF, 1987, BEHAV ECOLOGY 3 SPEC; INSEL TR, 1992, P NATL ACAD SCI USA, V89, P5981, DOI 10.1073/pnas.89.13.5981; Johnson ZV, 2015, CURR OPIN BEHAV SCI, V3, P38, DOI 10.1016/j.cobeha.2015.01.009; KREBS JR, 1990, PHILOS T ROY SOC B, V329, P153, DOI 10.1098/rstb.1990.0160; Kuiter R. H., 2002, BUTTERFLYFISHES BANN; KUWAMURA T, 1994, BEHAV ECOL, V5, P434, DOI 10.1093/beheco/5.4.434; Lawton RJ, 2012, ECOGRAPHY, V35, P566, DOI 10.1111/j.1600-0587.2011.07326.x; LOBEL PS, 1978, PAC SCI, V32, P193; Lukas D, 2013, SCIENCE, V341, P526, DOI 10.1126/science.1238677; MCGRAW L, 2010, SOCIAL BEHAV GENES E; McGraw LA, 2010, TRENDS NEUROSCI, V33, P103, DOI 10.1016/j.tins.2009.11.006; Munday PL, 2002, BEHAV ECOL SOCIOBIOL, V52, P247, DOI 10.1007/s00265-002-0517-8; NEUDECKER S, 1982, Z TIERPSYCHOL, V59, P299; Nowicki JP, 2017, BIORXIV, DOI [10.1101/214627, DOI 10.1101/214627]; O'Connor CM, 2016, HORM BEHAV, V80, P30, DOI 10.1016/j.yhbeh.2015.10.015; Oldfield RG, 2013, HORM BEHAV, V64, P44, DOI 10.1016/j.yhbeh.2013.04.006; Oliveira RF, 2012, J FISH BIOL, V81, P2127, DOI 10.1111/j.1095-8649.2012.03477.x; Ondrasek NR, 2016, ETHOLOGY, V122, P443, DOI 10.1111/eth.12493; Phelps SM, 2010, NEUROPHARMACOLOGY, V58, P17, DOI 10.1016/j.neuropharm.2009.06.043; Pratchett MS, 2015, CORAL REEFS, V34, P665, DOI 10.1007/s00338-014-1254-y; Pratchett MS, 2014, ECOL EVOL, V4, P3612, DOI 10.1002/ece3.1208; Pratchett MS, 2006, CORAL REEFS, V25, P85, DOI 10.1007/s00338-005-0081-6; Pratchett MS, 2005, MAR BIOL, V148, P373, DOI 10.1007/s00227-005-0084-4; Pratchett MS, 2014, Biology of Butterflyfishes, P1; Proges S., 2005, ATTACHMENT BONDING N; Pyle RL, 2016, ZOOKEYS, P137, DOI 10.3897/zookeys.614.10200; Quinlan RJ, 2007, CROSS-CULT RES, V41, P149, DOI 10.1177/1069397106298893; REESE E S, 1975, Zeitschrift fuer Tierpsychologie, V37, P37; REESE ES, 1973, COPEIA, P145, DOI 10.2307/1442375; REESE ES, 1991, ECOL INT B, V0019, P00029; Reese ES, 1978, CONTRASTS BEHAV, V347; Reichard U. H., 2003, MONOGAMY MATING STRA; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; ROBERTS CM, 1992, ENVIRON BIOL FISH, V34, P79, DOI 10.1007/BF00004786; Sale PF, 1978, REEF FISHES OTHER VE, P313; SHAPIRO DY, 1987, BIOSCIENCE, V37, P490, DOI 10.2307/1310421; Smith CM, 2000, CONDOR, V102, P201, DOI 10.1650/0010-5422(2000)102[0201:LTPBIH]2.0.CO;2; Summers K, 2013, SEXUAL SELECTION PER, P289; SUTTON M, 1985, ANIM BEHAV, V33, P1332, DOI 10.1016/S0003-3472(85)80194-9; Taborsky M, 2015, TRENDS NEUROSCI, V38, P189, DOI 10.1016/j.tins.2015.01.004; Tanaka N., 1992, GALAXEA, V11, P66; Thresher RE, 1984, REPROD REEF FISHES; Tricas T. C., 1985, P 5 INT COR REEF C, V5, P409; TRICAS TC, 1989, ANIM BEHAV, V37, P830, DOI 10.1016/0003-3472(89)90067-5; Tricas TC, 1986, LIFE HIST FORAGING E; Turner LM, 2010, MOL BIOL EVOL, V27, P1269, DOI 10.1093/molbev/msq013; Volkmar FR, 2001, J CLIN CHILD PSYCHOL, V30, P80, DOI 10.1207/S15374424JCCP3001_9; Wang ZX, 2004, PHYSIOL BEHAV, V83, P319, DOI 10.1016/j.physbeh.2004.08.024; Weitekamp CA, 2017, EVOLUTION NERVOUS SY, P327, DOI DOI 10.1016/B978-0-12-804042-3.00025-7; WEST G, 1990, AUST J MAR FRESH RES, V41, P199, DOI 10.1071/MF9900199; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Whiteman EA, 2004, BIOL REV, V79, P351, DOI 10.1017/S1464793103006304; Wilson, 2000, SOCIOBIOLOGY; WITTENBERGER JF, 1980, ANNU REV ECOL SYST, V11, P197, DOI 10.1146/annurev.es.11.110180.001213; Yabuta S, 1997, ICHTHYOL RES, V44, P183, DOI 10.1007/BF02678696; Yabuta S, 2000, J ETHOL, V18, P11, DOI 10.1007/s101640070018; Yabuta S, 1997, ICHTHYOL RES, V44, P177, DOI 10.1007/BF02678695; Yabuta S, 2002, ANIM BEHAV, V63, P165, DOI 10.1006/anbe.2001.1869; Yabuta S, 2014, BIOL BUTTERFLYFISHES; Yabuta S, 2007, ICHTHYOL RES, V54, P207, DOI 10.1007/s10228-006-0391-x; Yabuta S, 2014, BIOLOGY OF BUTTERFLYFISHES, P200; Young KA, 2011, FRONT NEUROENDOCRIN, V32, P53, DOI 10.1016/j.yfrne.2010.07.006; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Young LJ, 1997, BEHAV NEUROSCI, V111, P599, DOI 10.1037/0735-7044.111.3.599; Zwickl DJ, 2006, GARLI GENETIC ALGORI	121	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194465	10.1371/journal.pone.0194465	http://dx.doi.org/10.1371/journal.pone.0194465			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641529	Green Published, Green Submitted, gold			2022-12-26	WOS:000429742900031
J	Lawrence, JP; Mahony, M; Noonan, BP				Lawrence, J. P.; Mahony, Michael; Noonan, Brice P.			Differential responses of avian and mammalian predators to phenotypic variation in Australian Brood Frogs	PLOS ONE			English	Article							POISON FROG; WARNING SIGNALS; EVOLUTION; MIMICRY; APOSEMATISM; DIVERSITY; SELECTION; TOXICITY; COLORS	Anti-predator signaling is highly variable with numerous examples of species employing cryptic coloration to avoid detection or conspicuous coloration (often coupled with a secondary defense) to ensure detection and recollection. While the ends of this spectrum are clear in their function, how species use intermediate signals is less clear. Australian Brood Frogs (Pseudophryne) display conspicuous coloration on both their dorsum and venter. Coupled with the alkaloid toxins these frogs possess, this coloration may be aposematic, providing a protective warning signal to predators. We assessed predation rates of known and novel color patterns and found no difference for avian or mammalian predators. However, when Pseudophryne dorsal phenotypes were collectively compared to the high-contrast ventral phenotype of this genus, we found birds, but not mammals, attacked dorsal phenotypes significantly less frequently than the ventral phenotype. This study, importantly, shows a differential predator response to ventral coloration in this genus which has implications for the evolution of conspicuous signaling in Pseudophryne.	[Lawrence, J. P.; Noonan, Brice P.] Univ Mississippi, Dept Biol, University, MS 38677 USA; [Mahony, Michael] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW, Australia	University of Mississippi; University of Newcastle	Lawrence, JP (corresponding author), Univ Mississippi, Dept Biol, University, MS 38677 USA.	JPLarry@gmail.com		Lawrence, Justin/0000-0001-8577-4870	East Asia and Pacific Summer Institutes Fellowship program through the National Science Foundation [OISE-1515149]	East Asia and Pacific Summer Institutes Fellowship program through the National Science Foundation	This work was funded by the East Asia and Pacific Summer Institutes Fellowship program through the National Science Foundation grant no. OISE-1515149 to JPL (https://www.nsf.gov/pubs/2013/nsf13593/nsf13593.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WL, 2013, BEHAV ECOL, V24, P1237, DOI 10.1093/beheco/art058; Arrese CA, 2002, CURR BIOL, V12, P657, DOI 10.1016/S0960-9822(02)00772-8; Bowmaker JK, 1998, EYE, V12, P541, DOI 10.1038/eye.1998.143; BRODIE ED, 1993, EVOLUTION, V47, P227, DOI 10.1111/j.1558-5646.1993.tb01212.x; Chouteau M, 2011, AM NAT, V178, P810, DOI 10.1086/662667; Chouteau M, 2011, BIOL LETTERS, V7, P796, DOI 10.1098/rsbl.2011.0039; Comeault AA, 2011, J EVOLUTION BIOL, V24, P1374, DOI 10.1111/j.1420-9101.2011.02258.x; Darst CR, 2006, P NATL ACAD SCI USA, V103, P5852, DOI 10.1073/pnas.0600625103; Ebeling W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014231; Hegna RH, 2012, EVOL ECOL; Hegna RH, 2011, ANN ZOOL FENN, V48, P29, DOI 10.5735/086.048.0103; Kikuchi DW, 2013, Q REV BIOL, V88, P297, DOI 10.1086/673758; Kikuchi DW, 2010, AM NAT, V176, P830, DOI 10.1086/657041; Linnen CR, 2013, SCIENCE, V339, P1312, DOI 10.1126/science.1233213; Maan ME, 2012, AM NAT, V179, pE1, DOI 10.1086/663197; Maan ME, 2009, P NATL ACAD SCI USA, V106, P19072, DOI 10.1073/pnas.0903327106; Mappes J, 2005, TRENDS ECOL EVOL, V20, P598, DOI 10.1016/j.tree.2005.07.011; Noonan BP, 2009, BIOL LETTERS, V5, P51, DOI 10.1098/rsbl.2008.0586; OKANO T, 1992, P NATL ACAD SCI USA, V89, P5932, DOI 10.1073/pnas.89.13.5932; OSBORNE WS, 1989, AUST WILDLIFE RES, V16, P537; Paluh DJ, 2014, J HERPETOL, V48, P249, DOI 10.1670/13-027; Pfennig DW, 2001, NATURE, V410, P323, DOI 10.1038/35066628; Rojas B, 2014, BEHAV PROCESS, V109, P164, DOI 10.1016/j.beproc.2014.08.014; Rojas B, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0193; Roper TJ, 1997, ODOUR COLOUR CUES TA, P1241; Ruxton GD, 2005, AVOIDING ATTACK EVOL; Saporito RA, 2007, COPEIA, P1006, DOI 10.1643/0045-8511(2007)7[1006:EEFAIT]2.0.CO;2; Saporito RA, 2012, CHEMOECOLOGY, V22, P159, DOI 10.1007/s00049-011-0088-0; SCHWARZKOPF L, 1992, BEHAV ECOL SOCIOBIOL, V31, P17, DOI 10.1007/BF00167812; Smith BP, 2002, J NAT PROD, V65, P439, DOI 10.1021/np010506a; Valkonen J, 2011, EVOL ECOL, V25, P1047, DOI 10.1007/s10682-011-9463-0; Wang IJ, 2011, EVOLUTION, V65, P1637, DOI 10.1111/j.1558-5646.2011.01257.x; Williams CR, 2000, J HERPETOL, V34, P431, DOI 10.2307/1565367; Yeager Justin, 2011, Herpetological Review, V42, P357	34	3	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195446	10.1371/journal.pone.0195446	http://dx.doi.org/10.1371/journal.pone.0195446			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621321	Green Published, Green Submitted, gold			2022-12-26	WOS:000429206800085
J	Babii, C; Mihalache, G; Bahrin, LG; Neagu, AN; Gostin, I; Mihai, CT; Sarbu, LG; Birsa, LM; Stefan, M				Babii, Cornelia; Mihalache, Gabriela; Bahrin, Lucian Gabriel; Neagu, Anca-Narcisa; Gostin, Irina; Mihai, Cosmin Teodor; Sarbu, Laura-Gabriela; Birsa, Lucian Mihail; Stefan, Marius			A novel synthetic flavonoid with potent antibacterial properties: In vitro activity and proposed mode of action	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL ACTIVITIES; GENISTEIN; MECHANISM; DAMAGE; TWIGS; COLI; OIL	The emergence of pathogenic multidrug-resistant bacteria demands new approaches in finding effective antibacterial agents. Synthetic flavonoids could be a reliable solution due to their important antimicrobial activity. We report here the potent in vitro antibacterial activity of CICI-flav-a novel synthetic tricyclic flavonoid. The antimicrobial effects were tested using the minimum inhibitory concentration (MIC), time kill and biofilm formation assays. Fluorescence microscopy and scanning electron microscopy were employed to study the mechanism of action. MTT test was used to assess the cytotoxicity of CICI-flay. Our results showed that Gram positive bacteria were more sensitive (MIC = 0.24 mu g/mL) to CICI-flav compared to the Gram negative ones (MIC = 3.9 mu g/mL). We found that our compound showed significantly enhanced antibacterial activities, 32 to 72-fold more active than other synthetic flavonoids. CICI-flav showed bactericidal activity at concentrations ranging from 0.48 to 15.62 mu g/mL. At twice the MIC, all Escherichia coli and Klebsiella pneumoniae cells were killed within 1 h. Also CICI-flav presented good anti-biofilm activity. The mechanism of action is related to the impairment of the cell membrane integrity. No or very low cytotoxicity was evidenced at effective concentrations against Vero cells. Based on the strong antibacterial activity and cytotoxicity assessment, CICI-flav has a good potential for the design of new antimicrobial agents.	[Babii, Cornelia; Mihalache, Gabriela; Neagu, Anca-Narcisa; Gostin, Irina; Stefan, Marius] Alexandru Ioan Cuza Univ, Dept Biol, Fac Biol, Iasi, Romania; [Babii, Cornelia] Alexandru Ioan Cuza Univ, CERNESIM, Integrated Ctr Environm Sci Studies North Eastern, Iasi, Romania; [Bahrin, Lucian Gabriel; Sarbu, Laura-Gabriela; Birsa, Lucian Mihail] Alexandru Ioan Cuza Univ, Fac Chem, Iasi, Romania; [Mihai, Cosmin Teodor] Alexandru Ioan Cuza Univ, Interdisciplinary Res Dept Sci, Iasi, Romania; [Mihai, Cosmin Teodor] Univ Med & Pharm Grigore T Popa Iasi, Adv Res & Dev Ctr Expt Med CEMEX, Iasi, Romania	Alexandru Ioan Cuza University; Alexandru Ioan Cuza University; Alexandru Ioan Cuza University; Alexandru Ioan Cuza University; Grigore T Popa University of Medicine & Pharmacy	Stefan, M (corresponding author), Alexandru Ioan Cuza Univ, Dept Biol, Fac Biol, Iasi, Romania.; Birsa, LM (corresponding author), Alexandru Ioan Cuza Univ, Fac Chem, Iasi, Romania.	lbirsa@uaic.ro; stefanm@uaic.ro	Stefan, Marius/P-3261-2014; 孙, 琦/K-9357-2018; Birsa, Lucian Mihail/C-1568-2012; Sarbu, Laura/AAR-2110-2021; Gostin, Irina Neta N/H-5555-2013; Mihai, Cosmin-Teodor/F-7815-2011	Stefan, Marius/0000-0002-4967-6234; Birsa, Lucian Mihail/0000-0003-4483-873X; Sarbu, Laura/0000-0003-1789-2108; Mihai, Cosmin-Teodor/0000-0002-0945-5437; Bahrin, Lucian/0000-0001-9556-2804; Mihalache, Gabriela/0000-0003-4199-0306; Irina Neta, Gostin/0000-0003-1519-5122	Romanian National Authority for Scientific Research [152PED/2017]	Romanian National Authority for Scientific Research	This work was supported by research project 152PED/2017 funded by Romanian National Authority for Scientific Research, project leader - Prof. PhD Lucian Mihail Birsa. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez MD, 2004, BIOCELL, V28, P31; Babii C, 2016, J APPL MICROBIOL, V120, P630, DOI 10.1111/jam.13048; Bahrin LG, 2014, BIOORG MED CHEM LETT, V24, P2315, DOI 10.1016/j.bmcl.2014.03.071; Bahrin LG, 2016, BIOORGAN MED CHEM, V24, P3166, DOI 10.1016/j.bmc.2016.05.044; Burt SA, 2003, LETT APPL MICROBIOL, V36, P162, DOI 10.1046/j.1472-765X.2003.01285.x; Carson CF, 2002, ANTIMICROB AGENTS CH, V46, P1914, DOI 10.1128/AAC.46.6.1914-1920.2002; Cushnie TPT, 2011, INT J ANTIMICROB AG, V38, P99, DOI 10.1016/j.ijantimicag.2011.02.014; Cushnie TPT, 2005, J ETHNOPHARMACOL, V101, P243, DOI 10.1016/j.jep.2005.04.014; Gupta RS, 1998, MICROBIOL MOL BIOL R, V62, P1435, DOI 10.1128/MMBR.62.4.1435-1491.1998; Haraguchi H, 1998, PHYTOCHEMISTRY, V48, P125, DOI 10.1016/S0031-9422(97)01105-9; HUGO WB, 1964, J PHARM PHARMACOL, V16, P655, DOI 10.1111/j.2042-7158.1964.tb07384.x; IKIGAI H, 1993, BIOCHIM BIOPHYS ACTA, V1147, P132, DOI 10.1016/0005-2736(93)90323-R; JOSWICK HL, 1971, J BACTERIOL, V108, P492, DOI 10.1128/JB.108.1.492-500.1971; Kuete V, 2007, J ETHNOPHARMACOL, V112, P271, DOI 10.1016/j.jep.2007.03.008; Kumar S, 2013, SCI WORLD J, DOI 10.1155/2013/162750; Lambert RJW, 2001, J APPL MICROBIOL, V91, P453, DOI 10.1046/j.1365-2672.2001.01428.x; Lebaron P, 1998, APPL ENVIRON MICROB, V64, P2697; Lee KA, 2013, FOOD SCI BIOTECHNOL, V22, P1725, DOI 10.1007/s10068-013-0272-9; Mbaveng AT, 2008, J ETHNOPHARMACOL, V116, P483, DOI 10.1016/j.jep.2007.12.017; MORI A, 1987, PHYTOCHEMISTRY, V26, P2231, DOI 10.1016/S0031-9422(00)84689-0; Mosmann T., 1983, J IMMUNOL METHODS, V12, P16; Panacek A, 2009, BIOMATERIALS, V30, P6333, DOI 10.1016/j.biomaterials.2009.07.065; Park KD, 2010, EUR J MED CHEM, V45, P1028, DOI 10.1016/j.ejmech.2009.11.045; Rukayadi Y, 2010, BIOL PHARM BULL, V33, P1489, DOI 10.1248/bpb.33.1489; Rukayadi Y, 2009, ANTIMICROB AGENTS CH, V53, P4529, DOI 10.1128/AAC.00624-09; Rusin A, 2010, ACTA BIOCHIM POL, V57, P23; San Hipolito-Luengo A, 2017, NUTR CANCER, V69, P1019, DOI 10.1080/01635581.2017.1359309; Shanks RMQ, 2005, INFECT IMMUN, V73, P4596, DOI 10.1128/IAI.73.8.4596-4606.2005; Siddiqui ZN, 2011, BIOORG MED CHEM LETT, V21, P2860, DOI 10.1016/j.bmcl.2011.03.080; Ueckert J, 1995, INT J FOOD MICROBIOL, V28, P317, DOI 10.1016/0168-1605(95)00066-6; Wu T, 2013, BBA-BIOMEMBRANES, V1828, P2751, DOI 10.1016/j.bbamem.2013.07.029; Zhang LN, 2008, EUR J MED CHEM, V43, P1543, DOI 10.1016/j.ejmech.2007.09.008	32	28	28	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194898	10.1371/journal.pone.0194898	http://dx.doi.org/10.1371/journal.pone.0194898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617411	gold, Green Published, Green Submitted			2022-12-26	WOS:000429203800054
J	Cyriac, D; Hofmann, RW; Stewart, A; Sathish, P; Winefield, CS; Moot, DJ				Cyriac, Daliya; Hofmann, Rainer W.; Stewart, Alan; Sathish, P.; Winefield, Christopher S.; Moot, Derrick J.			Intraspecific differences in long-term drought tolerance in perennial ryegrass	PLOS ONE			English	Article							LOLIUM-PERENNE; OSMOTIC ADJUSTMENT; WATER RELATIONS; ABIOTIC STRESS; PHYSIOLOGICAL-RESPONSES; ABSCISIC-ACID; GROWTH; RECOVERY; GRASS; ACCUMULATION	Lolium perenne L. (perennial ryegrass) is the most important pasture grass species in temperate regions of the world. However, its growth is restricted in summer dry environments. Germplasm screening can be used to identify accessions or individual plants for incorporation into breeding programs for drought tolerance. We selected nine perennial ryegrass accessions from different global origins and from a range of climatic and environmental conditions. In addition, the perennial ryegrass cultivar 'Grasslands Impact' was chosen as a reference. The accessions were grown for 360 days in a controlled environment through six consecutive drought stress and recovery cycles. We observed intraspecific differences in drought stress responsiveness for shoot biomass and survival from the third stress cycle. An accession from Norway had 50% more shoot dry matter than the next best-performing accession after six drought cycles. Compared with the reference cultivar 'Grasslands Impact', shoot dry matter of the accession from Norway was more than seven times higher after six drought cycles, indicating superior performance of this ecotype under drought stress. Drought tolerance was characterized by osmotic adjustment and higher relative leaf water content at low soil moisture levels. Furthermore, the findings of this study identify solute potential as an early predictor of drought stress tolerance. These intraspecific differences can be used in breeding programs for the development of drought-tolerant perennial ryegrass cultivars.	[Cyriac, Daliya; Hofmann, Rainer W.; Winefield, Christopher S.; Moot, Derrick J.] Lincoln Univ, Agr & Life Sci Div, Canterbury, New Zealand; [Stewart, Alan] PGG Wrightson, Canterbury, New Zealand; [Sathish, P.] Indigenz Ltd, Auckland, New Zealand	Lincoln University - New Zealand	Cyriac, D; Hofmann, RW (corresponding author), Lincoln Univ, Agr & Life Sci Div, Canterbury, New Zealand.	Daliya.Cyriac@lincolnuni.ac.nz; Rainer.Hofmann@lincoln.ac.nz	Winefield, Chris/P-7696-2018	Winefield, Chris/0000-0002-6262-6370	Pastoral Genomics Ltd.; Callaghan Innovation	Pastoral Genomics Ltd.; Callaghan Innovation	The funding bodies, Pastoral Genomics Ltd. and Callaghan Innovation, provided financial support for the PhD study of the first author (DC). The funders did not have any role in the design of the study, data collection, analysis, decision to publish, or preparation of the manuscript.	Albrecht V, 2003, PLANT J, V36, P457, DOI 10.1046/j.1365-313X.2003.01892.x; BACON CW, 1993, AGR ECOSYST ENVIRON, V44, P123, DOI 10.1016/0167-8809(93)90042-N; Ballizany WL, 2012, FUNCT PLANT BIOL, V39, P167, DOI 10.1071/FP11193; BLUM A, 1989, CROP SCI, V29, P230, DOI 10.2135/cropsci1989.0011183X002900010052x; Blum A, 2017, PLANT CELL ENVIRON, V40, P4, DOI 10.1111/pce.12800; Bouma E., 2005, Bulletin OEPP, V35, P233; Brummer EC, 2009, GRASSLAND QUIETNESS, P157; Chappel PR, NIWA SCI TECHNOLOGY, V61, P1; Charlton J. F. L., 1999, Proceedings of the New Zealand Grassland Association, V61, P147; Chen THH, 2002, CURR OPIN PLANT BIOL, V5, P250, DOI 10.1016/S1369-5266(02)00255-8; Cheplick GP, 2004, AM J BOT, V91, P1960, DOI 10.3732/ajb.91.12.1960; CORNISH MA, 1979, HEREDITY, V43, P95, DOI 10.1038/hdy.1979.63; Cox JE, 1978, SOIL BUREAU B, P34; Cui Y, 2015, HORTSCIENCE, V50, P1148, DOI 10.21273/HORTSCI.50.8.1148; Easton HS, 2011, GRASSLAND RES PRACTI, V15, P139; ELMI AA, 1995, NEW PHYTOL, V131, P61, DOI 10.1111/j.1469-8137.1995.tb03055.x; Esperon-Rodriguez M, 2018, AUSTRAL ECOL, V43, P397, DOI 10.1111/aec.12577; Fang YJ, 2015, CELL MOL LIFE SCI, V72, P673, DOI 10.1007/s00018-014-1767-0; Foito A, 2009, PLANT BIOTECHNOL J, V7, P719, DOI 10.1111/j.1467-7652.2009.00437.x; GARWOOD EA, 1967, J AGR SCI-CAMBRIDGE, V68, P281, DOI 10.1017/S002185960001635X; GARWOOD EA, 1967, J AGR SCI-CAMBRIDGE, V69, P125, DOI 10.1017/S002185960001652X; Guy CL, 2003, CAN J BOT, V81, P1216, DOI [10.1139/b03-130, 10.1139/B03-130]; Han LB, 2008, ACTA HORTIC, P273; He L, 2017, CROP PASTURE SCI, V68, P176, DOI [10.1071/CP16208, 10.1071/cp16208]; He L, 2017, NZ J AGR RES, P1; Hesse U, 2003, GRASS FORAGE SCI, V58, P407, DOI 10.1111/j.1365-2494.2003.00393.x; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hulke BS, 2007, CROP SCI, V47, P1596, DOI 10.2135/cropsci2006.10.0671; Humphreys M, 1997, P 18 INT GRASSL C AS; Hunt W. F., 1989, Proceedings of the New Zealand Grassland Association, V50, P11; JONES MB, 1980, ANN APPL BIOL, V96, P87, DOI 10.1111/j.1744-7348.1980.tb04772.x; Jongdee B, 2002, FIELD CROP RES, V76, P153, DOI 10.1016/S0378-4290(02)00036-9; Kane KH, 2011, ENVIRON EXP BOT, V71, P337, DOI 10.1016/j.envexpbot.2011.01.002; Kannadan S, 2008, FUNCT ECOL, V22, P706, DOI 10.1111/j.1365-2435.2008.01395.x; Kasuga M, 2004, PLANT CELL PHYSIOL, V45, P346, DOI 10.1093/pcp/pch037; Korte C, 1983, P NZ GRASSLAND ASS; Kosgey J, 2011, THESIS; Lelievre F, 2009, CROP SCI, V49, P2371, DOI 10.2135/cropsci2009.06.0324; Liu JR, 2008, SCI HORTIC-AMSTERDAM, V115, P190, DOI 10.1016/j.scienta.2007.08.003; Liu SW, 2010, PHYSIOL PLANTARUM, V139, P375, DOI 10.1111/j.1399-3054.2010.01374.x; Matthew C, 2012, PR N Z GRASSL ASSOC, V74, P195; Mir RR, 2012, THEOR APPL GENET, V125, P625, DOI 10.1007/s00122-012-1904-9; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Mohammadi MHS, 2017, PLANT PHYSIOL BIOCH, V111, P129, DOI 10.1016/j.plaphy.2016.11.014; Moot DJ, 2000, NEW ZEAL J AGR RES, V43, P15, DOI 10.1080/00288233.2000.9513404; MORGAN JM, 1984, ANNU REV PLANT PHYS, V35, P299, DOI 10.1146/annurev.pp.35.060184.001503; Munne-Bosch S, 2004, FUNCT PLANT BIOL, V31, P203, DOI 10.1071/FP03236; NORRIS IB, 1982, J AGR SCI-CAMBRIDGE, V99, P547, DOI 10.1017/S0021859600031221; Patel M, 2015, PLANT BIOTECHNOL J, V13, P689, DOI 10.1111/pbi.12291; Salinger J, 2003, LEGUMES DRYLAND PAST; SHEPHERD W, 1977, J BRIT GRASSLAND SOC, V32, P225; Simpson WR, 2012, FUNGAL BIOL-UK, V116, P234, DOI 10.1016/j.funbio.2011.11.006; THOMAS H, 1990, ANN BOT-LONDON, V66, P521, DOI 10.1093/oxfordjournals.aob.a088061; THOMAS H, 1987, J EXP BOT, V38, P115, DOI 10.1093/jxb/38.1.115; THOMAS H, 1990, ANN APPL BIOL, V116, P371, DOI 10.1111/j.1744-7348.1990.tb06619.x; THOMAS H, 1989, ANN BOT-LONDON, V64, P581, DOI 10.1093/oxfordjournals.aob.a087879; THOMAS H, 1991, NEW PHYTOL, V118, P35, DOI 10.1111/j.1469-8137.1991.tb00563.x; Tveito OE, 2005, METEOROL APPL, V12, P57, DOI 10.1017/S1350482705001490; Verkerk G, 2003, THERIOGENOLOGY, V59, P553, DOI 10.1016/S0093-691X(02)01239-6; Volaire F, 1998, NEW PHYTOL, V140, P451, DOI [10.1046/j.1469-8137.1998.00287.x, 10.1111/j.1469-8137.1998.00287.x]; Westermeier P, 2016, P 26 GEN M EUR GRASS; WILSON D, 1975, ANN APPL BIOL, V79, P83, DOI 10.1111/j.1744-7348.1975.tb01524.x; WILSON JR, 1979, OECOLOGIA, V41, P77, DOI 10.1007/BF00344838; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Zhang ZX, 2008, BIOTECHNOL BIOTEC EQ, V22, P938, DOI 10.1080/13102818.2008.10817583	65	21	22	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194977	10.1371/journal.pone.0194977	http://dx.doi.org/10.1371/journal.pone.0194977			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617413	Green Submitted, Green Published, gold			2022-12-26	WOS:000429203800059
J	Czigany, Z; Bleilevens, C; Beckers, C; Stoppe, C; Mohring, M; Fulop, A; Szijarto, A; Lurje, G; Neumann, UP; Tolba, RH				Czigany, Zoltan; Bleilevens, Christian; Beckers, Christian; Stoppe, Christian; Moehring, Michaela; Fueloep, Andras; Szijarto, Attila; Lurje, Georg; Neumann, Ulf P.; Tolba, Rene H.			Limb remote ischemic conditioning of the recipient protects the liver in a rat model of arterialized orthotopic liver transplantation	PLOS ONE			English	Article							REPERFUSION INJURY; ISCHEMIA/REPERFUSION INJURY; MICROCIRCULATION; PRESERVATION; MECHANISMS; GRAFTS; CARDIOPROTECTION; PRETREATMENT; PROTOCOLS; APOPTOSIS	Background Ischemic-reperfusion (IR) injury still represents a major concern in clinical transplantation, especially in the era of extreme organ shortage and extended criteria donor organs. In the present study we aimed to investigate the hepatoprotective effects of remote ischemic conditioning (RIC) in a rat model of arterialized orthotopic liver transplantation (OLT). Methods Male Lewis rats were used (n = 144 / 72 OLT cases; 240-340g) as donors and recipients. Livers were flushed and stored in 4 degrees C HTK-solution for 8h before implantation. Recipients were randomly allocated into three experimental groups: RIC 1, RIC 2, Control. In RIC 1, RIC 2 groups, RIC was applied in the recipient before hepatectomy or after reperfusion (4x5-5min IR via clamping the infrarenal aorta), respectively. Animals were sacrificed at 1, 3,24,168h post-reperfusion (n = 6 recipient/group/time point). Hepatocellular injury, graft circulation, serum cytokines, tissue redox-stress and adenosine-triphosphate (ATP) levels have been assessed. Additional markers were analyzed, using Western blotting and reverse-transcription polymerase chain reaction. Results RIC 1 group showed significantly (p<0.05) improved portal venous and microcirculation flow as well as velocity. RIC has significantly reduced tissue injury according to the serum levels of transaminases and results of histopathological evaluation. Reduced TUNEL-staining (p<0.01 RIC 1-2 vs. Control) and elevated pBAD/BAD ratio was detected in the RIC groups (p<0.01 RIC 1 vs. Control). Supporting findings were obtained from measurements of serum IL-10 as well as tissue malondialdehyde and ATP levels. Hemoxygenase-1 (HO-1) mRNA-expression was significantly higher in RIC 1 compared to Control (p<0.05 RIC 1 vs. Control). Conclusion These results suggest that RIC might confer potent protection against the detrimental effects of IR injury including tissue damage, apoptosis, graft circulation, inflammation, tissue energetic status in OLT. HO-1 overexpression might play an orchestrating role in RIC mediated organ protection. An earlier intervention (RIC 1 protocol) was more effective than remote conditioning after graft reperfusion.	[Czigany, Zoltan; Moehring, Michaela; Tolba, Rene H.] Rhein Westfal TH Aachen, Inst Lab Anim Sci & Expt Surg, Aachen, Germany; [Czigany, Zoltan; Lurje, Georg; Neumann, Ulf P.] Rhein Westfal TH Aachen, Dept Surg & Transplantat, Aachen, Germany; [Bleilevens, Christian; Beckers, Christian; Stoppe, Christian] Rhein Westfal TH Aachen, Dept Intens Care Med, Aachen, Germany; [Fueloep, Andras; Szijarto, Attila] Semmelweis Univ, HPB Res Ctr, Dept Surg 1, Budapest, Hungary	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; Semmelweis University	Czigany, Z (corresponding author), Rhein Westfal TH Aachen, Inst Lab Anim Sci & Expt Surg, Aachen, Germany.; Czigany, Z (corresponding author), Rhein Westfal TH Aachen, Dept Surg & Transplantat, Aachen, Germany.	zczigany@ukaachen.de	Bleilevens, Christian/AAG-8034-2020	Bleilevens, Christian/0000-0002-2104-1843; Lurje, Georg/0000-0001-9674-0756; Czigany, Zoltan/0000-0003-0373-3210	German Academic Exchange Program (DAAD); European Society for Surgical Research (ESSR)	German Academic Exchange Program (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); European Society for Surgical Research (ESSR)	During the course of the project, ZC was supported by the German Academic Exchange Program (DAAD-https://www.daad.de/de/) and the Fellowship Award of the European Society for Surgical Research (ESSR-http://essr.info). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amara M, 2010, LIVER TRANSPLANT, V16, P1016, DOI 10.1002/lt.22117; An MY, 2017, BIOCHEM BIOPH RES CO, V488, P278, DOI 10.1016/j.bbrc.2017.05.014; Atanda AC, 2017, CARDIOVASC REVASCULA, V18, P549, DOI 10.1016/j.carrev.2017.06.001; Basalay M, 2012, EXP PHYSIOL, V97, P908, DOI 10.1113/expphysiol.2012.064923; Bromage DI, 2017, CARDIOVASC RES, V113, P288, DOI 10.1093/cvr/cvw219; Correa F, 2008, CELL PHYSIOL BIOCHEM, V22, P635, DOI 10.1159/000185547; Cotterell AH, 2015, DIGEST DIS SCI, V60, P2579, DOI 10.1007/s10620-015-3729-2; Czigany Z, 2014, J SURG RES; Czigany Z, 2015, EUR SURG RES, V55, P119, DOI 10.1159/000437095; Czigany Z, 2015, J SURG RES, V193, P642, DOI 10.1016/j.jss.2014.08.046; Czigany Z, 2013, J SURG RES, V185, P605, DOI 10.1016/j.jss.2013.07.018; Czigany Zoltan, 2012, Orvosi Hetilap, V153, P1579, DOI 10.1556/OH.2012.29469; Duan X, 2012, CARDIOLOGY, V122, P36, DOI 10.1159/000338149; Eitel I, 2015, EUR HEART J, V36, P3049, DOI 10.1093/eurheartj/ehv463; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Friedman BH, 2012, LIVER TRANSPLANT, V18, P166, DOI 10.1002/lt.22451; Fukai M, 2005, FREE RADICAL BIO MED, V38, P1372, DOI 10.1016/j.freeradbiomed.2005.02.004; Hata K, 2007, LIVER TRANSPLANT, V13, P114, DOI 10.1002/lt.20957; Hausenloy DJ, 2012, CARDIOVASC DRUG THER, V26, P87, DOI 10.1007/s10557-011-6364-y; Hess DC, 2013, STROKE, V44, P1191, DOI 10.1161/STROKEAHA.112.678482; Hess DC, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.223; Ho PWL, 2016, NEPHROLOGY, V21, P274, DOI 10.1111/nep.12614; Howells CC, 2011, J THEOR BIOL, V271, P114, DOI 10.1016/j.jtbi.2010.11.040; Jaeschke H, 2003, GASTROENTEROLOGY, V125, P1246, DOI 10.1016/S0016-5085(03)01209-5; Jia JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121972; Kim YH, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-16; Kono Y, 2014, DRUG DES DEV THER, V8, P1175, DOI 10.2147/DDDT.S68715; Kraemer R, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-32; Kume M, 2006, J SURG RES, V136, P209, DOI 10.1016/j.jss.2006.05.038; Lee D, 2014, APOPTOSIS, V19, P603, DOI 10.1007/s10495-013-0956-x; Liang RP, 2017, WORLD J GASTROENTERO, V23, P6995, DOI 10.3748/wjg.v23.i38.6995; McLeod SL, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005522; Minor T, 2000, CRYOBIOLOGY, V40, P182, DOI 10.1006/cryo.2000.2231; Nagai K, 2013, JOVE-J VIS EXP, DOI 10.3791/4376; Nagai K, 2013, TRANSPLANTATION, V95, P78, DOI 10.1097/TP.0b013e318277e2d1; Pickard JMJ, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0568-z; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Puhl G, 2005, LIVER TRANSPLANT, V11, P555, DOI 10.1002/lt.20394; Robertson FP, 2017, HPB, V19, P757, DOI 10.1016/j.hpb.2017.05.005; Saat TC, 2015, J SURG RES, V198, P217, DOI 10.1016/j.jss.2015.04.057; Shi W, 2012, CARDIOVASCULAR RES; Starzl TE, 2010, HEPATOLOGY, V51, P1869, DOI 10.1002/hep.23595; Sutter AG, 2014, EUR CYTOKINE NETW, V25, P69, DOI 10.1684/ecn.2015.0359; Szijarto A, 2012, J SURG RES, V178, P797, DOI 10.1016/j.jss.2012.06.067; Tamareille S, 2011, BASIC RES CARDIOL, V106, P1329, DOI 10.1007/s00395-011-0210-z; Teoh NC, 2003, J GASTROEN HEPATOL, V18, P891, DOI 10.1046/j.1440-1746.2003.03056.x; TOLEDOPEREYRA LH, 1975, AM J SURG, V129, P513, DOI 10.1016/0002-9610(75)90308-6; Vollmar B, 2009, PHYSIOL REV, V89, P1269, DOI 10.1152/physrev.00027.2008; Wang CF, 2011, WORLD J GASTROENTERO, V17, P3101, DOI 10.3748/wjg.v17.i26.3101; Wang M, 2012, J SURG RES; Wang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098834; Xie H, 2014, ACTA PHARMACOL SIN, V35, P1504, DOI 10.1038/aps.2014.78; Yagi S, 2011, J SURG RES, V167, pE375, DOI 10.1016/j.jss.2010.12.040; Zhai Y, 2011, AM J TRANSPLANT, V11, P1563, DOI 10.1111/j.1600-6143.2011.03579.x; Zhai Y, 2013, NAT REV GASTRO HEPAT, V10, P79, DOI 10.1038/nrgastro.2012.225	55	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195507	10.1371/journal.pone.0195507	http://dx.doi.org/10.1371/journal.pone.0195507			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617450	Green Published, Green Submitted, gold			2022-12-26	WOS:000429203800089
J	Hahne, J; Kloster, T; Rathmann, S; Weber, M; Lipski, A				Hahne, Julia; Kloster, Tabea; Rathmann, Sandra; Weber, Mareike; Lipski, Andre			Isolation and characterization of Corynebacterium spp. from bulk tank raw cow's milk of different dairy farms in Germany	PLOS ONE			English	Article							SP-NOV.; CORYNEFORM BACTERIA; IDENTIFICATION; STRAINS; TELLURITE; SURFACE; CLASSIFICATION; DIVERSITY; ALIGNMENT; SYSTEM	We detected Corynebacterium spp. in raw milk samples of three farms by means of a selective, tellurite-containing medium. The isolated strains were identified based on full 16S rRNA gene sequences and partial rpoB gene sequences as C. xerosis, C. variabile, C. lactis, C. callunae, C. confusum, C. glutamicum and C. crudilactis. The identification based on 16S rRNA and rpoB sequences was not reliable for isolates of C. xerosis. Chemotaxonomic markers of the isolates, fatty acids, acyl type of peptidoglycan, presence and length of mycolic acids, quinone patterns, and polar lipids, were in accord with the known characteristics of these species. Biochemical profiles, analyzed with the API Coryne system, were able to differentiate all groups, but were unable to identify the strains due to an inappropriate database for raw-milk associated corynebacteria. Most of the tested isolates showed a single-substance resistance against oxacillin, but three single isolates were classified as multidrug resistant.	[Hahne, Julia; Kloster, Tabea; Rathmann, Sandra; Weber, Mareike; Lipski, Andre] Rhein Friedrich Wilhelms Univ Bonn, Inst Nutr & Food Sci, Dept Food Microbiol & Hyg, Bonn, North Rhine Wes, Germany	University of Bonn	Lipski, A (corresponding author), Rhein Friedrich Wilhelms Univ Bonn, Inst Nutr & Food Sci, Dept Food Microbiol & Hyg, Bonn, North Rhine Wes, Germany.	lipski@uni-bonn.de						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAIRDPARKER AC, 1962, J APPL BACTERIOL, V25, P12, DOI 10.1111/j.1365-2672.1962.tb01113.x; BENDINGER B, 1992, INT J SYST BACTERIOL, V42, P474, DOI 10.1099/00207713-42-3-474; Bernard KA, 2002, J CLIN MICROBIOL, V40, P4375, DOI 10.1128/JCM.40.11.4375-4381.2002; Bernard KA, 1896, CORYNEBACTERIUM, P350; Bernard K, 2012, J CLIN MICROBIOL, V50, P3152, DOI 10.1128/JCM.00796-12; Bernard Wiebe, 2010, BERGEYS MANUAL SYSTE, V877, P245; Bockelmann W, 2001, INT DAIRY J, V11, P307, DOI 10.1016/S0958-6946(01)00060-7; Brennan NM, 2001, INT J SYST EVOL MICR, V51, P843, DOI 10.1099/00207713-51-3-843; BRENNAN PJ, 1971, LIPIDS, V6, P401, DOI 10.1007/BF02531377; BuchholzCleven BEE, 1997, SYST APPL MICROBIOL, V20, P301, DOI 10.1016/S0723-2020(97)80077-X; Clinical and Laboratory Standards Institute (CLSI), 2020, VET01S2 CLSI; COYLE MB, 1990, CLIN MICROBIOL REV, V3, P227, DOI 10.1128/CMR.3.3.227-246.1990; deMiguelMartinez I, 1996, EUR J CLIN MICROBIOL, V15, P617; Dolci P, 2009, J APPL MICROBIOL, V106, P278, DOI 10.1111/j.1365-2672.2008.04001.x; Fricker M, 2011, INT J FOOD MICROBIOL, V145, pS24, DOI 10.1016/j.ijfoodmicro.2010.08.025; Funke G, 1996, J CLIN MICROBIOL, V34, P1124, DOI 10.1128/JCM.34.5.1124-1128.1996; Funke G, 1998, INT J SYST BACTERIOL, V48, P1291, DOI 10.1099/00207713-48-4-1291; Funke G, 2008, J CLIN MICROBIOL, V46, P638, DOI 10.1128/JCM.01491-07; Goncalves JL, 2014, VET MICROBIOL, V173, P147, DOI 10.1016/j.vetmic.2014.06.028; Goncalves JL, 2016, VET J, V209, P87, DOI 10.1016/j.tvjl.2015.08.009; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Haltia L, 2006, ACTA VET SCAND, V48, DOI 10.1186/1751-0147-48-22; Harrigan W.F., 1998, LAB METHODS FOOD MIC; HOISCHEN C, 1990, J BACTERIOL, V172, P3409, DOI 10.1128/jb.172.6.3409-3416.1990; Hommez J, 1999, J CLIN MICROBIOL, V37, P954, DOI 10.1128/JCM.37.4.954-957.1999; Khamis A, 2005, J CLIN MICROBIOL, V43, P1934, DOI 10.1128/JCM.43.4.1934-1936.2005; Khamis A, 2004, J CLIN MICROBIOL, V42, P3925, DOI 10.1128/JCM.42.9.3925-3931.2004; Kim M, 2014, INT J SYST EVOL MICR, V64, P346, DOI 10.1099/ijs.0.059774-0; Konig C, 2014, J CLIN MICROBIOL, V52, P4318, DOI 10.1128/JCM.02291-14; Konrad R, 2010, EUROSURVEILLANCE, V15, P43, DOI DOI 10.2807/ESE.15.43.19699-EN.PII; LECHEVALIER MP, 1973, CAN J MICROBIOL, V19, P965, DOI 10.1139/m73-154; MINNIKIN DE, 1977, INT J SYST BACTERIOL, V27, P104, DOI 10.1099/00207713-27-2-104; Otsuka Y, 2005, J CLIN MICROBIOL, V43, P3713, DOI 10.1128/JCM.43.8.3713-3717.2005; Puech V, 2001, MICROBIOL-SGM, V147, P1365, DOI 10.1099/00221287-147-5-1365; Raats D, 2011, FOOD MICROBIOL, V28, P465, DOI 10.1016/j.fm.2010.10.009; Renaud FNR, 1998, J CLIN MICROBIOL, V36, P3698, DOI 10.1128/JCM.36.12.3698-3702.1998; Renaud FNR, 2001, INT J SYST EVOL MICR, V51, P1723, DOI 10.1099/00207713-51-5-1723; Renaud FNR, 2007, INT J SYST EVOL MICR, V57, P1113, DOI 10.1099/ijs.0.64665-0; RIEGEL P, 1994, J CLIN MICROBIOL, V32, P1860, DOI 10.1128/JCM.32.8.1860-1865.1994; Schukken YH, 2009, VET MICROBIOL, V134, P9, DOI 10.1016/j.vetmic.2008.09.014; SEGAL E, 1973, MED MICROBIOL IMMUN, V158, P165, DOI 10.1007/BF02120551; SOTO A, 1994, J CLIN PATHOL, V47, P756, DOI 10.1136/jcp.47.8.756; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TINSDALE GFW, 1947, J PATHOL BACTERIOL, V59, P461, DOI 10.1002/path.1700590313; Vacheyrou M, 2011, INT J FOOD MICROBIOL, V146, P253, DOI 10.1016/j.ijfoodmicro.2011.02.033; von Graevenitz A, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P819, DOI 10.1007/0-387-30743-5_31; WALTER EG, 1992, PLASMID, V27, P52, DOI 10.1016/0147-619X(92)90006-V; Watts JL, 2000, ANTIMICROB AGENTS CH, V44, P3476, DOI 10.1128/AAC.44.12.3476-3477.2000; Watts JL, 2000, J DAIRY SCI, V83, P2373, DOI 10.3168/jds.S0022-0302(00)75126-5; Weber M, 2014, J DAIRY SCI, V97, P6761, DOI 10.3168/jds.2014-8340; Wiertz R, 2013, INT J SYST EVOL MICR, V63, P4495, DOI 10.1099/ijs.0.050757-0; WILKINSO.SG, 1970, J BACTERIOL, V104, P1035, DOI 10.1128/JB.104.3.1035-1044.1970; YAMADA Y, 1976, J GEN APPL MICROBIOL, V22, P203, DOI 10.2323/jgam.22.203; ZEBOVITZ E, 1955, J BACTERIOL, V70, P686, DOI 10.1128/JB.70.6.686-690.1955; Zimmermann J, 2016, INT J SYST EVOL MICR, V66, P5288, DOI 10.1099/ijsem.0.001509	57	14	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194365	10.1371/journal.pone.0194365	http://dx.doi.org/10.1371/journal.pone.0194365			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617406	Green Published, gold, Green Submitted			2022-12-26	WOS:000429203800028
J	Liu, B; Arakawa, Y; Yokogawa, R; Tokunaga, S; Terada, Y; Murata, D; Matsui, Y; Fujimoto, K; Fukui, N; Tanji, M; Mineharu, Y; Minamiguchi, S; Miyamoto, S				Liu, Bin; Arakawa, Yoshiki; Yokogawa, Ryuta; Tokunaga, Shinya; Terada, Yukinori; Murata, Daiki; Matsui, Yasuzumi; Fujimoto, Ko-ichi; Fukui, Nobuyuki; Tanji, Masahiro; Mineharu, Yohei; Minamiguchi, Sachiko; Miyamoto, Susumu			PD-1/PD-L1 expression in a series of intracranial germinoma and its association with Foxp3+and CD8+infiltrating lymphocytes	PLOS ONE			English	Article							GERM-CELL TUMORS; LIGAND 1 EXPRESSION; NERVOUS-SYSTEM GERMINOMA; INFILTRATING LYMPHOCYTES; RADIATION-THERAPY; PD-L1 EXPRESSION; IMMUNE CHECKPOINTS; COLORECTAL-CANCER; BRAIN-TUMORS; LUNG-CANCER	One histopathological characteristic of intracranial germinoma is abundant tumor-infiltrating lymphocytes (TILs) showing a two-cell pattern with large undifferentiated tumor cells. The programmed cell death 1 (PD-1)/programmed cell death 1 ligand (PD-L) axis has recently been recognized as an anti-tumor immune system. To evaluate intratumor immune status in intracranial germinoma, we examined expressions of PD-1 and PD-L1 (clone 28-8) and subtypes of TILs. Expressions of PD-1 and PD-L1 were detected immunohistochemically in 25 formalin-fixed, paraffin-embedded tumor specimens from 24 patients with intracranial germinoma consisting of 22 primary and 3 recurrent tumors. To evaluate subtypes of TILs, quantification of lymphocytes with CD3, CD8, CD4, and Foxp3 was performed. Statistical analyses were performed among PD-1, PD-L1 and subtypes of TILs. In 25 tumor tissue, expressions of PD-1 in TILs and PD-L1 in tumor cells were identified in 96% (24/25) and 92% (23/25), respectively. Expression of PD-1 was associated with CD3+ TIL density. Expression of PD-1 correlated with Foxp3+ TIL density and CD8+ TIL density, but not with CD4+ TIL density. Furthermore, expression of PD-1 correlated strongly with Foxp3+/CD4+ ratio. Taken together, increase of PD-1+ expression is associated with accumulation of Foxp3+ and CD8+ TILs. These findings intimate that PD-1/PD-L1 axis might shape the immune infiltration suggesting a modulation of the immune response and subsequent tumor growth in intracranial germinoma. Anti-PD-1 and anti-PD-L1 are potential immune therapeutic strategies in intracranial germinoma.	[Liu, Bin; Arakawa, Yoshiki; Yokogawa, Ryuta; Tokunaga, Shinya; Terada, Yukinori; Murata, Daiki; Matsui, Yasuzumi; Fujimoto, Ko-ichi; Fukui, Nobuyuki; Tanji, Masahiro; Mineharu, Yohei; Miyamoto, Susumu] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, Japan; [Minamiguchi, Sachiko] Kyoto Univ, Grad Sch Med, Dept Diagnost Pathol, Kyoto, Japan	Kyoto University; Kyoto University	Arakawa, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, Japan.	yarakawa@kuhp.kyoto-u.ac.jp		Mineharu, Yohei/0000-0002-6346-3999	JSPS KAKENHI [JP25462254, JP16K10754]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to thank the members in the Department of Neurosurgery for constructive comments on the manuscript and throughout the project. This work was supported by JSPS KAKENHI Grant Number JP25462254 and JP16K10754.; This work was supported by JSPS KAKENHI Grant Number JP25462254 and JP16K10754 to YA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alapetite C, 2010, NEURO-ONCOLOGY, V12, P1318, DOI 10.1093/neuonc/noq093; Aoki T, 2016, PEDIATR BLOOD CANCER, V63, P1461, DOI 10.1002/pbc.26018; Aoyama H, 2002, J CLIN ONCOL, V20, P857, DOI 10.1200/JCO.20.3.857; Balmaceda C, 1996, J CLIN ONCOL, V14, P2908, DOI 10.1200/JCO.1996.14.11.2908; Bamberg M, 1999, J CLIN ONCOL, V17, P2585, DOI 10.1200/JCO.1999.17.8.2585; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Berghoff AS, 2015, NEURO-ONCOLOGY, V17, P1064, DOI 10.1093/neuonc/nou307; Callea M, 2015, CANCER IMMUNOL RES, V3, P1158, DOI 10.1158/2326-6066.CIR-15-0043; Chemaitilly W, 2010, ENDOCR-RELAT CANCER, V17, pR141, DOI 10.1677/ERC-10-0002; Cheng S, 2016, J NEURO-ONCOL, V127, P173, DOI 10.1007/s11060-015-2029-1; Cho KT, 2002, CHILD NERV SYST, V18, P30, DOI 10.1007/s00381-001-0547-y; Cierna Z, 2016, ANN ONCOL, V27, P300, DOI 10.1093/annonc/mdv574; D'Incecco A, 2015, BRIT J CANCER, V112, P95, DOI 10.1038/bjc.2014.555; Dahlin AM, 2011, MODERN PATHOL, V24, P671, DOI 10.1038/modpathol.2010.234; Darb-Esfahani S, 2016, ONCOTARGET, V7, P1486, DOI 10.18632/oncotarget.6429; Droeser RA, 2013, EUR J CANCER, V49, P2233, DOI 10.1016/j.ejca.2013.02.015; Fangusaro J, 2008, PEDIATR BLOOD CANCER, V50, P312, DOI [10.1002/pbc.21307, 10.1002/pbc.21555]; Fankhauser CD, 2015, BRIT J CANCER, V113, P411, DOI 10.1038/bjc.2015.244; Fu H, 2017, J CLIN NEUROSCIENCE; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Harter PN, 2015, ONCOTARGET, V6, P40836, DOI 10.18632/oncotarget.5696; Hattab EM, 2005, AM J SURG PATHOL, V29, P368, DOI 10.1097/01.pas.0000149709.19958.a7; Hino R, 2010, CANCER-AM CANCER SOC, V116, P1757, DOI 10.1002/cncr.24899; Janssen-Heijnen MLG, 2010, J CLIN ONCOL, V28, P2520, DOI 10.1200/JCO.2009.25.9697; JENNINGS MT, 1985, J NEUROSURG, V63, P155, DOI 10.3171/jns.1985.63.2.0155; Kamphorst AO, 2013, CURR OPIN IMMUNOL, V25, P381, DOI 10.1016/j.coi.2013.03.003; Kawabata Y, 2008, J NEURO-ONCOL, V88, P161, DOI 10.1007/s11060-008-9542-4; Kenjo M, 2015, JPN J RADIOL, V33, P336, DOI 10.1007/s11604-015-0424-3; Kim JW, 2014, ONCOLOGY-NY, V28, P15; Louis D.N., 2016, WHO CLASSIFICATION G, V4th ed.; Matsutani M, 1997, J NEUROSURG, V86, P446, DOI 10.3171/jns.1997.86.3.0446; Matsutani M, 2001, J NEURO-ONCOL, V54, P311, DOI 10.1023/A:1012743707883; Merchant TE, 2011, J CLIN ONCOL, V29, P4776, DOI 10.1200/JCO.2011.37.9453; Murata D, 2018, J NEUROSURG, V128, P710, DOI 10.3171/2016.11.JNS16991; NEUWELT EA, 1979, ANN NEUROL, V6, P133, DOI 10.1002/ana.410060211; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Osorio Diana S, 2015, CNS Oncol, V4, P273, DOI 10.2217/cns.15.13; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Roth P, 2013, EXPERT REV ANTICANC, V13, P1319, DOI 10.1586/14737140.2013.852473; SAITO T, 1989, J NEUROSURG, V70, P81, DOI 10.3171/jns.1989.70.1.0081; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Spiegler BJ, 2004, J CLIN ONCOL, V22, P706, DOI 10.1200/JCO.2004.05.186; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Utsuki S, 2006, NEUROL MED-CHIR, V46, P429, DOI 10.2176/nmc.46.429; van Vulpen M, 2002, ONCOL REP, V9, P683; Vasiljevic A, 2015, NEUROCHIRURGIE, V61, P130, DOI 10.1016/j.neuchi.2013.06.006; Wen PY, 2006, CLIN CANCER RES, V12, P4899, DOI 10.1158/1078-0432.CCR-06-0773; Wilmotte R, 2005, NEUROREPORT, V16, P1081, DOI 10.1097/00001756-200507130-00010; Zschabitz S, 2017, EUR J CANCER, V76, P1, DOI 10.1016/j.ejca.2017.01.033	49	15	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194594	10.1371/journal.pone.0194594	http://dx.doi.org/10.1371/journal.pone.0194594			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617441	Green Published, Green Submitted, gold			2022-12-26	WOS:000429203800039
J	Ratnayeke, S; van Manen, FT; Clements, GR; Kulaimi, NAM; Sharp, SP				Ratnayeke, Shyamala; van Manen, Frank T.; Clements, Gopalasamy Reuben; Kulaimi, Noor Azleen Mohd; Sharp, Stuart P.			Carnivore hotspots in Peninsular Malaysia and their landscape attributes	PLOS ONE			English	Article							OIL PALM AGRICULTURE; POPULATION-DENSITY; BIODIVERSITY LOSS; EXTINCTION RISK; CONSERVATION; CONFLICT; PATTERNS; LEOPARDS; MAMMALS; FOREST	Mammalian carnivores play a vital role in ecosystem functioning. However, they are prone to extinction because of low population densities and growth rates, and high levels of persecution or exploitation. In tropical biodiversity hotspots such as Peninsular Malaysia, rapid conversion of natural habitats threatens the persistence of this vulnerable group of animals. Here, we carried out the first comprehensive literature review on 31 carnivore species reported to occur in Peninsular Malaysia and updated their probable distribution. We georeferenced 375 observations of 28 species of carnivore from 89 unique geographic locations using records spanning 1948 to 2014. Using the Getis-Ord Gi*statistic and weighted survey records by IUCN Red List status, we identified hotspots of species that were of conservation concern and built regression models to identify environmental and anthropogenic landscape factors associated with Getis-Ord Gi* zscores. Our analyses identified two carnivore hot spots that were spatially concordant with two of the peninsula's largest and most contiguous forest complexes, associated with Taman Negara National Park and Royal Belum State Park. A cold spot overlapped with the southwestern region of the Peninsula, reflecting the disappearance of carnivores with higher conservation rankings from increasingly fragmented natural habitats. Getis-Ord Gi* zscores were negatively associated with elevation, and positively associated with the proportion of natural land cover and distance from the capital city. Malaysia contains some of the world's most diverse carnivore assemblages, but recent rates of forest loss are some of the highest in the world. Reducing poaching and maintaining large, contiguous tracts of lowland forests will be crucial, not only for the persistence of threatened carnivores, but for many mammalian species in general.	[Ratnayeke, Shyamala; Clements, Gopalasamy Reuben] Sunway Univ, Dept Biol Sci, Bandar Sunway, Malaysia; [van Manen, Frank T.] US Geol Survey, Northern Rocky Mt Sci Ctr, Interagency Grizzly Bear Study Team, Bozeman, MT USA; [Clements, Gopalasamy Reuben] Rimba, Kuala Lumpur, Malaysia; [Kulaimi, Noor Azleen Mohd] Dept Wildlife & Natl Pk, Ex Situ Conservat Div, Kuala Lumpur, Malaysia; [Sharp, Stuart P.] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England	Sunway University; United States Department of the Interior; United States Geological Survey; Lancaster University	Ratnayeke, S (corresponding author), Sunway Univ, Dept Biol Sci, Bandar Sunway, Malaysia.	shyamalar@sunway.edu.my	Sharp, Stuart P/F-8246-2014; Ratnayeke, Shyamala/AAB-9412-2019; kulaimi, noor azleen mohd/AAF-6330-2021	Sharp, Stuart P/0000-0002-3059-2532; noor azleen, kulaimi/0000-0002-1224-7735; Clements, Gopalasamy Reuben/0000-0002-9715-4385; T. van Manen, Frank/0000-0001-5340-8489				Abdullah SA, 2008, LANDSCAPE URBAN PLAN, V87, P147, DOI 10.1016/j.landurbplan.2008.05.008; Abdullah SA, 2006, LANDSCAPE URBAN PLAN, V77, P263, DOI 10.1016/j.landurbplan.2005.03.003; Adyla MNN, 2016, AIP CONF PROC, V1784, DOI 10.1063/1.4966876; Agus F., 2013, REPORTS TECH PANELS, P65; [Anonymous], 2008, J SCI TECHNOL TROPIC; Azad MAJBA, 2006, BIODIVERS CONSERV, V15, P1013, DOI 10.1007/s10531-004-3953-0; Azhar B, 2014, BIODIVERS CONSERV, V23, P1175, DOI 10.1007/s10531-014-0656-z; Aziz SA, 2010, FRONT ECOL ENVIRON, V8, P178, DOI 10.1890/10.WB.014; Berger J, 2001, ECOL APPL, V11, P947, DOI 10.2307/3061004; Boitani L, 2012, TECH ECOL CONSERVAT, P8; Brooke ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093195; BROOKFIELD H, 1990, GLOBAL ENVIRON CHANG, V1, P42, DOI 10.1016/0959-3780(90)90006-U; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Caro T, 2004, ANIM CONSERV, V7, P63, DOI 10.1017/S136794300300115X; Chapron G, 2008, J APPL ECOL, V45, P1667, DOI 10.1111/j.1365-2664.2008.01538.x; Choudhury A, 2015, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2015-4.RLTS.T41710A45220632.en, DOI 10.2305/IUCN.UK.2015-4.RLTS.T41710A45220632.EN]; Chye L. K, 2010, LANDSCAPE, V14, P15; Clements GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115376; Clements R, 2010, BIODIVERS CONSERV, V19, P1115, DOI 10.1007/s10531-009-9775-3; Corlett RT, 2014, Ecology of Tropical East Asia, 2nd Edition, P1, DOI 10.1093/acprof:oso/9780199681341.001.0001; Crook KR, 2002, CONSERV BIOL; Department of Statistics Malaysia, 2015, MAL POP STAT ETHN GR; Department of Statistics Malaysia, 2015, MAL A GLANC; Department of Wildlife and National Parks (DWNP), 2008, NAT TIG ACT PLAN MAL; Department of Wildlife and National Parks (DWNP) Peninsular Malaysia, 2009, RED LIST MAMM PEN MA, V1st; Di Minin E, 2016, SCI REP-UK, V6, DOI 10.1038/srep23814; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Edwards DP, 2012, CONSERV LETT, V5, P20, DOI 10.1111/j.1755-263X.2011.00209.x; Ellis Richard, 2005, TIGER BONE RHINO HOR; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fahrig L, 2009, ECOL SOC, V14; Fisher DO, 2011, BIOL CONSERV, V144, P1712, DOI 10.1016/j.biocon.2011.03.005; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gittleman JL, 2001, CONSERV BIOL SER, V5, P1; Gumal Melvin, 2014, Cat News, P10; Haines AM, 2012, WILDLIFE SOC B, V36, P685, DOI 10.1002/wsb.194; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hedges L., 2013, Small Carnivore Conservation, V49, P9; Hedges L, 2015, J WILDLIFE MANAGE, V79, P846, DOI 10.1002/jwmg.901; Hock S.S., 2007, POPULATION PENINSULA; Ikanda Dennis, 2008, Endangered Species Research, V6, P67, DOI 10.3354/esr00120; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; International Union for Conservation of Nature, 2001, 2001 IUCN RED LIST C; IUCN (International Union for Conservation of Nature), 2021, THE IUCN RED LIST TH, DOI [10.2305/IUCN.UK.2015-2.RLTS.T2446A22156678.en, DOI 10.2305/IUCN.UK.2015-2.RLTS.T2446A22156678.EN]; Kawanishi K, 2010, J ZOOL, V282, P201, DOI 10.1111/j.1469-7998.2010.00731.x; Kawanishi Kae, 2003, Cat News, V39, P3; Kiviat E, 2002, URBAN HABITATS, V2, P28; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; Koh LP, 2013, ENCY BIODIVERSITY, V1, P509, DOI DOI 10.1016/B978-0-12-384719-5.00357-9; Laidlaw RK, 2000, CONSERV BIOL, V14, P1639, DOI 10.1046/j.1523-1739.2000.99073.x; Laurance WF, 2007, CURR SCI INDIA, V93, P1544; Liberg O, 2012, P ROY SOC B-BIOL SCI, V279, P910, DOI 10.1098/rspb.2011.1275; Lynam AJ, 2007, ORYX, V41, P454, DOI 10.1017/S0030605307001019; McShea WJ, 2009, BIOL CONSERV, V142, P3108, DOI 10.1016/j.biocon.2009.08.009; Medway L., 1969, WILD MAMMALS MALAYA; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Phua MH, 2008, J ENVIRON MANAGE, V88, P784, DOI 10.1016/j.jenvman.2007.04.011; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Rao M, 2001, SCIENCE, V294, P1923; Ratnayeke S, 2012, URSUS, V23, P206, DOI 10.2192/URSUS-D-11-00029.1; Rayan DM, 2016, BIOL CONSERV, V204, P360, DOI 10.1016/j.biocon.2016.11.009; Rayan DM, 2007, TIGER MONITORI UNPUB; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Rostro-Garcia S, 2016, BIOL CONSERV, V201, P293, DOI 10.1016/j.biocon.2016.07.001; SABERWAL VK, 1994, CONSERV BIOL, V8, P501, DOI 10.1046/j.1523-1739.1994.08020501.x; Sasidhran S, 2016, FOREST ECOL MANAG, V363, P140, DOI 10.1016/j.foreco.2015.12.037; Schwabe KA, 2015, J ENVIRON DEV, V24, P54, DOI 10.1177/1070496514551173; Scott L. M., 2010, HDB APPL SPATIAL ANA, P2741, DOI DOI 10.1007/978-3-642-03647-7_2; Sen YH, 1990, J WILDL PARKS MALAYS, VX, P1; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Shekhar S, 2011, WIRES DATA MIN KNOWL, V1, P193, DOI 10.1002/widm.25; Shepherd Chris R., 2010, Traffic Bulletin, V23, P49; Shevade VS, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9070747; Shochat E, 2010, BIOSCIENCE, V60, P199, DOI 10.1525/bio.2010.60.3.6; Simberloff D, 1998, BIOL CONSERV, V83, P247, DOI 10.1016/S0006-3207(97)00081-5; SIVASOTHI N, 1994, HYDROBIOLOGIA, V285, P151, DOI 10.1007/BF00005663; Sollmann R, 2017, DIVERS DISTRIB, V23, P317, DOI 10.1111/ddi.12530; Swihart RK, 2009, DIVERS DISTRIB, V9, P1; Tan CKW, 2017, BIOL CONSERV, V206, P65, DOI 10.1016/j.biocon.2016.12.012; Thayne JB, 2012, ANN ASSOC AM GEOGR; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; van Langevelde F, 2009, J ENVIRON MANAGE, V90, P660, DOI 10.1016/j.jenvman.2007.09.003; VANBREE PJH, 1992, Z SAUGETIERKD, V57, P179; Wadey J, 2014, TROP CONSERV SCI, V7, P181; Webb Richard, 1998, Arboricultural Journal, V22, P287; Wei CTK, 2015, TROP CONSERV SCI, V8, P732, DOI 10.1177/194008291500800310; WELLS DR, 1989, NATURAL HIST B SIAM, V37, P87; Wicke B, 2011, LAND USE POLICY, V28, P193, DOI 10.1016/j.landusepol.2010.06.001; Woodroffe R, 2001, CONSERV BIOL SER, V5, P61; Yusof E, 2000, J WILDL PARKS, V18, P3	94	12	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194217	10.1371/journal.pone.0194217	http://dx.doi.org/10.1371/journal.pone.0194217			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617402	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000429203800024
J	Luchsinger, C; Aguilar, M; Burgos, PV; Ehrenfeld, P; Mardones, GA				Luchsinger, Charlotte; Aguilar, Marcelo; Burgos, Patricia V.; Ehrenfeld, Pamela; Mardones, Gonzalo A.			Functional disruption of the Golgi apparatus protein ARF1 sensitizes MDA-MB-231 breast cancer cells to the antitumor drugs Actinomycin D and Vinblastine through ERK and AKT signaling	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR-1; NUCLEOTIDE EXCHANGE FACTOR; BREFELDIN-A; GUANINE-NUCLEOTIDE; PHOSPHATIDYLINOSITOL 3-KINASE; ENDOPLASMIC-RETICULUM; SULFIDE DERIVATIVES; PRODRUG CANDIDATES; TYROSINE KINASE; LACTAM ANALOG	Increasing evidence indicates that the Golgi apparatus plays active roles in cancer, but a comprehensive understanding of its functions in the oncogenic transformation has not yet emerged. At the same time, the Golgi is becoming well recognized as a hub that integrates its functions of protein and lipid biosynthesis to signal transduction for cell proliferation and migration in cancer cells. Nevertheless, the active function of the Golgi apparatus in cancer cells has not been fully evaluated as a target for combined treatment. Here, we analyzed the effect of perturbing the Golgi apparatus on the sensitivity of the MDA-MB-231 breast cancer cell line to the drugs Actinomycin D and Vinblastine. We disrupted the function of ARF1, a protein necessary for the homeostasis of the Golgi apparatus. We found that the expression of the ARF1-Q71L mutant increased the sensitivity of MDA-MB-231 cells to both Actinomycin D and Vinblastine, resulting in decreased cell proliferation and cell migration, as well as in increased apoptosis. Likewise, the combined treatment of cells with Actinomycin D or Vinblastine and Brefeldin A or Golgicide A, two disrupting agents of the ARF1 function, resulted in similar effects on cell proliferation, cell migration and apoptosis. Interestingly, each combined treatment had distinct effects on ERK1/2 and AKT signaling, as indicated by the decreased levels of either phospho-ERK1/2 or phospho-AKT. Our results suggest that disruption of Golgi function could be used as a strategy for the sensitization of cancer cells to chemotherapy.	[Luchsinger, Charlotte; Aguilar, Marcelo; Burgos, Patricia V.; Mardones, Gonzalo A.] Univ Austral Chile, Sch Med, Dept Physiol, Valdivia, Chile; [Luchsinger, Charlotte; Aguilar, Marcelo; Burgos, Patricia V.; Ehrenfeld, Pamela; Mardones, Gonzalo A.] Univ Austral Chile, Ctr Interdisciplinary Studies Nervous Syst CISNe, Valdivia, Chile; [Burgos, Patricia V.; Mardones, Gonzalo A.] Univ San Sebastian, Sch Med & Sci, Ctr Cell Biol & Biomed CEBICEM, Santiago, Chile; [Burgos, Patricia V.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Aging & Regenerat CARE, Santiago, Chile; [Ehrenfeld, Pamela] Univ Austral Chile, Sch Med, Dept Anat Histol & Pathol, Valdivia, Chile	Universidad Austral de Chile; Universidad Austral de Chile; Universidad San Sebastian; Pontificia Universidad Catolica de Chile; Universidad Austral de Chile	Mardones, GA (corresponding author), Univ Austral Chile, Sch Med, Dept Physiol, Valdivia, Chile.; Mardones, GA (corresponding author), Univ Austral Chile, Ctr Interdisciplinary Studies Nervous Syst CISNe, Valdivia, Chile.; Mardones, GA (corresponding author), Univ San Sebastian, Sch Med & Sci, Ctr Cell Biol & Biomed CEBICEM, Santiago, Chile.	gonzalo.mardones@uach.cl	Luchsinger, Charlotte/AAZ-6028-2021	EHRENFELD, INGRID/0000-0002-2519-7570	Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT) [1130710, 1161252, 1171649]; Direccion de Investigacion y Desarrollo de la Universidad Austral de Chile (DID-UACh); Comision Nacional de Investigacion Cientifica y Tecnologica of Chile (CONICYT); Comision Nacional de Investigacion Cientifica y Tecnologica [PFB12/2007, AFB1700005]	Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Direccion de Investigacion y Desarrollo de la Universidad Austral de Chile (DID-UACh); Comision Nacional de Investigacion Cientifica y Tecnologica of Chile (CONICYT); Comision Nacional de Investigacion Cientifica y Tecnologica	This work was funded by grants 1130710, 1161252 (G.A.M.) and 1171649 (P.V.B.) from Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT; http://www.conicyt.cl/fondecyt), and from Direccion de Investigacion y Desarrollo de la Universidad Austral de Chile (DID-UACh; http://investigacion.uach.cl) (G.A.M. and P.V.B.). C.L. is supported by a fellowship from Comision Nacional de Investigacion Cientifica y Tecnologica of Chile (CONICYT; http://www.conicyt.cl). Comision Nacional de Investigacion Cientifica y Tecnologica PFB12/2007 to Patricia V. Burgos, Comision Nacional de Investigacion Cientifica y Tecnologica AFB1700005 to Patricia V. Burgos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyaneh HS, 2017, CANCERS, V9, DOI 10.3390/cancers9100137; Anadu NO, 2006, J MED CHEM, V49, P3897, DOI 10.1021/jm0602817; Archambaud S, 2005, SYNLETT, P139, DOI 10.1055/s-2004-835669; Argade AB, 1998, J ORG CHEM, V63, P273, DOI 10.1021/jo971292y; Argade AB, 1998, J MED CHEM, V41, P3337, DOI 10.1021/jm970746g; Ayala I, 2017, BIOL CELL, V109, P364, DOI 10.1111/boc.201700032; Bates D, 2017, BRIT J CLIN PHARMACO, V83, P255, DOI 10.1111/bcp.13126; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; BERNHARDT G, 1992, J CANCER RES CLIN, V118, P35, DOI 10.1007/BF01192309; Bloom GS, 1998, J CELL BIOL, V140, P1277, DOI 10.1083/jcb.140.6.1277; Boal F, 2010, TRAFFIC, V11, P1537, DOI 10.1111/j.1600-0854.2010.01122.x; BONADONNA G, 1978, ANNU REV MED, V29, P149, DOI 10.1146/annurev.me.29.020178.001053; Borchmann S, 2016, CURR OPIN ONCOL, V28, P377, DOI 10.1097/CCO.0000000000000314; Boulay PL, 2011, ONCOGENE, V30, P3846, DOI 10.1038/onc.2011.100; Boulay PL, 2008, J BIOL CHEM, V283, P36425, DOI 10.1074/jbc.M803603200; Braga S, 2016, METHODS MOL BIOL, V1395, P105, DOI 10.1007/978-1-4939-3347-1_8; Cancino J, 2013, TRAFFIC, V14, P121, DOI 10.1111/tra.12022; Casalou Cristina, 2016, Small GTPases, V7, P270; Chalakur-Ramireddy NKR, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171357; Charest A, 2003, P NATL ACAD SCI USA, V100, P916, DOI 10.1073/pnas.242741799; Chen FM, 2003, BIOPHYS J, V84, P432, DOI 10.1016/S0006-3495(03)74863-2; CIOCCA DR, 1992, CANCER RES, V52, P3648; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Davis JE, 2016, ONCOTARGET, V7, P39834, DOI 10.18632/oncotarget.9405; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; Dong CM, 2011, J BIOL CHEM, V286, P43361, DOI 10.1074/jbc.M111.267286; Elyaman W, 2002, J NEUROCHEM, V81, P870, DOI 10.1046/j.1471-4159.2002.00838.x; Forster S, 2008, SYNLETT, P831, DOI 10.1055/s-2008-1042899; Forster S, 2011, EUR J ORG CHEM, V2011, P878, DOI 10.1002/ejoc.201001297; Fox BM, 2001, J MED CHEM, V44, P3915, DOI 10.1021/jm010054z; Gao J, 2008, TETRAHEDRON, V64, P11105, DOI 10.1016/j.tet.2008.09.065; Gendarme M, 2017, MOL BIOL CELL, V28, P3756, DOI 10.1091/mbc.E17-03-0176; Goldstein DP, 2015, EXPERT REV ANTICANC, V15, P1293, DOI 10.1586/14737140.2015.1088786; Gu GF, 2017, ONCOL REP, V37, P1511, DOI 10.3892/or.2017.5388; Haines E, 2015, CANCER BIOL THER, V16, P1535, DOI 10.1080/15384047.2015.1071737; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Ho CY, 2008, J CELL BIOCHEM, V105, P835, DOI 10.1002/jcb.21879; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Hosoi H, 2016, PEDIATR INT, V58, P81, DOI 10.1111/ped.12867; Hubscher T, 2006, SYNLETT, P1323, DOI 10.1055/s-2006-941575; Ignashkova TI, 2017, TRAFFIC, V18, P530, DOI 10.1111/tra.12493; ISHII S, 1989, J ANTIBIOT, V42, P1877, DOI 10.7164/antibiotics.42.1877; Ishizaki R, 2008, MOL BIOL CELL, V19, P2650, DOI 10.1091/mbc.E07-10-1067; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Jordan M. A., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P1, DOI 10.2174/1568011023354290; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kaczmarek B, 2017, BIOL CELL, V109, P391, DOI 10.1111/boc.201700042; Kandula Mahesh, 2013, World J Oncol, V4, P137, DOI 10.4021/wjon681e; Kang HJ, 2009, BIOCHEMISTRY-US, V48, P7392, DOI 10.1021/bi9006836; Kawamoto K, 2002, TRAFFIC, V3, P483, DOI 10.1034/j.1600-0854.2002.30705.x; Kawanishi Shosuke, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P415, DOI 10.2174/1568011043352867; Kim MJ, 2015, INT J MOL SCI, V16, P29305, DOI 10.3390/ijms161226168; LADINSKY MS, 1992, EUR J CELL BIOL, V59, P92; Lang LW, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0583-4; Lewis-Saravalli S, 2013, CELL SIGNAL, V25, P1813, DOI 10.1016/j.cellsig.2013.05.011; Linardou H, 2015, ANTICANCER RES, V35, P1105; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lowe M, 2011, CURR OPIN CELL BIOL, V23, P85, DOI 10.1016/j.ceb.2010.10.004; Makowski SL, 2017, CURR OPIN CELL BIOL, V45, P17, DOI 10.1016/j.ceb.2017.01.004; Mamdani H, 2015, CURR TREAT OPTION ON, V16, DOI 10.1007/s11864-015-0364-2; Mao LN, 2013, J CELL SCI, V126, P1498, DOI 10.1242/jcs.121954; Mardones GA, 2006, MOL BIOL CELL, V17, P525, DOI 10.1091/mbc.E05-05-0447; Migita T, 2012, INT J BIOCHEM CELL B, V44, P1872, DOI 10.1016/j.biocel.2012.06.004; Morohashi Y, 2010, BIOCHEM J, V427, P401, DOI 10.1042/BJ20091681; Nam YJ, 2016, N-S ARCH PHARMACOL, V389, P951, DOI 10.1007/s00210-016-1242-6; Nan XL, 2017, ONCOTARGET, V8, P75712, DOI 10.18632/oncotarget.20095; Ohashi Y, 2016, CANCER RES, V76, P3895, DOI 10.1158/0008-5472.CAN-15-2220; Ohashi Y, 2012, J BIOL CHEM, V287, P3885, DOI 10.1074/jbc.M111.316125; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; Oualla K, 2017, THER ADV MED ONCOL, V9, P493, DOI 10.1177/1758834017711380; Paek SM, 2007, HETEROCYCLES, V71, P1059; Paramanathan T, 2012, NUCLEIC ACIDS RES, V40, P4925, DOI 10.1093/nar/gks069; PHILLIPS LR, 1993, ANAL BIOCHEM, V211, P16, DOI 10.1006/abio.1993.1225; Ramos MC, 2017, EXPERT OPIN THER PAT, V27, P1251, DOI 10.1080/13543776.2017.1349106; Ross BC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087357; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Sakhrani NM, 2013, DRUG DES DEV THER, V7, P585, DOI 10.2147/DDDT.S45614; Samadi N, 2014, J CANCER RES THER, V10, P715, DOI 10.4103/0973-1482.139152; Schlienger S, 2015, CELL SIGNAL, V27, P403, DOI 10.1016/j.cellsig.2014.11.032; Seehafer K, 2013, J MED CHEM, V56, P5872, DOI 10.1021/jm400615g; Shao FY, 2017, ONCOTARGET, V8, P73329, DOI 10.18632/oncotarget.20274; Shao RG, 1996, EXP CELL RES, V227, P190, DOI 10.1006/excr.1996.0266; Shtutman M, 2011, P NATL ACAD SCI USA, V108, P12449, DOI 10.1073/pnas.1103842108; Sliva D, 2002, J BIOL CHEM, V277, P3150, DOI 10.1074/jbc.M109579200; So B, 2017, CRIT REV ONCOL HEMAT, V113, P135, DOI 10.1016/j.critrevonc.2017.03.004; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Sonpavde G, 2016, J CLIN ONCOL, V34, P780, DOI 10.1200/JCO.2015.65.4442; Sotiropoulou PA, 2014, DRUG DISCOV TODAY, V19, P1547, DOI 10.1016/j.drudis.2014.05.002; TAMURA G, 1968, J ANTIBIOT, V21, P160, DOI 10.7164/antibiotics.21.160; Tenorio MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154719; Tenorio MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135260; THYBERG J, 1978, CELL TISSUE RES, V193, P247; THYBERG J, 1985, EXP CELL RES, V159, P1, DOI 10.1016/S0014-4827(85)80032-X; Tsai MM, 2012, CANCER SCI, V103, P1136, DOI 10.1111/j.1349-7006.2012.02243.x; Tseng CN, 2014, MOLECULES, V19, P17464, DOI 10.3390/molecules191117464; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104; VIRTANEN I, 1986, EUR J CELL BIOL, V42, P281; Weaver MS, 2015, J PEDIAT HEMATOL ONC, V37, P237, DOI 10.1097/MPH.0000000000000286; WEHLAND J, 1983, P NATL ACAD SCI-BIOL, V80, P4286, DOI 10.1073/pnas.80.14.4286; Wilson C, 2011, BIOCHEM J, V433, P1, DOI 10.1042/BJ20101058; Wlodkowic D, 2009, LEUKEMIA RES, V33, P1440, DOI 10.1016/j.leukres.2009.05.025; Wong M, 2014, SCIENCE, V346, P601, DOI 10.1126/science.1256898; Wyrozumska P., 2014, CELL LOGIST, V4, P27732; Xie XY, 2016, ONCOTARGET, V7, P58111, DOI 10.18632/oncotarget.11185; Xu XH, 2017, ANN HEMATOL, V96, P847, DOI 10.1007/s00277-017-2949-2; Zeghouf M, 2005, BIOCHEM SOC T, V33, P1265, DOI 10.1042/BST0331265; ZHANG CJ, 1994, J CELL BIOL, V124, P289, DOI 10.1083/jcb.124.3.289; Zhang MH, 2014, TARGET ONCOL, V9, P349, DOI 10.1007/s11523-013-0300-y; Zhou C, 2013, NEUROSCIENCE, V254, P361, DOI 10.1016/j.neuroscience.2013.09.045; Zhou H, 2016, CELL DEATH DIFFER, V23, P2031, DOI 10.1038/cdd.2016.86; Zhu CF, 2011, J CANCER RES CLIN, V137, P1587, DOI 10.1007/s00432-011-1049-2	115	16	16	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195401	10.1371/journal.pone.0195401	http://dx.doi.org/10.1371/journal.pone.0195401			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614107	Green Published, Green Submitted, gold			2022-12-26	WOS:000429081600056
J	Ogawa, K; Aoki, M; Kadono, S; Odani, A				Ogawa, Kazuma; Aoki, Miho; Kadono, Sumi; Odani, Akira			Complexes of myo-inositol-hexakisphosphate (InsP6) with zinc or lanthanum to enhance excretion of radioactive strontium from the body	PLOS ONE			English	Article							CHERNOBYL; CALCIUM	Sr-90, which was released into the atmosphere and the ocean following the Chernobyl and Fukushima Daiichi nuclear power plant disasters, is an important nuclear fission element. Compounds that inhibit the absorption of Sr-90 into the bloodstream and enhance its elimination can be beneficial in decreasing the absorbed radiation dose in people exposed to Sr-90. Recently, we prepared complexes of myo-inositol-hexakisphosphate (InsP6) with zinc or lanthanum as decorporation agents. These complexes, called Zn-InsP6 and La-InsP6 respectively, are insoluble in water and can potentially chelate additional metal cations. Hypothesizing that these complexes can assist the excretion of Sr-90 from the body, we evaluated them using Sr-85 instead of Sr-90. In in vitro binding experiments, Zn-InsP6 showed higher strontium adsorption capacity than La-InsP6. We then performed in vivo biodistribution experiments of Zn-InsP6 in mice after oral administration of (SrCl2)-Sr-85. Mice treated with Zn-InsP6 showed significantly lower bone accumulation of radioactivity than mice in a non treatment control group. Zn-InsP6 adsorbed radiostrontium in the gastrointestinal tract, inhibited this ion's absorption into the bloodstream, and enhanced its excretion in the feces. Therefore, Zn-InsP6 appears to be a promising Sr-90 "decorporation" agent.	[Ogawa, Kazuma] Kanazawa Univ, Inst Frontier Sci Initiat, Kanazawa, Ishikawa, Japan; [Aoki, Miho; Kadono, Sumi; Odani, Akira] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University	Ogawa, K (corresponding author), Kanazawa Univ, Inst Frontier Sci Initiat, Kanazawa, Ishikawa, Japan.	kogawa@p.kanazawa-u.ac.jp	ODANI, Akira/B-3043-2011; Ogawa, Kazuma/D-8406-2015	ODANI, Akira/0000-0003-3786-6740; Ogawa, Kazuma/0000-0002-1691-7302				BARNES DWH, 1970, INT J RADIAT BIOL RE, V18, P531, DOI 10.1080/09553007014551461; Brumfiel G, 2011, NATURE, V474, P135, DOI 10.1038/474135a; Davis J, 2000, J NUCL MED, V41, P183; DUNGWORTH DL, 1969, BLOOD-J HEMATOL, V34, P610, DOI 10.1182/blood.V34.5.610.610; Evangeliou N, 2014, ENVIRON INT, V64, P17, DOI 10.1016/j.envint.2013.11.020; GRAF E, 1990, FREE RADICAL BIO MED, V8, P61, DOI 10.1016/0891-5849(90)90146-A; Graf E., 1983, Journal of the American Oil Chemists' Society, V60, P1861; Haratake M, 2012, CHEM PHARM BULL, V60, P1258, DOI 10.1248/cpb.c12-00430; HARRISON JE, 1966, CAN MED ASSOC J, V94, P1092; Kanai Y, 2012, J ENVIRON RADIOACTIV, V111, P33, DOI 10.1016/j.jenvrad.2011.10.011; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Liepe K, 2003, J NUCL MED, V44, P953; Ogawa K, 2012, CURR MED CHEM, V19, P3290, DOI 10.2174/092986712801215865; OGAWA K, 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0148080; Ogawa K, 2017, CHEM PHARM BULL, V65, P261, DOI 10.1248/cpb.c16-00792; Ogawa K, 2009, NUCL MED BIOL, V36, P129, DOI 10.1016/j.nucmedbio.2008.11.007; SIMPSON CJ, 1990, BRIT J NUTR, V64, P225, DOI 10.1079/BJN19900024; Stabin MG, 2005, J NUCL MED, V46, P1023; SUTTON A, 1967, NATURE, V216, P1005, DOI 10.1038/2161005a0; Szkudelski T, 2005, J ANIM PHYSIOL AN N, V89, P397, DOI 10.1111/j.1439-0396.2005.00532.x; Yablokov AV, 2009, ANN NY ACAD SCI, V1181, P5, DOI [10.1111/j.1749-6632.2009.04821.x, 10.1111/j.1749-6632.2009.04820.x]	21	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195067	10.1371/journal.pone.0195067	http://dx.doi.org/10.1371/journal.pone.0195067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614122	Green Published, gold, Green Submitted			2022-12-26	WOS:000429081600028
J	Perez-Rueda, E; Hernandez-Guerrero, R; Martinez-Nunez, MA; Armenta-Medina, D; Sanchez, I; Ibarra, JA				Perez-Rueda, Ernesto; Hernandez-Guerrero, Rafael; Martinez-Nunez, Mario Alberto; Armenta-Medina, Dagoberto; Sanchez, Israel; Ibarra, J. Antonio			Abundance, diversity and domain architecture variability in prokaryotic DNA-binding transcription factors	PLOS ONE			English	Article							ARAC/XYLS FAMILY; GENOME SIZE; REGULATORS; DATABASE; INFORMATION; REPERTOIRE; EVOLUTION; PROTEINS; BACTERIA; MOTIF	Gene regulation at the transcriptional level is a central process in all organisms, and DNA binding transcription factors, known as TFs, play a fundamental role. This class of proteins usually binds at specific DNA sequences, activating or repressing gene expression. In general, TFs are composed of two domains: the DNA-binding domain (DBD) and an extra domain, which in this work we have named "companion domain" (CD). This latter could be involved in one or more functions such as ligand binding, protein-protein interactions or even with enzymatic activity. In contrast to DBDs, which have been widely characterized both experimentally and bioinformatically, information on the abundance, distribution, variability and possible role of the CDs is scarce. Here, we investigated these issues associated with the domain architectures of TFs in prokaryotic genomes. To this end, 19 families of TFs in 761 non-redundant bacterial and archaeal genomes were evaluated. In this regard we found four main groups based on the abundance and distribution in the analyzed genomes: i) LysR and TetR/AcrR; ii) AraC/XyIS, SinR, and others; iii) Lrp, Fis, ArsR, and others; and iv) a group that included only two families, ArgR and BirA. Based on a classification of the organisms according to the life-styles, a major abundance of regulatory families in free-living organisms, in contrast with pathogenic, extremophilic or intracellular organisms, was identified. Finally, the protein architecture diversity associated to the 19 families considering a weight score for domain promiscuity evidenced which regulatory families were characterized by either a large diversity of CDs, here named as "promiscuous" families given the elevated number of variable domains found in those TFs, or a low diversity of CDs. Altogether this information helped us to understand the diversity and distribution of the 19 Prokaryotes TF families. Moreover, initial steps were taken to comprehend the variability of the extra domain in those TFs, which eventually might assist in evolutionary and functional studies.	[Perez-Rueda, Ernesto; Hernandez-Guerrero, Rafael; Sanchez, Israel] Univ Nacl Autonoma Mexico, Unidad Acad Yucatan, Inst Invest Matemat Aplicadas & Sistemas, Merida, Yucatan, Mexico; [Perez-Rueda, Ernesto] UNAM, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca, Morelos, Mexico; [Martinez-Nunez, Mario Alberto] UNAM, Fac Ciencias, Lab Ecogen, Unidad Acad Ciencias & Tecnol Yucatan, Merida, Yucatan, Mexico; [Armenta-Medina, Dagoberto] Infotec, Aguascalientes, Aguascalientes, Mexico; [Ibarra, J. Antonio] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Microbiol, Lab Genet Microbiana, Ciudad De Mexico, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; INFOTEC - Centro de Investigacion e Innovacion en Tecnologias de la Informacion y Comunicacion; Instituto Politecnico Nacional - Mexico	Perez-Rueda, E (corresponding author), Univ Nacl Autonoma Mexico, Unidad Acad Yucatan, Inst Invest Matemat Aplicadas & Sistemas, Merida, Yucatan, Mexico.; Perez-Rueda, E (corresponding author), UNAM, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca, Morelos, Mexico.; Ibarra, JA (corresponding author), Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Microbiol, Lab Genet Microbiana, Ciudad De Mexico, Mexico.	ernesto.perez@iimas.unam.mx; jaig19@gmail.com	Ibarra, J. Antonio/R-2030-2018; Martinez-Nuñez, Mario Alberto/AAH-6079-2019; Perez-Rueda, Ernesto/D-7468-2016	Ibarra, J. Antonio/0000-0002-5016-0622; Martinez-Nuñez, Mario Alberto/0000-0001-8907-2542; Perez-Rueda, Ernesto/0000-0002-6879-0673; Hernandez Guerrero, Rafael/0000-0003-1096-5968	Secretaria de Investigacion y Posgrado from Instituto Politecnico Nacional [20180647]; DGAPA-Universidad Nacional Autonoma de Mexico [IN-201117, IA-205417]	Secretaria de Investigacion y Posgrado from Instituto Politecnico Nacional; DGAPA-Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	JAI was supported by grant 20180647 from Secretaria de Investigacion y Posgrado from Instituto Politecnico Nacional; EP-R and MAM-N were funded by DGAPA-Universidad Nacional Autonoma de Mexico (IN-201117 and IA-205417, respectively). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martinez-Nunez MA, 2015, PROTEINS, V83, P1625, DOI 10.1002/prot.24847; Martinez-Nunez MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069707; Butala M, 2009, CELL MOL LIFE SCI, V66, P82, DOI 10.1007/s00018-008-8378-6; Cases I, 2003, TRENDS MICROBIOL, V11, P248, DOI 10.1016/S0966-842X(03)00103-3; Chakravartty V, 2013, J BIOL CHEM, V288, P36029, DOI 10.1074/jbc.M113.525618; Charlier D, 2004, BIOCHEM SOC T, V32, P310, DOI 10.1042/BST0320310; Engstrom MD, 2017, SYN SYST BIOTECHNO, V2, P176, DOI 10.1016/j.synbio.2017.09.003; Fernandez-Lopez R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00648; Fillat MF, 2014, ARCH BIOCHEM BIOPHYS, V546, P41, DOI 10.1016/j.abb.2014.01.029; GALLEGOS MT, 1993, NUCLEIC ACIDS RES, V21, P807, DOI 10.1093/nar/21.4.807; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Gama-Castro S, 2016, NUCLEIC ACIDS RES, V44, pD133, DOI 10.1093/nar/gkv1156; Ibarra JA, 2008, GENETICA, V133, P65, DOI 10.1007/s10709-007-9185-y; Balderas-Martinez YI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065723; Kummerfeld SK, 2006, NUCLEIC ACIDS RES, V34, pD74, DOI 10.1093/nar/gkj131; Lee B, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S5; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Pareja E, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-29; Pasek S, 2006, BIOINFORMATICS, V22, P1418, DOI 10.1093/bioinformatics/btl135; Perez-Rueda Ernesto, 2012, Science Progress, V95, P315, DOI 10.3184/003685012X13420097673409; Perez-Rueda E, 2009, MOL BIOSYST, V5, P1494, DOI 10.1039/b907384a; R-Programming Development Core Team, 2011, R LANG ENV STAT COMP; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Ranea JAG, 2005, TRENDS GENET, V21, P21, DOI 10.1016/j.tig.2004.11.014; Ranea JAG, 2004, J MOL BIOL, V336, P871, DOI 10.1016/j.jmb.2003.12.044; Rigali S, 2004, NUCLEIC ACIDS RES, V32, P3418, DOI 10.1093/nar/gkh673; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Stothard P, 2005, NUCLEIC ACIDS RES, V33, pD317, DOI 10.1093/nar/gki075; Suvorova IA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132618; Vogel C, 2006, PLOS COMPUT BIOL, V2, P370, DOI 10.1371/journal.pcbi.0020048; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762; Yang J, 2011, TRENDS MICROBIOL, V19, P128, DOI 10.1016/j.tim.2010.12.001	34	29	31	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195332	10.1371/journal.pone.0195332	http://dx.doi.org/10.1371/journal.pone.0195332			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614096	Green Published, Green Submitted, gold			2022-12-26	WOS:000429081600049
J	Craft, CL; Moore, BD; Ran, Y; Chakrabarty, P; Levites, Y; Golde, TE; Giasson, BI				Craft, Cara L.; Moore, Brenda D.; Ran, Yong; Chakrabarty, Paramita; Levites, Yona; Golde, Todd E.; Giasson, Benoit I.			Novel monoclonal antibodies targeting the microtubule-binding domain of human tau	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; PROGRESSIVE SUPRANUCLEAR PALSY; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; CORTICOBASAL DEGENERATION; PICKS-DISEASE; MOUSE MODEL; PROTEIN-TAU; HUMAN-BRAIN; ISOFORMS	Tauopathies including Alzheimer's disease and Progressive Supranuclear Palsy are a diverse group of progressive neurodegenerative disorders pathologically defined by inclusions containing aberrantly aggregated, post-translationally modified tau. The tau pathology burden correlates with neurodegeneration and dementia observed in these diseases. The microtubule binding domain of tau is essential for its physiological functions in promoting neuronal cytoskeletal stability, however it is also required for tau to assemble into an amyloid structure that comprises pathological inclusions. A series of novel monoclonal antibodies were generated which recognize the second and fourth microtubule-binding repeat domain of tau, thus enabling the identification specifically of 4-repeat tau versus 3-/4-repeat tau, respectively. These antibodies are highly specific for tau and recognize pathological tau inclusions in human tauopathies including Alzheimer's disease and Progressive Supranuclear Palsy and in transgenic mouse models of tauopathies. These new antibodies will be useful for identifying and characterizing different tauopathies and as tools to target tau pathology in these diseases.	[Craft, Cara L.; Moore, Brenda D.; Ran, Yong; Chakrabarty, Paramita; Levites, Yona; Golde, Todd E.; Giasson, Benoit I.] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; [Craft, Cara L.; Moore, Brenda D.; Ran, Yong; Chakrabarty, Paramita; Levites, Yona; Golde, Todd E.; Giasson, Benoit I.] Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32611 USA; [Chakrabarty, Paramita; Levites, Yona; Golde, Todd E.; Giasson, Benoit I.] Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Giasson, BI (corresponding author), Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA.; Giasson, BI (corresponding author), Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32611 USA.; Giasson, BI (corresponding author), Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL 32611 USA.	bgiasson@ufl.edu		Moore, Brenda/0000-0002-9685-6561; Croft, Cara Louise/0000-0001-7969-5084	National Institute of Neurological Disorders and Stroke [NS089622]; National Institute on Aging [AG047266]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089622] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institute of Neurological Disorders and Stroke (NS089622) (https://www.ninds.nih.gov/) to BIG and the National Institute on Aging (AG047266) (https://www.nia.nih.gov/) to TEG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Institute of Neurological Disorders and Stroke (NS089622) to Benoit I. Giasson and the National Institute on Aging (AG047266) to Todd E. Golde.	Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Avale ME, 2013, HUM MOL GENET, V22, P2603, DOI 10.1093/hmg/ddt108; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRANDT R, 1994, CELL MOTIL CYTOSKEL, V28, P143, DOI 10.1002/cm.970280206; Brier MR, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2362; Buee L, 1999, BRAIN PATHOL, V9, P681; Coughlin D, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0779-1; Croft CL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.97; Dawson HN, 2001, J CELL SCI, V114, P1179; Espinoza M, 2008, J ALZHEIMERS DIS, V14, P1; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0298-7; Golde TE, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt233; Golde TE, 2013, NEURON, V80, P254, DOI 10.1016/j.neuron.2013.10.009; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; Hasegawa M, 2014, ACTA NEUROPATHOL, V127, P303, DOI 10.1007/s00401-013-1191-9; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; HIMMLER A, 1989, MOL CELL BIOL, V9, P1389, DOI 10.1128/MCB.9.4.1389; Hong M, 1998, SCIENCE, P282; Komori T, 1999, BRAIN PATHOL, V9, P663; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2016, ACTA NEUROPATHOL, V131, P27, DOI 10.1007/s00401-015-1507-z; Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Noble W, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00083; Peck A, 2011, CYTOSKELETON, V68, P44, DOI 10.1002/cm.20494; Perez-Nievas BG, 2013, BRAIN, V136, P2510, DOI 10.1093/brain/awt171; Pooler AM, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt214; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sengupta A, 1998, ARCH BIOCHEM BIOPHYS, V357, P299, DOI 10.1006/abbi.1998.0813; STEELE JC, 1964, ARCH NEUROL-CHICAGO, V10, P333, DOI 10.1001/archneur.1964.00460160003001; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; WANG JZ, 1995, J BIOL CHEM, V270, P4854, DOI 10.1074/jbc.270.9.4854; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Yanamandra K, 2015, ANN CLIN TRANSL NEUR, V2, P278, DOI 10.1002/acn3.176; Yanamandra K, 2013, NEURON, V80, P402, DOI 10.1016/j.neuron.2013.07.046; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	46	8	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195211	10.1371/journal.pone.0195211	http://dx.doi.org/10.1371/journal.pone.0195211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608591	Green Published, gold, Green Submitted			2022-12-26	WOS:000428988800038
J	Skjaervold, NK; Knai, K; Elvemo, N				Skjaervold, Nils Kristian; Knai, Kathrine; Elvemo, Nicolas			Some oscillatory phenomena of blood glucose regulation: An exploratory pilot study in pigs	PLOS ONE			English	Article							PULSATILE INSULIN-SECRETION; GLYCEMIC PROFILE; COMPLEXITY; ROUTE	It is well-known that blood glucose oscillates with a period of approximately 15 min (900 s) and exhibits an overall complex behaviour in intact organisms. This complexity is not thoroughly studied, and thus, we aimed to decipher the frequency bands entailed in blood glucose regulation. We explored high-resolution blood glucose time-series sampled using a novel continuous intravascular sensor in four pigs under general anaesthesia for almost 24 hours. In all time series, we found several interesting oscillatory components, especially in the 5000-10000 s, 500-1000 s, and 50-100 s regions (0.0002-0.0001 Hz, 0.002-0.001 Hz, and 0.02-0.01 Hz). The presence of these oscillations is not permanent, as they come and go. This is the first report of glucose oscillations in the 50-100 s range. The origin of these oscillations and their role in overall blood glucose regulation is unknown. Although the sample size is small, we believe this finding is important for our understanding of glucose regulation and perhaps for our understanding of general homeostatic regulation in intact organisms.	[Skjaervold, Nils Kristian; Knai, Kathrine] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway; [Skjaervold, Nils Kristian] Trondheim Reg & Univ Hosp, Dept Cardiothorac Anaesthesia & Intens Care Med, Trondheim, Norway; [Elvemo, Nicolas] Glucoset AS, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Skjaervold, NK (corresponding author), Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway.; Skjaervold, NK (corresponding author), Trondheim Reg & Univ Hosp, Dept Cardiothorac Anaesthesia & Intens Care Med, Trondheim, Norway.	nils.k.skjaervold@ntnu.no		Elvemo, Nicolas-Andreas/0000-0002-5527-7985; Skjaervold, Nils Kristian/0000-0002-0085-7042	Norwegian University of Science and Technology	Norwegian University of Science and Technology	The cost of the animal experiments and the salaries of NKS and KK were provided by Norwegian University of Science and Technology. The glucose sensors used were fabricated and provided by GlucoSet AS who provided support in the form of salaries for author NE who, as CEO and shareholder of GlucoSetAS, was involved in study design, analysis and interpretation of data and writing of the paper. GlucoSet AS did not have any additional role in the data collection or decision to publish. The specific role of NE is articulated in the 'author contributions' section.	ANDREWS RJ, 1994, NEUROSURGERY, V34, P466, DOI 10.1227/00006123-199403000-00012; [Anonymous], 2021, LANG ENV STAT COMP; Brunner R, 2012, CRIT CARE, V16, DOI 10.1186/cc11657; Churruca J, 2008, DIABETES METAB SYNDR, V1, P3; Fugal DL, 2009, CONC WAV DIG SIGN PR; Goldbeter A, 1997, BIOCH OSCILLATIONS C; Hellman B, 2009, UPSALA J MED SCI, V114, P193, DOI 10.3109/03009730903366075; Holt TA, 2002, DIABETIC MED, V19, P274, DOI 10.1046/j.1464-5491.2002.00662.x; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Kaneko K, 2006, LIFE INTRO COMPLEX S; Kroll MH, 1999, BIOSYSTEMS, V50, P189, DOI 10.1016/S0303-2647(99)00007-6; LANG DA, 1979, NEW ENGL J MED, V301, P1023, DOI 10.1056/NEJM197911083011903; Langeland H, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13216; Lundelin K, 2010, CRIT CARE MED, V38, P849, DOI 10.1097/CCM.0b013e3181ce49cf; Matveyenko AV, 2008, AM J PHYSIOL-ENDOC M, V295, pE569, DOI 10.1152/ajpendo.90335.2008; Porksen N, 2002, DIABETES, V51, pS245, DOI 10.2337/diabetes.51.2007.S245; Signal Matthew, 2013, J Diabetes Sci Technol, V7, P1492; Skjaervold NK, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/245152; Skjaervold NK, 2012, DIABETES TECHNOL THE, V14, P23, DOI 10.1089/dia.2011.0118; Skjaervold NK, 2011, ANESTHESIOLOGY, V114, P120, DOI 10.1097/ALN.0b013e3181ff4187; Tanaka Tadashi, 2005, J Anesth, V19, P277, DOI 10.1007/s00540-005-0341-1; Varela M, 2010, PERSPECT BIOL MED, V53, P584, DOI 10.1353/pbm.2010.0003	22	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0194826	10.1371/journal.pone.0194826	http://dx.doi.org/10.1371/journal.pone.0194826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608585	Green Published, Green Submitted, gold			2022-12-26	WOS:000428988800018
J	Wise, MG; Estabrook, MA; Sahm, DF; Stone, GG; Kazmierczak, KM				Wise, Mark G.; Estabrook, Mark A.; Sahm, Daniel F.; Stone, Gregory G.; Kazmierczak, Krystyna M.			Prevalence of mcr-type genes among colistin-resistant Enterobacteriaceae collected in 2014-2016 as part of the INFORM global surveillance program	PLOS ONE			English	Article							PLASMID-MEDIATED MCR-1; ESCHERICHIA-COLI; CARBAPENEM-RESISTANT; EXTENDED-SPECTRUM; INFECTIONS; EMERGENCE; STRAIN; SUSCEPTIBILITY; BLA(CTX-M-15); HOSPITALS	A set of 908 clinically derived colistin-resistant Enterobacteriaeae isolates collected worldwide in 2014-2016 were screened for the presence of the plasmid-borne mcr-1, mcr-2, mcr3, mcr-4 and mcr-5 genes. In total 3.2% (29/908) of the collection were positive for mcr, including 27 Escherichia coli, 1 Klebsiella pneumoniae and 1 Enterobacter cloacae. Twenty-four isolates possessed genes from the mcr-1 family, including the original mcr-1 (n = 22), as well as mcr-1.2 (n =1) and mcr-1.5 (n = 1), which each differ from mcr-1 by encoding single amino acid variations. Genes from the mcr-3 family were found in isolates from Thailand, including mcr-3.1 (n = 3) and mcr-3.2 (n = 1). An E. coli isolated from a patient with a urinary tract infection in Colombia contained the recently discovered mcr-5. The full colistin-resistant collection was tested against a panel of antimicrobial agents with ceftazidime-avibactam and tigecycline exhibiting the highest activity.	[Wise, Mark G.; Estabrook, Mark A.; Sahm, Daniel F.; Kazmierczak, Krystyna M.] Int Hlth Management Associates, Schaumburg, IL 60173 USA; [Stone, Gregory G.] AstraZeneca, Waltham, MA USA; [Stone, Gregory G.] Pfizer Inc, Groton, CT 06340 USA	AstraZeneca; Pfizer	Wise, MG (corresponding author), Int Hlth Management Associates, Schaumburg, IL 60173 USA.	mwise@ihma.com		Wise, Mark/0000-0001-7356-1851	AstraZeneca Pharmaceuticals, LP	AstraZeneca Pharmaceuticals, LP(AstraZeneca)	All work was performed at IHMA and sponsored by AstraZeneca Pharmaceuticals, LP, which also included compensation fees for manuscript preparation. AstraZeneca's rights to ceftazidime-avibactam were acquired by Pfizer in December 2016.	Al-Tawfiq JA, 2017, INT J INFECT DIS, V54, P77, DOI 10.1016/j.ijid.2016.11.415; Baron S, 2017, J GLOB ANTIMICROB RE, V10, P35, DOI 10.1016/j.jgar.2017.05.004; Borowiak M, 2017, J ANTIMICROB CHEMOTH; Carattoli A, 2017, EURO SURVEILL, V22; Castanheira M, 2016, ANTIMICROB AGENTS CH, V60, P5623, DOI 10.1128/AAC.01267-16; Clinical and laboratory standard institute, 2016, M100S26 CLSI; Clinical and Laboratory Standards Institute, 2015, M07 A10 METHODS DILU, V10th; Di Pilato V, 2016, ANTIMICROB AGENTS CH, V60, P5612, DOI 10.1128/AAC.01075-16; Du H, 2016, LANCET INFECT DIS, V16, P287, DOI 10.1016/S1473-3099(16)00056-6; EUCAST, 2016, CLIN BREAKP; Falagas ME, 2009, CLIN INFECT DIS, V48, P1729, DOI 10.1086/599226; Falgenhauer L, 2016, EMERG INFECT DIS, V22, P1689, DOI 10.3201/eid2209.160692; Forest Pharmaceuticals Inc, 2014, AV CEFT AV PRESCR IN; Fukuda A, 2017, INT J ANTIMICROB AGE; Haenni M, 2018, J ANTIMICROB CHEMOTH, V73, P533, DOI 10.1093/jac/dkx418; He QW, 2017, ANN CLIN MICROB ANTI, V16, DOI 10.1186/s12941-017-0207-z; Izadpanah M, 2015, J RES PHARM PRACT, V4, P105, DOI 10.4103/2279-042X.162360; Karlowsky JA, 2016, ANTIMICROB AGENTS CH, V60, P2849, DOI 10.1128/AAC.02286-15; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Lob SH, 2015, ANTIMICROB AGENTS CH, V59, P3606, DOI 10.1128/AAC.05186-14; Mediavilla JR, 2016, MBIO, V7, DOI 10.1128/mBio.01191-16; Nicolas-Chanoine MH, 2014, CLIN MICROBIOL REV, V27, P543, DOI 10.1128/CMR.00125-13; Olaitan AO, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00643; Poirel L, 2017, CLIN MICROBIOL REV, V30, P557, DOI 10.1128/CMR.00064-16; Pulss S, 2017, INT J ANTIMICROB AG, V50, P232, DOI 10.1016/j.ijantimicag.2017.03.014; Rocha IV, 2017, INT J ANTIMICROB AG, V49, P655, DOI 10.1016/j.ijantimicag.2017.03.001; Ronco T, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3415-6; Rossi F, 2017, CLINICS, V72, P642, DOI 10.6061/clinics/2017(10)09; Sanchez-Benito R, 2017, INT J ANTIMICROB AG, V50, P285, DOI 10.1016/j.ijantimicag.2017.05.005; Schwarz S, 2016, J ANTIMICROB CHEMOTH, V71, P2066, DOI 10.1093/jac/dkw274; Tacao M, 2017, EMERG INFECT DIS, V23, P1419, DOI 10.3201/eid2308.170162; Teo JQM, 2016, ANTIMICROB AGENTS CH, V60, P6435, DOI 10.1128/AAC.00804-16; Terveer EM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178598; Tygacil&REG;, 2010, TYG TIG FDA PRESCR I; Wong SCY, 2016, EMERG INFECT DIS, V22, P1667, DOI 10.3201/eid2209.160091; Xavier B. B., 2016, EURO SURVEILL, V21; Yang RS, 2016, ANTIMICROB AGENTS CH, V60, P6899, DOI 10.1128/AAC.01365-16; Yang YQ, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.01204-16, 10.1128/AAC.01204-16]; Yao X, 2016, LANCET INFECT DIS, V16, P288, DOI 10.1016/S1473-3099(16)00057-8; Yin W, 2017, MBIO, V8; Yu H, 2016, ANTIMICROB AGENTS CH, V60, P5033, DOI 10.1128/AAC.00440-16; Zeng KJ, 2016, ANTIMICROB AGENTS CH, V60, P3862, DOI 10.1128/AAC.00345-16; Zhang J, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0659-0; Zhang YW, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00242; Zhao FF, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02094; Zhong LL, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01962-16; Zurfluh K, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-017-0250-8	47	54	58	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195281	10.1371/journal.pone.0195281	http://dx.doi.org/10.1371/journal.pone.0195281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608599	gold, Green Published, Green Submitted			2022-12-26	WOS:000428988800045
J	Abramowitz, MK; Hall, CB; Amodu, A; Sharma, D; Androga, L; Hawkins, M				Abramowitz, Matthew K.; Hall, Charles B.; Amodu, Afolarin; Sharma, Deep; Androga, Lagu; Hawkins, Meredith			Muscle mass, BMI, and mortality among adults in the United States: A population-based cohort study	PLOS ONE			English	Article							LEAN MASS; INDEX; SARCOPENIA; OBESITY; HEALTH; ASSOCIATION; OUTCOMES; WHITE; MODEL; RISK	Background The level of body-mass index (BMI) associated with the lowest risk of death remains unclear. Although differences in muscle mass limit the utility of BMI as a measure of adiposity, no study has directly examined the effect of muscle mass on the BMI-mortality relationship. Methods Body composition was measured by dual-energy x-ray absorptiometry in 11,687 participants of the National Health and Nutrition Examination Survey 1999-2004. Low muscle mass was defined using sex-specific thresholds of the appendicular skeletal muscle mass index (ASMI). Proportional hazards models were created to model associations with all-cause mortality. Results At any level of BMI >= 22, participants with low muscle mass had higher body fat percentage (%TBF), an increased likelihood of diabetes, and higher adjusted mortality than other participants. Increases in %TBF manifested as 30-40% smaller changes in BMI than were observed in participants with preserved muscle mass. Excluding participants with low muscle mass or adjustment for ASMI attenuated the risk associated with low BMI, magnified the risk associated with high BMI, and shifted downward the level of BMI associated with the lowest risk of death. Higher ASMI was independently associated with lower mortality. Effects were similar in never-smokers and ever-smokers. Additional adjustment for waist circumference eliminated the risk associated with higher BMI. Results were unchanged after excluding unintentional weight loss, chronic illness, early mortality, and participants performing muscle-strengthening exercises or recommended levels of physical activity. Conclusions Muscle mass mediates associations of BMI with adiposity and mortality and is inversely associated with the risk of death. After accounting for muscle mass, the BMI associated with the greatest survival shifts downward toward the normal range. These results provide a concrete explanation for the obesity paradox.	[Abramowitz, Matthew K.; Sharma, Deep; Androga, Lagu; Hawkins, Meredith] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Abramowitz, Matthew K.; Hall, Charles B.; Hawkins, Meredith] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Hall, Charles B.] Albert Einstein Coll Med, Saul R Korey Dept Neurol, Bronx, NY 10467 USA; [Amodu, Afolarin] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Amodu, Afolarin] Massachusetts Gen Hosp, Boston, MA 02114 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Abramowitz, MK (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.; Abramowitz, MK (corresponding author), Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA.	matthew.abramowitz@einstein.yu.edu	Hall, Charles B./AAX-8216-2020; Androga, Lagu/HCH-8463-2022	Hall, Charles/0000-0001-9982-8120	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [K23 DK099438]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK099438, R01DK079974, R01DK069861, P30DK020541] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by K23 DK099438 to MKA from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (https://www.niddk.nih.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; [Anonymous], 2016, CTR DIS CONTR PREV, pX; [Anonymous], 2010, COMP AN NHANES 1999; [Anonymous], 2015, COMP AN NHIS PUBL US; Aune D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2716; Bangalore S, 2017, NEW ENGL J MED, V376, P1332, DOI 10.1056/NEJMoa1606148; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Baumgartner RN, 2004, OBES RES, V12, P1995, DOI 10.1038/oby.2004.250; Beavers KM, 2011, AM J CLIN NUTR, V94, P767, DOI 10.3945/ajcn.110.004895; Bowman K, 2017, J GERONTOL A-BIOL, V72, P203, DOI 10.1093/gerona/glw147; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; Castillo EM, 2003, AM J PREV MED, V25, P226, DOI 10.1016/S0749-3797(03)00197-1; Collamati A, 2016, J GERIATR CARDIOL, V13, P615, DOI 10.11909/j.issn.1671-5411.2016.07.004; Costanzo P, 2015, ANN INTERN MED, V162, P610, DOI 10.7326/M14-1551; Cruz-Jentoft AJ, 2014, AGE AGEING, V43, P748, DOI 10.1093/ageing/afu115; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Feliciano EMC, 2017, JAMA ONCOL, V3, DOI 10.1001/jamaoncol.2017.2319; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Gallagher D, 1997, J APPL PHYSIOL, V83, P229, DOI 10.1152/jappl.1997.83.1.229; Gomez-Ambrosi J, 2012, INT J OBESITY, V36, P286, DOI 10.1038/ijo.2011.100; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Heymsfield SB, 2011, AM J CLIN NUTR, V93, P736, DOI 10.3945/ajcn.110.007161; Karter AJ, 2013, DIABETES CARE, V36, P574, DOI 10.2337/dc12-0722; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li CY, 2009, AM J CLIN NUTR, V90, P1457, DOI 10.3945/ajcn.2009.28141; Lu JL, 2014, J AM SOC NEPHROL, V25, P2088, DOI 10.1681/ASN.2013070754; Muntner P, 2010, HYPERTENSION, V55, P1339, DOI 10.1161/HYPERTENSIONAHA.109.149609; National Center for Health Statistics, 2015, PUBL US LINK MORT FI; National Center for Health Statistics, 2013, NCHS 2011 LINK MORT; Newman AB, 2005, AM J CLIN NUTR, V82, P872, DOI 10.1093/ajcn/82.4.872; Padwal R, 2016, ANN INTERN MED, V164, P532, DOI 10.7326/M15-1181; Peter RS, 2017, J EPIDEMIOL, V27, P294, DOI 10.1016/j.je.2016.06.007; Prado CM, 2015, CURR OPIN CLIN NUTR, V18, P535, DOI 10.1097/MCO.0000000000000216; Rom O, 2012, ANN NY ACAD SCI, V1259, P47, DOI 10.1111/j.1749-6632.2012.06532.x; Schenker N, 2011, STAT MED, V30, P260, DOI 10.1002/sim.4080; Sharma A, 2015, AM J CARDIOL, V115, P1428, DOI 10.1016/j.amjcard.2015.02.024; Stevens J, 1998, OBES RES, V6, P268, DOI 10.1002/j.1550-8528.1998.tb00349.x; Tobias DK, 2014, NEW ENGL J MED, V370, P233, DOI 10.1056/NEJMoa1304501; van den Borst B, 2011, THORAX, V66, P961, DOI 10.1136/thoraxjnl-2011-200010; VanderWeele TJ, 2015, EXPLANATION CAUSAL I; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475	47	88	90	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194697	10.1371/journal.pone.0194697	http://dx.doi.org/10.1371/journal.pone.0194697			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641540	Green Published, Green Submitted, gold			2022-12-26	WOS:000429742900040
J	Lu, Y; Jin, XZ; Duan, CAX; Chang, F				Lu, Yun; Jin, Xiuze; Duan, Cheng-a-xin; Chang, Feng			Cost-effectiveness of daclatasvir plus asunaprevir for chronic hepatitis C genotype 1b treatment-naive patients in China	PLOS ONE			English	Article							VIRUS-INFECTION; HEPATOCELLULAR-CARCINOMA; GLOBAL EPIDEMIOLOGY; ECONOMIC-EVALUATION; ANTIVIRAL THERAPY; INTERFERON-ALPHA; RIBAVIRIN; METAANALYSIS; DISEASE; TRIAL	Background Hepatitis C is the second fastest growing infectious disease in China. The standard-of-care for chronic hepatitis C in China is Pegylated interferon plus ribavirin (PR), which is associated with tolerability and efficacy issues. An interferon- and ribavirin-free, all-oral regimen comprising daclatasvir (DCV) and asunaprevir (ASV), which displays higher efficacy and tolerability, has recently been approved in China. Objectives This study is to estimate the cost-effectiveness of DCV+ASV (24 weeks) for chronic hepatitis C genotype 1b treatment-naive patients compared with PR regimen (48 weeks) in China. Methods A cohort-based Markov model was developed from Chinese payer perspective to project the lifetime outcomes of treating 10,000 patients with an average age of 44.5 with two hypothetical regimens, DCV+ASV and PR. Chinese-specific health state costs and efficacy data were used. The annual discount rate was 5%. Base-case analysis and sensitivity analysis were conducted. Results For HCV Genotype 1b treatment-naive patients, DCV+ASV proved to be dominant over PR, with a cost saving of (sic)33,480(5,096 USD) and gains in QALYs and life years of 1.29 and 0.85, respectively. The lifetime risk of compensated cirrhosis, decompensated cirrhosis, hepatocellular carcinoma and liver-related death was greatly reduced with DCV+ASV. Univariate sensitivity analysis demonstrated that key influencers were the discount rate, time horizon, initial disease severity and sustained virological response rate of DCV+ASV, with all scenarios resulting in additional benefit. Probabilistic sensitivity analysis demonstrated that DCV+ASV has a high likelihood (100%) of being cost-effective. Conclusion DCV+ASV is not only an effective and well-tolerated regimen to treat chronic HCV genotype 1b infection treatment-naive patients, but also is more cost-effective than PR regimen. DCV+ASV can benefit both the public health and reimbursement system in China.	[Lu, Yun; Jin, Xiuze; Duan, Cheng-a-xin; Chang, Feng] China Pharmaceut Univ, Sch Int Pharmaceut Business, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University	Chang, F (corresponding author), China Pharmaceut Univ, Sch Int Pharmaceut Business, Nanjing, Jiangsu, Peoples R China.	cpucf@163.com		Chang, Feng/0000-0003-2689-4041; Chang, Feng/0000-0002-5089-9275	National Natural Science Foundation of China [71673298]; Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYCX17_0738]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postgraduate Research & Practice Innovation Program of Jiangsu Province	This work was supported by National Natural Science Foundation of China. Grant number: 71673298 (http://www.nsfc.gov.cn/) and the Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX17_0738) to XJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CANC TODAY; Chen GF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155934; Chen H, 2017, CHINA PLOS ONE, V12, DOI [10.1371/journal.pone.0175189, DOI 10.1371/JOURNAL.PONE.0175189]; Chen YD, 2002, HEPATOBILIARY PANCR, V1; Wei L, 2015, CHINESE J LIVER DISE, P19; Duan ZP, 2014, VALUE HEALTH, V17, pA805, DOI 10.1016/j.jval.2014.08.515; Duan ZP, 2014, J CLIN GASTROENTEROL, V48, P679, DOI 10.1097/MCG.0000000000000109; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hartwell D, 2009, INT J TECHNOL ASSESS, V25, P56, DOI 10.1017/S0266462309090084; Ishida H, 2004, HEPATOL RES, V28, P125, DOI 10.1016/j.hepres.2003.11.002; McEwan P, 2013, HEPATOLOGY, V58, P54, DOI 10.1002/hep.26304; McEwan P, 2013, APPL HEALTH ECON HEA, V11, P53, DOI 10.1007/s40258-012-0002-0; McEwan Philip, 2014, Value Health Reg Issues, V3, P5, DOI 10.1016/j.vhri.2013.08.001; Ministry of Health Labour & Welfare, 2013, STUD MED EC ASS MEAS; OrganizationWH, 2014, GUID SCREEN CAR TREA, P343; Parikh ND, 2017, DIGEST DIS SCI, V62, P3243, DOI 10.1007/s10620-017-4776-7; Petruzziello A, 2016, WORLD J GASTROENTERO, V22, P7824, DOI 10.3748/wjg.v22.i34.7824; Qin QQ, 2015, J VIRAL HEPATITIS, V22, P238, DOI 10.1111/jvh.12295; Rao HY, 2017, J GASTROEN HEPATOL, V32, P244, DOI 10.1111/jgh.13467; Rao HY, 2014, J GASTROEN HEPATOL, V29, P545, DOI 10.1111/jgh.12398; Saab S, 2010, LIVER TRANSPLANT, V16, P748, DOI 10.1002/lt.22072; Shepherd J, 2007, HEALTH TECHNOL ASSES, V11, P1; Shi J, 2005, BRIT J CANCER, V92, P607, DOI 10.1038/sj.bjc.6602333; Torrance GW, 1989, INT J TECHNOLOGY ASS, V5; Wei L, 26 C AS PAC ASS STUD; World Health Orgnisation, CHIN LIF TABL 2015; Wright M, 2006, HEALTH TECHNOL ASSES, V10, P1; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1	28	10	12	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195117	10.1371/journal.pone.0195117	http://dx.doi.org/10.1371/journal.pone.0195117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634736	Green Published, gold, Green Submitted			2022-12-26	WOS:000429522200024
J	Lu, J; Hu, XM; Meng, YT; Zhao, HY; Cao, Q; Jin, ML				Lu, Jun; Hu, Xiumei; Meng, Yutong; Zhao, Hongying; Cao, Qing; Jin, Mulan			The prognosis significance and application value of peritoneal elastic lamina invasion in colon cancer	PLOS ONE			English	Article							COLORECTAL-CARCINOMA; SEROSAL INVOLVEMENT; STAGING SYSTEM; CLASSIFICATION	Objectives The aims of this study were to evaluate the associations between peritoneal elastic lamina invasion (ELI) and the clinicopathological prognostic factors of colon cancer, to evaluate the feasibility of ELI with use of an elastic stain to help diagnose serosal invasion of colon cancer in routine practice, so as to help us to provide a more accurate estimate for prognosis and stage of patients and a marker for postoperative treatment. Methods 254 cases with colon cancer were included in the study. According to the presence of elastic lamina (EL) and elastic lamina invasion (ELI), all cases were divided into four groups: pT3 EL negative (pT3 EL (-)), pT3 ELI positive (pT3 ELI (+)), pT3 ELI negative (pT3 ELI (-)) and pT4a. Statistical analysis was used to analyze the relationship between elastic lamina invasion and other established adverse histologic features. Results The EL and ELI positive rates were 81.5% and 42.1% respectively. There were significant differences in mph node metastasis, venous invasion and tumor buds between pT3 ELI (-) and pT3 ELI (+), pT3 ELI (-) and pT4a. There was no significant difference in same factors between pT3 ELI (+) and pT4a. In pT3 stage, there were significant differences in lymph node metastasis, perineural invasion and tumor buds between EL (-) and ELI (+). There were no significant differences in same factors between EL (-) and ELI (-). EL was detected less frequently in right-sided tumors compared with left-sided tumors. Conclusions ELI might be the prognostic factors of colon cancer with II stage and might be the marker of postoperative adjuvant chemotherapy. Patients with pT3 ELI (+) might have similar prognosis to patients with pT4a. For patients with pT3 colon cancer, EL(-) might have similar prognosis as ELI (-) and might take the same therapy. In addition, the right half colon EL positive rate was lower than the left colon. Elastic staining might be a useful tool to help determine the invasive depth and stage of colon cancer.	[Lu, Jun; Hu, Xiumei; Meng, Yutong; Zhao, Hongying; Cao, Qing; Jin, Mulan] Capital Univ, Beijing Chaoyang Hosp, Dept Pathol, Beijing, Peoples R China		Jin, ML (corresponding author), Capital Univ, Beijing Chaoyang Hosp, Dept Pathol, Beijing, Peoples R China.	kinmokuran@163.com		Lu, Jun/0000-0003-0363-7288				DAVIS NC, 1983, AUST NZ J SURG, V53, P211, DOI 10.1111/j.1445-2197.1983.tb02430.x; Grin A, 2013, HUM PATHOL, V44, P2696, DOI 10.1016/j.humpath.2013.07.013; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; KNUDSEN PJT, 1991, J ANAT, V177, P41; Kojima M, 2010, AM J SURG PATHOL, V34, P1351, DOI 10.1097/PAS.0b013e3181ecfe98; Lennon AM, 2003, AM J CLIN PATHOL, V119, P108, DOI 10.1309/J6BDTWM2M792TN2V; Liang WY, 2013, AM J SURG PATHOL, V37, P1565, DOI 10.1097/PAS.0b013e31828ea2de; Ludeman L, 2005, HISTOPATHOLOGY, V47, P123, DOI 10.1111/j.1365-2559.2005.02189.x; Merkel S, 2001, CANCER, V92, P1435, DOI 10.1002/1097-0142(20010915)92:6<1435::AID-CNCR1467>3.0.CO;2-N; Morris M, 2006, BRIT J SURG, V93, P866, DOI 10.1002/bjs.5345; NEWLAND RC, 1987, CANCER, V60, P852, DOI 10.1002/1097-0142(19870815)60:4<852::AID-CNCR2820600422>3.0.CO;2-5; NEWLAND RC, 1995, CANCER, V76, P564, DOI 10.1002/1097-0142(19950815)76:4<564::AID-CNCR2820760405>3.0.CO;2-Z; Petersen VC, 2002, GUT, V51, P65, DOI 10.1136/gut.51.1.65; Puppa G, 2010, ARCH PATHOL LAB MED, V134, P837, DOI 10.1043/1543-2165-134.6.837; Shepherd NA, 1997, GASTROENTEROLOGY, V112, P1096, DOI 10.1016/S0016-5085(97)70119-7; Shinto E, 2004, DIS COLON RECTUM, V47, P467, DOI 10.1007/s10350-003-0083-9; Stewart C, 2006, HISTOPATHOLOGY, V49, P435, DOI 10.1111/j.1365-2559.2006.02498.x; Stewart Colin J R, 2011, Cancers (Basel), V3, P164, DOI 10.3390/cancers3010164; Travis WD, 2008, J THORAC ONCOL, V3, P1384, DOI 10.1097/JTO.0b013e31818e0d9f; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2	20	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194804	10.1371/journal.pone.0194804	http://dx.doi.org/10.1371/journal.pone.0194804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630617	Green Published, gold, Green Submitted			2022-12-26	WOS:000429505000018
J	Macgregor, LJ; Hunter, AM				Macgregor, Lewis J.; Hunter, Angus M.			High-threshold motor unit firing reflects force recovery following a bout of damaging eccentric exercise	PLOS ONE			English	Article							SURFACE EMG; BICEPS-BRACHII; MUSCLE DAMAGE; COMMON DRIVE; DECOMPOSITION; RECRUITMENT; SYNCHRONIZATION; PREVENTION; DISCHARGE; RESPONSES	Exercise-induced muscle damage (EIMD) is associated with impaired muscle function and reduced neuromuscular recruitment. However, motor unit firing behaviour throughout the recovery period is unclear. EIMD impairment of maximal voluntary force (MVC) will, in part, be caused by reduced high-threshold motor unit firing, which will subsequently increase to recover MVC. Fourteen healthy active males completed a bout of eccentric exercise on the knee extensors, with measurements of MVC, rate of torque development and surface electromyography performed pre-exercise and 2, 3, 7 and 14 days post-exercise, on both damaged and control limb. EIMD was associated with decreased MVC (235.2 +/- 49.3 Nm vs. 161.3 +/- 52.5 Nm; p <0.001) and rate of torque development (495.7 +/- 136.9 Nm.s-1 vs. 163.4 +/- 163.7 Nm.s-1; p <0.001) 48h post-exercise. Mean motor unit firing rate was reduced (16.4 +/- 2.2 Hz vs. 12.6 +/- 1.7 Hz; p <0.01) in high-threshold motor units only, 48h post-exercise, and common drive was elevated (0.36 +/- 0.027 vs. 0.56 +/- 0.032; p< 0.001) 48h post-exercise. The firing rate of high-threshold motor units was reduced in parallel with impaired muscle function, whilst early recruited motor units remained unaltered. Common drive of motor units increased in offset to the firing rate impairment. These alterations correlated with the recovery of force decrement, but not of pain elevation. This study provides fresh insight into the central mechanisms associated with EIMD recovery, relative to muscle function. These findings may in turn lead to development of novel management and preventative procedures.	[Macgregor, Lewis J.; Hunter, Angus M.] Univ Stirling, Fac Hlth Sci & Sport, Stirling, Scotland	University of Stirling	Hunter, AM (corresponding author), Univ Stirling, Fac Hlth Sci & Sport, Stirling, Scotland.	a.m.hunter1@stir.ac.uk	Macgregor, Lewis/N-2052-2019	Macgregor, Lewis/0000-0003-2310-6468; Hunter, Angus/0000-0001-7562-6145				Adam A, 2005, J APPL PHYSIOL, V99, P268, DOI 10.1152/japplphysiol.01344.2004; Amann M, 2012, CLIN EXP PHARMACOL P, V39, P831, DOI 10.1111/j.1440-1681.2012.05681.x; Aminian-Far A, 2011, J ATHL TRAINING, V46, P43, DOI 10.4085/1062-6050-46.1.43; Balshaw G, 2012, J ELECTROMYOGR KINES, V22, P308, DOI 10.1016/j.jelekin.2011.11.009; Balshaw TG, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13111; Beck TW, 2012, MUSCLE NERVE, V46, P759, DOI 10.1002/mus.23386; Blanc Y., 2010, TOREHJ, V3, P110, DOI [10.2174/1874943701003010110, DOI 10.2174/1874943701003010110]; Carpentier A, 2001, J PHYSIOL-LONDON, V534, P903, DOI 10.1111/j.1469-7793.2001.00903.x; Clarkson PM, 1997, INT J SPORTS MED, V18, pS314, DOI 10.1055/s-2007-972741; CLARKSON PM, 1986, INT J SPORTS MED, V7, P152, DOI 10.1055/s-2008-1025753; CLARKSON PM, 1992, MED SCI SPORT EXER, V24, P512; Cohen J.E., 1988, STAT POWER ANAL BEHA; Contessa P, 2013, J NEUROPHYSIOL, V109, P1548, DOI 10.1152/jn.00237.2012; Contessa P, 2009, J APPL PHYSIOL, V107, P235, DOI 10.1152/japplphysiol.00035.2009; Dartnall TJ, 2008, J NEUROPHYSIOL, V99, P1008, DOI 10.1152/jn.00686.2007; Dartnall TJ, 2011, J NEUROPHYSIOL, V105, P1225, DOI 10.1152/jn.00854.2010; Dartnall TJ, 2009, J NEUROPHYSIOL, V102, P413, DOI 10.1152/jn.91285.2008; De Luca CJ, 2006, J NEUROPHYSIOL, V96, P1646, DOI 10.1152/jn.00009.2006; De Luca CJ, 2015, J APPL PHYSIOL, V118, P1084, DOI 10.1152/japplphysiol.00061.2015; De Luca CJ, 2012, J NEUROPHYSIOL, V107, P178, DOI 10.1152/jn.00961.2010; De Luca CJ, 2011, J NEUROPHYSIOL, V105, P983, DOI 10.1152/jn.01060.2010; De Luca CJ, 2010, J NEUROPHYSIOL, V104, P1034, DOI 10.1152/jn.01018.2009; De Luca CJ, 2009, J NEUROPHYSIOL, V101, P1620, DOI 10.1152/jn.90245.2008; DE LUCA CJ, 1982, J PHYSIOL-LONDON, V329, P129, DOI 10.1113/jphysiol.1982.sp014294; DE LUCA CJ, 1994, TRENDS NEUROSCI, V17, P299, DOI 10.1016/0166-2236(94)90064-7; Defreitas JM, 2014, MUSCLE NERVE, V49, P575, DOI 10.1002/mus.23978; Evans RK, 2002, MED SCI SPORT EXER, V34, P1892, DOI 10.1097/00005768-200212000-00006; Fell J, 2008, J AGING PHYS ACTIV, V16, P97, DOI 10.1123/japa.16.1.97; Fling BW, 2009, J ELECTROMYOGR KINES, V19, P800, DOI 10.1016/j.jelekin.2008.06.003; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gauche E, 2009, J ELECTROMYOGR KINES, V19, pE481, DOI 10.1016/j.jelekin.2009.01.006; Gleeson NP, 1996, SPORTS MED, V21, P18, DOI 10.2165/00007256-199621010-00003; Gregory JE, 2004, EXP BRAIN RES, V157, P234, DOI 10.1007/s00221-004-1838-9; Gregory JE, 2002, J PHYSIOL-LONDON, V538, P209, DOI 10.1113/jphysiol.2001.012785; HENNEMAN E, 1985, J EXP BIOL, V115, P105; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Holobar A, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/1/016008; Howatson G, 2007, EUR J APPL PHYSIOL, V101, P207, DOI 10.1007/s00421-007-0489-5; Howatson G, 2008, SPORTS MED, V38, P483, DOI 10.2165/00007256-200838060-00004; Howatson G, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-20; Hu XG, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/6/066001; Hu XG, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/026007; Hu XG, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-99; Hu XG, 2012, IEEE ENG MED BIO, P4116, DOI 10.1109/EMBC.2012.6346872; Hunter AM, 2012, J ELECTROMYOGR KINES, V22, P334, DOI 10.1016/j.jelekin.2012.01.009; Jackman SR, 2010, MED SCI SPORT EXER, V42, P962, DOI 10.1249/MSS.0b013e3181c1b798; Kennedy DS, 2015, J APPL PHYSIOL, V118, P408, DOI 10.1152/japplphysiol.00375.2014; Kline JC, 2014, J NEUROPHYSIOL, V112, P2718, DOI 10.1152/jn.00724.2013; Knapik J J, 1983, J Orthop Sports Phys Ther, V5, P58; Komi PV, 2000, J BIOMECH, V33, P1197, DOI 10.1016/S0021-9290(00)00064-6; Macaluso F, 2012, J ATHL TRAINING, V47, P414, DOI 10.4085/1062-6050-47.4.13; MacIntyre DL, 2001, EUR J APPL PHYSIOL, V84, P180, DOI 10.1007/s004210170002; Maffiuletti NA, 2016, EUR J APPL PHYSIOL, V116, P1091, DOI 10.1007/s00421-016-3346-6; Martin V, 2004, MED SCI SPORT EXER, V36, P1907, DOI 10.1249/01.MSS.0000145526.43208.08; Minett GM, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00024; Molina R, 2012, CLIN PHYSIOL FUNCT I, V32, P179, DOI 10.1111/j.1475-097X.2011.01074.x; Murayama M, 2000, EUR J APPL PHYSIOL, V82, P361, DOI 10.1007/s004210000242; Nawab SH, 2010, CLIN NEUROPHYSIOL, V121, P1602, DOI 10.1016/j.clinph.2009.11.092; Paschalis V, 2005, CLIN BIOMECH, V20, P617, DOI 10.1016/j.clinbiomech.2005.02.011; Peake JM, 2017, J APPL PHYSIOL, V122, P531, DOI 10.1152/japplphysiol.00086.2017; Penailillo L, 2015, SCAND J MED SCI SPOR, V25, P417, DOI 10.1111/sms.12241; Piitulainen H, 2010, J ELECTROMYOGR KINES, V20, P879, DOI 10.1016/j.jelekin.2009.10.001; Pope ZK, 2016, J NEUROPHYSIOL, V115, P2608, DOI 10.1152/jn.00039.2016; Racinais S, 2008, EUR J APPL PHYSIOL, V102, P439, DOI 10.1007/s00421-007-0604-7; Rattray B, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00079; Semmler JG, 1998, EXP BRAIN RES, V119, P27, DOI 10.1007/s002210050316; Suresh N, 2011, IEEE ENG MED BIO, P8243, DOI 10.1109/IEMBS.2011.6092032; Toft AD, 2002, AM J PHYSIOL-CELL PH, V283, pC289, DOI 10.1152/ajpcell.00583.2001; Torres R, 2010, INT J SPORTS MED, V31, P410, DOI 10.1055/s-0030-1248285; Trevino Michael A, 2014, BMC Res Notes, V7, P611, DOI 10.1186/1756-0500-7-611; Vijayan K, 2001, J APPL PHYSIOL, V90, P770, DOI 10.1152/jappl.2001.90.3.770; Warren JD, 2002, MUSCLE NERVE, V25, P332, DOI 10.1002/mus.10053; Ye X, 2014, J MUSCULOSKEL NEURON, V14, P377; Ye X, 2015, HUM MOVEMENT SCI, V40, P24, DOI 10.1016/j.humov.2014.11.011; Zwarts MJ, 2003, MUSCLE NERVE, V28, P1, DOI 10.1002/mus.10358	75	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195051	10.1371/journal.pone.0195051	http://dx.doi.org/10.1371/journal.pone.0195051			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630622	Green Published, gold, Green Submitted			2022-12-26	WOS:000429505000023
J	Machler, E; Osathanunkul, M; Altermatt, F				Machler, Elvira; Osathanunkul, Maslin; Altermatt, Florian			Shedding light on eDNA: neither natural levels of UV radiation nor the presence of a filter feeder affect eDNA-based detection of aquatic organisms	PLOS ONE			English	Article							ENVIRONMENTAL DNA; DREISSENA-POLYMORPHA; ULTRAVIOLET-RADIATION; DEGRADATION; ECOSYSTEMS; TEMPERATURE; RATES; RARE	The use of environmental DNA (eDNA) as a species detection tool is attracting attention from both scientific and applied fields, especially for detecting invasive or rare species. In order to use eDNA as an efficient and reliable tool, however, we need to understand its origin and state as well as factors affecting its degradation. Various biotic and abiotic environmental factors have been proposed to affect degradation of eDNA in aquatic environments and thus to influence detection rates of species. Here, we were interested in two of them, namely UV light, which can break down DNA, and the presence of filter feeders, which can remove DNA and DNA-bound particles. A few, mostly laboratory-based studies have found minor effects of UVB on the degradation of eDNA. Ultraviolet A radiation (UVA), however, has been neglected although it also causes DNA lesions and is 10- to 100-fold more prevalent than UVB when reaching the earth's surface. Filter feeders are common in aquatic ecosystem, but their effects on eDNA has hitherto been ignored. We conducted a full-factorial aquatic mesocosm experiment under near-natural outdoor conditions manipulating UV radiation as well as the presence of Dreissena polymorpha, a strong filter feeder capable of filtering cells or organelles containing DNA. Surprisingly, we found that neither UV radiation nor the presence of the filter feeder affected eDNA-based detection rates of macroinvertebrates, even though the experiment took place in summer when UV radiation intensity and filtration activity is high for the chosen experimental site and conditions. These results, in combination with studies from marine or laboratory settings finding no effect of sunlight and its UV components on the detectability of eDNA, suggest that eDNA based species assessments could be relatively robust with respect to our two factors studied.	[Machler, Elvira; Osathanunkul, Maslin; Altermatt, Florian] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland; [Machler, Elvira; Altermatt, Florian] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Osathanunkul, Maslin] Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai, Thailand; [Osathanunkul, Maslin] Chiang Mai Univ, Ctr Excellence Bioresources Agr Ind & Med, Chiang Mai, Thailand	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Zurich; Chiang Mai University; Chiang Mai University	Machler, E (corresponding author), Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland.; Machler, E (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	elvira.maechler@eawag.ch		Machler, Elvira/0000-0003-0430-6173; Altermatt, Florian/0000-0002-4831-6958	Velux Foundation; Eawag discretionary fund; Swiss National Science Foundation [PP00P3_150698]	Velux Foundation(Velux Fonden); Eawag discretionary fund; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Financial support is provided by Velux Foundation, the Eawag discretionary fund and the Swiss National Science Foundation (Grant No. PP00P3_150698) to FA.	ALDRIDGE DW, 1995, CAN J FISH AQUAT SCI, V52, P1761, DOI 10.1139/f95-768; Altermatt F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110328; Andruszkiewicz EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185043; Barnes MA, 2016, CONSERV GENET, V17, P1, DOI 10.1007/s10592-015-0775-4; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bates D. M., 2010, LME4 MIXED EFFECTS M; Benson A, 2015, DREISSENA POLYMORPHA, V19, P2017; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; BLUMTHALER M, 1992, THEOR APPL CLIMATOL, V46, P39, DOI 10.1007/BF00866446; Blumthaler M, 2012, PLANTS IN ALPINE REGIONS: CELL PHYSIOLOGY OF ADAPTION AND SURVIVAL STRATEGIES, P11, DOI 10.1007/978-3-7091-0136-0_2; Bylemans J, 2017, METHODS ECOL EVOL, V8, P646, DOI 10.1111/2041-210X.12709; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Deiner K, 2017, MOL ECOL, V26, P5872, DOI 10.1111/mec.14350; Deiner K, 2016, NAT COMMUN, V7, P1, DOI 10.1038/ncomms12544; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Drummond AJ, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0086-1; Eichmiller JJ, 2016, ENVIRON SCI TECHNOL, V50, P1859, DOI 10.1021/acs.est.5b05672; Evans DO, 2011, J GREAT LAKES RES, V37, P36, DOI 10.1016/j.jglr.2011.04.002; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Flindt R, 2006, AMAZING NUMBERS BIOL; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Hader DP, 2003, PHOTOCH PHOTOBIO SCI, V2, P39, DOI 10.1039/b211160h; Hader DP, 2007, PHOTOCH PHOTOBIO SCI, V6, P267, DOI 10.1039/b700020k; HOSS M, 1992, NATURE, V359, P199, DOI 10.1038/359199a0; Jackson MC, 2016, ADV ECOL RES, V55, P615, DOI 10.1016/bs.aecr.2016.08.008; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Machler E, 2014, FRESHW SCI, V33, P1174, DOI 10.1086/678128; Maruyama A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114639; Moan J., 2001, RAD HOME OUTDOORS WO, P69; MOHLENBERG F, 1978, OPHELIA, V17, P239, DOI 10.1080/00785326.1978.10425487; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; R Core Team, 2021, R LANGUAGE ENV STAT; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; REEDERS HH, 1989, FRESHWATER BIOL, V22, P133, DOI 10.1111/j.1365-2427.1989.tb01088.x; Sassoubre LM, 2016, ENVIRON SCI TECHNOL, V50, P10456, DOI 10.1021/acs.est.6b03114; Seymour M, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-017-0005-3; Smart AS, 2015, ECOL APPL, V25, P1944, DOI 10.1890/14-1751.1; Strayer DL, 1999, BIOSCIENCE, V49, P19, DOI 10.2307/1313490; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; TABERLET P, 1992, NATURE, V358, P197, DOI 10.1038/358197a0; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Tsuji S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176608; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wilcox TM, 2016, BIOL CONSERV, V194, P209, DOI 10.1016/j.biocon.2015.12.023; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Williamson Craig E., 1996, International Journal of Environmental Studies, V51, P245, DOI 10.1080/00207239608711083	50	25	27	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195529	10.1371/journal.pone.0195529	http://dx.doi.org/10.1371/journal.pone.0195529			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624607	gold, Green Published, Green Accepted			2022-12-26	WOS:000429379600037
J	Belli, HM; Bresee, CS; Graff, MM; Hartmann, MJZ				Belli, Hayley M.; Bresee, Chris S.; Graff, Matthew M.; Hartmann, Mitra J. Z.			Quantifying the three-dimensional facial morphology of the laboratory rat with a focus on the vibrissae	PLOS ONE			English	Article							SEALS PHOCA-VITULINA; MORPHOMETRIC DIFFERENTIATION; MYSTACIAL VIBRISSAE; VISUAL-ACUITY; PREY CAPTURE; SIZE; GEOMETRY; BEHAVIOR; NEURONS; COLUMN	The morphology of an animal's face will have large effects on the sensory information it can acquire. Here we quantify the arrangement of cranial sensory structures of the rat, with special emphasis on the mystacial vibrissae (whiskers). Nearly all mammals have vibrissae, which are generally arranged in rows and columns across the face. The vibrissae serve a wide variety of important behavioral functions, including navigation, climbing, wake following, anemotaxis, and social interactions. To date, however, there are few studies that compare the morphology of vibrissal arrays across species, or that describe the arrangement of the vibrissae relative to other facial sensory structures. The few studies that do exist have exploited the whiskers' grid-like arrangement to quantify array morphology in terms of row and column identity. However, relying on whisker identity poses a challenge for comparative research because different species have different numbers and arrangements of whiskers. The present work introduces an approach to quantify vibrissal array morphology regardless of the number of rows and columns, and to quantify the array's location relative to other sensory structures. We use the three-dimensional locations of the whisker basepoints as fundamental parameters to generate equations describing the length, curvature, and orientation of each whisker. Results show that in the rat, whisker length varies exponentially across the array, and that a hard limit on intrinsic curvature constrains the whisker height-to-length ratio. Whiskers are oriented to "fan out" approximately equally in dorsal-ventral and rostral-caudal directions. Quantifying positions of the other sensory structures relative to the whisker basepoints shows remarkable alignment to the somatosensory cortical homunculus, an alignment that would not occur for other choices of coordinate systems (e.g., centered on the midpoint of the eyes). We anticipate that the quantification of facial sensory structures, including the vibrissae, will ultimately enable cross-species comparisons of multi-modal sensing volumes.	[Belli, Hayley M.; Hartmann, Mitra J. Z.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Bresee, Chris S.] Northwestern Univ, Interdept Neurosci Program, Evanston, IL USA; [Graff, Matthew M.; Hartmann, Mitra J. Z.] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Hartmann, MJZ (corresponding author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.; Hartmann, MJZ (corresponding author), Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA.	hartmann@northwestern.edu	Hartmann, Mitra/B-6766-2009	Bresee, Chris/0000-0003-0139-8201	National Science Foundation: Division of Integrative Organismal Systems [CAREER IOS-0846088]; Emerging Frontiers in Research and Innovation [EFRI-0938007]; Division of Integrative Organismal Systems [IOS-1558068]; Ruth L. Kirschstein Predoctoral Individual NRSA NIH [F31-NS-090872-01A1]; NSF IGERT: Integrative Research in Motor Control and Movement Grant [DGE-0903637]; NIH [T32 HD-057845]	National Science Foundation: Division of Integrative Organismal Systems(National Science Foundation (NSF)); Emerging Frontiers in Research and Innovation(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)NSF - Emerging Frontiers in Research & Innovation (EFRI)); Division of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Ruth L. Kirschstein Predoctoral Individual NRSA NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF IGERT: Integrative Research in Motor Control and Movement Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This multi-year research project was supported by a sequence of awards from the National Science Foundation: Division of Integrative Organismal Systems (https://www.nsf.gov/div/index.jsp?div=IOS), grant CAREER IOS-0846088; Emerging Frontiers in Research and Innovation (https://ww.nsf.gov/funding/pgm_summ.jsp?pims_id=13708), grant EFRI-0938007, and Division of Integrative Organismal Systems (https://www.nsf.gov/div/index.jsp?div=IOS), grant IOS-1558068 to MJZH. HMB was supported in part by Ruth L. Kirschstein Predoctoral Individual NRSA NIH F31-NS-090872-01A1 (https://researchtraining.nih.gov/programs/fellowships/F31). CSB was supported in part by NSF IGERT: Integrative Research in Motor Control and Movement Grant DGE-0903637 (http://www.igert.org),and by NIH Grant T32 HD-057845 (https://researchtraining.nih.gov/programs/training-grants/T32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjum F, 2006, P NATL ACAD SCI USA, V103, P16544, DOI 10.1073/pnas.0605573103; Anthwal N, 2013, J ANAT, V222, P147, DOI 10.1111/j.1469-7580.2012.01526.x; Arkley K, 2014, CURR BIOL, V24, P1507, DOI 10.1016/j.cub.2014.05.036; Baverstock H, 2013, J ANAT, V223, P46, DOI 10.1111/joa.12059; Belli HM, 2017, J NEUROPHYSIOL, V117, P1807, DOI 10.1152/jn.00054.2016; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; Burton RF, 2006, J ZOOL, V269, P225, DOI 10.1111/j.1469-7998.2006.00111.x; BYERS MR, 1989, J COMP NEUROL, V279, P117, DOI 10.1002/cne.902790110; Cox PG, 2008, J ANAT, V213, P583, DOI 10.1111/j.1469-7580.2008.00983.x; Cunningham SJ, 2011, J MORPHOL, V272, P118, DOI 10.1002/jmor.10908; Dehnhardt G, 2001, SCIENCE, V293, P102, DOI 10.1126/science.1060514; DEHNHARDT G, 1995, J EXP BIOL, V198, P2317; Gaspard JC, 2017, J COMP PHYSIOL A, V203, P111, DOI 10.1007/s00359-016-1142-8; GREEN DG, 1980, VISION RES, V20, P827, DOI 10.1016/0042-6989(80)90063-2; Gunduz I, 2007, MOL PHYLOGENET EVOL, V43, P916, DOI 10.1016/j.ympev.2007.02.021; Haidarliu S, 2001, J COMP NEUROL, V429, P372, DOI 10.1002/1096-9861(20010115)429:3<372::AID-CNE2>3.0.CO;2-3; Haidarliu S, 2010, ANAT REC, V293, P1192, DOI 10.1002/ar.21156; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Hobbs JA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004109; Hobbs JA, 2016, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00356; Hobbs JA, 2015, J EXP BIOL, V218, P2551, DOI 10.1242/jeb.116186; Huet LA, 2015, J NEUROPHYSIOL, V113, P3511, DOI 10.1152/jn.00011.2015; Hullar TE, 2006, ANAT REC PART A, V288A, P466, DOI 10.1002/ar.a.20304; Khammes-El Homsi N, 2010, MAMMALIA, V74, P199, DOI 10.1515/MAMM.2010.023; Kiltie RA, 2000, FUNCT ECOL, V14, P226, DOI 10.1046/j.1365-2435.2000.00404.x; Knutsen PM, 2008, NEURON, V59, P35, DOI 10.1016/j.neuron.2008.05.013; Koka K, 2011, HEARING RES, V272, P135, DOI 10.1016/j.heares.2010.10.007; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Madderson P.F.A., 1972, American Zoologist, V12, P159; Mcgovern KA, 2015, ANAT REC, V298, P750, DOI 10.1002/ar.23061; Meister Markus, 2013, F1000Res, V2, P176, DOI 10.12688/f1000research.2-176.v1; Meyer HS, 2011, P NATL ACAD SCI USA, V108, P16807, DOI 10.1073/pnas.1113648108; Meyer HS, 2010, CEREB CORTEX, V20, P2277, DOI 10.1093/cercor/bhq067; Muchlinski MN, 2013, AM J PHYS ANTHROPOL, V150, P301, DOI 10.1002/ajpa.22206; Muchlinski MN, 2010, J HUM EVOL, V58, P447, DOI 10.1016/j.jhevol.2010.01.012; O'Higgins P, 2012, EVOL BIOL, V39, P521, DOI 10.1007/s11692-012-9173-8; O'Higgins P, 2011, J ANAT, V218, P3, DOI 10.1111/j.1469-7580.2010.01301.x; PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3; Pfaff C, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0744; Pocock RI, 1914, P ZOOL SOC LOND, V1914, P889; Quist BW, 2012, J NEUROPHYSIOL, V107, P2298, DOI 10.1152/jn.00372.2011; Rajan R, 2006, SCIENCE, V311, P666, DOI 10.1126/science.1122096; ROBINSON R, 1981, J HERED, V72, P131, DOI 10.1093/oxfordjournals.jhered.a109445; Rodgers J., 2012, RATTUS NORVEGICUS; Ruf I, 2009, MAMM BIOL, V74, P100, DOI 10.1016/j.mambio.2008.01.002; Schlanbusch P, 2011, HYSTRIX, V22, P227, DOI 10.4404/Hystrix-22.2-4475; Seneviratne SS, 2008, BEHAV ECOL, V19, P784, DOI 10.1093/beheco/arn029; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; SIMPSON JI, 1981, ANN NY ACAD SCI, V374, P20, DOI 10.1111/j.1749-6632.1981.tb30856.x; Sun F, 2016, AFFINE SURFACE MATHW; The L, 2013, J NEUROSCI, V33, P4815, DOI 10.1523/JNEUROSCI.4770-12.2013; Towal RB, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001120; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; VANHORN RN, 1970, FOLIA PRIMATOL, V13, P241, DOI 10.1159/000155325; Varga Z, 2011, P NATL ACAD SCI USA, V108, P15420, DOI 10.1073/pnas.1112355108; von Koenigswald W, 2010, J MAMM EVOL, V17, P275, DOI 10.1007/s10914-010-9140-z; Wallace DJ, 2013, NATURE, V498, P65, DOI 10.1038/nature12153; WELKER C, 1971, BRAIN RES, V26, P259, DOI 10.1016/S0006-8993(71)80004-5; Wolfe J, 2011, BEHAV NEUROSCI, V125, P900, DOI 10.1037/a0026165; Yang AET, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00145; Yu YSW, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600716; Zhuang C, 2017, NEURAL INFO IN PRESS, V30; ZUCKER E, 1969, BRAIN RES, V12, P138, DOI 10.1016/0006-8993(69)90061-4	63	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194981	10.1371/journal.pone.0194981	http://dx.doi.org/10.1371/journal.pone.0194981			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621356	gold, Green Published, Green Submitted			2022-12-26	WOS:000429206800030
J	Gomez-Rial, J; Curras-Tuala, MJ; Rivero-Calle, I; Rodriguez-Tenreiro, C; Redondo-Collazo, L; Gomez-Carballa, A; Pardo-Seco, J; Salas, A; Martinon-Torres, F				Gomez-Rial, Jose; Jose Curras-Tuala, Maria; Rivero-Calle, Irene; Rodriguez-Tenreiro, Carmen; Redondo-Collazo, Lorenzo; Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Salas, Antonio; Martinon-Torres, Federico			Rotavirus intestinal infection induces an oral mucosa cytokine response	PLOS ONE			English	Article							EPITHELIAL-CELLS; IL-22; EXPRESSION; IGA; INTERLEUKIN-22	Introduction Salivary glands are known immune effector sites and considered to be part of the whole mucosal immune system. The aim of the present study was to assess the salivary immune response to rotavirus (RV) infection through the analysis of the cytokine immune profile in saliva. Material and methods A prospective comparative study of serial saliva samples from 27 RV-infected patients (sampled upon admission to the hospital during acute phase and at convalescence-i.e. at least three months after recovery) and 36 healthy controls was performed. Concentrations of 11 salivary cytokines (IFN-gamma, IFN-alpha(2), IL-1 beta, IL-6, IL-8, IL-10, IL-15,IL12(p70), INF-alpha, IFN lambda(1), IL-22) were determined. Cytokine levels were compared between healthy controls acute infection and convalescence. The correlation between clinical data and salivary cytokine profile in infected children was assessed. Results The salivary cytokine profile changes significantly in response to acute RV infection. In RV infected patients, IL-22 levels were increased in the acute phase with respect to convalescence (P-value < 0.001). Comparisons between infected and control group showed significant differences in salivary IFN-alpha(2), IL-1 beta, IL-6, IL-8, IL-10 and IL-22. Although acute-phase levels of IL-12, IL-10, IL-6 and IFN-gamma showed nominal association with Vesikari's severity, this trend did not reach statistical significance after multiple test adjustment. Conclusions RV infection induces a host salivary immune response, indicating that immune mucosal response to RV infection is not confined to the intestinal mucosa. Our data point to a whole mucosal implication in the RV infection as a result of the integrative mucosal immune response, and suggest the salivary gland as effector site for RV infection.	[Gomez-Rial, Jose; Jose Curras-Tuala, Maria; Rivero-Calle, Irene; Rodriguez-Tenreiro, Carmen; Redondo-Collazo, Lorenzo; Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Salas, Antonio; Martinon-Torres, Federico] Hosp Clin Univ Santiago de Compostela, Grp Invest Genet Vacunas Infecc & Pediat GENVIP, Galicia, Spain; [Gomez-Rial, Jose] Hosp Clin Univ Santiago de Compostela, Serv Anal Clin, Lab Inmunol, Galicia, Spain; [Rivero-Calle, Irene; Redondo-Collazo, Lorenzo; Martinon-Torres, Federico] Hosp Clin Univ Santiago de Compostela, Dept Pediat, Translat Pediat & Infect Dis, Galicia, Spain; [Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Salas, Antonio] Hosp Clin Univ Santiago de Compostela, Inst Invest Sanitarias IDIS, GenPoB Res Grp, Galicia, Spain; [Salas, Antonio] Univ Santiago de Compostela, Fac Med, Inst Ciencias Forenses, Dept Anat Patolox & Ciencias Forenses,Unidade Xen, Galicia, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela	Gomez-Rial, J (corresponding author), Hosp Clin Univ Santiago de Compostela, Grp Invest Genet Vacunas Infecc & Pediat GENVIP, Galicia, Spain.; Gomez-Rial, J (corresponding author), Hosp Clin Univ Santiago de Compostela, Serv Anal Clin, Lab Inmunol, Galicia, Spain.	jose.gomez.rial@sergas.es	Tuala, María José Currás/AAD-7498-2020; rivero, irene/ABC-9006-2020; Salas, Antonio/U-2029-2019; Salas, Antonio/E-3977-2012; Pardo-Seco, Jacobo J/G-3752-2016; Martinon-Torres, Federico/E-4982-2016; Gómez-Carballa, Alberto/I-4610-2014	Tuala, María José Currás/0000-0002-6390-8505; Salas, Antonio/0000-0002-2336-702X; Salas, Antonio/0000-0002-2336-702X; Pardo-Seco, Jacobo J/0000-0002-8059-8908; Martinon-Torres, Federico/0000-0002-9023-581X; Gómez-Carballa, Alberto/0000-0003-0927-1272; Redondo Collazo, Lorenzo/0000-0002-3521-678X; Gomez Rial, Jose/0000-0002-3173-8484; Rivero Calle, Irene/0000-0002-3678-9264	Institute de Salud Carlos III (Proyecto de Investigacion en Salud, Accion Estrategica en Salud) [GePEM ISCIII/PI16/01478, ReSVinext ISCIII/PI16/01569]; FEDER; Conselleria de Sanidade, Xunta de Galicia [RHI07/2, PI16/01569]; Fondo de Investigacion Sanitaria (FIS) del Plan Nacional de I + D + I [PI070069/PI1000540]; fondos FEDER; Consolidation e Estructuracion REDES (from Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia) [2016-PG071, 2016GI-1344]; G3VIP (Grupo Gallego de Genetica Vacunas Infecciones y Pedatria) [ED341D R2016/021]; Merck Sharp; Dohme	Institute de Salud Carlos III (Proyecto de Investigacion en Salud, Accion Estrategica en Salud); FEDER(European Commission); Conselleria de Sanidade, Xunta de Galicia(Xunta de Galicia); Fondo de Investigacion Sanitaria (FIS) del Plan Nacional de I + D + I; fondos FEDER(European Commission); Consolidation e Estructuracion REDES (from Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia); G3VIP (Grupo Gallego de Genetica Vacunas Infecciones y Pedatria); Merck Sharp; Dohme	This study received support from the Institute de Salud Carlos III (Proyecto de Investigacion en Salud, Accion Estrategica en Salud): project GePEM ISCIII/PI16/01478/Cofinanciado FEDER (AS.) and project ReSVinext ISCIII/PI16/01569/Cofinanciado FEDER (F.M.T.); Conselleria de Sanidade, Xunta de Galicia (RHI07/2-intensificacion de la actividad investigadora, PS09749 and 10PXIB918184PR), Institute de Salud Carlos III (Intensificacion de la actividad investigadora 2007-2012, PI16/01569), Fondo de Investigacion Sanitaria (FIS; PI070069/PI1000540) del Plan Nacional de I + D + I and 'fondos FEDER' (F.M.T.), and 2016-PG071 Consolidation e Estructuracion REDES 2016GI-1344 (from Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia) G3VIP (Grupo Gallego de Genetica Vacunas Infecciones y Pedatria, ED341D R2016/021) (A.S. and F.M.T) and funding from Merck Sharp and Dohme. Funding sources had no involvement in the design of the study, collection, analysis and interpretation of data, and in writing the manuscript. There was no additional external funding received for this study.	Aase A., 2015, MUCOSAL IMMUNOL; Arnold MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003064; Bielenberg DR, 1998, CANCER BIOTHER RADIO, V13, P375, DOI 10.1089/cbr.1998.13.375; Brandtzaeg P, 2004, J PEDIATR GASTR NUTR, V39, pS725, DOI 10.1097/00005176-200406003-00004; Candy DCA, 2007, PLOS MED, V4, P614, DOI 10.1371/journal.pmed.0040117; CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188; Deo Vikas, 2010, Dent Today, V29, P60; ECKMANN L, 1993, INFECT IMMUN, V61, P4569, DOI 10.1128/IAI.61.11.4569-4574.1993; Ganz T, 2002, P NATL ACAD SCI USA, V99, P3357, DOI 10.1073/pnas.072073199; Hsu ACY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032947; Katlinskaya YV, 2016, MOL CELL BIOL, V36, P1124, DOI 10.1128/MCB.00988-15; Kumar P, 2013, MUCOSAL IMMUNOL, V6, P69, DOI 10.1038/mi.2012.49; Lavoie TN, 2011, SCAND J IMMUNOL, V74, P377, DOI 10.1111/j.1365-3083.2011.02583.x; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Macpherson AJ, 2007, CURR OPIN GASTROEN, V23, P673, DOI 10.1097/MOG.0b013e3282f0d012; McGhee JR, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001397; OSBORNE MP, 1988, J PEDIATR GASTR NUTR, V7, P236, DOI 10.1097/00005176-198803000-00014; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; PIERCE NF, 1975, J EXP MED, V142, P1550, DOI 10.1084/jem.142.6.1550; Rivero-Calle I, 2016, J INFECTION, V72, pS98, DOI 10.1016/j.jinf.2016.04.029; Roescher N, 2010, ANN RHEUM DIS, V69, P945, DOI 10.1136/ard.2009.115378; Sack U, 1998, CLIN DIAGN LAB IMMUN, V5, P28, DOI 10.1128/CDLI.5.1.28-32.1998; Salas A, 2016, INFECT GENET EVOL, V44, P403, DOI 10.1016/j.meegid.2016.07.044; Sandros J, 2000, J DENT RES, V79, P1808, DOI 10.1177/00220345000790101301; Sherry B, 2009, J INTERF CYTOK RES, V29, P559, DOI 10.1089/jir.2009.0072; Silva N, 2015, J APPL ORAL SCI, V23, P329, DOI 10.1590/1678-775720140259; Stadnyk AW, 2002, CAN J GASTROENTEROL, V16, P241, DOI 10.1155/2002/941087; STADNYK AW, 1994, FASEB J, V8, P1041, DOI 10.1096/fasebj.8.13.7926369; Steele C, 2002, INFECT IMMUN, V70, P577, DOI 10.1128/IAI.70.2.577-583.2002; Sugawara S, 2002, J ENDOTOXIN RES, V8, P465, DOI 10.1179/096805102125001082; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Team R. D. C, 2011, R LANG ENV STAT COMP; Waterhouse CCM, 1999, CELL IMMUNOL, V193, P1, DOI 10.1006/cimm.1999.1468; Yin L, 2007, J MED MICROBIOL, V56, P976, DOI 10.1099/jmm.0.47198-0; Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001; Zhang BY, 2014, SCIENCE, V346, P861, DOI 10.1126/science.1256999	37	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195314	10.1371/journal.pone.0195314	http://dx.doi.org/10.1371/journal.pone.0195314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621276	Green Published, Green Submitted, gold			2022-12-26	WOS:000429206800058
J	Persson-Sjodin, E; Hernlund, E; Pfau, T; Andersen, PH; Rhodin, M				Persson-Sjodin, Emma; Hernlund, Elin; Pfau, Thilo; Andersen, Pia Haubro; Rhodin, Marie			Influence of seating styles on head and pelvic vertical movement symmetry in horses ridden at trot	PLOS ONE			English	Article							RISING TROT; LAMENESS; RIDER; ASYMMETRY; BACK; EQUITATION; KINEMATICS; SADDLE	Detailed knowledge of how a rider's seating style and riding on a circle influences the movement symmetry of the horse's head and pelvis may aid rider and trainer in an early recognition of low grade lameness. Such knowledge is also important during both subjective and objective lameness evaluations in the ridden horse in a clinical setting. In this study, inertial sensors were used to assess how different rider seating styles may influence head and pelvic movement symmetry in horses trotting in a straight line and on the circle in both directions. A total of 26 horses were subjected to 15 different conditions at trot: three unridden conditions and 12 ridden conditions where the rider performed three different seating styles (rising trot, sitting trot and two point seat). Rising trot induced systematic changes in movement symmetry of the horses. The most prominent effect was decreased pelvic rise that occurred as the rider was actively rising up in the stirrups, thus creating a downward momentum counteracting the horses push off. This mimics a push off lameness in the hindlimb that is in stance when the rider sits down in the saddle during the rising trot. On the circle, the asymmetries induced by rising trot on the correct diagonal counteracted the circle induced asymmetries, rendering the horse more symmetrical. This finding offers an explanation to the equestrian tradition of rising on the 'correct diagonal.' In horses with small preexisting movement asymmetries, the asymmetry induced by rising trot, as well as the circular track, attenuated or reduced the horse's baseline asymmetry, depending on the sitting diagonal and direction on the circle. A push off hindlimb lameness would be expected to increase when the rider sits during the lame hindlimb stance whereas an impact hindlimb lameness would be expected to decrease. These findings suggest that the rising trot may be useful for identifying the type of lameness during subjective lameness assessment of hindlimb lameness. This theory needs to be studied further in clinically lame horses.	[Persson-Sjodin, Emma; Hernlund, Elin; Rhodin, Marie] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Pfau, Thilo] Royal Vet Coll, Dept Clin Sci & Serv, Hatfield, Herts, England; [Andersen, Pia Haubro] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden	Swedish University of Agricultural Sciences; University of London; University of London Royal Veterinary College; Swedish University of Agricultural Sciences	Persson-Sjodin, E (corresponding author), Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden.	emma.persson.sjodin@slu.se	Andersen, Pia Haubro/B-7077-2015; Rhodin, Marie/AAD-7266-2020; Persson-Sjodin, Emma/E-5393-2016	Andersen, Pia Haubro/0000-0002-6039-7439; Persson-Sjodin, Emma/0000-0002-0331-6970; Hernlund, Elin/0000-0002-5769-3958	Swedish Research Council Formas	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This study was founded by the Swedish Research Council Formas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clayton HM, 2017, APPL ANIM BEHAV SCI, V190, P123, DOI 10.1016/j.applanim.2017.02.011; Egenvall A, 2013, PREV VET MED, V112, P387, DOI 10.1016/j.prevetmed.2013.09.013; Greve L, 2014, EQUINE VET J, V46, P687, DOI 10.1111/evj.12222; Heim C, 2016, EQUINE VET J, V48, P509, DOI 10.1111/evj.12455; Keegan KG, 2010, EQUINE VET J, V42, P92, DOI 10.2746/042516409X479568; Keegan KG, 2001, EQUINE VET J, V33, P446, DOI 10.2746/042516401776254781; Landman MAAM, 2004, VET REC, V155, P165, DOI 10.1136/vr.155.6.165; Licka T, 2004, EQUINE VET J, V36, P734, DOI 10.2746/0425164044848028; Martin P, 2016, J BIOMECH, V49, P1027, DOI 10.1016/j.jbiomech.2016.02.016; Penell JC, 2005, VET REC, V157, P470, DOI 10.1136/vr.157.16.470; Pfau T, 2016, EQUINE VET J, V48, P83, DOI 10.1111/evj.12374; Rhodin M, 2016, EQUINE VET J, V48, P315, DOI 10.1111/evj.12446; Rhodin M, 2013, VET J, V198, pE39, DOI 10.1016/j.tvjl.2013.09.031; Rhodin M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176253; Robartes H, 2013, VET J, V198, pE52, DOI 10.1016/j.tvjl.2013.09.033; Roepstorff L, 2009, EQUINE VET J, V41, P292, DOI 10.2746/042516409X397127; Ross M., 2011, DIAGNOSIS MANAGEMENT, P64; Starke SD, 2012, VET J, V193, P73, DOI 10.1016/j.tvjl.2011.10.019; Symes D, 2009, VET J, V181, P34, DOI 10.1016/j.tvjl.2009.03.016; van Beek FE, 2012, VET J, V193, P193, DOI 10.1016/j.tvjl.2011.10.007; van Hoogmoed LM, 2003, EQUINE VET J, V35, P375, DOI 10.2746/042516403776014325; Vos NJ, 2008, IRISH VET J, V61, P33, DOI 10.1186/2046-0481-61-1-33	22	20	20	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195341	10.1371/journal.pone.0195341	http://dx.doi.org/10.1371/journal.pone.0195341			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621299	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000429206800068
J	Shebanits, K; Andersson-Assarsson, JC; Larsson, I; Carlsson, LMS; Feuk, L; Larhammar, D				Shebanits, Kateryna; Andersson-Assarsson, Johanna C.; Larsson, Ingrid; Carlsson, Lena M. S.; Feuk, Lars; Larhammar, Dan			Copy number of pancreatic polypeptide receptor gene NPY4R correlates with body mass index and waist circumference	PLOS ONE			English	Article							DROPLET-DIGITAL PCR; FOOD-INTAKE; EXTREME OBESITY; HUMAN GENOME; LIFE-STYLE; PREDISPOSES; DISCOVERY; APPETITE; CHINESE; SEX	Multiple genetic studies have linked copy number variation (CNV) in different genes to body mass index (BMI) and obesity. A CNV on chromosome 10q11.22 has been associated with body weight. This CNV region spans NPY4R, the gene encoding the pancreatic polypeptide receptor Y4, which has been described as a satiety-stimulating receptor. We have investigated CNV of the NPY4R gene and analysed its relationship to BMI, waist circumference and self-reported dietary intake from 558 individuals (216 men and 342 women) representing a wide BMI range. The copy number for NPY4R ranged from 2 to 8 copies (average 4.6 +/- 0.8). Rather than the expected negative correlation, we observed a positive correlation between NPY4R copy number and BMI as well as waist circumference (r = 0.267, p = 2.65x 10(-7) and r = 0.256, p = 8x10(-7), respectively). Each additional copy of NPY4R correlated with 2.6 kg/m(2) increase in BMI and 5.67 cm increase in waist circumference (p = 3.3x10(-7) and p = 1x10(-6), respectively) for women. For men, there was no statistically significant correlation between CNV and BMI. Our results suggest that NPY4R genetic variation influences body weight in women, but the exact role of this receptor appears to be more complex than previously proposed.	[Shebanits, Kateryna; Larhammar, Dan] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Andersson-Assarsson, Johanna C.; Carlsson, Lena M. S.] Gothenburg Univ, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Larsson, Ingrid] Sahlgrens Univ Hosp, Dept Gastroenterol & Hepatol, Gothenburg, Sweden; [Feuk, Lars] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden	Uppsala University; University of Gothenburg; Sahlgrenska University Hospital; Uppsala University	Larhammar, D (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	dan.larhammar@neuro.uu.se	Andersson-Assarsson, Johanna/M-2524-2019; Carlsson, Lena/F-7570-2018	Andersson-Assarsson, Johanna/0000-0001-9082-8589; Carlsson, Lena/0000-0003-4145-6242	Swedish Research Council [K2013-54X-11285-19, K2013-55X-22189-01-2]; Swedish Brain Foundation [F02016-0217]; Sahlgrenska University Hospital Regional Agreement on Medical Education and Research; Swedish Research Council; Swedish Brain Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Sahlgrenska University Hospital Regional Agreement on Medical Education and Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation	This study was supported by the grants from the Swedish Research Council (https://www.vr.se/) K2013-54X-11285-19 (LC) and K2013-55X-22189-01-2 (DL), the Swedish Brain Foundation (http://www.hjarnfonden.se/) F02016-0217 (DL), and the Sahlgrenska University Hospital Regional Agreement on Medical Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge all the participants of our study for making this work possible. Our study was funded by the Swedish Research Council, the Swedish Brain Foundation, and the Sahlgrenska University Hospital Regional Agreement on Medical Education and Research. We thank Leif Andersson for access to the droplet digital PCR facility and Jennifer Meadows for input and guidance during the initial setup of the method.	Abou Tayoun AN, 2016, HUM MUTAT, V37, P119, DOI 10.1002/humu.22912; Aerts E, 2016, OBESITY, V24, P970, DOI 10.1002/oby.21435; Aronne LJ, 2002, OBES RES, V10, p14S, DOI 10.1038/oby.2002.184; Artuso R, 2011, J HUM GENET, V56, P508, DOI 10.1038/jhg.2011.50; Asakawa A, 2003, GASTROENTEROLOGY, V124, P1325, DOI 10.1016/S0016-5085(03)00216-6; BAER M, 1990, NUCLEIC ACIDS RES, V18, P97, DOI 10.1093/nar/18.1.97; Batterham RL, 2003, J CLIN ENDOCR METAB, V88, P3989, DOI 10.1210/jc.2003-030630; Campbell RE, 2003, J NEUROSCI, V23, P1487, DOI 10.1523/JNEUROSCI.23-04-01487.2003; Carlsson LMS, 2009, BIOCHEM BIOPH RES CO, V382, P309, DOI 10.1016/j.bbrc.2009.03.014; Chu JH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-157; Elks Cathy E, 2012, Front Endocrinol (Lausanne), V3, P29, DOI 10.3389/fendo.2012.00029; Falchi M, 2014, NAT GENET, V46, P492, DOI 10.1038/ng.2939; Fetissov SO, 2004, NEUROPEPTIDES, V38, P175, DOI 10.1016/j.npep.2004.05.009; Flores M, 2007, P NATL ACAD SCI USA, V104, P6099, DOI 10.1073/pnas.0701631104; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; HEITMANN BL, 1995, BRIT MED J, V311, P986; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Huda MSB, 2006, OBES REV, V7, P163, DOI 10.1111/j.1467-789X.2006.00245.x; Jarick I, 2011, HUM MOL GENET, V20, P840, DOI 10.1093/hmg/ddq518; Jesudason DR, 2007, BRIT J NUTR, V97, P426, DOI 10.1017/S0007114507336799; Johansson L, 1998, AM J CLIN NUTR, V68, P266, DOI 10.1093/ajcn/68.2.266; Kojima S, 2007, PEPTIDES, V28, P459, DOI 10.1016/j.peptides.2006.09.024; Larsson I, 2004, INT J OBESITY, V28, P1317, DOI 10.1038/sj.ijo.0802732; Lin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008488; LINDROOS AK, 1993, EUR J CLIN NUTR, V47, P461; Lissner L, 2002, PUBLIC HEALTH NUTR, V5, P889, DOI 10.1079/PHN2002388; Lissner L, 1998, EUR J CLIN NUTR, V52, P316, DOI 10.1038/sj.ejcn.1600567; LUNDELL I, 1995, J BIOL CHEM, V270, P29123, DOI 10.1074/jbc.270.49.29123; Macdiarmid J, 1998, NUTR RES REV, V11, P231, DOI 10.1079/NRR19980017; Mazaika E, 2014, CURR PROTOC HUM GENE, V82, p[7, 241], DOI DOI 10.1002/0471142905.HG0724S82; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Piotrowski A, 2008, HUM MUTAT, V29, P1118, DOI 10.1002/humu.20815; Reinehr T, 2006, INT J OBESITY, V30, P1476, DOI 10.1038/sj.ijo.0803393; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sha BY, 2009, J HUM GENET, V54, P199, DOI 10.1038/jhg.2009.10; Sillence KA, 2015, CLIN CHEM, V61, P1399, DOI 10.1373/clinchem.2015.239137; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Sun C, 2013, GENE, V516, P198, DOI 10.1016/j.gene.2012.12.081; Svobodova I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142572; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Wang K, 2010, DIABETES, V59, P2690, DOI 10.2337/db10-0192; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4	47	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194668	10.1371/journal.pone.0194668	http://dx.doi.org/10.1371/journal.pone.0194668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621259	Green Published, Green Submitted, gold			2022-12-26	WOS:000429206800023
J	Bossi, F; Gallucci, M; Ricciardelli, P				Bossi, Francesco; Gallucci, Marcello; Ricciardelli, Paola			How social exclusion modulates social information processing: A behavioural dissociation between facial expressions and gaze direction	PLOS ONE			English	Article							EYE GAZE; OSTRACISM; PERCEPTION; NEED; ATTENTION; BELONG; BRAIN; SEX; SENSITIVITY; VALIDATION	Social exclusion is a painful experience that is felt as a threat to the human need to belong and can lead to increased aggressive and anti-social behaviours, and results in emotional and cognitive numbness. Excluded individuals also seem to show an automatic tuning to positivity: they tend to increase their selective attention towards social acceptance signals. Despite these effects known in the literature, the consequences of social exclusion on social information processing still need to be explored in depth. The aim of this study was to investigate the effects of social exclusion on processing two features that are strictly bound in the appraisal of the meaning of facial expressions: gaze direction and emotional expression. In two experiments (N = 60, N = 45), participants were asked to identify gaze direction or emotional expressions from facial stimuli, in which both these features were manipulated. They performed these tasks in a four-block crossed design after being socially included or excluded using the Cyberball game. Participants' empathy and self-reported emotions were recorded using the Empathy Quotient (EQ) and PANAS questionnaires. The Need Threat Scale and three additional questions were also used as manipulation checks in the second experiment. In both experiments, excluded participants showed to be less accurate than included participants in gaze direction discrimination. Modulatory effects of direct gaze (Experiment 1) and sad expression (Experiment 2) on the effects of social exclusion were found on response times (RTs) in the emotion recognition task. Specific differences in the reaction to social exclusion between males and females were also found in Experiment 2: excluded male participants tended to be less accurate and faster than included male participants, while excluded females showed a more accurate and slower performance than included female participants. No influence of social exclusion on PANAS or EQ scores was found. Results are discussed in the context of the importance of identifying gaze direction in appraisal theories.	[Bossi, Francesco; Gallucci, Marcello; Ricciardelli, Paola] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Bossi, Francesco; Gallucci, Marcello; Ricciardelli, Paola] NeuroMl Milan Ctr Neurosci, Milan, Italy	University of Milano-Bicocca	Bossi, F (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.; Bossi, F (corresponding author), NeuroMl Milan Ctr Neurosci, Milan, Italy.	tbossi3@campus.unimib.it	Gallucci, Marcello/AAC-5495-2019; Gallucci, Marcello/H-3989-2012; Bossi, Francesco/AGU-0358-2022	Gallucci, Marcello/0000-0003-3546-0093; Gallucci, Marcello/0000-0003-3546-0093; Bossi, Francesco/0000-0003-3359-8187	Fondazione Cariplo and Regione Lombardia [2016-0925]; University of Milano-Bicocca	Fondazione Cariplo and Regione Lombardia(Regione Lombardia); University of Milano-Bicocca	This research was funded by a grant from Fondazione Cariplo and Regione Lombardia (pratica # 2016-0925) to Paola Ricciardelli and a scholarship from the University of Milano-Bicocca to Francesco Bossi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been supported by Fondazione Cariplo and Regione Lombardia (grant n. 2016-0925) to PR and a scholarship from the University of Milano-Bicocca to FB. The authors would like to thank Laura Caccia for her help with data collection. The authors have declared no conflicts of interest for this article.	Adams RB, 2005, EMOTION, V5, P3, DOI 10.1037/1528-3542.5.1.3; Adams RB, 2003, PSYCHOL SCI, V14, P644, DOI 10.1046/j.0956-7976.2003.psci_1479.x; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Artuso C, 2015, SOC COGNITION, V33, P543, DOI 10.1521/soco.2015.33.6.543; Artuso C, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00362; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, PARSIMONIOUS MIXED M, DOI DOI 10.1177/0146167220913363; Baumeister RF, 2005, J PERS SOC PSYCHOL, V88, P589, DOI 10.1037/0022-3514.88.4.589; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Baumeister RF, 2002, J PERS SOC PSYCHOL, V83, P817, DOI 10.1037//0022-3514.83.4.817; Baumeister RF, 2007, SOC PERSONAL PSYCHOL, V1, P506, DOI 10.1111/j.1751-9004.2007.00020.x; Bayliss AP, 2005, Q J EXP PSYCHOL-A, V58, P631, DOI 10.1080/02724980443000124; Bernstein MJ, 2008, PSYCHOL SCI, V19, P981, DOI 10.1111/j.1467-9280.2008.02187.x; Bernstein MJ, 2012, PERS SOC PSYCHOL B, V38, P185, DOI 10.1177/0146167211422449; Bockler A, 2014, SOC PSYCHOL PERS SCI, V5, P140, DOI 10.1177/1948550613488951; Carraro L, 2017, COGN PROCESS, V18, P97, DOI 10.1007/s10339-016-0785-2; Carter-Sowell AR, 2008, SOC INFLUENCE, V3, P143, DOI 10.1080/15534510802204868; Cohen J., 2013, APPL MULTIPLE CORREL, DOI DOI 10.4324/9780203774441; Cohen J.E., 1988, STAT POWER ANAL BEHA; DeWall CN, 2006, J PERS SOC PSYCHOL, V91, P1, DOI 10.1037/0022-3514.91.1.1; DeWall CN, 2011, EMOTION, V11, P623, DOI 10.1037/a0023534; DeWall CN, 2009, J PERS SOC PSYCHOL, V96, P729, DOI 10.1037/a0014634; Draine S., 2014, INQUISIT 4; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Frijda N. H., 1986, EMOTIONS STUDIES EMO; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Gonsalkorale K, 2007, EUR J SOC PSYCHOL, V37, P1176, DOI 10.1002/ejsp.392; Hartgerink CHJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127002; Jamieson JP, 2010, PERS SOC PSYCHOL B, V36, P690, DOI 10.1177/0146167209358882; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; LAZARUS RS, 1991, AM PSYCHOL, V46, P819, DOI 10.1037/0003-066X.46.8.819; Lipp OV, 2009, MOTIV EMOTION, V33, P249, DOI 10.1007/s11031-009-9136-2; Lyyra P, 2017, Q J EXP PSYCHOL, V70, P1713, DOI 10.1080/17470218.2016.1204327; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Otten M, 2013, SOC COGN AFFECT NEUR, V8, P789, DOI 10.1093/scan/nss071; Pavlova MA, 2017, J NEUROSCI RES, V95, P235, DOI 10.1002/jnr.23871; Pickett CL, 2004, PERS SOC PSYCHOL B, V30, P1095, DOI 10.1177/0146167203262085; R Core Team, 2021, R LANGUAGE ENV STAT; Ricciardelli P, 2002, NEUROREPORT, V13, P2259, DOI 10.1097/00001756-200212030-00018; Riva P, 2016, J SOCIAL PERSONAL RE, V34, P1; RStudio Inc, 2016, RSTUDIO INT DEV ENV; Sander D, 2007, EUR J COGN PSYCHOL, V19, P470, DOI 10.1080/09541440600757426; Scherer K. R., 1992, INT REV STUDIES EMOT, V2, P139; Scherer Klaus, 1984, NATURE FUNCTION EMOT; Scherer Klaus R., 2001, APPRAISAL PROCESSES; Selya AS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00111; Twenge JM, 2007, J PERS SOC PSYCHOL, V92, P56, DOI 10.1037/0022-3514.92.1.56; Twenge JM, 2003, J PERS SOC PSYCHOL, V85, P409, DOI 10.1037/0022-3514.85.3.409; Twenge JM, 2001, J PERS SOC PSYCHOL, V81, P1058, DOI 10.1037//0022-3514.81.6.1058; van Beest I, 2006, J PERS SOC PSYCHOL, V91, P918, DOI 10.1037/0022-3514.91.5.918; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wilkowski BM, 2009, PSYCHOL SCI, V20, P495, DOI 10.1111/j.1467-9280.2009.02321.x; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Williams KD, 1997, PERS SOC PSYCHOL B, V23, P693, DOI 10.1177/0146167297237003; Williams KD, 2009, ADV EXPT SOCIAL PSYC, V41; Williams KD, 2007, ANNU REV PSYCHOL, V58, P425, DOI 10.1146/annurev.psych.58.110405.085641; Williams KD, 2006, BEHAV RES METHODS, V38, P174, DOI 10.3758/BF03192765; Wirth JH, 2010, PERS SOC PSYCHOL B, V36, P869, DOI 10.1177/0146167210370032; Zadro L, 2004, J EXP SOC PSYCHOL, V40, P560, DOI 10.1016/j.jesp.2003.11.006	62	4	5	6	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195100	10.1371/journal.pone.0195100	http://dx.doi.org/10.1371/journal.pone.0195100			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617410	gold, Green Published, Green Submitted			2022-12-26	WOS:000429203800064
J	Doubell, TP; Alsetrawi, A; Bastawrous, DAS; Bastawrous, MAS; Daibes, A; Jadalla, A; Schnupp, JWH				Doubell, T. P.; Alsetrawi, A.; Bastawrous, D. A. S.; Bastawrous, M. A. S.; Daibes, A.; Jadalla, A.; Schnupp, J. W. H.			The effect of interaural timing on the posterior auricular muscle reflex in normal adult volunteers	PLOS ONE			English	Article							AUDITORY BRAIN-STEM; BINAURAL INTERACTION COMPONENT; DELAY-DEPENDENT CHANGES; EVOKED-POTENTIALS; PROCESSING DISORDERS; SOUND LOCALIZATION; PINNA MOVEMENTS; RESPONSES; CHILDREN; TIME	The posterior auricular muscle (PAM) reflex to sounds has been used clinically to determine hearing threshold as an alternative to other audiological diagnostic measures such as the auditory brainstem response. We have shown that the PAM response is also sensitive to interaural timing differences in normally hearing adults. PAM responses were evoked by both ipsilateral/contralateral monaural stimulation and by binaural stimulation. Introducing sound delays ipsilaterally or contralaterally decreased the PAM response amplitude and increased its latency. The PAM response in this study shows a qualitatively similar pattern to that seen by the binaural interaction component (BIC) of the auditory brainstem potential to binaural clicks described in previous studies, in that both: have their shortest latency and maximal amplitudes centred around zero interaural timing differences, have response latencies increase with increasing interaural delays up to 1.2 ms and have response amplitudes decrease with increasing interaural delays of up to 1.2 ms. Our data show that the PAM response may be useful in measuring binaural integration in humans non-invasively for diagnostic or research studies.	[Doubell, T. P.; Alsetrawi, A.; Bastawrous, D. A. S.; Bastawrous, M. A. S.; Daibes, A.; Jadalla, A.] Med Univ Bahrain, Royal Coll Surg Ireland, Sch Med, Busaiteen, Bahrain; [Schnupp, J. W. H.] City Univ Hong Kong, Dept Biomed Sci, Kowloon, Hong Kong, Peoples R China; [Schnupp, J. W. H.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	Royal College of Surgeons - Ireland; City University of Hong Kong; University of Oxford	Doubell, TP (corresponding author), Med Univ Bahrain, Royal Coll Surg Ireland, Sch Med, Busaiteen, Bahrain.	tdoubell@rcsi-mub.com		schnupp, jan w h/0000-0002-2604-0057	Royal College of Surgeons of Ireland:Medical University of Bahrain research committee	Royal College of Surgeons of Ireland:Medical University of Bahrain research committee	The equipment used in this study was purchased by a grant from the Royal College of Surgeons of Ireland:Medical University of Bahrain research committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agung K, 2005, INT J AUDIOL, V44, P631, DOI 10.1080/14992020500266613; Akeroyd MA, 2006, INT J AUDIOL, V45, pS25, DOI 10.1080/14992020600782626; Benning SD, 2004, PSYCHOPHYSIOLOGY, V41, P426, DOI 10.1111/j.1469-8986.00160.x; Benning SD, 2011, PSYCHOPHYSIOLOGY, V48, P410, DOI 10.1111/j.1469-8986.2010.01071.x; Brantberg K, 1999, SCAND AUDIOL, V28, P15, DOI 10.1080/010503999424879; CODY DTR, 1969, LARYNGOSCOPE, V79, P400, DOI 10.1288/00005537-196903000-00007; Cook A, 2014, EAR HEARING, V35, P230, DOI 10.1097/AUD.0b013e3182a4efdf; Dau T, 2000, J ACOUST SOC AM, V107, P1530, DOI 10.1121/1.428438; Delb W, 2003, INT J AUDIOL, V42, P401, DOI 10.3109/14992020309080049; Delb WF, 2004, INT J AUDIOL, V43, P69, DOI 10.1080/14992020400050012; DOBIE RA, 1980, ELECTROEN CLIN NEURO, V49, P303, DOI 10.1016/0013-4694(80)90224-2; DOBIE RA, 1979, ARCH OTOLARYNGOL, V105, P391; DUS V, 1975, ELECTROEN CLIN NEURO, V39, P523, DOI 10.1016/0013-4694(75)90055-3; Emanuel DC, 2011, AM J AUDIOL, V20, P48, DOI 10.1044/1059-0889(2011/10-0019); FRIAUF E, 1985, J COMP NEUROL, V240, P161, DOI 10.1002/cne.902400206; Furst M, 2004, HEARING RES, V187, P63, DOI 10.1016/S0378-5955(03)00331-9; FURST M, 1985, J ACOUST SOC AM, V78, P1644, DOI 10.1121/1.392802; Gibson WPR, 1975, THESIS; Goksoy C, 2005, BRAIN RES, V1054, P183, DOI 10.1016/j.brainres.2005.06.083; Gopal KV, 1999, SCAND AUDIOL, V28, P77, DOI 10.1080/010503999424798; Gordon KA, 2007, NEUROREPORT, V18, P613, DOI 10.1097/WNR.0b013e3280b10c15; Gordon KA, 2012, J NEUROSCI, V32, P4212, DOI 10.1523/JNEUROSCI.5741-11.2012; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; GUNNARSON AD, 1991, J SPEECH HEAR RES, V34, P1207, DOI 10.1044/jshr.3405.1207; Hackley SA, 2015, PSYCHOPHYSIOLOGY, V52, P1263, DOI 10.1111/psyp.12501; HENKEL CK, 1978, J COMP NEUROL, V182, P763, DOI 10.1002/cne.901820502; Horta-Junior JAC, 2008, J COMP NEUROL, V507, P1763, DOI 10.1002/cne.21625; Jaganathan R, 2002, OPTIMISING POST AURI; JERGER S, 1988, AM J OTOL, V9, P63; JEWETT DL, 1970, SCIENCE, V167, P1517, DOI 10.1126/science.167.3924.1517; Jiang ZD, 1996, PEDIATR RES, V39, P708, DOI 10.1203/00006450-199604000-00024; JONES SJ, 1990, ELECTROEN CLIN NEURO, V77, P214, DOI 10.1016/0168-5597(90)90040-K; King AJ, 2001, TRENDS COGN SCI, V5, P261, DOI 10.1016/S1364-6613(00)01660-0; Laumen G, 2016, EAR HEARING, V37, pE276, DOI 10.1097/AUD.0000000000000301; Laumen G, 2016, HEARING RES, V337, P46, DOI 10.1016/j.heares.2016.04.009; LEVINE RA, 1981, ANN NEUROL, V9, P384, DOI 10.1002/ana.410090412; MCPHERSON DL, 1995, HEARING RES, V89, P162, DOI 10.1016/0378-5955(95)00134-1; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; Mukerji S, 2010, TRENDS AMPLIF, V14, P170, DOI 10.1177/1084713810381771; O'Beirne GA, 1999, HEARING RES, V138, P115, DOI 10.1016/S0378-5955(99)00159-8; Patuzzi RB, 2000, AUDIOL NEURO-OTOL, V5, P322, DOI 10.1159/000013898; Populin LC, 1998, J NEUROSCI, V18, P4233; Pratt H, 1998, EVOKED POTENTIAL, V108, P511, DOI 10.1016/S0168-5597(98)00029-X; Purdy SC, 2005, INT J AUDIOL, V44, P625, DOI 10.1080/14992020500266639; Riedel H, 2006, HEARING RES, V218, P5, DOI 10.1016/j.heares.2006.03.018; Stollman MHP, 1996, BRIT J AUDIOL, V30, P227, DOI 10.3109/03005369609079043; THORNTON ARD, 1975, J LARYNGOL OTOL, V89, P997, DOI 10.1017/S0022215100081317; TOTSUKA G, 1954, ANN OTO RHINOL LARYN, V63, P939, DOI 10.1177/000348945406300406; Ungan P, 1997, HEARING RES, V106, P66, DOI 10.1016/S0378-5955(97)00003-8; WREGE KS, 1981, ARCH NEUROL-CHICAGO, V38, P572, DOI 10.1001/archneur.1981.00510090066008; YOSHIE N, 1969, ACTA OTO-LARYNGOL, VS, P89	51	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194965	10.1371/journal.pone.0194965	http://dx.doi.org/10.1371/journal.pone.0194965			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617426	gold, Green Published, Green Submitted			2022-12-26	WOS:000429203800058
J	Spitsyn, VM; Kondakov, AV; Bolotov, NI; Pham, NT; Gofarov, MY; Bolotov, IN				Spitsyn, Vitaly M.; Kondakov, Alexander V.; Bolotov, Nikita I.; Nhi Thi Pham; Gofarov, Mikhail Y.; Bolotov, Ivan N.			DNA barcoding unravels contrasting evolutionary history of two widespread Asian tiger moth species during the Late Pleistocene	PLOS ONE			English	Article							POPULATION-GENETICS; CREATONOTOS-TRANSIENS; GLOBAL PHYLOGEOGRAPHY; NEW-GUINEA; LEPIDOPTERA; ARCTIIDAE; COMMUNITIES; INFERENCES; SOFTWARE; SEQUENCE	Populations of widespread pest insects in tropical areas are characterized by a complex evolutionary history, with overlapping natural and human-mediated dispersal events, sudden expansions, and bottlenecks. Here, we provide biogeographic reconstructions for two widespread pest species in the tiger moth genus Creatonotos (Lepidoptera: Erebidae: Arctiinae) based on the mitochondrial cytochrome c oxidase subunit I (COI) gene. The Asian Creatonotos transiens reveals shallow genetic divergence between distant populations that does not support its current intraspecific systematics with several local subspecies. In contrast, the more widespread Creatonotos gangis comprises at least three divergent subclades corresponding to certain geographic areas, i.e. Australia, Arabia + South Asia and Southeast Asia. With respect to our approximate Bayesian computation (ABC) model, the expansion of Creatonotos gangis into Australia is placed in the Late Pleistocene (similar to 65-63 ka). This dating coincide with an approximate time of the earliest human migration into the continent (similar to 65-54 ka) and the period of intervisibility between Timor and Australia (similar to 65-62 ka). Our findings highlight that the drying Sunda and Sahul shelf areas likely support successful migrations of Asian taxa into Australia during the Pleistocene. The phylogeographic patterns discovered in this study can be used to improve the effectiveness of integrated pest control programs that is a task of substantial practical importance to a broad range of agricultural stakeholders.	[Spitsyn, Vitaly M.; Kondakov, Alexander V.; Gofarov, Mikhail Y.; Bolotov, Ivan N.] Northern Arctic Fed Univ, Lab Mol Ecol & Phylogenet, Arkhangelsk, Russia; [Spitsyn, Vitaly M.; Kondakov, Alexander V.; Bolotov, Nikita I.; Gofarov, Mikhail Y.; Bolotov, Ivan N.] Russian Acad Sci, Fed Ctr Integrated Arctic Res, Inst Biogeog & Genet Resources, Arkhangelsk, Russia; [Nhi Thi Pham] Vietnam Acad Sci & Technol, Inst Ecol & Biol Resources, Hanoi, Vietnam; [Nhi Thi Pham] Vietnam Acad Sci & Technol, Grad Univ Sci & Technol, Hanoi, Vietnam	Northern Arctic Federal University; N. Laverov Federal Center for Integrated Arctic Research; Russian Academy of Sciences; Vietnam Academy of Science & Technology (VAST); Vietnam Academy of Science & Technology (VAST)	Spitsyn, VM (corresponding author), Northern Arctic Fed Univ, Lab Mol Ecol & Phylogenet, Arkhangelsk, Russia.; Spitsyn, VM (corresponding author), Russian Acad Sci, Fed Ctr Integrated Arctic Res, Inst Biogeog & Genet Resources, Arkhangelsk, Russia.	vitalik91993@yandex.ru	Gofarov, Mikhail Y/U-9024-2017; Kondakov, Alexander V/C-9202-2018; Bolotov, Ivan N/P-2892-2015	Gofarov, Mikhail Y/0000-0002-8532-0307; Kondakov, Alexander V/0000-0002-6305-6496; Spitsyn, Vitaly M./0000-0003-2955-3795	National Geographic Society (USA) [9821-15]; Federal Agency for Scientific Organizations (Russia) [0409-20150143]	National Geographic Society (USA)(National Geographic Society); Federal Agency for Scientific Organizations (Russia)	The field works and sampling were supported by the National Geographic Society (USA, grant no. 9821-15) (http llama natonalgeographic corn). The molecular analyses were supported by the Federal Agency for Scientific Organizations (Russia, project no. 0409-20150143) (http//fano.gov.ru/en/).	ALLSOPP PG, 1980, B ENTOMOL RES, V70, P343, DOI 10.1017/S0007485300007628; [Anonymous], 2014, TRACER V1 6; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P832, DOI 10.1111/1755-0998.12131; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bergstrom A, 2016, CURR BIOL, V26, P809, DOI 10.1016/j.cub.2016.01.028; Biswas Olive, 2016, Journal of Entomology and Zoology Studies, V4, P13; Bito D, 2007, J BIOGEOGR, V34, P769, DOI 10.1111/j.1365-2699.2006.01652.x; Bolotov IN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02312-z; Bolotov IN, 2015, POLAR BIOL, V38, P905, DOI 10.1007/s00300-014-1643-2; BOPPRE M, 1986, NATURWISSENSCHAFTEN, V73, P17, DOI 10.1007/BF01168801; BOPPRE M, 1989, ZOOL J LINN SOC-LOND, V96, P339, DOI 10.1111/j.1096-3642.1989.tb02518.x; Braby MF, 2015, SYST BIODIVERS, V13, P386, DOI 10.1080/14772000.2014.992378; Catindig J. L. A., 1993, International Rice Research Notes, V18, P34; Catling D, 2013, BANGLADESH RICE J, V17, P75; Cerny Karel, 2011, Entomofauna, V32, P29; Condamine FL, 2015, SCI REPORTS, P5; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Craft KJ, 2010, P NATL ACAD SCI USA, V107, P5041, DOI 10.1073/pnas.0913084107; De Freina Josef J., 2007, Nota Lepidopterologica, V30, P375; Dubatolov V. V., 2010, Evraziatskii entomologicheskii Zhurnal, V9, P727; Dubatolov Vladimir V., 2010, Neue Entomologische Nachrichten, V65, P1; Dubatolov Vladimir V., 2007, Bonner Zoologische Beitraege, V55, P113; Epperson BK, 2003, GEOGRAPHICAL GENETIC, V356; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feller Z, 2013, ORG DIVERS EVOL, V13, P569; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Freina JJ, 2010, ESPERIANA BUCHREIHE, V15, P423; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Gurule S. A., 2010, Flora and Fauna (Jhansi), V16, P295; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hegna RH, 2015, J BIOGEOGR, V42, P1469, DOI 10.1111/jbi.12513; Holland D., 2009, Horticultural Reviews, V35, P127; Johnson CN, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2399; Kealy S, 2017, ARCHAEOL PROSPECT, P1570; Kumar Manoj, 2006, Indian Journal of Agricultural Research, V40, P42; Lohman DJ, 2011, ANNU REV ECOL EVOL S, V42, P205, DOI 10.1146/annurev-ecolsys-102710-145001; Lohman DJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-301; Ma C, 2012, MOL ECOL, V21, P4344, DOI 10.1111/j.1365-294X.2012.05684.x; Miller M.A., 2010, P GAT COMP ENV WORKS; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Paul Monalisa, 2016, Journal of Entomology and Zoology Studies, V4, P435; Ronka K, 2016, SYST ENTOMOL, V41, P844, DOI 10.1111/syen.12194; Rougerie R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101108; Saltre A F, 2016, NAT COMM, P7; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Schenekar T, 2011, HEREDITY, V107, P511, DOI 10.1038/hdy.2011.48; SCHNEIDER D, 1982, SCIENCE, V215, P1264, DOI 10.1126/science.215.4537.1264; Shah S. Kr., 2015, Journal of Zoology Studies, V2, P1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timmermann A, 2016, NATURE, V538, P92, DOI 10.1038/nature19365; Van Eecke R., 1927, 4 ZOOLOGISCHE MEDEDE, V10, P90; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Voda R, 2016, SCI REPORTS, P6; Wallace A. R., 1860, J LINN SOC LOND, V4, P172, DOI DOI 10.1111/J.1096-3642.1860.TB00090.X; WINK M, 1990, J COMP PHYSIOL B, V160, P389, DOI 10.1007/BF01075670; Wink M, 1997, J CHEM ECOL, V23, P1549, DOI 10.1023/B:JOEC.0000006421.49263.ae; WUNDERER H, 1989, J INSECT PHYSIOL, V35, P87, DOI 10.1016/0022-1910(89)90041-3; WUNDERER H, 1986, EXP BIOL, V46, P11; Yago M, 2008, ZOOTAXA, P15; Zahiri R, 2012, SYST ENTOMOL, V37, P102, DOI 10.1111/j.1365-3113.2011.00607.x; Zaspel JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101975; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zhou CL, 2012, PAN-PAC ENTOMOL, V88, P381, DOI 10.3956/2011-33.1; Zhou LH, 2016, J APPL ENTOMOL, P12371	68	2	6	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194200	10.1371/journal.pone.0194200	http://dx.doi.org/10.1371/journal.pone.0194200			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617397	gold, Green Submitted, Green Published			2022-12-26	WOS:000429203800023
J	da Silva, MJF; Kopp, GH; Casanova, C; Godinho, R; Minhos, T; Sa, R; Zinner, D; Bruford, MW				Ferreira da Silva, Maria Joana; Kopp, Gisela H.; Casanova, Catarina; Godinho, Raquel; Minhos, Tania; Sa, Rui; Zinner, Dietmar; Bruford, Michael W.			Disrupted dispersal and its genetic consequences: Comparing protected and threatened baboon populations (Papio papio) in West Africa	PLOS ONE			English	Article							SEX-BIASED DISPERSAL; MITOCHONDRIAL-DNA VARIATION; SPATIAL AUTOCORRELATION; PATTERNS; MIGRATION; DYNAMICS; HETEROGENEITY; CONSERVATION; IMMIGRATION; RELATEDNESS	Dispersal is a demographic process that can potentially counterbalance the negative impacts of anthropogenic habitat fragmentation. However, mechanisms of dispersal may become modified in populations living in human-dominated habitats. Here, we investigated dispersal in Guinea baboons (Papio papio) in areas with contrasting levels of anthropogenic fragmentation, as a case study. Using molecular data, we compared the direction and extent of sex-biased gene flow in two baboon populations: from Guinea-Bissau (GB, fragmented distribution, human-dominated habitat) and Senegal (SEN, continuous distribution, protected area). Individual-based Bayesian clustering, spatial autocorrelation, assignment tests and migrant identification suggested female-mediated gene flow at a large spatial scale for GB with evidence of contact between genetically differentiated males at one locality, which could be interpreted as male-mediated gene flow in southern GB. Gene flow was also found to be female-biased in SEN for a smaller scale. However, in the southwest coastal part of GB, at the same geographic scale as SEN, no sex-biased dispersal was detected and a modest or recent restriction in GB female dispersal seems to have occurred. This population-specific variation in dispersal is attributed to behavioural responses to human activity in GB. Our study highlights the importance of considering the genetic consequences of disrupted dispersal patterns as an additional impact of anthropogenic habitat fragmentation and is potentially relevant to the conservation of many species inhabiting human-dominated environments.	[Ferreira da Silva, Maria Joana; Bruford, Michael W.] Cardiff Univ, Sch Biosci, Organisms & Environm Div, Cardiff, S Glam, Wales; [Ferreira da Silva, Maria Joana; Godinho, Raquel] Univ Porto, CIBIO InBio, Ctr Invest Biodiversidade & Recursos Genet, Campus Agratio Vairao, Vairao, Portugal; [Ferreira da Silva, Maria Joana; Casanova, Catarina] Univ Lisbon, Sch Social & Polit Sci, CAPP, Rua Almerindo, Lisbon, Portugal; [Kopp, Gisela H.; Zinner, Dietmar] German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany; [Godinho, Raquel] Univ Porto, Fac Ciencias, Dept Biol, Rua Campo Alegre, Porto, Portugal; [Godinho, Raquel] Univ Johannesburg, Dept Zool, Fac Sci, Auckland Pk, South Africa; [Minhos, Tania] Univ Nova Lisboa, Fac Ciencias Sociais & Humanas, Dept Antropol, Lisbon, Portugal; [Minhos, Tania] Inst Univ Lisboa, Ctr Res Anthropol CRIA, Lisbon, Portugal; [Minhos, Tania] IGC, Rua Quinta Grande, Oeiras, Portugal; [Sa, Rui] Univ Lusofona Guine, Dept Ciencias Ambientais, Rua Vitorino Costa, Bissau, Guinea Bissau; [Sa, Rui] Univ Coimbra, Res Ctr Anthropol & Hlth, Coimbra, Portugal; [Bruford, Michael W.] Cardiff Univ, Sustainable Places Res Inst, Cardiff, S Glam, Wales; [Kopp, Gisela H.] Univ Konstanz, Zukunftskolleg, Constance, Germany; [Kopp, Gisela H.] Univ Konstanz, Dept Biol, Constance, Germany; [Kopp, Gisela H.] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany	Cardiff University; Universidade do Porto; Universidade de Lisboa; Deutsches Primatenzentrum (DPZ); Universidade do Porto; University of Johannesburg; Universidade Nova de Lisboa; Instituto Universitario de Lisboa; Universidade de Coimbra; Cardiff University; University of Konstanz; University of Konstanz; Max Planck Society	da Silva, MJF (corresponding author), Cardiff Univ, Sch Biosci, Organisms & Environm Div, Cardiff, S Glam, Wales.; da Silva, MJF (corresponding author), Univ Porto, CIBIO InBio, Ctr Invest Biodiversidade & Recursos Genet, Campus Agratio Vairao, Vairao, Portugal.; da Silva, MJF (corresponding author), Univ Lisbon, Sch Social & Polit Sci, CAPP, Rua Almerindo, Lisbon, Portugal.	ferreiradasilvamj@cf.ac.uk	Bruford, Michael W/D-3750-2009; Sá, Rui M./AAG-4028-2019; Da Silva, Maria Ferreira/C-5373-2012; Kopp, Gisela/AAB-3943-2020; Godinho, Raquel/L-6804-2013	Bruford, Michael W/0000-0001-6357-6080; Sá, Rui M./0000-0001-6407-4541; Da Silva, Maria Ferreira/0000-0001-6747-9827; Kopp, Gisela/0000-0001-8396-3264; Godinho, Raquel/0000-0002-4260-4799; Zinner, Dietmar/0000-0003-3967-8014; Casanova, Catarina/0000-0003-2123-0262	Portuguese Science and Technology Foundation (FCT) by the Ministerio da Educacao e Ciencia [SFRH/BPD/88496/2012, SFRH/BPD/87396/2012]; European Social Funds through POPH - QREN - Tipologia 4.1 Formacao Avancada; FCT IF [IF/00564/2012]; FCT [IF/00564/2012/CP0159/CT0003]; German Science Foundation [DFG Fi 707/9-1]; German Academic Exchange Service (DAAD); Christian-Vogel-Fonds; German Initiative of Excellence	Portuguese Science and Technology Foundation (FCT) by the Ministerio da Educacao e Ciencia; European Social Funds through POPH - QREN - Tipologia 4.1 Formacao Avancada; FCT IF(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); German Science Foundation(German Research Foundation (DFG)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Christian-Vogel-Fonds; German Initiative of Excellence	MJFS and TM were supported through Portuguese Science and Technology Foundation (FCT) postdoctoral fellowships (SFRH/BPD/88496/2012 to MJFS and SFRH/BPD/87396/2012 to TM) funded by the Ministerio da Educacao e Ciencia and European Social Funds through POPH - QREN - Tipologia 4.1 Formacao Avancada), http://www.fct.pt/. RG was supported by FCT IF's contract (IF/00564/2012). This work was partially funded by FCT (project IF/00564/2012/CP0159/CT0003). GHK was funded by the German Science Foundation (DFG Fi 707/9-1), http://www.dfg.de/en/, the German Academic Exchange Service (DAAD) https://www.daad.de/en/, the Christian-Vogel-Fonds - http://www.gf-primatologie.de and the German Initiative of Excellence, http://www.dfg.de/en/research_funding/programmes/excellence_initiative/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SC, 2001, AM J PRIMATOL, V53, P139, DOI 10.1002/ajp.1; Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; Amador R, 2014, J PRIMATOLOGY, V3; Andreasen AM, 2012, MOL ECOL, V21, P5689, DOI 10.1111/j.1365-294X.2012.05740.x; Banks SC, 2012, MOL ECOL, V21, P2092, DOI 10.1111/j.1365-294X.2012.05485.x; Bayes M. K., 2000, Conservation Genetics, V1, P173, DOI 10.1023/A:1026595324974; Beaumont M, 2001, MOL ECOL, V10, P319, DOI 10.1046/j.1365-294x.2001.01196.x; Beck NR, 2008, MOL ECOL, V17, P4346, DOI 10.1111/j.1365-294X.2008.03906.x; Bergl RA, 2007, MOL ECOL, V16, P501, DOI 10.1111/j.1365-294X.2006.03159.x; Borges F., 2017, COUNTRY LEVEL GENETI; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Bronikowski AM, 2002, P NATL ACAD SCI USA, V99, P9591, DOI 10.1073/pnas.142675599; Broquet T, 2004, MOL ECOL, V13, P3601, DOI 10.1111/j.1365-294X.2004.02352.x; Ca A., 2008, ESTUDOS CACA MERCADO; Casanova C, PLANO ACCAO NACL CON; Chaine AS, 2012, BEHAVIOURAL RESPONSES TO A CHANGING WORLD: MECHANISMS AND CONSEQUENCES, P63; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Clutton-Brock TH, 2012, MOL ECOL, V21, P472, DOI 10.1111/j.1365-294X.2011.05232.x; Cobben MMP, 2015, J THEOR BIOL, V373, P92, DOI 10.1016/j.jtbi.2015.03.019; Cowlishaw C, 2000, PRIMATE CONSERVATION; Di Fiore A, 2009, BEHAVIOUR, V146, P437, DOI 10.1163/156853909X426345; DiBattista JD, 2008, CONSERV GENET, V9, P141, DOI 10.1007/s10592-007-9317-z; Driscoll DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095053; Earl DA, 2012, CONSERVATION GENETIC; ELLSWORTH DL, 1994, EVOLUTION, V48, P122, DOI 10.1111/j.1558-5646.1994.tb01299.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Favre L, 1997, P ROY SOC B-BIOL SCI, V264, P127, DOI 10.1098/rspb.1997.0019; Ferreira da Silva M, 2012, HUNTING PRESSURE POP; Ferreira da Silva M, 2013, J THREATENED TAXA, V5, P441; da Silva MJF, 2014, CONSERV GENET, V15, P1339, DOI 10.1007/s10592-014-0621-0; Ferreira da Silva MJ, 2017, INT ENCY PRIMATOLOGY; Fontanillas P, 2004, EVOLUTION, V58, P886; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Galat Gerard, 2000, African Primates, V4, P69; Galat-Luong A, 2006, REPROD FITNESS BABOO; Gobush KS, 2008, CONSERV BIOL, V22, P1590, DOI 10.1111/j.1523-1739.2008.01035.x; Goossens B, 2006, PLOS BIOL, V4, P285, DOI 10.1371/journal.pbio.0040025; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Hapke A, 2001, BEHAV ECOL SOCIOBIOL, V50, P483, DOI 10.1007/s002650100393; Hsu MJ, 2001, ZOOL STUD, V40, P49; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Isbell LA, 1996, BEHAVIOUR, V133, P1, DOI 10.1163/156853996X00017; Jedrzejewski W, 2005, ACTA THERIOL, V50, P3, DOI 10.1007/BF03192614; Ji W, 2001, MOL ECOL, V10, P1527, DOI 10.1046/j.1365-294X.2001.01287.x; Jolly CJ, 2009, CURR ANTHROPOL, V50, P187, DOI 10.1086/597196; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Kopp GH, 2014, INT J PRIMATOL, V35, P210, DOI 10.1007/s10764-013-9725-5; Kopp GH, 2015, GENE FLOW DYNAMICS B; Kopp GH, 2015, AM J PRIMATOL, V77, P878, DOI 10.1002/ajp.22415; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; Minhos T, 2013, BIOL CONSERV, V167, P43, DOI 10.1016/j.biocon.2013.07.018; Minhos T, 2013, AM J PHYS ANTHROPOL, V150, P464, DOI 10.1002/ajpa.22223; Nyakaana S, 2001, ANIM CONSERV, V4, P231, DOI 10.1017/S1367943001001275; Oates J, PAPIO PAPIO; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Patzelt A, 2014, P NATL ACAD SCI USA, V111, P14740, DOI 10.1073/pnas.1405811111; Patzelt A, 2011, INT J PRIMATOL, V32, P652, DOI 10.1007/s10764-011-9493-z; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perez-Espona S, 2010, MOL ECOL, V19, P3101, DOI 10.1111/j.1365-294X.2010.04733.x; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Phillips BL, 2010, ECOLOGY, V91, P1617, DOI 10.1890/09-0910.1; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Radespiel U, 2014, CONSERV GENET, V15, P245, DOI 10.1007/s10592-013-0550-3; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Renaud P, 2006, INVENTAIRE AERIEN TE; Roeder AD, 2009, FOLIA PRIMATOL, V80, P63, DOI 10.1159/000211121; Schubert S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012929; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Smouse PE, 2008, MOL ECOL, V17, P3389, DOI 10.1111/j.1365-294X.2008.03839.x; StGeorge D, 1996, INT J PRIMATOL, V19, P273; Strier K.B., 2007, PRIMATE BEHAV ECOLOG, V3rd ed.; Sugiyama Y, 1999, PRIMATES, V40, P61, DOI 10.1007/BF02557702; Teixeira, 2016, LANDSCAPE GENETICS G; Temudo Marina Padrão, 2009, Etnográfica, V13, P237; Tung J, 2008, MOL ECOL, P17; Vale CG, 2015, J NAT CONSERV, V27, P26, DOI 10.1016/j.jnc.2015.06.004; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wooley-Barker T., 1999, SOCIAL ORG GENETIC S	84	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0194189	10.1371/journal.pone.0194189	http://dx.doi.org/10.1371/journal.pone.0194189			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614097	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000429081600009
J	Iheonu, FO; Fajolu, IB; Ezeaka, CV; Oyibo, WA				Iheonu, Franca Ogechi; Fajolu, Iretiola Bamikeolu; Ezeaka, Chinyere Veronica; Oyibo, Wellington Aghoghovwia			Transfusional malaria in the neonatal period in Lagos, South-West Nigeria	PLOS ONE			English	Article							TRANSMITTED MALARIA; BLOOD-TRANSFUSION	Background and objectives Sick neonates in malaria endemic areas are frequently transfused with donor blood unscreened for malaria parasite. Consequently, they are at risk of transfusional malaria which can lead to increased neonatal mortality. The study aimed to determine the burden of transfusional malaria in neonates to help in policy formulation on prevention of transfusional malaria. Materials and methods One hundred and sixty four neonates admitted into the neonatal unit of a tertiary hospital over a 10 month period who were scheduled for blood transfusion were screened for malaria parasites pre-transfusion, at three and 14 days post transfusion using Giemsa stained thick and thin films. Donor blood was screened for malaria parasites at the point of transfusion. Neonates who developed malaria parasitaemia post transfusion were followed up for signs of malaria. Results All recruited neonates tested negative to malaria parasite pre-transfusion. One hundred and twenty (73.2%) were term neonates with 94(57.3%) aged 1-7days. Four (2.4%) neonates developed malaria parasitaemia three days post transfusion and all four developed fever that resolved on treatment for malaria. Three (1.8%) of 164 donor blood samples had malaria parasitaemia and all three (100%) neonates who were transfused with the infected donor blood developed malaria parasitaemia post transfusion. However, one neonate who developed malaria parasitaemia post transfusion was transfused with non-infected donor blood. Conclusions The prevalence of transfusional malaria in this study is low (2.4%). However, 100% of neonates who received malaria infected donor blood developed transfusional malaria. We therefore recommend routine screening of donor pre-transfusion, testing of neonates who develop fever post transfusion and treatment of those who test positive to malaria.	[Iheonu, Franca Ogechi; Fajolu, Iretiola Bamikeolu; Ezeaka, Chinyere Veronica] Lagos Univ Teaching Hosp, Dept Paediat, Lagos, Nigeria; [Fajolu, Iretiola Bamikeolu; Ezeaka, Chinyere Veronica] Univ Lagos, Dept Paediat, Coll Med, Lagos, Nigeria; [Oyibo, Wellington Aghoghovwia] Univ Lagos, Dept Med Microbiol & Parasitol, Coll Med, Lagos, Nigeria	University of Lagos; University of Lagos	Iheonu, FO (corresponding author), Lagos Univ Teaching Hosp, Dept Paediat, Lagos, Nigeria.	francaiheonu@yahoo.com	Fajolu, Iretiola Bamikeolu/P-5759-2019	Fajolu, Iretiola Bamikeolu/0000-0003-3045-9616; Ezeaka, Veronica Chinyere/0000-0003-1880-4616; Oyibo, Wellington/0000-0002-5730-5396				Agboola T. F., 2010, Annals of Biological Research, V1, P72; AKINBOYE DO, 1987, T ROY SOC TROP MED H, V81, P398, DOI 10.1016/0035-9203(87)90147-7; Ali M. S. M., 2004, Ethiopian Journal of Health Development, V18, P70; Allain JP, 2016, LANCET, V387, P1753, DOI 10.1016/S0140-6736(16)00581-X; Alli J. A., 2010, Research Journal of Medical Sciences, V4, P255, DOI 10.3923/rjmsci.2010.255.275; [Anonymous], S LEONE J BIOMED RES; Ayede A I, 2011, Ann Ib Postgrad Med, V9, P30; Baye Gelaw, 2008, Ethiopian Journal of Health Development, V22, P3; Chattopadhyay R, 2011, TRANSFUSION, V51, P630, DOI 10.1111/j.1537-2995.2010.02872.x; Ghimire P, 2007, SCI WORLD, V5, P81, DOI [10.3126/sw.v5i5.2661, DOI 10.3126/SW.V5I5.2661]; Ibhanesebhor S. E., 1996, Postgraduate Doctor - Africa, V18, P38; Ibhanesebhor SE, 1995, J TROP PEDIATRICS, V41, P330, DOI 10.1093/tropej/41.6.330; Mukhtar M, 2007, Niger J Med, V16, P25; Nansseu JRN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-465; Ogunlesi TA, 2011, NIGER J CLIN PRACT, V14, P354, DOI 10.4103/1119-3077.86783; Ogunlesi T, 2016, J TROP PEDIATRICS, V62, P107, DOI 10.1093/tropej/fmv083; Okechukwu AA, 2011, J MED MED SCI, V2, P722; Okorafor UP, 2015, ARJ, V1, P354; Owusu-Ofori AK, 2013, CLIN INFECT DIS, V56, P1735, DOI 10.1093/cid/cit130; Owusu-Ofori AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034201; Owusu-Ofori AK, 2010, CLIN INFECT DIS, V51, P1192, DOI 10.1086/656806; WHO, MICR DET ID QUANT MA, P1; World Health Organization, WORLD MAL REP 2015; Zama I, 2013, INTERNAL MED INSIDE, V1	24	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195319	10.1371/journal.pone.0195319	http://dx.doi.org/10.1371/journal.pone.0195319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614095	Green Submitted, Green Published, gold			2022-12-26	WOS:000429081600045
J	Takagi, Y; Nakamura, H; Sumi, M; Shimizu, T; Hirai, Y; Horai, Y; Takatani, A; Kawakami, A; Eida, S; Sasaki, M; Nakamura, T				Takagi, Yukinori; Nakamura, Hideki; Sumi, Misa; Shimizu, Toshimasa; Hirai, Yasuko; Horai, Yoshiro; Takatani, Ayuko; Kawakami, Atsushi; Eida, Sato; Sasaki, Miho; Nakamura, Takashi			Combined classification system based on ACR/EULAR and ultrasonographic scores for improving the diagnosis of Sjogren's syndrome	PLOS ONE			English	Article							SALIVARY-GLAND ULTRASONOGRAPHY; AMERICAN-COLLEGE; DATA-DRIVEN; CRITERIA; CONSENSUS; SIALOGRAPHY; FEATURES; TOOL	We retrospectively evaluated the effectiveness of combined use of salivary gland ultrasonography (US) and the 2016 American College of Rheumatology/European League Against Rheumatic Disease (ACR/EULAR) classification criteria for improving the diagnostic efficiency in patients with Sjogren's syndrome (SS). A US-based salivary gland disease grading system was developed using a cohort comprising 213 SS or non-SS patients who fulfilled the minimum requirements for classifying SS based on the American-European Consensus Group (AECG) and ACR criteria. Using 62 SS or non-SS patients from the 213 patients and who had also undergone all the 5 examinations needed for the ACR/EULAR classification, we compared the diagnostic accuracy of various combinations of the ACR/EULAR and US classifications for diagnosing SS, using the clinical diagnosis of SS by rheumatologists as the gold standard. The ACR/EULAR criteria discriminated clinical SS patients with 77% and 79% accuracy for those with primary or secondary SS and for those with primary SS, respectively. However, the integrated score system of the ACR/EULAR and US classifications yielded 92% and 93% accuracy for these 2 SS patient groups, respectively, provided that US score of 3 was assigned to patients with US grade >= 2, and then patients with integrated threshold score of >= 5 were diagnosed as SS. Cross-validation also indicated improved accuracy of the integrated ACR/EULAR and US score system (91.9 and 93.0% for primary/secondary and primary SS patients, respectively) over that by the ACR/EULAR criteria alone. (74.2 and 86.0%, respectively). The integrated ACR/EULAR and US scoring system can improve the diagnosis of patients with clinical SS.	[Takagi, Yukinori; Sumi, Misa; Eida, Sato; Sasaki, Miho; Nakamura, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiol & Canc Biol, Nagasaki, Japan; [Nakamura, Hideki; Shimizu, Toshimasa; Hirai, Yasuko; Horai, Yoshiro; Takatani, Ayuko; Kawakami, Atsushi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Immunol & Rheumatol, Nagasaki, Japan; [Horai, Yoshiro] NHO, Nagasaki Med Ctr, Clin Res Ctr, Nagasaki, Japan	Nagasaki University; Nagasaki University	Nakamura, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiol & Canc Biol, Nagasaki, Japan.	taku@nagasaki-u.ac.jp			Grants-in-Aid for Scientific Research [15K11078, 17K11674] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Ariji Y, 1996, AM J ROENTGENOL, V166, P935, DOI 10.2214/ajr.166.4.8610577; Bryan RN, 2016, RADIOLOGY, V281, P665, DOI 10.1148/radiol.2016162151; Cornec D, 2014, RHEUMATOLOGY, V53, P1604, DOI 10.1093/rheumatology/keu037; Cornec D, 2013, ARTHRITIS RHEUM-US, V65, P216, DOI [10.1002/art.37698, 10.1002/art.37944]; D'Agostino MA, 2016, ANN RHEUM DIS, V75, P1902, DOI 10.1136/annrheumdis-2016-209646; Fidelix T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182287; Hocevar A, 2005, RHEUMATOLOGY, V44, P768, DOI 10.1093/rheumatology/keh588; Hofauer B, 2016, CLIN RHEUMATOL, V35, P2597, DOI 10.1007/s10067-016-3395-6; Jousse-Joulin S, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2016-000364; Jousse-Joulin S, 2015, ARTHRITIS RHEUMATOL, V67, P1623, DOI 10.1002/art.39088; Kami YN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150680; Knopf A, 2015, EUR RADIOL, V25, P3027, DOI 10.1007/s00330-015-3705-4; Kwak JY, 2011, RADIOLOGY, V260, P892, DOI 10.1148/radiol.11110206; Milic VD, 2010, SCAND J RHEUMATOL, V39, P160, DOI 10.3109/03009740903270623; Mossel E, 2017, ANN RHEUM DIS, V76, P1883, DOI 10.1136/annrheumdis-2017-211250; Ramos-Casals M, 2010, JAMA-J AM MED ASSOC, V304, P452, DOI 10.1001/jama.2010.1014; Salaffi F, 2008, RHEUMATOLOGY, V47, P1244, DOI 10.1093/rheumatology/ken222; Shiboski CH, 2017, ANN RHEUM DIS, V76, P9, DOI [10.1136/annrheumdis-2016-210571, 10.1002/art.39859]; Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591; Takagi Y, 2016, RHEUMATOLOGY, V55, P237, DOI 10.1093/rheumatology/kev278; Takagi Y, 2010, ANN RHEUM DIS, V69, P1321, DOI 10.1136/ard.2009.123836; Theander E, 2014, ARTHRIT CARE RES, V66, P1102, DOI 10.1002/acr.22264; Tsuboi H, 2017, ANN RHEUM DIS; Tzioufas AG, 2008, NAT CLIN PRACT RHEUM, V4, P454, DOI 10.1038/ncprheum0864; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Vitali C, 2013, ARTHRITIS RHEUM-US, V65, P1950, DOI 10.1002/art.37945; Yonetsu K, 2002, ANN RHEUM DIS, V61, P276, DOI 10.1136/ard.61.3.276	27	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195113	10.1371/journal.pone.0195113	http://dx.doi.org/10.1371/journal.pone.0195113			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614092	Green Published, gold, Green Submitted			2022-12-26	WOS:000429081600032
J	Chen, EM; Liu, GY; Zhou, XP; Zhang, W; Wang, C; Hu, DC; Xue, DT; Pan, ZJ				Chen, Erman; Liu, Guanyi; Zhou, Xiaopeng; Zhang, Wei; Wang, Cong; Hu, Dongcai; Xue, Deting; Pan, Zhijun			Concentration-dependent, dual roles of IL-10 in the osteogenesis of human BMSCs via P38/MAPK and NF-B signaling pathways	FASEB JOURNAL			English	Article						interleukin; osteogenic differentiation; stem cells	MESENCHYMAL STEM-CELLS; ALVEOLAR BONE LOSS; FRACTURE HEMATOMA; STROMAL CELLS; IMMUNE CELLS; TNF-ALPHA; INTERLEUKIN-10; MICROENVIRONMENT; DIFFERENTIATION; OSTEOBLAST	Microenvironmental conditions can influence the differentiation and functional roles of mesenchymal stem cells (MSCs). Recent studies have suggested that an inflammatory microenvironment can significantly affect the osteogenic differentiation of MSCs. Here, we show, for the first time, that IL-10 has concentration-dependent, dual roles in the osteogenesis of human bone marrow mesenchymal stem cells (hBMSCs). Low physiologic concentrations of IL-10 (0.01-1.0 ng/ml) activate the p38/MAPK signaling pathway to promote the osteogenesis of hBMSCs, but higher pathologic doses of IL-10 (10-100 ng/ml) inhibit p38/MAPK signaling by activating NF-B, inhibiting osteogenesis. These results demonstrate that p38/MAPK and NF-B signaling mediates the double-edged sword effect of IL-10 on hBMSCs. The osteogenic impairment was reversed at higher doses of IL-10 when cells were supplemented with the NF-B inhibitor BAY11-7082. These data provide important insights into the regulatory effects of IL-10 on the biologic behavior of hBMSCs.Chen, E., Liu, G., Zhou, X., Zhang, W., Wang, C., Hu, D., Xue, D., Pan, Z. Concentration-dependent, dual roles of IL-10 in the osteogenesis of human BMSCs via P38/MAPK and NF-B signaling pathways.	[Chen, Erman; Liu, Guanyi; Zhou, Xiaopeng; Zhang, Wei; Wang, Cong; Hu, Dongcai; Xue, Deting; Pan, Zhijun] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthoped, Hangzhou, Zhejiang, Peoples R China; [Chen, Erman; Liu, Guanyi; Zhou, Xiaopeng; Zhang, Wei; Xue, Deting; Pan, Zhijun] Zhejiang Univ, Orthoped Res Inst, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Xue, DT; Pan, ZJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	blueskine@zju.edu.cn; zrpzj@zju.edu.cn		Xue, deting/0000-0001-6388-2862	National Natural Science Foundation of China [81672147, 81201397]; Zhejiang Provincial Natural Science Foundation of China [LQ17H060002, LY15H060001, LY15H060002, LY16H060003]; Education Department of Zhejiang Province [Y201328201]; Public welfare projects of Zhejiang Science and Technology Department [2012C23079]; Zhejiang medical and health science and technology plan project [2015KYB182, 2017KY382, 2014KYA092]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Education Department of Zhejiang Province; Public welfare projects of Zhejiang Science and Technology Department; Zhejiang medical and health science and technology plan project	This work was supported by grants from the National Natural Science Foundation of China (Grants 81672147 and 81201397), Zhejiang Provincial Natural Science Foundation of China (Grants LQ17H060002, LY15H060001, LY15H060002, and LY16H060003), the Education Department of Zhejiang Province (Grant Y201328201), Public welfare projects of Zhejiang Science and Technology Department (Grant 2012C23079), and Zhejiang medical and health science and technology plan project (Grants 2015KYB182, 2017KY382, and 2014KYA092). The authors declare no conflicts of interest.	Abu-Amer Y, 2013, OSTEOPOROSIS INT, V24, P2377, DOI 10.1007/s00198-013-2313-x; Al-Rasheed A, 2003, J DENT RES, V82, P632, DOI 10.1177/154405910308200812; Bai WJ, 2014, CELL SIGNAL, V26, P942, DOI 10.1016/j.cellsig.2014.01.015; Barrachina L, 2017, STEM CELLS DEV, V26, P15, DOI 10.1089/scd.2016.0209; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Camorani S, 2017, THERANOSTICS, V7, P3595, DOI 10.7150/thno.18974; Campana L, 2018, J IMMUNOL, V200, P1169, DOI 10.4049/jimmunol.1701247; Chen EEM, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.429; Claudino M, 2010, EUR J ORAL SCI, V118, P19, DOI 10.1111/j.1600-0722.2009.00706.x; Crane JL, 2014, J CLIN INVEST, V124, P466, DOI 10.1172/JCI70050; Deng MY, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0693-0; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dresner-Pollak R, 2004, GASTROENTEROLOGY, V127, P792, DOI 10.1053/j.gastro.2004.06.013; El-Jawhari JJ, 2016, INJURY, V47, P2399, DOI 10.1016/j.injury.2016.10.008; Feng L, 2016, EXP THER MED, V12, P3941, DOI 10.3892/etm.2016.3857; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Fu WY, 2017, FASEB J, V31, P1354, DOI 10.1096/fj.201601134R; Giannoudis PV, 2008, INJURY, V39, pS5, DOI 10.1016/S0020-1383(08)70010-X; Giannoudis PV, 2011, INJURY, V42, P549, DOI 10.1016/j.injury.2011.03.037; Greenblatt MB, 2013, ANNU REV CELL DEV BI, V29, P63, DOI 10.1146/annurev-cellbio-101512-122347; Haller JM, 2015, J BONE JOINT SURG AM, V97A, P478, DOI 10.2106/JBJS.N.00200; Harwood PJ, 2005, J TRAUMA, V58, P446, DOI 10.1097/01.TA.0000153942.28015.77; Hauser CJ, 1997, J TRAUMA, V42, P895, DOI 10.1097/00005373-199705000-00021; Hauser CJ, 1996, SHOCK, V6, P3, DOI 10.1097/00024382-199607000-00002; Hoff P, 2013, CELL MOL IMMUNOL, V10, P151, DOI 10.1038/cmi.2012.56; Holgersen K, 2015, INFLAMM BOWEL DIS, V21, P257, DOI 10.1097/MIB.0000000000000269; Horst K, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/126060; Huh JE, 2013, BBA-MOL CELL RES, V1833, P2608, DOI 10.1016/j.bbamcr.2013.06.025; Jung YK, 2013, ARTHRITIS RHEUM-US, V65, P3153, DOI 10.1002/art.38181; Katagiri W, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12333; Kolar P, 2011, CLIN ORTHOP RELAT R, V469, P3118, DOI 10.1007/s11999-011-1865-3; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kong XW, 2013, BBA-GEN SUBJECTS, V1830, P5119, DOI 10.1016/j.bbagen.2013.07.027; Kovach TK, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/752510; Lastrucci C, 2015, CELL RES, V25, P1333, DOI 10.1038/cr.2015.123; Mao CY, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.204; Marinou I, 2007, ARTHRITIS RHEUM, V56, P2549, DOI 10.1002/art.22814; MIZUNO K, 1990, J BONE JOINT SURG BR, V72, P822, DOI 10.1302/0301-620X.72B5.2211764; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; Park SH, 2002, J ORTHOP RES, V20, P1197, DOI 10.1016/S0736-0266(02)00072-4; Rodriguez-Carballo E, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00040; Sharma N, 2017, CYTOKINE, V90, P169, DOI 10.1016/j.cyto.2016.11.010; Sidney LE, 2014, STEM CELLS DEV, V23, P605, DOI 10.1089/scd.2013.0336; Singh R, 2016, INJURY, V47, pS33, DOI 10.1016/S0020-1383(16)30837-3; Sullivan CB, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt492; Tabrez S, 2017, IUBMB LIFE, V69, P522, DOI 10.1002/iub.1637; van de Vyver M, 2016, SCAND J MED SCI SPOR, V26, P638, DOI 10.1111/sms.12497; VANVLASSELAER P, 1994, J CELL BIOL, V124, P569, DOI 10.1083/jcb.124.4.569; VANVLASSELAER P, 1993, BLOOD, V82, P2361; VANVLASSELAER P, 1995, CLIN ORTHOP RELAT R, P103; Walters G, 2018, J TISSUE ENG REGEN M, V12, pE1662, DOI 10.1002/term.2593; Wang BS, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0744-6; Xie GQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074126; Xue DT, 2017, ONCOTARGET, V8, P42098, DOI 10.18632/oncotarget.16887; Yamada PM, 2007, J APPL PHYSIOL, V103, P1196, DOI 10.1152/japplphysiol.00242.2007; Zhang X, 2016, SCI REP-UK, V6, DOI 10.1038/srep29359; Zheng YJ, 2013, CELL MOL IMMUNOL, V10, P330, DOI 10.1038/cmi.2013.3; Zong C, 2010, EUR CELLS MATER, V20, P109	59	35	37	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4917	4929		10.1096/fj.201701256RRR	http://dx.doi.org/10.1096/fj.201701256RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29630408				2022-12-26	WOS:000443817700025
J	Hu, Y; Fang, KH; Shen, LP; Cao, SY; Yuan, F; Su, YW; Xu, M; Pan, YF; Chen, YY; Liu, Y				Hu, Yao; Fang, Kai-Heng; Shen, Lu-Ping; Cao, Shi-Ying; Yuan, Fang; Su, Yuwen; Xu, Min; Pan, Yufeng; Chen, Yaoyu; Liu, Yan			The telomerase inhibitor AZT enhances differentiation and prevents overgrowth of human pluripotent stem cell-derived neural progenitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell differentiation; cell therapy; induced pluripotent stem cell (iPS cell) (iPSC); telomerase; transplantation	GAMMA-SECRETASE INHIBITORS; NEURONS IN-VITRO; ALZHEIMERS-DISEASE; INTERNEURONS; DEFICITS; SPECIFICATION; TISSUE; MICE	Human pluripotent stem cell (hPSC)-based cell-replacement therapy has emerged as a promising approach for addressing numerous neurological diseases. However, hPSC transplantation has the potential to cause human cell overgrowth and cancer, which represents a major obstacle to implementing hPSC-based therapies. Inhibition of the overgrowth of transplanted cells could help reduce the risk for hPSC transplantation-induced tumorigenesis. In this study, we report that the telomerase inhibitor azidothymidine (3-azido-3-deoxythymidine; AZT) enhances the differentiation of cortical neurons and significantly suppresses the proliferation of hPSC-derived cortical progenitors. Using human embryonic stem cells and induced pluripotent stem cells in culture, we found that AZT effectively reduces the number of dividing progenitors without inducing cell death. Furthermore, AZT promoted differentiation of cortical progenitors and maturation of cortical neurons. Of note, AZT-pretreated, hPSC-derived neural progenitors exhibited decreased proliferation and increased differentiation into cortical neurons when transplanted into the mouse brain. In summary, our findings indicate that AZT prevents the overgrowth of hPSC-derived neural precursors and enhances the differentiation of cortical neurons in both cell cultures and hPSC-transplanted mouse brain. We propose that our work could inform clinical applications of hPSC-based cell therapy.	[Hu, Yao; Liu, Yan] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 211166, Jiangsu, Peoples R China; [Hu, Yao; Fang, Kai-Heng; Shen, Lu-Ping; Cao, Shi-Ying; Yuan, Fang; Su, Yuwen; Xu, Min; Liu, Yan] Nanjing Med Univ, Sch Pharm, Inst Stem Cell & Neural Regenerat, Nanjing 211166, Jiangsu, Peoples R China; [Hu, Yao; Liu, Yan] Nanjing Med Univ, Collaborat Innovat Ctr Cardiovasc Dis Translat Me, Nanjing 211166, Jiangsu, Peoples R China; [Pan, Yufeng] Southeast Univ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Nanjing 210096, Jiangsu, Peoples R China; [Chen, Yaoyu] Jiangsu Prov Tradit Chinese Med Hosp, Div Hematol, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Southeast University - China	Liu, Y (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 211166, Jiangsu, Peoples R China.; Liu, Y (corresponding author), Nanjing Med Univ, Sch Pharm, Inst Stem Cell & Neural Regenerat, Nanjing 211166, Jiangsu, Peoples R China.; Liu, Y (corresponding author), Nanjing Med Univ, Collaborat Innovat Ctr Cardiovasc Dis Translat Me, Nanjing 211166, Jiangsu, Peoples R China.; Chen, YY (corresponding author), Jiangsu Prov Tradit Chinese Med Hosp, Div Hematol, Nanjing 210029, Jiangsu, Peoples R China.	yaoyu.chen@njmu.edu.cn; yanliu@njmu.edu.cn			National Natural Science Foundation of China [81471301, 81301162, 81570141, 81522001]; National Key Research and Development Program of China [2016YFC1306703]; Jiangsu Outstanding Young Investigator Program [BK20160044]; Jiangsu Province Natural Science Foundation [BK20130891]; Jiangsu Province's Innovation program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Jiangsu Outstanding Young Investigator Program; Jiangsu Province Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Jiangsu Province's Innovation program	This work was supported by National Natural Science Foundation of China Grants 81471301, 81301162, 81570141, and 81522001; National Key Research and Development Program of China Grant 2016YFC1306703; Jiangsu Outstanding Young Investigator Program Grant BK20160044; Jiangsu Province Natural Science Foundation Grant BK20130891; and the Jiangsu Province's Innovation program. The authors declare that they have no conflicts of interest with the contents of this article.	Aubry L, 2008, P NATL ACAD SCI USA, V105, P16707, DOI 10.1073/pnas.0808488105; Babizhayev MA, 2015, J BIOMED MATER RES A, V103, P3993, DOI 10.1002/jbm.a.35515; Bardy C, 2015, P NATL ACAD SCI USA, V112, pE2725, DOI 10.1073/pnas.1504393112; Cunningham M, 2014, CELL STEM CELL, V15, P559, DOI 10.1016/j.stem.2014.10.006; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Fao P, 2012, CLIN INFECT DIS, V55, P449, DOI 10.1093/cid/cis461; Fasano CA, 2010, CELL STEM CELL, V6, P336, DOI 10.1016/j.stem.2010.03.001; Fattahi F, 2016, NATURE, V531, P105, DOI 10.1038/nature16951; Fox IJ, 2014, SCIENCE, V345, P889, DOI 10.1126/science.1247391; Hu BY, 2009, DEVELOPMENT, V136, P1443, DOI 10.1242/dev.029447; Imbimbo BP, 2011, CURR TOP MED CHEM, V11, P1555; Krencik R, 2011, NAT BIOTECHNOL, V29, P528, DOI 10.1038/nbt.1877; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lambert JS, 2003, SEX TRANSM INFECT, V79, P448, DOI 10.1136/sti.79.6.448; Liu Y, 2013, NAT PROTOC, V8, P1670, DOI 10.1038/nprot.2013.106; Liu Y, 2013, NAT BIOTECHNOL, V31, P440, DOI 10.1038/nbt.2565; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Ogura A, 2013, STEM CELLS DEV, V22, P374, DOI 10.1089/scd.2012.0198; Okubo T, 2016, STEM CELL REP, V7, P649, DOI 10.1016/j.stemcr.2016.08.015; Olsauskas-Kuprys R, 2013, ONCOTARGETS THER, V6, P943, DOI 10.2147/OTT.S33766; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Tao YL, 2016, CELL STEM CELL, V19, P573, DOI 10.1016/j.stem.2016.10.015; Weick JP, 2013, P NATL ACAD SCI USA, V110, P9962, DOI 10.1073/pnas.1216575110; Weick JP, 2011, P NATL ACAD SCI USA, V108, P20189, DOI 10.1073/pnas.1108487108; Yuan F, 2015, SCI REP-UK, V5, DOI 10.1038/srep18550; Zhou QG, 2007, J NEUROCHEM, V103, P1843, DOI 10.1111/j.1471-4159.2007.04914.x; Zhou QG, 2011, J NEUROSCI, V31, P12258, DOI 10.1523/JNEUROSCI.0805-11.2011	29	2	2	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8722	8733		10.1074/jbc.M117.809889	http://dx.doi.org/10.1074/jbc.M117.809889			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29628445	hybrid, Green Published			2022-12-26	WOS:000434941900001
J	Roy, AR; Ahmed, A; DiStefano, PV; Chi, LJ; Khyzha, N; Galjart, N; Wilson, MD; Fish, JE; Delgado-Olguin, P				Roy, Anna R.; Ahmed, Abdalla; DiStefano, Peter V.; Chi, Lijun; Khyzha, Nadiya; Galjart, Niels; Wilson, Michael D.; Fish, Jason E.; Delgado-Olguin, Paul			The transcriptional regulator CCCTC-binding factor limits oxidative stress in endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						development; embryo; endothelial cell; frataxin; gene expression; gene regulation; placenta; reactive oxygen species (ROS); vascular; CTCF; vascular biology; oxidative stress; Friedreich's ataxia	HISTONE DEACETYLASE INHIBITORS; FRIEDREICH ATAXIA; VASCULAR DEVELOPMENT; FRATAXIN DEFICIENCY; MULTIPLE FUNCTIONS; CTCF; GENE; MOUSE; ANGIOGENESIS; EXPRESSION	The CCCTC-binding factor (CTCF) is a versatile transcriptional regulator required for embryogenesis, but its function in vascular development or in diseases with a vascular component is poorly understood. Here, we found that endothelial Ctcf is essential for mouse vascular development and limits accumulation of reactive oxygen species (ROS). Conditional knockout of Ctcf in endothelial progenitors and their descendants affected embryonic growth, and caused lethality at embryonic day 10.5 because of defective yolk sac and placental vascular development. Analysis of global gene expression revealed Frataxin (Fxn), the gene mutated in Friedreich's ataxia (FRDA), as the most strongly down-regulated gene in Ctcf-deficient placental endothelial cells. Moreover, in vitro reporter assays showed that Ctcf activates the Fxn promoter in endothelial cells. ROS are known to accumulate in the endothelium of FRDA patients. Importantly, Ctcf deficiency induced ROS-mediated DNA damage in endothelial cells in vitro, and in placental endothelium in vivo. Taken together, our findings indicate that Ctcf promotes vascular development and limits oxidative stress in endothelial cells. These results reveal a function for Ctcf in vascular development, and suggest a potential mechanism for endothelial dysfunction in FRDA.	[Roy, Anna R.; Ahmed, Abdalla; Chi, Lijun; Delgado-Olguin, Paul] Hosp Sick Children, Translat Med Res Program, Toronto, ON M5G 0A4, Canada; [Roy, Anna R.; Ahmed, Abdalla; Wilson, Michael D.; Delgado-Olguin, Paul] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [DiStefano, Peter V.; Khyzha, Nadiya; Fish, Jason E.] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON M5G 2C4, Canada; [Galjart, Niels] Erasmus MC, Dept Cell Biol & Genet, NL-3015 CN Rotterdam, Netherlands; [Wilson, Michael D.] Hosp Sick Children, Genet & Genome Biol Res Program, Toronto, ON M5G 0A4, Canada; [Fish, Jason E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Fish, Jason E.; Delgado-Olguin, Paul] Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON M5S 3H2, Canada; [Fish, Jason E.] Canadian Inst Hlth Res, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Erasmus University Rotterdam; Erasmus MC; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Institute for Work & Health	Delgado-Olguin, P (corresponding author), 686 Bay St, Toronto, ON M5G 0A4, Canada.	paul.delgadoolguin@sickkids.ca	Olguin, Paul Delgado/H-9293-2019; Galjart, Niels/D-1146-2010; Wilson, Michael/K-6294-2014	Olguin, Paul Delgado/0000-0002-5355-247X; Galjart, Niels/0000-0003-1964-3607; Fish, Jason/0000-0003-0640-7277; Wilson, Michael/0000-0002-4015-3066; Khyzha, Nadiya/0000-0001-8804-0039	Natural Sciences and Engineering Research Council of Canada (NSERC) [500865]; Heart and Stroke Foundation of Canada [G-17-0018613]; Canadian Institutes of Health Research (CIHR) [PJT-149046, MOP-119506]; Hospital for Sick Children	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Hospital for Sick Children	This work was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) Grant 500865 (to P.D.O). This work was also supported by the Heart and Stroke Foundation of Canada Grant G-17-0018613, the Canadian Institutes of Health Research (CIHR) Grant PJT-149046, and Operational Funds from the Hospital for Sick Children (to P.D.O.) and from the Canadian Institutes of Health Research (CIHR) Grant MOP-119506 (to J.E.F). The authors declare that they have no conflicts of interest with the contents of this article.	Abeti R, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.111; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson PR, 2008, P NATL ACAD SCI USA, V105, P611, DOI 10.1073/pnas.0709691105; Armstrong JS, 2002, CELL DEATH DIFFER, V9, P252, DOI 10.1038/sj.cdd.4400959; Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Battistelli C, 2014, J CELL SCI, V127, P3757, DOI 10.1242/jcs.149427; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Busslinger GA, 2017, NATURE, V544, P503, DOI 10.1038/nature22063; Chi LJ, 2018, METHODS MOL BIOL, V1752, P101, DOI 10.1007/978-1-4939-7714-7_10; Chi LJ, 2017, DEVELOPMENT, V144, P1976, DOI 10.1242/dev.148916; Chutake YK, 2014, J BIOL CHEM, V289, P15194, DOI 10.1074/jbc.M114.566414; Coant N, 2010, MOL CELL BIOL, V30, P2636, DOI 10.1128/MCB.01194-09; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Cross JC, 2005, PLACENTA, V26, pS3, DOI 10.1016/j.placenta.2005.01.015; Dalleau S, 2013, CELL DEATH DIFFER, V20, P1615, DOI 10.1038/cdd.2013.138; De Biase I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007914; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; Delgado-Olguin P, 2014, DEVELOPMENT, V141, P4610, DOI 10.1242/dev.112607; Delgado-Olguin P, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.164574; Demicheva E, 2014, FETAL DIAGN THER, V36, P143, DOI 10.1159/000353633; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fish JE, 2015, DEV DYNAM, V244, P391, DOI 10.1002/dvdy.24252; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Garcia MD, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00308; Gomez-Velazquez M, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006985; Gondor A, 2009, NATURE, V461, P212, DOI 10.1038/nature08453; Gottesfeld JM, 2013, J NEUROCHEM, V126, P147, DOI 10.1111/jnc.12302; Heath H, 2008, EMBO J, V27, P2839, DOI 10.1038/emboj.2008.214; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Herold M, 2012, DEVELOPMENT, V139, P1045, DOI 10.1242/dev.065268; Hirayama T, 2012, CELL REP, V2, P345, DOI 10.1016/j.celrep.2012.06.014; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Kim YW, 2014, BLOOD, V123, P625, DOI 10.1182/blood-2013-09-512749; Koutnikova H, 1997, NAT GENET, V16, P345, DOI 10.1038/ng0897-345; Lake RJ, 2016, NUCLEIC ACIDS RES, V44, P2125, DOI 10.1093/nar/gkv1219; Lee YK, 2016, INT J CARDIOL, V203, P964, DOI 10.1016/j.ijcard.2015.11.101; Lefevre S, 2012, BIOCHEM BIOPH RES CO, V418, P336, DOI 10.1016/j.bbrc.2012.01.022; Li T, 2004, J BIOL CHEM, V279, P27575, DOI 10.1074/jbc.M313942200; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu CY, 2007, ARCH BIOCHEM BIOPHYS, V457, P111, DOI 10.1016/j.abb.2006.09.010; Lu JR, 2012, TRANSCR-AUSTIN, V3, P73, DOI 10.4161/trns.19634; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Martelli A, 2007, HUM MOL GENET, V16, P2651, DOI 10.1093/hmg/ddm163; Moore JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034915; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nachbauer W, 2012, J NEUROPATH EXP NEUR, V71, P708, DOI 10.1097/NEN.0b013e31825fed76; Nakada Y, 2017, NATURE, V541, P222, DOI 10.1038/nature20173; Narendra V, 2016, GENE DEV, V30, P2657, DOI 10.1101/gad.288324.116; O'Neill HA, 2005, BIOCHEMISTRY-US, V44, P537, DOI 10.1021/bi048459j; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pandey A, 2013, J BIOL CHEM, V288, P36773, DOI 10.1074/jbc.M113.525857; Panth N., 2016, ADV MED, V2016, P9152732, DOI [10.1155/2016/9152732, DOI 10.1155/2016/9152732]; Park S, 2002, J BIOL CHEM, V277, P38589, DOI 10.1074/jbc.M206711200; Patel PI, 2001, AM J HUM GENET, V69, P15, DOI 10.1086/321283; Perdomini M, 2013, J NEUROCHEM, V126, P65, DOI 10.1111/jnc.12219; Peshavariya H, 2009, N-S ARCH PHARMACOL, V380, P193, DOI 10.1007/s00210-009-0413-0; Petry A, 2006, ANTIOXID REDOX SIGN, V8, P1473, DOI 10.1089/ars.2006.8.1473; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Proctor JM, 2005, J NEUROSCI, V25, P9940, DOI 10.1523/JNEUROSCI.3467-05.2005; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Raman SV, 2011, EUR HEART J, V32, P561, DOI 10.1093/eurheartj/ehq443; Roy AR, 2018, METHODS MOL BIOL, V1752, P11, DOI 10.1007/978-1-4939-7714-7_2; Sandi C, 2011, NEUROBIOL DIS, V42, P496, DOI 10.1016/j.nbd.2011.02.016; Santos R, 2010, ANTIOXID REDOX SIGN, V13, P651, DOI 10.1089/ars.2009.3015; Schoenfeld RA, 2005, HUM MOL GENET, V14, P3787, DOI 10.1093/hmg/ddi393; Schulz JB, 2000, NEUROLOGY, V55, P1719, DOI 10.1212/WNL.55.11.1719; Shaut CAE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000073; Siasos G., 2011, CIRCULATION S21, V124; Sohn SJ, 2002, J BIOL CHEM, V277, P43344, DOI 10.1074/jbc.M207573200; Soshnikova N, 2010, DEV CELL, V19, P819, DOI 10.1016/j.devcel.2010.11.009; Tang M, 2011, P NATL ACAD SCI USA, V108, P15231, DOI 10.1073/pnas.1104662108; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Valadez-Graham V, 2004, NUCLEIC ACIDS RES, V32, P1354, DOI 10.1093/nar/gkh301; Vuong S, 2018, METHODS MOL BIOL, V1752, P1, DOI 10.1007/978-1-4939-7714-7_1; Wan LB, 2008, DEVELOPMENT, V135, P2729, DOI 10.1242/dev.024539; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Yan HR, 2012, J INSECT PHYSIOL, V58, P782, DOI 10.1016/j.jinsphys.2012.02.003; Yandim C, 2013, J NEUROCHEM, V126, P21, DOI 10.1111/jnc.12254; Zhou YJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/374963; Ziebarth JD, 2013, NUCLEIC ACIDS RES, V41, pD188, DOI 10.1093/nar/gks1165; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	89	14	14	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8449	8461		10.1074/jbc.M117.814699	http://dx.doi.org/10.1074/jbc.M117.814699			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29610276	Green Published, hybrid			2022-12-26	WOS:000434205700010
J	Paolini, NA; Moore, KS; di Summa, FM; Fokkema, IFAC; 't Hoen, PAC; von Lindern, M				Paolini, Nahuel A.; Moore, Kat S.; di Summa, Franca M.; Fokkema, Ivo F. A. C.; 't Hoen, Peter A. C.; von Lindern, Marieke			Ribosome profiling uncovers selective mRNA translation associated with eIF2 phosphorylation in erythroid progenitors	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; REGULATED EIF2-ALPHA KINASE; GENE-EXPRESSION; IN-VIVO; STRESS; CELLS; REINITIATION; TRANSCRIPTS; MECHANISM; RECEPTOR	The regulation of translation initiation factor 2 (eIF2) is important for erythroid survival and differentiation. Lack of iron, a critical component of heme and hemoglobin, activates Heme Regulated Inhibitor (HRI). This results in phosphorylation of eIF2 and reduced eIF2 availability, which inhibits protein synthesis. Translation of specific transcripts such as Atf4, however, is enhanced. Upstream open reading frames (uORFs) are key to this regulation. The aim of this study is to investigate how tunicamycin treatment, that induces eIF2 phosphorylation, affects mRNA translation in erythroblasts. Ribosome profiling combined with RNA sequencing was used to determine translation initiation sites and ribosome density on individual transcripts. Treatment of erythroblasts with Tunicamycin (Tm) increased phosphorylation of eIF2 2-fold. At a false discovery rate of 1%, ribosome density was increased for 147 transcripts, among which transcriptional regulators such as Atf4, Tis7/Ifrd1, Pnrc2, Gtf2h, Mbd3, JunB and Kmt2e. Translation of 337 transcripts decreased more than average, among which Dym and Csde1. Ribosome profiling following Harringtonine treatment uncovered novel translation initiation sites and uORFs. Surprisingly, translated uORFs did not predict the sensitivity of transcripts to altered ribosome recruitment in presence or absence of Tm. The regulation of transcription and translation factors in reponse to eIF2 phosphorylation may explain the large overall response to iron deficiency in erythroblasts.	[Paolini, Nahuel A.; Moore, Kat S.; di Summa, Franca M.; von Lindern, Marieke] Sanquin Res, Dept Hematopoiesis, Amsterdam, Netherlands; [Paolini, Nahuel A.; Moore, Kat S.; di Summa, Franca M.; von Lindern, Marieke] Landsteiner Lab AMC UvA, Amsterdam, Netherlands; [Fokkema, Ivo F. A. C.; 't Hoen, Peter A. C.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; ['t Hoen, Peter A. C.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Ctr Mol & Biomol Informat, Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen	von Lindern, M (corresponding author), Sanquin Res, Dept Hematopoiesis, Amsterdam, Netherlands.; von Lindern, M (corresponding author), Landsteiner Lab AMC UvA, Amsterdam, Netherlands.	n.vonlindern@sanquin.nl	von Lindern, Marieke/AAH-2350-2020; Hoen, Peter A 't/D-3950-2018	Hoen, Peter A 't/0000-0003-4450-3112; Moore, Kat/0000-0002-5746-4098; von Lindern, Marieke/0000-0001-6162-6320	Landsteiner Foundation for Bloodtransfusion Research (LSBR) [1140, 1239]	Landsteiner Foundation for Bloodtransfusion Research (LSBR)	This work was funded by the Landsteiner Foundation for Bloodtransfusion Research (LSBR) www.lsbr.nl [projects 1140 and 1239 to MvL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreev DE, 2015, ELIFE, V4, DOI 10.7554/eLife.03971; Baird TD, 2014, MOL BIOL CELL, V25, P1686, DOI 10.1091/mbc.E14-02-0704; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bauer A, 1999, GENE DEV, V13, P2996, DOI 10.1101/gad.13.22.2996; Blazquez-Domingo M, 2005, MOL CELL BIOL, V25, P8496, DOI 10.1128/MCB.25.19.8496-8506.2005; Calkhoven CF, 2003, GENE DEV, V17, P959, DOI 10.1101/gad.251903; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Chen JJ, 2014, CURR OPIN HEMATOL, V21, P172, DOI 10.1097/MOH.0000000000000030; Cho H, 2015, P NATL ACAD SCI USA, V112, pE1540, DOI 10.1073/pnas.1409612112; Cho H, 2009, MOL CELL, V33, P75, DOI 10.1016/j.molcel.2008.11.022; Connor JH, 2001, MOL CELL BIOL, V21, P6841, DOI 10.1128/MCB.21.20.6841-6850.2001; de Klerk E, 2015, NUCLEIC ACIDS RES, V43, P4408, DOI 10.1093/nar/gkv281; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dragon S, 2002, AM J PHYSIOL-REG I, V282, pR1219, DOI 10.1152/ajpregu.00507.2001; Fritsch C, 2012, GENOME RES, V22, P2208, DOI 10.1101/gr.139568.112; Fujishima N, 2004, INT J HEMATOL, V80, P239, DOI 10.1532/IJH97.04053; Gerashchenko MV, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku671; Golovko A, 2016, CELL CYCLE, V15, P3115, DOI 10.1080/15384101.2016.1237324; Grech G, 2008, BLOOD, V112, P2750, DOI 10.1182/blood-2008-01-133140; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Harding HP, 2009, PNAS, V106, P1; HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Horos R, 2012, BLOOD, V119, P262, DOI 10.1182/blood-2011-06-358200; Horvathova M, 2012, HAEMATOL-HEMATOL J, V97, P1480, DOI 10.3324/haematol.2011.059550; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jacobs-Helber SM, 2002, J BIOL CHEM, V277, P4859, DOI 10.1074/jbc.M107243200; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Kuhn LC, 2015, METALLOMICS, V7, P232, DOI [10.1039/c4mt00164h, 10.1039/C4MT00164H]; Lareau LF, 2014, ELIFE, V3, DOI 10.7554/eLife.01257; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Malhotra JD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004424; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Masuoka HC, 2002, BLOOD, V99, P736, DOI 10.1182/blood.V99.3.736; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Michel AM, 2016, RNA BIOL, V13, P316, DOI 10.1080/15476286.2016.1141862; Michel AM, 2014, NUCLEIC ACIDS RES, V42, pD859, DOI 10.1093/nar/gkt1035; Nanda JS, 2013, J BIOL CHEM, V288, P5316, DOI 10.1074/jbc.M112.440693; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Patterson AD, 2006, MOL CELL BIOL, V26, P1644, DOI 10.1128/MCB.26.5.1644-1653.2006; Pereboom TC, 2014, EXP HEMATOL, V42, P394, DOI 10.1016/j.exphem.2013.12.010; PROSTKO CR, 1993, MOL CELL BIOCHEM, V128, P255, DOI 10.1007/BF01076776; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Reid DW, 2016, MOL CELL BIOL, V36, P1868, DOI 10.1128/MCB.00190-16; Reid DW, 2014, CELL, V158, P1362, DOI 10.1016/j.cell.2014.08.012; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sebastian S, 2009, P NATL ACAD SCI USA, V106, P4719, DOI 10.1073/pnas.0807136106; Sendoel A, 2017, NATURE, V541, P494, DOI 10.1038/nature21036; Simsek D, 2017, CELL, V169, P1051, DOI 10.1016/j.cell.2017.05.022; Stockel D, 2016, BIOINFORMATICS, V32, P1502, DOI 10.1093/bioinformatics/btv770; Suragani RNVS, 2012, BLOOD, V119, P5276, DOI 10.1182/blood-2011-10-388132; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; von Lindern M, 2001, ONCOGENE, V20, P3651, DOI 10.1038/sj.onc.1204494; Watson A, 2016, CELL SIGNAL, V28, P412, DOI 10.1016/j.cellsig.2016.01.014; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wildeman M, 2008, HUM MUTAT, V29, P6, DOI 10.1002/humu.20654; Zhang SP, 2018, BLOOD, V131, P450, DOI 10.1182/blood-2017-08-799908	61	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0193790	10.1371/journal.pone.0193790	http://dx.doi.org/10.1371/journal.pone.0193790			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634759	gold, Green Submitted, Green Published			2022-12-26	WOS:000429522200004
J	Yaguchi, C; Itoh, H; Tsuchiya, KJ; Furuta-Isomura, N; Horikoshi, Y; Matsumoto, M; Jeenat, FU; Keiko, MK; Kohmura-Kobatashi, Y; Tamura, N; Sugihara, K; Kanayama, N				Yaguchi, Chizuko; Itoh, Hiroaki; Tsuchiya, Kenji J.; Furuta-Isomura, Naomi; Horikoshi, Yoshimasa; Matsumoto, Masako; Jeenat, Ferdous U.; Keiko, Muramatsu-Kato; Kohmura-Kobatashi, Yukiko; Tamura, Naoaki; Sugihara, Kazuhiro; Kanayama, Naohiro			Placental pathology predicts infantile physical development during first 18 months in Japanese population: Hamamatsu birth cohort for mothers and children (HBC Study)	PLOS ONE			English	Article							HISTOLOGIC CHORIOAMNIONITIS; NONCOMMUNICABLE DISEASES; GESTATIONAL-AGE; HEALTH; TERM; PERSPECTIVE; PREGNANCIES; MEDICINE; FEATURES; LESIONS	The present study aimed to investigate the relationship between placental pathological findings and physiological development during the neonate and infantile periods. Study participants were 258 infants from singleton pregnancies enrolled in the Hamamatsu Birth Cohort for Mothers and Children (HBC Study) whose placentas were stored in our pathological division. They were followed up from birth to 18 months of age. Physiological development (body weight and the ponderal index [PI]) was assessed at 0, 1, 4, 6, 10, 14, and 18 months. Placental blocks were prepared by random sampling and eleven pathological findings were assessed, as follows: 'Accelerated villous maturation', Decidual vasculopathy', 'Thrombosis or Intramural fibrin deposition', Avascular villi', Delayed villous maturation', 'Maternal inflammatory response', 'Fetal inflammatory response', of unknown etiology (VUE)', Deciduitis', 'Maternal vascular malperfusion', and 'Fetal vascular malperfusion'. Mixed model analysis with the use of the xtmixedcommand by the generic statistical software, Stata version 13.1., identified 'Accelerated villous maturation' and 'Maternal vascular malperfusion' as significant predictors of a lower body weight and Deciduitis' as a significant predictor of a small PI, throughout the first 18 months of life. In conclusion, the present study is the first to demonstrate that some pathological findings of the placenta are associated with changes in infantile physical development during the initial 18 months of life in the Japanese population.	[Yaguchi, Chizuko; Itoh, Hiroaki; Furuta-Isomura, Naomi; Horikoshi, Yoshimasa; Matsumoto, Masako; Jeenat, Ferdous U.; Keiko, Muramatsu-Kato; Kohmura-Kobatashi, Yukiko; Tamura, Naoaki; Sugihara, Kazuhiro; Kanayama, Naohiro] Hamamatsu Univ Sch Med, Dept Obstet & Gynecol, Hamamatsu, Shizuoka, Japan; [Tsuchiya, Kenji J.] Hamamatsu Univ Sch Med, Res Ctr Child Mental Dev, Hamamatsu, Shizuoka, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Itoh, H (corresponding author), Hamamatsu Univ Sch Med, Dept Obstet & Gynecol, Hamamatsu, Shizuoka, Japan.	hitou-endo@umin.ac.jp	Tsuchiya, Kenji J./I-9123-2019	Tsuchiya, Kenji J./0000-0002-1314-4199; Yaguchi, Chizuko/0000-0002-7166-423X; Itoh, Hiroaki/0000-0001-8577-3878	Ministry of Education, Science, Culture and Sports, Japan [15H04882, 16K15703]; Grants-in-Aid for Scientific Research [15H04882] Funding Source: KAKEN	Ministry of Education, Science, Culture and Sports, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Culture and Sports, Japan (Nos. 15H04882 and 16K15703) to HI. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Culture and Sports, Japan (Nos. 15H04882 and 16K15703).	Agboola SO, 2013, QJM-INT J MED, V106, P791, DOI 10.1093/qjmed/hct088; Arizawa M., 2013, CLIN PLACENTOLOGY, V1; Baergen RN, 2011, MANUAL OF PATHOLOGY OF THE HUMAN PLACENTA, SECOND EDITION, P1, DOI 10.1007/978-1-4419-7494-5; Beebe LA, 1996, OBSTET GYNECOL, V87, P771, DOI 10.1016/0029-7844(95)00483-1; Benirschke K, 2012, PATHOLOGY HUMAN PLAC; Burton GJ, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.050; Catov JM, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.12.022; Chisholm KM, 2016, PEDIATR DEVEL PATHOL, V19, P37, DOI 10.2350/15-04-1621-OA.1; Conti N, 2015, EUR J OBSTET GYN R B, V188, P34, DOI 10.1016/j.ejogrb.2015.02.034; de Onis M, 2015, WORLD REV NUTR DIET, V113, P278, DOI 10.1159/000360352; DESA DJ, 1973, J PATHOL, V110, P347, DOI 10.1002/path.1711100409; Elimian A, 2000, OBSTET GYNECOL, V96, P333, DOI 10.1016/S0029-7844(00)00928-5; Fogarty NME, 2013, AM J PATHOL, V183, P144, DOI 10.1016/j.ajpath.2013.03.016; Gluckman P, 2006, DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, P1, DOI 10.2277/ 0521847435; Gomez-Lopez N, 2010, J LEUKOCYTE BIOL, V88, P625, DOI 10.1189/jlb.1209796; Gupta S, 2014, BBA-PROTEINS PROTEOM, V1844, P899, DOI 10.1016/j.bbapap.2013.12.020; Hanson MA, 2015, BEST PRACT RES CL OB, V29, P24, DOI 10.1016/j.bpobgyn.2014.06.007; Hanson MA, 2014, PHYSIOL REV, V94, P1027, DOI 10.1152/physrev.00029.2013; Imura H, 2013, P JPN ACAD B-PHYS, V89, P462, DOI 10.2183/pjab.89.462; Itoh H, 2017, DEV ORIGINS HLTH DIS; Itoh H, 2015, HYPERTENS RES PREGNA, V3, P1, DOI 10.14390/jsshp.3.1; Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339; Khalife N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040534; Khong TY, 2016, ARCH PATHOL LAB MED, V140, P698, DOI 10.5858/arpa.2015-0225-CC; Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS29, DOI 10.1016/j.ajog.2015.08.040; Kim Y.-S., 2014, J MAT, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0083901; Kingdom JC, 1997, PLACENTA, V18, P23; Kingdom JCP, 1997, PLACENTA, V18, P613, DOI 10.1016/S0143-4004(97)90000-X; Kraus F.T., 2004, PLACENTAL PATHOLOGY; Larsen WJ, 2001, HUMAN EMBRYOLOGY, V3; Macara L, 1996, PLACENTA, V17, P37, DOI 10.1016/S0143-4004(05)80642-3; Nakamura Y, 2015, HUM PATHOL, V46, P1171, DOI 10.1016/j.humpath.2015.04.007; Redline RW, 2007, HUM PATHOL, V38, P1439, DOI 10.1016/j.humpath.2007.05.025; Redline Raymond W, 2004, Semin Neonatol, V9, P265, DOI 10.1016/j.siny.2003.09.005; Redline RW, 2015, AM J OBSTET GYNECOL, V213, pS21, DOI 10.1016/j.ajog.2015.05.056; Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006; Sagawa N, 2002, PLACENTA, V23, pS80, DOI 10.1053/plac.2002.0814; Seidmann L, 2014, PLACENTA, V35, P925, DOI 10.1016/j.placenta.2014.07.018; Takagai S, 2016, INT J EPIDEMIOL, V45, P333, DOI 10.1093/ije/dyv290; Tarrade A, 2015, J EXP BIOL, V218, P50, DOI 10.1242/jeb.110320; Tsuchiya KJ, 2010, J DEV ORIG HLTH DIS, V1, P158, DOI 10.1017/S2040174410000140; Williams MC, 2000, AM J OBSTET GYNECOL, V183, P1094, DOI 10.1067/mob.2000.108866; Yamazaki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142609	43	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194988	10.1371/journal.pone.0194988	http://dx.doi.org/10.1371/journal.pone.0194988			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634735	Green Published, gold, Green Submitted			2022-12-26	WOS:000429522200020
J	Bourdon, M; Santulli, P; Maignien, C; Gayet, V; Pocate-Cheriet, K; Marcellin, L; Chapron, C				Bourdon, Mathilde; Santulli, Pietro; Maignien, Chloe; Gayet, Vanessa; Pocate-Cheriet, Khaled; Marcellin, Louis; Chapron, Charles			The deferred embryo transfer strategy improves cumulative pregnancy rates in endometriosis-related infertility: A retrospective matched cohort study	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; DEEPLY INFILTRATING ENDOMETRIOSIS; MAGNETIC-RESONANCE; FREEZE-ALL; ASSISTED REPRODUCTION; OVARIAN STIMULATION; LIVE BIRTH; FRESH; IVF; DIAGNOSIS	Background Controlled ovarian stimulation in assisted reproduction technology (ART) may alters endometrial receptivity by an advancement of endometrial development. Recently, technical improvements in vitrification make deferred frozen-thawed embryo transfer (Def-ET) a feasible alternative to fresh embryo transfer (ET). In endometriosis-related infertility the eutopic endometrium is abnormal and its functional alterations are seen as likely to alter the quality of endometrial receptivity. One question in the endometriosis ART-management is to know whether Def-ET could restore optimal receptivity in endometriosis-affected women leading to increase in pregnancy rates. Objective To compare cumulative ART-outcomes between fresh versus Def-ET in endometriosis-infertile women. Materials and methods This matched cohort study compared def-ET strategy to fresh ET strategy between 01/10/2012 and 31/12/2014. One hundred and thirty-five endometriosis-affected women with a scheduled def-ET cycle and 424 endometriosis-affected women with a scheduled fresh ET cycle were eligible for matching. Matching criteria were: age, number of prior ART cycles, and endometriosis phenotype. Statistical analyses were conducted using univariable and multivariable logistic regression models. Results 135 in the fresh ET group and 135 in the def-ET group were included in the analysis. The cumulative clinical pregnancy rate was significantly increased in the def-ET group compared to the fresh ET group [58 (43%) vs. 40 (29.6%), p = 0.047]. The cumulative ongoing pregnancy rate was 34.8% (n = 47) and 17.8% (n = 24) respectively in the Def-ET and the fresh-ET groups (p = 0.005). After multivariable conditional logistic regression analysis, Def-ET was associated with a significant increase in the cumulative ongoing pregnancy rate as compared to fresh ET (OR = 1.76, CI95% 1.06-2.92, p = 0.028). Conclusion Def-ET in endometriosis-affected women was associated with significantly higher cumulative ongoing pregnancy rates. Our preliminary results suggest that Def-ET for endometriosis-affected women is an attractive option that could increase their ART success rates. Future studies, with a randomized design, should be conducted to further confirm those results.	[Bourdon, Mathilde; Santulli, Pietro; Maignien, Chloe; Gayet, Vanessa; Marcellin, Louis; Chapron, Charles] Ctr Hosp Univ CHU Cochin, Dept Gynecol Obstet & Reprod Med 2, Paris, France; [Bourdon, Mathilde; Santulli, Pietro; Marcellin, Louis; Chapron, Charles] Univ Paris 05, Dept Stress Oxydant Proliferat Cellulaire & Infla, Inst Cochin, INSERM U1016,Sorbonne Paris Cite, Paris, France; [Santulli, Pietro; Marcellin, Louis; Chapron, Charles] Univ Paris 05, Dept Dev Reprod & Canc, Inst Cochin, INSERM U1016,Sorbonne Paris Cite, Paris, France; [Pocate-Cheriet, Khaled] Ctr Hosp Univ CHU Cochin, Dept Histol Embryol & Reprod Biol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Santulli, P (corresponding author), Ctr Hosp Univ CHU Cochin, Dept Gynecol Obstet & Reprod Med 2, Paris, France.; Santulli, P (corresponding author), Univ Paris 05, Dept Stress Oxydant Proliferat Cellulaire & Infla, Inst Cochin, INSERM U1016,Sorbonne Paris Cite, Paris, France.; Santulli, P (corresponding author), Univ Paris 05, Dept Dev Reprod & Canc, Inst Cochin, INSERM U1016,Sorbonne Paris Cite, Paris, France.	pietro.santulli@cch.aphp.fr	Santulli, Pietro/T-5201-2019; louis, marcellin/V-4728-2019	louis, marcellin/0000-0003-4482-9710; Santulli, Pietro/0000-0002-4985-7326	Finox Forward Research Grant	Finox Forward Research Grant	This study was partially supported by a Finox Forward Research Grant to CC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abrao MS, 2007, HUM REPROD, V22, P3092, DOI 10.1093/humrep/dem187; Ahn SH, 2016, FERTIL STERIL, V106, P1420, DOI 10.1016/j.fertnstert.2016.07.005; Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, Hum Reprod, V26, P1270, DOI 10.1093/humrep/der037; Barbosa MAP, 2014, ULTRASOUND OBST GYN, V44, P261, DOI 10.1002/uog.13366; Benaglia L, 2011, HUM REPROD, V26, P2368, DOI 10.1093/humrep/der208; Blockeel C, 2016, HUM REPROD, V31, P491, DOI 10.1093/humrep/dev339; Bourdon M, 2017, J ENDOMETR PELVIC PA, V9, P87, DOI 10.5301/jeppd.5000281; Bourdon M, 2017, REPROD SCI, V24, P1325, DOI 10.1177/1933719116687659; Bourdon M, 2017, REPROD BIOMED ONLINE, V34, P248, DOI 10.1016/j.rbmo.2016.11.015; Braddock CH, 1999, JAMA-J AM MED ASSOC, V282, P2313, DOI 10.1001/jama.282.24.2313; Brandes M, 2010, HUM REPROD, V25, P118, DOI 10.1093/humrep/dep341; Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Broekmans FJ, 2014, HUM REPROD, V29, P1688, DOI 10.1093/humrep/deu090; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Chapron C, 2004, ULTRASOUND OBST GYN, V24, P175, DOI 10.1002/uog.1107; Chapron C, 2011, HUM REPROD, V26, P2028, DOI 10.1093/humrep/der156; Chapron C, 2011, FERTIL STERIL, V95, P877, DOI 10.1016/j.fertnstert.2010.10.027; Check JH, 1999, J ASSIST REPROD GEN, V16, P416, DOI 10.1023/A:1020565408018; Chen ZJ, 2016, NEW ENGL J MED, V375, P523, DOI 10.1056/NEJMoa1513873; Corwin MT, 2014, RADIOLOGY, V271, P126, DOI 10.1148/radiol.13131394; de Ziegler D, 2010, FERTIL STERIL, V94, P2796, DOI 10.1016/j.fertnstert.2010.05.056; de Ziegler D, 2010, LANCET, V376, P730, DOI 10.1016/S0140-6736(10)60490-4; Dueholm M, 2007, CURR OPIN OBSTET GYN, V19, P505, DOI 10.1097/GCO.0b013e3282f1bf00; Evans J, 2014, HUM REPROD UPDATE, V20, P808, DOI 10.1093/humupd/dmu027; Fauque P, 2007, J ASSIST REPROD GEN, V24, P159, DOI 10.1007/s10815-007-9115-z; Ferrero S, 2015, FERTIL STERIL, V104, P771, DOI 10.1016/j.fertnstert.2015.08.031; Gardner DK, 2002, J REPROD IMMUNOL, V55, P85, DOI 10.1016/S0165-0378(01)00136-X; Germond M, 2004, HUM REPROD, V19, P2442, DOI 10.1093/humrep/deh501; Guerriero S, 2015, ULTRASOUND OBSTET GY; Hamdan M, 2015, OBSTET GYNECOL, V125, P79, DOI 10.1097/AOG.0000000000000592; Houshdaran S, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140434; Kao LC, 2003, ENDOCRINOLOGY, V144, P2870, DOI 10.1210/en.2003-0043; Kinkel K, 2006, EUR RADIOL, V16, P285, DOI 10.1007/s00330-005-2882-y; Maheshwari A, 2015, HUM REPROD, V30, P2703, DOI 10.1093/humrep/dev263; Maignien C, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.11.1042; Manzanares MA, 2010, FERTIL STERIL, V93, P1215, DOI 10.1016/j.fertnstert.2008.12.019; Marcellin L, 2015, HUM REPROD, V30, P392, DOI 10.1093/humrep/deu321; Medeiros LR, 2015, ARCH GYNECOL OBSTET, V291, P611, DOI 10.1007/s00404-014-3470-7; Millischer AE, 2015, ULTRASOUND OBST GYN, V46, P109, DOI 10.1002/uog.14712; Nikas G, 1999, HUM REPROD, V14, P787, DOI 10.1093/humrep/14.3.787; Opoien HK, 2012, FERTIL STERIL, V97, P912, DOI 10.1016/j.fertnstert.2012.01.112; Piketty M, 2009, HUM REPROD, V24, P602, DOI 10.1093/humrep/den405; Roque M, 2015, FERTIL STERIL, V103, P1190, DOI 10.1016/j.fertnstert.2015.01.045; Sampson JA, 1927, AM J PATHOL, V3, P93; Santulli P, 2016, HUM REPROD, V31, P1014, DOI 10.1093/humrep/dew035; Santulli P, 2016, FERTIL STERIL, V105, P978, DOI 10.1016/j.fertnstert.2015.12.006; Santulli P, 2014, J CLIN ENDOCR METAB, V99, P881, DOI 10.1210/jc.2013-2950; Santulli P, 2011, FERTIL STERIL, V95, P507, DOI 10.1016/j.fertnstert.2010.09.018; Shapiro BS, 2014, REPROD BIOMED ONLINE, V29, P286, DOI 10.1016/j.rbmo.2014.04.009; Shapiro BS, 2011, FERTIL STERIL, V96, P344, DOI 10.1016/j.fertnstert.2011.05.050; Somigliana E, 2008, HUM REPROD, V23, P1526, DOI 10.1093/humrep/den133; Velarde MC, 2009, ENDOCRINOLOGY, V150, P4701, DOI 10.1210/en.2009-0389; Zegers-Hochschild F, 2009, FERTIL STERIL, V92, P1520, DOI 10.1016/j.fertnstert.2009.09.009	53	27	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194800	10.1371/journal.pone.0194800	http://dx.doi.org/10.1371/journal.pone.0194800			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630610	gold, Green Submitted, Green Published			2022-12-26	WOS:000429505000017
J	Khan, Z; Ahmad, S; Al-Sweih, N; Joseph, L; Alfouzan, W; Asadzadeh, M				Khan, Ziauddin; Ahmad, Suhail; Al-Sweih, Noura; Joseph, Leena; Alfouzan, Wadha; Asadzadeh, Mohammad			Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait	PLOS ONE			English	Article							AMPHOTERICIN-B; COMBINATION THERAPY; SP NOV.; RESISTANT; FUNGEMIA; IDENTIFICATION; EMERGENCE; PATHOGEN; STATES	Candida auris is an emerging yeast pathogen of global significance. Its multidrug-resistant nature and inadequacies of conventional identification systems pose diagnostic and therapeutic challenges. This study investigated occurrence of C. auris in clinical specimens in Kuwait and its susceptibility to antifungal agents. Clinical yeast strains isolated during 3.5 year period and forming pink-colored colonies on CHROMagar Candida were studied by wet mount examination for microscopic morphology and Vitek 2 yeast identification system. A simple species-specific PCR assay was developed for molecular identification and results were confirmed by PCR-sequencing of rDNA. Antifungal susceptibility testing of one isolate from each patient was determined by Etest. The 280 isolates forming pink-colored colonies on CHROMagar Candida, were identified by Vitek 2 as Candida haemulonii (n = 166), Candida utilis (n = 49), Candida kefyr(n = 45), Candida guilliermondii (n = 9), Candida famata (n = 6) and Candida conglobata (n = 5). Species-specific PCR and PCR-sequencing of rDNA identified 166 C. haemulonii isolates as C. auris (n = 158), C. haemulonii (n = 6) and Candida duobushaemulonii (n = 2). C. auris isolates originated from diverse clinical specimens from 56 patients. Of 56 C. auris isolates tested, all were resistant to fluconazole, 41/ 56 (73%) and 13/56 (23%) were additionally resistant to voriconazole and amphotericin B, respectively. Eleven (20%) isolates were resistant to fluconazole, voriconazole and amphotericin B. One isolate was resistant to caspofungin and micafungin. Increasing isolation of C. auris in recent years from diverse clinical specimens including bloodstream shows that C. auris is an emerging non-albicans Candida species in Kuwait causing a variety of infections. Inability of conventional identification methods to accurately identify this pathogen and multidrug-resistant nature of many strains calls for a greater understanding of its epidemiology, risk factors for acquiring C. auris infection and management strategies in high-risk patients. This is the first comprehensive study on the emergence of this multidrug-resistant yeast from Kuwait and the Middle East.	[Khan, Ziauddin; Ahmad, Suhail; Al-Sweih, Noura; Joseph, Leena; Alfouzan, Wadha; Asadzadeh, Mohammad] Kuwait Univ, Dept Microbiol, Fac Med, Safat, Kuwait	Kuwait University	Khan, Z (corresponding author), Kuwait Univ, Dept Microbiol, Fac Med, Safat, Kuwait.	zkhan@hsc.edu.kw	Ahmad, Suhail/AAJ-5456-2021; Alfouzan, Wadha/AAR-8290-2021; Alfouzan, Wadha A/GRA-2552-2022	Alfouzan, Wadha/0000-0002-4501-5316; asadzadeh, Mohammad/0000-0002-9151-1505	Kuwait University [MI01/15]	Kuwait University	This work was supported by Kuwait University Research Sector Grant No. MI01/15.	Abdolrasouli A, 2017, MYCOSES, V60, P758, DOI 10.1111/myc.12699; Ahmad S, 2004, INT J MED MICROBIOL, V294, P45, DOI 10.1016/j.ijmm.2004.01.002; Ahmad S, 2003, MED MYCOL, V41, P487, DOI 10.1080/1369378031000147458; Al-Sweih N, 2017, J MYCOL MED, V27, P271, DOI 10.1016/j.mycmed.2017.01.010; Al-Sweih N, 2015, J CLIN MICROBIOL, V53, P1038, DOI 10.1128/JCM.03351-14; Al-Sweih N, 2014, MED MYCOL CASE REP, V5, P9, DOI 10.1016/j.mmcr.2014.04.004; Al-Sweih N, 2011, MED MYCOL, V49, P766, DOI 10.3109/13693786.2011.572300; Arendrup MC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.00485-17, 10.1128/AAC.00485-17]; Asadzadeh M, 2008, MYCOSES, V51, P318, DOI 10.1111/j.1439-0507.2008.01492.x; Asadzadeh M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142880; Ben-Ami R, 2017, EMERG INFECT DIS, V23, P195, DOI 10.3201/eid2302.161486; Cadnum JL, 2017, INFECT CONT HOSP EP, V38, P1240, DOI 10.1017/ice.2017.162; Calvo B, 2016, J INFECTION, V73, P369, DOI 10.1016/j.jinf.2016.07.008; Castanheira M, 2016, DIAGN MICR INFEC DIS, V85, P200, DOI 10.1016/j.diagmicrobio.2016.02.009; CDC, 2017, REC ID CAND AUR; Chakrabarti A, 2015, INTENS CARE MED, V41, P285, DOI 10.1007/s00134-014-3603-2; Chowdhary A, 2014, EUR J CLIN MICROBIOL, V33, P919, DOI 10.1007/s10096-013-2027-1; Chowdhary A, 2018, J ANTIMICROB CHEMOTH, V73, P891, DOI 10.1093/jac/dkx480; Chowdhary A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006290; Emara M, 2015, EMERG INFECT DIS, V21, P1091, DOI 10.3201/eid2106.150270; Jeffery-Smith A, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00029-17; Kathuria S, 2015, J CLIN MICROBIOL, V53, P1823, DOI 10.1128/JCM.00367-15; Kean R, 2018, J HOSP INFECT, V98, P433, DOI 10.1016/j.jhin.2017.11.015; Khan Z., 2017, CLIN MED RES PRACT, V7, P240, DOI [10.1016/j.cmrp.2017.11.004, DOI 10.1016/J.CMRP.2017.11.004]; Khan ZU, 2008, ANTON LEEUW INT J G, V94, P343, DOI 10.1007/s10482-008-9251-1; Khan ZU, 2007, J CLIN MICROBIOL, V45, P2025, DOI 10.1128/JCM.00222-07; Khan ZU, 2010, ANTON LEEUW INT J G, V97, P253, DOI 10.1007/s10482-009-9406-8; Kordalewska M, 2017, J CLIN MICROBIOL, V55, P2445, DOI 10.1128/JCM.00630-17; Kumar A, 2017, REV IBEROAM MICOL, V34, P109, DOI 10.1016/j.riam.2016.11.004; Lass-Florl C, 2011, CLIN MICROBIOL INFEC, V17, pE27, DOI 10.1111/j.1469-0691.2011.03644.x; Lepak AJ, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00791-17, 10.1128/aac.00791-17]; Lesho EP, 2018, INFECT CONT HOSP EP, V39, P53, DOI 10.1017/ice.2017.231; Lockhart SR, 2017, J CLIN MICROBIOL, V55, P3324, DOI 10.1128/JCM.01355-17; Lockhart SR, 2017, CLIN INFECT DIS, V64, P134, DOI 10.1093/cid/ciw691; Magobo RE, 2014, EMERG INFECT DIS, V20, P1250, DOI 10.3201/eid2007.131765; Mizusawa M, 2017, J CLIN MICROBIOL, V55, P638, DOI 10.1128/JCM.02202-16; Morales-Lopez SE, 2017, EMERG INFECT DIS, V23, P162, DOI 10.3201/eid2301.161497; Rudramurthy SM, 2017, J ANTIMICROB CHEMOTH, V72, P1794, DOI 10.1093/jac/dkx034; Gaitan ACR, 2017, REV IBEROAM MICOL, V34, P23, DOI 10.1016/j.riam.2016.11.002; Satoh K, 2009, MICROBIOL IMMUNOL, V53, P41, DOI 10.1111/j.1348-0421.2008.00083.x; Schelenz S, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0132-5; Sears D, 2017, INT J INFECT DIS, V63, P95, DOI 10.1016/j.ijid.2017.08.017; Sipavak ES, 2017, J CLIN MICROBIO 1122; Tsay S, 2018, CLIN INFECT DIS, V66, P306, DOI 10.1093/cid/cix744; Vallabhaneni S, 2017, AM J TRANSPLANT, V17, P296, DOI 10.1111/ajt.14121; Vallabhaneni S, 2016, MMWR-MORBID MORTAL W, V65, P1234, DOI 10.15585/mmwr.mm6544e1; Welsh RM, 2017, J CLIN MICROBIOL, V55, P2996, DOI [10.1128/jcm.00921-17, 10.1128/JCM.00921-17]	47	54	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195743	10.1371/journal.pone.0195743	http://dx.doi.org/10.1371/journal.pone.0195743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630658	Green Submitted, gold, Green Published			2022-12-26	WOS:000429505000070
J	Wang, SM; Lu, DY; Zhang, ZY; Jia, XY; Yang, L				Wang, Sumei; Lu, Dongyuan; Zhang, Zhenyu; Jia, Xingyuan; Yang, Lei			Effects of mechanical stretching on the morphology of extracellular polymers and the mRNA expression of collagens and small leucine-rich repeat proteoglycans in vaginal fibroblasts from women with pelvic organ prolapse	PLOS ONE			English	Article							STRESS URINARY-INCONTINENCE; GENE-EXPRESSION; BIOMECHANICAL PROPERTIES; CANCER BIOLOGY; DECORIN; FIBROMODULIN; LUMICAN; FIBRILLOGENESIS; BIGLYCAN; BINDING	To determine the effect of mechanical stretching load and the efficacy of postmenopausal estrogen therapy (ET) on pelvic organ prolapse (POP), vaginal fibroblasts isolated from postmenopausal women with or without POP were subjected to 0.1-Hz uniaxial cyclic mechanical stretching (CS) with 10% elongation and 10-8 M 17-I3-estradiol (E-2) treatment. We investigated the morphological characteristics of extracellular polymers using scanning electron microscopy (SEM) and monitored the mRNA expression of type I collagen (COL I) and type III collagen (COL III) as well as the small leucine-rich proteoglycan (SLRP) family members decorin (DCN), biglycan (BGN), fibromodulin (FMO), and lumican (LUM), using real-time quantitative polymerase chain reaction (RT-PCR). Using SEM, certain viscoelastic polymers were found to be randomly distributed among fibroblasts, which for normal fibroblasts formed clusters of plum flower-like patterns under static-culture conditions and resembled stretched strips when stretched in culture, whereas polymers among POP fibroblasts resembled stretched strips under static-cultured conditions and presented broken networks when stretched in culture. RT-PCR revealed that COL I, DCN, BGN, FMO, and LUM mRNA expression was significantly higher in POP than in normal fibroblasts under static-culture condition. Following CS, COL I and BGN mRNA expression was significantly up-regulated in normal fibroblasts, and DCN and FMO mRNA expression was down-regulated in POP fibroblasts. Following concomitant CS and E2 treatment, significantly elevated COL I and DCN mRNA expression was observed in normal fibroblasts, and significantly elevated COL I and BGN mRNA expression was observed in POP fibroblasts. COL III mRNA expression was not significantly different between the POP and normal group, and CS did not significantly affect expression in either group, though COL III was down-regulated in normal fibroblasts concomitantly treated with E-2 and CS. We conclude that the morphological distribution of extracellular polymers in POP fibroblasts exhibited higher sensitivity and lower tolerance to stretching loads than do normal fibroblasts. These mechanical properties were further reflected in the transcription of COL I. Defects in the compensatory function of BGN for DCN and LUM for FMO exist in POP fibroblasts, which further affect the structure and function of COL I in response to stretching load, ultimately resulting in abnormal reconstruction of pelvic supportive connective tissues and the occurrence of POP. ET can maintain stretching-induced elevations in COL I and DCN transcription in healthy women and improve stretching-induced COL I, DCN, BGN, and FMO transcriptional changes in POP women to prevent and improve POP. Only down-regulated COL III transcription was observed upon concomitant CS and E2 treatment in normal fibroblasts, which suggests that the tensile strength, not the elasticity, of the supportive connective tissues is damaged in POP and that the higher tensile strength induced by ET in healthy fibroblasts prevents POP. These findings confirm the role of higher sensitivity and lower tolerance to mechanical stretching in the pathogenesis of POP and further provide evidence supporting the use of ET to prevent and inhibit POP in postmenopausal women.	[Wang, Sumei; Zhang, Zhenyu] Capital Med Univ, Beijing Chaoyang Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China; [Lu, Dongyuan] Chinese Acad Sci, Inst Mech, Ctr Biomech & Bioengn, Key Lab Micrograv,Natl Micrograv Lab, Beijing, Peoples R China; [Lu, Dongyuan] Chinese Acad Sci, Inst Mech, Beijing Key Lab Engn Construct & Mechanobiol, Beijing, Peoples R China; [Jia, Xingyuan; Yang, Lei] Capital Med Univ, Beijing Chaoyang Hosp, Med Res Ctr, Beijing, Peoples R China	Capital Medical University; Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; Institute of Mechanics, CAS; Capital Medical University	Wang, SM; Zhang, ZY (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China.; Jia, XY (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Med Res Ctr, Beijing, Peoples R China.	sumeiwang@ccmu.edu.cn; Zhenyuzhang@ccmu.edu.cn; jiaxy@hotmail.com	YANG, LEI/GQH-4271-2022		National Key Technology Research and Development Program during the 11th Five-Year Plan Period [2007BAI04B05]	National Key Technology Research and Development Program during the 11th Five-Year Plan Period	This work was supported by the National Key Technology Research and Development Program during the 11th Five-Year Plan Period (2007BAI04B05)(ZZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitch SD, 2009, EUR J OBSTET GYN R B, V144, pS146, DOI 10.1016/j.ejogrb.2009.02.022; Alimohamad H, 2005, J PERIODONTAL RES, V40, P73, DOI 10.1111/j.1600-0765.2004.00776.x; Bildircin D, 2014, Minerva Ginecol, V66, P201; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; Chiquet M, 2009, BBA-MOL CELL RES, V1793, P911, DOI 10.1016/j.bbamcr.2009.01.012; Cowman Mary K, 2015, F1000Res, V4, P622, DOI 10.12688/f1000research.6885.1; DELANCEY JOL, 1993, CLIN OBSTET GYNECOL, V36, P897, DOI 10.1097/00003081-199312000-00015; DELANCEY JOL, 1994, AM J OBSTET GYNECOL, V170, P1713, DOI 10.1016/S0002-9378(12)91840-2; Ewies AAA, 2008, MOL HUM REPROD, V14, P127, DOI 10.1093/molehr/gam090; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; Fuermetz A, 2015, EUR J OBSTET GYN R B, V187, P45, DOI 10.1016/j.ejogrb.2015.02.021; Gautieri A, 2012, MATRIX BIOL, V31, P141, DOI 10.1016/j.matbio.2011.11.005; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Geng YQ, 2006, MATRIX BIOL, V25, P484, DOI 10.1016/j.matbio.2006.08.259; Ghodsi H, 2015, J MECH BEHAV BIOMED, V51, P194, DOI 10.1016/j.jmbbm.2015.07.015; HEDBOM E, 1993, J BIOL CHEM, V268, P27307; Hendrix SL, 2002, AM J OBSTET GYNECOL, V186, P1160, DOI 10.1067/mob.2002.123819; Jelovsek JE, 2007, LANCET, V369, P1027, DOI 10.1016/S0140-6736(07)60462-0; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Jia XY, 2013, EXP MOL PATHOL, V95, P68, DOI 10.1016/j.yexmp.2013.05.007; Jin Ling, 2007, Zhonghua Fu Chan Ke Za Zhi, V42, P18; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200; Karamanou K, 2017, SCI REP-UK, V7, DOI 10.1038/srep45138; Kim CM, 2007, INT J GYNECOL OBSTET, V98, P248, DOI 10.1016/j.ijgo.2007.02.019; Kim SG, 2002, CELL STRUCT FUNCT, V27, P139, DOI 10.1247/csf.27.139; Kobayashi H, 2014, MOL MED REP, V9, P9, DOI 10.3892/mmr.2013.1755; KRESSE H, 1993, EXPERIENTIA, V49, P403, DOI 10.1007/BF01923585; Lelievre SA, 2009, BBA-GEN SUBJECTS, V1790, P925, DOI 10.1016/j.bbagen.2009.03.013; Liu YM, 2006, HUM REPROD, V21, P303, DOI 10.1093/humrep/dei296; Markiewicz M, 2013, J INVEST DERMATOL, V133, P120, DOI 10.1038/jid.2012.264; Martins P, 2013, GYNECOL OBSTET INVES, V75, P85, DOI 10.1159/000343230; McEwan PA, 2006, J STRUCT BIOL, V155, P294, DOI 10.1016/j.jsb.2006.01.016; Merline R, 2009, J CELL COMMUN SIGNAL, V3, P323, DOI 10.1007/s12079-009-0066-2; Nakatani T, 2002, J ORTHOP RES, V20, P1380, DOI 10.1016/S0736-0266(02)00046-3; Neame PJ, 2000, CELL MOL LIFE SCI, V57, P859, DOI 10.1007/s000180050048; Neill T, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.975645; O'Dell KK, 2007, INT UROGYNECOL J, V18, P1481, DOI 10.1007/s00192-007-0387-8; Phillips CH, 2006, BJOG-INT J OBSTET GY, V113, P39, DOI 10.1111/j.1471-0528.2005.00773.x; Robinson KA, 2017, MATRIX BIOL, V64, P81, DOI 10.1016/j.matbio.2017.08.004; Ruiz-Zapata AM, 2013, INT UROGYNECOL J, V24, P1567, DOI 10.1007/s00192-013-2069-z; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Schaefer L, 2017, FEBS J, V284, P10, DOI 10.1111/febs.13963; SCHONHERR E, 1995, J BIOL CHEM, V270, P2776, DOI 10.1074/jbc.270.6.2776; SCOTT JE, 1988, BIOCHEM J, V252, P313, DOI 10.1042/bj2520313; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; Svensson L, 2000, FEBS LETT, V470, P178, DOI 10.1016/S0014-5793(00)01314-4; SVENSSON L, 1995, J BIOL CHEM, V270, P20712, DOI 10.1074/jbc.270.35.20712; Theocharis AD, 2015, BBA-REV CANCER, V1855, P276, DOI 10.1016/j.bbcan.2015.03.006; Wang JHC, 2007, GENE, V391, P1, DOI 10.1016/j.gene.2007.01.014; Wang SM, 2015, INT J MOL SCI, V16, P9406, DOI 10.3390/ijms16059406; Wen Y, 2007, HUM REPROD, V22, P1718, DOI 10.1093/humrep/dem039; Word RA, 2009, OBSTET GYN CLIN N AM, V36, P521, DOI 10.1016/j.ogc.2009.09.001; Yang GG, 2004, J BIOMECH, V37, P1543, DOI 10.1016/j.jbiomech.2004.01.005; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200	56	9	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0193456	10.1371/journal.pone.0193456	http://dx.doi.org/10.1371/journal.pone.0193456			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630675	gold, Green Published			2022-12-26	WOS:000429505000002
J	Yu, N; Wei, YL; Zhu, Y; Zhu, N; Wang, YL; Zhang, HP; Sun, AD				Yu, Ning; Wei, Yu-long; Zhu, Yue; Zhu, Ning; Wang, Yan-li; Zhang, Hai-ping; Sun, Ai-dong			Integrated approach for identifying and evaluating the quality of Marsdenia tenacissima in the medicine market	PLOS ONE			English	Article							POLYOXYPREGNANE GLYCOSIDES; IDENTIFICATION; AUTHENTICATION; HERBS; LEAVES; PLANTS; ITS2	The accurate identification and quality evaluation of herbal medical plants is highly necessary to ensure their safety and efficacy. In present study, a new strategy combining DNA barcoding techniques with thin-layer chromatography (TLC) and high-performance liquid chromatography (HPLC) was proposed to facilitate the identification and quality control of M. tenacissima. In present work, the internal transcribed spacer 2 (ITS2) barcode was successfully used to identify 58 M. tenacissima samples and its adulterants. TLC successfully identified the other three M. tenacissima samples that failed to produce ITS2 regions. An adulterant was found in all the 62 samples. Moreover, the content of active medicinal ingredients is important for herbal plants quality. The content of tenacissoside H (TS-H) of M. tenacissima samples was determined by HPLC to range from 0.39% to 1.09%, which meets the criterion of the Chinese Pharmacopoeia. Thus, DNA barcoding coupled with TLC and HPLC is very promising to identify and evaluate the quality of M. tenacissima in the medicine market.	[Yu, Ning; Wei, Yu-long; Zhu, Yue; Zhu, Ning; Wang, Yan-li; Zhang, Hai-ping; Sun, Ai-dong] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China; [Yu, Ning; Wei, Yu-long; Zhu, Yue; Zhu, Ning; Wang, Yan-li; Zhang, Hai-ping; Sun, Ai-dong] Beijing Forestry Univ, Beijing Key Lab Forest Food Proc & Safety, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Sun, AD (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China.; Sun, AD (corresponding author), Beijing Forestry Univ, Beijing Key Lab Forest Food Proc & Safety, Beijing, Peoples R China.	adsun@bjfu.edu.cn			Forestry public welfare industry research special funds [201504606]	Forestry public welfare industry research special funds	This research work was supported by Forestry public welfare industry research special funds (No. 201504606).	Briskin DP, 2000, PLANT PHYSIOL, V124, P507, DOI 10.1104/pp.124.2.507; Chen JJ, 2008, TALANTA, V77, P152, DOI 10.1016/j.talanta.2008.05.054; Chen SL, 2014, BIOTECHNOL ADV, V32, P1237, DOI 10.1016/j.biotechadv.2014.07.004; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chiou SJ, 2007, PLANTA MED, V73, P1421, DOI 10.1055/s-2007-990227; Coleman AW, 2007, NUCLEIC ACIDS RES, V35, P3322, DOI 10.1093/nar/gkm233; Deng J, 2005, PHYTOCHEMISTRY, V66, P1040, DOI 10.1016/j.phytochem.2005.03.018; Deng J, 2006, J CHROMATOGR A, V1116, P83, DOI 10.1016/j.chroma.2006.03.021; Donno D, 2015, J FUNCT FOODS, V18, P1070, DOI 10.1016/j.jff.2014.05.020; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gao T, 2010, J ETHNOPHARMACOL, V130, P116, DOI 10.1016/j.jep.2010.04.026; Han JP, 2016, SCI REP, P6; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Jiang LL, 2016, J PHARMACEUT BIOMED, V129, P398, DOI 10.1016/j.jpba.2016.07.030; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Kim HJ, 2010, ARCH PHARM RES, V33, P1355, DOI 10.1007/s12272-010-0909-7; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Li M, 2011, J SYST EVOL, V49, P271, DOI 10.1111/j.1759-6831.2011.00132.x; Liu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035146; Lo YT, 2015, CHIN MED-UK, V10, DOI 10.1186/s13020-015-0029-x; LUO SQ, 1993, PHYTOCHEMISTRY, V34, P1615, DOI 10.1016/S0031-9422(00)90856-2; Marichamy K., 2014, SCI PARK, V1, P23218045, DOI [DOI 10.9780/23218045/1202013/49, 10.9780/23218045/1202013/49]; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Mishra P, 2016, PLANT BIOTECHNOL J, V14, P8, DOI 10.1111/pbi.12419; Newmaster SG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-222; Poornima B., 2010, IJRAP, V1, P8; Sasidharan S, 2011, AFR J TRADIT COMPLEM, V8, P1; State Pharmacopoeia Committee, 2015, MARSD TEN ROXB, P296; Sun ZY, 2013, J NAT MED-TOKYO, V67, P296, DOI 10.1007/s11418-012-0681-8; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van Beek TA, 2009, J CHROMATOGR A, V1216, P2002, DOI 10.1016/j.chroma.2009.01.013; Xin TY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08337; Xin TY, 2013, FOOD RES INT, V54, P1699, DOI 10.1016/j.foodres.2013.10.007; Xu CJ, 2015, FOOD CHEM, V186, P83, DOI 10.1016/j.foodchem.2014.11.042; Yu N, 2016, MOLECULES, V21, DOI 10.3390/molecules21091221; Zhang Hailing, 2009, BMJ Case Rep, V2009, DOI 10.1136/bcr.09.2008.1016	37	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195240	10.1371/journal.pone.0195240	http://dx.doi.org/10.1371/journal.pone.0195240			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624609	Green Published, gold, Green Submitted			2022-12-26	WOS:000429379600020
J	Zhao, PW; Xu, CY; Zhou, M; Zhang, B; Ge, P; Zeng, N; Liu, HY				Zhao, Pengwu; Xu, Chongyang; Zhou, Mei; Zhang, Bo; Ge, Peng; Zeng, Nan; Liu, Hongyan			Rapid regeneration offsets losses from warming-induced tree mortality in an aspen dominated broad-leaved forest in northern China	PLOS ONE			English	Article							POPULUS-TREMULOIDES; CANOPY OPENNESS; BOREAL FOREST; DROUGHT; GROWTH; DYNAMICS; COMPETITION; RESILIENCE; SEEDLINGS; DECLINE	Worldwide tree mortality as induced by climate change presents a challenge to forest managers. To successfully manage vulnerable forests requires the capacity of regeneration to compensate for losses from tree mortality. We observed rapid regeneration and the growth release of young trees after warming-induced mortality in a David aspen-dominated (Populus davidiana) broad-leaved forest in Inner Mongolia, China, as based on individual tree measurements taken in 2012 and 2015 from a 6-ha permanent plot. Warming and drought stress killed large trees 10-15 m tall with a total number of 2881 trees during 2011-2012, and also thinned the upper crowns. David aspen recruitment increased 2 times during 2012-2015 and resulted in a high transition probability of David aspen replacing the same or other species, whereas the recruitment of Mongolian oak (Quercus mongolica) was much lower: it decreased from 2012 to 2015, indicating that rapid regeneration represented a regrowth phase for David aspen, and not succession to Mongolian oak. Further, we found that the recruitment density increased with canopy openness, thus implying that warming induced mortality enhanced regeneration. Our results suggest that David aspen has a high regrowth ability to offset individual losses from warming-induced mortality. This important insight has implications for managing this vulnerable forest in the semi-arid region of northern China.	[Zhao, Pengwu; Zhou, Mei; Ge, Peng; Zeng, Nan] Inner Mongolia Agr Univ, Acad Forestry, Hohhot, Inner Mongolia, Peoples R China; [Xu, Chongyang; Zhang, Bo; Liu, Hongyan] Peking Univ, Coll Urban & Environm Sci, Beijing, Peoples R China; [Xu, Chongyang; Zhang, Bo; Liu, Hongyan] Peking Univ, MOE Lab Earth Surface Proc, Beijing, Peoples R China	Inner Mongolia Agricultural University; Peking University; Peking University	Zhou, M (corresponding author), Inner Mongolia Agr Univ, Acad Forestry, Hohhot, Inner Mongolia, Peoples R China.; Liu, HY (corresponding author), Peking Univ, Coll Urban & Environm Sci, Beijing, Peoples R China.; Liu, HY (corresponding author), Peking Univ, MOE Lab Earth Surface Proc, Beijing, Peoples R China.	daxl528@aliyun.com; lhy@urban.pku.edu.cn			National Natural Science of China [41325002, 41530747]	National Natural Science of China(National Natural Science Foundation of China (NSFC))	This work was granted by National Natural Science of China to Hongyan Liu with grant No. 41325002 and 41530747. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL://www.nsfc.gov.cn/.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Baker WL, 1989, LANDSCAPE ECOL, V2, P112; Bose AK, 2014, FOREST ECOL MANAG, V329, P37, DOI 10.1016/j.foreco.2014.06.004; Brais S, 2004, CAN J FOREST RES, V34, P431, DOI [10.1139/x03-144, 10.1139/X03-144]; Brando PM, 2014, P NATL ACAD SCI USA, V111, P6347, DOI 10.1073/pnas.1305499111; Brandt JP, 2003, FOREST ECOL MANAG, V178, P287, DOI 10.1016/S0378-1127(02)00479-6; Bretfeld M, 2015, FOREST ECOL MANAG, V347, P96, DOI 10.1016/j.foreco.2015.03.006; BROWN JK, 1987, CAN J FOREST RES, V17, P1100, DOI 10.1139/x87-168; DeByle NV, 1985, RM119 FORT COLL; Dudley MM, 2015, FOREST ECOL MANAG, V353, P240, DOI 10.1016/j.foreco.2015.06.002; Dulamsuren C, 2013, ECOSYSTEMS, V16, P1536, DOI 10.1007/s10021-013-9700-1; Enoki T, 2004, PLANT ECOL, V173, P283, DOI 10.1023/B:VEGE.0000029336.80225.f0; ENRIGHT N, 1979, AUST J ECOL, V4, P3, DOI 10.1111/j.1442-9993.1979.tb01195.x; Feng HH, 2015, SCI REP-UK, V5, DOI 10.1038/srep18018; Frey BR, 2004, CAN J FOREST RES, V34, P1379, DOI 10.1139/X04-062; Gerhardt K, 1996, FOREST ECOL MANAG, V82, P33, DOI 10.1016/0378-1127(95)03700-4; Gradowski T, 2010, FOREST ECOL MANAG, V259, P383, DOI 10.1016/j.foreco.2009.10.033; Huang JP, 2016, NAT CLIM CHANGE, V6, P166, DOI [10.1038/nclimate2837, 10.1038/NCLIMATE2837]; Kaufmann J, 2014, CAN J FOREST RES, V44, P777, DOI 10.1139/cjfr-2014-0131; Kharuk VI, 2013, FOREST ECOL MANAG, V310, P312, DOI 10.1016/j.foreco.2013.08.042; Kharuk VI, 2013, FOREST ECOL MANAG, V289, P385, DOI 10.1016/j.foreco.2012.10.024; Kneeshaw DD, 1998, ECOLOGY, V79, P783, DOI 10.1890/0012-9658(1998)079[0783:CGCATR]2.0.CO;2; Kurzel BP, 2007, FOREST ECOL MANAG, V252, P176, DOI 10.1016/j.foreco.2007.06.027; Landhausser SM, 2015, CAN J FOREST RES, V45, P1056, DOI 10.1139/cjfr-2015-0062; Liu HY, 2013, GLOBAL CHANGE BIOL, V19, P2500, DOI 10.1111/gcb.12217; Liu HY, 2000, J VEG SCI, V11, P525, DOI 10.2307/3246582; Machado JL, 1999, CAN J FOREST RES, V29, P1438, DOI 10.1139/cjfr-29-9-1438; McDowell NG, 2013, NEW PHYTOL, V200, P289, DOI 10.1111/nph.12502; Mitton JB, 1996, BIOSCIENCE, V46, P25, DOI 10.2307/1312652; O'Brien MJ, 2014, NAT CLIM CHANGE, V4, P710, DOI [10.1038/nclimate2281, 10.1038/NCLIMATE2281]; Qi ZH, 2015, GLOBAL CHANGE BIOL, V21, P816, DOI 10.1111/gcb.12703; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Rogers PC, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1661; Rogers PC, 2014, J VEG SCI, V25, P457, DOI 10.1111/jvs.12099; Romme WH, 2005, ECOLOGY, V86, P404, DOI 10.1890/03-4093; Scholze M, 2006, P NATL ACAD SCI USA, V103, P13116, DOI 10.1073/pnas.0601816103; Shepperd WD, 2015, FOREST SCI, V61, P932, DOI 10.5849/forsci.14-101; Shepperd WD, 2001, CAN J FOREST RES, V31, P739, DOI 10.1139/cjfr-31-5-739; Strand EK, 2009, FOREST ECOL MANAG, V257, P1705, DOI 10.1016/j.foreco.2009.01.026; Hogg EH, 2015, GLOBAL CHANGE BIOL, V21, P1968, DOI 10.1111/gcb.12805; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Wang GG, 2003, CAN J FOREST RES, V33, P1998, DOI [10.1139/x03-123, 10.1139/X03-123]; Worrall JJ, 2008, FOREST ECOL MANAG, V255, P686, DOI 10.1016/j.foreco.2007.09.071; Worrall JJ, 2015, CAN J FOREST RES, V45, P1768, DOI 10.1139/cjfr-2015-0225; Worrall JJ, 2013, FOREST ECOL MANAG, V299, P35, DOI 10.1016/j.foreco.2012.12.033; Worrall JJ, 2010, FOREST ECOL MANAG, V260, P638, DOI 10.1016/j.foreco.2010.05.020; Xu CY, 2018, FOREST ECOL MANAG, V409, P298, DOI 10.1016/j.foreco.2017.11.035; Xu CY, 2017, GLOBAL CHANGE BIOL, V23, P2370, DOI 10.1111/gcb.13582; Yamanaka N., 2014, RESTORATION DEV DEGR, P49, DOI DOI 10.1007/978-4-431-54481-4_4; Zeng N, 2016, FOREST CHRON, V92, P336, DOI 10.5558/tfc2016-060; Zhang J, 2015, P NATL ACAD SCI USA, V112, P4009, DOI 10.1073/pnas.1420844112; Zhou GY, 2013, GLOBAL CHANGE BIOL, V19, P1197, DOI 10.1111/gcb.12128; Zou Hou-yuan, 2002, Xibei Zhiwu Xuebao, V22, P1	53	8	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195630	10.1371/journal.pone.0195630	http://dx.doi.org/10.1371/journal.pone.0195630			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624614	Green Published, Green Submitted, gold			2022-12-26	WOS:000429379600041
J	Cheng, X; Li, K; Xu, SS; Li, PZ; Yan, Y; Wang, G; Berman, Z; Guo, R; Liang, JX; Traore, S; Yang, XS				Cheng, Xin; Li, Ke; Xu, Shengsong; Li, Peizhi; Yan, Yu; Wang, Guang; Berman, Zachary; Guo, Rui; Liang, Jianxin; Traore, Sira; Yang, Xuesong			Applying chlorogenic acid in an alginate scaffold of chondrocytes can improve the repair of damaged articular cartilage	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; TISSUE-ENGINEERED CARTILAGE; MATRIX METALLOPROTEINASES; OXIDATIVE STRESS; IN-VIVO; MICE; OSTEOARTHRITIS; DEFECTS; MODEL; TRANSPLANTATION	Damaged cartilage has very low regenerative potential which has led to the search for novel tissue-engineering approaches to help treat cartilage defects. While various approaches have been reported, there is no perfect treatment currently. In this study we evaluated the effects of a plant extract, chlorogenic acid (CGA), as part of chondrocyte transplantation on a model of knee joint injury in chicks. First, primary cultured chondrocytes used to evaluate the effects of CGA on chondrogenesis. Then using an articular cartilage injury model of chick knee we assessed the functional recovery after transplantation of the complexes containing chondrocytes and CGA in an alginate scaffold. Histological analysis, PCR, and western blot were further used to understand the underlying mechanisms. We showed that 60 mu M CGA in alginate exhibited notable effects on stimulating chondrogenesis in vitro. Secondly, it was shown that the application of these complexes accelerated the recovery of injury-induced dysfunction by gait analysis when followed for 21 days. Histochemical analysis demonstrated that there was less abnormal vasculature formation, more chondrocyte proliferation and cartilage matrix synthesis in the presence of the complexes containing CGA. We discovered CGA treated transplantation up-regulated the expressions of Sox9 and Col2a1 which were responsible for the stimulation of chondrogenesis. Furthermore, the application of these complexes could suppress the abnormal angiogenesis and fibrosis at the injury site. Lastly, the elevated levels of inflammatory cytokines IL-1 beta, TNF-alpha, p-p65, and MMPs expression were decreased in the presence of CGA. This may be caused through adjusting cellular redox homeostasis associated with Nrf2. This study suggests that combining chondrocytes and CGA on an alginate scaffold can improve the recovery of damaged articular cartilage.	[Cheng, Xin; Li, Ke; Xu, Shengsong; Li, Peizhi; Yan, Yu; Wang, Guang; Guo, Rui; Liang, Jianxin; Traore, Sira; Yang, Xuesong] Jinan Univ, Med Coll, Joint Lab Embryon Dev & Prenatal Med, Dept Histol & Embryol, Guangzhou, Guangdong, Peoples R China; [Berman, Zachary] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Yang, Xuesong] Jinan Univ, Minist Educ, Key Lab Regenerat Med, Guangzhou, Guangdong, Peoples R China	Jinan University; University of California System; University of California San Diego; Jinan University	Yang, XS (corresponding author), Jinan Univ, Med Coll, Joint Lab Embryon Dev & Prenatal Med, Dept Histol & Embryol, Guangzhou, Guangdong, Peoples R China.; Yang, XS (corresponding author), Jinan Univ, Minist Educ, Key Lab Regenerat Med, Guangzhou, Guangdong, Peoples R China.	yang_xuesong@126.com	Xu, Shengsong/HHD-0354-2022; Wang, Guang/AAC-4624-2019	Xu, Shengsong/0000-0002-4349-6507; LIANG, Jianxin/0000-0002-6636-0872; Berman, Zachary/0000-0002-8651-9772	NSFC; Science and Technology Planning Project of Guangdong Province; Science and Technology Program of Guangzhou; Guangdong Natural Science Foundation; Research Grant of Key Laboratory of Regenerative Medicine, Ministry of Education, Jinan University	NSFC(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province; Science and Technology Program of Guangzhou; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Research Grant of Key Laboratory of Regenerative Medicine, Ministry of Education, Jinan University	This study was supported by NSFC, Science and Technology Planning Project of Guangdong Province, Science and Technology Program of Guangzhou, Guangdong Natural Science Foundation, and Research Grant of Key Laboratory of Regenerative Medicine, Ministry of Education, Jinan University.	Adamzyk C, 2016, J CRANIO MAXILL SURG, V44, P985, DOI 10.1016/j.jcms.2016.04.012; Ben Shoham A, 2016, DEVELOPMENT, V143, P3933, DOI 10.1242/dev.139253; Bishi DK, 2016, ADV HEALTHC MATER, V5, P1058, DOI 10.1002/adhm.201500897; Borthwick LA, 2013, BBA-MOL BASIS DIS, V1832, P1049, DOI 10.1016/j.bbadis.2012.09.014; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001; Chen B, 2015, J ENDOCRINOL, V225, pR83, DOI 10.1530/JOE-14-0662; Chen WP, 2014, INT J CLIN EXP PATHO, V7, P8797; Chen WP, 2011, INT IMMUNOPHARMACOL, V11, P23, DOI 10.1016/j.intimp.2010.09.021; Ching SH, 2017, CRIT REV FOOD SCI, V57, P1133, DOI 10.1080/10408398.2014.965773; Danisovic L, 2012, TISSUE CELL, V44, P69, DOI 10.1016/j.tice.2011.11.005; Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554; Feng RT, 2005, J BIOL CHEM, V280, P27888, DOI 10.1074/jbc.M503347200; Fujita N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375964; Gentile P, 2017, BIOMATER SCI-UK, V5, P1922, DOI 10.1039/c7bm00525c; Girirajan S, 2008, EUR J HUM GENET, V16, P941, DOI 10.1038/ejhg.2008.21; Gonthier MP, 2003, J NUTR, V133, P1853, DOI 10.1093/jn/133.6.1853; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Hattori K, 2005, ARTHRITIS RES THER, V7, pR552, DOI 10.1186/ar1710; Hauselmann HJ, 1996, AM J PHYSIOL-CELL PH, V271, pC742, DOI 10.1152/ajpcell.1996.271.3.C742; HELBING G, 1982, FORTSCHR MED, V100, P83; HEMBRY RM, 1994, VIRCHOWS ARCH, V425, P413; Kazemnejad S, 2016, CELL TISSUE RES, V364, P559, DOI 10.1007/s00441-015-2355-9; Klennert BJ, 2017, J BIOMECH, V52, P31, DOI 10.1016/j.jbiomech.2016.11.056; Liu CF, 2015, NUCLEIC ACIDS RES, V43, P8183, DOI 10.1093/nar/gkv688; Longobardi L, 2006, J BONE MINER RES, V21, P626, DOI 10.1359/JBMR.051213; Marijnissen WJCM, 2002, BIOMATERIALS, V23, P1511, DOI 10.1016/S0142-9612(01)00281-2; Marijnissen WJCM, 2000, BIOMATERIALS, V21, P571, DOI 10.1016/S0142-9612(99)00218-5; Markarian Gregory G, 2016, J Surg Orthop Adv, V25, P18; Qin L, 2015, BIOMATERIALS, V59, P125, DOI 10.1016/j.biomaterials.2015.04.038; Reimold AM, 1996, NATURE, V379, P262, DOI 10.1038/379262a0; Sittinger M, 1996, J BIOMED MATER RES, V33, P57, DOI 10.1002/(SICI)1097-4636(199622)33:2<57::AID-JBM1>3.0.CO;2-K; Tetlow LC, 2001, ARTHRITIS RHEUM-US, V44, P585, DOI 10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C; Tourtellotte WG, 1998, NAT GENET, V20, P87, DOI 10.1038/1757; VANBEUNINGEN HM, 1991, ARTHRITIS RHEUM, V34, P606, DOI 10.1002/art.1780340513; Wang G, 2016, J AGR FOOD CHEM, V64, P1610, DOI 10.1021/acs.jafc.5b05897; Wang PZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148372; Westacott CI, 1996, SEMIN ARTHRITIS RHEU, V25, P254, DOI 10.1016/S0049-0172(96)80036-9; Yang J, 2011, FEBS LETT, V585, P2992, DOI 10.1016/j.febslet.2011.08.013; Yoshihara Y, 2000, ANN RHEUM DIS, V59, P455, DOI 10.1136/ard.59.6.455	40	15	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195326	10.1371/journal.pone.0195326	http://dx.doi.org/10.1371/journal.pone.0195326			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621359	Green Submitted, Green Published, gold			2022-12-26	WOS:000429206800062
J	do Nascimento, SV; Magalhaes, MM; Cunha, RL; Costa, PHD; Alves, RCD; de Oliveira, GC; Valadares, RBD				do Nascimento, Sidney Vasconcelos; Magalhaes, Marcelo Murad; Cunha, Roberto Lisboa; de Oliveira Costa, Paulo Henrique; de Oliveira Alves, Ronnie Cley; de Oliveira, Guilherme Correa; da Silva Valadares, Rafael Borges			Differential accumulation of proteins in oil palms affected by fatal yellowing disease	PLOS ONE			English	Article							MITOCHONDRIAL ALDEHYDE DEHYDROGENASE; COMPARATIVE PROTEOMIC ANALYSIS; PHYTOPHTHORA-PALMIVORA; WATERLOGGING STRESS; METABOLISM; EXPRESSION; ARABIDOPSIS; PHLOEM; ROOTS; MAIZE	There is still no consensus on the true origin of fatal yellowing, one of the most important diseases affecting oil palm (Elaeis guineensis Jacq.) plantations. This study involved two-dimensional liquid chromatography coupled with tandem mass spectrometry (2D-UPLC-MSE) analyses to identify changes in protein profiles of oil palms affected by FY disease. Oil palm roots were sampled from two growing areas. Differential accumulation of proteins was assessed by comparing plants with and without symptoms and between plants at different stages of FY development. Most of the proteins identified with differential accumulation were those related to stress response and energy metabolism. The latter proteins include the enzymes alcohol dehydrogenase and aldehyde dehydrogenase, related to alcohol fermentation, which were identified in plants with and without symptoms. The presence of these enzymes suggests an anaerobic condition before or during FY. Transketolase, isoflavone reductase, cinnamyl alcohol dehydrogenase, caffeic acid 3-O-methyltransferase, S-adenosylmethionine synthase, aldehyde dehydrogenase and ferritin, among others, were identified as potential marker proteins and could be used to guide selection of FY-tolerant oil palm genotypes or to understand the source of this anomaly. When comparing different stages of FY, we observed high accumulation of alcohol dehydrogenase and other abiotic stress related-proteins at all disease stages. On the other hand, biological stress-related proteins were more accumulated at later stages of the disease. These results suggest that changes in abiotic factors can trigger FY development, creating conditions for the establishment of opportunistic pathogens.	[do Nascimento, Sidney Vasconcelos; de Oliveira Costa, Paulo Henrique; de Oliveira Alves, Ronnie Cley; de Oliveira, Guilherme Correa; da Silva Valadares, Rafael Borges] Inst Tecnol Vale, Belem, Para, Brazil; [do Nascimento, Sidney Vasconcelos; Cunha, Roberto Lisboa; da Silva Valadares, Rafael Borges] Univ Fed Rural Amazonia, Programa Posgrad Biotecnol Aplicada Agr, Belem, Para, Brazil; [Magalhaes, Marcelo Murad; Cunha, Roberto Lisboa] Embrapa Amazonia Oriental, Anal Sustainable Syst Lab, Belem, Para, Brazil	Instituto Tecnologico Vale Desenvolvimento Sustentavel; Universidade Federal Rural da Amazonia (UFRA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Valadares, RBD (corresponding author), Inst Tecnol Vale, Belem, Para, Brazil.; Valadares, RBD (corresponding author), Univ Fed Rural Amazonia, Programa Posgrad Biotecnol Aplicada Agr, Belem, Para, Brazil.	rafael.borges.valadares@itv.org	Alves, Ronnie/U-9893-2019; Cunha, Roberto Lisboa/S-9909-2019; cunha, roberto L/B-9346-2016	Alves, Ronnie/0000-0003-4139-0562; Cunha, Roberto Lisboa/0000-0002-2964-7938; cunha, roberto L/0000-0002-2964-7938; Valadares, Rafael/0000-0003-4481-982X	Institute Tecnologico Vale	Institute Tecnologico Vale	This work was supported by Institute Tecnologico Vale. The funder provided support in the form of salaries for authors RBSV, GO and ROA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acosta A., 2003, Better Crops International, V17, P22; Alam I, 2010, J BIOSCIENCES, V35, P49, DOI 10.1007/s12038-010-0007-5; Bernardes MSR, 2001, PESQUISA AMARELECIME; Bertolde FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108705; Boari AJ, 2009, S BRASILEIRO SENSORI, P523; Bostock RM, 2014, ANNU REV PHYTOPATHOL, V52, P517, DOI 10.1146/annurev-phyto-081211-172902; Botcher A, 2012, FERRITIN FUNCTIONS B, P65; Briat JF, 2010, ANN BOT-LONDON, V105, P811, DOI 10.1093/aob/mcp128; Campos Ndia Alves, 2016, Plant Omics, V9, P19; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Cheng Q, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01024; Chinchilla C, 2005, ASD OIL PALM PAP, V28, P21; Christianson JA, 2010, PLANT CELL PHYSIOL, V51, P21, DOI 10.1093/pcp/pcp163; Costa MR, 2014, REV SODEBRAS, V9, P40; Cristancho JA, 2012, ROLE SOIL PLANT NUTR, V33; de Llanos R, 2016, APPL ENVIRON MICROB, V82, P3052, DOI 10.1128/AEM.00305-16; Drew MC, 1997, ANNU REV PLANT PHYS, V48, P223, DOI 10.1146/annurev.arplant.48.1.223; Ernst AM, 2012, P NATL ACAD SCI USA, V109, pE1980, DOI 10.1073/pnas.1202999109; Fan R, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-16; Freeg HA, 2016, CERCET AGRON MOLD, V49; Froelich DR, 2011, PLANT CELL, V23, P4428, DOI 10.1105/tpc.111.093179; Vargas LHG, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1100-z; Govindaraj M, 2015, GENETICS RES INT, V2015, DOI [10.1155/2015/431487, DOI 10.1155/2015/431487]; Haque ME, 2011, PROTEIN PEPTIDE LETT, V18, P912; HENDRY GAF, 1985, NEW PHYTOL, V101, P199, DOI 10.1111/j.1469-8137.1985.tb02826.x; Henkes S, 2001, PLANT CELL, V13, P535, DOI 10.1105/tpc.13.3.535; Hossain Z, 2012, J PROTEOME RES, V11, P37, DOI 10.1021/pr200863r; Ismail AM, 2009, ANN BOT-LONDON, V103, P197, DOI 10.1093/aob/mcn211; Ismond KP, 2003, PLANT PHYSIOL, V132, P1292, DOI 10.1104/pp.103.022244; Jiang GL, 2016, ADV PLANT BREEDING S, V1, P431; Kamal AHM, 2015, J PROTEOMICS, V112, P1, DOI 10.1016/j.jprot.2014.08.014; KENNEDY RA, 1992, PLANT PHYSIOL, V100, P1, DOI 10.1104/pp.100.1.1; Laing D, 2012, INFORM AGRONOMICAS, P137; Less H, 2011, PLANT CELL, V23, P1264, DOI 10.1105/tpc.110.082867; Louise C, 1993, AN 14 C BRAS ENT JAN, P194; Majerus V, 2009, PLANT SOIL, V324, P253, DOI 10.1007/s11104-009-9952-x; Martinez G, 2014, PALMAS, V35, P11; Martinez G., 2010, PALMAS, V31, P43; Meguro N, 2006, ABIOTIC STRESS TOLERANCE IN PLANTS: TOWARD THE IMPROVEMENT OF GLOBAL ENVIRONMENT AND FOOD, P111, DOI 10.1007/1-4020-4389-9_7; Mekhilef S, 2011, RENEW SUST ENERG REV, V15, P1937, DOI 10.1016/j.rser.2010.12.012; Metwali EMR, 2016, ARCH BIOL SCI, V68, P427, DOI 10.2298/ABS150629126M; Miro B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00269; Morales-Olmedo M, 2015, CHIL J AGR RES, V75, P45, DOI 10.4067/S0718-58392015000300006; MUNEVAR MF, 2001, PALMAS, V22, P9; Nadeem MZ, 2017, BIOTECHNOLOGY BIOTEC, P1314; Nakazono M, 2000, PLANT PHYSIOL, V124, P587, DOI 10.1104/pp.124.2.587; Nanjo Y, 2010, J PROTEOME RES, V9, P3989, DOI 10.1021/pr100179f; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Neutelings G, 2011, PLANT SCI, V181, P379, DOI 10.1016/j.plantsci.2011.06.012; Pradhan SK, 2016, PLOS ONE, V11; Rojas CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00017; Sarria GA, 2016, EUR J PLANT PATHOL, V145, P39, DOI 10.1007/s10658-015-0810-9; Sarria G.A., 2008, PALMAS, V29, P31; Scheideler M, 2002, J BIOL CHEM, V277, P10555, DOI 10.1074/jbc.M104863200; Silva HM, 1996, WORKSH CULT DEND, P87; Silveira RI, 2000, EVOLUCAO SINTOMATOLO; SINGH D, 2016, PLOS ONE, V11; Souza RLR, 2000, DENPASA AMARELECIMEN; Srivastava VK, 2016, PLANT CELL REP, V35, P1021, DOI 10.1007/s00299-016-1935-9; Subbaiah CC, 2003, ANN BOT-LONDON, V91, P119, DOI 10.1093/aob/mcf210; Teixeira, 2010, ZONEAMENTO AGROECOLO, P153; Torres GA, 2010, PLANT DIS, V94, P1163, DOI 10.1094/PDIS-94-9-1163A; Torres GA, 2016, PHYTOPATHOLOGY; Trindade DR, 2005, PRAGAS DOENCAS CULTI, P439; Tsuji H, 2003, FEBS LETT, V546, P369, DOI 10.1016/S0014-5793(03)00631-8; Villon M., 2007, DRENAJE; Voesenek LACJ, 2015, NEW PHYTOL, V206, P57, DOI 10.1111/nph.13209; Wang JP, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01557; Wang W, 2006, ELECTROPHORESIS, V27, P2782, DOI 10.1002/elps.200500722; Yu F, 2015, PROTEOMICS, V15, P135, DOI 10.1002/pmic.201400156	70	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195538	10.1371/journal.pone.0195538	http://dx.doi.org/10.1371/journal.pone.0195538			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621343	Green Published, Green Submitted, gold			2022-12-26	WOS:000429206800099
J	Ogren, J; Irewall, AL; Soderstrom, L; Mooe, T				Ogren, Joachim; Irewall, Anna-Lotta; Soderstrom, Lars; Mooe, Thomas			Serious hemorrhages after ischemic stroke or TIA - Incidence, mortality, and predictors	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; ANTIPLATELET THERAPY; MYOCARDIAL-INFARCTION; NATIONWIDE COHORT; SUBGROUP ANALYSIS; VASCULAR-DISEASE; WARFARIN; ASPIRIN; ATTACK; PREVENTION	Background Data are lacking on the risk and impact of a serious hemorrhage on the prognosis after ischemic stroke (IS) or transient ischemic attack (TIA). We aimed to estimate the incidence of serious hemorrhage, analyze the impact on mortality, and identify predictors of hemorrhage after discharge from IS or TIA. Methods and findings All patients admitted to Ostersund Hospital for an IS or TIA in 2010-2013 were included (n = 1528, mean age: 75.1 years). Serious hemorrhages were identified until 31st December 2015. Incidence rates were calculated. The impact on mortality (stratified by functional level) was determined with Kaplan-Meier analysis. Non-parametric estimation under the assumption of competing risk was performed to assess the cumulative incidence and predictors of serious hemorrhages. The incidence rates of serious (n = 113) and intracranial hemorrhages (n = 45) after discharge from IS and TIA were 2.48% and 0.96% per year at risk, respectively. Patients with modified Rankin Scale (mRS) scores of 3-5 exhibited 58.9% mortality during follow-up and those with mRS scores of 0-2 exhibited 18.4% mortality. A serious hemorrhage did not affect mortality in patients with impaired functional status, but it increased the risk of death in patients with mRS scores of 0-2. Hypertension was associated with increased risk of serious hemorrhage. Conclusions We found that, after discharge from an IS or TIA, serious hemorrhages were fairly common. Impairments in function were associated with high mortality, but serious hemorrhages only increased the risk of mortality in patients with no or slight disability. Improved hypertension treatment may decrease the risk of serious hemorrhage, but in patients with low functional status, poor survival makes secondary prevention challenging.	[Ogren, Joachim; Irewall, Anna-Lotta; Mooe, Thomas] Umea Univ, Dept Publ Hlth & Clin Med, Ostersund, Sweden; [Soderstrom, Lars] Unit Res Dev & Educ, Ostersund, Sweden; [Ogren, Joachim] Ostersunds Sjukhus, Medicinmottagningen, Ostersund, Sweden	Umea University	Ogren, J (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Ostersund, Sweden.; Ogren, J (corresponding author), Ostersunds Sjukhus, Medicinmottagningen, Ostersund, Sweden.	joachim.ogren@regionjh.se		Ogren, Joachim/0000-0002-3542-7966	Research Development and Education Unit, Region Jamtland Harjedalen [JLL-640691]	Research Development and Education Unit, Region Jamtland Harjedalen	Fundings recieved from Research Development and Education Unit, Region Jamtland Harjedalen (Grant number: JLL-640691). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarenco P, 2009, LANCET NEUROL, V8, P453, DOI 10.1016/S1474-4422(09)70058-4; Asberg S, 2013, INT J STROKE, V8, P80, DOI 10.1111/j.1747-4949.2011.00718.x; Atar S, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2006.02.013; Badillo R, 2015, PHARMACOEPIDEM DR S, V24, P849, DOI 10.1002/pds.3817; Benavente OR, 2012, NEW ENGL J MED, V367, P817, DOI 10.1056/NEJMoa1204133; Berger PB, 2010, CIRCULATION, V121, P2575, DOI 10.1161/CIRCULATIONAHA.109.895342; Chen ZM, 2000, STROKE, V31, P1240, DOI 10.1161/01.STR.31.6.1240; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; CHIMOWITZ MI, 1995, NEUROLOGY, V45, P1488, DOI 10.1212/WNL.45.8.1488; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; Collins R, 2004, LANCET, V363, P757; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; De Schryver ELLM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001342.pub3; Diener HC, 2010, LANCET NEUROL, V9, P1157, DOI 10.1016/S1474-4422(10)70274-X; Douketis JD, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.06.008; Easton JD, 2012, LANCET NEUROL, V11, P503, DOI 10.1016/S1474-4422(12)70092-3; Eriksson M, 2008, CEREBROVASC DIS, V25, P423, DOI 10.1159/000121343; Evans A, 2000, STROKE, V31, P2106, DOI 10.1161/01.STR.31.9.2106; Feng WW, 2010, NEUROLOGY, V74, P588, DOI 10.1212/WNL.0b013e3181cff776; Friberg L, 2012, CIRCULATION, V125, P2298, DOI 10.1161/CIRCULATIONAHA.111.055079; Gulmez SE, 2009, BRIT J CLIN PHARMACO, V67, P460, DOI 10.1111/j.1365-2125.2009.03362.x; Halkes PHA, 2007, LANCET NEUROL, V6, P115, DOI 10.1016/S1474-4422(06)70685-8; Hankey GJ, 2012, LANCET NEUROL, V11, P315, DOI 10.1016/S1474-4422(12)70042-X; Hankey GJ, 2010, LANCET NEUROL, V9, P273, DOI 10.1016/S1474-4422(10)70038-7; Irewall AL, 2014, CEREBROVASC DIS EXTR, V4, P28, DOI 10.1159/000358121; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; Li LX, 2017, LANCET, V390, P490, DOI 10.1016/S0140-6736(17)30770-5; Mohan KM, 2011, STROKE, V42, P1489, DOI 10.1161/STROKEAHA.110.602615; Mohr JP, 2001, NEW ENGL J MED, V345, P1444, DOI 10.1056/NEJMoa011258; Ogren J, 2015, CIRC-CARDIOVASC QUAL, V8, P413, DOI 10.1161/CIRCOUTCOMES.114.001606; Petty GW, 1999, ANN INTERN MED, V130, P14, DOI 10.7326/0003-4819-130-1-199901050-00004; Saxena R, 2004, COCHRANE DB SYST REV; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Usman MHU, 2009, AM J CARDIOL, V103, P1107, DOI 10.1016/j.amjcard.2009.01.003; van Wijk I, 2005, LANCET, V365, P2098, DOI 10.1016/S0140-6736(05)66734-7	36	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195324	10.1371/journal.pone.0195324	http://dx.doi.org/10.1371/journal.pone.0195324			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621285	Green Published, gold, Green Submitted			2022-12-26	WOS:000429206800061
J	Choi, B; Lee, HW; Mo, S; Kim, JY; Kim, HW; Rhyu, IJ; Hong, E; Lee, YK; Choi, JS; Kim, CH; Kim, H				Choi, Byungil; Lee, Hyun Woo; Mo, Seojung; Kim, Jin Yong; Kim, Hyun Wook; Rhyu, Im Joo; Hong, Eunhwa; Lee, Yeon Kyung; Choi, June-Seek; Kim, Chong-Hyun; Kim, Hyun			Inositol 1,4,5-trisphosphate 3-kinase A overexpressed in mouse forebrain modulates synaptic transmission and mGluR-LTD of CA1 pyramidal neurons	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; LONG-TERM DEPRESSION; PROTEIN-KINASE-C; DHPG-INDUCED LTD; GYRUS IN-VITRO; SIGNAL-TRANSDUCTION; RAT HIPPOCAMPUS; BEHAVIORAL FLEXIBILITY; ENDOPLASMIC-RETICULUM; DENDRITIC SPINES	Inositol 1,4,5-trisphosphate 3-kinase A (IP3K-A) regulates the level of the inositol polyphosphates, inositol trisphosphate (IP3) and inositol tetrakisphosphate to modulate cellular signaling and intracellular calcium homeostasis in the central nervous system. IP3K-A binds to F-actin in an activity-dependent manner and accumulates in dendritic spines, where it is involved in the regulation of synaptic plasticity. IP3K-A knockout mice exhibit deficits in some forms of hippocampus-dependent learning and synaptic plasticity, such as long-term potentiation in the dentate gyrus synapses of the hippocampus. In the present study, to further elucidate the role of IP3K-A in the brain, we developed a transgenic (Tg) mouse line in which IP3K-A is conditionally overexpressed approximately 3-fold in the excitatory neurons of forebrain regions, including the hippocampus. The Tg mice showed an increase in both presynaptic release probability of evoked responses, along with bigger synaptic vesicle pools, and miniature excitatory postsynaptic current amplitude, although the spine density or the expression levels of the postsynaptic density-related proteins NR2B, synaptotagmin 1, and PSD-95 were not affected. Hippocampal-dependent learning and memory tasks, including novel object recognition and radial arm maze tasks, were partially impaired in Tg mice. Furthermore, (R,S)-3,5-dihydroxyphenylglycine-induced metabotropic glutamate receptor long-term depression was inhibited in Tg mice and this inhibition was dependent on protein kinase C but not on the IP3 receptor. Long-term potentiation and depression dependent on N-methyl-d-aspartate receptor were marginally affected in Tg mice. In summary, this study shows that overexpressed IP3K-A plays a role in some forms of hippocampus-dependent learning and memory tasks as well as in synaptic transmission and plasticity by regulating both presynaptic and postsynaptic functions.	[Choi, Byungil; Lee, Hyun Woo; Mo, Seojung; Kim, Jin Yong; Kim, Hyun Wook; Rhyu, Im Joo; Kim, Hyun] Korea Univ, Dept Anat, Coll Med, Brain Korea, Seoul, South Korea; [Hong, Eunhwa; Lee, Yeon Kyung; Choi, June-Seek] Korea Univ, Dept Psychol, Seoul, South Korea; [Kim, Chong-Hyun] Korea Inst Sci & Technol, Ctr Neurosci, Brain Sci Inst, Seoul, South Korea; [Kim, Chong-Hyun] Korea Univ Sci & Technol, KIST Sch, Div Biomed Sci & Technol, Neurosci Program, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST)	Kim, H (corresponding author), Korea Univ, Dept Anat, Coll Med, Brain Korea, Seoul, South Korea.; Kim, CH (corresponding author), Korea Inst Sci & Technol, Ctr Neurosci, Brain Sci Inst, Seoul, South Korea.; Kim, CH (corresponding author), Korea Univ Sci & Technol, KIST Sch, Div Biomed Sci & Technol, Neurosci Program, Seoul, South Korea.	ckimya@kist.re.kr; kimhyun@korea.ac.kr		Kim, Hyun/0000-0002-7210-5798; Kim, Jin Yong/0000-0001-8080-3206; Rhyu, Im Joo/0000-0002-5558-6278	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2017M3C7A1048566, NRF-2012M3A9B6055378, NRF-2017M3C7A1079692, NRF-2016M3C7A1905119]; KIST Institutional Program [2E28412]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; KIST Institutional Program(Korea Institute of Science & Technology (KIST))	This work was supported by National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT & Future Planning (NRF-2017M3C7A1048566, NRF-2012M3A9B6055378, NRF-2017M3C7A1079692 to H. Kim; NRF-2016M3C7A1905119 to C-H. Kim) and KIST Institutional Program (2E28412 to C-H. Kim).; This work was supported by National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT & Future Planning (NRF-2017M3C7A1048566, NRF-2017M3C7A1079692 to H. Kim; NRF-2016M3C7A1905119 to C-H. Kim) and KIST Institutional Program (2E28412 to C-H. Kim)	ABE T, 1992, J BIOL CHEM, V267, P13361; ARAMORI I, 1992, NEURON, V8, P757, DOI 10.1016/0896-6273(92)90096-V; Ashour DJ, 2015, CYTOSKELETON, V72, P93, DOI 10.1002/cm.21208; Bengtson CP, 2012, ADV EXP MED BIOL, V970, P377, DOI 10.1007/978-3-7091-0932-8_17; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bhardwaj SK, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00072; Camodeca N, 1999, NEUROPHARMACOLOGY, V38, P1597, DOI 10.1016/S0028-3908(99)00093-3; Chen A, 2017, PSYCHOPHARMACOLOGY, V234, P681, DOI 10.1007/s00213-016-4503-7; Chung S, 2016, SCI REP-UK, V6, DOI 10.1038/srep23757; Emptage NJ, 2003, NEURON, V38, P797, DOI 10.1016/S0896-6273(03)00325-8; ERNEUX C, 1989, EUR J BIOCHEM, V181, P317, DOI 10.1111/j.1432-1033.1989.tb14726.x; ERNEUX C, 1995, EUR J BIOCHEM, V234, P598, DOI 10.1111/j.1432-1033.1995.598_b.x; de Sevilla DF, 2008, J NEUROSCI, V28, P1469, DOI 10.1523/JNEUROSCI.2723-07.2008; de Sevilla DF, 2010, J NEUROSCI, V30, P11032, DOI 10.1523/JNEUROSCI.1848-10.2010; Fitzjohn SM, 1999, NEUROPHARMACOLOGY, V38, P1577, DOI 10.1016/S0028-3908(99)00123-9; Gerlai R, 1998, BEHAV BRAIN RES, V95, P37, DOI 10.1016/S0166-4328(98)00002-3; Hallett Penelope J, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0116s42; Heinke B, 2005, PAIN, V118, P145, DOI 10.1016/j.pain.2005.08.004; Jin I, 2012, P NATL ACAD SCI USA, V109, P9137, DOI 10.1073/pnas.1206846109; Jolas T, 2002, NEUROBIOL DIS, V11, P394, DOI 10.1006/nbdi.2002.0557; Jun KS, 1998, LEARN MEMORY, V5, P317; Kamsler A, 2010, P NATL ACAD SCI USA, V107, P1618, DOI 10.1073/pnas.0912540107; Kim IH, 2004, MOL BRAIN RES, V124, P12, DOI 10.1016/j.molbrainres.2003.12.016; Kim IH, 2009, J NEUROSCI, V29, P14039, DOI 10.1523/JNEUROSCI.2483-09.2009; Kim JI, 2011, NAT NEUROSCI, V14, P1447, DOI 10.1038/nn.2937; Lauri SE, 2003, NEURON, V39, P327, DOI 10.1016/S0896-6273(03)00369-6; Lee DM, 2012, J BIOL CHEM, V287, P15981, DOI 10.1074/jbc.M112.344101; Lu W, 2014, J BIOL CHEM, V289, P19218, DOI 10.1074/jbc.M113.511246; LUO JH, 1993, J BIOL CHEM, V268, P23580; Michalon A, 2005, GENESIS, V43, P205, DOI 10.1002/gene.20175; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Mihalas S, 2011, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00158; Miyakawa T, 2001, HIPPOCAMPUS, V11, P763, DOI 10.1002/hipo.1092; Mockett BG, 2011, J NEUROSCI, V31, P7380, DOI 10.1523/JNEUROSCI.6656-10.2011; Nicholls RE, 2008, NEURON, V58, P104, DOI 10.1016/j.neuron.2008.01.039; Nicoll RA, 1998, NEUROBIOL LEARN MEM, V70, P62, DOI 10.1006/nlme.1998.3838; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Nosyreva ED, 2005, J NEUROSCI, V25, P2992, DOI 10.1523/JNEUROSCI.3652-04.2005; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Pick JE, 2017, EMBO J, V36, P232, DOI 10.15252/embj.201694526; Rammes G, 2003, J PHYSIOL-LONDON, V546, P455, DOI 10.1113/jphysiol.2002.033514; Rush AM, 2002, J NEUROSCI, V22, P6121; Sanderson TM, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-30; Schell MJ, 2001, J BIOL CHEM, V276, P37537, DOI 10.1074/jbc.M104101200; Schnabel R, 2001, BRIT J PHARMACOL, V132, P1095, DOI 10.1038/sj.bjp.0703905; Simkus CRL, 2002, J PHYSIOL-LONDON, V545, P521, DOI 10.1113/jphysiol.2002.022103; Sun W, 2006, NEUROSCI LETT, V392, P181, DOI 10.1016/j.neulet.2005.09.048; Szinyei C, 1999, J PHYSIOL-LONDON, V516, P855, DOI 10.1111/j.1469-7793.1999.0855u.x; Windhorst S, 2012, CELL SIGNAL, V24, P750, DOI 10.1016/j.cellsig.2011.11.010; YAMADA M, 1992, BRAIN RES, V578, P41, DOI 10.1016/0006-8993(92)90227-Z; YAMADA M, 1993, BRAIN RES, V606, P335, DOI 10.1016/0006-8993(93)91004-C; Yang J, 2011, EMBO J, V30, P165, DOI 10.1038/emboj.2010.286; Yokoi M, 1996, SCIENCE, V273, P645, DOI 10.1126/science.273.5275.645; Zheng C, 2015, NEUROPHARMACOLOGY, V93, P80, DOI 10.1016/j.neuropharm.2015.01.016	54	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0193859	10.1371/journal.pone.0193859	http://dx.doi.org/10.1371/journal.pone.0193859			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617377	Green Submitted, gold, Green Published			2022-12-26	WOS:000429203800015
J	Kath, C; Goni-Oliver, P; Muller, R; Schultz, C; Haucke, V; Eickholt, B; Schmoranzer, J				Kath, Christina; Goni-Oliver, Paloma; Mueller, Rainer; Schultz, Carsten; Haucke, Volker; Eickholt, Britta; Schmoranzer, Jan			PTEN suppresses axon outgrowth by down-regulating the level of detyrosinated microtubules	PLOS ONE			English	Article							LHERMITTE-DUCLOS-DISEASE; TUMOR-SUPPRESSOR; CELL MOTILITY; POSTTRANSLATIONAL MODIFICATIONS; SELECTIVE STABILIZATION; DYNAMIC INSTABILITY; NEGATIVE REGULATION; SOMA SIZE; TUBULIN; MECHANISMS	Inhibition of the phospholipid phosphatase and tumor suppressor PTEN leads to excessive polarized cell growth during directed cell migration and neurite outgrowth. These processes require the precise regulation of both the actin and microtubule cytoskeleton. While PTEN is known to regulate actin dynamics through phospholipid modulation, whether and how PTEN regulates microtubule dynamics is unknown. Here, we show that depletion of PTEN leads to elevated levels of stable and post-translationally modified (detyrosinated) microtubules in fibroblasts and developing neurons. Further, PTEN depletion enhanced axon outgrowth, which was rescued by reducing the level of detyrosinated microtubules. These data demonstrate a novel role of PTEN in regulating the microtubule cytoskeleton. They further show a novel function of detyrosinated microtubules in axon outgrowth. Specifically, PTEN suppresses axon outgrowth by down-regulating the level of detyrosinated microtubules. Our results suggest that PTEN's role in preventing excessive cell growth in cancerous and neuro-developmental phenotypes is partially exerted by stabilization and detyrosination of the microtubule cytoskeleton.	[Kath, Christina; Goni-Oliver, Paloma; Eickholt, Britta; Schmoranzer, Jan] Charite, Virchowweg 6, Berlin, Germany; [Kath, Christina; Haucke, Volker; Schmoranzer, Jan] Leibniz Inst Mol Pharmacol, Robert Roessle Str 10, Berlin, Germany; [Mueller, Rainer; Schultz, Carsten] European Mol Biol Lab, Meyerhofstr 1, Heidelberg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); European Molecular Biology Laboratory (EMBL)	Schmoranzer, J (corresponding author), Charite, Virchowweg 6, Berlin, Germany.; Schmoranzer, J (corresponding author), Leibniz Inst Mol Pharmacol, Robert Roessle Str 10, Berlin, Germany.	jan.schmoranzer@charite.de		Eickholt, Britta/0000-0001-7873-8687; Mueller, Rainer/0000-0003-3464-494X; Schmoranzer, Jan/0000-0002-4482-7080	Deutsche Forschungsgemeinschaft (DFG) [SFB958/Z02, SFB958/A16, TRR186/A08]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by funding from the Deutsche Forschungsgemeinschaft (DFG) to J.S. (SFB958/Z02), to B.E. (SFB958/A16), to V.H. and C.S. (TRR186/A08).; This work was supported by funding from the Deutsche Forschungsgemeinschaft (DFG) to J.S. (SFB958/Z02), to B.E. (SFB958/A16), to V.H. and C.S. (TRR186/A08). We like to thank the Advanced Medical Bioimaging Core Facility (AMBIO) of the Charite-Universitatsmedizin for support in acquisition and analysis of imaging data.	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Aillaud C, 2017, SCIENCE, V358, P1448, DOI 10.1126/science.aao4165; ARCE CA, 1975, EUR J BIOCHEM, V59, P145, DOI 10.1111/j.1432-1033.1975.tb02435.x; Baas PW, 2016, CYTOSKELETON, V73, P442, DOI 10.1002/cm.21286; BAAS PW, 1991, J NEUROSCI RES, V30, P134, DOI 10.1002/jnr.490300115; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Burbank KS, 2006, CURR BIOL, V16, pR516, DOI 10.1016/j.cub.2006.06.044; Coles CH, 2015, CURR BIOL, V25, pR677, DOI 10.1016/j.cub.2015.06.020; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; Eng CH, 2006, MOL BIOL CELL, V17, P5004, DOI 10.1091/mbc.E05-10-0914; Fukushima N, 2009, J NEUROCHEM, V109, P683, DOI 10.1111/j.1471-4159.2009.06013.x; Gordon-Weeks PR, 2016, BRAIN RES BULL, V126, P293, DOI 10.1016/j.brainresbull.2016.06.015; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; HALLAK ME, 1977, FEBS LETT, V73, P147, DOI 10.1016/0014-5793(77)80968-X; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Kaul N, 2014, BIOPHYS J, V106, P2636, DOI 10.1016/j.bpj.2014.05.008; Kim YT, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00048; Knafo S, 2017, TRENDS NEUROSCI, V40, P83, DOI 10.1016/j.tins.2016.11.008; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Kreis P, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00023; Kreis P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071957; KREIS TE, 1987, EMBO J, V6, P2597, DOI 10.1002/j.1460-2075.1987.tb02550.x; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Laketa V, 2009, CHEM BIOL, V16, P1190, DOI 10.1016/j.chembiol.2009.10.005; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Leibinger M, 2017, P NATL ACAD SCI USA, V114, pE5454, DOI 10.1073/pnas.1621225114; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Liao GJ, 1998, J BIOL CHEM, V273, P9797, DOI 10.1074/jbc.273.16.9797; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Marcos S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005405; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Mester J, 2013, AM J MED GENET C, V163C, P114, DOI 10.1002/ajmg.c.31364; Mester JL, 2011, EUR J HUM GENET, V19, P763, DOI 10.1038/ejhg.2011.20; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Ning K, 2010, HUM MOL GENET, V19, P3159, DOI 10.1093/hmg/ddq226; Ohtake Y, 2015, NEURAL REGEN RES, V10, P1363, DOI 10.4103/1673-5374.165496; Pacheco A, 2016, BRAIN RES BULL, V126, P300, DOI 10.1016/j.brainresbull.2016.07.013; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Peris L, 2009, J CELL BIOL, V185, P1159, DOI 10.1083/jcb.200902142; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Prota AE, 2013, J CELL BIOL, V200, P259, DOI 10.1083/jcb.201211017; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tamura M, 1999, J BIOL CHEM, V274, P20693, DOI 10.1074/jbc.274.29.20693; Tsujita K, 2015, BBA-MOL CELL BIOL L, V1851, P824, DOI 10.1016/j.bbalip.2014.10.011; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Zhou J, 2012, CURR OPIN NEUROBIOL, V22, P873, DOI 10.1016/j.conb.2012.05.004; Zink S, 2012, J CELL SCI, V125, P5998, DOI 10.1242/jcs.109470	59	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0193257	10.1371/journal.pone.0193257	http://dx.doi.org/10.1371/journal.pone.0193257			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617365	Green Submitted, gold, Green Published			2022-12-26	WOS:000429203800006
J	Ramongolalaina, C; Teraishi, M; Okumoto, Y				Ramongolalaina, Clarissien; Teraishi, Masayoshi; Okumoto, Yutaka			QTLs underlying the genetic interrelationship between efficient compatibility of Bradyrhizobium strains with soybean and genistein secretion by soybean roots	PLOS ONE			English	Article							FROGEYE LEAF-SPOT; GEOGRAPHICAL-DISTRIBUTION; NODULATING BRADYRHIZOBIA; ANTIBACTERIAL ACTIVITY; ISOFLAVONE CONTENTS; GLYCINE-MAX; JAPONICUM; RESISTANCE; SEED; RHIZOBIUM	Soybean plants establish symbiotic relationships with soil rhizobia which form nodules on the plant roots. Nodule formation starts when the plant roots exudate isoflavonoids that induce nod gene expression of a specific Bradyrhizobium. We examined the specific indigenous rhizobia that form nodules with the soybean cultivars Peking and Tamahomare in different soils. PCR-RFLP analysis targeted to the 16S-23S rRNA gene internal transcribed spacer (ITS) region of the bacterial type of each root nodule showed that Bradyrhizobium japonicum (USDA110-type) and Bradyrhizobium elkanii (USDA94-type) had high compatibility with the Tamahomare and Peking cultivars, respectively. We grew 93 recombinant inbred lines (RIL) of soybean seeds derived from the cross between Peking and Tamahomare in three different field soils and identified the indigenous rhizobia nodulating each line using the same PCR-RFLP analysis. QTL analysis identified one QTL region in chromosome-18 with a highly significant additive effect that controls compatibility with both B. japonicum USDA110 and B. elkanii USDA94. We also measured the amount of daidzein and genistein secretion from roots of the 93 RILs by HPLC analysis. QTL analysis showed one QTL region in chromosome-18 controlling genistein secretion from roots and coinciding with that regulating compatibility of specific indigenous rhizobia with soybean. The amount of genistein may be a major regulatory factor in soybean-rhizobium compatibility.	[Ramongolalaina, Clarissien; Teraishi, Masayoshi; Okumoto, Yutaka] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto, Japan	Kyoto University	Teraishi, M (corresponding author), Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto, Japan.	temple@kais.kyoto-u.ac.jp	Teraishi, Masayoshi/AAC-1055-2021; Teraishi, Masayoshi/D-8602-2018	Teraishi, Masayoshi/0000-0002-6768-8052; Teraishi, Masayoshi/0000-0002-6768-8052				Akao S., 2004, SOIL SCI PLANT NUTR, V50, P517; Baker WA, 1999, CROP SCI, V39, P1021, DOI 10.2135/cropsci1999.0011183X003900040010x; BANFALVI Z, 1988, MOL GEN GENET, V214, P420, DOI 10.1007/BF00330475; Chianu JN, 2011, SUSTAINABLE AGR, V2; Chueire LMD, 1997, PLANT SOIL, V196, P1, DOI 10.1023/A:1004222218007; CHURCHILL GA, 1994, GENETICS, V138, P963; Concibido VC, 1997, CROP SCI, V37, P258, DOI 10.2135/cropsci1997.0011183X003700010046x; Cooper JE, 2007, J APPL MICROBIOL, V103, P1355, DOI 10.1111/j.1365-2672.2007.03366.x; DEMSKI JW, 1975, PHYTOPATHOLOGY, V65, P95, DOI 10.1094/Phyto-65-95; Devine TE, 1996, PLANT SOIL, V186, P173, DOI 10.1007/BF00035072; Dolatabadian A, 2012, S AFR J BOT, V79, P9, DOI 10.1016/j.sajb.2011.11.001; DUNN MF, 1992, FEMS MICROBIOL LETT, V97, P107; Geurts R, 2002, PLANT CELL, V14, pS239, DOI 10.1105/tpc.002451; Gibson KE, 2008, ANNU REV GENET, V42, P413, DOI 10.1146/annurev.genet.42.110807.091427; GRAHAM TL, 1991, PLANT PHYSIOL, V95, P594, DOI 10.1104/pp.95.2.594; Guo B, 2005, THEOR APPL GENET, V111, P965, DOI 10.1007/s00122-005-0031-2; Hayashi M, 2011, BREEDING SCI, V61, P544, DOI 10.1270/jsbbs.61.544; Hoeck JA, 2000, CROP SCI, V40, P48, DOI 10.2135/cropsci2000.40148x; Hong HK, 2006, J BASIC MICROB, V46, P329, DOI 10.1002/jobm.200510073; KEELING BL, 1982, PHYTOPATHOLOGY, V72, P807, DOI 10.1094/Phyto-72-807; KOSSLAK RM, 1990, APPL ENVIRON MICROB, V56, P1333, DOI 10.1128/AEM.56.5.1333-1341.1990; KOSSLAK RM, 1987, P NATL ACAD SCI USA, V84, P7428, DOI 10.1073/pnas.84.21.7428; Kouchi H, 2010, PLANT CELL PHYSIOL, V51, P1381, DOI 10.1093/pcp/pcq107; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lozovaya VV, 2005, CROP SCI, V45, P1934, DOI 10.2135/cropsci2004.0567; Miransari M, 2009, EUR J SOIL BIOL, V45, P146, DOI 10.1016/j.ejsobi.2008.11.002; Munoz N, 2014, BIOL FERT SOILS, V50, P207, DOI 10.1007/s00374-013-0843-1; Murphy SE, 2009, CROP SCI, V49, P1313, DOI 10.2135/cropsci2008.09.0533; Napoles MC, 2009, SPAN J AGRIC RES, V7, P665; Pradhan A, 2011, T ASABE, V54, P1031, DOI 10.13031/2013.37088; Pradhan A, 2009, AGR EC REP; Sadowsky MJ, 1991, RHIZOSPHERE PLANT GR, P173; Saeki Y, 2004, SOIL SCI PLANT NUTR, V50, P517, DOI 10.1080/00380768.2004.10408508; Saeki Y, 2006, SOIL SCI PLANT NUTR, V52, P418, DOI 10.1111/j.1747-0765.2006.00050.x; Saeki Y, 2011, SOYBEAN - MOLECULAR ASPECTS OF BREEDING, P163; Sayama T, 2009, PLANT SCI, V176, P514, DOI 10.1016/j.plantsci.2009.01.007; Shiro S, 2013, APPL ENVIRON MICROB, V79, P3610, DOI 10.1128/AEM.00236-13; Subramanian S, 2006, PLANT J, V48, P261, DOI 10.1111/j.1365-313X.2006.02874.x; Suss C, 2006, J BIOTECHNOL, V126, P69, DOI [10.1016/j.jbiotec.20063.03.037, 10.1016/j.jbiotec.2006.03.037]; Sugiyama A, 2016, BIOSCI BIOTECH BIOCH, V80, P89, DOI 10.1080/09168451.2015.1062714; Sugiyama A, 2008, PLANT SIGNAL BEHAV, V3, P38, DOI 10.4161/psb.3.1.4819; Tang F, 2016, PLANT PHYSIOL, V170, P26, DOI 10.1104/pp.15.01661; TJEPKEMA JD, 1980, SCIENCE, V209, P279, DOI 10.1126/science.7384801; Ulanowska K, 2006, ARCH MICROBIOL, V184, P271, DOI 10.1007/s00203-005-0063-7; Wang S, 2007, WINDOWS QTL CARTOGRA, V2, P5; Wang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118447; Yang SM, 2010, P NATL ACAD SCI USA, V107, P18735, DOI 10.1073/pnas.1011957107; Yang W, 2001, PLANT BREEDING, V120, P73, DOI 10.1046/j.1439-0523.2001.00563.x; Yoshikawa T, 2010, BREEDING SCI, V60, P243, DOI 10.1270/jsbbs.60.243; Zhang S, 2004, PLANT SOIL, V262, P277, DOI 10.1023/B:PLSO.0000037048.26437.fa; Zhao X, 2014, PLANT PROD SCI, V17, P103, DOI 10.1626/pps.17.103	51	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194671	10.1371/journal.pone.0194671	http://dx.doi.org/10.1371/journal.pone.0194671			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617389	Green Published, Green Submitted, gold			2022-12-26	WOS:000429203800044
J	Walles, JK; Tesfaye, F; Jansson, M; Balcha, TT; Winqvist, N; Kefeni, M; Abeya, SG; Belachew, F; Sturegard, E; Bjorkman, P				Walles, John Konig; Tesfaye, Fregenet; Jansson, Marianne; Balcha, Taye Tolera; Winqvist, Niclas; Kefeni, Mestawet; Abeya, Sileshi Garoma; Belachew, Feleke; Sturegard, Erik; Bjorkman, Per			Performance of QuantiFERON-TB Gold Plus for detection of latent tuberculosis infection in pregnant women living in a tuberculosis- and HIV-endemic setting	PLOS ONE			English	Article							HEALTH-CARE WORKERS; ANTIGEN-SPECIFIC CD4; INTERFERON-GAMMA; IFN-GAMMA; ASSAYS; RISK; SENSITIVITY; DIAGNOSIS	We evaluated the performance of QuantiFERON-TB Gold Plus (OFT-Plus), which includes two Mycobacterium tuberculosis antigen formulations (TB1 and TB2), for detection of latent tuberculosis infection during pregnancy. Eight-hundred-twenty-nine Ethiopian pregnant women (5.9% HIV-positive) were tested with QFT-Plus, with bacteriological sputum analysis performed for women with clinically suspected tuberculosis and HIV-positive women irrespective of clinical presentation. QFT-Plus read-out was categorized according to the conventional cut-off (0.35 IU/ml) for both antigen formulations. In addition, we analysed the distribution of QFT-Plus results within a borderline zone (0.20-0.70 IU/ml), and interferon-gamma response in relation to HIV infection and gestational age. Two-hundred-seventy-seven women (33%) were QFT-Plus-positive (HIV-positive 16/49 [33%]; HIV-negative 261/780 [33%]). There was a strong agreement between the two antigen formulations (kappa = 0.92), with discordant results in 29 cases (3.5%). Whereas discordant QFT-Plus results were rare in pregnancy, several results with both TB1 and TB2 within the borderline range were observed (11/49 [22%] vs. 43/780 [5.5%] in HIV-positive and HIV-negative women, respectively; p<0.0001). HIV-positive women had lower absolute interferon-gamma levels (TB1: 0.47 vs. 2.16 IU/ml; p<0.001, TB2: 0.49 vs. 2.24 IU/ml, p<0.001, considering results >= 0.20 IU/ml) compared to HIV-negative women. QFT-Plus-positive women who submitted samples at later stages of pregnancy had lower mitogen- (p<0.001) but higher TB-antigen-specific (p = 0.031 for TB1, p = 0.061 for TB2) interferon-gamma response. Considering their lower capacity to produce TB-specific interferon-y, a lower cut-off level for defining QFT-Plus-positivity may be considered in HIV-positive pregnant women.	[Walles, John Konig; Tesfaye, Fregenet; Balcha, Taye Tolera; Winqvist, Niclas; Sturegard, Erik; Bjorkman, Per] Lund Univ, Dept Translat Med, Clin Infect Med, Malmo, Sweden; [Walles, John Konig] Cent Hosp Kristianstad, Dept Infect Dis, Kristianstad, Sweden; [Jansson, Marianne] Lund Univ, Dept Lab Med, Med Microbiol, Lund, Sweden; [Balcha, Taye Tolera] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Winqvist, Niclas; Sturegard, Erik] Skane Reg Off Infect Dis Control & Prevent, Malmo, Sweden; [Kefeni, Mestawet; Belachew, Feleke] Adama Reg Lab, Adama, Ethiopia; [Abeya, Sileshi Garoma] Adama Hosp Med Coll, Adama, Ethiopia	Lund University; Lund University	Walles, JK (corresponding author), Lund Univ, Dept Translat Med, Clin Infect Med, Malmo, Sweden.; Walles, JK (corresponding author), Cent Hosp Kristianstad, Dept Infect Dis, Kristianstad, Sweden.	John.Konig_Walles@med.lu.se	Walles, John/AAE-9202-2019	Konig Walles, John/0000-0002-3445-7741; Jansson, Marianne/0000-0001-6536-8146				Ai JW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.10; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Aris A, 2008, J OBSTET GYNAECOL RE, V34, P7, DOI 10.1111/j.1447-0756.2007.00676.x; Asuquo B, 2012, J OBSTET GYNAECOL, V32, P635, DOI 10.3109/01443615.2012.704436; Barcellini L, 2016, EUR RESPIR J, V48, P1411, DOI 10.1183/13993003.00510-2016; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bates M, 2015, INT J INFECT DIS, V32, P124, DOI 10.1016/j.ijid.2014.12.014; Brock I, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-56; Costa JT, 2011, INT ARCH OCC ENV HEA, V84, P461, DOI 10.1007/s00420-010-0571-x; Dorman SE, 2014, AM J RESP CRIT CARE, V189, P77, DOI 10.1164/rccm.201302-0365OC; Esmail H, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1875-6; Ethiopia Federal Ministry of Health Implementation, 2007, GUID TB HIV COLL ACT; Gebreegziabiher D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/364137; Hoffmann H, 2016, CLIN MICROBIOL INFEC, V22, P701, DOI 10.1016/j.cmi.2016.05.006; Jonnalagadda S, 2010, J INFECT DIS, V202, P1826, DOI 10.1086/657411; Jonsson J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187313; Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566; LaCourse SM, 2016, INFECT DIS OBSTET GY, P21; LaCourse SM, 2017, JAIDS-J ACQ IMM DEF, V75, P128, DOI 10.1097/qai.0000000000001298; Leidl L, 2010, EUR RESPIR J, V35, P619, DOI 10.1183/09031936.00045509; Lin WC, 2016, J MICROBIOL IMMUNOL, V49, P729, DOI 10.1016/j.jmii.2014.08.010; Mathad JS, 2016, AM J RESP CRIT CARE, V193, P1421, DOI 10.1164/rccm.201508-1595OC; Mathad JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092308; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Metcalfe JZ, 2013, AM J RESP CRIT CARE, V187, P206, DOI 10.1164/rccm.201203-0430OC; Moon HW, 2017, J CLIN MICROBIOL, V55, P1650, DOI 10.1128/JCM.02498-16; Nemes E, 2017, AM J RESP CRIT CARE, V196, P638, DOI 10.1164/rccm.201704-0817OC; Nienhaus A, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/1745-6673-9-9; Nikolova M, 2013, DIAGN MICR INFEC DIS, V75, P277, DOI 10.1016/j.diagmicrobio.2012.11.023; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Petruccioli E, 2017, TUBERCULOSIS, V106, P38, DOI 10.1016/j.tube.2017.06.002; Petruccioli E, 2016, J INFECTION, V73, P588, DOI 10.1016/j.jinf.2016.09.008; Rendell NL, 2016, INT J TUBERC LUNG D, V20, P1615, DOI 10.5588/ijtld.16.0314; Sharma T, 2013, INDIAN J HEMATOL BLO, V29, P278; Sutherland R, 2006, AIDS, V20, P821, DOI 10.1097/01.aids.0000218545.31716.a4; Tagmouti Saloua, 2014, Ann Am Thorac Soc, V11, P1267, DOI 10.1513/AnnalsATS.201405-188OC; Telisinghe L, 2017, INT J TUBERC LUNG D, V21, P690, DOI 10.5588/ijtld.16.0764; Thanassi W, 2012, PULM MED, V2012, DOI 10.1155/2012/291294; Towers CV, 2010, J MATERN-FETAL NEO M, V23, P1091, DOI 10.3109/14767050903580359; Ufelle SA, 2017, BIOMED RES-INDIA, V28, P6282; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Zenner D, 2012, AM J RESP CRIT CARE, V185, P779, DOI 10.1164/rccm.201106-1083OC	43	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0193589	10.1371/journal.pone.0193589	http://dx.doi.org/10.1371/journal.pone.0193589			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617458	gold, Green Published, Green Submitted			2022-12-26	WOS:000429203800010
J	Kleyheeg, E; Claessens, M; Soons, MB				Kleyheeg, Erik; Claessens, Mascha; Soons, Merel B.			Interactions between seed traits and digestive processes determine the germinability of bird-dispersed seeds	PLOS ONE			English	Article							DABBLING DUCKS; DIETARY FIBER; GUT PASSAGE; ANAS; GERMINATION; MALLARDS; PLANTS; MORPHOLOGY; SUCCESS; SIZE	Waterbirds disperse a wide range of plant seeds via their guts, promoting biotic connectivity between isolated habitat patches. However, the intensity of digestive forces encountered by seeds, and therefore their potential to survive digestive tract passage, varies within and between waterbird species. Here, we investigate under controlled conditions how the interaction between seed traits and digestive strategies affect the germinability of seeds following waterbird-mediated dispersal. We exposed seeds of 30 wetland plant species to the main digestive processes in the dabbling duck digestive system: mechanical, chemical and intestinal digestion. These were simulated by 1) a pressure test and scarification treatment, 2) incubation in simulated gastric juice, and 3) incubation in intestinal contents of culled mallards (Anas platyrhynchos). We evaluated their separate and combined effects on seed germination, and identified the role of seed size and seed coat traits in resisting the digestive forces. Seeds were generally resistant to separate digestive processes, but highly sensitive to a combination. Resistance to mechanical break-down was reduced by up to 80% by chemical pre-treatment, especially for seeds with permeable coats. Scarified seeds were 12-17% more vulnerable to chemical and intestinal digestive processes than undamaged seeds. Large seeds and seeds with thin, permeable coats were particularly sensitive to chemical and intestinal digestion. These results indicate that efficient digestion of seeds requires multiple digestive processes. The gizzard, responsible for mechanical digestion, plays a key role in seed survival. Omnivorous birds, which have relatively light gizzards compared to pure herbivores or granivores, are thus most likely to disperse seeds successfully. Regardless of digestive strategy, small seeds with tough seed coats are most resistant to digestion and may be adapted to endozoochorous dispersal by waterbirds.	[Kleyheeg, Erik; Claessens, Mascha; Soons, Merel B.] Univ Utrecht, Inst Environm Biol, Ecol & Biodivers Grp, Utrecht, Netherlands; [Soons, Merel B.] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands; [Kleyheeg, Erik] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany	Utrecht University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Max Planck Society	Kleyheeg, E (corresponding author), Univ Utrecht, Inst Environm Biol, Ecol & Biodivers Grp, Utrecht, Netherlands.; Kleyheeg, E (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany.	erikkleyheeg@gmail.com	KNAW, NIOO-KNAW/A-4320-2012	KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Organization for Scientific Research [VIDI 864.10.006]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This study was funded by the Netherlands Organization for Scientific Research (https://www.nwo.nl/); grant number VIDI 864.10.006 to Merel B. Soons. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGAMI M, 1986, OECOLOGIA, V68, P473, DOI 10.1007/BF01036757; Albert A, 2015, ECOGRAPHY, V38, P440, DOI 10.1111/ecog.00709; BARNES EM, 1972, AM J CLIN NUTR, V25, P1475; BARNES GG, 1987, CAN J ZOOL, V65, P1812, DOI 10.1139/z87-274; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brochet AL, 2012, J ZOOL, V286, P171, DOI 10.1111/j.1469-7998.2011.00870.x; Brochet AL, 2010, FRESHWATER BIOL, V55, P1262, DOI 10.1111/j.1365-2427.2009.02350.x; Brochet AL, 2010, AQUAT BOT, V93, P99, DOI 10.1016/j.aquabot.2010.04.001; Brochet AL, 2009, ECOGRAPHY, V32, P919, DOI 10.1111/j.1600-0587.2009.05757.x; Charalambidou I, 2005, FUNCT ECOL, V19, P513, DOI 10.1111/j.1365-2435.2005.00998.x; Clench MH, 1999, J EXP ZOOL, V283, P441, DOI 10.1002/(SICI)1097-010X(19990301/01)283:4/5&lt;441::AID-JEZ13&gt;3.0.CO;2-8; Dawson W.R., 2000, P343, DOI 10.1016/B978-012747605-6/50015-8; Farner DS, 1960, BIOLOGY COMPARATIVE, P411; Figuerola J, 2010, NATURWISSENSCHAFTEN, V97, P555, DOI 10.1007/s00114-010-0671-1; Green AJ, 2002, ACTA OECOL, V23, P177, DOI 10.1016/S1146-609X(02)01149-9; Green AJ, 2014, BIOL REV, V89, P105, DOI 10.1111/brv.12045; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jozefiak D, 2004, ANIM FEED SCI TECH, V113, P1, DOI 10.1016/j.anifeedsci.2003.09.007; KEHOE FP, 1988, CAN J ZOOL, V66, P1597, DOI 10.1139/z88-233; Kleyheeg E., 2015, THESIS; Kleyheeg E, 2017, J ECOL, V105, P1279, DOI 10.1111/1365-2745.12738; Kleyheeg E, 2016, FRESHWATER BIOL, V61, P1746, DOI 10.1111/fwb.12814; Kleyheeg E, 2015, OIKOS, V124, P899, DOI 10.1111/oik.01894; Meyer GA, 1998, AM MIDL NAT, V140, P129, DOI 10.1674/0003-0031(1998)140[0129:IOSPBF]2.0.CO;2; MILLER MR, 1975, J WILDLIFE MANAGE, V39, P168, DOI 10.2307/3800481; Milotic T, 2016, BASIC APPL ECOL, V17, P165, DOI 10.1016/j.baae.2015.09.007; Mouissie AM, 2005, FUNCT ECOL, V19, P284, DOI 10.1111/j.0269-8463.2005.00955.x; Mueller MH, 2002, WETLANDS, V22, P170, DOI 10.1672/0277-5212(2002)022[0170:TPRODI]2.0.CO;2; Pakeman RJ, 2002, FUNCT ECOL, V16, P296, DOI 10.1046/j.1365-2435.2002.00625.x; PIERSMA T, 1993, AUK, V110, P552, DOI 10.2307/4088419; Pollux BJA, 2005, FRESHWATER BIOL, V50, P232, DOI 10.1111/j.1365-2427.2004.01314.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reynolds C, 2016, FRESHWATER BIOL, V61, P1157, DOI 10.1111/fwb.12776; Reynolds C, 2016, FRESHWATER BIOL, V61, P349, DOI 10.1111/fwb.12709; Ridley H., 1930, J ECOL, DOI DOI 10.2307/2255951; Santamaria L, 2002, ARCH HYDROBIOL, V156, P11, DOI 10.1127/0003-9136/2002/0156-0011; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; SCHUPP EW, 1993, VEGETATIO, V108, P15; Soons MB, 2008, J ECOL, V96, P619, DOI 10.1111/j.1365-2745.2008.01372.x; Soons MB, 2016, J ECOL, V104, P443, DOI 10.1111/1365-2745.12531; Starck JM, 1999, J EXP BIOL, V202, P3171; Traveset A., 2007, Seed dispersal: theory and its application in a changing world, P78, DOI 10.1079/9781845931650.0078; van Leeuwen CHA, 2012, J BIOGEOGR, V39, P2031, DOI 10.1111/jbi.12004; Whittow G.C., 2000, STURKEYS AVIAN PHYSL, V299, P325, DOI DOI 10.1016/C2012-0-02488-X; Wongsriphuek C, 2008, WETLANDS, V28, P290, DOI 10.1672/07-101.1; Ziswiler V., 1972, P343	47	19	19	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195026	10.1371/journal.pone.0195026	http://dx.doi.org/10.1371/journal.pone.0195026			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614085	Green Published, gold			2022-12-26	WOS:000429081600024
J	Pauciullo, A; Ogah, DM; Lannaccone, M; Erhardt, G; Di Stasio, L; Cosenza, G				Pauciullo, Alfredo; Ogah, Danlami Moses; Lannaccone, Marco; Erhardt, Georg; Di Stasio, Liliana; Cosenza, Gianfranco			Genetic characterization of the oxytocin-neurophysin I gene (OXT) and its regulatory regions analysis in domestic Old and New World camelids	PLOS ONE			English	Article							MEDITERRANEAN RIVER BUFFALO; LAMA-GLAMA MILK; MOLECULAR CHARACTERIZATION; SEQUENCE-ANALYSIS; PROMOTER ANALYSIS; DROMEDARIUS MILK; RESPONSE ELEMENT; VARIABILITY; RECEPTOR; LLAMA	Oxytocin is a neurohypophysial peptide linked to a wide range of biological functions, including milk ejection, temperament and reproduction. Aims of the present study were a) the characterization of the OXT(Oxytocin-neurophysin I) gene and its regulatory regions in Old and New world camelids; b) the investigation of the genetic diversity and the discovery of markers potentially affecting the gene regulation. On average, the gene extends over 814 bp, ranging between 825 bp in dromedary, 811 bp in Bactrian and 810 bp in llama and alpaca. Such difference in size is due to a duplication event of 21 bp in dromedary. The main regulatory elements, including the composite hormone response elements (CHREs), were identified in the promoter, whereas the presence of mature microRNAs binding sequences in the 3'UTR improves the knowledge on the factors putatively involved in the OXTgene regulation, although their specific biological effect needs to be still elucidated. The sequencing of genomic DNA allowed the identification of 17 intraspecific polymorphisms and 69 nucleotide differences among the four species. One of these (MF464535:g.622C>G) is responsible, in alpaca, for the loss of a consensus sequence for the transcription factor SP1. Furthermore, the same SNP falls within a CpG island and it creates a new methylation site, thus opening future possibilities of investigation to verify the influence of the novel allelic variant in the OXTgene regulation. A PCR-RFLP method was setup for the genotyping and the frequency of the allele C was 0.93 in a population of 71 alpacas. The obtained data clarify the structure of OXTgene in domestic camelids and add knowledge to the genetic variability of a genomic region, which has received little investigation so far. These findings open the opportunity for new investigations, including association studies with productive and reproductive traits.	[Pauciullo, Alfredo; Di Stasio, Liliana] Univ Torino, Dept Agr Forest & Food Sci, Grugliasco, TO, Italy; [Ogah, Danlami Moses] Nasarawa State Univ, Dept Anim Sci, Keffi, Shabu Lafia, Nigeria; [Lannaccone, Marco; Cosenza, Gianfranco] Univ Naples Federico II, Dept Agr Sci, Portici, NA, Italy; [Erhardt, Georg] Justus Liebig Univ Giessen, Dept Anim Breeding & Genet, Giessen, Germany	University of Turin; University of Naples Federico II; Justus Liebig University Giessen	Pauciullo, A (corresponding author), Univ Torino, Dept Agr Forest & Food Sci, Grugliasco, TO, Italy.	alfredo.pauciullo@unito.it	Pauciullo, Alfredo/AAF-7713-2020; IANNACCONE, Marco/K-7559-2016	Pauciullo, Alfredo/0000-0002-3140-9373; IANNACCONE, Marco/0000-0002-2283-6613	ProBufaLat Project, Department of Agricultural, Forest and Food Sciences, University of Torino, Grugliasco (Italy) [PAUA_RIL0_17_01]	ProBufaLat Project, Department of Agricultural, Forest and Food Sciences, University of Torino, Grugliasco (Italy)	This research was financially supported by ProBufaLat Project (PAUA_RIL0_17_01), Department of Agricultural, Forest and Food Sciences, University of Torino, Grugliasco (Italy). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAN RAH, 1993, MOL ENDOCRINOL, V7, P47, DOI 10.1210/me.7.1.47; ADAN RAH, 1992, J BIOL CHEM, V267, P3771; ANDERSEN B, 1994, J BIOL CHEM, V269, P29335; ANG HL, 1994, J ENDOCRINOL, V140, P53, DOI 10.1677/joe.0.1400053; Balmus G, 2007, CHROMOSOME RES, V15, P499, DOI 10.1007/s10577-007-1154-x; Bell CJ, 2006, J PSYCHOPHARMACOL, V20, P656, DOI 10.1177/0269881106060512; BURBACH JPH, 1994, J BIOL CHEM, V269, P15046; Burger PA, 2016, TROP ANIM HEALTH PRO, V48, P905, DOI 10.1007/s11250-016-1032-7; Cannell IG, 2008, DO MICRORNAS REGULAT; Choi JW, 2013, J NEUROCHEM, V126, P331, DOI 10.1111/jnc.12308; Cosenza G, 2007, ITAL J ANIM SCI, V6, P303; Cosenza G, 2017, J DAIRY RES, V84, P165, DOI 10.1017/S0022029917000097; Erhardt G., 2017, GENE, P36; Erhardt G, 2016, TROP ANIM HEALTH PRO, V48, P879, DOI 10.1007/s11250-016-0997-6; FAO, 2014, STAT LIV AN; Fitak RR, 2016, MOL ECOL RESOUR, V16, P314, DOI 10.1111/1755-0998.12443; FUCHS AR, 1982, SCIENCE, V215, P1396, DOI 10.1126/science.6278592; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Haas BW, 2016, P NATL ACAD SCI USA, V113, pE3816, DOI 10.1073/pnas.1602809113; IVELL R, 1984, EMBO J, V3, P2351, DOI 10.1002/j.1460-2075.1984.tb02139.x; Jirimutu, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2192; Kadwell M, 2001, P ROY SOC B-BIOL SCI, V268, P2575, DOI 10.1098/rspb.2001.1774; Kappeler S, 1998, J DAIRY RES, V65, P209, DOI 10.1017/S0022029997002847; Kimura T, 2003, J MOL ENDOCRINOL, V30, P109, DOI 10.1677/jme.0.0300109; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lollivier V, 2002, REPROD NUTR DEV, V42, P173, DOI 10.1051/rnd:2002016; Pauciullo A, 2017, J DAIRY SCI, V100, P1282, DOI 10.3168/jds.2016-11918; Pauciullo A, 2014, GENE, V547, P159, DOI 10.1016/j.gene.2014.06.055; Pauciullo A, 2013, GENE, V513, P22, DOI 10.1016/j.gene.2012.10.083; Pauciullo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34781; Pauciullo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124963; Pauciullo A, 2012, J DAIRY RES, V79, P150, DOI 10.1017/S0022029911000914; Pjanic M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-181; RICHARD S, 1991, J BIOL CHEM, V266, P21428; RICHARD S, 1990, J BIOL CHEM, V265, P6098; Riek A, 2006, J DAIRY SCI, V89, P3484, DOI 10.3168/jds.S0022-0302(06)72387-6; RUPPERT S, 1984, NATURE, V308, P554, DOI 10.1038/308554a0; Saadaoui B, 2014, ELECTROPHORESIS, V35, P1406, DOI 10.1002/elps.201300383; Safe S, 2004, PROG NUCLEIC ACID RE, V77, P1, DOI 10.1016/S0079-6603(04)77001-4; Safe S, 2001, VITAM HORM, V62, P231, DOI 10.1016/S0083-6729(01)62006-5; Sambrook J., 2001, MOL CLONING LAB MANU; Shuiep ES, 2013, INT DAIRY J, V28, P88, DOI 10.1016/j.idairyj.2012.09.002; Striepens N, 2011, FRONT NEUROENDOCRIN, V32, P426, DOI 10.1016/j.yfrne.2011.07.001; Volpato G, 2014, PASTORALISM, V4, DOI 10.1186/s13570-014-0007-4; Wardeh M, 1993, IMPORTANCE DROMEDARY; Wheeler J. C., 2012, Journal of Camelid Science, V5, P1; Wu HG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6188	48	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195407	10.1371/journal.pone.0195407	http://dx.doi.org/10.1371/journal.pone.0195407			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608621	Green Submitted, gold, Green Published			2022-12-26	WOS:000428988800051
J	Stantic, M; Wolfsberger, J; Sakil, HAM; Wilhelm, MT				Stantic, Marina; Wolfsberger, Johanna; Sakil, Habib A. M.; Wilhelm, Margareta T.			Delta Np73 enhances HIF-1 alpha protein stability through repression of the ECV complex	ONCOGENE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; BREAST-CANCER; TUMOR ANGIOGENESIS; UNFAVORABLE PROGNOSIS; FACTOR 1-ALPHA; UBIQUITIN LIGASES; POOR-PROGNOSIS; LUNG-CANCER; FACTOR-I; EXPRESSION	Cellular responses to low oxygen conditions are mainly regulated by the Hypoxia-inducible factors (HIFs). Induction of HIF-1 beta in tumor cells activates the angiogenic switch and allows for metabolic adaptations. HIF-1 alpha protein levels are tightly regulated through ubiquitin-mediated proteosomal degradation; however, high levels of HIF-1 alpha is a common feature in many solid tumors and is thought to enhance cancer cell proliferation, migration, and survival. Here, we report that the oncogenic p73 isoform, Delta Np73, increases HIF-1 alpha protein stability. We found that Delta Np73 represses expression of genes encoding subunits of the ECV complex, in particular Elongin C, Elongin B, Cullin 2, and Rbx1. The ECV complex is an E3 ligase complex responsible for polyubiquitinating HIF-1 alpha. Loss of Delta Np73 increases ubiquitination of HIF-1 alpha, leading to its degradation via the proteosomal pathway, and subsequent decrease of HIF-1 alpha target genes. Taken together, our data demonstrates that high levels of Delta Np73 stabilize HIF-1 alpha protein, allowing for it to accumulate and further potentiating its transcriptional activity and supporting tumor progression.	[Stantic, Marina; Wolfsberger, Johanna; Sakil, Habib A. M.; Wilhelm, Margareta T.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, S-17177 Stockholm, Sweden	Karolinska Institutet	Wilhelm, MT (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, S-17177 Stockholm, Sweden.	margareta.wilhelm@ki.se		Stantic, Marina/0000-0002-2800-5538; Wilhelm, Margareta/0000-0002-0516-9724	Swedish Cancer Society; Swedish Research Council; Swedish Childhood Cancer Society; Karolinska Institutet doctoral grants (KID); Young Investigator Award from the Swedish Cancer Society	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Childhood Cancer Society; Karolinska Institutet doctoral grants (KID); Young Investigator Award from the Swedish Cancer Society	This work was supported by grants from the Swedish Cancer Society and the Swedish Research Council. MS is supported by a postdoctoral fellowship from the Swedish Childhood Cancer Society. JW and HAMS are funded by Karolinska Institutet doctoral grants (KID). MW is supported by a Young Investigator Award from the Swedish Cancer Society.	Amelio I, 2015, P NATL ACAD SCI USA, V112, P226, DOI 10.1073/pnas.1410609111; Birner P, 2000, CANCER RES, V60, P4693; Cardote TAF, 2017, STRUCTURE, V25, P901, DOI 10.1016/j.str.2017.04.009; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; del Peso L, 2003, J BIOL CHEM, V278, P48690, DOI 10.1074/jbc.M308862200; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dominguez G, 2006, J CLIN ONCOL, V24, P805, DOI 10.1200/JCO.2005.02.2350; Dulloo I, 2015, CELL CYCLE, V14, P3533, DOI 10.1080/15384101.2015.1078038; Fernandez-Alonso R, 2015, CELL DEATH DIFFER, V22, P1287, DOI 10.1038/cdd.2014.214; Generali D, 2006, CLIN CANCER RES, V12, P4562, DOI 10.1158/1078-0432.CCR-05-2690; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Gruber G, 2004, BREAST CANCER RES, V6, pR191, DOI 10.1186/bcr775; Ivan M, 2017, MOL CELL, V66, P772, DOI 10.1016/j.molcel.2017.06.002; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Koeppel M, 2011, NUCLEIC ACIDS RES, V39, P6069, DOI 10.1093/nar/gkr028; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Kuschel A, 2012, J CELL PHYSIOL, V227, P514, DOI 10.1002/jcp.22798; Leung THY, 2013, BRIT J CANCER, V109, P965, DOI 10.1038/bjc.2013.397; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Madden SL, 1996, CANCER RES, V56, P5384; Mahrour N, 2008, J BIOL CHEM, V283, P8005, DOI 10.1074/jbc.M706987200; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; Mohlin S, 2017, EXP CELL RES, V356, P192, DOI 10.1016/j.yexcr.2017.03.007; Moll UM, 2001, BBA-REV CANCER, V1552, P47, DOI 10.1016/S0304-419X(01)00036-1; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muz B, 2015, HYPOXIA, V3, P83, DOI 10.2147/HP.S93413; Osada R, 2007, HUM PATHOL, V38, P1310, DOI 10.1016/j.humpath.2007.02.010; Sakil HAM, 2017, CELL ONCOL, V40, P631, DOI 10.1007/s13402-017-0340-x; Schindl M, 2002, CLIN CANCER RES, V8, P1831; Schoenfeld AR, 2000, P NATL ACAD SCI USA, V97, P8507, DOI 10.1073/pnas.97.15.8507; Shibaji T, 2003, ANTICANCER RES, V23, P4721; Soldevilla B, 2014, HUM MOL GENET, V23, P467, DOI 10.1093/hmg/ddt437; Stantic M, 2015, P NATL ACAD SCI USA, V112, P220, DOI 10.1073/pnas.1421697112; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Theodoropoulos VE, 2004, EUR UROL, V46, P200, DOI 10.1016/j.eururo.2004.04.008; Uramoto H, 2004, CLIN CANCER RES, V10, P6905, DOI 10.1158/1078-0432.CCR-04-0290; Uramoto H, 2006, ANTICANCER RES, V26, P1785; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Wang RH, 2016, BIOCHEM BIOPH RES CO, V470, P117, DOI 10.1016/j.bbrc.2016.01.005; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Yamamoto Y, 2008, BREAST CANCER RES TR, V110, P465, DOI 10.1007/s10549-007-9742-1; Yoshimura H, 2004, CLIN CANCER RES, V10, P8554, DOI 10.1158/1078-0432.CCR-0946-03; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zhong H, 1999, CANCER RES, V59, P5830; Zhou WH, 2013, CELL RES, V23, P599, DOI 10.1038/cr.2013.44; Zitterbart K, 2007, ACTA NEUROPATHOL, V114, P641, DOI 10.1007/s00401-007-0298-2	47	3	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 5	2018	37	27					3729	3739		10.1038/s41388-018-0195-2	http://dx.doi.org/10.1038/s41388-018-0195-2			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GM3CM	29628507	hybrid, Green Published			2022-12-26	WOS:000437975200009
J	Bohl, TE; Ieong, P; Lee, JK; Lee, T; Kankanala, J; Shi, K; Demir, O; Kurahashi, K; Amaro, RE; Wang, ZQ; Aihara, H				Bohl, Thomas E.; Ieong, Pek; Lee, John K.; Lee, Thomas; Kankanala, Jayakanth; Shi, Ke; Demir, Ozlem; Kurahashi, Kayo; Amaro, Rommie E.; Wang, Zhengqiang; Aihara, Hideki			The substrate-binding cap of the UDP-diacylglucosamine pyrophosphatase LpxH is highly flexible, enabling facile substrate binding and product release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						X-ray crystallography; hydrogen-deuterium exchange; molecular dynamics; lipopolysaccharide (LPS); lipid A; metalloenzyme; hydrolase; molecular docking; LpxH; pyrophosphatase	SOFTWARE; DYNAMICS; SYSTEM; RESISTANCE; ACCURACY; PYTHON; AMBER	Gram-negative bacteria are surrounded by a secondary membrane of which the outer leaflet is composed of the glycolipid lipopolysaccharide (LPS), which guards against hydrophobic toxins, including many antibiotics. Therefore, LPS synthesis in bacteria is an attractive target for antibiotic development. LpxH is a pyrophosphatase involved in LPS synthesis, and previous structures revealed that LpxH has a helical cap that binds its lipid substrates. Here, crystallography and hydrogen-deuterium exchange MS provided evidence for a highly flexible substrate-binding cap in LpxH. Furthermore, molecular dynamics simulations disclosed how the helices of the cap may open to allow substrate entry. The predicted opening mechanism was supported by activity assays of LpxH variants. Finally, we confirmed biochemically that LpxH is inhibited by a previously identified antibacterial compound, determined the potency of this inhibitor, and modeled its binding mode in the LpxH active site. In summary, our work provides evidence that the substrate-binding cap of LpxH is highly dynamic, thus allowing for facile substrate binding and product release between the capping helices. Our results also pave the way for the rational design of more potent LpxH inhibitors.	[Bohl, Thomas E.; Lee, John K.; Shi, Ke; Kurahashi, Kayo; Aihara, Hideki] Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Kankanala, Jayakanth; Wang, Zhengqiang] Univ Minnesota Twin Cities, Ctr Drug Design, Minneapolis, MN 55455 USA; [Ieong, Pek; Amaro, Rommie E.] Univ Calif San Diego, Natl Biomed Computat Resource, La Jolla, CA 92093 USA; [Demir, Ozlem; Amaro, Rommie E.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Lee, Thomas] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80303 USA; [Lee, John K.] Bristol Myers Squibb, Redwood City, CA 94063 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Colorado System; University of Colorado Boulder; Bristol-Myers Squibb	Bohl, TE; Aihara, H (corresponding author), Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	bohlx031@umn.edu; aihar001@umn.edu	Wang, Zhengqiang/AAN-4363-2021	Wang, Zhengqiang/0000-0002-1326-5986; , Ke/0000-0003-4175-3714; Bohl, Heather/0000-0003-0910-7456; Demir, Ozlem/0000-0002-3317-4731; KANKANALA, JAYAKANTH/0000-0002-9581-0844	NIGMS, National Institutes of Health [P41 GM103403, P41-GM103311]; National Institutes of Health-ORIP HEI [S10OD021527]; Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118000, P41GM103403, P41GM103311, P41GM103426, R35GM118047] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007237, S10OD021527] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health-ORIP HEI; Office of Science by Argonne National Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Surajit Banerjee for assistance at the Advanced Photon Source. In addition, we thank Kurt Peterson of Fluorescence Innovations for help in measuring luminescence. This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are supported by NIGMS, National Institutes of Health Grant P41 GM103403. The Eiger 16M detector on 24-ID-E Beamline is funded by National Institutes of Health-ORIP HEI Grant S10OD021527. This research used resources of the Advanced Photon Source, a U.S. Department of Energy Office of Science User Facility operated for the Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. UCSF Chimera was utilized for protein structure analysis and to generate figures; Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, which is supported by NIGMS, National Institutes of Health Grant P41-GM103311.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Babinski KJ, 2002, J BIOL CHEM, V277, P25947, DOI 10.1074/jbc.M204068200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beceiro A, 2014, ANTIMICROB AGENTS CH, V58, P518, DOI 10.1128/AAC.01597-13; Bohl TE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02712-9; Bojkovic J, 2016, J BACTERIOL, V198, P731, DOI 10.1128/JB.00639-15; Case DA, 2014, AMBER 14; Cho J, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.154, 10.1038/nmicrobiol.2016.154]; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frisch M.J., 2016, GAUSSIAN 09; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Hall Margaret Jean, 2011, NCHS Data Brief, P1; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; LOPPNOW H, 1989, J IMMUNOL, V142, P3229; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Malinverni JC, 2009, P NATL ACAD SCI USA, V106, P8009, DOI 10.1073/pnas.0903229106; Mark P, 2001, J PHYS CHEM A, V105, P9954, DOI 10.1021/jp003020w; Metzger LE, 2010, BIOCHEMISTRY-US, V49, P6715, DOI 10.1021/bi1008744; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nayar AS, 2015, J BACTERIOL, V197, P1726, DOI 10.1128/JB.02552-14; Okada C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32822; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Podobnik M, 2009, J BIOL CHEM, V284, P32846, DOI 10.1074/jbc.M109.049635; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rodriguez S, 2000, LIPIDS, V35, P1033, DOI 10.1007/s11745-000-0615-x; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Schariter JA, 2002, J LIQ CHROMATOGR R T, V25, P1615, DOI 10.1081/JLC-120005708; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Sours KM, 2010, METHODS MOL BIOL, V661, P239, DOI 10.1007/978-1-60761-795-2_14; Sutterlin HA, 2016, P NATL ACAD SCI USA, V113, pE1565, DOI 10.1073/pnas.1601375113; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Ventola C Lee, 2015, P T, V40, P344; Ventola C Lee, 2015, P T, V40, P277; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Young HE, 2016, MBIO, V7, DOI 10.1128/mBio.00090-16; Young HE, 2013, J BIOL CHEM, V288, P26987, DOI 10.1074/jbc.M113.497636	45	9	9	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					7969	7981		10.1074/jbc.RA118.002503	http://dx.doi.org/10.1074/jbc.RA118.002503			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29626094	Green Published, hybrid			2022-12-26	WOS:000433224600005
J	Smith, MP; Standl, M; Berdel, D; von Berg, A; Bauer, CP; Schikowski, T; Koletzko, S; Lehmann, I; Kramer, U; Heinrich, J; Schulz, H				Smith, Maia Phillips; Standl, Marie; Berdel, Dietrich; von Berg, Andrea; Bauer, Carl-Peter; Schikowski, Tamara; Koletzko, Sibylle; Lehmann, Irina; Kraemer, Ursula; Heinrich, Joachim; Schulz, Holger			Handgrip strength is associated with improved spirometry in adolescents	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; MUSCLE STRENGTH; PULMONARY REHABILITATION; CLINICAL-PRACTICE; PROGNOSTIC VALUE; PUBERTAL CHANGES; GRIP STRENGTH; LUNG-FUNCTION; EXERCISE; NUTRITION	Introduction Pulmonary rehabilitation, including aerobic exercise and strength training, improves function, such as spirometric indices, in lung disease. However, we found spirometry did not correlate with physical activity (PA) in healthy adolescents (Smith ERJ: 42(4), 2016). To address whether muscle strength did, we measured these adolescents' handgrip strength and correlated it with spirometry. Methods In 1846 non-smoking, non-asthmatic Germans (age 15.2 years, 47% male), we modeled spirometric indices as functions of handgrip strength by linear regression in each sex, corrected for factors including age, height, and lean body mass. Results Handgrip averaged 35.4 (SD 7.3) kg in boys, 26.6 (4.2) in girls. Spirometric volumes and flows increased linearly with handgrip. In boys each kg handgrip was associated with about 28 mL greater FEV1 and FVC; 60 mL/sec faster PEF; and 38 mL/sec faster FEF2575. Effects were 10-30% smaller in girls (all p<0.0001) and stable when Z-scores for spirometry and grip were modeled, after further correction for environment and/or other exposures, and consistent across stages of puberty. Conclusions Grip strength was associated with spirometry in a cohort of healthy adolescents whose PA was not. Thus, research into PA's relationship with lung function should consider strength as well as total PA. Strength training may benefit healthy lungs; interventions are needed to prove causality.	[Smith, Maia Phillips; Standl, Marie; Heinrich, Joachim; Schulz, Holger] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Smith, Maia Phillips] St Georges Univ, Dept Publ Hlth & Prevent Med, True Blue Point, Grenada; [Berdel, Dietrich; von Berg, Andrea] Marien Hosp Wesel, Res Inst, Dept Pediat, Wesel, Germany; [Bauer, Carl-Peter] Tech Univ Munich, Dept Pediat, Munich, Germany; [Schikowski, Tamara; Kraemer, Ursula] Heinrich Heine Univ Dusseldorf, IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Schikowski, Tamara; Kraemer, Ursula] Heinrich Heine Univ Dusseldorf, Med Fac, Dusseldorf, Germany; [Koletzko, Sibylle] Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, Munich, Germany; [Lehmann, Irina] UFZ Leipzig, Helmholtz Zentrum Umweltforsch, Core Facil Studien, Dept Umweltimmunol, Leipzig, Germany; [Schulz, Holger] German Ctr Lung Res, Comprehens Pneumol Ctr Munich CPC M, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; St. Marien Hospital; Technical University of Munich; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF); Heinrich Heine University Dusseldorf; University of Munich; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Smith, MP (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany.; Smith, MP (corresponding author), St Georges Univ, Dept Publ Hlth & Prevent Med, True Blue Point, Grenada.	maia.phillips.smith@gmail.com	Heinrich, Joachim/N-1720-2013	Heinrich, Joachim/0000-0002-9620-1629; Standl, Marie/0000-0002-5345-2049; Lehmann, Irina/0000-0001-8875-5587; Smith, Maia Phillips/0000-0002-1154-1158	Federal Ministry for Environment (IUF Dusseldorf) [FKZ 20462296]; company Mead Johnson; company Nestle; European Studies; Nestle; Mead Johnson; Numico; Pharmacia; Stiftung Kindergesundheit; Federal Ministry for Education, Science, Research and Technology; Helmholtz Zentrum Munich; Helmholtz Centre for Environmental Research-UFZ, Leipzig; Research Institute at Marien-Hospital Wesel, Pediatric Practice, Bad Honnef; Comprehensive Pneumology Center Munich (CPC-M); Federal Ministry for Education, Science, Research and Technology (interventional arm)	Federal Ministry for Environment (IUF Dusseldorf); company Mead Johnson; company Nestle(Nestle SA); European Studies; Nestle(Nestle SA); Mead Johnson; Numico(Danone NutriciaRoyal Numico N.V.); Pharmacia; Stiftung Kindergesundheit; Federal Ministry for Education, Science, Research and Technology; Helmholtz Zentrum Munich; Helmholtz Centre for Environmental Research-UFZ, Leipzig; Research Institute at Marien-Hospital Wesel, Pediatric Practice, Bad Honnef; Comprehensive Pneumology Center Munich (CPC-M); Federal Ministry for Education, Science, Research and Technology (interventional arm)	This study was part of the 15-year followup of two German birth cohorts, GINIplus (German Infant Study on the influence of Nutrition Intervention PLUS environmental and genetic influences on allergy development) and LISAplus (Influence of lifestyle factors on the development of the immune system and allergies Plus the influence of traffic emissions and genetics). We thank the GINIplus and LISAplus Study Groups for all their excellent work. The GINIplus Study Group includes the following: Institute of Epidemiology I, Helmholtz Zentrum Munchen-German Research Center for Environmental Health, Neuherberg (J. Heinrich, I. Bruske, H. Schulz, C. Flexeder, C. Zeller, M. Standl, M. Schnappinger, M. Sussmann, E. Thiering, C. Tiesler); Research Institute, Department of Pediatrics, Marien-Hospital, Wesel (D. Berdel, A. von Berg, B. Filipiak-Pittroff); Ludwig-Maximilians-University of Munich, Dr von Hauner Children's Hospital (S. Koletzko, K. Werkstetter); Department of Pediatrics, Technische Universitat Munchen and Deutsche Rentenversicherung Bayern (C.P. Bauer, U. Hoffmann); and IUF-Leibniz Institute for Environmental Research, Dusseldorf (B. Hoffmann, E. Link, C. Klumper, U. Kramer). The LISAplus Study Group includes the following: Institute of Epidemiology I, Helmholtz Zentrum Munchen, German Research Center for Environmental Health (J. Heinrich, I. Bruske, H. Schulz, M. Standl, M. Schnappinger, M. Sussmann, E. Thiering, C. Tiesler, C. Flexeder, C. Zeller); Department of Pediatrics, Marien Hospital Wesel, Wesel (A. von Berg); Pediatric Practice, Bad Honnef (B. Schaaf); Technical University, Munich (C.P. Bauer, U. Hoffmann); Helmholtz Centre for Environmental Research - UFZ, Department of Environmental Immunology/Core Facility Studies, Leipzig (I. Lehmann, M. Bauer, G. Herberth, J. Muller, S. Roder and M. Schilde); Department of Pediatrics, Municipal Hospital 'St. Georg', Leipzig (M. Borte, U. Diez, C. Dorn, E. Braun); and ZAUM - Center for Allergy and Environment, Technical University Munich (M. Ollert, J. Grosch). The GINIplus study was mainly supported for the first 3 years of the Federal Ministry for Education, Science, Research and Technology (interventional arm) and Helmholtz Zentrum Munich (former GSF) (observational arm). The 4 year, 6 year, and 10 year follow-up examinations of the GINIplus study were covered from the respective budgets of the 4 study centres: Helmholtz Zentrum Munich, Research Institute at Marien-Hospital Wesel, Ludwig-Maximilians-University Munich, Technical University Munich, and from 6 years onwards also from IUF-Leibniz Research-Institute for Environmental Medicine at the University of Dusseldorf, and a grant from the Federal Ministry for Environment (IUF Dusseldorf, FKZ 20462296). The 15-year follow-up of the GINI study was supported by the companies Mead Johnson and Nestle and in cooperation with European Studies (e.g. MeDALL, ESCAPE). Some projects not directly related to the intervention effect of the hydrolyzates (e.g. effect of cesarean section, effect of solid food introduction) were partly supported by Nestle, Mead Johnson, Numico, Pharmacia and Stiftung Kindergesundheit, and in cooperation with European studies (e.g. MeDALL). The LISAplus study was mainly supported by grants from the Federal Ministry for Education, Science, Research and Technology and in addition from Helmholtz Zentrum Munich (former GSF), Helmholtz Centre for Environmental Research-UFZ, Leipzig, Research Institute at Marien-Hospital Wesel, Pediatric Practice, Bad Honnef for the first 2 years.; The 4 year, 6 year, and 10 year follow-up examinations of the LISAplus study were covered from the respective budgets of the involved partners (Helmholtz Zentrum Munich (former GSF), Helmholtz Centre for Environmental Research UFZ, Leipzig, Research Institute at Marien-Hospital Wesel, Pediatric Practice, Bad Honnef, IUF - Leibniz-Research Institute for Environmental Medicine at the University of Dusseldorf) and in addition by a grant from the Federal Ministry for Environment (IUF Dusseldorf, FKZ 20462296). This work was supported by the Comprehensive Pneumology Center Munich (CPC-M) as member of the German Center for Lung Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The GINIplus study was mainly supported for the first 3 years of the Federal Ministry for Education, Science, Research and Technology (interventional arm) and Helmholtz Zentrum Munich (former GSF) (observational arm). The 4 year, 6 year, and 10 year follow-up examinations of the GINIplus study were covered from the respective budgets of the 4 study centres: Helmholtz Zentrum Munich, Research Institute at Marien-Hospital Wesel, Ludwig-Maximilians-University Munich, Technical University Munich, and from 6 years onwards also from IUF-Leibniz Research-Institute for Environmental Medicine at the University of Dusseldorf, and a grant from the Federal Ministry for Environment (IUF Dusseldorf, FKZ 20462296). The 15-year follow-up of the GINIplus study was supported by the companies Mead Johnson and Nestle and in cooperation with European Studies (e.g. MeDALL, ESCAPE). Some projects not directly related to the intervention effect of the hydrolyzates (e.g. effect of cesarean section, effect of solid food introduction) were partly supported by Nestle, Mead Johnson, Numico, Pharmacia and Stiftung Kindergesundheit, and in cooperation with European studies (e.g. MeDALL).; The LISAplus study was mainly supported by grants from the Federal Ministry for Education, Science, Research and Technology and in addition from Helmholtz Zentrum Munich (former GSF), Helmholtz Centre for Environmental Research-UFZ, Leipzig, Research Institute at Marien-Hospital Wesel, Pediatric Practice, Bad Honnef for the first 2 years. The 4 year, 6 year, and 10 year follow-up examinations of the LISAplus study were covered from the respective budgets of the involved partners (Helmholtz Zentrum Munich (former GSF), Helmholtz Centre for Environmental Research-UFZ, Leipzig, Research Institute at Marien-Hospital Wesel, Pediatric Practice, Bad Honnef, IUF-Leibniz-Research Institute for Environmental Medicine at the University of Dusseldorf) and in addition by a grant from the Federal Ministry for Environment (IUF Dusseldorf, FKZ 20462296).; This work was supported by the Comprehensive Pneumology Center Munich (CPC-M) as member of the German Center for Lung Research.	Latorre-Roman PA, 2014, IRAN J ALLERGY ASTHM, V13, P396; [Anonymous], 2012, GLI2012; [Anonymous], 2013, NATL J PHYSL PAHRM P, DOI DOI 10.5455/NJPPP.2013.3.109-114; Bae JY, 2015, J PHYS THER SCI, V27, P2687, DOI 10.1589/jpts.27.2687; Balas J, 2009, ISOKINET EXERC SCI, V17, P173, DOI 10.3233/IES-2009-0350; Berntsen S, 2008, PEDIATR EXERC SCI, V20, P402, DOI 10.1123/pes.20.4.402; Bohannon RW, 2015, CURR OPIN CLIN NUTR, V18, P465, DOI 10.1097/MCO.0000000000000202; Burr DB, 1997, J BONE MINER RES, V12, P1547, DOI 10.1359/jbmr.1997.12.10.1547; CARSKADON MA, 1993, J ADOLESCENT HEALTH, V14, P190, DOI 10.1016/1054-139X(93)90004-9; Courteix D, 1997, EUR J APPL PHYSIOL O, V76, P264, DOI 10.1007/s004210050246; COUSER JI, 1993, CHEST, V103, P37, DOI 10.1378/chest.103.1.37; CRAIG BW, 1989, MECH AGEING DEV, V49, P159, DOI 10.1016/0047-6374(89)90099-7; Cussler EC, 2005, MED SCI SPORTS EXERC, V35, P10; De Cocker K, 2011, PUBLIC HEALTH NUTR, V14, P246, DOI 10.1017/S1368980010000558; Greutmann M, 2011, HEART, V97, P1164, DOI 10.1136/hrt.2010.213579; Harms CA, 1997, J APPL PHYSIOL, V82, P1573, DOI 10.1152/jappl.1997.82.5.1573; Illi SK, 2012, SPORTS MED, V42, P707, DOI 10.2165/11631670-000000000-00000; Jarvis D, 2012, ALLERGY, V67, P91, DOI 10.1111/j.1398-9995.2011.02709.x; Ji J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066098; KEENS TG, 1977, AM REV RESPIR DIS, V116, P853; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Mazic S, 2015, REV PORT PNEUMOL, V21, P192, DOI 10.1016/j.rppnen.2014.12.003; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nici L, 2006, AM J RESP CRITICAL C, V173; Nystad W, 2006, INT J TUBERC LUNG D, V10, P1399; Ortega FB, 2011, BRIT J SPORT MED, V45, P20, DOI 10.1136/bjsm.2009.062679; Pelkonen M, 2003, AM J RESP CRIT CARE, V168, P494, DOI 10.1164/rccm.200208-954OC; Ploegmakers JJW, 2013, J PHYSIOTHER, V59, P255, DOI 10.1016/S1836-9553(13)70202-9; Quist M, BMC CANC; Rantanen T, 2000, J GERONTOL A-BIOL, V55, pM168, DOI 10.1093/gerona/55.3.M168; Rantanen T, 2012, AGE, V34, P563, DOI 10.1007/s11357-011-9256-y; Ries AL, 2007, CHEST, V131, p4S, DOI 10.1378/chest.06-2418; Romer LM, 2008, J APPL PHYSIOL, V104, P879, DOI 10.1152/japplphysiol.01157.2007; Rozek-Piechura K, 2014, ANN AGR ENV MED, V21, P369, DOI 10.5604/1232-1966.1108607; Sahin G, 2004, SOUTH MED J, V97, P25; Shah S, 2013, INDIAN J MED RES, V138, P492; Skloot GS, 2010, RESP CARE, V55; Smith M. P., 2016, EUROPEAN RESP J, V47; Smith M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135630; Smith MP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152217; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Troosters, ELF FACT SHEET YOUR; World Health Organization, 2011, GLOB REC PHYS ACT HL; Yadav Raj Kumar, 2001, Indian Journal of Physiology and Pharmacology, V45, P493	47	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194560	10.1371/journal.pone.0194560	http://dx.doi.org/10.1371/journal.pone.0194560			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641533	gold, Green Published, Green Submitted			2022-12-26	WOS:000429742900035
J	Stoneham, TR; Kuhn, DD; Taylor, DP; Neilson, AP; Smith, SA; Gatlin, DM; Chu, HSS; O'Keefe, SF				Stoneham, Tyler R.; Kuhn, David D.; Taylor, Daniel P.; Neilson, Andrew P.; Smith, Stephen A.; Gatlin, Delbert M.; Chu, Hyun Sik S.; O'Keefe, Sean F.			Production of omega-3 enriched tilapia through the dietary use of algae meal or fish oil: Improved nutrient value of fillet and offal	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; ALPHA-LINOLENIC ACID; OREOCHROMIS-NILOTICUS; NILE TILAPIA; SCHIZOCHYTRIUM SP; FLAXSEED OIL; PROFILES; PROTEIN; DIGESTIBILITY; INGREDIENTS	The goal of this project was to increase the nutrient value of fillets, by-product muscle, and offal of aquacultured tilapia. A diet that includes seafood with a high omega-3 (n-3) fatty acid content, more specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are known to have numerous health benefits for consumers. Improved nutrient value of the offal may also attract new market opportunities for the aquaculture industry. Tilapia were cultured on different experimental feeds that contained various levels of n-3 fatty acids from either fish oil (FO) or algae meal (AM) that were used to replace corn oil. The experimental diets included a control (corn oil 6.3%), FO1%, FO3%, FO5%, AM1.75%, AM5.26%, and AM8.77%. All diets were formulated to be isocaloric, isonitrogenous, and isolipid. Three hundred and fifty tilapia with an initial mean weight of 158 +/- 2 g were cultured in a recirculating aquaculture system (seven diets replicated at the tank level, 14 tanks, 25 fish per tank). For all of the production performance data, no differences (P>0.05) were observed between the experimental groups which included survival (overall mean +/- standard error, 99.4 +/- 0.3%), growth per week (45.4 +/- 1.0 g/wk), food conversion ratio (1.32 +/- 0.03), fillet yield (44.4 +/- 0.2%), hepatosomatic index (1.61 +/- 0.02), viscerosomatic index (2.86 +/- 0.06), and mesenteric fat index (0.97 +/- 0.04). Fillet and rib meat tissues were collected at weeks four and eight, and liver and mesenteric fat tissues were collected at week eight. Fatty acids were extracted, methylated and identified with gas chromatography-mass spectrometry. All tissues had improved fatty acid profiles (higher n-3, lower n-6, n-6: n-3) with increasing levels of FO and AM in the diet. For example, the best diet for significantly (P<0.05) improving the lipid profile in tilapia fillets at week eight was diet AM8.77%. In the fillet, total n-3 was increased (control versus AM8.77%) from 151.2 +/- 19.0 to 438.7 +/- 14.2 mg per 4 ounce (113 g) serving and n-6: n-3 ratio was improved from 5.19 +/- 0.76 to 1.29 +/- 0.03.	[Stoneham, Tyler R.; Kuhn, David D.; Taylor, Daniel P.; Neilson, Andrew P.; Chu, Hyun Sik S.; O'Keefe, Sean F.] Virginia Polytech Inst & State Univ, Dept Food Sci & Technol, Blacksburg, VA 24061 USA; [Smith, Stephen A.] Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathol, Blacksburg, VA USA; [Gatlin, Delbert M.] Texas A&M Univ, Dept Fisheries & Wildlife Sci, College Stn, TX USA	Virginia Polytechnic Institute & State University; Texas A&M University System; Texas A&M University College Station	Kuhn, DD (corresponding author), Virginia Polytech Inst & State Univ, Dept Food Sci & Technol, Blacksburg, VA 24061 USA.	davekuhn@vt.edu	OKeefe, Sean F/N-3101-2016; Neilson, Andrew P./T-4241-2019; Gatlin, Delbert/AAB-3615-2021; taylor, daniel/GYU-3348-2022; Taylor, Daniel/AAM-3465-2021	OKeefe, Sean F/0000-0002-2491-7900; Taylor, Daniel/0000-0001-8023-0348; Kuhn, David/0000-0003-3368-0375; Chu, Hyun Sik/0000-0003-4249-6916	Federal-State Marketing Improvement Program (FSMIP) of the Agricultural Marketing Service (AMS) [14-FSMIP-VA-0012]; Federal Initiative Hatch Grant (College of Agriculture and Life Sciences, Virginia Tech, Blacksburg, VA); Virginia Tech's Open Access Subvention Fund (OASF)	Federal-State Marketing Improvement Program (FSMIP) of the Agricultural Marketing Service (AMS); Federal Initiative Hatch Grant (College of Agriculture and Life Sciences, Virginia Tech, Blacksburg, VA); Virginia Tech's Open Access Subvention Fund (OASF)	State funds for this project were matched with Federal funds under the Federal-State Marketing Improvement Program (FSMIP) of the Agricultural Marketing Service (AMS) grant 14-FSMIP-VA-0012 to David D Kuhn, U.S. Department of Agriculture (USDA). This project was also partially supported by fiscal year (FY) 2015 Federal Initiative Hatch Grant (College of Agriculture and Life Sciences, Virginia Tech, Blacksburg, VA) to David D Kuhn. Article processing costs were paid for by Virginia Tech's Open Access Subvention Fund (OASF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackman RG, 1998, J AM OIL CHEM SOC, V75, P541, DOI 10.1007/s11746-998-0263-9; American Oil Chemists' Society (AOCS), 1998, AOCS OFF METH CE 1B; APHA AWWA WEF, STAND METH EX WAT WA, V22nd; Bahurmiz OM, 2007, AQUACULTURE, V262, P382, DOI 10.1016/j.aquaculture.2006.11.023; BIMBO AP, 1992, J AM OIL CHEM SOC, V69, P221, DOI 10.1007/BF02635890; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Burdge GC, 2005, REPROD NUTR DEV, V45, P581, DOI 10.1051/rnd:2005047; BURDGE GC, 2006, LEUKOTRIENES ESSENTI, P161, DOI DOI 10.1016/J.PLEFA.2006.05.013; de Oliveira PRC, 2010, BRAZ ARCH BIOL TECHN, V53, P1383, DOI 10.1590/S1516-89132010000600015; de Souza NE, 2007, J SCI FOOD AGR, V87, P1677, DOI 10.1002/jsfa.2877; DeSilva SS, 1997, AQUACULTURE, V153, P273, DOI 10.1016/S0044-8486(97)00035-5; EI-Sayed A.-F.M., 2006, TILAPIA CULTURE; Folador JF, 2006, J ANIM SCI, V84, P2752, DOI 10.2527/jas.2005-560; Ganuza E, 2008, AQUACULTURE, V277, P109, DOI 10.1016/j.aquaculture.2008.02.005; Han CY, 2013, AQUACULT INT, V21, P1209, DOI 10.1007/s10499-013-9624-y; Ibrahim S. M., 2009, World Journal of Dairy & Food Sciences, V4, P28; Justi KC, 2003, FOOD CHEM, V80, P489, DOI 10.1016/S0308-8146(02)00317-5; Karapanagiotidis IT, 2007, LIPIDS, V42, P547, DOI 10.1007/s11745-007-3057-1; Kim S., 2014, SEAFOOD PROCESSING P, V1st; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Kwetegyeka J, 2008, LIPIDS, V43, P1017, DOI 10.1007/s11745-008-3200-7; Li MHH, 2009, AQUACULTURE, V292, P232, DOI 10.1016/j.aquaculture.2009.04.033; Ling XP, 2015, BIORESOURCE TECHNOL, V184, P139, DOI 10.1016/j.biortech.2014.09.130; Ma XY, 2015, FISH PHYSIOL BIOCHEM, V41, P937, DOI 10.1007/s10695-015-0059-4; Miller MR, 2007, COMP BIOCHEM PHYS A, V148, P382, DOI 10.1016/j.cbpa.2007.05.018; Ng WK, 2013, REV AQUACULT, V5, P220, DOI 10.1111/raq.12014; Norambuena F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143622; OLSEN RE, 1990, FISH PHYSIOL BIOCHEM, V8, P261, DOI 10.1007/BF00004465; Rakocy JE, 1989, TANK CULTURE TILAPIA; RAO KSP, 1984, TOXICOL LETT, V21, P147, DOI 10.1016/0378-4274(84)90198-X; Rasoarahona JRE, 2005, FOOD CHEM, V91, P683, DOI 10.1016/j.foodchem.2004.07.001; Sarker PK, 2016, AQUACULT NUTR, V22, P109, DOI 10.1111/anu.12230; Sarker PK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156684; SHERIDAN MA, 1989, AQUACULTURE, V82, P191, DOI 10.1016/0044-8486(89)90408-0; Silva JFX, 2014, ANIM FEED SCI TECH, V196, P96, DOI 10.1016/j.anifeedsci.2014.06.010; Sinclair AJ, 2002, LIPIDS, V37, P1113, DOI 10.1007/s11745-002-1008-x; Suganya T, 2016, RENEW SUST ENERG REV, V55, P909, DOI 10.1016/j.rser.2015.11.026; Szabo A, 2011, AQUACULT NUTR, V17, pE132, DOI 10.1111/j.1365-2095.2009.00743.x; Teoh CY, 2011, AQUACULTURE, V312, P126, DOI 10.1016/j.aquaculture.2010.12.018; Trushenski JT, 2009, N AM J AQUACULT, V71, P242, DOI 10.1577/A08-051.1; Visentainer JV, 2005, FOOD CHEM, V90, P557, DOI 10.1016/j.foodchem.2004.05.016; Wang DZ, 2008, CANCER LETT, V267, P197, DOI 10.1016/j.canlet.2008.03.004; Watters CA, 2013, ISR J AQUACULT-BAMID, V65; Xu L, 2009, ENG LIFE SCI, V9, P178, DOI 10.1002/elsc.200800111	44	30	31	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194241	10.1371/journal.pone.0194241	http://dx.doi.org/10.1371/journal.pone.0194241			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641539	Green Published, Green Submitted, gold			2022-12-26	WOS:000429742900027
J	Pant, K; Anderson, B; Perdana, H; Malinowski, MA; Win, AT; Pabst, C; Williams, MC; Karpel, RL				Pant, Kiran; Anderson, Brian; Perdana, Hendrik; Malinowski, Matthew A.; Win, Aye T.; Pabst, Christopher; Williams, Mark C.; Karpel, Richard L.			The role of the C-domain of bacteriophage T4 gene 32 protein in ssDNA binding and dsDNA helix-destabilization: Kinetic, single-molecule, and cross-linking studies	PLOS ONE			English	Article							FORCE SPECTROSCOPY MEASUREMENTS; DOUBLE-STRANDED DNA; NUCLEIC-ACID; REPLICATION FORK; STRUCTURAL DOMAINS; GP32; RECOMBINATION; 32-PROTEIN; LATTICES; COOPERATIVITY	The model single-stranded DNA binding protein of bacteriophage T4, gene 32 protein (gp32) has well-established roles in DNA replication, recombination, and repair. gp32 is a single-chain polypeptide consisting of three domains. Based on thermodynamics and kinetics measurements, we have proposed that gp32 can undergo a conformational change where the acidic C-terminal domain binds internally to or near the single-stranded (ss) DNA binding surface in the core (central) domain, blocking ssDNA interaction. To test this model, we have employed a variety of experimental approaches and gp32 variants to characterize this conformational change. Utilizing stopped-flow methods, the association kinetics of wild type and truncated forms of gp32 with ssDNA were measured. When the C-domain is present, the log-log plot of k vs. [NaCl] shows a positive slope, whereas when it is absent (*I protein), there is little rate change with salt concentration, as expected for this model.A gp32 variant lacking residues 292-296 within the C-domain, Delta PR201, displays kinetic properties intermediate between gp32 and *I. The single molecule force-induced DNA helix-destabilizing activitiesas well as the single- and double-stranded DNA affinities of Delta PR201 and gp32 truncated at residue 295 also fall between full-length protein and *I. Finally, chemical cross linking of recombinant C-domain and gp32 lacking both N- and C-terminal domains is inhibited by increasing concentrations of a short single-stranded oligonucleotide, and the salt dependence of cross-linking mirrors that expected for the model. Taken together, these results provide the first evidence in support of this model that have been obtained through structural probes.	[Pant, Kiran; Williams, Mark C.] Northeastern Univ, Dept Phys, Dana Res Ctr, Boston, MA 02115 USA; [Anderson, Brian; Perdana, Hendrik; Malinowski, Matthew A.; Win, Aye T.; Pabst, Christopher; Karpel, Richard L.] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21228 USA; [Williams, Mark C.] Northeastern Univ, Dana Res Ctr, Ctr Interdisciplinary Res Complex Syst, Boston, MA 02115 USA	Northeastern University; University System of Maryland; University of Maryland Baltimore County; Northeastern University	Karpel, RL (corresponding author), Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21228 USA.	karpel@umbc.edu			NIH [GM 52049, GM072462]; NSF [MCB-1243883]; UMBC Designated Research Initiative Fund	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); UMBC Designated Research Initiative Fund	Funding for this project was provided by NIH (GM 52049, R.L.K., GM072462, M.C.W), NSF (MCB-1243883, M.C.W), and the UMBC Designated Research Initiative Fund (R.L.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this project was provided by NIH (GM 52049, R.L.K., GM072462, M.C.W), NSF (MCB-1243883, M.C.W), and the UMBC Designated Research Initiative Fund (R.L.K.). We would like to thank Benyam Addissie, Kevin Molloy, Roy Richardson, Min Wu, and Betel Zigale for their assistance and Julia Wolf for her expert advice (all UMBC).	ALBERTS BM, 1970, NATURE, V227, P1313, DOI 10.1038/2271313a0; ALBERTS BM, 1970, FED PROC, V29, P1154; Arcus V, 2002, CURR OPIN STRUC BIOL, V12, P794, DOI 10.1016/S0959-440X(02)00392-5; Bosaeus N, 2014, NUCLEIC ACIDS RES, V42, P8083, DOI 10.1093/nar/gku441; CASASFINET JR, 1992, P NATL ACAD SCI USA, V89, P1050, DOI 10.1073/pnas.89.3.1050; CASASFINET JR, 1993, BIOCHEMISTRY-US, V32, P9735, DOI 10.1021/bi00088a028; Chaurasiya KR, 2010, PHYS LIFE REV, V7, P299, DOI 10.1016/j.plrev.2010.06.001; Fasman G., 1976, HDB BIOCH SELECTED D; GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D; Hollis T, 2001, P NATL ACAD SCI USA, V98, P9557, DOI 10.1073/pnas.171317698; HOSODA J, 1978, J BIOL CHEM, V253, P7547; HURLEY JM, 1993, J MOL BIOL, V229, P398, DOI 10.1006/jmbi.1993.1042; JENSEN DE, 1977, ANAL BIOCHEM, V80, P267, DOI 10.1016/0003-2697(77)90645-5; JENSEN DE, 1976, J BIOL CHEM, V251, P7215; Jose D, 2015, NUCLEIC ACIDS RES, V43, P9291, DOI 10.1093/nar/gkv818; Jose D, 2015, NUCLEIC ACIDS RES, V43, P9276, DOI 10.1093/nar/gkv817; Karpel R.L., 1990, BIOL NONSPECIFIC DNA, P103; Karpel R. L., 2002, ENCY LIFE SCI, V15, P231; Karpel RL, 2002, IUBMB LIFE, V53, P161, DOI 10.1080/15216540212332; King GA, 2013, P NATL ACAD SCI USA, V110, P3859, DOI 10.1073/pnas.1213676110; KOWALCZYKOWSKI SC, 1981, J MOL BIOL, V145, P75, DOI 10.1016/0022-2836(81)90335-1; Kozlov AG, 2017, J MOL BIOL, V429, P2790, DOI 10.1016/j.jmb.2017.07.021; Kozlov AG, 2010, J BIOL CHEM, V285, P17246, DOI 10.1074/jbc.M110.118273; KRASSA KB, 1991, P NATL ACAD SCI USA, V88, P4010, DOI 10.1073/pnas.88.9.4010; Kreuzer KN, 2000, TRENDS BIOCHEM SCI, V25, P165, DOI 10.1016/S0968-0004(00)01559-0; Kundu SK, 1996, ANAL BIOCHEM, V235, P134, DOI 10.1006/abio.1996.0105; Lee W, 2016, NUCLEIC ACIDS RES, V44, P10691, DOI 10.1093/nar/gkw863; LOHMAN TM, 1981, J MOL BIOL, V152, P67, DOI 10.1016/0022-2836(81)90096-6; LOHMAN TM, 1984, BIOCHEMISTRY-US, V23, P4665, DOI 10.1021/bi00315a023; LONBERG N, 1981, J MOL BIOL, V145, P123, DOI 10.1016/0022-2836(81)90337-5; McCauley MJ, 2007, BIOPOLYMERS, V85, P154, DOI 10.1002/bip.20622; MCGHEE JD, 1976, BIOPOLYMERS, V15, P1345, DOI 10.1002/bip.1976.360150710; NEWPORT JW, 1981, J MOL BIOL, V145, P105, DOI 10.1016/0022-2836(81)90336-3; NOSSAL NG, 1992, FASEB J, V6, P871, DOI 10.1096/fasebj.6.3.1310946; Pant K, 2005, J MOL BIOL, V349, P317, DOI 10.1016/j.jmb.2005.03.065; Pant K, 2004, J MOL BIOL, V336, P851, DOI 10.1016/j.jmb.2003.12.025; Pant K, 2003, J MOL BIOL, V327, P571, DOI 10.1016/S0022-2836(03)00153-0; Phelps C, 2017, P NATL ACAD SCI USA, V114, pE3612, DOI 10.1073/pnas.1619819114; Rouzina I, 2005, BIOPHYS J, V89, P1941, DOI 10.1529/biophysj.105.063776; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Shokri L, 2008, BIOPHYS J, V95, P1248, DOI 10.1529/biophysj.108.132688; Shokri L, 2006, J BIOL CHEM, V281, P38689, DOI 10.1074/jbc.M608460200; Shokri L, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025002; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; van Mameren J, 2009, P NATL ACAD SCI USA, V106, P18231, DOI 10.1073/pnas.0904322106; Waidner LA, 2001, J BIOL CHEM, V276, P2509, DOI 10.1074/jbc.M007778200; Wenner JR, 2002, BIOPHYS J, V82, P3160, DOI 10.1016/S0006-3495(02)75658-0; Williams MC, 2008, METHOD CELL BIOL, V84, P517, DOI 10.1016/S0091-679X(07)84017-9; Williams MC, 2006, CURR ORG CHEM, V10, P419, DOI 10.2174/138527206776055321; Williams MC, 2004, SPECTROSC-INT J, V18, P203, DOI 10.1155/2004/403203; Wu M, 1999, J MOL BIOL, V286, P1107, DOI 10.1006/jmbi.1999.2541	52	3	3	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194357	10.1371/journal.pone.0194357	http://dx.doi.org/10.1371/journal.pone.0194357			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634784	Green Published, Green Submitted, gold			2022-12-26	WOS:000429522200009
J	Yang, R; Guan, Y; Wang, WX; Chen, HJ; He, ZC; Jia, AQ				Yang, Rui; Guan, Ying; Wang, Weixin; Chen, Hongjuan; He, Zhaochun; Jia, Ai-Qun			Antioxidant capacity of phenolics in Camellia nitidissima Chi flowers and their identification by HPLC Triple TOF MS/MS	PLOS ONE			English	Article							SOLID-STATE FERMENTATION; CORDYCEPS-MILITARIS SN-18; FLAVONOL GLYCOSIDES; BIOACTIVE COMPOUNDS; TEA; ENHANCEMENT; QUERCETIN; GLYCOSYLATION; KAEMPFEROL; SCAVENGERS	Camellia nitidissima Chi (CNC) is a valuable medicinal and edible plant in China. In this study, CNC flowers were extracted with 95% ethanol, then partitioned into dichloromethane, ethyl acetate, n-butanol, and water fractions, with the antioxidant capacity of flavonoids and other phytochemicals in CNC flowers investigated for the first time. Results showed that the ethyl acetate fraction exhibited the strongest antioxidant capacity and highest total phenolic content (TPC) compared with the other fractions. Furthermore, in the ethyl acetate fraction, the 50% effective concentrations (EC50) of ABTS(+) and DPPH radical scavenging activities were 64.24 +/- 1.80 and 78.80 +/- 0.34 mu g/mL, respectively, and the ferric reducing antioxidant power (FRAP) was 801.49 +/- 2.30 mu M FeSO4 at 1,000 mu g/mL. Pearson's correlation coefficients and principal component analyses (PCA) for the TPC and antioxidant capacity of the five fractions indicated that the phenolic compounds were the major antioxidant constituents in the flowers. To exploit the antioxidants in CNC flowers, 21 phenolic compounds in the ethanolic extract fraction were identified by HPLC Triple TOF MS/MS, next, 12 flavonoids were isolated and elucidated, of which compounds 1-5 showed potent antioxidant capacity. In addition, the potential structure-activity relationship among these 12 flavonoids showed that (1) the o-catechol group in the B-ring was primarily responsible for the antioxidant capacity of flavonoids and (2) steric hindrance, produced by glycosides and other groups, could reduce the antioxidant capacity of the flavonoids.	[Yang, Rui; Jia, Ai-Qun] Hainan Univ, State Key Lab Marine Resource Utilizat South Chin, Minist Educ, Key Lab Trop Biol Resources, Haikou, Hainan, Peoples R China; [Yang, Rui; Wang, Weixin; He, Zhaochun; Jia, Ai-Qun] Nanjing Univ Sci & Technol, Sch Environm & Biol Engn, Nanjing, Jiangsu, Peoples R China; [Guan, Ying] Suzhou Inst Measurement & Testing, Inspect & Pattern Evaluat Dept, Suzhou, Peoples R China; [Chen, Hongjuan] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China	Hainan University; Nanjing University of Science & Technology; Nanjing University	Jia, AQ (corresponding author), Hainan Univ, State Key Lab Marine Resource Utilizat South Chin, Minist Educ, Key Lab Trop Biol Resources, Haikou, Hainan, Peoples R China.; Jia, AQ (corresponding author), Nanjing Univ Sci & Technol, Sch Environm & Biol Engn, Nanjing, Jiangsu, Peoples R China.	aiqunj302@njust.edu.cn	Wang, Weixin/ABC-3184-2021	Jia, Ai-Qun/0000-0002-8089-6200	National Key Research and Development Program of China [2017YFD0201401]; National Natural Science Foundation of China [41766006]; Science and Technology Development Program of Modern Agriculture, Nanjing [201608052]; Six talent peaks project in Jiangsu Province; Fundamental Research Funds for the Central Universities [30916011307]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Program of Modern Agriculture, Nanjing; Six talent peaks project in Jiangsu Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the grants from the National Key Research and Development Program of China (2017YFD0201401, http://www.most.gov.cn/), National Natural Science Foundation of China (41766006, http://www.nsfc.gov.cn/), Science and Technology Development Program of Modern Agriculture, Nanjing (201608052, http://www.njkj.gov.cn/), Six talent peaks project in Jiangsu Province, (http://www.jshrss.gov.cn/), Fundamental Research Funds for the Central Universities (30916011307, http://www.moe.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Razak DL, 2015, BIOCATAL AGRIC BIOTE, V4, P33, DOI 10.1016/j.bcab.2014.11.003; Ablajan K, 2006, J MASS SPECTROM, V41, P352, DOI 10.1002/jms.995; Alvarez-Jubete L, 2010, FOOD CHEM, V119, P770, DOI 10.1016/j.foodchem.2009.07.032; Amakura Y, 2013, MOLECULES, V18, P5326, DOI 10.3390/molecules18055326; Amarowicz R, 2009, INT J MOL SCI, V10, P5513, DOI 10.3390/ijms10125513; Atoui AK, 2005, FOOD CHEM, V89, P27, DOI 10.1016/j.foodchem.2004.01.075; Boots AW, 2008, EUR J PHARMACOL, V585, P325, DOI 10.1016/j.ejphar.2008.03.008; Brodowska K.M., 2017, NATURAL FLAVONOIDS C, V7, P108, DOI [10.5281/zenodo.545778, DOI 10.5281/ZENODO.545778]; CHEN YY, 2009, GUANGXI TROPICAL AGR, V1, P14, DOI DOI 10.3969/J.ISSN.2095-0764.2009.01.005; Corea G, 2003, J NAT PROD, V66, P1405, DOI 10.1021/np030226q; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Dou JP, 2007, J AGR FOOD CHEM, V55, P7462, DOI 10.1021/jf0718603; El-Hawary SA, 2011, J FOOD SCI, V76, pC1195, DOI 10.1111/j.1750-3841.2011.02370.x; Fernandez SP, 2009, NEUROCHEM RES, V34, P1867, DOI 10.1007/s11064-009-9969-9; Ferreres F, 2003, PHYTOCHEM ANALYSIS, V14, P352, DOI 10.1002/pca.727; Gottumukkala Raju V S S, 2014, Int Sch Res Notices, V2014, P628196, DOI 10.1155/2014/628196; Guan Y, 2017, CYTA-J FOOD, V15, P155, DOI 10.1080/19476337.2016.1226955; Han JT, 2004, ARCH PHARM RES, V27, P390, DOI 10.1007/BF02980079; Harrison K, 2007, FOOD CHEM, V102, P932, DOI 10.1016/j.foodchem.2006.06.034; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Hollman PCH, 1997, FEBS LETT, V418, P152, DOI 10.1016/S0014-5793(97)01367-7; Jang DS, 2003, J NAT PROD, V66, P1166, DOI 10.1021/np0302100; Jayasinghe ULB, 2004, NAT PROD RES, V18, P499, DOI 10.1080/14786410310001620538; Jorgensen LV, 1998, FREE RADICAL RES, V29, P339, DOI 10.1080/10715769800300381; Juan MY, 2010, FOOD MICROBIOL, V27, P586, DOI 10.1016/j.fm.2009.11.002; Kim JH, 2005, ARCH PHARM RES, V28, P195, DOI 10.1007/BF02977715; La Casa C, 2000, J ETHNOPHARMACOL, V71, P45, DOI 10.1016/S0378-8741(99)00174-9; Li YF, 2017, FOOD CHEM, V216, P282, DOI 10.1016/j.foodchem.2016.08.017; Lin AS, 2007, CHEM PHARM BULL, V55, P635, DOI 10.1248/cpb.55.635; Lv HP, 2015, J FUNCT FOODS, V19, P194, DOI 10.1016/j.jff.2015.09.047; Mcnab H, 2009, INT J MASS SPECTROM, V284, P57, DOI 10.1016/j.ijms.2008.05.039; Miller NJ, 1996, FEBS LETT, V392, P40, DOI 10.1016/0014-5793(96)00780-6; Park JS, 2006, J AGR FOOD CHEM, V54, P2951, DOI 10.1021/jf052900a; Peng Z, 2002, AUST J GRAPE WINE R, V8, P70, DOI 10.1111/j.1755-0238.2002.tb00213.x; Plumb GW, 1998, FREE RADICAL RES, V29, P351, DOI 10.1080/10715769800300391; Qiu JA, 2010, PLANT CELL REP, V29, P1325, DOI 10.1007/s00299-010-0919-4; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; SALAH N, 1995, ARCH BIOCHEM BIOPHYS, V322, P339, DOI 10.1006/abbi.1995.1473; Silva MM, 2002, FREE RADICAL RES, V36, P1219, DOI 10.1080/198-1071576021000016472; Singh HB, 2010, BIORESOURCE TECHNOL, V101, P6444, DOI 10.1016/j.biortech.2010.03.057; Song LX, 2011, FOOD CHEM, V129, P351, DOI 10.1016/j.foodchem.2011.04.083; Sun N, 2013, CHEM NAT COMPD+, V49, P49, DOI 10.1007/s10600-013-0503-6; Taamalli A, 2012, J AGR FOOD CHEM, V60, P791, DOI 10.1021/jf204233u; Tarascou I, 2006, EUR J ORG CHEM, V2006, P5367, DOI 10.1002/ejoc.200600668; Teng XF, 2008, HELV CHIM ACTA, V91, P1305, DOI 10.1002/hlca.200890142; Wan CP, 2011, ASIAN J CHEM, V23, P2893; Wang WX, 2016, FOOD CHEM, V205, P204, DOI 10.1016/j.foodchem.2016.03.019; Wang ZW, 2005, J LIQ CHROMATOGR R T, V28, P1291, DOI 10.1081/JLC-200054769; Xiao Y, 2015, INNOV FOOD SCI EMERG, V31, P216, DOI 10.1016/j.ifset.2015.06.006; Xiao Y, 2015, J FUNCT FOODS, V16, P58, DOI 10.1016/j.jff.2015.04.032; Xiao Y, 2015, J FUNCT FOODS, V12, P33, DOI 10.1016/j.jff.2014.10.033; Xiao Y, 2014, J FUNCT FOODS, V10, P210, DOI 10.1016/j.jff.2014.06.008; Xu JG, 2009, J AGR FOOD CHEM, V57, P10392, DOI 10.1021/jf902778j; Yang R, 2018, J FOOD DRUG ANAL, V26, P252, DOI 10.1016/j.jfda.2017.03.007; Yilmaz Y, 2004, J AGR FOOD CHEM, V52, P255, DOI 10.1021/jf030117h; Zhang LH, 2011, FOOD BIOPROD PROCESS, V89, P234, DOI 10.1016/j.fbp.2010.04.007	56	18	23	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195508	10.1371/journal.pone.0195508	http://dx.doi.org/10.1371/journal.pone.0195508			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634769	Green Submitted, Green Published, gold			2022-12-26	WOS:000429522200036
J	Enane, LA; Mokete, K; Joel, D; Daimari, R; Tshume, O; Anabwani, G; Mazhani, L; Steenhoff, AP; Lowenthal, ED				Enane, Leslie A.; Mokete, Keboletse; Joel, Dipesalema; Daimari, Rahul; Tshume, Ontibile; Anabwani, Gabriel; Mazhani, Loeto; Steenhoff, Andrew P.; Lowenthal, Elizabeth D.			"We did not know what was wrong" Barriers along the care cascade among hospitalized adolescents with HIV in Gaborone, Botswana	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY ADHERENCE; INFECTION; CHILDREN; AFRICA; YOUTH; AGE	High mortality among adolescents with HIV reflects delays and failures in the care cascade. We sought to elucidate critical missed opportunities and barriers to care among adolescents hospitalized with HIV at Botswana's tertiary referral hospital. We enrolled all HIV-infected adolescents (aged 10-19 years) hospitalized with any diagnosis other than pregnancy from July 2015 to January 2016. Medical records were reviewed for clinical variables and past engagement in care. Semi-structured interviews of the adolescents (when feasible) and their caregivers explored delays and barriers to care. Twenty-one eligible adolescents were identified and 15 were enrolled. All but one were WHO Clinical Stage 3 or 4. Barriers to diagnosis included lack of awareness about perinatal HIV infection, illness or death of the mother, and fear of discrimination. Barriers to adherence to antiretroviral therapy included nondisclosure, isolation, and mental health concerns. The number of hospitalized HIV infected adolescents was lower than expected. However, among those hospitalized, the lack of timely diagnosis and subsequent gaps in the care cascade elucidated opportunities to improve outcomes and quality of life for this vulnerable group.	[Enane, Leslie A.; Steenhoff, Andrew P.] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; [Enane, Leslie A.; Steenhoff, Andrew P.; Lowenthal, Elizabeth D.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Enane, Leslie A.] Indiana Univ Sch Med, Ryan White Ctr Pediat Infect Dis & Global Hlth, Indianapolis, IN 46202 USA; [Enane, Leslie A.; Steenhoff, Andrew P.; Lowenthal, Elizabeth D.] Botswana UPenn Partnership, Gaborone, Botswana; [Mokete, Keboletse; Joel, Dipesalema; Tshume, Ontibile; Anabwani, Gabriel] Botswana Baylor Childrens Clin Ctr Excellence, Gaborone, Botswana; [Joel, Dipesalema; Daimari, Rahul; Mazhani, Loeto] Univ Botswana, Fac Med, Gaborone, Botswana; [Anabwani, Gabriel] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Steenhoff, Andrew P.; Lowenthal, Elizabeth D.] Childrens Hosp Philadelphia, Ctr Global Hlth, Philadelphia, PA 19104 USA; [Steenhoff, Andrew P.; Lowenthal, Elizabeth D.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lowenthal, Elizabeth D.] Univ Penn, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Indiana University System; Indiana University Bloomington; Baylor College of Medicine; University of Botswana; Baylor College of Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Enane, LA (corresponding author), Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA.; Enane, LA (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA.; Enane, LA (corresponding author), Indiana Univ Sch Med, Ryan White Ctr Pediat Infect Dis & Global Hlth, Indianapolis, IN 46202 USA.; Enane, LA (corresponding author), Botswana UPenn Partnership, Gaborone, Botswana.	lenane@iu.edu		Enane, Leslie A./0000-0001-8390-5881	National Institute of Mental Health [NIH K23 MH095669]; Penn Center for AIDS Research (CFAR), an NIH [P30 AI45008]	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Penn Center for AIDS Research (CFAR), an NIH	This work was supported by the National Institute of Mental Health under Grant NIH K23 MH095669 (EDL); and by the Penn Center for AIDS Research (CFAR), an NIH-funded program, under Grant P30 AI45008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesen R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177168; Botswana Ministry of Health, 2012, BOTSW NAT HIV AIDS T, P1; Buzdugan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053213; Cohn J, 2016, LANCET HIV, V3, pE473, DOI 10.1016/S2352-3018(16)30050-9; Farahani M, 2014, LANCET GLOB HEALTH, V2, pE44, DOI 10.1016/S2214-109X(13)70149-9; Fereday J., 2006, INT J QUAL METH, V5, P80, DOI [DOI 10.1177/160940690600500107, 10.1177/160940690600500107]; Ferrand RA, 2007, CLIN INFECT DIS, V44, P874, DOI 10.1086/511878; Ford N, 2015, LANCET HIV, V2, pE438, DOI 10.1016/S2352-3018(15)00137-X; Hall BJ, 2017, AIDS BEHAV, V21, P1755, DOI 10.1007/s10461-016-1537-0; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kondracki NL, 2002, J NUTR EDUC BEHAV, V34, P224, DOI 10.1016/S1499-4046(06)60097-3; Lamb MR, 2014, AIDS, V28, P559, DOI 10.1097/QAD.0000000000000054; Livingston Julie, 2005, DEBILITY MORAL IMAGI; Lowenthal ED, 2014, LANCET INFECT DIS, V14, P627, DOI 10.1016/S1473-3099(13)70363-3; Machine EM, 2016, AIDS CARE, V28, P1402, DOI 10.1080/09540121.2016.1179714; Mokdad AH, 2016, LANCET, V387, P2383, DOI 10.1016/S0140-6736(16)00648-6; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Ojwang' VO, 2016, AIDS CARE, V28, P500, DOI 10.1080/09540121.2015.1110234; Reif LK, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20859; Shaw S, 2016, JAIDS-J ACQ IMM DEF, V72, P387, DOI 10.1097/QAI.0000000000000977; Statistics Botswana, 2013, BOTS AIDS IMP SURV 4; Teasdale CA, 2016, JAIDS-J ACQ IMM DEF, V71, pE56, DOI [10.1097/QAI.0000000000000877, 10.1097/QAI.0000000000000902]; UNAIDS, 2015, ALL ENDADOLESCENTAID; UNAIDS, UNAIDS EST 2017; UNAIDS, 2016, EST; UNICEF World Bank World Food Program USAID ENGINE, 2016, EV CHILD END AIDS 7, P1; United Nations Children's Fund UNICEF, 2013, AIDS FREE GEN CHILDR, P1; Vreeman RC, 2015, AIDS BEHAV, V19, P626, DOI 10.1007/s10461-015-0998-x; WHO, 2014, HLTH WORLDS AD 2 CHA; WHO Expert Committee on Problems Related to Alcohol Consumption, 2007, World Health Organ Tech Rep Ser, P1; Williams S, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21922; Wolf HT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1154; Wood SM, 2015, JAMA PEDIATR, V169, P619, DOI 10.1001/jamapediatrics.2015.58; Yang E, 2018, AIDS CARE, V30, P224, DOI 10.1080/09540121.2017.1344767	34	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195372	10.1371/journal.pone.0195372	http://dx.doi.org/10.1371/journal.pone.0195372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630654	Green Published, gold			2022-12-26	WOS:000429505000044
J	Sedighi, A; Ulman, SM; Nussbaum, MA				Sedighi, Alireza; Ulman, Sophia M.; Nussbaum, Maury A.			Information presentation through a head worn display ("smart glasses") has a smaller influence on the temporal structure of gait variability during dual-task gait compared to handheld displays (paper-based system and smartphone)	PLOS ONE			English	Article							MOVEMENT VARIABILITY; APPROXIMATE ENTROPY; AUGMENTED REALITY; MENTAL WORKLOAD; MUSCLE-ACTIVITY; WALKING SPEED; PERFORMANCE; STABILITY; PRECISION; TREADMILL	The need to complete multiple tasks concurrently is a common occurrence both daily life and in occupational activities, which can often include simultaneous cognitive and physical demands. As one example, there is increasing availability of head-worn display technologies that can be employed when a user is mobile (e.g., while walking). This new method of information presentation may, however, introduce risks of adverse outcomes such as a decrement to gait performance. The goal of this study was thus to quantify the effects of a head worn display (i.e., smart glasses) on motor variability during gait and to compare these effects with those of other common information displays (i.e., smartphone and paper-based system). Twenty participants completed four walking conditions, as a single task and in three dual-task conditions (three information displays). In the dual-task conditions, the information display was used to present several cognitive tasks. Three different measures were used to quantify variability in gait parameters for each walking condition (using the cycle-to cycle standard deviation, sample entropy, and the "goal-equivalent manifold" approach). Our results indicated that participants used less adaptable gait strategies in dual-task walking using the paper-based system and smartphone conditions compared with single-task walking. Gait performance, however, was less affected during dual-task walking with the smart glasses. We conclude that the risk of an adverse gait event (e.g., a fall) in head-down walking conditions (i.e., the paper-based system and smartphone conditions) were higher than in single-task walking, and that head-worn displays might help reduce the risk of such events during dual-task gait conditions.	[Sedighi, Alireza; Ulman, Sophia M.; Nussbaum, Maury A.] Virginia Tech, Dept Ind & Syst Engn, Blacksburg, VA 24061 USA; [Nussbaum, Maury A.] Virginia Tech, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Nussbaum, MA (corresponding author), Virginia Tech, Dept Ind & Syst Engn, Blacksburg, VA 24061 USA.; Nussbaum, MA (corresponding author), Virginia Tech, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.	nussbaum@vt.edu	Nussbaum, Maury A/A-9655-2008	Nussbaum, Maury A/0000-0002-1887-8431; Sedighi, Alireza/0000-0001-5283-4523	NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [T03OH008613] Funding Source: NIH RePORTER	NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))		Amboni M, 2013, MOVEMENT DISORD, V28, P1520, DOI 10.1002/mds.25674; Asai T, 2013, GAIT POSTURE, V38, P830, DOI 10.1016/j.gaitpost.2013.04.005; Barnette JJ, 1998, ANN M MIDS ED RES AS; Beauchet O, 2005, J MOTOR BEHAV, V37, P259; Beauchet O, 2003, J AM GERIATR SOC, V51, P1187, DOI 10.1046/j.1532-5415.2003.51385.x; Beauchet O, 2005, J NEUROENG REHABIL, V2, P2, DOI [10.1186/1743-0003-2-2, DOI 10.1186/1743-0003-2-2]; Bernstein N, 1967, COORDINATION REGULAT; Birch L, 2000, SCAND J WORK ENV HEA, V26, P299, DOI 10.5271/sjweh.546; Blangsted AK, 2004, EUR J APPL PHYSIOL, V91, P253, DOI 10.1007/s00421-003-0979-z; Bohnsack-McLagan NK, 2016, J BIOMECH, V49, P229, DOI 10.1016/j.jbiomech.2015.12.010; Brodeur MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106953; Brusie T, 2015, SYST INF ENG DES S C; Chehrehrazi M, 2017, HUM MOVEMENT SCI, V51, P72, DOI 10.1016/j.humov.2016.11.005; Cirulis A, 2013, PROCEDIA COMPUT SCI, V26, P14, DOI 10.1016/j.procs.2013.12.003; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crowley P, 2016, EFFECTS MOBILE PHONE, V28, P101; Cusumano JP, 2013, HUM MOVEMENT SCI, V32, P899, DOI 10.1016/j.humov.2013.07.019; Cusumano JP, 2006, BIOL CYBERN, V94, P367, DOI 10.1007/s00422-006-0052-1; Davis KG, 2002, SPINE, V27, P2645, DOI 10.1097/00007632-200212010-00003; Decker LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041306; DiDomenico A, 2008, INT J IND ERGONOM, V38, P977, DOI 10.1016/j.ergon.2008.01.012; DiDomenico A, 2011, INT J IND ERGONOM, V41, P255, DOI 10.1016/j.ergon.2011.01.008; Dingwell JB, 2013, J NEUROPHYSIOL, V109, P225, DOI 10.1152/jn.00951.2011; Dingwell JB, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000856; Dubost V, 2006, HUM MOVEMENT SCI, V25, P372, DOI 10.1016/j.humov.2006.03.004; Fallavollita P, 2016, L N COMPUT VIS BIOME, P251, DOI 10.1007/978-3-319-23482-3_13; Finsen L, 2001, J ELECTROMYOGR KINES, V11, P373, DOI 10.1016/S1050-6411(01)00015-3; Fiorentino M, 2002, INTERNATIONAL SYMPOSIUM ON MIXED AND AUGMENTED REALITY, PROCEEDINGS, P86, DOI 10.1109/ISMAR.2002.1115077; Gaudez C, 2016, APPL ERGON, V53, P71, DOI 10.1016/j.apergo.2015.08.014; HART S G, 1988, P139; Hausdorff JM, 2008, J GERONTOL A-BIOL, V63, P1335, DOI 10.1093/gerona/63.12.1335; He JB, 2015, ACCIDENT ANAL PREV, V81, P218, DOI 10.1016/j.aap.2015.03.033; Hollman JH, 2007, GAIT POSTURE, V26, P113, DOI 10.1016/j.gaitpost.2006.08.005; Hou L, 2015, J COMPUT CIVIL ENG, V29, DOI 10.1061/(ASCE)CP.1943-5487.0000344; Iben H., 2009, P 2009 INT C MULTIMO, P281, DOI DOI 10.1145/1647314.1647374, Patent No. 1647374; Jordan K, 2007, GAIT POSTURE, V26, P128, DOI 10.1016/j.gaitpost.2006.08.010; Kaplan E., 2001, BOSTON NAMING TEST P; Kennedy R. S., 1993, INT J AVIAT PSYCHOL, V3, P203; Kopper M, 2016, ERGONOMICS, V59, P615, DOI 10.1080/00140139.2015.1100757; Lewis JR, 2009, LECT NOTES COMPUT SC, V5619, P94, DOI 10.1007/978-3-642-02806-9_12; Lindenberger U, 2000, PSYCHOL AGING, V15, P417, DOI 10.1037//0882-7974.15.3.417; Liu YC, 2004, INT J HUM-COMPUT ST, V61, P679, DOI 10.1016/j.ijhcs.2004.06.002; Magnani RM, 2017, GAIT POSTURE, V55, P105, DOI 10.1016/j.gaitpost.2017.04.019; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Malcolm BR, 2015, NEUROIMAGE, V117, P230, DOI 10.1016/j.neuroimage.2015.05.028; Mehta RK, 2012, EUR J APPL PHYSIOL, V112, P2891, DOI 10.1007/s00421-011-2264-x; Muller H, 2009, ADV EXP MED BIOL, V629, P439, DOI 10.1007/978-0-387-77064-2_23; Mustonen T, 2013, J EXP PSYCHOL-APPL, V19, P333, DOI 10.1037/a0034635; Newell KM, 1998, MOTOR BEHAVIOR AND HUMAN SKILL, P143; Newell KM, 1993, ISSUES VARIABILITY M; Orlosky J, 2014, MOB COMPUT COMMUN RE, V18, P20, DOI 10.1145/2636242.2636246; PENG CK, 1993, PHYS REV LETT, V70, P1343, DOI 10.1103/PhysRevLett.70.1343; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Riley PO, 2007, GAIT POSTURE, V26, P17, DOI 10.1016/j.gaitpost.2006.07.003; Roffey DM, 2010, SPINE J, V10, P262, DOI 10.1016/j.spinee.2009.12.023; Salinas MM, 2017, GAIT POSTURE, V57, P15, DOI 10.1016/j.gaitpost.2017.05.002; Sawyer BD, 2014, HUM FACTORS, V56, P1307, DOI 10.1177/0018720814555723; Schaefer S, 2015, GAIT POSTURE, V41, P258, DOI 10.1016/j.gaitpost.2014.10.013; Schaefer S, 2010, EUR J DEV PSYCHOL, V7, P371, DOI 10.1080/17405620802535666; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Scholz JP, 2001, EXP BRAIN RES, V141, P485, DOI 10.1007/s002210100878; Schoner G, 1995, ECOL PSYCHOL, V7, P291, DOI 10.1207/s15326969eco0704_5; Sedighi A, 2017, J ELECTROMYOGR KINES, V37, P61, DOI 10.1016/j.jelekin.2017.09.001; Srinivasan D, 2016, EUR J APPL PHYSIOL, V116, P227, DOI 10.1007/s00421-015-3268-8; Stergiou N., 2004, INNOVATIVE ANAL HUMA; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Trebuchon-Da Fonseca A, 2009, BRAIN, V132, P2772, DOI 10.1093/brain/awp083; Van Krevelen D., 2010, INT J VIRT REAL, V9, P1, DOI DOI 10.20870/IJVR.2010.9.2.2767; Verghese J, 2007, ARCH PHYS MED REHAB, V88, P50, DOI 10.1016/j.apmr.2006.10.007; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Wright P., 1983, Behaviour and Information Technology, V2, P227, DOI 10.1080/01449298308914479; Yang T, 2015, LECT NOTES COMPUT SC, V9179, P535, DOI 10.1007/978-3-319-21067-4_54; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	75	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195106	10.1371/journal.pone.0195106	http://dx.doi.org/10.1371/journal.pone.0195106			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630614	gold, Green Published, Green Submitted			2022-12-26	WOS:000429505000025
J	Petrovic, T; Sekler, M; Petric, D; Lazic, S; Debeljak, Z; Vidanovic, D; Cupina, AI; Lazic, G; Lupulovic, D; Kolarevic, M; Plavsic, B				Petrovic, Tamas; Sekler, Milanko; Petric, Dusan; Lazic, Sava; Debeljak, Zoran; Vidanovic, Dejan; Cupina, Aleksandra Ignjatovic; Lazic, Gospava; Lupulovic, Diana; Kolarevic, Migo; Plavsic, Budimir			Methodology and results of integrated WNV surveillance programmes in Serbia	PLOS ONE			English	Article							WEST-NILE-VIRUS; SEROLOGICAL EVIDENCE; INFECTION; VOJVODINA; MOSQUITO; TRANSMISSION; CIRCULATION; HORSES; BIRDS	Studies conducted during the past few years have confirmed active West Nile virus (WNV) circulation in Serbia. Based on these studies and the epidemiological situation, the Veterinary Directorate of the Ministry of Agriculture and Environmental Protection launched national WNV surveillance programmes in 2014 and 2015. The programmes encompassed the territory of Serbia and were conducted by the veterinary service in collaboration with entomologists and ornithologists. The objective of the programmes was early detection of WNV and timely reporting to the public health service and local authorities to increase both clinical and mosquito control preparedness. The WNV surveillance programmes were based on direct and indirect surveillance of the presence of WNV by the serological testing of initially seronegative sentinel horses and chickens as well as through viral detection in pooled mosquito and wild bird samples. The most intense WNV circulation was observed in all seven districts of Vojvodina Province (northern Serbia) and Belgrade City, where most of the positive samples were detected among sentinel animals, mosquitoes and wild birds. The West Nile virus surveillance programmes in 2014 and 2015 showed satisfactory results in their capacity to indicate the spatial distribution of the risk for humans and their sensitivity to early detect viral circulation at the enzootic level. Most of the human cases were preceded by the detection of WNV circulation as part of the surveillance programmes. According to the existing data, it can be reasonably assumed that WNV infection, now an endemic infection in Serbia, will continue to present a significant problem for the veterinary service and public health.	[Petrovic, Tamas; Lazic, Sava; Lazic, Gospava; Lupulovic, Diana] Sci Vet Inst Novi Sad, Dept Virol, Novi Sad, Serbia; [Sekler, Milanko; Debeljak, Zoran; Vidanovic, Dejan; Kolarevic, Migo] Specialized Vet Inst Kraljevo, Kraljevo, Serbia; [Petric, Dusan; Cupina, Aleksandra Ignjatovic] Univ Novi Sad, Fac Agr, Lab Med & Vet Entomol, Novi Sad, Serbia; [Plavsic, Budimir] Minist Agr & Environm Protect, Vet Directorate, Belgrade, Serbia	University of Novi Sad; University of Novi Sad	Petrovic, T (corresponding author), Sci Vet Inst Novi Sad, Dept Virol, Novi Sad, Serbia.	tomy@niv.ns.ac.rs	Vidanovic, Dejan/AAH-8241-2020; Petrovic, Tamas/H-3764-2019	Vidanovic, Dejan/0000-0003-0192-5120; Petrovic, Tamas/0000-0002-9164-3356; Lazic, Sava/0000-0001-8480-1283	Ministry of Education, Science and Technological Development of the Republic of Serbia [TR31084, III43007]; Veterinary Directorate, Ministry of Agriculture and Environment Protection, Republic of Serbia	Ministry of Education, Science and Technological Development of the Republic of Serbia; Veterinary Directorate, Ministry of Agriculture and Environment Protection, Republic of Serbia	This work was supported by project grants TR31084 and III43007 of the Ministry of Education, Science and Technological Development of the Republic of Serbia (http://www.mpn.gov.rs/). The implementation of WNV surveillance programs was funded by the Veterinary Directorate, Ministry of Agriculture and Environment Protection, Republic of Serbia (http://www.vet.minpoli.gov.rs/sr/pocetna). Also, part of the work of TP, DP, AIC and GL was done under the frame of EurNegVec COST Action TD1303 (http://www.cost.eu/COST_Actions/bmbs/TD1303). BP is employed in the Veterinary Directorate, Ministry of Agriculture and Environment Protection, Republic of Serbia, and has an active role in designing of the WNV surveillance programs and the review of the final work. The funders had no other role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Angelini P, 2010, EURO SURVEILL, V15; [Anonymous], 2012, EPISOUTH WEEKLY EPI; [Anonymous], 2014, PROGRAM NADZIRANJA G; [Anonymous], 2013, PENNSYLVANIA W NILE; Bakonyi T, 2006, EMERG INFECT DIS, V12, P618; Barbic L, 2012, VET MICROBIOL, V159, P504, DOI 10.1016/j.vetmic.2012.04.038; Barker C.M., 2012, P MOSQ CONTR ASS CAL, V80, P17; Blackmore CGM, 2003, AM J TROP MED HYG, V69, P141, DOI 10.4269/ajtmh.2003.69.141; Bordoski M, 1972, Vojnosanit Pregl, V29, P173; Calistri Paolo, 2010, Open Virol J, V4, P29, DOI 10.2174/1874357901004020029; Calzolari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014324; Castillo-Olivares J, 2004, VET RES, V35, P467, DOI 10.1051/vetres:2004022; CDC [Centers for Disease Control and Prevention], 2013, W NIL VIR US GUID SU; Chaintoutis SC, 2016, ACTA TROP, V163, P26, DOI 10.1016/j.actatropica.2016.07.018; ECDC (European Centre for Disease Prevention and Control), 2014, REP CAS W NIL FEV EU; ECDC (European Centre for Disease Prevention and Control), CUM NUMB W NIL FEV C; ECDC (European Centre for Disease Prevention and Control), 2012, REP CAS W NIL FEV EU; Erdelyi K, 2007, VECTOR-BORNE ZOONOT, V7, P181, DOI 10.1089/vbz.2006.0586; Groen TA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2484-y; Hrnjakovic-Cvjetkovic I., 2017, ARCH VET MED, V10, P77, DOI [10.46784/e-avm.v10i1.79, DOI 10.46784/E-AVM.V10I1.79]; Institute of Public Health of Serbia (Serbian CDC), 2014, INF AKT EP SIT GROZN; Komar N, 2002, EMERG INFECT DIS, V8, P741, DOI 10.3201/eid0807.020157; Linke S, 2007, AM J TROP MED HYG, V77, P358, DOI 10.4269/ajtmh.2007.77.358; Lupulovic D, 2011, VECTOR-BORNE ZOONOT, V11, P1303, DOI 10.1089/vbz.2010.0249; Medic S, 2014, J INFECT DEV COUNTR, V8, P914, DOI 10.3855/jidc.3885; Nemeth N, 2007, EMERG INFECT DIS, V13, P305, DOI 10.3201/eid1302.051626; Nemeth NM, 2007, AM J TROP MED HYG, V76, P431, DOI 10.4269/ajtmh.2007.76.431; Petric D, 2017, MOL CELL PROBE, V31, P28, DOI 10.1016/j.mcp.2016.10.011; Petric D, 2012, HEALTHMED, V6, P462; Petrovic T, 2014, ARCH BIOL SCI, V66, P473, DOI 10.2298/ABS1402473P; Petrovic T, 2013, EURO SURVEILL, V18, P20622; Platonov AE, 2008, PARASITOL RES, V103, pS45, DOI 10.1007/s00436-008-1050-0; Popovic N., 2013, EURO SURVEILL, V18; Rizzo C, 2012, EUROSURVEILLANCE, V17, P7; Savini G, 2012, VET MICROBIOL, V158, P267, DOI 10.1016/j.vetmic.2012.02.018; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; Vesenjak-Hirjan J, 1991, J Hyg Epidemiol Microbiol Immunol, V35, P129; Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025; Wodak E, 2011, VET MICROBIOL, V149, P358, DOI 10.1016/j.vetmic.2010.12.012; Ziegler U, 2012, ZOONOSES PUBLIC HLTH, V59, P95, DOI 10.1111/zph.12015	40	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195439	10.1371/journal.pone.0195439	http://dx.doi.org/10.1371/journal.pone.0195439			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624622	Green Published, gold, Green Submitted			2022-12-26	WOS:000429379600028
J	Cunningham, DJ; Shearer, DA; Carter, N; Drawer, S; Pollard, B; Bennett, M; Eager, R; Cook, CJ; Farrell, J; Russell, M; Kilduff, LP				Cunningham, Daniel J.; Shearer, David A.; Carter, Neil; Drawer, Scott; Pollard, Ben; Bennett, Mark; Eager, Robin; Cook, Christian J.; Farrell, John; Russell, Mark; Kilduff, Liam P.			Assessing worst case scenarios in movement demands derived from global positioning systems during international rugby union matches: Rolling averages versus fixed length epochs	PLOS ONE			English	Article							TEAM SOCCER MATCH; PHYSICAL DEMANDS; PLAY; FLUCTUATIONS; RELIABILITY; PERFORMANCE; RESPONSES; VELOCITY; INJURY; GAMES	The assessment of competitive movement demands in team sports has traditionally relied upon global positioning system (GPS) analyses presented as fixed-time epochs (e.g., 5-40 min). More recently, presenting game data as a rolling average has become prevalent due to concerns over a loss of sampling resolution associated with the windowing of data over fixed periods. Accordingly, this study compared rolling average (ROLL) and fixed-time (FIXED) epochs for quantifying the peak movement demands of international rugby union match-play as a function of playing position. Elite players from three different squads (n = 119) were monitored using 10 Hz GPS during 36 matches played in the 2014-2017 seasons. Players categorised broadly as forwards and backs, and then by positional sub-group (FR: front row, SR: second row, BR: back row, HB: half back, MF: midfield, B3: back three) were monitored during match-play for peak values of high-speed running (>5 m.s(-1); HSR) and relative distance covered (m.min(-1)) over 60-300 s using two types of sample-epoch (ROLL, FIXED). Irrespective of the method used, as the epoch length increased, values for the intensity of running actions decreased (e.g., For the backs using the ROLL method, distance covered decreased from 177.4 +/- 20.6 m.min(-1) in the 60 s epoch to 107.5 +/- 13.3 m.min(-1) for the 300 s epoch). For the team as a whole, and irrespective of position, estimates of fixed effects indicated significant between-method differences across all time-points for both relative distance covered and HSR. Movement demands were underestimated consistently by FIXED versus ROLL with differences being most pronounced using 60 s epochs (95% CI HSR: -6.05 to -4.70 m.min(-1), 95% CI distance: -18.45 to -16.43 m.min(-1)). For all HSR time epochs except one, all backs groups increased more (p < 0.01) from FIXED to ROLL than the forward groups. Linear mixed modelling of ROLL data highlighted that for HSR (except 60 s epoch), SR was the only group not significantly different to FR. For relative distance covered all other position groups were greater than the FR (p < 0.05). The FIXED method underestimated both relative distance (similar to 11%) and HSR values (up to similar to 20%) compared to the ROLL method. These differences were exaggerated for the HSR variable in the backs position who covered the greatest HSR distance; highlighting important consideration for those implementing the FIXED method of analysis. The data provides coaches with a worst-case scenario reference on the running demands required for periods of 60-300 s in length. This information offers novel insight into game demands and can be used to inform the design of training games to increase specificity of preparation for the most demanding phases of matches.	[Cunningham, Daniel J.; Cook, Christian J.; Kilduff, Liam P.] Swansea Univ, Coll Engn, Appl Sport Technol Exercise & Med Res Ctr A STEM, Swansea, W Glam, Wales; [Shearer, David A.] Univ South Wales, Sch Psychol & Therapeut Studies, Pontypridd, Wales; [Shearer, David A.; Kilduff, Liam P.] Swansea Univ, Welsh Inst Performance Sci, Coll Engn, Swansea, W Glam, Wales; [Carter, Neil] Swansea Univ, Dept Psychol, Coll Human & Hlth Sci, Swansea, W Glam, Wales; [Drawer, Scott] Team Sky, Sky Performance Hub, London, England; [Pollard, Ben] Saracens RFC, North London, England; [Bennett, Mark; Eager, Robin] Rugby Football Union, Greater London, England; [Cook, Christian J.] Univ Canberra, Res Inst Sport & Exercise, Canberra, ACT, Australia; [Farrell, John] Georgian Rugby Union, Tbilisi, Georgia; [Russell, Mark] Leeds Trinity Univ, Sch Social & Hlth Sci, Leeds, W Yorkshire, England	Swansea University; University of South Wales; Swansea University; Swansea University; University of Canberra	Kilduff, LP (corresponding author), Swansea Univ, Coll Engn, Appl Sport Technol Exercise & Med Res Ctr A STEM, Swansea, W Glam, Wales.; Kilduff, LP (corresponding author), Swansea Univ, Welsh Inst Performance Sci, Coll Engn, Swansea, W Glam, Wales.	l.kilduff@swansea.ac.uk	Shearer, David/K-8025-2019; Russell, Mark/M-1652-2019	Shearer, David/0000-0002-5877-8160; Russell, Mark/0000-0002-7305-1090; Cunningham, Dan/0000-0002-5249-0609; Cook, Christian/0000-0001-9677-0306	Rugby Football Union; Team Sky; Georgia Rugby	Rugby Football Union; Team Sky; Georgia Rugby	The author(s) received no specific funding for this work and no authors have any financial or other interest in the products or distributor of the products named in the study. The Rugby Football Union provided support in the form of salaries for authors Scott Drawer, Mark Bennett, Robin Eager and Ben Pollard, Team Sky provided support in the form of a salary to Scott Drawer and Georgia Rugby provided support in the form of a salary for John Farrell but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson L, 2016, INT J SPORTS PHYSL P; Anderson L, 2016, J SPORT SCI, V34, P1250, DOI 10.1080/02640414.2015.1106574; Austin DJ, 2013, J STRENGTH COND RES, V27, P14, DOI 10.1519/JSC.0b013e31824e108c; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Beato M, 2016, J HUM KINET, V54, P15, DOI 10.1515/hukin-2016-0031; Cahill N, 2013, J SPORT SCI, V31, P229, DOI 10.1080/02640414.2012.727456; Castellano J, 2011, J SPORT SCI MED, V10, P233; Cunniffe B, 2009, J STRENGTH COND RES, V23, P1195, DOI 10.1519/JSC.0b013e3181a3928b; Cunningham D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153275; Cunningham DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164990; Delaney JA, 2016, INT J SPORT PHYSIOL, V11, P802, DOI 10.1123/ijspp.2015-0424; Delaney JA, 2015, INT J SPORT PHYSIOL, V10, P725, DOI 10.1123/ijspp.2015-0092; Furlan N, 2015, INT J SPORT PHYSIOL, V10, P802, DOI 10.1123/ijspp.2014-0315; Gabbett TJ, 2016, BRIT J SPORT MED, V50, P273, DOI 10.1136/bjsports-2015-095788; Gabbett TJ, 2012, J STRENGTH COND RES, V26, P953, DOI 10.1519/JSC.0b013e3182302023; Gabbett TJ, 2012, J SCI MED SPORT, V15, P80, DOI 10.1016/j.jsams.2011.07.004; Gabbett TJ, 2011, J SCI MED SPORT, V14, P204, DOI 10.1016/j.jsams.2010.12.002; Gabbett TJ, 2006, J STRENGTH COND RES, V20, P309, DOI 10.1519/R-17655.1; Harley JA, 2010, J SPORT SCI, V28, P1391, DOI 10.1080/02640414.2010.510142; James N, 2005, J SPORT SCI, V23, P63, DOI 10.1080/02640410410001730106; Jones MR, 2015, EUR J SPORT SCI, V15, P488, DOI 10.1080/17461391.2015.1010106; Jones MR, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-38; Lacome M, 2018, INT J SPORT PHYSIOL, V13, P568, DOI 10.1123/ijspp.2017-0214; Lacome M, 2017, EUR J SPORT SCI, V17, P132, DOI 10.1080/17461391.2016.1220986; Laserna Jose de, 1916, IMPARCIAL 18 ENE, P1; Lindsay A, 2015, EUR J SPORT SCI, P1; Quarrie KL, 2013, J SCI MED SPORT, V16, P353, DOI 10.1016/j.jsams.2012.08.005; Reardon C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177072; Reardon C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133410; Roberts SP, 2008, J SPORT SCI, V26, P825, DOI 10.1080/02640410801942122; Russell M, 2016, HUM MOVEMENT SCI, V45, P96, DOI 10.1016/j.humov.2015.11.011; Russell M, 2015, J SPORT SCI, V33, P2133, DOI 10.1080/02640414.2015.1064153; Russell M, 2016, J STRENGTH COND RES, V30, P2839, DOI 10.1519/JSC.0000000000000805; Tierney P, 2016, SCAND J MED SCI SPOR; Tierney PJ, 2016, HUM MOVEMENT SCI, V49, P1, DOI 10.1016/j.humov.2016.05.007; Varley MC, 2012, INT J SPORT PHYSIOL, V7, P183, DOI 10.1123/ijspp.7.2.183; Varley MC, 2012, J SPORT SCI, V30, P121, DOI 10.1080/02640414.2011.627941	37	50	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195197	10.1371/journal.pone.0195197	http://dx.doi.org/10.1371/journal.pone.0195197			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621279	Green Published, gold, Green Submitted			2022-12-26	WOS:000429206800048
J	Hong, EH; Shin, YU; Kang, MH; Cho, H; Seong, M				Hong, Eun Hee; Shin, Yong Un; Kang, Min Ho; Cho, Heeyoon; Seong, Mincheol			Wide scan imaging with swept-source optical coherent tomography for glaucoma diagnosis	PLOS ONE			English	Article							CHOROIDAL THICKNESS; PROGRESSION; ABILITY; VOLUME; DAMAGE	Purpose To determine glaucoma-discriminating abilities of macular and circumpapillary retinal nerve fiber layer (cpRNFL) thickness measurements of wide scan (12X9mm) using swept-source optical coherence tomography (SS-OCT) compared to measurements of standard macula and disc scans (6 X 6 mm). Methods This retrospective chart review study included 60 glaucomatous and 62 healthy eyes of total 122 subjects who visited a glaucoma clinic and were examined with wide, standard macula, and standard disc scans of SS-OCT (DRI-OCT-1 Atlantis; Topcon Inc., Tokyo, Japan) on the same day. Thickness measurements of the ganglion cell layer plus inner plexiform layer (mGCIPL), mGCIPL plus nerve fiber layer (mGCC), and total retinal layer (TRL) were assessed in wide and standard macula scans. Thickness measurements of cpRNFL were assessed in wide and standard disc scans. The repeatability and agreement of measurements taken in each scan were evaluated using intraclass correlation coefficients (ICCs). The abilities of parameters to discriminate between glaucoma and normal groups were assessed using areas under receiver operating characteristic curves (AUCs). Results The repeatability and agreement of all parameters showed high ICC values (all >= 0.800). AUCs for mGCIPL thickness were 0.710-0.847 and 0.701-0.836 in standard macula and wide scans, respectively. AUCs for cpRNFL thickness were 0.749-0.902 and 0.726-0.897 in standard disc and wide scans, respectively. There were no significant differences in AUCs between wide and standard scans. Conclusions The agreement between SS-OCT wide and standard scans for mGCIPL, mGCC and cpRNFL measurements were excellent. As the glaucoma-discriminating ability of wide scans was comparable to that of standard macula/disc scans, a single wide scan can replace separate standard macula/disc scans for evaluating glaucoma.	[Hong, Eun Hee; Shin, Yong Un; Kang, Min Ho; Cho, Heeyoon; Seong, Mincheol] Hanyang Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea	Hanyang University	Seong, M (corresponding author), Hanyang Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	goddns76@hanmail.net	SHIN, Yong-Un/AAI-9824-2020; Shin, Yong Un/V-7668-2017	Shin, Yong Un/0000-0003-1251-8985; Seong, Mincheol/0000-0001-7912-0096	National Research Foundation of Korea [NRF-2017R1D1A1B03030905, NRF-2017R1D1A1803031934]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea NRF-2017R1D1A1B03030905 to YUS and NRF-2017R1D1A1803031934 to HC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshareef RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155319; Bagga H, 2005, J GLAUCOMA, V14, P358, DOI 10.1097/01.ijg.0000176930.21853.04; Bussel II, 2013, BR J OPHTHALMOL; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Griffith JF, 2015, CLIN OPHTHALMOL, V9, P1275, DOI 10.2147/OPTH.S85851; Hirata M, 2011, INVEST OPHTH VIS SCI, V52, P4971, DOI 10.1167/iovs.11-7729; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Kim KE, 2014, INVEST OPHTH VIS SCI, V55, P3501, DOI 10.1167/iovs.14-13925; Lee KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147964; Lee SY, 2017, J GLAUCOMA, V26, pE46, DOI [10.1097/IJG.000000000000536, 10.1097/IJG.0000000000000536]; Lee WJ, 2017, J GLAUCOMA, V26, P577, DOI 10.1097/IJG.0000000000000662; Leung CKS, 2014, CURR OPIN OPHTHALMOL, V25, P104, DOI 10.1097/ICU.0000000000000024; Mansouri K, 2013, OPHTHALMOLOGY, V120, P2508, DOI 10.1016/j.ophtha.2013.07.040; Medeiros FA, 2012, INVEST OPHTH VIS SCI, V53, P6939, DOI 10.1167/iovs.12-10345; Morooka S, 2012, INVEST OPHTH VIS SCI, V53, P4805, DOI 10.1167/iovs.12-9870; Nakano N, 2011, OPHTHALMOLOGY, V118, P2414, DOI 10.1016/j.ophtha.2011.06.015; Nakatani Y, 2011, J GLAUCOMA, V20, P252, DOI 10.1097/IJG.0b013e3181e079ed; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Yang ZY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125957; Yang ZY, 2015, AM J OPHTHALMOL, V159, P193, DOI 10.1016/j.ajo.2014.10.019	21	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195040	10.1371/journal.pone.0195040	http://dx.doi.org/10.1371/journal.pone.0195040			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621263	gold, Green Published, Green Submitted			2022-12-26	WOS:000429206800034
J	Nakayama, N; Arakawa, N; Ejiri, H; Matsuda, R; Makino, T				Nakayama, Natsuki; Arakawa, Naoko; Ejiri, Harumi; Matsuda, Reiko; Makino, Tsuneko			Heart rate variability can clarify students' level of stress during nursing simulation	PLOS ONE			English	Article							CLINICAL LEARNING-ENVIRONMENT; CRITICAL-CARE; SCALE	Simulation is regarded as an effective educational method for the delivery of clinical scenarios. However, exposure to unfamiliar environments during simulation can cause excessive stress among students, possibly leading to unnatural speech/behavior and poor skill learning (Yerkes-Dodson's law). Thus, assessing students' stress in a simulation can provide educators with a better understanding of their mental state. This study sought to clarify stress changes throughout the progression of the simulation by measuring heart rate variability and students' subjective reactions in 74 nursing students. Heart rate variability was calculated in terms of its high-frequency(HF) and low-frequency/high-frequency (LF/HF) components during 4 phases the break, patient care, reporting, and debriefing. Students were interviewed about stress experienced during the simulation. The results showed that HF decreased significantly from the break to the patient care and reporting phases. Furthermore, LF/HF increased significantly from the break to the reporting phases. Approximately 55 students felt stressed during the simulation, 24 of whom felt most stressed during the reporting phase. Therefore, the reporting phase involved high objective and subjective stress. It may be possible that the educator's evaluative attitude increased students' stress. Therefore, a stress intervention during the reporting phase might further improve students' performance during that phase. The debriefing phase did not significantly differ from the break phase for objective stress, and students did not report feeling stressed. Thus, in this phase, they were released from the stress of the reporting phase and the unfamiliar environment. During this phase, they might be able to learn what they could not understand owing to high stress in the patient care and reporting phases. This study provides objective and subjective evidence of students' stress during simulation, and indicates the necessity of providing support during the reporting phase and the importance of debriefing when using clinical scenarios for teaching clinical skills.	[Nakayama, Natsuki] Nagoya Univ, Grad Sch Med, Dept Nursing, Nagoya, Aichi, Japan; [Arakawa, Naoko; Ejiri, Harumi; Matsuda, Reiko; Makino, Tsuneko] Chubu Univ, Coll Life & Hlth Sci, Dept Nursing, Kasugai, Aichi, Japan	Nagoya University; Chubu University	Nakayama, N (corresponding author), Nagoya Univ, Grad Sch Med, Dept Nursing, Nagoya, Aichi, Japan.	nakayama@met.nagoya-u.ac.jp	Arakawa, Naoko/R-1031-2019					Abe Y, 2013, AM J CRIT CARE, V22, P33, DOI 10.4037/ajcc2013229; Biernacki M, 2012, MED PR, V63, P377; Bloomfield DM, 2001, AM J PHYSIOL-HEART C, V280, pH1145, DOI 10.1152/ajpheart.2001.280.3.H1145; Bolesta S, 2014, AM J PHARM EDUC, V78, DOI 10.5688/ajpe78594; Camm AJ, 1996, EUR HEART J, V17, P354; Castaldo R, 2016, IEEE ENG MED BIO, P3805, DOI 10.1109/EMBC.2016.7591557; Chan DSK, 2003, WESTERN J NURS RES, V25, P519, DOI 10.1177/0193945903253161; Decker S, 2013, CLIN SIMUL NURS, V9, pS26, DOI 10.1016/j.ecns.2013.04.008; Hagiwara A, 2008, GERIATR GERONTOL INT, V8, P143, DOI 10.1111/j.1447-0594.2008.00463.x; Hamaideh SH, 2017, J MENT HEALTH, V26, P197, DOI 10.3109/09638237.2016.1139067; Hinchey Paul R, 2011, Air Med J, V30, P86, DOI 10.1016/j.amj.2010.11.002; Javorka M, 2018, AM J PHYSIOL-REG I, V14; Labrague Leodoro J, 2017, J Ment Health, V26, P471, DOI 10.1080/09638237.2016.1244721; Li H, 2016, INT J PSYCHIAT MED, V51, P47, DOI 10.1177/0091217415621265; Lusk JM, 2013, NURS EDUC, V38, P16, DOI 10.1097/NNE.0b013e318276df8b; McCraty Rollin, 2015, Glob Adv Health Med, V4, P46, DOI 10.7453/gahmj.2014.073; McEwen BS, 2010, ANN NY ACAD SCI, V1186, P190, DOI 10.1111/j.1749-6632.2009.05331.x; McNiesh SG, 2011, J NURS EDUC, V50, P197, DOI 10.3928/01484834-20101029-03; Montano N, 2009, NEUROSCI BIOBEHAV R, V33, P71, DOI 10.1016/j.neubiorev.2008.07.006; Morrison A L, 2001, Aust Crit Care, V14, P116, DOI 10.1016/S1036-7314(01)80028-X; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Pinna GD, 2006, AM J PHYSIOL-HEART C, V290, pH424, DOI 10.1152/ajpheart.00438.2005; Roh YS, 2016, NURS HEALTH SCI, V18, P238, DOI 10.1111/nhs.12259; Shreeve MW, 2008, J CHIPROPR EDUC, V22, P23, DOI 10.7899/1042-5055-22.1.23; Skaalvik MW, 2011, J CLIN NURS, V20, P2294, DOI 10.1111/j.1365-2702.2011.03727.x; Springer R, 2013, SURGERY, V154, P345, DOI 10.1016/j.surg.2013.04.038; van der Zwan JE, 2015, APPL PSYCHOPHYS BIOF, V40, P257, DOI 10.1007/s10484-015-9293-x; Wu M, 2015, IEEE ENG MED BIO, P1625, DOI 10.1109/EMBC.2015.7318686; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	29	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195280	10.1371/journal.pone.0195280	http://dx.doi.org/10.1371/journal.pone.0195280			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621278	Green Submitted, Green Published, gold			2022-12-26	WOS:000429206800054
J	Semeraro, R; Orlandini, V; Magi, A				Semeraro, Roberto; Orlandini, Valerio; Magi, Alberto			Xome-Blender: A novel cancer genome simulator	PLOS ONE			English	Article							GENERATION SEQUENCING DATA; MYELOID-LEUKEMIA GENOME; COPY-NUMBER ALTERATION; ACCURATE; MUTATIONS; DISCOVERY; IDENTIFICATION; LANDSCAPE; FRAMEWORK	The adoption of next generation sequencing based methods in cancer research allowed for the investigation of the complex genetic structure of tumor samples. In the last few years, considerable importance was given to the research of somatic variants and several computational approaches were developed for this purpose. Despite continuous improvements to these programs, the validation of their results it's a hard challenge due to multiple sources of error. To overcome this drawback different simulation approaches are used to generate synthetic samples but they are often based on the addition of artificial mutations that mimic the complexity of genomic variations. For these reasons, we developed a novel software, Xome-Blender, that generates synthetic cancer genomes with user defined features such as the number of subclones, the number of somatic variants and the presence of copy number alterations (CNAs), without the addition of any synthetic element. The singularity of our method is the "morphological approach" used to generate mutation events. To demonstrate the power of our tool we used it to address the hard challenge of evaluating the performance of nine state-of-the-art somatic variant calling methods for small and large variants (VarScan2, MuTect, Shimmer, BCFtools, Strelka, EXCAVATOR2, Control-FREEC and CopywriteR). Through these analyses we observed that by using Xome-Blender data it is possible to appraise small differences between their performance and we have designated VarScan2 and EXCAVATOR2 as best tool for this kind of applications. Xome-Blender is unix-based, licensed under the GPLv3 and freely available at https://github.com/rsemeraro/XomeBlender.	[Semeraro, Roberto; Magi, Alberto] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Orlandini, Valerio] Meyer Childrens Univ Hosp, Med Genet Unit, Florence, Italy	University of Florence; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER	Semeraro, R (corresponding author), Univ Florence, Dept Expt & Clin Med, Florence, Italy.	roberto.semeraro@unifi.it	Semeraro, Roberto/AAB-2193-2019; MAGI, Alberto/M-6773-2015	Semeraro, Roberto/0000-0003-0601-6903; MAGI, Alberto/0000-0001-7393-4283; Orlandini, Valerio/0000-0002-6857-5471	Italian Ministry of Health, Young Investigators Award [GR-2011-02352026]	Italian Ministry of Health, Young Investigators Award	AM and RS were supported by Italian Ministry of Health, Young Investigators Award, Project GR-2011-02352026 Detecting copy number variants from whole-exome sequencing data applied to acute myeloid leukemias.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Angly FE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks251; [Anonymous], 2012, PILEUP2BASE; [Anonymous], 2010, PICARD TYPE; Bainbridge MN, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r62; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bodini M, 2015, BLOOD, V125, P600, DOI 10.1182/blood-2014-05-576157; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Boutros PC, 2014, NAT GENET, V46, P318, DOI 10.1038/ng.2932; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Consortium GP, 1000 GEN PROJ REP; D'Aurizio R, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw695; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Escalona M, 2016, NAT REV GENET, V17, P459, DOI 10.1038/nrg.2016.57; Ewing AD, 2015, NAT METHODS, V12, P623, DOI [10.1038/NMETH.3407, 10.1038/nmeth.3407]; Hansen NF, 2013, BIOINFORMATICS, V29, P1498, DOI 10.1093/bioinformatics/btt183; Holtgrewe M, 2010, MASON READ SIMULATOR; Hu XS, 2012, BIOINFORMATICS, V28, P1533, DOI 10.1093/bioinformatics/bts187; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Janin L, 2014, EAGLE ENHANCED ARTIF; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Ku CS, 2011, HUM GENET, V129, P351, DOI 10.1007/s00439-011-0964-2; Kuilman T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0617-1; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Magi A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r120; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; McElroy KE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-74; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pattnaik S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-40; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; Roberts ND, 2013, BIOINFORMATICS, V29, P2223, DOI 10.1093/bioinformatics/btt375; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; van de Wiel MA, 2007, BIOINFORMATICS, V23, P892, DOI 10.1093/bioinformatics/btm030; Wang QG, 2013, GENOME MED, V5, DOI 10.1186/gm495; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109	47	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0194472	10.1371/journal.pone.0194472	http://dx.doi.org/10.1371/journal.pone.0194472			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621252	Green Published, gold			2022-12-26	WOS:000429206800019
J	Betancor, PK; Hildebrand, A; Bohringer, D; Emmerich, F; Schlunck, G; Reinhard, T; Lapp, T				Betancor, Paola Kammrath; Hildebrand, Antonia; Bohringer, Daniel; Emmerich, Florian; Schlunck, Gunther; Reinhard, Thomas; Lapp, Thabo			Activation of human macrophages by human corneal allogen in vitro	PLOS ONE			English	Article							ALLOGRAFT-REJECTION; PENETRATING KERATOPLASTY; LYMPH-NODES; IMMUNE PRIVILEGE; ANTERIOR-CHAMBER; CELL PHENOTYPES; DENDRITIC CELLS; AQUEOUS-HUMOR; MECHANISMS; MONOCYTES	Purpose To study distinct aspects of human monocyte-derived macrophage (MDM) activation by human corneal tissue as a possible initial stage in human corneal allograft rejection. Methods Human monocytes were isolated from peripheral blood mononuclear cells (PBMC) and differentiated into MDM. Human corneas with or without endothelium were fragmented using a standardized protocol. MDM were stimulated with human corneal fragments, corneal fragment supernatant, lipopolysaccharide (LPS) or interferon-gamma (IFN gamma), and expression profiles for 34 cytokines were determined in MDM-conditioned media using a Luminex bead-based multiplex assay. Data from clinical aqueous humour samples served for comparison and validation. To assess cell recruitment, immunogenicity of corneal endothelial cells (CEC), monocyte survival and differentiation, we applied transwell migration assays, cell viability assays and fluorescence-activated cell sorting, respectively. Results Corneal fragments induced MDM to release distinct cytokines into the medium. Media thus conditioned in vitro by stimulated MDM shared cytokine patterns, namely MCP-1, MIP-1 alpha and MIP-1 beta, with human aqueous humor samples obtained in human corneal allograft rejection. The presence of CEC in tissue fragments used for MDM stimulation attenuated the upregulation of distinct pro-inflammatory chemokines, like MCP-3 and IL-8, reduced the monocyte survival time, and diminished monocyte-to-macrophage differentiation induced by conditioned media. Distinct anti-inflammatory cytokines, like IL-4 and IL-13, were upregulated in the presence of corneal endothelium. Cornea fragment-stimulated MDMs induced recruitment of monocytes from a PBMC pool in a transwell migration model, modulated immune cell viability and promoted further immune cell recruitment and differentiation. Conclusions Human macrophages respond to allogenic corneal tissue and generate an inflammatory milieu. This can drive further recruitment of immunocompetent cells and modulate cell survival and differentiation of the cells recruited. These observations are consistent with the hypothesis that macrophages play a significant role in the initiation of corneal transplant rejection. Our data also indicate that distinct aspects of early human corneal transplant rejection can be modelled in vitro.	[Betancor, Paola Kammrath; Hildebrand, Antonia; Bohringer, Daniel; Schlunck, Gunther; Reinhard, Thomas; Lapp, Thabo] Univ Freiburg, Fac Med, Ctr Eye, Med Ctr, Freiburg, Germany; [Emmerich, Florian] Univ Freiburg, Fac Med, Inst Transfus Med & Gene Therapy, Med Ctr, Freiburg, Germany	University of Freiburg; University of Freiburg	Lapp, T (corresponding author), Univ Freiburg, Fac Med, Ctr Eye, Med Ctr, Freiburg, Germany.	Thabo.Lapp@uniklinik-freiburg.de		Lapp, Thabo/0000-0001-7097-7587; Kammrath Betancor, Paola/0000-0001-7654-6032	"Ernst-und-Berta-Grimmke-Stiftung" (Germany); "Gertrud Kusen Stiftung (Germany); "Freunde der Universitats-Augenklinik Freiburg e.V." Foundation (Germany)	"Ernst-und-Berta-Grimmke-Stiftung" (Germany); "Gertrud Kusen Stiftung (Germany); "Freunde der Universitats-Augenklinik Freiburg e.V." Foundation (Germany)	This research was supported by a grant from: 1) the "Ernst-und-Berta-Grimmke-Stiftung" (Germany), research grant (to TL); 2) the "Gertrud Kusen Stiftung (Germany), research grant (to TL); and 3) the "Freunde der Universitats-Augenklinik Freiburg e.V." Foundation (Germany), Doctoral scholarship (to PKB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amouzegar A, 2016, J IMMUNOL, V196, P3983, DOI 10.4049/jimmunol.1600251; Boyette LB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176460; Camelo S, 2004, J IMMUNOL, V172, P5388, DOI 10.4049/jimmunol.172.9.5388; Coster DJ, 2009, EYE, V23, P1894, DOI 10.1038/eye.2009.17; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Cunnusamy K, 2010, INVEST OPHTH VIS SCI, V51, P6566, DOI 10.1167/iovs.10-6161; Flynn TH, 2008, AM J TRANSPLANT, V8, P1537, DOI 10.1111/j.1600-6143.2008.02285.x; Forrester JV, 2010, IMMUNOL REV, V234, P282, DOI 10.1111/j.0105-2896.2009.00873.x; Gain P, 2016, JAMA OPHTHALMOL, V134, P167, DOI 10.1001/jamaophthalmol.2015.4776; Gasser L, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0068-1; HOLLAND EJ, 1994, CORNEA, V13, P317, DOI 10.1097/00003226-199407000-00006; Hori J, 2010, INVEST OPHTH VIS SCI, V51, P6556, DOI 10.1167/iovs.09-4959; Kuffova L, 2001, TRANSPLANTATION, V72, P1292, DOI 10.1097/00007890-200110150-00019; Lapp T, 2015, INVEST OPHTH VIS SCI, V56, P7250, DOI 10.1167/iovs.15-16941; Larkin DFP, 1997, EYE, V11, P68, DOI 10.1038/eye.1997.13; Liu Y, 2002, J EXP MED, V195, P259, DOI 10.1084/jem.20010838; Mantovani A, 2014, CURR OPIN PHARMACOL, V17, P38, DOI 10.1016/j.coph.2014.07.004; McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110; NAIR S, 1995, INT IMMUNOL, V7, P679, DOI 10.1093/intimm/7.4.679; Niederkorn JY, 2007, CURR EYE RES, V32, P1005, DOI 10.1080/02713680701767884; Niederkorn JY, 2010, OCUL IMMUNOL INFLAMM, V18, P162, DOI 10.3109/09273948.2010.486100; Niederkorn JY, 2015, J CLIN EXP OPHTHALMO, V6; Noursadeghi M, 2008, J IMMUNOL METHODS, V329, P194, DOI 10.1016/j.jim.2007.10.015; Reinhard T, 2002, ARCH OPHTHALMOL-CHIC, V120, P1630; Reinhard T, 2002, CORNEA, V21, P56, DOI 10.1097/00003226-200201000-00013; Slegers TPAM, 2004, TRANSPLANTATION, V77, P1641, DOI 10.1097/01.TP.0000129410.89410.F2; Slegers TPAM, 2000, INVEST OPHTH VIS SCI, V41, P2239; Tsukamoto M, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-016-1216-6; VANDERVEEN G, 1994, INVEST OPHTH VIS SCI, V35, P3505; Varvel NH, 2016, P NATL ACAD SCI USA, V113, pE5665, DOI 10.1073/pnas.1604263113; Williams KA, 2008, TRANSPLANTATION, V86, P1720, DOI 10.1097/TP.0b013e3181903b0a; Yamagami S, 2003, CORNEA, V22, pS61, DOI 10.1097/00003226-200310001-00009; Yamagami S, 2001, INVEST OPHTH VIS SCI, V42, P1293; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	34	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194855	10.1371/journal.pone.0194855	http://dx.doi.org/10.1371/journal.pone.0194855			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617399	gold, Green Published, Green Submitted			2022-12-26	WOS:000429203800053
J	English, WR; Ireland-Zecchini, H; Baker, AH; Littlewood, TD; Bennett, MR; Murphy, G				English, William R.; Ireland-Zecchini, Heather; Baker, Andrew H.; Littlewood, Trevor D.; Bennett, Martin R.; Murphy, Gillian			Tissue Inhibitor of Metalloproteinase-3 (TIMP-3) induces FAS dependent apoptosis in human vascular smooth muscle cells	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; DEATH DOMAIN; LEUKEMIC-CELLS; LIPID RAFTS; CD95; OVEREXPRESSION; REDISTRIBUTION; MECHANISM; INVASION; PROLIFERATION	Over expression of Tissue Inhibitor of Metalloproteinases-3 (TIMP-3) in vascular smooth muscle cells (VSMCs) induces apoptosis and reduces neointima formation occurring after saphenous vein interposition grafting or coronary stenting. In studies to address the mechanism of TIMP-3-driven apoptosis in human VSMCs we find that TIMP-3 increased activation of caspase-8 and apoptosis was inhibited by expression of Cytokine response modifier A (CrmA) and dominant negative FAS-Associated protein with Death Domain (FADD). TIMP-3 induced apoptosis did not cause mitochondrial depolarisation, increase activation of caspase-9 and was not inhibited by over-expression of B-cell Lymphoma 2 (BcI2), indicating a mitochondrial independent/type-I death receptor pathway. TIMP-3 increased levels of the First Apoptosis Signal receptor (FAS) and depletion of FAS with shRNA showed TIMP-3-induced apoptosis was FAS dependent. TIMP-3 induced formation of the Death-Inducing Signalling Complex (DISC), as detected by immunoprecipitation and by immunofluorescence. Cellular-FADD-like IL-1 converting enzyme-Like Inhibitory Protein (c-FLIP) localised with FAS at the cell periphery in the absence of TIMP-3 and this localisation was lost on TIMP-3 expression with c-FLIP adopting a perinuclear localisation. Although TIMP-3 inhibited FAS shedding, this did not increase total surface levels of FAS but instead increased FAS levels within localised regions at the cell surface. A Disintegrin And Metalloproteinase 17 (ADAM17) is inhibited by TIMP-3 and depletion of ADAM17 with shRNA significantly decreased FAS shedding. However ADAM17 depletion did not induce apoptosis or replicate the effects of TIMP-3 by increasing localised clustering of cell surface FAS. ADAM17-depleted cells could activate caspase-3 when expressing levels of TIMP-3 that were otherwise sub-apoptotic, suggesting a partial role for ADAM17 mediated ectodomain shedding in TIMP-3 mediated apoptosis. We conclude that TIMP-3 induced apoptosis in VSMCs is highly dependent on FAS and is associated with changes in FAS and c-FLIP localisation, but is not solely dependent on shedding of the FAS ectodomain.	[English, William R.; Murphy, Gillian] Univ Cambridge, Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Robinson Way, Cambridge, England; [English, William R.] Univ Sheffield, Sch Med, Dept Oncol & Metab, Sheffield, S Yorkshire, England; [Ireland-Zecchini, Heather] Univ Cambridge, Microscopy Core Facil, Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Robinson Way, Cambridge, England; [Baker, Andrew H.] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Littlewood, Trevor D.] Univ Cambridge, Dept Biochem, Cambridge, England; [Bennett, Martin R.] Univ Cambridge, Addenbrookes Hosp, Div Cardiovasc Med, Cambridge, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Sheffield; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Glasgow; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	English, WR (corresponding author), Univ Cambridge, Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Robinson Way, Cambridge, England.; English, WR (corresponding author), Univ Sheffield, Sch Med, Dept Oncol & Metab, Sheffield, S Yorkshire, England.	w.english@sheffield.ac.uk	Baker, Andy/AAO-5250-2021	Baker, Andy/0000-0003-1441-5576; Bennett, Martin/0000-0002-2565-1825; English, William/0000-0003-3024-2441	Cancer Research UK; Hutchison Whampoa Limited; European Union [LSHC-CT-2003-503297]; British Heart Foundation; British Heart Foundation Intermediate Research Fellowship [FS/03/055/15910]; British Heart Foundation [RG/13/14/30314]; flowcytometry and microscopy facilities of the Cambridge Institute for Medical Research; Cancer Research UK Cambridge Institute, University of Cambridge UK	Cancer Research UK(Cancer Research UK); Hutchison Whampoa Limited; European Union(European Commission); British Heart Foundation(British Heart Foundation); British Heart Foundation Intermediate Research Fellowship; British Heart Foundation(British Heart Foundation); flowcytometry and microscopy facilities of the Cambridge Institute for Medical Research; Cancer Research UK Cambridge Institute, University of Cambridge UK	This work was supported by Cancer Research UK and Hutchison Whampoa Limited (WRE, HIZ, GM), European Union Framework Programme 6 LSHC-CT-2003-503297 (GM), and the British Heart Foundation (AHB, TDL, MRB). WRE was supported by a British Heart Foundation Intermediate Research Fellowship (FS/03/055/15910). MRB is supported by a British Heart Foundation Grant RG/13/14/30314. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for the support of the flowcytometry and microscopy facilities of the Cambridge Institute for Medical Research and the Cancer Research UK Cambridge Institute, University of Cambridge UK. We would also like to acknowledge the support of colleagues within the Tumour Microcirculation Group and Dr. Allan Lawrie for their assistance at the University of Sheffield, UK.	Ahonen M, 2003, ONCOGENE, V22, P2121, DOI 10.1038/sj.onc.1206292; Ahonen M, 2002, MOL THER, V5, P705, DOI 10.1006/mthe.2002.0606; Ahonen M, 1998, CANCER RES, V58, P2310; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Baker AH, 1999, BRIT J CANCER, V79, P1347, DOI 10.1038/sj.bjc.6690217; Baker AH, 1998, J CLIN INVEST, V101, P1478, DOI 10.1172/JCI1584; Barnhart BC, 2003, ONCOGENE, V22, P8634, DOI 10.1038/sj.onc.1207103; Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Bond M, 2002, J BIOL CHEM, V277, P13787, DOI 10.1074/jbc.M111507200; Bond M, 2000, J BIOL CHEM, V275, P41358, DOI 10.1074/jbc.M007929200; Charlier E, 2010, LEUKEMIA, V24, P821, DOI 10.1038/leu.2010.9; Delmas D, 2003, J BIOL CHEM, V278, P41482, DOI 10.1074/jbc.M304896200; Dorrie J, 2002, CYTOKINE, V18, P98, DOI 10.1006/cyto.2002.1030; Gajate C, 2000, INT J CANCER, V85, P674, DOI 10.1002/(SICI)1097-0215(20000301)85:5<674::AID-IJC13>3.0.CO;2-Z; Gajate C, 2004, J EXP MED, V200, P353, DOI 10.1084/jem.20040213; George SJ, 2000, CIRCULATION, V101, P296, DOI 10.1161/01.CIR.101.3.296; Ireland Zecchini H, 2012, CURR PROT CYT, V59; Johnson TW, 2005, ARTERIOSCL THROM VAS, V25, P754, DOI 10.1161/01.ATV.0000157582.33180.a9; Kallio JP, 2011, INT J CANCER, V128, P991, DOI 10.1002/ijc.25404; Kwak HI, 2009, MATRIX BIOL, V28, P470, DOI 10.1016/j.matbio.2009.07.007; Lam P, 2005, MOL THER, V12, P144, DOI 10.1016/j.ymthe.2005.02.028; Legembre P, 2006, J IMMUNOL, V176, P716, DOI 10.4049/jimmunol.176.2.716; Muppidi JR, 2004, NAT IMMUNOL, V5, P182, DOI 10.1038/ni1024; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Nicklin S A, 1999, Methods Mol Med, V30, P271, DOI 10.1385/1-59259-247-3:271; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Qi JH, 2015, APOPTOSIS, V20, P523, DOI 10.1007/s10495-014-1076-y; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Rosner D, 2006, AM J PATHOL, V168, P2054, DOI 10.2353/ajpath.2006.050473; Sata M, 2000, ARTERIOSCL THROM VAS, V20, P309, DOI 10.1161/01.ATV.20.2.309; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Shain KH, 2002, J IMMUNOL, V168, P2544, DOI 10.4049/jimmunol.168.5.2544; Sluijter JPG, 2006, CARDIOVASC RES, V69, P595, DOI 10.1016/j.cardiores.2005.11.026; Smith MR, 1997, CYTOKINE, V9, P770, DOI 10.1006/cyto.1997.0233; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Strand S, 2004, ONCOGENE, V23, P3732, DOI 10.1038/sj.onc.1207387; Woessner J.F., 2000, PROTEIN PROFILE SER; Zhang L, 2009, CANC GENE THER; Zhang Y, 2008, GYNECOL ONCOL, V108, P234, DOI 10.1016/j.ygyno.2007.09.033	41	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195116	10.1371/journal.pone.0195116	http://dx.doi.org/10.1371/journal.pone.0195116			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617412	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000429203800066
J	Hamiehli, A; Tayyarli, R; Tabajal, H; Zein, SEL; Khalil, PB; Karat, N; Kanafanil, ZA; Kanj, N; Aki, IB; Araj, G; Berjaoui, G; Kanj, SS				Hamiehli, Amal; Tayyarli, Ralph; Tabajal, Houssam; Zein, Saeed E. L.; Khalil, Pierre Bou; Karat, Nathalie; Kanafanil, Zeina A.; Kanj, Nadim; Aki, Imad Bou; Araj, George; Berjaoui, Ghina; Kanj, Souha S.			Emergence of Mycobacterium simiae: A retrospective study from a tertiary care center in Lebanon	PLOS ONE			English	Article							INFECTION; PULMONARY; COMPLEX; DISEASE; PARAENSE	Objective The objective of this study is to describe the clinical significance of Mycobacterium simiae at a major tertiary care center in Lebanon. Methods This is a retrospective study of patients with positive cultures for M. simiae isolated between 2004 and 2016 at the American University of Beirut Medical Center. Results This study included 103 M. simiae isolates recovered from 51 patients. Their mean age was 62.7 years. The majority were males and smokers. Specimens were mostly from respiratory sources (97%). Common comorbidities included chronic lung disease (such as chronic obstructive pulmonary disease), solid tumor, systemic disease, and diabetes mellitus. Productive cough and dyspnea were the most common symptoms. Frequent radiographic findings were infiltrates and nodules on chest X-ray and nodules, infiltrates, and bronchiectasis on chest computed tomography scan. Among 18 tested isolates, 5.8% were resistant to clarithromycin, 11.7% to amikacin, and 70-100% to other antimicrobials. Out of 13 patients receiving early treatment, 5 noted improvement, one had recurrence of symptoms, two received alternative diagnosis, and five died. Two of those deaths were related to M. simiae. Common treatment regimens included clarithromycin in different combinations with trimethoprim-sulfamethoxazole, moxifloxacin, and amikacin. Moreover, clofazimine was used in only two patients whose isolates were resistant to all but one agent. Duration of treatment ranged from 6-24 months. Conclusion In Lebanon, M. simiae is increasingly encountered with true infection rates of at least 47%. Furthermore, the prevalence of multidrug resistance among the Lebanese M. simiae isolates is very high limiting the treatment options.	[Hamiehli, Amal; Tayyarli, Ralph; Tabajal, Houssam; Zein, Saeed E. L.; Kanafanil, Zeina A.; Kanj, Souha S.] Amer Univ Beirut, Med Ctr, Dept Internal Med, Div Infect Dis, Beirut, Lebanon; [Khalil, Pierre Bou; Karat, Nathalie; Kanj, Nadim; Aki, Imad Bou] Amer Univ Beirut, Med Ctr, Dept Internal Med, Div Pulm & Crit Care Med, Beirut, Lebanon; [Araj, George] Amer Univ Beirut, Med Ctr, Dept Pathol & Lab Med, Beirut, Lebanon; [Berjaoui, Ghina] Amer Univ Beirut, Med Ctr, Dept Radiol, Beirut, Lebanon	American University of Beirut; American University of Beirut; American University of Beirut; American University of Beirut	Kanj, SS (corresponding author), Amer Univ Beirut, Med Ctr, Dept Internal Med, Div Infect Dis, Beirut, Lebanon.	sk11@aub.edu.lb	Tayyar, Ralph/GRR-3590-2022	Tayyar, Ralph/0000-0002-5354-0209; Bou Akl, Imad/0000-0001-8984-6683; Tabaja, Hussam/0000-0002-5650-4852; Kanj, Souha/0000-0001-6413-3396; Kanafani, Zeina/0000-0001-8814-1286				Aksamit TR, 2014, RESP MED, V108, P417, DOI 10.1016/j.rmed.2013.09.014; Al-Abdely HM, 2000, J INFECTION, V41, P143, DOI 10.1053/jinf.2000.0700; Araj George F, 2016, J Med Liban, V64, P1; Baghaei P, 2012, J INFECT DEV COUNTR, V6, P23, DOI 10.3855/jidc.1297; Baghizadeh A, 2017, CAN RESPIR J, V2017, P5; Balkis MM, 2009, INT J INFECT DIS, V13, pE286, DOI [10.1016/j.ijid.2008.10.015, 10.1016/j.ijid.2008.06.036]; Cruz AT, 2007, J CLIN MICROBIOL, V45, P2745, DOI 10.1128/JCM.00359-07; da Costa ARF, 2015, INT J SYST EVOL MICR, V65, P656, DOI 10.1099/ijs.0.068395-0; da Costa ARF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002340; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hankins D, 2013, J PEDIATR INFECT DIS, V2, P394, DOI 10.1093/jpids/pis098; Hashemi-Shahraki A, 2013, JPN J INFECT DIS, V66, P475, DOI 10.7883/yoken.66.475; Maoz C, 2008, EUR J CLIN MICROBIOL, V27, P945, DOI 10.1007/s10096-008-0522-6; MARCHEVSKY A, 1982, AM J CLIN PATHOL, V78, P695, DOI 10.1093/ajcp/78.5.695; Narang R, 2010, CLIN MICROBIOL INFEC, V16, P912, DOI 10.1111/j.1469-0691.2009.03021.x; Nasser M., 2014, J MED MICROB DIAGN, V4, P175; Onen ZP, 2010, TUBERK TORAK, V58, P306; Panagiotou M, 2014, PULM MED, V2014, DOI 10.1155/2014/894976; Piersimoni C, 2009, EMERG INFECT DIS, V15, P1351, DOI 10.3201/eid1509.081259; Poonawala H, 2017, J CLIN MICROBIOL, V55, P2283, DOI 10.1128/JCM.00663-17; ROSE HD, 1982, AM REV RESPIR DIS, V126, P1110; Shitrit D, 2008, RESP MED, V102, P1598, DOI 10.1016/j.rmed.2008.05.004; Tortoli E, 2011, INT J SYST EVOL MICR, V61, P1606, DOI 10.1099/ijs.0.025601-0; van Ingen J, 2008, EUR RESPIR J, V31, P106, DOI 10.1183/09031936.00076107; van Ingen J, 2012, ANTIMICROB AGENTS CH, V56, P6324, DOI 10.1128/AAC.01505-12; van Ingen J, 2012, INT J ANTIMICROB AG, V39, P173, DOI 10.1016/j.ijantimicag.2011.09.019	26	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195390	10.1371/journal.pone.0195390	http://dx.doi.org/10.1371/journal.pone.0195390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617415	Green Submitted, Green Published, gold			2022-12-26	WOS:000429203800081
J	Pellikaan, P; Giarmatzis, G; Vander Sloten, J; Verschueren, S; Jonkers, I				Pellikaan, Pim; Giarmatzis, Georgios; Vander Sloten, Jos; Verschueren, Sabine; Jonkers, Ilse			Ranking of osteogenic potential of physical exercises in postmenopausal women based on femoral neck strains	PLOS ONE			English	Article							BONE-MINERAL DENSITY; HIGH-IMPACT EXERCISE; TRABECULAR BONE; CORTICAL BONE; HIP FRACTURE; PROXIMAL FEMUR; OLDER MEN; WALKING; PRESERVATION; OSTEOPOROSIS	The current study aimed to assess the potential of different exercises triggering an osteogenic response at the femoral neck in a group of postmenopausal women. The osteogenic potential was determined by ranking the peak hip contact forces (HCFs) and consequent peak tensile and compressive strains at the superior and inferior part of the femoral neck during activities such as (fast) walking, running and resistance training exercises. Results indicate that fast walking (5-6 km/h) running and hopping induced significantly higher strains at the femoral neck than walking at 4 km/h which is considered a baseline exercise for bone preservation. Exercises with a high fracture risk such as hopping, need to be considered carefully especially in a frail elderly population and may therefore not be suitable as a training exercise. Since superior femoral neck frailness is related to elevated hip fracture risk, exercises such as fast walking (above 5 km/h) and running can be highly recommended to stimulate this particular area. Our results suggest that a training program including fast walking (above 5 km/h) and running exercises may increase or preserve the bone mineral density (BMD) at the femoral neck.	[Pellikaan, Pim; Vander Sloten, Jos] Katholieke Univ Leuven, Dept Mech Engn, Biomech Sect, Leuven, Belgium; [Giarmatzis, Georgios; Verschueren, Sabine] Katholieke Univ Leuven, Dept Rehabil Sci, Res Grp Musculoskeletal Rehabil, Leuven, Belgium; [Jonkers, Ilse] Katholieke Univ Leuven, Dept Movement Sci, Human Movement Biomech Res Grp, Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven	Pellikaan, P (corresponding author), Katholieke Univ Leuven, Dept Mech Engn, Biomech Sect, Leuven, Belgium.	pim.pellikaan@kuleuven.be	Giarmatzis, Georgios/AAC-1725-2022; Verschueren, Sabine/K-4213-2015	Giarmatzis, Georgios/0000-0003-1387-2134; Verschueren, Sabine/0000-0003-2592-494X	Fund for Scientific Research (FWO-Vlaanderen) [G0526512]; Materialise NV through the Materialise chair for patient-specific biomechanics	Fund for Scientific Research (FWO-Vlaanderen)(FWO); Materialise NV through the Materialise chair for patient-specific biomechanics	This study was supported by grant G0526512 from the Fund for Scientific Research (FWO-Vlaanderen www.fwo.be) to S. Verschueren and by the funding of Materialise NV through the Materialise chair for patient-specific biomechanics (www.materialise.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SJ, 2015, J BONE MINER RES, V30, P1709, DOI 10.1002/jbmr.2499; Allison SJ, 2013, BONE, V53, P321, DOI 10.1016/j.bone.2012.12.045; Anderson DE, 2013, J APPL BIOMECH, V29, P505, DOI 10.1123/jab.29.5.505; Anderson FC, 2001, J BIOMECH, V34, P153, DOI 10.1016/S0021-9290(00)00155-X; Bailey CA, 2010, BONE, V46, P1043, DOI 10.1016/j.bone.2009.12.001; Baker R, 2003, J BIOMECH, V36, P300, DOI 10.1016/S0021-9290(02)00336-6; BASSETT CAL, 1962, SCIENCE, V137, P1063, DOI 10.1126/science.137.3535.1063; Bell KL, 1999, J BONE MINER RES, V14, P111, DOI 10.1359/jbmr.1999.14.1.111; BIEWENER AA, 1993, CALCIFIED TISSUE INT, V53, pS68, DOI 10.1007/BF01673406; Bitsakos C, 2005, J BIOMECH, V38, P133, DOI 10.1016/j.jbiomech.2004.03.005; Boonen S, 2008, BEST PRACT RES CL EN, V22, P765, DOI 10.1016/j.beem.2008.07.002; Brown LE, 2001, J EXERC PHYSL ONLINE, V4, DOI DOI 10.4236/JEP.2013.46A001; CARTER DR, 1984, CALCIFIED TISSUE INT, V36, pS19, DOI 10.1007/BF02406129; Chen JC, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt318; COWIN SC, 1984, CALCIFIED TISSUE INT, V36, pS98, DOI 10.1007/BF02406141; De Groote F, 2008, J BIOMECH, V41, P3390, DOI 10.1016/j.jbiomech.2008.09.035; Edwards WB, 2016, J BIOMECH, V49, P1206, DOI 10.1016/j.jbiomech.2016.03.007; Engelke K, 2016, CLIN REV BONE MINER, V14, P26, DOI 10.1007/s12018-015-9201-1; Frost HM, 2001, ANAT RECORD, V262, P398, DOI 10.1002/ar.1049; Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119; Garcia J M, 2001, Comput Methods Biomech Biomed Engin, V4, P355, DOI 10.1080/10255840108908014; Giarmatzis G, 2017, GAIT POSTURE, V53, P155, DOI 10.1016/j.gaitpost.2017.01.020; Giarmatzis G, 2015, J BONE MINER RES, V30, P1431, DOI 10.1002/jbmr.2483; Gomez-Cabello A, 2012, SPORTS MED, V42, P301, DOI 10.2165/11597670-000000000-00000; Hamner SR, 2010, J BIOMECH, V43, P2709, DOI 10.1016/j.jbiomech.2010.06.025; HERNLUND E, 2013, ARCH OSTEOPOROS, V8, DOI DOI 10.1007/S11657-013-0136-1; Howe TE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000333, 10.1002/14651858.CD000333.pub2]; HUISKES R, 1987, J BIOMECH, V20, P1135, DOI 10.1016/0021-9290(87)90030-3; Johannesdottir F, 2011, BONE, V48, P1268, DOI 10.1016/j.bone.2011.03.776; Kelley GA, 2001, AM J PHYS MED REHAB, V80, P65, DOI 10.1097/00002060-200101000-00017; Kemmler W, 2011, PHYSICIAN SPORTSMED, V39, P142, DOI 10.3810/psm.2011.02.1872; Kerr D, 2001, J BONE MINER RES, V16, P175, DOI 10.1359/jbmr.2001.16.1.175; Kim WS, 2014, ANN REHABIL MED-ARM, V38, P101, DOI 10.5535/arm.2014.38.1.101; Loveridge N, 2004, BONE, V35, P929, DOI 10.1016/j.bone.2004.05.025; Ma D, 2013, MENOPAUSE, V20, P1216, DOI [10.1097/GME.0000000000000100, 10.1097/gme.0000000000000100]; Martelli S, 2014, J BIOMECH, V47, P1784, DOI 10.1016/j.jbiomech.2014.03.036; Martyn-St James M, 2006, OSTEOPOROSIS INT, V17, P1225, DOI 10.1007/s00198-006-0083-4; Martyn-St James M, 2009, BRIT J SPORT MED, V43, P898, DOI 10.1136/bjsm.2008.052704; Martyn-St James M, 2008, BONE, V43, P521, DOI 10.1016/j.bone.2008.05.012; Mayhew PM, 2005, LANCET, V366, P129, DOI 10.1016/S0140-6736(05)66870-5; Milovanovic P, 2012, BONE, V50, P63, DOI 10.1016/j.bone.2011.09.044; Modenese L, 2012, MULTIBODY SYST DYN, V28, P157, DOI 10.1007/s11044-011-9274-7; Mokhtarzadeh H, 2014, J BIOMECH, P1; Morgan EF, 2003, J BIOMECH, V36, P897, DOI 10.1016/S0021-9290(03)00071-X; Nikander R, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-47; Poole KES, 2010, J BONE MINER RES, V25, P482, DOI 10.1359/jbmr.090734; Speirs AD, 2007, J BIOMECH, V40, P2318, DOI 10.1016/j.jbiomech.2006.10.038; Steele KM, 2012, GAIT POSTURE, V35, P556, DOI 10.1016/j.gaitpost.2011.11.023; Taylor ME, 1996, MED ENG PHYS, V18, P122, DOI 10.1016/1350-4533(95)00031-3; Thomas CDL, 2009, J BONE MINER RES, V24, P1808, DOI [10.1359/jbmr.090504, 10.1359/JBMR.090504]; Vahdati A, 2014, J MECH BEHAV BIOMED, V30, P244, DOI 10.1016/j.jmbbm.2013.11.015; van Arkel RJ, 2013, J ORTHOP RES, V31, P1172, DOI 10.1002/jor.22364	52	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195463	10.1371/journal.pone.0195463	http://dx.doi.org/10.1371/journal.pone.0195463			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617448	Green Published, gold, Green Submitted			2022-12-26	WOS:000429203800087
J	Chagomerana, MB; Miller, WC; Tang, JH; Hoffman, IF; Mthiko, BC; Phulusa, J; John, M; Jumbe, A; Hosseinipour, MC				Chagomerana, Maganizo B.; Miller, William C.; Tang, Jennifer H.; Hoffman, Irving F.; Mthiko, Bryan C.; Phulusa, Jacob; John, Mathias; Jumbe, Allan; Hosseinipour, Mina C.			Optimizing prevention of HIV mother to child transmission: Duration of antiretroviral therapy and viral suppression at delivery among pregnant Malawian women	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RISK-FACTORS; ADHERENCE; INITIATION; LOAD; TIME; PREDICTORS; RESISTANCE; PROTEASE; DECLINE	Background Effective antiretroviral therapy during pregnancy minimizes the risk of vertical HIV transmission. Some women present late in their pregnancy for first antenatal visit; whether these women achieve viral suppression by delivery and how suppression varies with time on ART is unclear. Methods We conducted a prospective cohort study of HIV-infected pregnant women initiating antiretroviral therapy for the first time at Bwaila Hospital in Lilongwe, Malawi from June 2015 to November 2016. Multivariable Poisson models with robust variance estimators were used to estimate risk ratios (RR) and 95% confidence intervals (CI) of the association between duration of ART and both viral load (VL) >= 1000 copies/ml and VL >= 40 copies/ml at delivery. Results Of the 252 women who had viral load testing at delivery, 40 (16%) and 78 (31%) had VL >= 1000 copies/ml and VL >= 40 copies/ml, respectively. The proportion of women with poor adherence to ART was higher among women who were on ART for <= 12 weeks (9/50 = 18.0%) than among those who were on ART for 13-35 weeks (18/194 = 9.3%). Compared to women who were on ART for <= 12 weeks, women who were on ART for 13-20 weeks (RR = 0.52; 95% CI: 0.36-0.74) or 21-35 weeks (RR = 0.26; 95% CI: 0.14-0.48) had a lower risk of VL >= 40 copies/ml at delivery. Similar comparisons for VL >= 1000 copies/ml at delivery showed decrease in risk although not significant for those on ART 13-20 weeks. Conclusion Longer duration of ART during pregnancy was associated with suppressed viral load at delivery. Early ANC attendance in pregnancy to facilitate prompt ART initiation for HIV-positive women is essential in the effort to eliminate HIV vertical transmission.	[Chagomerana, Maganizo B.; Tang, Jennifer H.; Hoffman, Irving F.; Mthiko, Bryan C.; Phulusa, Jacob; John, Mathias; Jumbe, Allan; Hosseinipour, Mina C.] Kamuzu Cent Hosp, UNC Project Malawi, Lilongwe, Malawi; [Miller, William C.] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA; [Tang, Jennifer H.] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA; [Hoffman, Irving F.; Hosseinipour, Mina C.] Univ N Carolina, Dept Med, Chapel Hill, NC USA	University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Chagomerana, MB (corresponding author), Kamuzu Cent Hosp, UNC Project Malawi, Lilongwe, Malawi.	mchacjomerana@unclilongwe.org	Miller, William C/H-4800-2014	Miller, William C/0000-0002-1934-7827	National Institutes of Health [R25TW009340, R01 HD080485]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD080485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (grant numbers R25TW009340 to MBC and R01 HD080485 to MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglemyer A, 2013, COCHRANE DB SYST REV, V4; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Aziz N, 2013, BJOG-INT J OBSTET GY, V120, P1534, DOI 10.1111/1471-0528.12226; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Berg KM, 1999, J ACQ IMMUN DEF SYND, V43, pS79; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P592; Chesney M, 2003, AIDS PATIENT CARE ST, V17, P169, DOI 10.1089/108729103321619773; Chibwesha CJ, 2011, JAIDS-J ACQ IMM DEF, V58, P224, DOI 10.1097/QAI.0b013e318229147e; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; COURGNAUD V, 1991, AIDS RES HUM RETROV, V7, P337, DOI 10.1089/aid.1991.7.337; Dabis F, 2002, LANCET, V359, P2097, DOI 10.1016/S0140-6736(02)08909-2; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; Denoeud-Ndam L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059446; Duran S, 2001, HIV Clin Trials, V2, P38; Ebuy H, 2015, INT J INFECT DIS, V33, P123, DOI 10.1016/j.ijid.2014.12.026; EHRNST A, 1991, LANCET, V338, P203, DOI 10.1016/0140-6736(91)90347-R; Fawzi W, 2001, AIDS, V15, P1157, DOI 10.1097/00002030-200106150-00011; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Graham SM, 2007, AIDS, V21, P501, DOI 10.1097/QAD.0b013e32801424bd; Hoffman RM, 2010, JAIDS-J ACQ IMM DEF, V54, P35, DOI 10.1097/QAI.0b013e3181cf9979; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jourdain G, 2007, J INFECT DIS, V196, P1629, DOI 10.1086/522009; Lyons FE, 2005, AIDS, V19, P63, DOI 10.1097/00002030-200501030-00007; Mofenson LM, 1999, NEW ENGL J MED, V341, P385, DOI 10.1056/NEJM199908053410601; Myer L, 2017, HIV MED, V18, P80, DOI 10.1111/hiv.12397; Patel D, 2007, CLIN INFECT DIS, V44, P1647, DOI 10.1086/518284; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Phillips AN, 2001, JAMA-J AM MED ASSOC, V286, P2560, DOI 10.1001/jama.286.20.2560; Phillips T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163079; Schouten EJ, 2011, LANCET, V378, P282, DOI 10.1016/S0140-6736(10)62303-3; SOEIRO R, 1992, J INFECT DIS, V166, P699, DOI 10.1093/infdis/166.4.699; Townsend CL, 2014, AIDS, V28, P1049, DOI 10.1097/QAD.0000000000000212; Zeh C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000430	36	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195033	10.1371/journal.pone.0195033	http://dx.doi.org/10.1371/journal.pone.0195033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614083	gold, Green Published, Green Submitted			2022-12-26	WOS:000429081600027
J	Imasaki, T; Wenzel, S; Yamada, K; Bryant, ML; Takagi, Y				Imasaki, Tsuyoshi; Wenzel, Sabine; Yamada, Kentaro; Bryant, Megan L.; Takagi, Yuichiro			Titer estimation for quality control (TEQC) method: A practical approach for optimal production of protein complexes using the baculovirus expression vector system	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; GENERAL TRANSCRIPTION FACTOR; MEDIATOR HEAD MODULE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; INSECT CELLS; RECOMBINANT BACULOVIRUS; MULTIPROTEIN COMPLEXES; ESCHERICHIA-COLI; IN-VITRO	The baculovirus expression vector system (BEVS) is becoming the method of choice for expression of many eukaryotic proteins and protein complexes for biochemical, structural and pharmaceutical studies. Significant technological advancement has made generation of recombinant baculoviruses easy, efficient and user-friendly. However, there is a tremendous variability in the amount of proteins made using the BEVS, including different batches of virus made to express the same proteins. Yet, what influences the overall production of proteins or protein complexes remains largely unclear. Many downstream applications, particularly protein structure determination, require purification of large quantities of proteins in a repetitive manner, calling for a reliable experimental set-up to obtain proteins or protein complexes of interest consistently. During our investigation of optimizing the expression of the Mediator Head module, we discovered that the 'initial infectivity' was an excellent indicator of overall production of protein complexes. Further, we show that this initial infectivity can be mathematically described as a function of multiplicity of infection (M01), correlating recombinant protein yield and virus titer. All these findings led us to develop the Titer Estimation for Quality Control (TEQC) method, which enables researchers to estimate initial infectivity, titer/MOI values in a simple and affordable way, and to use these values to quantitatively optimize protein expressions utilizing BEVS in a highly reproducible fashion.	[Imasaki, Tsuyoshi; Wenzel, Sabine; Yamada, Kentaro; Bryant, Megan L.; Takagi, Yuichiro] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Imasaki, Tsuyoshi] RIKEN, Ctr Life Sci Technol, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Yamada, Kentaro] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; RIKEN; Indiana University System; Indiana University Bloomington	Takagi, Y (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	ytakagi@iu.edu		Takagi, Yuichiro/0000-0002-0988-6798; Imasaki, Tsuyoshi/0000-0001-5462-1820	US National Science Foundation [MCB-1157688]; National Institutes of Health/General Medical Sciences [R01 GM111695]; Showalter Trust Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111695] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Showalter Trust Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by US National Science Foundation grant MCB-1157688, the National Institutes of Health/General Medical Sciences (R01 GM111695), and Showalter Trust Fund to (YT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assenberg R, 2013, CURR OPIN STRUC BIOL, V23, P393, DOI 10.1016/j.sbi.2013.03.008; Barford D, 2013, CURR OPIN STRUC BIOL, V23, P357, DOI 10.1016/j.sbi.2013.03.009; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bieniossek C, 2013, NATURE, V493, P699, DOI 10.1038/nature11791; Bieniossek C, 2012, TRENDS BIOCHEM SCI, V37, P49, DOI 10.1016/j.tibs.2011.10.005; Bleichert F, 2015, NATURE, V519, P321, DOI 10.1038/nature14239; Boeger H, 2005, FEBS LETT, V579, P899, DOI 10.1016/j.febslet.2004.11.027; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; Egly JM, 2011, DNA REPAIR, V10, P714, DOI 10.1016/j.dnarep.2011.04.021; Ellis EL, 1939, J GEN PHYSIOL, V22, P365, DOI 10.1085/jgp.22.3.365; Fitzgerald DJ, 2007, STRUCTURE, V15, P275, DOI 10.1016/j.str.2007.01.016; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Galbraith MD, 2010, TRANSCR-AUSTIN, V1, P4, DOI 10.4161/trns.1.1.12373; Hopkins RF, 2009, BIOTECHNIQUES, V47, P785, DOI 10.2144/000113238; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; Janakiraman V, 2006, NAT PROTOC, V1, P2271, DOI 10.1038/nprot.2006.387; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Kwon MS, 2002, BIOTECHNOL PROGR, V18, P647, DOI 10.1021/bp020298s; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; LICARI P, 1991, BIOTECHNOL BIOENG, V37, P238, DOI 10.1002/bit.260370306; Lo HR, 2004, BIOTECHNOL PROGR, V20, P354, DOI 10.1021/bp034132i; LUCKOW VA, 1988, BIO-TECHNOL, V6, P47, DOI 10.1038/nbt0188-47; Massotte D, 2003, BBA-BIOMEMBRANES, V1610, P77, DOI 10.1016/S0005-2736(02)00720-4; MILLER LK, 1988, ANNU REV MICROBIOL, V42, P177, DOI 10.1146/annurev.micro.42.1.177; MULVANIA T, 2004, BIOPROCESS J, V3, P47, DOI DOI 10.12665/J33.MULVANIA; MURHAMMER DW, 1988, BIO-TECHNOL, V6, P1411, DOI 10.1038/nbt1288-1411; NEUTRA R, 1992, APPL MICROBIOL BIOT, V37, P74, DOI 10.1007/BF00174206; Ohto U, 2015, NATURE, V520, P702, DOI 10.1038/nature14138; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; POWER JF, 1994, BIOTECHNOL BIOENG, V44, P710, DOI 10.1002/bit.260440607; Radford KM, 1997, CYTOTECHNOLOGY, V24, P73, DOI 10.1023/A:1007962903435; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHOPF B, 1990, J BIOTECHNOL, V15, P169, DOI 10.1016/0168-1656(90)90059-K; Schreiber A, 2011, NATURE, V470, P227, DOI 10.1038/nature09756; SMITH GE, 1983, J VIROL, V46, P584, DOI 10.1128/JVI.46.2.584-593.1983; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Takagi Y, 2003, J BIOL CHEM, V278, P43897, DOI 10.1074/jbc.C300417200; Takagi Y, 2006, MOL CELL, V23, P355, DOI 10.1016/j.molcel.2006.06.007; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Tolia NH, 2006, NAT METHODS, V3, P55, DOI 10.1038/nmeth0106-55; van Oers MM, 2015, J GEN VIROL, V96, P6, DOI 10.1099/vir.0.067108-0; VOLKMAN LE, 1976, J VIROL, V19, P820, DOI 10.1128/JVI.19.3.820-832.1976; Wasilko DJ, 2009, PROTEIN EXPRES PURIF, V65, P122, DOI 10.1016/j.pep.2009.01.002; Wong KTK, 1996, BIOTECHNOL BIOENG, V49, P659, DOI 10.1002/(SICI)1097-0290(19960320)49:6&lt;659::AID-BIT7&gt;3.0.CO;2-N; Yang C, 2010, PROTEIN EXPRES PURIF, V70, P172, DOI 10.1016/j.pep.2009.09.021	53	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0195356	10.1371/journal.pone.0195356	http://dx.doi.org/10.1371/journal.pone.0195356			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614134	Green Published, Green Submitted, gold			2022-12-26	WOS:000429081600053
J	Horibata, S; Rice, EJ; Mukai, C; Marks, BA; Sams, K; Zheng, H; Anguish, LJ; Coonrod, SA; Danko, CG				Horibata, Sachi; Rice, Edward J.; Mukai, Chinatsu; Marks, Brooke A.; Sams, Kelly; Zheng, Hui; Anguish, Lynne J.; Coonrod, Scott A.; Danko, Charles G.			ER-positive breast cancer cells are poised for RET-mediated endocrine resistance	PLOS ONE			English	Article							COMPREHENSIVE MOLECULAR PORTRAITS; SIGNALING PATHWAYS; TRANSCRIPTION; ALPHA; INITIATION; ENHANCERS; REVEALS; KINASE; EXPRESSION; BINDING	The RET tyrosine kinase signaling pathway is involved in the development of endocrine resistant ER+ breast cancer. However, we know little about how ER+ cells activate RET signaling and initiate an endocrine resistant phenotype. Here we show that both ER+ endocrine resistant and sensitive breast cancers have a functional RET tyrosine kinase signaling pathway, but that endocrine sensitive breast cancer cells lack RET ligands that are necessary to drive endocrine resistance. Transcription of one RET ligand, GDNF, is necessary and sufficient to confer resistance in the ER+ MCF-7 cell line. Endogenous GDNF produced by endocrine resistant cells is translated, secreted into the media, and activates RET signaling in nearby cells. In patients, RET ligand expression predicts responsiveness to endocrine therapies and correlates with survival. Collectively, our findings show that ER+ tumor cells are "poised" for RET mediated endocrine resistance, expressing all components of the RET signaling pathway, but endocrine sensitive cells lack high expression of RET ligands that are necessary to initiate the resistance phenotype.	[Horibata, Sachi; Rice, Edward J.; Mukai, Chinatsu; Marks, Brooke A.; Sams, Kelly; Zheng, Hui; Anguish, Lynne J.; Coonrod, Scott A.; Danko, Charles G.] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Horibata, Sachi] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Coonrod, Scott A.; Danko, Charles G.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Coonrod, SA; Danko, CG (corresponding author), Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA.; Coonrod, SA; Danko, CG (corresponding author), Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA.	sac269@cornell.edu; dankoc@gmail.com	Horibata, Sachi/AAC-3204-2020	Horibata, Sachi/0000-0002-2629-7821; Sams, Kelly L/0000-0002-1404-0885; Danko, Charles/0000-0002-1999-7125	NHGRI (National Human Genome Research Institute) grants from the US National Institutes of Health [R01 HG009309-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009309] Funding Source: NIH RePORTER	NHGRI (National Human Genome Research Institute) grants from the US National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Work in this publication was supported by NHGRI (National Human Genome Research Institute) grants from the US National Institutes of Health under award number R01 HG009309-01 to CGD. The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health.r We thank X. Yao, L. Lan, as well as all members of the Danko and Coonrod labs for valuable insights and discussions. We also thank G. Leiman for edits, J. Lewis for input on the manuscript draft, and D.B. Mahat for technical support. Work in this publication was supported by NHGRI (National Human Genome Research Institute) grants from the US National Institutes of Health under award number R01 HG009309-01 to CGD. The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health.	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Andreucci E, 2016, ONCOTARGET, V7, P80543, DOI 10.18632/oncotarget.11826; Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Azofeifa JG, 2016, BIOINFORMATICS; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Boulay A, 2008, CANCER RES, V68, P3743, DOI 10.1158/0008-5472.CAN-07-5100; Chu T, 2017, CHROMATIN RUN ON REV; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Core LJ, 2014, NAT GENET IN PRESS; Coser KR, 2009, P NATL ACAD SCI USA, V106, P14536, DOI 10.1073/pnas.0907560106; Danko CG, 2015, NAT METHODS, V12, P433, DOI [10.1038/NMETH.3329, 10.1038/nmeth.3329]; Danko CG, 2013, MOL CELL, V50, P212, DOI 10.1016/j.molcel.2013.02.015; Duarte FM, 2016, GENE DEV, V30, P1731, DOI 10.1101/gad.284430.116; Esseghir S, 2007, CANCER RES, V67, P11732, DOI 10.1158/0008-5472.CAN-07-2343; Franco HL, 2015, MOL CELL, V58, P21, DOI 10.1016/j.molcel.2015.02.001; Gattelli A, 2013, EMBO MOL MED, V5, P1335, DOI 10.1002/emmm.201302625; Ghoussaini M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5999; Gonzalez-Malerva L, 2011, P NATL ACAD SCI USA, V108, P2058, DOI 10.1073/pnas.1018157108; Hah N, 2013, GENOME RES; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Kang J, 2010, ONCOGENE, V29, P3228, DOI 10.1038/onc.2010.71; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma CX, 2009, ONCOLOGY-NY, V23, P133; Mahat DB, 2016, MOL CELL, V62, P63, DOI 10.1016/j.molcel.2016.02.025; Mahat DB, 2016, NAT PROTOC, V11, P1455, DOI 10.1038/nprot.2016.086; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Miller WR, 2012, PHARMACOGENOMICS J, V12, P10, DOI 10.1038/tpj.2010.67; Mohammed H, 2015, NATURE, V523, P313, DOI 10.1038/nature14583; Mohammed H, 2013, CELL REP, V3, P342, DOI 10.1016/j.celrep.2013.01.010; Morandi A, 2013, CANCER RES, V73, P3783, DOI 10.1158/0008-5472.CAN-12-4265; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Plaza-Menacho I, 2010, ONCOGENE, V29, P4648, DOI 10.1038/onc.2010.209; Prenzel T, 2011, CANCER RES, V71, P5739, DOI 10.1158/0008-5472.CAN-11-1896; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Scruggs BS, 2015, MOL CELL, V58, P1101, DOI 10.1016/j.molcel.2015.04.006; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Stine ZE, 2011, HUM MOL GENET, V20, P3746, DOI 10.1093/hmg/ddr291; Team RDC, 2010, R LANG ENV STAT COMP; Wakeling AE, 2000, ENDOCR-RELAT CANCER, V7, P17, DOI 10.1677/erc.0.0070017; Wang Z, 2016, BIOINFORMATICS; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Zhong ZB, 2015, INT J CLIN EXP PATHO, V8, P10716; Zhou YM, 2005, INT J BIOCHEM CELL B, V37, P1130, DOI 10.1016/j.biocel.2004.09.006	50	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0194023	10.1371/journal.pdone.0194023	http://dx.doi.org/10.1371/journal.pdone.0194023			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608602				2022-12-26	WOS:000428988800007
J	McFarlane, JS; Davis, CL; Lamb, AL				McFarlane, Jeffrey S.; Davis, Cara L.; Lamb, Audrey L.			Staphylopine, pseudopaline, and yersinopine dehydrogenases: A structural and kinetic analysis of a new functional class of opine dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						siderophore; dehydrogenase; metal homeostasis; bacterial pathogenesis; protein structure; metallophore; opine; pseudopaline; staphylopine; yersinopine	PROTEIN-STRUCTURE ALIGNMENT; PSEUDOMONAS-AERUGINOSA; STEREOSELECTIVITY; BIOSYNTHESIS; METALLOPHORE; OCTOPINE; REVEALS; SYSTEM; ACIDS	Opine dehydrogenases (ODHs) from the bacterial pathogens Staphylococcus aureus, Pseudomonas aeruginosa, and Yersinia pestis perform the final enzymatic step in the biosynthesis of a new class of opine metallophores, which includes staphylopine, pseudopaline, and yersinopine, respectively. Growing evidence indicates an important role for this pathway in metal acquisition and virulence, including in lung and burn-wound infections (P. aeruginosa) and in blood and heart infections (S. aureus). Here, we present kinetic and structural characterizations of these three opine dehydrogenases. A steady-state kinetic analysis revealed that the three enzymes differ in -keto acid and NAD(P)H substrate specificity and nicotianamine-like substrate stereoselectivity. The structural basis for these differences was determined from five ODH X-ray crystal structures, ranging in resolution from 1.9 to 2.5 angstrom, with or without NADP(+) bound. Variation in hydrogen bonding with NADPH suggested an explanation for the differential recognition of this substrate by these three enzymes. Our analysis further revealed candidate residues in the active sites required for binding of the -keto acid and nicotianamine-like substrates and for catalysis. This work reports the first structural kinetic analyses of enzymes involved in opine metallophore biosynthesis in three important bacterial pathogens of humans.	[McFarlane, Jeffrey S.; Lamb, Audrey L.] Univ Kansas, Dept Mol Biosci, 5060 Haworth Hall,1200 Sunnyside Ave, Lawrence, KS 66045 USA; [Davis, Cara L.; Lamb, Audrey L.] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Lamb, AL (corresponding author), Univ Kansas, Dept Mol Biosci, 5060 Haworth Hall,1200 Sunnyside Ave, Lawrence, KS 66045 USA.	lamb@ku.edu	McFarlane, Jeffrey/AAE-8692-2021	McFarlane, Jeffrey/0000-0002-0033-4129; Lamb, Audrey/0000-0002-2352-2130; Loomis, Cara/0000-0002-6457-4674	National Science Foundation [CHE-1403293]; National Institutes of Health [T32 GM008545, P41GM103393]; NIGMS [P20 GM103418]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; U.S. Department of Energy Office of Biological and Environmental Research; Direct For Mathematical & Physical Scien [1403293] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103418, R01GM127655, T32GM008545, P41GM103393] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant CHE-1403293, by National Institutes of Health Graduate Training Program in the Dynamic Aspects of Chemical Biology Grant T32 GM008545 (to J.S.M.), and by an Institutional Development Award (IdeA) from the NIGMS via Grant P20 GM103418 (to C.L.D.). Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the U.S. Department of Energy Office of Biological and Environmental Research and by NIGMS, National Institutes of Health Grant P41GM103393. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andi B, 2007, BIOCHEMISTRY-US, V46, P12512, DOI 10.1021/bi701428m; ASANO Y, 1989, J BACTERIOL, V171, P4466, DOI 10.1128/JB.171.8.4466-4471.1989; Bielecki P, 2013, ENVIRON MICROBIOL, V15, P570, DOI 10.1111/1462-2920.12024; Bielecki P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024235; BIELLMANN JF, 1973, FEBS LETT, V32, P254, DOI 10.1016/0014-5793(73)80845-2; BIELLMANN JF, 1977, BIOORG CHEM, V6, P89, DOI 10.1016/0045-2068(77)90011-6; Britton KL, 1998, NAT STRUCT BIOL, V5, P593, DOI 10.1038/854; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Damron FH, 2016, SCI REP-UK, V6, DOI 10.1038/srep39172; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ghssein G, 2016, SCIENCE, V352, P1105, DOI 10.1126/science.aaf1018; Gi M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14644; Girdlestone C, 2016, J COMPUT BIOL, V23, P21, DOI 10.1089/cmb.2015.0143; Grieshaber M K, 1994, Rev Physiol Biochem Pharmacol, V125, P43, DOI 10.1007/BFb0030909; Grim KP, 2017, MBIO, V8, DOI [10.1128/mbio.01281-17, 10.1128/mBio.01281-17]; Hanses F, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0093-3; Harrison J., 1976, P1; Holbrook JJ., 1975, ENZYMES, P191; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kato Y, 1996, J MOL CATAL B-ENZYM, V1, P151, DOI 10.1016/1381-1177(95)00011-9; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lhospice S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16765-9; Mastropasqua MC, 2017, MOL MICROBIOL, V106, P543, DOI 10.1111/mmi.13834; McFarlane JS, 2017, BIOCHEMISTRY-US, V56, P5967, DOI 10.1021/acs.biochem.7b00804; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Moore LW, 1997, APPL ENVIRON MICROB, V63, P201, DOI 10.1128/AEM.63.1.201-207.1997; NAMBIAR KP, 1983, J AM CHEM SOC, V105, P5886, DOI 10.1021/ja00356a028; Remy L, 2013, MOL MICROBIOL, V87, P730, DOI 10.1111/mmi.12126; Skubak P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3777; Smitst SHJ, 2008, J MOL BIOL, V381, P200, DOI 10.1016/j.jmb.2008.06.003; THOMPSON J, 1992, ANNU REV BIOCHEM, V61, P517; THOMPSON J, 1988, J BIOL CHEM, V263, P2064; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; VANTHOAI N, 1959, BIOCHIM BIOPHYS ACTA, V35, P446, DOI 10.1016/0006-3002(59)90394-4; von Wiren N, 1999, PLANT PHYSIOL, V119, P1107, DOI 10.1104/pp.119.3.1107; Watanabe S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138434; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang J, 2017, J ORG CHEM, V82, P13643, DOI 10.1021/acs.joc.7b02342; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	42	20	24	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8009	8019		10.1074/jbc.RA118.002007	http://dx.doi.org/10.1074/jbc.RA118.002007			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29618515	Green Published, hybrid			2022-12-26	WOS:000433224600008
J	Yeh, ST; Zambrano, CM; Koch, WJ; Purcell, NH				Yeh, Szu-Tsen; Zambrano, Cristina M.; Koch, Walter J.; Purcell, Nicole H.			PH domain leucine-rich repeat protein phosphatase 2 (PHLPP2) regulates G-protein-coupled receptor kinase 5 (GRK5)-induced cardiac hypertrophy in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiac hypertrophy; cardiomyocyte; cell growth; cell signaling; phosphatase; GRK5; PHLPP2	NF-KAPPA-B; HEART-FAILURE; DELETION PROTECTS; AKT; ACTIVATION; CALCIUM; GRK5; OVEREXPRESSION; EXPRESSION; GROWTH	PH domain leucine-rich repeat protein phosphatase (PHLPP) is a serine/threonine phosphatase that has been shown to regulate cell growth and survival through dephosphorylation of several members of the AGC family of kinases. G-protein-coupled receptor kinase 5 (GRK5) is an AGC kinase that regulates phenylephrine (PE)-induced cardiac hypertrophy through its noncanonical function of directly targeting proteins to the nucleus to regulate transcription. Here we investigated the possibility that the PHLPP2 isoform can regulate GRK5-induced cardiomyocyte hypertrophy in neonatal rat ventricular myocytes (NRVMs). We show that removal of PHLPP2 by siRNA induces hypertrophic growth of NRVMs as measured by cell size changes at baseline, potentiated PE-induced cell size changes, and re-expression of fetal genes atrial natriuretic factor and brain natriuretic peptide. Endogenous GRK5 and PHLPP2 were found to interact in NRVMs, and PE-induced nuclear accumulation of GRK5 was enhanced upon down-regulation of PHLPP2. Conversely, overexpression of PHLPP2 blocked PE-induced hypertrophic growth, re-expression of fetal genes, and nuclear accumulation of GRK5, which depended on its phosphatase activity. Finally, using siRNA against GRK5, we found that GRK5 was necessary for the hypertrophic response induced by PHLPP2 knockdown. Our findings demonstrate for the first time a novel regulation of GRK5 by the phosphatase PHLPP2, which modulates hypertrophic growth. Understanding the signaling pathways affected by PHLPP2 has potential for new therapeutic targets in the treatment of cardiac hypertrophy and failure.	[Yeh, Szu-Tsen; Zambrano, Cristina M.; Purcell, Nicole H.] Univ Calif San Diego, Sch Med, Dept Pharmacol, 9500 Gilman Dr,Biomed Sci Bldg,Rm 3032, La Jolla, CA 92093 USA; [Koch, Walter J.] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19140 USA	University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Purcell, NH (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, 9500 Gilman Dr,Biomed Sci Bldg,Rm 3032, La Jolla, CA 92093 USA.	npurcell@ucsd.edu			NHLBI, National Institutes of Health [HL114949, HL091799]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114949, P01HL091799] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from NHLBI, National Institutes of Health Grants HL114949 (to N. H. P.) and HL091799 (to W. J. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bossuyt J, 2008, CIRC RES, V102, P695, DOI 10.1161/CIRCRESAHA.107.169755; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Catalucci D, 2008, FRONT BIOSCI-LANDMRK, V13, P312, DOI 10.2741/2681; Chen B, 2013, J CEREBR BLOOD F MET, V33, P196, DOI 10.1038/jcbfm.2012.150; Cittadini A, 2006, GENE THER, V13, P8, DOI 10.1038/sj.gt.3302589; Cook SA, 2002, J BIOL CHEM, V277, P22528, DOI 10.1074/jbc.M201462200; Dusaban SS, 2013, P NATL ACAD SCI USA, V110, P3609, DOI 10.1073/pnas.1217355110; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gold JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057324; Gold JI, 2012, CIRC RES, V111, P1048, DOI 10.1161/CIRCRESAHA.112.273367; Grzechnik AT, 2016, BIOCHEM SOC T, V44, P1675, DOI 10.1042/BST20160170; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hullmann J, 2016, PHARMACOL RES, V110, P52, DOI 10.1016/j.phrs.2016.05.008; Hullmann JE, 2014, CIRC RES, V115, P976, DOI 10.1161/CIRCRESAHA.116.304475; Islam KN, 2013, J BIOL CHEM, V288, P35683, DOI 10.1074/jbc.M113.529347; Islam KN, 2012, J BIOL CHEM, V287, P12771, DOI 10.1074/jbc.M111.324566; Johnson LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062508; Kehat I, 2010, CIRCULATION, V122, P2727, DOI 10.1161/CIRCULATIONAHA.110.942268; Kehat I, 2011, CIRC RES, V108, P176, DOI 10.1161/CIRCRESAHA.110.231514; Kim YK, 2006, BIOCHEM BIOPH RES CO, V347, P1088, DOI 10.1016/j.bbrc.2006.06.196; Li X, 2009, MOL CELL BIOL, V29, P6192, DOI 10.1128/MCB.00681-09; Liao YB, 2016, GYNECOL ONCOL, V143, P655, DOI 10.1016/j.ygyno.2016.09.010; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Liu JY, 2011, MOL CELL BIOL, V31, P4917, DOI 10.1128/MCB.05799-11; Lv DQ, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1711-1; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; Mathur A, 2017, J ENDOCRINOL, V233, pR185, DOI 10.1530/JOE-17-0081; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; Miyamoto S, 2010, CIRC RES, V107, P476, DOI 10.1161/CIRCRESAHA.109.215020; Moc C, 2015, CARDIOVASC RES, V105, P160, DOI 10.1093/cvr/cvu243; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Newton AC, 2016, CLIN SCI, V130, P1499, DOI 10.1042/CS20160036; Newton AC, 2014, ANNU REV PHARMACOL, V54, P537, DOI 10.1146/annurev-pharmtox-011112-140338; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pronin AN, 1997, J BIOL CHEM, V272, P18273, DOI 10.1074/jbc.272.29.18273; Pronin AN, 1997, J BIOL CHEM, V272, P3806, DOI 10.1074/jbc.272.6.3806; Purcell NH, 2007, P NATL ACAD SCI USA, V104, P14074, DOI 10.1073/pnas.0610906104; Sallese M, 2000, BBA-MOL CELL RES, V1498, P112, DOI 10.1016/S0167-4889(00)00088-4; Schumacher SM, 2017, J CARDIOVASC PHARM, V70, P129, DOI 10.1097/FJC.0000000000000483; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Sussman MA, 2011, PHYSIOL REV, V91, P1023, DOI 10.1152/physrev.00024.2010; Traynham CJ, 2016, J MOL CELL CARDIOL, V92, P196, DOI 10.1016/j.yjmcc.2016.01.027; Warfel NA, 2012, J BIOL CHEM, V287, P3610, DOI 10.1074/jbc.R111.318675; Yang ZZ, 2004, BIOCHEM SOC T, V32, P350, DOI 10.1042/BST0320350; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200; Zhang Y, 2011, CIRC-HEART FAIL, V4, P659, DOI 10.1161/CIRCHEARTFAILURE.111.962563; Zhang Y, 2011, J BIOL CHEM, V286, P26943, DOI 10.1074/jbc.M111.234757	52	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8056	8064		10.1074/jbc.M117.809913	http://dx.doi.org/10.1074/jbc.M117.809913			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29628444	Green Published, hybrid			2022-12-26	WOS:000433224600012
J	Huang, YP; Gu, LY; Li, GM				Huang, Yaping; Gu, Liya; Li, Guo-Min			H3K36me3-mediated mismatch repair preferentially protects actively transcribed genes from mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTL-ALPHA ENDONUCLEASE; SHORT READ ALIGNMENT; DNA-DAMAGE; HUMAN GENOME; HUMAN-CELLS; INDUCED APOPTOSIS; EXCISION-REPAIR; CANCER GENOMES; COUPLED REPAIR; HISTONE H3	Histone H3 trimethylation at lysine 36 (H3K36me3) is an important histone mark involved in both transcription elongation and DNA mismatch repair (MMR). It is known that H3K36me3 recruits the mismatch-recognition protein MutS to replicating chromatin via its physical interaction with MutS's PWWP domain, but the exact role of H3K36me3 in transcription is undefined. Using ChIP combined with whole-genome DNA sequencing analysis, we demonstrate here that H3K36me3, together with MutS, is involved in protecting against mutation, preferentially in actively transcribed genomic regions. We found that H3K36me3 and MutS are much more co-enriched in exons and actively transcribed regions than in introns and nontranscribed regions. The H3K36me3-MutS co-enrichment correlated with a much lower mutation frequency in exons and actively transcribed regions than in introns and nontranscribed regions. Correspondingly, depleting H3K36me3 or disrupting the H3K36me3-MutS interaction elevated the spontaneous mutation frequency in actively transcribed genes, but it had little influence on the mutation frequency in nontranscribed or transcriptionally inactive regions. Similarly, H2O2-induced mutations, which mainly cause base oxidations, preferentially occurred in actively transcribed genes in MMR-deficient cells. The data presented here suggest that H3K36me3-mediated MMR preferentially safeguards actively transcribed genes not only during replication by efficiently correcting mispairs in early replicating chromatin but also during transcription by directly or indirectly removing DNA lesions associated with a persistently open chromatin structure.	[Huang, Yaping; Li, Guo-Min] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China; [Gu, Liya; Li, Guo-Min] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA	Tsinghua University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Li, GM (corresponding author), Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China.; Li, GM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA.	guo-min.li@utsouthwestern.edu		Huang, Yaping/0000-0002-3928-5272	National Natural Science Foundation of China [31370766, 31570814, 81630077]; National Natural Science Foundation of China-Israeli Science Foundation Joint Research Program [31461143005]; National Key R&D Program of China [2016YFC1303300]; National Institutes of Health [GM112702, CA192003]; Tsinghua-Peking Joint Center for Life Sciences; NATIONAL CANCER INSTITUTE [R21CA192003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112702] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China-Israeli Science Foundation Joint Research Program; National Key R&D Program of China; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tsinghua-Peking Joint Center for Life Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Natural Science Foundation of China Grants 31370766, 31570814, and 81630077; National Natural Science Foundation of China-Israeli Science Foundation Joint Research Program Grant 31461143005; National Key R&D Program of China Grant 2016YFC1303300; National Institutes of Health Grants GM112702 and CA192003; and funds from Tsinghua-Peking Joint Center for Life Sciences. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Chen KF, 2015, NAT GENET, V47, P1149, DOI 10.1038/ng.3385; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; Costantino L, 2015, CURR OPIN CELL BIOL, V34, P39, DOI 10.1016/j.ceb.2015.04.008; Crouse GF, 2016, DNA REPAIR, V38, P102, DOI 10.1016/j.dnarep.2015.11.020; Daikoku T, 2006, J BIOL CHEM, V281, P11422, DOI 10.1074/jbc.M510314200; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Fang D, 2016, SCIENCE, V352, P1344, DOI 10.1126/science.aae0065; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Frigola J, 2017, NAT GENET, V49, P1684, DOI 10.1038/ng.3991; Gu LY, 2002, J NUTR BIOCHEM, V13, P355, DOI 10.1016/S0955-2863(02)00178-X; Hamperl S, 2014, DNA REPAIR, V19, P84, DOI 10.1016/j.dnarep.2014.03.023; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Haradhvala NJ, 2016, CELL, V164, P538, DOI 10.1016/j.cell.2015.12.050; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Ikehata H, 2007, PHOTOCHEM PHOTOBIOL, V83, P196, DOI 10.1562/2006-02-28-IR-822; Jinks-Robertson S, 2014, ANNU REV GENET, V48, P341, DOI 10.1146/annurev-genet-120213-092015; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kawasoe Y, 2016, ELIFE, V5, DOI 10.7554/eLife.15155; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; Kunkel TA, 2015, ANNU REV GENET, V49, P291, DOI 10.1146/annurev-genet-112414-054722; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Li GM, 1999, ONCOL RES, V11, P393; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2502; Lu C, 2016, SCIENCE, V352, P844, DOI 10.1126/science.aac7272; Lubelsky Y, 2014, GENOME RES, V24, P1102, DOI 10.1101/gr.160010.113; Mazurek A, 2002, J BIOL CHEM, V277, P8260, DOI 10.1074/jbc.M111269200; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; MELLON I, 1986, P NATL ACAD SCI USA, V83, P8878, DOI 10.1073/pnas.83.23.8878; Mellon I, 1996, SCIENCE, V272, P557, DOI 10.1126/science.272.5261.557; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Mu D, 1997, MOL CELL BIOL, V17, P760, DOI 10.1128/MCB.17.2.760; Ni TT, 1999, MOL CELL, V4, P439, DOI 10.1016/S1097-2765(00)80346-9; Pena-Diaz J, 2012, MOL CELL, V47, P669, DOI 10.1016/j.molcel.2012.07.006; Pfeifer GP, 2006, CURR TOP MICROBIOL, V301, P259; Pluciennik A, 2013, P NATL ACAD SCI USA, V110, P12277, DOI 10.1073/pnas.1311325110; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; Poulos RC, 2017, NUCLEIC ACIDS RES, V45, P7786, DOI 10.1093/nar/gkx463; Rochette PJ, 2002, ONCOGENE, V21, P5743, DOI 10.1038/sj.onc.1205641; Rodriguez GP, 2012, P NATL ACAD SCI USA, V109, P6153, DOI 10.1073/pnas.1115361109; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Shah KA, 2014, CELL REP, V9, P1594, DOI 10.1016/j.celrep.2014.10.048; Sima J, 2014, CURR OPIN GENET DEV, V25, P93, DOI 10.1016/j.gde.2013.11.022; Song QA, 2011, BIOINFORMATICS, V27, P870, DOI 10.1093/bioinformatics/btr030; Sonneveld E, 2001, ONCOGENE, V20, P538, DOI 10.1038/sj.onc.1204125; Sun L, 2016, J BIOL CHEM, V291, P17692, DOI 10.1074/jbc.M116.719971; Supek F, 2017, CELL, V170, P534, DOI 10.1016/j.cell.2017.07.003; Supek F, 2015, NATURE, V521, P81, DOI 10.1038/nature14173; Supek F, 2014, CELL, V156, P1324, DOI 10.1016/j.cell.2014.01.051; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Wang HX, 1999, J BIOL CHEM, V274, P16894, DOI 10.1074/jbc.274.24.16894; Woo YH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1982; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027; Zheng CL, 2014, CELL REP, V9, P1228, DOI 10.1016/j.celrep.2014.10.031	67	40	42	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7811	7823		10.1074/jbc.RA118.002839	http://dx.doi.org/10.1074/jbc.RA118.002839			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29610279	hybrid, Green Published			2022-12-26	WOS:000437256500029
J	He, C; Tian, CC; Li, G; Mei, YH; Zhang, QG; Jiao, YZ				He, Chao; Tian, Chaochao; Li, Gang; Mei, Yahe; Zhang, Quanguo; Jiao, Youzhou			Experimental study on the relationship between the mineral production capability and the physiochemical properties in the coproduction of Q phase-3CaO.3Al(2)O(3).CaSO4 cement clinker	PLOS ONE			English	Article							COAL	A coproduction tests of quaternary (Q) phase(6CaO.4Al2O3.MgO.SiO2)-3CaO-3Al(2)O(3).CaSO4 cement clinker and an experimental study on the relationship between the mineral production capability and the physiochemical properties are conducted in a two-stage multi-phase reaction test bed with Changguang coal. X-ray diffractometer (XRD) analyses are performed on the coproduction clinker samples. The results demonstrate that, with the reduction in particle sizes of the coal powder and the additives and expanded screening level differences between them, both the proportion of Q phase and the mass of 3CaO.3Al(2)O(3).CaSO4 in the clinker increase accordingly. When mixed coal powder particles are prepared through reducing particle sizes and expanding screening level differences between coal powder and additives, the additives CaO and MgO are more likely to be enclosed by coal powder to form globular polymerized particles. In addition, this preparation aids in polymerization and promotes even distribution of CaO, MgO and coal minerals, thus facilitating clinker mineral formation reactions of inorganic substances in the mixed coal powder. Target minerals, such as 2CaO.SiO2 and Q phase, are found in both industrial high-calcium limestone and low-calcium limestone coproduction clinker samples. A diffraction peak of free CaO is also evident in both samples. Compared with a coproduction clinker sample of high-calcium limestone, that of low-calcium limestone exhibits higher diffraction peaks for 2CaO.SiO2 and Q phase. With the current state of the art, it is not yet the optimum choice to substitute CaCO3 for CaO in Q-phase cement clinker coproduction. Before the technology matures and gains practical application, further study on the form and the mixing process of calcium-based additives for cement clinker coproduction will be required.	[He, Chao; Tian, Chaochao; Li, Gang; Mei, Yahe; Zhang, Quanguo; Jiao, Youzhou] Henan Agr Univ, Coll Mech & Elect Engn, Minist Agr, Key Lab New Mat & Facil Rural Renewable Energy, Zhengzhou, Henan, Peoples R China; [He, Chao; Tian, Chaochao; Li, Gang; Mei, Yahe; Zhang, Quanguo; Jiao, Youzhou] Collaborat Innovat Ctr Biomass Energy, Zhengzhou, Henan, Peoples R China	Henan Agricultural University; Ministry of Agriculture & Rural Affairs	Jiao, YZ (corresponding author), Henan Agr Univ, Coll Mech & Elect Engn, Minist Agr, Key Lab New Mat & Facil Rural Renewable Energy, Zhengzhou, Henan, Peoples R China.; Jiao, YZ (corresponding author), Collaborat Innovat Ctr Biomass Energy, Zhengzhou, Henan, Peoples R China.	jiaoyouzhou@126.com		He, Chao/0000-0003-4280-1802; He, Chao/0000-0002-6426-6858	Natural Science Foundation of China [51706063]; Special Fund for Agro-scientific Research in the Public Interest, Ministry of Agriculture, China [201403019-1]; Natural Science Foundation of Henan Province [162300410156]; Science and Technology Innovation Talents Program of Henan Province [164100510014]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest, Ministry of Agriculture, China; Natural Science Foundation of Henan Province; Science and Technology Innovation Talents Program of Henan Province	This work was supported by Natural Science Foundation of China (No.51706063), Special Fund for Agro-scientific Research in the Public Interest, Ministry of Agriculture, China (No. 201403019-1), Natural Science Foundation of Henan Province (No.162300410156), and Science and Technology Innovation Talents Program of Henan Province (No.164100510014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmaruzzaman M, 2010, PROG ENERG COMBUST, V36, P327, DOI 10.1016/j.pecs.2009.11.003; Jiao YZ, 2012, ADV MATER RES-SWITZ, V354-355, P240, DOI 10.4028/www.scientific.net/AMR.354-355.240; Jiao You-zhou, 2008, Journal of Zhejiang University, V42, P977; [焦有宙 Jiao Youzhou], 2010, [动力工程学报, Journal of Power Engineering], V30, P633; Kirgiz M. S., 2014, EUROPEAN J ENV CIVIL, V20, P38; Kirgiz M. S., 2016, EUROPEAN J ENV CIVIL, V20, P64; Kirgiz MS, 2015, ZKG INT, V68, P60; Kirgiz MS, 2014, ZKG INT, V67, P42; Liu Hao, 2005, Proceedings of the CSEE, V25, P72; Luo YJ, 2008, THESIS; Sharonova OM, 2010, FUEL PROCESS TECHNOL, V91, P573, DOI 10.1016/j.fuproc.2010.01.003; [王春梅 Wang Chunmei], 2004, [工程热物理学报, Journal of Engineering Thermophysics], V25, P1053; Wang W. L., 2004, J ZHEJIANG U, V37, P225; Wang Wen-long, 2005, Proceedings of the CSEE, V25, P96; Wang Wen-long, 2005, Proceedings of the CSEE, V25, P116; Wang WL, 2003, WASTE MANAGE RES, V21, P243, DOI 10.1177/0734242X0302100308; Zhao Yong-chun, 2007, Proceedings of the CSEE, V27, P12	17	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195505	10.1371/journal.pone.0195505	http://dx.doi.org/10.1371/journal.pone.0195505			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634732	gold, Green Published, Green Submitted			2022-12-26	WOS:000429522200035
J	Klishko, OK; Lopes-Lima, M; Bogan, AE; Matafonov, DV; Froufe, E				Klishko, Olga K.; Lopes-Lima, Manuel; Bogan, Arthur E.; Matafonov, Dmitry V.; Froufe, Elsa			Morphological and molecular analyses of Anodontinae species (Bivalvia, Unionidae) of Lake Baikal and Transbaikalia	PLOS ONE			English	Article							WATER; DIVERSITY; MOLLUSKS; MUSSELS; ANATINA; RUSSIA; SHELL; TCS	The diversity and taxonomy of anodontine species in Lake Baikal and Transbaikalia region has been contentious since it is based on a typological species concept, the so called "Comparatory Method". Using this method, six Comparatory anodontine species have been described for the study area as belonging to the genus Colletopterum. This genus was separated from Anodonta based on shell characteristics and further split into two subgenera, i.e. Colletopterum sensu stricto and Colletopterum (Piscinaliana). However, many authors do not recognize this separation maintaining all Colletopterum forms within Anodonta. The current study clarifies the taxonomy and systematics of Anodontinae in this region, using a combination of molecular, morphological and anatomical data. All previously recognized Comparatory forms are here recognized as a single species, i.e. Anodonta anatina.	[Klishko, Olga K.] Russian Acad Sci, Inst Nat Resources Ecol & Cryol, Siberian Branch, Chita, Russia; [Lopes-Lima, Manuel] Univ Porto, CIBIO InBIO Res Ctr Biodivers & Genet Resources, Vairao, Portugal; [Lopes-Lima, Manuel; Froufe, Elsa] Univ Porto, CIIMAR CIMAR Interdisciplinary Ctr Marine & Envir, Matosinhos, Portugal; [Lopes-Lima, Manuel; Bogan, Arthur E.] Int Union Conservat Nat, Species Survival Commiss, SSC IUCN Mollusc Specialist Grp, Cambridge, England; [Bogan, Arthur E.] North Carolina State Museum Nat Sci, Res Lab, Raleigh, NC USA; [Matafonov, Dmitry V.] Russian Acad Sci, Inst Gen & Expt Biol, Siberian Branch, Ulan Ude, Russia	Russian Academy of Sciences; Universidade do Porto; Universidade do Porto; Russian Academy of Sciences	Lopes-Lima, M (corresponding author), Univ Porto, CIBIO InBIO Res Ctr Biodivers & Genet Resources, Vairao, Portugal.; Lopes-Lima, M (corresponding author), Univ Porto, CIIMAR CIMAR Interdisciplinary Ctr Marine & Envir, Matosinhos, Portugal.; Lopes-Lima, M (corresponding author), Int Union Conservat Nat, Species Survival Commiss, SSC IUCN Mollusc Specialist Grp, Cambridge, England.	manuelpmlopeslima@gmail.com	Froufe, Elsa/F-2286-2013; Lopes-Lima, Manuel/N-1222-2014	Froufe, Elsa/0000-0003-0262-0791; Lopes-Lima, Manuel/0000-0002-2761-7962; Matafonov, Dmitry/0000-0001-9931-4816	Fundacao para a Ciencia e tecnologia (FCT [PTDC/AGRFOR/1627/2014];  [SFRH/BD/115728/2016];  [SFRH/BPD/108445/2015]	Fundacao para a Ciencia e tecnologia (FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); ; 	Fundacao para a Ciencia e tecnologia (FCT) funded the genetics work under project PTDC/AGRFOR/1627/2014. Research grants from the same institution were awarded to MLL (SFRH/BD/115728/2016) and EF (SFRH/BPD/108445/2015).	[Anonymous], 1870, SYNOPSIS FAMILY UNIO; Bogatov VV, 2012, ZOOL ZH, V91, P393; BOGATOV VV, 1992, ZOOL ZH, V71, P132; Bogatov VV, 2005, ZOOL ZH, V84, P1050; Bogatov VV, 2016, IDENTIFICATION GUIDE, V2, P285; Bolotov IN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122408; Bourguignat J, 1880, MATERIAUX SERVIR HIS; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; dos Santos AM, 2016, BIOINFORMATICS, V32, P627, DOI 10.1093/bioinformatics/btv636; Froufe E, 2014, AQUAT CONSERV, V24, P561, DOI 10.1002/aqc.2456; Galaziy GI, 1987, BAIKAL LAKE QUESTION; Graf DL, 2007, P ACAD NAT SCI PHILA, V156, P71, DOI 10.1635/0097-3157(2007)156[71:PFMMBU]2.0.CO;2; Graf DL, 2018, MUSSEL PROJECT WEB S; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Israel W, 1910, BEIL NACHR BL DT MAL, V4, P49; Kauffmann E.G, 1969, TREATISE INVERTEBRAT, P129; Klishko O, 2017, ZOOTAXA, V4286, P93, DOI 10.11646/zootaxa.4286.1.4; Klishko OK, 2018, SYST BIODIVERS, V16, P287, DOI 10.1080/14772000.2017.1383527; Klishko OK, 2016, ZOOKEYS, P13, DOI 10.3897/zookeys.580.7588; Klishko OK, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.438.7493; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kuster NC, 1854, SYSTEMATISCHES CONCH, P89; Kuster NC, 1842, SYSTEMATISCHES CONCH, P41; LOCARD A, 1890, ANN SOC LINNEENNE LY, V36, P50; Lopes-Lima M, 2017, MOL PHYLOGENET EVOL, V106, P174, DOI 10.1016/j.ympev.2016.08.021; Lopes-Lima M, 2017, BIOL REV, V92, P572, DOI 10.1111/brv.12244; Martens R, 1969, SUPERFAMILIA UNIONAC, P88; Modell H., 1945, JENA Z NATUR, V78, P58; Prozorova LA, 2006, HYDROBIOLOGIA, V568, P201, DOI 10.1007/s10750-006-0314-x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; ROPER DS, 1994, HYDROBIOLOGIA, V284, P205, DOI 10.1007/BF00006690; Sayenko E.M., 2014, Byulleten' Dal'nevostochnogo Malakologicheskogo Obshchestva, V18, P79; Seed R., 1980, Topics in Geobiology, V1, P23; Slugina ZV, 1999, GUIDE KEY BIVALVIA L; Stanley S.M., 1970, GEOLOGICAL SOC AM, V125, P1, DOI 10.1130/MEM125-p1; Starobogatov Ya.I., 1984, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V89, P74; Starobogatov YI, 2004, NAUKA, V6; Starobogatov YI, 1977, FAMILY UNIONIDAE IDE, P126; Tevesz M., 1980, SKELETAL GROWTH AQUA, P295; Vinarski MV, 2016, ANAL CATALOGUE FRESH; ZATRAVKIN MN, 1983, MOLLYUSKI SISTEMATIK, V7, P40; Zhadin VI, 1938, FAUNA USSR MOLLUSCA, V4; Zhadin VI, 1952, IDENTIFICATION GUIDE, V46; Zieritz A, 2015, J ZOOL SYST EVOL RES, V53, P76, DOI 10.1111/jzs.12077; Zieritz A, 2011, J MORPHOL, V272, P1365, DOI 10.1002/jmor.10990; Zieritz A, 2009, BIOL J LINN SOC, V98, P814, DOI 10.1111/j.1095-8312.2009.01329.x	46	18	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194944	10.1371/journal.pone.0194944	http://dx.doi.org/10.1371/journal.pone.0194944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630628	Green Published, gold, Green Submitted			2022-12-26	WOS:000429505000021
J	Xiao, C; Ma, TF; Dieng, AB; Blei, DM; Wang, F				Xiao, Cao; Ma, Tengfei; Dieng, Adji B.; Blei, David M.; Wang, Fei			Readmission prediction via deep contextual embedding of clinical concepts	PLOS ONE			English	Article								Objective Hospital readmission costs a lot of money every year. Many hospital readmissions are avoidable, and excessive hospital readmissions could also be harmful to the patients. Accurate prediction of hospital readmission can effectively help reduce the readmission risk. However, the complex relationship between readmission and potential risk factors makes readmission prediction a difficult task. The main goal of this paper is to explore deep learning models to distill such complex relationships and make accurate predictions. Materials and methods We propose CONTENT, a deep model that predicts hospital readmissions via learning interpretable patient representations by capturing both local and global contexts from patient Electronic Health Records (EHR) through a hybrid Topic Recurrent Neural Network (TopicRNN) model. The experiment was conducted using the EHR of a real world Congestive Heart Failure (CHF) cohort of 5,393 patients. Results The proposed model outperforms state-of-the-art methods in readmission prediction (e.g. 0.6103 +/- 0.0130 vs. second best 0.5998 +/- 0.0124 in terms of ROC-AUC). The derived patient representations were further utilized for patient phenotyping. The learned phenotypes provide more precise understanding of readmission risks. Discussion Embedding both local and global context in patient representation not only improves prediction performance, but also brings interpretable insights of understanding readmission risks for heterogeneous chronic clinical conditions. Conclusion This is the first of its kind model that integrates the power of both conventional deep neural network and the probabilistic generative models for highly interpretable deep patient representation learning. Experimental results and case studies demonstrate the improved performance and interpretability of the model.	[Xiao, Cao] IBM Res, AI Healthcare, Cambridge, MA USA; [Ma, Tengfei] IBM TJ Watson Res Ctr, Yorktown Hts, NY USA; [Dieng, Adji B.; Blei, David M.] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; [Wang, Fei] Cornell Univ, Weill Cornell Med Sch, New York, NY 10021 USA	International Business Machines (IBM); International Business Machines (IBM); Columbia University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Wang, F (corresponding author), Cornell Univ, Weill Cornell Med Sch, New York, NY 10021 USA.	few2001@med.cornell.edu		Ma, Tengfei/0000-0002-1086-529X	National Science Foundation [IIS-1650723, IIS-1716432]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation IIS-1650723 and IIS-1716432 to FW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, IEEE T BIG DATA; Arisoy E, 2012, IEEE T AUDIO SPEECH, V20, P540, DOI 10.1109/TASL.2011.2162323; Armenian SH, 2008, J CLIN ONCOL, V26, P5537, DOI 10.1200/JCO.2008.17.7428; Baytas IM, 2017, KDD'17: PROCEEDINGS OF THE 23RD ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P65, DOI 10.1145/3097983.3097997; Bengio Y, 2001, ADV NEUR IN, V13, P932; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Blei DM, 2017, J AM STAT ASSOC, V112, P859, DOI 10.1080/01621459.2017.1285773; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Che C, 2017, SIAM INT C DAT MIN; Cheng Y., 2016, 2016 SIAM INT C DATA, P432, DOI DOI 10.1137/1.9781611974348.49; Cho K., 2014, EMNLP 2014 2014 C EM, DOI DOI 10.3115/V1/D14-1179; Choi E, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1495, DOI 10.1145/2939672.2939823; Choi E, 2016, ADV NEUR IN, V29; Choi E, 2017, J AM MED INFORM ASSN, V24, P361, DOI 10.1093/jamia/ocw112; Dieng AB, 2017, INT C LEARN REPR; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Hammill BG, 2011, CIRC-CARDIOVASC QUAL, V4, P60, DOI 10.1161/CIRCOUTCOMES.110.954693; Hochreiter S., 1997, STUD COMPUT INTELL, DOI DOI 10.1007/978-3-642-24797-2; Hripcsak G, 2013, J AM MED INFORM ASSN, V20, P117, DOI 10.1136/amiajnl-2012-001145; Katz Stuart D, 2004, Congest Heart Fail, V10, P243, DOI 10.1111/j.1527-5299.2004.03298.x; Kingma Diederik P., 2013, ABS13126114 CORR; Kingma DP., 2014, ADAM METHOD STOCHAST; Lang CC, 2007, HEART, V93, P665, DOI 10.1136/hrt.2005.068296; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lin JH, 2008, J BIOMED INFORM, V41, P1, DOI 10.1016/j.jbi.2007.06.001; Little R. J. A., 1987, STAT ANAL MISSING DA; Ma T, 2018, SIAM INT C DAT MIN; Mathias JS, 2013, J AM MED INFORM ASSN, V20, pE118, DOI 10.1136/amiajnl-2012-001360; McIlvennan CK, 2015, CIRCULATION, V131, P1796, DOI 10.1161/CIRCULATIONAHA.114.010270; Mikolov T., 2012, CONTEXT DEPENDENT RE; Pascanu R., 2013, INT C MACH LEARN, P1310; Pfisterer M, 2009, JAMA-J AM MED ASSOC, V301, P383, DOI 10.1001/jama.2009.2; Nguyen P, 2017, IEEE J BIOMED HEALTH, V21, P22, DOI 10.1109/JBHI.2016.2633963; Pivovarov R, 2014, J BIOMED INFORM, V51, P24, DOI 10.1016/j.jbi.2014.03.016; Robert I, 2014, INT J BREAST CANC; Roy SB, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1691, DOI 10.1145/2783258.2788585; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Theano Development Team, 2016, ARXIV160502688; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Tran T, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0425-8; Wu J, 2010, MED CARE, V48	43	48	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195024	10.1371/journal.pone.0195024	http://dx.doi.org/10.1371/journal.pone.0195024			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC0YY	29630604	gold, Green Published, Green Submitted			2022-12-26	WOS:000429505000022
J	Ren, FJ; Liu, N				Ren, Fuji; Liu, Ning			Emotion computing using Word Mover's Distance features based on Ren_CECps	PLOS ONE			English	Article							SENTIMENT; VISUALIZATION; CORPUS; MODEL; BLOG	In this paper, we propose an emotion separated method(SeTEIDF) to assign the emotion labels of sentences with different values, which has a better visual effect compared with the values represented by TF.IDF in the visualization of a multi-label Chinese emotional corpus Ren_CECps. Inspired by the enormous improvement of the visualization map propelled by the changed distances among the sentences, we being the first group utilizes the Word Mover's Distance(WMD) algorithm as a way of feature representation in Chinese text emotion classification. Our experiments show that both in 80% for training, 20% for testing and 50% for training, 50% for testing experiments of Ren_CECps, WMD features get the best f1 scores and have a greater increase compared with the same dimension feature vectors obtained by dimension reduction TF.IDF method. Compared experiments in English corpus also show the efficiency of WMD features in the cross-language field.	[Ren, Fuji; Liu, Ning] Tokushima Univ, Fac Engn, Tokushima, Japan	Tokushima University	Ren, FJ (corresponding author), Tokushima Univ, Fac Engn, Tokushima, Japan.	ren@is.tokushima-u.ac.jp			Japan Society For The Promotion of Science, KAKENHI [15H01712]	Japan Society For The Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society For The Promotion of Science, KAKENHI Grant Number 15H01712 to FR, https://www.jsps.go.jp/index.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreevskaia A., 2006, P 11 C EUROPEAN CHAP, P209; Arleo A, 2017, INFORM SCIENCES, V381, P124, DOI 10.1016/j.ins.2016.11.012; Baccianella S., 2010, P 7 INT C LANG RES O, V10, P2200; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Buja A, 2008, J COMPUT GRAPH STAT, V17, P444, DOI 10.1198/106186008X318440; Cachopo AMdJC, 2007, IMPROVING METHODS SI, P124; Cambria E., 2016, P COLING 2016 26 INT, P2666, DOI DOI 10.1007/978-3-319-55209-5_5; Cambria E, 2016, IEEE INTELL SYST, V31, P102, DOI 10.1109/MIS.2016.31; Cao N, 2016, IEEE T VIS COMPUT GR, V22, P1149, DOI 10.1109/TVCG.2015.2424878; Cheng XY, 2017, ACM T ASIAN LOW-RESO, V17, DOI 10.1145/3132684; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Friendly M, 2005, J HIST BEHAV SCI, V41, P103, DOI 10.1002/jhbs.20078; Fu AY, 2006, IEEE T DEPEND SECURE, V3, P301, DOI 10.1109/TDSC.2006.50; Heimerl F, 2012, IEEE T VIS COMPUT GR, V18, P2839, DOI 10.1109/TVCG.2012.277; Huang XD, 2007, INFORM SCIENCES, V177, P2821, DOI 10.1016/j.ins.2007.02.016; Inselberg A, 1985, VISUAL COMPUT, V1, P69, DOI 10.1007/BF01898350; Kusner MJ, 2015, PR MACH LEARN RES, V37, P957; Li Ji, 2012, IEEJ T ELECT INFORM, V132, P1362; Li TMH, 2014, CRISIS, V35, P168, DOI 10.1027/0227-5910/a000248; Liao Jian, 2016, Chinese Computational Linguistics and Natural Language Processing Based on Naturally Annotated Big Data. 15th China National Conference, CCL 2016, and 4th International Symposium, NLP-NABD 2016. Proceedings: LNAI 10035, P227, DOI 10.1007/978-3-319-47674-2_20; Liu, 2014, NATURAL LANGUAGE PRO, P457, DOI [DOI 10.1007/978-3-662-45924-9_42, DOI 10.1007/978-3-662-45924-9_]; Lu Y, 2017, J NATURAL LANGUAGE P, V24, P205; Ma YX, 2017, INFORM SCIENCES, V390, P54, DOI 10.1016/j.ins.2016.03.021; Matsumoto K., 2011, 2011 7th International Conference on Natural Language Processing and Knowledge Engineering (NLPKE), P214, DOI 10.1109/NLPKE.2011.6138197; Mikolov Tomas, 2013, P ADV NEUR INF PROC, P3111, DOI DOI 10.1162/JMLR.2003.3.4-5.951; Minato J, 2006, LECT NOTES ARTIF INT, V4114, P924; Minsky M., 1985, SOC MIND, V16, P163; Mukherjee Subhabrata, 2012, Computational Linguistics and Intelligent Text Processing. Proceedings 13th International Conference (CICLing 2012), P475, DOI 10.1007/978-3-642-28604-9_39; Najim SA, 2014, INFORM SCIENCES, V278, P206, DOI 10.1016/j.ins.2014.03.048; Pagliardini M., 2017, UNSUPERVISED LEARNIN; Patel Vikram, 2007, Lancet, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pele O, 2009, IEEE I CONF COMP VIS, P460, DOI 10.1109/ICCV.2009.5459199; Petropoulos A, 2017, INFORM SCIENCES, V412, P50, DOI 10.1016/j.ins.2017.05.038; Picard RW, 1997, AFFECTIVE COMPUTING, V1, P35; Quan C., 2010, INT J ADV INTELLIGEN, V2, P105; Quan CQ, 2016, INFORM SCIENCES, V329, P581, DOI 10.1016/j.ins.2015.09.050; Quan CQ, 2010, COMPUT SPEECH LANG, V24, P726, DOI 10.1016/j.csl.2010.02.002; Le Q, 2014, PR MACH LEARN RES, V32, P1188; Rehurek R., 2010, P LREC 2010 WORKSH N; Ren FJ, 2016, IEEE J BIOMED HEALTH, V20, P1384, DOI 10.1109/JBHI.2015.2459683; Rubner Y, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P59, DOI 10.1109/ICCV.1998.710701; Rubner Y, 2000, INT J COMPUT VISION, V40, P99, DOI 10.1023/A:1026543900054; SALTON G, 1988, INFORM PROCESS MANAG, V24, P513, DOI 10.1016/0306-4573(88)90021-0; SALTON G, 1975, COMMUN ACM, V18, P613, DOI 10.1145/361219.361220; Spiegelhalter D, 2011, SCIENCE, V333, P1393, DOI 10.1126/science.1191181; STEWART GW, 1993, SIAM REV, V35, P551, DOI 10.1137/1035134; Su Q., 2008, P 17 INT C WORLD WID, P959, DOI DOI 10.1145/1367497.1367627; Tan SB, 2008, EXPERT SYST APPL, V34, P2622, DOI 10.1016/j.eswa.2007.05.028; Tang DY, 2016, IEEE T KNOWL DATA EN, V28, P496, DOI 10.1109/TKDE.2015.2489653; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wan XJ, 2007, INFORM SCIENCES, V177, P3718, DOI 10.1016/j.ins.2007.02.045; Wang Canhui, 2008, P 17 WWW, P457, DOI [10.1145/1367497.1367560, DOI 10.1145/1367497.1367560]; Wang C, 2010, IEEE INFOCOM SER, DOI 10.1109/PEDG.2010.5545769; Wang L, 2015, LECT NOTES ARTIF INT, V9332, P197, DOI 10.1007/978-3-319-27194-1_20; Wang L, 2016, IEEJ T ELECTR ELECTR, V11, P178, DOI 10.1002/tee.22204; Xiao KC, 2016, INT CONF SOFTW ENG, P922, DOI 10.1109/ICSESS.2016.7883216; Yang M, 2017, AAAI CONF ARTIF INTE, P5013; Zhang YS, 2016, CHINESE J ELECTRON, V25, P601, DOI 10.1049/cje.2016.07.002; Zhang YW, 2015, LECT NOTES ARTIF INT, V9078, P52, DOI 10.1007/978-3-319-18032-8_5; Zhao J., 2012, P 18 ACM SIGKDD INT, P1528, DOI DOI 10.1145/2339530.2339772	61	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0194136	10.1371/journal.pone.0194136	http://dx.doi.org/10.1371/journal.pone.0194136			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624573	Green Published, Green Submitted, gold			2022-12-26	WOS:000429379600004
J	Schiavon, S; Dalla Bona, M; Carco, G; Carraro, L; Bunger, L; Gallo, L				Schiavon, Stefano; Dalla Bona, Mirco; Carco, Giuseppe; Carraro, Luca; Bunger, Lutz; Gallo, Luigi			Effects of feed allowance and indispensable amino acid reduction on feed intake, growth performance and carcass characteristics of growing pigs	PLOS ONE			English	Article							LOW-PROTEIN DIETS; CURED HAM PRODUCTION; MEAT QUALITY; FINISHING PIGS; HEAVY PIGS; INTRAMUSCULAR FAT; DEFICIENT DIETS; FOOD-INTAKE; MUSCLE; TRAITS	The hypothesis that pigs placed on diets with reduced indispensable amino acid (AA) content attempts to offset the reduction in the nutrient density with increased feed intake was tested. In the experiment, feeds with a high or a low AA content were administrated to pigs fed ad-libitum or restrictively according to a 2 x 2 factorial design. Ninety-six barrows were housed in 8 pens (12 pigs/pen) equipped with automatic feeders. Within pen, and from 47 body weight (BW) onwards, 6 pigs were fed ad libitum. The others pigs were allowed to consume, as a maximum, the feed amounts indicated by the breeding company feeding plane to optimize the feed efficiency. In early (86-118 kg BW) and late (118-145 kg BW) finishing, the pigs of 4 pens received feeds with high indispensable AA contents (8.1 and 7.5 g lysine/kg in the two periods, respectively). The other pigs received feeds with reduced indispensable AA contents (lysine, methionine, threonine and tryptophan) by 9 and 18% in early and late finishing, respectively. Body lipid and protein (Pr) retentions were estimated from BW and back-fat depth measures recorded at the beginning and the end of each period. Nitrogen excretion was estimated as actual intake minus estimated N-retention (Pr/6.25). Pigs were slaughtered at 144 kg BW. Restricted feeding decreased feed intake (-7%), daily gain (-5%), carcass weight (-2.6%) and back -fat depth (-8.0%) but increased gain:feed ratio (+2%). The AA restriction increased feed intake (+5.9%), carcass weight (+4.9%) and intra-muscular fat (+17.6%), and reduced carcass weight variation (-36%), with no effects on the feed efficiency and the estimated Pr (142 g/d). N excreted was reduced by feed (-9%) and dietary AA (-15%) restrictions. Irrespectively of the feeding level, the pigs responded to a reduction of the dietary essential AA content by increasing their feed intake.	[Schiavon, Stefano; Dalla Bona, Mirco; Carco, Giuseppe; Carraro, Luca; Gallo, Luigi] Univ Padua, Dept Agron Food Nat Resources Anim & Environm, Legnaro, Italy; [Bunger, Lutz] Scotlands Rural Coll SRUC, Edinburgh, Midlothian, Scotland	University of Padua; Scotland's Rural College	Carco, G (corresponding author), Univ Padua, Dept Agron Food Nat Resources Anim & Environm, Legnaro, Italy.	giuseppe.carco@phd.unipd.it	Schiavon, Stefano/C-6253-2011; Bunger, Lutz/A-8751-2014; Bunger, Lutz/T-5647-2019	Schiavon, Stefano/0000-0002-5539-8947; Bunger, Lutz/0000-0003-4457-8288; Bunger, Lutz/0000-0003-4457-8288	University of Padua [CPDR143385/2014, DOR1655405/2016]; Regione Veneto [2105-41- 2121-2015]; Veronesi SPA (Quinto di Valpantena, Verona, Italy)	University of Padua; Regione Veneto(Regione Veneto); Veronesi SPA (Quinto di Valpantena, Verona, Italy)	This research was funded by the University of Padua under grants CPDR143385/2014 and DOR1655405/2016 (SS), and Regione Veneto under grant P.O.R.F.S.E. n. 2105-41- 2121-2015 (MD). The authors would like to thank Veronesi SPA (Quinto di Valpantena, Verona, Italy) (http://www.veronesi.it/) for financial and technical support (SS), and the Aldo Gini Foundation (Via Portello 15, Padua, Italy) for supporting the research activities of PhD student Giuseppe Carco, during his study period at the University of Zaragoza (http://www.unipd.it/fondazione-gini) (GC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso L, 2010, ANIMAL, V4, P1739, DOI 10.1017/S1751731110000819; (AOAC) International A of OAC, 2012, OFF METH AN ASS OFF; Black JL, 2009, VOLUNTARY FEED INTAKE IN PIGS, P323; Bosi P, 2004, ITAL J ANIM SCI, V3, P309, DOI 10.4081/ijas.2004.309; BOUCHARD J, 1988, J AGR FOOD CHEM, V36, P1188, DOI 10.1021/jf00084a016; Camara L, 2016, MEAT SCI, V114, P69, DOI 10.1016/j.meatsci.2015.12.013; Carco G, 2018, APPL ANIM BEHAV SCI, V198, P27, DOI 10.1016/j.applanim.2017.09.020; Chiba LI, 2002, LIVEST PROD SCI, V74, P93, DOI 10.1016/S0301-6226(01)00288-3; Cisneros F, 1996, ANIM SCI, V63, P517, DOI 10.1017/S1357729800015411; Council of Europe, 2005, EUROPEAN PHARMACOPOE, VVolume 5.0, P86; Dalla Bona M, 2016, ITAL J ANIM SCI, V15, P419, DOI 10.1080/1828051X.2016.1210993; Emmans G, 2001, P NUTR SOC, V60, P115, DOI 10.1079/PNS200059; Emmans G.C., 1988, BRIT SOC ANIMAL PROD, V12, P153, DOI [10.1017/S0263967X00003347, DOI 10.1017/S0263967X00003347]; Ferguson NS, 1997, ANIM SCI, V64, P365, DOI 10.1017/S1357729800015939; Ferguson NS, 2000, ANIM SCI, V70, P287, DOI 10.1017/S1357729800054746; Gallo L, 2015, LIVEST SCI, V172, P50, DOI 10.1016/j.livsci.2014.11.014; Gallo L, 2014, LIVEST SCI, V161, P130, DOI 10.1016/j.livsci.2013.12.027; He LQ, 2016, AMINO ACIDS, V48, P21, DOI 10.1007/s00726-015-2059-1; HENRY Y, 1992, J ANIM SCI, V70, P1873, DOI 10.2527/1992.7061873x; HENRY Y, 1995, ANN ZOOTECH, V44, P3, DOI 10.1051/animres:19950101; Kloareg M, 2006, ANIM SCI, V82, P241, DOI 10.1079/ASC200529; Knap PW, 2009, VOLUNTARY FEED INTAKE IN PIGS, P13; Kouba M, 2001, J ANIM SCI, V79, P81; KYRIAZAKIS I, 1991, PHYSIOL BEHAV, V50, P1197, DOI 10.1016/0031-9384(91)90582-9; Lebret B, 2008, ANIMAL, V2, P1548, DOI 10.1017/S1751731108002796; Mordenti A, 2003, ITAL J ANIM SCI, V2, P73, DOI 10.4081/ijas.2003.73; National Research Council (NRC), 2012, NUTR REQ SWIN, V11, DOI [10.17226/13298, DOI 10.17226/13298]; Nyachoti CM, 2004, CAN J ANIM SCI, V84, P549, DOI 10.4141/A04-001; Patience JF, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0031-2; Pierer M, 2016, NUTR CYCL AGROECOSYS, V104, P201, DOI 10.1007/s10705-016-9767-0; Rodriguez-Sanchez JA, 2011, J ANIM SCI, V89, P3651, DOI 10.2527/jas.2010-3791; Rossi R, 2014, FOOD RES INT, V65, P88, DOI 10.1016/j.foodres.2014.03.062; Schiavon S, 2015, ANIM FEED SCI TECH, V208, P170, DOI 10.1016/j.anifeedsci.2015.07.009; Schiavon S, 2013, LIVEST SCI, V157, P462, DOI 10.1016/j.livsci.2013.09.015; Schiavon S, 2000, BRIT J NUTR, V84, P873; Schiavon S, 2015, ANIM FEED SCI TECH, V208, P86, DOI 10.1016/j.anifeedsci.2015.07.016; SLUMP P, 1991, J SCI FOOD AGR, V55, P493, DOI 10.1002/jsfa.2740550318; Steyn WJ, 2012, S AFR J ANIM SCI, V42, P178, DOI 10.4314/sajas.v42i2.11; Suarez-Belloch J, 2015, ANIMAL, V9, P1731, DOI 10.1017/S1751731115001111; Teye GA, 2006, MEAT SCI, V73, P157, DOI 10.1016/j.meatsci.2005.11.010; Topigs, 2012, FEED MAN TAL; Tous N, 2014, J ANIM SCI, V92, P129, DOI 10.2527/jas.2012-6222; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Whittemore, 2006, WHITTEMORES SCI PRAC; Wood JD, 2013, MEAT SCI, V95, P123, DOI 10.1016/j.meatsci.2013.03.001	45	24	24	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195645	10.1371/journal.pone.0195645	http://dx.doi.org/10.1371/journal.pone.0195645			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621327	Green Published, Green Submitted, gold			2022-12-26	WOS:000429206800112
J	Seppanen, E; Tan, D; Corscadden, KJ; Currie, AJ; Richmond, PC; Thornton, RB; Kirkham, LAS				Seppanen, Elke; Tan, Dino; Corscadden, Karli J.; Currie, Andrew J.; Richmond, Peter C.; Thornton, Ruth B.; Kirkham, Lea-Ann S.			Evidence of functional cell-mediated immune responses to nontypeable Haemophilus influenzae in otitis-prone children	PLOS ONE			English	Article							NK CELLS; ADAPTIVE IMMUNITY; YOUNG-CHILDREN; MOUSE LUNG; MEMORY; LYMPHOCYTE; GENERATION; SUBSETS	Otitis media (OM) remains a common paediatric disease, despite advances in vaccinology. Susceptibility to recurrent acute OM (rAOM) has been postulated to involve defective cell-mediated immune responses to common otopathogenic bacteria. We compared the composition of peripheral blood mononuclear cells (PBMC) from 20 children with a history of rAOM (otitis-prone) and 20 healthy non-otitis-prone controls, and assessed innate and cell-mediated immune responses to the major otopathogen nontypeable Haemophilus influenzae (NTHi). NTHi was a potent stimulator of inflammatory cytokine secretion from PBMC within 4 hours, with no difference in cytokine levels produced between PBMC from cases or controls. In the absence of antigen stimulation, otitis-prone children had more circulating Natural Killer (NK) cells (p<0.01), particularly NKdim (CD56(lo)) cells (p<0.01), but fewer CD4(+) T cells (p<0.01) than healthy controls. NTHi challenge significantly increased the proportion of activated (CD107a(+)) NK cells in otitis-prone and non-otitis-prone children (p<0.01), suggesting that NK cells from otitis-prone children are functional and respond to NTHi. CD8(+) T cells and NK cells from both cases and controls produced IFN gamma in response to polyclonal stimulus (Staphylococcal enterotoxin B; SEB), with more IFN gamma(+) CD8(+) T cells present in cases than controls (p<0.05) but similar proportions of IFN gamma(+) NK cells. Otitis prone children had more circulating IFN gamma-producing NK cells (p<0.05) and more IFN gamma-producing CD4(+) (p<0.01) or CD8(+) T-cells (p<0.05) than healthy controls. In response to SEB, more CD107a-expressing CD8(+) T cells were present in cases than controls (p<0.01). Despite differences in PBMC composition, PBMC from otitis-prone children mounted innate and T cell-mediated responses to NTHi challenge that were comparable to healthy children. These data provide evidence that otitis-prone children do not have impaired functional cell mediated immunity.	[Seppanen, Elke; Corscadden, Karli J.; Richmond, Peter C.; Thornton, Ruth B.; Kirkham, Lea-Ann S.] Telethon Kids Inst, Wesfarmers Ctr Vaccines & Infect Dis, Perth, WA, Australia; [Tan, Dino] Univ Western Australia, Sch Med & Pharmacol, Ctr Resp Hlth, Perth, WA, Australia; [Currie, Andrew J.] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Currie, Andrew J.; Richmond, Peter C.] Univ Western Australia, Sch Med, Perth, WA, Australia; [Richmond, Peter C.] Perth Childrens Hosp, Perth, WA, Australia; [Thornton, Ruth B.] Univ Western Australia, Sch Biomed Sci, Perth, WA, Australia	Telethon Kids Institute; Wesfarmers Limited; University of Western Australia; Murdoch University; University of Western Australia; University of Western Australia	Kirkham, LAS (corresponding author), Telethon Kids Inst, Wesfarmers Ctr Vaccines & Infect Dis, Perth, WA, Australia.	lea-ann.kirkham@uwa.edu.au	Tan, Dino BA/A-5876-2013; Kirkham, Lea-Ann S/A-5847-2013; Seppanen, Elke/AHD-5402-2022; Richmond, Peter C/G-3379-2012; Currie, Andrew/C-2778-2015; Tan, Dino/R-1423-2019; Thornton, Ruth/GOP-2314-2022	Kirkham, Lea-Ann S/0000-0001-5421-8126; Richmond, Peter C/0000-0001-7562-7228; Currie, Andrew/0000-0002-5193-3404; Seppanen, Elke/0000-0003-1673-4167; Thornton, Ruth/0000-0001-9852-8310	Australian National Health and Medical Research Council [1011306, 1061428]; Perth Children's Hospital Foundation [9420]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Perth Children's Hospital Foundation	This work was supported by the Australian National Health and Medical Research Council, https://www.nhmrc.gov.au/, (App#1011306 (LK) and 1061428 (LK)) and the Perth Children's Hospital Foundation, https://pchf.org.au/, formerly the Princess Margaret Hospital for Children Foundation (App#9420 (LK, AC, RT, PR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKALETZ LO, 1988, INFECT IMMUN, V56, P331, DOI 10.1128/IAI.56.2.331-335.1988; Batoni G, 2005, SCAND J IMMUNOL, V62, P498, DOI 10.1111/j.1365-3083.2005.01692.x; de Jager W, 2003, CLIN DIAGN LAB IMMUN, V10, P133, DOI 10.1128/CDLI.10.1.133-139.2003; De Maria A, 2011, P NATL ACAD SCI USA, V108, P728, DOI 10.1073/pnas.1012356108; Foley B, 2012, J IMMUNOL, V189, P5082, DOI 10.4049/jimmunol.1201964; Foxwell AR, 1998, IMMUNOL CELL BIOL, V76, P323, DOI 10.1046/j.1440-1711.1998.00740.x; Habib S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153223; Kaur R, 2011, VACCINE, V29, P1023, DOI 10.1016/j.vaccine.2010.11.055; Kendirli T, 2008, TURKISH J PEDIATR, V50, P63; Kerr AR, 2005, MICROBES INFECT, V7, P845, DOI 10.1016/j.micinf.2005.02.011; King PT, 2008, CLIN EXP IMMUNOL, V153, P376, DOI 10.1111/j.1365-2249.2008.03697.x; King PT, 2008, CLIN EXP IMMUNOL, V152, P542, DOI 10.1111/j.1365-2249.2008.03667.x; King PT, 2003, AM J RESP CRIT CARE, V167, P587, DOI 10.1164/rccm.200207-728OC; Kirkham Lea-Ann S, 2013, BMC Res Notes, V6, P522, DOI 10.1186/1756-0500-6-522; Kodama H, 1999, ACTA OTO-LARYNGOL, V119, P377, DOI 10.1080/00016489950181422; Ngo CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150949; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Paust S, 2011, NAT IMMUNOL, V12, P500, DOI 10.1038/ni.2032; Pizzutto SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104236; Rapola S, 2001, PEDIATR INFECT DIS J, V20, P482, DOI 10.1097/00006454-200105000-00003; Sharma SK, 2013, CURR ALLERGY ASTHM R, V13, P495, DOI 10.1007/s11882-013-0370-z; Sharma SK, 2012, J INFECT DIS, V205, P1225, DOI 10.1093/infdis/jis179; Sharma SK, 2011, J INFECT DIS, V204, P645, DOI 10.1093/infdis/jir340; Strunk T, 2011, INNATE IMMUN-LONDON, V17, P508, DOI 10.1177/1753425910379840; Thornton RB, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00556-16; Vergison A, 2010, LANCET INFECT DIS, V10, P195, DOI 10.1016/S1473-3099(10)70012-8; Wang XR, 2002, J IMMUNOL, V168, P810, DOI 10.4049/jimmunol.168.2.810; Wieland CW, 2005, J IMMUNOL, V175, P6042, DOI 10.4049/jimmunol.175.9.6042; Wiertsema SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049061; Wiertsema SP, 2011, J MED VIROL, V83, P2008, DOI 10.1002/jmv.22221; Wiertsema SP, 2011, VACCINE, V29, P5163, DOI 10.1016/j.vaccine.2011.05.035; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x	32	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0193962	10.1371/journal.pone.0193962	http://dx.doi.org/10.1371/journal.pone.0193962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621281	Green Published, gold, Green Submitted			2022-12-26	WOS:000429206800012
J	Howell, DA; Hart, RI; Smith, AG; Macleod, U; Patmore, R; Cook, G; Roman, E				Howell, Debra A.; Hart, Ruth I.; Smith, Alexandra G.; Macleod, Una; Patmore, Russell; Cook, Gordon; Roman, Eve			Myeloma: Patient accounts of their pathways to diagnosis	PLOS ONE			English	Article							HEMATOLOGICAL MALIGNANCY RESEARCH; MULTIPLE-MYELOMA; CANCER-DIAGNOSIS; RESEARCH NETWORK; PRIMARY-CARE; QUALITATIVE DESCRIPTION; SUB-TYPE; SURVIVAL; DELAY; ROUTES	Background Pathways to myeloma diagnosis can be prolonged, and are often preceded by multiple GP consultations and emergency presentation. This is the first qualitative study to examine events leading to diagnosis by asking patients about their experiences during this time. Methods Set within a UK population-based cohort, semi-structured interviews were conducted with 20 myeloma patients with varying characteristics and pathways, 12 of whom invited their relatives to take part. Interviews were audio-recorded and qualitative analysis undertaken. Results Pre-diagnostic awareness of myeloma was minimal. Disease onset was typically described as gradual, and health changes vague but progressive, with increasing loss of function. A wide range of symptoms was reported, with the similarity of these to self-limiting conditions failing to raise suspicion of myeloma among patients and GPs. Patients tended to normalise symptoms at first, although all eventually sought GP advice. GPs often initially suggested benign diagnoses, which were sometimes only revised after multiple consultations with persistent/worsening symptoms. Referrals were made to various hospital specialities, and haematology if associated with abnormal blood tests suggestive of myeloma. Once in secondary care, progress towards diagnosis was generally rapid. Conclusions Accounts confirmed that pathways to diagnosis could be difficult, largely due to the way myeloma presents, and how symptoms are interpreted and managed by patients and GPs. Recognition of 'normal' health and consultation patterns for the individual could promote appropriate help-seeking and timely referral when changes occur, and may be more effective than raising awareness about the myriad of potential symptoms associated with this disease.	[Howell, Debra A.; Hart, Ruth I.; Smith, Alexandra G.; Roman, Eve] Univ York, Dept Hlth Sci, Epidemiol & Canc Stat Grp, York, N Yorkshire, England; [Macleod, Una] Univ Hull, Hull York Med Sch, Kingston Upon Hull, N Humberside, England; [Patmore, Russell] Castle Hill Hosp, Queens Ctr Oncol & Haematol, Dept Haematol, Kingston Upon Hull, N Humberside, England; [Cook, Gordon] St James Univ Hosp, St Jamess Inst Oncol, Dept Haematol, Leeds, W Yorkshire, England; [Hart, Ruth I.] Univ Edinburgh, Old Med Sch, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland	University of York - UK; University of Hull; University of York - UK; University of Hull; Saint James's University Hospital; University of Edinburgh	Howell, DA (corresponding author), Univ York, Dept Hlth Sci, Epidemiol & Canc Stat Grp, York, N Yorkshire, England.	debra.howell@york.ac.uk	Howell, Debra/P-3742-2018	Howell, Debra/0000-0002-7521-7402; Roman, Eve/0000-0001-7603-3704	Cancer Research UK (CRUK) [C38860/A13509]; Bloodwise [15037]	Cancer Research UK (CRUK)(Cancer Research UK); Bloodwise	This study was funded by Cancer Research UK (CRUK): Grant reference C38860/A13509. The Haematological Malignancy Research Network (HMRN) is funded by Bloodwise: Grant reference 15037. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; We are grateful to the patients and relatives who took part in this study and shared their experiences with us. This study was funded by Cancer Research UK (National Awareness and Early Diagnosis Initiative): grant reference C38860/A13509; HMRN is funded by Bloodwise: grant reference 15037.	ANDERSEN BL, 1995, BRIT J SOC PSYCHOL, V34, P33, DOI 10.1111/j.2044-8309.1995.tb01047.x; Black G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135027; Burt RS, 2005, BROKERAGE CLOSURE IN; Department of Health, 2000, NHS CANC PLAN PLAN I; Elliss-Brookes L, 2012, BRIT J CANCER, V107, P1220, DOI 10.1038/bjc.2012.408; Glaser B.G., 1968, DISCOV GROUNDED THEO; Howell D, 2017, BRIT J HAEMATOL, V177, P67, DOI 10.1111/bjh.14513; Howell Debra A, 2013, BMC Hematol, V13, P9, DOI 10.1186/2052-1839-13-9; Kariyawasan CC, 2007, QJM-INT J MED, V100, P635, DOI 10.1093/qjmed/hcm077; Keeble S, 2014, INT J CANCER, V135, P1220, DOI 10.1002/ijc.28763; Lyratzopoulos G, 2012, LANCET ONCOL, V13, P353, DOI 10.1016/S1470-2045(12)70041-4; Macleod U, 2009, BRIT J CANCER, V101, pS92, DOI 10.1038/sj.bjc.6605398; Mitchell ED, 2015, BRIT J CANCER, V112, pS50, DOI 10.1038/bjc.2015.42; Molassiotis A, 2010, EUR J CANCER CARE, V19, P98, DOI 10.1111/j.1365-2354.2008.01020.x; Neal RD, 2015, BRIT J CANCER, V112, pS92, DOI 10.1038/bjc.2015.48; Neal RD, 2013, BRIT J CANCER, V110, P584; NICE, 2015, SUSP CANC REC REF; *NICE, 2005, REF GUID SUSP CANC; Pope C, 2006, QUALITATIVE RES HLTH; Roman E, 2016, CANCER EPIDEMIOL, V42, P186, DOI 10.1016/j.canep.2016.03.011; Rubin GP, 2015, BRIT J CANCER, V112, P676, DOI 10.1038/bjc.2014.634; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Scott SE, 2013, BRIT J HEALTH PSYCH, V18, P45, DOI 10.1111/j.2044-8287.2012.02077.x; Shephard EA, 2015, BRIT J GEN PRACT, V65, pE106, DOI 10.3399/bjgp15X683545; Smith A, 2015, BRIT J CANCER, V112, P1575, DOI 10.1038/bjc.2015.94; Smith A, 2011, BRIT J CANCER, V105, P1684, DOI 10.1038/bjc.2011.450; Smith A, 2010, BRIT J HAEMATOL, V148, P739, DOI 10.1111/j.1365-2141.2009.08010.x; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Walter F, 2012, J HEALTH SERV RES PO, V17, P110, DOI 10.1258/jhsrp.2011.010113	30	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194788	10.1371/journal.pone.0194788	http://dx.doi.org/10.1371/journal.pone.0194788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617390	Green Published, gold, Green Accepted			2022-12-26	WOS:000429203800049
J	Kenyon, CR				Kenyon, Chris R.			HIV prevalence by ethnic group covaries with prevalence of herpes simplex virus-2 and high-risk sex in Uganda: An ecological study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; UNITED-STATES; PARTNER-CONCURRENCY; AIDS MORTALITY; SOUTH-AFRICA; INFECTION; BEHAVIOR; TYPE-2; ASSOCIATION; SEROPREVALENCE	Background HIV prevalence varies from 1.7% to 14.8% between ethnic groups in Uganda. Understanding the factors responsible for this heterogeneity in HIV spread may guide prevention efforts. Methods We evaluated the relationship between HIV prevalence by ethnic group and a range of risk factors as well as the prevalence of herpes simplex virus-2 (HSV-2), syphilis and symptomatic STIs in the 2004/2005 Uganda HIV/AIDS Sero-Behavioural Survey a two stage, nationally representative, population based survey of 15-59-year-olds. Spearman's correlation was used to assess the relationship between HIV prevalence and each variable. Results There was a positive association between HIV prevalence and HSV-2, symptomatic STIs and high-risk sex (sex with a non-cohabiting, non-marital partner) for women. Non-significant positive associations were present between HIV and high-risk sex for men and lifetime number of partners for men and women. Conclusion Variation in sexual behavior may contribute to the variations in HIV, HSV-2 and other STI prevalence by ethnic group in Uganda. Further work is necessary to delineate which combinations of risk factors determine differential STI spread in Uganda.	[Kenyon, Chris R.] Inst Trop Med, HIV STI Unit, Antwerp, Belgium; [Kenyon, Chris R.] Univ Cape Town, Div Infect Dis & HIV Med, Cape Town, South Africa	Institute of Tropical Medicine (ITM); University of Cape Town	Kenyon, CR (corresponding author), Inst Trop Med, HIV STI Unit, Antwerp, Belgium.; Kenyon, CR (corresponding author), Univ Cape Town, Div Infect Dis & HIV Med, Cape Town, South Africa.	ckenyon@itg.be		Kenyon, Chris/0000-0002-2557-8998				Aral SO, 2005, J INFECT DIS, V191, pS1, DOI 10.1086/425290; Aral SO, 1996, J INFECT DIS, V174, pS127, DOI 10.1093/infdis/174.Supplement_2.S127; Auvert B, 2001, AIDS, V15, pS15, DOI 10.1097/00002030-200108004-00003; Auvert B, 2001, AIDS, V15, P885, DOI 10.1097/00002030-200105040-00009; Biraro S, 2011, SEX TRANSM DIS, V38, P140, DOI 10.1097/OLQ.0b013e3181f0bafb; Bunnell R, 2008, AIDS, V22, P617, DOI 10.1097/QAD.0b013e3282f56b53; Chesson HW, 2003, SEX TRANSM DIS, V30, P419, DOI 10.1097/00007435-200305000-00008; Chimoyi LA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-555; Dingemanse M., ETHNOLINGUISTIC MAP; Fabiani Massimo, 2007, Confl Health, V1, P3, DOI 10.1186/1752-1505-1-3; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; Glynn JR, 2008, SEX TRANSM INFECT, V84, P356, DOI 10.1136/sti.2008.030056; Glynn JR, 2009, AIDS, V23, P1595, DOI 10.1097/QAD.0b013e32832e15e8; HACKETT C J, 1953, Bull World Health Organ, V8, P129; HACKETT CJ, 1947, BRIT MED J, V1, P88, DOI 10.1136/bmj.1.4489.88; HOGLE JA, 2002, WHAT HAPPENED UGANDA; Johnson LF, 2009, DEMOGR RES, V21, P289, DOI 10.4054/DemRes.2009.21.11; Kamali A, 1999, SEX TRANSM INFECT, V75, P98, DOI 10.1136/sti.75.2.98; Kenyon C, 2013, INT J STD AIDS, V24, P375, DOI 10.1177/0956462412472816; Kenyon C, 2013, INT J STD AIDS, V24, P211, DOI 10.1177/0956462412472455; Kenyon C, 2014, INTERDISCIPLINARY PE; Kenyon C, 2016, JOURNAL OF SEXUALLY; Kenyon CR, 2016, EPIDEMIOL INFECT, V144, P556, DOI 10.1017/S095026881500165X; Kenyon C, 2013, INT J STD AIDS, V24, P804, DOI 10.1177/0956462413482810; Kenyon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064080; Kenyon C, 2012, INT J INFECT DIS, V16, pE826, DOI 10.1016/j.ijid.2012.05.008; Kenyon CR, 2016, EPIDEMICS-NETH, V15, P56, DOI 10.1016/j.epidem.2016.02.002; Kenyon CR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140835; Kenyon CR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004711; Kenyon CR, 2014, INT J INFECT DIS, V29, P54, DOI 10.1016/j.ijid.2014.05.014; Kenyon CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106230; Knopf A, 2014, SOC SCI MED, V108, P175, DOI 10.1016/j.socscimed.2014.01.039; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; Ministry of Health (MOH) [Uganda] and ORC Macro, 2006, UG HIV AIDS SER BEH; Mishra V., 2009, LEVELS SPREAD HIV SE; Morris M, 2008, SEXUALLY TRANSMITTED, pxxv; Morris M, 2009, AM J PUBLIC HEALTH, V99, P1023, DOI 10.2105/AJPH.2008.147835; Oluoch T, 2011, OPEN AIDJ, V5; Osbak K, SEX TRANSM IN PRESS; Rubaihayo J, 2010, INFECT DIS REP, V2, P40, DOI [10.4081/idr.2010.e13, 10.4081/idr.2010.1585]; SERWADDA D, 1985, LANCET, V2, P849, DOI 10.1016/S0140-6736(85)90122-9; South African Department of Health, 2013, 2012 NAT ANT SENT HI; Uganda Ministry of Health, 2012, UG AIDS IND SURV 201; van Rooijen MS, 2016, SEX TRANSM INFECT, V92, P257, DOI 10.1136/sextrans-2015-052213; WAWER MJ, 1994, BRIT MED J, V308, P171, DOI 10.1136/bmj.308.6922.171; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	46	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195431	10.1371/journal.pone.0195431	http://dx.doi.org/10.1371/journal.pone.0195431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617423	Green Published, gold, Green Submitted			2022-12-26	WOS:000429203800085
J	Lee, EH; Park, CH; Choi, HJ; Kawala, RA; Bai, HW; Chung, BY				Lee, Eun-Hee; Park, Chul Hong; Choi, Hyo Jin; Kawala, Remigius Ambrose; Bai, Hyoung-Woo; Chung, Byung Yeoup			Dexamethasone modified by gamma irradiation as a novel anticancer drug in human non-small cell lung cancer	PLOS ONE			English	Article							PROSTATE-CANCER; GLUCOCORTICOIDS; CYTOTOXICITY; DOXORUBICIN; ROTENONE; CYCLE	Dexamethasone (Dex) is widely used in the management of leukemia and lymphoma. While Dex is commonly used for hematological malignancies, the effects of Dex in solid cancer cells remain controversial. To develop a more effective anticancer drug for solid cancers, Dex was modified by ionizing radiation and the anticancer activity of ionizing-radiation-irradiated Dex (Dex-IR) was investigated in human lung cancer cells. Using the MTT assay, the proliferation of non-small cell lung cancer cells was significantly inhibited after treatment with Dex-IR compared with Dex. Furthermore, Dex-IR induced apoptotic cell death and cell cycle arrest of H1650 human lung cancer cells. The invasiveness of H1650 cells was significantly reduced and the matrix metalloproteinase activity was strongly suppressed. These results indicate that Dex-IR acts as a tumor suppressor by both inducing apoptosis and arresting the cell cycle. Although the structure of Dex-IR remains to be determined, our results suggest it may be useful as a novel anticancer agent for the treatment of solid cancers.	[Lee, Eun-Hee; Park, Chul Hong; Choi, Hyo Jin; Kawala, Remigius Ambrose; Bai, Hyoung-Woo; Chung, Byung Yeoup] Korea Atom Energy Inst KAERI, Res Div Biotechnol, Adv Radiat Technol Inst ARTI, 29 Geumgu Gil, Jeongeup Si, Jeollabuk Do, South Korea; [Lee, Eun-Hee] Daegu Gyeongbuk Med Innovat Fdn, Med Device Dev Ctr, Daegu, South Korea; [Kawala, Remigius Ambrose; Bai, Hyoung-Woo] Univ Sci & Technol UST, Radiat Biotechnol & Appl Radioisotope Sci, Daejeon, South Korea	University of Science & Technology (UST)	Bai, HW; Chung, BY (corresponding author), Korea Atom Energy Inst KAERI, Res Div Biotechnol, Adv Radiat Technol Inst ARTI, 29 Geumgu Gil, Jeongeup Si, Jeollabuk Do, South Korea.; Bai, HW (corresponding author), Univ Sci & Technol UST, Radiat Biotechnol & Appl Radioisotope Sci, Daejeon, South Korea.	hbai@kaeri.re.kr; bychung@kaeri.re.kr		Kawala, Remigius Ambrose/0000-0001-9566-2151	Ministry of Science, ICT & Future Planning; Basic Science Research Program; Original Technology Research Program for Brain Science through the National Research Foundation - Korean government, MSIT [NRF-2016M3C7A1913933]	Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Basic Science Research Program; Original Technology Research Program for Brain Science through the National Research Foundation - Korean government, MSIT(Ministry of Science & ICT (MSIT), Republic of Korea)	This research was funded by the Ministry of Science, ICT & Future Planning and by the Basic Science Research Program and also the Original Technology Research Program for Brain Science through the National Research Foundation funded by the Korean government, MSIT(NRF-2016M3C7A1913933).The funders had a role in study design, data collection and analysis, and preparation of the manuscript.	Badaboina S, 2015, INT J MOL SCI, V16, P16806, DOI 10.3390/ijms160816806; Di Carlo A, 2006, ONCOL REP, V15, P1321; Fakih M, 2002, UROLOGY, V60, P553, DOI 10.1016/S0090-4295(02)01741-7; Frankfurt O, 2004, CURR OPIN ONCOL, V16, P553, DOI 10.1097/01.cco.0000142072.22226.09; Geng Y, 2014, GENET MOL RES, V13, P6827, DOI 10.4238/2014.August.29.4; Gennari A, 1996, ANN ONCOL, V7, P978, DOI 10.1093/oxfordjournals.annonc.a010806; Gundisch S, 2012, ANTICANCER RES, V32, P4251; Herr I, 2006, LANCET ONCOL, V7, P425, DOI 10.1016/S1470-2045(06)70694-5; Herr I, 2009, RESULTS PROBL CELL D, V49, P191, DOI 10.1007/400_2008_20; Jung HJ, 2009, RADIAT PHYS CHEM, V78, P386, DOI 10.1016/j.radphyschem.2009.03.004; Kim TH, 2011, BIOORG MED CHEM LETT, V21, P1512, DOI 10.1016/j.bmcl.2010.12.122; Komiya A, 2010, ONCOL LETT, V1, P73, DOI 10.3892/ol_00000013; Lee EH, 2017, ONCOTARGET, V8, P20645, DOI 10.18632/oncotarget.15830; Ling YH, 1996, MOL PHARMACOL, V49, P832; Lupertz R, 2010, TOXICOLOGY, V271, P115, DOI 10.1016/j.tox.2010.03.012; Park CH, 2013, BIOORG MED CHEM LETT, V23, P1099, DOI 10.1016/j.bmcl.2012.12.003; Paul-Clark MJ, 2002, P NATL ACAD SCI USA, V99, P1677, DOI 10.1073/pnas.022641099; Strehl C, 2011, CLIN EXP RHEUMATOL, V29, pS13; Wang H, 2007, INT J ONCOL, V30, P947; Wang LJ, 2016, ACTA PHARMACOL SIN, V37, P845, DOI 10.1038/aps.2016.39; Yuan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107447	21	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194341	10.1371/journal.pone.0194341	http://dx.doi.org/10.1371/journal.pone.0194341			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617386	Green Submitted, gold, Green Published			2022-12-26	WOS:000429203800027
J	Tramuto, F; Maida, CM; Pojero, F; Colomba, GME; Casucciol, A; Restivo, V; Vitale, F				Tramuto, Fabio; Maida, Carmelo Massimo; Pojero, Fanny; Colomba, Giuseppina Maria Elena; Casucciol, Alessandra; Restivo, Vincenzo; Vitale, Francesco			Case-based surveillance of measles in Sicily during 2012-2017: The changing molecular epidemiology and implications for vaccine strategies	PLOS ONE			English	Article							WILD-TYPE; VIRUS; ELIMINATION; INFECTION; EPITOPES; PROGRESS	Following the indication of the World Health Organization, a national plan for the elimination of measles was approved in Italy and this included the improvement of the molecular surveillance of measles viruses and the interruption of indigenous transmission of the disease. Nevertheless, large outbreaks continue to occur in almost all regions of the country, including Sicily. Here we describe the epidemiology and molecular dynamics of measles viruses as a result of the measles surveillance activity carried out by the "Reference Laboratory for Measles and Rubella" in Sicily over a 5-year period. Biological samples of 259 suspected measles cases were tested for viral RNA detection and a total of 223 (86.1%) were classified as laboratory confirmed. The median age of confirmed measles cases was 21.0 years and about half of them were adults aged 19 years and older. Overall, one-third of the patients showed clinical complications and these latter were more common among adults than children (44.9% vs. 25.7%). The vast majority of measles cases were unvaccinated (94.2%, n = 210). The phylogenetic analysis of 221 measles virus nucleotide sequences revealed sporadic detections of genotypes D4 and H1, while endemic circulation of genotypes D8 and B3 was documented. Genotype D8 was associated with epidemics occurred between 2013 and 2016, whereas genotype B3 was more recently introduced into Sicily characterizing the current measles outbreak. The results of this study confirm the autochthonous co-circulation of viral variants belonging to different genotypes during the study period, and emphasizes the need of measles surveillance programmes in order to investigate the viral dynamics, the pathways of disease transmission, and to eventually adapt the development of successfull vaccine formulations.	[Tramuto, Fabio; Maida, Carmelo Massimo; Pojero, Fanny; Colomba, Giuseppina Maria Elena; Casucciol, Alessandra; Restivo, Vincenzo; Vitale, Francesco] Univ Palermo, Dept Hlth Promot Sci & Mother Child Care G DAless, Hyg Sect, Palermo, Italy; [Tramuto, Fabio; Maida, Carmelo Massimo; Vitale, Francesco] Univ Hosp Paolo Giaccone, Clin Epidemiol Unit, Palermo, Italy	University of Palermo; University of Palermo; Policlinico Paolo Giaccone	Tramuto, F (corresponding author), Univ Palermo, Dept Hlth Promot Sci & Mother Child Care G DAless, Hyg Sect, Palermo, Italy.; Tramuto, F (corresponding author), Univ Hosp Paolo Giaccone, Clin Epidemiol Unit, Palermo, Italy.	fabio.tramuto@unipa.it	maida, carmelo massimo/AAH-1838-2021; Vitale, Francesco/AAC-6013-2022; Colomba, Giuseppina Maria Elena/AAI-6138-2021; Tramuto, Fabio/AAM-3478-2021	maida, carmelo massimo/0000-0002-6989-9259; Vitale, Francesco/0000-0002-6354-8060; Tramuto, Fabio/0000-0003-0108-4608; casuccio, alessandra/0000-0002-5676-9535	Regional Plan for Prevention Assessorato Regionale della Salute; Regione Siciliana	Regional Plan for Prevention Assessorato Regionale della Salute; Regione Siciliana(Regione Sicilia)	This research was funded by the Regional Plan for Prevention Assessorato Regionale della Salute, Regione Siciliana approved through the resolution no. 351 of 8 March 2016, to implement the understanding between State and Regions of 30 July 2015, Progetti Obiettivo di Piano Sanitario Nazionale 2015. Linea progettuale 2.9.15.3 Implementazione della rete di sorveglianza epidemiologico-molecolare per il morbillo e la rosolia del Piano Regionale della Prevenzione 2016-2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackley SF, 2017, GENOTYPE SPECIFIC ME; Amendola A, 2017, EUROSURVEILLANCE, V22, P8, DOI 10.2807/1560-7917.ES.2017.22.33.30596; Amendola A, 2017, INFECT GENET EVOL, V48, P120, DOI 10.1016/j.meegid.2016.12.013; Munoz-Alia MA, 2017, VIRUS RES, V236, P30, DOI 10.1016/j.virusres.2017.04.018; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P73; [Anonymous], GLOB MEASL RUB STRAT; Aquino F, 2017, VACCINE, V35, P4494, DOI 10.1016/j.vaccine.2017.07.029; Bankamp B, 2013, J CLIN VIROL, V58, P176, DOI 10.1016/j.jcv.2013.05.018; Berti E, 2016, EPIDEMIOL INFECT, V144, P2605, DOI 10.1017/S0950268816001023; Chen M, 2015, EMERG INFECT DIS, V21, P477, DOI 10.3201/eid2103.140646; Chibo D, 2000, J GEN VIROL, V81, P2511, DOI 10.1099/0022-1317-81-10-2511; degli Atti MC, 2017, PEDIATR INFECT DIS J, V36, P844, DOI 10.1097/INF.0000000000001609; El Mubarak HS, 2007, J GEN VIROL, V88, P2028, DOI 10.1099/vir.0.82804-0; European Centre for Disease Prevention and Control (ECDC), MEASL CAS DEF; European Centre for Disease Prevention and Control (ECDC), MONTHL MEASL EP UPD; Filia A, 2016, EUROSURVEILLANCE, V21; Finsterbusch T, 2009, J GEN VIROL, V90, P2739, DOI 10.1099/vir.0.013524-0; Grammens T, 2016, EUROSURVEILLANCE, V21, P17, DOI 10.2807/1560-7917.ES.2016.21.32.30313; Hubschen JM, 2008, J VIROL METHODS, V149, P246, DOI 10.1016/j.jviromet.2008.01.032; Hukic M, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES2015.20.9.21047; Istituto Superiore di (National Institute of Health Rome), 2017, EP WEEKL B MEASL IT, V35; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Magurano F, 2015, J CLIN VIROL, V64, P34, DOI 10.1016/j.jcv.2014.12.019; Ministero della Salute, PIAN NAZ EL MORB ROS; Munoz-Alfa MA, 2017, J VIROL, V91, DOI 10.1128/JVI.00209-17; Nasab GSF, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw089; Nic Lochlainn L, 2016, EUROSURVEILLANCE, V21; O'Connor P, 2017, CLIN MICROBIOL INFEC, V23, P504, DOI 10.1016/j.cmi.2017.01.003; Pan American Health Organization and World Health Organization (PAHO/ WHO), 2016, REG AM DECL MEASL; Piccirilli G, 2016, J CLIN VIROL, V81, P34, DOI 10.1016/j.jcv.2016.05.018; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rota PA, 2011, J INFECT DIS, V204, pS514, DOI 10.1093/infdis/jir118; Tahara M, 2013, J VIROL, V87, P666, DOI 10.1128/JVI.02033-12; TAMIN A, 1994, J INFECT DIS, V170, P795, DOI 10.1093/infdis/170.4.795; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tramuto F, 2015, EUROSURVEILLANCE, V20, P11, DOI 10.2807/1560-7917.ES2015.20.20.21134; Trentini F, 2017, LANCET INFECT DIS, V17, P1089, DOI 10.1016/S1473-3099(17)30421-8; Tu B, 2016, EPIDEMIOL INFECT, V144, P2613, DOI 10.1017/S0950268816001114; van Boven M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003061; World Health Organization (WHO), 2016, INF STAT MEASL RUB E; World Health Organization (WHO) D Dept. of Immunization Vaccines and Biologicals, MAN LAB DIAGN MEASL; Woudenberg T, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.3.30443	42	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195256	10.1371/journal.pone.0195256	http://dx.doi.org/10.1371/journal.pone.0195256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617454	Green Submitted, Green Published, gold			2022-12-26	WOS:000429203800071
J	Zhang, MS; Kelso, JAS; Tognoli, E				Zhang, Mengsen; Kelso, J. A. Scott; Tognoli, Emmanuelle			Critical diversity: Divided or united states of social coordination	PLOS ONE			English	Article							PHASE-TRANSITIONS; MULTIFREQUENCY COORDINATION; DYNAMICS; SYNCHRONIZATION; COMPLEXITY; OSCILLATORS; SEGREGATION; INTEGRATION; MECHANISM; NETWORKS	Much of our knowledge of coordination comes from studies of simple, dyadic systems or systems containing large numbers of components. The huge gap 'in between' is seldom addressed, empirically or theoretically. We introduce a new paradigm to study the coordination dynamics of such intermediate-sized ensembles with the goal of identifying key mechanisms of interaction. Rhythmic coordination was studied in ensembles of eight people, with differences in movement frequency ('diversity) manipulated within the ensemble. Quantitative change in diversity led to qualitative changes in coordination, a critical value separating regimes of integration and segregation between groups. Metastable and multifrequency coordination between participants enabled communication across segregated groups within the ensemble, without destroying overall order. These novel findings reveal key factors underlying coordination in ensemble sizes previously considered too complicated or 'messy' for systematic study and supply future theoretical/computational models with new empirical checkpoints.	[Zhang, Mengsen; Kelso, J. A. Scott; Tognoli, Emmanuelle] Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA; [Kelso, J. A. Scott] Ulster Univ, Intelligent Syst Res Ctr, Derry Londonderry, North Ireland	State University System of Florida; Florida Atlantic University; Ulster University	Zhang, MS (corresponding author), Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA.	zhang@ccs.fau.edu		Zhang, Mengsen/0000-0003-3085-152X	National Institute of Mental Health [MH080838, EB025819]; Chaire d'Excellence Pierre de Fermat; Davimos Family Endowment for Excellence in Science; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB025819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080838] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Chaire d'Excellence Pierre de Fermat(Region Occitanie); Davimos Family Endowment for Excellence in Science; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health (MH080838 and EB025819), the Chaire dExcellence Pierre de Fermat, and the Davimos Family Endowment for Excellence in Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Institute of Mental Health (MH080838), the Chaire d'Excellence Pierre de Fermat, and the Davimos Family Endowment for Excellence in Science. The paper is dedicated to Dr. Thomas C. Schelling, who passed away on December 13, 2016 and is best known to complex system scientists for his seminal paper "Dynamic models of segregation" (1971, The Journal of Mathematical Sociology). We thank Dr. Roxana Stefanescu for assisting in data collection.	Alderisio F, 2016, BIOL CYBERN, V110, P151, DOI 10.1007/s00422-016-0685-7; [Anonymous], 2009, COMPLEX ADAPTIVE SYS; Arnold V. I., 2009, COLLECTED WORKS REPR, P152; Ash J, 2007, PHYSICA A, V380, P673, DOI 10.1016/j.physa.2006.12.058; Assisi CG, 2005, BIOL CYBERN, V93, P6, DOI 10.1007/s00422-005-0558-y; Bar-Yam Y, 2004, COMPLEXITY, V9, P15, DOI 10.1002/cplx.20029; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; Blau P., 1977, INEQUALITY HETEROGEN; Boiger M, 2012, EMOT REV, V4, P221, DOI 10.1177/1754073912439765; BROWN FA, 1959, SCIENCE, V130, P1535, DOI 10.1126/science.130.3388.1535; BUCK J, 1976, SCI AM, V234, P74; BUCK J, 1988, Q REV BIOL, V63, P265, DOI 10.1086/415929; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G., 2006, RHYTHMS BRAIN; Camazine S., 2003, SELF ORG BIOL SYSTEM; CARNEIRO RL, 1967, SOUTHWEST J ANTHROP, V23, P234, DOI 10.1086/soutjanth.23.3.3629251; Changizi MA, 2005, COMPLEXITY, V10, P13, DOI 10.1002/cplx.20085; DEGUZMAN GC, 1991, BIOL CYBERN, V64, P485, DOI 10.1007/BF00202613; Dumas G, 2014, P NATL ACAD SCI USA, V111, pE3726, DOI 10.1073/pnas.1407486111; Dumas G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012166; Edelman GM, 2000, NEURAL CORRELATES OF CONSCIOUSNESS, P139; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Fogel A., 1992, SOC DEV, V1, P122, DOI [10.1111/j.1467-9507.1992.tb00116.x, DOI 10.1111/J.1467-9507.1992.TB00116.X, https://doi.org/10.1111/j.1467-9507.1992.tb00116.x]; Fuchs A, 1996, BIOL CYBERN, V74, P21, DOI 10.1007/BF00199134; Fuchs A, 2013, NONLINEAR DYNAMICS C; Glass L, 2001, NATURE, V410, P277, DOI 10.1038/35065745; Golubitsky M, 1999, NATURE, V401, P693, DOI 10.1038/44416; Haken H, 1996, PHYSICA D, V90, P179, DOI 10.1016/0167-2789(95)00235-9; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; HAKEN H, 2004, SYNERGETICS INTRO AD; Hasson U, 2012, TRENDS COGN SCI, V16, P114, DOI 10.1016/j.tics.2011.12.007; Holling CS, 2001, ECOSYSTEMS, V4, P390, DOI 10.1007/s10021-001-0101-5; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; JEKA JJ, 1995, J EXP PSYCHOL HUMAN, V21, P360, DOI 10.1037/0096-1523.21.2.360; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Kelso J, 1984, AM J PHYSIOL-REG I, V15, pR1000, DOI DOI 10.1152/ajpregu.1984.246.6.R1000; Kelso J. A. S., 1988, Neural and Synergetic Computers. Proceedings of the International Symposium, P180; Kelso J. A. S., 2006, COMPLEMENTARY NATURE; Kelso JAS, 2008, ECOL PSYCHOL, V20, P180, DOI 10.1080/10407410801949297; Kelso JAS, 2014, CRITICALITY IN NEURAL SYSTEMS, P67; Kelso JAS, 2013, NEURAL NETWORKS, V37, P120, DOI 10.1016/j.neunet.2012.09.003; Kelso JAS, 2012, PHILOS T R SOC B, V367, P906, DOI 10.1098/rstb.2011.0351; Kelso JAS, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00023; Kelso JAS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005749; KELSO JAS, 1990, ATTENTION PERFORM, V8, P139; KELSO JAS, 1992, J EXP PSYCHOL HUMAN, V18, P645, DOI 10.1037/0096-1523.18.3.645; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Kostrubiec V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142029; Kuramoto Y., 2002, Nonlinear Phenomena in Complex Systems, V5, P380; Kuramoto Y., 1983, CHEM OSCILLATIONS WA; Lagarde J, 2005, J MOTOR BEHAV, V37, P418, DOI 10.3200/JMBR.37.6.418-424; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lemke J.L., 2000, MIND CULTURE ACTIVIT, V7, P273, DOI [10.1207/S15327884MCA0704_03, DOI 10.1207/S15327884MCA0704_03]; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; Moody J, 2001, AM J SOCIOL, V107, P679, DOI 10.1086/338954; Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; Neda Z, 2000, PHYS REV E, V61, P6987, DOI 10.1103/PhysRevE.61.6987; Nishikawa T, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.114101; Noy L, 2011, P NATL ACAD SCI USA, V108, P20947, DOI 10.1073/pnas.1108155108; Oullier O., 2009, ENCY COMPLEXITY SYST, V19, P8198, DOI DOI 10.1007/978-0-387-30440-3_486; Oullier O, 2008, SOC NEUROSCI, V3, P178, DOI 10.1080/17470910701563392; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Parra J, 2003, BRAIN, V126, P1164, DOI 10.1093/brain/awg109; PEPER CE, 1995, J EXP PSYCHOL HUMAN, V21, P1117, DOI 10.1037/0096-1523.21.5.1117; Pfau T, 2009, SCIENCE, V325, P289, DOI 10.1126/science.1174605; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Richardson MJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00405; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schelling T., 1978, MICROMOTIVES MACROBE; SCHELLING TC, 1971, J MATH SOCIOL, V1, P143, DOI 10.1080/0022250X.1971.9989794; Schmidt RC, 2011, HUM MOVEMENT SCI, V30, P834, DOI 10.1016/j.humov.2010.05.014; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; SCHONER G, 1988, J THEOR BIOL, V135, P501, DOI 10.1016/S0022-5193(88)80273-X; SCHONER G, 1990, J THEOR BIOL, V142, P359, DOI 10.1016/S0022-5193(05)80558-2; SCHONER G, 1986, BIOL CYBERN, V53, P247, DOI 10.1007/BF00336995; SCHONER G, 1988, SCIENCE, V239, P1513, DOI 10.1126/science.3281253; Sekara V, 2016, P NATL ACAD SCI USA, V113, P9977, DOI 10.1073/pnas.1602803113; Simon HA., 1977, MODELS OF DISCOVERY, P245, DOI [10.1007/978-94-010-9521-1_14, DOI 10.1007/978-94-010-9521-1_14]; Sporns O, 2013, CURR OPIN NEUROBIOL, V23, P162, DOI 10.1016/j.conb.2012.11.015; Stark TH, 2012, SOCIOL EDUC, V85, P179, DOI 10.1177/0038040711427314; Stouffer DB, 2011, P NATL ACAD SCI USA, V108, P3648, DOI 10.1073/pnas.1014353108; Strogatz S., 2003, HYPERION, DOI [DOI 10.1063/1.1784276, 10.1063/1.1784276]; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; STROGATZ SH, 1993, SCI AM, V269, P102, DOI 10.1038/scientificamerican1293-102; Takamatsu A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.228102; Tognoli E, 2007, P NATL ACAD SCI USA, V104, P8190, DOI 10.1073/pnas.0611453104; Tognoli E, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00122; Tognoli E, 2014, NEURON, V81, P35, DOI 10.1016/j.neuron.2013.12.022; Tognoli E, 2009, PROG NEUROBIOL, V87, P31, DOI 10.1016/j.pneurobio.2008.09.014; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Valdesolo P, 2011, EMOTION, V11, P262, DOI 10.1037/a0021302; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Von Holst E., 1973, COLLECTED PAPERS E V, V1, P3; Wang J, 2012, P NATL ACAD SCI USA, V109, P14363, DOI 10.1073/pnas.1120867109; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; Wheatley T, 2012, SOC PERSONAL PSYCHOL, V6, P589, DOI 10.1111/j.1751-9004.2012.00450.x; Winfree AT., 1980, GEOMETRY BIOL TIME; Wunderlich F., 2008, STUDIES ENV AESTHETI, V6, P91; Yokoyama K, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002181; Zhang MA, 2016, ENERGY STORAGE MATER, V4, P1, DOI 10.1016/j.ensm.2016.02.001	105	19	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0193843	10.1371/journal.pone.0193843	http://dx.doi.org/10.1371/journal.pone.0193843			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6SR	29617371	Green Published, Green Submitted, gold			2022-12-26	WOS:000429203800014
J	Sarkar-Banerjee, S; Goyal, S; Gao, N; Mack, J; Thompson, B; Dunlap, D; Chattopadhyay, K; Finzi, L				Sarkar-Banerjee, Suparna; Goyal, Sachin; Gao, Ning; Mack, John; Thompson, Benito; Dunlap, David; Chattopadhyay, Krishnananda; Finzi, Laura			Specifically bound lambda repressor dimers promote adjacent non-specific binding	PLOS ONE			English	Article							PROTEIN-DNA INTERACTIONS; MOBILITY-SHIFT ASSAY; C-TERMINAL DOMAIN; OPERATOR BINDING; PHAGE REPRESSOR; MUTATIONS; MODEL	Genetic switches frequently include DNA loops secured by proteins. Recent studies of the lambda bacteriophage repressor (CI), showed that this arrangement in which the protein links two sets of three operators separated by approximately 2.3 kbp, optimizes both the stability and dynamics of DNA loops, compared to an arrangement with just two sets of two operators. Because adjacent dimers interact pairwise, we hypothesized that the odd number of operators in each set of the lambda regulatory system might have evolved to allow for semi-specific, pair-wise interactions that add stability to the loop while maintaining it dynamic. More generally, additional CI dimers may bind non-specifically to flanking DNA sequences making the genetic switch more sensitive to CI concentration. Here, we tested this hypothesis using spectroscopic and imaging approaches to study the binding of the lambda repressor (CI) dimer protein to DNA fragments. For fragments with only one operator and a short flanking sequence, fluorescence correlation spectroscopy measurements clearly indicated the presence of two distinct DNA-CI complexes; one is thought to have a non-specifically bound CI dimer on the flanking sequence. Scanning force micrographs of CI bound to DNA with all six operators revealed wild-type or mutant proteins bound at operator positions. The number of bound, wild-type proteins increased with CI concentration and was larger than expected for strictly specific binding to operators. In contrast, a mutant that fails to oligomerize beyond a dimer, D197G, only bound to operators. These data are evidence that CI cooperativity promotes oligomerization that extends from operator sites to influence the thermodynamics and kinetics of Cl-mediated looping.	[Sarkar-Banerjee, Suparna; Chattopadhyay, Krishnananda] CSIR Indian Inst Chem Biol, Struct Biol & Bioinformat Div, Prot Folding & Dynam Lab, Kolkata, India; [Goyal, Sachin] Univ Calif Merced, Dept Mech Engn, Merced, CA USA; [Gao, Ning; Mack, John; Thompson, Benito; Dunlap, David; Finzi, Laura] Emory Univ, Dept Phys, Atlanta, GA 30322 USA; [Sarkar-Banerjee, Suparna] UTHealth, Dept Integrat Biol & Pharmacol, McGovern Med Sch, Houston, TX USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); University of California System; University of California Merced; Emory University; University of Texas System; University of Texas Health Science Center Houston	Chattopadhyay, K (corresponding author), CSIR Indian Inst Chem Biol, Struct Biol & Bioinformat Div, Prot Folding & Dynam Lab, Kolkata, India.; Finzi, L (corresponding author), Emory Univ, Dept Phys, Atlanta, GA 30322 USA.	krishnanandac@yahoo.com; lfinzi@emory.edu	Sarkar-Banerjee, Suparna/L-6802-2013	Sarkar-Banerjee, Suparna/0000-0001-8496-199X	National Institutes of Health [RGM084070A]; CSIR network project grant (UNSEEN); UC Merced startup funds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSIR network project grant (UNSEEN); UC Merced startup funds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health (RGM084070A to L.F and D.D.D) and the CSIR network project grant (UNSEEN to KC) supported research covering materials and salary costs. UC Merced startup funds to SG will cover publication costs.	ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Babic AC, 2007, P NATL ACAD SCI USA, V104, P17741, DOI 10.1073/pnas.0602223104; BRENOWITZ M, 1986, METHOD ENZYMOL, V130, P132; BURZ DS, 1994, BIOCHEMISTRY-US, V33, P8406, DOI 10.1021/bi00194a004; Ding Y, 2014, P NATL ACAD SCI USA, V111, P15402, DOI 10.1073/pnas.1320644111; Galkin VE, 2009, J MOL BIOL, V385, P779, DOI 10.1016/j.jmb.2008.10.081; Gao N, 2013, PROTEIN EXPRES PURIF, V91, P30, DOI 10.1016/j.pep.2013.06.013; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; JOHNSON AD, 1979, P NATL ACAD SCI USA, V76, P5061, DOI 10.1073/pnas.76.10.5061; KOBLAN KS, 1991, BIOCHEMISTRY-US, V30, P7822, DOI 10.1021/bi00245a023; Lewis D, 2011, P NATL ACAD SCI USA, V108, P14807, DOI 10.1073/pnas.1111221108; Manzo C, 2012, BIOPHYS J, V103, P1753, DOI 10.1016/j.bpj.2012.09.006; NELSON HCM, 1985, CELL, V42, P549, DOI 10.1016/0092-8674(85)90112-6; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Ptashne M, 2004, GENETIC SWITCH PHAGE; Saiz L, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100061; Schubert F, 2003, BIOCHEMISTRY-US, V42, P10288, DOI 10.1021/bi034033d; SENEAR DF, 1991, BIOCHEMISTRY-US, V30, P6677, DOI 10.1021/bi00241a007; SENEAR DF, 1993, BIOCHEMISTRY-US, V32, P6179, DOI 10.1021/bi00075a010; SENEAR DF, 1991, J BIOL CHEM, V266, P13661; Stayrook S, 2008, NATURE, V452, P1022, DOI 10.1038/nature06831; TIRADO MM, 1979, J CHEM PHYS, V71, P2581, DOI 10.1063/1.438613; Vilar JMG, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238103; Wang HW, 2009, CURR PHARM BIOTECHNO, V10, P494, DOI 10.2174/138920109788922155; WHIPPLE FW, 1994, GENE DEV, V8, P1212, DOI 10.1101/gad.8.10.1212; Zurla C, 2009, NUCLEIC ACIDS RES, V37, P2789, DOI 10.1093/nar/gkp134	26	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0194930	10.1371/journal.pone.0194930	http://dx.doi.org/10.1371/journal.pone.0194930			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608611	Green Submitted, Green Published, gold			2022-12-26	WOS:000428988800019
J	Tang, QL; Lu, JC; Zou, CY; Shao, Y; Chen, Y; Narala, S; Fang, H; Xu, HY; Wang, J; Shen, JN; Khokha, R				Tang, Qinglian; Lu, Jinchang; Zou, Changye; Shao, Yang; Chen, Yan; Narala, Swami; Fang, Hui; Xu, Huaiyuan; Wang, Jin; Shen, Jingnan; Khokha, Rama			CDH4 is a novel determinant of osteosarcoma tumorigenesis and metastasis	ONCOGENE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; TYPHIMURIUM A1-R REGRESSES; CADHERIN EXPRESSION; PEDIATRIC OSTEOSARCOMA; OSTEOBLAST LINEAGE; LUNG METASTASIS; TUMOR-GROWTH; C-JUN; CELLS; CANCER	The era of cancer genomics now provides an opportunity to discover novel determinants of osteosarcoma (OS), the most common primary bone cancer in children and adolescents known for its poor prognosis due to lung metastasis. Here, we identify CDH4 amplification in 43.6% of human osteosarcoma using array CGH and demonstrate its critical role in osteosarcoma development and progression. Gain or loss-of-function of CDH4, which encodes R-cadherin, causally impacts multiple features of human OS cells including cell migration and invasion, osteogenic differentiation, and stemness. CDH4 overexpression activates c-Jun via the JNK pathway, while CDH4 knockdown suppresses both tumor xenograft growth and lung colonization. In OS patient specimens, high CDH4 expression associates with lung metastases and poor prognosis. Collectively, our bioinformatics, functional, molecular, and clinical analyses uncover an oncogenic function of CDH4 in osteosarcoma and its relationship with patient outcome.	[Tang, Qinglian; Lu, Jinchang; Shao, Yang; Chen, Yan; Narala, Swami; Fang, Hui; Khokha, Rama] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 0A3, Canada; [Tang, Qinglian; Lu, Jinchang; Zou, Changye; Xu, Huaiyuan; Wang, Jin; Shen, Jingnan] Sun Yat Sen Univ, Dept Orthoped Oncol, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Sun Yat Sen University	Khokha, R (corresponding author), Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 0A3, Canada.; Shen, JN (corresponding author), Sun Yat Sen Univ, Dept Orthoped Oncol, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China.	shenjingnan@126.com; rama.khokha@utoronto.ca			Canadian Institutes of Health Research (CIHR); Canadian Cancer Society Research Institute (CCSRI); International Science & Technology Cooperation Program of Guangzhou [201704030008]; Graduate Student Overseas Study Program of China Scholarship Council; National Natural Science Foundation of China [81502324]; National Postdoctoral Program for Innovative Talents [BX201600196]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute (CCSRI)(Canadian Cancer Society (CCS)); International Science & Technology Cooperation Program of Guangzhou; Graduate Student Overseas Study Program of China Scholarship Council; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Postdoctoral Program for Innovative Talents	This study is supported by funding from the Canadian Institutes of Health Research (CIHR) and the Canadian Cancer Society Research Institute (CCSRI) to RK, and International Science & Technology Cooperation Program of Guangzhou to JS (201704030008). Q.T. and J.L. are supported by Graduate Student Overseas Study Program of China Scholarship Council. Q.T. is also supported by National Natural Science Foundation of China (81502324), and J.L. is supported by National Postdoctoral Program for Innovative Talents (BX201600196).	Agiostratidou G, 2009, CANCER RES, V69, P5030, DOI 10.1158/0008-5472.CAN-08-4007; Aubin JE, 1998, BIOCHEM CELL BIOL, V76, P899, DOI 10.1139/bcb-76-6-899; Biermann J Sybil, 2007, J Natl Compr Canc Netw, V5, P420; Bjornland K, 2005, J SURG RES, V127, P151, DOI 10.1016/j.jss.2004.12.016; Both J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030907; Briccoli A, 2010, SURG ONCOL, V19, P193, DOI 10.1016/j.suronc.2009.05.002; Bubici C, 2014, BRIT J PHARMACOL, V171, P24, DOI 10.1111/bph.12432; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Fromigue O, 2008, J BIOL CHEM, V283, P30549, DOI 10.1074/jbc.M801436200; Gustems M, 2014, NUCLEIC ACIDS RES, V42, P3059, DOI 10.1093/nar/gkt1323; Gvozdenovic A, 2013, J BONE MINER RES, V28, P838, DOI 10.1002/jbmr.1817; Ibrahim EE, 2012, STEM CELLS, V30, P2076, DOI 10.1002/stem.1182; Igarashi K, 2017, CELL CYCLE, V16, P1164, DOI 10.1080/15384101.2017.1317417; Kashima T, 2003, INT J CANCER, V104, P147, DOI 10.1002/ijc.10931; Kashima T, 1999, AM J PATHOL, V155, P1549, DOI 10.1016/S0002-9440(10)65471-5; Kawaguchi J, 2001, J BONE MINER RES, V16, P260, DOI 10.1359/jbmr.2001.16.2.260; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kimura R, 2011, BBA-MOL CELL RES, V1813, P1543, DOI 10.1016/j.bbamcr.2011.04.008; Kitajima H, 2013, CANCER MED-US, V2, P267, DOI 10.1002/cam4.67; Kresse SH, 2009, GENE CHROMOSOME CANC, V48, P679, DOI 10.1002/gcc.20675; Krueger S, 2001, CANCER GENE THER, V8, P522, DOI 10.1038/sj.cgt.7700341; Kucharczak J, 2008, CANCER RES, V68, P6559, DOI 10.1158/0008-5472.CAN-08-0196; Lin YH, 2017, TRENDS MOL MED, V23, P737, DOI 10.1016/j.molmed.2017.06.004; Lorenz S, 2016, ONCOTARGET, V7, P5273, DOI 10.18632/oncotarget.6567; Lu J, 2017, ONCOGENE, V36, P231, DOI 10.1038/onc.2016.194; Lu JC, 2015, J CLIN INVEST, V125, P1839, DOI 10.1172/JCI78437; Luetke A, 2014, CANCER TREAT REV, V40, P523, DOI 10.1016/j.ctrv.2013.11.006; Martin Jeff W., 2012, Sarcoma, V2012, P627254, DOI 10.1155/2012/627254; Mathisen B, 2003, CLIN EXP METASTAS, V20, P701, DOI 10.1023/B:CLIN.0000006819.21361.03; Miotto E, 2004, CANCER RES, V64, P8156, DOI 10.1158/0008-5472.CAN-04-3000; Murakami T, 2017, ONCOTARGET, V8, P8035, DOI 10.18632/oncotarget.14040; Ozaki T, 2002, INT J CANCER, V102, P355, DOI 10.1002/ijc.10709; Papachristou DJ, 2003, BONE, V32, P364, DOI 10.1016/S8756-3282(03)00026-7; Pohlig F, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1315-6; Poos K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123082; Shin CS, 2000, J CELL BIOCHEM, V78, P566, DOI 10.1002/1097-4644(20000915)78:4<566::AID-JCB6>3.0.CO;2-K; Smida J, 2017, INT J CANCER, V141, P816, DOI 10.1002/ijc.30778; Smida J, 2010, CLIN CANCER RES, V16, P4256, DOI 10.1158/1078-0432.CCR-10-0284; Squire JA, 2003, GENE CHROMOSOME CANC, V38, P215, DOI 10.1002/gcc.10273; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tang N, 2008, CLIN ORTHOP RELAT R, V466, P2114, DOI 10.1007/s11999-008-0335-z; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Xie L, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/762098; Yoon CH, 2012, ONCOGENE, V31, P4655, DOI 10.1038/onc.2011.634; Zhang GY, 2011, ASIAN PAC J CANCER P, V12, P2075	45	23	25	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 5	2018	37	27					3617	3630		10.1038/s41388-018-0231-2	http://dx.doi.org/10.1038/s41388-018-0231-2			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GM3CM	29610525				2022-12-26	WOS:000437975200001
J	Heidrich, J; Junglas, B; Grytsyk, N; Hellmann, N; Rusitzka, K; Gebauer, W; Markl, J; Hellwig, P; Schneider, D				Heidrich, Jennifer; Junglas, Benedikt; Grytsyk, Natalia; Hellmann, Nadja; Rusitzka, Kristiane; Gebauer, Wolfgang; Markl, Juergen; Hellwig, Petra; Schneider, Dirk			Mg2+ binding triggers rearrangement of the IM30 ring structure, resulting in augmented exposure of hydrophobic surfaces competent for membrane binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane fusion; cyanobacteria; plant; membrane biogenesis; membrane biophysics; membrane binding; Mg2+; PspA; thylakoid membrane; Vipp1; IM30; circular dichroism; isothermal titration calorimetry; Fourier transform IR; protein denaturation	SP PCC 6803; TRANSFORM INFRARED-SPECTROSCOPY; LIGHT-DEPENDENT CHANGES; THYLAKOID MEMBRANES; ESCHERICHIA-COLI; ABSORPTION-SPECTROSCOPY; INTACT CHLOROPLASTS; FLUORESCENT PROTEIN; CO2 FIXATION; PHAGE SHOCK	The inner membrane-associated protein of 30 kDa (IM30), also known as vesicle-inducing protein in plastids 1 (Vipp1), is found in the majority of photosynthetic organisms that use oxygen as an energy source, and its occurrence appears to be coupled to the existence of thylakoid membranes in cyanobacteria and chloroplasts. IM30 is most likely involved in thylakoid membrane biogenesis and/or maintenance, and has recently been shown to function as a membrane fusion protein in presence of Mg2+. However, the precise role of Mg2+ in this process and its impact on the structure and function of IM30 remains unknown. Here, we show that Mg2+ binds directly to IM30 with a binding affinity of approximate to 1 mm. Mg2+ binding compacts the IM30 structure coupled with an increase in the thermodynamic stability of the proteins' secondary, tertiary, and quaternary structures. Furthermore, the structural alterations trigger IM30 double ring formation in vitro because of increased exposure of hydrophobic surface regions. However, in vivo Mg2+-triggered exposure of hydrophobic surface regions most likely modulates membrane binding and induces membrane fusion.	[Heidrich, Jennifer; Junglas, Benedikt; Hellmann, Nadja; Schneider, Dirk] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55128 Mainz, Germany; [Rusitzka, Kristiane; Gebauer, Wolfgang; Markl, Juergen] Johannes Gutenberg Univ Mainz, Inst Mol Physiol, D-55128 Mainz, Germany; [Grytsyk, Natalia; Hellwig, Petra] Univ Strasbourg, CNRS, UMR 7140, Lab Bioelectrochim & Spect, 1 Rue Blaise Pascal, D-67000 Strasbourg, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Schneider, D (corresponding author), Johann Joachim Becher Weg 30, D-55128 Mainz, Germany.	Dirk.Schneider@uni-mainz.de	Grytsyk, Natalia/ABG-5742-2021	Junglas, Benedikt/0000-0001-9348-3379; hellwig, petra/0000-0001-6294-5163	Max-Planck Graduate Center at the Max Planck Institutes; University of Mainz; icFRC Strasbourg	Max-Planck Graduate Center at the Max Planck Institutes; University of Mainz; icFRC Strasbourg	This work was funded by the Max-Planck Graduate Center at the Max Planck Institutes and the University of Mainz (to J.H., B.J., and D.S.) and icFRC Strasbourg (to N.G.).	Adam Z, 2011, PLANT MOL BIOL, V76, P221, DOI 10.1007/s11103-010-9693-5; ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6; Aseeva E, 2004, J BIOL CHEM, V279, P35535, DOI 10.1074/jbc.M401750200; Ataka K, 2004, J AM CHEM SOC, V126, P16199, DOI 10.1021/ja045951h; Baker BM, 1996, BIOPHYS J, V71, P2049, DOI 10.1016/S0006-3495(96)79403-1; Barthel S, 2013, PLANT PHYSIOL, V163, P1037, DOI 10.1104/pp.113.224428; BELLSOLELL L, 1994, J MOL BIOL, V238, P489, DOI 10.1006/jmbi.1994.1308; Bisicchia P, 2010, PLASMID, V64, P143, DOI 10.1016/j.plasmid.2010.06.002; BLACK CB, 1994, COORDIN CHEM REV, V135, P165, DOI 10.1016/0010-8545(94)80068-5; BRISSETTE JL, 1991, J MOL BIOL, V220, P35, DOI 10.1016/0022-2836(91)90379-K; BRISSETTE JL, 1990, P NATL ACAD SCI USA, V87, P862, DOI 10.1073/pnas.87.3.862; Bryan SJ, 2014, MOL MICROBIOL, V94, P1179, DOI 10.1111/mmi.12826; Bultema Jelle B, 2010, Commun Integr Biol, V3, P162; ChinSang ID, 1996, GENE DEV, V10, P2314, DOI 10.1101/gad.10.18.2314; Frain KM, 2016, BBA-BIOENERGETICS, V1857, P266, DOI 10.1016/j.bbabio.2015.08.010; Fritz H., 1984, METHODS ENZYMATIC AN; Fuhrmann E, 2009, MOL BIOL CELL, V20, P4620, DOI 10.1091/mbc.E09-04-0319; Fuhrmann E, 2009, PLANT PHYSIOL, V149, P735, DOI 10.1104/pp.108.132373; Gasymov OK, 2007, BBA-PROTEINS PROTEOM, V1774, P403, DOI 10.1016/j.bbapap.2007.01.002; Goormaghtigh E, 1994, Subcell Biochem, V23, P405; Grytsyk N, 2017, P NATL ACAD SCI USA, V114, P1530, DOI 10.1073/pnas.1621431114; Hankamer BD, 2004, J BIOL CHEM, V279, P8862, DOI 10.1074/jbc.M307889200; Heidrich J, 2017, BBA-BIOMEMBRANES, V1859, P537, DOI 10.1016/j.bbamem.2016.09.025; Heidrich J, 2016, J BIOL CHEM, V291, P14954, DOI 10.1074/jbc.M116.722686; Hemaprabha, 2012, J PHARM SCI INNOV, V1, P22, DOI DOI 10.7897/2277-4572; Hennig R, 2017, BBA-BIOENERGETICS, V1858, P126, DOI 10.1016/j.bbabio.2016.11.004; Hennig R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8018; HIND G, 1974, P NATL ACAD SCI USA, V71, P1484, DOI 10.1073/pnas.71.4.1484; Ishijima S, 2003, ARCH BIOCHEM BIOPHYS, V412, P126, DOI 10.1016/S0003-9861(03)00038-9; Kriegel S, 2014, BIOCHEMISTRY-US, V53, P6340, DOI 10.1021/bi500955a; Kroll D, 2001, P NATL ACAD SCI USA, V98, P4238, DOI 10.1073/pnas.061500998; LaPorte D. C., 2002, BIOCHEMISTRY-US, V19, P3814; LAU SYM, 1984, J BIOL CHEM, V259, P3253; LI HM, 1994, PLANT MOL BIOL, V25, P619, DOI 10.1007/BF00029601; Liberton M, 2013, J BIOL CHEM, V288, P3632, DOI 10.1074/jbc.M112.416933; LIN DC, 1971, ARCH BIOCHEM BIOPHYS, V145, P622, DOI 10.1016/S0003-9861(71)80022-X; Martin-Molina A, 2012, BIOPHYS J, V102, P2095, DOI 10.1016/j.bpj.2012.03.009; Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01; Myers JK, 1997, BIOCHEMISTRY-US, V36, P10923, DOI 10.1021/bi9707180; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ohki SY, 1997, BIOCHEMISTRY-US, V36, P4309, DOI 10.1021/bi962759m; Osadnik H, 2015, MOL MICROBIOL, V98, P743, DOI 10.1111/mmi.13154; Otters S, 2013, PLANTA, V237, P529, DOI 10.1007/s00425-012-1772-1; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; PORTIS AR, 1976, BIOCHIM BIOPHYS ACTA, V449, P434, DOI 10.1016/0005-2728(76)90154-7; PORTIS AR, 1977, BIOCHIM BIOPHYS ACTA, V461, P313, DOI 10.1016/0005-2728(77)90181-5; PORTIS AR, 1992, ANNU REV PLANT PHYS, V43, P415, DOI 10.1146/annurev.pp.43.060192.002215; PORTIS AR, 1981, PLANT PHYSIOL, V67, P985, DOI 10.1104/pp.67.5.985; Saur M, 2017, STRUCTURE, V25, P1380, DOI 10.1016/j.str.2017.07.001; Shaul O, 2002, BIOMETALS, V15, P309, DOI 10.1023/A:1016091118585; Shcolnick S, 2006, PLANT PHYSIOL, V141, P805, DOI 10.1104/pp.106.079251; Sissi C, 2009, NUCLEIC ACIDS RES, V37, P702, DOI 10.1093/nar/gkp024; Strambini GB, 2010, J PHYS CHEM B, V114, P1089, DOI 10.1021/jp909567q; Velazquez-Campoy Adrian, 2004, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1708s23; VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1243, DOI 10.1002/bip.360301309; Vothknecht UC, 2012, J EXP BOT, V63, P1699, DOI 10.1093/jxb/err357; Westphal S, 2001, P NATL ACAD SCI USA, V98, P4243, DOI 10.1073/pnas.061501198; Xie D, 1997, BIOCHEMISTRY-US, V36, P16166, DOI 10.1021/bi971550l	60	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8230	8241		10.1074/jbc.RA117.000991	http://dx.doi.org/10.1074/jbc.RA117.000991			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29618510	Green Published, hybrid			2022-12-26	WOS:000433224600027
J	Bailey, DC; Alexander, E; Rice, MR; Drake, EJ; Mydy, LS; Aldrich, CC; Gulick, AM				Bailey, Daniel C.; Alexander, Evan; Rice, Matthew R.; Drake, Eric J.; Mydy, Lisa S.; Aldrich, Courtney C.; Gulick, Andrew M.			Structural and functional delineation of aerobactin biosynthesis in hypervirulent Klebsiella pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDEROPHORE PRODUCTION; STRUCTURE REFINEMENT; PLASMID COLV-K30; OPTIMIZATION; SYNTHETASE; SYSTEM; GENES; CRYSTALLIZATION; YERSINIABACTIN; RECONSTITUTION	Aerobactin, a citryl-hydroxamate siderophore, is produced by a number of pathogenic Gram-negative bacteria to aid in iron assimilation. Interest in this well-known siderophore was reignited by recent investigations suggesting that it plays a key role in mediating the enhanced virulence of a hypervirulent pathotype of Klebsiella pneumoniae (hvKP). In contrast to classical opportunistic strains of K. pneumoniae, hvKP causes serious life-threatening infections in previously healthy individuals in the community. Multiple contemporary reports have confirmed fears that the convergence of multidrug-resistant and hvKP pathotypes has led to the evolution of a highly transmissible, drug-resistant, and virulent super bug. Despite hvKP harboring four distinct siderophore operons, knocking out production of only aerobactin led to a significant attenuation of virulence. Herein, we continue our structural and functional studies on the biosynthesis of this crucial virulence factor. In vivo heterologous production and in vitro reconstitution of aerobactin biosynthesis from hvKP was carried out, demonstrating the specificity, stereoselectivity, and kinetic throughput of the complete pathway. Additionally, we present a steady-state kinetic analysis and the X-ray crystal structure of the second aerobactin synthetase IucC, as well as describe a surface entropy reduction strategy that was employed for structure determination. Finally, we show solution X-ray scattering data that support a unique dimeric quaternary structure for IucC. These new insights into aerobactin assembly will help inform potential antivirulence strategies and advance our understanding of siderophore biosynthesis.	[Bailey, Daniel C.; Drake, Eric J.; Mydy, Lisa S.; Gulick, Andrew M.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Struct Biol, Buffalo, NY 14203 USA; [Bailey, Daniel C.; Rice, Matthew R.; Drake, Eric J.; Mydy, Lisa S.; Gulick, Andrew M.] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; [Alexander, Evan; Aldrich, Courtney C.] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Hauptman Woodward Medical Research Institute; University of Minnesota System; University of Minnesota Twin Cities	Gulick, AM (corresponding author), 955 Main St, Buffalo, NY 14203 USA.	gulick@hwi.buffalo.edu		Mydy, Lisa/0000-0002-6976-4426; Bailey, Daniel/0000-0003-4126-8700; Rice, Matthew/0000-0003-1077-7262; Gulick, Andrew/0000-0003-4238-7453	Richard W. and Mae Stone Goode Foundation; National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences Grant under Department of Energy [AGM-12006, DE-AC02-06CH11357]; National Institutes of Health Office of Research Infrastructure Program [1S10OD012289-01A1]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116998, T32AI007614] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012289] Funding Source: NIH RePORTER	Richard W. and Mae Stone Goode Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences Grant under Department of Energy; National Institutes of Health Office of Research Infrastructure Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Edward Snell for collecting the SAXS data on IucC, and Dr. Thomas Grant for guidance analyzing it. We thank Dr. Artem Evdokimov for invaluable assistance in SER mutant design. We thank Dr. Thomas Russo for insightful discussions regarding hvKP. The compact mass spectrometer was purchased with funds from the Richard W. and Mae Stone Goode Foundation. Diffraction data were collected at the GM/CAID-B beamline of APS, which is supported by the National Cancer Institute Grant ACB-12002, National Institute of General Medical Sciences Grant AGM-12006 under Department of Energy Contract Number DE-AC02-06CH11357 to APS, and the National Institutes of Health Office of Research Infrastructure Program Grant 1S10OD012289-01A1.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ancliff RA, 1997, TETRAHEDRON-ASYMMETR, V8, P3379, DOI 10.1016/S0957-4166(97)00435-7; Bailey DC, 2016, BIOCHEMISTRY-US, V55, P3559, DOI 10.1021/acs.biochem.6b00409; Boivin S, 2013, PROTEIN EXPRES PURIF, V91, P192, DOI 10.1016/j.pep.2013.08.002; Braykov NP, 2013, INFECT CONT HOSP EP, V34, P259, DOI 10.1086/669523; CARBONETTI NH, 1984, INFECT IMMUN, V46, P7, DOI 10.1128/IAI.46.1.7-12.1984; Challis GL, 2005, CHEMBIOCHEM, V6, P601, DOI 10.1002/cbic.200400283; Chen L, 2018, LANCET INFECT DIS, V18, P2, DOI 10.1016/S1473-3099(17)30517-0; Cooper DR, 2007, ACTA CRYSTALLOGR D, V63, P636, DOI 10.1107/S0907444907010931; COY M, 1986, BIOCHEMISTRY-US, V25, P2485, DOI 10.1021/bi00357a030; DELORENZO V, 1986, J BACTERIOL, V167, P350, DOI 10.1128/jb.167.1.350-355.1986; DELORENZO V, 1986, J BACTERIOL, V165, P570, DOI 10.1128/jb.165.2.570-578.1986; Duarte JM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-334; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Fischbach MA, 2006, NAT CHEM BIOL, V2, P132, DOI 10.1038/nchembio771; GIBSON F, 1969, BIOCHIM BIOPHYS ACTA, V192, P175, DOI 10.1016/0304-4165(69)90353-5; Goldschmidt L, 2014, METHODS MOL BIOL, V1140, P201, DOI 10.1007/978-1-4939-0354-2_16; Grant TD, 2015, ACTA CRYSTALLOGR D, V71, P45, DOI 10.1107/S1399004714010876; Gu DX, 2018, LANCET INFECT DIS, V18, P37, DOI [10.1016/S1473-3099(17)30489-9, 10.1016/s1473-3099(17)30489-9]; HAYGOOD MG, 1993, LIMNOL OCEANOGR, V38, P1091, DOI 10.4319/lo.1993.38.5.1091; HU JD, 1994, J ORG CHEM, V59, P4858, DOI 10.1021/jo00096a030; Iwasaki Y, 2017, INTERNAL MED, V56, P373, DOI 10.2169/internalmedicine.56.7384; 진수신, 2013, [The Korean Journal of Medicine, 대한내과학회지], V85, P540, DOI 10.3904/kjm.2013.85.5.540; Kashani AH, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-28; Keynan Y, 2007, INT J ANTIMICROB AG, V30, P385, DOI 10.1016/j.ijantimicag.2007.06.019; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V309, P1573, DOI 10.1001/jama.2013.2922; Kunkle CA, 2005, J BACTERIOL, V187, P422, DOI 10.1128/JB.187.2.422-433.2005; Kupper FC, 2006, INORG CHEM, V45, P6028, DOI 10.1021/ic0604967; Kwon Jang-Mi, 2013, Korean J Pediatr, V56, P407, DOI 10.3345/kjp.2013.56.9.407; Lamb AL, 2015, BBA-PROTEINS PROTEOM, V1854, P1054, DOI 10.1016/j.bbapap.2015.05.001; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Li B, 2014, FUTURE MICROBIOL, V9, P1071, DOI [10.2217/FMB.14.48, 10.2217/fmb.14.48]; LIU YC, 1986, ARCH INTERN MED, V146, P1913, DOI 10.1001/archinte.146.10.1913; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; MACHEROUX P, 1993, EUR J BIOCHEM, V213, P995, DOI 10.1111/j.1432-1033.1993.tb17846.x; Madsen JLH, 2015, J AM CHEM SOC, V137, P9117, DOI 10.1021/jacs.5b04557; Martel A, 2012, J SYNCHROTRON RADIAT, V19, P431, DOI 10.1107/S0909049512008072; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller DA, 2002, CHEM BIOL, V9, P333, DOI 10.1016/S1074-5521(02)00115-1; NASSIF X, 1986, INFECT IMMUN, V54, P603, DOI 10.1128/IAI.54.3.603-608.1986; Ng D, 2015, WEST J EMERG MED, V16, P165, DOI 10.5811/westjem.2014.11.23599; Nusca TD, 2012, J BIOL CHEM, V287, P16058, DOI 10.1074/jbc.M112.359349; Oves-Costales D, 2009, CHEM COMMUN, P6530, DOI 10.1039/b913092f; Oves-Costales D, 2009, CHEM COMMUN, P1389, DOI 10.1039/b823147h; Patel HM, 2001, BIOCHEMISTRY-US, V40, P9023, DOI 10.1021/bi010519n; Patel PK, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu028; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Prokesch Bonnie C, 2016, Lancet Infect Dis, V16, pe190, DOI 10.1016/S1473-3099(16)30021-4; RUSSO TA, 2013, GENOME ANNOUNCEMENTS, V0001; Russo TA, 2015, INFECT IMMUN, V83, P3325, DOI 10.1128/IAI.00430-15; Russo TA, 2014, INFECT IMMUN, V82, P2356, DOI 10.1128/IAI.01667-13; Russo TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026734; Sanchez GV, 2013, EMERG INFECT DIS, V19, P133, DOI 10.3201/eid1901.120310; Schmelz S, 2011, J MOL BIOL, V412, P495, DOI 10.1016/j.jmb.2011.07.059; Schmelz S, 2009, NAT CHEM BIOL, V5, P174, DOI 10.1038/nchembio.145; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Shon AS, 2013, VIRULENCE, V4, P107, DOI 10.4161/viru.22718; Shon AS, 2012, FUTURE MICROBIOL, V7, P669, DOI [10.2217/FMB.12.43, 10.2217/fmb.12.43]; Smolsky IL, 2007, J APPL CRYSTALLOGR, V40, pS453, DOI 10.1107/S0021889807009624; Struve C, 2015, MBIO, V6, DOI 10.1128/mBio.00630-15; Takahashi K, 2015, INTERNAL MED, V54, P355, DOI 10.2169/internalmedicine.54.3485; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vandevelde A, 2014, CASE REP INFECT DIS, V2014, DOI 10.1155/2014/137248; Weaver R, 1997, TETRAHEDRON, V53, P5537, DOI 10.1016/S0040-4020(97)00210-X; WU MX, 1993, ANAL BIOCHEM, V211, P320, DOI 10.1006/abio.1993.1276; Zajdowicz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034591	69	26	28	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7841	7852		10.1074/jbc.RA118.002798	http://dx.doi.org/10.1074/jbc.RA118.002798			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29618511	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000437256500031
J	Fan, XZ; Zhao, J; Ren, FL; Wang, YY; Feng, YR; Ding, LD; Zhao, LP; Shang, Y; Li, J; Ni, JQ; Jia, BQ; Liu, YL; Chang, ZJ				Fan, Xuanzi; Zhao, Juan; Ren, Fangli; Wang, Yinyin; Feng, Yarui; Ding, Lidan; Zhao, Linpeng; Shang, Yu; Li, Jun; Ni, Jianquan; Jia, Baoqing; Liu, Yule; Chang, Zhijie			Dimerization of p15RS mediated by a leucine zipper-like motif is critical for its inhibitory role on Wnt signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; TRANSCRIPTION FACTORS; PROTEIN; PATHWAY; DIMER; CREPT; DNA; MELANOMA; DISEASES; COMPLEX	We previously demonstrated that p15RS, a newly discovered tumor suppressor, inhibits Wnt/-catenin signaling by interrupting the formation of -catenin<bold>TCF</bold>4 complex. However, it remains unclear how p15RS helps exert such an inhibitory effect on Wnt signaling based on its molecular structure. In this study, we reported that dimerization of p15RS is required for its inhibition on the transcription regulation of Wnt-targeted genes. We found that p15RS forms a dimer through a highly conserved leucine zipper-like motif in the coiled-coil terminus domain. In particular, residues Leu-248 and Leu-255 were identified as being responsible for p15RS dimerization, as mutation of these two leucines into prolines disrupted the homodimer formation of p15RS and weakened its suppression of Wnt signaling. Functional studies further confirmed that mutations of p15RS at these residues results in diminishment of its inhibition on cell proliferation and tumor formation. We therefore concluded that dimerization of p15RS governed by the leucine zipper-like motif is critical for its inhibition of Wnt/-catenin signaling and tumorigenesis.	[Fan, Xuanzi; Zhao, Juan; Ren, Fangli; Wang, Yinyin; Feng, Yarui; Ding, Lidan; Ni, Jianquan; Chang, Zhijie] Tsinghua Univ, Sch Med, State Key Lab Membrane Biol, Beijing 100084, Peoples R China; [Fan, Xuanzi; Liu, Yule] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Zhao, Linpeng; Shang, Yu] Beijing Normal Univ, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Dept Cell Biol,Coll Life Sci, Beijing 100875, Peoples R China; [Li, Jun] Third Mil Med Univ, PLA, Inst Immunol, Chongqing 400038, Peoples R China; [Jia, Baoqing] Chinese Peoples Liberat Army Gen Hosp, Dept Gen Surg Pathol, Beijing 100853, Peoples R China	Tsinghua University; Tsinghua University; Beijing Normal University; Army Medical University; Chinese People's Liberation Army General Hospital	Chang, ZJ (corresponding author), Tsinghua Univ, Sch Med, State Key Lab Membrane Biol, Beijing 100084, Peoples R China.	zhijiec@tsinghua.edu.cn	Wang, Yin/HCI-9352-2022; Liu, Yule/E-5700-2010; Chang, Zhijie/AAH-8109-2019	Liu, Yule/0000-0002-4423-6045; Chang, Zhijie/0000-0003-1567-3227	Chinese National Major Scientific Research Program [2016YFA0500301]; National Natural Science Foundation of China [81230044, 81372167, 81572729, 81572728, 81402293, 81372372]	Chinese National Major Scientific Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese National Major Scientific Research Program Grant 2016YFA0500301 and National Natural Science Foundation of China Grants 81230044, 81372167, 81572729, 81572728, 81402293, and 81372372. The authors declare that they have no conflicts of interest with the contents of this article.	Amoutzias GD, 2008, TRENDS BIOCHEM SCI, V33, P220, DOI 10.1016/j.tibs.2008.02.002; Beckett D, 2001, J MOL BIOL, V314, P335, DOI 10.1006/jmbi.2001.5134; Deitrick J, 2016, PROG MOL BIOL TRANSL, V144, P49, DOI 10.1016/bs.pmbts.2016.09.010; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; Hattori T, 2003, ONCOGENE, V22, P1273, DOI 10.1038/sj.onc.1206204; He B, 2006, Ernst Schering Found Symp Proc, P27; HOPE IA, 1987, EMBO J, V6, P2781, DOI 10.1002/j.1460-2075.1987.tb02573.x; Jin K, 2018, J CELL BIOCHEM, V119, P1083, DOI 10.1002/jcb.26277; Johnson ML, 2006, REV ENDOCR METAB DIS, V7, P41, DOI 10.1007/s1154-006-9003-3; Kaur A, 2016, BRIT J CANCER, V115, P1273, DOI 10.1038/bjc.2016.332; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Liu CX, 2015, J BIOL CHEM, V290, P9701, DOI 10.1074/jbc.M114.620872; Liu J, 2002, BIOCHEM BIOPH RES CO, V299, P880, DOI 10.1016/S0006-291X(02)02684-0; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu DD, 2012, CANCER CELL, V21, P92, DOI 10.1016/j.ccr.2011.12.016; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Matthews JM, 2012, ADV EXP MED BIOL, V747, P1, DOI 10.1007/978-1-4614-3229-6_1; Mei KR, 2014, SCI CHINA LIFE SCI, V57, P97, DOI 10.1007/s11427-013-4589-7; Neklesa TK, 2017, PHARMACOL THERAPEUT, V174, P138, DOI 10.1016/j.pharmthera.2017.02.027; Ni ZY, 2014, NAT STRUCT MOL BIOL, V21, P686, DOI 10.1038/nsmb.2853; Ni ZY, 2011, TRANSCR-AUSTIN, V2, P237, DOI 10.4161/trns.2.5.17803; Poy F, 2001, NAT STRUCT BIOL, V8, P1053, DOI 10.1038/nsb720; Sampietro J, 2006, MOL CELL, V24, P293, DOI 10.1016/j.molcel.2006.09.001; Shang S, 2017, ONCOTARGET, V8, P33972, DOI 10.18632/oncotarget.15687; Togi S, 2011, J BIOL CHEM, V286, P19170, DOI 10.1074/jbc.M110.189829; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; Wu YY, 2010, J BIOL CHEM, V285, P34621, DOI 10.1074/jbc.M110.148791; Xie WY, 2015, INTERVIROLOGY, V58, P297, DOI 10.1159/000441978; Xiong B, 2006, DEV CELL, V11, P225, DOI 10.1016/j.devcel.2006.06.012; Xue GD, 2016, CANCER TREAT REV, V49, P1, DOI 10.1016/j.ctrv.2016.06.009; Yaku H, 1997, FEBS LETT, V417, P409, DOI 10.1016/S0014-5793(97)01329-X; Zhang XC, 2012, CELL CYCLE, V11, P1988, DOI 10.4161/cc.20400; Zhang YQ, 2014, J BIOL CHEM, V289, P22589, DOI 10.1074/jbc.M114.560979	34	2	2	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7618	7628		10.1074/jbc.RA118.001969	http://dx.doi.org/10.1074/jbc.RA118.001969			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29618509	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000437256500014
J	Gabilondo, H; Rubio-Ferrera, I; Losada-Perez, M; del Saz, D; Leon, Y; Molina, I; Torroja, L; Allan, DW; Benito-Sipos, J				Gabilondo, Hugo; Rubio-Ferrera, Irene; Losada-Perez, Maria; del Saz, Delia; Leon, Yolanda; Molina, Isabel; Torroja, Laura; Allan, Douglas W.; Benito-Sipos, Jonathan			Segmentally homologous neurons acquire two different terminal neuropeptidergic fates in the Drosophila nervous system	PLOS ONE			English	Article							EMBRYONIC CNS; CELL FATE; MELANOGASTER; NEUROBLASTS; LINEAGES; PATTERN; GENES	In this study, we identify the means by which segmentally homologous neurons acquire different neuropeptide fates in Drosophila. Ventral abdominal (Va)-neurons in the A1 segment of the ventral nerve cord express DH31 and AstA neuropeptides (neuropeptidergic fate I) by virtue of Ubxactivity, whereas the A2-A4 Va-neurons express the Capa neuropeptide (neuropeptidergic fate II) under the influence of abdA. These different fates are attained through segment-specific programs of neural subtype specification undergone by segmentally homologous neurons. This is an attractive alternative by which Hox genes can shape Drosophila segmental neural architecture (more sophisticated than the previously identified binary "to live" or "not to live" mechanism). These data refine our knowledge of the mechanisms involved in diversifying neuronal identity within the central nervous system.	[Gabilondo, Hugo; Rubio-Ferrera, Irene; Losada-Perez, Maria; del Saz, Delia; Leon, Yolanda; Molina, Isabel; Torroja, Laura; Benito-Sipos, Jonathan] Univ Autonoma Madrid, Dept Biol, Madrid, Spain; [Allan, Douglas W.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC, Canada	Autonomous University of Madrid; University of British Columbia	Benito-Sipos, J (corresponding author), Univ Autonoma Madrid, Dept Biol, Madrid, Spain.	jonathan.benito@uam.es	Torroja, Laura/L-2449-2013; Molina, Isabel/L-2432-2013; Leon, Yolanda/ABG-6797-2020; Torroja, Laura/AAU-7896-2021; Losada Perez, Maria/E-8779-2013	Torroja, Laura/0000-0001-6939-6259; Molina, Isabel/0000-0003-1687-2447; Torroja, Laura/0000-0001-6939-6259; , Irene/0000-0001-6372-440X; Benito-Sipos, Jonathan/0000-0002-1159-3644; Losada Perez, Maria/0000-0002-6717-7762	 [BFU2013-43858-P]		This study was supported by grant number: BFU2013-43858-P, URL: http://www.mineco.gob.es.	Berger C, 2005, NAT CELL BIOL, V7, P56, DOI 10.1038/ncb1203; Berger C, 2007, DEV DYNAM, V236, P3562, DOI 10.1002/dvdy.21372; Birkholz O, 2013, DEVELOPMENT, V140, P1830, DOI 10.1242/dev.090043; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Gabilondo H, 2011, MECH DEVELOP, V128, P208, DOI 10.1016/j.mod.2011.01.002; GONZALEZREYES A, 1990, CELL, V61, P515, DOI 10.1016/0092-8674(90)90533-K; Karlsson D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000368; Miguel-Aliaga I, 2004, DEVELOPMENT, V131, P6093, DOI 10.1242/dev.01521; Moris-Sanz M, 2014, DEVELOPMENT, V141, P4366, DOI 10.1242/dev.113381; Park D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001896; Rogulja-Ortmann A, 2008, FLY, V2, P316, DOI 10.4161/fly.7464; Schmid A, 1999, DEVELOPMENT, V126, P4653; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; STRUHL G, 1985, CELL, V43, P507, DOI 10.1016/0092-8674(85)90180-1; Suska A, 2011, DEV BIOL, V353, P72, DOI 10.1016/j.ydbio.2011.02.015; Technau GM, 2006, DEV DYNAM, V235, P861, DOI 10.1002/dvdy.20566; UDOLPH G, 1993, DEVELOPMENT, V118, P765; Ulvklo C, 2012, DEVELOPMENT, V139, P678, DOI 10.1242/dev.074500; Veverytsa L, 2012, P NATL ACAD SCI USA, V109, pE748, DOI 10.1073/pnas.1114710109	19	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194281	10.1371/journal.pone.0194281	http://dx.doi.org/10.1371/journal.pone.0194281			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634720	Green Submitted, gold, Green Published			2022-12-26	WOS:000429522200008
J	Sasaki, Y; Kawamoto, A; Tahara, H; Kasuga, K; Sato, R; Ohnishi, M; Nakamura, S; Koizumi, N				Sasaki, Yuya; Kawamoto, Akihiro; Tahara, Hajime; Kasuga, Kie; Sato, Ryoichi; Ohnishi, Makoto; Nakamura, Shuichi; Koizumi, Nobuo			Leptospiral flagellar sheath protein FcpA interacts with FIaA2 and FIaB1 in Leptospira biflexa	PLOS ONE			English	Article							PERIPLASMIC FLAGELLA; BORRELIA-BURGDORFERI; PSEUDOMONAS-AERUGINOSA; MOTILITY; SPIROCHETE; INTERROGANS; VIRULENCE; INVOLVEMENT; CHEMOTAXIS; MORPHOLOGY	Leptospira spp. are spirochete bacteria that possess periplasmic flagella (PFs) underneath the outer membrane; each flagellum is attached to each end of the protoplasmic cylinder. PFs of Leptospira have a coiled shape that bends the end of the cell body. However, the molecular mechanism by which multiple flagellar proteins organize to form the distinctively curled PF of Leptospira remains unclear. Here we obtained a slow-motility mutant of L. biflexa MD4-3 by random insertion mutagenesis using a Himarl transposon. In MD4-3, the gene encoding the flagellar sheath protein, flagellar-coiling protein A (FcpA), which was recently identified in L. interrogans, was inactivated. As with L. interrogans triangle fcpA strains, the L. biflexa triangle fcpA strain lacked a distinct curvature at both ends of the cell body, and its motility was significantly reduced as compared with that of the wild-type strain. PFs isolated from the AfcpA strain were straight and were thinner than those isolated from the wild-type strain. Western blot analysis revealed that flagellar proteins FlaAl, FIaA2, FIaB1, and FIaB2 were expressed in the triangle fcpA strain but the flagellar proteins, except for FIaB2 were not incorporated in its PFs. Immunoprecipitation assay using anti-FcpA antiserum demonstrated that FcpA associates with FIaA2 and FIaB1. The association between FcpA and FIaA2 was also verified using pull-down assay. The regions of FIaA2 and FIaB1 interacting with FcpA were determined using a bacterial two-hybrid assay. These results suggest that FcpA together with FIaA2, produces coiling of PF of the Leptospira, and the interaction between the sheath and core filament may be mediated by FcpA and FIaB1.	[Sasaki, Yuya; Sato, Ryoichi] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Koganei, Tokyo, Japan; [Sasaki, Yuya; Ohnishi, Makoto; Koizumi, Nobuo] Natl Inst Infect Dis, Dept Bacteriol 1, Shinjuku Ku, Tokyo, Japan; [Kawamoto, Akihiro] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Tahara, Hajime; Nakamura, Shuichi] Tohoku Univ, Grad Sch Engn, Dept Appl Phys, Sendai, Miyagi, Japan; [Kasuga, Kie] Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Niigata, Niigata, Japan; [Kasuga, Kie] Kanazawa Univ, Div Med Sci, Grad Sch Med, Kanazawa, Ishikawa, Japan; [Kawamoto, Akihiro] Osaka Univ, Inst Prot Res, Suita, Osaka, Japan	Tokyo University of Agriculture & Technology; National Institute of Infectious Diseases (NIID); Osaka University; Tohoku University; Niigata University; Kanazawa University; Osaka University	Koizumi, N (corresponding author), Natl Inst Infect Dis, Dept Bacteriol 1, Shinjuku Ku, Tokyo, Japan.	nkoizumi@niid.go.jp	Kasuga, Kie/D-2308-2013; Sato, Ryoichi/G-1074-2013	Kasuga, Kie/0000-0003-0489-194X; Koizumi, Nobuo/0000-0002-5733-535X; Nakamura, Shuichi/0000-0003-3972-7779	JSPS KAKENHI [25460557, 16K08797];  [15H01307]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); 	This work was supported by JSPS KAKENHI Grant Numbers 25460557 and 16K08797 to NK and the Grant-in-Aid for Scientific Research on Innovative Areas "Harmonized Supramolecular Motility Machinery and Its Diversity" to SN (15H01307). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Berg HC, 1978, S SOC GEN MICROBIOL, P285; BROMLEY DB, 1979, J BACTERIOL, V137, P1406, DOI 10.1128/JB.137.3.1406-1412.1979; CHARON NW, 1991, J BACTERIOL, V173, P4820, DOI 10.1128/jb.173.15.4820-4826.1991; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; CHARON NW, 1992, RES MICROBIOL, V143, P597, DOI 10.1016/0923-2508(92)90117-7; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Ge YG, 1997, J BACTERIOL, V179, P552, DOI 10.1128/jb.179.2.552-556.1997; Goldstein SF, 1996, J BACTERIOL, V178, P6539, DOI 10.1128/jb.178.22.6539-6545.1996; GOLDSTEIN SF, 1990, P NATL ACAD SCI USA, V87, P4895, DOI 10.1073/pnas.87.13.4895; Kan WX, 2007, BIOPHYS J, V93, P54, DOI 10.1529/biophysj.106.103143; KELLYWINTENBERG K, 1993, J BACTERIOL, V175, P2458, DOI 10.1128/JB.175.8.2458-2461.1993; KELLYWINTENBERG K, 1990, J BACTERIOL, V172, P5135, DOI 10.1128/jb.172.9.5135-5139.1990; KOOPMAN MBH, 1992, INFECT IMMUN, V60, P2920, DOI 10.1128/IAI.60.7.2920-2925.1992; Lambert A, 2012, INFECT IMMUN, V80, P2019, DOI 10.1128/IAI.00131-12; Li CH, 2000, J MOL MICROB BIOTECH, V2, P345; Li CH, 2000, J BACTERIOL, V182, P6698, DOI 10.1128/JB.182.23.6698-6706.2000; Li C, 2008, J BACTERIOL, V190, P5607, DOI 10.1128/JB.00319-08; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Martin FS, 2017, ACTA CRYSTALLOGR F, V73, P123, DOI 10.1107/S2053230X17002096; Motaleb MA, 2000, P NATL ACAD SCI USA, V97, P10899, DOI 10.1073/pnas.200221797; Motaleb MA, 2004, J BACTERIOL, V186, P3703, DOI 10.1128/JB.186.12.3703-3711.2004; Nakamura S, 2017, METHODS MOL BIOL, V1593, P243, DOI 10.1007/978-1-4939-6927-2_19; Nakamura S, 2014, BIOPHYS J, V106, P47, DOI 10.1016/j.bpj.2013.11.1118; Picardeau M, 2001, MOL MICROBIOL, V40, P189, DOI 10.1046/j.1365-2958.2001.02374.x; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Picardeau M, 2008, APPL ENVIRON MICROB, V74, P319, DOI 10.1128/AEM.02172-07; Picardeau M, 2017, NAT REV MICROBIOL, V15, P297, DOI 10.1038/nrmicro.2017.5; Raddi G, 2012, J BACTERIOL, V194, P1299, DOI 10.1128/JB.06474-11; Rosey EL, 1996, INFECT IMMUN, V64, P4154, DOI 10.1128/IAI.64.10.4154-4162.1996; Sal MS, 2008, J BACTERIOL, V190, P1912, DOI 10.1128/JB.01421-07; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Slamti Leyla, 2012, Methods Mol Biol, V859, P169, DOI 10.1007/978-1-61779-603-6_9; Slamti L, 2011, J BACTERIOL, V193, P6266, DOI 10.1128/JB.05695-11; Sowa Y, 2008, Q REV BIOPHYS, V41, P103, DOI 10.1017/S0033583508004691; Toma C, 2014, CELL MICROBIOL, V16, P1366, DOI 10.1111/cmi.12296; Wunder EA, 2016, MOL MICROBIOL, V101, P457, DOI 10.1111/mmi.13403	38	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e019492	10.1371/journal.pone.0194923	http://dx.doi.org/10.1371/journal.pone.0194923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634754	Green Published, Green Submitted, gold			2022-12-26	WOS:000429522200017
J	Godai, K; Hasegawa-Moriyama, M; Matsunaga, A; Kanmura, Y				Godai, Kohei; Hasegawa-Moriyama, Maiko; Matsunaga, Akira; Kanmura, Yuichi			Phenylephrine does not improve oxygenation during one-lung ventilation: A randomized, double-blind, cross-over study	PLOS ONE			English	Article							PULSE PRESSURE VARIATION; FLUID RESPONSIVENESS; MANAGEMENT; ANESTHESIA; HYPOXEMIA	Background Phenylephrine is an alpha(1) adrenergic receptor agonist that causes pulmonary vasoconstriction, and so may effectively enhance hypoxic pulmonary vasoconstriction (HPV). However, there is little evidence that phenylephrine augments HPV in clinical situations. This study aimed to evaluate the clinical effects of phenylephrine infusion on oxygenation during one-lung ventilation (OLV) in patients undergoing thoracic surgery. Methods This was a prospective, randomized, double-blind, cross-over study. Included patients were those undergoing elective thoracic surgery in the lateral decubitus position with OLV. Patients were randomly allocated to two groups. The N-P group initially had OLV with normal saline infusion for 30 minutes; after a 10 minute interval, OLV was then maintained with phenylephrine infusion for 30 minutes. The P-N group had the drug-infusion in the reverse order. The primary outcome was arterial partial pressure of oxygen. Secondary outcomes were mean arterial pressure, heart rate, pulse pressure variation, perfusion index, and difference between bladder and skin temperature. Statistical analysis was performed using the student t-test, Fisher's exact test, and ANOVA for Cross-over design. P < 0.05 was considered statistically significant. Results Twenty-nine patients were analyzed. Although phenylephrine infusion significantly increased mean arterial pressure (P < 0.001), arterial partial pressure of oxygen did not differ between the two timepoints (P = 0.19). There was no carryover effect in arterial partial pressure of oxygen (P = 0.14). Phenylephrine infusion significantly decreased heart rate (P = 0.02) and pulse pressure variation (P < 0.001). Conclusions Phenylephrine infusion did not improve oxygenation during OLV. The present results indicate that phenylephrine does not have clinically meaningful effects on HPV.	[Godai, Kohei; Hasegawa-Moriyama, Maiko; Matsunaga, Akira; Kanmura, Yuichi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Anesthesiol & Crit Care Med, Kagoshima, Japan	Kagoshima University	Godai, K (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Anesthesiol & Crit Care Med, Kagoshima, Japan.	kxg179@icloud.com	Godai, Kohei/T-4675-2018	Godai, Kohei/0000-0002-5333-9417				Allen TK, 2010, ANESTH ANALG, V111, P1221, DOI 10.1213/ANE.0b013e3181e1db21; APPLETON C, 1985, J PHARMACOL EXP THER, V233, P729; Biais M, 2012, ANESTHESIOLOGY, V116, P1354, DOI 10.1097/ALN.0b013e318256ee28; Brassard CL, 2014, CAN J ANESTH, V61, P1103, DOI 10.1007/s12630-014-0246-2; Unzueta MC, 2007, ANESTH ANALG, V104, P1029, DOI 10.1213/01.ane.0000260313.63893.2f; Doering EB, 1997, ANESTHESIOLOGY, V87, P18, DOI 10.1097/00000542-199707000-00004; Fu Q, 2015, DRUG DISCOV THER, V9, P296, DOI 10.5582/ddt.2015.01046; Karzai W, 2009, ANESTHESIOLOGY, V110, P1402, DOI 10.1097/ALN.0b013e31819fb15d; Lee JH, 2011, EUR J ANAESTH, V28, P39, DOI 10.1097/EJA.0b013e32834089cf; Li T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004327; Lumb AB, 2015, ANESTHESIOLOGY, V122, P932, DOI 10.1097/ALN.0000000000000569; Montes FR, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-99; Raphael J, 2017, CURR OPIN ANESTHESIO, V30, P7, DOI 10.1097/ACO.0000000000000408; Rebet O, 2016, EUR J ANAESTH, V33, P638, DOI 10.1097/EJA.0000000000000470; Sato K, 2001, Masui, V50, P1118; Schloss B, 2013, THORAC CARD SURG REP, V2, P16, DOI 10.1055/s-0033-1343734; Tanaka M, 1994, Masui, V43, P1124; Xia JY, 2016, EXP THER MED, V12, P1141, DOI 10.3892/etm.2016.3432	18	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195576	10.1371/journal.pone.0195576	http://dx.doi.org/10.1371/journal.pone.0195576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630639	Green Submitted, Green Published, gold			2022-12-26	WOS:000429505000059
J	Nilson, F; Borjesson, M				Nilson, Finn; Borjesson, Mats			Mortality in long-distance running races in Sweden-2007-2016	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; UNITED-STATES; MARATHON; EXERCISE; RUNNERS; ARREST; HEALTH	Background During the last decade, an increasing popularity of marathons has been seen. Although running has been shown to have considerable positive health effects, the risk of sudden death, most often due to sudden cardiac arrests, is also a risk runners expose themselves to. Whilst there are some studies on the mortality amongst long-distance runners, much of the evidence is dated. Given the increased popularity in running during the 21(st) century as well as the improvements in medical care at marathons, more knowledge is required on the mortality risk. Materials and method Publicly available racing and news databases were used to identify the number of entrants and finishers in half to full marathons in Sweden between 2007 and 2016 and the number of deaths that occurred in conjunction with the races. Results A total of 1,156,271 runners entered a long distance (21-42km) running race in Sweden between 2007 and 2016, and 834,412 runners finished the races (72.2%). A large majority of the finishers (677,050 (81%)) competed in distances under a full marathon. Two deaths occurred during the time period, meaning that the death rate was 0.24 (95% confidence interval 0.04-0.79) per 100,000 finishers. Conclusions This study can show that death rates in long distance running races between 2007 and 2016 in Sweden are very low, compared to previous studies. When added to the existing literature, the combined picture suggests a general downward trend in the risk of death during marathons since the 1980s.	[Nilson, Finn] Karlstad Univ, Dept Environm & Life Sci, Karlstad, Sweden; [Borjesson, Mats] Univ Gothenburg, Sahlgrenska Acad, Dept Neurosci & Physiol, Gothenburg, Sweden; [Borjesson, Mats] Sahlgrens Univ Hosp, Dept Food Nutr & Sport Sci, Gothenburg, Sweden	Karlstad University; University of Gothenburg; Sahlgrenska University Hospital	Nilson, F (corresponding author), Karlstad Univ, Dept Environm & Life Sci, Karlstad, Sweden.	finn.nilson@kau.se	Nilson, Finn/H-2383-2017	Nilson, Finn/0000-0002-6928-0683				[Anonymous], 2016, 2016 STAT SPORT US R; [Anonymous], 2007, CIRCULATION, DOI DOI 10.1161/CIRCULATIONAHA.107.185649; Borjesson M, 2009, BRIT J SPORT MED, V43, P644, DOI 10.1136/bjsm.2008.054718; Borjesson M, 2011, EUR HEART J, V32, P2119, DOI 10.1093/eurheartj/ehr178; Chakravarty EF, 2008, ARCH INTERN MED, V168, P1638, DOI 10.1001/archinte.168.15.1638; Davis MF., 2005, EXPERT GUIDE SPORTS; Drezner JA, 2011, BRIT J SPORT MED, V45, P947, DOI 10.1136/bjsports-2011-090077; Harmon KG, 2014, BRIT J SPORT MED; Hart Lawrence, 2013, Clin J Sport Med, V23, P409, DOI 10.1097/01.jsm.0000433155.97054.c8; Jones BR W., ACSMS GUIDELINES TEA; Khan KM, 2012, LANCET, V380, P59, DOI 10.1016/S0140-6736(12)60865-4; Kim JH, 2012, NEW ENGL J MED, V366, P130, DOI 10.1056/NEJMoa1106468; Lee D., 2017, PROGR CARDIOVASCULAR; Maron BJ, 1996, J AM COLL CARDIOL, V28, P428, DOI 10.1016/0735-1097(96)00137-4; Mathews SC, 2012, AM J SPORT MED, V40, P1495, DOI 10.1177/0363546512444555; Ots M, 2009, J COMMUN INQ, V33, P376, DOI 10.1177/0196859909340581; Pedoe DST, 2007, SPORTS MED, V37, P448, DOI 10.2165/00007256-200737040-00046; Pyne SW., 2016, 34 MASS PARTICIPATIO, P339; Redelmeier DA, 2007, BRIT MED J, V335, P1275, DOI 10.1136/bmj.39384.551539.25; Roberts WO, 2000, MED SCI SPORT EXER, V32, P1549; Roberts WO, 2005, J AM COLL CARDIOL, V46, P1373, DOI 10.1016/j.jacc.2005.07.008; Roberts WO, 2012, BRIT J SPORT MED; Schwabe K, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093470; Shirakawa T., 2017, INT J CLIN MED, V08, P472, DOI [10.4236/ijcm.2017.87044, DOI 10.4236/IJCM.2017.87044]; Torell MF, 2017, EUR J PREV CARDIOL, V24, P1673, DOI 10.1177/2047487317729251; Waite O, 2016, PHYSICIAN SPORTSMED, V44, P79, DOI 10.1080/00913847.2016.1135036; Webner D, 2012, MED SCI SPORT EXER, V44, P1843, DOI 10.1249/MSS.0b013e318258b59a; Williams PT, 2009, MED SCI SPORT EXER, V41, P523, DOI 10.1249/MSS.0b013e31818c1752	28	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195626	10.1371/journal.pone.0195626	http://dx.doi.org/10.1371/journal.pone.0195626			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630680	Green Submitted, Green Published, gold			2022-12-26	WOS:000429505000067
J	Feijo, A; Patterson, BD; Cordeiro-Estrela, P				Feijo, Anderson; Patterson, Bruce D.; Cordeiro-Estrela, Pedro			Taxonomic revision of the long-nosed armadillos, Genus Dasypus Linnaeus, 1758 (Mammalia, Cingulata)	PLOS ONE			English	Article							9-BANDED ARMADILLO; DISTRIBUTIONAL LIMITS; RANGE EXPANSION; XENARTHRA; DASYPODIDAE; INVERTEBRATES; NOVEMCINCTUS; POLYEMBRYONY; COLLECTION; PHYLOGENY	Dasypus is the most speciose genus of the order Cingulata, including approximately 40% of known living armadillos. Nine species are currently recognized, although comprehensive analyses of the entire genus have never been done. Our aim is to revise the taxonomy of the long-nosed armadillos and properly define the taxa. We examined 2126 specimens of Dasypus preserved in 39 different museum collections, including 17 type specimens. Three complementary methods were applied to explore morphological datasets both qualitatively and quantitatively. Qualitative morphological variation in discrete characters was assessed by direct observations of specimens. Linear morphometric variation was based on external data and cranial measurements of 887 adult skulls. The shape and size of the skull was abstracted through two-dimensional geometric morphometric analyses of dorsal, lateral and ventral views of respectively 421, 211, and 220 adult specimens. Our results converge on the recognition of eight living species (D. beniensis, D. kappleri, D. mazzai, D. novemcinctus, D. pastasae, D. pilosus, D. sabanicola, and D. septemcinctus), and three subspecies of D. septemcinctus (D. s. septemcinctus, D. s. hybridus, and a new subspecies from Cordoba described here). Information on type material, diagnosis, distribution, and taxonomic comments for each taxon are provided. We designate a lectotype for D. novemcinctus; and a neotype for Loricatus hybridus (= D. septemcinctus hybridus).	[Feijo, Anderson; Cordeiro-Estrela, Pedro] Univ Fed Paraiba, Lab Mamiferos, Dept Sisternat & Ecol, Ctr Ciencias Exatas & Nat, Campus 1, Joao Pessoa, Paraiba, Brazil; [Feijo, Anderson; Cordeiro-Estrela, Pedro] Univ Fed Paraiba, Programa Posgrad Ciencias Biol Zool, Dept Sistemat & Ecol, Ctr Ciencias Exatas & Nat, Campus 1, Joao Pessoa, Paraiba, Brazil; [Feijo, Anderson; Patterson, Bruce D.] Field Museum Nat Hist, Integrat Res Ctr, Chicago, IL 60605 USA; [Feijo, Anderson] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China	Universidade Federal da Paraiba; Universidade Federal da Paraiba; Field Museum of Natural History (Chicago); Chinese Academy of Sciences; Institute of Zoology, CAS	Feijo, A (corresponding author), Univ Fed Paraiba, Lab Mamiferos, Dept Sisternat & Ecol, Ctr Ciencias Exatas & Nat, Campus 1, Joao Pessoa, Paraiba, Brazil.; Feijo, A (corresponding author), Univ Fed Paraiba, Programa Posgrad Ciencias Biol Zool, Dept Sistemat & Ecol, Ctr Ciencias Exatas & Nat, Campus 1, Joao Pessoa, Paraiba, Brazil.; Feijo, A (corresponding author), Field Museum Nat Hist, Integrat Res Ctr, Chicago, IL 60605 USA.; Feijo, A (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	andefeijo@gmail.com	Feijó, Anderson/F-4287-2018; Patterson, Bruce D/O-5068-2019	Patterson, Bruce D/0000-0002-2249-7260; Feijo, Anderson/0000-0002-4643-2293; Cordeiro-Estrela, Pedro/0000-0003-3383-571X	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); AMNH Grants Program; Field Museum of Natural History's Brown Fund for Mammal Research; Chinese Academy of Sciences President's International Fellowship Initiative [2018PB0040]	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); AMNH Grants Program; Field Museum of Natural History's Brown Fund for Mammal Research; Chinese Academy of Sciences President's International Fellowship Initiative	Funded by CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) (AF), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) (AF), AMNH Grants Program (Collection Study) (AF), Field Museum of Natural History's Brown Fund for Mammal Research, and Chinese Academy of Sciences President's International Fellowship Initiative (Grant number 2018PB0040).	Abba AM, 2015, J MAMMAL, V96, P673, DOI 10.1093/jmammal/gyv082; Abba Agustín M., 2011, Mastozool. neotrop., V18, P185; Abba AM, 2012, MAMMALIA, V76, P123, DOI 10.1515/mammalia-2011-0089; Abba AM, 2016, MAMM SPECIES, V48, P931; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Anderson Sydney, 1997, Bulletin of the American Museum of Natural History, V231, P1; ATKIN L, 1988, J TROP ECOL, V4, P307, DOI 10.1017/S026646740000287X; Avila-Pires F. D. de., 1965, American Museum Novitates, VNo. 2209, P1; Azara F., 1802, APUNTAMIENTOS HIST N; Azara F., 1801, ESSAIS HIST NATURELL; Bailey V., 1905, N AMER FAUNA, V25, P1; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Balete DS, 2007, J MAMMAL, V88, P287, DOI 10.1644/06-MAMM-A-090R.1; Balk L, 1749, AMOENITATES ACAD, V1, P277; Billet G, 2017, PEERJ, V5, DOI 10.7717/peerj.3593; Blanford W.T., 1879, SCI RESULTS 2 YARKAN, P1; Blumenbach J.F., 1779, HDB NATURGESCHICHTE; Boily Patrice, 2008, P126; Braun Janet K., 1995, Mastozoologia Neotropical, V2, P173; Burmeister H., 1854, WELCHE WAHREND REISE; Burmeister H., 1848, ZOOTOMIE PALAEOZOOLO, V1, P199; Burmeister H., 1862, ABH NATURF GES HALLE, V6, P145; CABANIS J, 1848, REISEN BRIT GUIANA J, P766; Cabrera A., 1958, Revista del Museo Argentino de Ciencias Naturales Bernardino Rivadavia (Zool), V4, P1; Castro M.C., 2015, Revista del Museo de La Plata Seccion Paleontologia, V15, P1; Castro MC, 2015, ZOOTAXA, V3947, P30, DOI 10.11646/zootaxa.3947.1.2; Castro MC, 2014, NATURWISSENSCHAFTEN, V101, P77, DOI 10.1007/s00114-013-1131-5; Castro MC, 2013, QUATERN INT, V317, P80, DOI 10.1016/j.quaint.2013.04.032; Ciancio MR, 2012, J MAMM EVOL, V19, P1, DOI 10.1007/s10914-011-9177-7; Costa FR, 2010, ZOOTAXA, P61; Cracraft J., 1983, Current Ornithology, V1, P159; CUVIER F, 1825, DENTS MAMMIFERES CON; de Queiroz K, 2005, BIOESSAYS, V27, P1263, DOI 10.1002/bies.20325; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Delsuc F, 2003, MOL PHYLOGENET EVOL, V28, P261, DOI 10.1016/S1055-7903(03)00111-8; Delsuc F, 2002, MOL BIOL EVOL, V19, P1656, DOI 10.1093/oxfordjournals.molbev.a003989; Delsuc F, 2012, MOL PHYLOGENET EVOL, V62, P673, DOI 10.1016/j.ympev.2011.11.008; Desmarest AG., 1803, PAIRS DETEVILLE, V21, P428; Desmarest AG, 1822, ENCY METHODIQUE, P277; Desmarest AG., 1804, PAIRS DETERVILLE, V24, P5; Diaz M. Monica, 2000, Occasional Papers of the Oklahoma Museum of Natural History, V10, P1; NASCIMENTO FABIO OLIVEIRA DO, 2017, Pap. Avulsos Zool., V57, P231, DOI 10.11606/0031-1049.2017.57.19; Du Rietz G. E., 1930, SVENSK BOT TIDSKRIFT, V24, P333; Erxleben J.C.P., 1777, SYSTEMA REGNI ANIMAL; Esselstyn JA, 2012, BIOL LETTERS, V8, P990, DOI 10.1098/rsbl.2012.0574; Feijo A, 2017, THESIS; Feijo A., 2013, REV NORDESTINA BIOL, V22, P3, DOI DOI 10.11606/D.41.2006.TDE-16082007-065514; Feijo A, 2016, ZOOTAXA, V4170, P271, DOI 10.11646/zootaxa.4170.2.3; Feijo A, 2014, ZOOTAXA, V3887, P88, DOI 10.11646/zootaxa.3887.1.6; Fermin P., 1769, RIVIERES FORTERESSES; Fitzinger, 1856, TAGEBLATT, V32, P123; Fitzinger LJ, 1871, SITZUNGSBERICHTE MN, V64, P329; Flower W. H., 1886, Proceedings of the Zoological Society, P420; Flower WH, 1894, P ZOOL SOC LOND, P655; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Fraley C, 2012, 597 U WASH DEP STAT; Frechkop S, 1949, B I ROYAL SCI NATURE, V25, P1; Frisch J.L., 1775, NATUR SYSTEM VIERFUS; Galbreath G.J., 1985, P243; Gardner A.L., 2005, MAMMAL SPECIES WORLD, P94; Gardner A. L., 2008, MAMMALS S AM, V1, DOI DOI 10.1644/08-MAMM-R-296.1; Gibb GC, 2016, MOL BIOL EVOL, V33, P621, DOI 10.1093/molbev/msv250; GOLDMAN EA, 1920, SMITHSONIAN MISCELLA, V69, P1; Gotelli N. J., 2004, PRIMER ECOLOGICAL ST; Gray, 1865, P ZOOL SOC LOND, V1865, P359, DOI DOI 10.1111/J.1469-7998.1865.TB02351.X; Gray J. E., 1869, P398; Gray JE., 1873, HAND LIST EDENTATE T; Gray JE, 1874, P ZOOL SOC LOND, P244; Hall E. R., 1981, MAMMALS N AM, V1; HAMLETT G. W. D., 1939, JOUR MAMMAL, V20, P328, DOI 10.2307/1374259; Harbers A, 2014, COLLECTING NATURE, P137; HARDY ICW, 1995, TRENDS ECOL EVOL, V10, P179, DOI 10.1016/S0169-5347(00)89045-X; HAUTIER L, 2017, PEERJ, V5, DOI DOI 10.7717/PEERJ.3650; Helgen KM, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.324.5827; HERSHKOVITZ P, 1987, Fieldiana Zoology, P11; Hollister N., 1925, Journal of Mammalogy, V6, P60; Honaker J, 2011, J STAT SOFTW, V45, P1; HUMPHREY SR, 1974, BIOSCIENCE, V24, P457, DOI 10.2307/1296853; Husson AM, 1978, LEIDEN ZOOLOGISCHE M, V2; ICZN, 1954, OP 258 REJ NOM PURP, V5, P245; ICZN, 1963, B ZOOL NOMENCLATURE, V20, P187; International Commission on Zoological Nomenclature (ICZN), 1999, INT CODE ZOOLOGICAL; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Krauss F., 1862, ARCH NATURGESCH, V28, P19; Lacepede BG de la V, 1801, HIST NATURELLE BUFFO; LAINSON R, 1979, T ROY SOC TROP MED H, V73, P239, DOI 10.1016/0035-9203(79)90225-6; Lesson R-P, 1827, MANUEL MAMMALOGIE HI; Linnaeus C., 1758, SYSTEMA NATURAE REGN, V1; Linnaeus C, 1748, SECUNDUM SEXTAM STOC; Linnaeus C, 1767, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; Linnaeus C, 1754, MUSEUM SAE RAE MITIS; Linnaeus C, 1749, AMOEN ACAD HOLM, V1, P27; Lonnberg E., 1928, Arkiv for Zoologi Stockholm, V20A, P1; Lonnberg E, 1913, ARK ZOOL, V8, P1, DOI DOI 10.5962/BHL.PART.1065; Lonnberg Einar, 1942, ARKIV ZOOL [STOCKHOLM], V34A, P1; Loughry WJ, 2015, J MAMMAL, V96, P635, DOI 10.1093/jmammal/gyv005; Loughry W.J., 2013, 9 BANDED ARMADILLO N; Loughry WJ, 1998, AM SCI, V86, P274; Abba AM, 2008, CONTRIB MACN, P5; Marcgrave G., 1648, HIST NATURALIS BRASI; Mayr E., 1942, P1; MAYR E., 1991, PRINCIPLES SYSTEMATI, V2nd; MCBEE K, 1982, Mammalian Species, P1, DOI 10.2307/3503864; Moeller W., 1968, Zoologische Jahrbuecher (Anatomie), V85, P411; Mondolfi E, 1968, MEMORIA SOC CIENCIAS, V27, P149; Nunez D, 2004, SMITHSON HERPETOL IN, V134, P1; OBRIEN SJ, 1991, SCIENCE, V251, P1187, DOI 10.1126/science.251.4998.1187; OLSON DM, 1994, J TROP ECOL, V10, P129, DOI 10.1017/S0266467400007793; Outomuro D, 2017, J ANIM ECOL, P1; Palin OF, 2011, BIOTROPICA, V43, P100, DOI 10.1111/j.1744-7429.2010.00650.x; Patton James L., 2015, P733; Paynter Jr R. A., 1991, ORNITHOLOGICAL GAZET; Paynter Jr RA, 1997, ORNITHOLOGICAL GAZET; Paynter Jr RA, 1994, ORNITHOLOGICAL GAZET; Paynter R. A., 1995, ORNITHOLOGICAL GAZET; Peters W., 1864, GEOMYS HAPLODON DASY, V1865, P177; Prodohl PA, 1996, P ROY SOC B-BIOL SCI, V263, P1643, DOI 10.1098/rspb.1996.0240; R Core Team, 2021, R LANGUAGE ENV STAT; Renaud S, 2007, ZOOL SCR, V36, P525, DOI 10.1111/j.1463-6409.2007.00297.x; Rhoads SN, 1894, P ACAD NAT SCI PHILA, V1894, P111; Rincon AD, 2008, J VERT PALEONTOL, V28, P197; Rohlf, 2013, TPSDIG VERSION 2 17; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; RUSSELL ROBERT J., 1953, PROC BIOL SOC WASHINGTON, V66, P21; Sanborn CC., 1929, FIELD MUS NAT HIST Z, V17, P47, DOI 10.5962/bhl.title.3241; Schlager S., 2020, MORPHO CALCULATIONS; Schreber J, 1774, SAUGTHIERE ABBILDUNG, P1774; Shapiro B, 2015, BOREAS, V44, P14, DOI 10.1111/bor.12094; SIMPSON GEORGE GAYLORD, 1961; Soibelzon E, 2013, QUATERN INT, V299, P72, DOI 10.1016/j.quaint.2012.09.009; Stangl FB, 1995, TEX J SCI, V47, P39; Superina M, 2014, MAMMAL REV, V44, P69, DOI 10.1111/mam.12010; TABER FW, 1945, J MAMMAL, V26, P211, DOI 10.2307/1374817; Talmage RV, 1954, ARMADILLO DASYPUS NO, V41; Taulman JF, 2014, J BIOGEOGR, V41, P1626, DOI 10.1111/jbi.12319; Taulman JF, 1996, J BIOGEOGR, V23, P635, DOI 10.1111/j.1365-2699.1996.tb00024.x; Garbino GST, 2015, INT J PRIMATOL, V36, P1049, DOI 10.1007/s10764-015-9882-9; Thomas O., 1901, Annals of Natural History, V(7), P366; Thomas O, 1911, P ZOOL SOC LOND, V1911, P687; Thomas O., 1880, Proceedings of the Zoological Society, P393; Truman R, 2005, LEPROSY REV, V76, P198; Truman Richard W., 2008, P111; Turner Jr HN, 1853, P ZOOL SOC LOND, V1851, P205; Vaccaro Olga B., 1998, Iheringia Serie Zoologia, V85, P67; Vizcaino Sergio F., 1997, Edentata, V3, P7; Vizcaino Sergio F., 1995, Mastozoologia Neotropical, V2, P5; Voss RS, 2009, B AM MUS NAT HIST, V331, P406, DOI 10.1206/582-11.1; Wagler JG, 1830, NATURLICHES SYSTEM A; Wetzel R.M., 1979, P43; Wetzel R.M., 1985, P23; Wetzel RM, 2008, MAMMALS S AM, V1, P128, DOI [10.7208/chicago/9780226282428.001.0001, DOI 10.7208/CHICAGO/9780226282428.001.0001]; WHEELER A, 1991, ZOOL J LINN SOC-LOND, V103, P145, DOI 10.1111/j.1096-3642.1991.tb00901.x; Wible JR, 2004, ANN CARNEGIE MUS, V73, P117; Yepes J., 1928, Revista de la Universidad de Buenos Aires, V24, P461; Yepes J., 1933, Physis Buenos Aires, V11, P225; Zachos FE, 2016, MAMM BIOL, V81, P185, DOI 10.1016/j.mambio.2015.10.002; Zamorano Martin, 2008, BioScriba, V1, P17; Zuur AF, 2007, STAT BIOL HEALTH, P163	159	18	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195084	10.1371/journal.pone.0195084	http://dx.doi.org/10.1371/journal.pone.0195084			69	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624590	Green Submitted, Green Published, gold			2022-12-26	WOS:000429379600015
J	Gibbs, A; Dunkle, K; Washington, L; Willan, S; Shai, N; Jewkes, R				Gibbs, Andrew; Dunkle, Kristin; Washington, Laura; Willan, Samantha; Shai, Nwabisa; Jewkes, Rachel			Childhood traumas as a risk factor for HIV-risk behaviours amongst young women and men living in urban informal settlements in South Africa: A cross-sectional study	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; SEXUAL-ABUSE; PREVALENCE; CHILDREN; MULTICOUNTRY; ADOLESCENTS; INFECTIONS; DEPRESSION; THERAPY; SOWETO	Childhood traumas, in the form of physical, sexual, and emotional abuse and neglect, are globally widespread and highly prevalent, and associated with a range of subsequent poor health outcomes. This study sought to understand the relationship between physical, sexual and emotional childhood abuse and subsequent HIV-risk behaviours amongst young people (18-30) living in urban informal settlements in Durban, South Africa. Data came from self completed questionnaires amongst 680 women and 677 men comprising the baseline of the Stepping Stones and Creating Futures intervention trial. Men and women were analysed separately. Logistic regression models assessed the relationship between six HIV-risk behaviours and four measures of trauma: the form of trauma, the severity of each trauma, the range of traumas, and overall severity of childhood trauma. Childhood traumas were incredibly prevalent in this population. All childhood traumas were associated with a range of HIV-risk behaviours. This was for the ever/never trauma, as well as the severity of each type of trauma, the range of trauma, and overall severity of childhood trauma. Despite the wider harsh contexts of urban informal settlements, childhood traumas still play a significant role in shaping subsequent HIV-risk behaviours amongst young people. Interventions to reduce childhood traumas for populations in informal settlements need to be developed. In addition, trauma focused therapies need to be considered as part of wider HIV-prevention interventions for young adults.	[Gibbs, Andrew; Dunkle, Kristin; Willan, Samantha; Shai, Nwabisa; Jewkes, Rachel] South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa; [Gibbs, Andrew] Univ KwaZulu Natal, Hlth Econ & HIV AIDS Res Div HEARD, Durban, South Africa; [Washington, Laura] Project Empower, Durban, South Africa; [Jewkes, Rachel] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	South African Medical Research Council; University of Kwazulu Natal; University of Witwatersrand	Gibbs, A (corresponding author), South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa.; Gibbs, A (corresponding author), Univ KwaZulu Natal, Hlth Econ & HIV AIDS Res Div HEARD, Durban, South Africa.	Andrew.gibbs@mrc.ac.za	Dunkle, Kristin/AAU-5488-2020	Dunkle, Kristin/0000-0003-3071-5544; Gibbs, Andrew/0000-0003-2812-5377; Shai, Nwabisa/0000-0003-4171-9129; Jewkes, Rachel/0000-0002-4330-6267	What Works To Prevent Violence? A Global Programme on Violence Against Women and Girls (VAWG) - UK Government's Department for International Development (DFID); South African Medical Research Council (SAMRC)	What Works To Prevent Violence? A Global Programme on Violence Against Women and Girls (VAWG) - UK Government's Department for International Development (DFID); South African Medical Research Council (SAMRC)	This trial is funded through the What Works To Prevent Violence? A Global Programme on Violence Against Women and Girls (VAWG) funded by the UK Government's Department for International Development (DFID). However, the views expressed do not necessarily reflect the department's official policies and the funders had no role in study design; collection, management, analysis, and interpretation of data; writing of the report; and the decision to submit the paper for publication. Funding was managed by the South African Medical Research Council (SAMRC), who also supported the project team.	Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; [Anonymous], 2015, 22 UN HAB; Arriola KRJ, 2005, CHILD ABUSE NEGLECT, V29, P725, DOI 10.1016/j.chiabu.2004.10.014; Artz L., 2016, OPTIMUS STUDY S AFRI; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Closson K, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3832-0; Cushman LF, 1998, FAM PLANN PERSPECT, V30, P240, DOI 10.2307/2991611; de Arellano MAR, 2014, PSYCHIAT SERV, V65, P591, DOI 10.1176/appi.ps.201300255; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Dunkle KL, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001472; Fleming PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118639; Fonseka RW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136321; Fulu E, 2017, LANCET GLOB HEALTH, V5, pE512, DOI 10.1016/s2214-109x(17)30103-1; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gibbs A, GLOBAL PUBL IN PRESS, P1; Gibbs A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4223-x; Gibbs A, 2016, AJAR-AFR J AIDS RES, V15, P141, DOI 10.2989/16085906.2016.1204331; Gibbs A, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17362; Hillis S, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-4079; Irish L, 2009, J PEDIATR PSYCHOL; Jewkes R, 2006, TROP MED INT HEALTH, V11, P3, DOI 10.1111/j.1365-3156.2005.01530.x; Jewkes R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-325; Jewkes R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038210; Jewkes RK, 2010, CHILD ABUSE NEGLECT, V34, P833, DOI 10.1016/j.chiabu.2010.05.002; Knerr W, 2013, PREV SCI, V14, P352, DOI 10.1007/s11121-012-0314-1; Maharaj P, 2005, INT FAMILY PLANNING, P24; Meinck F, 2016, J EPIDEMIOL COMMUN H, V70, P910, DOI 10.1136/jech-2015-205860; Meinck F, 2015, TRAUMA VIOLENCE ABUS, V16, P81, DOI 10.1177/1524838014523336; Murray LK, 2015, JAMA PEDIATR, V169, P761, DOI 10.1001/jamapediatrics.2015.0580; Nduna M, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-44; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sikweyiya Y, 2009, CULT HEALTH SEX, V11, P529, DOI 10.1080/13691050902912783; Suliman S, 2009, COMPR PSYCHIAT, V50, P121, DOI 10.1016/j.comppsych.2008.06.006; UNAIDS & Habitat, 2015, END AIDS EP ADV CIT; United Nations Children's Fund, 2014, HIDD PLAIN SIGHT STA; WILLIAMS LM, 1994, J CONSULT CLIN PSYCH, V62, P1167, DOI 10.1037//0022-006X.63.3.343; World Health Organisation, 2010, HIDD CIT UNM OV HLTH	39	28	28	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195369	10.1371/journal.pone.0195369	http://dx.doi.org/10.1371/journal.pone.0195369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB9FN	29624612	Green Published, gold, Green Submitted			2022-12-26	WOS:000429379600024
J	Berlow, NE; Svalina, MN; Quist, MJ; Settelmeyer, TP; Zherebitskiy, V; Kogiso, M; Qi, L; Du, YC; Hawkins, CE; Hulleman, E; Li, XN; Gultekin, SH; Keller, C				Berlow, Noah E.; Svalina, Matthew N.; Quist, Michael J.; Settelmeyer, Teagan P.; Zherebitskiy, Viktor; Kogiso, Mari; Qi, Lin; Du, Yuchen; Hawkins, Cynthia E.; Hulleman, Esther; Li, Xiao-Nan; Gultekin, Sakir H.; Keller, Charles			IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma	PLOS ONE			English	Article							HIGH-GRADE GLIOMAS; PANCREATIC DUCTAL ADENOCARCINOMA; PEDIATRIC BRAIN-TUMORS; HIGH-DOSE-CHEMOTHERAPY; GLIOBLASTOMA-MULTIFORME; BISPECIFIC ANTIBODY; PSEUDOMONAS EXOTOXIN; MALIGNANT GLIOMA; STEM GLIOMAS; CELLS	Diffuse intrinsic pontine glioma (DIPG) is a universally fatal childhood cancer of the brain. Despite the introduction of conventional chemotherapy and radiotherapy, improvements in survival have been marginal and long-term survivorship is uncommon. Thus, new targets for therapeutics are critically needed. Early phase clinical trials exploring molecularly-targeted therapies against the epidermal growth factor receptor (EGFR) and novel immunotherapies targeting interleukin receptor-13 alpha 2 (IL-13R alpha 2) have demonstrated activity in this disease. To identify additional therapeutic markers for cell surface receptors, we performed exome sequencing (16 new samples, 22 previously published samples, total 38 with 26 matched normal DNA samples), RNA deep sequencing (17 new samples, 11 previously published samples, total 28 with 18 matched normal RNA samples), and immunohistochemistry (17 DIPG tissue samples) to examine the expression of the interleukin-4 (IL-4) signaling axis components (IL-4, interleukin 13 (IL-13), and their respective receptors IL-4R alpha, IL-13R alpha 1, and IL-13R alpha 2). In addition, we correlated cytokine and receptor expression with expression of the oncogenes EGFR and c-MET. In DIPG tissues, transcript-level analysis found significant expression of IL-4, IL-13, and IL-13R alpha 1/2, with strong differential expression of IL-13R alpha 1/2 in tumor versus normal brain. At the protein level, immunohistochemical studies revealed high content of IL-4 and IL-13R alpha 1/2 but notably low expression of IL-13. Additionally, a strong positive correlation was observed between c-Met and IL-4R alpha. The genomic and transcriptional landscape across all samples was also summarized. These data create a foundation for the design of potential new immunotherapies targeting IL-13 cell surface receptors in DIPG.	[Berlow, Noah E.; Svalina, Matthew N.; Quist, Michael J.; Settelmeyer, Teagan P.; Keller, Charles] Childrens Canc Therapy Dev Inst, Beaverton, OR 97005 USA; [Zherebitskiy, Viktor; Gultekin, Sakir H.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Kogiso, Mari; Qi, Lin; Du, Yuchen; Li, Xiao-Nan] Texas Childrens Canc Ctr, Dept Pediat, Houston, TX USA; [Hawkins, Cynthia E.] Hosp Sick Children, Div Pathol, Toronto, ON, Canada; [Hulleman, Esther] Vrije Univ Univ, Med Ctr, Canc Ctr Amsterdam, Neurooncol Res Grp, Amsterdam, Netherlands; [Keller, Charles] Oregon Hlth & Sci Univ, Dept Pediat, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA	Oregon Health & Science University; Texas Children's Cancer Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Oregon Health & Science University	Keller, C (corresponding author), Childrens Canc Therapy Dev Inst, Beaverton, OR 97005 USA.; Keller, C (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA.	charles@cc-tdi.org	Hulleman, Esther/AAD-7073-2021; Hawkins, Cynthia/M-2571-2019	Keller, Charles/0000-0003-2505-7487; Hulleman, Esther/0000-0001-9256-947X	Lyla Nsouli Foundation	Lyla Nsouli Foundation	Funded by Lyla Nsouli Foundation: http://www.lylansoulifoundation.org (CK). With Purpose: http://www.with-purpose.org/ (CK).	Bax DA, 2009, CLIN CANCER RES, V15, P5753, DOI 10.1158/1078-0432.CCR-08-3210; Benedetti S, 2000, NAT MED, V6, P447, DOI 10.1038/74710; Bouffet E, 2000, CANCER, V88, P685, DOI 10.1002/(SICI)1097-0142(20000201)88:3<685::AID-CNCR27>3.0.CO;2-K; Brehmer D, 2005, CANCER RES, V65, P379; Brown CE, 2016, NEW ENGL J MED, V375, P2561, DOI 10.1056/NEJMoa1610497; Cohen KJ, 2011, NEURO-ONCOLOGY, V13, P410, DOI 10.1093/neuonc/noq205; Conradt L, 2011, NEOPLASIA, V13, P1026, DOI 10.1593/neo.111016; Debinski W, 1998, CRIT REV ONCOGENESIS, V9, P255; Debinski W, 1999, CLIN CANCER RES, V5, P985; Debinski W, 1995, CLIN CANCER RES, V1, P1253; Donaldson SS, 2006, J CLIN ONCOL, V24, P1266, DOI 10.1200/JCO.2005.04.6599; Dreier T, 2002, INT J CANCER, V100, P690, DOI 10.1002/ijc.10557; Dunkel IJ, 1996, PEDIATR NEUROSURG, V24, P263, DOI 10.1159/000121049; FINLAY JL, 1990, J NEURO-ONCOL, V9, P239, DOI 10.1007/BF02341155; Finlay JL, 2005, J NEURO-ONCOL, V75, P253, DOI 10.1007/s11060-005-6747-7; Geoerger B, 2011, NEURO-ONCOLOGY, V13, P109, DOI 10.1093/neuonc/noq141; Grasso CS, 2015, NAT MED, V21, P555, DOI 10.1038/nm.3855; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hamasuna R, 2001, INT J CANCER, V93, P339, DOI 10.1002/ijc.1349; Hargrove D, 2006, LANCET ONCOL, V7, P241, DOI 10.1016/S1470-2045(06)70615-5; He QZ, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-70; Jalali R, 2010, INT J RADIAT ONCOL, V77, P113, DOI 10.1016/j.ijrobp.2009.04.031; Jennings MT, 2002, J CLIN ONCOL, V20, P3431, DOI 10.1200/JCO.2002.04.109; Joshi BH, 2000, CANCER RES, V60, P1168; Karajannis M, 2008, J CELL PHYSIOL, V217, P584, DOI 10.1002/jcp.21544; Kawakami M, 2004, CANCER-AM CANCER SOC, V101, P1036, DOI 10.1002/cncr.20470; Kellner C, 2008, J IMMUNOTHER, V31, P871, DOI 10.1097/CJI.0b013e318186c8b4; Kunwar S, 2007, J CLIN ONCOL, V25, P837, DOI 10.1200/JCO.2006.08.1117; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LANGMOEN IA, 1991, CHILD NERV SYST, V7, P13, DOI 10.1007/BF00263825; Li G, 2012, J NEURO-ONCOL, V108, P395, DOI 10.1007/s11060-012-0842-3; Lonigro RJ, 2011, NEOPLASIA, V13, P1019, DOI 10.1593/neo.111252; MacDonald TJ, 2011, NEURO-ONCOLOGY, V13, P1049, DOI 10.1093/neuonc/nor092; Mardor Y, 2009, J PHARMACOL EXP THER, V330, P520, DOI 10.1124/jpet.109.154401; Mazzoleni S, 2010, CANCER RES, V70, P7500, DOI 10.1158/0008-5472.CAN-10-2353; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; PACKER RJ, 1990, ANN NEUROL, V27, P167, DOI 10.1002/ana.410270212; Paugh BS, 2011, J CLIN ONCOL, V29, P3999, DOI 10.1200/JCO.2011.35.5677; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Pollack IF, 2014, J CLIN ONCOL, V32, P2050, DOI 10.1200/JCO.2013.54.0526; Rahaman SO, 2005, CANCER RES, V65, P2956, DOI 10.1158/0008-5472.CAN-04-3592; Shimamura T, 2007, CANCER RES, V67, P9903, DOI 10.1158/0008-5472.CAN-06-4558; Smith SE, 2014, PEDIATR BLOOD CANCER, V61, P765, DOI 10.1002/pbc.24923; Suzuki A, 2015, CYTOKINE, V75, P79, DOI 10.1016/j.cyto.2015.05.026; Thaci B, 2014, NEURO-ONCOLOGY, V16, P1304, DOI 10.1093/neuonc/nou045; Van Mieghem E, 2013, EUR J NEUROL, V20, P1335, DOI 10.1111/ene.12192; Wu G, 2014, NAT GENET, V46, P444, DOI 10.1038/ng.2938; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yano H, 2001, Brain Tumor Pathol, V18, P7, DOI 10.1007/BF02478919	49	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0193565	10.1371/journal.pone.0193565	http://dx.doi.org/10.1371/journal.pone.0193565			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621254	Green Published, gold, Green Submitted			2022-12-26	WOS:000429206800008
J	Findling, S; Stotz, HU; Zoeller, M; Krischke, M; Zander, M; Gatz, C; Berger, S; Mueller, MJ				Findling, Simone; Stotz, Henrik U.; Zoeller, Maria; Krischke, Markus; Zander, Mark; Gatz, Christiane; Berger, Susanne; Mueller, Martin J.			TGA2 signaling in response to reactive electrophile species is not dependent on cysteine modification of TGA2	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; 12-OXO-PHYTODIENOIC ACID; DEFENSE RESPONSES; HYDROGEN-PEROXIDE; REDOX REGULATION; PLANT-RESPONSES; DNA-BINDING; PROTEIN	Reactive electrophile species (RES), including prostaglandins, phytoprostanes and 12-oxo phytodienoic acid (OPDA), activate detoxification responses in plants and animals. However, the pathways leading to the activation of defense reactions related to abiotic or biotic stress as a function of RES formation, accumulation or treatment are poorly understood in plants. Here, the thiol-modification of proteins, including the RES-activated basic region/leucine zipper transcription factor TGA2, was studied. TGA2 contains a single cysteine residue (Cys186) that was covalently modified by reactive cyclopentenones but not required for induction of detoxification genes in response to OPDA or prostaglandin Al. Activation of the glutathione-S-transferase 6 (GST6) promoter was responsive to cyclopentenones but not to unreactive cyclopentanones, including jasmonic acid suggesting that thiol reactivity of RES is important to activate the TGA2-dependent signaling pathway resulting in GST6 activation We show that RES modify thiols in numerous proteins in vivo, however, thiol reactivity alone appears not to be sufficient for biological activity as demonstrated by the failure of several membrane permeable thiol reactive reagents to activate the GST6 promoter.	[Findling, Simone; Stotz, Henrik U.; Zoeller, Maria; Krischke, Markus; Berger, Susanne; Mueller, Martin J.] Univ Wurzburg, Julius von Sachs Inst Biosci, Bioctr, Pharmaceut Biol, Wurzburg, Germany; [Zander, Mark; Gatz, Christiane] Georg August Univ Goettingen, Albrecht von Haller Inst Plant Sci, Gottingen, Germany; [Stotz, Henrik U.] Univ Hertfordshire, Sch Life & Med Sci, Hatfield, Herts, England; [Zander, Mark] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	University of Wurzburg; University of Gottingen; University of Hertfordshire; Salk Institute	Mueller, MJ (corresponding author), Univ Wurzburg, Julius von Sachs Inst Biosci, Bioctr, Pharmaceut Biol, Wurzburg, Germany.	martin.mueller@biozentrum.uni-wuerzburg.de	mueller, martin j/C-7616-2019	Stotz, Henrik/0000-0003-2954-8566; Berger, Susanne/0000-0001-7853-6778	Research Training Group Lipid Signaling, DFG (Deutsche Forschungsgemeinschaft [GRK 1342]	Research Training Group Lipid Signaling, DFG (Deutsche Forschungsgemeinschaft	The project was funded by the Research Training Group GRK 1342 Lipid Signaling, DFG (Deutsche Forschungsgemeinschaft, http://www.dfg.de/en/. Recipient: SF. Project leaders: SB, MJM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas MS, 2015, PLANT PHYSIOL, V168, P885, DOI 10.1104/pp.115.256834; Bottcher C, 2009, FEBS J, V276, P4693, DOI 10.1111/j.1742-4658.2009.07195.x; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chen WQ, 1996, PLANT J, V10, P955, DOI 10.1046/j.1365-313X.1996.10060955.x; Chen WQ, 1999, PLANT J, V19, P667, DOI 10.1046/j.1365-313x.1999.00560.x; Despres C, 2003, PLANT CELL, V15, P2181, DOI 10.1105/tpc.012849; Domingues RM, 2013, J PROTEOMICS, V92, P110, DOI 10.1016/j.jprot.2013.06.004; Dueckershoff K, 2008, BBA-PROTEINS PROTEOM, V1784, P1975, DOI 10.1016/j.bbapap.2008.09.003; Farmer EE, 2007, CURR OPIN PLANT BIOL, V10, P380, DOI 10.1016/j.pbi.2007.04.019; Farmer EE, 2013, ANNU REV PLANT BIOL, V64, P429, DOI 10.1146/annurev-arplant-050312-120132; Fode B, 2008, PLANT CELL, V20, P3122, DOI 10.1105/tpc.108.058974; Huang LJ, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0886-1; Kang HG, 2005, PLANT MOL BIOL, V57, P541, DOI 10.1007/s11103-005-0409-1; Kholod N, 2001, BIOTECHNIQUES, V31, P322, DOI 10.2144/01312st03; Koster J, 2012, PLANT PHYSIOL, V159, P1292, DOI 10.1104/pp.112.900440; Li S, 2009, PLANT CELL, V21, P429, DOI 10.1105/tpc.108.064477; Lindermayr C, 2010, PLANT CELL, V22, P2894, DOI 10.1105/tpc.109.066464; Loeffler C, 2005, PLANT PHYSIOL, V137, P328, DOI 10.1104/pp.104.051714; Mano J, 2012, PLANT PHYSIOL BIOCH, V59, P90, DOI 10.1016/j.plaphy.2012.03.010; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Moos PJ, 2003, J BIOL CHEM, V278, P745, DOI 10.1074/jbc.M211134200; Mosblech A, 2009, PLANT PHYSIOL BIOCH, V47, P511, DOI 10.1016/j.plaphy.2008.12.011; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Mueller MJ, 2009, PHYTOCHEMISTRY, V70, P1511, DOI 10.1016/j.phytochem.2009.05.018; Mueller S, 2008, PLANT CELL, V20, P768, DOI 10.1105/tpc.107.054809; Park SW, 2013, P NATL ACAD SCI USA, V110, P9559, DOI 10.1073/pnas.1218872110; Rudolph TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290re7; SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5; Stange C, 1997, PLANT J, V11, P1315, DOI 10.1046/j.1365-313X.1997.11061315.x; Stotz HU, 2013, J EXP BOT, V64, P963, DOI 10.1093/jxb/ers389; Stotz HU, 2011, PLANT CELL PHYSIOL, V52, P1941, DOI 10.1093/pcp/pcr127; Straus DS, 2001, MED RES REV, V21, P185, DOI 10.1002/med.1006; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Taki N, 2005, PLANT PHYSIOL, V139, P1268, DOI 10.1104/pp.105.067058; Thurow C, 2005, PLANT J, V44, P100, DOI 10.1111/j.1365-313X.2005.02513.x; Wasternack C, 2013, BIOCHIMIE, V95, P79, DOI 10.1016/j.biochi.2012.06.005; Wible RS, 2017, CHEM RES TOXICOL, V30, P729, DOI 10.1021/acs.chemrestox.6b00428; Zander M, 2014, PLANT PHYSIOL, V165, P1671, DOI 10.1104/pp.114.243360; Zander M, 2012, MOL PLANT, V5, P831, DOI 10.1093/mp/ssr113; Zander M, 2010, PLANT J, V61, P200, DOI 10.1111/j.1365-313X.2009.04044.x; Zhang YL, 2003, PLANT CELL, V15, P2647, DOI 10.1105/tpc.014894; ZIMMERMAN DH, 1978, AM SOCIOL, V13, P6	43	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195398	10.1371/journal.pone.0195398	http://dx.doi.org/10.1371/journal.pone.0195398			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608605	Green Published, Green Submitted, gold			2022-12-26	WOS:000428988800050
J	Takala, H; Lehtivuori, HK; Berntsson, O; Hughes, A; Nanekar, R; Niebling, S; Panman, M; Henry, L; Menzel, A; Westenhoff, S; Ihalainen, JA				Takala, Heikki; Lehtivuori, Heli K.; Berntsson, Oskar; Hughes, Ashley; Nanekar, Rahul; Niebling, Stephan; Panman, Matthijs; Henry, Leocadie; Menzel, Andreas; Westenhoff, Sebastian; Ihalainen, Janne A.			On the (un)coupling of the chromophore, tongue interactions, and overall conformation in a bacterial phytochrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						photoreceptor; cell signaling; mutagenesis; protein structure; X-ray crystallography; structural biology; protein conformation; chromophore-binding domain; photoconversion; phytochrome	CRYSTAL-STRUCTURE; DEINOCOCCUS-RADIODURANS; PLANT PHYTOCHROME; BINDING DOMAIN; BACTERIOPHYTOCHROME; PHOTOCONVERSION; MODULE; AGP1; FTIR; REARRANGEMENTS	Phytochromes are photoreceptors in plants, fungi, and various microorganisms and cycle between metastable red light-absorbing (Pr) and far-red light-absorbing (Pfr) states. Their light responses are thought to follow a conserved structural mechanism that is triggered by isomerization of the chromophore. Downstream structural changes involve refolding of the so-called tongue extension of the phytochrome-specific GAF-related (PHY) domain of the photoreceptor. The tongue is connected to the chromophore by conserved DIP and PRXSF motifs and a conserved tyrosine, but the role of these residues in signal transduction is not clear. Here, we examine the tongue interactions and their interplay with the chromophore by substituting the conserved tyrosine (Tyr(263)) in the phytochrome from the extremophile bacterium Deinococcus radiodurans with phenylalanine. Using optical and FTIR spectroscopy, X-ray solution scattering, and crystallography of chromophore-binding domain (CBD) and CBD-PHY fragments, we show that the absence of the Tyr(263) hydroxyl destabilizes the -sheet conformation of the tongue. This allowed the phytochrome to adopt an -helical tongue conformation regardless of the chromophore state, hence distorting the activity state of the protein. Our crystal structures further revealed that water interactions are missing in the Y263F mutant, correlating with a decrease of the photoconversion yield and underpinning the functional role of Tyr(263) in phytochrome conformational changes. We propose a model in which isomerization of the chromophore, refolding of the tongue, and globular conformational changes are represented as weakly coupled equilibria. The results also suggest that the phytochromes have several redundant signaling routes.	[Takala, Heikki] Univ Helsinki, Fac Med, Dept Anat, FI-00014 Helsinki, Finland; [Takala, Heikki; Nanekar, Rahul; Ihalainen, Janne A.] Univ Jyvaskyla, Dept Biol & Environm Sci, Nanosci Ctr, FI-40014 Jyvaskyla, Finland; [Lehtivuori, Heli K.] Univ Jyvaskyla, Dept Phys, Nanosci Ctr, FI-40014 Jyvaskyla, Finland; [Berntsson, Oskar; Hughes, Ashley; Niebling, Stephan; Panman, Matthijs; Henry, Leocadie; Westenhoff, Sebastian] Univ Gothenburg, Dept Chem & Mol Biol, SE-40530 Gothenburg, Sweden; [Menzel, Andreas] Paul Scherrer Inst, CH-5232 Villigen 15, Switzerland	University of Helsinki; University of Jyvaskyla; University of Jyvaskyla; University of Gothenburg; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Takala, H (corresponding author), Univ Helsinki, Fac Med, FI-00014 Helsinki, Finland.	heikki.takala@helsinki.fi	Menzel, Andreas/C-4388-2012; Panman, Matthijs/N-3455-2019; Takala, Heikki/GVT-1834-2022; Takala, Heikki/ABC-9139-2020; Panman, Matthijs/D-4873-2011	Menzel, Andreas/0000-0002-0489-609X; Panman, Matthijs/0000-0003-3853-123X; Takala, Heikki/0000-0003-2518-8583; Takala, Heikki/0000-0003-2518-8583; Panman, Matthijs/0000-0003-3853-123X; Ihalainen, Janne/0000-0002-8741-1587; Berntsson, Oskar/0000-0003-1843-6278; Niebling, Stephan/0000-0001-6582-5984; Lehtivuori, Heli/0000-0002-7450-2578	Academy of Finland [285461, 277194, 296135]; Foundation of Strategic Research, Sweden [FFL09-0106]; European Research Council [279944]; Emil Aaltonen Foundation; Jane and Aatos Erkko Foundation	Academy of Finland(Academy of Finland); Foundation of Strategic Research, Sweden; European Research Council(European Research Council (ERC)European Commission); Emil Aaltonen Foundation; Jane and Aatos Erkko Foundation	This work was supported by Academy of Finland Grants 285461 (to H. T.), 277194 (to H. L.), and 296135 (to J. A. I.); the Foundation of Strategic Research, Sweden, Grant FFL09-0106, and European Research Council, Agreement 279944 (to S. W.); the Emil Aaltonen Foundation (to H. L.); and Jane and Aatos Erkko Foundation (to J. A. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Auldridge ME, 2012, J BIOL CHEM, V287, P7000, DOI 10.1074/jbc.M111.295121; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Berntsson O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00300-5; Bhattacharya S, 2014, J BIOL CHEM, V289, P32144, DOI 10.1074/jbc.M114.589739; Bjorling A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600920; Bjorling A, 2015, J PHYS CHEM LETT, V6, P3379, DOI 10.1021/acs.jpclett.5b01629; Burgie ES, 2016, STRUCTURE, V24, P448, DOI 10.1016/j.str.2016.01.001; Burgie ES, 2014, PLANT CELL, V26, P4568, DOI 10.1105/tpc.114.131623; Burgie ES, 2014, J BIOL CHEM, V289, P24573, DOI 10.1074/jbc.M114.571661; Burgie ES, 2014, P NATL ACAD SCI USA, V111, P10179, DOI 10.1073/pnas.1403096111; Casino P, 2010, CURR OPIN STRUC BIOL, V20, P763, DOI 10.1016/j.sbi.2010.09.010; Edlund P, 2016, SCI REP-UK, V6, DOI 10.1038/srep35279; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Foerstendorf H, 2001, BIOCHEMISTRY-US, V40, P14952, DOI 10.1021/bi0156916; Gourinchas G, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602498; Jeong AR, 2016, PLANT PHYSIOL, V171, P2826, DOI 10.1104/pp.16.00342; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kacprzak S, 2017, J BIOL CHEM, V292, P7598, DOI 10.1074/jbc.M116.761882; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Lamparter T, 2003, J BIOL CHEM, V278, P33786, DOI 10.1074/jbc.M305563200; Lehtivuori H, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00065; Lehtivuori H, 2013, J PHYS CHEM B, V117, P11049, DOI 10.1021/jp312061b; Mailliet J, 2011, J MOL BIOL, V413, P115, DOI 10.1016/j.jmb.2011.08.023; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagano S, 2016, J BIOL CHEM, V291, P20674, DOI 10.1074/jbc.M116.739136; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Stojkovic EA, 2014, J PHYS CHEM LETT, V5, P2512, DOI 10.1021/jz501189t; Su YS, 2007, PLANT CELL, V19, P2124, DOI 10.1105/tpc.107.051516; Takahashi R, 2007, BIOCHEMISTRY-US, V46, P6459, DOI 10.1021/bi7004653; Takala H, 2016, STRUCT DYNAM-US, V3, DOI 10.1063/1.4961911; Takala H, 2015, J BIOL CHEM, V290, P16383, DOI 10.1074/jbc.M115.650127; Takala H, 2014, BIOCHEMISTRY-US, V53, P7076, DOI 10.1021/bi501180s; Takala H, 2014, NATURE, V509, P245, DOI 10.1038/nature13310; Tkachenko N.V., 2006, OPTICAL SPECTROSCOPY; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang XJ, 2015, STRUCTURE, V23, P1179, DOI 10.1016/j.str.2015.04.022; Zhang JR, 2013, PLANT PHYSIOL, V161, P1445, DOI 10.1104/pp.112.208892	41	37	38	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8161	8172		10.1074/jbc.RA118.001794	http://dx.doi.org/10.1074/jbc.RA118.001794			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29622676	hybrid, Green Published			2022-12-26	WOS:000433224600021
J	McNitt, DH; Choi, SJ; Keene, DR; Van De Water, L; Squeglia, F; Berisio, R; Lukomski, S				McNitt, Dudley H.; Choi, Soo Jeon; Keene, Douglas R.; Van De Water, Livingston; Squeglia, Flavia; Berisio, Rita; Lukomski, Slawomir			Surface-exposed loops and an acidic patch in the Scl1 protein of group A Streptococcus enable Scl1 binding to wound-associated fibronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN-LIKE PROTEIN; CRYSTAL-STRUCTURE; BACILLUS-ANTHRACIS; INTEGRIN ALPHA-9-BETA-1; CELLULAR FIBRONECTIN; DENSITY-LIPOPROTEIN; ELECTRON-MICROSCOPY; VIRULENCE FACTOR; VARIABLE DOMAIN; TRIPLE-HELICES	Keratinized epidermis constitutes a powerful barrier of the mucosa and skin, effectively preventing bacterial invasion, unless it is wounded and no longer protective. Wound healing involves deposition of distinct extracellular matrix (ECM) proteins enriched in cellular fibronectin (cFn) isoforms containing extra domain A (EDA). The streptococcal collagen-like protein 1 (Scl1) is a surface adhesin of group A Streptococcus (GAS), which contains an N-terminal variable (V) domain and a C-terminally located collagen-like domain. During wound infection, Scl1 selectively binds EDA/cFn isoforms and laminin, as well as low-density lipoprotein (LDL), through its V domain. The trimeric V domain has a six-helical bundle fold composed of three pairs of anti-parallel -helices interconnected by hypervariable loops, but the roles of these structures in EDA/cFn binding are unclear. Here, using recombinant Scl (rScl) constructs to investigate structure-function determinants of the Scl1-EDA/cFn interaction, we found that full-length rScl1, containing both the globular V and the collagen domains, is necessary for EDA/cFn binding. We established that the surface-exposed loops, interconnecting conserved -helices, guide recognition and binding of Scl1-V to EDA and binding to laminin and LDL. Moreover, electrostatic surface potential models of the Scl1-V domains pointed to a conserved, negatively charged pocket, surrounded by positively charged and neutral regions, as a determining factor for the binding. In light of these findings, we propose an updated model of EDA/cFn recognition by the Scl1 adhesin from GAS, representing a significant step in understanding the Scl1-ECM interactions within the wound microenvironment that underlie GAS pathogenesis.	[McNitt, Dudley H.; Choi, Soo Jeon; Lukomski, Slawomir] West Virginia Univ, Sch Med, Dept Microbiol Immunol & Cell Biol, 2095 Heath Sci North,POB 9177, Morgantown, WV 26506 USA; [Keene, Douglas R.] Shriners Hosp Children, Microimaging Ctr, Portland, OR 97239 USA; [Van De Water, Livingston] Albany Med Coll, Dept Surg & Regenerat & Canc Cell Biol, Albany, NY 12208 USA; [Squeglia, Flavia; Berisio, Rita] Italian Natl Res Council, Inst Biostruct & Bioimaging, Via Mezzocannone 16, I-80134 Naples, Italy	West Virginia University; Albany Medical College; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR)	Lukomski, S (corresponding author), West Virginia Univ, Sch Med, Dept Microbiol Immunol & Cell Biol, 2095 Heath Sci North,POB 9177, Morgantown, WV 26506 USA.	slukomski@hsc.wvu.edu	Squeglia, Flavia/ABC-6150-2020; Squeglia, Flavia/AAA-8152-2019	Squeglia, Flavia/0000-0001-9142-3313; McNitt, Dudley/0000-0001-8592-4015	National Institutes of Health (NIH) Equipment Grant [S10OD016165]; NIGMS, NIH, Grant [P30GM103488]; Shriners Hospital for Children; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050666, R21AI083683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103488] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016165] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Equipment Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, NIH, Grant; Shriners Hospital for Children; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Paolo Fagone for assistance with rEDA purification, Kathleen Brundage for flow cytometry assistance, and Janusz Bujnicki for initial bioinformatic analyses. We thank Nyles Charon for critical reading of the manuscript. We especially thank the Shriners Hospital for Children for support of the Micro-Imaging Center in the Portland Research Unit. Flow cytometry experiments were performed in the West Virginia University Flow Cytometry and Single Cell Core Facility, which is supported by National Institutes of Health (NIH) Equipment Grant S10OD016165 and NIGMS, NIH, Grant P30GM103488 (CoBRE).	Akiyama H, 2003, J DERMATOL SCI, V32, P193, DOI 10.1016/S0923-1811(03)00096-3; Bachert BA, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00090; Back CR, 2017, J BIOL CHEM, V292, P1538, DOI 10.1074/jbc.M116.760975; Bisno AL, 2005, CLIN INFECT DIS, V41, P1150, DOI 10.1086/444505; Bourhis JM, 2012, NAT STRUCT MOL BIOL, V19, P1031, DOI 10.1038/nsmb.2389; Boydston JA, 2005, J BACTERIOL, V187, P5310, DOI 10.1128/JB.187.15.5310-5317.2005; BRODSKYDOYLE B, 1976, BIOCHEM J, V159, P279, DOI 10.1042/bj1590279; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Caswell CC, 2008, MOL MICROBIOL, V67, P584, DOI 10.1111/j.1365-2958.2007.06067.x; Caswell CC, 2007, MOL MICROBIOL, V64, P1319, DOI 10.1111/j.1365-2958.2007.05741.x; Caswell CC, 2010, FEMS MICROBIOL LETT, V303, P61, DOI 10.1111/j.1574-6968.2009.01864.x; Caswell CC, 2008, J BIOL CHEM, V283, P36168, DOI 10.1074/jbc.M806865200; Chen SM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-320; Christner M, 2010, MOL MICROBIOL, V75, P187, DOI 10.1111/j.1365-2958.2009.06981.x; Coito AJ, 1997, AM J PATHOL, V150, P1757; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dabo SM, 2006, INFECT IMMUN, V74, P2513, DOI 10.1128/IAI.74.5.2513-2521.2006; Efstratiou A., 2016, STREPTOCOCCUS PYOGEN, P1; ENGEL J, 1987, METHOD ENZYMOL, V145, P3; FFRENCHCONSTANT C, 1995, EXP CELL RES, V221, P261, DOI 10.1006/excr.1995.1374; FFRENCHCONSTANT C, 1989, J CELL BIOL, V109, P903, DOI 10.1083/jcb.109.2.903; FFRENCHCONSTANT C, 1989, DEVELOPMENT, V106, P375; Flores AR, 2015, INFECT IMMUN, V83, P1122, DOI 10.1128/IAI.02860-14; Forsgren N, 2009, PROTEIN SCI, V18, P1896, DOI 10.1002/pro.200; Gao YM, 2010, FEMS MICROBIOL LETT, V309, P55, DOI 10.1111/j.1574-6968.2010.02013.x; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Han RL, 2006, MOL MICROBIOL, V61, P351, DOI 10.1111/j.1365-2958.2006.05237.x; Han RL, 2006, APPL MICROBIOL BIOT, V72, P109, DOI 10.1007/s00253-006-0387-5; Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x; Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200; Hynes RO, 1990, FIBRONECTINS; Kanwal S, 2017, MOL MICROBIOL, V105, P839, DOI 10.1111/mmi.13740; Kelsh R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102974; Kingsley RA, 2004, MOL MICROBIOL, V52, P345, DOI 10.1111/j.1365-2958.2004.03995.x; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Liao YF, 2002, J BIOL CHEM, V277, P14467, DOI 10.1074/jbc.M201100200; Liu CQ, 2008, BIOTECHNOL BIOENG, V99, P774, DOI 10.1002/bit.21637; Longmate WM, 2017, J CELL BIOL, V216, P1473, DOI 10.1083/jcb.201510042; Lukomski S, 2001, INFECT IMMUN, V69, P1729, DOI 10.1128/IAI.69.3.1729-1738.2001; Lukomski S, 2000, INFECT IMMUN, V68, P6542, DOI 10.1128/IAI.68.12.6542-6553.2000; Lukomski S, 2017, MOL MICROBIOL, V103, P919, DOI 10.1111/mmi.13604; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Mullen LM, 2008, INFECT IMMUN, V76, P1093, DOI 10.1128/IAI.01349-07; Niimi T, 2001, J BIOMOL NMR, V21, P281, DOI 10.1023/A:1012947209393; Oliver-Kozup H, 2013, MOL MICROBIOL, V87, P672, DOI 10.1111/mmi.12125; Pahlman LI, 2007, J BIOL CHEM, V282, P24873, DOI 10.1074/jbc.M610015200; PALMER EL, 1993, J CELL BIOL, V123, P1289, DOI 10.1083/jcb.123.5.1289; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Paterson GK, 2008, FEMS MICROBIOL LETT, V285, P170, DOI 10.1111/j.1574-6968.2008.01217.x; Pavone P, 2006, J CHILD NEUROL, V21, P727, DOI 10.1177/08830738060210091401; Pfoh E, 2008, PEDIATRICS, V121, P229, DOI 10.1542/peds.2007-0484; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rasmussen M, 2000, INFECT IMMUN, V68, P6370, DOI 10.1128/IAI.68.11.6370-6377.2000; Rasmussen M, 2001, MOL MICROBIOL, V40, P1427, DOI 10.1046/j.1365-2958.2001.02493.x; Rego S, 2016, J BIOL CHEM, V291, P15985, DOI 10.1074/jbc.M116.726562; Rety S, 2005, J BIOL CHEM, V280, P43073, DOI 10.1074/jbc.M510087200; Reuter M, 2010, J BIOL CHEM, V285, P38473, DOI 10.1074/jbc.M110.143727; Roberts AL, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-3; Shinde AV, 2008, J BIOL CHEM, V283, P2858, DOI 10.1074/jbc.M708306200; Shinde AV, 2015, MATRIX BIOL, V41, P26, DOI 10.1016/j.matbio.2014.11.004; Singh P, 2004, J INVEST DERMATOL, V123, P1176, DOI 10.1111/j.0022-202X.2004.23485.x; Singh P, 2009, J INVEST DERMATOL, V129, P217, DOI 10.1038/jid.2008.201; Squeglia F, 2014, J BIOL CHEM, V289, P5122, DOI 10.1074/jbc.M113.523597; Squeglia F, 2013, ACTA CRYSTALLOGR F, V69, P1023, DOI 10.1107/S174430911302068X; To WS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-21; Troffer-Charlier N, 2002, J MOL BIOL, V318, P179, DOI 10.1016/S0022-2836(02)00025-6; Tsang TM, 2012, J BIOL CHEM, V287, P16759, DOI 10.1074/jbc.M112.358978; Webb B, 2017, METHODS MOL BIOL, V1654, P39, DOI 10.1007/978-1-4939-7231-9_4; Whatmore AM, 2001, MICROBIOL-UK, V147, P419, DOI 10.1099/00221287-147-2-419; Xu CY, 2010, BIOMACROMOLECULES, V11, P348, DOI 10.1021/bm900894b; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yamaguchi M, 2013, CELL MICROBIOL, V15, P503, DOI 10.1111/cmi.12083; Yu ZX, 2010, PROTEIN SCI, V19, P775, DOI 10.1002/pro.356	74	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7796	7810		10.1074/jbc.RA118.002250	http://dx.doi.org/10.1074/jbc.RA118.002250			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29615492	hybrid, Green Published			2022-12-26	WOS:000437256500028
J	Palama, A; Malsert, J; Gentaz, E				Palama, Amaya; Malsert, Jennifer; Gentaz, Edouard			Are 6-month-old human infants able to transfer emotional information (happy or angry) from voices to faces? An eye-tracking study	PLOS ONE			English	Article							FACIAL EXPRESSIONS; 7-MONTH-OLD INFANTS; GENERALIZED DISCRIMINATION; PERCEPTION; RECOGNITION; NEWBORNS; LIFE; ATTENTION; MOTHERS	The present study examined whether 6-month-old infants could transfer amodal information (i.e. independently of sensory modalities) from emotional voices to emotional faces. Thus, sequences of successive emotional stimuli (voice or face from one sensory modality-auditory-to another sensory modality-visual-), corresponding to a cross-modal transfer, were displayed to 24 infants. Each sequence presented an emotional (angry or happy) or neutral voice, uniquely, followed by the simultaneous presentation of two static emotional faces (angry or happy, congruous or incongruous with the emotional voice). Eye movements in response to the visual stimuli were recorded with an eye-tracker. First, results suggested no difference in infants' looking time to happy or angry face after listening to the neutral voice or the angry voice. Nevertheless, after listening to the happy voice, infants looked longer at the incongruent angry face (the mouth area in particular) than the congruent happy face. These results revealed that a cross-modal transfer (from auditory to visual modalities) is possible for 6-month-old infants only after the presentation of a happy voice, suggesting that they recognize this emotion amodally.	[Palama, Amaya; Malsert, Jennifer; Gentaz, Edouard] Univ Geneva, Fac Psychol & Educ Sci, SensoriMotor Affect & Social Dev Lab, Geneva, Switzerland; [Malsert, Jennifer; Gentaz, Edouard] Univ Geneva, Swiss Ctr Affect Sci, Campus Biotech, Geneva, Switzerland; [Gentaz, Edouard] CNRS, Grenoble, France	University of Geneva; University of Geneva; Centre National de la Recherche Scientifique (CNRS)	Gentaz, E (corresponding author), Univ Geneva, Fac Psychol & Educ Sci, SensoriMotor Affect & Social Dev Lab, Geneva, Switzerland.; Gentaz, E (corresponding author), Univ Geneva, Swiss Ctr Affect Sci, Campus Biotech, Geneva, Switzerland.; Gentaz, E (corresponding author), CNRS, Grenoble, France.	edouard.gentaz@unige.ch		Palama, Amaya/0000-0002-9251-0520; Gentaz, Edouard/0000-0003-0574-5557	Swiss National Fund [100019-156073]	Swiss National Fund(Swiss National Science Foundation (SNSF))	This research was supported by the Swiss National Fund for the research grant 100019-156073 awarded to E.G.	Amso D, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00180; Arnal LH, 2015, CURR BIOL, V25, P2051, DOI 10.1016/j.cub.2015.06.043; BARRERA ME, 1981, CHILD DEV, V52, P714, DOI 10.2307/1129196; Bayet L., 2015, THESES U GRENOBLE; Bayet L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129812; Bayet L, 2014, ANN PSYCHOL, V114, P469; Belin P, 2008, BEHAV RES METHODS, V40, P531, DOI 10.3758/BRM.40.2.531; Bornstein MH, 2011, INFANT BEHAV DEV, V34, P100, DOI 10.1016/j.infbeh.2010.10.002; Bornstein MH, 2003, DEVELOPMENTAL SCI, V6, P585, DOI 10.1111/1467-7687.00314; CARON AJ, 1988, CHILD DEV, V59, P604, DOI 10.1111/j.1467-8624.1988.tb03219.x; CARON RF, 1982, CHILD DEV, V53, P1008, DOI 10.1111/j.1467-8624.1982.tb01365.x; CARON RF, 1985, CHILD DEV, V56, P1552, DOI 10.2307/1130474; Dollion N., 2015, J VISION, V15, pe795, DOI [10.1167/15.12.795, DOI 10.1167/15.12.795]; Dollion N, 2015, CHEM SENSES, V40, P241; Farroni T, 2007, EUR J DEV PSYCHOL, V4, P2, DOI 10.1080/17405620601046832; Feron J, 2006, COGNITIVE DEV, V21, P81, DOI 10.1016/j.cogdev.2006.01.005; Flom R, 2007, DEV PSYCHOL, V43, P238, DOI 10.1037/0012-1649.43.1.238; Geangu E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027132; Geangu E, 2010, INFANT BEHAV DEV, V33, P279, DOI 10.1016/j.infbeh.2010.03.004; Gentaz E, 2016, VIE SECRETE ENFANTS; Godard O, 2016, DEVELOPMENTAL SCI, V19, P155, DOI 10.1111/desc.12292; Hoehl S, 2014, EMOTION PROCESSING I, P1; Hunnius S, 2011, COGNITION EMOTION, V25, P193, DOI 10.1080/15298861003771189; Iacobucci D, 2001, J CONSUM PSYCHOL, V10, P1, DOI 10.1207/S15327663JCP1001&2_01; Kotsoni E, 2001, PERCEPTION, V30, P1115, DOI 10.1068/p3155; KUCHUK A, 1986, CHILD DEV, V57, P1054; LABARBERA JD, 1976, CHILD DEV, V47, P535, DOI 10.2307/1128816; LARGO RH, 1989, DEV MED CHILD NEUROL, V31, P440, DOI 10.1111/j.1469-8749.1989.tb04022.x; Leppanen J, 2010, INT J BEHAV DEV, V34, P547, DOI 10.1177/0165025410365804; Leppanen JM, 2009, NAT REV NEUROSCI, V10, P37, DOI 10.1038/nrn2554; LUDEMANN PM, 1991, CHILD DEV, V62, P55, DOI 10.2307/1130704; LUDEMANN PM, 1988, DEV PSYCHOL, V24, P492, DOI 10.1037/0012-1649.24.4.492; Lundqvist D., 1998, KAROLINSKA DIRECTED; Montague DPF, 2002, CHILD DEV, V73, P1339, DOI 10.1111/1467-8624.00475; NELSON CA, 1987, CHILD DEV, V58, P889, DOI 10.2307/1130530; NELSON CA, 1985, CHILD DEV, V56, P58, DOI 10.2307/1130173; Oster H., 1981, INFANT SOCIAL COGNIT, P85; Peltola MJ, 2011, PSYCHOPHYSIOLOGY, V48, P1291, DOI 10.1111/j.1469-8986.2011.01188.x; Peltola MJ, 2009, EMOTION, V9, P560, DOI 10.1037/a0015806; Rigato S, 2011, EUR J DEV PSYCHOL, V8, P624, DOI 10.1080/17405629.2011.602239; Sander D, 2014, TRAITE PSYCHOL EMOTI; Schurgin MW, 2014, J VISION, V14, DOI 10.1167/14.13.14; SOKEN NH, 1992, CHILD DEV, V63, P787; Soken NH, 1999, CHILD DEV, V70, P1275, DOI 10.1111/1467-8624.00093; Streri A, 2004, Q J EXP PSYCHOL-A, V57, P523, DOI 10.1080/02724980343000378; Striano T, 2002, INFANCY, V3, P115, DOI 10.1207/S15327078IN0301_6; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Turati C, 2006, CHILD DEV, V77, P297, DOI 10.1111/j.1467-8624.2006.00871.x; YOUNGBROWNE G, 1977, CHILD DEV, V48, P555, DOI 10.1111/j.1467-8624.1977.tb01197.x	49	11	11	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194579	10.1371/journal.pone.0194579	http://dx.doi.org/10.1371/journal.pone.0194579			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641530	gold, Green Published			2022-12-26	WOS:000429742900036
J	Keren-Aviram, G; Dachet, F; Bagla, S; Balan, K; Loeb, JA; Dratz, EA				Keren-Aviram, Gal; Dachet, Fabien; Bagla, Shruti; Balan, Karina; Loeb, Jeffrey A.; Dratz, Edward A.			Proteomic analysis of human epileptic neocortex predicts vascular and glial changes in epileptic regions	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; ALPHA-B-CRYSTALLIN; FIBRILLARY ACIDIC PROTEIN; DYSFUNCTION; GENE; HIPPOCAMPUS; EXPRESSION; TISSUE; GFAP; IDENTIFICATION	Epilepsy is a common neurological disorder, which is not well understood at the molecular level. Exactly why some brain regions produce epileptic discharges and others do not is not known. Patients who fail to respond to antiseizure medication (refractory epilepsy) can benefit from surgical removal of brain regions to reduce seizure frequency. The tissue removed in these surgeries offers an invaluable resource to uncover the molecular and cellular basis of human epilepsy. Here, we report a proteomic study to determine whether there are common proteomic patterns in human brain regions that produce epileptic discharges. We analyzed human brain samples, as part of the Systems Biology of Epilepsy Project (SBEP). These brain pieces are in vivo electrophysiologically characterized human brain samples withdrawn from the neocortex of six patients with refractory epilepsy. This study is unique in that for each of these six patients the comparison of protein expression was made within the same patient: a more epileptic region was compared to a less epileptic brain region. The amount of epileptic activity was defined for each patient as the frequency of their interictal spikes (electric activity between seizures that is a parameter strongly linked to epilepsy). Proteins were resolved from three subcellular fractions, using a 2D differential gel electrophoresis (2D-DIGE), revealing 31 identified protein spots that changed significantly. Interestingly, glial fibrillary acidic protein (GFAP) was found to be consistently down regulated in high spiking brain tissue and showed a strong negative correlation with spike frequency. We also developed a two-step analysis method to select for protein species that changed frequently among the patients and identified these proteins. A total of 397 protein spots of interest (S01) were clustered by protein expression patterns across all samples. These clusters were used as markers and this analysis predicted proteomic changes due to both histological differences and molecular pathways, revealed by examination of gene ontology clusters. Our experimental design and proteomic data analysis predicts novel glial changes, increased angiogenesis, and changes in cytoskeleton and neuronal projections between high and low interictal spiking regions. Quantitative histological staining of these same tissues for both the vascular and glial changes confirmed these findings, which provide new insights into the structural and functional basis of neocortical epilepsy.	[Keren-Aviram, Gal; Dratz, Edward A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Dachet, Fabien; Bagla, Shruti; Balan, Karina; Loeb, Jeffrey A.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Dachet, Fabien; Loeb, Jeffrey A.] Univ Illinois, Dept Neurol & Rehabil, Chicago, IL 60607 USA	Montana State University System; Montana State University Bozeman; Wayne State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Loeb, JA (corresponding author), Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA.; Loeb, JA (corresponding author), Univ Illinois, Dept Neurol & Rehabil, Chicago, IL 60607 USA.	jaloeb@uic.edu		Dachet, Fabien/0000-0002-5146-3449	NIH/HINDS [R01NS045207, R01NS058802, R56 NS083527]; NIH [R21RR16240, R42RR021790, P20RR024237, P20GM104935]; NSF [0321267]; Montana Board of Research and Commercialization of Technology [5-14, 6-46, 08-17]; Murdock Charitable Trust	NIH/HINDS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Montana Board of Research and Commercialization of Technology; Murdock Charitable Trust	This work was funded by NIH/HINDS Grants R01NS045207, R01NS058802, and R56 NS083527 (to Jeffrey A. Loeb) and NIH R21RR16240, NSF 0321267, Montana Board of Research and Commercialization of Technology #5-14, #6-46 and #08-17, Murdock Charitable Trust, NIH R42RR021790, NIH P20RR024237, and NIH P20GM104935 (to Edward A. Dratz).	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2012, CLUSTER CLUSTER ANAL; Aronica E, 2012, GLIA, V60, P1258, DOI 10.1002/glia.22312; Asano E, 2003, EPILEPSIA, V44, P425, DOI 10.1046/j.1528-1157.2003.38902.x; Beaumont TL, 2012, J NEUROSCI, V32, P14389, DOI 10.1523/JNEUROSCI.3408-12.2012; Beyreuther BK, 2007, CNS DRUG REV, V13, P21, DOI 10.1111/j.1527-3458.2007.00001.x; Boer K, 2010, EPILEPSY RES, V90, P99, DOI 10.1016/j.eplepsyres.2010.03.014; Boulpaep EL, 2009, MED PHYSL, P3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Che Y, 2001, J NEUROSCI RES, V65, P425, DOI 10.1002/jnr.1170; Cheng CY, 2009, CRIT REV BIOCHEM MOL, V44, P245, DOI 10.1080/10409230903061207; D'Amici GM, 2012, NAT PROTOC, V7, P36, DOI 10.1038/nprot.2011.427; Dachet F, 2015, BRAIN; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; Eun JP, 2004, EXP MOL MED, V36, P185, DOI 10.1038/emm.2004.26; Ezzet F., 2007, PHARMACOMETRICS, P103, DOI [10.1002/9780470087978.ch4, DOI 10.1002/9780470087978.CH4]; Fisher NI, 1984, BIOMETRICS, V40, P567; Fornasiero EF, 2010, CELL MOL LIFE SCI, V67, P1383, DOI 10.1007/s00018-009-0227-8; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Guo RY, 2007, J CELL PHYSIOL, V211, P327, DOI 10.1002/jcp.20937; Hagemann TL, 2009, HUM MOL GENET, V18, P1190, DOI 10.1093/hmg/ddp013; Hashimoto M, 2002, J BIOL CHEM, V277, P11465, DOI 10.1074/jbc.M111428200; Heinemann U, 2012, GLIA, V60, P1251, DOI 10.1002/glia.22311; Hensley K, 2011, MOL NEUROBIOL, V43, P180, DOI 10.1007/s12035-011-8166-4; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Kelemen Halasz P, 2010, NEUROPSYCHIATRIC DIS, V465; Kim JE, 2010, J COMP NEUROL, V518, P4612, DOI 10.1002/cne.22482; Kovacs R, 2012, EPILEPSIA, V53, P53, DOI 10.1111/j.1528-1167.2012.03703.x; Kragh-Hansen U, 2002, BIOL PHARM BULL, V25, P695, DOI 10.1248/bpb.25.695; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lilley KS, 2004, EXPERT REV PROTEOMIC, V1, P401, DOI 10.1586/14789450.1.4.401; Lipovich L, 2012, GENETICS, V192, P1133, DOI 10.1534/genetics.112.145128; Liu JYW, 2012, BRAIN, V135, P3115, DOI 10.1093/brain/aws147; Liu X, 2009, MASS SPECTROMETRY RE; Loeb JA, 2010, EPILEPSIA, V51, P171, DOI 10.1111/j.1528-1167.2010.02635.x; Loeb JA, 2011, NEUROSCI LETT, V497, P205, DOI 10.1016/j.neulet.2011.02.041; Maaty WS, 2013, J BIOL CHEM, V288, P27042, DOI 10.1074/jbc.M113.484113; Maaty WS, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00411; Mantuano E, 2008, J BIOL CHEM, V283, P19904, DOI 10.1074/jbc.M801762200; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Marchi N, 2012, EPILEPSIA, V53, P1877, DOI 10.1111/j.1528-1167.2012.03637.x; Martinian L, 2009, NEUROPATH APPL NEURO, V35, P394, DOI [10.1111/j.1365-2990.2008.00996.x, 10.1111/j.1365-2990.2009.00996.x]; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Mirza N, 2011, HUM MOL GENET, V20, P4381, DOI 10.1093/hmg/ddr365; Morin-Brureau M, 2011, J NEUROSCI, V31, P10677, DOI 10.1523/JNEUROSCI.5692-10.2011; NEWCOMBE J, 1986, J NEUROCHEM, V47, P1713, DOI 10.1111/j.1471-4159.1986.tb13079.x; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Papageorgiou IE, 2011, GLIA, V59, P1706, DOI 10.1002/glia.21217; Rakhade SN, 2008, EPILEPSIA, V49, P226, DOI 10.1111/j.1528-1167.2007.01310.x; Rakhade SN, 2005, ANN NEUROL, V58, P736, DOI 10.1002/ana.20633; Rigau V, 2007, BRAIN, V130, P1942, DOI 10.1093/brain/awm118; Roux-Dalvai F, 2008, MOL CELL PROTEOMICS, V7, P2254, DOI 10.1074/mcp.M800037-MCP200; Sarnat HB, 2009, CAN J NEUROL SCI, V36, P566, DOI 10.1017/S0317167100008052; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seifert G, 2013, EXP NEUROL, V244, P4, DOI 10.1016/j.expneurol.2011.08.024; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Spencer S, 2008, LANCET NEUROL, V7, P525, DOI 10.1016/S1474-4422(08)70109-1; Stewart TH, 2010, J NEUROPHYSIOL, V104, P3345, DOI 10.1152/jn.00398.2010; Visanji NP, 2012, EPILEPSIA, V53, pe50, DOI 10.1111/j.1528-1167.2011.03369.x; Walpurgis K, 2012, ELECTROPHORESIS, V33, P2537, DOI 10.1002/elps.201200151; Weissberg Itai, 2011, Epilepsy Res Treat, V2011, P143908, DOI 10.1155/2011/143908; Wilson SM, 2012, NEUROSCIENCE, V210, P451, DOI 10.1016/j.neuroscience.2012.02.038; Witcher MR, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00061; Wu HC, 2017, EPILEPSIA, V58, P1626, DOI 10.1111/epi.13848; Yang JW, 2005, MOL BRAIN RES, V139, P348, DOI 10.1016/j.molbrainres.2005.06.010; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; You JS, 2005, PROTEOMICS, V5, P290, DOI 10.1002/pmic.200400889; Yun CH, 2006, EPILEPSIA, V47, P574, DOI 10.1111/j.1528-1167.2006.00470.x; Zhang Y, 2013, SPRINGER SERIES TRAN, P141; Zhao FH, 2012, SYNAPSE, V66, P781, DOI 10.1002/syn.21567; Ziemba KS, 2011, NEUROLOGIST, V17, P176, DOI 10.1097/NRL.0b013e318217368e	78	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195639	10.1371/journal.pone.0195639	http://dx.doi.org/10.1371/journal.pone.0195639			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634780	gold, Green Published, Green Submitted			2022-12-26	WOS:000429522200044
J	Pagliai, FA; Pan, L; Silva, D; Gonzalez, CF; Lorca, GL				Pagliai, Fernando A.; Pan, Lei; Silva, Danilo; Gonzalez, Claudio F.; Lorca, Graciela L.			Zinc is an inhibitor of the LdtR transcriptional activator	PLOS ONE			English	Article							CANDIDATUS LIBERIBACTER ASIATICUS; MULTIPLE-ANTIBIOTIC-RESISTANCE; COMPLETE GENOME SEQUENCE; CRYSTAL-STRUCTURE; AGROBACTERIUM-TUMEFACIENS; GENE-EXPRESSION; UPTAKE SYSTEM; MARR FAMILY; REGULATOR; PROTEIN	LdtR is a master regulator of gene expression in Liberibacter asiaticus, one of the causative agents of citrus greening disease. LdtR belongs to the MarR-family of transcriptional regulators and it has been linked to the regulation of more than 180 genes in Liberibacter species, most of them gathered in the following Clusters of Orthologous Groups: cell motility, cell wall envelope, energy production, and transcription. Our previous transcriptomic evidence suggested that LdtR is directly involved in the modulation of the zinc uptake system genes (znu) in the closely related L. crescens. In this report, we show that LdtR is involved in the regulation of one of the two encoded zinc uptake mechanisms in L. asiaticus, named znu(2). We also show that LdtR binds zinc with higher affinity than benzbromarone, a synthetic effector inhibitory molecule, resulting in the disruption of the LdtR:promoter interactions. Using site directed mutagenesis, electrophoretic mobility shift assays (EMSAs), and isothermal titration calorimetry, we identified that residues C28 and T43 in LdtR, located in close proximity to the Benz1 pocket, are involved in the interaction with zinc. These results provided new evidence of a high-affinity effector molecule targeting a key player in L. asiaticus' physiology and complemented our previous findings about the mechanisms of signal transduction in members of the MarR-family.	[Pagliai, Fernando A.; Pan, Lei; Silva, Danilo; Gonzalez, Claudio F.; Lorca, Graciela L.] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Genet Inst, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Lorca, GL (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Genet Inst, Gainesville, FL 32611 USA.	glorca@ufl.edu	Pagliai, Fernando A./J-9921-2019; Pan, Lei/K-2570-2019	Pan, Lei/0000-0002-7194-0302; Pagliai, Fernando A./0000-0002-0434-4594	Specialty Crop Research Initiative [2015-70016-23029]; Plant Biotic Interactions Program from the USDA National Institute of Food and Agriculture [201703060]	Specialty Crop Research Initiative; Plant Biotic Interactions Program from the USDA National Institute of Food and Agriculture	This work is supported by the Specialty Crop Research Initiative (Award number 2015-70016-23029 to G.L.L. and C.F.G), and the Plant Biotic Interactions Program (Award number 201703060 to C.F.G.) from the USDA National Institute of Food and Agriculture, http://nifa/usda.gov/.	Ahmad K, 2016, PLANT SOIL MICROBES, V1, P225, DOI [10.1007/978-3-319-27455-3_12, DOI 10.1007/978-3-319-27455-3_12]; Ahmad K, 2011, AFR J MICROBIOL RES, V5, P4967, DOI 10.5897/AJMR11.236; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Andreini C, 2006, J PROTEOME RES, V5, P3173, DOI 10.1021/pr0603699; Bassanezi RB, 2009, EUR J PLANT PATHOL, V125, P565, DOI 10.1007/s10658-009-9506-3; Bhubhani S, 2014, MICROBIOL-SGM, V160, P2452, DOI 10.1099/mic.0.082446-0; Bove JM, 2006, J PLANT PATHOL, V88, P7; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Butof L, 2017, COMPONENTS UNIQUE RE, V199, P1, DOI [10.1128/JB, DOI 10.1128/JB]; Cevallos-Cevallos JM, 2011, PHYTOCHEM ANALYSIS, V22, P236, DOI 10.1002/pca.1271; Chaoprasid P, 2016, APPL ENVIRON MICROB, V82, P3503, DOI 10.1128/AEM.00299-16; Choudhury R, 2001, CURR SCI INDIA, V81, P768; D'Orazio M, 2015, METALLOMICS, V7, P1023, DOI 10.1039/c5mt00017c; DAGRACA JV, 1991, ANNU REV PHYTOPATHOL, V29, P109, DOI 10.1146/annurev.py.29.090191.000545; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Duval V, 2013, J BACTERIOL, V195, P3341, DOI 10.1128/JB.02224-12; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellison ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075389; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Gardner CL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01630; Gilston BA, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001987; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Guerra AJ, 2011, J AM CHEM SOC, V133, P19614, DOI 10.1021/ja2080532; Hantke K, 2005, CURR OPIN MICROBIOL, V8, P196, DOI 10.1016/j.mib.2005.02.001; Hazai Eszter, 2009, Acta Pharm Hung, V79, P17; Hijaz F, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1183084; Leonard MT, 2012, STAND GENOMIC SCI, V7, P271, DOI 10.4056/sigs.3326772; Li JY, 2017, MOL PLANT MICROBE IN, V30, P620, DOI [10.1094/mpmi-12-16-0257-r, 10.1094/MPMI-12-16-0257-R]; Loto F, 2017, MICROB BIOTECHNOL, V10, P642, DOI 10.1111/1751-7915.12706; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; McCauley A., 2009, NUTR MANAG, V9, P1, DOI DOI 10.1109/ISTC.2012.6325235; McFedries A, 2013, CHEM BIOL, V20, P667, DOI 10.1016/j.chembiol.2013.04.008; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pW299, DOI 10.1093/nar/gkq531; Nwugo CC, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-59; Pagliai FA, 2017, MICROB BIOTECHNOL, V10, P896, DOI 10.1111/1751-7915.12728; Pagliai FA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01314; Pagliai FA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004101; Pagliai FA, 2014, MOL MICROBIOL, V92, P853, DOI 10.1111/mmi.12598; Pagliai FA, 2010, J BIOL CHEM, V285, P16921, DOI 10.1074/jbc.M110.111138; Pan L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01591; Patzer SI, 1998, MOL MICROBIOL, V28, P1199, DOI 10.1046/j.1365-2958.1998.00883.x; Pederick VG, PSEUDOMONAS AERUGINO, P1, DOI [10.1038/srep13139, DOI 10.1038/SREP13139]; Rajasekaran P, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00062; Reyes-Caballero H, 2011, BIOPHYS CHEM, V156, P103, DOI 10.1016/j.bpc.2011.03.010; Reyes-Caballero H, 2010, J MOL BIOL, V403, P197, DOI 10.1016/j.jmb.2010.08.030; Sambrook J, 1989, MOL CLONING LAB MANU, P626; Saridakis V, 2008, J MOL BIOL, V377, P655, DOI 10.1016/j.jmb.2008.01.001; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; SCHWARZ R E, 1970, Phytophylactica, V2, P59; Sharma N, 2016, BBA-PROTEINS PROTEOM, V1864, P1649, DOI 10.1016/j.bbapap.2016.08.016; Sharma N, 2015, J STRUCT BIOL, V189, P184, DOI 10.1016/j.jsb.2015.01.012; Spann T.M., 2011, CITRUS IND, V92, P6; Trivedi P, 2010, APPL ENVIRON MICROB, V76, P3427, DOI 10.1128/AEM.02901-09; Trzaskowski B, 2008, J BIOL INORG CHEM, V13, P133, DOI 10.1007/s00775-007-0306-y; Vahling-armstrong CM, 2012, 2 PLANT BACTERIA S M, P7, DOI [10.1371/journal.pone.0037340, DOI 10.1371/JOURNAL.PONE.0037340]; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Wang N, 2013, PHYTOPATHOLOGY, V103, P652, DOI 10.1094/PHYTO-12-12-0331-RVW; Yan Q, 2013, MOL PLANT PATHOL, V14, P391, DOI 10.1111/mpp.12015; Yu LL, 2009, BIOCHEMISTRY-US, V48, P2099, DOI 10.1021/bi801662s; Zhang MQ, 2016, J APPL MICROBIOL, V120, P1616, DOI 10.1111/jam.13102	61	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195746	10.1371/journal.pone.0195746	http://dx.doi.org/10.1371/journal.pone.0195746			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634775	Green Published, Green Submitted, gold			2022-12-26	WOS:000429522200055
J	Eberly, L; Richter, D; Comerci, G; Ocksrider, J; Mercer, D; Mlady, G; Wascher, D; Schenck, R				Eberly, Lauren; Richter, Dustin; Comerci, George; Ocksrider, Justin; Mercer, Deana; Mlady, Gary; Wascher, Daniel; Schenck, Robert			Psychosocial and demographic factors influencing pain scores of patients with knee osteoarthritis	PLOS ONE			English	Article							RHEUMATIC-DISEASES; OSTEO-ARTHRITIS; UNITED-STATES; DISABILITY; VARIABLES; HEALTH; DISCORDANCE; PREDICTORS; COMMUNITY; SEVERITY	Background Pain levels in patients with osteoarthritis (OA) of the knee are commonly assessed by using a numeric scoring system, but results may be influenced by factors other than the patient's actual physical discomfort or disease severity, including psychosocial and demographic variables. We examined the possible relation between knee-pain scores and several psychosocial, sociodemographic, disease, and treatment variables in 355 patients with knee OA. Methods The pain-evaluation instrument was a 0- to 10-point rating scale. Data obtained retrospectively from the patients' medical records were demographic characteristics, body mass index (BMI), concomitant disorders, illicit and prescription drug use, alcohol use, smoking, knee OA treatment, and severity of knee OA indicated by Kellgren-Lawrence (KL) radiographic grade. Univariate and multivariate analyses were performed to determine whether these variables correlated with reported pain scores. Results On univariate analysis, higher pain scores were significantly associated with Native American or Hispanic ethnicity; a higher BMI; current prescription for an opioid, antidepressant, or gabapentinoid medication; depression; diabetes mellitus; fibromyalgia; illicit drug use; lack of health insurance; smoking; previous knee injection; and recommendation by the clinician that the patient undergo knee surgery. Neither the patient's sex nor the KL grade showed a correlation. On multivariate analysis, depression, current opioid prescription, and Native American or Hispanic ethnicity retained a significant association with higher pain scores. Conclusions and implications Our results in a large, ethnically diverse group of patients with knee OA suggest that psycho social and sociodemographic factors may be important determinants of pain levels reported by patients with knee OA.	[Eberly, Lauren; Richter, Dustin; Ocksrider, Justin; Mercer, Deana; Wascher, Daniel; Schenck, Robert] Univ New Mexico, Dept Orthopaed & Rehabil, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Comerci, George] Univ New Mexico, Dept Internal Med, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Mlady, Gary] Univ New Mexico, Dept Radiol, Hlth Sci Ctr, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Richter, D (corresponding author), Univ New Mexico, Dept Orthopaed & Rehabil, Hlth Sci Ctr, Albuquerque, NM 87131 USA.	DLRichter@salud.unm.edu	Wascher, Daniel/Q-1703-2019	Wascher, Daniel/0000-0002-8766-826X; Richter, Dustin/0000-0001-9935-6493	Orthopaedic Rehabilitation Association	Orthopaedic Rehabilitation Association	We thank William D. Tandberg, MD for performing the statistical analysis and Renee Robillard and Sahar Freedman for editorial assistance. This study received the Vernon L. Nickel Award of 2015 by the Orthopaedic Rehabilitation Association and was presented at the 68th Annual Meeting of the Association of Bone and Joint Surgeons.	BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bernardy K, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009796.pub2; Callahan LF, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3492; CARMAN WJ, 1989, SEMIN ARTHRITIS RHEU, V18, P10, DOI 10.1016/0049-0172(89)90009-7; Castrejon I, 2014, ARTHRIT CARE RES, V66, P934, DOI 10.1002/acr.22237; Creamer P, 1999, J RHEUMATOL, V26, P1785; DAVIS MA, 1992, J RHEUMATOL, V19, P1943; DEXTER P, 1994, J RHEUMATOL, V21, P279; Doehring A, 2013, PAIN, V154, P15, DOI 10.1016/j.pain.2012.06.011; Edwards RR, 2006, ARTHRIT RHEUM-ARTHR, V55, P325, DOI 10.1002/art.21865; Hannan MT, 2000, J RHEUMATOL, V27, P1513; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P485, DOI 10.1136/ard.16.4.485; Kramer BJ, 2002, ARTHRIT RHEUM-ARTHR, V47, P588, DOI 10.1002/art.10795; Lachance L, 2001, OSTEOARTHR CARTILAGE, V9, P527, DOI 10.1053/joca.2000.0429; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; LICHTENBERG PA, 1986, J PSYCHOSOM RES, V30, P327, DOI 10.1016/0022-3999(86)90010-3; Linton SJ, 2011, EUR J PAIN, V15, P416, DOI 10.1016/j.ejpain.2010.08.009; MCALINDON TE, 1992, BRIT J RHEUMATOL, V31, P189; Parker JC, 1995, ARTHRIT CARE RES, V8, P279, DOI 10.1002/art.1790080412; Pud D, 2006, DRUG ALCOHOL DEPEN, V82, P218, DOI 10.1016/j.drugalcdep.2005.09.007; SALAFFI F, 1991, J RHEUMATOL, V18, P1581; Shih M, 2006, J GEN INTERN MED, V21, P1160, DOI 10.1111/j.1525-1497.2006.00573.x; Sokka T, 2003, BEST PRACT RES CL RH, V17, P427, DOI 10.1016/S1521-6942(03)00020-2; Somers TJ, 2009, J PAIN SYMPTOM MANAG, V37, P863, DOI 10.1016/j.jpainsymman.2008.05.009; Sullivan MJL, 2001, CLIN J PAIN, V17, P52, DOI 10.1097/00002508-200103000-00008; SUMMERS MN, 1988, ARTHRITIS RHEUM, V31, P204, DOI 10.1002/art.1780310208	27	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195075	10.1371/journal.pone.0195075	http://dx.doi.org/10.1371/journal.pone.0195075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630676	Green Published, Green Submitted, gold			2022-12-26	WOS:000429505000024
J	Polyzos, AA; Wood, NI; Williams, P; Wipf, P; Morton, AJ; McMurray, CT				Polyzos, Aris A.; Wood, Nigel I.; Williams, Paul; Wipf, Peter; Morton, A. Jennifer; McMurray, Cynthia T.			XJB-5-131-mediated improvement in physiology and behaviour of the R6/2 mouse model of Huntington's disease is age-and sex-dependent	PLOS ONE			English	Article							CAG REPEAT; CARDIOLIPIN OXIDATION; MOTOR DEFICITS; MICE; PHENOTYPE; LENGTH; PATHOPHYSIOLOGY; ABNORMALITIES; INSTABILITY; NITROXIDE	We have reported that the radical scavenger XJB-5-131 attenuates or reverses progression of the disease phenotype in the HdhQ(150/150) mouse, a slow onset model of HD. Here, we tested whether XJB-5-131 has beneficial effects in R6/2 mice, a severe early onset model of HD. We found that XJB-5-131 has beneficial effects in R6/2 mice, by delaying features of the motor and histological phenotype. The impact was sex-dependent, with a stronger effect in male mice. XJB-5-131 treatment improved some locomotor deficits in female R6/2 mice, but the effects were, in general, greater in male mice. Chronic treatment of male R6/2 mice with XJB-5-1-131 reduced weight loss, and improved the motor and temperature regulation deficits, especially in male mice. Treatment with XJB-5-131 had no effect on the lifespan of R6/2 mice. Nevertheless, it significantly slowed somatic expansion at 90 days, and reduced the density of inclusions. Our data show that while treatment with XJB-5-131 had complex effects on the phenotype of R6/2 mice, it produced a number of significant improvements in this severe model of HD.	[Polyzos, Aris A.; Williams, Paul; McMurray, Cynthia T.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Wood, Nigel I.; Morton, A. Jennifer] Univ Cambridge, Dept Physiol Dev & Neurosci, Anat Bldg, Cambridge, England; [Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Cambridge; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	McMurray, CT (corresponding author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.	ctmcmurray@lbl.gov	Classen, Scott/AAY-8176-2020; Wipf, Peter/AAG-1771-2021; Morton, Jenny/AAT-8642-2020	Wipf, Peter/0000-0001-7693-5863; Morton, Jenny/0000-0003-0181-6346; Polyzos, Aris/0000-0002-9542-5807	National Institutes of Health [NS060115, CA092584, GM066359, AG04337601]; CHDI Inc.; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHDI Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants, NS060115 (to CTM), and CA092584 (to CTM), GM066359 (to CTM), AG04337601 (to PW). AJM is funded by CHDI Inc.	Bjorkqvist M, 2005, HUM MOL GENET, V14, P565, DOI 10.1093/hmg/ddi053; Budworth H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005267; Carter RJ, 1999, J NEUROSCI, V19, P3248; Chan RB, 2012, NAT NEUROSCI, V15, P1325, DOI 10.1038/nn.3222; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; Dorner JL, 2007, BEHAV BRAIN RES, V178, P90, DOI 10.1016/j.bbr.2006.12.004; Dragatsis I, 2009, NEUROBIOL DIS, V33, P315, DOI 10.1016/j.nbd.2008.10.009; Duzdevich D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017119; Epperly MW, 2017, IN VIVO, V31, P39, DOI 10.21873/invivo.11022; Escobales N, 2014, J MOL CELL CARDIOL, V77, P136, DOI 10.1016/j.yjmcc.2014.10.009; Fink MP, 2007, BIOCHEM PHARMACOL, V74, P801, DOI 10.1016/j.bcp.2007.05.019; Glynn D, 2003, HUM MOL GENET, V12, P2431, DOI 10.1093/hmg/ddg249; Goodman AOG, 2008, EXP NEUROL, V210, P691, DOI 10.1016/j.expneurol.2007.12.026; Hunt MJ, 2005, EXP BRAIN RES, V166, P220, DOI 10.1007/s00221-005-2357-z; Javadov S, 2015, ONCOTARGET, V6, P39469, DOI 10.18632/oncotarget.5783; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Kagan VE, 2009, ADV DRUG DELIVER REV, V61, P1375, DOI 10.1016/j.addr.2009.06.008; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Kovtun IV, 2004, HUM MOL GENET, V13, P3057, DOI 10.1093/hmg/ddh325; Kovtun IV, 2001, NAT GENET, V27, P407, DOI 10.1038/86906; Krainz T, 2016, ACS CENTRAL SCI, V2, P653, DOI 10.1021/acscentsci.6b00199; Larson E, 2015, NEUROBIOL DIS, V76, P98, DOI 10.1016/j.nbd.2015.01.004; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lione LA, 1999, J NEUROSCI, V19, P10428; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Morton AJ, 2009, NEUROBIOL DIS, V33, P331, DOI 10.1016/j.nbd.2008.11.015; Morton AJ, 2000, J NEUROCYTOL, V29, P679, DOI 10.1023/A:1010887421592; Nasto LA, 2013, J ORTHOP RES, V31, P1150, DOI 10.1002/jor.22320; Orr AL, 2008, J BIOL CHEM, V283, P16027, DOI 10.1074/jbc.M710606200; Polyzos A, 2016, HUM MOL GENET, V25, P1792, DOI 10.1093/hmg/ddw051; Rasband W.S., 2015, IMAGE J; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Skillings EA, 2016, J HUNTINGTONS DIS, V5, P19, DOI 10.3233/JHD-160189; Trushina E, 2014, HUM MOL GENET, V23, P129, DOI 10.1093/hmg/ddt406; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P1379, DOI 10.1093/hmg/ddi147; Wood NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009077; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004; Xun ZY, 2012, CELL REP, V2, P1137, DOI 10.1016/j.celrep.2012.10.001	40	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0194580	10.1371/journal.pone.0194580	http://dx.doi.org/10.1371/journal.pone.0194580			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630611	Green Published, gold, Green Submitted			2022-12-26	WOS:000429505000013
J	Olariu, E; Pooley, N; Danel, A; Miret, M; Preiser, JC				Olariu, Elena; Pooley, Nicholas; Danel, Aurelie; Miret, Montserrat; Preiser, Jean-Charles			A systematic scoping review on the consequences of stress-related hyperglycaemia	PLOS ONE			English	Review							CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; RANDOMIZED CONTROLLED-TRIAL; CONVENTIONAL GLUCOSE CONTROL; TRAUMA PATIENTS; INSULIN THERAPY; ADMISSION HYPERGLYCEMIA; PERSISTENT HYPERGLYCEMIA; HOSPITAL MORTALITY; GLYCEMIC CONTROL	Background Stress-related hyperglycaemia (SHG) is commonly seen in acutely ill patients and has been associated with poor outcomes in many studies performed in different acute care settings. We aimed to review the available evidence describing the associations between SHG and different outcomes in acutely ill patients admitted to an ICU. Study designs, populations, and outcome measures used in observational studies were analysed. Methods We conducted a systematic scoping review of observational studies following the Joanna Briggs methodology. Medline, Embase, and the Cochrane Library were searched for publications between January 2000 and December 2015 that reported on SHG and mortality, infection rate, length of stay, time on ventilation, blood transfusions, renal replacement therapy, or acquired weakness. Results The search yielded 3,063 articles, of which 43 articles were included (totalling 536,476 patients). Overall, the identified studies were heterogeneous in study conduct, SHG definition, blood glucose measurements and monitoring, treatment protocol, and outcome reporting. The most frequently reported outcomes were mortality (38 studies), ICU and hospital length of stay (23 and 18 studies, respectively), and duration of mechanical ventilation (13 studies). The majority of these studies (40 studies) compared the reported outcomes in patients who experienced SHG with those who did not. Fourteen studies (35.9%) identified an association between hyperglycaemia and increased mortality (odds ratios ranging from 1.13 to 2.76). Five studies identified hyperglycaemia as an independent risk factor for increased infection rates, and one identified it as an independent predictor of increased ICU length of stay. Discussion SHG was consistently associated with poor outcomes. However, the wide divergences in the literature mandate standardisation of measuring and monitoring SHG and the creation of a consensus on SHG definition. A better comparability between practices will improve our knowledge on SHG consequences and management.	[Olariu, Elena; Pooley, Nicholas] PHMR Ltd, London, England; [Danel, Aurelie; Miret, Montserrat] Nestle Hlth Sci, Vevey, Switzerland; [Preiser, Jean-Charles] Univ Libre Bruxelles, Erasme Univ Hosp, Dept Intens Care, Brussels, Belgium	Nestle SA; Universite Libre de Bruxelles	Preiser, JC (corresponding author), Univ Libre Bruxelles, Erasme Univ Hosp, Dept Intens Care, Brussels, Belgium.	Jean-Charles.Preiser@erasme.ulb.ac.be	Preiser, Jean-Charles/AAL-2355-2021; Olariu, Elena/B-1303-2015	Preiser, Jean-Charles/0000-0003-3163-0390; Olariu, Elena/0000-0002-8718-5516	Nestle (Vevey, Switzerland)	Nestle (Vevey, Switzerland)	PHMR was commissioned by Nestle Health Science to perform this research. In collaboration with Nestle Health Science, PHMR wrote the scoping review's protocol, designed the search strategy and eligibility criteria, performed the study selection, charted the data and summarised the results. A protocol was not registered for this systematic scoping review as PROSPERO currently does not accept systematic scoping review protocols (personal communication). All authors had full access to the data. All authors had final responsibility for the decision to submit for publication. At the time of writing, EO and NP were permanent employees of PHMR; AD and MM are permanent employees of Nestle Health Science; J-CP has received honoraria for speeches and consultancy fees from Nestle (Vevey, Switzerland).	Abdelhamid YA, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1471-6; Annane D, 2010, JAMA-J AM MED ASSOC, V303, P341, DOI 10.1001/jama.2010.2; Arabi YM, 2008, CRIT CARE MED, V36, P3190, DOI 10.1097/CCM.0b013e31818f21aa; Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Bochicchio GV, 2007, J TRAUMA, V63, P1353, DOI 10.1097/TA.0b013e31815b83c4; Bochicchio GV, 2005, AM SURGEON, V71, P171; Bochicchio GV, 2005, J TRAUMA, V58, P921, DOI 10.1097/01.TA.0000162141.26392.07; Chabok SY, 2009, ACTA MED IRANICA; Corstjens AM, 2006, CRIT CARE, V10, DOI 10.1186/cc4957; Deckers JW, 2013, AM J CARDIOL, V112, P1306, DOI 10.1016/j.amjcard.2013.06.007; De la Rosa GD, 2008, CRIT CARE, V12, DOI 10.1186/cc7017; Diaz JJ, 2009, J TRAUMA, V66, P226, DOI 10.1097/TA.0b013e31815eb776; Dickerson RN, 2013, JPEN-PARENTER ENTER, V37, P506, DOI 10.1177/0148607112458526; Donati A, 2014, CRIT CARE RESUSC, V16, P13; Duane TM, 2008, J TRAUMA, V64, P1184, DOI 10.1097/TA.0b013e31816c5c95; Duane TM, 2006, AM SURGEON, V72, P613; Dungan KM, 2009, LANCET, V373, P1798, DOI 10.1016/S0140-6736(09)60553-5; Eslami S, 2011, INTENS CARE MED, V37, P583, DOI 10.1007/s00134-010-2129-5; Eslami S, 2008, CRIT CARE, V12, DOI 10.1186/cc7114; Falciglia M, 2009, CRIT CARE MED, V37, P3001, DOI 10.1097/CCM.0b013e3181b083f7; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finfer S, 2013, CRIT CARE, V17, DOI 10.1186/cc12537; Gale SC, 2007, AM SURGEON, V73, P454; Gornik I, 2010, CRIT CARE, V14, DOI 10.1186/cc9101; Gray CS, 2004, AGE AGEING, V33, P71, DOI 10.1093/ageing/afh026; Hermans G, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0993-7; Jacka MJ, 2009, CAN J NEUROL SCI, V36, P436, DOI 10.1017/S0317167100007757; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Jones S, 2011, JBI LIB SYST REV, V9, P418; Juneja R, 2009, CRIT CARE, V13, DOI 10.1186/cc8129; Kadri Z, 2006, HEART, V92, P910, DOI 10.1136/hrt.2005.073791; Kalfon P, 2014, INTENS CARE MED, V40, P171, DOI 10.1007/s00134-013-3189-0; Kennedy-Martin T, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1023-4; Kreutziger J, 2015, INJURY, V46, P15, DOI 10.1016/j.injury.2014.09.018; Krinsley JS, 2017, ENDOCR PRACT, V23, P318, DOI 10.4158/EP161532.OR; Krinsley JS, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0908-7; Krinsley JS, 2013, CRIT CARE, V17, DOI 10.1186/cc12547; Krinsley JS, 2003, MAYO CLIN PROC, V78, P1471, DOI 10.4065/78.12.1471; Kuppinger D, 2013, NUTRITION, V29, P708, DOI 10.1016/j.nut.2012.11.019; Lacherade JC, 2007, INTENS CARE MED, V33, P814, DOI 10.1007/s00134-007-0543-0; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; Leite SAO, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-49; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Levin PD, 2008, ENDOCRINOLOGIST, V18, P304, DOI 10.1097/TEN.0b013e31818fee7c; Lionel KR, 2014, INDIAN J CRIT CARE M, V18, P21, DOI 10.4103/0972-5229.125431; Lucas Marília Coelho Silva, 2012, Rev. bras. ter. intensiva, V24, P157, DOI 10.1590/S0103-507X2012000200010; Marik PE, 2013, CRIT CARE, V17, DOI 10.1186/cc12514; Marik PE, 2010, CHEST, V137, P544, DOI 10.1378/chest.09-1737; McAllister DA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001708; Meier R, 2008, CRIT CARE, V12, DOI 10.1186/cc6974; Mesotten D, 2015, LANCET DIABETES ENDO, V3, P723, DOI 10.1016/S2213-8587(15)00223-5; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Peters MDJ, 2015, INT J EVID-BASED HEA, V13, P141, DOI 10.1097/XEB.0000000000000050; Plummer MP, 2014, INTENS CARE MED, V40, P973, DOI 10.1007/s00134-014-3287-7; Preiser JC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1607-3; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; RAYFIELD EJ, 1982, AM J MED, V72, P439, DOI 10.1016/0002-9343(82)90511-3; Richards JE, 2013, J ORTHOP TRAUMA, V27, P16, DOI 10.1097/BOT.0b013e31825d60e5; Safavi M, 2009, ULUS TRAVMA ACIL CER, V15, P120; Salim A, 2009, AM SURGEON, V75, P25; Santhanam R, 2007, NEUROL INDIA, V55, P349; Schlussel AT, 2012, J SURG RES, V176, P202, DOI 10.1016/j.jss.2011.07.004; Schlussel Andrew T, 2011, J Diabetes Sci Technol, V5, P731; Shin S, 2007, AM SURGEON, V73, P769; Siegelaar SE, 2010, CRIT CARE, V14, DOI 10.1186/cc9369; Smith RS, 2012, AM J SURG, V204, P915, DOI 10.1016/j.amjsurg.2012.05.016; Sperry JL, 2009, J TRAUMA, V66, P1076, DOI 10.1097/TA.0b013e31817db0de; Sung J, 2005, J TRAUMA, V59, P80, DOI 10.1097/01.TA.0000171452.96585.84; Umpierrez GE, 2002, J CLIN ENDOCR METAB, V87, P978, DOI 10.1210/jc.87.3.978; Van Ackerbroeck S, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1064-9; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Whitcomb BW, 2005, CRIT CARE MED, V33, P2772, DOI 10.1097/01.CCM.0000189741.44071.25; Yendamuri S, 2003, J TRAUMA, V55, P33, DOI 10.1097/01.TA.0000074434.39928.72; Yuan YH, 2009, AM J GASTROENTEROL, V104, P1086, DOI 10.1038/ajg.2009.118	76	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0194952	10.1371/journal.pone.0194952	http://dx.doi.org/10.1371/journal.pone.0194952			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624594	Green Published, gold, Green Submitted			2022-12-26	WOS:000429379600011
J	Pinto, HA; Goncalves, NQ; Lopez-Hernandez, D; Pulido-Murillo, EA; Melo, AL				Pinto, Hudson A.; Goncalves, Nicole Q.; Lopez-Hernandez, Danimar; Pulido-Murillo, Eduardo A.; Melo, Alan L.			The life cycle of a zoonotic parasite reassessed: Experimental infection of Melanoides tuberculata (Mollusca: Thiaridae) with Centrocestus formosanus (Trematoda: Heterophyidae)	PLOS ONE			English	Article							CRYPTOCOTYLE-LINGUA CREPLIN; FRESH-WATER FISH; DIGENEA-HETEROPHYIDAE; SYSTEMATIC POSITION; INTERMEDIATE HOST; CHIANG-MAI; MORPHOLOGY; HISTORY; METACERCARIAE; PREVALENCE	Centrocestus formosanus is a foodborne intestinal trematode that is native to Asia and has been introduced into the Americas and Europe. Although there are several studies of C. formosanus in definitive vertebrate hosts (birds and mammals, including humans), and in intermediate vertebrate hosts (fish and amphibians), there is little published information regarding interaction with its transmitting mollusc. In this study we studied the miracidial development of C. formosanus using a mouse as a source of eggs. Adult parasites were maintained in water in order to develop miracidia in intrauterine eggs. Miracidia appeared at 12 days of incubation, with no hatching observed for up to 40 days. Subsequently, we placed dead C. formosanus containing eggs with miracidia individually in contact with 48 specimens of Melanoides tuberculata, and observed the absence of the parasites after 1 h of exposure, suggesting that they were ingested by the snails. Of the 33 experimentally-infected snails that were alive after 84-89 days post-infection (DPI), seven (21%) shed cercariae. We detected young C. formosanus rediae in 21/33 (64%) M. tuberculata at 90 DPI. To our knowledge, this report is the first to show that, in the life cycle of C. formosanus, infection of molluscs occurs passively by ingestion of eggs, followed by a long intramolluscan phase. We compare these data with those described for other Heterophyidae, and discuss on the phylogenetic background of the pattern of miracidial development verified in these parasites.	[Pinto, Hudson A.; Goncalves, Nicole Q.; Lopez-Hernandez, Danimar; Pulido-Murillo, Eduardo A.; Melo, Alan L.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Parasitol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais	Pinto, HA (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Parasitol, Belo Horizonte, MG, Brazil.	hudsonalves13@icb.ufmg.br	Pinto, Hudson/AAE-7958-2021	Pinto, Hudson/0000-0002-5519-1348; Pulido Murillo, Eduardo Alberto/0000-0002-9039-3068	Pro-Reitoria de Pesquisa, Universidade Federal de Minas Gerais (PRPq-UFMG) [Edital 02/2018]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Pro-Reitoria de Pesquisa, Universidade Federal de Minas Gerais (PRPq-UFMG); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Pro-Reitoria de Pesquisa, Universidade Federal de Minas Gerais (PRPq-UFMG), with grant from the Edital 02/2018, to HAP. NQG received funding from Fundacao de Amparo a Pesquisa do Estado de Minas Gerais. DL-H and EAP-M received funding from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAWAL P K, 1981, Rivista di Parassitologia, V42, P185; AMEEL DJ, 1950, J PARASITOL, V36, P427, DOI 10.2307/3273167; AMEEL DONALD J., 1938, JOUR PARASITOL, V24, P219, DOI 10.2307/3272291; Bearup A. J., 1962, Proceedings of the Linnean Society of New South Wales, V86, P251; BURNS WC, 1953, J PARASITOL, V39, P60, DOI 10.2307/3274061; Cable RM, 1937, Q J MED SCI, V76, P573; Cameron T. W. M., 1937, Canadian Journal of Research Ottawa D, V15, P38; Cantu V, 2013, PARASITOLOGY, V140, P814, DOI 10.1017/S0031182013000085; Chai Jong-Yil, 2017, Food Waterborne Parasitol, V8-9, P33, DOI 10.1016/j.fawpar.2017.09.001; Chai JY, 2013, J PARASITOL, V99, P531, DOI 10.1645/12-37.1; CHEN H. T., 1948, LINGNANSCI JOUR, V22, P93; CHEN H. T., 1942, JOUR PARASITOL, V28, P285, DOI 10.2307/3272966; CRIBB TH, 1986, AUST J ZOOL, V34, P279, DOI 10.1071/ZO9860279; DUDGEON D, 1986, J ZOOL, V208, P37; El-Naffar M.K., 1980, Journal of the Egyptian Society of Parasitology, V10, P117; Simoes SBE, 2010, ACTA TROP, V113, P226, DOI 10.1016/j.actatropica.2009.10.020; Simoes SBE, 2009, MEM I OSWALDO CRUZ, V104, P106, DOI 10.1590/S0074-02762009000100016; Faust E. C., 1926, Journal of Parasitology Urbana, V13, P91, DOI 10.2307/3271705; FAUST EC, 1927, AM J HYG, V8, P1; Fleming BP, 2011, J AQUAT ANIM HEALTH, V23, P117, DOI 10.1080/08997659.2011.616840; Frankel VM, 2015, INT J PARASITOL, V45, P703, DOI 10.1016/j.ijpara.2015.03.012; Garcia-Vedrenne AE, 2017, INT J PARASITOL, V47, P41, DOI 10.1016/j.ijpara.2016.10.003; Han ET, 2008, KOREAN J PARASITOL, V46, P49, DOI 10.3347/kjp.2008.46.1.49; Huston DC, 2014, J PARASITOL, V100, P239, DOI 10.1645/13-419.1; Iakovleva NV, 2006, EXP PARASITOL, V113, P24, DOI 10.1016/j.exppara.2005.12.002; IRWIN SWB, 1978, PARASITOLOGY, V76, P193, DOI 10.1017/S0031182000047776; Mendoza-Estrada LJ, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8272407; Johnson MS, 2012, J PARASITOL, V98, P111, DOI 10.1645/GE-2841.1; Kimura D, 2007, VET PARASITOL, V146, P367, DOI 10.1016/j.vetpar.2007.02.032; KOIE M, 1990, SYST PARASITOL, V15, P141, DOI 10.1007/BF00009992; Krailas D, 2016, ACTA TROP, V156, P79, DOI 10.1016/j.actatropica.2016.01.007; Kudo N, 2014, J VET MED SCI, V76, P1531, DOI 10.1292/jvms.14-0281; KUNTZ RE, 1956, J PARASITOL, V42, P613, DOI 10.2307/3274882; Kvach Y, 2017, PARASITOL RES, V116, P1973, DOI 10.1007/s00436-017-5480-4; Lo CT, 1996, J PARASITOL, V82, P347, DOI 10.2307/3284178; LYSTER L. L., 1940, CANADIAN JOUR RES SECT D ZOOL SCI, V18, P106; MARTIN WE, 1958, J PARASITOL, V44, P305, DOI 10.2307/3274597; Mitchell AJ, 2005, FISHERIES, V30, P11, DOI 10.1577/1548-8446(2005)30[11:SOAEFT]2.0.CO;2; Moszczynska A, 2009, MOL ECOL RESOUR, V9, P75, DOI 10.1111/j.1755-0998.2009.02634.x; NIEMI DR, 1974, P HELM SOC WASH, V41, P223; NISHIGORI M., 1924, TAIWAN IGAKKAI ZASSH, V234, P181; NODA K, 1959, J PARASITOL, V45, P635, DOI 10.2307/3274816; dos Santos EGN, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-92; ODENING K, 1970, Z PARASITENK, V33, P194; Ostrowski de Nunez M, 2001, ACTA PARASITOL, V46, P119; PERKINS K. W., 1956, AMER MIDLAND NAT, V55, P139, DOI 10.2307/2422329; Pinto Hudson A, 2014, ScientificWorldJournal, V2014, P807492, DOI 10.1155/2014/807492; Pinto HA, 2015, PARASITOL INT, V64, P236, DOI 10.1016/j.parint.2015.02.002; Pinto HA, 2011, ZOOTAXA, P15, DOI 10.11646/zootaxa.2799.1.2; Pinto HA, 2012, REV BRAS PARASITOL V, V21, P334, DOI 10.1590/S1984-29612012000300032; Pinto HA, 2010, REV INST MED TROP SP, V52, P207, DOI 10.1590/S0036-46652010000400008; Scholz T, 2000, AM MIDL NAT, V143, P185, DOI 10.1674/0003-0031(2000)143[0185:TIADOC]2.0.CO;2; SHAMEEM U, 1988, SYST PARASITOL, V11, P73, DOI 10.1007/BF00006979; SHEN W. X., 1959, ACTA ZOOL SINICA, V11, P470; Shimazu T, 2015, KOREAN J PARASITOL, V53, P627, DOI 10.3347/kjp.2015.53.5.627; Stoyanov B, 2015, SYST PARASITOL, V91, P1, DOI 10.1007/s11230-015-9559-y; Stunkard HW, 1930, J MORPHOL, V50, P143, DOI 10.1002/jmor.1050500106; STUNKARD HW, 1955, BIOL BULL, V109, P475, DOI 10.2307/1539177; TARASCHEWSKI H, 1985, Z PARASITENKD, V71, P505, DOI 10.1007/BF00928353; Mati VLT, 2013, REV INST MED TROP SP, V55, P133, DOI 10.1590/S0036-46652013000200013; Thaenkham U, 2012, PARASITOL INT, V61, P90, DOI 10.1016/j.parint.2011.06.004; Thaenkham U, 2011, PARASITOL INT, V60, P521, DOI 10.1016/j.parint.2011.07.015; Le TH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1968-0; Tolley-Jordan LR, 2012, HANDBOOK OF GLOBAL FRESHWATER INVASIVE SPECIES, P401; Van KV, 2012, NANFANG NONGYE XUEBA, V43, P520, DOI DOI 10.3969/j:issn.2095-1191.2012.04.520; Wanlop A, 2017, KOREAN J PARASITOL, V55, P445, DOI 10.3347/kjp.2017.55.4.445; Wongsawad C, 2017, KOREAN J PARASITOL, V55, P31, DOI 10.3347/kjp.2017.55.1.31; WOOTTON DM, 1957, J PARASITOL, V43, P271, DOI 10.2307/3274345; YAMAGUTI S, 1975, SYNOPTICAL REV LIFE; Yousif F, 2016, EXP PARASITOL, V168, P56, DOI 10.1016/j.exppara.2016.06.007	70	3	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0194161	10.1371/journal.pone.0194161	http://dx.doi.org/10.1371/journal.pone.0194161			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624583	Green Submitted, Green Published, gold			2022-12-26	WOS:000429379600005
J	Vano, YA; Oudard, S; By, MA; Tetu, P; Thibault, C; Aboudagga, H; Scotte, F; Elaidi, R				Vano, Yann-Alexandre; Oudard, Stephane; By, Marie-Agnes; Tetu, Pauline; Thibault, Constance; Aboudagga, Hail; Scotte, Florian; Elaidi, Reza			Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients	PLOS ONE			English	Article							PRETREATMENT NEUTROPHIL; NEUTROPHIL/LYMPHOCYTE RATIO; INDEPENDENT PREDICTOR; PROGNOSTIC-FACTOR; MONOCYTE COUNTS; SURVIVAL; CHEMOTHERAPY; INFLAMMATION; CARCINOMA; INDICATOR	This study assessed the prognostic value of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in patients with metastatic solid tumors. Clinical and biological data for patients with metastatic solid tumors treated in an oncology outpatient department and prospectively followed by a call center (PROCHE program) between January 2008 and December 2011 were analyzed. All patients with an NLR value within 28 days before the first cycle of first line of chemotherapy were included (cohort 1). To assess influence of chemotherapy line on NLR prognostic value, data from patients treated with later chemotherapy lines were also analyzed (cohort 2). Adjusted multivariate Cox regressions with or without non-linear and time-dependent effects were performed. Optimal NLR cut-off was investigated by time dependent sensitivity analysis using several indices. There were 317 and 134 patients in cohorts 1 and 2, respectively. Elevated NLR was associated with worse survival (hazard ratio [HR] for death, 1.35 [95% confidence interval 1.19-1.54]; p<0.0001). The optimal NLR cut-off in cohort 1 was dependent on index used and time of assessment: HR values were non-significant at a cut-off of 3.0 (1.34 [0.99-1.32], but significant when the cut-off was 4.0 (1.53 [1.11-2.10]). NLR was linearly related to mortality risk; in subgroup analysis, no significant interaction was found with co-variables or tumor localization overall (cohorts 1+2). Pretreatment NLR is a useful prognostic tool in patients with metastatic solid tumors, irrespective of primary tumor site, chemotherapy line, age, gender and performance status. However, using an NLR cut-off value for clinical decision-making requires extreme caution.	[Vano, Yann-Alexandre; Oudard, Stephane; Tetu, Pauline; Thibault, Constance; Scotte, Florian] Hop Europeen Georges Pompidou, Dept Oncol, Paris, France; [Vano, Yann-Alexandre; Oudard, Stephane; Tetu, Pauline; Thibault, Constance; Aboudagga, Hail; Scotte, Florian] Univ Paris 5 Descartes, Paris, France; [Vano, Yann-Alexandre] Cordeliers Res Ctr, Canc Immune Control & Escape, UMRS1138, Paris, France; [Oudard, Stephane] INSERM U970, Angiogenesis & Immunotherapy Lab, PARCC, Team 10, Paris, France; [By, Marie-Agnes] CHU Bretonneau, Dept Oncol, Tours, France; [Aboudagga, Hail] Hop Europeen Georges Pompidou, Dept Pharm, Paris, France; [Elaidi, Reza] Hop Europeen Georges Pompidou, Dept Oncol, Assoc Rech Therapeut Innovantes Cancerol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Vano, YA (corresponding author), Hop Europeen Georges Pompidou, Dept Oncol, Paris, France.; Vano, YA (corresponding author), Univ Paris 5 Descartes, Paris, France.; Vano, YA (corresponding author), Cordeliers Res Ctr, Canc Immune Control & Escape, UMRS1138, Paris, France.	yann.vano@aphp.fr		Vano, Yann-Alexandre/0000-0002-9410-1368; OUDARD, Stephane/0000-0003-0893-285X				Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Beuselinck B, 2014, BJU INT, V114, P81, DOI 10.1111/bju.12494; Botta C, 2011, EUR J CANCER, V47, pS181, DOI 10.1016/S0959-8049(11)70932-7; Cho H, 2009, BIOMARKERS, V14, P161, DOI 10.1080/13547500902777616; Chua W, 2011, BRIT J CANCER, V104, P1288, DOI 10.1038/bjc.2011.100; Contal C, 1999, COMPUT STAT DATA AN, V30, P253, DOI 10.1016/S0167-9473(98)00096-6; Dirican A, 2015, INT J CLIN ONCOL, V20, P70, DOI 10.1007/s10147-014-0672-8; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Giraldo NA, 2015, VIRCHOWS ARCH, V467, P127, DOI 10.1007/s00428-015-1787-7; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ishizuka M, 2012, ANTICANCER RES, V32, P3291; Kao SCH, 2010, CLIN CANCER RES, V16, P5805, DOI 10.1158/1078-0432.CCR-10-2245; Luo Y, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001670; Ma Jin-ping, 2011, Zhonghua Wei Chang Wai Ke Za Zhi, V14, P944; McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; Millrud CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051120; Miskolci V, 2007, MOL MED, V13, P134, DOI 10.2119/2006-00072.Miskolci; Nakamura Y, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0904-7; Ohki S, 2012, ONCOL REP, V28, P453, DOI 10.3892/or.2012.1812; Peng B, 2015, INT J CLIN EXP MED, V8, P3098; Proctor MJ, 2012, BRIT J CANCER, V107, P695, DOI 10.1038/bjc.2012.292; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Roxburgh CSD, 2010, FUTURE ONCOL, V6, P149, DOI 10.2217/FON.09.136; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Salim DK, 2015, MOL CLIN ONCOL, V3, P839, DOI 10.3892/mco.2015.557; Saroha S, 2013, J UROLOGY, V189, P454, DOI 10.1016/j.juro.2012.09.166; Schmidt H, 2005, BRIT J CANCER, V93, P273, DOI 10.1038/sj.bjc.6602702; Scotte F, 2013, EUR J CANCER, V49, P541, DOI 10.1016/j.ejca.2012.08.025; Taguchi S, 2015, INT J UROL, V22, P638, DOI 10.1111/iju.12766; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; van Soest RJ, 2015, ANN ONCOL, V26, P743, DOI 10.1093/annonc/mdu569; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Wang SY, 2011, ONCOL LETT, V2, P735, DOI 10.3892/ol.2011.304; Wang Y, 2015, CANCER CHEMOTH PHARM, V75, P255, DOI 10.1007/s00280-014-2622-6; Zhang GM, 2015, INT J CLIN ONCOL, DOI 10.1007/s10147-015-0894-4; Zhao QT, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S90875; Zhao WW, 2016, SCI REP-UK, V6, DOI 10.1038/srep31394	40	45	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2018	13	4							e0195042	10.1371/journal.pone.0195042	http://dx.doi.org/10.1371/journal.pone.0195042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB9FN	29624591	Green Submitted, Green Published, gold			2022-12-26	WOS:000429379600012
J	Jehu, DA; Cantu, H; Hill, A; Paquette, C; Cote, JN; Nantel, J				Jehu, Deborah A.; Cantu, Hiram; Hill, Allen; Paquette, Caroline; Cote, Julie N.; Nantel, Julie			Medication and trial duration influence postural and pointing parameters during a standing repetitive pointing task in individuals with Parkinson's disease	PLOS ONE			English	Article							DISCRETE COGNITIVE TASKS; OLDER-ADULTS; LIMB MOVEMENTS; DUAL-TASKING; GAIT; FALLS; BALANCE; PEOPLE; SWAY; STABILITY	We aimed to determine the effects of levodopa medication on the performance of a repetitive pointing task while standing, and to investigate the optimal trial duration in individuals with Parkinson's disease, and older adults. Seventeen individuals with Parkinson's disease (5 freezers) and 9 older adults stood on force platforms for 30 s and 120 s while performing a bilateral repetitive pointing task, tracked by motion capture. Participants with Parkinson's disease were assessed on and off medication and older adults were also assessed on separate days. The main findings were that: 1) on medication, participants with Parkinson's exhibited greater center of pressure root mean square in the medial-lateral direction, greater velocity in the medial-lateral and anterior-posterior directions, and greater range in the medial-lateral direction than off medication; 2) longer trial durations resulted in greater center of pressure range in the medial-lateral and anterior-posterior directions and greater coefficient of variation in finger pointing on the least affected side; 3) Parkinson's participants exhibited larger range in the medial-lateral direction compared to older adults; 4) off medication, freezers presented with less range and root mean square in the anterior-posterior direction than non-freezers; and 5) a correlation emerged between the freezing of gait questionnaire and pointing asymmetry and the coefficient of variation of pointing on the most affected side. Therefore, Parkinson's medication may increase instability during a repetitive pointing task. Longer trials may provide a better depiction of sway by discriminating between those with and without neurological impairment. Individuals with Parkinson's were less stable than older adults, supporting that they are at a greater risk for falls. The greater restrictive postural strategy in freezers compared to non-freezers is likely a factor that augments fall risk. Lastly, the link between freezing of gait and upper-limb movement indicates that freezing may manifest first in the lower-limbs.	[Jehu, Deborah A.; Hill, Allen; Nantel, Julie] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada; [Cantu, Hiram; Paquette, Caroline; Cote, Julie N.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada; [Paquette, Caroline; Cote, Julie N.] Ctr Interdisciplinary Res Rehabil CRIR, Montreal, PQ, Canada	University of Ottawa; McGill University; Universite de Montreal	Nantel, J (corresponding author), Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada.	jnantel@uottawa.ca	Nantel, Julie/AAE-8114-2021; paquette, caroline/U-3793-2019	paquette, caroline/0000-0001-8109-5301; Jehu, Deborah/0000-0002-9084-7445; Hill, Allen/0000-0003-0939-0765; Nantel, Julie/0000-0001-7253-9222	Canada Foundation for Innovation [10131]; Natural Sciences and Engineering Research Council [05111]; National Council on Science and Technology of Mexico (CONACYT); Bloomberg Manulife Fellowship	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Council on Science and Technology of Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Bloomberg Manulife Fellowship	This project was supported by grants from: 1. The Canada Foundation for Innovation (#10131), https://www.innovation.ca/fr; 2. The Natural Sciences and Engineering Research Council (#05111), http://www.nserc-crsng.gc.ca; 3. Hiram Cantu was supported by PhD fellowships from the National Council on Science and Technology of Mexico (CONACYT), https://twas.org/partner/national-council-science-and-technology-mexico; and 4. The Bloomberg Manulife Fellowship, https://www.mcgill.ca/bloomberg-manulife/fellowships.	Adamovich SV, 2001, NEUROSCIENCE, V104, P1027, DOI 10.1016/S0306-4522(01)00099-9; Almeida QJ, 2002, MOVEMENT DISORD, V17, P30, DOI 10.1002/mds.10030; Armand S, 2009, PARKINSONISM RELAT D, V15, P359, DOI 10.1016/j.parkreldis.2008.08.007; Balash Y, 2005, J NEUROL, V252, P1310, DOI 10.1007/s00415-005-0855-3; Barbe MT, 2014, J NEUROL, V261, P330, DOI 10.1007/s00415-013-7199-1; Barbieri FA, 2016, HUM MOVEMENT SCI, V46, P96, DOI 10.1016/j.humov.2015.12.009; Beaulne-Seguin Z, 2016, GAIT POSTURE, V49, P443, DOI 10.1016/j.gaitpost.2016.08.002; Blaszczyk JW, 2011, HUM MOVEMENT SCI, V30, P396, DOI 10.1016/j.humov.2010.07.017; Bleom BR, 2006, J NEUROL SCI, V248, P196, DOI 10.1016/j.jns.2006.05.010; Carpenter MG, 2001, GAIT POSTURE, V13, P35, DOI 10.1016/S0966-6362(00)00093-X; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Dona F, 2016, PHYSIOTHERAPY, V102, P272, DOI 10.1016/j.physio.2015.08.009; Frenklach A, 2009, MOVEMENT DISORD, V24, P377, DOI 10.1002/mds.22358; Giladi N, 2001, NEUROLOGY, V56, P1712, DOI 10.1212/WNL.56.12.1712; Giladi N, 2008, MOVEMENT DISORD, V23, pS423, DOI 10.1002/mds.21927; Hayes HA, 2015, MOTOR CONTROL, V19, P325, DOI 10.1123/mc.2014-0039; Marjorie JH, 2008, ARCH PHYS MED REHAB, V89, P1708, DOI 10.1016/j.apmr.2008.01.023; Horak FB, 1996, J NEUROPHYSIOL, V75, P2380, DOI 10.1152/jn.1996.75.6.2380; Jacobs JV, 2006, NEUROSCIENCE, V141, P999, DOI 10.1016/j.neuroscience.2006.04.014; Jacobs JV, 2014, PARKINSONISM RELAT D, V20, P779, DOI 10.1016/j.parkreldis.2014.04.001; Jehu DA, MOTOR CONTR IN PRESS; Jehu DA, 2016, AGING CLIN EXP RES, V28, P1211, DOI 10.1007/s40520-015-0513-2; Johnson L, 2013, MOVEMENT DISORD, V28, P1250, DOI 10.1002/mds.25449; Kahneman D., 1973, ATTENTION EFFORT; Kirchner M, 2012, PHYSICA A, V391, P4692, DOI 10.1016/j.physa.2012.05.034; Lafond D, 2004, ARCH PHYS MED REHAB, V85, P896, DOI 10.1016/j.apmr.2003.08.089; LAJOIE Y, 1993, EXP BRAIN RES, V97, P139; Lajoie Y, 2017, GAIT POSTURE, V55, P43, DOI 10.1016/j.gaitpost.2017.04.003; Lajoie Y, 2016, J MOTOR BEHAV, V48, P264, DOI 10.1080/00222895.2015.1089833; Lamont RM, 2017, GAIT POSTURE, V55, P62, DOI 10.1016/j.gaitpost.2017.04.005; Louie S, 2009, MOVEMENT DISORD, V24, P1991, DOI 10.1002/mds.22741; Maki BE, 2000, J GERONTOL A-BIOL, V55, pM270, DOI 10.1093/gerona/55.5.M270; Maki BE, 2006, AGE AGEING, V35, P12, DOI 10.1093/ageing/afl078; Mancini M, 2008, CLIN BIOMECH, V23, P450, DOI 10.1016/j.clinbiomech.2007.11.007; Mansfield A, 2009, J BIOMECH, V42, P1023, DOI 10.1016/j.jbiomech.2009.02.007; Maurer C, 2003, BRAIN, V126, P1146, DOI 10.1093/brain/awg100; McNeely ME, 2012, GAIT POSTURE, V36, P144, DOI 10.1016/j.gaitpost.2012.02.009; Nanhoe-Mahabier W, 2011, NEUROSCIENCE, V182, P217, DOI 10.1016/j.neuroscience.2011.02.061; Nantel J, 2012, NEUROSCIENCE, V221, P151, DOI 10.1016/j.neuroscience.2012.07.007; Nantel J, 2014, PARKINSONISM RELAT D, V20, P447, DOI 10.1016/j.parkreldis.2014.01.017; Nantel J, 2012, PARKINSONISM RELAT D, V18, P285, DOI 10.1016/j.parkreldis.2011.11.005; Nantel J, 2011, GAIT POSTURE, V34, P329, DOI 10.1016/j.gaitpost.2011.05.020; Nieuwboer A, 2009, EUR J NEUROSCI, V29, P1422, DOI 10.1111/j.1460-9568.2009.06681.x; Nova IC, 2004, PARKINSONISM RELAT D, V10, P411, DOI 10.1016/j.parkreldis.2004.04.004; Plotnik M, 2005, ANN NEUROL, V57, P656, DOI 10.1002/ana.20452; Poizner H, 1998, Motor Control, V2, P251; Sciadas R, 2016, HUM MOVEMENT SCI, V47, P135, DOI 10.1016/j.humov.2016.03.003; Spildooren J, 2010, MOVEMENT DISORD, V25, P2563, DOI 10.1002/mds.23327; Su KJ, 2014, GAIT POSTURE, V39, P65, DOI 10.1016/j.gaitpost.2013.05.029; Tagliabue M, 2009, NEUROSCIENCE, V158, P1206, DOI 10.1016/j.neuroscience.2008.12.007; Tombu M, 2005, J EXP PSYCHOL HUMAN, V31, P790, DOI 10.1037/0096-1523.31.4.790; Vercruysse S, 2012, NEUROREHAB NEURAL RE, V26, P636, DOI 10.1177/1545968311431964; Vercruysse S, 2012, MOVEMENT DISORD, V27, P254, DOI 10.1002/mds.24015; Vossius C, 2010, ACTA NEUROL SCAND, V121, P38, DOI 10.1111/j.1600-0404.2009.01239.x; Wu T, 2015, NEUROBIOL DIS, V82, P226, DOI 10.1016/j.nbd.2015.06.014; Zia S, 2000, ANN NEUROL, V47, P218, DOI 10.1002/1531-8249(200002)47:2<218::AID-ANA12>3.3.CO;2-R; Ziv I, 1999, ACTA NEUROL SCAND, V99, P106, DOI 10.1111/j.1600-0404.1999.tb00666.x	57	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195322	10.1371/journal.pone.0195322	http://dx.doi.org/10.1371/journal.pone.0195322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621320	gold, Green Submitted, Green Published			2022-12-26	WOS:000429206800060
J	Lavalle, L; Thomas, AS; Beaton, B; Ebrahim, H; Reed, M; Ramaswami, U; Elliott, P; Mehta, AB; Hughes, DA				Lavalle, L.; Thomas, A. S.; Beaton, B.; Ebrahim, H.; Reed, M.; Ramaswami, U.; Elliott, P.; Mehta, A. B.; Hughes, D. A.			Phenotype and biochemical heterogeneity in late onset Fabry disease defined by N215S mutation	PLOS ONE			English	Article							ALPHA-GALACTOSIDASE; PLASMA; GLOBOTRIAOSYLSPHINGOSINE; HYPERTROPHY; URINE; GENE	Background Fabry disease (FD) results from X-linked inheritance of a mutation in the GLA gene, encoding for alpha galactosidase A, and is characterized by heterogeneous clinical manifestations. Two phenotypes have been described "Classic" and "late onset" which cannot be predicted exclusively by genotype. The latter has been considered an attenuated form of the disease often affecting a single organ system commonly the heart. Recent studies have demonstrated that cardiac outcomes are similar in patients with classic and late onset mutations. In this study we investigate the relationship between clinical heterogeneity and plasma lyso-Gb3 in a large single centre cohort of N215S patients and compare this to patients with other mutations. Methods In this single-centre, retrospective, cross-sectional study we analysed a cohort of 251 FD patients: 84 N215S mutation (37 males) and 167 non-N215S mutations (58 males). The Mainz severity score index (MSSI) was used as an index of overall disease severity. Cardiac function and morphology were assessed by electrocardiogram and echocardiogram. Left ventricular mass was calculated using the Devereux formula and the left ventricular mass index (LVMI) calculated to adjust for height (g/m(2.7)). The presence of white matter lesions was assessed by cerebral MRI or computed tomography (CT). GFR was measured by radio-isotope (chromium-EDTA) method and adjusted for patient height (ml/min/m(2.7)), and urinary protein quantification was undertaken by 24 hour urine collection. Plasma globotriaosylsphingosine (lyso-Gb3) was analysed prior to ERT in 84 patients. Results N215S patients showed later symptom onset (males: p< 0.0001, females: p<0.03), later development of left ventricular hypertrophy (LVH) (median survival without LVH: 41 (non- N215S) vs. 64 (N215S) years, p< 0.0001), later development of proteinuria (median survival without proteinuria 43 (non-N215S) vs 71 years (N215S), p< 0.0001), later occurrence of cerebrovascular events (stroke/ Transient lschaemic Attacks (TIA); median survival without stroke: 74 years (non-N215S) vs. not reached (N215S), p< 0.02), later decline in renal function to GFR <60 ml/min/1.73m(2) (median survival: 56 (non-N215S) vs. 72 (N215S) years, p< 0.01), and greater overall survival (median survival 81 (N215S) vs. 66 (non-N215S) years, p< 0.0006). Lyso-Gb3 was found to be less elevated in N215S compared to non-N215S male and female patients. However, the N215S population eventually reached an overall severity measured by MSSI comparable to the non-N215S without equivalent elevation of lyso-Gb3 (means: 6.7 vs. 74.3 nmol/L, p < 0.001). In addition, N215S patients showed strong correlations between lyso-Gb3 levels and LVMI, GFR, and MSSI. These associations became stronger when we investigated individuals' life time exposure to lyso-Gb3 (calculated as [lyso-Gb3]*age): MSSI (r(2) = 0.88, p< 0.0001), LVMI (r(2) = 0.59, p< 0.005), and GFR (r(2) = 0.75, p = 0.0001). Conclusion These results demonstrate that the N215S mutation results in a late onset phenotype involving the heart and other organs. Correlations between clinical manifestations and plasma lyso-Gb3 variations in this group suggest a Fabry-relevant disease mechanism for the heterogeneity observed in this group.	[Lavalle, L.; Beaton, B.; Ebrahim, H.; Reed, M.; Ramaswami, U.; Mehta, A. B.; Hughes, D. A.] Royal Free Hosp, Dept Haematol, Lysosomal Storage Disorders Unit, London, England; [Lavalle, L.; Beaton, B.; Ebrahim, H.; Reed, M.; Ramaswami, U.; Mehta, A. B.; Hughes, D. A.] UCL, Med Sch, London, England; [Thomas, A. S.] Barts Hlth NHS Trust, Barts Heart Ctr, UCL Inst Cardiovasc Sci, London, England; [Elliott, P.] St Georges Hosp NHS Fdn Trust, Haematol Dept, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Barts Health NHS Trust; University of London; University College London	Hughes, DA (corresponding author), Royal Free Hosp, Dept Haematol, Lysosomal Storage Disorders Unit, London, England.	rmgvdah@ucl.ac.uk	Mehta, Atul/GPC-7364-2022; Elliott, Perry/AAR-3430-2020; Mehta, Atul/AAF-3559-2022; Mehta, Atul/AFI-0044-2022	Elliott, Perry/0000-0003-3383-3984; 	Shire [IIRGBR000297]; MPS Society	Shire; MPS Society	This study was funded by Shire (IIRGBR000297, Dr Derralynn Hughes) and the MPS Society (Dr Derralynn Hughes). The funders of this study had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073/pnas.0712309105; Arends M, 2017, J AM SOC NEPHROL, V28, P1631, DOI 10.1681/ASN.2016090964; Auray-Blais C, 2010, CLIN CHIM ACTA, V411, P1906, DOI 10.1016/j.cca.2010.07.038; Carpio D, 2015, HUM MOL GENET; DAVIES JP, 1993, HUM MOL GENET, V2, P1051, DOI 10.1093/hmg/2.7.1051; Deegan PB, 2006, J MED GENET; Desnick RJ, 2004, J PEDIATR-US, V144, pS20, DOI 10.1016/j.jpeds.2004.01.051; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; ELLEDER M, 1990, VIRCHOWS ARCH A, V417, P449, DOI 10.1007/BF01606034; Eng CM, 1997, MOL MED, V3, P174, DOI 10.1007/BF03401671; ENG CM, 1993, AM J HUM GENET, V53, P1186; Eng CM, 1994, HUM MUTAT; Ferreira S, 2015, MOL GENET METAB; Germain DP, 1999, BIOCHEM BIOPH RES CO, V257, P708, DOI 10.1006/bbrc.1999.0310; Gold H, 2013, CLIN CHEM, V59, P547, DOI 10.1373/clinchem.2012.192138; Hsu TR, 2016, J AM COLL CARDIOL, V68, P2554, DOI 10.1016/j.jacc.2016.09.943; Hughes DA, 2010, MOL GENET METAB, V101, P219, DOI 10.1016/j.ymgme.2010.06.002; Lang RM, 2006, EUR J ECHOCARDIOGR; Liao HC, 2013, CLIN CHIM ACTA; Liu HC, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0111-y; Lukas J, 2015, HUM MUTAT; Mehta A, 2002, GENEREVIEWS; MORGAN SH, 1990, Q J MED, V75, P491; Niemann M, 2014, CIRC CARDIOVASC GENE; Nowak A, 2017, MOL GENET METAB; Oder D, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.116.001691; Park JL, 2008, CLIN EXP PHARMACOL P, V35, P1156, DOI 10.1111/j.1440-1681.2008.04984.x; Patel V, 2016, HEART; Ranieri M, 2016, CURR TREAT OPTION NE, V18, DOI 10.1007/s11940-016-0414-5; RedonnetVernhet I, 1996, J MED GENET, V33, P682, DOI 10.1136/jmg.33.8.682; Reuter C, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.117.001918; Ries M., 2006, FABRY DIS PERSPECTIV; Rombach SM, 2010, BIOCH BIOPHYS ACTA; Sanchez-Nino MD, 2011, NEPHROL DIAL TRANSPL; Schiffmann R, 2016, GENET MED; Schiffmann R, 2013, GENET MED, V15, P983, DOI 10.1038/gim.2013.56; Seydelmann N, 2015, BEST PRACT RES CLIN; Smid BE, 2015, J MED GENET, V52, P262, DOI 10.1136/jmedgenet-2014-102872; Sterns JD, 2014, FRONT CELL DEV BIOL; Tondel C, 2013, J AM SOC NEPHROL; Vedder AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000598; Whybra C, 2004, CLIN GENET, V65, P299, DOI 10.1111/j.1399-0004.2004.00219.x; Young E, 2005, ACTA PAEDIATR, V94, P51, DOI 10.1080/08035320510028111	43	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0193550	10.1371/journal.pone.0193550	http://dx.doi.org/10.1371/journal.pone.0193550			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621274	Green Published, gold, Green Submitted			2022-12-26	WOS:000429206800007
J	Kularatne, RS; Muller, EE; Maseko, DV; Kufa-Chakezha, T; Lewis, DA				Kularatne, Ranmini S.; Muller, Etienne E.; Maseko, Dumisile V.; Kufa-Chakezha, Tendesayi; Lewis, David A.			Trends in the relative prevalence of genital ulcer disease pathogens and association with HIV infection in Johannesburg, South Africa, 2007-2015	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; SYPHILIS; UGANDA; ETIOLOGY; RAKAI; CIRCUMCISION; CARCINOMA; STAGE; MEN	Background In South Africa, treatment of genital ulcer disease (GUD) occurs in the context of syndromic management. GUD aetiological studies have been conducted in Johannesburg since 2007. We report on GUD pathogen prevalence, sero-prevalence of STI co-infections and aetiological trends among GUD patients presenting to a community-based primary healthcare facility in Johannesburg over a 9-year period. Methods and findings GUD surveys were conducted from January to April each year. Consecutive genital ulcers were sampled from consenting adults. Swab-extracted DNA was tested by multiplex realtime PCR assays for herpes simplex virus (HSV), Treponema pallidum (TP), Haemophilus ducreyi (HD) and Chlamydia trachomatis (CT). HSV-positive DNA extracts were further sub typed into HSV-1 and HSV-2 using a commercial PCR assay; CT-positive extracts were tested with an in-house PCR assay specific for serovars L1-L3 (lymphogranuloma venereum). Sera were tested for HIV, HSV-2, and syphilis co-infections. Giemsa-stained ulcer smears were screened for Klebsiella granulomatis by microscopy. Data were analysed with STATA (TM) version 14. Of 771 GUD specimens, 503 (65.2%) had a detectable pathogen: HSV 468 (60.7%); TP 30 (3.9%); CT L1-3 7 (0.9%); HD 4 (0.5%). No aetiological agents were detected in 270 (34.8%) ulcer specimens. Seroprevalence rates were as follows: HIV 61.7%; HSV-2 80.2% and syphilis 5.8%. There was a strong association between GUD pathogen detection and HIV seropositivity (p < 0.001); 68% of cases caused by HSV were co-infected with HIV. There was a significant decline in the relative prevalence of ulcer derived HSV over time, predominantly from 2013-2015 (p-value for trend = 0.023); and a trend towards a decrease in the HIV seropositivity rate (p-value for trend = 0.209). Conclusions HSV remains the leading cause of pathogen-detectable GUD in South Africa. The prevalence of HIV co-infection among GUD patients is high, underlining the importance of linkage to universal HIV testing and treatment in primary healthcare settings.	[Kularatne, Ranmini S.; Muller, Etienne E.; Maseko, Dumisile V.; Kufa-Chakezha, Tendesayi] Natl Inst Communicable Dis, Ctr HIV & STIs, Johannesburg, South Africa; [Kularatne, Ranmini S.] Univ Witwatersrand, Fac Hlth Sci, Dept Clin Microbiol & Infect Dis, Johannesburg, South Africa; [Lewis, David A.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia; [Lewis, David A.] Western Sydney Local Hlth Dist, Western Sydney Sexual Hlth Ctr, Sydney, NSW, Australia	National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Sydney	Kularatne, RS (corresponding author), Natl Inst Communicable Dis, Ctr HIV & STIs, Johannesburg, South Africa.; Kularatne, RS (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Dept Clin Microbiol & Infect Dis, Johannesburg, South Africa.	ranminik@nicd.ac.za		Lewis, David/0000-0002-5534-8392; Kufa, Tendesayi/0000-0002-9797-616X				Bailey GP, 2010, J INFECT DIS, V201, P1811, DOI 10.1086/652785; Ballard RC, 2002, SEX TRANSM INFECT, V78, P274, DOI 10.1136/sti.78.4.274; Brankin AE, 2009, INT J STD AIDS, V20, P650, DOI 10.1258/ijsa.2009.009067; Brunasso AMG, 2012, UROLOGY, V80, pE9, DOI 10.1016/j.urology.2012.04.022; Childs T, 2015, EUROSURVEILLANCE, V20, P9, DOI 10.2807/1560-7917.ES.2015.20.48.30076; Cohen Myron S, 2004, Top HIV Med, V12, P104; Gonzalez-Beiras C, 2016, EMERG INFECT DIS, V22, P1, DOI 10.3201/eid2201.150425; Gratzer B, 2014, SEX TRANSM DIS, V41, P285, DOI 10.1097/OLQ.0000000000000126; Gupta V, 2016, INT J STD AIDS, V27, P323, DOI 10.1177/0956462415584484; Hata H, 2010, ACTA DERM-VENEREOL, V90, P539, DOI 10.2340/00015555-0902; Hope-Rapp E, 2010, SEX TRANSM DIS, V37, P153, DOI 10.1097/OLQ.0b013e3181bf5a98; Karumudi Usha Rani, 2005, Expert Rev Anti Infect Ther, V3, P825, DOI 10.1586/14787210.3.5.825; Keogan MT, 2009, CLIN EXP IMMUNOL, V156, P1, DOI 10.1111/j.1365-2249.2008.03857.x; Kiddugavu MG, 2005, SEX TRANSM DIS, V32, P1, DOI 10.1097/01.olq.0000148297.48590.d8; Knaute DF, 2012, CLIN INFECT DIS, V55, P1615, DOI 10.1093/cid/cis757; Lewis D. A., 2009, Southern African Journal of Epidemiology & Infection, V24, P6; Lewis DA, 2012, SEX TRANSM DIS, V39, P880, DOI 10.1097/OLQ.0b013e318269cf90; Mehta SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038991; Morre SA, 2005, EMERG INFECT DIS, V11, P1311, DOI 10.3201/eid1108.050535; National Department of Health, 2008, 1 LIN COMPR MAN CONT, P1; National Department of Health, 2015, SEX TRANSM INF MAN G; O'Farrell N, 2001, INT J STD AIDS, V12, P423, DOI 10.1258/0956462011923435; Paz-Bailey G, 2010, CLIN INFECT DIS, V50, P1060, DOI 10.1086/651115; Phiri S, 2013, SEX TRANSM DIS, V40, P923, DOI 10.1097/OLQ.0000000000000051; Posavad CM, 2004, J INFECT DIS, V190, P693, DOI 10.1086/422755; Ryder N, 2009, SEX TRANSM INFECT, V85, P416, DOI 10.1136/sti.2008.033902; Serwadda D, 2003, J INFECT DIS, V188, P1492, DOI 10.1086/379333; Shamini N., 2001, SMJ Singapore Medical Journal, V42, P292; STIGMA, 2019, GUID MAN SEX TRANSM; Tan DHS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004210; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411	32	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194125	10.1371/journal.pone.0194125	http://dx.doi.org/10.1371/journal.pone.0194125			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617372	Green Published, gold, Green Submitted			2022-12-26	WOS:000429203800019
J	Sobieski, C; Warikoo, N; Shu, HJ; Mennerick, S				Sobieski, Courtney; Warikoo, Natasha; Shu, Hong-Jin; Mennerick, Steven			Ambient but not local lactate underlies neuronal tolerance to prolonged glucose deprivation	PLOS ONE			English	Article							RAT HIPPOCAMPAL SLICES; MOUSE WHITE-MATTER; SYNAPTIC FUNCTION; IN-VITRO; OXIDATIVE-METABOLISM; EXTRACELLULAR POTASSIUM; ASTROCYTIC GLYCOLYSIS; CULTURED ASTROCYTES; GLYCOGEN-METABOLISM; ENERGY-METABOLISM	Neurons require a nearly constant supply of ATP. Glucose is the predominant source of brain ATP, but the direct effects of prolonged glucose deprivation on neuronal viability and function remain unclear. In sparse rat hippocampal microcultures, neurons were surprisingly resilient to 16 h glucose removal in the absence of secondary excitotoxicity. Neuronal survival and synaptic transmission were unaffected by prolonged removal of exogenous glucose. Inhibition of lactate transport decreased microculture neuronal survival during concurrent glucose deprivation, suggesting that endogenously released lactate is important for tolerance to glucose deprivation. Tandem depolarization and glucose deprivation also reduced neuronal survival, and trace glucose concentrations afforded neuroprotection. Mass cultures, in contrast to microcultures, were insensitive to depolarizing glucose deprivation, a difference attributable to increased extracellular lactate levels. Removal of local astrocyte support did not reduce survival in response to glucose deprivation or alter evoked excitatory transmission, suggesting that on-demand, local lactate shuttling is not necessary for neuronal tolerance to prolonged glucose removal. Taken together, these data suggest that endogenously produced lactate available globally in the extracellular milieu sustains neurons in the absence of glucose. A better understanding of resilience mechanisms in reduced preparations could lead to therapeutic strategies aimed to bolster these mechanisms in vulnerable neuronal populations.	[Sobieski, Courtney; Warikoo, Natasha; Shu, Hong-Jin; Mennerick, Steven] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63130 USA; [Sobieski, Courtney] Washington Univ, Sch Med, Grad Program Neurosci, St Louis, MO USA; [Warikoo, Natasha; Shu, Hong-Jin; Mennerick, Steven] Washington Univ, Sch Med, Taylor Family Inst Innovat Psychiat Res, St Louis, MO 63130 USA; [Mennerick, Steven] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Mennerick, S (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63130 USA.; Mennerick, S (corresponding author), Washington Univ, Sch Med, Taylor Family Inst Innovat Psychiat Res, St Louis, MO 63130 USA.; Mennerick, S (corresponding author), Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63130 USA.	menneris@wustl.edu	Mennerick, Steven/O-2806-2017	Mennerick, Steven/0000-0003-0868-0664; Warikoo, Natasha/0000-0002-8329-7801	National Institutes of Health (NIH) [MH078823, MH099658, MH104506, MH106198]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) grants MH078823 (SM), MH099658 (SM), MH104506 (SM), and MH106198 (CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH grants MH078823, MH099658, MH104506, and MH106198. We thank Ann Benz for technical help with cultures, Amanda Taylor for help with early survival data collection, and Shannon Macauley-Rambach for help with lactate measurements. We also thank Colin Nichols, Joe Henry Steinbach, Shannon Macauley-Rambach, Joe Dougherty, Andrew Yoo and lab members for discussion and insights.	Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; AUER R, 1985, ACTA NEUROPATHOL, V67, P279, DOI 10.1007/BF00687813; AUESTAD N, 1991, J NEUROCHEM, V56, P1376, DOI 10.1111/j.1471-4159.1991.tb11435.x; Bardy C, 2015, P NATL ACAD SCI USA, V112, pE2725, DOI 10.1073/pnas.1504393112; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Bittner Carla X, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00026; Bittner CX, 2011, J NEUROSCI, V31, P4709, DOI 10.1523/JNEUROSCI.5311-10.2011; Brown AM, 2004, J NEUROCHEM, V89, P537, DOI 10.1111/j.1471-4159.2004.02421.x; Brown AM, 2005, J NEUROSCI RES, V79, P74, DOI 10.1002/jnr.20335; Brown AM, 2003, J PHYSIOL-LONDON, V549, P501, DOI 10.1113/jphysiol.2003.042416; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Budd SL, 1996, J NEUROCHEM, V67, P2282; CATALDO AM, 1986, J ELECTRON MICR TECH, V3, P413, DOI 10.1002/jemt.1060030406; Cater HL, 2001, J PHYSIOL-LONDON, V531, P459, DOI 10.1111/j.1469-7793.2001.0459i.x; CECCARELLI B, 1979, J CELL BIOL, V81, P178, DOI 10.1083/jcb.81.1.178; CHOI DW, 1994, PROG BRAIN RES, V100, P47; Choi HB, 2012, NEURON, V75, P1094, DOI 10.1016/j.neuron.2012.08.032; Chung C, 2010, J NEUROSCI, V30, P1363, DOI 10.1523/JNEUROSCI.3427-09.2010; Dienel GA, 2006, NEUROCHEM INT, V48, P586, DOI 10.1016/j.neuint.2006.01.004; DRINGEN R, 1993, BRAIN RES, V623, P208, DOI 10.1016/0006-8993(93)91429-V; EDMOND J, 1987, J NEUROSCI RES, V18, P551, DOI 10.1002/jnr.490180407; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Hassel B, 2002, NEUROCHEM RES, V27, P167, DOI 10.1023/A:1014827327690; HERTZ L, 1988, NEUROCHEM RES, V13, P605, DOI 10.1007/BF00973275; Honegger P, 1999, J CEREBR BLOOD F MET, V19, P1051, DOI 10.1097/00004647-199909000-00013; Howarth C, 2010, J CEREBR BLOOD F MET, V30, P403, DOI 10.1038/jcbfm.2009.231; Izumi Y, 1998, J CLIN INVEST, V101, P1121, DOI 10.1172/JCI1009; Izumi Y, 1997, J NEUROSCI, V17, P9448; IZUMI Y, 1994, NEUROREPORT, V5, P617, DOI 10.1097/00001756-199401000-00021; Jang S, 2016, NEURON, V90, P278, DOI 10.1016/j.neuron.2016.03.011; Kleman AM, 2008, J NEUROSCI METH, V167, P292, DOI 10.1016/j.jneumeth.2007.08.028; Kreft M, 2012, ASN NEURO, V4, DOI 10.1042/AN20120007; Li BW, 2015, J NEUROCHEM, V135, P742, DOI 10.1111/jnc.13143; LIPTON P, 1982, J PHYSIOL-LONDON, V325, P51, DOI 10.1113/jphysiol.1982.sp014135; Llorente-Folch I, 2016, J NEUROSCI, V36, P4443, DOI 10.1523/JNEUROSCI.3691-15.2016; Lujan B, 2016, J NEUROPHYSIOL, V116, P2523, DOI 10.1152/jn.00629.2016; Mattson MP, 2000, J NEUROSCI, V20, P1358; Maus M, 1999, EUR J NEUROSCI, V11, P3215, DOI 10.1046/j.1460-9568.1999.00745.x; McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444; McKenna MC, 2012, NEUROCHEM RES, V37, P2613, DOI 10.1007/s11064-012-0901-3; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; MENNERICK S, 1995, J NEUROPHYSIOL, V73, P320, DOI 10.1152/jn.1995.73.1.320; Mennerick S, 1996, J NEUROSCI, V16, P55; Moulder KL, 2007, J NEUROSCI, V27, P9846, DOI 10.1523/JNEUROSCI.2803-07.2007; Nagase M, 2014, J NEUROSCI, V34, P2605, DOI 10.1523/JNEUROSCI.4687-12.2014; Pathak D, 2015, J BIOL CHEM, V290, P22325, DOI 10.1074/jbc.M115.656405; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; PENG L, 1994, BRAIN RES, V663, P168, DOI 10.1016/0006-8993(94)90475-8; PRICHARD J, 1991, P NATL ACAD SCI USA, V88, P5829, DOI 10.1073/pnas.88.13.5829; Rangaraju V, 2014, CELL, V156, P825, DOI 10.1016/j.cell.2013.12.042; Rau TF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047877, 10.1371/journal.pone.0040881]; Rich L, 2017, NEUROSCIENTIST, V23, P356, DOI 10.1177/1073858416672622; ROTHMAN SM, 1995, TRENDS NEUROSCI, V18, P57; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Ruminot I, 2011, J NEUROSCI, V31, P14264, DOI 10.1523/JNEUROSCI.2310-11.2011; Saez I, 2014, J CEREBR BLOOD F MET, V34, P945, DOI 10.1038/jcbfm.2014.33; Sara Y, 2002, J NEUROSCI, V22, P1608, DOI 10.1523/JNEUROSCI.22-05-01608.2002; Schurr A, 1999, J NEUROSCI, V19, P34, DOI 10.1523/JNEUROSCI.19-01-00034.1999; Schurr A, 2001, NEUROSCI LETT, V307, P151, DOI 10.1016/S0304-3940(01)01937-1; SCHURR A, 1988, SCIENCE, V240, P1326, DOI 10.1126/science.3375817; Shute AA, 2005, NEUROSCIENCE, V131, P349, DOI 10.1016/j.neuroscience.2004.11.025; Sobieski C, 2017, J NEUROSCI, V37, P1888, DOI 10.1523/JNEUROSCI.2712-16.2017; Sobieski C, 2015, J NEUROSCI, V35, P11105, DOI 10.1523/JNEUROSCI.1289-15.2015; Sonnewald U, 1996, NEUROCHEM RES, V21, P987, DOI 10.1007/BF02532408; Sotelo-Hitschfeld T, 2015, J NEUROSCI, V35, P4168, DOI 10.1523/JNEUROSCI.5036-14.2015; Suh SW, 2003, J NEUROSCI, V23, P10681; SWANSON RA, 1990, J NEUROCHEM, V54, P490, DOI 10.1111/j.1471-4159.1990.tb01898.x; Takahashi S, 2014, ASN NEURO, V6, DOI 10.1177/1759091414550997; Takano T, 2014, GLIA, V62, P78, DOI 10.1002/glia.22588; Tang F, 2014, NAT COMMUN, V5, pra26; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; TOMBAUGH GC, 1990, BRAIN RES, V506, P343, DOI 10.1016/0006-8993(90)91277-N; Waagepetersen HS, 2002, NEUROCHEM RES, V27, P1431, DOI 10.1023/A:1021636102735; WALZ W, 1988, GLIA, V1, P366, DOI 10.1002/glia.440010603; Wender R, 2000, J NEUROSCI, V20, P6804, DOI 10.1523/JNEUROSCI.20-18-06804.2000; WIELOCH T, 1985, NEUROSCI LETT, V58, P25, DOI 10.1016/0304-3940(85)90323-4; Wijnen JP, 2015, NMR BIOMED, V28, P514, DOI 10.1002/nbm.3278; Wyss MT, 2011, J NEUROSCI, V31, P7477, DOI 10.1523/JNEUROSCI.0415-11.2011	80	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195520	10.1371/journal.pone.0195520	http://dx.doi.org/10.1371/journal.pone.0195520			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617444	Green Published, gold, Green Submitted			2022-12-26	WOS:000429203800090
J	Wheelwright, M; Win, Z; Mikkila, JL; Amen, KY; Alford, PW; Metzger, JM				Wheelwright, Matthew; Win, Zaw; Mikkila, Jennifer L.; Amen, Kamilah Y.; Alford, Patrick W.; Metzger, Joseph M.			Investigation of human iPSC-derived cardiac myocyte functional maturation by single cell traction force microscopy	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MUSCULAR-DYSTROPHY; HEART-FAILURE; CONTRACTION; CALCIUM; EXPRESSION; HYPERTROPHY; SHAPE	Recent advances have made it possible to readily derive cardiac myocytes from human induced pluripotent stem cells (hiPSC-CMs). HiPSC-CMs represent a valuable new experimental model for studying human cardiac muscle physiology and disease. Many laboratories have devoted substantial effort to examining the functional properties of isolated hiPSC-CMs, but to date, force production has not been adequately characterized. Here, we utilized traction force microscopy (TFM) with micro-patterning cell printing to investigate the maximum force production of isolated single hiPSC-CMs under varied culture and assay conditions. We examined the role of length of differentiation in culture and the effects of varied extracellular calcium concentration in the culture media on the maturation of hiPSC-CMs. Results show that hiPSC-CMs developing in culture for two weeks produced significantly less force than cells cultured from one to three months, with hiPSC-CMs cultured for three months resembling the cell morphology and function of neonatal rat ventricular myocytes in terms of size, dimensions, and force production. Furthermore, hiPSC-CMs cultured long term in conditions of physiologic calcium concentrations were larger and produced more force than hiPSC-CMs cultured in standard media with sub-physiological calcium. We also examined relationships between cell morphology, substrate stiffness and force production. Results showed a significant relationship between cell area and force. Implementing directed modifications of substrate stiffness, by varying stiffness from embryonic-like to adult myocardium-like, hiPSC-CMs produced maximal forces on substrates with a lower modulus and significantly less force when assayed on increasingly stiff adult myocardium like substrates. Calculated strain energy measurements paralleled these findings. Collectively, these findings further establish single cell TFM as a valuable approach to illuminate the quantitative physiological maturation of force in hiPSC-CMs.	[Wheelwright, Matthew; Mikkila, Jennifer L.; Metzger, Joseph M.] Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA; [Win, Zaw; Amen, Kamilah Y.; Alford, Patrick W.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Metzger, JM (corresponding author), Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA.	metzgerj@umn.edu		Wheelwright, Matthew/0000-0001-8883-4453; Win, Zaw/0000-0001-7512-8816	NIH [U01HL100407, R01HL132874]; Summers' Wish Pediatric Cardiology Innovators Fund; Regenerative Medicine Minnesota Award [RMM 2016 GSCH 002R]; Muscular Dystrophy Association; Dr. Warren J. Warwick and Henrietta Holm Warwick Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132874] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Summers' Wish Pediatric Cardiology Innovators Fund; Regenerative Medicine Minnesota Award; Muscular Dystrophy Association(Muscular Dystrophy Association); Dr. Warren J. Warwick and Henrietta Holm Warwick Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from NIH (U01HL100407 to JMM; R01HL132874), Summers' Wish Pediatric Cardiology Innovators Fund to JMM, Regenerative Medicine Minnesota Award (RMM 2016 GSCH 002R to MW), the Muscular Dystrophy Association and the Dr. Warren J. Warwick and Henrietta Holm Warwick Fellowship to MW. The funders had no role instudy design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen ND, 2015, J MOL CELL CARDIOL, V80, P1, DOI 10.1016/j.yjmcc.2014.12.016; Bedada FB, 2014, STEM CELL REP, V3, P594, DOI 10.1016/j.stemcr.2014.07.012; BENNINGER C, 1980, BRAIN RES, V187, P165, DOI 10.1016/0006-8993(80)90502-8; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Beussman KM, 2016, METHODS, V94, P43, DOI 10.1016/j.ymeth.2015.09.005; Boheler KR, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/214203; Boothe SD, 2016, CELL BIOCHEM BIOPHYS, V74, P527, DOI 10.1007/s12013-016-0758-1; Bray MA, 2008, CELL MOTIL CYTOSKEL, V65, P641, DOI 10.1002/cm.20290; CANNELL MB, 1995, SCIENCE, V268, P1045, DOI 10.1126/science.7754384; Chang WT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168071; Davis J, 2007, CIRC RES, V100, P1494, DOI 10.1161/01.RES.0000268412.34364.50; Desai RA, 2004, METHOD CELL BIOL, V119, P3; Echegaray K, 2017, REV ESP CARDIOL, V16, P30462; Elosegui-Artola A, 2016, NAT CELL BIOL, V18, P540, DOI 10.1038/ncb3336; Elustondo PA, 2017, J BIOENERG BIOMEMBR, V49, P113, DOI 10.1007/s10863-016-9676-6; Foglia MJ, 2016, DEVELOPMENT, V143, P729, DOI 10.1242/dev.132910; Hashimoto A, 2016, INT HEART J, V57, P112, DOI 10.1536/ihj.15-376; Hazeltine Laurie B, 2012, Int J Cell Biol, V2012, P508294, DOI 10.1155/2012/508294; Hersch N, 2013, BIOL OPEN, V2, P351, DOI 10.1242/bio.20133830; Huebsch N, 2016, SCI REP-UK, V6, DOI 10.1038/srep24726; Ivaschenko CY, 2013, AM J PHYSIOL-HEART C, V305, P913; Jacot JG, 2010, J BIOMECH, V43, P93, DOI 10.1016/j.jbiomech.2009.09.014; Jones AR, 2016, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00089; JONES HC, 1987, J PHYSIOL-LONDON, V383, P441; Kuo PL, 2012, AM J PATHOL, V181, P2030, DOI 10.1016/j.ajpath.2012.08.045; Kuzmenkin A, 2009, FASEB J, V23, P4168, DOI 10.1096/fj.08-128546; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Li Min, 2014, Biomed Res Int, V2014, P375262, DOI 10.1155/2014/375262; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Redondo F, 2016, J PHARMACOL SCI, V131, P141, DOI 10.1016/j.jphs.2016.04.015; Martiel JL, 2015, METHOD CELL BIOL, V125, P269, DOI 10.1016/bs.mcb.2014.10.008; Mattei G, 2016, ACTA BIOMATER, V45, P60, DOI 10.1016/j.actbio.2016.08.055; Miller DJ, 2004, J PHYSIOL-LONDON, V555, P585, DOI 10.1113/jphysiol.2004.060731; MOORE GE, 1967, J AMER MED ASSOC, V199, P519, DOI 10.1001/jama.199.8.519; Oakes PW, 2014, BIOPHYS J, V107, P825, DOI 10.1016/j.bpj.2014.06.045; Paige SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011134; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Pfannkuche K, 2009, CELL PHYSIOL BIOCHEM, V24, P73, DOI 10.1159/000227815; Pioner JM, 2016, STEM CELL REP, V6, P885, DOI 10.1016/j.stemcr.2016.04.006; Posterino GS, 2011, J APPL PHYSIOL, V111, P236, DOI 10.1152/japplphysiol.00067.2011; Raeker MO, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00014; Ribeiro AJS, 2015, P NATL ACAD SCI USA, V112, P12705, DOI 10.1073/pnas.1508073112; Ribeiro MC, 2015, BIOMATERIALS, V51, P138, DOI 10.1016/j.biomaterials.2015.01.067; Robertson C, 2013, STEM CELLS, V31, P829, DOI 10.1002/stem.1331; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Sheehy SP, 2014, STEM CELL REP, V2, P282, DOI 10.1016/j.stemcr.2014.01.015; Shimizu T., 2016, Reproductive Medicine and Biology, V15, P35, DOI 10.1007/s12522-015-0213-9; Siedner S, 2003, J PHYSIOL-LONDON, V548, P493, DOI 10.1113/JPHYSIOL.2002.036509; Sorensen AB, 2013, FEBS J, V280, P5511, DOI 10.1111/febs.12337; Stricker J, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194104; terKeurs HEDJ, 1996, CAN J CARDIOL, V12, P1047; Tham YK, 2015, ARCH TOXICOL, V89, P1401, DOI 10.1007/s00204-015-1477-x; Tse J.R., 2010, CURR PROTOC CELL BIO, V10, pUnit, DOI [DOI 10.1002/0471143030.CB1016S47, 10.1002/0471143030.cb1016s47]; Tseng QZ, 2012, P NATL ACAD SCI USA, V109, P1506, DOI 10.1073/pnas.1106377109; Tyrode MV, 1910, ARCH INT PHARMACOD T, V20, P205; Wang N, 2002, CELL MOTIL CYTOSKEL, V52, P97, DOI 10.1002/cm.10037; Wang YanFei, 2013, Journal of Chemistry, V2013, P784543; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Young JL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06425; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang JH, 2012, CIRC RES, V111, P1125, DOI 10.1161/CIRCRESAHA.112.273144	62	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0194909	10.1371/journal.pone.0194909	http://dx.doi.org/10.1371/journal.pone.0194909			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617427	Green Published, gold, Green Submitted			2022-12-26	WOS:000429203800055
J	Nirschl, JJ; Janowczyk, A; Peyster, EG; Frank, R; Margulies, KB; Feldman, MD; Madabhushi, A				Nirschl, Jeffrey J.; Janowczyk, Andrew; Peyster, Eliot G.; Frank, Renee; Margulies, Kenneth B.; Feldman, Michael D.; Madabhushi, Anant			A deep-learning classifier identifies patients with clinical heart failure using whole-slide images of H&E tissue	PLOS ONE			English	Article							COLLEGE-OF-CARDIOLOGY; WORKING FORMULATION; NEURAL-NETWORKS; CLASS DISCOVERY; DIAGNOSIS; ASSOCIATION; INFORMATION; MANAGEMENT; DISEASE; UPDATE	Over 26 million people worldwide suffer from heart failure annually. When the cause of heart failure cannot be identified, endomyocardial biopsy (EMB) represents the gold-standard for the evaluation of disease. However, manual EMB interpretation has high inter-rater variability. Deep convolutional neural networks (CNNs) have been successfully applied to detect cancer, diabetic retinopathy, and dermatologic lesions from images. In this study, we develop a CNN classifier to detect clinical heart failure from H&E stained whole-slide images from a total of 209 patients, 104 patients were used for training and the remaining 105 patients for independent testing. The CNN was able to identify patients with heart failure or severe pathology with a 99% sensitivity and 94% specificity on the test set, outperforming conventional feature-engineering approaches. Importantly, the CNN outperformed two expert pathologists by nearly 20%. Our results suggest that deep learning analytics of EMB can be used to predict cardiac outcome.	[Nirschl, Jeffrey J.] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Janowczyk, Andrew; Madabhushi, Anant] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Peyster, Eliot G.; Margulies, Kenneth B.] Univ Penn, Cardiovasc Res Inst, Philadelphia, PA 19104 USA; [Frank, Renee; Feldman, Michael D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Case Western Reserve University; University of Pennsylvania; University of Pennsylvania	Madabhushi, A (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	axm788@case.edu	Madabhushi, Anant/AAG-2908-2019; Nirschl, Jeffrey/GYQ-5009-2022	Madabhushi, Anant/0000-0002-5741-0399; Nirschl, Jeffrey/0000-0001-6857-341X	National Cancer Institute of the National Institutes of Health [R01CA202752-01A1, R01CA208236-01A1, R01 CA216579-01A1, R21CA179327-01, R21CA195152-01, U24CA199374-01]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK098503-02]; National Center for Advancing Translational Sciences [TL1TR001880]; National Heart Lung and Blood Institute [R01-HL105993]; DOD Prostate Cancer Synergistic Idea Development Award [PC120857]; National Institute of Diabetes and Digestive and Kidney Diseases (US) [5T32DK007470]; National Center for Research Resources [1 C06 RR12463-01]; DOD Lung Cancer Idea Development New Investigator Award [LC130463]; DOD Peer Reviewed Cancer Research Program [W81XWH-16-1-0329]; Case Comprehensive Cancer Center Pilot Grant; Ohio Third Frontier Technology Validation Fund; VelaSano Grant from the Cleveland Clinic the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University; Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering; Clinical and Translational Science Award Program (CTSA) at Case Western Reserve University; I-Corps@Ohio Program; NINDS [F30NS092227]; NATIONAL CANCER INSTITUTE [R01CA216579, U24CA199374, R01CA220581, R01CA208236, R01CA202752] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS092227] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DOD Prostate Cancer Synergistic Idea Development Award; National Institute of Diabetes and Digestive and Kidney Diseases (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOD Lung Cancer Idea Development New Investigator Award; DOD Peer Reviewed Cancer Research Program; Case Comprehensive Cancer Center Pilot Grant; Ohio Third Frontier Technology Validation Fund; VelaSano Grant from the Cleveland Clinic the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University; Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering; Clinical and Translational Science Award Program (CTSA) at Case Western Reserve University; I-Corps@Ohio Program; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award numbers (R01CA202752-01A1, R01CA208236-01A1, R01 CA216579-01A1, R21CA179327-01, R21CA195152-01 and U24CA199374-01) the National Institute of Diabetes and Digestive and Kidney Diseases under award number R01DK098503-02, The National Center for Advancing Translational Sciences under award number TL1TR001880, the National Heart Lung and Blood Institute under award number R01-HL105993, the DOD Prostate Cancer Synergistic Idea Development Award (PC120857); the National Institute of Diabetes and Digestive and Kidney Diseases (US) under award number 5T32DK007470, the National Center for Research Resources under award number under the award number 1 C06 RR12463-01, the DOD Lung Cancer Idea Development New Investigator Award (LC130463), the DOD Prostate Cancer Synergistic Idea Development Award (PC120857); the DOD Peer Reviewed Cancer Research Program (W81XWH-16-1-0329), the Case Comprehensive Cancer Center Pilot Grant, The Ohio Third Frontier Technology Validation Fund, the VelaSano Grant from the Cleveland Clinic the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University, the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering, the The Clinical and Translational Science Award Program (CTSA) at Case Western Reserve University, and the I-Corps@Ohio Program. JJN was supported by NINDS F30NS092227. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; Angelini A, 2011, J HEART LUNG TRANSPL, V30, P1214, DOI 10.1016/j.healun.2011.05.011; Basavanhally Ajay, 2011, J Pathol Inform, V2, pS1, DOI 10.4103/2153-3539.92027; Beck AH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002564; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Bhargava R, 2016, ANNU REV BIOMED ENG, V18, P387, DOI 10.1146/annurev-bioeng-112415-114722; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caccomo S., 2017, FDA ALLOWS MARKETING; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cooper LT, 2007, CIRCULATION, V116, P2216, DOI 10.1161/CIRCULATIONAHA.107.186093; Cruz-Roa A, 2014, SPIE MED IMAGING SPI, P15; Cruz-Roa A, 2017, SCI REP-UK, V7, DOI 10.1038/srep46450; Dahl GE, 2013, INT CONF ACOUST SPEE, P8609, DOI 10.1109/ICASSP.2013.6639346; Doyle S, 2012, IEEE T BIO-MED ENG, V59, P1205, DOI 10.1109/TBME.2010.2053540; Duchi J, 2011, J MACH LEARN RES, V12, P2121; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Ghaznavi F, 2013, ANNU REV PATHOL-MECH, V8, P331, DOI 10.1146/annurev-pathol-011811-120902; Gho JMIH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094820; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; He K., 2016, CVPR, P770; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Ioffe S., 2015, INT C ONMACHINE LEAR, V37, P448, DOI DOI 10.1007/S13398-014-0173-7.2; Janowczyk Andrew, 2016, J Pathol Inform, V7, P29, DOI 10.4103/2153-3539.186902; Kochanek Kenneth D, 2011, Natl Vital Stat Rep, V60, P1; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lafarge MW, 2017, LECT NOTES COMPUT SC, V10553, P83, DOI 10.1007/978-3-319-67558-9_10; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097954; Lewis JS, 2014, AM J SURG PATHOL, V38, P128, DOI 10.1097/PAS.0000000000000086; Litjens G, 2016, SCI REP-UK, V6, DOI 10.1038/srep26286; Madabhushi A, 2016, MED IMAGE ANAL, V33, P170, DOI 10.1016/j.media.2016.06.037; Madabhushi A, 2011, COMPUT MED IMAG GRAP, V35, P506, DOI 10.1016/j.compmedimag.2011.01.008; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nair V., 2010, P 27 INT C INT C MAC, P807; Nirschl JJ, 2017, ELS MIC SOC BOOK SER, P179, DOI 10.1016/B978-0-12-810408-8.00011-0; Orlov N, 2008, PATTERN RECOGN LETT, V29, P1684, DOI 10.1016/j.patrec.2008.04.013; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Powers D. M, 2011, ARXIV201016061; Romo-Bucheli D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32706; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; Szegedy C, 2015, PROC CVPR IEEE, P1, DOI 10.1109/CVPR.2015.7298594; Wang DK, 2016, ALTRE MOD-RIV STUD L, P1, DOI 10.13130/2035-7680/6845; Wang HB, 2014, J MED IMAGING, V1, DOI 10.1117/1.JMI.1.3.034003; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Williams E, 2017, NAT METHODS, V14, P775, DOI [10.1038/NMETH.4326, 10.1038/nmeth.4326]; Yu KH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12474	50	54	55	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2018	13	4							e0192726	10.1371/journal.pone.0192726	http://dx.doi.org/10.1371/journal.pone.0192726			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5DC	29614076	Green Submitted, gold, Green Published			2022-12-26	WOS:000429081600001
J	Nicolae, CM; O'Connor, MJ; Constantin, D; Moldovan, GL				Nicolae, Claudia M.; O'Connor, Michael J.; Constantin, Daniel; Moldovan, George-Lucian			NF kappa B regulates p21 expression and controls DNA damage-induced leukemic differentiation	ONCOGENE			English	Article							ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; HL-60 CELLS; GENE; ACTIVATION; MUTATIONS; EVOLUTION; APOPTOSIS; SURVIVAL; DISEASE	DNA damage exposure is a major modifier of cell fate in both normal and cancer tissues. In response to DNA damage, myeloid leukemia cells activate a poorly understood terminal differentiation process. Here, we show that the NF kappa B pathway directly activates expression of the proliferation inhibitor p21 in response to DNA damage in myeloid leukemia cells. In order to understand the role of this unexpected regulatory event, we ablated the NF kappa B binding site we identified in the p21 promoter, using CRISPR/Cas9-mediated genome editing. We found that NF kappa B-mediated p21 activation controls DNA damage-induced myeloid differentiation. Our results uncover a p53-independent pathway for p21 activation involved in controlling hematopoietic cell fate.	[Nicolae, Claudia M.; O'Connor, Michael J.; Constantin, Daniel; Moldovan, George-Lucian] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, 500 Univ Dr, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Moldovan, GL (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, 500 Univ Dr, Hershey, PA 17033 USA.	glm29@psu.edu		Nicolae, Claudia/0000-0003-4933-5496; George-Lucian, Moldovan/0000-0003-3825-149X	Department of Defense [CA140303]; St. Baldrick Foundation	Department of Defense(United States Department of Defense); St. Baldrick Foundation	We would like to thank Wafik el-Deiry, Sinisa Dovat, David Claxton, Gregory Yochum, Sergei Grigoryev, James Broach, and the Penn State Flow Cytometry Core for materials, advice, and support. This work was supported by the Department of Defense (award CA140303) and the St. Baldrick Foundation.	Asada M, 1998, LEUKEMIA, V12, P1944, DOI 10.1038/sj.leu.2401228; Bruserud O, 2000, Oncologist, V5, P454, DOI 10.1634/theoncologist.5-6-454; Cheung KJJ, 2009, BRIT J HAEMATOL, V146, P257, DOI 10.1111/j.1365-2141.2009.07739.x; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Figarola JL, 2012, INVEST NEW DRUG, V30, P1413, DOI 10.1007/s10637-011-9711-8; Galanos P, 2016, NAT CELL BIOL, V18, P777, DOI 10.1038/ncb3378; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Georgakilas AG, 2017, TRENDS MOL MED, V23, P310, DOI 10.1016/j.molmed.2017.02.001; Grove CS, 2014, DIS MODEL MECH, V7, P941, DOI 10.1242/dmm.015974; Gupta D, 2014, CURR PROTOC IMMUNOL, V104; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hou HA, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.59; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Lee S, 2001, P NATL ACAD SCI USA, V98, P3340, DOI 10.1073/pnas.051013798; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Melo Monica B, 2002, Hematology, V7, P13, DOI 10.1080/10245330290020090; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Pennington KN, 2001, MOL CELL BIOL, V21, P1930, DOI 10.1128/MCB.21.6.1930-1941.2001; Price JG, 2015, NAT IMMUNOL, V16, P1060, DOI 10.1038/ni.3270; Rizzo MG, 1998, BRIT J CANCER, V77, P1429, DOI 10.1038/bjc.1998.236; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Santos MA, 2014, NATURE, V514, P107, DOI 10.1038/nature13483; Sherman MH, 2011, TRENDS CELL BIOL, V21, P312, DOI 10.1016/j.tcb.2011.01.004; SUGIMOTO K, 1992, BLOOD, V79, P2378, DOI 10.1182/blood.V79.9.2378.2378; Tilstra JS, 2011, AGING DIS, V2, P449; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Watts JM, 2014, BLOOD REV, V28, P205, DOI 10.1016/j.blre.2014.07.001; WOLF D, 1985, P NATL ACAD SCI USA, V82, P790, DOI 10.1073/pnas.82.3.790	30	12	14	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 5	2018	37	27					3647	3656		10.1038/s41388-018-0219-y	http://dx.doi.org/10.1038/s41388-018-0219-y			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GM3CM	29622796				2022-12-26	WOS:000437975200003
J	Cohen, A; Habib, A; Laor, D; Yadav, S; Kupiec, M; Weisman, R				Cohen, Adiel; Habib, Aline; Laor, Dana; Yadav, Sudhanshu; Kupiec, Martin; Weisman, Ronit			TOR complex 2 in fission yeast is required for chromatin-mediated gene silencing and assembly of heterochromatic domains at subtelomeres	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; heterochromatin; gene silencing; gene expression; Schizosaccharomyces pombe; Epe1; mating-type locus; Paf1 complex; subtelomeres; TORC2	REGULATES MITOTIC COMMITMENT; SCHIZOSACCHAROMYCES-POMBE; PAF1 COMPLEX; NITROGEN STARVATION; LYSINE-9 METHYLATION; HISTONE ACETYLATION; EPIGENETIC CONTROL; KINASE PATHWAY; PROTEIN; RNAI	The conserved serine/threonine protein kinase target of rapamycin (TOR) is a major regulator of eukaryotic cellular and organismal growth and a valuable target for drug therapy. TOR forms the core of two evolutionary conserved complexes, TOR complex 1 (TORC1) and TORC2. In the fission yeast Schizosaccharomyces pombe, TORC2 responds to glucose levels and, by activating the protein kinase Gad8 (an orthologue of human AKT), is required for well-regulated cell cycle progression, starvation responses, and cell survival. Here, we report that TORC2-Gad8 is also required for gene silencing and the formation of heterochromatin at the S. pombe mating-type locus and at subtelomeric regions. Deletion of TORC2-Gad8 resulted in loss of the heterochromatic modification of histone 3 lysine 9 dimethylation (H3K9me2) and an increase in euchromatic modifications, including histone 3 lysine 4 trimethylation (H3K4me3) and histone 4 lysine 16 acetylation (H4K16Ac). Accumulation of RNA polymerase II (Pol II) at subtelomeric genes in TORC2-Gad8 mutant cells indicated a defect in silencing at the transcriptional level. Moreover, a concurrent decrease in histone 4 lysine 20 dimethylation (H4K20me2) suggested elevated histone turnover. Loss of gene silencing in cells lacking TORC2-Gad8 is partially suppressed by loss of the anti-silencer Epe1 and fully suppressed by loss of the Pol II-associated Paf1 complex, two chromatin regulators that have been implicated in heterochromatin stability and spreading. Taken together, our findings suggest that TORC2-Gad8 signaling contributes to epigenetic stability at subtelomeric regions and the mating-type locus in S. pombe.	[Cohen, Adiel; Yadav, Sudhanshu; Weisman, Ronit] Open Univ Israel, Dept Nat & Life Sci, Univ Rd 1, IL-4353701 Ranana, Israel; [Habib, Aline; Laor, Dana; Kupiec, Martin] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69977801 Tel Aviv, Israel; [Yadav, Sudhanshu] CSIC, Dept Immunol & Oncol, Natl Biotechnol Ctr, Darwin 3 Cantoblanco, Madrid 28049, Spain	Open University Israel; Tel Aviv University; Consejo Superior de Investigaciones Cientificas (CSIC)	Weisman, R (corresponding author), Open Univ Israel, Dept Nat & Life Sci, Univ Rd 1, IL-4353701 Ranana, Israel.	ronitwe@openu.ac.il		Yadav, Sudhanshu/0000-0003-0418-8058; Laor Bar-Yosef, Dana/0000-0003-1699-3839	Israel Science Foundation [688/14]; Open University of Israel [31040]	Israel Science Foundation(Israel Science Foundation); Open University of Israel	This work was supported by Israel Science Foundation Grant 688/14 and Open University of Israel Grant 31040 (to R. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Allshire RC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018770; Alvarez B, 2006, J CELL SCI, V119, P4475, DOI 10.1242/jcs.03241; Atlasi Y, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.57; Aygun O, 2013, NAT STRUCT MOL BIOL, V20, P547, DOI 10.1038/nsmb.2565; Ayoub N, 2003, MOL CELL BIOL, V23, P4356, DOI 10.1128/MCB.23.12.4356-4370.2003; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Baker K, 2016, J CELL SCI, V129, P2613, DOI 10.1242/jcs.190124; Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Braun S, 2011, CELL, V144, P41, DOI 10.1016/j.cell.2010.11.051; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Chen HF, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-29; Cohen A, 2016, J BIOL CHEM, V291, P9371, DOI 10.1074/jbc.M115.705251; Cohen A, 2014, J BIOL CHEM, V289, P21727, DOI 10.1074/jbc.M114.573824; Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Dheur S, 2011, MOL CELL BIOL, V31, P1088, DOI 10.1128/MCB.01290-10; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hansen KR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001268; Hatano T, 2015, CELL CYCLE, V14, P848, DOI 10.1080/15384101.2014.1000215; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Inada M, 2016, NUCLEIC ACIDS RES, V44, P9180, DOI 10.1093/nar/gkw603; Isaac S, 2007, GENETICS, V175, P1549, DOI 10.1534/genetics.106.068684; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Jih G, 2017, NATURE, V547, P463, DOI 10.1038/nature23267; Kawai M, 2001, CURR GENET, V39, P166; Kowalik KM, 2015, NATURE, V520, P248, DOI 10.1038/nature14337; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Laboucarie T, 2017, EMBO REP, V18, P2197, DOI 10.15252/embr.201744942; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laor D, 2015, MBIO, V6, DOI 10.1128/mBio.00959-15; Lee NN, 2013, CELL, V155, P1061, DOI 10.1016/j.cell.2013.10.027; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Lun ATL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1191; Martin R, 2017, CURR BIOL, V27, P175, DOI 10.1016/j.cub.2016.11.037; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Matsuo T, 2003, EMBO J, V22, P3073, DOI 10.1093/emboj/cdg298; Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06; Mbogning J, 2015, NUCLEIC ACIDS RES, V43, P9766, DOI 10.1093/nar/gkv837; Mikheyeva IV, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004740; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Otsubo Y, 2008, CRIT REV BIOCHEM MOL, V43, P277, DOI [10.1080/10409230802254911, 10.1080/10409230802254911 ]; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Petersen J, 2009, BIOCHEM SOC T, V37, P273, DOI 10.1042/BST0370273; Reyes-Turcu FE, 2011, NAT STRUCT MOL BIOL, V18, P1132, DOI 10.1038/nsmb.2122; Roguev A, 2003, J BIOL CHEM, V278, P8487, DOI 10.1074/jbc.M209562200; Rohde JR, 2003, MOL CELL BIOL, V23, P629, DOI 10.1128/MCB.23.2.629-635.2003; Sadeghi L, 2015, EMBO REP, V16, P1673, DOI 10.15252/embr.201541214; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schonbrun M, 2013, J BIOL CHEM, V288, P19649, DOI 10.1074/jbc.M113.464974; Schonbrun M, 2009, MOL CELL BIOL, V29, P4584, DOI 10.1128/MCB.01879-08; Shimada A, 2009, GENE DEV, V23, P18, DOI 10.1101/gad.1708009; Shimada Y, 2016, GENE DEV, V30, P2571, DOI 10.1101/gad.292599.116; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Sugiyama T, 2016, MOL CELL, V61, P747, DOI 10.1016/j.molcel.2016.01.029; Svensson JP, 2015, GENOME RES, V25, P872, DOI 10.1101/gr.188870.114; Tashiro S, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx780; Tatebe H, 2010, CURR BIOL, V20, P1975, DOI 10.1016/j.cub.2010.10.026; Thon G, 2000, GENETICS, V155, P551; Trewick SC, 2007, EMBO J, V26, P4670, DOI 10.1038/sj.emboj.7601892; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Van Oss SB, 2017, TRENDS BIOCHEM SCI, V42, P788, DOI 10.1016/j.tibs.2017.08.003; Verrier L, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150045; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang JY, 2013, GENE DEV, V27, P1886, DOI 10.1101/gad.221010.113; Weisman R, 2005, GENETICS, V169, P539, DOI 10.1534/genetics.104.034983; Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200; Weisman R, 2007, GENETICS, V175, P1153, DOI 10.1534/genetics.106.064170; Weisman R, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.FUNK-0006-2016; Workman JJ, 2016, GENETICS, V203, P1733, DOI 10.1534/genetics.116.188458; Workman JJ, 2014, CELL CYCLE, V13, P714, DOI 10.4161/cc.28112; Yi SA, 2016, MOL CELL, V62, P443, DOI 10.1016/j.molcel.2016.03.011; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010; Zofall M, 2012, SCIENCE, V335, P96, DOI 10.1126/science.1211651; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	78	16	16	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8138	8150		10.1074/jbc.RA118.002270	http://dx.doi.org/10.1074/jbc.RA118.002270			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29632066	Green Published, hybrid			2022-12-26	WOS:000433224600019
J	Sun, J; Hu, QW; Peng, H; Peng, C; Zhou, LH; Lu, JS; Huang, CX				Sun, Jian; Hu, Qianwen; Peng, Hong; Peng, Cheng; Zhou, Liheng; Lu, Jinsong; Huang, Chuanxin			The ubiquitin-specific protease USP8 deubiquitinates and stabilizes Cx43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin ligase; ubiquitylation (ubiquitination); autophagy; connexin; deubiquitylation (deubiquitination); USP8; Cx43; ubiquitin; degradation; autophagy	GAP-JUNCTIONS; INTERCELLULAR COMMUNICATION; PLASMA-MEMBRANE; CONNEXINS; DEGRADATION; INTERNALIZATION; AUTOPHAGY; DISEASE; CANCER; ENDOCYTOSIS	Connexin-43 (Cx43, also known as GJA1) is the most ubiquitously expressed connexin isoform in mammalian tissues. It forms intercellular gap junction (GJ) channels, enabling adjacent cells to communicate both electrically and metabolically. Cx43 is a short-lived protein which can be quickly degraded by the ubiquitin-dependent proteasomal, endolysosomal, and autophagosomal pathways. Here, we report that the ubiquitin-specific peptidase 8 (USP8) interacts with and deubiquitinates Cx43. USP8 reduces both multiple monoubiquitination and polyubiquitination of Cx43 to prevent autophagy-mediated degradation. Consistently, knockdown of USP8 results in decreased Cx43 protein levels in cultured cells and suppresses intercellular communication, revealed by the dye transfer assay. In human breast cancer specimens, the expression levels of USP8 and Cx43 proteins are positively correlated. Taken together, these results identified USP8 as a crucial and bona fide deubiquitinating enzyme involved in autophagy-mediated degradation of Cx43.	[Sun, Jian; Zhou, Liheng; Lu, Jinsong] Shanghai Jiao Tong Univ, Renji Hosp, Dept Breast Surg, Sch Med, Shanghai 200025, Peoples R China; [Hu, Qianwen; Peng, Hong; Peng, Cheng; Huang, Chuanxin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200025, Peoples R China; [Hu, Qianwen; Peng, Hong; Peng, Cheng; Huang, Chuanxin] Shanghai Jiao Tong Univ, Sch Med, Dept Immunol & Microbiol, Key Lab Cell Differentiat & Apoptosis,Chinese Min, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Lu, JS (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Dept Breast Surg, Sch Med, Shanghai 200025, Peoples R China.; Huang, CX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200025, Peoples R China.; Huang, CX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Immunol & Microbiol, Key Lab Cell Differentiat & Apoptosis,Chinese Min, Shanghai 200025, Peoples R China.	lujjss@163.com; huangcx@shsmu.edu.cn			1000 Youth Elite Program; Shanghai Jiao Tong University School of Medicine [15PJ1407400]; Science and Technology Commission of Shanghai Municipality Grant [1402700]; National Natural Science Foundation of China [81172505]; Municipality Cross Research Foundation of Shanghai Jiao Tong University [YG2017QN49]; Shanghai Municipality Commission of Health and Family Planning [201640006]; Shanghai Pujiang Scholarship [15PJ1407400]	1000 Youth Elite Program; Shanghai Jiao Tong University School of Medicine; Science and Technology Commission of Shanghai Municipality Grant(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Municipality Cross Research Foundation of Shanghai Jiao Tong University; Shanghai Municipality Commission of Health and Family Planning; Shanghai Pujiang Scholarship(Shanghai Pujiang Program)	This work was supported in part by the 1000 Youth Elite Program, the startup fund by Shanghai Jiao Tong University School of Medicine and Shanghai Pujiang Scholarship 15PJ1407400 (to C. H.); Science and Technology Commission of Shanghai Municipality Grant 1402700 (to J. L.); National Natural Science Foundation of China Grant 81172505 (to J. L.); Municipality Cross Research Foundation of Shanghai Jiao Tong University Grant YG2017QN49 (to L. Z.); and Shanghai Municipality Commission of Health and Family Planning Grant 201640006 (to J. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Aasen T, 2016, NAT REV CANCER, V16, P775, DOI 10.1038/nrc.2016.105; Alexopoulou Z, 2016, P NATL ACAD SCI USA, V113, pE4688, DOI 10.1073/pnas.1523597113; Basheer WA, 2015, J MOL CELL CARDIOL, V88, P1, DOI 10.1016/j.yjmcc.2015.09.004; Bejarano E, 2012, MOL BIOL CELL, V23, P2156, DOI 10.1091/mbc.E11-10-0844; Carette D, 2015, BIOL CELL, V107, P218, DOI 10.1111/boc.201400048; Chen VC, 2012, J PROTEOME RES, V11, P6134, DOI 10.1021/pr300790h; Durcan TM, 2014, EMBO J, V33, P2473, DOI 10.15252/embj.201489729; Falk MM, 2014, FEBS LETT, V588, P1221, DOI 10.1016/j.febslet.2014.01.031; Falk MM, 2009, MOL BIOL CELL, V20, P3342, DOI 10.1091/mbc.E09-04-0288; Fong JT, 2012, AUTOPHAGY, V8, P794, DOI 10.4161/auto.19390; Funmilayo E, 2016, J BIOL CHEM, V291, P15753, DOI 10.1074/jbc.M116.718023; Girao H, 2009, EXP CELL RES, V315, P3587, DOI 10.1016/j.yexcr.2009.10.003; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Grek CL, 2016, CANCER LETT, V374, P117, DOI 10.1016/j.canlet.2016.02.008; Juul MH, 2000, CELL ADHES COMMUN, V7, P501, DOI 10.3109/15419060009040307; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Leithe E, 2004, J BIOL CHEM, V279, P50089, DOI 10.1074/jbc.M402006200; Leithe E, 2004, J CELL SCI, V117, P1211, DOI 10.1242/jcs.00951; Leithe E, 2007, J MEMBRANE BIOL, V217, P43, DOI 10.1007/s00232-007-9050-z; Leithe E, 2016, BBA-REV CANCER, V1865, P133, DOI 10.1016/j.bbcan.2016.02.001; Leithe E, 2012, BBA-BIOMEMBRANES, V1818, P1870, DOI 10.1016/j.bbamem.2011.09.029; Li S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001239; Ma ZY, 2015, CELL RES, V25, P306, DOI 10.1038/cr.2015.20; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Naviglio S, 1998, EMBO J, V17, P3241, DOI 10.1093/emboj/17.12.3241; Niendorf S, 2007, MOL CELL BIOL, V27, P5029, DOI 10.1128/MCB.01566-06; Pan X, 2011, NAT MED, V17, P708, DOI 10.1038/nm.2369; Piehl M, 2007, MOL BIOL CELL, V18, P337, DOI 10.1091/mbc.E06-06-0487; Reincke M, 2015, NAT GENET, V47, P31, DOI 10.1038/ng.3166; Ribeiro-Rodrigues TM, 2014, FASEB J, V28, P4629, DOI 10.1096/fj.13-248963; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Sohl G, 2003, CELL COMMUN ADHES, V10, P173, DOI 10.1080/15419060390262877; Su V, 2010, J BIOL CHEM, V285, P40979, DOI 10.1074/jbc.M110.170753; Totland MZ, 2017, J CELL SCI, V130, P2867, DOI 10.1242/jcs.202408; Urbe S, 2006, BIOCHEM SOC T, V34, P754, DOI 10.1042/BST0340754	40	19	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8275	8284		10.1074/jbc.RA117.001315	http://dx.doi.org/10.1074/jbc.RA117.001315			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29626091	Green Published, hybrid			2022-12-26	WOS:000433224600031
J	Hannan, NJ; Binder, NK; Beard, S; Nguyen, TV; Kaitu'u-Lino, TJ; Tong, S				Hannan, Natalie J.; Binder, Natalie K.; Beard, Sally; Tuong-Vi Nguyen; Kaitu'u-Lino, Tu'uhevaha J.; Tong, Stephen			Melatonin enhances antioxidant molecules in the placenta, reduces secretion of soluble fms-like tyrosine kinase 1 (sFLT) from primary trophoblast but does not rescue endothelial dysfunction: An evaluation of its potential to treat preeclampsia	PLOS ONE			English	Article							OXIDATIVE STRESS; ANTIANGIOGENIC FACTORS; MITOCHONDRIAL DAMAGE; SERUM MELATONIN; PREGNANCY; ENDOGLIN; RATS; WOMEN; HYPERTENSION; PATHOGENESIS	Preeclampsia is one of the most serious complications of pregnancy. Currently there are no medical treatments. Given placental oxidative stress may be an early trigger in the pathogenesis of preeclampsia, therapies that enhance antioxidant pathways have been proposed as treatments. Melatonin is a direct free-radical scavenger and indirect antioxidant. We performed in vitro assays to assess whether melatonin 1) enhances the antioxidant response element genes (heme-oxygenase 1, (HO-1), glutamate-cysteine ligase (GCLC), NAD(P)H: quinone acceptor oxidoreductase 1 (NQO1), thioredoxin (TXN)) or 2) alters secretion of the anti-angiogenic factors soluble fms-like tyrosine kinase-1 (sFLT) or soluble endoglin (sENG) from human primary trophoblasts, placental explants and human umbilical vein endothelial cells (HUVECs) and 3) can rescue TNF-alpha induced endothelial dysfunction. In primary trophoblast melatonin treatment increased expression of the antioxidant enzyme TXN. Expression of TXN, GCLC and NQO1 was upregulated in placental tissue with melatonin treatment. HUVECs treated with melatonin showed an increase in both TXN and GCLC. Melatonin did not increase HO-1 expression in any of the tissues examined. Melatonin reduced sFLT secretion from primary trophoblasts, but had no effect on sFLT or sENG secretion from placental explants or HUVECs. Melatonin did not rescue TNF-alpha induced VCAM-1 and ET-1 expression in endothelial cells. Our findings suggest that melatonin induces antioxidant pathways in placenta and endothelial cells. Furthermore, it may have effects in reducing sFLT secretion from trophoblast, but does not reduce endothelial dysfunction. Given it is likely to be safe in pregnancy, it may have potential as a therapeutic agent to treat or prevent preeclampsia.	[Hannan, Natalie J.; Binder, Natalie K.; Beard, Sally; Tuong-Vi Nguyen; Kaitu'u-Lino, Tu'uhevaha J.; Tong, Stephen] Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Translat Obstet Grp,Mercy Perinatal, Heidelberg, Vic, Australia	University of Melbourne	Hannan, NJ (corresponding author), Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Translat Obstet Grp,Mercy Perinatal, Heidelberg, Vic, Australia.	nhannan@unimelb.edu.au		Hannan, Natalie/0000-0001-8446-2250; Tong, Stephen/0000-0002-2319-0586; Binder, Natalie K/0000-0002-8943-2269; Kaitu'u-Lino, Tu'uhevaha/0000-0001-6233-9737	National Health and Medical Research Council of Australia (NHMRC) [1050765, 1062418]; University of Melbourne CR Roper Fellowship	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne CR Roper Fellowship(University of Melbourne)	The National Health and Medical Research Council of Australia (NHMRC) provided salary support (#1050765 to ST; #1062418 to TKL). NJH salary was supported by a University of Melbourne CR Roper Fellowship. The funders had no role in study design, data collection, analysis or decision to publish.	Agarwal I, 2011, PREGNANCY HYPERTENS, V1, P17, DOI 10.1016/j.preghy.2010.10.007; Allegra M, 2003, J PINEAL RES, V34, P1, DOI 10.1034/j.1600-079X.2003.02112.x; Atamer Y, 2005, EUR J OBSTET GYN R B, V119, P60, DOI 10.1016/j.ejogrb.2004.06.033; Brownfoot FC, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.12.019; Brownfoot FC, 2015, HYPERTENSION, V66, P687, DOI 10.1161/HYPERTENSIONAHA.115.05445; Cagnacci A, 1998, AM J PHYSIOL-REG I, V274, pR335, DOI 10.1152/ajpregu.1998.274.2.R335; Cindrova-Davies T, 2011, CARDIOVASC RES, V89, P671, DOI 10.1093/cvr/cvq346; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; Hannan NJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01993-w; Hardeland R, 2005, ENDOCRINE, V27, P119, DOI 10.1385/ENDO:27:2:119; Hastie R, 2017, REPROD SCI, V24, P1245, DOI 10.1177/1933719116681516; Hobson SR, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003788; Hung MW, 2013, J PINEAL RES, V55, P247, DOI 10.1111/jpi.12067; Jahnke G, 1999, TOXICOL SCI, V50, P271, DOI 10.1093/toxsci/50.2.271; JANES SL, 1995, THROMB HAEMOSTASIS, V74, P1059; Jauniaux E, 2003, AM J PATHOL, V162, P115, DOI 10.1016/S0002-9440(10)63803-5; Kaitu'u-Lino TJ, 2014, PREGNANCY HYPERTENS, V4, P287, DOI 10.1016/j.preghy.2014.09.003; KIVELA A, 1991, ACTA ENDOCRINOL-COP, V124, P233, DOI 10.1530/acta.0.1240233; Laflamme AK, 1998, AM J HYPERTENS, V11, P219, DOI 10.1016/S0895-7061(97)00401-9; Lanoix D, 2008, J PINEAL RES, V45, P50, DOI 10.1111/j.1600-079X.2008.00555.x; Lanoix D, 2013, MOL CELL ENDOCRINOL, V381, P35, DOI 10.1016/j.mce.2013.07.010; Lanoix D, 2012, J PINEAL RES, V53, P417, DOI 10.1111/j.1600-079X.2012.01012.x; Lanoix D, 2012, MOL CELL ENDOCRINOL, V348, P1, DOI 10.1016/j.mce.2011.08.025; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Miller SL, 2012, NEUROENDOCRINOLOGY, V96, P13, DOI 10.1159/000336378; Mol BJ, 2016, LANCET, V387, P999, DOI 10.1016/S0140-6736(15)00070-7; Nagai R, 2008, J PINEAL RES, V45, P271, DOI 10.1111/j.1600-079X.2008.00586.x; Nakamura Y, 2001, J PINEAL RES, V30, P29, DOI 10.1034/j.1600-079X.2001.300104.x; Okatani Y, 2001, J PINEAL RES, V31, P173, DOI 10.1034/j.1600-079x.2001.310212.x; Onda K TS, 2017, HYPERTENSION; Onda K, 2015, HYPERTENSION, V65, P855, DOI 10.1161/HYPERTENSIONAHA.114.04781; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Rahman R, 2016, PREGNANCY HYPERTENS, V6, P259, DOI 10.1016/j.preghy.2016.09.001; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; REDMAN CWG, 1978, BRIT MED J, V1, P467, DOI 10.1136/bmj.1.6111.467; REITER RJ, 1991, ENDOCR REV, V12, P151, DOI 10.1210/edrv-12-2-151; Reiter RJ, 2000, J BIOMED SCI, V7, P444, DOI 10.1007/BF02253360; Richter HG, 2009, J PINEAL RES, V46, P357, DOI 10.1111/j.1600-079X.2009.00671.x; Simko F, 2007, J PINEAL RES, V42, P319, DOI 10.1111/j.1600-079X.2007.00436.x; Soliman A, 2015, J PINEAL RES, V59, P38, DOI 10.1111/jpi.12236; Tan Dun-Xian, 2002, Current Topics in Medicinal Chemistry, V2, P181, DOI 10.2174/1568026023394443; Tong S, 2015, HYPERTENSION, V66, P1073, DOI 10.1161/HYPERTENSIONAHA.115.05847; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Voiculescu S E, 2014, J Med Life, V7, P488; Wang ZQ, 2016, J PINEAL RES, V60, P217, DOI 10.1111/jpi.12305; Wiktor H, 2004, VIRCHOWS ARCH, V445, P74, DOI 10.1007/s00428-004-1024-2; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149	50	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0187082	10.1371/journal.pone.0187082	http://dx.doi.org/10.1371/journal.pone.0187082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641523	gold, Green Published			2022-12-26	WOS:000429742900002
J	Hemminger, J; Arole, V; Ayoub, I; Brodsky, SV; Nadasdy, T; Satoskar, AA				Hemminger, Jessica; Arole, Vidya; Ayoub, Isabelle; Brodsky, Sergey V.; Nadasdy, Tibor; Satoskar, Anjali A.			Acute glomerulonephritis with large confluent IgA-dominant deposits associated with liver cirrhosis	PLOS ONE			English	Article							IMMUNE-COMPLEXES; KUPFFER CELLS; DISEASE; RECEPTOR; MICE; GN	Background Small glomerular IgA deposits have been reported in patients with liver cirrhosis, mainly as an incidental finding in autopsy studies. We recently encountered nine cirrhotic patients who presented with acute proliferative glomerulonephritis with unusually large, exuberant glomerular immune complex deposits, in the absence of systemic lupus erythematosus (SLE) or monoclonal gammopathy-related kidney disease. Deposits were typically IgA dominant/codominant. Our aim was to further elucidate the etiology, diagnostic pitfalls, and clinical outcomes. Methods We present clinical features and kidney biopsy findings of nine cirrhotic patients with an unusual acute immune complex glomerulonephritis. We also identified native kidney biopsies from all patients with liver cirrhosis at our institution over a 13-year period (January 2004 to December 2016) to evaluate presence of glomerular IgA deposits in them (n = 118). Results Six of nine cirrhotic patients with the large immune deposits had a recent/concurrent acute bacterial infection, prompting a diagnosis of infection-associated glomerulonephritis and treatment with antibiotics. In the remaining three patients, no infection was identified and corticosteroids were initiated. Three of nine patients recovered kidney function (one recovered kidney function after liver transplant); three patients developed chronic kidney disease but remained off dialysis; two patients became dialysis-dependent and one patient developed sepsis and expired shortly after biopsy. Within the total cohort of 118 patients with cirrhosis, 67 others also showed IgA deposits, albeit small; and 42 patients had no IgA deposits. Conclusions These cases provide support to the theory that liver dysfunction may compromise clearance of circulating immune complexes, enabling deposition in the kidney. At least in a subset of cirrhotic patients, a superimposed bacterial infection may serve as a "second-hit" and lead to acute glomerulonephritis with exuberant immune complex deposits. Therefore, a trial of antibiotics is recommended and caution is advised before immunosuppressive treatment is offered. Unfortunately, most of these patients have advanced liver failure; therefore both diagnosis and management remain a challenge.	[Hemminger, Jessica; Arole, Vidya; Brodsky, Sergey V.; Nadasdy, Tibor; Satoskar, Anjali A.] Ohio State Univ, Dept Pathol, Wexner Med Ctr, Div Renal & Transplant Pathol, Columbus, OH 43210 USA; [Ayoub, Isabelle] Ohio State Univ, Dept Internal Med, Wexner Med Ctr, Div Nephrol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Satoskar, AA (corresponding author), Ohio State Univ, Dept Pathol, Wexner Med Ctr, Div Renal & Transplant Pathol, Columbus, OH 43210 USA.	Anjaii.Satoskar@osumn.edu	brodsky, sergey/AAU-3507-2021; Satoska, Anjali/U-6053-2019	Satoskar, Anjali/0000-0002-3332-0161				AREND WP, 1972, J EXP MED, V136, P514, DOI 10.1084/jem.136.3.514; Asrani SK, 2013, GASTROENTEROLOGY, V145, P375, DOI 10.1053/j.gastro.2013.04.005; Berger J, 1977, Adv Nephrol Necker Hosp, V7, P3; Boils CL, 2015, KIDNEY INT, V87, P1241, DOI 10.1038/ki.2014.424; Bu R, 2015, AM J NEPHROL, V41, P98, DOI 10.1159/000377684; BURGESS JB, 1992, HEPATOLOGY, V15, P702, DOI 10.1002/hep.1840150425; D'Agati V, 2014, RENAL DIS SYSTEMIC L; ENDO Y, 1983, ACTA PATHOL JAPON, V33, P333; FUKUDA Y, 1982, ACTA PATHOL JAPON, V32, P561; GHABRA N, 1991, CLIN NEPHROL, V35, P6; HAAKENSTAD AO, 1974, J IMMUNOL, V112, P1939; Haas M., 2014, IGA NEPHROPATHY IGA; KAWAGUCHI K, 1986, HUM PATHOL, V17, P1137, DOI 10.1016/S0046-8177(86)80419-1; MONTOLIU J, 1986, AM J NEPHROL, V6, P199, DOI 10.1159/000167116; NAKAMOTO Y, 1981, VIRCHOWS ARCH A, V392, P45, DOI 10.1007/BF00430547; Nasr SH, 2013, KIDNEY INT, V83, P792, DOI 10.1038/ki.2012.407; NEWELL GC, 1987, AM J KIDNEY DIS, V9, P183, DOI 10.1016/S0272-6386(87)80053-7; Nochy D, 1976, Clin Nephrol, V6, P422; Pouria S, 1999, NEPHROL DIAL TRANSPL, V14, P2279, DOI 10.1093/ndt/14.10.2279; RIFAI A, 1984, J EXP MED, V160, P125, DOI 10.1084/jem.160.1.125; SANCHO J, 1984, IMMUNOLOGY, V53, P283; SANCHO J, 1982, CLIN EXP IMMUNOL, V47, P327; Satoskar A, 2014, POSTINFECTIOUS INFEC, V7th; Satoskar AA, 2006, CLIN J AM SOC NEPHRO, V1, P1179, DOI 10.2215/CJN.01030306; Satoskar AA, 2017, CLIN J AM SOC NEPHRO, V12, P39, DOI 10.2215/CJN.05070516; Sethi S, 2016, J AM SOC NEPHROL, V27, P1278, DOI 10.1681/ASN.2015060612; SILVAIN C, 1995, J IMMUNOL, V155, P1606; Sise ME, 2016, KIDNEY INT REP, V1, P135, DOI 10.1016/j.ekir.2016.06.006; SKOGH T, 1985, IMMUNOLOGY, V55, P585; Takada D, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0769-1	30	16	16	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0193274	10.1371/journal.pone.0193274	http://dx.doi.org/10.1371/journal.pone.0193274			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634718	gold, Green Submitted, Green Published			2022-12-26	WOS:000429522200001
J	Nualnoi, T; Kirosingh, A; Basallo, K; Hau, D; Gates-Hollingsworth, MA; Thorkildson, P; Crump, RB; Reed, DE; Pandit, S; AuCoin, DP				Nualnoi, Teerapat; Kirosingh, Adam; Basallo, Kaitlin; Hau, Derrick; Gates-Hollingsworth, Marcellene A.; Thorkildson, Peter; Crump, Reva B.; Reed, Dana E.; Pandit, Sujata; AuCoin, David P.			Immunoglobulin G subclass switching impacts sensitivity of an immunoassay targeting Francisella tularensis Iipopolysaccharide	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; POTENTIAL AGENT; O-ANTIGEN; TULAREMIA; IGG; LIPOPOLYSACCHARIDE; BIOTERRORISM; EPIDEMIOLOGY; DIAGNOSIS; EVOLUTION	The CDC Tier 1 select agent Francisella tularensis is a small, Gram-negative bacterium and the causative agent of tularemia, a potentially life-threatening infection endemic in the United States, Europe and Asia. Currently, there is no licensed vaccine or rapid point-of care diagnostic test for tularemia. The purpose of this research was to develop monoclonal antibodies (mAbs) specific to the F. tularensis surface-expressed lipopolysaccharide (LPS) for a potential use in a rapid diagnostic test. Our initial antigen capture ELISA was developed using murine IgG3 mAb 1A4. Due to the low sensitivity of the initial assay, IgG subclass switching, which is known to have an effect on the functional affinity of a mAb, was exploited for the purpose of enhancing assay sensitivity. The ELISA developed using the IgG1 or IgG2b mAbs from the subclass-switch family of 1A4 IgG3 yielded improved assay sensitivity. However, surface plasmon resonance (SPR) demonstrated that the functional affinity was decreased as a result of subclass switching. Further investigation using direct ELISA revealed the potential self-association of 1A4 IgG3, which could explain the higher functional affinity and higher assay background seen with this mAb. Additionally, the higher assay background was found to negatively affect assay sensitivity. Thus, enhancement of the assay sensitivity by subclass switching is likely due to the decrease in assay background, simply by avoiding the self-association of IgG3.	[Nualnoi, Teerapat; Kirosingh, Adam; Basallo, Kaitlin; Hau, Derrick; Gates-Hollingsworth, Marcellene A.; Thorkildson, Peter; Crump, Reva B.; Reed, Dana E.; Pandit, Sujata; AuCoin, David P.] Univ Nevada, Dept Microbiol & Immunol, Reno Sch Med, Reno, NV 89557 USA; [Nualnoi, Teerapat] Prince Songkla Univ, Fac Pharmaceut Sci, Dept Pharmaceut Technol, Hat Yai, Thailand; [Basallo, Kaitlin] InBios Int Inc, Seattle, WA USA; [Crump, Reva B.] Univ Nevada, Dept Biol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Prince of Songkla University; Nevada System of Higher Education (NSHE); University of Nevada Reno	AuCoin, DP (corresponding author), Univ Nevada, Dept Microbiol & Immunol, Reno Sch Med, Reno, NV 89557 USA.	daucoin@med.unr.edu	; Nualnoi, Teerapat/G-9819-2017	Kirosingh, Adam/0000-0003-0500-9269; Hau, Derrick/0000-0002-4301-6403; Nualnoi, Teerapat/0000-0003-3294-1975	National Institute of Allergy and Infectious Diseases [U54AI065359]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant (U54AI065359) from the National Institute of Allergy and Infectious Diseases (www.niaid.nih.gov) to DPA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreotti PE, 2003, BIOTECHNIQUES, V35, P850, DOI 10.2144/03354ss02; Barker JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157842; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Chaignat V, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-234; COOPER LJN, 1994, MOL IMMUNOL, V31, P577, DOI 10.1016/0161-5890(94)90165-1; COOPER LJN, 1991, J IMMUNOL, V146, P2659; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Dillon MJ, 2016, VIRULENCE, V7, P691, DOI 10.1080/21505594.2016.1176655; Drozdowski Brian, 2010, J Immune Based Ther Vaccines, V8, P9, DOI 10.1186/1476-8518-8-9; Dulay SB, 2014, ANAL BIOANAL CHEM, V406, P4685, DOI 10.1007/s00216-014-7860-2; Franek M, 2001, ANAL CHIM ACTA, V444, P131, DOI 10.1016/S0003-2670(01)01162-X; Fukui T, 2004, LAB INVEST, V84, P485, DOI 10.1038/labinvest.3700056; GREENSPAN NS, 1992, IMMUNOL TODAY, V13, P164, DOI 10.1016/0167-5699(92)90120-V; Grunow R, 2000, CLIN DIAGN LAB IMMUN, V7, P86, DOI 10.1128/CDLI.7.1.86-90.2000; Gunnell MK, 2016, CURR ISSUES MOL BIOL, V18, P79; Harik NS, 2013, PEDIATR ANN, V42, P288, DOI 10.3928/00904481-20130619-13; Houghton RL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002727; Hovenden M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003306; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; Kozel TR, 2004, P NATL ACAD SCI USA, V101, P5042, DOI 10.1073/pnas.0401351101; Leeming JP, 2005, J CLIN MICROBIOL, V43, P4972, DOI 10.1128/JCM.43.10.4972-4976.2005; Maurin M, 2015, EXPERT REV ANTI-INFE, V13, P141, DOI 10.1586/14787210.2015.986463; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Nuti DE, 2011, MBIO, V2, DOI 10.1128/mBio.00136-11; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; PERLMUTTER RM, 1978, J IMMUNOL, V121, P566; Peruski AH, 2003, CLIN DIAGN LAB IMMUN, V10, P506, DOI 10.1128/CDLI.10.4.506-513.2003; Prior JL, 2003, J MED MICROBIOL, V52, P845, DOI 10.1099/jmm.0.05184-0; Roche MI, 2011, HYBRIDOMA, V30, P19, DOI 10.1089/hyb.2010.0083; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Rowe HM, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00094; Santos NC, 2003, CHEMBIOCHEM, V4, P96, DOI 10.1002/cbic.200390020; SCHREIBER JR, 1993, J INFECT DIS, V167, P221, DOI 10.1093/infdis/167.1.221; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Splettstoesser WD, 2005, J VET MED B, V52, P249, DOI 10.1111/j.1439-0450.2005.00863.x; Tarnvik A, 2007, ANN NY ACAD SCI, V1105, P378, DOI 10.1196/annals.1409.017; Torres M, 2007, J BIOL CHEM, V282, P13917, DOI 10.1074/jbc.M700661200; Ulu-Kilic A, 2014, TRAVEL MED INFECT DI, V12, P609, DOI 10.1016/j.tmaid.2014.10.007; Wagar E, 2016, CLIN MICROBIOL REV, V29, P175, DOI 10.1128/CMR.00033-15; World Health Organization, 2007, WHO GUIDELINES TULAR; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	41	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195308	10.1371/journal.pone.0195308	http://dx.doi.org/10.1371/journal.pone.0195308			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630613	Green Published, Green Submitted, gold			2022-12-26	WOS:000429505000039
J	van der Star, BJ; van Dijk, CE; Zock, JP; Smit, LAM; Baliatsas, C; Heederik, DJJ; Yzermans, CJ				van der Star, Baukje J.; van Dijk, Christel E.; Zock, Jan-Paul; Smit, Lidwien A. M.; Baliatsas, Christos; Heederik, Dick J. J.; Yzermans, C. Joris			Healthcare utilisation prior to the diagnosis of inflammatory bowel diseases and the influence of livestock exposure: A longitudinal case-control study	PLOS ONE			English	Article							CROHNS-DISEASE; ULCERATIVE-COLITIS; FARMS; PREVALENCE; RESIDENTS; SYMPTOMS; EUROPE; COHORT; DELAY; COPD	An increased prevalence of the inflammatory bowel diseases, ulcerative colitis and Crohn's disease, was found amongst residents in a livestock dense area. We hypothesised that exposure to livestock farms might be a substantial environmental factor that contributes to the development of these diseases and that in the lead up to inflammatory bowel diseases potential risk factors can be identified. This study aimed to investigate the contribution of livestock exposure to the development of these diseases and the clinical events prior to the diagnosis. Electronic health records from 2006-2013 of general practices were used. The study population consisted of patients with a new diagnosis of inflammatory bowel diseases resident in areas with a high (n = 141) or lower (n = 109) livestock density. Patients with low back pain (n = 10,469) were used as controls. For those in a livestock dense area, distance to livestock farms was determined. Associations between morbidities and drug prescriptions in the reporting year and three years previous to the diagnosis, and the residential proximity to livestock exposure were investigated with multivariable logistic regression analyses. Acute and chronic morbidity of the gastrointestinal tract and associated drug prescriptions were predictive for the development of inflammatory bowel diseases. In addition, a positive association was found between infections and living within 500 meter of poultry farms and the development of inflammatory bowel diseases [OR: 3.3 (1.1-9.9)]. Nonetheless, overall livestock exposure contributed little to the development of these diseases. These results suggest that exposure to livestock farms on its own contributes minimal to the development of inflammatory bowel diseases. Nonetheless, having infections appeared to be a risk factor for neighbouring residents of poultry farms. More research is warranted to explain the increased prevalence of inflammatory bowel diseases amongst residents in areas with a high density of livestock.	[van der Star, Baukje J.; van Dijk, Christel E.; Zock, Jan-Paul; Baliatsas, Christos; Yzermans, C. Joris] NIVEL, Netherlands Inst Hlth Serv Res, Utrecht, Netherlands; [Smit, Lidwien A. M.; Heederik, Dick J. J.] Univ Utrecht, IRAS, Utrecht, Netherlands; [van der Star, Baukje J.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands	Netherlands Institute for Health Services Research; Utrecht University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van der Star, BJ (corresponding author), NIVEL, Netherlands Inst Hlth Serv Res, Utrecht, Netherlands.; van der Star, BJ (corresponding author), Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands.	b.vanderstar@vumc.nl	Smit, Lidwien AM/AFC-8689-2022; Zock, Jan-Paul/P-5034-2018	Smit, Lidwien AM/0000-0003-0292-0946; Zock, Jan-Paul/0000-0002-2941-6259; Heederik, Dick/0000-0002-4550-1437	Dutch Ministry of Economic Affairs ("Ministerie van Economische Zaken"); Ministry of Health, Welfare and Sport ("Ministerie van Volksgezondheid, Welzijn en Sport"), as part of the VGO study (Dutch acronym for Livestock Farming and Neighbouring Residents' Health)	Dutch Ministry of Economic Affairs ("Ministerie van Economische Zaken"); Ministry of Health, Welfare and Sport ("Ministerie van Volksgezondheid, Welzijn en Sport"), as part of the VGO study (Dutch acronym for Livestock Farming and Neighbouring Residents' Health)	This work was supported by the Dutch Ministry of Economic Affairs ("Ministerie van Economische Zaken"), and the Ministry of Health, Welfare and Sport ("Ministerie van Volksgezondheid, Welzijn en Sport"), as part of the VGO study (Dutch acronym for Livestock Farming and Neighbouring Residents' Health) to CEVD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar T, 2014, CLIN IMMUNOL, V153, P199, DOI 10.1016/j.clim.2014.04.012; Bamias G, 2005, ANN INTERN MED, V143, P895, DOI 10.7326/0003-4819-143-12-200512200-00007; Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; Boneberger A, 2011, J CROHNS COLITIS, V5, P525, DOI 10.1016/j.crohns.2011.04.012; Borlee F, 2015, EUR RESPIR J, V46, P1605, DOI 10.1183/13993003.00265-2015; Brassard P, 2015, EUR RESPIR J, V45, P962, DOI 10.1183/09031936.00079414; Burisch J, 2014, J CROHNS COLITIS, V8, P607, DOI 10.1016/j.crohns.2013.11.021; Coburn LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082300; Cohen AD, 2009, J EUR ACAD DERMATOL, V23, P561, DOI 10.1111/j.1468-3083.2008.03031.x; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; Haapamaki J, 2011, J CROHNS COLITIS, V5, P41, DOI 10.1016/j.crohns.2010.09.008; Heederik D., 2011, MOGELIJKE EFFECTEN I; Hooiveld M, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0123-2; Hutfless S, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/690581; Jeziorska M, 2001, J PATHOL, V194, P484, DOI 10.1002/path.904; Kariyawasam VC, 2014, INFLAMM BOWEL DIS, V20, P1382, DOI 10.1097/MIB.0000000000000119; Lamberts H., 1987, ICPC INT CLASSIFICAT; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; LINDBERG E, 1992, GUT, V33, P779, DOI 10.1136/gut.33.6.779; Mir A, 2002, AM J GASTROENTEROL, V97, P1452, DOI 10.1016/S0002-9270(02)04043-1; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Pimentel M, 2000, AM J GASTROENTEROL, V95, P3458; Prins M, 2015, ZORG HUISARTS JAARCI; Radon K, 2007, PEDIATRICS, V120, P354, DOI 10.1542/peds.2006-3624; Raj AA, 2008, RESP MED, V102, P780, DOI 10.1016/j.rmed.2007.08.014; Schoepfer AM, 2013, AM J GASTROENTEROL, V108, P1744, DOI 10.1038/ajg.2013.248; Smit LAM, 2014, OCCUP ENVIRON MED, V71, P134, DOI 10.1136/oemed-2013-101485; Smit LAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038843; Spray C, 2001, ACTA PAEDIATR, V90, P400, DOI 10.1080/080352501750126230; Timm S, 2014, EUR J EPIDEMIOL, V29, P429, DOI 10.1007/s10654-014-9922-3; van Dijk CE, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0421-3; van Dooren C., 2016, 10 INT C LIF CYCL AS; van Gils-van Rooij ESJ, 2015, J AM BOARD FAM MED, V28, P807, DOI 10.3122/jabfm.2015.06.140261; Vavricka SR, 2012, INFLAMM BOWEL DIS, V18, P496, DOI 10.1002/ibd.21719; WHOCC, 2014, GUID ATC CLASS DDD A	35	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2018	13	4							e0195305	10.1371/journal.pone.0195305	http://dx.doi.org/10.1371/journal.pone.0195305			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC0YY	29630633	Green Published, Green Submitted, gold			2022-12-26	WOS:000429505000038
J	Chanani, S; Waingankar, A; More, NS; Pantvaidya, S; Fernandez, A; Jayaraman, A				Chanani, Sheila; Waingankar, Anagha; More, Neena Shah; Pantvaidya, Shanti; Fernandez, Armida; Jayaraman, Anuja			Participation of pregnant women in a community-based nutrition program in Mumbai's informal settlements: Effect on exclusive breastfeeding practices	PLOS ONE			English	Article							PROMOTION INTERVENTIONS; PEER COUNSELORS; DETERMINANTS; EFFICACY; GROWTH; INDIA; BIRTH	Background In urban Maharashtra, India, approximately half of mothers exclusively breastfeed. For children residing in informal settlements of Mumbai, this study examines factors associated with exclusive breastfeeding, and whether exclusive breastfeeding, in a community-based nutrition program to prevent and treat wasting among children under age three, is associated with enrolment during the mother's pregnancy. Methods The nutrition program conducted a cross-sectional endline survey (October-December 2015) of caregivers in intervention areas. Factors associated with exclusive breastfeeding for infants under six months of age were explored using multi-level logistic regressions. Additionally, program surveillance data collected during home-based counselling visits documented breastfeeding practices for children under six months of age. Using the surveillance data (January 2014-March 2016), exclusive breastfeeding status was regressed adjusting for child, maternal and socioeconomic characteristics, and whether the child was enrolled in the program in utero or after birth. Results The community-based endline survey included 888 mothers of infants. Mothers who received the nutrition program home visits or attended group counselling sessions were more likely to exclusively breastfeed (adjusted odds ratio 1.67, 95% CI 1.16, 2.41). Having a normal weight-for-height z-score (adjusted odds ratio 1.57, 95% CI 1.00, 2.45) was associated positively with exclusive breastfeeding. As expected, being an older infant aged three to five months (adjusted odds ratio 0.34, 95% CI 0.25, 0.48) and receiving a prelacteal feed after birth (adjusted odds ratio 0.57, 95% CI 0.41, 0.80) were associated with lower odds of exclusively breastfeeding. Surveillance data (N = 3420) indicate that infants enrolled in utero have significantly higher odds of being exclusively breastfed (adjusted odds ratio 1.55, 95% CI 1.30, 1.84) than infants enrolled after birth. Conclusions Prenatal enrolment in community-based programs working on child nutrition in urban informal settlements of India can improve exclusive breastfeeding practices.	[Chanani, Sheila; Waingankar, Anagha; More, Neena Shah; Pantvaidya, Shanti; Fernandez, Armida; Jayaraman, Anuja] Soc Nutr Educ & Hlth Act, Bombay, Maharashtra, India		Chanani, S (corresponding author), Soc Nutr Educ & Hlth Act, Bombay, Maharashtra, India.	sheila.chanani@gmail.com		Chanani, Sheila/0000-0001-8518-3114	Forbes Marshall Foundation; Quadrivium Foundation	Forbes Marshall Foundation; Quadrivium Foundation	Funding for analysis, interpretation of data, and dissemination of program findings came from Forbes Marshall Foundation and Quadrivium Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts C, 2000, INT J EPIDEMIOL, V29, P1041, DOI 10.1093/ije/29.6.1041; Achadi E, 2016, GLOBAL NUTR REPORT 2; Anderson AK, 2005, ARCH PEDIAT ADOL MED, V159, P836, DOI 10.1001/archpedi.159.9.836; Bhandari N, 2003, LANCET, V361, P1418, DOI 10.1016/S0140-6736(03)13134-0; Bryce J, 2008, LANCET, V371, P510, DOI 10.1016/S0140-6736(07)61694-8; Chandhiok N, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-015-0059-0; Commissioner C Road M., 2011, CENS IND 2011 PROV P; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Dyson P, 2012, TOURISM GEOGR, V14, P254, DOI 10.1080/14616688.2011.609900; Ezeh A, 2016, LANCET, V6736, P1, DOI DOI 10.1016/50140-6736(16)31650-6; Giugliani ERJ, 2015, ACTA PAEDIATR, V104, P20, DOI 10.1111/apa.13160; Gupta A, 2010, INDIAN J PEDIATR, V77, P413, DOI 10.1007/s12098-010-0049-6; Haider R, 2000, LANCET, V356, P1643, DOI 10.1016/S0140-6736(00)03159-7; Haroon S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S20; Heikens GT, 2008, LANCET, V371, P181, DOI 10.1016/S0140-6736(07)61691-2; Hunegnaw MT, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0121-1; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S25; International Institute for Population Sciences, 2016, NAT FAM HLTH SURV 4; Johns Hopkins Bloomberg School of Public Health, 2016, 2016 PNEUM DIARRH PR; Kerac M, 2015, FOOD NUTR BULL, V36, pS30, DOI 10.1177/15648265150361S105; Kronborg H, 2007, ACTA PAEDIATR, V96, P1064, DOI 10.1111/j.1651-2227.2007.00341.x; Lamberti LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S15; Leroy JL, 2008, J NUTR, V138, P628, DOI 10.1093/jn/138.3.628; Malhotra R, 2008, MATERN CHILD NUTR, V4, P181, DOI 10.1111/j.1740-8709.2007.00130.x; McKenna KM, 2009, J MIDWIFERY WOM HEAL, V54, P78, DOI 10.1016/j.jmwh.2008.07.012; Milligan P, 2004, INT J EPIDEMIOL, V33, P469, DOI 10.1093/ije/dyh096; More NS, 2018, GLOB HEALTH-SCI PRAC, V6, P103, DOI 10.9745/GHSP-D-17-00182; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; Pagel C, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-151; Patel A, 2010, FOOD NUTR BULL, V31, P314, DOI 10.1177/156482651003100221; Perez-Escamilla R, 2012, ADV NUTR, V3, P790, DOI 10.3945/an.112.002873; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Sachdev H P, 1995, Indian Pediatr, V32, P1287; Setegn T, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-17; Sinha B, 2015, ACTA PAEDIATR, V104, P114, DOI 10.1111/apa.13127; Thakur SK, 2012, EUR J CLIN NUTR, V66, P376, DOI 10.1038/ejcn.2011.182; Tiwari R, 2009, J TROP PEDIATRICS, V55, P49, DOI 10.1093/tropej/fmn037; Tylleskar T, 2011, LANCET, V378, P420, DOI 10.1016/S0140-6736(11)60738-1; UN-Habitat, 2016, INT J, DOI [10.1016/S0264-2751(03)00010-6, DOI 10.1016/S0264-2751(03)00010-6]; UNICEF, 2016, STATE WORLDS CHILDRE; USAID, 2017, COM BAS MAN AC MALN; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; World Health Organisation WHO: Maternal I Health C, 2013, ESS NUTR ACT IMPR MA, P144; World Health Organization, 1998, EV 10 STEPS SUCC BRE, V23, P1; World Health Organization; United Nations Children's Fund (UNICEF), 2017, 1000 DAYS A T NURT H; 2013, Lancet, V13, P1	47	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195619	10.1371/journal.pone.0195619	http://dx.doi.org/10.1371/journal.pone.0195619			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621355	Green Submitted, Green Published, gold			2022-12-26	WOS:000429206800108
J	de la Rubia, E; Diaz-Estrella, A; Reyes-Lecuona, A; Langley, A; Brown, M; Sharples, S				de la Rubia, Ernesto; Diaz-Estrella, Antonio; Reyes-Lecuona, Arcadio; Langley, Alyson; Brown, Michael; Sharples, Sarah			Natural locomotion based on a reduced set of inertial sensors: Decoupling body and head directions indoors	PLOS ONE			English	Article							REALITY	Inertial sensors offer the potential for integration into wireless virtual reality systems that allow the users to walk freely through virtual environments. However, owing to drift errors, inertial sensors cannot accurately estimate head and body orientations in the long run, and when walking indoors, this error cannot be corrected by magnetometers, due to the magnetic field distortion created by ferromagnetic materials present in buildings. This paper proposes a technique, called EHBD (Equalization of Head and Body Directions), to address this problem using two head- and shoulder-located magnetometers. Due to their proximity, their distortions are assumed to be similar and the magnetometer measurements are used to detect when the user is looking straight forward. Then, the system corrects the discrepancies between the estimated directions of the head and the shoulder, which are provided by gyroscopes and consequently are affected by drift errors. An experiment is conducted to evaluate the performance of this technique in two tasks (navigation and navigation plus exploration) and using two different locomotion techniques: (1) gaze-directed mode (GD) in which the walking direction is forced to be the same as the head direction, and (2) decoupled direction mode (DD) in which the walking direction can be different from the viewing direction. The obtained results show that both locomotion modes show similar matching of the target path during the navigation task, while DD's path matches the target path more closely than GD in the navigation plus exploration task. These results validate the EHBD technique especially when allowing different walking and viewing directions in the navigation plus exploration tasks, as expected. While the proposed method does not reach the accuracy of optical tracking (ideal case), it is an acceptable and satisfactory solution for users and is much more compact, portable and economical.	[de la Rubia, Ernesto; Diaz-Estrella, Antonio; Reyes-Lecuona, Arcadio] Univ Malaga, Dept Tecnol Elect, Escuela Tecn Super Ingn Telecomunicac, Campus Teatinos, Malaga, Spain; [Langley, Alyson; Brown, Michael; Sharples, Sarah] Univ Nottingham, Human Factors Res Grp, Fac Engn, Nottingham, England	Universidad de Malaga; University of Nottingham	de la Rubia, E (corresponding author), Univ Malaga, Dept Tecnol Elect, Escuela Tecn Super Ingn Telecomunicac, Campus Teatinos, Malaga, Spain.	e@uma.es	Reyes-Lecuona, Arcadio/M-7022-2014	Reyes-Lecuona, Arcadio/0000-0002-3699-4065; Diaz Estrella, Antonio/0000-0002-2773-0113	Junta de Andalucia; project CENIT Espana Virtual, within the Ingenio program - Elecnor Deimos	Junta de Andalucia(Junta de Andalucia); project CENIT Espana Virtual, within the Ingenio program - Elecnor Deimos	This research has been supported by the Junta de Andalucia and the project CENIT Espana Virtual, within the Ingenio 2010 program, subcontracted by Elecnor Deimos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Bachmann ER, 2012, 2012 17TH INTERNATIONAL CONFERENCE ON COMPUTER GAMES (CGAMES), P108, DOI 10.1109/CGames.2012.6314560; Barrie P., 2009, P 6 INT C MOB TECHN, DOI [10.1145/1710035.1710096, DOI 10.1145/1710035.1710096]; Bruder G, 2009, 3DUI : IEEE SYMPOSIUM ON 3D USER INTERFACES 2009, PROCEEDINGS, P75, DOI 10.1109/3DUI.2009.4811208; Cirio G., 2009, P 16 ACM S VIRT REAL, P155, DOI DOI 10.1145/1643928.1643965; Colosio C, 2008, FP6IST5034525 SATIN; Darken RP, 1997, ACM S US INT SOFTW T, P213; de la Rubia E., 2013, ELECTRON LETT, V49, P488; de la Rubia E, 2015, PRESENCE-VIRTUAL AUG, V24, P298, DOI 10.1162/PRES_a_00236; De Luca A, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P5051, DOI 10.1109/IROS.2009.5354610; Fischer C, 2013, IEEE PERVAS COMPUT, V12, P17, DOI 10.1109/MPRV.2012.16; Fourati H, 2013, 2013 EUROPEAN CONTROL CONFERENCE (ECC), P4208; Freitag S, 2014, 2014 IEEE SYMPOSIUM ON 3D USER INTERFACES (3DUI), P119, DOI 10.1109/3DUI.2014.6798852; Gozick B, IEEE T INSTRUMENTATI, V60, P3883; Inertial Labs, 2014, 3DSUIT MOT CAPT SYST; Intersense, 2012, 072000940D05 INT; Iwata H, 2005, IEEE COMPUT GRAPH, V25, P64, DOI 10.1109/MCG.2005.5; Iwata H, 2001, P IEEE VIRT REAL ANN, P131, DOI 10.1109/VR.2001.913779; Iwata H, ACM SIGGRAPH 2006 EM; Jiung-yao H, 2000, J COMPUTER GRAPHICS, V8, P1; Kennedy R. S., 1993, INT J AVIAT PSYCHOL, V3, P203; La Valle SM, 2017, VIRTUAL REALITY TRAC; Medina Eliana, 2008, Proceedings of the Human Factors and Ergonomics Society. 52nd Annual Meeting, P2102, DOI 10.1518/107118108X352490; Metamotion, 2014, METAMOTION IGS 190; Nabiyouni Mahdi, 2015, 2015 IEEE Symposium on 3D User Interfaces (3DUI), P3, DOI 10.1109/3DUI.2015.7131717; Neth CT, 2011, P IEEE VIRT REAL ANN, P151, DOI 10.1109/VR.2011.5759454; Nitzsche N, 2003, PROC SPIE, V5079, P265, DOI 10.1117/12.488379; Peck TC, 2011, P IEEE VIRT REAL ANN, P55, DOI 10.1109/VR.2011.5759437; Razzaque S., 2005, REDIRECTED WALKING; Roetenberg Daniel, 2009, 1 XSENS MOT TECHN BV, V1, P1; Ruddle RA, 2009, ACM T COMPUT-HUM INT, V16, DOI 10.1145/1502800.1502805; Sharples S, 2008, DISPLAYS, V29, P58, DOI 10.1016/j.displa.2007.09.005; Smit P, 2011, HUM-COMPUT INT-SPRIN, P35, DOI 10.1007/978-0-85729-433-3_4; Souman JL, 2011, ACM T APPL PERCEPT, V8, DOI 10.1145/2043603.2043607; Steinice F, 2008, IEEE VIRTUAL REALITY 2008, PROCEEDINGS, P291; Steinicke F, 2010, IEEE T VIS COMPUT GR, V16, P17, DOI 10.1109/TVCG.2009.62; Steinicke Frank, 2008, P ACM S VIRTUAL REAL, P149, DOI [10.1145/1450579.1450611, DOI 10.1145/1450579.1450611]; Suma EA, 2010, P IEEE VIRT REAL ANN, P305, DOI 10.1109/VR.2010.5444752; Suma EA, 2009, IEEE VIRTUAL REALITY 2009, PROCEEDINGS, P245, DOI 10.1109/VR.2009.4811037; Suryajaya M., 2009, P 16 ACM S VIRT REAL, P31; Sutherland I.E., 1965, PROC IFIP C, P506, DOI DOI 10.1109/MC.2005.274; Swapp D, 2010, IEEE SYMPOSIUM ON 3D USER INTERFACES (3DUI 2010), P71, DOI 10.1109/3DUI.2010.5444717; Vasylevska K, 2013, P IEEE VIRT REAL ANN, P109, DOI 10.1109/VR.2013.6549386; Vasylevska K, 2013, 2013 IEEE SYMPOSIUM ON 3D USER INTERFACES (3DUI), P39, DOI 10.1109/3DUI.2013.6550194; Vincent D. E, 2012, PORTABLE INDOOR MULT; Waller D, 2007, BEHAV RES METHODS, V39, P835, DOI 10.3758/BF03192976; Williams B, 2007, APGV 2007: SYMPOSIUM ON APPLIED PERCEPTION IN GRAPHICS AND VISUALIZATION, PROCEEDINGS, P41; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686; Xie X., 2010, P 7 S APPL PERCEPTIO, P65, DOI [10.1145/1836248.1836260, DOI 10.1145/1836248.1836260]; XSens, 2014, MULT FULL BOD IMM VR; YEI Technology, PRIOVR 2016; Yoon J, 2006, INT J ROBOT RES, V25, P687, DOI 10.1177/0278364906067373; Zhu R, 2009, IEEE SENS J, V9, P223, DOI 10.1109/JSEN.2008.2012196	53	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195191	10.1371/journal.pone.0195191	http://dx.doi.org/10.1371/journal.pone.0195191			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621298	Green Published, Green Submitted, gold			2022-12-26	WOS:000429206800047
J	Feng, QZ; Liu, ZL; Weber, SA; Li, SZ				Feng, Quanzhou; Liu, Z. Lewis; Weber, Scott A.; Li, Shizhong			Signature pathway expression of xylose utilization in the genetically engineered industrial yeast Saccharomyces cerevisiae	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; BIOMASS CONVERSION INHIBITORS; EXTERNAL RNA CONTROLS; ETHANOLOGENIC YEAST; ETHANOLIC FERMENTATION; ALCOHOLIC FERMENTATION; FUNCTIONAL EXPRESSION; HEXOSE TRANSPORTERS; PICHIA-STIPITIS; GENE-EXPRESSION	Haploid laboratory strains of Saccharomyces cerevisiae are commonly used for genetic engineering to enable their xylose utilization but little is known about the industrial yeast which is often recognized as diploid and as well as haploid and tetraploid. Here we report three unique signature pathway expression patterns and gene interactions in the centre metabolic pathways that signify xylose utilization of genetically engineered industrial yeast S. cerevisiae NRRL Y-50463, a diploid yeast. Quantitative expression analysis revealed outstanding high levels of constitutive expression of YXI, a synthesized yeast codon-optimized xylose isomerase gene integrated into chromosome XV of strain Y-50463. Comparative expression analysis indicated that the YX/was necessary to initiate the xylose metabolic pathway along with a set of heterologous xylose transporter and utilization facilitating genes including XUT4, XUT6, XKS1 and XYL2. The highly activated transketolase and transaldolase genes TKL1, TKL2, TAL1 and NQM1 as well as their complex interactions in the non oxidative pentose phosphate pathway branch were critical for the serial of sugar transformation to drive the metabolic flow into glycolysis for increased ethanol production. The significantly increased expression of the entire PRS gene family facilitates functions of the life cycle and biosynthesis superpathway for the yeast. The outstanding higher levels of constitutive expression of YXI and the first insight into the signature pathway expression and the gene interactions in the closely related centre metabolic pathways from the industrial yeast aid continued efforts for development of the next-generation biocatalyst. Our results further suggest the industrial yeast is a desirable delivery vehicle for new strain development for efficient lignocellulose-to-advanced biofuels production.	[Feng, Quanzhou; Liu, Z. Lewis; Weber, Scott A.] ARS, Bioenergy Res Unit, USDA, Natl Ctr Agr Utilizat Res, Peoria, IL 61604 USA; [Feng, Quanzhou; Li, Shizhong] Tsinghua Univ, Inst New Energy Technol, Beijing, Peoples R China; [Liu, Z. Lewis; Li, Shizhong] USDA MOST Joint Res Ctr Biofuels, Peoria, IL USA	United States Department of Agriculture (USDA); Tsinghua University	Liu, ZL (corresponding author), ARS, Bioenergy Res Unit, USDA, Natl Ctr Agr Utilizat Res, Peoria, IL 61604 USA.; Li, SZ (corresponding author), Tsinghua Univ, Inst New Energy Technol, Beijing, Peoples R China.; Liu, ZL; Li, SZ (corresponding author), USDA MOST Joint Res Ctr Biofuels, Peoria, IL USA.	ZLewis.Liu@ars.usda.gov; szli@mail.tsinghua.edu.cn						Alff-Tuomala S, 2016, APPL MICROBIOL BIOT, V100, P969, DOI 10.1007/s00253-015-7038-7; Applied Biosystem, 2006, USITC PUBL, V127AP05-03; Argueso JL, 2009, GENOME RES, V19, P2258, DOI 10.1101/gr.091777.109; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Bradbury JE, 2006, ANTON LEEUW INT J G, V89, P27, DOI 10.1007/s10482-005-9006-1; Brat D, 2009, APPL ENVIRON MICROB, V75, P2304, DOI 10.1128/AEM.02522-08; BRUINENBERG PM, 1983, EUR J APPL MICROBIOL, V18, P287, DOI 10.1007/BF00500493; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; CARTER AT, 1994, YEAST, V10, P1031, DOI 10.1002/yea.320100805; Eliasson A, 2001, ENZYME MICROB TECH, V29, P288, DOI 10.1016/S0141-0229(01)00386-6; FLETCHER TS, 1992, BIOCHEMISTRY-US, V31, P1892, DOI 10.1021/bi00121a044; Fonseca C, 2011, ENZYME MICROB TECH, V48, P518, DOI 10.1016/j.enzmictec.2011.02.010; GONG CS, 1981, APPL ENVIRON MICROB, V41, P430, DOI 10.1128/AEM.41.2.430-436.1981; Hamacher T, 2002, MICROBIOL-SGM, V148, P2783, DOI 10.1099/00221287-148-9-2783; Hernando Y, 1999, J BIOL CHEM, V274, P12480, DOI 10.1074/jbc.274.18.12480; Ho NWY, 1998, APPL ENVIRON MICROB, V64, P1852; Huang H, 2008, PROTEINS, V73, P1076, DOI 10.1002/prot.22237; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jin YS, 2000, J MICROBIOL BIOTECHN, V10, P564; Jin YS, 2004, APPL ENVIRON MICROB, V70, P6816, DOI 10.1128/AEM.70.11.6816-6825.2004; Johansson B, 2002, FEMS YEAST RES, V2, P277, DOI 10.1016/S1567-1356(02)00114-9; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Karhumaa K, 2005, YEAST, V22, P359, DOI 10.1002/yea.1216; Karhumaa K, 2007, APPL MICROBIOL BIOT, V73, P1039, DOI 10.1007/s00253-006-0575-3; Kuyper M, 2005, FEMS YEAST RES, V5, P399, DOI 10.1016/j.femsyr.2004.09.010; Kuyper M, 2003, FEMS YEAST RES, V4, P69, DOI 10.1016/S1567-1356(03)00141-7; Kuyper M, 2004, FEMS YEAST RES, V4, P655, DOI 10.1016/j.femsyr.2004.01.003; Liu Z. L., 2011, COMPLETE CODONS OF S; Liu ZL, 2007, J MICROBIOL METH, V68, P486, DOI 10.1016/j.mimet.2006.10.014; Liu ZL, 2006, APPL MICROBIOL BIOT, V73, P27, DOI 10.1007/s00253-006-0567-3; Liu ZL, 2015, BIOENERG RES, V8, P1203, DOI 10.1007/s12155-014-9575-9; Liu ZL, 2008, BIOENERGY, P17; Liu ZL, 2009, MOL GENET GENOMICS, V282, P233, DOI 10.1007/s00438-009-0461-7; Liu ZL, 2009, J BIOTECHNOL, V143, P10, DOI 10.1016/j.jbiotec.2009.06.006; Liu ZL, 2005, APPL BIOCHEM BIOTECH, V121, P451, DOI 10.1385/ABAB:121:1-3:0451; Ma M, 2012, BIOENERG RES, V5, P459, DOI 10.1007/s12155-011-9176-9; Madhavan A, 2009, APPL MICROBIOL BIOT, V82, P1037, DOI 10.1007/s00253-008-1818-2; Mannazzu I, 2002, BIODIVERSITY AND BIOTECHNOLOGY OF WINE YEASTS, P19; Matsushika A, 2012, MICROBIAL STRESS TOL, V22, P137; Matsushika A, 2009, BIORESOURCE TECHNOL, V100, P2392, DOI 10.1016/j.biortech.2008.11.047; Matsushika A, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-16; Matsushika A, 2012, ENZYME MICROB TECH, V51, P16, DOI 10.1016/j.enzmictec.2012.03.008; Matsushika A, 2009, APPL MICROBIOL BIOT, V84, P37, DOI 10.1007/s00253-009-2101-x; Moon JW, 2013, BIOCATAL AGRIC BIOTE, V2, P247, DOI 10.1016/j.bcab.2013.03.005; Moyses DN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030207; Regenberg B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r107; Rintala E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-461; Ronald J, 2006, GENETICS, V174, P541, DOI 10.1534/genetics.106.060863; Runquist D, 2009, APPL MICROBIOL BIOT, V82, P123, DOI 10.1007/s00253-008-1773-y; Runquist D, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-5; Salusjarvi L, 2006, APPL BIOCHEM BIOTECH, V128, P237, DOI 10.1385/ABAB:128:3:237; Salusjarvi L, 2003, YEAST, V20, P295, DOI 10.1002/yea.960; Salusjarvi L, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-18; SCHAAFF I, 1990, EUR J BIOCHEM, V188, P597, DOI 10.1111/j.1432-1033.1990.tb15440.x; Sedlak M, 2004, YEAST, V21, P671, DOI 10.1002/yea.1060; Toivari MH, 2004, APPL ENVIRON MICROB, V70, P3681, DOI 10.1128/aem.70.6.3681-3686.2004; Toivari MH, 2001, METAB ENG, V3, P236, DOI 10.1006/mben.2000.0191; van Maris AJA, 2006, ANTON LEEUW INT J G, V90, P391, DOI 10.1007/s10482-006-9085-7; VANZYL C, 1989, J GEN MICROBIOL, V135, P2791; WALFRIDSSON M, 1995, APPL ENVIRON MICROB, V61, P4184, DOI 10.1128/AEM.61.12.4184-4190.1995; Walfridsson M, 1996, APPL ENVIRON MICROB, V62, P4648, DOI 10.1128/AEM.62.12.4648-4651.1996; Young E, 2011, APPL ENVIRON MICROB, V77, P3311, DOI 10.1128/AEM.02651-10; Zeng WY, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-016-0223-y; Zhou Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep06556	64	21	21	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195633	10.1371/journal.pone.0195633	http://dx.doi.org/10.1371/journal.pone.0195633			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621349	Green Published, Green Submitted, gold			2022-12-26	WOS:000429206800111
J	Khan, T; Zaman, G; Alshomrani, AS				Khan, Tahir; Zaman, Gui; Alshomrani, Ali Saleh			Spreading dynamic of acute and carrier hepatitis B with nonlinear incidence	PLOS ONE			English	Article							MODEL	Hepatitis B infection caused by the hepatitis B virus. It is one of the serious viral infection and a global health problem. In the transmission of hepatitis B infection different phases, i.e., acute and chronic carrier stages play an important role. The chronic carries individuals do not exhibit any symptoms and are able to transmit the infection. Here we assessed the transmissibility associated with different infection stages of hepatitis B and generated an epidemic model with nonlinear incidence rate. In order to do this, first we formulate the model by splitting the infectious class into two subclasses, namely acutely infected and chronic carries with both horizontal and vertical transmission. The basic properties of the proposed model are presented. The basic reproductive number is obtained by using the next generation matrix approach. Biological sense of the threshold condition is investigated and discussed in detail. We also find the conditions to investigate all possible equilibria of the model in terms of the basic reproduction number. Finally, we perform numerical simulations to support our analytical work.	[Khan, Tahir; Zaman, Gui] Univ Malakand, Dept Math, Chakdara Dir Lower, Khyber Pakhtunkhawa, Pakistan; [Alshomrani, Ali Saleh] King Abdulaziz Univ, Fac Sci, Dept Math, Jeddah, Saudi Arabia	King Abdulaziz University	Zaman, G (corresponding author), Univ Malakand, Dept Math, Chakdara Dir Lower, Khyber Pakhtunkhawa, Pakistan.	gzaman@uom.edu.pk	ALSHOMRANI, ALI SALEH/Q-4236-2017	ALSHOMRANI, ALI SALEH/0000-0001-9222-8915	Higher Education Commission (HEC) of Pakistan [20-1983/R, D/HEC/11]; Department of Mathematics, Faculty of Science, King Abdul Aziz University, Jeddah, Saudi Arabia	Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan); Department of Mathematics, Faculty of Science, King Abdul Aziz University, Jeddah, Saudi Arabia	This work has been partially supported by Higher Education Commission (HEC) of Pakistan under the project No. 20-1983/R and D/HEC/11 and the Department of Mathematics, Faculty of Science, King Abdul Aziz University, Jeddah, Saudi Arabia.	Allen L., 2008, LECT NOTES MATH EPID; Fan M, 2001, MATH BIOSCI, V170, P199, DOI 10.1016/S0025-5564(00)00067-5; Kamien M.I., 2012, DYNAMIC OPTIMIZATION, VSecond; Khan T, 2017, J BIOL DYNAM, V11, P172, DOI 10.1080/17513758.2016.1256441; Khan T, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2706-3; Lashari AA, 2013, APPL MATH INFORM SCI, V7, P301, DOI 10.12785/amis/070138; Li JQ, 2002, MATH COMPUT MODEL, V35, P1235, DOI 10.1016/S0895-7177(02)00082-1; Li L, 2016, J BIOL SYST, V24, P519, DOI 10.1142/S0218339016500261; Li L, 2015, APPL MATH COMPUT, V252, P397, DOI 10.1016/j.amc.2014.11.107; Li MT, 2017, J MATH ANAL APPL, V446, P1292, DOI 10.1016/j.jmaa.2016.09.043; Mann J, 2011, J THEOR BIOL, V269, P266, DOI 10.1016/j.jtbi.2010.10.028; Mukherjee A, 2015, CHAOS SOLITON FRACT, V78, P16, DOI 10.1016/j.chaos.2015.06.020; Pang LY, 2015, APPL MATH COMPUT, V256, P131, DOI 10.1016/j.amc.2014.12.096; Sun GQ, 2017, COMMUN NONLINEAR SCI, V45, P235, DOI 10.1016/j.cnsns.2016.10.007; Sun GQ, 2014, APPL MATH COMPUT, V246, P336, DOI 10.1016/j.amc.2014.08.028; Thornley S, 2008, J THEOR BIOL, V254, P599, DOI 10.1016/j.jtbi.2008.06.022; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Zaman G, 2008, BIOSYSTEMS, V93, P240, DOI 10.1016/j.biosystems.2008.05.004; Zaman G, 2009, BIOSYSTEMS, V98, P43, DOI 10.1016/j.biosystems.2009.05.006; Zeb A, 2013, APPL MATH MODEL, V37, P5326, DOI 10.1016/j.apm.2012.10.005; Zou L, 2015, J THEOR BIOL, V369, P1, DOI 10.1016/j.jtbi.2015.01.005; Zou L, 2010, J THEOR BIOL, V262, P330, DOI 10.1016/j.jtbi.2009.09.035	22	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0191914	10.1371/journal.pone.0191914	http://dx.doi.org/10.1371/journal.pone.0191914			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6TQ	29621241	Green Published, gold, Green Submitted			2022-12-26	WOS:000429206800002
J	Massey, AJ				Massey, Andrew J.			A high content, high throughput cellular thermal stability assay for measuring drug-target engagement in living cells	PLOS ONE			English	Article							KINASE 1 CHK1; SHIFT ASSAY; IDENTIFICATION; COMBINATION; INHIBITOR	Determining and understanding drug target engagement is critical for drug discovery. This can be challenging within living cells as selective readouts are often unavailable. Here we describe a novel method for measuring target engagement in living cells based on the principle of altered protein thermal stabilization / destabilization in response to ligand binding. This assay (HCIF-CETSA) utilizes high content, high throughput single cell immunofluorescent detection to determine target protein levels following heating of adherent cells in a 96 well plate format. We have used target engagement of Chk1 by potent small molecule inhibitors to validate the assay. Target engagement measured by this method was subsequently compared to target engagement measured by two alternative methods (autophosphorylation and CETSA). The HCIF-CETSA method appeared robust and a good correlation in target engagement measured by this method and CETSA for the selective Chk1 inhibitor V158411 was observed. However, these EC50 values were 23- and 12-fold greater than the autophosphorylation IC50. The described method is therefore a valuable advance in the CETSA method allowing the high throughput determination of target engagement in adherent cells.	[Massey, Andrew J.] Vernalis Res, Granta Pk, Cambridge, England	Vernalis	Massey, AJ (corresponding author), Vernalis Res, Granta Pk, Cambridge, England.	a.massey@vernalis.com	Massey, Andrew J./H-6954-2019	Massey, Andrew J./0000-0002-0276-2573	Vernalis Research	Vernalis Research	This work was funded by Vernalis Research who agreed to the publication of this manuscript. The funder provided support in the form of salaries for author AJM, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific role of the author are articulated in the 'author contributions' section.	Blackwood E, 2013, MOL CANCER THER, V12, P1968, DOI 10.1158/1535-7163.MCT-12-1218; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Franken H, 2015, NAT PROTOC, V10, P1567, DOI 10.1038/nprot.2015.101; Geneste CC, 2017, SLAS DISCOV; Han XZ, 2016, J BIOL CHEM, V291, P12951, DOI 10.1074/jbc.M115.713248; He XJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw064; Huber KVM, 2015, NAT METHODS, V12, P1055, DOI [10.1038/NMETH.3590, 10.1038/nmeth.3590]; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Lackner DH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10237; Liu QH, 2000, GENE DEV, V14, P1448; Massey AJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40778; Massey AJ, 2016, MOL ONCOL, V10, P101, DOI 10.1016/j.molonc.2015.08.004; Massey AJ, 2015, ONCOTARGET, V6, P35797, DOI 10.18632/oncotarget.5929; McNulty DE, 2017, SLAS DISCOV; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Montano R, 2012, MOL CANCER THER, V11, P427, DOI 10.1158/1535-7163.MCT-11-0406; Reinhard FBM, 2015, NAT METHODS, V12, P1129, DOI 10.1038/nmeth.3652; Savitski MM, 2014, SCIENCE, V346, P55, DOI 10.1126/science.1255784; Seashore-Ludlow B, 2016, J BIOMOL SCREEN, V21, P1019, DOI 10.1177/1087057116659256; Wang JN, 2012, J BIOL CHEM, V287, P25501, DOI 10.1074/jbc.M112.350397; Wayne J, 2016, ONCOTARGET, V7, P85033, DOI 10.18632/oncotarget.13119; Zhang YW, 2014, INT J CANCER, V134, P1013, DOI 10.1002/ijc.28226	22	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195050	10.1371/journal.pone.0195050	http://dx.doi.org/10.1371/journal.pone.0195050			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617433	Green Submitted, gold, Green Published			2022-12-26	WOS:000429203800060
J	van Schijndel, TJP; Huijpen, K; Visser, I; Raijmakers, MEJ				van Schijndel, Tessa J. P.; Huijpen, Kim; Visser, Ingmar; Raijmakers, Maartje E. J.			Investigating the development of causal inference by studying variability in 2-to 5-year-olds' behavior	PLOS ONE			English	Article							BALANCE SCALE TASK; LATENT CLASS ANALYSIS; YOUNG-CHILDREN; EARLY-CHILDHOOD; BAYES NETS; KNOWLEDGE; BLICKETS; INFANTS; MODELS; CATEGORIZATION	This study investigated the development of young children's causal inference by studying variability in behavior. Two possible sources of variability, strategy use and accuracy in strategy execution, were discriminated and related to age. To this end, a relatively wide range of causal inference trials was administered to children of a relatively broad age range: 2- to 5-year-olds. Subsequently, individuals' response patterns over trials were analyzed with a latent variable technique. The results showed that variability in children's behavior could largely be explained by strategy use. Three different strategies were distinguished, and tentative interpretations suggest these could possibly be labeled as "rational", "associative", and "uncertainty avoidance" strategies. The strategies were found to be related to age, and this age-related strategy use better explained the variability in children's behavior than age-related increase in accuracy of executing a single strategy. This study can be considered a first step in introducing a new, fruitful approach for investigating the development of causal inference.	[van Schijndel, Tessa J. P.] Univ Amsterdam, Res Inst Child Dev & Educ, Amsterdam, Netherlands; [van Schijndel, Tessa J. P.] Leiden Univ, Leiden Univ Grad Sch Teaching ICLON, Leiden, Netherlands; [van Schijndel, Tessa J. P.; Visser, Ingmar; Raijmakers, Maartje E. J.] Univ Amsterdam, Res Prior Area Yield, Amsterdam, Netherlands; [Huijpen, Kim; Visser, Ingmar; Raijmakers, Maartje E. J.] Univ Amsterdam, Dev Psychol, Amsterdam, Netherlands; [Visser, Ingmar; Raijmakers, Maartje E. J.] Univ Amsterdam, Amsterdam Brain & Cognit, Amsterdam, Netherlands; [Raijmakers, Maartje E. J.] Leiden Univ, Educ Sci, Leiden, Netherlands	University of Amsterdam; Leiden University; Leiden University - Excl LUMC; University of Amsterdam; University of Amsterdam; University of Amsterdam; Leiden University; Leiden University - Excl LUMC	van Schijndel, TJP (corresponding author), Univ Amsterdam, Res Inst Child Dev & Educ, Amsterdam, Netherlands.; van Schijndel, TJP (corresponding author), Leiden Univ, Leiden Univ Grad Sch Teaching ICLON, Leiden, Netherlands.; van Schijndel, TJP (corresponding author), Univ Amsterdam, Res Prior Area Yield, Amsterdam, Netherlands.	t.j.p.vanschijnciel@uva.nl		Raijmakers, Maartje/0000-0003-1843-6462; Visser, Ingmar/0000-0003-3855-2778	Aspasia grant from The Netherlands Organisation for Scientific Research [015.003.015]; Curious Minds program - Dutch Ministry of Education, Culture and Science; Platform Beta Techniek	Aspasia grant from The Netherlands Organisation for Scientific Research; Curious Minds program - Dutch Ministry of Education, Culture and Science; Platform Beta Techniek	The research was funded by an Aspasia grant (015.003.015) from The Netherlands Organisation for Scientific Research, http://www.nwo.ni/ (MR) and a grant from the Curious Minds program, http://talentenkracht.ni/, which is supported by the Dutch Ministry of Education, Culture and Science and the Platform Beta Techniek (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, J EXPT CHILD PSYCHOL, V120, P17; Beckers T, 2009, EXP PSYCHOL, V56, P27, DOI 10.1027/1618-3169.56.1.27; Bonawitz EB, 2010, COGNITION, V115, P104, DOI 10.1016/j.cognition.2009.12.001; Boom J, 2001, COGNITIVE DEV, V16, P717, DOI 10.1016/S0885-2014(01)00056-9; Bouwmeester S, 2004, EUR J DEV PSYCHOL, V1, P67, DOI 10.1080/17405620344000031; Bouwmeester S, 2012, COGNITIVE DEV, V27, P168, DOI 10.1016/j.cogdev.2012.03.001; De Houwer J, 2002, Q J EXP PSYCHOL-B, V55, P289, DOI 10.1080/02724990244000034; Dickinson A, 2001, CURR DIR PSYCHOL SCI, V10, P127, DOI 10.1111/1467-8721.00132; Glymour C., 2001, MINDS ARROWS BAYES N, DOI 10.7551/mitpress/4638.001.0001; Gopnik A, 2000, CHILD DEV, V71, P1205, DOI 10.1111/1467-8624.00224; Gopnik A, 2004, PSYCHOL REV, V111, P3, DOI 10.1037/0033-295X.111.1.3; Gopnik A, 2001, DEV PSYCHOL, V37, P620, DOI 10.1037//0012-1649.37.5.620; Gopnik A, 2012, PSYCHOL BULL, V138, P1085, DOI 10.1037/a0028044; Griffiths TL, 2011, COGNITIVE SCI, V35, P1407, DOI 10.1111/j.1551-6709.2011.01203.x; Jansen BRJ, 2002, J EXP CHILD PSYCHOL, V81, P383, DOI 10.1006/jecp.2002.2664; Jansen BRJ, 2001, DEV REV, V21, P450, DOI 10.1006/drev.2001.0530; Jansen BRJ, 1997, DEV REV, V17, P321, DOI 10.1006/drev.1997.0437; Kirkham NZ, 2002, COGNITION, V83, pB35, DOI 10.1016/S0010-0277(02)00004-5; Koppenol-Gonzalez GV, 2012, J EXP CHILD PSYCHOL, V111, P439, DOI 10.1016/j.jecp.2011.10.001; Kushnir T, 2005, PSYCHOL SCI, V16, P678, DOI 10.1111/j.1467-9280.2005.01595.x; Langeheine R, 1996, SOCIOL METHOD RES, V24, P492, DOI 10.1177/0049124196024004004; LEMAIRE P, 1995, J EXP PSYCHOL GEN, V124, P83, DOI 10.1037/0096-3445.124.1.83; McCutcheon AL, 1987, LATENT CLASS ANAL; Nazzi T, 2003, COGNITIVE DEV, V18, P299, DOI 10.1016/S0885-2014(03)00025-X; Nazzi T, 2000, DEVELOPMENTAL SCI, V3, P389, DOI 10.1111/1467-7687.00133; R Development Core Team, 2009, R LANG ENV STAT COMP; Raijmakers MEJ, 2004, DEV REV, V24, P289, DOI 10.1016/j.dr.2004.06.002; Reichenbach H., 1956, DIRECTION TIME; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Rickard TC, 2004, J EXP PSYCHOL LEARN, V30, P65, DOI 10.1037/0278-7393.30.1.65; RINDSKOPF D, 1987, DEV REV, V7, P66, DOI 10.1016/0273-2297(87)90005-0; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Schmittmann VD, 2012, J EXP CHILD PSYCHOL, V111, P644, DOI 10.1016/j.jecp.2011.10.010; Schulz L, 2012, TRENDS COGN SCI, V16, P382, DOI 10.1016/j.tics.2012.06.004; Schulz LE, 2006, CHILD DEV, V77, P427, DOI 10.1111/j.1467-8624.2006.00880.x; Schulz LE, 2004, DEV PSYCHOL, V40, P162, DOI 10.1037/0012-1649.40.2.162; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Siegler R. S., 1996, EMERGING MINDS PROCE; SIEGLER RS, 1981, MONOGR SOC RES CHILD, V46, P1, DOI 10.2307/1165995; SIEGLER RS, 1976, COGNITIVE PSYCHOL, V8, P481, DOI 10.1016/0010-0285(76)90016-5; Sobel DM, 2007, DEVELOPMENTAL SCI, V10, P298, DOI 10.1111/j.1467-7687.2007.00589.x; Sobel DM, 2006, DEV PSYCHOL, V42, P1103, DOI 10.1037/0012-1649.42.6.1103; Sobel DM, 2009, DEV PSYCHOL, V45, P511, DOI 10.1037/a0014944; Sobel DM, 2004, COGNITIVE SCI, V28, P303, DOI 10.1016/j.cogsci.2003.11.001; Steyvers M, 2003, COGNITIVE SCI, V27, P453, DOI 10.1016/S0364-0213(03)00010-7; Straatemeier M, 2008, J EXP CHILD PSYCHOL, V100, P276, DOI 10.1016/j.jecp.2008.03.004; van der Maas HLJ, 2008, DEVELOPMENTAL SCI, V11, P449, DOI 10.1111/j.1467-7687.2008.00690.x; Van Es SE, P 31 ANN C COGN SCI; Visser I, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i07; Wickens T. D., 1982, MODELS BEHAV STOCHAS	50	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195019	10.1371/journal.pone.0195019	http://dx.doi.org/10.1371/journal.pone.0195019			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB3VV	29608583	Green Submitted, Green Published, gold			2022-12-26	WOS:000428988800022
J	Arya, SB; Kumar, G; Kaur, H; Kaur, A; Tuli, A				Arya, Subhash B.; Kumar, Gaurav; Kaur, Harmeet; Kaur, Amandeep; Tuli, Amit			ARL11 regulates lipopolysaccharide-stimulated macrophage activation by promoting mitogen-activated protein kinase (MAPK) signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						macrophage; lipopolysaccharide (LPS); GTPase; mitogen-activated protein kinase (MAPK); extracellular-signal-regulated kinase (ERK); ARL11; ARLTS1; Salmonella	TUMOR-SUPPRESSOR GENE; ARLTS1 CYS148ARG VARIANT; FAMILIAL BREAST-CANCER; COLORECTAL-CANCER; APOPTOSIS; ERK; MALIGNANCIES; INFLAMMATION; ASSOCIATION; EXPRESSION	ADP-ribosylation factor-like GTPase 11 (ARL11) is a cancer-predisposing gene that has remained functionally uncharacterized to date. In this study, we report that ARL11 is endogenously expressed in mouse and human macrophages and regulates their activation in response to lipopolysaccharide (LPS) stimulation. Accordingly, depletion of ARL11 impaired both LPS-stimulated pro-inflammatory cytokine production by macrophages and their ability to control intracellular replication of Salmonella. LPS-stimulated activation of extracellular signal-regulated kinase (ERK) and p38 mitogen-activated protein kinase (MAPK) was substantially compromised in Arl11-silenced macrophages. In contrast, increased expression of ARL11 led to constitutive ERK1/2 phosphorylation, resulting in macrophage exhaustion. Finally, we found that ARL11 forms a complex with phospho-ERK in macrophages within minutes of LPS stimulation. Taken together, our findings establish ARL11 as a novel regulator of ERK signaling in macrophages, required for macrophage activation and immune function.	[Arya, Subhash B.; Kumar, Gaurav; Kaur, Harmeet; Kaur, Amandeep; Tuli, Amit] CSIR Inst Microbial Technol IMTECH, Div Cell Biol & Immunol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Arya, SB; Tuli, A (corresponding author), CSIR Inst Microbial Technol IMTECH, Div Cell Biol & Immunol, Chandigarh 160036, India.	subhasharya8@gmail.com; atuli@imtech.res.in	Arya, Subhash Babu/GPJ-9725-2022	Arya, Subhash Babu/0000-0002-5671-8666; Tuli, Amit/0000-0001-5476-4127	Wellcome Trust/Department of Biotechnology (DBT) India Alliance Intermediate Fellowship [IA/I/14/2/501543]; CSIR-IMTECH [OLP-144]; CSIR-JRF; CSIR-UGC; Wellcome Trust/DBT India Alliance; CSIR-IMTECH; DST-INSPIRE	Wellcome Trust/Department of Biotechnology (DBT) India Alliance Intermediate Fellowship(Wellcome Trust DBT India Alliance); CSIR-IMTECH; CSIR-JRF(Council of Scientific & Industrial Research (CSIR) - India); CSIR-UGC(Council of Scientific & Industrial Research (CSIR) - IndiaUniversity Grants Commission, India); Wellcome Trust/DBT India Alliance(Wellcome TrustWellcome Trust DBT India Alliance); CSIR-IMTECH; DST-INSPIRE(Department of Science & Technology (India))	This work was supported by Wellcome Trust/Department of Biotechnology (DBT) India Alliance Intermediate Fellowship IA/I/14/2/501543 (to A.T.).This work received infrastructure and financial support from CSIR-IMTECH (OLP-144, communication 046/2017). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the CSIR-JRF.; Supported by the CSIR-UGC.; Supported by the Wellcome Trust/DBT India Alliance and CSIR-IMTECH.; Supported by a DST-INSPIRE Fellowship.	Akisik E, 2011, MOL BIOL REP, V38, P343, DOI 10.1007/s11033-010-0113-3; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Calin GA, 2005, NEW ENGL J MED, V352, P1667, DOI 10.1056/NEJMoa042280; Castellvi-Bel S, 2007, CARCINOGENESIS, V28, P1687, DOI 10.1093/carcin/bgm098; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Endo M, 2005, J BIOCHEM, V138, P501, DOI 10.1093/jb/mvi143; Endo M, 2006, J IMMUNOL, V176, P6245, DOI 10.4049/jimmunol.176.10.6245; Frank B, 2006, INT J CANCER, V118, P2505, DOI 10.1002/ijc.21687; Frank B, 2006, CANCER LETT, V244, P172, DOI 10.1016/j.canlet.2005.12.006; Hamadou WS, 2017, B CANCER, V104, P123, DOI 10.1016/j.bulcan.2016.10.016; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Jones Edward, 2007, J Inflamm (Lond), V4, P23, DOI 10.1186/1476-9255-4-23; Kang HG, 2017, INT J ONCOL, V50, P545, DOI 10.3892/ijo.2017.3841; Kavanagh E, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.514; Khatter Divya, 2015, Cell Logist, V5, pe1086501; La Starza R, 1998, BLOOD, V91, P231, DOI 10.1182/blood.V91.1.231.231_231_237; Lioberas J, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00028; Lombardo E, 2007, J IMMUNOL, V178, P3731, DOI 10.4049/jimmunol.178.6.3731; Marwaha R, 2017, J CELL BIOL, V216, P1051, DOI 10.1083/jcb.201607085; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Mendoza MC, 2011, MOL CELL, V41, P661, DOI 10.1016/j.molcel.2011.02.031; Petrocca F, 2006, CANCER RES, V66, P10287, DOI 10.1158/0008-5472.CAN-06-2289; POMERANTZ RJ, 1990, J EXP MED, V172, P253, DOI 10.1084/jem.172.1.253; Siltanen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072040; Siltanen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026595; Sindhwani A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006700; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; WEINSTEIN SL, 1992, J BIOL CHEM, V267, P14955; Xiao YQ, 2002, J BIOL CHEM, V277, P14884, DOI 10.1074/jbc.M111718200; YANG X, 2009, J BEIJING SPORT U, V3, P6; Yendamuri S, 2008, CANCER LETT, V264, P11, DOI 10.1016/j.canlet.2008.02.021; Yendamuri S, 2007, CANCER RES, V67, P7738, DOI 10.1158/0008-5472.CAN-07-1481; Yin ZN, 1999, ONCOGENE, V18, P7576, DOI 10.1038/sj.onc.1203203; Yoo YH, 2004, FEBS LETT, V556, P39, DOI 10.1016/S0014-5793(03)01361-9	37	14	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9892	9909		10.1074/jbc.RA117.000727	http://dx.doi.org/10.1074/jbc.RA117.000727			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29618517	Green Published, hybrid			2022-12-26	WOS:000436102300030
J	Sipila, KH; Drushinin, K; Rappu, P; Jokinen, J; Salminen, TA; Salo, AM; Kapyla, J; Myllyharju, J; Heino, J				Sipila, Kalle H.; Drushinin, Kati; Rappu, Pekka; Jokinen, Johanna; Salminen, Tiina A.; Salo, Antti M.; Kapyla, Jarmo; Myllyharju, Johanna; Heino, Jyrki			Proline hydroxylation in collagen supports integrin binding by two distinct mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE COLLAGEN; MEDIATED CELL-ADHESION; ALPHA-SUBUNIT ISOFORM; RECOGNITION SITE; I COLLAGEN; ALPHA-1-BETA-1; MICE; ALPHA(2)BETA(1); ALPHA-2-BETA-1; SEQUENCE	Collagens are the most abundant extracellular matrix proteins in vertebrates and have a characteristic triple-helix structure. Hydroxylation of proline residues is critical for helix stability, and diminished prolyl hydroxylase activity causes wide-spread defects in connective tissues. Still, the role of proline hydroxylation in the binding of collagen receptors such as integrins is unclear. Here, we isolated skin collagen from genetically modified mice having reduced prolyl 4-hydroxylase activity. At room temperature, the reduced proline hydroxylation did not affect interactions with the recombinant integrin 2I domain, but at 37 degrees C, collagen hydroxylation correlated with the avidity of 2I domain binding. Of note, LC-MS/MS analysis of isolated skin collagens revealed no major changes in the hydroxyproline content of the main integrin-binding sites. Thus, the disrupted 2I domain binding at physiological temperatures was most likely due to structural destabilization of the collagenous helix. Integrin 2I binding to the triple-helical GFPGER motif was slightly weaker than to GFOGER (O = hydroxyproline). This phenomenon was more prominent when 1 integrin was tested. Integrin 11 expressed on CHO cells and recombinant 1I domain showed remarkably slower binding velocity and weaker avidity to GFPGER when compared with GFOGER. Structural modeling revealed the critical interaction between Arg-218 in 1I and the hydroxyproline residue in the integrin-binding motif. The role of Arg-218 was further validated by testing a variant R218D 1I domain in solid-phase binding assays. Thus, our results show that the lack of proline hydroxylation in collagen can affect integrin binding by a direct mechanism and via structural destabilization of the triple helix.	[Sipila, Kalle H.; Rappu, Pekka; Jokinen, Johanna; Kapyla, Jarmo; Heino, Jyrki] Univ Turku, Dept Biochem, FI-20014 Turku, Finland; [Drushinin, Kati; Salo, Antti M.; Myllyharju, Johanna] Univ Oulu, Bioctr Oulu, FI-90014 Oulu, Finland; [Drushinin, Kati; Salo, Antti M.; Myllyharju, Johanna] Univ Oulu, Fac Biochem & Mol Med, FI-90014 Oulu, Finland; [Salminen, Tiina A.] Abo Akad Univ, Fac Sci & Engn, Struct Bioinformat Lab, Biochem, FI-20520 Turku, Finland; [Sipila, Kalle H.] Kings Coll London, London WC2R 2LS, England	Finland National Institute for Health & Welfare; University of Turku; University of Oulu; University of Oulu; Abo Akademi University; University of London; King's College London	Heino, J (corresponding author), Univ Turku, Dept Biochem, FI-20014 Turku, Finland.	jyrki.heino@utu.fi	Salminen, Tiina A./AAM-5443-2021; Salminen, Tiina A/G-7492-2019	Salminen, Tiina A./0000-0002-4135-8020; Salminen, Tiina A/0000-0002-4135-8020; Kapyla, Jarmo/0000-0003-3036-713X; Rappu, Pekka/0000-0002-5068-2842	University of Oulu; Biocenter Finland	University of Oulu; Biocenter Finland	We thank Anne Kokko and Maria Tuominen for excellent technical assistance and Dr. Hongmin Tu from the Biocenter Oulu core facility for protein analysis (co-funded by the University of Oulu and Biocenter Finland) for help in CD analyses. We thank the bioinformatics (J.V. Lehtonen), translational activities, and structural biology infrastructure support from the Biocenter Finland, and the CSC IT Center for Science for computational infrastructure support at the Structural Bioinformatics Laboratory, Abo Akademi University. We also thank the University of Oulu Laboratory Animal Center.	Annunen P, 1997, J BIOL CHEM, V272, P17342, DOI 10.1074/jbc.272.28.17342; Aro E, 2015, J BIOL CHEM, V290, P16964, DOI 10.1074/jbc.M115.662635; Bengtsson T, 2005, J CELL SCI, V118, P929, DOI 10.1242/jcs.01678; Blumbach K, 2012, J BIOL CHEM, V287, P6431, DOI 10.1074/jbc.M111.283119; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; Chen JC, 2002, AM J PATHOL, V161, P337, DOI 10.1016/S0002-9440(10)64185-5; Chin YKY, 2013, J BIOL CHEM, V288, P36796, DOI 10.1074/jbc.M113.480251; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; EBLE JA, 1993, EMBO J, V12, P4795, DOI 10.1002/j.1460-2075.1993.tb06168.x; Ekholm E, 2002, AM J PATHOL, V160, P1779, DOI 10.1016/S0002-9440(10)61124-8; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Gardner H, 1999, J CELL SCI, V112, P263; Ghatak S, 2016, AM J PATHOL, V186, P3011, DOI 10.1016/j.ajpath.2016.06.021; Golbik R, 2000, J MOL BIOL, V297, P501, DOI 10.1006/jmbi.2000.3575; Grosso G, 2013, FRONT BIOSCI-LANDMRK, V18, P1017, DOI 10.2741/4160; Hamaia SW, 2012, J BIOL CHEM, V287, P26019, DOI 10.1074/jbc.M112.353144; HELAAKOSKI T, 1995, P NATL ACAD SCI USA, V92, P4427, DOI 10.1073/pnas.92.10.4427; Holster T, 2007, J BIOL CHEM, V282, P2512, DOI 10.1074/jbc.M606608200; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Johnson MS, 2013, EVOLUTION EXTRACELLU, P243; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Kapyla J, 2004, J BIOL CHEM, V279, P51677, DOI 10.1074/jbc.M409412200; Kapyla J, 2000, J BIOL CHEM, V275, P3348, DOI 10.1074/jbc.275.5.3348; Kim JK, 2005, J BIOL CHEM, V280, P32512, DOI 10.1074/jbc.M502431200; Kivirikko K. I., 1992, POSTTRANSLATIONAL MO, P1; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lahti M, 2011, J BIOL CHEM, V286, P43343, DOI 10.1074/jbc.M111.261909; Li SH, 2003, AM J PATHOL, V163, P1045, DOI 10.1016/S0002-9440(10)63464-5; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nykvist P, 2000, J BIOL CHEM, V275, P8255, DOI 10.1074/jbc.275.11.8255; Perret S, 2003, J BIOL CHEM, V278, P29873, DOI 10.1074/jbc.M304073200; Popova SN, 2007, MOL CELL BIOL, V27, P4306, DOI 10.1128/MCB.00041-07; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; ROSENBLO.J, 1973, ARCH BIOCHEM BIOPHYS, V158, P478, DOI 10.1016/0003-9861(73)90539-0; Sacca B, 2003, BIOCHEMISTRY-US, V42, P3429, DOI 10.1021/bi0206762; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Seo N, 2010, J BIOL CHEM, V285, P31046, DOI 10.1074/jbc.M110.151357; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Sipila K, 2014, FASEB J, V28, P3758, DOI 10.1096/fj.13-247767; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Woltersdorf C, 2017, MATRIX BIOL, V63, P91, DOI 10.1016/j.matbio.2017.02.001; Zeltz C, 2016, J CELL SCI, V129, P653, DOI 10.1242/jcs.180992; Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200; Zou YQ, 2017, HUM MOL GENET, V26, P2207, DOI 10.1093/hmg/ddx110; Zweers MC, 2007, J INVEST DERMATOL, V127, P467, DOI 10.1038/sj.jid.5700546; Zwolanek D, 2014, BIOCHEM J, V459, P217, DOI 10.1042/BJ20130642	52	33	33	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7645	7658		10.1074/jbc.RA118.002200	http://dx.doi.org/10.1074/jbc.RA118.002200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29615493	hybrid, Green Published			2022-12-26	WOS:000437256500016
J	Iglesias-Escudero, M; Moro-Garcia, MA; Marcos-Fernandez, R; Garcia-Torre, A; Alvarez-Arguelles, ME; Suarez-Fernandez, ML; Martinez-Camblor, P; Rodriguez, M; Alonso-Arias, R				Iglesias-Escudero, Maria; Antonio Moro-Garcia, Marco; Marcos-Fernandez, Raquel; Garcia-Torre, Alejandra; Elena Alvarez-Arguelles, Marta; Luisa Suarez-Fernandez, Maria; Martinez-Camblor, Pablo; Rodriguez, Minerva; Alonso-Arias, Rebeca			Levels of anti-CMV antibodies are modulated by the frequency and intensity of virus reactivations in kidney transplant patients	PLOS ONE			English	Article							SOLID-ORGAN TRANSPLANTATION; T-CELL SUBSETS; CYTOMEGALOVIRUS-INFECTION; CARDIOVASCULAR-DISEASE; NORFOLK COHORT; IMMUNE-SYSTEM; OLDER WOMEN; FOLLOW-UP; MORTALITY; PEOPLE	Anti-CMV (cytomegalovirus) antibody titers are related to immune alterations and increased risk of mortality. To test whether they represent a marker of infection history, we analyzed the effect of viral reactivations on the production of specific antibodies in kidney transplant patients. We quantified CMV-DNAemia and antibody titers in 58 kidney transplant patients before transplantation and during a follow-up of 315 days (standard deviation, SD: 134.5 days). In order to calculate the intensity of the infection, we plotted the follow-up time of the infection on the x-axis and the number of DNA-CMV copies on the y-axis and calculated the area under the curve (CMV-AUC). The degree of T-lymphocyte differentiation was analyzed with flow cytometry, the cells were labelled with different monoclonal antibodies in order to distinguish their differentiation state, from naive T-cells to senescent T-cells. Peak viremia was significantly higher in patients experiencing a primary infection (VI) compared to patients experiencing viral reactivation (VR). Our data indicate that the overall CMV viral load over the course of a primary infection is significantly higher than in a reactivation of a previously established infection. Whereas patients who experienced an episode of CMV reactivation during the course of our observation showed increased levels of CMV-specific antibodies, patients who did not experience CMV reactivation (WVR) showed a drop in CMV antibody levels that corresponds to an overall drop in antibody levels, probably due to the continuing immunosuppression after the renal transplant. We found a positive correlation between the CMV viremia over the course of the infection or reactivation and the CMV-specific antibody titers in the examined patients. We also observed a positive correlation between anti-CMV titers and T-cell differentiation. In conclusion, our data show that anti-CMV antibody titers are related to the course of CMV infection in kidney transplant patients.	[Iglesias-Escudero, Maria; Antonio Moro-Garcia, Marco; Marcos-Fernandez, Raquel; Garcia-Torre, Alejandra; Alonso-Arias, Rebeca] HUCA, Immunol Dept, Oviedo, Spain; [Elena Alvarez-Arguelles, Marta] HUCA, Dept Microbiol, Oviedo, Spain; [Luisa Suarez-Fernandez, Maria; Rodriguez, Minerva] HUCA, Nephrol Dept, Oviedo, Spain; [Martinez-Camblor, Pablo] HUCA, Stat Dept, Oviedo, Spain	Central University Hospital Asturias; Central University Hospital Asturias; Central University Hospital Asturias; Central University Hospital Asturias	Alonso-Arias, R (corresponding author), HUCA, Immunol Dept, Oviedo, Spain.	ralonsoarias@hotmail.es	Camblor, Pablo Martinez/Z-4834-2019; García, Marco Antonio Moro/AAK-9701-2020; RG, SMABSS/N-3322-2018	Camblor, Pablo Martinez/0000-0001-7845-3905; García, Marco Antonio Moro/0000-0001-9601-5757; RG, SMABSS/0000-0001-9944-3861; Iglesias Escudero, Maria/0000-0003-1645-4130; Alonso-Arias, Rebeca/0000-0002-9596-3787	Plan Estatal de I+D+i - Instituto de Salud Carlos III [PI14/01566, PI17/00714]; Fondo Europeo de Desarrollo Regional (FEDER)	Plan Estatal de I+D+i - Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	This work was supported by grants PI14/01566 and PI17/00714 from Plan Estatal de I+D+i 2013-2016, co-funded by "Instituto de Salud Carlos III" and by "Fondo Europeo de Desarrollo Regional (FEDER).	Aiello AE, 2006, J AM GERIATR SOC, V54, P1046, DOI 10.1111/j.1532-5415.2006.00796.x; Arias RA, 2013, J VIROL, V87, P4486, DOI 10.1128/JVI.02425-12; Moro-Garcia MA, 2012, AGE, V34, P479, DOI 10.1007/s11357-011-9240-6; Atabani SF, 2012, AM J TRANSPLANT, V12, P2457, DOI 10.1111/j.1600-6143.2012.04087.x; de la Torre-Cisneros J, 2011, ENFERM INFEC MICR CL, V29, P735, DOI 10.1016/j.eimc.2011.05.022; Effros RB, 2005, IMMUNOL REV, V205, P147, DOI 10.1111/j.0105-2896.2005.00259.x; Fann M, 2005, IMMUNOL REV, V205, P190, DOI 10.1111/j.0105-2896.2005.00262.x; Gerna G, 2008, J GEN VIROL, V89, P853, DOI 10.1099/vir.0.83523-0; Gkrania-Klotsas E, 2013, CLIN INFECT DIS, V56, P1421, DOI 10.1093/cid/cit083; Gkrania-Klotsas E, 2012, J INFECT DIS, V206, P1897, DOI 10.1093/infdis/jis620; Goronzy JJ, 2007, EXP GERONTOL, V42, P400, DOI 10.1016/j.exger.2006.11.016; Harari A, 2004, HUM IMMUNOL, V65, P500, DOI 10.1016/j.humimm.2004.02.012; Harkins L, 2002, LANCET, V360, P1557, DOI 10.1016/S0140-6736(02)11524-8; Hodson EM, 2005, LANCET, V365, P2105, DOI 10.1016/S0140-6736(05)66553-1; Houghtelin A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01272; Issa NC, 2009, CLIN INFECT DIS, V48, P772, DOI 10.1086/597089; Kasiske BL, 2013, AM J TRANSPLANT, V13, P199, DOI 10.1111/ajt.12026; Koch S, 2008, IMMUN AGEING, V5, DOI [10.1186/1742-4933-5-6, 10.1186/1742-4933-5-11]; Kotton CN, 2013, TRANSPLANTATION, V96, P333, DOI 10.1097/TP.0b013e31829df29d; Kutza AST, 1998, CLIN INFECT DIS, V26, P1076, DOI 10.1086/520307; Leng SX, 2011, AGE, V33, P607, DOI 10.1007/s11357-011-9205-9; Li HF, 2014, EXP GERONTOL, V54, P84, DOI 10.1016/j.exger.2014.01.010; Mathei C, 2011, J AM GERIATR SOC, V59, P2201, DOI 10.1111/j.1532-5415.2011.03719.x; Meijers RWJ, 2015, AM J TRANSPLANT, V15, P3143, DOI 10.1111/ajt.13396; Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318; Pawelec G, 2005, IMMUNOL REV, V205, P257, DOI 10.1111/j.0105-2896.2005.00271.x; Prosch S, 2000, VIROLOGY, V272, P357, DOI 10.1006/viro.2000.0367; Roberts ET, 2010, AM J EPIDEMIOL, V172, P363, DOI 10.1093/aje/kwq177; Sagedal S, 2004, KIDNEY INT, V66, P329, DOI 10.1111/j.1523-1755.2004.00735.x; Simanek AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016103; Simanek AM, 2009, INT J EPIDEMIOL, V38, P775, DOI 10.1093/ije/dyn273; Strandberg TE, 2009, JAMA-J AM MED ASSOC, V301, P380, DOI 10.1001/jama.2009.4; Vallejo AN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026558; Wang GC, 2010, AM J EPIDEMIOL, V171, P1144, DOI 10.1093/aje/kwq062; Weltevrede M, 2016, EXP GERONTOL, V77, P87, DOI 10.1016/j.exger.2016.02.005; Weng NP, 2006, IMMUNITY, V24, P495, DOI 10.1016/j.immuni.2006.05.001; Xu H, 2014, AM J TRANSPLANT, V14, P319, DOI 10.1111/ajt.12574; Yong MK, 2017, J INFECT DIS, V215, P1684, DOI 10.1093/infdis/jix192	38	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194789	10.1371/journal.pone.0194789	http://dx.doi.org/10.1371/journal.pone.0194789			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641536	Green Published, gold, Green Submitted			2022-12-26	WOS:000429742900046
J	Griffin, FR; Mode, NA; Ejiogu, N; Zonderman, AB; Evans, MK				Griffin, Felicia R.; Mode, Nicolle A.; Ejiogu, Ngozi; Zonderman, Alan B.; Evans, Michele K.			Frailty in a racially and socioeconomically diverse sample of middle-aged Americans in Baltimore	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; OLDER AUSTRALIAN WOMEN; ALL-CAUSE MORTALITY; UNITED-STATES; HEALTH SURVEY; ADULTS; SCALE; VALIDITY; RISK; RACE	Frailty is a risk factor for disability and mortality, and is more prevalent among African American (AA) elderly than whites. We examine frailty in middle-aged racially and economically diverse adults, and investigate how race, poverty and frailty are associated with mortality. Data were from 2541 participants in the Healthy Aging in Neighborhoods of Diversity across the Life Span study in Baltimore, Maryland; 35-64 years old at initial assessment (56% women; 58% AA). Frailty was assessed using a modified FRAIL scale of fatigue, resistance, ambulation, illness and weight loss, and compared with difficulties in physical functioning and daily activities. Frailty prevalence was calculated across race and age groups, and associations with survival were assessed by Cox Regression. 278 participants were frail (11%); 924 pre-frail (36%); 1339 not frail (53%). For those aged 45-54, a higher proportion of whites (13%) than AAs (8%) were frail; while the proportions were similar for those 55-64 (14%,16%). Frailty was associated with overall survival with an average follow-up of 6.6 years, independent of race, sex and poverty status (HR = 2.30; 95%Cl 1.67-3.18). In this sample of economically and racially diverse older adults, the known association of frailty prevalence and age differed across race with whites having higher prevalence at younger ages. Frailty was associated with survival beyond the risk factors of race and poverty status in this middle-aged group. Early recognition of frailty at these younger ages may provide an effective method for preventing or delaying disabilities.	[Griffin, Felicia R.] Florida State Univ, Dept Stat, Tallahassee, FL 32306 USA; [Mode, Nicolle A.; Ejiogu, Ngozi; Zonderman, Alan B.; Evans, Michele K.] NIA, Lab Epidemiol & Populat Sci, NIH, Baltimore, MD 21224 USA; [Griffin, Felicia R.] Winston Salem State Univ, Dept Math, Winston Salem, NC USA	State University System of Florida; Florida State University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Winston-Salem State University	Mode, NA (corresponding author), NIA, Lab Epidemiol & Populat Sci, NIH, Baltimore, MD 21224 USA.	nicolle.mode@nih.gov	Evans, Michele Kim/AAE-4776-2019; Ezike, Ngozi/AAL-3075-2021	Mode, Nicolle/0000-0002-8193-0554	National Institute on Aging Intramural Research Program, National Institutes of Health [AG000513]; NATIONAL INSTITUTE ON AGING [ZIAAG000513, ZIAAG000199] Funding Source: NIH RePORTER	National Institute on Aging Intramural Research Program, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research is entirely supported by the National Institute on Aging Intramural Research Program, National Institutes of Health AG000513 (MKE). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandeen-Roche K, 2015, J GERONTOL A-BIOL, V70, P1427, DOI 10.1093/gerona/glv133; Bruyere O, 2017, AGING CLIN EXP RES, V29, P905, DOI 10.1007/s40520-017-0806-8; Ensrud KE, 2007, J GERONTOL A-BIOL, V62, P744, DOI 10.1093/gerona/62.7.744; Evans MK, 2010, ETHNIC DIS, V20, P267; Faber MJ, 2006, ARCH PHYS MED REHAB, V87, P885, DOI 10.1016/j.apmr.2006.04.005; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gardiner PA, 2015, J AM MED DIR ASSOC, V16, P781, DOI 10.1016/j.jamda.2015.05.005; Gnjidic D, 2012, CLIN PHARMACOL THER, V91, P521, DOI 10.1038/clpt.2011.258; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hahn RA, 1996, INT J HEALTH SERV, V26, P673, DOI 10.2190/967K-LC4F-DU66-W5P9; Hirsch C, 2006, ANN EPIDEMIOL, V16, P545, DOI 10.1016/j.annepidem.2005.10.003; Tarazona-Santabalbina FJ, 2016, J AM MED DIR ASSOC, V17, P426, DOI 10.1016/j.jamda.2016.01.019; Kehler DS, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0423-6; Lepkowski J., 2011, HANDLS PRINCIPLE CIT; Lopez D, 2012, J AM GERIATR SOC, V60, P171, DOI 10.1111/j.1532-5415.2011.03746.x; Malmstrom TK, 2014, J AM GERIATR SOC, V62, P721, DOI 10.1111/jgs.12735; Morley JE, 2012, J NUTR HEALTH AGING, V16, P601, DOI 10.1007/s12603-012-0084-2; National Center for Health Statistics, 2015, HLTH US 2014 SPEC FE; Ng TP, 2015, AM J MED, V128, P1225, DOI 10.1016/j.amjmed.2015.06.017; Organization WH, 2015, SUMM WORLD REP AG HL; Prado CM, 2015, CURR OPIN CLIN NUTR, V18, P535, DOI 10.1097/MCO.0000000000000216; R Core Team, 2013, R LANG ENV STAT COMP; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ravindrarajah R, 2013, ARCH GERONTOL GERIAT, V57, P360, DOI 10.1016/j.archger.2013.06.010; Rockwood K, 2011, CAN MED ASSOC J, V183, pE487, DOI 10.1503/cmaj.101271; Rosas-Carrasco O, 2016, J AM MED DIR ASSOC, V17, P1094, DOI 10.1016/j.jamda.2016.07.008; Santos-Eggimann B, 2009, J GERONTOL A-BIOL, V64, P675, DOI 10.1093/gerona/glp012; Susanto M, 2018, J AM MED DIR ASSOC, V19, P65, DOI 10.1016/j.jamda.2017.08.003; Szanton SL, 2010, J EPIDEMIOL COMMUN H, V64, P63, DOI 10.1136/jech.2008.078428; Theou O, 2013, J AM GERIATR SOC, V61, P1537, DOI 10.1111/jgs.12420; Van Kan GA, 2008, J NUTR HEALTH AGING, V12, P29, DOI 10.1007/BF02982161; van Kan GA, 2008, J AM MED DIR ASSOC, V9, P71, DOI 10.1016/j.jamda.2007.11.005; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Woo J, 2005, GERONTOLOGY, V51, P402, DOI 10.1159/000088705; Woo J, 2015, J AM MED DIR ASSOC, V16, P412, DOI 10.1016/j.jamda.2015.01.087; Woo J, 2012, J AM GERIATR SOC, V60, P1478, DOI 10.1111/j.1532-5415.2012.04074.x; Zonderman AB, 2016, JAMA INTERN MED, V176, P1394, DOI 10.1001/jamainternmed.2016.3649	37	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195637	10.1371/journal.pone.0195637	http://dx.doi.org/10.1371/journal.pone.0195637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC1EM	29634767	Green Submitted, gold, Green Published			2022-12-26	WOS:000429522200043
J	Scherer, U; Kuhnhardt, M; Schuett, W				Scherer, Ulrike; Kuhnhardt, Mira; Schuett, Wiebke			Predictability is attractive: Female preference for behaviourally consistent males but no preference for the level of male aggression in a bi-parental cichlid	PLOS ONE			English	Article							MATE CHOICE; INDIVIDUAL-DIFFERENCES; JAPANESE-QUAIL; FIGHTING MALES; PERSONALITY; BOLDNESS; FISH; EAVESDROP; SELECTION; ECOLOGY	Although personality traits can largely affect individual fitness we know little about the evolutionary forces generating and maintaining personality variation. Here, we investigated the hypothesis that personality variation in aggression is sexually selected in the monogamous, bi-parental cichlid Pelvicachromis pulcher. In this species, breeding pairs form territories and they aggressively defend their territory and offspring against con- and heterospecific intruders. In our mate choice study, we followed up two alternative hypotheses. We either expected females to show a directional preference for a high level and high consistency of aggression (potentially indicating mate choice for male parental quality). Alternatively, we expected females to choose males for (dis-)similarity in the level/consistency of aggression (potentially indicating mate choice for compatibility). Individual level and consistency of aggression were assessed for males and females using mirror tests. After eavesdropping on aggressive behaviour of two males (differing in level and consistency of aggression) females were then allowed to choose between the two males. Males, but not females, showed personality variation in aggression. Further, females generally preferred consistent over inconsistent males independent of their level of aggression. We did not detect a general preference for the level of male aggression. However, we found an above average preference for consistent high-aggression males; whereas female preference for inconsistent high-aggression did not deviate from random choice. Our results suggest behavioural consistency of aggression in male rainbow kribs is selected for via female mate choice. Further, our study underlines the importance of considering both the level and the consistency of a behavioural trait in studies of animal behaviour.	[Scherer, Ulrike; Kuhnhardt, Mira; Schuett, Wiebke] Univ Hamburg, Zool Inst, Bioctr Grindel, Hamburg, Germany; [Schuett, Wiebke] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Hamburg; University of Sussex	Scherer, U (corresponding author), Univ Hamburg, Zool Inst, Bioctr Grindel, Hamburg, Germany.	u.k.scherer@gmail.com	Scherer, Ulrike/AAC-8286-2020	Scherer, Ulrike/0000-0003-1086-8527; Schuett, Wiebke/0000-0002-4149-6095	DFG (Deutsche Forschungsgemeinschaft) [SCHU-2927/2-1]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This study was funded by DFG (Deutsche Forschungsgemeinschaft, http://www.dfg.de/), grant to W.S. (SCHU-2927/2-1).	Adriaenssens B, 2011, BEHAV ECOL, V22, P135, DOI 10.1093/beheco/arq185; Aquiloni L, 2008, CURR BIOL, V18, pR462, DOI 10.1016/j.cub.2008.04.006; Ariyomo TO, 2015, J FISH BIOL, V86, P1852, DOI 10.1111/jfb.12674; Ariyomo TO, 2012, ANIM BEHAV, V83, P41, DOI 10.1016/j.anbehav.2011.10.004; Ballew NG, 2017, AM NAT, V189, P396, DOI 10.1086/690909; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bierbach D, 2013, BEHAV ECOL SOCIOBIOL, V67, P675, DOI 10.1007/s00265-013-1487-8; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Bleu J, 2012, ANIM BEHAV, V83, P131, DOI 10.1016/j.anbehav.2011.10.017; Budaev SV, 1999, ANIM BEHAV, V58, P195, DOI 10.1006/anbe.1999.1124; Cain KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077816; Castellano S, 2011, J THEOR BIOL, V274, P161, DOI 10.1016/j.jtbi.2011.01.001; Chira A, 2014, ANN FOR RES, V57, P347; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Dechaume-Moncharmont FX, 2011, CR BIOL, V334, P906, DOI 10.1016/j.crvi.2011.08.004; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Doutrelant C, 2000, BEHAVIOUR, V137, P1655, DOI 10.1163/156853900502763; DUFTY AM, 1989, HORM BEHAV, V23, P185, DOI 10.1016/0018-506X(89)90059-7; Dugatkin LA, 1996, P NATL ACAD SCI USA, V93, P2770, DOI 10.1073/pnas.93.7.2770; Dyer JRG, 2009, BEHAV ECOL, V20, P165, DOI 10.1093/beheco/arn129; Fawcett TW, 2003, P ROY SOC B-BIOL SCI, V270, P1637, DOI 10.1098/rspb.2003.2328; GRANT JWA, 1990, CAN J FISH AQUAT SCI, V47, P915, DOI 10.1139/f90-105; Herb BM, 2003, BEHAVIOUR, V140, P71, DOI 10.1163/156853903763999908; Ioannou CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep33991; ITZKOWITZ M, 1984, BEHAVIOUR, V89, P251, DOI 10.1163/156853984X00407; Jaeger B, 2016, R2GLMM COMPUTES R SQ; Kralj-Fiser S, 2013, BEHAV ECOL, V24, P824, DOI 10.1093/beheco/art030; Laubu C, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501013; LAVERY RJ, 1994, ETHOLOGY, V97, P265; MacPhail RC, 2009, NEUROTOXICOLOGY, V30, P52, DOI 10.1016/j.neuro.2008.09.011; Makowicz AM, 2010, BEHAVIOUR, V147, P1657, DOI 10.1163/000579510X528206; McKaye KR, 2008, CARIBB J SCI, V44, P13; Montiglio PO, 2016, J ANIM ECOL, V85, P125, DOI 10.1111/1365-2656.12436; Mutzel A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1019; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nandy B, 2016, ANIM BEHAV, V114, P3, DOI 10.1016/j.anbehav.2016.01.019; Ophir AG, 2003, ANIM BEHAV, V66, P399, DOI 10.1006/anbe.2003.2230; Poschadel JR, 2009, ACTA ETHOL, V12, P55, DOI 10.1007/s10211-009-0055-8; Qvarnstrom A, 1998, TRENDS ECOL EVOL, V13, P498, DOI 10.1016/S0169-5347(98)01513-4; R Core Team, 2021, R LANGUAGE ENV STAT; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Royle NJ, 2010, BEHAV ECOL, V21, P1125, DOI 10.1093/beheco/arq156; Scherer U, 2017, ANIM BEHAV, V128, P117, DOI 10.1016/j.anbehav.2017.04.007; Scherer U, 2016, J FISH BIOL, V89, P1866, DOI 10.1111/jfb.13069; SCHLINGER BA, 1987, PHYSIOL BEHAV, V40, P343, DOI 10.1016/0031-9384(87)90057-6; SCHLUPP I, 1994, SCIENCE, V263, P373, DOI 10.1126/science.8278809; Schlupp I, 1999, BEHAVIOUR, V136, P519, DOI 10.1163/156853999501450; Schluter A, 1998, ANIM BEHAV, V56, P147, DOI 10.1006/anbe.1998.0762; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuett W, 2011, ETHOLOGY, V117, P908, DOI 10.1111/j.1439-0310.2011.01945.x; Schuett W, 2011, ANIM BEHAV, V81, P609, DOI 10.1016/j.anbehav.2010.12.006; Schuett W, 2010, J ETHOL, V28, P273, DOI 10.1007/s10164-009-0181-9; Schuett W, 2010, BIOL REV, V85, P217, DOI 10.1111/j.1469-185X.2009.00101.x; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; SMITH JM, 1988, PHILOS T ROY SOC B, V319, P557, DOI 10.1098/rstb.1988.0065; Spritzer MD, 2005, ANIM BEHAV, V69, P1121, DOI 10.1016/j.anbehav.2004.06.033; Stamps JA, 2012, ANIM BEHAV, V83, P1325, DOI 10.1016/j.anbehav.2012.02.017; Stoffel MA, 2017, RPTR REPEATABILITY E, P1639, DOI [10.1111/2041-210X.12797, DOI 10.1111/2041-210X.12797]; Teyssier A, 2014, BEHAV ECOL, V25, P723, DOI 10.1093/beheco/aru049; Thunken T, 2007, CURR BIOL, V17, P225, DOI 10.1016/j.cub.2006.11.053; Witte K, 2010, BEHAV ECOL, V21, P193, DOI 10.1093/beheco/arp154	62	8	8	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195766	10.1371/journal.pone.0195766	http://dx.doi.org/10.1371/journal.pone.0195766			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634757	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000429522200056
J	Sharma, A; Benbrook, DM; Woo, S				Sharma, Ankur; Benbrook, Doris Mangiaracina; Woo, Sukyung			Pharmacokinetics and interspecies scaling of a novel, orally-bioavailable anti-cancer drug, SHetA2	PLOS ONE			English	Article							RETINOIC ACID RECEPTOR; FLEXIBLE-HETEROAROTINOIDS; INDUCE APOPTOSIS; ANTITUMOR AGENT; CANCER; PREDICTION; CELLS; SUFFICIENT; METABOLISM; ABSORPTION	SHetA2 is a small molecule drug with promising cancer prevention and therapeutic activity and a high preclinical safety profile. The study objectives were to perform interspecies scaling and pharmacokinetic (PK) modeling of SHetA2 for human PK prediction. The PK data obtained from mice, rats, and dogs after intravenous and oral doses were used for simultaneous fitting to PK models. The disposition of SHetA2 was best described by a two-compartment model. The absorption kinetics was well characterized with a first-order absorption model for mice and rats, and a gastrointestinal transit model for dogs. Oral administration of SHetA2 showed a relatively fast absorption in mice, prolonged absorption (i.e., flip-flop kinetics) toward high doses in rats, and an early peak followed by a secondary peak at high doses in dogs. The oral bioavailability was 17.7-19.5% at 20-60 mg/kg doses in mice, <1.6% at 100-2000 mg/kg in rats, and 11.2% at 100 mg/kg decreasing to 3.45% at 400 mg/kg and 1.11% at 1500 mg/kg in dogs. The disposition parameters were well correlated with the body weight for all species using the allometric equation, which predicted values of CL (17.3 L/h), V-1(36.2 L/h), V-2 (68.5 L/h) and CLD (15.2 L/h) for a 70-kg human. The oral absorption rate and bioavailability of SHetA2 was highly dependent on species, doses, formulations, and possibly other factors. The limited bioavailability at high doses was taken into consideration for the suggested first-in-human dose, which was much lower than the dose estimated based on toxicology studies. In summary, the present study provided the PK model for SHetA2 that depicted the disposition and absorption kinetics in preclinical species, and computational tools for human PK prediction.	[Sharma, Ankur; Woo, Sukyung] Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Oklahoma City, OK 73190 USA; [Benbrook, Doris Mangiaracina] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Obstet & Gynecol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Woo, S (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Oklahoma City, OK 73190 USA.	sukyung-woo@ouhsc.edu		Benbrook, Doris/0000-0001-7606-8245; Woo, Sukyung/0000-0003-3932-7185	NCI PREVENT Program [N01-CN-43306]; non-confidential NCI PREVENT grant award "Flexible Heteroarotinoids for Chemoprevention"; NATIONAL CANCER INSTITUTE [R01CA196200] Funding Source: NIH RePORTER	NCI PREVENT Program; non-confidential NCI PREVENT grant award "Flexible Heteroarotinoids for Chemoprevention"; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The IV and oral PK data of SHetA2 in mice [13] and rats [11], and oral PK data in dogs [11] referenced during the study have been previously published. The IV PK data in dogs was extracted from a NCI PREVENT Program report (N01-CN-43306 Work assignment 21). The data was generated under a non-confidential NCI PREVENT grant award "Flexible Heteroarotinoids for Chemoprevention" to Dr. Benbrook and transferred to her under a Material Transfer Agreement between the NCI and the University of Oklahoma. The data was provided in a table as part of a final report "Fourteen Day Oral Range-Finding Study of SHetA2 in Dogs" prepared by Kasim K. Kabirov, M.D., Ph.D. Queries regarding this data should be sent to lyublmov@uic.edu. The authors do not have any special access privileges to this data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee AK, 2010, 49 ANN M SOC TOX MAR; Benbrook DM, 2005, INVEST NEW DRUG, V23, P417, DOI 10.1007/s10637-005-2901-5; Benbrook DM, 2014, INVEST NEW DRUG, V32, P412, DOI 10.1007/s10637-013-0041-x; Benbrook DM, 2013, CANCER PREV RES, V6, P908, DOI 10.1158/1940-6207.CAPR-13-0171; BOXENBAUM H, 1983, AM J PHYSIOL, V245, pR768, DOI 10.1152/ajpregu.1983.245.6.R768; BOXENBAUM H, 1982, J PHARMACOKINET BIOP, V10, P201, DOI 10.1007/BF01062336; Darwich AS, 2012, J PHARM PHARMACOL, V64, P1008, DOI 10.1111/j.2042-7158.2012.01538.x; DEDRICK RL, 1973, J PHARMACOKINET BIOP, V1, P435, DOI 10.1007/BF01059667; Doppalapudi RS, 2012, MUTAT RES-GEN TOX EN, V746, P78, DOI 10.1016/j.mrgentox.2012.03.009; FDA, 2005, EST MAX SAF START DO; FDA, 2006, GUID IND INV REV EXP; Feng MR, 2000, PHARM RES-DORDR, V17, P410, DOI 10.1023/A:1007520818956; Gabrielsson J., 2007, PHARMACOKINETIC PHAR, V4th; Gnanasekaran KK, 2015, EUR J MED CHEM, V96, P209, DOI 10.1016/j.ejmech.2015.03.070; Huang WL, 2009, AAPS J, V11, P217, DOI 10.1208/s12248-009-9098-z; Izumi T, 1996, J PHARMACOL EXP THER, V277, P1630; Kabirov KK, 2013, DRUG CHEM TOXICOL, V36, P284, DOI 10.3109/01480545.2012.710632; LIN JH, 1995, DRUG METAB DISPOS, V23, P1008; Liu SQ, 2004, J MED CHEM, V47, P999, DOI 10.1021/jm030346v; Liu TZ, 2007, MOL CANCER THER, V6, P1814, DOI 10.1158/1535-7163.MCT-06-0279; Liu TZ, 2009, MOL CANCER THER, V8, P1227, DOI 10.1158/1535-7163.MCT-08-1069; Liu ZF, 2008, RAPID COMMUN MASS SP, V22, P3371, DOI 10.1002/rcm.3744; Mahmood I, 1996, XENOBIOTICA, V26, P887, DOI 10.3109/00498259609052491; Masamha CP, 2009, CANCER RES, V69, P6565, DOI 10.1158/0008-5472.CAN-09-0913; Mic FA, 2003, P NATL ACAD SCI USA, V100, P7135, DOI 10.1073/pnas.1231422100; Mukai H, 1999, INT J PHARM, V186, P215, DOI 10.1016/S0378-5173(99)00184-2; NIMMO W S, 1976, Clinical Pharmacokinetics, V1, P189, DOI 10.2165/00003088-197601030-00002; Roberts MS, 2002, CLIN PHARMACOKINET, V41, P751, DOI 10.2165/00003088-200241100-00005; Sharma A, 2017, J PHARM TECHNOL DRUG, V6, P1; Vuppugalla R, 2011, J PHARM SCI-US, V100, P4111, DOI 10.1002/jps.22551; Wang YX, 1999, DRUG METAB DISPOS, V27, P855; Yanez JA, 2011, THER DELIV, V2, P643, DOI [10.4155/TDE.11.19, 10.4155/tde.11.19]; Yu LX, 1996, ADV DRUG DELIVER REV, V19, P359, DOI 10.1016/0169-409X(96)00009-9; Zhang YL, 2006, CANCER CHEMOTH PHARM, V58, P561, DOI 10.1007/s00280-006-0211-z	34	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0194046	10.1371/journal.pone.0194046	http://dx.doi.org/10.1371/journal.pone.0194046			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634717	gold, Green Submitted, Green Published			2022-12-26	WOS:000429522200006
J	Turcsan, B; Wallis, L; Viranyi, Z; Range, F; Muller, CA; Huber, L; Riemer, S				Turcsan, Borbala; Wallis, Lisa; Viranyi, Zsofia; Range, Friederike; Mueller, Corsin A.; Huber, Ludwig; Riemer, Stefanie			Personality traits in companion dogs-Results from the VIDOPET	PLOS ONE			English	Article							POTENTIAL GUIDE DOGS; GERMAN-SHEPHERD DOGS; SHELTER DOGS; TEMPERAMENT TEST; DOMESTIC DOGS; BEHAVIOR TEST; PREDICTIVE-VALIDITY; AGGRESSIVE-BEHAVIOR; STARTLING STIMULI; CANIS-FAMILIARIS	Individual behavioural differences in pet dogs are of great interest from a basic and applied research perspective. Most existing dog personality tests have specific (practical) goals in mind and so focused only on a limited aspect of dogs' personality, such as identifying problematic (aggressive or fearful) behaviours, assessing suitability as working dogs, or improving the results of adoption. Here we aimed to create a comprehensive test of personality in pet dogs that goes beyond traditional practical evaluations by exposing pet dogs to a range of situations they might encounter in everyday life. The Vienna Dog Personality Test (VIDO-PET) consists of 15 subtests and was performed on 217 pet dogs. A two-step data reduction procedure (principal component analysis on each subtest followed by an exploratory factor analysis on the subtest components) yielded five factors: Sociability-obedience, Activity-independence, Novelty seeking, Problem orientation, and Frustration tolerance. A comprehensive evaluation of reliability and validity measures demonstrated excellent inter- and intra-observer reliability and adequate internal consistency of all factors. Moreover the test showed good temporal consistency when re-testing a subsample of dogs after an average of 3.8 years a considerably longer test-retest interval than assessed for any other dog personality test, to our knowledge. The construct validity of the test was investigated by analysing the correlations between the results of video coding and video rating methods and the owners' assessment via a dog personality questionnaire. The results demonstrated good convergent as well as discriminant validity. To conclude, the VIDOPET is not only a highly reliable and valid tool for measuring dog personality, but also the first test to show consistent behavioural traits related to problem solving ability and frustration tolerance in pet dogs.	[Turcsan, Borbala; Wallis, Lisa; Viranyi, Zsofia; Range, Friederike; Mueller, Corsin A.; Huber, Ludwig; Riemer, Stefanie] Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Clever Dog Lab,Comparat Cognit, Vienna, Austria; [Turcsan, Borbala; Wallis, Lisa; Viranyi, Zsofia; Range, Friederike; Mueller, Corsin A.; Huber, Ludwig; Riemer, Stefanie] Univ Vienna, Vienna, Austria; [Turcsan, Borbala; Wallis, Lisa] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Turcsan, Borbala] Hungarian Acad Sci, Inst Cognit Neurosci & Psychol, Res Ctr Nat Sci, Budapest, Hungary; [Riemer, Stefanie] Univ Bern, Vetsuisse Fac, Div Anim Welf, Bern, Switzerland	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna; Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Bern	Turcsan, B (corresponding author), Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Clever Dog Lab,Comparat Cognit, Vienna, Austria.; Turcsan, B (corresponding author), Univ Vienna, Vienna, Austria.; Turcsan, B (corresponding author), Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary.; Turcsan, B (corresponding author), Hungarian Acad Sci, Inst Cognit Neurosci & Psychol, Res Ctr Nat Sci, Budapest, Hungary.	borbala.turcsan@gmail.com	Wallis, Lisa/GVS-6425-2022; Turcsán, Borbála/I-7983-2018	Wallis, Lisa/0000-0003-3931-3250; Turcsán, Borbála/0000-0002-0197-5243; Riemer, Stefanie/0000-0001-8008-5291; Range, Friederike/0000-0003-3127-5536	Austrian Science Fund (FWF) [P21418]; FWF DK CogCom Programme; FWF [P24840, 11271]; European Science Foundation CompCog Exchange Visit Grant [4089]; Osterreichischer Austauschdienst (OeAD) [74ou3]; Hungarian Academy of Sciences Post Doctorate Research Program; Vienna Science and Technology Fund (WWTF) [CS11-005]; WWTF [CS11-026]; European Research Council (ERC) under the European Union's Horizon research and innovation programme [680040]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); FWF DK CogCom Programme; FWF(Austrian Science Fund (FWF)); European Science Foundation CompCog Exchange Visit Grant; Osterreichischer Austauschdienst (OeAD); Hungarian Academy of Sciences Post Doctorate Research Program; Vienna Science and Technology Fund (WWTF); WWTF; European Research Council (ERC) under the European Union's Horizon research and innovation programme(European Research Council (ERC))	This research was supported by the Austrian Science Fund (FWF, www.fwf.ac.at) grant P21418 to L.H. and F.R.; FWF DK CogCom Programme to S.R.; FWF grant P24840 to F.R.; European Science Foundation (www.esf.org) CompCog Exchange Visit Grant (4089), the Osterreichischer Austauschdienst (OeAD, https://oead.at, project number: 74ou3) and the Hungarian Academy of Sciences Post Doctorate Research Program (http://mta.hu) to B.T.; Vienna Science and Technology Fund (WWTF, https//www.wwtf.at) grant CS11-005 to L.H.; and FWF grant 11271 and WWTF grant CS11-026 to Zs.V., and our sponsor Royal Canin. Finally, this project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (Grant Agreement No. 680040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher L, 2013, J VET BEHAV, V8, P431, DOI 10.1016/j.jveb.2013.08.004; Barnard S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149831; BEAUDET R, 1994, APPL ANIM BEHAV SCI, V40, P273, DOI 10.1016/0168-1591(94)90068-X; Berry A, 2013, J ALTERN COMPLEM MED, V19, P73, DOI 10.1089/acm.2011.0835; Bollen KS, 2008, APPL ANIM BEHAV SCI, V112, P120, DOI 10.1016/j.applanim.2007.07.007; Bram M, 2008, J VET BEHAV, V3, P152, DOI 10.1016/j.jveb.2008.04.001; Carmines EdwardG., 1979, RELIABILITY VALIDITY, P17; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Christensen E, 2007, APPL ANIM BEHAV SCI, V106, P85, DOI 10.1016/j.applanim.2006.07.002; Cimarelli G, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01979; De Palma C, 2005, BEHAVIOUR, V142, P1307, DOI 10.1163/156853905774539337; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Dowling-Guyer S, 2011, APPL ANIM BEHAV SCI, V130, P107, DOI 10.1016/j.applanim.2010.12.004; Foyer P, 2014, APPL ANIM BEHAV SCI, V155, P93, DOI 10.1016/j.applanim.2014.03.006; Fratkin JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054907; Gartner MC, 2015, PERS INDIV DIFFER, V75, P102, DOI 10.1016/j.paid.2014.10.042; GODDARD ME, 1985, BEHAV GENET, V15, P69, DOI 10.1007/BF01071933; GODDARD ME, 1986, APPL ANIM BEHAV SCI, V15, P247, DOI 10.1016/0168-1591(86)90095-X; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Gosling SD, 2003, J PERS SOC PSYCHOL, V85, P1161, DOI 10.1037/0022-3514.85.6.1161; Gosling SD, 2002, J RES PERS, V36, P607, DOI 10.1016/S0092-6566(02)00511-1; Harvey ND, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174261; Harvey ND, 2016, J VET BEHAV, V11, P65, DOI 10.1016/j.jveb.2015.09.005; Head E, 1997, PHYSIOL BEHAV, V62, P963, DOI 10.1016/S0031-9384(97)00198-4; Hejjas K, 2007, ANIM GENET, V38, P629, DOI 10.1111/j.1365-2052.2007.01657.x; Hejjas K, 2009, GENES BRAIN BEHAV, V8, P330, DOI 10.1111/j.1601-183X.2008.00475.x; Hennessy MB, 2001, APPL ANIM BEHAV SCI, V73, P217, DOI 10.1016/S0168-1591(01)00139-3; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Jones A.C., 2008, THESIS; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; Jones KE, 2004, JAVMA-J AM VET MED A, V225, P854, DOI 10.2460/javma.2004.225.854; King T, 2003, APPL ANIM BEHAV SCI, V82, P45, DOI 10.1016/S0168-1591(03)00040-6; King T, 2012, APPL ANIM BEHAV SCI, V137, P1, DOI 10.1016/j.applanim.2011.11.016; King T, 2009, APPL ANIM BEHAV SCI, V120, P84, DOI 10.1016/j.applanim.2009.04.011; Kis A, 2014, VET REC, V174, P196, DOI 10.1136/vr.101955; Kis A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083993; Kotrschal K, 2009, BEHAV PROCESS, V81, P383, DOI 10.1016/j.beproc.2009.04.001; Kubinyi E, 2015, ACTA BIOL HUNG, V66, P27, DOI 10.1556/ABiol.66.2015.1.3; Kubinyi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030271; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; Ley J, 2007, APPL ANIM BEHAV SCI, V104, P71, DOI 10.1016/j.applanim.2006.03.021; Ley JM, 2009, APPL ANIM BEHAV SCI, V116, P220, DOI 10.1016/j.applanim.2008.09.009; Lucidi P, 2005, APPL ANIM BEHAV SCI, V95, P103, DOI 10.1016/j.applanim.2005.04.006; Marinelli L, 2007, APPL ANIM BEHAV SCI, V108, P143, DOI 10.1016/j.applanim.2006.11.018; Meagher RK, 2009, APPL ANIM BEHAV SCI, V119, P1, DOI 10.1016/j.applanim.2009.02.026; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Mirko E, 2013, APPL ANIM BEHAV SCI, V149, P45, DOI 10.1016/j.applanim.2013.10.003; Mirko E, 2012, APPL ANIM BEHAV SCI, V138, P88, DOI 10.1016/j.applanim.2012.02.016; Mongillo P, 2015, J VET BEHAV, V10, P103, DOI 10.1016/j.jveb.2014.11.005; Muller CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147753; Netto WJ, 1997, APPL ANIM BEHAV SCI, V52, P243, DOI 10.1016/S0168-1591(96)01126-4; Nunnally J., 1967, PSYCHOMETRIC THEORY, V226, P6; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; Palestrini C, 2010, APPL ANIM BEHAV SCI, V124, P61, DOI 10.1016/j.applanim.2010.01.014; Palmer R, 2008, APPL ANIM BEHAV SCI, V109, P306, DOI 10.1016/j.applanim.2007.04.002; Posluns JA, 2017, APPL ANIM BEHAV SCI, V188, P68, DOI 10.1016/j.applanim.2016.12.013; Prato-Previde E, 2008, ANIM COGN, V11, P167, DOI 10.1007/s10071-007-0102-7; Range F, 2009, APPL ANIM BEHAV SCI, V120, P170, DOI 10.1016/j.applanim.2009.05.012; Rayment DJ, 2015, APPL ANIM BEHAV SCI, V163, P1, DOI 10.1016/j.applanim.2014.11.020; Riemer S, 2016, APPL ANIM BEHAV SCI, V180, P78, DOI 10.1016/j.applanim.2016.04.021; Riemer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101237; Riemer S, 2014, ANIM COGN, V17, P815, DOI 10.1007/s10071-013-0701-4; Rintala DH, 2008, J REHABIL RES DEV, V45, P489, DOI 10.1682/JRRD.2007.06.0094; Ruefenacht S, 2002, APPL ANIM BEHAV SCI, V79, P113, DOI 10.1016/S0168-1591(02)00134-X; Schosswender J., 2013, THESIS; Scott J., 1976, GUIDE DOGS BLIND THE, P39; Seksel K, 1999, APPL ANIM BEHAV SCI, V62, P335, DOI 10.1016/S0168-1591(98)00232-9; Sforzini E, 2009, J VET BEHAV, V4, P3, DOI 10.1016/j.jveb.2008.09.035; Sinn DL, 2010, APPL ANIM BEHAV SCI, V127, P51, DOI 10.1016/j.applanim.2010.08.007; Slabbert JM, 1999, APPL ANIM BEHAV SCI, V64, P269, DOI 10.1016/S0168-1591(99)00038-6; Strandberg E, 2005, LIVEST PROD SCI, V93, P33, DOI 10.1016/j.livprodsci.2004.11.004; Streiner DL, 2003, J PERS ASSESS, V80, P217, DOI 10.1207/S15327752JPA8003_01; Svartberg K, 2005, APPL ANIM BEHAV SCI, V91, P103, DOI 10.1016/j.applanim.2004.08.030; Svartberg K, 2005, ANIM BEHAV, V69, P283, DOI 10.1016/j.anbehav.2004.04.011; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P157, DOI 10.1016/S0168-1591(02)00120-X; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P133, DOI 10.1016/S0168-1591(02)00121-1; Svobodova I, 2008, APPL ANIM BEHAV SCI, V113, P139, DOI 10.1016/j.applanim.2007.09.010; Tabachnick B. G., 2001, USING MULTIVARIATE S; Taylor KD, 2006, J VET BEHAV, V1, P94, DOI 10.1016/j.jveb.2006.09.002; Valsecchi P, 2011, J VET BEHAV, V6, P161, DOI 10.1016/j.jveb.2011.01.002; Vas J, 2005, APPL ANIM BEHAV SCI, V94, P99, DOI 10.1016/j.applanim.2005.02.001; Vazire S., 2007, HDB RES METHODS PERS, P190; Wan M, 2013, ANIM GENET, V44, P717, DOI 10.1111/age.12058; Wemelsfelder F, 2004, ANIM WELFARE, V13, P261; Wilsson E, 1998, APPL ANIM BEHAV SCI, V58, P151, DOI 10.1016/S0168-1591(97)00093-2; Wilsson E, 2012, APPL ANIM BEHAV SCI, V141, P158, DOI 10.1016/j.applanim.2012.08.012; Zilcha-Mano S, 2012, J RES PERS, V46, P571, DOI 10.1016/j.jrp.2012.06.005	88	15	15	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195448	10.1371/journal.pone.0195448	http://dx.doi.org/10.1371/journal.pone.0195448			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC1EM	29634747	Green Published, gold, Green Submitted			2022-12-26	WOS:000429522200031
J	Vasquez-Suarez, A; Lobos-Gonzalez, F; Cronshaw, A; Sepulveda-Ugarte, J; Figueroa, M; Dagnino-Leone, J; Bunster, M; Martinez-Oyanedel, J				Vasquez-Suarez, Aleikar; Lobos-Gonzalez, Francisco; Cronshaw, Andrew; Sepulveda-Ugarte, Jose; Figueroa, Maximiliano; Dagnino-Leone, Jorge; Bunster, Marta; Martinez-Oyanedel, Jose			The gamma(33) subunit of R-phycoerythrin from Gracilaria chilensis has a typical double linked phycourobilin similar to y subunit	PLOS ONE			English	Article							BILIN ATTACHMENT SITES; C-PHYCOCYANIN; BETA-SUBUNITS; RED ALGAE; EVOLUTION; PROTEINS; LIGHT; PHYCOBILIPROTEINS; PHYCOBILISOMES; CYANOBACTERIA	Phycobilisomes (PBS) are accessory light harvesting protein complexes formed mainly by phycobiliproteins (PBPs). The PBPs absorb light that is efficiently transferred to Photosystems due to chromophores covalently bound to specific cysteine residues. Besides phycobiliproteins (PE), the PBS contains linker proteins responsible for assembly and stabilization of the whole complex and the tuning of energy transfer steps between chromophores. The linker (gamma(33)) from Gracilaria chilensis, is a chromophorylated rod linker associated to (alpha beta)(6) hexamers of R-phycoerythrin (R-PE). Its role in the energy transfer process is not clear yet. Structural studies as well as the composition and location of the chromophores are essential to understand their involvement in the energy transfer process in PBS. To achieve this, the coding gene of gamma(33) was cloned and sequenced. The sequence was analyzed by informatics tools, to obtain preliminary information which leaded the next experiments. The protein was purified from R-phycoerythrin, and the sequence confirmed by mass spectrometry. The coding sequence analysis revealed a protein of 318 aminoacid residues containing a chloroplastidial transit peptide (cTP) of 39 aminoacids at the N-terminus. The conservation of cysteines revealed possible chromophorylation sites. Using a and 13 R-PE subunits as spectroscopic probes in denaturation assays, we deduced a double bonded phycourobilin (PUB) on gamma(33) subunit that were confirmed between Cys62 and Cys73 (DL-PUB62/73) by mass spectrometry. The cysteines involved in the double link are located in a helical region, in a conformation that reminds the position of the DL-PUB50/61 in the beta subunit of R-PE. The position of single linked PUB at Cys(95) and a single linked PEB at Cys(172) were also confirmed. Spectroscopic studies show the presence of both types of chromophores and that there are not energy transfer by FRET among them.	[Vasquez-Suarez, Aleikar; Lobos-Gonzalez, Francisco; Sepulveda-Ugarte, Jose; Figueroa, Maximiliano; Dagnino-Leone, Jorge; Bunster, Marta; Martinez-Oyanedel, Jose] Univ Concepcion, Fac Ciencias Biol, Dept Bioquim & Biol Mol, Lab Biofis Mol, Concepcion, Chile; [Cronshaw, Andrew] Univ Edinburgh, Michael Swann Bldg,Kings Bldg, Edinburgh, Midlothian, Scotland	Universidad de Concepcion; University of Edinburgh	Bunster, M; Martinez-Oyanedel, J (corresponding author), Univ Concepcion, Fac Ciencias Biol, Dept Bioquim & Biol Mol, Lab Biofis Mol, Concepcion, Chile.	mbunster@udec.cl; jmartine@udec.cl			FONDECYT [113.0256]; VRID_UDEC [216.037.021-1.0]; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [63130071]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); VRID_UDEC; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by FONDECYT #113.0256; VRID_UDEC #216.037.021-1.0; and Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) #63130071 Beca Doctoral to AVS.	APT KE, 1993, J BIOL CHEM, V268, P16208; APT KE, 1995, J MOL BIOL, V248, P79, DOI 10.1006/jmbi.1995.0203; ARCIERO DM, 1988, J BIOL CHEM, V263, P18343; Barton C, 2010, MICRON, V47, P915; Biegert A, 2008, BIOINFORMATICS, V24, P807, DOI 10.1093/bioinformatics/btn039; Blot N, 2009, J BIOL CHEM, V284, P9290, DOI 10.1074/jbc.M809784200; Braiman MS, 1999, J PHYS CHEM B, V103, P4744, DOI 10.1021/jp983011b; Brawley SH, 2017, P NATL ACAD SCI USA, V114, pE6361, DOI 10.1073/pnas.1703088114; BRYANT DA, 1978, J BIOL CHEM, V253, P220; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Bunster M, 1997, BOL SOC CHIL QUIM, V42, P449; Chang WR, 1996, J MOL BIOL, DOI [10.1006/JMBI.1996.0547PMID:8876649, DOI 10.1006/JMBI.1996.0547PMID:8876649]; Collen J, 2013, P NATL ACAD SCI USA, V110, P5247, DOI 10.1073/pnas.1221259110; Contreras-Martel C, 2001, ACTA CRYSTALLOGR D, V57, P52, DOI 10.1107/S0907444900015274; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Figueroa M, 2012, PROTEIN SCI, V21, P1921, DOI 10.1002/pro.2176; GLAZER AN, 1985, ANNU REV BIOPHYS BIO, V14, P47, DOI 10.1146/annurev.biophys.14.1.47; Hu ZN, 2004, J APPL PHYCOL, V16, P161, DOI 10.1023/B:JAPH.0000048456.26639.1a; KLOTZ AV, 1985, J BIOL CHEM, V260, P4856; Liu LN, 2005, BBA-BIOENERGETICS, V1708, P133, DOI 10.1016/j.bbabio.2005.04.001; Martinez-Oyanedel J, 2004, BIOL RES, V37, P733, DOI 10.4067/S0716-97602004000500003; Mullineaux CW, 2008, PHOTOSYNTH RES, V95, P175, DOI 10.1007/s11120-007-9249-y; NAGY JO, 1985, J BIOL CHEM, V260, P4864; Pizarro SA, 2001, PHOTOCHEM PHOTOBIOL, V73, P556, DOI 10.1562/0031-8655(2001)073<0556:SSOTLH>2.0.CO;2; Ritter S, 1999, J STRUCT BIOL, V126, P86, DOI 10.1006/jsbi.1999.4106; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2742, DOI 10.1038/nprot.2006.481; Sepulveda-Ugarte J, 2011, J PHOTOCH PHOTOBIO A, V219, P211, DOI 10.1016/j.jphotochem.2011.02.012; van Montfort BA, 2002, J MASS SPECTROM, V37, P322, DOI 10.1002/jms.288; Wang LZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118553; Wang S, 2004, ACTA BOT SIN, V46, P1135; Yi ZW, 2005, FEBS LETT, V579, P3569, DOI 10.1016/j.febslet.2005.05.033; Zhang J, 2017, NATURE, V551, P57, DOI 10.1038/nature24278	34	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2018	13	4							e0195656	10.1371/journal.pone.0195656	http://dx.doi.org/10.1371/journal.pone.0195656			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC1EM	29634783	gold, Green Published, Green Submitted			2022-12-26	WOS:000429522200045
J	Hertz, U; Bahrami, B; Keramati, M				Hertz, Uri; Bahrami, Bahador; Keramati, Mehdi			Stochastic satisficing account of confidence in uncertain value-based decisions	PLOS ONE			English	Article							BANDIT PROBLEMS; HUMAN BRAIN; METACOGNITION; RISK; CHOICE; BIASES	Every day we make choices under uncertainty; choosing what route to work or which queue in a supermarket to take, for example. It is unclear how outcome variance, e.g. uncertainty about waiting time in a queue, affects decisions and confidence when outcome is stochastic and continuous. How does one evaluate and choose between an option with unreliable but high expected reward, and an option with more certain but lower expected reward? Here we used an experimental design where two choices' payoffs took continuous values, to examine the effect of outcome variance on decision and confidence. We found that our participants' probability of choosing the good (high expected reward) option decreased when the good or the bad options' payoffs were more variable. Their confidence ratings were affected by outcome variability, but only when choosing the good option. Unlike perceptual detection tasks, confidence ratings correlated only weakly with decisions' time, but correlated with the consistency of trial-by-trial choices. Inspired by the satisficing heuristic, we propose a "stochastic satisficing" (SSAT) model for evaluating options with continuous uncertain outcomes. In this model, options are evaluated by their probability of exceeding an acceptability threshold, and confidence reports scale with the chosen option's thus-defined satisficing probability. Participants' decisions were best explained by an expected reward model, while the SSAT model provided the best prediction of decision confidence. We further tested and verified the predictions of this model in a second experiment. Our model and experimental results generalize the models of metacognition from perceptual detection tasks to continuous-value based decisions. Finally, we discuss how the stochastic satisficing account of decision confidence serves psychological and social purposes associated with the evaluation, communication and justification of decision-making.	[Hertz, Uri] Univ Haifa, Informat Syst Dept, Haifa, Israel; [Hertz, Uri] Univ Haifa, Sch Polit Sci, Haifa, Israel; [Bahrami, Bahador] UCL, Inst Cognit Neurosci, London, England; [Bahrami, Bahador] Ludwig Maximilians Univ Munchen, Fac Psychol & Educ Sci, Munich, Germany; [Keramati, Mehdi] UCL, Gatsby Computat Neurosci Unit, London, England; [Keramati, Mehdi] UCL, Max Planck Ctr Computat Psychiat & Ageing Res, London, England	University of Haifa; University of Haifa; University of London; University College London; University of Munich; University of London; University College London; University of London; University College London	Hertz, U (corresponding author), Univ Haifa, Informat Syst Dept, Haifa, Israel.; Hertz, U (corresponding author), Univ Haifa, Sch Polit Sci, Haifa, Israel.	uhertz@is.haifa.ac.il	Hertz, Uri/AAA-4799-2020	Hertz, Uri/0000-0003-4852-3516	European Research Council [NeuroCoDec 309865]; John Templeton Foundation; Gatsby Charitable Foundation	European Research Council(European Research Council (ERC)European Commission); John Templeton Foundation; Gatsby Charitable Foundation	UH and BB are supported by the European Research Council (NeuroCoDec 309865). UH is also supported by the John Templeton Foundation. MK is supported by the Gatsby Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1979, MACROECONOMIC THEORY; Bang D, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170193; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Camerer Colin F, 2011, ADV BEHAV EC; Carpenter B, 2015, J STAT SOFTW; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; De Martino B, 2013, NAT NEUROSCI, V16, P105, DOI 10.1038/nn.3279; Erev I, 2005, PSYCHOL REV, V112, P912, DOI 10.1037/0033-295X.112.4.912; Fleming SM, 2016, PSYCHOL REV, V124, P1; Fleming SM, 2012, J NEUROSCI, V32, P6117, DOI 10.1523/JNEUROSCI.6489-11.2012; Fleming SM, 2010, SCIENCE, V329, P1541, DOI 10.1126/science.1191883; Glimcher PW, 2005, ANNU REV PSYCHOL, V56, P25, DOI 10.1146/annurev.psych.55.090902.141429; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kruschke J. K., 2015, DOING BAYESIAN DATA, V2nd, DOI 10.1016/B978-0-12-405888-0.00010-6; Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146; Lebreton M, 2009, NEURON, V64, P431, DOI 10.1016/j.neuron.2009.09.040; Lerner JS, 1999, PSYCHOL BULL, V125, P255, DOI 10.1037/0033-2909.125.2.255; Ma WJ, 2014, ANNU REV NEUROSCI, V37, P205, DOI 10.1146/annurev-neuro-071013-014017; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Meyniel F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004305; Navajas J, 2017, NAT HUM BEHAV, V1, P810, DOI 10.1038/s41562-017-0215-1; Navajas J, 2016, CURR OPIN BEHAV SCI, V11, P55, DOI 10.1016/j.cobeha.2016.05.005; Nicolle A, 2011, J NEUROSCI, V31, P3320, DOI 10.1523/JNEUROSCI.5615-10.2011; Niv Y, 2012, J NEUROSCI, V32, P551, DOI 10.1523/JNEUROSCI.5498-10.2012; Pouget A, 2016, NAT NEUROSCI, V19, P366, DOI 10.1038/nn.4240; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Reverdy P, 2017, IEEE T AUTOMAT CONTR, V62, P3788, DOI 10.1109/TAC.2016.2644380; Reverdy P, 2014, IEEE DECIS CONTR P, P5718, DOI 10.1109/CDC.2014.7040284; Reverdy PB, 2014, P IEEE, V102, P544, DOI 10.1109/JPROC.2014.2307024; Samuelson W, 1988, J RISK UNCERTAINTY, V1, P7, DOI 10.1007/BF00055564; Sanders JI, 2016, NEURON, V90, P499, DOI 10.1016/j.neuron.2016.03.025; Sani A, 2013, NIPS, P1; Shea N, 2014, TRENDS COGN SCI, V18, P186, DOI 10.1016/j.tics.2014.01.006; Simon H. A., 1982, MODELS BOUNDED RATIO; Simon H. A., 1997, ADM BEHAV STUDY DECI, V4th; SIMON HA, 1956, PSYCHOL REV, V63, P129, DOI 10.1037/h0042769; Sutton R.S., 2012, REINFORCEMENT LEARNI, V2nd; Symmonds M, 2011, NEUROIMAGE, V58, P1139, DOI 10.1016/j.neuroimage.2011.06.087; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Von Neumann J, 1966, THEORY GAMES EC BEHA; Watanabe S, 2010, J MACH LEARN RES, V11, P3571; WINTER SG, 1971, Q J ECON, V85, P237, DOI 10.2307/1880703; Winter SG, 2000, STRATEGIC MANAGE J, V21, P981, DOI 10.1002/1097-0266(200010/11)21:10/11<981::AID-SMJ125>3.0.CO;2-4; Yeung N, 2012, PHILOS T R SOC B, V367, P1310, DOI 10.1098/rstb.2011.0416	45	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 5	2018	13	4							e0195399	10.1371/journal.pone.0195399	http://dx.doi.org/10.1371/journal.pone.0195399			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GB6TQ	29621325	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000429206800075
J	Fabris, S; MacLean, DA				Fabris, Sergio; MacLean, David A.			Doxorubicin chemotherapy affects the intracellular and interstitial free amino acid pools in skeletal muscle	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; NITRIC-OXIDE; CANCER; CACHEXIA; METABOLISM; MECHANISMS; PATHWAYS; CELLS; CARDIOTOXICITY; ANTHRACYCLINES	Skeletal muscle (SM) health and integrity is dependent on the dynamic balance between protein synthesis and degradation, and central to this process is the availability of amino acids (AA) in the amino pool. While Doxorubicin (DOX) remains one of the most widely used chemotherapeutic agents for the treatment of solid and hematological malignancies, little is known of the effect of the drug on SM, particularly its effect on the availability of amino acids in the tissue. The purpose of this study was to examine the effect of DOX administration on vascular, interstitial and intracellular concentrations of AA in SM of the rat up to 8 days after the administration of a 1.5 or 4.5 mg/kg i.p. dose of DOX. In the plasma, total amino acids (TAA) were significantly increased compared to control where greater (P<0.05) concentrations were observed following the 1.5 mg/kg dose compared to the 4.5 mg/kg dose. Compared to control, the 1.5 mg/kg dose resulted in an increase (P<0.05) in interstitial TAA whereas the 4.5 mg/kg resulted in a sustained decrease (P<0.05). Intracellular TAA, essential amino acids (EAA) and branched-chain amino acids (BCAA) where significantly increased in each muscle group analyzed, following the 1.5 and 4.5 mg/kg doses compared to control. This study provides important insight into the amino acid response following DOX chemotherapy and presents a substantial foundation for future studies focused on reducing SM damage and recovery by targeting amino acid metabolism.	[Fabris, Sergio; MacLean, David A.] Laurentian Univ, Biomol Sci, Sudbury, ON, Canada; [MacLean, David A.] Northern Ontario Sch Med, Div Med Sci, Sudbury, ON, Canada; [MacLean, David A.] Northern Ontario Sch Med, Div Med Sci, Thunder Bay, ON, Canada	Laurentian University; Northern Ontario School of Medicine; Northern Ontario School of Medicine	Fabris, S (corresponding author), Laurentian Univ, Biomol Sci, Sudbury, ON, Canada.	fabris.sergo@gmail.com			Natural Sciences and Engineering Research Council of Canada (NSERC); Natural Sciences and Engineering Research Council	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC, http://www.nserc-crsng.gc.ca/index_eng.asp) to DAM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Dr. Pamela Chenard for her excellent technical assistance. This study was supported by the Natural Sciences and Engineering Research Council.	Ananieva Elitsa, 2015, World J Biol Chem, V6, P281, DOI 10.4331/wjbc.v6.i4.281; Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; Catania C, 2011, INT J OBESITY, V35, P751, DOI 10.1038/ijo.2010.208; Cole JT, 2015, NUTR HEALTH SER, P13, DOI 10.1007/978-1-4939-1923-9_2; de Lima EA, 2016, J CACHEXIA SARCOPENI, V7, P615, DOI 10.1002/jcsm.12104; DELGADO JMR, 1972, ARCH INT PHARMACOD T, V198, P9; Esper Dema Halasa, 2005, Nutr Clin Pract, V20, P369, DOI 10.1177/0115426505020004369; Fabris S, 2016, CELL BIOL TOXICOL, V32, P121, DOI 10.1007/s10565-016-9325-1; Fabris S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139070; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Fearon KCH, 2010, HPB, V12, P323, DOI 10.1111/j.1477-2574.2010.00178.x; FELIG P, 1973, METABOLISM, V22, P179, DOI 10.1016/0026-0495(73)90269-2; Graham TE, 2000, AM J PHYSIOL-ENDOC M, V278, pE83, DOI 10.1152/ajpendo.2000.278.1.E83; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Hall M N, 2008, Transplant Proc, V40, pS5, DOI 10.1016/j.transproceed.2008.10.009; HALL TR, 1993, J BIOL CHEM, V268, P3092; Holecek M, 2011, CURR NUTR FOOD SCI, V7, P50, DOI 10.2174/157340111794941139; Hyde R, 2003, BIOCHEM J, V373, P1, DOI 10.1042/BJ20030405; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; LEFRAK EA, 1973, CANCER-AM CANCER SOC, V32, P302, DOI 10.1002/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2; Leuenberger UA, 2008, EUR J APPL PHYSIOL, V102, P457, DOI 10.1007/s00421-007-0601-x; Lu Min, 2011, Genes Cancer, V2, P985, DOI 10.1177/1947601911436199; MacLean D, 1998, J APPL PHYSIOL, V85, P1583, DOI 10.1152/jappl.1998.85.4.1583; MACLEAN DA, 1994, AM J PHYSIOL-ENDOC M, V267, pE1010, DOI 10.1152/ajpendo.1994.267.6.E1010; MacLean DA, 1998, CIRCULATION, V98, P1990, DOI 10.1161/01.CIR.98.19.1990; MacLean DA, 2001, AM J PHYSIOL-HEART C, V280, pH546, DOI 10.1152/ajpheart.2001.280.2.H546; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; MOMPARLER RL, 1976, CANCER RES, V36, P2891; Narendrula R, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2197-1; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Norton LE, 2006, J NUTR, V136, p533S, DOI 10.1093/jn/136.2.533S; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Porporato PE, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.3; RUDERMAN NB, 1974, J BIOL CHEM, V249, P5500; RYAZANOV AG, 1989, FEBS LETT, V251, P187, DOI 10.1016/0014-5793(89)81452-8; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Taylor PM, 2014, AM J CLIN NUTR, V99, p223S, DOI 10.3945/ajcn.113.070086; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Vaughan VC, 2013, J CACHEXIA SARCOPENI, V4, P95, DOI 10.1007/s13539-012-0087-1; Wagenmakers AJM, 1998, ADV EXP MED BIOL, V441, P307; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; WEISS RB, 1992, SEMIN ONCOL, V19, P670; White-Gilbertson S, 2009, MOL ONCOL, V3, P402, DOI 10.1016/j.molonc.2009.05.003; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475	45	2	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195330	10.1371/journal.pone.0195330	http://dx.doi.org/10.1371/journal.pone.0195330			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617462	Green Submitted, Green Published, gold			2022-12-26	WOS:000429203800075
J	Gerzanich, V; Kwon, MS; Woo, SK; Ivanov, A; Simard, JM				Gerzanich, Volodymyr; Kwon, Min Seong; Woo, Seung Kyoon; Ivanov, Alexander; Simard, J. Marc			SUR1-TRPM4 channel activation and phasic secretion of MMP-9 induced by tPA in brain endothelial cells	PLOS ONE			English	Article							NONSELECTIVE CATION CHANNEL; NF-KAPPA-B; SULFONYLUREA RECEPTOR 1; OPERATED CA2+ ENTRY; HEMORRHAGIC TRANSFORMATION; TRPC3 CHANNELS; DEPENDENT MODULATION; REACTIVE ASTROCYTES; VASOGENIC EDEMA; ISCHEMIC-STROKE	Background Hemorrhagic transformation is a major complication of ischemic stroke, is linked to matrix metalloproteinase-9 (MMP-9), and is exacerbated by tissue plasminogen activator (tPA). Cerebral ischemia/reperfusion is characterized by SUR1-TRPM4 (sulfonylurea receptor 1 transient receptor potential melastatin 4) channel upregulation in microvascular endothelium. In humans and rodents with cerebral ischemia/reperfusion (I/R), the SUR1 antagonist, glibenclamide, reduces hemorrhagic transformation and plasma MMP-9, but the mechanism is unknown. We hypothesized that tPA induces protease activated receptor 1 (PAR1)mediated, Ca2+-dependent phasic secretion of MMP-9 from activated brain endothelium, and that SUR1-TRPM4 is required for this process. Methods Cerebral I/R, of 2 and 4 hours duration, respectively, was obtained using conventional middle cerebral artery occlusion. Immunolabeling was used to quantify p65 nuclear translocation. Murine and human brain endothelial cells (BEC) were studied in vitro, without and with NF-kappa B activation, using immunoblot, zymography and ELISA, patch clamp electrophysiology, and calcium imaging. Genetic and pharmacological manipulations were used to identify signaling pathways. Results Cerebral I/R caused prominent nuclear translocation of p65 in microvascular endothelium. NF-kappa B-activation of BEC caused de novo expression of SUR1-TRPM4 channels. In NF-kappa B activated BEC: (i) tPA caused opening of SUR1-TRPM4 channels in a plasmin-, PAR1-, TRPC3- and Ca2+-dependent manner; (ii) tPA caused PAR1-dependent secretion of MMP-9; (iii) tonic secretion of MMP-9 by activated BEC was not influenced by SUR1 inhibition; (iv) phasic secretion of MMP-9 induced by tPA or the PAR1-agonist, TFLLR, required functional SUR1-TRPM4 channels, with inhibition of SUR1 decreasing tPA-induced MMP-9 secretion. Conclusions tPA induces PAR1-mediated, SUR1-TRPM4-dependent, phasic secretion of MMP-9 from activated brain endothelium.	[Gerzanich, Volodymyr; Kwon, Min Seong; Woo, Seung Kyoon; Ivanov, Alexander; Simard, J. Marc] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Simard, JM (corresponding author), Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA.; Simard, JM (corresponding author), Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.; Simard, JM (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	msimard@som.umaryland.edu			National Heart, Lung, and Blood Institute [R01HL082517]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082517] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported National Heart, Lung, and Blood Institute, grant# R01HL082517. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral MD, 2007, J NEUROSCI, V27, P5179, DOI 10.1523/JNEUROSCI.5499-06.2007; Bartha K, 2000, J CEREBR BLOOD F MET, V20, P175, DOI 10.1097/00004647-200001000-00022; Boulay AC, 2015, JOVE-J VIS EXP, DOI 10.3791/53208; Bouron A, 2015, PFLUG ARCH EUR J PHY, V467, P1143, DOI 10.1007/s00424-014-1590-3; Brown RC, 2008, MICROCIRCULATION, V15, P359, DOI 10.1080/10739680701762656; Cameron M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155468; Carroll JE, 1998, MOL BRAIN RES, V56, P186, DOI 10.1016/S0169-328X(98)00045-X; Chang CJ, 2009, BIOCHEM BIOPH RES CO, V385, P241, DOI 10.1016/j.bbrc.2009.05.049; Chen MK, 2003, J NEUROSCI, V23, P8568; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; del Zoppo GJ, 2013, SEMIN THROMB HEMOST, V39, P856, DOI 10.1055/s-0033-1357490; Eishingdrelo Haifeng, 2013, Curr Chem Genom Transl Med, V7, P9, DOI 10.2174/2213988501307010009; Feine I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041633; Gonzales AL, 2010, AM J PHYSIOL-CELL PH, V299, pC1195, DOI 10.1152/ajpcell.00269.2010; Guetg N, 2010, P NATL ACAD SCI USA, V107, P13924, DOI 10.1073/pnas.1000909107; Guinamard R, 2014, BRIT J PHARMACOL, V171, P1600, DOI 10.1111/bph.12582; Guo SZ, 2010, CEREBROVASC DIS, V30, P290, DOI 10.1159/000319072; HAJJAR KA, 1986, J BIOL CHEM, V261, P1656; Harteneck C, 2011, CURR PHARM BIOTECHNO, V12, P35, DOI 10.2174/138920111793937943; Hill WD, 2001, BRAIN RES BULL, V55, P375, DOI 10.1016/S0361-9230(01)00503-2; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hosomi N, 2005, J CEREBR BLOOD F MET, V25, P959, DOI 10.1038/sj.jcbfm.9600086; Howard EF, 1998, NEUROSCI LETT, V248, P199, DOI 10.1016/S0304-3940(98)00239-0; Jickling GC, 2014, J CEREBR BLOOD F MET, V34, P185, DOI 10.1038/jcbfm.2013.203; Junge CE, 2003, P NATL ACAD SCI USA, V100, P13019, DOI 10.1073/pnas.2235594100; Kataoka H, 2003, BLOOD, V102, P3224, DOI 10.1182/blood-2003-04-1130; Kimberly WT, 2014, NEUROCRIT CARE, V20, P193, DOI 10.1007/s12028-013-9917-z; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Kochukov MY, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000913; Kunte H, 2012, ANN NEUROL, V72, P799, DOI 10.1002/ana.23680; Kurland DB, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0599-2; Lee M, 2012, STROKE, V43, P3189, DOI 10.1161/STROKEAHA.112.670604; Li J, 2011, CIRC RES, V108, P1190, DOI 10.1161/CIRCRESAHA.111.243352; Liu XS, 2006, J CEREBR BLOOD F MET, V26, P787, DOI 10.1038/sj.jcbfm.9600227; Liu XY, 2009, NEURON, V61, P425, DOI 10.1016/j.neuron.2008.12.015; Lopez-Atalaya JP, 2008, J CEREBR BLOOD F MET, V28, P1212, DOI 10.1038/jcbfm.2008.14; Lu HQ, 2009, J BIOL CHEM, V284, P11100, DOI 10.1074/jbc.M806956200; Machida T, 2017, NEUROSCIENCE, V350, P146, DOI 10.1016/j.neuroscience.2017.03.026; Maryanoff Bruce E., 2003, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V1, P13, DOI 10.2174/1568016033356724; Matsuguchi T, 2000, BLOOD, V95, P1378, DOI 10.1182/blood.V95.4.1378.004k08_1378_1385; Mccoy KL, 2010, MOL PHARMACOL, V77, P1005, DOI 10.1124/mol.109.062018; Mehta RI, 2015, J NEUROPATH EXP NEUR, V74, P835, DOI 10.1097/NEN.0000000000000223; Morita H, 2007, J PHARMACOL SCI, V103, P417, DOI 10.1254/jphs.FP0061332; Moshal KS, 2006, AM J PHYSIOL-HEART C, V291, pH2825, DOI 10.1152/ajpheart.00377.2006; Moshal KS, 2006, AM J PHYSIOL-CELL PH, V290, pC883, DOI 10.1152/ajpcell.00359.2005; Mosnier LO, 2012, BLOOD, V120, P5237, DOI 10.1182/blood-2012-08-452169; Niego B, 2014, J CEREBR BLOOD F MET, V34, P1283, DOI 10.1038/jcbfm.2014.99; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2005, J BIOL CHEM, V280, P22899, DOI 10.1074/jbc.M501686200; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Park JY, 2008, BIOCHEM BIOPH RES CO, V368, P677, DOI 10.1016/j.bbrc.2008.01.153; Rajagopal S, 2017, CELL SIGNAL, V41, P9, DOI 10.1016/j.cellsig.2017.01.024; Rajput PS, 2014, NEUROSCIENCE; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Rosell A, 2008, STROKE, V39, P1121, DOI 10.1161/STROKEAHA.107.500868; Schleifer H, 2012, BRIT J PHARMACOL, V167, P1712, DOI 10.1111/j.1476-5381.2012.02126.x; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; Sheth KN, 2016, LANCET NEUROL, V15, P1160, DOI 10.1016/S1474-4422(16)30196-X; Simard JM, 2007, BBA-MOL BASIS DIS, V1772, P947, DOI 10.1016/j.bbadis.2007.03.004; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Simard JM, 2012, ANN NY ACAD SCI, V1268, P95, DOI 10.1111/j.1749-6632.2012.06705.x; Simard JM, 2012, J CEREBR BLOOD F MET, V32, P1699, DOI 10.1038/jcbfm.2012.91; Simard JM, 2012, TRANSL STROKE RES, V3, P286, DOI 10.1007/s12975-012-0149-x; Simard JM, 2009, J CEREBR BLOOD F MET, V29, P317, DOI 10.1038/jcbfm.2008.120; Simard JM, 2009, STROKE, V40, P604, DOI 10.1161/STROKEAHA.108.522409; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Soto AG, 2015, P NATL ACAD SCI USA, V112, pE3600, DOI 10.1073/pnas.1508838112; Sundivakkam PC, 2013, J BIOL CHEM, V288, P17030, DOI 10.1074/jbc.M112.411272; Syrovets T, 2012, J LEUKOCYTE BIOL, V92, P509, DOI 10.1189/jlb.0212056; Turner RJ, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00056; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vennekens R., 2007, V179, P269; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Wardlaw JM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub3; Woo SK, 2013, J BIOL CHEM, V288, P3655, DOI 10.1074/jbc.M112.428219; Woo SK, 2012, J CEREBR BLOOD F MET, V32, P525, DOI 10.1038/jcbfm.2011.159; Woo SK, 2002, MOL CELL BIOL, V22, P5753, DOI 10.1128/MCB.22.16.5753-5760.2002; Yang Z, 2017, MOL PHARMACOL, V92, P201, DOI 10.1124/mol.116.107839; Yepes M, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00304, 10.3389/fncel.2015.00304]; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200; Zlokovic BV, 2011, TRENDS NEUROSCI, V34, P198, DOI 10.1016/j.tins.2011.01.005	81	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195526	10.1371/journal.pone.0195526	http://dx.doi.org/10.1371/journal.pone.0195526			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617457	gold, Green Submitted, Green Published			2022-12-26	WOS:000429203800091
J	Spergser, J; Loncaric, I; Tichy, A; Fritz, J; Scope, A				Spergser, Joachim; Loncaric, Igor; Tichy, Alexander; Fritz, Johannes; Scope, Alexandra			The cultivable autochthonous microbiota of the critically endangered Northern bald ibis (Geronticus eremita)	PLOS ONE			English	Article							INTESTINAL BACTERIAL COMMUNITY; ESCHERICHIA-COLI; GASTROINTESTINAL MICROBIOTA; INTERSPECIFIC VARIATIONS; FECAL MICROBIOTA; GUT MICROBIOTA; BIRD AGE; DIVERSITY; WILD; PREVALENCE	The critically endangered Northern bald ibis (Geronticus eremita) is a migratory bird that became extinct in Europe centuries ago. Since 2014, the Northern bald ibis is subject to an intensive rehabilitation and conservation regime aiming to reintroduce the bird in its original distribution range in Central Europe and concurrently to maintain bird health and increase population size. Hitherto, virtually nothing is known about the microbial communities associated with the ibis species; an information pivotal for the veterinary management of these birds. Hence, the present study was conducted to provide a baseline description of the cultivable microbiota residing in the Northern bald ibis. Samples derived from the choana, trachea, crop and cloaca were examined employing a culturomic approach in order to identify microbes at each sampling site and to compare their frequency among age classes, seasonal appearances and rearing types. In total, 94 microbial species including 14 potentially new bacterial taxa were cultivated from the Northern bald ibis with 36, 58 and 59 bacterial species isolated from the choana, crop and cloaca, respectively. The microbiota of the Northern bald ibis was dominated by members of the phylum Firmicutes, followed by Proteobacteria, Actinobacteria, Bacteroidetes and Fusobacteria, altogether phylotypes commonly observed within avian gut environments. Differences in relative abundances of various microbial taxa were evident among sample types indicating mucosa-specific colonisation properties and tissue tropism. Besides, results of the present study indicate that the composition of microbiota was also affected by age, season (environment) and rearing type. While the prevalence of traditional pathogenic microbial species was extremely low, several opportunists including Clostridium perfringens toxotype A were frequently present in samples indicating that the Northern bald ibis may represent an important animal reservoir for these pathogens. In summary, the presented study provides a first inventory of the cultivable microbiota residing in the critically endangered Northern bald ibis and represents a first step in a wider investigation of the ibis microbiome with the ultimate goal to contribute to the management and survival of this critically endangered bird.	[Spergser, Joachim; Loncaric, Igor] Univ Vet Med, Dept Pathobiol, Inst Microbiol, Vienna, Austria; [Tichy, Alexander] Univ Vet Med, Dept Biomed Sci, Bioinformat & Biostat Platform, Vienna, Austria; [Fritz, Johannes] Waldrappteam, Mutters, Austria; [Scope, Alexandra] Univ Vet Med, Clin Unit Internal Med Small Anim, Dept Compan Anim & Horses, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Spergser, J (corresponding author), Univ Vet Med, Dept Pathobiol, Inst Microbiol, Vienna, Austria.	Joachim.Spergser@vetmeduni.ac.at		Fritz, Johannes/0000-0003-4691-2892	European Union [LIFE+12-BIO_AT_000143]	European Union(European Commission)	The reintroduction project runs with 50 % contribution of the LIFE financial instrument of the European Union (LIFE+12-BIO_AT_000143, LIFE Northern Bald Ibis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Baele M, 2001, J APPL MICROBIOL, V91, P488, DOI 10.1046/j.1365-2672.2001.01407.x; Banks JC, 2009, ENVIRON MICROBIOL, V11, P577, DOI 10.1111/j.1462-2920.2008.01816.x; Bennett DC, 2013, VET MICROBIOL, V166, P304, DOI 10.1016/j.vetmic.2013.05.018; Benskin CMH, 2009, BIOL REV, V84, P349, DOI 10.1111/j.1469-185X.2008.00076.x; Bisgaard M, 2005, 14 WORLD VET POULTR, P110; Bittar F, 2014, SCI REP-UK, V4, DOI 10.1038/srep07174; Blanco G, 2006, J APPL ECOL, V43, P990, DOI 10.1111/j.1365-2664.2006.01200.x; Bottacini F, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S4; Braconaro P, 2015, MICROB PATHOGENESIS, V88, P65, DOI 10.1016/j.micpath.2015.08.006; BRITTINGHAM MC, 1988, J WILDLIFE DIS, V24, P299, DOI 10.7589/0090-3558-24.2.299; Casado E, 2002, COMP BIOCHEM PHYS A, V131, P233, DOI 10.1016/S1095-6433(01)00483-4; Christman J, 2008, ROUT STUD CONTEMP PH, V14, P146; Dec M, 2014, RES MICROBIOL, V165, P190, DOI 10.1016/j.resmic.2014.02.003; Deem S. L., 2007, International Zoo Yearbook, V41, P3, DOI 10.1111/j.1748-1090.2007.00020.x; Deem SL, 2001, CONSERV BIOL, V15, P1224, DOI 10.1046/j.1523-1739.2001.00336.x; Dewar ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099996; Dewar ML, 2014, FEMS MICROBIOL ECOL, V89, P47, DOI 10.1111/1574-6941.12332; Dewar ML, 2013, MICROBIOLOGYOPEN, V2, P195, DOI 10.1002/mbo3.66; Diaz-Sanchez S, 2012, EUR J WILDLIFE RES, V58, P99, DOI 10.1007/s10344-011-0547-5; Eisenberg T, 2016, VIRULENCE, V7, P630, DOI 10.1080/21505594.2016.1177694; Fritz J., 2017, International Zoo Yearbook, V51, P107, DOI 10.1111/izy.12163; Glunder G, 2002, DEUT TIERARZTL WOCH, V109, P266; Godoy-Vitorino F, 2008, APPL ENVIRON MICROB, V74, P5905, DOI 10.1128/AEM.00574-08; Godoy-Vitorino F, 2010, ISME J, V4, P611, DOI 10.1038/ismej.2009.147; Gomez G, 2011, J COMP PATHOL, V144, P219, DOI 10.1016/j.jcpa.2010.08.007; Gong J, 2008, J APPL MICROBIOL, V104, P1372, DOI 10.1111/j.1365-2672.2007.03699.x; Gonzalez-Braojos S, 2012, J ORNITHOL, V153, P181, DOI 10.1007/s10336-011-0725-y; Goossens E, 2017, VET RES, V48, DOI 10.1186/s13567-017-0413-x; Grady EN, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0603-7; Hammons S, 2010, SYST APPL MICROBIOL, V33, P275, DOI 10.1016/j.syapm.2010.04.003; Hansen DL, 2009, APPL ENVIRON MICROB, V75, P1546, DOI 10.1128/AEM.00444-08; Jost BH, 2005, INFECT IMMUN, V73, P652, DOI 10.1128/IAI.73.1.652-656.2005; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Keyburn AL, 2010, VET RES, V41, DOI 10.1051/vetres/2009069; Klomp JE, 2008, J AVIAN BIOL, V39, P530, DOI 10.1111/j.0908-8857.2008.04333.x; Kohl KD, 2012, J COMP PHYSIOL B, V182, P591, DOI 10.1007/s00360-012-0645-z; KUMERLOEVE H, 1984, BIOL CONSERV, V30, P363, DOI 10.1016/0006-3207(84)90053-3; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lombardo MP, 1996, CONDOR, V98, P167, DOI 10.2307/1369521; Lu JR, 2008, APPL ENVIRON MICROB, V74, P3969, DOI 10.1128/AEM.00019-08; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Macfarlane GT, 2009, DIGEST DIS, V27, P90, DOI 10.1159/000268127; Mead Geoffrey C., 1997, P216; Meng XL, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.137; Muller D, 2007, APPL ENVIRON MICROB, V73, P3380, DOI 10.1128/AEM.02855-06; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Roggenbuck M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6498; Ryu H, 2012, APPL ENVIRON MICROB, V78, P4338, DOI 10.1128/AEM.07923-11; Saidenberg A. B. S., 2005, Ciencia Veterinaria nos Tropicos, V8, P16; Santos SS, 2012, FEMS MICROBIOL ECOL, V82, P63, DOI 10.1111/j.1574-6941.2012.01407.x; Schmidt-Ukaj S, 2014, VET DERMATOL, V25, P555, DOI 10.1111/vde.12146; Scupham AJ, 2007, FEMS MICROBIOL ECOL, V60, P136, DOI 10.1111/j.1574-6941.2006.00245.x; Shin SJ, 2010, J CLIN MICROBIOL, V48, P4057, DOI 10.1128/JCM.00904-10; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Stackebrandt E., 2006, MICROBIOL TODAY, V33, P152; Stanley D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084290; Su HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099826; Taverniti V, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00392; Tel OY, 2013, J ZOO WILDLIFE MED, V44, P21, DOI 10.1638/1042-7260-44.1.21; van der Wielen PWJJ, 2002, MICROBIAL ECOL, V44, P286, DOI 10.1007/s00248-002-2015-y; van Dongen WFD, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-11; Waite DW, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00223; Waite DW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00673; Waite DW, 2014, APPL ENVIRON MICROB, V80, P4650, DOI 10.1128/AEM.00975-14; Waite DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035803; Walter J, 2008, APPL ENVIRON MICROB, V74, P4985, DOI 10.1128/AEM.00753-08; Welchman DD, 2013, AVIAN PATHOL, V42, P171, DOI 10.1080/03079457.2013.778387; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xenoulis PG, 2010, VET MICROBIOL, V146, P320, DOI 10.1016/j.vetmic.2010.05.024; Yoo HS, 1997, J CLIN MICROBIOL, V35, P228, DOI 10.1128/JCM.35.1.228-232.1997; Yoon SH, 2017, INT J SYST EVOL MICR, V67, P1613, DOI 10.1099/ijsem.0.001755; Zoetendal EG, 2004, J NUTR, V134, P465, DOI 10.1093/jn/134.2.465	73	10	11	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2018	13	4							e0195255	10.1371/journal.pone.0195255	http://dx.doi.org/10.1371/journal.pone.0195255			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB6SR	29617453	gold, Green Published			2022-12-26	WOS:000429203800070
J	Martell, L; Bracale, R; Carrion, SA; Purcell, JE; Lezzi, M; Gravili, C; Piraino, S; Boero, F				Martell, Luis; Bracale, Roberta; Carrion, Steven A.; Purcell, Jennifer E.; Lezzi, Marco; Gravili, Cinzia; Piraino, Stefano; Boero, Ferdinando			Successional dynamics of marine fouling hydroids (Cnidaria: Hydrozoa) at a finfish aquaculture facility in the Mediterranean Sea	PLOS ONE			English	Article							BIOFOULING COMMUNITIES; PINCTADA-FUCATA; ASSEMBLAGES; PATTERNS; SEASONALITY; VARIABILITY; MARICULTURE; MECHANISMS; STABILITY; JELLYFISH	Aquaculture is increasing rapidly to meet global seafood demand. Some hydroid populations have been linked to mortality and health issues in finfish and shellfish, but their dynamics in and around aquaculture farms remain understudied. In the present work, two experiments, each with 36 panels, tested colonization (factors: depth, season of immersion) and succession (factors: depth, submersion duration) over one year. Hydroid surface cover was estimated for each species, and data were analyzed with multivariate techniques. The assemblage of hydrozoans was species-poor, although species richness, frequency and abundance increased with time, paralleling the overall increase in structural complexity of fouling assemblages. Submersion duration and season of immersion were particularly important in determining the species composition of the assemblages in the succession and colonization experiments, respectively. Production of water-borne propagules, including medusae, from the hydroids was observed from locally abundant colonies, among them the well-known fouling species Obelia dichotoma, potentially representing a nuisance for cultured fish through contact-driven envenomations and gill disorders. The results illustrate the potential importance of fouling hydroids and their medusae to the health of organisms in the aquaculture industry.	[Martell, Luis] Univ Bergen, Univ Museum Bergen, Dept Nat Hist, Bergen, Norway; [Martell, Luis; Bracale, Roberta; Lezzi, Marco; Gravili, Cinzia; Piraino, Stefano; Boero, Ferdinando] Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali, Lecce, Italy; [Carrion, Steven A.] Univ Cent Florida, Orlando, FL 32816 USA; [Purcell, Jennifer E.] Western Washington Univ, Bellingham, WA 98225 USA; [Gravili, Cinzia; Piraino, Stefano; Boero, Ferdinando] Consorzio Nazl Interuniv Sci Mare, CoNISMa, Rome, Italy; [Boero, Ferdinando] UO Genova, CNR ISMAR, Ist Sci Marine, CNR, Genoa, Italy	University of Bergen; University of Salento; State University System of Florida; University of Central Florida; Western Washington University; CoNISMa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Martell, L (corresponding author), Univ Bergen, Univ Museum Bergen, Dept Nat Hist, Bergen, Norway.; Martell, L (corresponding author), Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali, Lecce, Italy.	luisfmartell@gmail.com	Gravili, Cinzia/ABB-4127-2020; Piraino, Stefano/J-5234-2012; lezzi, marco/AAA-5969-2020	Gravili, Cinzia/0000-0001-8412-4390; Piraino, Stefano/0000-0002-8752-9390; lezzi, marco/0000-0002-6888-7790; Martell, Luis/0000-0002-7062-8915; Boero, Ferdinando/0000-0002-6317-2710	National Council of Science and Technology of Mexico (CONACyT, Mexico) [312520]; Ronald E. McNair Post baccalaureate Achievement Program (Department of Education, U. S. A.) [P217A120229]	National Council of Science and Technology of Mexico (CONACyT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ronald E. McNair Post baccalaureate Achievement Program (Department of Education, U. S. A.)	This work was supported by grants from the National Council of Science and Technology of Mexico (CONACyT, Mexico) [312520 to LM], and the Ronald E. McNair Post baccalaureate Achievement Program (Department of Education, U. S. A.) [P217A120229 to SAC]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ANDERSON MJ, 1994, J EXP MAR BIOL ECOL, V184, P217, DOI 10.1016/0022-0981(94)90006-X; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Antoniadou C, 2014, MAR ECOL-EVOL PERSP, V35, P281, DOI 10.1111/maec.12079; Antoniadou C, 2013, J MAR BIOL ASSOC UK, V93, P1593, DOI 10.1017/S0025315412001932; Bavestrello G, 2006, CHEM ECOL, V22, P197, DOI 10.1080/02757540600670810; Baxter EJ, 2011, AQUACULT ENV INTERAC, V1, P245, DOI 10.3354/aei00024; BENEDETTICECCHI L, 1993, J EXP MAR BIOL ECOL, V169, P15, DOI 10.1016/0022-0981(93)90040-U; Bloecher N, 2013, AQUACULTURE, V416, P302, DOI 10.1016/j.aquaculture.2013.09.025; BOERO F, 1984, MAR ECOL-P S Z N I, V5, P93, DOI 10.1111/j.1439-0485.1984.tb00310.x; Bosch-Belmar M, 2016, THESIS; Bosch-Belmar M, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00240; Bouillon J, 2004, SCI MAR, V68, P5, DOI 10.3989/scimar.2004.68s25; Bouillon Jean, 2006, Memoires du Museum National d'Histoire Naturelle, V194, P1; Braithwaite RA, 2005, ADV MAR BIOL, V47, P215; BREITBURG DL, 1985, OECOLOGIA, V65, P173, DOI 10.1007/BF00379215; CALDER DR, 1990, CAN J ZOOL, V68, P442, DOI 10.1139/z90-065; Cardellicchio N, 2016, ENVIRON SCI POLLUT R, V23, P12495, DOI 10.1007/s11356-015-4924-6; Caroppo C, 2012, ECOL SOC, V17, DOI [10.5751/ES-04543-170110, 10.5751/ES-04950-170310]; Chaplygina SF, 1994, RUSS J MAR BIOL, V19, P85; CLAEREBOUDT MR, 1994, AQUACULTURE, V121, P327, DOI 10.1016/0044-8486(94)90268-2; Clarke K.R., 2006, PRIMER VERSION 6 USE; Coma R, 2000, TRENDS ECOL EVOL, V15, P448, DOI 10.1016/S0169-5347(00)01970-4; Coma Rafael, 1992, Scientia Marina, V56, P161; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Cook EJ, 2006, ICES J MAR SCI, V63, P637, DOI 10.1016/j.icesjms.2005.12.007; Cowie P. R., 2010, BIOFOULING, P87, DOI DOI 10.1002/9781444315462.CH6; Dabo KK, 1979, P INT WORKSH PEN CAG, P118; de Nys R, 2009, WOODHEAD PUBL MATER, P177, DOI 10.1533/9781845696313.1.177; Briz LMD, 2012, HYDROBIOLOGIA, V690, P215, DOI 10.1007/s10750-012-1040-1; Durr S., 2010, BIOFOULING, P267, DOI DOI 10.1002/9781444315462.CH19; Edwards CD, 2015, AQUAC RES, V46, P2225, DOI 10.1111/are.12380; FAO, 2019, STATE WORLD FISHERIE; Martell-Hernandez LF, 2011, J PARASITOL, V97, P68, DOI 10.1645/GE-2384.1; Ferguson HW, 2010, J VET DIAGN INVEST, V22, P376, DOI 10.1177/104063871002200305; Fitridge I, 2013, BIOFOULING, V29, P119, DOI 10.1080/08927014.2012.752465; Fitridge I, 2012, BIOFOULING, V28, P649, DOI 10.1080/08927014.2012.700478; Genzano G, 2008, LAT AM J AQUAT RES, V36, P301, DOI [10.3856/vol36-issue2-fulltext-11, 10.4067/S0718-560X2008000200011]; Gili JM, 1995, OCEANOGR MAR BIOL, V33, P351; Gravier-Bonnet N, 2005, INVERTEBR REPROD DEV, V48, P63, DOI 10.1080/07924259.2005.9652171; Gravili C, 2015, ZOOTAXA, V3908, P1, DOI 10.11646/zootaxa.3908.1.1; Guenther J, 2006, BIOFOULING, V22, P163, DOI 10.1080/08927010600691929; Guenther J, 2006, AQUACULTURE, V253, P366, DOI 10.1016/j.aquaculture.2005.08.003; Guenther J, 2011, BIOFOULING, V27, P1033, DOI 10.1080/08927014.2011.627092; Guenther J, 2010, AQUACULTURE, V300, P120, DOI 10.1016/j.aquaculture.2010.01.005; Guenther J, 2009, AQUACULTURE, V292, P252, DOI 10.1016/j.aquaculture.2009.04.018; Havenhand JN, 2010, BIOFOULING, P1; Hodson SL, 2000, AQUACULTURE, V184, P277, DOI 10.1016/S0044-8486(99)00328-2; Huve P, 1955, B I OCEANOGR MONACO, V52, P1; Istituto Idrografico della Marina, 2002, CART NAUT UFF STAT; Jara VC, 2006, MAR ECOL PROG SER, V308, P37, DOI 10.3354/meps308037; Jenkins S.R., 2010, BIOFOULING, V456, P60, DOI [10.1002/9781444315462.ch4, DOI 10.1002/9781444315462.CH4]; Khalaman V.V., 2001, RUSS J MAR BIOL+, V27, P345, DOI [DOI 10.1023/A:1013751403059, 10.1023/A:1013751403059]; Lacoste E, 2015, REV AQUACULT, V7, P187, DOI 10.1111/raq.12063; Lane A., 2004, FISH FARMING INT, V44, P34; LAWLER AR, 1978, GULF RES REP, V6, P177; Lin HJ, 2002, ZOOL STUD, V41, P170; LOGAN A, 1984, ESTUAR COAST SHELF S, V18, P571, DOI 10.1016/0272-7714(84)90091-X; Mattei N, 1997, NOAA TECHNICAL REPOR, V129, P201; Megina C, 2013, MAR BIOL, V160, P371, DOI 10.1007/s00227-012-2094-3; Montanari M, 1977, ATT 9 C SOC IT BIOL, P293; Morri C., 1980, Atti della Societa Toscana di Scienze Naturali Residente in Pisa Memorie Serie B, V86, P305; MORRI C, 1980, Natura (Milan), V71, P3; Morri C, 1986, CATALOGUE MAIN MARIN, V7, P1; Morri C, B MUS CIVICO STORIA; Mortensen S, 2000, AQUACULT INT, V8, P267, DOI 10.1023/A:1009287706756; Phillippi AL, 2001, AQUACULTURE, V195, P225, DOI 10.1016/S0044-8486(00)00556-1; Pierri C, 2010, J MAR BIOL ASSOC UK, V90, P159, DOI 10.1017/S0025315409990798; Purcell JE, 2013, WOODHEAD PUBL FOOD S, P404, DOI 10.1533/9780857097460.2.404; Ross KA, 2004, AQUACULTURE, V229, P99, DOI 10.1016/S0044-8486(03)00328-4; Ruane N. M., 2012, FISH VET J, V13, P17; SANDIFER PA, 1974, AQUACULTURE, V4, P55, DOI 10.1016/0044-8486(74)90018-0; Scardino AJ, 2004, BIOFOULING, V20, P249, DOI 10.1080/08927010400016608; Sievers M, 2014, BIOFOULING, V30, P203, DOI 10.1080/08927014.2013.856888; Stachowitsch M, 2002, MAR POLLUT BULL, V44, P853, DOI 10.1016/S0025-326X(02)00085-1; Standing J.D., 1976, P155; SUTHERLAND JP, 1977, ECOL MONOGR, V47, P425, DOI 10.2307/1942176; Tan CKF, 2002, AQUACULTURE, V210, P49, DOI 10.1016/S0044-8486(01)00858-4; Terlizzi A., 2010, BIOFOULING, P170, DOI [10. 1002/9781444315462.ch12, DOI 10.1002/9781444315462.CH12]; Terlizzi A, 2007, MAR ECOL PROG SER, V332, P25, DOI 10.3354/meps332025; Underwood AJ, 2006, J EXP MAR BIOL ECOL, V330, P221, DOI 10.1016/j.jembe.2005.12.029; Willemsen P., 2005, EUR AQUACULT SOC SPE, V35, P82; Woods CMC, 2012, AQUACULT INT, V20, P537, DOI 10.1007/s10499-011-9484-2	83	14	14	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2018	13	4							e0195352	10.1371/journal.pone.0195352	http://dx.doi.org/10.1371/journal.pone.0195352			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB3VV	29608614	gold, Green Published, Green Submitted			2022-12-26	WOS:000428988800047
